PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Goelman, G; Gordon, N; Bonne, O				Goelman, Gadi; Gordon, Noam; Bonne, Omer			Maximizing Negative Correlations in Resting-State Functional Connectivity MRI by Time-Lag	PLOS ONE			English	Article							BOLD RESPONSES; DEFAULT-MODE; STRESS RESILIENCE; NEURONAL-ACTIVITY; NEURAL ORIGIN; GLOBAL SIGNAL; HUMAN BRAIN; BLOOD-FLOW; NETWORKS; FLUCTUATIONS	This paper aims to better understand the physiological meaning of negative correlations in resting state functional connectivity MRI (r-fcMRI). The correlations between anatomy-based brain regions of 18 healthy humans were calculated and analyzed with and without a correction for global signal and with and without spatial smoothing. In addition, correlations between anatomy-based brain regions of 18 naive anesthetized rats were calculated and compared to the human data. T-statistics were used to differentiate between positive and negative connections. The application of spatial smoothing and global signal correction increased the number of significant positive connections but their effect on negative connections was complex. Positive connections were mainly observed between cortical structures while most negative connections were observed between cortical and non-cortical structures with almost no negative connections between non-cortical structures. In both human and rats, negative connections were never observed between bilateral homologous regions. The main difference between positive and negative connections in both the human and rat data was that positive connections became less significant with time-lags, while negative connections became more significant with time-lag. This effect was evident in all four types of analyses (with and without global signal correction and spatial smoothing) but was most significant in the analysis with no correction for the global signal. We hypothesize that the valence of r-fcMRI connectivity reflects the relative contributions of cerebral blood volume (CBV) and flow (CBF) to the BOLD signal and that these relative contributions are location-specific. If cerebral circulation is primarily regulated by CBF in one region and by CBV in another, a functional connection between these regions can manifest as an r-fcMRI negative and time-delayed correlation. Similarly, negative correlations could result from spatially inhomogeneous responses of rCBV or rCBF alone. Consequently, neuronal regulation of brain circulation may be deduced from the valence of r-fcMRI connectivity.	[Goelman, Gadi; Gordon, Noam] Hadassah Hebrew Univ, Med Ctr, Human Biol Res Ctr, Dept Med Biophys,MRI MRS Lab, Jerusalem, Israel; [Bonne, Omer] Hadassah Hebrew Univ, Med Ctr, Dept Psychiat, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Goelman, G (corresponding author), Hadassah Hebrew Univ, Med Ctr, Human Biol Res Ctr, Dept Med Biophys,MRI MRS Lab, Jerusalem, Israel.	gadig@hadassah.org.il			Israel Ministry of Health under the Era-Net-Neuron program [8430]; Israeli Ministry of Science [3-9814]	Israel Ministry of Health under the Era-Net-Neuron program; Israeli Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel)	Funding was provided by Israel Ministry of Health grant number 8430 under the Era-Net-Neuron program and the Israeli Ministry of Science grant number 3-9814. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arichi T, 2012, NEUROIMAGE, V63, P663, DOI 10.1016/j.neuroimage.2012.06.054; Bianciardi M, 2011, J CEREBR BLOOD F MET, V31, P401, DOI 10.1038/jcbfm.2010.164; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; Carbonell F, 2011, BRAIN CONNECT, V1, P496, DOI 10.1089/brain.2011.0065; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Chai XQJ, 2011, NEUROPSYCHOPHARMACOL, V36, P2009, DOI 10.1038/npp.2011.88; Chang C, 2010, FILM COMMENT, V46, P81; Chen YI, 2010, DEV NEUROSCI-BASEL, V32, P125, DOI 10.1159/000286215; Choi JK, 2010, PSYCHOPHARMACOLOGY, V212, P59, DOI 10.1007/s00213-010-1924-6; Choi JK, 2006, NEUROIMAGE, V30, P700, DOI 10.1016/j.neuroimage.2005.10.029; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Devor A, 2007, J NEUROSCI, V27, P4452, DOI 10.1523/JNEUROSCI.0134-07.2007; Easton N, 2009, NEUROPHARMACOLOGY, V57, P653, DOI 10.1016/j.neuropharm.2009.08.018; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Goelman G, 2014, EUR J NEUROSCI; Goense J, 2012, NEURON, V76, P629, DOI 10.1016/j.neuron.2012.09.019; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Grimm S, 2009, NEUROPSYCHOPHARMACOL, V34, P932, DOI 10.1038/npp.2008.81; Kalthoff D, 2013, NMR BIOMED, V26, P638, DOI 10.1002/nbm.2908; Kastrup A, 2008, NEUROIMAGE, V41, P1364, DOI 10.1016/j.neuroimage.2008.03.049; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Kobayashi E, 2006, HUM BRAIN MAPP, V27, P488, DOI 10.1002/hbm.20193; Liu XA, 2011, CEREB CORTEX, V21, P374, DOI 10.1093/cercor/bhq105; Lotan A, 2014, MOL PSYCHIATR, V19, P243, DOI 10.1038/mp.2013.123; Lotan A, 2014, MOL PSYCHIATR, V19, P144, DOI 10.1038/mp.2013.191; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Mueggler T, 2011, EUR NEUROPSYCHOPHARM, V21, P344, DOI 10.1016/j.euroneuro.2010.06.010; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nakata H, 2009, NEUROSCI LETT, V462, P101, DOI 10.1016/j.neulet.2009.06.088; Northoff G, 2007, NAT NEUROSCI, V10, P1515, DOI 10.1038/nn2001; Pasley BN, 2007, NEUROIMAGE, V36, P269, DOI 10.1016/j.neuroimage.2006.09.015; Paxinos G., 2007, RAT BRAIN STEREOTACT; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Schridde U, 2008, CEREB CORTEX, V18, P1814, DOI 10.1093/cercor/bhm208; Sforazzini F, 2014, NEUROIMAGE, V87, P403, DOI 10.1016/j.neuroimage.2013.09.050; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Shih YYI, 2009, J NEUROSCI, V29, P3036, DOI 10.1523/JNEUROSCI.3447-08.2009; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Smith AT, 2004, HUM BRAIN MAPP, V21, P213, DOI 10.1002/hbm.20017; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wang K, 2011, NMR BIOMED, V24, P61, DOI 10.1002/nbm.1556; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zong XP, 2012, NEUROIMAGE, V60, P2238, DOI 10.1016/j.neuroimage.2012.02.052; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	58	30	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e111554	10.1371/journal.pone.0111554	http://dx.doi.org/10.1371/journal.pone.0111554			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396416	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558500019
J	Hormann, N; Brandao, I; Jackel, S; Ens, N; Lillich, M; Walter, U; Reinhardt, C				Hoermann, Nives; Brandao, Ines; Jaeckel, Sven; Ens, Nelli; Lillich, Maren; Walter, Ulrich; Reinhardt, Christoph			Gut Microbial Colonization Orchestrates TLR2 Expression, Signaling and Epithelial Proliferation in the Small Intestinal Mucosa	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; INNATE IMMUNITY; GERM-FREE; CELLS; MICE; RECOGNITION; MICROFLORA; COMMENSAL; PATHWAY; TRIF	The gut microbiota is an environmental factor that determines renewal of the intestinal epithelium and remodeling of the intestinal mucosa. At present, it is not resolved if components of the gut microbiota can augment innate immune sensing in the intestinal epithelium via the up-regulation of Toll-like receptors (TLRs). Here, we report that colonization of germ-free (GF) Swiss Webster mice with a complex gut microbiota augments expression of TLR2. The microbiota-dependent upregulation of components of the TLR2 signaling complex could be reversed by a 7 day broad-spectrum antibiotic treatment. TLR2 downstream signaling via the mitogen-activated protein kinase (ERK1/2) and protein-kinase B (AKT) induced by bacterial TLR2 agonists resulted in increased proliferation of the small intestinal epithelial cell line MODE-K. Mice that were colonized from birth with a normal gut microbiota (conventionally-raised; CONV-R) showed signs of increased small intestinal renewal and apoptosis compared with GF controls as indicated by elevated mRNA levels of the proliferation markers Ki67 and Cyclin D1, elevated transcripts of the apoptosis marker Caspase-3 and increased numbers of TUNEL-positive cells per intestinal villus structure. In accordance, TLR2-deficient mice showed reduced proliferation and reduced apoptosis. Our findings suggest that a tuned proliferation response of epithelial cells following microbial colonization could aid to protect the host from its microbial colonizers and increase intestinal surface area.	[Hoermann, Nives; Brandao, Ines; Jaeckel, Sven; Ens, Nelli; Lillich, Maren; Walter, Ulrich; Reinhardt, Christoph] Univ Med Ctr Mainz, Ctr Thrombosis & Hemostasis, Jr Grp Translat Res Thrombosis & Hemostasis, Mainz, Germany	Johannes Gutenberg University of Mainz	Reinhardt, C (corresponding author), Univ Med Ctr Mainz, Ctr Thrombosis & Hemostasis, Jr Grp Translat Res Thrombosis & Hemostasis, Mainz, Germany.	Christoph.Reinhardt@unimedizin-mainz.de	Walter, ulrich/W-2478-2017; Brandão, Inês/Y-4252-2019	Walter, ulrich/0000-0001-6784-2307; Brandão, Inês/0000-0003-3767-9515	EU Reintegration Grant [PERG05-GA-2009-249313]; Universitatsbund Wurzburg; Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich 688]; DFG Individual Grants [RE 3450/3-1, RE 3450/5-1]; Stiftung Pathobiochemie; Molekulare Diagnostik; German Federal Ministry for Education and Research (CTH, Junior Group, TRP A6) [BMBF 01EO1003]; Center for Thrombosis and Hemostasis (CTH) Doctoral Candidate Fellowship [BMBF 01EO1003]	EU Reintegration Grant; Universitatsbund Wurzburg; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG Individual Grants; Stiftung Pathobiochemie; Molekulare Diagnostik; German Federal Ministry for Education and Research (CTH, Junior Group, TRP A6); Center for Thrombosis and Hemostasis (CTH) Doctoral Candidate Fellowship	This project was funded by an EU Reintegration Grant PERG05-GA-2009-249313 to Christoph Reinhardt, a project grant of the Universitatsbund Wurzburg to C.R., TP A2 of the Sonderforschungsbereich 688 of the Deutsche Forschungsgemeinschaft (DFG) to U.W., DFG Individual Grants to C.R. (RE 3450/3-1; RE 3450/5-1), a project grant from the Stiftung Pathobiochemie and Molekulare Diagnostik to C.R., and the German Federal Ministry for Education and Research (CTH, Junior Group, TRP A6, BMBF 01EO1003). N.H. was an associated member of GRK 1043 - DFG Graduate School of Immunotherapy and received a Center for Thrombosis and Hemostasis (CTH) Doctoral Candidate Fellowship (BMBF 01EO1003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS GD, 1963, LAB INVEST, V12, P355; Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Caricilli AM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001212; Cario E, 2002, AM J PATHOL, V160, P165, DOI 10.1016/S0002-9440(10)64360-X; Cherbuy C, 2010, AM J PHYSIOL-GASTR L, V299, pG348, DOI 10.1152/ajpgi.00384.2009; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Fuller Z, 2007, BRIT J NUTR, V98, P364, DOI 10.1017/S0007114507709091; Gao QX, 2012, MOL CELL BIOCHEM, V361, P31, DOI 10.1007/s11010-011-1084-y; Goke M, 1998, GASTROENTEROLOGY, V114, P697, DOI 10.1016/S0016-5085(98)70583-9; Hanson PJ, 2011, INNATE IMMUN-LONDON, V17, P269, DOI 10.1177/1753425910367813; Hornef MW, 2002, J EXP MED, V195, P559, DOI 10.1084/jem.20011788; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Ji YW, 2014, CELL REP, V8, P137, DOI 10.1016/j.celrep.2014.05.040; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Kaczmarek A, 2012, J PATHOL, V226, P598, DOI 10.1002/path.3009; Kamada N, 2013, NAT IMMUNOL, V14, P685, DOI 10.1038/ni.2608; Lundin A, 2008, CELL MICROBIOL, V10, P1093, DOI 10.1111/j.1462-5822.2007.01108.x; Nigro G, 2014, CELL HOST MICROBE, V15, P792, DOI 10.1016/j.chom.2014.05.003; Ortega-Cava CF, 2003, J IMMUNOL, V170, P3977, DOI 10.4049/jimmunol.170.8.3977; Otte JM, 2004, GASTROENTEROLOGY, V126, P1054, DOI 10.1053/j.gastro.2004.01.007; Ouyang XS, 2007, BIOCHEM BIOPH RES CO, V354, P1045, DOI 10.1016/j.bbrc.2007.01.090; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Petnicki-Ocwieja T, 2013, INFECT IMMUN, V81, P402, DOI 10.1128/IAI.00890-12; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reinhardt C, 2012, NATURE, V483, P627, DOI 10.1038/nature10893; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; SAVAGE DC, 1981, APPL ENVIRON MICROB, V42, P996, DOI 10.1128/AEM.42.6.996-1001.1981; Shaykhiev R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001393; Sheng H, 2003, GUT, V52, P1472, DOI 10.1136/gut.52.10.1472; Sommer F, 2015, MUCOSAL IMMUNOL, V8, P372, DOI 10.1038/mi.2014.74; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Tomas J, 2015, ISME J, V9, P46, DOI 10.1038/ismej.2014.111; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; VIDAL K, 1993, J IMMUNOL METHODS, V166, P63, DOI 10.1016/0022-1759(93)90329-6; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200	37	71	72	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113080	10.1371/journal.pone.0113080	http://dx.doi.org/10.1371/journal.pone.0113080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396415	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500130
J	Li, JJ; Wei, F; Chen, JG; Yu, YW; Gu, HY; Jiang, R; Wu, XL; Sun, Q				Li, Jing-Jie; Wei, Fang; Chen, Ju-Gang; Yu, Yan-Wei; Gu, Hong-Yue; Jiang, Rui; Wu, Xiu-Li; Sun, Qian			Assessment of Atrial Fibrillation and Vulnerability in Patients with Wolff-Parkinson-White Syndrome Using Two-Dimensional Speckle Tracking Echocardiography	PLOS ONE			English	Article							ELECTROPHYSIOLOGICAL CHARACTERISTICS; ACCESSORY PATHWAY; CATHETER ABLATION; RISK; TACHYCARDIA; MECHANISMS; MORTALITY; IMPACT	Purpose: The aim was to assess atrial fibrillation (AF) and vulnerability in Wolff-Parkinson-White (WPW) syndrome patients using two-dimensional speckle tracking echocardiography (2D-STE). Methods: All patients were examined via transthoracic echocardiography and 2D-STE in order to assess atrial function 7 days before and 10 days after RF catheter ablation. A postoperative 3-month follow-up was performed via outpatient visit or telephone calls. Results: Results showed significant differences in both body mass index (BMI) and supraventricular tachycardia (SVT) duration between WPW patients and DAVNP patients (both P<0.05). Echocardiography revealed that the maximum left atrial volume (LAV(max)) and the left ventricular mass index (LVMI) in diastole increased noticeably in patients with WPW compared to patients with DAVNP both before and after ablation (all P<0.05). Before ablation, there were obvious differences in the levels of SRs, SRe, and SRa from the 4-chamber view (LA) in the WPW patients group compared with patients in the DAVNP group (all P<0.05). In the AF group, there were significant differences in the levels of systolic strain rate (SRs), early diastolic strain rate (SRe), and late diastolic strain rate (SRa) from the 4-chamber view (LA) both before and after ablation (all P<0.05). In the non-AF group, there were decreased SRe levels from the 4-chamber view (LA/RA) pre-ablation compared to post-ablation (all P<0.05). Conclusion: Our findings provide convincing evidence that WPW syndrome may result in increased atrial vulnerability and contribute to the development of AF. Further, RF catheter ablation of AAV pathway can potentially improve atrial function in WPW syndrome patients. Two-dimensional speckle tracking echocardiography imaging in WPW patients would be necessary in the evaluation and improvement of the overall function of RF catheter ablation in a long-term follow-up period.	[Li, Jing-Jie; Chen, Ju-Gang; Yu, Yan-Wei; Gu, Hong-Yue; Jiang, Rui; Wu, Xiu-Li; Sun, Qian] Harbin Med Univ, Affiliated Hosp 1, Dept Cardiol, Harbin, Peoples R China; [Wei, Fang] Taiyuan Iron & Steel Co, Gen Hosp, Dept Cardiol, Taiyuan, Peoples R China	Harbin Medical University	Gu, HY (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Cardiol, Harbin, Peoples R China.	guhongyue218@126.com			Natural Science Foundation of Heilongjiang Province [D201285]; Post-doctoral research starting capital of Heilongjiang Province [LBH-Q12035]	Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Post-doctoral research starting capital of Heilongjiang Province	This study was funded by Natural Science Foundation of Heilongjiang Province No. (D201285) and Post-doctoral research starting capital of Heilongjiang Province No.(LBH-Q12035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldhoon B, 2010, PHYSIOL RES, V59, P1, DOI 10.33549/physiolres.931651; Ball J, 2013, INT J CARDIOL, V167, P1807, DOI 10.1016/j.ijcard.2012.12.093; Blessberger H, 2010, HEART, V96, P716, DOI 10.1136/hrt.2007.141002; Cai QJ, 2012, INT J CARDIOVAS IMAG, V28, P725, DOI 10.1007/s10554-011-9880-8; Cappato R, 2010, CIRC-ARRHYTHMIA ELEC, V3, P32, DOI 10.1161/CIRCEP.109.859116; Centurion OA, 2008, EUROPACE, V10, P292, DOI 10.1093/europace/eun031; Christophersen IE, 2013, CIRC-ARRHYTHMIA ELEC, V6, P10, DOI 10.1161/CIRCEP.112.971580; de Veire NRV, 2008, HEART, V94, P1065, DOI [10.1136/hrt.2007.120758, 10.1136/hrt.2006.099424corr1]; DELLABELLA P, 1991, J AM COLL CARDIOL, V17, P1352, DOI 10.1016/S0735-1097(10)80146-9; Disertori M, 2009, NEW ENGL J MED, V360, P1606, DOI 10.1056/NEJMoa0805710; Emkanjoo Z, 2010, INT J CARDIOL, V142, P196, DOI 10.1016/j.ijcard.2008.11.114; Erdem Alim, 2010, Indian Pacing Electrophysiol J, V10, P195; Cianciulli TF, 2010, WORLD J CARDIOL, V2, P163, DOI 10.4330/wjc.v2.i7.163; Friberg L, 2013, J Intern Med, V274, P461, DOI 10.1111/joim.12114; Geyer H, 2010, J AM SOC ECHOCARDIOG, V23, P351, DOI 10.1016/j.echo.2010.02.015; Hogarth AJ, 2013, J HUM HYPERTENS, V27, P707, DOI 10.1038/jhh.2013.75; Huang YC, 2013, J CARDIOVASC ELECTR, V24, P1306, DOI 10.1111/jce.12177; Katritsis DG, 2013, EUROPACE, V15, P779, DOI 10.1093/europace/eus374; Kim HK, 2007, J AM SOC ECHOCARDIOG, V20, P45, DOI 10.1016/j.echo.2006.07.007; Kroesen Michiel, 2012, J Pediatr Pharmacol Ther, V17, P93, DOI 10.5863/1551-6776-17.1.93; Lalani SR, 2009, J MED GENET, V46, P168, DOI 10.1136/jmg.2008.061002; Li CH, 2011, J CARDIOVASC ELECTR, V22, P274, DOI 10.1111/j.1540-8167.2010.01906.x; Lim PB, 2011, J CARDIOVASC ELECTR, V22, P638, DOI 10.1111/j.1540-8167.2010.01992.x; Liu XP, 2010, J CARDIOVASC ELECTR, V21, P1024, DOI 10.1111/j.1540-8167.2010.01746.x; Lubitz SA, 2010, CIRC-ARRHYTHMIA ELEC, V3, P291, DOI 10.1161/CIRCEP.110.942441; Mah DY, 2013, PACE, V36, P1117, DOI 10.1111/pace.12144; Mase M, 2012, AM J PHYSIOL-HEART C, V303, pH1219, DOI 10.1152/ajpheart.00228.2012; Nattel S, 2008, CIRC-ARRHYTHMIA ELEC, V1, P62, DOI 10.1161/CIRCEP.107.754564; Oakes RS, 2009, CIRCULATION, V119, P1758, DOI 10.1161/CIRCULATIONAHA.108.811877; Obeyesekere M, 2012, CIRCULATION, V125, P659, DOI 10.1161/CIRCULATIONAHA.111.085159; Oddsson H, 2002, EUROPACE, V4, P201, DOI 10.1053/eupc.2002.0223; Pappone C, 2012, CIRCULATION, V125, P661, DOI 10.1161/CIRCULATIONAHA.111.065722; Patel Sandeep M, 2011, Indian Pacing Electrophysiol J, V11, P43; Piccini JP, 2012, CIRC-CARDIOVASC QUAL, V5, P85, DOI 10.1161/CIRCOUTCOMES.111.962688; Pinho-Gomes AC, 2013, ANTIOXID REDOX SIGNA; Rentschler S, 2011, J CLIN INVEST, V121, P525, DOI 10.1172/JCI44470; Roberts JD, 2010, J AM COLL CARDIOL, V55, P705, DOI 10.1016/j.jacc.2009.12.005; Rosner MH, 1999, AM J EMERG MED, V17, P705, DOI 10.1016/S0735-6757(99)90167-5; Schnabel RB, 2010, CIRCULATION, V121, P200, DOI 10.1161/CIRCULATIONAHA.109.882241; Takahashi K, 2013, J ELECTROCARDIOL, V46, P663, DOI 10.1016/j.jelectrocard.2013.01.007	40	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e108315	10.1371/journal.pone.0108315	http://dx.doi.org/10.1371/journal.pone.0108315			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397668	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558500001
J	Nielsen, DE; El-Sohemy, A				Nielsen, Daiva E.; El-Sohemy, Ahmed			Disclosure of Genetic Information and Change in Dietary Intake: A Randomized Controlled Trial	PLOS ONE			English	Article							PERSONALIZED NUTRITION; SALT SENSITIVITY; CHRONIC DISEASES; CYP1A2 GENOTYPE; RISK; INTERVENTIONS; NUTRIGENOMICS; INDIVIDUALS; ASSOCIATION; CONSUMPTION	Background: Proponents of consumer genetic tests claim that the information can positively impact health behaviors and aid in chronic disease prevention. However, the effects of disclosing genetic information on dietary intake behavior are not clear. Methods: A double-blinded, parallel group, 2:1 online randomized controlled trial was conducted to determine the short-and long-term effects of disclosing nutrition-related genetic information for personalized nutrition on dietary intakes of caffeine, vitamin C, added sugars, and sodium. Participants were healthy men and women aged 20-35 years (n = 138). The intervention group (n = 92) received personalized DNA-based dietary advice for 12-months and the control group (n = 46) received general dietary recommendations with no genetic information for 12-months. Food frequency questionnaires were collected at baseline and 3- and 12-months after the intervention to assess dietary intakes. General linear models were used to compare changes in intakes between those receiving general dietary advice and those receiving DNA-based dietary advice. Results: Compared to the control group, no significant changes to dietary intakes of the nutrients were observed at 3-months. At 12-months, participants in the intervention group who possessed a risk version of the ACE gene, and were advised to limit their sodium intake, significantly reduced their sodium intake (mg/day) compared to the control group (-287.3 +/- 114.1 vs. 129.8 +/- 118.2, p = 0.008). Those who had the non-risk version of ACE did not significantly change their sodium intake compared to the control group (12-months: -244.2 +/- 150.2, p = 0.11). Among those with the risk version of the ACE gene, the proportion who met the targeted recommendation of 1500 mg/day increased from 19% at baseline to 34% after 12 months (p = 0.06). Conclusions: These findings demonstrate that disclosing genetic information for personalized nutrition results in greater changes in intake for some dietary components compared to general population-based dietary advice.	[Nielsen, Daiva E.; El-Sohemy, Ahmed] Univ Toronto, Dept Nutr Sci, Toronto, ON M5S 3E2, Canada	University of Toronto	El-Sohemy, A (corresponding author), Univ Toronto, Dept Nutr Sci, 150 Coll St, Toronto, ON M5S 3E2, Canada.	a.el.sohemy@utoronto.ca	Nielsen, Daiva/AAT-5028-2020; Nielsen, Daiva/ACI-1414-2022	Nielsen, Daiva/0000-0002-4265-5748; El-Sohemy, Ahmed/0000-0002-8877-6414	Advanced Foods and Materials Network (AFMNet); Canadian Institutes of Health Research (CIHR) [MOP-89829]; Ontario Graduate Scholarship; Banting & Best Diabetes Centre Graduate Studentship	Advanced Foods and Materials Network (AFMNet); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Banting & Best Diabetes Centre Graduate Studentship	This study was supported by a grant from the Advanced Foods and Materials Network (AFMNet) and the Canadian Institutes of Health Research (CIHR; MOP-89829). AE-S holds a Canada Research Chair in Nutrigenomics. DEN is a recipient of an Ontario Graduate Scholarship and a Banting & Best Diabetes Centre Graduate Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkadianos I, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-29; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Bloss CS, 2011, PERS MED, V8, P659, DOI 10.2217/PME.11.73; Bloss CS, 2011, NEW ENGL J MED, V364, P524, DOI 10.1056/NEJMoa1011893; Cahill LE, 2009, AM J CLIN NUTR, V90, P1411, DOI 10.3945/ajcn.2009.28327; Caulfield T, 2012, ANNU REV MED, V63, P23, DOI 10.1146/annurev-med-062110-123753; Chao S, 2008, ALZ DIS ASSOC DIS, V22, P94, DOI 10.1097/WAD.0b013e31815a9dcc; Cherkas LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013473; Christensen KD, 2013, PERS MED, V10, P377, DOI [10.2217/PME.13.24, 10.2217/pme.13.24]; Collier R, 2012, CAN MED ASSOC J, V184, pE407, DOI 10.1503/cmaj.109-4157; Cornelis MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002033; Cornelis MC, 2006, JAMA-J AM MED ASSOC, V295, P1135, DOI 10.1001/jama.295.10.1135; Desroches S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-111; Eny KM, 2010, AM J CLIN NUTR, V92, P1501, DOI 10.3945/ajcn.2010.29836; Eny KM, 2009, J NUTRIGENET NUTRIGE, V2, P235, DOI 10.1159/000276991; Ferguson LR, 2012, NUTR DIET, V69, P198, DOI 10.1111/j.1747-0080.2012.01623.x; Giner V, 2000, HYPERTENSION, V35, P512, DOI 10.1161/01.HYP.35.1.512; Goddard KAB, 2009, AM J PUBLIC HEALTH, V99, P442, DOI 10.2105/AJPH.2007.131631; Gollust SE, 2012, PUBLIC HEALTH GENOM, V15, P22, DOI 10.1159/000327296; Grant RW, 2013, DIABETES CARE, V36, P13, DOI 10.2337/dc12-0884; Green ED, 2011, NATURE, V470, P204, DOI 10.1038/nature09764; Hamza TH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002237; He J, 2013, CIRC-CARDIOVASC GENE, V6, P598, DOI 10.1161/CIRCGENETICS.113.000307; Institute of Medicine, 2013, SOD INT POP ASS EV; Kaput J, 2008, CURR OPIN BIOTECH, V19, P110, DOI 10.1016/j.copbio.2008.02.005; Kaufman DJ, 2012, J GENET COUNS, V21, P413, DOI 10.1007/s10897-012-9483-0; Kolor K, 2012, GENET MED, V14, P860, DOI 10.1038/gim.2012.67; Leighton JW, 2012, PUBLIC HEALTH GENOM, V15, P11, DOI 10.1159/000327159; Maher B, 2011, NATURE, V478, P19, DOI 10.1038/478019a; Marteau TM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007275.pub2; McBride CM, 2012, AM J PUBLIC HEALTH, V102, P401, DOI 10.2105/AJPH.2011.300513; McBride CM, 2010, ANNU REV PUBL HEALTH, V31, P89, DOI 10.1146/annurev.publhealth.012809.103532; National Research Council, 2006, DIETARY REFERENCE IN; Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840; Nielsen DE, 2012, PERS MED, V9, P739, DOI [10.2217/pme.12.79, 10.2217/PME.12.79]; Nielsen DE, 2012, GENES NUTR, V7, P559, DOI 10.1007/s12263-012-0290-x; Nishida C, 2004, PUBLIC HEALTH NUTR, V7, P245, DOI 10.1079/PHN2003592; Palatini P, 2009, J HYPERTENS, V27, P1594, DOI 10.1097/HJH.0b013e32832ba850; Poch E, 2001, HYPERTENSION, V38, P1204, DOI 10.1161/hy1101.099479; Stewart-Knox BJ, 2009, BRIT J NUTR, V101, P982, DOI 10.1017/S0007114508055657; Wesselius A, 2013, OA EPIDEMIOLOGY, V1, P4	41	80	82	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112665	10.1371/journal.pone.0112665	http://dx.doi.org/10.1371/journal.pone.0112665			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398084	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558500072
J	Wannhoff, A; Muller, OJ; Friedrich, K; Rupp, C; Kloters-Plachky, P; Leopold, Y; Brune, M; Senner, M; Weiss, KH; Stremmel, W; Schemmer, P; Katus, HA; Gotthardt, DN				Wannhoff, Andreas; Mueller, Oliver J.; Friedrich, Kilian; Rupp, Christian; Kloeters-Plachky, Petra; Leopold, Yvonne; Brune, Maik; Senner, Mirja; Weiss, Karl-Heinz; Stremmel, Wolfgang; Schemmer, Peter; Katus, Hugo A.; Gotthardt, Daniel N.			Effects of Increased Von Willebrand Factor Levels on Primary Hemostasis in Thrombocytopenic Patients with Liver Cirrhosis	PLOS ONE			English	Article							PLATELET-FUNCTION ANALYZER; BLEEDING-TIME; DISEASE; DESMOPRESSIN; PFA-100(TM); THROMBOSIS; ADHESION; MARKER; RISK	In patients with liver cirrhosis procoagulant and anticoagulant changes occur simultaneously. During primary hemostasis, platelets adhere to subendothelial structures, via von Willebrand factor (vWF). We aimed to investigate the influence of vWF on primary hemostasis in patients with liver cirrhosis. Therefore we assessed in-vitro bleeding time as marker of primary hemostasis in cirrhotic patients, measuring the Platelet Function Analyzer (PFA-100) closure times with collagen and epinephrine (Col-Epi, upper limit of normal <= 165 s) or collagen and ADP (Col-ADP, upper limit of normal <= 118 s). If Col-Epi and Col-ADP were prolonged, the PFA-100 was considered to be pathological. Effects of vWF on primary hemostasis in thrombocytopenic patients were analyzed and plasma vWF levels were modified by adding recombinant vWF or anti-vWF antibody. Of the 72 included cirrhotic patients, 32 (44.4%) showed a pathological result for the PFA-100. They had mean closure times (+/- SD) of 180 +/- 62 s with Col-Epi and 160 +/- 70 s with Col-ADP. Multivariate analysis revealed that hematocrit (P = 0.027) and vWF-antigen levels (P = 0.010) are the predictors of a pathological PFA-100 test in cirrhotic patients. In 21.4% of cirrhotic patients with platelet count >= 150/nL and hematocrit >= 27.0%, pathological PFA-100 results were found. In thrombocytopenic (<150/nL) patients with cirrhosis, normal PFA-100 results were associated with higher vWF-antigen levels (462.3 +/- 235.9% vs. 338.7 +/- 151.6%, P = 0.021). These results were confirmed by multivariate analysis in these patients as well as by adding recombinant vWF or polyclonal anti-vWF antibody that significantly shortened or prolonged closure times, respectively. In conclusion, primary hemostasis is impaired in cirrhotic patients. The effect of reduced platelet count in cirrhotic patients can at least be partly compensated by increased vWF levels. Recombinant vWF could be an alternative to platelet transfusions in the future.	[Wannhoff, Andreas; Friedrich, Kilian; Rupp, Christian; Kloeters-Plachky, Petra; Leopold, Yvonne; Senner, Mirja; Weiss, Karl-Heinz; Stremmel, Wolfgang; Gotthardt, Daniel N.] Univ Heidelberg Hosp, Dept Internal Med 4, Heidelberg, Germany; [Mueller, Oliver J.; Katus, Hugo A.] Univ Heidelberg Hosp, Dept Internal Med 3, Heidelberg, Germany; [Brune, Maik] Univ Heidelberg Hosp, Dept Internal Med & Clin Chem 1, Heidelberg, Germany; [Schemmer, Peter] Univ Heidelberg Hosp, Dept Gen & Transplant Surg, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Gotthardt, DN (corresponding author), Univ Heidelberg Hosp, Dept Internal Med 4, Heidelberg, Germany.	Daniel_Gotthardt@med.uni-heidelberg.de	Müller, Oliver/AAA-4399-2021; Müller, Oliver J./H-4739-2016; Rupp, Christian/E-7652-2019; Weiss, Karl Heinz/AAA-9117-2022	Müller, Oliver/0000-0001-8223-2638; Rupp, Christian/0000-0003-2808-9230; Stremmel, Wolfgang/0000-0002-8545-1753	Dekanat der Medizinischen Fakultat Heidelberg (Medical faculty Heidelberg); Deutsche Forschungsgemeinschaft (German Research Foundation)	Dekanat der Medizinischen Fakultat Heidelberg (Medical faculty Heidelberg); Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	AW received a grant from the Dekanat der Medizinischen Fakultat Heidelberg (Medical faculty Heidelberg). DNG was supported by a grant from Deutsche Forschungsgemeinschaft (German Research Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitrano L, 2004, J HEPATOL, V40, P736, DOI 10.1016/j.jhep.2004.01.001; BURROUGHS AK, 1985, BRIT MED J, V291, P1377, DOI 10.1136/bmj.291.6506.1377; Buyukasik Y, 2002, BLOOD COAGUL FIBRIN, V13, P349, DOI 10.1097/00001721-200206000-00011; Escolar G, 1999, HAEMATOLOGICA, V84, P614; Ferlitsch M, 2012, HEPATOLOGY, V56, P1439, DOI 10.1002/hep.25806; Ferro D, 1996, HEPATOLOGY, V23, P1377, DOI 10.1053/jhep.1996.v23.pm0008675154; Giannini EG, 2008, CURR OPIN HEMATOL, V15, P473, DOI 10.1097/MOH.0b013e32830a9746; Harrison P, 1999, BLOOD COAGUL FIBRIN, V10, P25, DOI 10.1097/00001721-199901000-00004; Haubelt H, 2005, BRIT J HAEMATOL, V130, P759, DOI 10.1111/j.1365-2141.2005.05680.x; Hollestellel MJ, 2004, THROMB HAEMOSTASIS, V91, P267, DOI 10.1160/TH03-05-0310; Horvatits T, 2014, J HEPATOL; KUNDU SK, 1995, SEMIN THROMB HEMOST, V21, P106; La Mura V, 2011, GUT, V60, P1133, DOI 10.1136/gut.2010.235689; LAFFI G, 1992, GASTROENTEROLOGY, V103, P641, DOI 10.1016/0016-5085(92)90859-W; LAFFI G, 1993, GASTROENTEROLOGY, V105, P148, DOI 10.1016/0016-5085(93)90020-D; LAFFI G, 1986, GASTROENTEROLOGY, V90, P274, DOI 10.1016/0016-5085(86)90921-2; Lenting PJ, 2012, J THROMB HAEMOST, V10, P2428, DOI 10.1111/jth.12008; Levy GG, 2005, BLOOD, V106, P11, DOI 10.1182/blood-2004-10-4097; Lisman T, 2006, HEPATOLOGY, V44, P53, DOI 10.1002/hep.21231; Lisman T, 2010, BLOOD, V116, P878, DOI 10.1182/blood-2010-02-261891; Lisman T, 2010, SEMIN THROMB HEMOST, V36, P170, DOI 10.1055/s-0030-1251501; Mammen EF, 1998, SEMIN THROMB HEMOST, V24, P195, DOI 10.1055/s-2007-995840; MANNUCCI PM, 1986, BLOOD, V67, P1148; Mannucci PM, 1998, ARTERIOSCL THROM VAS, V18, P1359, DOI 10.1161/01.ATV.18.9.1359; Mannucci PM, 2001, BLOOD, V98, P2730, DOI 10.1182/blood.V98.9.2730; Pihusch R, 2002, J HEPATOL, V37, P548, DOI 10.1016/S0168-8278(02)00239-8; SAKARIASSEN KS, 1979, NATURE, V279, P636, DOI 10.1038/279636a0; Saner FH, 2013, DIGESTION, V88, P135, DOI 10.1159/000354400; Sogaard KK, 2009, AM J GASTROENTEROL, V104, P96, DOI 10.1038/ajg.2008.34; Tripodi A, 2006, HEPATOLOGY, V44, P440, DOI 10.1002/hep.21266; Tripodi Armando, 2013, Hepatology, V58, P1177, DOI 10.1002/hep.26502; Tripodi A, 2011, NEW ENGL J MED, V365, P147, DOI 10.1056/NEJMra1011170; Da Rocha ECV, 2009, CLIN GASTROENTEROL H, V7, P988, DOI 10.1016/j.cgh.2009.04.019; Violi F, 2011, J HEPATOL, V55, P1415, DOI 10.1016/j.jhep.2011.06.008; Zupan IP, 2003, AM J KIDNEY DIS, V42, P746, DOI 10.1016/S0272-6386(03)00913-2	35	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112583	10.1371/journal.pone.0112583	http://dx.doi.org/10.1371/journal.pone.0112583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397410	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558500063
J	Hirose, T; Hamaguchi, S; Matsumoto, N; Irisawa, T; Seki, M; Tasaki, O; Hosotsubo, H; Yamamoto, N; Yamamoto, K; Akeda, Y; Oishi, K; Tomono, K; Shimazu, T				Hirose, Tomoya; Hamaguchi, Shigeto; Matsumoto, Naoya; Irisawa, Taro; Seki, Masafumi; Tasaki, Osamu; Hosotsubo, Hideo; Yamamoto, Norihisa; Yamamoto, Kouji; Akeda, Yukihiro; Oishi, Kazunori; Tomono, Kazunori; Shimazu, Takeshi			Presence of Neutrophil Extracellular Traps and Citrullinated Histone H3 in the Bloodstream of Critically Ill Patients	PLOS ONE			English	Article							CIRCULATING FREE DNA; CELL-DEATH; ASPIRATION PNEUMONIA; LUNG EPITHELIUM; INNATE IMMUNITY; CF-DNA/NETS; SEPSIS; RECOGNITION; EXPRESSION; NETOSIS	Neutrophil extracellular traps (NETs), a newly identified immune mechanism, are induced by inflammatory stimuli. Modification by citrullination of histone H3 is thought to be involved in the in vitro formation of NETs. The purposes of this study were to evaluate whether NETs and citrullinated histone H3 (Cit-H3) are present in the bloodstream of critically ill patients and to identify correlations with clinical and biological parameters. Blood samples were collected from intubated patients at the time of ICU admission from April to June 2011. To identify NETs, DNA and histone H3 were visualized simultaneously by immunofluorescence in blood smears. Cit-H3 was detected using a specific antibody. We assessed relationships of the presence of NETs and Cit-H3 with the existence of bacteria in tracheal aspirate, SIRS, diagnosis, WBC count, and concentrations of IL-8, TNF-alpha, cf-DNA, lactate, and HMGB1. Forty-nine patients were included. The median of age was 66.0 (IQR: 52.5-76.0) years. The diagnoses included trauma (7, 14.3%), infection (14, 28.6%), resuscitation from cardiopulmonary arrest (8, 16.3%), acute poisoning (4, 8.1%), heart disease (4, 8.1%), brain stroke (8, 16.3%), heat stroke (2, 4.1%), and others (2, 4.1%). We identified NETs in 5 patients and Cit-H3 in 11 patients. NETs and/or Cit-H3 were observed more frequently in "the presence of bacteria in tracheal aspirate'' group (11/22, 50.0%) than in "the absence of bacteria in tracheal aspirate'' group (4/27, 14.8%) (p<.01). Multiple logistic regression analysis showed tht only the presence of bacteria in tracheal aspirate was significantly associated with the presence of NETs and/or Cit-H3. The presence of bacteria in tracheal aspirate may be one important factor associated with NET formation. NETs may play a pivotal role in the biological defense against the dissemination of pathogens from the respiratory tract to the bloodstream in potentially infected patients.	[Hirose, Tomoya; Matsumoto, Naoya; Irisawa, Taro; Hosotsubo, Hideo; Shimazu, Takeshi] Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, Osaka, Japan; [Hamaguchi, Shigeto; Seki, Masafumi; Yamamoto, Norihisa; Tomono, Kazunori] Osaka Univ, Grad Sch Med, Div Infect Control & Prevent, Osaka, Japan; [Tasaki, Osamu] Nagasaki Univ, Grad Sch Biomed Sci, Unit Clin Med, Dept Emergency Med, Nagasaki 852, Japan; [Yamamoto, Kouji] Osaka Univ Hosp, Dept Med Innovat, Osaka 553, Japan; [Akeda, Yukihiro; Oishi, Kazunori] Osaka Univ, Microbial Dis Res Inst, Int Res Ctr Infect Dis, Osaka, Japan	Osaka University; Osaka University; Nagasaki University; Osaka University; Osaka University	Hirose, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, Osaka, Japan.	htomoya1979@hp-emerg.med.osaka-u.ac.jp	はまぐち しげと, 濱口 重人/GQZ-8515-2022	Hamaguchi, Shigeto/0000-0003-2560-9982	Ministry of Education, Culture, Sports, Science and Technology in Japan [21390163, 25293366, 25861718]; ZENKYOREN (National Mutual Insurance Federation of Agricultural Cooperatives)	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ZENKYOREN (National Mutual Insurance Federation of Agricultural Cooperatives)	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology in Japan (no. 21390163, no. 25293366 and no. 25861718) and by ZENKYOREN (National Mutual Insurance Federation of Agricultural Cooperatives). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adnet F, 1996, LANCET, V348, P123, DOI 10.1016/S0140-6736(05)64630-2; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Cho JH, 2005, BLOOD, V106, P2551, DOI 10.1182/blood-2005-02-0530; Curran CS, 2006, CELL IMMUNOL, V242, P23, DOI 10.1016/j.cellimm.2006.08.006; Evans SE, 2010, ANNU REV PHYSIOL, V72, P413, DOI 10.1146/annurev-physiol-021909-135909; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Gupta AK, 2005, HUM IMMUNOL, V66, P1146, DOI 10.1016/j.humimm.2005.11.003; Gupta AK, 2010, FEBS LETT, V584, P3193, DOI 10.1016/j.febslet.2010.06.006; Hamaguchi S, 2013, J INT MED RES, V41, P162, DOI 10.1177/0300060513475958; Hippenstiel S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-97; Hiraiwa K, 2014, LUNG INFLAMMATION; Hirose T, 2012, AM J RESP CRIT CARE, V185, P1130, DOI 10.1164/ajrccm.185.10.1130; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Kamat AA, 2006, CANCER BIOL THER, V5, P1369, DOI 10.4161/cbt.5.10.3240; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Lekstrom-Himes JA, 2000, NEW ENGL J MED, V343, P1703, DOI 10.1056/NEJM200012073432307; Logters T, 2009, MED MICROBIOL IMMUN, V198, P211, DOI 10.1007/s00430-009-0121-x; Logters T, 2009, J ORTHOP RES, V27, P1401, DOI 10.1002/jor.20911; Margraf S, 2008, SHOCK, V30, P352, DOI 10.1097/SHK.0b013e31816a6bb1; Marik PE, 2001, NEW ENGL J MED, V344, P665, DOI 10.1056/NEJM200103013440908; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; McDonald B, 2012, CELL HOST MICROBE, V12, P324, DOI 10.1016/j.chom.2012.06.011; Mitroulis I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029318; Mitsushima H, 2002, MICROB PATHOGENESIS, V33, P203, DOI 10.1006/mpat.2002.0529; Neeli I, 2008, J IMMUNOL, V180, P1895, DOI 10.4049/jimmunol.180.3.1895; Pittet JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063907; Remijsen Q, 2011, CELL DEATH DIFFER, V18, P581, DOI 10.1038/cdd.2011.1; Savchenko AS, 2011, PATHOL INT, V61, P290, DOI 10.1111/j.1440-1827.2011.02651.x; Sousa S, 2005, CURR OPIN CELL BIOL, V17, P489, DOI 10.1016/j.ceb.2005.08.013; Sozzi G, 2003, J CLIN ONCOL, V21, P3902, DOI 10.1200/JCO.2003.02.006; Swarup V, 2007, FEBS LETT, V581, P795, DOI 10.1016/j.febslet.2007.01.051; Tadie JM, 2013, AM J PHYSIOL-LUNG C, V304, pL342, DOI 10.1152/ajplung.00151.2012; Thijssen MAMA, 2002, ANTICANCER RES, V22, P421; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; van der Vaart M, 2007, CLIN CHEM, V53, P2215, DOI 10.1373/clinchem.2007.092734; Vitkov L, 2009, J PERIODONTAL RES, V44, P664, DOI 10.1111/j.1600-0765.2008.01175.x; Wang H, 2004, J INTERN MED, V255, P320, DOI 10.1111/j.1365-2796.2003.01302.x; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847; Zhang LT, 2008, SHOCK, V29, P278, DOI 10.1097/shk.0b013e31811ff581	45	76	79	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e111755	10.1371/journal.pone.0111755	http://dx.doi.org/10.1371/journal.pone.0111755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392950	gold, Green Published, Green Submitted			2022-12-27	WOS:000347709300022
J	Lenz, A; Toren-Haritan, G; Efrat, S				Lenz, Ayelet; Toren-Haritan, Ginat; Efrat, Shimon			Redifferentiation of Adult Human beta Cells Expanded In Vitro by Inhibition of the WNT Pathway	PLOS ONE			English	Article							COLORECTAL-CANCER CELLS; MESENCHYMAL TRANSITION; C-MYC; PROLIFERATION; CATENIN; TRANSCRIPTION; TARGET; GROWTH; GENE; DEDIFFERENTIATION	In vitro expansion of adult human islet beta cells is an attractive solution for the shortage of tissue for cell replacement therapy of type 1 diabetes. Using a lineage tracing approach we have demonstrated that beta-cell-derived (BCD) cells rapidly dedifferentiate in culture and can proliferate for up to 16 population doublings. Dedifferentiation is associated with changes resembling epithelial-mesenchymal transition (EMT). The WNT pathway has been shown to induce EMT and plays key roles in regulating replication and differentiation in many cell types. Here we show that BCD cell dedifferentiation is associated with beta-catenin translocation into the nucleus and activation of the WNT pathway. Inhibition of beta-catenin expression in expanded BCD cells using short hairpin RNA resulted in growth arrest, mesenchymal-epithelial transition, and redifferentiation, as judged by activation of beta-cell gene expression. Furthermore, inhibition of beta-catenin expression synergized with redifferentiation induced by a combination of soluble factors, as judged by an increase in the number of C-peptide-positive cells. Simultaneous inhibition of the WNT and NOTCH pathways also resulted in a synergistic effect on redifferentiation. These findings, which were reproducible in cells derived from multiple human donors, suggest that inhibition of the WNT pathway may contribute to a therapeutically applicable way for generation of functional insulin-producing cells following ex-vivo expansion.	[Lenz, Ayelet; Toren-Haritan, Ginat; Efrat, Shimon] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Efrat, S (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	sefrat@post.tau.ac.il		Efrat, Shimon/0000-0001-5987-232X	Israel Science Foundation [244/09]	Israel Science Foundation(Israel Science Foundation)	This work was funded by grant 244/09 from the Israel Science Foundation (http://www.isf.org.il/english/) to SE. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar Y, 2008, DIABETES, V57, P2413, DOI 10.2337/db07-1323; Bar Y, 2012, J BIOL CHEM, V287, P17269, DOI 10.1074/jbc.M111.319152; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Blaschuk OW, 2002, MOL MEMBR BIOL, V19, P75, DOI 10.1080/09687680210132467; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Dessimoz J, 2005, CURR BIOL, V15, P1677, DOI 10.1016/j.cub.2005.08.037; Dihlmann S, 2005, CARCINOGENESIS, V26, P1503, DOI 10.1093/carcin/bgi120; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Hayward P, 2008, DEVELOPMENT, V135, P411, DOI 10.1242/dev.000505; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Heiser PW, 2006, DEVELOPMENT, V133, P2023, DOI 10.1242/dev.02366; Kam Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004580; Karslioglu E, 2011, MOL ENDOCRINOL, V25, P1760, DOI 10.1210/me.2011-1074; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kobayashi M, 2012, AM J PHYSIOL-ENDOC M, V302, pE603, DOI 10.1152/ajpendo.00469.2011; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Lechner A, 2005, BIOCHEM BIOPH RES CO, V327, P581, DOI 10.1016/j.bbrc.2004.12.043; Liu H, 2009, DIABETES, V58, P663, DOI 10.2337/db07-1208; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Murtaugh LC, 2005, DEVELOPMENT, V132, P4663, DOI 10.1242/dev.02063; Ouziel-Yahalom L, 2006, BIOCHEM BIOPH RES CO, V341, P291, DOI 10.1016/j.bbrc.2005.12.187; Papadopoulou S, 2005, DIABETES, V54, P2844, DOI 10.2337/diabetes.54.10.2844; Rulifson IC, 2007, P NATL ACAD SCI USA, V104, P6247, DOI 10.1073/pnas.0701509104; Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283; Russ HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025566; Russ HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006417; Saito-Diaz K, 2013, GROWTH FACTORS, V31, P1, DOI 10.3109/08977194.2012.752737; Schinner S, 2008, DIABETOLOGIA, V51, P147, DOI 10.1007/s00125-007-0848-0; Sherry NA, 2006, DIABETES, V55, P3238, DOI 10.2337/db05-1034; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Stamos JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007898; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Wang ZY, 2014, CELL METAB, V19, P872, DOI 10.1016/j.cmet.2014.03.010; White MG, 2013, DIABETES CARE, V36, P3818, DOI 10.2337/dc13-0705; Yang W, 2001, ONCOGENE, V20, P1688, DOI 10.1038/sj.onc.1204245	38	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112914	10.1371/journal.pone.0112914	http://dx.doi.org/10.1371/journal.pone.0112914			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393025	Green Published, gold, Green Submitted			2022-12-27	WOS:000347709300121
J	Zhang, Y; Kang, Y; Zhou, QJ; Zhou, JZ; Wang, HJ; Jin, H; Liu, XH; Ma, D; Li, XT				Zhang, Ying; Kang, Yuan; Zhou, Qiongjie; Zhou, Jizi; Wang, Huijun; Jin, Hong; Liu, Xiaohui; Ma, Duan; Li, Xiaotian			Quantitative Proteomic Analysis of Serum from Pregnant Women Carrying a Fetus with Conotruncal Heart Defect Using Isobaric Tags for Relative and Absolute Quantitation (iTRAQ) Labeling	PLOS ONE			English	Article							AMNIOTIC-FLUID; GELSOLIN EXPRESSION; PROTEIN MARKERS; DOWN-REGULATION; IDENTIFICATION; PEPTIDES; DISEASE; PREECLAMPSIA; ASSOCIATION; BIOMARKERS	Objective: To identify differentially expressed proteins from serum of pregnant women carrying a conotruncal heart defects (CTD) fetus, using proteomic analysis. Methods: The study was conducted using a nested case-control design. The 5473 maternal serum samples were collected at 14-18 weeks of gestation. The serum from 9 pregnant women carrying a CTD fetus, 10 with another CHD (ACHD) fetus, and 11 with a normal fetus were selected from the above samples, and analyzed by using isobaric tags for relative and absolute quantitation (iTRAQ) coupled with two-dimensional liquid chromatography-tandem mass spectrometry(2D LC-MS/MS). The differentially expressed proteins identified by iTRAQ were further validated with Western blot. Results: A total of 105 unique proteins present in the three groups were identified, and relative expression data were obtained for 92 of them with high confidence by employing the iTRAQ-based experiments. The downregulation of gelsolin in maternal serum of fetus with CTD was further verified by Western blot. Conclusions: The identification of differentially expressed protein gelsolin in the serum of the pregnant women carrying a CTD fetus by using proteomic technology may be able to serve as a foundation to further explore the biomarker for detection of CTD fetus from the maternal serum.	[Zhang, Ying; Kang, Yuan; Zhou, Qiongjie; Zhou, Jizi; Li, Xiaotian] Fudan Univ, Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China; [Wang, Huijun] Fudan Univ, Childrens Hosp, Shanghai 200433, Peoples R China; [Jin, Hong; Liu, Xiaohui] Fudan Univ, Dept Chem, Shanghai 200433, Peoples R China; [Jin, Hong] Fudan Univ, Inst Biomed, Shanghai 200433, Peoples R China; [Ma, Duan; Li, Xiaotian] Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Minist Educ,Key Lab Mol Med,Inst Biomed Sci, Shanghai 200433, Peoples R China; [Li, Xiaotian] Shanghai Key Lab Female Reprod Endocrine Related, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University	Li, XT (corresponding author), Fudan Univ, Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China.	duanma@fudan.edu.cn; xiaotianli555@163.com	wang, huimin/HDM-8421-2022; Ma, Duan/I-8330-2014; Li, Xiaotian/ABI-3309-2020; wang, hui/GRS-4730-2022	Li, Xiaotian/0000-0002-2051-4581; 	Shanghai Municipal Natural Science Foundation [10ZRI404900]; Health industry special funds for Public Benefit Research Foundation from the Ministry of Health, People's Republic of China [201002013]; National Science Fund of China [81270712]; Program of Shanghai Subject Chief Scientist [12XD1401300]; Program of Shanghai Leading Talent; Shanghai Municipal Health Bureau [12GWZX0301]; National Key Basic Research Plan of China (973 Plan) [2010CB529500]	Shanghai Municipal Natural Science Foundation; Health industry special funds for Public Benefit Research Foundation from the Ministry of Health, People's Republic of China; National Science Fund of China(National Natural Science Foundation of China (NSFC)); Program of Shanghai Subject Chief Scientist; Program of Shanghai Leading Talent; Shanghai Municipal Health Bureau; National Key Basic Research Plan of China (973 Plan)(National Basic Research Program of China)	This project was supported by Shanghai Municipal Natural Science Foundation (10ZRI404900), Health industry special funds for Public Benefit Research Foundation from the Ministry of Health, People's Republic of China (201002013), the National Science Fund of China (81270712), Program of Shanghai Subject Chief Scientist (12XD1401300), Program of Shanghai Leading Talent (2012), Shanghai Municipal Health Bureau (12GWZX0301), and National Key Basic Research Plan of China (973 Plan) (2010CB529500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostopoulos AK, 2010, J PROTEOMICS, V73, P943, DOI 10.1016/j.jprot.2009.12.009; Auer J, 2010, J PROTEOMICS, V73, P1004, DOI 10.1016/j.jprot.2009.12.014; Benson D. Woodrow, 1996, Current Opinion in Pediatrics, V8, P505, DOI 10.1097/00008480-199610000-00015; Botto LD, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e32; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buskens E, 1996, OBSTET GYNECOL, V87, P423, DOI 10.1016/0029-7844(95)00439-4; Cantinotti M, 2011, CLIN CHEM LAB MED, V49, P567, DOI 10.1515/CCLM.2011.106; Cecconi D, 2011, ELECTROPHORESIS, V32, P3630, DOI 10.1002/elps.201100256; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P773; Clark EB, 1996, SEMIN PERINATOL, V20, P465, DOI 10.1016/S0146-0005(96)80062-0; Cohen TS, 2011, CYTOKINE, V54, P235, DOI 10.1016/j.cyto.2011.02.006; Datta A, 2014, J PROTEOMICS, V99, P54, DOI 10.1016/j.jprot.2014.01.011; Debrus S, 1996, HUM GENET, V97, P138, DOI 10.1007/BF02265254; Eindhoven JA, 2012, J AM COLL CARDIOL, V60, P2140, DOI 10.1016/j.jacc.2012.02.092; Galindo A, 2009, EUR J OBSTET GYN R B, V146, P55, DOI 10.1016/j.ejogrb.2009.04.032; Gardiner H.M., 2001, HEART, V86, P12; Gay F, 2008, HUM PATHOL, V39, P1420, DOI 10.1016/j.humpath.2008.02.020; Gercel-Taylor C, 2012, AM J OBSTET GYNECOL, V206, pE3, DOI 10.1016/j.ajog.2011.09.010; Graves SW, 2011, AM J OBSTET GYNECOL, V204, pS46, DOI 10.1016/j.ajog.2010.09.021; Gravett MG, 2004, JAMA-J AM MED ASSOC, V292, P462, DOI 10.1001/jama.292.4.462; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Hu WS, 2014, MOL CELL BIOCHEM, V390, P263, DOI 10.1007/s11010-014-1977-7; Huang ZL, 2012, TOXICOLOGY, V291, P56, DOI 10.1016/j.tox.2011.10.023; Hutson Mary Redmond, 2003, Birth Defects Research, V69, P2, DOI 10.1002/bdrc.10002; Jin Y, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.01.002; Kang Y, 2012, PRENATAL DIAG, V32, P284, DOI 10.1002/pd.3829; KIRBY ML, 1995, CIRC RES, V77, P211, DOI 10.1161/01.RES.77.2.211; Kolialexi A, 2008, PRENATAL DIAG, V28, P691, DOI 10.1002/pd.2040; Kolialexi A, 2010, J PROTEOME RES, V9, P5164, DOI 10.1021/pr100459q; Kolla V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/952047; Lee HK, 1999, PROSTATE, V40, P14, DOI 10.1002/(SICI)1097-0045(19990615)40:1<14::AID-PROS2>3.0.CO;2-6; Liao CJ, 2011, GYNECOL ONCOL, V120, P135, DOI 10.1016/j.ygyno.2010.10.005; Lisowski LA, 2010, HERZ, V35, P19, DOI 10.1007/s00059-010-3244-3; Long J, 2010, BIRTH DEFECTS RES A, V88, P971, DOI 10.1002/bdra.20724; Mani SK, 2008, AM J PHYSIOL-HEART C, V295, pH314, DOI 10.1152/ajpheart.00085.2008; Mavrou A, 2008, J PROTEOME RES, V7, P1862, DOI 10.1021/pr700588u; MERKATZ IR, 1984, AM J OBSTET GYNECOL, V148, P886, DOI 10.1016/0002-9378(84)90530-1; Nir A, 2012, BIOMARK MED, V6, P827, DOI [10.2217/BMM.12.73, 10.2217/bmm.12.73]; Noske A, 2005, EUR J CANCER, V41, P461, DOI 10.1016/j.ejca.2004.10.025; Park J, 2011, EXP MOL MED, V43, P427, DOI 10.3858/emm.2011.43.7.047; Park SJ, 2006, PROTEOMICS, V6, P349, DOI 10.1002/pmic.200500084; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Plageman TF, 2006, DEV DYNAM, V235, P2868, DOI 10.1002/dvdy.20923; Ratajska A, 2009, BIRTH DEFECTS RES A, V85, P599, DOI 10.1002/bdra.20578; Scholl PF, 2012, PLACENTA, V33, P424, DOI 10.1016/j.placenta.2012.02.009; Sezen D, 2009, AM J OBSTET GYNECOL, V200, pe191; Shaw GM, 2010, BIRTH DEFECTS RES A, V88, P144, DOI 10.1002/bdra.20648; van Beynum IM, 2006, EUR HEART J, V27, P981, DOI 10.1093/eurheartj/ehi815; Wald N J, 1997, J Med Screen, V4, P181; Wang TH, 2009, FERTIL STERIL, V92, P96, DOI 10.1016/j.fertnstert.2008.05.038; Winston JS, 2001, BREAST CANCER RES TR, V65, P11, DOI 10.1023/A:1006446108411; Xianhui L, 2014, BURNS, V40, P1552; Xu JF, 2012, J TRAUMA ACUTE CARE, V72, P491, DOI 10.1097/TA.0b013e318226ec39; Xuan C, 2014, ANN THORAC SURG, V97, P1414, DOI 10.1016/j.athoracsur.2013.11.069; Yang JC, 2000, CIRCULATION, V102, P3046; Zhang XP, 2012, ANALYST, V137, P490, DOI 10.1039/c1an15551b	56	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e111645	10.1371/journal.pone.0111645	http://dx.doi.org/10.1371/journal.pone.0111645			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393621	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300017
J	Huang, YW; Liou, RS; Lin, YT; Huang, HH; Yang, TC				Huang, Yi-Wei; Liou, Rung-Shiuan; Lin, Yi-Tsung; Huang, Hsin-Hui; Yang, Tsuey-Ching			A Linkage between SmeIJK Efflux Pump, Cell Envelope Integrity, and sigma(E)-Mediated Envelope Stress Response in Stenotrophomonas maltophilia	PLOS ONE			English	Article							ESCHERICHIA-COLI; DRUG-RESISTANCE; SYSTEM; TRANSCRIPTION; INDUCTION; SIGMA(E)	Resistance nodulation division (RND) efflux pumps, such as the SmeIJK pump of Stenotrophomonas maltophilia, are known to contribute to the multidrug resistance in Gram-negative bacteria. However, some RND pumps are constitutively expressed even though no antimicrobial stresses occur, implying that there should be some physical implications for these RND pumps. In this study, the role of SmeIJK in antimicrobials resistance, envelope integrity, and sigma(E)-mediated envelope stress response (ESR) of S. maltophilia was assessed. SmeIJK was involved in the intrinsic resistance of S. maltophilia KJ to aminoglycosides and leucomycin. Compared with the wild-type KJ, the smeIJK deletion mutant exhibited growth retardation in the MH medium, an increased sensitivity to membrane-damaging agents (MDAs), as well as activation of an sigma(E)-mediated ESR. Moreover, the expression of smeIJK was further induced by sub-lethal concentrations of MDAs or surfactants in an sigma(E)-dependent manner. These data collectively suggested an alternative physiological role of smeIJK in cell envelope integrity maintenance and sigma(E)-mediated ESR beyond the efflux of antibiotics. Because of the necessity of the physiological role of SmeIJK in protecting S. maltophilia from the envelope stress, smeIJK is constitutively expressed, which, in turn, contributes the intrinsic resistance to aminoglycoside and leucomycin. This is the first demonstration of the linkage among RND-type efflux pump, cell envelope integrity, and sigma(E)-mediated ESR in S. maltophilia.	[Huang, Yi-Wei; Liou, Rung-Shiuan; Huang, Hsin-Hui; Yang, Tsuey-Ching] Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei 112, Taiwan; [Lin, Yi-Tsung] Taipei Vet Gen Hosp, Dept Med, Div Infect Dis, Taipei, Taiwan; [Lin, Yi-Tsung] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Yang, TC (corresponding author), Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei 112, Taiwan.	tcyang@ym.edu.tw	Huang, Yi-Wei/K-9717-2019		Ministry of Science and Technology of Taiwan [NSC 101-2320-B-010-053-MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	TCY: Ministry of Science and Technology of Taiwan, NSC 101-2320-B-010-053-MY3, http://www.most.gov.tw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebusuyi AA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-252; Baranova N, 2002, J BACTERIOL, V184, P4168, DOI 10.1128/JB.184.15.4168-4176.2002; Begic S, 2008, CAN J MICROBIOL, V54, P411, DOI [10.1139/W08-019, 10.1139/w08-019]; Bordes P, 2011, J BACTERIOL, V193, P246, DOI 10.1128/JB.00884-10; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; Cheng CY, 2008, FEMS MICROBIOL LETT, V289, P250, DOI 10.1111/j.1574-6968.2008.01392.x; Clinical Laboratory Standards Institute (CLSI), M7S20 CLSI, P20; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; Fraud S, 2008, ANTIMICROB AGENTS CH, V52, P4478, DOI 10.1128/AAC.01072-08; Hayden JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001573; Krulwich TA, 2005, NAT REV MICROBIOL, V3, P566, DOI 10.1038/nrmicro1181; Kumar A, 2005, ANTIMICROB AGENTS CH, V49, P1495, DOI 10.1128/AAC.49.4.1495-1501.2005; Leblanc SKD, 2011, J BACTERIOL, V193, P3367, DOI 10.1128/JB.01534-10; Lin CW, 2009, RES MICROBIOL, V160, P152, DOI 10.1016/j.resmic.2008.11.001; Lin J, 2003, INFECT IMMUN, V71, P4250, DOI 10.1128/IAI.71.8.4250-4259.2003; Mima T, 2009, MICROBIOL-SGM, V155, P3509, DOI 10.1099/mic.0.031260-0; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; Nagakubo S, 2002, J BACTERIOL, V184, P4161, DOI 10.1128/JB.184.15.4161-4167.2002; Paulsen IT, 2001, J MOL MICROB BIOTECH, V3, P145; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Raivio TL, 2013, J BACTERIOL, V195, P2755, DOI 10.1128/JB.00105-13; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Staron A, 2009, MOL MICROBIOL, V74, P557, DOI 10.1111/j.1365-2958.2009.06870.x; Thanassi DG, 1997, J BACTERIOL, V179, P2512, DOI 10.1128/jb.179.8.2512-2518.1997; Wood LF, 2012, MBIO, V3, DOI 10.1128/mBio.00094-12; Yang TC, 2009, ANTIMICROB AGENTS CH, V53, P2902, DOI 10.1128/AAC.01513-08	27	31	32	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111784	10.1371/journal.pone.0111784	http://dx.doi.org/10.1371/journal.pone.0111784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390933	Green Submitted, Green Published, gold			2022-12-27	WOS:000349144400033
J	Vleminckx, J; Morin-Rivat, J; Biwole, AB; Dainou, K; Gillet, JF; Doucet, JL; Drouet, T; Hardy, OJ				Vleminckx, Jason; Morin-Rivat, Julie; Biwole, Achille B.; Dainou, Kasso; Gillet, Jean-Francois; Doucet, Jean-Louis; Drouet, Thomas; Hardy, Olivier J.			Soil Charcoal to Assess the Impacts of Past Human Disturbances on Tropical Forests	PLOS ONE			English	Article							TREE SPECIES COMPOSITION; RAIN-FOREST; SOUTHERN NIGERIA; PLATEAU FOREST; HOLOCENE; OKOMU; WOOD; BP; HISTORY; AFRICA	The canopy of many central African forests is dominated by light-demanding tree species that do not regenerate well under themselves. The prevalence of these species might result from ancient slash-and-burn agricultural activities that created large openings, while a decline of these activities since the colonial period could explain their deficit of regeneration. To verify this hypothesis, we compared soil charcoal abundance, used as a proxy for past slash-and-burn agriculture, and tree species composition assessed on 208 rainforest 0.2 ha plots located in three areas from Southern Cameroon. Species were classified in regeneration guilds (pioneer, non-pioneer light-demanding, shade-bearer) and characterized by their wood-specific gravity, assumed to reflect light requirement. We tested the correlation between soil charcoal abundance and: (i) the relative abundance of each guild, (ii) each species and family abundance and (iii) mean wood-specific gravity. Charcoal was found in 83% of the plots, indicating frequent past forest fires. Radiocarbon dating revealed two periods of fires: "recent" charcoal were on average 300 years old (up to 860 BP, n = 16) and occurred in the uppermost 20 cm soil layer, while "ancient" charcoal were on average 1900 years old (range: 1500 to 2800 BP, n = 43, excluding one sample dated 9400 BP), and found in all soil layers. While we expected a positive correlation between the relative abundance of light-demanding species and charcoal abundance in the upper soil layer, overall there was no evidence that the current heterogeneity in tree species composition can be explained by charcoal abundance in any soil layer. The absence of signal supporting our hypothesis might result from (i) a relatively uniform impact of past slash-and-burn activities, (ii) pedoturbation processes bringing ancient charcoal to the upper soil layer, blurring the signal of centuries-old Human disturbances, or (iii) the prevalence of other environmental factors on species composition.	[Vleminckx, Jason; Hardy, Olivier J.] Univ Libre Bruxelles, Serv Evolut Biol & Ecol, Fac Sci, Brussels, Belgium; [Morin-Rivat, Julie; Biwole, Achille B.; Dainou, Kasso; Gillet, Jean-Francois; Doucet, Jean-Louis] Univ Liege, Unite Gest Ressources Forestieres & Milieux Nat, Lab Foresterie Reg Trop & Subtrop, Gembloux Agrobio Tech, Gembloux, Belgium; [Morin-Rivat, Julie] Royal Museum Cent Africa, Lab Wood Biol & Xylarium, Tervuren, Belgium; [Dainou, Kasso] Univ Abomey Calavi, Lab Appl Ecol, Cotonou, Benin; [Drouet, Thomas] Univ Libre Bruxelles, Fac Sci, Lab Ecol Vegetale & Biogeochim, Brussels, Belgium	Universite Libre de Bruxelles; Royal Museum for Central Africa; University of Abomey Calavi; Universite Libre de Bruxelles	Vleminckx, J (corresponding author), Univ Libre Bruxelles, Serv Evolut Biol & Ecol, Fac Sci, Brussels, Belgium.	jason.vleminckx@ulb.ac.be	Daïnou, Kasso/J-8920-2019	Daïnou, Kasso/0000-0003-2486-1895; Achille, Biwole/0000-0003-3964-771X; Drouet, Thomas/0000-0002-0023-0418	FRFC project (Fonds pour la Recherche Fondamentale et Collective) "Dynamics of tree and herbaceous communities of the tropical forests of Central Africa, in relation with past anthropogenic and climatic disturbance" [2.4577.10]; Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA); CoForChange project - ERA-net BiodivERsA	FRFC project (Fonds pour la Recherche Fondamentale et Collective) "Dynamics of tree and herbaceous communities of the tropical forests of Central Africa, in relation with past anthropogenic and climatic disturbance"(Fonds de la Recherche Scientifique - FNRS); Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS); CoForChange project - ERA-net BiodivERsA	This study is part of the FRFC project (<< Fonds pour la Recherche Fondamentale et Collective >>, convention n<SUP>o</SUP> 2.4577.10) entitled "Dynamics of tree and herbaceous communities of the tropical forests of Central Africa, in relation with past anthropogenic and climatic disturbance". J. Vleminckx and J. Morin-Rivat are funded by the "Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA)". The authors gratefully acknowledge the CoForChange project funded through the ERA-net BiodivERsA (http://www.coforchange.eu/fr/). The authors declare that the funders only provided financial support for the field inventories and had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo AGM, 2013, J ARCHAEOL SCI, V40, P2124, DOI 10.1016/j.jas.2012.12.035; Biwole AB, 2014, PLANT ECOLO IN PRESS, V148; Chabal L., 1997, DOCUMENTS ARCHEOLOGI; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Clist B., 2005, THESIS U LIBRE BRUXE; Dauby G, 2011, ECOGRAPHY, V34, P001; Denham TP, 2003, SCIENCE, V301, P189, DOI 10.1126/science.1085255; Elenga H, 1996, CR ACAD SCI II A, V323, P403; Fayolle A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042381; Gillet J.-F., 2013, THESIS U LIEGE; Glaser B, 2012, GEOCHIM COSMOCHIM AC, V82, P39, DOI 10.1016/j.gca.2010.11.029; Gouveia SEM, 2000, CR ACAD SCI II A, V330, P133, DOI 10.1016/S1251-8050(00)00114-2; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Hawthorne W.D., 1995, ECOLOGICAL PROFILES; Hubau W, 2013, THESIS GHENT U; JM Fay, 1997, THESIS WASHINGTON U; JOHNSON DL, 1990, SOIL SCI, V149, P84, DOI 10.1097/00010694-199002000-00004; JONES EW, 1955, J ECOL, V43, P564, DOI 10.2307/2257012; JONES EW, 1956, J ECOL, V44, P83, DOI 10.2307/2257155; KEALHOFER L, 2003, ASIAN PERSPECT, V42, P72; Lavelle P, 1983, SOIL FAUNA TROPICAL; Lebrun J., 1954, PUBLICATION INEAC SE, V63; Lee K. E., 1971, TERMITES AND SOILS; MALEY J, 1992, B SOC GEOL FR, V163, P363; MANTEL N, 1967, CANCER RES, V27, P209; MCBREARTY S, 1990, J ARCHAEOL SCI, V17, P111, DOI 10.1016/0305-4403(90)90054-9; Miklos AAW, 1992, THESIS U PARIX 6 FRA; MORAN PAP, 1948, J ROY STAT SOC B, V10, P243; Morin-Rivat J, 2014, RADIOCARBON, V56, P209, DOI 10.2458/56.16485; Neumann K, 2012, QUATERN INT, V249, P53, DOI 10.1016/j.quaint.2011.03.024; Ngomanda A, 2009, QUATERNARY RES, V71, P307, DOI 10.1016/j.yqres.2008.12.002; Oslisly R, 1996, GROWTH FARMING COMMU, VXXIX-XXX, P324; Oslisly R, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0304; R Core Team, 2020, R LANG ENV STAT COMP; Ramsey CB, 2001, RADIOCARBON, V43, P355; Ramsey CB, 1995, RADIOCARBON, V37, P425, DOI 10.1017/S0033822200030903; Ramsey CB, 2012, SCIENCE, V338, P370, DOI 10.1126/science.1226660; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Ross NJ, 2011, ECOL APPL, V21, P75, DOI 10.1890/09-0662.1; SCHWARTZ D, 1992, B SOC GEOL FR, V163, P353; Shanahan TM, 2012, PALAEOGEOGR PALAEOCL, V361, P49, DOI 10.1016/j.palaeo.2012.08.001; Slik JWF, 2006, J TROP ECOL, V22, P481, DOI 10.1017/S0266467406003324; Slik JWF, 2005, FOREST ECOL MANAG, V205, P241, DOI 10.1016/j.foreco.2004.10.011; SWAINE MD, 1988, J TROP ECOL, V4, P253, DOI 10.1017/S0266467400002819; Talon B, 2005, QUATERNARY RES, V64, P36, DOI 10.1016/j.yqres.2005.03.003; Talon B, 2010, HOLOCENE, V20, P35, DOI 10.1177/0959683609348842; van Gemerden BS, 2003, J BIOGEOGR, V30, P1381, DOI 10.1046/j.1365-2699.2003.00937.x; Vincens A, 1998, QUATERNARY RES, V50, P34, DOI 10.1006/qres.1998.1979; White LJT, 1999, GLOBAL ECOL BIOGEOGR, V8, P355, DOI 10.1046/j.1365-2699.1999.00149.x; Willis KJ, 2004, SCIENCE, V304, P402, DOI 10.1126/science.1093991; Wotzka H.-P., 2006, GRUNDLEGUNGEN BEITRA, P271; WRB (World Reference Base for Soil Resources), 2006, WORLD SOIL RES REP, V103; Zanne AE, 2009, GLOBAL WOOD DENSITY	53	26	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e108121	10.1371/journal.pone.0108121	http://dx.doi.org/10.1371/journal.pone.0108121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391134	Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400004
J	Eggert, T; Medina-Echeverz, J; Kapanadze, T; Kruhlak, MJ; Korangy, F; Greten, TF				Eggert, Tobias; Medina-Echeverz, Jose; Kapanadze, Tamar; Kruhlak, Michael J.; Korangy, Firouzeh; Greten, Tim F.			Tumor Induced Hepatic Myeloid Derived Suppressor Cells Can Cause Moderate Liver Damage	PLOS ONE			English	Article							DENDRITIC CELLS; IMMUNE-RESPONSE; T-CELLS; MECHANISMS; DIFFERENTIATION; RECRUITMENT; APOPTOSIS; ACCUMULATION; INFLAMMATION; GENERATION	Subcutaneous tumors induce the accumulation of myeloid derived suppressor cells (MDSC) not only in blood and spleens, but also in livers of these animals. Unexpectedly, we observed a moderate increase in serum transaminases in mice with EL4 subcutaneous tumors, which prompted us to study the relationship of hepatic MDSC accumulation and liver injury. MDSC were the predominant immune cell population expanding in livers of all subcutaneous tumor models investigated (RIL175, B16, EL4, CT26 and BNL), while liver injury was only observed in EL4 and B16 tumor-bearing mice. Elimination of hepatic MDSC in EL4 tumor-bearing mice using low dose 5-fluorouracil (5-FU) treatment reversed transaminase elevation and adoptive transfer of hepatic MDSC from B16 tumor-bearing mice caused transaminase elevation indicating a direct MDSC mediated effect. Surprisingly, hepatic MDSC from B16 tumor-bearing mice partially lost their damage-inducing potency when transferred into mice bearing non damage-inducing RIL175 tumors. Furthermore, MDSC expansion and MDSC-mediated liver injury further increased with growing tumor burden and was associated with different cytokines including GM-CSF, VEGF, interleukin-6, CCL2 and KC, depending on the tumor model used. In contrast to previous findings, which have implicated MDSC only in protection from T cell-mediated hepatitis, we show that tumor-induced hepatic MDSC themselves can cause moderate liver damage.	[Eggert, Tobias; Medina-Echeverz, Jose; Kapanadze, Tamar; Korangy, Firouzeh; Greten, Tim F.] NCI, Gastrointestinal Malignancy Sect, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Kapanadze, Tamar] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Kruhlak, Michael J.] NCI, Expt Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Hannover Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Greten, TF (corresponding author), NCI, Gastrointestinal Malignancy Sect, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	tim.greten@nih.gov	Greten, Tim F/B-3127-2015	Greten, Tim F/0000-0002-0806-2535	National Institutes of Health intramural research program; NATIONAL CANCER INSTITUTE [ZIABC011345] Funding Source: NIH RePORTER	National Institutes of Health intramural research program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The underlying research reported in the study was funded by the National Institutes of Health intramural research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI Y, 1994, HEPATOLOGY, V20, P453, DOI 10.1002/hep.1840200227; Adams DH, 2010, TOXICOL SCI, V115, P307, DOI 10.1093/toxsci/kfq009; Black D, 2007, BIOCHIMIE, V89, P1464, DOI 10.1016/j.biochi.2007.09.001; Bonder CS, 2004, J IMMUNOL, V172, P45, DOI 10.4049/jimmunol.172.1.45; Bronte V, 2003, J IMMUNOL, V170, P270, DOI 10.4049/jimmunol.170.1.270; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Cheng LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017631; Connolly MK, 2010, J LEUKOCYTE BIOL, V87, P713, DOI 10.1189/jlb.0909607; Conrad E, 2014, HEPATOLOGY, V59, P1555, DOI 10.1002/hep.26915; Corazza Nadia, 2009, Semin Immunopathol, V31, P267, DOI 10.1007/s00281-009-0168-1; Corzo CA, 2009, J IMMUNOL, V182, P5693, DOI 10.4049/jimmunol.0900092; Deng ZB, 2009, HEPATOLOGY, V50, P1412, DOI 10.1002/hep.23148; Drozdzik M, 2000, J HEPATOL, V32, P279, DOI 10.1016/S0168-8278(00)80073-2; Eksteen B, 2007, SEMIN LIVER DIS, V27, P351, DOI 10.1055/s-2007-991512; Faubion WA, 1999, HEPATOLOGY, V29, P1, DOI 10.1002/hep.510290101; FIDLER IJ, 1975, CANCER RES, V35, P218; Filipazzi P, 2007, J CLIN ONCOL, V25, P2546, DOI 10.1200/JCO.2006.08.5829; Gabrilovich D, 1998, BLOOD, V92, P4150, DOI 10.1182/blood.V92.11.4150.423k45_4150_4166; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; GORER PA, 1959, CANCER RES, V19, P824; GRISWOLD DP, 1975, CANCER, V36, P2441, DOI 10.1002/1097-0142(197512)36:6<2441::AID-CNCR2820360627>3.0.CO;2-P; Hori Y, 2000, SURGERY, V127, P641, DOI 10.1067/msy.2000.105499; Huang B, 2007, CANCER LETT, V252, P86, DOI 10.1016/j.canlet.2006.12.012; Iimuro Y, 1997, HEPATOLOGY, V26, P1530; Ilkovitch D, 2009, CANCER RES, V69, P5514, DOI 10.1158/0008-5472.CAN-08-4625; Jaeschke H, 1997, J LEUKOCYTE BIOL, V61, P647, DOI 10.1002/jlb.61.6.647; Jaeschke H, 2006, LIVER INT, V26, P912, DOI 10.1111/j.1478-3231.2006.01327.x; Jaeschke H, 2006, AM J PHYSIOL-GASTR L, V290, pG1083, DOI 10.1152/ajpgi.00568.2005; Kapanadze T, 2013, J HEPATOL, V59, P1007, DOI 10.1016/j.jhep.2013.06.010; Kaplowitz N, 2002, SEMIN LIVER DIS, V22, P137, DOI 10.1055/s-2002-30100; Kono H, 2010, J IMMUNOL, V184, P4470, DOI 10.4049/jimmunol.0902485; Kusmartsev S, 2005, J IMMUNOL, V175, P4583, DOI 10.4049/jimmunol.175.7.4583; Li HQ, 2009, J IMMUNOL, V182, P240, DOI 10.4049/jimmunol.182.1.240; Liu ZX, 2006, HEPATOLOGY, V43, P1220, DOI 10.1002/hep.21175; Ma C, 2012, J LEUKOCYTE BIOL, V92, P1199, DOI 10.1189/jlb.0212059; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Menetrier-Caux C, 1998, BLOOD, V92, P4778, DOI 10.1182/blood.V92.12.4778; Miura K, 2012, AM J PHYSIOL-GASTR L, V302, pG1310, DOI 10.1152/ajpgi.00365.2011; Nefedova Y, 2005, CANCER RES, V65, P9525, DOI 10.1158/0008-5472.CAN-05-0529; Nefedova Y, 2004, J IMMUNOL, V172, P464, DOI 10.4049/jimmunol.172.1.464; NELSON SD, 1990, SEMIN LIVER DIS, V10, P267, DOI 10.1055/s-2008-1040482; Rutschman R, 2001, J IMMUNOL, V166, P2173, DOI 10.4049/jimmunol.166.4.2173; Sarra M, 2013, HEPATOLOGY, V58, P1436, DOI 10.1002/hep.26446; Schrum LW, 2001, AM J PHYSIOL-GASTR L, V280, pG139, DOI 10.1152/ajpgi.2001.280.1.G139; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Serafini P, 2004, CANCER RES, V64, P6337, DOI 10.1158/0008-5472.CAN-04-0757; Shima Y, 1999, HEPATOLOGY, V30, P1215, DOI 10.1002/hep.510300503; Terabe M, 2003, J EXP MED, V198, P1741, DOI 10.1084/jem.20022227; Teufelhofer O, 2005, CARCINOGENESIS, V26, P319, DOI 10.1093/carcin/bgh320; Vincent J, 2010, CANCER RES, V70, P3052, DOI 10.1158/0008-5472.CAN-09-3690; Wu DF, 2009, SEMIN LIVER DIS, V29, P141, DOI 10.1055/s-0029-1214370; Xia S, 2011, J BIOL CHEM, V286, P23591, DOI 10.1074/jbc.M111.237123; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Youn JI, 2012, J LEUKOCYTE BIOL, V91, P167, DOI 10.1189/jlb.0311177; Zender L, 2005, COLD SH Q B, V70, P251, DOI 10.1101/sqb.2005.70.059; Zuo DM, 2013, HEPATOLOGY, V57, P228, DOI 10.1002/hep.25983	57	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112717	10.1371/journal.pone.0112717	http://dx.doi.org/10.1371/journal.pone.0112717			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401795	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700065
J	Loghmanpour, NA; Druzdzel, MJ; Antaki, JF				Loghmanpour, Natasha A.; Druzdzel, Marek J.; Antaki, James F.			Cardiac Health Risk Stratification System (CHRiSS): A Bayesian-Based Decision Support System for Left Ventricular Assist Device (LVAD) Therapy	PLOS ONE			English	Article							DESTINATION THERAPY; PATIENT SELECTION; MODEL; NETWORK; PROGNOSIS; SURVIVAL; FAILURE; CANCER; SCORE; TREE	This study investigated the use of Bayesian Networks (BNs) for left ventricular assist device (LVAD) therapy; a treatment for end-stage heart failure that has been steadily growing in popularity over the past decade. Despite this growth, the number of LVAD implants performed annually remains a small fraction of the estimated population of patients who might benefit from this treatment. We believe that this demonstrates a need for an accurate stratification tool that can help identify LVAD candidates at the most appropriate point in the course of their disease. We derived BNs to predict mortality at five endpoints utilizing the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) database: containing over 12,000 total enrolled patients from 153 hospital sites, collected since 2006 to the present day, and consisting of approximately 230 pre-implant clinical variables. Synthetic minority oversampling technique (SMOTE) was employed to address the uneven proportion of patients with negative outcomes and to improve the performance of the models. The resulting accuracy and area under the ROC curve (%) for predicted mortality were 30 day: 94.9 and 92.5; 90 day: 84.2 and 73.9; 6 month: 78.2 and 70.6; 1 year: 73.1 and 70.6; and 2 years: 71.4 and 70.8. To foster the translation of these models to clinical practice, they have been incorporated into a web-based application, the Cardiac Health Risk Stratification System (CHRiSS). As clinical experience with LVAD therapy continues to grow, and additional data is collected, we aim to continually update these BN models to improve their accuracy and maintain their relevance. Ongoing work also aims to extend the BN models to predict the risk of adverse events post-LVAD implant as additional factors for consideration in decision making.	[Loghmanpour, Natasha A.; Antaki, James F.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Druzdzel, Marek J.] Univ Pittsburgh, Sch Informat Sci, Decis Syst Lab, Pittsburgh, PA USA; [Druzdzel, Marek J.] Bialystok Tech Univ, Fac Comp Sci, Bialystok, Poland	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Bialystok University of Technology	Antaki, JF (corresponding author), Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA.	antaki@cmu.edu	Druzdzel, Marek J/AAR-9653-2020; Antaki, James/S-3051-2016; Antaki, James Francis/AAC-5331-2020	Druzdzel, Marek J/0000-0002-7598-2286; Antaki, James/0000-0002-5430-7353; Antaki, James Francis/0000-0002-5430-7353	National Institutes of Health grants [1R41 HL120428-01, 1R01HL086918, U01HL101066-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R41HL120428, R01HL086918, U01HL101066] Funding Source: NIH RePORTER	National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was provided by the 1R41 HL120428-01, 1R01HL086918, and U01HL101066-01 National Institutes of Health grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin RM, 2010, ARCH PATHOL LAB MED, V134, P744, DOI 10.1043/1543-2165-134.5.744; Berry DA, 2006, NAT REV DRUG DISCOV, V5, P27, DOI 10.1038/nrd1927; Brahnam S, 2011, INTELLIGENT DECISION; Cao CG, 1998, INT J MED INFORM, V51, P13, DOI 10.1016/S1386-5056(98)00085-9; Charitos T, 2009, EXPERT SYST APPL, V36, P1249, DOI 10.1016/j.eswa.2007.11.065; Chawla N. V., 2011, ARXIV11061813; Cooper Gregory F., 1991, UNCERTAINTY ARTIFICI, V1991, P86, DOI DOI 10.1016/B978-1-55860-203-8.50015-2; Cowger J, 2013, J AM COLL CARDIOL, V61, P313, DOI 10.1016/j.jacc.2012.09.055; Diez FJ, 1997, ARTIF INTELL MED, V10, P59, DOI 10.1016/S0933-3657(97)00384-9; Druzdzel MJ, 1999, J AM MED INFORM ASSN, P1206; Eom JH, 2008, EXPERT SYST APPL, V34, P2465, DOI 10.1016/j.eswa.2007.04.015; Faller H, 2005, PSYCHOTHER PSYCH MED, V55, P200, DOI 10.1055/s-2004-834597; FDA, 2010, OUTL KEY DIFF MED DE; Gevaert O, 2006, BIOINFORMATICS, V22, pE184, DOI 10.1093/bioinformatics/btl230; Heckerman D, 1998, TUTORIAL LEARNING BA; Hoot Nathan, 2005, AMIA Annu Symp Proc, P345; Ibrahim J. G., 2005, BAYESIAN SURVIVAL AN; Kanwar M, 2013, J AM COLL CARDIOLOGY, V61; Koller D., 1996, OPTIMAL FEATURE SELE; Kratz A, 2004, NEW ENGL J MED, V351, P1548, DOI 10.1056/NEJMcpc049016; Lietz K, 2007, CIRCULATION, V116, P497, DOI 10.1161/CIRCULATIONAHA.107.691972; Lietz K, 2008, SEMIN THORAC CARDIOV, V20, P225, DOI 10.1053/j.semtcvs.2008.08.004; Lin JH, 2008, J BIOMED INFORM, V41, P1, DOI 10.1016/j.jbi.2007.06.001; Loghmanpour NA, 2013, J HEART LUNG TRANSPL, V32, pS232, DOI 10.1016/j.healun.2013.01.593; Lucas P, 2001, P EUNITE WORKSH INT, P73; Miller LW, 2011, CIRCULATION, V123, P1552, DOI 10.1161/CIRCULATIONAHA.110.958991; Musen M.A., 2014, BIOMEDICAL INFORM, P643, DOI [10.1007/978-1-4471-4474-8_22, DOI 10.1007/978-1-4471-4474-8_22, DOI 10.1007/978-1-4471-4474-822]; Onioeko ADM, 2014, 13 INT C ART INT SOF; Onisko A, 2002, ADV SOFT COMP, V17, P351; Onisko A, 2013, ARTIF INTELL MED, V57, P197, DOI 10.1016/j.artmed.2013.01.004; Parameters NH, 2009, LABORATORY VALUES; PEARL J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Peura JL, 2012, CIRCULATION, V126, P2648, DOI 10.1161/CIR.0b013e3182769a54; Rose EA, 1999, ANN THORAC SURG, V67, P723, DOI 10.1016/S0003-4975(99)00042-9; Sadeghi S, 2006, INT J MED INFORM, V75, P403, DOI 10.1016/j.ijmedinf.2005.07.028; Santelices LC, 2010, ANN THORAC SURG, V90, P713, DOI 10.1016/j.athoracsur.2010.03.073; Stewart GC, 2011, CIRCULATION, V123, P1559, DOI 10.1161/CIRCULATIONAHA.110.982512; Teuteberg JJ, 2012, J AM COLL CARDIOL, V60, P44, DOI 10.1016/j.jacc.2012.02.032; Wang Y, 2010, MACH LEARN APPL ICML, P293; Wang YJ, 2012, IEEE T INF TECHNOL B, V16, P383, DOI 10.1109/TITB.2012.2187458; Wang YJ, 2012, J HEART LUNG TRANSPL, V31, P140, DOI 10.1016/j.healun.2011.11.003; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Witten I. H., 2005, DATA MINING PRACTICA	43	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e111264	10.1371/journal.pone.0111264	http://dx.doi.org/10.1371/journal.pone.0111264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397576	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500014
J	Rahman, AS; Islam, MR; Koehlmoos, TP; Raihan, MJ; Hasan, MM; Ahmed, T; Larson, CP				Rahman, Ahmed S.; Islam, Mohammad Rafiqul; Koehlmoos, Tracey P.; Raihan, Mohammad Jyoti; Hasan, Mohammad Mehedi; Ahmed, Tahmeed; Larson, Charles P.			Impact of NGO Training and Support Intervention on Diarrhoea Management Practices in a Rural Community of Bangladesh: An Uncontrolled, Single-Arm Trial	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; DEVELOPING-COUNTRIES; ACUTE GASTROENTERITIS; CHILDHOOD DIARRHEA; POOLED ANALYSIS; HEALTH-CARE; CHILDREN; ZINC; MORTALITY; FUTURE	Purpose/Objective: The evolving Non-Governmental Organization (NGO) sector in Bangladesh provides health services directly, however some NGOs indirectly provide services by working with unlicensed providers. The primary objective of this study was to examine the impact of NGO training of unlicensed providers on diarrhoea management and the scale up of zinc treatment in rural populations. Methods: An uncontrolled, single-arm trial for a training and support intervention on diarrhoea outcomes was employed in a rural sub-district of Bangladesh during 2008. Two local NGOs and their catchment populations were chosen for the study. The intervention included training of unlicensed health care providers in the management of acute childhood diarrhoea, particularly emphasizing zinc treatment. In addition, community-based promotion of zinc treatment was carried out. Baseline and endline ecologic surveys were carried out in intervention and control villages to document changes in treatments received for diarrhoea in under-five children. Results: Among surveyed household with an active or recent acute childhood diarrhoea episode, 69% sought help from a health provider. Among these, 62.8% visited an unlicensed private provider. At baseline, 23.9% vs. 22% of control and intervention group children with diarrhoea had received zinc of any type. At endline (6 months later) this had changed to 15.3% vs. 30.2%, respectively. The change in zinc coverage was significantly higher in the intervention villages (p<0.01). Adherence with giving zinc for 10 days or more was significantly higher in the intervention households (9.2% vs. 2.5%; p<0.01). Child's age, duration of diarrhoea, type of diarrhoea, parental year of schooling as well as oral rehydration solution (ORS) and antibiotic usage were significant predictors of zinc usage. Conclusion: Training of unlicensed healthcare providers through NGOs increased zinc coverage in the diarrhoea management of under-five children in rural Bangladesh households.	[Rahman, Ahmed S.; Raihan, Mohammad Jyoti; Hasan, Mohammad Mehedi; Ahmed, Tahmeed] Int Ctr Diarrhoeal Dis Res, Ctr Nutr & Food Secur, Dhaka, Bangladesh; [Islam, Mohammad Rafiqul] Univ Newcastle, CCEB, Sch Med & Publ Hlth, Newcastle, NSW 2300, Australia; [Koehlmoos, Tracey P.] George Mason Univ, Dept Hlth Adm & Policy, Coll Hlth & Human Serv, Fairfax, VA 22030 USA; [Larson, Charles P.] Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada; [Larson, Charles P.] BC Childrens Hosp, Ctr Int Child Hlth, Vancouver, BC, Canada	International Centre for Diarrhoeal Disease Research (ICDDR); University of Newcastle; George Mason University; University of British Columbia; BC Childrens Hospital; University of British Columbia	Rahman, AS (corresponding author), Int Ctr Diarrhoeal Dis Res, Ctr Nutr & Food Secur, Dhaka, Bangladesh.	ashafiq@icddrb.org			Bill & Melinda Gates Foundation [HRN-AA-00-98-00047-00]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by a grant from the Bill & Melinda Gates Foundation (contract # HRN-AA-00-98-00047-00.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S.M., 2005, EXPLORING HLTH SEEKI; Ahmed SM, 2013, LANCET, V382, P1746, DOI 10.1016/S0140-6736(13)62147-9; Ahmed SM, 2009, HEALTH POLICY PLANN, V24, P467, DOI 10.1093/heapol/czp037; Ahmed T, 2012, J HEALTH POPUL NUTR, V30, P1; Ahs J.W., 2010, OPEN INFECT DIS J, V4, P113, DOI 10.2174/1874279301004010113; Bajait C, 2011, INDIAN J PHARMACOL, V43, P232, DOI 10.4103/0253-7613.81495; Bhutta ZA, 1999, J PEDIATR-US, V135, P689, DOI 10.1016/S0022-3476(99)70086-7; Bhutta ZA, 2000, AM J CLIN NUTR, V72, P1516; Boschi-Pinto C, 2008, B WORLD HEALTH ORGAN, V86, P710, DOI 10.2471/BLT.07.050054; Chowdhury AMR, 1997, LANCET, V350, P169, DOI 10.1016/S0140-6736(96)11311-8; Farthing M, 2010, WORLD GASTROENTEROLO; Guarino A, 2008, J PEDIATR GASTR NUTR, V46, P619, DOI 10.1097/MPG.0b013e31816e219e; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Larson CP, 2006, INT J EPIDEMIOL, V35, P1430, DOI 10.1093/ije/dyl167; Larson CP, 2012, HEALTH POLICY PLANN, V27, P102, DOI 10.1093/heapol/czr015; Larson CP, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000175; Lazzerini M, 2008, COCHRANE DATABASE SY, V3; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Mahmood SS, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-18; Mercer A, 2004, HEALTH POLICY PLANN, V19, P187, DOI 10.1093/heapol/czh024; Ministry of Health and Family Welfare B, 2011, WELF PWMOHAF; OSHINAME FO, 1992, SOC SCI MED, V35, P1477, DOI 10.1016/0277-9536(92)90050-Z; Parkhurst JO, 2006, J HEALTH POPUL NUTR, V24, P438; Salim MAH, 2006, B WORLD HEALTH ORGAN, V84, P479, DOI 10.2471/BLT.05.023929; Szajewska H, 2000, J PEDIATR GASTR NUTR, V30, P522, DOI 10.1097/00005176-200005000-00011; Thapar N, 2004, LANCET, V363, P641, DOI 10.1016/S0140-6736(04)15599-2; WALKER CF, 1990, IEEE ENG MED BIOL, V9, P12; Walker CLF, 2010, INT J EPIDEMIOL, V39, P63, DOI 10.1093/ije/dyq023; Wardlaw T, 2010, LANCET, V375, P870, DOI 10.1016/S0140-6736(09)61798-0; WHO U, 2004, WHO UNICEF JOINT STA	30	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112308	10.1371/journal.pone.0112308	http://dx.doi.org/10.1371/journal.pone.0112308			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398082	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558500045
J	Virel, A; Faergemann, E; Oradd, G; Stromberg, I				Virel, Ana; Faergemann, Erik; Oradd, Greger; Stromberg, Ingrid			Magnetic Resonance Imaging (MRI) to Study Striatal Iron Accumulation in a Rat Model of Parkinson's Disease	PLOS ONE			English	Article							BRAIN IRON; IN-VIVO; NEURODEGENERATIVE DISORDERS; SUBSTANTIA-NIGRA; 6-HYDROXYDOPAMINE; METABOLISM; FERRITIN; LESIONS; IMMUNOHISTOCHEMISTRY; DEGENERATION	Abnormal accumulation of iron is observed in neurodegenerative disorders. In Parkinson's disease, an excess of iron has been demonstrated in different structures of the basal ganglia and is suggested to be involved in the pathogenesis of the disease. Using the 6-hydroxydopamine (6-OHDA) rat model of Parkinson's disease, the edematous effect of 6-OHDA and its relation with striatal iron accumulation was examined utilizing in vivo magnetic resonance imaging (MRI). The results revealed that in comparison with control animals, injection of 6-OHDA into the rat striatum provoked an edematous process, visible in T2-weighted images that was accompanied by an accumulation of iron clearly detectable in T2*-weighted images. Furthermore, Prussian blue staining to detect iron in sectioned brains confirmed the existence of accumulated iron in the areas of T2* hypointensities. The presence of ED1-positive microglia in the lesioned striatum overlapped with this accumulation of iron, indicating areas of toxicity and loss of dopamine nerve fibers. Correlation analyses demonstrated a direct relation between the hyperintensities caused by the edema and the hypointensities caused by the accumulation of iron.	[Virel, Ana; Faergemann, Erik; Stromberg, Ingrid] Umea Univ, Dept Integrat Med Biol, Umea, Sweden; [Oradd, Greger] Umea Univ, Dept Radiat Sci, Umea, Sweden	Umea University; Umea University	Virel, A (corresponding author), Umea Univ, Dept Integrat Med Biol, Umea, Sweden.	ana.virel@umu.se			Swedish brain foundation (Hjarnfonden); Swedish Research Council [09917]; Lars Hiertas Minne foundation; Ahlen foundation; Umea University Medical Faculty Foundations	Swedish brain foundation (Hjarnfonden); Swedish Research Council(Swedish Research CouncilEuropean Commission); Lars Hiertas Minne foundation; Ahlen foundation; Umea University Medical Faculty Foundations	This work was supported by grants from the Swedish brain foundation (Hjarnfonden), Swedish Research Council grant number 09917, Lars Hiertas Minne, Ahlen foundations, and Umea University Medical Faculty Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LJ, 2011, PROG CARDIOVASC DIS, V54, P287, DOI 10.1016/j.pcad.2011.07.004; Batista-Nascimento L, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/128647; Berg D, 2006, MOVEMENT DISORD, V21, P1299, DOI 10.1002/mds.21020; Brass Steven D, 2006, Top Magn Reson Imaging, V17, P31, DOI 10.1097/01.rmr.0000245459.82782.e4; Burke RE, 2013, EXP NEUROL, V246, P72, DOI 10.1016/j.expneurol.2012.01.011; Carvey PM, 2005, EUR J NEUROSCI, V22, P1158, DOI 10.1111/j.1460-9568.2005.04281.x; Cozzi A, 2010, NEUROBIOL DIS, V37, P77, DOI 10.1016/j.nbd.2009.09.009; Dexter DT, 2011, J NEURAL TRANSM, V118, P223, DOI 10.1007/s00702-010-0531-3; Dhawan JK, 1998, BRAIN RES BULL, V45, P333, DOI 10.1016/S0361-9230(97)00404-8; Double KL, 1998, J NEUROCHEM, V70, P2492; GERLACH M, 1994, J NEUROCHEM, V63, P793, DOI 10.1046/j.1471-4159.1994.63030793.x; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; HALL S, 1992, J NEUROL SCI, V113, P198, DOI 10.1016/0022-510X(92)90247-I; Hare D, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00034; Hare D, 2009, METALLOMICS, V1, P53, DOI 10.1039/b816188g; Hare DJ, 2014, CHEM SCI, V5, P2160, DOI 10.1039/c3sc53461h; He Y, 1999, FREE RADICAL RES, V31, P103, DOI 10.1080/10715769900301611; HILL JM, 1985, P NATL ACAD SCI USA, V82, P4553, DOI 10.1073/pnas.82.13.4553; JELLINGER K, 1990, J NEURAL TRANSM-PARK, V2, P327, DOI 10.1007/BF02252926; Jiang H, 2010, CELL RES, V20, P345, DOI 10.1038/cr.2010.20; Ke Y, 2003, LANCET NEUROL, V2, P246, DOI 10.1016/S1474-4422(03)00353-3; Kondoh T, 2005, EXP NEUROL, V192, P194, DOI 10.1016/j.expneurol.2004.12.016; Kortekaas R, 2005, ANN NEUROL, V57, P176, DOI 10.1002/ana.20369; Kwan JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035241; Lei P, 2012, NAT MED, V18, P291, DOI 10.1038/nm.2613; Li WJ, 2011, NEUROTOX RES, V19, P435, DOI 10.1007/s12640-010-9187-x; Lv ZY, 2011, J NEURAL TRANSM, V118, P361, DOI 10.1007/s00702-010-0434-3; Moos T, 2007, J NEUROCHEM, V103, P1730, DOI 10.1111/j.1471-4159.2007.04976.x; Mounsey Ross B, 2012, Int J Cell Biol, V2012, P983245, DOI 10.1155/2012/983245; Nunez MT, 2012, BIOMETALS, V25, P761, DOI 10.1007/s10534-012-9523-0; Ohta E, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/197438; Ortega R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000925; Rite I, 2007, J NEUROCHEM, V101, P1567, DOI 10.1111/j.1471-4159.2007.04567.x; Rossi M, 2013, CLIN IMAG, V37, P631, DOI 10.1016/j.clinimag.2013.02.001; Rouault TA, 2001, PEDIATR NEUROL, V25, P130, DOI 10.1016/S0887-8994(01)00260-0; SACHS C, 1975, BIOCHEM PHARMACOL, V24, P1, DOI 10.1016/0006-2952(75)90304-4; Sadrzadeh S M Hossein, 2004, Am J Clin Pathol, V121 Suppl, pS64; SAUER H, 1994, NEUROSCIENCE, V59, P401, DOI 10.1016/0306-4522(94)90605-X; Schenck JF, 2003, J NEUROL SCI, V207, P99, DOI 10.1016/S0022-510X(02)00431-8; Schipper HM, 2012, BBA-MOL BASIS DIS, V1822, P350, DOI 10.1016/j.bbadis.2011.06.016; SCHMIDTKASTNER R, 1993, J NEUROSCI METH, V46, P121, DOI 10.1016/0165-0270(93)90147-J; Soria G, 2011, EUR J NEUROSCI, V33, P1551, DOI 10.1111/j.1460-9568.2011.07639.x; Stankiewicz J, 2007, NEUROTHERAPEUTICS, V4, P371, DOI 10.1016/j.nurt.2007.05.006; STROMBERG I, 1986, BRAIN RES BULL, V17, P225, DOI 10.1016/0361-9230(86)90119-X; Tarohda T, 2005, ANAL BIOANAL CHEM, V383, P224, DOI 10.1007/s00216-005-3423-x; Ulla M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057904; Van Camp N, 2010, MAGN RESON MATER PHY, V23, P65, DOI 10.1007/s10334-010-0198-7; Wachter B, 2012, BEHAV BRAIN RES, V232, P148, DOI 10.1016/j.bbr.2012.04.005; Wallis LI, 2008, J MAGN RESON IMAGING, V28, P1061, DOI 10.1002/jmri.21563; Wang J, 2004, NEUROCHEM RES, V29, P2239, DOI 10.1007/s11064-004-7031-5; Wood JC, 2011, HEMATOL-AM SOC HEMAT, P443, DOI 10.1182/asheducation-2011.1.443; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhang JQ, 2010, BRAIN RES, V1330, P124, DOI 10.1016/j.brainres.2010.03.036	53	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112941	10.1371/journal.pone.0112941	http://dx.doi.org/10.1371/journal.pone.0112941			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398088	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558500115
J	Guseva, D; Loers, G; Schachner, M				Guseva, Daria; Loers, Gabriele; Schachner, Melitta			Function-Triggering Antibodies to the Adhesion Molecule L1 Enhance Recovery after Injury of the Adult Mouse Femoral Nerve	PLOS ONE			English	Article							SPINAL-CORD-INJURY; IMMUNOELECTRON MICROSCOPIC LOCALIZATION; RETINAL GANGLION-CELLS; GROWTH CONE MOTILITY; N-CAM; SCHWANN-CELLS; RECOGNITION MOLECULES; SCIATIC-NERVE; CARBOHYDRATE EPITOPE; CHOLINERGIC NEURONS	L1 is among the few adhesion molecules that favors repair after trauma in the adult central nervous system of vertebrates by promoting neuritogenesis and neuronal survival, among other beneficial features. In the peripheral nervous system, L1 is up-regulated in Schwann cells and regrowing axons after nerve damage, but the functional consequences of this expression remain unclear. Our previous study of L1-deficient mice in a femoral nerve injury model showed an unexpected improved functional recovery, attenuated motoneuronal cell death, and enhanced Schwann cell proliferation, being attributed to the persistent synthesis of neurotrophic factors. On the other hand, transgenic mice over-expressing L1 in neurons led to improved remyelination, but not improved functional recovery. The present study was undertaken to investigate whether the monoclonal L1 antibody 557 that triggers beneficial L1 functions in vitro would trigger these also in femoral nerve repair. We analyzed femoral nerve regeneration in C57BL/6J mice that received this antibody in a hydrogel filled conduit connecting the cut and sutured nerve before its bifurcation, leading to short-term release of antibody by diffusion. Video-based quantitative analysis of motor functions showed improved recovery when compared to mice treated with conduits containing PBS in the hydrogel scaffold, as a vehicle control. This improved recovery was associated with attenuated motoneuron loss, remyelination and improved precision of preferential motor reinnervation. We suggest that function-triggering L1 antibodies applied to the lesion site at the time of injury over a limited time period will not only be beneficial in peripheral, but also central nervous system regeneration.	[Guseva, Daria; Loers, Gabriele] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, Hamburg, Germany; [Guseva, Daria] Hannover Med Sch, Hannover, Germany; [Schachner, Melitta] Shantou Univ, Coll Med, Ctr Neurosci, Shantou, Peoples R China; [Schachner, Melitta] Rutgers State Univ, WM Keck Ctr Collaborat Neurosci, Piscataway, NJ USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School; Shantou University; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Schachner, M (corresponding author), Shantou Univ, Coll Med, Ctr Neurosci, Shantou, Peoples R China.	schachner@stu.edu.cn	Guseva, Daria/AAW-2546-2021; Guseva, Daria/S-8582-2018	Guseva, PD, PhD, Daria/0000-0002-8844-572X	Hertie Stiftung [1.01.1/06/005]	Hertie Stiftung(Austrian Science Fund (FWF))	This work was supported by a grant from the Hertie Stiftung (1.01.1/06/005). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock KH, 2004, EUR J NEUROSCI, V20, P1425, DOI 10.1111/j.1460-9568.2004.03573.x; Ahlborn P, 2007, EXP NEUROL, V208, P137, DOI 10.1016/j.expneurol.2007.08.005; Apostolova I, 2006, J NEUROSCI, V26, P7849, DOI 10.1523/JNEUROSCI.1526-06.2006; APPEL F, 1995, J NEUROBIOL, V28, P297, DOI 10.1002/neu.480280304; Becker T, 2005, MOL CELL NEUROSCI, V30, P265, DOI 10.1016/j.mcn.2005.07.008; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bennett V, 2001, CURR OPIN CELL BIOL, V13, P61, DOI 10.1016/S0955-0674(00)00175-7; Bernhardt RR, 1996, J COMP NEUROL, V376, P253, DOI 10.1002/(SICI)1096-9861(19961209)376:2<253::AID-CNE7>3.0.CO;2-2; Bernreuther C, 2006, J NEUROSCI, V26, P11532, DOI 10.1523/JNEUROSCI.2688-06.2006; BIXBY JL, 1988, J CELL BIOL, V107, P353, DOI 10.1083/jcb.107.1.353; Brannstrom T, 1999, EXP BRAIN RES, V125, P19, DOI 10.1007/s002210050653; BurdenGulley SM, 1997, CELL TISSUE RES, V290, P415, DOI 10.1007/s004410050948; Bushman J, 2014, NEUROPHARMACOLOGY, V79, P456, DOI 10.1016/j.neuropharm.2013.09.014; Chaisuksunt V, 2000, NEUROSCIENCE, V100, P87, DOI 10.1016/S0306-4522(00)00254-2; Chen J, 2007, BRAIN, V130, P954, DOI 10.1093/brain/awm049; Cui XZ, 2011, BRAIN BEHAV, V1, P73, DOI 10.1002/brb3.15; Cui YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017126; Cui YF, 2010, BRAIN, V133, P189, DOI 10.1093/brain/awp290; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; DANILOFF JK, 1986, J CELL BIOL, V103, P929, DOI 10.1083/jcb.103.3.929; DAVIS JQ, 1994, J BIOL CHEM, V269, P27163; Djogo N, 2013, NEUROBIOL DIS, V56, P104, DOI 10.1016/j.nbd.2013.04.014; Eberhardt KA, 2006, EXP NEUROL, V198, P500, DOI 10.1016/j.expneurol.2005.12.018; FAISSNER A, 1984, DEV BRAIN RES, V15, P69, DOI 10.1016/0165-3806(84)90141-X; GROTHE C, 1989, NEUROSCIENCE, V31, P649, DOI 10.1016/0306-4522(89)90430-2; Guan HJ, 2010, CEREB CORTEX, V20, P2684, DOI 10.1093/cercor/bhq016; Guseva D, 2011, EXP NEUROL, V229, P339, DOI 10.1016/j.expneurol.2011.02.018; Guseva D, 2009, BRAIN, V132, P2180, DOI 10.1093/brain/awp160; HALL DE, 1987, J CELL BIOL, V104, P623, DOI 10.1083/jcb.104.3.623; Haney CA, 1999, J CELL BIOL, V146, P1173, DOI 10.1083/jcb.146.5.1173; Hortsch M, 2003, FRONT BIOSCI, V8, pD357, DOI 10.2741/1006; Hortsch M, 2009, CELL MOL BIOL LETT, V14, P57, DOI 10.2478/s11658-008-0035-4; Huang A, 2000, J NEUROPHYSIOL, V83, P3537, DOI 10.1152/jn.2000.83.6.3537; Irintchev A, 2005, EUR J NEUROSCI, V22, P802, DOI 10.1111/j.1460-9568.2005.04274.x; IRINTCHEV A, 1990, NEUROSCIENCE, V39, P231, DOI 10.1016/0306-4522(90)90236-W; Irintchev A, 2005, CEREB CORTEX, V15, P950, DOI 10.1093/cercor/bhh195; Irintchev A, 2011, J NEUROTRAUM, V28, P1295, DOI 10.1089/neu.2011.1775; Itoh K, 2005, MOL CELL NEUROSCI, V30, P131, DOI 10.1016/j.mcn.2005.06.006; Jung M, 1997, MOL CELL NEUROSCI, V9, P116, DOI 10.1006/mcne.1997.0611; KADMON G, 1990, J CELL BIOL, V110, P209, DOI 10.1083/jcb.110.1.209; Kamiguchi H, 1997, J NEUROSCI RES, V49, P1, DOI 10.1002/(SICI)1097-4547(19970701)49:1<1::AID-JNR1>3.0.CO;2-H; Khristy W, 2009, BRAIN RES, V1273, P9, DOI 10.1016/j.brainres.2009.03.060; KLEITMAN N, 1988, EXP NEUROL, V102, P298, DOI 10.1016/0014-4886(88)90223-3; Lavdas AA, 2010, J NEUROCHEM, V115, P1137, DOI 10.1111/j.1471-4159.2010.07003.x; LEIFER D, 1984, SCIENCE, V224, P303, DOI 10.1126/science.6143400; Loers G, 2014, BIOCH J; Loers G, 2007, J NEUROCHEM, V101, P865, DOI 10.1111/j.1471-4159.2006.04409.x; Loers G, 2014, BIOCHEM J, V460, P437, DOI 10.1042/BJ20131677; Lutz D, 2014, J BIOL CHEM; Lutz D, 2012, J BIOL CHEM, V287, P17161, DOI 10.1074/jbc.M112.346759; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; MARTINI R, 1986, J CELL BIOL, V103, P2439, DOI 10.1083/jcb.103.6.2439; MARTINI R, 1994, J NEUROCYTOL, V23, P1, DOI 10.1007/BF01189813; MARTINI R, 1988, J CELL BIOL, V106, P1735, DOI 10.1083/jcb.106.5.1735; Mason MRJ, 2003, EUR J NEUROSCI, V18, P789, DOI 10.1046/j.1460-9568.2003.02809.x; McPhail LT, 2004, EXP NEUROL, V188, P331, DOI 10.1016/j.expneurol.2004.04.010; Mehanna A, 2009, BRAIN, V132, P1449, DOI 10.1093/brain/awp128; Miles GB, 2007, P NATL ACAD SCI USA, V104, P2448, DOI 10.1073/pnas.0611134104; NIEKE J, 1985, DIFFERENTIATION, V30, P141, DOI 10.1111/j.1432-0436.1985.tb00525.x; Ramirez-Jarquin UN, 2014, NEUROPHARMACOLOGY, V82, P101, DOI 10.1016/j.neuropharm.2013.10.003; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; Ourednik V, 2009, STEM CELLS, V27, P2846, DOI 10.1002/stem.227; PERSOHN E, 1987, J CELL BIOL, V105, P569, DOI 10.1083/jcb.105.1.569; Roonprapunt C, 2003, J NEUROTRAUM, V20, P871, DOI 10.1089/089771503322385809; Rudomin P, 2009, EXP BRAIN RES, V196, P139, DOI 10.1007/s00221-009-1758-9; Schuch U, 1989, NEURON, V3, P13; SEILHEIMER B, 1988, J CELL BIOL, V107, P341, DOI 10.1083/jcb.107.1.341; SEILHEIMER B, 1989, J CELL BIOL, V109, P3095, DOI 10.1083/jcb.109.6.3095; SEILHEIMER B, 1987, EMBO J, V6, P1611, DOI 10.1002/j.1460-2075.1987.tb02408.x; Shelton DL, 2005, PAIN, V116, P8, DOI 10.1016/j.pain.2005.03.039; Simova O, 2006, ANN NEUROL, V60, P430, DOI 10.1002/ana.20948; Stallcup WB, 2000, J NEUROSCI RES, V61, P33, DOI 10.1002/1097-4547(20000701)61:1<33::AID-JNR4>3.0.CO;2-Y; STYREN SD, 1995, EXP NEUROL, V131, P165, DOI 10.1016/0014-4886(95)90038-1; Takeda Yasuo, 2001, Keio Journal of Medicine, V50, P240; WILLIAMS EJ, 1992, J CELL BIOL, V119, P883, DOI 10.1083/jcb.119.4.883; WOOD P, 1990, ANN NY ACAD SCI, V605, P1, DOI 10.1111/j.1749-6632.1990.tb42376.x; WOOD PM, 1990, J NEUROSCI, V10, P3635; Woolhead CL, 1998, J COMP NEUROL, V391, P259; Xu JC, 2011, J NEUROTRAUM, V28, P1921, DOI 10.1089/neu.2011.1783; ZHANG Y, 1995, J COMP NEUROL, V361, P193, DOI 10.1002/cne.903610202	80	8	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112984	10.1371/journal.pone.0112984	http://dx.doi.org/10.1371/journal.pone.0112984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393007	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300132
J	Liu, J; Wang, Q; Sun, MY; Zhu, LL; Yang, M; Zhao, Y				Liu, Jing; Wang, Qun; Sun, Minying; Zhu, Linlin; Yang, Michael; Zhao, Yu			Selection of Reference Genes for Quantitative Real-Time PCR Normalization in Panax ginseng at Different Stages of Growth and in Different Organs	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MESSENGER-RNA EXPRESSION; INTERNAL CONTROL; ANTLER-TIP; IDENTIFICATION; TRANSCRIPTOME; VALIDATION; BIOSYNTHESIS; CONSTITUENTS	Quantitative real-time reverse transcription PCR (qRT-PCR) has become a widely used method for gene expression analysis; however, its data interpretation largely depends on the stability of reference genes. The transcriptomics of Panax ginseng, one of the most popular and traditional ingredients used in Chinese medicines, is increasingly being studied. Furthermore, it is vital to establish a series of reliable reference genes when qRT-PCR is used to assess the gene expression profile of ginseng. In this study, we screened out candidate reference genes for ginseng using gene expression data generated by a high-throughput sequencing platform. Based on the statistical tests, 20 reference genes (10 traditional housekeeping genes and 10 novel genes) were selected. These genes were tested for the normalization of expression levels in five growth stages and three distinct plant organs of ginseng by qPCR. These genes were subsequently ranked and compared according to the stability of their expressions using geNorm, NormFinder, and BestKeeper computational programs. Although the best reference genes were found to vary across different samples, CYP and EF-1 alpha were the most stable genes amongst all samples. GAPDH/30S RPS20, CYP/60S RPL13 and CYP/QCR were the optimum pair of reference genes in the roots, stems, and leaves. CYP/60S RPL13, CYP/eIF-5A, aTUB/V-ATP, eIF-5A/SAR1, and aTUB/pol IIa were the most stably expressed combinations in each of the five developmental stages. Our study serves as a foundation for developing an accurate method of qRT-PCR and will benefit future studies on gene expression profiles of Panax Ginseng.	[Liu, Jing; Wang, Qun; Sun, Minying; Zhu, Linlin; Zhao, Yu] Changchun Univ Tradit Chinese Med, Tradit Chinese Med & Biotechnol Res & Dev Ctr, Changchun, Jilin, Peoples R China; [Yang, Michael] Columbia Univ, Coll Dent Med, New York, NY USA	Changchun University of Chinese Medicine; Columbia University	Zhao, Y (corresponding author), Changchun Univ Tradit Chinese Med, Tradit Chinese Med & Biotechnol Res & Dev Ctr, Changchun, Jilin, Peoples R China.	cnzhaoyu1972@126.com			National Natural Science Foundation of China [81373937]; National Key Technology R&D Program of China [2011BAI03B01-04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program of China(National Key Technology R&D Program)	This work was supported by the National Natural Science Foundation of China (no. 81373937, URL: http://www.nsfc.gov.cn/Portal0/default152.htm) and the National Key Technology R&D Program of China (no. 2011BAI03B01-04, URL: http://www.863.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], 2009, ALTERN MED REV, V14, P172; Attele AS, 1999, BIOCHEM PHARMACOL, V58, P1685, DOI 10.1016/S0006-2952(99)00212-9; Bemeur C, 2004, NEUROSCI LETT, V357, P211, DOI 10.1016/j.neulet.2003.12.081; Briskin DP, 2000, PLANT PHYSIOL, V124, P507, DOI 10.1104/pp.124.2.507; Cankorur-Cetinkaya A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038351; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Chen WY, 2010, GINSENG DEV PRACTICA; Chi XY, 2012, MOL GENET GENOMICS, V287, P167, DOI 10.1007/s00438-011-0665-5; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Etschmann B, 2006, VET PATHOL, V43, P934, DOI 10.1354/vp.43-6-934; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Foldager CB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-94; Gamm M, 2011, MOL GENET GENOMICS, V285, P273, DOI 10.1007/s00438-011-0607-2; Goossens K, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-27; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Han JY, 2011, PLANT CELL PHYSIOL, V52, P2062, DOI 10.1093/pcp/pcr150; Han XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043084; HOU JP, 1977, COMP MED EAST WEST, V5, P123, DOI 10.1142/S0147291777000209; Jackson CJC, 2003, J GINSENG RES, V27, P135; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kim YK, 2012, J KOREAN SOC APPL BI, V55, P27, DOI 10.1007/s13765-012-0005-4; Kiselev KV, 2010, BIOL PLANTARUM, V54, P621, DOI 10.1007/s10535-010-0112-1; Lee OR, 2012, MOL BIOL REP, V39, P2365, DOI 10.1007/s11033-011-0987-8; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Liu DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046451; MacRae T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072884; Maess MB, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-90; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Pierzchala M, 2011, ANIM SCI PAP REP, V29, P53; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Sathiyaraj G, 2010, MOL BIOL REP, V37, P3445, DOI 10.1007/s11033-009-9936-1; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Volkov RA, 2003, J EXP BOT, V54, P2343, DOI 10.1093/jxb/erg244; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008; Wang Hongwei, 2009, Chin Med, V4, P20, DOI 10.1186/1749-8546-4-20; Wu Q, 2012, PLANT OMICS, V5, P414; Xie JT, 2011, GINSENG BENEFICIAL P; Yao BJ, 2012, BIOTECHNOL LETT, V34, P813, DOI 10.1007/s10529-011-0841-z; Yao BJ, 2012, MOL CELL BIOCHEM, V364, P93, DOI 10.1007/s11010-011-1209-3; YIP TT, 1985, AM J CHINESE MED, V13, P77, DOI 10.1142/S0192415X85000125; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405	48	36	44	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112177	10.1371/journal.pone.0112177	http://dx.doi.org/10.1371/journal.pone.0112177			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393243	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300039
J	Miles, KM; Seshadri, M; Ciamporcero, E; Adelaiye, R; Gillard, B; Sotomayor, P; Attwood, K; Shen, L; Conroy, D; Kuhnert, F; Lalani, AS; Thurston, G; Pili, R				Miles, Kiersten Marie; Seshadri, Mukund; Ciamporcero, Eric; Adelaiye, Remi; Gillard, Bryan; Sotomayor, Paula; Attwood, Kristopher; Shen, Li; Conroy, Dylan; Kuhnert, Frank; Lalani, Alshad S.; Thurston, Gavin; Pili, Roberto			Dll4 Blockade Potentiates the Anti-Tumor Effects of VEGF Inhibition in Renal Cell Carcinoma Patient-Derived Xenografts	PLOS ONE			English	Article							TUMOR-GROWTH; CANCER; ANGIOGENESIS; EXPRESSION; RESISTANCE; THERAPY	Background: The Notch ligand Delta-like 4 (Dll4) is highly expressed in vascular endothelium and has been shown to play a pivotal role in regulating tumor angiogenesis. Blockade of the Dll4-Notch pathway in preclinical cancer models has been associated with non-productive angiogenesis and reduced tumor growth. Given the cross-talk between the vascular endothelial growth factor (VEGF) and Delta-Notch pathways in tumor angiogenesis, we examined the activity of a function-blocking Dll4 antibody, REGN1035, alone and in combination with anti-VEGF therapy in renal cell carcinoma (RCC). Methods and Results: Severe combined immunodeficiency (SCID) mice bearing patient-derived clear cell RCC xenografts were treated with REGN1035 and in combination with the multi-targeted tyrosine kinase inhibitor sunitinib or the VEGF blocker ziv-aflibercept. Immunohistochemical and immunofluorescent analyses were carried out, as well as magnetic resonance imaging (MRI) examinations pre and 24 hours and 2 weeks post treatment. Single agent treatment with REGN1035 resulted in significant tumor growth inhibition (36-62%) that was equivalent to or exceeded the single agent anti-tumor activity of the VEGF pathway inhibitors sunitinib (38-54%) and ziv-aflibercept (46%). Importantly, combination treatments with REGN1035 plus VEGF inhibitors resulted in enhanced anti-tumor effects (72-80% growth inhibition), including some tumor regression. Magnetic resonance imaging showed a marked decrease in tumor perfusion in all treatment groups. Interestingly, anti-tumor efficacy of the combination of REGN1035 and ziv-aflibercept was also observed in a sunitinib resistant ccRCC model. Conclusions: Overall, these findings demonstrate the potent anti-tumor activity of Dll4 blockade in RCC patient-derived tumors and a combination benefit for the simultaneous targeting of the Dll4 and VEGF signaling pathways, highlighting the therapeutic potential of this treatment modality in RCC.	[Miles, Kiersten Marie; Shen, Li; Conroy, Dylan; Pili, Roberto] Roswell Pk Canc Inst, Genitourinary Program, Buffalo, NY 14263 USA; [Seshadri, Mukund; Gillard, Bryan] SUNY Buffalo, Roswell Pk Canc Inst Div, Dept Pharmacol & Therapeut, Buffalo, NY 14260 USA; [Adelaiye, Remi; Pili, Roberto] SUNY Buffalo, Roswell Pk Canc Inst Div, Dept Canc Pathol & Prevent, Buffalo, NY 14260 USA; [Sotomayor, Paula] SUNY Buffalo, Roswell Pk Canc Inst Div, Dept Mol & Cellular Biol, Buffalo, NY 14260 USA; [Attwood, Kristopher] SUNY Buffalo, Roswell Pk Canc Inst Div, Dept Biostat & Bioinformat, Buffalo, NY 14260 USA; [Ciamporcero, Eric] Univ Turin, Turin, Italy; [Kuhnert, Frank; Lalani, Alshad S.; Thurston, Gavin] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Turin; Regeneron	Pili, R (corresponding author), Roswell Pk Canc Inst, Genitourinary Program, Buffalo, NY 14263 USA.	Roberto.Pili@RoswellPark.org	Ciamporcero, Eric/M-6580-2017; Seshadri, Mukund/AAB-5011-2020	Ciamporcero, Eric/0000-0002-3856-6435; Thurston, Gavin/0000-0002-4105-5919; Adelaiye-Ogala, Remi/0000-0002-6581-7359	National Cancer Institute, National Institutes of Health [P30CA016056]; Regeneron Pharmaceuticals, Inc.; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Regeneron Pharmaceuticals, Inc.(Regeneron); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the National Cancer Institute, National Institutes of Health (P30CA016056) (RP), and by a research grant from Regeneron Pharmaceuticals, Inc. (RP). The funder provided support in the form of salaries for authors GT, ASL, FK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio LMA, 2011, CANCER GENOM PROTEOM, V8, P93; Bridges E, 2011, FUTURE ONCOL, V7, P569, DOI [10.2217/FON.11.20, 10.2217/fon.11.20]; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Ellis L, 2012, MOL CANCER THER, V11, P383, DOI 10.1158/1535-7163.MCT-11-0748; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Gaya A, 2012, CANCER TREAT REV, V38, P484, DOI 10.1016/j.ctrv.2011.12.008; Gurney A, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-18; Hammers HJ, 2010, MOL CANCER THER, V9, P1525, DOI 10.1158/1535-7163.MCT-09-1106; Hassan KA, 2013, CLIN CANCER RES, V19, P1972, DOI 10.1158/1078-0432.CCR-12-0370; Hoey T, 2009, CELL STEM CELL, V5, P168, DOI 10.1016/j.stem.2009.05.019; Hu W, 2011, CANCER RES, V71, P6030, DOI 10.1158/0008-5472.CAN-10-2719; Ioffe E, 2012, P 103 ANN M AACR 201; Jubb AM, 2011, CLIN CANCER RES, V17, P372, DOI 10.1158/1078-0432.CCR-10-1791; Jubb AM, 2010, AM J PATHOL, V176, P2019, DOI 10.2353/ajpath.2010.090908; Kuhnert F, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-20; Li JL, 2011, CANCER RES, V71, P6073, DOI 10.1158/0008-5472.CAN-11-1704; Li JL, 2010, FUTURE ONCOL, V6, P1099, DOI [10.2217/fon.10.62, 10.2217/FON.10.62]; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Seshadri M, 2006, NEOPLASIA, V8, P534, DOI 10.1593/neo.06295; Verheul HMW, 2007, CLIN CANCER RES, V13, P4201, DOI 10.1158/1078-0432.CCR-06-2553; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Yan MH, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-17; Yan MH, 2010, NATURE, V463, pE6, DOI 10.1038/nature08751; Zhang JX, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0390-x	26	39	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112371	10.1371/journal.pone.0112371	http://dx.doi.org/10.1371/journal.pone.0112371			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393540	Green Submitted, Green Published, gold			2022-12-27	WOS:000347709300054
J	Nostl, A; Marsh, JE; Sorqvist, P				Nostl, Anatole; Marsh, John E.; Sorqvist, Patrik			What We Expect Is Not Always What We Get: Evidence for Both the Direction-of-Change and the Specific-Stimulus Hypotheses of Auditory Attentional Capture	PLOS ONE			English	Article							BRAIN; ACTIVATION; MECHANISMS; NOVELTY; MEMORY	Participants were requested to respond to a sequence of visual targets while listening to a well-known lullaby. One of the notes in the lullaby was occasionally exchanged with a pattern deviant. Experiment 1 found that deviants capture attention as a function of the pitch difference between the deviant and the replaced/expected tone. However, when the pitch difference between the expected tone and the deviant tone is held constant, a violation to the direction-of-pitch change across tones can also capture attention (Experiment 2). Moreover, in more complex auditory environments, wherein it is difficult to build a coherent neural model of the sound environment from which expectations are formed, deviations can capture attention but it appears to matter less whether this is a violation from a specific stimulus or a violation of the current direction-of-change (Experiment 3). The results support the expectation violation account of auditory distraction and suggest that there are at least two different expectations that can be violated: One appears to be bound to a specific stimulus and the other would seem to be bound to a more global cross-stimulus rule such as the direction-of-change based on a sequence of preceding sound events. Factors like base-rate probability of tones within the sound environment might become the driving mechanism of attentional capture-rather than violated expectations-in complex sound environments.	[Nostl, Anatole; Marsh, John E.; Sorqvist, Patrik] Univ Gavle, Dept Bldg Energy & Environm Engn, Gavle, Sweden; [Marsh, John E.] Univ Cent Lancashire, Sch Psychol, Preston PR1 2HE, Lancs, England; [Sorqvist, Patrik] Linkoping Univ, Swedish Inst Disabil Res, Linnaeus Ctr HEAD, Linkoping, Sweden	University of Gavle; University of Central Lancashire; Linkoping University	Nostl, A (corresponding author), Univ Gavle, Dept Bldg Energy & Environm Engn, Gavle, Sweden.	anatole.nostl@hig.se		Marsh, John Everett/0000-0002-9494-1287; Sorqvist, Patrik/0000-0002-7584-2275	Swedish Research Council [2010-2042]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	The research reported in this article was financially supported by a grant from the Swedish Research Council (2010-2042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Bendixen A, 2012, INT J PSYCHOPHYSIOL, V83, P120, DOI 10.1016/j.ijpsycho.2011.08.003; Bendixen A, 2009, J NEUROSCI, V29, P8447, DOI 10.1523/JNEUROSCI.1493-09.2009; Corral MJ, 2008, NEUROREPORT, V19, P1535, DOI 10.1097/WNR.0b013e3283110416; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Jaramillo M, 2000, NEUROSCI LETT, V290, P101, DOI 10.1016/S0304-3940(00)01344-6; Kimura M, 2010, J COGNITIVE NEUROSCI, V22, P1124, DOI 10.1162/jocn.2009.21299; Marsh JE, 2014, PSYCH J, V3, P58, DOI 10.1002/pchj.50; Miranda RA, 2007, NEUROIMAGE, V38, P331, DOI 10.1016/j.neuroimage.2007.07.034; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; Nostl A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048569; Parmentier FBR, 2011, COGNITION, V119, P374, DOI 10.1016/j.cognition.2011.02.001; Roer JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084166; Schroger E, 1997, PSYCHOPHYSIOLOGY, V34, P245, DOI 10.1111/j.1469-8986.1997.tb02395.x; Sorqvist P, 2012, PSYCHON B REV, V19, P245, DOI 10.3758/s13423-011-0203-9; Vachon F, 2012, J EXP PSYCHOL LEARN, V38, P164, DOI 10.1037/a0025054; Yago E, 2001, NEUROREPORT, V12, P4093, DOI 10.1097/00001756-200112210-00046	17	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e111997	10.1371/journal.pone.0111997	http://dx.doi.org/10.1371/journal.pone.0111997			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY6YT	25393298	gold, Green Submitted, Green Published			2022-12-27	WOS:000347709300027
J	Sarikonda, G; Fousteri, G; Sachithanantham, S; Miller, JF; Dave, A; Juntti, T; Coppieters, KT; von Herrath, M				Sarikonda, Ghanashyam; Fousteri, Georgia; Sachithanantham, Sowbarnika; Miller, Jacqueline F.; Dave, Amy; Juntti, Therese; Coppieters, Ken T.; von Herrath, Matthias			BDC12-4.1 T-Cell Receptor Transgenic Insulin-Specific CD4 T Cells Are Resistant to In Vitro Differentiation into Functional Foxp3(+) T Regulatory Cells	PLOS ONE			English	Article							NOD MICE; ANTIGEN; EPITOPE; ESCAPE; MHC; TOLERANCE; PEPTIDES; MOUSE	The infusion of ex vivo-expanded autologous T regulatory (Treg) cells is potentially an effective immunotherapeutic strategy against graft-versus-host disease (GvHD) and several autoimmune diseases, such as type 1 diabetes (T1D). However, in vitro differentiation of antigen-specific T cells into functional and stable Treg (iTreg) cells has proved challenging. As insulin is the major autoantigen leading to T1D, we tested the capacity of insulin-specific T-cell receptor (TCR) transgenic CD4(+) T cells of the BDC12-4.1 clone to convert into Foxp3(+) iTreg cells. We found that in vitro polarization toward Foxp3(+) iTreg was effective with a majority (>70%) of expanded cells expressing Foxp3. However, adoptive transfer of Foxp3(+) BDC12-4.1 cells did not prevent diabetes onset in immunocompetent NOD mice. Thus, in vitro polarization of insulin-specific BDC12-4.1 TCR transgenic CD4(+) T cells toward Foxp3(+) cells did not provide dominant tolerance in recipient mice. These results highlight the disconnect between an in vitro acquired Foxp3(+) cell phenotype and its associated in vivo regulatory potential.	[Sarikonda, Ghanashyam; Fousteri, Georgia; Sachithanantham, Sowbarnika; Miller, Jacqueline F.; Dave, Amy; Juntti, Therese; von Herrath, Matthias] La Jolla Inst Allergy & Immunol, Ctr Diabet, La Jolla, CA 92037 USA; [Coppieters, Ken T.; von Herrath, Matthias] Novo Nordisk Inc, Type Diabet R&D Ctr 1, Seattle, WA USA	La Jolla Institute for Immunology; Novo Nordisk	von Herrath, M (corresponding author), La Jolla Inst Allergy & Immunol, Ctr Diabet, La Jolla, CA 92037 USA.	matthias@liai.org	; Fousteri, Georgia/B-1226-2012	Jhatakia, Amy/0000-0001-6855-5342; Fousteri, Georgia/0000-0001-7745-7517	National Institute of Diabetes and Digestive and Kidney (NIDDK) [U01 (DK078013)]; University of Colorado, Denver (UCD); NIH [5U19AI050864-08]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI050864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK078013] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Colorado, Denver (UCD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a U01 (DK078013) National Institute of Diabetes and Digestive and Kidney (NIDDK) grant to MvH and a subaward from the University of Colorado, Denver (UCD) to LIAI, issued under NIH award number 5U19AI050864-08 to UCD under the direction of Dr. George S. Eisenbarth. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crawford F, 2011, P NATL ACAD SCI USA, V108, P16729, DOI 10.1073/pnas.1113954108; Daniel C, 2011, J EXP MED, V208, P1501, DOI 10.1084/jem.20110574; DANIEL D, 1995, EUR J IMMUNOL, V25, P1056, DOI 10.1002/eji.1830250430; Du W, 2006, J CLIN INVEST, V116, P1360, DOI 10.1172/JCI27030; FAIRCHILD PJ, 1993, INT IMMUNOL, V5, P1151, DOI 10.1093/intimm/5.9.1151; Fousteri G, 2012, DIABETES; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Jasinski JM, 2006, DIABETES, V55, P1978, DOI 10.2337/db06-0058; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; Marek-Trzonkowska N, 2013, PEDIATR DIABETES, V14, P322, DOI 10.1111/pedi.12029; Marek-Trzonkowska N, 2012, DIABETES CARE, V35, P1817, DOI 10.2337/dc12-0038; Mingueneau M, 2012, J EXP MED, V209, P623, DOI 10.1084/jem.20112593; Mohan JF, 2011, J EXP MED, V208, P2375, DOI 10.1084/jem.20111502; Mohan JF, 2010, NAT IMMUNOL, V11, P350, DOI 10.1038/ni.1850; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; WEGMANN DR, 1994, J AUTOIMMUN, V7, P833, DOI 10.1006/jaut.1994.1066; WEGMANN DR, 1994, EUR J IMMUNOL, V24, P1853, DOI 10.1002/eji.1830240820; Yu B, 2000, EUR J IMMUNOL, V30, P2497, DOI 10.1002/1521-4141(200009)30:9<2497::AID-IMMU2497>3.0.CO;2-J; Zekzer D, 1997, DIABETES, V46, P1124, DOI 10.2337/diabetes.46.7.1124; Zhang L, 2008, CURR OPIN IMMUNOL, V20, P111, DOI 10.1016/j.coi.2007.11.005	21	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112242	10.1371/journal.pone.0112242	http://dx.doi.org/10.1371/journal.pone.0112242			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393309	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300041
J	Zhao, D; Cho, J; Kim, MH; Friedman, D; Guallar, E				Zhao, Di; Cho, Juhee; Kim, Myung Hun; Friedman, David; Guallar, Eliseo			Diabetes, Glucose Metabolism, and Glaucoma: The 2005-2008 National Health and Nutrition Examination Survey	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; RISK-FACTOR; INSULIN-RESISTANCE; EYE DISEASES; MELLITUS; POPULATION; PREVALENCE; ABNORMALITIES; HYPERTENSION	Background: Diabetes may affect vascular autoregulation of the retina and optic nerve and may be associated with an increased risk of glaucoma, but the association of prediabetes, insulin resistance, markers of glucose metabolismwith glaucoma has not beenevaluated in general population samples. Objective: To examine the relation between diabetes, pre-diabetes, metabolic syndrome and its components and the levels of fasting glucose, HbA1c and HOMA-IR with the prevalence of glaucoma in the general U.S. population. Methods: Cross-sectional study of 3,299 adult men and women from the 2005-2008 National Health and NutritionExamination Survey (NHANES). The presence of diabetes, prediabetes, the metabolic syndrome and its individual components and biomarkers of glucose metabolisms were based on standardized questionnaire and physical exam data and laboratory tests. The history of glaucoma was assessed through questionnaire during the home interview. Results: Diabetes was strongly associated with prevalent glaucoma. In fully adjusted models, the odds ratiofor glaucoma comparing participants with diabetes with participants in the reference group with neither pre-diabetes nor diabetes was 2.12 (95% CI: 1.23, 3.67). The corresponding odd ratio comparing participants with pre-diabetes to those in the reference group was 1.01 (95% CI: 0.57, 1.82). Patients with 5 or more years of diabetes duration hadan OR for glaucoma of 3.90 (95% CI: 1.63, 9.32) compared with patients with <5 years of diabetes duration. We also found a hockey-stick shaped associations between biomarkers of glucose metabolisms and the prevalence of glaucoma. Conclusions: Diabetes was associated with higher risk of glaucoma. Participants without diabetes but at the higher levels of fasting glucose, fasting insulin, HbA1c and HOMA-IR spectrum may also be at greater risk of glaucoma.	[Zhao, Di; Guallar, Eliseo] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Zhao, Di; Guallar, Eliseo] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Cho, Juhee] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul, South Korea; [Kim, Myung Hun] Saevit Eye Hosp, Goyang, Gyeonggi Do, South Korea; [Friedman, David] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Sungkyunkwan University (SKKU); Samsung Medical Center; Johns Hopkins University	Kim, MH (corresponding author), Saevit Eye Hosp, Goyang, Gyeonggi Do, South Korea.	philip.mhkim@gmail.com	Cho, Juhee/ABD-2280-2021	Friedman, David/0000-0002-2055-5797	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK079637] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ascaso JF, 2003, DIABETES CARE, V26, P3320, DOI 10.2337/diacare.26.12.3320; Bonovas S, 2004, DIABETIC MED, V21, P609, DOI 10.1111/j.1464-5491.2004.01173.x; Centers for Disease Control and Prevention, 2005 2006 NAT HLTH N; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, 2007 2008 NAT HLTH N; Chang YC, 2010, EYE, V24, P1037, DOI 10.1038/eye.2009.247; Charliat G, 1994, Ophthalmic Epidemiol, V1, P131, DOI 10.3109/09286589409047221; Chen HY, 2005, SOUTH MED J, V98, P28, DOI 10.1097/01.SMJ.0000145389.15201.7F; Chopra V, 2008, OPHTHALMOLOGY, V115, P227, DOI 10.1016/j.ophtha.2007.04.049; de Voogd S, 2006, OPHTHALMOLOGY, V113, P1827, DOI 10.1016/j.ophtha.2006.03.063; Dielemans I, 1996, OPHTHALMOLOGY, V103, P1271, DOI 10.1016/S0161-6420(96)30511-3; Elisaf M, 2001, ACTA OPHTHALMOL SCAN, V79, P129, DOI 10.1034/j.1600-0420.2001.079002129.x; Ellis JD, 2000, BRIT J OPHTHALMOL, V84, P1218, DOI 10.1136/bjo.84.11.1218; Graw J, 2011, INVEST OPHTH VIS SCI, V52, P7778, DOI 10.1167/iovs.10-7113; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Howard DL, 2011, J NATL MED ASSOC, V103, P332, DOI 10.1016/S0027-9684(15)30314-X; Jonas JB, 1998, GRAEF ARCH CLIN EXP, V236, P202, DOI 10.1007/s004170050065; Kaimbo DKW, 2001, J CLIN EPIDEMIOL, V54, P166, DOI 10.1016/S0895-4356(00)00291-2; Kaimbo Wa Kaimbo D, 1997, Bull Soc Belge Ophtalmol, V267, P29; Kanamori A, 2004, CURR EYE RES, V28, P47, DOI 10.1076/ceyr.28.1.47.23487; King GL, 1996, ENDOCRIN METAB CLIN, V25, P255, DOI 10.1016/S0889-8529(05)70324-8; KLEIN BEK, 1994, OPHTHALMOLOGY, V101, P1173; Leske MC, 2007, OPHTHAL EPIDEMIOL, V14, P166, DOI 10.1080/09286580701501931; LESKE MC, 1995, ARCH OPHTHALMOL-CHIC, V113, P918, DOI 10.1001/archopht.1995.01100070092031; Lin CP, 2012, EUR J INTERN MED, V23, P76, DOI 10.1016/j.ejim.2011.06.002; MacLennan PA, 2013, CURR EYE RES, V38, P1, DOI 10.3109/02713683.2012.733054; Mitchell P, 1997, OPHTHALMOLOGY, V104, P712, DOI 10.1016/S0161-6420(97)30247-4; Nakamura M, 2005, OPHTHALMOLOGICA, V219, P1, DOI 10.1159/000081775; Nakamura M, 2001, J BIOL CHEM, V276, P43748, DOI 10.1074/jbc.M108594200; Newman-Casey PA, 2011, OPHTHALMOLOGY, V118, P1318, DOI 10.1016/j.ophtha.2010.11.022; Oh SW, 2005, DIABETES-METAB RES, V21, P434, DOI 10.1002/dmrr.529; Orzalesi N, 2007, GRAEF ARCH CLIN EXP, V245, P795, DOI 10.1007/s00417-006-0457-5; Park Sang-shin, 2010, J Prev Med Public Health, V43, P125, DOI 10.3961/jpmph.2010.43.2.125; Pasquale LR, 2006, OPHTHALMOLOGY, V113, P1081, DOI 10.1016/j.ophtha.2006.01.066; Patty L, 2012, OPHTHALMOLOGY, V119, P1725, DOI 10.1016/j.ophtha.2012.02.029; Quigley HA, 2001, ARCH OPHTHALMOL-CHIC, V119, P1819, DOI 10.1001/archopht.119.12.1819; Sato T, 2002, INVEST OPHTH VIS SCI, V43, P170; Stanga P E, 1999, Curr Opin Ophthalmol, V10, P483, DOI 10.1097/00055735-199912000-00018; Szaflik JP, 2010, MUTAT RES-GEN TOX EN, V697, P19, DOI 10.1016/j.mrgentox.2010.02.003; Tan GS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1354, DOI 10.1001/archophthalmol.2009.268; TIELSCH JM, 1995, ARCH OPHTHALMOL-CHIC, V113, P216, DOI 10.1001/archopht.1995.01100020100038; Uhm K B, 1992, Korean J Ophthalmol, V6, P91; van Dam PS, 2002, DIABETES-METAB RES, V18, P176, DOI 10.1002/dmrr.287; Welinder Lotte G, 2009, Clin Epidemiol, V1, P125; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wise LA, 2011, ANN EPIDEMIOL, V21, P430, DOI 10.1016/j.annepidem.2011.03.006; World Health Organization, GLOB REC PHYS ACT HL; Xu L, 2009, EYE, V23, P676, DOI 10.1038/sj.eye.6703104	48	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112460	10.1371/journal.pone.0112460	http://dx.doi.org/10.1371/journal.pone.0112460			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393836	Green Submitted, gold, Green Published			2022-12-27	WOS:000347709300057
J	Partha, R; Raman, K				Partha, Raghavendran; Raman, Karthik			Revisiting Robustness and Evolvability: Evolution in Weighted Genotype Spaces	PLOS ONE			English	Article							AU-RICH ELEMENTS; SECONDARY STRUCTURES; RNA; SEQUENCES; PLASTICITY	Robustness and evolvability are highly intertwined properties of biological systems. The relationship between these properties determines how biological systems are able to withstand mutations and show variation in response to them. Computational studies have explored the relationship between these two properties using neutral networks of RNA sequences (genotype) and their secondary structures (phenotype) as a model system. However, these studies have assumed every mutation to a sequence to be equally likely; the differences in the likelihood of the occurrence of various mutations, and the consequence of probabilistic nature of the mutations in such a system have previously been ignored. Associating probabilities to mutations essentially results in the weighting of genotype space. We here perform a comparative analysis of weighted and unweighted neutral networks of RNA sequences, and subsequently explore the relationship between robustness and evolvability. We show that assuming an equal likelihood for all mutations (as in an unweighted network), underestimates robustness and overestimates evolvability of a system. In spite of discarding this assumption, we observe that a negative correlation between sequence (genotype) robustness and sequence evolvability persists, and also that structure (phenotype) robustness promotes structure evolvability, as observed in earlier studies using unweighted networks. We also study the effects of base composition bias on robustness and evolvability. Particularly, we explore the association between robustness and evolvability in a sequence space that is AU-rich -sequences with an AU content of 80% or higher, compared to a normal (unbiased) sequence space. We find that evolvability of both sequences and structures in an AU-rich space is lesser compared to the normal space, and robustness higher. We also observe that AU-rich populations evolving on neutral networks of phenotypes, can access less phenotypic variation compared to normal populations evolving on neutral networks.	[Partha, Raghavendran; Raman, Karthik] Indian Inst Technol, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Raman, K (corresponding author), Indian Inst Technol, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	kraman@iitm.ac.in	Raman, Karthik/Q-5278-2019; Partha, Raghavendran/L-1273-2019; Raman, Karthik/A-6459-2011	Partha, Raghavendran/0000-0002-7900-4375; Raman, Karthik/0000-0002-9311-7093	Indian Institute of Technology Madras; Centre for Industrial Consultancy and Sponsored Research, IITM [BIO/12-13/579/NFSC/KARH]	Indian Institute of Technology Madras; Centre for Industrial Consultancy and Sponsored Research, IITM	This work was supported from the Indian Institute of Technology Madras (IITM; http://www.iitm.ac.in/) and the seed grant BIO/12-13/579/NFSC/KARH from the Centre for Industrial Consultancy and Sponsored Research, IITM (https://icandsr.iitm.ac.in/) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancel LW, 2000, J EXP ZOOL, V288, P242, DOI 10.1002/1097-010X(20001015)288:3<242::AID-JEZ5>3.0.CO;2-O; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Birdsell JA, 2002, MOL BIOL EVOL, V19, P1181, DOI 10.1093/oxfordjournals.molbev.a004176; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Gruner W, 1996, MONATSH CHEM, V127, P355, DOI 10.1007/BF00810881; Hershberg R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001115; Hurst LD, 2001, P ROY SOC B-BIOL SCI, V268, P493, DOI 10.1098/rspb.2000.1397; Huynen MA, 1996, J MOL EVOL, V43, P165; KIMURA M, 1989, GENOME, V31, P24, DOI 10.1139/g89-009; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; Schuster P, 2005, EVOLUTIONARY DYNAMIC, P1; Stich M, 2008, J THEOR BIOL, V252, P750, DOI 10.1016/j.jtbi.2008.02.018; Stich M, 2011, J THEOR BIOL, V280, P117, DOI 10.1016/j.jtbi.2011.03.010; Sumedha, 2007, BIOSYSTEMS, V90, P475, DOI 10.1016/j.biosystems.2006.11.007; Wagner A., 2005, ROBUSTNESS EVOLVABIL; Wagner A, 2008, P ROY SOC B-BIOL SCI, V275, P91, DOI 10.1098/rspb.2007.1137; Wagner A, 2014, BIOPHYS J, V106, P955, DOI [10.1016/j.bpj.2014.01.003, 10.1016/j.bpj.2013.01.003]; Wakeley J, 1996, TRENDS ECOL EVOL, V11, P158, DOI 10.1016/0169-5347(96)10009-4; Wuchty S, 1999, BIOPOLYMERS, V49, P145, DOI 10.1002/(SICI)1097-0282(199902)49:2<145::AID-BIP4>3.3.CO;2-7	24	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112792	10.1371/journal.pone.0112792	http://dx.doi.org/10.1371/journal.pone.0112792			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390641	Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400128
J	Van Soom, C; Donche, V				Van Soom, Carolien; Donche, Vincent			Profiling First-Year Students in STEM Programs Based on Autonomous Motivation and Academic Self-Concept and Relationship with Academic Achievement	PLOS ONE			English	Article							STRUCTURAL EQUATION MODELS; HIGHER-EDUCATION; HIGH-SCHOOL; PREDICTORS; EFFICACY; GENDER; PERFORMANCE; SUCCESS; MATHEMATICS; PERSONALITY	The low success rate of first-year college students in Science, Technology, Engineering, and Mathematics ( STEM) programs has spurred many academic achievement studies in which explanatory factors are studied. In this study, we investigated from a person-oriented perspective whether different motivational and academic self-concept profiles could be discerned between male and female first-year college students in STEM and whether differences in early academic achievement were associated with these student groups. Data on autonomous motivation, academic self-concept, and early academic achievement of 1,400 first-year STEM college students were collected. Cluster analyses were used to distinguish motivational profiles based on the relative levels of autonomous motivation and academic self-concept for male and female students. Differences in early academic achievement of the various profiles were studied by means of ANCOVA. Four different motivational profiles were discerned based on the dimensions of autonomous motivation (A) and academic self-concept (S): students scoring high and respectively low on both dimensions (HA-HS or LA-LS), and students scoring high on one dimension and low on the other (HA-LS or LA-HS). Also gender differences were found in this study: male students with high levels of academic self-concept and autonomous motivation had higher academic achievement compared to male students with low levels on both motivational dimensions. For female students, motivational profiles were not associated with academic achievement. The findings partially confirm the internal and external validity of the motivational theories underpinning this study and extend the present insights on identifying subgroup(s) of at risk students in contemporary STEM programs at university level.	[Van Soom, Carolien] Univ Leuven, Fac Sci, LESEC, Leuven, Belgium; [Donche, Vincent] Univ Antwerp, Inst Educ & Informat Sci, Antwerp, Belgium	KU Leuven; University of Antwerp	Van Soom, C (corresponding author), Univ Leuven, Fac Sci, LESEC, Leuven, Belgium.	carolien.vansoom@wet.kuleuven.be	Donche, Vincent/R-5757-2016	Donche, Vincent/0000-0002-9405-3896				Ackerman PL, 2013, J EDUC PSYCHOL, V105, P911, DOI 10.1037/a0032338; Adamuti-Trache M, 2008, INT J SCI EDUC, V30, P1557, DOI 10.1080/09500690701324208; Ashwin P, 2012, HIGH EDUC RES DEV, V31, P449, DOI 10.1080/07294360.2011.634384; BESWICK G, 1988, AUST PSYCHOL, V23, P207, DOI 10.1080/00050068808255605; Bong M, 2003, EDUC PSYCHOL REV, V15, P1, DOI 10.1023/A:1021302408382; Brunner M, 2010, J EDUC PSYCHOL, V102, P964, DOI 10.1037/a0019644; Burton KD, 2006, J PERS SOC PSYCHOL, V91, P750, DOI 10.1037/0022-3514.91.4.750; Busato VV, 2000, PERS INDIV DIFFER, V29, P1057, DOI 10.1016/S0191-8869(99)00253-6; Choi N, 2005, PSYCHOL SCHOOLS, V42, P197, DOI 10.1002/pits.20048; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dalton D, 2011, J BUS ETHICS, V103, P73, DOI 10.1007/s10551-011-0843-8; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Delisle MN, 2009, LEARN INDIVID DIFFER, V19, P468, DOI 10.1016/j.lindif.2009.04.002; Donche V, 2012, REFLECTING ED, V8, P114, DOI DOI 10.1371/JOURNAL.PONE.0067854; Donche V, 2013, BRIT J EDUC PSYCHOL, V83, P238, DOI 10.1111/bjep.12016; Field A., 2009, DISCOVERING STAT USI, V3, DOI DOI 10.1080/1057610X.2016.1157408; Gonzalez A, 2012, SPAN J PSYCHOL, V15, P1069, DOI 10.5209/rev_SJOP.2012.v15.n3.39397; Guay F, 2003, J EDUC PSYCHOL, V95, P124, DOI 10.1037/0022-0663.95.1.124; Guay F, 2010, LEARN INDIVID DIFFER, V20, P644, DOI 10.1016/j.lindif.2010.08.001; Guay F, 2008, CAN PSYCHOL, V49, P233, DOI 10.1037/a0012758; Hutchison-Green MA, 2008, J ENG EDUC, V97, P177, DOI 10.1002/j.2168-9830.2008.tb00966.x; Jackson C, 2003, OXFORD REV EDUC, V29, P331, DOI 10.1080/03054980307448; Jones BD, 2010, J ENG EDUC, V99, P319, DOI 10.1002/j.2168-9830.2010.tb01066.x; Lent RW, 1997, J COUNS PSYCHOL, V44, P307, DOI 10.1037/0022-0167.44.3.307; Magnusson D, 1998, METHODS AND MODELS FOR STUDYING THE INDIVIDUAL, P33; Marsh HW, 2006, PERSPECT PSYCHOL SCI, V1, P133, DOI 10.1111/j.1745-6916.2006.00010.x; Marsh HW, 2011, BRIT J EDUC PSYCHOL, V81, P59, DOI 10.1348/000709910X503501; MARSH HW, 1988, J EDUC PSYCHOL, V80, P366, DOI 10.1037/0022-0663.80.3.366; Marsh HW, 1998, AM EDUC RES J, V35, P705, DOI 10.2307/1163464; Marsh HW, 2005, CHILD DEV, V76, P397, DOI 10.1111/j.1467-8624.2005.00853.x; Marsh HW, 1997, AM EDUC RES J, V34, P691, DOI 10.3102/00028312034004691; Marsh HW, 1997, J EDUC PSYCHOL, V89, P41, DOI 10.1037/0022-0663.89.1.41; MARSH HW, 1987, J EDUC PSYCHOL, V79, P280, DOI 10.1037/0022-0663.79.3.280; MARSH HW, 1990, J EDUC PSYCHOL, V82, P646, DOI 10.1037/0022-0663.82.4.646; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; Osborne J, 2003, INT J SCI EDUC, V25, P1049, DOI 10.1080/0950069032000032199; Pelletier LG, 2001, MOTIV EMOTION, V25, P279, DOI 10.1023/A:1014805132406; Pinxten M, 2013, IRISH EDUC STUD, V32, P157, DOI 10.1080/03323315.2012.749058; Ratelle CF, 2007, J EDUC PSYCHOL, V99, P734, DOI 10.1037/0022-0663.99.4.734; Richardson M, 2012, PSYCHOL BULL, V138, P353, DOI 10.1037/a0026838; Rubie-Davies CM, 2013, EDUC STUD-UK, V39, P56, DOI 10.1080/03055698.2012.671513; SENECAL C, 1995, J SOC PSYCHOL, V135, P607, DOI 10.1080/00224545.1995.9712234; SHAVELSON RJ, 1976, REV EDUC RES, V46, P407, DOI 10.3102/00346543046003407; Skaalvik EM, 1999, J EXP EDUC, V67, P135, DOI 10.1080/00220979909598349; Steele CM, 1997, AM PSYCHOL, V52, P613, DOI 10.1037/0003-066X.52.6.613; Tyson W, 2011, J ENG EDUC, V100, P760, DOI 10.1002/j.2168-9830.2011.tb00035.x; VALLERAND RJ, 1992, EDUC PSYCHOL MEAS, V52, P1003, DOI 10.1177/0013164492052004025; VALLERAND RJ, 1992, J PERS, V60, P599, DOI 10.1111/j.1467-6494.1992.tb00922.x; VALLERAND RJ, 1993, EDUC PSYCHOL MEAS, V53, P159, DOI 10.1177/0013164493053001018; Vansteenkiste M, 2009, J EDUC PSYCHOL, V101, P671, DOI 10.1037/a0015083; Vanthournout G., 2013, LEARNING PATTERNS HI, P11; Veenstra CP, 2008, J ENG EDUC, V97, P467, DOI 10.1002/j.2168-9830.2008.tb00993.x; von Eye A, 2006, MERRILL PALMER QUART, V52, P390, DOI 10.1353/mpq.2006.0032; Wormington SV, 2012, LEARN INDIVID DIFFER, V22, P429, DOI 10.1016/j.lindif.2012.03.004; Wouters S, 2011, SCAND J PSYCHOL, V52, P586, DOI 10.1111/j.1467-9450.2011.00905.x; Wylie R. C., 1979, THE SELF CONCEPT; Zhang GL, 2004, J ENG EDUC, V93, P313, DOI 10.1002/j.2168-9830.2004.tb00820.x	57	33	34	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112489	10.1371/journal.pone.0112489	http://dx.doi.org/10.1371/journal.pone.0112489			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CP	25390942	Green Submitted, gold, Green Published			2022-12-27	WOS:000349144400087
J	Hornseth, ML; Walpole, AA; Walton, LR; Bowman, J; Ray, JC; Fortin, MJ; Murray, DL				Hornseth, Megan L.; Walpole, Aaron A.; Walton, Lyle R.; Bowman, Jeff; Ray, Justina C.; Fortin, Marie-Josee; Murray, Dennis L.			Habitat Loss, Not Fragmentation, Drives Occurrence Patterns of Canada Lynx at the Southern Range Periphery	PLOS ONE			English	Article							SNOWSHOE HARE POPULATION; GENETIC DIVERSITY; ABUNDANCE; CONNECTIVITY; CONSERVATION; SELECTION; THRESHOLDS; MODELS; FOREST; MAINE	Peripheral populations often experience more extreme environmental conditions than those in the centre of a species' range. Such extreme conditions include habitat loss, defined as a reduction in the amount of suitable habitat, as well as habitat fragmentation, which involves the breaking apart of habitat independent of habitat loss. The 'threshold hypothesis' predicts that organisms will be more affected by habitat fragmentation when the amount of habitat on the landscape is scarce (i.e., less than 30%) than when habitat is abundant, implying that habitat fragmentation may compound habitat loss through changes in patch size and configuration. Alternatively, the 'flexibility hypothesis' predicts that individuals may respond to increased habitat disturbance by altering their selection patterns and thereby reducing sensitivity to habitat loss and fragmentation. While the range of Canada lynx (Lynx canadensis) has contracted during recent decades, the relative importance of habitat loss and habitat fragmentation on this phenomenon is poorly understood. We used a habitat suitability model for lynx to identify suitable land cover in Ontario, and contrasted occupancy patterns across landscapes differing in cover, to test the 'threshold hypothesis' and 'flexibility hypothesis'. When suitable land cover was widely available, lynx avoided areas with less than 30% habitat and were unaffected by habitat fragmentation. However, on landscapes with minimal suitable land cover, lynx occurrence was not related to either habitat loss or habitat fragmentation, indicating support for the 'flexibility hypothesis'. We conclude that lynx are broadly affected by habitat loss, and not specifically by habitat fragmentation, although occurrence patterns are flexible and dependent on landscape condition. We suggest that lynx may alter their habitat selection patterns depending on local conditions, thereby reducing their sensitivity to anthropogenically-driven habitat alteration.	[Hornseth, Megan L.] Trent Univ, Peterborough, ON K9J 7B8, Canada; [Walpole, Aaron A.; Bowman, Jeff] Ontario Minist Nat Resources & Forestry, Wildlife Res & Monitoring Sect, Peterborough, ON, Canada; [Walton, Lyle R.] Ontario Minist Nat Resources, Reg Operat Div, South Porcupine, ON, Canada; [Ray, Justina C.] Wildlife Conservat Soc Canada, Toronto, ON, Canada; [Fortin, Marie-Josee] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Murray, Dennis L.] Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada	Trent University; Ministry of Natural Resources & Forestry; Ministry of Natural Resources & Forestry; University of Toronto; Trent University	Hornseth, ML (corresponding author), Lakehead Univ, Ontario Minist Nat Resources & Forestry, Ctr Northern Forest Ecol Res, Thunder Bay, ON P7B 5E1, Canada.	mhornseth@gmail.com	Bowman, Jeff/B-4147-2009	Bowman, Jeff/0000-0002-1892-4469; Hornseth, Megan/0000-0002-9596-0316	Panthera Foundation; Ontario Ministry of Natural Resources North East Science and Information Section; Strategic Natural Sciences and Engineering Research grant; Natural Sciences and Engineering Research Industrial Postgraduate Scholarship; Wildlife Conservation Society Canada	Panthera Foundation; Ontario Ministry of Natural Resources North East Science and Information Section; Strategic Natural Sciences and Engineering Research grant; Natural Sciences and Engineering Research Industrial Postgraduate Scholarship; Wildlife Conservation Society Canada	This study was funded by the Wildlife Conservation Society Kaplan Awards Program (now the Panthera Foundation, given to MLH), the Ontario Ministry of Natural Resources North East Science and Information Section, a Strategic Natural Sciences and Engineering Research grant to DLM, and a Natural Sciences and Engineering Research Industrial Postgraduate Scholarship with the Wildlife Conservation Society Canada to Megan Hornseth. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard-Duchene A, 2014, FOREST ECOL MANAG, V313, P17, DOI 10.1016/j.foreco.2013.10.046; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Aubry Keith B., 2000, P373; Barnagaud JY, 2011, GLOBAL ECOL BIOGEOGR, V20, P630, DOI 10.1111/j.1466-8238.2010.00629.x; Bayne EM, 2008, CAN J ZOOL, V86, P1189, DOI 10.1139/Z08-099; Bonn A, 2001, ECOGRAPHY, V24, P483, DOI 10.1034/j.1600-0587.2001.d01-204.x; Burdett CL, 2007, J MAMMAL, V88, P457, DOI 10.1644/06-MAMM-A-181R.1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Channell R, 2000, NATURE, V403, P84, DOI 10.1038/47487; Cheng E, 2014, MOL ECOL, V23, P2929, DOI 10.1111/mec.12790; Clevenger AP, 2002, CONSERV BIOL, V16, P503, DOI 10.1046/j.1523-1739.2002.00328.x; Crooks KR, 2011, PHILOS T R SOC B, V366, P2642, DOI 10.1098/rstb.2011.0120; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2002, J WILDLIFE MANAGE, V61, P603; Ferreras P, 2001, BIOL CONSERV, V100, P125, DOI 10.1016/S0006-3207(00)00213-5; Flather CH, 2002, AM NAT, V159, P40, DOI 10.1086/324120; Fuller AK, 2007, J WILDLIFE MANAGE, V71, P1980, DOI 10.2193/2006-288; Gaston K. J., 2003, STRUCTURE DYNAMICS G, P266; Girvetz EH, 2008, LANDSCAPE URBAN PLAN, V86, P205, DOI 10.1016/j.landurbplan.2008.02.007; Girvetz EH, 2007, LANDSCAPE ECOL, V22, P1131, DOI 10.1007/s10980-007-9104-8; GRANT MC, 1978, EVOLUTION, V32, P822, DOI [10.2307/2407497, 10.1111/j.1558-5646.1978.tb04637.x]; Holloway GL, 2004, HABITAT RELATIONSHIP; Holt RD, 2008, ISR J ECOL EVOL, V54, P295, DOI 10.1560/IJEE.54.3-4.295; Homyack JA, 2006, WILDLIFE SOC B, V34, P74, DOI 10.2193/0091-7648(2006)34[74:QDOSHI]2.0.CO;2; Hoving CL, 2005, J WILDLIFE MANAGE, V69, P739, DOI 10.2193/0022-541X(2005)069[0739:BPOCLO]2.0.CO;2; Jaeger JAG, 2000, LANDSCAPE ECOL, V15, P115, DOI 10.1023/A:1008129329289; Koen EL, 2014, ECOGRAPHY, V37, P754, DOI 10.1111/j.1600-0587.2013.00629.x; Larue MA, 2008, ECOL MODEL, V212, P372, DOI 10.1016/j.ecolmodel.2007.10.036; LAWTON JH, 1993, TRENDS ECOL EVOL, V8, P409, DOI 10.1016/0169-5347(93)90043-O; Lewis CW, 2011, J MAMMAL, V92, P561, DOI 10.1644/10-MAMM-A-095.1; LITVAITIS JA, 1985, J WILDLIFE MANAGE, V49, P866, DOI 10.2307/3801359; Maxie AJ, 2010, FOREST CHRON, V86, P77, DOI 10.5558/tfc86077-1; Mowat G, 2003, CAN J ZOOL, V81, P1736, DOI 10.1139/Z03-174; Mowat Garth, 2000, P265; Murray DL, 2008, J WILDLIFE MANAGE, V72, P1463, DOI 10.2193/2007-389; Murray DL, 2000, CAN J ZOOL, V78, P1207, DOI 10.1139/cjz-78-7-1207; MURRAY DL, 1994, CAN J ZOOL, V72, P1444, DOI 10.1139/z94-191; OMNR, 2011, ANN REP FOR MAN 2009; Peers MJL, 2014, GLOBAL CHANGE BIOL, V20, P1126, DOI 10.1111/gcb.12469; Peers MJL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051488; Perera AH, 2000, SPATIAL PATTERNS MAN, P74; Poole KG, 2003, CAN FIELD NAT, V117, P360, DOI 10.22621/cfn.v117i3.738; Radford JQ, 2004, BIOL CONSERV, V117, P375, DOI 10.1016/j.biocon.2003.08.002; Reunanen P., 2004, Ecological Bulletins, V51, P277; Roth JD, 2007, ECOLOGY, V88, P2736, DOI 10.1890/07-0147.1; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Steury TD, 2004, BIOL CONSERV, V117, P127, DOI 10.1016/S0006-3207(03)00287-8; Swift TL, 2010, BIOL REV, V85, P35, DOI 10.1111/j.1469-185X.2009.00093.x; Swihart RK, 2006, DIVERS DISTRIB, V12, P277, DOI 10.1111/j.1366-9516.2006.00242.x; Tischendorf L, 2000, OIKOS, V90, P7, DOI 10.1034/j.1600-0706.2000.900102.x; Vashon JH, 2008, J WILDLIFE MANAGE, V72, P1479, DOI 10.2193/2007-462; Walpole AA, 2012, LANDSCAPE ECOL, V27, P761, DOI 10.1007/s10980-012-9728-1; Wirsing AJ, 2002, CAN J ZOOL, V80, P169, DOI 10.1139/Z01-214; Yackulic CB, 2011, P NATL ACAD SCI USA, V108, P4024, DOI 10.1073/pnas.1015097108	55	13	13	3	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113511	10.1371/journal.pone.0113511	http://dx.doi.org/10.1371/journal.pone.0113511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401737	Green Published, Green Submitted, gold			2022-12-27	WOS:000345158700139
J	Lane, T; Osmand, T; Marr, A; Shade, SB; Dunkle, K; Sandfort, T; Struthers, H; Kegeles, S; McIntyre, JA				Lane, Tim; Osmand, Thomas; Marr, Alexander; Shade, Starley B.; Dunkle, Kristin; Sandfort, Theodorus; Struthers, Helen; Kegeles, Susan; McIntyre, James A.			The Mpumalanga Men's Study (MPMS): Results of a Baseline Biological and Behavioral HIV Surveillance Survey in Two MSM Communities in South Africa	PLOS ONE			English	Article							SEXUAL RISK BEHAVIOR; YOUNG GAY; MPOWERMENT PROJECT; BISEXUAL MEN; CAPE-TOWN; BLACK-MEN; INFECTION; PREVALENCE; PREVENTION; CARE	The Mpumalanga Men's Study (MPMS) is the assessment of the Project Boithato HIV prevention intervention for South African MSM. Boithato aims to increase consistent condom use, regular testing for HIV-negative MSM, and linkage to care for HIV-positive MSM. The MPMS baseline examined HIV prevalence and associated risk behaviors, and testing, care, and treatment behaviors among MSM in Gert Sibande and Ehlanzeni districts in Mpumalanga province, South Africa in order to effectively target intervention activities. We recruited 307 MSM in Gert Sibande and 298 in Ehlanzeni through respondentdriven sampling (RDS) between September 2012-March 2013. RDS-adjusted HIV prevalence estimates are 28.3% (95% CI 21.1%-35.3%) in Gert Sibande, and 13.7% (95% CI 9.1%-19.6%) in Ehlanzeni. Prevalence is significantly higher among MSM over age 25 [ 57.8% (95% CI 43.1%-72.9%) vs. 17.9% (95% CI 10.6%-23.9%), P < 0.001 in Gert Sibande; 34.5% (95% CI 20.5%-56.0%) vs. 9.1% (95% CI 4.6%-13.9%), P < 0.001 in Ehlanzeni]. In Gert Sibande, prevalence is higher among self-identified gay and transgender MSM vs. other MSM [39.3% (95% CI, 28.3%-47.9%), P < 0.01], inconsistent condom users [38.1% (18.1%64.2%), P < 0.05], those with a current regular male partner [35.0% (27.1%-46.4%), P < 0.05], and those with lifetime experience of intimate partner violence with men [40.4%, (95% CI 28.9%-50.9%), P < 0.05]. Prevalence of previous HIV testing was 65.8% (95% CI 58.8%-74.0%) in Gert Sibande, and 69.3% (95% CI 61.9%-76.8%) in Ehlanzeni. Regular HIV testing was uncommon [(34.6%, (95% CI 27.9%-41.4%) in Gert Sibande; 31.0% (95% CI 24.9%-37.8%) in Ehlanzeni]. Among HIV-positive participants, few knew their status (28.1% in Gert Sibande and 14.5% in Ehlanzeni), or were appropriately linked to care (18.2% and 11.3%, respectively), or taking antiretroviral therapy (13.6% and 9.6% respectively). MPMS results demonstrate the importance of implementing interventions for MSM to increase consistent condom use, regular HIV testing, and linkage and engagement in care for HIV-infected MSM.	[Lane, Tim; Osmand, Thomas; Marr, Alexander; Shade, Starley B.; Kegeles, Susan] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [Dunkle, Kristin] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Sandfort, Theodorus] Columbia Univ, HIV Ctr Clin & Behav Studies, New York, NY USA; [Struthers, Helen; McIntyre, James A.] Anova Hlth Inst, Johannesburg, South Africa; [Struthers, Helen] Univ Cape Town, Dept Med, Div Infect Dis & HIV Med, ZA-7925 Cape Town, South Africa; [McIntyre, James A.] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa	University of California System; University of California San Francisco; Emory University; Rollins School Public Health; Columbia University; University of Cape Town; University of Cape Town	Lane, T (corresponding author), Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA.	Tim.Lane@ucsf.edu	Harding, Richard/G-9729-2012; Dunkle, Kristin/AAU-5488-2020; Sandfort, Theo/D-1796-2011	Dunkle, Kristin/0000-0003-3071-5544; Sandfort, Theo/0000-0002-4986-1739	National Institute of Allergy and Infectious Disease (NIAID) [R01AI089292]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH043520, P30MH062246] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the National Institute of Allergy and Infectious Disease (NIAID) R01AI089292. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, UNAIDS REP GLOB AIDS; Arnold MP, 2012, AIDS BEHAV; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-766; Baral S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004997; Baral SD, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.4.18768; Beyrer C, 2006, HIV EPIDEMIOLOGY UPD; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Dahoma M, 2011, AIDS BEHAV, V15, P186, DOI 10.1007/s10461-009-9646-7; Hays RB, 2003, AM J COMMUN PSYCHOL, V31, P301, DOI 10.1023/A:1023966905973; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Heckathorn DD, 2007, SOCIOL METHODOL, V37, P151, DOI 10.1111/j.1467-9531.2007.00188.x; Imrie J, 2013, AIDS BEHAV, V17, pS70, DOI 10.1007/s10461-012-0356-1; Johnson CA, 2007, MAP HIV AIDS PROGRAM; Johnston LG, 2008, AIDS BEHAV, V12, P294, DOI 10.1007/s10461-007-9300-1; Kegeles SM, 1999, AIDS, V13, P1753, DOI 10.1097/00002030-199909100-00020; Kegeles SM, 1996, AM J PUBLIC HEALTH, V86, P1129, DOI 10.2105/AJPH.86.8_Pt_1.1129; Knox J, 2011, INT J STD AIDS, V22, P709, DOI 10.1258/ijsa.2011.010350; Knox J, 2013, AIDS BEHAV, V17, P350, DOI 10.1007/s10461-012-0337-4; Knox J, 2010, PSYCHOL HEALTH MED, V15, P660, DOI 10.1080/13548506.2010.507772; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; Lane T, 2008, SEX TRANSM INFECT, V84, P430, DOI 10.1136/sti.2008.031567; Lane T, 2008, AIDS BEHAV, V12, pS78, DOI 10.1007/s10461-008-9389-x; Lane T, 2011, AIDS BEHAV, V15, P626, DOI 10.1007/s10461-009-9598-y; Merrigan M, 2011, SEX TRANSM INFECT, V87, P65, DOI 10.1136/sti.2008.034991; Millett GA, 2006, AM J PUBLIC HEALTH, V96, P1007, DOI 10.2105/AJPH.2005.066720; Millett GA, 2012, LANCET, V380, P411, DOI 10.1016/S0140-6736(12)60722-3; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Oster Alexandra M., 2011, Morbidity and Mortality Weekly Report, V60, P694; Park JN, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.4.18752; Price MA, 2012, JAIDS-J ACQ IMM DEF, V59, P185, DOI 10.1097/QAI.0b013e31823d8693; Rispel LC, 2011, J PUBLIC HEALTH POL, V32, pS137, DOI 10.1057/jphp.2011.29; Rispel LC, 2011, JAIDS-J ACQ IMM DEF, V57, P69, DOI 10.1097/QAI.0b013e318211b40a; Salganik M, 2004, SOCIOLOGICA IN PRESS; Sanders EJ, 2013, AIDS, V27, P437, DOI 10.1097/QAD.0b013e32835b0f81; South African National AIDS Council, 2011, NAT STRAT PLAN HIV S, P2012; South African National Department of Health, 2011, 2011 NAT ANT SENT HI; Statistics South Africa, 2011, STAT PLAC; Stephenson R, 2013, AIDS BEHAV, V17, pS43, DOI 10.1007/s10461-012-0293-z; Stephenson R, 2012, AIDS CARE, V24, P529, DOI 10.1080/09540121.2011.617413; Vu L, 2013, JAIDS-J ACQ IMM DEF, V63, P221, DOI 10.1097/QAI.0b013e31828a3e60; World Health Organization, 2014, POL BRIEF CONS GUID	44	48	48	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e111063	10.1371/journal.pone.0111063	http://dx.doi.org/10.1371/journal.pone.0111063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8BL	25401785	gold, Green Published, Green Submitted			2022-12-27	WOS:000345158700012
J	Pan, SF; Tian, HQ; Dangal, SRS; Zhang, C; Yang, J; Tao, B; Ouyang, ZY; Wang, XK; Lu, CQ; Ren, W; Banger, K; Yang, QC; Zhang, BW; Li, X				Pan, Shufen; Tian, Hanqin; Dangal, Shree R. S.; Zhang, Chi; Yang, Jia; Tao, Bo; Ouyang, Zhiyun; Wang, Xiaoke; Lu, Chaoqun; Ren, Wei; Banger, Kamaljit; Yang, Qichun; Zhang, Bowen; Li, Xia			Complex Spatiotemporal Responses of Global Terrestrial Primary Production to Climate Change and Increasing Atmospheric CO2 in the 21st Century	PLOS ONE			English	Article							NET PRIMARY PRODUCTION; WATER-USE EFFICIENCY; CARBON SEQUESTRATION; ECOSYSTEM CARBON; ELEVATED CO2; ENVIRONMENTAL-CHANGES; NITROGEN DEPOSITION; FOREST PRODUCTIVITY; PLANT GEOGRAPHY; LEAF-AREA	Quantitative information on the response of global terrestrial net primary production (NPP) to climate change and increasing atmospheric CO2 is essential for climate change adaptation and mitigation in the 21st century. Using a process-based ecosystem model (the Dynamic Land Ecosystem Model, DLEM), we quantified the magnitude and spatiotemporal variations of contemporary (2000s) global NPP, and projected its potential responses to climate and CO2 changes in the 21st century under the Special Report on Emission Scenarios (SRES) A2 and B1 of Intergovernmental Panel on Climate Change (IPCC). We estimated a global terrestrial NPP of 54.6 (52.8-56.4) PgC yr(-1) as a result of multiple factors during 2000-2009. Climate change would either reduce global NPP (4.6%) under the A2 scenario or slightly enhance NPP (2.2%) under the B1 scenario during 2010-2099. In response to climate change, global NPP would first increase until surface air temperature increases by 1.5 degrees C (until the 2030s) and then level-off or decline after it increases by more than 1.5 degrees C (after the 2030s). This result supports the Copenhagen Accord Acknowledgement, which states that staying below 2 degrees C may not be sufficient and the need to potentially aim for staying below 1.5 degrees C. The CO2 fertilization effect would result in a 12%-13.9% increase in global NPP during the 21st century. The relative CO2 fertilization effect, i.e. change in NPP on per CO2 (ppm) bases, is projected to first increase quickly then level off in the 2070s and even decline by the end of the 2080s, possibly due to CO2 saturation and nutrient limitation. Terrestrial NPP responses to climate change and elevated atmospheric CO2 largely varied among biomes, with the largest increases in the tundra and boreal needleleaf deciduous forest. Compared to the low emission scenario (B1), the high emission scenario (A2) would lead to larger spatiotemporal variations in NPP, and more dramatic and counteracting impacts from climate and increasing atmospheric CO2.	[Pan, Shufen; Tian, Hanqin; Dangal, Shree R. S.; Yang, Jia; Tao, Bo; Lu, Chaoqun; Ren, Wei; Banger, Kamaljit; Yang, Qichun; Zhang, Bowen; Li, Xia] Auburn Univ, Sch Forestry & Wildlife Sci, Int Ctr Climate & Global Change Res, Auburn, AL 36849 USA; [Pan, Shufen; Ouyang, Zhiyun; Wang, Xiaoke] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China; [Zhang, Chi] Chinese Acad Sci, Xinjian Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Peoples R China	Auburn University System; Auburn University; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS	Tian, HQ (corresponding author), Auburn Univ, Sch Forestry & Wildlife Sci, Int Ctr Climate & Global Change Res, Auburn, AL 36849 USA.	tianhan@auburn.edu	Lu, Chaoqun/A-6497-2012; Tian, Hanqin/A-6484-2012; Banger, Kamaljit/B-3215-2016; Lu, Chaoqun/D-6694-2018; Ren, Wei/G-8317-2016; Ren, Wei/I-4048-2014; Yang, Jia/A-6483-2012; Lu, Chaoqun/HCH-9102-2022; Dangal, Shree R. S./N-3393-2015	Tian, Hanqin/0000-0002-1806-4091; Lu, Chaoqun/0000-0002-1526-0513; Ren, Wei/0000-0002-4840-4835; Yang, Jia/0000-0003-2019-9603; Lu, Chaoqun/0000-0002-1526-0513; Dangal, Shree R. S./0000-0001-9529-8206; pan, shufen/0000-0001-7920-1427; Yang, Qichun/0000-0002-8689-2550; Zhang, Bowen/0000-0002-8370-0509	NSF Decadal and Regional Climate Prediction using Earth System Models [AGS-1243220]; NSF Dynamics of Coupled Natural and Human Systems [1210360]; NASA Interdisciplinary Science Program [NNX10AU06G, NNG04GM39C]; US Department of Energy NICCR Program [DUKE-UN-07-SC-NICCR-1014]	NSF Decadal and Regional Climate Prediction using Earth System Models; NSF Dynamics of Coupled Natural and Human Systems; NASA Interdisciplinary Science Program(National Aeronautics & Space Administration (NASA)); US Department of Energy NICCR Program(United States Department of Energy (DOE))	This study was supported by NSF Decadal and Regional Climate Prediction using Earth System Models (AGS-1243220), NSF Dynamics of Coupled Natural and Human Systems (1210360), NASA Interdisciplinary Science Program (NNX10AU06G, NNG04GM39C), US Department of Energy NICCR Program (DUKE-UN-07-SC-NICCR-1014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accord C, 2009, UN FRAM CONV CLIM CH; Adam JC, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002499; Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Black TA, 2000, GEOPHYS RES LETT, V27, P1271, DOI 10.1029/1999GL011234; Boisvenue C, 2006, GLOBAL CHANGE BIOL, V12, P862, DOI 10.1111/j.1365-2486.2006.01134.x; Bonan G., 1996, LAND SURFACE MODEL L; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Cao MK, 1998, NATURE, V393, P249, DOI 10.1038/30460; Chapin FS, 2006, ECOSYSTEMS, V9, P1041, DOI 10.1007/s10021-005-0105-7; Chapin FS, 2009, J ECOL, V97, P840, DOI 10.1111/j.1365-2745.2009.01529.x; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Clark DA, 2003, P NATL ACAD SCI USA, V100, P5852, DOI 10.1073/pnas.0935903100; COLLATZ GJ, 1991, AGR FOREST METEOROL, V54, P107, DOI 10.1016/0168-1923(91)90002-8; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Cramer W, 1999, GLOBAL CHANGE BIOL, V5, P1, DOI 10.1046/j.1365-2486.1999.00009.x; Dangal SRS, 2014, J GEOPHYS RES-BIOGEO, V119, P35, DOI 10.1002/2013JG002409; DeFries R, 2008, ANNU REV ENV RESOUR, V33, P369, DOI 10.1146/annurev.environ.33.020107.113339; Dentener F.J, 2006, GLOBAL MAPS ATMOSPHE; Dore MHI, 2005, ENVIRON INT, V31, P1167, DOI 10.1016/j.envint.2005.03.004; Evans JR, 2001, PLANT CELL ENVIRON, V24, P755, DOI 10.1046/j.1365-3040.2001.00724.x; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Felzer B, 2004, TELLUS B, V56, P230, DOI 10.1111/j.1600-0889.2004.00097.x; Felzer BS, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001621; Feng XH, 1999, GEOCHIM COSMOCHIM AC, V63, P1891, DOI 10.1016/S0016-7037(99)00088-5; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Friedlingstein P, 2001, GEOPHYS RES LETT, V28, P1543, DOI 10.1029/2000GL012015; Ge ZM, 2013, CLIMATIC CHANGE, V118, P259, DOI 10.1007/s10584-012-0607-1; Goldewijk KK, 2011, GLOBAL ECOL BIOGEOGR, V20, P73, DOI 10.1111/j.1466-8238.2010.00587.x; Hanson PJ, 2000, SCI TOTAL ENVIRON, V262, P205, DOI 10.1016/S0048-9697(00)00523-4; Hickler T, 2008, GLOBAL CHANGE BIOL, V14, P1531, DOI 10.1111/j.1365-2486.2008.01598.x; Hill GB, 2011, GLOBAL CHANGE BIOL, V17, P276, DOI 10.1111/j.1365-2486.2010.02244.x; Hui DF, 2003, TREE PHYSIOL, V23, P433, DOI 10.1093/treephys/23.7.433; Hyvonen R, 2007, NEW PHYTOL, V173, P463, DOI 10.1111/j.1469-8137.2007.01967.x; IPCC, 2014, CLIMATE CHANGE 2014, P1132; Irvine J, 2004, TREE PHYSIOL, V24, P753, DOI 10.1093/treephys/24.7.753; Jentsch A, 2007, FRONT ECOL ENVIRON, V5, P365, DOI 10.1890/1540-9295(2007)5[365:ANGOCE]2.0.CO;2; Joshi M, 2003, CLIM DYNAM, V20, P843, DOI 10.1007/s00382-003-0305-9; Kaufman DS, 2009, SCIENCE, V325, P1236, DOI 10.1126/science.1173983; KIRSCHBAUM MUF, 1994, PLANT CELL ENVIRON, V17, P747, DOI 10.1111/j.1365-3040.1994.tb00167.x; Knapp AK, 2008, BIOSCIENCE, V58, P811, DOI 10.1641/B580908; Leakey ADB, 2009, J EXP BOT, V60, P2859, DOI 10.1093/jxb/erp096; Leff B, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002108; Lehner B, 2004, J HYDROL, V296, P1, DOI 10.1016/j.jhydrol.2004.03.028; Liu ML, 2013, WATER RESOUR RES, V49, P1988, DOI 10.1002/wrcr.20180; LONG SP, 1991, PLANT CELL ENVIRON, V14, P729, DOI 10.1111/j.1365-3040.1991.tb01439.x; Long SP, 2006, SCIENCE, V312, P1918, DOI 10.1126/science.1114722; Lu CQ, 2013, GLOBAL CHANGE BIOL, V19, P571, DOI 10.1111/gcb.12049; Lu CQ, 2012, ECOL APPL, V22, P53, DOI 10.1890/10-1685.1; Luo YQ, 2008, GLOBAL CHANGE BIOL, V14, P1986, DOI 10.1111/j.1365-2486.2008.01629.x; Maurer E, 2008, HYDROL EARTH SYST SC, V5, P3099, DOI [10.5194/hessd-5-3099-2008, DOI 10.5194/HESSD-5-3099-2008]; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; Mohamed MAA, 2004, SCI TOTAL ENVIRON, V332, P123, DOI 10.1016/j.scitotenv.2004.03.009; Morales P, 2007, GLOBAL CHANGE BIOL, V13, P108, DOI 10.1111/j.1365-2486.2006.01289.x; MORISON JIL, 1984, AUST J PLANT PHYSIOL, V11, P361, DOI 10.1071/PP9840361; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Norby RJ, 2005, P NATL ACAD SCI USA, V102, P18052, DOI 10.1073/pnas.0509478102; Ollinger SV, 1997, ECOL APPL, V7, P1237, DOI 10.1890/1051-0761(1997)007[1237:SOEOFP]2.0.CO;2; Pan SF, 2014, ADV METEOROL, V2014, DOI 10.1155/2014/965936; Piao SL, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002888; Potter C, 2012, CLIMATIC CHANGE, V115, P365, DOI 10.1007/s10584-012-0460-2; Ren W, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008521; Ren W, 2012, GLOBAL CHANGE BIOL, V18, P2945, DOI 10.1111/j.1365-2486.2012.02741.x; Ren W, 2011, GLOBAL ECOL BIOGEOGR, V20, P391, DOI 10.1111/j.1466-8238.2010.00606.x; Running SW, 2004, BIOSCIENCE, V54, P547, DOI 10.1641/0006-3568(2004)054[0547:ACSMOG]2.0.CO;2; RYAN MG, 1991, ECOL APPL, V1, P157, DOI 10.2307/1941808; Saxton KE, 2006, SOIL SCI SOC AM J, V70, P1569, DOI 10.2136/sssaj2005.0117; Seidel DJ, 2008, NAT GEOSCI, V1, P21, DOI 10.1038/ngeo.2007.38; Sellers PJ, 1996, J CLIMATE, V9, P676, DOI 10.1175/1520-0442(1996)009<0676:ARLSPF>2.0.CO;2; Shaw MR, 2002, SCIENCE, V298, P1987, DOI 10.1126/science.1075312; Siebert S., 2007, GLOBAL MAP IRRIGATIO; Sitch S, 2008, GLOBAL CHANGE BIOL, V14, P2015, DOI 10.1111/j.1365-2486.2008.01626.x; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; Snover A, 2013, CLIMATE CHANGE IMPAC, P130; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Song X, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00398.1; Tian H, 1999, TELLUS B, V51, P414, DOI 10.1034/j.1600-0889.1999.00021.x; Tian H, 2010, BIOGEOSCIENCES, V7, P2673, DOI 10.5194/bg-7-2673-2010; Tian H, 2000, GLOBAL ECOL BIOGEOGR, V9, P315, DOI 10.1046/j.1365-2699.2000.00198.x; Tian HQ, 2012, ECOSYSTEMS, V15, P674, DOI 10.1007/s10021-012-9539-x; Tian HQ, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001393; Tian HQ, 2011, ECOHYDROLOGY, V4, P322, DOI 10.1002/eco.216; Tian HQ, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003838; Tian HQ, 2010, FOREST ECOL MANAG, V259, P1311, DOI 10.1016/j.foreco.2009.10.009; Tian Hanqin, 2009, P235, DOI 10.1007/978-0-387-77942-3_9; VITOUSEK PM, 1986, BIOSCIENCE, V36, P368, DOI 10.2307/1310258; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wei Y, 2013, GEOSCI MODEL DEV DIS, V6, P5375, DOI DOI 10.5194/GMDD-6-5375-2013; Wood AW, 2004, CLIMATIC CHANGE, V62, P189, DOI 10.1023/B:CLIM.0000013685.99609.9e; Xu X, 2010, BIOGEOSCIENCES DISCU, V7, P5383, DOI [10.5194/bgd-7-5383-2010, DOI 10.5194/BGD-7-5383-2010]; Zhang XY, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2006JG000217; Zhao MS, 2010, SCIENCE, V329, P940, DOI 10.1126/science.1189590	93	39	42	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112810	10.1371/journal.pone.0112810	http://dx.doi.org/10.1371/journal.pone.0112810			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401492	Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700073
J	Janardhan, SV; Marks, R; Gajewski, TF				Janardhan, Sujit V.; Marks, Reinhard; Gajewski, Thomas F.			Primary Murine CD4(+) T Cells Fail to Acquire the Ability to Produce Effector Cytokines When Active Ras Is Present during Th1/Th2 Differentiation	PLOS ONE			English	Article							ERYTHROID-DIFFERENTIATION; DNA METHYLTRANSFERASE; TRANSCRIPTION FACTOR; ANTIGEN RECEPTOR; GENE-EXPRESSION; ERK ACTIVATION; SELECTION; PATHWAY; ANERGY; SOS1	Constitutive Ras signaling has been shown to augment IL-2 production, reverse anergy, and functionally replace many aspects of CD28 co-stimulation in CD4(+) T cells. These data raise the possibility that introduction of active Ras into primary T cells might result in improved functionality in pathologic situations of T cell dysfunction, such as cancer or chronic viral infection. To test the biologic effects of active Ras in primary T cells, CD4(+) T cells from Coxsackie-Adenovirus Receptor Transgenic mice were transduced with an adenovirus encoding active Ras. As expected, active Ras augmented IL-2 production in naive CD4(+) T cells. However, when cells were cultured for 4 days under conditions to promote effector cell differentiation, active Ras inhibited the ability of CD4(+) T cells to acquire a Th1 or Th2 effector cytokine profile. This differentiation defect was not due to deficient STAT4 or STAT6 activation by IL-12 or IL-4, respectively, nor was it associated with deficient induction of T-bet and GATA-3 expression. Impaired effector cytokine production in active Ras-transduced cells was associated with deficient demethylation of the IL-4 gene locus. Our results indicate that, despite augmenting acute activation of naive T cells, constitutive Ras signaling inhibits the ability of CD4(+) T cells to properly differentiate into Th1/Th2 effector cytokine-producing cells, in part by interfering with epigenetic modification of effector gene loci. Alternative strategies to potentiate Ras pathway signaling in T cells in a more regulated fashion should be considered as a therapeutic approach to improve immune responses in vivo.	[Janardhan, Sujit V.; Marks, Reinhard; Gajewski, Thomas F.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Gajewski, Thomas F.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Gajewski, TF (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	tgajewsk@medicine.bsd.uchicago.edu			National Institutes of Health [R21 AI59818, R01 CA118153]; NATIONAL CANCER INSTITUTE [R01CA118153] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI059818] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by R21 AI59818 and R01 CA118153 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; BOWTELL D, 1992, P NATL ACAD SCI USA, V89, P6511, DOI 10.1073/pnas.89.14.6511; Brown IE, 2006, J IMMUNOL, V177, P4521, DOI 10.4049/jimmunol.177.7.4521; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Crespo P, 2000, CELL MOL LIFE SCI, V57, P1613, DOI 10.1007/PL00000645; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Deng C, 1998, BIOL CHEM, V379, P1113, DOI 10.1515/bchm.1998.379.8-9.1113; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Ehrhardt A, 2002, EXP HEMATOL, V30, P1089, DOI 10.1016/S0301-472X(02)00904-9; Farrar JD, 2002, J CLIN INVEST, V109, P431, DOI 10.1172/JCI200215093; Fields PE, 1996, SCIENCE, V271, P1276, DOI 10.1126/science.271.5253.1276; GAJEWSKI TF, 1989, J IMMUNOL, V143, P15; Genot E, 2000, CURR OPIN IMMUNOL, V12, P289, DOI 10.1016/S0952-7915(00)00089-3; GUERRERO I, 1984, SCIENCE, V225, P1159, DOI 10.1126/science.6474169; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hermann-Kleiter N, 2010, BLOOD, V115, P2989, DOI 10.1182/blood-2009-10-233585; Iborra S, 2013, J EXP MED, V210, P1463, DOI 10.1084/jem.20112495; Janardhan SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024931; Kang CD, 1999, EXP MOL MED, V31, P76, DOI 10.1038/emm.1999.13; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kong KF, 2011, NAT IMMUNOL, V12, P1105, DOI 10.1038/ni.2120; Kortum RL, 2013, TRENDS IMMUNOL, V34, P259, DOI 10.1016/j.it.2013.02.004; Kortum RL, 2013, J IMMUNOL, V190, P147, DOI 10.4049/jimmunol.1201458; Kortum RL, 2011, P NATL ACAD SCI USA, V108, P12407, DOI 10.1073/pnas.1104295108; Lee DU, 2002, IMMUNITY, V16, P649, DOI 10.1016/S1074-7613(02)00314-X; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Marks RE, 2003, BIOCHEM BIOPH RES CO, V312, P691, DOI 10.1016/j.bbrc.2003.10.168; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Omidvar N, 2006, MOL CELL BIOL, V26, P3966, DOI 10.1128/MCB.26.10.3966-3975.2006; Perez de Castro I, 2004, MOL CELL BIOL, V24, P3485, DOI 10.1128/MCB.24.8.3485-3496.2004; Philips MR, 2005, BIOCHEM SOC T, V33, P657, DOI 10.1042/BST0330657; Poltorak M, 2014, EUR J IMMUNOL, V44, P1535, DOI 10.1002/eji.201344046; Prasad A, 2009, P NATL ACAD SCI USA, V106, P528, DOI 10.1073/pnas.0805981105; ROULEAU J, 1995, J BIOL CHEM, V270, P1595, DOI 10.1074/jbc.270.4.1595; Rouquette-Jazdanian AK, 2012, MOL CELL, V48, P298, DOI 10.1016/j.molcel.2012.08.011; SEDER RA, 1994, J ALLERGY CLIN IMMUN, V94, P1195, DOI 10.1016/0091-6749(94)90332-8; Staveley-O'Carroll K, 1998, P NATL ACAD SCI USA, V95, P1178, DOI 10.1073/pnas.95.3.1178; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Wan YY, 2000, P NATL ACAD SCI USA, V97, P13784, DOI 10.1073/pnas.250356297; Wang XZ, 2000, J VIROL, V74, P11296, DOI 10.1128/JVI.74.23.11296-11303.2000; Warnecke N, 2012, EMBO REP, V13, P386, DOI 10.1038/embor.2012.17; Zaker F, 1997, LEUKEMIA RES, V21, P635, DOI 10.1016/S0145-2126(97)00022-2; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	51	2	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112831	10.1371/journal.pone.0112831	http://dx.doi.org/10.1371/journal.pone.0112831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397617	gold, Green Submitted, Green Published			2022-12-27	WOS:000345558500097
J	Perkins, TL; Clements, K; Baas, JH; Jago, CF; Jones, DL; Malham, SK; McDonald, JE				Perkins, Tracy L.; Clements, Katie; Baas, Jaco H.; Jago, Colin F.; Jones, Davey L.; Malham, Shelagh K.; McDonald, James E.			Sediment Composition Influences Spatial Variation in the Abundance of Human Pathogen Indicator Bacteria within an Estuarine Environment	PLOS ONE			English	Article							WATERBORNE ESCHERICHIA-COLI; FECAL-COLIFORMS; CAMPYLOBACTER-JEJUNI; MICROBIAL PATHOGENS; ENTERIC BACTERIA; VIBRIO-CHOLERAE; MARINE WATERS; SURVIVAL; TEMPERATURE; QUALITY	Faecal contamination of estuarine and coastal waters can pose a risk to human health, particularly in areas used for shellfish production or recreation. Routine microbiological water quality testing highlights areas of faecal indicator bacteria (FIB) contamination within the water column, but fails to consider the abundance of FIB in sediments, which under certain hydrodynamic conditions can become resuspended. Sediments can enhance the survival of FIB in estuarine environments, but the influence of sediment composition on the ecology and abundance of FIB is poorly understood. To determine the relationship between sediment composition (grain size and organic matter) and the abundance of pathogen indicator bacteria (PIB), sediments were collected from four transverse transects of the Conwy estuary, UK. The abundance of culturable Escherichia coli, total coliforms, enterococci, Campylobacter, Salmonella and Vibrio spp. in sediments was determined in relation to sediment grain size, organic matter content, salinity, depth and temperature. Sediments that contained higher proportions of silt and/or clay and associated organic matter content showed significant positive correlations with the abundance of PIB. Furthermore, the abundance of each bacterial group was positively correlated with the presence of all other groups enumerated. Campylobacter spp. were not isolated from estuarine sediments. Comparisons of the number of culturable E. coli, total coliforms and Vibrio spp. in sediments and the water column revealed that their abundance was 281, 433 and 58-fold greater in sediments (colony forming units (CFU)/100 g) when compared with the water column (CFU/100 ml), respectively. These data provide important insights into sediment compositions that promote the abundance of PIB in estuarine environments, with important implications for the modelling and prediction of public health risk based on sediment resuspension and transport.	[Perkins, Tracy L.; McDonald, James E.] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales; [Clements, Katie; Baas, Jaco H.; Jago, Colin F.; Malham, Shelagh K.] Bangor Univ, Sch Ocean Sci, Bangor, Gwynedd, Wales; [Jones, Davey L.] Bangor Univ, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales; [Malham, Shelagh K.] Bangor Univ, Ctr Appl Marine Sci, Bangor, Gwynedd, Wales	Bangor University; Bangor University; Bangor University; Bangor University	McDonald, JE (corresponding author), Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales.	j.mcdonald@bangor.ac.uk	Jones, Davey L/C-7411-2011; jones, davey/AAN-5606-2020; Jones, Davey/AAD-6037-2020; Malham, Shelagh K/O-9054-2014	Jones, Davey L/0000-0002-1482-4209; Jones, Davey/0000-0002-1482-4209; McDonald, James/0000-0002-6328-3752	Knowledge Economy Skills Scholarship (KESS); European Social Fund (ESF) through the European Union's Convergence program; Natural Environment Research Council consortium grant under the Macronutrient Cycles Research Programme [NE/J011908/1]; Natural Environment Research Council [NE/J011908/1] Funding Source: researchfish; NERC [NE/J011908/1] Funding Source: UKRI	Knowledge Economy Skills Scholarship (KESS); European Social Fund (ESF) through the European Union's Convergence program; Natural Environment Research Council consortium grant under the Macronutrient Cycles Research Programme; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by a Knowledge Economy Skills Scholarship (KESS), part-funded by the European Social Fund (ESF) through the European Union's Convergence program administered by the Welsh Government in association with Dwr Cymru Cyf/Welsh Water Ltd. (http://www.higherskillswales.co.uk/kess/index.php.en?menu = 0&catid = 0), and a Natural Environment Research Council consortium grant under the Macronutrient Cycles Research Programme (NE/J011908/1) (http://www.nerc.ac.uk/research/funded/programmes/macronutrient/#xcollapse3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO JL, 1993, WATER RES, V27, P1559, DOI 10.1016/0043-1354(93)90100-V; An YJ, 2002, ENVIRON POLLUT, V120, P771, DOI 10.1016/S0269-7491(02)00173-2; Anderson ML, 2005, APPL ENVIRON MICROB, V71, P3041, DOI 10.1128/AEM.71.6.3041-3048.2005; Bakr W. M. K., 2011, The Journal of American Science, V7, P663; Barcina I, 1997, FEMS MICROBIOL ECOL, V23, P1, DOI 10.1111/j.1574-6941.1997.tb00385.x; Berthe T, 2008, MAR POLLUT BULL, V57, P59, DOI 10.1016/j.marpolbul.2007.10.013; Bordalo AA, 2002, J APPL MICROBIOL, V93, P864, DOI 10.1046/j.1365-2672.2002.01760.x; BURTON GA, 1987, APPL ENVIRON MICROB, V53, P633, DOI 10.1128/AEM.53.4.633-638.1987; Cabral JPS, 2010, INT J ENV RES PUB HE, V7, P3657, DOI 10.3390/ijerph7103657; Carrero-Colon M, 2011, FECAL BACTERIA, P23; Coburn B, 2007, IMMUNOL CELL BIOL, V85, P112, DOI 10.1038/sj.icb.7100007; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Cox AM, 2012, APPL ENVIRON MICROB, V78, P2996, DOI 10.1128/AEM.07519-11; Craig DL, 2004, J APPL MICROBIOL, V96, P922, DOI 10.1111/j.1365-2672.2004.02243.x; Danovaro R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007006; Davies CM, 2000, J APPL MICROBIOL, V89, P349, DOI 10.1046/j.1365-2672.2000.01118.x; DAVIES CM, 1991, J APPL BACTERIOL, V70, P265, DOI 10.1111/j.1365-2672.1991.tb02935.x; DAVIES CM, 1995, APPL ENVIRON MICROB, V61, P1888, DOI 10.1128/AEM.61.5.1888-1896.1995; Davies-Colley RJ, 1999, WATER RES, V33, P1220, DOI 10.1016/S0043-1354(98)00321-2; Droppo IG, 2009, ENVIRON SCI TECHNOL, V43, P1737, DOI 10.1021/es802321w; Dziejman M, 2002, P NATL ACAD SCI USA, V99, P1556, DOI 10.1073/pnas.042667999; Edge TA, 2011, FECAL BACTERIA, P241; EVISON LM, 1988, WATER SCI TECHNOL, V20, P309, DOI 10.2166/wst.1988.0300; FAUST MA, 1975, APPL MICROBIOL, V30, P800, DOI 10.1128/AEM.30.5.800-806.1975; Figueras MJ, 1997, MAR POLLUT BULL, V34, P148, DOI 10.1016/S0025-326X(97)00107-0; Garzio-Hadzick A, 2010, WATER RES, V44, P2753, DOI 10.1016/j.watres.2010.02.011; GERBA CP, 1976, APPL ENVIRON MICROB, V32, P114, DOI 10.1128/AEM.32.1.114-120.1976; GESAMP, 2001, GESAMP REP STUD, V70, P19; GRIMES DJ, 1975, APPL MICROBIOL, V29, P109, DOI 10.1128/AEM.29.1.109-111.1975; Haller L, 2009, WATER AIR SOIL POLL, V203, P217, DOI 10.1007/s11270-009-0005-0; Hong HC, 2010, J ENVIRON SCI-CHINA, V22, P663, DOI 10.1016/S1001-0742(09)60160-1; Howell JM, 1996, J ENVIRON QUAL, V25, P1216, DOI 10.2134/jeq1996.00472425002500060007x; Ishii S, 2007, ENVIRON SCI TECHNOL, V41, P2203, DOI 10.1021/es0623156; JONES GE, 1964, J BACTERIOL, V87, P483, DOI 10.1128/JB.87.3.483-499.1964; KORHONEN LK, 1991, J APPL BACTERIOL, V71, P379, DOI 10.1111/j.1365-2672.1991.tb03804.x; Levin RE, 2007, FOOD BIOTECHNOL, V21, P271, DOI 10.1080/08905430701536565; Malham SK, 2014, ENVIRON SCI-PROC IMP, V16, P2145, DOI [10.1039/c4em00031e, 10.1039/C4EM00031E]; MARINO RP, 1991, WATER RES, V25, P1089, DOI 10.1016/0043-1354(91)90202-2; Obiri-Danso K, 2000, WATER RES, V34, P519, DOI 10.1016/S0043-1354(99)00146-3; Okpokwasili GC, 1996, ENVIRON TOXIC WATER, V11, P77; Oliver LR, 2008, HYDROBIOLOGIA, V606, P117, DOI 10.1007/s10750-008-9339-7; Polo F, 1998, FEMS MICROBIOL LETT, V160, P253, DOI 10.1016/S0378-1097(98)00040-8; POMMEPUY M, 1992, WATER SCI TECHNOL, V25, P93, DOI 10.2166/wst.1992.0341; Pote J, 2009, J ENVIRON SCI, V21, P62, DOI 10.1016/S1001-0742(09)60012-7; Power ML, 2005, ENVIRON MICROBIOL, V7, P631, DOI 10.1111/j.1462-2920.2005.00729.x; Quilliam RS, 2011, J WATER HEALTH, V9, P734, DOI 10.2166/wh.2011.057; Roper MM, 1974, MICROB ECOL, V1, P1, DOI 10.1007/BF02512375; Shuval Hillel, 2003, Journal of Water and Health, V1, P53; SINGLETON FL, 1982, APPL ENVIRON MICROB, V44, P1047, DOI 10.1128/AEM.44.5.1047-1058.1982; SINTON LW, 1994, APPL ENVIRON MICROB, V60, P2040, DOI 10.1128/AEM.60.6.2040-2048.1994; Straub TM, 2003, J MICROBIOL METH, V53, P185, DOI 10.1016/S0167-7012(03)00023-X; Thorn CE, 2011, ANAEROBE, V17, P330, DOI 10.1016/j.anaerobe.2011.04.021; Thorns CJ, 2000, REV SCI TECH OIE, V19, P226, DOI 10.20506/rst.19.1.1219; Topp E, 2009, BIORESOURCE TECHNOL, V100, P5395, DOI 10.1016/j.biortech.2008.11.001; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494	55	55	60	7	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112951	10.1371/journal.pone.0112951	http://dx.doi.org/10.1371/journal.pone.0112951			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397595	Green Submitted, gold, Green Published			2022-12-27	WOS:000345558500118
J	Tognetti, R; Lombardi, F; Lasserre, B; Cherubini, P; Marchetti, M				Tognetti, Roberto; Lombardi, Fabio; Lasserre, Bruno; Cherubini, Paolo; Marchetti, Marco			Tree-Ring Stable Isotopes Reveal Twentieth-Century Increases in Water-Use Efficiency of Fagus sylvatica and Nothofagus spp. in Italian and Chilean Mountains	PLOS ONE			English	Article							LONG-TERM TRENDS; CARBON-DIOXIDE; CLIMATE-CHANGE; QUERCUS-PUBESCENS; CENTRAL APENNINES; BEECH FOREST; GROWTH; DELTA-C-13; DROUGHT; L.	Changes in intrinsic water use efficiency (iWUE) were investigated in Fagus sylvatica and Nothofagus spp. over the last century. We combined dendrochronological methods with dual-isotope analysis to investigate whether atmospheric changes enhanced iWUE of Fagus and Nothofagus and tree growth (basal area increment, BAI) along latitudinal gradients in Italy and Chile. Post-maturation phases of the trees presented different patterns in delta C-13, Delta C-13, delta O-18, Ci (internal CO2 concentration), iWUE, and BAI. A continuous enhancement in isotope-derived iWUE was observed throughout the twentieth century, which was common to all sites and related to changes in Ca (ambient CO2 concentration) and secondarily to increases in temperature. In contrast to other studies, we observed a general increasing trend of BAI, with the exception of F. sylvatica in Aspromonte. Both iWUE and BAI were uncoupled with the estimated drought index, which is in agreement with the absence of enduring decline in tree growth. In general, delta C-13 and delta O-18 showed a weak relationship, suggesting the major influence of photosynthetic rate on Ci and delta C-13, and the minor contribution of the regulation of stomatal conductance to iWUE. The substantial warming observed during the twentieth century did not result in a clear pattern of increased drought stress along these latitudinal transects, because of the variability in temporal trends of precipitation and in specific responses of populations.	[Tognetti, Roberto; Lombardi, Fabio; Lasserre, Bruno; Marchetti, Marco] Univ Molise, Dipartimento Biosci & Terr, Pesche, Italy; [Tognetti, Roberto] Edmund Mach Fdn, EFI Project Ctr Mt Forests MOUNTFOR, San Michele All Adige, Italy; [Cherubini, Paolo] WSL Swiss Fed Inst Forest Snow & Landscape Res, Birmensdorf, Switzerland	University of Molise; Fondazione Edmund Mach; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Tognetti, R (corresponding author), Univ Molise, Dipartimento Biosci & Terr, Pesche, Italy.	tognetti@unimol.it	Cherubini, Paolo/N-9702-2013; Tognetti, Roberto/C-4962-2008; Cherubini, Paolo/AAC-3121-2021; lasserre, bruno/G-1409-2011; Marchetti, Marco/D-9277-2012	Cherubini, Paolo/0000-0002-9809-250X; Tognetti, Roberto/0000-0002-7771-6176; Cherubini, Paolo/0000-0002-9809-250X; lasserre, bruno/0000-0003-1150-8064; Marchetti, Marco/0000-0002-5275-5769; Lombardi, Fabio/0000-0003-3517-5890	MIUR, Italy; FIRB, MIUR, Italy	MIUR, Italy(Ministry of Education, Universities and Research (MIUR)); FIRB, MIUR, Italy(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	Financial support was provided by the project "Ciclo del carbonio ed altri gas serra in ecosistemi forestali, naturali ed artificiali dell'America Latina: analisi preliminare, studio di fattibilita e comparazione con ecosistemi italiani'' (Internationalization 2008, MIUR, Italy) and "Sviluppo di modelli innovativi per il monitoraggio multiscala degli indicatori di servizi ecosistemici nelle foreste Mediterranee'' (FIRB 2012, MIUR, Italy) - http://www.istruzione.it/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderegg WRL, 2012, TRENDS PLANT SCI, V17, P693, DOI 10.1016/j.tplants.2012.09.006; Anderson W. T., 2005, Dendrochronologia, V23, P1, DOI 10.1016/j.dendro.2005.07.006; Andreu-Hayles L, 2011, GLOBAL CHANGE BIOL, V17, P2095, DOI 10.1111/j.1365-2486.2010.02373.x; Barber VA, 2000, NATURE, V405, P668, DOI 10.1038/35015049; Barbour MM, 2007, FUNCT PLANT BIOL, V34, P83, DOI 10.1071/FP06228; Barbour MM, 2002, PLANT CELL ENVIRON, V25, P1483, DOI 10.1046/j.0016-8025.2002.00931.x; Barnard HR, 2012, TREE PHYSIOL, V32, P1183, DOI 10.1093/treephys/tps078; Bascietto M, 2004, CAN J FOREST RES, V34, P481, DOI 10.1139/X03-214; Battipaglia G, 2008, PALAEOGEOGR PALAEOCL, V261, P193, DOI 10.1016/j.palaeo.2008.01.020; Borella S, 1998, J GEOPHYS RES-ATMOS, V103, P19519, DOI 10.1029/98JD01169; BORGHETTI M, 1993, FUNCT ECOL, V7, P713, DOI 10.2307/2390193; Linares JC, 2012, GLOBAL CHANGE BIOL, V18, P1000, DOI 10.1111/j.1365-2486.2011.02566.x; CHAPIN FS, 1990, ANNU REV ECOL SYST, V21, P423, DOI 10.1146/annurev.ecolsys.21.1.423; Choat B, 2012, NATURE, V491, P752, DOI 10.1038/nature11688; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Cook E., 1990, METHODS DENDROCHRONO, P104, DOI 10.1007/978-94-015-7879-0; Cullen LE, 2001, J ECOL, V89, P1061, DOI 10.1111/j.1365-2745.2001.00628.x; Cullen LE, 2008, TREE PHYSIOL, V28, P1525, DOI 10.1093/treephys/28.10.1525; Dai AG, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015541; Daniels LD, 2004, ECOLOGY, V85, P1284, DOI 10.1890/03-0092; Di Filippo A, 2012, GLOBAL CHANGE BIOL, V18, P960, DOI 10.1111/j.1365-2486.2011.02617.x; Dittmar C, 2003, FOREST ECOL MANAG, V173, P63, DOI 10.1016/S0378-1127(01)00816-7; Douville H, 2013, NAT CLIM CHANGE, V3, P59, DOI [10.1038/nclimate1632, 10.1038/NCLIMATE1632]; Duquesnay A, 1998, PLANT CELL ENVIRON, V21, P565, DOI 10.1046/j.1365-3040.1998.00304.x; Eilmann B, 2012, TREE PHYSIOL, V32, P178, DOI 10.1093/treephys/tps004; Fajardo A, 2011, NEW PHYTOL, V189, P259, DOI 10.1111/j.1469-8137.2010.03468.x; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; FARQUHAR GD, 1984, AUST J PLANT PHYSIOL, V11, P539, DOI 10.1071/PP9840539; Feng XH, 1999, GEOCHIM COSMOCHIM AC, V63, P1891, DOI 10.1016/S0016-7037(99)00088-5; Francey RJ, 1999, TELLUS B, V51, P170, DOI 10.1034/j.1600-0889.1999.t01-1-00005.x; FRANCEY RJ, 1982, NATURE, V297, P28, DOI 10.1038/297028a0; Fritts H. C., 1976, TREE RINGS CLIMATE; Gagen M, 2011, GLOBAL CHANGE BIOL, V17, P1064, DOI 10.1111/j.1365-2486.2010.02273.x; Gessler A, 2014, TREE PHYSL IN PRESS; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Grams TEE, 2007, PLANT CELL ENVIRON, V30, P1023, DOI 10.1111/j.1365-3040.2007.01696.x; Granda E, 2014, OECOLOGIA, V174, P307, DOI 10.1007/s00442-013-2742-4; Grossiord C, 2014, P NATL ACAD SCI USA, V111, P14812, DOI 10.1073/pnas.1411970111; GUTIERREZ E, 1988, ACTA OECOL-OEC PLANT, V9, P301; Hardtle W, 2013, ECOSYSTEMS, V16, P1413, DOI 10.1007/s10021-013-9692-x; Hanewinkel M, 2013, NAT CLIM CHANGE, V3, P203, DOI [10.1038/nclimate1687, 10.1038/NCLIMATE1687]; HARGREAVES GH, 1982, J IRR DRAIN DIV-ASCE, V108, P225; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Hietz P, 2005, TREE PHYSIOL, V25, P745, DOI 10.1093/treephys/25.6.745; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Holtmeier FK, 2005, GLOBAL ECOL BIOGEOGR, V14, P395, DOI 10.1111/j.1466-822x.2005.00168.x; Kaennel M, 1995, MULTILINGUAL GLOSSAR; Keitel C, 2006, PLANT CELL ENVIRON, V29, P1492, DOI 10.1111/j.1365-3040.2006.01520.x; Kendall MG, 1976, RANK CORRELATION MET; KORNER C, 1991, OECOLOGIA, V88, P30, DOI 10.1007/BF00328400; Kress A, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003613; Lara A, 2005, J BIOGEOGR, V32, P879, DOI 10.1111/j.1365-2699.2005.01191.x; Lara A, 2001, CAN J FOREST RES, V31, P925, DOI 10.1139/cjfr-31-6-925; LEAVITT SW, 1986, ECOLOGY, V67, P1002, DOI 10.2307/1939823; Li JB, 2008, GLOBAL CHANGE BIOL, V14, P2096, DOI 10.1111/j.1365-2486.2008.01603.x; Linares JC, 2009, OECOLOGIA, V161, P611, DOI 10.1007/s00442-009-1409-7; Loader NJ, 1997, CHEM GEOL, V136, P313, DOI 10.1016/S0009-2541(96)00133-7; Lombardi F, 2008, ECOSYSTEMS, V11, P882, DOI 10.1007/s10021-008-9167-7; Lombardi F, 2011, AUSTRAL ECOL, V36, P329, DOI 10.1111/j.1442-9993.2010.02154.x; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; Marchetti M, 2010, PLANT BIOSYST, V144, P130, DOI 10.1080/11263500903560470; Marshall JD, 1996, OECOLOGIA, V105, P13, DOI 10.1007/BF00328786; McCarroll D, 2004, QUATERNARY SCI REV, V23, P771, DOI 10.1016/j.quascirev.2003.06.017; McDowell NG, 2011, TRENDS ECOL EVOL, V26, P523, DOI 10.1016/j.tree.2011.06.003; McMahon SM, 2010, P NATL ACAD SCI USA, V107, P3611, DOI 10.1073/pnas.0912376107; Nock CA, 2011, GLOBAL CHANGE BIOL, V17, P1049, DOI 10.1111/j.1365-2486.2010.02222.x; OLEARY MH, 1981, PHYTOCHEMISTRY, V20, P553, DOI 10.1016/0031-9422(81)85134-5; Osmond C. B., 1980, PHYSL PROCESSES PLAN, DOI 10.1007/978-3-642-67637-6; Penuelas J, 2008, GLOBAL CHANGE BIOL, V14, P1076, DOI 10.1111/j.1365-2486.2008.01563.x; Penuelas J, 2011, GLOBAL ECOL BIOGEOGR, V20, P597, DOI 10.1111/j.1466-8238.2010.00608.x; Piovesan G, 2005, ACTA OECOL, V27, P197, DOI 10.1016/j.actao.2005.01.001; Piovesan G, 2008, GLOBAL CHANGE BIOL, V14, P1265, DOI 10.1111/j.1365-2486.2008.01570.x; Premoli AC, 2007, AUSTRAL ECOL, V32, P515, DOI 10.1111/j.1442-9993.2007.01720.x; Richardson SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058878; Rigling A, 2013, GLOBAL CHANGE BIOL, V19, P229, DOI 10.1111/gcb.12038; Ripullone F, 2009, IFOREST, V2, P59, DOI 10.3832/ifor0491-002; Roden JS, 2012, TREE PHYSIOL, V32, P490, DOI 10.1093/treephys/tps019; Salzer MW, 2009, P NATL ACAD SCI USA, V106, P20348, DOI 10.1073/pnas.0903029106; Saurer M, 1997, PLANT CELL ENVIRON, V20, P1543, DOI 10.1046/j.1365-3040.1997.d01-53.x; Scartazza A, 2013, TREE PHYSIOL, V33, P730, DOI 10.1093/treephys/tpt045; Scheidegger Y, 2000, OECOLOGIA, V125, P350, DOI 10.1007/s004420000466; Schollaen K, 2013, QUATERNARY SCI REV, V73, P170, DOI 10.1016/j.quascirev.2013.05.018; Silva LCR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053089; Silva LCR, 2013, GLOBAL ECOL BIOGEOGR, V22, P83, DOI 10.1111/j.1466-8238.2012.00783.x; Silva LCR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011543; Silva LCR, 2009, GLOBAL CHANGE BIOL, V15, P2387, DOI 10.1111/j.1365-2486.2009.01859.x; Song X, 2014, PLANT CELL IN PRESS; Srur AM, 2008, REV CHIL HIST NAT, V81, P239; Suarez ML, 2004, J ECOL, V92, P954, DOI 10.1111/j.1365-2745.2004.00941.x; Switsur R., 1998, STABLE ISOTOPES INTE, P303; Tognetti R, 1999, TREE PHYSIOL, V19, P261; Tognetti R, 1998, ENVIRON EXP BOT, V39, P233, DOI 10.1016/S0098-8472(98)00013-6; Tognetti R, 1998, TREES-STRUCT FUNCT, V12, P326, DOI 10.1007/s004680050158; TOGNETTI R, 1995, TREES-STRUCT FUNCT, V9, P348, DOI 10.1007/BF00202499; TOGNETTI R, 1994, TREE PHYSIOL, V14, P751, DOI 10.1093/treephys/14.7-8-9.751; Tognetti R, 2012, TREES-STRUCT FUNCT, V26, P1805, DOI 10.1007/s00468-012-0749-9; Villalba R, 2003, CLIMATIC CHANGE, V59, P177, DOI 10.1023/A:1024452701153; Villalba R, 1997, CLIMATIC CHANGE, V36, P425, DOI 10.1023/A:1005366317996; Villalba R, 2012, NAT GEOSCI, V5, P793, DOI [10.1038/NGEO1613, 10.1038/ngeo1613]; Weber P, 2013, TREES-STRUCT FUNCT, V27, P171, DOI 10.1007/s00468-012-0786-4	101	49	49	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113136	10.1371/journal.pone.0113136	http://dx.doi.org/10.1371/journal.pone.0113136			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398040	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500135
J	Li, L; Guo, YF; Zhai, HX; Yin, YX; Zhang, JJ; Chen, HW; Wang, L; Li, N; Liu, RM; Xia, YF				Li, Liang; Guo, Yingfei; Zhai, Hongxia; Yin, Yaxin; Zhang, Jinjin; Chen, Haiwei; Wang, Lei; Li, Na; Liu, Runmei; Xia, Yunfeng			Aging Increases the Susceptivity of MSCs to Reactive Oxygen Species and Impairs Their Therapeutic Potency for Myocardial Infarction	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; BONE-MARROW; ISCHEMIC-HEART; TRANSPLANTATION; RATS; PROGENITOR; ADIPOSE; ISCHEMIA/REPERFUSION; CARDIOMYOCYTES	Myocardial infarction (MI) is one of the leading causes of death worldwide and Mesenchymal Stem Cells (MSCs) transplantation has been considered a promising therapy. Recently, it was reported that the therapeutic effectiveness of MSCs is dependent on the age of the donor, yet the underlying mechanism has not been thoroughly investigated. This study was designed to investigate whether this impaired therapeutic potency is caused by an increased susceptivity of MSCs from old donors to reactive oxygen species (ROS). The MSCs were isolated from the subcutaneous inguinal region of young (8-10 weeks) and old (18 months) Sprague-Dawley (SD) rats. By exposing these MSCs to H2O2, we found that the adhesion of MSCs from old donors was damaged more severely. Specifically, decreased expression of integrin and reduced phosphorylation of focal adhesion kinase Src and FAK were observed. Furthemore, H2O2 triggered an increased apoptosis of MSCs from old donors. To study the viability and therapeutic potency of MSCs from young and old donors in vivo, these MSCs were transplanted into acute MI model rats. We observed a more rapidly decreased survival rate of the old MSCs in the infarct region, which may be caused by their increased susceptivity to the micro-environmental ROS, as transplantation of the old MSCs with N-acetyl-L-cysteine (NAC), a ROS scavenger, protected them. The low viability of engrafted old MSCs consequently impaired their therapeutic effectiveness, judging by the histology and function of heart. Our study may help to understand the mechanism of MSCs-host interaction during MI, as well as shed light on the design of therapeutic strategy in clinic.	[Li, Liang; Zhai, Hongxia; Yin, Yaxin; Zhang, Jinjin; Chen, Haiwei; Wang, Lei; Li, Na; Liu, Runmei; Xia, Yunfeng] Gen Hosp Peoples Liberat Army, Hosp 1, Dept Cadres 1, Beijing, Peoples R China; [Guo, Yingfei] Gen Hosp Peoples Liberat Army, Hosp 1, Dept Emergency, Beijing, Peoples R China		Xia, YF (corresponding author), Gen Hosp Peoples Liberat Army, Hosp 1, Dept Cadres 1, Beijing, Peoples R China.	xiayf3691@sina.com	zhang, jin/GXV-9154-2022					Angelos MG, 2006, AM J PHYSIOL-HEART C, V290, pH341, DOI 10.1152/ajpheart.00223.2005; Ayala-Lugo A, 2011, CELL TRANSPLANT, V20, P407, DOI 10.3727/096368909X519283; Bajek A, 2012, AGING CLIN EXP RES, V24, P404, DOI 10.3275/8424; Banfi A, 2002, TISSUE ENG, V8, P901, DOI 10.1089/107632702320934001; Carvalho PH, 2013, ARQ BRAS CARDIOL, V100, P82, DOI 10.1590/S0066-782X2012005000114; Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034; Dai WD, 2005, CIRCULATION, V112, P214, DOI 10.1161/CIRCULATIONAHA.104.527937; DiGirolamo CM, 1999, BRIT J HAEMATOL, V107, P275, DOI 10.1046/j.1365-2141.1999.01715.x; Fan Q, 2013, AGE, V35, P1017, DOI 10.1007/s11357-012-9421-y; Fan QA, 2011, CLIN SCI, V120, P251, DOI 10.1042/CS20100369; Fang J, 2008, J AM COLL CARDIOL, V52, P428, DOI 10.1016/j.jacc.2008.03.061; Hahn JY, 2008, J AM COLL CARDIOL, V51, P933, DOI 10.1016/j.jacc.2007.11.040; Jain M, 2005, CORONARY ARTERY DIS, V16, P93, DOI 10.1097/00019501-200503000-00003; Katritsis DG, 2005, CATHETER CARDIO INTE, V65, P321, DOI 10.1002/ccd.20406; Khan M, 2011, J CELL MOL MED, V15, P1515, DOI 10.1111/j.1582-4934.2009.00998.x; Li WZ, 2007, STEM CELLS, V25, P2118, DOI 10.1634/stemcells.2006-0771; Liu MB, 2012, AGE, V34, P621, DOI 10.1007/s11357-011-9259-8; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Mantovani C, 2012, EXP CELL RES, V318, P2034, DOI 10.1016/j.yexcr.2012.05.008; Mias C, 2009, STEM CELLS, V27, P2734, DOI 10.1002/stem.169; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Piccirillo G, 2013, HEART RHYTHM; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Ruan W, 2005, CHINESE MED J-PEKING, V118, P1175; Schachinger V, 2006, EUR HEART J, V27, P2775, DOI 10.1093/eurheartj/ehl388; Shake JG, 2002, ANN THORAC SURG, V73, P1919, DOI 10.1016/S0003-4975(02)03517-8; Shi RZ, 2008, BIOCHEM BIOPH RES CO, V376, P247, DOI 10.1016/j.bbrc.2008.09.004; Song H, 2010, STEM CELLS, V28, P555, DOI 10.1002/stem.302; Stolzing A, 2006, AGING CELL, V5, P213, DOI 10.1111/j.1474-9726.2006.00213.x; White HD, 2008, LANCET, V372, P570, DOI 10.1016/S0140-6736(08)61237-4; Wu LW, 2014, TRANSPL IMMUNOL, V30, P122, DOI 10.1016/j.trim.2014.03.001; Xaymardan M, 2012, J MOL CELL CARDIOL, V52, P1265, DOI 10.1016/j.yjmcc.2012.03.002; Xu GW, 2007, CELL RES, V17, P240, DOI 10.1038/cr.2007.4; Yao EH, 2006, CURR PHARM BIOTECHNO, V7, P101, DOI 10.2174/138920106776597685	37	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e111850	10.1371/journal.pone.0111850	http://dx.doi.org/10.1371/journal.pone.0111850			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393016	Green Published, gold, Green Submitted			2022-12-27	WOS:000347709300024
J	Li, XF; Xu, L; Li, JF; Li, BQ; Bai, XH; Strauss, JF; Zhang, ZB; Wang, HB				Li, Xiaofei; Xu, Lei; Li, Jianfeng; Li, Boqin; Bai, Xiaohui; Strauss, Jerome F., III; Zhang, Zhibing; Wang, Haibo			Otitis Media in Sperm-Associated Antigen 6 (Spag6)-Deficient Mice	PLOS ONE			English	Article							PRIMARY CILIARY DYSKINESIA; CENTRAL APPARATUS; POLARITY; HYDROCEPHALUS; MICROTUBULE; EPITHELIUM; EXPRESSION; EFFUSION; CHILDREN; PROTEIN	Mammalian SPAG6 protein is localized to the axoneme central apparatus, and it is required for normal flagella and cilia motility. Recent studies demonstrated that the protein also regulates ciliogenesis and cilia polarity in the epithelial cells of brain ventricles and trachea. Motile cilia are also present in the epithelial cells of the middle ear and Eustachian tubes, where the ciliary system participates in the movement of serous fluid and mucus in the middle ear. Cilia defects are associated with otitis media (OM), presumably due to an inability to efficiently transport fluid, mucus and particles including microorganisms. We investigated the potential role of SPAG6 in the middle ear and Eustachian tubes by studying mice with a targeted mutation in the Spag6 gene. SPAG6 is expressed in the ciliated cells of middle ear epithelial cells. The orientation of the ciliary basal feet was random in the middle ear epithelial cells of Spag6-deficient mice, and there was an associated disrupted localization of the planar cell polarity (PCP) protein, FZD6. These features are associated with disordered cilia orientation, confirmed by scanning electron microscopy, which leads to uncoordinated cilia beating. The Spag6 mutant mice were also prone to develop OM. However, there were no significant differences in bacterial populations, epithelial goblet cell density, mucin expression and Eustachian tube angle between the mutant and wild-type mice, suggesting that OM was due to accumulation of fluid and mucus secondary to the ciliary dysfunction. Our studies demonstrate a role for Spag6 in the pathogenesis of OM in mice, possibly through its role in the regulation of cilia/basal body polarity through the PCP-dependent mechanisms in the middle ear and Eustachian tubes.	[Li, Xiaofei; Xu, Lei; Wang, Haibo] Shandong Univ, Prov Hosp, Jinan 250100, Shandong, Peoples R China; [Li, Xiaofei; Li, Jianfeng; Li, Boqin; Bai, Xiaohui; Wang, Haibo] Shandong Prov Key Lab Otol, Jinan, Shandong, Peoples R China; [Strauss, Jerome F., III; Zhang, Zhibing] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA 23284 USA; [Strauss, Jerome F., III; Zhang, Zhibing] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA USA	Shandong University; Virginia Commonwealth University; Virginia Commonwealth University	Zhang, ZB (corresponding author), Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA 23284 USA.	zzhang4@vcu.edu; wang.hb7585@hotmail.com	Li, xiaofei/GXF-7187-2022	Bai, Xiaohui/0000-0002-4027-7798; Li, Xiaofei/0000-0001-6968-6256	National Basic Research Program of China (973 Program) [2014CB541703]; 12th Five-Year National key technologies R D program [2012BAI12B01]; National Institutes of Health [HD076257]; VCU Massey Cancer Center Award; National Natural Science Foundation of China [81000407, 81470704]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD076257] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); 12th Five-Year National key technologies R D program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VCU Massey Cancer Center Award; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Basic Research Program of China (973 Program 2014CB541703 to HBW), The 12th Five-Year National key technologies R & D program (No. 2012BAI12B01 to HBW), National Institutes of Health grant (HD076257 to ZBZ), VCU Massey Cancer Center Award (to ZBZ), and National Natural Science Foundation of China (81000407, 81470704 to XHB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHO OP, 1995, ARCH OTOLARYNGOL, V121, P432; Bayly R, 2011, NAT REV GENET, V12, P385, DOI 10.1038/nrg2956; BOISVIEUXULRICH E, 1991, BIOL CELL, V72, P3, DOI 10.1016/0248-4900(91)90072-U; Campbell RG, 2009, INT J PEDIATR OTORHI, V73, P1630, DOI 10.1016/j.ijporl.2009.08.024; Depreux FFS, 2008, J CLIN INVEST, V118, P651, DOI 10.1172/JCI32899; GREEN MARGARET C., 1952, OHIO JOUR SCI, V52, P31; Hendolin PH, 1997, J CLIN MICROBIOL, V35, P2854, DOI 10.1128/JCM.35.11.2854-2858.1997; Juhn S K, 1985, Auris Nasus Larynx, V12 Suppl 1, pS63; Kerschner JE, 2013, INT J PEDIATR OTORHI, V77, P1, DOI 10.1016/j.ijporl.2012.11.038; Kerschner JE, 2010, ARCH OTOLARYNGOL, V136, P819, DOI 10.1001/archoto.2010.123; Leigh MW, 2009, GENET MED, V11, P473, DOI 10.1097/GIM.0b013e3181a53562; Lin JZ, 2003, JARO-J ASSOC RES OTO, V4, P384, DOI 10.1007/s10162-002-3023-9; Majithia A, 2005, INT J PEDIATR OTORHI, V69, P1061, DOI 10.1016/j.ijporl.2005.02.013; Mata M, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0420-1; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Preciado D, 2010, PEDIATR RES, V68, P231, DOI 10.1203/00006450-201011001-00451; Riley B, 2011, PLOS ONE, V6; Rosenfeld RM, 2004, OTOLARYNG HEAD NECK, V130, pS95, DOI 10.1016/j.otohns.2004.02.002; Rousseau K, 2007, AM J PHYSIOL-LUNG C, V292, pL1396, DOI 10.1152/ajplung.00444.2006; SADE J, 1975, ACTA OTO-LARYNGOL, V79, P277, DOI 10.3109/00016487509124685; Sapiro R, 2002, MOL CELL BIOL, V22, P6298, DOI 10.1128/MCB.22.17.6298-6305.2002; Sapiro R, 2000, BIOL REPROD, V62, P511, DOI 10.1095/biolreprod62.3.511; Shimada Y, 2006, DEV CELL, V10, P209, DOI 10.1016/j.devcel.2005.11.016; Smith EF, 1996, J CELL BIOL, V132, P359, DOI 10.1083/jcb.132.3.359; Teves ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107271; Thompson H, 2013, SCIENCE, V339, P1453, DOI 10.1126/science.1232862; Trune DR, 2009, BRAIN RES, V1277, P90, DOI 10.1016/j.brainres.2009.02.047; Vladar EK, 2012, CURR BIOL, V22, P2203, DOI 10.1016/j.cub.2012.09.046; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Wansleeben C, 2011, DEV DYNAM, V240, P616, DOI 10.1002/dvdy.22564; Zhang X, 2012, PLOS ONE, V7; Zhang ZB, 2007, CELL MOTIL CYTOSKEL, V64, P360, DOI 10.1002/cm.20189	32	18	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112879	10.1371/journal.pone.0112879	http://dx.doi.org/10.1371/journal.pone.0112879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393619	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300116
J	Torre, S; Tattini, M; Brunetti, C; Fineschi, S; Fini, A; Ferrini, F; Sebastiani, F				Torre, Sara; Tattini, Massimiliano; Brunetti, Cecilia; Fineschi, Silvia; Fini, Alessio; Ferrini, Francesco; Sebastiani, Federico			RNA-Seq Analysis of Quercus pubescens Leaves: De Novo Transcriptome Assembly, Annotation and Functional Markers Development	PLOS ONE			English	Article							CLIMATE-CHANGE; TRICHOMES; DROUGHT; L.; BIOSYNTHESIS; PYRIMIDINE; RESPONSES; PURINE; END; OAK	Quercus pubescens Willd., a species distributed from Spain to southwest Asia, ranks high for drought tolerance among European oaks. Q. pubescens performs a role of outstanding significance in most Mediterranean forest ecosystems, but few mechanistic studies have been conducted to explore its response to environmental constrains, due to the lack of genomic resources. In our study, we performed a deep transcriptomic sequencing in Q. pubescens leaves, including de novo assembly, functional annotation and the identification of new molecular markers. Our results are a pre-requisite for undertaking molecular functional studies, and may give support in population and association genetic studies. 254,265,700 clean reads were generated by the Illumina HiSeq 2000 platform, with an average length of 98 bp. De novo assembly, using CLC Genomics, produced 96,006 contigs, having a mean length of 618 bp. Sequence similarity analyses against seven public databases (Uniprot, NR, RefSeq and KOGs at NCBI, Pfam, InterPro and KEGG) resulted in 83,065 transcripts annotated with gene descriptions, conserved protein domains, or gene ontology terms. These annotations and local BLAST allowed identify genes specifically associated with mechanisms of drought avoidance. Finally, 14,202 microsatellite markers and 18,425 single nucleotide polymorphisms (SNPs) were, in silico, discovered in assembled and annotated sequences. We completed a successful global analysis of the Q. pubescens leaf transcriptome using RNA-seq. The assembled and annotated sequences together with newly discovered molecular markers provide genomic information for functional genomic studies in Q. pubescens, with special emphasis to response mechanisms to severe constrain of the Mediterranean climate. Our tools enable comparative genomics studies on other Quercus species taking advantage of large intra-specific ecophysiological differences.	[Torre, Sara; Tattini, Massimiliano; Brunetti, Cecilia; Fineschi, Silvia] Natl Res Council Italy CNR, Dept Biol Agr & Food Sci, Inst Plant Protect, Sesto Fiorentino, Italy; [Brunetti, Cecilia; Fini, Alessio; Ferrini, Francesco] Univ Florence, Dept Agri Food & Environm Sci, Sesto Fiorentino, Italy; [Sebastiani, Federico] Natl Res Council Italy CNR, Dept Biol Agr & Food Sci, Inst Biosci & BioResources, Sesto Fiorentino, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR)	Sebastiani, F (corresponding author), Natl Res Council Italy CNR, Dept Biol Agr & Food Sci, Inst Biosci & BioResources, Sesto Fiorentino, Italy.	federico.sebastiani@ibbr.cnr.it	Cecilia, Brunetti/Q-4724-2018; Fineschi, Silvia/ABF-9775-2020; Tattini, Massimiliano/K-1238-2019; Brunetti, Cecilia/D-3439-2016	Tattini, Massimiliano/0000-0001-5434-8860; FINI, ALESSIO/0000-0002-9713-689X; TORRE, SARA/0000-0002-3496-4057; Brunetti, Cecilia/0000-0002-8531-6076; SEBASTIANI, FEDERICO/0000-0003-4676-7381; FINESCHI, SILVIA/0000-0002-3583-6073; ferrini, Francesco/0000-0003-2222-0437	Italian Ministry of University and Research (MIUR/PRIN TreeCity)	Italian Ministry of University and Research (MIUR/PRIN TreeCity)(Ministry of Education, Universities and Research (MIUR))	This work was supported by the following Research Grants: Italian Ministry of University and Research (MIUR/PRIN-2012 TreeCity). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS MD, 1990, TREE PHYSIOL, V7, P227, DOI 10.1093/treephys/7.1-2-3-4.227; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Ashrafi H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-571; Avise J, 2004, MOL MARKERS NATURAL; Barbara T, 2007, MOL ECOL, V16, P3759, DOI 10.1111/j.1365-294X.2007.03439.x; Blanca J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-104; Boldt R, 2003, PHYSIOL PLANTARUM, V117, P297, DOI 10.1034/j.1399-3054.2003.00030.x; Bouck A, 2007, MOL ECOL, V16, P907, DOI 10.1111/j.1365-294X.2006.03195.x; Brautigam A, 2011, J EXP BOT, V62, P3093, DOI 10.1093/jxb/err029; Breda N, 2006, ANN FOREST SCI, V63, P625, DOI 10.1051/forest:2006042; Broun P, 2005, CURR OPIN PLANT BIOL, V8, P272, DOI 10.1016/j.pbi.2005.03.006; Bruschi P, 2003, ANN BOT-LONDON, V91, P707, DOI 10.1093/aob/mcg075; Bussotti F, 1998, NEW PHYTOL, V138, P469, DOI 10.1046/j.1469-8137.1998.00121.x; Bussotti F, 2014, ENVIRON EXP BOT, V103, P80, DOI 10.1016/j.envexpbot.2013.09.013; Christensen JH, 2007, CLIMATIC CHANGE, V81, P1, DOI 10.1007/s10584-006-9211-6; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; DAMESIN C, 1995, NEW PHYTOL, V131, P159, DOI 10.1111/j.1469-8137.1995.tb05717.x; Dickson RE, 1996, ANN SCI FOREST, V53, P181, DOI 10.1051/forest:19960202; Diffenbaugh NS, 2005, P NATL ACAD SCI USA, V102, P15774, DOI 10.1073/pnas.0506042102; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Durand J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-570; EHLERINGER JR, 1984, OECOLOGIA, V63, P153, DOI 10.1007/BF00379871; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Grivet D, 2011, MOL BIOL EVOL, V28, P101, DOI 10.1093/molbev/msq190; Hamberger B, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0426; Hanewinkel M, 2013, NAT CLIM CHANGE, V3, P203, DOI [10.1038/nclimate1687, 10.1038/NCLIMATE1687]; Hu B, 2013, TREE PHYSIOL, V33, P489, DOI 10.1093/treephys/tpt025; Ishida T, 2008, ANNU REV PLANT BIOL, V59, P365, DOI 10.1146/annurev.arplant.59.032607.092949; JOHNSON PS, 2002, ECOLOGY SILVICULTURE; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; KUBISKE ME, 1993, PLANT CELL ENVIRON, V16, P1123, DOI 10.1111/j.1365-3040.1996.tb02070.x; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Morales F, 2002, TREES-STRUCT FUNCT, V16, P504, DOI 10.1007/s00468-002-0195-1; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ohlemuller R, 2006, GLOBAL CHANGE BIOL, V12, P1788, DOI 10.1111/j.1365-2486.2006.01231.x; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Petit RJ, 2005, TAXON, V54, P877, DOI 10.2307/25065474; Petritan AM, 2009, EUR J FOREST RES, V128, P61, DOI 10.1007/s10342-008-0239-1; Rozen S, 2000, Methods Mol Biol, V132, P365; Schellmann S, 2005, INT J DEV BIOL, V49, P579, DOI 10.1387/ijdb.051983ss; Sebastiani F, 2012, CONSERV GENET RESOUR, V4, P231, DOI 10.1007/s12686-011-9513-5; Serna L, 2006, TRENDS PLANT SCI, V11, P274, DOI 10.1016/j.tplants.2006.04.008; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Shi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063993; Stasolla C, 2003, J PLANT PHYSIOL, V160, P1271, DOI 10.1078/0176-1617-01169; Struve D, 2010, HORTSCIENCE, V45, P1729, DOI 10.21273/HORTSCI.45.11.1729; Tattini M, 2007, PLANT BIOLOGY, V9, P411, DOI 10.1055/s-2006-924662; Tattini M, 2005, NEW PHYTOL, V167, P457, DOI 10.1111/j.1469-8137.2005.01442.x; Torales SL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-705; Torales SL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-291; Ueno S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-650; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; Vasemagi A, 2005, MOL BIOL EVOL, V22, P1067, DOI 10.1093/molbev/msi093; Wang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-836; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Xia ZH, 2011, PLANT MOL BIOL, V77, P299, DOI 10.1007/s11103-011-9811-z; Zhao L, 2013, FUNCT INTEGR GENOMIC, V13, P75, DOI 10.1007/s10142-012-0301-4; Zrenner R, 2006, ANNU REV PLANT BIOL, V57, P805, DOI 10.1146/annurev.arplant.57.032905.105421	63	38	39	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112487	10.1371/journal.pone.0112487	http://dx.doi.org/10.1371/journal.pone.0112487			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393112	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300059
J	Gierman, HJ; Fortney, K; Roach, JC; Coles, NS; Li, H; Glusman, G; Markov, GJ; Smith, JD; Hood, L; Coles, LS; Kim, SK				Gierman, Hinco J.; Fortney, Kristen; Roach, Jared C.; Coles, Natalie S.; Li, Hong; Glusman, Gustavo; Markov, Glenn J.; Smith, Justin D.; Hood, Leroy; Coles, L. Stephen; Kim, Stuart K.			Whole-Genome Sequencing of the World's Oldest People	PLOS ONE			English	Article							RIGHT-VENTRICULAR CARDIOMYOPATHY; GENETIC-VARIATION; ACMG RECOMMENDATIONS; WIDE ASSOCIATION; HUMAN LONGEVITY; TWIN PAIRS; LIFE-SPAN; SUPERCENTENARIANS; VARIANTS; CENTENARIANS	Supercentenarians (110 years or older) are the world's oldest people. Seventy four are alive worldwide, with twenty two in the United States. We performed whole-genome sequencing on 17 supercentenarians to explore the genetic basis underlying extreme human longevity. We found no significant evidence of enrichment for a single rare protein-altering variant or for a gene harboring different rare protein altering variants in supercentenarian compared to control genomes. We followed up on the gene most enriched for rare protein-altering variants in our cohort of supercentenarians, TSHZ3, by sequencing it in a second cohort of 99 long-lived individuals but did not find a significant enrichment. The genome of one supercentenarian had a pathogenic mutation in DSC2, known to predispose to arrhythmogenic right ventricular cardiomyopathy, which is recommended to be reported to this individual as an incidental finding according to a recent position statement by the American College of Medical Genetics and Genomics. Even with this pathogenic mutation, the proband lived to over 110 years. The entire list of rare protein-altering variants and DNA sequence of all 17 supercentenarian genomes is available as a resource to assist the discovery of the genetic basis of extreme longevity in future studies.	[Gierman, Hinco J.; Fortney, Kristen; Markov, Glenn J.; Smith, Justin D.; Kim, Stuart K.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Gierman, Hinco J.; Fortney, Kristen; Markov, Glenn J.; Smith, Justin D.; Kim, Stuart K.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Roach, Jared C.; Li, Hong; Glusman, Gustavo; Hood, Leroy] Inst Syst Biol, Seattle, WA USA; [Coles, Natalie S.; Coles, L. Stephen] Gerontol Res Grp, Los Angeles, CA USA; [Coles, Natalie S.; Coles, L. Stephen] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Stanford University; Stanford University; Institute for Systems Biology (ISB); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kim, SK (corresponding author), Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA.	stuartkm@stanford.edu		Glusman, Gustavo/0000-0001-8060-5955; Smith, Justin/0000-0003-3079-3534	Ellison Medical Foundation/American Federation for Aging Research Fellowship; Stanford Dean's Fellowship; Paul Glenn Foundation Biology of Aging Seed Grant; National Institute of General Medical Sciences Center for Systems Biology [P50 GM076547]; University of Luxembourg - Institute for Systems Biology Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025941] Funding Source: NIH RePORTER	Ellison Medical Foundation/American Federation for Aging Research Fellowship; Stanford Dean's Fellowship; Paul Glenn Foundation Biology of Aging Seed Grant; National Institute of General Medical Sciences Center for Systems Biology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Luxembourg - Institute for Systems Biology Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Ellison Medical Foundation/American Federation for Aging Research Fellowship, Stanford Dean's Fellowship, The Paul Glenn Foundation Biology of Aging Seed Grant, National Institute of General Medical Sciences Center for Systems Biology (P50 GM076547) and the University of Luxembourg - Institute for Systems Biology Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Andersen SL, 2012, J GERONTOL A-BIOL, V67, P395, DOI 10.1093/gerona/glr223; Ball MP, 2012, P NATL ACAD SCI USA, V109, P11920, DOI 10.1073/pnas.1201904109; Baskin B, 2013, HUM GENET, V132, P1245, DOI 10.1007/s00439-013-1323-2; Bick AG, 2012, AM J HUM GENET, V91, P513, DOI 10.1016/j.ajhg.2012.07.017; Blake JA, 2013, NUCLEIC ACIDS RES, V41, pD530, DOI 10.1093/nar/gks1050; Carvalho MA, 2007, CANCER RES, V67, P1494, DOI 10.1158/0008-5472.CAN-06-3297; Coles LS, 2014, REJUV RES, V17, P80, DOI 10.1089/rej.2014.1553; Cooper DN, 1996, HUM GENET, V98, P629, DOI 10.1007/s004390050272; Deelen J, 2011, AGING CELL, V10, P686, DOI 10.1111/j.1474-9726.2011.00705.x; Dewey FE, 2014, JAMA-J AM MED ASSOC, V311, P1035, DOI 10.1001/jama.2014.1717; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Evert J, 2003, J GERONTOL A-BIOL, V58, P232; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; Gerontology Research Group, 2014, TABL A VER SUP; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Han J, 2013, MECH AGEING DEV, V134, P478, DOI 10.1016/j.mad.2013.01.005; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Heuser A, 2006, AM J HUM GENET, V79, P1081, DOI 10.1086/509044; Hjelmborg JV, 2006, HUM GENET, V119, P312, DOI 10.1007/s00439-006-0144-y; Holstege H, 2014, GENOME RES, V24, P733, DOI 10.1101/gr.162131.113; Huff CD, 2011, GENOME RES, V21, P768, DOI 10.1101/gr.115972.110; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Li H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004144; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Nebel A, 2011, MECH AGEING DEV, V132, P324, DOI 10.1016/j.mad.2011.06.008; Panguluri RCK, 1999, HUM GENET, V105, P28, DOI 10.1007/s004390051059; Pavlidis N, 2012, CRIT REV ONCOL HEMAT, V83, P145, DOI 10.1016/j.critrevonc.2011.09.007; Perl Development Team, 2013, PERL PROGR LANG; Perls T, 2007, J GERONTOL A-BIOL, V62, P1028, DOI 10.1093/gerona/62.9.1028; Perls TT, 2002, P NATL ACAD SCI USA, V99, P8442, DOI 10.1073/pnas.122587599; R Core Team, 2013, INT J AGING HUM DEV, DOI DOI 10.2190/8M7H-CJL7-6K5T-UMFV; Rajpathak SN, 2011, J AM GERIATR SOC, V59, P1509, DOI 10.1111/j.1532-5415.2011.03498.x; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Schoenhofen EA, 2006, J AM GERIATR SOC, V54, P1237, DOI 10.1111/j.1532-5415.2006.00826.x; Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508; Sebastiani Paola, 2012, Frontiers in Genetics, V2, P90, DOI 10.3389/fgene.2011.00090; Sebastiani Paola, 2012, Frontiers in Genetics, V3, P277, DOI 10.3389/fgene.2012.00277; Sebastiani P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029848; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van der Zwaag PA, 2009, HUM MUTAT, V30, P1278, DOI 10.1002/humu.21064; van Tintelen JP, 2007, CURR OPIN CARDIOL, V22, P185, DOI 10.1097/HCO.0b013e3280d942c4; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Willcox DC, 2008, J GERONTOL A-BIOL, V63, P1201, DOI 10.1093/gerona/63.11.1201; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Ye K, 2013, TWIN RES HUM GENET, V16, P1026, DOI 10.1017/thg.2013.73	54	41	43	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112430	10.1371/journal.pone.0112430	http://dx.doi.org/10.1371/journal.pone.0112430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390934	gold, Green Published, Green Submitted			2022-12-27	WOS:000349144400081
J	Izzo, NJ; Xu, J; Zeng, C; Kirk, MJ; Mozzoni, K; Silky, C; Rehak, C; Yurko, R; Look, G; Rishton, G; Safferstein, H; Cruchaga, C; Goate, A; Cahill, MA; Arancio, O; Mach, RH; Craven, R; Head, E; LeVine, H; Spires-Jones, TL; Catalano, SM				Izzo, Nicholas J.; Xu, Jinbin; Zeng, Chenbo; Kirk, Molly J.; Mozzoni, Kelsie; Silky, Colleen; Rehak, Courtney; Yurko, Raymond; Look, Gary; Rishton, Gilbert; Safferstein, Hank; Cruchaga, Carlos; Goate, Alison; Cahill, Michael A.; Arancio, Ottavio; Mach, Robert H.; Craven, Rolf; Head, Elizabeth; LeVine, Harry, III; Spires-Jones, Tara L.; Catalano, Susan M.			Alzheimer's Therapeutics Targeting Amyloid Beta 1-42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity	PLOS ONE			English	Article							MEMBRANE COMPONENT 1; SOLUBLE A-BETA; SYNAPTIC PLASTICITY; MOLECULAR-BASIS; CELL-DEATH; DISEASE; PROTEIN; ACTIVATION; LIGANDS; BRAIN	Amyloid beta (Abeta) 1-42 oligomers accumulate in brains of patients with Mild Cognitive Impairment (MCI) and disrupt synaptic plasticity processes that underlie memory formation. Synaptic binding of Abeta oligomers to several putative receptor proteins is reported to inhibit long-term potentiation, affect membrane trafficking and induce reversible spine loss in neurons, leading to impaired cognitive performance and ultimately to anterograde amnesia in the early stages of Alzheimer's disease (AD). We have identified a receptor not previously associated with AD that mediates the binding of Abeta oligomers to neurons, and describe novel therapeutic antagonists of this receptor capable of blocking Abeta toxic effects on synapses in vitro and cognitive deficits in vivo. Knockdown of sigma-2/PGRMC1 (progesterone receptor membrane component 1) protein expression in vitro using siRNA results in a highly correlated reduction in binding of exogenous Abeta oligomers to neurons of more than 90%. Expression of sigma-2/PGRMC1 is upregulated in vitro by treatment with Abeta oligomers, and is dysregulated in Alzheimer's disease patients' brain compared to age-matched, normal individuals. Specific, high affinity small molecule receptor antagonists and antibodies raised against specific regions on this receptor can displace synthetic Abeta oligomer binding to synaptic puncta in vitro and displace endogenous human AD patient oligomers from brain tissue sections in a dose-dependent manner. These receptor antagonists prevent and reverse the effects of Abeta oligomers on membrane trafficking and synapse loss in vitro and cognitive deficits in AD mouse models. These findings suggest sigma-2/PGRMC1 receptors mediate saturable oligomer binding to synaptic puncta on neurons and that brain penetrant, small molecules can displace endogenous and synthetic oligomers and improve cognitive deficits in AD models. We propose that sigma-2/PGRMC1 is a key mediator of the pathological effects of Abeta oligomers in AD and is a tractable target for small molecule disease-modifying therapeutics.	[Izzo, Nicholas J.; Mozzoni, Kelsie; Silky, Colleen; Rehak, Courtney; Yurko, Raymond; Look, Gary; Rishton, Gilbert; Safferstein, Hank; Catalano, Susan M.] Cognit Therapeut Inc, Pittsburgh, PA 15203 USA; [Xu, Jinbin; Zeng, Chenbo; Mach, Robert H.] Washington Univ, Med Ctr, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; [LeVine, Harry, III] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Craven, Rolf; Head, Elizabeth] Univ Kentucky, Dept Mol & Biol Pharmacol, Lexington, KY USA; [Kirk, Molly J.; Spires-Jones, Tara L.] Harvard Univ, Sch Med, Dept Neurol & Neurosci, Boston, MA USA; [Cruchaga, Carlos; Goate, Alison] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Arancio, Ottavio] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY USA; [Arancio, Ottavio] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Spires-Jones, Tara L.] Univ Edinburgh, Ctr Cognit & Neural Syst & Euan MacDonald, Ctr Motorneurone Dis, Edinburgh, Midlothian, Scotland; [Kirk, Molly J.] Charles Sturt Univ, Northeastern Univ, Sch Biomed Sci 10, Dept Neurol, Wagga Wagga, NSW, Australia	Washington University (WUSTL); University of Kentucky; Harvard University; Harvard Medical School; Washington University (WUSTL); Columbia University; Columbia University; Charles Sturt University	Catalano, SM (corresponding author), Cognit Therapeut Inc, Pittsburgh, PA 15203 USA.	scatalano@cogrx.com	Cruchaga, Carlos/ABF-4065-2020; Xu, Jinbin/ABG-1280-2020; CAHILL, Michael/J-8035-2012; Spires-Jones, Tara/AAR-7697-2020; Kirk, Molly/AAW-5286-2021; arancio, ottavio/AAB-7959-2019	Cruchaga, Carlos/0000-0002-0276-2899; Xu, Jinbin/0000-0002-2120-8287; CAHILL, Michael/0000-0002-8593-8844; Spires-Jones, Tara/0000-0003-2530-0598; Mach, Robert/0000-0002-7645-2869; arancio, ottavio/0000-0001-6335-164X; Goate, Alison/0000-0002-0576-2472; Catalano, Susan/0000-0001-7278-3233; Izzo, Nicholas/0000-0002-0196-2055; Kirk, Molly/0000-0003-2265-6169	National Institute on Aging [SC AG-037337, TS AG033670]; National Institute on Neurological Diseases and Stroke The Alzheimer's Drug Discovery Foundation [SC NS-083175, OA NS-49442]; Alzheimer's Research, UK; Charles and Joanne Knight Alzheimer's Research Initiative; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS090214, R43NS083175, R01NS049442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG033670, K99AG033670, R43AG037337] Funding Source: NIH RePORTER; Alzheimers Research UK [ARUK-SPG2013-1] Funding Source: researchfish	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Neurological Diseases and Stroke The Alzheimer's Drug Discovery Foundation; Alzheimer's Research, UK(Alzheimer's Research UK (ARUK)); Charles and Joanne Knight Alzheimer's Research Initiative; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	National Institute on Aging http://www.nia.nih.gov/(SC AG-037337), TS AG033670) National Institute on Neurological Diseases and Stroke http://www.ninds.nih.gov/(SC NS-083175, OA NS-49442) The Alzheimer's Drug Discovery Foundation http://www.alzdiscovery.org/(SC) Alzheimer's Research, UK http://www.alzheimersresearchuk.org/(TS) Charles and Joanne Knight Alzheimer's Research Initiative http://alzheimer.wustl.edu/(RM) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed IS, 2010, J BIOL CHEM, V285, P24775, DOI 10.1074/jbc.M110.134585; Bao FX, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.05.003; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Cahill MA, 2007, J STEROID BIOCHEM, V105, P16, DOI 10.1016/j.jsbmb.2007.02.002; Catalano SM, 2006, CURR TOP MED CHEM, V6, P597, DOI 10.2174/156802606776743066; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Esparza TJ, 2013, ANN NEUROL, V73, P104, DOI 10.1002/ana.23748; Ferreira IL, 2012, CELL CALCIUM, V51, P95, DOI 10.1016/j.ceca.2011.11.008; Ganapathy ME, 1999, J PHARMACOL EXP THER, V289, P251; Haes AJ, 2005, J AM CHEM SOC, V127, P2264, DOI 10.1021/ja044087q; Herskovits AZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067898; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hyman BT, 2011, NAT NEUROSCI, V14, P5, DOI 10.1038/nn0111-5; Izzo NJ, 2014, PLOS ONE, V10; Jo J, 2011, NAT NEUROSCI, V14, P545, DOI 10.1038/nn.2785; Kam TI, 2013, J CLIN INVEST, V123, P2791, DOI 10.1172/JCI66827; Kessels HW, 2013, P NATL ACAD SCI USA, V110, P4033, DOI 10.1073/pnas.1219605110; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Klein WL, 2013, J ALZHEIMERS DIS, V33, pS49, DOI 10.3233/JAD-2012-129039; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Klyubin I, 2011, NEUROBIOL AGING, V32, P614, DOI 10.1016/j.neurobiolaging.2009.04.005; Koffie RM, 2012, BRAIN, V135, P2155, DOI 10.1093/brain/aws127; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Leonard BE, 2004, PHARMACOPSYCHIATRY, V37, pS166, DOI 10.1055/s-2004-832674; Lesne SE, 2013, BRAIN, V136, P1383, DOI 10.1093/brain/awt062; Marcello E, 2008, EUR J PHARMACOL, V585, P109, DOI 10.1016/j.ejphar.2007.11.083; McDonald JM, 2012, BRAIN RES, V1450, P138, DOI 10.1016/j.brainres.2012.02.041; Mir SUR, 2012, INT J CANCER, V131, pE1, DOI 10.1002/ijc.26432; Mir SU, 2013, SIGMA 2 RECEPTOR ASS; Mishina M, 2008, ANN NUCL MED, V22, P151, DOI 10.1007/s12149-007-0094-z; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Nolte I, 2000, BBA-PROTEIN STRUCT M, V1543, P123, DOI 10.1016/S0167-4838(00)00188-6; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Rohe HJ, 2009, PHARMACOL THERAPEUT, V121, P14, DOI 10.1016/j.pharmthera.2008.09.006; Savage MJ, 2014, J NEUROSCI, V34, P2884, DOI 10.1523/JNEUROSCI.1675-13.2014; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Selkoe DJ, 2013, CELL, V154, P468, DOI 10.1016/j.cell.2013.07.003; Shankar GM, 2009, NEUROBIOL DIS, V36, P293, DOI 10.1016/j.nbd.2009.07.021; Shrestha BR, 2006, MOL CELL NEUROSCI, V33, P274, DOI 10.1016/j.mcn.2006.07.011; Sun J, 2013, NEUROSCIENCE, V248, P112, DOI 10.1016/j.neuroscience.2013.05.048; Szczesna-Skorupa E, 2011, MOL PHARMACOL, V79, P340, DOI 10.1124/mol.110.068478; Thomas P, 2014, ENDOCRINOLOGY; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Troy CM, 2000, J NEUROSCI, V20, P1386; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; VILNER BJ, 1995, CANCER RES, V55, P408; Viola KL, 2008, J NUTR HEALTH AGING, V12, p51S, DOI 10.1007/BF02982587; Xu JB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1386; Yang T, 2013, ALZHEIMERS DEMENT, V9, P99, DOI 10.1016/j.jalz.2012.11.005; Zempel H, 2013, EMBO J, V32, P2920, DOI 10.1038/emboj.2013.207; Zempel H, 2012, NEURODEGENER DIS, V10, P64, DOI 10.1159/000332816; Zeng C, 2012, BRIT J CANCER, V106, P693, DOI 10.1038/bjc.2011.602; Zeng CB, 2014, ANAL BIOCHEM, V448, P68, DOI 10.1016/j.ab.2013.12.008	60	124	127	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111899	10.1371/journal.pone.0111899	http://dx.doi.org/10.1371/journal.pone.0111899			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390692	Green Published, gold			2022-12-27	WOS:000349144400038
J	Giron-Martinez, A; Perez-Rial, S; Terron-Exposito, R; Diaz-Gil, JJ; Gonzalez-Mangado, N; Peces-Barba, G				Giron-Martinez, Alvaro; Perez-Rial, Sandra; Terron-Exposito, Raul; Jose Diaz-Gil, Juan; Gonzalez-Mangado, Nicolas; Peces-Barba, German			Proliferative Activity of Liver Growth Factor is Associated with an Improvement of Cigarette Smoke-Induced Emphysema in Mice	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SPONTANEOUSLY HYPERTENSIVE-RATS; NEURAL STEM-CELLS; OXIDATIVE STRESS; IN-VIVO; II CELL; LUNG; REPAIR; KERATINOCYTE; EXPRESSION	Cigarette smoke (CS)-induced emphysema is a major component of chronic obstructive pulmonary disease (COPD). COPD treatment is based on the administration of bronchodilators and corticosteroids to control symptoms and exacerbations, however, to date, there are no effective therapies to reverse disease progression. Liver growth factor (LGF) is an albumin-bilirubin complex with mitogenic properties, whose therapeutic effects have previously been reported in a model of emphysema and several rodent models of human disease. To approach the therapeutic effect of LGF in a model of previously established emphysema, morphometric and lung function parameters, matrix metalloproteinase (MMP) activity and the expression of several markers, such as VEGF, PCNA, 3NT and Nrf2, were assessed in air-exposed and CS-exposed C57BL/6J male mice with and without intraperitoneal (i.p.) injection of LGF. CS-exposed mice presented a significant enlargement of alveolar spaces, higher alveolar internal area and loss of lung function that correlated with higher MMP activity, higher expression of 3NT and lower expression of VEGF. CS-exposed mice injected with LGF, showed an amelioration of emphysema and improved lung function, which correlated with lower MMP activity and 3NT expression and higher levels of VEGF, PCNA and Nrf2. Taken together, this study suggests that LGF administration ameliorates CS-induced emphysema, highlights the ability of LGF to promote alveolar cell proliferation and may be a promising strategy to revert COPD progression.	[Giron-Martinez, Alvaro; Perez-Rial, Sandra; Terron-Exposito, Raul; Jose Diaz-Gil, Juan; Gonzalez-Mangado, Nicolas; Peces-Barba, German] UAM, CIBERES, FJD, IIS,Resp Res Grp, Madrid, Spain	Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Fundacion Jimenez Diaz	Giron-Martinez, A (corresponding author), UAM, CIBERES, FJD, IIS,Resp Res Grp, Madrid, Spain.	agiron@fjd.es	Rial, Sandra Pérez/C-6809-2019	Rial, Sandra Pérez/0000-0002-7349-7682	Ministry of Science and Innovation of Spain [SAF2008-05412-C02-02]; Spanish Society of Pneumology and Thoracic Surgery (SEPAR) [139]	Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Society of Pneumology and Thoracic Surgery (SEPAR)	This work was funded by the Ministry of Science and Innovation of Spain (SAF2008-05412-C02-02) and the Spanish Society of Pneumology and Thoracic Surgery (SEPAR-#139). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoshiba K, 2003, AM J RESP CELL MOL, V28, P555, DOI 10.1165/rcmb.2002-0090OC; Barreiro E, 2012, RESP PHYSIOL NEUROBI, V182, P9, DOI 10.1016/j.resp.2012.02.001; Bellusci S, 1996, DEVELOPMENT, V122, P1693; Brown KRS, 2001, AM J PHYSIOL-LUNG C, V281, pL1001, DOI 10.1152/ajplung.2001.281.4.L1001; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; Conde MV, 2011, AM J PHYSIOL-HEART C, V301, pH1153, DOI 10.1152/ajpheart.00886.2010; Condezo-Hoyos L, 2012, J HYPERTENS, V30, P1185, DOI 10.1097/HJH.0b013e328353824b; Condezo-Hoyos L, 2009, FREE RADICAL BIO MED, V46, P656, DOI 10.1016/j.freeradbiomed.2008.12.002; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Diab KJ, 2010, AM J RESP CRIT CARE, V181, P344, DOI 10.1164/rccm.200906-0826OC; Diaz-Gil JJ, 2003, J HEPATOL, V38, P598, DOI 10.1016/S0168-8278(03)00030-8; Diaz-Gil JJ, 2009, HISTOL HISTOPATHOL, V24, P473, DOI 10.14670/HH-24.473; DIAZGIL JJ, 1986, BIOCHEM J, V235, P49, DOI 10.1042/bj2350049; DIAZGIL JJ, 1987, BIOCHEM J, V243, P443, DOI 10.1042/bj2430443; DIAZGIL JJ, 1988, HEPATOLOGY, V8, P484, DOI 10.1002/hep.1840080308; Driscoll B, 2000, AM J PHYSIOL-LUNG C, V279, pL1191, DOI 10.1152/ajplung.2000.279.6.L1191; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Finlay GA, 1997, THORAX, V52, P502, DOI 10.1136/thx.52.6.502; Foronjy RF, 2006, AM J RESP CRIT CARE, V173, P623, DOI 10.1164/rccm.200506-850OC; Fujita M, 2004, THORAX, V59, P224, DOI 10.1136/thx.2003.010785; GIL JJD, 1994, GROWTH REGULAT, V4, P113; Gonzalo-Gobernado R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067771; Gonzalo-Gobernado R, 2009, J HISTOCHEM CYTOCHEM, V57, P491, DOI 10.1369/jhc.2009.952275; Gosker HR, 2009, AM J RESP CELL MOL, V40, P710, DOI 10.1165/rcmb.2008-0312OC; Huang ZP, 2012, J BIOL CHEM, V287, P18091, DOI 10.1074/jbc.M111.313163; Ichinose M, 2000, AM J RESP CRIT CARE, V162, P701, DOI 10.1164/ajrccm.162.2.9908132; Iizuka T, 2005, GENES CELLS, V10, P1113, DOI 10.1111/j.1365-2443.2005.00905.x; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; Kyriazis A, 2010, IEEE T BIO-MED ENG, V57, P1745, DOI 10.1109/TBME.2010.2042596; Lee J, 2006, AM J PHYSIOL-LUNG C, V290, pL685, DOI 10.1152/ajplung.00020.2005; Liu C, 2003, AM J PHYSIOL-LUNG C, V285, pL1246, DOI 10.1152/ajplung.00443.2002; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Martinez-Galan L, 2010, ARCH BRONCONEUMOL, V46, P20, DOI 10.1016/j.arbres.2009.10.006; MARTINHIDALGO A, 2007, FEBS J S1, V274, P296; Massaro GD, 1997, NAT MED, V3, P675, DOI 10.1038/nm0697-675; Molet S, 2005, INFLAMM RES, V54, P31, DOI 10.1007/s00011-004-1319-4; Morissette Mathieu C, 2009, Int J Chron Obstruct Pulmon Dis, V4, P19; Muyal JP, 2013, LUNG, V191, P147, DOI 10.1007/s00408-012-9438-0; PANOS RJ, 1995, J CLIN INVEST, V96, P2026, DOI 10.1172/JCI118250; Perez-Crespo M, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-21; Perez-Rial S, 2014, AM J PHYSL LUNG CELL; Perez-Rial S, 2011, MOL IMAGING, V10, P398, DOI 10.2310/7290.2011.00010; Plantier L, 2007, AM J PHYSIOL-LUNG C, V293, pL1230, DOI 10.1152/ajplung.00460.2006; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Reddy R, 2004, AM J PHYSIOL-LUNG C, V286, pL658, DOI 10.1152/ajplung.00159.2003; Reimers D, 2006, J HISTOCHEM CYTOCHEM, V54, P457, DOI 10.1369/jhc.5A6805.2005; Reimers D, 2012, CURR STEM CELL RES T, V7, P15, DOI 10.2174/157488812798483421; Rubio ML, 2000, EUR RESPIR J, V15, P505, DOI 10.1034/j.1399-3003.2000.15.13.x; Serrano-Mollar A, 2007, AM J RESP CRIT CARE, V176, P1261, DOI 10.1164/rccm.200610-1491OC; Shigemura N, 2005, CIRCULATION, V111, P1407, DOI 10.1161/01.CIR.0000158433.89103.85; Somoza B, 2006, CARDIOVASC RES, V69, P764, DOI 10.1016/j.cardiores.2005.08.021; Tang KC, 2004, J APPL PHYSIOL, V97, P1559, DOI 10.1152/japplphysiol.00221.2004; Tetley Teresa D., 2005, Current Drug Targets - Inflammation and Allergy, V4, P607, DOI 10.2174/156801005774912824; van der Vliet A, 1999, AM J RESP CRIT CARE, V160, P1; Wang D, 2007, P NATL ACAD SCI USA, V104, P4449, DOI 10.1073/pnas.0700052104; Ware LB, 2002, AM J PHYSIOL-LUNG C, V282, pL924, DOI 10.1152/ajplung.00439.2001	58	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112995	10.1371/journal.pone.0112995	http://dx.doi.org/10.1371/journal.pone.0112995			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401951	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700090
J	Wahab, T; Birdsell, DN; Hjertqvist, M; Mitchell, CL; Wagner, DM; Keim, PS; Hedenstrom, I; Lofdahl, S				Wahab, Tara; Birdsell, Dawn N.; Hjertqvist, Marika; Mitchell, Cedar L.; Wagner, David M.; Keim, Paul S.; Hedenstrom, Ingela; Lofdahl, Sven			Insights to Genetic Characterization Tools for Epidemiological Tracking of Francisella tularensis in Sweden	PLOS ONE			English	Article							TANDEM REPEAT ANALYSIS; MULTIPLE-LOCUS; UNITED-STATES; TULAREMIA; PHYLOGEOGRAPHY; HOLARCTICA; STRAINS; GENOME	Tularaemia, caused by the bacterium Francisella tularensis, is endemic in Sweden and is poorly understood. The aim of this study was to evaluate the effectiveness of three different genetic typing systems to link a genetic type to the source and place of tularemia infection in Sweden. Canonical single nucleotide polymorphisms (canSNPs), MLVA including five variable number of tandem repeat loci and PmeI-PFGE were tested on 127 F. tularensis positive specimens collected from Swedish case-patients. All three typing methods identified two major genetic groups with near-perfect agreement. Higher genetic resolution was obtained with canSNP and MLVA compared to PFGE; F. tularensis samples were first assigned into ten phylogroups based on canSNPs followed by 33 unique MLVA types. Phylogroups were geographically analysed to reveal complex phylogeographic patterns in Sweden. The extensive phylogenetic diversity found within individual counties posed a challenge to linking specific genetic types with specific geographic locations. Despite this, a single phylogroup (B.22), defined by a SNP marker specific to a lone Swedish sequenced strain, did link genetic type with a likely geographic place. This result suggests that SNP markers, highly specific to a particular reference genome, may be found most frequently among samples recovered from the same location where the reference genome originated. This insight compels us to consider whole-genome sequencing (WGS) as the appropriate tool for effectively linking specific genetic type to geography. Comparing the WGS of an unknown sample to WGS databases of archived Swedish strains maximizes the likelihood of revealing those rare geographically informative SNPs.	[Wahab, Tara; Hjertqvist, Marika; Hedenstrom, Ingela; Lofdahl, Sven] Publ Hlth Agcy Sweden, Dept Microbiol, Stockholm, Sweden; [Birdsell, Dawn N.; Mitchell, Cedar L.; Wagner, David M.; Keim, Paul S.] No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA	Public Health Agency of Sweden; Northern Arizona University	Wahab, T (corresponding author), Publ Hlth Agcy Sweden, Dept Microbiol, Stockholm, Sweden.	tara.wahab@folkhalsomyndigheten.se		Wagner, David/0000-0003-2684-6007	Swedish Emergency Management Agency; US Department of Homeland Security Science and Technology Directorate [HSHQDC-10-C-00139]	Swedish Emergency Management Agency; US Department of Homeland Security Science and Technology Directorate(United States Department of Homeland Security (DHS))	This work was supported by grants from the Swedish Emergency Management Agency and by the US Department of Homeland Security Science and Technology Directorate via award HSHQDC-10-C-00139. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broekhuijsen M, 2003, J CLIN MICROBIOL, V41, P2924, DOI 10.1128/JCM.41.7.2924-2931.2003; Carvalho DDB, 2012, INT J COMPUT ASS RAD, V7, P207, DOI 10.1007/s11548-011-0633-x; Chanturia G, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-139; Del Blanco NG, 2002, J CLIN MICROBIOL, V40, P2964, DOI 10.1128/JCM.40.8.2964-2972.2002; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Farlow J, 2001, J CLIN MICROBIOL, V39, P3186, DOI 10.1128/JCM.39.9.3186-3192.2001; Gyuranecz M, 2012, EMERG INFECT DIS, V18, P290, DOI 10.3201/eid1802.111305; Johansson A, 2004, J BACTERIOL, V186, P5808, DOI 10.1128/JB.186.17.5808-5818.2004; Karlsson E, 2013, ENVIRON MICROBIOL, V15, P634, DOI 10.1111/1462-2920.12052; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Keim P, 2004, INFECT GENET EVOL, V4, P205, DOI 10.1016/j.meegid.2004.02.005; Klevytska AM, 2001, J CLIN MICROBIOL, V39, P3179, DOI 10.1128/JCM.39.9.3179-3185.2001; Larsson P, 2007, EMERG INFECT DIS, V13, P1725, DOI 10.3201/eid1311.070603; MORNER T, 1983, NORD VET MED, V35, P82; Padeshki PI, 2010, EPIDEMIOL INFECT, V138, P376, DOI 10.1017/S0950268809990513; Payne L, 2005, EMERG INFECT DIS, V11, P1440, DOI 10.3201/eid1109.041189; Staples JE, 2006, EMERG INFECT DIS, V12, P1113; Svensson K, 2009, EMERG INFECT DIS, V15, P1937, DOI 10.3201/eid1512.090487; Swaminathan B, 2001, EMERG INFECT DIS, V7, P382; Vogler AJ, 2009, J BACTERIOL, V191, P2474, DOI 10.1128/JB.01786-08; Weir B.S., 1990, GENETIC DATA ANAL ME	21	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112167	10.1371/journal.pone.0112167	http://dx.doi.org/10.1371/journal.pone.0112167			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401326	gold, Green Published, Green Submitted			2022-12-27	WOS:000345158700033
J	Agis, H; Collins, A; Taut, AD; Jin, QM; Kruger, L; Gorlach, C; Giannobile, WV				Agis, Hermann; Collins, Amy; Taut, Andrei D.; Jin, Qiming; Kruger, Laura; Goerlach, Christoph; Giannobile, William V.			Cell Population Kinetics of Collagen Scaffolds in Ex Vivo Oral Wound Repair	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; GINGIVAL FIBROBLASTS; TGF-BETA; IN-VITRO; MATRICELLULAR PROTEIN; EXTRACELLULAR-MATRIX; VOLUME AUGMENTATION; STEM-CELLS; MEMBRANES; REGENERATION	Biodegradable collagen scaffolds are used clinically for oral soft tissue augmentation to support wound healing. This study sought to provide a novel ex vivo model for analyzing healing kinetics and gene expression of primary human gingival fibroblasts (hGF) within collagen scaffolds. Sponge type and gel type scaffolds with and without platelet-derived growth factor-BB (PDGF) were assessed in an hGF containing matrix. Morphology was evaluated with scanning electron microscopy, and hGF metabolic activity using MTT. We quantitated the population kinetics within the scaffolds based on cell density and distance from the scaffold border of DiI-labled hGFs over a two-week observation period. Gene expression was evaluated with gene array and qPCR. The sponge type scaffolds showed a porous morphology. Absolute cell number and distance was higher in sponge type scaffolds when compared to gel type scaffolds, in particular during the first week of observation. PDGF incorporated scaffolds increased cell numbers, distance, and formazan formation in the MTT assay. Gene expression dynamics revealed the induction of key genes associated with the generation of oral tissue. DKK1, CYR61, CTGF, TGFBR1 levels were increased and integrin ITGA2 levels were decreased in the sponge type scaffolds compared to the gel type scaffold. The results suggest that this novel model of oral wound healing provides insights into population kinetics and gene expression dynamics of biodegradable scaffolds.	[Agis, Hermann; Collins, Amy; Taut, Andrei D.; Kruger, Laura; Giannobile, William V.] Univ Michigan, Sch Dent, Ann Arbor, MI 48109 USA; [Agis, Hermann] Med Univ Vienna, Dept Conservat Dent & Periodontol, Vienna, Austria; [Agis, Hermann] Austrian Cluster Tissue Regenerat, Vienna, Austria; [Jin, Qiming] Univ Michigan, Sch Dent, Dept Cariol Restorat Sci & Endodont, Ann Arbor, MI 48109 USA; [Goerlach, Christoph] Geistlich Pharma AG, Wolhusen, Switzerland; [Giannobile, William V.] Univ Michigan, Coll Engn, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Medical University of Vienna; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Giannobile, WV (corresponding author), Univ Michigan, Sch Dent, Ann Arbor, MI 48109 USA.	wgiannob@umich.edu	Agis, Hermann/O-4596-2016	Agis, Hermann/0000-0001-9509-1555; Giannobile, William/0000-0002-7102-9746	Geistlich Pharma AG (Wolhusen, Switzerland); Austrian Science Fund (FWF) [J3379-B19]	Geistlich Pharma AG (Wolhusen, Switzerland); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by Geistlich Pharma AG (www.geistlich-pharma.com, Wolhusen, Switzerland). Christoph Gorlach is employed by Geistlich Pharma AG. The authors confirm that the funder provided support in the form of salary for Christoph Gorlach, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section. Hermann Agis received the Erwin Schrodinger Fellowship from the Austrian Science Fund (FWF, fwf.ac.at): J3379-B19. The Austrian Science Fund had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Akman AC, 2010, J BIOMED MATER RES A, V92A, P953, DOI 10.1002/jbm.a.32428; Anusaksathien O, 2003, TISSUE ENG, V9, P745, DOI 10.1089/107632703768247421; Behring J, 2008, ODONTOLOGY, V96, P1, DOI 10.1007/s10266-008-0087-y; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Black SA, 2008, J BIOL CHEM, V283, P10835, DOI 10.1074/jbc.M710363200; Bunyaratavej P, 2001, J PERIODONTOL, V72, P215, DOI 10.1902/jop.2001.72.2.215; Crowston JG, 2006, INVEST OPHTH VIS SCI, V47, P946, DOI 10.1167/iovs.05-1048; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Ehashi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085132; Froelich K, 2013, CELLS TISSUES ORGANS, V197, P384, DOI 10.1159/000346714; Ghanaati S, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015010; Goissis G, 1999, BIOMATERIALS, V20, P27, DOI 10.1016/S0142-9612(97)00198-1; Grinnell F, 2006, EXP CELL RES, V312, P86, DOI 10.1016/j.yexcr.2005.010.001; Gruber R, 2004, PLATELETS, V15, P29, DOI 10.1080/09537100310001643999; Hakkinen L, 2000, PERIODONTOL 2000, V24, P127, DOI 10.1034/j.1600-0757.2000.2240107.x; Heng ECK, 2006, J CELL BIOCHEM, V98, P409, DOI 10.1002/jcb.20810; Herford AS, 2012, INT J ORAL MAX IMPL, V27, P1351; IRWIN CR, 1994, J PERIODONTAL RES, V29, P309, DOI 10.1111/j.1600-0765.1994.tb01227.x; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Kabashima K, 2010, AM J PATHOL, V176, P721, DOI 10.2353/ajpath.2010.090454; Kim HN, 2012, BIOMATERIALS, V33, P8782, DOI 10.1016/j.biomaterials.2012.08.038; Kinikoglu B, 2009, BIOMATERIALS, V30, P6418, DOI 10.1016/j.biomaterials.2009.08.010; Kobayashi K, 2010, BIOMATERIALS, V31, P4855, DOI 10.1016/j.biomaterials.2010.02.027; Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3; Martin MM, 2007, AM J PHYSIOL-LUNG C, V293, pL790, DOI 10.1152/ajplung.00099.2007; Marx G, 2008, J BIOMED MATER RES B, V84B, P571, DOI 10.1002/jbm.b.30905; Mathes SH, 2010, BIOTECHNOL BIOENG, V107, P1029, DOI 10.1002/bit.22893; MINABE M, 1989, J PERIODONTOL, V60, P35, DOI 10.1902/jop.1989.60.1.35; Mio T, 1996, IN VITRO CELL DEV-AN, V32, P427; Mumford JH, 2001, J PERIODONTOL, V72, P331, DOI 10.1902/jop.2001.72.3.331; OCCLESTON NL, 1994, INVEST OPHTH VIS SCI, V35, P3681; Ohshima M, 2010, J DENT RES, V89, P1315, DOI 10.1177/0022034510378423; Orsini M, 2004, J PERIODONTOL, V75, P470, DOI 10.1902/jop.2004.75.3.470; Ravindran S, 2010, TISSUE ENG PT A, V16, P327, DOI [10.1089/ten.tea.2009.0110, 10.1089/ten.TEA.2009.0110]; Rothamel D, 2005, CLIN ORAL IMPLAN RES, V16, P369, DOI 10.1111/j.1600-0501.2005.01108.x; Rothamel D, 2004, CLIN ORAL IMPLAN RES, V15, P443, DOI 10.1111/j.1600-0501.2004.01039.x; San Martin S, 2013, J TISSUE ENG REGEN M, V7, P10, DOI 10.1002/term.490; Sanz M, 2009, J CLIN PERIODONTOL, V36, P868, DOI 10.1111/j.1600-051X.2009.01460.x; Schlegel AK, 1997, BIOMATERIALS, V18, P535, DOI 10.1016/S0142-9612(96)00175-5; Schor S L, 1996, Oral Dis, V2, P155; Simion M, 2012, INT J PERIODONT REST, V32, P273; Stalling SS, 2009, ACTA BIOMATER, V5, P1911, DOI 10.1016/j.actbio.2009.02.020; Stoecklin-Wasmer C, 2013, J DENT RES, V92, P773, DOI 10.1177/0022034513496428; Thoma DS, 2011, J CLIN PERIODONTOL, V38, P1063, DOI 10.1111/j.1600-051X.2011.01786.x; Thoma DS, 2010, J CLIN PERIODONTOL, V37, P659, DOI 10.1111/j.1600-051X.2010.01581.x; Thoma DS, 2009, CLIN ORAL IMPLAN RES, V20, P146, DOI 10.1111/j.1600-0501.2009.01784.x; Wang HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056330; Wilkes MC, 2005, CANCER RES, V65, P10431, DOI 10.1158/0008-5472.CAN-05-1522; Yamaguchi Y, 2008, FASEB J, V22, P1009, DOI 10.1096/fj.07-9475com; Zhang XJ, 2009, BIOMATERIALS, V30, P2666, DOI 10.1016/j.biomaterials.2009.01.018	52	13	13	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112680	10.1371/journal.pone.0112680	http://dx.doi.org/10.1371/journal.pone.0112680			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397671	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558500077
J	Kumari, P; Sahal, D; Chauhan, VS				Kumari, Pinky; Sahal, Dinkar; Chauhan, Virander S.			Dendrimeric Template of Plasmodium falciparum Histidine Rich Protein II Repeat Motifs Bearing Asp -> Asn Mutation Exhibits Heme Binding and beta-Hematin Formation	PLOS ONE			English	Article							HYDROGEN-BOND ACCEPTORS; ANION-PI INTERACTIONS; MALARIA PIGMENT; AROMATIC RINGS; X-RAY; PEPTIDES; CONFORMATION	Plasmodium falciparum (Pf) employs a crucial PfHRPII catalyzed reaction that converts toxic heme into hemozoin. Understanding heme polymerization mechanism is the first step for rational design of new drugs, targeting this pathway. Heme binding and hemozoin formation have been ascribed to PfHRPII aspartate carboxylate-heme metal ionic interactions. To investigate, if this ionic interaction is indeed pivotal, we examined the comparative heme binding and beta-hematin forming abilities of a wild type dendrimeric peptide BNT1 {harboring the native sequence motif of PfHRPII (AHHAHHAADA)} versus a mutant dendrimeric peptide BNTM {in which ionic Aspartate residues have been replaced by the neutral Asparaginyl residues (AHHAHHAANA)}. UV and IR data reported here reveal that at pH 5, both BNT1 and BNTM exhibit comparable heme binding as well as beta-hematin forming abilities, thus questioning the role of PfHRPII aspartate carboxylate-heme metal ionic interactions in heme binding and beta-hematin formation. Based on our data and information in the literature we suggest the possible role of weak dispersive interactions like N-H center dot center dot center dot pi and lone-pair center dot center dot center dot pi in heme binding and hemozoin formation.	[Kumari, Pinky; Sahal, Dinkar; Chauhan, Virander S.] Int Ctr Genet Engn & Biotechnol, Malaria Res Lab, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Sahal, D (corresponding author), Int Ctr Genet Engn & Biotechnol, Malaria Res Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	dinkar@icgeb.res.in; virander@icgeb.res.in	SAHAL, DINKAR/GYD-7570-2022; Chauhan, Virander S./K-5276-2019		Malaria Core Fund, ICGEB, New Delhi; University Grants Commission, New Delhi, India [10-2(5)/2005(i)-E.U.II]	Malaria Core Fund, ICGEB, New Delhi; University Grants Commission, New Delhi, India(University Grants Commission, India)	This study was supported by Malaria Core Fund, ICGEB, New Delhi. Pinky Kumari got financial assistance from University Grants Commission, New Delhi, India in the form of "CSIR-UGC Research Fellowship, Award No - F.No. 10-2(5)/2005(i)-E.U.II". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breman JG, 2001, AM J TROP MED HYG, V64, P1; Choi CYH, 1999, BIOCHEMISTRY-US, V38, P16916, DOI 10.1021/bi991665k; Dauster I, 2008, PHYS CHEM CHEM PHYS, V10, P2827, DOI 10.1039/b717823a; Egan TJ, 2008, MOL BIOCHEM PARASIT, V157, P127, DOI 10.1016/j.molbiopara.2007.11.005; EGLI M, 1995, P NATL ACAD SCI USA, V92, P180, DOI 10.1073/pnas.92.1.180; FITCH CD, 1987, J BIOL CHEM, V262, P15552; Frontera A, 2005, CHEM-EUR J, V11, P6560, DOI 10.1002/chem.200500783; Gallivan JP, 1999, ORG LETT, V1, P103, DOI 10.1021/ol990577p; Jani D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000053; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; LEVITT M, 1988, J MOL BIOL, V201, P751, DOI 10.1016/0022-2836(88)90471-8; Li Y, 2003, BIOORG MED CHEM LETT, V13, P3261, DOI 10.1016/S0960-894X(03)00662-0; Lynn A, 1999, FEBS LETT, V459, P267, DOI 10.1016/S0014-5793(99)01260-0; MORGAN WT, 1985, BIOCHEMISTRY-US, V24, P1496, DOI 10.1021/bi00327a031; Niles JC, 2009, P NATL ACAD SCI USA, V106, P13266, DOI 10.1073/pnas.0906370106; Ottiger P, 2009, J PHYS CHEM B, V113, P2937, DOI 10.1021/jp8110474; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Pandey AV, 1999, J PHARMACEUT BIOMED, V20, P203, DOI 10.1016/S0731-7085(99)00021-7; PANTON LJ, 1989, MOL BIOCHEM PARASIT, V35, P149, DOI 10.1016/0166-6851(89)90117-5; PERUTZ MF, 1986, J AM CHEM SOC, V108, P1064, DOI 10.1021/ja00265a036; Sarkhel S, 2003, J AM CHEM SOC, V125, P8998, DOI 10.1021/ja0357801; Schneider EL, 2005, BIOCHEMISTRY-US, V44, P979, DOI 10.1021/bi048570p; Schottel BL, 2006, J AM CHEM SOC, V128, P5895, DOI 10.1021/ja0606273; SLATER AFG, 1991, P NATL ACAD SCI USA, V88, P325, DOI 10.1073/pnas.88.2.325; Sullivan DJ, 2002, INT J PARASITOL, V32, P1645, DOI 10.1016/S0020-7519(02)00193-5; Sullivan DJ, 1996, SCIENCE, V271, P219, DOI 10.1126/science.271.5246.219; Tilley L, 2001, INFEC DIS S, P87; WELLEMS TE, 1986, P NATL ACAD SCI USA, V83, P6065, DOI 10.1073/pnas.83.16.6065; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WLODAWER A, 1984, J MOL BIOL, V180, P301, DOI 10.1016/S0022-2836(84)80006-6; Ziegler J, 1999, J AM CHEM SOC, V121, P2395, DOI 10.1021/ja983220+	31	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112087	10.1371/journal.pone.0112087	http://dx.doi.org/10.1371/journal.pone.0112087			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398028	gold, Green Submitted, Green Published			2022-12-27	WOS:000345558500031
J	Lejeune, M; Moreau, F; Chadee, K				Lejeune, Manigandan; Moreau, France; Chadee, Kris			Loss of EP2 Receptor Subtype in Colonic Cells Compromise Epithelial Barrier Integrity by Altering Claudin-4	PLOS ONE			English	Article							TIGHT JUNCTION; PROSTANOID RECEPTORS; DISEASE-ACTIVITY; EXPRESSION; CANCER; PERMEABILITY; INFLAMMATION; EICOSANOIDS; INTESTINE; COMPLEX	Prostaglandin E-2 (PGE(2)) is a bioactive lipid mediator that exerts its biological function through interaction with four different subtypes of E-Prostanoid receptor namely EP1, EP2, EP3 and EP4. It has been known that EP2 receptor is differentially over-expressed in the epithelia of inflamed human colonic mucosa. However, the significance of the differential expression in altering epithelial barrier function is not known. In this study, we used Caco-2 cells expressing EP2 receptor, either high (EP2S) or low (EP2A), as a model epithelia and determined the barrier function of these cell monolayers by measuring the trans epithelial resistance (TER). Basal TER of EP2A (but not EP2S) monolayer was significantly lower suggesting a loss of colonic epithelial barrier integrity. In comparison, the TER of wild type Caco-2 was decreased in response to an EP2 receptor specific antagonist (AH-6809) indicating an important role for EP2 receptor in the maintenance of epithelial barrier function. The decrease TER in EP2A monolayer corresponded with a significant loss of the tight junction (TJ) protein claudin-4 without affecting other major TJ proteins. Similarly, EP2 receptor antagonism/siRNA based silencing significantly decreased claudin-4 expression in EP2S cells. Surprisingly, alteration in claudin-4 was not transcriptionally regulated in EP2A cells but rather undergoes increased proteosomal degradation. Moreover, among the TER compromising cytokines examined (IL-8, IL-1 beta, TNF-alpha, IFN-gamma) only IFN-gamma was significantly up regulated in EP2A cells. However, IFN-gamma did not significantly decreased claudin-4 expression in Caco-2 cells indicating no role for IFN-gamma in degrading claudin-4. We conclude that differential down-regulation of EP2 receptor play a major role in compromising colonic epithelial barrier function by selectively increasing proteosomal degradation of claudin-4.	[Lejeune, Manigandan; Moreau, France; Chadee, Kris] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada	University of Calgary	Chadee, K (corresponding author), Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada.	kchadee@ucalgary.ca	Lejeune, Manigandan/AAI-9474-2021		Canadian Institute for Health Research; Crohn's and Colitis Canada	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Crohn's and Colitis Canada	This work was supported by the Canadian Institute for Health Research (KC); Crohn's and Colitis Canada (KC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRENSTEDT O, 1994, J GASTROEN HEPATOL, V9, P539, DOI 10.1111/j.1440-1746.1994.tb01557.x; Al-Sadi RM, 2007, J IMMUNOL, V178, P4641, DOI 10.4049/jimmunol.178.7.4641; Atay S, 2000, PROSTAG OTH LIPID M, V61, P105, DOI 10.1016/S0090-6980(00)00067-8; Boivin MA, 2009, J INTERF CYTOK RES, V29, P45, DOI 10.1089/jir.2008.0128; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Buret AG, 2002, PARASITOLOGY, V125, P11, DOI 10.1017/S0031182002001853; Cosme R, 2000, HUM IMMUNOL, V61, P684, DOI 10.1016/S0198-8859(00)00131-2; Denker BM, 1998, AM J PHYSIOL-RENAL, V274, pF1, DOI 10.1152/ajprenal.1998.274.1.F1; Dey I, 2006, BRIT J PHARMACOL, V149, P611, DOI 10.1038/sj.bjp.0706923; Dey I, 2009, BRIT J PHARMACOL, V156, P475, DOI 10.1111/j.1476-5381.2008.00056.x; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Hoshino T, 2003, J BIOL CHEM, V278, P12752, DOI 10.1074/jbc.M212097200; Houchen CW, 2003, AM J PHYSIOL-GASTR L, V284, pG490, DOI 10.1152/ajpgi.00240.2002; Jang TJ, 2004, GUT, V53, P27, DOI 10.1136/gut.53.1.27; Krause W, 2000, PROSTAG OTH LIPID M, V61, P145, DOI 10.1016/S0090-6980(00)00069-1; Leroy A, 2000, FASEB J, V14, P1139, DOI 10.1096/fasebj.14.9.1139; Moeser AJ, 2004, GASTROENTEROLOGY, V127, P802, DOI 10.1053/j.gastro.2004.06.004; Mohajer B, 2000, PROSTAG OTH LIPID M, V61, P125, DOI 10.1016/S0090-6980(00)00068-X; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Nava P, 2004, J CELL SCI, V117, P5509, DOI 10.1242/jcs.01425; OBANION MK, 1992, P NATL ACAD SCI USA, V89, P4888, DOI 10.1073/pnas.89.11.4888; RAMPTON DS, 1980, GUT, V21, P591, DOI 10.1136/gut.21.7.591; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P294, DOI 10.1111/j.1749-6632.2009.04062.x; Shoji Y, 2004, GUT, V53, P1151, DOI 10.1136/gut.2003.028787; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Sonoshita M, 2001, NAT MED, V7, P1048, DOI 10.1038/nm0901-1048; STAEHELIN LA, 1973, J CELL SCI, V13, P763; Takafuji V, 2000, PROSTAG LEUKOTR ESS, V63, P223, DOI 10.1054/plef.2000.0144; Takafuji VA, 2002, PROSTAG LEUKOTR ESS, V66, P71, DOI 10.1054/plef.2001.0299; Tanaka MN, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-63; Thanabalasuriar A, 2010, CELL MICROBIOL, V12, P31, DOI 10.1111/j.1462-5822.2009.01376.x; Tsuji S, 1996, PROSTAG LEUKOTR ESS, V55, P179, DOI 10.1016/S0952-3278(96)90095-2; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; XIE WL, 1991, P NATL ACAD SCI USA, V88, P2692, DOI 10.1073/pnas.88.7.2692	37	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113270	10.1371/journal.pone.0113270	http://dx.doi.org/10.1371/journal.pone.0113270			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396731	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500145
J	Miao, Y; Wang, L; Zhang, XP; Xu, XH; Jiang, GY; Fan, CF; Liu, Y; Lin, XY; Yu, JH; Zhang, Y; Wang, EH				Miao, Yuan; Wang, Liang; Zhang, Xiupeng; Xu, Xiaohan; Jiang, Guiyang; Fan, Chuifeng; Liu, Yang; Lin, Xuyong; Yu, Juanhan; Zhang, Yong; Wang, Enhua			Promoter Methylation-Mediated Silencing of beta-Catenin Enhances Invasiveness of Non-Small Cell Lung Cancer and Predicts Adverse Prognosis	PLOS ONE			English	Article							E-CADHERIN; MICROSATELLITE INSTABILITY; DNA METHYLATION; POOR-PROGNOSIS; BREAST-CANCER; EXPRESSION; GENES; HYPERMETHYLATION; CARCINOMA; SUPPRESSION	beta-Catenin plays dual role in adhesion complex formation and the Wnt signaling pathway. Although beta-catenin expression appears to be upregulated and Wnt signaling pathway is activated in the majority of cancers, its expression level seems to be lost in non-small cell lung cancer (NSCLC). We previously reported that the promoter of beta-catenin was hypermethylated in two NSCLC cell lines. In the current study, we expanded our analysis for the methylation status of beta-catenin promoter region and its protein expression in seven NSCLC cell lines and a series of 143 cases of primary human lung cancer with adjacent non-neoplastic tissues. Quantitative methylation specific PCR (qMSP) analysis showed methylation of beta-catenin promoter region in five NSCLC cell lines, with increased beta-catenin protein levels upon 5'-Aza-2'-deoxycytidine (5-aza-dC) treatment. The methylation status in SPC (methylated) and A549 (unmethylated) was confirmed by bisulfite sequencing PCR. 5-Aza-dC treatment inhibited invasiveness of SPC but not A549. Immunofluorescence analysis showed membranous bcatenin expression was lost in SPC and could be re-established by 5-aza-dC, while Wnt3a treatment led to nuclear translocation of b-catenin in both SPC and A549. Dual-luciferase assays indicated that 5-aza-dC treatment caused no significant increase in Wnt signaling activity compared with Wnt3a treatment. The effect of demethylation agent in SPC can be reversed by beta-catenin depletion but not E-cadherin depletion which indicated that the methylation mediated beta-catenin silencing might enhance NSCLC invasion and metastasis in an E-cadherin independent manner. Subsequent immunohistochemistry results further confirmed that beta-catenin promoter hypermethylation correlated with loss of immunoreactive protein expression, positive lymph node metastasis, high TNM stage and poor prognosis. The present study implicates beta-catenin promoter hypermethylation in the mechanism of epigenetic changes underlying NSCLC metastasis and progression, thus indicating the potential of beta-catenin as a novel epigenetic target for the treatment of NSCLC patients.	[Miao, Yuan; Wang, Liang; Zhang, Xiupeng; Jiang, Guiyang; Fan, Chuifeng; Liu, Yang; Lin, Xuyong; Yu, Juanhan; Zhang, Yong; Wang, Enhua] China Med Univ, Dept Pathol, Hosp 1, Shenyang, Peoples R China; [Miao, Yuan; Wang, Liang; Zhang, Xiupeng; Jiang, Guiyang; Fan, Chuifeng; Liu, Yang; Lin, Xuyong; Yu, Juanhan; Zhang, Yong; Wang, Enhua] China Med Univ, Coll Basic Med Sci, Shenyang, Peoples R China; [Xu, Xiaohan] China Med Univ, Year Program Med 96K 7, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Wang, EH (corresponding author), China Med Univ, Dept Pathol, Hosp 1, Shenyang, Peoples R China.	wangeh@hotmail.com	Wang, Liang/AAM-2378-2021; Miao, Yuan/AAG-9754-2021	Wang, Liang/0000-0003-4015-9385; 	National Natural Science Foundation of China [81000942, 30900562]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81000942 to Yuan Miao and No. 30900562 to Yang Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belinsky SA, 2004, NAT REV CANCER, V4, P707, DOI 10.1038/nrc1432; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; Cho YH, 2012, BREAST CANCER RES TR, V131, P197, DOI 10.1007/s10549-011-1712-y; Ebert MPA, 2003, J CLIN ONCOL, V21, P1708, DOI 10.1200/JCO.2003.10.017; Fu YJ, 2011, INT J CANCER, V129, P1541, DOI 10.1002/ijc.26102; Goldstraw P, 2011, SURG ONCOL CLIN N AM, V20, P655, DOI 10.1016/j.soc.2011.07.005; Hugh TJ, 1999, INT J CANCER, V82, P504, DOI 10.1002/(SICI)1097-0215(19990812)82:4<504::AID-IJC6>3.0.CO;2-6; Kase S, 2000, CLIN CANCER RES, V6, P4789; Konigshoff M, 2010, AM J RESP CELL MOL, V42, P21, DOI 10.1165/rcmb.2008-0485TR; Kumper S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011801; Kwon MJ, 2013, HUM PATHOL, V44, P1722, DOI 10.1016/j.humpath.2013.03.004; Liu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087537; Mareel M, 1996, J CELL BIOCHEM, V61, P524; Miao Y, 2013, PATHOL ONCOL RES, V19, P281, DOI 10.1007/s12253-012-9580-2; Miao Y, 2012, FOLIA HISTOCHEM CYTO, V50, P392, DOI [10.5603/FHC.2012.0053, 10.5603/11957]; Mirabelli-Primdahl L, 1999, CANCER RES, V59, P3346; Nakata S, 2006, CANCER-AM CANCER SOC, V106, P2190, DOI 10.1002/cncr.21870; Pirinen RT, 2001, J CLIN PATHOL, V54, P391, DOI 10.1136/jcp.54.5.391; Retera JMAM, 1998, J CLIN PATHOL, V51, P891, DOI 10.1136/jcp.51.12.891; Russo AL, 2005, CLIN CANCER RES, V11, P2466, DOI 10.1158/1078-0432.CCR-04-1962; Salon Caroline, 2005, Future Oncol, V1, P649, DOI 10.2217/14796694.1.5.649; Sarrio D, 2003, INT J CANCER, V106, P208, DOI 10.1002/ijc.11197; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Takahashi Y, 2008, INT J CANCER, V123, P2315, DOI 10.1002/ijc.23812; Travis WD., 2004, TRAVIS WB WHO CLASSI; Travis WD, 2011, CLIN CHEST MED, V32, P669, DOI 10.1016/j.ccm.2011.08.005; Tsou JA, 2002, ONCOGENE, V21, P5450, DOI 10.1038/sj.onc.1205605; Vaissiere T, 2009, CANCER RES, V69, P243, DOI 10.1158/0008-5472.CAN-08-2489; Van Scoyk M, 2008, TRANSL RES, V151, P175, DOI 10.1016/j.trsl.2007.12.011; Wong AST, 2003, J CELL BIOL, V161, P1191, DOI 10.1083/jcb.200212033; Yanagawa N, 2003, CANCER SCI, V94, P589, DOI 10.1111/j.1349-7006.2003.tb01487.x; Zochbauer-Muller S, 2001, CANCER RES, V61, P249	32	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112258	10.1371/journal.pone.0112258	http://dx.doi.org/10.1371/journal.pone.0112258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396757	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558500041
J	Wu, WC; Liu, CH; Wang, NK; Chen, KJ; Chen, TL; Hwang, YS; Liao, PJ; Li, LM; Lai, CC				Wu, Wei-Chi; Liu, Chi-Hsien; Wang, Nan-Kai; Chen, Kwan-Jen; Chen, Tun-Lu; Hwang, Yih-Shiou; Liao, Pei-Ju; Li, Lien-Min; Lai, Chi-Chun			Lens Subluxation after Plasmin and SF6 Injections in Rabbit Eyes	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ENZYME-ASSISTED VITRECTOMY; POSTERIOR VITREOUS DETACHMENT; DIABETIC MACULAR EDEMA; RETINAL VEIN OCCLUSION; PHARMACOLOGICAL VITREOLYSIS; EXTRACELLULAR-MATRIX; STAGE-5 RETINOPATHY; CILIARY ZONULE; PREMATURITY	Purpose: To investigate the rate of lens subluxation following plasmin and/or SF6 injections in eyes, and whether a subsequent elevated level of vascular endothelial growth factor (VEGF) and vitreous tap would aggravate subluxation. Methods: Four groups of rabbits were used. Group 1 received an intravitreal injection (IVI) of plasmin and SF6 in the right eye; group 2 received an IVI of plasmin in the right eye; group 3 received an IVI of SF6 in the right eye; and group 4 received an IVI of balanced salt solution in the right eye. After treatment, IVIs of VEGF were given and vitreous tap was performed three times, followed by clinical observation of lens subluxation and scanning electronic microscope evaluation of the zonular fibers. Results: After IVIs of plasmin and SF6, and VEGF and vitreous tap had been performed one to three times, lens subluxation was noted in 0%, 43%, 71%, 71%, and 86% of the eyes in group 1. After IVIs of plasmin, VEGF, and vitreous tap had been performed one to three times, lens subluxation was noted in 11%, 22%, 44%, 44%, and 67% of the eyes in group 2. The eyes in group 3 and 4 did not show signs of lens subluxation after VEGF IVIs and vitreous tap. Histology confirmed zonular fiber damage in the eyes treated with plasmin. Conclusions: The incidence of lens subluxation increased following plasmin injections in the eyes, and this was aggravated by the subsequent high VEGF level in the eyes and vitreous tapping. Zonular fibers were disrupted following plasmin treatment. These effects should be kept in mind when using plasmin enzymes in patients with vitreoretinal abnormalities.	[Wu, Wei-Chi; Wang, Nan-Kai; Chen, Kwan-Jen; Chen, Tun-Lu; Hwang, Yih-Shiou; Li, Lien-Min; Lai, Chi-Chun] Chang Gung Mem Hosp, Dept Ophthalmol, Taoyuan, Taiwan; [Wu, Wei-Chi; Wang, Nan-Kai; Chen, Kwan-Jen; Chen, Tun-Lu; Hwang, Yih-Shiou; Lai, Chi-Chun] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Liu, Chi-Hsien] Chang Gung Univ, Grad Inst Biochem & Biomed Engn, Taoyuan, Taiwan; [Liao, Pei-Ju] Oriental Inst Technol, Dept Hlth Care Adm, New Taipei City, Taiwan; [Liao, Pei-Ju] Natl Taiwan Univ, Dept Business Adm, Taipei 10764, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Asia Eastern University of Science & Technology; National Taiwan University	Wu, WC (corresponding author), Chang Gung Mem Hosp, Dept Ophthalmol, Taoyuan, Taiwan.	weichi666@gmail.com	Wang, Nan-Kai/D-6608-2011; Wang, Nan-Kai/AAO-6559-2020	Wang, Nan-Kai/0000-0002-6277-9879; Wang, Nan-Kai/0000-0002-6277-9879; Lai, Chi-Chun/0000-0001-9547-7212; Chen, Kuan-Jen/0000-0002-4994-8391	National Science Council, Taipei, Taiwan [NSC101-2314-B-182A-055-MY3]; Chang Gung Memorial Hospital, Taoyuan, Taiwan [CMRPG3A0391, CMRPG3A0392]	National Science Council, Taipei, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Taoyuan, Taiwan(Chang Gung Memorial Hospital)	This study was supported by grants from the National Science Council, Taipei, Taiwan (NSC101-2314-B-182A-055-MY3) and Chang Gung Memorial Hospital, Taoyuan, Taiwan (CMRPG3A0391 and CMRPG3A0392). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Boyd SR, 2002, ARCH OPHTHALMOL-CHIC, V120, P1644; CHAN FL, 1995, HISTOCHEM CELL BIOL, V104, P369, DOI 10.1007/BF01458131; Costagliola C, 2013, EXP EYE RES, V110, P50, DOI 10.1016/j.exer.2013.02.004; Diaz-Llopis M, 2009, J OCUL PHARMACOL TH, V25, P379, DOI 10.1089/jop.2008.0118; Dureau P, 2008, CURR OPIN OPHTHALMOL, V19, P27, DOI 10.1097/ICU.0b013e3282f29f01; GOLDFISCHER S, 1985, TISSUE CELL, V17, P441, DOI 10.1016/0040-8166(85)90023-0; Henderson M, 1996, J HISTOCHEM CYTOCHEM, V44, P1389, DOI 10.1177/44.12.8985131; Hermel M, 2006, GRAEF ARCH CLIN EXP, V244, P996, DOI 10.1007/s00417-005-0159-4; HIKICHI T, 1995, RETINA-J RET VIT DIS, V15, P29, DOI 10.1097/00006982-199515010-00006; Hoffman RS, 2013, J CATARACT REFR SURG, V39, P1904, DOI 10.1016/j.jcrs.2013.09.005; Joshi MM, 2006, RETINA-J RET VIT DIS, V26, pS38, DOI 10.1097/01.iae.0000244287.63757.5a; Kim BT, 2013, OPHTHAL SURG LAS IM, V44, P334, DOI 10.3928/23258160-20130715-05; Kliche S, 2001, IUBMB LIFE, V52, P61, DOI 10.1080/15216540252774784; KOHNO T, 1987, INVEST OPHTH VIS SCI, V28, P506; Lauer G, 2000, J INVEST DERMATOL, V115, P12, DOI 10.1046/j.1523-1747.2000.00036.x; LEE B, 1991, NATURE, V352, P330, DOI 10.1038/352330a0; LIOTTA LA, 1981, CANCER RES, V41, P4629; MACHEMER R, 1985, OPHTHALMOLOGY, V92, P1000; MAGENIS RE, 1991, GENOMICS, V11, P346, DOI 10.1016/0888-7543(91)90142-2; Margherio AR, 1998, OPHTHALMOLOGY, V105, P1617, DOI 10.1016/S0161-6420(98)99027-3; MARSHALL GE, 1992, INVEST OPHTH VIS SCI, V33, P2546; NASRALLAH FP, 1988, OPHTHALMOLOGY, V95, P1335; Noma H, 2005, AM J OPHTHALMOL, V140, P256, DOI 10.1016/j.ajo.2005.03.003; Peer J, 1996, BRIT J OPHTHALMOL, V80, P241, DOI 10.1136/bjo.80.3.241; Proksch JW, 2008, J OCUL PHARMACOL TH, V24, P320, DOI 10.1089/jop.2007.0120; Quiram PA, 2007, RETINA-J RET VIT DIS, V27, P1090, DOI 10.1097/IAE.0b013e3180654229; RAVIOLA G, 1971, INVEST OPHTH VISUAL, V10, P851; Rezende FA, 2014, AM J OPHTHA IN PRESS; Robison CD, 2009, AM J OPHTHALMOL, V148, P79, DOI 10.1016/j.ajo.2009.01.014; RUSSELL SR, 1991, INVEST OPHTH VIS SCI, V32, P1986; Sato T, 2009, OPHTHALMOLOGY, V116, P2165, DOI 10.1016/j.ophtha.2009.04.026; Sato T, 2009, OPHTHALMOLOGY, V116, P1599, DOI 10.1016/j.ophtha.2008.12.023; SCHEPENS CL, 1984, SURV OPHTHALMOL, V28, P499, DOI 10.1016/0039-6257(84)90232-7; Sebag J, 2007, GRAEF ARCH CLIN EXP, V245, P576, DOI 10.1007/s00417-006-0394-3; Sounni NE, 2004, J BIOL CHEM, V279, P13564, DOI 10.1074/jbc.M307688200; Stalmans P, 2012, NEW ENGL J MED, V367, P606, DOI 10.1056/NEJMoa1110823; TAGAWA H, 1986, OPHTHALMOLOGY, V93, P596; Trese MT, 2000, OPHTHALMOLOGY, V107, P1607, DOI 10.1016/S0161-6420(00)00210-4; Tsukahara Y, 2007, AM J OPHTHALMOL, V144, P139, DOI 10.1016/j.ajo.2007.03.020; Vempati P, 2014, CYTOKINE GROWTH F R, V25, P1, DOI 10.1016/j.cytogfr.2013.11.002; VERSTRAETEN TC, 1993, ARCH OPHTHALMOL-CHIC, V111, P849, DOI 10.1001/archopht.1993.01090060139038; Wang FH, 2004, INVEST OPHTH VIS SCI, V45, P3286, DOI 10.1167/iovs.04-0026; Wang ZL, 2009, RETINA-J RET VIT DIS, V29, P269, DOI 10.1097/IAE.0b013e3181923ff0; Wij WC, 2007, RETINA-J RET VIT DIS, V27, P1079, DOI 10.1097/IAE.0b013e31806196d0; Williams JG, 2001, OPHTHALMOLOGY, V108, P1902, DOI 10.1016/S0161-6420(01)00720-5; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Wu WC, 2008, RETINA-J RET VIT DIS, V28, pS75, DOI 10.1097/IAE.0b013e318158ea0e; Wu WC, 2007, AM J OPHTHALMOL, V144, P668, DOI 10.1016/j.ajo.2007.07.027; Wu WC, 2012, MOL VIS, V18, P2361; Wu WC, 2010, INVEST OPHTH VIS SCI, V51, P3701, DOI 10.1167/iovs.09-4425	51	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112957	10.1371/journal.pone.0112957	http://dx.doi.org/10.1371/journal.pone.0112957			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397749	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558500119
J	Ma, F; Ding, XY; Fan, Y; Ying, JM; Zheng, S; Lu, N; Xu, BH				Ma, Fei; Ding, Xiaoyan; Fan, Ying; Ying, Jianming; Zheng, Shan; Lu, Ning; Xu, Binghe			A CLDN1-Negative Phenotype Predicts Poor Prognosis in Triple-Negative Breast Cancer	PLOS ONE			English	Article							INVASIVE DUCTAL CARCINOMA; LOW INTRINSIC SUBTYPE; CLAUDIN EXPRESSION; FEATURES; MARKERS; GRADE	Introduction: Triple-negative breast cancer (TNBC) is a heterogeneous disease with no definitive prognostic markers. As a major component of tight junctions, claudins (CLDNs) presumably play an important role in carcinogenesis and progression of breast cancer. This study was aimed at determining the relationship between the expression of CLDNs and the clinical outcomes of TNBCs. Materials and Methods: The surgical specimens of primary breast tumors from a consecutive cohort of 173 TNBC patients were retrospectively collected. The membranous expression of CLDN1, CLDN2, CLDN4, and CLDN7 was measured by immunohistochemistry. Then, the associations between CLDN expression, clinicopathological features, and clinical outcomes were assessed. Results: Positive CLDN1, CLDN2, CLDN4, and CLDN7 membrane expression was detected in 44.5%, 54.9%, 76.9%, and 73.4% of the cohort specimens, respectively. A lack of CLDN1 expression was related to only lymph node metastasis (P = 0.014). The rate of CLDN4-positive tumors was significantly increased in tumors of a higher grade (P = 0.003). Importantly, negative CLDN1 expression was associated with worse relapse-free survival (RFS) in both lymph node positive (LN+) and negative (LN2) cases (both P<0.001). Similarly it was also associated with shorter overall survival (OS)(P = 0.003 in LN+ cases; P = 0.018 in LN- cases). In the LN+ subgroup, CLDN2-negative cases had a significantly higher risk of recurrence (P = 0.008). Multivariate analysis revealed that negative CLDN1 expression was an independent prognostic factor for high risk of both recurrence and death (HR 5.529, 95% CI 2.664-11.475, P<0.001; HR 3.459, 95% CI 1.555-7.696, P = 0.002). However, neither CLDN4 nor CLDN7 expression was associated with survival. Conclusion: In TNBC, the CLDN1-negative phenotype predicts a high risk of recurrence and death. The absence of CLDN1 expression is strongly suggested to be an independent adverse prognostic factor in this heterogeneous subtype of breast cancer.	[Ma, Fei; Fan, Ying; Xu, Binghe] Chinese Acad Med Sci, Canc Hosp, Dept Med Oncol, Beijing 100730, Peoples R China; [Ma, Fei; Fan, Ying; Ying, Jianming; Zheng, Shan; Lu, Ning; Xu, Binghe] Peking Union Med Coll, Beijing 100021, Peoples R China; [Ding, Xiaoyan] Capital Med Univ, Beijing DiTan Hosp, Dept Med Oncol, Beijing, Peoples R China; [Ying, Jianming; Zheng, Shan; Lu, Ning] Chinese Acad Med Sci, Canc Hosp, Dept Pathol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Lu, N (corresponding author), Chinese Acad Med Sci, Canc Hosp, Dept Pathol, Beijing 100730, Peoples R China.	nlu03@126.com; binghxu@126.com		Ma, Fei/0000-0001-9432-1902	Beijing Medicine Research and Development Fund [2011-4002-02]; Beijing Hope Run Special Fund [LC2012A51]	Beijing Medicine Research and Development Fund; Beijing Hope Run Special Fund	The present study was supported by Beijing Medicine Research and Development Fund (2011-4002-02) and Beijing Hope Run Special Fund (LC2012A51). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1982, Am J Clin Pathol, V78, P806; Bevers TB, 2009, J NATL COMPR CANC NE, V7, P1060, DOI 10.6004/jnccn.2009.0070; Blanchard AA, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-268; Blanchard AA, 2009, VIRCHOWS ARCH, V454, P647, DOI 10.1007/s00428-009-0770-6; Charpin C, 2012, INT J CANCER, V131, pE236, DOI 10.1002/ijc.27371; De Brot M, 2009, REV ASSOC MED BRAS, V55, P529, DOI 10.1590/S0104-42302009000500014; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Eichhorn JH, 2004, SEMIN DIAGN PATHOL, V21, P65, DOI 10.1053/j.semdp.2003.10.005; Fortier AM, 2013, J BIOL CHEM, V288, P11555, DOI 10.1074/jbc.M112.428920; Fountzilas G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037946; Gerhard R, 2012, BREAST, V21, P354, DOI 10.1016/j.breast.2012.03.001; Gluz O, 2009, ANN ONCOL, V20, P1913, DOI 10.1093/annonc/mdp492; Hammond MEH, 2010, J ONCOL PRACT, V6, P195, DOI 10.1200/JOP.777003; Hernandez-Aya LF, 2011, J CLIN ONCOL, V29, P2628, DOI 10.1200/JCO.2010.32.1877; Hewitt KJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-186; Hoevel T, 2004, INT J CANCER, V108, P374, DOI 10.1002/ijc.11571; Kashiwagi S, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3068; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kim TH, 2008, HISTOPATHOLOGY, V53, P48, DOI 10.1111/j.1365-2559.2008.03052.x; Kolokytha P, 2014, APPL IMMUNOHISTO M M, V22, P125, DOI 10.1097/PAI.0b013e31828d9d62; Kominsky SL, 2003, ONCOGENE, V22, P2021, DOI 10.1038/sj.onc.1206199; Kulka J, 2009, PATHOL ONCOL RES, V15, P59, DOI 10.1007/s12253-008-9089-x; Lu SL, 2013, MODERN PATHOL, V26, P485, DOI 10.1038/modpathol.2012.187; Mahler-Araujo B, 2008, J CLIN PATHOL, V61, P615, DOI 10.1136/jcp.2007.053991; Martinez-Estrada OM, 2006, BIOCHEM J, V394, P449, DOI 10.1042/BJ20050591; Mineta K, 2011, FEBS LETT, V585, P606, DOI 10.1016/j.febslet.2011.01.028; Morohashi S, 2007, INT J MOL MED, V20, P139; Myal Y, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/956897; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Sauer T, 2005, CYTOPATHOLOGY, V16, P193, DOI 10.1111/j.1365-2303.2005.00257.x; Singletary SE, 2003, SURG CLIN N AM, V83, P803, DOI 10.1016/S0039-6109(03)00034-3; Szasz AM, 2011, CLIN EXP METASTAS, V28, P55, DOI 10.1007/s10585-010-9357-5; Tokes AM, 2005, BREAST CANCER RES, V7, pR296, DOI 10.1186/bcr983; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775	36	28	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112765	10.1371/journal.pone.0112765	http://dx.doi.org/10.1371/journal.pone.0112765			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393310	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300099
J	Padhi, S; Burri, RR; Jameel, S; Priyakumar, UD				Padhi, Siladitya; Burri, Raghunadha Reddy; Jameel, Shahid; Priyakumar, U. Deva			Atomistic Detailed Mechanism and Weak Cation-Conducting Activity of HIV-1 Vpu Revealed by Free Energy Calculations	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; VIRUS PROTEIN-U; INTEGRAL MEMBRANE-PROTEIN; CHANNEL-FORMING PROTEINS; GATED ION-CHANNEL; TRANSMEMBRANE DOMAIN; MEAN FORCE; 3-DIMENSIONAL STRUCTURE; COMPUTER-SIMULATIONS; FUNCTIONAL MOTIONS	The viral protein U (Vpu) encoded by HIV-1 has been shown to assist in the detachment of virion particles from infected cells. Vpu forms cation-specific ion channels in host cells, and has been proposed as a potential drug target. An understanding of the mechanism of ion transport through Vpu is desirable, but remains limited because of the unavailability of an experimental structure of the channel. Using a structure of the pentameric form of Vpu - modeled and validated based on available experimental data - umbrella sampling molecular dynamics simulations (cumulative simulation time of more than 0.4 mu s) were employed to elucidate the energetics and the molecular mechanism of ion transport in Vpu. Free energy profiles corresponding to the permeation of Na+ and K+ were found to be similar to each other indicating lack of ion selection, consistent with previous experimental studies. The Ser23 residue is shown to enhance ion transport via two mechanisms: creating a weak binding site, and increasing the effective hydrophilic length of the channel, both of which have previously been hypothesized in experiments. A two-dimensional free energy landscape has been computed to model multiple ion permeation, based on which a mechanism for ion conduction is proposed. It is shown that only one ion can pass through the channel at a time. This, along with a stretch of hydrophobic residues in the transmembrane domain of Vpu, explains the slow kinetics of ion conduction. The results are consistent with previous conductance studies that showed Vpu to be a weakly conducting ion channel.	[Padhi, Siladitya; Burri, Raghunadha Reddy; Priyakumar, U. Deva] Int Inst Informat Technol, Ctr Computat Nat Sci & Bioinformat, Hyderabad, Andhra Pradesh, India; [Jameel, Shahid] Int Ctr Genet Engn & Biotechnol, New Delhi, India	International Institute of Information Technology Hyderabad; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Priyakumar, UD (corresponding author), Int Inst Informat Technol, Ctr Computat Nat Sci & Bioinformat, Hyderabad, Andhra Pradesh, India.	deva@iiit.ac.in	Priyakumar, Deva/F-6793-2010	Padhi, Siladitya/0000-0002-4272-6040	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR12729/BID/07/297/2009]	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This work was supported by the Department of Biotechnology, Ministry of Science and Technology, Government of India (http://dbtindia.nic.in/index.asp, grant no. BT/PR12729/BID/07/297/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2014, CHEM PHYS LETT, V599, P116, DOI 10.1016/j.cplett.2014.03.033; Allen TW, 2006, BIOPHYS J, V90, P3447, DOI 10.1529/biophysj.105.077073; Allen TW, 2004, P NATL ACAD SCI USA, V101, P117, DOI 10.1073/pnas.2635314100; BEGLOV D, 1994, J CHEM PHYS, V100, P9050, DOI 10.1063/1.466711; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bu LT, 2007, BIOPHYS J, V92, P854, DOI 10.1529/biophysj.106.095216; Chipot C, 2014, WIRES COMPUT MOL SCI, V4, P71, DOI 10.1002/wcms.1157; COHEN EA, 1988, NATURE, V334, P532, DOI 10.1038/334532a0; de Jesus AJ, 2013, BBA-BIOMEMBRANES, V1828, P851, DOI 10.1016/j.bbamem.2012.09.012; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Egwolf B, 2010, J MOL BIOL, V401, P831, DOI 10.1016/j.jmb.2010.07.006; Ewart GD, 1996, J VIROL, V70, P7108, DOI 10.1128/JVI.70.10.7108-7115.1996; Federau T, 1996, INT J PEPT PROT RES, V47, P297; Fischer WB, 2014, BBA-BIOMEMBRANES, V1838, P1113, DOI 10.1016/j.bbamem.2013.08.017; Fischer WB, 2011, BBA-BIOMEMBRANES, V1808, P561, DOI 10.1016/j.bbamem.2010.05.014; Fowler PW, 2013, J CHEM THEORY COMPUT, V9, P5176, DOI 10.1021/ct4005933; Fritsch S, 2011, BIOPHYS J, V100, P390, DOI 10.1016/j.bpj.2010.11.077; Grossfield A., WHAM WEIGHTED HISTOG; Hsu HJ, 2012, J MOL MODEL, V18, P501, DOI 10.1007/s00894-011-1092-6; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hussain A, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-81; Johnston JM, 2011, CURR OPIN STRUC BIOL, V21, P552, DOI 10.1016/j.sbi.2011.06.008; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kastner J, 2011, WIRES COMPUT MOL SCI, V1, P932, DOI 10.1002/wcms.66; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; Khalili-Araghi F, 2009, CURR OPIN STRUC BIOL, V19, P128, DOI 10.1016/j.sbi.2009.02.011; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kukol A, 1999, BIOPHYS J, V77, P1594, DOI 10.1016/S0006-3495(99)77007-4; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lai CL, 2013, J MOL BIOL, V425, P3073, DOI 10.1016/j.jmb.2013.05.026; Li LH, 2013, BIOPOLYMERS, V99, P517, DOI 10.1002/bip.22210; Lopez CF, 2002, BIOPHYS J, V83, P1259, DOI 10.1016/S0006-3495(02)73898-8; Ma C, 2002, PROTEIN SCI, V11, P546, DOI 10.1110/ps.37302; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MALDARELLI F, 1993, J VIROL, V67, P5056, DOI 10.1128/JVI.67.8.5056-5061.1993; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Marassi FM, 1999, P NATL ACAD SCI USA, V96, P14336, DOI 10.1073/pnas.96.25.14336; Mehnert T, 2008, PROTEINS, V70, P1488, DOI 10.1002/prot.21642; Mehnert T, 2007, J BIOMOL STRUCT DYN, V24, P589, DOI 10.1080/07391102.2007.10507148; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Padhi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079779; Park SH, 2006, BIOPHYS J, V91, P3032, DOI 10.1529/biophysj.106.087106; Park SH, 2003, J MOL BIOL, V333, P409, DOI 10.1016/j.jmb.2003.08.048; Patargias G, 2009, J BIOMOL STRUCT DYN, V27, P1; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Priyakumar UD, 2006, CHEM REV, V106, P489, DOI 10.1021/cr040475z; Priyakumar UD, 2006, J AM CHEM SOC, V128, P678, DOI 10.1021/ja056445a; ROUX B, 1995, COMPUT PHYS COMMUN, V91, P275, DOI 10.1016/0010-4655(95)00053-I; Roux B, 2011, J GEN PHYSIOL, V137, P415, DOI 10.1085/jgp.201010577; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schubert U, 1996, FEBS LETT, V398, P12, DOI 10.1016/S0014-5793(96)01146-5; Schubert U, 1996, J VIROL, V70, P809, DOI 10.1128/JVI.70.2.809-819.1996; Shaikh SA, 2013, BIOCHEMISTRY-US, V52, P569, DOI 10.1021/bi301086x; Shaikh SA, 2010, J COMPUT THEOR NANOS, V7, P2481, DOI 10.1166/jctn.2010.1636; Stansfeld PJ, 2011, STRUCTURE, V19, P1562, DOI 10.1016/j.str.2011.10.002; STREBEL K, 1988, SCIENCE, V241, P1221, DOI 10.1126/science.3261888; Strebel K, 2014, BBA-BIOMEMBRANES, V1838, P1074, DOI 10.1016/j.bbamem.2013.06.029; Tokarev Andrey, 2011, Cell Logist, V1, P90; Wang K, 2011, BBA-BIOMEMBRANES, V1808, P510, DOI 10.1016/j.bbamem.2010.05.006; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; WRAY V, 1995, INT J PEPT PROT RES, V45, P35; Wray V, 1999, BIOCHEMISTRY-US, V38, P5272, DOI 10.1021/bi982755c; Zhu FQ, 2010, P NATL ACAD SCI USA, V107, P19814, DOI 10.1073/pnas.1009313107	66	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112983	10.1371/journal.pone.0112983	http://dx.doi.org/10.1371/journal.pone.0112983			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392993	gold, Green Submitted, Green Published			2022-12-27	WOS:000347709300131
J	Slootweg, IA; Lombarts, KMJMH; Boerebach, BCM; Heineman, MJ; Scherpbier, AJJA; van der Vleuten, CPM				Slootweg, Irene A.; Lombarts, Kiki M. J. M. H.; Boerebach, Benjamin C. M.; Heineman, Maas Jan; Scherpbier, Albert J. J. A.; van der Vleuten, Cees P. M.			Development and Validation of an Instrument for Measuring the Quality of Teamwork in Teaching Teams in Postgraduate Medical Training (TeamQ)	PLOS ONE			English	Article							HEALTH-CARE; EDUCATION; PERFORMANCE; MANAGEMENT; FEEDBACK; PROFESSIONALS; BEHAVIOR; SAFETY; MODEL	Background: Teamwork between clinical teachers is a challenge in postgraduate medical training. Although there are several instruments available for measuring teamwork in health care, none of them are appropriate for teaching teams. The aim of this study is to develop an instrument (TeamQ) for measuring teamwork, to investigate its psychometric properties and to explore how clinical teachers assess their teamwork. Method: To select the items to be included in the TeamQ questionnaire, we conducted a content validation in 2011, using a Delphi procedure in which 40 experts were invited. Next, for pilot testing the preliminary tool, 1446 clinical teachers from 116 teaching teams were requested to complete the TeamQ questionnaire. For data analyses we used statistical strategies: principal component analysis, internal consistency reliability coefficient, and the number of evaluations needed to obtain reliable estimates. Lastly, the median TeamQ scores were calculated for teams to explore the levels of teamwork. Results: In total, 31 experts participated in the Delphi study. In total, 114 teams participated in the TeamQ pilot. The median team response was 7 evaluations per team. The principal component analysis revealed 11 factors; 8 were included. The reliability coefficients of the TeamQ scales ranged from 0.75 to 0.93. The generalizability analysis revealed that 5 to 7 evaluations were needed to obtain internal reliability coefficients of 0.70. In terms of teamwork, the clinical teachers scored residents' empowerment as the highest TeamQ scale and feedback culture as the area that would most benefit from improvement. Conclusions: This study provides initial evidence of the validity of an instrument for measuring teamwork in teaching teams. The high response rates and the low number of evaluations needed for reliably measuring teamwork indicate that TeamQ is feasible for use by teaching teams. Future research could explore the effectiveness of feedback on teamwork in follow up measurements.	[Slootweg, Irene A.; Lombarts, Kiki M. J. M. H.; Boerebach, Benjamin C. M.; Heineman, Maas Jan] Univ Amsterdam, Acad Med Ctr, Ctr Expertise Evidence Based Educ, Profess Performance Res Grp, NL-1105 AZ Amsterdam, Netherlands; [Slootweg, Irene A.; van der Vleuten, Cees P. M.] Univ Maastricht, Dept Educ Dev & Res, Maastricht, Netherlands; [Scherpbier, Albert J. J. A.] Univ Maastricht, Fac Hlth Med & Life Sci, Maastricht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; Maastricht University	Slootweg, IA (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Expertise Evidence Based Educ, Profess Performance Res Grp, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	I.A.Slootweg@amc.uva.nl		Lombarts, Kiki/0000-0001-6167-0620; Boerebach, Benjamin/0000-0002-5931-9783; van der Vleuten, Cees/0000-0001-6802-3119	Dutch Ministry of Health; Academic Medical Center, Amsterdam; Faculty of Health and Life Sciences of the University of Maastricht	Dutch Ministry of Health; Academic Medical Center, Amsterdam; Faculty of Health and Life Sciences of the University of Maastricht	This study is part of the research project Quality of Clinical Teachers and Residency Training Programs, which is co-financed by the Dutch Ministry of Health, the Academic Medical Center, Amsterdam, and the Faculty of Health and Life Sciences of the University of Maastricht. The funding organizations had no role in the design of the study, nor in data collection, data analysis, data interpretation, or the writing of the report.	Albert M, 2007, ADV HEALTH SCI EDUC, V12, P103, DOI 10.1007/s10459-006-9026-2; Arah OA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025983; Bergman Esther, 2012, Acad Med, V87, P545, DOI 10.1097/ACM.0b013e31824fbc8a; Boerebach BCM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069449; Boor K, 2011, MED TEACH, V33, P820, DOI 10.3109/0142159X.2010.541533; Bunniss S, 2010, MED EDUC, V44, P358, DOI 10.1111/j.1365-2923.2009.03611.x; Burke CS, 2006, J APPL PSYCHOL, V91, P1189, DOI 10.1037/0021-9010.91.6.1189; Clay-Williams R, 2014, J CONTIN EDUC HEALTH, V34, P56, DOI 10.1002/chp.21218; DeChurch LA, 2010, J APPL PSYCHOL, V95, P32, DOI 10.1037/a0017328; Deneckere S, 2011, EVAL HEALTH PROF, V34, P258, DOI 10.1177/0163278710393736; DeShon RP, 2004, J APPL PSYCHOL, V89, P1035, DOI 10.1037/0021-9010.89.6.1035; Edmondson A, 1999, ADMIN SCI QUART, V44, P350, DOI 10.2307/2666999; Edmondson A. C., 2012, TEAMING ORG LEARN IN; Finch H, 2006, J EDUC MEAS, V43, P39, DOI 10.1111/j.1745-3984.2006.00003.x; Frank JR, 2010, MED TEACH, V32, P638, DOI 10.3109/0142159X.2010.501190; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Holey EA, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-52; Jagsi R, 2008, ARCH INTERN MED, V168, P493, DOI 10.1001/archinternmed.2007.129; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Lemieux-Charles L, 2006, MED CARE RES REV, V63, P263, DOI 10.1177/1077558706287003; Lombarts KMJM, 2009, ANESTHESIOLOGY, V111; Mathieu J, 2008, J MANAGE, V34, P410, DOI 10.1177/0149206308316061; Mushquash C, 2006, BEHAV RES METHODS, V38, P542, DOI 10.3758/BF03192810; NADLER DA, 1979, ORGAN BEHAV HUM PERF, V23, P309, DOI 10.1016/0030-5073(79)90001-1; Neily J, 2010, JAMA-J AM MED ASSOC, V304, P1693, DOI 10.1001/jama.2010.1506; Norman GR, 2008, BIOSTATISTICS BARE E, V3rd; Salas E, 2005, SMALL GR RES, V36, P555, DOI 10.1177/1046496405277134; Salas E, 2007, FOSTERING TEAM EFFEC; Senior B, 2007, BRIT J MANAGE, V18, P138, DOI 10.1111/j.1467-8551.2006.00507.x; Slootweg I, 2013, MED TEACH, V35, P46, DOI 10.3109/0142159X.2012.731108; Stewart GL, 2010, J MANAGE, V36, P801, DOI 10.1177/0149206310371512; Teunissen PW, 2007, MED EDUC, V41, P763, DOI 10.1111/j.1365-2923.2007.02778.x; Valentine MA, 2011, MEASURING TEAMWORK H, P11; van der Leeuw R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019142; van der Leeuw RM, 2013, MED EDUC, V47, P1089, DOI 10.1111/medu.12257; Varkey P, 2007, MAYO CLIN PROC, V82, P735, DOI 10.4065/82.6.735; Wenger E., 1998, COMMUNITIES PRACTICE; Wright MC, 2009, MED TEACH, V31, P30, DOI 10.1080/01421590802070853	38	6	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112805	10.1371/journal.pone.0112805	http://dx.doi.org/10.1371/journal.pone.0112805			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY6YT	25393006	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300108
J	Wang, WZ; Hu, YM; Lu, PO; Li, YC; Chen, YF; Tian, MH; Yu, LJ				Wang, Wenzhi; Hu, Yumin; Lu, Peiou; Li, Yingci; Chen, Yunfu; Tian, Mohan; Yu, Lijuan			Evaluation of the Diagnostic Performance of Magnetic Resonance Spectroscopy in Brain Tumors: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							PROTON MR SPECTROSCOPY; POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL GLIOMA GRADE; RADIATION NECROSIS; NONINVASIVE EVALUATION; RECURRENCE; DIFFERENTIATION; IDENTIFICATION; RADIOSURGERY; PROGRESSION	Object: The aim of this study was to determine the suitability of magnetic resonance spectroscopy (MRS) for screening brain tumors, based on a systematic review and meta-analysis of published data on the diagnostic performance of MRS. Methods: The PubMed and PHMC databases were systematically searched for relevant studies up to December 2013. The sensitivities and specificities of MRS in individual studies were calculated and the pooled diagnostic accuracies, with 95% confidence intervals (CI), were assessed under a fixed-effects model. Results: Twenty-four studies were included, comprising a total of 1013 participants. Overall, no heterogeneity of diagnostic effects was observed between studies. The pooled sensitivity and specificity of MRS were 80.05% (95% CI = 75.97%-83.59%) and 78.46% (95% CI: 73.40%-82.78%), respectively. The area under the summary receiver operating characteristic curve was 0.78. Stratified meta analysis showed higher sensitivity and specificity in child than adult. CSI had higher sensitivity and SV had higher specificity. Higher sensitivity and specificity were obtained in short TE value. Conclusion: Although the qualities of the studies included in the meta-analysis were moderate, current evidence suggests that MRS may be a valuable adjunct to magnetic resonance imaging for diagnosing brain tumors, but requires selection of suitable technique and TE value.	[Wang, Wenzhi; Hu, Yumin; Lu, Peiou; Li, Yingci; Chen, Yunfu; Tian, Mohan; Yu, Lijuan] Harbin Med Univ, Canc Hosp, Ctr PET CT MRI, Harbin 150081, Peoples R China	Harbin Medical University	Tian, MH (corresponding author), Harbin Med Univ, Canc Hosp, Ctr PET CT MRI, Harbin 150081, Peoples R China.	tianmohan2000@126.com; yulijuan2003@126.com						Amin A, 2012, J NEURO-ONCOL, V106, P579, DOI 10.1007/s11060-011-0694-2; Chernov M, 2005, MINIM INVAS NEUROSUR, V48, P228, DOI 10.1055/s-2005-870952; Crisi G, 2013, J COMPUT ASSIST TOMO, V37, P265, DOI 10.1097/RCT.0b013e318282d2ba; Davies NP, 2008, NMR BIOMED, V21, P908, DOI 10.1002/nbm.1283; DICHIRO G, 1982, NEUROLOGY, V32, P1323, DOI 10.1212/WNL.32.12.1323; DOOMS GC, 1986, RADIOLOGY, V158, P149, DOI 10.1148/radiology.158.1.3940373; Fayed N, 2006, ACAD RADIOL, V13, P728, DOI 10.1016/j.acra.2006.01.047; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Floeth FW, 2005, J NEUROSURG, V102, P318, DOI 10.3171/jns.2005.102.2.0318; Guillevin R, 2011, BRIT J CANCER, V104, P1854, DOI 10.1038/bjc.2011.174; Haroon HA, 2007, BRIT J RADIOL, V80, P161, DOI 10.1259/bjr/17112059; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hlaihel C, 2010, J NEURO-ONCOL, V97, P73, DOI 10.1007/s11060-009-9991-4; Kickingereder P, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-52; Kwock L, 2006, LANCET ONCOL, V7, P859, DOI 10.1016/S1470-2045(06)70905-6; Law M, 2003, AM J NEURORADIOL, V24, P1989; Liu ZL, 2012, J INT MED RES, V40, P76, DOI 10.1177/147323001204000108; Martin AJ, 2001, AM J NEURORADIOL, V22, P959; Moller-Hartmann W, 2002, NEURORADIOLOGY, V44, P371, DOI 10.1007/s00234-001-0760-0; Palumbo B, 2006, Q J NUCL MED MOL IM, V50, P88; Pamir MN, 2013, J NEUROSURG, V118, P1191, DOI 10.3171/2013.1.JNS111561; Peng J, 2012, EUR J RADIOL, V81, P4057, DOI 10.1016/j.ejrad.2012.06.005; Prat R, 2010, J CLIN NEUROSCI, V17, P50, DOI 10.1016/j.jocn.2009.02.035; Reddy K, 2013, J MED IMAG RADIAT ON, V57, P349, DOI 10.1111/j.1754-9485.2012.02472.x; Sahin N, 2013, NEURORADIOL J, V26, P531, DOI 10.1177/197140091302600506; Schlemmer HP, 2002, NEURORADIOLOGY, V44, P216, DOI 10.1007/s002340100703; Seeger A, 2013, ACAD RADIOL, V20, P1557, DOI 10.1016/j.acra.2013.09.003; Senft C, 2009, NEUROSURGERY, V65, P908, DOI 10.1227/01.NEU.0000356982.82378.BA; Serizawa T, 2005, J NEUROSURG, V102, P266, DOI 10.3171/jns.2005.102.s_supplement.0266; Server A, 2011, EUR J RADIOL, V80, P462, DOI 10.1016/j.ejrad.2010.07.017; Tate AR, 2006, NMR BIOMED, V19, P411, DOI 10.1002/nbm.1016; Thompson TP, 1999, STEREOT FUNCT NEUROS, V73, P9, DOI 10.1159/000029743; Thorlund K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039471; Truong MT, 2006, NEUROSURGERY, V59, P86, DOI 10.1227/01.NEU.0000219858.80351.38; Vellido A, 2012, NMR BIOMED, V25, P819, DOI 10.1002/nbm.1797; Walter SD, 2002, STAT MED, V21, P1237, DOI 10.1002/sim.1099; WANG ZY, 1995, AM J NEURORADIOL, V16, P1821; Yu X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034419; Zeng QS, 2007, J NEURO-ONCOL, V84, P63, DOI 10.1007/s11060-007-9341-3; Zeng QS, 2011, MAGN RESON IMAGING, V29, P25, DOI 10.1016/j.mri.2010.07.017; Zou QG, 2011, CLIN RADIOL, V66, P953, DOI 10.1016/j.crad.2011.05.001	41	19	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112577	10.1371/journal.pone.0112577	http://dx.doi.org/10.1371/journal.pone.0112577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393009	Green Submitted, Green Published, gold			2022-12-27	WOS:000347709300072
J	Wei, FH; Zhang, YY; Zhao, WM; Yu, XP; Liu, CJ				Wei, Fanhua; Zhang, Yuying; Zhao, Weiming; Yu, Xiuping; Liu, Chuan-ju			Progranulin Facilitates Conversion and Function of Regulatory T Cells under Inflammatory Conditions	PLOS ONE			English	Article							GROWTH-FACTOR PROGRANULIN; GRANULIN-EPITHELIN PRECURSOR; INTRAVENOUS IMMUNOGLOBULIN; TNF-ALPHA; RHEUMATOID-ARTHRITIS; HOST-DEFENSE; AUTOIMMUNE; PROLIFERATION; DEFICIENCY; MECHANISMS	The progranulin (PGRN) is known to protect regulatory T cells (Tregs) from a negative regulation by TNF-alpha, and its levels are elevated in various kinds of autoimmune diseases. Whether PGRN directly regulates the conversion of CD4+CD25-T cells into Foxp3-expressing regulatory T cells (iTreg), and whether PGRN affects the immunosuppressive function of Tregs, however, remain unknown. In this study we provide evidences demonstrating that PGRN is able to stimulate the conversion of CD4+CD25-T cells into iTreg in a dose-dependent manner in vitro. In addition, PGRN showed synergistic effects with TGF-beta 1 on the induction of iTreg. PGRN was required for the immunosuppressive function of Tregs, since PGRN-deficient Tregs have a significant decreased ability to suppress the proliferation of effector T cells (Teff). In addition, PGRN deficiency caused a marked reduction in Tregs number in the course of inflammatory arthritis, although no significant difference was observed in the numbers of Tregs between wild type and PGRN deficient mice during development. Furthermore, PGRN deficiency led to significant upregulation of the Wnt receptor gene Fzd2. Collectively, this study reveals that PGRN directly regulates the numbers and function of Tregs under inflammatory conditions, and provides new insight into the immune regulatory mechanism of PGRN in the pathogenesis of inflammatory and immune-related diseases.	[Wei, Fanhua; Zhang, Yuying; Liu, Chuan-ju] NYU, Med Ctr, Dept Orthopaed Surg, New York, NY 10016 USA; [Wei, Fanhua; Zhao, Weiming; Yu, Xiuping] Shandong Univ, Sch Med, Inst Pathogen Biol, Jinan 250100, Peoples R China; [Liu, Chuan-ju] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; Shandong University; New York University	Liu, CJ (corresponding author), NYU, Med Ctr, Dept Orthopaed Surg, New York, NY 10016 USA.	chuanju.liu@nyumc.org	Liu, Chuan-ju/AAT-8165-2021	liu, chuanju/0000-0002-7181-8032; Wei, Fanhua/0000-0002-2997-922X	NIH [R01AR062207, R01AR061484, R56AI100901]; Disease Targeted Research Grant from Rheumatology Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI100901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061484, R01AR062207] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Disease Targeted Research Grant from Rheumatology Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported partly by NIH research grants R01AR062207, R01AR061484, R56AI100901, and a Disease Targeted Research Grant from Rheumatology Research Foundation. The authors state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANAKWE OO, 1990, BIOL REPROD, V42, P317, DOI 10.1095/biolreprod42.2.317; Bayry J, 2007, DRUG DISCOV TODAY, V12, P548, DOI 10.1016/j.drudis.2007.05.002; Bayry J, 2012, J RHEUMATOL, V39, P450, DOI 10.3899/jrheum.111123; Bluestone JA, 2008, NAT MED, V14, P118, DOI 10.1038/nm0208-118; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; De Riz M, 2010, NEUROSCI LETT, V469, P234, DOI 10.1016/j.neulet.2009.12.002; Ding Y, 2008, NAT MED, V14, P162, DOI 10.1038/nm1707; Dons EM, 2012, HUM IMMUNOL, V73, P328, DOI 10.1016/j.humimm.2011.12.011; Egashira Y, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-105; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Ephrem A, 2008, BLOOD, V111, P715, DOI 10.1182/blood-2007-03-079947; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Feng JAQ, 2010, FASEB J, V24, P1879, DOI 10.1096/fj.09-144659; Guo ZL, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/540794; He ZH, 2002, CANCER RES, V62, P5590; Hu Y, 2014, IMMUNOLOGY, V142, P193, DOI 10.1111/imm.12241; Jian JL, 2013, FEBS LETT, V587, P3428, DOI 10.1016/j.febslet.2013.09.024; Jian JL, 2013, J LEUKOCYTE BIOL, V93, P199, DOI 10.1189/jlb.0812429; Kawase R, 2013, CARDIOVASC RES, V100, P125, DOI 10.1093/cvr/cvt178; Kessel A, 2007, J IMMUNOL, V179, P5571, DOI 10.4049/jimmunol.179.8.5571; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Lan Q, 2012, J MOL CELL BIOL, V4, P22, DOI 10.1093/jmcb/mjr039; Li ML, 2014, CELL SIGNAL, V26, P1539, DOI 10.1016/j.cellsig.2014.03.026; Maddur MS, 2010, J CLIN IMMUNOL, V30, pS4, DOI 10.1007/s10875-010-9394-5; Miller ZA, 2013, J NEUROL NEUROSUR PS, V84, P956, DOI 10.1136/jnnp-2012-304644; Miyara M, 2014, NAT REV RHEUMATOL; Nie H, 2013, NAT MED, V19, P322, DOI 10.1038/nm.3085; Ong CHP, 2003, HISTOL HISTOPATHOL, V18, P1275, DOI 10.14670/HH-18.1275; Ouyang WM, 2010, IMMUNITY, V32, P642, DOI 10.1016/j.immuni.2010.04.012; Qiu F, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-88; Rosen EY, 2011, NEURON, V71, P1030, DOI 10.1016/j.neuron.2011.07.021; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; Schmitt EG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00152; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Takahashi T, 2003, INT REV CYTOL, V225, P1, DOI 10.1016/S0074-7696(05)25001-5; Takahashi T, 2003, CURR MOL MED, V3, P693, DOI 10.2174/1566524033479429; Tanaka A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4087; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Thurner L, 2014, DIGESTIVE DIS SCI; Thurner L, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4406; Thurner L, 2013, J AUTOIMMUN, V42, P29, DOI 10.1016/j.jaut.2012.10.003; Tian QY, 2014, FRONT BIOSCI-LANDMRK, V19, P1176, DOI 10.2741/4274; Trinath J, 2013, BLOOD, V122, P1419, DOI 10.1182/blood-2012-11-468264; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; Van Damme P, 2008, J CELL BIOL, V181, P37, DOI 10.1083/jcb.200712039; van Loosdregt J, 2013, IMMUNITY, V39, P298, DOI 10.1016/j.immuni.2013.07.019; Vezina A, 2014, CANCER LETT, V345, P100, DOI 10.1016/j.canlet.2013.11.021; Wexler EM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002282; Xu JD, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.017; Xu L, 2010, MUCOSAL IMMUNOL, V3, P230, DOI 10.1038/mi.2010.7; Yamamoto Y, 2014, INCREASED SERUM GP88; Yamano Y, 2005, J CLIN INVEST, V115, P1361, DOI [10.1172/JCI200523913, 10.1172/JCI23913]; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068; Zhao YP, 2013, FEBS LETT, V587, P1805, DOI 10.1016/j.febslet.2013.04.037; Zhou XH, 2011, AUTOIMMUNITY, V44, P43, DOI 10.3109/08916931003782163; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	57	33	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112110	10.1371/journal.pone.0112110	http://dx.doi.org/10.1371/journal.pone.0112110			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393765	Green Published, gold, Green Submitted			2022-12-27	WOS:000347709300032
J	Xie, P; Hu, ZZ; Zhang, XJ; Li, XH; Gao, ZS; Yuan, DQ; Liu, QH				Xie, Ping; Hu, Zizhong; Zhang, Xiaojun; Li, Xinhua; Gao, Zhishan; Yuan, Dongqing; Liu, Qinghuai			Application of 3-Dimensional Printing Technology to Construct an Eye Model for Fundus Viewing Study	PLOS ONE			English	Article							CONTACT-LENS; OPTICAL-PERFORMANCE; SYSTEM; ABERRATIONS	Objective: To construct a life-sized eye model using the three-dimensional (3D) printing technology for fundus viewing study of the viewing system. Methods: We devised our schematic model eye based on Navarro's eye and redesigned some parameters because of the change of the corneal material and the implantation of intraocular lenses (IOLs). Optical performance of our schematic model eye was compared with Navarro's schematic eye and other two reported physical model eyes using the ZEMAX optical design software. With computer aided design (CAD) software, we designed the 3D digital model of the main structure of the physical model eye, which was used for three-dimensional (3D) printing. Together with the main printed structure, polymethyl methacrylate(PMMA) aspherical cornea, variable iris, and IOLs were assembled to a physical eye model. Angle scale bars were glued from posterior to periphery of the retina. Then we fabricated other three physical models with different states of ammetropia. Optical parameters of these physical eye models were measured to verify the 3D printing accuracy. Results: In on-axis calculations, our schematic model eye possessed similar size of spot diagram compared with Navarro's and Bakaraju's model eye, much smaller than Arianpour's model eye. Moreover, the spherical aberration of our schematic eye was much less than other three model eyes. While in off-axis simulation, it possessed a bit higher coma and similar astigmatism, field curvature and distortion. The MTF curves showed that all the model eyes diminished in resolution with increasing field of view, and the diminished tendency of resolution of our physical eye model was similar to the Navarro's eye. The measured parameters of our eye models with different status of ametropia were in line with the theoretical value. Conclusions: The schematic eye model we designed can well simulate the optical performance of the human eye, and the fabricated physical one can be used as a tool in fundus range viewing research.	[Xie, Ping; Hu, Zizhong; Yuan, Dongqing; Liu, Qinghuai] Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing 210029, Jiangsu, Peoples R China; [Zhang, Xiaojun] Nanjing Med Univ, Affiliated Hosp 2, Dept Ophthalmol, Nanjing 210000, Jiangsu, Peoples R China; [Li, Xinhua; Gao, Zhishan] Nanjing Univ Sci & Technol, Sch Opt Engn, Nanjing 210094, Jiangsu, Peoples R China; [Li, Xinhua] Jinling Inst Technol, Ophthalm Technol Coll, Nanjing 210001, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing University of Science & Technology; Jinling Institute of Technology	Liu, QH (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing 210029, Jiangsu, Peoples R China.	liuqh@njmu.edu.cn	zhang, jin/GXV-9154-2022	Liu, Qinghuai/0000-0003-1605-1964; Xie, Ping/0000-0003-4257-8970; hu, zizhong/0000-0001-6289-1804	National Basic Research Program of China (973 Program) [2011CB510200, 2013CB967500]; National Natural Science Foundation of China [81170855, 60977008]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding from the National Basic Research Program of China (973 Program): No. 2011CB510200 (http://www.973.gov.cn/English/Index.aspx) to Qinghuai Liu; National Basic Research Program of China (973 Program): No. 2013CB967500 (http://www.973.gov.cn/English/Index.aspx) to Qinghuai Liu; National Natural Science Foundation of China: No. 81170855 (http://www.nsfc.gov.cn) to Qinghuai Liu; National Natural Science Foundation of China: No. 60977008 (http://www.nsfc.gov.cn) to Zhishan Gao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann R, 2013, BIOMED OPT EXPRESS, V4, P220, DOI 10.1364/BOE.4.000220; Arianpour A, 2013, J REFRACT SURG, V29, P126, DOI 10.3928/1081597X-20130117-08; Bakaraju RC, 2010, OPT EXPRESS, V18, P16868, DOI 10.1364/OE.18.016868; Chalam KV, 2004, SURV OPHTHALMOL, V49, P437, DOI 10.1016/j.survophthal.2004.04.010; Choi J, 2008, J REFRACT SURG, V24, P218, DOI 10.3928/1081597X-20080301-02; Eppig T, 2008, OPHTHAL PHYSL OPT, V28, P467, DOI 10.1111/j.1475-1313.2008.00582.x; Escudero-Sanz I, 1999, J OPT SOC AM A, V16, P1881, DOI 10.1364/JOSAA.16.001881; Gobbi PG, 2006, J CATARACT REFR SURG, V32, P643, DOI 10.1016/j.jcrs.2006.01.026; Gullstrand A., 1909, PHYSIOLOGISCHE OPTIK, V1, P350; Hitani K, 2011, OPHTHAL SURG LAS IM, V42, P523, DOI 10.3928/15428877-20111017-02; Holladay JT, 2002, J REFRACT SURG, V18, P683; Huang TQ, 2014, BIOMED MICRODEVICES, V16, P127, DOI 10.1007/s10544-013-9812-6; Hull CW, 1986, US Patent, Patent No. [4575330A, 4575330, 4,575,330]; Inoue M, 2013, AM J OPHTHALMOL, V155, P243, DOI 10.1016/j.ajo.2012.07.017; Inoue M, 2011, AM J OPHTHALMOL, V151, P644, DOI 10.1016/j.ajo.2010.09.029; International Organization for Standardization, 119792 ISO; Kamei M, 2012, CLIN OPHTHALMOL, V6, P1321, DOI [10.2147/Opth.S33595, 10.2147/OPTH.S33595]; Kasparova M, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-49; Kiyokawa Masatoshi, 2009, International Ophthalmology, V29, P169, DOI 10.1007/s10792-007-9181-3; KOOIJMAN AC, 1983, J OPT SOC AM, V73, P1544, DOI 10.1364/JOSA.73.001544; Mashiko T, 2013, WORLD NEURO IN PRESS; Murthy RK, 2010, RETINA-J RET VIT DIS, V30, P1551, DOI 10.1097/IAE.0b013e3181f442f7; NAVARRO R, 1985, J OPT SOC AM A, V2, P1273, DOI 10.1364/JOSAA.2.001273; Norrby S, 2007, APPL OPTICS, V46, P6597, DOI 10.1364/AO.46.006597; Ohji M, 2011, RETINA-J RET VIT DIS, V31, P1958, DOI 10.1097/IAE.0b013e31822a900b; Ohtsuki M, 2012, RETINA-J RET VIT DIS, V32, P1983, DOI 10.1097/IAE.0b013e31826711be; RETZLAFF JA, 1990, J CATARACT REFR SURG, V16, P333, DOI 10.1016/S0886-3350(13)80705-5; Xue Shi-hua, 2013, Beijing Da Xue Xue Bao Yi Xue Ban, V45, P105; Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004	29	20	24	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e109373	10.1371/journal.pone.0109373	http://dx.doi.org/10.1371/journal.pone.0109373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393277	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300003
J	Baeten, J; Deforce, K; Challe, S; De Vos, D; Degryse, P				Baeten, Jan; Deforce, Koen; Challe, Sophie; De Vos, Dirk; Degryse, Patrick			Holy Smoke in Medieval Funerary Rites: Chemical Fingerprints of Frankincense in Southern Belgian Incense Burners	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; BRASSICACEAE SEED OIL; PINE WOOD ORIGIN; GAS-CHROMATOGRAPHY; ORGANIC RESIDUES; ARCHAEOLOGICAL FRANKINCENSE; TRITERPENOID HYDROCARBONS; BOSWELLIA-CARTERII; OLIVE OIL; SEDIMENTS	Frankincense, the oleogum resin from Boswellia sp., has been an early luxury good in both Western and Eastern societies and is particularly used in Christian funerary and liturgical rites. The scant grave goods in late medieval burials comprise laterally perforated pottery vessels which are usually filled with charcoal. They occur in most regions of western Europe and are interpreted as incense burners but have never been investigated with advanced analytical techniques. We herein present chemical and anthracological results on perforated funerary pots from 4 Wallonian sites dating to the 12-14 th century AD. Chromatographic and mass spectrometric analysis of lipid extracts of the ancient residues and comparison with extracts from four Boswellia species clearly evidence the presence of degraded frankincense in the former, based on characteristic triterpenoids, viz. boswellic and tirucallic acids, and their myriad dehydrated and oxygenated derivatives. Cembrane-type diterpenoids indicate B. sacra (southern Arabia) and B. serrata (India) as possible botanical origins. Furthermore, traces of juniper and possibly pine tar demonstrate that small amounts of locally available fragrances were mixed with frankincense, most likely to reduce its cost. Additionally, markers of ruminant fats in one sample from a domestic context indicate that this vessel was used for food preparation. Anthracological analysis demonstrates that the charcoal was used as fuel only and that no fragrant wood species were burned. The chars derived from local woody plants and were most likely recovered from domestic fires. Furthermore, vessel recycling is indicated by both contextual and biomarker evidence. The results shed a new light on funerary practices in the Middle Ages and at the same time reveal useful insights into the chemistry of burned frankincense. The discovery of novel biomarkers, namely Delta(2)-boswellic acids and a series of polyunsaturated and aromatic hydrocarbons, demonstrates the high potential for organic chemical analyses of incense residues.	[Baeten, Jan; De Vos, Dirk] Katholieke Univ Leuven, Ctr Surface Chem & Catalysis, Leuven, Belgium; [Baeten, Jan; De Vos, Dirk; Degryse, Patrick] Katholieke Univ Leuven, Ctr Archaeol Sci, Leuven, Belgium; [Deforce, Koen] Royal Belgian Inst Nat Sci, OD Earth & Hist Life, Brussels, Belgium; [Challe, Sophie] Serv Publ Wallonie, Direct Archeol, Jambes, Belgium	KU Leuven; KU Leuven; Royal Belgian Institute of Natural Sciences	De Vos, D (corresponding author), Katholieke Univ Leuven, Ctr Surface Chem & Catalysis, Leuven, Belgium.	dirk.devos@biw.kuleuven.be	Degryse, Patrick/ABF-5329-2020	Degryse, Patrick/0000-0003-3604-6505	Belgian Programme on Interuniversity Poles of Attraction [IAP 7/09]; KU Leuven (Centre for Archaeological Sciences); Research Foundation - Flanders [G.0486.12]	Belgian Programme on Interuniversity Poles of Attraction; KU Leuven (Centre for Archaeological Sciences); Research Foundation - Flanders(FWO)	This research was supported by the Belgian Programme on Interuniversity Poles of Attraction (IAP 7/09, iap-cores.be), the special research fund of the KU Leuven (Centre for Archaeological Sciences, ees.kuleuven.be/cas) and the Research Foundation - Flanders (G.0486.12, www.fwo.be). The Research Foundation Flanders is acknowledged for enabling the acquisition of a new GC-MS instrument. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allios D, 2013, CERAMIQUE CONTEXTES, P189; [Anonymous], 1990, MICROSCOPIC WOOD ANA; Asouti E, 2005, ENVIRON ARCHAEOL, V10, P1, DOI 10.1179/env.2005.10.1.1; Baeten J, 2013, ARCHAEOMETRY, V55, P1150, DOI 10.1111/j.1475-4754.2012.00731.x; Baeten J, 2012, J ARCHAEOL SCI, V39, P1143, DOI 10.1016/j.jas.2011.12.019; Basar S., 2005, THESIS; BECK CW, 1989, ADV CHEM SER, P369; Bergmann J, 2004, THESIS; Bleck RD, 1967, ALT THURINGEN, V9, P204; Boivin N, 2009, J WORLD PREHIST, V22, P113, DOI 10.1007/s10963-009-9018-2; Brocks JJ, 2008, GEOCHIM COSMOCHIM AC, V72, P871, DOI 10.1016/j.gca.2007.11.028; Buchele B, 2003, J CHROMATOGR B, V791, P21, DOI 10.1016/S1570-0232(03)00160-0; CHAFFEE AL, 1984, GEOCHIM COSMOCHIM AC, V48, P2037, DOI 10.1016/0016-7037(84)90384-3; Challe S, 2014, ACT C POTS TOMB; Charlier P, 2013, SCI REPORTS; Cleene Marcel de, 2002, COMPENDIUM SYMBOLIC, VI; Colombini MP, 2005, J MASS SPECTROM, V40, P890, DOI 10.1002/jms.865; Connan J, 2003, J ARCHAEOL SCI, V30, P709, DOI 10.1016/S0305-4403(02)00243-1; Copley MS, 2005, ANALYST, V130, P860, DOI 10.1039/b500403a; CORBET B, 1980, J AM CHEM SOC, V102, P1171, DOI 10.1021/ja00523a048; CRONE P., 1987, MECCAN TRADE RISE IS; Cuthbert EG, 1909, HIST USE INCENSE DIV; Deforce K, 2013, J ARCHAEOL SCI, V40, P681, DOI 10.1016/j.jas.2012.07.009; Deforce K, 2012, J ARCHAEOL SCI, V39, P1338, DOI 10.1016/j.jas.2011.12.024; Denis M, 2010, ARCHAEOLOGICA MEDIA, V33, P55; Dudd SN, 1998, ORG GEOCHEM, V29, P1345, DOI 10.1016/S0146-6380(98)00093-X; Durand M., 1988, REV ARCHEOLOGIQUE PI; Egenberg IM, 2002, J ANAL APPL PYROL, V62, P143, DOI 10.1016/S0165-2370(01)00112-7; Evershed RP, 2008, ARCHAEOMETRY, V50, P101, DOI 10.1111/j.1475-4754.2007.00368.x; Evershed RP, 2008, WORLD ARCHAEOL, V40, P26, DOI 10.1080/00438240801889373; Evershed RP, 1997, NATURE, V390, P667, DOI 10.1038/37741; EVERSHED RP, 1985, NATURE, V314, P528, DOI 10.1038/314528a0; FREEMAN KH, 1994, ORG GEOCHEM, V21, P1037, DOI 10.1016/0146-6380(94)90067-1; Gartner T, 2007, Z ARCHAEOLOGIE MITTE, V35, P61; Gauthier C, 2008, PARFUMS ANTIQUITE RO, P343; Gilchrist R., 2005, REQUIEM MEDIEVAL MON; Groom, 1981, FRANKINCENSE MYRRH S, P285; Grosser D, 2003, HOLZER MITTEILEUROPA; Hamm S, 2005, PHYTOCHEMISTRY, V66, P1499, DOI 10.1016/j.phytochem.2005.04.025; Hardy-Guilbert C, 2010, ARAB ARCHAEOL EPIGR, V21, P46, DOI 10.1111/j.1600-0471.2009.00322.x; Heller Frederic, 2014, CHRONIQUE ARCHEOLOGI, V21, P15; HERON C, 1991, J ARCHAEOL SCI, V18, P641, DOI 10.1016/0305-4403(91)90027-M; Heron C., 1988, P C APPL SCI TECHN A; Husi P., 1990, REV ARCHEOLOGIQUE CT REV ARCHEOLOGIQUE CT, V29, P131; Jacob J, 2007, ORG GEOCHEM, V38, P180, DOI 10.1016/j.orggeochem.2006.10.007; Keiluweit M, 2012, ENVIRON SCI TECHNOL, V46, P9333, DOI 10.1021/es302125k; Kimpe K, 2001, J CHROMATOGR A, V937, P87, DOI 10.1016/S0021-9673(01)01304-8; Kimpe K., 2003, THESIS KU LEUVEN; Lallemand A, 2008, PARFUMS LANTIQUITE R, P335; Lange W., 1983, Berliner Beitrage zur Archaometrie, V8, P289; Langenheim J.H., 2003, PLANT RESINS CHEM EV; Lin Ta-Chang, 2008, Clin Mol Allergy, V6, P3, DOI 10.1186/1476-7961-6-3; Madsen PK, 1983, J DANISH ARCHAEOLOGY, V2, P171; Mathe C, 2004, J CHROMATOGR A, V1023, P277, DOI 10.1016/j.chroma.2003.10.016; Mathe C, 2007, ANN CHIM-ROME, V97, P433, DOI 10.1002/adic.200790029; Mills J.S., 1994, ORGANIC CHEM MUSEUM; Morse D., 1976, MED HIST, V20, P461; Mottram HR, 1999, J CHROMATOGR A, V833, P209, DOI 10.1016/S0021-9673(98)01041-3; Moussaieff A, 2007, MOL PHARMACOL, V72, P1657, DOI 10.1124/mol.107.038810; Moussaieff A, 2009, J PHARM PHARMACOL, V61, P1281, DOI [10.1211/jpp/61.10.0003, 10.1211/jpp.61.10.0003]; Otte M, 1983, FOUILLES PLACE SAINT; Otto A, 2001, BOT REV, V67, P141, DOI 10.1007/BF02858076; Paul M., 2012, THESIS; Paul M, 2012, PHYTOCHEM ANALYSIS, V23, P184, DOI 10.1002/pca.1341; Peters C, 2013, CHRONIQUE ARCHEOLOGI, V20, P160; Pfeifer M., 1997, WEIHRAUCH GESCH BEDE; Prigent D, 1996, ARCHAEOLOGIE CIMETIE, V11, P215; Raven AM, 1997, J ANAL APPL PYROL, V40-1, P267, DOI 10.1016/S0165-2370(97)00036-3; Regert M, 2008, ARCHAEOMETRY, V50, P668, DOI 10.1111/j.1475-4754.2007.00372.x; ROBINSON N, 1987, ANALYST, V112, P637, DOI 10.1039/an9871200637; Romanus K, 2008, ANAL BIOANAL CHEM, V390, P783, DOI 10.1007/s00216-007-1704-2; Romanus K, 2009, J ARCHAEOL SCI, V36, P900, DOI 10.1016/j.jas.2008.11.024; Rougeulle A, 2004, ANN ISLAMOLOGIQUES, V38, P201; Scalarone D, 2003, J ANAL APPL PYROL, V68-9, P115, DOI 10.1016/S0165-2370(03)00005-6; Schmidt TJ, 2011, PLANTA MED, V77, P849, DOI 10.1055/s-0030-1250612; Schoch W., 2004, WOOD ANATOMY CENTRAL; Schweingruber FH, 1990, ANATOMY EUROPEAN WOO; Schweitz D., 1981, REV ARCHEOLOGIQUE CT, V20, P27; Sedov A., 2007, FOOD GODS NEW LIGHT, P71; Simoneit BRT, 2002, APPL GEOCHEM, V17, P129, DOI 10.1016/S0883-2927(01)00061-0; Simoneit BRT, 2000, CHEMOSP GLOB CHANGE, V2, P107, DOI 10.1016/S1465-9972(99)00048-3; Singer C., 2007, FOOD GODS NEW LIGHT, P4; Steele V, 2013, ACS SYM SER, V1147, P89; STOUT SA, 1992, ORG GEOCHEM, V18, P51, DOI 10.1016/0146-6380(92)90143-L; TENHAVEN HL, 1992, GEOCHIM COSMOCHIM AC, V56, P2001, DOI 10.1016/0016-7037(92)90326-E; TENHAVEN HL, 1992, GEOCHIM COSMOCHIM AC, V56, P1993, DOI 10.1016/0016-7037(92)90325-D; TUCKER AO, 1986, ECON BOT, V40, P425, DOI 10.1007/BF02859654; vanBergen PF, 1997, TETRAHEDRON LETT, V38, P8409, DOI 10.1016/S0040-4039(97)10234-9; Vanmechelen R, 2010, CHRONIQUE ARCHEOLOGI, V17, P198; Vichi S, 2008, ANAL CHIM ACTA, V628, P222, DOI 10.1016/j.aca.2008.09.005; WOLFF GA, 1989, TETRAHEDRON, V45, P6721, DOI 10.1016/S0040-4020(01)89142-0; Woolley CL, 2012, J CHROMATOGR A, V1261, P158, DOI 10.1016/j.chroma.2012.06.073; Yang TT, 2013, AEROSOL AIR QUAL RES, V13, P662, DOI 10.4209/aaqr.2012.07.0182; Zhang YX, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-153	94	13	13	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e113142	10.1371/journal.pone.0113142	http://dx.doi.org/10.1371/journal.pone.0113142			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CA8CP	25391130	Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400148
J	Chen, SC; Su, YC; Lu, YT; Ko, PCI; Chang, PY; Lin, HJ; Ho, HN; Lai, YP				Chen, Shu-Ching; Su, Yu-Chia; Lu, Ya-Ting; Ko, Patrick Chow-In; Chang, Pei-Yu; Lin, Hung-Ju; Ho, Hong-Nerng; Lai, Yo-Ping			Defects in the Acquisition of Tumor-Killing Capability of CD8(+) Cytotoxic T Cells in Streptozotocin-Induced Diabetic Mice	PLOS ONE			English	Article							CYTOLYTIC ACTIVITY; COLORECTAL-CANCER; IMMUNE-RESPONSE; B-CELL; LYMPHOCYTES; MELLITUS; ACTIVATION; CTL; DIFFERENTIATION; IMMUNOTHERAPY	Emerging evidences have shown that diabetes mellitus not only raises risk but also heightens mortality rate of cancer. It is not clear, however, whether antitumor CD8(+) cytotoxic T lymphocyte (CTL) response is down-modulated in diabetic hosts. We investigated the impact of hyperglycemia on CTLs' acquisition of tumor-killing capability by utilizing streptozotocin-induced diabetic (STZ-diabetic) mice. Murine diabetes was induced by intraperitoneal injection of STZ (200 mg/kg) in C57BL/6 mice, 2C-T cell receptor (TCR) transgenic and P14-TCR transgenic mice. The study found that, despite harboring intact proliferative capacity measured with CFSE labeling and MTT assay, STZ-diabetic CD8(+) CTLs displayed impaired effector functions. After stimulation, STZ-diabetic CD8(+) CTLs produced less perforin and TNF alpha assessed by intracellular staining, as well as expressed less CD103 protein. Furthermore, adoptive transfer of STZ-diabetic P14 CD8(+) effector cells showed an insufficient recruitment to the B16.gp33 melanoma and inadequate production of perforin, granzyme B and TNF alpha determined by immunohistochemistry in the tumor milieu. As a result, STZ-diabetic CD8(+) effector cells were neither able to eliminate tumor nor to improve survival of tumor-bearing mice. Taken together, our data suggest that CD8(+) CTLs are crippled to infiltrate into tumors and thus fail to acquire tumor-killing capability in STZ-diabetic hosts.	[Chen, Shu-Ching; Chang, Pei-Yu] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Su, Yu-Chia] Natl Lab Anim Ctr, Natl Appl Res Labs, Taipei, Taiwan; [Lu, Ya-Ting; Lin, Hung-Ju; Lai, Yo-Ping] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Ko, Patrick Chow-In] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Ho, Hong-Nerng] Natl Taiwan Univ, Coll Med, Dept Obstet & Gynecol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Applied Research Laboratories - Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Lai, YP (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	yopinglai@ntu.edu.tw	NTU, Ref07/AAX-7890-2021	Chen, Shu-Ching/0000-0001-9112-1526	National Science Council (NSC) [99-2314-B-002-081-MY3]; National Taiwan University Hospital (NTUH) [98P22]; Liver Disease Prevention and Treatment Research Foundation	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital (NTUH); Liver Disease Prevention and Treatment Research Foundation	The study was supported by grants from National Science Council (NSC 99-2314-B-002-081-MY3), National Taiwan University Hospital (NTUH. 98P22) and Liver Disease Prevention and Treatment Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anikeeva N, 2005, P NATL ACAD SCI USA, V102, P6437, DOI 10.1073/pnas.0502467102; BENTAL M, 1993, MAGN RESON MED, V29, P317, DOI 10.1002/mrm.1910290307; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Chen HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067420; Connolly GC, 2012, CANCER INVEST, V30, P698, DOI 10.3109/07357907.2012.732162; DELESPESSE G, 1974, CLIN EXP IMMUNOL, V18, P461; DEMARIA R, 1994, EUR J IMMUNOL, V24, P999; DIEPERSLOOT RJA, 1987, DIABETOLOGIA, V30, P397, DOI 10.1007/BF00292541; Eibl N, 2002, CLIN IMMUNOL, V103, P249, DOI 10.1006/clim.2002.5220; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Franciszkiewicz K, 2013, CANCER RES, V73, P617, DOI 10.1158/0008-5472.CAN-12-2569; Franciszkiewicz K, 2009, CANCER RES, V69, P6249, DOI 10.1158/0008-5472.CAN-08-3571; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Ganss R, 2002, CANCER RES, V62, P1462; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; JANEWAY CA, 1987, J IMMUNOL, V138, P1051; Johansson A, 2012, ONCOIMMUNOLOGY, V1, P1395, DOI 10.4161/onci.20981; Johansson A, 2012, P NATL ACAD SCI USA, V109, P7841, DOI 10.1073/pnas.1118296109; JUNOD A, 1969, J CLIN INVEST, V48, P2129, DOI 10.1172/JCI106180; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; KAKIUCHI T, 1983, J IMMUNOL, V131, P109; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Lai YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007766; LAVECCHIA C, 1991, EUR J CANCER, V27, P582, DOI 10.1016/0277-5379(91)90223-Z; Le Floc'h A, 2007, J EXP MED, V204, P559, DOI 10.1084/jem.20061524; Lyman MA, 2004, J IMMUNOL, V172, P6558, DOI 10.4049/jimmunol.172.11.6558; MacIver NJ, 2008, J LEUKOCYTE BIOL, V84, P949, DOI 10.1189/jlb.0108024; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; MAHMOUD AAF, 1976, J CLIN INVEST, V57, P362, DOI 10.1172/JCI108287; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Milstein O, 2011, BLOOD, V117, P1042, DOI 10.1182/blood-2010-05-283770; Naito Y, 1998, CANCER RES, V58, P3491; Prevost-Blondel A, 1998, J IMMUNOL, V161, P2187; RAKIETEN N, 1963, CANCER CHEMOTH REP, P91; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; Stattin P, 2007, DIABETES CARE, V30, P561, DOI 10.2337/dc06-0922; Stentz FB, 2003, CURR DRUG TARGETS, V4, P493, DOI 10.2174/1389450033490966; WILLIAMS JC, 1984, CANCER, V54, P3070, DOI 10.1002/1097-0142(19841215)54:12<3070::AID-CNCR2820541243>3.0.CO;2-N	39	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e109961	10.1371/journal.pone.0109961	http://dx.doi.org/10.1371/journal.pone.0109961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390652	Green Submitted, Green Published, gold			2022-12-27	WOS:000349144400008
J	Costa, A; Hortal, E; Ianez, E; Azorin, JM				Costa, Alvaro; Hortal, Enrique; Ianez, Eduardo; Azorin, Jose M.			A Supplementary System for a Brain-Machine Interface Based on Jaw Artifacts for the Bidimensional Control of a Robotic Arm	PLOS ONE			English	Article							COMPUTER-INTERFACE; POTENTIALS; BCI	Non-invasive Brain-Machine Interfaces (BMIs) are being used more and more these days to design systems focused on helping people with motor disabilities. Spontaneous BMIs translate user's brain signals into commands to control devices. On these systems, by and large, 2 different mental tasks can be detected with enough accuracy. However, a large training time is required and the system needs to be adjusted on each session. This paper presents a supplementary system that employs BMI sensors, allowing the use of 2 systems (the BMI system and the supplementary system) with the same data acquisition device. This supplementary system is designed to control a robotic arm in two dimensions using electromyographical (EMG) signals extracted from the electroencephalographical (EEG) recordings. These signals are voluntarily produced by users clenching their jaws. EEG signals (with EMG contributions) were registered and analyzed to obtain the electrodes and the range of frequencies which provide the best classification results for 5 different clenching tasks. A training stage, based on the 2-dimensional control of a cursor, was designed and used by the volunteers to get used to this control. Afterwards, the control was extrapolated to a robotic arm in a 2-dimensional workspace. Although the training performed by volunteers requires 70 minutes, the final results suggest that in a shorter period of time (45 min), users should be able to control the robotic arm in 2 dimensions with their jaws. The designed system is compared with a similar 2-dimensional system based on spontaneous BMIs, and our system shows faster and more accurate performance. This is due to the nature of the control signals. Brain potentials are much more difficult to control than the electromyographical signals produced by jaw clenches. Additionally, the presented system also shows an improvement in the results compared with an electrooculographic system in a similar environment.	[Costa, Alvaro; Hortal, Enrique; Ianez, Eduardo; Azorin, Jose M.] Miguel Hernandez Univ, Brain Machine Interface Syst Lab, Elche, Spain		Costa, A (corresponding author), Miguel Hernandez Univ, Brain Machine Interface Syst Lab, Elche, Spain.	acosta@umh.es	Azorin, Jose M/G-2157-2011; Iáñez, Eduardo/J-9765-2014; Hortal, Enrique/R-9176-2018; Azorin, Jose M./M-8956-2019	Azorin, Jose M/0000-0001-5548-9657; Iáñez, Eduardo/0000-0001-8057-5952; Hortal, Enrique/0000-0003-2119-4169; Azorin, Jose M./0000-0001-5548-9657	Commission of the European Union [IFP7-ICT- 2013-10-611695]	Commission of the European Union(European Commission)	This research has been funded by the Commission of the European Union under the BioMot project - Smart Wearable Robots with Bioinspired Sensory-Motor Skills (Grant Agreement number IFP7-ICT- 2013-10-611695). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi LZ, 2014, IEEE T INTELL TRANSP, V15, P959, DOI 10.1109/TITS.2013.2291402; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Daly I, 2013, IEEE T NEUR SYS REH, V21, P427, DOI 10.1109/TNSRE.2013.2254724; Dasey TJ, 2000, IEEE T INF TECHNOL B, V4, P216, DOI 10.1109/4233.870032; Duvinage M, 2012, IEEE ENG MED BIO, P3845, DOI 10.1109/EMBC.2012.6346806; Fatourechi M, 2007, CLIN NEUROPHYSIOL, V118, P480, DOI 10.1016/j.clinph.2006.10.019; Frisoli A, 2012, IEEE T SYST MAN CY C, V42, P1169, DOI 10.1109/TSMCC.2012.2226444; Fujita T, 2011, RES AUTISM SPECT DIS, V5, P277, DOI 10.1016/j.rasd.2010.04.009; Guger C, 2000, IEEE T REHABIL ENG, V8, P447, DOI 10.1109/86.895947; Hamadicharef Brahim, 2010, 2010 10th International Conference on Information Sciences, Signal Processing and their Applications (ISSPA 2010), P626, DOI 10.1109/ISSPA.2010.5605421; HJORTH B, 1975, ELECTROEN CLIN NEURO, V39, P526, DOI 10.1016/0013-4694(75)90056-5; Hortal E, 2014, COMPUTER METHODS PRO; Huang DD, 2012, IEEE T NEUR SYS REH, V20, P379, DOI 10.1109/TNSRE.2012.2190299; Ianez Eduardo, 2013, Natural and Artificial Models in Computation and Biology. 5th International Work-Conference on the Interplay Between Natural and Artificial Computation, IWINAC 2013. Proceedings, Part I: LNCS 7930, P151, DOI 10.1007/978-3-642-38637-4_16; Marshall D, 2013, IEEE T COMP INTEL AI, V5, P82, DOI 10.1109/TCIAIG.2013.2263555; Nakamae T, 2010, EUR SPINE J, V19, P685, DOI 10.1007/s00586-009-1246-8; Postelnicu CC, 2013, IEEE T BIO-MED ENG, V60, P534, DOI 10.1109/TBME.2012.2228645; Roy RN, 2013, IEEE ENG MED BIO, P6607, DOI 10.1109/EMBC.2013.6611070; Ruth R, 1991, OTOLARYNGOLOGIC CLIN, V24; Savelainen A., 2010, INDEPENDENT RES PROJ; Blasco JLS, 2012, EXPERT SYST APPL, V39, P7908, DOI 10.1016/j.eswa.2012.01.110; SOKOL S, 1976, Survey of Ophthalmology, V21, P18, DOI 10.1016/0039-6257(76)90046-1; Takahashi K, 2005, 2005 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATIONS, VOLS 1-4, CONFERENCE PROCEEDINGS, P999; Trejo LJ, 2006, IEEE T NEUR SYS REH, V14, P225, DOI 10.1109/TNSRE.2006.875578; Ubeda A, 2011, IEEE-ASME T MECH, V16, P870, DOI 10.1109/TMECH.2011.2160354; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Volosyak I, 2010, IEEE ENG MED BIO, P4201, DOI 10.1109/IEMBS.2010.5627390; YONG XY, 2008, COMM CONTR SIGN PROC, P729, DOI DOI 10.1109/ISCCSP.2008.4537319	28	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112352	10.1371/journal.pone.0112352	http://dx.doi.org/10.1371/journal.pone.0112352			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390372	Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400073
J	Feyissa, TR; Melka, AS				Feyissa, Tesfaye Regassa; Melka, Alemu Sufa			Demand for Modern Family Planning among Married Women Living with HIV in Western Ethiopia	PLOS ONE			English	Article							UNMET NEED; INFECTION	Introduction: People living with HIV (PLHIV) have diverse family planning (FP) needs. Little is reported on FP needs among women living with HIV in Ethiopia. Thus, the objective of the study was to assess the demand for modern FP among married women living with HIV in western Ethiopia. Methods: A facility-based cross-sectional survey was conducted on 401 married women living with HIV selected from Nekemte Referral Hospital and Health Center, Nekemte, Oromia, Ethiopia. Convenience sampling of every other eligible patient was used to recruit respondents. Data were collected using a pretested, structured questionnaire. We first calculated frequency and percentage of unmet need, met need and total demand by each explanatory variable, and performed chi-squared testing to assess for differences in groups. We then fitted logistic regression models to identify correlates of unmet need for modern FP at 95% CL. Results: The proportion of respondents with met need for modern FP among married women living with HIV was 61.6% (30.7% for spacing and 30.9% for limiting). Demand for family planning was reported in 77.0% (38.2% for spacing and 38.8% for limiting), making unmet need for modern FP prevalent in 15.4% (7.5% for spacing and 7.9% for limiting). Whereas age 25-34 years [adjusted odds ratio (AOR) (95% confidence interval (CI)) = .397 (.204-.771)] was protective against unmet need for modern FP, not having knowledge of MTCT [AOR (95% CI) = 2.531 (1.689-9.290)] and not discussing FP with a partner [AOR (95% CI) = 3.616(1.869-6.996)] were associated with increased odds of unmet need for modern FP. Conclusions: There is high unmet need for modern FP in HIV-positive married women in western Ethiopia. Health care providers and program managers at a local and international level should work to satisfy the unmet need for modern family planning.	[Feyissa, Tesfaye Regassa; Melka, Alemu Sufa] Wollega Univ, Coll Med & Hlth Sci, Nekemte, Oromia, Ethiopia	University of Gondar	Feyissa, TR (corresponding author), Wollega Univ, Coll Med & Hlth Sci, Nekemte, Oromia, Ethiopia.	regassatesfaye@gmail.com	Feyissa, Tesfaye R/K-1003-2017	Feyissa, Tesfaye Regassa/0000-0002-6883-7312	Wollega University	Wollega University	This study was supported by Wollega University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe M, 2012, SCI TECHNOLOGY ARTS, V1, P38; Adir T, 2007, DESIRE CHILDREN UNME; Agboghoroma Chris O, 2011, Afr J Reprod Health, V15, P15; Akelo V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066593; Ali AAA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-102; Baroncelli S, 2011, AIDS PATIENT CARE ST, V25, P639, DOI 10.1089/apc.2011.0172; Bizuneh G, 2008, UNMET NEED EVALUATIO, P9; Bradley SEK, 2012, REVISING UNMET NEED, P3; Cooper D, 2009, AIDS BEHAV, V13, pS38, DOI 10.1007/s10461-009-9550-1; Delvaux T, 2007, REPROD HEALTH MATTER, V15, P46, DOI 10.1016/S0968-8080(07)29031-7; FHAPCO, 2011, HIV AIDS EST PROJ ET, P1; Finocchario-Kessler S, 2010, AIDS PATIENT CARE ST, V24, P317, DOI 10.1089/apc.2009.0293; Halperin DT, 2009, AIDS, V23, pS123, DOI 10.1097/01.aids.0000363785.73450.5a; Hladik W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007691; Jhangri GS, 2012, J FAM PLAN REPROD H, V38, P23, DOI 10.1136/jfprhc-2011-0108; Mccoy SI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105320; Mekonnen W, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-37; MOH, 2011, GUID PREV MOTH CHILD, P3; MOH, 2007, GUID PREV MOTH TO CH; Oliveras E, 2013, ADDRESSING UNMET NEE, P6; Yeatman S, 2009, STUD FAMILY PLANN, V40, P261, DOI 10.1111/j.1728-4465.2009.00210.x; Yeatman SE, 2009, AIDS BEHAV, V13, pS12, DOI 10.1007/s10461-009-9534-1	22	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e113008	10.1371/journal.pone.0113008	http://dx.doi.org/10.1371/journal.pone.0113008			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CP	25390620	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400146
J	Mastrogiacomo, R; D'Ambrosio, C; Niccolini, A; Serra, A; Gazzano, A; Scaloni, A; Pelosi, P				Mastrogiacomo, Rosa; D'Ambrosio, Chiara; Niccolini, Alberto; Serra, Andrea; Gazzano, Angelo; Scaloni, Andrea; Pelosi, Paolo			An Odorant-Binding Protein Is Abundantly Expressed in the Nose and in the Seminal Fluid of the Rabbit	PLOS ONE			English	Article							MAJOR URINARY PROTEIN; BOAR SALIVARY LIPOCALIN; LIGAND-BINDING; NASAL-MUCOSA; POSTTRANSLATIONAL MODIFICATIONS; DIFFERENTIAL EXPRESSION; PERIRECEPTOR EVENTS; OLFACTORY RECEPTOR; PHEROMONE BINDING; MASS-SPECTROMETRY	We have purified an abundant lipocalin from the seminal fluid of the rabbit, which shows significant similarity with the subclass of pheromone carriers "urinary" and "salivary" and presents an N-terminal sequence identical with that of an odorant-binding protein (rabOBP3) expressed in the nasal tissue of the same species. This protein is synthesised in the prostate and found in the seminal fluid, but not in sperm cells. The same protein is also expressed in the nasal epithelium of both sexes, but is completely absent in female reproductive organs. It presents four cysteines, among which two are arranged to form a disulphide bridge, and is glycosylated. This is the first report of an OBP identified at the protein level in the seminal fluid of a vertebrate species. The protein purified from seminal fluid is bound to some organic chemicals whose structure is currently under investigation. We reasonably speculate that, like urinary and salivary proteins reported in other species of mammals, this lipocalin performs a dual role, as carrier of semiochemicals in the seminal fluid and as detector of chemical signals in the nose.	[Mastrogiacomo, Rosa; Serra, Andrea; Pelosi, Paolo] Univ Pisa, Dept Agr Food & Environm, Pisa, Italy; [D'Ambrosio, Chiara; Scaloni, Andrea] CNR, ISPAAM, Prote & Mass Spectrometry Lab, I-80125 Naples, Italy; [Niccolini, Alberto; Gazzano, Angelo] Univ Pisa, Dept Vet Sci, Pisa, Italy	University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto Per Il Sistema Produzione Animale In Ambiente Mediterraneo (ISPAAM-CNR); University of Pisa	Scaloni, A (corresponding author), CNR, ISPAAM, Prote & Mass Spectrometry Lab, I-80125 Naples, Italy.	andrea.scaloni@ispaam.cnr.it; ppelosi@agr.unipi.it	Gazzano, Angelo/AAH-1640-2020; Rocco, Patricia/I-7460-2012; D'Ambrosio, Chiara/C-2753-2012; Serra, Andrea/AFO-7144-2022	Gazzano, Angelo/0000-0001-9649-2027; Rocco, Patricia/0000-0003-1412-7136; D'Ambrosio, Chiara/0000-0003-2810-9270; Serra, Andrea/0000-0001-7728-3430; Scaloni, Andrea/0000-0001-9362-8515; NICCOLINI MARMONT DU HAUT CHAMP, CARLO ALBERTO/0000-0003-4726-9747				AVANZINI F, 1987, CELL TISSUE RES, V247, P461, DOI 10.1007/BF00218329; BACCHINI A, 1992, EXPERIENTIA, V48, P419, DOI 10.1007/BF01923448; BIGNETTI E, 1985, EUR J BIOCHEM, V149, P227, DOI 10.1111/j.1432-1033.1985.tb08916.x; Blanchet MA, 1996, NAT STRUCT BIOL, V3, P934, DOI 10.1038/nsb1196-934; BOCSKEI Z, 1992, NATURE, V360, P186, DOI 10.1038/360186a0; Briand L, 2002, BIOCHEMISTRY-US, V41, P7241, DOI 10.1021/bi015916c; CAVAGGIONI A, 1990, COMP BIOCHEM PHYS B, V96, P513, DOI 10.1016/0305-0491(90)90049-Y; CAVAGGIONI A, 1987, FEBS LETT, V212, P225, DOI 10.1016/0014-5793(87)81349-2; Charra R, 2012, BEHAV BRAIN RES, V226, P179, DOI 10.1016/j.bbr.2011.09.008; D'Innocenzo B, 2006, BIOCHEMISTRY-US, V45, P13418, DOI 10.1021/bi061409p; Dal Monte M, 1993, CHEM SENSES, V18, P713; Dal Monte M, 1991, COMP BIOCHEM PHYS B, V99, P445, DOI 10.1016/0305-0491(91)90068-O; DINH BAO-LMH, 1965, J IMMUNOL, V95, P574; FINLAYSON JS, 1965, SCIENCE, V149, P981, DOI 10.1126/science.149.3687.981; Flower DR, 1996, BIOCHEM J, V318, P1; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P46, DOI 10.1016/S0167-4838(00)00147-3; Ganni M, 1997, COMP BIOCHEM PHYS B, V117, P287, DOI 10.1016/S0305-0491(97)00089-8; Garibotti M, 1997, CHEM SENSES, V22, P383, DOI 10.1093/chemse/22.4.383; Herent MF, 1995, CHEM SENSES, V20, P601, DOI 10.1093/chemse/20.6.601; Hilger C, 2012, CURR ALLERGY ASTHM R, V12, P438, DOI 10.1007/s11882-012-0283-2; Hilvo M, 2008, J BIOL CHEM, V283, P27799, DOI 10.1074/jbc.M800938200; Hurst JL, 2001, NATURE, V414, P631, DOI 10.1038/414631a; Lacazette E, 2000, HUM MOL GENET, V9, P289, DOI 10.1093/hmg/9.2.289; Lobel D, 1998, EUR J BIOCHEM, V254, P318, DOI 10.1046/j.1432-1327.1998.2540318.x; Loebel D, 2000, BIOCHEM J, V350, P369, DOI 10.1042/0264-6021:3500369; Marchese S, 1998, EUR J BIOCHEM, V252, P563, DOI 10.1046/j.1432-1327.1998.2520563.x; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; Mechref Y, 2000, GLYCOBIOLOGY, V10, P231, DOI 10.1093/glycob/10.3.231; Millery J, 2005, EUR J NEUROSCI, V22, P1389, DOI 10.1111/j.1460-9568.2005.04337.x; MIYAWAKI A, 1994, EMBO J, V13, P5835, DOI 10.1002/j.1460-2075.1994.tb06927.x; MONACO HL, 1995, SCIENCE, V268, P1039, DOI 10.1126/science.7754382; Ohno K, 1996, NEUROSCIENCE, V71, P355, DOI 10.1016/0306-4522(95)00454-8; Paolini S, 1998, CHEM SENSES, V23, P689, DOI 10.1093/chemse/23.6.689; PELOSI P, 1982, BIOCHEM J, V201, P245, DOI 10.1042/bj2010245; Pelosi P, 2001, CELL MOL LIFE SCI, V58, P503, DOI 10.1007/PL00000875; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pelosi P, 1996, J NEUROBIOL, V30, P3; PELOSI P, 1994, CRIT REV BIOCHEM MOL, V29, P199, DOI 10.3109/10409239409086801; Pelosi P, 1998, ANN NY ACAD SCI, V855, P281, DOI 10.1111/j.1749-6632.1998.tb10584.x; PELOSI P, 1981, CHEM SENSES, V6, P77, DOI 10.1093/chemse/6.2.77; Perez-Miller S, 2010, PROTEIN SCI, V19, P1469, DOI 10.1002/pro.426; PES D, 1995, COMP BIOCHEM PHYS B, V112, P471, DOI 10.1016/0305-0491(95)00063-1; Pes D, 1998, GENE, V212, P49, DOI 10.1016/S0378-1119(98)00131-0; PEVSNER J, 1990, J BIOL CHEM, V265, P6118; PEVSNER J, 1985, P NATL ACAD SCI USA, V82, P3050, DOI 10.1073/pnas.82.9.3050; PEVSNER J, 1988, P NATL ACAD SCI USA, V85, P2383, DOI 10.1073/pnas.85.7.2383; Picariello G, 2008, PROTEOMICS, V8, P3833, DOI 10.1002/pmic.200701057; ROBERTSON DHL, 1993, J CHEM ECOL, V19, P1405, DOI 10.1007/BF00984885; Rouvinen J, 1999, J BIOL CHEM, V274, P2337, DOI 10.1074/jbc.274.4.2337; Salzano AM, 2013, J PROTEOMICS, V94, P240, DOI 10.1016/j.jprot.2013.09.007; Sawyer L, 2000, BBA-PROTEIN STRUCT M, V1482, P136, DOI 10.1016/S0167-4838(00)00160-6; Scaloni A, 1999, BIOCHEM BIOPH RES CO, V266, P386, DOI 10.1006/bbrc.1999.1791; Schaal B, 2003, NATURE, V424, P68, DOI 10.1038/nature01739; SINGER AG, 1986, J BIOL CHEM, V261, P3323; Spinelli S, 2002, EUR J BIOCHEM, V269, P2449, DOI 10.1046/j.1432-1033.2002.02901.x; Spinelli S, 1998, BIOCHEMISTRY-US, V37, P7913, DOI 10.1021/bi980179e; Sun YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030040; Sun YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032759; Swarup S, 2011, GENES BRAIN BEHAV, V10, P648, DOI 10.1111/j.1601-183X.2011.00704.x; Tegoni M, 2000, BBA-PROTEIN STRUCT M, V1482, P229, DOI 10.1016/S0167-4838(00)00167-9; Tegoni M, 1996, NAT STRUCT BIOL, V3, P863, DOI 10.1038/nsb1096-863; Vincent F, 2004, EUR J BIOCHEM, V271, P3832, DOI 10.1111/j.1432-1033.2004.04315.x; Vincent F, 2001, J MOL BIOL, V305, P459, DOI 10.1006/jmbi.2000.4241; Vincent F, 2000, J MOL BIOL, V300, P127, DOI 10.1006/jmbi.2000.3820; Virtanen T, 2012, CLIN EXP ALLERGY, V42, P494, DOI 10.1111/j.1365-2222.2011.03903.x; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031	66	25	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111932	10.1371/journal.pone.0111932	http://dx.doi.org/10.1371/journal.pone.0111932			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391153	Green Submitted, Green Published, gold			2022-12-27	WOS:000349144400040
J	Paladini, F; Porciello, N; Camilli, G; Tuncer, S; Cocco, E; Fiorillo, MT; Sorrentino, R				Paladini, Fabiana; Porciello, Nicla; Camilli, Giorgio; Tuncer, Sinem; Cocco, Elisa; Fiorillo, Maria Teresa; Sorrentino, Rosa			Single Nucleotide Polymorphisms in the 3 ' UTR of VPAC-1 Cooperate in Modulating Gene Expression and Impact Differently on the Interaction with miR525-5p	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; CYCLASE-ACTIVATING PROTEIN; 3' UNTRANSLATED REGIONS; RECEPTOR 1 GENE; DEPENDENT ASSOCIATION; EMERGING ROLES; DISEASE; NEUROPEPTIDE; AUTOIMMUNE; CELLS	Complex immune and neurodegenerative disorders are the result of multiple interactions between common genetic variations having, individually, a weak effect on the disease susceptibility or resistance. Interestingly, some genes have been found to be associated with more than one disease although not necessarily the same SNPs are involved. In this context, single nucleotide polymorphisms in the 3'UTR region of type 1 receptor (VPAC-1) for vasoactive intestinal peptide (VIP) have been reported to be associated with some immune-mediated as well as with neurodegenerative diseases such as Alzheimer's Disease (AD). Here, we demonstrate that variations at the 3'UTR of the VPAC-1 gene act synergistically to affect the expression of the luciferase as well as of the GFP reporter genes expressed in HEK293T cells. Moreover, the miRNA 525-5p, previously shown by us to target the 3'UTR of VPAC-1, is more efficient in decreasing GFP expression when co-expressed with constructs carrying the allele C at rs896 (p<10(-3)) suggesting that this miRNA regulates VPAC-1 expression at different levels depending on rs896 polymorphism and thus adding complexity to the network of disease susceptibility.	[Paladini, Fabiana; Porciello, Nicla; Camilli, Giorgio; Tuncer, Sinem; Cocco, Elisa; Fiorillo, Maria Teresa; Sorrentino, Rosa] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, I-00185 Rome, Italy	Sapienza University Rome	Paladini, F (corresponding author), Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	fabiana.paladini@uniroma1.it	Porciello, Nicla/AHH-2927-2022; Tunçer, Sinem/AAF-5871-2021; Sorrentino, Rosa/G-5472-2012	Tunçer, Sinem/0000-0002-8947-8646; Sorrentino, Rosa/0000-0002-9632-2383; Camilli, Giorgio/0000-0002-6662-0072; FIORILLO, Maria Teresa/0000-0002-6859-5851; Porciello, Nicla/0000-0002-5603-4408; Paladini, Fabiana/0000-0003-1040-452X	Istituto Pasteur-Fondazione Cenci- Bolognetti; Sapienza University of Rome through "Progetti di Ateneo" [C26A13RJ5WC26A13RJ5W]	Istituto Pasteur-Fondazione Cenci- Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Sapienza University of Rome through "Progetti di Ateneo"	This work was supported by Istituto Pasteur-Fondazione Cenci- Bolognetti and by Sapienza University of Rome through "Progetti di Ateneo" (C26A13RJ5WC26A13RJ5W). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad C, 2003, GASTROENTEROLOGY, V124, P961, DOI 10.1053/gast.2003.50141; Choi JY, 2007, J CLIN INVEST, V117, P3118, DOI 10.1172/JCI31992; Chorny A, 2008, AM J PATHOL, V172, P1297, DOI 10.2353/ajpath.2008.070969; Cocco E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012067; Couvineau A, 2012, FRONT ENDOCRINOL LAU, V16, P139; Delgado M, 1999, J BIOL CHEM, V274, P31930, DOI 10.1074/jbc.274.45.31930; Delgado M, 2003, FASEB J, V17, P944, DOI 10.1096/fj.02-0799fje; Delgado M, 2004, PHARMACOL REV, V56, P249, DOI 10.1124/pr.56.2.7; Delgado M, 2001, NAT MED, V7, P563, DOI 10.1038/87887; Delgado M, 2008, ARTHRITIS RHEUM-US, V58, P1010, DOI 10.1002/art.23482; Delgado M, 2013, AMINO ACIDS, V45, P25, DOI 10.1007/s00726-011-1184-8; Dorsam G, 2000, ANN NY ACAD SCI, V921, P79; El Zein N, 2007, CELL SIGNAL, V19, P152, DOI 10.1016/j.cellsig.2006.05.031; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Gonzalez-Rey E, 2006, AM J PATHOL, V168, P1179, DOI 10.2353/ajpath.2006.051081; Gonzalez-Rey E, 2006, GASTROENTEROLOGY, V131, P1799, DOI 10.1053/j.gastro.2006.10.023; Gonzalez-Rey E, 2007, ANN RHEUM DIS, V66, P70, DOI 10.1136/ard.2007.078519; Harfi I, 2005, J IMMUNOL, V175, P4091, DOI 10.4049/jimmunol.175.6.4091; Herrera JL, 2006, ANN NY ACAD SCI, V1070, P337, DOI 10.1196/annals.1317.041; Lara-Marquez ML, 2001, J IMMUNOL, V166, P2522, DOI 10.4049/jimmunol.166.4.2522; Li J, 2013, CANCER LETT, V337, P22, DOI 10.1016/j.canlet.2013.05.034; Lodde BM, 2006, ANN RHEUM DIS, V65, P195, DOI 10.1136/ard.2005.038232; Martin B, 2005, NEUROMOL MED, V7, P3, DOI 10.1385/NMM:7:1-2:003; Michalova E, 2013, INT J MOL SCI, V14, P15681, DOI 10.3390/ijms140815681; Nunan R, 2014, GLIA, V62, P1313, DOI 10.1002/glia.22682; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; Paladini F, 2009, NEUROGASTROENT MOTIL, V21, P597, DOI 10.1111/j.1365-2982.2009.01284.x; Paladini F, 2008, GENES IMMUN, V9, P659, DOI 10.1038/gene.2008.60; Paladini F, 2012, GENE, V493, P278, DOI 10.1016/j.gene.2011.11.055; Prasse A, 2010, AM J RESP CRIT CARE, V182, P540, DOI 10.1164/rccm.200909-1451OC; Ramirez-Bello J, 2013, GAC MED MEX, V149, P220; Sorrentino R, 2014, IMMUNOL LETT, V158, P116, DOI 10.1016/j.imlet.2013.12.005; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhang WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031429	34	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112646	10.1371/journal.pone.0112646	http://dx.doi.org/10.1371/journal.pone.0112646			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390694	Green Submitted, Green Published, gold			2022-12-27	WOS:000349144400116
J	Cameron, EG; Robinson, PR				Cameron, Evan G.; Robinson, Phyllis R.			beta-Arrestin-Dependent Deactivation of Mouse Melanopsin	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; PROTEIN-COUPLED RECEPTORS; VISUAL ARRESTIN; 7-TRANSMEMBRANE RECEPTORS; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; LIGHT; RHODOPSIN; BINDING; ENDOCYTOSIS	In mammals, the expression of the unusual visual pigment, melanopsin, is restricted to a small subset of intrinsically photosensitive retinal ganglion cells (ipRGCs), whose signaling regulate numerous non-visual functions including sleep, circadian photoentrainment and pupillary constriction. IpRGCs exhibit attenuated electrical responses following sequential and prolonged light exposures indicative of an adaptational response. The molecular mechanisms underlying deactivation and adaptation in ipRGCs however, have yet to be fully elucidated. The role of melanopsin phosphorylation and beta-arrestin binding in this adaptive process is suggested by the phosphorylation-dependent reduction of melanopsin signaling in vitro and the ubiquitous expression of beta-arrestin in the retina. These observations, along with the conspicuous absence of visual arrestin in ipRGCs, suggest that a beta-arrestin terminates melanopsin signaling. Here, we describe a light-and phosphorylation-dependent reduction in melanopsin signaling mediated by both beta-arrestin 1 and beta-arrestin 2. Using an in vitro calcium imaging assay, we demonstrate that increasing the cellular concentration of beta-arrestin 1 and beta-arrestin 2 significantly increases the rate of deactivation of light-activated melanopsin in HEK293 cells. Furthermore, we show that this response is dependent on melanopsin carboxyl-tail phosphorylation. Crosslinking and co-immunoprecipitation experiments confirm beta-arrestin 1 and beta-arrestin 2 bind to melanopsin in a light-and phosphorylation-dependent manner. These data are further supported by proximity ligation assays (PLA), which demonstrate a melanopsin/beta-arrestin interaction in HEK293 cells and ipRGCs. Together, these results suggest that melanopsin signaling is terminated in a light-and phosphorylation-dependent manner through the binding of a beta-arrestin within the retina.	[Cameron, Evan G.; Robinson, Phyllis R.] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA	University System of Maryland; University of Maryland Baltimore County	Robinson, PR (corresponding author), Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA.	probinso@umbc.edu			National Institute of Health [RO1EY019053, NIH/NIGMS T32GM066706]; NATIONAL EYE INSTITUTE [R01EY019053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066706] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by PRR, National Institute of Health RO1EY019053, EGC, National Institute of Health training grant NIH/NIGMS T32GM066706. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Blasic JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045387; Blasic JR, 2012, CELL MOL LIFE SCI, V69, P1551, DOI 10.1007/s00018-011-0891-3; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Defea K, 2008, BRIT J PHARMACOL, V153, pS298, DOI 10.1038/sj.bjp.0707508; Do MTH, 2013, P NATL ACAD SCI USA, V110, P7470, DOI 10.1073/pnas.1304039110; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Giesbers ME, 2008, PHOTOCHEM PHOTOBIOL; Gooley JJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000741; Graham DM, 2008, J NEUROPHYSIOL, V99, P2522, DOI 10.1152/jn.01066.2007; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; GUREVICH VV, 1994, J BIOL CHEM, V269, P8721; Gurevich VV, 1997, MOL PHARMACOL, V51, P161, DOI 10.1124/mol.51.1.161; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; HODGES RS, 1988, J BIOL CHEM, V263, P11768; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Leuchowius K., 2011, CURR PROTOC CYTOM, V56, P9, DOI [10.1002/0471142956.cy0936s56, DOI 10.1002/0471142956.CY0936S56]; Lucas RJ, 2013, CURR BIOL, V23, pR125, DOI 10.1016/j.cub.2012.12.029; Luttrell LM, 2008, MOL BIOTECHNOL, V39, P239, DOI 10.1007/s12033-008-9031-1; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Pal K, 2013, J BIOL CHEM, V288, P3265, DOI 10.1074/jbc.M112.400234; Porter ML, 2012, P ROY SOC B-BIOL SCI, V279, P3, DOI 10.1098/rspb.2011.1819; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sand A, 2012, PROG RETIN EYE RES, V31, P287, DOI 10.1016/j.preteyeres.2012.03.003; Schmidt TM, 2009, J NEUROSCI, V29, P476, DOI 10.1523/JNEUROSCI.4117-08.2009; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Tsai JW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000125; Warren EJ, 2006, EUR J NEUROSCI, V23, P2477, DOI 10.1111/j.1460-9568.2006.04777.x; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Wong KY, 2012, J NEUROSCI, V32, P11478, DOI 10.1523/JNEUROSCI.1423-12.2012; Wong KY, 2005, NEURON, V48, P1001, DOI 10.1016/j.neuron.2005.11.016; Xue YK, 2010, CLIM DYNAM, V35, P1, DOI 10.1007/s00382-010-0831-1; Zhang J, 1999, J BIOL CHEM, V274, P10999, DOI 10.1074/jbc.274.16.10999	45	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113138	10.1371/journal.pone.0113138	http://dx.doi.org/10.1371/journal.pone.0113138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401926	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700116
J	Lai, CK; Moon, Y; Kuchenbauer, F; Starzcynowski, DT; Argiropoulos, B; Yung, E; Beer, P; Schwarzer, A; Sharma, A; Park, G; Leung, M; Lin, G; Vollett, S; Fung, S; Eaves, CJ; Karsan, A; Weng, AP; Humphries, RK; Heuser, M				Lai, Courteney K.; Moon, Yeonsook; Kuchenbauer, Florian; Starzcynowski, Daniel T.; Argiropoulos, Bob; Yung, Eric; Beer, Philip; Schwarzer, Adrian; Sharma, Amit; Park, Gyeongsin; Leung, Malina; Lin, Grace; Vollett, Sarah; Fung, Stephen; Eaves, Connie J.; Karsan, Aly; Weng, Andrew P.; Humphries, R. Keith; Heuser, Michael			Cell Fate Decisions in Malignant Hematopoiesis: Leukemia Phenotype Is Determined by Distinct Functional Domains of the MN1 Oncogene	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; GENE-EXPRESSION; STEM-CELLS; FUSION GENE; MUTATIONS; OVEREXPRESSION; IDENTIFICATION; REVEALS; CANCER; MODEL	Extensive molecular profiling of leukemias and preleukemic diseases has revealed that distinct clinical entities, like acute myeloid (AML) and T-lymphoblastic leukemia (T-ALL), share similar pathogenetic mutations. It is not well understood how the cell of origin, accompanying mutations, extracellular signals or structural differences in a mutated gene determine the phenotypic identity of leukemias. We dissected the functional aspects of different protein regions of the MN1 oncogene and their effect on the leukemic phenotype, building on the ability of MN1 to induce leukemia without accompanying mutations. We found that the most C-terminal region of MN1 was required to block myeloid differentiation at an early stage, and deletion of an extended C-terminal region resulted in loss of myeloid identity and cell differentiation along the T-cell lineage in vivo. Megakaryocytic/erythroid lineage differentiation was blocked by the N-terminal region. In addition, the N-terminus was required for proliferation and leukemogenesis in vitro and in vivo through upregulation of HoxA9, HoxA10 and Meis2. Our results provide evidence that a single oncogene can modulate cellular identity of leukemic cells based on its active gene regions. It is therefore likely that different mutations in the same oncogene may impact cell fate decisions and phenotypic appearance of malignant diseases.	[Lai, Courteney K.; Yung, Eric; Beer, Philip; Leung, Malina; Lin, Grace; Vollett, Sarah; Fung, Stephen; Eaves, Connie J.; Weng, Andrew P.; Humphries, R. Keith] BC Canc Agcy Res Ctr, Terry Fox Lab, Vancouver, BC, Canada; [Lai, Courteney K.; Eaves, Connie J.; Humphries, R. Keith] Univ British Columbia, Fac Med, Dept Med, Vancouver, BC, Canada; [Moon, Yeonsook] Inha Univ, Sch Med, Dept Lab Med, Inchon, South Korea; [Kuchenbauer, Florian] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany; [Kuchenbauer, Florian] Univ Hosp Ulm, Ctr Comprehens Canc, Inst Expt Canc Res, Ulm, Germany; [Starzcynowski, Daniel T.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Argiropoulos, Bob] Univ Calgary, Dept Med Genet, Calgary, AB, Canada; [Schwarzer, Adrian; Sharma, Amit] Hannover Med Sch, Inst Expt Hematol, Hannover, Germany; [Park, Gyeongsin] Catholic Univ Korea, Dept Hosp Pathol, Seoul, South Korea; [Karsan, Aly] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC, Canada; [Karsan, Aly; Weng, Andrew P.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Heuser, Michael] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany	University of British Columbia; Inha University; Ulm University; Ulm University; Cincinnati Children's Hospital Medical Center; University of Calgary; Hannover Medical School; Catholic University of Korea; British Columbia Cancer Agency; University of British Columbia; Hannover Medical School	Humphries, RK (corresponding author), BC Canc Agcy Res Ctr, Terry Fox Lab, Vancouver, BC, Canada.	khumphri@bccrc.ca	Schwarzer, Adrian/AAA-2571-2022; Karsan, Aly/K-2067-2015; Heuser, Michael/S-2363-2017	Heuser, Michael/0000-0001-5318-9044; Eaves, Connie/0000-0002-3452-1926; Humphries, Richard/0000-0003-0540-7005; Schwarzer, Adrian/0000-0001-5684-2280; Beer, Philip/0000-0003-3056-5419; Kuchenbauer, Florian/0000-0002-9820-3409; Yung, Eric/0000-0002-7328-7204	Terry Fox Foundation, Canada [18006, 122869]; Cancer Research Society, Canada; Stem Cell Network of Canada; Deutsche Krebshilfe e.V [109003, 110284, 110292, 111267]; Deutsche-Jose-Carreras Leukamie-Stiftung e.V [DJCLS H09/1f, R 10/22, R13/14]; H. W. & J. Hector Stiftung [M 47.1]; German Federal Ministry of Education and Research [01EO0802 (IFB-Tx)]; DFG [HE 5240/4-1, HE 5240/5-1]; Canadian Institute of Health Research; University of British Columbia; BC Cancer Agency; Deutsche Krebshilfe [109420]; European Hematology Association [2010/04]; Deutsche Forschungsgemeinschaft [D.3955, SFB 1074]; Kay Kendall Leukaemia Fund; BC Cancer Studentship from the BC Cancer Agency	Terry Fox Foundation, Canada; Cancer Research Society, Canada; Stem Cell Network of Canada; Deutsche Krebshilfe e.V(Deutsche Krebshilfe); Deutsche-Jose-Carreras Leukamie-Stiftung e.V; H. W. & J. Hector Stiftung; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); University of British Columbia; BC Cancer Agency; Deutsche Krebshilfe(Deutsche Krebshilfe); European Hematology Association; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Kay Kendall Leukaemia Fund; BC Cancer Studentship from the BC Cancer Agency	This study was supported by grants from the Terry Fox Foundation, Canada (http://www.terryfox.org/TerryFox/The_Terry_Fox_Foundation.html) (grant Nos. 18006 and 122869), the Cancer Research Society, Canada (http://www.crs-src.ca/), the Stem Cell Network of Canada (http://www.stemcellnetwork.ca/index.php?page = funding-opportunities), Deutsche Krebshilfe e.V (grant No. 109003, 110284, 110292, and 111267) (http://www.krebshilfe.de/metanavigation/english.html), grant No. DJCLS H09/1f, R 10/22, and R13/14 from the Deutsche-Jose-Carreras Leukamie-Stiftung e.V (http://www.carreras-stiftung.de/); grant No. M 47.1 from the H. W. & J. Hector Stiftung (http://www.hector-stiftung.de/), the German Federal Ministry of Education and Research grant 01EO0802 (IFB-Tx) (http://www.bmbf.de/en/14580.php), and DFG grants HE 5240/4-1, HE 5240/5-1 (http://www.dfg.de/en/research_funding/programmes/individual/research_grants/). CKL was supported by studentships from the Canadian Institute of Health Research (http://www.cihr-irsc.gc.ca/e/193.html#), the University of British Columbia (https://www.grad.ubc.ca/awards/four-year-doctoral-fellowship-4yf), and the BC Cancer Agency (http://www.bccancer.bc.ca/default.htm). FK was supported by grants from Deutsche Krebshilfe grant 109420 (Max-Eder program) (http://www.krebshilfe.de/metanavigation/english.html); fellowship 2010/04 by the European Hematology Association (http://www.ehaweb.org/career/career-development-grants/eha-research-fellowships-and-the-jose-carreras-foundation-eha-young-investigator-fellowship/); and by the Deutsche Forschungsgemeinschaft (grant D.3955 (SFB 1074)) (http://www.dfg.de/en/research_funding/programmes/individual/). PB was supported by an intermediate fellowship from the Kay Kendall Leukaemia Fund (http://www.kklf.org.uk/intermediate.html). GL was supported by a BC Cancer Studentship from the BC Cancer Agency (http://www.bccancer.bc.ca/default.htm). SV was supported by a studentship from the Stem Cell Network of Canada (http://www.stemcellnetwork.ca/index.php?page = co-op-award). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Bruce MA, 2013, OPT EXPRESS, V21, P4766, DOI 10.1364/OE.21.004766; BUIJS A, 1995, ONCOGENE, V10, P1511; Burnett AK, 2010, BLOOD, V115, P948, DOI 10.1182/blood-2009-08-236588; Carella C, 2007, LEUKEMIA, V21, P1679, DOI 10.1038/sj.leu.2404778; Deshpande AJ, 2006, CANCER CELL, V10, P363, DOI 10.1016/j.ccr.2006.08.023; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Funnell APW, 2012, MOL CELL BIOL, V32, P3281, DOI 10.1128/MCB.00173-12; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilliland DG, 2001, CURR OPIN HEMATOL, V8, P189, DOI 10.1097/00062752-200107000-00001; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Gurevich RM, 2004, BLOOD, V104, P1127, DOI 10.1182/blood-2003-10-3550; Haferlach C, 2012, GENE CHROMOSOME CANC, V51, P257, DOI 10.1002/gcc.20950; Heuser M, 2007, BLOOD, V110, P1639, DOI 10.1182/blood-2007-03-080523; Heuser M, 2006, BLOOD, V108, P3898, DOI 10.1182/blood-2006-04-014845; Heuser M, 2011, CANCER CELL, V20, P39, DOI 10.1016/j.ccr.2011.06.020; Heuser M, 2009, BLOOD, V114, P3983, DOI 10.1182/blood-2009-06-227603; Heuser M, 2009, BLOOD, V113, P1432, DOI [10.1182/blood-2008-02-162263, 10.1182/blood-2008-06-162263]; Horton SJ, 2013, LEUKEMIA, V27, P1116, DOI 10.1038/leu.2012.343; Jacobs-Helber SM, 2004, BLOOD, V104, P696, DOI 10.1182/blood-2003-05-1754; Kalra IS, 2011, BRIT J HAEMATOL, V154, P248, DOI 10.1111/j.1365-2141.2011.08710.x; Kandilci A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061706; Kandilci A, 2009, BLOOD, V114, P1596, DOI 10.1182/blood-2009-02-205443; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kawagoe H, 2005, BLOOD, V106, P4278, DOI 10.1182/blood-2005-04-1674; Kirstetter P, 2008, CANCER CELL, V13, P299, DOI 10.1016/j.ccr.2008.02.008; Langer C, 2009, J CLIN ONCOL, V27, P3198, DOI 10.1200/JCO.2008.20.6110; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Liu T, 2010, LEUKEMIA, V24, P601, DOI 10.1038/leu.2009.272; Marini MG, 2010, BRIT J HAEMATOL, V149, P748, DOI 10.1111/j.1365-2141.2010.08130.x; Meester-Smoor MA, 2007, J MOL ENDOCRINOL, V38, P113, DOI 10.1677/jme.1.02110; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Neumann M, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2011.49; Neumann M, 2013, BLOOD, V121, P4749, DOI 10.1182/blood-2012-11-465138; Pineault N, 2003, BLOOD, V101, P4529, DOI 10.1182/blood-2002-08-2484; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Schambach A, 2000, MOL THER, V2, P435, DOI 10.1006/mthe.2000.0191; Schwind S, 2011, BLOOD, V118, P4188, DOI 10.1182/blood-2011-06-357764; Sharma A YH, 2014, LEUKEMIA; Smyth G, 2005, LIMMA LINEAR MODELS; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Starczynowski DT, 2010, NAT MED, V16, P49, DOI 10.1038/nm.2054; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thol F, 2011, J CLIN ONCOL, V29, P2889, DOI 10.1200/JCO.2011.35.4894; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van Wely KHM, 2003, ONCOGENE, V22, P699, DOI 10.1038/sj.onc.1206124; Vannucchi AM, 2013, LEUKEMIA, V27, P1861, DOI 10.1038/leu.2013.119; Vonesch C, 2008, IEEE T IMAGE PROCESS, V17, P539, DOI 10.1109/TIP.2008.917103; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020	51	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112671	10.1371/journal.pone.0112671	http://dx.doi.org/10.1371/journal.pone.0112671			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401736	Green Published, Green Submitted, gold			2022-12-27	WOS:000345158700062
J	Lasley-Rasher, RS; Kramer, AM; Burdett-Coutts, V; Yen, J				Lasley-Rasher, Rachel S.; Kramer, Andrew M.; Burdett-Coutts, Victoria; Yen, Jeannette			Assessing the In Situ Fertilization Status of Two Marine Copepod Species, Temora longicornis and Eurytemora herdmani; How Common Are Unfertilized Eggs in Nature?	PLOS ONE			English	Article							REPRODUCTIVE-BIOLOGY; CALANOID COPEPODS; HATCHING SUCCESS; PELAGIC COPEPOD; FOOD LIMITATION; POPULATION-DYNAMICS; OITHONA-DAVISAE; MATING SUCCESS; PREDATION RISK; ACARTIA-CLAUSI	We utilized an egg staining technique to measure the in situ fertilization success of two marine copepod species, Temora longicornis and Eurytemora herdmani from May to October 2008 in coastal Maine and correlated fertilization success with environmental conditions in their habitat. T. longicornis is a free spawning species that releases eggs into the ambient seawater after mating. In contrast, E. herdmani carries eggs in an egg sac until they hatch. The proportion of fertilized eggs within E. herdmani egg sacs was significantly higher than the freely spawned clutches of T. longicornis. This may be a result of the asymmetrical costs associated with carrying vs. spawning unfertilized eggs. T. longicornis frequently laid both fertilized and unfertilized eggs within their clutch. T. longicornis fertilization was negatively associated with chlorophyll concentration and positively associated with population density in their local habitat. The fertilization status of E. herdmani egg sacs was high throughout the season, but the proportion of ovigerous females was negatively associated with an interaction between predators and the proportion of females in the population. This study emphasizes that, in addition to population level processes, community and ecosystem level processes strongly influence the fertilization success and subsequent productivity of copepods.	[Lasley-Rasher, Rachel S.; Yen, Jeannette] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Kramer, Andrew M.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Burdett-Coutts, Victoria] Mem Univ Newfoundland, Dept Ocean Sci, St John, NF, Canada	University System of Georgia; Georgia Institute of Technology; University System of Georgia; University of Georgia; Memorial University Newfoundland	Lasley-Rasher, RS (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	rachel.lasleyrasher@maine.edu	Kramer, Andrew/C-5495-2008	Kramer, Andrew/0000-0002-9031-6580	National Science Foundation Integrated Graduate Education and Research Traineeship grant (Division of Graduate Education) [0114400]; Directorate For Geosciences [1226209] Funding Source: National Science Foundation	National Science Foundation Integrated Graduate Education and Research Traineeship grant (Division of Graduate Education); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by National Science Foundation Integrated Graduate Education and Research Traineeship grant (Division of Graduate Education-0114400), http://www.nsf.gov/, RLR. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ban SH, 1997, MAR ECOL PROG SER, V157, P287, DOI 10.3354/meps157287; Belmonte G, 2007, J PLANKTON RES, V29, pI39, DOI 10.1093/plankt/fbl064; Boyer S, 2013, ESTUAR COAST SHELF S, V117, P125, DOI 10.1016/j.ecss.2012.11.006; Brugnano C, 2009, MAR BIOL, V156, P331, DOI 10.1007/s00227-008-1086-9; Castellani C, 2003, J PLANKTON RES, V25, P527, DOI 10.1093/plankt/25.5.527; Ceballos S, 2014, J PLANKTON RES, V36, P736, DOI 10.1093/plankt/fbu021; Ceballos S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018870; Choi KH, 2008, LIMNOL OCEANOGR, V53, P1656, DOI 10.4319/lo.2008.53.4.1656; Choi KH, 2009, MAR ECOL PROG SER, V377, P183, DOI 10.3354/meps07819; Crawley MJ, 2005, STAT INTRO USING R; Dagg MJ, 2003, DEEP-SEA RES PT II, V50, P675, DOI 10.1016/S0967-0645(02)00590-8; Devreker D, 2005, J EXP MAR BIOL ECOL, V318, P145, DOI [10.1016/j.jembe.2004.12.011, 10.1016/j.jembre.2004.12.011]; Devreker D, 2009, J EXP MAR BIOL ECOL, V368, P113, DOI 10.1016/j.jembe.2008.10.015; DURBIN EG, 1983, LIMNOL OCEANOGR, V28, P1199, DOI 10.4319/lo.1983.28.6.1199; Dutz J, 2012, MAR ECOL PROG SER, V462, P51, DOI 10.3354/meps09830; GERRITSEN J, 1980, AM NAT, V115, P718, DOI 10.1086/283594; Goetze E, 2008, MAR ECOL PROG SER, V370, P185, DOI 10.3354/meps07616; HAIRSTON NG, 1995, ECOLOGY, V76, P1706, DOI 10.2307/1940704; Heuschele J, 2014, MAR BIOL, V161, P1653, DOI 10.1007/s00227-014-2449-z; Holste L, 2009, MAR BIOL, V156, P527, DOI DOI 10.1007/s00227-008-1101-1; HOPKINS CCE, 1982, J EXP MAR BIOL ECOL, V60, P91, DOI 10.1016/0022-0981(81)90183-0; HUNTLEY ME, 1992, AM NAT, V140, P201, DOI 10.1086/285410; Ianora A, 1999, LIMNOL OCEANOGR, V44, P147, DOI 10.4319/lo.1999.44.1.0147; IANORA A, 1993, LIMNOL OCEANOGR, V38, P1615, DOI 10.4319/lo.1993.38.8.1615; IANORA A, 1989, MAR BIOL, V101, P187, DOI 10.1007/BF00391457; IANORA A, 1995, MAR BIOL, V121, P533, DOI 10.1007/BF00349463; Ianora A, 2004, NATURE, V429, P403, DOI 10.1038/nature02526; Ianora A, 2010, ECOTOXICOLOGY, V19, P493, DOI 10.1007/s10646-009-0434-y; Irigoien X, 2002, NATURE, V419, P387, DOI 10.1038/nature01055; JACOBY CA, 1983, MAR BIOL, V76, P77, DOI 10.1007/BF00393058; Jonasdottir SH, 2002, MAR BIOL, V140, P1195, DOI 10.1007/s00227-002-0782-0; Kimmerer WJ, 2005, ESTUARIES, V28, P541, DOI 10.1007/BF02696065; Kiorboe T, 2006, OECOLOGIA, V148, P40, DOI 10.1007/s00442-005-0346-3; KIORBOE T, 1990, MAR ECOL PROG SER, V59, P19, DOI 10.3354/meps059019; KIORBOE T, 1994, J PLANKTON RES, V16, P1353, DOI 10.1093/plankt/16.10.1353; Kiorboe T, 2007, LIMNOL OCEANOGR, V52, P1511, DOI 10.4319/lo.2007.52.4.1511; Kramer AM, 2008, ECOLOGY, V89, P2760, DOI 10.1890/07-1505.1; Lasley-Rasher RS, 2012, LIMNOL OCEANOGR, V57, P433, DOI 10.4319/lo.2012.57.2.0433; LEVITAN DR, 1992, ECOLOGY, V73, P248, DOI 10.2307/1938736; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; Maier G, 2000, J PLANKTON RES, V22, P1977, DOI 10.1093/plankt/22.10.1977; Marcus NH, 1996, HYDROBIOLOGIA, V320, P141, DOI 10.1007/BF00016815; Mauchline J, 1998, ADV MAR BIOL, V33, P1; McAlice C, 1977, PRELIMINARY OCEANOGR; Moore PJ, 2007, AM NAT, V169, P311, DOI 10.1086/510687; Niehoff B, 2004, J EXP MAR BIOL ECOL, V307, P237, DOI 10.1016/j.jembe.2004.02.006; Ohtsuka S, 2001, HYDROBIOLOGIA, V453, P441, DOI 10.1023/A:1013162605809; Parsons T.R., 1984, MANUAL BIOL CHEM MET; PETERSON WT, 1994, LIMNOL OCEANOGR, V39, P1594, DOI 10.4319/lo.1994.39.7.1594; RUNGE JA, 1988, HYDROBIOLOGIA, V167, P61, DOI 10.1007/BF00026294; Seuront L, 2006, J PLANKTON RES, V28, P805, DOI 10.1093/plankt/fbl012; Sichlau MH, 2011, MAR ECOL PROG SER, V442, P123, DOI 10.3354/meps09402; Tang KW, 2005, J EXP MAR BIOL ECOL, V318, P85, DOI 10.1016/j.jembe.2004.12.004; Team RCD, 2011, R LANG ENV STAT COMP; Thompson BP, 2006, THESIS U MAINE; Thum RA, 2007, OIKOS, V116, P759, DOI 10.1111/j.2007.0030-1299.15782.x; UNESCO, 1994, IOC MAN GUID, V29; UYE S, 1995, MAR ECOL PROG SER, V118, P121, DOI 10.3354/meps118121; UYE SI, 1982, J EXP MAR BIOL ECOL, V57, P55, DOI 10.1016/0022-0981(82)90144-7; Wesche A, 2007, MAR BIOL, V151, P1309, DOI 10.1007/s00227-006-0560-5; WILLIAMSON CE, 1986, LIMNOL OCEANOGR, V31, P393, DOI 10.4319/lo.1986.31.2.0393; Zirbel MJ, 2007, LIMNOL OCEANOGR-METH, V5, P106, DOI 10.4319/lom.2007.5.106	62	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112920	10.1371/journal.pone.0112920	http://dx.doi.org/10.1371/journal.pone.0112920			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397669	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558500112
J	Liang, TM; Yang, C; Li, P; Liu, C; Guo, L				Liang, Tingming; Yang, Chen; Li, Ping; Liu, Chang; Guo, Li			Genetic Analysis of Loop Sequences in the Let-7 Gene Family Reveal a Relationship between Loop Evolution and Multiple IsomiRs	PLOS ONE			English	Article							NUCLEOTIDES CONTROL; MICRORNA; RECOGNITION; REPERTOIRE; EXPRESSION; MOUSE	While mature miRNAs have been widely studied, the terminal loop sequences are rarely examined despite regulating both primary and mature miRNA functions. Herein, we attempted to understand the evolutionary pattern of loop sequences by analyzing loops in the let-7 gene family. Compared to the stable miRNA length distributions seen in most metazoans, higher metazoan species exhibit a longer length distribution. Examination of these loop sequence length distributions, in addition to phylogenetic tree construction, implicated loop sequences as the main evolutionary drivers in miRNA genes. Moreover, loops from relevant clustered miRNA gene families showed varying length distributions and higher levels of nucleotide divergence, even between homologous pre-miRNA loops. Furthermore, we found that specific nucleotides were dominantly distributed in the 5' and 3' terminal loop ends, which may contribute to the relatively precise cleavage that leads to a stable isomiR expression profile. Overall, this study provides further insight into miRNA processing and maturation and further enriches our understanding of miRNA biogenesis.	[Liang, Tingming; Yang, Chen; Li, Ping; Liu, Chang] Nanjing Normal Univ, Jiangsu Key Lab Mol & Med Biotechnol, Coll Life Sci, Nanjing 210023, Jiangsu, Peoples R China; [Guo, Li] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing 211166, Jiangsu, Peoples R China	Nanjing Normal University; Nanjing Medical University	Guo, L (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing 211166, Jiangsu, Peoples R China.	gl8008@163.com	Liang, Tingming/ACL-6141-2022		National Basic Research Program of China (973 Program) [2012CB947600, 2013CB911600]; National Natural Science Foundation of China [31171137, 31271261, 31401009, 61301251]; Program for New Century Excellent Talents in University by the Chinese Ministry of Education [NCET-11- 0990]; Program for the Top Young Talents by the Organization Department of the CPC Central Committee; Collaborative Innovation Center for Cardiovascular Disease Translational Medicine (Nanjing Medical University); Research Fund for the Doctoral Program of Higher Education of China [20133234120009]; National Natural Science Foundation of Jiangsu [BK20130885]; Natural Science Foundation of the Jiangsu Higher Education Institutions [12KJB360001, 13KJB330003]; NSFC [J1103507]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University by the Chinese Ministry of Education; Program for the Top Young Talents by the Organization Department of the CPC Central Committee; Collaborative Innovation Center for Cardiovascular Disease Translational Medicine (Nanjing Medical University); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Natural Science Foundation of Jiangsu; Natural Science Foundation of the Jiangsu Higher Education Institutions; NSFC(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by National Basic Research Program of China (973 Program) (No. 2012CB947600 and 2013CB911600), the National Natural Science Foundation of China (No. 31171137, 31271261, 31401009 and 61301251), the Program for New Century Excellent Talents in University by the Chinese Ministry of Education (No. NCET-11- 0990), the Program for the Top Young Talents by the Organization Department of the CPC Central Committee, the Collaborative Innovation Center for Cardiovascular Disease Translational Medicine (Nanjing Medical University), the Research Fund for the Doctoral Program of Higher Education of China (No. 20133234120009), the National Natural Science Foundation of Jiangsu (No. BK20130885), the Natural Science Foundation of the Jiangsu Higher Education Institutions (No. 12KJB360001 and 13KJB330003), NSFC for Talents Training in Basic Science (J1103507), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boudreau RL, 2009, MOL THER, V17, P169, DOI 10.1038/mt.2008.231; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Guo L, 2013, MICRORNA NONCODING R, P127; Guo L, 2014, GENE, V544, P1, DOI 10.1016/j.gene.2014.04.039; Guo L, 2012, MOL BIOL REP, V39, P2031, DOI 10.1007/s11033-011-0950-8; Guo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021072; Guo L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011387; Guo L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007944; Heimberg AM, 2008, P NATL ACAD SCI USA, V105, P2946, DOI 10.1073/pnas.0712259105; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; Hinton Tracey M, 2008, J RNAi Gene Silencing, V4, P295; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lai EC, 2003, CURR BIOL, V13, pR925, DOI 10.1016/j.cub.2003.11.017; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Liu G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003592; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; McManus MT, 2002, RNA, V8, P842, DOI 10.1017/S1355838202024032; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Neilsen CT, 2012, TRENDS GENET, V28, P544, DOI 10.1016/j.tig.2012.07.005; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Schopman NCT, 2010, ANTIVIR RES, V86, P204, DOI 10.1016/j.antiviral.2010.02.320; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Tsutsumi A, 2011, NAT STRUCT MOL BIOL, V18, P1153, DOI 10.1038/nsmb.2125; Vermeulen A, 2005, RNA, V11, P674, DOI 10.1261/rna.7272305; Vlassov AV, 2007, OLIGONUCLEOTIDES, V17, P223, DOI 10.1089/oli.2006.0069; Xu JZ, 2008, RNA, V14, P1276, DOI 10.1261/rna.997708; Yue SB, 2011, RNA BIOL, V8, P1115, DOI 10.4161/rna.8.6.17626; Zeng Y, 2004, NUCLEIC ACIDS RES, V32, P4776, DOI 10.1093/nar/gkh824; Zhang R, 2007, GENOME RES, V17, P612, DOI 10.1101/gr.6146507	43	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113042	10.1371/journal.pone.0113042	http://dx.doi.org/10.1371/journal.pone.0113042			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397967	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558500127
J	Liu, XP; Wang, D; Zheng, LS; Mou, TY; Liu, H; Li, GX				Liu, Xiaoping; Wang, Da; Zheng, Liansheng; Mou, Tingyu; Liu, Hao; Li, Guoxin			Is Early Oral Feeding after Gastric Cancer Surgery Feasible? A Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							FAST-TRACK SURGERY; ENHANCED RECOVERY PROGRAM; TOTAL GASTRECTOMY; POSTOPERATIVE RECOVERY; ANASTOMOTIC LEAKAGE; COLORECTAL SURGERY; DISTAL GASTRECTOMY; ENTERAL NUTRITION; CLINICAL-TRIAL; SURGICAL CARE	Aim: To assess the feasibility and safety of early oral feeding (EOF) after gastrectomy for gastric cancer through a systematic review and meta-analysis based on randomized controlled trials. Methods: A literature search in PubMed, Embase, Web of Science and Cochrane library databases was performed for eligible studies published between January 1995 and March 2014. Systematic review was carried out to identify randomized controlled trials comparing EOF and traditional postoperative oral feeding after gastric cancer surgery. Meta-analyses were performed by either a fixed effects model or a random effects model according to the heterogeneity using RevMan 5.2 software. Results: Six studies remained for final analysis. Included studies were published between 2005 and 2013 reporting on a total of 454 patients. No significant differences were observed for postoperative complication (RR = 0.95; 95% CI, 0.70 to 1.29; P = 0.75), the tolerability of oral feeding (RR = 0.98; 95% CI, 0.91 to 1.06; P = 0.61), readmission rate (RR = 1; 95% CI, 0.30 to 3.31; P = 1.00) and incidence of anastomotic leakage (RR = 0.31; 95% CI, 0.01 to 7.30; P = 0.47) between two groups. EOF after gastrectomy for gastric cancer was associated with significant shorter duration of the hospital stay (WMD = -2.36; 95% CI, - 3.37 to -1.34; P<0.0001) and time to first flatus (WMD = -19.94; 95% CI, -32.03 to -7.84; P = 0.001). There were no significant differences in postoperative complication, tolerability of oral feeding, readmission rates, duration of hospital stay and time to first flatus among subgroups stratified by the time to start EOF or by partial and total gastrectomy or by laparoscopic and open surgery. Conclusions: The result of this meta-analysis showed that EOF after gastric cancer surgery seems feasible and safe, even started at the day of surgery irrespective of the extent of the gastric resection and the type of surgery. However, more prospective, well-designed multicenter RCTs with more clinical outcomes are needed for further validation.	[Liu, Xiaoping; Wang, Da; Zheng, Liansheng; Mou, Tingyu; Liu, Hao; Li, Guoxin] Southern Med Univ, Nanfang Hosp, Dept Gen Surg, Guangzhou, Guangdong, Peoples R China; [Liu, Xiaoping] Gannan Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Ganzhou, Jiangxi, Peoples R China	Southern Medical University - China; Gannan Medical University	Liu, H (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Gen Surg, Guangzhou, Guangdong, Peoples R China.	liuhaofbi@163.com; gzliguoxin@163.com	Liu, Hao/I-9884-2019	Liu, Hao/0000-0003-1227-2954	National Key Technology RD Program [2013BAI05B00]; Major Program of Science and Technology Program of Guangzhou [201300000087]; Research Fund of Public welfare in Health Industry of Health [201402015]; Ministry of Health of PR China; program of the national key clinical medical specialty	National Key Technology RD Program(National Key Technology R&D Program); Major Program of Science and Technology Program of Guangzhou; Research Fund of Public welfare in Health Industry of Health; Ministry of Health of PR China; program of the national key clinical medical specialty	This study was supported by The National Key Technology R&D Program (No. 2013BAI05B00), the Major Program of Science and Technology Program of Guangzhou (No. 201300000087), Research Fund of Public welfare in Health Industry of Health (No. 201402015), Ministry of Health of PR China, and The program of the national key clinical medical specialty. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armijo-Olivo S, 2012, J EVAL CLIN PRACT, V18, P12, DOI 10.1111/j.1365-2753.2010.01516.x; Bisgaard T, 2002, NUTRITION, V18, P944, DOI 10.1016/S0899-9007(02)00990-5; Chen ZX, 2014, WORLD J GASTROENTERO, V20, P578, DOI 10.3748/wjg.v20.i2.578; CSENDES A, 1990, HEPATO-GASTROENTEROL, V37, P174; Dag A, 2011, CLINICS, V66, P2001, DOI 10.1590/S1807-59322011001200001; de Martel C, 2013, GASTROENTEROL CLIN N, V42, P219, DOI 10.1016/j.gtc.2013.01.003; Di Fronzo LA, 1999, ARCH SURG-CHICAGO, V134, P941, DOI 10.1001/archsurg.134.9.941; El Nakeeb A, 2009, INT J SURG, V7, P206, DOI 10.1016/j.ijsu.2009.03.003; Feng F, 2013, WORLD J GASTROENTERO, V19, P3642, DOI 10.3748/wjg.v19.i23.3642; Feo CV, 2004, ANZ J SURG, V74, P298, DOI 10.1111/j.1445-1433.2004.02985.x; Fukuzawa J, 2007, WORLD J SURG, V31, P1234, DOI 10.1007/s00268-007-9003-9; Gianotti L, 2011, INT J COLORECTAL DIS, V26, P747, DOI 10.1007/s00384-011-1138-3; Grantcharov TP, 2010, BRIT J SURG, V97, P1547, DOI 10.1002/bjs.7184; Hanna GB, 2013, HISTOPATHOLOGY, V63, P316, DOI 10.1111/his.12167; Hayakawa T, 2003, J GASTROEN HEPATOL, V18, P505, DOI 10.1046/j.1440-1746.2003.03008.x; Hu JC, 2012, J GASTROINTEST SURG, V16, P1830, DOI 10.1007/s11605-012-1969-4; Hur H, 2011, SURGERY, V149, P561, DOI 10.1016/j.surg.2010.10.003; Jeong O, 2014, GASTRIC CANCER, V17, P324, DOI 10.1007/s10120-013-0275-5; Kehlet H, 2008, ANN SURG, V248, P189, DOI 10.1097/SLA.0b013e31817f2c1a; Kim JW, 2012, WORLD J SURG, V36, P2879, DOI 10.1007/s00268-012-1741-7; Klappenbach RF, 2013, WORLD J SURG, V37, P2293, DOI 10.1007/s00268-013-2143-1; Koeda K, 2011, WORLD J SURG, V35, P1469, DOI 10.1007/s00268-011-1051-5; Lee HJ, 2012, ASIAN J ENDOSC SURG, V5, P5, DOI 10.1111/j.1758-5910.2011.00111.x; Lewis SJ, 2001, BRIT MED J, V323, P773, DOI 10.1136/bmj.323.7316.773; Lewis SJ, 2009, J GASTROINTEST SURG, V13, P569, DOI 10.1007/s11605-008-0592-x; Liao GX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081946; Liu XX, 2010, JPEN-PARENTER ENTER, V34, P313, DOI 10.1177/0148607110362583; Minig L, 2009, ANN SURG ONCOL, V16, P1660, DOI 10.1245/s10434-009-0444-2; Minig L, 2009, ANN SURG ONCOL, V16, P3101, DOI 10.1245/s10434-009-0681-4; Palmer DJ, 2012, CURR ALLERGY ASTHM R, V12, P321, DOI 10.1007/s11882-012-0271-6; Prescott SL, 2008, PEDIAT ALLERG IMM-UK, V19, P375, DOI 10.1111/j.1399-3038.2008.00718.x; Schuchert MJ, 2008, J GASTROINTEST SURG, V12, P1479, DOI 10.1007/s11605-008-0541-8; Sierzega M, 2010, BRIT J SURG, V97, P1035, DOI 10.1002/bjs.7038; Vlug MS, 2009, COLORECTAL DIS, V11, P335, DOI 10.1111/j.1463-1318.2008.01679.x; Wang DS, 2010, J GASTROINTEST SURG, V14, P620, DOI 10.1007/s11605-009-1139-5; Wu B, 2013, HEPATO-GASTROENTEROL, V60, P387, DOI 10.5754/hge12719; Yamada T, 2012, GASTRIC CANCER, V15, P34, DOI 10.1007/s10120-011-0057-x; Yu Z, 2014, LANGENBECK ARCH SURG, V399, P85, DOI 10.1007/s00423-013-1148-4; Zhao HY, 2013, J CANCER RES CLIN, V139, P1465, DOI 10.1007/s00432-013-1466-5; Zhou T, 2006, WORLD J GASTROENTERO, V12, P2459, DOI 10.3748/wjg.v12.i15.2459; Zhuang CL, 2013, DIGEST SURG, V30, P225, DOI 10.1159/000353136	41	34	41	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112062	10.1371/journal.pone.0112062	http://dx.doi.org/10.1371/journal.pone.0112062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397686	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500029
J	Luetz, A; Balzer, F; Radtke, FM; Jones, C; Citerio, G; Walder, B; Weiss, B; Wernecke, KD; Spies, C				Luetz, Alawi; Balzer, Felix; Radtke, Finn M.; Jones, Christina; Citerio, Giuseppe; Walder, Bernhard; Weiss, Bjoern; Wernecke, Klaus-Dieter; Spies, Claudia			Delirium, Sedation and Analgesia in the Intensive Care Unit: A Multinational, Two-Part Survey among Intensivists	PLOS ONE			English	Article							MECHANICALLY VENTILATED PATIENTS; CRITICAL ILLNESS; RISK-FACTORS; PAIN; ICU; PERCEPTIONS; MANAGEMENT; STRESSORS; MORTALITY; IMPROVES	Analgesia, sedation and delirium management are important parts of intensive care treatment as they are relevant for patients' clinical and functional long-term outcome. Previous surveys showed that despite this fact implementation rates are still low. The primary aim of the prospective, observational multicenter study was to investigate the implementation rate of delirium monitoring among intensivists. Secondly, current practice concerning analgesia and sedation monitoring as well as treatment strategies for patients with delirium were assesed. In addition, this study compares perceived and actual practice regarding delirium, sedation and analgesia management. Data were obtained with a two-part, anonymous survey, containing general data from intensive care units in a first part and data referring to individual patients in a second part. Questionnaires from 101 hospitals (part 1) and 868 patients (part 2) were included in data analysis. Fifty-six percent of the intensive care units reported to monitor for delirium in clinical routine. Fourty-four percent reported the use of a validated delirium score. In this respect, the survey suggests an increasing use of delirium assessment tools compared to previous surveys. Nevertheless, part two of the survey revealed that in actual practice 73% of included patients were not monitored with a validated score. Furthermore, we observed a trend towards moderate or deep sedation which is contradicting to guideline-recommendations. Every fifth patient was suffering from pain. The implementation rate of adequate pain-assessment tools for mechanically ventilated and sedated patients was low (30%). In conclusion, further efforts are necessary to implement guideline recommendations into clinical practice.	[Luetz, Alawi; Balzer, Felix; Radtke, Finn M.; Weiss, Bjoern; Spies, Claudia] Charite, Dept Anesthesiol & Intens Care Med, Campus Charite Mitte, D-13353 Berlin, Germany; [Luetz, Alawi; Balzer, Felix; Radtke, Finn M.; Weiss, Bjoern; Spies, Claudia] Charite, Campus Virchow Klinikum, D-13353 Berlin, Germany; [Jones, Christina] Whiston Hosp, Crit Care Unit, Liverpool, Merseyside, England; [Citerio, Giuseppe] Hosp San Gerardo, Dept Emergency Med, Monza, Italy; [Walder, Bernhard] Hop Univ Geneve, Anesthesiol Serv, Geneva, Switzerland; [Wernecke, Klaus-Dieter] Sostana GmbH, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Whiston Hospital; University of Geneva; Sostana GmbH	Spies, C (corresponding author), Charite, Dept Anesthesiol & Intens Care Med, Campus Charite Mitte, D-13353 Berlin, Germany.	claudia.spies@charite.de	Jones, Christina/M-9509-2019; Citerio, Giuseppe/B-1839-2015; Spies, Claudia/AAJ-5412-2020	Citerio, Giuseppe/0000-0002-5374-3161; Spies, Claudia/0000-0002-1062-0495; Luetz, Alawi/0000-0001-8814-1809; Weiss, Bjorn/0000-0003-3139-595X; Radtke, Finn M./0000-0001-5260-5384; Balzer, Felix/0000-0003-1575-2056	European Critical Care Research Network of the European Society of Intensive Care Medicine	European Critical Care Research Network of the European Society of Intensive Care Medicine	We are very grateful to Sebastian Fueger for helping us collecting the data. Many thanks to Subhash Arora, Cori Gruetter, Anne Berit Guttormsen, Matthias Hanggi, Luis Sanchez Hurtado, Jesus Caballero Lopez, Jesus Lopez-Herce, Flavio E. Nacul, Joel Starkopf, Chris Subbe, Alessia Vargiolu and all ESICM members who participated in this survey. Furthermore we want to thank the European Critical Care Research Network of the European Society of Intensive Care Medicine for supporting this study.	Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Battle CE, 2013, CRIT CARE, V17, DOI 10.1186/cc12746; Chanques G, 2006, CRIT CARE MED, V34, P1691, DOI 10.1097/01.CCM.0000218416.62457.56; Devlin JW, 2008, CRIT CARE, V12, DOI 10.1186/cc6793; Devlin JW, 2007, CRIT CARE MED, V35, P2721, DOI 10.1097/01.CCM.0000292011.93074.82; Devlin JW, 2011, ANN PHARMACOTHER, V45, P1217, DOI 10.1345/aph.1Q332; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Forsgren Lena M, 2010, Intensive Crit Care Nurs, V26, P296, DOI 10.1016/j.iccn.2010.07.003; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Goncalves F, 2012, SUPPORT CARE CANCER, V20, P3123, DOI 10.1007/s00520-012-1442-7; Luetz A, 2010, CRIT CARE MED, V38, P409, DOI 10.1097/CCM.0b013e3181cabb42; Martin J, 2005, CRIT CARE, V9, pR117, DOI 10.1186/cc3035; Martin J, 2007, CRIT CARE, V11, DOI 10.1186/cc6189; Martin Jorg, 2010, Ger Med Sci, V8, pDoc02, DOI 10.3205/000091; Novaes MAFP, 1999, INTENS CARE MED, V25, P1421, DOI 10.1007/s001340051091; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Pandharipande P, 2008, J TRAUMA, V65, P34, DOI 10.1097/TA.0b013e31814b2c4d; Pang PSK, 2008, J CLIN NURS, V17, P2681, DOI 10.1111/j.1365-2702.2008.02280.x; Patel RP, 2009, CRIT CARE MED, V37, P825, DOI 10.1097/CCM.0b013e31819b8608; Payen JF, 2009, ANESTHESIOLOGY, V111, P1308, DOI 10.1097/ALN.0b013e3181c0d4f0; Radtke FM, 2012, INTENS CARE MED, V38, P1974, DOI 10.1007/s00134-012-2658-1; Shehabi Y, 2008, ANAESTH INTENS CARE, V36, P570, DOI 10.1177/0310057X0803600423; Shehabi Y, 2013, INTENS CARE MED, V39, P910, DOI 10.1007/s00134-013-2830-2; Spronk PE, 2009, INTENS CARE MED, V35, P1276, DOI 10.1007/s00134-009-1466-8; Trupkovic Tomislav, 2011, J Intensive Care Med, V26, P397, DOI 10.1177/0885066610393442; Van Eijk Maarten M J, 2008, Intensive Crit Care Nurs, V24, P218, DOI 10.1016/j.iccn.2008.04.005; Young J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3704	27	56	58	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e110935	10.1371/journal.pone.0110935	http://dx.doi.org/10.1371/journal.pone.0110935			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398099	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558500011
J	Qin, JL; Ying, WW; Cheng, XD; Wu, XD; Lu, BJ; Liang, Y; Wang, XY; Wan, XY; Xie, X; Lu, WG				Qin, Jiale; Ying, Weiwen; Cheng, Xiaodong; Wu, Xiaodong; Lu, Bingjian; Liang, Yun; Wang, Xinyu; Wan, Xiaoyun; Xie, Xing; Lu, Weiguo			A Well-Circumscribed Border with Peripheral Doppler Signal in Sonographic Image Distinguishes Epithelioid Trophoblastic Tumor from Other Gestational Trophoblastic Neoplasms	PLOS ONE			English	Article							PLACENTAL SITE; DISEASE; MANAGEMENT; DIAGNOSIS; PATHOLOGY; LESIONS	As epithelioid trophoblastic tumor (ETT) shares similar clinical features with other gestational trophoblastic neoplasms (GTNs), it is likely to be clinically misdiagnosed and subsequently treated in an improper way. This study aimed to identify the sonographic features of ETT that are distinct from other GTNs, including placental site trophoblastic tumor (PSTT) and invasive mole/choriocarcinoma (IM/CC). Here, we retrospectively analyzed ultrasound images of 12 patients with ETT in comparison with those of 21 patients with PSTT and 24 patients with IM/CC. The results showed that maximal diameter and hemodynamic parameters were not significantly different among ETT, PSTT and IM/CC (P>0.05). However, a well-circumscribed border with hypoechogenic halo was identified in the gray-scale sonogram in all 12 cases of ETT, while only in 1 out of 21 cases of PSTT and 1 out of 16 cases of IM/CC (P<0.001 for ETT vs. PSTT or IM/CC). Moreover, a peripheral pattern of Doppler signals was observed in 11 out of 12 ETT lesions, showing relatively more Doppler signal spots around the tumor border than within the boundary, while a non-peripheral pattern of Doppler signals in all 21 PSTT cases and 14 out of 16 IM/CC cases: with minimal, moderate or remarkable signal spots within the tumor, but not along the tumor (P, 0.001 for ETT vs. PSTT or IM/CC). These distinct sonographic features of ETT correlated with histopathologic observations, such as expansive growth pattern and vascular morphology. Thus, we draw the conclusions that the well-circumscribed border with peripheral Doppler signal may serve as a reliable sonographic feature to discriminate ETT from other types of GTNs. With further validation in a larger patient set in our ongoing multi-center study, this finding will be potentially developed into a non-invasive pre-operative GTN subtyping method for ETT.	[Qin, Jiale] Zhejiang Univ, Sch Med, Womens Hosp, Dept Ultrasound, Hangzhou, Zhejiang, Peoples R China; [Ying, Weiwen] Zhejiang Univ, Sch Med, Womens Hosp, Dept Womens Hlth, Hangzhou, Zhejiang, Peoples R China; [Cheng, Xiaodong; Wu, Xiaodong; Wang, Xinyu; Wan, Xiaoyun; Xie, Xing; Lu, Weiguo] Zhejiang Univ, Sch Med, Womens Hosp, Dept Oncol, Hangzhou, Zhejiang, Peoples R China; [Lu, Bingjian; Liang, Yun] Zhejiang Univ, Sch Med, Womens Hosp, Dept Pathol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Lu, WG (corresponding author), Zhejiang Univ, Sch Med, Womens Hosp, Dept Oncol, Hangzhou, Zhejiang, Peoples R China.	lwg@hzcnc.com	Lu, Wei/AAE-2921-2022	Lu, Wei/0000-0002-4150-8674	Population and Family Planning Commission of Zhejiang Province, China [JSW2012-A019]; Education Bureau of Zhejiang Province, China [Y200909401]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents; Health Bureau of Zhejiang Province, China; Zhejiang University international collaboration funding for postgraduate	Population and Family Planning Commission of Zhejiang Province, China; Education Bureau of Zhejiang Province, China; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents; Health Bureau of Zhejiang Province, China; Zhejiang University international collaboration funding for postgraduate	This work was funded by: 1 Grant numbers: JSW2012-A019, Institution: Population and Family Planning Commission of Zhejiang Province, China, The author funded: JQ. 2 Grant numbers: Y200909401, URLs:www.zjedu.gov.cn/upload/col31/20100224092329.xls, Institution: Education Bureau of Zhejiang Province, China, The author funded: JQ. 3 Grant name: Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents, URLs:www.zjwst.gov.cn/./-1/1401231329189903539.doc, Institution: Health Bureau of Zhejiang Province, China, The author funded: WL. 4 Grant name: Zhejiang University international collaboration funding for postgraduate(2013), URLs:http://grs.zju.edu.cn/News/html/grs/pygcjgl/gpcg/gpcg_tz/2013-07-09/270-20130709095525.html, The author funded: JQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SD, 2006, CLIN RADIOL, V61, P301, DOI 10.1016/j.crad.2005.12.003; Berkowitz RS, 2009, NEW ENGL J MED, V360, P1639, DOI 10.1056/NEJMcp0900696; Genest DR, 2003, WHO CLASSIFICATION T, P250; Horn LC, 2004, PATHOLOGE, V25, P281, DOI 10.1007/s00292-004-0702-9; Hui P, 2013, EPITHELIOID TROPHOBL, P105; Kani KK, 2012, CURR PROBL DIAGN RAD, V41, P1, DOI 10.1067/j.cpradiol.2011.06.002; Kohorn EI, 2001, INT J GYNECOL CANCER, V11, P73, DOI 10.1046/j.1525-1438.2001.011001073.x; Leone FPG, 2010, ULTRASOUND OBST GYN, V35, P103, DOI 10.1002/uog.7487; Luiza John W, 2014, Gynecol Oncol Case Rep, V7, P13, DOI 10.1016/j.gynor.2013.11.001; Lurain JR, 2011, AM J OBSTET GYNECOL, V204, P11, DOI 10.1016/j.ajog.2010.06.072; Lurain JR, 2010, AM J OBSTET GYNECOL, V203, P531, DOI 10.1016/j.ajog.2010.06.073; Moutte A, 2013, GYNECOL ONCOL, V128, P568, DOI 10.1016/j.ygyno.2012.11.010; Okumura M, 2010, ULTRASOUND OBST GYN, V36, P249, DOI 10.1002/uog.7560; Palmer JE, 2008, J REPROD MED, V53, P465; Shih IM, 2007, ANN DIAGN PATHOL, V11, P228, DOI 10.1016/j.anndiagpath.2007.04.001; Shih IM, 2001, INT J GYNECOL PATHOL, V20, P31, DOI 10.1097/00004347-200101000-00004; Shih IM, 1998, AM J SURG PATHOL, V22, P1393, DOI 10.1097/00000478-199811000-00010; Shih IM, 2004, AM J SURG PATHOL, V28, P1177, DOI 10.1097/01.pas.0000130325.66448.a1; Sung WJ, 2013, KOREAN J PATHOL, V47, P67, DOI 10.4132/KoreanJPathol.2013.47.1.67; Timmerman D, 2000, ULTRASOUND OBST GYN, V16, P500, DOI 10.1046/j.1469-0705.2000.00287.x; Zhang XF, 2013, INT J GYNECOL CANCER, V23, P1334, DOI 10.1097/IGC.0b013e31829ea023	21	15	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112618	10.1371/journal.pone.0112618	http://dx.doi.org/10.1371/journal.pone.0112618			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396428	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558500068
J	Borrayo, E; Mendizabal-Ruiz, EG; Velez-Perez, H; Romo-Vazquez, R; Mendizabal, AP; Morales, JA				Borrayo, Ernesto; Gerardo Mendizabal-Ruiz, E.; Velez-Perez, Hugo; Romo-Vazquez, Rebeca; Mendizabal, Adriana P.; Alejandro Morales, J.			Genomic Signal Processing Methods for Computation of Alignment-Free Distances from DNA Sequences	PLOS ONE			English	Article							SIMILARITY; IDENTIFICATION; PREDICTION; SEARCH	Genomic signal processing (GSP) refers to the use of digital signal processing (DSP) tools for analyzing genomic data such as DNA sequences. A possible application of GSP that has not been fully explored is the computation of the distance between a pair of sequences. In this work we present GAFD, a novel GSP alignment-free distance computation method. We introduce a DNA sequence-to-signal mapping function based on the employment of doublet values, which increases the number of possible amplitude values for the generated signal. Additionally, we explore the use of three DSP distance metrics as descriptors for categorizing DNA signal fragments. Our results indicate the feasibility of employing GAFD for computing sequence distances and the use of descriptors for characterizing DNA fragments.	[Borrayo, Ernesto; Gerardo Mendizabal-Ruiz, E.; Velez-Perez, Hugo; Romo-Vazquez, Rebeca; Alejandro Morales, J.] Univ Guadalajara, CUCEI, Dept Comp Sci, Guadalajara 44430, Jalisco, Mexico; [Mendizabal, Adriana P.] Univ Guadalajara, CUCEI, Mol Biol Lab, Farmacobiol Dept, Guadalajara 44430, Jalisco, Mexico; [Alejandro Morales, J.] Univ Guadalajara, Ctr Theoret Res & High Performance Comp, CUCEI, Guadalajara 44430, Jalisco, Mexico	Universidad de Guadalajara; Universidad de Guadalajara; Universidad de Guadalajara	Morales, JA (corresponding author), Univ Guadalajara, CUCEI, Dept Comp Sci, Guadalajara 44430, Jalisco, Mexico.	alejandro.morales@cucei.udg.mx	Mendizabal, Adriana P/A-9689-2015; Romo-Vazquez, Rebeca/AAS-2119-2021; Morales, J. Alejandro/G-1938-2018	Mendizabal, Adriana P/0000-0001-7553-6350; Morales, J. Alejandro/0000-0001-8088-9724; romo-vazquez, rebeca/0000-0001-6459-8070; Borrayo, Ernesto/0000-0002-0752-6721	National Council for Science and Technology (CONACyT); FOMIXJal project [2010-10-149481]	National Council for Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); FOMIXJal project	The authors wish to thank the National Council for Science and Technology (CONACyT) for PhD scholarship support to EB, and FOMIXJal project no. 2010-10-149481 that supported the infrastructure for experimentation.	Akhtar M, 2007, IEEE INT WORK GENOM, P54; Akhtar M, 2008, IEEE J-STSP, V2, P310, DOI 10.1109/JSTSP.2008.923854; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anastassiou D, 2001, IEEE SIGNAL PROC MAG, V18, P8, DOI 10.1109/79.939833; Anastassiou D, 2000, BIOINFORMATICS, V16, P1073, DOI 10.1093/bioinformatics/16.12.1073; [Anonymous], [No title captured]; Antoniadis A., 2001, J STAT SOFTW, V6, P1, DOI [10.18637/jss.v006.i06, DOI 10.18637/JSS.V006.I06]; Antoniadis A, 2007, STAT SURV, V1, P16, DOI 10.1214/07-SS014; Bernaola-Galvan P, 2002, GENE, V300, P105, DOI 10.1016/S0378-1119(02)01037-5; Chakravarthy N, 2004, EURASIP J APPL SIG P, V2004, P13, DOI 10.1155/S111086570430925X; Cristea PD, 2002, J CELL MOL MED, V6, P279, DOI 10.1111/j.1582-4934.2002.tb00196.x; DEMELER B, 1991, NUCLEIC ACIDS RES, V19, P1593, DOI 10.1093/nar/19.7.1593; Donoho DL, 1995, J AM STAT ASSOC, V90, P1200, DOI 10.1080/01621459.1995.10476626; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; Gabrielian A, 1996, FEBS LETT, V393, P65, DOI 10.1016/0014-5793(96)00855-1; Holden T, 2007, PROC SPIE, V6694, DOI 10.1117/12.732283; Hon Keung Kwan, 2009, 2009 IEEE International Conference on Electro/Information Technology (EIT '09), P307, DOI 10.1109/EIT.2009.5189632; Inbamalar TM, 2012, INT P COMP SCI INF T, V28, P1; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kotlar D, 2003, GENOME RES, V13, P1930, DOI 10.1101/gr.1261703; Liao B, 2004, CHEM PHYS LETT, V388, P195, DOI 10.1016/j.cplett.2004.02.089; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Lorenzo-Ginori JV, 2009, CURR BIOINFORM, V4, P28, DOI 10.2174/157489309787158134; Marhon SA, 2011, J COMPUT BIOL, V18, P639, DOI 10.1089/cmb.2010.0184; Nair AS, 2006, BIOINFORMATION, V1, P197; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Panjkovich A, 2005, BIOINFORMATICS, V21, P711, DOI 10.1093/bioinformatics/bti066; Qi XQ, 2012, SCI WORLD J, DOI 10.1100/2012/104269; Qi XQ, 2011, EVOL BIOINFORM, V7, P149, DOI 10.4137/EBO.S7364; Ranawana R, 2005, NEURAL COMPUT APPL, V14, P122, DOI 10.1007/s00521-004-0447-7; Reese E, 2010, BIOINFORMATION, V4, P463, DOI 10.6026/97320630004463; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Vazquez RR, 2012, BIOMED SIGNAL PROCES, V7, P389, DOI 10.1016/j.bspc.2011.06.005; Rosen GL, 2009, CURR GENOMICS, V10, P493, DOI 10.2174/138920209789208255; Rushdi A., 2006, 2006 IEEE INT C AC S, P1024; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Sharma D, 2004, BIOINFORMATICS, V20, P1405, DOI 10.1093/bioinformatics/bth103; SILVERMAN BD, 1986, J THEOR BIOL, V118, P295, DOI 10.1016/S0022-5193(86)80060-1; Sims GE, 2009, P NATL ACAD SCI USA, V106, P2677, DOI 10.1073/pnas.0813249106; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; STUDIER JA, 1988, MOL BIOL EVOL, V5, P729; Tang YY, 2001, LECT NOTES COMPUTER, V2251, DOI [10.1007/3-540-45333-4, DOI 10.1007/3-540-45333-4]; Tiwari S, 1997, COMPUT APPL BIOSCI, V13, P263; VELEZPEREZ H, 2008, C P INT C IEEE ENG M, P2606; Vinga S, 2003, BIOINFORMATICS, V19, P513, DOI 10.1093/bioinformatics/btg005; VOSS RF, 1992, PHYS REV LETT, V68, P3805, DOI 10.1103/PhysRevLett.68.3805; Yan M, 1998, BIOINFORMATICS, V14, P685, DOI 10.1093/bioinformatics/14.8.685; Yin CC, 2005, J COMPUT BIOL, V12, P1153, DOI 10.1089/cmb.2005.12.1153; Yu JF, 2009, J THEOR BIOL, V261, P459, DOI 10.1016/j.jtbi.2009.08.005; Yu ZG, 2007, WMSCI 2007: 11TH WORLD MULTI-CONFERENCE ON SYSTEMICS, CYBERNETICS AND INFORMATICS, VOL I, PROCEEDINGS, P171; Zhang YS, 2011, J BIOMOL STRUCT DYN, V28, P557, DOI 10.1080/07391102.2011.10508595	53	20	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e110954	10.1371/journal.pone.0110954	http://dx.doi.org/10.1371/journal.pone.0110954			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393409	Green Submitted, Green Published, gold			2022-12-27	WOS:000347709300006
J	Cheng, YQ; Xu, J; Yu, HJ; Nie, BB; Li, N; Luo, CR; Li, HJ; Liu, F; Bai, Y; Shan, BC; Xu, L; Xu, XF				Cheng, Yuqi; Xu, Jian; Yu, Hongjun; Nie, Binbin; Li, Na; Luo, Chunrong; Li, Haijun; Liu, Fang; Bai, Yan; Shan, Baoci; Xu, Lin; Xu, Xiufeng			Delineation of Early and Later Adult Onset Depression by Diffusion Tensor Imaging	PLOS ONE			English	Article							LATE-LIFE DEPRESSION; OBSESSIVE-COMPULSIVE DISORDER; WHITE-MATTER ABNORMALITIES; DORSOLATERAL PREFRONTAL CORTEX; ANTERIOR CINGULATE CORTEX; MAJOR DEPRESSION; GERIATRIC DEPRESSION; ANISOTROPY; REMISSION; RECURRENT	Background: Due to a lack of evidence, there is no consistent age of onset to define early onset (EO) versus later onset (LO) major depressive disorder (MDD). Fractional anisotropy (FA), derived from diffusion tensor imaging (DTI), has been widely used to study neuropsychiatric disorders by providing information about the brain circuitry, abnormalities of which might facilitate the delineation of EO versus LO MDD. Method: In this study, 61 pairs of untreated, non-elderly, first-episode MDD patients and healthy controls (HCs) aged 18-45 years old received DTI scans. The voxel-based analysis method (VBM), classification analysis, using the Statistical Package for the Social Sciences (SPSS), and regression analyses were used to determine abnormal FA clusters and their correlations with age of onset and clinical symptoms. Results: Classification analysis suggested in the best model that there were two subgroups of MDD patients, delineated by an age of onset of 30 years old, by which MDD patients could be divided into EO (18-29 years old) and LO (30-45 years old) groups. LO MDD was characterized by decreased FA, especially in the white matter (WM) of the fronto-occipital fasciculus and posterior limb of internal capsule, with a negative correlation with the severity of depressive symptoms; in marked contrast, EO MDD showed increased FA, especially in the WM of the corpus callosum, corticospinal midbrain and inferior fronto-occipital fasciculus, while FA of the WM near the midbrain had a positive correlation with the severity of depressive symptoms. Conclusion: Specific abnormalities of the brain circuitry in EO vs. LO MDD were delineated by an age of onset of 30 years old, as demonstrated by distinct abnormal FA clusters with opposite correlations with clinical symptoms. This DTI study supported the evidence of an exact age for the delineation of MDD, which could have broad multidisciplinary importance.	[Cheng, Yuqi; Li, Na; Liu, Fang; Bai, Yan; Xu, Xiufeng] Kunming Med Univ, Affiliated Hosp 1, Dept Psychiat, Kunming, Peoples R China; [Xu, Jian] Kunming Med Univ, Affiliated Hosp 1, Dept Internal Med, Kunming, Peoples R China; [Yu, Hongjun; Luo, Chunrong; Li, Haijun] First Hosp Kunming City, Magnet Resonance Imaging Ctr, Kunming, Peoples R China; [Nie, Binbin; Shan, Baoci] Chinese Acad Sci, Inst High Energy Phys, Key Lab Nucl Anal Tech, Beijing, Peoples R China; [Xu, Lin] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Peoples R China; [Xu, Lin] Kunming Inst Zool, Kunming, Peoples R China	Kunming Medical University; Kunming Medical University; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology	Xu, L (corresponding author), Kunming Med Univ, Affiliated Hosp 1, Dept Psychiat, Kunming, Peoples R China.	lxu@vip.163.com; xfxu2004@sina.com	Xu, Lin/T-5531-2017	Xu, Lin/0000-0002-2710-3507; Nie, Binbin/0000-0002-8038-7772; Shan, Baoci/0000-0001-7417-5063	National Natural Science Foundation of China [81101005, 81160379, 81160171, U1032605, 81161120536]; 973 Program from the Ministry of Science and Technology of China [2009CB941300]; Yunnan Provincial Health Science and Technology Plan [2011WS008]; NSFC-Yunnan Joint Foundation [U1032605]; united founding of Yunnan Administration of Science & Technology and Kunming Medical University [2011FB167]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program from the Ministry of Science and Technology of China(National Basic Research Program of China); Yunnan Provincial Health Science and Technology Plan; NSFC-Yunnan Joint Foundation; united founding of Yunnan Administration of Science & Technology and Kunming Medical University	This work is supported by grants from National Natural Science Foundation of China (81101005, 81160379, 81160171, U1032605, and 81161120536), the 973 Program from the Ministry of Science and Technology of China (2009CB941300), Yunnan Provincial Health Science and Technology Plan (2011WS008), the NSFC-Yunnan Joint Foundation (U1032605), and the united founding of Yunnan Administration of Science & Technology and Kunming Medical University (2011FB167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos GS, 2008, AM J PSYCHIAT, V165, P238, DOI 10.1176/appi.ajp.2007.07050744; Alexopoulos GS, 2009, J AFFECT DISORDERS, V119, P132, DOI 10.1016/j.jad.2009.03.004; Alexopoulos GS, 2002, AM J PSYCHIAT, V159, P1929, DOI 10.1176/appi.ajp.159.11.1929; Bae JN, 2006, BIOL PSYCHIAT, V60, P1356, DOI 10.1016/j.biopsych.2006.03.052; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Blood AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013945; Cannistraro PA, 2007, DEPRESS ANXIETY, V24, P440, DOI 10.1002/da.20246; Cotter D, 2001, ARCH GEN PSYCHIAT, V58, P545, DOI 10.1001/archpsyc.58.6.545; Dong Q, 2004, J MAGN RESON IMAGING, V19, P6, DOI 10.1002/jmri.10424; Drevets WC, 2007, ANN NY ACAD SCI, V1121, P499, DOI 10.1196/annals.1401.029; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Giles DE, 1989, AM J PSYCHIAT; Herrmann LL, 2008, J NEUROL NEUROSUR PS, V79, P619, DOI 10.1136/jnnp.2007.124651; Hubl D, 2004, ARCH GEN PSYCHIAT, V61, P658, DOI 10.1001/archpsyc.61.7.658; Janssen J, 2004, BIOL PSYCHIAT, V56, P825, DOI 10.1016/j.biopsych.2004.09.011; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Levinson DF, 2006, BIOL PSYCHIAT, V60, P84, DOI 10.1016/j.biopsych.2005.08.024; Linden DEJ, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.049.2009; Lyons DM, 2004, J NEUROSCI, V24, P3655, DOI 10.1523/JNEUROSCI.0324-04.2004; Lyons MJ, 1998, ARCH GEN PSYCHIAT, V55, P468, DOI 10.1001/archpsyc.55.5.468; Ma N, 2007, AM J PSYCHIAT, V164, P823, DOI 10.1176/appi.ajp.164.5.823; MacMaster FP, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-2; Marazita ML, 1997, AM J HUM GENET, V61, P1370, DOI 10.1086/301627; MENDLEWICZ J, 1981, BRIT J PSYCHIAT, V139, P463, DOI 10.1192/bjp.139.5.463; MERIKANGAS KR, 1994, BRIT J PSYCHIAT, V164, P342, DOI 10.1192/bjp.164.3.342; Mondimore FM, 2006, AM J PSYCHIAT, V163, P1554, DOI 10.1176/appi.ajp.163.9.1554; Murphy CF, 2007, BIOL PSYCHIAT, V61, P1007, DOI 10.1016/j.biopsych.2006.07.028; Nakamae T, 2008, PROG NEURO-PSYCHOPH, V32, P1221, DOI 10.1016/j.pnpbp.2008.03.010; Nobuhara K, 2004, NEUROPSYCHOBIOLOGY, V50, P48, DOI 10.1159/000077941; Pfefferbaum A, 2000, MAGNET RESON MED, V44, P259, DOI 10.1002/1522-2594(200008)44:2<259::AID-MRM13>3.0.CO;2-6; PRICE RA, 1987, ARCH GEN PSYCHIAT, V44, P434; Rajkowska G., 2007, CNS & Neurological Disorders-Drug Targets, V6, P219, DOI 10.2174/187152707780619326; Sinha R, 2004, ANN NY ACAD SCI, V1032, P254, DOI 10.1196/annals.1314.032; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Taylor WD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003267; Taylor WD, 2004, AM J PSYCHIAT, V161, P1293, DOI 10.1176/appi.ajp.161.7.1293; Thomason ME, 2010, ANN REV CLIN PSYCHOL; Versace A, 2010, BIOL PSYCHIAT, V68, P560, DOI 10.1016/j.biopsych.2010.04.036; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; WEISSMAN MM, 1984, ARCH GEN PSYCHIAT, V41, P1136; Yoo SY, 2007, ACTA PSYCHIAT SCAND, V116, P211, DOI 10.1111/j.1600-0447.2007.01046.x	41	39	43	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112307	10.1371/journal.pone.0112307	http://dx.doi.org/10.1371/journal.pone.0112307			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393297	gold, Green Submitted, Green Published			2022-12-27	WOS:000347709300051
J	Fajs, L; Humolli, I; Saksida, A; Knap, N; Jelovsek, M; Korva, MA; Dedushaj, I; Avsic-Zupanc, T				Fajs, Luka; Humolli, Isme; Saksida, Ana; Knap, Natasa; Jelovsek, Mateja; Korva, Misa A.; Dedushaj, Isuf; Avsic-Zupanc, Tatjana			Prevalence of Crimean-Congo Hemorrhagic Fever Virus in Healthy Population, Livestock and Ticks in Kosovo	PLOS ONE			English	Article							VIRAL LOAD; SEROPREVALENCE; EPIDEMIOLOGY; PATHOGENESIS	Crimean-Congo hemorrhagic fever (CCHF) is an acute, tick borne disease often associated with hemorrhagic presentations and high case fatality rate. Kosovo is a highly endemic area for CCHF, with a significant case fatality rate. The aim of our study was to determine the prevalence of CCHF in Kosovo. We tested 1105 serum samples from healthy population in both endemic and non-endemic areas in the country. Our results revealed a seroprevalence of 4.0% (range 0-9.3%) which is comparable to the seroprevalence in other countries. We show that seroprevalence is correlated to the disease incidence in each studied municipality. We also tested 401 animal sera (353 cow, 30 sheep, 10 goat and 8 chicken) in four endemic municipalities in Kosovo. We detected specific antibodies in all animals except in chicken. Seroprevalence in cows is comparable to other endemic areas and correlates to the seroprevalence in humans. No CCHF RNA could be detected in 105 tick samples obtained in 2012 and 2013. Sequencing of CCHFV positive ticks from 2001 revealed that the virus is most closely related to viral strains that were detected in CCHF patients from Kosovo. Results suggest that mild CCHF cases are most probably underdiagnosed and consequently that the burden of disease is higher than reported. Our study provides key information for CCHF surveillance and raises awareness for possible imported cases in CCHF non-endemic countries.	[Fajs, Luka; Saksida, Ana; Knap, Natasa; Jelovsek, Mateja; Korva, Misa A.; Avsic-Zupanc, Tatjana] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia; [Humolli, Isme; Dedushaj, Isuf] Natl Inst Publ Hlth Kosovo, Pristina, Kosovo, Uruguay	University of Ljubljana	Avsic-Zupanc, T (corresponding author), Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia.	tatjana.avsic@mf.uni-lj.si		Korva, Misa/0000-0003-1501-1004; AVSIC ZUPANC, TATJANA/0000-0001-6243-0688; Knap, Natasa/0000-0002-8068-7302	European Commission under the Health Cooperation Work Programme of the 7th Framework Programme [260427]; European Virus Archive, FP7 CAPACITIES project, GA [228292]	European Commission under the Health Cooperation Work Programme of the 7th Framework Programme; European Virus Archive, FP7 CAPACITIES project, GA	This work is a part of the CCH Fever network (Collaborative Project) supported by the European Commission under the Health Cooperation Work Programme of the 7th Framework Programme (grant agreement no. 260427) and by European Virus Archive, FP7 CAPACITIES project, GA no. 228292. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam IA, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-178; Avsic-Zupanc T, 2007, CRIMEAN CONGO HEMORR, P328; Bente DA, 2013, ANTIVIR RES, V100, P159, DOI 10.1016/j.antiviral.2013.07.006; Bodur H, 2012, EMERG INFECT DIS, V18, P640, DOI 10.3201/eid1804.111374; Christova I, 2013, EMERG INFECT DIS, V19, P177, DOI 10.3201/eid1901.120299; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dokuzoguz B, 2013, CLIN INFECT DIS, V57, P1270, DOI 10.1093/cid/cit527; Duh D, 2006, J VIROL METHODS, V133, P175, DOI 10.1016/j.jviromet.2005.11.006; Duh D, 2007, EMERG INFECT DIS, V13, P1769, DOI 10.3201/eid1311.070222; Duh D, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-7; Durmisi E, 2011, VECTOR-BORNE ZOONOT, V11, P659, DOI 10.1089/vbz.2010.0054; Ertugrul B, 2012, SCAND J INFECT DIS, V44, P276, DOI 10.3109/00365548.2011.621445; Estrada-Pena A, 2012, VECTOR-BORNE ZOONOT, V12, P743, DOI 10.1089/vbz.2011.0767; Fajs L, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002647; Gergova I, 2013, J VECTOR DIS, V50, P265; HOOGSTRAAL H, 1979, J MED ENTOMOL, V15, P307, DOI 10.1093/jmedent/15.4.307; Humolli Isme, 2010, Med Arh, V64, P91; Koksal I, 2013, EPIDEMIOL INFECT, V21, P1; Mostafavi E, 2013, AM J TROP MED HYG, V89, P1135, DOI 10.4269/ajtmh.12-0509; Mourya DT, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001653; Rodriguez LL, 1997, AM J TROP MED HYG, V57, P512, DOI 10.4269/ajtmh.1997.57.512; Saksida A, 2010, CLIN VACCINE IMMUNOL, V17, P1086, DOI 10.1128/CVI.00530-09; Sidira P, 2012, CLIN MICROBIOL INFEC, V18, pE16, DOI 10.1111/j.1469-0691.2011.03718.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vanhomwegen J, 2012, EMERG INFECT DIS, V18, P1958, DOI 10.3201/eid1812.120710; Yagci-Caglayik D, 2014, J MED VIROL, V86, P306, DOI 10.1002/jmv.23699	26	31	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e110982	10.1371/journal.pone.0110982	http://dx.doi.org/10.1371/journal.pone.0110982			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393542	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300007
J	Cheng, JQ; Gonzalez-Vallejo, C				Cheng, Jiuqing; Gonzalez-Vallejo, Claudia			Hyperbolic Discounting: Value and Time Processes of Substance Abusers and Non-Clinical Individuals in Intertemporal Choice	PLOS ONE			English	Article							DELAY; PERCEPTION; REWARDS	The single parameter hyperbolic model has been frequently used to describe value discounting as a function of time and to differentiate substance abusers and non-clinical participants with the model's parameter k. However, k says little about the mechanisms underlying the observed differences. The present study evaluates several alternative models with the purpose of identifying whether group differences stem from differences in subjective valuation, and/ or time perceptions. Using three two-parameter models, plus secondary data analyses of 14 studies with 471 indifference point curves, results demonstrated that adding a valuation, or a time perception function led to better model fits. However, the gain in fit due to the flexibility granted by a second parameter did not always lead to a better understanding of the data patterns and corresponding psychological processes. The k parameter consistently indexed group and context ( magnitude) differences; it is thus a mixed measure of person and task level effects. This was similar for a parameter meant to index payoff devaluation. A time perception parameter, on the other hand, fluctuated with contexts in a non-predicted fashion and the interpretation of its values was inconsistent with prior findings that supported enlarged perceived delays for substance abusers compared to controls. Overall, the results provide mixed support for hyperbolic models of intertemporal choice in terms of the psychological meaning afforded by their parameters.	[Cheng, Jiuqing; Gonzalez-Vallejo, Claudia] Ohio Univ, Dept Psychol, Athens, OH 45701 USA	Ohio University	Cheng, JQ (corresponding author), Ohio Univ, Dept Psychol, Athens, OH 45701 USA.	jc311609@ohio.edu	Gonzalez-Vallejo, Claudia/H-7681-2016					Aaberge R, 2001, REV INCOME WEALTH, P181; Andersen S, 2008, ECONOMETRICA, V76, P583, DOI 10.1111/j.1468-0262.2008.00848.x; Bernoulli D, 1954, ECONOMETRICA, V22, P23, DOI 10.2307/1909829; Bickel WK, 2011, BIOL PSYCHIAT, V69, P260, DOI 10.1016/j.biopsych.2010.08.017; Burks SV, 2009, P NATL ACAD SCI USA, V106, P7745, DOI 10.1073/pnas.0812360106; Chabris CF, 2008, J RISK UNCERTAINTY, V37, P237, DOI 10.1007/s11166-008-9053-x; Cheng JQ, 2012, EXP CLIN PSYCHOPHARM, V20, P400, DOI 10.1037/a0029657; de Wit H, 2009, ADDICT BIOL, V14, P22, DOI 10.1111/j.1369-1600.2008.00129.x; Espin AM, 2012, P ROY SOC B-BIOL SCI, V279, P4923, DOI 10.1098/rspb.2012.2043; ESTES WK, 1956, PSYCHOL BULL, V53, P134, DOI 10.1037/h0045156; Estle SJ, 2006, MEM COGNITION, V34, P914, DOI 10.3758/BF03193437; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; French S., 1986, DECISION THEORY INTR; Gonzalez-Vallejo C, 2001, ORGAN BEHAV HUM DEC, V86, P216, DOI 10.1006/obhd.2001.2953; GONZALEZVALLEJO C, 1992, J EXP PSYCHOL LEARN, V18, P855, DOI 10.1037/0278-7393.18.4.855; GONZALEZVALLEJO CC, 1994, AM J PSYCHOL, V107, P157, DOI 10.2307/1423035; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Hadiati W, 2011, LONG QUEUES ZIMBABWE; Hunter J.E., 2004, METHODS META ANAL CO; Johnson MW, 2002, J EXP ANAL BEHAV, V77, P129, DOI 10.1901/jeab.2002.77-129; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; LOEWENSTEIN G, 1992, Q J ECON, V107, P573, DOI 10.2307/2118482; MacKillop J, 2011, PSYCHOPHARMACOLOGY, V216, P305, DOI 10.1007/s00213-011-2229-0; Mazur J.E., 1987, QUANTITATIVE ANAL BE, P55; McKerchar TL, 2009, BEHAV PROCESS, V81, P256, DOI 10.1016/j.beproc.2008.12.017; Meier S, 2012, PSYCHOL SCI, V23, P56, DOI 10.1177/0956797611425931; Mercer DE, 1999, INDIVIDUAL DRUG COUN; MYERSON J, 1995, J EXP ANAL BEHAV, V64, P263, DOI 10.1901/jeab.1995.64-263; Myerson J, 2001, J EXP ANAL BEHAV, V76, P235, DOI 10.1901/jeab.2001.76-235; Odum AL, 2000, DRUG ALCOHOL DEPEN, V60, P259, DOI 10.1016/S0376-8716(00)00111-3; Rachlin H, 2006, J EXP ANAL BEHAV, V85, P425, DOI 10.1901/jeab.2006.85-05; RODRIGUEZ ML, 1988, J EXP PSYCHOL ANIM B, V14, P105, DOI 10.1037/0097-7403.14.1.105; Roelofsma PHMP, 2000, J BEHAV DECIS MAKING, V13, P161, DOI 10.1002/(SICI)1099-0771(200004/06)13:2<161::AID-BDM348>3.0.CO;2-P; Scholten M, 2006, MANAGE SCI, V52, P1424, DOI 10.1287/mnsc.1060.0534; Scholten M, 2010, PSYCHOL REV, V117, P925, DOI 10.1037/a0019619; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SIDMAN M, 1952, PSYCHOL BULL, V49, P263, DOI 10.1037/h0063643; STEVENS SS, 1957, PSYCHOL REV, V64, P153, DOI 10.1037/h0046162; Takahashi T, 2011, NEUROENDOCRINOL LETT, V32, P221; Wittmann M, 2007, DRUG ALCOHOL DEPEN, V90, P183, DOI 10.1016/j.drugalcdep.2007.03.005; Zauberman G, 2009, J MARKETING RES, V46, P543, DOI 10.1509/jmkr.46.4.543	42	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111378	10.1371/journal.pone.0111378	http://dx.doi.org/10.1371/journal.pone.0111378			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CP	25390941	gold, Green Published, Green Submitted			2022-12-27	WOS:000349144400021
J	Goyal, U; Renvoise, B; Chang, J; Blackstone, C				Goyal, Uma; Renvoise, Benoit; Chang, Jaerak; Blackstone, Craig			Spastin-Interacting Protein NA14/SSNA1 Functions in Cytokinesis and Axon Development	PLOS ONE			English	Article							MICROTUBULE-SEVERING PROTEINS; AUTOSOMAL-DOMINANT; ESCRT-III; SUBCELLULAR-LOCALIZATION; NEURONAL DEVELOPMENT; SJOGRENS-SYNDROME; GENE DOSAGE; IN-VITRO; PARAPLEGIA; NA14	Hereditary spastic paraplegias (HSPs) are a genetically diverse group of inherited neurological disorders (SPG1-72) with the cardinal feature of prominent lower-extremity spasticity due to a length-dependent axonopathy of corticospinal motor neurons. The most frequent form of autosomal dominant HSP results from mutations of the SPG4 gene product spastin. This is an ATPase associated with diverse cellular activities (AAA) protein that binds to and severs microtubules. While spastin participates in crucial cellular processes such as cytokinesis, endosomal tubulation, and axon development, its role in HSP pathogenesis remains unclear. Spastin interacts in cells with the NA14 protein, a major target for auto-antibodies in Sjogren's syndrome (nuclear autoantigen 1; SSNA1). Our analysis of endogenous spastin and NA14 proteins in HeLa cells and rat cortical neurons in primary culture revealed a clear distribution of both proteins to centrosomes, with NA14 localizing specifically to centrioles. Stable NA14 knockdown in cell lines dramatically affected cell division, in particular cytokinesis. Furthermore, overexpression of NA14 in neurons significantly increased axon outgrowth and branching, while also enhancing neuronal differentiation. We postulate that NA14 may act as an adaptor protein regulating spastin localization to centrosomes, temporally and spatially regulating the microtubule-severing activity of spastin that is particularly critical during the cell cycle and neuronal development.	[Goyal, Uma; Renvoise, Benoit; Chang, Jaerak; Blackstone, Craig] NINDS, Cell Biol Sect, Neurogenet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Blackstone, C (corresponding author), NINDS, Cell Biol Sect, Neurogenet Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	blackstc@ninds.nih.gov		Chang, Jaerak/0000-0003-1732-2076	Intramural Research Program of the National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH); Howard Hughes Medical Institute-NIH Research Scholars Program; NIH Clinical Research Training Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002992] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH); Howard Hughes Medical Institute-NIH Research Scholars Program(Howard Hughes Medical Institute); NIH Clinical Research Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH). U.G. was supported by the Howard Hughes Medical Institute-NIH Research Scholars Program, and A.T. was supported by the NIH Clinical Research Training Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad FJ, 1999, J CELL BIOL, V145, P305, DOI 10.1083/jcb.145.2.305; Aki T, 2008, J CELL PHYSIOL, V217, P194, DOI 10.1002/jcp.21492; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Avidor-Reiss T, 2013, CURR OPIN CELL BIOL, V25, P72, DOI 10.1016/j.ceb.2012.10.016; Baas PW, 1996, MOL NEUROBIOL, V12, P145, DOI 10.1007/BF02740651; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Blackstone C, 2012, ANNU REV NEUROSCI, V35, P25, DOI 10.1146/annurev-neuro-062111-150400; Blackstone C, 2011, NAT REV NEUROSCI, V12, P31, DOI 10.1038/nrn2946; Casanova M, 2009, MOL MICROBIOL, V71, P1353, DOI 10.1111/j.1365-2958.2009.06594.x; Charron F, 2007, ADV EXP MED BIOL, V621, P116, DOI 10.1007/978-0-387-76715-4_9; Claudiani P, 2005, EXP CELL RES, V309, P358, DOI 10.1016/j.yexcr.2005.06.009; Connell JW, 2009, TRAFFIC, V10, P42, DOI 10.1111/j.1600-0854.2008.00847.x; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; Denton KR, 2014, STEM CELLS, V32, P414, DOI 10.1002/stem.1569; Dogterom M, 2013, CURR OPIN CELL BIOL, V25, P23, DOI 10.1016/j.ceb.2012.12.002; Errico A, 2002, HUM MOL GENET, V11, P153, DOI 10.1093/hmg/11.2.153; Errico A, 2004, HUM MOL GENET, V13, P2121, DOI 10.1093/hmg/ddh223; Fink JK, 2013, ACTA NEUROPATHOL, V126, P307, DOI 10.1007/s00401-013-1115-8; Finsterer J, 2012, J NEUROL SCI, V318, P1, DOI 10.1016/j.jns.2012.03.025; Gress TM, 1996, ONCOGENE, V13, P1819; HARDING AE, 1983, LANCET, V1, P1151; Havlicek S, 2014, HUM MOL GENET, V23, P2527, DOI 10.1093/hmg/ddt644; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Lai CK, 2011, MOL BIOL CELL, V22, P1104, DOI 10.1091/mbc.E10-07-0596; Lee S, 2012, MOL BIOL CELL, V23, P4347, DOI 10.1091/mbc.E12-04-0292; McDermott CJ, 2003, ANN NEUROL, V54, P748, DOI 10.1002/ana.10757; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; Nozawa K, 2009, FRONT BIOSCI-LANDMRK, V14, P3733, DOI [10.2741/4084, 10.2741/3484]; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; Pfannenschmid F, 2003, J CELL SCI, V116, P1449, DOI 10.1242/jcs.00337; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Price HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031842; Ramos-Morales F, 1998, J BIOL CHEM, V273, P1634, DOI 10.1074/jbc.273.3.1634; Reid E, 2003, J MED GENET, V40, P81, DOI 10.1136/jmg.40.2.81; Renvoise B, 2012, HUM MOL GENET, V21, P3604, DOI 10.1093/hmg/dds191; Renvoise B, 2010, MOL BIOL CELL, V21, P3293, DOI 10.1091/mbc.E09-10-0879; Riano E, 2009, J NEUROCHEM, V108, P1277, DOI 10.1111/j.1471-4159.2009.05875.x; Rodriguez-Rodriguez M, 2011, PROTEIN ENG DES SEL, V24, P883, DOI 10.1093/protein/gzr050; Schoppmeier J, 2005, CELL MOTIL CYTOSKEL, V61, P189, DOI 10.1002/cm.20074; Soderblom C, 2006, PHARMACOL THERAPEUT, V109, P42, DOI 10.1016/j.pharmthera.2005.06.001; Solowska JM, 2008, J NEUROSCI, V28, P2147, DOI 10.1523/JNEUROSCI.3159-07.2008; Stone MC, 2012, CELL REP, V2, P1340, DOI 10.1016/j.celrep.2012.09.032; Svenson IK, 2005, NEUROGENETICS, V6, P135, DOI 10.1007/s10048-005-0219-2; van Vlierberghe P, 2006, LEUKEMIA, V20, P1245, DOI 10.1038/sj.leu.2404247; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512; Yu WQ, 2008, MOL BIOL CELL, V19, P1485, DOI 10.1091/mbc.E07-09-0878; Zhu PP, 2003, J BIOL CHEM, V278, P49063, DOI 10.1074/jbc.M306702200; Zhu PP, 2006, HUM MOL GENET, V15, P1343, DOI 10.1093/hmg/ddl054; Zmuda JF, 1998, CELL MOTIL CYTOSKEL, V41, P18, DOI 10.1002/(SICI)1097-0169(1998)41:1<18::AID-CM2>3.0.CO;2-B	50	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112428	10.1371/journal.pone.0112428	http://dx.doi.org/10.1371/journal.pone.0112428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390646	Green Submitted, gold, Green Published			2022-12-27	WOS:000349144400080
J	Haeseker, MB; Croes, S; Neef, C; Bruggeman, CA; Stolk, LML; Verbon, A				Haeseker, Michiel B.; Croes, Sander; Neef, Cees; Bruggeman, Cathrien A.; Stolk, Leo M. L.; Verbon, Annelies			Vancomycin Dosing in Neutropenic Patients	PLOS ONE			English	Article							AUGMENTED RENAL CLEARANCE; INTENSIVE-CARE-UNIT; CRITICALLY-ILL PATIENTS; FEBRILE NEUTROPENIA; SERUM CREATININE; LEUKEMIA	Background: To compare vancomycin pharmacokinetic parameters in patients with and without neutropenia. Methods: Patients >= 18 years admitted on general wards were included. Routinely vancomycin trough and peak plasma concentrations were measured with a fluorescence polarization immunoassay. Pharmacokinetic parameters of individual patients were determined with maximum a posterior Bayesian estimation (MW Pharm 3.60). Neutropenia was defined as neutrophils <0.5X10(9) cells/L. Principal Findings: A total of 171 patients were included. Patients with neutropenia (n = 56) had higher clearance of vancomycin (CLva), 67 (+/- 26) mL/min, compared to patients without neutropenia (n = 115), CLva 50 (622) mL/min (p, 0.001). No significant difference was found in serum creatinine and vancomycin volume of distribution. Neutropenia was positively associated with CLva, independently of relevant co-variables (B: 12.122, 95% CI: 1.095 to 23.149, p = 0.031). On average patients with neutropenia needed 33% higher doses of vancomycin to attain adequate exposure, i.e. AUC(24)>= 400 mgxh/L. Furthermore, 15 initially neutropenic patients in our study group received vancomycin for a second administration period. Ten patients received the second administration period during another neutropenic period and 5 patients during a non-neutropenic phase. All 5 patients with vancomycin during both neutropenic and non-neutropenic phase had higher CLva (91 (+/- 26) mL/min) during the neutropenic period and lower CLva (45 (+/- 10) mL/min) during the non-neutropenic phase (p = 0.009). Conclusion: This study shows that most patients with neutropenia have augmented CLva. In a small group of patients that received vancomycin during two episodes, the augmented CLva seems to be reversible in the non-neutropenic period. Our data indicate that it is important to increase the daily dose with one third in patients with neutropenia (from 15 mg/kg twice daily to 13 mg/kg three times daily). Frequent performance of therapeutic drug monitoring in patients with neutropenia may prevent both therapy failure due to low AUCs and overcomes toxicity due to high vancomycin trough concentrations during recovery from neutropenia.	[Haeseker, Michiel B.; Bruggeman, Cathrien A.; Verbon, Annelies] Maastricht Univ, Med Ctr, Dept Med Microbiol, NL-6200 MD Maastricht, Netherlands; [Haeseker, Michiel B.; Bruggeman, Cathrien A.] CAPHRI, Maastricht, Netherlands; [Croes, Sander; Neef, Cees; Stolk, Leo M. L.] Maastricht Univ, Med Ctr, Dept Clin Pharm & Toxicol, NL-6200 MD Maastricht, Netherlands; [Verbon, Annelies] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands	Maastricht University; Maastricht University; Maastricht University; Erasmus University Rotterdam; Erasmus MC	Haeseker, MB (corresponding author), Maastricht Univ, Med Ctr, Dept Med Microbiol, NL-6200 MD Maastricht, Netherlands.	m.haeseker@mumc.nl			department of Pharmacy laboratory	department of Pharmacy laboratory	The authors acknowledge the support provided by department of Pharmacy laboratory and the excellent statistical advice of Casper den Heijer.	Buelga DS, 2005, ANTIMICROB AGENTS CH, V49, P4934, DOI 10.1128/AAC.49.12.4934-4941.2005; Claus BOM, 2013, J CRIT CARE, V28, P695, DOI 10.1016/j.jcrc.2013.03.003; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Grootaert V, 2012, ANN PHARMACOTHER, V46, P952, DOI 10.1345/aph.1Q708; Hoste EAJ, 2005, NEPHROL DIAL TRANSPL, V20, P747, DOI 10.1093/ndt/gfh707; Pea F, 2005, ANTIMICROB AGENTS CH, V49, P3550, DOI 10.1128/AAC.49.8.3550-3553.2005; Pea F, 2004, CLIN PHARMACOKINET, V43, P405, DOI 10.2165/00003088-200443060-00004; PROOST JH, 1992, COMPUT BIOL MED, V22, P155, DOI 10.1016/0010-4825(92)90011-B; PRYKA RD, 1989, THER DRUG MONIT, V11, P450; Revilla N, 2010, BRIT J CLIN PHARMACO, V70, P201, DOI 10.1111/j.1365-2125.2010.03679.x; RODVOLD KA, 1989, THER DRUG MONIT, V11, P269, DOI 10.1097/00007691-198905000-00009; Schelenz S, 2013, J ANTIMICROB CHEMOTH, V68, P1431, DOI 10.1093/jac/dkt002; Scott BL, 2008, BIOL BLOOD MARROW TR, V14, P799, DOI 10.1016/j.bbmt.2008.04.011; Sepkowitz KA, 2002, BONE MARROW TRANSPL, V29, P367, DOI 10.1038/sj.bmt.1703366; Sime FB, 2014, ANTIMICROB AGENTS CH; Troger U, 2012, INT J ANTIMICROB AG, V40, P370, DOI 10.1016/j.ijantimicag.2012.05.010; Udy AA, 2010, INT J ANTIMICROB AG, V35, P606, DOI 10.1016/j.ijantimicag.2010.02.013; Udy AA, 2010, CLIN PHARMACOKINET, V49, P1, DOI 10.2165/11318140-000000000-00000; van der Meer AF, 2011, THER DRUG MONIT, V33, P133, DOI 10.1097/FTD.0b013e31820f40f8	19	15	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112008	10.1371/journal.pone.0112008	http://dx.doi.org/10.1371/journal.pone.0112008			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390637	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400044
J	Vieira, S; Martins, S; Hawkes, LA; Marco, A; Teodosio, MA				Vieira, Sara; Martins, Samir; Hawkes, Lucy A.; Marco, Adolfo; Alexandra Teodosio, M.			Biochemical Indices and Life Traits of Loggerhead Turtles (Caretta caretta) from Cape Verde Islands	PLOS ONE			English	Article							SEA-TURTLE; INCUBATION-TEMPERATURE; RNA/DNA RATIOS; SATELLITE TRACKING; MARINE TURTLES; ADULT FEMALE; BODY-SIZE; CONSERVATION; HATCHLINGS; DICHOTOMY	The loggerhead turtle (Caretta caretta) is an endangered marine reptile for whom assessing population health requires knowledge of demographic parameters such as individual growth rate. In Cape Verde, as within several populations, adult female loggerhead sea turtles show a size-related behavioral and trophic dichotomy. While smaller females are associated with oceanic habitats, larger females tend to feed in neritic habitats, which is reflected in their physiological condition and in their offspring. The ratio of RNA/DNA provides a measure of cellular protein synthesis capacity, which varies depending on changes in environmental conditions such as temperature and food availability. The purpose of this study was to evaluate the combined use of morphometric data and biochemical indices as predictors of the physiological condition of the females of distinct sizes and hatchlings during their nesting season and how temperature may influence the physiological condition on the offspring. Here we employed biochemical indices based on nucleic acid derived indices (standardized RNA/DNA ratio-sRD, RNA concentration and DNA concentration) in skin tissue as a potential predictor of recent growth rate in nesting females and hatchling loggerhead turtles. Our major findings were that the physiological condition of all nesting females (sRD) decreased during the nesting season, but that females associated with neritic habitats had a higher physiological condition than females associated with oceanic habitats. In addition, the amount of time required for a hatchling to right itself was negatively correlated with its physiological condition (sRD) and shaded nests produced hatchlings with lower sRD. Overall, our results showed that nucleic acid concentrations and ratios of RNA to DNA are an important tool as potential biomarkers of recent growth in marine turtles. Hence, as biochemical indices of instantaneous growth are likely temperature-, size- and age-dependent, the utility and validation of these indices on marine turtles stocks deserves further study.	[Vieira, Sara; Martins, Samir; Alexandra Teodosio, M.] Univ Algarve, Ctr Ciencias Mar, Faro, Portugal; [Hawkes, Lucy A.] Univ Exeter, Coll Life & Environm Sci, Penryn, Cornwall, England; [Marco, Adolfo] CSIC, Estn Biol Donana, E-41080 Seville, Spain	Universidade do Algarve; University of Exeter; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Teodosio, MA (corresponding author), Univ Algarve, Ctr Ciencias Mar, Campus Gambelas, Faro, Portugal.	mchichar@ualg.pt	Teodosio, M A/B-5077-2013; Marco, Adolfo/B-7118-2009; Hawkes, Lucy/L-7407-2014	Teodosio, M A/0000-0002-0939-9885; Marco, Adolfo/0000-0002-6523-9704; Hawkes, Lucy/0000-0002-6696-1862; Martins, Samir/0000-0003-3156-9630; Vieira, Sara/0000-0001-6113-1862	Cape Verde Ministry of Environment (General Direction for the Environment); INDP (National Fisheries Institution); Canary Islands Government (D.G. Africa); ICCM (Canarian Institution for Marine Sciences); Andalusian Government (Andalusian Environmental Office); AEGINA PROJECT (INTERREG IIIB); European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme; national funds through FCT [PEst-C/MAR/LA0015/2011]; Canary Islands Government (D.G. Research and Universities)	Cape Verde Ministry of Environment (General Direction for the Environment); INDP (National Fisheries Institution); Canary Islands Government (D.G. Africa); ICCM (Canarian Institution for Marine Sciences); Andalusian Government (Andalusian Environmental Office); AEGINA PROJECT (INTERREG IIIB); European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme; national funds through FCT(Portuguese Foundation for Science and Technology); Canary Islands Government (D.G. Research and Universities)	The authors thank the Cape Verde Ministry of Environment (General Direction for the Environment), INDP (National Fisheries Institution), the Canary Islands Government (D.G. Africa and D.G. Research and Universities), ICCM (Canarian Institution for Marine Sciences), the Andalusian Government (Andalusian Environmental Office) and AEGINA PROJECT (INTERREG IIIB) for funding and hosting them during this study. The authors also thank the European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme, and national funds through FCT - PEst-C/MAR/LA0015/2011 for supporting the biochemical analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral V, 2008, MAR FRESHWATER RES, V59, P726, DOI 10.1071/MF08006; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; BJORNDAL KA, 1995, COPEIA, P71; Booth DT, 2004, INT CONGR SER, V1275, P226, DOI 10.1016/j.ics.2004.08.057; Broad S, 2003, TRADE IN WILDLIFE: REGULATION FOR CONSERVATION, P3; Buckley LJ, 2008, MAR ECOL PROG SER, V371, P221, DOI 10.3354/meps07648; Caldarone EM, 2006, LIMNOL OCEANOGR-METH, V4, P153, DOI 10.4319/lom.2006.4.153; Caldarone EM, 2001, PROTOCOL GUIDE ESTIM; CHEREL Y, 1988, AM J PHYSIOL, V254, pR170, DOI 10.1152/ajpregu.1988.254.2.R170; Chicharo MA, 2003, FISH RES, V1525, P1; Chicharo MA, 2008, INT J MOL SCI, V9, P1453, DOI 10.3390/ijms9081453; Davenport J, 1997, J THERM BIOL, V22, P479, DOI 10.1016/S0306-4565(97)00066-1; Delmas V, 2007, BIOL J LINN SOC, V91, P99, DOI 10.1111/j.1095-8312.2007.00780.x; Dutton P.H., 1996, P INT S SEA TURTL CO, V396, P17, DOI [10.1051/parasite/2014024, DOI 10.1051/PARASITE/2014024]; Eder E, 2012, MAR ECOL PROG SER, V470, P113, DOI 10.3354/meps10018; Esteves E, 2000, J EXP MAR BIOL ECOL, V245, P43, DOI 10.1016/S0022-0981(99)00150-1; Frommel A, 2009, SCI MAR, V73, P159, DOI 10.3989/scimar.2009.73s1159; Godley B. J., 2008, Endangered Species Research, V4, P3, DOI 10.3354/esr00060; Goldberg DW, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot016; Gyuris Emma, 2000, P143; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hamann M, 2002, J COMP PHYSIOL B, V172, P485, DOI [10.1002/s00360-002-0271-2, 10.1007/s00360-002-0271-2]; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Hatase H, 2007, J ZOOL, V273, P46, DOI 10.1111/j.1469-7998.2007.00298.x; Hatase H, 2014, J EXP MAR BIOL ECOL, V455, P56, DOI 10.1016/j.jembe.2014.03.002; Hatase H, 2010, MAR BIOL, V157, P1337, DOI 10.1007/s00227-010-1413-9; Hawkes LA, 2006, CURR BIOL, V16, P990, DOI 10.1016/j.cub.2006.03.063; Hawkes LA, 2013, AQUAT BIOL, V18, P9, DOI 10.3354/ab00475; Hawkes Lucy A., 2009, Endangered Species Research, V7, P137, DOI 10.3354/esr00198; Ikeda T, 2007, AQUAT BIOL, V1, P99, DOI 10.3354/ab00011; JANZEN FJ, 1993, ECOLOGY, V74, P332, DOI 10.2307/1939296; Ji X, 2002, J EXP ZOOL, V292, P649, DOI 10.1002/jez.10101; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; LIMPUS CJ, 1979, HERPETOLOGICA, V35, P335; LIMPUS CJ, 1992, WILDLIFE RES, V19, P457, DOI 10.1071/WR9920457; Limpus CJ, 1993, FAUNA OF AUSTR, V2, P113; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Marco A, 2012, ANIM CONSERV, V15, P351, DOI 10.1111/j.1469-1795.2012.00547.x; Meyer S, 2012, J MARINE SYST, V93, P11, DOI 10.1016/j.jmarsys.2011.09.010; Miller Jeffrey D., 1997, P51; Monzon-Arguello C, 2010, CONSERV GENET, V11, P1871, DOI 10.1007/s10592-010-0079-7; Mortimer Jeanne A., 1999, P175; Ozdemir A, 2007, ZOOL SCI, V24, P376, DOI 10.2108/zsj.24.376; Packard G.C., 1988, Biology of Reptilia, V16, P523; Pendoley KL, 2014, MAR BIOL, V161, P1455, DOI 10.1007/s00227-014-2433-7; Perrault JR, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou002; Olivar MP, 2009, SCI MAR, V73, P171, DOI 10.3989/scimar.2009.73s1171; PINCKNEY J, 1990, B MAR SCI, V47, P670; Plot V, 2013, PHYSIOL BIOCHEM ZOOL, V86, P385, DOI 10.1086/671127; Rafferty AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021038; Roark AM, 2009, J EXP MAR BIOL ECOL, V376, P59, DOI 10.1016/j.jembe.2009.06.004; Seminoff JA, 2008, J EXP MAR BIOL ECOL, V356, P52, DOI 10.1016/j.jembe.2007.12.007; Steyermark AC, 2001, COPEIA, P129; VANBUSKIRK J, 1994, COPEIA, P66; Varo Cruz Nuria, 2007, P127; Wallace BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024510; Wood A, 2014, J EXP MAR BIOL ECOL, V451, P105, DOI 10.1016/j.jembe.2013.11.005; Zbinden JA, 2011, MAR ECOL PROG SER, V421, P291, DOI 10.3354/meps08871	59	13	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112181	10.1371/journal.pone.0112181	http://dx.doi.org/10.1371/journal.pone.0112181			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390348	gold, Green Published, Green Submitted			2022-12-27	WOS:000349144400061
J	Han, JY; Lee, KS; Park, WH; Park, CH; Lee, JG; Lee, JZ; Kim, DY; Na, YG; Kwon, DD; Choo, MS				Han, Ji-Yeon; Lee, Kyu-Sung; Park, Won Hee; Park, Choal Hee; Lee, Jeong Gu; Lee, Jeong Zoo; Kim, Duk Yoon; Na, Yong Gil; Kwon, Dong Deuk; Choo, Myung-Soo			A Comparative Study on the Efficacy of Solifenacin Succinate in Patients with Urinary Frequency with or without Urgency	PLOS ONE			English	Article							OVERACTIVE BLADDER SYNDROME; SYMPTOM; PERCEPTION; IMPACT	Objectives: Patients with overactive bladder (OAB) often have trouble perceiving urgency because of difficulties in distinguishing between urgency and desire to void. Empirical antimuscarinic treatment of patients with frequency only may be reasonable if conservative management has failed. We compared the efficacy of solifenacin in patients with frequency with or without urgency. Materials and Methods: This multicenter, 12-week, open-label, comparative, non-inferiority clinical trial assessed whether the solifenacin efficacy for frequency without urgency is non-inferior to its efficacy for frequency with urgency. All patients had micturition frequency >= 8 voids/day with or without urgency. Primary efficacy variable: daily frequency change at 12 weeks relative to baseline. Secondary efficacy variables: change at 12 weeks relative to baseline in Patients' Perception of Bladder Condition (PPBC), OAB Symptom Score (OABSS), and Benefit, Satisfaction, Willingness to continue (BSW) questionnaire. Results: Of the 286 enrolled patients, 240 (83.9%) completed the study (without urgency n = 115; with urgency n = 125). Full dataset analysis revealed that the groups without and with urgency exhibited significant reductions in daily micturition frequency of -2.49 +/- 0.35 (mean +/- standard error) and -2.63 +/- 0.37, respectively. The lower limit of the 95% two-sided CI of the comparison of the two group means was -1.14, which is smaller than the -0.8 margin of clinical equivalence. The two groups did not differ in improvement in PPBC, OABSS, or BSW scores. Both tolerated the treatment well. Conclusions: It was not possible to verify that the solifenacin efficacy for frequency alone was non-inferior to its efficacy for OAB. Nevertheless, solifenacin tended to be effective for frequency regardless of urgency.	[Han, Ji-Yeon] Pusan Natl Univ, Yangsan Hosp, Dept Urol, Yangsan, South Korea; [Lee, Kyu-Sung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Urol, Seoul, South Korea; [Park, Won Hee] Inha Univ, Coll Med, Dept Urol, Inchon, South Korea; [Park, Choal Hee] Keimyung Univ, Sch Med, Dept Urol, Taegu, South Korea; [Lee, Jeong Gu] Korea Univ, Coll Med, Dept Urol, Seoul 136705, South Korea; [Lee, Jeong Zoo] Pusan Natl Univ Hosp, Dept Urol, Pusan, South Korea; [Kim, Duk Yoon] Catholic Univ, Daegu Sch Med, Dept Urol, Taegu, South Korea; [Na, Yong Gil] Chungnam Natl Univ, Sch Med, Dept Urol, Taejon, South Korea; [Kwon, Dong Deuk] Chonnam Natl Univ, Chonnam Natl Univ Hwasun Hosp, Sch Med, Dept Urol, Kwangju, South Korea; [Choo, Myung-Soo] Univ Ulsan, Asan Med Ctr, Coll Med, Dept Urol, Seoul, South Korea	Pusan National University; Pusan National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Inha University; Keimyung University; Korea University; Korea University Medicine (KU Medicine); Pusan National University; Pusan National University Hospital; Catholic University of Korea; Chungnam National University; Chonnam National University; Chonnam National University Hospital; University of Ulsan; Asan Medical Center	Choo, MS (corresponding author), Pusan Natl Univ, Yangsan Hosp, Dept Urol, Yangsan, South Korea.	mschoo@amc.seoul.kr		Na, Yong-Gil/0000-0002-0794-5459	Astellas Pharma, Korea	Astellas Pharma, Korea	Funding provided by Astellas Pharma, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Abrams P, 2012, WORLD J UROL, V30, P385, DOI 10.1007/s00345-011-0742-8; Brubaker L, 2004, UROLOGY, V64, P12, DOI 10.1016/j.urology.2004.10.073; Chapple CR, 2008, EUR UROL, V54, P543, DOI 10.1016/j.eururo.2008.06.047; Chapple CR, 2005, BJU INT, V95, P335, DOI 10.1111/j.1464-410X.2005.05294.x; Coyne KS, 2006, EUR UROL, V49, P1079, DOI 10.1016/j.eururo.2006.01.007; Coyne KS, 2012, NEUROUROL URODYNAM, V31, P455, DOI 10.1002/nau.21242; Coyne KS, 2011, NEUROUROL URODYNAM, V30, P360, DOI 10.1002/nau.21005; Darling R, 2005, J UROLOGY, V173, P487, DOI 10.1097/01.ju.0000148950.38369.66; Digesu GA, 2008, NEUROUROL URODYNAM, V27, P368, DOI 10.1002/nau.20527; Elinoff V, 2006, INT J CLIN PRACT, V60, P745, DOI 10.1111/j.1742-1241.2006.00986.x; Finney SM, 2006, BJU INT, V98, P503, DOI 10.1111/j.1464-410X.2006.06258.x; Harvey J, 2012, BJU INT, V110, P1756, DOI 10.1111/j.1464-410X.2012.11078.x; Homma Y, 2006, UROLOGY, V68, P318, DOI 10.1016/j.urology.2006.02.042; Honjo H, 2010, NEUROUROL URODYNAM, V29, P1286, DOI 10.1002/nau.20874; Irwin DE, 2011, BJU INT, V108, P1132, DOI 10.1111/j.1464-410X.2010.09993.x; Lee KS, 2010, BJU INT, V105, P1565, DOI 10.1111/j.1464-410X.2009.09050.x; Nixon A, 2005, J UROLOGY, V174, P604, DOI 10.1097/01.ju.0000165461.38088.7b; Panayi DC, 2010, INT UROGYNECOL J, V21, P841, DOI 10.1007/s00192-010-1123-3; Starkman JS, 2008, NEUROUROL URODYNAM, V27, P13, DOI 10.1002/nau.20472; Stav K, 2009, J UROLOGY, V181, P2176, DOI 10.1016/j.juro.2009.01.042; Yamaguchi O, 2010, NEUROUROL URODYNAM, V29, P112, DOI 10.1002/nau.20796	22	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112063	10.1371/journal.pone.0112063	http://dx.doi.org/10.1371/journal.pone.0112063			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401784	Green Published, Green Submitted, gold			2022-12-27	WOS:000345158700025
J	Liu, TF; Qu, H; Luo, CL; Li, XW; Shu, DM; Lund, MS; Su, GS				Liu, Tianfei; Qu, Hao; Luo, Chenglong; Li, Xuewei; Shu, Dingming; Lund, Mogens Sando; Su, Guosheng			Genomic Selection for the Improvement of Antibody Response to Newcastle Disease and Avian Influenza Virus in Chickens	PLOS ONE			English	Article							GENETIC-RELATIONSHIP INFORMATION; ESTIMATED BREEDING VALUES; LAYING HENS; CROSSBRED PERFORMANCE; HOLSTEIN POPULATION; NORDIC HOLSTEIN; MAREKS-DISEASE; BODY-WEIGHT; RESISTANCE; TRAITS	Newcastle disease (ND) and avian influenza (AI) are the most feared diseases in the poultry industry worldwide. They can cause flock mortality up to 100%, resulting in a catastrophic economic loss. This is the first study to investigate the feasibility of genomic selection for antibody response to Newcastle disease virus (Ab-NDV) and antibody response to Avian Influenza virus (Ab-AIV) in chickens. The data were collected from a crossbred population. Breeding values for Ab-NDV and Ab-AIV were estimated using a pedigree-based best linear unbiased prediction model (BLUP) and a genomic best linear unbiased prediction model (GBLUP). Single-trait and multiple-trait analyses were implemented. According to the analysis using the pedigree-based model, the heritability for Ab-NDV estimated from the single-trait and multiple-trait models was 0.478 and 0.487, respectively. The heritability for Ab-AIV estimated from the two models was 0.301 and 0.291, respectively. The estimated genetic correlation between the two traits was 0.438. A four-fold cross-validation was used to assess the accuracy of the estimated breeding values (EBV) in the two validation scenarios. In the family sample scenario each half-sib family is randomly allocated to one of four subsets and in the random sample scenario the individuals are randomly divided into four subsets. In the family sample scenario, compared with the pedigree-based model, the accuracy of the genomic prediction increased from 0.086 to 0.237 for Ab-NDV and from 0.080 to 0.347 for Ab-AIV. In the random sample scenario, the accuracy was improved from 0.389 to 0.427 for Ab-NDV and from 0.281 to 0.367 for Ab-AIV. The multiple-trait GBLUP model led to a slightly higher accuracy of genomic prediction for both traits. These results indicate that genomic selection for antibody response to ND and AI in chickens is promising.	[Liu, Tianfei; Li, Xuewei] Sichuan Agr Univ, Coll Anim Sci & Technol, Yaan, Peoples R China; [Liu, Tianfei; Qu, Hao; Luo, Chenglong; Shu, Dingming] Guangdong Acad Agr Sci, Inst Anim Sci, Guangzhou, Guangdong, Peoples R China; [Liu, Tianfei; Lund, Mogens Sando; Su, Guosheng] Aarhus Univ, Dept Mol Biol & Genet, Ctr Quantitat Genet & Genom, Tjele, Denmark; [Liu, Tianfei; Qu, Hao; Luo, Chenglong; Shu, Dingming] State Key Lab Livestock & Poultry Breeding, Guangzhou, Guangdong, Peoples R China	Sichuan Agricultural University; Guangdong Academy of Agricultural Sciences; Aarhus University	Li, XW (corresponding author), Sichuan Agr Univ, Coll Anim Sci & Technol, Yaan, Peoples R China.	lixuewei9125@126.com; shudm@263.net; Guosheng.Su@agrsci.dk	Lund, Mogens S/I-4321-2016; Liu, Tianfei/X-9848-2019	Liu, Tianfei/0000-0003-1835-9807	National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2011BAD28B03]; Key Technology Research and Development Program of Guangdong Emerging Strategic Industries [2012A020800005]	National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Key Technology Research and Development Program of Guangdong Emerging Strategic Industries	This work was supported by grants from the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (grant no. 2011BAD28B03, http://www.most.gov.cn/) and Key Technology Research and Development Program of Guangdong Emerging Strategic Industries (grant no. 2012A020800005, http://www.gdstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ababneha MMK, 2012, RES VET SCI, V93, P1512, DOI 10.1016/j.rvsc.2012.03.004; Alexander D, 2001, BRIT POULTRY SCI, V42, P5, DOI 10.1080/713655022; ALEXANDER DJ, 1995, J COMP PATHOL, V112, P105, DOI 10.1016/S0021-9975(05)80054-4; Bacon LD, 2000, POULTRY SCI, V79, P1082, DOI 10.1093/ps/79.8.1082; Biscarini F, 2010, ANIM GENET, V41, P26, DOI 10.1111/j.1365-2052.2009.01960.x; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Calus MPL, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-26; Capua I, 2009, POULTRY SCI, V88, P842, DOI 10.3382/ps.2008-00289; Christensen OF, 2012, ANIMAL, V6, P1565, DOI 10.1017/S1751731112000742; Fulton JE, 2013, AVIAN DIS, V57, P519, DOI 10.1637/10408-100212-Reg.1; Gao H, 2013, J DAIRY SCI, V96, P4678, DOI 10.3168/jds.2012-6406; GAVORA JS, 1974, POULTRY SCI, V53, P889, DOI 10.3382/ps.0530889; Gavora S., 1983, ANIMAL BLOOD GROUPS, V14, P159; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; Grimm D, 2007, P NATL ACAD SCI USA, V104, P6806, DOI 10.1073/pnas.0701849104; Groenen MAM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-274; GROSS WG, 1980, POULTRY SCI, V59, P205, DOI 10.3382/ps.0590205; Guo G, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-30; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Habier D, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-5; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Jaworek B, 1978, GENET SEL EVOL, V10, P1; Jia Y, 2012, GENETICS, V192, P1513, DOI 10.1534/genetics.112.144246; Kapell DNRG, 2012, POULTRY SCI, V91, P3032, DOI 10.3382/ps.2012-02578; Legarra A, 2011, POULTRY SCI, V90, P731, DOI 10.3382/ps.2010-01260; Legarra A, 2008, GENETICS, V180, P611, DOI 10.1534/genetics.108.088575; Lund M. S., 2009, BMC P S1, V3, pS1, DOI DOI 10.1186/1753-6561-3-S1-S1; Luo CL, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-42; Madsen P, 2010, P 9 WORLD C GEN APPL; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen THE, 2009, GENETICS SELECTION E, V41, P35; Meuwissen T, 2013, ANNU REV ANIM BIOSCI, V1, P221, DOI 10.1146/annurev-animal-031412-103705; MOYER SE, 1962, POULTRY SCI, V41, P1374, DOI 10.3382/ps.0411374; Newman S, 2002, J ANIM SCI, V80, P1801; Ostersen T, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-38; PINARD MH, 1992, J ANIM SCI, V70, P2986, DOI 10.2527/1992.70102986x; Saatchi M, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-40; SACCO RE, 1994, AVIAN DIS, V38, P33, DOI 10.2307/1591833; Sanchez JP, 2008, J ANIM SCI, V86, P267, DOI 10.2527/jas.2007-0064; Sartore S, 2010, POULTRY SCI, V89, P1115, DOI 10.3382/ps.2009-00556; Sheng ZY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-151; Sironi Laura, 2011, BMC Proc, V5 Suppl 4, pS25, DOI 10.1186/1753-6561-5-S4-S25; Su G, 2012, J DAIRY SCI, V95, P4657, DOI 10.3168/jds.2012-5379; Su G, 2010, J DAIRY SCI, V93, P1175, DOI 10.3168/jds.2009-2192; Tsuruta S, 2011, J DAIRY SCI, V94, P4198, DOI 10.3168/jds.2011-4256; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Wang Y, 2012, POULTRY SCI, V91, P3019, DOI 10.3382/ps.2012-02471; WEI M, 1995, J ANIM SCI, V73, P2220; WILSON LL, 1971, J HERED, V62, P123, DOI 10.1093/oxfordjournals.jhered.a108138; Wolc A, 2013, POULTRY SCI, V92, P2270, DOI 10.3382/ps.2013-03085; Wolc A, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-23; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457	53	12	15	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112685	10.1371/journal.pone.0112685	http://dx.doi.org/10.1371/journal.pone.0112685			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401767	gold, Green Submitted, Green Published			2022-12-27	WOS:000345158700064
J	Zhang, BP; Liu, B; Zhang, H; Wang, JZ				Zhang, Baoping; Liu, Bin; Zhang, Hong; Wang, Jizeng			Erythrocyte Stiffness during Morphological Remodeling Induced by Carbon Ion Radiation	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; BLOOD-CELL MEMBRANE; BONE-MARROW-CELLS; PERIPHERAL-BLOOD; MECHANICAL-PROPERTIES; VISCOELASTIC PROPERTIES; HEMATOPOIETIC SYNDROME; LARGE-DEFORMATION; BODY IRRADIATION; ELASTIC-MODULI	The adverse effect induced by carbon ion radiation (CIR) is still an unavoidable hazard to the treatment object. Thus, evaluation of its adverse effects on the body is a critical problem with respect to radiation therapy. We aimed to investigate the change between the configuration and mechanical properties of erythrocytes induced by radiation and found differences in both the configuration and the mechanical properties with involving in morphological remodeling process. Syrian hamsters were subjected to whole-body irradiation with carbon ion beams (1, 2, 4, and 6 Gy) or X-rays (2, 4, 6, and 12 Gy) for 3, 14 and 28 days. Erythrocytes in peripheral blood and bone marrow were collected for cytomorphological analysis. The mechanical properties of the erythrocytes were determined using atomic force microscopy, and the expression of the cytoskeletal protein spectrin-alpha 1 was analyzed via western blotting. The results showed that dynamic changes were evident in erythrocytes exposed to different doses of carbon ion beams compared with X-rays and the control (0 Gy). The magnitude of impairment of the cell number and cellular morphology manifested the subtle variation according to the irradiation dose. In particular, the differences in the size, shape and mechanical properties of the erythrocytes were well exhibited. Furthermore, immunoblot data showed that the expression of the cytoskeletal protein spectrin-alpha 1 was changed after irradiation, and there was a common pattern among its substantive characteristics in the irradiated group. Based on these findings, the present study concluded that CIR could induce a change in mechanical properties during morphological remodeling of erythrocytes. According to the unique characteristics of the biomechanical categories, we deduce that changes in cytomorphology and mechanical properties can be measured to evaluate the adverse effects generated by tumor radiotherapy. Additionally, for the first time, the current study provides a new strategy for enhancing the assessment of the curative effects and safety of clinical radiotherapy, as well as reducing adverse effects.	[Zhang, Baoping; Wang, Jizeng] Lanzhou Univ, Sch Civil Engn & Mech, Lanzhou 730000, Peoples R China; [Zhang, Baoping; Wang, Jizeng] Lanzhou Univ, Minist Educ China, Key Lab Mech Disaster & Environm Western China, Lanzhou 730000, Peoples R China; [Zhang, Baoping; Liu, Bin; Wang, Jizeng] Lanzhou Univ, Inst Biomech & Med Engn, Lanzhou 730000, Peoples R China; [Liu, Bin; Zhang, Hong] Chinese Acad Sci, Inst Modern Phys, Dept Heavy Ion Radiat Med, Lanzhou 730000, Peoples R China	Lanzhou University; Lanzhou University; Ministry of Education, China; Lanzhou University; Chinese Academy of Sciences; Institute of Modern Physics, CAS	Wang, JZ (corresponding author), Lanzhou Univ, Sch Civil Engn & Mech, Lanzhou 730000, Peoples R China.	jizengwangibme@gmail.com	Wang, Jizeng/A-2706-2008	Wang, Jizeng/0000-0002-8383-5868	National Natural Science Foundation of China [11032006, 11072094, 11121202]; PhD Program Foundation of the Ministry of Education of China [20100211110022]; New Century Excellent Talents in University [NCET-10-0445]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); PhD Program Foundation of the Ministry of Education of China(Ministry of Education, China); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by grants from the National Natural Science Foundation of China (grants No. 11032006, No. 11072094, and No. 11121202), the PhD Program Foundation of the Ministry of Education of China (grant No. 20100211110022), and New Century Excellent Talents in University (program No. NCET-10-0445). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrin R, 2012, CYTOSKELETON, V69, P101, DOI 10.1002/cm.21001; Alonso JL, 2003, LIFE SCI, V72, P2553, DOI 10.1016/S0024-3205(03)00165-6; An X, 2010, TRANSFUS CLIN BIOL, V17, P197, DOI 10.1016/j.tracli.2010.06.009; Baines AJ, 2010, TRANSFUS CLIN BIOL, V17, P95, DOI 10.1016/j.tracli.2010.06.008; Bao G, 2003, NAT MATER, V2, P715, DOI 10.1038/nmat1001; Bao YZ, 2012, MUTAT RES-GEN TOX EN, V743, P67, DOI 10.1016/j.mrgentox.2011.12.025; Blanc L, 2010, BIOCHEMISTRY-US, V49, P4516, DOI 10.1021/bi1003684; Boey SK, 1998, BIOPHYS J, V75, P1573, DOI 10.1016/S0006-3495(98)74075-5; Broderick MJF, 2005, ADV PROTEIN CHEM, V70, P203, DOI 10.1016/S0065-3233(04)70007-8; Buys AV, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-25; Callan-Jones A, 2012, BIOPHYS J, V103, P2475, DOI 10.1016/j.bpj.2012.11.008; Cardamone L, 2011, P NATL ACAD SCI USA, V108, P13978, DOI 10.1073/pnas.1100549108; Carl P, 2008, PFLUG ARCH EUR J PHY, V457, P551, DOI 10.1007/s00424-008-0524-3; Chan MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054902; Coates PJ, 2004, MUTAT RES-FUND MOL M, V568, P5, DOI 10.1016/j.mrfmmm.2004.06.042; Corre I, 2010, MUTAT RES-REV MUTAT, V704, P61, DOI 10.1016/j.mrrev.2010.01.014; Daniels G, 2007, VOX SANG, V93, P331, DOI 10.1111/j.1423-0410.2007.00970.x; Darling EM, 2008, J BIOMECH, V41, P454, DOI 10.1016/j.jbiomech.2007.06.019; De Nunzio C, 2012, EUR UROL, V61, P560, DOI 10.1016/j.eururo.2011.11.013; de Oliveira M, 2010, ANN BIOMED ENG, V38, P2956, DOI 10.1007/s10439-010-0040-4; Debaugnies F, 2011, CLIN CHEM LAB MED, V49, P485, DOI 10.1515/CCLM.2011.066; Delaunay J, 2007, BLOOD REV, V21, P1, DOI 10.1016/j.blre.2006.03.005; Dimitriadis EK, 2002, BIOPHYS J, V82, P2798, DOI 10.1016/S0006-3495(02)75620-8; Discher DE, 2001, CELL MOL BIOL LETT, V6, P593; Discher DE, 1998, BIOPHYS J, V75, P1584, DOI 10.1016/S0006-3495(98)74076-7; Dubreuil RR, 2006, J MEMBRANE BIOL, V211, P151, DOI 10.1007/s00232-006-0863-y; Fedosov DA, 2010, COMPUT METHOD APPL M, V199, P1937, DOI 10.1016/j.cma.2010.02.001; Foretz M, 2011, FASEB J, V25, P337, DOI 10.1096/fj.10-169383; Franke RP, 2013, CLIN HEMORHEOL MICRO, V54, P273, DOI 10.3233/CH-131733; Garaj-Vrhovac V, 2011, INT J HYG ENVIR HEAL, V214, P59, DOI 10.1016/j.ijheh.2010.08.003; Gavara N, 2012, NAT NANOTECHNOL, V7, P733, DOI [10.1038/NNANO.2012.163, 10.1038/nnano.2012.163]; Ghorai A, 2014, SCIENTIFICA, V2014, DOI DOI 10.1155/2014/438030; Ghosh S, 2011, MUTAT RES-FUND MOL M, V716, P10, DOI 10.1016/j.mrfmmm.2011.07.015; Grande T, 2006, INT J RADIAT ONCOL, V64, P612, DOI 10.1016/j.ijrobp.2005.09.036; Guo SL, 2006, BIOMACROMOLECULES, V7, P1630, DOI 10.1021/bm0600724; Haghparast SMA, 2013, J BIOSCI BIOENG, V116, P380, DOI 10.1016/j.jbiosc.2013.03.003; Hansen JC, 1996, BIOPHYS J, V70, P146, DOI 10.1016/S0006-3495(96)79556-5; Heinrich V, 2001, BIOPHYS J, V81, P1452, DOI 10.1016/S0006-3495(01)75800-6; Hu SW, 2011, HEALTH PHYS, V101, P67, DOI 10.1097/HP.0b013e31820dba65; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141; Kabaso D, 2010, BIOPHYS J, V99, P808, DOI 10.1016/j.bpj.2010.04.067; Katira P, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.028103; Ketene AN, 2012, NANOMED-NANOTECHNOL, V8, P93, DOI 10.1016/j.nano.2011.05.012; Ketene AN, 2011, AFM STUDY OVARIAN CE; Kim Y, 2011, MED BIOL ENG COMPUT, V49, P453, DOI 10.1007/s11517-010-0730-y; Koshino I, 2012, J BIOL CHEM, V287, P35244, DOI 10.1074/jbc.M111.305441; Kozlova EK, 2013, MICRON, V44, P218, DOI 10.1016/j.micron.2012.06.012; Kulkarni S, 2010, CURR DRUG TARGETS, V11, P1375, DOI 10.2174/1389450111009011375; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; Kuriakose S, 2013, SOFT MATTER, V9, P4284, DOI 10.1039/c3sm27683j; Kusunoki H, 2004, STRUCTURE, V12, P645, DOI 10.1016/j.str.2004.02.022; Lara P. C., 2013, CANC LETT; Lekka M, 2005, BIORHEOLOGY, V42, P307; Li J, 2007, P NATL ACAD SCI USA, V104, P4937, DOI 10.1073/pnas.0700257104; Li M, 2012, SCI CHINA LIFE SCI, V55, P968, DOI 10.1007/s11427-012-4399-3; Li QS, 2008, BIOCHEM BIOPH RES CO, V374, P609, DOI 10.1016/j.bbrc.2008.07.078; Li QF, 2014, INT J RADIAT BIOL, V90, P36, DOI 10.3109/09553002.2014.847294; Li W, 2004, EXP HEMATOL, V32, P1088, DOI 10.1016/j.exphem.2004.07.015; Li XJ, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0389; Liesveld JL, 2014, HEMATOPOIETIC SYSTEM, P623, DOI DOI 10.1007/978-3-540-75863-1; Lim CT, 2011, THEOR APPL MECH LETT, V1, DOI 10.1063/2.1101400; LIN S, 1977, J BIOL CHEM, V252, P5464; Liu F, 2003, CELL BIOCHEM BIOPHYS, V38, P251, DOI 10.1385/CBB:38:3:251; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; Ludwig T, 2008, PFLUG ARCH EUR J PHY, V456, P29, DOI 10.1007/s00424-007-0398-9; Ma XF, 2011, MUTAT RES-FUND MOL M, V716, P20, DOI 10.1016/j.mrfmmm.2011.07.016; Machnicka B, 2012, CELL MOL LIFE SCI, V69, P191, DOI 10.1007/s00018-011-0804-5; Machnicka B, 2013, BIOCHIM BIOPHYS ACTA, V1838, P620; Maciaszek JL, 2011, J BIOMECH, V44, P657, DOI 10.1016/j.jbiomech.2010.11.008; Manda K, 2014, MUTAT RES REV MUTAT; MARCHESI V. T., 1968, SCIENCE, V159, P203, DOI 10.1126/science.159.3811.203; Matsunaga A, 2010, CANCER-AM CANCER SOC, V116, P3740, DOI 10.1002/cncr.25134; MOHANDAS N, 1994, ANNU REV BIOPH BIOM, V23, P787, DOI 10.1146/annurev.bb.23.060194.004035; Moroni M, 2014, INT J RADIAT BIOL, V90, P363, DOI 10.3109/09553002.2014.892226; Moroni M, 2011, RADIAT RES, V176, P89, DOI 10.1667/RR2481.1; Mukherjee D, 2013, INT J RADIAT BIOL, V89, P139, DOI 10.3109/09553002.2013.741280; Muravyov AV, 2013, CLIN HEMORHEOL MICRO, V53, P45, DOI 10.3233/CH-2012-1575; Nambiar R, 2009, P NATL ACAD SCI USA, V106, P11972, DOI 10.1073/pnas.0901641106; Nans A, 2011, BIOPHYS J, V101, P2341, DOI 10.1016/j.bpj.2011.09.050; Nikkhah M, 2010, BIOMATERIALS, V31, P4552, DOI 10.1016/j.biomaterials.2010.02.034; Nomura T, 2008, MUTAT RES-GEN TOX EN, V657, P68, DOI 10.1016/j.mrgentox.2008.08.006; Pan CQ, 2012, CELL SIGNAL, V24, P2143, DOI 10.1016/j.cellsig.2012.06.002; Park HJ, 2012, RADIAT RES, V177, P311, DOI 10.1667/RR2773.1; Park Y, 2010, P NATL ACAD SCI USA, V107, P6731, DOI 10.1073/pnas.0909533107; Park YK, 2010, P NATL ACAD SCI USA, V107, P1289, DOI 10.1073/pnas.0910785107; Peng ZL, 2013, P NATL ACAD SCI USA, V110, P13356, DOI 10.1073/pnas.1311827110; Peslak SA, 2011, EXP HEMATOL, V39, P434, DOI 10.1016/j.exphem.2011.01.010; Picas L, 2013, ACS NANO, V7, P1054, DOI 10.1021/nn303824j; Rico F, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021914; Rojas-Aguirre Y, 2012, BBA-BIOMEMBRANES, V1818, P738, DOI 10.1016/j.bbamem.2011.11.026; Salomao M, 2006, P NATL ACAD SCI USA, V103, P643, DOI 10.1073/pnas.0507661103; Samanta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028169; SCHMIDT CF, 1993, SCIENCE, V259, P952, DOI 10.1126/science.8438153; SHEETZ MP, 1980, J BIOL CHEM, V255, P9955; Shi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061170; Sneddon IN., 1965, INT J ENG SCI, V3, P47, DOI [10.1016/0020-7225(65)90019-4, DOI 10.1016/0020-7225(65)90019-4, 10.1016/0020-7225(65)90019-4.477, DOI 10.1016/0020-7225(65)90019-4.477]; Sonmez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076579; Stewart MP, 2012, NAT PROTOC, V7, P143, DOI 10.1038/nprot.2011.434; STREY H, 1995, BIOPHYS J, V69, P478, DOI 10.1016/S0006-3495(95)79921-0; Strobl JS, 2010, BIOMATERIALS, V31, P7043, DOI 10.1016/j.biomaterials.2010.05.023; Suresh S, 2005, ACTA BIOMATER, V1, P15, DOI 10.1016/j.actbio.2004.09.001; Suzuki Y, 2008, J RADIAT RES, V49, P473, DOI 10.1269/jrr.07107; Svelc T, 2012, CELL MOL BIOL LETT, V17, P217, DOI 10.2478/s11658-012-0005-8; Svetina S, 2004, BIOELECTROCHEMISTRY, V62, P107, DOI 10.1016/j.bioelechem.2003.08.002; Swihart AH, 2001, J MICROSC-OXFORD, V204, P212, DOI 10.1046/j.1365-2818.2001.00960.x; Szarama KB, 2012, DEVELOPMENT, V139, P2187, DOI 10.1242/dev.073734; Takeuchi M, 1998, BIOPHYS J, V74, P2171, DOI 10.1016/S0006-3495(98)77926-3; Umegaki K, 2001, FREE RADICAL BIO MED, V31, P1066, DOI 10.1016/S0891-5849(01)00689-X; Wang CS, 2013, INT J RADIAT BIOL, V89, P132, DOI 10.3109/09553002.2013.734947; Wang Y, 2010, FREE RADICAL BIO MED, V48, P348, DOI 10.1016/j.freeradbiomed.2009.11.005; Weng HB, 2014, BBA-BIOMEMBRANES, V1838, P185, DOI 10.1016/j.bbamem.2013.09.014; Xu H, 2012, CANCER BIOTHER RADIO, V27, P113, DOI 10.1089/cbr.2011.1037; Zhang R, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2958268; Zhu Q, 2008, BIOPHYS J, V94, P2529, DOI 10.1529/biophysj.107.119438; Zhu Q, 2007, BIOPHYS J, V93, P386, DOI 10.1529/biophysj.106.094383; Zou S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073499; Zuk A, 2011, INT J NANOMED, V6, P249, DOI 10.2147/IJN.S15802	118	14	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112624	10.1371/journal.pone.0112624	http://dx.doi.org/10.1371/journal.pone.0112624			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401336	Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700059
J	Zhang, X; Zhang, W; Feng, LJ				Zhang, Xi; Zhang, Wei; Feng, Li-jin			Prognostic Significance of Neutrophil Lymphocyte Ratio in Patients with Gastric Cancer: A Meta-Analysis	PLOS ONE			English	Article							PREDICTS POOR SURVIVAL; PREOPERATIVE NEUTROPHIL; TUMOR; STATISTICS; RESECTION; DISEASE; SCORES	Background: Several studies have shown that neutrophil lymphocyte ratio (NLR) may be associated with the prognosis of gastric cancer (GC), but the results are controversial. Methods: This study was performed to evaluate the prognostic implications of neutrophil lymphocyte ratio of GC in all available studies. We surveyed 2 medical databases, PubMed and EMBASE, to identifyall relevant studies. Data were collected from studies comparing overall survival (OS), disease-free survival (DFS) and progression-free survival (PFS) in patients with GC. Results: Ten studies (n = 2,952) evaluated the role of NLR as a predictor of outcome were involved for this meta-analysis (10 for OS, 3 for DFS, and 2 for PFS). Overall and disease-free survival were significantly better in patients with low NLR value and the pooled HRs was significant at 1.83 ([95% CI], 1.62-2.07) and 1.58 ([95% CI], 1.12-2.21), respectively. For progression-free survival, the pooled hazard ratio of NLR was significant at 1.54 ([95% CI], 1.22-1.95). No evidence of significant heterogeneity or publication bias for OS and DFS was seen in any of the included studies. Conclusion: This meta-analysis indicated that elevated NLR may be associated with a worse prognosis for patients with GC.	[Zhang, Wei; Feng, Li-jin] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Pathol, Shanghai 200092, Peoples R China; [Zhang, Xi] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Med Oncol, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Feng, LJ (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Pathol, Shanghai 200092, Peoples R China.	fenglijinmd@163.com						Aizawa M, 2011, WORLD J SURG, V35, P2717, DOI 10.1007/s00268-011-1269-2; Aliustaoglu M, 2010, MED ONCOL, V27, P1060, DOI 10.1007/s12032-009-9335-4; An X, 2010, BIOMARKERS, V15, P516, DOI 10.3109/1354750X.2010.491557; Aoyama T, 2011, GASTRIC CANCER, V14, P274, DOI 10.1007/s10120-011-0038-0; Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Aurello P, 2014, ANN SURG ONCOL, V21, P1998, DOI 10.1245/s10434-014-3533-9; Cho IR, 2014, GASTRIC CANC; Cook Emily J, 2007, Int J Surg, V5, P27, DOI 10.1016/j.ijsu.2006.05.013; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dirican A, 2013, CANCER BIOMARK, V13, P11, DOI 10.3233/CBM-130331; Dutta S, 2012, AM J SURG, V204, P294, DOI 10.1016/j.amjsurg.2011.10.015; Han YJ, 2011, INT J BIOL MARKER, V26, P209, DOI 10.5301/JBM.2011.8872; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jablonska E, 2005, CYTOKINE, V30, P93, DOI 10.1016/j.cyto.2004.12.004; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeong JH, 2012, ONCOLOGY-BASEL, V83, P292, DOI 10.1159/000342376; Jiang N, 2014, BIOMARKERS, P1; Jin HL, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-112; Jung MR, 2011, J SURG ONCOL, V104, P504, DOI 10.1002/jso.21986; Kim Jin-Pok, 1998, Gastric Cancer, V1, P125, DOI 10.1007/s101200050006; Lee DY, 2013, J GASTRIC CANCER, V13, P111, DOI 10.5230/jgc.2013.13.2.111; Lee S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-350; Li MX, 2014, INT J CANCER, V134, P2403, DOI 10.1002/ijc.28536; Mihmanli M, 2004, HEPATO-GASTROENTEROL, V51, P1544; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Nakayama Y, 2014, SURG TODAY, V16; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; SHAU H, 1988, J IMMUNOL, V141, P4395; Shimada H, 2010, GASTRIC CANCER, V13, P170, DOI 10.1007/s10120-010-0554-3; Shiraishi N, 2000, CANCER-AM CANCER SOC, V89, P255, DOI 10.1002/1097-0142(20000715)89:2<255::AID-CNCR8>3.0.CO;2-N; Stotz M, 2013, BRIT J CANCER, V109, P416, DOI 10.1038/bjc.2013.332; Tamhane UU, 2008, AM J CARDIOL, V102, P653, DOI 10.1016/j.amjcard.2008.05.006; Teramukai S, 2009, EUR J CANCER, V45, P1950, DOI 10.1016/j.ejca.2009.01.023; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Wagner AD, 2006, J CLIN ONCOL, V24, P2903, DOI 10.1200/JCO.2005.05.0245; Wang DS, 2012, TUMOR BIOL, V33, P749, DOI 10.1007/s13277-011-0285-z; Webb NJA, 1998, CYTOKINE, V10, P254, DOI 10.1006/cyto.1997.0297; Wells GA, 2011, NEWCASTLE OTTAWA SCA; Xiao LJ, 2013, ONCOL LETT, V6, P1277, DOI 10.3892/ol.2013.1532	41	70	75	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e111906	10.1371/journal.pone.0111906	http://dx.doi.org/10.1371/journal.pone.0111906			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401500	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700021
J	Cabrera, S; Sanchez, E; Requena, T; Martinez-Bueno, M; Benitez, J; Perez, N; Trinidad, G; Soto-Varela, A; Santos-Perez, S; Martin-Sanz, E; Fraile, J; Perez, P; Alarcon-Riquelme, ME; Batuecas, A; Espinosa-Sanchez, JM; Aran, I; Lopez-Escamez, JA				Cabrera, Sonia; Sanchez, Elena; Requena, Teresa; Martinez-Bueno, Manuel; Benitez, Jesus; Perez, Nicolas; Trinidad, Gabriel; Soto-Varela, Andres; Santos-Perez, Sofia; Martin-Sanz, Eduardo; Fraile, Jesus; Perez, Paz; Alarcon-Riquelme, Marta E.; Batuecas, Angel; Espinosa-Sanchez, Juan M.; Aran, Ismael; Lopez-Escamez, Jose A.			Intronic Variants in the NFKB1 Gene May Influence Hearing Forecast in Patients with Unilateral Sensorineural Hearing Loss in Meniere's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; KAPPA-B; PROGRESSION; DATABASE; INNATE; REGION; COMMON	Meniere's disease is an episodic vestibular syndrome associated with sensorineural hearing loss (SNHL) and tinnitus. Patients with MD have an elevated prevalence of several autoimmune diseases (rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis and psoriasis), which suggests a shared autoimmune background. Functional variants of several genes involved in the NF-kB pathway, such as REL, TNFAIP3, NFKB1 and TNIP1, have been associated with two or more immune-mediated diseases and allelic variations in the TLR10 gene may influence bilateral affectation and clinical course in MD. We have genotyped 716 cases of MD and 1628 controls by using the ImmunoChip, a high-density genotyping array containing 186 autoimmune loci, to explore the association of immune system related-loci with sporadic MD. Although no single nucleotide polymorphism (SNP) reached a genome-wide significant association (p<10(-8)), we selected allelic variants in the NF-kB pathway for further analyses to evaluate the impact of these SNPs in the clinical outcome of MD in our cohort. None of the selected SNPs increased susceptibility for MD in patients with uni or bilateral SNHL. However, two potential regulatory variants in the NFKB1 gene (rs3774937 and rs4648011) were associated with a faster hearing loss progression in patients with unilateral SNHL. So, individuals with unilateral MD carrying the C allele in rs3774937 or G allele in rs4648011 had a shorter mean time to reach hearing stage 3 (>40 dB HL) (log-rank test, corrected p values were p = 0.009 for rs3774937 and p = 0.003 for rs4648011, respectively). No variants influenced hearing in bilateral MD. Our data support that the allelic variants rs3774937 and rs4648011 can modify hearing outcome in patients with MD and unilateral SNHL.	[Cabrera, Sonia; Requena, Teresa; Espinosa-Sanchez, Juan M.; Lopez-Escamez, Jose A.] Pfizer Univ Granada Junta Andalucia GENYO, Ctr Genom & Invest Oncol, Dept Genom Med, Otol & Neurotol Grp CTS495, Granada, Spain; [Sanchez, Elena] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Martinez-Bueno, Manuel; Alarcon-Riquelme, Marta E.] Pfizer Univ Granada Junta Andalucia GENYO, Ctr Genom & Invest Oncol, Dept Genom Med, Grp Genet Complex Dis, Granada, Spain; [Benitez, Jesus] Hosp Univ Gran Canaria Dr Negrin, Dept Otolaryngol, Las Palmas Gran Canaria, Spain; [Perez, Nicolas] Univ Navarra Clin, Dept Otolaryngol, Pamplona, Spain; [Trinidad, Gabriel] Complejo Hosp Badajoz, Dept Otorhinolaryngol, Div Otoneurol, Badajoz, Spain; [Soto-Varela, Andres; Santos-Perez, Sofia] Complexo Hosp Univ, Dept Otorhinolaryngol, Div Otoneurol, Santiago De Compostela, Spain; [Martin-Sanz, Eduardo] Hosp Univ Getafe, Dept Otolaryngol, Getafe, Spain; [Fraile, Jesus] Hosp Miguel Servet, Dept Otolaryngol, Zaragoza, Spain; [Perez, Paz] Hosp Cabuenes, Dept Otorhinolaryngol, Gijon, Spain; [Batuecas, Angel] Hosp Univ Salamanca, Dept Otolaryngol, Salamanca, Spain; [Espinosa-Sanchez, Juan M.] Hosp San Agustin, Dept Otorhinolaryngol, Jaen, Spain; [Aran, Ismael] Complexo Hosp Pontevedra, Dept Otolaryngol, Pontevedra, Spain; [Lopez-Escamez, Jose A.] Hosp Poniente, Dept Otolaryngol, El Ejido, Almeria, Spain	Pfizer; University of Granada; Icahn School of Medicine at Mount Sinai; Pfizer; University of Granada; University of Navarra; Hospital Universitario de Getafe; Miguel Servet University Hospital; Hospital de Cabuenes; University of Salamanca; Hospital San Agustin; Complexo Hospitalario Universitario de Pontevedra	Lopez-Escamez, JA (corresponding author), Pfizer Univ Granada Junta Andalucia GENYO, Ctr Genom & Invest Oncol, Dept Genom Med, Otol & Neurotol Grp CTS495, Granada, Spain.	antonio.lopezescamez@genyo.es	Espinosa-Sanchez, Juan M./AAV-8380-2021; Pérez Vázquez, Paz/F-8759-2013; Alarcón-Riquelme, Marta E./ABF-8163-2020; Sanchez, Elena/AAC-1985-2021; Sanchez, Elena/B-4140-2017; Caletrio, Angel Batuecas/AAC-3333-2019; TRINIDAD-RUIZ, GABRIEL/X-8071-2019; RUIZ, GABRIEL GTR TRINIDAD/H-6501-2017; Perez, Paz/H-7366-2017; Martin-Sanz, Eduardo/N-5814-2014; Perez, Nicolas/A-7850-2015; Soto-Varela, Andrés/H-6489-2019; Lopez-Escamez, Jose Antonio/D-6642-2018	Espinosa-Sanchez, Juan M./0000-0001-8436-5629; Pérez Vázquez, Paz/0000-0002-4383-9151; Alarcón-Riquelme, Marta E./0000-0002-7632-4154; Sanchez, Elena/0000-0002-7041-5485; Caletrio, Angel Batuecas/0000-0003-2613-670X; TRINIDAD-RUIZ, GABRIEL/0000-0002-6917-4928; RUIZ, GABRIEL GTR TRINIDAD/0000-0002-6917-4928; Perez, Paz/0000-0002-4383-9151; Martin-Sanz, Eduardo/0000-0003-1175-3844; Perez, Nicolas/0000-0002-1192-5901; Soto-Varela, Andrés/0000-0001-6763-329X; Lopez-Escamez, Jose Antonio/0000-0002-8583-1430; Requena, Teresa/0000-0001-8355-6028; Martinez Bueno, Manuel/0000-0002-4333-4487	Instituto de Salud Carlos III; FEDER Funds from the EU; COST Action BM1306 TINNET	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); FEDER Funds from the EU; COST Action BM1306 TINNET(European Cooperation in Science and Technology (COST))	This project was funded by Research Grants PI09/00920 and PI13/1242 from Instituto de Salud Carlos III by FEDER Funds from the EU. The authors also acknowledge the COST Action BM1306 TINNET which supports part of their networking activities (http://tinnet.tinnitusresearch.net/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2009, NEUROSCIENCE, V160, P530, DOI 10.1016/j.neuroscience.2009.02.073; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Bowes J, 2011, ANN RHEUM DIS, V70, P164, DOI [10.1136/ard.2011.150102.1, DOI 10.1136/ARD.2011.150102.1]; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Caamano J, 2002, CLIN MICROBIOL REV, V15, P414, DOI 10.1128/CMR.15.3.414-429.2002; Campbell CA, 2010, AM J MED GENET A, V152A, P67, DOI 10.1002/ajmg.a.33114; Chung SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001323; Clemmens C, 2012, OTOL NEUROTOL, V33, P1266, DOI 10.1097/MAO.0b013e31826426b9; Cooper JD, 2012, HUM MOL GENET, V21, P5202, DOI 10.1093/hmg/dds357; Ellinghaus D, 2013, NAT GENET, V45, P808, DOI 10.1038/ng.2642; Gazquez I, 2013, EUR ARCH OTO-RHINO-L, V270, P1521, DOI 10.1007/s00405-012-2268-0; Gazquez I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026759; Gazquez I, 2012, OTOL NEUROTOL, V33, P223, DOI 10.1097/MAO.0b013e31824296c8; Greco A, 2012, AUTOIMMUN REV, V11, P731, DOI 10.1016/j.autrev.2012.01.004; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Hietikko E, 2012, INT J AUDIOL, V51, P841, DOI 10.3109/14992027.2012.705900; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Huang TT, 2000, P NATL ACAD SCI USA, V97, P1014, DOI 10.1073/pnas.97.3.1014; Hughes T, 2013, NAT GENET, V45, P319, DOI 10.1038/ng.2551; Hunt KA, 2013, NATURE, V498, P232, DOI 10.1038/nature12170; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li XN, 2012, J ALLERGY CLIN IMMUN, V130, P861, DOI 10.1016/j.jaci.2012.04.041; Liu JZ, 2012, NAT GENET, V44, P1137, DOI 10.1038/ng.2395; Lopez-Escamez JA, 2007, OTOL NEUROTOL, V28, P891; Lopez-Escamez JA, 2010, LARYNGOSCOPE, V120, P103, DOI 10.1002/lary.20650; MONSELL EM, 1995, OTOLARYNG HEAD NECK, V113, P181, DOI 10.1016/S0194-5998(95)70102-8; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Pathak S, 2011, J IMMUNOL, V186, P1870, DOI 10.4049/jimmunol.1002275; Platt M, 2014, OTOLARYNG HEAD NECK, V150, P460, DOI 10.1177/0194599813514725; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Requena T, 2013, IMMUNOGENETICS, V65, P345, DOI 10.1007/s00251-013-0683-z; Ricano-Ponce I, 2013, ANNU REV GENOM HUM G, V14, P325, DOI 10.1146/annurev-genom-091212-153450; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Svrakic M, 2012, ARCH OTOLARYNGOL, V138, P1052, DOI 10.1001/2013.jamaoto.76; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tryka KA, 2014, NUCLEIC ACIDS RES, V42, pD975, DOI 10.1093/nar/gkt1211; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Tyrrell JS, 2014, EAR HEARING, V35, pE162, DOI 10.1097/AUD.0000000000000041; Waldner H, 2009, AUTOIMMUN REV, V8, P400, DOI 10.1016/j.autrev.2008.12.019; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Xia K, 2012, BIOINFORMATICS, V28, P451, DOI 10.1093/bioinformatics/btr678; Zhao RJ, 2013, INT IMMUNOPHARMACOL, V17, P658, DOI 10.1016/j.intimp.2013.08.012; Zhu JK, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/781235	46	22	30	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112171	10.1371/journal.pone.0112171	http://dx.doi.org/10.1371/journal.pone.0112171			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397881	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558500037
J	Fayaz, SM; Kumar, VSS; Rajanikant, KG				Fayaz, Shaik M.; Kumar, Valsala S. Suvanish; Rajanikant, Krishnamurthy G.			Finding Needles in a Haystack: Application of Network Analysis and Target Enrichment Studies for the Identification of Potential Anti-Diabetic Phytochemicals	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; P38 MAPK INHIBITION; NF-KAPPA-B; ALDOSE REDUCTASE; GALLIC ACID; INSULIN-RESISTANCE; MEDICINAL-PLANTS; XANTHINE-OXIDASE; OXIDATIVE STRESS; ALPHA-AMYLASE	Diabetes mellitus is a debilitating metabolic disorder and remains a significant threat to public health. Herbal medicines have been proven to be effective anti-diabetic agents compared to synthetic drugs in terms of side effects. However, the complexity in their chemical constituents and mechanism of action, hinder the effort to discover novel anti-diabetic drugs. Hence, understanding the biological and chemical basis of pharmacological action of phytochemicals is essential for the discovery of potential anti-diabetic drugs. Identifying important active compounds, their protein targets and the pathways involved in diabetes would serve this purpose. In this context, the present study was aimed at exploring the mechanism of action of anti-diabetic plants phytochemicals through network and chemical-based approaches. This study also involves a focused and constructive strategy for preparing new effective anti-diabetic formulations. Further, a protocol for target enrichment was proposed, to identify novel protein targets for important active compounds. Therefore, the successive use of network analysis combined with target enrichment studies would accelerate the discovery of potential anti-diabetic phytochemicals.	[Fayaz, Shaik M.; Kumar, Valsala S. Suvanish; Rajanikant, Krishnamurthy G.] Natl Inst Technol Calicut, Sch Biotechnol, Calicut 673601, Kerala, India	National Institute of Technology (NIT System); National Institute of Technology Calicut	Rajanikant, KG (corresponding author), Natl Inst Technol Calicut, Sch Biotechnol, Calicut 673601, Kerala, India.	rajanikant@nitc.ac.in	G.K, Rajanikant/H-3275-2019; S.M., Fayaz/P-6103-2015	S.M., Fayaz/0000-0002-1212-7952; KUMAR, SUVANISH/0000-0001-9033-0422; , Rajanikant/0000-0001-9754-997X	Kerala State Council for Science, Technology and Environment, Kerala Biotechnology Commission, Government of Kerala, Thiruvananthapuram, India [1051/2013/KSCSTE]	Kerala State Council for Science, Technology and Environment, Kerala Biotechnology Commission, Government of Kerala, Thiruvananthapuram, India	This work was supported by the Kerala State Council for Science, Technology and Environment, Kerala Biotechnology Commission, Government of Kerala, Thiruvananthapuram, India (Grant number: 1051/2013/KSCSTE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Amin ZM, 2006, BRIT J NUTR, V96, P660, DOI 10.1079/BJN20061849; Alqahtani A, 2013, CURR MED CHEM, V20, P908; Alvarado-Vasquez N, 2003, COMP BIOCHEM PHYS C, V134, P521, DOI 10.1016/S1532-0456(03)00046-2; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Awazu M, 1999, J AM SOC NEPHROL, V10, P738; Ayyanar Muniappan, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P240, DOI 10.1016/S2221-1691(12)60050-1; Babu PA, 2006, BIOINFORMATION, V1, P130, DOI 10.6026/97320630001130; Baker DJ, 2005, DIABETES, V54, P2453, DOI 10.2337/diabetes.54.8.2453; Bhatia H, 2014, J ETHNOPHARMACOL, V151, P1005, DOI 10.1016/j.jep.2013.12.017; BISCHOFF H, 1995, CLIN INVEST MED, V18, P303; Bjerre M, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-658; Bravard A, 2011, AM J PHYSIOL-ENDOC M, V300, pE581, DOI 10.1152/ajpendo.00455.2010; Cheriyan J, 2011, CIRCULATION, V123, P515, DOI 10.1161/CIRCULATIONAHA.110.971986; Chethan S, 2008, BIOORGAN MED CHEM, V16, P10085, DOI 10.1016/j.bmc.2008.10.003; CHOWDHURY AR, 2002, MED SCI MONITOR, V8, P254; Davalli AM, 2012, ACTA DIABETOL, V49, P167, DOI 10.1007/s00592-011-0364-z; de la Monte Suzanne M, 2008, J Diabetes Sci Technol, V2, P1101; de Melo CL, 2009, J AGR FOOD CHEM, V57, P8776, DOI 10.1021/jf900768w; Desco MC, 2002, DIABETES, V51, P1118, DOI 10.2337/diabetes.51.4.1118; Dhanbal SP, 2004, INDIAN J PHARM EDUC, V8, P163; Drel VR, 2008, INT J MOL MED, V21, P667; Du YP, 2010, INVEST OPHTH VIS SCI, V51, P2158, DOI 10.1167/iovs.09-3674; Dunlop M, 2000, KIDNEY INT, V58, pS3, DOI 10.1046/j.1523-1755.2000.07702.x; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Ferreira ST, 2014, ALZHEIMERS DEMENT, V10, pS76, DOI 10.1016/j.jalz.2013.12.010; Freiherr J, 2013, CNS DRUGS, V27, P505, DOI 10.1007/s40263-013-0076-8; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078; Grover JK, 2002, J ETHNOPHARMACOL, V81, P81, DOI 10.1016/S0378-8741(02)00059-4; Gupta O. P., 2003, INT J DIABETES DEV C, V23, P37; Hachmeister Jorge E., 2003, Yale Journal of Biology and Medicine, V76, P81; He H, 2013, J AGR FOOD CHEM, V61, P8110, DOI 10.1021/jf4019323; He L, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep095; Hodgkinson AD, 2001, KIDNEY INT, V60, P211, DOI 10.1046/j.1523-1755.2001.00788.x; Holscher C, 2014, ALZHEIMERS DEMENT, V10, pS33, DOI 10.1016/j.jalz.2013.12.006; Hu G, 2007, DIABETES CARE, V30, P842, DOI 10.2337/dc06-2011; Hwang EY, 2008, FEBS LETT, V582, P3793, DOI 10.1016/j.febslet.2008.10.010; Jangra Meenu, 2011, International Journal of Green Pharmacy, V5, P266, DOI 10.4103/0973-8258.94345; Jornayvaz FR, 2011, P NATL ACAD SCI USA, V108, P5748, DOI 10.1073/pnas.1103451108; Jung M, 2006, CURR MED CHEM, V13, P1203, DOI 10.2174/092986706776360860; Kapoor, 2000, HDB AYURVEDIC MED PL; Kharjul A, 2012, INT J PHARM SCI RES, V3, P4913, DOI 10.13040/IJPSR.0975-8232.3(12).4913-18; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Kowluru RA, 2003, FREE RADICAL RES, V37, P1169, DOI 10.1080/10715760310001604189; Lakshmi CM, 2003, SCI BASIS AYURVEDIC; Lim S, 2012, J CELL BIOCHEM, V113, P3436, DOI 10.1002/jcb.24220; Lima MMS, 2014, CNS NEUROL DISORD-DR, V13, P418, DOI 10.2174/18715273113126660155; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu IM, 2007, LIFE SCI, V81, P1479, DOI 10.1016/j.lfs.2007.08.045; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; Liu Zhenqi, 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P38; Madlener S, 2007, CANCER LETT, V245, P156, DOI 10.1016/j.canlet.2006.01.001; Mathew M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086804; Medicherla S, 2009, DIABET METAB SYND OB, V2, P91; Medikayala S, 2011, AM J PHYSIOL-CELL PH, V300, pC338, DOI 10.1152/ajpcell.00248.2010; Melloul D, 2008, BIOCHEM SOC T, V36, P334, DOI 10.1042/BST0360334; Melzig MF, 2007, WIEN MED WOCHENSCHR, V157, P320, DOI 10.1007/s10354-007-0433-7; Mezzano S, 2004, NEPHROL DIAL TRANSPL, V19, P2505, DOI 10.1093/ndt/gfh207; Modak M, 2007, J CLIN BIOCHEM NUTR, V40, P163, DOI 10.3164/jcbn.40.163; Mukherjee PK, 2006, J ETHNOPHARMACOL, V106, P1, DOI 10.1016/j.jep.2006.03.021; Nair SB, 2013, COMB CHEM HIGH T SCR, V16, P449; Nair SB, 2012, COMPUT BIOL MED, V42, P697, DOI 10.1016/j.compbiomed.2012.04.001; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; Ong KC, 1997, GEN PHARMACOL-VASC S, V29, P121, DOI 10.1016/S0306-3623(96)00421-1; Ozcan F, 2012, CLIN EXP MED, V12, P265, DOI 10.1007/s10238-011-0167-0; Padberg I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085082; Paek JH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/679463; Palanisamy Bhuvaneswari, 2012, International Journal of Green Pharmacy, V6, P330; Pan MH, 2008, MOL NUTR FOOD RES, V52, P1467, DOI 10.1002/mnfr.200700515; Pandey KB, 2009, Z NATURFORSCH C, V64, P626; Pari L, 2003, BRAZ J MED BIOL RES, V36, P861, DOI 10.1590/S0100-879X2003000700006; Pari L, 2000, PHYTOTHER RES, V14, P136, DOI 10.1002/(SICI)1099-1573(200003)14:2&lt;136::AID-PTR607&gt;3.0.CO;2-K; Patel JR, 2011, J ETHNOPHARMACOL, V138, P286, DOI 10.1016/j.jep.2011.09.040; Patel SS, 2011, PHARMACOGN RES, V3, P239, DOI 10.4103/0974-8490.89743; Persaud SJ, 2007, DIABETES, V56, P197, DOI 10.2337/db06-0490; Prajapati H, 2012, CHEM BIOL INTERFACE, V2, P38; Prakasam A, 2003, POL J PHARMACOL, V55, P43; Punithavathi VR, 2011, J BIOCHEM MOL TOXIC, V25, P68, DOI 10.1002/jbt.20360; Punithavathi VR, 2011, EUR J PHARMACOL, V650, P465, DOI 10.1016/j.ejphar.2010.08.059; Purves T, 2001, FASEB J, V15, P2508, DOI 10.1096/fj.01-0253hyp; Raina, 1989, INDIAN DRUGS, V26, P199; Rajesh M, 2009, J CELL MOL MED, V13, P2330, DOI 10.1111/j.1582-4934.2008.00564.x; Ramkumar KM, 2014, HUM EXP TOXICOL, V33, P638, DOI 10.1177/0960327113504792; Reddy SV, 2005, PHYTOTHER RES, V19, P277, DOI 10.1002/ptr.1491; Sankeshi V, 2013, J ETHNOPHARMACOL, V149, P215, DOI 10.1016/j.jep.2013.06.025; Santhosh Kumari K. S., 1993, Indian Journal of Experimental Biology, V31, P595; Santiago JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083940; Saxena A, 2004, J ALTERN COMPLEM MED, V10, P369, DOI 10.1089/107555304323062365; Sekhar RV, 2011, DIABETES CARE, V34, P162, DOI 10.2337/dc10-1006; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SOCHOR M, 1986, BIOCHEM J, V234, P573, DOI 10.1042/bj2340573; Steffensen KR, 2004, DIABETES, V53, pS36, DOI 10.2337/diabetes.53.2007.S36; Steinkamp-Fenske K, 2007, J PHARMACOL EXP THER, V322, P836, DOI 10.1124/jpet.107.123356; Sudha P, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-5; Talukder FZ, 2012, DRUG DISCOV THER, V6, P298, DOI 10.5582/ddt.2012.v6.6.298; Tapola N, 2005, NUTR METAB CARDIOVAS, V15, P255, DOI 10.1016/j.numecd.2004.09.003; Tayade PM, 2011, PHARM ONLINE, V1, P282; Teli MK, 2012, MOL DIVERS, V16, P193, DOI 10.1007/s11030-011-9338-x; Tiwari S, 2012, INT J PHARM SCI RES, V3, P3354, DOI 10.13040/IJPSR.0975-8232.3(9).3354-61; Todorov IN, 2009, BIOCHEMISTRY-MOSCOW+, V74, P962, DOI 10.1134/S000629790909003X; Tolman KG, 2007, DIABETES CARE, V30, P734, DOI 10.2337/dc06-1539; Tundis R, 2010, MINI-REV MED CHEM, V10, P315, DOI 10.2174/138955710791331007; Tzeng TF, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/neq017; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Vozarova B, 2002, DIABETES, V51, P1889, DOI 10.2337/diabetes.51.6.1889; Yeh GY, 2003, DIABETES CARE, V26, P1277, DOI 10.2337/diacare.26.4.1277; Zhao HJ, 2006, J AM SOC NEPHROL, V17, P2664, DOI 10.1681/ASN.2006070798	107	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112911	10.1371/journal.pone.0112911	http://dx.doi.org/10.1371/journal.pone.0112911			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396726	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558500110
J	Hu, XW; Wu, YP; Ding, XY; Zhang, R; Wang, YR; Baskin, JM; Baskin, CC				Hu, Xiao Wen; Wu, Yan Pei; Ding, Xing Yu; Zhang, Rui; Wang, Yan Rong; Baskin, Jerry M.; Baskin, Carol C.			Seed Dormancy, Seedling Establishment and Dynamics of the Soil Seed Bank of Stipa bungeana (Poaceae) on the Loess Plateau of Northwestern China	PLOS ONE			English	Article							AFTER-RIPENING TIME; ABSCISIC-ACID; GERMINATION; TEMPERATURE; BREAKING; MECHANISMS; EMERGENCE; RELEASE; ECOLOGY; GREEN	Studying seed dormancy and its consequent effect can provide important information for vegetation restoration and management. The present study investigated seed dormancy, seedling emergence and seed survival in the soil seed bank of Stipa bungeana, a grass species used in restoration of degraded land on the Loess Plateau in northwest China. Dormancy of fresh seeds was determined by incubation of seeds over a range of temperatures in both light and dark. Seed germination was evaluated after mechanical removal of palea and lemma (hulls), chemical scarification and dry storage. Fresh and one-year-stored seeds were sown in the field, and seedling emergence was monitored weekly for 8 weeks. Furthermore, seeds were buried at different soil depths, and then retrieved every 1 or 2 months to determine seed dormancy and seed viability in the laboratory. Fresh seeds (caryopses enclosed by palea and lemma) had non-deep physiological dormancy. Removal of palea and lemma, chemical scarification, dry storage (afterripening), gibberellin (GA(3)) and potassium nitrate (KNO3) significantly improved germination. Dormancy was completely released by removal of the hulls, but seeds on which hulls were put back to their original position germinated to only 46%. Pretreatment of seeds with a 30% NaOH solution for 60 min increased germination from 25% to 82%. Speed of seedling emergence from fresh seeds was significantly lower than that of seeds stored for 1 year. However, final percentage of seedling emergence did not differ significantly for seeds sown at depths of 0 and 1 cm. Most fresh seeds of S. bungeana buried in the field in early July either had germinated or lost viability by September. All seeds buried at a depth of 5 cm had lost viability after 5 months, whereas 12% and 4% seeds of those sown on the soil surface were viable after 5 and 12 months, respectively.	[Hu, Xiao Wen; Wu, Yan Pei; Ding, Xing Yu; Zhang, Rui; Wang, Yan Rong] Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou 730020, Peoples R China; [Baskin, Jerry M.; Baskin, Carol C.] Univ Kentucky, Dept Biol, Lexington, KY 40506 USA; [Baskin, Carol C.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40546 USA	Lanzhou University; University of Kentucky; University of Kentucky	Hu, XW (corresponding author), Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou 730020, Peoples R China.	huxw@lzu.edu.cn; yrwang@lzu.edu.cn			Program for Changjiang Scholars and Innovative Research Team in University [IRT13019]; National Key Technology Research and Development Program [2011BAD17B02]; Gansu Provincial Key Grant Project [1203FKDA035]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Key Technology Research and Development Program(National Key Technology R&D Program); Gansu Provincial Key Grant Project	This study was supported by Program for Changjiang Scholars and Innovative Research Team in University (IRT13019), the National Key Technology Research and Development Program (2011BAD17B02) and the Gansu Provincial Key Grant Project (1203FKDA035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins SW, 2002, EUPHYTICA, V126, P13, DOI 10.1023/A:1019623706427; ALBALADEJO J, 1996, SOIL DEGRADATION DES, P265; [Anonymous], 2012, SEED SCI TECHNOL S, V27; Bair NB, 2006, SEED SCI RES, V16, P17, DOI 10.1079/SSR2005237; Baskin CC, 2006, SEED SCI RES, V16, P165, DOI 10.1079/SSR2006247; Baskin CC, 2014, SEEDS: ECOLOGY, BIOGEOGRAPHY, AND EVOLUTION OF DORMANCY AND GERMINATION, 2ND EDITION, P1, DOI 10.1016/B978-0-12-416677-6.00001-9; Baskin Carol C., 1998, P30, DOI 10.1017/CBO9780511525445.004; Baskin JM, 2004, SEED SCI RES, V14, P1, DOI 10.1079/SSR2003150; Benech-Arnold RL, 1999, SEED SCI RES, V9, P39, DOI 10.1017/S0960258599000045; Brady NC, 2008, NATURE PROPERTIES SO, V14; Cheng J, 2010, AFR J BIOTECHNOL, V9, P6733; ELLIS RH, 1983, SEED SCI TECHNOL, V11, P77; Fenner M., 2005, ECOLOGY SEEDS; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Footitt S, 2011, P NATL ACAD SCI USA, V108, P20236, DOI 10.1073/pnas.1116325108; Francis D.F., 1990, SOIL DEGRADATION REH, P87; FULBRIGHT TE, 1983, J RANGE MANAGE, V36, P390, DOI 10.2307/3898496; Gasque M, 2003, PLANT ECOL, V168, P279, DOI 10.1023/A:1024471827734; Gianinetti A, 2007, J EXP BOT, V58, P3449, DOI 10.1093/jxb/erm198; Graeber K, 2012, PLANT CELL ENVIRON, V35, P1769, DOI 10.1111/j.1365-3040.2012.02542.x; GUTTERMAN Y, 1980, EXPERIENTIA, V36, P662, DOI 10.1007/BF01970124; Gutterman Y, 1996, J ARID ENVIRON, V33, P337, DOI 10.1006/jare.1996.0069; Gutterman Yitzchak, 2002, P1; He XQ, 2011, THESIS LANZHOU U LAN; He Xue-qing, 2010, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V30, P120; Hou JW, 2009, THESIS LANZHOU U LAN; Hu XW, 2013, ECOL RES, V28, P801, DOI 10.1007/s11284-013-1063-8; Hu XW, 2012, PLANT GROWTH REGUL, V67, P199, DOI 10.1007/s10725-012-9677-3; Huang ZY, 2004, AUST J BOT, V52, P519, DOI 10.1071/BT03149; Jin Y, 1997, ACTA AGRESTIA SINICA, V5, P93; Koller D, 1969, Symp Soc Exp Biol, V23, P449; Kucera B, 2005, SEED SCI RES, V15, P281, DOI 10.1079/SSR2005218; LAVIE D, 1974, NATURE, V249, P388, DOI 10.1038/249388a0; Linkies A, 2012, PLANT CELL REP, V31, P253, DOI 10.1007/s00299-011-1180-1; Liu K, 2011, AM J BOT, V98, P12, DOI 10.3732/ajb.1000043; Ma HY, 2008, J ARID ENVIRON, V72, P573, DOI 10.1016/j.jaridenv.2007.06.013; Ma HY, 2010, J PLANT ECOL, V3, P269, DOI 10.1093/jpe/rtp035; Mensching HG, 1986, DESERTIFICATION EURO, P3; Morgan RPC, 1990, SOIL DEGRADATION REH, P69; PONS TL, 1989, ANN BOT-LONDON, V63, P139, DOI 10.1093/oxfordjournals.aob.a087716; POPAY AI, 1970, J ECOL, V58, P123, DOI 10.2307/2258172; Probert R. J., 2000, Seeds: the ecology of regeneration in plant communities, P261, DOI 10.1079/9780851994321.0261; ROBERTS EH, 1962, J EXP BOT, V13, P75, DOI 10.1093/jxb/13.1.75; SIMPSON GM, 1990, SEED DORMANCY GRASS; Steadman KJ, 2003, FUNCT PLANT BIOL, V30, P345, DOI 10.1071/FP02175; THANOS CA, 1991, ANN BOT-LONDON, V68, P469, DOI 10.1093/oxfordjournals.aob.a088280; Wang N, 2011, SEED SCI RES, V21, P295, DOI 10.1017/S0960258511000195; [王彦荣 Wang Yanrong], 2004, [生态学报, Acta Ecologica Sinica], V24, P402; Zhang FC, 2003, CAN J BOT, V81, P375, DOI [10.1139/B03-035, 10.1139/b03-035]; [赵凌平 ZHAO Lingping], 2008, [水土保持通报, Bulletin of Soil and Water Conservation], V28, P60; Zheng FL, 2006, PEDOSPHERE, V16, P420, DOI 10.1016/S1002-0160(06)60071-4; [周芝琴 Zhou Zhiqin], 2013, [草业科学, Pratacultural Science], V30, P218; Zhu YJ, 2007, FLORA, V202, P249, DOI 10.1016/j.flora.2006.05.006	54	14	14	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112579	10.1371/journal.pone.0112579	http://dx.doi.org/10.1371/journal.pone.0112579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396423	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558500061
J	Hussain, Z; Katas, H; Amin, MCIM; Kumolosasi, E				Hussain, Zahid; Katas, Haliza; Amin, Mohd Cairul Iqbal Mohd; Kumolosasi, Endang			Efficient Immuno-Modulation of T-H1/T-H2 Biomarkers in 2,4-Dinitrofluorobenzene-Induced Atopic Dermatitis: Nanocarrier-Mediated Transcutaneous Co-Delivery of Anti-Inflammatory and Antioxidant Drugs	PLOS ONE			English	Article							SKIN PENETRATION ENHANCEMENT; EX-VIVO; IN-VIVO; NANOPARTICLES; CHITOSAN; PERMEATION; ACCUMULATION; SUPPRESSION; LESIONS; ACID	The present study was conducted with the aim to investigate the immuno-modulatory and histological stabilization effects of nanocarrier-based transcutaneous co-delivery of hydrocortisone (HC) and hydroxytyrosol (HT). In this investigation, the clinical and pharmacological efficacies of nanoparticle (NP)-based formulation to alleviate 2,4-dinitrofluorobenzene (DNFB)-induced atopic dermatitis (AD) was explored by using an NC/Nga mouse model. Ex vivo visual examination of AD induction in experimental mice indicated remarkable control of NP-based formulations in reducing pathological severity of AD-like skin lesions. Therapeutic effectiveness of NP-based formulations was also evaluated by comparing skin thickness of AD-induced NP-treated mice (456 +/- 627 mm) with that of atopic mice (916 +/- 37 mm). Analysis of the immuno-spectrum of AD also revealed the dominance of NP-based formulations in restraining immunoglobulin-E (IgE), histamine, prostaglandin-E-2 (PGE(2)), vascular endothelial growth factor-alpha (VEGF-alpha), and T-helper cells (T-H1/T-H2) producing cytokines in serum and skin biopsies of tested mice. These anti-AD data were further supported by histological findings that revealed alleviated pathological features, including collagen fiber deposition, fibroblasts infiltration, and fragmentation of elastic fibers in experimental mice. Thus, NP-mediated transcutaneous co-delivery of HC and HT can be considered as a promising therapy for managing immunological and histological spectra associated with AD.	[Hussain, Zahid; Katas, Haliza; Amin, Mohd Cairul Iqbal Mohd; Kumolosasi, Endang] Univ Kebangsaan Malaysia, Fac Pharm, Ctr Drug Delivery Res, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia	Katas, H (corresponding author), Univ Kebangsaan Malaysia, Fac Pharm, Ctr Drug Delivery Res, Kuala Lumpur, Malaysia.	haliz12@hotmail.com	KATAS, HALIZA/I-6417-2016; HUSSAIN, ZAHID/AAX-8822-2020; Hussain, Zahid/HGU-8912-2022; Hussain, Za hid/AAD-8892-2020	KATAS, HALIZA/0000-0001-7249-1628; Hussain, Zahid/0000-0003-4989-6496; Hussain, Za hid/0000-0002-6978-3133	UKM Arus Perdana grant [AP-2013-002]	UKM Arus Perdana grant	This work was supported by the UKM Arus Perdana grant (AP-2013-002). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abramovits W, 2005, J AM ACAD DERMATOL, V53, pS86, DOI 10.1016/j.jaad.2005.04.034; Almeida IF, 2006, INT J PHARMACEUT, V327, P73, DOI 10.1016/j.ijpharm.2006.07.036; Alomar A, 2004, BRIT J DERMATOL, V151, P3, DOI 10.1111/j.1365-2133.2004.06269.x; Biruss B, 2006, EUR J PHARM BIOPHARM, V62, P210, DOI 10.1016/j.ejpb.2005.08.004; Clausen AE, 2001, EUR J PHARM BIOPHARM, V51, P25, DOI 10.1016/S0939-6411(00)00130-2; Contreras MD, 2002, INT J PHARMACEUT, V234, P149, DOI 10.1016/S0378-5173(01)00954-1; COUVREUR P, 1995, EUR J PHARM BIOPHARM, V41, P2; El-Hefian EA, 2010, TURK J CHEM, V34, P47, DOI 10.3906/kim-0901-38; Fang YP, 2009, EUR J PHARM BIOPHARM, V73, P391, DOI 10.1016/j.ejpb.2009.07.011; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Godwin DA, 2002, EUR J PHARM BIOPHARM, V53, P23, DOI 10.1016/S0939-6411(01)00215-6; Grewe M, 1998, IMMUNOL TODAY, V19, P359, DOI 10.1016/S0167-5699(98)01285-7; Hussain Z, 2013, INT J PHARMACEUT, V444, P109, DOI 10.1016/j.ijpharm.2013.01.024; Hussain Z, 2013, J PHARM SCI-US, V102, P1063, DOI 10.1002/jps.23446; Izidoro DR, 2008, LWT-FOOD SCI TECHNOL, V41, P1018, DOI 10.1016/j.lwt.2007.07.009; Jenning V, 2000, EUR J PHARM BIOPHARM, V49, P211, DOI 10.1016/S0939-6411(99)00075-2; Jung MK, 2010, J INVEST DERMATOL, V130, P1459, DOI 10.1038/jid.2009.401; Kang MJ, 2010, INT J PHARMACEUT, V402, P198, DOI 10.1016/j.ijpharm.2010.09.030; Kuchler S, 2009, EUR J PHARM BIOPHARM, V71, P243, DOI 10.1016/j.ejpb.2008.08.019; Lademann J, 2007, EUR J PHARM BIOPHARM, V66, P159, DOI 10.1016/j.ejpb.2006.10.019; Lee HS, 2006, BRIT J DERMATOL, V155, P33, DOI 10.1111/j.1365-2133.2006.07303.x; Leung DYM, 2000, J ALLERGY CLIN IMMUN, V105, P860, DOI 10.1067/mai.2000.106484; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; Lippacher A, 2001, INT J PHARM, V214, P9, DOI 10.1016/S0378-5173(00)00623-2; Matsuda H, 1997, INT IMMUNOL, V9, P461, DOI 10.1093/intimm/9.3.461; Mei ZN, 2005, DRUG DEV IND PHARM, V31, P161, DOI 10.1081/DDC-200047791; Moser K, 2001, EUR J PHARM BIOPHARM, V52, P103, DOI 10.1016/S0939-6411(01)00166-7; Papadimitriou S, 2008, CARBOHYD POLYM, V73, P44, DOI 10.1016/j.carbpol.2007.11.007; Park EJ, 2007, J INVEST DERMATOL, V127, P1154, DOI 10.1038/sj.jid.5700658; Prausnitz MR, 2004, ADV DRUG DELIVER REV, V56, P581, DOI 10.1016/j.addr.2003.10.023; Sammeta SM, 2010, J CONTROL RELEASE, V142, P361, DOI 10.1016/j.jconrel.2009.10.036; Schoepe S, 2006, EXP DERMATOL, V15, P406, DOI 10.1111/j.0906-6705.2006.00435.x; Senyigit T, 2009, INT J PHARMACEUT, V380, P155, DOI 10.1016/j.ijpharm.2009.07.018; Shu XZ, 2002, EUR J PHARM BIOPHARM, V54, P235, DOI 10.1016/S0939-6411(02)00052-8; Suda N, 2002, IMMUNOL LETT, V79, P177; Tomimori Y, 2005, J INVEST DERMATOL, V124, P119, DOI 10.1111/j.0022-202X.2004.23516.x; Trotta M, 2002, INT J PHARM, V241, P319, DOI 10.1016/S0378-5173(02)00266-1; Wu HL, 2001, INT J PHARM, V220, P63, DOI 10.1016/S0378-5173(01)00671-8; Wuthrich B, 2007, ANN AGR ENV MED, V14, P195; Zhang Y, 2006, ARCH DERMATOL RES, V297, P425, DOI 10.1007/s00403-006-0641-9; Zoller NN, 2008, TOXICOL IN VITRO, V22, P747, DOI 10.1016/j.tiv.2007.11.022	41	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113143	10.1371/journal.pone.0113143	http://dx.doi.org/10.1371/journal.pone.0113143			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396426	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558500137
J	Luo, YQ; Ma, XJ; Shen, Y; Hao, YP; Hu, YQ; Xiao, YF; Bao, YQ; Jia, WP				Luo, Yuqi; Ma, Xiaojing; Shen, Yun; Hao, Yaping; Hu, Yaqin; Xiao, Yunfeng; Bao, Yuqian; Jia, Weiping			Positive Relationship between Serum Low-Density Lipoprotein Cholesterol Levels and Visceral Fat in a Chinese Nondiabetic Population	PLOS ONE			English	Article							SUBCUTANEOUS ADIPOSE-TISSUE; ABDOMINAL OBESITY; RISK-FACTOR; METABOLIC SYNDROME; APOLIPOPROTEIN-B; LIPIDS; ASSOCIATION; EVENTS	Background: It has been reported that obesity and serum low-density lipoprotein cholesterol (LDL-c) are important risk factors of cardiovascular disease (CVD). It is recognized that regionalized adiposity has different cardiovascular risk, visceral versus subcutaneous, is a better predictor of CVD. However, the relationship between regionalized adiposity and LDL-c is unclear. The present study was designed to investigate the relationship between visceral fat accumulation and serum LDL-c levels in a Chinese cohort. Methods: A total of 1 538 subjects (539 men, 999 women; 20-75 years old) with normal glucose tolerance and blood pressure were recruited. All subjects underwent magnetic resonance imaging to quantify visceral fat area (VFA) and subcutaneous fat area. Serum LDL-c levels were detected by direct assay method. Results: Overweight/obese subjects (body mass index (BMI) >= 25 kg/m(2)) had significantly higher serum LDL-c levels than the lean subjects (BMI <25 kg/m(2)) (P<0.01). An increasing trend in serum LDL-c levels was found to accompany the increase in VFA (P for trend <0.01). Within the same BMI category, subjects with abdominal obesity (VFA >= 80 cm(2)) had significantly higher LDL-c levels than those without abdominal obesity (VFA <80 cm(2)) (P<0.05). Multiple stepwise regression analysis showed that increased VFA was an independent risk factor for elevated LDL-c levels, not only in the entire study population (Standard beta = 0.138; P<0.01), but also when the study population was subdivided into men, premenopausal and postmenopausal women (Standard beta = 0.117, 0.145, 0.090 respectively for men, premenopausal women, postmenopausal women; all P<0.01). Conclusions: VFA was positively correlated with serum LDL-c levels in a nondiabetic Chinese population with normal blood pressure.	[Luo, Yuqi; Ma, Xiaojing; Shen, Yun; Hao, Yaping; Hu, Yaqin; Bao, Yuqian; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab, Shanghai 200233, Peoples R China; [Luo, Yuqi; Ma, Xiaojing; Shen, Yun; Hao, Yaping; Hu, Yaqin; Bao, Yuqian; Jia, Weiping] Shanghai Clin Ctr Diabet, Shanghai 200233, Peoples R China; [Luo, Yuqi; Ma, Xiaojing; Shen, Yun; Hao, Yaping; Hu, Yaqin; Bao, Yuqian; Jia, Weiping] Shanghai Key Clin Ctr Metab Dis, Shanghai 200233, Peoples R China; [Luo, Yuqi; Ma, Xiaojing; Shen, Yun; Hao, Yaping; Hu, Yaqin; Bao, Yuqian; Jia, Weiping] Shanghai Diabet Inst, Shanghai 200233, Peoples R China; [Luo, Yuqi; Ma, Xiaojing; Shen, Yun; Hao, Yaping; Hu, Yaqin; Bao, Yuqian; Jia, Weiping] Shanghai Key Lab Diabet Mellitus, Shanghai 200233, Peoples R China; [Xiao, Yunfeng] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Radiol, Shanghai 200233, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Bao, YQ (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab, Shanghai 200233, Peoples R China.	byq522@163.com	, zz/AAG-3515-2020	Shen, Yun/0000-0002-9850-122X; Hu, Yaqin/0000-0003-0637-4209	973 Program of China [2013CB530606]; National Key Technology R&D Program of China [2012BAI02B03]; Project of National Natural Science Foundation of China [81100563]; Key Project of Science and Technology of Shanghai [13XD1403000]; Shanghai Health and Family Planning Commission [2013ZYJB1001]	973 Program of China(National Basic Research Program of China); National Key Technology R&D Program of China(National Key Technology R&D Program); Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Science and Technology of Shanghai; Shanghai Health and Family Planning Commission	Funded by 973 Program of China (2013CB530606), National Key Technology R&D Program of China (2012BAI02B03), Project of National Natural Science Foundation of China (81100563), Key Project of Science and Technology of Shanghai (13XD1403000), and grant from Shanghai Health and Family Planning Commission (2013ZYJB1001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Bao YQ, 2013, J CLIN ENDOCR METAB, V98, P345, DOI 10.1210/jc.2012-2906; Bao YQ, 2008, ATHEROSCLEROSIS, V201, P378, DOI 10.1016/j.atherosclerosis.2008.03.001; Bjorntorp P, 1988, Acta Med Scand Suppl, V723, P121; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Demerath EW, 2008, AM J CLIN NUTR, V88, P1263, DOI 10.3945/ajcn.2008.26546; Eckel RH, 1998, CIRCULATION, V97, P2099, DOI 10.1161/01.CIR.97.21.2099; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; GOFMAN JW, 1950, SCIENCE, V111, P166, DOI 10.1126/science.111.2877.166; Kastelein JJP, 2008, CIRCULATION, V117, P3002, DOI 10.1161/CIRCULATIONAHA.107.713438; Klopfenstein BJ, 2012, BRIT J RADIOL, V85, pE826, DOI 10.1259/bjr/57987644; LEMIEUX S, 1995, ATHEROSCLEROSIS, V118, P155, DOI 10.1016/0021-9150(95)05603-T; Onat A, 2004, INT J OBESITY, V28, P1018, DOI 10.1038/sj.ijo.0802695; Onat A, 2013, EUR J CLIN INVEST, V43, P1129, DOI 10.1111/eci.12150; Peleska J, 2002, ST HEAL T, V90, P268; Pelletier-Beaumont E, 2012, ATHEROSCLEROSIS, V221, P577, DOI 10.1016/j.atherosclerosis.2012.01.023; Robinson JG, 2009, J AM COLL CARDIOL, V55, P42, DOI 10.1016/j.jacc.2009.07.056; Sadeghi M, 2013, J RES MED SCI, V18, P326; Sadeghi M, 2013, ARCH IRAN MED, V16, P149, DOI 013163/AIM.006; Sharma S, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-10; Sniderman AD, 2003, LANCET, V361, P777, DOI 10.1016/S0140-6736(03)12663-3; Soeki T, 1999, JPN CIRC J, V63, P976, DOI 10.1253/jcj.63.976; Wang Y, 2012, INT J OBESITY, V36, P1203, DOI 10.1038/ijo.2011.222; World Health Organization, 1999, DIAGN CLASS DIAB M 1; Yang WY, 2012, CIRCULATION, V125, P2212, DOI 10.1161/CIRCULATIONAHA.111.065904	28	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112715	10.1371/journal.pone.0112715	http://dx.doi.org/10.1371/journal.pone.0112715			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398089	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558500080
J	Sato, R; Maekawa, M; Genma, R; Shirai, K; Ohki, S; Morita, H; Suda, T; Watanabe, H				Sato, Ryosuke; Maekawa, Masato; Genma, Rieko; Shirai, Kenji; Ohki, Shigeru; Morita, Hiroshi; Suda, Takafumi; Watanabe, Hiroshi			Final Height and Cardiometabolic Outcomes in Young Adults with Very Low Birth Weight (< 1500 g)	PLOS ONE			English	Article							INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; PLASMA-GLUCOSE; SHORT STATURE; RISK-FACTORS; GROWTH; AGE; LENGTH; HEART; OSTEOPOROSIS	Objective: Individuals with very low birth weight (VLBW; <1500 g) are known to be predisposed to both short final height and cardiometabolic disorders. However, associations between final height and cardiometabolic outcomes including glucose metabolism in VLBW individuals in young adulthood are not fully investigated. Methods: We investigated glucose metabolism and other cardiometabolic outcomes such as lipid profiles, blood pressure, renal function, urinary albumin, and thyroid function in young adults with VLBW born between 1980 and 1990. Short stature was defined as a final height <10th percentile. Glucose intolerance [diabetes, impaired glucose tolerance (IGT), and impaired fasting glucose (IFG)] was determined using 75-g oral glucose tolerance tests. Associations between final height and cardiometabolic outcomes were examined using logistic or multiple linear regression. Results: A total of 628 VLBW individuals were screened and 111 young adults with VLBW (19-30 years) participated in the study. Of the participants, 40 subjects (36%) had short stature with a final height <10th percentile. Eight subjects (7.2%) had glucose intolerance (1, diabetes; 6, IGT; 1, IFG). Short stature was correlated with glucose intolerance (odds ratio 11.1; 95% CI 1.92, 99.7; P = 0.006). Final height was inversely associated with the homeostatic model assessment (HOMA) of insulin resistance, HOMA-beta, insulinogenic index, and total/LDL-cholesterol. The associations of final height with insulin sensitivity and lipid profiles remained after adjustment for target height and age at puberty onset. Conclusions: Shorter final height was associated with less favorable metabolic profiles in young adults with VLBW, and may be partly mediated by reduced insulin sensitivity. These associations were independent of target height or age at puberty onset.	[Sato, Ryosuke; Suda, Takafumi] Hamamatsu Univ Sch Med, Dept Internal Med 2, Hamamatsu, Shizuoka 4313192, Japan; [Sato, Ryosuke; Genma, Rieko] Seirei Hamamatsu Gen Hosp, Dept Endocrinol & Metab, Hamamatsu, Shizuoka, Japan; [Maekawa, Masato] Hamamatsu Univ Sch Med, Dept Lab Med, Hamamatsu, Shizuoka 4313192, Japan; [Shirai, Kenji; Ohki, Shigeru] Seirei Hamamatsu Gen Hosp, Dept Neonatol, Hamamatsu, Shizuoka, Japan; [Watanabe, Hiroshi] Hamamatsu Univ Sch Med, Dept Clin Pharmacol & Therapeut, Hamamatsu, Shizuoka 4313192, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Sato, R (corresponding author), Pharmaceut & Med Devices Agcy, Tokyo, Japan.	sato-ryosuke@pmda.go.jp		Maekawa, Masato/0000-0001-9710-5324	Japan Society for the Promotion of Science [24390144]; Ministry of Health, Labour and Welfare in Japan [H23-Cardiovascular disease, Diabetes-011]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan)	This study was partly supported by grants from the Japan Society for the Promotion of Science (24390144) and from the Ministry of Health, Labour and Welfare in Japan (H23-Cardiovascular disease and Diabetes-011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2008, DIABETES CARE, V31, P1650, DOI 10.2337/dc08-0225; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Asao K, 2006, DIABETES CARE, V29, P1632, DOI 10.2337/dc05-1997; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Biro FM, 2001, J PEDIATR-US, V138, P636, DOI 10.1067/mpd.2001.114476; Eichenwald EC, 2008, NEW ENGL J MED, V358, P1700, DOI 10.1056/NEJMra0707601; Eriksson JG, 2006, DIABETOLOGIA, V49, P2853, DOI 10.1007/s00125-006-0459-1; Field DJ, 2008, BMJ-BRIT MED J, V336, P1221, DOI 10.1136/bmj.39555.670718.BE; Gavin JR, 1997, DIABETES CARE, V20, P1183; He QM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094385; Hovi P, 2007, NEW ENGL J MED, V356, P2053, DOI 10.1056/NEJMoa067187; Johnston LW, 2013, DIABETES CARE, V36, P3599, DOI 10.2337/dc13-0254; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kaijser M, 2009, DIABETES, V58, P523, DOI 10.2337/db08-0558; Kindblom JM, 2006, DIABETES, V55, P3047, DOI 10.2337/db06-0192; Lakshman R, 2008, DIABETOLOGIA, V51, P781, DOI 10.1007/s00125-008-0948-5; Lakshman R, 2009, J CLIN ENDOCR METAB, V94, P4953, DOI 10.1210/jc.2009-1789; Lawlor DA, 2002, DIABETOLOGIA, V45, P1097, DOI 10.1007/s00125-002-0887-5; Leger J, 1997, BRIT MED J, V315, P341; Lettre G, 2011, HUM GENET, V129, P465, DOI 10.1007/s00439-011-0969-x; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; Liu J, 2009, DIABETES CARE, V32, P739, DOI 10.2337/dc08-1547; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ministry of Health Labour and Welfare Japan, 2007, NAT HLTH NUTR SURV J; Must A, 2002, AM J EPIDEMIOL, V155, P672, DOI 10.1093/aje/155.7.672; OGATA T, 1990, JPN J PAEDIAT, V94, P1535; Paajanen TA, 2010, EUR HEART J, V31, P1802, DOI 10.1093/eurheartj/ehq155; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Qiu CS, 2013, J CLIN ENDOCR METAB, V98, P1612, DOI 10.1210/jc.2012-2919; Radetti G, 2004, J CLIN ENDOCR METAB, V89, P6320, DOI 10.1210/jc.2003-032185; Rinaudo P, 2012, ANNU REV PHYSIOL, V74, P107, DOI 10.1146/annurev-physiol-020911-153245; Sato R, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000327; Smits MM, 2012, DIABETOLOGIA, V55, P1679, DOI 10.1007/s00125-012-2500-x; Succurro E, 2009, ATHEROSCLEROSIS, V207, P245, DOI 10.1016/j.atherosclerosis.2009.04.006; Taylor PN, 2013, J CLIN ENDOCR METAB, V98, P3562, DOI 10.1210/jc.2013-1315; The study group of the Health Ministry in Japan, 1994, FET GROWTH CURV JAP; Walsh JP, 2010, J CLIN ENDOCR METAB, V95, P1095, DOI 10.1210/jc.2009-1977; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Widen E, 2012, DIABETES CARE, V35, P850, DOI 10.2337/dc11-1365	40	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112286	10.1371/journal.pone.0112286	http://dx.doi.org/10.1371/journal.pone.0112286			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397968	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558500044
J	Tvrdonova, V; Rokic, MB; Stojilkovic, SS; Zemkova, H				Tvrdonova, Vendula; Rokic, Milos B.; Stojilkovic, Stanko S.; Zemkova, Hana			Identification of Functionally Important Residues of the Rat P2X4 Receptor by Alanine Scanning Mutagenesis of the Dorsal Fin and Left Flipper Domains	PLOS ONE			English	Article							HUMAN P2X(1) RECEPTORS; GATED ION CHANNELS; ATP-BINDING-SITE; AGONIST BINDING; TRANSMEMBRANE SEGMENTS; CATION PERMEABILITY; KINASE-C; ACTIVATION; DESENSITIZATION; IVERMECTIN	Crystallization of the zebrafish P2X4 receptor in both open and closed states revealed conformational differences in the ectodomain structures, including the dorsal fin and left flipper domains. Here, we focused on the role of these domains in receptor activation, responsiveness to orthosteric ATP analogue agonists, and desensitization. Alanine scanning mutagenesis of the R203-L214 (dorsal fin) and the D280-N293 (left flipper) sequences of the rat P2X4 receptor showed that ATP potency/efficacy was reduced in 15 out of 26 alanine mutants. The R203A, N204A, and N293A mutants were essentially non-functional, but receptor function was restored by ivermectin, an allosteric modulator. The I205A, T210A, L214A, P290A, G291A, and Y292A mutants exhibited significant changes in the responsiveness to orthosteric analog agonists 2-(methylthio) adenosine 5'-triphosphate, adenosine 5'-(gamma-thio) triphosphate, 2'(3'-O-(4-benzoylbenzoyl) adenosine 5'-triphosphate, and alpha,beta-methyleneadenosine 5'-triphosphate. In contrast, the responsiveness of L206A, N208A, D280A, T281A, R282A, and H286A mutants to analog agonists was comparable to that of the wild type receptor. Among these mutants, D280A, T281A, R282A, H286A, G291A, and Y292A also exhibited increased time-constant of the desensitizing current response. These experiments, together with homology modeling, indicate that residues located in the upper part of the dorsal fin and left flipper domains, relative to distance from the channel pore, contribute to the organization of the ATP binding pocket and to the initiation of signal transmission towards residues in the lower part of both domains. The R203 and N204 residues, deeply buried in the protein, may integrate the output signal from these two domains towards the gate. In addition, the left flipper residues predominantly account for the control of transition of channels from an open to a desensitized state.	[Tvrdonova, Vendula; Rokic, Milos B.; Zemkova, Hana] Acad Sci Czech Republic, Inst Physiol, Dept Cellular & Mol Neuroendocrinol, Prague, Czech Republic; [Tvrdonova, Vendula] Charles Univ Prague, Fac Sci, Dept Anim Physiol, Prague, Czech Republic; [Rokic, Milos B.; Stojilkovic, Stanko S.] NICHHD, Sect Cellular Signaling, Program Dev Neurosci, NIH, Bethesda, MD 20892 USA	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Charles University Prague; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Zemkova, H (corresponding author), Acad Sci Czech Republic, Inst Physiol, Dept Cellular & Mol Neuroendocrinol, Prague, Czech Republic.	zemkova@biomed.cas.cz	Stillerova (Tvrdonova), Vendula/G-3060-2014; Zemkova, Hana/C-1844-2012; ROKIC, MILOS/O-7204-2014	Stillerova (Tvrdonova), Vendula/0000-0001-5295-2837; Zemkova, Hana/0000-0001-5219-8563; ROKIC, MILOS/0000-0002-9148-2716	Grant Agency of the Czech Republic [P304/12/G069]; Centrum of Biomedicine Research [CZ.1.07/2.3.00/30.0025]; "BIOCEV'' project; Biotechnology and Biomedicine Centre of the Academy of Sciences; Grant Agency of Charles University in Prague [3446/2011]; Academy of Sciences of the Czech Republic [RVO 67985823]; Intramural Research Program of the NICHD, NIH; Charles University in Vestec from the European Regional Development Fund [CZ.1.05/1.1.00/02.0109]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000195] Funding Source: NIH RePORTER	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Centrum of Biomedicine Research; "BIOCEV'' project; Biotechnology and Biomedicine Centre of the Academy of Sciences; Grant Agency of Charles University in Prague; Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Intramural Research Program of the NICHD, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Charles University in Vestec from the European Regional Development Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Grant Agency of the Czech Republic (P304/12/G069), the Centrum of Biomedicine Research (CZ.1.07/2.3.00/30.0025), the "BIOCEV'' project with the Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University in Vestec (CZ.1.05/1.1.00/02.0109) from the European Regional Development Fund, the Grant Agency of Charles University in Prague (3446/2011), the Academy of Sciences of the Czech Republic (Research Project No. RVO 67985823, and the Intramural Research Program of the NICHD, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriouch S, 2008, FASEB J, V22, P861, DOI 10.1096/fj.07-9294com; Allsopp RC, 2011, J BIOL CHEM, V286, P29207, DOI 10.1074/jbc.M111.260364; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Bodnar M, 2011, J BIOL CHEM, V286, P2739, DOI 10.1074/jbc.M110.167437; Carugo O, 1999, PROTEIN ENG, V12, P1021, DOI 10.1093/protein/12.12.1021; Coddou C, 2003, J BIOL CHEM, V278, P36777, DOI 10.1074/jbc.M305177200; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Coddou C, 2011, REV NEUROSCIENCE, V22, P335, DOI 10.1515/RNS.2011.014; Collo G, 1996, J NEUROSCI, V16, P2495; Digby HR, 2005, J NEUROCHEM, V95, P1746, DOI 10.1111/j.1471-4159.2005.03494.x; Du J, 2012, P NATL ACAD SCI USA, V109, P4140, DOI 10.1073/pnas.1119546109; Egan TM, 1998, J NEUROSCI, V18, P2350; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; Fabbretti E, 2004, J BIOL CHEM, V279, P53109, DOI 10.1074/jbc.M409772200; Friday SC, 2008, J NEUROCHEM, V105, P1264, DOI 10.1111/j.1471-4159.2008.05228.x; Haines WR, 2001, J NEUROSCI, V21, P5885, DOI 10.1523/JNEUROSCI.21-16-05885.2001; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Huang LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097528; Jelinkova I, 2008, PFLUG ARCH EUR J PHY, V456, P939, DOI 10.1007/s00424-008-0450-4; Jelinkova I, 2006, BIOCHEM BIOPH RES CO, V349, P619, DOI 10.1016/j.bbrc.2006.08.084; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; Jiang LH, 2001, J BIOL CHEM, V276, P14902, DOI 10.1074/jbc.M011327200; Jiang RT, 2011, P NATL ACAD SCI USA, V108, P9066, DOI 10.1073/pnas.1102170108; Karplus PA, 1997, PROTEIN SCI, V6, P1302; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 2005, J BIOL CHEM, V280, P6118, DOI 10.1074/jbc.M411324200; Khakh BS, 1999, J NEUROSCI, V19, P7289, DOI 10.1523/JNEUROSCI.19-17-07289.1999; Kowalski M, 2014, BRIT J PHARMACOL, V171, P5093, DOI 10.1111/bph.12830; Le KT, 1998, J NEUROSCI, V18, P7152; Li ZY, 2004, J NEUROSCI, V24, P7378, DOI 10.1523/JNEUROSCI.1423-04.2004; Lorinczi E, 2012, P NATL ACAD SCI USA, V109, P11396, DOI 10.1073/pnas.1118759109; Marquez-Klaka B, 2007, J NEUROSCI, V27, P1456, DOI 10.1523/JNEUROSCI.3105-06.2007; Migita K, 2001, J BIOL CHEM, V276, P30934, DOI 10.1074/jbc.M103366200; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Ormond SJ, 2006, MOL PHARMACOL, V69, P1692, DOI 10.1124/mol.105.020404; Petrenko N, 2011, BIOCHEMISTRY-US, V50, P8427, DOI 10.1021/bi200812u; Priel A, 2004, J GEN PHYSIOL, V123, P281, DOI 10.1085/jgp.200308986; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Rettinger J, 2004, J BIOL CHEM, V279, P6426, DOI 10.1074/jbc.M306987200; Roberts JA, 2006, J NEUROCHEM, V96, P843, DOI 10.1111/j.1471-4159.2005.03593.x; Roberts JA, 2008, J BIOL CHEM, V283, P20126, DOI 10.1074/jbc.M800294200; Roberts JA, 2007, J NEUROSCI, V27, P4072, DOI 10.1523/JNEUROSCI.2310-06.2007; Rokic MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059411; Samways DSK, 2008, J BIOL CHEM, V283, P5110, DOI 10.1074/jbc.M708713200; Samways DSK, 2011, P NATL ACAD SCI USA, V108, P13800, DOI 10.1073/pnas.1017550108; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Silberberg SD, 2005, J GEN PHYSIOL, V125, P347, DOI 10.1085/jgp.200409221; Stanchev D, 2006, NEUROSCI LETT, V393, P78, DOI 10.1016/j.neulet.2005.09.045; Toulme E, 2006, MOL PHARMACOL, V69, P576, DOI 10.1124/mol.105.018812; Wirkner K, 2005, J NEUROSCI, V25, P7734, DOI 10.1523/JNEUROSCI.2028-05.2005; Xiong KM, 2004, NEUROSCI LETT, V365, P195, DOI 10.1016/j.neulet.2004.04.078; Xu J, 2014, J GEN PHYSIOL, V144, P79, DOI 10.1085/jgp.201411169; Yan ZH, 2005, MOL PHARMACOL, V67, P1078, DOI 10.1124/mol.104.010108; Yan ZH, 2006, J BIOL CHEM, V281, P32649, DOI 10.1074/jbc.M512791200; Zemkova H, 2004, J NEUROSCI, V24, P6968, DOI 10.1523/JNEUROSCI.1471-04.2004; Zemkova H., 2014, PFLUGERS ARCH; Zemkova H, 2007, J NEUROCHEM, V102, P1139, DOI 10.1111/j.1471-4159.2007.04616.x; Zhang LM, 2014, BIOCHEMISTRY-US, V53, P3012, DOI 10.1021/bi401711n; Zhao WS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5189	60	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112902	10.1371/journal.pone.0112902	http://dx.doi.org/10.1371/journal.pone.0112902			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398027	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558500107
J	Wong, CKM; Liang, J; Chan, ML; Chan, YH; Chan, L; Wan, KY; Ng, MS; Chan, DCC; Wong, SYS; Wong, MCS				Wong, Carmen K. M.; Liang, Jun; Chan, Man L.; Chan, Yin H.; Chan, Laam; Wan, Kwong Y.; Ng, Ming S.; Chan, Dicken C. C.; Wong, Samuel Y. S.; Wong, Martin C. S.			Prevalence and Psychosocial Correlates of Depressive Symptoms in Urban Chinese Women during Midlife	PLOS ONE			English	Article							NATIONAL COMORBIDITY SURVEY; MAJOR DEPRESSION; HONG-KONG; MENOPAUSAL TRANSITION; GENDER-DIFFERENCES; LIFE EVENTS; HEALTH; POPULATION; ONSET; SEX	Objective: Depression is common in women with much research focusing on hormonal changes and menopausal symptoms but with little exploration of psychosocial problems in midlife. This study investigates the prevalence of clinically relevant depressive symptoms in midlife Chinese women and its association with psychosocial factors. Methods: A cross-sectional, community-based household survey of women aged 45 to 64 years of age was conducted in Hong Kong from September 2010 to March 2011. The structured questionnaire included demographic data, educational status, marital status and household income, as well as perceived current stressful events and significant life events in the past 12 months. Information on clinically relevant depressive symptoms was measured by the validated chinese Patient Health Questionnaire (PHQ-9). Results: A total of 402 participants were recruited in the study period. Of the 393 women who completed the questionnaire, the prevalence of clinically relevant depressive symptoms (PHQ-9 score >= 10) was 11.0%. In multiple regression analysis, being single/divorced/separated/widowed, having an educational level of primary school level or below, having multiple chronic diseases, loss of hobby or loss of close social support in the past 12 months in midlife were associated with clinically relevant depressive symptoms. Conclusions: Correlates of clinically relevant depressive symptoms in midlife Chinese women can be used to identify those at increased risk and potentiate further studies to explore early psychosocial and community interventions.	[Wong, Carmen K. M.; Chan, Dicken C. C.; Wong, Samuel Y. S.; Wong, Martin C. S.] Chinese Univ Hong Kong, Div Family Med & Primary Hlth Care, JC Sch Publ Hlth & Primary Care, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Liang, Jun; Chan, Man L.; Chan, Yin H.; Chan, Laam; Wan, Kwong Y.; Ng, Ming S.] Tuen Mun Hosp, Hong Kong Primary Care Res Network, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Tuen Mun Hospital	Wong, MCS (corresponding author), Chinese Univ Hong Kong, Div Family Med & Primary Hlth Care, JC Sch Publ Hlth & Primary Care, Prince Wales Hosp, 4-F,Sch Publ Hlth Bldg, Shatin, Hong Kong, Peoples R China.	wong_martin@cuhk.edu.hk	Wong, Martin/L-4568-2014; WONG, Samuel Yeung Shan/D-7311-2013	Wong, Martin/0000-0001-7706-9370; WONG, Samuel Yeung Shan/0000-0003-0934-6385				Angst J, 1997, J AFFECT DISORDERS, V45, P31, DOI 10.1016/S0165-0327(97)00057-8; BLAZER DG, 1994, AM J PSYCHIAT, V151, P979; Bracke P, 2000, SOC SCI MED, V51, P51, DOI 10.1016/S0277-9536(99)00432-3; Bromberger JT, 2007, J AFFECT DISORDERS, V103, P267, DOI 10.1016/j.jad.2007.01.034; Bromberger JT, 2004, AM J PUBLIC HEALTH, V94, P1378, DOI 10.2105/AJPH.94.8.1378; Buist-Bouwman MA, 2005, ACTA PSYCHIAT SCAND, V111, P436, DOI 10.1111/j.1600-0447.2005.00513.x; Census and Statistics Department, 2011, CENS 2011; Cheng C., 2007, J ESTHET RESTOR DENT, V29, P381, DOI [DOI 10.1016/J.JAD.2013.07.014, 10.1016/j.jad.2013.07.014]; Chi I, 2005, AM J GERIAT PSYCHIAT, V13, P409, DOI 10.1176/appi.ajgp.13.5.409; Chou KL, 2005, INT J GERIATR PSYCH, V20, P41, DOI 10.1002/gps.1246; Cohen LS, 2006, ARCH GEN PSYCHIAT, V63, P385, DOI 10.1001/archpsyc.63.4.385; Coiro MJ, 2001, WOMEN HEALTH, V32, P1, DOI 10.1300/J013v32n01_01; Department of Health, 2010, ANN REP 2009 2010; Eaton WW, 2001, J HEALTH SOC BEHAV, V42, P277, DOI 10.2307/3090215; Elliott M, 2001, WOMEN HEALTH, V33, P163; Freeman EW, 2006, ARCH GEN PSYCHIAT, V63, P375, DOI 10.1001/archpsyc.63.4.375; Ho SC, 2003, MATURITAS, V44, P149, DOI 10.1016/S0378-5122(02)00325-0; KENDLER KS, 1993, AM J PSYCHIAT, V150, P1139; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; KESSLER RC, 1994, J AFFECT DISORDERS, V30, P15, DOI 10.1016/0165-0327(94)90147-3; KESSLER RC, 1981, AM SOCIOL REV, V46, P443, DOI 10.2307/2095263; Kessler RC, 1997, ANNU REV PSYCHOL, P48191; Krause N., 1999, HDB SOCIOLOGY MENTAL, P183, DOI [10.1007/0-387-36223-1_10, DOI 10.1007/0-387-36223-1_10]; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LAU EMC, 1995, J EPIDEMIOL COMMUN H, V49, P492, DOI 10.1136/jech.49.5.492; Levav I, 2002, ISRAEL J PSYCHIAT, V39, P50; Liu JZ, 2007, MATURITAS, V58, P359, DOI 10.1016/j.maturitas.2007.09.007; Loh FH, 2005, MATURITAS, V52, P169, DOI 10.1016/j.maturitas.2004.11.004; Mirowsky J, 2017, SOCIAL CAUSES PSYCHO; Nazroo JY, 1997, PSYCHOL MED, V27, P9, DOI 10.1017/S0033291796004187; O'Campo P, 2004, SOC SCI MED, V58, P585, DOI 10.1016/S0277-9536(03)00230-2; Scott KM, 2007, J AFFECT DISORDERS, V103, P113, DOI 10.1016/j.jad.2007.01.015; Shim RS, 2011, J AM BOARD FAM MED, V24, P33, DOI 10.3122/jabfm.2011.01.100121; Simonsick EM, 1995, NIH PUB, V95-4009; Simpson HB, 1997, ARCH GEN PSYCHIAT, V54, P633; Taylor SE, 2000, PSYCHOL REV, V107, P411, DOI 10.1037/0033-295X.107.3.411; TURNER RJ, 1989, J NERV MENT DIS, V177, P443, DOI 10.1097/00005053-198908000-00001; Wong SYS, 2006, J AFFECT DISORDERS, V92, P215, DOI 10.1016/j.jad.2006.01.027; WOO J, 1994, ACTA PSYCHIAT SCAND, V89, P8, DOI 10.1111/j.1600-0447.1994.tb01478.x	39	42	46	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e110877	10.1371/journal.pone.0110877	http://dx.doi.org/10.1371/journal.pone.0110877			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DF	25398009	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558500010
J	Yang, JP; Wei, F; Schafer, C; Wong, DTW				Yang, Jieping; Wei, Fang; Schafer, Christopher; Wong, David T. W.			Detection of Tumor Cell-Specific mRNA and Protein in Exosome-Like Microvesicles from Blood and Saliva	PLOS ONE			English	Article							BIOMARKERS; CANCER; CARCINOMA; VESICLES; IDENTIFICATION; MUTATIONS; MICRORNAS; MELANOMA; RELEASE; PLASMA	The discovery of disease-specific biomarkers in oral fluids has revealed a new dimension in molecular diagnostics. Recent studies have reported the mechanistic involvement of tumor cells derived mediators, such as exosomes, in the development of saliva-based mRNA biomarkers. To further our understanding of the origins of disease-induced salivary biomarkers, we here evaluated the hypothesis that tumor-shed secretory lipidic vesicles called exosome-like microvesicles (ELMs) that serve as protective carriers of tissue-specific information, mRNAs, and proteins, throughout the vasculature and bodily fluids. RNA content was analyzed in cell free-saliva and ELM-enriched fractions of saliva. Our data confirmed that the majority of extracellular RNAs (exRNAs) in saliva were encapsulated within ELMs. Nude mice implanted with human lung cancer H460 cells expressing hCD63-GFP were used to follow the circulation of tumor cell specific protein and mRNA in the form of ELMs in vivo. We were able to identify human GAPDH mRNA in ELMs of blood and saliva of tumor bearing mice using nested RT-qPCR. ELMs positive for hCD63-GFP were detected in the saliva and blood of tumor bearing mice as well as using electric field-induced release and measurement (EFIRM). Altogether, our results demonstrate that ELMs carry tumor cell-specific mRNA and protein from blood to saliva in a xenografted mouse model of human lung cancer. These results therefore strengthen the link between distal tumor progression and the biomarker discovery of saliva through the ELMs.	[Yang, Jieping; Wei, Fang; Schafer, Christopher; Wong, David T. W.] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Wong, DTW (corresponding author), Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA.	dtww@ucla.edu			Ruth L. Kirschstein National Research Service Award [T32-DE07296]; National Institute of Dental and Craniofacial Research/National Institutes of Health [UO1-DE017790, RO1-DE15970]; National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR000124]; California Tobacco-Related Diseases Research Program (TRDRP) [20PT-0032, 21RT-0112]; DoD [LS110207]; Univerity of California, Los Angeles School of Dentistry [441901-69749-FWEI-FY11DR]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015970, T32DE007296, U01DE017790] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Dental and Craniofacial Research/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); California Tobacco-Related Diseases Research Program (TRDRP); DoD(United States Department of Defense); Univerity of California, Los Angeles School of Dentistry; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by a Ruth L. Kirschstein National Research Service Award (grant T32-DE07296) and the National Institute of Dental and Craniofacial Research/National Institutes of Health (grants UO1-DE017790 and RO1-DE15970). The project described was also supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health (grant UL1TR000124). It was also supported by the California Tobacco-Related Diseases Research Program (TRDRP) 20PT-0032, 21RT-0112 and also DoD grant LS110207. Support was also received from a Faculty Seed Grant from the Univerity of California, Los Angeles School of Dentistry (grant 441901-69749-FWEI-FY11DR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; BLAND J, 2008, ALTERN THER HEALTH M, V14, P18; Bossuyt PMM, 2011, JAMA-J AM MED ASSOC, V305, P2229, DOI 10.1001/jama.2011.729; Brinkmann O, 2011, ADV CLIN CHEM, V55, P21, DOI 10.1016/B978-0-12-387042-1.00002-2; Chalmin F, 2010, J CLIN INVEST, V120, P457, DOI 10.1172/JCI40483; Ciravolo V, 2012, J CELL PHYSIOL, V227, P658, DOI 10.1002/jcp.22773; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; De la Pena H, 2009, J IMMUNOL METHODS, V344, P121, DOI 10.1016/j.jim.2009.03.011; Desnoyers L, 2008, ONCOGENE, V27, P85, DOI 10.1038/sj.onc.1210623; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Dimov I, 2009, THESCIENTIFICWORLDJO, V9, P1107, DOI 10.1100/tsw.2009.128; Farrell JJ, 2012, GUT, V61, P582, DOI 10.1136/gutjnl-2011-300784; Frangogiannis NG, 2012, TRANSL RES, V159, P197, DOI 10.1016/j.trsl.2012.01.023; Gao K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005875; Gray RD, 2010, CHEST, V137, P635, DOI 10.1378/chest.09-1047; Hess C, 1999, J IMMUNOL, V163, P4564; Hu S, 2007, ARTHRITIS RHEUM-US, V56, P3588, DOI 10.1002/art.22954; Hu S, 2011, PROTEOMICS, V11, P1499, DOI 10.1002/pmic.201000206; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Kraus-Berthier L, 2000, CLIN CANCER RES, V6, P297; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Lau C, 2013, J BIOL CHEM; Lee YH, 2012, J MOL MED, V90, P427, DOI 10.1007/s00109-011-0829-0; Lee YH, 2011, CLIN CHEM, V57, P1295, DOI 10.1373/clinchem.2010.159210; Lee YH, 2009, AM J DENT, V22, P241; Li Y, 2004, CLIN CANCER RES, V10, P8442, DOI 10.1158/1078-0432.CCR-04-1167; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Lotvall J, 2007, CELL ADHES MIGR, V1, P156, DOI 10.4161/cam.1.3.5114; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Marzesco AM, 2005, J CELL SCI, V118, P2849, DOI 10.1242/jcs.02439; Nonaka D, 2005, CANCER RES, V65, P1207, DOI 10.1158/0008-5472.CAN-04-3461; Ogata-Kawata H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092921; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Palanisamy V, 2008, J DENT RES, V87, P772, DOI 10.1177/154405910808700803; Palanisamy V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008577; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Park NJ, 2006, CLIN CHEM, V52, P988, DOI 10.1373/clinchem.2005.063206; Petty TL, 2000, CANCER, V89, P2461; Putz U, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003084; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Sawey ET, 2011, CANCER CELL, V19, P347, DOI 10.1016/j.ccr.2011.01.040; Sharma S, 2010, ACS NANO, V4, P1921, DOI 10.1021/nn901824n; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Sreekumar PG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012578; Streckfus C, 2000, CLIN CANCER RES, V6, P2363; Taylor DD, 2002, GYNECOL ONCOL, V84, P443, DOI 10.1006/gyno.2001.6551; Taylor DD, 2011, METHODS MOL BIOL, V728, P235, DOI 10.1007/978-1-61779-068-3_15; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Webber J, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.19861; Wei F, 2013, BIOSENS BIOELECTRON, V44, P115, DOI 10.1016/j.bios.2012.12.046; Wei F, 2009, CLIN CANCER RES, V15, P4446, DOI 10.1158/1078-0432.CCR-09-0050; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Yang C, 2011, CLIN DEV IMMUNOL, V2011, P11, DOI DOI 10.1155/2011/842849; Zhang L, 2012, CELL MOL LIFE SCI, V69, P3341, DOI 10.1007/s00018-012-1027-0; Zhang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015573; Zhang L, 2010, GASTROENTEROLOGY, V138, P949, DOI 10.1053/j.gastro.2009.11.010; Zhang L, 2010, J CLIN MICROBIOL, V48, P2965, DOI 10.1128/JCM.02391-09	64	75	81	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e110641	10.1371/journal.pone.0110641	http://dx.doi.org/10.1371/journal.pone.0110641			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397880	Green Published, gold			2022-12-27	WOS:000345558500009
J	Zhang, X; Li, F; Zhang, L; Zhao, ZH; Norback, D				Zhang, Xin; Li, Fan; Zhang, Li; Zhao, Zhuohui; Norback, Dan			A Longitudinal Study of Sick Building Syndrome (SBS) among Pupils in Relation to SO2, NO2, O-3 and PM10 in Schools in China	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; INDOOR AIR-POLLUTION; SYMPTOMS; HEALTH; PREVALENCE; ASSOCIATIONS; VENTILATION; ENVIRONMENT; OUTDOOR; QUALITY	There are fewer longitudinal studies from China on symptoms as described for the sick building syndrome (SBS). Here, we performed a two-year prospective study and investigated associations between environmental parameters such as room temperature, relative air humidity (RH), carbon dioxide (CO2), nitrogen dioxide (NO2), sulphur dioxide (SO2), ozone (O-3), particulate matter (PM10), and health outcomes including prevalence, incidence and remission of SBS symptoms in junior high schools in Taiyuan, China. Totally 2134 pupils participated at baseline, and 1325 stayed in the same classrooms during the study period (2010-2012). The prevalence of mucosal symptoms, general symptoms and symptoms improved when away from school (school-related symptoms) was 22.7%, 20.4% and 39.2%, respectively, at baseline, and the prevalence increased during follow-up (P<0.001). At baseline, both indoor and outdoor SO2 were found positively associated with prevalence of school-related symptoms. Indoor O-3 was shown to be positively associated with prevalence of skin symptoms. At follow-up, indoor PM10 was found to be positively associated with new onset of skin, mucosal and general symptoms. CO2 and RH were positively associated with new onset of mucosal, general and school-related symptoms. Outdoor SO2 was positively associated with new onset of skin symptoms, while outdoor NO2 was positively associated with new onset of skin, general and mucosal symptoms. Outdoor PM10 was found to be positively associated with new onset of skin, general and mucosal symptoms as well as school-related symptoms. In conclusion, symptoms as described for SBS were commonly found in school children in Taiyuan City, China, and increased during the two-year follow-up period. Environmental pollution, including PM10, SO2 and NO2, could increase the prevalence and incidence of SBS and decrease the remission rate. Moreover, parental asthma and allergy (heredity) and pollen or pet allergy (atopy) can be risk factors for SBS.	[Zhang, Xin; Li, Fan; Zhang, Li] Shanxi Univ, Inst Environm Sci, Taiyuan, Peoples R China; [Zhao, Zhuohui] Fudan Univ, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Norback, Dan] Uppsala Univ, Dept Med Sci Occupat & Environm Med, Uppsala, Sweden	Shanxi University; Fudan University; Uppsala University	Zhao, ZH (corresponding author), Fudan Univ, Sch Publ Hlth, Shanghai 200433, Peoples R China.	zhzhao@fudan.edu.cn		Norback, Dan/0000-0002-5174-6668	Swedish Research Council [348-2011-7402]; National Natural Science Foundation of China [21207083]; Natural Science Foundation of Shanxi Province of China [2013021033-1]; Shanxi Scholarship Council of China [2012-005]; Taiyuan Environmental Protection Agency for Environmental Sciences and Technology [201218]	Swedish Research Council(Swedish Research CouncilEuropean Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanxi Province of China(Natural Science Foundation of Shanxi Province); Shanxi Scholarship Council of China; Taiyuan Environmental Protection Agency for Environmental Sciences and Technology	This study was supported by grants from the Swedish Research Council (348-2011-7402), the National Natural Science Foundation of China (21207083), Natural Science Foundation of Shanxi Province of China (2013021033-1), a research project supported by Shanxi Scholarship Council of China (2012-005), and Taiyuan Environmental Protection Agency for Environmental Sciences and Technology (201218). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahman M, 2000, INDOOR AIR, V10, P57, DOI 10.1034/j.1600-0668.2000.010001057.x; APTER A, 1994, J ALLERGY CLIN IMMUN, V94, P277, DOI 10.1016/0091-6749(94)90087-6; ASHRAE, 1989, 621989 ASHRAE; Bjornsson E, 1998, INT J TUBERC LUNG D, V2, P1023; Cai GH, 2011, PEDIAT ALLERG IMM-UK, V22, P290, DOI 10.1111/j.1399-3038.2010.01127.x; CAMPBELL GW, 1994, ATMOS ENVIRON, V28, P477, DOI 10.1016/1352-2310(94)90125-2; Daisey JM, 2003, INDOOR AIR, V13, P53, DOI 10.1034/j.1600-0668.2003.00153.x; Ferm M, 1998, ATMOS ENVIRON, V32, P1377, DOI 10.1016/S1352-2310(97)00170-2; Fox A, 2005, J ENVIRON MONITOR, V7, P450, DOI 10.1039/b418038k; Guo P, 2013, INT J ENV RES PUB HE, V10, P1489, DOI 10.3390/ijerph10041489; Hwang BF, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-23; Lee SC, 2000, CHEMOSPHERE, V41, P109, DOI 10.1016/S0045-6535(99)00396-3; Mendell MJ, 2005, INDOOR AIR, V15, P27, DOI 10.1111/j.1600-0668.2004.00320.x; Mengersen K, 2011, INDOOR AIR, V21, P25, DOI 10.1111/j.1600-0668.2010.00679.x; Meyer HW, 2004, INDOOR AIR, V14, P65, DOI 10.1046/j.1600-0668.2003.00213.x; Mi YH, 2006, INDOOR AIR, V16, P454, DOI 10.1111/j.1600-0668.2006.00439.x; Morales-Suarez-Varela M, 2013, IRAN J ALLERGY ASTHM, V12, P220; Norback D, 2008, INDOOR AIR, V18, P293, DOI 10.1111/j.1600-0668.2008.00530.x; NORBACK D, 1990, BRIT J IND MED, V47, P733; NORBACK D, 1991, BRIT J IND MED, V48, P451; Norback D, 2009, CURR OPIN ALLERGY CL, V9, P55, DOI 10.1097/ACI.0b013e32831f8f08; Oeder S, 2012, INDOOR AIR, V22, P148, DOI 10.1111/j.1600-0668.2011.00743.x; Oeder S, 2012, AM J RESP CELL MOL, V47, P575, DOI 10.1165/rcmb.2012-0139OC; Penard-Morand C, 2005, CLIN EXP ALLERGY, V35, P1279, DOI 10.1111/j.1365-2222.2005.02336.x; Redlich CA, 1997, LANCET, V349, P1013, DOI 10.1016/S0140-6736(96)07220-0; Reinikainen LM, 2003, INDOOR AIR, V13, P344, DOI 10.1111/j.1600-0668.2003.00155.x; Reinikainen LM, 2001, ARCH ENVIRON HEALTH, V56, P365, DOI 10.1080/00039890109604469; Richter A, 2005, NATURE, V437, P129, DOI 10.1038/nature04092; Sahlberg B, 2013, SCI TOTAL ENVIRON, V444, P433, DOI 10.1016/j.scitotenv.2012.10.114; Saijo Yasuaki, 2009, Environmental Health and Preventive Medicine, V14, P26, DOI 10.1007/s12199-008-0052-y; Saijo Yasuaki, 2010, Environmental Health and Preventive Medicine, V15, P276, DOI 10.1007/s12199-010-0139-0; Salo PM, 2009, J ALLERGY CLIN IMMUN, V124, P185, DOI 10.1016/j.jaci.2009.05.012; Satish U, 2012, ENVIRON HEALTH PERSP, V120, P1671, DOI 10.1289/ehp.1104789; Simoni M, 2010, EUR RESPIR J, V35, P742, DOI 10.1183/09031936.00016309; SKOV P, 1992, ANN NY ACAD SCI, V641, P17, DOI 10.1111/j.1749-6632.1992.tb16528.x; SOINE L, 1995, SOC WORK HEALTH CARE, V20, P51, DOI 10.1300/J010v20n03_04; Sun YX, 2013, BUILD ENVIRON, V68, P134, DOI 10.1016/j.buildenv.2013.06.010; Sundell J, 2011, INDOOR AIR, V21, P191, DOI 10.1111/j.1600-0668.2010.00703.x; Syazwan AI, 2013, THER CLIN RISK MANAG, V9, DOI 10.2147/TCRM.S39136; Wang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072385; WHO, 2009, GUID IND AIR QUAL DA; WHO, 1983, IND AIR POLL EXP HLT; WHO, 2005, AIR QUAL GUID GLOB U; Zhang JF, 2002, ENVIRON HEALTH PERSP, V110, P961, DOI 10.1289/ehp.02110961; Zhang X, 2011, INDOOR AIR, V21, P462, DOI 10.1111/j.1600-0668.2011.00726.x; Zhang X, 2012, SCI TOTAL ENVIRON, V430, P75, DOI 10.1016/j.scitotenv.2012.04.040	46	30	30	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112933	10.1371/journal.pone.0112933	http://dx.doi.org/10.1371/journal.pone.0112933			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398002	gold, Green Submitted, Green Published			2022-12-27	WOS:000345558500114
J	Kim, E; Lin, Y; Kerney, R; Blumenberg, L; Bishop, C				Kim, Eunsoo; Lin, Yuan; Kerney, Ryan; Blumenberg, Lili; Bishop, Cory			Phylogenetic Analysis of Algal Symbionts Associated with Four North American Amphibian Egg Masses	PLOS ONE			English	Article							AMBYSTOMATID SALAMANDERS CAUDATA; GREEN-ALGAE; EMBRYONIC-DEVELOPMENT; SEQUENCE COMPARISONS; MOLECULAR PHYLOGENY; SPOTTED SALAMANDER; HATCHING SUCCESS; SSU RDNA; MACULATUM; CHLOROPHYCEAE	Egg masses of the yellow-spotted salamander Ambystoma maculatum form an association with the green alga "Oophila amblystomatis'' (Lambert ex Wille), which, in addition to growing within individual egg capsules, has recently been reported to invade embryonic tissues and cells. The binomial O. amblystomatis refers to the algae that occur in A. maculatum egg capsules, but it is unknown whether this population of symbionts constitutes one or several different algal taxa. Moreover, it is unknown whether egg masses across the geographic range of A. maculatum, or other amphibians, associate with one or multiple algal taxa. To address these questions, we conducted a phylogeographic study of algae sampled from egg capsules of A. maculatum, its allopatric congener A. gracile, and two frogs: Lithobates sylvatica and L. aurora. All of these North American amphibians form associations with algae in their egg capsules. We sampled algae from egg capsules of these four amphibians from localities across North America, established representative algal cultures, and amplified and sequenced a region of 18S rDNA for phylogenetic analysis. Our combined analysis shows that symbiotic algae found in egg masses of four North American amphibians are closely related to each other, and form a well-supported clade that also contains three strains of free-living chlamydomonads. We designate this group as the 'Oophila' clade, within which the symbiotic algae are further divided into four distinct subclades. Phylogenies of the host amphibians and their algal symbionts are only partially congruent, suggesting that host-switching and co-speciation both play roles in their associations. We also established conditions for isolating and rearing algal symbionts from amphibian egg capsules, which should facilitate further study of these egg mass specialist algae.	[Kim, Eunsoo; Blumenberg, Lili] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Kim, Eunsoo; Blumenberg, Lili] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Lin, Yuan; Bishop, Cory] St Francis Xavier Univ, Dept Biol, Antigonish, NS B2G 1C0, Canada; [Kerney, Ryan] Gettysburg Coll, Dept Biol, Gettysburg, PA 17325 USA	American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); Saint Francis Xavier University - Canada; Gettysburg College	Kim, E (corresponding author), Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA.	ekim1@amnh.org; cbishop@stfx.ca		Blumenberg, Lili/0000-0002-4886-8752	Natural Sciences and Engineering Research Council of Canada; Direct For Biological Sciences [1428065, 1428062] Funding Source: National Science Foundation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by the Natural Sciences and Engineering Research Council of Canada - Discovery Grant to CB (http://www.nserc-crsng.gc.ca/professors-professeurs/grants-subs/dgigp-psigp_eng.asp). EK and RK were funded by startup grants by their respective institutions, which are intramural by definition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACHMANN MD, 1986, CAN J ZOOL, V64, P1586, DOI 10.1139/z86-239; Bianchini K, 2012, PHYSIOL BIOCHEM ZOOL, V85, P470, DOI 10.1086/667407; Collins FS, 1905, PHYCOTHECA BOREALI A, P1267; Gatz J, 1973, J HERPETOL, V7, P137; Gilbert PW, 1944, ECOLOGY, V25, P366, DOI 10.2307/1931284; Gilbert PW, 1942, ECOLOGY, V23, P215, DOI 10.2307/1931088; Gilbert S. F., 2008, ECOLOGICAL DEV BIOL; GOFF LJ, 1978, LIFE SCI, V22, P1463, DOI 10.1016/0024-3205(78)90641-0; Gontcharov AA, 2004, MOL BIOL EVOL, V21, P612, DOI 10.1093/molbev.msh052; Gontcharov AA, 2003, J MOL EVOL, V56, P89, DOI 10.1007/s00239-002-2383-4; Graham ER, 2013, J EXP BIOL, V216, P452, DOI 10.1242/jeb.076711; HARDY LM, 1991, COMP BIOCHEM PHYS A, V100, P653, DOI 10.1016/0300-9629(91)90385-P; Harrison R.G, 1969, ORG DEV EMBRYO, V1, P44; Hoham RW, 2002, J PHYCOL, V38, P1051, DOI 10.1046/j.1529-8817.2002.t01-1-01227.x; Hoshina R, 2008, PROTIST, V159, P53, DOI 10.1016/j.protis.2007.08.002; JONES TR, 1993, SYST BIOL, V42, P92, DOI 10.2307/2992560; Kawaida H, 2013, MOL PHYLOGENET EVOL, V66, P906, DOI 10.1016/j.ympev.2012.11.018; Kerney R, 2011, SYMBIOSIS, V54, P107, DOI 10.1007/s13199-011-0134-2; Kerney R, 2011, P NATL ACAD SCI USA, V108, P6497, DOI 10.1073/pnas.1018259108; Kim E, 2006, MOL BIOL EVOL, V23, P2455, DOI 10.1093/molbev/msl120; Kim E, 2013, PROTIST, V164, P160, DOI 10.1016/j.protis.2012.10.002; Lee R., 2008, PHYCOLOGY, VFourth, DOI DOI 10.1016/j.energy.2014.06.023; Maddison WP, 2011, MESQUITE MODULAR SYS; Nakada T, 2008, MOL PHYLOGENET EVOL, V48, P281, DOI 10.1016/j.ympev.2008.03.016; NatureServe and IUCN (International Union for Conservation of Nature), 2007, IUCN 2012 IUCN RED L; ORR H, 1888, Q J MICRO SCI N S, V115, P483; PINDER AW, 1994, J EXP BIOL, V197, P17; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2018, R LANG ENV STAT COMP; RUTH BC, 1993, J HERPETOL, V27, P306, DOI 10.2307/1565152; Sacerdote AB, 2009, WETLANDS, V29, P1202, DOI 10.1672/08-235.1; SAGER R, 1954, J GEN PHYSIOL, V37, P729, DOI 10.1085/jgp.37.6.729; SHAFFER HB, 1991, SYST ZOOL, V40, P284, DOI 10.2307/2992323; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tattersall GJ, 2008, CAN J ZOOL, V86, P1289, DOI 10.1139/Z08-115; Valls JH, 2007, J EXP BIOL, V210, P2430, DOI 10.1242/jeb.003541; Wantanabe MM, 2000, MICROALGAE PROTOZOA; Wille N, 1909, 7 ABTEILUNG CHLOROPH, V6; Yumoto K, 2013, J MICROBIOL CULT COL, V29, P1; Zamudio KR, 2003, EVOLUTION, V57, P1631	42	14	16	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e108915	10.1371/journal.pone.0108915	http://dx.doi.org/10.1371/journal.pone.0108915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393119	gold, Green Published			2022-12-27	WOS:000347709300002
J	Verstrepen, BE; Oostermeijer, H; Fagrouch, Z; van Heteren, M; Niphuis, H; Haaksma, T; Kondova, I; Bogers, WM; de Filette, M; Sanders, N; Stertman, L; Magnusson, S; Lorincz, O; Lisziewicz, J; Barzon, L; Palu, G; Diamond, MS; Chabierski, S; Ulbert, S; Verschoor, EJ				Verstrepen, Babs E.; Oostermeijer, Herman; Fagrouch, Zahra; van Heteren, Melanie; Niphuis, Henk; Haaksma, Tom; Kondova, Ivanela; Bogers, Willy M.; de Filette, Marina; Sanders, Niek; Stertman, Linda; Magnusson, Sofia; Lorincz, Orsolya; Lisziewicz, Julianna; Barzon, Luisa; Palu, Giorgio; Diamond, Michael S.; Chabierski, Stefan; Ulbert, Sebastian; Verschoor, Ernst J.			Vaccine-Induced Protection of Rhesus Macaques against Plasma Viremia after Intradermal Infection with a European Lineage 1 Strain of West Nile Virus	PLOS ONE			English	Article							CYCLE FLAVIVIRUS VACCINE; CD8(+) T-CELLS; IMMUNE-RESPONSES; PRECLINICAL EVALUATION; ENCEPHALITIS-VIRUS; ENVELOPE PROTEIN; UNITED-STATES; REPLIVAX WN; MICE; IMMUNOGENICITY	The mosquito-borne West Nile virus (WNV) causes human and animal disease with outbreaks in several parts of the world including North America, the Mediterranean countries, Central and East Europe, the Middle East, and Africa. Particularly in elderly people and individuals with an impaired immune system, infection with WNV can progress into a serious neuroinvasive disease. Currently, no treatment or vaccine is available to protect humans against infection or disease. The goal of this study was to develop a WNV-vaccine that is safe to use in these high-risk human target populations. We performed a vaccine efficacy study in non-human primates using the contemporary, pathogenic European WNV genotype 1a challenge strain, WNV-Ita09. Two vaccine strategies were evaluated in rhesus macaques (Macaca mulatta) using recombinant soluble WNV envelope (E) ectodomain adjuvanted with Matrix-M, either with or without DNA priming. The DNA priming immunization was performed with WNV-DermaVir nanoparticles. Both vaccination strategies successfully induced humoral and cellular immune responses that completely protected the macaques against the development of viremia. In addition, the vaccine was well tolerated by all animals. Overall, The WNV E protein adjuvanted with Matrix-M is a promising vaccine candidate for a non-infectious WNV vaccine for use in humans, including at-risk populations.	[Verstrepen, Babs E.; Oostermeijer, Herman; Fagrouch, Zahra; Niphuis, Henk; Bogers, Willy M.; Verschoor, Ernst J.] BPRC, Dept Virol, Rijswijk, Netherlands; [Haaksma, Tom; Kondova, Ivanela] BPRC, Dept Anim Sci, Div Pathol & Microbiol, Rijswijk, Netherlands; [de Filette, Marina; Sanders, Niek] Univ Ghent, Fac Vet Sci, Lab Gene Therapy, Merelbeke, Belgium; [Stertman, Linda; Magnusson, Sofia] Novavax AB, Uppsala, Sweden; [Lorincz, Orsolya; Lisziewicz, Julianna] eMMUNITY Inc, Budapest, Hungary; [Barzon, Luisa; Palu, Giorgio] Univ Padua, Dept Mol Med, Padua, Italy; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med Mol Microbiol & Pathol, St Louis, MO USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Immunol, St Louis, MO USA; [Chabierski, Stefan; Ulbert, Sebastian] Fraunhofer Inst Cell Therapy & Immunol, Dept Immunol, Leipzig, Germany	Ghent University; University of Padua; Washington University (WUSTL); Washington University (WUSTL); Fraunhofer Gesellschaft	Verschoor, EJ (corresponding author), BPRC, Dept Virol, Rijswijk, Netherlands.	verschoor@bprc.nl	Barzon, Luisa/K-7961-2016; Diamond, Michael/AAH-1733-2019	Barzon, Luisa/0000-0003-0720-8456; Diamond, Michael/0000-0002-8791-3165; Lorincz, Orsolya/0000-0003-4847-526X; Verstrepen, Babs E/0000-0002-4666-0798; Ulbert, Sebastian/0000-0001-5910-3643; Lisziewicz, Julianna/0000-0002-3349-4495; Sanders, Niek/0000-0003-4585-0343	European Community FP7 project WINGS [261426]	European Community FP7 project WINGS	The project was funded by the European Community FP7 project WINGS (grant no. 261426). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanna IJ, 2012, NAT MED, V18, P974, DOI 10.1038/nm.2763; Arroyo J, 2004, J VIROL, V78, P12497, DOI 10.1128/JVI.78.22.12497-12507.2004; Bakonyi T, 2013, VET MICROBIOL, V165, P61, DOI 10.1016/j.vetmic.2013.03.005; Barzon L, 2009, EURO SURVEILL, V14, P19384; Barzon L, 2012, EURO SURVEILL, V17, P20260; Barzon L, 2013, EURO SURVEILL, V18; Bengtsson KL, 2013, EXPERT REV VACCINES, V12, P821, DOI 10.1586/14760584.2013.814822; Brandler S, 2013, VIRUSES-BASEL, V5, P2384, DOI 10.3390/v5102384; Brien JD, 2007, EUR J IMMUNOL, V37, P1855, DOI 10.1002/eji.200737196; Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467; Chung WM, 2013, JAMA-J AM MED ASSOC, V310, P297, DOI 10.1001/jama.2013.8267; Danis K, 2011, EMERG INFECT DIS, V17, P1868, DOI 10.3201/eid1710.110525; De Filette M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087837; De Filette M, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-16; Diamond MS, 2003, VIRAL IMMUNOL, V16, P259, DOI 10.1089/088282403322396082; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Diebold SS, 1999, J BIOL CHEM, V274, P19087, DOI 10.1074/jbc.274.27.19087; Donaldson MM, 2012, J IMMUNOL METHODS, V386, P10, DOI 10.1016/j.jim.2012.08.011; ECDC, 2012, EP SIT W NIL VIR INF; Hughes HR, 2012, VIROLOGY, V424, P129, DOI 10.1016/j.virol.2011.12.012; Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914; Koup RA, 2011, NAT REV IMMUNOL, V11, P65, DOI 10.1038/nri2890; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Lanciotti RS, 2002, VIROLOGY, V298, P96, DOI 10.1006/viro.2002.1449; Larsen MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012697; Lieberman MM, 2009, CLIN VACCINE IMMUNOL, V16, P1332, DOI 10.1128/CVI.00119-09; Lorincz O, 2012, NANOMED-NANOTECHNOL, V8, P497, DOI 10.1016/j.nano.2011.07.013; Magnusson SE, 2014, VACCINE, V32, P800, DOI 10.1016/j.vaccine.2013.12.030; Magnusson SE, 2013, VACCINE, V31, P1725, DOI 10.1016/j.vaccine.2013.01.039; Monath TP, 2006, P NATL ACAD SCI USA, V103, P6694, DOI 10.1073/pnas.0601932103; Mooij P, 2004, J VIROL, V78, P3333, DOI 10.1128/JVI.78.7.3333-3342.2004; Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731; Murray KO, 2010, VET RES, V41, DOI 10.1051/vetres/2010039; Netland J, 2013, VIRUSES-BASEL, V5, P2573, DOI 10.3390/v5102573; Nolan MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040374; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07; Papa A, 2012, EXPERT REV ANTI-INFE, V10, P743, DOI [10.1586/ERI.12.59, 10.1586/eri.12.59]; Pervanidou D, 2014, EURO SURVEILL, V19, P20758; Pesko KN, 2012, INFECT GENET EVOL, V12, P181, DOI 10.1016/j.meegid.2011.11.014; Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042; Pinto AK, 2013, J VIROL, V87, P1926, DOI 10.1128/JVI.02903-12; Pletnev AG, 2006, VACCINE, V24, P6392, DOI 10.1016/j.vaccine.2006.06.008; Popovic N, 2013, EUROSURVEILLANCE, V18, P18, DOI 10.2807/1560-7917.ES2013.18.43.20613; Purtha WE, 2007, EUR J IMMUNOL, V37, P1845, DOI 10.1002/eji.200737192; Rollier C, 2005, J INFECT DIS, V192, P920, DOI 10.1086/432517; Sambri V, 2013, CLIN MICROBIOL INFEC, V19, P699, DOI 10.1111/1469-0691.12211; Schneeweiss A, 2011, VACCINE, V29, P6352, DOI 10.1016/j.vaccine.2011.04.116; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Spohn G, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-146; Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132; Throsby M, 2007, EXPERT REV VACCINES, V6, P183, DOI 10.1586/14760584.6.2.183; Toke ER, 2010, INT J PHARMACEUT, V392, P261, DOI 10.1016/j.ijpharm.2010.03.048; Vazquez A, 2010, EMERG INFECT DIS, V16, P549, DOI 10.3201/eid1603.091033; Verstrepen BE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002797; Wang T, 2001, J IMMUNOL, V167, P5273, DOI 10.4049/jimmunol.167.9.5273; Whiteman MC, 2010, VACCINE, V28, P1075, DOI 10.1016/j.vaccine.2009.10.112; Widman DG, 2010, AM J TROP MED HYG, V82, P1160, DOI 10.4269/ajtmh.2010.09-0310; Widman DG, 2009, VACCINE, V27, P5550, DOI 10.1016/j.vaccine.2009.07.016	60	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112568	10.1371/journal.pone.0112568	http://dx.doi.org/10.1371/journal.pone.0112568			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392925	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300070
J	Robert, J; Grayfer, L; Edholm, ES; Ward, B; Andino, FD				Robert, Jacques; Grayfer, Leon; Edholm, Eva-Stina; Ward, Brian; Andino, Francisco De Jesus			Inflammation-Induced Reactivation of the Ranavirus Frog Virus 3 in Asymptomatic Xenopus laevis	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; T-CELL RESPONSES; PERITONEAL LEUKOCYTES; FAMILY-IRIDOVIRIDAE; AMPHIBIAN XENOPUS; IN-VITRO; INFECTION; ANTIGEN; ADULT; FROG-VIRUS-3	Natural infections of ectothermic vertebrates by ranaviruses (RV, family Iridoviridae) are rapidly increasing, with an alarming expansion of RV tropism and resulting die-offs of numerous animal populations. Notably, infection studies of the amphibian Xenopus laevis with the ranavirus Frog Virus 3 (FV3) have revealed that although the adult frog immune system is efficient at controlling RV infections, residual quiescent virus can be detected in mononuclear phagocytes of otherwise asymptomatic animals following the resolution of RV infections. It is noteworthy that macrophage-lineage cells are now believed to be a critical element in the RV infection strategy. In the present work, we report that inflammation induced by peritoneal injection of heat-killed bacteria in asymptomatic frogs one month after infection with FV3 resulted in viral reactivation including detectable viral DNA and viral gene expression in otherwise asymptomatic frogs. FV3 reactivation was most prominently detected in kidneys and in peritoneal HAM56+ mononuclear phagocytes. Notably, unlike adult frogs that typically clear primary FV3 infections, a proportion of the animals succumbed to the reactivated FV3 infection, indicating that previous exposure does not provide protection against subsequent reactivation in these animals.	[Robert, Jacques; Grayfer, Leon; Edholm, Eva-Stina; Ward, Brian; Andino, Francisco De Jesus] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14627 USA	University of Rochester	Robert, J (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14627 USA.	Jacques_Robert@urmc.rochester.edu	Ward, Brian/AAQ-4895-2020; Robert, Jacques/B-2179-2008	Robert, Jacques/0000-0003-4380-1476	National Institutes of Health [R24-AI-059830]; Life Sciences Research Fellowship from the Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI059830] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Life Sciences Research Fellowship from the Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the National Institutes of Health Grant (R24-AI-059830); LG was supported by a Life Sciences Research Fellowship from the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams AJ, 2013, J GEN VIROL, V94, P2082, DOI 10.1099/vir.0.052837-0; Allender MC, 2006, J WILDLIFE DIS, V42, P677, DOI 10.7589/0090-3558-42.3.677; Andino FD, 2012, VIROLOGY, V432, P435, DOI 10.1016/j.virol.2012.07.001; BLEICHER PA, 1983, DEV COMP IMMUNOL, V7, P483, DOI 10.1016/0145-305X(83)90033-2; Chen GC, 2011, J VIROL, V85, P11131, DOI 10.1128/JVI.05589-11; Cunningham AA, 2008, J COMP PATHOL, V138, P3, DOI 10.1016/j.jcpa.2007.08.003; de Vries RD, 2012, CURR OPIN VIROL, V2, P248, DOI 10.1016/j.coviro.2012.03.005; Duncan CJA, 2011, VIRUSES-BASEL, V3, P2255, DOI 10.3390/v3112255; Gantress J, 2003, VIROLOGY, V311, P254, DOI 10.1016/S0042-6822(03)00151-X; GENDRAULT JL, 1981, VIROLOGY, V112, P375, DOI 10.1016/0042-6822(81)90284-1; Gray MJ, 2009, DIS AQUAT ORGAN, V87, P243, DOI 10.3354/dao02138; Grayfer L, 2014, J LEUK BIOL IN PRESS; Grayfer L, 2012, VIRUSES-BASEL, V4, P1075, DOI 10.3390/v4071075; GUT JP, 1981, LAB INVEST, V45, P218; HADJIAZIMI I, 1987, DEV COMP IMMUNOL, V11, P807, DOI 10.1016/0145-305X(87)90068-1; Hyatt AD, 2002, J WILDLIFE DIS, V38, P239, DOI 10.7589/0090-3558-38.2.239; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; Jancovich JK, 2010, J VIROL, V84, P2636, DOI 10.1128/JVI.01991-09; Lei XY, 2012, ARCH VIROL, V157, P1559, DOI 10.1007/s00705-012-1316-9; Marr S, 2005, IMMUNOGENETICS, V56, P735, DOI 10.1007/s00251-004-0736-4; Marr S, 2007, J IMMUNOL, V179, P6783, DOI 10.4049/jimmunol.179.10.6783; Miller DL, 2007, EMERG INFECT DIS, V13, P342, DOI 10.3201/eid1302.061073; Morales H, 2008, BIOL PROCED ONLINE, V10, P1, DOI 10.1251/bpo137; Morales HD, 2007, J VIROL, V81, P2240, DOI 10.1128/JVI.01104-06; Morales HD, 2010, J VIROL, V84, P4912, DOI 10.1128/JVI.02486-09; Robert J, 2005, VIROLOGY, V332, P667, DOI 10.1016/j.virol.2004.12.012; Robert J, 2008, J IMMUNOL, V180, P3176, DOI 10.4049/jimmunol.180.5.3176; Robert J, 2007, J WILDLIFE DIS, V43, P645, DOI 10.7589/0090-3558-43.4.645; Robert J, 2012, DEV COMP IMMUNOL, V36, P259, DOI 10.1016/j.dci.2011.08.008; Robert J, 2011, VIROLOGY, V417, P410, DOI 10.1016/j.virol.2011.06.026; Robert J, 2009, DEV DYNAM, V238, P1249, DOI 10.1002/dvdy.21891; Smith GL, 2013, J GEN VIROL, V94, P2367, DOI 10.1099/vir.0.055921-0; Tan WGH, 2004, VIROLOGY, V323, P70, DOI 10.1016/j.virol.2004.02.019; Weck KE, 1996, J VIROL, V70, P6775, DOI 10.1128/JVI.70.10.6775-6780.1996; Whitley DS, 2010, VIROLOGY, V405, P448, DOI 10.1016/j.virol.2010.06.034	35	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112904	10.1371/journal.pone.0112904	http://dx.doi.org/10.1371/journal.pone.0112904			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390636	gold, Green Submitted, Green Published			2022-12-27	WOS:000349144400140
J	Zhang, L; Ma, HJ; Chen, TT; Pen, J; Yu, SX; Zhao, XH				Zhang, Lei; Ma, Huijuan; Chen, Tingting; Pen, Jun; Yu, Shuxun; Zhao, Xinhua			Morphological and Physiological Responses of Cotton (Gossypium hirsutum L.) Plants to Salinity	PLOS ONE			English	Article							ANTIOXIDANT ENZYME-ACTIVITY; INDUCED OXIDATIVE STRESS; SALT-TOLERANCE; LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; ION ACCUMULATION; RICE SEEDLINGS; GLUTATHIONE-REDUCTASE; SUPEROXIDE-DISMUTASE; PERENNIAL HALOPHYTE	Salinization usually plays a primary role in soil degradation, which consequently reduces agricultural productivity. In this study, the effects of salinity on growth parameters, ion, chlorophyll, and proline content, photosynthesis, antioxidant enzyme activities, and lipid peroxidation of two cotton cultivars, [ CCRI-79 (salt tolerant) and Simian 3 (salt sensitive)], were evaluated. Salinity was investigated at 0 mM, 80 mM, 160 mM, and 240 mM NaCl for 7 days. Salinity induced morphological and physiological changes, including a reduction in the dry weight of leaves and roots, root length, root volume, average root diameter, chlorophyll and proline contents, net photosynthesis and stomatal conductance. In addition, salinity caused ion imbalance in plants as shown by higher Na+ and Cl- contents and lower K+, Ca2+, and Mg2+ concentrations. Ion imbalance was more pronounced in CCRI-79 than in Simian 3. In the leaves and roots of the salt-tolerant cultivar CCRI-79, increasing levels of salinity increased the activities of superoxide dismutase (SOD), ascorbate peroxidase (APX), and glutathione reductase (GR), but reduced catalase (CAT) activity. The activities of SOD, CAT, APX, and GR in the leaves and roots of CCRI-79 were higher than those in Simian 3. CAT and APX showed the greatest H2O2 scavenging activity in both leaves and roots. Moreover, CAT and APX activities in conjunction with SOD seem to play an essential protective role in the scavenging process. These results indicate that CCRI-79 has a more effective protection mechanism and mitigated oxidative stress and lipid peroxidation by maintaining higher antioxidant activities than those in Simian 3. Overall, the chlorophyll a, chlorophyll b, and Chl (a+b) contents, net photosynthetic rate and stomatal conductance, SOD, CAT, APX, and GR activities showed the most significant variation between the two cotton cultivars.	[Zhang, Lei; Ma, Huijuan; Chen, Tingting; Pen, Jun; Yu, Shuxun; Zhao, Xinhua] CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Yu, SX (corresponding author), CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China.	yu@cricaas.com.cn; zhaoxinhua1968@126.com			National Natural Science Foundation of China [31301262]; China Postdoctoral Science Foundation [2013M540169]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (31301262) and China Postdoctoral Science Foundation (Grant no. 2013M540169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abogadallah GM, 2010, PLANT SIGNAL BEHAV, V5, P369, DOI 10.4161/psb.5.4.10873; Amor NB, 2007, J INTEGR PLANT BIOL, V126, P446; Arzani A, 2008, IN VITRO CELL DEV-PL, V44, P373, DOI 10.1007/s11627-008-9157-7; Asgari HR, 2012, INT J PLANT PROD, V6, P195; Asharf M, 2005, ADV AGRON, V88, P223; Ashraf M, 2009, BIOTECHNOL ADV, V27, P84, DOI 10.1016/j.biotechadv.2008.09.003; Ashraf M, 2006, J ARID ENVIRON, V64, P209, DOI 10.1016/j.jaridenv.2005.04.015; Aziz I, 2001, AQUAT BOT, V70, P259, DOI 10.1016/S0304-3770(01)00160-7; BEERS RF, 1952, J BIOL CHEM, V195, P133; Ben Amor N, 2005, PLANT SCI, V168, P889, DOI 10.1016/j.plantsci.2004.11.002; Berkelaar E, 2000, CAN J BOT, V78, P381, DOI 10.1139/cjb-78-3-381; Bernt E., 1974, METHOD ENZYMAT AN, V4, P2246, DOI DOI 10.1016/B978-0-12-091304-6.50090-2; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; BLUM A, 1981, CROP SCI, V21, P43, DOI 10.2135/cropsci1981.0011183X002100010013x; Boo YC, 1999, J PLANT PHYSIOL, V155, P255, DOI 10.1016/S0176-1617(99)80016-9; Borsani O, 2003, PLANT CELL TISS ORG, V73, P101, DOI 10.1023/A:1022849200433; Bower C, 1992, ANNU REV PLANT PHYS, V43, P81; BRUGNOLI E, 1991, PLANT PHYSIOL, V95, P628, DOI 10.1104/pp.95.2.628; Cuartero J, 1999, SCI HORTIC-AMSTERDAM, V78, P83, DOI 10.1016/S0304-4238(98)00191-5; CURTIS PS, 1986, AUST J PLANT PHYSIOL, V13, P553, DOI 10.1071/PP9860553; de Lacerda CF, 2003, ENVIRON EXP BOT, V49, P107, DOI 10.1016/S0098-8472(02)00064-3; Delfine S, 1999, PLANT PHYSIOL, V119, P1101, DOI 10.1104/pp.119.3.1101; Demiral T, 2005, ENVIRON EXP BOT, V53, P247, DOI 10.1016/j.envexpbot.2004.03.017; Dionisio-Sese ML, 1998, PLANT SCI, V135, P1, DOI 10.1016/S0168-9452(98)00025-9; Dubey RS, 1997, BOOKS SOIL PLANT ENV, P859; FEDINA IS, 1993, PHOTOSYNTHETICA, V29, P521; Foyer CH, 2000, NEW PHYTOL, V146, P359, DOI 10.1046/j.1469-8137.2000.00667.x; Foyer CH, 1997, PHYSIOL PLANTARUM, V100, P241, DOI 10.1034/j.1399-3054.1997.1000205.x; FOYER CH, 1976, PLANTA, V133, P21, DOI 10.1007/BF00386001; Garratt LC, 2002, FREE RADICAL BIO MED, V33, P502, DOI 10.1016/S0891-5849(02)00838-9; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; GOSSETT DR, 1994, CROP SCI, V34, P706, DOI 10.2135/cropsci1994.0011183X003400030020x; GRAIFENBERG A, 1995, SCI HORTIC-AMSTERDAM, V63, P1, DOI 10.1016/0304-4238(95)00797-W; Gratao PL, 2005, FUNCT PLANT BIOL, V32, P481, DOI 10.1071/FP05016; Guo WX, 2012, PRECIS AGRIC, V13, P678, DOI 10.1007/s11119-012-9277-2; Hassan, 2002, ASIAN J PLANT SCI, DOI [10.3923/ajps.2002.715.719, DOI 10.3923/AJPS.2002.715.719]; Henandez JA, 2000, PLANT CELL ENVIRON, V23, P853; Hernandez JA, 2000, PLANT CELL ENVIRON, V23, P853, DOI 10.1046/j.1365-3040.2000.00602.x; Hernandez JA, 2002, PLANT CELL ENVIRON, V23, P853; Kaya C, 2007, ENVIRON EXP BOT, V60, P397, DOI 10.1016/j.envexpbot.2006.12.008; Khan MA, 2000, ANN BOT-LONDON, V85, P225, DOI 10.1006/anbo.1999.1022; Laspina NV, 2005, PLANT SCI, V169, P323, DOI 10.1016/j.plantsci.2005.02.007; Lee DH, 2001, J PLANT PHYSIOL, V158, P737, DOI 10.1078/0176-1617-00174; Lee MH, 2013, PLANT PHYSIOL BIOCH, V70, P325, DOI 10.1016/j.plaphy.2013.05.047; Liang YC, 2003, J PLANT PHYSIOL, V160, P1157, DOI 10.1078/0176-1617-01065; Liu J, 2010, PHOTOSYNTHETICA, V48, P278, DOI 10.1007/s11099-010-0034-3; Locato V, 2008, PLANT CELL ENVIRON, V31, P1606, DOI 10.1111/j.1365-3040.2008.01867.x; Locy RD, 1996, PLANT PHYSIOL, V110, P321, DOI 10.1104/pp.110.1.321; Meloni DA, 2003, ENVIRON EXP BOT, V49, P69, DOI 10.1016/S0098-8472(02)00058-8; Meloni DA, 2001, J PLANT NUTR, V24, P599, DOI 10.1081/PLN-100104983; Meneguzzo S, 1999, J PLANT PHYSIOL, V155, P274, DOI 10.1016/S0176-1617(99)80019-4; Meng HB, 2011, AGR SCI CHINA, V10, P363, DOI 10.1016/S1671-2927(11)60015-1; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mittova V, 2003, PLANT CELL ENVIRON, V26, P845, DOI 10.1046/j.1365-3040.2003.01016.x; Morita S, 1999, PLANT CELL PHYSIOL, V40, P417, DOI 10.1093/oxfordjournals.pcp.a029557; Munns R, 2006, J EXP BOT, V57, P1025, DOI 10.1093/jxb/erj100; MUNNS R, 1995, AUST J PLANT PHYSIOL, V22, P561, DOI 10.1071/PP9950561; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; NIU XM, 1995, PLANT PHYSIOL, V109, P735, DOI 10.1104/pp.109.3.735; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Parida AK, 2004, TREES-STRUCT FUNCT, V18, P167, DOI 10.1007/s00468-003-0293-8; Qidar M, 1997, J AGRON CROP SCI, V179, P101; Queval G, 2008, J EXP BOT, V59, P135, DOI 10.1093/jxb/erm193; Rabie GH, 2005, AFR J BIOTECHNOL, V4, P210; Rout NP, 2001, PLANT SCI, V160, P415, DOI 10.1016/S0168-9452(00)00406-4; RuizLozano JM, 1997, SYMBIOSIS, V23, P9; Seckin B, 2010, ENVIRON EXP BOT, V69, P76, DOI 10.1016/j.envexpbot.2010.02.013; Sekmen AH, 2007, PHYSIOL PLANTARUM, V131, P399, DOI 10.1111/j.1399-3054.2007.00970.x; Senadheera P, 2012, RICE SCI, V19, P36, DOI 10.1016/S1672-6308(12)60018-3; Sestak K., 1971, PLANT PHOTOSYNTHETIC; Sharma SS, 2006, J EXP BOT, V57, P711, DOI 10.1093/jxb/erj073; Sigaud-Kutner TCS, 2002, PHYSIOL PLANTARUM, V114, P566, DOI 10.1034/j.1399-3054.2002.1140409.x; SINGH AK, 1995, PHOTOSYNTHETICA, V31, P489; Siroka B, 2004, BIOLOGIA, V59, P513; Steduto P, 2000, ENVIRON EXP BOT, V44, P243, DOI 10.1016/S0098-8472(00)00071-X; Sudhakar C, 2001, PLANT SCI, V161, P613, DOI 10.1016/S0168-9452(01)00450-2; Takemura T, 2000, AQUAT BOT, V68, P15, DOI 10.1016/S0304-3770(00)00106-6; TALEISNIK E, 1994, PHYSIOL PLANTARUM, V92, P528, DOI 10.1111/j.1399-3054.1994.tb08847.x; Tan W, 2008, PHOTOSYNTHETICA, V46, P21, DOI 10.1007/s11099-008-0005-0; THIEL G, 1988, J PLANT PHYSIOL, V132, P38, DOI 10.1016/S0176-1617(88)80180-9; Xiong L, 2002, PLANT CELL ENVIRON, V25, P131, DOI 10.1046/j.1365-3040.2002.00782.x; Xu R, 2013, PEDOSPHERE, V23, P213, DOI 10.1016/S1002-0160(13)60009-0; Zhang L, 2013, J PLANT RES, V126, P293, DOI 10.1007/s10265-012-0533-3; Zhang Q, 2011, PHOTOSYNTHETICA, V49, P201, DOI 10.1007/s11099-011-0012-4; Zhang Q, 2005, ENVIRON SCI TECHNOL, V39, P4938, DOI 10.1021/es048568l; Zheng CF, 2009, PLANT SCI, V176, P575, DOI 10.1016/j.plantsci.2009.01.015; Zheng YH, 2008, ENVIRON EXP BOT, V62, P129, DOI 10.1016/j.envexpbot.2007.07.011	89	107	113	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112807	10.1371/journal.pone.0112807	http://dx.doi.org/10.1371/journal.pone.0112807			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391141	gold, Green Published, Green Submitted			2022-12-27	WOS:000349144400130
J	Garde, A; Dehkordi, P; Karlen, W; Wensley, D; Ansermino, JM; Dumont, GA				Garde, Ainara; Dehkordi, Parastoo; Karlen, Walter; Wensley, David; Ansermino, J. Mark; Dumont, Guy A.			Development of a Screening Tool for Sleep Disordered Breathing in Children Using the Phone Oximeter (TM)	PLOS ONE			English	Article							BLOOD-OXYGEN SATURATION; PULSE-RATE VARIABILITY; APNEA; ADENOTONSILLECTOMY; POLYSOMNOGRAPHY; OXIMETRY; DIAGNOSIS; OUTCOMES; SIGNAL; HOME	Background: Sleep disordered breathing (SDB) can lead to daytime sleepiness, growth failure and developmental delay in children. Polysomnography (PSG), the gold standard to diagnose SDB, is a highly resource-intensive test, confined to the sleep laboratory. Aim: To combine the blood oxygen saturation (SpO(2)) characterization and cardiac modulation, quantified by pulse rate variability (PRV), to identify children with SDB using the Phone Oximeter, a device integrating a pulse oximeter with a smartphone. Methods: Following ethics approval and informed consent, 160 children referred to British Columbia Children's Hospital for overnight PSG were recruited. A second pulse oximeter sensor applied to the finger adjacent to the one used for standard alongside the PSG. Results: We studied 146 children through the analysis of the SpO(2) pattern, and PRV as an estimate of heart rate variability calculated from the PPG. SpO(2) variability and SpO(2) spectral power at low frequency, was significantly higher in children with SDB due to the modulation provoked by airway obstruction during sleep (p-value <0:01). PRV analysis reflected a significant augmentation of sympathetic activity provoked by intermittent hypoxia in SDB children. A linear classifier was trained with the most discriminating features to identify children with SDB. The classifier was validated with internal and external cross-validation, providing a high negative predictive value (92.6%) and a good balance between sensitivity (88.4%) and specificity (83.6%). Combining SpO(2) and PRV analysis improved the classification performance, providing an area under the receiver operating characteristic curve of 88%, beyond the 82% achieved using SpO(2) analysis alone. Conclusions: These results demonstrate that the implementation of this algorithm in the Phone Oximeter will provide an improved portable, at-home screening tool, with the capability of monitoring patients over multiple nights.	[Garde, Ainara; Dehkordi, Parastoo; Karlen, Walter; Ansermino, J. Mark; Dumont, Guy A.] Univ British Columbia, Elect & Comp Engn Med Grp, Vancouver, BC V5Z 1M9, Canada; [Garde, Ainara; Dehkordi, Parastoo; Karlen, Walter; Wensley, David; Ansermino, J. Mark; Dumont, Guy A.] BC Childrens Hosp, Vancouver, BC, Canada; [Ansermino, J. Mark] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Wensley, David] Univ British Columbia, Div Crit Care, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; BC Childrens Hospital; University of British Columbia; University of British Columbia; University of British Columbia	Garde, A (corresponding author), Univ British Columbia, Elect & Comp Engn Med Grp, Vancouver, BC V5Z 1M9, Canada.	ainara.garde@cw.bc.ca	Karlen, Walter/C-6290-2008; Garde, Ainara/J-9442-2017; Karlen, Walter/AAN-9397-2020	Karlen, Walter/0000-0001-8643-3074; Garde, Ainara/0000-0002-9503-6908; Karlen, Walter/0000-0001-8643-3074; Ansermino, J Mark/0000-0001-8427-2035; Dumont, Guy/0000-0003-2048-4391; Wensley, David/0000-0001-7228-4274	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research through the Collaborative Health Research Projects program [NSERC-CHRP 395100-11]; Child and Family Research Institute at the University of British Columbia through a Postdoctoral Fellowship	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research through the Collaborative Health Research Projects program(Canadian Institutes of Health Research (CIHR)); Child and Family Research Institute at the University of British Columbia through a Postdoctoral Fellowship	This work was supported in part by The Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca), the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca) through the Collaborative Health Research Projects program (NSERC-CHRP 395100-11), and the Child and Family Research Institute at the University of British Columbia through a Postdoctoral Fellowship (www.cfri.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarez D, 2006, PHYSIOL MEAS, V27, P399, DOI 10.1088/0967-3334/27/4/006; Alvarez D, 2007, ARTIF INTELL MED, V41, P13, DOI 10.1016/j.artmed.2007.06.002; Alvarez D, 2013, INT J NEURAL SYST, V23, DOI 10.1142/S0129065713500202; Alvarez D, 2010, IEEE T BIO-MED ENG, V57, P2816, DOI 10.1109/TBME.2010.2056924; BERGER RD, 1986, IEEE T BIO-MED ENG, V33, P900, DOI 10.1109/TBME.1986.325789; Bhattacharjee R, 2010, AM J RESP CRIT CARE, V182, P676, DOI 10.1164/rccm.200912-1930OC; Chervin RD, 1999, ANN INTERN MED, V130, P496, DOI 10.7326/0003-4819-130-6-199903160-00006; Chouchou F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086434; Chung F, 2012, ANESTH ANALG, V114, P993, DOI 10.1213/ANE.0b013e318248f4f5; de Chazal P, 2009, PHILOS T R SOC A, V367, P369, DOI 10.1098/rsta.2008.0156; Dehkordi P, 2013, COMPUTING C IN PRESS; Dehkordi P, 2013, IEEE ENG MED BIO, P6563, DOI 10.1109/EMBC.2013.6611059; Deutsch PA, 2006, J CLIN SLEEP MED, V2, P145; Garde A, 2014, IEEE ENG MED BIO, P2257; Garde A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086427; Garde A, 2013, IEEE ENG MED BIO, P2531, DOI 10.1109/EMBC.2013.6610055; Garde A, 2010, IEEE T BIO-MED ENG, V57, P1964, DOI 10.1109/TBME.2010.2044176; Gil E, 2010, PHYSIOL MEAS, V31, P1271, DOI 10.1088/0967-3334/31/9/015; Gil E, 2010, IEEE T BIO-MED ENG, V57, P1079, DOI 10.1109/TBME.2009.2037734; Gil E, 2009, IEEE T BIO-MED ENG, V56, P1005, DOI 10.1109/TBME.2008.2009340; Heneghan C, 2008, SLEEP, V31, P1432; Horwood L, 2014, JAMA OTOLARYNGO 0522; Huang YS, 2014, SLEEP, V37, P71, DOI 10.5665/sleep.3310; Hudson J, 2012, ANAESTHESIA, V67, P957, DOI 10.1111/j.1365-2044.2012.07196.x; Iber C, 2007, AASM MANUAL SCORING; Johnson EO, 2006, SLEEP, V29, P1135, DOI 10.1093/sleep/29.9.1135; Kang KT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078666; Karlen W, 2012, PHYSIOL MEAS, V33, P1617, DOI 10.1088/0967-3334/33/10/1617; Karlen W, 2011, HEALTHINF 2011: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON HEALTH INFORMATICS, P433; Kushida CA, 2005, SLEEP, V28, P499, DOI 10.1093/sleep/28.4.499; Lazaro J, 2014, IEEE J BIOMED HEALTH, V18, P240, DOI 10.1109/JBHI.2013.2267096; Marcus CL, 2013, NEW ENGL J MED, V368, P2366, DOI 10.1056/NEJMoa1215881; Marcus CL, 2012, PEDIATRICS, V130, P576, DOI 10.1542/peds.2012-1671; Marcus CL, 2002, PEDIATRICS, V109, P704; Medical Services Commission of British Columbia, 2013, RESPIROLOGY; Montesano M, 2010, SLEEP, V33, P1349, DOI 10.1093/sleep/33.10.1349; Nixon GM, 2004, PEDIATRICS, V113, pE19, DOI 10.1542/peds.113.1.e19; Petersen CL, 2013, SENSORS-BASEL, V13, P16882, DOI 10.3390/s131216882; RISSANEN J, 1978, AUTOMATICA, V14, P465, DOI 10.1016/0005-1098(78)90005-5; Rosen CL, 2003, J PEDIATR-US, V142, P383, DOI 10.1067/mpd.2003.28; Sinha D, 2010, INDIAN J MED RES, V131, P311; Stats BC, 2014, 2013 SUBPROVINCIAL P; Wildhaber JH, 2007, SWISS MED WKLY, V137, P689, DOI 2007/49/smw-11986; Zhao J, 2011, EUR J PEDIATR, V170, P1097, DOI 10.1007/s00431-011-1409-6	44	89	90	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112959	10.1371/journal.pone.0112959	http://dx.doi.org/10.1371/journal.pone.0112959			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401696	Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700086
J	Porcellato, I; Brachelente, C; Guelfi, G; Reginato, A; Sforna, M; Bongiovanni, L; Mechelli, L				Porcellato, Ilaria; Brachelente, Chiara; Guelfi, Gabriella; Reginato, Alice; Sforna, Monica; Bongiovanni, Laura; Mechelli, Luca			A Retrospective Investigation on Canine Papillomavirus 1 (CPV1) in Oral Oncogenesis Reveals Dogs Are Not a Suitable Animal Model for High-Risk HPV-Induced Oral Cancer	PLOS ONE			English	Article							INFERIOR MESENTERIC PLEXUS; MALE GERM-CELLS; SPERM MOTILITY; IN-VITRO; ISOFLURANE ANESTHESIA; MAMMALIAN SPERMATOZOA; HAMSTER SPERMATOZOA; ACROSOME REACTION; HUMAN TESTIS; CATECHOLAMINES	CPV1 (also called COPV) is a papillomavirus responsible for oral papillomatosis in young dogs. The involvement of this viral type in oral oncogenesis has been hypothesized in oral squamous cell carcinomas (SCCs), but has never been investigated in other neoplastic and hyperplastic oral lesions of dogs. Aim of this study was to investigate the presence of CPV1 in different neoplastic and hyperplastic lesions in order to assess its role in canine oral oncogenesis; according to the results obtained, a second aim of the study was to define if the dog can be considered a valid animal model for oral high risk HPV-induced tumors. Eighty-eight formalin-fixed, paraffin-embedded (FFPE) canine oral lesions including 78 oral tumors (papillomas, SCCs, melanomas, ameloblastomas, oral adenocarcinomas) and 10 hyperplastic lesions (gingival hyperplasia) were investigated with immunohistochemistry for the presence of papillomavirus L1 protein and with Real-Time PCR for CPV1 DNA. RT-PCR for RNA was performed on selected samples. All viral papillomas tested were positive for immunohistochemistry and Real-time PCR. In 3/33 (10%) SCCs, viral DNA was demonstrated but no viral RNA could be found. No positivity was observed both with immunohistochemistry and Real-Time PCR in the other hyperplastic and neoplastic lesions of the oral cavity of dogs. Even though the finding of CPV1 DNA in few SCCs in face of a negative immunohistochemistry could support the hypothesis of an abortive infection in the development of these lesions, the absence of viral RNA points out that CPV1 more likely represents an innocent bystander in SCC oncogenesis. The study demonstrates a strong association between CPV1 and oral viral papillomas whereas viral contribution to the pathogenesis of other oral lesions seems unlikely. Moreover, it suggests that a canine model of CPV1 infection for HPV-induced oncogenesis could be inappropriate.	[Porcellato, Ilaria; Brachelente, Chiara; Guelfi, Gabriella; Reginato, Alice; Sforna, Monica; Mechelli, Luca] Univ Perugia, Dept Vet Med, I-06100 Perugia, Italy; [Bongiovanni, Laura] Univ Teramo, Fac Vet Med, Teramo, Italy	University of Perugia; University of Teramo	Porcellato, I (corresponding author), Univ Perugia, Dept Vet Med, I-06100 Perugia, Italy.	ilariaporcellato@yahoo.it	Porcellato, Ilaria/J-2228-2018; Guelfi, Gabriella/AAE-6081-2019; Bongiovanni, Laura/R-4056-2019	Porcellato, Ilaria/0000-0003-2882-6739; Guelfi, Gabriella/0000-0003-3695-9275; 				Adeoya-Osiguwa SA, 2007, HUM REPROD, V22, P756, DOI 10.1093/humrep/del454; Adeoya-Osiguwa SA, 2006, HUM REPROD, V21, P1555, DOI 10.1093/humrep/del016; Ayala I, 2012, RES VET SCI, V93, P103, DOI 10.1016/j.rvsc.2011.05.013; Bae SE, 2001, REPRODUCTION, V122, P275, DOI 10.1530/reprod/122.2.275; BAVISTER BD, 1979, J REPROD FERTIL, V56, P507, DOI 10.1530/jrf.0.0560507; BILLUPS KL, 1990, J UROLOGY, V143, P625, DOI 10.1016/S0022-5347(17)40043-7; BILLUPS KL, 1990, FERTIL STERIL, V53, P1076; BONISCH H, 1980, PHARMACOLOGY, V21, P93, DOI 10.1159/000137422; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAUD M, 1983, PHARMACOL RES COMMUN, V15, P923, DOI 10.1016/S0031-6989(83)80022-8; CORNETT LE, 1979, BIOL REPROD, V20, P925, DOI 10.1095/biolreprod20.4.925; CORNETT LE, 1978, P NATL ACAD SCI USA, V75, P4954, DOI 10.1073/pnas.75.10.4954; Cortes-Gutierrez EI, 2008, THERIOGENOLOGY, V69, P1022, DOI 10.1016/j.theriogenology.2008.02.002; Davidoff MS, 2005, HISTOCHEM CELL BIOL, V124, P313, DOI 10.1007/s00418-005-0024-x; Fait G, 2001, ANDROLOGIA, V33, P347, DOI 10.1046/j.1439-0272.2001.00461.x; Frungieri MB, 2000, NEUROENDOCRINOLOGY, V71, P43, DOI 10.1159/000054519; Gil AG, 2005, VET REC, V157, P589; Gil AG, 2007, LAB ANIM-UK, V41, P411, DOI 10.1258/002367707782314274; HELM G, 1982, BIOL REPROD, V26, P553, DOI 10.1095/biolreprod26.4.553; KHATCHADOURIAN C, 1987, HUM REPROD, V2, P1; Kotwica G, 2003, THERIOGENOLOGY, V60, P953, DOI 10.1016/S0093-691X(03)00086-4; LINDAHL PE, 1981, EXPERIENTIA, V37, P860, DOI 10.1007/BF01985681; Mason JN, 2005, J NEUROSCI METH, V143, P3, DOI 10.1016/j.jneumeth.2004.09.028; Mayerhofer A, 1999, J ANDROL, V20, P341; Mayerhofer A, 1996, BIOL REPROD, V55, P509, DOI 10.1095/biolreprod55.3.509; MEIZEL S, 1980, BIOL REPROD, V22, P211, DOI 10.1095/biolreprod22.2.211; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Otth C, 2007, J CELL BIOCHEM, V100, P141, DOI 10.1002/jcb.21037; Oz M, 2010, J NEUROCHEM, V114, P1019, DOI 10.1111/j.1471-4159.2010.06828.x; Ramirez AR, 2009, BIOL REPROD, V80, P753, DOI 10.1095/biolreprod.108.070961; Schwartz JW, 2005, J BIOL CHEM, V280, P19177, DOI 10.1074/jbc.M412923200; Villarroel-Espindola F, 2013, J CELL BIOCHEM, V114, P1653, DOI 10.1002/jcb.24507; Way AL, 2002, J ANDROL, V23, P352; Wu XH, 1999, GENE, V233, P163, DOI 10.1016/S0378-1119(99)00143-2	34	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112833	10.1371/journal.pone.0112833	http://dx.doi.org/10.1371/journal.pone.0112833			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401953	Green Submitted, gold, Green Published			2022-12-27	WOS:000345158700078
J	Trivers, R; Fink, B; Russell, M; McCarty, K; James, B; Palestis, BG				Trivers, Robert; Fink, Bernhard; Russell, Mark; McCarty, Kristofor; James, Bruce; Palestis, Brian G.			Lower Body Symmetry and Running Performance in Elite Jamaican Track and Field Athletes	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; DEVELOPMENTAL INSTABILITY	In a study of degree of lower body symmetry in 73 elite Jamaican track and field athletes we show that both their knees and ankles (but not their feet) are-on average-significantly more symmetrical than those of 116 similarly aged controls from the rural Jamaican countryside. Within the elite athletes, events ranged from the 100 to the 800 m, and knee and ankle asymmetry was lower for those running the 100 m dashes than those running the longer events with turns. Nevertheless, across all events those with more symmetrical knees and ankles (but not feet) had better results compared to international standards. Regression models considering lower body symmetry combined with gender, age and weight explain 27 to 28% of the variation in performance among athletes, with symmetry related to about 5% of this variation. Within 100 m sprinters, the results suggest that those with more symmetrical knees and ankles ran faster. Altogether, our work confirms earlier findings that knee and probably ankle symmetry are positively associated with sprinting performance, while extending these findings to elite athletes.	[Trivers, Robert] Rutgers State Univ, Grad Program Ecol & Evolut, New Brunswick, NJ 08903 USA; [Fink, Bernhard] Univ Gottingen, Courant Res Ctr, D-37073 Gottingen, Germany; [Fink, Bernhard] Univ Gottingen, Inst Psychol, D-37073 Gottingen, Germany; [Russell, Mark] Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [McCarty, Kristofor] Northumbria Univ, Fac Hlth & Life Sci, Dept Psychol, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [James, Bruce] Univ Technol, MVP Track & Field Club, Kingston, Jamaica; [Palestis, Brian G.] Wagner Coll, Dept Biol Sci, Staten Isl, NY 10301 USA	Rutgers State University New Brunswick; University of Gottingen; University of Gottingen; Northumbria University; Northumbria University; University of Technology - Jamaica	Trivers, R (corresponding author), Rutgers State Univ, Grad Program Ecol & Evolut, New Brunswick, NJ 08903 USA.	trivers@rci.rutgers.edu	Russell, Mark/M-1652-2019; Fink, Bernhard/G-7312-2011	Russell, Mark/0000-0002-7305-1090; Fink, Bernhard/0000-0003-2739-5236; McCarty, Kristofor/0000-0001-9189-1520	Enhanced Education Foundation; Ann and Gordon Getty Foundation; Biosocial Research Foundation; Center for Human Evolutionary Studies (CHES); German Science Foundation (DFG)	Enhanced Education Foundation; Ann and Gordon Getty Foundation; Biosocial Research Foundation; Center for Human Evolutionary Studies (CHES); German Science Foundation (DFG)(German Research Foundation (DFG))	The authors thank the Enhanced Education Foundation, the Ann and Gordon Getty Foundation, the Biosocial Research Foundation, the Center for Human Evolutionary Studies (CHES), and the German Science Foundation (DFG) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouchard C, 1992, Exerc Sport Sci Rev, V20, P27; Deason M, 2012, SCAND J MED SCI SPOR, V22, P217, DOI 10.1111/j.1600-0838.2010.01289.x; Deason ML, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-24; Furlow B, 1998, P ROY SOC B-BIOL SCI, V265, P1, DOI 10.1098/rspb.1998.0255; Gangestad SW, 1998, ANIM BEHAV, V55, P497, DOI 10.1006/anbe.1997.0610; Graham JH, 1998, BIOL J LINN SOC, V64, P1, DOI 10.1111/j.1095-8312.1998.tb01530.x; Holden C, 2004, SCIENCE, V305, P637, DOI 10.1126/science.305.5684.637; Kulmala JP, 2013, MED SCI SPORT EXER, V45, P2306, DOI 10.1249/MSS.0b013e31829efcf7; Manning JT, 2000, LATERALITY, V5, P121, DOI 10.1080/135765000396744; MANNING JT, 1994, NATURE, V370, P185, DOI 10.1038/370185a0; Manning JT, 1997, EVOL HUM BEHAV, V18, P15, DOI 10.1016/S1090-5138(96)00072-4; Manning JT, 1998, INT J SPORTS MED, V19, P205, DOI 10.1055/s-2007-971905; Manning JT, 1998, HUM NATURE-INT BIOS, V9, P53, DOI 10.1007/s12110-998-1011-4; Moller AP, 2006, INFECT GENET EVOL, V6, P133, DOI 10.1016/j.meegid.2005.03.005; Moller AP, 1999, APPL ANIM BEHAV SCI, V62, P57, DOI 10.1016/S0168-1591(98)00213-5; Moller AP, 1997, ASYMMETRY DEV STABIL; Palmer, 1994, DEV INSTABILITY ITS, P335, DOI DOI 10.1007/978-94-011-0830-0_; Palmer A. Richard, 2003, P279; RICE WR, 1994, TRENDS ECOL EVOL, V9, P235, DOI 10.1016/0169-5347(94)90258-5; Ruxton GD, 2010, METHODS ECOL EVOL, V1, P114, DOI 10.1111/j.2041-210X.2010.00014.x; Simms TM, 2010, AM J PHYS ANTHROPOL, V142, P49, DOI 10.1002/ajpa.21194; Spiriev B, 2011, IAAF SCORING TABLES; Tomkinson GR, 2003, J SPORT SCI, V21, P201, DOI 10.1080/0264041031000071029a; Trivers R, 1999, HUM BIOL, V71, P417; Trivers R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072244; VANVALEN L, 1962, EVOLUTION, V16, P125; Vollestad LA, 1999, HEREDITY, V83, P206, DOI 10.1046/j.1365-2540.1999.00555.x	27	20	20	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113106	10.1371/journal.pone.0113106	http://dx.doi.org/10.1371/journal.pone.0113106			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401732	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700113
J	Shen, YC; Wen, ZJ; Wang, N; Zheng, Z; Liu, K; Xia, X; Gu, Q; Shi, YY; Xu, X				Shen, Yinchen; Wen, Zujia; Wang, Ning; Zheng, Zhi; Liu, Kun; Xia, Xin; Gu, Qing; Shi, Yongyong; Xu, Xun			Investigation of Variants in UCP2 in Chinese Type 2 Diabetes and Diabetic Retinopathy	PLOS ONE			English	Article							UNCOUPLING PROTEIN-2 GENE; RETINAL MITOCHONDRIA; POLYMORPHISMS; RISK; ASSOCIATION; PROMOTER; PREVALENCE; POPULATION; EXPRESSION; CAUCASIANS	Purpose: The aim of this study was to investigate variants in UCP2 genes in type 2 diabetes mellitus (DM) and diabetic retinopathy (DR) in Chinese population. Materials and Methods: We conducted a single nucleotide polymorphism-based and haplotype-based case-control study between the variants of UCP2 and DM and between the variants of UCP2 and DR in 479 Chinese patients with type 2 DM and 479 control subjects without DM. Two SNPs (rs660339 and rs659366) were selected as genetic markers. Results: The risk allele C at UCP2 rs660339 was closely associated with DM in Chinese population. There was significant difference in rs660339 between DM and controls (P = 0.0016; OR [95% CI] = 1.37 (1.14-1.65)). Subjects who were homozygous of the C allele were more likely to develop DM. The frequency of C allele was higher in DM (58%) than in control (51%). But this locus didn't have a definite effect on the onset of non-proliferative diabetic retinopathy (NPDR) (P = 0.44; OR [95% CI] = 0.80 (0.56-1.14)) and proliferative diabetic retinopathy (PDR) (P = 1.00; OR [95% CI] = 0.99 (0.74-1.34)) comparing to subjects with DM without retinopathy (DWR), respectively. Moreover, the UCP2 rs659366 polymorphism showed no significant difference between DM and control (P = 0.66; OR [95% CI] = 1.10 (0.91-1.32)). However, there was a significant difference between PDR and DWR (P = 0.016; OR [95% CI] = 0.66 (0.49-0.90)), but there was no difference between NPDR and DWR (P = 1.00; OR [95% CI] = 0.96 (0.67-1.37)). Participants who carried the G allele at rs659366 were more likely to develop PDR. For the haplotype, C-A was present more frequently in DM than in control (16% vs 7%), indicating that it was risky, and T-A was present less in DM than in control (29% vs 35%). Haplotype frequencies in DR and DWR showed no significant difference (P = 0.068). Conclusion: It was indicated that UCP2 may be implicated in the pathogenesis of type 2 DM and DR in Chinese population.	[Shen, Yinchen; Wang, Ning; Zheng, Zhi; Liu, Kun; Xia, Xin; Gu, Qing; Xu, Xun] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai Key Lab Fundus Dis, Shanghai 200030, Peoples R China; [Wen, Zujia; Shi, Yongyong] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, N (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai Key Lab Fundus Dis, Shanghai 200030, Peoples R China.	drwangning@126.com	Shi, Yongyong/GSO-1627-2022	Shi, Yongyong/0000-0003-1710-1505	National Natural Science Foundation of China [81100679, 81273424]; Major Basic Research Development Program of China (973 Program) [2011CB707500]; Shanghai Guide Fund for Medical Projects [124119a9600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Shanghai Guide Fund for Medical Projects	This work was sponsored by grants from the National Natural Science Foundation of China (No. 81100679; No. 81273424), Major Basic Research Development Program of China (973 Program) (No. 2011CB707500) and Shanghai Guide Fund for Medical Projects (No. 124119a9600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SH, 2000, J NUTR, V130, P711, DOI 10.1093/jn/130.4.711; Bulotta A, 2005, J CLIN ENDOCR METAB, V90, P1176, DOI 10.1210/jc.2004-1072; Cilensek I, 2012, DIS MARKERS, V32, P93, DOI [10.1155/2012/675628, 10.3233/DMA-2011-0863]; Crispim D, 2010, CLIN ENDOCRINOL, V72, P612, DOI 10.1111/j.1365-2265.2009.03684.x; D'Adamo M, 2004, DIABETES, V53, P1905, DOI 10.2337/diabetes.53.7.1905; de Souza BM, 2012, EXP EYE RES, V94, P49, DOI 10.1016/j.exer.2011.11.004; de Souza BM, 2011, ARQ BRAS ENDOCRINOL, V55, P239, DOI 10.1590/S0004-27302011000400001; Duval C, 2002, BIOCHEM CELL BIOL, V80, P757, DOI 10.1139/O02-158; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Gioli-Pereira L, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-40; He Y, 2014, INT J MOL MED, V33, P1275, DOI 10.3892/ijmm.2014.1676; Heidari J, 2010, ARCH IRAN MED, V13, P384, DOI 010135/AIM.004; Hsu YH, 2008, DIABETES, V57, P1101, DOI 10.2337/db07-1269; Kanwar M, 2007, INVEST OPHTH VIS SCI, V48, P3805, DOI 10.1167/iovs.06-1280; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P520, DOI 10.1001/archopht.1984.01040030398010; Kowluru RA, 2007, EXP DIABETES RES, DOI 10.1155/2007/43603; Lee HJ, 2008, CLIN CHIM ACTA, V398, P27, DOI 10.1016/j.cca.2008.07.029; Liew G, 2008, INT OPHTHALMOL CLIN, V49, P35; Lindholm E, 2004, J DIABETES COMPLICAT, V18, P103, DOI 10.1016/S1056-8727(03)00019-9; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Oktavianthi S, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-41; Petrovic D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/540416; Piconi L, 2003, CLIN CHEM LAB MED, V41, P1144, DOI 10.1515/CCLM.2003.177; Qin LJ, 2013, GENET MOL RES, V12, P3324, DOI 10.4238/2013.September.3.9; Rudofsky G, 2006, DIABETES CARE, V29, P89, DOI 10.2337/diacare.29.01.06.dc05-0757; Rudofsky G, 2007, HORM METAB RES, V39, P306, DOI 10.1055/s-2007-973816; Santos JM, 2012, FREE RADICAL BIO MED, V53, P1729, DOI 10.1016/j.freeradbiomed.2012.08.588; Sasahara M, 2004, DIABETES, V53, P482, DOI 10.2337/diabetes.53.2.482; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Threatt J, 2013, AM J MED SCI, V345, P266, DOI 10.1097/MAJ.0b013e31828aa6fb; Vimaleswaran KS, 2011, DIABETES TECHNOL THE, V13, P19, DOI 10.1089/dia.2010.0091; Xu K, 2011, DIABETOLOGIA, V54, P2315, DOI 10.1007/s00125-011-2245-y; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Yu XH, 2005, CLIN CHEM, V51, P1451, DOI 10.1373/clinchem.2004.044859	36	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112670	10.1371/journal.pone.0112670	http://dx.doi.org/10.1371/journal.pone.0112670			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396419	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558500074
J	Tsai, MS; Lin, YC; Sun, CK; Huang, SC; Lee, PH; Kao, YH				Tsai, Ming-Shian; Lin, Yu-Chun; Sun, Cheuk-Kwan; Huang, Shih-Che; Lee, Po-Huang; Kao, Ying-Hsien			Up-Regulation of Nerve Growth Factor in Cholestatic Livers and Its Hepatoprotective Role against Oxidative Stress	PLOS ONE			English	Article							P75 NEUROTROPHIN RECEPTOR; HEPATIC STELLATE CELLS; PC12 CELLS; HEPATOCELLULAR-CARCINOMA; PARACRINE REGULATION; SYMPATHETIC NEURONS; GASTRIC PERFORATION; HYDROGEN-PEROXIDE; INDUCED APOPTOSIS; FACTOR EXPRESSION	The role of nerve growth factor (NGF) in liver injury induced by bile duct ligation (BDL) remains elusive. This study aimed to investigate the relationship between inflammation and hepatic NGF expression, to explore the possible upstream molecules up-regulating NGF, and to determine whether NGF could protect hepatocytes from oxidative liver injury. Biochemical and molecular detection showed that NGF was up-regulated in cholestatic livers and plasma, and well correlated with systemic and hepatic inflammation. Conversely, systemic immunosuppression reduced serum NGF levels and resulted in higher mortality in BDL-treated mice. Immunohistochemistry showed that the up-regulated NGF was mainly localized in parenchymal hepatocytes. In vitro mechanistic study further demonstrated that TGF-beta 1 up-regulated NGF expression in clone-9 and primary rat hepatocytes. Exogenous NGF supplementation and endogenous NGF overexpression effectively protected hepatocytes against TGF-beta 1- and oxidative stress-induced cell death in vitro, along with reduced formation of oxidative adducted proteins modified by 4-HNE and 8-OHdG. TUNEL staining confirmed the involvement of anti-apoptosis in the NGF-exhibited hepatoprotection. Moreover, NGF potently induced Akt phosphorylation and increased Bcl-2 to Bax ratios, whereas these molecular alterations by NGF were only seen in the H2O2-, but not TGF-beta 1-treated hepatocytes. In conclusion, NGF exhibits anti-oxidative and hepatoprotective effects and is suggested to be therapeutically applicable in treating cholestatic liver diseases.	[Tsai, Ming-Shian; Lee, Po-Huang] E DA Hosp, Dept Surg, Kaohsiung, Taiwan; [Tsai, Ming-Shian] I Shou Univ, Sch Med Postbaccalaureate, Kaohsiung, Taiwan; [Lin, Yu-Chun; Huang, Shih-Che; Kao, Ying-Hsien] E DA Hosp, Dept Med Res, Kaohsiung, Taiwan; [Sun, Cheuk-Kwan] E DA Hosp, Dept Med Educ, Kaohsiung, Taiwan; [Lee, Po-Huang] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Surg, Taipei 10764, Taiwan	E-Da Hospital; I Shou University; E-Da Hospital; E-Da Hospital; National Taiwan University; National Taiwan University Hospital	Lee, PH (corresponding author), E DA Hosp, Dept Surg, Kaohsiung, Taiwan.	pohuang1115@ntu.edu.tw; danyhkao@gmail.com	Sun, Cheuk-Kwan/K-5723-2012; Kao, Ying-Hsien/H-4134-2019	LEE, PO-HUANG/0000-0001-5831-035X; Sun, Cheuk-Kwan/0000-0002-2524-9684; Kao, Ying-Hsien/0000-0001-7803-9384	EDA Hospital [EDAHP-100004, EDAHT-100021]	EDA Hospital	This study was supported in part by grants from EDA Hospital (EDAHP-100004 to MST and EDAHT-100021 to YHK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assimakopoulos SF, 2008, REDOX REP, V13, P179, DOI 10.1179/135100008X308902; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Cao GF, 2011, BIOCHEM BIOPH RES CO, V414, P499, DOI 10.1016/j.bbrc.2011.09.094; Chiba T, 2004, ONCOLOGY-BASEL, V66, P481, DOI 10.1159/000079503; COSGAYA JM, 1995, J NEUROCHEM, V65, P2484; Czaja MJ, 2002, ANTIOXID REDOX SIGN, V4, P759, DOI 10.1089/152308602760598909; Franklin CC, 2003, FASEB J, V17, P1535, DOI 10.1096/fj.02-0867fje; Gigliozzi A, 2004, GASTROENTEROLOGY, V127, P1198, DOI 10.1053/j.gastro.2004.06.023; Guerios SD, 2008, AM J PHYSIOL-REG I, V295, pR111, DOI 10.1152/ajpregu.00728.2007; Gujral JS, 2003, HEPATOLOGY, V38, P355, DOI 10.1053/jhep.2003.50341; Haas SL, 2009, GROWTH FACTORS, V27, P289, DOI 10.1080/08977190903132273; Herrera B, 2004, J CELL PHYSIOL, V201, P385, DOI 10.1002/jcp.20078; Hofmann AF, 2002, LIVER, V22, P14, DOI 10.1034/j.1600-0676.2002.00002.x; Hu TH, 2003, CANCER-AM CANCER SOC, V98, P1444, DOI 10.1002/cncr.11653; Jaeschke H, 2011, J GASTROEN HEPATOL, V26, P173, DOI 10.1111/j.1440-1746.2010.06592.x; Kao YH, 2010, J HEPATOL, V52, P96, DOI 10.1016/j.jhep.2009.10.002; Kendall TJ, 2009, HEPATOLOGY, V49, P901, DOI 10.1002/hep.22701; Kirschner PB, 1996, BRAIN RES, V713, P178, DOI 10.1016/0006-8993(95)01513-2; Kishibe K, 2002, GASTROENTEROLOGY, V122, P1978, DOI 10.1053/gast.2002.33581; Li JF, 2013, MOL MED REP, V8, P813, DOI 10.3892/mmr.2013.1590; Lin N, 2009, LIFE SCI, V85, P291, DOI 10.1016/j.lfs.2009.06.007; Lindholm D, 1990, Neuroreport, V1, P9; Liu JW, 2007, PHARMACOL REP, V59, P573; Ljubuncic P, 2000, GUT, V47, P710, DOI 10.1136/gut.47.5.710; Lockhart ST, 1997, J NEUROSCI, V17, P9573; Lu J, 2010, BRAIN PATHOL, V20, P952, DOI 10.1111/j.1750-3639.2010.00397.x; Marin JJG, 2013, FREE RADICAL BIO MED, V61, P218, DOI 10.1016/j.freeradbiomed.2013.04.002; Maroto R, 1997, J NEUROCHEM, V69, P514; Nair P, 2000, CELL DEATH DIFFER, V7, P207, DOI 10.1038/sj.cdd.4400628; Oakley F, 2003, AM J PATHOL, V163, P1849, DOI 10.1016/S0002-9440(10)63544-4; Ohkubo T, 2002, J HEPATOL, V36, P210, DOI 10.1016/S0168-8278(01)00258-6; Passino MA, 2007, SCIENCE, V315, P1853, DOI 10.1126/science.1137603; Pinkse GGM, 2004, LIVER INT, V24, P218, DOI 10.1111/j.1478-3231.2004.0914.x; SAMPATH D, 1994, J NEUROCHEM, V62, P2476; Satoh T, 1996, J BIOCHEM-TOKYO, V120, P540; Schoemaker MH, 2002, J HEPATOL, V36, P742, DOI 10.1016/S0168-8278(02)00063-6; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Suzuki K, 2008, GASTROENTEROLOGY, V135, P270, DOI 10.1053/j.gastro.2008.03.075; Trim N, 2000, AM J PATHOL, V156, P1235, DOI 10.1016/S0002-9440(10)64994-2; Tsai MS, 2011, J SURG RES, V171, P205, DOI 10.1016/j.jss.2010.01.021; Tsai MS, 2010, SHOCK, V33, P170, DOI 10.1097/SHK.0b013e3181ab9ee0; Valdovinos-Flores C, 2013, FREE RADICAL RES, V47, P404, DOI 10.3109/10715762.2013.783210; Xu LB, 2010, WORLD J SURG, V34, P1039, DOI 10.1007/s00268-010-0417-4; Yongchaitrakul T, 2007, EUR J ORAL SCI, V115, P57, DOI 10.1111/j.1600-0722.2007.00420.x	44	8	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112113	10.1371/journal.pone.0112113	http://dx.doi.org/10.1371/journal.pone.0112113			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397406	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558500035
J	Gadalla, KKE; Ross, PD; Riddell, JS; Bailey, MES; Cobb, SR				Gadalla, Kamal K. E.; Ross, Paul D.; Riddell, John S.; Bailey, Mark E. S.; Cobb, Stuart R.			Gait Analysis in a Mecp2 Knockout Mouse Model of Rett Syndrome Reveals Early-Onset and Progressive Motor Deficits	PLOS ONE			English	Article							CPG-BINDING PROTEIN-2; PARKINSONS-DISEASE; MICE; SYMPTOMS; REVERSAL; MUTATION; NEURONS	Rett syndrome (RTT) is a genetic disorder characterized by a range of features including cognitive impairment, gait abnormalities and a reduction in purposeful hand skills. Mice harbouring knockout mutations in the Mecp2 gene display many RTT-like characteristics and are central to efforts to find novel therapies for the disorder. As hand stereotypies and gait abnormalities constitute major diagnostic criteria in RTT, it is clear that motor and gaitrelated phenotypes will be of importance in assessing preclinical therapeutic outcomes. We therefore aimed to assess gait properties over the prodromal phase in a functional knockout mouse model of RTT. In male Mecp2 knockout mice, we observed alterations in stride, coordination and balance parameters at 4 weeks of age, before the onset of other overt phenotypic changes as revealed by observational scoring. These data suggest that gait measures may be used as a robust and early marker of MeCP2-dysfunction in future preclinical therapeutic studies.	[Gadalla, Kamal K. E.; Ross, Paul D.; Riddell, John S.; Cobb, Stuart R.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Bailey, Mark E. S.] Univ Glasgow, Coll Med Vet & Life Sci, Sch Life Sci, Glasgow, Lanark, Scotland; [Gadalla, Kamal K. E.] Tanta Univ, Fac Med, Dept Pharmacol, Tanta, Egypt	University of Glasgow; University of Glasgow; Egyptian Knowledge Bank (EKB); Tanta University	Cobb, SR (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland.	stuart.cobb@glasgow.ac.uk		Gadalla, Kamal/0000-0002-1657-8953; , Paul/0000-0002-4093-5703; Riddell, John/0000-0001-6366-6545; Bailey, Mark E. S./0000-0002-9788-2278	Rett Syndrome Research Trust; Rett Syndrome Association Scotland; Chief Scientist Office; Chief Scientist Office [ETM/334] Funding Source: researchfish	Rett Syndrome Research Trust; Rett Syndrome Association Scotland; Chief Scientist Office; Chief Scientist Office	The work was supported by the following: Rett Syndrome Research Trust (www.rsrt.org/) SC/MB; Rett Syndrome Association Scotland (http://rettsyndromescotland.co.uk/) SC/MB; and Chief Scientist Office (http://www.cso.scot.nhs.uk/) SC/MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amende Ivo, 2005, J Neuroeng Rehabil, V2, P20, DOI 10.1186/1743-0003-2-20; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Asaka Y, 2006, NEUROBIOL DIS, V21, P217, DOI 10.1016/j.nbd.2005.07.005; Basso DM, 2002, RESTOR NEUROL NEUROS, V20, P189; Carter RJ, 1999, J NEUROSCI, V19, P3248; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Cheval H, 2012, HUM MOL GENET, V21, P3806, DOI 10.1093/hmg/dds208; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Domanskyi A, 2011, FASEB J, V25, P2898, DOI 10.1096/fj.11-181958; Fernagut PO, 2002, J NEUROSCI METH, V113, P123, DOI 10.1016/S0165-0270(01)00485-X; Gadalla KKE, 2013, MOL THER, V21, P18, DOI 10.1038/mt.2012.200; Gadalla KKE, 2011, BIOCHEM J, V439, P1, DOI 10.1042/BJ20110648; Garg SK, 2013, J NEUROSCI, V33, P13612, DOI 10.1523/JNEUROSCI.1854-13.2013; Glajch KE, 2012, BEHAV BRAIN RES, V230, P309, DOI 10.1016/j.bbr.2011.12.007; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; HAGBERG B, 1986, AM J MED GENET S, V1, P47; Johnson EM, 2007, J PHYSIOL-LONDON, V582, P629, DOI 10.1113/jphysiol.2007.133561; Katz DM, 2012, DIS MODEL MECH, V5, P733, DOI 10.1242/dmm.011007; Kerr B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011534; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; McGraw CM, 2011, SCIENCE, V333, P186, DOI 10.1126/science.1206593; NAIDU S, 1986, American Journal of Medical Genetics, P61; Neul JL, 2010, ANN NEUROL, V68, P944, DOI 10.1002/ana.22124; NOMURA Y, 1992, BRAIN DEV-JPN, V14, pS21; NOMURA Y, 1990, BRAIN DEV-JPN, V12, P27, DOI 10.1016/S0387-7604(12)80170-7; Robinson L, 2012, BRAIN, V135, P2699, DOI 10.1093/brain/aws096; Santos M, 2010, NEUROSCIENCE, V170, P453, DOI 10.1016/j.neuroscience.2010.07.010; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Stearns NA, 2007, NEUROSCIENCE, V146, P907, DOI 10.1016/j.neuroscience.2007.02.009; Weng SM, 2011, NEUROSCIENCE, V180, P314, DOI 10.1016/j.neuroscience.2011.01.061; Wooley CM, 2005, MUSCLE NERVE, V32, P43, DOI 10.1002/mus.20228	33	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112889	10.1371/journal.pone.0112889	http://dx.doi.org/10.1371/journal.pone.0112889			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392929	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000347709300118
J	Scheuing, N; Holl, RW; Dockter, G; Hermann, JM; Junge, S; Koerner-Rettberg, C; Naehrlich, L; Smaczny, C; Staab, D; Thalhammer, G; van Koningsbruggen-Rietschel, S; Ballmann, M				Scheuing, Nicole; Holl, Reinhard W.; Dockter, Gerd; Hermann, Julia M.; Junge, Sibylle; Koerner-Rettberg, Cordula; Naehrlich, Lutz; Smaczny, Christina; Staab, Doris; Thalhammer, Gabriela; van Koningsbruggen-Rietschel, Silke; Ballmann, Manfred			High Variability in Oral Glucose Tolerance among 1,128 Patients with Cystic Fibrosis: A Multicenter Screening Study	PLOS ONE			English	Article							PREVALENCE; CHILDREN	Background: In cystic fibrosis, highly variable glucose tolerance is suspected. However, no study provided within-patient coefficients of variation. The main objective of this short report was to evaluate within-patient variability of oral glucose tolerance. Methods: In total, 4,643 standardized oral glucose tolerance tests of 1,128 cystic fibrosis patients (median age at first test: 15.5 [11.5; 21.5] years, 48.8% females) were studied. Patients included were clinically stable, non-pregnant, and had at least two oral glucose tolerance tests, with no prior lung transplantation or systemic steroid therapy. Transition frequency from any one test to the subsequent test was analyzed and within-patient coefficients of variation were calculated for fasting and two hour blood glucose values. All statistical analysis was implemented with SAS 9.4. Results: A diabetic glucose tolerance was confirmed in 41.2% by the subsequent test. A regression to normal glucose tolerance at the subsequent test was observed in 21.7% and to impaired fasting glucose, impaired glucose tolerance or both in 15.2%, 12.0% or 9.9%. The average within-patient coefficient of variation for fasting blood glucose was 11.1% and for two hour blood glucose 25.3%. Conclusion: In the cystic fibrosis patients studied, a highly variable glucose tolerance was observed. Compared to the general population, variability of two hour blood glucose was 1.5 to 1.8-fold higher.	[Scheuing, Nicole; Holl, Reinhard W.; Hermann, Julia M.] Univ Ulm, Cent Inst Biomed Technol, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Dockter, Gerd] Saarland Univ Hosp Pediat & Adolescent Med, Cyst Fibrosis Ctr, Homburg, Germany; [Junge, Sibylle] Hannover Med Sch, Clin Pediat Pneumol & Neonatol, Hannover, Germany; [Koerner-Rettberg, Cordula; Ballmann, Manfred] Ruhr Univ Bochum, St Josef Hosp Pediat Clin, Dept Pediat Pulmonol, Bochum, Germany; [Naehrlich, Lutz] Univ Giessen, Dept Pediat, D-35390 Giessen, Germany; [Smaczny, Christina] Goethe Univ Frankfurt, Univ Hosp Frankfurt Main, Med Clin 1, Frankfurt, Germany; [Staab, Doris] Charite, Dept Pediat, Div Pulmonol & Immunol, Berlin, Germany; [Thalhammer, Gabriela] Med Univ Graz, Dept Pediat Pulmonol & Allergol, Graz, Austria; [van Koningsbruggen-Rietschel, Silke] Univ Cologne, Childrens Hosp, Cyst Fibrosis Ctr Cologne, D-50931 Cologne, Germany	Ulm University; Hannover Medical School; Ruhr University Bochum; Justus Liebig University Giessen; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Medical University of Graz; University of Cologne	Scheuing, N (corresponding author), Univ Ulm, Cent Inst Biomed Technol, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany.	nicole.scheuing@uni-ulm.de	Koerner-Rettberg, Cordula/AGI-3532-2022; Ballmann, Manfred/AAE-3730-2019; Naehrlich, Lutz/F-4574-2015	Koerner-Rettberg, Cordula/0000-0003-0946-1009; Naehrlich, Lutz/0000-0002-7146-6997; Holl, Reinhard/0000-0003-1395-4842	German CF association (Mukoviszidose e.V. and its regional group Saarland-Pfalz, Vaincre de la Mucoviszidose); French CF association (Mukoviszidose e.V. and its regional group Saarland-Pfalz, Vaincre de la Mucoviszidose); Novo Nordisk	German CF association (Mukoviszidose e.V. and its regional group Saarland-Pfalz, Vaincre de la Mucoviszidose); French CF association (Mukoviszidose e.V. and its regional group Saarland-Pfalz, Vaincre de la Mucoviszidose); Novo Nordisk(Novo Nordisk)	The study was funded by the German and French CF associations (Mukoviszidose e.V. and its regional group Saarland-Pfalz, Vaincre de la Mucoviszidose), and by Novo Nordisk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	FESKENS EJM, 1991, J CLIN EPIDEMIOL, V44, P947, DOI 10.1016/0895-4356(91)90058-H; Konrad K, 2013, DIABETES CARE, V36, P879, DOI 10.2337/dc12-0807; LANNG S, 1994, ACTA PAEDIATR, V83, P72, DOI 10.1111/j.1651-2227.1994.tb12956.x; Mooy JM, 1996, DIABETOLOGIA, V39, P298, DOI 10.1007/BF00418345; Moran A, 2010, DIABETES CARE, V33, P2697, DOI 10.2337/dc10-1768; Moran A, 2009, DIABETES CARE, V32, P1626, DOI 10.2337/dc09-0586; Naehrlich L, 2013, 026023 AWMF; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Ode KL, 2010, PEDIATR DIABETES, V11, P487, DOI 10.1111/j.1399-5448.2009.00632.x; Rosario AS, 2010, EUR J CLIN NUTR, V64, P341, DOI 10.1038/ejcn.2010.8; Scheuing N, 2015, PEDIATR DIABETES, V16, P10, DOI 10.1111/pedi.12158; Scheuing N, 2014, J CYST FIBROS, V13, P730, DOI 10.1016/j.jcf.2014.05.006; Scheuing N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081545; Schmid K, 2014, J CYST FIBROS, V13, P80, DOI 10.1016/j.jcf.2013.06.001; Selvin E, 2007, ARCH INTERN MED, V167, P1545, DOI 10.1001/archinte.167.14.1545; Sterescu AE, 2010, J PEDIATR-US, V156, P613, DOI 10.1016/j.jpeds.2009.10.019	16	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112578	10.1371/journal.pone.0112578	http://dx.doi.org/10.1371/journal.pone.0112578			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393021	Green Published, gold			2022-12-27	WOS:000347709300073
J	Xing, J; Wang, C; Kimura, H; Takasaki, Y; Kunimoto, S; Yoshimi, A; Nakamura, Y; Koide, T; Banno, M; Kushima, I; Uno, Y; Okada, T; Aleksic, B; Ikeda, M; Iwata, N; Ozaki, N				Xing, Jingrui; Wang, Chenyao; Kimura, Hiroki; Takasaki, Yuto; Kunimoto, Shohko; Yoshimi, Akira; Nakamura, Yukako; Koide, Takayoshi; Banno, Masahiro; Kushima, Itaru; Uno, Yota; Okada, Takashi; Aleksic, Branko; Ikeda, Masashi; Iwata, Nakao; Ozaki, Norio			Resequencing and Association Analysis of PTPRA, a Possible Susceptibility Gene for Schizophrenia and Autism Spectrum Disorders	PLOS ONE			English	Article							GENOME-WIDE; PREFRONTAL CORTEX; RPTP-ALPHA; ERBB4; VARIANTS; MATTER; WHITE; NEUREGULIN-1; METAANALYSIS; EXPRESSION	Background: The PTPRA gene, which encodes the protein RPTP-alpha, is critical to neurodevelopment. Previous linkage studies, genome-wide association studies, controlled expression analyses and animal models support an association with both schizophrenia and autism spectrum disorders, both of which share a substantial portion of genetic risks. Methods: We sequenced the protein-encoding areas of the PTPRA gene for single nucleotide polymorphisms or small insertions/deletions (InDel) in 382 schizophrenia patients. To validate their association with the disorders, rare (minor allele frequency, <1%), missense mutations as well as one InDel in the 39UTR region were then genotyped in another independent sample set comprising 944 schizophrenia patients, 336 autism spectrum disorders patients, and 912 healthy controls. Results: Eight rare mutations, including 3 novel variants, were identified during the mutation-screening phase. In the following association analysis, L59P, one of the two missense mutations, was only observed among patients of schizophrenia. Additionally, a novel duplication in the 3'UTR region, 174620_174623dupTGAT, was predicted to be located within a Musashi Binding Element. Major Conclusions: No evidence was seen for the association of rare, missense mutations in the PTPRA gene with schizophrenia or autism spectrum disorders; however, we did find some rare variants with possibly damaging effects that may increase the susceptibility of carriers to the disorders.	[Xing, Jingrui; Wang, Chenyao; Kimura, Hiroki; Takasaki, Yuto; Kunimoto, Shohko; Yoshimi, Akira; Nakamura, Yukako; Koide, Takayoshi; Banno, Masahiro; Kushima, Itaru; Uno, Yota; Okada, Takashi; Aleksic, Branko; Ozaki, Norio] Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi 4648601, Japan; [Ikeda, Masashi; Iwata, Nakao] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 47011, Japan	Nagoya University; Fujita Health University	Aleksic, B (corresponding author), Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi 4648601, Japan.	branko@med.nagoya-u.ac.jp	KUSHIMA, Itaru/M-8872-2014; YOSHIMI, Akira/M-8934-2014; Aleksic, Branko/G-1540-2011; Ozaki, Norio/M-8908-2014; Aleksic, Branko/L-7851-2019; nakamura, yukako/M-8889-2014; Banno, Masahiro/E-5341-2010; UNO, Yota/M-8928-2014; OKADA, Takashi/M-8902-2014	Aleksic, Branko/0000-0001-8982-4580; Ozaki, Norio/0000-0002-7360-4898; Aleksic, Branko/0000-0001-8982-4580; nakamura, yukako/0000-0002-3306-7127; Banno, Masahiro/0000-0002-2539-1031; Yoshimi, Akira/0000-0001-6636-7970; Kushima, Itaru/0000-0002-0018-5178; IWATA, Nakao/0000-0003-3189-6076; OKADA, Takashi/0000-0001-5580-9913	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Science, Sports and Culture of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding for this study was provided by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Ministry of Health, Labor and Welfare of Japan; Grant-in-Aid for "Integrated research on neuropsychiatric disorders'' carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan; Grant-in-Aid for Scientific Research on Innovative Areas, "Glial assembly: a new regulatory machinery of brain function and disorders''; and Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Ministry of Education, Science, Sports and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Bartlett CW, 2012, BIOL PSYCHIAT, V72, P692, DOI 10.1016/j.biopsych.2012.05.019; Bodrikov V, 2005, J CELL BIOL, V168, P127, DOI 10.1083/jcb.200405073; Bodrikov V, 2008, J CELL BIOL, V182, P1185, DOI 10.1083/jcb.200803045; Buonanno A, 2010, BRAIN RES BULL, V83, P122, DOI 10.1016/j.brainresbull.2010.07.012; Buxbaum JD, 2008, MOL PSYCHIATR, V13, P162, DOI 10.1038/sj.mp.4001991; Carmody DP, 2010, DEV PSYCHOBIOL, V52, P755, DOI 10.1002/dev.20471; Crespi BJ, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-15; Fanous AH, 2008, BIOL PSYCHIAT, V64, P121, DOI 10.1016/j.biopsych.2007.11.023; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Firth HVea, 2009, AM J HUM GENET; Fischbach GD, 2007, NEURON, V54, P495, DOI 10.1016/j.neuron.2007.05.009; Ginsberg MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044736; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Hoistad M, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.009.2009; Hong Eun Pyo, 2012, Genomics & Informatics, V10, P117, DOI 10.5808/GI.2012.10.2.117; Ikeda M, 2011, BIOL PSYCHIAT, V69, P472, DOI 10.1016/j.biopsych.2010.07.010; Johnson NL, 2013, J NURS SCHOLARSHIP, V45, P69, DOI 10.1111/j.1547-5069.2012.01483.x; Kleinhans NM, 2012, BRAIN RES, V1479, P1, DOI 10.1016/j.brainres.2012.07.056; Ku CS, 2013, MOL PSYCHIATR, V18, P141, DOI 10.1038/mp.2012.58; Li B, 2007, NEURON, V54, P583, DOI 10.1016/j.neuron.2007.03.028; Lin Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074264; Liu L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003443; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Martins-de-Souza D, 2010, J PSYCHIATR RES, V44, P149, DOI 10.1016/j.jpsychires.2009.07.007; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Mistry M, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-105; Okano H, 2002, J CELL SCI, V115, P1355; Owen MJ, 2010, ARCH GEN PSYCHIAT, V67, P667, DOI 10.1001/archgenpsychiatry.2010.69; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Silberberg G, 2006, AM J MED GENET B, V141B, P142, DOI 10.1002/ajmg.b.30275; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Takahashi N, 2011, BIOL PSYCHIAT, V70, P626, DOI 10.1016/j.biopsych.2011.06.016; Takahashi N, 2011, PROG NEUROBIOL, V93, P13, DOI 10.1016/j.pneurobio.2010.09.004; Teltsh O, 2008, AM J MED GENET B, V147B, P209, DOI 10.1002/ajmg.b.30591; Vawter MP, 2011, BRIEF FUNCT GENOMICS, V10, P387, DOI 10.1093/bfgp/elr036; Wang PS, 2009, J BIOL CHEM, V284, P33692, DOI 10.1074/jbc.M109.061770; Ward AJ, 2010, J PATHOL, V220, P152, DOI 10.1002/path.2649; Wen L, 2010, P NATL ACAD SCI USA, V107, P1211, DOI 10.1073/pnas.0910302107; Ye H, 2008, EMBO J, V27, P188, DOI 10.1038/sj.emboj.7601939	44	2	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112531	10.1371/journal.pone.0112531	http://dx.doi.org/10.1371/journal.pone.0112531			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393624	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300065
J	Do, S; Karl, WC; Singh, S; Kalra, M; Brady, T; Shin, E; Pien, H				Do, Synho; Karl, William Clem; Singh, Sarabjeet; Kalra, Mannudeep; Brady, Tom; Shin, Ellie; Pien, Homer			High Fidelity System Modeling for High Quality Image Reconstruction in Clinical CT	PLOS ONE			English	Article							BEAM COMPUTED-TOMOGRAPHY; LOW-DOSE CT; ITERATIVE RECONSTRUCTION; RADIATION; MAXIMUM; REDUCTION; ALGORITHM; FORMULATION; EXPOSURE; MATRIX	Today, while many researchers focus on the improvement of the regularization term in IR algorithms, they pay less concern to the improvement of the fidelity term. In this paper, we hypothesize that improving the fidelity term will further improve IR image quality in low-dose scanning, which typically causes more noise. The purpose of this paper is to systematically test and examine the role of high-fidelity system models using raw data in the performance of iterative image reconstruction approach minimizing energy functional. We first isolated the fidelity term and analyzed the importance of using focal spot area modeling, flying focal spot location modeling, and active detector area modeling as opposed to just flying focal spot motion. We then compared images using different permutations of all three factors. Next, we tested the ability of the fidelity terms to retain signals upon application of the regularization term with all three factors. We then compared the differences between images generated by the proposed method and Filtered-Back-Projection. Lastly, we compared images of low-dose in vivo data using Filtered-Back-Projection, Iterative Reconstruction in Image Space, and the proposed method using raw data. The initial comparison of difference maps of images constructed showed that the focal spot area model and the active detector area model also have significant impacts on the quality of images produced. Upon application of the regularization term, images generated using all three factors were able to substantially decrease model mismatch error, artifacts, and noise. When the images generated by the proposed method were tested, conspicuity greatly increased, noise standard deviation decreased by 90% in homogeneous regions, and resolution also greatly improved. In conclusion, the improvement of the fidelity term to model clinical scanners is essential to generating higher quality images in low-dose imaging.	[Do, Synho; Singh, Sarabjeet; Kalra, Mannudeep; Brady, Tom; Shin, Ellie; Pien, Homer] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Do, Synho; Singh, Sarabjeet; Kalra, Mannudeep; Brady, Tom; Shin, Ellie; Pien, Homer] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Karl, William Clem] Boston Univ, Dept Elect & Comp Engn, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Boston University	Do, S (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA.	sdo@mgh.harvard.edu						Alessio AM, 2006, IEEE T MED IMAGING, V25, P828, DOI 10.1109/TMI.2006.873222; ANDERSEN AH, 1984, ULTRASONIC IMAGING, V6, P81, DOI 10.1016/0161-7346(84)90008-7; Beekman FJ, 1999, MED PHYS, V26, P2311, DOI 10.1118/1.598745; Bittencourt MS, 2011, INT J CARDIOVAS IMAG, V27, P1081, DOI 10.1007/s10554-010-9756-3; Bittencourt MS, 2010, INT J CARDIOVASCULAR, P1; Brenner DJ, 2010, JAMA-J AM MED ASSOC, V304, P208, DOI 10.1001/jama.2010.973; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; BROWNE JA, 1995, APPL OPTICS, V34, P5199, DOI 10.1364/AO.34.005199; Chan TF, 1999, SIAM J NUMER ANAL, V36, P354, DOI 10.1137/S0036142997327075; De Man B, 2001, IEEE T MED IMAGING, V20, P999, DOI 10.1109/42.959297; DO S, 2009, ACCURATED MODEL BASE, P330; Do S, 2011, PHYS MED BIOL, V56, P7109, DOI 10.1088/0031-9155/56/22/008; Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; FESSLER JA, 1994, IEEE T MED IMAGING, V13, P290, DOI 10.1109/42.293921; Flohr TG, 2005, MED PHYS, V32, P2536, DOI 10.1118/1.1949787; Fu L, 2013, 2013 IEEE NUCL SCI S, P1; Hentschel D, 1999, GOOGLE PATENTS; Hofmann C, 2014, MED PHYS, V41, DOI 10.1118/1.4862510; Hsieh J., 2003, COMPUTED TOMOGRAPHY; Hsieh Jiang, 2009, COMPUTED TOMOGRAPHY; HUDSON HM, 1994, IEEE T MED IMAGING, V13, P601, DOI 10.1109/42.363108; Husmann L, 2007, EUROPEAN HEART J; Jacobs F., 1998, Journal of Computing and Information Technology - CIT, V6, P89; Jang B, 2009, ARCHITECTURE AWARE O, P62; Kachelriess M, 2006, IEEE T NUCL SCI, V53, P1238, DOI 10.1109/TNS.2006.874076; Kalra MK, 2005, RADIOLOGY, V235, P523, DOI 10.1148/radiol.2352040331; Kalra MK, 2004, RADIOLOGY, V230, P619, DOI 10.1148/radiol.2303021726; Kalra MK, 2003, RADIOLOGY, V228, P251, DOI 10.1148/radiol.2281020693; Kan MWK, 2008, INT J RADIAT ONCOL, V70, P272, DOI 10.1016/j.ijrobp.2007.08.062; Kwan ALC, 2005, MED PHYS, V32, P2967, DOI 10.1118/1.1954908; La Riviere PJ, 2004, IEEE T MED IMAGING, V23, P738, DOI 10.1109/TMI.2004.826950; LEVITAN E, 1987, IEEE T MED IMAGING, V6, P185, DOI 10.1109/TMI.1987.4307826; Li JH, 2007, AM J ROENTGENOL, V188, P547, DOI 10.2214/AJR.06.0370; Little KJ, 2012, IEEE NUCL SCI CONF R, P2174; Marin D, 2010, RADIOLOGY, V254, P145, DOI 10.1148/radiol.09090094; McCollough CH, 2006, RADIOGRAPHICS, V26, P503, DOI 10.1148/rg.262055138; Panin VY, 2006, IEEE T MED IMAGING, V25, P907, DOI 10.1109/TMI.2006.876171; Park JC, 2012, MED PHYS, V39, P1207, DOI 10.1118/1.3679865; Pontana F, 2011, EUR RADIOL, V21, P636, DOI 10.1007/s00330-010-1991-4; Prakash P, 2010, INVEST RADIOL, V45, P202, DOI 10.1097/RLI.ob013e3181dzfeec; Qi JY, 2005, PHYS MED BIOL, V50, P3297, DOI 10.1088/0031-9155/50/14/007; Ramani S, 2010, MED IMAGING IEEE T, P1; SAUER K, 1993, IEEE T SIGNAL PROCES, V41, P534, DOI 10.1109/78.193196; Scheffel H, 2008, HEART, V94, P1132, DOI 10.1136/hrt.2008.149971; Shepp L A, 1982, IEEE Trans Med Imaging, V1, P113, DOI 10.1109/TMI.1982.4307558; SIDDON RL, 1985, MED PHYS, V12, P252, DOI 10.1118/1.595715; Sidky EY, 2008, PHYS MED BIOL, V53, P4777, DOI 10.1088/0031-9155/53/17/021; Sidky EY, 2009, MED PHYS, V36, P4920, DOI 10.1118/1.3232211; Singh S, 2009, RADIOLOGY, V252, P200, DOI 10.1148/radiol.2521081554; Sunnegardh J, 2007, NEW ANTIALIASED PROJ, P124; Tang J, 2009, PHYS MED BIOL, V54, P5781, DOI 10.1088/0031-9155/54/19/008; Thibault JB, 2007, MED PHYS, V34, P4526, DOI 10.1118/1.2789499; Tipnis S, ITERATIVE RECONSTRUC; Tohme MS, 2009, PHYS MED BIOL, V54, P3709, DOI 10.1088/0031-9155/54/12/007; Vogel CR, 1996, SIAM J SCI COMPUT, V17, P227, DOI 10.1137/0917016	56	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111625	10.1371/journal.pone.0111625	http://dx.doi.org/10.1371/journal.pone.0111625			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390888	Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400027
J	Doyle, JR; Harwood, BN; Krishnaji, ST; Krishnamurthy, VM; Lin, WE; Fortin, JP; Kumar, K; Kopin, AS				Doyle, Jamie R.; Harwood, Benjamin N.; Krishnaji, Subrahmanian Tarakkad; Krishnamurthy, Vijay M.; Lin, Wei-En; Fortin, Jean-Philippe; Kumar, Krishna; Kopin, Alan S.			A Two-Step Strategy to Enhance Activity of Low Potency Peptides	PLOS ONE			English	Article							CHOLECYSTOKININ-B RECEPTOR; MEMBRANE-TETHERED LIGANDS; PROTEIN-COUPLED RECEPTORS; HUMAN SERUM-ALBUMIN; FATTY-ACIDS; IN-VITRO; REVERSIBLE LIPIDIZATION; PHARMACOLOGICAL PROFILE; NEUROKININ-1 RECEPTOR; ALPHA-AMIDATION	Novel strategies are needed to expedite the generation and optimization of peptide probes targeting G protein-coupled receptors (GPCRs). We have previously shown that membrane tethered ligands (MTLs), recombinant proteins comprised of a membrane anchor, an extracellular linker, and a peptide ligand can be used to identify targeted receptor modulators. Although MTLs provide a useful tool to identify and/or modify functionally active peptides, a major limitation of this strategy is the reliance on recombinant protein expression. We now report the generation and pharmacological characterization of prototype peptide-linker-lipid conjugates, synthetic membrane anchored ligands (SMALs), which are designed as mimics of corresponding MTLs. In this study, we systematically compare the activity of selected peptides as MTLs versus SMALs. As prototypes, we focused on the precursor proteins of mature Substance P (SubP) and Cholecystokinin 4 (CCK4), specifically non-amidated SubP (SubP-COOH) and glycine extended CCK4 (CCK4-Gly-COOH). As low affinity soluble peptides these ligands each presented a challenging test case for assessment of MTL/SMAL technology. For each ligand, MTLs and corresponding SMALs showed agonist activity and comparable subtype selectivity. In addition, our results illustrate that membrane anchoring increases ligand potency. Furthermore, both MTL and SMAL induced signaling can be blocked by specific non-peptide antagonists suggesting that the anchored constructs may be orthosteric agonists. In conclusion, MTLs offer a streamlined approach for identifying low activity peptides which can be readily converted to higher potency SMALs. The ability to recapitulate MTL activity with SMALs extends the utility of anchored peptides as probes of GPCR function.	[Doyle, Jamie R.; Harwood, Benjamin N.; Fortin, Jean-Philippe; Kopin, Alan S.] Tufts Med Ctr, Mol Pharmacol Res Ctr, Mol Cardiol Res Inst, Boston, MA USA; [Harwood, Benjamin N.; Kopin, Alan S.] Tufts Univ, Sackler Sch Grad Biomed Sci, Genet Program, Boston, MA 02111 USA; [Krishnaji, Subrahmanian Tarakkad; Krishnamurthy, Vijay M.; Lin, Wei-En; Kumar, Krishna] Tufts Univ, Dept Chem, Medford, MA USA	Tufts Medical Center; Tufts University; Tufts University	Kumar, K (corresponding author), Tufts Univ, Dept Chem, Medford, MA 02155 USA.	krishna.kumar@tufts.edu; akopin@tuftsmedicalcenter.org	Kumar, Krishna/B-3151-2009	Kumar, Krishna/0000-0002-0548-5014; Tarakkad Krishnaji, Subrahmanian/0000-0001-8950-6072	National Institutes of Health Heart, Lung, and Blood Institute [T32-HL069770]; National Institutes of Health Neurological Disorders and Stroke [T32-NS061764]; National Institutes of Health General Medical Sciences [R01-GM65500]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS061764] Funding Source: NIH RePORTER	National Institutes of Health Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health Heart, Lung, and Blood Institute [Grant T32-HL069770] (www.nhlbi.nih.gov); The National Institutes of Health Neurological Disorders and Stroke [Grant T32-NS061764] (www.drugabuse.gov); The National Institutes of Health General Medical Sciences [Grant R01-GM65500](www.nigms.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beinborn M, 1998, YALE J BIOL MED, V71, P337; Bellmann-Sickert K, 2011, J MED CHEM, V54, P2658, DOI 10.1021/jm101357e; Bellucci F, 2002, BRIT J PHARMACOL, V135, P266, DOI 10.1038/sj.bjp.0704443; Bhattacharya AA, 2000, J MOL BIOL, V303, P721, DOI 10.1006/jmbi.2000.4158; Choi C, 2009, CURR BIOL, V19, P1167, DOI 10.1016/j.cub.2009.06.029; Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328; CUTTITTA F, 1993, ANAT REC, V236, P87, DOI 10.1002/ar.1092360112; Dasgupta P, 2000, BRIT J PHARMACOL, V129, P101, DOI 10.1038/sj.bjp.0702990; Doyle JR, 2012, J PHARMACOL EXP THER, V342, P318, DOI 10.1124/jpet.112.194548; EIPPER BA, 1988, ANNU REV PHYSIOL, V50, P333, DOI 10.1146/annurev.ph.50.030188.002001; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; EIPPER BA, 1993, PROTEIN SCI, V2, P489; Fortin JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024693; Fortin JP, 2009, P NATL ACAD SCI USA, V106, P8049, DOI 10.1073/pnas.0900149106; Fujita T, 1998, PHARMACEUT RES, V15, P1387, DOI 10.1023/A:1011997404306; Fujiwara SI, 2008, BIOPHYS J, V94, P95, DOI 10.1529/biophysj.107.111377; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Harwood BN, 2013, MOL PHARMACOL, V83, P814, DOI 10.1124/mol.112.081570; HUGHES J, 1990, P NATL ACAD SCI USA, V87, P6728, DOI 10.1073/pnas.87.17.6728; ITO M, 1993, J BIOL CHEM, V268, P18300; Kaspar AA, 2013, DRUG DISCOV TODAY, V18, P807, DOI 10.1016/j.drudis.2013.05.011; LEE YM, 1993, J BIOL CHEM, V268, P8164; Leeman SE, 2000, NEUROPEPTIDES, V34, P249, DOI 10.1054/npep.2000.0826; Lindstrom E, 2007, J PHARMACOL EXP THER, V322, P1286, DOI 10.1124/jpet.107.124958; MATSUEDA GR, 1982, INT J PEPT PROT RES, V20, P26; MCLEAN S, 1993, J PHARMACOL EXP THER, V267, P472; Myers SR, 1997, DIABETES, V46, P637, DOI 10.2337/diabetes.46.4.637; NISHIDA A, 1994, J PHARMACOL EXP THER, V269, P725; Pennington M W, 1994, Methods Mol Biol, V35, P41; PISEGNA JR, 1994, ANN NY ACAD SCI, V713, P338, DOI 10.1111/j.1749-6632.1994.tb44086.x; Rask-Andersen M, 2014, ANNU REV PHARMACOL, V54, P9, DOI 10.1146/annurev-pharmtox-011613-135943; Schlyer S, 2006, DRUG DISCOV TODAY, V11, P481, DOI 10.1016/j.drudis.2006.04.008; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Seong B. L., 2001, BIOTECHNOL BIOPROC E, V6, P244; SETOH K, 1995, J PHARM PHARMACOL, V47, P808, DOI 10.1111/j.2042-7158.1995.tb05745.x; Tanaka K, 1996, BBA-BIOMEMBRANES, V1283, P119, DOI 10.1016/0005-2736(96)00087-9; TENMA T, 1993, PHARMACEUT RES, V10, P1488, DOI 10.1023/A:1018983511247; Wang J, 2006, J DRUG TARGET, V14, P127, DOI 10.1080/10611860600648221; Wise A, 2002, DRUG DISCOV TODAY, V7, P235, DOI 10.1016/S1359-6446(01)02131-6; YODOYA E, 1994, J PHARMACOL EXP THER, V271, P1509; Yuan LY, 2005, PHARM RES-DORDR, V22, P220, DOI 10.1007/s11095-004-1189-z; Zarandi M, 2006, P NATL ACAD SCI USA, V103, P4610, DOI 10.1073/pnas.0511348103; Zhang L, 2012, CURR MED CHEM, V19, P1602	43	7	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e110502	10.1371/journal.pone.0110502	http://dx.doi.org/10.1371/journal.pone.0110502			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391026	Green Submitted, Green Published, gold			2022-12-27	WOS:000349144400015
J	Hocking, DP; Salverson, M; Fitzgerald, EMG; Evans, AR				Hocking, David P.; Salverson, Marcia; Fitzgerald, Erich M. G.; Evans, Alistair R.			Australian Fur Seals (Arctocephalus pusillus doriferus) Use Raptorial Biting and Suction Feeding When Targeting Prey in Different Foraging Scenarios	PLOS ONE			English	Article							DIET; BEHAVIOR; KINEMATICS	Foraging behaviours used by two female Australian fur seals (Arctocephalus pusillus doriferus) were documented during controlled feeding trials. During these trials the seals were presented with prey either free-floating in open water or concealed within a mobile ball or a static box feeding device. When targeting free-floating prey both subjects primarily used raptorial biting in combination with suction, which was used to draw prey to within range of the teeth. When targeting prey concealed within either the mobile or static feeding device, the seals were able to use suction to draw out prey items that could not be reached by biting. Suction was followed by lateral water expulsion, where water drawn into the mouth along with the prey item was purged via the sides of the mouth. Vibrissae were used to explore the surface of the feeding devices, especially when locating the openings in which the prey items had been hidden. The mobile ball device was also manipulated by pushing it with the muzzle to knock out concealed prey, which was not possible when using the static feeding device. To knock prey out of this static device one seal used targeted bubble blowing, where a focused stream of bubbles was blown out of the nose into the openings in the device. Once captured in the jaws, prey items were manipulated and re-oriented using further mouth movements or chews so that they could be swallowed head first. While most items were swallowed whole underwater, some were instead taken to the surface and held in the teeth, while being vigorously shaken to break them into smaller pieces before swallowing. The behavioural flexibility displayed by Australian fur seals likely assists in capturing and consuming the extremely wide range of prey types that are targeted in the wild, during both benthic and epipelagic foraging.	[Hocking, David P.; Evans, Alistair R.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia; [Hocking, David P.; Fitzgerald, Erich M. G.; Evans, Alistair R.] Museum Victoria, Melbourne, Vic, Australia; [Hocking, David P.; Salverson, Marcia] Zoos Victoria, Wild Sea Precinct, Melbourne, Vic, Australia	Monash University; Museum Victoria	Hocking, DP (corresponding author), Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia.	email@david-hocking.com	Evans, Alistair R/D-4239-2011; Hocking, David Philip/A-2666-2017	Evans, Alistair R/0000-0002-4078-4693; Hocking, David Philip/0000-0001-6848-1208	Holsworth Wildlife Research Endowment and Monash University; Australian Research Council	Holsworth Wildlife Research Endowment and Monash University; Australian Research Council(Australian Research Council)	This study was supported by the Holsworth Wildlife Research Endowment and Monash University. ARE acknowledges the support of the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Peter J., 2002, Oryctos, V4, P83; Arnould JPY, 2006, LOW WAKE FI, P309; Arnould JPY, 2007, AQUAT CONSERV, V17, pS53, DOI 10.1002/aqc.908; Arnould JPY, 2001, CAN J ZOOL, V79, P35, DOI 10.1139/cjz-79-1-35; Bloodworth B, 2005, J EXP BIOL, V208, P3721, DOI 10.1242/jeb.01807; Bowen WD, 2002, MAR ECOL PROG SER, V244, P235, DOI 10.3354/meps244235; Davis RW, 1999, SCIENCE, V283, P993, DOI 10.1126/science.283.5404.993; Deagle BE, 2009, MOL ECOL, V18, P2022, DOI 10.1111/j.1365-294X.2009.04158.x; GALES R, 1993, AUST J MAR FRESH RES, V44, P657; GALES R, 1994, AUST J MAR FRESH RES, V45, P653; Hocking DP, 2013, POLAR BIOL, V36, P211, DOI 10.1007/s00300-012-1253-9; Hume F, 2004, MAR BIOL, V144, P407, DOI 10.1007/s00227-003-1219-0; Jones KE, 2013, ANAT REC, V296, P1049, DOI 10.1002/ar.22710; Kane EA, 2009, J EXP BIOL, V212, P3939, DOI 10.1242/jeb.034686; KASTELEIN R A, 1991, Aquatic Mammals, V17, P156; Kastelein R.A., 1989, Aquatic Mammals, V15, P3; Kirkwood R, 2013, AUSTRAL NAT HIST SER, P1; Kirkwood R, 2008, MAR ECOL PROG SER, V369, P297, DOI 10.3354/meps07633; KLAGES NTW, 1990, POLAR BIOL, V10, P403; Marshall CD, 2008, J EXP BIOL, V211, P699, DOI 10.1242/jeb.009852; Marshall CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086710; R Core Team, 2021, R LANGUAGE ENV STAT; Werth A, 2000, MAR MAMMAL SCI, V16, P299, DOI 10.1111/j.1748-7692.2000.tb00926.x; Werth Alexander, 2000, P487, DOI 10.1016/B978-012632590-4/50017-4; Werth AJ, 2006, J MORPHOL, V267, P1415, DOI 10.1002/jmor.10486; Ydesen KS, 2014, J EXP BIOL, V217, P2239, DOI 10.1242/jeb.100016	26	24	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112521	10.1371/journal.pone.0112521	http://dx.doi.org/10.1371/journal.pone.0112521			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390347	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400091
J	Cohen, SS; Park, YY; Signorello, LB; Patel, AV; Boggs, DA; Kolonel, LN; Kitahara, CM; Knutsen, SF; Gillanders, E; Monroe, KR; de Gonzalez, AB; Bethea, TN; Black, A; Fraser, G; Gapstur, S; Hartge, P; Matthews, CE; Park, SY; Purdue, MP; Singh, P; Harvey, C; Blot, WJ; Palmer, JR				Cohen, Sarah S.; Park, Yikyung; Signorello, Lisa B.; Patel, Alpa V.; Boggs, Deborah A.; Kolonel, Laurence N.; Kitahara, Cari M.; Knutsen, Synnove F.; Gillanders, Elizabeth; Monroe, Kristine R.; de Gonzalez, Amy Berrington; Bethea, Traci N.; Black, Amanda; Fraser, Gary; Gapstur, Susan; Hartge, Patricia; Matthews, Charles E.; Park, Song-Yi; Purdue, Mark P.; Singh, Pramil; Harvey, Chinonye; Blot, William J.; Palmer, Julie R.			A Pooled Analysis of Body Mass Index and Mortality among African Americans	PLOS ONE			English	Article							SELF-REPORTED HEIGHT; UNITED-STATES; US ADULTS; PROSPECTIVE COHORT; OBESITY; WEIGHT; ASSOCIATION; OVERWEIGHT; WHITE; WOMEN	Pooled analyses among whites and East Asians have demonstrated positive associations between all-cause mortality and body mass index (BMI), but studies of African Americans have yielded less consistent results. We examined the association between BMI and all-cause mortality in a sample of African Americans pooled from seven prospective cohort studies: NIH-AARP, 1995-2009; Adventist Health Study 2, 2002-2008; Black Women's Health Study, 1995-2009; Cancer Prevention Study II, 1982-2008; Multiethnic Cohort Study, 1993-2007; Prostate, Lung, Colorectal and Ovarian Screening Trial, 1993-2009; Southern Community Cohort Study, 2002-2009. 239,526 African Americans (including 100,175 never smokers without baseline heart disease, stroke, or cancer), age 30-104 (mean 52) and 71% female, were followed up to 26.5 years (mean 11.7). Hazard ratios (HR) and 95% confidence intervals (CI) for mortality were derived from multivariate Cox proportional hazards models. Among healthy, never smokers (11,386 deaths), HRs (CI) for BMI 25-27.4, 27.5-29.9, 30-34.9, 35-39.9, 40-49.9, and 50-60 kg/m(2) were 1.02 (0.92-1.12), 1.06 (0.95-1.18), 1.32 (1.18-1.47), 1.54 (1.29-1.83), 1.93 (1.46-2.56), and 1.93 (0.80-4.69), respectively among men and 1.06 (0.99-1.15), 1.15 (1.06-1.25), 1.24 (1.15-1.34), 1.58 (1.43-1.74), 1.80 (1.60-2.02), and 2.31 (1.74-3.07) respectively among women (reference category 22.5-24.9). HRs were highest among those with the highest educational attainment, longest follow-up, and for cardiovascular disease mortality. Obesity was associated with a higher risk of mortality in African Americans, similar to that observed in pooled analyses of whites and East Asians. This study provides compelling evidence to support public health efforts to prevent excess weight gain and obesity in African Americans.	[Cohen, Sarah S.; Blot, William J.] Int Epidemiol Inst, Rockville, MD 20850 USA; [Cohen, Sarah S.] EpidStat Inst, Ann Arbor, MI USA; [Park, Yikyung; Kitahara, Cari M.; de Gonzalez, Amy Berrington; Black, Amanda; Hartge, Patricia; Matthews, Charles E.; Purdue, Mark P.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Signorello, Lisa B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Patel, Alpa V.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Boggs, Deborah A.; Bethea, Traci N.; Palmer, Julie R.] Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA; [Kolonel, Laurence N.; Park, Song-Yi] Univ Hawaii, Ctr Canc, Canc Epidemiol Program, Honolulu, HI 96822 USA; [Knutsen, Synnove F.; Fraser, Gary] Loma Linda Univ, Sch Publ Hlth, Ctr Nutr Hlth Lifestyle & Dis Prevent, Loma Linda, CA 92350 USA; [Gillanders, Elizabeth] NCI, Div Canc Control & Populat Sci, NIH, Bethesda, MD 20892 USA; [Monroe, Kristine R.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Singh, Pramil] Loma Linda Univ, Sch Publ Hlth, Ctr Hlth Res, Loma Linda, CA 92350 USA; [Harvey, Chinonye] NCI, Epidemiol & Genom Res Program, NIH, Bethesda, MD 20892 USA; [Blot, William J.] Vanderbilt Univ, Med Ctr, Dept Med, Div Epidemiol, Nashville, TN 37235 USA; [Blot, William J.] Vanderbilt Ingram Canc Ctr, Nashville, TN USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard T.H. Chan School of Public Health; American Cancer Society; Boston University; Cancer Research Center of Hawaii; University of Hawaii System; Loma Linda University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Southern California; Loma Linda University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vanderbilt University; Vanderbilt University	Cohen, SS (corresponding author), Int Epidemiol Inst, Rockville, MD 20850 USA.	sarah@epidstat.com	Purdue, Mark P/C-9228-2016; Kitahara, Cari M/R-8267-2016; de gonzalez, amy berrington/L-7017-2017; matthews, Charles e/E-8073-2015	Purdue, Mark P/0000-0003-1177-3108; Kitahara, Cari M/0000-0001-6416-4432; de gonzalez, amy berrington/0000-0002-7332-8387; matthews, Charles e/0000-0001-8037-3103; Park, Yikyung/0000-0002-6281-489X; Singh, Pramil/0000-0002-9820-2887; Cohen, Sarah/0000-0003-0421-1983; Bethea, Traci/0000-0003-3205-2078	National Cancer Institute's (NCI) Intramural Research Program, Division of Cancer Epidemiology and Genetics (DCEG); Epidemiology and Genomics Research Program, Division of Cancer Control and Populations Sciences; Intramural Research Program of the National Cancer Institute, National Institutes of Health; National Cancer Institute [R01 CA94594, R01 CA058420, R37 CA54281, R01 CA092447, 3R01 CA092447-08S1]; American Cancer Society; Division of Cancer Prevention, National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA094594, R01CA058420, ZIACP010196, R37CA054281, R01CA092447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092986] Funding Source: NIH RePORTER	National Cancer Institute's (NCI) Intramural Research Program, Division of Cancer Epidemiology and Genetics (DCEG); Epidemiology and Genomics Research Program, Division of Cancer Control and Populations Sciences; Intramural Research Program of the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Division of Cancer Prevention, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This pooled analysis was supported by the National Cancer Institute's (NCI) Intramural Research Program, Division of Cancer Epidemiology and Genetics (DCEG) and the Epidemiology and Genomics Research Program, Division of Cancer Control and Populations Sciences. The NIH-AARP study is supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health. The Adventist Health Study 2 is funded by grant R01 CA94594 from the National Cancer Institute. The Black Women's Health Study is funded by grant R01 CA058420 from the National Cancer Institute. The Cancer Prevention Study II Nutrition Cohort is supported by the American Cancer Society. The authors thank all of the men and women in the Cancer Prevention Study II Nutrition Cohort for their many years of dedicated participation in the study. The Multiethnic Cohort Study (MEC) is funded by grant R37 CA54281 from the National Cancer Institute. The PLCO is supported by contracts from the Division of Cancer Prevention, National Cancer Institute, National Institutes of Health. The PLCO investigators thank the Screening Center investigators and staff of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial, Mr. Tom Riley and staff, Information Management Services, Inc., Ms. Barbara O'Brien and staff, Westat, Inc. Most importantly, we acknowledge the study participants for their contributions to making this study possible. The Southern Community Cohort Study (SCCS) is funded by grant R01 CA092447 from the National Cancer Institute including special allocations from the American Recovery and Reinvestment Act (3R01 CA092447-08S1). The funding sources for this study did not participate in the design and conduct of the study, collection, management, analysis, and interpretation of the data, preparation, review, or approval of the manuscript, or the decision to submit the manuscript for publication.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Beydoun MA, 2009, OBESITY, V17, P169, DOI 10.1038/oby.2008.492; Boggs DA, 2011, NEW ENGL J MED, V365, P901, DOI 10.1056/NEJMoa1104119; Calle EE, 2004, ONCOGENE, V23, P6365, DOI 10.1038/sj.onc.1207751; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Craig BM, 2009, MATERN CHILD HLTH J, V13, P489, DOI 10.1007/s10995-008-0384-7; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Doubeni CA, 2012, AM J PUBLIC HEALTH, V102, P680, DOI 10.2105/AJPH.2011.300158; DurazoArvizu R, 1997, ANN EPIDEMIOL, V7, P383, DOI 10.1016/S1047-2797(97)00044-6; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Keith SW, 2011, INT J OBESITY, V35, P401, DOI 10.1038/ijo.2010.148; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; PAPPAS G, 1993, NEW ENGL J MED, V329, P103, DOI 10.1056/NEJM199307083290207; Park SY, 2012, EUR J EPIDEMIOL, V27, P489, DOI 10.1007/s10654-012-9695-5; Reis JP, 2009, ANN EPIDEMIOL, V19, P134, DOI 10.1016/j.annepidem.2008.10.008; SORLIE PD, 1995, AM J PUBLIC HEALTH, V85, P949, DOI 10.2105/AJPH.85.7.949; Stevens J, 1998, OBES RES, V6, P268, DOI 10.1002/j.1550-8528.1998.tb00349.x; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679	23	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e111980	10.1371/journal.pone.0111980	http://dx.doi.org/10.1371/journal.pone.0111980			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8BL	25401742	Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700023
J	Dakshinamoorthy, G; von Gegerfelt, A; Andersen, H; Lewis, M; Kalyanasundaram, R				Dakshinamoorthy, Gajalakshmi; von Gegerfelt, Agneta; Andersen, Hanne; Lewis, Mark; Kalyanasundaram, Ramaswamy			Evaluation of a Multivalent Vaccine against Lymphatic Filariasis in Rhesus macaque Model	PLOS ONE			English	Article							BRUGIA-MALAYI; BANCROFTIAN FILARIASIS; CYTOKINE RESPONSES; IMMUNOGLOBULIN-G; IMMUNE-RESPONSE; INFECTION; MONKEYS; ALBENDAZOLE; ELIMINATION; INDUCTION	Lymphatic filariasis affects 120 million people worldwide and another 1.2 billion people are at risk of acquiring the infection. Chemotherapy with mass drug administration is substantially reducing the incidence of the infection. Nevertheless, an effective vaccine is needed to prevent the infection and eradicate the disease. Previously we reported that a multivalent fusion protein vaccine (rBmHAT) composed of small heat shock proteins 12.6 (HSP12.6), abundant larval transcript-2 (ALT-2) and large extracellular domain of tetraspanin (TSP LEL) could confer >95% protection against the challenge infection with Brugia malayi infective larvae (L3) in mouse and gerbil models. In this study we evaluated the immunogenicity and efficacy of rBmHAT fusion protein vaccine in a rhesus macaque model. Our results show that rBmHAT is highly immunogenic in rhesus macaques. All the vaccinated monkeys developed significant titers of antigen-specific IgG antibodies against each of the component antigens (16,000 for rBmHSP12.6), (24,000 for rBmALT-2) and (16,000 for rBmTSP-LEL). An in vitro antibody dependent cellular cytotoxicity (ADCC) assay performed using the sera samples from vaccinated monkeys showed that the anti-rBmHAT antibodies are functional with 35% killing of B. malayi L3s. Vaccinated monkeys also had antigen responding cells in the peripheral blood. Vaccine-induced protection was determined after challenging the monkeys with 500 B. malayi L3. Following challenge infection, 3 out of 5 vaccinated macaques failed to develop the infection. These three protected macaques had high titers of IgG1 antibodies and their PBMC secreted significantly high levels of IFN-gamma in response to the vaccine antigens. The two vaccinated macaques that picked the infection had slightly low titers of antibodies and their PBMC secreted high levels of IL-10. Based on these findings we conclude that the rBmHAT vaccine is highly immunogenic and safe and can confer significant protection against challenge infections in rhesus macaques.	[Dakshinamoorthy, Gajalakshmi; Kalyanasundaram, Ramaswamy] Univ Illinois Coll Med Rockford, Dept Biomed Sci, Rockford, IL 61101 USA; [von Gegerfelt, Agneta; Andersen, Hanne; Lewis, Mark] Bioqual Inc, Rockville, MD USA	BIOQUAL Inc.	Kalyanasundaram, R (corresponding author), Univ Illinois Coll Med Rockford, Dept Biomed Sci, Rockford, IL 61101 USA.	ramswamy@uic.edu		Elyard, Hanne/0000-0003-1103-9608	PIPB by the Division of Microbial and Infectious Diseases [HHSN27220100006I/HHSN2720003]; NIH RO1 grant [AI064745]; Bioqual Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI064745, R01AI064745] Funding Source: NIH RePORTER	PIPB by the Division of Microbial and Infectious Diseases; NIH RO1 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bioqual Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for these studies was provided through PIPB by the Division of Microbial and Infectious Diseases contract number HHSN27220100006I/HHSN2720003 to Bioqual, and additional funding was from NIH RO1 grant AI064745 to RK. Bioqual Inc. provided support in the form of salaries for authors AVG, HA, and ML, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad G, 2011, J INFECT DIS, V204, P1437, DOI 10.1093/infdis/jir545; Anand SB, 2007, PARASITOL RES, V101, P981, DOI 10.1007/s00436-007-0571-2; Choi YJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001409; CRANDELL RB, 1983, ACTA TROP, V40, P53; Critchley J, 2005, TROP MED INT HEALTH, V10, P818, DOI 10.1111/j.1365-3156.2005.01458.x; Dakshinamoorthy G, 2013, VACCINE, V32, P19, DOI 10.1016/j.vaccine.2013.10.083; Dakshinamoorthy G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077394; Dakshinamoorthy G, 2013, VACCINE, V31, P1616, DOI 10.1016/j.vaccine.2012.09.055; Dakshinamoorthy G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034077; DAY KP, 1991, PARASITOL TODAY, V7, P341, DOI 10.1016/0169-4758(91)90215-A; deAlmeida AB, 1996, J INFECT DIS, V173, P1453, DOI 10.1093/infdis/173.6.1453; ELBIHARI S, 1971, J PARASITOL, V57, P1170, DOI 10.2307/3277959; Farid HA, 2005, AM J TROP MED HYG, V73, P108, DOI 10.4269/ajtmh.2005.73.108; FOLSE DS, 1988, LYMPHOLOGY, V21, P244; Gardner MB, 2008, ILAR J, V49, P220, DOI 10.1093/ilar.49.2.220; Giambartolomei GH, 1998, EXP PARASITOL, V90, P77, DOI 10.1006/expr.1998.4312; Gnanasekar M, 2004, INFECT IMMUN, V72, P4707, DOI 10.1128/IAI.72.8.4707-4715.2004; Hotez PJ, 2009, CLIN PHARMACOL THER, V85, P659, DOI 10.1038/clpt.2009.16; Jin Bo-Ra, 2013, Immune Netw, V13, P10, DOI 10.4110/in.2013.13.1.10; Joseph SK, 2013, VACCINE, V31, P3320, DOI 10.1016/j.vaccine.2013.05.077; LIU JY, 1989, J TROP MED HYG, V92, P93; MAHANTY S, 1995, PARASITE IMMUNOL, V17, P385, DOI 10.1111/j.1365-3024.1995.tb00906.x; Mahanty S, 1996, EXP PARASITOL, V84, P282, DOI 10.1006/expr.1996.0114; MAIZELS RM, 1995, PARASITOL TODAY, V11, P50, DOI 10.1016/0169-4758(95)80116-2; Maizels RM, 1999, IMMUNOL REV, V171, P125, DOI 10.1111/j.1600-065X.1999.tb01345.x; Mishra K, 2005, ACTA TROP, V93, P233, DOI 10.1016/j.actatropica.2005.01.001; Molyneux DH, 2002, ANN TROP MED PARASIT, V96, pS15, DOI 10.1179/000349802125002374; Parish CR, 2009, CURR PROTOC IMMUNOL; PEARLMAN E, 1993, J IMMUNOL, V151, P4857; PEARLMAN E, 1993, EXP PARASITOL, V76, P200, DOI 10.1006/expr.1993.1023; Rao RU, 2006, J CLIN MICROBIOL, V44, P3887, DOI 10.1128/JCM.00969-06; Shearer MH, 1999, CLIN DIAGN LAB IMMUN, V6, P953, DOI 10.1128/CDLI.6.6.953-958.1999; Shedlock DJ, 2009, NAT REV IMMUNOL, V9, P717, DOI 10.1038/nri2636; Thirugnanam S, 2007, EXP PARASITOL, V116, P483, DOI 10.1016/j.exppara.2007.02.017; TURNER P, 1993, TROP MED PARASITOL, V44, P45; Veerapathran A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000457; WONG M M, 1977, Southeast Asian Journal of Tropical Medicine and Public Health, V8, P265; WONG MM, 1969, B WORLD HEALTH ORGAN, V40, P493	38	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112982	10.1371/journal.pone.0112982	http://dx.doi.org/10.1371/journal.pone.0112982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401783	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700089
J	Mattioli, S; Farioli, A; Legittimo, P; Miligi, L; Benvenuti, A; Ranucci, A; Salvan, A; Rondelli, R; Magnani, C				Mattioli, Stefano; Farioli, Andrea; Legittimo, Patrizia; Miligi, Lucia; Benvenuti, Alessandra; Ranucci, Alessandra; Salvan, Alberto; Rondelli, Roberto; Magnani, Corrado		SETIL Study Grp	Tobacco Smoke and Risk of Childhood Acute Non-Lymphocytic Leukemia: Findings from the SETIL Study	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; MARGINAL STRUCTURAL MODELS; IN-UTERO; EXPOSURE; CANCER; PREGNANCY; ETIOLOGY	Background: Parental smoking and exposure of the mother or the child to environmental tobacco smoke (ETS) as risk factors for Acute non-Lymphocytic Leukemia (AnLL) were investigated. Methods: Incident cases of childhood AnLL were enrolled in 14 Italian Regions during 1998-2001. We estimated odds ratios (OR) and 95% confidence intervals (95% CI) conducting logistic regression models including 82 cases of AnLL and 1,044 controls. Inverse probability weighting was applied adjusting for: age; sex; provenience; birth order; birth weight; breastfeeding; parental educational level age, birth year, and occupational exposure to benzene. Results: Paternal smoke in the conception period was associated with AnLL (OR for >= 11 cigarettes/day = 1.79, 95% CI 1.01-3.15; P trend 0.05). An apparent effect modification by maternal age was identified: only children of mothers aged below 30 presented increased risks. We found weak statistical evidence of an association of AnLL with maternal exposure to ETS (OR for exposure. 3 hours/day = 1.85, 95% CI 0.97-3.52; P trend 0.07). No association was observed between AnLL and either maternal smoking during pregnancy or child exposure to ETS. Conclusions: This study is consistent with the hypothesis that paternal smoke is associated with AnLL. We observed statistical evidence of an association between maternal exposure to ETS and AnLL, but believe bias might have inflated our estimates.	[Mattioli, Stefano; Farioli, Andrea] Univ Bologna, Dept Med & Surg Sci DIMEC, Bologna, Italy; [Legittimo, Patrizia] S Orsola Malpighi Univ Hosp, Unit Occupat Med, Bologna, Italy; [Legittimo, Patrizia; Miligi, Lucia; Benvenuti, Alessandra] ISPO Canc Prevent & Res Inst, Occupat & Environm Epidemiol Unit, Florence, Italy; [Ranucci, Alessandra; Magnani, Corrado] CPO Piemonte, Dept Translat Med, Canc Epidemiol Unit, Novara, Italy; [Salvan, Alberto] CNR, IASI, Rome, Italy; [Rondelli, Roberto] St Orsola Marcello Malpighi Hosp, Bologna, Italy	University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; Consiglio Nazionale delle Ricerche (CNR); IRCCS Azienda Ospedaliero-Universitaria di Bologna	Mattioli, S (corresponding author), Univ Bologna, Dept Med & Surg Sci DIMEC, Bologna, Italy.	s.mattioli@unibo.it	LAGORIO, Susanna/I-5033-2012; Lagorio, Susanna/AAL-8389-2021; Michelozzi, Paola/J-8608-2016; Farioli, Andrea/K-9256-2016; Kirchmayer, Ursula/L-7847-2016; Forastiere, Francesco/J-9067-2016	LAGORIO, Susanna/0000-0001-8883-8745; Lagorio, Susanna/0000-0001-8883-8745; Michelozzi, Paola/0000-0002-1646-2555; Farioli, Andrea/0000-0003-2001-2140; chiavarini, manuela/0000-0002-3551-7486; Kirchmayer, Ursula/0000-0001-7732-0166; Forastiere, Francesco/0000-0002-9162-5684; Miligi, Lucia/0000-0002-8223-485X; Mattioli, Stefano/0000-0002-9639-7430	AIRC (Italian Association on Research on Cancer); MIUR (Ministry for Instruction, University and Research, PRIN Program); Ministry of Health (Ricerca Sanitaria Finalizzata Program); Ministry of Labour and Welfare; Associazione Neuroblastoma; Piemonte Region (Ricerca Sanitaria Finalizzata Regione Piemonte Program); Liguria Region; Comitato per la vita "Daniele Chianelli"-Associazione per la Ricerca e la Cura delle Leucemie, Linfomi e Tumori di Adulti e Bambini, (Perugia)	AIRC (Italian Association on Research on Cancer)(Fondazione AIRC per la ricerca sul cancro); MIUR (Ministry for Instruction, University and Research, PRIN Program)(Ministry of Education, Universities and Research (MIUR)); Ministry of Health (Ricerca Sanitaria Finalizzata Program); Ministry of Labour and Welfare; Associazione Neuroblastoma; Piemonte Region (Ricerca Sanitaria Finalizzata Regione Piemonte Program); Liguria Region(Regione Liguria); Comitato per la vita "Daniele Chianelli"-Associazione per la Ricerca e la Cura delle Leucemie, Linfomi e Tumori di Adulti e Bambini, (Perugia)	The SETIL study was financially supported by research grants received by AIRC (Italian Association on Research on Cancer), MIUR (Ministry for Instruction, University and Research, PRIN Program), Ministry of Health (Ricerca Sanitaria Finalizzata Program), Ministry of Labour and Welfare, Associazione Neuroblastoma, Piemonte Region (Ricerca Sanitaria Finalizzata Regione Piemonte Program), Liguria Region, Comitato per la vita "Daniele Chianelli"-Associazione per la Ricerca e la Cura delle Leucemie, Linfomi e Tumori di Adulti e Bambini, (Perugia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIRTUM Working Group, 2008, Epidemiol Prev, V32, P5; AIRTUM Working Group, 2008, EPIDEMIOL PREV S2, V32, P5; AIRTUM Working Group, 2008, EPIDEMIOL PREV, V32, P16; Badaloni C, 2013, OCCUP ENVIRON MED, V70, P876, DOI 10.1136/oemed-2013-101604; Belson M, 2007, ENVIRON HEALTH PERSP, V115, P138, DOI 10.1289/ehp.9023; Boffetta P, 2000, ENVIRON HEALTH PERSP, V108, P73, DOI 10.2307/3454298; Chang Jeffrey S., 2009, V472, P103, DOI 10.1007/978-1-60327-492-0_5; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Eden T, 2010, CANCER TREAT REV, V36, P286, DOI 10.1016/j.ctrv.2010.02.004; Farioli A, 2014, CANCER CAUSE CONTROL, V25, P683, DOI 10.1007/s10552-014-0371-9; Greaves M, 2005, EARLY HUM DEV, V81, P123, DOI 10.1016/j.earlhumdev.2004.10.004; Greaves M, 2006, NAT REV CANCER, V6, P193, DOI 10.1038/nrc1816; GREAVES MF, 1993, LEUKEMIA, V7, P349; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Lee KM, 2009, LEUKEMIA RES, V33, P250, DOI 10.1016/j.leukres.2008.06.031; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Mansson R, 2007, AM J EPIDEMIOL, V166, P332, DOI 10.1093/aje/kwm069; Menezo YJ, 2006, REPROD BIOMED ONLINE, V12, P616, DOI 10.1016/S1472-6483(10)61188-1; Metayer C, 2013, CANCER EPIDEMIOL, V37, P336, DOI 10.1016/j.canep.2012.12.011; Miligi L, 2013, OCCUP ENVIRON MED, V70, P648, DOI 10.1136/oemed-2012-100951; Milne E, 2012, AM J EPIDEMIOL, V175, P43, DOI 10.1093/aje/kwr275; Post A, 2008, PAEDIATR PERINAT EP, V22, P155, DOI 10.1111/j.1365-3016.2007.00917.x; Pui CH, 2006, CHILDHOOD LEUKEMIAS, 2ND EDITION, P1, DOI 10.1017/CBO9780511471001; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Sasco AJ, 1999, HUM EXP TOXICOL, V18, P192, DOI 10.1191/096032799678839905; Schnatter AR, 2005, CHEM-BIOL INTERACT, V153, P9, DOI 10.1016/j.cbi.2005.03.039; Tchernis R, 2005, STAT MED, V24, P2197, DOI 10.1002/sim.2095; TREDANIEL J, 1994, PAEDIATR PERINAT EP, V8, P233, DOI 10.1111/j.1365-3016.1994.tb00455.x; WHO-IARC, 2009, IARC MON EV CARC R E, V100	29	15	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e111028	10.1371/journal.pone.0111028	http://dx.doi.org/10.1371/journal.pone.0111028			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401754	Green Published, Green Submitted, gold			2022-12-27	WOS:000345158700011
J	Pitts, TM; Newton, TP; Bradshaw-Pierce, EL; Addison, R; Arcaroli, JJ; Klauck, PJ; Bagby, SM; Hyatt, SL; Purkey, A; Tentler, JJ; Tan, AC; Messersmith, WA; Eckhardt, SG; Leong, S				Pitts, Todd M.; Newton, Timothy P.; Bradshaw-Pierce, Erica L.; Addison, Rebecca; Arcaroli, John J.; Klauck, Peter J.; Bagby, Stacey M.; Hyatt, Stephanie L.; Purkey, Alicia; Tentler, John J.; Tan, Aik Choon; Messersmith, Wells A.; Eckhardt, S. Gail; Leong, Stephen			Dual Pharmacological Targeting of the MAP Kinase and PI3K/mTOR Pathway in Preclinical Models of Colorectal Cancer	PLOS ONE			English	Article							PREVIOUSLY TREATED PATIENTS; ORAL MEK INHIBITOR; SMALL-CELL LUNG; BREAST-CANCER; PHASE-I; TUBEROUS SCLEROSIS; ANTITUMOR-ACTIVITY; SIGNALING PATHWAY; CARCINOMA-CELLS; COLON-CANCER	Background: The activation of the MAPK and PI3K/AKT/mTOR pathways is implicated in the majority of cancers. Activating mutations in both of these pathways has been described in colorectal cancer (CRC), thus indicating their potential as therapeutic targets. This study evaluated the combination of a PI3K/mTOR inhibitor (PF-04691502/PF-502) in combination with a MEK inhibitor (PD-0325901/PD-901) in CRC cell lines and patient-derived CRC tumor xenograft models (PDTX). Materials and Methods: The anti-proliferative effects of PF-502 and PD-901 were assessed as single agents and in combination against a panel of CRC cell lines with various molecular backgrounds. Synergy was evaluated using the Bliss Additivity method. In selected cell lines, we investigated the combination effects on downstream effectors by immunoblotting. The combination was then evaluated in several fully genetically annotated CRC PDTX models. Results: The in vitro experiments demonstrated a wide range of IC50 values for both agents against a cell line panel. The combination of PF-502 and PD-901 demonstrated synergistic anti-proliferative activity with Bliss values in the additive range. As expected, p-AKT and p-ERK were downregulated by PF-502 and PD-901, respectively. In PDTX models, following a 30-day exposure to PF-502, PD-901 or the combination, the combination demonstrated enhanced reduction in tumor growth as compared to either single agent regardless of KRAS or PI3K mutational status. Conclusions: The combination of a PI3K/mTOR and a MEK inhibitor demonstrated enhanced anti-proliferative effects against CRC cell lines and PDTX models.	[Pitts, Todd M.; Newton, Timothy P.; Addison, Rebecca; Arcaroli, John J.; Klauck, Peter J.; Bagby, Stacey M.; Hyatt, Stephanie L.; Purkey, Alicia; Tentler, John J.; Tan, Aik Choon; Messersmith, Wells A.; Eckhardt, S. Gail; Leong, Stephen] Univ Colorado, Sch Med, Div Med Oncol, Aurora, CO 80045 USA; [Bradshaw-Pierce, Erica L.] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO USA; [Pitts, Todd M.; Bradshaw-Pierce, Erica L.; Arcaroli, John J.; Tentler, John J.; Tan, Aik Choon; Messersmith, Wells A.; Eckhardt, S. Gail; Leong, Stephen] Univ Colorado, Ctr Canc, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Pitts, TM (corresponding author), Univ Colorado, Sch Med, Div Med Oncol, Anschutz Med Campus, Aurora, CO 80045 USA.	Todd.Pitts@ucdenver.edu	Tan, Aik Choon/A-3135-2011	Tan, Aik Choon/0000-0003-2955-8369; Purkey, Alicia/0000-0002-1865-1421	Pfizer Inc; University of Colorado Cancer Center [P30 CA046934]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER	Pfizer Inc(Pfizer); University of Colorado Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Pfizer Inc and University of Colorado Cancer Center Grant P30 CA046934. The funders had a minor role in study design and decision to publish. The funders had no role in data collection and analysis, or preparation of the manuscript.	Ballif BA, 2005, P NATL ACAD SCI USA, V102, P667, DOI 10.1073/pnas.0409143102; Bennouna J, 2011, INVEST NEW DRUG, V29, P1021, DOI 10.1007/s10637-010-9392-8; Boasberg PD, 2011, CANCER CHEMOTH PHARM, V68, P547, DOI 10.1007/s00280-011-1620-1; Britten C WZ, 2012, MULTIARM PHASE 1 DOS; Britten CD, 2014, INVEST NEW DRUG, V32, P510, DOI 10.1007/s10637-013-0062-5; Buck E, 2006, MOL CANCER THER, V5, P2676, DOI 10.1158/1535-7163.MCT-06-0166; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Cheng HM, 2013, BIOORG MED CHEM LETT, V23, P2787, DOI 10.1016/j.bmcl.2013.02.020; Corcoran RB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005753; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Dienstmann R, 2012, MOL CANCER THER, V11, P2062, DOI 10.1158/1535-7163.MCT-12-0290; Fasolo A, 2011, EXPERT OPIN INV DRUG, V20, P381, DOI 10.1517/13543784.2011.541154; Haura EB, 2010, CLIN CANCER RES, V16, P2450, DOI 10.1158/1078-0432.CCR-09-1920; Henderson YC, 2010, MOL CANCER THER, V9, P1968, DOI 10.1158/1535-7163.MCT-10-0062; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Johansson CH, 2014, PHARMACOL THERAPEUT, V142, P176, DOI 10.1016/j.pharmthera.2013.11.011; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; LoRusso P, 2012, J CLIN ONCOL, V2566; LoRusso PM, 2010, CLIN CANCER RES, V16, P1924, DOI 10.1158/1078-0432.CCR-09-1883; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Mao ML, 2013, CLIN CANCER RES, V19, P657, DOI 10.1158/1078-0432.CCR-11-1446; Migliardi G, 2012, CLIN CANCER RES, V18, P2515, DOI 10.1158/1078-0432.CCR-11-2683; MORIKAWA K, 1988, CANCER RES, V48, P6863; Mueller H, 2000, INT J CANCER, V89, P384, DOI 10.1002/1097-0215(20000720)89:4<384::AID-IJC11>3.0.CO;2-R; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nandan MO, 2011, CURR COLORECT CANC R, V7, P113, DOI 10.1007/s11888-011-0086-1; Nosho K, 2008, NEOPLASIA, V10, P534, DOI 10.1593/neo.08336; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pitts TM, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00035; Pitts TM, 2010, CLIN CANCER RES, V16, P3193, DOI 10.1158/1078-0432.CCR-09-3191; Rinehart J, 2004, J CLIN ONCOL, V22, P4456, DOI 10.1200/JCO.2004.01.185; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roper J, 2014, CANC LETT; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Sheppard KE, 2013, EUR J CANCER, V49, P3936, DOI 10.1016/j.ejca.2013.08.007; Suk Heist R, 2013, J CLIN ONCOL, V2530; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Towers M, 1967, S Afr Med J, V41, P181; Valentino JD, 2014, CLIN CANCER RES, V20, P1212, DOI 10.1158/1078-0432.CCR-13-1897; Yu M, 2012, THER ADV GASTROENTER, V5, P319, DOI 10.1177/1756283X12448456; Yuan J, 2011, MOL CANCER THER, V10, P2189, DOI 10.1158/1535-7163.MCT-11-0185; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244; Zhou HY, 2012, CHIN J CANCER, V31, P8, DOI 10.5732/cjc.011.10281; Zitzmann K, 2010, CANCER LETT, V295, P100, DOI 10.1016/j.canlet.2010.02.018	51	36	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113037	10.1371/journal.pone.0113037	http://dx.doi.org/10.1371/journal.pone.0113037			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401499	Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700098
J	Robertson, ED; Wasylyk, C; Ye, T; Jung, AC; Wasylyk, B				Robertson, E. Douglas; Wasylyk, Christine; Ye, Tao; Jung, Alain C.; Wasylyk, Bohdan			The Oncogenic MicroRNA Hsa-miR-155-5p Targets the Transcription Factor ELK3 and Links It to the Hypoxia Response	PLOS ONE			English	Article							COMPLEX FACTOR NET; GENE-EXPRESSION; UP-REGULATION; CLIP-SEQ; MIR-155; CANCER; INHIBITION; PROLIFERATION; MIGRATION; STARBASE	The molecular response to hypoxia is a critical cellular process implicated in cancer, and a target for drug development. The activity of the major player, HIF1 alpha, is regulated at different levels by various factors, including the transcription factor ELK3. The molecular mechanisms of this intimate connection remain largely unknown. Whilst investigating global ELK3-chromatin interactions, we uncovered an unexpected connection that involves the microRNA hsa-miR-155-5p, a hypoxia-inducible oncomir that targets HIF1 alpha. One of the ELK3 chromatin binding sites, detected by Chromatin Immuno-Precipitation Sequencing (ChIP-seq) of normal Human Umbilical Vein Endothelial Cells (HUVEC), is located at the transcription start site of the MIR155HG genes that expresses hsa-miR-155-5p. We confirmed that ELK3 binds to this promoter by ChIP and quantitative polymerase chain reaction (QPCR). We showed that ELK3 and hsa-miR-155-5p form a double-negative regulatory loop, in that ELK3 depletion induced hsa-miR-155-5p expression and hsa-miR-155-5p expression decreased ELK3 expression at the RNA level through a conserved target sequence in its 3'-UTR. We further showed that the activities of hsa-miR-155-5p and ELK3 are functionally linked. Pathway analysis indicates that both factors are implicated in related processes, including cancer and angiogenesis. Hsa-miR-155-5p expression and ELK3 depletion have similar effects on expression of known ELK3 target genes, and on in-vitro angiogenesis and wound closure. Bioinformatic analysis of cancer RNA-seq data shows that hsa-miR-155-5p and ELK3 expression are significantly anti-correlated, as would be expected from hsa-miR-155-5p targeting ELK3 RNA. Finally, hypoxia (0% oxygen) down-regulates ELK3 mRNA in a microRNA and hsa-miR-155-5p dependent manner. These results tie ELK3 into the hypoxia response pathway through an oncogenic microRNA and into a circuit implicated in the dynamics of the hypoxic response. This crosstalk could be important for the development of new treatments for a range of pathologies.	[Robertson, E. Douglas; Wasylyk, Christine; Ye, Tao; Wasylyk, Bohdan] Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; [Robertson, E. Douglas; Wasylyk, Christine; Ye, Tao; Wasylyk, Bohdan] CNRS, UMR7104, Illkirch Graffenstaden, France; [Robertson, E. Douglas; Wasylyk, Christine; Ye, Tao; Wasylyk, Bohdan] INSERM, U964, Illkirch Graffenstaden, France; [Robertson, E. Douglas; Wasylyk, Christine; Ye, Tao; Wasylyk, Bohdan] Univ Strasbourg, Illkirch Graffenstaden, France; [Jung, Alain C.] Univ Strasbourg, Ctr Reg Lutte Canc Paul Strauss, Lab Biol Tumorale, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UNICANCER; Centre Paul Strauss	Wasylyk, B (corresponding author), Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France.	boh@igbmc.fr	Jung, Alain/X-5384-2019; Jung, Alain/AAC-6598-2019; Wasylyk, Bohdan/ABG-6778-2020	Jung, Alain/0000-0002-4049-4151; Wasylyk, Bohdan/0000-0002-1718-1237	Institut National du Cancer (INCa; HypoNet) [PLBIO2010]; Association pour la Recherche sur le Cancer; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); Universite de Strasbourg (UdS); Conference de Coordination Interregionale du Grand Est (CCIR-GE) de la Ligue Contre le Cancer	Institut National du Cancer (INCa; HypoNet)(Institut National du Cancer (INCA) France); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite de Strasbourg (UdS); Conference de Coordination Interregionale du Grand Est (CCIR-GE) de la Ligue Contre le Cancer(General Electric)	The authors are thankful for financial support from the Institut National du Cancer (INCa; HypoNet, PLBIO2010), the Association pour la Recherche sur le Cancer, the Centre National de la Recherche Scientifique (CNRS), the Institut National de la Sante et de la Recherche Medicale (INSERM), the Universite de Strasbourg (UdS) and the Conference de Coordination Interregionale du Grand Est (CCIR-GE) de la Ligue Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayadi A, 2001, EMBO J, V20, P5139, DOI 10.1093/emboj/20.18.5139; Babar IA, 2011, CANCER BIOL THER, V12, P908, DOI 10.4161/cbt.12.10.17681; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bruning U, 2011, MOL CELL BIOL, V31, P4087, DOI 10.1128/MCB.01276-10; Buchwalter G, 2005, MOL CELL BIOL, V25, P10853, DOI 10.1128/MCB.25.24.10853-10862.2005; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Chan SY, 2010, CELL CYCLE, V9, P1072, DOI 10.4161/cc.9.6.11006; Chen ZL, 2014, J CELL PHYSIOL, V229, P545, DOI 10.1002/jcp.24492; Criqui-Filipe P, 1999, EMBO J, V18, P3392, DOI 10.1093/emboj/18.12.3392; Czyzyk-Krzeska MF, 2014, ONCOGENE, V33, P677, DOI 10.1038/onc.2013.26; Dai Y, 2012, PLACENTA, V33, P824, DOI 10.1016/j.placenta.2012.07.012; Elton TS, 2013, GENE, V532, P1, DOI 10.1016/j.gene.2012.12.009; Esnault C, 2014, GENE DEV, V28, P943, DOI 10.1101/gad.239327.114; Fasanaro P, 2009, J BIOL CHEM, V284, P35134, DOI 10.1074/jbc.M109.052779; Ferrajoli A, 2013, BLOOD, V122, P1891, DOI 10.1182/blood-2013-01-478222; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Fontijn RD, 2008, AM J PHYSIOL-HEART C, V294, pH891, DOI 10.1152/ajpheart.01248.2007; GIOVANE A, 1994, GENE DEV, V8, P1502, DOI 10.1101/gad.8.13.1502; Goda N, 2012, INT J HEMATOL, V95, P457, DOI 10.1007/s12185-012-1069-y; Goke J, 2013, MOL CELL, V50, P844, DOI 10.1016/j.molcel.2013.04.030; Gross C, 2008, ONCOGENE, V27, P1333, DOI 10.1038/sj.onc.1210736; Gross C, 2007, MOL CELL BIOL, V27, P4133, DOI 10.1128/MCB.01867-06; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; Higgs Gadareth, 2013, J Clin Bioinforma, V3, P17, DOI 10.1186/2043-9113-3-17; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kong W, 2014, ONCOGENE, V33, P679, DOI 10.1038/onc.2012.636; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Liao WL, 2014, BIOMARKERS GENOMIC M; Liu SH, 2011, BIOCHEM BIOPH RES CO, V414, P618, DOI 10.1016/j.bbrc.2011.09.131; Maira SM, 1996, EMBO J, V15, P5849, DOI 10.1002/j.1460-2075.1996.tb00972.x; Mucaj V, 2012, INT J HEMATOL, V95, P464, DOI 10.1007/s12185-012-1070-5; O'Geen H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-689; Oda Y, 2012, TOXICOL APPL PHARM, V260, P222, DOI 10.1016/j.taap.2012.02.012; Odrowaz Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002694; Peng H, 2012, FASEB J, V26, P3140, DOI 10.1096/fj.11-198515; Serchov T, 2010, J BIOL CHEM, V285, P21223, DOI 10.1074/jbc.M110.121723; Shen GM, 2013, ACTA PHARMACOL SIN, V34, P336, DOI 10.1038/aps.2012.195; Tsuchiya S, 2011, J BIOL CHEM, V286, P420, DOI 10.1074/jbc.M110.170852; van Beijnum JR, 2008, EXP CELL RES, V314, P264, DOI 10.1016/j.yexcr.2007.08.013; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; WILLIAMS RL, 1988, CELL, V52, P121; Wozniak MA, 2012, CURR BIOL, V22, P2017, DOI 10.1016/j.cub.2012.08.050; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Zheng H, 2003, GENE DEV, V17, P2283, DOI 10.1101/gad.272503	47	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113050	10.1371/journal.pone.0113050	http://dx.doi.org/10.1371/journal.pone.0113050			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401928	Green Published, Green Submitted, gold			2022-12-27	WOS:000345158700102
J	Xi, T; Schreurs, R; Heerink, WJ; Berge, SJ; Maal, TJJ				Xi, Tong; Schreurs, Ruud; Heerink, Wout J.; Berge, Stefaan J.; Maal, Thomas J. J.			A Novel Region-Growing Based Semi-Automatic Segmentation Protocol for Three-Dimensional Condylar Reconstruction Using Cone Beam Computed Tomography (CBCT)	PLOS ONE			English	Article							RESORPTION; ACCURACY; OSTEOTOMIES; ADVANCEMENT	Objective: To present and validate a semi-automatic segmentation protocol to enable an accurate 3D reconstruction of the mandibular condyles using cone beam computed tomography (CBCT). Materials and Methods: Approval from the regional medical ethics review board was obtained for this study. Bilateral mandibular condyles in ten CBCT datasets of patients were segmented using the currently proposed semi-automatic segmentation protocol. This segmentation protocol combined 3D region-growing and local thresholding algorithms. The segmentation of a total of twenty condyles was performed by two observers. The Dice-coefficient and distance map calculations were used to evaluate the accuracy and reproducibility of the segmented and 3D rendered condyles. Results: The mean inter-observer Dice-coefficient was 0.98 (range [0.95-0.99]). An average 90th percentile distance of 0.32 mm was found, indicating an excellent inter-observer similarity of the segmented and 3D rendered condyles. No systematic errors were observed in the currently proposed segmentation protocol. Conclusion: The novel semi-automated segmentation protocol is an accurate and reproducible tool to segment and render condyles in 3D. The implementation of this protocol in the clinical practice allows the CBCT to be used as an imaging modality for the quantitative analysis of condylar morphology.	[Xi, Tong; Schreurs, Ruud; Berge, Stefaan J.; Maal, Thomas J. J.] Radboud Univ Nijmegen, Med Ctr, Dept Oral & Maxillofacial Surg, NL-6525 ED Nijmegen, Netherlands; [Heerink, Wout J.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands	Radboud University Nijmegen; University of Groningen	Xi, T (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Oral & Maxillofacial Surg, NL-6525 ED Nijmegen, Netherlands.	Tong.Xi@radboudumc.nl	Maal, Thomas JJ/L-4497-2015; Berge, Stefaan/AAP-3708-2020; Xi, Tong/P-6268-2015; Bergé, S.J./H-8011-2014; Schreurs, Ruud/P-6769-2015	Maal, Thomas JJ/0000-0002-1702-4733; Xi, Tong/0000-0002-9142-9253; Schreurs, Ruud/0000-0003-2429-2071; Heerink, Wouter/0000-0002-5629-1359	Netherlands Organization for Scientific Research [017.005.006]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This study was supported by a Mozaiek grant (project number 017.005.006) from the Netherlands Organization for Scientific Research, granted to TX. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Jiwanasha Manish, 2013, J Contemp Dent Pract, V14, P153; Borstlap WA, 2004, INT J ORAL MAX SURG, V33, P649, DOI 10.1016/j.ijom.2004.01.018; De Vos W, 2009, INT J ORAL MAX SURG, V38, P609, DOI 10.1016/j.ijom.2009.02.028; Engelbrecht WP, 2013, CLIN ORAL INVESTIGAT; Fourie Z, 2012, EUR J RADIOL, V81, pE524, DOI 10.1016/j.ejrad.2011.06.001; Honey OB, 2007, AM J ORTHOD DENTOFAC, V132, P429, DOI 10.1016/j.ajodo.2005.10.032; Hoppenreijs TJM, 1998, INT J ORAL MAX SURG, V27, P81, DOI 10.1016/S0901-5027(98)80301-9; Katsumata A, 2007, ORAL SURG ORAL MED O, V104, P829, DOI 10.1016/j.tripleo.2006.12.005; Kobayashi T, 2012, BRIT J ORAL MAX SURG, V50, P176, DOI 10.1016/j.bjoms.2011.02.006; Ludlow JB, 2007, ORAL SURG ORAL MED O, V103, P534, DOI 10.1016/j.tripleo.2006.04.008; Paniagua B, 2011, COMPUT MED IMAG GRAP, V35, P345, DOI 10.1016/j.compmedimag.2010.11.012; Paniagua B, 2011, INT J COMPUT ASS RAD, V6, P617, DOI 10.1007/s11548-010-0539-z; Park SB, 2011, J ORAL MAXILLOFACIAL; Scarfe William C, 2008, Dent Clin North Am, V52, P707, DOI 10.1016/j.cden.2008.05.005; Schlueter B, 2008, ANGLE ORTHOD, V78, P880, DOI 10.2319/072007-339.1; Shafi MI, 2013, INT J ORAL MAXILLOFA; Xi T, 2013, INT J ORAL MAX SURG, V42, P1023, DOI 10.1016/j.ijom.2013.01.016; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	18	42	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e111126	10.1371/journal.pone.0111126	http://dx.doi.org/10.1371/journal.pone.0111126			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401954	Green Published, Green Submitted, gold			2022-12-27	WOS:000345158700013
J	Ishikawa, A; Okuno, S				Ishikawa, Akira; Okuno, Sin-ichiro			Fine Mapping and Candidate Gene Search of Quantitative Trait Loci for Growth and Obesity Using Mouse Intersubspecific Subcongenic Intercrosses and Exome Sequencing	PLOS ONE			English	Article							POSTNATAL-GROWTH; BODY-WEIGHT; FAT; RECEPTOR; REVEALS; QTL; INFLAMMATION; EXPRESSION; PHENOTYPES; VARIANTS	Although growth and body composition traits are quantitative traits of medical and agricultural importance, the genetic and molecular basis of those traits remains elusive. Our previous genome-wide quantitative trait locus (QTL) analyses in an intersubspecific backcross population between C57BL/6JJcl (B6) and wild Mus musculus castaneus mice revealed a major growth QTL (named Pbwg1) on a proximal region of mouse chromosome 2. Using the B6. Cg-Pbwg1 intersubspecific congenic strain created, we revealed 12 closely linked QTLs for body weight and body composition traits on an approximately 44.1-Mb wild-derived congenic region. In this study, we narrowed down genomic regions harboring three (Pbwg1.12, Pbwg1.3 and Pbwg1.5) of the 12 linked QTLs and searched for possible candidate genes for the QTLs. By phenotypic analyses of F-2 intercross populations between B6 and each of four B6. Cg-Pbwg1 subcongenic strains with overlapping and non-overlapping introgressed regions, we physically defined Pbwg1.12 affecting body weight to a 3.8-Mb interval (61.5-65.3 Mb) on chromosome 2. We fine-mapped Pbwg1.3 for body length to an 8.0-Mb interval (57.3-65.3) and Pbwg1.5 for abdominal white fat weight to a 2.1-Mb interval (59.4-61.5). The wild-derived allele at Pbwg1.12 and Pbwg1.3 uniquely increased body weight and length despite the fact that the wild mouse has a smaller body size than that of B6, whereas it decreased fat weight at Pbwg1.5. Exome sequencing and candidate gene prioritization suggested that Gcg and Grb14 are putative candidate genes for Pbwg1.12 and that Ly75 and Itgb6 are putative candidate genes for Pbwg1.5. These genes had nonsynonymous SNPs, but the SNPs were predicted to be not harmful to protein functions. These results provide information helpful to identify wild-derived quantitative trait genes causing enhanced growth and resistance to obesity.	[Ishikawa, Akira; Okuno, Sin-ichiro] Nagoya Univ, Grad Sch Bioagr Sci, Lab Anim Genet, Nagoya, Aichi 4648601, Japan	Nagoya University	Ishikawa, A (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Lab Anim Genet, Nagoya, Aichi 4648601, Japan.	ishikawa@agr.nagoya-u.ac.jp	Ishikawa, Akira/I-6856-2014	Ishikawa, Akira/0000-0002-8275-4230	Japan Society for the Promotion of Science to A Ishikawa	Japan Society for the Promotion of Science to A Ishikawa(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science to A Ishikawa. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Baeza E, 2013, ANIMAL, V7, P965, DOI 10.1017/S1751731113000153; Cariou B, 2004, FRONT BIOSCI-LANDMRK, V9, P1626, DOI 10.2741/1228; Caspar-Bauguil S, 2005, FEBS LETT, V579, P3487, DOI 10.1016/j.febslet.2005.05.031; Cheverud JM, 2008, P NATL ACAD SCI USA, V105, P4253, DOI 10.1073/pnas.0706562105; Cooney GJ, 2004, EMBO J, V23, P582, DOI 10.1038/sj.emboj.7600082; Darvasi A, 1997, MAMM GENOME, V8, P163, DOI 10.1007/s003359900382; Darvasi A, 1997, BEHAV GENET, V27, P125, DOI 10.1023/A:1025685324830; Drinkwater NR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002975; Eisen EJ, 2005, MOUSE IN ANIMAL GENETICS AND BREEDING RESEARCH, P1, DOI 10.1142/9781860947162; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fall T, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001474; Farber CR, 2007, MAMM GENOME, V18, P635, DOI 10.1007/s00335-007-9046-0; Flint J, 2009, GENOME RES, V19, P723, DOI 10.1101/gr.086660.108; Guo M, 2000, HUM IMMUNOL, V61, P729, DOI 10.1016/S0198-8859(00)00144-0; Hayashi Y, 2011, DIABETES OBES METAB, V13, P151, DOI 10.1111/j.1463-1326.2011.01456.x; Hayashi Y, 2009, MOL ENDOCRINOL, V23, P1990, DOI 10.1210/me.2009-0296; Huang XZ, 1996, J CELL BIOL, V133, P921, DOI 10.1083/jcb.133.4.921; Ishikawa A, 2000, MAMM GENOME, V11, P824, DOI 10.1007/s003350010145; Ishikawa A, 2005, GENET RES, V85, P127, DOI 10.1017/S001667230500738X; Ishikawa A, 2004, GENES GENET SYST, V79, P27, DOI 10.1266/ggs.79.27; Ishikawa A, 2007, MAMM GENOME, V18, P229, DOI 10.1007/s00335-007-9009-5; Ishikawa A, 2009, J HERED, V100, P501, DOI 10.1093/jhered/esp004; Jarvis JP, 2005, J LIPID RES, V46, P1692, DOI 10.1194/jlr.M500073-JLR200; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Kasowski M, 2013, SCIENCE, V342, P750, DOI 10.1126/science.1242510; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kilpinen H, 2013, SCIENCE, V342, P744, DOI 10.1126/science.1242463; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Mighiu PI, 2013, NAT MED, V19, P766, DOI 10.1038/nm.3115; Mollah MBR, 2011, MAMM GENOME, V22, P282, DOI 10.1007/s00335-011-9323-9; Mollah MBR, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-84; Mollah MBR, 2013, ANIM SCI J, V84, P296, DOI 10.1111/asj.12004; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Partridge CG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-99; Radonjic M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006646; Robins Diane M, 2005, Novartis Found Symp, V268, P42; Tranchevent LC, 2008, NUCLEIC ACIDS RES, V36, pW377, DOI 10.1093/nar/gkn325; Wang B, 2007, HEPATOLOGY, V46, P1404, DOI 10.1002/hep.21849; Yalcin B, 2011, NATURE, V477, P326, DOI 10.1038/nature10432; Yogosawa S, 2013, DIABETES, V62, P115, DOI 10.2337/db12-0295	44	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113233	10.1371/journal.pone.0113233	http://dx.doi.org/10.1371/journal.pone.0113233			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398139	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558500143
J	Lin, YH; Deng, KH; Sun, YX; Zeng, DZ; Liu, WY; Kong, XW; Singh, A				Lin, Yuanhua; Deng, Kuanhai; Sun, Yongxing; Zeng, Dezhi; Liu, Wanying; Kong, Xiangwei; Singh, Ambrish			Burst Strength of Tubing and Casing Based on Twin Shear Unified Strength Theory	PLOS ONE			English	Article							PREDICTION; PRESSURE	The internal pressure strength of tubing and casing often cannot satisfy the design requirements in high pressure, high temperature and high H2S gas wells. Also, the practical safety coefficient of some wells is lower than the design standard according to the current API 5C3 standard, which brings some perplexity to the design. The ISO 10400: 2007 provides the model which can calculate the burst strength of tubing and casing better than API 5C3 standard, but the calculation accuracy is not desirable because about 50 percent predictive values are remarkably higher than real burst values. So, for the sake of improving strength design of tubing and casing, this paper deduces the plastic limit pressure of tubing and casing under internal pressure by applying the twin shear unified strength theory. According to the research of the influence rule of yield-to-tensile strength ratio and mechanical properties on the burst strength of tubing and casing, the more precise calculation model of tubing-casing's burst strength has been established with material hardening and intermediate principal stress. Numerical and experimental comparisons show that the new burst strength model is much closer to the real burst values than that of other models. The research results provide an important reference to optimize the tubing and casing design of deep and ultra-deep wells.	[Lin, Yuanhua; Deng, Kuanhai] Southwest Petr Univ, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu 610500, Sichuan, Peoples R China; [Sun, Yongxing; Zeng, Dezhi; Kong, Xiangwei; Singh, Ambrish] Southwest Petr Univ, CNPC Key Lab Tubular Goods Engn, Chengdu 610500, Sichuan, Peoples R China; [Liu, Wanying] Sichuan Univ, Sch Mat Sci & Engn, Chengdu 610000, Sichuan, Peoples R China	Southwest Petroleum University; Southwest Petroleum University; Sichuan University	Lin, YH (corresponding author), Southwest Petr Univ, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu 610500, Sichuan, Peoples R China.	yhlin28@163.com		Singh, Ambrish/0000-0002-9652-7717	National Natural Science Foundation of China [51274170]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 51274170) to LYH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen JA, 2007, J PETROL SCI ENG, V56, P232, DOI 10.1016/j.petrol.2006.09.005; American National Standards Institute, 1984, MAN DET REM STRENGHT; Committee on Standardization of Tubular Goods, 1994, B FORM CALC CAS TUB; [冯剑军 Feng Jianjun], 2004, [固体力学学报, Acta Mechanica Solida Sinica], V25, P208; Gao DL, 2004, J PETROL SCI ENG, V41, P183, DOI 10.1016/S0920-4105(03)00152-9; Hasan S, 2012, INT J PRES VES PIP, V89, P48, DOI 10.1016/j.ijpvp.2011.09.005; ISO Technical Committees, 2007, PETR NAT GAS IND FOR; Jianan W, 1980, METALLOGRAPHY HEAT T; Kamaya M, 2008, INT J PRES VES PIP, V85, P628, DOI 10.1016/j.ijpvp.2007.11.005; Kiefner JF., 1989, PR3805 BATT MEM I; Klever FJ, 1992, 7029 SPE; Law M, 2007, INT J PRES VES PIP, V84, P487, DOI 10.1016/j.ijpvp.2007.04.002; Lee YK, 1996, INT J PLASTICITY, V12, P1179, DOI 10.1016/S0749-6419(96)00047-2; Lin W, 2010, THESIS SW PETROLEUM; Mao-hong Y.U., 2004, UNIFIED STRENGTH THE; Maohong Y, 1997, CHINA CIVIL ENG J, V30, P182; Nadai A, 1931, PLASCITY; Paslay PR, 1998, 48327 SPE; STEWART G., 1998, 48329 SPE; Stewart G, 1998, 48330 SPE; Tallin AG, 1998, 48320 SPE; Wang LZ, 2011, INT J MECH SCI, V53, P348, DOI 10.1016/j.ijmecsci.2011.02.004; Xiankui Z, 2005, J PRESSURE VESSEL TE, V127, P436; Yongxing S, 2009, PETROLEUM DRILLING T, V37, P35; Yongxing S, 2008, THESIS SW PETROLEUM; Yuanhua L, 2013, J PRESSURE VESSEL TE, V135; Zhang SH, 2014, J CENT SOUTH UNIV, V21, P460, DOI 10.1007/s11771-014-1960-1; [赵均海 Zhao Junhai], 2013, [石油学报, Acta Petrolei Sinica], V34, P969; Zhilun X., 2006, ELASTICITY MECH	29	11	11	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e111426	10.1371/journal.pone.0111426	http://dx.doi.org/10.1371/journal.pone.0111426			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397886	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558500016
J	Lovrics, A; Gao, Y; Juhasz, B; Bock, I; Byrne, HM; Dinnyes, A; Kovacs, KA				Lovrics, Anna; Gao, Yu; Juhasz, Bianka; Bock, Istvan; Byrne, Helen M.; Dinnyes, Andras; Kovacs, Krisztian A.			Boolean Modelling Reveals New Regulatory Connections between Transcription Factors Orchestrating the Development of the Ventral Spinal Cord	PLOS ONE			English	Article							PROGENITOR-CELL IDENTITY; NEURONAL FATE; MOTOR-NEURON; ARABIDOPSIS-THALIANA; SUBTYPE IDENTITY; GENETIC-CONTROL; NKX2.2; DIFFERENTIATION; SPECIFICATION; DETERMINES	We have assembled a network of cell-fate determining transcription factors that play a key role in the specification of the ventral neuronal subtypes of the spinal cord on the basis of published transcriptional interactions. Asynchronous Boolean modelling of the network was used to compare simulation results with reported experimental observations. Such comparison highlighted the need to include additional regulatory connections in order to obtain the fixed point attractors of the model associated with the five known progenitor cell types located in the ventral spinal cord. The revised gene regulatory network reproduced previously observed cell state switches between progenitor cells observed in knock-out animal models or in experiments where the transcription factors were overexpressed. Furthermore the network predicted the inhibition of Irx3 by Nkx2.2 and this prediction was tested experimentally. Our results provide evidence for the existence of an as yet undescribed inhibitory connection which could potentially have significance beyond the ventral spinal cord. The work presented in this paper demonstrates the strength of Boolean modelling for identifying gene regulatory networks.	[Lovrics, Anna; Gao, Yu; Juhasz, Bianka; Bock, Istvan; Dinnyes, Andras; Kovacs, Krisztian A.] Biotalentum Ltd, Godollo, Hungary; [Bock, Istvan; Dinnyes, Andras] Szent Istvan Univ, Mol Anim Biotechnol Lab, Godollo, Hungary; [Byrne, Helen M.] Univ Oxford, Oxford Ctr Collaborat Appl Math, Math Inst, Oxford, England; [Dinnyes, Andras] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands; [Kovacs, Krisztian A.] IST Austria, Klosterneuburg, Austria	BioTalentum Ltd; Hungarian University of Agriculture & Life Sciences; University of Oxford; Utrecht University; Institute of Science & Technology - Austria	Lovrics, A (corresponding author), Hungarian Acad Sci, Inst Enzymol, Budapest, Hungary.	anna.lovrics@gmail.com	; Dinnyes, Andras/D-5131-2013	Gao, Yu/0000-0001-5090-8250; Byrne, Helen/0000-0003-1771-5910; Dinnyes, Andras/0000-0003-3791-2583; Bock, Istvan/0000-0001-9178-4506; Kovacs, Krisztian/0000-0001-6251-1007	IDPbyNMR; PluriSys; InduStem; RESOLVE; EpiHealth; Stem-Cam; EC Seventh Framework Programme [PITN-GA-2010-264257, HEALTH-F4-2009-223485, PIAP-GA-2008-230675, FP7-HEALTH-F4-2008-202047, HEALTH-2012-F2-278418, PIAP-GA-2009-251186, PIAPP-GA-2011-286264]; Research Centre of Excellence [8526-5/2014/TUDPOL]; King Abdullah University of Science and Technology (KAUST) [KUK-C1-013-04]; IST FELLOWSHIP under REA grant [P IST EU01, 291734]; Biotalentum Ltd	IDPbyNMR; PluriSys; InduStem; RESOLVE; EpiHealth; Stem-Cam; EC Seventh Framework Programme(European Commission); Research Centre of Excellence; King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology); IST FELLOWSHIP under REA grant; Biotalentum Ltd	This publication was based on work supported in part by IDPbyNMR, PluriSys, InduStem, RESOLVE, EpiHealth, Stem-Cam, ANISTEM (grant agreement numbers PITN-GA-2010-264257, HEALTH-F4-2009-223485, PIAP-GA-2008-230675, FP7-HEALTH-F4-2008-202047, HEALTH-2012-F2-278418, PIAP-GA-2009-251186, PIAPP-GA-2011-286264) projects funded by the EC Seventh Framework Programme, Research Centre of Excellence, 8526-5/2014/TUDPOL, Award No. KUK-C1-013-04, made by King Abdullah University of Science and Technology (KAUST) and the IST FELLOWSHIP awarded to Krisztian A Kovacs (Project: P IST EU01 under REA grant agreement no 291734). Al, YG, BJ and KK were affiliated to Biotalentum Ltd. IB and AD are still affiliated to Biotalentum Ltd, and received salary from them to support this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Alvarez-Medina R, 2008, DEVELOPMENT, V135, P237, DOI 10.1242/dev.012054; Anderson KR, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-65; Balaskas N, 2012, CELL, V148, P273, DOI 10.1016/j.cell.2011.10.047; Boykin ER, 2010, MOL BIOSYST, V6, P1993, DOI 10.1039/c0mb00006j; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Chaves M, 2005, J THEOR BIOL, V235, P431, DOI 10.1016/j.jtbi.2005.01.023; Cheng XR, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0574; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; Cohen M, 2013, CURR OPIN GENET DEV, V23, P423, DOI 10.1016/j.gde.2013.04.003; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Dessaud E, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000382; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Giacomantonio CE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000936; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Harvey I, 1997, FROM ANIM ANIMAT, P67; Hill JT, 2010, MOL ENDOCRINOL, V24, P381, DOI 10.1210/me.2009-0360; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kiecker C, 2004, NAT NEUROSCI, V7, P1242, DOI 10.1038/nn1338; Kiecker C, 2005, NAT REV NEUROSCI, V6, P553, DOI 10.1038/nrn1702; Kobayashi D, 2002, DEVELOPMENT, V129, P83; Kovacs KA, 2003, J BIOL CHEM, V278, P36959, DOI 10.1074/jbc.M303147200; Lai K, 2004, BIOPHYS J, V86, P2748, DOI 10.1016/S0006-3495(04)74328-3; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Li XJ, 2008, STEM CELLS, V26, P886, DOI 10.1634/stemcells.2007-0620; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Lupo G, 2006, NAT REV NEUROSCI, V7, P103, DOI 10.1038/nrn1843; Mendoza L, 1999, BIOINFORMATICS, V15, P593, DOI 10.1093/bioinformatics/15.7.593; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Nishi Y, 2009, BBA-GENE REGUL MECH, V1789, P299, DOI 10.1016/j.bbagrm.2009.01.002; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Oosterveen T, 2012, DEV CELL, V23, P1006, DOI 10.1016/j.devcel.2012.09.015; Panovska-Griffiths J, 2013, J R SOC INTERFACE, V10; Papizan JB, 2011, GENE DEV, V25, P2291, DOI 10.1101/gad.173039.111; Peter IS, 2012, P NATL ACAD SCI US; Ragvin A, 2010, P NATL ACAD SCI USA, V107, P775, DOI 10.1073/pnas.0911591107; Ribes V, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002014; Ribes V, 2010, GENE DEV, V24, P1186, DOI 10.1101/gad.559910; Saadatpour A, 2010, J THEOR BIOL, V266, P641, DOI 10.1016/j.jtbi.2010.07.022; Saha K, 2006, DEVELOPMENT, V133, P889, DOI 10.1242/dev.02254; Sanchez-Corrales YE, 2010, J THEOR BIOL, V264, P971, DOI 10.1016/j.jtbi.2010.03.006; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; THOMAS R, 1973, J THEOR BIOL, V42, P563, DOI 10.1016/0022-5193(73)90247-6; Todd KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031176; Tozer S, 2013, DEVELOPMENT, V140, P1467, DOI 10.1242/dev.090118; Ulloa F, 2010, DEV DYNAM, V239, P69, DOI 10.1002/dvdy.22058; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Wittmann DM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000569; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	55	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e111430	10.1371/journal.pone.0111430	http://dx.doi.org/10.1371/journal.pone.0111430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398016	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500017
J	Yamaoka, M; Maeda, N; Takayama, Y; Sekimoto, R; Tsushima, Y; Matsuda, K; Mori, T; Inoue, K; Nishizawa, H; Tominaga, M; Funahashi, T; Shimomura, I				Yamaoka, Masaya; Maeda, Norikazu; Takayama, Yasunori; Sekimoto, Ryohei; Tsushima, Yu; Matsuda, Keisuke; Mori, Takuya; Inoue, Kana; Nishizawa, Hitoshi; Tominaga, Makoto; Funahashi, Tohru; Shimomura, Iichiro			Adipose Hypothermia in Obesity and Its Association with Period Homolog 1, Insulin Sensitivity, and Inflammation in Fat	PLOS ONE			English	Article							CLOCK GENE-EXPRESSION; PROTEIN-KINASE-A; METABOLIC SYNDROME; CIRCADIAN CLOCK; FEEDBACK LOOP; MICE; TISSUE; THERMOGENESIS; CELLS; CALPROTECTIN	Visceral fat adiposity plays an important role in the development of metabolic syndrome. We reported previously the impact of human visceral fat adiposity on gene expression profile of peripheral blood cells. Genes related to circadian rhythm were highly associated with visceral fat area and period homolog 1 (PER1) showed the most significant negative correlation with visceral fat area. However, regulation of adipose Per1 remains poorly understood. The present study was designed to understand the regulation of Per1 in adipose tissues. Adipose Per1 mRNA levels of ob/ob mice were markedly low at 25 and 35 weeks of age. The levels of other core clock genes of white adipose tissues were also low in ob/ob mice at 25 and 35 weeks of age. Per1 mRNA was mainly expressed in the mature adipocyte fraction (MAF) and it was significantly low in MAF of ob/ob mice. To examine the possible mechanisms, 3T3-L1 adipocytes were treated with H2O2, tumor necrosis factor-alpha (TNF-alpha), S100A8, and lipopolysaccharide (LPS). However, no significant changes in Per1 mRNA level were observed by these agents. Exposure of cultured 3T3-L1 adipocytes to low temperature (33 degrees C) decreased Per1 and catalase, and increased monocyte chemoattractant protein-1 (Mcp-1) mRNA levels. Hypothermia also worsened insulin-mediated Akt phosphorylation in 3T3-L1 adipocytes. Finally, telemetric analysis showed low temperature of adipose tissues in ob/ob mice. In obesity, adipose hypothermia seems to accelerate adipocyte dysfunction.	[Yamaoka, Masaya; Maeda, Norikazu; Sekimoto, Ryohei; Tsushima, Yu; Matsuda, Keisuke; Mori, Takuya; Inoue, Kana; Nishizawa, Hitoshi; Funahashi, Tohru; Shimomura, Iichiro] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka 5650871, Japan; [Takayama, Yasunori; Tominaga, Makoto] Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Okazaki, Aichi 4448787, Japan; [Tominaga, Makoto] Grad Univ Adv Studies, Dept Physiol Sci, Okazaki, Aichi 4448585, Japan; [Funahashi, Tohru] Osaka Univ, Grad Sch Med, Dept Metab & Atherosclerosis, Suita, Osaka 5650871, Japan	Osaka University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan; Osaka University	Maeda, N (corresponding author), Osaka Univ, Grad Sch Med, Dept Metab Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	norikazu_maeda@endmet.med.osaka-u.ac.jp			Takeda Science Foundation; Japan Diabetes Foundation; Suzuken Memorial Foundation;  [22590979];  [24390238];  [22126008]	Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Diabetes Foundation; Suzuken Memorial Foundation; ; ; 	This work was supported in part by a Grants-in-Aid for Scientific Research (C) no. 22590979 (to NM), a Grants-in-Aid for Scientific Research (B) no. 24390238 (to IS), a Grants-in-Aid for Scientific Research on Innovative Areas no. 22126008 (to TF), Takeda Science Foundation (to NM), Japan Diabetes Foundation (to NM), and Suzuken Memorial Foundation (to NM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando H, 2011, ENDOCRINOLOGY, V152, P1347, DOI 10.1210/en.2010-1068; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Becerril S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010962; Burioka N, 2008, EUR RESPIR J, V32, P105, DOI 10.1183/09031936.00138207; Burioka N, 2005, CHRONOBIOL INT, V22, P585, DOI 10.1081/CBI-200062416; Canaple L, 2006, MOL ENDOCRINOL, V20, P1715, DOI 10.1210/me.2006-0052; Dallmann R, 2010, CHRONOBIOL INT, V27, P1317, DOI 10.3109/07420528.2010.489166; de Weerd L, 2011, CLIN PLAST SURG, V38, P277, DOI 10.1016/j.cps.2011.03.013; Du GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072044; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Funahashi T, 2007, ANN MED, V39, P482, DOI 10.1080/07853890701491026; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gilbert MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017051; Gimble JM, 2011, NAT REV ENDOCRINOL, V7, P98, DOI 10.1038/nrendo.2010.214; Gorbach AM, 2008, J SURG RES, V149, P310, DOI 10.1016/j.jss.2008.02.007; Hiuge-Shimizu A, 2011, ARTERIOSCL THROM VAS, V31, P792, DOI 10.1161/ATVBAHA.110.221747; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Huang W, 2012, J LIPID RES, V53, P368, DOI 10.1194/jlr.M019687; Husse J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052983; Inoue K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087661; Jurgens HS, 2006, PHYSIOL GENOMICS, V25, P234, DOI 10.1152/physiolgenomics.00252.2005; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Maeda N, 2004, P NATL ACAD SCI USA, V101, P17801, DOI 10.1073/pnas.0406230101; Matsuzawa Y, 2006, NAT CLIN PRACT CARD, V3, P35, DOI 10.1038/ncpcardio0380; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; Merla A, 2008, INT J IMMUNOPATH PH, V21, P679, DOI 10.1177/039463200802100322; Mori T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076199; Morioka N, 2010, J PHARMACOL SCI, V113, P234, DOI 10.1254/jphs.10031FP; Neels JG, 2006, J CLIN INVEST, V116, P33, DOI 10.1172/JCI27280; Ohno H, 2013, NATURE, V504, P163, DOI 10.1038/nature12652; Reddy TE, 2012, MOL CELL BIOL, V32, P3756, DOI 10.1128/MCB.00062-12; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ring Francis, 2010, J Diabetes Sci Technol, V4, P857; Sekimoto R, 2012, BIOCHEM BIOPH RES CO, V419, P782, DOI 10.1016/j.bbrc.2012.02.102; Sugimoto T, 2011, NEUROSCIENCE, V185, P1, DOI 10.1016/j.neuroscience.2011.04.024; Terazono H, 2003, P NATL ACAD SCI USA, V100, P6795, DOI 10.1073/pnas.0936797100; Wang NN, 2008, CELL METAB, V8, P482, DOI 10.1016/j.cmet.2008.10.009; Xi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036453; Yamaoka M, 2013, BIOCHEM BIOPH RES CO, V433, P450, DOI 10.1016/j.bbrc.2013.02.096; Yamaoka M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047377; Ye L, 2012, CELL, V151, P96, DOI 10.1016/j.cell.2012.08.034; Yoo HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096432; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	48	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112813	10.1371/journal.pone.0112813	http://dx.doi.org/10.1371/journal.pone.0112813			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397888	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500092
J	Chen, C; Sun, P; Dai, QS; Weng, HW; Li, HP; Ye, S				Chen, Cui; Sun, Peng; Dai, Qiang-sheng; Weng, Hui-wen; Li, He-ping; Ye, Sheng			The Glasgow Prognostic Score Predicts Poor Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma	PLOS ONE			English	Article							PLATELET-LYMPHOCYTE RATIO; IV COLORECTAL-CANCER; NEUTROPHIL-LYMPHOCYTE; SYSTEMIC INFLAMMATION; LUNG-CANCER; EPIDEMIOLOGY; CACHEXIA; THERAPY; EBV	Background: Several inflammation-based prognostic scoring systems, including Glasgow Prognostic Score (GPS), neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) have been reported to predict survival in many malignancies, whereas their role in metastatic nasopharyngeal carcinoma (NPC) remains unclear. The aim of this study is to evaluate the clinical value of these prognostic scoring systems in a cohort of cisplatin-based treated patients with metastatic NPC. Methods: Two hundred and eleven patients with histologically proven metastatic NPC treated with first-line cisplatin-based chemotherapy were retrospectively evaluated. Demographics, disease-related characteristics and relevant laboratory data before treatment were recorded. GPS, NLR and PLR were calculated as described previously. Response to first-line therapy and survival data were also collected. Survival was analyzed in Cox regressions and stability of the models was examined by bootstrap resampling. The area under the receiver operating characteristics curve (AUC) was calculated to compare the discriminatory ability of each scoring system. Results: Among the above three inflammation-based prognostic scoring systems, GPS (P<0.001) and NLR (P = 0.019) were independently associated with overall survival, which showed to be stable in a bootstrap resampling study. The GPS consistently showed a higher AUC value at 6-month (0.805), 12-month (0.705), and 24-month (0.705) in comparison with NLR and PLR. Further analysis of the association of GPS with progression-free survival showed GPS was also associated independently with progression-free survival (P<0.001). Conclusions: Our study demonstrated that the GPS may be of prognostic value in metastatic NPC patients treated with cisplatin-based palliative chemotherapy and facilitate individualized treatment. However a prospective study to validate this prognostic model is still needed.	[Chen, Cui; Dai, Qiang-sheng; Weng, Hui-wen; Li, He-ping; Ye, Sheng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Sun, Peng] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Sun, Peng] Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; State Key Lab Oncology South China	Ye, S (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Oncol, Guangzhou 510275, Guangdong, Peoples R China.	yes20111212@163.com						An X, 2011, CANCER-AM CANCER SOC, V117, P3750, DOI 10.1002/cncr.25932; An X, 2011, TUMOR BIOL, V32, P317, DOI 10.1007/s13277-010-0124-7; Bensouda Y, 2011, EUR ANN OTORHINOLARY, V128, P79, DOI 10.1016/j.anorl.2010.10.003; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Chiesa F, 2001, ORL J OTO-RHINO-LARY, V63, P214, DOI 10.1159/000055743; Donohoe CL, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/601434; Eliopoulos AG, 1997, ONCOGENE, V14, P2899, DOI 10.1038/sj.onc.1201258; Fearon KC, 2006, AM J CLIN NUTR, V83, P1345, DOI 10.1093/ajcn/83.6.1345; Feng JF, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-58; Fuchs CS, 2013, J CLIN ONCOL, V31, P4358, DOI 10.1200/JCO.2013.52.0080; Gioulbasanis I, 2012, LUNG CANCER, V77, P383, DOI 10.1016/j.lungcan.2012.04.008; Gridelli C, 2007, LANCET ONCOL, V8, P500, DOI 10.1016/S1470-2045(07)70146-8; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; He JR, 2012, HEAD NECK-J SCI SPEC, V34, P1769, DOI 10.1002/hed.22008; Ishizuka M, 2013, AM J SURG, V205, P22, DOI 10.1016/j.amjsurg.2012.04.012; Kinoshita A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-52; Kwon HC, 2012, BIOMARKERS, V17, P216, DOI 10.3109/1354750X.2012.656705; Laviano A, 2005, NAT CLIN PRACT ONCOL, V2, P158, DOI 10.1038/ncponc0112; Liaw CC, 1997, ACTA ONCOL, V36, P159, DOI 10.3109/02841869709109224; Liu MT, 2003, JPN J CLIN ONCOL, V33, P501, DOI 10.1093/jjco/hyg092; Maeda K, 2013, ANTICANCER RES, V33, P5567; McMillan DC, 2013, CANCER TREAT REV, V39, P534, DOI 10.1016/j.ctrv.2012.08.003; McMillan DC, 2009, CURR OPIN CLIN NUTR, V12, P223, DOI 10.1097/MCO.0b013e32832a7902; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; SENBA M, 1994, LANCET, V343, P1104, DOI 10.1016/S0140-6736(94)90217-8; Szumilo Justyna, 2009, Pol Merkur Lekarski, V27, P408; Twu CW, 2007, INT J RADIAT ONCOL, V67, P130, DOI 10.1016/j.ijrobp.2006.07.012; Vashist YK, 2011, ANN SURG ONCOL, V18, P1130, DOI 10.1245/s10434-010-1383-7; Wang DS, 2012, MED ONCOL, V29, P3092, DOI 10.1007/s12032-012-0226-8; Wang DS, 2012, TUMOR BIOL, V33, P749, DOI 10.1007/s13277-011-0285-z; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858	32	27	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112581	10.1371/journal.pone.0112581	http://dx.doi.org/10.1371/journal.pone.0112581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393117	Green Submitted, gold, Green Published			2022-12-27	WOS:000347709300074
J	Kumar, NP; Banurekha, VV; Nair, D; Sridhar, R; Kornfeld, H; Nutman, TB; Babu, S				Kumar, Nathella Pavan; Banurekha, Vaithilingam V.; Nair, Dina; Sridhar, Rathinam; Kornfeld, Hardy; Nutman, Thomas B.; Babu, Subash			Coincident Pre-Diabetes Is Associated with Dysregulated Cytokine Responses in Pulmonary Tuberculosis	PLOS ONE			English	Article							IMPAIRED FASTING GLUCOSE; TYPE-2; IMMUNITY; INNATE	Background: Cytokines play an important role in the pathogenesis of pulmonary tuberculosis (PTB) - Type 2 diabetes mellitus co-morbidity. However, the cytokine interactions that characterize PTB coincident with pre-diabetes (PDM) are not known. Methods: To identify the influence of coincident PDM on cytokine levels in PTB, we examined circulating levels of a panel of cytokines in the plasma of individuals with TB-PDM and compared them with those without PDM (TB-NDM). Results: TB-PDM is characterized by elevated circulating levels of Type 1 (IFN gamma, TNF alpha and IL-2), Type 17 (IL-17A and IL-17F) and other pro-inflammatory (IL-1 beta, IFN beta and GM-CSF) cytokines. TB-PDM is also characterized by increased systemic levels of Type 2 (IL-5) and regulatory (IL-10 and TGF beta) cytokines. Moreover, TB antigen stimulated whole blood also showed increased levels of pro-inflammatory (IFN gamma, TNF alpha and IL-1 beta) cytokines as well. However, the cytokines did not exhibit any significant correlation with HbA1C levels or with bacterial burdens. Conclusion: Our data reveal that pre-diabetes in PTB individuals is characterized by heightened cytokine responsiveness, indicating that a balanced pro and anti - inflammatory cytokine milieu is a feature of pre-diabetes -TB co-morbidity.	[Kumar, Nathella Pavan; Babu, Subash] Int Ctr Excellence Res, Natl Inst Hlth, Madras, Tamil Nadu, India; [Kumar, Nathella Pavan; Banurekha, Vaithilingam V.; Nair, Dina] Natl Inst Res TB, Madras, Tamil Nadu, India; [Sridhar, Rathinam] Govt Stanley Med Hosp, Madras, Tamil Nadu, India; [Kornfeld, Hardy] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA; [Nutman, Thomas B.; Babu, Subash] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Babu, S (corresponding author), Int Ctr Excellence Res, Natl Inst Hlth, Madras, Tamil Nadu, India.	sbabu@mail.nih.gov	Kornfeld, Hardy/AAS-2903-2021; Kumar, Nathella Pavan/AAU-2328-2021; Babu, Subash/GXG-4746-2022		Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001065] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abdul-Ghani MA, 2009, CURR DIABETES REP, V9, P193, DOI 10.1007/s11892-009-0032-7; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Cooper AM, 2011, MUCOSAL IMMUNOL, V4, P252, DOI 10.1038/mi.2011.13; Deepa M, 2003, J Assoc Physicians India, V51, P863; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Dorhoi A, 2014, SEMIN IMMUNOL, V26, P203, DOI 10.1016/j.smim.2014.04.003; Ellner JJ, 2010, CTS-CLIN TRANSL SCI, V3, P23, DOI 10.1111/j.1752-8062.2010.00180.x; Forouhi NG, 2007, DIABETIC MED, V24, P200, DOI 10.1111/j.1464-5491.2007.02068.x; Harries AD, 2011, INT J TUBERC LUNG D, V15, P1436, DOI 10.5588/ijtld.11.0503; Kapur A, 2013, DIABETES RES CLIN PR; Kumar Nathella Pavan, 2013, Ann Am Thorac Soc, V10, P441, DOI 10.1513/AnnalsATS.201305-112OC; Kumar NP, 2013, J INFECT DIS, V208, P739, DOI 10.1093/infdis/jit241; Kumar NP, 2014, J INFECT DIS; Marais BJ, 2013, LANCET INFECT DIS, V13, P436, DOI 10.1016/S1473-3099(13)70015-X; Martinez N, 2014, EUR J IMMUNOL, V44, P617, DOI 10.1002/eji.201344301; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Mayer-Barber KD, 2011, IMMUNITY, V35, P1023, DOI 10.1016/j.immuni.2011.12.002; McNelis JC, 2014, IMMUNITY, V41, P36, DOI 10.1016/j.immuni.2014.05.010; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Restrepo BI, 2014, DIABETES RES CLIN PR; Restrepo BI, 2008, CLIN INFECT DIS, V47, P634, DOI 10.1086/590565; Restrepo BI, 2013, TUBERCULOSIS, V93, pS10, DOI 10.1016/S1472-9792(13)70004-0; Rook GAW, 2007, CURR MOL MED, V7, P327; Sullivan T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001269; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Torrado E, 2013, ADV EXP MED BIOL, V783, P121, DOI 10.1007/978-1-4614-6111-1_7; Torrado E, 2011, TRENDS IMMUNOL, V32, P66, DOI 10.1016/j.it.2010.12.001; Velloso LA, 2013, NAT REV ENDOCRINOL, V9, P750, DOI 10.1038/nrendo.2013.131; Viswanathan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041367; Wang QZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082660; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029	33	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112108	10.1371/journal.pone.0112108	http://dx.doi.org/10.1371/journal.pone.0112108			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393696	Green Accepted, gold, Green Published			2022-12-27	WOS:000347709300031
J	Redlarski, G; Gradolewski, D; Palkowski, A				Redlarski, Grzegorz; Gradolewski, Dawid; Palkowski, Aleksander			A System for Heart Sounds Classification	PLOS ONE			English	Article							NEURAL-NETWORK CLASSIFICATION; SUPPORT VECTOR MACHINES; DIAGNOSIS; IDENTIFICATION; SIGNALS	The future of quick and efficient disease diagnosis lays in the development of reliable non-invasive methods. As for the cardiac diseases - one of the major causes of death around the globe - a concept of an electronic stethoscope equipped with an automatic heart tone identification system appears to be the best solution. Thanks to the advancement in technology, the quality of phonocardiography signals is no longer an issue. However, appropriate algorithms for auto-diagnosis systems of heart diseases that could be capable of distinguishing most of known pathological states have not been yet developed. The main issue is non-stationary character of phonocardiography signals as well as a wide range of distinguishable pathological heart sounds. In this paper a new heart sound classification technique, which might find use in medical diagnostic systems, is presented. It is shown that by combining Linear Predictive Coding coefficients, used for future extraction, with a classifier built upon combining Support Vector Machine and Modified Cuckoo Search algorithm, an improvement in performance of the diagnostic system, in terms of accuracy, complexity and range of distinguishable heart sounds, can be made. The developed system achieved accuracy above 93% for all considered cases including simultaneous identification of twelve different heart sound classes. The respective system is compared with four different major classification methods, proving its reliability.	[Redlarski, Grzegorz; Gradolewski, Dawid; Palkowski, Aleksander] Gdansk Univ Technol, Dept Mechatron & High Voltage Engn, Gdansk, Poland	Fahrenheit Universities; Gdansk University of Technology	Palkowski, A (corresponding author), Gdansk Univ Technol, Dept Mechatron & High Voltage Engn, Gdansk, Poland.	a.palkowski@eia.pg.gda.pl	Palkowski, Aleksander/J-7272-2012	Palkowski, Aleksander/0000-0002-3140-8469; /0000-0003-1597-5145				ABDELMOTALEB I, 2012, EL INF TECHN EIT 201, P1; Agostinho M, 1997, P 19 ANN INT C IEEE, V1, P201, DOI [DOI 10.1109/IEMBS.1997.754540, 10.1109/IEMBS.1997.754540]; Avci E, 2009, EXPERT SYST APPL, V36, P10618, DOI 10.1016/j.eswa.2009.02.053; Avci E, 2009, EXPERT SYST APPL, V36, P2873, DOI 10.1016/j.eswa.2008.01.030; Babaei S, 2009, COMPUT BIOL MED, V39, P8, DOI 10.1016/j.compbiomed.2008.10.004; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Boutana D, 2011, IET SIGNAL PROCESS, V5, P527, DOI 10.1049/iet-spr.2010.0013; Chauhan S, 2008, COMPUT BIOL MED, V38, P221, DOI 10.1016/j.compbiomed.2007.10.006; Civicioglu P, 2013, ARTIF INTELL REV, V39, P315, DOI 10.1007/s10462-011-9276-0; Comak E, 2007, COMPUT BIOL MED, V37, P21, DOI 10.1016/j.compbiomed.2005.11.002; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; GIVEKI D, 2012, CORR; Goel S., 2011, Proceedings of the 2011 World Congress on Information and Communication Technologies (WICT), P916, DOI 10.1109/WICT.2011.6141370; Gupta CN, 2007, APPL SOFT COMPUT, V7, P286, DOI 10.1016/j.asoc.2005.06.006; Jabbari S, 2011, COMPUT BIOL MED, V41, P802, DOI 10.1016/j.compbiomed.2011.06.016; Jian-bo Wu, 2012, 2012 International Conference on Systems and Informatics (ICSAI 2012), P1732, DOI 10.1109/ICSAI.2012.6223377; Jiang ZW, 2006, EXPERT SYST APPL, V31, P286, DOI 10.1016/j.eswa.2005.09.025; Kapp MN, 2012, APPL SOFT COMPUT, V12, P2550, DOI 10.1016/j.asoc.2012.04.001; Maglogiannis I, 2009, COMPUT METH PROG BIO, V95, P47, DOI 10.1016/j.cmpb.2009.01.003; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Melgani F, 2008, IEEE T INF TECHNOL B, V12, P667, DOI 10.1109/TITB.2008.923147; Redlarski Grzegorz, 2013, Przeglad Elektrotechniczny, V89, P40; Syed Z, 2007, IEEE T BIO-MED ENG, V54, P651, DOI 10.1109/TBME.2006.889189; Turkoglu I, 2002, EXPERT SYST APPL, V23, P229, DOI 10.1016/S0957-4174(02)00042-8; Valian E., 2011, INT J ARTIFICIAL INT, V2, P36, DOI DOI 10.5121/IJAIA.2011.2304; Vazquez RA, 2011, IEEE C EVOL COMPUTAT, P679; Walton S, 2011, CHAOS SOLITON FRACT, V44, P710, DOI 10.1016/j.chaos.2011.06.004; WEI J, 2011, EXPERT SYSTEMS APPL, V38, P4390; Yang XS, 2009, WOR CONG NAT BIOL, P210, DOI 10.1109/nabic.2009.5393690; Yang XS, 2014, NEURAL COMPUT APPL, V24, P169, DOI 10.1007/s00521-013-1367-1; Zahiri SH, 2007, J FRANKLIN I, V344, P362, DOI 10.1016/j.jfranklin.2005.12.006	31	39	42	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112673	10.1371/journal.pone.0112673	http://dx.doi.org/10.1371/journal.pone.0112673			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393113	gold, Green Published, Green Submitted			2022-12-27	WOS:000347709300083
J	Seidensticker, M; Seidensticker, R; Damm, R; Mohnike, K; Pech, M; Sangro, B; Hass, P; Wust, P; Kropf, S; Gademann, G; Ricke, J				Seidensticker, Max; Seidensticker, Ricarda; Damm, Robert; Mohnike, Konrad; Pech, Maciej; Sangro, Bruno; Hass, Peter; Wust, Peter; Kropf, Siegfried; Gademann, Guenther; Ricke, Jens			Prospective Randomized Trial of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid for Prevention of Radiation-Induced Liver Toxicity	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; HEPATIC VENOOCCLUSIVE DISEASE; STEM-CELL TRANSPLANTATION; REGIMEN-RELATED TOXICITIES; MOLECULAR-WEIGHT HEPARIN; IN-VIVO ASSESSMENT; GD-EOB-DTPA; TOLERANCE; URSODIOL; INJURY	Background/Aim: Targeted radiotherapy of liver malignancies has found to be effective in selected patients. A key limiting factor of these therapies is the relatively low tolerance of the liver parenchyma to radiation. We sought to assess the preventive effects of a combined regimen of pentoxifylline (PTX), ursodeoxycholic acid (UDCA) and low-dose low molecular weight heparin (LMWH) on focal radiation-induced liver injury (fRILI). Methods and Materials: Patients with liver metastases from colorectal carcinoma who were scheduled for local ablation by radiotherapy (image-guided high-dose-rate interstitial brachytherapy) were prospectively randomized to receive PTX, UDCA and LMWH for 8 weeks (treatment) or no medication (control). Focal RILI at follow-up was assessed using functional hepatobiliary magnetic resonance imaging (MRI). A minimal threshold dose, i.e. the dose to which the outer rim of the fRILI was formerly exposed to, was quantified by merging MRI and dosimetry data. Results: Results from an intended interim-analysis made a premature termination necessary. Twenty-two patients were included in the per-protocol analysis. Minimal mean hepatic threshold dose 6 weeks after radiotherapy (primary endpoint) was significantly higher in the study treatment-group compared with the control (19.1 Gy versus 14.6 Gy, p = 0.011). Qualitative evidence of fRILI by MRI at 6 weeks was observed in 45.5% of patients in the treatment versus 90.9% of the control group. No significant differences between the groups were observed at the 12-week follow-up. Conclusions: The post-therapeutic application of PTX, UDCA and low-dose LMWH significantly reduced the extent and incidence fRILI at 6 weeks after radiotherapy. The development of subsequent fRILI at 12 weeks (4 weeks after cessation of PTX, UDCA and LMWH during weeks 1-8) in the treatment group was comparable to the control group thus supporting the observation that the agents mitigated fRILI.	[Seidensticker, Max; Seidensticker, Ricarda; Damm, Robert; Mohnike, Konrad; Pech, Maciej; Ricke, Jens] Univ Magdeburg, Klin Radiol & Nukl Med, D-39106 Magdeburg, Germany; [Seidensticker, Max; Seidensticker, Ricarda; Damm, Robert; Mohnike, Konrad; Pech, Maciej; Ricke, Jens] Deutsch Akad Mikrotherapie, Int Sch Image Guided Intervent, Magdeburg, Germany; [Sangro, Bruno] Univ Navarra Clin, Liver Unit, Dept Internal Med, Pamplona, Spain; [Hass, Peter; Gademann, Guenther] Univ Klin Magdeburg, Klin Strahlentherapie, Magdeburg, Germany; [Wust, Peter] Charite, Klin Radioonkol & Strahlentherapie, D-13353 Berlin, Germany; [Kropf, Siegfried] Univ Klin Magdeburg, Inst Biometrie & Med Informat, Magdeburg, Germany; [Pech, Maciej] Med Univ Gdansk, Dept Radiol 2, Gdansk, Poland	Otto von Guericke University; University of Navarra; University Hospital Magdeburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University Hospital Magdeburg; Fahrenheit Universities; Medical University Gdansk	Seidensticker, M (corresponding author), Univ Magdeburg, Klin Radiol & Nukl Med, D-39106 Magdeburg, Germany.	max.seidensticker@med.ovgu.de	Hass, Peter/AAP-8768-2021; Mohnike, Konrad/AAJ-9729-2020; Sangro, Bruno/AFW-4106-2022	Hass, Peter/0000-0003-0164-5284; Seidensticker, Max/0000-0002-2481-5410; Sangro, Bruno/0000-0002-4177-6417	Sirtex medical by university hospital of Magdeburg; Sirtex medical	Sirtex medical by university hospital of Magdeburg; Sirtex medical	This study was funded in full by Sirtex medical (http://www.sirtex.com.au/eu/), funding received by university hospital of Magdeburg. The writing of this paper was funded in part by Sirtex medical. Writing support was provided by Rae Hobbs and was funded by Sirtex medical. Apart from that, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATTAL M, 1993, BLOOD, V82, P732; ATTAL M, 1992, BLOOD, V79, P2834; BIANCO JA, 1991, BLOOD, V78, P1205; Boda-Heggemann J, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-92; Catani L, 1996, BONE MARROW TRANSPL, V17, P277; CLIFT RA, 1993, BLOOD, V82, P2025; EMAMI B, 1991, INT J RADIAT ONCOL, V21, P109, DOI 10.1016/0360-3016(91)90171-Y; Essell JH, 1998, ANN INTERN MED, V128, P975, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00002; FAJARDO LF, 1980, ARCH PATHOL LAB MED, V104, P584; FARTHING MJG, 1982, GUT, V23, P465, DOI 10.1136/gut.23.6.465; Forrest DL, 2003, BONE MARROW TRANSPL, V31, P1143, DOI 10.1038/sj.bmt.1704087; GERACI JP, 1993, RADIAT RES, V136, P205, DOI 10.2307/3578612; Kowdley KV, 2000, AM J MED, V108, P481, DOI 10.1016/S0002-9343(00)00318-1; Lakshminarayanan S, 2010, PEDIATR TRANSPLANT, V14, P618, DOI 10.1111/j.1399-3046.2009.01285.x; LAWRENCE TS, 1995, INT J RADIAT ONCOL, V31, P1237, DOI 10.1016/0360-3016(94)00418-K; Lee JH, 1998, BONE MARROW TRANSPL, V22, P883, DOI 10.1038/sj.bmt.1701445; Lindner H, 1997, BLOOD, V89, P1931, DOI 10.1182/blood.V89.6.1931; MCDONALD GB, 1984, HEPATOLOGY, V4, P116, DOI 10.1002/hep.1840040121; MCDONALD GB, 1985, TRANSPLANTATION, V39, P603, DOI 10.1097/00007890-198506000-00005; Neuman MG, 1998, GASTROENTEROLOGY, V115, P157, DOI 10.1016/S0016-5085(98)70377-4; Ohashi K, 2000, AM J HEMATOL, V64, P32, DOI 10.1002/(SICI)1096-8652(200005)64:1<32::AID-AJH6>3.3.CO;2-E; Or R, 1996, TRANSPLANTATION, V61, P1067, DOI 10.1097/00007890-199604150-00014; Park SH, 2002, BONE MARROW TRANSPL, V29, P137, DOI 10.1038/sj.bmt.1703342; Pascolo L, 1999, BIOCHEM BIOPH RES CO, V257, P746, DOI 10.1006/bbrc.1999.0454; REED GB, 1966, AM J PATHOL, V48, P597; Ricke J, 2005, INT J RADIAT ONCOL, V62, P776, DOI 10.1016/j.ijrobp.2004.11.022; Ricke J, 2010, INT J RADIAT ONCOL, V78, P479, DOI 10.1016/j.ijrobp.2009.09.026; Rodrigues CMP, 1998, J CLIN INVEST, V101, P2790, DOI 10.1172/JCI1325; Ruutu T, 2002, BLOOD, V100, P1977, DOI 10.1182/blood-2001-12-0159; Sangro B, 2008, CANCER-AM CANCER SOC, V112, P1538, DOI 10.1002/cncr.23339; SCHUHMANNGIAMPIERI G, 1992, RADIOLOGY, V183, P59, DOI 10.1148/radiology.183.1.1549695; Seidensticker M, 2014, CARDIOVASCULAR INTER; Seidensticker M, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-40; Seidensticker R, 2012, CARDIOVASC INTER RAD, V35, P1066, DOI 10.1007/s00270-011-0234-7; Shin NY, 2012, EUR RADIOL, V22, P864, DOI 10.1007/s00330-011-2333-x; SHULMAN HM, 1992, BONE MARROW TRANSPL, V10, P197; SHULMAN HM, 1987, AM J PATHOL, V127, P549; Watanabe H, 2011, RADIOLOGY, V259, P142, DOI 10.1148/radiol.10100621; Wybranski C, 2009, RADIAT RES, V172, P598, DOI 10.1667/RR1773.1	39	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112731	10.1371/journal.pone.0112731	http://dx.doi.org/10.1371/journal.pone.0112731			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393877	Green Published, gold			2022-12-27	WOS:000347709300091
J	Zhou, ZX; Zhang, BC; Sun, L				Zhou, Zhi-xia; Zhang, Bao-cun; Sun, Li			Poly(I:C) Induces Antiviral Immune Responses in Japanese Flounder (Paralichthys olivaceus) That Require TLR3 and MDA5 and Is Negatively Regulated by Myd88	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; I-LIKE RECEPTORS; RAINBOW-TROUT; FUNCTIONAL-CHARACTERIZATION; ADAPTER MOLECULE; DNA VACCINES; VIRUS; GENE; EXPRESSION	Polyinosinic:polycytidylic acid (poly(I:C)) is a ligand of toll-like receptor (TLR) 3 that has been used as an immunostimulant in humans and mice against viral diseases based on its ability to enhance innate and adapt immunity. Antiviral effect of poly(I:C) has also been observed in teleost, however, the underling mechanism is not clear. In this study, we investigated the potential and signaling mechanism of poly(I:C) as an antiviral agent in a model of Japanese flounder (Paralichthys olivaceus) infected with megalocytivirus. We found that poly(I:C) exhibited strong antiviral activity and enhanced activation of head kidney macrophages and peripheral blood leukocytes. In vivo studies showed that (i) TLR3 as well as MDA5 knockdown reduced poly(I:C)-mediated immune response and antiviral activity to significant extents; (ii) when Myd88 was overexpressed in flounder, poly(I:C)-mediated antiviral activity was significantly decreased; (iii) when Myd88 was inactivated, the antiviral effect of poly(I:C) was significantly increased. Cellular study showed that (i) the NF-kappa B activity induced by poly(I:C) was upregulated in Myd88-overexpressing cells and unaffected in Myd88-inactivated cells; (ii) Myd88 overexpression inhibited and upregulated the expression of poly(I:C)-induced antiviral genes and inflammatory genes respectively; (iii) Myd88 inactivation enhanced the expression of the antiviral genes induced by poly(I:C). Taken together, these results indicate that poly(I:C) is an immunostimulant with antiviral potential, and that the immune response of poly(I:C) requires TLR3 and MDA5 and is negatively regulated by Myd88 in a manner not involving NK-kappa B. These results provide insights to the working mechanism of poly(I:C), TLR3, and Myd88 in fish.	[Zhou, Zhi-xia; Zhang, Bao-cun; Sun, Li] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Zhang, Bao-cun] Univ Chinese Acad Sci, Beijing, Peoples R China; [Sun, Li] Zhejiang Univ, Collaborat Innovat Ctr Deep Sea Biol, Hangzhou 310003, Zhejiang, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Zhejiang University	Sun, L (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	lsun@qdio.ac.cn		Zhang, Bao-cun/0000-0001-6104-0848; Zhou, Zhixia/0000-0002-4080-5749	China Postdoctoral Science Foundation [Y22121102H]; National Basic Research Program of China [2012CB114406]; Taishan Scholar Program of Shandong Province	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Basic Research Program of China(National Basic Research Program of China); Taishan Scholar Program of Shandong Province	This work was supported by grants from China Postdoctoral Science Foundation (Y22121102H), the National Basic Research Program of China (2012CB114406), and the Taishan Scholar Program of Shandong Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2012, J VIROL, V86, P185, DOI 10.1128/JVI.05245-11; Abston ED, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/129486; Akazawa T, 2007, P NATL ACAD SCI USA, V104, P252, DOI 10.1073/pnas.0605978104; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Baoprasertkul P, 2006, IMMUNOGENETICS, V58, P817, DOI 10.1007/s00251-006-0144-z; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Chang MX, 2011, J VIROL, V85, P8403, DOI 10.1128/JVI.00445-10; Chen LJ, 2013, FISH SHELLFISH IMMUN, V34, P909, DOI 10.1016/j.fsi.2013.01.003; Chi H, 2014, DEV COMP IMMUNOL, V42, P125, DOI 10.1016/j.dci.2013.09.001; Esposito S, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-270; Groskreutz DJ, 2006, J IMMUNOL, V176, P1733, DOI 10.4049/jimmunol.176.3.1733; Guo YQ, 2011, J EXP MED, V208, P2083, DOI 10.1084/jem.20101568; Hafner AM, 2013, ADV DRUG DELIVER REV, V65, P1386, DOI 10.1016/j.addr.2013.05.013; Han KJ, 2010, J BIOL CHEM, V285, P12543, DOI 10.1074/jbc.M109.072231; Hardarson HS, 2007, AM J PHYSIOL-HEART C, V292, pH251, DOI 10.1152/ajpheart.00398.2006; Hidaka F, 2006, CLIN IMMUNOL, V119, P188, DOI 10.1016/j.clim.2006.01.005; Hutchens M, 2008, J IMMUNOL, V180, P483, DOI 10.4049/jimmunol.180.1.483; Hwang SD, 2012, DEV COMP IMMUNOL, V37, P87, DOI 10.1016/j.dci.2011.12.004; Jensen I, 2002, FISH SHELLFISH IMMUN, V13, P311, DOI 10.1006/fsim.2001.0406; Jiao XD, 2009, VACCINE, V27, P5195, DOI 10.1016/j.vaccine.2009.06.071; Johnson AC, 2008, J BIOL CHEM, V283, P3988, DOI 10.1074/jbc.M707264200; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Kim HJ, 2009, DIS AQUAT ORGAN, V83, P105, DOI 10.3354/dao02000; Kindberg E, 2011, J INFECT DIS, V203, P523, DOI 10.1093/infdis/jiq082; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Lee KG, 2012, P NATL ACAD SCI USA, V109, P5791, DOI 10.1073/pnas.1119238109; Li GG, 2013, TUMOR BIOL, V34, P1589, DOI 10.1007/s13277-013-0689-z; Li XJ, 2009, J BIOL CHEM, V284, P13881, DOI 10.1074/jbc.M900818200; Lockhart K, 2004, FISH SHELLFISH IMMUN, V17, P347, DOI 10.1016/j.fsi.2004.04.011; Matsumoto M, 2011, REV MED VIROL, V21, P67, DOI 10.1002/rmv.680; Matsuo A, 2008, J IMMUNOL, V181, P3474, DOI 10.4049/jimmunol.181.5.3474; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Mikami T, 2012, GENE, V503, P235, DOI 10.1016/j.gene.2012.04.007; Negishi H, 2008, P NATL ACAD SCI USA, V105, P20446, DOI 10.1073/pnas.0810372105; Oh MJ, 2012, J FISH DIS, V35, P187, DOI 10.1111/j.1365-2761.2011.01334.x; Ohtani M, 2011, DEV COMP IMMUNOL, V35, P554, DOI 10.1016/j.dci.2010.12.013; Oshiumi H, 2003, IMMUNOGENETICS, V54, P791, DOI 10.1007/s00251-002-0519-8; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Peng J, 2010, EUR J IMMUNOL, V40, P1738, DOI 10.1002/eji.200940034; Perales-Linares R, 2013, IMMUNOLOGY, V140, P153, DOI 10.1111/imm.12143; Phelan PE, 2005, MOL IMMUNOL, V42, P1057, DOI 10.1016/j.molimm.2004.11.005; Plant KP, 2005, DEV COMP IMMUNOL, V29, P627, DOI 10.1016/j.dci.2004.09.008; Pott J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002670; Pulko V, 2009, J IMMUNOL, V183, P3634, DOI 10.4049/jimmunol.0900974; Purcell MK, 2004, FISH SHELLFISH IMMUN, V17, P447, DOI 10.1016/j.fsi.2004.04.017; Reimer T, 2008, J LEUKOCYTE BIOL, V83, P1249, DOI 10.1189/jlb.0607412; Rivieccio MA, 2006, J IMMUNOL, V177, P4735, DOI 10.4049/jimmunol.177.7.4735; Rodriguez MF, 2005, IMMUNOGENETICS, V57, P510, DOI 10.1007/s00251-005-0013-1; Rong YH, 2013, INFLAMMATION, V36, P413, DOI 10.1007/s10753-012-9560-4; Saito T, 2008, J EXP MED, V205, P1523, DOI 10.1084/jem.20081210; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Shojaei H, 2009, CANCER RES, V69, P8710, DOI 10.1158/0008-5472.CAN-09-1602; Siednienko J, 2011, J IMMUNOL, V186, P2514, DOI 10.4049/jimmunol.1003093; Siednienko J, 2010, EUR J IMMUNOL, V40, P3150, DOI 10.1002/eji.201040547; Strandskog G, 2011, DEV COMP IMMUNOL, V35, P1116, DOI 10.1016/j.dci.2011.03.016; Su JG, 2010, FISH SHELLFISH IMMUN, V28, P712, DOI 10.1016/j.fsi.2010.01.009; Sullivan C, 2007, J IMMUNOL, V178, P4517, DOI 10.4049/jimmunol.178.7.4517; Svingerud T, 2012, J IMMUNOL, V189, P5912, DOI 10.4049/jimmunol.1201188; Swaminathan G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002937; Takami I, 2010, DIS AQUAT ORGAN, V89, P109, DOI 10.3354/dao02185; Thim HL, 2012, VACCINE, V30, P4828, DOI 10.1016/j.vaccine.2012.05.010; Tong SL, 1997, AQUACULTURE, V156, P327, DOI 10.1016/S0044-8486(97)00070-7; Wang HR, 2009, VACCINE, V27, P4047, DOI 10.1016/j.vaccine.2009.04.023; Wang Q, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002070; Wornle M, 2006, AM J PATHOL, V168, P370, DOI 10.2353/ajpath.2006.050491; Yu LP, 2013, FISH SHELLFISH IMMUN, V35, P1293, DOI 10.1016/j.fsi.2013.07.043; Yu M, 2011, CYTOKINE GROWTH F R, V22, P63, DOI 10.1016/j.cytogfr.2011.02.001; Yuk JM, 2011, NAT IMMUNOL, V12, P742, DOI 10.1038/ni.2064; Zhang J, 2013, VET IMMUNOL IMMUNOP, V152, P303, DOI 10.1016/j.vetimm.2012.12.018; Zhang M, 2012, FISH SHELLFISH IMMUN, V33, P1192, DOI 10.1016/j.fsi.2012.09.010; Zheng WJ, 2011, FISH SHELLFISH IMMUN, V30, P638, DOI 10.1016/j.fsi.2010.12.014; Zhou ZX, 2014, DEV COMP IMMUNOL, V44, P124, DOI 10.1016/j.dci.2013.12.002; Zou PF, 2014, IMMUNOLOGY, V141, P192, DOI 10.1111/imm.12179	73	168	170	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112918	10.1371/journal.pone.0112918	http://dx.doi.org/10.1371/journal.pone.0112918			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393122	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300122
J	Banerjee, S; Ghosh, T; Barik, S; Das, A; Ghosh, S; Bhuniya, A; Bose, A; Baral, R				Banerjee, Saptak; Ghosh, Tithi; Barik, Subhasis; Das, Arnab; Ghosh, Sarbari; Bhuniya, Avishek; Bose, Anamika; Baral, Rathindranath			Neem Leaf Glycoprotein Prophylaxis Transduces Immune Dependent Stop Signal for Tumor Angiogenic Switch within Tumor Microenvironment	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MURINE EHRLICH CARCINOMA; BLOOD MONONUCLEAR-CELLS; T-CELLS; ANTIANGIOGENIC THERAPY; B16 MELANOMA; BONE-MARROW; NK CELLS; INHIBITION; VACCINE	We have reported that prophylactic as well as therapeutic administration of neem leaf glycoprotein (NLGP) induces significant restriction of solid tumor growth in mice. Here, we investigate whether the effect of such pretreatment (25 mu g/mice; weekly, 4 times) benefits regulation of tumor angiogenesis, an obligate factor for tumor progression. We show that NLGP pretreatment results in vascular normalization in melanoma and carcinoma bearing mice along with downregulation of CD31, VEGF and VEGFR2. NLGP pretreatment facilitates profound infiltration of CD8(+) T cells within tumor parenchyma, which subsequently regulates VEGF-VEGFR2 signaling in CD31(+) vascular endothelial cells to prevent aberrant neovascularization. Pericyte stabilization, VEGF dependent inhibition of VEC proliferation and subsequent vascular normalization are also experienced. Studies in immune compromised mice confirmed that these vascular and intratumoral changes in angiogenic profile are dependent upon active adoptive immunity particularly those mediated by CD8+ T cells. Accumulated evidences suggest that NLGP regulated immunomodulation is active in tumor growth restriction and normalization of tumor angiogenesis as well, thereby, signifying its clinical translation.	[Banerjee, Saptak; Ghosh, Tithi; Barik, Subhasis; Das, Arnab; Ghosh, Sarbari; Bhuniya, Avishek; Bose, Anamika; Baral, Rathindranath] CNCI, Dept Immunoregulat & Immunodiagnost, Kolkata, India		Baral, R (corresponding author), CNCI, Dept Immunoregulat & Immunodiagnost, Kolkata, India.	baralrathin@hotmail.com	Banerjee, Dr Saptak/HDO-6987-2022	Banerjee, Dr Saptak/0000-0001-9211-2074; Bhuniya, Avishek/0000-0001-6253-0400; GHOSH HALDER, TITHI/0000-0002-4292-1153; Barik, Subhasis/0000-0002-0488-0434	Council of Scientific and Industrial Research, New Delhi [09/030(0050)/2008-EMR-I, 09/030(0063)/2011-EMRI]	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The work was partially supported by Council of Scientific and Industrial Research, New Delhi (grant no. 09/030(0050)/2008-EMR-I to S. Banerjee, grant no. 09/030(0063)/2011-EMRI to S. Barik and grant SRA, Scientists' Pool Scheme No: 8463A to A. Bose). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2010, DRUG RESIST UPDATE, V13, P16, DOI 10.1016/j.drup.2009.12.001; Bailey J.L., 1967, TECHNIQUES PROTEIN C; Baral R, 2005, INT IMMUNOPHARMACOL, V5, P1343, DOI 10.1016/j.intimp.2005.03.008; Baral R, 2004, INT IMMUNOPHARMACOL, V4, P355, DOI 10.1016/j.intimp.2003.09.006; Barik S, 2013, TRIALS VACCINOLOGY; Barik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066501; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Bose A, 2009, HUM IMMUNOL, V70, P6, DOI 10.1016/j.humimm.2008.09.004; Bose A, 2007, HUM IMMUNOL, V68, P823, DOI 10.1016/j.humimm.2007.08.002; Bose A, 2007, PHYTOTHER RES, V21, P914, DOI 10.1002/ptr.2185; Bose A, 2009, J IMMUNOTHER, V32, P42, DOI 10.1097/CJI.0b013e31818e997d; Breier G, 2000, PLACENTA, V21, pS11, DOI 10.1053/plac.1999.0525; Chakraborty K, 2008, INT IMMUNOPHARMACOL, V8, P330, DOI 10.1016/j.intimp.2007.10.015; Chakraborty K, 2010, CELL MOL IMMUNOL, V7, P396, DOI 10.1038/cmi.2010.29; Chakraborty T, 2011, IMMUNOTHERAPY-UK, V3, P949, DOI [10.2217/IMT.11.81, 10.2217/imt.11.81]; Chatterjee S, 2013, J CLIN INVEST, V123, P1732, DOI 10.1172/JCI65385; Cirone P, 2004, HUM GENE THER, V15, P945, DOI 10.1089/hum.2004.15.945; Daniel WM, AM J PATHOL, V167, P1389; Dudley AC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006536; Duraiswamy J, 2013, CANCER RES, V73, P3591, DOI 10.1158/0008-5472.CAN-12-4100; Facciabene A, 2012, CANCER RES, V72, P2162, DOI 10.1158/0008-5472.CAN-11-3687; Goel S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006486; Goswami KK, 2014, MOL IMMUNOL, V59, P119, DOI 10.1016/j.molimm.2014.01.015; Goswami S, 2010, VACCINE, V28, P1241, DOI 10.1016/j.vaccine.2009.11.018; Guillem EB, 2002, CANCER RES, V62, P7042; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Haque E, 2006, IMMUNOPHARM IMMUNOT, V28, P33, DOI 10.1080/08923970600623632; Haque E, 2006, IMMUNOBIOLOGY, V211, P721, DOI 10.1016/j.imbio.2006.02.005; Hernandez GL, 2001, J EXP MED, V193, P607, DOI 10.1084/jem.193.5.607; Itasaka S, 2007, INT J RADIAT ONCOL, V67, P870, DOI 10.1016/j.ijrobp.2006.10.030; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kaigler D, 2003, TISSUE ENG, V9, P95, DOI 10.1089/107632703762687573; Khan M, 2012, CLIN CANCER INVESTIG, V1, P127, DOI 10.4103/2278-0513.102880; Kim H, 2010, CIRC RES, V107, P602, DOI 10.1161/CIRCRESAHA.110.218396; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; Mallick A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047434; Niethammer AG, 2002, NAT MED, V8, P1369, DOI 10.1038/nm794; Qin ZH, 2003, CANCER RES, V63, P4095; Rafiee Parvaneh, 2004, Cell Commun Signal, V2, P3, DOI 10.1186/1478-811X-2-3; Ribatti D, 2009, J CELL MOL MED, V13, P2822, DOI 10.1111/j.1582-4934.2009.00810.x; Roy S, 2011, CLIN VACCINE IMMUNOL, V18, P571, DOI 10.1128/CVI.00499-10; Shi SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065757; Shiao SL, 2011, GENE DEV, V25, P2559, DOI 10.1101/gad.169029.111; Sihvo EIT, 2003, J THORAC CARDIOV SUR, V126, P1952, DOI 10.1016/j.jtcvs.2003.08.014; Sonnenschein C, 2013, J BIOSCIENCES, V38, P651, DOI 10.1007/s12038-013-9335-6; Tartour E, 2011, CANCER METAST REV, V30, P83, DOI 10.1007/s10555-011-9281-4; Terme M, 2012, ANTIANGIOGENIC MOL C, V2012, P1, DOI DOI 10.1155/2012/492920; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Vosseler S, 2005, CANCER RES, V65, P1294, DOI 10.1158/0008-5472.CAN-03-3986; Wang D, 2008, BIOTECH HISTOCHEM, V83, P179, DOI 10.1080/10520290802451085; Zhou H, 2005, BLOOD, V106, P2026, DOI 10.1182/blood-2005-03-0969; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	53	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e110040	10.1371/journal.pone.0110040	http://dx.doi.org/10.1371/journal.pone.0110040			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391149	Green Submitted, Green Published, gold			2022-12-27	WOS:000349144400010
J	Burke, DF; Smith, DJ				Burke, David F.; Smith, Derek J.			A Recommended Numbering Scheme for Influenza A HA Subtypes	PLOS ONE			English	Article							HUMAN-TYPE RECEPTOR; AMINO-ACID; HEMAGGLUTININ PROTEIN; VIRUS HEMAGGLUTININ; BINDING; TRANSMISSION; SPECIFICITY; EVOLUTION; CLEAVAGE; FERRETS	Comparisons of residues between sub-types of influenza virus is increasingly used to assess the zoonotic potential of a circulating strain and for comparative studies across subtypes. An analysis of N-terminal cleavage sites for thirteen subtypes of influenza A hemagglutinin (HA) sequences, has previously been described by Nobusawa and colleagues. We have expanded this analysis for the eighteen known subtypes of influenza. Due to differences in the length of HA, we have included strains from multiple clades of H1 and H5, as well as strains of H5 and H7 subtypes with both high and low pathogenicity. Analysis of known structures of influenza A HA enables us to define amino acids which are structurally and functionally equivalent across all HA subtypes using a numbering system based on the mature HA sequence. We provide a list of equivalences for amino acids which are known to affect the phenotype of the virus.	[Burke, David F.; Smith, Derek J.] Univ Cambridge, Dept Zool, Cambridge, England	University of Cambridge	Burke, DF (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	dfb21@cam.ac.uk	Smith, Derek/Z-3075-2019; Burke, David F/C-2091-2013	Smith, Derek/0000-0002-2393-1890; Burke, David F/0000-0001-8830-3951	Bill & Melinda Gates Foundation Global Health [OPPGH5383]; European Union FP7 program ANTIGONE [278976]; National Institute of Allergy and Infectious disease [HHSN266200700010C]	Bill & Melinda Gates Foundation Global Health; European Union FP7 program ANTIGONE; National Institute of Allergy and Infectious disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by (DJS) Bill & Melinda Gates Foundation Global Health (http://www.gatesfoundation.org/) Grant # OPPGH5383, (DJS) European Union FP7 program ANTIGONE (http://cordis.europa.eu/programme/rcn/852_en.html) (278976) and (DJS) National Institute of Allergy and Infectious disease (http://www.niaid.nih.gov) Contract HHSN266200700010C. The funders had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	Auewarakul P, 2007, J VIROL, V81, P9950, DOI 10.1128/JVI.00468-07; BOSCH FX, 1981, VIROLOGY, V113, P725, DOI 10.1016/0042-6822(81)90201-4; Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10; DeLano WL, 2002, J VIROL; DESHPANDE KL, 1987, P NATL ACAD SCI USA, V84, P36, DOI 10.1073/pnas.84.1.36; Gambaryan A, 2006, VIROLOGY, V344, P432, DOI 10.1016/j.virol.2005.08.035; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; McDonald NJ, 2007, J GEN VIROL, V88, P3209, DOI 10.1099/vir.0.83184-0; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Murakami S, 2012, J VIROL, V86, P1405, DOI 10.1128/JVI.06009-11; Naughtin M, 2011, ANTIMICROB AGENTS CH, V55, P2004, DOI 10.1128/AAC.01773-10; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Reed ML, 2009, J VIROL, V83, P3568, DOI 10.1128/JVI.02238-08; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Suarez DL, 1999, J VIROL, V73, P3567, DOI 10.1128/JVI.73.5.3567-3573.1999; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; Watanabe Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002068; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165; Zaraket H, 2013, J VIROL, V87, P9911, DOI 10.1128/JVI.01175-13	26	94	96	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112302	10.1371/journal.pone.0112302	http://dx.doi.org/10.1371/journal.pone.0112302			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391151	Green Submitted, Green Published, gold			2022-12-27	WOS:000349144400070
J	De Maio, F; Maulucci, G; Minerva, M; Anoosheh, S; Palucci, I; Iantomasi, R; Palmieri, V; Camassa, S; Sali, M; Sanguinetti, M; Bitter, W; Manganelli, R; De Spirito, M; Delogu, G				De Maio, Flavio; Maulucci, Giuseppe; Minerva, Mariachiara; Anoosheh, Saber; Palucci, Ivana; Iantomasi, Raffaella; Palmieri, Valentina; Camassa, Serena; Sali, Michela; Sanguinetti, Maurizio; Bitter, Wilbert; Manganelli, Riccardo; De Spirito, Marco; Delogu, Giovanni			Impact of Protein Domains on PE_PGRS30 Polar Localization in Mycobacteria	PLOS ONE			English	Article							PE-PGRS PROTEINS; VII SECRETION; CELL-WALL; OUTER-MEMBRANE; TUBERCULOSIS; EXPRESSION; COMPLEX; VACCINE; SYSTEM; ESX-5	PE_PGRS proteins are unique to the Mycobacterium tuberculosis complex and a number of other pathogenic mycobacteria. PE_PGRS30, which is required for the full virulence of M. tuberculosis (Mtb), has three main domains, i.e. an N-terminal PE domain, repetitive PGRS domain and the unique C-terminal domain. To investigate the role of these domains, we expressed a GFP-tagged PE_PGRS30 protein and a series of its functional deletion mutants in different mycobacterial species ( Mtb, Mycobacterium bovis BCG and Mycobacterium smegmatis) and analysed protein localization by confocal microscopy. We show that PE_PGRS30 localizes at the mycobacterial cell poles in Mtb and M. bovis BCG but not in M. smegmatis and that the PGRS domain of the protein strongly contributes to protein cellular localization in Mtb. Immunofluorescence studies further showed that the unique C-terminal domain of PE_PGRS30 is not available on the surface, except when the PGRS domain is missing. Immunoblot demonstrated that the PGRS domain is required to maintain the protein strongly associated with the non-soluble cellular fraction. These results suggest that the repetitive GGA-GGN repeats of the PGRS domain contain specific sequences that contribute to protein cellular localization and that polar localization might be a key step in the PE_PGRS30-dependent virulence mechanism.	[De Maio, Flavio; Minerva, Mariachiara; Palucci, Ivana; Iantomasi, Raffaella; Camassa, Serena; Sali, Michela; Sanguinetti, Maurizio; Delogu, Giovanni] Univ Cattolica Sacro Cuore, Inst Microbiol, Rome, Italy; [Maulucci, Giuseppe; Palmieri, Valentina; De Spirito, Marco] Univ Cattolica Sacro Cuore, Inst Phys, Rome, Italy; [Bitter, Wilbert] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands; [Manganelli, Riccardo] Univ Padua, Dept Mol Med, Padua, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Vrije Universiteit Amsterdam; University of Padua	Delogu, G (corresponding author), Univ Cattolica Sacro Cuore, Inst Microbiol, Rome, Italy.	gdelogu@rm.unicatt.it	anoosheh, saber/D-1891-2011; Bitter, W/CAJ-5778-2022; Bitter, Wilbert/AAA-6872-2019; De Spirito, Marco/C-5386-2008; Bitter, Wilbert/ABG-3726-2020; Sanguinetti, Maurizio/A-1453-2019; Palmieri, Valentina/AAB-3564-2021; De Maio, Flavio/J-9452-2018; Anoosheh, Saber/AAK-3400-2021; Manganelli, Riccardo/A-7361-2009; De Spirito, Marco/U-3817-2019; Palmieri, Valentina/H-7836-2012; De Maio, Flavio/AAL-7355-2021; Maulucci, Giuseppe/C-7400-2009; De Maio, Flavio/AAD-1076-2022; palucci, ivana/J-8542-2018	anoosheh, saber/0000-0003-4614-0757; De Spirito, Marco/0000-0003-4260-5107; Bitter, Wilbert/0000-0001-8347-6511; Sanguinetti, Maurizio/0000-0002-9780-7059; Palmieri, Valentina/0000-0002-6358-9647; De Maio, Flavio/0000-0002-4744-9820; Manganelli, Riccardo/0000-0003-0940-7336; De Spirito, Marco/0000-0003-4260-5107; Palmieri, Valentina/0000-0002-6358-9647; De Maio, Flavio/0000-0002-4744-9820; Maulucci, Giuseppe/0000-0002-2154-319X; Minerva, Mariachiara/0000-0003-1518-7050; palucci, ivana/0000-0003-2106-1761	EU (FP7) [201762]; MIUR (Ministero dell'istruzione, Universita e Ricerca of the Italian Governement) [Y8RZTF]	EU (FP7); MIUR (Ministero dell'istruzione, Universita e Ricerca of the Italian Governement)	This work was funded by the EU (FP7/2007-2013) under grant agreement no201762 awarded to GD and RM and by MIUR (Ministero dell'istruzione, Universita e Ricerca of the Italian Governement) (project number PRIN 2008 Y8RZTF) awarded to GD and RM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Balaji KN, 2007, MICROBES INFECT, V9, P271, DOI 10.1016/j.micinf.2006.11.013; Balogh G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021182; Banu S, 2002, MOL MICROBIOL, V44, P9, DOI 10.1046/j.1365-2958.2002.02813.x; Bitter W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000507; Bottai D, 2012, MOL MICROBIOL; Bottai D, 2012, MOL MICROBIOL, V83, P1195, DOI 10.1111/j.1365-2958.2012.08001.x; Brennan MJ, 2002, TRENDS MICROBIOL, V10, P246, DOI 10.1016/S0966-842X(02)02335-1; Brennan MJ, 2001, INFECT IMMUN, V69, P7326, DOI 10.1128/IAI.69.12.7326-7333.2001; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Cadieux N, 2011, MICROBIOL-SGM, V157, P793, DOI 10.1099/mic.0.041996-0; Campuzano J, 2007, VACCINE, V25, P3722, DOI 10.1016/j.vaccine.2006.12.042; Carlsson F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000285; Cascioferro A, 2007, MOL MICROBIOL, V66, P1536, DOI 10.1111/j.1365-2958.2007.06023.x; Cascioferro A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027713; Chatrath S, 2014, FEBS LETT, V588, P990, DOI 10.1016/j.febslet.2014.01.059; Chatrath S, 2011, FEMS MICROBIOL LETT, V322, P194, DOI 10.1111/j.1574-6968.2011.02354.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Copin R, 2014, MBIO, V5, DOI 10.1128/mBio.00960-13; Daleke MH, 2012, J BIOL CHEM, V287, P31939, DOI 10.1074/jbc.M112.397596; Daleke MH, 2012, P NATL ACAD SCI USA, V109, P11342, DOI 10.1073/pnas.1119453109; Daleke MH, 2011, J BIOL CHEM; Delogu G, 2000, INFECT IMMUN, V68, P3097, DOI 10.1128/IAI.68.6.3097-3102.2000; Delogu G, 2014, CLIN MICROBIOL INFEC, V20, P59, DOI 10.1111/1469-0691.12460; Delogu G, 2004, MOL MICROBIOL, V52, P725, DOI 10.1111/j.1365-2958.2004.04007.x; Delogu G, 2008, HDB TUBERCULOSIS, P131; Delogu G, 2006, MICROBES INFECT, V8, P2061, DOI 10.1016/j.micinf.2006.03.015; Dorhoi A, 2011, IMMUNOL REV, V240, P235, DOI 10.1111/j.1600-065X.2010.00994.x; Hagedorn M, 2009, SCIENCE, V323, P1729, DOI 10.1126/science.1169381; Hett EC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001020; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Houben ENG, 2012, MOL MICROBIOL, V86, P472, DOI 10.1111/j.1365-2958.2012.08206.x; Huang Y, 2010, MOL CELL BIOCHEM, V340, P223, DOI 10.1007/s11010-010-0421-x; Iantomasi R, 2012, CELL MICROBIOL, V14, P356, DOI 10.1111/j.1462-5822.2011.01721.x; Maulucci G, 2009, BIOSENS BIOELECTRON, V25, P682, DOI 10.1016/j.bios.2009.07.038; McEvoy CRE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030593; Morandi M, 2013, J INFECT DEV COUNTR, V7, P169, DOI 10.3855/jidc.3114; Moreno-Altamirano Maria Maximina Bertha, 2012, Microb Inform Exp, V2, P9, DOI 10.1186/2042-5783-2-9; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Riley R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000174; Sali M, 2010, INFECT IMMUN, V78, P5202, DOI 10.1128/IAI.00267-10; Sani M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000794; Sayes F, 2012, CELL HOST MICROBE, V11, P352, DOI 10.1016/j.chom.2012.03.003; Simeone R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002507; Singh PP, 2008, MICROBIOL-SGM, V154, P3469, DOI 10.1099/mic.0.2008/019968-0; Soldini S, 2011, TUBERCULOSIS EDINB; Stoop EJM, 2012, TRENDS MICROBIOL, V20, P477, DOI 10.1016/j.tim.2012.07.001; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Supply P, 2013, NAT GENET, V45, P172, DOI 10.1038/ng.2517; Thi EP, 2013, CELL MICROBIOL, V15, P795, DOI 10.1111/cmi.12073; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wirth SE, 2012, MOL MICROBIOL, V83, P654, DOI 10.1111/j.1365-2958.2011.07958.x; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07; Zumbo A, 2013, PATHOG DIS, V69, P232, DOI 10.1111/2049-632X.12096	56	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112482	10.1371/journal.pone.0112482	http://dx.doi.org/10.1371/journal.pone.0112482			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390359	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400085
J	Duan, GC; Yang, HY; Shi, LB; Sun, WM; Sui, ML; Zhang, RG; Wang, XH; Wang, F; Zhang, WD; Xi, YL; Fan, QT				Duan, Guangcai; Yang, Haiyan; Shi, Lubin; Sun, Wumei; Sui, Meili; Zhang, Rongguang; Wang, Xinhong; Wang, Fang; Zhang, Weidong; Xi, Yuanlin; Fan, Qingtang			Serum Inflammatory Cytokine Levels Correlate with Hand-Foot-Mouth Disease Severity: A Nested Serial Case-Control Study	PLOS ONE			English	Article							ENTEROVIRUS 71 INFECTION; BRAIN-STEM ENCEPHALITIS; CENTRAL-NERVOUS-SYSTEM; CHILDREN; TAIWAN; COMPLICATIONS; SINGAPORE; EPIDEMIC; MALAYSIA; CHINA	Background: Hand-food-mouth disease (HFMD) cases can be fatal. These cases develop rapidly, and it is important to predict the severity of HFMD from mild to fatal and to identify risk factors for mild HFMD. The objective of this study was to correlate the levels of serum inflammatory cytokines with HFMD severity. Methods: This study was designed as a nested serial case-control study. The data collected included general information, clinical symptoms and signs, laboratory findings and serum cytokine levels. Results: The levels of IL-4, IL-6, IL-10, TNF-alpha and IFN-gamma in patients with severe HFMD were significantly higher than in mild patients during the 2nd to 5th day after disease onset. The levels of IL-4, IL-6, IL-10 and IFN-gamma increased from the 2nd day to the 4th day and later decreased. The levels of TNF-alpha were high on the first two days and subsequently decreased. The changes of IL-10, TNF-alpha and IFN-gamma in the controls were similar for all cases. The levels of IL-4, IL-6 and IL-17 in the controls were not significantly different with the progression of HFMD. Conclusions: Our findings indicate that the IL-4, IL-6, IL-10, TNF-alpha and IFN-gamma levels correlate with HFMD severity.	[Duan, Guangcai; Yang, Haiyan; Shi, Lubin; Sun, Wumei; Sui, Meili; Zhang, Rongguang; Zhang, Weidong; Xi, Yuanlin; Fan, Qingtang] Zhengzhou Univ, Coll Publ Hlth, Dept Epidemiol, Zhengzhou 450052, Henan, Peoples R China; [Duan, Guangcai] Xinxiang Med Univ, Henan Innovat Ctr Mol Diag & Lab Med, Xinxiang, Henan, Peoples R China; [Shi, Lubin] Henan Ctr Dis Control & Prevent, Zhengzhou, Henan, Peoples R China; [Wang, Xinhong; Wang, Fang] Childrens Hosp Zhengzhou City, Zhengzhou, Henan, Peoples R China	Zhengzhou University; Xinxiang Medical University	Duan, GC (corresponding author), Zhengzhou Univ, Coll Publ Hlth, Dept Epidemiol, Zhengzhou 450052, Henan, Peoples R China.	gcduan@zzu.edu.cn			National Natural Science Foundation of China [81172740]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from National Natural Science Foundation of China (81172740) (http://isisn.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P629; Chang LY, 2006, PEDIATR RES, V60, P466, DOI 10.1203/01.pdr.0000238247.86041.19; Chang LY, 2004, JAMA-J AM MED ASSOC, V291, P222, DOI 10.1001/jama.291.2.222; Chen JG, 2012, J MED VIROL, V84, P763, DOI 10.1002/jmv.23254; Chong CY, 2003, ACTA PAEDIATR, V92, P1163, DOI 10.1080/08035250310005242; Chua Kaw Bing, 2011, Virologica Sinica, V26, P221, DOI 10.1007/s12250-011-3195-8; Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058; DUFF MF, 1968, BMJ-BRIT MED J, V2, P661, DOI 10.1136/bmj.2.5606.661; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Lin MT, 2006, J CRIT CARE, V21, P280, DOI 10.1016/j.jcrc.2006.02.005; Lin TY, 2003, CLIN INFECT DIS, V36, P269, DOI 10.1086/345905; Lin TY, 2002, ACTA PAEDIATR, V91, P632, DOI 10.1080/080352502760069016; Liu CC, 2000, J CLIN VIROL, V17, P23, DOI 10.1016/S1386-6532(00)00068-8; Ma E, 2010, INT J INFECT DIS, V14, pE775, DOI 10.1016/j.ijid.2010.02.2265; Momoki TS, 2009, JPN J INFECT DIS, V62, P471; Ooi MH, 2007, CLIN INFECT DIS, V44, P646, DOI 10.1086/511073; RICHARDSON HB, 1965, J PEDIATR-US, V67, P6, DOI 10.1016/S0022-3476(65)80297-9; Ryu WS, 2010, J CLIN MICROBIOL, V48, P2490, DOI 10.1128/JCM.02369-09; Wan J, 2008, ANHUI MED J, V29, P344, DOI DOI 10.3969/J.ISSN.1000-0399.2008.04.003; Wang SM, 2006, J CLIN VIROL, V37, P47, DOI 10.1016/j.jcv.2006.05.009; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Wang SM, 1999, CLIN INFECT DIS, V29, P184, DOI 10.1086/520149; Wei RC, 2013, VIRUS RES, V177, P62, DOI 10.1016/j.virusres.2013.07.009; Yang TC, 2012, EUR J PEDIATR, V171, P1359, DOI 10.1007/s00431-012-1731-7; Zeng M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002599; Zhang J, 2011, BIOMED ENVIRON SCI, V24, P214, DOI 10.3967/0895-3988.2011.03.002; Zheng X, 2013, CLIN EXP MED, DOI [10.1007/s10238-10013-10237-10236, DOI 10.1007/S10238-10013-10237-10236]; Zhu D, 2013, DIAGN MICR INFEC DIS, V76, P162, DOI 10.1016/j.diagmicrobio.2013.02.011	30	28	35	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112676	10.1371/journal.pone.0112676	http://dx.doi.org/10.1371/journal.pone.0112676			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391156	Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400118
J	Soto-Hermida, A; Fernandez-Moreno, M; Oreiro, N; Fernandez-Lopez, C; Pertega, S; Cortes-Pereira, E; Rego-Perez, I; Blanco, FJ				Soto-Hermida, Angel; Fernandez-Moreno, Mercedes; Oreiro, Natividad; Fernandez-Lopez, Carlos; Pertega, Sonia; Cortes-Pereira, Estefania; Rego-Perez, Ignacio; Blanco, Francisco J.			Mitochondrial DNA (mtDNA) Haplogroups Influence the Progression of Knee Osteoarthritis. Data from the Osteoarthritis Initiative (OAI)	PLOS ONE			English	Article							NORMAL HUMAN CHONDROCYTES; RECEPTOR ANTAGONIST GENE; DEGENERATIVE DISEASES; DYSFUNCTION; ASSOCIATION; CARTILAGE; POPULATION; SUSCEPTIBILITY; SENSITIVITY; PREVALENCE	Objective: To evaluate the influence of the mtDNA haplogroups on knee osteoarthritis progression in Osteoarthritis Initiative ( OAI) participants through longitudinal data from radiographs and magnetic resonance imaging (MRI). Methods: Four-year knee osteoarthritis progression was analyzed as increase in Kellgren and Lawrence (KL) grade, in addition to increase in OARSI atlas grade for joint space narrowing (JSN), osteophytes and subchondral sclerosis in the tibia medial compartment of 891 Caucasian individuals from the progression subcohort. The influence of the haplogroups on the rate of structural progression was also assessed as the four-year change in minimum joint space width (mJSW in millimetres) in both knees of (n = 216) patients with baseline unilateral medial-tibiofemoral JSN. Quantitative cartilage measures from longitudinal MRI data were those related to cartilage thickness and volume with a 24 month follow-up period (n = 381). Results: During the four-year follow-up period, knee OA patients with the haplogroup T showed the lowest increase in KL grade (Hazard Risk [HR] = 0.499; 95% Confidence Interval [CI]: 0.261-0.819; p<0.05) as well as the lowest cumulative probability of progression for JSN (HR = 0.547; 95% CI: 0.280-0.900; p<0.05), osteophytes (HR = 0.573; 95% CI: 0.304-0.893; p, 0.05) and subchondral sclerosis (HR = 0.549; 95% CI: 0.295-0.884; p<0.05). They also showed the lowest decline in mJSW (standardized response means (SRM) = 20.39; p = 0.037) in those knees without baseline medial JSN (no-JSN knees). Normalized cartilage volume loss was significantly lower in patients carrying the haplogroup T at medial tibia femoral (SRM = 20.33; p = 0.023) and central medial femoral (SRM = 20.27; p = 0.031) compartments. Cartilage thickness loss was significantly lower in carriers of haplogroup T at central medial tibia-femoral (SRM = 20.42; p = 0.011), medial tibia femoral (SRM = 20.32; p = 0.018), medial tibia anterior (SRM = + 0.31; p = 0.013) and central medial femoral (SRM = 20.19; p = 0.013) compartments. Conclusions: Mitochondrial genome seems to play a role in the progression of knee osteoarthritis. mtDNA variation could improve identification of patients predisposed to faster or severe progression of the disease.	[Soto-Hermida, Angel; Fernandez-Moreno, Mercedes; Oreiro, Natividad; Fernandez-Lopez, Carlos; Cortes-Pereira, Estefania; Rego-Perez, Ignacio; Blanco, Francisco J.] UDC, Complexo Hosp Univ A Coruna CHUAC, Inst Invest Biomed A Coruna INIBIC, Grp Genom,Serv Reumatol, La Coruna, Spain; [Pertega, Sonia] UDC, Complexo Hosp Univ A Coruna CHUAC, Inst Invest Biomed A Coruna INIBIC, Unidad Epidemiol, La Coruna, Spain	Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC)	Rego-Perez, I (corresponding author), UDC, Complexo Hosp Univ A Coruna CHUAC, Inst Invest Biomed A Coruna INIBIC, Grp Genom,Serv Reumatol, La Coruna, Spain.	Igancio.rego.perez@sergas.es; fblagar@sergas.es	Pértega-Díaz, Sonia/E-4353-2013; Soto-Hermida, Angel/ABE-1924-2020; fernandez-moreno, mercedes MFM/I-3219-2017; Blanco, Francisco J./C-3192-2014; Rego-Pérez, Ignacio/B-1665-2012	Pértega-Díaz, Sonia/0000-0003-3891-3203; Soto-Hermida, Angel/0000-0003-2475-9305; fernandez-moreno, mercedes MFM/0000-0001-5077-1274; Blanco, Francisco J./0000-0001-9821-7635; Rego-Pérez, Ignacio/0000-0003-1754-1164	Fundacion Espanola de Reumatologia (programa GEN-SER); Fondo Investigacion Sanitaria-Spain [CIBERCB06/01/0040]; Fondo Investigacion Sanitaria-PI [08/2028]; Ministerio Ciencia e Innovacion [PLE2009-0144]; FEDER (European Community); Contrato Miguel Servet-Fondo Investigacion Sanitaria [CP12/03192]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [N01AR022262, N01AR022260, N01AR022258, N01AR022261, N01AR022259] Funding Source: NIH RePORTER	Fundacion Espanola de Reumatologia (programa GEN-SER); Fondo Investigacion Sanitaria-Spain(Instituto de Salud Carlos III); Fondo Investigacion Sanitaria-PI; Ministerio Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER (European Community)(European Commission); Contrato Miguel Servet-Fondo Investigacion Sanitaria; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by grants from Fundacion Espanola de Reumatologia (programa GEN-SER) and from Fondo Investigacion Sanitaria (CIBERCB06/01/0040)-Spain, Fondo Investigacion Sanitaria-PI 08/2028, Ministerio Ciencia e Innovacion PLE2009-0144, with a contribution of funds from FEDER (European Community). IRP was supported by Contrato Miguel Servet-Fondo Investigacion Sanitaria (CP12/03192). The authors would like to thank the participants, principal investigators, coinvestigators and staff of the OAI. The Osteoarthritis Initiative (OAI) is a public-private partnership comprised of five contracts (N01-AR-2-2258; N01-AR-2-2259; N01-AR-2-2260; N01-AR-2-2261; N01-AR-2-2262) funded by the National Institutes of Health, a branch of the Department of Health and Human Services, and conducted by the OAI Study Investigators. Private funding partners include Pfizer, Inc.; Novartis Pharmaceuticals Corporation; Merck Research Laboratories; and GlaxoSmithKline. Private sector funding for the OAI is managed by the Foundation for the National Institutes of Health. This manuscript was prepared using an OAI public use data set and does not necessarily reflect the opinions or views of the OAI investigators, the NIH, or the private funding partners. This manuscript has received the approval of the OAI Publications Committee based on a review of its scientific content and data interpretation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN RD, 1995, OSTEOARTHR CARTILAGE, V3, P3; Attur M, 2010, ANN RHEUM DIS, V69, P856, DOI 10.1136/ard.2009.113043; Benichou OD, 2010, ARTHRIT CARE RES, V62, P924, DOI 10.1002/acr.20149; Blanco FJ, 2004, MITOCHONDRION, V4, P715, DOI 10.1016/j.mito.2004.07.022; Blanco FJ, 2011, NAT REV RHEUMATOL, V7, P161, DOI 10.1038/nrrheum.2010.213; Brown, 2006, APPL MIXED MODELS ME; Cillero-Pastor B, 2008, ARTHRITIS RHEUM-US, V58, P2409, DOI 10.1002/art.23644; Cillero-Pastor B, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-235; Dato S, 2004, EUR J HUM GENET, V12, P1080, DOI 10.1038/sj.ejhg.5201278; Eckstein F, 2009, ANN RHEUM DIS, V68, P674, DOI 10.1136/ard.2008.089904; Eckstein F, 2013, ANN RHEUM DIS, V72, P707, DOI 10.1136/annrheumdis-2011-201164; Eckstein F, 2012, NAT REV RHEUMATOL, V8, P622, DOI 10.1038/nrrheum.2012.113; Eckstein F, 2011, ARTHRIT CARE RES, V63, P311, DOI 10.1002/acr.20370; Fang HZ, 2014, INT J MOL SCI, V15, P2646, DOI 10.3390/ijms15022646; Fernandez-Moreno M, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-283; Fernandez-Moreno M, 2008, CURR GENOMICS, V9, P542, DOI 10.2174/138920208786847953; Garnero P, 2003, CURR OPIN RHEUMATOL, V15, P641, DOI 10.1097/00002281-200309000-00020; Gavriilidis C, 2013, ARTHRITIS RHEUM-US, V65, P378, DOI 10.1002/art.37782; Gomez-Duran A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246; Grishko VI, 2009, OSTEOARTHR CARTILAGE, V17, P107, DOI 10.1016/j.joca.2008.05.009; Henrotin Y, 2007, CURR DRUG TARGETS, V8, P347, DOI 10.2174/138945007779940151; Herrnstadt C, 2004, MITOCHONDRION, V4, P791, DOI 10.1016/j.mito.2004.07.041; Hudson G, 2013, ANN RHEUM DIS, V72, P136, DOI 10.1136/annrheumdis-2012-201932; Kamarainen OP, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2374; Kenney MC, 2014, BBA-MOL BASIS DIS, V1842, P208, DOI 10.1016/j.bbadis.2013.10.016; Kenney MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054339; Kerkhof HJM, 2011, OSTEOARTHR CARTILAGE, V19, P265, DOI 10.1016/j.joca.2010.12.003; Kim HA, 2007, CURR DRUG TARGETS, V8, P333, DOI 10.2174/138945007779940025; Le Graverand MPH, 2008, ANN RHEUM DIS, V67, P1562, DOI 10.1136/ard.2007.077834; LEDINGHAM J, 1993, ANN RHEUM DIS, V52, P520, DOI 10.1136/ard.52.7.520; Maneiro E, 2003, ARTHRITIS RHEUM, V48, P700, DOI 10.1002/art.10837; Mazzuca SA, 2006, ANN RHEUM DIS, V65, P515, DOI 10.1136/ard.2005.039115; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Mueller EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052367; Nardelli C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/631082; Pan W, 1999, J COMPUT GRAPH STAT, V8, P109, DOI 10.2307/1390923; Rego I, 2010, ANN RHEUM DIS, V69, P210, DOI 10.1136/ard.2008.105254; Rego-Perez I, 2011, ANN RHEUM DIS, V70, P646, DOI 10.1136/ard.2010.133637; Rego-Perez I, 2010, ANN RHEUM DIS, V69, P910, DOI 10.1136/ard.2009.117416; Rego-Perez I, 2008, ARTHRITIS RHEUM-US, V58, P2387, DOI 10.1002/art.23659; Rego-Perez Ignacio, 2013, Front Biosci (Schol Ed), V5, P360; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Soto-Hermida A, 2014, MITOCHONDRION, V15, P18, DOI 10.1016/j.mito.2014.03.001; Soto-Hermida A, 2014, RHEUMATOL INT; Suantawee T, 2013, J CLIN DIAGN RES, V7, P1855, DOI 10.7860/JCDR/2013/5802.3333; Sun J., 2006, STAT ANAL INTERVAL C; Takahashi H, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3157; Torroni A, 1996, GENETICS, V144, P1835; TURNBULL BW, 1976, J R STAT SOC B, V38, P290; Vaamonde-Garcia C, 2012, ARTHRITIS RHEUM-US, V64, P2927, DOI 10.1002/art.34508; Valdes AM, 2004, ARTHRITIS RHEUM-US, V50, P2497, DOI 10.1002/art.20443; Valdes AM, 2011, NAT REV RHEUMATOL, V7, P23, DOI 10.1038/nrrheum.2010.191; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 2003, COLD SPRING HARB SYM, V68, P479; Wallace DC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0267; Wirth W, 2010, OSTEOARTHR CARTILAGE, V18, P547, DOI 10.1016/j.joca.2009.12.003; Wirth W, 2009, OSTEOARTHR CARTILAGE, V17, P291, DOI 10.1016/j.joca.2008.07.008; Wu LH, 2014, CURR DRUG TARGETS, V15, P710, DOI 10.2174/1389450115666140417120305; Wu X, 2013, OSTEOARTHR CARTILAGE, V21, P930, DOI 10.1016/j.joca.2013.04.003; Zeggini E, 2012, LANCET, V380, P815, DOI 10.1016/S0140-6736(12)60681-3; Zhai G, 2007, OSTEOARTHR CARTILAGE, V15, P222, DOI 10.1016/j.joca.2006.09.004; Zhao D, 2007, J ORTHOP RES, V25, P593, DOI 10.1002/jor.20362	63	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112735	10.1371/journal.pone.0112735	http://dx.doi.org/10.1371/journal.pone.0112735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390621	Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400122
J	Cheng, ML; Weng, SF; Kuo, CH; Ho, HY				Cheng, Mei-Ling; Weng, Shiue-Fen; Kuo, Chih-Hao; Ho, Hung-Yao			Enterovirus 71 Induces Mitochondrial Reactive Oxygen Species Generation That is Required for Efficient Replication	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; VIRUS PB1-F2 PROTEIN; OXIDATIVE STRESS; OUTER-MEMBRANE; HEPATOMA-CELLS; MOUTH-DISEASE; CYTOCHROME-C; INFECTION; APOPTOSIS; OUTBREAK	Redox homeostasis is an important host factor determining the outcome of infectious disease. Enterovirus 71 (EV71) infection has become an important endemic disease in Southeast Asia and China. We have previously shown that oxidative stress promotes viral replication, and progeny virus induces oxidative stress in host cells. The detailed mechanism for reactive oxygen species (ROS) generation in infected cells remains elusive. In the current study, we demonstrate that mitochondria were a major ROS source in EV71-infected cells. Mitochondria in productively infected cells underwent morphologic changes and exhibited functional anomalies, such as a decrease in mitochondrial electrochemical potential Delta Psi(m) and an increase in oligomycin-insensitive oxygen consumption. Respiratory control ratio of mitochondria from infected cells was significantly lower than that of normal cells. The total adenine nucleotide pool and ATP content of EV71-infected cells significantly diminished. However, there appeared to be a compensatory increase in mitochondrial mass. Treatment with mito-TEMPO reduced eIF2 alpha phosphorylation and viral replication, suggesting that mitochondrial ROS act to promote viral replication. It is plausible that EV71 infection induces mitochondrial ROS generation, which is essential to viral replication, at the sacrifice of efficient energy production, and that infected cells up-regulate biogenesis of mitochondria to compensate for their functional defect.	[Cheng, Mei-Ling] Chang Gung Univ, Coll Med, Dept Biomed Sci, Taoyuan, Taiwan; [Cheng, Mei-Ling; Ho, Hung-Yao] Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan, Taiwan; [Cheng, Mei-Ling] Chang Gung Univ, Metabol Core Lab, Taoyuan, Taiwan; [Weng, Shiue-Fen; Kuo, Chih-Hao; Ho, Hung-Yao] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan; [Ho, Hung-Yao] Chang Gung Mem Hosp, Off Res & Dev, Taoyuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Ho, HY (corresponding author), Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan, Taiwan.	hoh01@mail.cgu.edu.tw		zheng, mei ling/0000-0003-2006-133X	Chang Gung University [CMRPD190443, CMRPD1A0562, CMRPD1C0751, CMRPD1A0563, CMRPD1A0521, CMRPD1A0522, CMRPD391683, CMRPD1C0441, CMRPD1C0761]; National Science Council of Taiwan [NSC99-2320-B-182-021-MY3, NSC101-2320-B-182-024-MY3]; Ministry of Education of Taiwan [EMRPD1C0271, EMRPD1D0241]	Chang Gung University; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education of Taiwan(Ministry of Education, Taiwan)	This project is supported by grants from Chang Gung University (CMRPD190443, CMRPD1A0562, CMRPD1C0751, CMRPD1A0563, CMRPD1A0521, CMRPD1A0522, CMRPD391683, CMRPD1C0441, and CMRPD1C0761), National Science Council of Taiwan (NSC99-2320-B-182-021-MY3 and NSC101-2320-B-182-024-MY3), and the Ministry of Education of Taiwan (EMRPD1C0271 and EMRPD1D0241). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopova O V, 2012, Fiziol Zh, V58, P3; Anand SK, 2013, ADV VIROL, V2013, DOI 10.1155/2013/738794; Aquaro S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-76; Beck MA, 2005, FREE RADICAL BIO MED, V38, P112, DOI 10.1016/j.freeradbiomed.2004.10.007; Beck MA, 2003, J NUTR, V133, p1463S, DOI 10.1093/jn/133.5.1463S; Beck MA, 2000, ANN NY ACAD SCI, V917, P906; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Cai JY, 2003, FREE RADICAL BIO MED, V34, P928, DOI 10.1016/S0891-5849(03)00023-6; Chang SC, 2004, J NEUROVIROL, V10, P338, DOI 10.1080/13550280490521032; Cheng ML, 2013, FREE RADICAL RES, V47, P699, DOI 10.3109/10715762.2013.816420; Cheng ML, 2011, BIOCHEM PHARMACOL, V82, P1549, DOI 10.1016/j.bcp.2011.07.104; Claus C, 2013, J VIROL, V87, P8481, DOI 10.1128/JVI.00533-13; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; da Costa LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033871; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; El-Bacha T, 2004, MOL CELL BIOCHEM, V266, P191, DOI 10.1023/B:MCBI.0000049154.17866.00; Gibbs JS, 2003, J VIROL, V77, P7214, DOI 10.1128/JVI.77.13.7214-7224.2003; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Grek CL, 2013, J BIOL CHEM, V288, P26497, DOI 10.1074/jbc.R113.461368; Hanson PJ, 2013, VIRAL REPLICATION, P103; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Ho HY, 2008, INT J ONCOL, V33, P969, DOI 10.3892/ijo_00000084; Ho HY, 2008, J GEN VIROL, V89, P2080, DOI 10.1099/vir.0.2008/001404-0; Ho HY, 2009, J AGR FOOD CHEM, V57, P6140, DOI 10.1021/jf901128u; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hollander JM, 2014, AM J PHYSL HEART CIR; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; ISHIMARU Y, 1980, ARCH DIS CHILD, V55, P583, DOI 10.1136/adc.55.8.583; Ito T, 1999, J BIOL CHEM, V274, P15427, DOI 10.1074/jbc.274.22.15427; Jackson AC, 2011, ADV VIRUS RES, V79, P127, DOI 10.1016/B978-0-12-387040-7.00008-1; Jheng JR, 2010, CELL MICROBIOL, V12, P796, DOI 10.1111/j.1462-5822.2010.01434.x; Joshi M, 2013, BIOCHIMIE, V95, P1980, DOI 10.1016/j.biochi.2013.07.030; Kaarbo M, 2011, MITOCHONDRION, V11, P935, DOI 10.1016/j.mito.2011.08.008; Kaul P, 2000, J INFECT DIS, V181, P1885, DOI 10.1086/315504; Kim S, 2007, J VIROL, V81, P1714, DOI 10.1128/JVI.01863-06; Koike K, 2007, J GASTROEN HEPATOL, V22, pS108, DOI 10.1111/j.1440-1746.2006.04669.x; KORNBLITH PL, 1978, J NEUROSURG, V48, P580, DOI 10.3171/jns.1978.48.4.0580; Korytowski W, 2011, J BIOL CHEM, V286, P26334, DOI 10.1074/jbc.M110.188516; Koshiba T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001147; Kristian T, 2006, J NEUROSCI METH, V152, P136, DOI 10.1016/j.jneumeth.2005.08.018; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Lachgar A, 1999, J VIROL, V73, P1447, DOI 10.1128/JVI.73.2.1447-1452.1999; Lecoeur H, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.21; Li QH, 2005, J CLIN VIROL, V34, P133, DOI 10.1016/j.jcv.2004.12.019; Lin CJ, 2010, FREE RADICAL BIO MED, V49, P361, DOI 10.1016/j.freeradbiomed.2010.04.019; Lin TY, 2002, CLIN INFECT DIS, V34, pS52, DOI 10.1086/338819; Liu ZW, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-158; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Mochizuki H, 2009, INFLAMMATION, V32, P252, DOI 10.1007/s10753-009-9128-0; Moran M, 2010, BBA-MOL BASIS DIS, V1802, P443, DOI 10.1016/j.bbadis.2010.02.001; Nchoutmboube JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003401; Nomura-Takigawa Y, 2006, J GEN VIROL, V87, P1935, DOI 10.1099/vir.0.81701-0; ODA T, 1989, SCIENCE, V244, P974, DOI 10.1126/science.2543070; Ohta A, 2011, MITOCHONDRION, V11, P1, DOI 10.1016/j.mito.2010.08.006; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; Paracha UZ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-251; Parekh AB, 2003, NEWS PHYSIOL SCI, V18, P252, DOI 10.1152/nips.01458.2003; Piccoli C, 2009, BBA-BIOENERGETICS, V1787, P539, DOI 10.1016/j.bbabio.2008.11.008; Piccoli C, 2007, HEPATOLOGY, V46, P58, DOI 10.1002/hep.21679; Prinarakis E, 2008, EMBO J, V27, P865, DOI 10.1038/emboj.2008.28; Quarato G, 2013, INT J BIOCHEM CELL B, V45, P156, DOI 10.1016/j.biocel.2012.06.008; Racaniello V.R., 2001, FIELDS VIROLOGY, P455; Rahmani Z, 2000, J VIROL, V74, P2840, DOI 10.1128/JVI.74.6.2840-2846.2000; Rojo G, 1998, J VIROL, V72, P7583, DOI 10.1128/JVI.72.9.7583-7588.1998; Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; RUTKA JT, 1987, ACTA NEUROPATHOL, V75, P92, DOI 10.1007/BF00686798; Sasaki O, 2013, BBA-MOL CELL RES, V1833, P1017, DOI 10.1016/j.bbamcr.2013.01.010; Schachtele SJ, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-35; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Schrand AM, 2010, NAT PROTOC, V5, P744, DOI 10.1038/nprot.2010.2; Schwer B, 2004, J VIROL, V78, P7958, DOI 10.1128/JVI.78.15.7958-7968.2004; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shih SR, 2004, J NEUROVIROL, V10, P293, DOI 10.1080/13550280490499551; Tal MC, 2011, IMMUNOL REV, V243, P215, DOI 10.1111/j.1600-065X.2011.01038.x; Tung WH, 2011, J CELL PHYSIOL, V226, P3316, DOI 10.1002/jcp.22677; Verfaillie T, 2012, CELL DEATH DIFFER, V19, P1880, DOI 10.1038/cdd.2012.74; Wang T, 2006, J GASTROEN HEPATOL, V21, pS34, DOI 10.1111/j.1440-1746.2006.04591.x; Waris G, 2001, MOL CELL BIOL, V21, P7721, DOI 10.1128/MCB.21.22.7721-7730.2001; Yamada H, 2004, FEBS LETT, V578, P331, DOI 10.1016/j.febslet.2004.11.017; Yang F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-508; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Zhang SM, 2005, ARCH VIROL, V150, P1579, DOI 10.1007/s00705-005-0521-1	83	45	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113234	10.1371/journal.pone.0113234	http://dx.doi.org/10.1371/journal.pone.0113234			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401329	Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700123
J	Kamiya, K; Shimizu, K; Iijima, A; Kobashi, H				Kamiya, Kazutaka; Shimizu, Kimiya; Iijima, Ayaka; Kobashi, Hidenaga			Factors Influencing Contrast Sensitivity Function in Myopic Eyes	PLOS ONE			English	Article							LIGHT-SCATTERING; SCHEIMPFLUG SYSTEM; ABERRATIONS; PUPIL; QUALITY; VISTECH; CHARTS; AGE	Purpose: To evaluate the factors affecting the area under the log contrast sensitivity function (AULCSF) in healthy myopic eyes. Methods: We retrospectively examined 201 eyes of 201 consecutive subjects (age, 31.8 +/- 7.4 years (mean +/- standard deviation)) with myopic refractive errors of -1.25 to -8.25 diopters (D). From the contrast sensitivity data, the area under the log contrast sensitivity function (AULCSF) was calculated. Stepwise multiple regression analysis was used to assess the factors affecting the AULCSF. Results: The mean AULSCF was 1.09 +/- 0.09 (0.89 to 1.55). Explanatory variables relevant to the AULCSF were, in order of influence, the objective scattering index (OSI) (p = 0.018, partial regression coefficient B = -0.032) and logMAR CDVA (p = 0.022, B = -0.209) (adjusted R-2 = 0.231). No significant correlation was seen with other clinical factors such as gender, manifest refraction, pupil size, lens density, corneal HOAs, or ocular HOAs. Conclusions: Although the great majority of the variance remains unexplained, eyes with lower OSI and better CDVA are more predisposed to show higher contrast sensitivity function. These results indicate that not only CDVA but also intraocular forward scattering may play some role in predicting the contrast sensitivity function in myopic subjects.	[Kamiya, Kazutaka; Shimizu, Kimiya; Iijima, Ayaka; Kobashi, Hidenaga] Kitasato Univ, Sch Med, Dept Ophthalmol, Sagamihara, Kanagawa 228, Japan	Kitasato University	Kamiya, K (corresponding author), Kitasato Univ, Sch Med, Dept Ophthalmol, Sagamihara, Kanagawa 228, Japan.	kamiyak-tky@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24592642]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (24592642). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSONS I, 1992, ARCH OPHTHALMOL-CHIC, V110, P1081, DOI 10.1001/archopht.1992.01080200061025; Applegate RA, 1998, J REFRACT SURG, V14, P397, DOI 10.3928/1081-597X-19980701-05; Artal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016823; Feizi S, 2009, JPN J OPHTHALMOL, V53, P414, DOI 10.1007/s10384-009-0677-4; Fujikado T, 2004, J CATARACT REFR SURG, V30, P1198, DOI 10.1016/j.jcrs.2003.12.023; Hennelly ML, 1998, OPHTHAL PHYSL OPT, V18, P197, DOI 10.1016/S0275-5408(97)00077-X; Hernandez C, 1996, OPHTHAL PHYSL OPT, V16, P336, DOI 10.1016/0275-5408(95)00116-6; JINDRA LF, 1989, J CATARACT REFR SURG, V15, P141, DOI 10.1016/S0886-3350(89)80002-1; Kim JS, 2009, J CATARACT REFR SURG, V35, P1204, DOI 10.1016/j.jcrs.2009.02.032; Lee H, 2014, OPTOMETRY VISION SCI, V91, P437, DOI 10.1097/OPX.0000000000000190; Liang JZ, 1997, J OPT SOC AM A, V14, P2873, DOI 10.1364/JOSAA.14.002873; Oshika T, 2006, INVEST OPHTH VIS SCI, V47, P1334, DOI 10.1167/iovs.05-1154; Oshika T, 2006, OPHTHALMOLOGY, V113, P1807, DOI 10.1016/j.ophtha.2006.03.061; OWSLEY C, 1983, VISION RES, V23, P689, DOI 10.1016/0042-6989(83)90210-9; Pei X, 2008, BRIT J OPHTHALMOL, V92, P1471, DOI 10.1136/bjo.2007.136978; Perez GM, 2009, J VISION, V9, DOI 10.1167/9.3.19; Pesudovs K, 2004, BRIT J OPHTHALMOL, V88, P11, DOI 10.1136/bjo.88.1.11; REEVES BC, 1991, OPTOMETRY VISION SCI, V68, P728, DOI 10.1097/00006324-199109000-00010; SNYDER AW, 1979, BIOL CYBERN, V32, P9, DOI 10.1007/BF00337446; Strang NC, 1999, OPHTHAL PHYSL OPT, V19, P415, DOI 10.1016/S0275-5408(99)00014-9; THAUNG J, 1995, INVEST OPHTH VIS SCI, V36, P2313; VANDENBERG TJTP, 1986, DOC OPHTHALMOL, V61, P327, DOI 10.1007/BF00142360; VIRSU V, 1979, EXP BRAIN RES, V37, P475	23	19	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113562	10.1371/journal.pone.0113562	http://dx.doi.org/10.1371/journal.pone.0113562			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401751	Green Submitted, gold, Green Published			2022-12-27	WOS:000345158700140
J	Mullick, S; Mukherjee, A; Ghosh, S; Pazhani, GP; Sur, D; Manna, B; Nataro, JP; Levine, MM; Ramamurthy, T; Chawla-Sarkar, M				Mullick, Satarupa; Mukherjee, Anupam; Ghosh, Santanu; Pazhani, Gururaja P.; Sur, Dipika; Manna, Byomkesh; Nataro, James P.; Levine, Myron M.; Ramamurthy, Thandavarayan; Chawla-Sarkar, Mamta			Community Based Case-Control Study of Rotavirus Gastroenteritis among Young Children during 2008-2010 Reveals Vast Genetic Diversity and Increased Prevalence of G9 Strains in Kolkata	PLOS ONE			English	Article							GROUP-A ROTAVIRUS; HOSPITAL-BASED SURVEILLANCE; GLOBAL ENTERIC MULTICENTER; MOLECULAR CHARACTERIZATION; CLOSE RELATIONSHIP; G12; GENOTYPE; EASTERN; INFANTS; INDIA	Background: Group A Rotaviruses are a major etiologic agent of gastroenteritis in infants and young children (, 5 years) worldwide. Although rotavirus vaccines have been successfully administered in many countries, in India the introduction of rotavirus vaccine in national immunization program was approved in 2014. Since high disease burden and large number of genetic variants have been reported from low income countries including India, monitoring of rotavirus was initiated prior to implementation of the vaccine in the region. Methods: A total number of 3,582 stool samples were collected from an urban slum community in Kolkata, among which 1,568 samples were obtained from children of <= 5 years of age, with moderate to severe diarrhoea and 2,014 samples were collected from age-sex matched healthy neighbourhood controls. Rotavirus positive samples were typed by multiplex seminested PCR and nucleotide sequencing. Circulating strains were phylogenetically analyzed. Results: Among 1,568 children with diarrhoea, 395 (25.2%), and among 2,014 asymptomatic children, 42 (2%) were rotavirus positive. G1P[8] was identified as the most common strain (32%) followed by G9P[8] (16.9%), G2P[4] (13.5%) and G9P[4] (10.75%). G12 strains with combinations of P[4], P[6] and P[8] comprised 11.9% of total positive strains. The rest (<10%) were rare and uncommon strains like G1P[4], G1P[6], G2P[8] and animal-like strains G4P[6], G6P[14] and G11P[25]. The 42 rotavirus positive samples from asymptomatic children revealed common genotypes like G1, G2 and G9. Conclusion: This community based case-control study showed increased predominance of genotype G9 in Kolkata. It also confirmed co-circulation of a large number of genetic variants in the community. Asymptomatic rotavirus positive children though low in number can also be a source of dispersal of infection in the community. This study provides background information to the policy makers for implementation of rotavirus vaccines in this region.	[Mullick, Satarupa; Mukherjee, Anupam; Ghosh, Santanu; Pazhani, Gururaja P.; Sur, Dipika; Manna, Byomkesh; Ramamurthy, Thandavarayan; Chawla-Sarkar, Mamta] Natl Inst Cholera & Enter Dis, Kolkata, India; [Nataro, James P.] Univ Virginia, Sch Med, Dept Paediat, Charlottesville, VA 22908 USA; [Levine, Myron M.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); University of Virginia; University System of Maryland; University of Maryland Baltimore	Chawla-Sarkar, M (corresponding author), Natl Inst Cholera & Enter Dis, Kolkata, India.	chawlam70@gmail.com	Mukherjee, Anupam/ABB-9438-2020	Mukherjee, Anupam/0000-0002-0612-2258; Pazhani, Gururaja Perumal/0000-0001-9500-006X	Bill & Melinda Gates Foundation [38874]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Bill & Melinda Gates Foundation (grant number 38874). http://www.gatesfoundation.org/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akihara S, 2005, ARCH VIROL, V150, P2061, DOI 10.1007/s00705-005-0540-y; Banerjee I, 2007, J MED VIROL, V79, P1768, DOI 10.1002/jmv.20988; Banerjee I, 2007, J MED VIROL, V79, P1413, DOI 10.1002/jmv.20872; Barril P, 2013, J MED VIROL, V85, P363, DOI 10.1002/jmv.23462; Bhandari N, 2014, LANCET, V383, P2136, DOI 10.1016/S0140-6736(13)62630-6; Caprioli A, 1996, PEDIATR INFECT DIS J, V15, P876, DOI 10.1097/00006454-199610000-00009; Chakravarti A, 2010, SE ASIAN J TROP MED, V41, P1145; Cilla G, 2014, ENFERM INFEC MICR CL, V32, P405, DOI 10.1016/j.eimc.2014.01.012; DAS BK, 1994, J CLIN MICROBIOL, V32, P1820, DOI 10.1128/JCM.32.7.1820-1822.1994; Das S, 2004, J MED VIROL, V72, P156, DOI 10.1002/jmv.10542; Do LP, 2014, ARCH VIROL, V159, P315, DOI 10.1007/s00705-013-1804-6; Donato CM, 2014, INFECT GENET EVOL, V25, P97, DOI 10.1016/j.meegid.2014.04.009; Forster J, 2009, PEDIATRICS, V123, pe393, DOI 10.1542/peds.2008-2088; Ghosh S, 2006, ARCH VIROL, V151, P1329, DOI 10.1007/s00705-005-0714-7; Gomez MM, 2014, INFECT GENET EVOL, V28, P385, DOI 10.1016/j.meegid.2014.04.007; Iturriza-Gomara M, 2011, EPIDEMIOL INFECT, V139, P895, DOI 10.1017/S0950268810001810; Jiang V, 2010, HUM VACCINES, V6, P532, DOI 10.4161/hv.6.7.11278; Kang G, 2005, J INFECT DIS, V192, pS120, DOI 10.1086/431496; Kang G, 2009, J INFECT DIS, V200, pS147, DOI 10.1086/605031; Kawai K, 2012, VACCINE, V30, P1244, DOI 10.1016/j.vaccine.2011.12.092; Kiulia NM, 2014, PEDIATR INFECT DIS J, V33, pS85, DOI 10.1097/INF.0000000000000059; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kotloff KL, 2012, CLIN INFECT DIS, V55, pS232, DOI 10.1093/cid/cis753; Kumar D, 2012, J VIROL METHODS, V179, P201, DOI 10.1016/j.jviromet.2011.10.017; Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788; Levine MM, 2012, CLIN INFECT DIS, V55, pS215, DOI 10.1093/cid/cis761; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Matthijnssens J, 2008, ARCH VIROL, V153, P1621, DOI 10.1007/s00705-008-0155-1; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Matthijnssens J, 2012, EXPERT REV VACCINES, V11, P1347, DOI [10.1586/ERV.12.105, 10.1586/erv.12.105]; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Matthijnssens J, 2010, MOL BIOL EVOL, V27, P2431, DOI 10.1093/molbev/msq137; Matthijnssens J, 2010, EMERG INFECT DIS, V16, P625, DOI 10.3201/eid1604.091591; Matthijnssens J, 2009, J VIROL, V83, P2917, DOI 10.1128/JVI.02246-08; Mijatovic-Rustempasic S, 2014, INFECT GENET EVOL, V21, P214, DOI 10.1016/j.meegid.2013.11.004; Morris SK, 2012, B WORLD HEALTH ORGAN, V90, P720, DOI 10.2471/BLT.12.101873; Moyo SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097562; Mukherjee A, 2010, INFECT GENET EVOL, V10, P311, DOI 10.1016/j.meegid.2010.01.002; Mullick S, 2014, VACCINE, V32, pA20, DOI 10.1016/j.vaccine.2014.03.018; Mullick S, 2013, INFECT GENET EVOL, V14, P15, DOI 10.1016/j.meegid.2012.11.010; Nair GB, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-4; National Collaborating Centre for Women's and Children's Health, 2009, DIARRH VOM CAUS GAST; Olesen B, 2005, J CLIN MICROBIOL, V43, P3636, DOI 10.1128/JCM.43.8.3636-3641.2005; Paul SK, 2008, ARCH VIROL, V153, P1999, DOI 10.1007/s00705-008-0212-9; Payne DC, 2008, PEDIATRICS, V122, P1235, DOI 10.1542/peds.2007-3378; Rahman M, 2003, J CLIN MICROBIOL, V41, P2088, DOI 10.1128/JCM.41.5.2088-2095.2003; Rahman M, 2007, EMERG INFECT DIS, V13, P18, DOI 10.3201/eid1301.060910; Samajdar S, 2006, J CLIN VIROL, V36, P183, DOI 10.1016/j.jcv.2006.03.006; Samajdar S, 2008, J CLIN VIROL, V43, P334, DOI 10.1016/j.jcv.2008.07.007; Sanchez-Fauquier A, 2014, ENFERM INFEC MICR CL, V32, P280, DOI 10.1016/j.eimc.2013.07.012; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Shimizu H, 2007, INFECT GENET EVOL, V7, P279, DOI 10.1016/j.meegid.2006.11.005; Steele AD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-213; TANIGUCHI K, 1992, EPIDEMIOL INFECT, V109, P303, DOI 10.1017/S0950268800050263; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Theamboonlers A, 2014, INFECT GENET EVOL, V21, P295, DOI 10.1016/j.meegid.2013.11.020; Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0	57	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112970	10.1371/journal.pone.0112970	http://dx.doi.org/10.1371/journal.pone.0112970			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401757	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700088
J	Jiang, L; Wang, H; Shi, CL; Liu, K; Liu, MD; Wang, NA; Wang, KK; Zhang, HL; Wang, GL; Xiao, XZ				Jiang, Lei; Wang, Hao; Shi, Chunli; Liu, Ke; Liu, Meidong; Wang, Nian; Wang, Kangkai; Zhang, Huali; Wang, Guiliang; Xiao, Xianzhong			ZNF667/Mipu1 Is a Novel Anti-Apoptotic Factor That Directly Regulates the Expression of the Rat Bax Gene in H9c2 Cells	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; PEROXIDE-INDUCED APOPTOSIS; BCL-2 FAMILY PROTEINS; OXIDATIVE STRESS; UP-REGULATION; MITOCHONDRIAL DYSFUNCTION; FUNCTIONAL-ANALYSIS; DEATH; MIPU1; TRANSCRIPTION	ZNF667/Mipu1, a C2H2-type zinc finger transcription factor, was suggested to play an important role in oxidative stress. However, none of the target genes or potential roles of ZNF667 in cardiomyocytes have been elucidated. Here, we investigated the functional role of ZNF667 in H9c2 cell lines focusing on its molecular mechanism by which it protects the cells from apoptosis. We found that ZNF667 inhibited the expression and the promoter activity of the rat proapoptotic gene Bax gene, and at the same time prevented apoptosis of H9c2 cells, induced by H2O2 and Dox. Western immunoblotting analysis revealed that ZNF667 also inhibited Bax protein expression, accompanied by attenuation of the mitochondrial translocation of Bax protein, induced by H2O2. EMSA and target detection assay showed that the purified ZNF667 fusion proteins could interact with the Bax promoter sequence in vitro, and this interaction was dependent upon the ZNF667 DNA binding sequences or its core sequence in the promoter. Furthermore, ChIP assay demonstrated that a stimulus H2O2 could enhance the ability of ZNF667 protein binding to the promoter. Finally, a reporter gene assay showed that ZNF667 could repress the activity of the Bax gene promoter, and the repression was dependent upon its binding to the specific DNA sequence in the promoter. Our work demonstrates that ZNF667 that confers cytoprotection is a novel regulator of the rat Bax gene, mediating the inhibition of the Bax mRNA and protein expression in H9c2 cardiomyocytes in response to H2O2 treatment.	[Jiang, Lei; Wang, Hao; Shi, Chunli; Liu, Ke; Liu, Meidong; Wang, Nian; Wang, Kangkai; Zhang, Huali; Wang, Guiliang; Xiao, Xianzhong] Cent S Univ, Xiangya Sch Med, Dept Pathophysiol, Changsha 410078, Hunan, Peoples R China	Central South University	Xiao, XZ (corresponding author), Cent S Univ, Xiangya Sch Med, Dept Pathophysiol, 110 Xiangya Rd, Changsha 410078, Hunan, Peoples R China.	xianzhongxiao@xysm.net	xiao, xiang/GWU-6035-2022		Major National Basic Research Program of China [2007CB512007]; National Natural Science Foundation of China [30971205]	Major National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Major National Basic Research Program of China (2007CB512007 for X. X.) and the National Natural Science Foundation of China (30971205 for L.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burdach J, 2012, TRENDS BIOCHEM SCI, V37, P199, DOI 10.1016/j.tibs.2012.02.001; Danial NN, 2007, CLIN CANCER RES, V13, P7254, DOI 10.1158/1078-0432.CCR-07-1598; Dewson G, 2012, CELL DEATH DIFFER, V19, P661, DOI 10.1038/cdd.2011.138; Fletchera JI, 2008, P NATL ACAD SCI USA, V105, P18081, DOI 10.1073/pnas.0808691105; Fortuno MA, 1999, HYPERTENSION, V33, P1348, DOI 10.1161/01.HYP.33.6.1348; Gonzalez-Girones DM, 2013, APOPTOSIS, V18, P1008, DOI 10.1007/s10495-013-0850-6; Gou DM, 2004, BBA-GENE STRUCT EXPR, V1676, P203, DOI 10.1016/j.bbaexp.2003.11.011; Jheon AH, 2001, J BIOL CHEM, V276, P18282, DOI 10.1074/jbc.M010885200; Jiang L, 2007, BIOCHEM BIOPH RES CO, V356, P829, DOI 10.1016/j.bbrc.2007.02.138; Jiang L, 2009, MOL CELL BIOCHEM, V328, P137, DOI 10.1007/s11010-009-0083-8; Jin HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051720; Jin KL, 2001, J NEUROCHEM, V77, P1508, DOI 10.1046/j.1471-4159.2001.00361.x; Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu K, 2013, LIVER INT, V33, P1566, DOI 10.1111/liv.12238; Liu S, 2007, BIOCHEM BIOPH RES CO, V354, P109, DOI 10.1016/j.bbrc.2006.12.152; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Nelson DP, 2002, ANN THORAC SURG, V73, P156, DOI 10.1016/S0003-4975(01)03303-3; Nishikawa S, 2006, J MOL CELL CARDIOL, V40, P510, DOI 10.1016/j.yjmcc.2006.01.020; Nunez N, 2011, J BIOL CHEM, V286, P38190, DOI 10.1074/jbc.M111.301234; Plumier JCL, 1996, J MOL CELL CARDIOL, V28, P1251, DOI 10.1006/jmcc.1996.0115; Qu SL, 2010, FREE RADICAL BIO MED, V49, P580, DOI 10.1016/j.freeradbiomed.2010.05.004; Razin SV, 2012, BIOCHEMISTRY-MOSCOW+, V77, P217, DOI 10.1134/S0006297912030017; Sardao VA, 2009, CANCER CHEMOTH PHARM, V64, P811, DOI 10.1007/s00280-009-0932-x; Shigematsu S, 2011, EXP CELL RES, V317, P1851, DOI 10.1016/j.yexcr.2011.05.012; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tian C, 2009, NAT CELL BIOL, V11, P580, DOI 10.1038/ncb1864; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Wang G, 2010, BRAZ J MED BIOL RES, V43, P43, DOI 10.1590/S0100-879X2009005000010; Wang GL, 2009, INT J MOL SCI, V10, P492, DOI 10.3390/ijms10020492; Wang GL, 2009, MOL CELL BIOCHEM, V322, P93, DOI 10.1007/s11010-008-9944-9; Wang KK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082827; Wang Z, 2013, CHIN J NEUROSURG DIS, V12, P37; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Xiang SY, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004405; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yuan C, 2004, PROG BIOCHEM BIOPHYS, V31, P231; Yuan C, 2004, J CLIN RES, V21, P837; Zhang B, 2010, CELL STRESS CHAPERON, V15, P249, DOI 10.1007/s12192-009-0138-5; Zhou X, 2010, CARDIOLOGY, V115, P243, DOI 10.1159/000301278; ZweidlerMcKay PA, 1996, MOL CELL BIOL, V16, P4024	41	8	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e111653	10.1371/journal.pone.0111653	http://dx.doi.org/10.1371/journal.pone.0111653			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397408	Green Submitted, gold, Green Published			2022-12-27	WOS:000345558500021
J	Lai, LM; Ge, SX				Lai, Liming; Ge, Steven X.			Meta-Analysis of Gene Expression Signatures Reveals Hidden Links among Diverse Biological Processes in Arabidopsis	PLOS ONE			English	Article							NETWORKS; DATABASE	The model plant Arabidopsis has been well-studied using high-throughput genomics technologies, which usually generate lists of differentially expressed genes under various conditions. Our group recently collected 1065 gene lists from 397 gene expression studies as a knowledgebase for pathway analysis. Here we systematically analyzed these gene lists by computing overlaps in all-vs.-all comparisons. We identified 16,261 statistically significant overlaps, represented by an undirected network in which nodes correspond to gene lists and edges indicate significant overlaps. The network highlights the correlation across the gene expression signatures of the diverse biological processes. We also partitioned the main network into 20 sub-networks, representing groups of highly similar expression signatures. These are common sets of genes that were co-regulated under different treatments or conditions and are often related to specific biological themes. Overall, our result suggests that diverse gene expression signatures are highly interconnected in a modular fashion.	[Lai, Liming; Ge, Steven X.] S Dakota State Univ, Dept Math & Stat, Brookings, SD 57007 USA	South Dakota State University	Ge, SX (corresponding author), S Dakota State Univ, Dept Math & Stat, Brookings, SD 57007 USA.	xijin.ge@sdstate.edu	Ge, Xijin/AAP-6237-2021; liming, lai/HGB-0743-2022; Ge, Steven/ABF-1186-2021	Ge, Steven/0000-0001-7406-3782	National Institute of General Medical Studies at the National Institutes of Health [GM083226]; National Science Foundation/EPSCoR [IIA-1355423]; state of South Dakota; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083226] Funding Source: NIH RePORTER	National Institute of General Medical Studies at the National Institutes of Health; National Science Foundation/EPSCoR(National Science Foundation (NSF)); state of South Dakota; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Studies at the National Institutes of Health (GM083226 to SXG, in part) and this material is based upon work supported partially by the National Science Foundation/EPSCoR Award No. IIA-1355423 and by the state of South Dakota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GLASS GV MET AN; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Cahan P, 2005, GENE, V360, P78, DOI 10.1016/j.gene.2005.07.008; Day RC, 2008, PLANT PHYSIOL, V148, P1964, DOI 10.1104/pp.108.128108; Edwards YJK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002712; Ge SX, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-87; Gonzali S, 2006, J PLANT RES, V119, P115, DOI 10.1007/s10265-005-0251-1; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hsieh MH, 2008, SOC NETWORKS, V30, P146, DOI 10.1016/j.socnet.2007.11.002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ioannidis JPA, 2009, NAT GENET, V41, P149, DOI 10.1038/ng.295; Lai LM, 2012, BIOINFORMATICS, V28, P2291, DOI 10.1093/bioinformatics/bts421; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Miller BG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009466; Newman JC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r81; Rogic S, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.15.001.2009; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Team RC, 2012, R LANG ENV STAT COMP; Tiwari S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-72; Wikipedia, 2008, AR THAL; Yang XN, 2007, BMC BIOINFORMATICS, P8	25	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e108567	10.1371/journal.pone.0108567	http://dx.doi.org/10.1371/journal.pone.0108567			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398003	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558500003
J	Lee, T; Kim, J; Kim, S; Kim, K; Park, Y; Kim, Y; Lee, YS; Kwon, HS; Kim, SH; Chang, YS; Cho, YS; Jang, AS; Park, JW; Nahm, DH; Yoon, HJ; Cho, SH; Cho, YJ; Choi, BW; Moon, HB; Kim, TB				Lee, Taehoon; Kim, Jinhee; Kim, Sujeong; Kim, Kyoungjoo; Park, Yunjin; Kim, Yuri; Lee, Yoon Su; Kwon, Hyouk-Soo; Kim, Sae-Hoon; Chang, Yoon-Seok; Cho, You Sook; Jang, An-Soo; Park, Jung-Won; Nahm, Dong-Ho; Yoon, Ho-Joo; Cho, Sang-Heon; Cho, Young-Joo; Choi, Byoung Whui; Moon, Hee-Bom; Kim, Tae-Bum		COREA Study Grp	Risk Factors for Asthma-Related Healthcare Use: Longitudinal Analysis Using the NHI Claims Database in a Korean Asthma Cohort	PLOS ONE			English	Article							INHALED CORTICOSTEROIDS; RESOURCE UTILIZATION; AIRWAY-OBSTRUCTION; ADULT ASTHMA; HOSPITALIZATION; POPULATION; PREVALENCE; MEDICAID; CHILDREN; DEATH	Background: Though insurance claims data are useful for researching asthma, they have important limitations, such as a diagnostic inaccuracy and a lack of clinical information. To overcome these drawbacks, we used the novel method by merging the clinical data from our asthma cohort with the National Health Insurance (NHI) claims data. Methods and Results: Longitudinal analysis of asthma-related healthcare use from the NHI claims database, merged with data of 736 patients registered in a Korean asthma cohort, was conducted for three consecutive years from registration of the cohort. Asthma-related asthma healthcare referred to outpatient and emergency department visits, hospitalizations, and the use of systemic corticosteroids. Univariate and multivariate logistic regression analysis was used to evaluate risk factors for asthma-related healthcare. Over three years after enrollment, many patients changed from tertiary to primary/secondary hospitals with a lack of maintenance of inhaled corticosteroid-based controllers. An independent risk factor for emergency visits was a previous history of asthma exacerbation. In hospitalizations, old age and Asthma Control Test (ACT) score variability were independent risk factors. An independent risk factor for per person cumulative duration of systemic corticosteroids was the FEV1 (Forced expiratory volume in one second)%. The use of systemic corticosteroids was independently associated with being female, the FEV1%, and ACT score variability. Conclusion: We found that old age, being female, long-standing asthma, a low FEV1%, asthma brittleness, asthma drug compliance, and a history of asthma exacerbation were independent risk factors for increased asthma-related healthcare use in Korea.	[Lee, Taehoon; Kim, Sujeong; Lee, Yoon Su; Kwon, Hyouk-Soo; Cho, You Sook; Moon, Hee-Bom; Kim, Tae-Bum] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Allergy & Clin Immunol, Seoul, South Korea; [Lee, Taehoon] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Internal Med, Ulsan 680749, South Korea; [Kim, Jinhee; Kim, Kyoungjoo; Kim, Yuri] Natl Evidence Based Healthcare Collaborating Agcy, Seoul, South Korea; [Kim, Jinhee] Chosun Univ, Coll Med, Dept Nursing, Kwangju, South Korea; [Kim, Sujeong] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Taegu, South Korea; [Park, Yunjin] Dongguk Univ, Dept Stat, Seoul, South Korea; [Kim, Sae-Hoon; Chang, Yoon-Seok; Cho, Sang-Heon] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Jang, An-Soo] Soonchunhyang Univ, Bucheon Hosp, Dept Internal Med, Puchon, South Korea; [Park, Jung-Won] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Nahm, Dong-Ho] Ajou Univ, Coll Med, Dept Internal Med, Suwon 441749, South Korea; [Yoon, Ho-Joo] Hanyang Univ, Coll Med, Dept Internal Med, Seoul 133791, South Korea; [Cho, Young-Joo] Ewha Womans Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Choi, Byoung Whui] Chung Ang Univ, Coll Med, Dept Internal Med, Seoul 156756, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Ulsan University Hospital; National Evidence-based Healthcare Collaborating Agency (NECA); Chosun University; Kyungpook National University; Dongguk University; Seoul National University (SNU); Soonchunhyang University; Yonsei University; Yonsei University Health System; Ajou University; Hanyang University; Ewha Womans University; Chung Ang University; Chung Ang University Hospital	Moon, HB (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Allergy & Clin Immunol, Seoul, South Korea.	hbmoon@amc.seoul.kr; allergy@medimail.co.kr	Chang, Yoon-Seok/J-5628-2012; Lee, Taehoon/AHA-1437-2022	Chang, Yoon-Seok/0000-0003-3157-0447; Lee, Taehoon/0000-0002-9224-0866	Korea Healthcare Technology R & D Project, Ministry of Health and Welfare, Republic of Korea [A102065, HI13C0776]	Korea Healthcare Technology R & D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a grant of the Korea Healthcare Technology R & D Project, Ministry of Health and Welfare, Republic of Korea (grant no. A102065 & HI13C0776). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 2000, THORAX, V55, P566, DOI 10.1136/thorax.55.7.566; [Anonymous], 2000, AM J RESP CRIT CARE, V162, P2341; Ayres JG, 1998, THORAX, V53, P315, DOI 10.1136/thx.53.4.315; Bai TR, 2005, CLIN SCI, V108, P463, DOI 10.1042/CS20040342; Bateman ED, 2010, GLOBAL STRATEGY ASTH, P1; Blais R, 2001, CHEST, V119, P1316, DOI 10.1378/chest.119.5.1316; BRAMAN SS, 1991, AM REV RESPIR DIS, V143, P336, DOI 10.1164/ajrccm/143.2.336; Centers for Disease Control and Prevention (CDC), 1996, MMWR Morb Mortal Wkly Rep, V45, P350; Chan J, 2007, J MANAG CARE PHARM, V13, P21, DOI 10.18553/jmcp.2007.13.1.21; Clark T, 2002, GLOBAL INITIATIVE AS, P1; Diette GB, 2002, ARCH INTERN MED, V162, P1123, DOI 10.1001/archinte.162.10.1123; Guilbert TW, 2011, J ASTHMA, V48, P126, DOI 10.3109/02770903.2010.535879; Hasford J, 2010, ALLERGY, V65, P347, DOI 10.1111/j.1398-9995.2009.02161.x; Kang HY, 2008, YONSEI MED J, V49, P521, DOI 10.3349/ymj.2008.49.4.521; Kim S, 2013, ALLERGY, V68, P1435, DOI 10.1111/all.12256; Kim TB, 2013, EUR RESPIR J, V41, P1308, DOI 10.1183/09031936.00100811; Kim TB, 2009, ANN ALLERG ASTHMA IM, V103, P311, DOI 10.1016/S1081-1206(10)60530-3; Lanes SF, 1998, AM J RESP CRIT CARE, V158, P857, DOI 10.1164/ajrccm.158.3.9803047; Lee T, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-1; LOZANO P, 1995, JAMA-J AM MED ASSOC, V274, P469, DOI 10.1001/jama.274.6.469; MANFREDA J, 1993, CHEST, V103, P151, DOI 10.1378/chest.103.1.151; Park Choon Seon, 2006, J Prev Med Public Health, V39, P397; Ray NF, 1998, CHEST, V113, P1277, DOI 10.1378/chest.113.5.1277; Salamzadeh J, 2003, J ASTHMA, V40, P645, DOI 10.1081/JAS-120019035; Sawicki GS, 2010, ANN ALLERG ASTHMA IM, V104, P30, DOI 10.1016/j.anai.2009.11.004; Schatz M, 2003, J ALLERGY CLIN IMMUN, V111, P503, DOI 10.1067/mai.2003.178; Schokker S, 2010, PRIM CARE RESP J, V19, P28, DOI 10.4104/pcrj.2009.00039; Shaya FT, 2009, CHEST, V136, P405, DOI 10.1378/chest.08-2304; SPITZER WO, 1992, NEW ENGL J MED, V326, P501, DOI 10.1056/NEJM199202203260801; Stanford RH, 2010, CLIN THER, V32, P1782, DOI 10.1016/j.clinthera.2010.09.012; Stock S, 2005, EUR RESPIR J, V25, P47, DOI 10.1183/09031936.04.00116203; Suissa S, 1996, AM J RESP CRIT CARE, V154, P1598, DOI 10.1164/ajrccm.154.6.8970341; Suissa S, 2000, NEW ENGL J MED, V343, P332, DOI 10.1056/NEJM200008033430504; TUUPONEN T, 1993, AGE AGEING, V22, P97, DOI 10.1093/ageing/22.2.97; van Manen JG, 2001, J CLIN EPIDEMIOL, V54, P287, DOI 10.1016/S0895-4356(01)00346-8; Vollmer WM, 2002, AM J RESP CRIT CARE, V165, P195, DOI 10.1164/ajrccm.165.2.2102127; Wenzel SE, 2007, J ALLERGY CLIN IMMUN, V119, P14, DOI 10.1016/j.jaci.2006.10.025	37	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112844	10.1371/journal.pone.0112844	http://dx.doi.org/10.1371/journal.pone.0112844			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397972	Green Submitted, gold, Green Published			2022-12-27	WOS:000345558500099
J	Noordzij, W; van Beek, AP; Tio, RA; van der Horst-Schrivers, AN; de Vries, EG; van Ginkel, B; Walenkamp, AM; Glaudemans, AW; Slart, RH; Dierckx, RA				Noordzij, Walter; van Beek, Andre P.; Tio, Rene A.; van der Horst-Schrivers, Anouk N.; de Vries, Elisabeth G.; van Ginkel, Bram; Walenkamp, Annemiek M.; Glaudemans, Andor W.; Slart, Riemer H.; Dierckx, Rudi A.			Myocardial Metastases on 6-[F-18] fluoro-L-DOPA PET/CT: A Retrospective Analysis of 116 Serotonin Producing Neuroendocrine Tumour Patients	PLOS ONE			English	Article							CARCINOID HEART-DISEASE; F-18-DIHYDROXY-PHENYL-ALANINE; ECHOCARDIOGRAPHY; GUIDELINES; MANAGEMENT	Purpose: This study evaluates the prevalence of cardiac metastases in patients with serotonin producing neuroendocrine tumours (NET), examined with F-18-FDOPA PET/CT, and the relationship of these metastases to the presence of carcinoid heart disease (CHD) based on echocardiography. Background: CHD occurs in patients with serotonin producing NET. The diagnostic method of choice remains echocardiography. The precise prevalence of cardiac metastases is unknown given the limitations of standard technologies. Nuclear medicine modalities have the potential to visualize metastases of NET. Methods: All patients who underwent F-18-FDOPA PET/CT because of serotonin producing NET between November 2009 and May 2012 were retrospectively analyzed. The presence of cardiac metastasis was defined as myocardial tracer accumulation higher than the surrounding physiological myocardial uptake. Laboratory tests and transthoracic echocardiography (TTE) results were digitally collected. Results: 116 patients (62 male) underwent F-18-FDOPA PET/CT, mean age was 61 +/- 13 years. TTE was performed in 79 patients. Cardiac metastases were present in 15 patients, of which 10 patients also underwent TTE. One patient had both cardiac metastasis (only on F-18-FDOPA PET/CT) and echocardiographic signs of CHD. There were no differences in echocardiographic parameters for CHD between patients with and without cardiac metastases. TTE in none of the 79 patients showed cardiac metastases. Conclusion: The prevalence of cardiac metastases detected with F-18-FDOPA PET/CT in this study is 13%. F-18-FDOPA PET/CT can visualize cardiac metastases in serotonin producing NET patients. There appears to be no relationship between the presence of cardiac metastases and TTE parameters of CHD.	[Noordzij, Walter; Glaudemans, Andor W.; Slart, Riemer H.; Dierckx, Rudi A.] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands; [van Beek, Andre P.; van der Horst-Schrivers, Anouk N.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [Tio, Rene A.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [de Vries, Elisabeth G.; Walenkamp, Annemiek M.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands; [van Ginkel, Bram] Univ Groningen, Univ Med Ctr Groningen, Fac Med, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	Noordzij, W (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands.	w.noordzij@umcg.nl	Tio, Rene/ABG-2820-2020; van Beek, Andre/O-3753-2014	de Vries, Elisabeth/0000-0002-8949-7425; van Beek, Andre/0000-0002-0335-8177; Glaudemans, Andor/0000-0001-8081-0641				American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021; Anderson AS, 1997, AM HEART J, V134, P693, DOI 10.1016/S0002-8703(97)70053-X; Bernheim AM, 2007, PROG CARDIOVASC DIS, V49, P439, DOI 10.1016/j.pcad.2006.12.002; Bhattacharyya S, 2010, CIRC-CARDIOVASC IMAG, V3, P103, DOI 10.1161/CIRCIMAGING.109.886846; Boellaard R, 2010, EUR J NUCL MED MOL I, V37, P181, DOI 10.1007/s00259-009-1297-4; Boellaard R, 2008, EUR J NUCL MED MOL I, V35, P2320, DOI 10.1007/s00259-008-0874-2; Calissendorff J, 2014, ENDOCRINE, V47, P169, DOI 10.1007/s12020-013-0108-7; Carreras Cecilia, 2013, Recent Results Cancer Res, V194, P379, DOI 10.1007/978-3-642-27994-2_20; Castillo JG, 2013, SEMIN CARDIOTHORAC V, V17, P212, DOI 10.1177/1089253212465475; Denney WD, 1998, J AM COLL CARDIOL, V32, P1017, DOI 10.1016/S0735-1097(98)00354-4; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fiebrich HB, 2008, CIRCULATION, V118, P1602, DOI 10.1161/CIRCULATIONAHA.108.767111; Jann H, 2010, HORM METAB RES, V42, P967, DOI 10.1055/s-0030-1267204; Koestenberger M, 2009, J AM SOC ECHOCARDIOG, V22, P715, DOI 10.1016/j.echo.2009.03.026; Koopmans KP, 2008, J CLIN ONCOL, V26, P1489, DOI 10.1200/JCO.2007.15.1126; Moller JE, 2005, CIRCULATION, V112, P3320, DOI 10.1161/CIRCULATIONAHA.105.553750; Palaniswamy C, 2012, CARDIOL REV, V20, P167, DOI 10.1097/CRD.0b013e31824c866e; Pandya UH, 2002, J AM COLL CARDIOL, V40, P1328, DOI 10.1016/S0735-1097(02)02109-5; Pape UF, 2012, NEUROENDOCRINOLOGY, V95, P135, DOI 10.1159/000335629; PELLIKKA PA, 1993, CIRCULATION, V87, P1188, DOI 10.1161/01.CIR.87.4.1188; ROBERTS WC, 1964, AM J MED, V36, P5, DOI 10.1016/0002-9343(64)90145-7; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	23	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112278	10.1371/journal.pone.0112278	http://dx.doi.org/10.1371/journal.pone.0112278			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397775	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558500043
J	Sax, PE; Sypek, A; Berkowitz, BK; Morris, BL; Losina, E; Paltiel, AD; Kelly, KA; Seage, GR; Walensky, RP; Weinstein, MC; Eron, J; Freedberg, KA				Sax, Paul E.; Sypek, Alexis; Berkowitz, Bethany K.; Morris, Bethany L.; Losina, Elena; Paltiel, A. David; Kelly, Kathleen A.; Seage, George R., III; Walensky, Rochelle P.; Weinstein, Milton C.; Eron, Joseph; Freedberg, Kenneth A.			HIV Cure Strategies: How Good Must They Be to Improve on Current Antiretroviral Therapy?	PLOS ONE			English	Article							QUALITY-OF-LIFE; COST-EFFECTIVENESS; UNITED-STATES; HEPATITIS-C; INFECTION; VACCINE; TRANSPLANTATION; POPULATION; VORINOSTAT; LYMPHOMA	Background: We examined efficacy, toxicity, relapse, cost, and quality-of-life thresholds of hypothetical HIV cure interventions that would make them cost-effective compared to life-long antiretroviral therapy (ART). Methods: We used a computer simulation model to assess three HIV cure strategies: Gene Therapy, Chemotherapy, and Stem Cell Transplantation (SCT), each compared to ART. Efficacy and cost parameters were varied widely in sensitivity analysis. Outcomes included quality-adjusted life expectancy, lifetime cost, and cost-effectiveness in dollars/quality-adjusted life year ($/QALY) gained. Strategies were deemed cost-effective with incremental cost-effectiveness ratios <$100,000/QALY. Results: For patients on ART, discounted quality-adjusted life expectancy was 16.4 years and lifetime costs were $591,400. Gene Therapy was cost-effective with efficacy of 10%, relapse rate 0.5%/month, and cost $54,000. Chemotherapy was cost-effective with efficacy of 88%, relapse rate 0.5%/month, and cost $12,400/month for 24 months. At $150,000/procedure, SCT was cost-effective with efficacy of 79% and relapse rate 0.5%/month. Moderate efficacy increases and cost reductions made Gene Therapy cost-saving, but substantial efficacy/cost changes were needed to make Chemotherapy or SCT cost-saving. Conclusions: Depending on efficacy, relapse rate, and cost, cure strategies could be cost-effective compared to current ART and potentially cost-saving. These results may help provide performance targets for developing cure strategies for HIV.	[Sax, Paul E.; Walensky, Rochelle P.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Losina, Elena] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Sax, Paul E.; Losina, Elena; Walensky, Rochelle P.; Freedberg, Kenneth A.] Harvard Univ, Ctr AIDS Res, Boston, MA 02115 USA; [Seage, George R., III; Weinstein, Milton C.; Freedberg, Kenneth A.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Sypek, Alexis; Berkowitz, Bethany K.; Morris, Bethany L.; Losina, Elena; Kelly, Kathleen A.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Dept Med, Div Gen Med, Boston, MA 02114 USA; [Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA; [Sypek, Alexis; Berkowitz, Bethany K.; Morris, Bethany L.; Losina, Elena; Kelly, Kathleen A.; Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Dept Med, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Freedberg, Kenneth A.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Paltiel, A. David] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Eron, Joseph] Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Boston University; Boston University; Yale University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sax, PE (corresponding author), Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA.	psax@partners.org	Morris, Bethany L./GNH-4419-2022	Losina, ELENA/0000-0002-3424-0892; Walensky, Rochelle P./0000-0002-8795-379X; Paltiel, A. David/0000-0002-4861-3290	National Institute of Allergy and Infectious Diseases [R37 AI042006, AI051966, R01 AI093269, U01 AI 069472, U01 AI068636, UM1 AI 069423]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093269, UM1AI069423, R37AI042006, U01AI069472, R56AI114617, K24AI051966, P30AI050410, U01AI068636] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by the National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov/Pages/default.aspx): R37 AI042006 (PS, AS, BB, BM, EL, ADP, KK, RW, MW, KF), AI051966 (GS), R01 AI093269 (RW, KF, ADP, MW), U01 AI 069472 (PS, EL, KF, RQ, ADP, AS, BB, BM, KK) (Partners/Harvard AIDS Clinical Trials Unit), U01 AI068636 (PS, EL, KF, RQ, ADP, AS, BB, BM, KK) (Central AIDS Clinical Trials Group), and UM1 AI 069423 (JE) (UNC Global Clinical Trials Unit). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Althoff KN, 2010, CLIN INFECT DIS, V50, P1512, DOI 10.1086/652650; Andrinopoulos K, 2011, AIDS EDUC PREV, V23, P367, DOI 10.1521/aeap.2011.23.4.367; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Bozzette SA, 1998, NEW ENGL J MED, V339, P1897, DOI 10.1056/NEJM199812243392606; Centers for Medicare and Medicaid Services, 2012, MED PHYS FEE SCHED 2; Centers for Medicare and Medicaid Services American Medical Association, 2012, CLIN DIAGN LAB FEE S; Crespo C, 2012, CLIN THER, V34, P1774, DOI 10.1016/j.clinthera.2012.06.029; Dignan FL, 2013, CLIN TRANSPLANT, V27, pE56, DOI 10.1111/ctr.12065; Dotinga R, 2010, GENE THERAPY HIV INC; Elting LS, 2003, CANCER, V97, P1541, DOI 10.1002/cncr.11195; Farnham PG, 2013, JAIDS-J ACQ IMM DEF, V64, P183, DOI 10.1097/QAI.0b013e3182973966; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Gebo Kelly A, 2003, Hopkins HIV Rep, V15, P5; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Havrilesky LJ, 2012, CANCER-AM CANCER SOC, V118, P386, DOI 10.1002/cncr.26199; Kasiske BL, 2000, JAMA-J AM MED ASSOC, V283, P2445, DOI 10.1001/jama.283.18.2445; Kavanaugh SA, 2010, AM J HEALTH-SYST PH, V67, P793, DOI 10.2146/ajhp090247; Lambers FAE, 2011, AIDS, V25, pF21, DOI 10.1097/QAD.0b013e32834bac44; Lederman MM, 2013, ADV IMMUNOL, V119, P51, DOI 10.1016/B978-0-12-407707-2.00002-3; Leelahavarong P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-534; Lewin SR, 2014, ANN INTERN MED, V161, P368, DOI 10.7326/M14-1573; Margolis DM, 2013, CURR OPIN HIV AIDS, V8, P230, DOI 10.1097/COH.0b013e32835ef089; Martin A, 2009, CLIN INFECT DIS, V49, P1591, DOI 10.1086/644769; Mellors J, 2014, NCT01933594; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Merck Sharp & Dohme Corp, 2006, ZOL VOR PACK INS; Messou E, 2011, JAIDS-J ACQ IMM DEF, V56, P356, DOI 10.1097/QAI.0b013e3182084b5a; Moore RD, 2011, CLIN INFECT DIS, V53, P600, DOI 10.1093/cid/cir467; National Bone Marrow Transplant Link, 2010, BON MARR STEM CELL T; Paltiel AD, 2009, CLIN INFECT DIS, V48, P806, DOI 10.1086/597095; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2013, GUID PREV TREATM OPP; Pepper PV, 2002, MED DECIS MAKING, V22, pS45, DOI 10.1177/027298902237705; Petta S, 2014, HEPATOLOGY, V59, P1692, DOI 10.1002/hep.27010; Pozniak AL, 2006, JAIDS-J ACQ IMM DEF, V43, P535; RED BOOK Online, 2013, PROD INF ANT DRUG PR; Rodger AJ, 2013, AIDS, V27, P973, DOI 10.1097/QAD.0b013e32835cae9c; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Shenoy S, 2011, HEMATOL-AM SOC HEMAT, P273, DOI 10.1182/asheducation-2011.1.273; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Stamatovic D, 2011, VOJNOSANIT PREGL, V68, P1026, DOI 10.2298/VSP1112026S; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Ubel PA, 2003, ARCH INTERN MED, V163, P1637, DOI 10.1001/archinte.163.14.1637; United Nations. Department of Economic and Social Affairs. Population Division, 2009, ESAPWP210 UN DEP EC; University HealthSystems Consortium, 2008, CDP ONL REP; US Department of Health and Human Services. Office of Inspector General, 2005, MED DRUG PRIC COMP A; Vertex Pharmaceuticals Incorporated, 2012, KAL IV PACK INS; Walensky RP, 2013, ANN INTERN MED, V158, P84, DOI 10.7326/0003-4819-158-2-201301150-00002; Walensky RP, 2004, VACCINE, V22, P4044, DOI 10.1016/j.vaccine.2004.03.059	50	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113031	10.1371/journal.pone.0113031	http://dx.doi.org/10.1371/journal.pone.0113031			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397616	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500125
J	Zampieri, S; Bianchi, E; Cantile, C; Saleri, R; Bembi, B; Dardis, A				Zampieri, Stefania; Bianchi, Ezio; Cantile, Carlo; Saleri, Roberta; Bembi, Bruno; Dardis, Andrea			Characterization of a Spontaneous Novel Mutation in the NPC2 Gene in a Cat Affected by Niemann Pick Type C Disease	PLOS ONE			English	Article							PROTEIN-DEFICIENT; BINDING; LINKAGE; MODEL; HE-1	Niemann-Pick C disease (NPC) is an autosomal recessive lysosomal storage disorder characterized by accumulation of unesterified cholesterol and other lipids within the lysosomes due to mutation in NPC1 or NPC2 genes. A feline model of NPC carrying a mutation in NPC1 gene has been previously described. We have identified two kittens affected by NPC disease due to a mutation in NPC2 gene. They manifested with tremors at the age of 3 months, which progressed to dystonia and severe ataxia. At 6 months of age cat 2 was unable to stand without assistance and had bilaterally reduced menace response. It died at the age of 10 months. Post-mortem histological analysis of the brain showed the presence of neurons with cytoplasmic swelling and vacuoles, gliosis of the substantia nigra and degeneration of the white matter. Spheroids with accumulation of ubiquitinated aggregates were prominent in the cerebellar cortex. Purkinje cells were markedly reduced in number and they showed prominent intracytoplasmic storage. Scattered perivascular aggregates of lymphocytes and microglial cells proliferation were present in the thalamus and midbrain. Proliferation of Bergmann glia was also observed. In the liver, hepatocytes were swollen because of accumulation of small vacuoles and foamy Kupffer cells were also detected. Foamy macrophages were observed within the pulmonary interstitium and alveoli as well. At 9 months cat 1 was unable to walk, developed seizures and it was euthanized at 21 months. Filipin staining of cultured fibroblasts showed massive storage of unesterified cholesterol. Molecular analysis of NPC1 and NPC2 genes showed the presence of a homozygous intronic mutation (c.82+5G>A) in the NPC2 gene. The subsequent analysis of the mRNA showed that the mutation causes the retention of 105 bp in the mature mRNA, which leads to the in frame insertion of 35 amino acids between residues 28 and 29 of NPC2 protein (p.G28_S29ins35).	[Zampieri, Stefania; Bembi, Bruno; Dardis, Andrea] Univ Hosp Santa Maria Misericordia, Reg Coordinator Ctr Rare Dis, Udine, Italy; [Bianchi, Ezio; Saleri, Roberta] Univ Parma, Dept Vet Med Sci, I-43100 Parma, Italy; [Cantile, Carlo] Univ Pisa, Dept Vet Sci, Pisa, Italy	Hospital Santa Maria della Misericordia; University of Parma; University of Pisa	Dardis, A (corresponding author), Univ Hosp Santa Maria Misericordia, Reg Coordinator Ctr Rare Dis, Udine, Italy.	dardis.andrea@aoud.sanita.fvg.it	Zampieri, Stefania/AAC-2314-2022; Dardis, Andrea/AAB-9900-2022; Cantile, Carlo/I-7309-2019; Cantile, Carlo/B-2147-2018	Cantile, Carlo/0000-0003-0141-6449; Bianchi, Ezio/0000-0002-5160-8898; zampieri, stefania/0000-0003-3921-8405				Bjurulf B, 2008, MED SCI MONITOR, V14, pCS71; BLANCHETTEMACKIE EJ, 1988, P NATL ACAD SCI USA, V85, P8022, DOI 10.1073/pnas.85.21.8022; BROWN DE, 1994, AM J PATHOL, V144, P1412; CARSTEA ED, 1993, P NATL ACAD SCI USA, V90, P2002, DOI 10.1073/pnas.90.5.2002; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; Griese M, 2010, CLIN GENET, V77, P119, DOI 10.1111/j.1399-0004.2009.01325.x; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Klunemann HH, 2002, ANN NEUROL, V52, P743, DOI 10.1002/ana.10366; KUWAMURA M, 1993, ACTA NEUROPATHOL, V85, P345, DOI 10.1007/BF00227733; Maue RA, 2012, HUM MOL GENET, V21, P730, DOI 10.1093/hmg/ddr505; Millat G, 2005, MOL GENET METAB, V86, P220, DOI 10.1016/j.ymgme.2005.07.007; Millat G, 2001, AM J HUM GENET, V69, P1013, DOI 10.1086/324068; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Patterson M, 2001, METABOLIC MOL BASIS, V3, P611; PENTCHEV PG, 1984, J BIOL CHEM, V259, P5784; Pineda M, 2010, MOL GENET METAB, V99, P358, DOI 10.1016/j.ymgme.2009.11.007; Sleat DE, 2004, P NATL ACAD SCI USA, V101, P5886, DOI 10.1073/pnas.0308456101; Perez-Poyato MS, 2012, GENE, V506, P207, DOI 10.1016/j.gene.2012.06.054; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Somers KL, 2003, MOL GENET METAB, V79, P99, DOI 10.1016/S1096-7192(03)00074-X; Vanier MT, 2004, BBA-MOL CELL BIOL L, V1685, P14, DOI 10.1016/j.bbalip.2004.08.007; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; Vanier MT, 1996, AM J HUM GENET, V58, P118; Verot L, 2007, CLIN GENET, V71, P320, DOI 10.1111/j.1399-0004.2007.00782.x; Vite CH, 2008, PEDIATR RES, V64, P544, DOI 10.1203/PDR.0b013e318184d2ce; Xu S, 2007, J BIOL CHEM, V282, P23525, DOI 10.1074/jbc.M703848200	26	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112503	10.1371/journal.pone.0112503	http://dx.doi.org/10.1371/journal.pone.0112503			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396745	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558500055
J	Lee, CW; Wang, HJ; Hwang, JK; Tseng, CP				Lee, Chi-Wen; Wang, Hsiu-Jung; Hwang, Jenn-Kang; Tseng, Ching-Ping			Protein Thermal Stability Enhancement by Designing Salt Bridges: A Combined Computational and Experimental Study	PLOS ONE			English	Article							CHARGE-CHARGE INTERACTIONS; MOLECULAR-DYNAMICS SIMULATIONS; BETA-GLUCOSIDASE; ELECTROSTATIC CONTRIBUTIONS; BACILLUS-POLYMYXA; HYPERTHERMOPHILIC PROTEINS; SOLVENT ACCESSIBILITY; SECONDARY STRUCTURE; CATALYTIC-ACTIVITY; CRYSTAL-STRUCTURE	Protein thermal stability is an important factor considered in medical and industrial applications. Many structural characteristics related to protein thermal stability have been elucidated, and increasing salt bridges is considered as one of the most efficient strategies to increase protein thermal stability. However, the accurate simulation of salt bridges remains difficult. In this study, a novel method for salt-bridge design was proposed based on the statistical analysis of 10,556 surface salt bridges on 6,493 X-ray protein structures. These salt bridges were first categorized based on pairing residues, secondary structure locations, and C alpha-C alpha distances. Pairing preferences generalized from statistical analysis were used to construct a salt-bridge pair index and utilized in a weighted electrostatic attraction model to find the effective pairings for designing salt bridges. The model was also coupled with B-factor, weighted contact number, relative solvent accessibility, and conservation prescreening to determine the residues appropriate for the thermal adaptive design of salt bridges. According to our method, eight putative salt-bridges were designed on a mesophilic beta-glucosidase and 24 variants were constructed to verify the predictions. Six putative salt-bridges leaded to the increase of the enzyme thermal stability. A significant increase in melting temperature of 8.8, 4.8, 3.7, 1.3, 1.2, and 0.7 degrees C of the putative salt-bridges N437K-D49, E96R-D28, E96K-D28, S440K-E70, T231K-D388, and Q277E-D282 was detected, respectively. Reversing the polarity of T231K-D388 to T231D-D388K resulted in a further increase in melting temperatures by 3.6 degrees C, which may be caused by the transformation of an intra-subunit electrostatic interaction into an inter-subunit one depending on the local environment. The combination of the thermostable variants (N437K, E96R, T231D and D388K) generated a melting temperature increase of 15.7 degrees C. Thus, this study demonstrated a novel method for the thermal adaptive design of salt bridges through inference of suitable positions and substitutions.	[Lee, Chi-Wen; Hwang, Jenn-Kang] Natl Chiao Tung Univ, Coll Biol Sci & Technol, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Wang, Hsiu-Jung; Tseng, Ching-Ping] Natl Chiao Tung Univ, Coll Biol Sci & Technol, Dept Biol Sci & Technol, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Hwang, JK (corresponding author), Natl Chiao Tung Univ, Coll Biol Sci & Technol, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan.	jkhwang@cc.nctu.edu.tw; cpts@cc.nctu.edu.tw			National Science Council, Taiwan [NSC-98-2321-B-009-002]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council, Taiwan (NSC-98-2321-B-009-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop E, 2003, PROTEIN ENG, V16, P871, DOI 10.1093/protein/gzg131; Anbar M, 2012, APPL ENVIRON MICROB, V78, P3458, DOI 10.1128/AEM.07985-11; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Binter A, 2009, FEBS J, V276, P5263, DOI 10.1111/j.1742-4658.2009.07222.x; Bleicher L, 2011, J PHYS CHEM B, V115, P7940, DOI 10.1021/jp200330z; Bogin O, 2002, PROTEIN SCI, V11, P2561, DOI 10.1110/ps.0222102; Bosshard HR, 2004, J MOL RECOGNIT, V17, P1, DOI 10.1002/jmr.657; Brian N., 2004, PROTEIN-STRUCT FUNCT, V57, P128; Cavagnero S, 1998, BIOCHEMISTRY-US, V37, P3369, DOI 10.1021/bi9721795; Chan CH, 2004, PROTEINS, V57, P684, DOI 10.1002/prot.20263; Chang CS, 1999, J MOL BIOL, V288, P623, DOI 10.1006/jmbi.1999.2696; Charbonneau DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076675; DAGGETT V, 1992, P NATL ACAD SCI USA, V89, P5142, DOI 10.1073/pnas.89.11.5142; DELBONI LF, 1995, PROTEIN SCI, V4, P2594, DOI 10.1002/pro.5560041217; Demirjian DC, 2001, CURR OPIN CHEM BIOL, V5, P144, DOI 10.1016/S1367-5931(00)00183-6; Donald JE, 2011, PROTEINS, V79, P898, DOI 10.1002/prot.22927; El-Bondkly AMA, 2012, ANTON LEEUW INT J G, V101, P331, DOI 10.1007/s10482-011-9639-1; Elcock AH, 1998, J MOL BIOL, V284, P489, DOI 10.1006/jmbi.1998.2159; Fukuchi S, 2001, J MOL BIOL, V309, P835, DOI 10.1006/jmbi.2001.4718; Gonzalez-Blasco G, 2000, J BIOL CHEM, V275, P13708, DOI 10.1074/jbc.275.18.13708; GONZALEZCANDELAS L, 1989, APPL ENVIRON MICROB, V55, P3173; Gribenko AV, 2009, P NATL ACAD SCI USA, V106, P2601, DOI 10.1073/pnas.0808220106; Jaenicke R, 2000, P NATL ACAD SCI USA, V97, P2962, DOI 10.1073/pnas.97.7.2962; Jelesarov Ilian, 2009, V490, P227, DOI 10.1007/978-1-59745-367-7_10; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kumar S, 2000, PROTEINS, V41, P485, DOI 10.1002/1097-0134(20001201)41:4<485::AID-PROT60>3.3.CO;2-5; Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218; Kumar S, 2002, BIOPHYS J, V83, P1595, DOI 10.1016/S0006-3495(02)73929-5; Lam SY, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001027; Lazaridis T, 1997, PROTEIN SCI, V6, P2589; Liang HK, 2005, PROTEINS, V59, P58, DOI 10.1002/prot.20386; Lin CP, 2008, PROTEINS, V72, P929, DOI 10.1002/prot.21983; Loladze VV, 1999, BIOCHEMISTRY-US, V38, P16419, DOI 10.1021/bi992271w; Lu CH, 2008, PROTEINS, V72, P625, DOI 10.1002/prot.21954; Luke KA, 2007, FEBS J, V274, P4023, DOI 10.1111/j.1742-4658.2007.05955.x; Olson CA, 2001, PROTEINS, V44, P123, DOI 10.1002/prot.1079; Parthasarathy S, 2000, PROTEIN ENG, V13, P9, DOI 10.1093/protein/13.1.9; Qin SB, 2005, PROTEINS, V61, P473, DOI 10.1002/prot.20645; Rader AJ, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016002; Radestock S, 2011, PROTEINS, V79, P1089, DOI 10.1002/prot.22946; Reetz MT, 2006, ANGEW CHEM INT EDIT, V45, P7745, DOI 10.1002/anie.200602795; Rosato V, 2002, TRENDS GENET, V18, P278, DOI 10.1016/S0168-9525(02)02691-4; ROST B, 1994, PROTEINS, V20, P216, DOI 10.1002/prot.340200303; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; Rovo P, 2011, J PEPT SCI, V17, P610, DOI 10.1002/psc.1377; Sandgren M, 2003, PROTEIN SCI, V12, P848, DOI 10.1110/ps.0237703; Sanz-Aparicio J, 1998, PROTEINS, V33, P567, DOI 10.1002/(SICI)1097-0134(19981201)33:4<567::AID-PROT9>3.0.CO;2-U; Sanz-Aparicio J, 1998, J MOL BIOL, V275, P491, DOI 10.1006/jmbi.1997.1467; Schweiker KL, 2007, PROTEIN SCI, V16, P2694, DOI 10.1110/ps.073091607; Tanaka Y, 2004, J BIOL CHEM, V279, P32957, DOI 10.1074/jbc.M404405200; Vetriani C, 1998, P NATL ACAD SCI USA, V95, P12300, DOI 10.1073/pnas.95.21.12300; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Xiao L, 1999, J MOL BIOL, V289, P1435, DOI 10.1006/jmbi.1999.2810; ZAMOST BL, 1991, J IND MICROBIOL, V8, P71, DOI 10.1007/BF01578757; Zhou HX, 2003, BIOPHYS J, V84, P2216, DOI 10.1016/S0006-3495(03)75027-9	55	34	35	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112751	10.1371/journal.pone.0112751	http://dx.doi.org/10.1371/journal.pone.0112751			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393107	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300096
J	Puig-Barbera, J; Garcia-de-Lomas, J; Diez-Domingo, J; Arnedo-Pena, A; Ruiz-Garcia, M; Limon-Ramirez, R; Perez-Vilar, S; Mico-Esparza, JL; Tortajada-Girbes, M; Carratala-Munuera, C; Larrea-Gonzalez, R; Beltran-Garrido, JM; Otero-Reigada, MD; Mollar-Maseres, J; Correcher-Medina, P; Schwarz-Chavarri, G; Gil-Guillen, V				Puig-Barbera, Joan; Garcia-de-Lomas, Juan; Diez-Domingo, Javier; Arnedo-Pena, Alberto; Ruiz-Garcia, Montserrat; Limon-Ramirez, Ramon; Perez-Vilar, Silvia; Luis Mico-Esparza, Jose; Tortajada-Girbes, Miguel; Carratala-Munuera, Concha; Larrea-Gonzalez, Rosa; Manuel Beltran-Garrido, Juan; del Carmen Otero-Reigada, Maria; Mollar-Maseres, Joan; Correcher-Medina, Patricia; Schwarz-Chavarri, German; Gil-Guillen, Vicente		Valencia Hosp Network Study Influe	Influenza Vaccine Effectiveness in Preventing Influenza A(H3N2)-Related Hospitalizations in Adults Targeted for Vaccination by Type of Vaccine: A Hospital-Based Test-Negative Study, 2011-2012 A(H3N2) Predominant Influenza Season, Valencia, Spain	PLOS ONE			English	Article							LABORATORY-CONFIRMED INFLUENZA; RESPIRATORY SYNCYTIAL VIRUS; DESIGN; PROTECTION; MORTALITY; EFFICACY; ANTIBODY	Background: Most evidence of the effectiveness of influenza vaccines comes from studies conducted in primary care, but less is known about their effectiveness in preventing serious complications. Here, we examined the influenza vaccine effectiveness (IVE) against hospitalization with PCR-confirmed influenza in the predominant A(H3N2) 2011-2012 influenza season. Methods: A hospital-based, test-negative study was conducted in nine hospitals in Valencia, Spain. All emergency admissions with a predefined subset of symptoms were eligible. We enrolled consenting adults age 18 and over, targeted for influenza vaccination because of comorbidity, with symptoms of influenza-like-illness within seven days of admission. We estimated IVE as (1-adjusted vaccination odds ratio)* 100 after accounting for major confounders, calendar time and recruitment hospital. Results: The subjects included 544 positive for influenza A(H3N2) and 1,370 negative for influenza admissions. Age was an IVE modifying factor. Regardless of vaccine administration, IVE was 72% (38 to 88%) in subjects aged under 65 and 21% (-5% to 40%) in subjects aged 65 and over. By type of vaccine, the IVE of classical intramuscular split-influenza vaccine, used in subjects 18 to 64, was 68% (12% to 88%). The IVE for intradermal and virosomal influenza vaccines, used in subjects aged 65 and over, was 39% (11% to 58%) and 16% (-39% to 49%), respectively. Conclusions: The split-influenza vaccine was effective in preventing influenza-associated hospitalizations in adults aged under 65. The intradermal vaccine was moderately effective in those aged 65 and over.	[Puig-Barbera, Joan; Diez-Domingo, Javier] Fdn Fomento Invest Sanitaria & Biomed Comunitat V, Valencia, Spain; [Puig-Barbera, Joan; Arnedo-Pena, Alberto; Ruiz-Garcia, Montserrat] Ctr Salud Publ Castellon, Castellon de La Plana, Spain; [Garcia-de-Lomas, Juan] Inst Valenciano Microbiol, Valencia, Spain; [Limon-Ramirez, Ramon; Perez-Vilar, Silvia] Hosp Plana, Vila Real, Spain; [Luis Mico-Esparza, Jose] Hosp Aranau de Vilanova, Valencia, Spain; [Tortajada-Girbes, Miguel] Hosp Doctor Peset, Valencia, Spain; [Carratala-Munuera, Concha] Hosp San Juan, Alicante, Spain; [Carratala-Munuera, Concha; Gil-Guillen, Vicente] Univ Miguel Hernandez, Dept Clin Med, Catedra Med Familia, Alicante, Spain; [Larrea-Gonzalez, Rosa; Manuel Beltran-Garrido, Juan] Hosp Gen Castellon, Castellon de La Plana, Spain; [del Carmen Otero-Reigada, Maria; Mollar-Maseres, Joan] Hosp Univ & Politecn La Fe, Valencia, Spain; [Correcher-Medina, Patricia] Hosp Lluis Alcanyis, Xativa, Spain; [Schwarz-Chavarri, German] Ctr Salud San Blas, Alicante, Spain; [Gil-Guillen, Vicente] Hosp Elda, Elda, Spain	Universidad Miguel Hernandez de Elche; Hospital Universitari i Politecnic La Fe	Puig-Barbera, J (corresponding author), Fdn Fomento Invest Sanitaria & Biomed Comunitat V, Valencia, Spain.	puig_joa@gva.es	Medina, Patricia Correcher/AAL-9598-2020; Puig-Barberà, Joan/F-1563-2015; Domingo, Javier Diez/B-7293-2015; Guillén, Vicente Francisco Gil/AAE-8201-2019; Perez-Vilar, Silvia/H-4372-2016; Carratala-Munuera, Concepcion/ABH-1205-2020	Medina, Patricia Correcher/0000-0002-9704-9534; Puig-Barberà, Joan/0000-0001-5783-0409; Domingo, Javier Diez/0000-0003-1008-3922; Perez-Vilar, Silvia/0000-0003-1272-1502; Carratala-Munuera, Concepcion/0000-0002-1303-6294; Gil-Guillen, Vicente F/0000-0003-3793-9786	FISABIO-Salud Publica; Sanofi-Pasteur; Sanofi-Pasteur MSD	FISABIO-Salud Publica; Sanofi-Pasteur; Sanofi-Pasteur MSD	The study was funded by contracts between FISABIO-Salud Publica (former CSISP) and Sanofi-Pasteur and FISABIO-Salud Publica (former CSISP) and Sanofi-Pasteur MSD. Sanofi-Pasteur and Sanofi-Pasteur MSD did not participate in the design or conduct of the study, collection, management, analysis, or interpretation of the data, writing of the manuscript, and the decision to submit the manuscript for publication.	[Anonymous], 2013, Weekly Epidemiological Record, V88, P225; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P101; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P83; Belongia EA, 2009, J INFECT DIS, V199, P159, DOI 10.1086/595861; Benach Joan, 2004, Gac Sanit, V18, P16, DOI 10.1157/13062246; Bloom-Feshbach K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054445; Bonmarin I, 2012, EUROSURVEILLANCE, V17; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Castilla J, 2013, EURO SURVEILL, V18; Cheng AC, 2013, COMMUN DIS INTELL, V37, pE246; De Serres G, 2013, EUROSURVEILLANCE, V18; Delgado-Sanz C, 2013, B EPIDEMIOLOGICO SEM, V20, P153; European Influenza Surveillance Network (EISN) website, INFL CAS DEF CLIN CR; Foppa IM, 2013, VACCINE, V31, P3104, DOI 10.1016/j.vaccine.2013.04.026; GREENLAND S, 1985, AM J EPIDEMIOL, V122, P495, DOI 10.1093/oxfordjournals.aje.a114131; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jackson LA, 2006, INT J EPIDEMIOL, V35, P345, DOI 10.1093/ije/dyi275; Jackson ML, 2013, VACCINE, V31, P2165, DOI 10.1016/j.vaccine.2013.02.053; Jimenez-Jorge S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-441; KATZ JM, 1989, J INFECT DIS, V160, P191, DOI 10.1093/infdis/160.2.191; Kissling E, 2013, EURO SURVEILL, V18; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; Legrand J, 2006, VACCINE, V24, P6605, DOI 10.1016/j.vaccine.2006.05.063; Maciosek MV, 2006, AM J PREV MED, V31, P90, DOI 10.1016/j.amepre.2006.03.011; McElhaney JE, 2013, LANCET INFECT DIS, V13, P485, DOI 10.1016/S1473-3099(13)70046-X; Ndifon W, 2009, P NATL ACAD SCI USA, V106, P8701, DOI 10.1073/pnas.0903427106; Nelson JC, 2009, J CLIN EPIDEMIOL, V62, P687, DOI 10.1016/j.jclinepi.2008.06.014; Ohmit SE, 2014, CLIN INFECT DIS, V58, P319, DOI 10.1093/cid/cit736; Olson DR, 2007, PLOS MED, V4, P1349, DOI 10.1371/journal.pmed.0040247; Orenstein EW, 2007, INT J EPIDEMIOL, V36, P623, DOI 10.1093/ije/dym021; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Pebody R., 2013, EURO SURVEILL, V18; Portero-Alonso A, 2012, INFORME DIRECCION GE; Puig-Barbera J, 2004, VACCINE, V23, P283, DOI 10.1016/j.vaccine.2004.07.017; Puig-Barbera J, 2012, VACCINE, V30, P5714, DOI 10.1016/j.vaccine.2012.07.006; Puig-Barbera J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100497; Puig-Barbera J, 2010, VACCINE, V28, P7460, DOI 10.1016/j.vaccine.2010.09.042; Regidor E, 2001, Rev Esp Salud Publica, V75, P13; ROCHA EP, 1993, J GEN VIROL, V74, P2513, DOI 10.1099/0022-1317-74-11-2513; Rothman KJ, 2008, MODERN EPIDEMIOLOGY, P111; Skowronski DM, 2014, J INFECT DIS, V210, P126, DOI 10.1093/infdis/jiu048; Skowronski DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092153; Skowronski DM, 2012, J INFECT DIS, V206, P1852, DOI 10.1093/infdis/jis500; Smith DJ, 1999, P NATL ACAD SCI USA, V96, P14001, DOI 10.1073/pnas.96.24.14001; Talbot HK, 2013, CLIN INFECT DIS, V56, P1774, DOI 10.1093/cid/cit124; Thomas HL, 2014, EPIDEMIOL INFECT, V142, P126, DOI 10.1017/S0950268813000824; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Turner N, 2014, VACCINE; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	50	13	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112294	10.1371/journal.pone.0112294	http://dx.doi.org/10.1371/journal.pone.0112294			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392931	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300046
J	Tsukumo, Y; Tsukahara, S; Furuno, A; Iemura, S; Natsume, T; Tomida, A				Tsukumo, Yoshinori; Tsukahara, Satomi; Furuno, Aki; Iemura, Shun-ichiro; Natsume, Toru; Tomida, Akihiro			TBL2 Is a Novel PERK-Binding Protein that Modulates Stress-Signaling and Cell Survival during Endoplasmic Reticulum Stress	PLOS ONE			English	Article							MESSENGER-RNA; ER STRESS; TRANSCRIPTIONAL INDUCTION; TRANSLATION; ATF6; IDENTIFICATION; EXPRESSION; DELETION; PATHWAY; REPEAT	Under ER stress, PKR-like ER-resident kinase (PERK) phosphorylates translation initiation factor eIF2a, resulting in repression of global protein synthesis and concomitant upregulation of the translation of specific mRNAs such as activating transcription factor 4 (ATF4). This PERK function is important for cell survival under ER stress and poor nutrient conditions. However, mechanisms of the PERK signaling pathway are not thoroughly understood. Here we identify transducin (beta)like 2 (TBL2) as a novel PERK-binding protein. We found that TBL2 is an ER-localized type-I transmembrane protein and preferentially binds to the phosphorylated form of PERK, but not another eIF2a kinase GCN2 or ER-resident kinase IRE1, under ER stress. Immunoprecipitation analysis using various deletion mutants revealed that TBL2 interacts with PERK via the N-terminus proximal region and also associates with eIF2a via the WD40 domain. In addition, TBL2 knockdown can lead to impaired ATF4 induction under ER stress or poor nutrient conditions such as glucose and oxygen deprivation. Consistently, TBL2 knockdown rendered cells vulnerable to stresses similarly to PERK knockdown. Thus, TBL2 serves as a potential regulator of the PERK pathway.	[Tsukumo, Yoshinori; Tsukahara, Satomi; Furuno, Aki; Tomida, Akihiro] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Koto Ku, Tokyo 170, Japan; [Iemura, Shun-ichiro; Natsume, Toru] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Koto Ku, Tokyo, Japan	Japanese Foundation for Cancer Research; National Institute of Advanced Industrial Science & Technology (AIST)	Tomida, A (corresponding author), Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Koto Ku, Tokyo 170, Japan.	akihiro.tomida@jfcr.or.jp	Natsume, Tohru/M-7627-2018	Natsume, Tohru/0000-0002-1510-2582	Ministry of Education, Culture, Sports, Science and Technology of Japan [22700892, 22300342, 25290061, 24650626]; National Cancer Center Research and Development Fund from the Ministry of Health, Labour and Welfare [21-3-1]; Kobayashi Foundation for Cancer Research; Vehicle Racing Commemorative Foundation; Grants-in-Aid for Scientific Research [24650626] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Cancer Center Research and Development Fund from the Ministry of Health, Labour and Welfare; Kobayashi Foundation for Cancer Research(Kobayashi Foundation for Cancer Research); Vehicle Racing Commemorative Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid for Young Scientists (B) (22700892 YT), a Grant-in-Aid for scientific research (B) (22300342, 25290061 AT), a Grant-in-Aid for challenging Exploratory Research (24650626 AT), from the Ministry of Education, Culture, Sports, Science and Technology of Japan, National Cancer Center Research and Development Fund (21-3-1) from the Ministry of Health, Labour and Welfare, a Grant from Kobayashi Foundation for Cancer Research, and from the Vehicle Racing Commemorative Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; Holm M, 2001, EMBO J, V20, P118, DOI 10.1093/emboj/20.1.118; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Jurado LAP, 1999, CYTOGENET CELL GENET, V86, P277, DOI 10.1159/000015319; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kim YJ, 2011, NAT GENET, V43, P990, DOI 10.1038/ng.939; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Marciniak SJ, 2006, J CELL BIOL, V172, P201, DOI 10.1083/jcb.200508099; Meng X, 1998, HUM GENET, V103, P590, DOI 10.1007/s004390050874; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Pober Barbara R, 2010, N Engl J Med, V362, P239, DOI 10.1056/NEJMra0903074; Roberts LO, 2009, PROG MOL BIOL TRANSL, V90, P313, DOI 10.1016/S1877-1173(09)90009-6; Saito S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045845; Shan JX, 2009, J BIOL CHEM, V284, P21241, DOI 10.1074/jbc.M109.011338; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Singleton DC, 2012, EXPERT OPIN THER TAR, V16, P1189, DOI 10.1517/14728222.2012.728207; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Stephens SB, 2005, MOL BIOL CELL, V16, P5819, DOI 10.1091/mbc.E05-07-0685; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Tsukumo Y, 2007, J BIOL CHEM, V282, P29264, DOI 10.1074/jbc.M705038200; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	35	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112761	10.1371/journal.pone.0112761	http://dx.doi.org/10.1371/journal.pone.0112761			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393282	gold, Green Published, Green Submitted			2022-12-27	WOS:000347709300098
J	Zerillo, MM; Caballero, JI; Woeste, K; Graves, AD; Hartel, C; Pscheidt, JW; Tonos, J; Broders, K; Cranshaw, W; Seybold, SJ; Tisserat, N				Zerillo, Marcelo M.; Caballero, Jorge Ibarra; Woeste, Keith; Graves, Andrew D.; Hartel, Colleen; Pscheidt, Jay W.; Tonos, Jadelys; Broders, Kirk; Cranshaw, Whitney; Seybold, Steven J.; Tisserat, Ned			Population Structure of Geosmithia morbida, the Causal Agent of Thousand Cankers Disease of Walnut Trees in the United States	PLOS ONE			English	Article							BEETLE PITYOPHTHORUS-JUGLANDIS; TWIG BEETLE; BAYESIAN-INFERENCE; FUNGUS; NIGRA; DIFFERENTIATION; INTRODUCTIONS; DIVERSITY; GENETICS; FUSARIUM	The ascomycete Geosmithia morbida and the walnut twig beetle Pityophthorus juglandis are associated with thousand cankers disease of Juglans (walnut) and Pterocarya (wingnut). The disease was first reported in the western United States (USA) on several Juglans species, but has been found more recently in the eastern USA in the native range of the highly susceptible Juglans nigra. We performed a comprehensive population genetic study of 209 G. morbida isolates collected from Juglans and Pterocarya from 17 geographic regions distributed across 12 U.S. states. The study was based on sequence typing of 27 single nucleotide polymorphisms from three genomic regions and genotyping with ten microsatellite primer pairs. Using multilocus sequence-typing data, 197 G. morbida isolates were placed into one of 57 haplotypes. In some instances, multiple haplotypes were recovered from isolates collected on the same tree. Twenty-four of the haplotypes (42%) were recovered from more than one isolate; the two most frequently occurring haplotypes (H02 and H03) represented 36% of all isolates. These two haplotypes were abundant in California, but were not recovered from Arizona or New Mexico. G. morbida population structure was best explained by four genetically distinct groups that clustered into three geographic regions. Most of the haplotypes isolated from the native range of J. major (Arizona and New Mexico) were found in those states only or present in distinct genetic clusters. There was no evidence of sexual reproduction or genetic recombination in any population. The scattered distribution of the genetic clusters indicated that G. morbida was likely disseminated to different regions at several times and from several sources. The large number of haplotypes observed and the genetic complexity of G. morbida indicate that it evolved in association with at least one Juglans spp. and the walnut twig beetle long before the first reports of the disease.	[Zerillo, Marcelo M.; Caballero, Jorge Ibarra; Cranshaw, Whitney; Tisserat, Ned] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Woeste, Keith] Purdue Univ, Dept Forestry & Nat Resources, USDA, US Forest Service,Hardwood Tree Improvement & Reg, W Lafayette, IN 47907 USA; [Graves, Andrew D.] US Forest Serv, USDA, Forest Hlth Protect, Albuquerque, NM USA; [Hartel, Colleen; Tonos, Jadelys] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA; [Pscheidt, Jay W.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Broders, Kirk] Univ New Hampshire, Dept Biol Sci, Durham, NC USA; [Seybold, Steven J.] US Forest Serv, USDA, Pacific Southwest Res Stn, Davis, CA USA	Colorado State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Oregon State University; University System Of New Hampshire; University of New Hampshire; United States Department of Agriculture (USDA); United States Forest Service	Zerillo, MM (corresponding author), Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA.	mzerillo@colostate.edu	zerillo, marcelo M/AAE-1735-2022	Broders, Kirk/0000-0002-8569-6005	USDA NIFA Western Region IPM Center; Critical Issues-Emerging and New Plant and Animal Pests and Diseases grant programs; USDA Forest Service Forest Health Monitoring Program [INT-DM-09-01, INT-EM-B-11-03]; USDA Forest Service Special Technology Development [R4-2011-01]	USDA NIFA Western Region IPM Center; Critical Issues-Emerging and New Plant and Animal Pests and Diseases grant programs; USDA Forest Service Forest Health Monitoring Program(United States Department of Agriculture (USDA)United States Forest Service); USDA Forest Service Special Technology Development	This research was supported by funds provided by the USDA NIFA Western Region IPM Center and Critical Issues-Emerging and New Plant and Animal Pests and Diseases grant programs, the USDA Forest Service Forest Health Monitoring Program (Detection Monitoring Grant No. INT-DM-09-01 and Evaluation Monitoring Grant No. INT-EM-B-11-03), and USDA Forest Service Special Technology Development Grant R4-2011-01 (administered by A. S. Munson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Blackman MW, 1928, B NEW YORK STATE COL, V1, P183; Bright D. E., 2014, Insecta Mundi, P1; BRIGHT DE, 1981, MEM ENTOMOL SOC CAN, P1; Broders KD, 2012, ECOL EVOL, V2, P2114, DOI 10.1002/ece3.332; Ciosi M, 2008, MOL ECOL, V17, P3614, DOI 10.1111/j.1365-294X.2008.03866.x; Cranshaw W, 2011, COLEOPTS BULL, V65, P48, DOI 10.1649/0010-065X-65.1.48; Debourgogne A, 2010, J MICROBIOL METH, V82, P319, DOI 10.1016/j.mimet.2010.07.008; Delmotte F, 2008, INFECT GENET EVOL, V8, P534, DOI 10.1016/j.meegid.2008.02.012; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Excoffier L, 1995, AMOVA ANAL MOL VARIA; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fisher J. R., 2013, PLANT HLTH PROG, DOI [10.1094/ PHP-2013-1201-01-BR, DOI 10.1094/PHP-2013-1201-01-BR, 10.1094/PHP-2013-1201-01-BR]; Force PFPT, 2012, COMM PENNS 1000 CANK; Fournier E, 2008, J EVOLUTION BIOL, V21, P122, DOI 10.1111/j.1420-9101.2007.01462.x; Freeland E, 2012, PLANT HLTH PROGR, DOI [10.1094/PHP-2012-0618-01-RS, DOI 10.1094/PHP-2012-0618-01-RS]; Freeland E., 2012, INTRASPECIFIC VARIAB; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Goss EM, 2011, PHYTOPATHOLOGY, V101, P166, DOI 10.1094/PHYTO-05-10-0133; Grant JF, 2011, FORESTS, V2, P741, DOI 10.3390/f2030741; Graves AD, 2011, MONITORING WALNUT HL; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340; Griffin JR, 1972, PSW82 USDA FOR SERV; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hadziabdic D, 2014, PLANT DIS, V98, P992, DOI 10.1094/PDIS-06-13-0630-PDN; Hadziabdic D, 2014, CURR GENET, V60, P75, DOI 10.1007/s00294-013-0414-x; Halkett F, 2005, TRENDS ECOL EVOL, V20, P194, DOI 10.1016/j.tree.2005.01.001; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hanson MA, 2011, WALNUT 1000 CANKERS; Hardin JW, 2000, HARLOW HARRARS TXB D; Haun WG, 2010, STATE TENNESSEE 1000; Huang WC, 2008, GENOME RES, V18, P1538, DOI 10.1101/gr.076067.108; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Keller SR, 2012, MOL ECOL, V21, P4721, DOI 10.1111/j.1365-294X.2012.05751.x; Kolarik M, 2013, MICROB ECOL, V66, P682, DOI 10.1007/s00248-013-0228-x; Kolarik M, 2011, MYCOLOGIA, V103, P325, DOI 10.3852/10-124; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Little EL, 1979, CHECKLIST US TREES N; Montecchio L, 2014, PLANT DIS, V98, P696, DOI 10.1094/PDIS-10-13-1027-PDN; Newton L, 2009, PATHWAY ASSESSMENT G, V1; Nicodemus MA, 2008, TREES-STRUCT FUNCT, V22, P685, DOI 10.1007/s00468-008-0226-7; ODonnell K, 1997, MOL PHYLOGENET EVOL, V7, P103, DOI 10.1006/mpev.1996.0376; Pritchard JK, 2000, GENETICS, V155, P945; Pscheidt JW, 2014, PACIFIC NW PLANT DIS; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rozen S, 2000, Methods Mol Biol, V132, P365; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Serdani M., 2013, PLANT HLTH PROGR, DOI [10.1094/PHP-2013-1018-01-BR, DOI 10.1094/PHP-2013-1018-01-BR]; Services. VDoAaC, 2011, VDACS PLANT PEST SER; Seybold SJ, 2013, NAPR0210 USDA FOR SE; Seybold SJ, 2012, PAN-PAC ENTOMOL, V88, P277, DOI 10.3956/2012-32.1; Sitz R, 2013, MANAGEMENT OPTIONS W; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tisserat N., 2011, PLANT HLTH PROGR, V10, P1094, DOI DOI 10.1094/PHP-2011-0630-01-BR; Tisserat N., 2009, PLANT HLTH PROGR, V11; USDA-FS, 2001, USDA FS SW REG FOR F; Utley C, 2013, PLANT DIS, V97, P601, DOI 10.1094/PDIS-07-12-0636-RE; Williams R.D., 1990, SILVICS N AM, V2, P391	64	33	34	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112847	10.1371/journal.pone.0112847	http://dx.doi.org/10.1371/journal.pone.0112847			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393300	gold, Green Published, Green Submitted			2022-12-27	WOS:000347709300113
J	Chen, MP; Cabantchik, ZI; Chan, S; Chan, GCF; Cheung, YF				Chen, Mei-pian; Cabantchik, Z. Ioav; Chan, Shing; Chan, Godfrey Chi-fung; Cheung, Yiu-fai			Iron Overload and Apoptosis of HL-1 Cardiomyocytes: Effects of Calcium Channel Blockade	PLOS ONE			English	Article							TRANSFERRIN-BOUND-IRON; CA2+ CHANNELS; CARDIOVASCULAR FUNCTION; BETA-THALASSEMIA; HEART-FAILURE; EXPRESSION; DEATH; CARDIOMYOPATHY; MITOCHONDRIA; DEFERIPRONE	Background: Iron overload cardiomyopathy that prevails in some forms of hemosiderosis is caused by excessive deposition of iron into the heart tissue and ensuing damage caused by a raise in labile cell iron. The underlying mechanisms of iron uptake into cardiomyocytes in iron overload condition are still under investigation. Both L-type calcium channels (LTCC) and T-type calcium channels (TTCC) have been proposed to be the main portals of non-transferrinic iron into heart cells, but controversies remain. Here, we investigated the roles of LTCC and TTCC as mediators of cardiac iron overload and cellular damage by using specific Calcium channel blockers as potential suppressors of labile Fe(II) and Fe(III) ingress in cultured cardiomyocytes and ensuing apoptosis. Methods: Fe(II) and Fe(III) uptake was assessed by exposing HL-1 cardiomyocytes to iron sources and quantitative real-time fluorescence imaging of cytosolic labile iron with the fluorescent iron sensor calcein while iron-induced apoptosis was quantitatively measured by flow cytometry analysis with Annexin V. The role of calcium channels as routes of iron uptake was assessed by cell pretreatment with specific blockers of LTCC and TTCC. Results: Iron entered HL-1 cardiomyocytes in a time-and dose-dependent manner and induced cardiac apoptosis via mitochondria-mediated caspase-3 dependent pathways. Blockade of LTCC but not of TTCC demonstrably inhibited the uptake of ferric but not of ferrous iron. However, neither channel blocker conferred cardiomyocytes with protection from iron-induced apoptosis. Conclusion: Our study implicates LTCC as major mediators of Fe(III) uptake into cardiomyocytes exposed to ferric salts but not necessarily as contributors to ensuing apoptosis. Thus, to the extent that apoptosis can be considered a biological indicator of damage, the etiopathology of cardiosiderotic damage that accompanies some forms of hemosiderosis would seem to be unrelated to LTCC or TTCC, but rather to other routes of iron ingress present in heart cells.	[Chen, Mei-pian; Chan, Shing; Chan, Godfrey Chi-fung; Cheung, Yiu-fai] Univ Hong Kong, Dept Pediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Cabantchik, Z. Ioav] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel	University of Hong Kong; Hebrew University of Jerusalem	Chan, GCF (corresponding author), Univ Hong Kong, Dept Pediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China.	gcfchan@hku.hk; xfcheung@hku.hk	Cheung, Yiu Fai/C-4240-2009; Chan, Godfrey Chi Fung/C-4205-2009	Cheung, Yiu Fai/0000-0002-7279-4992; Chan, Godfrey Chi Fung/0000-0001-5032-8985	Children's Thalassemia Foundation; Edward Sai Kim Hotung Pediatric Education and Research Fund	Children's Thalassemia Foundation; Edward Sai Kim Hotung Pediatric Education and Research Fund	This work was supported by Children's Thalassemia Foundation and Edward Sai Kim Hotung Pediatric Education and Research Fund (http://www.thalassaemia.org.hk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATAR D, 1995, J BIOL CHEM, V270, P2473, DOI 10.1074/jbc.270.6.2473; CATTERALL WA, 1992, TRENDS PHARMACOL SCI, V13, P256, DOI 10.1016/0165-6147(92)90079-L; Chattipakorn N, 2011, WORLD J CARDIOL, V3, P215, DOI 10.4330/wjc.v3.i7.215; Chiong M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.130; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Dai JS, 2004, TOXICOLOGY, V203, P199, DOI 10.1016/j.tox.2004.06.009; Esposito BP, 2003, BLOOD, V102, P2670, DOI 10.1182/blood-2003-03-0807; Foo RSY, 2005, J CLIN INVEST, V115, P565, DOI 10.1172/JCI200524569; Glickstein H, 2005, BLOOD, V106, P3242, DOI 10.1182/blood-2005-02-0460; Grandi E, 2011, CIRC RES, V109, P1055, DOI 10.1161/CIRCRESAHA.111.253955; Gujja P, 2010, J AM COLL CARDIOL, V56, P1001, DOI 10.1016/j.jacc.2010.03.083; HAMANN SR, 1984, CLIN PHARMACOKINET, V9, P26, DOI 10.2165/00003088-198409010-00002; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hershko Chaim M, 2005, Curr Hematol Rep, V4, P110; Horwitz LD, 1999, VASC MED, V4, P93, DOI 10.1191/135886399676588477; Huang BY, 2000, CARDIOVASC RES, V46, P442, DOI 10.1016/S0008-6363(00)00017-1; Jonsson MKB, 2011, ASSAY DRUG DEV TECHN, V9, P589, DOI 10.1089/adt.2011.0396; Kang PM, 2000, CIRC RES, V86, P1107; Kolnagou A, 2011, HEMOGLOBIN, V35, P186, DOI 10.3109/03630269.2011.576153; Kontoghiorghes GJ, 2006, HEMOGLOBIN, V30, P183, DOI 10.1080/03630260600642450; KREMASTINOS DT, 1995, CIRCULATION, V91, P66, DOI 10.1161/01.CIR.91.1.66; Kremastinos DT, 1999, CIRCULATION, V100, P2074, DOI 10.1161/01.CIR.100.20.2074; Kumfu S, 2012, EUR J HAEMATOL, V88, P535, DOI 10.1111/j.1600-0609.2012.01779.x; Kumfu S, 2011, EUR J HAEMATOL, V86, P156, DOI 10.1111/j.1600-0609.2010.01549.x; LANSMAN JB, 1986, J GEN PHYSIOL, V88, P321, DOI 10.1085/jgp.88.3.321; Lecoeur H, 2008, METHOD ENZYMOL, V442, P51, DOI 10.1016/S0076-6879(08)01403-1; Lee Y, 2009, APOPTOSIS, V14, P536, DOI 10.1007/s10495-008-0302-x; Li W, 2008, HAEMATOLOGICA, V93, P311, DOI 10.3324/haematol.11958; Lieu Pauline T., 2001, Molecular Aspects of Medicine, V22, P1, DOI 10.1016/S0098-2997(00)00006-6; Lu Wen-yi, 2013, Zhonghua Yi Xue Za Zhi, V93, P930; Lu Wen-yi, 2013, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V35, P6, DOI 10.3881/j.issn.1000-503X.2013.01.002; MAK IT, 1990, CIRC RES, V66, P1449, DOI 10.1161/01.RES.66.5.1449; Martinez ML, 1999, J MOL CELL CARDIOL, V31, P1617, DOI 10.1006/jmcc.1999.0998; Muhlestein JB, 2000, HEMOCHROMATOSIS: GENETICS, PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT, P297; Munoz JP, 2010, FREE RADICAL BIO MED, V48, P526, DOI 10.1016/j.freeradbiomed.2009.11.017; Murphy CJ, 2010, J CARD FAIL, V16, P888, DOI 10.1016/j.cardfail.2010.05.009; Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603; Nday CM, 2012, J INORG BIOCHEM, V117, P342, DOI 10.1016/j.jinorgbio.2012.08.009; Oancea Marcela, 2006, V129, P279; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; OLIVIERI NF, 1994, NEW ENGL J MED, V331, P574, DOI 10.1056/NEJM199409013310903; Oteiza PI, 2011, NEUROTOXICOLOGY, V32, P75; Oudit GY, 2006, J MOL MED, V84, P349, DOI 10.1007/s00109-005-0029-x; Oudit GY, 2004, CIRCULATION, V109, P1877, DOI 10.1161/01.CIR.0000124229.40424.80; Oudit GY, 2003, NAT MED, V9, P1187, DOI 10.1038/nm920; Parkes JG, 1997, TOXICOLOGY, V117, P141, DOI 10.1016/S0300-483X(96)03566-4; RANDELL EW, 1994, J BIOL CHEM, V269, P16046; Rao F, 2013, EXP PHYSIOL, V98, P172, DOI 10.1113/expphysiol.2012.066761; Rosa JM, 2012, J MOL NEUROSCI; Rousan RM, 2009, AM J HEMATOL, V84, P565; Shvartsman M, 2007, AM J PHYSIOL-CELL PH, V293, pC1383, DOI 10.1152/ajpcell.00054.2007; Shvartsman M, 2012, BIOMETALS, V25, P711, DOI 10.1007/s10534-012-9529-7; Shvartsman M, 2010, BIOCHEM J, V429, P185, DOI 10.1042/BJ20100213; Sohn YS, 2012, HAEMATOL-HEMATOL J, V97, P670, DOI 10.3324/haematol.2011.054858; Tsushima RG, 1999, CIRC RES, V84, P1302, DOI 10.1161/01.RES.84.11.1302; Wang TX, 2013, BIOSENS BIOELECTRON, V49, P9, DOI 10.1016/j.bios.2013.04.039; Wang YL, 2011, J PHARMACOL EXP THER, V336, P56, DOI 10.1124/jpet.110.172668; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; WINEGAR BD, 1991, J GEN PHYSIOL, V97, P351, DOI 10.1085/jgp.97.2.351; Xia M, 2004, J MOL CELL CARDIOL, V36, P111, DOI 10.1016/j.yjmcc.2003.10.007; Yasui K, 2005, J PHARM SCI, V99, P205	63	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112915	10.1371/journal.pone.0112915	http://dx.doi.org/10.1371/journal.pone.0112915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390893	Green Submitted, Green Published, gold			2022-12-27	WOS:000349144400141
J	Huang, F; Qureshi, JA; Meagher, RL; Reisig, DD; Head, GP; Andow, DA; Ni, XZ; Kerns, D; Buntin, GD; Niu, Y; Yang, F; Dangal, V				Huang, Fangneng; Qureshi, Jawwad A.; Meagher, Robert L., Jr.; Reisig, Dominic D.; Head, Graham P.; Andow, David A.; Ni, Xinzi; Kerns, David; Buntin, G. David; Niu, Ying; Yang, Fei; Dangal, Vikash			Cry1F Resistance in Fall Armyworm Spodoptera frugiperda: Single Gene versus Pyramided Bt Maize	PLOS ONE			English	Article							BORER LEPIDOPTERA CRAMBIDAE; FIELD-EVOLVED RESISTANCE; FLORIDA POPULATIONS; PUERTO-RICO; F-2 SCREEN; NOCTUIDAE; SUSCEPTIBILITY; CORN; PROTEINS; LOUISIANA	Evolution of insect resistance to transgenic crops containing Bacillus thuringiensis (Bt) genes is a serious threat to the sustainability of this technology. However, field resistance related to the reduced efficacy of Bt maize has not been documented in any lepidopteran pest in the mainland U. S. after 18 years of intensive Bt maize planting. Here we report compelling evidence of field resistance in the fall armyworm, Spodoptera frugiperda (J.E. Smith), to Cry1F maize (TC 3507) in the southeastern region of the U. S. An F-2 screen showed a surprisingly high (0.293) Cry1F resistance allele frequency in a population collected in 2011 from non-Bt maize in south Florida. Field populations from non-Bt maize in 2012-2013 exhibited 18.8-fold to >85.4-fold resistance to purified Cry1F protein and those collected from unexpectedly damaged Bt maize plants at several locations in Florida and North Carolina had >85.4-fold resistance. In addition, reduced efficacy and control failure of Cry1F maize against natural populations of S. frugiperda were documented in field trials using Cry1F-based and pyramided Bt maize products in south Florida. The Cry1F-resistant S. frugiperda also showed a low level of cross-resistance to Cry1A.105 and related maize products, but not to Cry2Ab2 or Vip3A. The occurrence of Cry1F resistance in the U.S. mainland populations of S. frugiperda likely represents migration of insects from Puerto Rico, indicating the great challenges faced in achieving effective resistance management for long-distance migratory pests like S. frugiperda.	[Huang, Fangneng; Kerns, David; Niu, Ying; Yang, Fei; Dangal, Vikash] Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA; [Qureshi, Jawwad A.] Univ Florida, Dept Entomol & Nematol, Inst Food & Agr Sci, Southwest Florida Res & Educ Ctr, Immokalee, FL USA; [Meagher, Robert L., Jr.] ARS, Insect Behav & Biocontrol Unit, USDA, CMAVE, Gainesville, FL USA; [Reisig, Dominic D.] N Carolina State Univ, Vernon G James Res & Extens Ctr, Dept Entomol, Plymouth, NC USA; [Head, Graham P.] Monsanto Co, St Louis, MO USA; [Andow, David A.] Univ Minnesota, Dept Entomol, St Paul, MN USA; [Ni, Xinzi] ARS, USDA, Crop Genet & Breeding Res Unit, Tifton, GA USA; [Buntin, G. David] Univ Georgia, Dept Entomol, Griffin, GA USA	Louisiana State University System; Louisiana State University; State University System of Florida; University of Florida; United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University; Monsanto; University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA); University System of Georgia; University of Georgia	Huang, F (corresponding author), Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA.	fhuang@agcenter.lsu.edu	Yang, Fei/Q-6498-2016	Yang, Fei/0000-0001-5162-4575; Head, Graham/0000-0003-0521-0616; Reisig, Dominic/0000-0002-9979-5813	Louisiana Soybean; Feed Grain Promotion Board; Monsanto Company; Hatch funds from the USDA National Institute of Food and Agriculture; Monsanto	Louisiana Soybean; Feed Grain Promotion Board; Monsanto Company; Hatch funds from the USDA National Institute of Food and Agriculture; Monsanto	This project represents work supported by the Louisiana Soybean and Feed Grain Promotion Board, Monsanto Company, and Hatch funds from the USDA National Institute of Food and Agriculture. The funder Monsanto provided support in the form of salaries for the coauthor (G. P. H.), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. All other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions'' section. The authors also confirm that this does not alter their adherence to PLOS ONE policies on sharing data and materials. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by Louisiana State University Agricultural Center, University of Florida or the U.S. Department of Agriculture.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Andow D, 1999, J ECON ENTOMOL, V92, P755, DOI 10.1093/jee/92.4.755; Andow DA, 1998, J ECON ENTOMOL, V91, P572, DOI 10.1093/jee/91.3.572; Biosafety Cleaning-House, 2014, GEN DNA SEQ CRY1A 10; Brevault T, 2009, J ECON ENTOMOL, V102, P2301, DOI 10.1603/029.102.0636; Buntin D, 2012, BT CORN PRODUCTS SE; Burkness Eric C, 2010, GM Crops, V1, P337, DOI 10.4161/gmcr.1.5.14765; Capinera JL, 1999, U FLA PUBLI; Davis FM, 1992, MISS AGR FORESTRY EX, V186; DIFONZO C., 2012, HANDY BT TRAIT TABLE; FINNEY D J, 1971, P333; Frizzas MR, 2014, CIENC RURAL, V44, P203, DOI 10.1590/S0103-84782014000200002; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Hardke JT, 2011, CROP PROT, V30, P168, DOI 10.1016/j.cropro.2010.10.005; Huang Fangneng, 2006, Insect Science, V13, P73, DOI 10.1111/j.1744-7917.2006.00070.x; Huang FN, 2012, INSECT SCI, V19, P570, DOI 10.1111/j.1744-7917.2012.01507.x; Huang FN, 2011, ENTOMOL EXP APPL, V140, P1, DOI 10.1111/j.1570-7458.2011.01138.x; Jakka SRK, 2014, J ECON ENTOMOL, V107, P342, DOI 10.1603/EC13326; Matten, 2012, REGULATION AGR BIOTE, P1752267; Matten Sharlene R., 2008, V5, P27, DOI 10.1007/978-1-4020-8373-0_2; MITCHELL ER, 1991, J ENTOMOL SCI, V26, P39, DOI 10.18474/0749-8004-26.1.39; Nagoshi RN, 2010, J ECON ENTOMOL, V103, P360, DOI 10.1603/EC09253; NASS (National Agricultural Statistics Service), 2013, ACR; Niu Y, 2014, CROP PROT, V59, P22, DOI 10.1016/j.cropro.2014.01.005; Niu Y, 2013, FLA ENTOMOL, V96, P701, DOI 10.1653/024.096.0302; PASHLEY DP, 1988, FLA ENTOMOL, V71, P227, DOI 10.2307/3495425; Ritchie S.W., 1993, 48 IOW STAT U SCI TE; Hernandez-Rodriguez CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068164; SAS Institute Inc, 2010, SAS STAT 9 3 US; Sena JAD, 2009, APPL ENVIRON MICROB, V75, P2236, DOI 10.1128/AEM.02342-08; Sivasupramaniam S, 2008, J ECON ENTOMOL, V101, P546, DOI 10.1603/0022-0493(2008)101[546:TACOCE]2.0.CO;2; SPARKS AN, 1979, FLA ENTOMOL, V62, P82, DOI 10.2307/3494083; Stodola TJ, 2004, J ECON ENTOMOL, V97, P1756, DOI 10.1603/0022-0493-97.5.1756; Storer Nicholas P, 2012, GM Crops Food, V3, P154, DOI 10.4161/gmcr.20945; Storer NP, 2012, J INVERTEBR PATHOL, V110, P294, DOI 10.1016/j.jip.2012.04.007; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Sumerford DV, 2013, J ECON ENTOMOL, V106, P1525, DOI 10.1603/EC13103; Sumerford DV, 2014, CROP PROT IN PRESS; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; US EPA (U.S. Environmental Protection Agency), 2001, BIOP REG ACT DOC BAC; US-EPA (U.S. Environmental Protection Agency), 2007, TC1507 MAIZ FALL ARM; Velez AM, 2013, B ENTOMOL RES, V103, P700, DOI 10.1017/S0007485313000448; Wu XY, 2009, J INVERTEBR PATHOL, V100, P29, DOI 10.1016/j.jip.2008.10.003; Yang F, 2013, FLA ENTOMOL, V96, P714, DOI 10.1653/024.096.0303; Yang F, 2013, CROP PROT, V50, P37, DOI 10.1016/j.cropro.2013.04.002; Zhang LP, 2013, J INVERTEBR PATHOL, V112, P267, DOI 10.1016/j.jip.2012.12.007	47	195	212	5	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112958	10.1371/journal.pone.0112958	http://dx.doi.org/10.1371/journal.pone.0112958			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401494	Green Published, Green Submitted, gold			2022-12-27	WOS:000345158700085
J	Hung, CS; Lee, JK; Yang, CY; Hsieh, HR; Ma, WY; Lin, MS; Liu, PH; Shih, SR; Liou, JM; Chuang, LM; Chen, MF; Lin, JW; Wei, JN; Li, HY				Hung, Chi-Sheng; Lee, Jen-Kuang; Yang, Chung-Yi; Hsieh, Hung-Ren; Ma, Wen-Ya; Lin, Mao-Shin; Liu, Pi-Hua; Shih, Shyang-Rong; Liou, Jyh-Ming; Chuang, Lee-Ming; Chen, Ming-Fong; Lin, Jou-Wei; Wei, Jung-Nan; Li, Hung-Yuan			Measurement of Visceral Fat: Should We Include Retroperitoneal Fat?	PLOS ONE			English	Article							METABOLIC SYNDROME; INSULIN-RESISTANCE; PORTAL THEORY; OBESE MEN; ADIPOSITY; RISK; ASSOCIATION; DEFINITION; STATEMENT; PROGRAM	Objective: Whether retroperitoneal fat should be included in the measurement of visceral fat remains controversial. We compared the relationships of fat areas in peritoneal, retroperitoneal, and subcutaneous compartments to metabolic syndrome, adipokines, and incident hypertension and diabetes. Methods: We enrolled 432 adult participants (153 men and 279 women) in a community-based cohort study. Computed tomography at the umbilicus level was used to measure the fat areas. Results: Retroperitoneal fat correlated significantly with metabolic syndrome (adjusted odds ratio (OR), 5.651, p < 0.05) and the number of metabolic abnormalities (p < 0.05). Retroperitoneal fat area was significantly associated with blood pressure, plasma glycemic indices, lipid profile, C-reactive protein, adiponectin (r = -0.244, p < 0.05), and leptin (r = 0.323, p < 0.05), but not plasma renin or aldosterone concentrations. During the 2.94 +/- 0.84 years of follow-up, 32 participants developed incident hypertension. Retroperitoneal fat area (hazard ration (HR) 1.62, p = 0.003) and peritoneal fat area (HR 1.62, p = 0.009), but not subcutaneous fat area (p = 0.14) were associated with incident hypertension. Neither retroperitoneal fat area, peritoneal fat area, nor subcutaneous fat areas was associated with incident diabetes after adjustment. Conclusions: Retroperitoneal fat is similar to peritoneal fat, but differs from subcutaneous fat, in terms of its relationship with metabolic syndrome and incident hypertension. Retroperitoneal fat area should be included in the measurement of visceral fat for cardio-metabolic studies in human.	[Hung, Chi-Sheng; Lin, Mao-Shin; Shih, Shyang-Rong; Liou, Jyh-Ming; Chuang, Lee-Ming; Chen, Ming-Fong; Li, Hung-Yuan] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Lee, Jen-Kuang] Far Eastern Mem Hosp, Dept Clin Pathol, New Taipei City, Taiwan; [Yang, Chung-Yi] Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei, Taiwan; [Yang, Chung-Yi] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Hsieh, Hung-Ren] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Radiol, Yunlin, Taiwan; [Ma, Wen-Ya] Cardinal Tien Hosp, Dept Internal Med, Div Endocrinol, Xindian, Taiwan; [Liu, Pi-Hua] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Gueishan, Taiwan; [Lin, Jou-Wei] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Internal Med, Yunlin, Taiwan; [Wei, Jung-Nan] Chia Nan Univ Pharm & Sci, Tainan, Taiwan	National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Chang Gung University; National Taiwan University; National Taiwan University Hospital; Chia Nan University of Pharmacy & Science	Li, HY (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	larsli@ntuh.gov.tw	Chuang, Lee-Ming/AAF-3324-2019; Chen, Ming/GVU-8412-2022	LIOU, JYH-MING/0000-0002-7945-5408; SHIH, SHYANG-RONG/0000-0001-7424-1358; Liu, Pi-Hua/0000-0002-7165-6248; CHUANG, LEE-MING/0000-0003-0978-2662; Li, Hung-Yuan/0000-0001-9644-2855	National Science Council, Taiwan [NSC 98-2314-B-002-024-MY3]; Diabetes Association of the Republic of China, Taiwan [DAROC2012YPI-0001]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Diabetes Association of the Republic of China, Taiwan	This work was supported in part by a grant (NSC 98-2314-B-002-024-MY3) from the National Science Council, Taiwan, and a grant (DAROC2012YPI-0001) from the Diabetes Association of the Republic of China, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Betz MJ, 2013, J CLIN ENDOCR METAB, V98, P4097, DOI 10.1210/jc.2012-3535; Borel AL, 2013, DIABETES CARE, V36, P3254, DOI 10.2337/dc12-2353; Chapados N, 2008, BRIT J NUTR, V100, P518, DOI 10.1017/S0007114508921735; Cohen CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066477; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; Dekker JM, 2005, CIRCULATION, V112, P666, DOI 10.1161/CIRCULATIONAHA.104.516948; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Ersoz F, 2011, WORLD J SURG, V35, P986, DOI 10.1007/s00268-011-1012-z; Foster MC, 2011, HYPERTENSION, V58, P784, DOI 10.1161/HYPERTENSIONAHA.111.175315; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hung CS, 2011, CLIN ENDOCRINOL, V75, P780, DOI 10.1111/j.1365-2265.2011.04129.x; Kabir M, 2005, AM J PHYSIOL-ENDOC M, V288, pE454, DOI 10.1152/ajpendo.00203.2004; Li HY, 2011, ENDOCR J, V58, P441, DOI 10.1507/endocrj.K11E-005; Little RR, 2001, CLIN CHEM, V47, P1985; Ma WY, 2013, DIABETES CARE, V36, P1660, DOI 10.2337/dc12-1452; Ross R, 2002, AM J PHYSIOL-ENDOC M, V282, pE657, DOI 10.1152/ajpendo.00469.2001; Rytka JM, 2011, DIABETES, V60, P56, DOI 10.2337/db10-0697; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Tchkonia T, 2005, AM J PHYSIOL-ENDOC M, V288, pE267, DOI 10.1152/ajpendo.00265.2004; Yoshii H, 2006, AM J PHYSIOL-ENDOC M, V290, pE1089, DOI 10.1152/ajpendo.00306.2005; Yoshizumi T, 1999, RADIOLOGY, V211, P283, DOI 10.1148/radiology.211.1.r99ap15283	24	43	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112355	10.1371/journal.pone.0112355	http://dx.doi.org/10.1371/journal.pone.0112355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401949	gold, Green Submitted, Green Published			2022-12-27	WOS:000345158700040
J	Ren, KQ; Yuan, J; Yang, MJ; Gao, X; Ding, XF; Zhou, JL; Hu, XW; Cao, JG; Deng, XY; Xiang, SL; Zhang, J				Ren, Kaiqun; Yuan, Jing; Yang, Manjun; Gao, Xiang; Ding, Xiaofeng; Zhou, Jianlin; Hu, Xingwang; Cao, Jianguo; Deng, Xiyun; Xiang, Shuanglin; Zhang, Jian			KCTD10 Is Involved in the Cardiovascular System and Notch Signaling during Early Embryonic Development	PLOS ONE			English	Article							CELL NUCLEAR ANTIGEN; INHIBITS TUMOR-GROWTH; DNA-POLYMERASE-DELTA; UBIQUITIN LIGASES; VASCULAR DEVELOPMENT; PROTEIN; MICE; ANGIOGENESIS; GENES; EXPRESSION	As a member of the polymerase delta-interacting protein 1 (PDIP1) gene family, potassium channel tetramerisation domain-containing 10 (KCTD10) interacts with proliferating cell nuclear antigen (PCNA) and polymerase delta, participates in DNA repair, DNA replication and cell-cycle control. In order to further investigate the physiological functions of KCTD10, we generated the KCTD10 knockout mice. The heterozygous KCTD10(+/-) mice were viable and fertile, while the homozygous KCTD10(-/-) mice showed delayed growth from E9.0, and died at approximately E10.5, which displayed severe defects in angiogenesis and heart development. Further study showed that VEGF induced the expression of KCTD10 in a time-and dose-dependent manner. Quantitative real-time PCR and western blotting results revealed that several key members in Notch signaling were up-regulated either in KCTD10-deficient embryos or in KCTD10-silenced HUVECs. Meanwhile, the endogenous immunoprecipitation (IP) analysis showed that KCTD10 interacted with Cullin3 and Notch1 simultaneously, by which mediating Notch1 proteolytic degradation. Our studies suggest that KCTD10 plays crucial roles in embryonic angiogenesis and heart development in mammalians by negatively regulating the Notch signaling pathway.	[Ren, Kaiqun; Yuan, Jing; Yang, Manjun; Ding, Xiaofeng; Zhou, Jianlin; Hu, Xingwang; Xiang, Shuanglin; Zhang, Jian] Hunan Normal Univ, Coll Life Sci, Key Lab Prot Chem & Dev Biol, State Educ Minist China, Changsha, Hunan, Peoples R China; [Ren, Kaiqun; Gao, Xiang] Nanjing Univ, Sch Med, MOE Key Lab Model Anim Dis Res, Model Anim Res Ctr, Nanjing, Jiangsu, Peoples R China; [Ren, Kaiqun; Cao, Jianguo; Deng, Xiyun] Hunan Normal Univ, Coll Med, Changsha, Hunan, Peoples R China	Hunan Normal University; Nanjing University; Hunan Normal University	Xiang, SL (corresponding author), Hunan Normal Univ, Coll Life Sci, Key Lab Prot Chem & Dev Biol, State Educ Minist China, Changsha, Hunan, Peoples R China.	xshlin@hunnu.edu.cn; Zhangjian@hunnu.edu.cn	Zhou, Jianlin/R-1304-2019; Hu, Xingwang/ABG-6400-2021	Zhou, Jianlin/0000-0001-8640-5364; Hu, Xingwang/0000-0002-2320-3279	Ministry of Science and Technique of China [2010CB529900]; Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province [20134486]; program for excellent talents in Hunan Normal University [ET13107]; Construct Program of the Key Discipline of Basic Medicine in Hunan Province	Ministry of Science and Technique of China(Ministry of Science and Technology, China); Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province; program for excellent talents in Hunan Normal University; Construct Program of the Key Discipline of Basic Medicine in Hunan Province	This work was supported by the 973 project of Ministry of Science and Technique of China (No. 2010CB529900), the Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province (No. 20134486), the program for excellent talents in Hunan Normal University (No. ET13107), and the Construct Program of the Key Discipline of Basic Medicine in Hunan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN HS, 1994, DEVELOPMENT, V120, P2539; Bayon Y, 2008, FEBS J, V275, P3900, DOI 10.1111/j.1742-4658.2008.06537.x; Boucher J, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00081; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Delibas Sennur, 2009, Acta Neurol Taiwan, V18, P262; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Gale NW, 1999, GENE DEV, V13, P1055, DOI 10.1101/gad.13.9.1055; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; He H, 2001, P NATL ACAD SCI USA, V98, P11979, DOI 10.1073/pnas.221452098; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hu X, 2014, ACTA BIOCH BIOPHYS S; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jain R, 2010, ANN NY ACAD SCI, V1188, P184, DOI 10.1111/j.1749-6632.2009.05099.x; Jiang J, 2006, CELL CYCLE, V5, P2457, DOI 10.4161/cc.5.21.3406; Kokubo H, 2007, DEVELOPMENT, V134, P747, DOI 10.1242/dev.02777; Krebs LT, 2000, GENE DEV, V14, P1343; Kubota D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073896; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Liu R, 2009, FEBS J, V276, P1114, DOI 10.1111/j.1742-4658.2008.06855.x; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Marshall J, 2011, ADV EXP MED BIOL, V717, P115, DOI 10.1007/978-1-4419-9557-5_10; McCright B, 2001, DEVELOPMENT, V128, P491; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Rho SB, 2010, CANCER LETT, V294, P49, DOI 10.1016/j.canlet.2010.01.021; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Sainson RCA, 2005, FASEB J, V19, P1027, DOI 10.1096/fj.04-3172fje; Sekhar KR, 2010, TOXICOL APPL PHARM, V244, P21, DOI 10.1016/j.taap.2009.06.016; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shawber CJ, 2004, BIOESSAYS, V26, P225, DOI 10.1002/bies.20004; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Sun Ji-Kang, 2007, Sheng Wu Gong Cheng Xue Bao, V23, P1011; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Thurston G, 2004, INT J HEMATOL, V80, P7, DOI 10.1532/ijh97.04065; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Tong XJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4153; Wang YB, 2009, J CELL BIOCHEM, V106, P409, DOI 10.1002/jcb.22026; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Zhou JL, 2005, BBA-GENE STRUCT EXPR, V1729, P200, DOI 10.1016/j.bbaexp.2005.05.005; Zhou JL, 2005, FEBS LETT, V579, P1715, DOI 10.1016/j.febslet.2005.02.027; Zhou JL, 2005, J EXP ZOOL PART A, V303A, P227, DOI 10.1002/jez.a.150; Zhou W, 2013, BIOCH BIOPHYS ACTA; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	52	20	22	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112275	10.1371/journal.pone.0112275	http://dx.doi.org/10.1371/journal.pone.0112275			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401743	Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700037
J	Tijore, A; Wen, F; Lam, CRI; Tay, CY; Tan, LP				Tijore, Ajay; Wen, Feng; Lam, Chee Ren Ivan; Tay, Chor Yong; Tan, Lay Poh			Modulating Human Mesenchymal Stem Cell Plasticity Using Micropatterning Technique	PLOS ONE			English	Article							MYOGENIC DIFFERENTIATION; PRECURSOR CELLS; ADIPOSE-TISSUE; BONE-MARROW; INDUCTION; PLATFORM; SHAPE	In our previous work, we have reported that enforced elongation of human mesenchymal stem cells (hMSCs) through micropatterning promoted their myocardial lineage commitment. However, whether this approach is robust enough to retain the commitment when subsequently subjected to different conditions remains unsolved. This de-differentiation, if any, would have significant implication on the application of these myocardial-like hMSCs either as tissue engineered product or in stem cell therapy. Herein, we investigated the robustness of micropatterning induced differentiation by evaluating the retention of myocardial differentiation in patterned hMSCs when challenged with non-myocardial differentiation cues. Altogether, we designed four groups of experiments; 1) Patterned hMSCs cultured in normal growth medium serving as a positive control; 2) Patterned hMSCs cultured in normal growth medium for 14 days followed by osteogenic and adipogenic media for next 7 days (to study the robustness of the effect of micropatterning); 3) Patterned hMSCs (initially grown in normal growth medium for 14 days) trypsinized and recultured in different induction media for next 7 days (to study the robustness of the effect of micropatterning without any shape constrain) and 4) Patterned hMSCs cultured in osteogenic and adipogenic media for 14 days (to study the effects of biochemical cues versus biophysical cues). It was found that hMSCs that were primed to commit to myocardial lineage (Groups 2 and 3) were able to maintain myocardial lineage commitment despite subsequent culturing in osteogenic and adipogenic media. However, for hMSCs that were not primed (Group 4), the biochemical cues seem to dominate over the biophysical cue in modulating hMSCs differentiation. It demonstrates that cell shape modulation is not only capable of inducing stem cell differentiation but also ensuring the permanent lineage commitment.	[Tijore, Ajay; Wen, Feng; Lam, Chee Ren Ivan; Tan, Lay Poh] Nanyang Technol Univ, Sch Mat Sci & Engn, Mat Technol Div, Singapore 639798, Singapore; [Tay, Chor Yong] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117548, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Tan, LP (corresponding author), Nanyang Technol Univ, Sch Mat Sci & Engn, Mat Technol Div, Singapore 639798, Singapore.	lptan@ntu.edu.sg	Tay, Chor Yong/C-1999-2016; Tan, LP/A-2229-2011	Tan, LP/0000-0002-0172-1569; Tay, Chor Yong/0000-0001-6721-7106	Nanyang Technological University, Singapore	Nanyang Technological University, Singapore(Nanyang Technological University)	This work was supported by Nanyang Technological University, Singapore (LPT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cameron HA, 1998, CURR OPIN NEUROBIOL, V8, P677, DOI 10.1016/S0959-4388(98)80099-8; D'Andrea F, 2008, TISSUE ENG PART C-ME, V14, P233, DOI 10.1089/ten.tec.2008.0108; d'Aquino R, 2009, EUR CELLS MATER, V18, P75, DOI 10.22203/eCM.v018a07; Dang JM, 2007, ADV MATER, V19, P2775, DOI 10.1002/adma.200602159; Desiderio V, 2013, J CELL PHYSIOL, V228, P1762, DOI 10.1002/jcp.24336; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Giuliani A, 2013, STEM CELL TRANSL MED, V2, P316, DOI 10.5966/sctm.2012-0136; Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575; La Noce M, 2014, J DENT, V42, P761, DOI 10.1016/j.jdent.2014.02.018; Leong DT, 2006, DIFFERENTIATION, V74, P519, DOI 10.1111/j.1432-0436.2006.00092.x; Leong DT, 2012, J CELL BIOCHEM, V113, P2744, DOI 10.1002/jcb.24150; Leong DT, 2006, CELLS TISSUES ORGANS, V182, P1, DOI 10.1159/000091713; Li HQ, 2012, ACTA BIOMATER, V8, P531, DOI 10.1016/j.actbio.2011.09.029; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Morrison SJ, 2001, CURR BIOL, V11, pR7, DOI 10.1016/S0960-9822(00)00033-6; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rider DA, 2008, STEM CELLS, V26, P1598, DOI 10.1634/stemcells.2007-0480; Tay CY, 2011, SMALL, V7, P1416, DOI 10.1002/smll.201002298; Tay CY, 2010, EXP CELL RES, V316, P1159, DOI 10.1016/j.yexcr.2010.02.010; Teo BKK, 2010, METHOD CELL BIOL, V98, P241, DOI 10.1016/S0091-679X(10)98011-4; Tijore A, 2014, ACS APPL MATER INTER, V6, P15686, DOI 10.1021/am504407n; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/nmat3889, 10.1038/NMAT3889]; Yeong WY, 2010, TISSUE ENG PART C-ME, V16, P1011, DOI [10.1089/ten.tec.2009.0604, 10.1089/ten.TEC.2009.0604]; Yu HY, 2013, ADV HEALTHC MATER, V2, P442, DOI 10.1002/adhm.201200142; Yu HY, 2013, STEM CELLS DEV, V22, P136, DOI 10.1089/scd.2012.0160	31	7	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113043	10.1371/journal.pone.0113043	http://dx.doi.org/10.1371/journal.pone.0113043			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401734	Green Published, gold			2022-12-27	WOS:000345158700100
J	Donega, V; Nijboer, CH; Braccioli, L; Slaper-Cortenbach, I; Kavelaars, A; van Bel, F; Heijnen, CJ				Donega, Vanessa; Nijboer, Cora H.; Braccioli, Luca; Slaper-Cortenbach, Ineke; Kavelaars, Annemieke; van Bel, Frank; Heijnen, Cobi J.			Intranasal Administration of Human MSC for Ischemic Brain Injury in the Mouse: In Vitro and In Vivo Neuroregenerative Functions	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; THERAPY POSITION STATEMENT; STROMAL CELLS; NEONATAL ENCEPHALOPATHY; INTERNATIONAL-SOCIETY; HYPOXIA-ISCHEMIA; TRANSPLANTATION; NEUROGENESIS; CYTOKINES; FATE	Intranasal treatment with C57BL/6 MSCs reduces lesion volume and improves motor and cognitive behavior in the neonatal hypoxic-ischemic (HI) mouse model. In this study, we investigated the potential of human MSCs (hMSCs) to treat HI brain injury in the neonatal mouse. Assessing the regenerative capacity of hMSCs is crucial for translation of our knowledge to the clinic. We determined the neuroregenerative potential of hMSCs in vitro and in vivo by intranasal administration 10 d post-HI in neonatal mice. HI was induced in P9 mouse pups. 1 x 10(6) or 2 x 10(6) hMSCs were administered intranasally 10 d post-HI. Motor behavior and lesion volume were measured 28 d post-HI. The in vitro capacity of hMSCs to induce differentiation of mouse neural stem cell (mNSC) was determined using a transwell co-culture differentiation assay. To determine which chemotactic factors may play a role in mediating migration of MSCs to the lesion, we performed a PCR array on 84 chemotactic factors 10 days following sham-operation, and at 10 and 17 days post-HI. Our results show that 2610 6 hMSCs decrease lesion volume, improve motor behavior, and reduce scar formation and microglia activity. Moreover, we demonstrate that the differentiation assay reflects the neuroregenerative potential of hMSCs in vivo, as hMSCs induce mNSCs to differentiate into neurons in vitro. We also provide evidence that the chemotactic factor CXCL10 may play an important role in hMSC migration to the lesion site. This is suggested by our finding that CXCL10 is significantly upregulated at 10 days following HI, but not at 17 days after HI, a time when MSCs no longer reach the lesion when given intranasally. The results described in this work also tempt us to contemplate hMSCs not only as a potential treatment option for neonatal encephalopathy, but also for a plethora of degenerative and traumatic injuries of the nervous system.	[Donega, Vanessa; Nijboer, Cora H.; Braccioli, Luca; Heijnen, Cobi J.] Univ Med Ctr Utrecht, Lab Neuroimmunol & Dev Origins Dis, Utrecht, Netherlands; [Slaper-Cortenbach, Ineke] Univ Med Ctr Utrecht, Cell Therapy Facil, Dept Clin Pharm, Utrecht, Netherlands; [Kavelaars, Annemieke; Heijnen, Cobi J.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Symptom Res, Houston, TX 77030 USA; [van Bel, Frank] Univ Med Ctr Utrecht, Dept Neonatol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Utrecht University; Utrecht University Medical Center	Heijnen, CJ (corresponding author), Univ Med Ctr Utrecht, Lab Neuroimmunol & Dev Origins Dis, Utrecht, Netherlands.	CJHeijnen@mdanderson.org	Donega, Vanessa/M-8058-2014; Braccioli, Luca/P-8142-2019	Donega, Vanessa/0000-0002-3152-2675	Zon-MW Project [116002003]	Zon-MW Project	This study was supported by Zon-MW Project (no 116002003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borlongan CV, 2011, PEDIATR RES, V70, P3, DOI 10.1203/PDR.0b013e31821d0d00; Croft AP, 2009, EXP NEUROL, V216, P329, DOI 10.1016/j.expneurol.2008.12.010; Dammann O, 2011, PEDIATR RES, V70, P1, DOI 10.1203/01.pdr.0000403893.61640.b6; de Haan M, 2006, DEVELOPMENTAL SCI, V9, P350, DOI 10.1111/j.1467-7687.2006.00499.x; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Donega V, 2014, EXP NEUROL, V261, P53, DOI 10.1016/j.expneurol.2014.06.009; Donega V, 2013, J CEREBR BLOOD F MET, V33, P625, DOI 10.1038/jcbfm.2013.3; Donega V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051253; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Gonzalo-Daganzo R, 2009, CYTOTHERAPY, V11, P278, DOI 10.1080/14653240902807018; Graham EM, 2008, AM J OBSTET GYNECOL, V199, P587, DOI 10.1016/j.ajog.2008.06.094; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hack MA, 2004, MOL CELL NEUROSCI, V25, P664, DOI 10.1016/j.mcn.2003.12.012; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Lee JA, 2010, PEDIATR RES, V67, P42, DOI 10.1203/PDR.0b013e3181bf594b; Liu H, 2006, BRAIN, V129, P2734, DOI 10.1093/brain/awl207; Prins HJ, 2009, TISSUE ENG PT A, V15, P3741, DOI [10.1089/ten.tea.2008.0666, 10.1089/ten.TEA.2008.0666]; RANSOHOFF RM, 1993, FASEB J, V7, P592, DOI 10.1096/fasebj.7.6.8472896; Reglero-Real N, 2012, CELL MOL LIFE SCI, V69, P3079, DOI 10.1007/s00018-012-0987-4; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2014, NEUROSCIENTIST, V20, P160, DOI 10.1177/1073858413504466; Titomanlio L, 2011, ANN NEUROL, V70, P698, DOI 10.1002/ana.22518; Toyama K, 2009, EXP NEUROL, V216, P47, DOI 10.1016/j.expneurol.2008.11.010; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Ubogu EE, 2006, TRENDS PHARMACOL SCI, V27, P48, DOI 10.1016/j.tips.2005.11.002; van Handel M, 2007, EUR J PEDIATR, V166, P645, DOI 10.1007/s00431-007-0437-8; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Velthoven CTJ, 2014, MOL THER, V22, P645, DOI 10.1038/mt.2013.260; van Velthoven CTJ, 2012, ANN NEUROL, V71, P785, DOI 10.1002/ana.23543; van Velthoven CTJ, 2010, J NEUROSCI, V30, P9603, DOI 10.1523/JNEUROSCI.1835-10.2010; Velthoven C, 2011, BRAIN BEHAV IMMUN, V25, P1342; Wake H, 2013, TRENDS NEUROSCI, V36, P209, DOI 10.1016/j.tins.2012.11.007; Wang CC, 2008, CARDIOVASC RES, V77, P515, DOI 10.1093/cvr/cvm046; Yang B, 2012, STEM CELLS DEV, V21, P3332, DOI 10.1089/scd.2012.0037; Yasuhara T, 2008, J CEREBR BLOOD F MET, V28, P1804, DOI 10.1038/jcbfm.2008.68; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	40	62	64	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112339	10.1371/journal.pone.0112339	http://dx.doi.org/10.1371/journal.pone.0112339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396420	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558500047
J	Hyun, TK; van der Graaff, E; Albacete, A; Eom, SH; Grosskinsky, DK; Bohm, H; Janschek, U; Rim, Y; Ali, WW; Kim, SY; Roitsch, T				Hyun, Tae Kyung; van der Graaff, Eric; Albacete, Alfonso; Eom, Seung Hee; Grosskinsky, Dominik K.; Boehm, Hannah; Janschek, Ursula; Rim, Yeonggil; Ali, Walid Wahid; Kim, Soo Young; Roitsch, Thomas			The Arabidopsis PLAT Domain Protein1 Is Critically Involved in Abiotic Stress Tolerance	PLOS ONE			English	Article							ABSCISIC-ACID; ENDOPLASMIC-RETICULUM; SALICYLIC-ACID; TRANSCRIPTION FACTORS; GENE-EXPRESSION; PSEUDOMONAS-SYRINGAE; SIGNAL-TRANSDUCTION; PLANTS RESPONSE; COLD STRESS; SALT STRESS	Despite the completion of the Arabidopsis genome sequence, for only a relatively low percentage of the encoded proteins experimental evidence concerning their function is available. Plant proteins that harbour a single PLAT (Polycystin, Lipoxygenase, Alpha-toxin and Triacylglycerol lipase) domain and belong to the PLAT-plant-stress protein family are ubiquitously present in monocot and dicots. However, the function of PLAT-plant-stress proteins is still poorly understood. Therefore, we have assessed the function of the uncharacterised Arabidopsis PLAT-plant-stress family members through a combination of functional genetic and physiological approaches. PLAT1 overexpression conferred increased abiotic stress tolerance, including cold, drought and salt stress, while loss-of-function resulted in opposite effects on abiotic stress tolerance. Strikingly, PLAT1 promoted growth under non-stressed conditions. Abiotic stress treatments induced PLAT1 expression and caused expansion of its expression domain. The ABF/ABRE transcription factors, which are positive mediators of abscisic acid signalling, activate PLAT1 promoter activity in transactivation assays and directly bind to the ABRE elements located in this promoter in electrophoretic mobility shift assays. This suggests that PLAT1 represents a novel downstream target of the abscisic acid signalling pathway. Thus, we showed that PLAT1 critically functions as positive regulator of abiotic stress tolerance, but also is involved in regulating plant growth, and thereby assigned a function to this previously uncharacterised PLAT domain protein. The functional data obtained for PLAT1 support that PLAT-plant-stress proteins in general could be promising targets for improving abiotic stress tolerance without yield penalty.	[Hyun, Tae Kyung; van der Graaff, Eric; Albacete, Alfonso; Eom, Seung Hee; Grosskinsky, Dominik K.; Boehm, Hannah; Janschek, Ursula; Roitsch, Thomas] Graz Univ, Inst Plant Sci, Graz, Austria; [Hyun, Tae Kyung; Eom, Seung Hee; Rim, Yeonggil] Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Jinju, South Korea; [van der Graaff, Eric; Grosskinsky, Dominik K.; Roitsch, Thomas] Univ Copenhagen, Copenhagen Plant Sci Ctr, Dept Plant & Environm Sci, Taastrup, Denmark; [Albacete, Alfonso] CEBAS CSIC, Dept Nutr Vegetal, Murcia, Spain; [Ali, Walid Wahid] Univ Wurzburg, Dept Pharmaceut Biol, D-97070 Wurzburg, Germany; [Kim, Soo Young] Chonnam Natl Univ, Coll Agr & Life Sci, Dept Mol Biotechnol, Kwangju, South Korea; [Kim, Soo Young] Chonnam Natl Univ, Coll Agr & Life Sci, Kumho Life Sci Lab, Kwangju, South Korea; [Roitsch, Thomas] CzechGlobe AS CR, Vvi, Global Change Res Ctr, Drasov, Czech Republic	University of Graz; Gyeongsang National University; University of Copenhagen; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS); University of Wurzburg; Chonnam National University; Chonnam National University; Czech Academy of Sciences; Global Change Research Centre of the Czech Academy of Sciences	Roitsch, T (corresponding author), Graz Univ, Inst Plant Sci, Graz, Austria.	roitsch@plen.ku.dk	van der Graaff, Eric/F-8198-2014; Großkinsky, Dominik/F-9011-2014; Albacete, Alfonso/K-6093-2014; Roitsch, Thomas G/H-4347-2014; Albacete, Alfonso/AGE-8957-2022; Albacete, Alfonso/AAO-3481-2020	van der Graaff, Eric/0000-0002-5265-4239; Großkinsky, Dominik/0000-0001-8976-1057; Albacete, Alfonso/0000-0003-1332-8593; Roitsch, Thomas G/0000-0001-7109-3134; Albacete, Alfonso/0000-0003-1332-8593; Albacete, Alfonso/0000-0003-1332-8593	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Republic of Korea [NRF-2014R1A1A2004432]; Fundacion Seneca, Comunidad Autonoma de la Region de Murcia	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Republic of Korea; Fundacion Seneca, Comunidad Autonoma de la Region de Murcia(Fundacion Seneca)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2014R1A1A2004432), Republic of Korea (T.K.H.), and by the Fundacion Seneca, Comunidad Autonoma de la Region de Murcia (A.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard JB, 2005, CURR PROTEIN PEPT SC, V6, P125, DOI 10.2174/1389203053545417; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Audenaert K, 2002, MOL PLANT MICROBE IN, V15, P1147, DOI 10.1094/MPMI.2002.15.11.1147; Barrero JM, 2010, PLANT J, V61, P611, DOI 10.1111/j.1365-313X.2009.04088.x; Bateman A, 1999, CURR BIOL, V9, pR588, DOI 10.1016/S0960-9822(99)80380-7; Bhardwaj PK, 2011, GENE, V483, P49, DOI 10.1016/j.gene.2011.05.014; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Choudhary SP, 2012, TRENDS PLANT SCI, V17, P594, DOI 10.1016/j.tplants.2012.05.012; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Craft J, 2005, PLANT J, V41, P899, DOI 10.1111/j.1365-313X.2005.02342.x; Duan LN, 2013, PLANT CELL, V25, P324, DOI 10.1105/tpc.112.107227; Eek P, 2012, J BIOL CHEM, V287, P22377, DOI 10.1074/jbc.M112.343285; Fan J, 2009, PLANT PHYSIOL, V150, P1750, DOI 10.1104/pp.109.137943; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Fukaki H, 2009, PLANT MOL BIOL, V69, P437, DOI 10.1007/s11103-008-9417-2; Golldack D, 2011, PLANT CELL REP, V30, P1383, DOI 10.1007/s00299-011-1068-0; Grokinsky DK, 2014, MOL PLANT, V7, P1053, DOI 10.1093/mp/ssu015; Grosskinsky DK, 2014, PHYTOPATHOLOGY, V104, P1283, DOI 10.1094/PHYTO-03-14-0076-R; Grosskinsky DK, 2012, PHYTOPATHOLOGY, V102, P662, DOI 10.1094/PHYTO-02-12-0022-R; Grosskinsky DK, 2011, PLANT PHYSIOL, V157, P815, DOI 10.1104/pp.111.182931; Hara-Nishimura I, 2003, CURR OPIN PLANT BIOL, V6, P583, DOI 10.1016/j.pbi.2003.09.015; Hong YW, 2000, P NATL ACAD SCI USA, V97, P8717, DOI 10.1073/pnas.140213697; Howell SH, 2013, ANNU REV PLANT BIOL, V64, P477, DOI 10.1146/annurev-arplant-050312-120053; Hsu FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028888; Hu JH, 2005, MOL BIOL CELL, V16, P458, DOI 10.1091/mbc.E04-09-0851; Hussain SS, 2011, BIOTECHNOL PROGR, V27, P297, DOI 10.1002/btpr.514; Hyun TK, 2009, FUNCT PLANT BIOL, V36, P1088, DOI 10.1071/FP09136; Inamdar M. I., 2010, Karnataka Journal of Agricultural Sciences, V23, P350; Islam S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080035; Joshi N, 2013, BIOCHEMISTRY-US, V52, P8026, DOI 10.1021/bi4010649; Joshi-Saha A, 2011, MOL PLANT, V4, P562, DOI 10.1093/mp/ssr055; Kim JB, 2004, PLANT BIOTECHNOL J, V2, P459, DOI 10.1111/j.1467-7652.2004.00090.x; Kim JS, 2011, PLANT CELL PHYSIOL, V52, P2136, DOI 10.1093/pcp/pcr143; Leal GA, 2007, MOL PLANT PATHOL, V8, P279, DOI 10.1111/J.1364-3703.2007.00393.X; Lee KH, 2006, CELL, V126, P1109, DOI 10.1016/j.cell.2006.07.034; Lee SC, 2006, PLANT MOL BIOL, V62, P151, DOI 10.1007/s11103-006-9010-5; Lee SC, 2012, PLANT CELL ENVIRON, V35, P53, DOI 10.1111/j.1365-3040.2011.02426.x; Li ST, 2012, PLANT MOL BIOL REP, V30, P1283, DOI 10.1007/s11105-012-0439-1; Liu JX, 2007, PLANT CELL, V19, P4111, DOI 10.1105/tpc.106.050021; Liu JX, 2010, PLANT CELL, V22, P2930, DOI 10.1105/tpc.110.078154; Liu LJ, 2011, CELL RES, V21, P957, DOI 10.1038/cr.2010.181; Matsushima R, 2003, PLANT CELL PHYSIOL, V44, P661, DOI 10.1093/pcp/pcg089; Minor W, 1996, BIOCHEMISTRY-US, V35, P10687, DOI 10.1021/bi960576u; Mosher S, 2010, PLANT PHYSIOL, V152, P1901, DOI 10.1104/pp.109.152603; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Padmalatha KV, 2012, PLANT MOL BIOL, V78, P223, DOI 10.1007/s11103-011-9857-y; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; Scott MS, 2005, PLOS COMPUT BIOL, V1, P518, DOI 10.1371/journal.pcbi.0010066; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Sharma N, 2007, PLANT MOL BIOL, V63, P171, DOI 10.1007/s11103-006-9080-4; Shin R, 2004, PLANT PHYSIOL, V135, P561, DOI 10.1104/pp.103.035436; Shin Y, 2003, PLANT CELL PHYSIOL, V44, P549, DOI 10.1093/pcp/pcg069; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Thaler JS, 2004, ECOLOGY, V85, P48, DOI 10.1890/02-0710; Tomchick DR, 2001, BIOCHEMISTRY-US, V40, P7509, DOI 10.1021/bi002893d; Ton J, 2009, TRENDS PLANT SCI, V14, P310, DOI 10.1016/j.tplants.2009.03.006; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; van der Graaff E, 2000, DEVELOPMENT, V127, P4971; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yamada K, 2011, PLANT CELL PHYSIOL, V52, P2039, DOI 10.1093/pcp/pcr156; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Yuasa T, 2004, GENOMICS, V84, P126, DOI 10.1016/j.ygeno.2004.02.008; Zhang HM, 2010, PLANT J, V64, P764, DOI 10.1111/j.1365-313X.2010.04367.x; Zhao ZX, 2008, PLANT CELL, V20, P3210, DOI 10.1105/tpc.108.063263	66	32	34	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112946	10.1371/journal.pone.0112946	http://dx.doi.org/10.1371/journal.pone.0112946			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396746	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558500117
J	Lombardo, G; Serrao, S; Rosati, M; Lombardo, M				Lombardo, Giuseppe; Serrao, Sebastiano; Rosati, Marianna; Lombardo, Marco			Analysis of the Viscoelastic Properties of the Human Cornea Using Scheimpflug Imaging in Inflation Experiment of Eye Globes	PLOS ONE			English	Article							COLLAGEN FIBRILS; BIOMECHANICAL PROPERTIES; MECHANICAL-PROPERTIES; ANTERIOR STROMA; CROSS-LINKING; BOVINE; ORGANIZATION; ELASTICITY; RABBIT; STRAIN	Purpose: To demonstrate a Scheimpflug-based imaging procedure for investigating the depth-and time-dependent strain response of the human cornea to inflation testing of whole eye globes. Methods: Six specimens, three of which with intact corneal epithelium, were mounted in a customized apparatus within a humidity and temperature-monitored wet chamber. Each specimen was subjected to two mechanical tests in order to measure corneal strain resulting from application of cyclic (cyclic regimen) and constant (creep regimen) stress by changing the intra-ocular pressure (IOP) within physiological ranges (18-42 mmHg). Corneal shape changes were analyzed as a function of IOP and both corneal stress-strain curves and creep curves were generated. Results: The procedure was highly accurate and repeatable. Upon cyclic stress application, a biomechanical corneal elasticity gradient was found in the front-back direction. The average Young's modulus of the anterior cornea ranged between 2.28 +/- 0.87 MPa and 3.30 +/- 0.90 MPa in specimens with and without intact epithelium (P = 0.05) respectively. The Young's modulus of the posterior cornea was on average 0.21 +/- 0.09 MPa and 0.17 +/- 0.06 MPa (P>0.05) respectively. The time-dependent strain response of the cornea to creep testing was quantified by fitting data to a modified Zener model for extracting both the relaxation time and compliance function. Conclusion: Cyclic and creep mechanical tests are valuable for investigating the strain response of the intact human cornea within physiological IOP ranges, providing meaningful results that can be translated to clinic. The presence of epithelium influences the results of anterior corneal shape changes when monitoring deformation via Scheimpflug imaging in inflation experiments of whole eye globes.	[Lombardo, Giuseppe] CNR IPCF, Unit Support Cosenza, I-87036 Cosenza, Italy; [Lombardo, Giuseppe] Vis Engn Italy Srl, I-00198 Rome, Italy; [Serrao, Sebastiano; Rosati, Marianna; Lombardo, Marco] Fdn GB Bietti, IRCCS, I-00198 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per i Processi Chimico-Fisici (IPCF-CNR); IRCCS - Fondazione "G.B. Bietti" per lo Studio e la Ricerca in Oftalmologia	Lombardo, G (corresponding author), CNR IPCF, Unit Support Cosenza, I-87036 Cosenza, Italy.	mlombardo@visioeng.it; giuseppe.lombardo@cnr.it	; Lombardo, Giuseppe/B-2656-2012	Lombardo, Marco/0000-0001-8842-7102; Lombardo, Giuseppe/0000-0002-9416-967X	National Framework Program for Research and Innovation PON [01_00110]	National Framework Program for Research and Innovation PON	This work was supported by a grant from the National Framework Program for Research and Innovation PON (research program n. 01_00110). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boote C, 2005, J STRUCT BIOL, V149, P1, DOI 10.1016/j.jsb.2004.08.009; Boote C, 2003, INVEST OPHTH VIS SCI, V44, P2941, DOI 10.1167/iovs.03-0131; Boschetti F, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4006089; Boyce BL, 2007, J BIOMECH, V40, P2367, DOI 10.1016/j.jbiomech.2006.12.001; Boyce BL, 2008, BIOMATERIALS, V29, P3896, DOI 10.1016/j.biomaterials.2008.06.011; Browning AC, 2004, BRIT J OPHTHALMOL, V88, P1395, DOI 10.1136/bjo.2003.037887; Bueno JM, 2011, CORNEA, V30, P692, DOI 10.1097/ICO.0b013e3182000f94; BUREK H, 1993, OPHTHAL PHYSL OPT, V13, P68, DOI 10.1111/j.1475-1313.1993.tb00428.x; CASTORO JA, 1988, INVEST OPHTH VIS SCI, V29, P963; Dias JM, 2013, EXP EYE RES, V115, P41, DOI 10.1016/j.exer.2013.06.004; Dupps WJ, 2007, J REFRACT SURG, V23, P66; Dupps WJ, 2005, J REFRACT SURG, V21, P186; Elsheikh A, 2005, J R SOC INTERFACE, V2, P177, DOI 10.1098/rsif.2005.0034; Elsheikh A, 2008, EXP EYE RES, V86, P445, DOI 10.1016/j.exer.2007.12.002; Elsheikh A, 2008, CURR EYE RES, V33, P205, DOI 10.1080/02713680701882519; Elsheikh A, 2007, J REFRACT SURG, V23, P808, DOI 10.3928/1081-597X-20071001-11; Elsheikh A, 2007, CURR EYE RES, V32, P11, DOI 10.1080/02713680601077145; FUNG YC, 1993, BIOMECHANICS MECH PR, pCH7; Gatinel D, 2011, CORNEA, V30, P508, DOI 10.1097/ICO.0b013e3181fb4fa7; Glass DH, 2008, INVEST OPHTH VIS SCI, V49, P3919, DOI 10.1167/iovs.07-1321; Hamaoui M, 2001, CORNEA, V20, P317, DOI 10.1097/00003226-200104000-00015; Hatami-Marbini H, 2014, EXP EYE RES, V120, P103, DOI 10.1016/j.exer.2013.11.017; Hatami-Marbini H, 2013, EXP EYE RES, V116, P47, DOI 10.1016/j.exer.2013.07.016; Hennighausen H, 1998, INVEST OPHTH VIS SCI, V39, P253; Hjortdal JO, 1996, J BIOMECH, V29, P931, DOI 10.1016/0021-9290(95)00152-2; HJORTDAL JO, 1995, ACTA OPHTHALMOL SCAN, V73, P5; HOELTZEL DA, 1992, J BIOMECH ENG-T ASME, V114, P202, DOI 10.1115/1.2891373; JUE B, 1986, J BIOMECH, V19, P847, DOI 10.1016/0021-9290(86)90135-1; Kling S, 2013, J REFRACT SURG, V29, P490, DOI 10.3928/1081597X-20130617-08; Kling S, 2010, INVEST OPHTH VIS SCI, V51, P3961, DOI 10.1167/iovs.09-4536; KOMAI Y, 1991, INVEST OPHTH VIS SCI, V32, P2244; Lombardo M, 2014, J CATARACT REFR SURG, V40, P1706, DOI 10.1016/j.jcrs.2014.04.024; Lombardo M, 2012, INVEST OPHTH VIS SCI, V53, P1050, DOI 10.1167/iovs.11-8720; Lombardo M, 2011, INVEST OPHTH VIS SCI, V52, P6994, DOI 10.1167/iovs.10-7052; Lombardo M, 2009, CORNEA, V28, P408, DOI 10.1097/ICO.0b013e31818d33c7; MEEK KM, 1987, CURR EYE RES, V6, P841, DOI 10.3109/02713688709034853; MILLODOT M, 1979, VISION RES, V19, P685, DOI 10.1016/0042-6989(79)90244-X; Miranda MA, 2009, CORNEA, V28, P657, DOI 10.1097/ICO.0b013e31819b01b5; Morishige N, 2011, INVEST OPHTH VIS SCI, V52, P911, DOI 10.1167/iovs.10-5657; Muller LJ, 2001, BRIT J OPHTHALMOL, V85, P437, DOI 10.1136/bjo.85.4.437; Muller LJ, 2004, EXP EYE RES, V78, P493, DOI 10.1016/S0014-4835(03)00206-9; NASH IS, 1982, EXP EYE RES, V35, P413, DOI 10.1016/0014-4835(82)90040-9; Navarro R, 2006, J OPT SOC AM A, V23, P219, DOI 10.1364/JOSAA.23.000219; Nguyen TD, 2011, BIOMECH MODEL MECHAN, V10, P323, DOI 10.1007/s10237-010-0237-3; Nguyen TD, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2947399; Pandolfi A, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2982251; Perez-Escudero A, 2009, INVEST OPHTH VIS SCI, V50, P4146, DOI 10.1167/iovs.09-3411; Pinsky PM, 2005, J CATARACT REFR SURG, V31, P136, DOI 10.1016/j.jcrs.2004.10.048; Preussner PR, 2003, J CATARACT REFR SURG, V29, P471, DOI 10.1016/S0886-3350(02)01512-2; Reinhardt HW, 2009, CREEP SHRINKAGE DURA, P65; Scarcelli G, 2013, INVEST OPHTH VIS SCI, V53, P185; Serrao S, 2014, J CATARACT REFR SURG, V40, P531, DOI 10.1016/j.jcrs.2013.11.027; Serrao S, 2013, J REFRACT SURG, V29, P418, DOI 10.3928/1081597X-20130430-01; Shin TJ, 1997, J BIOMECH, V30, P497, DOI 10.1016/S0021-9290(97)84433-8; Studer H, 2010, J BIOMECH, V43, P836, DOI 10.1016/j.jbiomech.2009.11.021; TERRY MA, 1994, ARCH OPHTHALMOL-CHIC, V112, P538, DOI 10.1001/archopht.1994.01090160118031; Wainwright SA, 1976, MECHANICAL DESIGN OR, P6; WILSON G, 1984, INVEST OPHTH VIS SCI, V25, P1105	58	22	22	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112169	10.1371/journal.pone.0112169	http://dx.doi.org/10.1371/journal.pone.0112169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397674	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558500036
J	Petrica, L; Vlad, A; Gluhovschi, G; Gadalean, F; Dumitrascu, V; Gluhovschi, C; Velciov, S; Bob, F; Vlad, D; Popescu, R; Milas, O; Ursoniu, S				Petrica, Ligia; Vlad, Adrian; Gluhovschi, Gheorghe; Gadalean, Florica; Dumitrascu, Victor; Gluhovschi, Cristina; Velciov, Silvia; Bob, Flaviu; Vlad, Daliborca; Popescu, Roxana; Milas, Oana; Ursoniu, Sorin			Proximal Tubule Dysfunction Is Associated with Podocyte Damage Biomarkers Nephrin and Vascular Endothelial Growth Factor in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study	PLOS ONE			English	Article							KIDNEY-DISEASE; GLYCATED ALBUMIN; CYSTATIN C; NEPHROPATHY; URINARY; EXPRESSION; PROTEINURIA; MARKERS; PLASMA; BETA	Background: There is an ongoing debate as to whether early diabetic nephropathy in Type 2 diabetes mellitus may be attributed to the glomerulus or to the proximal tubule. Urinary excretion of nephrin and vascular endothelial growth factor may increase even in the normoalbuminuria stage. In the course of diabetic nephropathy, the proximal tubule may be involved in the uptake of urinary nephrin and vascular endothelial growth factor. Materials and Methods: Two groups of consecutive Type 2 diabetes mellitus outpatients (38 normo-, 32 microalbuminuric) and 21 healthy subjects were enrolled in a cross-sectional study and evaluated concerning the relation of proximal tubule dysfunction with the podocyte biomarkers excretion, assessed by ELISA methods. The impact of advanced glycation end-products on this relation was also queried. Results: Urinary alpha1-microglobulin and kidney injury molecule-1 correlated with urinary albumin: creatinine ratio (R-2 = 0.269; p<0.001; R-2 = 0.125; p<0.001), nephrinuria (R-2 = 0.529; p<0.001; R-2 = 0.203; p<0.001), urinary vascular endothelial growth factor (R-2 = 0.709; p<0.001; R-2 = 0.360; p<0.001), urinary advanced glycation end-products (R-2 = 0.578; p<0.001; R-2 = 0.405; p<0.001), serum cystatin C (R-2 = 0.130; p<0.001; R-2 = 0.128; p<0.001), and glomerular filtration rate (R-2 = 0.167; p<0.001; R-2 = 0.166; p<0.001); nephrinuria and urinary vascular endothelial growth factor correlated with urinary albumin: creatinine ratio (R-2 = 0.498; p<0.001; R-2 = 0.227; p<0.001), urinary advanced glycation endproducts (R-2 = 0.251; p<0.001; R-2 = 0.308; p<0.001), serum cystatin C (R-2 = 0.157; p<0.001; R-2 = 0.226; p<0.001), and glomerular filtration rate (R-2 = 0.087; p = 0.007; R-2 = 0.218; p<0.001). Conclusions: In Type 2 diabetes mellitus there is an association of proximal tubule dysfunction with podocyte damage biomarkers, even in the normoalbuminuria stage. This observation suggests a potential role of the proximal tubule in urinary nephrin and urinary vascular endothelial growth factor processing in early diabetic nephropathy, a fact which could be related to advanced glycation end-products intervention. Podocyte damage and proximal tubule dysfunction biomarkers could be validated as a practical approach to the diagnosis of early diabetic nephropathy by further studies on larger cohorts.	[Petrica, Ligia; Gluhovschi, Gheorghe; Gadalean, Florica; Gluhovschi, Cristina; Velciov, Silvia; Bob, Flaviu] Victor Babes Univ Med & Pharm, Dept Nephrol, Timisoara, Romania; [Vlad, Adrian] Victor Babes Univ Med & Pharm, Dept Diabet & Metab Dis, Timisoara, Romania; [Dumitrascu, Victor; Vlad, Daliborca] Victor Babes Univ Med & Pharm, Dept Pharmacol, Timisoara, Romania; [Popescu, Roxana] Victor Babes Univ Med & Pharm, Dept Cellular Biol, Timisoara, Romania; [Petrica, Ligia; Vlad, Adrian; Gluhovschi, Gheorghe; Gadalean, Florica; Dumitrascu, Victor; Gluhovschi, Cristina; Velciov, Silvia; Bob, Flaviu; Vlad, Daliborca; Popescu, Roxana; Milas, Oana] Cty Emergency Hosp, Timisoara, Romania; [Ursoniu, Sorin] Victor Babes Univ Med & Pharm, Dept Publ Hlth Med, Timisoara, Romania	Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara	Vlad, A (corresponding author), Victor Babes Univ Med & Pharm, Dept Diabet & Metab Dis, Timisoara, Romania.	vladrian@hotmail.com	Popescu, Roxana/AAB-1809-2019; Popescu, Roxana/C-1456-2012; Ursoniu, Sorin/D-1935-2015	Popescu, Roxana/0000-0002-9387-1141; Ursoniu, Sorin/0000-0001-9215-5154; Petrica, Ligia/0000-0003-3138-3051; Milas, Livia-Oana/0000-0003-4017-9204; Vlad, Adrian/0000-0002-1824-2628	"Victor Babes" University of Medicine and Pharmacy Timisoara [PIII-C1-PCFI-2014/2015]	"Victor Babes" University of Medicine and Pharmacy Timisoara	This research received funding from an internal grant of "Victor Babes" University of Medicine and Pharmacy Timisoara, PIII-C1-PCFI-2014/2015, www.umft.ro. LP received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter ML, 2012, CLIN LAB, V58, P659, DOI 10.7754/Clin.Lab.2011.111010; Borges RL, 2010, NEPHRON CLIN PRACT, V114, pC127, DOI 10.1159/000254385; Cohen MP, 2005, KIDNEY INT, V68, P1554, DOI 10.1111/j.1523-1755.2005.00567.x; Comper WD, 2008, J AM SOC NEPHROL, V19, P427, DOI 10.1681/ASN.2007090997; Disease Kidney, 2013, KIDNEY INT S, V3, P1; Doublier S, 2003, DIABETES, V52, P1023, DOI 10.2337/diabetes.52.4.1023; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Fioretto P, 2007, SEMIN NEPHROL, V27, P195, DOI 10.1016/j.semnephrol.2007.01.012; Fu WJ, 2012, DIABETES RES CLIN PR, V95, P105, DOI 10.1016/j.diabres.2011.09.031; Hong CY, 2003, DIABETES CARE, V26, P338, DOI 10.2337/diacare.26.2.338; Jefferson JA, 2008, KIDNEY INT, V74, P22, DOI 10.1038/ki.2008.128; Jeon YK, 2011, J KOREAN MED SCI, V26, P258, DOI 10.3346/jkms.2011.26.2.258; Jerums G, 2009, NAT REV NEPHROL, V5, P397, DOI 10.1038/nrneph.2009.91; Jim B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036041; Kern EFO, 2010, AM J KIDNEY DIS, V55, P824, DOI 10.1053/j.ajkd.2009.11.009; Kim NH, 2004, DIABETIC MED, V21, P545, DOI 10.1111/j.1464-5491.2004.01200.x; Kim SS, 2012, DIABETES RES CLIN PR, V97, P251, DOI 10.1016/j.diabres.2012.02.019; Kravaritou M, 2009, DIABETES RES CLIN PR, V85, P317, DOI 10.1016/j.diabres.2009.06.019; MacIsaac R, 2004, DIABETES CARE, V27, P195, DOI 10.2337/diacare.27.1.195; Nakagawa T, 2011, NAT REV NEPHROL, V7, P36, DOI 10.1038/nrneph.2010.152; Nauta FL, 2011, DIABETES CARE, V34, P975, DOI 10.2337/dc10-1545; Ng DPK, 2011, NEPHROL DIAL TRANSPL, V26, P2508, DOI 10.1093/ndt/gfq738; Ozdemir AM, 2005, ANN NY ACAD SCI, V1043, P625, DOI 10.1196/annals.1338.071; Patari A, 2003, DIABETES, V52, P2969, DOI 10.2337/diabetes.52.12.2969; Petrica L, 2011, DIABETES RES CLIN PR, V94, P22, DOI 10.1016/j.diabres.2011.05.032; Petrica L, 2011, NEPHRON CLIN PRACT, V118, pC155, DOI 10.1159/000320038; Petrica L, 2009, WIEN KLIN WOCHENSCHR, V121, P765, DOI 10.1007/s00508-009-1279-3; Ritz E, 2010, DIABETOLOGIA, V53, P49, DOI 10.1007/s00125-009-1577-3; Russo LM, 2009, J AM SOC NEPHROL, V20, P489, DOI 10.1681/ASN.2008050503; Schernthaner G, 2011, NEPHROL DIAL TRANSPL, V26, P454, DOI 10.1093/ndt/gfq837; Tang SCW, 2011, CONTRIB NEPHROL, V170, P124, DOI 10.1159/000325647; Thallas-Bonke V, 2013, NEPHROLOGY, V18, P47, DOI 10.1111/j.1440-1797.2012.01665.x; Tsuchida K, 1999, DIABETOLOGIA, V42, P579, DOI 10.1007/s001250051198; US Renal Data System, 2008, USRDS 2008 ANN DAT R; Vaidya VS, 2011, KIDNEY INT, V79, P464, DOI 10.1038/ki.2010.404; Ziyadeh FN, 2008, CURR DIABETES REV, V4, P39, DOI 10.2174/157339908783502370	36	41	43	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112538	10.1371/journal.pone.0112538	http://dx.doi.org/10.1371/journal.pone.0112538			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397960	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500058
J	Xavier, CH; Ianzer, D; Lima, AM; Marins, FR; Pedrino, GR; Vaz, G; Menezes, GB; Nalivaiko, E; Antonio, M; Fontes, P				Xavier, Carlos Henrique; Ianzer, Danielle; Lima, Augusto Martins; Marins, Fernanda Ribeiro; Pedrino, Gustavo Rodrigues; Vaz, Gisele; Menezes, Gustavo Batista; Nalivaiko, Eugene; Antonio, Marco; Fontes, Peliky			Excitatory Amino Acid Receptors Mediate Asymmetry and Lateralization in the Descending Cardiovascular Pathways from the Dorsomedial Hypothalamus	PLOS ONE			English	Article							ROSTRAL VENTROLATERAL MEDULLA; SYMPATHETIC PREGANGLIONIC NEURONS; PERIAQUEDUCTAL GRAY; HEART-RATE; CARDIAC-ARRHYTHMIAS; EMOTIONAL-STRESS; CONSCIOUS RATS; GABA-A; NUCLEUS; ORGANIZATION	The dorsomedial hypothalamus (DMH) and lateral/dorsolateral periaqueductal gray (PAG) are anatomically and functionally connected. Both the DMH and PAG depend on glutamatergic inputs for activation. We recently reported that removal of GABA-ergic tone in the unilateral DMH produces: asymmetry, that is, a right- (R-) sided predominance in cardiac chronotropism, and lateralization, that is, a greater increase in ipsilateral renal sympathetic activity (RSNA). In the current study, we investigated whether excitatory amino acid (EAA) receptors in the DMH-PAG pathway contribute to the functional interhemispheric difference. In urethane (1.2 to 1.4 g/kg, i.p.) anesthetized rats, we observed that: (i) nanoinjections of N-methyl D-aspartate (NMDA 100 pmol/100 nl) into the unilateral DMH produced the same right- sided predominance in the control of cardiac chronotropy, (ii) nanoinjections of NMDA into the ipsilateral DMH or PAG evoked lateralized RSNA responses, and (iii) blockade of EAA receptors in the unilateral DMH attenuated the cardiovascular responses evoked by injection of NMDA into either the R- or left- (L-) PAG. In awake rats, nanoinjection of kynurenic acid (1 nmol/100 nL) into the L-DMH or R- or L- PAG attenuated the tachycardia evoked by air stress. However, the magnitude of stress-evoked tachycardia was smallest when the EAA receptors of the R-DMH were blocked. We conclude that EAA receptors contribute to the right-sided predominance in cardiac chronotropism. This interhemispheric difference that involves EAA receptors was observed in the DMH but not in the PAG.	[Xavier, Carlos Henrique; Pedrino, Gustavo Rodrigues] Univ Fed Goias, Inst Ciencias Biol, Dept Ciencias Fisiol, Lab Fisiol & Terapeut Cardiovasc, Goiania, Go, Brazil; [Xavier, Carlos Henrique; Ianzer, Danielle; Lima, Augusto Martins; Marins, Fernanda Ribeiro; Vaz, Gisele; Fontes, Peliky] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Fisiol & Biofis, Belo Horizonte, MG, Brazil; [Nalivaiko, Eugene] Univ Newcastle, Sch Biomed Sci & Pharm, Newcastle, NSW 2300, Australia; [Menezes, Gustavo Batista] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil	Universidade Federal de Goias; Universidade Federal de Minas Gerais; University of Newcastle; Universidade Federal de Minas Gerais	Xavier, CH (corresponding author), Univ Fed Goias, Inst Ciencias Biol, Dept Ciencias Fisiol, Lab Fisiol & Terapeut Cardiovasc, Goiania, Go, Brazil.	carlosxavier@ufg.br	Xavier, Carlos Henrique/AAE-8390-2022; Pedrino, Gustavo R/I-5614-2015; Lima, Augusto Martins/D-7730-2015; Menezes, Gustavo B/B-3350-2013; Custodio, Carlos Henrique Xavier/F-8450-2010; Fontes, Marco Antônio Peliky/AAT-7570-2021; Xavier, Carlos H/C-8561-2013	Xavier, Carlos Henrique/0000-0003-4006-8213; Pedrino, Gustavo R/0000-0003-0488-5400; Fontes, Marco Antônio Peliky/0000-0003-4525-3565; Xavier, Carlos H/0000-0003-4006-8213; Nalivaiko, Eugene/0000-0002-6449-8181; Martins Lima, Augusto/0000-0002-0461-1226	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [143005/2008-1, 301519/2009-9]; INCT NanoBiofar; FAPEMIG	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCT NanoBiofar; FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq processos (143005/2008-1; 301519/2009-9), INCT NanoBiofar, and FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1990, NEUROSCI LETT, V118, P112, DOI 10.1016/0304-3940(90)90261-7; Apps R, 2007, NAT PROTOC, V2, P1862, DOI 10.1038/nprot.2007.263; Bandler R, 1996, PROG BRAIN RES, V107, P285; BANDLER R, 1988, BRAIN RES, V439, P95, DOI 10.1016/0006-8993(88)91465-5; BEART PM, 1990, NEUROSCIENCE, V34, P163, DOI 10.1016/0306-4522(90)90310-Z; Bernard JF, 1998, J COMP NEUROL, V401, P429; Campos RR, 1999, AM J PHYSIOL-REG I, V276, pR1102, DOI 10.1152/ajpregu.1999.276.4.R1102; Cao WH, 2004, NEUROSCIENCE, V126, P229, DOI 10.1016/j.neuroscience.2004.03.013; CARRIVE P, 1993, BEHAV BRAIN RES, V58, P27, DOI 10.1016/0166-4328(93)90088-8; Carrive P, 2009, ENCY NEUROSCIENCE, P923; Carrive P, 2008, EUR J NEUROSCI, V28, P428, DOI 10.1111/j.1460-9568.2008.06351.x; Critchley HD, 2005, BRAIN, V128, P75, DOI 10.1093/brain/awh324; Da Silva LG, 2006, NEUROSCIENCE, V139, P1129, DOI 10.1016/j.neuroscience.2005.12.041; da Silva LG, 2003, BRAIN RES, V984, P206, DOI 10.1016/S0006-8993(03)03157-3; de Menezes RCA, 2008, AM J PHYSIOL-REG I, V295, pR881, DOI 10.1152/ajpregu.00181.2008; de Menezes RCA, 2009, J PHYSIOL-LONDON, V587, P1201, DOI 10.1113/jphysiol.2008.161463; de Oliveira RW, 2000, BRAIN RES BULL, V51, P457, DOI 10.1016/S0361-9230(99)00248-8; Dimicco JA, 1992, CENTRAL NEURAL MECH, VII; FANG HS, 1962, AM J PHYSIOL, V203, P147, DOI 10.1152/ajplegacy.1962.203.1.147; Farkas E, 1998, BRAIN RES, V792, P179, DOI 10.1016/S0006-8993(98)00029-8; Fontes MAP, 2011, NEUROSCIENCE, V184, P64, DOI 10.1016/j.neuroscience.2011.03.018; Fontes MAP, 2001, AM J PHYSIOL-HEART C, V280, pH2891, DOI 10.1152/ajpheart.2001.280.6.H2891; FURNIVAL CM, 1968, J PHYSIOL-LONDON, V197, pP74; Harris JA, 1996, NEUROSCI BIOBEHAV R, V20, P637, DOI 10.1016/0149-7634(95)00077-1; Horiuchi J, 2009, J PHYSIOL-LONDON, V587, P5149, DOI 10.1113/jphysiol.2009.179739; Huang JH, 2002, AUTON NEUROSCI-BASIC, V95, P57, DOI 10.1016/S1566-0702(01)00356-3; KAMOSINSKA B, 1989, J AUTONOM NERV SYST, V26, P241, DOI 10.1016/0165-1838(89)90173-2; Kerman IA, 2008, EXP BRAIN RES, V187, P1, DOI 10.1007/s00221-008-1337-5; Lane RD, 2014, HDB CARDIOV IN PRESS; Menezes RCA, 2007, NEUROSCIENCE, V144, P336, DOI 10.1016/j.neuroscience.2006.08.062; Moon EA, 2002, BRAIN RES, V929, P181, DOI 10.1016/S0006-8993(01)03388-1; Myers B, 2014, BRAIN STRUCT FUNCT, V219, P1287, DOI 10.1007/s00429-013-0566-y; Oppenheimer S, 2006, CLIN AUTON RES, V16, P6, DOI 10.1007/s10286-006-0276-0; Fontes MAP, 2014, BRAIN RES, V1554, P49, DOI 10.1016/j.brainres.2014.01.043; RANDALL WC, 1972, FED PROC, V31, P1199; Shafton AD, 1998, BRAIN RES, V801, P239, DOI 10.1016/S0006-8993(98)00587-3; Soltis RP, 1998, AM J PHYSIOL-REG I, V275, pR624, DOI 10.1152/ajpregu.1998.275.2.R624; SOLTIS RP, 1991, AM J PHYSIOL, V260, pR13, DOI 10.1152/ajpregu.1991.260.1.R13; SOLTIS RP, 1991, AM J PHYSIOL, V261, pR427, DOI 10.1152/ajpregu.1991.261.2.R427; StottPotter EH, 1996, J NEUROSCI, V16, P1173; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; TAYLOR RB, 1992, AM J PHYSIOL, V263, pH1026, DOI 10.1152/ajpheart.1992.263.4.H1026; TERHORST GJ, 1986, BRAIN RES BULL, V16, P231; Thompson RH, 1996, J COMP NEUROL, V376, P143, DOI 10.1002/(SICI)1096-9861(19961202)376:1<143::AID-CNE9>3.0.CO;2-3; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Vianna DML, 2003, BRAZ J MED BIOL RES, V36, P557, DOI 10.1590/S0100-879X2003000500002; Winter J, 2012, AUTON NEUROSCI-BASIC, V166, P4, DOI 10.1016/j.autneu.2011.08.004; Wittling W, 1997, ACTA PHYSIOL SCAND, V161, P55; Xavier CH, 2009, NEUROSCIENCE, V164, P1360, DOI 10.1016/j.neuroscience.2009.09.018; Xavier CH, 2013, AM J PHYSIOL-REG I, V304, pR664, DOI 10.1152/ajpregu.00401.2012; Xavier CH, 2011, AUTON NEUROSCI-BASIC, V163, P57; YANOWITZ F, 1966, CIRC RES, V18, P416, DOI 10.1161/01.RES.18.4.416; Zaretskaia MV, 2008, BRAIN RES, V1200, P39, DOI 10.1016/j.brainres.2008.01.018	53	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112412	10.1371/journal.pone.0112412	http://dx.doi.org/10.1371/journal.pone.0112412			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397884	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500051
J	Xiao, XS; Chen, B; Liu, XP; Liu, P; Zheng, GP; Ye, F; Tang, HL; Xie, XM				Xiao, Xiangsheng; Chen, Bo; Liu, Xiaoping; Liu, Peng; Zheng, Guopei; Ye, Feng; Tang, Hailin; Xie, Xiaoming			Diallyl Disulfide Suppresses SRC/Ras/ERK Signaling-Mediated Proliferation and Metastasis in Human Breast Cancer by Up-Regulating miR-34a	PLOS ONE			English	Article							HUMAN GASTRIC-CANCER; CELL-LINE MCF-7; INDUCED APOPTOSIS; MICRORNAS; ACTIVATION; PATHWAY; EXPRESSION; ARREST; KINASE; P53	Diallyl disulfide (DADS) is one of the major volatile components of garlic oil. DADS has various biological properties, including anticancer, antiangiogenic, and antioxidant effects. However, the anticancer mechanisms of DADS in human breast cancer have not been elucidated, particularly in vivo. In this study, we demonstrated that the expression of miR-34a was up-regulated in DADS-treated MDA-MB-231 cells. miR-34a not only inhibited breast cancer growth but also enhanced the antitumor effect of DADS, both in vitro and in vivo. Furthermore, Src was identified as a target of miR-34a, with miR-34a inhibiting SRC expression and consequently triggering the suppression of the SRC/Ras/ERK pathway. These results suggest that DADS could be a promising anticancer agent for breast cancer. miR-34a may also demonstrate a potential gene therapy agent that could enhance the antitumor effects of DADS.	[Xiao, Xiangsheng; Chen, Bo; Liu, Xiaoping; Liu, Peng; Ye, Feng; Tang, Hailin; Xie, Xiaoming] Sun Yat Sen Univ, Ctr Canc, Dept Breast Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Xiao, Xiangsheng; Chen, Bo; Liu, Xiaoping; Liu, Peng; Ye, Feng; Tang, Hailin; Xie, Xiaoming] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China; [Zheng, Guopei] Guangzhou Med Univ, Affiliated Canc Hosp, Guangzhou 510095, Guangdong, Peoples R China; [Zheng, Guopei] Guangzhou Med Univ, Canc Res Inst, Guangzhou 510095, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Guangzhou Medical University; Guangzhou Medical University	Tang, HL (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Breast Oncol, Guangzhou 510275, Guangdong, Peoples R China.	tanghl@sysucc.org.cn; xiexm@sysucc.org.cn	xiao, xiang/GWU-6035-2022		National Natural Science Foundation of China [81472575, 81472469, 31100935, 81272514, 81302318, 81372133, 81301798]; Key Programme of the National Natural Science Foundation of China [31030061]; China Postdoctoral Science Foundation [2012M520075, 2014M550447]; Science and Technology Planning Project of Guangzhou [2014J4100169]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Programme of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Science and Technology Planning Project of Guangzhou	This work was supported by funds from the National Natural Science Foundation of China (81472575, 81472469, 31100935, 81272514, 81302318, 81372133, and 81301798), the Key Programme of the National Natural Science Foundation of China (31030061), the China Postdoctoral Science Foundation (2012M520075 and 2014M550447), and the Science and Technology Planning Project of Guangzhou (2014J4100169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2008, HYPERTENS RES, V31, P987, DOI 10.1291/hypres.31.987; Altonsy MO, 2012, NUTR CANCER, V64, P1251, DOI 10.1080/01635581.2012.721156; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Catuogno Silvia, 2011, Cancers (Basel), V3, P1877, DOI 10.3390/cancers3021877; Damiano L, 2010, ONCOGENE, V29, P3677, DOI 10.1038/onc.2010.128; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Elsberger B, 2014, CRIT REV ONCOL HEMAT, V89, P343, DOI 10.1016/j.critrevonc.2013.12.009; Fan MY, 2013, J BIOL CHEM, V288, P27480, DOI 10.1074/jbc.M113.491803; Filomeni G, 2005, CANCER RES, V65, P11735, DOI 10.1158/0008-5472.CAN-05-3067; Filomeni G, 2003, CANCER RES, V63, P5940; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Huang YS, 2011, MOL MED REP, V4, P553, DOI 10.3892/mmr.2011.453; Landskroner-Eiger S, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006643; Lei XY, 2008, ACTA PHARMACOL SIN, V29, P1233, DOI 10.1111/j.1745-7254.2008.00851.x; Nakagawa H, 2001, CARCINOGENESIS, V22, P891, DOI 10.1093/carcin/22.6.891; Nguyen DHD, 2000, J BIOL CHEM, V275, P19382, DOI 10.1074/jbc.M909575199; Peiro G, 2014, BR J CANC; Peurala H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026122; Pratheeshkumar P, 2010, J ENVIRON PATHOL TOX, V29, P113, DOI 10.1615/JEnvironPatholToxicolOncol.v29.i2.50; Profumo Valentina, 2013, Critical Reviews in Oncogenesis, V18, P341; Rakha EA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2607; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Serpico D, 2014, CANCER TREAT REV, V40, P595, DOI 10.1016/j.ctrv.2013.11.002; Sundaram SG, 1996, BBA-MOL BASIS DIS, V1315, P15, DOI 10.1016/0925-4439(95)00088-7; Tang HL, 2013, CANCER LETT, V340, P72, DOI 10.1016/j.canlet.2013.06.027; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Tsubura A, 2011, ANTI-CANCER AGENT ME, V11, P249, DOI 10.2174/187152011795347441; Wang X, 2009, RNA, V15, P637, DOI 10.1261/rna.1442309; Wang YH, 2014, MOL CELL BIOCHEM, V393, P77, DOI 10.1007/s11010-014-2048-9; Xiao DH, 2005, MOL CANCER THER, V4, P1388, DOI 10.1158/1535-7163.MCT-05-0152; Xu Y, 2014, INT J BIOL SCI, V10, P396, DOI 10.7150/ijbs.8193; Yuan JP, 2004, WORLD J GASTROENTERO, V10, P2731, DOI 10.3748/wjg.v10.i18.2731; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	36	53	57	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112720	10.1371/journal.pone.0112720	http://dx.doi.org/10.1371/journal.pone.0112720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396727	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558500082
J	Zang, MD; Zhang, BG; Zhang, YQ; Li, JF; Su, LP; Zhu, ZG; Gu, QL; Liu, BY; Yan, M				Zang, Mingde; Zhang, Baogui; Zhang, Yunqiang; Li, Jianfang; Su, Liping; Zhu, Zhenggang; Gu, Qinlong; Liu, Bingya; Yan, Min			CEACAM6 Promotes Gastric Cancer Invasion and Metastasis by Inducing Epithelial-Mesenchymal Transition via PI3K/AKT Signaling Pathway	PLOS ONE			English	Article							DOWN-REGULATION; PROLIFERATION; DETERMINANT; EXPRESSION; THERAPY; EMT	Overexpressed CEACAM6 in tumor tissues plays important roles in invasion, metastasis and anoikis resistance in a variety of human cancers. We recently reported that CEACAM6 expression is upregulated in Gastric cancer (GC) tissues and promoted GC metastasis. Here, we report that CEACAM6 promotes peritoneal metastases in vivo and is negatively correlated with E-cadherin expression in GC tissues. Overexpressed CEACAM6 induced epithelial-mesenchymal transition (EMT) in GC, as measured by increases in the EMT markers N-cadherin, Vimentin and Slug while E-cadherin expression was decreased in CEACAM6-overexpressing GC cells; opposing results were observed in CEACAM6-silenced cells. Furthermore, E-cadherin expression was negatively correlated with depth of tumor invasion, lymph node metastasis and TNM stage in GC tissues. Additionally, CEACAM6 elevated matrix metalloproteinase-9 (MMP-9) activity in GC, and anti-MMP-9 antibody could reverse the increasing invasion and migration induced by CEACAM6. CEACAM6 also increased the levels of phosphorylated AKT, which is involved in the progression of a variety of human tumors. We further observed that LY294002, a PI3K inhibitor, could reverse CEACAM6-induced EMT via mesenchymal-epithelial transition. These findings suggest that CEACAM6 enhances invasion and metastasis in GC by promoting EMT via the PI3K/AKT signaling pathway.	[Zang, Mingde; Zhang, Baogui; Zhang, Yunqiang; Li, Jianfang; Su, Liping; Zhu, Zhenggang; Gu, Qinlong; Liu, Bingya; Yan, Min] Shanghai Jiao Tong Univ, Sch Med, Dept Surg,Ruijin Hosp, Shanghai Key Lab Gastr Neoplasms,Shanghai Inst Di, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Liu, BY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Surg,Ruijin Hosp, Shanghai Key Lab Gastr Neoplasms,Shanghai Inst Di, Shanghai 200030, Peoples R China.	byliu@sjtu.edu.cn; ym10299@163.com	Liu, Bingya/GMW-5655-2022	Liu, Bingya/0000-0002-4406-3762	National Natural Science Foundation of China [81172324, 91229106, 81272749, 81372231]; Key Project of Shanghai Education Committee [12ZZ105, 12ZZ102]; Science and Technology Commission of Shanghai Municipality [13ZR1425600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Shanghai Education Committee; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by grants from the National Natural Science Foundation of China (No. 81172324, No. 91229106, No. 81272749, and No. 81372231), and Key Project of Shanghai Education Committee (No. 12ZZ105 and No. 12ZZ102) and Science and Technology Commission of Shanghai Municipality (No. 13ZR1425600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauchemin N, 2013, CANCER METAST REV, V32, P643, DOI 10.1007/s10555-013-9444-6; Camacho-Leal P, 2007, J CELL PHYSIOL, V211, P791, DOI 10.1002/jcp.20989; Chang L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.407; Chen JM, 2013, INT J ONCOL, V43, P877, DOI 10.3892/ijo.2013.2015; Correa P, 2013, GASTROENTEROL CLIN N, V42, P211, DOI 10.1016/j.gtc.2013.01.002; Duxbury MS, 2004, ANN SURG, V240, P667, DOI 10.1097/01.sla.0000140755.97224.9a; Duxbury MS, 2004, BRIT J CANCER, V91, P1384, DOI 10.1038/sj.bjc.6602113; Duxbury MS, 2004, CANCER RES, V64, P3987, DOI 10.1158/0008-5472.CAN-04-0424; Duxbury MS, 2004, ONCOGENE, V23, P465, DOI 10.1038/sj.onc.1207036; Fujitani K, 2013, DIGEST SURG, V30, P119, DOI 10.1159/000350877; Ha GH, 2013, CANCER LETT, V332, P63, DOI 10.1016/j.canlet.2013.01.013; Han SU, 2008, ONCOGENE, V27, P675, DOI 10.1038/sj.onc.1210686; Hu L, 2014, ONCOTARGET, V5, P1885, DOI 10.18632/oncotarget.1871; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Ilantzis C, 2002, NEOPLASIA, V4, P151, DOI 10.1038/sj.neo.7900201; Jantscheff P, 2003, J CLIN ONCOL, V21, P3638, DOI 10.1200/JCO.2003.55.135; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim KS, 2013, CLIN CHIM ACTA, V415, P12, DOI 10.1016/j.cca.2012.09.003; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Liang FB, 2007, J BIOL CHEM, V282, P5413, DOI 10.1074/jbc.M608940200; Macha MA, 2013, CANCER LETT, V341, P166, DOI 10.1016/j.canlet.2013.07.037; Nicholson TB, 2006, J CELL BIOL, V175, P647, DOI 10.1083/jcb.200605001; Ruan K, 2009, CELL MOL LIFE SCI, V66, P2219, DOI 10.1007/s00018-009-0013-7; Savagner P, 2010, ANN ONCOL, V21, P89, DOI 10.1093/annonc/mdq292; Scholzel S, 2000, AM J PATHOL, V156, P595, DOI 10.1016/S0002-9440(10)64764-5; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wang H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.122; Zhang YQ, 2014, ACTA BIOCH BIOPH SIN, V46, P283, DOI 10.1093/abbs/gmu001	30	40	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112908	10.1371/journal.pone.0112908	http://dx.doi.org/10.1371/journal.pone.0112908			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398131	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500108
J	Engstrom, M; Warntjes, JBM; Tisell, A; Landtblom, AM; Lundberg, P				Engstrom, Maria; Warntjes, Jan B. M.; Tisell, Anders; Landtblom, Anne-Marie; Lundberg, Peter			Multi-Parametric Representation of Voxel-Based Quantitative Magnetic Resonance Imaging	PLOS ONE			English	Article							APPEARING WHITE-MATTER; HIGH-RESOLUTION T-1; GRAY-MATTER; BRAIN; SCLEROSIS; T2; QUANTIFICATION; RELAXOMETRY; DISABILITY; INJURY	The aim of the study was to explore the possibilities of multi-parametric representations of voxel-wise quantitative MRI data to objectively discriminate pathological cerebral tissue in patients with brain disorders. For this purpose, we recruited 19 patients with Multiple Sclerosis (MS) as benchmark samples and 19 age and gender matched healthy subjects as a reference group. The subjects were examined using quantitative Magnetic Resonance Imaging (MRI) measuring the tissue structure parameters: relaxation rates, R-1 and R-2, and proton density. The resulting parameter images were normalized to a standard template. Tissue structure in MS patients was assessed by voxel-wise comparisons with the reference group and with correlation to a clinical measure, the Expanded Disability Status Scale (EDSS). The results were visualized by conventional geometric representations and also by multi-parametric representations. Data showed that MS patients had lower R-1 and R-2, and higher proton density in periventricular white matter and in wide-spread areas encompassing central and sub-cortical white matter structures. MS-related tissue abnormality was highlighted in posterior white matter whereas EDSS correlation appeared especially in the frontal cortex. The multi-parameter representation highlighted disease-specific features. In conclusion, the proposed method has the potential to visualize both high-probability focal anomalies and diffuse tissue changes. Results from voxel-based statistical analysis, as exemplified in the present work, may guide radiologists where in the image to inspect for signs of disease. Future clinical studies must validate the usability of the method in clinical practice.	[Engstrom, Maria] Linkoping Univ, Dept Med & Hlth Sci, Div Radiol, Linkoping, Sweden; [Engstrom, Maria; Warntjes, Jan B. M.; Tisell, Anders; Landtblom, Anne-Marie; Lundberg, Peter] Linkoping Univ, Ctr Med Image Sci & Visualizat CMIV, Linkoping, Sweden; [Warntjes, Jan B. M.] Linkoping Univ, Dept Med & Hlth Sci, Div Cardiovasc Med, Linkoping, Sweden; [Warntjes, Jan B. M.] SyntheticMR AB, Linkoping, Sweden; [Tisell, Anders; Lundberg, Peter] Linkoping Univ, Dept Med & Hlth Sci, Div Radiat Phys, Linkoping, Sweden; [Landtblom, Anne-Marie] Linkoping Univ, Dept Clin & Expt Med, Div Neurol, Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University; Linkoping University; Linkoping University	Engstrom, M (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Div Radiol, Linkoping, Sweden.	maria.engstrom@liu.se	Lundberg, Peter/AGD-9679-2022	Landtblom, Anne-Marie/0000-0001-9567-470X; Engstrom, Maria/0000-0002-2167-2450	National Research Council [VR/NT 2008-3368]; Linkoping University; County Council of Ostergotland	National Research Council(Consiglio Nazionale delle Ricerche (CNR)); Linkoping University; County Council of Ostergotland	The National Research Council (grant number VR/NT 2008-3368), Linkoping University, and the County Council of Ostergotland are acknowledged for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SyntheticMR AB provided support in the form of salary for author JBMW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alfano B, 1997, MAGNET RESON MED, V37, P84, DOI 10.1002/mrm.1910370113; Ambarki K, 2012, AM J NEURORADIOL, V33, P1951, DOI 10.3174/ajnr.A3067; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Audoin B, 2004, J MAGN RESON IMAGING, V20, P765, DOI 10.1002/jmri.20178; Barkhof F, 2002, CURR OPIN NEUROL, V15, P239, DOI 10.1097/00019052-200206000-00003; Bates D., 2013, LME4 LINEAR MIXED EF; BOBMAN SA, 1985, AM J NEURORADIOL, V6, P265; Bodini B, 2009, HUM BRAIN MAPP, V30, P2852, DOI 10.1002/hbm.20713; Ceccarelli A, 2008, NEUROIMAGE, V39, P1499, DOI 10.1016/j.neuroimage.2007.11.002; Deichmann R, 2005, MAGNET RESON MED, V54, P20, DOI 10.1002/mrm.20552; Deoni SCL, 2005, MAGN RESON MED, V53, P237, DOI 10.1002/mrm.20314; Draganski B, 2011, NEUROIMAGE, V55, P1423, DOI 10.1016/j.neuroimage.2011.01.052; Filippi M, 2010, J MAGN RESON IMAGING, V31, P770, DOI 10.1002/jmri.22102; Filippi M, 2000, J NEUROVIROL, V6, pS115; Hasan KM, 2012, J MAGN RESON IMAGING, V35, P1300, DOI 10.1002/jmri.23539; Hasan KM, 2012, J NEUROL SCI, V313, P99, DOI 10.1016/j.jns.2011.09.015; Jure L, 2010, J MAGN RESON IMAGING, V32, P424, DOI 10.1002/jmri.22265; Kincses ZT, 2011, MULT SCLER J, V17, P681, DOI 10.1177/1352458510391342; Kumar R, 2012, J MAGN RESON IMAGING, V35, P300, DOI 10.1002/jmri.22831; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LARSSON HBW, 1989, MAGNET RESON MED, V11, P337, DOI 10.1002/mrm.1910110308; Levesque IR, 2009, MAGN RESON MED, V62, P1487, DOI 10.1002/mrm.22131; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Neeb H, 2006, NEUROIMAGE, V31, P1156, DOI 10.1016/j.neuroimage.2005.12.063; Neema M, 2007, J NEUROIMAGING, V17, p16S, DOI 10.1111/j.1552-6569.2007.00131.x; Neema M, 2009, NEUROIMAGE, V46, P633, DOI 10.1016/j.neuroimage.2009.03.001; Oh J, 2005, J MAGN RESON IMAGING, V21, P701, DOI 10.1002/jmri.20335; RCore Team, 2020, R LANG ENV STAT COMP; Riederer S J, 1986, Acta Radiol Suppl, V369, P466; Roosendaal SD, 2009, NEUROIMAGE, V44, P1397, DOI 10.1016/j.neuroimage.2008.10.026; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Tofts P, 2003, QUANTITATIVE MRI OF THE BRAIN: MEASURING CHANGES CAUSED BY DISEASE, pXV; Vagberg M, 2013, AM J NEURORADIOL, V34, P498, DOI 10.3174/ajnr.A3262; Warnties JBM, 2008, MAGN RESON MED, V60, P320, DOI 10.1002/mrm.21635; Warntjes J, 2012, PLOS ONE, V8; Warntjes JBM, 2007, MAGN RESON MED, V57, P528, DOI 10.1002/mrm.21165; West JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066212; Whittall KP, 2002, MAGNET RESON MED, V47, P403, DOI 10.1002/mrm.10076	39	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e111688	10.1371/journal.pone.0111688	http://dx.doi.org/10.1371/journal.pone.0111688			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393722	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300018
J	Lewinska, M; Juvan, P; Perse, M; Jeruc, J; Kos, S; Lorbek, G; Urlep, Z; Keber, R; Horvat, S; Rozman, D				Lewinska, Monika; Juvan, Peter; Perse, Martina; Jeruc, Jera; Kos, Spela; Lorbek, Gregor; Urlep, Ziga; Keber, Rok; Horvat, Simon; Rozman, Damjana			Hidden Disease Susceptibility and Sexual Dimorphism in the Heterozygous Knockout of Cyp51 from Cholesterol Synthesis	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; LANOSTEROL 14-ALPHA-DEMETHYLASE CYP51; FATTY LIVER-DISEASE; BILE-ACID SYNTHESIS; STEROL 27-HYDROXYLASE; EMBRYONIC LETHALITY; MICE REVEALS; MOUSE-MODEL; GENE; METABOLISM	We examined the genotype-phenotype interactions of Cyp51(+/-) mice carrying one functional allele of lanosterol 14 alpha-demethylase from cholesterol biosynthesis. No distinct developmental or morphological abnormalities were observed by routine visual inspection of Cyp51(+/-) and Cyp51(+/+) mice and fertility was similar. We further collected a large data-set from female and male Cyp51(+/-) mice and controls fed for 16 weeks with three diets and applied linear regression modeling. We used 3 predictor variables (genotype, sex, diet), and 39 response variables corresponding to the organ characteristics (7), plasma parameters (7), and hepatic gene expression (25). We observed significant differences between Cyp51(+/-) and wildtype mice in organ characteristics and blood lipid profile. Hepatomegaly was observed in Cyp51(+/-) males, together with elevated total and low-density lipoprotein cholesterol. Cyp51(+/-) females fed high-fat, high-cholesterol diet were leaner and had elevated plasma corticosterone compared to controls. We observed elevated hepatocyte apoptosis, mitosis and lipid infiltration in heterozygous knockouts of both sexes. The Cyp51(+/-) females had a modified lipid storage homeostasis protecting them from weight-gain when fed high-fat high-cholesterol diet. Malfunction of one Cyp51 allele therefore initiates disease pathways towards cholesterol-linked liver pathologies and sex-dependent response to dietary challenge.	[Lewinska, Monika; Juvan, Peter; Kos, Spela; Lorbek, Gregor; Urlep, Ziga; Rozman, Damjana] Univ Ljubljana, Ctr Funct Genom & Biochips, Fac Med, SI-1000 Ljubljana, Slovenia; [Perse, Martina; Jeruc, Jera] Univ Ljubljana, Inst Pathol, Ctr Med Expt, Fac Med, SI-1000 Ljubljana, Slovenia; [Kos, Spela] Inst Oncol Ljubljana, SI-1000 Ljubljana, Slovenia; [Keber, Rok; Horvat, Simon] Univ Ljubljana, Biotech Fac, Dept Anim Sci, Domzale 1230, Slovenia; [Horvat, Simon] Natl Inst Chem, Ljubljana 1000, Slovenia	University of Ljubljana; University of Ljubljana; Institute of Oncology - Slovenia; University of Ljubljana; National Institute of Chemistry - Slovenia	Rozman, D (corresponding author), Univ Ljubljana, Ctr Funct Genom & Biochips, Fac Med, SI-1000 Ljubljana, Slovenia.	damjana.rozman@mf.uni-lj.si	Lewinska, Monika/N-9919-2017; Perse, Martina/AAS-2898-2020; Jeruc, Jera/AAL-5258-2021	Lewinska, Monika/0000-0002-5275-992X; Juvan, Peter/0000-0003-2873-5247	FP7 FightingDrugFailure ITN Marie Curie grant [238132]; Slovenian Research Agency [P1-0104, P1-0010, J7-4053]	FP7 FightingDrugFailure ITN Marie Curie grant; Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This study was supported by FP7 FightingDrugFailure ITN Marie Curie grant #238132 and Slovenian Research Agency program grant P1-0104, grant P1-0010 and project J7-4053. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acimovic J, 2013, MOLECULES, V18, P4002, DOI 10.3390/molecules18044002; Aldahmesh MA, 2012, GENET MED, V14, P955, DOI 10.1038/gim.2012.86; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BJORKHEM I, 1994, P NATL ACAD SCI USA, V91, P8592, DOI 10.1073/pnas.91.18.8592; Bream ENA, 2013, PEDIATR RES, V73, P135, DOI 10.1038/pr.2012.166; Caldas H, 2005, MOL GENET METAB, V84, P48, DOI 10.1016/j.ymgme.2004.08.007; Caldas H, 2003, HUM MOL GENET, V12, P2981, DOI 10.1093/hmg/ddg321; Chuang JC, 2010, J LIPID RES, V51, P1344, DOI 10.1194/jlr.M002196; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Cunningham D, 2009, MOL GENETICS METABOL, V98, P356; D'souza AM, 2012, AM J PHYSIOL-GASTR L, V302, pG850, DOI 10.1152/ajpgi.00378.2011; De Marinis E, 2008, J ENDOCRINOL, V198, P635, DOI 10.1677/JOE-08-0242; Debeljak N, 2000, ARCH BIOCHEM BIOPHYS, V379, P37, DOI 10.1006/abbi.2000.1859; Derry JMJ, 1999, NAT GENET, V22, P286, DOI 10.1038/10350; DIETSCHY JM, 1984, KLIN WOCHENSCHR, V62, P338, DOI 10.1007/BF01716251; Dietschy JM, 2002, J BIOL CHEM, V277, P3801, DOI 10.1074/jbc.R100057200; Erickson SK, 2003, J LIPID RES, V44, P1001, DOI 10.1194/jlr.M200489-JLR200; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Febbraio M, 2002, MOL CELL BIOCHEM, V239, P193, DOI 10.1023/A:1020515210972; Fernandez C, 2005, J LIPID RES, V46, P920, DOI 10.1194/jlr.M400407-JLR200; Fitzky BU, 2001, J CLIN INVEST, V108, P905, DOI 10.1172/JCI200112103; Fox J., 2019, R COMPANION APPL REG, V.; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gatti DM, 2010, PHYSIOL GENOMICS, V42, P456, DOI 10.1152/physiolgenomics.00110.2009; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Geske FJ, 2001, HUM PATHOL, V32, P1029, DOI 10.1053/hupa.2001.28250; Goedeke L, 2012, CELL MOL LIFE SCI, V69, P915, DOI 10.1007/s00018-011-0857-5; Goluszko P, 2005, INFECT IMMUN, V73, P7791, DOI 10.1128/IAI.73.12.7791-7796.2005; Hager EJ, 2007, J INHERIT METAB DIS, V30, P888, DOI 10.1007/s10545-007-0776-7; Henkel AS, 2011, J LIPID RES, V52, P289, DOI 10.1194/jlr.M012781; Horvat S, 2011, DRUG METAB REV, V43, P69, DOI 10.3109/03602532.2010.540580; Ikonen E, 2006, PHYSIOL REV, V86, P1237, DOI 10.1152/physrev.00022.2005; Ishibashi S, 1996, J BIOL CHEM, V271, P18017, DOI 10.1074/jbc.271.30.18017; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Itabe H, 2007, J ATHEROSCLER THROMB, V14, P1, DOI 10.5551/jat.14.1; Jokela H, 2010, ENDOCRINOLOGY, V151, P1884, DOI 10.1210/en.2009-0928; Kavanagh IC, 2003, ATHEROSCLEROSIS, V168, P271, DOI 10.1016/S0021-9150(03)00148-5; Keber R, 2013, J LIPID RES, V54, P1653, DOI 10.1194/jlr.M035717; Keber R, 2013, J LIPID RES, V54, P20, DOI 10.1194/jlr.R032326; Keber R, 2011, J BIOL CHEM, V286, P29086, DOI 10.1074/jbc.M111.253245; Kosir R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-60; Krakowiak PA, 2003, HUM MOL GENET, V12, P1631, DOI 10.1093/hmg/ddg172; Lewinska M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082554; Lewinska M, 2013, ACTA CHIM SLOV, V60, P875; Li-Hawkins J, 2002, J CLIN INVEST, V110, P1191, DOI 10.1172/JCI200216309; Li-Hawkins J, 2000, J BIOL CHEM, V275, P16536, DOI 10.1074/jbc.M001811200; Lorbek G, 2013, MOLECULES, V18, P11067, DOI 10.3390/molecules180911067; Lorbek G, 2012, FEBS J, V279, P1516, DOI 10.1111/j.1742-4658.2011.08432.x; Mirza R, 2006, J INVEST DERMATOL, V126, P638, DOI 10.1038/sj.jid.5700111; Muscarella LA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/854737; Ohashi K, 2003, J BIOL CHEM, V278, P42936, DOI 10.1074/jbc.M307228200; Pellegrini M, 2014, CURRENT MED CHEM; Pikuleva I, 2003, ARCH BIOCHEM BIOPHYS, V420, P35, DOI 10.1016/j.abb.2003.09.028; Porter FD, 2011, J LIPID RES, V52, P6, DOI 10.1194/jlr.R009548; Repa JJ, 2000, J BIOL CHEM, V275, P39685, DOI 10.1074/jbc.M007653200; Ricart-Jane D, 2002, METABOLISM, V51, P925, DOI 10.1053/meta.2002.33353; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Romero-Aleshire MJ, 2009, AM J PHYSIOL-REG I, V297, pR587, DOI 10.1152/ajpregu.90762.2008; Shea HC, 2007, P NATL ACAD SCI USA, V104, P11526, DOI 10.1073/pnas.0705089104; Singh P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058833; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Steffen KM, 2007, J PERINATOL, V27, P672, DOI 10.1038/sj.jp.7211806; Team RDC, 2013, R LANG ENV STAT COMP; Tozawa R, 1999, J BIOL CHEM, V274, P30843, DOI 10.1074/jbc.274.43.30843; Trapani L, 2010, EXP GERONTOL, V45, P119, DOI 10.1016/j.exger.2009.10.014; TURLEY SD, 1995, J LIPID RES, V36, P67; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANDIEST PJ, 1992, HUM PATHOL, V23, P603, DOI 10.1016/0046-8177(92)90313-R; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Wang XW, 2011, J CLIN ENDOCR METAB, V96, P885, DOI 10.1210/jc.2010-2061; Wechsler A, 2003, SCIENCE, V302, P2087, DOI 10.1126/science.1090776; Wieckowska A, 2006, HEPATOLOGY, V44, P27, DOI 10.1002/hep.21223; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Younossi ZM, 2012, MEDICINE, V91, P319, DOI 10.1097/MD.0b013e3182779d49; Yu LQ, 2002, P NATL ACAD SCI USA, V99, P16237, DOI 10.1073/pnas.252582399	75	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112787	10.1371/journal.pone.0112787	http://dx.doi.org/10.1371/journal.pone.0112787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393872	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300104
J	Li, LH; Chen, X; Lv, S; Dong, MM; Zhang, L; Tu, JH; Yang, J; Zhang, LL; Song, YA; Xu, LT; Zou, J				Li, Lihui; Chen, Xi; Lv, Shuang; Dong, Miaomiao; Zhang, Li; Tu, Jiaheng; Yang, Jie; Zhang, Lingli; Song, Yinan; Xu, Leiting; Zou, Jun			Influence of Exercise on Bone Remodeling-Related Hormones and Cytokines in Ovariectomized Rats: A Model of Postmenopausal Osteoporosis	PLOS ONE			English	Article							MINERAL DENSITY; MECHANICAL-PROPERTIES; REPLACEMENT THERAPY; ENDURANCE EXERCISE; OLDER WOMEN; ESTROGEN; MASS; METABOLISM; RESORPTION; RECEPTOR	This study aims to explore the effects of exercise on postmenopausal osteoporosis and the mechanisms by which exercise affects bone remodeling. Sixty-three Wistar female rats were randomly divided into five groups: (1) control group, (2) shamoperated group, (3) OVX (Ovariectomy) group, (4) DES-OVX (Diethylstilbestrol-OVX) group, and (5) Ex-OVX (Exercise-OVX) group. The rat osteoporosis model was established through ovariectomy. The Ex-OVX rats were made to run 251.2 meters every day, 6 d/wk for 3 months in a running wheel. Trabecular bone volume (TBV%), total resorption surface (TRS%), trabecular formation surface (TFS%), mineralization rate (MAR), bone cortex mineralization rate (mAR), and osteoid seam width (OSW) were determined by bone histomorphometry. The mRNA and protein levels of interleukin-1 beta (IL-1 beta(2)), interleukin-6 (IL-6), and cyclooxygenase-2 (Cox-2) were determined by in situ hybridization and immunohistochemistry, respectively. Serum levels of estrogen estradiol (E-2), calcitonin (CT), osteocalcin (BGP), and parathyroid hormone (PTH) were determined by ELISA assays. The investigation revealed that compared to the control and the sham-operated groups, the OVX group showed significantly lower levels of TBV%, E-2, and CT, but much higher levels of TRS%, TFS%, MAR, OSW, BGP, and PTH. The Ex-OVX group showed increased TBV% and serum levels of E-2 and CT compared to the OVX group. Ovariectomy also led to a significant increase in IL-1 beta mRNA and protein levels in the bone marrow and IL-6 and Cox-2 protein levels in tibias. In addition, the Ex-OVX group showed lower levels of IL-beta mRNA and protein, IL-6 mRNA, and Cox-2 mRNA and protein than those in the OVX group. The upshot of the study suggests that exercise can significantly increase bone mass in postmenopausal osteoporosis rat models by inhibiting bone resorption and increasing bone formation, especially in trabecular bones.	[Li, Lihui; Chen, Xi; Lv, Shuang; Dong, Miaomiao; Zhang, Li; Tu, Jiaheng; Yang, Jie; Zhang, Lingli; Song, Yinan; Xu, Leiting] Shanghai Univ Sport, Sch Kinesiol, Shanghai, Peoples R China; [Zou, Jun] Shanghai Univ Sport, Sci Res Dept, Shanghai, Peoples R China; [Xu, Leiting] Ningbo Univ, Sch Med, Ningbo 315211, Zhejiang, Peoples R China; [Chen, Xi] Wenzhou Med Univ, Sch Sports Sci, Wenzhou, Peoples R China	Shanghai University of Sport; Shanghai University of Sport; Ningbo University; Wenzhou Medical University	Xu, LT (corresponding author), Shanghai Univ Sport, Sch Kinesiol, Shanghai, Peoples R China.	xuleiting@nbu.edu.cn; zoujun777@126.com	Chen, Xi/AGS-6702-2022		Shanghai Key Lab of Human Sport Competence Development and Maintenance (Shanghai University of sport) [11DZ2261100]; National Natural Science Foundation of China [81170323]	Shanghai Key Lab of Human Sport Competence Development and Maintenance (Shanghai University of sport); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Shanghai Key Lab of Human Sport Competence Development and Maintenance (Shanghai University of sport) (NO. 11DZ2261100), The National Natural Science Foundation of China (Grant No. 81170323). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARENGOLTS EI, 1994, BONE MINER, V26, P133, DOI 10.1016/S0169-6009(08)80058-X; BARENGOLTS EI, 1993, J BONE MINER RES, V8, P937; Campbell KL, 2007, CANCER EPIDEM BIOMAR, V16, P731, DOI 10.1158/1055-9965.EPI-06-0784; Carrillo-Lopez N, 2009, J AM SOC NEPHROL, V20, P2009, DOI 10.1681/ASN.2008121258; Chachra D, 2000, BIOMED SCI INSTRUM, V395, P123; Charatcharoenwitthaya N, 2007, J BONE MINER RES, V22, P724, DOI 10.1359/JBMR.070207; Chen YJ, 2011, EUR J APPL PHYSIOL, V111, P1759, DOI 10.1007/s00421-010-1820-0; Cummings SR, 2010, NEW ENGL J MED, V362, P686, DOI 10.1056/NEJMoa0808692; de Araujo RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066391; Denkert C, 2004, CLIN CANCER RES, V10, P5580, DOI 10.1158/1078-0432.CCR-04-0070; Doggrell SA, 2004, EXPERT OPIN PHARMACO, V5, P1635, DOI 10.1517/14656566.5.7.1635; Edwards CJ, 2010, OSTEOPOROSIS INT, V21, P1287, DOI 10.1007/s00198-010-1192-7; Evans EM, 2007, MENOPAUSE, V14, P481, DOI 10.1097/01.gme.0000243570.78570.f7; Gesty-Palmer D, 2011, BRIT J PHARMACOL, V164, P59, DOI 10.1111/j.1476-5381.2011.01450.x; Going S, 2003, OSTEOPOROSIS INT, V14, P637, DOI 10.1007/s00198-003-1436-x; Gong YS, 2006, J ASIAN NAT PROD RES, V8, P649, DOI 10.1080/10286020500246063; Inada Masaki, 2011, Clin Calcium, V21, P164, DOI CliCa1102164170; Iwamoto Jun, 1998, Keio Journal of Medicine, V47, P162; Joo YI, 2003, BONE, V33, P485, DOI 10.1016/S8756-3282(03)00212-6; Karsdal MA, 2008, BIODRUGS, V22, P137, DOI 10.2165/00063030-200822030-00001; Kemmler W, 2010, ARCH INTERN MED, V170, P179, DOI 10.1001/archinternmed.2009.499; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Lacey JV, 2002, JAMA-J AM MED ASSOC, V288, P334, DOI 10.1001/jama.288.3.334; LeBlanc A, 2013, OSTEOPOROSIS INT, V24, P2105, DOI 10.1007/s00198-012-2243-z; Liu M, 2012, CHINESE MED J-PEKING, V125, P1784, DOI 10.3760/cma.j.issn.0366-6999.2012.10.018; Liu SQ, 1996, CHINESE J PATHOL, V25, P49; Nakamura M, 2003, ENDOCRINOLOGY, V144, P5441, DOI 10.1210/en.2003-0717; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Nelson HD, 2002, JAMA-J AM MED ASSOC, V288, P872, DOI 10.1001/jama.288.7.872; Prestwood KM, 2003, JAMA-J AM MED ASSOC, V290, P1042, DOI 10.1001/jama.290.8.1042; PRICE PA, 1980, J CLIN INVEST, V66, P878, DOI 10.1172/JCI109954; Sakakura Y, 2001, J BONE MINER METAB, V19, P159, DOI 10.1007/s007740170036; SAVILLE PD, 1969, J AM GERIATR SOC, V17, P155, DOI 10.1111/j.1532-5415.1969.tb03169.x; Scott JPR, 2014, J CLIN ENDOCR METAB, V99, P1774, DOI 10.1210/jc.2013-3027; Steeve KT, 2004, CYTOKINE GROWTH F R, V15, P49, DOI 10.1016/j.cytogfr.2003.10.005; Subbaramaiah K, 2003, J BIOL CHEM, V278, P37637, DOI 10.1074/jbc.M301481200; Tromp AM, 2006, CALCIFIED TISSUE INT, V79, P404, DOI 10.1007/s00223-006-0045-z; Wallace BA, 2000, CALCIFIED TISSUE INT, V67, P10, DOI 10.1007/s00223001089; Winters-Stone KM, 2013, OSTEOPOROSIS INT, V24, P1637, DOI 10.1007/s00198-012-2143-2; Wood CE, 2012, TOXICOL PATHOL, V40, P55, DOI 10.1177/0192623311425509; Yuk TH, 2002, AM J CHINESE MED, V30, P95, DOI 10.1142/S0192415X02000119; Zhao X, 2011, J ETHNOPHARMACOL, V137, P1083, DOI 10.1016/j.jep.2011.07.017	42	45	49	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112845	10.1371/journal.pone.0112845	http://dx.doi.org/10.1371/journal.pone.0112845			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393283	Green Published, gold, Green Submitted			2022-12-27	WOS:000347709300112
J	Ma, XT; Tan, JJ; Su, M; Li, CH; Zhang, XY; Wang, CX				Ma, Xueting; Tan, Jianjun; Su, Min; Li, Chunhua; Zhang, Xiaoyi; Wang, Cunxin			Molecular Dynamics Studies of the Inhibitor C34 Binding to the Wild-Type and Mutant HIV-1 gp41: Inhibitory and Drug Resistant Mechanism	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; VIRAL MEMBRANE-FUSION; ENVELOPE GLYCOPROTEIN; TRANSMEMBRANE GLYCOPROTEIN; INTERHELICAL INTERACTIONS; ATOMIC-STRUCTURE; 6-HELIX BUNDLE; BASE-LINE; ENFUVIRTIDE; PEPTIDE	Mutations on NHR (N-terminal heptad repeat) associated with resistance to fusion inhibitor were observed. In addition, mutations on CHR (C-terminal heptad repeat) accompanied NHR mutations of gp41 are noted in many cases, like N43D/S138A double mutation. In this work, we explored the drug resistant mechanism of N43D mutation and the role of S138A second mutation in drug resistance. The binding modes of the wild type gp41 and the two mutants, N43D and N43D/S138A, with the HIV-1 fusion inhibitor C34, a 34-residue peptide mimicking CHR of gp41, were carried out by using molecular dynamics simulations. Based on the MD simulations, N43D mutation affects not only the stability of C34 binding, but also the binding energy of the inhibitor C34. Because N43D mutation may also affect the stable conformation of 6-HB, we introduced S138A second mutation into CHR of gp41 and determined the impact of this mutation. Through the comparative analysis of MD results of the N43D mutant and the N43D/S138A mutant, we found that CHR with S138A mutation shown more favorable affinity to NHR. Compelling differences in structures have been observed for these two mutants, particularly in the binding modes and in the hydrophobic interactions of the CHR (C34) located near the hydrophobic groove of the NHR. Because the conformational stability of 6-HB is important to HIV-1 infection, we suggested a hypothetical mechanism for the drug resistance: N43D single mutation not only impact the binding of inhibitor, but also affect the affinity between NHR and CHR of gp41, thus may reduce the rate of membrane fusion; compensatory mutation S138A would induce greater hydrophobic interactions between NHR and CHR, and render the CHR more compatible to NHR than inhibitors.	[Ma, Xueting; Tan, Jianjun; Su, Min; Li, Chunhua; Zhang, Xiaoyi; Wang, Cunxin] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing, Peoples R China	Beijing University of Technology	Tan, JJ (corresponding author), Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing, Peoples R China.	tanjianjun@bjut.edu.cn	Tan, Jianjun/E-5867-2011	Tan, Jianjun/0000-0003-3573-0807	Chinese Natural Science Foundation [21173014, 31100523, 31171267]	Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC))	The authors thank Chinese Natural Science Foundation project (No. 21173014, 31100523, and 31171267). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armand-Ugon M, 2005, VIROLOGY, V343, P141, DOI 10.1016/j.virol.2005.08.007; Armand-Ugon M, 2003, ANTIVIR RES, V59, P137, DOI 10.1016/S0166-3542(03)00071-8; Bai XF, 2008, BIOCHEMISTRY-US, V47, P6662, DOI 10.1021/bi702509d; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chong HH, 2012, J BIOL CHEM, V287, P34558, DOI 10.1074/jbc.M112.390393; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Follis KE, 2002, J VIROL, V76, P7356, DOI 10.1128/JVI.76.14.7356-7362.2002; Greenberg ML, 2004, J ANTIMICROB CHEMOTH, V54, P333, DOI 10.1093/jac/dkh330; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; He YX, 2008, J BIOL CHEM, V283, P11126, DOI 10.1074/jbc.M800200200; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Leung MYK, 2011, BIOPHYS J, V100, P1960, DOI 10.1016/j.bpj.2011.02.053; Li CY, 2003, COMPOS SCI TECHNOL, V63, P1517, DOI 10.1016/S0266-3538(03)00072-1; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; Lu J, 2004, J VIROL, V78, P4628, DOI 10.1128/JVI.78.9.4628-4637.2004; Lu M, 1997, J BIOMOL STRUCT DYN, V15, P465, DOI 10.1080/07391102.1997.10508958; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Lu M, 1999, J VIROL, V73, P4433, DOI 10.1128/JVI.73.5.4433-4438.1999; Lu M, 2001, J VIROL, V75, P11146, DOI 10.1128/JVI.75.22.11146-11156.2001; Luo R, 2002, J COMPUT CHEM, V23, P1244, DOI 10.1002/jcc.10120; Malashkevich VN, 1998, P NATL ACAD SCI USA, V95, P9134, DOI 10.1073/pnas.95.16.9134; Melby T, 2006, AIDS RES HUM RETROV, V22, P375, DOI 10.1089/aid.2006.22.375; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; MILTON RCD, 1992, SCIENCE, V256, P1445, DOI 10.1126/science.1604320; Mink M, 2005, J VIROL, V79, P12447, DOI 10.1128/JVI.79.19.12447-12454.2005; Nameki D, 2005, J VIROL, V79, P764, DOI 10.1128/JVI.79.2.764-770.2005; Ray N, 2009, J VIROL, V83, P2989, DOI 10.1128/JVI.02496-08; Reeves JD, 2005, J VIROL, V79, P4991, DOI 10.1128/JVI.79.8.4991-4999.2005; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sabin C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001195; Suntoke TR, 2005, J BIOL CHEM, V280, P19852, DOI 10.1074/jbc.M502196200; Tan JJ, 2010, DRUG DISCOV TODAY, V15, P186, DOI 10.1016/j.drudis.2010.01.004; Tan JJ, 2005, MOL SIMULAT, V31, P1051, DOI 10.1080/08927020500447132; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Wang RR, 2009, BIOCHEM BIOPH RES CO, V382, P540, DOI 10.1016/j.bbrc.2009.03.057; Watabe T, 2009, J MOL BIOL, V392, P657, DOI 10.1016/j.jmb.2009.07.027; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093; Xu L, 2005, ANTIMICROB AGENTS CH, V49, P1113, DOI 10.1128/AAC.49.3.1113-1119.2005	41	3	3	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e111923	10.1371/journal.pone.0111923	http://dx.doi.org/10.1371/journal.pone.0111923			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393106	Green Submitted, Green Published, gold			2022-12-27	WOS:000347709300025
J	Susser, S; Herrmann, E; Lange, C; Hamdi, N; Muller, T; Berg, T; Perner, D; Zeuzem, S; Sarrazin, C				Susser, Simone; Herrmann, Eva; Lange, Christian; Hamdi, Nabila; Mueller, Tobias; Berg, Thomas; Perner, Dany; Zeuzem, Stefan; Sarrazin, Christoph			Predictive Value of Interferon-Lambda Gene Polymorphisms for Treatment Response in Chronic Hepatitis C	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENOTYPE 1 INFECTION; VIRUS-INFECTION; VIROLOGICAL RESPONSE; TREATMENT FAILURE; STIMULATED GENES; INTERLEUKIN 28B; VIRAL CLEARANCE; IL28B GENOTYPE; HCV INFECTION	Background: IL28B gene polymorphism is the best baseline predictor of response to interferon alfa-based antiviral therapies in chronic hepatitis C. Recently, a new IFN-L4 polymorphism was identified as first potential functional variant for induction of IL28B expression. Individualization of interferon alfa-based therapies based on a combination of IL28B/IFN-L4 polymorphisms may help to optimize virologic outcome and economic resources. Methods: Optimization of treatment outcome prediction was assessed by combination of different IL28B and IFN-L4 polymorphisms in patients with chronic HCV genotype 1 (n = 385), 2/3 (n = 267), and 4 (n = 220) infection treated with pegylated interferon alfa (PEG-IFN) and ribavirin with (n = 79) or without telaprevir. Healthy people from Germany (n = 283) and Egypt (n = 96) served as controls. Results: Frequencies of beneficial IL28B rs12979860 C/C genotypes were lower in HCV genotype 1/4 infected patients in comparison to controls (20-35% vs. 46-47%) this was also true for ss469415590 TT/TT (20-35% vs. 45-47%). Single interferon-lambda SNPs (rs12979860, rs8099917, ss469415590) correlated with sustained virologic response (SVR) in genotype 1, 3, and 4 infected patients while no association was observed for genotype 2. Interestingly, in genotype 3 infected patients, best SVR prediction was based on IFN-L4 genotype. Prediction of SVR with high accuracy (71-96%) was possible in genotype 1, 2, 3 and 4 infected patients who received PEG-IFN/ribavirin combination therapy by selection of beneficial IL28B rs12979860 C/C and/or ss469415590 TT/TT genotypes (p<0.001). For triple therapy with first generation protease inhibitors (PIs) (boceprevir, telaprevir) prediction of high SVR (90%) rates was based on the presence of at least one beneficial genotype of the 3 IFN-lambda SNPs. Conclusion: IFN-L4 seems to be the best single predictor of SVR in genotype 3 infected patients. For optimized prediction of SVR by treatment with dual combination or first generation PI triple therapies, grouping of interferon-lambda haplotypes may be helpful with positive predictive values of 71-96%.	[Susser, Simone; Lange, Christian; Perner, Dany; Zeuzem, Stefan; Sarrazin, Christoph] Goethe Univ Hosp Frankfurt Main, Med Dept 1, Frankfurt, Germany; [Herrmann, Eva] Goethe Univ Hosp Frankfurt Main, Inst Biostat & Math Modeling, Frankfurt, Germany; [Hamdi, Nabila] German Univ Cairo, Dept Pharmacol & Toxicol, Cairo, Egypt; [Mueller, Tobias; Berg, Thomas] Univ Hosp Leipzig, Sect Hepatol, Gastroenterol Clin, Leipzig, Germany	Egyptian Knowledge Bank (EKB); German University in Cairo; Leipzig University	Sarrazin, C (corresponding author), Goethe Univ Hosp Frankfurt Main, Med Dept 1, Frankfurt, Germany.	sarrazin@em.uni-frankfurt.de	Hamdi, Nabila/AAF-2049-2020; Zeuzem, Stefan/AAE-7435-2019	Mueller, Tobias/0000-0003-3426-5421; Berg, Thomas/0000-0003-0003-6241				Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Bibert S, 2013, J EXP MED, V210, P1109, DOI 10.1084/jem.20130012; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Duong FHT, 2014, J EXP MED, V211, P857, DOI 10.1084/jem.20131557; Fischer J, 2012, HEPATOLOGY, V55, P1700, DOI 10.1002/hep.25582; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Heim MH, 2013, J HEPATOL, V58, P564, DOI 10.1016/j.jhep.2012.10.005; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Jimenez-Sousa MA, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-6; Lagging M, 2012, PHARMACOGENOMICS, V13, P847, DOI [10.2217/PGS.12.57, 10.2217/pgs.12.57]; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Mangia A, 2013, WORLD J GASTROENTERO, V19, P8924, DOI 10.3748/wjg.v19.i47.8924; Meissner EG, 2014, J INFECT DIS, V209, P1700, DOI 10.1093/infdis/jit827; Metz P, 2013, J HEPATOL, V59, P1331, DOI 10.1016/j.jhep.2013.07.033; Nelson DR, 2013, J HEPATOL, V58, pS362, DOI 10.1016/S0168-8278(13)60883-1; Pearlman BL, 2014, HEPATOLOGY, V59, P71, DOI 10.1002/hep.26624; Pol S, 2013, J HEPATOL, V58, P883, DOI 10.1016/j.jhep.2012.12.023; Poordad F, 2012, GASTROENTEROLOGY, V143, P608, DOI 10.1053/j.gastro.2012.05.011; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Sarrazin C, 2011, GASTROENTEROLOGY, V141, P1656, DOI 10.1053/j.gastro.2011.07.019; Sarrazin C, 2011, J HEPATOL, V54, P415, DOI 10.1016/j.jhep.2010.07.041; Schreiber J, 2012, ALIMENT PHARM THER, V36, P353, DOI 10.1111/j.1365-2036.2012.05197.x; Shemis MA, 2012, HEPAT MON, V12, P265, DOI 10.5812/hepatmon.830; Stattermayer AF, 2014, ALIMENT PHARM THER, V39, P104, DOI 10.1111/apt.12547; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; World Health Organization, 2013, HEP C FACT SHEET 164; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	38	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112592	10.1371/journal.pone.0112592	http://dx.doi.org/10.1371/journal.pone.0112592			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393304	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300077
J	Casellato, C; Antonietti, A; Garrido, JA; Carrillo, RR; Luque, NR; Ros, E; Pedrocchi, A; D'Angelo, E				Casellato, Claudia; Antonietti, Alberto; Garrido, Jesus A.; Carrillo, Richard R.; Luque, Niceto R.; Ros, Eduardo; Pedrocchi, Alessandra; D'Angelo, Egidio			Adaptive Robotic Control Driven by a Versatile Spiking Cerebellar Network	PLOS ONE			English	Article							VESTIBULO-OCULAR-REFLEX; NEURAL-NETWORKS; INFERIOR OLIVE; PURKINJE-CELLS; MODEL; NEURONS; SIMULATION; OSCILLATIONS; STIMULATION; ADAPTATION	The cerebellum is involved in a large number of different neural processes, especially in associative learning and in fine motor control. To develop a comprehensive theory of sensorimotor learning and control, it is crucial to determine the neural basis of coding and plasticity embedded into the cerebellar neural circuit and how they are translated into behavioral outcomes in learning paradigms. Learning has to be inferred from the interaction of an embodied system with its real environment, and the same cerebellar principles derived from cell physiology have to be able to drive a variety of tasks of different nature, calling for complex timing and movement patterns. We have coupled a realistic cerebellar spiking neural network (SNN) with a real robot and challenged it in multiple diverse sensorimotor tasks. Encoding and decoding strategies based on neuronal firing rates were applied. Adaptive motor control protocols with acquisition and extinction phases have been designed and tested, including an associative Pavlovian task (Eye blinking classical conditioning), a vestibulo-ocular task and a perturbed arm reaching task operating in closed-loop. The SNN processed in real-time mossy fiber inputs as arbitrary contextual signals, irrespective of whether they conveyed a tone, a vestibular stimulus or the position of a limb. A bidirectional long-term plasticity rule implemented at parallel fibers-Purkinje cell synapses modulated the output activity in the deep cerebellar nuclei. In all tasks, the neurorobot learned to adjust timing and gain of the motor responses by tuning its output discharge. It succeeded in reproducing how human biological systems acquire, extinguish and express knowledge of a noisy and changing world. By varying stimuli and perturbations patterns, real-time control robustness and generalizability were validated. The implicit spiking dynamics of the cerebellar model fulfill timing, prediction and learning functions.	[Casellato, Claudia; Antonietti, Alberto; Pedrocchi, Alessandra] Politecn Milan, Dept Elect Informat & Bioengn, NeuroEngn & Med Robot Lab, I-20133 Milan, Italy; [Antonietti, Alberto; Garrido, Jesus A.; D'Angelo, Egidio] Brain Connect Ctr, Ist Ricovero & Cura Carattere Sci, Ist Neurol Nazl Casimiro Mondino, Pavia, Italy; [Garrido, Jesus A.; D'Angelo, Egidio] Univ Pavia, Dept Brain & Behav Sci, I-27100 Pavia, Italy; [Carrillo, Richard R.; Luque, Niceto R.; Ros, Eduardo] Univ Granada, Escuela Tecn Super Ingn Informat & Telecomunca, Granada, Spain	Polytechnic University of Milan; IRCCS Fondazione Casimiro Mondino; University of Pavia; University of Granada	Casellato, C (corresponding author), Politecn Milan, Dept Elect Informat & Bioengn, NeuroEngn & Med Robot Lab, I-20133 Milan, Italy.	claudia.casellato@polimi.it; dangelo@unipv.it	Ros, Eduardo/B-1107-2012; Garrido, Jesus A/J-3892-2014; Pedrocchi, Alessandra/A-6634-2012; D'Angelo, Egidio/AAC-3846-2022; Antonietti, Alberto/M-8981-2014; Pedrocchi, Alessandra/AAF-2655-2019; Luque, Niceto Rafael/AAK-7407-2020	Ros, Eduardo/0000-0001-6613-5256; Garrido, Jesus A/0000-0001-6648-7075; Pedrocchi, Alessandra/0000-0001-9957-2786; D'Angelo, Egidio/0000-0002-6007-7187; Antonietti, Alberto/0000-0003-0388-6321; Pedrocchi, Alessandra/0000-0001-9957-2786; Luque, Niceto Rafael/0000-0002-0626-5048; Carrillo, Richard R./0000-0003-3359-4565; casellato, claudia/0000-0002-8729-0391	European Union (Human Brain Project) [REALNET FP7-ICT270434, CEREBNET FP7-ITN238686, HBP-604102]	European Union (Human Brain Project)	The study design, data collection and analysis were supported by European Union grants [REALNET FP7-ICT270434, CEREBNET FP7-ITN238686, Human Brain Project HBP-604102] to ED, AP and ER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Bahro M, 1995, PSYCHOPHARMACOLOGY, V122, P395, DOI 10.1007/BF02246273; Batllori R, 2011, PROCEDIA COMPUT SCI, V6, DOI 10.1016/j.procs.2011.08.060; Bouganis A., 2010, 2010 INT JOINT C NEU, P1, DOI DOI 10.1109/IJCNN.2010.5596525; Boyden ES, 2004, NEUROSCIENCE, V27; Bracha V, 2000, BRAIN RES, V860, P87, DOI 10.1016/S0006-8993(00)01995-8; Bruderle D, 2011, BIOL CYBERN, V104, P263, DOI 10.1007/s00422-011-0435-9; Carrillo RR, 2008, BIOSYSTEMS, V94, P18, DOI 10.1016/j.biosystems.2008.05.008; Casellato Claudia, 2013, IJCCI 2013. 5th International Joint Conference on Computational Intelligence. Proceedings, P568; Cheron G, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/853654; Chettih SN, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00072; Clopath C, 2014, J NEUROSCI, V34, P7203, DOI 10.1523/JNEUROSCI.2791-13.2014; D'Angelo E, 2005, LECT NOTES COMPUT SC, V3512, P107; D'Angelo E, 2009, NEUROSCIENCE, V162, P805, DOI 10.1016/j.neuroscience.2009.01.048; D'Angelo E, 2013, FUNCT NEUROL, V28, P153, DOI 10.11138/FNeur/2013.28.3.153; Day JJ, 2006, EUR J NEUROSCI, V23, P1341, DOI 10.1111/j.1460-9568.2006.04654.x; de Gruijl JR, 2009, NEUROSCIENCE, V162, P777, DOI 10.1016/j.neuroscience.2009.02.041; Gamez D, 2010, CONSCIOUS COGN, V19, P294, DOI 10.1016/j.concog.2009.11.001; Gao ZY, 2012, NAT REV NEUROSCI, V13, P619, DOI 10.1038/nrn3312; Garrido JA, 2013, BMC NEUROSCI, V14, pP81, DOI DOI 10.1186/1471-2202-14-S1-P81; Garrido JA, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00159; Gerstner W, 2002, SPIKING NEURON MODEL; Gerwig M, 2005, J NEUROSCI, V25, P3919, DOI 10.1523/JNEUROSCI.0266-05.2005; Hagras H, 2004, IEEE INT CONF ROBOT, P4620, DOI 10.1109/ROBOT.2004.1302446; Herreros I, 2013, NEURAL NETWORKS, V47, P64, DOI 10.1016/j.neunet.2013.01.026; Hoffland BS, 2012, J PHYSIOL-LONDON, V590, P887, DOI 10.1113/jphysiol.2011.218537; Hofstotter C, 2002, EUR J NEUROSCI, V16, P1361, DOI 10.1046/j.1460-9568.2002.02182.x; Indiveri GC, 1999, IEEE T CIRCUITS-II, V46, P1337, DOI 10.1109/82.803473; ITO M, 1978, EXP BRAIN RES, V33, P143; ITO M, 1982, ANNU REV NEUROSCI, V5, P275, DOI 10.1146/annurev.ne.05.030182.001423; Ito M, 1997, INT REV NEUROBIOL, V41, P475, DOI 10.1016/S0074-7742(08)60366-9; Ito M, 2011, UNDERSTANDING STRETC, V44, P435; Ivry R B, 1992, Curr Opin Neurobiol, V2, P212, DOI 10.1016/0959-4388(92)90015-D; Jaeger D, 2003, J COMPUT NEUROSCI, V14, P311, DOI 10.1023/A:1023217111784; Kimpo RR, 2005, J NEUROPHYSIOL, V94, P3092, DOI 10.1152/jn.00048.2005; Lang EJ, 1999, J NEUROSCI, V19, P2728; Lazdins E., 2011, P INT WORKSH BIOINSP; Lenz A, 2009, IEEE T SYST MAN CY B, V39, P1420, DOI 10.1109/TSMCB.2009.2018138; Lepora NF, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00140; Lu J, 2011, J NEUROSCI, V31, P15065, DOI 10.1523/JNEUROSCI.2364-11.2011; Luque NR, 2011, INT J NEURAL SYST, V21, P385, DOI 10.1142/S0129065711002900; Luque NR, 2012, INT J NEURAL SYST, V22, DOI 10.1142/S012906571250013X; Luque NR, 2011, IEEE T NEURAL NETWOR, V22, P1321, DOI 10.1109/TNN.2011.2156809; Maass W, 1997, NEURAL NETWORKS, V10, P1659, DOI 10.1016/S0893-6080(97)00011-7; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Masuda N, 2008, J COMPUT NEUROSCI, V24, P137, DOI 10.1007/s10827-007-0045-7; Mathy A, 2009, NEURON, V62, P388, DOI 10.1016/j.neuron.2009.03.023; MAUK MD, 1986, P NATL ACAD SCI USA, V83, P5349, DOI 10.1073/pnas.83.14.5349; McKinstry JL, 2006, P NATL ACAD SCI USA, V103, P3387, DOI 10.1073/pnas.0511281103; Medina JF, 2001, J NEUROSCI, V21, P4081, DOI 10.1523/JNEUROSCI.21-11-04081.2001; Medina JF, 2000, CURR OPIN NEUROBIOL, V10, P717, DOI 10.1016/S0959-4388(00)00154-9; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Naveros F, 2013, BMC NEUROSCI, V14, pP328; Nolfi S, 2002, TRENDS COGN SCI, V6, P31, DOI 10.1016/S1364-6613(00)01812-X; Porrill J, 2007, PLOS COMPUT BIOL, V3, P1935, DOI 10.1371/journal.pcbi.0030197; Luque NR, 2011, IEEE T SYST MAN CY B, V41, P1299, DOI 10.1109/TSMCB.2011.2138693; Rasmussen A, 2013, J NEUROSCI, V33, P13436, DOI 10.1523/JNEUROSCI.1527-13.2013; Ros E, 2006, NEURAL COMPUT, V18, P2959, DOI 10.1162/neco.2006.18.12.2959; Sarlegna FR, 2010, NEUROPSYCHOLOGIA, V48, P60, DOI 10.1016/j.neuropsychologia.2009.08.011; Scheidt RA, 2000, J NEUROPHYSIOL, V84, P853, DOI 10.1152/jn.2000.84.2.853; Schemmel J, 2007, IEEE INT SYMP CIRC S, P3367, DOI 10.1109/ISCAS.2007.378289; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Sharp T, 2011, LECT NOTES COMPUT SC, V7064, P424, DOI 10.1007/978-3-642-24965-5_48; Shibuki K, 1996, NEURON, V16, P587, DOI 10.1016/S0896-6273(00)80078-1; Simpson JI, 1996, BEHAV BRAIN SCI, V19, P384, DOI 10.1017/S0140525X00081486; Solinas S, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00012; Spoelstra J, 2000, BIOL CYBERN, V82, P321, DOI 10.1007/s004220050586; Spoelstra J, 2001, AUTON ROBOT, V11, P273, DOI 10.1023/A:1012447225242; STONE LS, 1990, J NEUROPHYSIOL, V63, P1241, DOI 10.1152/jn.1990.63.5.1241; Thompson RF, 2009, NEUROSCIENCE, V162, P732, DOI 10.1016/j.neuroscience.2009.01.041; Trhan P, 2010, COMPUTING INFORM, V29; TYRRELL T, 1992, PHILOS T ROY SOC B, V336, P239, DOI 10.1098/rstb.1992.0059; van der Smagt P, 2000, ROBOT AUTON SYST, V32, P237, DOI 10.1016/S0921-8890(00)00090-7; Verschure P, 1999, BILDUNG ERZIEHUNG, V52, P317; Vijayakumar S, 2005, NEURAL COMPUT, V17, P2602, DOI 10.1162/089976605774320557; Voegtlin T, 1999, REV NEUROSCIENCE, V10, P291; WELSH JP, 1991, J PHYSIOL-LONDON, V444, P459, DOI 10.1113/jphysiol.1991.sp018888; Yamamoto K, 2007, J NEUROPHYSIOL, V97, P1588, DOI 10.1152/jn.00206.2006; Yamazaki T, 2007, NEURAL NETWORKS, V20, P290, DOI 10.1016/j.neunet.2007.04.004; Yamazaki T, 2013, NEURAL NETWORKS, V47, P103, DOI 10.1016/j.neunet.2013.01.019; Yamazaki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033319	81	47	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112265	10.1371/journal.pone.0112265	http://dx.doi.org/10.1371/journal.pone.0112265			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390365	Green Submitted, Green Published, gold			2022-12-27	WOS:000349144400067
J	Estevez, S; Marrero, MT; Quintana, J; Estevez, F				Estevez, Sara; Teresa Marrero, Maria; Quintana, Jose; Estevez, Francisco			Eupatorin-Induced Cell Death in Human Leukemia Cells Is Dependent on Caspases and Activates the Mitogen-Activated Protein Kinase Pathway	PLOS ONE			English	Article							MAPK PATHWAY; APOPTOSIS; CANCER; FLAVONOIDS; CONSTITUENTS; METABOLISM; CLEAVAGE; THERAPY	Eupatorin is a naturally occurring flavone that inhibits cell proliferation in human tumor cells. Here we demonstrate that eupatorin arrests cells at the G(2)-M phase of the cell cycle and induces apoptotic cell death involving activation of multiple caspases, mitochondrial release of cytochrome c and poly(ADP-ribose) polymerase cleavage in human leukemia cells. This flavonoid induced the phosphorylation of members of the mitogen-activated protein kinases and cell death was attenuated by inhibition of c-jun N-terminal kinases/stress activated protein kinases. Eupatorin-induced cell death is mediated by both the extrinsic and the intrinsic apoptotic pathways and through a mechanism dependent on reactive oxygen species generation.	[Estevez, Sara; Teresa Marrero, Maria; Quintana, Jose; Estevez, Francisco] Univ Las Palmas Gran Canaria, Dept Biochem & Mol Biol, Las Palmas Gran Canaria, Spain	Universidad de Las Palmas de Gran Canaria	Estevez, F (corresponding author), Univ Las Palmas Gran Canaria, Dept Biochem & Mol Biol, Las Palmas Gran Canaria, Spain.	francisco.estevez@ulpgc.es	Quintana, José/K-5709-2014; Estévez, Francisco/K-5125-2014	Quintana, José/0000-0001-8225-4538; Estévez, Francisco/0000-0002-9728-2774	Spanish Ministry of Science and Innovation [SAF2010-21380]; European Regional Development Fund	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund(European Commission)	This work was supported by a grant (number: SAF2010-21380) from the Spanish Ministry of Science and Innovation and European Regional Development Fund (URL: www.micinn.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson SA, 2000, CANCER RES, V60, P6101; Androutsopoulos V, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2090; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bellows DS, 2000, J VIROL, V74, P5024, DOI 10.1128/JVI.74.11.5024-5031.2000; Benov L, 1998, FREE RADICAL BIO MED, V25, P826, DOI 10.1016/S0891-5849(98)00163-4; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; DIVE C, 1991, BRIT J CANCER, V64, P192, DOI 10.1038/bjc.1991.269; FISHER DE, 1994, CELL, V78, P539, DOI 10.1016/0092-8674(94)90518-5; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Havsteen BH, 2002, PHARMACOL THERAPEUT, V96, P67, DOI 10.1016/S0163-7258(02)00298-X; HICKMAN JA, 1992, CANCER METAST REV, V11, P121, DOI 10.1007/BF00048059; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Nagao T, 2002, BIOL PHARM BULL, V25, P875, DOI 10.1248/bpb.25.875; Norberg E, 2010, BIOCHEM BIOPH RES CO, V396, P95, DOI 10.1016/j.bbrc.2010.02.163; Olsson M, 2011, CELL DEATH DIFFER, V18, P1441, DOI 10.1038/cdd.2011.30; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Ramos S, 2007, J NUTR BIOCHEM, V18, P427, DOI 10.1016/j.jnutbio.2006.11.004; Ravishankar D, 2013, INT J BIOCHEM CELL B, V45, P2821, DOI 10.1016/j.biocel.2013.10.004; Rubio S, 2007, CARCINOGENESIS, V28, P2105, DOI 10.1093/carcin/bgm131; Sarig R, 2003, J BIOL CHEM, V278, P10707, DOI 10.1074/jbc.M210296200; Schinella GR, 1998, J PHARM PHARMACOL, V50, P1069, DOI 10.1111/j.2042-7158.1998.tb06924.x; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tezuka Y, 2000, CHEM PHARM BULL, V48, P1711, DOI 10.1248/cpb.48.1711; Torres F, 2008, APOPTOSIS, V13, P716, DOI 10.1007/s10495-008-0202-0; Torres F, 2010, MOL CARCINOGEN, V49, P464, DOI 10.1002/mc.20619; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wood DE, 2000, EXP CELL RES, V256, P375, DOI 10.1006/excr.2000.4859	30	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112536	10.1371/journal.pone.0112536	http://dx.doi.org/10.1371/journal.pone.0112536			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390937	Green Submitted, gold, Green Published			2022-12-27	WOS:000349144400093
J	Khan, S; Greco, D; Michailidou, K; Milne, RL; Muranen, TA; Heikkinen, T; Aaltonen, K; Dennis, J; Bolla, MK; Liu, J; Hall, P; Irwanto, A; Humphreys, K; Li, J; Czene, K; Chang-Claude, J; Hein, R; Rudolph, A; Seibold, P; Flesch-Janys, D; Fletcher, O; Peto, J; Silva, ID; Johnson, N; Gibson, L; Aitken, Z; Hopper, JL; Tsimiklis, H; Bui, M; Makalic, E; Schmidt, DF; Southey, MC; Apicella, C; Stone, J; Waisfisz, Q; Meijers-Heijboer, H; Adank, MA; van der Luijt, RB; Meindl, A; Schmutzler, RK; Muller-Myhsok, B; Lichtner, P; Turnbull, C; Rahman, N; Chanock, SJ; Hunter, DJ; Cox, A; Cross, SS; Reed, MWR; Schmidt, MK; Broeks, A; Van't Veer, LJ; Hogervorst, FB; Fasching, PA; Schrauder, MG; Ekici, AB; Beckmann, MW; Bojesen, SE; Nordestgaard, BG; Nielsen, SF; Flyger, H; Benitez, J; Zamora, PM; Perez, JIA; Haiman, CA; Henderson, BE; Schumacher, F; Le Marchand, L; Pharoah, PDP; Dunning, AM; Shah, M; Luben, R; Brown, J; Couch, FJ; Wang, X; Vachon, C; Olson, JE; Lambrechts, D; Moisse, M; Paridaens, R; Christiaens, MR; Guenel, P; Truong, T; Laurent-Puig, P; Mulot, C; Marme, F; Burwinkel, B; Schneeweiss, A; Sohn, C; Sawyer, EJ; Tomlinson, I; Kerin, MJ; Miller, N; Andrulis, IL; Knight, JA; Tchatchou, S; Mulligan, AM; Dork, T; Bogdanova, NV; Antonenkova, NN; Anton-Culver, H; Darabi, H; Eriksson, M; Garcia-Closas, M; Figueroa, J; Lissowska, J; Brinton, L; Devilee, P; Tollenaar, RAEM; Seynaeve, C; van Asperen, CJ; Kristensen, VN; Slager, S; Toland, AE; Ambrosone, CB; Yannoukakos, D; Lindblom, A; Margolin, S; Radice, P; Peterlongo, P; Barile, M; Mariani, P; Hooning, MJ; Martens, JWM; Collee, JM; Jager, A; Jakubowska, A; Lubinski, J; Jaworska-Bieniek, K; Durda, K; Giles, GG; McLean, C; Brauch, H; Bruning, T; Ko, YD; Brenner, H; Dieffenbach, AK; Arndt, V; Stegmaier, C; Swerdlow, A; Ashworth, A; Orr, N; Jones, M; Simard, J; Goldberg, MS; Labreche, F; Dumont, M; Winqvist, R; Pylkas, K; Jukkola-Vuorinen, A; Grip, M; Kataja, V; Kosma, VM; Hartikainen, JM; Mannermaa, A; Hamann, U; Chenevix-Trench, G; Blomqvist, C; Aittomaki, K; Easton, DF; Nevanlinna, H				Khan, Sofia; Greco, Dario; Michailidou, Kyriaki; Milne, Roger L.; Muranen, Taru A.; Heikkinen, Tuomas; Aaltonen, Kirsimari; Dennis, Joe; Bolla, Manjeet K.; Liu, Jianjun; Hall, Per; Irwanto, Astrid; Humphreys, Keith; Li, Jingmei; Czene, Kamila; Chang-Claude, Jenny; Hein, Rebecca; Rudolph, Anja; Seibold, Petra; Flesch-Janys, Dieter; Fletcher, Olivia; Peto, Julian; Silva, Isabel dos Santos; Johnson, Nichola; Gibson, Lorna; Aitken, Zoe; Hopper, John L.; Tsimiklis, Helen; Bui, Minh; Makalic, Enes; Schmidt, Daniel F.; Southey, Melissa C.; Apicella, Carmel; Stone, Jennifer; Waisfisz, Quinten; Meijers-Heijboer, Hanne; Adank, Muriel A.; van der Luijt, Rob B.; Meindl, Alfons; Schmutzler, Rita K.; Muller-Myhsok, Bertram; Lichtner, Peter; Turnbull, Clare; Rahman, Nazneen; Chanock, Stephen J.; Hunter, David J.; Cox, Angela; Cross, Simon S.; Reed, Malcolm W. R.; Schmidt, Marjanka K.; Broeks, Annegien; Van't Veer, Laura J.; Hogervorst, Frans B.; Fasching, Peter A.; Schrauder, Michael G.; Ekici, Arif B.; Beckmann, Matthias W.; Bojesen, Stig E.; Nordestgaard, Borge G.; Nielsen, Sune F.; Flyger, Henrik; Benitez, Javier; Zamora, Pilar M.; Perez, Jose I. A.; Haiman, Christopher A.; Henderson, Brian E.; Schumacher, Fredrick; Le Marchand, Loic; Pharoah, Paul D. P.; Dunning, Alison M.; Shah, Mitul; Luben, Robert; Brown, Judith; Couch, Fergus J.; Wang, Xianshu; Vachon, Celine; Olson, Janet E.; Lambrechts, Diether; Moisse, Matthieu; Paridaens, Robert; Christiaens, Marie-Rose; Guenel, Pascal; Truong, Therese; Laurent-Puig, Pierre; Mulot, Claire; Marme, Frederick; Burwinkel, Barbara; Schneeweiss, Andreas; Sohn, Christof; Sawyer, Elinor J.; Tomlinson, Ian; Kerin, Michael J.; Miller, Nicola; Andrulis, Irene L.; Knight, Julia A.; Tchatchou, Sandrine; Mulligan, Anna Marie; Dork, Thilo; Bogdanova, Natalia V.; Antonenkova, Natalia N.; Anton-Culver, Hoda; Darabi, Hatef; Eriksson, Mikael; Garcia-Closas, Montserrat; Figueroa, Jonine; Lissowska, Jolanta; Brinton, Louise; Devilee, Peter; Tollenaar, Robert A. E. M.; Seynaeve, Caroline; van Asperen, Christi J.; Kristensen, Vessela N.; Slager, Susan; Toland, Amanda E.; Ambrosone, Christine B.; Yannoukakos, Drakoulis; Lindblom, Annika; Margolin, Sara; Radice, Paolo; Peterlongo, Paolo; Barile, Monica; Mariani, Paolo; Hooning, Maartje J.; Martens, John W. M.; Collee, J. Margriet; Jager, Agnes; Jakubowska, Anna; Lubinski, Jan; Jaworska-Bieniek, Katarzyna; Durda, Katarzyna; Giles, Graham G.; McLean, Catriona; Brauch, Hiltrud; Bruning, Thomas; Ko, Yon-Dschun; Brenner, Hermann; Dieffenbach, Aida Karina; Arndt, Volker; Stegmaier, Christa; Swerdlow, Anthony; Ashworth, Alan; Orr, Nick; Jones, Michael; Simard, Jacques; Goldberg, Mark S.; Labreche, France; Dumont, Martine; Winqvist, Robert; Pylkas, Katri; Jukkola-Vuorinen, Arja; Grip, Mervi; Kataja, Vesa; Kosma, Veli-Matti; Hartikainen, Jaana M.; Mannermaa, Arto; Hamann, Ute; Chenevix-Trench, Georgia; Blomqvist, Carl; Aittomaki, Kristiina; Easton, Douglas F.; Nevanlinna, Heli		KConFab Investigators; Australian Ovarian Canc Study Grp; GENICA Network	MicroRNA Related Polymorphisms and Breast Cancer Risk	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SINGLE-NUCLEOTIDE POLYMORPHISMS; BINDING-SITES; COMMON VARIANT; REDUCED RISK; IDENTIFIES 3; HUMAN GENES; CASP8 GENE; SUSCEPTIBILITY; EXPRESSION	Genetic variations, such as single nucleotide polymorphisms (SNPs) in microRNAs (miRNA) or in the miRNA binding sites may affect the miRNA dependent gene expression regulation, which has been implicated in various cancers, including breast cancer, and may alter individual susceptibility to cancer. We investigated associations between miRNA related SNPs and breast cancer risk. First we evaluated 2,196 SNPs in a case-control study combining nine genome wide association studies (GWAS). Second, we further investigated 42 SNPs with suggestive evidence for association using 41,785 cases and 41,880 controls from 41 studies included in the Breast Cancer Association Consortium (BCAC). Combining the GWAS and BCAC data within a meta-analysis, we estimated main effects on breast cancer risk as well as risks for estrogen receptor (ER) and age defined subgroups. Five miRNA binding site SNPs associated significantly with breast cancer risk: rs1045494 (odds ratio (OR) 0.92; 95% confidence interval (CI): 0.88-0.96), rs1052532 (OR 0.97; 95% CI: 0.95-0.99), rs10719 (OR 0.97; 95% CI: 0.94-0.99), rs4687554 (OR 0.97; 95% CI: 0.95-0.99, and rs3134615 (OR 1.03; 95% CI: 1.01-1.05) located in the 3' UTR of CASP8, HDDC3, DROSHA, MUSTN1, and MYCL1, respectively. DROSHA belongs to miRNA machinery genes and has a central role in initial miRNA processing. The remaining genes are involved in different molecular functions, including apoptosis and gene expression regulation. Further studies are warranted to elucidate whether the miRNA binding site SNPs are the causative variants for the observed risk effects.	[Khan, Sofia; Greco, Dario; Muranen, Taru A.; Heikkinen, Tuomas; Aaltonen, Kirsimari; Nevanlinna, Heli] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Khan, Sofia; Greco, Dario; Muranen, Taru A.; Heikkinen, Tuomas; Aaltonen, Kirsimari; Nevanlinna, Heli] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Greco, Dario] Finnish Inst Occupat Hlth, Helsinki, Finland; [Michailidou, Kyriaki; Dennis, Joe; Bolla, Manjeet K.; Pharoah, Paul D. P.; Brown, Judith; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England; [Milne, Roger L.; Giles, Graham G.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Australia; [Milne, Roger L.; Giles, Graham G.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Australia; [Aaltonen, Kirsimari; Aittomaki, Kristiina] Univ Helsinki, Dept Clin Genet, Helsinki, Finland; [Aaltonen, Kirsimari; Blomqvist, Carl; Aittomaki, Kristiina] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Aaltonen, Kirsimari; Blomqvist, Carl] Univ Helsinki, Dept Oncol, Helsinki, Finland; [Liu, Jianjun; Irwanto, Astrid; Li, Jingmei] Genome Inst Singapore, Div Human Genet, Singapore, Singapore; [Hall, Per; Humphreys, Keith; Czene, Kamila; Darabi, Hatef; Eriksson, Mikael] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Chang-Claude, Jenny; Hein, Rebecca; Rudolph, Anja; Seibold, Petra] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Hein, Rebecca] Univ Cologne, Dept Child & Adolescent Psychiat & Psychotherapy, PMV Res Grp, D-50931 Cologne, Germany; [Flesch-Janys, Dieter] Univ Clin Hamburg Eppendorf, Dept Canc Epidemiol, Clin Canc Registry, Hamburg, Germany; [Flesch-Janys, Dieter] Univ Clin Hamburg Eppendorf, Inst Med Biometr & Epidemiol, Hamburg, Germany; [Fletcher, Olivia; Johnson, Nichola; Ashworth, Alan; Orr, Nick] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Peto, Julian; Silva, Isabel dos Santos; Gibson, Lorna; Aitken, Zoe] London Sch Hyg & Trop Med, Dept Non Communicable Dis Epidemiol Dept, London WC1, England; [Hopper, John L.; Bui, Minh; Makalic, Enes; Schmidt, Daniel F.; Apicella, Carmel; Stone, Jennifer] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Biostat & Epidemiol, Melbourne, Australia; [Tsimiklis, Helen; Southey, Melissa C.] Univ Melbourne, Dept Pathol, Melbourne, Australia; [Waisfisz, Quinten; Meijers-Heijboer, Hanne; Adank, Muriel A.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [van der Luijt, Rob B.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Meindl, Alfons] Tech Univ Munich, Div Gynaecol & Obstet, D-80290 Munich, Germany; [Schmutzler, Rita K.] Univ Hosp, Dept Obstet & Gynaecol, Div Mol Gynecooncol, Cologne, Germany; [Schmutzler, Rita K.] Univ Hosp, Ctr Familial Breast & Ovarian Canc, Cologne, Germany; [Schmutzler, Rita K.] Univ Hosp, CIO, Cologne, Germany; [Schmutzler, Rita K.] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Muller-Myhsok, Bertram] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Lichtner, Peter] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Human Genet, Neuherberg, Germany; [Turnbull, Clare; Rahman, Nazneen] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Chanock, Stephen J.; Figueroa, Jonine; Brinton, Louise] Natl Canc Inst, Div Canc Epidemiol & Genet, Rockville, MD USA; [Hunter, David J.] Harvard Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA USA; [Hunter, David J.] Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Cox, Angela; Reed, Malcolm W. R.] Univ Sheffield, Dept Oncol, CRUK YCR Sheffield Canc Res Ctr, Sheffield, S Yorkshire, England; [Cross, Simon S.] Univ Sheffield, Dept Neurosci, Acad Unit Pathol, Sheffield, S Yorkshire, England; [Schmidt, Marjanka K.; Broeks, Annegien; Van't Veer, Laura J.; Hogervorst, Frans B.] Antoni Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands; [Fasching, Peter A.; Schrauder, Michael G.; Beckmann, Matthias W.] Univ Erlangen Nurnberg, Univ Breast Ctr Franconia, Dept Gynecol & Obstet, Univ Hosp Erlangen,Comprehens Canc Canc Erlangen, D-91054 Erlangen, Germany; [Fasching, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Ekici, Arif B.] Univ Erlangen Nurnberg, Inst Human Genet, Univ Hosp Erlangen, Comprehens Canc Ctr Erlangen EMN, D-91054 Erlangen, Germany; [Bojesen, Stig E.; Nordestgaard, Borge G.; Nielsen, Sune F.] Herlev Hosp, Copenhagen Univ Hosp, Copenhagen, Denmark; [Bojesen, Stig E.; Nordestgaard, Borge G.; Nielsen, Sune F.] Herlev Hosp, Copenhagen Univ Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Flyger, Henrik] Copenhagen Univ Hosp, Herlev Hosp, Dept Breast Surg, Copenhagen, Denmark; [Benitez, Javier] Spanish Natl Canc Res Ctr CNIO, Human Canc Genet Program, Human Genet Grp, Madrid, Spain; [Benitez, Javier] Centro Invest Red Enfermedades Raras CIBERER, Valencia, Spain; [Zamora, Pilar M.] Hosp Univ La Paz, Serv Oncol Med, Madrid, Spain; [Perez, Jose I. A.] Hosp Monte Naranco, Serv Cirugia Gen & Especialidades, Oviedo, Spain; [Haiman, Christopher A.; Henderson, Brian E.; Schumacher, Fredrick] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Le Marchand, Loic] Univ Hawaii, Canc Res Ctr, Program Epidemiol, Honolulu, HI 96822 USA; [Pharoah, Paul D. P.; Dunning, Alison M.; Shah, Mitul; Easton, Douglas F.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Oncol, Cambridge, England; [Luben, Robert] Univ Cambridge, Dept Publ Hlth & Primary Care, Clin Gerontol, Cambridge, England; [Couch, Fergus J.; Wang, Xianshu] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Vachon, Celine; Olson, Janet E.; Slager, Susan] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Lambrechts, Diether; Moisse, Matthieu] VIB, VRC, Leuven, Belgium; [Lambrechts, Diether; Moisse, Matthieu] Univ Leuven, Dept Oncol, Lab Translat Genet, Leuven, Belgium; [Paridaens, Robert; Christiaens, Marie-Rose] Univ Hosp Gasthuisberg, Dept Oncol, Leuven, Belgium; [Guenel, Pascal; Truong, Therese] INSERM, Ctr Res Epidemiol & Populat Health, Natl Inst Hlth & Med Res, CESP,U1018, Villejuif, France; [Guenel, Pascal; Truong, Therese] Univ Paris Sud, UMRS 1018, Villejuif, France; [Laurent-Puig, Pierre; Mulot, Claire] Univ Paris Sorbonne Cite, INSERM, UMR S775, Paris, France; [Marme, Frederick; Burwinkel, Barbara; Schneeweiss, Andreas; Sohn, Christof] Heidelberg Univ, Dept Obstet & Gynecol, Heidelberg, Germany; [Marme, Frederick; Schneeweiss, Andreas] Heidelberg Univ, Natl Ctr Tumor Dis, Heidelberg, Germany; [Burwinkel, Barbara] German Canc Res Ctr, Mol Epidemiol Grp, Heidelberg, Germany; [Sawyer, Elinor J.] Guys Hosp, Kings Coll London, Div Canc Studies, London SE1 9RT, England; [Tomlinson, Ian] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Tomlinson, Ian] Univ Oxford, Oxford Biomed Res Ctr, Oxford, England; [Kerin, Michael J.; Miller, Nicola] Univ Hosp, Inst Clin Sci, Galway, Ireland; [Andrulis, Irene L.; Tchatchou, Sandrine] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Andrulis, Irene L.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Knight, Julia A.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Prosserman Ctr Hlth Res, Toronto, ON M5G 1X5, Canada; [Knight, Julia A.] Univ Toronto, Div Epidemiol, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Mulligan, Anna Marie] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Mulligan, Anna Marie] St Michaels Hosp, Dept Lab Med, Toronto, ON M5B 1W8, Canada; [Mulligan, Anna Marie] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Dork, Thilo] Hannover Med Sch, Dept Obstet & Gynaecol, Hannover, Germany; [Bogdanova, Natalia V.] Hannover Med Sch, Dept Radiat Oncol, Hannover, Germany; [Antonenkova, Natalia N.] NN Alexandrov Res Inst Oncol & Med Radiol, Minsk, BELARUS; [Anton-Culver, Hoda] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA; [Garcia-Closas, Montserrat; Jones, Michael] Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England; [Garcia-Closas, Montserrat] Inst Canc Res, Div Breast Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Lissowska, Jolanta] M Sklodowska Curie Mem Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Human Genet & Dept Pathol, Leiden, Netherlands; [Tollenaar, Robert A. E. M.] Leiden Univ, Med Ctr, Dept Surg Oncol, Leiden, Netherlands; [Seynaeve, Caroline] Erasmus MC Daniel Hoed Canc Ctr, Dept Med Oncol, Family Canc Clin, Rotterdam, Netherlands; [van Asperen, Christi J.] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands; [Kristensen, Vessela N.] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Kristensen, Vessela N.] Univ Oslo, Dept Clin Mol Biol EpiGen, Oslo, Norway; [Kristensen, Vessela N.] Oslo Univ Hosp, Dept Genet, Inst Canc Res, Radiumhosp, Oslo, Norway; [KConFab Investigators] Peter MacCallum Canc Ctr, Melbourne, Australia; [Australian Ovarian Canc Study Grp] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Toland, Amanda E.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Ambrosone, Christine B.] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Yannoukakos, Drakoulis] IRRP, Mol Diagnost Lab, Natl Ctr Sci Res Demokritos Aghia Paraskevi Attik, Athens, Greece; [Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Margolin, Sara] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Radice, Paolo] Fdn IRCCS, INT, Dept Prevent & Predict Med, Unit Mol Bases Genet Risk & Genet Testing, Milan, Italy; [Peterlongo, Paolo; Mariani, Paolo] IFOM, Fdn Ist FIRC Oncol Mol, Milan, Italy; [Barile, Monica] IEO, Div Canc Prevent & Genet, Milan, Italy; [Mariani, Paolo] Cogentech Canc Genet Test Lab, Milan, Italy; [Hooning, Maartje J.; Martens, John W. M.; Jager, Agnes] Erasmus Univ, Med Ctr, Dept Med Oncol, Rotterdam, Netherlands; [Collee, J. Margriet] Erasmus Univ, Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; [Jakubowska, Anna; Lubinski, Jan; Jaworska-Bieniek, Katarzyna; Durda, Katarzyna] Pomeranian Med Univ, Dept Genet & Pathol, Szczecin, Poland; [Jaworska-Bieniek, Katarzyna] Med Univ Warsaw, Postgrad Sch Mol Med, Warsaw, Poland; [McLean, Catriona] Alfred Hosp, Melbourne, Australia; [Brauch, Hiltrud] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Clin Pharmacol, Stuttgart, Germany; [Brauch, Hiltrud] Univ Tubingen, Tubingen, Germany; [Bruning, Thomas] Univ Bochum IPA, Inst Prevent & Occupat Med German Social Accid In, Inst Ruhr, Bochum, Germany; [Ko, Yon-Dschun] Evangel Kliniken Bonn gGmbH, Dept Internal Med, Bonn, Germany; [Hamann, Ute] German Canc Res Ctr, Heidelberg, Germany; Univ Med Ctr Hamburg Eppendorf, Inst Occupat Med & Maritime Med, Hamburg, Germany; [GENICA Network] Univ Bonn, Inst Pathol, Fac Med, Bonn, Germany; [Brenner, Hermann; Dieffenbach, Aida Karina; Arndt, Volker] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Brenner, Hermann; Dieffenbach, Aida Karina] German Canc Consortium DKTK, Heidelberg, Germany; [Stegmaier, Christa] Saarland Canc Registry, Saarbrucken, Germany; [Swerdlow, Anthony] Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England; [Swerdlow, Anthony] Inst Canc Res, Div Breast Canc Res, Sutton, Surrey, England; [Simard, Jacques; Dumont, Martine] Univ Quebec, Res Ctr, Ctr Hosp, Ste Foy, PQ G1V 2M3, Canada; [Simard, Jacques; Dumont, Martine] Univ Laval, Canc Genom Lab, Quebec City, PQ G1K 7P4, Canada; [Goldberg, Mark S.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Goldberg, Mark S.] McGill Univ Hlth Ctr, Royal Victoria Hosp, Div Clin Epidemiol, Montreal, PQ, Canada; [Labreche, France] Univ Montreal, Dept Sante Environm, Montreal, PQ, Canada; [Labreche, France] Univ Montreal, Dept Sante Travail, Montreal, PQ, Canada; [Labreche, France] Univ Montreal, Dept Sociale Med, Montreal, PQ, Canada; [Labreche, France] Univ Montreal, Dept Prevent, Montreal, PQ, Canada; [Winqvist, Robert; Pylkas, Katri] Univ Oulu, Lab Canc Genet & Tumor Biol, Dept Clin Chem & Biocenter Oulu, NordLab Oulu,Oulu Univ Hosp, Oulu, Finland; [Jukkola-Vuorinen, Arja] Univ Oulu, Dept Oncol, Oulu Univ Hosp, Oulu, Finland; [Grip, Mervi] Univ Oulu, Oulu Univ Hosp, Dept Surg, Oulu, Finland; [Kataja, Vesa] Univ Eastern Finland, Inst Clin Med Oncol, Sch Med, Kuopio, Finland; [Kataja, Vesa] Kuopio Univ Hosp, Ctr Canc, SF-70210 Kuopio, Finland; [Kosma, Veli-Matti; Hartikainen, Jaana M.; Mannermaa, Arto] Univ Eastern Finland, Inst Clin Med Pathol & Forens Med, Sch Med, Kuopio, Finland; [Kosma, Veli-Matti; Hartikainen, Jaana M.; Mannermaa, Arto] Kuopio Univ Hosp, Imaging Ctr, Dept Clin Pathol, SF-70210 Kuopio, Finland; [Kosma, Veli-Matti; Hartikainen, Jaana M.; Mannermaa, Arto] Univ Eastern Finland, Canc Ctr Eastern Finland, Kuopio, Finland; [Chenevix-Trench, Georgia] QIMR Berghofer Med Res Inst, Dept Genet, Brisbane, Qld, Australia	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Finnish Institute of Occupational Health; University of Cambridge; Cancer Council Victoria; University of Melbourne; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Karolinska Institutet; Helmholtz Association; German Cancer Research Center (DKFZ); University of Cologne; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Melbourne; University of Melbourne; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center; Technical University of Munich; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of London; Institute of Cancer Research - UK; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Sheffield; University of Sheffield; Netherlands Cancer Institute; University of Erlangen Nuremberg; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Erlangen Nuremberg; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario La Paz; University of Southern California; Cancer Research Center of Hawaii; University of Hawaii System; University of Cambridge; Mayo Clinic; Mayo Clinic; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University Hospital Leuven; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Ollscoil na Gaillimhe-University of Galway; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Hannover Medical School; Hannover Medical School; University of California System; University of California Irvine; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Oslo; University of Oslo; University of Oslo; Peter Maccallum Cancer Center; QIMR Berghofer Medical Research Institute; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Roswell Park Cancer Institute; National Centre of Scientific Research "Demokritos"; Karolinska Institutet; Karolinska Institutet; IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Pomeranian Medical University; Medical University of Warsaw; Florey Institute of Neuroscience & Mental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Ruhr University Bochum; Helmholtz Association; German Cancer Research Center (DKFZ); University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bonn; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; Laval University; University of Quebec; Laval University; McGill University; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; University of Oulu; University of Oulu; University of Oulu; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; QIMR Berghofer Medical Research Institute	Nevanlinna, H (corresponding author), Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland.	mkh39@medschl.cam.ac.uk; dfe20@medschl.cam.ac.uk	/AAM-5330-2020; Hartikainen, Jaana M/E-6256-2015; Figueroa, Jonine/AAG-1065-2022; Dörk, Thilo/J-8620-2012; Devilee, Peter/GXV-8005-2022; Reed, Malcolm Walter/AAG-9219-2020; Garcia-Closas, Montserrat/F-3871-2015; Flyger, Henrik/AAM-6494-2021; Chenevix-Trench, Georgia/AAV-2014-2020; Lambrechts, Diether/AAJ-3167-2020; Muranen, Taru/AAC-8418-2019; Bowtell, David/H-1007-2016; Knight, Julia/A-6843-2012; Arndt, Volker/B-4999-2014; truong, therese/A-2837-2013; Laurent-Puig, Pierre/K-3641-2019; Guenel, Pascal/AAS-7688-2021; Zamora, Pilar/AAM-9336-2021; Jakubowska, Anna/O-8050-2014; Radice, Paolo/O-3119-2013; jager, agnes/V-6381-2017; DEVILEE, PETER/ABR-2140-2022; Figueroa, Jonine/AFK-2752-2022; Arndt, Volker/AAI-7282-2020; Guenel, Pascal/H-3728-2018; Schmidt, Marjanka K/G-9058-2011; Nordestgaard, Borge Gronne/ABF-1310-2020; Lissowska, Jolanta/AAH-3252-2020; Peterlongo, Paolo/Q-4717-2018; laurent-puig, pierre/B-2226-2013; Brinton, Louise A/G-7486-2015; Brüning, Thomas/G-8120-2015; Miller, Nicola/F-4009-2018; Haviv, Izhak/E-3782-2015; Bogdanova, Natalia V./Y-2205-2019; Margolin, Sara/AAX-9034-2020; Schneeweiss, Andreas/HHS-4098-2022; van Asperen, Christi J/D-3970-2012; Figueroa, Jonine/GWD-1322-2022; Garcia-Closas, Montserrat/AAZ-6930-2021; Michailidou, Kyriaki/ABD-5122-2020; Li, Jingmei/I-2904-2012; Schumacher, Fredrick/R-6043-2019; Knight, Julia/R-5617-2019; Liu, Jianjun/AAK-4989-2020; Brenner, Hermann/ABE-6383-2020; Turnbull, Clare/AAA-6596-2019; Greco, Dario/T-7113-2019; Ekici, Arif B/C-3971-2013; Pharoah, Paul/V-6658-2019; Fasching, Peter A/ABH-9912-2020; Brenner, Hermann/B-4627-2017; Luben, Robert N/H-5519-2015; Rahman, Nazneen/D-2802-2013; Wyld, David/B-8893-2015	Hartikainen, Jaana M/0000-0001-8267-1905; Figueroa, Jonine/0000-0002-5100-623X; Dörk, Thilo/0000-0002-9458-0282; Reed, Malcolm Walter/0000-0001-7442-2132; Garcia-Closas, Montserrat/0000-0003-1033-2650; Chenevix-Trench, Georgia/0000-0002-1878-2587; Lambrechts, Diether/0000-0002-3429-302X; Muranen, Taru/0000-0002-5895-1808; Bowtell, David/0000-0001-9089-7525; Arndt, Volker/0000-0001-9320-8684; truong, therese/0000-0002-2943-6786; Laurent-Puig, Pierre/0000-0001-8475-5459; Guenel, Pascal/0000-0002-8359-518X; Jakubowska, Anna/0000-0002-5650-0501; Radice, Paolo/0000-0001-6298-4111; jager, agnes/0000-0002-7713-1450; Figueroa, Jonine/0000-0002-5100-623X; Arndt, Volker/0000-0001-9320-8684; Guenel, Pascal/0000-0002-8359-518X; Schmidt, Marjanka K/0000-0002-2228-429X; Lissowska, Jolanta/0000-0003-2695-5799; Peterlongo, Paolo/0000-0001-6951-6855; laurent-puig, pierre/0000-0001-8475-5459; Brinton, Louise A/0000-0003-3853-8562; Brüning, Thomas/0000-0001-9560-5464; Miller, Nicola/0000-0002-5416-7047; Haviv, Izhak/0000-0002-0837-5005; van Asperen, Christi J/0000-0002-1436-7650; Figueroa, Jonine/0000-0002-5100-623X; Garcia-Closas, Montserrat/0000-0003-1033-2650; Michailidou, Kyriaki/0000-0001-7065-1237; Li, Jingmei/0000-0001-8587-7511; Schumacher, Fredrick/0000-0002-3073-7463; Knight, Julia/0000-0002-7610-7635; Liu, Jianjun/0000-0002-3255-3019; Brenner, Hermann/0000-0002-6129-1572; Greco, Dario/0000-0001-9195-9003; Ekici, Arif B/0000-0001-6099-7066; Pharoah, Paul/0000-0001-8494-732X; Fasching, Peter A/0000-0003-4885-8471; Brenner, Hermann/0000-0002-6129-1572; Luben, Robert N/0000-0002-5088-6343; eriksson, mikael/0000-0001-8135-4270; Makalic, Enes/0000-0003-3017-0871; Turnbull, Clare/0000-0002-1734-5772; Bui, Minh/0000-0002-9099-6870; Swerdlow, Anthony/0000-0001-5550-4159; van der Luijt, Rob/0000-0002-0018-1089; Giles, Graham/0000-0003-4946-9099; Stone, Jennifer/0000-0001-5077-0124; Yannoukakos, Drakoulis/0000-0001-7509-3510; Kataja, Vesa/0000-0003-4846-4843; Nordestgaard, Borge/0000-0002-1954-7220; Pylkas, Katri/0000-0002-2449-0521; Moisse, Matthieu/0000-0001-8880-9311; Khan, Sofia/0000-0003-4185-8882; Winqvist, Robert/0000-0003-0932-9104; dos Santos Silva, Isabel/0000-0002-6596-8798; Bojesen, Stig/0000-0002-4061-4133; Brauch, Hiltrud/0000-0001-7531-2736; Blomqvist, Carl/0000-0003-3041-1938; Southey, Melissa/0000-0002-6313-9005; Aitken, Zoe/0000-0002-5413-2450; Kerin, Michael/0000-0003-4164-5561; Simard, Jacques/0000-0001-6906-3390; Czene, Kamila/0000-0002-3233-5695; Margolin, Sara/0000-0002-5526-5570; Durocher, Francine/0000-0001-8012-4641; Mulligan, Anna Marie/0000-0002-7239-5297; Fletcher, Olivia/0000-0001-9387-7116; Roth, Rebecca/0000-0002-2841-4921; Devilee, Peter/0000-0002-8023-2009; Labreche, France/0000-0001-8722-0433; Cox, Angela/0000-0002-5138-1099; Lotz, Anne/0000-0002-8715-0743; Dunning, Alison Margaret/0000-0001-6651-7166; Rahman, Nazneen/0000-0003-4376-0440; Lubinski, Jan/0000-0003-2931-3003; Wyld, David/0000-0001-9523-4333; McLean, Catriona/0000-0002-0302-5727; Jones, Michael/0000-0001-7479-3451; Heikkinen, Tuomas/0000-0003-1154-6204; Waisfisz, Quinten/0000-0002-7384-9182; Cross, Simon/0000-0003-2044-1754	European Community's Seventh Framework Programme (COGS) [223175 (HEALTH-F2-2009-223175)]; Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program; Ministry of Economic Development, Innovation and Export Trade of Quebec [PSR-SIIRI-701]; Helsinki University Central Hospital Research Fund; Academy of Finland [266528]; Finnish Cancer Society; Nordic Cancer Union; Sigrid Juselius Foundation; Nordic Center of Excellence in Disease Genetics; Wellcome Trust; Cancer Research UK [C8620/A8372]; United States National Cancer Institute, National Institutes of Health (NIH) [RFA-CA-06-503]; Cancer Care Ontario [U01 CA69467]; Northern California Cancer Center [U01 CA69417]; University of Melbourne [U01 CA69638]; Canadian Institutes of Health Research for "CIHR Team in Familial Risks of Breast Cancer" program; National Cancer Institute [UM1 CA164920]; National Health and Medical Research Council of Australia; New South Wales Cancer Council; Victorian Health Promotion Foundation (Australia); Victorian Breast Cancer Research Consortium; Dutch Cancer Society [NKI 2007-3839, 2009 4363, DDHK 2004-3124, DDHK 2009-4318, RUL 1997-1505]; Dutch government (NWO) [184.021.007]; Dutch National Genomics Initiative; Breakthrough Breast Cancer; NHS; National Cancer Research Network (NCRN); Institut National de Cancer; ELAN-Fond of the University Hospital of Erlangen; NIHR Comprehensive Biomedical Research Centre; Guy's & St. Thomas' NHS Foundation Trust; King's College London, United Kingdom; Oxford Biomedical Research Centre; Dietmar-Hopp Foundation; Helmholtz Society; German Cancer Research Center; Fondation de France [2004012618, 2007005156]; Institut National du Cancer (INCa) [2007-1/SPC2, 2008-1-CP-4, 2009-1-SHS/SP-04]; Ligue Nationale contre le Cancer; Association pour la Recherche contre le Cancer (ARC) [2008-1-CP-4]; Agence Francaise de Securite Sanitaire de l'Environnement et du Travail (AFSSET - ANSES) [ST-2005-003, EST2008/1/26, VS-2009-21]; Ligue contre le Cancer Grand Ouest; Chief Physician Johan Boserup and Lise Boserup Fund; Danish Medical Research Council; Herlev Hospital; Genome Spain Foundation; Red Tematica de Investigacion Cooperativa en Cancer; Asociacion Espanola Contra el Cancer; Fondo de Investigacion Sanitario [PI11/00923, PI081120]; Human Genotyping-CEGEN Unit (CNIO); Instituto de Salud Carlos III; California Breast Cancer Act of 1993; National Institutes of Health [R01 CA77398]; Lon V Smith Foundation [LVS39420]; California Breast Cancer Research Fund [97-10500]; California Department of Public Health, statewide cancer reporting program [103885]; Hellenic Cooperative Oncology Group research grant [HR R_BG/04]; Greek General Secretary for Research and Technology (GSRT) Program, Research Excellence II; European Union; Netherlands Organisation for Scientific Research (NWO), ZonMw/VIDI [91756341]; Netherlands Organisation of Scientific Research NWO Investments [175.010.2005.011, 911-03-012]; Research Institute for Diseases in the Elderly [014-93-015, RIDE2]; Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) [050-060-810]; Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; Baden Wurttemberg Ministry of Science, Research and Arts; German Cancer Aid (Deutsche Krebshilfe); Friends of Hannover Medical School; Rudolf Bartling Foundation; Stockholm County Council; Karolinska Institutet; Swedish Cancer Society; Bert von Kantzow foundation; Deutsche Krebshilfe [107054]; German Cancer Research Centre (DKFZ); German Cancer Aid [107352]; Federal Ministry of Education and Research (BMBF) Germany [01KW9975/5, 01KW9976/8, 01KW9977/0, 01KW0114, 01KH0402]; Robert Bosch Foundation; Stuttgart; Deutsches Krebsforschungszentrum (DKFZ); Heidelberg; German Social Accident Insurance; Institute of the Ruhr University Bochum (IPA), Germany; Department of Internal Medicine; Evangelische Kliniken Bonn gGmbH; Johanniter Krankenhaus, Bonn, Germany; Government Funding (EVO) of Kuopio University Hospital grants; Cancer Fund of North Savo; Finnish Cancer Organizations; University of Eastern Finland; National Breast Cancer Foundation; National Health and Medical Research Council (NHMRC); Queensland Cancer Fund; Cancer Council of New South Wales; Cancer Council of Victoria; Cancer Council of Tasmania; Cancer Council of South Australia; Cancer Foundation of Western Australia; NHMRC [145684, 288704, 454508, 199600]; United States Army Medical Research and Materiel Command [DAMD17-01-1-0729]; Stichting tegen Kanker [232-2008, 196-2010]; FWO; Deutsche Krebshilfe e.V. [70-2892-BR I]; Hamburg Cancer Society; Italian Association for Cancer Research (AIRC); INT-Institutional strategic projects "5x1000"; Specialized Program of Research Excellence (SPORE) in Breast Cancer [CA116201]; Breast Cancer Research Foundation; VicHealth and Cancer Council Victoria; Australian NHMRC [209057, 251553, 504711]; NIH [CA122340, CA63464, CA54281, CA098758, CA132839, CA128978, CA 65725, CA87969, CA49449, CA67262, CA50385, 5UO1CA098233]; Canadian Breast Cancer Research Initiative; Quebec Breast Cancer Foundation; Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program [CRN-87521]; Ministry of Economic Development, Innovation and Export Trade [PSR-SIIRI-701]; Norwegian Research council [155218/V40, 175240/S10, FUGE-NFR 181600/V11]; Swizz Bridge Award; Finnish Cancer Foundation; Academy of Finland; University of Oulu; Oulu University Hospital; Biobanking and Biomolecular Resources Research Infrastructure [BBMRI-NL CP16]; Stefanie Spielman fund; OSU Comprehensive Cancer Center; Intramural Research Funds of the National Cancer Institute, Department of Health and Human Services, USA; Marit and Hans Rausings Initiative Against Breast Cancer; Cancer Risk Prediction Center, Linneus Centre - Swedish Research Council [70867902]; Swedish Research Council; RPCI DataBank and BioRepository (DBBR), Cancer Center Support Grant Shared Resource [P30 CA016056-32]; Agency for Science, Technology and Research of Singapore (A*STAR); US National Institute of Health (NIH); Susan G. Komen Breast Cancer Foundation; Yorkshire Cancer Research [S295, S299, S305PA]; programme grant from Cancer Research UK [C490/A10124]; UK National Institute for Health Research Biomedical Research Centre at the University of Cambridge; Joseph Mitchell Fund; DKFZ; Polish Foundation of Science; Komen Foundation for the Cure; Ohio State University Comprehensive Cancer Center; Stefanie Spielman fund for Breast Cancer Research; European Union (European Social Fund - ESF); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program of the General Secretariat for Research & Technology: ARISTEIA; Institute of Cancer Research (ICR);  [KULPFV/10/016-SymBioSysII];  [PBZ_KBN_122/P05/2004]; MRC [G0700491] Funding Source: UKRI; Cancer Research UK [15106, 16565, 16561, 16563] Funding Source: researchfish; Medical Research Council [G0700491] Funding Source: researchfish; National Institute for Health Research [03/DHCS/03/G121/51] Funding Source: researchfish; Cancer Foundation Finland sr [130168] Funding Source: researchfish; National Breast Cancer Foundation [IF-12-06] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R37CA054281, R01CA063464, U01CA069638, UM1CA164920, R01CA132839, U01CA049449, P30CA016056, U01CA069417, P01CA087969, R01CA122340, U01CA063464, P50CA116201, U01CA098758, R01CA065725, R01CA067262, R01CA050385, ZIACP010126, R01CA128978, R01CA049449, R01CA077398, U01CA067262, U01CA098233, U01CA069467, R01CA054281] Funding Source: NIH RePORTER	European Community's Seventh Framework Programme (COGS); Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program(Canadian Institutes of Health Research (CIHR)); Ministry of Economic Development, Innovation and Export Trade of Quebec; Helsinki University Central Hospital Research Fund; Academy of Finland(Academy of Finland); Finnish Cancer Society; Nordic Cancer Union; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Nordic Center of Excellence in Disease Genetics; Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); United States National Cancer Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Care Ontario; Northern California Cancer Center; University of Melbourne(University of Melbourne); Canadian Institutes of Health Research for "CIHR Team in Familial Risks of Breast Cancer" program(Canadian Institutes of Health Research (CIHR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); New South Wales Cancer Council(Cancer Council New South Wales); Victorian Health Promotion Foundation (Australia); Victorian Breast Cancer Research Consortium; Dutch Cancer Society(KWF Kankerbestrijding); Dutch government (NWO); Dutch National Genomics Initiative; Breakthrough Breast Cancer; NHS; National Cancer Research Network (NCRN); Institut National de Cancer; ELAN-Fond of the University Hospital of Erlangen; NIHR Comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); Guy's & St. Thomas' NHS Foundation Trust; King's College London, United Kingdom; Oxford Biomedical Research Centre; Dietmar-Hopp Foundation; Helmholtz Society(Helmholtz Association); German Cancer Research Center; Fondation de France(Fondation de France); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Agence Francaise de Securite Sanitaire de l'Environnement et du Travail (AFSSET - ANSES); Ligue contre le Cancer Grand Ouest(Ligue nationale contre le cancer); Chief Physician Johan Boserup and Lise Boserup Fund; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Herlev Hospital; Genome Spain Foundation; Red Tematica de Investigacion Cooperativa en Cancer; Asociacion Espanola Contra el Cancer; Fondo de Investigacion Sanitario; Human Genotyping-CEGEN Unit (CNIO); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); California Breast Cancer Act of 1993; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lon V Smith Foundation; California Breast Cancer Research Fund; California Department of Public Health, statewide cancer reporting program; Hellenic Cooperative Oncology Group research grant; Greek General Secretary for Research and Technology (GSRT) Program, Research Excellence II; European Union(European Commission); Netherlands Organisation for Scientific Research (NWO), ZonMw/VIDI(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation of Scientific Research NWO Investments(Netherlands Organization for Scientific Research (NWO)); Research Institute for Diseases in the Elderly; Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)Netherlands Government); Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Baden Wurttemberg Ministry of Science, Research and Arts; German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe); Friends of Hannover Medical School; Rudolf Bartling Foundation; Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Swedish Cancer Society(Swedish Cancer Society); Bert von Kantzow foundation; Deutsche Krebshilfe(Deutsche Krebshilfe); German Cancer Research Centre (DKFZ)(Helmholtz Association); German Cancer Aid(Deutsche Krebshilfe); Federal Ministry of Education and Research (BMBF) Germany(Federal Ministry of Education & Research (BMBF)); Robert Bosch Foundation; Stuttgart; Deutsches Krebsforschungszentrum (DKFZ)(Helmholtz Association); Heidelberg; German Social Accident Insurance; Institute of the Ruhr University Bochum (IPA), Germany; Department of Internal Medicine; Evangelische Kliniken Bonn gGmbH; Johanniter Krankenhaus, Bonn, Germany; Government Funding (EVO) of Kuopio University Hospital grants; Cancer Fund of North Savo; Finnish Cancer Organizations; University of Eastern Finland; National Breast Cancer Foundation; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Queensland Cancer Fund; Cancer Council of New South Wales(Cancer Council New South Wales); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Cancer Council of Tasmania(Cancer Council Tasmania); Cancer Council of South Australia(Cancer Council South Australia); Cancer Foundation of Western Australia(Cancer Council Western Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Stichting tegen Kanker; FWO(FWO); Deutsche Krebshilfe e.V.(Deutsche Krebshilfe); Hamburg Cancer Society; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); INT-Institutional strategic projects "5x1000"; Specialized Program of Research Excellence (SPORE) in Breast Cancer; Breast Cancer Research Foundation; VicHealth and Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Breast Cancer Research Initiative; Quebec Breast Cancer Foundation; Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program(Canadian Institutes of Health Research (CIHR)); Ministry of Economic Development, Innovation and Export Trade; Norwegian Research council(Research Council of NorwayEuropean Commission); Swizz Bridge Award; Finnish Cancer Foundation; Academy of Finland(Academy of Finland); University of Oulu; Oulu University Hospital; Biobanking and Biomolecular Resources Research Infrastructure; Stefanie Spielman fund; OSU Comprehensive Cancer Center; Intramural Research Funds of the National Cancer Institute, Department of Health and Human Services, USA; Marit and Hans Rausings Initiative Against Breast Cancer; Cancer Risk Prediction Center, Linneus Centre - Swedish Research Council; Swedish Research Council(Swedish Research CouncilEuropean Commission); RPCI DataBank and BioRepository (DBBR), Cancer Center Support Grant Shared Resource; Agency for Science, Technology and Research of Singapore (A*STAR)(Agency for Science Technology & Research (A*STAR)); US National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Yorkshire Cancer Research; programme grant from Cancer Research UK; UK National Institute for Health Research Biomedical Research Centre at the University of Cambridge; Joseph Mitchell Fund; DKFZ(Helmholtz Association); Polish Foundation of Science; Komen Foundation for the Cure(Susan G. Komen Breast Cancer Foundation); Ohio State University Comprehensive Cancer Center; Stefanie Spielman fund for Breast Cancer Research; European Union (European Social Fund - ESF)(European Social Fund (ESF)European Commission); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program of the General Secretariat for Research & Technology: ARISTEIA; Institute of Cancer Research (ICR); ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Cancer Foundation Finland sr; National Breast Cancer Foundation; The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for the iCOGS infrastructure came from the European Community's Seventh Framework Programme under grant agreement number 223175 (HEALTH-F2-2009-223175) (COGS). iCOGS was also partly supported by the Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program (JS & DFE), and the Ministry of Economic Development, Innovation and Export Trade of Quebec - grant # PSR-SIIRI-701 (JS & DFE, P. Hall). HEBCS was financially supported by the Helsinki University Central Hospital Research Fund, Academy of Finland (266528), the Finnish Cancer Society, The Nordic Cancer Union and the Sigrid Juselius Foundation. The population allele and genotype frequencies were obtained from the data source funded by the Nordic Center of Excellence in Disease Genetics based on samples regionally selected from Finland, Sweden and Denmark. The UK2 GWAS was funded by Wellcome Trust and Cancer Research UK. It included samples collected through the FBCS study which is funded by Cancer Research UK [C8620/A8372]. The WTCCC was funded by the Wellcome Trust. The ABCFS and OFBCR studies were supported by the United States National Cancer Institute, National Institutes of Health (NIH) under RFA-CA-06-503 and through cooperative agreements with members of the Breast Cancer Family Registry (BCFR) and Principal Investigators, including Cancer Care Ontario (U01 CA69467), Northern California Cancer Center (U01 CA69417), University of Melbourne (U01 CA69638). Samples from the NC-BCFR were processed and distributed by the Coriell Institute for Medical Research. OFBCR was supported by the Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program and grant UM1 CA164920 from the National Cancer Institute. The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the Breast Cancer Family Registry (BCFR), nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government or the BCFR. The ABCFS was also supported by the National Health and Medical Research Council of Australia, the New South Wales Cancer Council, the Victorian Health Promotion Foundation (Australia) and the Victorian Breast Cancer Research Consortium. JLH is a National Health and Medical Research Council (NHMRC) Australia Fellow and a Victorian Breast Cancer Research Consortium Group Leader. MCS is a NHMRC Senior Research Fellow and a Victorian Breast Cancer Research Consortium Group Leader. JLH and MCS are both group leaders of the Victoria Breast Cancer Research Consortium. The ABCS study was supported by the Dutch Cancer Society [grants NKI 2007-3839; 2009 4363]; BBMRI-NL, which is a Research Infrastructure financed by the Dutch government (NWO 184.021.007); and the Dutch National Genomics Initiative. The BBCS is funded by Cancer Research UK and Breakthrough Breast Cancer and acknowledges NHS funding to the NIHR Biomedical Research Centre, and the National Cancer Research Network (NCRN). The BBCS GWAS received funding from The Institut National de Cancer. The work of the BBCC was partly funded by ELAN-Fond of the University Hospital of Erlangen. ES (BIGGS) is supported by NIHR Comprehensive Biomedical Research Centre, Guy's & St. Thomas' NHS Foundation Trust in partnership with King's College London, United Kingdom. IT is supported by the Oxford Biomedical Research Centre.; The BSUCH study was supported by the Dietmar-Hopp Foundation, the Helmholtz Society and the German Cancer Research Center (DKFZ). The CECILE study was funded by Fondation de France [contract grant number 2004012618 and 2007005156], Institut National du Cancer (INCa) [2007-1/SPC2, 2008-1-CP-4 and 2009-1-SHS/SP-04], Ligue Nationale contre le Cancer, Association pour la Recherche contre le Cancer (ARC) [2008-1-CP-4]; Agence Francaise de Securite Sanitaire de l'Environnement et du Travail (AFSSET - ANSES) [ST-2005-003, EST2008/1/26, and VS-2009-21], Ligue contre le Cancer Grand Ouest. The CGPS was supported by the Chief Physician Johan Boserup and Lise Boserup Fund, the Danish Medical Research Council and Herlev Hospital. The CNIO-BCS was supported by the Genome Spain Foundation, the Red Tematica de Investigacion Cooperativa en Cancer and grants from the Asociacion Espanola Contra el Cancer and the Fondo de Investigacion Sanitario (PI11/00923 and PI081120). We acknowledge the support of Alvarez lvarez, Daniel Herrero, Primitiva Menendez and the Human Genotyping-CEGEN Unit (CNIO). The Human Genotyping-CEGEN Unit is supported by the Instituto de Salud Carlos III. The CTS was supported by the California Breast Cancer Act of 1993; National Institutes of Health (grants R01 CA77398 and the Lon V Smith Foundation [LVS39420].); and the California Breast Cancer Research Fund (contract 97-10500). Collection of cancer incidence data used in this study was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885. DEMOKRITOS is supported by a Hellenic Cooperative Oncology Group research grant (HR R_BG/04) and the Greek General Secretary for Research and Technology (GSRT) Program, Research Excellence II, funded at 75% by the European Union. The DFBBCS GWAS was funded by The Netherlands Organisation for Scientific Research (NWO) as part of a ZonMw/VIDI grant number 91756341. The generation and management of GWAS genotype data for the Rotterdam Study is supported by the Netherlands Organisation of Scientific Research NWO Investments (nr. 175.010.2005.011, 911-03-012). This study is funded by the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) project nr. 050-060-810. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The ESTHER study was supportd by a grant from the Baden Wurttemberg Ministry of Science, Research and Arts. Additional cases were recruited in the context of the VERDI study, which was supported by a grant from the German Cancer Aid (Deutsche Krebshilfe). The HMBCS was supported by a grant from the Friends of Hannover Medical School and by the Rudolf Bartling Foundation. The Financial support for KARBAC was provided through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet, The Swedish Cancer Society and Bert von Kantzow foundation. The GC-HBOC was supported by Deutsche Krebshilfe [107054], the Dietmar-Hopp Foundation, the Helmholtz society and the German Cancer Research Centre (DKFZ).; The GC-HBOC GWAS was supported by the German Cancer Aid (grant no. 107352). The GENICA was funded by the Federal Ministry of Education and Research (BMBF) Germany grants 01KW9975/5, 01KW9976/8, 01KW9977/0 and 01KW0114, the Robert Bosch Foundation, Stuttgart, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Germany, as well as the Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany. The KBCP was financially supported by the special Government Funding (EVO) of Kuopio University Hospital grants, Cancer Fund of North Savo, the Finnish Cancer Organizations, and by the strategic funding of the University of Eastern Finland. kConFab is supported by a grant from the National Breast Cancer Foundation, and previously by the National Health and Medical Research Council (NHMRC), the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania and South Australia, and the Cancer Foundation of Western Australia. The kConFab Clinical Follow Up Study was funded by the NHMRC [145684, 288704, 454508]. Financial support for the AOCS was provided by the United States Army Medical Research and Materiel Command [DAMD17-01-1-0729], the Cancer Council of Tasmania and Cancer Foundation of Western Australia and the NHMRC [199600]. GCT is supported by the NHMRC. LMBC is supported by the 'Stichting tegen Kanker' (232-2008 and 196-2010). Diether Lambrechts is supported by the FWO and the KULPFV/10/016-SymBioSysII. The MARIE study was supported by the Deutsche Krebshilfe e.V. [70-2892-BR I], the Hamburg Cancer Society, the German Cancer Research Center and the genotype work in part by the Federal Ministry of Education and Research (BMBF) Germany [01KH0402]. MBCSG is supported by grants from the Italian Association for Cancer Research (AIRC) and by funds from the Italian citizens who allocated the 5/1000 share of their tax payment in support of the Fondazione IRCCS Istituto Nazionale Tumori, according to Italian laws (INT-Institutional strategic projects "5x1000"). The MCBCS was supported by the NIH grants [CA122340, CA128978] and a Specialized Program of Research Excellence (SPORE) in Breast Cancer [CA116201], the Breast Cancer Research Foundation and a generous gift from the David F. and Margaret T. Grohne Family Foundation and the Ting Tsung and Wei Fong Chao Foundation. MCCS cohort recruitment was funded by VicHealth and Cancer Council Victoria. The MCCS was further supported by Australian NHMRC grants 209057, 251553 and 504711 and by infrastructure provided by Cancer Council Victoria. The MEC was supported by NIH grants CA63464, CA54281, CA098758 and CA132839. For the MTLGEBCS study, the initial case-control study was supported by the Canadian Breast Cancer Research Initiative. Work was also supported by the Quebec Breast Cancer Foundation, the Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program - grant # CRN-87521 and the Ministry of Economic Development, Innovation and Export Trade - grant # PSR-SIIRI-701. The NBCS was supported by grants from the Norwegian Research council, 155218/V40, 175240/S10 to ALBD, FUGE-NFR 181600/V11 to VNK and a Swizz Bridge Award to ALBD. The OBCS was supported by research grants from the Finnish Cancer Foundation, the Academy of Finland, the University of Oulu, and the Oulu University Hospital.; The ORIGO study was supported by the Dutch Cancer Society (RUL 1997-1505) and the Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-NL CP16). The OSU study was funded by the Stefanie Spielman fund and the OSU Comprehensive Cancer Center. The PBCS was funded by Intramural Research Funds of the National Cancer Institute, Department of Health and Human Services, USA. The pKARMA study was supported by Marit and Hans Rausings Initiative Against Breast Cancer and Cancer Risk Prediction Center, a Linneus Centre (contract 70867902) financed by the Swedish Research Council. The RBCS was funded by the Dutch Cancer Society (DDHK 2004-3124, DDHK 2009-4318). The RPCI study was supported by RPCI DataBank and BioRepository (DBBR), a Cancer Center Support Grant Shared Resource (P30 CA016056-32). The SASBAC study was supported by funding from the Agency for Science, Technology and Research of Singapore (A*STAR), the US National Institute of Health (NIH) and the Susan G. Komen Breast Cancer Foundation. The SBCS was supported by Yorkshire Cancer Research S295, S299, S305PA. SEARCH is funded by a programme grant from Cancer Research UK [C490/A10124] and supported by the the UK National Institute for Health Research Biomedical Research Centre at the University of Cambridge. AMD has been supported by Cancer Research UK grant [C8197/A10865] and by the Joseph Mitchell Fund. SKKDKFZS is supported by the DKFZ. The SZBCS was supported by Grant PBZ_KBN_122/P05/2004; Katarzyna Jaworska is a fellow of International PhD program, Postgraduate School of Molecular Medicine, Warsaw Medical University, supported by the Polish Foundation of Science. The TNBCC was supported by the NIH grant [CA128978], the Breast Cancer Research Foundation, Komen Foundation for the Cure, the Ohio State University Comprehensive Cancer Center, the Stefanie Spielman fund for Breast Cancer Research and a generous gift from the David F. and Margaret T. Grohne Family Foundation and the Ting Tsung and Wei Fong Chao Foundation. Part of the TNBCC (DEMOKRITOS) has been co-financed by the European Union (European Social Fund - ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program of the General Secretariat for Research & Technology: ARISTEIA. The UKBGS is funded by Breakthrough Breast Cancer and the Institute of Cancer Research (ICR). ICR acknowledges NHS funding to the NIHR Biomedical Research Centre. CGEMS, The Nurses' Health Studies are supported by NIH grants CA 65725, CA87969, CA49449, CA67262, CA50385 and 5UO1CA098233. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/ng.959; BIRRER MJ, 1988, MOL CELL BIOL, V8, P2668, DOI 10.1128/MCB.8.6.2668; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; de Martino M, 2013, J UROL; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Dite GS, 2003, J NATL CANCER I, V95, P448, DOI 10.1093/jnci/95.6.448; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Farazi TA, 2013, ADV EXP MED BIOL, V774, P1, DOI 10.1007/978-94-007-5590-1_1; Fiesch-Janys D, 2008, INT J CANCER, V123, P933, DOI 10.1002/ijc.23655; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fletcher O, 2006, J NATL CANCER I, V98, P1014, DOI 10.1093/jnci/djj268; Frank B, 2006, CARCINOGENESIS, V27, P606, DOI 10.1093/carcin/bgi248; Frank B, 2005, J NATL CANCER I, V97, P1012, DOI 10.1093/jnci/dji178; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Guo L, 2012, MOL BIOL REP; Hiard S, 2010, NUCLEIC ACIDS RES, V38, pD640, DOI 10.1093/nar/gkp926; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kapushesky M, 2012, NUCLEIC ACIDS RES, V40, pD1077, DOI 10.1093/nar/gkr913; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kontorovich T, 2010, INT J CANCER, V127, P589, DOI 10.1002/ijc.25065; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Landi D, 2008, CARCINOGENESIS, V29, P579, DOI 10.1093/carcin/bgm304; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Leu M, 2010, EUR J HUM GENET, V18, P1322, DOI 10.1038/ejhg.2010.112; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JM, 2011, BREAST CANCER RES TR, V126, P717, DOI 10.1007/s10549-010-1172-9; Liang D, 2010, CANCER RES, V70, P9765, DOI 10.1158/0008-5472.CAN-10-0130; Liang Zhongxing, 2010, Biochem Pharmacol, V79, P817, DOI 10.1016/j.bcp.2009.10.017; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lin WY, 2014, HUM MOL GENET; Lombardo F, 2004, FASEB J, V18, P52, DOI 10.1096/fj.03-0521com; MacPherson G, 2004, JNCI-J NATL CANCER I, V96, P1866, DOI 10.1093/jnci/dji001; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Peng SH, 2011, BREAST CANCER RES TR, V127, P309, DOI 10.1007/s10549-011-1459-5; Ruiz-Ruiz C, 2000, CANCER RES, V60, P5673; Shukla Girish C, 2011, Mol Cell Pharmacol, V3, P83; Song FJ, 2009, CLIN CANCER RES, V15, P6292, DOI 10.1158/1078-0432.CCR-09-0826; Sosio M, 2004, MICROBIOL-SGM, V150, P95, DOI 10.1099/mic.0.26507-0; Sun D, 2010, NAT STRUCT MOL BIOL, V17, P1188, DOI 10.1038/nsmb.1906; Sung H, 2011, BREAST CANCER RES TR, V130, P939, DOI 10.1007/s10549-011-1656-2; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Volinia S, 2013, P NATL ACAD SCI USA, V110, P7413, DOI 10.1073/pnas.1304977110; Wang XG, 2013, ONCOL REP, V30, P643, DOI 10.3892/or.2013.2530; Witkos TM, 2011, CURR MOL MED, V11, P93; Wu R, 2003, AM J PATHOL, V162, P1603, DOI 10.1016/S0002-9440(10)64294-0; Xiong F, 2011, CANCER RES, V71, P5175, DOI 10.1158/0008-5472.CAN-10-4407; Zhong Xiaomin, 2012, Methods Mol Biol, V822, P295, DOI 10.1007/978-1-61779-427-8_21	53	30	33	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e109973	10.1371/journal.pone.0109973	http://dx.doi.org/10.1371/journal.pone.0109973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390939	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000349144400009
J	Guilherme, FR				Guilherme, Flavio Ricardo		PLOS One Staff	Hypertriglyceridemic Waist and Metabolic Abnormalities in Brazilian Schoolchildren (vol 9, e111724, 2014)	PLOS ONE			English	Correction									Univ Estadual Maringa, Dept Educ Phys, Maringa, Parana, Brazil		Guilherme, FR (corresponding author), Univ Estadual Maringa, Dept Educ Phys, Maringa, Parana, Brazil.		Rinaldi, Wilson WR/T-4560-2017	Alexandre Molena Fernandes, Carlos/0000-0002-4019-8379; Ricardo Guilherme, Flavio/0000-0003-4808-6192				Guilherme FR, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0111724, 10.1371/journal.pone.0116445]	1	6	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e116445	10.1371/journal.pone.0116445	http://dx.doi.org/10.1371/journal.pone.0116445			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25397885	Green Published, gold			2022-12-27	WOS:000348563300106
J	Hu, WT; Anand, G; Sivaraman, J; Leung, KY; Mok, YK				Hu, Wentao; Anand, Ganesh; Sivaraman, J.; Leung, Ka Yin; Mok, Yu-Keung			A Disordered Region in the EvpP Protein from the Type VI Secretion System of Edwardsiella tarda EvpC Binding	PLOS ONE			English	Article							BACTERIAL TYPE-VI; PSEUDOMONAS-AERUGINOSA; IMMUNITY PROTEIN; STRUCTURAL INSIGHTS; EFFECTOR; CHAPERONE; COMPLEX; COMPETITION; INHIBITION; PROTEOMICS	The type VI secretion system (T6SS) of pathogenic bacteria plays important roles in both virulence and inter-bacterial competitions. The effectors of T6SS are presumed to be transported either by attaching to the tip protein or by interacting with HcpI (haemolysin corregulated protein 1). In Edwardsiella tarda PPD130/91, the T6SS secreted protein EvpP (E. tarda virulent protein P) is found to be essential for virulence and directly interacts with EvpC (Hcp-like), suggesting that it could be a potential effector. Using limited protease digestion, nuclear magnetic resonance heteronuclear Nuclear Overhauser Effects, and hydrogen-deuterium exchange mass spectrometry, we confirmed that the dimeric EvpP (40 kDa) contains a substantial proportion (40%) of disordered regions but still maintains an ordered and folded core domain. We show that an N-terminal, 10-kDa, protease-resistant fragment in EvpP connects to a shorter, 4-kDa protease-resistant fragment through a highly flexible region, which is followed by another disordered region at the C-terminus. Within this C-terminal disordered region, residues Pro143 to Ile168 are essential for its interaction with EvpC. Unlike the highly unfolded T3SS effector, which has a lower molecular weight and is maintained in an unfolded conformation with a dedicated chaperone, the T6SS effector seems to be relatively larger, folded but partially disordered and uses HcpI as a chaperone.	[Hu, Wentao; Anand, Ganesh; Sivaraman, J.; Mok, Yu-Keung] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Leung, Ka Yin] Trinity Western Univ, Fac Nat & Appl Sci, Dept Biol, Langley, BC V2Y 1Y1, Canada; [Leung, Ka Yin] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China	National University of Singapore; Trinity Western University; East China University of Science & Technology	Mok, YK (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbsmokh@nus.edu.sg	Anand, Ganesh/H-8473-2012	J, Sivaraman/0000-0001-9781-5326	Academic Research Fund, National University of Singapore [R-154-000-498-112]; National Science and Engineering Research Council (NSERC), Canada [372373-2010]; Open Funding Project of the State Key Laboratory of Bioreactor Engineering of China	Academic Research Fund, National University of Singapore(National University of Singapore); National Science and Engineering Research Council (NSERC), Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Open Funding Project of the State Key Laboratory of Bioreactor Engineering of China	This project was supported by Academic Research Fund, National University of Singapore grant R-154-000-498-112 to Y.K.M. K.Y.L. was supported by a grant from the National Science and Engineering Research Council (NSERC) Discovery Grant (372373-2010), Canada, and the Open Funding Project of the State Key Laboratory of Bioreactor Engineering of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzalimov RR, 2009, J AM SOC MASS SPECTR, V20, P1514, DOI 10.1016/j.jasms.2009.04.006; Basler M, 2013, CELL, V152, P884, DOI 10.1016/j.cell.2013.01.042; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4; Brunet YR, 2013, CELL REP, V3, P36, DOI 10.1016/j.celrep.2012.11.027; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Chakraborty S, 2011, J BIOL CHEM, V286, P39417, DOI 10.1074/jbc.M111.295188; Chou S, 2012, CELL REP, V1, P656, DOI 10.1016/j.celrep.2012.05.016; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dong C, 2013, BIOCHEM J, V454, P59, DOI 10.1042/BJ20130193; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Durand E, 2012, J BIOL CHEM, V287, P14157, DOI 10.1074/jbc.M111.338731; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Felisberto-Rodrigues C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002386; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Goddard TD, KNELLER DG SPARKY; Ho BT, 2014, CELL HOST MICROBE, V15, P9, DOI 10.1016/j.chom.2013.11.008; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Jobichen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012910; Kaltashov IA, 2009, ANAL CHEM, V81, P7892, DOI 10.1021/ac901366n; Kapitein N, 2013, CURR OPIN MICROBIOL, V16, P52, DOI 10.1016/j.mib.2012.11.009; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Koskiniemi S, 2013, P NATL ACAD SCI USA, V110, P7032, DOI 10.1073/pnas.1300627110; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Leung KY, 2012, MICROBES INFECT, V14, P26, DOI 10.1016/j.micinf.2011.08.005; Leung KY, 2011, CURR OPIN MICROBIOL, V14, P9, DOI 10.1016/j.mib.2010.09.017; Lossi NS, 2013, J BIOL CHEM, V288, P7536, DOI 10.1074/jbc.M112.439273; Lu DF, 2014, MOL MICROBIOL, V92, P1092, DOI 10.1111/mmi.12616; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Radics J, 2014, NAT STRUCT MOL BIOL, V21, P82, DOI 10.1038/nsmb.2722; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Rao PSS, 2004, MOL MICROBIOL, V53, P573, DOI 10.1111/j.1365-2958.2004.04123.x; Records AR, 2011, MOL PLANT MICROBE IN, V24, P751, DOI 10.1094/MPMI-11-10-0262; Robb CS, 2013, ACTA CRYSTALLOGR F, V69, P607, DOI 10.1107/S1744309113012220; Rodgers L, 2008, J BIOL CHEM, V283, P20857, DOI 10.1074/jbc.M802339200; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Shneider MM, 2013, NATURE, V500, P350, DOI 10.1038/nature12453; Silverman JM, 2013, MOL CELL, V51, P584, DOI 10.1016/j.molcel.2013.07.025; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; Teilum K, 2009, CELL MOL LIFE SCI, V66, P2231, DOI 10.1007/s00018-009-0014-6; van Soest JJ, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-58; Vogelaar NJ, 2010, BIOCHEMISTRY-US, V49, P5870, DOI 10.1021/bi100432e; Wang TY, 2013, ACTA CRYSTALLOGR D, V69, P1889, DOI 10.1107/S090744491301576X; Wang X, 2009, FISH SHELLFISH IMMUN, V27, P469, DOI 10.1016/j.fsi.2009.06.013; Xu YQ, 2006, NAT METHODS, V3, P931, DOI 10.1038/NMETH938; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zhang H, 2013, J BIOL CHEM, V288, P5928, DOI 10.1074/jbc.M112.434357; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081074; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x; Zheng ZD, 2012, BIOCHEM BIOPH RES CO, V417, P129, DOI 10.1016/j.bbrc.2011.11.070; Zoued A, 2013, J BIOL CHEM, V288, P27031, DOI 10.1074/jbc.M113.499772	53	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e110810	10.1371/journal.pone.0110810	http://dx.doi.org/10.1371/journal.pone.0110810			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401506	gold, Green Published, Green Submitted			2022-12-27	WOS:000345158700008
J	Uetake, J; Tanaka, S; Hara, K; Tanabe, Y; Samyn, D; Motoyama, H; Imura, S; Kohshima, S				Uetake, Jun; Tanaka, Sota; Hara, Kosuke; Tanabe, Yukiko; Samyn, Denis; Motoyama, Hideaki; Imura, Satoshi; Kohshima, Shiro			Novel Biogenic Aggregation of Moss Gemmae on a Disappearing African Glacier	PLOS ONE			English	Article							GULKANA GLACIER; PHYLOGENETIC ANALYSIS; MICROBIAL ACTIVITY; UNIVERSAL PRIMERS; CRYOCONITE HOLES; AMPLIFICATION; BRYOPHYTES; MORPHOLOGY; FALLJOKULL; BERGGRENII	Tropical regions are not well represented in glacier biology, yet many tropical glaciers are under threat of disappearance due to climate change. Here we report a novel biogenic aggregation at the terminus of a glacier in the Rwenzori Mountains, Uganda. The material was formed by uniseriate protonemal moss gemmae and protonema. Molecular analysis of five genetic markers determined the taxon as Ceratodon purpureus, a cosmopolitan species that is widespread in tropical to polar region. Given optimal growing temperatures of isolate is 20-30 degrees C, the cold glacier surface might seem unsuitable for this species. However, the cluster of protonema growth reached approximately 10 degrees C in daytime, suggesting that diurnal increase in temperature may contribute to the moss's ability to inhabit the glacier surface. The aggregation is also a habitat for microorganisms, and the disappearance of this glacier will lead to the loss of this unique ecosystem.	[Uetake, Jun] Transdisciplinary Res Integrat Ctr, Minato Ku, Tokyo, Japan; [Uetake, Jun] Natl Inst Polar Res, Tachikawa, Tokyo, Japan; [Tanaka, Sota; Motoyama, Hideaki; Imura, Satoshi] Chiba Univ, Fac Sci, Chiba, Japan; [Hara, Kosuke] Kyoto Univ, Grad Sch Sci, Kyoto, Japan; [Tanabe, Yukiko] Waseda Univ, Inst Adv Study, Shinjuku Ku, Tokyo, Japan; [Samyn, Denis] Nagaoka Univ Technol, Dept Mech Engn, Nagaoka, Niigata 94021, Japan; [Kohshima, Shiro] Kyoto Univ, Wildlife Res Ctr, Kyoto, Japan	Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; Chiba University; Kyoto University; Waseda University; Nagaoka University of Technology; Kyoto University	Uetake, J (corresponding author), Transdisciplinary Res Integrat Ctr, Minato Ku, Tokyo, Japan.	juetake@nipr.ac.jp	Uetake, Jun/V-4853-2018		Ministry of Education, Culture, Sports, Science and Technology [22241005]; Proposal for Seeds of Transdisciplinary Research from the Transdisciplinary Research Integration Center; NIPR; Grants-in-Aid for Scientific Research [25740012] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Proposal for Seeds of Transdisciplinary Research from the Transdisciplinary Research Integration Center; NIPR(National Institute of Polar Research (NIPR) - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partially supported by Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid for Scientific Research (A) No. 22241005 and by Proposal for Seeds of Transdisciplinary Research from the Transdisciplinary Research Integration Center, and by an NIPR publication subsidy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen R.A., 2005, ALGAL CULTURING TECH, P437; Anesio AM, 2009, GLOBAL CHANGE BIOL, V15, P955, DOI 10.1111/j.1365-2486.2008.01758.x; Benninghoff W.S., 1955, J GLACIOL, V2, P514; Cameron KA, 2012, FEMS MICROBIOL ECOL, V82, P254, DOI 10.1111/j.1574-6941.2011.01277.x; Chiang TY, 1998, BOT BULL ACAD SINICA, V39, P245; Coulson SJ, 2012, POLAR BIOL, V35, P1651, DOI 10.1007/s00300-012-1205-4; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edwards A, 2011, ISME J, V5, P150, DOI 10.1038/ismej.2010.100; Eythorsson J, 1951, J GLACIOL, V1, P503, DOI 10.1017/S0022143000026538; Hamilton TL, 2013, ISME J, V7, P1402, DOI 10.1038/ismej.2013.31; Hauman L., 1942, BULL JARD BOT ETAT BRUXELLES, V16, P311, DOI 10.2307/3666740; HEUSSER CJ, 1972, B TORREY BOT CLUB, V99, P34, DOI 10.2307/2484240; HICKLENTON PR, 1976, CAN J BOT, V54, P1104, DOI 10.1139/b76-118; Higuchi S, 2003, J PLANT RES, V116, P461, DOI 10.1007/s10265-003-0125-3; Hodson A, 2008, ECOL MONOGR, V78, P41, DOI 10.1890/07-0187.1; Hope GS, 1976, EQUATORIAL GLACIERS, P81; Imura S., 1986, MEMOIRS NATL I POLAR, V44, P241; Kanda H, 1979, MEM NATL I POLAR RES, V11, P58; Kaser G, 2002, TROPICAL GLACIERS, P63; La Farge C, 2013, P NATL ACAD SCI USA, V110, P9839, DOI 10.1073/pnas.1304199110; Lentini G, 2011, GEOGR FIS DIN QUAT, V34, P183, DOI 10.4461/GFDQ.2011.34.17; Longton R.E., 1988, BIOL POLAR BRYOPHYTE, P141; McDaniel SF, 2005, MOL ECOL, V14, P1121, DOI 10.1111/j.1365-294X.2005.02484.x; McMinn A, 2004, J MAR BIOL ASSOC UK, V84, P865, DOI 10.1017/S0025315404010112h; Moelg T, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026384; NADOT S, 1995, MOL PHYLOGENET EVOL, V4, P257, DOI 10.1006/mpev.1995.1024; Oechel WC, 1978, VEGETATION PRODUCTIO, P269; Porter PR, 2008, ANN GLACIOL-SER, V48, P25, DOI 10.3189/172756408784700734; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rabatel A, 2013, CRYOSPHERE, V7, P81, DOI 10.5194/tc-7-81-2013; Remias D, 2012, FEMS MICROBIOL ECOL, V79, P638, DOI 10.1111/j.1574-6941.2011.01245.x; SATAKE K, 1990, J BRYOL, V16, P109, DOI 10.1179/jbr.1990.16.1.109; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segawa T, 2010, MICROBES ENVIRON, V25, P171, DOI 10.1264/jsme2.ME10119; Shaw AJ, 2003, AM J BOT, V90, P1777, DOI 10.3732/ajb.90.12.1777; SHAW J, 1991, BRYOLOGIST, V94, P270, DOI 10.2307/3243964; Smith LRI, 1999, J VEG SCI, V10, P231; Sonoike K, 1998, J PLANT RES, V111, P121, DOI 10.1007/BF02507158; SouzaChies TT, 1997, PLANT SYST EVOL, V204, P109, DOI 10.1007/BF00982535; Stibal M, 2008, BIOGEOCHEMISTRY, V90, P1, DOI 10.1007/s10533-008-9226-3; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Takeuchi N, 2001, HYDROL PROCESS, V15, P3447, DOI 10.1002/hyp.1040; Takeuchi N., 2005, B GLACIOLOG RES, V22, P1; Takeuchi N, 2006, ANN GLACIOL-SER, V43, P378, DOI 10.3189/172756406781812113; Takeuchi N, 2010, ANN GLACIOL, V51, P9, DOI 10.3189/172756411795932010; Tanabe Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014690; Taylor RG, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025962; Telling J, 2011, J GEOPHYS RES, V116, P2; Thompson LG, 2013, SCIENCE, V340, P945, DOI 10.1126/science.1234210; Thompson LG, 2009, P NATL ACAD SCI USA, V106, P19770, DOI 10.1073/pnas.0906029106; Uetake J, 2012, FEMS MICROBIOL ECOL, V82, P279, DOI 10.1111/j.1574-6941.2012.01323.x; WHARTON RA, 1985, BIOSCIENCE, V35, P499, DOI 10.2307/1309818	52	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112510	10.1371/journal.pone.0112510	http://dx.doi.org/10.1371/journal.pone.0112510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401789	gold, Green Published, Green Submitted			2022-12-27	WOS:000345158700051
J	Barbic, SP; Durisko, Z; Andrews, PW				Barbic, Skye P.; Durisko, Zachary; Andrews, Paul W.			Measuring the Bright Side of Being Blue: A New Tool for Assessing Analytical Rumination in Depression	PLOS ONE			English	Article							PRIMARY-CARE; COGNITIVE THERAPY; DECISION-MAKING; RATING-SCALES; MOOD; SYMPTOMS; ANTIDEPRESSANTS; ADAPTATION; ACCURACY; BENEFITS	Background: Diagnosis and management of depression occurs frequently in the primary care setting. Current diagnostic and management of treatment practices across clinical populations focus on eliminating signs and symptoms of depression. However, there is debate that some interventions may pathologize normal, adaptive responses to stressors. Analytical rumination (AR) is an example of an adaptive response of depression that is characterized by enhanced cognitive function to help an individual focus on, analyze, and solve problems. To date, research on AR has been hampered by the lack of theoretically-derived and psychometrically sound instruments. This study developed and tested a clinically meaningful measure of AR. Methods: Using expert panels and an extensive literature review, we developed a conceptual framework for AR and 22 candidate items. Items were field tested to 579 young adults; 140 of whom completed the items at a second time point. We used Rasch measurement methods to construct and test the item set; and traditional psychometric analyses to compare items to existing rating scales. Results: Data were high quality (<1% missing; high reliability: Cronbach's alpha = 0.92, test-retest intraclass correlations >0.81; evidence for divergent validity). Evidence of misfit for 2 items suggested that a 20-item scale with 4-point response categories best captured the concept of AR, fitting the Rasch model (chi(2) = 95.26; df = 76, p = 0.07), with high reliability (r(p) = 0.86), ordered response scale structure, and no item bias (gender, age, time). Conclusion: Our study provides evidence for a 20-item Analytical Rumination Questionnaire (ARQ) that can be used to quantify AR in adults who experience symptoms of depression. The ARQ is psychometrically robust and a clinically useful tool for the assessment and improvement of depression in the primary care setting. Future work is needed to establish the validity of this measure in people with major depression.	[Barbic, Skye P.; Durisko, Zachary] Ctr Addict & Mental Hlth, Canadian Inst Hlth Res CIHR Training Program, Toronto, ON, Canada; [Andrews, Paul W.] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada	University of Toronto; Centre for Addiction & Mental Health - Canada; McMaster University	Andrews, PW (corresponding author), McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada.	pandrews@mcmaster.ca	Barbic, Skye/AAW-4044-2020	Andrews, Paul/0000-0002-5794-1747; Barbic, Skye/0000-0002-7076-2452	Social Aetiology of Mental Illness Funding Program, Centre for Addiction and Mental Health [TGF-96115]	Social Aetiology of Mental Illness Funding Program, Centre for Addiction and Mental Health	Funding from the Social Aetiology of Mental Illness Funding Program, Centre for Addiction and Mental Health, TGF-96115. The role of the funder was to provide salary support for the two post-doctoral students who participated in the study (SB, ZD). The authors report that the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos GS, 2000, ARCH GEN PSYCHIAT, V57, P285, DOI 10.1001/archpsyc.57.3.285; Andrews PW, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00117; Andrews PW, 2009, PSYCHOL REV, V116, P620, DOI 10.1037/a0016242; ANDRICH D, 1997, RUMM 2030 4 0 WINDOW; Andrich D, 2007, RUMM2020 RASCH UNIDI; Andrich D, 1982, ED RES PERSPECTIVES, V9, P95; Andrich D., 1988, SAGE PUBLICATIONS; Andrich D, 2011, EXPERT REV PHARM OUT, V11, P571, DOI [10.1586/ERP.11.59, 10.1586/erp.11.59]; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Au K, 2003, ORGAN BEHAV HUM DEC, V91, P322, DOI 10.1016/S0749-5978(02)00510-1; Barlow DH, 2010, AM PSYCHOL, V65, P13, DOI 10.1037/a0015643; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Braverman J, 2005, PERS SOC PSYCHOL B, V31, P1487, DOI 10.1177/0146167205276152; Brune M, 2008, TXB EVOLUTIONARY PSY; Cameron JI, 2011, STROKE, V42, P302, DOI 10.1161/STROKEAHA.110.597963; Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Cuijpers P, 2014, PSYCHOL MED, V44, P685, DOI 10.1017/S0033291713000457; Dowrick C, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7140; Ferrari AJ, 2013, 43PSYCHOLOGICAL MED; Food and Drug Administration, 2009, PAT REP OUTC MEAS US; Forgas J, 1998, J PERSONALITY SOCIAL, V75; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Freedland KE, 2005, PSYCHOSOM MED, V67, pS42, DOI 10.1097/01.psy.0000162255.55629.9c; Gluckman PD, 2009, PRINCIPLES EVOLUTION; Gut E, 1985, BRIT J PSYCHOTHERAPY, V2, P95; Hagen EH, 2011, CAN J PSYCHIAT, V56, P716, DOI 10.1177/070674371105601203; Hamilton JP, 2012, AM J PSYCHIAT, V169, P693, DOI 10.1176/appi.ajp.2012.11071105; Hayes AM, 2007, J CONSULT CLIN PSYCH, V75, P409, DOI 10.1037/0022-006X.75.3.409; Hayes AM, 2005, INT J BEHAV MED, V12, P111, DOI 10.1207/s15327558ijbm1202_9; Hertel G, 2000, COGNITION EMOTION, V14, P441, DOI 10.1080/026999300402754; Hobart JC, 2007, LANCET NEUROL, V6, P1094, DOI 10.1016/S1474-4422(07)70290-9; Hollon SD, 2002, PSYCHOL SCI, P39, DOI 10.1111/1529-1006.00008; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; Katzelnick DJ, 1997, PSYCHIATR SERV, V48, P59; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Krebber AMH, 2014, PSYCHO-ONCOLOGY, V23, P121, DOI 10.1002/pon.3409; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Krpan KM, 2013, J AFFECT DISORDERS, V150, P1148, DOI 10.1016/j.jad.2013.05.065; LYUBOMIRSKY S, 1993, J PERS SOC PSYCHOL, V65, P339, DOI 10.1037/0022-3514.65.2.339; Marais Ida, 2008, J Appl Meas, V9, P105; MARTIN LL, 1996, ADV SOC COG, V9, P1; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Mojtabai R, 2011, HEALTH AFFAIR, V30, P1434, DOI 10.1377/hlthaff.2010.1024; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Nesse RM, 2000, ARCH GEN PSYCHIAT, V57, P14, DOI 10.1001/archpsyc.57.1.14; Nezu A, 2001, J PSYCHOTHERAPY INTE, V11; NEZU AM, 1986, J CONSULT CLIN PSYCH, V54, P196, DOI 10.1037/0022-006X.54.2.196; NOLENHOEKSEMA S, 1991, J PERS SOC PSYCHOL, V61, P115, DOI 10.1037/0022-3514.61.1.115; NOLENHOEKSEMA S, 1994, J PERS SOC PSYCHOL, V67, P92, DOI 10.1037/0022-3514.67.1.92; Olesen SC, BMC PSYCHIAT; Overall NC, 2013, PERS SOC PSYCHOL B, V39, P636, DOI 10.1177/0146167213480188; Papageorgiou C, 2001, COGN BEHAV PRACT, V8, P160, DOI 10.1016/S1077-7229(01)80021-3; Pickett YR, 2014, AM J GERIAT PSYCHIAT, V22, P207, DOI 10.1016/j.jagp.2012.08.018; Pies R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g179; PIETROMONACO PR, 1987, J PERS SOC PSYCHOL, V52, P399, DOI 10.1037/0022-3514.52.2.399; Rochette A, 2007, CLIN REHABIL, V21, P554, DOI 10.1177/0269215507073490; Sideridis GD, 2011, RASCH MEASUREMENT T, V25, P1334; Sinclair R, 1998, ORG BEHAV HUMAN DECI, V42, P22; SINCLAIR RC, 1995, COGNITION EMOTION, V9, P417, DOI 10.1080/02699939508408974; Smoski MJ, 2008, J BEHAV THER EXP PSY, V39, P567, DOI 10.1016/j.jbtep.2008.01.004; Stenner AJ, 2011, MODEL TEST MECH MAKE; Stevens A., 2000, EVOLUTIONARY PSYCHIA; Stone M H, 1999, J Outcome Meas, V3, P308; Storbeck J, 2005, PSYCHOL SCI, V16, P785, DOI 10.1111/j.1467-9280.2005.01615.x; Streiner D, 2007, HLTH MEASUREMENT SCA; Teasdale JD, 2001, J CONSULT CLIN PSYCH, V69, P347, DOI 10.1037//0022-006X.69.3.347; Valenstein ES., 1998, BLAMING BRAIN TRUTH; von Helversen B, 2011, J ABNORM PSYCHOL, V120, P962, DOI 10.1037/a0023238; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Whitebird RR, 2013, QUAL HEALTH RES, V23, P805, DOI 10.1177/1049732313482399; Whooley MA, 2013, ANNU REV CLIN PSYCHO, V9, P327, DOI 10.1146/annurev-clinpsy-050212-185526; WILLIAMS GC, 1991, Q REV BIOL, V66, P1, DOI 10.1086/417048; Wong EC, 2014, J IMMIGR MINOR HEALT, V16, P422, DOI 10.1007/s10903-013-9781-0	75	18	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112077	10.1371/journal.pone.0112077	http://dx.doi.org/10.1371/journal.pone.0112077			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DF	25397902	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558500030
J	da Costa, AC; Costa, AD; de Oliveira, FM; Nogueira, SV; Rosa, JD; Resende, DP; Kipnis, A; Junqueira-Kipnis, AP				da Costa, Adeliane Castro; Costa-Junior, Abadio de Oliveira; de Oliveira, Fabio Muniz; Nogueira, Sarah Veloso; Rosa, Joseane Damaceno; Resende, Danilo Pires; Kipnis, Andre; Junqueira-Kipnis, Ana Paula			A New Recombinant BCG Vaccine Induces Specific Th17 and Th1 Effector Cells with Higher Protective Efficacy against Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS BCG; BACILLUS-CALMETTE-GUERIN; T-CELLS; FUSION PROTEIN; NITRIC-OXIDE; INFECTION; CYTOKINE; RESPONSES; MOREAU; HSPX	Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (Mtb) that is a major public health problem. The vaccine used for TB prevention is Mycobacterium bovis bacillus Calmette-Guerin (BCG), which provides variable efficacy in protecting against pulmonary TB among adults. Consequently, several groups have pursued the development of a new vaccine with a superior protective capacity to that of BCG. Here we constructed a new recombinant BCG (rBCG) vaccine expressing a fusion protein (CMX) composed of immune dominant epitopes from Ag85C, MPT51, and HspX and evaluated its immunogenicity and protection in a murine model of infection. The stability of the vaccine in vivo was maintained for up to 20 days post-vaccination. rBCG-CMX was efficiently phagocytized by peritoneal macrophages and induced nitric oxide (NO) production. Following mouse immunization, this vaccine induced a specific immune response in cells from lungs and spleen to the fusion protein and to each of the component recombinant proteins by themselves. Vaccinated mice presented higher amounts of Th1, Th17, and polyfunctional specific T cells. rBCG-CMX vaccination reduced the extension of lung lesions caused by challenge with Mtb as well as the lung bacterial load. In addition, when this vaccine was used in a prime-boost strategy together with rCMX, the lung bacterial load was lower than the result observed by BCG vaccination. This study describes the creation of a new promising vaccine for TB that we hope will be used in further studies to address its safety before proceeding to clinical trials.	[da Costa, Adeliane Castro; Costa-Junior, Abadio de Oliveira; Nogueira, Sarah Veloso; Rosa, Joseane Damaceno; Resende, Danilo Pires; Junqueira-Kipnis, Ana Paula] Univ Fed Goias, Inst Patol Trop & Saude Publ, Lab Imunopatol Doencas Infecciosas, Goiania, Go, Brazil; [de Oliveira, Fabio Muniz; Kipnis, Andre] Univ Fed Goias, Inst Patol Trop & Saude Publ, Lab Bacteriol Mol, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias	Junqueira-Kipnis, AP (corresponding author), Univ Fed Goias, Inst Patol Trop & Saude Publ, Lab Imunopatol Doencas Infecciosas, Goiania, Go, Brazil.	apkipnis@gmail.com	de Oliveira, Fábio Muniz/AAG-4987-2019; Junqueira-Kipnis, Ana Paula/I-5534-2012; Castro da Costa, Adeliane/G-3848-2015; Kipnis, Andre/ABG-5707-2020; Kipnis, Andre/M-7485-2017; Castro da Costa, Adeliane/CAF-9210-2022	de Oliveira, Fábio Muniz/0000-0002-4470-8444; Castro da Costa, Adeliane/0000-0002-5440-8613; Kipnis, Andre/0000-0001-5950-106X; Kipnis, Andre/0000-0001-5950-106X; Resende, Danilo/0000-0002-3329-7352	National Council for Scientific and Technological Development (CNPq) [301976/2011-2, 472906/2011-9, 301198/2009-8, 472909/2011-8]; Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG-PRONEX); CNPq; PIBIC-CNPq	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG-PRONEX); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PIBIC-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was financed by the National Council for Scientific and Technological Development (CNPq, Project #301976/2011-2, 472906/2011-9, 301198/2009-8, 472909/2011-8) and by Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG-PRONEX). ACC received a PhD fellowship from CNPq. AOCJ, DPR, and FMO each received a MSc fellowship from CNPq. SVN received a Post Doc fellowship from CNPq. JDR received an undergraduate fellowship from PIBIC-CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe F, 2012, CLIN EXP IMMUNOL, V169, P213, DOI 10.1111/j.1365-2249.2012.04614.x; Achkar JM, 2010, CLIN VACCINE IMMUNOL, V17, P384, DOI 10.1128/CVI.00503-09; Andrade PM, 2010, UROL ONCOL-SEMIN ORI, V28, P520, DOI 10.1016/j.urolonc.2008.12.017; Bastos RG, 2009, VACCINE, V27, P6495, DOI 10.1016/j.vaccine.2009.08.044; Behr MA, 1997, NATURE, V389, P133, DOI 10.1038/38151; Berredo-Pinho M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-80; Brosch R, 2000, INT J MED MICROBIOL, V290, P143; Calmette A, 1929, ANN I PASTEUR, V41, P201; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Clark SO, 2010, VACCINE, V28, P7109, DOI 10.1016/j.vaccine.2010.07.087; Cooper AM, 2002, TRENDS MICROBIOL, V10, P221, DOI 10.1016/S0966-842X(02)02344-2; Cruz A, 2010, J EXP MED, V207, P1609, DOI 10.1084/jem.20100265; da Costa AC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00152; de Araujo JA, 2008, TUBERCULOSIS, V88, P474, DOI 10.1016/j.tube.2008.06.002; de Sousa EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047781; Silva BDD, 2009, VACCINE, V27, P4402, DOI 10.1016/j.vaccine.2009.05.049; Deng YH, 2014, J MICROBIOL IMMUNOL, V47, P48, DOI 10.1016/j.jmii.2012.11.005; Desel C, 2011, J INFECT DIS, V204, P1573, DOI 10.1093/infdis/jir592; Farinacci M, 2012, VACCINE, V30, P7608, DOI 10.1016/j.vaccine.2012.10.031; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Vasconcellos HLF, 2012, VACCINE, V30, P5999, DOI 10.1016/j.vaccine.2012.05.083; Geluk A, 2007, INFECT IMMUN, V75, P2914, DOI 10.1128/IAI.01990-06; Gomes LHF, 2011, J BACTERIOL, V193, P5600, DOI 10.1128/JB.05827-11; Hoft DF, 2008, J INFECT DIS, V198, P1491, DOI 10.1086/592450; Huynh KK, 2011, CURR OPIN IMMUNOL, V23, P464, DOI 10.1016/j.coi.2011.06.002; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Jain R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003869; Junqueira-Kipnis AP, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00188; Junqueira-Kipnis AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078639; Kamath AT, 2005, VACCINE, V23, P3753, DOI 10.1016/j.vaccine.2005.03.001; Kashyap RS, 2013, CLIN NEUROL NEUROSUR, V115, P678, DOI 10.1016/j.clineuro.2012.07.031; Kaufmann SHE, 2014, LANCET RESP MED, V2, P301, DOI 10.1016/S2213-2600(14)70033-5; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Lienhardt C, 2005, LANCET, V366, P1414, DOI 10.1016/S0140-6736(05)67535-6; Lin CW, 2012, APMIS, V120, P72, DOI 10.1111/j.1600-0463.2011.02815.x; Maroof A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003875; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Muranski P, 2011, IMMUNITY, V35, P972, DOI 10.1016/j.immuni.2011.09.019; Nascimento IP, 2000, INFECT IMMUN, V68, P4877, DOI 10.1128/IAI.68.9.4877-4883.2000; Nascimento IP, 2009, VACCINE, V27, P7346, DOI 10.1016/j.vaccine.2009.09.043; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Partnership WST, 2010, GLOB PLAN STOP TB 20; Pearl JE, 2012, EUR J IMMUNOL, V42, P3267, DOI 10.1002/eji.201142158; Rabahi MF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-148; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Shi CW, 2010, VACCINE, V28, P5237, DOI 10.1016/j.vaccine.2010.05.063; Soares AP, 2008, J IMMUNOL, V180, P3569, DOI 10.4049/jimmunol.180.5.3569; Spratt Joanne M, 2010, Bioeng Bugs, V1, P61, DOI 10.4161/bbug.1.1.10027; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Tang C, 2008, J INFECT DIS, V197, P1263, DOI 10.1086/586902; Tullius MV, 2008, INFECT IMMUN, V76, P5200, DOI 10.1128/IAI.00434-08; Ulrichs T, 2005, J INFECT DIS, V192, P89, DOI 10.1086/430621; Varaldo PB, 2004, INFECT IMMUN, V72, P3336, DOI 10.1128/IAI.72.6.3336-3343.2004; Wang C, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/563838; Wareham AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088149; *WHO, 1998, GLOB TUB CONTR; Wilson RA, 2004, J MOL BIOL, V335, P519, DOI 10.1016/j.jmb.2003.11.001; World Health Organization, 2013, GLOB TUB CONTR EP ST; Xu WM, 2005, CELL RES, V15, P63, DOI 10.1038/sj.cr.7290267; Yuk JM, 2014, CLIN EXP VACCINE RES, V3, P155, DOI 10.7774/cevr.2014.3.2.155; Zhang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071243	61	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112848	10.1371/journal.pone.0112848	http://dx.doi.org/10.1371/journal.pone.0112848			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398087	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500100
J	Duszyk, A; Bierzynska, M; Radzikowska, Z; Milanowski, P; Kus, R; Suffczynski, P; Michalska, M; Labecki, M; Zwolinski, P; Durka, P				Duszyk, Anna; Bierzynska, Maria; Radzikowska, Zofia; Milanowski, Piotr; Kus, Rafal; Suffczynski, Piotr; Michalska, Magdalena; Labecki, Maciej; Zwolinski, Piotr; Durka, Piotr			Towards an Optimization of Stimulus Parameters for Brain-Computer Interfaces Based on Steady State Visual Evoked Potentials	PLOS ONE			English	Article							GANGLION-CELLS; RECEPTIVE-FIELDS; PRIMATE RETINA; EEG; DYNAMICS; MONKEY	Efforts to construct an effective brain-computer interface (BCI) system based on Steady State Visual Evoked Potentials (SSVEP) commonly focus on sophisticated mathematical methods for data analysis. The role of different stimulus features in evoking strong SSVEP is less often considered and the knowledge on the optimal stimulus properties is still fragmentary. The goal of this study was to provide insight into the influence of stimulus characteristics on the magnitude of SSVEP response. Five stimuli parameters were tested: size, distance, colour, shape, and presence of a fixation point in the middle of each flickering field. The stimuli were presented on four squares on LCD screen, with each square highlighted by LEDs flickering with different frequencies. Brighter colours and larger dimensions of flickering fields resulted in a significantly stronger SSVEP response. The distance between stimulation fields and the presence or absence of the fixation point had no significant effect on the response. Contrary to a popular belief, these results suggest that absence of the fixation point does not reduce the magnitude of SSVEP response. However, some parameters of the stimuli such as colour and the size of the flickering field play an important role in evoking SSVEP response, which indicates that stimuli rendering is an important factor in building effective SSVEP based BCI systems.	[Duszyk, Anna; Radzikowska, Zofia] Univ Social Sci & Humanities, Warsaw, Poland; [Milanowski, Piotr; Kus, Rafal; Suffczynski, Piotr; Michalska, Magdalena; Labecki, Maciej; Durka, Piotr] Univ Warsaw, Fac Phys, Warsaw, Poland; [Bierzynska, Maria] Nencki Inst Expt Biol PAS, Warsaw, Poland; [Zwolinski, Piotr] Warsaw Mem Child Hosp, Dept Neurosurg, Warsaw, Poland	SWPS University of Social Sciences & Humanities; University of Warsaw; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Duszyk, A (corresponding author), Univ Social Sci & Humanities, Warsaw, Poland.	aduszyk@st.swps.edu.pl	Suffczynski, Piotr/ABG-5183-2020	Durka, Piotr/0000-0001-5816-8082; Duszyk, Anna/0000-0002-5984-2339; Suffczynski, Piotr/0000-0002-2300-1415	Polish funds for science; project "Optimisation of stimuli for SSVEP-based Brain Computer Interfaces based on psychophysiology of phenomenon" realized within the Ventures Programme of Foundation for Polish Science	Polish funds for science; project "Optimisation of stimuli for SSVEP-based Brain Computer Interfaces based on psychophysiology of phenomenon" realized within the Ventures Programme of Foundation for Polish Science	This research was financed from Polish funds for science and the project "Optimisation of stimuli for SSVEP-based Brain Computer Interfaces based on psychophysiology of phenomenon" realized within the Ventures Programme of Foundation for Polish Science, operated within the Innovative Economy Operational Programme (IE OP) 2007-2013 within European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Allison BZ, 2008, CLIN NEUROPHYSIOL, V119, P399, DOI 10.1016/j.clinph.2007.09.121; Allison BZ, 2007, EXPERT REV MED DEVIC, V4, P463, DOI 10.1586/17434440.4.4.463; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Busch NA, 2004, CLIN NEUROPHYSIOL, V115, P1810, DOI 10.1016/j.clinph.2004.03.015; Cheong SK, 2013, J NEUROSCI, V33, P6864, DOI 10.1523/JNEUROSCI.5208-12.2013; CRONER LJ, 1995, VISION RES, V35, P7, DOI 10.1016/0042-6989(94)E0066-T; Durka PJ, 2012, B POL ACAD SCI-TECH, V60, P427, DOI 10.2478/v10175-012-0054-1; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Fukunaga K., 2013, INTRO STAT PATTERN R; Gerloff M, 2012, BIOMED ENG-BIOMED TE, V57, P95, DOI 10.1515/bmt-2012-4119; Hevre A, 2007, BONFERONI SIDAK CORR, P103; Hoffmann U, 2009, I IEEE EMBS C NEUR E, P459; Holcombe AO, 2009, TRENDS COGN SCI, V13, P216, DOI 10.1016/j.tics.2009.02.005; Kalloniatis Michael, 2007, WEBVISION ORG RETINA; KAPLAN E, 1986, P NATL ACAD SCI USA, V83, P2755, DOI 10.1073/pnas.83.8.2755; Kaplan E, 2003, VISUAL NEUROSCIENCES, P481; Kelly SP, 2005, IEEE T BIO-MED ENG, V52, P1588, DOI 10.1109/TBME.2005.851510; Kus R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077536; LEE BB, 1990, J OPT SOC AM A, V7, P2223, DOI 10.1364/JOSAA.7.002223; Lotto RB, 2000, P NATL ACAD SCI USA, V97, P12834, DOI 10.1073/pnas.210369597; MACLEOD DIA, 1979, J OPT SOC AM, V69, P1183, DOI 10.1364/JOSA.69.001183; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Ng KB, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036008; Pastor MA, 2003, J NEUROSCI, V23, P11621; PURPURA K, 1990, VISUAL NEUROSCI, V4, P75, DOI 10.1017/S0952523800002789; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; REGAN D, 1975, NATURE, V253, P401, DOI 10.1038/253401a0; Regan D, 1977, ELECTROENCEPHALOGR C, V25, P231; Regan David, 2000, HUMAN PERCEPTION OBJ; Summers RJ, 2009, VISION RES, V49, P1894, DOI 10.1016/j.visres.2009.04.027; Vialatte F, 2008, P 15 INT C ADV NEUR; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; Wang NY, 2010, 2ND IEEE INTERNATIONAL CONFERENCE ON ADVANCED COMPUTER CONTROL (ICACC 2010), VOL. 4, P355, DOI 10.1109/ICACC.2010.5486907; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Zhu Danhua, 2010, Comput Intell Neurosci, P702357, DOI 10.1155/2010/702357	37	42	43	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112099	10.1371/journal.pone.0112099	http://dx.doi.org/10.1371/journal.pone.0112099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398134	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500032
J	Nagasaki, H; Katsumata, T; Oishi, H; Tai, PH; Sekiguchi, Y; Koshida, R; Jung, Y; Kudo, T; Takahashi, S				Nagasaki, Haruka; Katsumata, Tokio; Oishi, Hisashi; Tai, Pei-Han; Sekiguchi, Yukari; Koshida, Ryusuke; Jung, Yunshin; Kudo, Takashi; Takahashi, Satoru			Generation of Insulin-Producing Cells from the Mouse Liver Using beta Cell-Related Gene Transfer Including Mafa and Mafb	PLOS ONE			English	Article							IN-VIVO; DNA-BINDING; PHOSPHORYLATION; EXPRESSION; GLUCOSE; MICE; PANCREAS; PLASTICITY; TARGET	Recent studies on the large Maf transcription factors have shown that Mafb and Mafa have respective and distinctive roles in beta-cell development and maturation. However, whether this difference in roles is due to the timing of the gene expression (roughly, expression of Mafb before birth and of Mafa after birth) or to the specific function of each gene is unclear. Our aim was to examine the functional differences between these genes that are closely related to beta cells by using an in vivo model of beta-like cell generation. We monitored insulin gene transcription by measuring bioluminescence emitted from the liver of insulin promoter-luciferase transgenic (MIP-Luc-VU) mice. Adenoviral gene transfers of Pdx1/Neurod/Mafa (PDA) and Pdx1/Neurod/Mafb (PDB) combinations generated intense luminescence from the liver that lasted for more than 1 week and peaked at 3 days after transduction. The peak signal intensities of PDA and PDB were comparable. However, PDA but not PDB transfer resulted in significant bioluminescence on day 10, suggesting that Mafa has a more sustainable role in insulin gene activation than does Mafb. Both PDA and PDB transfers ameliorated the glucose levels in a streptozotocin (STZ)-induced diabetic model for up to 21 days and 7 days, respectively. Furthermore, PDA transfer induced several gene expressions necessary for glucose sensing and insulin secretion in the liver on day 9. However, a glucose tolerance test and liver perfusion experiment did not show glucose-stimulated insulin secretion from intrahepatic beta-like cells. These results demonstrate that bioluminescence imaging in MIP-Luc-VU mice provides a noninvasive means of detecting beta-like cells in the liver. They also show that Mafa has a markedly intense and sustained role in beta-like cell production in comparison with Mafb.	[Nagasaki, Haruka; Katsumata, Tokio; Oishi, Hisashi; Tai, Pei-Han; Sekiguchi, Yukari; Koshida, Ryusuke; Jung, Yunshin; Kudo, Takashi; Takahashi, Satoru] Univ Tsukuba, Fac Med, Dept Anat & Embryol, Tsukuba, Ibaraki, Japan; [Oishi, Hisashi; Takahashi, Satoru] Univ Tsukuba, Life Sci Ctr, Tsukuba Adv Res Alliance, Tsukuba, Ibaraki, Japan; [Takahashi, Satoru] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba	Oishi, H (corresponding author), Univ Tsukuba, Fac Med, Dept Anat & Embryol, Tsukuba, Ibaraki, Japan.	hoishi@md.tsukuba.ac.jp; satoruta@md.tsukuba.ac.jp		Jung, Yunshin/0000-0001-8093-5620; Kudo, Takashi/0000-0001-5477-7235; Koshida, Ryusuke/0000-0003-4726-7282	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [21220009]	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research (21220009) from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo-Mazzucato C, 2013, DIABETES, V62, P1569, DOI 10.2337/db12-0849; Artner I, 2008, J ENDOCRINOL, V198, P271, DOI 10.1677/JOE-08-0063; Artner I, 2010, DIABETES, V59, P2530, DOI 10.2337/db10-0190; Banga A, 2012, P NATL ACAD SCI USA, V109, P15336, DOI 10.1073/pnas.1201701109; Benkhelifa S, 2001, MOL CELL BIOL, V21, P4441, DOI 10.1128/MCB.21.14.4441-4452.2001; Blum B, 2012, NAT BIOTECHNOL, V30, P261, DOI 10.1038/nbt.2141; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; Guo SL, 2010, J BIOL CHEM, V285, P12655, DOI 10.1074/jbc.M110.105759; Guo SL, 2009, J BIOL CHEM, V284, P759, DOI 10.1074/jbc.M806314200; Ham DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079076; Han S, 2007, MOL CELL BIOL, V27, P6593, DOI 10.1128/MCB.01573-06; Hang Y, 2011, TRENDS ENDOCRIN MET, V22, P364, DOI 10.1016/j.tem.2011.05.003; Horb ME, 2003, CURR BIOL, V13, P105, DOI 10.1016/S0960-9822(02)01434-3; Kajihara M, 2003, BIOCHEM BIOPH RES CO, V312, P831, DOI 10.1016/j.bbrc.2003.10.196; Kaneto H, 2005, J BIOL CHEM, V280, P15047, DOI 10.1074/jbc.M412013200; Kataoka K, 2007, J BIOCHEM, V141, P775, DOI 10.1093/jb/mvm105; Katsumata T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060411; Kojima H, 2003, NAT MED, V9, P596, DOI 10.1038/nm867; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lu YX, 2004, MOL THER, V9, P428, DOI 10.1016/j.ymthe.2004.01.008; Minami K, 2005, P NATL ACAD SCI USA, V102, P15116, DOI 10.1073/pnas.0507567102; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; NISHIZAWA M, 1989, P NATL ACAD SCI USA, V86, P7711, DOI 10.1073/pnas.86.20.7711; Palumbo MO, 2006, DIABETES, V55, P2595, DOI 10.2337/db05-1651; Puri S, 2010, DEV CELL, V18, P342, DOI 10.1016/j.devcel.2010.02.005; Rocques N, 2007, MOL CELL, V28, P584, DOI 10.1016/j.molcel.2007.11.009; Sadikot Ruxana T., 2008, V477, P383, DOI 10.1007/978-1-60327-517-0_29; Sekiguchi Y, 2012, EXP ANIM TOKYO, V61, P445, DOI 10.1538/expanim.61.445; Shao CL, 2009, J BIOL CHEM, V284, P3117, DOI 10.1074/jbc.M806286200; Szabat M, 2012, DIABETES, V61, P1365, DOI 10.2337/db11-1361; Virostko J, 2010, MOL IMAGING BIOL, V12, P42, DOI 10.1007/s11307-009-0240-1; Walde SSI, 2002, LIFE SCI, V71, P1681, DOI 10.1016/S0024-3205(02)01918-5; Yamazaki H, 2012, MOL CELL BIOL, V32, P808, DOI 10.1128/MCB.06543-11; Yechoor V, 2009, DEV CELL, V16, P358, DOI 10.1016/j.devcel.2009.01.012; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001; Zinn KR, 2008, ILAR J, V49, P103, DOI 10.1093/ilar.49.1.103	36	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113022	10.1371/journal.pone.0113022	http://dx.doi.org/10.1371/journal.pone.0113022			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397325	gold, Green Submitted, Green Published			2022-12-27	WOS:000345558500124
J	Ohno, M; Deguchi, F; Izumi, K; Ishigaki, H; Sarui, H; Sasaki, A; Segawa, T; Yamaki, T; Kojima, T; Ohashi, H				Ohno, Michiya; Deguchi, Fumiko; Izumi, Kumiko; Ishigaki, Hirotoshi; Sarui, Hiroshi; Sasaki, Akihiko; Segawa, Tomonori; Yamaki, Takahiko; Kojima, Takao; Ohashi, Hiroshige			Correlation between Renal Function and Common Risk Factors for Chronic Kidney Disease in a Healthy Middle-Aged Population: A Prospective Observational 2-Year Study	PLOS ONE			English	Article							SERUM URIC-ACID; GENERAL JAPANESE POPULATION; COMMUNITY-BASED POPULATION; METABOLIC SYNDROME; BLOOD-PRESSURE; INDEPENDENT MECHANISM; SCREENED COHORT; HYPERURICEMIA; HYPERTENSION; PROGRESSION	Background/Aims: Age, proteinuria, metabolic syndrome, and hyperuricemia are the reported risk factors for chronic kidney disease (CKD) and cardiovascular disease (CVD). However, the best predictor of changes in renal function in the early stages of renal disease in a healthy middle-aged population is still unknown. Our study evaluated the correlation between changes in renal function and common risk factors to determine such a predictor. Methods: In total, 2,853 healthy persons aged <= 50 years participated in the study. They had no proteinuria and were not on medications for hypertension, diabetes mellitus, hyperlipidemia, or hyperuricemia. Over 2 years, participants underwent annual health screening. The relationship between changes in estimated glomerular filtration rate (eGFR) and changes in risk factors for CKD was evaluated using univariate and multivariate linear regression analyses. Results: Over 2 years, eGFR showed a significant decrease. Univariate regression analysis revealed that changes in fasting plasma glucose (FPG), total cholesterol, LDL-cholesterol, serum uric acid levels, and hemoglobin showed a significant negative correlation with changes in eGFR. Multiple regression analysis confirmed that changes in FPG, serum uric acid levels, in particular, and hemoglobin had a significant negative correlation with changes in eGFR. Conclusion: The changes in eGFR and other variables over 2 years were small and could be within expected biologic variation. A longer observational study is needed to elucidate whether FPG, serum uric acid and hemoglobin represent the earliest markers of eGFR decline.	[Ohno, Michiya; Izumi, Kumiko; Ishigaki, Hirotoshi; Ohashi, Hiroshige] Asahi Univ, Sch Dent, Murakami Mem Hosp, Div Nephrol, Gifu, Japan; [Deguchi, Fumiko; Kojima, Takao] Asahi Univ, Sch Dent, Murakami Mem Hosp, Div Hlth Ctr, Gifu, Japan; [Sarui, Hiroshi; Sasaki, Akihiko] Asahi Univ, Sch Dent, Murakami Mem Hosp, Div Diabet & Endocrinol, Gifu, Japan; [Segawa, Tomonori; Yamaki, Takahiko] Asahi Univ, Sch Dent, Murakami Mem Hosp, Div Cardiol, Gifu, Japan	Asahi University; Asahi University; Asahi University; Asahi University	Ohno, M (corresponding author), Asahi Univ, Sch Dent, Murakami Mem Hosp, Div Nephrol, Gifu, Japan.	mohno@murakami.asahi-u.ac.jp						Badve SV, 2011, NAT REV NEPHROL, V7, P295, DOI 10.1038/nrneph.2010.186; Bellomo G, 2010, AM J KIDNEY DIS, V56, P264, DOI 10.1053/j.ajkd.2010.01.019; Choi HK, 2007, AM J MED, V120, P442, DOI 10.1016/j.amjmed.2006.06.040; Culleton BF, 1999, ARCH INTERN MED, V159, P1785, DOI 10.1001/archinte.159.15.1785; Feig DI, 2009, CURR OPIN NEPHROL HY, V18, P526, DOI 10.1097/MNH.0b013e328330d9d0; Ford ES, 2007, CIRCULATION, V115, P2526, DOI 10.1161/CIRCULATIONAHA.106.657627; Forman JP, 2007, J AM SOC NEPHROL, V18, P287, DOI 10.1681/ASN.2006080865; Girillo P, 2006, J AM SOC NEPHROL, V17, pS165, DOI 10.1681/ASN.2006080909; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Imai E, 2008, HYPERTENS RES, V31, P433, DOI 10.1291/hypres.31.433; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Iseki K, 2001, HYPERTENS RES, V24, P691, DOI 10.1291/hypres.24.691; Iseki K, 2013, HYPERTENS RES, V36, P650, DOI 10.1038/hr.2013.11; Ishizaka N, 2005, ARTERIOSCL THROM VAS, V25, P1038, DOI 10.1161/01.ATV.0000161274.87407.26; Kanbay M, 2011, AM J NEPHROL, V33, P325, DOI 10.1159/000324916; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Kang DH, 2002, J AM SOC NEPHROL, V13, P2888, DOI 10.1097/01.ASN.0000034910.58454.FD; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Kimiyoshi I, 2012, NAT COMMUN, V3, P1; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; Mazzali M, 2002, AM J PHYSIOL-RENAL, V282, pF991, DOI 10.1152/ajprenal.00283.2001; Nagahama K, 2004, HYPERTENS RES, V27, P835, DOI 10.1291/hypres.27.835; Nagahama K, 2004, HYPERTENS RES, V27, P227, DOI 10.1291/hypres.27.227; Nakanishi N, 1999, INT J EPIDEMIOL, V28, P888, DOI 10.1093/ije/28.5.888; Nashar K, 2012, ADV CHRONIC KIDNEY D, V19, P386, DOI 10.1053/j.ackd.2012.05.004; Ninomiya T, 2005, KIDNEY INT, V68, P228, DOI 10.1111/j.1523-1755.2005.00397.x; Ninomiya T, 2006, AM J KIDNEY DIS, V48, P383, DOI 10.1053/j.ajkd.2006.06.003; Ryan TP, 2009, AM J NEPHROL, V29, P620, DOI 10.1159/000194455; Sanchez-Lozada LG, 2002, AM J PHYSIOL-RENAL, V283, pF1105, DOI 10.1152/ajprenal.00170.2002; Siu YP, 2006, AM J KIDNEY DIS, V47, P51, DOI 10.1053/j.ajkd.2005.10.006; Sonoda H, 2011, AM J NEPHROL, V33, P352, DOI 10.1159/000326848; Sundstrom J, 2005, HYPERTENSION, V45, P28, DOI 10.1161/01.HYP.0000150784.92944.9a; Suzuki K, 2013, CLIN EXP NEPHROL, V17, P541, DOI 10.1007/s10157-012-0743-y; Weiner DE, 2008, J AM SOC NEPHROL, V19, P1204, DOI 10.1681/ASN.2007101075; Yamada T, 2011, AM J MED SCI, V342, P461, DOI 10.1097/MAJ.0b013e318218bd89; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Yu MA, 2010, J HYPERTENS, V28, P1234, DOI 10.1097/HJH.0b013e328337da1d	39	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113263	10.1371/journal.pone.0113263	http://dx.doi.org/10.1371/journal.pone.0113263			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396414	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558500144
J	Rodriguez, J; Pitts, JP; von Dohlen, CD; Wilson, JS				Rodriguez, Juanita; Pitts, James P.; von Dohlen, Carol D.; Wilson, Joseph S.			Mullerian Mimicry as a Result of Codivergence between Velvet Ants and Spider Wasps	PLOS ONE			English	Article							EVOLUTION; HYMENOPTERA; DIET; MUTILLIDAE; PIGEONS; FROGS	Recent studies have delineated a large Nearctic Mullerian mimicry complex in Dasymutilla velvet ants. Psorthaspis spider wasps live in areas where this mimicry complex is found and are phenotypically similar to Dasymutilla. We tested the idea that Psorthaspis spider wasps are participating in the Dasymutilla mimicry complex and that they codiverged with Dasymutilla. We performed morphometric analyses and human perception tests, and tabulated distributional records to determine the fit of Psorthaspis to the Dasymutilla mimicry complex. We inferred a dated phylogeny using nuclear molecular markers (28S, elongation factor 1-alpha, long-wavelength rhodopsin and wingless) for Psorthaspis species and compared it to a dated phylogeny of Dasymutilla. We tested for codivergence between the two groups using two statistical analyses. Our results show that Psorthaspis spider wasps are morphologically similar to the Dasymutilla mimicry rings. In addition, our tests indicate that Psorthaspis and Dasymutilla codiverged to produce similar color patterns. This study expands the breadth of the Dasymutilla Mullerian mimicry complex and provides insights about how codivergence influenced the evolution of mimicry in these groups.	[Rodriguez, Juanita; Pitts, James P.; von Dohlen, Carol D.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Wilson, Joseph S.] Utah State Univ Tooele, Dept Biol, Tooele, UT USA	Utah System of Higher Education; Utah State University	Rodriguez, J (corresponding author), Utah State Univ, Dept Biol, Logan, UT 84322 USA.	juanitarodrigueza@gmail.com	Rodriguez, Juanita/M-6973-2016	Rodriguez, Juanita/0000-0001-9922-1978; von Dohlen, Carol/0000-0002-3961-251X	National Science Foundation [DEB-0743763]; Utah Agricultural Experiment Station, Utah State UAES [8743]	National Science Foundation(National Science Foundation (NSF)); Utah Agricultural Experiment Station, Utah State UAES	This work was supported by National Science Foundation (www.nsf.gov) award DEB-0743763 to JPP and CDvD, and Utah Agricultural Experiment Station (http://uaes.usu.edu/), Utah State UAES #8743, to JPP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACORN J H, 1988, Coleopterists Bulletin, V42, P28; Anderson MJ, 2005, PERMANOVA; Bain RS, 2007, P R SOC B, V274, P1949, DOI 10.1098/rspb.2007.0458; BENSON WW, 1972, SCIENCE, V176, P936, DOI 10.1126/science.176.4037.936; BEST TL, 1987, SOUTHWEST NAT, V32, P415, DOI 10.2307/3671473; Chouteau M, 2011, BIOL LETTERS, V7, P796, DOI 10.1098/rsbl.2011.0039; Cicek Kerim, 2007, Turkish Journal of Zoology, V31, P83; Cuthill JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036464; DITTRICH W, 1993, P ROY SOC B-BIOL SCI, V251, P195, DOI 10.1098/rspb.1993.0029; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edwards G.B., 1984, Peckhamia, V2, P46; EVANS H E, 1968, Psyche (Cambridge), V75, P1, DOI 10.1155/1968/76089; Flanagan NS, 2004, P NATL ACAD SCI USA, V101, P9704, DOI 10.1073/pnas.0306243101; Futuyma D.J., 1983, P1; Gilbert L.E., 1983, P263; Green PR, 1999, BEHAV PROCESS, V46, P97, DOI 10.1016/S0376-6357(99)00022-4; Hines HM, 2011, P NATL ACAD SCI USA, V108, P19666, DOI 10.1073/pnas.1110096108; Hommola K, 2009, MOL BIOL EVOL, V26, P1457, DOI 10.1093/molbev/msp062; Honkavaara J, 2002, OIKOS, V98, P505, DOI 10.1034/j.1600-0706.2002.980315.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jenks G. E., 1938, National Geographic Magazine Washington, V74, P807; Jones RT, 2013, EVOLUTION, V67, P2323, DOI 10.1111/evo.12114; Lanteri AA, 2005, COLEOPTS BULL, V59, P47, DOI 10.1649/683; Legendre P, 2002, SYST BIOL, V51, P217, DOI 10.1080/10635150252899734; Manley DG, 2001, SOUTHWEST NAT, V46, P221, DOI 10.2307/3672534; MAWDSLEY JR, 1994, COLEOPTS BULL, V48, P115; Merrill RM, 2009, CURR BIOL, V19, pR687, DOI 10.1016/j.cub.2009.07.008; MULLER F., 1879, T ENTOMOL SOC LOND, V1879, pxx; NENTWIG W, 1985, STUD NEOTROP FAUNA E, V20, P113, DOI 10.1080/01650528509360679; NIJHOUT HF, 1994, BIOSCIENCE, V44, P148, DOI 10.2307/1312251; Nylander J.A.A, 2004, MRMODELTEST V2; Page RDM, 2003, TANGLED TREES: PHYLOGENY, COSPECIATION AND COEVOLUTION, P1; Parker ML, 2004, J HERPETOL, V38, P127, DOI 10.1670/19-03N; Penney HD, 2012, NATURE, V483, P461, DOI 10.1038/nature10961; Punzo F, 2003, TEX J SCI, V55, P75; R Core Team, 2021, R LANGUAGE ENV STAT; Rambaut A, 2013, TRACER V1 5; Reed RD, 2011, SCIENCE, V333, P1137, DOI 10.1126/science.1208227; Rodriguez J, 2014, J BIOGEOGR IN PRESS; Schmidt JO, 2004, J KANSAS ENTOMOL SOC, V77, P402, DOI 10.2317/E-39.1; SHEPPARD PM, 1985, PHILOS T R SOC B, V308, P433, DOI 10.1098/rstb.1985.0066; Symula R, 2001, P ROY SOC B-BIOL SCI, V268, P2415, DOI 10.1098/rspb.2001.1812; Toledo Luis Felipe, 2009, International Journal of Zoology, V2009, P1, DOI 10.1155/2009/910892; Tschopp A, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-74; Williams KA, 2012, THESIS UTAH STATE U; Wilson JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061610; Wilson JS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2275	49	14	14	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112942	10.1371/journal.pone.0112942	http://dx.doi.org/10.1371/journal.pone.0112942			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396424	Green Submitted, gold, Green Published			2022-12-27	WOS:000345558500116
J	Eli, K; Howell, K; Fisher, PA; Nowicka, P				Eli, Karin; Howell, Kyndal; Fisher, Philip A.; Nowicka, Paulina			"Those Comments Last Forever'': Parents and Grandparents of Preschoolers Recount How They Became Aware of Their Own Body Weights as Children	PLOS ONE			English	Article							PREVENTION; OBESITY; DISSATISFACTION; IMAGE; MEDIA; ASSOCIATIONS; OVERWEIGHT; STIGMA; GIRLS; FAT	Background: Parents' and grandparents' willingness to talk about children's body weights may be influenced by their own childhood experiences of body weight awareness and 'weight talk' in the family; however, little is known about how adults describe their recollected weight-related childhood experiences. Aims: This paper examines how parents and grandparents of preschoolers describe the emergence of their own body weight awareness in childhood or adolescence. The analysis highlights the sources that participants identify as having instigated their body weight awareness, the feelings and experiences participants associate with the experience of becoming aware of their body weights, and their framings of potential links between childhood experiences and attitudes and practices in adulthood. Methods: 49 participants (22 parents, 27 grandparents, 70% women, 60% with overweight/obesity) from sixteen low-income families of children aged 3-5 years (50% girls, 56% with overweight/obesity) in the Pacific Northwest were interviewed. The interviews were videotaped, transcribed, and analyzed qualitatively. Results: Twenty-five participants (51%) said they became aware of their body weights in childhood or adolescence. Fourteen participants said their body weight awareness emerged through comments made by others, with the majority citing parents or peers. No participant described the emergence of body weight awareness in positive terms. Four participants directly linked their own negative experiences to the decision not to discuss body weight with their preschoolers. All four cited critical comments from their parents as instigating their own body weight awareness in childhood. Conclusions: In most cases, participants associated their emergent awareness of body weight with overtly negative feelings or consequences; some participants said these negative experiences continued to affect them as adults. Since family-based childhood obesity interventions involve open discussion of children's body sizes, the results suggest that clinicians should reframe the discussion to deconstruct obesity stigma and emphasize inclusive, affirmative, and health-focused messages.	[Eli, Karin; Nowicka, Paulina] Univ Oxford, Inst Social & Cultural Anthropol, Unit Biocultural Variat & Obes, Oxford, England; [Howell, Kyndal; Fisher, Philip A.] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; [Nowicka, Paulina] Karolinska Inst, Dept Clin Sci Intervent & Technol, Pediat Unit, Stockholm, Sweden	University of Oxford; University of Oregon; Karolinska Institutet	Eli, K (corresponding author), Univ Oxford, Inst Social & Cultural Anthropol, Unit Biocultural Variat & Obes, Oxford, England.	karin.eli@anthro.ox.ac.uk		Fisher, Philip/0000-0002-5399-7233; Nowicka, Paulina/0000-0001-9707-8768; Eli, Karin/0000-0001-9132-8404	Sweden-America Foundation; Oregon Social Learning Center; Marie Curie VINNMER International Qualification [2011-03443]	Sweden-America Foundation; Oregon Social Learning Center; Marie Curie VINNMER International Qualification	PN received funding for this study from the Sweden-America Foundation, the Oregon Social Learning Center and the Marie Curie VINNMER International Qualification (grant number 2011-03443). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ata RN, 2010, OBESITY FACTS, V3, P41, DOI 10.1159/000276547; Becker A, 2004, CULT MED PSYCHIAT, V28, P533, DOI 10.1007/s11013-004-1067-5; Borra ST, 2003, J AM DIET ASSOC, V103, P721, DOI 10.1053/jada.2003.50140; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brewis AA, 2011, CURR ANTHROPOL, V52, P269, DOI 10.1086/659309; Bronfenbrenner U., 1992, 6 THEORIES CHILD DEV, P187, DOI DOI 10.1037/10518-046; Clark L, 2006, SOC DEV, V15, P628, DOI 10.1111/j.1467-9507.2006.00361.x; Davison KK, 2001, PEDIATRICS, V107, P46, DOI 10.1542/peds.107.1.46; Eisenberg ME, 2003, ARCH PEDIAT ADOL MED, V157, P733, DOI 10.1001/archpedi.157.8.733; Hargreaves Duane A, 2004, Body Image, V1, P351, DOI 10.1016/j.bodyim.2004.10.002; Hart LM, 2014, BODY IMAGE, V11, P418, DOI 10.1016/j.bodyim.2014.06.010; Hayes S, 2010, BRIT J DEV PSYCHOL, V28, P413, DOI 10.1348/026151009X424240; Hoelscher DM, 2013, J ACAD NUTR DIET, V113, P1375, DOI 10.1016/j.jand.2013.08.004; Krebs NF, 2007, PEDIATRICS, V120, pS193, DOI 10.1542/peds.2007-2329D; Kuczmarski RJ., 2000, ADV DATA, P1; Kuczmarski RJ., 2002, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Latner JD, 2003, OBES RES, V11, P452, DOI 10.1038/oby.2003.61; McCabe MP, 2004, J PSYCHOSOM RES, V56, P675, DOI 10.1016/S0022-3999(03)00129-6; Neumark-Sztainer D, 2005, INT J EAT DISORDER, V38, P220, DOI 10.1002/eat.20181; Neumark-Sztainer D, 2002, INT J OBESITY, V26, P123, DOI 10.1038/sj.ijo.0801853; Neumark-Sztainer D, 2010, J ADOLESCENT HEALTH, V47, P270, DOI 10.1016/j.jadohealth.2010.02.001; O'Dea JA, 2005, HEALTH EDUC RES, V20, P259, DOI 10.1093/her/cyg116; Oude Luttikhuis H, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001872.pub2; Pagnini D, 2009, INT J PEDIATR OBES, V4, P233, DOI 10.3109/17477160902763333; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Savage JS, 2007, J LAW MED ETHICS, V35, P22, DOI 10.1111/j.1748-720X.2007.00111.x; Schwartz DJ, 1999, INT J EAT DISORDER, V25, P339, DOI 10.1002/(SICI)1098-108X(199904)25:3<339::AID-EAT13>3.0.CO;2-V; Sleddens EFC, 2012, OBES REV, V13, P1015, DOI 10.1111/j.1467-789X.2012.01018.x; Smolak L, 1999, INT J EAT DISORDER, V25, P263, DOI 10.1002/(SICI)1098-108X(199904)25:3&lt;263::AID-EAT3&gt;3.0.CO;2-V; Starks H, 2007, QUAL HEALTH RES, V17, P1372, DOI 10.1177/1049732307307031; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; VAN IJZENDOORN MH, 1992, DEV REV, V12, P76, DOI 10.1016/0273-2297(92)90004-L; Ventura AK, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-15; World Health Organization, 2000, WHO TECHN REP SER, P894	34	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e111974	10.1371/journal.pone.0111974	http://dx.doi.org/10.1371/journal.pone.0111974			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY6YT	25393236	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300026
J	Kamburova, EG; Koenen, HJPM; van den Hoogen, MWF; Baas, MC; Joosten, I; Hilbrands, LB				Kamburova, Elena G.; Koenen, Hans J. P. M.; van den Hoogen, Martijn W. F.; Baas, Marije C.; Joosten, Irma; Hilbrands, Luuk B.			Longitudinal Analysis of T and B Cell Phenotype and Function in Renal Transplant Recipients with or without Rituximab Induction Therapy	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ALLOGRAFT DYSFUNCTION; CYTOKINE PRODUCTION; DEPLETING THERAPY; LYMPHOCYTE; REJECTION; PROLIFERATION; RESPONSES; BAFF; DIFFERENTIATION	Background: Prevention of rejection after renal transplantation requires treatment with immunosuppressive drugs. Data on their in vivo effects on T-and B-cell phenotype and function are limited. Methods: In a randomized double-blind placebo-controlled study to prevent renal allograft rejection, patients were treated with tacrolimus, mycophenolate mofetil (MMF), steroids, and a single dose of rituximab or placebo during transplant surgery. In a subset of patients, we analyzed the number and phenotype of peripheral T and B cells by multiparameter flow cytometry before transplantation, and at 3, 6, 12, and 24 months after transplantation. Results: In patients treated with tacrolimus/MMF/steroids the proportion of central memory CD4(+) and CD8(+) T cells was higher at 3 months post-transplant compared to pre-transplant levels. In addition, the ratio between the percentage of central memory CD4(+) and CD4(+) regulatory T cells was significantly higher up to 24 months post-transplant compared to pre-transplant levels. Interestingly, treatment with tacrolimus/MMF/steroids resulted in a shift toward a more memory-like B-cell phenotype post-transplant. Addition of a single dose of rituximab resulted in a long-lasting B-cell depletion. At 12 months post-transplant, the small fraction of repopulated B cells consisted of a high percentage of transitional B cells. Rituximab treatment had no effect on the T-cell phenotype and function post-transplant. Conclusions: Renal transplant recipients treated with tacrolimus/MMF/steroids show an altered memory T and B-cell compartment post-transplant. Additional B-cell depletion by rituximab leads to a relative increase of transitional and memory-like B cells, without affecting T-cell phenotype and function.	[Kamburova, Elena G.; Koenen, Hans J. P. M.; Joosten, Irma] Radboud Univ Nijmegen Med Ctr, Dept Lab Med Med Immunol, Nijmegen, Netherlands; [van den Hoogen, Martijn W. F.; Baas, Marije C.; Hilbrands, Luuk B.] Radboud Univ Nijmegen Med Ctr, Dept Nephrol, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Hilbrands, LB (corresponding author), Radboud Univ Nijmegen Med Ctr, Dept Nephrol, Nijmegen, Netherlands.	Luuk.Hilbrands@radboudumc.nl	van den Hoogen, Martijn W.F./H-7614-2012; Hilbrands, Luuk/B-4921-2011; Baas, Marije C/L-4179-2015; Koenen, Hans J.P.M./A-2852-2014; Kamburova, Elena/AAM-8485-2021; Joosten, Irma/N-4418-2013; Kamburova, Elena/M-2202-2013	van den Hoogen, Martijn W.F./0000-0003-0790-2405; Hilbrands, Luuk/0000-0002-4935-9765; Kamburova, Elena/0000-0003-0252-5153; Joosten, Irma/0000-0003-2950-4977; Kamburova, Elena/0000-0003-0252-5153	Dutch Kidney Foundation [C09-2301]	Dutch Kidney Foundation	This study was supported by research funding from the Dutch Kidney Foundation (nr C09-2301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Or A, 2010, ANN NEUROL, V67, P452, DOI 10.1002/ana.21939; Bloom D, 2009, AM J TRANSPLANT, V9, P1835, DOI 10.1111/j.1600-6143.2009.02710.x; Bohnhorst JO, 2001, J IMMUNOL, V167, P3610, DOI 10.4049/jimmunol.167.7.3610; Chapman JR, 2005, J AM SOC NEPHROL, V16, P3015, DOI 10.1681/ASN.2005050463; CUPPS TR, 1985, J CLIN INVEST, V75, P754, DOI 10.1172/JCI111757; de ITI, 2010, ANN RHEUM DIS, V69, P2181; Demmers MWHJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064916; Duddy ME, 2004, J IMMUNOL, V172, P3422, DOI 10.4049/jimmunol.172.6.3422; Eickenberg S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3835; HANSON RG, 1986, HEPATOLOGY, V6, P173, DOI 10.1002/hep.1840060204; Harris DP, 2000, NAT IMMUNOL, V1, P475, DOI 10.1038/82717; Heidt S, 2008, TRANSPLANTATION, V86, P1292, DOI 10.1097/TP.0b013e3181874a36; Hippen BE, 2005, AM J TRANSPLANT, V5, P2248, DOI 10.1111/j.1600-6143.2005.01009.x; Iwata S, 2011, J RHEUMATOL, V38, P633, DOI 10.3899/jrheum.100729; JANEWAY CA, 1987, J IMMUNOL, V138, P1051; Jordan SC, 2011, CURR OPIN ORGAN TRAN, V16, P416, DOI 10.1097/MOT.0b013e32834874f7; Kahan BD, 2003, NAT REV IMMUNOL, V3, P831, DOI 10.1038/nri1204; Kamburova EG, 2013, AM J TRANSPLANT, V13, P1503, DOI 10.1111/ajt.12220; Kamburova EG, 2012, AM J TRANSPLANT, V12, P341, DOI 10.1111/j.1600-6143.2011.03833.x; Koenen HJPM, 2003, TRANSPLANTATION, V75, P1581, DOI 10.1097/01.TP.0000053752.87383.67; Kreijveld E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002711; Lechler RI, 2003, NAT REV IMMUNOL, V3, P147, DOI 10.1038/nri1002; Lehnhardt A, 2012, PEDIATR NEPHROL, V27, P1389, DOI 10.1007/s00467-012-2142-8; Matz M, 2006, KIDNEY INT, V69, P1683, DOI 10.1038/sj.ki.5000343; Otten HG, 2012, AM J TRANSPLANT, V12, P1618, DOI 10.1111/j.1600-6143.2011.03985.x; Piccio L, 2010, ARCH NEUROL-CHICAGO, V67, P707, DOI 10.1001/archneurol.2010.99; Pieper K, 2013, J ALLERGY CLIN IMMUN, V131, P959, DOI 10.1016/j.jaci.2013.01.046; Safinia N, 2010, KIDNEY INT, V78, pS2, DOI 10.1038/ki.2010.416; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2; Smeekens SP, 2013, TRANSPL IMMUNOL, V28, P183, DOI 10.1016/j.trim.2013.04.008; Stasi R, 2008, BLOOD, V112, P1147, DOI 10.1182/blood-2007-12-129262; Thurlings RM, 2008, ANN RHEUM DIS, V67, P917, DOI 10.1136/ard.2007.080960; Vallerskog T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2076; van de Berg PJEJ, 2012, IMMUNOLOGY, V136, P198, DOI 10.1111/j.1365-2567.2012.03570.x; Vigna-Perez M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1954; Warnatz K, 2009, P NATL ACAD SCI USA, V106, P13945, DOI 10.1073/pnas.0903543106; Wood KJ, 2012, NAT REV IMMUNOL, V12, P417, DOI 10.1038/nri3227; Zarkhin V, 2008, KIDNEY INT, V74, P664, DOI 10.1038/ki.2008.249; Zarkhin V, 2010, TRANSPLANT REV-ORLAN, V24, P67, DOI 10.1016/j.trre.2010.01.004; Zarkhin V, 2009, TRANSPLANTATION, V88, P1229, DOI 10.1097/TP.0b013e3181bbba1a	41	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112658	10.1371/journal.pone.0112658	http://dx.doi.org/10.1371/journal.pone.0112658			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393622	gold, Green Published, Green Submitted			2022-12-27	WOS:000347709300080
J	Morelli, A; Haugner, J; Seelig, B				Morelli, Aleardo; Haugner, John; Seelig, Burckhard			Thermostable Artificial Enzyme Isolated by In Vitro Selection	PLOS ONE			English	Article							DIRECTED EVOLUTION; MESSENGER-RNA; PROTEIN STABILITY; STRATEGIES; LESSONS; DESIGN	Artificial enzymes hold the potential to catalyze valuable reactions not observed in nature. One approach to build artificial enzymes introduces mutations into an existing protein scaffold to enable a new catalytic activity. This process commonly results in a simultaneous reduction of protein stability as an undesired side effect. While protein stability can be increased through techniques like directed evolution, care needs to be taken that added stability, conversely, does not sacrifice the desired activity of the enzyme. Ideally, enzymatic activity and protein stability are engineered simultaneously to ensure that stable enzymes with the desired catalytic properties are isolated. Here, we present the use of the in vitro selection technique mRNA display to isolate enzymes with improved stability and activity in a single step. Starting with a library of artificial RNA ligase enzymes that were previously isolated at ambient temperature and were therefore mostly mesophilic, we selected for thermostable active enzyme variants by performing the selection step at 65 degrees C. The most efficient enzyme, ligase 10C, was not only active at 65 degrees C, but was also an order of magnitude more active at room temperature compared to related enzymes previously isolated at ambient temperature. Concurrently, the melting temperature of ligase 10C increased by 35 degrees compared to these related enzymes. While low stability and solubility of the previously selected enzymes prevented a structural characterization, the improved properties of the heat-stable ligase 10C finally allowed us to solve the three-dimensional structure by NMR. This artificial enzyme adopted an entirely novel fold that has not been seen in nature, which was published elsewhere. These results highlight the versatility of the in vitro selection technique mRNA display as a powerful method for the isolation of thermostable novel enzymes.	[Seelig, Burckhard] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Seelig, B (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	seelig@umn.edu	Seelig, Burckhard/D-1042-2013	Seelig, Burckhard/0000-0001-8598-0586	US National Aeronautics and Space Administration (NASA) through the NASA Astrobiology Institute-Ames Research Center [NNX09AH70A]; US National Institutes of Health (NIH) [T32 GM08347]; Biocatalysis Initiative of the BioTechnology Institute at the University of Minnesota; Minnesota Medical Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008347] Funding Source: NIH RePORTER	US National Aeronautics and Space Administration (NASA) through the NASA Astrobiology Institute-Ames Research Center; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biocatalysis Initiative of the BioTechnology Institute at the University of Minnesota; Minnesota Medical Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the US National Aeronautics and Space Administration (NASA) Agreement no. NNX09AH70A through the NASA Astrobiology Institute-Ames Research Center (to A.M. and B.S.), the US National Institutes of Health (NIH) (T32 GM08347 to J.C.H.) and by a grant from the Biocatalysis Initiative of the BioTechnology Institute at the University of Minnesota and the Minnesota Medical Foundation (to B.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold FH, 2001, TRENDS BIOCHEM SCI, V26, P100, DOI 10.1016/S0968-0004(00)01755-2; Auerbach G, 1998, STRUCTURE, V6, P769, DOI 10.1016/S0969-2126(98)00078-1; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bommarius AS, 2013, CHEM SOC REV, V42, P6534, DOI 10.1039/c3cs60137d; Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117; Chao FA, 2013, NAT CHEM BIOL, V9, P81, DOI [10.1038/NCHEMBIO.1138, 10.1038/nchembio.1138]; Chaput JC, 2004, CHEM BIOL, V11, P865, DOI 10.1016/j.chembiol.2004.04.006; Cho GS, 2006, CHEM BIOL, V13, P139, DOI 10.1016/j.chembiol.2005.10.015; Diaz JE, 2011, PROTEIN SCI, V20, P1597, DOI 10.1002/pro.691; Eijsink VGH, 2005, BIOMOL ENG, V22, P21, DOI 10.1016/j.bioeng.2004.12.003; Elias M, 2014, TRENDS BIOCHEM SCI, V39, P1, DOI 10.1016/j.tibs.2013.11.001; Golynskiy MV, 2013, CHEMBIOCHEM, V14, P1553, DOI 10.1002/cbic.201300326; Golynskiy Misha V, 2013, Methods Mol Biol, V978, P73, DOI 10.1007/978-1-62703-293-3_6; Golynskiy MV, 2010, TRENDS BIOTECHNOL, V28, P340, DOI 10.1016/j.tibtech.2010.04.003; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Haugner JC, 2013, CHEM COMMUN, V49, P7322, DOI 10.1039/c3cc44454f; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Jackel C, 2010, J MOL BIOL, V399, P541, DOI 10.1016/j.jmb.2010.04.039; Lane MD, 2014, CURR OPIN CHEM BIOL, V22, P129, DOI 10.1016/j.cbpa.2014.09.013; MacedoRibeiro S, 1996, STRUCTURE, V4, P1291, DOI 10.1016/S0969-2126(96)00137-2; Martin A, 2001, J MOL BIOL, V309, P717, DOI 10.1006/jmbi.2001.4698; MOORE MJ, 1992, SCIENCE, V256, P992, DOI 10.1126/science.1589782; Nashine VC, 2010, CURR OPIN CHEM BIOL, V14, P644, DOI 10.1016/j.cbpa.2010.07.020; Nemoto N, 1997, FEBS LETT, V414, P405, DOI 10.1016/S0014-5793(97)01026-0; Palackal N, 2004, PROTEIN SCI, V13, P494, DOI 10.1110/ps.03333504; Ramanathan A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001193; Reetz MT, 2009, ANGEW CHEM INT EDIT, V48, P8268, DOI 10.1002/anie.200904209; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Russell RJM, 1998, STRUCTURE, V6, P351, DOI 10.1016/S0969-2126(98)00037-9; Schmid FX, 2011, CHEMBIOCHEM, V12, P1501, DOI 10.1002/cbic.201100018; Seelig B, 2007, NATURE, V448, P828, DOI 10.1038/nature06032; Seelig B, 2011, NAT PROTOC, V6, P540, DOI 10.1038/nprot.2011.312; Sieber V, 1998, NAT BIOTECHNOL, V16, P955, DOI 10.1038/nbt1098-955; Smith MD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000467; Socha RD, 2013, FEBS J, V280, P5582, DOI 10.1111/febs.12354; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tokuriki N, 2009, TRENDS BIOCHEM SCI, V34, P53, DOI 10.1016/j.tibs.2008.10.009; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wigley WC, 2001, NAT BIOTECHNOL, V19, P131, DOI 10.1038/84389; Wijma HJ, 2013, CURR OPIN STRUC BIOL, V23, P588, DOI 10.1016/j.sbi.2013.04.008	43	10	10	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112028	10.1371/journal.pone.0112028	http://dx.doi.org/10.1371/journal.pone.0112028			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393375	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300028
J	Dusane, DH; Hosseinidoust, Z; Asadishad, B; Tufenkji, N				Dusane, Devendra H.; Hosseinidoust, Zeinab; Asadishad, Bahareh; Tufenkji, Nathalie			Alkaloids Modulate Motility, Biofilm Formation and Antibiotic Susceptibility of Uropathogenic Escherichia coli	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; GENE-EXPRESSION; BLACK PEPPER; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; BACTERIAL BIOFILMS; SWARMING MOTILITY; MECHANISMS; PIPERINE; CIPROFLOXACIN	Alkaloid-containing natural compounds have shown promise in the treatment of microbial infections. However, practical application of many of these compounds is pending a mechanistic understanding of their mode of action. We investigated the effect of two alkaloids, piperine (found in black pepper) and reserpine (found in Indian snakeroot), on the ability of the uropathogenic bacterium Escherichia coli CFT073 to colonize abiotic surfaces. Sub-inhibitory concentrations of both compounds (0.5 to 10 mu g/mL) decreased bacterial swarming and swimming motilities and increased biofilm formation. qRT-PCR revealed a decrease in the expression of the flagellar gene (fliC) and motility genes (motA and motB) along with an increased expression of adhesin genes (fimA, papA, uvrY). Interestingly, piperine increased penetration of the antibiotics ciprofloxacin and azithromycin into E. coli CFT073 biofilms and consequently enhanced the ability of these antibiotics to disperse pre-established biofilms. The findings suggest that these alkaloids can potentially affect bacterial colonization by hampering bacterial motility and may aid in the treatment of infection by increasing antibiotic penetration in biofilms.	[Dusane, Devendra H.; Hosseinidoust, Zeinab; Asadishad, Bahareh; Tufenkji, Nathalie] McGill Univ, Dept Chem Engn, Montreal, PQ, Canada	McGill University	Tufenkji, N (corresponding author), McGill Univ, Dept Chem Engn, Montreal, PQ, Canada.	nathalie.tufenkji@mcgill.ca	Dusane, PhD, Devendra/AAZ-9820-2021; Dusane, Devendra/P-9829-2018; Hosseinidoust, zeinab/G-7617-2012	Dusane, Devendra/0000-0003-4340-6214; Hosseinidoust, zeinab/0000-0001-9261-7611	Natural Sciences and Engineering Research Council of Canada [311566]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was funded by the Natural Sciences and Engineering Research Council of Canada (Grant #311566, www.nserc.ca) awarded to NT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubacker M.N., 2011, DRUG INVENT TODAY, V3, P16; Anderl JN, 2000, ANTIMICROB AGENTS CH, V44, P1818, DOI 10.1128/AAC.44.7.1818-1824.2000; Asadishad B, 2012, FEMS MICROBIOL LETT, V334, P87, DOI 10.1111/j.1574-6968.2012.02622.x; ATAL CK, 1985, J PHARMACOL EXP THER, V232, P258; Badmaev V, 1999, NUTR RES, V19, P381, DOI 10.1016/S0271-5317(99)00007-X; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; Boll EJ, 2013, INFECT IMMUN, V81, P1164, DOI 10.1128/IAI.01376-12; Chagnot C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00303; Corona F, 2013, ANTIBIOTICS-BASEL, V2, P237, DOI 10.3390/antibiotics2020237; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564; Daniels R, 2004, FEMS MICROBIOL REV, V28, P261, DOI 10.1016/j.femsre.2003.09.004; Desai MG, 2012, INDIAN J CLIN PRACTI, V22, P11; Dhakal BK, 2008, EUR J CLIN INVEST, V38, P2, DOI 10.1111/j.1365-2362.2008.01986.x; Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; DUNNE WM, 1990, ANTIMICROB AGENTS CH, V34, P390, DOI 10.1128/AAC.34.3.390; Ferrieres L, 2003, MOL MICROBIOL, V50, P1665, DOI 10.1046/j.1365-2958.2003.03815.x; Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154; Guttenplan SB, 2013, FEMS MICROBIOL REV, V37, P849, DOI 10.1111/1574-6976.12018; Han HK, 2011, EXPERT OPIN DRUG MET, V7, P721, DOI 10.1517/17425255.2011.570332; Hancock V, 2007, FEMS MICROBIOL LETT, V267, P30, DOI 10.1111/j.1574-6968.2006.00507.x; Hidalgo G, 2011, APPL ENVIRON MICROB, V77, P6852, DOI 10.1128/AEM.05561-11; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Hosseinidoust Z, 2013, BIOFOULING, V29, P457, DOI 10.1080/08927014.2013.779370; Jones BV, 2004, INFECT IMMUN, V72, P3941, DOI 10.1128/IAI.72.7.3941-3950.2004; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; Khan IA, 2006, ANTIMICROB AGENTS CH, V50, P810, DOI 10.1128/AAC.50.2.810-812.2006; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; Lane MC, 2007, J BACTERIOL, V189, P5523, DOI 10.1128/JB.00434-07; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACNAB RM, 1992, ANNU REV GENET, V26, P131, DOI 10.1146/annurev.ge.26.120192.001023; Mitra A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055492; O'May C, 2012, BIOFOULING, V28, P1063, DOI 10.1080/08927014.2012.725130; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Pesavento C, 2008, GENE DEV, V22, P2434, DOI 10.1101/gad.475808; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Serra DO, 2013, MBIO, V4, DOI 10.1128/mBio.00103-13; Sharma A, 2009, INDIAN J PHARM SCI, V71, P136, DOI 10.4103/0250-474X.54279; Singh M, 2005, J Vet Sci, V6, P197; Singh R, 2010, J ANTIMICROB CHEMOTH, V65, P1955, DOI 10.1093/jac/dkq257; Srinivasan K, 2007, CRIT REV FOOD SCI, V47, P735, DOI 10.1080/10408390601062054; Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196; STOCK J, 1994, CURR BIOL, V4, P143, DOI 10.1016/S0960-9822(94)00033-3; Trautner BW, 2004, AM J INFECT CONTROL, V32, P177, DOI 10.1016/j.ajic.2003.08.005; Walters MC, 2003, ANTIMICROB AGENTS CH, V47, P317, DOI 10.1128/AAC.47.1.317-323.2003; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007; Williams D H, 2004, Minerva Urol Nefrol, V56, P15; Wink M, 2008, MODERN ALKALOIDS STR, P3, DOI [10.1002/9783527621071.ch1, DOI 10.1002/9783527621071.CHL]; WOLFE AJ, 1989, P NATL ACAD SCI USA, V86, P6973, DOI 10.1073/pnas.86.18.6973	51	31	31	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112093	10.1371/journal.pone.0112093	http://dx.doi.org/10.1371/journal.pone.0112093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391152	Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400052
J	Hull, JJ; Chaney, K; Geib, SM; Fabrick, JA; Brent, CS; Walsh, D; Lavine, LC				Hull, J. Joe; Chaney, Kendrick; Geib, Scott M.; Fabrick, Jeffrey A.; Brent, Colin S.; Walsh, Douglas; Lavine, Laura Corley			Transcriptome-Based Identification of ABC Transporters in the Western Tarnished Plant Bug Lygus hesperus	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTERS; MULTIDRUG-RESISTANCE PROTEINS; GENOME-WIDE ANALYSIS; RNASE-L INHIBITOR; RED-EYE MUTANT; DROSOPHILA-MELANOGASTER; GENE FAMILY; P-GLYCOPROTEIN; MALPIGHIAN TUBULES; FUNCTIONAL-ANALYSIS	ATP-binding cassette (ABC) transporters are a large superfamily of proteins that mediate diverse physiological functions by coupling ATP hydrolysis with substrate transport across lipid membranes. In insects, these proteins play roles in metabolism, development, eye pigmentation, and xenobiotic clearance. While ABC transporters have been extensively studied in vertebrates, less is known concerning this superfamily in insects, particularly hemipteran pests. We used RNA-Seq transcriptome sequencing to identify 65 putative ABC transporter sequences (including 36 full-length sequences) from the eight ABC subfamilies in the western tarnished plant bug (Lygus hesperus), a polyphagous agricultural pest. Phylogenetic analyses revealed clear orthologous relationships with ABC transporters linked to insecticide/xenobiotic clearance and indicated lineage specific expansion of the L. hesperus ABCG and ABCH subfamilies. The transcriptional profile of 13 LhABCs representative of the ABCA, ABCB, ABCC, ABCG, and ABCH subfamilies was examined across L. hesperus development and within sex-specific adult tissues. All of the transcripts were amplified from both reproductively immature and mature adults and all but LhABCA8 were expressed to some degree in eggs. Expression of LhABCA8 was spatially localized to the testis and temporally timed with male reproductive development, suggesting a potential role in sexual maturation and/or spermatozoa protection. Elevated expression of LhABCC5 in Malpighian tubules suggests a possible role in xenobiotic clearance. Our results provide the first transcriptome-wide analysis of ABC transporters in an agriculturally important hemipteran pest and, because ABC transporters are known to be important mediators of insecticidal resistance, will provide the basis for future biochemical and toxicological studies on the role of this protein family in insecticide resistance in Lygus species.	[Hull, J. Joe; Chaney, Kendrick; Fabrick, Jeffrey A.; Brent, Colin S.] USDA ARS, Arid Land Agr Res Ctr, Maricopa, AZ 85138 USA; [Geib, Scott M.] USDA ARS, Daniel K Inouye Pacific Basin Agr Res Ctr, Hilo, HI USA; [Walsh, Douglas; Lavine, Laura Corley] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Washington State University	Hull, JJ (corresponding author), USDA ARS, Arid Land Agr Res Ctr, Maricopa, AZ 85138 USA.	joe.hull@ars.usda.gov		Fabrick, Jeffrey/0000-0002-3893-9545; Geib, Scott/0000-0002-9511-5139; Brent, Colin/0000-0003-2078-1417; Lavine, Laura/0000-0002-0262-359X	CSB - Cotton Incorporated [12-373]; KC - Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2011-38422-30955]; SMG - National Science Foundation [OCI-1053575XSEDE, TG-MCB140032]	CSB - Cotton Incorporated; KC - Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture; SMG - National Science Foundation	This work was supported by CSB - Cotton Incorporated (project no. 12-373), by KC - Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture (no. 2011-38422-30955), and by SMG - National Science Foundation (no. OCI-1053575XSEDE under allocation TG-MCB140032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele R, 2011, ESSAYS BIOCHEM, V50, P249, DOI [10.1042/BSE0500249, 10.1042/bse0500249]; Abrabam EG, 2000, MOL GEN GENET, V264, P11, DOI 10.1007/s004380000283; Abruzzi KC, 2011, GENE DEV, V25, P2374, DOI [10.1101/gad.178079.111, 10.1101/gad.174110.111]; Aittoniemi J, 2009, PHILOS T R SOC B, V364, P257, DOI 10.1098/rstb.2008.0142; Akasaka T, 2006, P NATL ACAD SCI USA, V103, P11999, DOI 10.1073/pnas.0603098103; Akiyama M, 2005, J CLIN INVEST, V115, P1777, DOI 10.1172/JCI24834; Albrecht C, 2007, PFLUG ARCH EUR J PHY, V453, P581, DOI 10.1007/s00424-006-0047-8; Allen M. L., 2013, Open Journal of Animal Sciences, V3, P1; Anaka M, 2008, J NEUROGENET, V22, P243, DOI 10.1080/01677060802309629; Annilo T, 2006, GENOMICS, V88, P1, DOI 10.1016/j.ygeno.2006.03.001; Atsumi S, 2012, P NATL ACAD SCI USA, V109, pE1591, DOI 10.1073/pnas.1120698109; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Azad P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005371; Bain LJ, 1996, TOXICOL APPL PHARM, V141, P288, DOI 10.1016/S0041-008X(96)80035-4; Bao YY, 2010, J INSECT PHYSIOL, V56, P1087, DOI 10.1016/j.jinsphys.2010.03.004; Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692; Barthelme D, 2011, P NATL ACAD SCI USA, V108, P3228, DOI 10.1073/pnas.1015953108; Baum JA, 2012, J ECON ENTOMOL, V105, P616, DOI 10.1603/EC11207; Baxter SW, 2011, GENETICS, V189, P675, DOI 10.1534/genetics.111.130971; Beckstead RB, 2007, INSECT BIOCHEM MOLEC, V37, P570, DOI 10.1016/j.ibmb.2007.03.001; Beers MF, 2011, J LIPID RES, V52, P1471, DOI 10.1194/jlr.M013284; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; BISBAL C, 1995, J BIOL CHEM, V270, P13308, DOI 10.1074/jbc.270.22.13308; Borycz J, 2008, J EXP BIOL, V211, P3454, DOI 10.1242/jeb.021162; Brent CS, 2014, J INSECT PHYSIOL, V60, P104, DOI 10.1016/j.jinsphys.2013.12.001; Broehan G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-6; Bryon A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-815; Buchmann J, 2007, ENDOCRINOLOGY, V148, P1561, DOI 10.1210/en.2006-1244; Buss DS, 2008, PESTIC BIOCHEM PHYS, V90, P141, DOI 10.1016/j.pestbp.2007.12.001; Chahine S, 2011, J EXP BIOL, V214, P462, DOI 10.1242/jeb.048884; Chahine S, 2009, J INSECT PHYSIOL, V55, P927, DOI 10.1016/j.jinsphys.2009.06.005; Dassa E, 2001, RES MICROBIOL, V152, P211, DOI 10.1016/S0923-2508(01)01194-9; Leite JCD, 2014, MOL REPROD DEV, V81, P66, DOI 10.1002/mrd.22283; de Boussac H, 2012, BIOCHEM BIOPH RES CO, V426, P172, DOI 10.1016/j.bbrc.2012.08.046; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Dean M, 2005, ANNU REV GENOM HUM G, V6, P123, DOI 10.1146/annurev.genom.6.080604.162122; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; DEBOLT JW, 1982, ANN ENTOMOL SOC AM, V75, P119, DOI 10.1093/aesa/75.2.119; Dermauw W, 2014, INSECT BIOCHEM MOLEC, V45, P89, DOI 10.1016/j.ibmb.2013.11.001; Dermauw W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-317; Dong JS, 2004, J BIOL CHEM, V279, P42157, DOI 10.1074/jbc.M404502200; Dow JAT, 2006, J INSECT PHYSIOL, V52, P365, DOI 10.1016/j.jinsphys.2005.10.007; Dow JAT, 2009, J EXP BIOL, V212, P435, DOI 10.1242/jeb.024224; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; EWART GD, 1994, J BIOL CHEM, V269, P10370; Fernandez-Ayala DJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008549; Figueira-Mansur J, 2013, INSECT MOL BIOL, V22, P648, DOI 10.1111/imb.12052; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; George AM, 2012, PROG BIOPHYS MOL BIO, V109, P95, DOI 10.1016/j.pbiomolbio.2012.06.003; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Grailles M, 2003, GENE, V307, P41, DOI 10.1016/S0378-1119(03)00455-4; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Heckel DG, 2012, PESTIC BIOCHEM PHYS, V104, P103, DOI 10.1016/j.pestbp.2012.05.007; Hock T, 2000, P NATL ACAD SCI USA, V97, P9519, DOI 10.1073/pnas.160271797; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huang H, 2007, PHYSIOL GENOMICS, V29, P260, DOI 10.1152/physiolgenomics.00166.2006; Hull JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055105; Itoh TQ, 2011, GENES CELLS, V16, P1159, DOI 10.1111/j.1365-2443.2011.01559.x; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Jones SR, 2011, TOXICOL SCI, V119, P369, DOI 10.1093/toxsci/kfq318; Jordan IK, 2008, P NATL ACAD SCI USA, V105, P18865, DOI 10.1073/pnas.0806306105; Kaminski WE, 2006, BBA-MOL BASIS DIS, V1762, P510, DOI 10.1016/j.bbadis.2006.01.011; KARTNER N, 1983, SCIENCE, V221, P1285, DOI 10.1126/science.6137059; Keppler D, 2011, HANDB EXP PHARMACOL, V201, P299, DOI 10.1007/978-3-642-14541-4_8; Kerr ID, 2011, BRIT J PHARMACOL, V164, P1767, DOI 10.1111/j.1476-5381.2010.01177.x; Khoshnevis S, 2010, EMBO REP, V11, P214, DOI 10.1038/embor.2009.272; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; Kim Y, 2013, GENOMICS, V101, P354, DOI 10.1016/j.ygeno.2013.04.003; Komoto N, 2009, INSECT BIOCHEM MOLEC, V39, P152, DOI 10.1016/j.ibmb.2008.10.003; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kruh GD, 2006, PFLUGERS ARCH, V453, P675; Kulkarni SR, 2014, ANTIOXID REDOX SIGN, V20, P15, DOI 10.1089/ars.2012.5082; Labbe R, 2011, INSECT MOL BIOL, V20, P243, DOI 10.1111/j.1365-2583.2010.01064.x; Labbe R, 2011, J EXP BIOL, V214, P937, DOI 10.1242/jeb.051060; Lage H, 2003, INT J ANTIMICROB AG, V22, P188, DOI 10.1016/S0924-8579(03)00203-6; Lei YY, 2014, GENE, V533, P180, DOI 10.1016/j.gene.2013.09.091; Leprohon P, 2011, ESSAYS BIOCHEM, V50, P121, DOI [10.1042/BSE0500121, 10.1042/bse0500121]; Li YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066251; Liu SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063895; Liu SH, 2014, INSECT SCI, V21, P469, DOI 10.1111/1744-7917.12049; Liu SM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-491; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Luckenbach T, 2008, AM J PHYSIOL-REG I, V294, pR1919, DOI 10.1152/ajpregu.00563.2007; Luo L, 2013, INSECT BIOCHEM MOLEC, V43, P627, DOI 10.1016/j.ibmb.2013.04.006; Mackenzie SM, 1999, BBA-BIOMEMBRANES, V1419, P173, DOI 10.1016/S0005-2736(99)00064-4; Mamidala P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-6; Martins GF, 2012, ISJ-INVERT SURVIV J, V9, P139; Merzendorfer H, 2012, INSECT BIOCHEM MOLEC, V42, P264, DOI 10.1016/j.ibmb.2011.12.008; Meyer F, 2013, PEST MANAG SCI, V69, P1136, DOI 10.1002/ps.3476; Monnier V, 2002, GENESIS, V34, P76, DOI 10.1002/gene.10130; Morita M, 2012, BBA-MOL BASIS DIS, V1822, P1387, DOI 10.1016/j.bbadis.2012.02.009; Morozova TV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r231; Morozova TV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r95; Mosallanejad H, 2010, J INSECT PHYSIOL, V56, P1973, DOI 10.1016/j.jinsphys.2010.08.022; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Parcej D, 2010, NAT CHEM BIOL, V6, P572, DOI [10.1038/NCHEMBIO.410, 10.1038/nchembio.410]; Park Y, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-46; Pavlidi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066533; Paytubi S, 2009, J BIOL CHEM, V284, P24061, DOI 10.1074/jbc.M109.031625; Peelman F, 2003, J MOL BIOL, V325, P259, DOI 10.1016/S0022-2836(02)01105-1; Popovic M, 2010, MAR ENVIRON RES, V69, pS11, DOI 10.1016/j.marenvres.2009.10.016; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Qin W, 2005, INSECT MOL BIOL, V14, P607, DOI 10.1111/j.1365-2583.2005.00589.x; Quan GX, 2002, INSECT MOL BIOL, V11, P217, DOI 10.1046/j.1365-2583.2002.00328.x; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Ricardo S, 2009, SCIENCE, V323, P943, DOI 10.1126/science.1166239; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Robinson SW, 2013, NUCLEIC ACIDS RES, V41, pD744, DOI 10.1093/nar/gks1141; Roth CW, 2003, MOL CELLS, V15, P150; Scott D.R., 1977, Bulletin Ent Soc Amer, V23, P19; Seo BY, 2011, J ASIA-PAC ENTOMOL, V14, P469, DOI 10.1016/j.aspen.2011.06.005; Shah S, 2012, PEST MANAG SCI, V68, P38, DOI 10.1002/ps.2218; Shan N, 1996, J BIOL CHEM, V271, P8725, DOI 10.1074/jbc.271.15.8725; Sheps JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r15; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Slot AJ, 2011, ESSAYS BIOCHEM, V50, P179, DOI [10.1042/BSE0500179, 10.1042/bse0500179]; Snodgrass GL, 2009, J ECON ENTOMOL, V102, P699, DOI 10.1603/029.102.0231; Snodgrass GL, 1996, J ECON ENTOMOL, V89, P783, DOI 10.1093/jee/89.4.783; Snodgrass GL, 2002, ANN ENTOMOL SOC AM, V95, P366, DOI 10.1603/0013-8746(2002)095[0366:COAREM]2.0.CO;2; Snodgrass GL, 2002, SOUTHWEST ENTOMOL, V27, P191; Sooksa-Nguan T, 2009, J BIOL CHEM, V284, P354, DOI 10.1074/jbc.M806501200; Strauss AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098637; Strauss AS, 2013, ELIFE, V2, DOI 10.7554/eLife.01096; Sturm A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-170; SULLIVAN DT, 1980, BIOCHEM GENET, V18, P1109, DOI 10.1007/BF00484342; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan A, 2008, MOL CELL ENDOCRINOL, V291, P42, DOI 10.1016/j.mce.2008.05.006; Tanaka S, 2013, FEBS J, V280, P1782, DOI 10.1111/febs.12200; Tapadia MG, 2005, CELL STRESS CHAPERON, V10, P7, DOI 10.1379/CSC-67R.1; Tarr PT, 2009, BBA-MOL CELL BIOL L, V1791, P584, DOI 10.1016/j.bbalip.2009.01.007; Tatematsu K, 2011, GENES CELLS, V16, P331, DOI 10.1111/j.1365-2443.2011.01490.x; Telonis-Scott M, 2009, J INSECT PHYSIOL, V55, P549, DOI 10.1016/j.jinsphys.2009.01.010; Tian LX, 2013, INT J MOL SCI, V14, P22891, DOI 10.3390/ijms141122891; Toyoda Y, 2008, XENOBIOTICA, V38, P833, DOI [10.1080/00498250701883514, 10.1080/00498250701883514 ]; Tyzack JK, 2000, J BIOL CHEM, V275, P34131, DOI 10.1074/jbc.M002868200; Vache C, 2007, ENVIRON TOXICOL CHEM, V26, P1418, DOI 10.1897/06-552R.1; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Wanders RJA, 2007, PFLUG ARCH EUR J PHY, V453, P719, DOI 10.1007/s00424-006-0142-x; Wang J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r69; Wang LY, 2013, INSECT BIOCHEM MOLEC, V43, P562, DOI 10.1016/j.ibmb.2013.03.011; Wasbrough ER, 2010, J PROTEOMICS, V73, P2171, DOI 10.1016/j.jprot.2010.09.002; Weber AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034745; Wheeler Jr A. G., 2001, BIOL PLANT BUGS; WU CT, 1991, MOL CELL BIOL, V11, P3940, DOI 10.1128/MCB.11.8.3940; Xia J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068185; Xie XD, 2012, MOL BIOL REP, V39, P7281, DOI 10.1007/s11033-012-1558-3; Yang J, 2007, PHYSIOL GENOMICS, V30, P223, DOI 10.1152/physiolgenomics.00018.2007; Yang N, 2013, INSECT MOL BIOL, V22, P485, DOI 10.1111/imb.12038; Yasui K, 2004, CANCER RES, V64, P1403, DOI 10.1158/0008-5472.CAN-3263-2; Ye XD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-370; Yepiskoposyan H, 2006, NUCLEIC ACIDS RES, V34, P4866, DOI 10.1093/nar/gkl606; You MS, 2013, NAT GENET, V45, P220, DOI 10.1038/ng.2524; YOUNG OP, 1986, ANN ENTOMOL SOC AM, V79, P747, DOI 10.1093/aesa/79.4.747; Zhang S, 2009, DIS MODEL MECH, V2, P247, DOI 10.1242/dmm.000653; Zhu F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01456	162	43	45	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113046	10.1371/journal.pone.0113046	http://dx.doi.org/10.1371/journal.pone.0113046			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401762	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700101
J	Li, WL; Duan, HK; Chen, FY; Wang, Z; Huang, XQ; Deng, X; Liu, YX				Li, Wenlong; Duan, Huikun; Chen, Fengying; Wang, Zhi; Huang, Xueqing; Deng, Xin; Liu, Yongxiu			Identification of Quantitative Trait Loci Controlling High Calcium Response in Arabidopsis thaliana	PLOS ONE			English	Article							INBRED LINE POPULATION; PLANT DEVELOPMENT; NATURAL VARIATION; SEED DORMANCY; ADAPTATION; STRESS; GENES; QTL; EXPRESSION; RESISTANCE	Natural variation for primary root growth response to high Ca stress in Arabidopsis thaliana was studied by screening a series of accessions (ecotypes) under high Calcium (40 mM CaCl2) conditions. The genetic basis of this variation was further investigated by QTL analysis using recombinant inbred lines from Landsberg erecta (Ler)xCape Verde Islands (Cvi) cross. Four QTLs were identified in chromosome 1, 2 and 5, and named response to high Calcium (RHCA) 1-4. The three QTLs (RHCA1, RHCA2 and RHCA4) were further confirmed by analysis of near isogenic lines harboring Cvi introgression fragments in Ler background. Real-time PCR analysis showed that several genes associated with high Ca response including SMT1 and XHT25 have changed expression pattern between Ler and near isogenic lines. These results were useful for detecting molecular mechanisms of plants for high Ca adaption.	[Li, Wenlong; Duan, Huikun; Deng, Xin] Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing 100093, Peoples R China; [Li, Wenlong; Chen, Fengying; Wang, Zhi; Liu, Yongxiu] Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing 100093, Peoples R China; [Huang, Xueqing] Fudan Univ, Sch Life Sci, Inst Plant Biol, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Li, Wenlong] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Fudan University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, YX (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing 100093, Peoples R China.	yongxiu@ibcas.ac.cn	Wang, Zhi/AGG-0325-2022; Xin, deng/AAH-4009-2020	Wang, Zhi/0000-0002-8207-776X; 	National Natural Science Foundation of China [30970431]; National Basic Research Program of China (973 Program) [2006CB403200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This research was supported by the National Natural Science Foundation of China (No. 30970431, http://www.nsfc.gov.cn/) and the National Basic Research Program of China (973 Program) (No. 2006CB403200, http://www.973.gov.cn/AreaAppl.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Hernandez HS, 2011, J PLANT PHYSIOL, V168, P2102, DOI 10.1016/j.jplph.2011.06.006; Alonso-Blanco C, 2003, GENETICS, V164, P711; Alonso-Blanco C, 1998, PLANT J, V14, P259, DOI 10.1046/j.1365-313X.1998.00115.x; Alonso-Blanco C, 2009, PLANT CELL, V21, P1877, DOI 10.1105/tpc.109.068114; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Berger S, 1996, PLANT PHYSIOL, V111, P525, DOI 10.1104/pp.111.2.525; Blanco F, 2005, PLANT MOL BIOL, V59, P927, DOI 10.1007/s11103-005-2227-x; [曹建华 Cao Jian hua], 2003, [地球科学进展, Advance in Earth Sciences], V18, P37; Chan CWM, 2008, FEBS LETT, V582, P967, DOI 10.1016/j.febslet.2008.02.043; Chan CWM, 2003, PLANT PHYSIOL, V132, P728, DOI 10.1104/pp.102.019216; Chen FS, 2011, FOOD CHEM, V126, P450, DOI 10.1016/j.foodchem.2010.11.009; CREELMAN RA, 1995, P NATL ACAD SCI USA, V92, P4114, DOI 10.1073/pnas.92.10.4114; Day M, 2011, KARST MANAGEMENT, P439, DOI 10.1007/978-94-007-1207-2_20; Dayod M, 2010, PROTOPLASMA, V247, P215, DOI 10.1007/s00709-010-0182-0; Diener AC, 2000, PLANT CELL, V12, P853, DOI 10.1105/tpc.12.6.853; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; FALKENGRENGRERUP U, 1995, ENVIRON EXP BOT, V35, P9, DOI 10.1016/0098-8472(94)00039-8; Gilliham M, 2011, J EXP BOT, V62, P2233, DOI 10.1093/jxb/err111; Gunter CC, 2008, AM J POTATO RES, V85, P324, DOI 10.1007/s12230-008-9025-3; Hirschi KD, 2009, ANNU REV NUTR, V29, P401, DOI 10.1146/annurev-nutr-080508-141143; Huang XQ, 2010, MOL ECOL, V19, P1335, DOI 10.1111/j.1365-294X.2010.04557.x; Keurentjes JJB, 2007, GENETICS, V175, P891, DOI 10.1534/genetics.106.066423; Keuskamp DH, 2011, PLANT J, V67, P208, DOI 10.1111/j.1365-313X.2011.04597.x; Kusnierczyk A, 2007, J EXP BOT, V58, P2537, DOI 10.1093/jxb/erm043; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ookawa T, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1132; Pfalz M, 2011, PLANT CELL, V23, P716, DOI 10.1105/tpc.110.081711; Reddy VS, 2002, J BIOL CHEM, V277, P9840, DOI 10.1074/jbc.M111626200; Rose JKC, 2002, PLANT CELL PHYSIOL, V43, P1421, DOI 10.1093/pcp/pcf171; SCAIFE MA, 1978, PLANT SOIL, V50, P723, DOI 10.1007/BF02107226; SIMMONS KE, 1987, AM POTATO J, V64, P119, DOI 10.1007/BF02854208; Song WY, 2011, P NATL ACAD SCI USA, V108, P19808, DOI 10.1073/pnas.1104905108; Vaughn LM, 2011, G3-GENES GENOM GENET, V1, P105, DOI 10.1534/g3.111.000331; Vreugdenhil D, 2004, PLANT CELL ENVIRON, V27, P828, DOI 10.1111/j.1365-3040.2004.01189.x; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164; Yuan DX, 2001, ACTA GEOL SIN-ENGL, V75, P336; Yuan DX, 1988, SCI KARST ENV	37	2	3	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112511	10.1371/journal.pone.0112511	http://dx.doi.org/10.1371/journal.pone.0112511			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401959	Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700052
J	Trujillo-de Santiago, G; Rojas-de Gante, C; Garcia-Lara, S; Ballesca-Estrada, A; Alvarez, MM				Trujillo-de Santiago, Grissel; Rojas-de Gante, Cecilia; Garcia-Lara, Silverio; Ballesca-Estrada, Adriana; Moises Alvarez, Mario			Studying Mixing in Non-Newtonian Blue Maize Flour Suspensions Using Color Analysis	PLOS ONE			English	Article							TRANSITIONAL FLOW; PH; RHEOLOGY; FLUIDS; FERMENTATION; CONSUMPTION; SIMULATION; TURBULENT; GELATION; RANGE	Background: Non-Newtonian fluids occur in many relevant flow and mixing scenarios at the lab and industrial scale. The addition of acid or basic solutions to a non-Newtonian fluid is not an infrequent operation, particularly in Biotechnology applications where the pH of Non-Newtonian culture broths is usually regulated using this strategy. Methodology and Findings: We conducted mixing experiments in agitated vessels using Non-Newtonian blue maize flour suspensions. Acid or basic pulses were injected to reveal mixing patterns and flow structures and to follow their time evolution. No foreign pH indicator was used as blue maize flours naturally contain anthocyanins that act as a native, wide spectrum, pH indicator. We describe a novel method to quantitate mixedness and mixing evolution through Dynamic Color Analysis (DCA) in this system. Color readings corresponding to different times and locations within the mixing vessel were taken with a digital camera (or a colorimeter) and translated to the CIELab scale of colors. We use distances in the Lab space, a 3D color space, between a particular mixing state and the final mixing point to characterize segregation/mixing in the system. Conclusion and Relevance: Blue maize suspensions represent an adequate and flexible model to study mixing (and fluid mechanics in general) in Non-Newtonian suspensions using acid/base tracer injections. Simple strategies based on the evaluation of color distances in the CIELab space (or other scales such as HSB) can be adapted to characterize mixedness and mixing evolution in experiments using blue maize suspensions.	[Trujillo-de Santiago, Grissel; Garcia-Lara, Silverio; Ballesca-Estrada, Adriana; Moises Alvarez, Mario] Tecnol Monterrey, Ctr Biotecnol FEMSA, Monterrey, Nuevo Leon, Mexico; [Trujillo-de Santiago, Grissel] Tecnol Monterrey, Ctr Invest & Desarrollo Prot CIDPRO, Monterrey, Nuevo Leon, Mexico; [Rojas-de Gante, Cecilia] Tecnol Monterrey, Dept Ingn Biotecnol, Tlalpan, DF, Mexico	Tecnologico de Monterrey; Tecnologico de Monterrey; Tecnologico de Monterrey	Alvarez, MM (corresponding author), Tecnol Monterrey, Ctr Biotecnol FEMSA, Monterrey, Nuevo Leon, Mexico.	mario.alvarez@itesm.mx	García-Lara, Silverio/B-5746-2009; García-Lara, Silverio/D-9687-2012	García-Lara, Silverio/0000-0002-3463-957X; García-Lara, Silverio/0000-0002-3463-957X; Alvarez, Mario Moises/0000-0002-9131-5344; Trujillo de Santiago, Grissel/0000-0001-9230-4607	Tecnologico de Monterrey [CAT-122]; CONACYT	Tecnologico de Monterrey; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors gratefully acknowledge the financial support of Tecnologico de Monterrey (through the seed fund CAT-122), and CONACYT (through the doctoral scholarship provided to GTdeS). The authors deeply appreciate the donation of the blue maize used in the experiments by EDOMEX Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshari-Jouybari H, 2011, J FOOD ENG, V106, P170, DOI 10.1016/j.jfoodeng.2011.02.034; Aguirre-Ezkauriatza EJ, 2008, J DAIRY SCI, V91, P4454, DOI 10.3168/jds.2008-1140; Alberini F, 2014, AICHE J, V60, P332, DOI 10.1002/aic.14237; Alvarez M, 2000, THESIS RUTGERS STATE; Alvarez MM, 2002, CAN J CHEM ENG, V80, P546; Arratia PE, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.084501; Bhattacharya S, 2004, CHEM ENG RES DES, V82, P1153, DOI 10.1205/cerd.82.9.1153.44173; Bouvier L, 2011, J FOOD SCI, V76, pE384, DOI 10.1111/j.1750-3841.2011.02183.x; Bryant CM, 1997, CEREAL CHEM, V74, P171, DOI 10.1094/CCHEM.1997.74.2.171; Bulnes-Abundis D, 2013, AICHE J, V59, P3092, DOI 10.1002/aic.14064; Bulnes-Abundis D, 2013, BIOTECHNOL BIOENG, V110, P1106, DOI 10.1002/bit.24780; Castaneda-Ovando A, 2010, FOOD ANAL METHOD, V3, P12, DOI 10.1007/s12161-008-9068-6; Celli JP, 2007, BIOMACROMOLECULES, V8, P1580, DOI 10.1021/bm0609691; Chang GF, 2014, BIORESOURCE TECHNOL, V152, P234, DOI 10.1016/j.biortech.2013.11.002; Chen SJ, 2012, CHEM SCI, V3, P1804, DOI 10.1039/c2sc01108e; Chen Y, 2013, BIORESOURCE TECHNOL, V134, P173, DOI 10.1016/j.biortech.2013.02.023; Craig KJ, 2013, WATER RES, V47, P4485, DOI 10.1016/j.watres.2013.05.011; Curran SJ, 2002, J FOOD SCI, V67, P176, DOI 10.1111/j.1365-2621.2002.tb11379.x; de la Rosa-Millan J, 2010, STARCH-STARKE, V62, P549, DOI 10.1002/star.201000023; Dhillon GS, 2013, FOOD BIOPROCESS TECH, V6, P1240, DOI 10.1007/s11947-011-0771-8; Domingues N, 2012, J POLYM ENG, V32, P81, DOI 10.1515/polyeng-2012-0501; Fayolle F, 2013, J FOOD ENG, V116, P390, DOI 10.1016/j.jfoodeng.2012.12.009; Fubin Y, 2013, J RENEWABLE SUSTAINA, V5; Gabelle JC, 2012, CHEM ENG SCI, V75, P408, DOI 10.1016/j.ces.2012.03.053; Guida A, 2011, AICHE J, V57, P2302, DOI 10.1002/aic.12456; Hanwu Lei, 2008, International Journal of Agricultural and Biological Engineering, V1, P55, DOI 10.3965/j.issn.1934-6344.2008.02.055-063; Harrington JC, 2012, J APPL POLYM SCI, V126, P770, DOI 10.1002/app.36946; Karsheva M., 2013, J CHEM TECHNOLOGY ME, V48, P483; Kelly W, 2003, CHEM ENG SCI, V58, P2141, DOI 10.1016/S0009-2509(03)00060-5; KING DW, 1989, MAR CHEM, V26, P5, DOI 10.1016/0304-4203(89)90061-3; Liu Q, 2014, J FOOD ENG, V121, P58, DOI 10.1016/j.jfoodeng.2013.08.016; Machado MB, 2013, CHEM ENG SCI, V98, P218, DOI 10.1016/j.ces.2013.04.039; Maingonnat JF, 2008, J FOOD ENG, V87, P82, DOI 10.1016/j.jfoodeng.2007.11.015; Mendez-Montealvo G, 2008, J CEREAL SCI, V48, P420, DOI 10.1016/j.jcs.2007.10.007; Migliori M, 2013, INT J FOOD SCI TECH, V48, P121, DOI 10.1111/j.1365-2621.2012.03167.x; Moreira HR, 2014, CARBOHYD POLYM, V103, P339, DOI 10.1016/j.carbpol.2013.12.057; Mouquet C, 2001, INT J FOOD SCI NUTR, V52, P389, DOI 10.1080/09637480120078276; Nguyen TH, 2014, SENSOR ACTUAT B-CHEM, V191, P498, DOI 10.1016/j.snb.2013.09.072; Nunez-Santiago MC, 2003, J FOOD ENG, V60, P55, DOI 10.1016/S0260-8774(03)00018-9; Olmos E, 2013, BIOPROC BIOSYST ENG, V36, P259, DOI 10.1007/s00449-012-0794-1; Patel D, 2014, AICHE J, V60, P315, DOI 10.1002/aic.14235; Rao M. A., 2014, RHEOLOGY FLUID SEMIS, P161, DOI 10.1007/978-1-4614-9230-6_4; Ryu SH, 2013, ECON BOT, V67, P98, DOI 10.1007/s12231-013-9232-9; Cervantes MIS, 2006, CHEM ENG SCI, V61, P8075, DOI 10.1016/j.ces.2006.09.035; Perez JAS, 2006, CHEM ENG J, V124, P1, DOI 10.1016/j.cej.2006.07.002; Shi HF, 2014, J COLLOID INTERF SCI, V418, P95, DOI 10.1016/j.jcis.2013.11.078; Soos M, 2008, J COLLOID INTERF SCI, V319, P577, DOI 10.1016/j.jcis.2007.12.005; Suzuki K, 2002, ANAL CHEM, V74, P5766, DOI 10.1021/ac0259414; Tamburini A, 2013, CHEM ENG SCI, V87, P341, DOI 10.1016/j.ces.2012.11.005; Urias-Peraldi M, 2013, FIELD CROP RES, V141, P69, DOI 10.1016/j.fcr.2012.11.008; WOLFBEIS OS, 1987, FRESEN Z ANAL CHEM, V327, P347, DOI 10.1007/BF00491840; Wong ACY, 2009, ADV POLYM TECH, V28, P1, DOI 10.1002/adv.20142; Zhang HL, 2012, ENERGY, V48, P380, DOI 10.1016/j.energy.2012.05.015; Zhang ZX, 2014, POLYM INT IN PRESS	54	1	1	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112954	10.1371/journal.pone.0112954	http://dx.doi.org/10.1371/journal.pone.0112954			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401332	gold, Green Published, Green Submitted			2022-12-27	WOS:000345158700084
J	Tynkevich, E; Flamant, M; Haymann, JP; Metzger, M; Thervet, E; Boffa, JJ; Vrtovsnik, F; Houillier, P; Froissart, M; Stengel, B				Tynkevich, Elena; Flamant, Martin; Haymann, Jean-Philippe; Metzger, Marie; Thervet, Eric; Boffa, Jean-Jacques; Vrtovsnik, Francois; Houillier, Pascal; Froissart, Marc; Stengel, Benedicte		NephroTest Study Grp	Decrease in Urinary Creatinine Excretion in Early Stage Chronic Kidney Disease	PLOS ONE			English	Article							CHRONIC-RENAL-FAILURE; MAINTENANCE HEMODIALYSIS-PATIENTS; INFLAMMATION COMPLEX SYNDROME; GLOMERULAR-FILTRATION-RATE; BODY-MASS INDEX; MUSCLE MASS; NUTRITIONAL-STATUS; DIALYSIS PATIENTS; SKELETAL-MUSCLE; SERUM-ALBUMIN	Background: Little is known about muscle mass loss in early stage chronic kidney disease (CKD). We used 24-hour urinary creatinine excretion rate to assess determinants of muscle mass and its evolution with kidney function decline. We also described the range of urinary creatinine concentration in this population. Methods: We included 1072 men and 537 women with non-dialysis CKD stages 1 to 5, all of them with repeated measurements of glomerular filtration rate (mGFR) by Cr-51-EDTA renal clearance and several nutritional markers. In those with stage 1 to 4 at baseline, we used a mixed model to study factors associated with urinary creatinine excretion rate and its change over time. Results: Baseline mean urinary creatinine excretion decreased from 15.3 +/- 3.1 to 12.1 +/- 3.3 mmol/24 h (0.20 +/- 0.03 to 0.15 +/- 0.04 mmol/kg/24 h) in men, with mGFR falling from >60 to <15 mL/min/1.73 m(2), and from 9.6 +/- 1.9 to 7.6 +/- 2.5 (0.16 +/- 0.03 to 0.12 +/- 0.03) in women. In addition to mGFR, an older age, diabetes, and lower levels of body mass index, proteinuria, and protein intake assessed by urinary urea were associated with lower mean urinary creatinine excretion at baseline. Mean annual decline in mGFR was 1.53 +/- 0.12 mL/min/1.73 m(2) per year and that of urinary creatinine excretion rate, 0.28 +/- 0.02 mmol/24 h per year. Patients with fast annual decline in mGFR of 5 mL/min/1.73 m(2) had a decrease in urinary creatinine excretion more than twice as big as in those with stable mGFR, independent of changes in urinary urea as well as of other determinants of low muscle mass. Conclusions: Decrease in 24-hour urinary creatinine excretion rate may appear early in CKD patients, and is greater the more mGFR declines independent of lowering protein intake assessed by 24-hour urinary urea. Normalizing urine analytes for creatininuria may overestimate their concentration in patients with reduced kidney function and low muscle mass.	[Tynkevich, Elena; Metzger, Marie; Froissart, Marc; Stengel, Benedicte] INSERM, Ctr Epidemiol & Populat Hlth, CESP, Unit 1018, Villejuif, France; [Tynkevich, Elena; Metzger, Marie; Stengel, Benedicte] Univ Paris 11, UMRS 1018, Villejuif, France; [Flamant, Martin] Hop Bichat Claude Bernard, AP HP, Dept Physiol, F-75877 Paris, France; [Haymann, Jean-Philippe] Hop Tenon, AP HP, Dept Physiol, F-75970 Paris, France; [Haymann, Jean-Philippe; Boffa, Jean-Jacques] INSERM, UNIT 702, Paris, France; [Haymann, Jean-Philippe; Boffa, Jean-Jacques] Univ Paris 06, UMRS 702, Paris, France; [Thervet, Eric] Hop Europeen Georges Pompidou, AP HP, Dept Nephrol, Paris, France; [Thervet, Eric] Hop Europeen Georges Pompidou, AP HP, DHU Common & Rare Arterial Dis, Paris, France; [Boffa, Jean-Jacques] Hop Tenon, AP HP, Dept Nephrol, Paris, France; [Vrtovsnik, Francois] Hop Bichat Claude Bernard, AP HP, Dept Nephrol, F-75877 Paris, France; [Houillier, Pascal] Univ Paris 05, UMRS 775, Paris, France; [Houillier, Pascal] Hop Europe Georges Pompidou, AP HP, Dept Physiol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Tynkevich, E (corresponding author), INSERM, Ctr Epidemiol & Populat Hlth, CESP, Unit 1018, Villejuif, France.	elena.tynkevich@inserm.fr	Combe, Christian/N-3726-2015; Stengel, Benedicte/G-5730-2015; Froissart, Marc/L-7493-2014; Houillier, Pascal/AAD-4903-2019; Metzger, Marie/K-9772-2018	Combe, Christian/0000-0002-0360-573X; Stengel, Benedicte/0000-0001-9469-0804; Froissart, Marc/0000-0002-4010-3173; Houillier, Pascal/0000-0003-4953-6917; Vrtovsnik, Francois/0000-0003-1554-314X; Metzger, Marie/0000-0003-3597-5409; Eladari, Dominique/0000-0003-1067-0844; DAUGAS, Eric/0000-0001-7256-7979; Vidal-Petiot, Emmanuelle/0000-0001-9356-7302	INSERM GIS-IReSP [AO 8113LS TGIR]; French Ministry of Health [AOM 09114]; INSERM [AO 8022LS]; Agence de la Biomedecine [R0 8156LL]; AURA; Roche [2009-152-447G]	INSERM GIS-IReSP; French Ministry of Health; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence de la Biomedecine; AURA; Roche(Roche Holding)	The NephroTest CKD cohort study is supported by the following grants: INSERM GIS-IReSP AO 8113LS TGIR (B. S.), French Ministry of Health AOM 09114 (M.Fr.), INSERM AO 8022LS (B. S.), Agence de la Biomedecine R0 8156LL (B. S.), AURA (M.Fr.), and Roche 2009-152-447G (M.Fr.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2011, J RENAL NUTR, V21, P429, DOI 10.1053/j.jrn.2010.09.007; Aparicio M, 1999, NEPHROL DIAL TRANSPL, V14, P1679, DOI 10.1093/ndt/14.7.1679; Avesani CM, 2006, KIDNEY INT, V70, pS8, DOI 10.1038/sj.ki.5001969; Bailey JL, 1996, J CLIN INVEST, V97, P1447, DOI 10.1172/JCI118566; Bansal N, 2011, AM J CARDIOL, V108, P179, DOI 10.1016/j.amjcard.2011.03.020; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Baumgartner RN, 1996, AM J CLIN NUTR, V64, P552, DOI 10.1093/ajcn/64.4.552; BHATLA B, 1995, ASAIO J, V41, pM442, DOI 10.1097/00002480-199507000-00048; BLUMENKRANTZ MJ, 1980, AM J CLIN NUTR, V33, P1567, DOI 10.1093/ajcn/33.7.1567; Cano NJM, 2002, KIDNEY INT, V62, P593, DOI 10.1046/j.1523-1755.2002.00457.x; Carrero JJ, 2008, CLIN NUTR, V27, P557, DOI 10.1016/j.clnu.2008.04.007; Carrero JJ, 2009, CLIN J AM SOC NEPHRO, V4, pS49, DOI 10.2215/CJN.02720409; Chertow GM, 2000, KIDNEY INT, V58, P2512, DOI 10.1046/j.1523-1755.2000.00435.x; De Keyzer W, 2012, BRIT J NUTR, V108, P1118, DOI 10.1017/S0007114511006295; Evans WJ, 2010, AM J CLIN NUTR, V91, p1123S, DOI 10.3945/ajcn.2010.28608A; Foley RN, 2007, AM J NEPHROL, V27, P279, DOI 10.1159/000101827; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Fouque D, 2011, KIDNEY INT, V80, P348, DOI 10.1038/ki.2011.118; Gama-Axelsson T, 2012, CLIN J AM SOC NEPHRO, V7, P1446, DOI 10.2215/CJN.10251011; HEYMSFIELD SB, 1983, AM J CLIN NUTR, V37, P478, DOI 10.1093/ajcn/37.3.478; Honda H, 2007, AM J CLIN NUTR, V86, P633, DOI 10.1093/ajcn/86.3.633; Ix JH, 2011, CLIN J AM SOC NEPHRO, V6, P184, DOI 10.2215/CJN.05030610; Ix JH, 2010, CIRCULATION, V121, P1295, DOI 10.1161/CIRCULATIONAHA.109.924266; JONES JD, 1974, CLIN CHEM, V20, P1204; Kalantar-Zadeh K, 2004, SEMIN DIALYSIS, V17, P455, DOI 10.1111/j.0894-0959.2004.17606.x; Kalantar-Zadeh K, 2003, AM J KIDNEY DIS, V42, P864, DOI 10.1016/j.ajkd.2003.07.016; Kalantar-Zadeh K, 2001, AM J KIDNEY DIS, V38, P1343, DOI 10.1053/ajkd.2001.29250; Kaysen GA, 2005, AM J CLIN NUTR, V82, P988, DOI 10.1093/ajcn/82.5.988; Kopple JD, 2000, KIDNEY INT, V57, P1688, DOI 10.1046/j.1523-1755.2000.00014.x; Kovesdy CP, 2010, SEMIN DIALYSIS, V23, P353, DOI 10.1111/j.1525-139X.2010.00745.x; Kovesdy CP, 2009, AM J CLIN NUTR, V90, P407, DOI 10.3945/ajcn.2008.27390; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Mak RH, 2011, J CACHEXIA SARCOPENI, V2, P119, DOI 10.1007/s13539-011-0026-6; Mak RH, 2011, J CACHEXIA SARCOPENI, V2, P9, DOI 10.1007/s13539-011-0019-5; Micco LD, 2013, CLIN J AM SOC NEPHRO, DOI [10.2215/CJN.01350213, DOI 10.2215/CJN.01350213]; Mitsiopoulos N, 1998, J APPL PHYSIOL, V85, P115, DOI 10.1152/jappl.1998.85.1.115; Molnar MZ, 2011, AM J TRANSPLANT, V11, P725, DOI 10.1111/j.1600-6143.2011.03468.x; Moranne O, 2009, J AM SOC NEPHROL, V20, P164, DOI 10.1681/ASN.2008020159; Noori N, 2010, CLIN J AM SOC NEPHRO, V5, P2258, DOI 10.2215/CJN.02080310; Ortega O, 2002, NEPHROL DIAL TRANSPL, V17, P1105, DOI 10.1093/ndt/17.6.1105; Oterdoom LH, 2008, TRANSPLANTATION, V86, P391, DOI 10.1097/TP.0b013e3181788aea; Oterdoom LH, 2009, ATHEROSCLEROSIS, V207, P534, DOI 10.1016/j.atherosclerosis.2009.05.010; Proctor DN, 1999, AM J PHYSIOL-ENDOC M, V277, pE489, DOI 10.1152/ajpendo.1999.277.3.E489; Pupim LB, 2005, KIDNEY INT, V68, P2368, DOI 10.1111/j.1523-1755.2005.00699.x; Qureshi AR, 2002, J AM SOC NEPHROL, V13, pS28; Qureshi AR, 1998, KIDNEY INT, V53, P773, DOI 10.1046/j.1523-1755.1998.00812.x; Rule AD, 2009, KIDNEY INT, V75, P1071, DOI 10.1038/ki.2008.698; Siew ED, 2007, KIDNEY INT, V71, P146, DOI 10.1038/sj.ki.5001984; Stenvinkel P, 2000, NEPHROL DIAL TRANSPL, V15, P953, DOI 10.1093/ndt/15.7.953; Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x; Workeneh BT, 2010, AM J CLIN NUTR, V91, p1128S, DOI 10.3945/ajcn.2010.28608B; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Zimmermann J, 1999, KIDNEY INT, V55, P648, DOI 10.1046/j.1523-1755.1999.00273.x	53	32	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e111949	10.1371/journal.pone.0111949	http://dx.doi.org/10.1371/journal.pone.0111949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401694	Green Published, Green Submitted, gold			2022-12-27	WOS:000345158700022
J	Finsen, AV; Ueland, T; Sjaastad, I; Ranheim, T; Ahmed, MS; Dahl, CP; Askevold, ET; Aakhus, S; Husberg, C; Fiane, AE; Lipp, M; Gullestad, L; Christensen, G; Aukrust, P; Yndestad, A				Finsen, Alexandra Vanessa; Ueland, Thor; Sjaastad, Ivar; Ranheim, Trine; Ahmed, Mohammed S.; Dahl, Christen P.; Askevold, Erik T.; Aakhus, Svend; Husberg, Cathrine; Fiane, Arnt E.; Lipp, Martin; Gullestad, Lars; Christensen, Geir; Aukrust, Pal; Yndestad, Arne			The Homeostatic Chemokine CCL21 Predicts Mortality in Aortic Stenosis Patients and Modulates Left Ventricular Remodeling	PLOS ONE			English	Article							RECEPTOR CCR7; EXPRESSION; ECHOCARDIOGRAPHY; CARDIOLOGY; DISEASE	Background: CCL21 acting through CCR7, is termed a homeostatic chemokine. Based on its role in concerting immunological responses and its proposed involvement in tissue remodeling, we hypothesized that this chemokine could play a role in myocardial remodeling during left ventricular (LV) pressure overload. Methods and Results: Our main findings were: (i) Serum levels of CCL21 were markedly raised in patients with symptomatic aortic stenosis (AS, n = 136) as compared with healthy controls (n = 20). (ii) A CCL21 level in the highest tertile was independently associated with all-cause mortality in these patients. (iii) Immunostaining suggested the presence of CCR7 on macrophages, endothelial cells and fibroblasts within calcified human aortic valves. (iv). Mice exposed to LV pressure overload showed enhanced myocardial expression of CCL21 and CCR7 mRNA, and increased CCL21 protein levels. (v) CCR7(-/-) mice subjected to three weeks of LV pressure overload had similar heart weights compared to wild type mice, but increased LV dilatation and reduced wall thickness. Conclusions: Our studies, combining experiments in clinical and experimental LV pressure overload, suggest that CCL21/CCR7 interactions might be involved in the response to pressure overload secondary to AS.	[Finsen, Alexandra Vanessa; Ueland, Thor; Ranheim, Trine; Dahl, Christen P.; Askevold, Erik T.; Aukrust, Pal; Yndestad, Arne] Oslo Univ Hosp, Rikshosp, Internal Med Res Inst, Oslo, Norway; [Finsen, Alexandra Vanessa; Dahl, Christen P.; Askevold, Erik T.; Aakhus, Svend; Gullestad, Lars] Oslo Univ Hosp, Rikshosp, Dept Cardiol, Oslo, Norway; [Ueland, Thor] Oslo Univ Hosp, Rikshosp, Endocrinol Sect, Oslo, Norway; [Fiane, Arnt E.] Oslo Univ Hosp, Rikshosp, Dept Cardiothorac Surg, Oslo, Norway; [Aukrust, Pal] Oslo Univ Hosp, Rikshosp, Sect Clin Immunol & Infect Dis, Oslo, Norway; [Ahmed, Mohammed S.] Oslo Univ Hosp, Rikshosp, Inst Surg Res, Oslo, Norway; [Sjaastad, Ivar; Husberg, Cathrine; Christensen, Geir] Univ Oslo, Ulleval Hosp, Expt Med Res Inst, Oslo, Norway; [Sjaastad, Ivar] Univ Oslo, Ulleval Hosp, Dept Cardiol, Oslo, Norway; [Finsen, Alexandra Vanessa; Sjaastad, Ivar; Ahmed, Mohammed S.; Dahl, Christen P.; Askevold, Erik T.; Aakhus, Svend; Husberg, Cathrine; Gullestad, Lars; Christensen, Geir; Yndestad, Arne] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Aukrust, Pal; Yndestad, Arne] Univ Oslo, KG Jebsen Inflammat Res Ctr, Oslo, Norway; [Ueland, Thor; Sjaastad, Ivar; Gullestad, Lars; Christensen, Geir] Univ Oslo, KG Jebsen Cardiac Res Ctr, Oslo, Norway; [Sjaastad, Ivar; Ranheim, Trine; Fiane, Arnt E.; Gullestad, Lars; Christensen, Geir; Aukrust, Pal; Yndestad, Arne] Univ Oslo, Fac Med, Oslo, Norway; [Lipp, Martin] Max Delbruck Ctr Mol Med, Dept Mol Tumor Genet & Immunogenet, Berlin, Germany; [Askevold, Erik T.] Lovisenberg Diakonale Hosp, Dept Med, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Finsen, AV (corresponding author), Oslo Univ Hosp, Rikshosp, Internal Med Res Inst, Oslo, Norway.	a.v.finsen@medisin.uio.no		Lipp, Martin/0000-0002-0087-2672	Center for Heart Failure Research, University of Oslo; Regional Health Authorities of South-Eastern Norway; Norwegian Research Council	Center for Heart Failure Research, University of Oslo; Regional Health Authorities of South-Eastern Norway; Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was funded by Center for Heart Failure Research, University of Oslo, the Regional Health Authorities of South-Eastern Norway and the Norwegian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akat K, 2009, HEART, V95, P616, DOI 10.1136/hrt.2007.134783; Banas B, 2004, KIDNEY INT, V66, P2256, DOI 10.1111/j.1523-1755.2004.66037.x; Bruhl H, 2008, RHEUMATOLOGY, V47, P1771, DOI 10.1093/rheumatology/ken383; Damas JK, 2007, ARTERIOSCL THROM VAS, V27, P614, DOI 10.1161/01.ATV.0000255581.38523.7c; Finsen AV, 2005, J APPL PHYSIOL, V98, P680, DOI 10.1152/japplphysiol.00924.2004; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Freeman RV, 2005, CIRCULATION, V111, P3316, DOI 10.1161/CIRCULATIONAHA.104.486738; Kaur D, 2006, AM J RESP CRIT CARE, V174, P1179, DOI 10.1164/rccm.200603-394OC; Kawashima D, 2005, J CLIN PATHOL, V58, P1057, DOI 10.1136/jcp.2004.024828; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LAURENT GJ, 1981, ANAL BIOCHEM, V113, P301, DOI 10.1016/0003-2697(81)90081-6; Liu HJ, 1998, J CHROMATOGR A, V828, P383, DOI 10.1016/S0021-9673(98)00836-X; Muller G, 2002, J LEUKOCYTE BIOL, V72, P1; Ngo DTM, 2004, J AM SOC ECHOCARDIOG, V17, P1123, DOI 10.1016/j.echo.2004.06.012; Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4; Pickens SR, 2012, ARTHRITIS RHEUM-US, V64, P2471, DOI 10.1002/art.34452; Pierce EM, 2007, EUR RESPIR J, V29, P1082, DOI 10.1183/09031936.00122806; Rajamannan NM, 2007, NAT CLIN PRACT CARD, V4, P254, DOI 10.1038/ncpcardio0827; Ross J Jr, 1968, Circulation, V38, P61; SKJAERPE T, 1985, CIRCULATION, V72, P810, DOI 10.1161/01.CIR.72.4.810; Waehre A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018668; Yndestad A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033038	22	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112172	10.1371/journal.pone.0112172	http://dx.doi.org/10.1371/journal.pone.0112172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398010	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000345558500038
J	Fischer, S; Lemmer, G; Gollwitzer, M; Nater, UM				Fischer, Susanne; Lemmer, Gunnar; Gollwitzer, Mario; Nater, Urs M.			Stress and Resilience in Functional Somatic Syndromes - A Structural Equation Modeling Approach	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; CHRONIC-FATIGUE-SYNDROME; MEDICALLY UNEXPLAINED SYMPTOMS; GENERAL-APPROACH; FIT INDEXES; FIBROMYALGIA; PREVALENCE; PAIN; QUESTIONNAIRE; PERSONALITY	Background: Stress has been suggested to play a role in the development and perpetuation of functional somatic syndromes. The mechanisms of how this might occur are not clear. Purpose: We propose a multi-dimensional stress model which posits that childhood trauma increases adult stress reactivity (i.e., an individual's tendency to respond strongly to stressors) and reduces resilience (e. g., the belief in one's competence). This in turn facilitates the manifestation of functional somatic syndromes via chronic stress. We tested this model cross-sectionally and prospectively. Methods: Young adults participated in a web survey at two time points. Structural equation modeling was used to test our model. The final sample consisted of 39054 participants, and 429 of these participated in the follow-up survey. Results: Our proposed model fit the data in the cross-sectional (x 2 (21) = 48.808, p,. 001, CFI = .995, TLI = .992, RMSEA = .021, 90% CI [.013.029]) and prospective analyses (chi(2)(21) = 32.675, p<.05, CFI = .982, TLI = .969, RMSEA = .036, 90% CI [.001.059]). Discussion: Our findings have several clinical implications, suggesting a role for stress management training in the prevention and treatment of functional somatic syndromes.	[Fischer, Susanne; Lemmer, Gunnar; Gollwitzer, Mario; Nater, Urs M.] Univ Marburg, Dept Psychol, D-35032 Marburg, Hesse, Germany	Philipps University Marburg	Fischer, S (corresponding author), Univ Marburg, Dept Psychol, D-35032 Marburg, Hesse, Germany.	susanne.fischer@uni-marburg.de	Gollwitzer, Mario/A-4099-2015; Nater, Urs/Q-5208-2019; Gollwitzer, Mario/AAE-6042-2020; Gollwitzer, Mario/ABA-7217-2021; Fischer, Susanne/AAM-4472-2021	Gollwitzer, Mario/0000-0003-4310-4793; Nater, Urs/0000-0002-2430-5090; Gollwitzer, Mario/0000-0003-4310-4793; Fischer, Susanne/0000-0002-9111-9933				Afari N, 2014, PSYCHOSOM MED, V76, P2, DOI 10.1097/PSY.0000000000000010; APA, 2000, DIAGN STAT MAN MENT; Assumpcao A, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-64; Bach DR, 2006, EUR J GASTROEN HEPAT, V18, P629, DOI 10.1097/00042737-200606000-00009; Bagozzi RP, 1998, ORGAN RES METHODS, V1, P45, DOI 10.1177/109442819800100104; Bagozzi RP, 1994, STRUCT EQU MODELING, V1, P35, DOI 10.1080/10705519409539961; Bandalos D. L., 2001, ADV STRUCTURAL EQUAT; Barsky AJ, 1999, ANN INTERN MED, V130, P910, DOI 10.7326/0003-4819-130-11-199906010-00016; Becker P., 2004, TRIERER INVENTAR ZUM; Bengtson MB, 2006, GUT, V55, P1754, DOI 10.1136/gut.2006.097287; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Brown RJ, 2004, PSYCHOL BULL, V130, P793, DOI 10.1037/0033-2909.130.5.793; Browne M. W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; Buchwald D, 2001, PSYCHOSOM MED, V63, P936, DOI 10.1097/00006842-200111000-00012; Campbell-Sills L, 2006, BEHAV RES THER, V44, P585, DOI 10.1016/j.brat.2005.05.001; Campbell-Sills L, 2009, J PSYCHIATR RES, V43, P1007, DOI 10.1016/j.jpsychires.2009.01.013; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Feder A, 2009, NAT REV NEUROSCI, V10, P446, DOI 10.1038/nrn2649; Fischer S., 2013, VERHALTENSTHERAPIE V, V34, P419; Fischer S, 2013, INT J BEHAV MED, V20, P184, DOI 10.1007/s12529-012-9266-x; Fossion P, 2013, J AFFECT DISORDERS, V151, P973, DOI 10.1016/j.jad.2013.08.018; Friborg O, 2006, J PSYCHOSOM RES, V61, P213, DOI 10.1016/j.jpsychores.2005.12.007; Gonzalez-Ramirez MT, 2011, ACTAS ESP PSIQUIATRI, V39, P81; Hazlett-Stevens H, 2003, J PSYCHOSOM RES, V55, P501, DOI 10.1016/S0022-3999(03)00019-9; Heim CM, 2013, AM J PSYCHIAT, V170, P616, DOI 10.1176/appi.ajp.2013.12070950; Hickie I, 2006, BRIT MED J, V333, P575, DOI 10.1136/bmj.38933.585764.AE; Hillila MT, 2010, SCAND J GASTROENTERO, V45, P582, DOI 10.3109/00365521003637211; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Iffland B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-980; Kato K, 2009, PSYCHOL MED, V39, P497, DOI 10.1017/S0033291708003784; Kato K, 2006, ARCH INTERN MED, V166, P1649, DOI 10.1001/archinte.166.15.1649; Keller A, 2012, HEALTH PSYCHOL, V31, P677, DOI 10.1037/a0026743; Klingmann PO, 2008, ANN NY ACAD SCI, V1148, P446, DOI 10.1196/annals.1410.020; Koloski NA, 2002, AM J GASTROENTEROL, V97, P2290; Lazarus R.S., 1984, EMOTION ADAPTATION; Lin Jin-Mann S, 2011, Cost Eff Resour Alloc, V9, P1, DOI 10.1186/1478-7547-9-1; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Lustyk MKB, 2007, WOMEN HEALTH, V46, P61, DOI 10.1300/J013v46n04_04; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Miro E, 2011, BRIT J HEALTH PSYCH, V16, P799, DOI 10.1111/j.2044-8287.2011.02016.x; Moss-Morris R, 2006, PSYCHOSOM MED, V68, P463, DOI 10.1097/01.psy.0000221384.07521.05; Motzer SA, 2003, NURS RES, V52, P329, DOI 10.1097/00006199-200309000-00007; Murray TL, 2007, STRESS HEALTH, V23, P3, DOI 10.1002/smi.1102; Muthen B., 1997, ROBUST INFERENCE USI; Nacul LC, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-91; Nasser F, 2003, APPL MEAS EDUC, V16, P75, DOI 10.1207/S15324818AME1601_4; Nater UM, 2013, ADAPTIVE MALADAPTIVE, P147; Nater UM, 2011, CURR PSYCHIATRY REV, V7, P152, DOI 10.2174/157340011796391184; Nater UM, 2011, VERHALTENSTHERAPIE, V21, P263, DOI 10.1159/000333298; Nater UM, 2011, PSYCHIAT RES, V189, P318, DOI 10.1016/j.psychres.2011.07.015; Nater UM, 2009, PSYCHOSOM MED, V71, P557, DOI 10.1097/PSY.0b013e31819ea179; Nimnuan C, 2001, J PSYCHOSOM RES, V51, P361, DOI 10.1016/S0022-3999(01)00223-9; Piche M, 2010, PAIN, V148, P49, DOI 10.1016/j.pain.2009.10.005; Rasmusson AM, 2000, BIOL PSYCHIAT, V47, P526, DOI 10.1016/S0006-3223(99)00185-7; Reyes M, 2003, ARCH INTERN MED, V163, P1530, DOI 10.1001/archinte.163.13.1530; Russo SJ, 2012, NAT NEUROSCI, V15, P1475, DOI 10.1038/nn.3234; Schlotz W., 2012, ENCY BEHAV MED, V3, P1891; Schlotz W, 2013, STRESS HEALTH, V29, P56, DOI 10.1002/smi.2425; Schlotz W, 2011, PSYCHOL ASSESSMENT, V23, P80, DOI 10.1037/a0021148; Schulz P, 2005, DIAGNOSTICA, V51, P124, DOI 10.1026/0012-1924.51.3.124; Schumacher J, 2005, Z KLIN PSYCH PSYCHIA, V53, P16; Simeon D, 2007, PSYCHONEUROENDOCRINO, V32, P1149, DOI 10.1016/j.psyneuen.2007.08.005; Smith BW, 2008, PAIN, V140, P420, DOI 10.1016/j.pain.2008.09.018; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI 10.2307/270723; Spitzer RL, 2002, MANUAL KOMPLETTVERSI, V2; Sterrenburg L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028128; Suarez-Hitz KA, 2012, PSYCHOSOM MED, V74, P221, DOI 10.1097/PSY.0b013e318244fb82; Tak LM, 2010, J PSYCHOSOM RES, V68, P461, DOI 10.1016/j.jpsychores.2009.12.004; van Gils A, 2014, J PSYCHOSOM RES, V77, P34, DOI 10.1016/j.jpsychores.2014.04.006; Videlock EJ, 2009, GASTROENTEROLOGY, V137, P1954, DOI 10.1053/j.gastro.2009.08.058; Wagnild G M, 1993, J Nurs Meas, V1, P165; Wilson S, 2004, BRIT J GEN PRACT, V54, P495; Wingenfeld K, 2010, PSYCHOTHER PSYCH MED, V60, P442, DOI 10.1055/s-0030-1247564; Winkelmann A, 2011, APPL HEALTH ECON HEA, V9, P125, DOI 10.2165/11535250-000000000-00000; WOLFE F, 1995, ARTHRITIS RHEUM-US, V38, P19, DOI 10.1002/art.1780380104	78	12	13	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e111214	10.1371/journal.pone.0111214	http://dx.doi.org/10.1371/journal.pone.0111214			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DF	25396736	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558500013
J	Kawaguchi, Y; Sugawara, Y; Akamatsu, N; Kaneko, J; Hamada, T; Tanaka, T; Ishizawa, T; Tamura, S; Aoki, T; Sakamoto, Y; Hasegawa, K; Kokudo, N				Kawaguchi, Yoshikuni; Sugawara, Yasuhiko; Akamatsu, Nobuhisa; Kaneko, Junichi; Hamada, Tsuyoshi; Tanaka, Tomohiro; Ishizawa, Takeaki; Tamura, Sumihito; Aoki, Taku; Sakamoto, Yoshihiro; Hasegawa, Kiyoshi; Kokudo, Norihiro			Impact of Early Reoperation following Living-Donor Liver Transplantation on Graft Survival	PLOS ONE			English	Article							SINGLE-CENTER; RISK-FACTORS; COMPLICATIONS; MORTALITY; OUTCOMES; HEPATECTOMY; HEMORRHAGE; EXPERIENCE; THROMBOSIS; MORBIDITY	Background: The reoperation rate remains high after liver transplantation and the impact of reoperation on graft and recipient outcome is unclear. The aim of our study is to evaluate the impact of early reoperation following living-donor liver transplantation (LDLT) on graft and recipient survival. Methods: Recipients that underwent LDLT (n = 111) at the University of Tokyo Hospital between January 2007 and December 2012 were divided into two groups, a reoperation group (n = 27) and a non-reoperation group (n = 84), and case-control study was conducted. Results: Early reoperation was performed in 27 recipients (24.3%). Mean time [standard deviation] from LDLT to reoperation was 10 [9.4] days. Female sex, Child-Pugh class C, Non-HCV etiology, fulminant hepatitis, and the amount of intraoperative fresh frozen plasma administered were identified as possibly predictive variables, among which females and the amount of FFP were identified as independent risk factors for early reoperation by multivariable analysis. The 3-, and 6-month graft survival rates were 88.9% (95% confidential intervals [CI], 70.7-96.4), and 85.2% (95% CI, 66.5-94.3), respectively, in the reoperation group (n = 27), and 95.2% (95% CI, 88.0-98.2), and 92.9% (95% CI, 85.0-96.8), respectively, in the non-reoperation group (n = 84) (the log-rank test, p = 0.31). The 12- and 36-month overall survival rates were 96.3% (95% CI, 77.9-99.5), and 88.3% (95% CI, 69.3-96.2), respectively, in the reoperation group, and 89.3% (95% CI, 80.7-94.3) and 88.0% (95% CI, 79.2-93.4), respectively, in the non-reoperation group (the log-rank test, p = 0.59). Conclusions: Observed graft survival for the recipients who underwent reoperation was lower compared to those who did not undergo reoperation, though the result was not significantly different. Recipient overall survival with reoperation was comparable to that without reoperation. The present findings enhance the importance of vigilant surveillance for postoperative complication and surgical rescue at an early postoperative stage in the LDLT setting.	[Kawaguchi, Yoshikuni; Sugawara, Yasuhiko; Akamatsu, Nobuhisa; Kaneko, Junichi; Ishizawa, Takeaki; Tamura, Sumihito; Aoki, Taku; Sakamoto, Yoshihiro; Hasegawa, Kiyoshi; Kokudo, Norihiro] Univ Tokyo, Dept Surg, Artificial Organ & Transplantat Surg Div, Grad Sch Med, Tokyo, Japan; [Tanaka, Tomohiro] Univ Tokyo, Organ Transplantat Serv, Tokyo, Japan; [Hamada, Tsuyoshi] Univ Tokyo, Dept Gastroenterol, Grad Sch Med, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Sugawara, Y (corresponding author), Univ Tokyo, Dept Surg, Artificial Organ & Transplantat Surg Div, Grad Sch Med, Tokyo, Japan.	yasusugatky@yahoo.co.jp	Kawaguchi, Yoshikuni/AAB-1718-2022	Kawaguchi, Yoshikuni/0000-0003-2986-3224	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan (AIDS Research)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan (AIDS Research)(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and from the Ministry of Health, Labor and Welfare of Japan (AIDS Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam P, 2003, LIVER TRANSPLANT, V9, P1231, DOI 10.1016/j.lts.2003.09.018; Anderson ML, 2012, CIRCULATION, V126, P2190, DOI 10.1161/CIRCULATIONAHA.112.111369; [Anonymous], 2010, JPN J TRANSPL, V46, P524; Arshad F, 2013, LIVER INT, V33, P820, DOI 10.1111/liv.12140; Barbas AS, 2013, J AM COLL SURGEONS, V216, P915, DOI 10.1016/j.jamcollsurg.2013.01.008; Duailibi DF, 2010, TRANSPL P, V42, P517, DOI 10.1016/j.transproceed.2010.01.017; Freise CE, 2008, AM J TRANSPLANT, V8, P2569, DOI 10.1111/j.1600-6143.2008.02440.x; Hendriks HGD, 2004, TRANSPL INT, V17, P673, DOI 10.1111/j.1432-2277.2004.tb00493.x; Imamura H, 2003, ARCH SURG-CHICAGO, V138, P1198, DOI 10.1001/archsurg.138.11.1198; Jain A, 2000, ANN SURG, V232, P490, DOI 10.1097/00000658-200010000-00004; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kappa SF, 2010, AM SURGEON, V76, P969; Khalaf H, 2010, TRANSPL P, V42, P865, DOI 10.1016/j.transproceed.2010.02.037; Kokudo N, 2005, AM J TRANSPLANT, V5, P1694, DOI 10.1111/j.1600-6143.2005.00917.x; Lisman T, 2010, J HEPATOL, V53, P362, DOI 10.1016/j.jhep.2010.01.042; Lisman T, 2009, TRANSPL INT, V22, P162, DOI 10.1111/j.1432-2277.2008.00762.x; Onaca NN, 2003, LIVER TRANSPLANT, V9, P117, DOI 10.1053/jlts.2003.50027; Peterson ED, 2001, AM J CARDIOL, V88, P359, DOI 10.1016/S0002-9149(01)01679-4; Pomposelli JJ, 2006, AM J TRANSPLANT, V6, P589, DOI 10.1111/j.1600-6143.2005.01220.x; Rahbari NN, 2011, HPB, V13, P528, DOI 10.1111/j.1477-2574.2011.00319.x; Sanada Y, 2013, J HEPATOBILIARY PANC; Schroeder RA, 2006, ANN SURG, V243, P373, DOI 10.1097/01.sla.0000201483.95911.08; Soong RS, 2012, TRANSPL P, V44, P784, DOI 10.1016/j.transproceed.2012.03.028; STARZL TE, 1981, NEW ENGL J MED, V305, P266, DOI 10.1056/NEJM198107303050507; Sugawara Y, 2004, LIVER TRANSPLANT, V10, P541, DOI 10.1002/lt.20129; Sugawara Y, 2002, CLIN TRANSPLANT, V16, P102, DOI 10.1034/j.1399-0012.2002.1o106.x; Sugawara Yasuhiko, 2003, J Hepatobiliary Pancreat Surg, V10, P1; Tripodi A, 2009, GASTROENTEROLOGY, V137, P2105, DOI 10.1053/j.gastro.2009.08.045; URATA K, 1995, HEPATOLOGY, V21, P1317, DOI 10.1016/0270-9139(95)90053-5; Yoshiya S, 2012, TRANSPLANTATION, V94, P947, DOI 10.1097/TP.0b013e31826969e6	30	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e109731	10.1371/journal.pone.0109731	http://dx.doi.org/10.1371/journal.pone.0109731			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396413	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558500005
J	Kumar, KA; Lalitha, A; Reddy, U; Chandak, GR; Sengupta, S; Raghunath, M				Kumar, Kalle Anand; Lalitha, Anumula; Reddy, Umakar; Chandak, Giriraj Ratan; Sengupta, Shantanu; Raghunath, Manchala			Chronic Maternal Vitamin B12 Restriction Induced Changes in Body Composition & Glucose Metabolism in the Wistar Rat Offspring Are Partly Correctable by Rehabilitation	PLOS ONE			English	Article							INSULIN-RESISTANCE; OXIDATIVE STRESS; SKELETAL-MUSCLE; BIRTH-WEIGHT; PREGNANCY; FOLATE; FAT; SUPPLEMENTATION; HOMOCYSTEINE; METHYLATION	Maternal under-nutrition increases the risk of developing metabolic diseases. We studied the effects of chronic maternal dietary vitamin B12 restriction on lean body mass (LBM), fat free mass (FFM), muscle function, glucose tolerance and metabolism in Wistar rat offspring. Prevention/reversibility of changes by rehabilitating restricted mothers from conception or parturition and their offspring from weaning was assessed. Female weaning Wistar rats (n = 30) were fed ad libitum for 12 weeks, a control diet (n = 6) or the same with 40% restriction of vitamin B12 (B12R) (n = 24); after confirming deficiency, were mated with control males. Six each of pregnant B12R dams were rehabilitated from conception and parturition and their offspring weaned to control diet. While offspring of six B12R dams were weaned to control diet, those of the remaining six B12R dams continued on B12R diet. Biochemical parameters and body composition were determined in dams before mating and in male offspring at 3, 6, 9 and 12 months of their age. Dietary vitamin B12 restriction increased body weight but decreased LBM% and FFM% but not the percent of tissue associated fat (TAF%) in dams. Maternal B12R decreased LBM% and FFM% in the male offspring, but their TAF%, basal and insulin stimulated glucose uptake by diaphragm were unaltered. At 12 months age, B12R offspring had higher (than controls) fasting plasma glucose, insulin, HOMA-IR and impaired glucose tolerance. Their hepatic gluconeogenic enzyme activities were increased. B12R offspring had increased oxidative stress and decreased antioxidant status. Changes in body composition, glucose metabolism and stress were reversed by rehabilitating B12R dams from conception, whereas rehabilitation from parturition and weaning corrected them partially, highlighting the importance of vitamin B12 during pregnancy and lactation on growth, muscle development, glucose tolerance and metabolism in the offspring.	[Kumar, Kalle Anand; Lalitha, Anumula; Raghunath, Manchala] Indian Council Med Res, Natl Inst Nutr, Div Endocrinol & Metab, Hyderabad, Telangana, India; [Reddy, Umakar; Chandak, Giriraj Ratan] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Telangana, India; [Sengupta, Shantanu] CSIR, Inst Genom & Integrat Biol, New Delhi 110001, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Raghunath, M (corresponding author), Indian Council Med Res, Natl Inst Nutr, Div Endocrinol & Metab, Hyderabad, Telangana, India.	mraghunath55@yahoo.com		Chandak, Giriraj Ratan/0000-0002-3095-9453	Department of Biotechnology, Government of India, New Delhi, India [BT/PR-7506/PID/20/294/2006]; Indian Council of Medical Research (ICMR), India	Department of Biotechnology, Government of India, New Delhi, India(Department of Biotechnology (DBT) India); Indian Council of Medical Research (ICMR), India(Indian Council of Medical Research (ICMR))	This work was supported by a research grant (#BT/PR-7506/PID/20/294/2006) to Manchala Raghunath, Giriraj Ratan Chandak and Shantanu Sengupta, from the Department of Biotechnology, Government of India, New Delhi, India (URL: http://dbtindia.nic.in/index.asp). The authors acknowledge the support and encouragement received from the Directors of National Institute of Nutrition and the Centre for Cellular and Molecular Biology, Hyderabad in the conduct of these studies. Kalle Anand Kumar is grateful to the Indian Council of Medical Research (ICMR), India, for awarding a senior research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2013, J PROTEOMICS, V91, P297, DOI 10.1016/j.jprot.2013.07.027; Alwan NA, 2011, HUM REPROD, V26, P911, DOI 10.1093/humrep/der005; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Bertram CE, 2001, BRIT MED BULL, V60, P103, DOI 10.1093/bmb/60.1.103; Bourre JM, 2006, J NUTR HEALTH AGING, V10, P377; BUCHER T, 1955, METHOD ENZYMOL, V1, P435, DOI 10.1016/0076-6879(55)01071-9; Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004; Casanueva E, 2003, J NUTR, V133, p1700S, DOI 10.1093/jn/133.5.1700S; Choi SW, 2004, J NUTR, V134, P750, DOI 10.1093/jn/134.4.750; Devrim E, 2006, J SOC GYNECOL INVEST, V13, P502, DOI 10.1016/j.jsgi.2006.07.004; Donahue RP, 1997, DIABETES CARE, V20, P1670, DOI 10.2337/diacare.20.11.1670; Drake AJ, 2004, J ENDOCRINOL, V180, P1, DOI 10.1677/joe.0.1800001; Du M, 2010, J ANIM SCI, V88, pE51, DOI 10.2527/jas.2009-2311; EMERSON GA, 1949, FED PROC, V8, P381; Frith AL, 2009, AM J CLIN NUTR, V90, P141, DOI 10.3945/ajcn.2008.26817; Ganeshan M, 2011, EXP DIABETES RES, DOI 10.1155/2011/486316; GAUTHIER GF, 1966, J CELL BIOL, V28, P333, DOI 10.1083/jcb.28.2.333; GIEROW P, 1982, METHOD ENZYMOL, V89, P44; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Iannotti LL, 2008, AM J CLIN NUTR, V88, P154, DOI 10.1093/ajcn/88.1.154; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; JONES AP, 1982, SCIENCE, V215, P1518, DOI 10.1126/science.7063860; Karen LY, 1999, THESIS U TORONTO; KIPNIS DM, 1957, J BIOL CHEM, V224, P681; Krishnaveni GV, 2009, DIABETOLOGIA, V52, P2350, DOI 10.1007/s00125-009-1499-0; Krishnaveni GV, 2011, AM J CLIN NUTR, V93, P628, DOI 10.3945/ajcn.110.003921; Kulkarni A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017706; Kumar KA, 2013, J NUTR BIOCHEM, V24, P25, DOI 10.1016/j.jnutbio.2012.01.004; Lawlor DA, 2002, BMJ-BRIT MED J, V325, P359, DOI 10.1136/bmj.325.7360.359; Leeda M, 1998, AM J OBSTET GYNECOL, V179, P135, DOI 10.1016/S0002-9378(98)70263-7; Lin YF, 2005, J NUTR, V135, P2457, DOI 10.1093/jn/135.10.2457; LING CT, 1952, J BIOL CHEM, V198, P439; Louet Jean-Francois, 2004, Curr Atheroscler Rep, V6, P180, DOI 10.1007/s11883-004-0030-9; MARCUS F, 1982, METHOD ENZYMOL, V90, P352; Mitrou P, 2010, ENDOCR REV, V31, P663, DOI 10.1210/er.2009-0046; MORBACH CA, 1992, J PEDIATR GASTR NUTR, V14, P283, DOI 10.1097/00005176-199204000-00009; Muthayya S, 2006, EUR J CLIN NUTR, V60, P791, DOI 10.1038/sj.ejcn.1602383; Nelen WLDM, 2000, OBSTET GYNECOL, V95, P519, DOI 10.1016/S0029-7844(99)00610-9; NUUTILA P, 1995, DIABETES, V44, P31, DOI 10.2337/diabetes.44.1.31; Padmavathi IJN, 2010, DIABETES, V59, P98, DOI 10.2337/db09-0779; Padmavathi IJN, 2009, EXP PHYSIOL, V94, P761, DOI 10.1113/expphysiol.2008.045856; Pilkis S J, 1975, Methods Enzymol, V42, P31; Raghunath M, 2009, INDIAN J MED RES, V130, P655; Ramakrishnan U, 2004, AM J CLIN NUTR, V79, P17; Rao S, 2001, J NUTR, V131, P1217, DOI 10.1093/jn/131.4.1217; Relton CL, 2005, BRIT J NUTR, V93, P593, DOI 10.1079/BJN20041395; Selhub J, 2002, J Nutr Health Aging, V6, P39; Sen S, 2010, DIABETES, V59, P3058, DOI 10.2337/db10-0301; Sengupta S, 2001, J BIOL CHEM, V276, P30111, DOI 10.1074/jbc.M104324200; Setola E, 2004, EUR J ENDOCRINOL, V151, P483, DOI 10.1530/eje.0.1510483; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Smith U, 2002, INT J OBESITY, V26, P897, DOI 10.1038/sj.ijo.0802028; Sucharita S, 2014, MATERN CHILD NUTR, V10, P226, DOI 10.1111/j.1740-8709.2012.00418.x; Torrens C, 2006, HYPERTENSION, V47, P982, DOI 10.1161/01.HYP.0000215580.43711.d1; Urakawa H, 2003, J CLIN ENDOCR METAB, V88, P4673, DOI 10.1210/jc.2003-030202; US Department of Health Education and Welfare: Guide for the Care and Use of Laboratory Animals, 1985, US DHEW NIH PUBL, P85; Veena SR, 2010, J NUTR, V140, P1014, DOI 10.3945/jn.109.118075; Venu L, 2004, DIABETOLOGIA, V47, P1493, DOI 10.1007/s00125-004-1506-4; Venu L, 2004, EUR J ENDOCRINOL, V151, P287, DOI 10.1530/eje.0.1510287; Venu L, 2008, OBESITY, V16, P1270, DOI 10.1038/oby.2008.72; WARDZALA LJ, 1983, BIOCHIM BIOPHYS ACTA, V730, P49, DOI 10.1016/0005-2736(83)90315-2; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Yajnik CS, 2008, DIABETOLOGIA, V51, P29, DOI 10.1007/s00125-007-0793-y; Zhang XA, 2011, J MOL ENDOCRINOL, V46, pR11, DOI 10.1677/JME-10-0053; Zhu MJ, 2006, J PHYSIOL-LONDON, V575, P241, DOI 10.1113/jphysiol.2006.112110	66	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112991	10.1371/journal.pone.0112991	http://dx.doi.org/10.1371/journal.pone.0112991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398136	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558500122
J	Wang, WJ; Li, YH; Wang, HM; Zu, YG				Wang, Wenjie; Li, Yanhong; Wang, Huimei; Zu, Yuangang			Differences in the Activities of Eight Enzymes from Ten Soil Fungi and Their Possible Influences on the Surface Structure, Functional Groups, and Element Composition of Soil Colloids	PLOS ONE			English	Article							ACID-PHOSPHATASE; ENZYMATIC-ACTIVITY; CHITINASE ACTIVITY; MYCORRHIZAL FUNGI; FOREST SOILS; ECTOMYCORRHIZAL; PLANT; BIODIVERSITY; VARIABILITY; PHOSPHORUS	How soil fungi function in soil carbon and nutrient cycling is not well understood by using fungal enzymatic differences and their interactions with soil colloids. Eight extracellular enzymes, EEAs (chitinase, carboxymethyl cellulase, beta-glucosidase, protease, acid phosphatase, polyphenol oxidase, laccase, and guaiacol oxidase) secreted by ten fungi were compared, and then the fungi that showed low and high enzymatic activity were co-cultured with soil colloids for the purpose of finding fungi-soil interactions. Some fungi (Gomphidius rutilus, Russula integra, Pholiota adiposa, and Geastrum mammosum) secreted 3-4 enzymes with weak activities, while others (Cyathus striatus, Suillus granulate, Phallus impudicus, Collybia dryophila, Agaricus sylvicola, and Lactarius deliciosus) could secret over 5 enzymes with high activities. The differences in these fungi contributed to the alterations of functional groups (stretching bands of O-H, N-H, C-H, C = O, COO-decreased by 11-60%, while P = O, C-O stretching, O-H bending and Si-O-Si stretching increased 9-22%), surface appearance (disappearance of adhesive organic materials), and elemental compositions (11-49% decreases in C1s) in soil colloids. Moreover, more evident changes were generally in high enzymatic fungi (C. striatus) compared with low enzymatic fungi (G. rutilus). Our findings indicate that inter-fungi differences in EEA types and activities might be responsible for physical and chemical changes in soil colloids (the most active component of soil matrix), highlighting the important roles of soil fungi in soil nutrient cycling and functional maintenance.	[Wang, Wenjie; Li, Yanhong; Wang, Huimei; Zu, Yuangang] Minist Educ, Key Lab Forest Plant Ecol, Harbin, Heilongjiang Pr, Peoples R China		Wang, HM (corresponding author), Minist Educ, Key Lab Forest Plant Ecol, Harbin, Heilongjiang Pr, Peoples R China.	whm0709@hotmail.com	wang, wenjie/G-9041-2014; li, yan/GTI-4638-2022	wang, wenjie/0000-0003-0465-686X; 	China's Ministry of Science and Technology [2011CB403205]; Fundamental Research Funds for the Central Universities [2572014EA01]; China's National Foundation of Natural Sciences [31170575, 41373075]	China's Ministry of Science and Technology(Ministry of Science and Technology, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China's National Foundation of Natural Sciences	This study was supported financially by the China's Ministry of Science and Technology (2011CB403205), Fundamental Research Funds for the Central Universities (2572014EA01), China's National Foundation of Natural Sciences (31170575, 41373075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksieva P, 2003, Z NATURFORSCH C, V58, P239; Baldrian P, 2011, PLANT SOIL, V338, P111, DOI 10.1007/s11104-010-0324-3; Bandick AK, 1999, SOIL BIOL BIOCHEM, V31, P1471, DOI 10.1016/S0038-0717(99)00051-6; Barton CD, 2003, WATER AIR SOIL POLL, V143, P3, DOI 10.1023/A:1022886225564; BOLAN NS, 1991, PLANT SOIL, V134, P189, DOI 10.1007/BF00012037; Bridge P, 2001, PLANT SOIL, V232, P147, DOI 10.1023/A:1010346305799; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Burke RM, 2002, MYCORRHIZA, V12, P105, DOI 10.1007/s00572-002-0162-0; Cairney JWG, 1998, PLANT SOIL, V205, P181, DOI 10.1023/A:1004376731209; Caldwell BA, 2005, PEDOBIOLOGIA, V49, P637, DOI 10.1016/j.pedobi.2005.06.003; Carter DO, 2007, PEDOBIOLOGIA, V51, P295, DOI 10.1016/j.pedobi.2007.05.002; CHEN KS, 1994, ELECTROPHORESIS, V15, P662, DOI 10.1002/elps.1150150193; Clemmensen KE, 2013, SCIENCE, V339, P1615, DOI 10.1126/science.1231923; Cosgrove DJ, 1977, MICROBIAL TRANSFORMA, P95; Cullings K, 2008, OECOLOGIA, V158, P77, DOI 10.1007/s00442-008-1119-6; DeNovio NM, 2004, VADOSE ZONE J, V3, P338, DOI 10.2113/3.2.338; Desai S, 2014, MYCORRHIZA, V24, P369, DOI 10.1007/s00572-013-0548-1; Dirks-Hofmeister ME, 2012, PLANT MOL BIOL, V80, P203, DOI 10.1007/s11103-012-9943-9; Ekenler M, 2003, SOIL BIOL BIOCHEM, V35, P871, DOI 10.1016/S0038-0717(03)00094-4; Fansler SJ, 2005, BIOL FERT SOILS, V42, P17, DOI 10.1007/s00374-005-0867-2; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; GELLERSTEDT G, 1989, WOOD SCI TECHNOL, V23, P75, DOI 10.1007/BF00350609; GIANFREDA L, 1993, SOIL BIOL BIOCHEM, V25, P671, DOI 10.1016/0038-0717(93)90106-L; HAZEN GG, 1965, ANN NY ACAD SCI, V130, P761, DOI 10.1111/j.1749-6632.1965.tb12620.x; Hilszczanska D, 2008, POL J ENVIRON STUD, V17, P881; Huang QY, 2005, COLLOID SURFACE B, V45, P209, DOI 10.1016/j.colsurfb.2005.08.011; Jarosz-Wilkolazka A, 2002, ENZYME MICROB TECH, V30, P566, DOI 10.1016/S0141-0229(02)00022-4; Johnson CT, 1996, METHODS SOIL ANAL 3; Kelleher BP, 2003, LANGMUIR, V19, P9411, DOI 10.1021/la034971e; Klose S, 2003, WATER AIR SOIL POLL, V142, P3, DOI 10.1023/A:1022075130048; Leduc SD, 2013, OECOLOGIA, V172, P257, DOI 10.1007/s00442-012-2471-0; Li Yan-Hong, 2013, Bulletin of Botanical Research, V33, P404, DOI 10.7525/j.issn.1673-5102.2013.04.004; Li YH, 2013, SCI WORLD J, DOI 10.1155/2013/698752; Marcote I, 2001, BIORESOURCE TECHNOL, V79, P147, DOI 10.1016/S0960-8524(01)00048-7; MAURIZI MR, 1992, EXPERIENTIA, V48, P178, DOI 10.1007/BF01923511; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mucha J, 2006, ARCH MICROBIOL, V185, P69, DOI 10.1007/s00203-005-0068-2; NICHOLSORIANS C, 1991, J CHEM ECOL, V17, P1811, DOI 10.1007/BF00993730; Ohnuma T, 2011, FEBS J, V278, P3991, DOI 10.1111/j.1742-4658.2011.08301.x; Olander LP, 2000, BIOGEOCHEMISTRY, V49, P175, DOI 10.1023/A:1006316117817; Pointing SB, 2001, APPL MICROBIOL BIOT, V57, P20; Rao MA, 2000, SOIL BIOL BIOCHEM, V32, P1007, DOI 10.1016/S0038-0717(00)00010-9; Redlak K, 2001, BIOL FERT SOILS, V33, P83, DOI 10.1007/s003740000295; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Schreiner RP, 1997, PLANT SOIL, V188, P199, DOI 10.1023/A:1004271525014; Shaik NM, 2013, MOL BIOL REP, V40, P1351, DOI 10.1007/s11033-012-2179-6; Shao L.P., 1997, FOREST MUSHROOM CHIN; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Snajdr J, 2011, FEMS MICROBIOL ECOL, V75, P291, DOI 10.1111/j.1574-6941.2010.00999.x; Srinivasulu M, 2013, INT J ENVIRON SCI TE, V10, P341, DOI 10.1007/s13762-012-0133-8; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; Wang WJ, 2011, PLANT SOIL, V339, P177, DOI 10.1007/s11104-010-0565-1; WOLF DC, 1989, J ENVIRON QUAL, V18, P39, DOI 10.2134/jeq1989.00472425001800010007x; [谢丽源 Xie Liyuan], 2010, [食品工业科技, Science & Technology of Food Industry], V31, P183; Xu Y, 2009, ADV ATMOS SCI, V26, P783, DOI 10.1007/s00376-009-9034-2; [于富强 Yu Fuqiang], 2002, [生态学报, Acta Ecologica Sinica], V22, P2217; Zhou DM, 2011, J SOIL SEDIMENT, V11, P491, DOI 10.1007/s11368-010-0331-2; Zifcakova L, 2011, FUNGAL ECOL, V4, P427, DOI 10.1016/j.funeco.2011.04.002	59	14	14	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e111740	10.1371/journal.pone.0111740	http://dx.doi.org/10.1371/journal.pone.0111740			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398013	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558500024
J	Yu, YJ; Wu, IW; Huang, CY; Hsu, KH; Lee, CC; Sun, CY; Hsu, HJ; Wu, MS				Yu, Yu-Jen; Wu, I-Wen; Huang, Chun-Yu; Hsu, Kuang-Hung; Lee, Chin-Chan; Sun, Chio-Yin; Hsu, Heng-Jung; Wu, Mai-Szu			Multidisciplinary Predialysis Education Reduced the Inpatient and Total Medical Costs of the First 6 Months of Dialysis in Incident Hemodialysis Patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; CARE; MORTALITY; SURVIVAL; IMPACT; TAIWAN; COHORT; TRENDS	Background: The multidisciplinary pre-dialysis education (MPE) retards renal progression, reduce incidence of dialysis and mortality of CKD patients. However, the financial benefit of this intervention on patients starting hemodialysis has not yet been evaluated in prospective and randomized trial. Methods: We studied the medical expenditure and utilization incurred in the first 6 months of dialysis initiation in 425 incident hemodialysis patients who were randomized into MPE and non-MPE groups before reaching end-stage renal disease. The content of the MPE was standardized in accordance with the National Kidney Foundation Dialysis Outcomes Quality Initiative guidelines. Results: The mean age of study patients was 63.8 +/- 13.2 years, and 221 (49.7%) of them were men. The mean serum creatinine level and estimated glomerular filtration rate was 6.1 +/- 4.0 mg/dL and 7.6 +/- 2.9 mL.min(-1).1.73 m 22, respectively, at dialysis initiation. MPE patients tended to have lower total medical cost in the first 6 months after hemodialysis initiation (9147.6 +/- 0.1 USD/patient vs. 11190.6 +/- 0.1 USD/patient, p = 0.003), fewer in numbers [0 (1) vs. 1 (2), p<0.001] and length of hospitalization [0 (15) vs. 8 (27) days, p<0.001], and also lower inpatient cost [0 (2617.4) vs. 1559,4 (5019.6) USD/patient, p<0.001] than non-MPE patients, principally owing to reduced cardiovascular hospitalization and vascular access-related surgeries. The decreased inpatient and total medical cost associated with MPE were independent of patients' demographic characteristics, concomitant disease, baseline biochemistry and use of double-lumen catheter at initiation of hemodialysis. Conclusions: Participation of multidisciplinary education in pre-dialysis period was independently associated with reduction in the inpatient and total medical expenditures of the first 6 months post-dialysis owing to decreased inpatient service utilization secondary to cardiovascular causes and vascular access-related surgeries.	[Yu, Yu-Jen; Wu, I-Wen; Lee, Chin-Chan; Sun, Chio-Yin; Hsu, Heng-Jung; Wu, Mai-Szu] Chang Gung Mem Hosp, Dept Nephrol, Keelung, Taiwan; [Yu, Yu-Jen; Wu, I-Wen; Lee, Chin-Chan; Sun, Chio-Yin; Hsu, Heng-Jung] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Huang, Chun-Yu; Hsu, Kuang-Hung] Chang Gung Univ, Dept Hlth Care Management, Lab Epidemiol, Taoyuan, Taiwan; [Wu, Mai-Szu] Taipei Med Univ Hosp, Div Nephrol, Taipei, Taiwan; [Wu, Mai-Szu] Taipei Med Univ, Sch Med, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University	Wu, MS (corresponding author), Chang Gung Mem Hosp, Dept Nephrol, Keelung, Taiwan.	maiszuwu@gmail.com		WU, I-WEN/0000-0001-8535-3582; Hsu, Kuang-Hung/0000-0003-2642-7689	Chang Gung Memorial Hospital at Keelung [CMRPG260323, CMRPG2A0422]	Chang Gung Memorial Hospital at Keelung	Chang Gung Memorial Hospital at Keelung provided grant support for this research (CMRPG260323/CMRPG2A0422). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradbury BD, 2007, CLIN J AM SOC NEPHRO, V2, P89, DOI 10.2215/CJN.01170905; Chen SH, 2011, NEPHROL DIAL TRANSPL, V26, P3560, DOI 10.1093/ndt/gfr047; Chen YR, 2013, NEPHROL DIAL TRANSPL, V28, P671, DOI 10.1093/ndt/gfs469; Cho EJ, 2012, NEPHROLOGY, V17, P472, DOI 10.1111/j.1440-1797.2012.01598.x; Collins A, 2014, AM J KIDNEY DIS, V63, pE1; Department of Health, 2014, NAT HLTH INS ANN STA; Devins GM, 2005, AM J KIDNEY DIS, V46, P1088, DOI 10.1053/j.ajkd.2005.08.017; Dogan E, 2005, NEPHROLOGY, V10, P516, DOI 10.1111/j.1440-1797.2005.00433.x; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Goldstein M, 2004, AM J KIDNEY DIS, V44, P706, DOI 10.1053/j.ajkd.2004.06.012; Hwang SJ, 2010, NEPHROLOGY, V15, P3, DOI 10.1111/j.1440-1797.2010.01304.x; Jungers P, 2001, NEPHROL DIAL TRANSPL, V16, P2357, DOI 10.1093/ndt/16.12.2357; Lysaght MJ, 2002, J AM SOC NEPHROL, V13, pS37; Muntner P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133745; Stroupe KT, 2011, MED CARE, V49, P248, DOI 10.1097/MLR.0b013e31820192ba; Tseng CL, 2008, ARCH INTERN MED, V168, P55, DOI 10.1001/archinternmed.2007.9; US Renal Data System (USRDS), 2013, CKD CHILDR AD; Wei SY, 2010, NEPHROLOGY, V15, P108, DOI 10.1111/j.1440-1797.2009.01154.x; Wu IW, 2009, NEPHROL DIAL TRANSPL, V24, P3426, DOI 10.1093/ndt/gfp259; Wu M.-S., 2011, ACTA NEPHROL, V25, P148; Wu MS, 2003, PERITON DIALYSIS INT, V23, P39; Yang WC, 2008, NEPHROL DIAL TRANSPL, V23, P3977, DOI 10.1093/ndt/gfn406	22	34	34	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112820	10.1371/journal.pone.0112820	http://dx.doi.org/10.1371/journal.pone.0112820			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398129	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558500094
J	Zheng, C; Ge, LS; Zhao, JL; Zhang, WW; Chen, XS; Chen, XX; Li, YC				Zheng Cheng; Ge Li-Sha; Zhao Jing-Lin; Zhang Wen-Wu; Chen Xue-Si; Chen Xing-Xing; Li Yue-Chun			Protective Role of the Cholinergic Anti-Inflammatory Pathway in a Mouse Model of Viral Myocarditis	PLOS ONE			English	Article							NF-KAPPA-B; NICOTINIC ACETYLCHOLINE-RECEPTOR; VAGUS NERVE; ISCHEMIA/REPERFUSION INJURY; INFLAMMATORY REFLEX; IMPROVES SURVIVAL; ACTIVATION; STIMULATION; AUTOIMMUNITY; AGONIST	Background: Activation of the cholinergic anti-inflammatory pathway, which relies on the alpha 7nAchR (alpha 7 nicotinic acetylcholine receptor), has been shown to decrease proinflammatory cytokines. This relieves inflammatory responses and improves the prognosis of patients with experimental sepsis, endotoxemia, ischemia/reperfusion injury, hemorrhagic shock, pancreatitis, arthritis and other inflammatory syndromes. However, whether the cholinergic anti-inflammatory pathway has an effect on acute viral myocarditis has not been investigated. Here, we studied the effects of the cholinergic anti-inflammatory pathway on acute viral myocarditis. Methodology/Principal Findings: In a coxsackievirus B3 murine myocarditis model (Balb/c), nicotine and methyllycaconitine were used to stimulate and block the cholinergic anti-inflammatory pathway, respectively. Relevant signal pathways were studied to compare their effects on myocarditis, survival rate, histopathological changes, ultrastructural changes, and cytokine levels. Nicotine treatments significantly improved survival rate, attenuated myocardial lesions, and downregulated the expression of TNF-alpha and IL-6. Methyllycaconitine decreased survival rate, aggravated myocardial lesions, and upregulated the expression of TNF-alpha and IL-6. In addition, levels of the signaling protein phosphorylated STAT3 were higher in the nicotine group and lower in the methyllycaconitine group compared with the untreated myocarditis group. Conclusions/Significance: These results show that nicotine protects mice from CVB3-induced viral myocarditis and that methyllycaconitine aggravates viral myocarditis in mice. Because nicotine is a alpha 7nAchR agonist and methyllycaconitine is a alpha 7nAchR antagonist, we conclude that alpha 7nAchR activation increases the phosphorylation of STAT3, reduces the expression of TNF-alpha and IL-6, and, ultimately, alleviates viral myocarditis. We also conclude that blocking alpha 7nAchR reduces the phosphorylation of STAT3, increases the expression of TNF-alpha and IL-6, aggravating viral myocarditis.	[Zheng Cheng; Zhao Jing-Lin; Zhang Wen-Wu; Chen Xue-Si; Chen Xing-Xing; Li Yue-Chun] Wenzhou Med Univ, Affiliated Hosp 2, Dept Cardiol, Wenzhou 325000, Peoples R China; [Ge Li-Sha] Wenzhou Med Univ, Affiliated Hosp 2, Dept Pediat, Wenzhou 325000, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Li, YC (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Cardiol, Wenzhou 325000, Peoples R China.	liyuechun1980@sina.com	Chen, Xuesi/ABB-5039-2020		National Natural Science Foundation of China [81200165]; Zhejiang Provincial Natural Science Foundation of China [LY14H310011]; Wenzhou Municipal Science and Technology Commission, China [Y20130038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Wenzhou Municipal Science and Technology Commission, China	This study was supported by the National Natural Science Foundation of China (Grant No. 81200165), the Zhejiang Provincial Natural Science Foundation of China (Grant No. LY14H310011) and the Wenzhou Municipal Science and Technology Commission, China (Grant No. Y20130038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Altavilla D, 2006, SHOCK, V25, P500, DOI 10.1097/01.shk.0000209539.91553.82; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Caforio ALP, 1996, INT J CARDIOL, V54, P157, DOI 10.1016/0167-5273(96)02593-4; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; Cui WY, 2013, MOL PHARMACOL, V83, P61, DOI 10.1124/mol.112.081497; Cui WY, 2010, J NEUROIMMUNE PHARM, V5, P479, DOI 10.1007/s11481-010-9210-2; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Ferrero-Miliani L, 2007, CLIN EXP IMMUNOL, V147, P227, DOI 10.1111/j.1365-2249.2006.03261.x; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Guarini S, 2003, CIRCULATION, V107, P1189, DOI 10.1161/01.CIR.0000050627.90734.ED; Han Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086166; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Huston JM, 2007, CRIT CARE MED, V35, P2762, DOI 10.1097/01.CCM.0000288102.15975.BA; Lakhan SE, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-129; Lee SE, 2013, NEUROSCI LETT, V548, P291, DOI 10.1016/j.neulet.2013.05.073; Leib C, 2011, CIRC RES, V109, P130, DOI 10.1161/CIRCRESAHA.111.245563; Li H, 2009, MED HYPOTHESES, V73, P725, DOI 10.1016/j.mehy.2009.04.036; Mabley J, 2011, INFLAMMATION, V34, P231, DOI 10.1007/s10753-010-9228-x; Nicolussi EM, 2009, NEUROBIOL DIS, V35, P24, DOI 10.1016/j.nbd.2009.03.010; Nizri E, 2009, J IMMUNOL, V183, P6681, DOI 10.4049/jimmunol.0902212; Oke SL, 2009, ANN NY ACAD SCI, V1172, P172, DOI 10.1196/annals.1393.013; Park J, 2013, EUR J PHARMACOL, V707, P61, DOI 10.1016/j.ejphar.2013.03.026; Pavlov VA, 2007, CRIT CARE MED, V35, P1139, DOI 10.1097/01.CCM.0000259381.56526.96; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rosas-Ballina M, 2009, J INTERN MED, V265, P663, DOI 10.1111/j.1365-2796.2009.02098.x; Rose NR, 2000, NAT MED, V6, P631, DOI 10.1038/76199; Sadis C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000469; Safieh-Garabedian B, 2013, NEUROSCIENCE, V250, P455, DOI 10.1016/j.neuroscience.2013.07.031; Shi FD, 2009, J IMMUNOL, V182, P1730, DOI 10.4049/jimmunol.182.3.1730; Sun P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069424; The FO, 2007, GASTROENTEROLOGY, V133, P1219, DOI 10.1053/j.gastro.2007.07.022; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; USTINOVA EE, 1994, CIRC RES, V74, P904, DOI 10.1161/01.RES.74.5.904; Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Zhao M, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0345-1; Zhou YO, 2012, RHEUMATOL INT, V32, P97, DOI 10.1007/s00296-010-1549-4	39	14	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112719	10.1371/journal.pone.0112719	http://dx.doi.org/10.1371/journal.pone.0112719			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396421	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500081
J	Azouaoui, H; Montigny, C; Ash, MR; Fijalkowski, F; Jacquot, A; Gronberg, C; Lopez-Marques, RL; Palmgren, MG; Garrigos, M; le Maire, M; Decottignies, P; Gourdon, P; Nissen, P; Champeil, P; Lenoir, G				Azouaoui, Hassina; Montigny, Cedric; Ash, Miriam-Rose; Fijalkowski, Frank; Jacquot, Aurore; Gronberg, Christina; Lopez-Marques, Rosa L.; Palmgren, Michael G.; Garrigos, Manuel; le Maire, Marc; Decottignies, Paulette; Gourdon, Pontus; Nissen, Poul; Champeil, Philippe; Lenoir, Guillaume			A High-Yield Co-Expression System for the Purification of an Intact Drs2p-Cdc50p Lipid Flippase Complex, Critically Dependent on and Stabilized by Phosphatidylinositol-4-Phosphate	PLOS ONE			English	Article							P-TYPE ATPASE; SARCOPLASMIC-RETICULUM CA2+-ATPASE; MEMBRANE-SURFACE CHARGE; PLASMA-MEMBRANE; PHOSPHOLIPID FLIPPASE; CRYSTAL-STRUCTURE; AMINOPHOSPHOLIPID TRANSLOCASE; SUBCELLULAR-LOCALIZATION; PROTEIN-TRANSPORT; CDC50 PROTEINS	P-type ATPases from the P4 subfamily (P4-ATPases) are energy-dependent transporters, which are thought to establish lipid asymmetry in eukaryotic cell membranes. Together with their Cdc50 accessory subunits, P4-ATPases couple ATP hydrolysis to lipid transport from the exoplasmic to the cytoplasmic leaflet of plasma membranes, late Golgi membranes, and endosomes. To gain insights into the structure and function of these important membrane pumps, robust protocols for expression and purification are required. In this report, we present a procedure for high-yield co-expression of a yeast flippase, the Drs2p-Cdc50p complex. After recovery of yeast membranes expressing both proteins, efficient purification was achieved in a single step by affinity chromatography on streptavidin beads, yielding, similar to 1-2 mg purified Drs2p-Cdc50p complex per liter of culture. Importantly, the procedure enabled us to recover a fraction that mainly contained a 1: 1 complex, which was assessed by size-exclusion chromatography and mass spectrometry. The functional properties of the purified complex were examined, including the dependence of its catalytic cycle on specific lipids. The dephosphorylation rate was stimulated in the simultaneous presence of the transported substrate, phosphatidylserine (PS), and the regulatory lipid phosphatidylinositol-4-phosphate (PI4P), a phosphoinositide that plays critical roles in membrane trafficking events from the trans-Golgi network (TGN). Likewise, overall ATP hydrolysis by the complex was critically dependent on the simultaneous presence of PI4P and PS. We also identified a prominent role for PI4P in stabilization of the Drs2p-Cdc50p complex towards temperature-or C12E8-induced irreversible inactivation. These results indicate that the Drs2p-Cdc50p complex remains functional after affinity purification and that PI4P as a cofactor tightly controls its stability and catalytic activity. This work offers appealing perspectives for detailed structural and functional characterization of the Drs2p-Cdc50p lipid transport mechanism.	[Azouaoui, Hassina; Montigny, Cedric; Jacquot, Aurore; Garrigos, Manuel; le Maire, Marc; Champeil, Philippe; Lenoir, Guillaume] Univ Paris 11, UMR 8221, Orsay, France; [Azouaoui, Hassina; Montigny, Cedric; Jacquot, Aurore; Garrigos, Manuel; le Maire, Marc; Champeil, Philippe; Lenoir, Guillaume] CEA, iBiTec S Inst Biol & Technol Saclay, SB2 SM Serv Bioenerget Biol Struct & Mecanismes, Lab Prot Membranaires, Gif Sur Yvette, France; [Azouaoui, Hassina; Montigny, Cedric; Jacquot, Aurore; Garrigos, Manuel; le Maire, Marc; Champeil, Philippe; Lenoir, Guillaume] CNRS, UMR 8221, Gif Sur Yvette, France; [Ash, Miriam-Rose; Fijalkowski, Frank; Gronberg, Christina; Lopez-Marques, Rosa L.; Palmgren, Michael G.; Gourdon, Pontus; Nissen, Poul] Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, Aarhus, Denmark; [Ash, Miriam-Rose; Fijalkowski, Frank; Gronberg, Christina; Gourdon, Pontus; Nissen, Poul] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Lopez-Marques, Rosa L.; Palmgren, Michael G.] Univ Copenhagen, Dept Plant & Environm Sci, Copenhagen, Denmark; [Decottignies, Paulette] CNRS, Inst Biochim & Biophys Mol & Cellulair, UMR 8619, F-91405 Orsay, France; [Decottignies, Paulette] Univ Paris 11, Orsay, France	UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Danmarks Grundforskningsfond; Aarhus University; University of Copenhagen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Lenoir, G (corresponding author), Univ Paris 11, UMR 8221, Orsay, France.	guillaume.lenoir@cea.fr	Palmgren, Michael/A-9808-2013; Marques, Rosa Laura Lopez/AAI-8071-2020; Lenoir, Guillaume/I-4002-2019; Gourdon, Pontus/E-1076-2014; Gourdon, Pontus/HCI-8898-2022; Lopez-Marques, Rosa L/F-8536-2014; MONTIGNY, Cédric/AAH-4216-2021	Palmgren, Michael/0000-0002-9982-6114; Marques, Rosa Laura Lopez/0000-0002-5663-7903; Lenoir, Guillaume/0000-0002-8759-5179; Gourdon, Pontus/0000-0002-8631-3539; Lopez-Marques, Rosa L/0000-0002-5663-7903; Ash, Miriam-Rose/0000-0002-0573-9854; Nissen, Poul/0000-0003-0948-6628; Gronberg, Christina/0000-0002-2231-8816	Agence Nationale pour la Recherche (ANR Blanc program) [MIT-2M]; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; Lundbeck Foundation [R139-2012-12689] Funding Source: researchfish	Agence Nationale pour la Recherche (ANR Blanc program)(French National Research Agency (ANR)); French Infrastructure for Integrated Structural Biology (FRISBI); Lundbeck Foundation(Lundbeckfonden)	This work was supported by a grant from the Agence Nationale pour la Recherche (ANR Blanc program MIT-2M to MlM and CM) and by the French Infrastructure for Integrated Structural Biology (FRISBI, ANR-10-INSB-05-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Alexander RT, 2011, EMBO J, V30, P679, DOI 10.1038/emboj.2010.356; Angelaccio S, 2002, ANAL BIOCHEM, V306, P346, DOI 10.1006/abio.2002.5689; Baekgaard L, 2005, J BIOENERG BIOMEMBR, V37, P369, DOI 10.1007/s10863-005-9473-0; Baldridge RD, 2013, P NATL ACAD SCI USA, V110, pE358, DOI 10.1073/pnas.1216948110; Baldridge RD, 2012, P NATL ACAD SCI USA, V109, pE290, DOI 10.1073/pnas.1115725109; Bohdanowicz M, 2013, PHYSIOL REV, V93, P69, DOI 10.1152/physrev.00002.2012; Bryde S, 2010, J BIOL CHEM, V285, P40562, DOI 10.1074/jbc.M110.139543; Cardi D, 2010, J BIOL CHEM, V285, P26406, DOI 10.1074/jbc.M109.090340; CHAMPEIL P, 1988, J BIOL CHEM, V263, P12288; Chantalat S, 2004, J CELL SCI, V117, P711, DOI 10.1242/jcs.00896; Chen CY, 1999, J CELL BIOL, V147, P1223, DOI 10.1083/jcb.147.6.1223; Chen S, 2006, TRAFFIC, V7, P1503, DOI 10.1111/j.1600-0854.2006.00485.x; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; Coleman JA, 2012, P NATL ACAD SCI USA, V109, P1449, DOI 10.1073/pnas.1108862109; Coleman JA, 2011, J BIOL CHEM, V286, P17205, DOI 10.1074/jbc.M111.229419; DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001; DRUECKES P, 1995, ANAL BIOCHEM, V230, P173, DOI 10.1006/abio.1995.1453; Ekberg K, 2010, J BIOL CHEM, V285, P7344, DOI 10.1074/jbc.M109.096123; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; GARRIGOS M, 1991, ANAL BIOCHEM, V194, P82, DOI 10.1016/0003-2697(91)90154-L; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Goren MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6115; Gourdon P, 2011, NATURE, V475, P59, DOI 10.1038/nature10191; Gurtler A, 2013, ANAL BIOCHEM, V433, P105, DOI 10.1016/j.ab.2012.10.010; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; Hatori Y, 2008, J BIOL CHEM, V283, P22541, DOI 10.1074/jbc.M802735200; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Jacquot A, 2012, J BIOL CHEM, V287, P13249, DOI 10.1074/jbc.M111.313916; Ladner CL, 2004, ANAL BIOCHEM, V326, P13, DOI 10.1016/j.ab.2003.10.047; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lenoir G, 2004, J BIOL CHEM, V279, P32125, DOI 10.1074/jbc.M402934200; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; Lenoir G, 2007, CURR OPIN CHEM BIOL, V11, P654, DOI 10.1016/j.cbpa.2007.09.008; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Liu K, 2008, MOL BIOL CELL, V19, P3526, DOI 10.1091/mbc.E08-01-0025; Lopez-Marques RL, 2014, PFLUG ARCH EUR J PHY, V466, P1227, DOI 10.1007/s00424-013-1363-4; LUND S, 1988, J BIOL CHEM, V263, P1654; Menon I, 2011, CURR BIOL, V21, P149, DOI 10.1016/j.cub.2010.12.031; Montigny C, 2014, OVEREXPRESSION MEMBR; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Natarajan P, 2009, NAT CELL BIOL, V11, P1421, DOI 10.1038/ncb1989; ONEAL SG, 1979, BIOCHEM BIOPH RES CO, V89, P845, DOI 10.1016/0006-291X(79)91855-2; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Picard M, 2006, J BIOL CHEM, V281, P3360, DOI 10.1074/jbc.M511385200; PICK U, 1982, J BIOL CHEM, V257, P6111; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Poulsen LR, 2008, PLANT CELL, V20, P658, DOI 10.1105/tpc.107.054767; ROSING J, 1980, J BIOL CHEM, V255, P274; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Sebastian TT, 2012, BIOCH BIOPHYS ACTA; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sorensen TLM, 2006, J BIOTECHNOL, V124, P704, DOI 10.1016/j.jbiotec.2006.02.004; Takeda M, 2014, EUKARYOT CELL, V13, P363, DOI 10.1128/EC.00279-13; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; van der Velden LM, 2010, J BIOL CHEM, V285, P40088, DOI 10.1074/jbc.M110.139006; Vestergaard AL, 2014, P NATL ACAD SCI USA, V111, pE1334, DOI 10.1073/pnas.1321165111; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Zhang BL, 2001, J BIOL CHEM, V276, P8958, DOI 10.1074/jbc.M008720200; Zhou XM, 2013, J BIOL CHEM, V288, P31807, DOI 10.1074/jbc.M113.481986; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106	67	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112176	10.1371/journal.pone.0112176	http://dx.doi.org/10.1371/journal.pone.0112176			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393116	Green Submitted, Green Published, gold			2022-12-27	WOS:000347709300038
J	Cai, CW; Shen, J; Zhao, D; Qiao, YQ; Xu, AT; Jin, S; Ran, ZH; Zheng, Q				Cai, Chenwen; Shen, Jun; Zhao, Di; Qiao, Yuqi; Xu, Antao; Jin, Shuang; Ran, Zhihua; Zheng, Qing			Serological Investigation of Food Specific Immunoglobulin G Antibodies in Patients with Inflammatory Bowel Diseases	PLOS ONE			English	Article							ULCERATIVE-COLITIS; CROHNS-DISEASE; IGG ANTIBODIES; CLINICAL-COURSE; DIETARY FACTORS; ALLERGY; ANTIGENS; INTOLERANCE; IMMUNITY; RISK	Objective: Dietary factors have been indicated to influence the pathogenesis and nature course of inflammatory bowel diseases (IBD) with their wide variances. The aim of the study was to assess the prevalence and clinical significance of 14 serum food specific immunoglobulin G (sIgG) antibodies in patients with IBD. Methods: This retrospective study comprised a total of 112 patients with IBD, including 79 with Crohn's disease (CD) and 33 with ulcerative colitis (UC). Medical records, clinical data and laboratory results were collected for analysis. Serum IgG antibodies against 14 unique food allergens were detected by semi-quantitative enzyme linked immunosorbent assay (ELISA). Results: Food sIgG antibodies were detected in 75.9% (60/79) of CD patients, 63.6% (21/33) of UC patients and 33.1% (88/266) of healthy controls (HC). IBD patients showed the significantly higher antibodies prevalence than healthy controls (CD vs. HC, P = 0.000; UC vs. HC, P = 0.001). However no marked difference was observed between CD and UC groups (P = 0.184). More subjects were found with sensitivity to multiple antigens (>= 3) in IBD than in HC group (33.9% vs. 0.8%, P = 0.000). Egg was the most prevalent food allergen. There was a remarkable difference in the levels of general serum IgM (P = 0.045) and IgG (P = 0.041) between patients with positive and negative sIgG antibodies. Patients with multiple positive allergens (>= 3) were especially found with significant higher total IgG levels compared with sIgG-negative patients (P = 0.003). Age was suggested as a protective factor against the occurrence of sIgG antibodies (P = 0.002). Conclusions: The study demonstrates a high prevalence of serum IgG antibodies to specific food allergens in patients with IBD. sIgG antibodies may potentially indicate disease status in clinical and be utilized to guide diets for patients.	[Cai, Chenwen; Shen, Jun; Zhao, Di; Qiao, Yuqi; Xu, Antao; Jin, Shuang; Ran, Zhihua; Zheng, Qing] Shanghai Jiao Tong Univ, Shanghai Inst Digest Dis, Key Lab Gastroenterol & Hepatol,Sch Med, Minist Hlth,Div Gastroenterol & Hepatol,Ren Ji Ho, Shanghai 200001, Peoples R China	Shanghai Jiao Tong University	Zheng, Q (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Digest Dis, Key Lab Gastroenterol & Hepatol,Sch Med, Minist Hlth,Div Gastroenterol & Hepatol,Ren Ji Ho, 145 Middle Shandong Rd, Shanghai 200001, Peoples R China.	qingzheng101@163.com			National Key Technology R&D Program of China [2012BAI06B03]; National Natural Science Foundations of China [81170362, 81200280, 81370508]	National Key Technology R&D Program of China(National Key Technology R&D Program); National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	The work was supported by grants from the National Key Technology R&D Program of China (No. 2012BAI06B03), http://kjzc.jhgl.org/and National Natural Science Foundations of China (No. 81170362, 81200280 and 81370508), http://isisn.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson W, 2004, GUT, V53, P1459, DOI 10.1136/gut.2003.037697; Banai Janos, 2009, Orvosi Hetilap, V150, P839, DOI 10.1556/OH.2009.28599; Bentz S, 2010, DIGESTION, V81, P252, DOI 10.1159/000264649; Bernstein C N, 2001, Curr Gastroenterol Rep, V3, P477; BINDER HJ, 1966, AM J DIG DIS, V11, P858, DOI 10.1007/BF02233942; Brunner B, 2007, DIS COLON RECTUM, V50, P83, DOI 10.1007/s10350-006-0749-1; Cashman KD, 2003, EUR J GASTROEN HEPAT, V15, P607, DOI 10.1097/00042737-200306000-00005; Chahine BG, 2010, CURR OPIN ALLERGY CL, V10, P220, DOI 10.1097/ACI.0b013e32833982ab; CROWE SE, 1992, GASTROENTEROLOGY, V103, P1075, DOI 10.1016/0016-5085(92)90047-3; David TJ, 2000, BRIT MED BULL, V56, P34, DOI 10.1258/0007142001902950; Foster AP, 2003, VET IMMUNOL IMMUNOP, V92, P113, DOI 10.1016/S0165-2427(03)00033-3; GLASSMAN MS, 1990, AM J GASTROENTEROL, V85, P838; Goh KL, 2009, J DIGEST DIS, V10, P1, DOI 10.1111/j.1751-2980.2008.00355.x; Haboubi NY, 2005, GUT, V54, P567; HARVEY RF, 1980, LANCET, V1, P514; Hou JK, 2011, AM J GASTROENTEROL, V106, P563, DOI 10.1038/ajg.2011.44; HUSBY S, 1985, INT ARCH ALLER A IMM, V77, P416, DOI 10.1159/000233819; Isolauri E, 2004, GUT, V53, P1391, DOI 10.1136/gut.2004.044990; Jowett SL, 2004, GUT, V53, P1479, DOI 10.1136/gut.2003.024828; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Magee EA, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-7; Malbec O, 2007, IMMUNOL REV, V217, P206, DOI 10.1111/j.1600-065X.2007.00510.x; Mekkel Gabriella, 2005, Orvosi Hetilap, V146, P797; Meulenbroek LAPM, 2013, J IMMUNOL, V191, P3526, DOI 10.4049/jimmunol.1202398; Mishkin B, 1997, AM J GASTROENTEROL, V92, P1148; Ortolani C, 2006, BEST PRACT RES CL GA, V20, P467, DOI 10.1016/j.bpg.2005.11.010; Palmieri B, 2011, Minerva Gastroenterol Dietol, V57, P1; Sai Xiao-yong, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P302; Sakamoto N, 2005, INFLAMM BOWEL DIS, V11, P154, DOI 10.1097/00054725-200502000-00009; Sampson HA, 2004, J ALLERGY CLIN IMMUN, V113, P805, DOI 10.1016/j.jaci.2004.03.014; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Stange EF, 2008, J CROHNS COLITIS, V2, P1, DOI 10.1016/j.crohns.2007.11.001; TRUELOVE SC, 1955, BRIT MED J, V2, P1041, DOI 10.1136/bmj.2.4947.1041; TRUELOVE SC, 1961, BMJ-BRIT MED J, V1, P154, DOI 10.1136/bmj.1.5220.154; Van Assche G, 2010, J CROHNS COLITIS, V4, P7, DOI 10.1016/j.crohns.2009.12.003; Van Den Bogaerde J, 2002, ALIMENT PHARM THER, V16, P1903, DOI 10.1046/j.1365-2036.2002.01360.x; Vidal A, 2008, INFLAMM BOWEL DIS, V14, P977, DOI 10.1002/ibd.20388; Wang J, 2009, CLIN EXP ALLERGY, V39, P1381, DOI 10.1111/j.1365-2222.2009.03225.x; Wuthrich B, 2009, Praxis (Bern 1994), V98, P375, DOI 10.1024/1661-8157.98.7.375; Zallot C, 2013, INFLAMM BOWEL DIS, V19, P66, DOI 10.1002/ibd.22965; Zar S, 2001, ALIMENT PHARM THER, V15, P439, DOI 10.1046/j.1365-2036.2001.00951.x	41	27	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112154	10.1371/journal.pone.0112154	http://dx.doi.org/10.1371/journal.pone.0112154			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393003	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300036
J	Carrieri, PM; Michel, L; Lions, C; Cohen, J; Vray, M; Mora, M; Marcellin, F; Spire, B; Morel, A; Roux, P				Carrieri, Patrizia Maria; Michel, Laurent; Lions, Caroline; Cohen, Julien; Vray, Muriel; Mora, Marion; Marcellin, Fabienne; Spire, Bruno; Morel, Alain; Roux, Perrine		Methaville Study Grp	Methadone Induction in Primary Care for Opioid Dependence: A Pragmatic Randomized Trial (ANRS Methaville)	PLOS ONE			English	Article							BUPRENORPHINE TREATMENT; SUBSTITUTION TREATMENT; RETROSPECTIVE COHORT; HEROIN DEPENDENCE; DRUG-USERS; MAINTENANCE; EXPERIENCE; RETENTION; INJECTION; METAANALYSIS	Objective: Methadone coverage is poor in many countries due in part to methadone induction being possible only in specialized care (SC). This multicenter pragmatic trial compared the effectiveness of methadone treatment between two induction models: primary care (PC) and SC. Methods: In this study, registered at ClinicalTrials.Gov (NCT00657397), opioid-dependent individuals not on methadone treatment for at least one month or receiving buprenorphine but needing to switch were randomly assigned to start methadone in PC (N = 155) or in SC (N = 66) in 10 sites in France. Visits were scheduled at months M0, M3, M6 and M12. The primary outcome was self-reported abstinence from street-opioids at 12 months (M12) (with an underlying 15% non-inferiority hypothesis for PC). Secondary outcomes were abstinence during follow-up, engagement in treatment (i.e. completing the induction period), retention and satisfaction with the explanations provided by the physician. Primary analysis used intention to treat (ITT). Mixed models and the log-rank test were used to assess the arm effect (PC vs. SC) on the course of abstinence and retention, respectively. Results: In the ITT analysis (n = 155 in PC, 66 in SC), which compared the proportions of street-opioid abstinent participants, 85/155 (55%) and 22/66 (33%) of the participants were classified as street-opioid abstinent at M12 in PC and SC, respectively. This ITT analysis showed the non-inferiority of PC (21.5 [7.7; 35.3]). Engagement in treatment and satisfaction with the explanations provided by the physician were significantly higher in PC than SC. Retention in methadone and abstinence during follow-up were comparable in both arms (p = 0.47, p = 0.39, respectively). Conclusions: Under appropriate conditions, methadone induction in primary care is feasible and acceptable to both physicians and patients. It is as effective as induction in specialized care in reducing street-opioid use and ensuring engagement and retention in treatment for opioid dependence.	[Carrieri, Patrizia Maria; Lions, Caroline; Cohen, Julien; Mora, Marion; Marcellin, Fabienne; Spire, Bruno; Roux, Perrine] INSERM, SESSTIM, UMR912, F-13258 Marseille, France; [Carrieri, Patrizia Maria; Lions, Caroline; Cohen, Julien; Mora, Marion; Marcellin, Fabienne; Spire, Bruno; Roux, Perrine] Aix Marseille Univ, UMR S912, Marseille, France; [Carrieri, Patrizia Maria; Lions, Caroline; Cohen, Julien; Mora, Marion; Marcellin, Fabienne; Spire, Bruno; Roux, Perrine] ORS PACA, Marseille, France; [Michel, Laurent] INSERM, Res Unit 669, Paris, France; [Michel, Laurent] Univ Paris 11, Paris, France; [Michel, Laurent] Univ Paris 05, UMR S0669, Paris, France; [Michel, Laurent] Ctr Pierre Nicole, Paris, France; [Vray, Muriel] Inst Pasteur, Unite Rech & Expertise Epidemiol Malad Emergentes, Paris, France; [Vray, Muriel] INSERM, Paris, France; [Morel, Alain] Oppelia, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Carrieri, PM (corresponding author), INSERM, SESSTIM, UMR912, F-13258 Marseille, France.	pmcarrieri@aol.com	Roux, Perrine/P-1306-2016; Spire, Bruno/F-5546-2013; Vray, Muriel/M-7947-2018	Roux, Perrine/0000-0002-5069-4982; Spire, Bruno/0000-0002-3546-8020; Carrieri, Patrizia/0000-0002-6794-4837; Marcellin, Fabienne/0000-0001-8853-3829; MICHEL, laurent/0000-0002-2000-7838	French National Agency for Research on Aids and Viral Hepatitis (ANRS); French Ministry of Health	French National Agency for Research on Aids and Viral Hepatitis (ANRS)(ANRSFrench National Research Agency (ANR)); French Ministry of Health	The study received external funding by the French National Agency for Research on Aids and Viral Hepatitis (ANRS) and the French Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auriacombe M, 2004, AM J ADDICTION, V13, pS17, DOI 10.1080/10550490490440780; Bouvenot G, 2006, ESSAIS CLIN THEORIE; Brands B, 2008, J ADDICT DIS, V27, P37, DOI 10.1080/10550880802122620; Cadet-Tairou A, 2004, RAPPORT 2004 APPROCH, P28; Carrieri MP, 2006, CLIN INFECT DIS, V43, pS197, DOI 10.1086/508184; Coons SJ, 2011, CLIN PHARMACOL THER, V90, P743, DOI 10.1038/clpt.2011.203; DARKE S, 1992, BRIT J ADDICT, V87, P733; del Giudice P, 2004, BRIT J DERMATOL, V150, P1, DOI 10.1111/j.1365-2133.2004.05607.x; Fareed A, 2010, J ADDICT DIS, V29, P1, DOI 10.1080/10550880903436010; Farre M, 2002, DRUG ALCOHOL DEPEN, V65, P283, DOI 10.1016/S0376-8716(01)00171-5; Fiellin DA, 2001, JAMA-J AM MED ASSOC, V286, P1724, DOI 10.1001/jama.286.14.1724; Fransen GAJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-16; Gibson AE, 2003, MED J AUSTRALIA, V179, P38, DOI 10.5694/j.1326-5377.2003.tb05417.x; Hamer RM, 2009, AM J PSYCHIAT, V166, P639, DOI 10.1176/appi.ajp.2009.09040458; Hser YI, 2014, ADDICTION, V109, P79, DOI 10.1111/add.12333; Keen J, 2003, BRIT J GEN PRACT, V53, P461; Kerr T, 2007, DRUG ALCOHOL DEPEN, V87, P39, DOI 10.1016/j.drugalcdep.2006.07.009; MacArthur GJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5945; MacGowan RJ, 1996, J PSYCHOACTIVE DRUGS, V28, P259, DOI 10.1080/02791072.1996.10472487; McCowan C, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2225; Nosyk B, 2012, ADDICTION, V107, P1621, DOI 10.1111/j.1360-0443.2012.03870.x; O'Connor PG, 1998, AM J MED, V105, P100, DOI 10.1016/S0002-9343(98)00194-6; Roux P, 2008, ADDICTION, V103, P1828, DOI 10.1111/j.1360-0443.2008.02323.x; Roux P, 2008, DRUG ALCOHOL DEPEN, V97, P105, DOI 10.1016/j.drugalcdep.2008.03.025; Roux P, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-488; Schwartz RP, 2007, DRUG ALCOHOL DEPEN, V86, P30, DOI 10.1016/j.drugalcdep.2006.04.017; Schwartz RP, 2012, ADDICTION, V107, P943, DOI 10.1111/j.1360-0443.2011.03700.x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Snyder CF, 2011, J CLIN ONCOL, V29, P1216, DOI 10.1200/JCO.2010.33.2080; Soyka M, 2011, WORLD J BIOL PSYCHIA, V12, P160, DOI 10.3109/15622975.2011.561872; Strain EC, 1999, JAMA-J AM MED ASSOC, V281, P1000, DOI 10.1001/jama.281.11.1000; Teesson M, 2006, DRUG ALCOHOL DEPEN, V83, P174, DOI 10.1016/j.drugalcdep.2005.11.009; Vray M, 1996, J CLIN EPIDEMIOL, V49, P949, DOI 10.1016/0895-4356(96)00047-9; Weinrich M, 2000, JAMA-J AM MED ASSOC, V283, P1343, DOI 10.1001/jama.283.10.1343; Wittchen HU, 2008, DRUG ALCOHOL DEPEN, V95, P245, DOI 10.1016/j.drugalcdep.2008.01.015; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X	36	31	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112328	10.1371/journal.pone.0112328	http://dx.doi.org/10.1371/journal.pone.0112328			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393311	Green Published, gold, Green Submitted			2022-12-27	WOS:000347709300052
J	Chen, YY; Tseng, FC; Chang, JR; Kuo, SC; Lee, JJ; Yeh, JJ; Chiueh, TS; Sun, JR; Su, IJ; Dou, HY				Chen, Yih-Yuan; Tseng, Fan-Chen; Chang, Jia-Ru; Kuo, Shu-Chen; Lee, Jen-Jyh; Yeh, Jun-Jun; Chiueh, Tzong-Shi; Sun, Jun-Ren; Su, Ih-Jen; Dou, Horng-Yunn			Distinct Modes of Transmission of Tuberculosis in Aboriginal and Non-Aboriginal Populations in Taiwan	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; ASSOCIATION; DATABASE; STRAINS; CHINA	Tuberculosis incidence among aborigines is significantly higher than for Han Chinese in Taiwan, but the extent to which Mycobacterium tuberculosis (MTB) strain characteristics contribute to this difference is not well understood. MTB isolates from aborigines and Han Chinese living in eastern and southern Taiwan, the major regions of aborigines, were analyzed by spoligotyping and 24-loci MIRU-VNTR. In eastern Taiwan, 60% of aboriginal patients were <= 20 years old, significantly younger than the non-aboriginal patients there; aborigines were more likely to have clustered MTB isolates than Han Chinese (odds ratio (OR) = 5.98, p<0.0001). MTB lineages with high clustering were EAI (54.9%) among southern people, and Beijing (62.5%) and Haarlem (52.9%) among eastern aborigines. Resistance to first-line drugs and multidrug resistance (MDR) were significantly higher among eastern aborigines (>= 15%) than in any other geographic and ethnic group (p<0.05); MDR was detected in 5 of 28 eastern aboriginal patients <= 20 years old. Among patients from the eastern region, clustered strains (p = 0.01) and aboriginal ethnicity (p = 0.04) were independent risk factors for MDR. The lifestyles of aborigines in eastern Taiwan may explain why the percentage of infected aborigines is much higher than for their Han Chinese counterparts. The significantly higher percentage of the MDR-MTB strains in the aboriginal population warrants close attention to control policy and vaccination strategy.	[Chen, Yih-Yuan; Tseng, Fan-Chen; Chang, Jia-Ru; Kuo, Shu-Chen; Su, Ih-Jen; Dou, Horng-Yunn] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Miaoli, Taiwan; [Tseng, Fan-Chen] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Lee, Jen-Jyh] Hualien Tzu Chi Med Ctr, Dept Microbiol, Hualien, Taiwan; [Yeh, Jun-Jun] Chia Yi Christian Hosp, Ditmanson Med Fdn, Chiayi, Taiwan; [Yeh, Jun-Jun] China Nan Univ Pharm & Sci, Tainan, Taiwan; [Yeh, Jun-Jun] Meiho Univ, Pingtung, Taiwan; [Yeh, Jun-Jun] Pingtung Christian Hosp, Dept Med Res, Pingtung, Taiwan; [Yeh, Jun-Jun] Chung Shan Med Univ, Taichung, Taiwan; [Chiueh, Tzong-Shi; Sun, Jun-Ren] Triserv Gen Hosp, Dept Pathol, Div Clin Pathol, Taipei, Taiwan; [Chiueh, Tzong-Shi; Sun, Jun-Ren] Natl Def Med Ctr, Taipei, Taiwan	National Health Research Institutes - Taiwan; China Medical University Taiwan; Buddhist Tzu Chi General Hospital; Chung Shan Medical University; Tri-Service General Hospital; National Defense Medical Center	Dou, HY (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Miaoli, Taiwan.	hydou@nhri.org.tw	Dou, Horng-Yunn/B-2652-2010; Su, Ih-Jen/B-2655-2010; Tseng, Fan-Chen/D-2097-2010; Kuo, Shu-Chen/G-9108-2011	Sun, jun-ren/0000-0002-8769-9170	National Health Research Institutes; National Science Council, Taiwan [NSC 102-2320-B-400-006]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This project was supported by grants from National Health Research Institutes and National Science Council (NSC 102-2320-B-400-006), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; CDC, 2012, TUB CONTR REP 2012; Chakraborty P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062966; Chang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043018; Chen YY, 2014, J INFECTION, V68, P332, DOI 10.1016/j.jinf.2013.12.004; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Dou HY, 2011, INT J EVOL BIOL, V2011; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Han H, 2007, J MED MICROBIOL, V56, P1219, DOI 10.1099/jmm.0.47005-0; Hsu AH, 2010, INT J TUBERC LUNG D, V14, P924; Hsu YH, 2006, J FORMOS MED ASSOC, V105, P363, DOI 10.1016/S0929-6646(09)60131-5; Huang SF, 2012, INFECT GENET EVOL, V12, P28, DOI 10.1016/j.meegid.2011.10.001; Iwamoto T, 2009, J CLIN MICROBIOL, V47, P3340, DOI 10.1128/JCM.01061-09; Jeon BY, 2008, INFECT IMMUN, V76, P5173, DOI 10.1128/IAI.00019-08; KOLK AHJ, 1992, J CLIN MICROBIOL, V30, P2567, DOI 10.1128/JCM.30.10.2567-2575.1992; Lai CC, 2011, INT J ANTIMICROB AG, V38, P125, DOI 10.1016/j.ijantimicag.2011.03.016; Li WM, 2005, INT J TUBERC LUNG D, V9, P1314; PA W, 2000, SUSCEPTIBILITY TESTI; Shamputa IC, 2010, J CLIN MICROBIOL, V48, P387, DOI 10.1128/JCM.02167-09; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; WHO Global Tuberculosis Control Report, 2010, CENT EUR J PUBL HEAL, V18, P237; Yung-Ming Chang, 2006, Southeast Asian J Trop Med Public Health, V37 Suppl 3, P161	23	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112633	10.1371/journal.pone.0112633	http://dx.doi.org/10.1371/journal.pone.0112633			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393403	gold, Green Published, Green Submitted			2022-12-27	WOS:000347709300078
J	Poissonnier, LA; Simpson, SJ; Dussutour, A				Poissonnier, Laure-Anne; Simpson, Stephen J.; Dussutour, Audrey			Observations of the "Egg White Injury'' in Ants	PLOS ONE			English	Article							IMPORTED FIRE ANT; BIOTIN-BINDING PROTEIN; WORKERS; HEALTH; GROWTH; AVIDIN; ADULT	A key determinant of the relationship between diet and longevity is the balance of protein to carbohydrate in the diet. Eating excess protein relative to carbohydrate shortens lifespan in solitary and social insects. Here we explored how lifespan and behavior in ants was affected by the quality of protein ingested and the presence of associated antinutrients (i.e. compounds that interfere with the absorption of nutrients). We tested diets prepared with either egg white protein only or a protein mixture. Egg white contains an anti-nutrient called avidin. Avidin binds to the B vitamin biotin, preventing its absorption. First, we demonstrate that an egg-white diet was twice as deleterious as a protein-mixture diet. Second, we show that ingestion of egg-white diet drastically affected social behavior, triggering elevated levels of aggression within the colony. Lastly, we reveal that by adding biotin to the egg white diet we were able to lessen its detrimental effects. This latest result suggests that ants suffered biotin deficiency when fed the egg white diet. In conclusion, anti-nutrients were known to affect health and performance of animals, but this is the first study showing that anti-nutrients also lead to severe changes in behavior.	[Poissonnier, Laure-Anne; Dussutour, Audrey] Natl Ctr Sci Res, Res Ctr Anim Cognit, Toulouse, France; [Poissonnier, Laure-Anne; Dussutour, Audrey] Toulouse Univ, Toulouse, France; [Simpson, Stephen J.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); University of Sydney	Dussutour, A (corresponding author), Natl Ctr Sci Res, Res Ctr Anim Cognit, Toulouse, France.	dussutou@gmail.com	Poissonnier, Laure-Anne/GXW-1856-2022; Dussutour, Audrey/A-2399-2012	Dussutour, Audrey/0000-0002-1377-3550; Simpson, Stephen J./0000-0003-0256-7687	Agence Nationale de la Recherche [JSV7-0009-01]	Agence Nationale de la Recherche(French National Research Agency (ANR))	AD was supported by a grant from the "Agence Nationale de la Recherche 2011, Programme Jeunes Chercheurs, Reference number: JSV7-0009-01". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaye SZ, 2010, J EXP BIOL, V213, P3311, DOI 10.1242/jeb.046953; Arganda S, 2014, J INSECT PH IN PRESS; BHATKAR A, 1970, Florida Entomologist, V53, P229, DOI 10.2307/3493193; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; Bos N, 2012, J EVOLUTION BIOL, V25, P342, DOI 10.1111/j.1420-9101.2011.02425.x; Chapuisat M, 2002, P ROY SOC B-BIOL SCI, V269, P909, DOI 10.1098/rspb.2002.1962; Christeller JT, 2010, J ECON ENTOMOL, V103, P497, DOI 10.1603/EC09149; Christensen KL, 2010, NATURWISSENSCHAFTEN, V97, P941, DOI 10.1007/s00114-010-0705-8; Cohen AC, 1999, US Patent, Patent No. 5945271; Cook SC, 2010, BIOTROPICA, V42, P135, DOI 10.1111/j.1744-7429.2009.00616.x; Cook SC, 2010, ANIM BEHAV, V79, P429, DOI 10.1016/j.anbehav.2009.11.022; COOPER RA, 1992, ENTOMOL EXP APPL, V63, P123, DOI 10.1007/BF00343572; DADD RH, 1973, ANNU REV ENTOMOL, V18, P381, DOI 10.1146/annurev.en.18.010173.002121; Dussutour A, 2008, INSECT SOC, V55, P329, DOI 10.1007/s00040-008-1008-3; Dussutour A, 2008, J EXP BIOL, V211, P2224, DOI 10.1242/jeb.017509; Dussutour A, 2012, P ROY SOC B-BIOL SCI, V279, P2402, DOI 10.1098/rspb.2012.0051; Dussutour A, 2009, CURR BIOL, V19, P740, DOI 10.1016/j.cub.2009.03.015; Gilani GS, 2012, BRIT J NUTR, V108, pS315, DOI 10.1017/S0007114512002371; GLANCEY BM, 1981, INSECT SOC, V28, P395, DOI 10.1007/BF02224196; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; GREEN NM, 1970, BIOCHEM J, V118, P67, DOI 10.1042/bj1180067; Heinze J, 2010, CURR BIOL, V20, P249, DOI 10.1016/j.cub.2009.12.031; Hinchliffe G, 2010, J INSECT PHYSIOL, V56, P629, DOI 10.1016/j.jinsphys.2010.01.007; Holldobler B., 1990, pi; Kramer KJ, 2000, NAT BIOTECHNOL, V18, P670, DOI 10.1038/76531; Lee KP, 2007, J EXP BIOL, V210, P3236, DOI 10.1242/jeb.008060; LENOIR A, 1983, Z TIERPSYCHOL, V63, P213; Lenoir A, 2009, J CHEM ECOL, V35, P913, DOI 10.1007/s10886-009-9669-6; LEVINSON H. Z., 1967, Journal of Stored Products Research, V3, P345, DOI 10.1016/0022-474X(67)90037-9; Makkar HPS, 1993, OCCASIONAL PUBLICATI, V16, P69, DOI 10.1017/S0263967X00031086; Malone LA, 2004, APIDOLOGIE, V35, P655, DOI 10.1051/apido:2004063; Malone LA, 2002, APIDOLOGIE, V33, P447, DOI 10.1051/apido:2002030; Mann J, 2002, ESSENTIALS HUMAN NUT; McKay BE, 2004, J COMP NEUROL, V473, P86, DOI 10.1002/cne.20109; MORGAN TD, 1993, ENTOMOL EXP APPL, V69, P97, DOI 10.1007/BF02380637; Pasteels J.M., 1987, Experientia Supplementum (Basel), V54, P155; PETRALIA RS, 1980, CELL TISSUE RES, V206, P145, DOI 10.1007/BF00233615; Pirk CWW, 2010, APIDOLOGIE, V41, P62, DOI 10.1051/apido/2009055; RICKS BL, 1972, ENTOMOL EXP APPL, V15, P329, DOI 10.1007/BF00428298; Rueppell O, 2010, J EVOLUTION BIOL, V23, P1538, DOI 10.1111/j.1420-9101.2010.02022.x; SCHMIDHEMPEL P, 1985, BEHAV ECOL SOCIOBIOL, V17, P61, DOI 10.1007/BF00299430; Simpson S.J., 2012, NATURE NUTR; Simpson SJ, 2000, ADV STUD BEHAV, V29, P1, DOI 10.1016/S0065-3454(08)60102-3; Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009; Wu G, 2013, AMINO ACIDS: BIOCHEMISTRY AND NUTRITION, P1, DOI 10.1201/b14661; Yossa R, 2015, REV AQUACULT, V7, P59, DOI 10.1111/raq.12053; Zempleni J, 2009, BIOFACTORS, V35, P36, DOI 10.1002/biof.8	47	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112801	10.1371/journal.pone.0112801	http://dx.doi.org/10.1371/journal.pone.0112801			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392989	Green Published, gold, Green Submitted			2022-12-27	WOS:000347709300107
J	Sandor, N; Walter, FR; Bocsik, A; Santha, P; Schilling-Toth, B; Lener, V; Varga, Z; Kahan, Z; Deli, MA; Safrany, G; Hegyesi, H				Sandor, Nikolett; Walter, Fruzsina R.; Bocsik, Alexandra; Santha, Petra; Schilling-Toth, Boglarka; Lener, Violetta; Varga, Zoltan; Kahan, Zsuzsanna; Deli, Maria A.; Safrany, Geza; Hegyesi, Hargita			Low Dose Cranial Irradiation-Induced Cerebrovascular Damage Is Reversible in Mice	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; ENDOTHELIAL PROGENITOR CELLS; IONIZING-RADIATION; RAT-BRAIN; X-IRRADIATION; PERMEABILITY; RADIOTHERAPY; MECHANISMS; CHILDHOOD; EXPOSURE	Background: High-dose radiation-induced blood-brain barrier breakdown contributes to acute radiation toxicity syndrome and delayed brain injury, but there are few data on the effects of low dose cranial irradiation. Our goal was to measure blood-brain barrier changes after low (0.1 Gy), moderate (2 Gy) and high (10 Gy) dose irradiation under in vivo and in vitro conditions. Methodology: Cranial irradiation was performed on 10-day-old and 10-week-old mice. Blood-brain barrier permeability for Evans blue, body weight and number of peripheral mononuclear and circulating endothelial progenitor cells were evaluated 1, 4 and 26 weeks postirradiation. Barrier properties of primary mouse brain endothelial cells co-cultured with glial cells were determined by measurement of resistance and permeability for marker molecules and staining for interendothelial junctions. Endothelial senescence was determined by senescence associated beta-galactosidase staining. Principle Findings: Extravasation of Evans blue increased in cerebrum and cerebellum in adult mice 1 week and in infant mice 4 weeks postirradiation at all treatment doses. Head irradiation with 10 Gy decreased body weight. The number of circulating endothelial progenitor cells in blood was decreased 1 day after irradiation with 0.1 and 2 Gy. Increase in the permeability of cultured brain endothelial monolayers for fluorescein and albumin was time-and radiation dose dependent and accompanied by changes in junctional immunostaining for claudin-5, ZO-1 and beta-catenin. The number of cultured brain endothelial and glial cells decreased from third day of postirradiation and senescence in endothelial cells increased at 2 and 10 Gy. Conclusion: Not only high but low and moderate doses of cranial irradiation increase permeability of cerebral vessels in mice, but this effect is reversible by 6 months. In-vitro experiments suggest that irradiation changes junctional morphology, decreases cell number and causes senescence in brain endothelial cells.	[Sandor, Nikolett; Schilling-Toth, Boglarka; Lener, Violetta; Safrany, Geza; Hegyesi, Hargita] Frederic Joliot Curie Natl Res Inst Radiobiol & R, Div Mol Radiobiol & Biodosimetry, Budapest, Hungary; [Walter, Fruzsina R.; Bocsik, Alexandra; Santha, Petra; Deli, Maria A.] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, Biol Barriers Res Grp, H-6701 Szeged, Hungary; [Varga, Zoltan; Kahan, Zsuzsanna] Univ Szeged, Dept Oncotherapy, Szeged, Hungary; [Lener, Violetta; Hegyesi, Hargita] Semmelweis Univ, Fac Hlth Care, Dept Morphol & Physiol, H-1085 Budapest, Hungary; [Sandor, Nikolett] Semmelweis Univ, Doctoral Sch Pathol Sci, H-1085 Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Szeged University; Semmelweis University; Semmelweis University	Hegyesi, H (corresponding author), Frederic Joliot Curie Natl Res Inst Radiobiol & R, Div Mol Radiobiol & Biodosimetry, Budapest, Hungary.	hegyesi.hargita@osski.hu	Deli, Mária A./I-2885-2019	Deli, Mária A./0000-0001-6084-6524; Hegyesi, Hargita/0000-0002-8800-5169	European Union [FP7/CEREBRAD-295552]; Hungarian Research Fund [OTKA K77766]; European Social Fund [TAMOP 4.2.4.A/2-11/1-2012-0001, TAMOP-4.2.2.A-11/1/KONV-2012-0052]	European Union(European Commission); Hungarian Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Social Fund(European Social Fund (ESF))	This research was supported by grants from the European Union (FP7/CEREBRAD-295552), the Hungarian Research Fund (OTKA K77766), and co-financed by the European Social Fund in the framework of TAMOP 4.2.4.A/2-11/1-2012-0001 'National Excellence Program' and TAMOP-4.2.2.A-11/1/KONV-2012-0052. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2012, EPILEPSIA, V53, P1, DOI 10.1111/j.1528-1167.2012.03696.x; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abraham CS, 1996, NEUROSCI LETT, V208, P85; Allen AR, 2014, INT J RADIAT BIOL, V90, P214, DOI 10.3109/09553002.2014.859761; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 2011, STEM CELLS, V29, P1650, DOI 10.1002/stem.745; Asosingh K, 2007, J IMMUNOL, V178, P6482, DOI 10.4049/jimmunol.178.10.6482; Brandes RP, 2005, CARDIOVASC RES, V66, P286, DOI 10.1016/j.cardiores.2004.12.027; Burrell K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038366; CALVO W, 1988, BRIT J RADIOL, V61, P1043, DOI 10.1259/0007-1285-61-731-1043; Cho KH, 2010, INT J RADIAT ONCOL, V78, P390, DOI 10.1016/j.ijrobp.2009.08.029; Deli MA, 2000, NEUROREPORT, V11, P3931, DOI 10.1097/00001756-200011270-00064; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Deli MA, 2010, J ALZHEIMERS DIS, V22, P777, DOI 10.3233/JAD-2010-100759; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Diserbo M, 2002, CAN J PHYSIOL PHARM, V80, P670, DOI 10.1139/Y02-070; Eigenmann DE, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-33; El Assar M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00132; Erickson MA, 2013, J CEREBR BLOOD F MET, V33, P1500, DOI 10.1038/jcbfm.2013.135; Erusalimsky JD, 2009, EXP PHYSIOL, V94, P299, DOI 10.1113/expphysiol.2008.043133; Fauquette W, 2012, BRAIN RES, V1433, P114, DOI 10.1016/j.brainres.2011.11.022; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Heissig B, 2005, J EXP MED, V202, P739, DOI 10.1084/jem.20050959; HICKS HH, 1967, J AM DENT ASSOC, V75, P1194, DOI 10.14219/jada.archive.1967.0354; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hwang SY, 2006, NEUROBIOL DIS, V21, P457, DOI 10.1016/j.nbd.2005.08.006; Jia D, 2010, RADIAT RES, V173, P579, DOI 10.1667/RR2030.1; Kataoka Y, 2006, J RADIAT RES, V47, P245, DOI 10.1269/jrr.0628; Kaya M, 2004, BRAIN RES, V1019, P105, DOI 10.1016/j.brainres.2004.05.102; Kim JH, 2008, J NEURO-ONCOL, V87, P279, DOI 10.1007/s11060-008-9520-x; Kinev AV, 2013, CANCER INVEST, V31, P359, DOI 10.3109/07357907.2013.789903; KOBAYASHI S, 1967, ELECTROEN CLIN NEURO, V23, P463, DOI 10.1016/0013-4694(67)90189-7; Kouloulias V, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/401261; Kyrkanides S, 1999, J NEUROIMMUNOL, V95, P95, DOI 10.1016/S0165-5728(98)00270-7; Lee MO, 2012, ARTERIOSCL THROM VAS, V32, P343, DOI 10.1161/ATVBAHA.111.237651; Legros H, 2009, J CEREBR BLOOD F MET, V29, P1146, DOI 10.1038/jcbfm.2009.39; Li YQ, 1996, CANCER RES, V56, P5417; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Liu Y, 2010, AM J NEURORADIOL, V31, P383, DOI 10.3174/ajnr.A1801; LJUBIMOVA NV, 1991, BRIT J RADIOL, V64, P934, DOI 10.1259/0007-1285-64-766-934; Mao XW, 2010, RADIAT RES, V173, P486, DOI 10.1667/RR1728.1; Martins T, 2011, BRAIN RES, V1411, P28, DOI 10.1016/j.brainres.2011.07.013; Minamino T, 2008, FRONT BIOSCI-LANDMRK, V13, P2971, DOI 10.2741/2902; Murasawa S, 2005, PHYSIOLOGY, V20, P36, DOI 10.1152/physiol.00033.2004; Nakagawa S, 2007, CELL MOL NEUROBIOL, V27, P687, DOI 10.1007/s10571-007-9195-4; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; NAKATA H, 1995, ACTA NEUROCHIR, V136, P82, DOI 10.1007/BF01411440; Nordal RA, 2005, INT J RADIAT ONCOL, V62, P279, DOI 10.1016/j.ijrobp.2005.01.039; Park S, 2004, PLAST RECONSTR SURG, V113, P284, DOI 10.1097/01.PRS.0000091169.51035.A5; Patterson CE, 2000, ENDOTHELIUM-NEW YORK, V7, P287, DOI 10.3109/10623320009072215; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; REIDY MA, 1981, LAB INVEST, V44, P301; REINHOLD HS, 1990, INT J RADIAT ONCOL, V18, P37, DOI 10.1016/0360-3016(90)90264-K; REMLER MP, 1986, INT J RADIAT ONCOL, V12, P1965, DOI 10.1016/0360-3016(86)90133-1; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; ROSEN EM, 1989, RADIAT RES, V117, P395, DOI 10.2307/3577346; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; RUBIN P, 1994, RADIOTHER ONCOL, V31, P51, DOI 10.1016/0167-8140(94)90413-8; SCHULTHEISS TE, 1995, INT J RADIAT ONCOL, V31, P1093, DOI 10.1016/0360-3016(94)00655-5; Serduc R, 2006, INT J RADIAT ONCOL, V64, P1519, DOI 10.1016/j.ijrobp.2005.11.047; SHELINE GE, 1980, INT J RADIAT ONCOL, V6, P1215, DOI 10.1016/0360-3016(80)90175-3; Skowronska-Gardas A, 2009, REV RECENT CLIN TRIA, V4, P42, DOI 10.2174/157488709787047567; SLATKIN DN, 1995, P NATL ACAD SCI USA, V92, P8783, DOI 10.1073/pnas.92.19.8783; Smibert E, 1996, BRIT J CANCER, V73, P825, DOI 10.1038/bjc.1996.145; Spiegler BJ, 2004, J CLIN ONCOL, V22, P706, DOI 10.1200/JCO.2004.05.186; Takahashi A, 2005, CANCER LETT, V229, P171, DOI 10.1016/j.canlet.2005.07.016; Ungvari Z, 2013, J GERONTOL A-BIOL, V68, P1443, DOI 10.1093/gerona/glt057; van Vulpen M, 2002, ONCOL REP, V9, P683; Veszelka S, 2007, NEUROCHEM INT, V50, P219, DOI 10.1016/j.neuint.2006.08.006; Veszelka S, 2013, J ALZHEIMERS DIS, V36, P487, DOI 10.3233/JAD-120163; Wang Q, 2011, NEUROSCI LETT, V498, P78, DOI 10.1016/j.neulet.2011.04.067; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; Wong CS, 2004, MOL INTERV, V4, P273, DOI 10.1124/mi.4.5.7; YAAR I, 1982, J NEUROL NEUROSUR PS, V45, P166, DOI 10.1136/jnnp.45.2.166; Yentrapalli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070024; YOSHII Y, 1982, ACTA NEUROCHIR, V64, P87, DOI 10.1007/BF01405622	79	44	44	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112397	10.1371/journal.pone.0112397	http://dx.doi.org/10.1371/journal.pone.0112397			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393626	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000347709300055
J	Menhofer, MH; Kubisch, R; Schreiner, L; Zorn, M; Foerster, F; Mueller, R; Raedler, JO; Wagner, E; Vollmar, AM; Zahler, S				Menhofer, Magdalena H.; Kubisch, Rebekka; Schreiner, Laura; Zorn, Matthias; Foerster, Florian; Mueller, Rolf; Raedler, Joachim O.; Wagner, Ernst; Vollmar, Angelika M.; Zahler, Stefan			The Actin Targeting Compound Chondramide Inhibits Breast Cancer Metastasis via Reduction of Cellular Contractility	PLOS ONE			English	Article							DRIVES INVASION; TUMOR-CELLS; CYTOSKELETON; MIGRATION; AGENTS; MYXOBACTERIA; PROTEOLYSIS; ANTIFUNGAL; ACTIVATION; MECHANISMS	Background: A major player in the process of metastasis is the actin cytoskeleton as it forms key structures in both invasion mechanisms, mesenchymal and amoeboid migration. We tested the actin binding compound Chondramide as potential anti-metastatic agent. Methods: In vivo, the effect of Chondramide on metastasis was tested employing a 4T1-Luc BALB/c mouse model. In vitro, Chondramide was tested using the highly invasive cancer cell line MDA-MB-231 in Boyden-chamber assays, fluorescent stainings, Western blot and Pull down assays. Finally, the contractility of MDA-MB-231 cells was monitored in 3D environment and analyzed via PIV analysis. Results: In vivo, Chondramide treatment inhibits metastasis to the lung and the migration and invasion of MDA-MB-231 cells is reduced by Chondramide in vitro. On the signaling level, RhoA activity is decreased by Chondramide accompanied by reduced MLC-2 and the stretch induced guanine nucleotide exchange factor Vav2 activation. At same conditions, EGF-receptor autophosphorylation, Akt and Erk as well as Rac1 are not affected. Finally, Chondramide treatment disrupted the actin cytoskeleton and decreased the ability of cells for contraction. Conclusions: Chondramide inhibits cellular contractility and thus represents a potential inhibitor of tumor cell invasion.	[Menhofer, Magdalena H.; Kubisch, Rebekka; Schreiner, Laura; Foerster, Florian; Wagner, Ernst; Vollmar, Angelika M.; Zahler, Stefan] Univ Munich, Dept Pharm, Munich, Germany; [Zorn, Matthias; Raedler, Joachim O.] Univ Munich, Dept Phys Soft Matter Phys & Biophys, Munich, Germany; [Mueller, Rolf] Univ Saarland, Helmholtz Ctr Infect Res, Helmholtz Inst Pharmaceut Res Saarland, D-66123 Saarbrucken, Germany; [Mueller, Rolf] Univ Saarland, Dept Pharmaceut Biotechnol, D-66123 Saarbrucken, Germany	University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center for Infection Research; Saarland University; Saarland University	Zahler, S (corresponding author), Univ Munich, Dept Pharm, Munich, Germany.	stefan.zahler@cup.uni-muenchen.de	Müller, Rolf/B-1559-2008; Wagner, Ernst/ABB-5976-2020; Wagner, Ernst/A-7435-2012	Müller, Rolf/0000-0002-1042-5665; Wagner, Ernst/0000-0001-8413-0934; Wagner, Ernst/0000-0001-8413-0934; Zahler, Stefan/0000-0002-5140-7287	German Research Foundation (DFG) [FOR 1406, SFB1032]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was in part supported by grants from the German Research Foundation (http://www.dfg.de/): DFG FOR 1406: RM, EW, AV)) and by SFB1032 (SZ, JR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allingham JS, 2006, CELL MOL LIFE SCI, V63, P2119, DOI 10.1007/s00018-006-6157-9; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bloom RJ, 2008, BIOPHYS J, V95, P4077, DOI 10.1529/biophysj.108.132738; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Goswami S, 2004, CANCER RES, V64, P7664, DOI 10.1158/0008-5472.CAN-04-2027; Herrmann J, 2013, CHEMBIOCHEM, V14, P1573, DOI 10.1002/cbic.201300140; Jiang P, 2009, CANCER LETT, V284, P122, DOI 10.1016/j.canlet.2009.02.034; KUNZE B, 1995, J ANTIBIOT, V48, P1262, DOI 10.7164/antibiotics.48.1262; Lessey EC, 2012, BIOCHEMISTRY-US, V51, P7420, DOI 10.1021/bi300758e; Li J, 2004, ONCOGENE, V23, P9359, DOI 10.1038/sj.onc.1208039; Liebl J, 2010, J BIOL CHEM, V285, P35932, DOI 10.1074/jbc.M110.126177; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Molli PR, 2008, CLIN CANCER RES, V14, P6161, DOI 10.1158/1078-0432.CCR-07-5288; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Nurnberg A, 2011, NAT REV CANCER, V11, P177, DOI 10.1038/nrc3003; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Peng FF, 2010, CELL SIGNAL, V22, P34, DOI 10.1016/j.cellsig.2009.09.003; Poincloux R, 2011, P NATL ACAD SCI USA, V108, P1943, DOI 10.1073/pnas.1010396108; Rosel D, 2008, MOL CANCER RES, V6, P1410, DOI 10.1158/1541-7786.MCR-07-2174; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Sasse F, 1998, J NATL CANCER I, V90, P1559, DOI 10.1093/jnci/90.20.1559; SCOTT VR, 1988, ANTIMICROB AGENTS CH, V32, P1154, DOI 10.1128/AAC.32.8.1154; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yoshioka K, 1999, CANCER RES, V59, P2004	28	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112542	10.1371/journal.pone.0112542	http://dx.doi.org/10.1371/journal.pone.0112542			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391145	Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400094
J	Viet, CT; Dang, D; Achdjian, S; Ye, Y; Katz, SG; Schmidt, BL				Viet, Chi T.; Dang, Dongmin; Achdjian, Stacy; Ye, Yi; Katz, Samuel G.; Schmidt, Brian L.			Decitabine Rescues Cisplatin Resistance in Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							REFRACTORY SOLID TUMORS; ORAL-CANCER PAIN; DNA METHYLATION; PHASE-II; OVARIAN-CANCER; LUNG-CANCER; CHEMOTHERAPY; CARBOPLATIN; TRIAL; METAANALYSES	Cisplatin resistance in head and neck squamous cell carcinoma (HNSCC) reduces survival. In this study we hypothesized that methylation of key genes mediates cisplatin resistance. We determined whether a demethylating drug, decitabine, could augment the anti-proliferative and apoptotic effects of cisplatin on SCC-25/CP, a cisplatin-resistant tongue SCC cell line. We showed that decitabine treatment restored cisplatin sensitivity in SCC-25/CP and significantly reduced the cisplatin dose required to induce apoptosis. We then created a xenograft model with SCC-25/CP and determined that decitabine and cisplatin combination treatment resulted in significantly reduced tumor growth and mechanical allodynia compared to control. To establish a gene classifier we quantified methylation in cancer tissue of cisplatin-sensitive and cisplatin-resistant HNSCC patients. Cisplatin-sensitive and cisplatin-resistant patient tumors had distinct methylation profiles. When we quantified methylation and expression of genes in the classifier in HNSCC cells in vitro, we showed that decitabine treatment of cisplatin-resistant HNSCC cells reversed methylation and gene expression toward a cisplatin-sensitive profile. The study provides direct evidence that decitabine restores cisplatin sensitivity in in vitro and in vivo models of HNSCC. Combination treatment of cisplatin and decitabine significantly reduces HNSCC growth and HNSCC pain. Furthermore, gene methylation could be used as a biomarker of cisplatin-resistance.	[Viet, Chi T.; Schmidt, Brian L.] NYU, Dept Oral Maxillofacial Surg, New York, NY 10012 USA; [Viet, Chi T.; Dang, Dongmin; Achdjian, Stacy; Ye, Yi; Katz, Samuel G.; Schmidt, Brian L.] NYU, Bluestone Ctr Clin Res, New York, NY USA	New York University	Schmidt, BL (corresponding author), NYU, Dept Oral Maxillofacial Surg, New York, NY 10012 USA.	vietc01@nyu.edu		Schmidt, Brian/0000-0002-2409-8984	NIH [R01 DE19796]; Oral and Maxillofacial Surgery Foundation Research Support Grant; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019796] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oral and Maxillofacial Surgery Foundation Research Support Grant; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIH R01 DE19796 and Oral and Maxillofacial Surgery Foundation Research Support Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amptoulach Sousana, 2011, Chemother Res Pract, V2011, P843019, DOI 10.1155/2011/843019; Appleton K, 2007, J CLIN ONCOL, V25, P4603, DOI 10.1200/JCO.2007.10.8688; Blum W, 2010, P NATL ACAD SCI USA, V107, P7473, DOI 10.1073/pnas.1002650107; Candelaria M, 2007, ANN ONCOL, V18, P1529, DOI 10.1093/annonc/mdm204; Cashen AF, 2010, J CLIN ONCOL, V28, P556, DOI 10.1200/JCO.2009.23.9178; Chang XF, 2010, CANCER RES, V70, P2870, DOI 10.1158/0008-5472.CAN-09-3427; Connelly ST, 2004, J PAIN, V5, P505, DOI 10.1016/j.jpain.2004.09.002; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; Coronel J, 2010, MED ONCOLOGY; Daskalakis M, 2010, RECENT RESULTS CANC, V184, P131, DOI 10.1007/978-3-642-01222-8_10; Everdingen MHJVDBV, 2007, ANN ONCOL, V18, P1437, DOI 10.1093/annonc/mdm056; Fischer DJ, 2010, SUPPORT CARE CANCER, V18, P801, DOI 10.1007/s00520-009-0712-5; Glasspool RM, 2014, BRIT J CANCER, V110, P1923, DOI 10.1038/bjc.2014.116; Ibanez de Caceres I, 2010, ONCOGENE, V29, P1681, DOI 10.1038/onc.2009.454; Kolokythas A, 2007, J PAIN, V8, P950, DOI 10.1016/j.jpain.2007.06.012; Marcu LG, 2012, J THEOR BIOL, V297, P41, DOI 10.1016/j.jtbi.2011.12.001; Ogino S, 2006, J MOL DIAGN, V8, P209, DOI 10.2353/jmoldx.2006.050135; Pignon JP, 2007, INT J RADIAT ONCOL, V69, pS112, DOI 10.1016/j.ijrobp.2007.04.088; Pignon JP, 2009, RADIOTHER ONCOL, V92, P4, DOI 10.1016/j.radonc.2009.04.014; Pignon JP, 2000, LANCET, V355, P949, DOI 10.1016/S0140-6736(00)90011-4; Plumb JA, 2000, CANCER RES, V60, P6039; Rezaee M, 2013, INT J RADIAT ONCOL, V87, P847, DOI 10.1016/j.ijrobp.2013.06.2037; Shi W, 2009, J CLIN ONCOL, V27, P6213, DOI 10.1200/JCO.2009.23.1670; Shiboski CH, 2005, CANCER-AM CANCER SOC, V103, P1843, DOI 10.1002/cncr.20998; Stewart DJ, 2007, CRIT REV ONCOL HEMAT, V63, P12, DOI 10.1016/j.critrevonc.2007.02.001; Stewart DJ, 2009, CLIN CANCER RES, V15, P3881, DOI 10.1158/1078-0432.CCR-08-2196; TEICHER BA, 1986, CANCER RES, V46, P4379; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; VERNHAM GA, 1994, CLIN OTOLARYNGOL, V19, P120, DOI 10.1111/j.1365-2273.1994.tb01194.x; Viet CT, 2012, J DENT RES, V91, P447, DOI 10.1177/0022034511424156; Viet CT, 2011, PAIN, V152, P2323, DOI 10.1016/j.pain.2011.06.025; Viet CT, 2014, CLIN CANC RES; Zeller C, 2012, ONCOGENE, V31, P4567, DOI 10.1038/onc.2011.611	33	38	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112880	10.1371/journal.pone.0112880	http://dx.doi.org/10.1371/journal.pone.0112880			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391133	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400136
J	Barageine, JK; Tumwesigye, NM; Byamugisha, JK; Almroth, L; Faxelid, E				Barageine, Justus Kafunjo; Tumwesigye, Nazarius Mbona; Byamugisha, Josaphat K.; Almroth, Lars; Faxelid, Elisabeth			Risk Factors for Obstetric Fistula in Western Uganda: A Case Control Study	PLOS ONE			English	Article							WOMEN	Introduction: Two million women worldwide are living with genital fistula with an annual incidence of 50,000-100,000 women. Risk factors for obstetric fistula are context bound. Studies from other countries show variation in the risk factors for obstetric fistula. This study was conducted to identify risk factors for obstetric fistula in western Ugandan context. Methods: A case control study comparing background factors of women with obstetric fistula (cases) and women without fistula (controls) was conducted in western Uganda. Data was collected using face-to-face interviews. Univariate, bivariate and multivariate analysis was conducted using Stata 12. Results: Altogether, 420 respondents (140 cases and 280 controls) participated in the study. Duration of labour was used to form the product terms when assessing for interaction and confounding since it was one the most significant factors at bivariate level with a narrow confidence interval and was hence considered the main predictor. After adjusting for interaction and confounding, significant risk factors associated with development of obstetric fistula in western Uganda were: Caesarean section (adjusted odds ratio [AOR] = 13.30, 95% CI = 6.74-26.39), respondent height of 150 cm or less (AOR = 2.63, 95% CI = 1.35-5.26), baby weight of 3.5 kg or more (AOR = 1.52, 95% CI = 1.15-1.99), prolonged labour (AOR = 1.06, 95% CI = 1.04-1.08. A quarter of the fistulas had resulted from iatrogenic complication during caesarean section. Compared to no education, post primary level of education was protective against obstetric fistula (AOR = 0.31, 95% CI = 0.13-0.72) and there was no difference between respondents without education and those with primary level education. Conclusions: Surgeons contribute to a big proportion (25%) of fistula cases hence caesarean section being a risk factor in this region. Other risk factors include; prolonged labour, weight of the baby of 3.5 kg or more, respondent height of 150 cm or less (short stature), and low or no education are risk factors for obstetric fistula in western Ugandan.	[Barageine, Justus Kafunjo; Byamugisha, Josaphat K.] Makerere Univ, Mulago Natl Referral Hosp, Coll Hlth Sci, Dept Obstet & Gynecol,Sch Med, Kampala, Uganda; [Barageine, Justus Kafunjo; Almroth, Lars; Faxelid, Elisabeth] Karolinska Inst, Dept Publ Hlth Sci, Global Hlth IHCAR, Stockholm, Sweden; [Tumwesigye, Nazarius Mbona] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda	Makerere University; Mulago National Referral Hospital; Karolinska Institutet; Makerere University	Barageine, JK (corresponding author), Makerere Univ, Mulago Natl Referral Hosp, Coll Hlth Sci, Dept Obstet & Gynecol,Sch Med, Kampala, Uganda.	barageinej@gmail.com	Byamugisha, Josaphat/AAL-5776-2020	Byamugisha, Josaphat/0000-0002-3438-9662; Tumwesigye, Nazarius Mbona/0000-0001-7085-8780	Swedish International Development Cooperation Agency (Sida) under the Makerere University - Karolinska Institutet collaboration Phase 3	Swedish International Development Cooperation Agency (Sida) under the Makerere University - Karolinska Institutet collaboration Phase 3	The study was funded by Swedish International Development Cooperation Agency (Sida) under the Makerere University - Karolinska Institutet collaboration Phase 3. The funders had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	Abrams P, 2012, OBSTET FISTULA DEV W, P17; AMPOFO EK, 1990, TROP DOCT, V20, P138, DOI 10.1177/004947559002000320; [Anonymous], 2012, UG DEM HLTH SURV 201; Browning A, 2014, BJOG-INT J OBSTET GY, V121, P604, DOI 10.1111/1471-0528.12527; Danso K A, 1996, Int Urogynecol J Pelvic Floor Dysfunct, V7, P117, DOI 10.1007/BF01894198; Donnay F, 2006, INT J GYNECOL OBSTET, V94, P254, DOI 10.1016/j.ijgo.2006.04.005; FIGO P, 2011, GLOB COMP BAS FIST S, P119; Goh JWT, 2004, FEMALE GENITAL TRACT; Hadar E, 2011, ARCH GYNECOL OBSTET, V283, P735, DOI 10.1007/s00404-010-1450-0; Hancock B, 2005, 1 STEPS VESICO VAGIN; Hancock B, 2009, TXB PRACTICAL OBSTET; Harrison KA, 1996, J ROY SOC MED, V89, P361, DOI 10.1177/014107689608900701; HOSMER DW, 1989, APPL LOGISTIC REGRES; Kabayambi J, 2014, INT J TROPICAL DIS H, V4, P352, DOI DOI 10.9734/IJTDH/2014/7505; Kelly J, 2007, INT J GYNECOL OBSTET, V99, pS21, DOI 10.1016/j.ijgo.2007.06.017; Kelly J, 1993, INT UROGYNECOL J, V4, P278; Kelsey JL., 1996, METHODS OBSERVATIONA; Larissa M, 2007, AM J OBSTET GYNECOL, V197, p90 e91; Lewis G., 2006, OBSTET FISTULA GUIDI; Melah GS, 2007, J OBSTET GYNAECOL, V27, P819, DOI 10.1080/01443610701709825; Muleta M, 2004, ETHIOPIAN MED J, V42, P9; Murray C, 2002, BJOG-INT J OBSTET GY, V109, P828, DOI 10.1111/j.1471-0528.2002.00124.x; Murray CJL, 1998, HLTH DIAMENSIONS SEX; Ntozi JPM, 1988, MARRIAGE PATTERNS AN; Olusegun AK, 2009, J NATL MED ASSOC, V101, P593, DOI 10.1016/S0027-9684(15)30946-9; Onsrud M, 2011, INT J GYNECOL OBSTET, V114, P10, DOI 10.1016/j.ijgo.2011.01.018; Raassen TJIP, 2008, INT UROGYNECOL J, V19, P73, DOI 10.1007/s00192-007-0389-6; Roka ZG, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-56; Serour GI, 2006, INT J GYNECOL OBSTET, V94, P174, DOI 10.1016/j.ijgo.2006.06.007; STATA Corp, 2011, STATA REL 12 STAT SO; TAHZIB F, 1983, BRIT J OBSTET GYNAEC, V90, P387, DOI 10.1111/j.1471-0528.1983.tb08933.x; Tann Carolyn J, 2007, BMC Pregnancy Childbirth, V7, P23, DOI 10.1186/1471-2393-7-23; Tebeu PM, 2012, INT UROGYNECOL J, V23, P387, DOI 10.1007/s00192-011-1622-x; Tebeu PM, 2009, INT J GYNECOL OBSTET, V107, P12, DOI 10.1016/j.ijgo.2009.05.019; Thomson AM, 2007, MIDWIFERY, V23, P335, DOI 10.1016/j.midw.2007.09.004; UBOS, 2007, UG DEM HLTH SURV 200; UNFPA, 2005, ANN REPORT; UNFPA, 2005, CAMP END FIST; Waaldijk K, 1998, STEP STEP SURG VESIC; Waaldijk K, 2008, OBSTET FISTULA SURG; Wall L L, 2005, Obstet Gynecol Surv, V60, pS3, DOI 10.1097/00006254-200507001-00002; Wall LL, 2004, AM J OBSTET GYNECOL, V190, P1011, DOI 10.1016/j.ajog.2004.02.007; WHO, 2005, MAK EV MOTH CHILD CO; Williams G, 2007, SURG-J R COLL SURG E, V5, P54, DOI 10.1016/S1479-666X(07)80113-2; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	45	27	27	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112299	10.1371/journal.pone.0112299	http://dx.doi.org/10.1371/journal.pone.0112299			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401756	Green Published, Green Submitted, gold			2022-12-27	WOS:000345158700038
J	Lazarus, EM; Otwombe, K; Adonis, T; Sebastian, E; Gray, G; Grunenberg, N; Roux, S; Churchyard, G; Innes, C; Laher, F				Lazarus, Erica Maxine; Otwombe, Kennedy; Adonis, Tania; Sebastian, Elaine; Gray, Glenda; Grunenberg, Nicole; Roux, Surita; Churchyard, Gavin; Innes, Craig; Laher, Fatima			Uptake of Genital Mucosal Sampling in HVTN 097, a Phase 1b HIV Vaccine Trial in South Africa	PLOS ONE			English	Article							SYSTEMIC VACCINATION; WILLINGNESS; PARTICIPATE; PREPAREDNESS; ENROLLMENT; INFECTION; COMMUNITY; IMMUNITY; COHORT	Because sexual transmission of HIV occurs across mucosal membranes, understanding the immune responses of the genital mucosa to vaccines may contribute knowledge to finding an effective candidate HIV vaccine. We describe the uptake of rectal secretion, cervical secretion and seminal mucosal secretion sampling amongst volunteers in a Phase 1b HIV vaccine trial. Age at screening, gender, study site and the designation of the person conducting the informed consent procedure were collected for volunteers who screened for the HVTN 097 study. A total of 211 volunteers (54% female) were screened at three sites in South Africa: Soweto (n = 70, 33%), Cape Town (n = 68, 32%) and Klerksdorp (n = 73, 35%). Overall uptake of optional mucosal sampling amongst trial volunteers was 71% (n = 149). Compared to Cape Town, volunteers from Soweto and Klerksdorp were less likely to consent to sampling (Soweto OR 0.08 CI: 0.03-0.25 p < 0.001 and Klerksdorp OR 0.13 CI: 0.04-0.41 p = 0.001). In contrast, volunteers over 25 years of age were 2.39 times more likely to consent than younger volunteers (CI: 1.13-5.08, p = 0.02). Further studies are required to better understand the cultural, demographic and sociobehavioral factors which influence willingness to participate in mucosal sampling in HIV prevention studies.	[Lazarus, Erica Maxine; Otwombe, Kennedy; Gray, Glenda; Laher, Fatima] Univ Witwatersrand, Fac Hlth Sci, Perinatal HIV Res Unit, Johannesburg, South Africa; [Adonis, Tania; Churchyard, Gavin; Innes, Craig] Aurum Inst, Klerksdorp, South Africa; [Sebastian, Elaine; Roux, Surita] Univ Cape Town, Desmond Tutu HIV Fdn, ZA-7925 Cape Town, South Africa; [Grunenberg, Nicole] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	University of Witwatersrand; University of Cape Town; Fred Hutchinson Cancer Center	Lazarus, EM (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Perinatal HIV Res Unit, Johannesburg, South Africa.	lazaruse@phru.co.za		Churchyard, Gavin/0000-0002-4269-3699	United States National institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068635, UM1AI068614, UM1AI069453] Funding Source: NIH RePORTER	United States National institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	HVTN 097 was funded by grants from the United States National institute of Allergy and Infectious Diseases (NIAID) to the HIV vaccines Trials Networks. The opinions expressed in this article are those of the authors and do not represent the official views of the NIAID. The NIAID had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alary M., 2001, GUIDELINES MANAGEMEN; Baig J, 2002, J VIROL, V76, P11484, DOI 10.1128/JVI.76.22.11484-11490.2002; Buchbinder SP, 2004, JAIDS-J ACQ IMM DEF, V36, P604, DOI 10.1097/00126334-200405010-00009; de Bruyn Guy, 2008, BMC Res Notes, V1, P76, DOI 10.1186/1756-0500-1-76; DEWARAJA R, 1991, AM J PSYCHOTHER, V45, P14, DOI 10.1176/appi.psychotherapy.1991.45.1.14; Dhalla S, 2011, AIDS CARE, V23, P1430, DOI 10.1080/09540121.2011.555750; Fincham D, 2010, AIDS CARE, V22, P452, DOI 10.1080/09540120903202939; Iqbal SM, 2008, AM J REPROD IMMUNOL, V59, P44; Lakhani A, 2001, REPROD HEALTH MATTER, V9, P49, DOI 10.1016/S0968-8080(01)90090-4; Lewis D. A., 2009, Southern African Journal of Epidemiology & Infection, V24, P6; Mattapallil JJ, 2006, J MED PRIMATOL, V35, P217, DOI 10.1111/j.1600-0684.2006.00170.x; Mazzoli S, 1997, NAT MED, V3, P1250, DOI 10.1038/nm1197-1250; Mehra V, 2010, VACCINE, V28, P4689, DOI 10.1016/j.vaccine.2010.04.092; Meston CM, 1996, ARCH SEX BEHAV, V25, P33, DOI 10.1007/BF02437906; Middelkoop K, 2008, J ADOLESCENT HEALTH, V43, P8, DOI 10.1016/j.jadohealth.2007.11.144; Otwombe KN, 2011, JAIDS-J ACQ IMM DEF, V58, P211, DOI 10.1097/QAI.0b013e31822b7702; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Ruzagira E, 2009, TROP MED INT HEALTH, V14, P196, DOI 10.1111/j.1365-3156.2008.02200.x; Shisana O, 2014, S AFRICAN NATL HIV P; Smit J, 2006, INT J STD AIDS, V17, P176, DOI 10.1258/095646206775809259; South African National Department of Health, 2000, NAT GUID CERV CANC S; Stover J, 2007, HEALTH AFFAIR, V26, P1147, DOI 10.1377/hlthaff.26.4.1147; UNAIDS, 2014, GAP REP; United States Army Medical Research and Materiel Command, 2014, RV306 US ARM MED RES; Wright PF, 2004, J INFECT DIS, V189, P1221, DOI 10.1086/382088; Yang OO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088621	26	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112303	10.1371/journal.pone.0112303	http://dx.doi.org/10.1371/journal.pone.0112303			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8BL	25401780	Green Published, gold			2022-12-27	WOS:000345158700039
J	Wang, JL; Wang, F; Chu, LM; Wang, H; Zhong, ZP; Liu, ZP; Gao, JY; Duan, HR				Wang, Jiali; Wang, Fang; Chu, Limin; Wang, Hao; Zhong, Zhiping; Liu, Zhipei; Gao, Jianyong; Duan, Hairong			High Genetic Diversity and Novelty in Eukaryotic Plankton Assemblages Inhabiting Saline Lakes in the Qaidam Basin	PLOS ONE			English	Article							BACTERIAL DIVERSITY; MOLECULAR DIVERSITY; MICROBIAL DIVERSITY; RARE BIOSPHERE; 80S RIBOSOME; SALT LAKES; REVEALS; PICOEUKARYOTES; SEA; DNA	Saline lakes are intriguing ecosystems harboring extremely productive microbial communities in spite of their extreme environmental conditions. We performed a comprehensive analysis of the genetic diversity (18S rRNA gene) of the planktonic microbial eukaryotes (nano- and picoeukaryotes) in six different inland saline lakes located in the Qaidam Basin. The novelty level are high, with about 11.23% of the whole dataset showing <90% identity to any previously reported sequence in GenBank. At least 4 operational taxonomic units (OTUs) in mesosaline lakes, while up to eighteen OTUs in hypersaline lakes show very low CCM and CEM scores, indicating that these sequences are highly distantly related to any existing sequence. Most of the 18S rRNA gene sequence reads obtained in investigated mesosaline lakes is closely related to Holozoa group (48.13%), whereas Stramenopiles (26.65%) and Alveolates (10.84%) are the next most common groups. Hypersaline lakes in the Qaidam Basin are also dominated by Holozoa group, accounting for 26.65% of the total number of sequence reads. Notably, Chlorophyta group are only found in high abundance in Lake Gasikule (28.00%), whereas less represented in other hypersaline lakes such as Gahai (0.50%) and Xiaochaidan (1.15%). Further analysis show that the compositions of planktonic eukaryotic assemblages are also most variable between different sampling sites in the same lake. Out of the parameters, four show significant correlation to this CCA: altitude, calcium, sodium and potassium concentrations. Overall, this study shows important gaps in the current knowledge about planktonic microbial eukaryotes inhabiting Qaidam Basin (hyper) saline water bodies. The identified diversity and novelty patterns among eukaryotic plankton assemblages in saline lake are of great importance for understanding and interpreting their ecology and evolution.	[Wang, Jiali; Wang, Fang; Chu, Limin; Wang, Hao] China Inst Water Resources & Hydropower Res, State Key Lab Simulat & Regulat Water Cycle River, Beijing, Peoples R China; [Wang, Jiali] Inst Shandong River Wetlands, Laiwu, Peoples R China; [Chu, Limin] Hohai Univ, Coll Hydrol & Water Resource, Nanjing, Jiangsu, Peoples R China; [Zhong, Zhiping; Liu, Zhipei] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China; [Gao, Jianyong; Duan, Hairong] Genewiz Inc, Beijing, Peoples R China	China Institute of Water Resources & Hydropower Research; Hohai University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Wang, F (corresponding author), A-1 Fuxing Rd, Beijing, Peoples R China.	wangf@iwhr.com	Zhong, ZhiPing/AAH-9652-2019	Zhong, ZhiPing/0000-0002-4275-0403	Independent Study Project of State Key Laboratory of Simulation and Regulation of Water Cycle in River Basin [2013ZY06]	Independent Study Project of State Key Laboratory of Simulation and Regulation of Water Cycle in River Basin	Independent Study Project of State Key Laboratory of Simulation and Regulation of Water Cycle in River Basin (NO. 2013ZY06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AF, 2010, ISME J, V4, P171, DOI 10.1038/ismej.2009.108; Auguet JC, 2010, ISME J, V4, P182, DOI 10.1038/ismej.2009.109; Barberan A, 2010, AQUAT MICROB ECOL, V59, P1, DOI 10.3354/ame01389; BEAVER JR, 1989, MICROBIAL ECOL, V17, P111, DOI 10.1007/BF02011847; Bryant RG, 1996, INT J REMOTE SENS, V17, P315, DOI 10.1080/01431169608949008; Buchheim MA, 2013, EUR J PHYCOL, V48, P318, DOI 10.1080/09670262.2013.830344; Caron D, 2012, ANNU REV MAR SCI, V4, P61; Casamayor EO, 2013, FEMS MICROBIOL ECOL, V85, P503, DOI 10.1111/1574-6941.12139; Casamayor EO, 2002, ENVIRON MICROBIOL, V4, P338, DOI 10.1046/j.1462-2920.2002.00297.x; Chandramouli P, 2008, STRUCTURE, V16, P535, DOI 10.1016/j.str.2008.01.007; Charvet S, 2014, FEMS MICROBIOL ECOL, V88, P550, DOI 10.1111/1574-6941.12324; Cheung MK, 2010, ISME J, V4, P1053, DOI 10.1038/ismej.2010.26; Countway PD, 2005, J EUKARYOT MICROBIOL, V52, P95, DOI 10.1111/j.1550-7408.2005.05202006.x; Countway PD, 2007, ENVIRON MICROBIOL, V9, P1219, DOI 10.1111/j.1462-2920.2007.01243.x; del Campo J, 2011, PROTIST, V162, P435, DOI 10.1016/j.protis.2010.10.003; Demergasso C, 2008, EXTREMOPHILES, V12, P491, DOI 10.1007/s00792-008-0153-y; Diez B, 2001, APPL ENVIRON MICROB, V67, P2932, DOI 10.1128/AEM.67.7.2932-2941.2001; Dillon JG, 2009, HYDROBIOLOGIA, V632, P49, DOI 10.1007/s10750-009-9827-4; Ebenezer V, 2012, MAR BIOTECHNOL, V14, P129, DOI 10.1007/s10126-011-9427-y; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eiler A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053516; FRONTIER S, 1985, OCEANOGR MAR BIOL, V23, P253; Gaedke U, 2004, AQUAT MICROB ECOL, V34, P247, DOI 10.3354/ame034247; Greenberg A.E., 1984, P AWWA WAT QUAL TECH, P11; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hadziavdic K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087624; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hauer G, 2005, CELL ORIG LIFE EXTRE, V9, P519; Heidelberg KB, 2013, FRONTIERS MICROBIOLO, V4, P1, DOI DOI 10.3389/FMIC; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Hosoi-Tanabe S, 2005, HARMFUL ALGAE, V4, P319, DOI 10.1016/j.hal.2004.04.002; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Ki JS, 2012, J APPL PHYCOL, V24, P1035, DOI 10.1007/s10811-011-9730-z; Kilias E, 2013, J PHYCOL, V49, P996, DOI 10.1111/jpy.12109; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lanzen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072577; Lefevre E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002324; Lefranc M, 2005, APPL ENVIRON MICROB, V71, P5935, DOI 10.1128/AEM.71.10.5935-5942.2005; Lepere C, 2008, APPL ENVIRON MICROB, V74, P2940, DOI 10.1128/AEM.01156-07; Lepere C, 2013, FEMS MICROBIOL ECOL, V85, P85, DOI 10.1111/1574-6941.12100; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Logares R, 2013, ISME J, V7, P937, DOI 10.1038/ismej.2012.168; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Makhdoumi-Kakhki A, 2012, MICROBES ENVIRON, V27, P87, DOI 10.1264/jsme2.ME11267; Mangot JF, 2013, ENVIRON MICROBIOL, V15, P1745, DOI 10.1111/1462-2920.12065; Massana R, 2004, FEMS MICROBIOL ECOL, V50, P231, DOI 10.1016/j.femsec.2004.07.001; Massana R, 2011, ISME J, V5, P184, DOI 10.1038/ismej.2010.104; Medinger R, 2010, MOL ECOL, V19, P32, DOI 10.1111/j.1365-294X.2009.04478.x; Metfies K, 2008, APPL ENVIRON MICROB, V74, P2814, DOI 10.1128/AEM.02122-07; Narasingarao P, 2012, ISME J, V6, P81, DOI 10.1038/ismej.2011.78; Oren A, 2002, J IND MICROBIOL BIOT, V28, P56, DOI 10.1038/sj.jim.7000176; Oren A., 2009, NAT RESOUR ENV ISS, V15, P51; Pagaling E, 2009, APPL ENVIRON MICROB, V75, P5750, DOI 10.1128/AEM.00040-09; Parnell JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012919; Pedros-Alio C, 2000, FEMS MICROBIOL ECOL, V32, P143, DOI 10.1016/S0168-6496(00)00025-8; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Ramsar Convention Secretariat, 2010, RAMS HDB WIS US WETL, V17; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; TERBRAAK CJF, 1995, AQUAT SCI, V57, P255, DOI 10.1007/BF00877430; Triado-Margarit X, 2013, FEMS MICROBIOL ECOL, V85, P27, DOI 10.1111/1574-6941.12095; Triado-Margarit X, 2012, ENVIRON MICROBIOL, V14, P2445, DOI 10.1111/j.1462-2920.2012.02797.x; Waiser MJ, 2009, ENCY INLAND WATERS; Williams WD, 2002, ENVIRON CONSERV, V29, P154, DOI 10.1017/S0376892902000103; Wolf C, 2014, POLAR BIOL, V37, P375, DOI 10.1007/s00300-013-1438-x; Wu QLL, 2009, MICROB ECOL, V58, P569, DOI 10.1007/s00248-009-9526-8; Wuyts J, 2001, NUCLEIC ACIDS RES, V29, P5017, DOI 10.1093/nar/29.24.5017	70	11	12	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112812	10.1371/journal.pone.0112812	http://dx.doi.org/10.1371/journal.pone.0112812			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401703	Green Published, Green Submitted, gold			2022-12-27	WOS:000345158700074
J	Gambini, A; De Stefano, A; Bevacqua, RJ; Karlanian, F; Salamone, DF				Gambini, Andres; De Stefano, Adrian; Jimena Bevacqua, Romina; Karlanian, Florencia; Felipe Salamone, Daniel			The Aggregation of Four Reconstructed Zygotes is the Limit to Improve the Developmental Competence of Cloned Equine Embryos	PLOS ONE			English	Article							CELL NUCLEAR TRANSFER; IN-VITRO CULTURE; BOVINE PREIMPLANTATION EMBRYOS; TREATED DONOR CELLS; WELL WOW SYSTEM; GENE-EXPRESSION; POSTHATCHING DEVELOPMENT; CHIMERIC EMBRYOS; PORCINE EMBRYOS; SIZE REGULATION	Embryo aggregation has been demonstrated to improve cloning efficiency in mammals. However, since no more than three embryos have been used for aggregation, the effect of using a larger number of cloned zygotes is unknown. Therefore, the goal of the present study was to determine whether increased numbers of cloned aggregated zygotes results in improved in vitro and in vivo embryo development in the equine. Zona-free reconstructed embryos (ZFRE's) were cultured in the well of the well system in four different experimental groups: I. 1x, only one ZFRE per microwell; II. 3x, three per microwell; III. 4x, four per microwell; and IV. 5x, five ZFRE's per microwell. Embryo size was measured on day 7, after which blastocysts from each experimental group were either a) maintained in culture from day 8 until day 16 to follow their growth rates, b) fixed to measure DNA fragmentation using the TUNEL assay, or c) transferred to synchronized mares. A higher blastocyst rate was observed on day 7 in the 4x group than in the 5x group. Non-aggregated embryos were smaller on day 8 compared to those aggregated, but from then on the in vitro growth was not different among experimental groups. Apoptotic cells averaged 10% of total cells of day 8 blastocysts, independently of embryo aggregation. Only pregnancies resulting from the aggregation of up to four embryos per microwell went beyond the fifth month of gestation, and two of these pregnancies, derived from experimental groups 3x and 4x, resulted in live cloned foals. In summary, we showed that the in vitro and in vivo development of cloned zona-free embryos improved until the aggregation of four zygotes and declined when five reconstructed zygotes were aggregated.	[Gambini, Andres; De Stefano, Adrian; Jimena Bevacqua, Romina; Karlanian, Florencia; Felipe Salamone, Daniel] Univ Buenos Aires, Fac Agr, Lab Anim Biotechnol, Buenos Aires, DF, Argentina; [Gambini, Andres; Jimena Bevacqua, Romina; Felipe Salamone, Daniel] Natl Inst Sci & Technol Res, Buenos Aires, DF, Argentina	University of Buenos Aires	Salamone, DF (corresponding author), Univ Buenos Aires, Fac Agr, Lab Anim Biotechnol, Buenos Aires, DF, Argentina.	salamone@agro.uba.ar	Gambini, Andres/H-9119-2019; Salamone, Daniel F/G-1096-2019; Bevacqua, Romina/AAU-9227-2021	Gambini, Andres/0000-0002-3652-2068; Salamone, Daniel F/0000-0003-0858-0313; Bevacqua, Romina J/0000-0002-3903-6508	SIDUS Company	SIDUS Company	This work was partially funded by SIDUS Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi S, 2011, J REPROD DEVELOP, V57, P500, DOI 10.1262/jrd.10-140A; Alexopoulos NI, 2009, ANIM REPROD SCI, V114, P43, DOI 10.1016/j.anireprosci.2008.09.010; Allen WR, 2001, REPROD FERT DEVELOP, V13, P623, DOI 10.1071/RD01063; Balbach ST, 2010, DEV BIOL, V343, P71, DOI 10.1016/j.ydbio.2010.04.012; Balbach ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035322; Bertolini M, 2002, MOL REPROD DEV, V63, P318, DOI 10.1002/mrd.90015; Boediono A, 1999, MOL REPROD DEV, V53, P159, DOI 10.1002/(SICI)1098-2795(199906)53:2&lt;159::AID-MRD5&gt;3.0.CO;2-X; Boiani M, 2003, EMBO J, V22, P5304, DOI 10.1093/emboj/cdg507; Brandao DO, 2004, BIOL REPROD, V71, P2048, DOI 10.1095/biolreprod.103.025916; Choi YH, 2013, THERIOGENOLOGY, V79, P791, DOI 10.1016/j.theriogenology.2012.12.005; Choi YH, 2009, CLONING STEM CELLS, V11, P301, DOI 10.1089/clo.2008.0077; Eckardt S, 2004, ANIM REPROD SCI, V82-3, P97, DOI 10.1016/j.anireprosci.2004.04.017; FISCHER B, 1991, ANAT EMBRYOL, V183, P17; Galli C, 2003, NATURE, V424, P635, DOI 10.1038/424635a; Gambini A, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.098855; Gopichandran N, 2006, REPRODUCTION, V131, P269, DOI 10.1530/rep.1.00677; Hao YH, 2003, BIOL REPROD, V69, P501, DOI 10.1095/biolreprod.103.016170; Hardy K, 1997, MOL HUM REPROD, V3, P919, DOI 10.1093/molehr/3.10.919; Hardy K, 2003, BIOL REPROD, V68, P1165, DOI 10.1095/biolreprod.102.010090; He Wenteng, 2013, Genomics Proteomics & Bioinformatics, V11, P327, DOI 10.1016/j.gpb.2013.09.007; HILLMAN N, 1972, J EMBRYOL EXP MORPH, V28, P263; Hinrichs K, 2007, REPRODUCTION, V134, P319, DOI 10.1530/REP-07-0069; Hinrichs K, 2006, REPRODUCTION, V131, P1063, DOI 10.1530/rep.1.01095; Hiriart MI, 2013, THERIOGENOLOGY, V80, P357, DOI 10.1016/j.theriogenology.2013.04.023; Hoelker M, 2009, REPRODUCTION, V137, P415, DOI 10.1530/REP-08-0370; Johnson AK, 2010, JAVMA-J AM VET MED A, V236, P983, DOI 10.2460/javma.236.9.983; Kurosaka S, 2007, CLONING STEM CELLS, V9, P630, DOI 10.1089/clo.2007.0015; Lagutina I, 2005, REPRODUCTION, V130, P559, DOI 10.1530/rep.1.00772; Lagutina I, 2007, THERIOGENOLOGY, V67, P90, DOI 10.1016/j.theriogenology.2006.09.011; Lee SG, 2007, MOL REPROD DEV, V74, P1436, DOI 10.1002/mrd.20728; Levy RR, 2001, MARC MALPIG SYMP SER, V8, P101; LEWIS NE, 1982, J EMBRYOL EXP MORPH, V72, P169; Li J, 2013, ZYGOTE, V15, P1; Machado GM, 2013, MOL REPROD DEV, V80, P936, DOI 10.1002/mrd.22230; Machado GM, 2013, REPROD FERT DEVELOP, V25, P600, DOI 10.1071/RD11282; Maddox-Hyttel P, 2003, REPRODUCTION, P103; Melka MG, 2010, REPROD DOMEST ANIM, V45, P915, DOI 10.1111/j.1439-0531.2009.01463.x; Misica-Turner PA, 2007, BIOL REPROD, V76, P268, DOI 10.1095/biolreprod.106.050922; Moussa M, 2004, THERIOGENOLOGY, V61, P921, DOI 10.1016/S0093-691X(03)00280-2; Nakano K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061900; Oback B, 2008, REPROD DOMEST ANIM, V43, P407, DOI 10.1111/j.1439-0531.2008.01192.x; Ohtsuka M, 2012, CELL TISSUE RES, V350, P251, DOI 10.1007/s00441-012-1470-0; Pedersen HG, 2005, MOL CELL ENDOCRINOL, V234, P137, DOI 10.1016/j.mce.2004.08.016; PETTERS RM, 1984, THERIOGENOLOGY, V22, P167, DOI 10.1016/0093-691X(84)90429-1; Pomar FJR, 2005, THERIOGENOLOGY, V63, P2254, DOI 10.1016/j.theriogenology.2004.10.015; RANDS GF, 1986, J EMBRYOL EXP MORPH, V94, P139; Ribeiro ED, 2009, CLONING STEM CELLS, V11, P377, DOI 10.1089/clo.2009.0022; Sananmuang T, 2013, J REPROD DEVELOP, V59, P180, DOI 10.1262/jrd.2012-116; Sancho M, 2013, DEV CELL, V26, P19, DOI 10.1016/j.devcel.2013.06.012; Shan ZY, 2012, DEV GROWTH DIFFER, V54, P481, DOI 10.1111/j.1440-169X.2012.01335.x; Siriboon C, 2014, REPROD FERT DEVELOP, V26, P395, DOI 10.1071/RD12243; Taka M, 2005, J REPROD DEVELOP, V51, P533, DOI 10.1262/jrd.17005; Tecirlioglu RT, 2005, REPROD FERT DEVELOP, V17, P573, DOI 10.1071/RD04122; Terashita Y, 2011, REPROD DOMEST ANIM, V46, P189, DOI 10.1111/j.1439-0531.2010.01614.x; Tremoleda JL, 2003, BIOL REPROD, V69, P1895, DOI 10.1095/biolreprod.103.018515; Vajta G, 2000, ANIM REPROD SCI, V60, P357, DOI 10.1016/S0378-4320(00)00097-X; Vajta G, 2000, MOL REPROD DEV, V55, P256, DOI 10.1002/(SICI)1098-2795(200003)55:3&lt;256::AID-MRD3&gt;3.0.CO;2-7; Vejlsted M, 2006, THERIOGENOLOGY, V65, P153, DOI 10.1016/j.theriogenology.2005.09.021; Woods GL, 2003, SCIENCE, V301, P1063, DOI 10.1126/science.1086743; Yang FK, 2007, REPRODUCTION, V133, P219, DOI 10.1530/rep.1.01206; Zhou WL, 2008, MOL REPROD DEV, V75, P1281, DOI 10.1002/mrd.20875	61	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e110998	10.1371/journal.pone.0110998	http://dx.doi.org/10.1371/journal.pone.0110998			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396418	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500012
J	He, C; O'Halloran, DM				He, Chao; O'Halloran, Damien M.			Analysis of the Na+/Ca2+ Exchanger Gene Family within the Phylum Nematoda	PLOS ONE			English	Article							BEST-FIT MODELS; NA+-CA2+ EXCHANGER; PROTEIN EVOLUTION; ADULT-RAT; NCX1; CA2+; K+; MECHANISM; SELECTION; ISOFORMS	Na+/Ca2+ exchangers are low affinity, high capacity transporters that rapidly transport calcium at the plasma membrane, mitochondrion, endoplasmic (and sarcoplasmic) reticulum, and the nucleus. Na+/Ca2+ exchangers are widely expressed in diverse cell types where they contribute homeostatic balance to calcium levels. In animals, Na+/Ca2+ exchangers are divided into three groups based upon stoichiometry: Na+/Ca2+ exchangers (NCX), Na+/Ca2+/K+ exchangers (NCKX), and Ca2+/Cation exchangers (CCX). In mammals there are three NCX genes, five NCKX genes and one CCX (NCLX) gene. The genome of the nematode Caenorhabditis elegans contains ten Na+/Ca2+ exchanger genes: three NCX; five CCX; and two NCKX genes. Here we set out to characterize structural and taxonomic specializations within the family of Na+/Ca2+ exchangers across the phylum Nematoda. In this analysis we identify Na+/Ca2+ exchanger genes from twelve species of nematodes and reconstruct their phylogenetic and evolutionary relationships. The most notable feature of the resulting phylogenies was the heterogeneous evolution observed within exchanger subtypes. Specifically, in the case of the CCX exchangers we did not detect members of this class in three Clade III nematodes. Within the Caenorhabditis and Pristionchus lineages we identify between three and five CCX representatives, whereas in other Clade V and also Clade IV nematode taxa we only observed a single CCX gene in each species, and in the Clade III nematode taxa that we sampled we identify NCX and NCKX encoding genes but no evidence of CCX representatives using our mining approach. We also provided re-annotation for predicted CCX gene structures from Heterorhabditis bacteriophora and Caenorhabditis japonica by RT-PCR and sequencing. Together, these findings reveal a complex picture of Na+/Ca2+ transporters in nematodes that suggest an incongruent evolutionary history of proteins that provide central control of calcium dynamics.	[He, Chao; O'Halloran, Damien M.] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; [He, Chao; O'Halloran, Damien M.] George Washington Univ, Inst Neurosci, Washington, DC 20052 USA	George Washington University; George Washington University	O'Halloran, DM (corresponding author), George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA.	damienoh@gwu.edu			George Washington University (GW) Columbian College of Arts and Sciences; GW Office of the Vice-President for Research; GW Department of Biological Sciences	George Washington University (GW) Columbian College of Arts and Sciences; GW Office of the Vice-President for Research; GW Department of Biological Sciences	Funding was from The George Washington University ( GW) Columbian College of Arts and Sciences, GW Office of the Vice-President for Research, and the GW Department of Biological Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altimimi HF, 2013, ADV EXP MED BIOL, V961, P81, DOI 10.1007/978-1-4614-4756-6_8; BAKER PF, 1969, J PHYSIOL-LONDON, V200, P431, DOI 10.1113/jphysiol.1969.sp008702; BLAUSTEIN MP, 1968, J GEN PHYSIOL, V51, P293, DOI 10.1085/jgp.51.3.293; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; BRENNER S, 1974, GENETICS, V77, P71; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Cai XJ, 2004, J BIOL CHEM, V279, P5867, DOI 10.1074/jbc.M310908200; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Giladi M, 2010, J BIOL CHEM, V285, P28117, DOI 10.1074/jbc.M110.127001; Gobbi P, 2007, PHARMACOL RES, V56, P556, DOI 10.1016/j.phrs.2007.10.005; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harris TW, 2014, NUCLEIC ACIDS RES, V42, pD789, DOI 10.1093/nar/gkt1063; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Jeon D, 2003, NEURON, V38, P965, DOI 10.1016/S0896-6273(03)00334-9; Kang KJ, 2005, J BIOL CHEM, V280, P6834, DOI 10.1074/jbc.M412933200; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kiontke K, 2002, NEMATOLOGY, V4, P933, DOI 10.1163/156854102321122557; Kovacs R, 2005, J NEUROSCI, V25, P4260, DOI 10.1523/JNEUROSCI.4000-04.2005; Lee SH, 2002, J NEUROSCI, V22, P6891; LEVESQUE PC, 1991, ANN NY ACAD SCI, V639, P386, DOI 10.1111/j.1749-6632.1991.tb17327.x; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; LI ZP, 1994, J BIOL CHEM, V269, P17434; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liebich I, 2002, NUCLEIC ACIDS RES, V30, P372, DOI 10.1093/nar/30.1.372; Lytton J, 2002, ANN NY ACAD SCI, V976, P382; Marshall CR, 2005, PHYSIOL GENOMICS, V21, P161, DOI 10.1152/physiolgenomics.00286.2004; Martin J, 2012, NUCLEIC ACIDS RES, V40, pD720, DOI 10.1093/nar/gkr1194; Minelli A, 2007, CELL CALCIUM, V41, P221, DOI 10.1016/j.ceca.2006.06.004; Molinaro P, 2013, ADV EXP MED BIOL, V961, P213, DOI 10.1007/978-1-4614-4756-6_18; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Nicoll DA, 1996, J BIOL CHEM, V271, P24914, DOI 10.1074/jbc.271.40.24914; Nita II, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046649; O'Halloran D, 2014, JOVE-J VIS EXP, DOI 10.3791/50975; O'Halloran DM, 2003, PARASITOLOGY, V127, P375, DOI 10.1017/S0031182003003688; O'Leary SA, 1998, J PARASITOL, V84, P665, DOI 10.2307/3284567; On C, 2009, AM J PHYSIOL-CELL PH, V296, pC173, DOI 10.1152/ajpcell.00455.2008; On C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-127; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Palty R, 2012, J BIOL CHEM, V287, P31650, DOI 10.1074/jbc.R112.355867; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Pannaccione A, 2012, J NEUROSCI, V32, P10609, DOI 10.1523/JNEUROSCI.6429-11.2012; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Quednau BD, 1997, AM J PHYSIOL-CELL PH, V272, pC1250, DOI 10.1152/ajpcell.1997.272.4.C1250; Ren XY, 2013, J MOL CELL CARDIOL, V57, P68, DOI 10.1016/j.yjmcc.2013.01.010; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Schulze DH, 2002, ANN NY ACAD SCI, V976, P187; Sharma V, 2014, GENESIS, V52, P93, DOI 10.1002/dvg.22735; Sharma V, 2013, GENETICS, V195, P611, DOI 10.1534/genetics.113.153106; Shu XD, 2007, DEVELOPMENT, V134, P1921, DOI 10.1242/dev.02851; Sisalli MJ, 2014, CELL DEATH DIFFER, V21, P1142, DOI 10.1038/cdd.2014.32; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; WHITE G. F., 1927, SCIENCE, V66, P302, DOI 10.1126/science.66.1709.302-a; Wood-Kaczmar A, 2013, ADV EXP MED BIOL, V961, P241, DOI 10.1007/978-1-4614-4756-6_20; WOODRING JL, 1998, SOUTHERN COOPERATIVE; Wu MS, 2010, J BIOL CHEM, V285, P2554, DOI 10.1074/jbc.M109.059162; Wu MS, 2009, J MOL BIOL, V387, P104, DOI 10.1016/j.jmb.2009.01.045; Yang H, 2010, MOL REPROD DEV, V77, P971, DOI 10.1002/mrd.21245	65	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112841	10.1371/journal.pone.0112841	http://dx.doi.org/10.1371/journal.pone.0112841			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397810	gold, Green Submitted, Green Published			2022-12-27	WOS:000345558500098
J	Liu, H; Liang, JP; Li, PB; Peng, W; Peng, YY; Zhang, GM; Xie, CS; Long, CF; Su, WW				Liu, Hong; Liang, Jie-ping; Li, Pei-bo; Peng, Wei; Peng, Yao-yao; Zhang, Gao-min; Xie, Cheng-shi; Long, Chao-feng; Su, Wei-wei			Core Bioactive Components Promoting Blood Circulation in the Traditional Chinese Medicine Compound Xueshuantong Capsule (CXC) Based on the Relevance Analysis between Chemical HPLC Fingerprint and In Vivo Biological Effects	PLOS ONE			English	Article							GREY RELATIONAL ANALYSIS; GINSENOSIDE-RD; CELLS; COAGULATION; RECEPTOR; FLOW	Compound xueshuantong capsule (CXC) is an oral traditional Chinese herbal formula (CHF) comprised of Panax notoginseng (PN), Radix astragali (RA), Salvia miltiorrhizae (SM), and Radix scrophulariaceae (RS). The present investigation was designed to explore the core bioactive components promoting blood circulation in CXC using high-performance liquid chromatography (HPLC) and animal studies. CXC samples were prepared with different proportions of the 4 herbs according to a four-factor, nine-level uniform design. CXC samples were assessed with HPLC, which identified 21 components. For the animal experiments, rats were soaked in ice water during the time interval between two adrenaline hydrochloride injections to reduce blood circulation. We assessed whole-blood viscosity (WBV), erythrocyte aggregation and red corpuscle electrophoresis indices (EAI and RCEI, respectively), plasma viscosity (PV), maximum platelet aggregation rate (MPAR), activated partial thromboplastin time (APTT), and prothrombin time (PT). Based on the hypothesis that CXC sample effects varied with differences in components, we performed grey relational analysis (GRA), principal component analysis (PCA), ridge regression (RR), and radial basis function (RBF) to evaluate the contribution of each identified component. Our results indicate that panaxytriol, ginsenoside Rb1, angoroside C, protocatechualdehyde, ginsenoside Rd, and calycosin-7-O-beta-D-glucoside are the core bioactive components, and that they might play different roles in the alleviation of circulation dysfunction. Panaxytriol and ginsenoside Rb1 had close relevance to red blood cell (RBC) aggregation, angoroside C was related to platelet aggregation, protocatechualdehyde was involved in intrinsic clotting activity, ginsenoside Rd affected RBC deformability and plasma proteins, and calycosin-7-O-beta-D-glucoside influenced extrinsic clotting activity. This study indicates that angoroside C, calycosin-7-O-beta-D-glucoside, panaxytriol, and protocatechualdehyde may have novel therapeutic uses.	[Liu, Hong; Liang, Jie-ping; Li, Pei-bo; Peng, Wei; Peng, Yao-yao; Zhang, Gao-min; Su, Wei-wei] Sun Yat Sen Univ, Sch Life Sci, Guangdong Key Lab Plant Resources, Guangzhou Qual R&D Ctr Tradit Chinese Med, Guangzhou 510275, Guangdong, Peoples R China; [Xie, Cheng-shi; Long, Chao-feng] Guangdong Zhongsheng Pharmaceut Co Ltd, Dongguan, Peoples R China	Sun Yat Sen University	Su, WW (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangdong Key Lab Plant Resources, Guangzhou Qual R&D Ctr Tradit Chinese Med, Guangzhou 510275, Guangdong, Peoples R China.	lsssww@126.com	su, wei/GZM-3986-2022	Liu, Hong/0000-0002-7320-0260	National Science and Technology Major Projects of Significant Drug Discovery of China [2011ZX09201-201-22]; Science and Technology Project for Medical and Health Units of Dongguan city [2012105102004]	National Science and Technology Major Projects of Significant Drug Discovery of China; Science and Technology Project for Medical and Health Units of Dongguan city	This work is financially supported by the National Science and Technology Major Projects of Significant Drug Discovery of China (No 2011ZX09201-201-22), and Science and Technology Project for Medical and Health Units of Dongguan city (No 2012105102004). Guangdong Zhongsheng Pharmaceutical Co., Ltd., provided support in the form of the supply of 4 herbs (PN, RA, SM, and RS), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj SP, 1999, SEMIN THROMB HEMOST, V25, P407, DOI 10.1055/s-2007-994943; Bensky D, 2004, CHINESE HERBAL MED M, P265; Chen Q., 2006, TRADITIONAL CHINESE; Chiu CC, 2002, COMPUT METH PROG BIO, V69, P1, DOI 10.1016/S0169-2607(01)00181-X; Diaz AM, 2004, LIFE SCI, V74, P2515, DOI 10.1016/j.lfs.2003.10.008; Fan Y, 2003, EUR J PHARMACOL, V481, P33, DOI 10.1016/j.ejphar.2003.09.007; GACHET C, 1991, NOUV REV FR HEMATOL, V33, P347; Guan YY, 2006, EUR J PHARMACOL, V548, P129, DOI 10.1016/j.ejphar.2006.08.001; He F Y, 2004, WORLD SCI TECHNOL MO, V6, P44; He XQ, 2011, APPL REGRESSION ANAL, P169; Kamal AH, 2007, MAYO CLIN PROC, V82, P864, DOI 10.4065/82.7.864; Kesmarky G, 2006, CLIN HEMORHEOL MICRO, V35, P67; Kim YS, 2007, EUR J PHARMACOL, V569, P171, DOI 10.1016/j.ejphar.2007.05.054; Kong WJ, 2011, FOOD CHEM, V127, P1342, DOI 10.1016/j.foodchem.2011.01.095; Kuo Y, 2008, COMPUT IND ENG, V55, P80, DOI 10.1016/j.cie.2007.12.002; Li J, 2011, EUR J PHARMACOL, V652, P104, DOI 10.1016/j.ejphar.2010.11.017; Li R, 2002, J ED CHINESE MED, V21, P62; Liang JP, 2012, J CHINESE MED MAT, V35, P146; Liang YZ, 2001, CHEMOMETR INTELL LAB, V58, P43, DOI 10.1016/S0169-7439(01)00139-3; Liu L, 2012, J ETHNOPHARMACOL, V139, P381, DOI 10.1016/j.jep.2011.11.016; Lu HM, 2006, CHEM PHARM BULL, V54, P725, DOI 10.1248/cpb.54.725; Mchedlishvili G, 1998, CLIN HEMORHEOL MICRO, V19, P315; Ng F, 2008, TETRAHEDRON LETT, V49, P7178, DOI 10.1016/j.tetlet.2008.09.169; Ngo SH, 2003, CHEMOMETR INTELL LAB, V67, P69, DOI 10.1016/S0169-7439(03)00062-5; Ning LiLi, 2000, Acta Pharmaceutica Sinica, V35, P131; Normile D, 2003, SCIENCE, V299, P188, DOI 10.1126/science.299.5604.188; QIN R, 1999, HEMORRHEOLOGY, P45; Qu N, 2007, EUR J PHARM SCI, V31, P156, DOI 10.1016/j.ejps.2007.03.006; Shao ML, 2010, PHARM PEOPLES REPUBL, P909; Shibahara N, 1996, J AUTONOM NERV SYST, V61, P109, DOI 10.1016/S0165-1838(96)00065-3; Song QB, 2011, EXPERT SYST APPL, V38, P7302, DOI 10.1016/j.eswa.2010.12.005; Sun K, 2007, LIFE SCI, V81, P509, DOI 10.1016/j.lfs.2007.06.008; Thrall G, 2005, THROMB RES, V115, P171, DOI 10.1016/j.thromres.2004.08.021; Tian Y, 2010, J ETHNOPHARMACOL, V129, P1, DOI 10.1016/j.jep.2010.02.023; Tziakas DN, 2007, ATHEROSCLEROSIS, V193, P196, DOI 10.1016/j.atherosclerosis.2006.06.016; Wang XC, 1989, APPL GREY SYSTEM MOD, P1; Wen ZY, 2000, CLIN HEMORHEOL MICRO, V23, P51; [肖小河 XIAO Xiao-he], 2010, [中草药, Chinese Traditional and Herbal Drugs], V41, P505; Xue TH, 2003, SCIENCE, V300, P740, DOI 10.1126/science.300.5620.740; Ye RD, 2011, NEUROPHARMACOLOGY, V61, P815, DOI 10.1016/j.neuropharm.2011.05.029; Ye RD, 2011, NEUROCHEM INT, V58, P391, DOI 10.1016/j.neuint.2010.12.015; Yu DH, 2009, BIOMED ENVIRON SCI, V22, P50, DOI 10.1016/S0895-3988(09)60022-2	42	15	23	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112675	10.1371/journal.pone.0112675	http://dx.doi.org/10.1371/journal.pone.0112675			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396725	Green Submitted, gold, Green Published			2022-12-27	WOS:000345558500075
J	Matas, E; Bau, L; Martinez-Iniesta, M; Romero-Pinel, L; Mane, MA; Cobo-Calvo, A; Martinez-Yelamos, S				Matas, Elisabet; Bau, Laura; Martinez-Iniesta, Maria; Romero-Pinel, Lucia; Alba Mane, M.; Cobo-Calvo, Alvaro; Martinez-Yelamos, Sergio			Baseline MxA mRNA Expression Predicts Interferon Beta Response in Multiple Sclerosis Patients	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; THERAPY; SIGNATURE; MULTICENTER; DISABILITY; RELEVANCE; EFFICACY; CRITERIA; MS	Background: Myxovirus resistance protein A (MxA) is a molecule induced after interferon-beta injection, mostly used to evaluate its bioactivity. There is little available data on clinical utility of baseline MxA mRNA status. The objective of the study is to investigate whether baseline MxA mRNA expression can predict relapse and disease progression in multiple sclerosis patients treated with interferon-beta. Methods: Baseline blood samples were obtained before the first interferon-beta dose was administered to evaluate MxA mRNA expression using real-time polymerase chain reaction (PCR). Demographic and clinical variables were prospectively recorded to define treatment responder and non responder groups. Results: 104 patients were included in the study. Baseline MxA mRNA expression was significantly lower in the group of patients who met the definition of responders (1.07 vs 1.95, Student t test, p<0.0001). A threshold of 1.096 was established using Receiver Operating Characteristic analysis to differentiate between responders and non-responders (sensitivity 73.9%, specificity 69.0%). Survival analysis using this threshold showed that time to next relapse (p<0.0001) and to EDSS progression (p = 0.01) were significantly higher in patients with lower MxA titers. Conclusion: The results suggest that baseline MxA mRNA levels may be useful for predicting whether multiple sclerosis patients will respond or not to interferon-beta treatment.	[Matas, Elisabet; Bau, Laura; Romero-Pinel, Lucia; Alba Mane, M.; Cobo-Calvo, Alvaro; Martinez-Yelamos, Sergio] Hosp Univ Bellvitge IDIBELL, Dept Neurol, Multiple Sclerosis Unit, Barcelona, Spain; [Martinez-Iniesta, Maria] Inst Catala Oncol IDIBELL, Translat Res Lab, Barcelona, Spain; [Alba Mane, M.] Univ Rovira & Virgili, Dept Neurol, Joan Univ Hosp 23, E-43007 Tarragona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Universitat Rovira i Virgili	Matas, E (corresponding author), Hosp Univ Bellvitge IDIBELL, Dept Neurol, Multiple Sclerosis Unit, Barcelona, Spain.	ematas@bellvitgehospital.cat	ROMERO-PINEL, Lucia/ABH-3560-2020; VILA, Laura BAU/ABH-3568-2020; MARTÍNEZ-YÉLAMOS, Sergio/ABH-3087-2020; MARTÍN, Elisabet MATAS/ABH-3565-2020	Romero Pinel, Lucia/0000-0001-8054-0565; MARTINEZ YELAMOS, SERGIO/0000-0001-9889-2040; Cobo-Calvo, Alvaro/0000-0002-2574-0721; Martinez-Iniesta, Maria/0000-0001-6252-6671	Convenio de Investigacion, Dep. de Salut, Generalitat de Catalunya [352/05]	Convenio de Investigacion, Dep. de Salut, Generalitat de Catalunya	This work was supported by the Convenio de Investigacion, Dep. de Salut, Generalitat de Catalunya (grant number 352/05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Bertolotto A, 2001, J IMMUNOL METHODS, V256, P141, DOI 10.1016/S0022-1759(01)00434-3; Comabella M, 2009, BRAIN, V132, P3353, DOI 10.1093/brain/awp228; CONFAVREUX C, 1992, J NEUROL NEUROSUR PS, V55, P671, DOI 10.1136/jnnp.55.8.671; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Feng X, 2002, J NEUROIMMUNOL, V129, P205, DOI 10.1016/S0165-5728(02)00182-0; Francis G, 2001, NEUROLOGY, V56, P1628; Hesse D, 2007, MULT SCLER, V13, pS37; Hesse D, 2009, NEUROLOGY, V73, P372, DOI 10.1212/WNL.0b013e3181b04c98; Hundeshagen A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-140; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Malucchi S, 2008, NEUROLOGY, V70, P1119, DOI 10.1212/01.wnl.0000304040.29080.7b; Malucchi S, 2011, J NEUROL, V258, P895, DOI 10.1007/s00415-010-5844-5; PATY DW, 1993, NEUROLOGY, V43, P662, DOI 10.1212/WNL.43.4.662; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Rio J, 2002, ANN NEUROL, V52, P400, DOI 10.1002/ana.10290; Rudick RA, 1997, NEUROLOGY, V49, P358, DOI 10.1212/WNL.49.2.358; Rudick RA, 2004, ANN NEUROL, V56, P548, DOI 10.1002/ana.20224; SCHUMACHER GA, 1965, ANN NY ACAD SCI, V122, P552; Serana F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094794; Sominanda A, 2008, J NEUROL NEUROSUR PS, V79, P57, DOI 10.1136/jnnp.2007.122549; Sominanda A, 2007, MULT SCLER, V13, P208, DOI 10.1177/1352458506070762; Sottini A., 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P14; van Baarsen LGM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001927; van der Voort LF, 2010, NEUROLOGY, V75, P1228, DOI 10.1212/WNL.0b013e3181f6c556; Verweij CL, 2013, DISCOV MED, V15, P51	28	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112758	10.1371/journal.pone.0112758	http://dx.doi.org/10.1371/journal.pone.0112758			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396411	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558500088
J	Wales, KM; Kavazos, K; Nataatmadja, M; Brooks, PR; Williams, C; Russell, FD				Wales, Kathryn M.; Kavazos, Kristyn; Nataatmadja, Maria; Brooks, Peter R.; Williams, Chloe; Russell, Fraser D.			N-3 PUFAs Protect against Aortic Inflammation and Oxidative Stress in Angiotensin II-Infused Apolipoprotein E-/- Mice	PLOS ONE			English	Article							RESOLVIN D1; ACID SUPPLEMENTATION; RANDOMIZED-TRIAL; RISK-FACTORS; FATTY-ACID; RESOLUTION; ANEURYSMS; CIRCUITS; OMEGA-3-FATTY-ACIDS; ATHEROSCLEROSIS	Abdominal aortic aneurysm is associated with infiltration of inflammatory cells into the aortic wall. The inflammatory response is also evident in animal models, such as apolipoprotein E-deficient (ApoE(-/-)) mice that have been infused with angiotensin II, prior to development of aortic aneurysm. Since omega-3 polyunsaturated fatty acids (n-3 PUFAs) and their metabolites have anti-inflammatory and pro-resolving activity, we hypothesised that dietary supplementation with n-3 PUFAs would protect against inflammatory processes in this mouse model. Twenty C57 and 20 ApoE(-/-) 3-4 week old male mice were supplemented with a low (0.14%, n = 10/group) or high (0.70%, n = 10/group) n-3 PUFA diet for 8 weeks before 2-day infusion with 0.9% saline or angiotensin II (1000 ng/kg/min). Four ApoE(-/-) mice on the low n-3 PUFA diet and none of the ApoE(-/-) mice on the high n-3 PUFA diet showed morphological evidence of abdominal aortic dissection. The plasma concentration of the n-3 PUFA metabolite, resolvin D1 was higher in angiotensin II-infused ApoE(-/-) mice fed the high, compared to the low n-3 PUFA diet. The number of neutrophils and macrophages infiltrating the abdominal aorta was elevated in ApoE(-/-) mice on the low n-3 PUFA diet, and this was significantly attenuated in mice that were fed the high n-3 PUFA diet. Most neutrophils and macrophages were associated with dissected aortas. Immunoreactivity of the catalytic subunit of nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase, Nox2, and superoxide were elevated in ApoE(-/-) mice that were fed the low n-3 PUFA diet, and this was also significantly attenuated in mice that were fed the high n-3 PUFA diet. Together, the findings indicate that supplementation of ApoE(-/-) mice with a diet high in n-3 PUFA content protected the mice against pro-inflammatory and oxidative stress responses following short-term infusion with angiotensin II.	[Wales, Kathryn M.; Kavazos, Kristyn; Brooks, Peter R.; Williams, Chloe; Russell, Fraser D.] Univ Sunshine Coast, Sch Hlth & Sport Sci, Inflammat & Healing Res Cluster, Maroochydore, Qld, Australia; [Nataatmadja, Maria] Univ Queensland, Prince Charles Hosp, Dept Med, Cardiovasc Res Grp, Herston, Qld, Australia	University of the Sunshine Coast; Prince Charles Hospital; University of Queensland	Russell, FD (corresponding author), Univ Sunshine Coast, Sch Hlth & Sport Sci, Inflammat & Healing Res Cluster, Maroochydore, Qld, Australia.	FRussell@usc.edu.au	Nataatmadja, Maria/F-6338-2010	Russell, Fraser/0000-0001-8396-4558; Wales, Kathryn/0000-0002-7164-4140; Brooks, Peter/0000-0003-4915-4986	Faculty Seed Grant	Faculty Seed Grant	This study was funded by a Faculty Seed Grant to FR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel A, 2007, TRENDS IMMUNOL, V28, P176, DOI 10.1016/j.it.2007.02.007; Blasbalg TL, 2011, AM J CLIN NUTR, V93, P950, DOI 10.3945/ajcn.110.006643; Cao J, 2006, CLIN CHEM, V52, P2265, DOI 10.1373/clinchem.2006.072322; Chavis C, 1996, J EXP MED, V183, P1633, DOI 10.1084/jem.183.4.1633; Daugherty A, 2008, FUTURE LIPIDOL, V3, P625, DOI 10.2217/17460875.3.6.625; Duffield JS, 2006, J IMMUNOL, V177, P5902, DOI 10.4049/jimmunol.177.9.5902; Eliason JL, 2005, CIRCULATION, V112, P232, DOI 10.1161/CIRCULATIONAHA.104.517391; Garrido AM, 2009, MOL CELL ENDOCRINOL, V302, P148, DOI 10.1016/j.mce.2008.11.003; Geppert J, 2005, LIPIDS, V40, P807, DOI 10.1007/s11745-005-1442-9; Givens DI, 2008, P NUTR SOC, V67, P273, DOI 10.1017/S0029665108007167; Guzik B, 2013, INT J CARDIOL, V168, P2389, DOI 10.1016/j.ijcard.2013.01.278; Howe P, 2006, NUTRITION, V22, P47, DOI 10.1016/j.nut.2005.05.009; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Kurihara T, 2012, CIRCULATION, V126, P3070, DOI 10.1161/CIRCULATIONAHA.112.097097; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Mas E, 2012, CLIN CHEM, V58, P1476, DOI 10.1373/clinchem.2012.190199; Nogi A, 2007, J OCCUP HEALTH, V49, P205, DOI 10.1539/joh.49.205; Norling LV, 2012, ARTERIOSCLER THROMB, V32, P1; Nobre MEP, 2013, NUTR RES, V33, P422, DOI 10.1016/j.nutres.2013.02.011; Plourde M, 2007, APPL PHYSIOL NUTR ME, V32, P619, DOI 10.1139/H07-034; Ramos-Mozo P, 2011, ARTERIOSCL THROM VAS, V31, P3011, DOI 10.1161/ATVBAHA.111.237537; Recchiuti A, 2013, PROSTAG OTH LIPID M, V107, P64, DOI 10.1016/j.prostaglandins.2013.02.004; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Root M, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-40; Russell FD, 2012, MAR DRUGS, V10, P2535, DOI 10.3390/md10112535; Saraff K, 2003, ARTERIOSCL THROM VAS, V23, P1621, DOI 10.1161/01.ATV.0000085631.76095.64; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Sun YP, 2007, J BIOL CHEM, V282, P9323, DOI 10.1074/jbc.M609212200; Tjonahen E, 2006, CHEM BIOL, V13, P1193, DOI 10.1016/j.chembiol.2006.09.011; Wang YH, 2012, AGING CELL, V11, P410, DOI 10.1111/j.1474-9726.2012.00796.x; Zhou RH, 2012, ARTERIOSCL THROM VAS, V32, P745, DOI 10.1161/ATVBAHA.111.243121	33	26	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112816	10.1371/journal.pone.0112816	http://dx.doi.org/10.1371/journal.pone.0112816			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398022	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558500093
J	Ahn, SJ; Shin, HJ; Chang, JH; Lee, SK				Ahn, Sung Jun; Shin, Hyun Joo; Chang, Jong-Hee; Lee, Seung-Koo			Differentiation between Primary Cerebral Lymphoma and Glioblastoma Using the Apparent Diffusion Coefficient: Comparison of Three Different ROI Methods	PLOS ONE			English	Article							PRIMARY CNS LYMPHOMA; MULTIFORME; PERFUSION; REGION; TUMORS	Objective: Apparent diffusion coefficients (ADC) can help differentiate between central nervous system (CNS) lymphoma and Glioblastoma (GBM). However, overlap between ADCs for GBM and lymphoma have been reported because of various region of interest (ROI) methods. Our aim is to explore ROI method to provide the most reproducible results for differentiation. Materials and Methods: We studied 25 CNS lymphomas and 62 GBMs with three ROI methods: (1) ROI1, whole tumor volume; (2) ROI2, multiple ROIs; and (3) ROI3, a single ROI. Interobserver variability of two readers for each method was analyzed by intraclass correlation(ICC). ADCs were compared between GBM and lymphoma, using two-sample t-test. The discriminative ability was determined by ROC analysis. Results: ADCs from ROI1 showed most reproducible results (ICC >0.9). For ROI1, ADC(mean) for lymphoma showed significantly lower values than GBM (p = 0.03). The optimal cut-off value was 0.98x10(-3) mm(2)/s with 85% sensitivity and 90% specificity. For ROI2, ADC(min) for lymphoma was significantly lower than GBM (p = 0.02). The cut-off value was 0.69x10(-3) mm(2)/s with 87% sensitivity and 88% specificity. Conclusion: ADC values were significantly dependent on ROI method. ADCs from the whole tumor volume had the most reproducible results. ADC(mean) from the whole tumor volume may aid in differentiating between lymphoma and GBM. However, multi-modal imaging approaches are recommended than ADC alone for differentiation.	[Ahn, Sung Jun; Shin, Hyun Joo; Lee, Seung-Koo] Yonsei Univ, Coll Med, Severance Hosp, Dept Radiol, Seoul 120752, South Korea; [Chang, Jong-Hee] Yonsei Univ, Coll Med, Dept Neurosurg, Seoul 120752, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, SK (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Radiol, Seoul 120752, South Korea.	slee@yuhs.ac		Ahn, Sung Jun/0000-0003-0075-2432; Lee, Seung-Koo/0000-0001-5646-4072; Chang, Jong Hee/0000-0003-1509-9800; Shin, Hyun Joo/0000-0002-7462-2609				Al-Okaili RN, 2007, RADIOLOGY, V243, P539, DOI 10.1148/radiol.2432060493; Batchelor T, 2006, J CLIN ONCOL, V24, P1281, DOI 10.1200/JCO.2005.04.8819; Batra A, 2004, Australas Radiol, V48, P388, DOI 10.1111/j.0004-8461.2004.01324.x; Calli C, 2006, EUR J RADIOL, V58, P394, DOI 10.1016/j.ejrad.2005.12.032; Cha S, 2006, AM J NEURORADIOL, V27, P475; Chalian H, 2012, RADIOLOGY, V262, P853, DOI 10.1148/radiol.11110106; Doskaliyev A, 2012, EUR J RADIOL, V81, P339, DOI 10.1016/j.ejrad.2010.11.005; Giese A, 2001, J CANCER RES CLIN, V127, P217, DOI 10.1007/s004320000188; Goh V, 2008, RADIOLOGY, V247, P726, DOI 10.1148/radiol.2473070414; Haldorsen IS, 2011, AM J NEURORADIOL, V32, P984, DOI 10.3174/ajnr.A2171; Huang BC, 2010, J INT MED RES, V38, P686, DOI 10.1177/147323001003800233; Kang Y, 2011, RADIOLOGY, V261, P882, DOI 10.1148/radiol.11110686; Kickingereder P, 2014, AM J NEURORADIOL, V35, P1503, DOI 10.3174/ajnr.A3915; Kickingereder P, 2014, RADIOLOGY, V272, P843, DOI 10.1148/radiol.14132740; Kim HS, 2009, AM J NEURORADIOL, V30, P1574, DOI 10.3174/ajnr.A1635; Lambregts DMJ, 2011, EUR RADIOL, V21, P2567, DOI 10.1007/s00330-011-2220-5; Liao WH, 2009, ACTA RADIOL, V50, P217, DOI 10.1080/02841850802616752; Makino K, 2011, ANN NUCL MED, V25, P432, DOI 10.1007/s12149-011-0483-1; Rees JH, 1996, RADIOGRAPHICS, V16, P1413, DOI 10.1148/radiographics.16.6.8946545; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Surawicz T S, 1999, Neuro Oncol, V1, P14, DOI 10.1093/neuonc/1.1.14; Toh CH, 2008, AM J NEURORADIOL, V29, P471, DOI 10.3174/ajnr.A0872; Toh CH, 2006, J NEUROSURG, V105, P132, DOI 10.3171/jns.2006.105.1.132; Tozer DJ, 2007, NMR BIOMED, V20, P49, DOI 10.1002/nbm.1091; Yamasaki F, 2005, RADIOLOGY, V235, P985, DOI 10.1148/radiol.2353031338; Yamashita K, 2013, NEURORADIOLOGY, V55, P135, DOI 10.1007/s00234-012-1089-6	26	41	46	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112948	10.1371/journal.pone.0112948	http://dx.doi.org/10.1371/journal.pone.0112948			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393543	Green Published, gold, Green Submitted			2022-12-27	WOS:000347709300126
J	Gu, HF; Nie, YX; Tong, QZ; Tang, YL; Zeng, Y; Jing, KQ; Zheng, XL; Liao, DF				Gu, Hong-Feng; Nie, Ya-Xiong; Tong, Qiao-Zhen; Tang, Ya-Ling; Zeng, Yang; Jing, Kai-Quan; Zheng, Xi-Long; Liao, Duan-Fang			Epigallocatechin-3-Gallate Attenuates Impairment of Learning and Memory in Chronic Unpredictable Mild Stress-Treated Rats by Restoring Hippocampal Autophagic Flux	PLOS ONE			English	Article							ALZHEIMERS-DISEASE MODEL; NEURODEGENERATIVE DISEASES; TRANSGENIC MICE; MOUSE MODEL; TAU PATHOLOGY; EGCG; CELLS; GALLATE; DEFICITS; ACCUMULATION	Epigallocatechin gallate (EGCG) is a major polyphenol in green tea with beneficial effects on the impairment in learning and memory. Autophagy is a cellular process that protects neurons from stressful conditions. The present study was designed to investigate whether EGCG can rescue chronic unpredictable mild stress (CUMS)-induced cognitive impairment in rats and whether its protective effect involves improvement of autophagic flux. As expected, our results showed that CUMS significantly impaired memory performance and inhibited autophagic flux as indicated by elevated LC3-II and p62 protein levels. At the same time, we observed an increased neuronal loss and activated mammalian target of rapamycin (mTOR)/p70 ribosomal protein S6 kinase (p70S6k) signaling in the CA1 regions. Interestingly, chronic treatment with EGCG (25 mg/kg, i.p.) significantly improved those behavioral alterations, attenuated histopathological abnormalities in hippocampal CA1 regions, reduced amyloid beta1-42 (A beta(1-42)) levels, and restored autophagic flux. However, blocking autophagic flux with chloroquine, an inhibitor of autophagic flux, reversed these effects of EGCG. Taken together, these findings suggest that the impaired autophagy in CA1 regions of CUMS rats may contribute to learning and memory impairment. Therefore, we conclude that EGCG attenuation of CUMS-induced learning and memory impairment may be through rescuing autophagic flux.	[Gu, Hong-Feng; Tang, Ya-Ling] Univ South China, Dept Physiol, Hengyang, Peoples R China; [Gu, Hong-Feng; Tang, Ya-Ling] Univ South China, Inst Neurosci, Hengyang, Peoples R China; [Gu, Hong-Feng; Tong, Qiao-Zhen; Zheng, Xi-Long] Hunan Univ Chinese Med, Div Stem Cell Regulat & Applicat, State Key Lab Chinese Med Powder & Med Innovat Hu, Changsha, Hunan, Peoples R China; [Nie, Ya-Xiong; Zeng, Yang; Jing, Kai-Quan] Univ South China, Dept Neurol, Affiliated Hosp 1, Hengyang, Peoples R China; [Zheng, Xi-Long; Liao, Duan-Fang] Univ Calgary, Fac Med, Smooth Muscle Res Grp, Dept Biochem & Mol Biol,Libin Cardiovasc Inst Alb, Calgary, AB, Canada	University of South China; University of South China; Hunan University of Chinese Medicine; University of South China; Libin Cardiovascular Institute Of Alberta; University of Calgary	Liao, DF (corresponding author), Univ Calgary, Fac Med, Smooth Muscle Res Grp, Dept Biochem & Mol Biol,Libin Cardiovasc Inst Alb, Calgary, AB, Canada.	dfliao66@aliyun.com		Zheng, Xi-Long/0000-0002-0889-1827	National Natural Science Foundation of China [81170278]; Nature Science Foundation of Hunan Province [08JJ3036]; construct program of the key discipline in hunan province, China (Basic Medicine Sciences in University of South China); Foundation of Hunan Educational Committee [09C835]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); construct program of the key discipline in hunan province, China (Basic Medicine Sciences in University of South China); Foundation of Hunan Educational Committee	This work was supported by grants from the National Natural Science Foundation of China (grant no. 81170278), http://www.nsfc.gov.cn/; the Nature Science Foundation of Hunan Province (08JJ3036), http://www.hnst.gov.cn/; the construct program of the key discipline in hunan province, China (Basic Medicine Sciences in University of South China), http://gov.hnedu.cn/; the Nature Science Foundation of Hunan Province (08JJ3036) and the Foundation of Hunan Educational Committee (09C835), http://gov.hnedu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25; Cai J, 2014, J NUTR BIOCHEM, V25, P716, DOI 10.1016/j.jnutbio.2014.02.012; Carroll JC, 2011, J NEUROSCI, V31, P14436, DOI 10.1523/JNEUROSCI.3836-11.2011; Castilla-Ortega E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025522; Chen D, 2012, BIOORGAN MED CHEM, V20, P3031, DOI 10.1016/j.bmc.2012.03.002; Cherra SJ, 2008, FUTUR NEUROL, V3, P309, DOI 10.2217/14796708.3.3.309; Chu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065367; Han J, 2012, AUTOPHAGY, V8, P812, DOI 10.4161/auto.19471; Hashimoto K, 2008, ANTICANCER RES, V28, P1713; Huang CH, 2009, MOL NUTR FOOD RES, V53, P1156, DOI 10.1002/mnfr.200800592; Jeong YH, 2006, FASEB J, V20, P729, DOI 10.1096/fj.05-4265fje; Jiang P, 2013, PSYCHONEUROENDOCRINO, V38, P2091, DOI 10.1016/j.psyneuen.2013.03.017; Kim HS, 2013, J BIOL CHEM, V288, P22693, DOI 10.1074/jbc.M113.477505; Koo JW, 2003, FASEB J, V17, P1556, DOI 10.1096/fj.02-1032fje; Kuang X, 2012, EUR J PHARMACOL, V676, P51, DOI 10.1016/j.ejphar.2011.11.037; Li CW, 2013, EXP BIOL MED, V238, P744, DOI 10.1177/1535370213493705; Liang JH, 2014, NEUROSCI BULL, V30, P308, DOI 10.1007/s12264-013-1418-8; Lim J, 2012, J BIOL CHEM, V287, P23271, DOI 10.1074/jbc.M112.364281; Ling DJ, 2011, ACTA NEUROPATHOL, V121, P183, DOI 10.1007/s00401-010-0772-0; Liu MY, 2014, MOL NEUROBIOL, V49, P1350, DOI 10.1007/s12035-013-8608-2; Mohammadi HS, 2014, BEHAV BRAIN RES, V270, P196, DOI 10.1016/j.bbr.2014.05.015; Murrow L, 2013, ANNU REV PATHOL-MECH, V8, P105, DOI 10.1146/annurev-pathol-020712-163918; Nassif M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-78; Nilsson P, 2013, CELL REP, V5, P61, DOI 10.1016/j.celrep.2013.08.042; Parganlija D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095288; Peairs A, 2010, CELL MOL IMMUNOL, V7, P123, DOI 10.1038/cmi.2010.1; Pervanidou P, 2010, PROG BRAIN RES, V182, P149, DOI 10.1016/S0079-6123(10)82005-9; Renna M, 2010, J BIOL CHEM, V285, P11061, DOI 10.1074/jbc.R109.072181; Rezai-Zadeh K, 2008, BRAIN RES, V1214, P177, DOI 10.1016/j.brainres.2008.02.107; Rossi M, 2009, J CELL SCI, V122, P3330, DOI 10.1242/jcs.048181; Sarkar S, 2013, BIOCHEM SOC T, V41, P1103, DOI 10.1042/BST20130134; Shinojima N, 2007, AUTOPHAGY, V3, P635, DOI 10.4161/auto.4916; Tan CC, 2014, NEUROBIOL AGING, V35, P941, DOI 10.1016/j.neurobiolaging.2013.11.019; Viscomi MT, 2012, AUTOPHAGY, V8, P222, DOI 10.4161/auto.8.2.18599; Wang P, 2013, AUTOPHAGY, V9, P604, DOI 10.4161/auto.23459; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Xie J, 2010, NEUROSCI LETT, V479, P26, DOI 10.1016/j.neulet.2010.05.020; Yang DS, 2011, AUTOPHAGY, V7, P788, DOI 10.4161/auto.7.7.15596; Yang DS, 2011, BRAIN, V134, P258, DOI 10.1093/brain/awq341; Zhou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087161; Zhu ZY, 2013, J NEUROSCI, V33, P13138, DOI 10.1523/JNEUROSCI.4790-12.2013	41	50	50	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112683	10.1371/journal.pone.0112683	http://dx.doi.org/10.1371/journal.pone.0112683			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393306	gold, Green Submitted, Green Published			2022-12-27	WOS:000347709300086
J	Miosic, S; Thill, J; Milosevic, M; Gosch, C; Pober, S; Molitor, C; Ejaz, S; Rompel, A; Stich, K; Halbwirth, H				Miosic, Silvija; Thill, Jana; Milosevic, Malvina; Gosch, Christian; Pober, Sabrina; Molitor, Christian; Ejaz, Shaghef; Rompel, Annette; Stich, Karl; Halbwirth, Heidi			Dihydroflavonol 4-Reductase Genes Encode Enzymes with Contrasting Substrate Specificity and Show Divergent Gene Expression Profiles in Fragaria Species	PLOS ONE			English	Article							FRUIT-DEVELOPMENT; X ANANASSA; STRAWBERRY; BIOSYNTHESIS; SYNTHASE; ACHENES	During fruit ripening, strawberries show distinct changes in the flavonoid classes that accumulate, switching from the formation of flavan 3-ols and flavonols in unripe fruits to the accumulation of anthocyanins in the ripe fruits. In the common garden strawberry (Fragariaxananassa) this is accompanied by a distinct switch in the pattern of hydroxylation demonstrated by the almost exclusive accumulation of pelargonidin based pigments. In Fragaria vesca the proportion of anthocyanins showing one (pelargonidin) and two (cyanidin) hydroxyl groups within the B-ring is almost equal. We isolated two dihydroflavonol 4-reductase (DFR) cDNA clones from strawberry fruits, which show 82% sequence similarity. The encoded enzymes revealed a high variability in substrate specificity. One enzyme variant did not accept DHK (with one hydroxyl group present in the B-ring), whereas the other strongly preferred DHK as a substrate. This appears to be an uncharacterized DFR variant with novel substrate specificity. Both DFRs were expressed in the receptacle and the achenes of both Fragaria species and the DFR2 expression profile showed a pronounced dependence on fruit development, whereas DFR1 expression remained relatively stable. There were, however, significant differences in their relative rates of expression. The DFR1/DFR2 expression ratio was much higher in the Fragariaxananassa and enzyme preparations from F.xananassa receptacles showed higher capability to convert DHK than preparations from F. vesca. Anthocyanin concentrations in the F.xananassa cultivar were more than twofold higher and the cyanidin: pelargonidin ratio was only 0.05 compared to 0.51 in the F. vesca cultivar. The differences in the fruit colour of the two Fragaria species can be explained by the higher expression of DFR1 in F.xananassa as compared to F. vesca, a higher enzyme efficiency (Kcat/Km values) of DFR1 combined with the loss of F3'H activity late in fruit development of F.xananassa.	[Miosic, Silvija; Thill, Jana; Milosevic, Malvina; Gosch, Christian; Pober, Sabrina; Stich, Karl; Halbwirth, Heidi] Vienna Univ Technol, Inst Chem Engn, A-1040 Vienna, Austria; [Molitor, Christian; Rompel, Annette] Univ Vienna, Fak Chem, Inst Biophys Chem, Vienna, Austria; [Ejaz, Shaghef] Bahauddin Zakariya Univ, Dept Hort, Multan, Pakistan	Technische Universitat Wien; University of Vienna; Bahauddin Zakariya University	Halbwirth, H (corresponding author), Vienna Univ Technol, Inst Chem Engn, A-1040 Vienna, Austria.	hhalb@mail.zserv.tuwien.ac.at	Ejaz, Shaghef/J-1617-2014; Molitor, Christian/S-2178-2018	Molitor, Christian/0000-0003-1685-0141; Halbwirth, Heidi/0000-0001-9059-5850; Haselmair-Gosch, Christian/0000-0003-3231-0962; Ejaz, Shaghef/0000-0003-4018-9189; Rompel, Annette/0000-0002-5919-0553	Austrian Science Fund (FWF) [V18-B03, P24331-B16]; Austrian Science Fund (FWF) [P 24331] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Investigations were supported by a grant from the Austrian Science Fund (FWF, www.fwf.ac.at): [Projects V18-B03 and P24331-B16]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaby K, 2005, J AGR FOOD CHEM, V53, P4032, DOI 10.1021/jf048001o; Aharoni A, 2002, J EXP BOT, V53, P2073, DOI 10.1093/jxb/erf026; Almeida JRM, 2007, ARCH BIOCHEM BIOPHYS, V465, P61, DOI 10.1016/j.abb.2007.04.040; Araguez I, 2013, J PROTEOMICS, V83, P160, DOI 10.1016/j.jprot.2013.03.016; Chandra A, 2001, J AGR FOOD CHEM, V49, P3515, DOI 10.1021/jf010389p; Cheng H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072017; CLAUDOT AC, 1992, PHYTOCHEMISTRY, V31, P3377, DOI 10.1016/0031-9422(92)83689-V; Des Marais DL, 2008, NATURE, V454, P762, DOI 10.1038/nature07092; Fait A, 2008, PLANT PHYSIOL, V148, P730, DOI 10.1104/pp.108.120691; Fischer TC, 2003, ARCH BIOCHEM BIOPHYS, V412, P223, DOI 10.1016/S0003-9861(03)00013-4; Gosch C, 2003, EUR J HORTIC SCI, V68, P144; Halbwirth H, 2006, PLANT SCI, V170, P587, DOI 10.1016/j.plantsci.2005.10.013; Halbwirth H, 2006, J AGR FOOD CHEM, V54, P1479, DOI 10.1021/jf0524170; Halbwirth H, 2009, J AGR FOOD CHEM, V57, P4983, DOI 10.1021/jf900121z; Harborne J.B., 1967, COMP BIOCH FLAVONOID; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Inagaki Y, 1999, GENE, V226, P181, DOI 10.1016/S0378-1119(98)00571-X; Johnson ET, 1999, PLANT J, V19, P81, DOI 10.1046/j.1365-313X.1999.00502.x; Johnson ET, 2001, PLANT J, V25, P325, DOI 10.1046/j.1365-313x.2001.00962.x; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; MEYER P, 1987, NATURE, V330, P677, DOI 10.1038/330677a0; Moyano E, 1998, PLANT PHYSIOL, V117, P711, DOI 10.1104/pp.117.2.711; Nakanishi K., 1999, COMPREHENSIVE NATURA, V1, P713; Petit P, 2007, J MOL BIOL, V368, P1345, DOI 10.1016/j.jmb.2007.02.088; Pfaffl MW, 2004, BIOSPEKTRUM, V01, P92; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; SANDERMANN H, 1972, J BIOL CHEM, V247, P5123; Shimada N, 2005, J EXP BOT, V56, P2573, DOI 10.1093/jxb/eri251; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SONDHEIMER E, 1956, NATURE, V178, P648, DOI 10.1038/178648a0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thill J, 2013, PLANT PHYSL BIOCH; Thill J, 2013, PLANT PHYSIOL BIOCH, V72, P72, DOI 10.1016/j.plaphy.2013.03.019; Xie DY, 2004, PLANT PHYSIOL, V134, P979, DOI 10.1104/pp.103.030221	36	28	36	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112707	10.1371/journal.pone.0112707	http://dx.doi.org/10.1371/journal.pone.0112707			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393679	gold, Green Published, Green Submitted			2022-12-27	WOS:000347709300089
J	Srivastava, R; Srivastava, G; Dilcher, DL				Srivastava, Rashmi; Srivastava, Gaurav; Dilcher, David L.			Coryphoid Palm Leaf Fossils from the Maastrichtian-Danian of Central India with Remarks on Phytogeography of the Coryphoideae (Arecaceae)	PLOS ONE			English	Article							GLOBAL BIOGEOGRAPHY; SHEDS LIGHT; DIVERSIFICATION; EVOLUTION; GENUS; CLASSIFICATION; TRANSITION; PALEOCENE; VOLCANISM; PATTERNS	Premise of research: A large number of fossil coryphoid palm wood and fruits have been reported from the Deccan Intertrappean beds of India. We document the oldest well-preserved and very rare costapalmate palm leaves and inflorescence like structures from the same horizon. Methodology: A number of specimens were collected from Maastrichtian-Danian sediments of the Deccan Intertrappean beds, Ghughua, near Umaria, Dindori District, Madhya Pradesh, India. The specimens are compared with modern and fossil taxa of the family Arecaceae. Pivotal results: Sabalites dindoriensis sp. nov. is described based on fossil leaf specimens including basal to apical parts. These are the oldest coryphoid fossil palm leaves from India as well as, at the time of deposition, from the Gondwana-derived continents. Conclusions: The fossil record of coryphoid palm leaves presented here and reported from the Eurasian localities suggests that this is the oldest record of coryphoid palm leaves from India and also from the Gondwana-derived continents suggesting that the coryphoid palms were well established and wide spread on both northern and southern hemispheres by the Maastrichtian-Danian. The coryphoid palms probably dispersed into India from Europe via Africa during the latest Cretaceous long before the Indian Plate collided with the Eurasian Plate.	[Srivastava, Rashmi; Srivastava, Gaurav] Birbal Sahni Inst Paleobot, Cenozo Palaeoflorist Lab, Lucknow 226007, Uttar Pradesh, India; [Dilcher, David L.] Indiana Univ, Dept Geol, Bloomington, IN 47405 USA	Department of Science & Technology (India); Birbal Sahni Institute of Palaeobotany (BSIP); Indiana University System; Indiana University Bloomington	Srivastava, R (corresponding author), Birbal Sahni Inst Paleobot, Cenozo Palaeoflorist Lab, 53 Univ Rd, Lucknow 226007, Uttar Pradesh, India.	rashmi57.bsip@gmail.com	Srivastava, Gaurav/A-1384-2019	Srivastava, Gaurav/0000-0001-7498-4338				Ambwani K., 1990, GEOPHYTOLOGY, V19, P70; [Anonymous], 1982, TERT RES; [Anonymous], HERB CAT; Asmussen CB, 2006, BOT J LINN SOC, V151, P15, DOI 10.1111/j.1095-8339.2006.00521.x; ASMUSSEN CB, 2000, MONOCOTS SYSTEMATICS, P525; Baker WJ, 2013, J BIOGEOGR, V40, P286, DOI 10.1111/j.1365-2699.2012.02794.x; Baker WJ, 2013, J BIOGEOGR, V40, P274, DOI 10.1111/j.1365-2699.2012.02795.x; BANDE M.B., 1992, PALAEOBOTANIST, V40, P275; Bande MB, 1982, PALEOBOTANIST, V30, P303; Barman G, 1970, SCI CULT, V36, P63; BERRY E.W., 1914, US GEOL SURV PROF PA, V84, P5; Bjorholm S, 2006, BOT J LINN SOC, V151, P113, DOI 10.1111/j.1095-8339.2006.00527.x; Bjorholm S, 2005, GLOBAL ECOL BIOGEOGR, V14, P423, DOI 10.1111/j.1466-822x.2005.00167.x; Bonde S.D., 2008, PALAEOBOTANIST, V57, P141, DOI DOI 10.1016/S0034-6667(97)00012-2; Bonde SD, 1986, BIOVIGYANAM, V12, P89; Bonde SD, 1986, BIOVIGYANAM, V12, P113; Chase Mark W., 2006, Aliso, V22, P63; Chatterjee S, 2013, GONDWANA RES, V23, P238, DOI 10.1016/j.gr.2012.07.001; Chenet AL, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005644; Couvreur TLP, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-44; Cripps JA, 2005, PALAEOGEOGR PALAEOCL, V216, P303, DOI 10.1016/j.palaeo.2004.11.007; Daghlian CP, 1976, PALAEONTOGR ABT B, V166B, P44; Davis JI, 2006, TAXON, V55, P857, DOI 10.2307/25065681; Dransfield J., 2008, GENERA PALMARUM THE; Dransfield John, 2005, Kew Bulletin, V60, P559; El-Saadawi W, 2004, REV PALAEOBOT PALYNO, V129, P199, DOI 10.1016/j.revpalbo.2004.02.001; El-Soughier Maher I., 2011, Palaeoworld, V20, P75, DOI 10.1016/j.palwor.2010.09.016; Ezcurra MD, 2012, SYST BIOL, V61, P553, DOI 10.1093/sysbio/syr115; Gibbons M, 2003, POCKET GUIDE PALMS; Govaerts R., 2005, World checklist of palms; GULERIA J.S., 1999, PALEOBOTANIST, V47, P68; Guleria JS., 2005, PALEOBOTANIST, V54, P61; Guleria JS, 2000, HIMAL GEOL, V21, P43; HERNGREEN G F W, 1981, Pollen et Spores, V23, P441; HERNGREEN GFW, 1996, AM ASS STRATIGR PALY, V3, P1157; Hofmann C, 2000, EARTH PLANET SC LETT, V180, P13, DOI 10.1016/S0012-821X(00)00159-X; Huzioka K., 1970, J MINING COLL AKITA, V4, P1; Jacobs BF, 2004, PHILOS T R SOC B, V359, P1573, DOI 10.1098/rstb.2004.1533; Jay AE, 2008, J GEOL SOC LONDON, V165, P177, DOI 10.1144/0016-76492006-062; JONES DL, 1995, PALMS THROUGHOUT WOR; Kapoor R, 1987, B INDIAN GEOLOGISTS, V20, P17; Kar R. K., 1998, GEOPHYTOLOGY, V27, P17; Keller G, 2009, EARTH PLANET SC LETT, V282, P10, DOI 10.1016/j.epsl.2009.02.016; Khosla A, 2003, J ASIAN EARTH SCI, V21, P895, DOI 10.1016/S1367-9120(02)00092-5; Khosla SC, 1999, MICROPALEONTOLOGY, V45, P319, DOI 10.2307/1486140; KULKARNI A R, 1977, Geophytology, V7, P208; Kulkarni AR, 2004, CURR SCI INDIA, V86, P1598; KUMARAN KPN, 1994, REV PALAEOBOT PALYNO, V81, P337, DOI 10.1016/0034-6667(94)90117-1; Kvacek J, 2004, REV PALAEOBOT PALYNO, V128, P323, DOI 10.1016/S0034-6667(03)00154-4; Lakhanpal R.N., 1983, GEOLOGY INDUS SUTURE, P179; Lakhanpal R.N., 1984, PALAEOBOTANIST, V31, P201; LAKHANPAL RN, 1964, CURR SCI INDIA, V33, P276; Lakhanpal RN, 1982, PALEOBOTANIST, V30, P279; Lakhanpal RN, 1976, CATALOGUE INDIAN FOS; Mabberley D. J, 2005, PLANT BOOK PORTABLE; MAHABALE TS, 1968, CURR SCI INDIA, V37, P158; Mahesh Prasad, 2006, Phytomorphology, V56, P9; Manchester SR, 2010, INT J PLANT SCI, V171, P679, DOI 10.1086/653688; Marmi J, 2010, REV PALAEOBOT PALYNO, V163, P73, DOI 10.1016/j.revpalbo.2010.10.007; Mathur AK, 1996, PALAEONTOLOGIA INDIC, V1, P1; Mehrotra R. C., 2007, Journal of the Palaeontological Society of India, V52, P159; Mehrotra R.C., 2000, PALAEOBOTANIST, V49, P255; Mehrotra RC, 2003, GEOBIOS-LYON, V36, P83, DOI 10.1016/S0016-6995(02)00107-9; Mohabey DM, 1986, MEMOIR GEOLOGICAL SO, V37, P363; Morley R.J., 2000, ORIGIN EVOLUTION TRO; Paul SK, 2007, CURR SCI INDIA, V92, P727; Punyasena SW, 2008, J BIOGEOGR, V35, P117, DOI 10.1111/j.1365-2699.2007.01773.x; Rao GV, 1989, P SPEC IND GEOPH C P; READ R W, 1972, Taxon, V21, P129, DOI 10.2307/1219237; Sahni B, 1964, REVISON INDIAN FOS 3; Sahni B., 1934, CURR SCI INDIA, V3, P134; Samant B, 2009, J BIOSCIENCES, V34, P811, DOI 10.1007/s12038-009-0064-9; Samant B., 2005, GONDWANA GEOLOGICAL, V8, P151; SAPORTA G., 1865, ANN SCI NATURELLES B, V5, P5; SHETE R H, 1980, Palaeontographica Abteilung B Palaeophytologie, V172, P117; Shete RH, 1985, J INDIAN BOT SOC, V64, P45; Sheth HC, 2001, GEOPHYS RES LETT, V28, P3513, DOI 10.1029/2001GL012921; Shukla P.N., 1997, PALAEOBOTANIST, V46, P127; Singh MC, 2012, J GEOL SOC INDIA, V79, P287, DOI 10.1007/s12594-012-0042-y; Singh RR, 2012, J GEOL SOC INDIA, V79, P85, DOI 10.1007/s12594-012-0008-0; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; Srivastava G, 2012, J EARTH SYST SCI, V121, P747, DOI 10.1007/s12040-012-0179-5; Srivastava R., 2011, GEOL SOC AM MEM, V77, P281; Srivastava R, 2005, CATALOGUE CENOZOIC T; Srivastava R, 1991, CATALOGUE FOSSIL PLA; Survey of India, 1950, TOP 64A; Svenning JC, 2008, J BIOGEOGR, V35, P394, DOI 10.1111/j.1365-2699.2007.01841.x; Tomlinson PB, 2006, BOT J LINN SOC, V151, P5, DOI 10.1111/j.1095-8339.2006.00520.x; Tomlinson PB, 1990, STRUCTURAL BIOL PALM; TRIVEDI BS, 1971, CURR SCI INDIA, V40, P526; VENKATESAN TR, 1993, EARTH PLANET SC LETT, V119, P181, DOI 10.1016/0012-821X(93)90015-2; Walther GR, 2007, GLOBAL ECOL BIOGEOGR, V16, P801, DOI 10.1111/j.1466-8238.2007.00328.x; Woodward F. I., 1988, CLIMATE PLANT DISTRI; Zhou WJ, 2013, SCI CHINA EARTH SCI, V56, P1493, DOI 10.1007/s11430-013-4681-7	94	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e111738	10.1371/journal.pone.0111738	http://dx.doi.org/10.1371/journal.pone.0111738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25394208	Green Published, gold, Green Submitted			2022-12-27	WOS:000347709300021
J	Abiko, Y; Nagano, K; Yoshida, Y; Yoshimura, F				Abiko, Yuki; Nagano, Keiji; Yoshida, Yasuo; Yoshimura, Fuminobu			Characterization of Treponema denticola Mutants Defective in the Major Antigenic Proteins, Msp and TmpC	PLOS ONE			English	Article							GINGIVAL EPITHELIAL-CELLS; OUTER SHEATH PROTEIN; CHYMOTRYPSIN-LIKE PROTEASE; PORPHYROMONAS-GINGIVALIS; ORAL SPIROCHETE; TANNERELLA-FORSYTHIA; MEMBRANE COMPLEXES; BINDING-PROPERTIES; PALLIDUM ANTIGENS; SURFACE PROTEIN	Treponema denticola, a gram-negative and anaerobic spirochete, is associated with advancing severity of chronic periodontitis. In this study, we confirmed that two major antigenic proteinswere Msp and TmpC, and examined their physiological and pathological roles using gene-deletion mutants. Msp formed a large complex that localized to the outer membrane, while TmpC existed as a monomer and largely localized to the inner membrane. However, TmpC was also detected in the outer membrane fraction, but its cell-surface exposure was not detected. Msp defects increased cell-surface hydrophobicity and secretion of TNF-alpha from macrophage-like cells, whereas TmpC defects decreased autoagglutination and chymotrypsin-like protease activities. Both mutants adhered to gingival epithelial cells similarly to the wild-type and showed slightly decreased motility. In addition, in Msp-defective mutants, the TDE1072 protein, which is a major membrane protein, was abolished; therefore, phenotypic changes in the mutant can be, at least in part, attributed to the loss of the TDE1072 protein. Thus, the major antigenic proteins, Msp and TmpC, have significant and diverse impacts on the characteristics of T. denticola, especially cell surface properties.	[Abiko, Yuki; Nagano, Keiji; Yoshida, Yasuo; Yoshimura, Fuminobu] Aichi Gakuin Univ, Sch Dent, Dept Microbiol, Nagoya, Aichi 464, Japan	Aichi Gakuin University	Nagano, K (corresponding author), Aichi Gakuin Univ, Sch Dent, Dept Microbiol, 1-100 Kusumoto Cho, Nagoya, Aichi 464, Japan.	nagano@dpc.agu.ac.jp	Nagano, Keiji/AAS-4912-2020	Nagano, Keiji/0000-0003-3587-7606	JSPS KAKENHI [24791973, 25462880]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers 24791973 (YA) and 25462880 (KN). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2003, CELLULAR MOL IMMUNOL; Abiko Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089051; Anand A, 2013, J BACTERIOL, V195, P2060, DOI 10.1128/JB.00078-13; Bamford CV, 2007, INFECT IMMUN, V75, P4364, DOI 10.1128/IAI.00258-07; BenMohamed L, 2002, LANCET INFECT DIS, V2, P425, DOI 10.1016/S1473-3099(02)00318-3; Bian XL, 2005, INFECT IMMUN, V73, P1252, DOI 10.1128/IAI.73.2.1252-1255.2005; Bodet C, 2006, MICROBES INFECT, V8, P27, DOI 10.1016/j.micinf.2005.05.015; Brissette CA, 2008, ORAL MICROBIOL IMMUN, V23, P474, DOI 10.1111/j.1399-302X.2008.00452.x; Capone R, 2008, ORAL MICROBIOL IMMUN, V23, P165, DOI 10.1111/j.1399-302X.2007.00404.x; COCKAYNE A, 1989, J GEN MICROBIOL, V135, P3209; Cogoni V, 2012, MICROBIOL-SGM, V158, P759, DOI 10.1099/mic.0.055939-0; Dashper SG, 2011, J DENT RES, V90, P691, DOI 10.1177/0022034510385242; Deka RK, 2006, J BIOL CHEM, V281, P8072, DOI 10.1074/jbc.M511405200; Edwards AM, 2005, INFECT IMMUN, V73, P2891, DOI 10.1128/IAI.73.5.2891-2898.2005; EGLI C, 1993, INFECT IMMUN, V61, P1694, DOI 10.1128/IAI.61.5.1694-1699.1993; Fenno JC, 1996, J BACTERIOL, V178, P2489, DOI 10.1128/jb.178.9.2489-2497.1996; Fenno JC, 1998, FEMS MICROBIOL LETT, V163, P209, DOI 10.1111/j.1574-6968.1998.tb13047.x; Fenno JC, 1997, J BACTERIOL, V179, P1082, DOI 10.1128/jb.179.4.1082-1089.1997; Fenno JC, 1998, INFECT IMMUN, V66, P1869, DOI 10.1128/IAI.66.5.1869-1877.1998; Fenno JC, 2000, INFECT IMMUN, V68, P1884, DOI 10.1128/IAI.68.4.1884-1892.2000; Fenno JC, 2001, INFECT IMMUN, V69, P6193, DOI 10.1128/IAI.69.10.6193-6200.2001; Fenno JC, 2012, J ORAL MICROBIOL, V4; FLETCHER HM, 1995, INFECT IMMUN, V63, P1521, DOI 10.1128/IAI.63.4.1521-1528.1995; Gaibani P, 2010, J PERIODONTAL RES, V45, P361, DOI 10.1111/j.1600-0765.2009.01246.x; Godovikova V, 2011, INFECT IMMUN, V79, P4868, DOI 10.1128/IAI.05701-11; Godovikova V, 2010, J BACTERIOL, V192, P3337, DOI 10.1128/JB.00274-10; Goetting-Minesky MP, 2010, J MICROBIOL METH, V83, P66, DOI 10.1016/j.mimet.2010.07.020; GRENIER D, 1990, INFECT IMMUN, V58, P347, DOI 10.1128/IAI.58.2.347-351.1990; HAAPASALO M, 1992, INFECT IMMUN, V60, P2058, DOI 10.1128/IAI.60.5.2058-2065.1992; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Ishihara K, 1999, FEMS MICROBIOL LETT, V181, P199; Ishihara K, 1998, J BACTERIOL, V180, P3837, DOI 10.1128/JB.180.15.3837-3844.1998; Izard J, 2001, J BACTERIOL, V183, P1078, DOI 10.1128/JB.183.3.1078-1084.2001; Ji S, 2007, J PERIODONTAL RES, V42, P503, DOI 10.1111/j.1600-0765.2007.00974.x; Kesavalu L, 1997, INFECT IMMUN, V65, P5096, DOI 10.1128/IAI.65.12.5096-5102.1997; Kesavalu L, 1999, INFECT IMMUN, V67, P5736, DOI 10.1128/IAI.67.11.5736-5746.1999; Kurniyati K, 2013, MOL MICROBIOL, V89, P842, DOI 10.1111/mmi.12311; Nagano K, 2005, J BACTERIOL, V187, P902, DOI 10.1128/JB.187.3.902-911.2005; Nagano K, 2007, J MED MICROBIOL, V56, P1536, DOI 10.1099/jmm.0.47289-0; Nagano K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043722; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; NIKAIDO H, 1989, ANTIMICROB AGENTS CH, V33, P1831, DOI 10.1128/AAC.33.11.1831; Nussbaum G, 2009, INFECT IMMUN, V77, P3939, DOI 10.1128/IAI.00488-09; Rosen G, 1999, INFECT IMMUN, V67, P1180, DOI 10.1128/IAI.67.3.1180-1186.1999; Rosen G, 2008, FEMS MICROBIOL LETT, V289, P59, DOI 10.1111/j.1574-6968.2008.01373.x; ROSENBERG M, 1981, J BACTERIOL, V148, P51, DOI 10.1128/JB.148.1.51-57.1981; Sakakibara J, 2007, MICROBIOL-SGM, V153, P866, DOI 10.1099/mic.0.29275-0; Sakon H, 2008, INT J SYST EVOL MICR, V58, P970, DOI 10.1099/ijs.0.65456-0; SCHOULS LM, 1991, INFECT IMMUN, V59, P3536, DOI 10.1128/IAI.59.10.3536-3546.1991; Schultz CP, 1998, J BIOL CHEM, V273, P15661, DOI 10.1074/jbc.273.25.15661; Sela MN, 2001, CRIT REV ORAL BIOL M, V12, P399, DOI 10.1177/10454411010120050301; Socransky SS, 2002, PERIODONTOL 2000, V28, P12, DOI 10.1034/j.1600-0757.2002.280102.x; Tamai R, 2009, ANAEROBE, V15, P87, DOI 10.1016/j.anaerobe.2008.12.004; UMEMOTO T, 1989, INFECT IMMUN, V57, P2470, DOI 10.1128/IAI.57.8.2470-2474.1989; Umemoto T, 1987, JPN J ORAL BIOL, V29, P488; Veith PD, 2009, BBA-PROTEINS PROTEOM, V1794, P1421, DOI 10.1016/j.bbapap.2009.06.001; WICHER K, 1989, INT ARCH ALLER A IMM, V89, P128, DOI 10.1159/000234935	57	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113565	10.1371/journal.pone.0113565	http://dx.doi.org/10.1371/journal.pone.0113565			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401769	gold, Green Submitted, Green Published			2022-12-27	WOS:000345158700141
J	Madec, S; Pichereau, V; Jacq, A; Paillard, M; Boisset, C; Guerard, F; Paillard, C; Nicolas, JL				Madec, Stephanie; Pichereau, Vianney; Jacq, Annick; Paillard, Mathieu; Boisset, Claire; Guerard, Fabienne; Paillard, Christine; Nicolas, Jean-Louis			Characterization of the Secretomes of Two Vibrios Pathogenic to Mollusks	PLOS ONE			English	Article							BROWN RING DISEASE; OYSTER CRASSOSTREA-GIGAS; AUTOPROCESSING RTX TOXIN; RUDITAPES-PHILIPPINARUM; PROTEOMIC ANALYSIS; MANILA CLAM; VIRULENCE; TAPETIS; CHOLERAE; METALLOPROTEASE	Vibrio tapetis causes the brown ring disease in the Japanese clam Ruditapes philippinarum while Vibrio aestuarianus is associated with massive oyster mortalities. As extracellular proteins are often associated with the virulence of pathogenic bacteria, we undertook a proteomic approach to characterize the secretomes of both vibrios. The extracellular proteins (ECPs) of both species were fractionated by SEC-FPLC and in vitro assays were performed to measure the effects of each fraction on hemocyte cellular parameters (phagocytosis and adhesion). Fractions showing a significant effect were subjected to SDS-PAGE, and proteins were identified by nano LC-MS/MS. 45 proteins were identified for V. aestuarianus and 87 for V. tapetis. Most of them belonged to outer membrane or were periplasmic, including porins or adhesins that were already described as virulence factors in other bacterial species. Others were transporter components, flagella proteins, or proteins of unknown function (14 and 15 respectively). Interestingly, for V. aestuarianus, we noted the secretion of 3 extracellular enzymes including the Vam metalloprotease and two other enzymes (one putative lipase and one protease). For V. tapetis, we identified five extracellular enymes, i.e. two different endochitinases, one protease, one lipase and an adhesin. A comparison of both secretomes also showed that only the putative extracellular lipase was common to both secretomes, underscoring the difference in pathogenicity mechanisms between these two species. Overall, these results characterize for the first time the secretomes of these two marine pathogenic vibrios and constitute a useful working basis to further analyze the contribution of specific proteins in the virulence mechanisms of these species.	[Madec, Stephanie] UBO, Lab Univ Biodivers & Ecol Microbienne EA3882, ScInBios SFR48, UEB,ESIAB, F-29280 Plouzane, France; [Pichereau, Vianney; Paillard, Mathieu; Guerard, Fabienne; Paillard, Christine; Nicolas, Jean-Louis] UBO, UMR UBO CNRS IRD Ifremer 6539, Lab Sci Environm Marin, Inst Univ Europeen Mer, F-29280 Plouzane, France; [Jacq, Annick] Univ Paris 11, CNRS, UMR8621, Inst Genet & Microbiol, F-91405 Orsay, France; [Boisset, Claire] CERMAV CNRS, Ctr Rech Macromol Vegetales, F-38041 Grenoble, France	Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Madec, S (corresponding author), UBO, Lab Univ Biodivers & Ecol Microbienne EA3882, ScInBios SFR48, UEB,ESIAB, Technopole Brest Iroise, F-29280 Plouzane, France.	stephanie.madec@univ-brest.fr	PICHEREAU, Vianney/B-2168-2008; PICHEREAU, Vianney/Q-7236-2019; Jacq, Annick/H-3896-2012	PICHEREAU, Vianney/0000-0003-1078-9407; PICHEREAU, Vianney/0000-0003-1078-9407; Jacq, Annick/0000-0002-8526-5942; Paillard, Christine/0000-0002-3812-0724; MADEC, Stephanie/0000-0002-4684-7931	Bivalife FP7 KBBE program [266157]	Bivalife FP7 KBBE program	The work was funded by the Bivalife FP7 KBBE program (ref 266157). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam B, 2006, FISH SHELLFISH IMMUN, V20, P374, DOI 10.1016/j.fsi.2005.05.012; Austin B, 2010, VET MICROBIOL, V140, P310, DOI 10.1016/j.vetmic.2009.03.015; Barbey C, 2009, VET MICROBIOL, V135, P334, DOI 10.1016/j.vetmic.2008.09.086; Barh D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052773; Benachour A, 2009, CAN J MICROBIOL, V55, P967, DOI [10.1139/W09-052, 10.1139/w09-052]; Chaudhuri S, 2013, MBIO, V4, DOI 10.1128/mBio.00617-12; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; Choquet G, 2003, DIS AQUAT ORGAN, V57, P109, DOI 10.3354/dao057109; Combie H., 2008, SUMMER MORTALITY PAC; DebRoy S, 2006, P NATL ACAD SCI USA, V103, P19146, DOI 10.1073/pnas.0608279103; Garnier M, 2007, MICROB ECOL, V53, P187, DOI 10.1007/s00248-006-9061-9; Gay M, 2004, DIS AQUAT ORGAN, V62, P65, DOI 10.3354/dao062065; Gomez-Leon J, 2005, APPL ENVIRON MICROB, V71, P98, DOI 10.1128/AEM.71.1.98-104.2005; KOTHARY MH, 1995, INFECT IMMUN, V63, P2418, DOI 10.1128/IAI.63.7.2418-2423.1995; Labreuche Y, 2006, DEV COMP IMMUNOL, V30, P367, DOI 10.1016/j.dci.2005.05.003; Labreuche Y, 2010, FISH SHELLFISH IMMUN, V29, P753, DOI 10.1016/j.fsi.2010.07.007; Lakhal F, 2008, APPL ENVIRON MICROB, V74, P5750, DOI 10.1128/AEM.01043-08; Lang C, 2011, EUR J CELL BIOL, V90, P903, DOI 10.1016/j.ejcb.2010.12.003; Le Roux F, 2007, APPL ENVIRON MICROB, V73, P777, DOI 10.1128/AEM.02147-06; Linhartova I, 2010, FEMS MICROBIOL REV, V34, P1076, DOI 10.1111/j.1574-6976.2010.00231.x; Lopez-Cortes L, 1999, FISH SHELLFISH IMMUN, V9, P543, DOI 10.1006/fsim.1999.0211; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Matson JS, 2007, INFECT IMMUN, V75, P5542, DOI 10.1128/IAI.01094-07; Mendez JA, 2012, J PROTEOME RES, V11, P5678, DOI 10.1021/pr300496c; Merino S, 1999, INFECT IMMUN, V67, P4008, DOI 10.1128/IAI.67.8.4008-4013.1999; Olivier V, 2007, INFECT IMMUN, V75, P5035, DOI 10.1128/IAI.00506-07; PAILLARD C, 1990, CR ACAD SCI III-VIE, V310, P15; PAILLARD C, 1995, J INVERTEBR PATHOL, V65, P101, DOI 10.1006/jipa.1995.1016; Paillard C, 2004, AQUAT LIVING RESOUR, V17, P467, DOI 10.1051/alr:2004053; Paillard C, 2004, DIS AQUAT ORGAN, V59, P249, DOI 10.3354/dao059249; Paillard C, 2004, AQUAT LIVING RESOUR, V17, P477, DOI 10.1051/alr:2004054; Pocsfalvi G, 2008, PROTEOMICS, V8, P2462, DOI 10.1002/pmic.200700965; Romalde JL, 2014, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00413; Ruiz-Perez F, 2014, CELL MOL LIFE SCI, V71, P745, DOI 10.1007/s00018-013-1355-8; Santos ED, 2011, ISME J, V5, P1471, DOI 10.1038/ismej.2011.19; Segarra A, 2010, VIRUS RES, V153, P92, DOI 10.1016/j.virusres.2010.07.011; Sikora AE, 2011, J BIOL CHEM, V286, P16555, DOI 10.1074/jbc.M110.211078; Thiele H, 2010, J INTEGR BIOINFORMAT, V7, DOI 10.2390/biecoll-jib-2010-141; Unal CM, 2011, SEMIN IMMUNOPATHOL, V33, P395, DOI 10.1007/s00281-010-0231-y; Vaitkevicius K, 2006, P NATL ACAD SCI USA, V103, P9280, DOI 10.1073/pnas.0601754103; Varina M, 2008, J BACTERIOL, V190, P6589, DOI 10.1128/JB.00535-08; Ziolo KJ, 2014, INFECT IMMUN, V82, P2148, DOI 10.1128/IAI.00017-14	42	13	13	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113097	10.1371/journal.pone.0113097	http://dx.doi.org/10.1371/journal.pone.0113097			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401495	Green Published, gold			2022-12-27	WOS:000345158700111
J	Xie, BB; Zhang, XM; Hashimoto, T; Tien, AH; Chen, A; Ge, J; Yang, XJ				Xie, Bin-Bin; Zhang, Xiang-Mei; Hashimoto, Takao; Tien, Amy H.; Chen, Andrew; Ge, Jian; Yang, Xian-Jie			Differentiation of Retinal Ganglion Cells and Photoreceptor Precursors from Mouse Induced Pluripotent Stem Cells Carrying an Atoh7/Math5 Lineage Reporter	PLOS ONE			English	Article							MAMMALIAN RETINA; PROGENITOR CELLS; COMPETENCE STATE; XENOPUS RETINA; SONIC HEDGEHOG; MULLER GLIA; MATH5; GENERATION; NEUROGENESIS; NEURONS	The neural retina is a critical component of the visual system, which provides the majority of sensory input in humans. Various retinal degenerative diseases can result in the permanent loss of retinal neurons, especially the light-sensing photoreceptors and the centrally projecting retinal ganglion cells (RGCs). The replenishment of lost RGCs and the repair of optic nerve damage are particularly challenging, as both RGC specification and their subsequent axonal growth and projection involve complex and precise regulation. To explore the developmental potential of pluripotent stem cell-derived neural progenitors, we have established mouse iPS cells that allow cell lineage tracing of progenitors that have expressed Atoh7/Math5, a bHLH transcription factor required for RGC production. These Atoh7 lineage reporter iPS cells encode Cre to replace one copy of the endogenous Atoh7 gene and a Cre-dependent YFP reporter in the ROSA locus. In addition, they express pluripotent markers and are capable of generating teratomas in vivo. Under anterior neural induction and neurogenic conditions in vitro, the Atoh7-Cre/ROSA-YFP iPS cells differentiate into neurons that co-express various RGC markers and YFP, indicating that these neurons are derived from Atoh7-expressing progenitors. Consistent with previous in vivo cell lineage studies, the Atoh7-Cre/ROSA-YFP iPS cells also give rise to a subset of Crx-positive photoreceptor precursors. Furthermore, inhibition of Notch signaling in the iPSC cultures results in a significant increase of YFP-positive RGCs and photoreceptor precursors. Together, these results show that Atoh7-Cre/ROSA-YFP iPS cells can be used to monitor the development and survival of RGCs and photoreceptors from pluripotent stem cells.	[Xie, Bin-Bin; Ge, Jian] Sun Yat Sen Univ, Zhong Shan Ophthalm Ctr, Guangzhuo, Peoples R China; [Zhang, Xiang-Mei; Hashimoto, Takao; Tien, Amy H.; Chen, Andrew; Yang, Xian-Jie] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90024 USA; [Yang, Xian-Jie] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	Sun Yat Sen University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Yang, XJ (corresponding author), Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90024 USA.	Yang@jsei.ucla.edu	Chen, Andrew/AAT-6318-2021	Chen, Andrew/0000-0002-6688-7674	National Institute of Health [RO1 EY019052]; Oppenheimer Family Foundation; Ernest G. Herman Endowed Chair in Ophthalmology; Research to Prevent Blindness Foundation; National Eye Institute [EY00331]; NATIONAL EYE INSTITUTE [P30EY000331, R01EY019052] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oppenheimer Family Foundation; Ernest G. Herman Endowed Chair in Ophthalmology; Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was in part supported by grants from National Institute of Health RO1 EY019052, the Oppenheimer Family Foundation, and the Ernest G. Herman Endowed Chair in Ophthalmology to X.-J. Y., and Research to Prevent Blindness Foundation unrestricted funds and National Eye Institute Core Grant EY00331 for vision research at UCLA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTIN CP, 1995, DEVELOPMENT, V121, P3637; Badea TC, 2009, NEURON, V61, P852, DOI 10.1016/j.neuron.2009.01.020; Bernardos RL, 2007, J NEUROSCI, V27, P7028, DOI 10.1523/JNEUROSCI.1624-07.2007; Brown NL, 1998, DEVELOPMENT, V125, P4821; Brown NL, 2001, DEVELOPMENT, V128, P2497; Brzezinski JA, 2012, DEV BIOL, V365, P395, DOI 10.1016/j.ydbio.2012.03.006; Chen MF, 2010, INVEST OPHTH VIS SCI, V51, P5970, DOI 10.1167/iovs.09-4504; DORSKY RI, 1995, NEURON, V14, P487, DOI 10.1016/0896-6273(95)90305-4; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; FIELDSBERRY SC, 1992, P NATL ACAD SCI USA, V89, P693, DOI 10.1073/pnas.89.2.693; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Hashimoto T, 2007, GENE THER, V14, P584, DOI 10.1038/sj.gt.3302897; Hashimoto T, 2006, DEVELOPMENT, V133, P2201, DOI 10.1242/dev.02385; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; Hufnagel RB, 2010, DEV BIOL, V340, P490, DOI 10.1016/j.ydbio.2010.02.002; Hyde DR, 2014, EXP EYE RES; Ikeda H, 2005, P NATL ACAD SCI USA, V102, P11331, DOI 10.1073/pnas.0500010102; Jadhav AR, 2006, DEVELOPMENT, V133, P913, DOI 10.1242/dev.02245; Jiang Y, 2013, J BIOL CHEM, V288, P18429, DOI 10.1074/jbc.M113.478503; Karl Mike O, 2012, Methods Mol Biol, V884, P213, DOI 10.1007/978-1-61779-848-1_15; Kim J, 2005, SCIENCE, V308, P1927, DOI 10.1126/science.1110175; La Torre Anna, 2012, Methods Mol Biol, V884, P229, DOI 10.1007/978-1-61779-848-1_16; Lamba DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008763; Lee HY, 2005, DEV BIOL, V284, P464, DOI 10.1016/j.ydbio.2005.06.010; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Omori Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019685; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Osakada F, 2009, NAT PROTOC, V4, P811, DOI 10.1038/nprot.2009.51; Philips GT, 2005, DEV BIOL, V279, P308, DOI 10.1016/j.ydbio.2004.12.018; Ramsden CM, 2013, DEVELOPMENT, V140, P2576, DOI 10.1242/dev.092270; Riazifar H, 2014, STEM CELL TRANSL MED, V3, P424, DOI 10.5966/sctm.2013-0147; Riesenberg AN, 2009, J NEUROSCI, V29, P12865, DOI 10.1523/JNEUROSCI.3382-09.2009; Riesenberg AN, 2009, GENESIS, V47, P175, DOI 10.1002/dvg.20479; Sakagami K, 2009, J NEUROSCI, V29, P6932, DOI 10.1523/JNEUROSCI.0289-09.2009; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Wan J, 2012, DEV CELL, V22, P334, DOI 10.1016/j.devcel.2011.11.020; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wang YP, 2005, DEVELOPMENT, V132, P5103, DOI 10.1242/dev.02096; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; Xiang MQ, 1996, P NATL ACAD SCI USA, V93, P11950, DOI 10.1073/pnas.93.21.11950; Yang ZY, 2003, DEV BIOL, V264, P240, DOI 10.1016/j.ydbio.2003.08.005; Yaron O, 2006, DEVELOPMENT, V133, P1367, DOI 10.1242/dev.02311; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; YOUNG RW, 1985, DEV BRAIN RES, V21, P229, DOI 10.1016/0165-3806(85)90211-1; Zhang XM, 2001, DEVELOPMENT, V128, P943	49	18	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112175	10.1371/journal.pone.0112175	http://dx.doi.org/10.1371/journal.pone.0112175			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401462	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700034
J	Kairamkonda, S; Nongthomba, U				Kairamkonda, Subhash; Nongthomba, Upendra			Beadex Function in the Motor Neurons Is Essential for Female Reproduction in Drosophila melanogaster	PLOS ONE			English	Article							SEMINAL FLUID PROTEIN; MEDIATES OVULATION; WING DEVELOPMENT; SENSORY NEURONS; SPERM STORAGE; RECEPTOR OAMB; LIM DOMAIN; GENE; EXPRESSION; OCTOPAMINE	Drosophila melanogaster has served as an excellent model system for understanding the neuronal circuits and molecular mechanisms regulating complex behaviors. The Drosophila female reproductive circuits, in particular, are well studied and can be used as a tool to understand the role of novel genes in neuronal function in general and female reproduction in particular. In the present study, the role of Beadex, a transcription co-activator, in Drosophila female reproduction was assessed by generation of mutant and knock down studies. Null allele of Beadex was generated by transposase induced excision of P-element present within an intron of Beadex gene. The mutant showed highly compromised reproductive abilities as evaluated by reduced fecundity and fertility, abnormal oviposition and more importantly, the failure of sperm release from storage organs. However, no defect was found in the overall ovariole development. Tissue specific, targeted knock down of Beadex indicated that its function in neurons is important for efficient female reproduction, since its neuronal knock down led to compromised female reproductive abilities, similar to Beadex null females. Further, different neuronal class specific knock down studies revealed that Beadex function is required in motor neurons for normal fecundity and fertility of females. Thus, the present study attributes a novel and essential role for Beadex in female reproduction through neurons.	[Kairamkonda, Subhash; Nongthomba, Upendra] Indian Inst Sci, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Nongthomba, U (corresponding author), Indian Inst Sci, Bangalore 560012, Karnataka, India.	upendra@mrdg.iisc.ernet.in	Nongthomba, Upendra/AAY-3009-2021	Nongthomba, Upendra/0000-0002-0616-5995	Department of Biotechnology; Indian Institute of Science	Department of Biotechnology; Indian Institute of Science(Indian Institute of Science (IISC) - Bangalore)	This work was supported by the Department of Biotechnology (http://dbtindia.nic.in/index.asp, to UN), and Indian Institute of Science (www.iisc.ernet.in, to UN and SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmar J, 2008, DEV BIOL, V316, P487, DOI 10.1016/j.ydbio.2008.01.040; Avila FW, 2012, P NATL ACAD SCI USA, V109, P4562, DOI 10.1073/pnas.1117689109; Avila FW, 2010, GENETICS, V186, P595, DOI 10.1534/genetics.110.119735; Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; Chapman T, 2001, P ROY SOC B-BIOL SCI, V268, P1647, DOI 10.1098/rspb.2001.1684; Cole SH, 2005, J BIOL CHEM, V280, P14948, DOI 10.1074/jbc.M414197200; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Hasemeyer M, 2009, NEURON, V61, P511, DOI 10.1016/j.neuron.2009.01.009; Heifetz Y, 2000, CURR BIOL, V10, P99, DOI 10.1016/S0960-9822(00)00288-8; Hodin J, 2000, EVOLUTION, V54, P1638, DOI 10.1111/j.0014-3820.2000.tb00708.x; Joshi K, 2009, NEURON, V61, P839, DOI 10.1016/j.neuron.2009.02.011; Kahsai L, 2011, INT REV NEUROBIOL, V99, P139, DOI 10.1016/B978-0-12-387003-2.00006-9; Lasek AW, 2010, GENES BRAIN BEHAV, V9, P817, DOI 10.1111/j.1601-183X.2010.00620.x; Lasek AW, 2011, ALCOHOL CLIN EXP RES, V35, P1600, DOI 10.1111/j.1530-0277.2011.01506.x; Lasek AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022636; Lee HG, 2003, DEV BIOL, V264, P179, DOI 10.1016/j.ydbio.2003.07.018; Lee HG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004716; LIFSCHYTZ E, 1979, MOL GEN GENET, V171, P153, DOI 10.1007/BF00270001; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; McGuire SE, 2003, DROS RES C, V44, P153; Middleton CA, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-17; Milan M, 1998, GENE DEV, V12, P2912, DOI 10.1101/gad.12.18.2912; Monastirioti M, 2003, DEV BIOL, V264, P38, DOI 10.1016/j.ydbio.2003.07.019; Prado A, 1999, GENETICS, V151, P163; Qazi MCB, 2003, DEV BIOL, V256, P195, DOI 10.1016/S0012-1606(02)00125-2; Ranganayakulu G, 1996, DEV BIOL, V176, P143, DOI 10.1006/dbio.1996.9987; Ren J, 2014, CELL RES, V24, P636, DOI 10.1038/cr.2014.24; ROBERTSON HM, 1988, GENETICS, V118, P461; Rodriguez-Valentin R, 2006, J CELL PHYSIOL, V209, P183, DOI 10.1002/jcp.20722; Rubinstein CD, 2013, P NATL ACAD SCI USA, V110, P17420, DOI 10.1073/pnas.1220018110; Santel A, 1997, MECH DEVELOP, V64, P19, DOI 10.1016/S0925-4773(97)00031-2; Sanyal S, 2009, GENE EXPR PATTERNS, V9, P371, DOI 10.1016/j.gep.2009.01.002; Shoresh M, 1998, GENETICS, V150, P283; Soller M, 1999, DEV BIOL, V208, P337, DOI 10.1006/dbio.1999.9210; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Thor S, 1997, NEURON, V18, P397, DOI 10.1016/S0896-6273(00)81241-6; Tsai LTY, 2004, PLOS BIOL, V2, P2122, DOI 10.1371/journal.pbio.0020408; Villella A, 2008, ADV GENET, V62, P67, DOI 10.1016/S0065-2660(08)00603-2; Vu D, 2003, MOL BRAIN RES, V115, P93, DOI 10.1016/S0169-328X(03)00119-0; Weihe U, 2001, DEVELOPMENT, V128, P4615; Wolfner M.F., 2007, P183; Wolfram V, 2014, J NEUROSCI, V34, P2538, DOI 10.1523/JNEUROSCI.4511-13.2014; Wolfram V, 2012, NEURON, V75, P663, DOI 10.1016/j.neuron.2012.06.015; Yang CH, 2009, NEURON, V61, P519, DOI 10.1016/j.neuron.2008.12.021; Zeng CY, 1998, P NATL ACAD SCI USA, V95, P10637, DOI 10.1073/pnas.95.18.10637; Zenvirt S, 2008, GENETICS, V179, P1989, DOI 10.1534/genetics.108.090076; ZHU TH, 1995, ONCOGENE, V11, P1283; Zwarts L, 2012, FLY, V6, P35, DOI 10.4161/fly.19249	49	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113003	10.1371/journal.pone.0113003	http://dx.doi.org/10.1371/journal.pone.0113003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396431	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000345558500123
J	Ding, L; Kim, MJ; Kanchi, KL; Dees, ND; Lu, C; Griffith, M; Fenstermacher, D; Sung, H; Miller, CA; Goetz, B; Wendl, MC; Griffith, O; Cornelius, LA; Linette, GP; McMichael, JF; Sondak, VK; Fields, RC; Ley, TJ; Mule, JJ; Wilson, RK; Weber, JS				Ding, Li; Kim, Minjung; Kanchi, Krishna L.; Dees, Nathan D.; Lu, Charles; Griffith, Malachi; Fenstermacher, David; Sung, Hyeran; Miller, Christopher A.; Goetz, Brian; Wendl, Michael C.; Griffith, Obi; Cornelius, Lynn A.; Linette, Gerald P.; McMichael, Joshua F.; Sondak, Vernon K.; Fields, Ryan C.; Ley, Timothy J.; Mule, James J.; Wilson, Richard K.; Weber, Jeffrey S.			Clonal Architectures and Driver Mutations in Metastatic Melanomas	PLOS ONE			English	Article							TERT PROMOTER MUTATIONS; SOMATIC MUTATIONS; BRAF MUTATIONS; GENOME; CANCER; SENESCENCE; NEVI; RESOLUTION; LANDSCAPE; EVOLUTION	To reveal the clonal architecture of melanoma and associated driver mutations, whole genome sequencing (WGS) and targeted extension sequencing were used to characterize 124 melanoma cases. Significantly mutated gene analysis using 13 WGS cases and 15 additional paired extension cases identified known melanoma genes such as BRAF, NRAS, and CDKN2A, as well as a novel gene EPHA3, previously implicated in other cancer types. Extension studies using tumors from another 96 patients discovered a large number of truncation mutations in tumor suppressors (TP53 and RB1), protein phosphatases (e.g., PTEN, PTPRB, PTPRD, and PTPRT), as well as chromatin remodeling genes (e.g., ASXL3, MLL2, and ARID2). Deep sequencing of mutations revealed subclones in the majority of metastatic tumors from 13 WGS cases. Validated mutations from 12 out of 13 WGS patients exhibited a predominant UV signature characterized by a high frequency of C->T transitions occurring at the 39 base of dipyrimidine sequences while one patient (MEL9) with a hypermutator phenotype lacked this signature. Strikingly, a subclonal mutation signature analysis revealed that the founding clone in MEL9 exhibited UV signature but the secondary clone did not, suggesting different mutational mechanisms for two clonal populations from the same tumor. Further analysis of four metastases from different geographic locations in 2 melanoma cases revealed phylogenetic relationships and highlighted the genetic alterations responsible for differential drug resistance among metastatic tumors. Our study suggests that clonal evaluation is crucial for understanding tumor etiology and drug resistance in melanoma.	[Ding, Li; Kanchi, Krishna L.; Dees, Nathan D.; Lu, Charles; Griffith, Malachi; Miller, Christopher A.; Wendl, Michael C.; Griffith, Obi; McMichael, Joshua F.; Ley, Timothy J.; Wilson, Richard K.] Washington Univ, Genome Inst, St Louis, MO USA; [Ding, Li; Griffith, Obi; Cornelius, Lynn A.; Linette, Gerald P.; Ley, Timothy J.] Washington Univ, Dept Med, St Louis, MO USA; [Ding, Li; Griffith, Malachi; Wilson, Richard K.] Washington Univ, Dept Genet, St Louis, MO USA; [Ding, Li; Linette, Gerald P.; Fields, Ryan C.; Ley, Timothy J.; Wilson, Richard K.] Washington Univ, Siteman Canc Ctr, St Louis, MO USA; [Kim, Minjung; Fenstermacher, David; Sung, Hyeran; Sondak, Vernon K.; Mule, James J.; Weber, Jeffrey S.] H Lee Moffitt Canc Ctr & Res Inst, Donald A Adam Comprehens Melanoma Res Ctr, Tampa, FL 33612 USA; [Goetz, Brian; Cornelius, Lynn A.; Fields, Ryan C.] Washington Univ, Dept Surg, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); H Lee Moffitt Cancer Center & Research Institute; Washington University (WUSTL)	Weber, JS (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Donald A Adam Comprehens Melanoma Res Ctr, Tampa, FL 33612 USA.	Jeffrey.weber@moffitt.org	Griffith, Malachi/P-1285-2014; Wilson, Richard K./AAF-4139-2019; Griffith, Obi/P-1286-2014	Griffith, Malachi/0000-0002-6388-446X; Wilson, Richard K./0000-0002-1992-1358; Cornelius, Lynn A/0000-0002-6329-2819; Griffith, Obi/0000-0002-0843-4271; Miller, Christopher/0000-0003-4266-6700; Kim, Minjung/0000-0002-5682-6640	Donald A. Adam Comprehensive Melanoma Research Center; Melanoma Inc. Foundation; Come Out Swinging Inc. Foundation	Donald A. Adam Comprehensive Melanoma Research Center; Melanoma Inc. Foundation; Come Out Swinging Inc. Foundation	This work was supported by the Donald A. Adam Comprehensive Melanoma Research Center. The authors gratefully thank the Our Mark on Melanoma Inc. Foundation and the Come Out Swinging Inc. Foundation for additional funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer J, 2007, J INVEST DERMATOL, V127, P179, DOI 10.1038/sj.jid.5700490; Bennett DC, 2003, ONCOGENE, V22, P3063, DOI 10.1038/sj.onc.1206446; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Davies MA, 2010, ONCOGENE, V29, P5545, DOI 10.1038/onc.2010.323; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Grafstrom E, 2005, CLIN CANCER RES, V11, P2991, DOI 10.1158/1078-0432.CCR-04-1731; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Hocker T, 2007, HUM MUTAT, V28, P578, DOI 10.1002/humu.20481; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Kamb A, 1994, Nat Genet, V8, P23; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Koboldt DC, 2012, GENOME RES; Larson DE, 2011, BIOINFORMATICS; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Prickett TD, NAT GENET, V43, P1119; Prickett TD, 2011, NAT GENET, V43, P1119, DOI 10.1038/ng.950; Prickett TD, 2009, NAT GENET, V41, P1127, DOI 10.1038/ng.438; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shi HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1727; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Smalley KSM, 2010, J INVEST DERMATOL, V130, P28, DOI 10.1038/jid.2009.177; Stark MS, 2012, NAT GENET, V44, P165, DOI 10.1038/ng.1041; Turajlic S, GENOME RES, V22, P196; Turajlic S, 2012, GENOME RES, V22, P196, DOI 10.1101/gr.125591.111; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	44	58	59	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e111153	10.1371/journal.pone.0111153	http://dx.doi.org/10.1371/journal.pone.0111153			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393105	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300011
J	Dossena, M; Bedini, G; Rusmini, P; Giorgetti, E; Canazza, A; Tosetti, V; Salsano, E; Sagnelli, A; Mariotti, C; Gellera, C; Navone, SE; Marfia, G; Alessandri, G; Corsi, F; Parati, EA; Pareyson, D; Poletti, A				Dossena, Marta; Bedini, Gloria; Rusmini, Paola; Giorgetti, Elisa; Canazza, Alessandra; Tosetti, Valentina; Salsano, Ettore; Sagnelli, Anna; Mariotti, Caterina; Gellera, Cinzia; Navone, Stefania Elena; Marfia, Giovanni; Alessandri, Giulio; Corsi, Fabio; Parati, Eugenio Agostino; Pareyson, Davide; Poletti, Angelo			Human Adipose-Derived Mesenchymal Stem Cells as a New Model of Spinal and Bulbar Muscular Atrophy	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; ELONGATED POLYGLUTAMINE TRACT; REPEAT ANDROGEN RECEPTOR; SMOOTH-MUSCLE-CELLS; MOTOR-NEURONS; STROMAL CELLS; 5-ALPHA-REDUCTASE TYPE-2; REGENERATIVE MEDICINE; INTERNATIONAL-SOCIETY; EXPRESSION	Spinal and bulbar muscular atrophy (SBMA) or Kennedy's disease is an X-linked CAG/polyglutamine expansion motoneuron disease, in which an elongated polyglutamine tract (polyQ) in the N-terminal androgen receptor (ARpolyQ) confers toxicity to this protein. Typical markers of SBMA disease are ARpolyQ intranuclear inclusions. These are generated after the ARpolyQ binds to its endogenous ligands, which promotes AR release from chaperones, activation and nuclear translocation, but also cell toxicity. The SBMA mouse models developed so far, and used in preclinical studies, all contain an expanded CAG repeat significantly longer than that of SBMA patients. Here, we propose the use of SBMA patients adipose-derived mesenchymal stem cells (MSCs) as a new human in vitro model to study ARpolyQ toxicity. These cells have the advantage to express only ARpolyQ, and not the wild type AR allele. Therefore, we isolated and characterized adipose-derived MSCs from three SBMA patients (ADSC from Kennedy's patients, ADSCK) and three control volunteers (ADSCs). We found that both ADSCs and ADSCKs express mesenchymal antigens, even if only ADSCs can differentiate into the three typical cell lineages (adipocytes, chondrocytes and osteocytes), whereas ADSCKs, from SBMA patients, showed a lower growth potential and differentiated only into adipocyte. Moreover, analysing AR expression on our mesenchymal cultures we found lower levels in all ADSCKs than ADSCs, possibly related to negative pressures exerted by toxic ARpolyQ in ADSCKs. In addition, with proteasome inhibition the ARpolyQ levels increased specifically in ADSCKs, inducing the formation of HSP70 and ubiquitin positive nuclear ARpolyQ inclusions. Considering all of this evidence, SBMA patients adipose-derived MSCs cultures should be considered an innovative in vitro human model to understand the molecular mechanisms of ARpolyQ toxicity and to test novel therapeutic approaches in SBMA.	[Dossena, Marta; Bedini, Gloria; Canazza, Alessandra; Tosetti, Valentina; Navone, Stefania Elena; Marfia, Giovanni; Alessandri, Giulio; Parati, Eugenio Agostino] Fdn IRCCS Ist Neurol Carlo Besta, Unit Cerebrovasc Dis, Cellular Neurobiol Lab, Milan, Italy; [Rusmini, Paola; Giorgetti, Elisa; Poletti, Angelo] Univ Milan, Dipartimento Sci Farmacol & Biomol, Ctr Interdipartimentale Malattie Neurodegenerat, Milan, Italy; [Giorgetti, Elisa] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Salsano, Ettore; Sagnelli, Anna; Pareyson, Davide] Fdn IRCCS Ist Neurol Carlo Besta, Dept Clin Neurosci, Clin Cent & Peripheral Degenerat Neuropathies Uni, Milan, Italy; [Mariotti, Caterina; Gellera, Cinzia] Fdn IRCCS Ist Neurol Carlo Besta, Dept Diagnost & Appl Technol, Unit Genet Neurodegenerat & Metab Dis, Milan, Italy; [Corsi, Fabio] Univ Milan, Div Surg, Dept Clin Sci, Luigi Sacco Hosp, Milan, Italy	IRCCS Istituto Neurologico Besta; University of Milan; University of Michigan System; University of Michigan; IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta; University of Milan; Luigi Sacco Hospital	Pareyson, D (corresponding author), Fdn IRCCS Ist Neurol Carlo Besta, Dept Clin Neurosci, Clin Cent & Peripheral Degenerat Neuropathies Uni, Milan, Italy.	davide.pareyson@istituto-besta.it; angelo.poletti@unimi.it	navone, stefania e/K-7264-2016; Gellera, Cinzia/J-7887-2016; Corsi, Fabio/ABH-9554-2020; navone, stefania/Y-4779-2019; Pareyson, Davide/K-5890-2016; Corsi, Fabio/E-9204-2017; Marfia, Giovanni/N-4650-2014; Parati, Eugenio Agostino/AAN-5893-2021; BEDINI, GLORIA/K-3012-2016; Dossena, Marta/I-2125-2012; Salsano, Ettore/I-7996-2018; Poletti, Angelo/A-9016-2011; Mariotti, Caterina/AAP-9425-2021; Marfia, Giovanni/AAB-8702-2020	navone, stefania e/0000-0002-0097-9146; Gellera, Cinzia/0000-0002-3582-665X; Corsi, Fabio/0000-0002-6469-4086; navone, stefania/0000-0002-0097-9146; Pareyson, Davide/0000-0001-6854-765X; Corsi, Fabio/0000-0002-6469-4086; Marfia, Giovanni/0000-0002-5849-7000; Parati, Eugenio Agostino/0000-0001-5020-6523; BEDINI, GLORIA/0000-0002-3653-427X; Salsano, Ettore/0000-0001-9167-1878; Poletti, Angelo/0000-0002-8883-0468; Mariotti, Caterina/0000-0003-2405-3564; Marfia, Giovanni/0000-0002-5849-7000; alessandri, giulio/0000-0002-1861-8461; Dossena, Marta/0000-0003-1717-8350; RUSMINI, PAOLA/0000-0001-9989-0733	Regione Lombardia; AriSLA Foundation Italy [ALS_HSPB8]; Telethon - Italy [GGP14039]; Italian Ministry of Labour, Health and Social Affairs (Convenzione Fondazione Mondino/UNIMI); Universita degli Studi di Milano; Fondazione CARIPLO [2008-2307]; Fondation Thierry Latran, France; Association Francaise contre les Myopathies	Regione Lombardia(Regione Lombardia); AriSLA Foundation Italy; Telethon - Italy(Fondazione Telethon); Italian Ministry of Labour, Health and Social Affairs (Convenzione Fondazione Mondino/UNIMI); Universita degli Studi di Milano; Fondazione CARIPLO(Fondazione Cariplo); Fondation Thierry Latran, France; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This work was funded by Regione Lombardia (to D.P., A.P., E.A.P.); AriSLA Foundation Italy (ALS_HSPB8 to A.P), Telethon - Italy (GGP14039 to A.P.); Italian Ministry of Labour, Health and Social Affairs (Convenzione Fondazione Mondino/UNIMI to A.P.); Universita degli Studi di Milano (to A.P.); Fondazione CARIPLO (2008-2307 to A.P.); Fondation Thierry Latran, France (to A.P.), Association Francaise contre les Myopathies (to A.P.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel A, 2001, HUM MOL GENET, V10, P107, DOI 10.1093/hmg/10.2.107; Adachi H, 2001, HUM MOL GENET, V10, P1039, DOI 10.1093/hmg/10.10.1039; Alessandri G, 2004, LANCET, V364, P1872, DOI 10.1016/S0140-6736(04)17443-6; Avanzini MA, 2009, HAEMATOL-HEMATOL J, V94, P1649, DOI 10.3324/haematol.2009.006171; Bourin P, 2013, CYTOTHERAPY, V15, P641, DOI 10.1016/j.jcyt.2013.02.006; Brooks BP, 1997, NEUROBIOL DIS, V3, P313, DOI 10.1006/nbdi.1997.0126; Brooks BP, 1998, J NEUROCHEM, V70, P1054; Casteilla L, 2006, DIABETES METAB, V32, P393, DOI 10.1016/S1262-3636(07)70297-5; Chazenbalk G, 2013, STEROIDS, V78, P920, DOI 10.1016/j.steroids.2013.05.001; Chevalier-Larsen ES, 2004, J NEUROSCI, V24, P4778, DOI 10.1523/JNEUROSCI.0808-04.2004; Chua JP, 2014, HUM MOL GENET, V23, P1376, DOI 10.1093/hmg/ddt527; Cortes CJ, 2014, NEURON, V82, P295, DOI 10.1016/j.neuron.2014.03.001; de la Garza-Rodea AS, 2012, CELL TRANSPLANT, V21, P153, DOI 10.3727/096368911X580554; Desiderio V, 2013, J CELL PHYSIOL, V228, P1762, DOI 10.1002/jcp.24336; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fischbeck KH, 1997, J INHERIT METAB DIS, V20, P152, DOI 10.1023/A:1005344403603; Grunseich C, 2014, ORAL DIS, V20, P6, DOI 10.1111/odi.12121; Grunseich C, 2014, NEUROBIOL DIS, V70, P12, DOI 10.1016/j.nbd.2014.05.038; Huang CK, 2013, BBA-MOL CELL RES, V1833, P1222, DOI 10.1016/j.bbamcr.2013.01.007; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Jordan CL, 2008, CURR OPIN PHARMACOL, V8, P752, DOI 10.1016/j.coph.2008.08.006; Katsuno M, 2003, NAT MED, V9, P768, DOI 10.1038/nm878; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Kotaja N, 2002, J BIOL CHEM, V277, P30283, DOI 10.1074/jbc.M204768200; La Spada AR, 1998, HUM MOL GENET, V7, P959, DOI 10.1093/hmg/7.6.959; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Lieberman AP, 2014, CELL REP, V7, P774, DOI 10.1016/j.celrep.2014.02.008; Marra KG, 2011, METHODS MOL BIOL, V702, P261, DOI 10.1007/978-1-61737-960-4_19; Ogura F, 2014, STEM CELLS DEV, V23, P717, DOI 10.1089/scd.2013.0473; Piccioni F, 2002, FASEB J, V16, P1418, DOI 10.1096/fj.01-1035fje; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poletti A, 2004, FRONT NEUROENDOCRIN, V25, P1, DOI 10.1016/j.yfrne.2004.03.001; Poletti A, 2001, J NEUROENDOCRINOL, V13, P353, DOI 10.1046/j.1365-2826.2001.00635.x; Pozzi P, 2003, J NEUROENDOCRINOL, V15, P882, DOI 10.1046/j.1365-2826.2003.01074.x; Rocchi A, 2013, J MOL NEUROSCI, V50, P514, DOI 10.1007/s12031-013-9978-7; Rusmini P, 2007, NEUROBIOL AGING, V28, P1099, DOI 10.1016/j.neurobiolaging.2006.05.015; Rusmini P, 2013, NEUROBIOL AGING, V34, P2585, DOI 10.1016/j.neurobiolaging.2013.05.026; Simeoni S, 2000, HUM MOL GENET, V9, P133, DOI 10.1093/hmg/9.1.133; Sopher BL, 2004, NEURON, V41, P687, DOI 10.1016/S0896-6273(04)00082-0; Tsai MY, 2011, BIOCHEM BIOPH RES CO, V411, P477, DOI 10.1016/j.bbrc.2011.06.113; Wang C, 2010, TISSUE ENG PT A, V16, P1201, DOI 10.1089/ten.TEA.2009.0303; Yu ZG, 2006, AM J PATHOL, V168, P195, DOI 10.2353/ajpath.2006.050619	43	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112746	10.1371/journal.pone.0112746	http://dx.doi.org/10.1371/journal.pone.0112746			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392924	Green Published, gold			2022-12-27	WOS:000347709300094
J	Greig, JA; Peng, H; Ohlstein, J; Medina-Jaszek, CA; Ahonkhai, O; Mentzinger, A; Grant, RL; Roy, S; Chen, SJ; Bell, P; Tretiakova, AP; Wilson, JM				Greig, Jenny A.; Peng, Hui; Ohlstein, Jason; Medina-Jaszek, C. Angelica; Ahonkhai, Omua; Mentzinger, Anne; Grant, Rebecca L.; Roy, Soumitra; Chen, Shu-Jen; Bell, Peter; Tretiakova, Anna P.; Wilson, James M.			Intramuscular Injection of AAV8 in Mice and Macaques Is Associated with Substantial Hepatic Targeting and Transgene Expression	PLOS ONE			English	Article							COAGULATION-FACTOR-IX; HEMOPHILIA-B DOGS; T-LYMPHOCYTE RESPONSES; MEDIATED GENE-TRANSFER; SKELETAL-MUSCLE; IN-VIVO; NEUTRALIZING ANTIBODIES; SUSTAINED EXPRESSION; BETA-GALACTOSIDASE; CLINICAL-TRIAL	Intramuscular (IM) administration of adeno-associated viral (AAV) vectors has entered the early stages of clinical development with some success, including the first approved gene therapy product in the West called Glybera. In preparation for broader clinical development of IM AAV vector gene therapy, we conducted detailed pre-clinical studies in mice and macaques evaluating aspects of delivery that could affect performance. We found that following IM administration of AAV8 vectors in mice, a portion of the vector reached the liver and hepatic gene expression contributed significantly to total expression of secreted transgenes. The contribution from liver could be controlled by altering injection volume and by the use of traditional (promoter) and non-traditional (tissue-specific microRNA target sites) expression control elements. Hepatic distribution of vector following IM injection was also noted in rhesus macaques. These pre-clinical data on AAV delivery should inform safe and efficient development of future AAV products.	[Greig, Jenny A.; Peng, Hui; Ohlstein, Jason; Medina-Jaszek, C. Angelica; Ahonkhai, Omua; Mentzinger, Anne; Grant, Rebecca L.; Roy, Soumitra; Chen, Shu-Jen; Bell, Peter; Tretiakova, Anna P.; Wilson, James M.] Univ Penn, Div Transfus Med, Dept Pathol & Lab Med, Gene Therapy Program, Philadelphia, PA 19104 USA	University of Pennsylvania	Wilson, JM (corresponding author), Univ Penn, Div Transfus Med, Dept Pathol & Lab Med, Gene Therapy Program, TRL Suite 2000,125 South 31st St, Philadelphia, PA 19104 USA.	wilsonjm@mail.med.upenn.edu	Roy, Soumitra/B-9113-2008; Wilson, James M/F-9220-2011	Wilson, James M/0000-0002-9630-3131; Mentzinger, Anne/0000-0001-7364-4112	Bill & Melinda Gates Foundation [51061]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Bill & Melinda Gates Foundation, grant number 51061 and URL http://www.gatesfoundation.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruda VR, 2004, BLOOD, V103, P85, DOI 10.1182/blood-2003-05-1446; Balazs AB, 2013, NAT BIOTECHNOL, V31, P647, DOI 10.1038/nbt.2618; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Bell P, 2005, HISTOCHEM CELL BIOL, V124, P77, DOI 10.1007/s00418-005-0793-2; Bell P, 2006, MOL THER, V14, P34, DOI 10.1016/j.ymthe.2006.03.008; Brantly ML, 2009, P NATL ACAD SCI USA, V106, P16363, DOI 10.1073/pnas.0904514106; Breous E, 2011, GASTROENTEROLOGY, V141, P348, DOI 10.1053/j.gastro.2011.04.002; Breous E, 2009, HEPATOLOGY, V50, P612, DOI 10.1002/hep.23043; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Calcedo R, 2009, J INFECT DIS, V199, P381, DOI 10.1086/595830; Cao O, 2007, BLOOD, V110, P1132, DOI 10.1182/blood-2007-02-073304; CHMP EMA, 2012, GLYB EPAR ASS REP; Dobrzynski E, 2004, BLOOD, V104, P969, DOI 10.1182/blood-2004-03-0847; Dobrzynski E, 2006, P NATL ACAD SCI USA, V103, P4592, DOI 10.1073/pnas.0508685103; Flotte TR, 2011, HUM GENE THER, V22, P1239, DOI 10.1089/hum.2011.053; Gao GP, 2006, MOL THER, V13, P77, DOI 10.1016/j.ymthe.2005.08.017; Geisler A, 2011, GENE THER, V18, P199, DOI 10.1038/gt.2010.141; Geisler A, 2013, MOL THER, V21, P924, DOI 10.1038/mt.2012.276; Gentner B, 2009, NAT METHODS, V6, P63, DOI [10.1038/NMETH.1277, 10.1038/nmeth.1277]; Glamann J, 2000, J VIROL, V74, P7158, DOI 10.1128/JVI.74.15.7158-7163.2000; Glamann J, 1998, J VIROL, V72, P585, DOI 10.1128/JVI.72.1.585-592.1998; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Herzog RW, 2002, HUM GENE THER, V13, P1281, DOI 10.1089/104303402760128513; Herzog RW, 1997, P NATL ACAD SCI USA, V94, P5804, DOI 10.1073/pnas.94.11.5804; Hoffman BE, 2007, HUM GENE THER, V18, P603, DOI 10.1089/hum.2007.042; Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967; Karali M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022166; Kay MA, 2000, NAT GENET, V24, P257, DOI 10.1038/73464; Kessler PD, 1996, P NATL ACAD SCI USA, V93, P14082, DOI 10.1073/pnas.93.24.14082; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Limberis MP, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006299; Manno CS, 2003, BLOOD, V101, P2963, DOI 10.1182/blood-2002-10-3296; Martino AT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006376; Meister G, 2007, CELL, V131, P25, DOI 10.1016/j.cell.2007.09.021; Mingozzi F, 2003, J CLIN INVEST, V111, P1347, DOI 10.1172/JCI200316887; Mount JD, 2002, BLOOD, V99, P2670, DOI 10.1182/blood.V99.8.2670; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Qiao C, 2011, GENE THER, V18, P403, DOI 10.1038/gt.2010.157; Rivera VM, 2005, BLOOD, V105, P1424, DOI 10.1182/blood-2004-06-2501; Robinson JE, 2010, J VIROL, V84, P3443, DOI 10.1128/JVI.02617-09; Song SH, 2002, MOL THER, V6, P329, DOI 10.1006/mthe.2002.0673; Toromanoff A, 2008, MOL THER, V16, P1291, DOI 10.1038/mt.2008.87; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang B, 2008, GENE THER, V15, P1489, DOI 10.1038/gt.2008.104; Wang L, 2011, J THROMB HAEMOST, V9, P2009, DOI 10.1111/j.1538-7836.2011.04491.x; Wang LL, 2000, MOL THER, V1, P154, DOI 10.1006/mthe.2000.0031; Wang LL, 2005, BLOOD, V105, P3079, DOI 10.1182/blood-2004-10-3867; Wright JF, 2013, MOL THER, V21, pS210; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	53	33	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112268	10.1371/journal.pone.0112268	http://dx.doi.org/10.1371/journal.pone.0112268			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393537	gold, Green Submitted, Green Published			2022-12-27	WOS:000347709300043
J	Park, CH; Kim, EH; Roh, YH; Kim, HY; Lee, SK				Park, Chan Hyuk; Kim, Eun Hye; Roh, Yun Ho; Kim, Ha Yan; Lee, Sang Kil			The Association between the Use of Proton Pump Inhibitors and the Risk of Hypomagnesemia: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							LOW SERUM MAGNESIUM; PREVALENCE; OMEPRAZOLE; COMMUNITY	Background: Although many case reports have described patients with proton pump inhibitor (PPI)-induced hypomagnesemia, the impact of PPI use on hypomagnesemia has not been fully clarified through comparative studies. We aimed to evaluate the association between the use of PPI and the risk of developing hypomagnesemia by conducting a systematic review with meta-analysis. Methods: We conducted a systematic search of MEDLINE, EMBASE, and the Cochrane Library using the primary keywords "proton pump,'' "dexlansoprazole,'' "esomeprazole,'' "ilaprazole,'' "lansoprazole,'' "omeprazole,'' "pantoprazole,'' "rabeprazole,'' "hypomagnesemia,'' "hypomagnesaemia,'' and "magnesium.'' Studies were included if they evaluated the association between PPI use and hypomagnesemia and reported relative risks or odds ratios or provided data for their estimation. Pooled odds ratios with 95% confidence intervals were calculated using the random effects model. Statistical heterogeneity was assessed with Cochran's Q test and I 2 statistics. Results: Nine studies including 115,455 patients were analyzed. The median Newcastle-Ottawa quality score for the included studies was seven (range, 6-9). Among patients taking PPIs, the median proportion of patients with hypomagnesemia was 27.1% (range, 11.3-55.2%) across all included studies. Among patients not taking PPIs, the median proportion of patients with hypomagnesemia was 18.4% (range, 4.3-52.7%). On meta-analysis, pooled odds ratio for PPI use was found to be 1.775 (95% confidence interval 1.077-2.924). Significant heterogeneity was identified using Cochran's Q test (df = 7, P<0.001, I-2 = 98.0%). Conclusions: PPI use may increase the risk of hypomagnesemia. However, significant heterogeneity among the included studies prevented us from reaching a definitive conclusion.	[Park, Chan Hyuk; Kim, Eun Hye; Lee, Sang Kil] Yonsei Univ, Coll Med, Severance Hosp, Inst Gastroenterol,Dept Internal Med,Div Gastroen, Seoul 120749, South Korea; [Roh, Yun Ho; Kim, Ha Yan] Yonsei Univ, Coll Med, Biostat Collaborat Unit, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, SK (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Inst Gastroenterol,Dept Internal Med,Div Gastroen, Seoul 120749, South Korea.	sklee@yuhs.ac	Park, Chan Hyuk/I-1794-2016	Park, Chan Hyuk/0000-0003-3824-3481; Lee, Sang Kil/0000-0002-0721-0364; Kim, Eun Hye/0000-0001-6691-6837				Alhosaini M, 2014, AM J NEPHROL, V39, P204, DOI 10.1159/000360011; Bai JPF, 2012, MOL PHARMACEUT, V9, P3495, DOI 10.1021/mp300323q; Broeren MAC, 2009, ANN INTERN MED, V151, P755, DOI 10.7326/0003-4819-151-10-200911170-00016; Castillo JJ, 2012, BLOOD, V119, P4845, DOI 10.1182/blood-2011-06-362830; Corleto VD, 2014, CURR OPIN ENDOCRINOL, V21, P3, DOI 10.1097/MED.0000000000000031; Cundy T, 2008, CLIN ENDOCRINOL, V69, P338, DOI 10.1111/j.1365-2265.2008.03194.x; Danziger J, 2013, KIDNEY INT, V83, P692, DOI 10.1038/ki.2012.452; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; El-Charabaty E, 2013, INT J GEN MED, V6, P515, DOI 10.2147/IJGM.S46932; Epstein M, 2006, NEW ENGL J MED, V355, P1834, DOI 10.1056/NEJMc066308; Famularo G, 2013, EXPERT OPIN DRUG SAF, V12, P709, DOI 10.1517/14740338.2013.809062; Furlanetto TW, 2011, ARCH INTERN MED, V171, P1391, DOI 10.1001/archinternmed.2011.199; Gau JT, 2012, PHARMACOEPIDEM DR S, V21, P553, DOI 10.1002/pds.3224; Gray SL, 2010, ARCH INTERN MED, V170, P765, DOI 10.1001/archinternmed.2010.94; Hawkey CJ, 1998, NEW ENGL J MED, V338, P727, DOI 10.1056/NEJM199803123381105; Herzig SJ, 2009, JAMA-J AM MED ASSOC, V301, P2120, DOI 10.1001/jama.2009.722; Hess MW, 2012, ALIMENT PHARM THER, V36, P405, DOI 10.1111/j.1365-2036.2012.05201.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hoorn EJ, 2010, AM J KIDNEY DIS, V56, P112, DOI 10.1053/j.ajkd.2009.11.019; Howell MD, 2010, ARCH INTERN MED, V170, P784, DOI 10.1001/archinternmed.2010.89; Kahrilas Peter J, 2008, Gastroenterology, V135, P1383, DOI 10.1053/j.gastro.2008.08.045; Khan AM, 2013, CIRCULATION, V127, P33, DOI 10.1161/CIRCULATIONAHA.111.082511; Kim S, 2013, AM J THER; Koulouridis I, 2013, AM J KIDNEY DIS, V62, P730, DOI 10.1053/j.ajkd.2013.02.373; Kuipers MT, 2009, NETH J MED, V67, P169; Lacy BE, 2012, ALIMENT PHARM THER, V36, P3, DOI 10.1111/j.1365-2036.2012.05128.x; Liamis G, 2013, AM J MED, V126, P256, DOI 10.1016/j.amjmed.2012.06.037; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Lindner G, 2014, INT J CLIN PRACT; Mackay JD, 2010, QJM-INT J MED, V103, P387, DOI 10.1093/qjmed/hcq021; Markovits N, 2014, J CLIN PHARM; Michalek W, 2011, DIGEST DIS SCI, V56, P1735, DOI 10.1007/s10620-010-1479-8; Perazella MA, 2013, KIDNEY INT, V83, P553, DOI 10.1038/ki.2012.462; Reffelmann T, 2010, ATHEROSCLEROSIS, V213, P563, DOI 10.1016/j.atherosclerosis.2010.08.073; Regolisti G, 2010, AM J KIDNEY DIS, V56, P168, DOI 10.1053/j.ajkd.2010.03.013; Rondon LJ, 2008, AM J PHYSIOL-REG I, V294, pR2001, DOI 10.1152/ajpregu.00153.2007; Sheen E, 2011, DIGEST DIS SCI, V56, P931, DOI 10.1007/s10620-010-1560-3; Sierra F, 2007, ALIMENT PHARM THER, V26, P545, DOI 10.1111/j.1365-2036.2007.03407.x; Singh S, 2013, GASTROENTEROLOGY, V144, P323, DOI 10.1053/j.gastro.2012.10.005; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Van Ende C, 2014, J NEPHROL; Wells G.A., NEWCASTLE OTTAWA SCA; Xiao YL, 2010, AM J GASTROENTEROL, V105, P2626, DOI 10.1038/ajg.2010.351; Yeomans ND, 1998, NEW ENGL J MED, V338, P719, DOI 10.1056/NEJM199803123381104	45	79	83	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112558	10.1371/journal.pone.0112558	http://dx.doi.org/10.1371/journal.pone.0112558			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25394217	gold, Green Published, Green Submitted			2022-12-27	WOS:000347709300069
J	Shi, L; Yan, FH; Pan, ZL; Liu, B; Liu, HH; Wang, BS; Zhang, H; Yu, YY				Shi, Lei; Yan, Fuhua; Pan, Zilai; Liu, Bo; Liu, Huanhuan; Wang, Baisong; Zhang, Huan; Yu, Yingyan			Stomach Virtual Non-Enhanced CT with Second-Generation, Dual-Energy CT: A Preliminary Study	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; GASTRIC-CARCINOMA; IMAGE QUALITY; DIFFERENTIATION; TUMOR	Objectives: To compare the true non-enhanced (TNE) and virtual non-enhanced (VNE) data sets in patients who underwent gastric preoperative dual-energy CT (DECT) and to evaluate potential radiation dose reduction by omitting a TNE scan. Methods: A total of 74 patients underwent gastric DECT. The mean CT values, length, image quality and effective radiation doses for VNE and TNE images were compared. Results: There was no statistical difference in maximal thickness of gastric tumors and maximal diameter of enlarged lymph nodes among the TNE and VNE images (P>0.05). The mean CT value differences between TNE and VNE were statistically significant for all tissue types, except for aorta attenuation measurements (P<0.05), but the absolute differences were under 10 HU. Lower noise was found for VNE images than TNE images (P<0.01). Image quality of VNE was diagnostic but lower than that of TNE (P<0.01). The dose reduction achieved by omitting the TNE acquisition was 21.40 +/- 4.44%. Conclusion: VNE scan may potentially replace TNE as part of a multi-phase gastric preoperative staging imaging protocol with consequent saving in radiation dose.	[Shi, Lei; Yan, Fuhua; Pan, Zilai; Liu, Huanhuan; Zhang, Huan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Radiol, Shanghai, Peoples R China; [Liu, Bo] Siemens Hlth Care, Shanghai, Peoples R China; [Wang, Baisong] Shanghai Jiao Tong Univ, Sch Med, Dept Biomed Stat, Shanghai, Peoples R China; [Yu, Yingyan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Digest Surg, Shanghai, Peoples R China	Shanghai Jiao Tong University; Siemens AG; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yan, FH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Radiol, Shanghai, Peoples R China.	yfh11655@rjh.com.cn; huanzhangy@yahoo.com			fund of Shanghai science and technology development [134119a5900]; Medical Engineer cross subject [YG2012MS48]; NSFC [81171312]	fund of Shanghai science and technology development; Medical Engineer cross subject; NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by fund of Shanghai science and technology development (No. 134119a5900), Medical Engineer cross subject (No. YG2012MS48), and NSFC (No. 81171312). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett T, 2012, EUR J RADIOL, V81, P1438, DOI 10.1016/j.ejrad.2011.03.042; Behrendt FF, 2009, INVEST RADIOL, V44, P1, DOI 10.1097/RLI.0b013e31818c3d4b; Chen CY, 2007, RADIOLOGY, V242, P472, DOI 10.1148/radiol.2422051557; Coursey CA, 2010, RADIOGRAPHICS, V30, P1037, DOI 10.1148/rg.304095175; De Cecco CN, 2010, EUR RADIOL, V20, P2870, DOI 10.1007/s00330-010-1874-8; Fletcher JG, 2009, RADIOL CLIN N AM, V47, P41, DOI 10.1016/j.rcl.2008.10.003; Flohr TG, 2006, EUR RADIOL, V16, P256, DOI 10.1007/s00330-005-2919-2; Graser A, 2009, RADIOLOGY, V252, P433, DOI 10.1148/radiol.2522080557; Graser A, 2009, EUR RADIOL, V19, P13, DOI 10.1007/s00330-008-1122-7; Hong X, 2006, RADIOGRAPHICS, V26, P481, DOI 10.1148/rg.262055097; Johnson TRC, 2007, EUR RADIOL, V17, P1510, DOI 10.1007/s00330-006-0517-6; Karlo C, 2011, EUR RADIOL, V21, P385, DOI 10.1007/s00330-010-1926-0; LIBSON E, 1985, COMPUT RADIOL, V9, P255, DOI 10.1016/0730-4862(85)90083-6; Menzel H, 2000, PUBLICATION EUROPEAN, P735; Mileto A, 2012, CLIN RADIOL, V67, P334, DOI 10.1016/j.crad.2011.09.004; Oliver JH, 1997, RADIOLOGY, V205, P709, DOI 10.1148/radiology.205.3.9393525; Park MS, 2002, RADIOLOGY, V223, P540, DOI 10.1148/radiol.2232010905; Toepker M, 2012, EUR J RADIOL, V81, pE398, DOI 10.1016/j.ejrad.2011.12.011; Yan C, 2009, J SURG ONCOL, V100, P205, DOI 10.1002/jso.21316; Yeh BM, 2009, AM J ROENTGENOL, V193, P47, DOI 10.2214/AJR.09.2592; Yu LF, 2009, MED PHYS, V36, P1019, DOI 10.1118/1.3077921; Zhang LJ, 2010, EUR RADIOL, V20, P2257, DOI 10.1007/s00330-010-1778-7	22	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112295	10.1371/journal.pone.0112295	http://dx.doi.org/10.1371/journal.pone.0112295			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393001	Green Published, gold, Green Submitted			2022-12-27	WOS:000347709300047
J	Ueda, M; Nishitani, Y; Kaneko, Y; Omote, A				Ueda, Michihito; Nishitani, Yu; Kaneko, Yukihiro; Omote, Atsushi			Back-Propagation Operation for Analog Neural Network Hardware with Synapse Components Having Hysteresis Characteristics	PLOS ONE			English	Article							DEVICE	To realize an analog artificial neural network hardware, the circuit element for synapse function is important because the number of synapse elements is much larger than that of neuron elements. One of the candidates for this synapse element is a ferroelectric memristor. This device functions as a voltage controllable variable resistor, which can be applied to a synapse weight. However, its conductance shows hysteresis characteristics and dispersion to the input voltage. Therefore, the conductance values vary according to the history of the height and the width of the applied pulse voltage. Due to the difficulty of controlling the accurate conductance, it is not easy to apply the back-propagation learning algorithm to the neural network hardware having memristor synapses. To solve this problem, we proposed and simulated a learning operation procedure as follows. Employing a weight perturbation technique, we derived the error change. When the error reduced, the next pulse voltage was updated according to the back-propagation learning algorithm. If the error increased the amplitude of the next voltage pulse was set in such way as to cause similar memristor conductance but in the opposite voltage scanning direction. By this operation, we could eliminate the hysteresis and confirmed that the simulation of the learning operation converged. We also adopted conductance dispersion numerically in the simulation. We examined the probability that the error decreased to a designated value within a predetermined loop number. The ferroelectric has the characteristics that the magnitude of polarization does not become smaller when voltages having the same polarity are applied. These characteristics greatly improved the probability even if the learning rate was small, if the magnitude of the dispersion is adequate. Because the dispersion of analog circuit elements is inevitable, this learning operation procedure is useful for analog neural network hardware.	[Ueda, Michihito; Nishitani, Yu; Kaneko, Yukihiro; Omote, Atsushi] Panasonic Corp, Adv Res Div, Sora Ku, Kyoto, Japan	Panasonic	Ueda, M (corresponding author), Panasonic Corp, Adv Res Div, Sora Ku, Kyoto, Japan.	ueda.michihito@jp.panasonic.com		Kaneko, Yukihiro/0000-0003-0000-5840				Alibart F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3072; Bryson AE, 1969, APPL OPTIMAL CONTROL, P481; Coates A., 2013, INT C MACHINE LEARNI, P1337; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Hu M., 2014, IEEE T NEURAL NETWOR; Ishii H., 1992, International Electron Devices Meeting 1992. Technical Digest (Cat. No.92CH3211-0), P435, DOI 10.1109/IEDM.1992.307395; JABRI M, 1992, IEEE T NEURAL NETWOR, V3, P154, DOI 10.1109/72.105429; Jo SH, 2010, NANO LETT, V10, P1297, DOI 10.1021/nl904092h; Kaneko Yukihiro, 2013, 2013 Symposium on VLSI Technology, pT238; Kaneko Y, 2011, APPL PHYS LETT, P99; Kaneko Y, 2014, IEEE T ELECTRON DEV, V61, P2827, DOI 10.1109/TED.2014.2331707; Kaneko Y, 2011, J APPL PHYS, V110, DOI 10.1063/1.3651098; Kato Y, 2008, JPN J APPL PHYS, V47, P2719, DOI 10.1143/JJAP.47.2719; Kuzum D, 2012, NANO LETT, V12, P2179, DOI 10.1021/nl201040y; Le QV, 2013, INT CONF ACOUST SPEE, P8595, DOI 10.1109/ICASSP.2013.6639343; MILLER SL, 1990, J APPL PHYS, V68, P6463, DOI 10.1063/1.346845; Nishitani Y, 2012, J APPL PHYS, V111, DOI 10.1063/1.4729915; Nishitani Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.04CE06; Partzsch J, 2011, IEEE T NEURAL NETWOR, V22, P919, DOI 10.1109/TNN.2011.2134109; Strukov DB, 2008, NATURE, V453, P80, DOI 10.1038/nature06932; Ueda M, 2011, J APPL PHYS, V110, DOI 10.1063/1.3653830; Wang CA, 1999, IEEE T NEURAL NETWOR, V10, P1511, DOI 10.1109/72.809097; Xia QF, 2009, NANO LETT, V9, P3640, DOI 10.1021/nl901874j; Yenpo Ho, 2009, Proceedings of the 2009 IEEE/ACM International Conference on Computer-Aided Design (ICCAD 2009), P485	24	4	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112659	10.1371/journal.pone.0112659	http://dx.doi.org/10.1371/journal.pone.0112659			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393715	gold, Green Published, Green Submitted			2022-12-27	WOS:000347709300081
J	Wang, Y; Zhu, TT; Ke, SS; Fang, N; Irwin, DM; Lei, M; Zhang, JP; Shi, HZ; Zhang, SY; Wang, Z				Wang, Yao; Zhu, Tengteng; Ke, Shanshan; Fang, Na; Irwin, David M.; Lei, Ming; Zhang, Junpeng; Shi, Huizhen; Zhang, Shuyi; Wang, Zhe			The Great Roundleaf Bat (Hipposideros armiger) as a Good Model for Cold-Induced Browning of Intra-Abdominal White Adipose Tissue	PLOS ONE			English	Article							GENE-EXPRESSION; OBESITY; FAT; ADIPOCYTES; MICE; THERMOGENESIS; ANGIOGENESIS; ACCLIMATION; ACTIVATION; ABLATION	Background: Inducing beige fat from white adipose tissue (WAT) is considered to be a shortcut to weight loss and increasingly becoming a key area in research into treatments for obesity and related diseases. However, currently, animal models of beige fat are restricted to rodents, where subcutaneous adipose tissue (sWAT, benign WAT) is more liable to develop into the beige fat under specific activators than the intra-abdominal adipose tissue (aWAT, malignant WAT) that is the major source of obesity related diseases in humans. Methods: Here we induced beige fat by cold exposure in two species of bats, the great roundleaf bat (Hipposideros armiger) and the rickett's big-footed bat (Myotis ricketti), and compared the molecular and morphological changes with those seen in the mouse. Expression of thermogenic genes (Ucp1 and Pgc1a) was measured by RT-qPCR and adipocyte morphology examined by HE staining at three adipose locations, sWAT, aWAT and iBAT (interscapular brown adipose tissue). Results: Expression of Ucp1 and Pgc1a was significantly upregulated, by 729 and 23 fold, respectively, in aWAT of the great roundleaf bat after exposure to 10 degrees C for 7 days. Adipocyte diameters of WATs became significantly reduced and the white adipocytes became brown-like in morphology. In mice, similar changes were found in the sWAT, but much lower amounts of changes in aWAT were seen. Interestingly, the rickett's big-footed bat did not show such a tendency in beige fat. Conclusions: The great roundleaf bat is potentially a good animal model for human aWAT browning research. Combined with rodent models, this model should be helpful for finding therapies for reducing harmful aWAT in humans.	[Wang, Yao; Zhu, Tengteng; Ke, Shanshan; Fang, Na; Lei, Ming; Zhang, Junpeng; Shi, Huizhen; Zhang, Shuyi; Wang, Zhe] E China Normal Univ, Inst Mol Ecol & Evolut, Shanghai 200062, Peoples R China; [Irwin, David M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	East China Normal University; University of Toronto	Zhang, SY (corresponding author), E China Normal Univ, Inst Mol Ecol & Evolut, Shanghai 200062, Peoples R China.	syzhang@bio.ecnu.edu.cn; zwang@sat.ecnu.edu.cn	Wang, Yao/ABX-6690-2022	Wang, Yao/0000-0002-9631-8309; Irwin, David/0000-0001-6131-4933	State Education Ministry of China [20130076120017]; National Natural Science Foundation of China [31301191, 31172077, 91120001]; Chinese Academy of Sciences (CAS Cross-disciplinary Collaborative Teams Program for Science, Technology and Innovation); East China Normal University	State Education Ministry of China(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences (CAS Cross-disciplinary Collaborative Teams Program for Science, Technology and Innovation); East China Normal University	This work was funded by grants from the State Education Ministry of China (No. 20130076120017), National Natural Science Foundation of China (No. 31301191, 31172077, 91120001), Chinese Academy of Sciences (CAS Cross-disciplinary Collaborative Teams Program for Science, Technology and Innovation) and East China Normal University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Belavy DL, 2014, INT J OBESITY, V38, P1478, DOI 10.1038/ijo.2014.26; Bray GA, 2004, INT J OBESITY, V28, P34, DOI 10.1038/sj.ijo.0802479; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Celedon JC, 2014, NAT MED, V20, P20, DOI 10.1038/nm.3433; Chau Y-Y, 2014, NATURE CELL BIOL; Cinti S, 2001, ADIPOSE ORGAN MORPHO, P319; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; DeMarco VG, 2014, NATURE REV ENDOCRINO; El-Serag HB, 2005, AM J GASTROENTEROL, V100, P2151, DOI 10.1111/j.1572-0241.2005.00251.x; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Greenhill Claire, 2013, Nat Rev Endocrinol, V9, P566, DOI 10.1038/nrendo.2013.156; Hammarstedt A, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-42; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hayward J. S., 1967, MAMMALIAN HIBERNATIO, P346; Jones KE, 2002, BIOL REV, V77, P223, DOI 10.1017/S1464793101005899; Kaiser J, 2013, SCIENCE, V342, P1028, DOI 10.1126/science.342.6162.1028; Kim SG, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.035501; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Lee P, 2012, J CLIN ENDOCRINOLOGY, V98, pE98; Lee YH, 2010, ATHEROSCLEROSIS, V213, P592, DOI 10.1016/j.atherosclerosis.2010.09.012; Lim S, 2012, NAT PROTOC, V7, P606, DOI 10.1038/nprot.2012.013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manolopoulos KN, 2010, INT J OBESITY, V34, P949, DOI 10.1038/ijo.2009.286; McArdle M. A, 2013, FRONTIERS ENDOCRINOL, V4; Nedergaard J, 2013, BBA-MOL CELL BIOL L, V1831, P943, DOI 10.1016/j.bbalip.2013.01.009; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Rosell M, 2014, AM J PHYSIOL-ENDOC M, V306, pE945, DOI 10.1152/ajpendo.00473.2013; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Stier A, 2013, J EXP BIOL; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Walden TB, 2012, AM J PHYSIOL-ENDOC M, V302, pE19, DOI 10.1152/ajpendo.00249.2011; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; Wang Z, 2008, ZOOL STUD, V47, P215; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xue Y, 2009, CELL METAB, V9, P99, DOI 10.1016/j.cmet.2008.11.009; Ye L, 2013, P NATL ACAD SCI USA, V110, P12480, DOI 10.1073/pnas.1310261110; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347	46	7	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112495	10.1371/journal.pone.0112495	http://dx.doi.org/10.1371/journal.pone.0112495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393240	Green Published, gold, Green Submitted			2022-12-27	WOS:000347709300060
J	Hollingdale, J; Greitemeyer, T				Hollingdale, Jack; Greitemeyer, Tobias			The Effect of Online Violent Video Games on Levels of Aggression	PLOS ONE			English	Article							PROSOCIAL BEHAVIOR; PLAY; HOSTILE; EXPOSURE; ADOLESCENTS; COMPETITION; COGNITION; FEELINGS; THOUGHTS; OUTCOMES	Background: In recent years the video game industry has surpassed both the music and video industries in sales. Currently violent video games are among the most popular video games played by consumers, most specifically First-Person Shooters (FPS). Technological advancements in game play experience including the ability to play online has accounted for this increase in popularity. Previous research, utilising the General Aggression Model (GAM), has identified that violent video games increase levels of aggression. Little is known, however, as to the effect of playing a violent video game online. Methods/Principal Findings: Participants (N = 101) were randomly assigned to one of four experimental conditions; neutral video game-offline, neutral video game-online, violent video game-offline and violent video game-online. Following this they completed questionnaires to assess their attitudes towards the game and engaged in a chilli sauce paradigm to measure behavioural aggression. The results identified that participants who played a violent video game exhibited more aggression than those who played a neutral video game. Furthermore, this main effect was not particularly pronounced when the game was played online. Conclusions/Significance: These findings suggest that both playing violent video games online and offline compared to playing neutral video games increases aggression.	[Hollingdale, Jack] Univ Sussex, Sch Psychol, Brighton, E Sussex, England; [Greitemeyer, Tobias] Univ Innsbruck, Inst Psychol, A-6020 Innsbruck, Austria	University of Sussex; University of Innsbruck	Hollingdale, J (corresponding author), Univ Sussex, Sch Psychol, Brighton, E Sussex, England.	jack.hollingdale@live.co.uk			Austrian Science Fund [P23809]; Austrian Science Fund (FWF) [P 23809] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was supported by grant P23809 from the Austrian Science Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi PJC, 2013, J YOUTH ADOLESCENCE, V42, P1041, DOI 10.1007/s10964-013-9913-9; Adachi PJC, 2011, PSYCHOL VIOLENCE, V1, P259, DOI 10.1037/a0024908; Anderson CA, 2002, ANNU REV PSYCHOL, V53, P27, DOI 10.1146/annurev.psych.53.100901.135231; Anderson CA, 2000, J PERS SOC PSYCHOL, V78, P772, DOI 10.1037//0022-3514.78.4.772; Anderson CA, 2004, ADV EXP SOC PSYCHOL, V36, P199, DOI 10.1016/S0065-2601(04)36004-1; Anderson CA, 2001, PSYCHOL SCI, V12, P353, DOI 10.1111/1467-9280.00366; Anderson CA, 2008, PEDIATRICS, V122, pE1067, DOI 10.1542/peds.2008-1425; Anderson CA, 2010, PSYCHOL BULL, V136, P151, DOI 10.1037/a0018251; Anderson CA, 2009, J EXP SOC PSYCHOL, V45, P731, DOI 10.1016/j.jesp.2009.04.019; Barlett CP, 2007, AGGRESSIVE BEHAV, V33, P486, DOI 10.1002/ab.20227; British Broadcasting Corporation (BBC), 2011, CALL DUT ENJ REC SAL; Carnagey NL, 2005, PSYCHOL SCI, V16, P882, DOI 10.1111/j.1467-9280.2005.01632.x; DeLisi M, 2013, YOUTH VIOLENCE JUV J, V11, P132, DOI 10.1177/1541204012460874; Dill K.E., 2005, FEATURING FEMALES FE, P115, DOI DOI 10.1037/11213-008; Eastin MS, 2007, HUM COMMUN RES, V33, P450, DOI 10.1111/j.1468-2958.2007.00307.x; Eastin MS, 2006, COMMUN RES, V33, P448, DOI 10.1177/0093650206293249; Eastin MS, 2006, HUM COMMUN RES, V32, P351, DOI 10.1111/j.1468-2958.2006.00279.x; Elson M, 2014, EUR PSYCHOL, V19, P33, DOI 10.1027/1016-9040/a000147; Entertainment Retailers Association, 2012, VOIC ENT RET; Ewoldsen DR, 2012, CYBERPSYCH BEH SOC N, V15, P277, DOI 10.1089/cyber.2011.0308; Ferguson CJ, 2010, EUR PSYCHOL, V15, P99, DOI 10.1027/1016-9040/a000010; Gentile DA, 2009, PERS SOC PSYCHOL B, V35, P752, DOI 10.1177/0146167209333045; Greitemeyer T, 2014, PERS SOC PSYCHOL B, V40, P578, DOI 10.1177/0146167213520459; Greitemeyer T, 2014, J EXP SOC PSYCHOL, V50, P52, DOI 10.1016/j.jesp.2013.09.004; Greitemeyer T, 2013, SOC PSYCHOL-GERMANY, V44, P408, DOI 10.1027/1864-9335/a000154; Greitemeyer T, 2013, EUR J SOC PSYCHOL, V43, P224, DOI 10.1002/ejsp.1940; Greitemeyer T, 2012, COMPUT HUM BEHAV, V28, P1465, DOI 10.1016/j.chb.2012.03.009; Greitemeyer T, 2012, EUR J SOC PSYCHOL, V42, P235, DOI 10.1002/ejsp.1837; Greitemeyer T, 2011, CURR DIR PSYCHOL SCI, V20, P251, DOI 10.1177/0963721411415229; Greitemeyer T, 2010, J PERS SOC PSYCHOL, V98, P211, DOI 10.1037/a0016997; Greitemeyer T, 2009, J EXP SOC PSYCHOL, V45, P896, DOI 10.1016/j.jesp.2009.04.005; Hollingdale J, 2013, J APPL SOC PSYCHOL, V43, P1862, DOI 10.1111/jasp.12148; Krahe B, 2004, J ADOLESCENCE, V27, P53, DOI 10.1016/j.adolescence.2003.10.006; Lim S, 2010, INT J HUM-COMPUT ST, V68, P57, DOI 10.1016/j.ijhcs.2009.09.008; McGregor HA, 1998, J PERS SOC PSYCHOL, V74, P590, DOI 10.1037/0022-3514.74.3.590; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Moller I, 2009, AGGRESSIVE BEHAV, V35, P75, DOI 10.1002/ab.20290; Pan European Game Information (PEGI), 2013, WHAT DO LAB MEAN; Prot S, 2014, PSYCHOL SCI, V25, P358, DOI 10.1177/0956797613503854; Ritter D, 2005, AGGRESSIVE BEHAV, V31, P407, DOI 10.1002/ab.20066; Rosenthal Robert., 1985, CONTRAST ANAL FOCUSE; Schmierbach M, 2010, COMMUN RES, V37, P256, DOI 10.1177/0093650209356394; Schubert T, 2000, PRES 2000 3 INT WORK; Sherry JL, 2001, HUM COMMUN RES, V27, P409, DOI 10.1093/hcr/27.3.409; Steiger JH, 2004, PSYCHOL METHODS, V9, P164, DOI 10.1037/1082-989X.9.2.164; Tear MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068382; Velez JA, 2014, COMMUN RES, V41, P607, DOI 10.1177/0093650212456202; Wei R, 2007, CYBERPSYCHOL BEHAV, V10, P371, DOI 10.1089/cpb.2006.9942; Williams D, 2005, COMMUN MONOGR, V72, P217, DOI 10.1080/03637750500111781; Willoughby T, 2012, DEV PSYCHOL, V48, P1044, DOI 10.1037/a0026046	50	21	22	20	146	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111790	10.1371/journal.pone.0111790	http://dx.doi.org/10.1371/journal.pone.0111790			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CP	25391143	gold, Green Submitted, Green Published			2022-12-27	WOS:000349144400034
J	Husebye, T; Eritsland, J; Arnesen, H; Bjornerheim, R; Mangschau, A; Seljeflot, I; Andersen, GO				Husebye, Trygve; Eritsland, Jan; Arnesen, Harald; Bjornerheim, Reidar; Mangschau, Arild; Seljeflot, Ingebjorg; Andersen, Geir Oystein			Association of Interleukin 8 and Myocardial Recovery in Patients with ST-Elevation Myocardial Infarction Complicated by Acute Heart Failure	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; CYTOKINE LEVELS; LEVOSIMENDAN; DYSFUNCTION; RECEPTORS; TRIAL	Background: No data from controlled trials exists regarding the inflammatory response in patients with de novo heart failure (HF) complicating ST-elevation myocardial infarction (STEMI) and a possible role in the recovery of contractile function. We therefore explored the time course and possible associations between levels of inflammatory markers and recovery of impaired left ventricular function as well as levosimendan treatment in STEMI patients in a substudy of the LEvosimendan in Acute heart Failure following myocardial infarction (LEAF) trial. Methods: A total of 61 patients developing HF within 48 hours after a primary PCI-treated STEMI were randomised double-blind to a 25 hours infusion of levosimendan or placebo. Levels of IL-6, CRP, sIL-6R, sgp130, MCP-1, IL-8, MMP-9, sICAM-1, sVCAM-1 and TNF-alpha were measured at inclusion (median 22 h, interquartile range (IQR) 14, 29 after PCI), on day 1, day 2, day 5 and 6 weeks. Improvement in left ventricular function was evaluated as change in wall motion score index (WMSI) by echocardiography. Results: Only circulating levels of IL-8 at inclusion were associated with change in WMSI from baseline to 6 weeks, r = divided by 0.41 (p = 0.002). No association, however, was found between IL-8 and WMSI at inclusion or peak troponin T. Furthermore, there was a significant difference in change in WMSI from inclusion to 6 weeks between patients with IL-8 levels below, compared to above median value, divided by 0.44 (IQR divided by 0.57, divided by 0.19) vs. divided by 0.07 (IQR divided by 0.27, 0.07), respectively (p<0.0001). Levosimendan did not affect the levels of inflammary markers compared to control. Conclusion: High levels of IL-8 in STEMI patients complicated with HF were associated with less improvement in left ventricular function during the first 6 weeks after PCI, suggesting a possible role of IL-8 in the reperfusion-related injury of post-ischemic myocardium. Further studies are needed to confirm this hypothesis.	[Husebye, Trygve; Eritsland, Jan; Bjornerheim, Reidar; Mangschau, Arild; Seljeflot, Ingebjorg; Andersen, Geir Oystein] Univ Oslo, Hosp Ulleval, Dept Cardiol, Oslo, Norway; [Arnesen, Harald; Seljeflot, Ingebjorg; Andersen, Geir Oystein] Univ Oslo, Hosp Ulleval, Ctr Clin Heart Res, Oslo, Norway; [Husebye, Trygve; Eritsland, Jan; Arnesen, Harald; Bjornerheim, Reidar; Mangschau, Arild; Seljeflot, Ingebjorg; Andersen, Geir Oystein] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Husebye, Trygve; Arnesen, Harald; Seljeflot, Ingebjorg] Univ Oslo, Fac Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Husebye, T (corresponding author), Univ Oslo, Hosp Ulleval, Dept Cardiol, Oslo, Norway.	tr-huse@online.no	Andersen, Geir/AAR-3010-2020		Orion Pharma; Centre for Heart Failure Research University of Oslo; South-Eastern Norway Regional Health Authority; Scientific Council at Oslo University Hospital Ulleval	Orion Pharma; Centre for Heart Failure Research University of Oslo; South-Eastern Norway Regional Health Authority; Scientific Council at Oslo University Hospital Ulleval	The Centre for Heart Failure Research University of Oslo, South-Eastern Norway Regional Health Authority, The Scientific Council at Oslo University Hospital Ulleval, an unrestricted grant from Orion Pharma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen GO, 2011, HEART, V97, P460, DOI 10.1136/hrt.2010.206714; Avgeropoulou C, 2005, EUR J HEART FAIL, V7, P882, DOI 10.1016/j.ejheart.2005.02.002; Bolognese L, 2004, CIRCULATION, V109, P1121, DOI 10.1161/01.CIR.0000118496.44135.A7; Chen David, 2008, Crit Care Med, V36, pS9, DOI 10.1097/01.CCM.0000297160.48694.90; Deswal A, 2001, CIRCULATION, V103, P2055; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Gerber BL, 2000, CIRCULATION, V101, P2734, DOI 10.1161/01.CIR.101.23.2734; Gibbons RJ, 2000, CIRCULATION, V101, P101, DOI 10.1161/01.CIR.101.1.101; Heymans S, 2009, EUR J HEART FAIL, V11, P119, DOI 10.1093/eurjhf/hfn043; Husebye T, 2013, EUR J HEART FAIL, V15, P565, DOI 10.1093/eurjhf/hfs215; Kanda T, 2000, CARDIOLOGY, V93, P191, DOI 10.1159/000007025; LEVINE B, 1990, NEW ENGL J MED, V323, P236, DOI 10.1056/NEJM199007263230405; Limalanathan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071780; Miettinen KH, 2008, EUR J HEART FAIL, V10, P396, DOI 10.1016/j.ejheart.2008.02.008; Milo-Cotter O, 2011, CARDIOLOGY, V119, P96, DOI 10.1159/000330409; Niccoli G, 2009, J AM COLL CARDIOL, V54, P281, DOI 10.1016/j.jacc.2009.03.054; Nijveldt R, 2008, J AM COLL CARDIOL, V52, P181, DOI 10.1016/j.jacc.2008.04.006; Nymo SH, 2014, EUR J HEART FAIL, V16, P68, DOI 10.1093/eurjhf/hft125; Parissis JT, 2008, ATHEROSCLEROSIS, V197, P278, DOI 10.1016/j.atherosclerosis.2007.04.023; Parissis JT, 2004, AM J CARDIOL, V93, P1309, DOI 10.1016/j.amjcard.2004.01.073; Ritschel Vibeke N, 2014, Results Immunol, V4, P8, DOI 10.1016/j.rinim.2013.11.002; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Solheim S, 2008, SCAND J CLIN LAB INV, V68, P555, DOI 10.1080/00365510701884584; Suzuki H, 2005, INT J CARDIOL, V100, P415, DOI 10.1016/j.ijcard.2004.08.041; TorreAmione G, 1996, J AM COLL CARDIOL, V27, P1201, DOI 10.1016/0735-1097(95)00589-7; Trikas A, 2006, EUR J HEART FAIL, V8, P804, DOI 10.1016/j.ejheart.2006.03.003; Ueda K, 1999, AM HEART J, V138, P908, DOI 10.1016/S0002-8703(99)70016-5; Unverzagt S, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009669.pub2	28	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112359	10.1371/journal.pone.0112359	http://dx.doi.org/10.1371/journal.pone.0112359			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390695	Green Submitted, gold, Green Published			2022-12-27	WOS:000349144400074
J	Favaro, B; Claar, DC; Fox, CH; Freshwater, C; Holden, JJ; Roberts, A				Favaro, Brett; Claar, Danielle C.; Fox, Caroline H.; Freshwater, Cameron; Holden, Jessica J.; Roberts, Allan		Uvic Res Derby	Trends in Extinction Risk for Imperiled Species in Canada	PLOS ONE			English	Article							HABITAT LOSS; RECOVERY; THREATS; FISHES; BIODIVERSITY; ECOSYSTEM; SCIENCE; ACT	Protecting and promoting recovery of species at risk of extinction is a critical component of biodiversity conservation. In Canada, the Committee on the Status of Endangered Wildlife in Canada (COSEWIC) determines whether species are at risk of extinction or extirpation, and has conducted these assessments since 1977. We examined trends in COSEWIC assessments to identify whether at-risk species that have been assessed more than once tended to improve, remain constant, or deteriorate in status, as a way of assessing the effectiveness of biodiversity conservation in Canada. Of 369 species that met our criteria for examination, 115 deteriorated, 202 remained unchanged, and 52 improved in status. Only 20 species (5.4%) improved to the point where they were 'not at risk', and five of those were due to increased sampling efforts rather than an increase in population size. Species outcomes were also dependent on the severity of their initial assessment; for example, 47% of species that were initially listed as special concern deteriorated between assessments. After receiving an at-risk assessment by COSEWIC, a species is considered for listing under the federal Species at Risk Act (SARA), which is the primary national tool that mandates protection for at-risk species. We examined whether SARA-listing was associated with improved COSEWIC assessment outcomes relative to unlisted species. Of 305 species that had multiple assessments and were SARA-listed, 221 were listed at a level that required identification and protection of critical habitat; however, critical habitat was fully identified for only 56 of these species. We suggest that the Canadian government should formally identify and protect critical habitat, as is required by existing legislation. In addition, our finding that at-risk species in Canada rarely recover leads us to recommend that every effort be made to actively prevent species from becoming at-risk in the first place.	[Favaro, Brett; Claar, Danielle C.; Freshwater, Cameron; Holden, Jessica J.] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; [Favaro, Brett] Mem Univ Newfoundland, Fisheries & Marine Inst, Ctr Sustainable Aquat Resources, St John, NF, Canada; [Favaro, Brett] Mem Univ Newfoundland, Dept Ocean Sci, St John, NF, Canada; [Fox, Caroline H.] Univ Victoria, Dept Geog, Victoria, BC, Canada; [Fox, Caroline H.] Raincoast Conservat Fdn, Sidney, BC, Canada; [Roberts, Allan] Bamfield Marine Sci Ctr, Bamfield East, BC, Canada; [Uvic Res Derby] Univ Victoria, Sch Environm Studies, Victoria, BC, Canada	University of Victoria; Memorial University Newfoundland; Memorial University Newfoundland; University of Victoria; Simon Fraser University; University of Victoria	Favaro, B (corresponding author), Univ Victoria, Dept Biol, POB 1700, Victoria, BC V8W 2Y2, Canada.	brett.favaro@mi.mun.ca	Claar, Danielle/AAP-9348-2020	Claar, Danielle/0000-0003-2389-111X	Liber Ero postdoctoral fellowship; Raincoast Conservation Foundation; National Sciences and Engineering Research Council of Canada; University of Victoria Graduate Fellowships	Liber Ero postdoctoral fellowship; Raincoast Conservation Foundation; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Victoria Graduate Fellowships	BF was supported by a Liber Ero postdoctoral fellowship (http://liberero.ca/). CHF was supported by the Raincoast Conservation Foundation (http://www.raincoast.org/) and the National Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/). DCC and CF were supported by University of Victoria Graduate Fellowships. Catering for the UVIC Research Derby event was provided by the University of Victoria Environmental Science and Biology departments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, SARA SPECIES RISK AC, V29, P15; Arponen A, 2012, BIODIVERS CONSERV, V21, P875, DOI 10.1007/s10531-012-0242-1; Auditor General of Canada, 2013, AN REP COMM ENV SUST, P1; Barton J, 2010, ENVIRON SCI TECHNOL, V44, P3947, DOI 10.1021/es903183r; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Canada Gazette, 2013, SPEC RISK ACT; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Christensen R., 2013, R PACKAGE VERSION 20, P08; Christensen R. H. B., 2013, TUTORIAL FITTING CUM; Convention on Biological Diversity, 2010, GLOBAL BIODIVERSITY; COSEWIC, 2011, COSEWICS ASS PROC CR; COSEWIC, 2013, TERMS REF COMM STAT; COSEWIC, 2013, DAT WILDL SPEC ASS C; COSEWIC, 2005, OR CRIT DEF US STAT; Favaro B, 2013, IDEAS ECOL EVOL, V6, P40, DOI 10.4033/iee.2013.6.9.n; Favaro B, 2012, SCIENCE, V337, P154, DOI 10.1126/science.1225523; Findlay CS, 2009, CONSERV BIOL, V23, P1609, DOI 10.1111/j.1523-1739.2009.01255.x; Government of Canada, 2014, SPEC RISK ACT PUBL R; Hassan RM, 2005, FINDINGS CONDITION T; Homan RN, 2004, ECOL APPL, V14, P1547, DOI 10.1890/03-5125; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hutchings JA, 2013, FISHERIES, V38, P497, DOI 10.1080/03632415.2013.848345; IUCN, 2022, GUID US IUCN RED LIS; KAREIVA P, 1995, NATURE, V373, P299, DOI 10.1038/373299a0; Kirchhoff D, 2014, IMPACT ASSESS PROJ A, V32, P108, DOI 10.1080/14615517.2014.894673; Kowalchuk KA, 2012, ECOL SOC, V17, DOI 10.5751/ES-04893-170304; Lukey JR, 2010, CONSERV BIOL, V24, P1398, DOI 10.1111/j.1523-1739.2010.01555.x; Lukey JR, 2009, CAN J FISH AQUAT SCI, V66, P959, DOI 10.1139/F09-054; McCune JL, 2013, BIOL CONSERV, V166, P254, DOI 10.1016/j.biocon.2013.07.006; Mooers AO, 2007, CONSERV BIOL, V21, P572, DOI 10.1111/j.1523-1739.2007.00689.x; Mooers AO, 2010, BIOSCIENCE, V60, P843, DOI 10.1525/bio.2010.60.10.11; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Powles H, 2011, FISHERIES, V36, P231, DOI 10.1080/03632415.2011.574582; R Core Team, 2021, R LANGUAGE ENV STAT; Rands MRW, 2010, SCIENCE, V329, P1298, DOI 10.1126/science.1189138; Redford KH, 2011, BIOSCIENCE, V61, P39, DOI 10.1525/bio.2011.61.1.9; Schultz JA, 2013, MAR POLICY, V42, P125, DOI 10.1016/j.marpol.2013.01.021; Taylor EB, 2013, ENVIRON REV, V21, P93, DOI 10.1139/er-2013-0002; Taylor MFJ, 2011, BIODIVERS CONSERV, V20, P767, DOI 10.1007/s10531-010-9977-8; Taylor MFJ, 2005, BIOSCIENCE, V55, P360, DOI 10.1641/0006-3568(2005)055[0360:TEOTES]2.0.CO;2; Tutz G, 1996, COMPUT STAT DATA AN, V22, P537, DOI 10.1016/0167-9473(96)00004-7; VanderZwaag DL, 2005, OCEAN DEV INT LAW, V36, P219, DOI 10.1080/00908320591004333; Venter O, 2006, BIOSCIENCE, V56, P903, DOI 10.1641/0006-3568(2006)56[903:TTESIC]2.0.CO;2; Waples RS, 2013, BIOSCIENCE, V63, P723, DOI 10.1525/bio.2013.63.9.8; Westwood A, 2014, BIOL CONSERV, V172, P155, DOI 10.1016/j.biocon.2014.02.031; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420	46	38	39	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113118	10.1371/journal.pone.0113118	http://dx.doi.org/10.1371/journal.pone.0113118			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401772	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000345158700115
J	Ganesan, AN; Kuklik, P; Gharaviri, A; Brooks, A; Chapman, D; Lau, DH; Roberts-Thomson, KC; Sanders, P				Ganesan, Anand N.; Kuklik, Pawel; Gharaviri, Ali; Brooks, Anthony; Chapman, Darius; Lau, Dennis H.; Roberts-Thomson, Kurt C.; Sanders, Prashanthan			Origin and Characteristics of High Shannon Entropy at the Pivot of Locally Stable Rotors: Insights from Computational Simulation	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; RECORDING TECHNIQUES; ELECTROGRAMS; ABLATION	Background: Rotors are postulated to maintain cardiac fibrillation. Despite the importance of bipolar electrograms in clinical electrophysiology, few data exist on the properties of bipolar electrograms at rotor sites. The pivot of a spiral wave is characterized by relative uncertainty of wavefront propagation direction compared to the periphery. The bipolar electrograms used in electrophysiology recording encode information on both direction and timing of approaching wavefronts. Objective: To test the hypothesis that bipolar electrograms from the pivot of rotors have higher Shannon entropy (ShEn) than electrograms recorded at the periphery due to the spatial dynamics of spiral waves. Methods and Results: We studied spiral wave propagation in 2-dimensional sheets constructed using a simple cell automaton (FitzHugh-Nagumo), atrial (Courtemanche-Ramirez-Nattel) and ventricular (Luo-Rudy) myocyte cell models and in a geometric model spiral wave. In each system, bipolar electrogram recordings were simulated, and Shannon entropy maps constructed as a measure of electrogram information content. ShEn was consistently highest in the pivoting region associated with the phase singularity of the spiral wave. This property was consistently preserved across; (i) variation of model system (ii) alterations in bipolar electrode spacing, (iii) alternative bipolar electrode orientation (iv) bipolar electrogram filtering and (v) in the presence of rotor meander. Directional activation plots demonstrated that the origin of high ShEn at the pivot was the directional diversity of wavefront propagation observed in this location. Conclusions: The pivot of the rotor is consistently associated with high Shannon entropy of bipolar electrograms despite differences in action potential model, bipolar electrode spacing, signal filtering and rotor meander. Maximum ShEn is colocated with the pivot for rotors observed in the bipolar electrogram recording mode, and may be an intrinsic property of spiral wave dynamic behaviour.	[Ganesan, Anand N.; Brooks, Anthony; Chapman, Darius; Lau, Dennis H.; Roberts-Thomson, Kurt C.; Sanders, Prashanthan] Univ Adelaide, SAHMRI, CHRD, Adelaide, SA, Australia; [Ganesan, Anand N.; Brooks, Anthony; Chapman, Darius; Lau, Dennis H.; Roberts-Thomson, Kurt C.; Sanders, Prashanthan] Royal Adelaide Hosp, Adelaide, SA 5000, Australia; [Kuklik, Pawel; Gharaviri, Ali] Maastricht Univ, Med Ctr, Dept Physiol, Maastricht, Netherlands; [Kuklik, Pawel] Univ Heart Ctr, Dept Cardiol, Hamburg, Germany	South Australian Health & Medical Research Institute (SAHMRI); University of Adelaide; Royal Adelaide Hospital; Maastricht University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Ganesan, AN (corresponding author), Univ Adelaide, SAHMRI, CHRD, Adelaide, SA, Australia.	anand.ganesan@adelaide.edu.au	Lau, Dennis H/G-6234-2013; Ganesan, Anand/AAG-9125-2021; Ganesan, Anand N/A-4902-2019; Gharaviri, Ali/K-6200-2017; Kuklik, Pawel/A-8813-2011; Sanders, Prashanthan/D-7641-2013	Lau, Dennis H/0000-0001-7753-1318; Ganesan, Anand/0000-0002-2734-3025; Ganesan, Anand N/0000-0002-2734-3025; Gharaviri, Ali/0000-0003-1803-8237; Kuklik, Pawel/0000-0001-8440-654X; Sanders, Prashanthan/0000-0003-3803-8429	Heart Rhythm Society; Asia Pacific Heart Rhythm Society	Heart Rhythm Society; Asia Pacific Heart Rhythm Society	The authors acknowledge the kind advice regarding presentation of Dr Sonia Cortassa, Division of Cardiology, Johns Hopkins University School of Medicine. Presented in part by Dr Ganesan who was awarded the Heart Rhythm Society Young Investigator Award (Clinical), May 2012, published in abstract form in Heart Rhythm 2012 9:5 SUPPL. 1 (S494-S495), and Asia Pacific Heart Rhythm Society Young Investigator Award (Basic Science), October 2012.	Allessie MA, 2010, CIRC-ARRHYTHMIA ELEC, V3, P606, DOI 10.1161/CIRCEP.109.910125; Alonso S, 2007, CHAOS, V17, DOI 10.1063/1.2430638; Courtemanche M, 1998, AM J PHYSIOL-HEART C, V275, pH301, DOI 10.1152/ajpheart.1998.275.1.H301; DAVIDENKO JM, 1992, NATURE, V355, P349, DOI 10.1038/355349a0; de Bakker JMT, 2010, CIRC-ARRHYTHMIA ELEC, V3, P204, DOI 10.1161/CIRCEP.109.904763; de Groot NMS, 2010, CIRCULATION, V122, P1674, DOI 10.1161/CIRCULATIONAHA.109.910901; Ganesan AN, 2013, CIRC-ARRHYTHMIA ELEC, V6, P48, DOI 10.1161/CIRCEP.112.976654; Gray RA, 1998, NATURE, V392, P75, DOI 10.1038/32164; Haissaguerre M, 2013, J CARDIOVASC ELECTRO; Iyer AN, 2001, ANN BIOMED ENG, V29, P47, DOI 10.1114/1.1335538; Jalife J, 2011, CARDIOVASC RES, V89, P766, DOI 10.1093/cvr/cvq364; Kuklik P, 2010, COMPUT BIOL MED, V40, P775, DOI 10.1016/j.compbiomed.2010.07.005; LUO CH, 1991, CIRC RES, V68, P1501, DOI 10.1161/01.RES.68.6.1501; Maalmivuo JPR, 1995, BIOELECTROMAGNETISM; Mandapati R, 2000, CIRCULATION, V101, P194, DOI 10.1161/01.CIR.101.2.194; Narayan SM, 2012, J AM COLL CARDIOL, V60, P628, DOI 10.1016/j.jacc.2012.05.022; Ng J, 2010, J CARDIOVASC ELECTR, V21, P649, DOI 10.1111/j.1540-8167.2009.01695.x; Qu ZL, 2000, ANN BIOMED ENG, V28, P755, DOI 10.1114/1.1289474; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Skanes AC, 1998, CIRCULATION, V98, P1236, DOI 10.1161/01.CIR.98.12.1236; Stevenson WG, 2005, J CARDIOVASC ELECTR, V16, P1017, DOI 10.1111/j.1540-8167.2005.50155.x; Umapathy K, 2008, HEART RHYTHM, V5, P1029, DOI 10.1016/j.hrthm.2008.03.022; Winfree AT, 1990, GEOMETRY BIOL TIME, pp440; Zlochiver S, 2008, HEART RHYTHM, V5, P846, DOI 10.1016/j.hrthm.2008.03.010	24	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e110662	10.1371/journal.pone.0110662	http://dx.doi.org/10.1371/journal.pone.0110662			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401331	Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700007
J	Qin, GM; Luo, LS; Lv, LH; Xiao, YF; Tu, JF; Tao, LS; Wu, JQ; Tang, XX; Pan, WS				Qin, Guangming; Luo, Laisheng; Lv, Lihong; Xiao, Yufei; Tu, Jiangfeng; Tao, Lisha; Wu, Jiaqi; Tang, Xiaoxiao; Pan, Wensheng			Decision Tree Analysis of Traditional Risk Factors of Carotid Atherosclerosis and a Cutpoint-Based Prevention Strategy	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS	Background: Reducing the exposure to risk factors for the prevention of cardio-cerebral vascular disease is a crucial issue. Few reports have described practical interventions for preventing cardiovascular disease in different genders and age groups, particularly detailed and specific cutpoint-based prevention strategies. Methods: We collected the health examination data of 5822 subjects between 20 and 80 years of age. The administration of medical questionnaires and physical examinations and the measurement of blood pressure, fasting plasma glucose (FPG) and blood lipids [total cholesterol (TC), triglycerides (TG), high density lipoprotein-cholesterol (HDL-C), and low density lipoprotein-cholesterol (LDL-C)] were performed by physicians. Carotid ultrasound was performed to examine the carotid intima-media thickness (CIMT), which was defined as carotid atherosclerosis when CIMT >= 0.9 mm. Decision tree analysis was used to screen for the most important risk factors for carotid atherosclerosis and to identify the relevant cutpoints. Results: In the study population, the incidence of carotid atherosclerosis was 12.20% (men: 14.10%, women: 9.20%). The statistical analysis showed significant differences in carotid atherosclerosis incidence between different genders (P, 0.0001) and age groups (P, 0.001). The decision tree analysis showed that in men, the most important traditional risk factors for carotid atherosclerosis were TC (cutpoint [CP]: 6.31 mmol/L) between the ages of 20-40 and FPG (CP: 5.79 mmol/L) between the ages of 41-59. By comparison, LDL-C (CP: 4.27 mmol/L) became the major risk factor when FPG <= 5.79 mmol/L. FPG (CP: 5.52 mmol/L) and TG (CP: 1.51 mmol/L) were the most important traditional risk factors for women between 20-40 and 41-59 years of age, respectively. Conclusion: Traditional risk factors and relevant cutpoints were not identical in different genders and age groups. A specific gender and age group-based cutpoint strategy might contribute to preventing cardiovascular disease.	[Qin, Guangming; Xiao, Yufei] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Luo, Laisheng; Lv, Lihong; Tu, Jiangfeng; Tao, Lisha; Wu, Jiaqi; Tang, Xiaoxiao; Pan, Wensheng] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Pan, Wensheng] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Pan, WS (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China.	wspan223@163.com			National Health Key Special Fund [200802112]; Health Department Fund [2007A093]; Traditional Chinese Medicine Bureau Fund [2007ZA019]; Natural Science Fund of Zhejiang Province [Y2080001, Y12H160121]; Zhejiang Province Education Department Fund [Y201121724]; Zhejiang Province Health Department Fund [201343550]; Key Project of Zhejiang Province [2009C03012-5, 2013C03044-5]; National Natural Science Foundation of China [81372302]	National Health Key Special Fund; Health Department Fund; Traditional Chinese Medicine Bureau Fund; Natural Science Fund of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Zhejiang Province Education Department Fund; Zhejiang Province Health Department Fund; Key Project of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the National Health Key Special Fund (No. 200802112), the Health Department Fund (No. 2007A093), the Traditional Chinese Medicine Bureau Fund (No. 2007ZA019), the Natural Science Fund of Zhejiang Province (No. Y2080001 and Y12H160121), the Zhejiang Province Education Department Fund (No. Y201121724), the Zhejiang Province Health Department Fund (No. 201343550), the Key Project of Zhejiang Province (No. 2009C03012-5 and No. 2013C03044-5) and the National Natural Science Foundation of China (general project No. 81372302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer MS, 2014, AM J CARDIOVASC DIS, V4, P14; Bauer M, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13705; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P866; Chevalier P, 2013, CIRC-ARRHYTHMIA ELEC, V6, P185, DOI 10.1161/CIRCEP.112.970459; Chinese Society of Cardiology, 2013, CHINESE J CARDIOLOGY, V41, P820; Crooke Michael, 2007, Clin Biochem Rev, V28, P19; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P177, DOI 10.1161/ATVBAHA.108.173609; Gandomi AH, 2013, SCI WORLD J, DOI 10.1155/2013/346285; George JM, 2013, J CLIN DIAGN RES, V7, P1082, DOI 10.7860/JCDR/2013/4767.3029; Hamirani YS, 2010, ATHEROSCLEROSIS, V211, P141, DOI 10.1016/j.atherosclerosis.2010.01.020; Johnsen SH, 2007, STROKE, V38, P2873, DOI 10.1161/STROKEAHA.107.487264; Khalil A, 2013, INT J CARDIOL, V167, P1322, DOI 10.1016/j.ijcard.2012.03.180; Kozakova M, 2013, ARTERIOSCL THROM VAS, V33, P1409, DOI 10.1161/ATVBAHA.112.300948; Kweon SS, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-112; Liu Li-Sheng, 2011, Zhonghua Xin Xue Guan Bing Za Zhi, V39, P579; Lorenz MW, 2012, LANCET, V379, P2053, DOI 10.1016/S0140-6736(12)60441-3; Marshall RJ, 2001, J CLIN EPIDEMIOL, V54, P603, DOI 10.1016/S0895-4356(00)00344-9; Pearson TA, 2002, CIRCULATION, V105, P886, DOI 10.1161/hc0702.103727; Rundek T, 2013, STROKE, V44, P2101, DOI 10.1161/STROKEAHA.111.000745; Sirimarco G, 2013, STROKE, V44, P373, DOI 10.1161/STROKEAHA.112.673129; Sun Jia-Yi, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P649; Tabatabaei-Malazy O, 2012, J DIABETES METAB DIS, V11, DOI 10.1186/2251-6581-11-13; Takahashi R, 2012, INT HEART J, V53, P29, DOI 10.1536/ihj.53.29; Ton VK, 2013, CLIN CARDIOL, V36, pE1, DOI 10.1002/clc.22079; Viikki K, 2001, J Med Syst, V25, P133, DOI 10.1023/A:1005624715089; Wang Wei, 2010, Zhonghua Xin Xue Guan Bing Za Zhi, V38, P1118; Wang Wei, 2010, Zhonghua Xin Xue Guan Bing Za Zhi, V38, P553; [杨颖 YANG Ying], 2010, [中华超声影像学杂志, Chinese Journal of Ultrasonography], V19, P120	28	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e111769	10.1371/journal.pone.0111769	http://dx.doi.org/10.1371/journal.pone.0111769			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398126	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500025
J	Strickland, DH; Fear, V; Shenton, S; Wikstrom, ME; Zosky, G; Larcombe, AN; Holt, PG; Berry, C; von Garnier, C; Stumbles, PA				Strickland, Deborah H.; Fear, Vanessa; Shenton, Seth; Wikstrom, Mathew E.; Zosky, Graeme; Larcombe, Alexander N.; Holt, Patrick G.; Berry, Cassandra; von Garnier, Christophe; Stumbles, Philip A.			Persistent and Compartmentalised Disruption of Dendritic Cell Subpopulations in the Lung following Influenza A Virus Infection	PLOS ONE			English	Article							RESPIRATORY-SYNCYTIAL-VIRUS; COLONY-STIMULATING FACTOR; CD8 T-CELLS; MHC CLASS-I; AIRWAY EPITHELIUM; ANTIGEN PRESENTATION; ALLERGIC DISEASE; EARLY-LIFE; AGE 13; INDUCTION	Immunological homeostasis in the respiratory tract is thought to require balanced interactions between networks of dendritic cell (DC) subsets in lung microenvironments in order to regulate tolerance or immunity to inhaled antigens and pathogens. Influenza A virus (IAV) poses a serious threat of long-term disruption to this balance through its potent pro-inflammatory activities. In this study, we have used a BALB/c mouse model of A/PR8/34 H1N1 Influenza Type A Virus infection to examine the effects of IAV on respiratory tissue DC subsets during the recovery phase following clearance of the virus. In adult mice, we found differences in the kinetics and activation states of DC residing in the airway mucosa (AMDC) compared to those in the parenchymal lung (PLDC) compartments. A significant depletion in the percentage of AMDC was observed at day 4 post-infection that was associated with a change in steady-state CD11b(+) and CD11b(-) AMDC subset frequencies and significantly elevated CD40 and CD80 expression and that returned to baseline by day 14 post-infection. In contrast, percentages and total numbers of PLDC were significantly elevated at day 14 and remained so until day 21 post-infection. Accompanying this was a change in CD11b(+) and CD11b(-) PLDC subset frequencies and significant increase in CD40 and CD80 expression at these time points. Furthermore, mice infected with IAV at 4 weeks of age showed a significant increase in total numbers of PLDC, and increased CD40 expression on both AMDC and PLDC, when analysed as adults 35 days later. These data suggest that the rate of recovery of DC populations following IAV infection differs in the mucosal and parenchymal compartments of the lung and that DC populations can remain disrupted and activated for a prolonged period following viral clearance, into adulthood if infection occurred early in life.	[Strickland, Deborah H.; Fear, Vanessa; Shenton, Seth; Wikstrom, Mathew E.; Zosky, Graeme; Larcombe, Alexander N.; Holt, Patrick G.; von Garnier, Christophe; Stumbles, Philip A.] Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; [Strickland, Deborah H.; Fear, Vanessa; Shenton, Seth; Wikstrom, Mathew E.; Zosky, Graeme; Larcombe, Alexander N.; Holt, Patrick G.; von Garnier, Christophe; Stumbles, Philip A.] Univ Western Australia, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Shenton, Seth; Berry, Cassandra; Stumbles, Philip A.] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Zosky, Graeme] Univ Tasmania, Sch Med, Hobart, Tas, Australia; [Holt, Patrick G.] Univ Queensland, Queensland Childrens Med Res Inst, Brisbane, Qld, Australia; [von Garnier, Christophe] Univ Bern, Univ Hosp Bern, Bern, Switzerland; [von Garnier, Christophe] Univ Bern, Dept Clin Res, Bern, Switzerland	Telethon Kids Institute; University of Western Australia; University of Western Australia; Murdoch University; University of Tasmania; University of Queensland; University of Bern; University Hospital of Bern; University of Bern	Stumbles, PA (corresponding author), Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia.	p.stumbles@murdoch.edu.au	Fear, Vanessa/O-5618-2019; Zosky, Graeme/B-2048-2014; Larcombe, Alexander/AAG-8533-2019; Berry, Cassandra/AAX-7145-2020; Holt, Patrick G/H-1548-2011; Strickland, Deborah/AGV-6937-2022; Fear, Vanessa S/AAF-9805-2020; strickland, deborah/K-4597-2019	Larcombe, Alexander/0000-0003-4196-4482; Holt, Patrick G/0000-0003-1193-0935; Strickland, Deborah/0000-0003-0114-4201; Fear, Vanessa S/0000-0001-8363-6685; Berry, Cassandra/0000-0003-0768-0857; von Garnier, Christophe/0000-0003-3585-9176; Zosky, Graeme/0000-0001-9039-0302	National Health and Medical Research Council of Australia [211912, 437200]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia (APP ID 211912, 437200; www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Garawi AA, 2009, J IMMUNOL, V182, P3095, DOI 10.4049/jimmunol.0802837; Beaty SR, 2007, J IMMUNOL, V178, P1882, DOI 10.4049/jimmunol.178.3.1882; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Beyer M, 2004, J ALLERGY CLIN IMMUN, V113, P127, DOI 10.1016/j.jaci.2003.10.057; BILYK N, 1993, J EXP MED, V177, P1773, DOI 10.1084/jem.177.6.1773; Bozanicha EM, 2008, RESP PHYSIOL NEUROBI, V162, P190, DOI 10.1016/j.resp.2008.06.011; Brimnes MK, 2003, J EXP MED, V198, P133, DOI 10.1084/jem.20030266; Cull VS, 2002, IMMUNOLOGY, V106, P428, DOI 10.1046/j.1365-2567.2002.01423.x; Dahl ME, 2004, NAT IMMUNOL, V5, P337, DOI 10.1038/ni1041; Eyles JL, 2006, NAT CLIN PRACT RHEUM, V2, P500, DOI 10.1038/ncprheum0291; Fear VS, 2011, J IMMUNOL, V187, P4561, DOI 10.4049/jimmunol.1004189; Gern JE, 2008, PEDIATR INFECT DIS J, V27, pS97, DOI 10.1097/INF.0b013e318168b718; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Gill MA, 2005, J INFECT DIS, V191, P1105, DOI 10.1086/428589; Hantos Z, 2003, J APPL PHYSIOL, V95, P1695, DOI 10.1152/japplphysiol.00104.2003; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Ho AWS, 2011, J IMMUNOL, V187, P6011, DOI 10.4049/jimmunol.1100987; Holt PG, 2008, NAT REV IMMUNOL, V8, P142, DOI 10.1038/nri2236; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Ingulli E, 2009, J IMMUNOL, V182, P29, DOI 10.4049/jimmunol.182.1.29; Iwane MK, 2004, PEDIATRICS, V113, P1758, DOI 10.1542/peds.113.6.1758; Julia V, 2002, IMMUNITY, V16, P271, DOI 10.1016/S1074-7613(02)00276-5; Kim TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004204; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Lambrecht BN, 2010, LANCET, V376, P835, DOI 10.1016/S0140-6736(10)61226-3; Legge KL, 2003, IMMUNITY, V18, P265, DOI 10.1016/S1074-7613(03)00023-2; Lemanske RF, 2005, J ALLERGY CLIN IMMUN, V116, P571, DOI 10.1016/j.jaci.2005.06.024; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; McWilliam AS, 1997, J VIROL, V71, P226, DOI 10.1128/JVI.71.1.226-236.1997; McWilliam AS, 1996, J EXP MED, V184, P2429, DOI 10.1084/jem.184.6.2429; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Moltedo B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002345; Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013; Sigurs N, 2005, AM J RESP CRIT CARE, V171, P137, DOI 10.1164/rccm.200406-730OC; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Southam DS, 2002, AM J PHYSIOL-LUNG C, V282, pL833, DOI 10.1152/ajplung.00173.2001; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; STERK PJ, 1993, EUR RESPIR J, V6, P894; Stumbles PA, 1998, J EXP MED, V188, P2019, DOI 10.1084/jem.188.11.2019; Stumbles PA, 2001, J IMMUNOL, V167, P228, DOI 10.4049/jimmunol.167.1.228; Stumbles PA, 2010, METHODS MOL BIOL, V595, P249, DOI 10.1007/978-1-60761-421-0_17; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Suzuki S, 1998, J ALLERGY CLIN IMMUN, V102, P732, DOI 10.1016/S0091-6749(98)70012-0; Tsitoura DC, 2000, J IMMUNOL, V165, P3484, DOI 10.4049/jimmunol.165.6.3484; von Garnier C, 2005, J IMMUNOL, V175, P1609, DOI 10.4049/jimmunol.175.3.1609; von Garnier C, 2007, J IMMUNOL, V179, P5748, DOI 10.4049/jimmunol.179.9.5748; Wikstrom ME, 2007, IMMUNOL CELL BIOL, V85, P182, DOI 10.1038/sj.icb.7100039; Wikstrom ME, 2006, J IMMUNOL, V177, P913, DOI 10.4049/jimmunol.177.2.913; Yoo JK, 2013, J ALLERGY CLIN IMMUN, V132, P1263, DOI 10.1016/j.jaci.2013.06.006; Zosky GR, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-15	51	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e111520	10.1371/journal.pone.0111520	http://dx.doi.org/10.1371/journal.pone.0111520			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398128	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558500018
J	Erb, S; Sidler, JA; Elzi, L; Gurke, L; Battegay, M; Widmer, AF; Weisser, M				Erb, Stefan; Sidler, Jan A.; Elzi, Luigia; Gurke, Lorenz; Battegay, Manuel; Widmer, Andreas F.; Weisser, Maja			Surgical and Antimicrobial Treatment of Prosthetic Vascular Graft Infections at Different Surgical Sites: A Retrospective Study of Treatment Outcomes	PLOS ONE			English	Article							ABDOMINAL AORTIC GRAFTS; PROSPECTIVE OBSERVATIONAL COHORT; RANDOMIZED CONTROLLED-TRIAL; COATED POLYESTER GRAFTS; ARTERIAL RECONSTRUCTION; ENDOGRAFT INFECTION; THORACIC AORTA; SINGLE-CENTER; MANAGEMENT; RIFAMPIN	Objective: Little is known about optimal management of prosthetic vascular graft infections, which are a rare but serious complication associated with graft implants. The goal of this study was to compare and characterize these infections with respect to the location of the graft and to identify factors associated with outcome. Methods: This was a retrospective study over more than a decade at a tertiary care university hospital that has an established multidisciplinary approach to treating graft infections. Cases of possible prosthetic vascular graft infection were identified from the hospital's infectious diseases database and evaluated against strict diagnostic criteria. Patients were divided into groups according to the locations of their grafts: thoracic-aortic, abdominal-aortic, or peripheral-arterial. Statistical analyses included evaluation of patient and infection characteristics, time to treatment failure, and factors associated specifically with cure rates in aortic graft infections. The primary endpoint was cure at one year after diagnosis of the infection. Results: Characterization of graft infections according to the graft location did show that these infections differ in terms of their characteristics and that the prognosis for treatment seems to be influenced by the location of the infection. Cure rate and all-cause mortality at one year were 87.5% and 12.5% in 24 patients with thoracic-aortic graft infections, 37.0% and 55.6% in 27 patients with abdominal-aortic graft infections, and 70.0% and 30.0% in 10 patients with peripheral-arterial graft infections. In uni- and multivariate analysis, the type of surgical intervention used in managing infections (graft retention versus graft replacement) did not affect primary outcome, whereas a rifampicin-based antimicrobial regimen was associated with a higher cure rate. Conclusions: We recommend that future prospective studies differentiate prosthetic vascular graft infections according to the location of the grafts and that rifampicin-based antimicrobial regimens be evaluated in clinical trials involving vascular graft infections caused by staphylococci.	[Erb, Stefan; Sidler, Jan A.; Elzi, Luigia; Battegay, Manuel; Widmer, Andreas F.; Weisser, Maja] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland; [Gurke, Lorenz] Univ Basel Hosp, Dept Vasc Surg, CH-4031 Basel, Switzerland; [Erb, Stefan; Sidler, Jan A.; Elzi, Luigia; Gurke, Lorenz; Battegay, Manuel; Widmer, Andreas F.; Weisser, Maja] Univ Basel Hosp, Dept Clin Res, CH-4031 Basel, Switzerland	University of Basel; University of Basel; University of Basel	Weisser, M (corresponding author), Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland.	maja.weisser@usb.ch		Weisser, Maja/0000-0002-0134-1929; Roth, Jan Adam/0000-0003-4502-1123				Aboshady I, 2012, J VASC SURG, V56, P794, DOI 10.1016/j.jvs.2012.02.008; Akowuah E, 2007, J THORAC CARDIOV SUR, V134, P1051, DOI 10.1016/j.jtcvs.2007.02.055; Baddour LM, 2001, AM J MED SCI, V322, P209, DOI 10.1097/00000441-200110000-00011; Bandyk DF, 2001, J SURG RES, V95, P44, DOI 10.1006/jsre.2000.6035; Batt M, 2008, EUR J VASC ENDOVASC, V36, P182, DOI 10.1016/j.ejvs.2008.02.013; Batt M, 2003, J VASC SURG, V38, P983, DOI 10.1016/S0741-5214(03)00554-8; Blanch M, 2010, ANN VASC SURG, V24, DOI 10.1016/j.avsg.2009.11.003; CALLIGARO KD, 1994, ANN SURG, V220, P461, DOI 10.1097/00000658-199410000-00005; Chalmers RTA, 1999, BRIT J SURG, V86, P1433, DOI 10.1046/j.1365-2168.1999.01267.x; Cirioni O, 2010, EUR J VASC ENDOVASC, V40, P817, DOI 10.1016/j.ejvs.2010.08.009; COLBURN MD, 1992, J VASC SURG, V16, P651, DOI 10.1016/0741-5214(92)90172-5; Coselli JS, 1999, ANN THORAC SURG, V67, P1990, DOI 10.1016/S0003-4975(99)00355-0; Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415; de Donato G, 2014, J CARDIOVASC SURG; Ducasse E, 2004, ANN VASC SURG, V18, P521, DOI 10.1007/s10016-004-0075-9; GAHTAN V, 1995, J SURG RES, V58, P105, DOI 10.1006/jsre.1995.1017; Gao H, 2012, EUR J VASC ENDOVASC, V43, P582, DOI 10.1016/j.ejvs.2012.02.011; Garot M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-215; HARGROVE WC, 1984, ANN THORAC SURG, V37, P72, DOI 10.1016/S0003-4975(10)60714-X; Hayes PD, 1999, J VASC SURG, V30, P92, DOI 10.1016/S0741-5214(99)70180-1; Herscu G, 2009, SURG CLIN N AM, V89, P391, DOI 10.1016/j.suc.2008.09.007; Heyer KS, 2009, J VASC INTERV RADIOL, V20, P173, DOI 10.1016/j.jvir.2008.10.032; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Kieffer E, 2001, J VASC SURG, V33, P671, DOI 10.1067/mva.2001.112314; Lawrence PF, 2011, SEMIN VASC SURG, V24, P199, DOI 10.1053/j.semvascsurg.2011.10.014; Legout L, 2012, MED MALADIES INFECT, V42, P102, DOI 10.1016/j.medmal.2012.01.003; Legout L, 2012, CLIN MICROBIOL INFEC, V18, P352, DOI 10.1111/j.1469-0691.2011.03618.x; Legout L, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-228; Leroy O, 2012, CURR OPIN INFECT DIS, V25, P154, DOI 10.1097/QCO.0b013e3283501853; Maze MJ, 2013, EUR J VASC ENDOVASC, V45, P373, DOI 10.1016/j.ejvs.2013.01.019; Nakajima N, 1999, ANN THORAC SURG, V67, P1994, DOI 10.1016/S0003-4975(99)00358-6; NEVELSTEEN A, 1995, J VASC SURG, V22, P129, DOI 10.1016/S0741-5214(95)70106-0; O'Connor S, 2006, J VASC SURG, V44, P38, DOI 10.1016/j.jvs.2006.02.053; Oderich GS, 2006, J VASC SURG, V43, P1166, DOI 10.1016/j.jvs.2006.02.040; OHARA PJ, 1986, J VASC SURG, V3, P725, DOI 10.1067/mva.1986.avs0030725; Roy D, 2000, J INFECTION, V40, P184, DOI 10.1016/S0163-4453(00)80014-6; Saleem BR, 2008, J VASC SURG, V47, P635, DOI 10.1016/j.jvs.2007.09.029; Saleem BR, 2010, AM J SURG, V200, P47, DOI 10.1016/j.amjsurg.2009.05.018; Setacci C, 2010, J CARDIOVASC SURG, V51, P33; Stewart AH, 2007, J VASC SURG, V46, P148, DOI 10.1016/j.jvs.2007.02.065; SZILAGYI DE, 1972, ANN SURG, V176, P321, DOI 10.1097/00000658-197209000-00008; TORSELLO G, 1993, J VASC SURG, V17, P768, DOI 10.1016/0741-5214(93)90124-5; Valentine R J, 2001, Semin Vasc Surg, V14, P292, DOI 10.1053/svas.2001.27874; Yeager RA, 1999, J VASC SURG, V30, P76, DOI 10.1016/S0741-5214(99)70178-3; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181; Zimmerli W, 1998, JAMA-J AM MED ASSOC, V279, P1537, DOI 10.1001/jama.279.19.1537	46	46	49	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112947	10.1371/journal.pone.0112947	http://dx.doi.org/10.1371/journal.pone.0112947			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393400	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300125
J	Gutsfeld, C; Olaru, ID; Vollrath, O; Lange, C				Gutsfeld, Christian; Olaru, Ioana D.; Vollrath, Oliver; Lange, Christoph			Attitudes about Tuberculosis Prevention in the Elimination Phase: A Survey among Physicians in Germany	PLOS ONE			English	Article							HEALTH-CARE WORKERS; STEM-CELL TRANSPLANTATION; MYCOBACTERIUM-TUBERCULOSIS; RISK-FACTORS; PULMONARY TUBERCULOSIS; ANTIRETROVIRAL THERAPY; LATENT TUBERCULOSIS; UNITED-STATES; CLINICAL CHARACTERISTICS; RHEUMATOID-ARTHRITIS	Background: Targeted and stringent measures of tuberculosis prevention are necessary to achieve the goal of tuberculosis elimination in countries of low tuberculosis incidence. Methods: We ascertained the knowledge about tuberculosis risk factors and stringency of tuberculosis prevention measures by a standardized questionnaire among physicians in Germany involved in the care of individuals from classical risk groups for tuberculosis. Results: 510 physicians responded to the online survey. Among 16 risk factors immunosuppressive therapy, HIV-infection and treatment with TNF-antagonist were thought to be the most important risk factors for the development of tuberculosis in Germany. Exposure to a patient with tuberculosis ranked on the 10 th position. In the event of a positive tuberculin-skin-test or interferon-gamma release assay only 50%, 40%, 36% and 25% of physicians found that preventive chemotherapy was indicated for individuals undergoing tumor necrosis factor-antagonist therapy, close contacts of tuberculosis patients, HIV-infected individuals and migrants, respectively. Conclusions: A remarkably low proportion of individuals with latent infection with Mycobacterium tuberculosis belonging to classical risk groups for tuberculosis are considered candidates for preventive chemotherapy in Germany. Better knowledge about the risk for tuberculosis in different groups and more stringent and targeted preventive interventions will probably be necessary to achieve tuberculosis elimination in Germany.	[Gutsfeld, Christian; Olaru, Ioana D.; Lange, Christoph] Res Ctr Borstel, German Ctr Infect Res, Div Clin Infect Dis, TB Unit, Borstel, Germany; [Gutsfeld, Christian] Sachsenklin, Dept Psychosomat Med, Bad Lausick, Germany; [Vollrath, Oliver] Univ Hosp Schleswig Holstein, Inst Med Informat & Stat, Kiel, Germany; [Lange, Christoph] Med Univ Lubeck, D-23538 Lubeck, Germany; [Lange, Christoph] Univ Namibia, Dept Internal Med, Sch Med, Windhoek, Namibia; [Lange, Christoph] Karolinska Inst, Dept Med, Stockholm, Sweden	Forschungszentrum Borstel; German Center for Infection Research; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; University of Namibia; Karolinska Institutet	Lange, C (corresponding author), Res Ctr Borstel, German Ctr Infect Res, Div Clin Infect Dis, TB Unit, Borstel, Germany.	clange@fz-borstel.de	Lange, Christoph/J-6289-2012	Lange, Christoph/0000-0002-9691-4741	German Center for Infection Research (DZIF)	German Center for Infection Research (DZIF)	The study was funded by the German Center for Infection Research (DZIF). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abgrall S, 2010, AIDS, V24, P763, DOI 10.1097/QAD.0b013e3283366747; Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381; Brassard P, 2006, CLIN INFECT DIS, V43, P717, DOI 10.1086/506935; BRUCE RM, 1977, ANN INTERN MED, V87, P574, DOI 10.7326/0003-4819-87-5-574; BUSH OB, 1965, AM REV RESPIR DIS, V92, P732; Calvert GM, 2003, OCCUP ENVIRON MED, V60, P122, DOI 10.1136/oem.60.2.122; Castaneda-Hernandez DM, 2013, TUBERCULOSIS, V93, P275, DOI 10.1016/j.tube.2013.02.001; Chee CBE, 2013, RESPIROLOGY, V18, P205, DOI 10.1111/resp.12002; Chegou NN, 2014, EUR RESPIR J, V43, P1472, DOI 10.1183/09031936.00151413; Chia S, 1998, INT J TUBERC LUNG D, V2, P989; Cohn DL, 2006, REICHMAN HERSHFIELDS, P265; Coker R, 2006, BRIT MED J, V332, P85, DOI 10.1136/bmj.38684.687940.80; Costagliola D, 2005, CLIN INFECT DIS, V41, P1772, DOI 10.1086/498315; COWIE RL, 1994, AM J RESP CRIT CARE, V150, P1460, DOI 10.1164/ajrccm.150.5.7952577; de Bibiana JT, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-833; de la Camara R, 2000, BONE MARROW TRANSPL, V26, P291, DOI 10.1038/sj.bmt.1702506; del Amo J, 2012, CLIN INFECT DIS, V54, P1364, DOI 10.1093/cid/cis203; Diel R, 2011, GESUNDHEITSWESEN, V73, P369, DOI 10.1055/s-0030-1256574; Diel R, 2011, AM J RESP CRIT CARE, V183, P88, DOI 10.1164/rccm.201006-0974OC; Dorman SE, 2014, AM J RESP CRIT CARE, V189, P77, DOI 10.1164/rccm.201302-0365OC; Elzi L, 2007, CLIN INFECT DIS, V44, P94, DOI 10.1086/510080; Erkens CGM, 2010, EUR RESPIR J, V36, P925, DOI 10.1183/09031936.00201609; European Centre for Disease Prevention and Control, 2010, PROGR TB EL; Fallab-Stubi CL, 1998, INT J TUBERC LUNG D, V2, P525; FEREBEE SH, 1962, AM REV RESPIR DIS, V85, P490; FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28; Friedman LN, 1996, NEW ENGL J MED, V334, P828, DOI 10.1056/NEJM199603283341304; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; Haldar P, 2013, THORAX, V68, P240, DOI 10.1136/thoraxjnl-2011-200956; Horsburgh CR, 2010, CHEST, V137, P401, DOI 10.1378/chest.09-0394; Karo B, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-148; KATZ J, 1965, AM REV RESPIR DIS, V91, P345, DOI 10.1164/arrd.1965.91.3.345; Kim CH, 2014, INFECTION; Kim HA, 1998, CLIN EXP RHEUMATOL, V16, P9; Kollan C, 2011, DTSCH OST AIDS K HAN; Korner MM, 1997, CHEST, V111, P365, DOI 10.1378/chest.111.2.365; Ku SC, 2001, BONE MARROW TRANSPL, V27, P1293, DOI 10.1038/sj.bmt.1703092; Landry J, 2008, INT J TUBERC LUNG D, V12, P1352; Lange C, 2011, AM J RESP CRIT CARE, V183, P3, DOI 10.1164/rccm.201011-1881ED; Leung CC, 2011, EUR RESPIR J, V37, P690, DOI 10.1183/09031936.00079310; Liu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032158; LUNDIN AP, 1979, AM J MED, V67, P597, DOI 10.1016/0002-9343(79)90240-7; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Marks SM, 2000, AM J RESP CRIT CARE, V162, P2033, DOI 10.1164/ajrccm.162.6.2004022; McAdam JM, 2009, EMERG INFECT DIS, V15, P1109, DOI 10.3201/eid1507.080410; Moran-Mendoza O, 2010, INT J TUBERC LUNG D, V14, P1112; Mulder C, 2012, EUR RESPIR J, V40, P1443, DOI 10.1183/09031936.00010612; Nienhaus A, 2014, J OCCUP MED TOXICOL, V9, DOI 10.1186/1745-6673-9-9; PablosMendez A, 1997, AM J PUBLIC HEALTH, V87, P574, DOI 10.2105/AJPH.87.4.574; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; Pareek M, 2011, EUR RESPIR J, V37, P1175, DOI 10.1183/09031936.00105810; PICKLEMAN JR, 1975, JAMA-J AM MED ASSOC, V234, P744, DOI 10.1001/jama.234.7.744; Ringshausen FC, 2013, EUR RESP C BARC 7 11; Ringshausen FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082005; Ringshausen FC, 2011, CLIN VACCINE IMMUNOL, V18, P1176, DOI 10.1128/CVI.05058-11; Robert Koch Institute, 2013, BER EP TUB DEUTSCHL, P99; Schaberg T, 2012, Pneumologie, V66, P133, DOI 10.1055/s-0031-1291619; Scharlach M, 2013, EPIDEMIOLOGISCHES B; Sester M, 2014, AM J RESP CRIT CARE; Slater ML, 2013, AM J RESP CRIT CARE, V188, P1005, DOI 10.1164/rccm.201305-0831OC; STEIGER Z, 1976, AM J SURG, V131, P668, DOI 10.1016/0002-9610(76)90174-4; Torre-Cisneros J, 2009, CLIN INFECT DIS, V48, P1657, DOI 10.1086/599035; Valin N, 2005, INT J TUBERC LUNG D, V9, P528; VANDENBROEK J, 1993, INT J EPIDEMIOL, V22, P1159, DOI 10.1093/ije/22.6.1159; Veening G J, 1968, Bull Int Union Tuberc, V41, P169; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2009, GLOB TUB CONTR EP ST; Yamada T, 2006, ANN RHEUM DIS, V65, P1661, DOI 10.1136/ard.2005.047274	68	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112681	10.1371/journal.pone.0112681	http://dx.doi.org/10.1371/journal.pone.0112681			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393241	Green Submitted, Green Published, gold			2022-12-27	WOS:000347709300084
J	Szalai, G; Xu, Y; Romero, R; Chaiworapongsa, T; Xu, ZH; Chiang, PJ; Ahn, H; Sundell, B; Plazyo, O; Jiang, Y; Olive, M; Wang, B; Jacques, SM; Qureshi, F; Tarca, AL; Erez, O; Dong, Z; Papp, Z; Hassan, SS; Hernandez-Andrade, E; Than, NG				Szalai, Gabor; Xu, Yi; Romero, Roberto; Chaiworapongsa, Tinnakorn; Xu, Zhonghui; Chiang, Po Jen; Ahn, Hyunyoung; Sundell, Birgitta; Plazyo, Olesya; Jiang, Yang; Olive, Mary; Wang, Bing; Jacques, Suzanne M.; Qureshi, Faisal; Tarca, Adi L.; Erez, Offer; Dong, Zhong; Papp, Zoltan; Hassan, Sonia S.; Hernandez-Andrade, Edgar; Than, Nandor Gabor			In Vivo Experiments Reveal the Good, the Bad and the Ugly Faces of sFlt-1 in Pregnancy	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; ANTI-ANGIOGENIC FACTORS; FOR-GESTATIONAL-AGE; HUMAN FETOPLACENTAL VASCULOGENESIS; FACTOR RECEPTOR-1 CONCENTRATION; MATERNAL INFLAMMATORY RESPONSE; SOLUBLE ENDOGLIN; METABOLIC CHARACTERISTICS; TYROSINE KINASE-1; OXIDATIVE STRESS	Objective: Soluble fms-like tyrosine kinase (sFlt)-1-e15a, a primate-specific sFlt-1-isoform most abundant in the human placenta in preeclampsia, can induce preeclampsia in mice. This study compared the effects of full-length human (h) sFlt-1-e15a with those of truncated mouse (m)sFlt-1(1-3) used in previous preeclampsia studies on pregnancy outcome and clinical symptoms in preeclampsia. Methods: Mice were injected with adenoviruses or fiber-mutant adenoviruses overexpressing hsFlt-1-e15a, msFlt-1(1-3) or control GFP under the CMV or CYP19A1 promoters on gestational day 8 (GD8) and GD11. Placentas and pups were delivered by cesarean section, and dams were monitored postpartum. Blood pressure was telemetrically recorded. Urine samples were collected with cystocentesis and examined for albumin/creatinine ratios. Tissue specimens were evaluated for transgene as well as endogenous mFlt-1 and msFlt-1-i13 expression. H&E-, Jones- and PAS-stained kidney sections were histopathologically examined. Placental GFP expression and aortic ring assays were investigated with confocal microscopy. Results: Mean arterial blood pressure (MAP) was elevated before delivery in hsFlt-1-e15a-treated mice compared to controls (GD18: Delta MAP = 7.8 mmHg, p = 0.009), while Delta MAP was 12.8 mmHg (GD18, p = 0.005) in msFlt-1(1-3)-treated mice. Urine albumin/creatinine ratio was higher in hsFlt-1-e15a-treated mice than in controls (GD18, p = 0.04; PPD8, p = 0.03), and msFlt-1(1-3)-treated mice had marked proteinuria postpartum (PPD8, p = 4x10(-5)). Focal glomerular changes were detected in hsFlt-1-e15a and msFlt-1(1-3)-treated mice. Aortic ring microvessel outgrowth was decreased in hsFlt-1-e15a (p = 0.007) and msFlt-1(1-3)-treated (p = 0.02) mice. Full-length msFlt-1-i13 expression was unique for the placenta. In hsFlt-1-e15a-treated mice, the number of pups (p = 0.046), total weight of living pups (p = 0.04) and maternal weights (p = 0.04) were higher than in controls. These differences were not observed in truncated msFlt-1(1-3)-treated mice. Conclusions: Truncated msFlt-1(1-3) simulated the preeclampsia-promoting effects of full-length hsFlt-1. MsFlt-1(1-3) had strong effect on maternal endothelium but not on placentas and embryos. In contrast, hsFlt-1-e15a induced preeclampsialike symptoms; however, it also increased litter size. In accord with the predominant placental expression of hsFlt-1-e15a and msFlt-1-i13, full-length sFlt-1 may have a role in the regulation of embryonic development. These observations point to the difference in the biological effects of full-length and truncated sFlt-1 and the changes in the effect of full-length sFlt-1 during pregnancy, and may have important implications in the management of preeclampsia.	[Szalai, Gabor; Xu, Yi; Romero, Roberto; Chaiworapongsa, Tinnakorn; Xu, Zhonghui; Chiang, Po Jen; Ahn, Hyunyoung; Sundell, Birgitta; Plazyo, Olesya; Jiang, Yang; Olive, Mary; Wang, Bing; Tarca, Adi L.; Dong, Zhong; Hassan, Sonia S.; Hernandez-Andrade, Edgar; Than, Nandor Gabor] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Szalai, Gabor; Xu, Yi; Romero, Roberto; Chaiworapongsa, Tinnakorn; Xu, Zhonghui; Chiang, Po Jen; Ahn, Hyunyoung; Sundell, Birgitta; Plazyo, Olesya; Jiang, Yang; Olive, Mary; Wang, Bing; Tarca, Adi L.; Dong, Zhong; Hassan, Sonia S.; Hernandez-Andrade, Edgar; Than, Nandor Gabor] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, NIH, US Dept HHS, Detroit, MI USA; [Chaiworapongsa, Tinnakorn; Hassan, Sonia S.; Hernandez-Andrade, Edgar; Than, Nandor Gabor] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Olive, Mary] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Jacques, Suzanne M.; Qureshi, Faisal] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; [Tarca, Adi L.] Wayne State Univ, Dept Comp Sci, Detroit, MI 48202 USA; [Tarca, Adi L.] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48202 USA; [Erez, Offer] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Obstet & Gynecol, Soroka Univ Med Ctr, Beer Sheva, Israel; [Papp, Zoltan; Than, Nandor Gabor] Semmelweis Univ, Matern Private Dept, H-1085 Budapest, Hungary; [Than, Nandor Gabor] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wayne State University; Wayne State University; Wayne State University; Wayne State University; Wayne State University; Ben Gurion University; Soroka Medical Center; Semmelweis University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Romero, R (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, NIH, US Dept HHS, Bethesda, MD 20892 USA.	romeror@mail.nih.gov; nthan@med.wayne.edu	Xu, Zhonghui/F-3353-2018; Than, Nandor G/N-1442-2016; Romero, Roberto/A-5268-2019	Xu, Zhonghui/0000-0002-6469-9178; Plazyo, Olesya/0000-0002-6859-7590; Romero, Roberto/0000-0002-4448-5121	Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH); NICHD, NIH [HHSN275201300006C]; NIH Center grant [P30CA22453]; Perinatology Research Branch (NICHD/NIH); Hungarian Academy of Sciences Momentum Grant [LP2014-7/2014]; NATIONAL CANCER INSTITUTE [P30CA022453] Funding Source: NIH RePORTER	Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH); NICHD, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH Center grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perinatology Research Branch (NICHD/NIH); Hungarian Academy of Sciences Momentum Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported, in part, by the Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH); and, in part, with Federal funds from NICHD, NIH under Contract No. HHSN275201300006C. The Microscopy, Imaging and Cytometry Resources Core is supported, in part, by NIH Center grant P30CA22453 to the Karmanos Cancer Institute, Wayne State University, and the Perinatology Research Branch (NICHD/NIH). Manuscript writing was supported, in part, by the Hungarian Academy of Sciences Momentum Grant "LP2014-7/2014" (to N.G.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson SL, 2002, DEV BIOL, V250, P358, DOI 10.1006/dbio.2002.0773; AHMED A, 1995, GROWTH FACTORS, V12, P235, DOI 10.3109/08977199509036883; Ahn H, 2014, ULTRASOUND GUI UNPUB; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Ananth CV, 2007, OBSTET GYNECOL, V110, P128, DOI 10.1097/01.AOG.0000266983.77458.71; Ananth CV, 2007, AM J OBSTET GYNECOL, V197; Balogh A, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.023; Baumwell S, 2007, NEPHRON CLIN PRACT, V106, pC72, DOI 10.1159/000101801; Bdolah Y, 2005, CROAT MED J, V46, P728; Bergmann A, 2010, J CELL MOL MED, V14, P1857, DOI 10.1111/j.1582-4934.2009.00820.x; Berkane N, 2007, NEPHROL DIAL TRANSPL, V22, P2753, DOI 10.1093/ndt/gfm429; Blackwell S, 2003, J Matern Fetal Neonatal Med, V14, P241, DOI 10.1080/713606670; Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680; BROSENS IA, 1977, CLIN OBSTET GYNAECOL, V4, P573; Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009; Brosens I, 2010, HUM REPROD, V25, P569, DOI 10.1093/humrep/dep474; Bujold E, 2005, J MATERN-FETAL NEO M, V18, P9, DOI 10.1080/14767050500202493; Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009; Burton GJ, 2009, PLACENTA, V30, pS43, DOI 10.1016/j.placenta.2008.11.003; Burton GJ, 2009, J ANAT, V215, P27, DOI 10.1111/j.1469-7580.2008.00978.x; Byers BD, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.044; Bytautiene E, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.01.042; Bytautiene E, 2010, AM J PHYSIOL-HEART C, V298, pH189, DOI 10.1152/ajpheart.00792.2009; Carter AM, 2007, PLACENTA, V28, pS41, DOI 10.1016/j.placenta.2006.11.002; Chaiworapongsa T, 2004, AM J OBSTET GYNECOL, V190, P1541, DOI 10.1016/j.ajog.2004.03.043; Chaiworapongsa T, 2005, J MATERN-FETAL NEO M, V17, P3, DOI 10.1080/14767050400028816; Chaiworapongsa T, 2002, AM J OBSTET GYNECOL, V187, P889, DOI 10.1067/mob.2002.127309; Chaiworapongsa T, 2010, ULTRASOUND OBST GYN, V35, P155, DOI 10.1002/uog.7491; Chaiworapongsa T, 2008, J MATERN-FETAL NEO M, V21, P41, DOI 10.1080/14767050701831397; Chaiworapongsa T, 2008, J MATERN-FETAL NEO M, V21, P25, DOI 10.1080/14767050701832833; Chaiworapongsa T, 2011, J MATERN-FETAL NEO M, V24, P1187, DOI 10.3109/14767058.2011.589932; Chaiworapongsa T, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.04.002; Charnock-Jones DS, 2004, PLACENTA, V25, P103, DOI 10.1016/j.placenta.2003.10.004; Christiaens I, 2008, J REPROD IMMUNOL, V79, P50, DOI 10.1016/j.jri.2008.04.002; Clark DE, 1998, BIOL REPROD, V59, P1540, DOI 10.1095/biolreprod59.6.1540; Cooper JC, 1996, BRIT J OBSTET GYNAEC, V103, P1191, DOI 10.1111/j.1471-0528.1996.tb09627.x; Costantine MM, 2010, OBSTET GYNECOL, V116, P114, DOI 10.1097/AOG.0b013e3181e10ebd; Cox B, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.37; De Falco S, 2012, EXP MOL MED, V44, P1, DOI 10.3858/emm.2012.44.1.025; Drost JT, 2010, MATURITAS, V67, P321, DOI 10.1016/j.maturitas.2010.08.002; Dynon K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045956; Eastabrook G, 2011, BEST PRACT RES CL OB, V25, P435, DOI 10.1016/j.bpobgyn.2011.01.005; Erez O, 2008, J MATERN-FETAL NEO M, V21, P279, DOI 10.1080/14767050802034545; Erez O, 2008, J MATERN-FETAL NEO M, V21, P345, DOI 10.1080/14767050802034859; Erez O, 2008, J MATERN-FETAL NEO M, V21, P855, DOI 10.1080/14767050802361872; Erez O, 2009, J MATERN-FETAL NEO M, V22, P672, DOI 10.1080/14767050902853117; Erez O, 2009, J MATERN-FETAL NEO M, V22, P662, DOI 10.1080/14767050902801751; Erlebacher A, 2010, TRENDS ENDOCRIN MET, V21, P428, DOI 10.1016/j.tem.2010.02.003; Eshkoli T, 2013, J MATERN-FETAL NEO M, V26, P116, DOI 10.3109/14767058.2012.722725; Espinoza J, 2006, J PERINAT MED, V34, P447, DOI 10.1515/JPM.2006.089; Fan XJ, 2014, J CLIN INVEST, V124, P4941, DOI 10.1172/JCI76864; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Fox KA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.083; Georgiades P, 2002, PLACENTA, V23, P3, DOI 10.1053/plac.2001.0738; Germain SJ, 2007, J IMMUNOL, V178, P5949, DOI 10.4049/jimmunol.178.9.5949; GERRETSEN G, 1981, BRIT J OBSTET GYNAEC, V88, P876, DOI 10.1111/j.1471-0528.1981.tb02222.x; Gervasi M T, 2002, J Matern Fetal Neonatal Med, V11, P171, DOI 10.1080/713605490; Gervasi MT, 2001, AM J OBSTET GYNECOL, V185, P1124, DOI 10.1067/mob.2001.117681; Gervasi MT, 2001, AM J OBSTET GYNECOL, V185, P792, DOI 10.1067/mob.2001.117311; Girardi G, 2011, MOL IMMUNOL, V48, P1621, DOI 10.1016/j.molimm.2011.04.011; Gomez-Lopez N, 2013, AM J REPROD IMMUNOL, V69, P212, DOI 10.1111/aji.12074; Gotsch F, 2008, J MATERN-FETAL NEO M, V21, P389, DOI 10.1080/14767050802046069; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; Haddad R, 2006, AM J OBSTET GYNECOL, V195, P394, DOI 10.1016/j.ajog.2005.08.057; Han YM, 2008, BIOL REPROD, V79, P954, DOI 10.1095/biolreprod.108.069260; Hassan SS, 2009, J MATERN-FETAL NEO M, V22, P1183, DOI 10.3109/14767050903353216; He YL, 1999, MOL ENDOCRINOL, V13, P537, DOI 10.1210/me.13.4.537; Hertig A, 2004, CLIN CHEM, V50, P1702, DOI 10.1373/clinchem.2004.036715; Hertig A, 2008, EUR J OBSTET GYN R B, V140, P138, DOI 10.1016/j.ejogrb.2007.09.007; Hertig A, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.006; Heydarian M, 2009, PLACENTA, V30, P250, DOI 10.1016/j.placenta.2008.12.010; Higgins JR, 1998, AM J OBSTET GYNECOL, V179, P464, DOI 10.1016/S0002-9378(98)70380-1; Hunt JS, 2006, IMMUNOL REV, V213, P36, DOI 10.1111/j.1600-065X.2006.00436.x; Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213; JACKSON MR, 1994, PLACENTA, V15, P341, DOI 10.1016/0143-4004(94)90002-7; Jauniaux E, 2003, PLACENTA, V24, pS86, DOI 10.1053/plac.2002.0932; Jauniaux E, 2003, AM J PATHOL, V162, P115, DOI 10.1016/S0002-9440(10)63803-5; Jauniaux E, 1999, HUM REPROD, V14, P2901, DOI 10.1093/humrep/14.11.2901; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; Jebbink J, 2011, HYPERTENSION, V58, P70, DOI 10.1161/HYPERTENSIONAHA.110.164079; Kaitu'u-Lino TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032509; Kalkunte S, 2009, J REPROD IMMUNOL, V83, P134, DOI 10.1016/j.jri.2009.08.006; Kamat A, 2005, ENDOCRINOLOGY, V146, P2481, DOI 10.1210/en.2004-1606; Karumanchi SA, 2007, AM J OBSTET GYNECOL, V196, P287, DOI 10.1016/j.ajog.2007.02.013; Karumanchi SA, 2005, KIDNEY INT, V67, P2101, DOI 10.1111/j.1523-1755.2005.00316.x; Katayama K, 2011, BIOMATERIALS, V32, P4185, DOI 10.1016/j.biomaterials.2011.02.038; Katz AB, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.029; Kaufmann P, 2004, PLACENTA, V25, P114, DOI 10.1016/j.placenta.2003.10.009; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; Kendall RL, 1996, BIOCHEM BIOPH RES CO, V226, P324, DOI 10.1006/bbrc.1996.1355; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Kim CJ, 2010, MODERN PATHOL, V23, P1000, DOI 10.1038/modpathol.2010.73; Kim SK, 2009, J PERINAT MED, V37, P543, DOI 10.1515/JPM.2009.106; Kim YM, 2006, HISTOPATHOLOGY, V49, P506, DOI 10.1111/j.1365-2559.2006.02542.x; Kim YW, 2013, J MOL MED, V91, P323, DOI 10.1007/s00109-013-1007-3; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Koga K, 2003, J CLIN ENDOCR METAB, V88, P2348, DOI 10.1210/jc.2002-021942; Kondo K, 1998, GENE, V208, P297, DOI 10.1016/S0378-1119(98)00006-7; KRAAYENBRINK AA, 1993, AM J OBSTET GYNECOL, V169, P160, DOI 10.1016/0002-9378(93)90154-B; Kumasawa K, 2011, P NATL ACAD SCI USA, V108, P1451, DOI 10.1073/pnas.1011293108; Kusanovic JP, 2009, J MATERN-FETAL NEO M, V22, P1021, DOI 10.3109/14767050902994754; Lam C, 2005, HYPERTENSION, V46, P1077, DOI 10.1161/01.HYP.0000187899.34379.b0; Lee J, 2011, HISTOPATHOLOGY, V59, P928, DOI 10.1111/j.1365-2559.2011.04038.x; Lee J, 2011, AM J REPROD IMMUNOL, V66, P510, DOI 10.1111/j.1600-0897.2011.01066.x; Lee J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016806, 10.1371/journal.pone.0020933]; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2005, CLIN OBSTET GYNECOL, V48, P372, DOI 10.1097/01.grf.0000160313.82606.d7; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Li Y, 2011, J CLIN ENDOCR METAB, V96, P403, DOI 10.1210/jc.2010-1405; Li ZH, 2007, HYPERTENSION, V50, P686, DOI 10.1161/HYPERTENSIONAHA.107.092098; LONG PA, 1980, BRIT J OBSTET GYNAEC, V87, P13, DOI 10.1111/j.1471-0528.1980.tb04419.x; Lu F, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.064; Madsen-Bouterse SA, 2010, AM J REPROD IMMUNOL, V63, P73, DOI 10.1111/j.1600-0897.2009.00791.x; Mateus J, 2011, AM J PHYSIOL-HEART C, V301, pH1781, DOI 10.1152/ajpheart.00373.2011; Mayhew TM, 2004, PLACENTA, V25, P127, DOI 10.1016/j.placenta.2003.10.010; Maynard SE, 2005, PEDIATR RES, V57, p1R, DOI 10.1203/01.PDR.0000159567.85157.B7; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Maynard S, 2008, ANNU REV MED, V59, P61, DOI 10.1146/annurev.med.59.110106.214058; Maynard SE, 2011, SEMIN NEPHROL, V31, P33, DOI 10.1016/j.semnephrol.2010.10.004; MEDAWAR PB, 1953, SYM SOC EXP BIOL, V7, P320; Mitchell MD, 2005, J CLIN ENDOCR METAB, V90, P4244, DOI 10.1210/jc.2004-2496; Mizuguchi H, 2001, GENE THER, V8, P730, DOI 10.1038/sj.gt.3301453; Moffett A, 2004, PLACENTA, V25, P1, DOI 10.1016/S0143-4004(03)00167-X; Moldenhauer JS, 2003, AM J OBSTET GYNECOL, V189, P1173, DOI 10.1067/S0002-9378(03)00576-3; Mole DR, 2008, PEDIATR NEPHROL, V23, P681, DOI 10.1007/s00467-007-0632-x; Moore AG, 2012, J MATERN-FETAL NEO M, V25, P2651, DOI 10.3109/14767058.2012.713055; Mor G, 2011, ANN NY ACAD SCI, V1221, P80, DOI 10.1111/j.1749-6632.2010.05938.x; Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x; Muttukrishna S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018041; Myatt L, 2009, J THROMB HAEMOST, V7, P375, DOI 10.1111/j.1538-7836.2008.03259.x; Naccasha N, 2001, AM J OBSTET GYNECOL, V185, P1118, DOI 10.1067/mob.2001.117682; National Research Council of the National Academy of Sciences, 2011, GUID CAR US LAB AN; Ness RB, 1996, AM J OBSTET GYNECOL, V175, P1365, DOI 10.1016/S0002-9378(96)70056-X; Ogge G, 2011, J PERINAT MED, V39, P641, DOI [10.1515/JPM.2011.098, 10.1515/jpm.2011.098]; Ogge G, 2010, J MATERN-FETAL NEO M, V23, P820, DOI 10.3109/14767050903366119; Ogge G, 2010, J MATERN-FETAL NEO M, V23, P476, DOI 10.3109/14767050903216033; PAGE E W, 1948, Obstet Gynecol Surv, V3, P615, DOI 10.1097/00006254-194810000-00002; PAGE ERNEST W., 1949, CALIFORNIA MED, V70, P1; Paulesu L, 2010, CURR PHARM DESIGN, V16, P3601, DOI 10.2174/138161210793797933; Pijnenborg Robert, 2002, Reprod Biomed Online, V4 Suppl 3, P14; Powers RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013263; Preedy, 2012, HDB GROWTH GROWTH MO, P1867; Rana S, 2012, CIRCULATION, V125, P911, DOI 10.1161/CIRCULATIONAHA.111.054361; Rasmussen S, 2003, OBSTET GYNECOL, V101, P575, DOI 10.1016/S0029-7844(02)03071-5; Raymond D, 2011, OBSTET GYNECOL SURV, V66, P497, DOI 10.1097/OGX.0b013e3182331028; Redman CW, 2014, PLACENTA, V35, pS20, DOI 10.1016/j.placenta.2013.12.008; Redman CWG, 2012, PLACENTA, V33, pS48, DOI 10.1016/j.placenta.2011.12.006; Redman CWG, 2009, PLACENTA, V30, pS38, DOI 10.1016/j.placenta.2008.11.021; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Redman CWG, 2000, PLACENTA, V21, P597, DOI 10.1053/plac.2000.0560; Redman CWG, 2003, PLACENTA, V24, pS21, DOI 10.1053/plac.2002.0930; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; REDMAN CWG, 1991, PLACENTA, V12, P301, DOI 10.1016/0143-4004(91)90339-H; Reimer T, 2013, J MATERN-FETAL NEO M, V26, P263, DOI 10.3109/14767058.2012.733747; Renaud SJ, 2011, PLACENTA, V32, pS130, DOI 10.1016/j.placenta.2010.12.017; Reuvekamp A, 1999, BRIT J OBSTET GYNAEC, V106, P1019, DOI 10.1111/j.1471-0528.1999.tb08107.x; Richani K, 2005, J PERINAT MED, V33, P296, DOI 10.1515/JPM.2005.052; Roberts JM, 2009, PLACENTA, V30, pS32, DOI 10.1016/j.placenta.2008.11.009; ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200, DOI 10.1016/0002-9378(89)90665-0; ROBERTSON WB, 1967, J PATHOL BACTERIOL, V93, P581, DOI 10.1002/path.1700930219; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; ROMERO R, 1989, OBSTET GYNECOL, V73, P31; ROMERO R, 1990, J REPROD MED, V35, P235; Romero R, 2008, J MATERN-FETAL NEO M, V21, P9, DOI 10.1080/14767050701830480; Romero R, 2007, NUTR REV, V65, pS194, DOI 10.1301/nr.2007.dec.S194-S202; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Romero R, 2006, SEMIN FETAL NEONAT M, V11, P317, DOI 10.1016/j.siny.2006.05.001; Romero R, 2012, J MATERN-FETAL NEO M, V25, P558, DOI 10.3109/14767058.2011.599083; Romero R, 2010, J MATERN-FETAL NEO M, V23, P1384, DOI 10.3109/14767051003681121; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Sacks GP, 1998, AM J OBSTET GYNECOL, V179, P80, DOI 10.1016/S0002-9378(98)70254-6; Sargent IL, 2003, J REPROD IMMUNOL, V59, P153, DOI 10.1016/S0165-0378(03)00044-5; Scholz CC, 2013, CURR OPIN PHARMACOL, V13, P646, DOI 10.1016/j.coph.2013.04.009; Sebire N J, 2005, J Obstet Gynaecol, V25, P117; Sela S, 2008, CIRC RES, V102, P1566, DOI 10.1161/CIRCRESAHA.108.171504; SHARKEY AM, 1993, J REPROD FERTIL, V99, P609; Sharma S, 2010, J REPROD IMMUNOL, V85, P112, DOI 10.1016/j.jri.2010.01.002; Sherer DM, 2001, PLACENTA, V22, P1, DOI 10.1053/plac.2000.0588; Shibuya M, 2001, CELL STRUCT FUNCT, V26, P25, DOI 10.1247/csf.26.25; SHIBUYA M, 1990, ONCOGENE, V5, P519; Shibuya M, 2011, P JPN ACAD B-PHYS, V87, P167, DOI 10.2183/pjab.87.167; Shiraishi S, 1996, PLACENTA, V17, P111, DOI 10.1016/S0143-4004(96)80004-X; Shore VH, 1997, PLACENTA, V18, P657, DOI 10.1016/S0143-4004(97)90007-2; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Silasi M, 2010, OBSTET GYN CLIN N AM, V37, P239, DOI 10.1016/j.ogc.2010.02.013; Singh H, 2010, PLACENTA, V31, P1085, DOI 10.1016/j.placenta.2010.10.003; Smith GCS, 2009, CURR OPIN OBSTET GYN, V21, P111, DOI 10.1097/GCO.0b013e328328cf7d; Staff AC, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.036; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suzuki H, 2009, HYPERTENSION, V54, P1129, DOI 10.1161/HYPERTENSIONAHA.109.134668; Szalai G, 2014, FULL LENGHT HU UNPUB; TAFURI A, 1995, SCIENCE, V270, P630, DOI 10.1126/science.270.5236.630; Taylor RN, 1998, SEMIN REPROD ENDOCR, V16, P17, DOI 10.1055/s-2007-1016249; Terness P, 2007, AM J REPROD IMMUNOL, V58, P238, DOI 10.1111/j.1600-0897.2007.00510.x; Thadhani R, 2004, J CLIN ENDOCR METAB, V89, P770, DOI 10.1210/jc.2003-031244; Thadhani R, 2011, CIRCULATION, V124, P940, DOI 10.1161/CIRCULATIONAHA.111.034793; Than NG, 2008, P NATL ACAD SCI USA, V105, P15819, DOI 10.1073/pnas.0807606105; Than NG, 2008, VIRCHOWS ARCH, V453, P387, DOI 10.1007/s00428-008-0658-x; Thomas CP, 2009, J CLIN ENDOCR METAB, V94, P2524, DOI 10.1210/jc.2009-0017; Thomas C, 2007, ANIMAL, V1, P1, DOI 10.1017/S1751731107658467; Trowsdale J, 2006, NAT IMMUNOL, V7, P241, DOI 10.1038/ni1317; Vaisbuch E, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.049; Vatten LJ, 2007, AM J OBSTET GYNECOL, V196, P239, DOI 10.1016/j.ajog.2006.10.909; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Verlohren S, 2012, CLIN SCI, V122, P43, DOI 10.1042/CS20110097; von Dadelszen P, 2003, HYPERTENS PREGNANCY, V22, P143, DOI 10.1081/PRG-120021060; Vuckovic M, 1996, J ANAT, V188, P361; Vuorela P, 2000, OBSTET GYNECOL, V95, P353, DOI 10.1016/S0029-7844(99)00565-7; Wang A, 2009, PHYSIOLOGY, V24, P147, DOI 10.1152/physiol.00043.2008; Wang HM, 2003, MOL REPROD DEV, V65, P123, DOI 10.1002/mrd.10308; Webster RR, 2008, PLACENTA, V29, P985, DOI 10.1016/j.placenta.2008.09.003; Weed S, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.003; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; WHEELER T, 1995, PLACENTA, V16, P289, DOI 10.1016/0143-4004(95)90115-9; Whitehead CL, 2011, BJOG-INT J OBSTET GY, V118, P1268, DOI 10.1111/j.1471-0528.2011.02962.x; Wilson JM, 1996, NEW ENGL J MED, V334, P1185, DOI 10.1056/NEJM199605023341809; Wilting J, 1996, DEV BIOL, V176, P76, DOI 10.1006/dbio.1996.9993; Xing AY, 2000, HUM GENE THER, V11, P167, DOI 10.1089/10430340050016247; Xiong X, 2002, AM J EPIDEMIOL, V155, P203, DOI 10.1093/aje/155.3.203; Yamaguchi S, 2002, BIOCHEM BIOPH RES CO, V291, P554, DOI 10.1006/bbrc.2002.6478; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149; Zenclussen AC, 2006, EUR J IMMUNOL, V36, P82, DOI 10.1002/eji.200535428; Zhou Y, 1997, J CLIN INVEST, V99, P2152, DOI 10.1172/JCI119388	225	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e110867	10.1371/journal.pone.0110867	http://dx.doi.org/10.1371/journal.pone.0110867			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393290	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300004
J	Wu, S; Miller, T; Masanz, J; Coarr, M; Halgrim, S; Carrell, D; Clark, C				Wu, Stephen; Miller, Timothy; Masanz, James; Coarr, Matt; Halgrim, Scott; Carrell, David; Clark, Cheryl			Negation's Not Solved: Generalizability Versus Optimizability in Clinical Natural Language Processing	PLOS ONE			English	Article							CLASSIFICATION; ARCHITECTURE; SYSTEM; TEXT	A review of published work in clinical natural language processing (NLP) may suggest that the negation detection task has been "solved.'' This work proposes that an optimizable solution does not equal a generalizable solution. We introduce a new machine learning-based Polarity Module for detecting negation in clinical text, and extensively compare its performance across domains. Using four manually annotated corpora of clinical text, we show that negation detection performance suffers when there is no in-domain development (for manual methods) or training data (for machine learning-based methods). Various factors (e.g., annotation guidelines, named entity characteristics, the amount of data, and lexical and syntactic context) play a role in making generalizability difficult, but none completely explains the phenomenon. Furthermore, generalizability remains challenging because it is unclear whether to use a single source for accurate data, combine all sources into a single model, or apply domain adaptation methods. The most reliable means to improve negation detection is to manually annotate in-domain training data (or, perhaps, manually modify rules); this is a strategy for optimizing performance, rather than generalizing it. These results suggest a direction for future work in domain-adaptive and task-adaptive methods for clinical NLP.	[Wu, Stephen; Masanz, James] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55902 USA; [Miller, Timothy] Harvard Univ, Sch Med, Childrens Hosp Boston Informat Program, Boston, MA USA; [Coarr, Matt; Clark, Cheryl] Mitre Corp, Human Language Technol Dept, Bedford, MA 01730 USA; [Halgrim, Scott; Carrell, David] Grp Hlth Res Inst, Seattle, WA USA; [Wu, Stephen] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Mayo Clinic; Harvard University; Boston Children's Hospital; Harvard Medical School; MITRE Corporation; Oregon Health & Science University	Wu, S (corresponding author), Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55902 USA.	wst@ohsu.edu			SHARPn (Strategic Health IT Advanced Research Projects) Area 4: Secondary Use of EHR Data Cooperative Agreement from the HHS Office of the National Coordinator, Washington, DC [DHHS 90TR000201]	SHARPn (Strategic Health IT Advanced Research Projects) Area 4: Secondary Use of EHR Data Cooperative Agreement from the HHS Office of the National Coordinator, Washington, DC	This work was supported in part by the SHARPn (Strategic Health IT Advanced Research Projects) Area 4: Secondary Use of EHR Data Cooperative Agreement from the HHS Office of the National Coordinator, Washington, DC. DHHS 90TR000201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright D, 2013, J AM MED INFORM ASS; [Anonymous], 2012, P 17 AUSTR DOC COMP; Cairns Brian L, 2011, AMIA Annu Symp Proc, V2011, P171; Chapman WW, 2013, STUD HEALTH TECHNOL, V192, P677, DOI 10.3233/978-1-61499-289-9-677; Chapman WW, 2001, J BIOMED INFORM, V34, P301, DOI 10.1006/jbin.2001.1029; Clark C, 2011, J AM MED INFORM ASSN, V18, P563, DOI 10.1136/amiajnl-2011-000164; Daume H., 2007, P 45 ANN M ASS COMP, P256; Elkin Peter L, 2005, BMC Med Inform Decis Mak, V5, P13, DOI 10.1186/1472-6947-5-13; Farkas Richard, 2010, P 14 C COMP NAT LANG, P1; Garla V, 2011, J AM MED INFORM ASSN, V18, P614, DOI 10.1136/amiajnl-2011-000093; Goldin I., 2003, P SIGAIR WORKSH TEXT; Harkema H, 2009, J BIOMED INFORM, V42, P839, DOI 10.1016/j.jbi.2009.05.002; Huang Y, 2007, J AM MED INFORM ASSN, V14, P304, DOI 10.1197/jamia.M2284; Morante R, 2012, COMPUT LINGUIST, V38, P223, DOI 10.1162/COLI_a_00095; Mutalik PG, 2001, J AM MED INFORM ASSN, V8, P598, DOI 10.1136/jamia.2001.0080598; Pighin D., 2010, P 14 C COMP NAT LANG, P223; RATNAPARKHI A, 1997, P 2 C EMP METH NAT L, P1; Savova GK, 2010, J AM MED INFORM ASSN, V17, P507, DOI 10.1136/jamia.2009.001560; Sohn Sunghwan, 2012, AMIA Jt Summits Transl Sci Proc, V2012, P1; South Brett R, 2007, AMIA Annu Symp Proc, P1118; Uzuner O, 2011, J AM MED INFORM ASSN, V18, P552, DOI 10.1136/amiajnl-2011-000203; Vincze V, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S11-S9	22	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112774	10.1371/journal.pone.0112774	http://dx.doi.org/10.1371/journal.pone.0112774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY6YT	25393544	gold, Green Published			2022-12-27	WOS:000347709300101
J	Lipka, AE; Lu, F; Cherney, JH; Buckler, ES; Casler, MD; Costich, DE				Lipka, Alexander E.; Lu, Fei; Cherney, Jerome H.; Buckler, Edward S.; Casler, Michael D.; Costich, Denise E.			Accelerating the Switchgrass (Panicum virgatum L.) Breeding Cycle Using Genomic Selection Approaches	PLOS ONE			English	Article							PREDICTION; REGRESSION; ACCURACY; PLANT; TRAITS; REGULARIZATION; ASSOCIATION; ADAPTATION; MODELS	Switchgrass (Panicum virgatum L.) is a perennial grass undergoing development as a biofuel feedstock. One of the most important factors hindering breeding efforts in this species is the need for accurate measurement of biomass yield on a per-hectare basis. Genomic selection on simple-to-measure traits that approximate biomass yield has the potential to significantly speed up the breeding cycle. Recent advances in switchgrass genomic and phenotypic resources are now making it possible to evaluate the potential of genomic selection of such traits. We leveraged these resources to study the ability of three widely-used genomic selection models to predict phenotypic values of morphological and biomass quality traits in an association panel consisting of predominantly northern adapted upland germplasm. High prediction accuracies were obtained for most of the traits, with standability having the highest ten-fold cross validation prediction accuracy (0.52). Moreover, the morphological traits generally had higher prediction accuracies than the biomass quality traits. Nevertheless, our results suggest that the quality of current genomic and phenotypic resources available for switchgrass is sufficiently high for genomic selection to significantly impact breeding efforts for biomass yield.	[Lipka, Alexander E.; Lu, Fei; Buckler, Edward S.; Costich, Denise E.] Cornell Univ, Inst Genom Div, Ithaca, NY USA; [Cherney, Jerome H.] Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY USA; [Buckler, Edward S.; Costich, Denise E.] USDA ARS, Ithaca, NY 14853 USA; [Buckler, Edward S.] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY USA; [Casler, Michael D.] USDA ARS, Madison, WI USA; [Casler, Michael D.] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA	Cornell University; Cornell University; United States Department of Agriculture (USDA); Cornell University; United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison	Lipka, AE (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	alipka@illinois.edu	Buckler, Edward/GPS-4932-2022; Buckler, Edward/L-7651-2019	Buckler, Edward/0000-0002-3100-371X	Department of Energy-United States Department of Agriculture Plant Feedstock Genomics for Bioenergy Program [DE-A102-07ER64454]; United States Department of Agriculture-Agricultural Research Services	Department of Energy-United States Department of Agriculture Plant Feedstock Genomics for Bioenergy Program; United States Department of Agriculture-Agricultural Research Services	This work was supported by Department of Energy-United States Department of Agriculture Plant Feedstock Genomics for Bioenergy Program Project Number DE-A102-07ER64454 (http://genomicscience.energy.gov/research/DOEUSDA/) and United States Department of Agriculture-Agricultural Research Services (http://www.ars.usda.gov/main/main.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asoro FG, 2011, PLANT GENOME-US, V4, P132, DOI 10.3835/plantgenome2011.02.0007; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Buckler Lab for Maize Genetics and Diversity, BUCKL LAB PHEN TOOLS; Casler MD, 2007, CROP SCI, V47, P2249, DOI 10.2135/cropsci2006.12.0780; Casler MD, 2004, CROP SCI, V44, P293, DOI 10.2135/cropsci2004.2930; Casler MD, 2012, SWITCHGRASS, P29, DOI [10.1007/978-1-4471-2903-5, DOI 10.1007/978-1-4471-2903-5_2]; CATHEY HM, 1990, USDA PLANT HARDINESS; Chandler K, 2013, CROP SCI, V53, P189, DOI 10.2135/cropsci2012.02.0129; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gianola D, 2013, GENETICS, V194, P573, DOI 10.1534/genetics.113.151753; Gilmour AR, 2009, ASREML USER GUIDE RE; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Heffner EL, 2010, CROP SCI, V50, P1681, DOI 10.2135/cropsci2009.11.0662; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Heslot N, 2012, CROP SCI, V52, P146, DOI 10.2135/cropsci2011.06.0297; Holland JB, 2002, PL BRED RE, V22, P9; Hung HY, 2012, HEREDITY, V108, P490, DOI 10.1038/hdy.2011.103; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Joint Genome Institute, 2014, PHYT 10 PAN VIRG V1; Kutner M., 2004, APPL LINEAR STAT MOD; Lipka AE, 2013, G3-GENES GENOM GENET, V3, P1287, DOI 10.1534/g3.113.006148; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; Martinez-Reyna JM, 2002, CROP SCI, V42, P1800, DOI 10.2135/cropsci2002.1800; Meuwissen THE, 2001, GENETICS, V157, P1819; Perrin R, 2008, BIOENERG RES, V1, P91, DOI 10.1007/s12155-008-9005-y; PORTER CL, 1966, ECOLOGY, V47, P980, DOI 10.2307/1935646; Resende MFR, 2012, GENETICS, V190, P1503, DOI 10.1534/genetics.111.137026; Resende MFR, 2012, NEW PHYTOL, V193, P617, DOI 10.1111/j.1469-8137.2011.03895.x; Resende MDV, 2012, NEW PHYTOL, V194, P116, DOI 10.1111/j.1469-8137.2011.04038.x; Riedelsheimer C, 2012, NAT GENET, V44, P217, DOI 10.1038/ng.1033; Sanderson MA, 2006, CAN J PLANT SCI, V86, P1315, DOI 10.4141/P06-136; SAS Institute, 2012, SAS SYSTEM WINDOWS R; Schaeffer LR, 2006, J ANIM BREED GENET, V123, P218, DOI 10.1111/j.1439-0388.2006.00595.x; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Resende RMS, 2014, CROP SCI, V54, P143, DOI 10.2135/cropsci2013.05.0353; Stubbendieck J., 1992, N AM RANGE PLANTS, V4; Team RC, 2012, R LANG ENV STAT COMP; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Vogel KP, 2011, BIOENERG RES, V4, P96, DOI 10.1007/s12155-010-9104-4; Vogel KP, 2014, J PLANT REGIST; Wolc A, 2011, GENET SEL EVOL, V43; Zhang YW, 2011, CROP SCI, V51, P2626, DOI 10.2135/cropsci2011.02.0104; Zhang YW, 2011, GENETICA, V139, P933, DOI 10.1007/s10709-011-9597-6; Zhao YuSheng, 2012, TAG Theoretical and Applied Genetics, V124, P769, DOI 10.1007/s00122-011-1745-y; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	49	43	43	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112227	10.1371/journal.pone.0112227	http://dx.doi.org/10.1371/journal.pone.0112227			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390940	Green Submitted, Green Published, gold			2022-12-27	WOS:000349144400063
J	Liu, YM; Wu, HH; Kou, LH; Liu, XJ; Zhang, JZ; Guo, YP; Ma, EB				Liu, Yaoming; Wu, Haihua; Kou, Lihua; Liu, Xiaojian; Zhang, Jianzhen; Guo, Yaping; Ma, Enbo			Two Metallothionein Genes in Oxya chinensis: Molecular Characteristics, Expression Patterns and Roles in Heavy Metal Stress	PLOS ONE			English	Article							TYPE-2 METALLOTHIONEIN; ANTIOXIDANT ENZYMES; DIETARY-CADMIUM; CLONING; COPPER; HOMEOSTASIS; PROTECTION; DROSOPHILA; PROTEIN; FAMILY	Metallothioneins (MTs) are small, cysteine-rich, heavy metal-binding proteins involved in metal homeostasis and detoxification in living organisms. In the present study, we cloned two MT genes (OcMT1 and OcMT2) from Oxya chinensis, analyzed the expression patterns of the OcMT transcripts in different tissues and at varying developmental stages using realtime quantitative PCR (RT-qPCR), evaluated the functions of these two MTs using RNAi and recombinant proteins in an E. coli expression system. The full-length cDNAs of OcMT1 and OcMT2 encoded 40 and 64 amino acid residues, respectively. We found Cys-Cys, Cys-X-Cys and Cys-X-Y-Z-Cys motifs in OcMT1 and OcMT2. These motifs might serve as primary chelating sites, as in other organisms. These characteristics suggest that OcMT1 and OcMT2 may be involved in heavy metal detoxification by capturing the metals. Two OcMT were expressed at all developmental stages, and the highest levels were found in the eggs. Both transcripts were expressed in all eleven tissues examined, with the highest levels observed in the brain and optic lobes, followed by the fat body. The expression of OcMT2 was also relatively high in the ovaries. The functions of OcMT1 and OcMT2 were explored using RNA interference (RNAi) and different concentrations and treatment times for the three heavy metals. Our results indicated that mortality increased significantly from 8.5% to 16.7%, and this increase was both time-and dose-dependent. To evaluate the abilities of these two MT proteins to confer heavy metal tolerance to E. coli, the bacterial cells were transformed with pET-28a plasmids containing the OcMT genes. The optical densities of both the MT-expressing and control cells decreased with increasing concentrations of CdCl2. Nevertheless, the survival rates of the MT-overexpressing cells were higher than those of the controls. Our results suggest that these two genes play important roles in heavy metal detoxification in O. chinensis.	[Liu, Yaoming; Wu, Haihua; Kou, Lihua; Liu, Xiaojian; Zhang, Jianzhen; Ma, Enbo] Shanxi Univ, Inst Appl Biol, Taiyuan 030006, Shanxi, Peoples R China; [Guo, Yaping] Shanxi Univ, Coll Life Sci, Taiyuan 030006, Shanxi, Peoples R China	Shanxi University; Shanxi University	Guo, YP (corresponding author), Shanxi Univ, Coll Life Sci, Taiyuan 030006, Shanxi, Peoples R China.	guoyp1955@163.com; maenbo2003@sxu.edu.cn			National Natural Science Foundation of China [31071980, 31201548, 31320103921, 31172161]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 31071980, 31201548, 31320103921 and 31172161). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2004, BIOCHEM BIOPH RES CO, V323, P72, DOI 10.1016/j.bbrc.2004.08.056; Amiard JC, 2006, AQUAT TOXICOL, V76, P160, DOI 10.1016/j.aquatox.2005.08.015; Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9; Aras MA, 2011, ANTIOXID REDOX SIGN, V15, P2249, DOI 10.1089/ars.2010.3607; Atanesyan L, 2011, J BIOL INORG CHEM, V16, P1047, DOI 10.1007/s00775-011-0825-4; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; Brouwer M, 2002, J INORG BIOCHEM, V88, P228, DOI 10.1016/S0162-0134(01)00381-6; Capdevila M, 2011, J BIOL INORG CHEM, V16, P977, DOI 10.1007/s00775-011-0798-3; Carpene E, 2007, J TRACE ELEM MED BIO, V21, P35, DOI 10.1016/j.jtemb.2007.09.011; Chaturvedi AK, 2012, GENE, V499, P280, DOI 10.1016/j.gene.2012.03.001; CHUNG WP, 1991, J AM CHEM SOC, V113, P525, DOI 10.1021/ja00002a021; Coyle P, 2002, CELL MOL LIFE SCI, V59, P627, DOI 10.1007/s00018-002-8454-2; Dietz K. J., 1999, HEAVY METAL STRESS P, P73, DOI DOI 10.1007/978-3-662-07745-0_4; Domenech J, 2007, RES PROGR METALLOTHI, P11; DURLIAT M, 1995, BIOMETALS, V8, P339; Egli D, 2006, MOL CELL BIOL, V26, P2286, DOI 10.1128/MCB.26.6.2286-2296.2006; Egli D, 2003, EMBO J, V22, P100, DOI 10.1093/emboj/cdg012; Freisinger E, 2011, J BIOL INORG CHEM, V16, P1035, DOI 10.1007/s00775-011-0801-z; Gonzalez-Mendoza D, 2007, AQUAT TOXICOL, V83, P306, DOI 10.1016/j.aquatox.2007.05.005; Guo WJ, 2003, NEW PHYTOL, V159, P369, DOI 10.1046/j.1469-8137.2003.00813.x; Henkel G, 2004, CHEM REV, V104, P801, DOI 10.1021/cr020620d; Hensbergen PJ, 2000, COMP BIOCHEM PHYS C, V125, P17, DOI 10.1016/S0742-8413(99)00087-0; Hensbergen PJ, 2006, COMP BIOCH PHYSL C, V125, P17; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; Klaassen CD, 2009, TOXICOL APPL PHARM, V238, P215, DOI 10.1016/j.taap.2009.03.026; Langston W. J., 1998, METAL METABOLISM AQU, P219; Levin ED, 2006, PHYSIOL BEHAV, V87, P513, DOI 10.1016/j.physbeh.2005.11.014; Liang SH, 2009, COMP BIOCHEM PHYS C, V149, P349, DOI 10.1016/j.cbpc.2008.09.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manso Y, 2011, J BIOL INORG CHEM, V16, P1103, DOI 10.1007/s00775-011-0802-y; Mao H, 2012, AQUAT TOXICOL, V110, P208, DOI 10.1016/j.aquatox.2012.01.018; Maremanda KP, 2014, BIOCHEM BIOPH RES CO, V445, P591, DOI 10.1016/j.bbrc.2014.02.055; MARGOSHES M, 1957, J AM CHEM SOC, V79, P4813, DOI 10.1021/ja01574a064; MARTIN M, 1981, MAR POLLUT BULL, V12, P305, DOI 10.1016/0025-326X(81)90081-3; MAYO KE, 1982, CELL, V29, P99, DOI 10.1016/0092-8674(82)90094-0; Molto E, 2005, GENE, V361, P140, DOI 10.1016/j.gene.2005.07.026; Moulis JM, 2010, BIOMETALS, V23, P877, DOI 10.1007/s10534-010-9336-y; Mudalkar S, 2014, MOL BIOL REP, V41, P113, DOI 10.1007/s11033-013-2843-5; Nakamori T, 2010, ENVIRON POLLUT, V158, P1689, DOI 10.1016/j.envpol.2009.11.022; Nakano H, 2006, BIOL PHARM BULL, V29, P55, DOI 10.1248/bpb.29.55; Pan LQ, 2006, COMP BIOCHEM PHYS C, V144, P67, DOI 10.1016/j.cbpc.2006.06.001; Ren F, 2011, MOL BIOL REP, V38, P2383, DOI 10.1007/s11033-010-0372-z; Roesijadi G, 1996, TOXICOL APPL PHARM, V140, P356, DOI 10.1006/taap.1996.0231; Ruttkay-Nedecky B, 2013, INT J MOL SCI, V14, P6044, DOI 10.3390/ijms14036044; Sato M, 2002, TOHOKU J EXP MED, V196, P9, DOI 10.1620/tjem.196.9; SATO M, 1993, FREE RADICAL BIO MED, V14, P325, DOI 10.1016/0891-5849(93)90029-T; Sharma S, 2014, NEUROCHEM INT, V65, P40, DOI 10.1016/j.neuint.2013.12.009; Sharma S, 2013, INT J NANOMED, V8, P1477, DOI 10.2147/IJN.S42019; Sturzenbaum SR, 2001, J BIOL CHEM, V276, P34013, DOI 10.1074/jbc.M103605200; Tang T, 2011, COMP BIOCHEM PHYS B, V160, P81, DOI 10.1016/j.cbpb.2011.06.008; Thirumoorthy N, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-54; Trinchella F, 2008, GENE, V423, P48, DOI 10.1016/j.gene.2008.06.027; Usha B, 2009, MOL GENET GENOMICS, V281, P99, DOI 10.1007/s00438-008-0398-2; Vasak M, 2005, J TRACE ELEM MED BIO, V19, P13, DOI 10.1016/j.jtemb.2005.03.003; Viarengo A., 1999, AM J PHYSIOL, V277, P1612, DOI DOI 10.1152/AJPREGU.1999.277.6.R1612; West AK, 2008, NEUROTOXICOLOGY, V29, P489, DOI 10.1016/j.neuro.2007.12.006; Won EJ, 2012, ENVIRON SCI POLLUT R, V19, P2606, DOI 10.1007/s11356-012-0905-1; Xiang DF, 2013, AQUAT TOXICOL, V140, P1, DOI 10.1016/j.aquatox.2013.05.004; Yang JL, 2011, MOL BIOL REP, V38, P1567, DOI 10.1007/s11033-010-0265-1; Yang LF, 2014, TOXICOL LETT, V225, P333, DOI 10.1016/j.toxlet.2013.12.024; Yang Z, 2009, PLANT MOL BIOL, V70, P219, DOI 10.1007/s11103-009-9466-1; Yoshida M, 2005, TOXICOLOGY, V213, P74, DOI 10.1016/j.tox.2005.05.008; Zhang YP, 2014, ENVIRON ENTOMOL, V43, P171, DOI 10.1603/EN13025; Zhang YP, 2011, ECOTOX ENVIRON SAFE, V74, P1355, DOI 10.1016/j.ecoenv.2011.03.002	64	18	20	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112759	10.1371/journal.pone.0112759	http://dx.doi.org/10.1371/journal.pone.0112759			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391131	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400124
J	McQuillan, HJ; Nakagawa, S; Mercer, AR				McQuillan, H. James; Nakagawa, Shinichi; Mercer, Alison R.			Juvenile Hormone Enhances Aversive Learning Performance in 2-Day Old Worker Honey Bees while Reducing Their Attraction to Queen Mandibular Pheromone	PLOS ONE			English	Article							CABBAGE-LOOPER MOTHS; APIS-MELLIFERA; BIOGENIC-AMINES; OLFACTORY MEMORY; NERVOUS-TISSUE; SEX-PHEROMONE; OCTOPAMINE; DROSOPHILA; RESPONSES; DOPAMINE	Previous studies have shown that exposing young worker bees (Apis mellifera) to queen mandibular pheromone (QMP) reduces their aversive learning performance, while enhancing their attraction to QMP. As QMP has been found to reduce the rate of juvenile hormone (JH) synthesis in worker bees, we examined whether aversive learning in 2-day old workers exposed to QMP from the time of adult emergence could be improved by injecting JH (10 mu g in a 2 mu l volume) into the haemolymph. We examined in addition, the effects of JH treatment on worker attraction to QMP, and on the levels of expression of amine receptor genes in the antennae, as well as in the mushroom bodies of the brain. We found that memory acquisition and 1-hour memory recall were enhanced by JH. In contrast, JH treatment reduced the bees' attraction towards a synthetic strip impregnated with QMP (Bee Boost). Levels of expression of the dopamine receptor gene Amdop1 were significantly lower in the mushroom bodies of JH-treated bees than in bees treated with vehicle alone (acetone diluted with bee ringer). Expression of the octopamine receptor gene, Amoa1, in this brain region was also affected by JH treatment, and in the antennae, Amoa1 transcript levels were significantly lower in JH-treated bees compared to controls. The results of this study suggest that QMP's effects on JH synthesis may contribute to reducing aversive learning performance and enhancing attraction to QMP in young worker bees.	[McQuillan, H. James; Nakagawa, Shinichi; Mercer, Alison R.] Univ Otago, Dept Zool, Dunedin, New Zealand	University of Otago	McQuillan, HJ (corresponding author), Univ Otago, Dept Zool, POB 56, Dunedin, New Zealand.	jamie.mcquillan@otago.ac.nz	Nakagawa, Shinichi/B-5571-2011	Nakagawa, Shinichi/0000-0002-7765-5182; Mercer, Alison/0000-0001-8110-4247	Royal Society of New Zealand Marsden Fund Grant [UOO0910]	Royal Society of New Zealand Marsden Fund Grant(Royal Society of New ZealandMarsden Fund (NZ))	This work was supported by a grant from the Royal Society of New Zealand Marsden Fund Grant UOO0910. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025371; Amdam GV, 2010, EVOL DEV, V12, P428, DOI 10.1111/j.1525-142X.2010.00429.x; Beggs KT, 2007, P NATL ACAD SCI USA, V104, P2460, DOI 10.1073/pnas.0608224104; Berry JA, 2012, NEURON, V74, P530, DOI 10.1016/j.neuron.2012.04.007; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Flecke C, 2009, J COMP PHYSIOL A, V195, P529, DOI 10.1007/s00359-009-0429-4; Geddes LH, 2013, LEARN MEMORY, V20, P399, DOI 10.1101/lm.030825.113; Grosmaitre X, 2001, CHEM SENSES, V26, P653, DOI 10.1093/chemse/26.6.653; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Jarriault D, 2009, HORM BEHAV, V56, P185, DOI 10.1016/j.yhbeh.2009.04.005; Jassim O, 2000, J INSECT PHYSIOL, V46, P243, DOI 10.1016/S0022-1910(99)00176-6; JAYCOX ER, 1974, ANN ENTOMOL SOC AM, V67, P529, DOI 10.1093/aesa/67.4.529; KAATZ HH, 1992, J COMP PHYSIOL B, V162, P588, DOI 10.1007/BF00296638; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; Kosmidis I., 2007, BRGLM BIAS REDUCTION; LINN CE, 1994, COMP BIOCHEM PHYS C, V108, P87, DOI 10.1016/1367-8280(94)90093-0; LINN CE, 1994, COMP BIOCHEM PHYS C, V108, P99, DOI 10.1016/1367-8280(94)90094-9; LINN CE, 1986, ARCH INSECT BIOCHEM, V3, P161, DOI 10.1002/arch.940030206; McQuillan HJ, 2012, LEARN MEMORY, V19, P151, DOI 10.1101/lm.025353.111; McQuillan HJ, 2012, J COMP PHYSIOL A, V198, P753, DOI 10.1007/s00359-012-0745-y; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; PAIN JANINE, 1966, ANN ABEILLE [PARIS], V9, P71, DOI 10.1051/apido:19660106; Pankiw T, 1998, J INSECT PHYSIOL, V44, P685, DOI 10.1016/S0022-1910(98)00040-7; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pophof B, 2000, J COMP PHYSIOL A, V186, P307, DOI 10.1007/s003590050431; Pophof B, 2002, J COMP PHYSIOL A, V188, P659, DOI 10.1007/s00359-002-0343-5; Rein J, 2013, J COMP PHYSIOL A, V199, P947, DOI 10.1007/s00359-013-0805-y; ROBINSON GE, 1987, GEN COMP ENDOCR, V66, P457, DOI 10.1016/0016-6480(87)90258-9; Schulz DJ, 2002, HORM BEHAV, V42, P222, DOI 10.1006/hbeh.2002.1806; Slessor KN, 2005, J CHEM ECOL, V31, P2731, DOI 10.1007/s10886-005-7623-9; Srivastava DP, 2005, J NEUROSCI, V25, P6145, DOI 10.1523/JNEUROSCI.1005-05.2005; Sullivan JP, 2000, HORM BEHAV, V37, P1, DOI 10.1006/hbeh.1999.1552; Team RDC, 2012, R LANG ENV STAT COMP; Velarde RA, 2009, J INSECT PHYSIOL, V55, P59, DOI 10.1016/j.jinsphys.2008.10.006; Vergoz V, 2007, SCIENCE, V317, P384, DOI 10.1126/science.1142448; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; Vergoz V, 2009, P NATL ACAD SCI USA, V106, P20930, DOI 10.1073/pnas.0907563106; Winston M.L., 1991, BIOL HONEY BEE; Zhukovskaya MI, 2006, J INSECT PHYSIOL, V52, P76, DOI 10.1016/j.jinsphys.2005.09.005	42	11	11	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112740	10.1371/journal.pone.0112740	http://dx.doi.org/10.1371/journal.pone.0112740			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390885	Green Submitted, Green Published, gold			2022-12-27	WOS:000349144400123
J	Otowa, T; Maher, BS; Aggen, SH; McClay, JL; van den Oord, EJ; Hettema, JM				Otowa, Takeshi; Maher, Brion S.; Aggen, Steven H.; McClay, Joseph L.; van den Oord, Edwin J.; Hettema, John M.			Genome-Wide and Gene-Based Association Studies of Anxiety Disorders in European and African American Samples	PLOS ONE			English	Article							METAANALYSIS; REPLICATION; POPULATION; NEUROTICISM; DISEASES; CANCER; BRCA2; PALB2; SCANS; RISK	Anxiety disorders (ADs) are common mental disorders caused by a combination of genetic and environmental factors. Since ADs are highly comorbid with each other, partially due to shared genetic basis, studying AD phenotypes in a coordinated manner may be a powerful strategy for identifying potential genetic loci for ADs. To detect these loci, we performed genome-wide association studies (GWAS) of ADs. In addition, as a complementary approach to single-locus analysis, we also conducted gene-and pathway-based analyses. GWAS data were derived from the control sample of the Molecular Genetics of Schizophrenia (MGS) project (2,540 European American and 849 African American subjects) genotyped on the Affymetrix GeneChip 6.0 array. We applied two phenotypic approaches: (1) categorical case-control comparisons (CC) based upon psychiatric diagnoses, and (2) quantitative phenotypic factor scores (FS) derived from a multivariate analysis combining information across the clinical phenotypes. Linear and logistic models were used to analyse the association with ADs using FS and CC traits, respectively. At the single locus level, no genome-wide significant association was found. A transpopulation gene-based meta-analysis across both ethnic subsamples using FS identified three genes (MFAP3L on 4q32.3, NDUFAB1 and PALB2 on 16p12) with genome-wide significance (false discovery rate (FDR] <5%). At the pathway level, several terms such as transcription regulation, cytokine binding, and developmental process were significantly enriched in ADs (FDR <5%). Our approaches studying ADs as quantitative traits and utilizing the full GWAS data may be useful in identifying susceptibility genes and pathways for ADs.	[Otowa, Takeshi; Aggen, Steven H.; Hettema, John M.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Dept Psychiat, Richmond, VA 23284 USA; [Otowa, Takeshi] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Maher, Brion S.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [McClay, Joseph L.; van den Oord, Edwin J.] Virginia Commonwealth Univ, Ctr Biomarker Res & Personalized Med, Dept Pharm, Richmond, VA USA	Virginia Commonwealth University; University of Tokyo; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Virginia Commonwealth University	Hettema, JM (corresponding author), Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Dept Psychiat, Richmond, VA 23284 USA.	jhettema@vcu.edu	McClay, Joseph/C-9931-2009	McClay, Joseph/0000-0002-3628-2447	Japan Society for the Promotion of Science [21-8373]; NIH [R01MH087646]; NIMH Schizophrenia Genetics Initiative [U01s: MH046276, MH46289, MH46318, MGS Part 1 (MGS1) and Part 2 (MGS2) R01s: MH67257, MH59588, MH59571, MH59565, MH59587, MH60870, MH59566, MH59586, MH61675, MH60879]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH046289, U01MH046276, R01MH061675, R01MH060879, R01MH059566, R01MH067257, R01MH059586, R01MH059588, R01MH060870, U01MH046318, R01MH059571, R01MH059565, R01MH059587, R01MH087646] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH Schizophrenia Genetics Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by NIH grant R01MH087646 (JMH). Samples and associated phenotype data for the MGS study were collected under the following grants: NIMH Schizophrenia Genetics Initiative U01s: MH046276 (CR Cloninger), MH46289 (C Kaufmann), and MH46318 (MT Tsuang); and MGS Part 1 (MGS1) and Part 2 (MGS2) R01s: MH67257 (NG Buccola), MH59588 (BJ Mowry), MH59571 (PV Gejman), MH59565 (Robert Freedman), MH59587 (F Amin), MH60870 (WF Byerley), MH59566 (DW Black), MH59586 (JM Silverman), MH61675 (DF Levinson), and MH60879 (CR Cloninger). TO was supported by a research fellowship from the Japan Society for the Promotion of Science (no. 21-8373). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beaulieu JM, 2009, ANNU REV PHARMACOL, V49, P327, DOI 10.1146/annurev.pharmtox.011008.145634; Becker J, 2012, EUR J HUM GENET, V20, P97, DOI 10.1038/ejhg.2011.156; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cheung CL, 2012, OSTEOPOROSIS INT, V23, P131, DOI 10.1007/s00198-011-1779-7; COHEN J, 1983, APPL PSYCH MEAS, V7, P249, DOI 10.1177/014662168300700301; Cowen DS, 2007, J NEUROCHEM, V101, P1161, DOI 10.1111/j.1471-4159.2006.04420.x; Erhardt A, 2011, MOL PSYCHIATR, V16, P647, DOI 10.1038/mp.2010.41; Guffanti G, 2013, PSYCHONEUROENDOCRINO, V38, P3029, DOI 10.1016/j.psyneuen.2013.08.014; Hettema JM, 2006, AM J PSYCHIAT, V163, P857, DOI 10.1176/appi.ajp.163.5.857; Hettema JM, 2001, AM J PSYCHIAT, V158, P1568, DOI 10.1176/appi.ajp.158.10.1568; Hettema JM, 2011, BIOL PSYCHIAT, V70, P888, DOI 10.1016/j.biopsych.2011.07.012; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; JARDINE R, 1984, Genetic Epidemiology, V1, P89, DOI 10.1002/gepi.1370010202; Kaabi B, 2006, AM J HUM GENET, V78, P543, DOI 10.1086/501072; Kang B, 2008, J PROTEOME RES, V7, P3507, DOI 10.1021/pr800238p; Kendler KS, 2007, PSYCHOL MED, V37, P453, DOI 10.1017/S0033291706009135; Kessler R.C., 1998, INT J METHODS PSYCHI, V7, P171, DOI [10.1002/mpr.47, DOI 10.1002/MPR.47]; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kitagishi Y, 2012, INT J MOL MED, V30, P1255, DOI 10.3892/ijmm.2012.1152; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Logue MW, 2013, MOL PSYCHIATR, V18, P937, DOI 10.1038/mp.2012.113; Miller AH, 2013, DEPRESS ANXIETY, V30, P297, DOI 10.1002/da.22084; Muthen LK, 2006, MPLUS USERS GUIDE; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Otowa T, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.89; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sanders AR, 2010, AM J PSYCHIAT, V167, P854, DOI 10.1176/appi.ajp.2010.09071050; Sheppard Karen E., 2012, Critical Reviews in Oncogenesis, V17, P69; Shi J, 2011, MOL PSYCHIATR, V16, P193, DOI 10.1038/mp.2009.124; Smoller JW, 2009, DEPRESS ANXIETY, V26, P965, DOI 10.1002/da.20623; Star S.A., 1949, STUDIES SOCIAL PSYCH, V1; Stewart SE, 2013, MOL PSYCHIATR, V18, P788, DOI 10.1038/mp.2012.85; Tesli M, 2010, AM J MED GENET B, V153B, P1276, DOI 10.1002/ajmg.b.31098; van den Oord EJCG, 2008, ARCH GEN PSYCHIAT, V65, P1062, DOI 10.1001/archpsyc.65.9.1062; Walter S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080326; Wang X, 2012, EUR J HUM GENET, V20, P469, DOI 10.1038/ejhg.2011.219; Webb BT, 2012, EUR J HUM GENET, V20, P1078, DOI 10.1038/ejhg.2012.47; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Xie PX, 2013, BIOL PSYCHIAT, V74, P656, DOI 10.1016/j.biopsych.2013.04.013; Yang J, 2010, GENET EPIDEMIOL, V34, P254, DOI 10.1002/gepi.20456; Zhang QH, 2002, SCIENCE, V295, P1895	48	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112559	10.1371/journal.pone.0112559	http://dx.doi.org/10.1371/journal.pone.0112559			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390645	Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400098
J	Roberti, JA; SanClements, MD; Loescher, HW; Ayres, E				Roberti, Joshua A.; SanClements, Michael D.; Loescher, Henry W.; Ayres, Edward			Traceable Calibration, Performance Metrics, and Uncertainty Estimates of Minirhizotron Digital Imagery for Fine-Root Measurements	PLOS ONE			English	Article							SOIL RESPIRATION; ATMOSPHERIC CO2; ORGANIC-MATTER; TURNOVER; NITROGEN; DYNAMICS; FOREST; RHIZOMORPHS; TEMPERATURE; LIMITATIONS	Even though fine-root turnover is a highly studied topic, it is often poorly understood as a result of uncertainties inherent in its sampling, e.g., quantifying spatial and temporal variability. While many methods exist to quantify fine-root turnover, use of minirhizotrons has increased over the last two decades, making sensor errors another source of uncertainty. Currently, no standardized methodology exists to test and compare minirhizotron camera capability, imagery, and performance. This paper presents a reproducible, laboratory-based method by which minirhizotron cameras can be tested and validated in a traceable manner. The performance of camera characteristics was identified and test criteria were developed: we quantified the precision of camera location for successive images, estimated the trueness and precision of each camera's ability to quantify root diameter and root color, and also assessed the influence of heat dissipation introduced by the minirhizotron cameras and electrical components. We report detailed and defensible metrology analyses that examine the performance of two commercially available minirhizotron cameras. These cameras performed differently with regard to the various test criteria and uncertainty analyses. We recommend a defensible metrology approach to quantify the performance of minirhizotron camera characteristics and determine sensor-related measurement uncertainties prior to field use. This approach is also extensible to other digital imagery technologies. In turn, these approaches facilitate a greater understanding of measurement uncertainties (signal-to-noise ratio) inherent in the camera performance and allow such uncertainties to be quantified and mitigated so that estimates of fine-root turnover can be more confidently quantified.	[Roberti, Joshua A.; SanClements, Michael D.; Loescher, Henry W.; Ayres, Edward] NEON, Boulder, CO 80301 USA; [SanClements, Michael D.; Loescher, Henry W.; Ayres, Edward] Univ Colorado, Inst Arctic & Alpine Res INSTAAR, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Roberti, JA (corresponding author), NEON, Boulder, CO 80301 USA.	jroberti@neoninc.org	Ayres, Edward/A-4172-2008	Ayres, Edward/0000-0001-5190-258X; Roberti, Joshua/0000-0002-3888-4900	National Science Foundation [DBI-0752017]; Div Of Biological Infrastructure [1029808] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding provided by National Science Foundation (http://www.nsf.gov/); Grant #: DBI-0752017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Society for Testing and Materials (ASTM), 1999, E308 ASTM; Ballico M, 2000, METROLOGIA, V37, P61, DOI 10.1088/0026-1394/37/1/8; Bates G.H., 1937, NATURE, V139, P966, DOI [10.1038/139966b0, DOI 10.1038/139966B0]; Bauhus J, 1999, AGRON J, V91, P142, DOI 10.2134/agronj1999.00021962009100010022x; CHENG W, 1990, J APPL ECOL, V27, P592, DOI 10.2307/2404304; CHENG WX, 1991, AGR ECOSYST ENVIRON, V34, P261, DOI 10.1016/0167-8809(91)90113-C; CID Bio-Science Inc, 2012, IN SIT ROOT IM CI 60; CIE, 2004, TECHN REP COL; Comas LH, 2010, AUST J GRAPE WINE R, V16, P131, DOI 10.1111/j.1755-0238.2009.00078.x; Comas LH, 2000, NEW PHYTOL, V147, P171, DOI 10.1046/j.1469-8137.2000.00679.x; Comas LH, 2005, NEW PHYTOL, V167, P829, DOI 10.1111/j.1469-8137.2005.01456.x; COX TL, 1978, PEDOBIOLOGIA, V18, P264; Dannoural M, 2008, PLANT ROOT, V2, P14, DOI 10.3117/plantroot.2.14; Early EA, 2004, COLOR RES APPL, V29, P205, DOI 10.1002/col.20006; Fahey TJ, 1999, LT EC RES NETWK SER, V2, P437; Fitter AH, 1998, OECOLOGIA, V114, P20, DOI 10.1007/s004420050415; Gardner JL, 2000, COLOR RES APPL, V25, P349, DOI 10.1002/1520-6378(200010)25:5<349::AID-COL5>3.0.CO;2-N; Gaudinski JB, 2001, OECOLOGIA, V129, P420, DOI 10.1007/s004420100746; Gill RA, 2000, NEW PHYTOL, V147, P13, DOI 10.1046/j.1469-8137.2000.00681.x; Hecht E., 2002, OPTICS; Hendrick RL, 1996, J ECOL, V84, P167, DOI 10.2307/2261352; HENDRICK RL, 1992, ECOLOGY, V73, P1094, DOI 10.2307/1940183; Hong GW, 2001, COLOR RES APPL, V26, P76, DOI 10.1002/1520-6378(200102)26:1<76::AID-COL8>3.0.CO;2-3; Ilie A, 2005, IEEE I CONF COMP VIS, P1268, DOI 10.1109/ICCV.2005.88; Jackson RB, 1997, P NATL ACAD SCI USA, V94, P7362, DOI 10.1073/pnas.94.14.7362; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; JCGM, 2008, EV MEAS DAT GUID EXP; Johnson MG, 2001, ENVIRON EXP BOT, V45, P263, DOI 10.1016/S0098-8472(01)00077-6; Johnson T, 1996, DISPLAYS, V16, P183, DOI 10.1016/0141-9382(96)01012-8; Joint Commitee for Guides in Metrology (JCGM), 2012, INT VOCABULARY METRO, V3; Jonkman JEN, 2003, METHOD ENZYMOL, V360, P416; Joslin J.D., 1982, CENTR HARDW FOR C P, P220; JOSLIN JD, 1987, FOREST SCI, V33, P330; Kucbel S, 2011, PLANT ROOT, V5, P46, DOI 10.3117/plantroot.5.46; KURZ WA, 1987, CAN J FOREST RES, V17, P909, DOI 10.1139/x87-142; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Loescher HW, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006932; Lukac M, 2012, MEASURING ROOTS: AN UPDATED APPROACH, P363, DOI 10.1007/978-3-642-22067-8_18; Majdi H, 1996, PLANT SOIL, V185, P255, DOI 10.1007/BF02257530; Majdi H, 2005, PLANT SOIL, V276, P1, DOI 10.1007/s11104-005-3104-8; Majdi H, 2005, ECOSYSTEMS, V8, P191, DOI 10.1007/s10021-004-0246-0; MCCLAUGHERTY CA, 1982, ECOLOGY, V63, P1481, DOI 10.2307/1938874; MCMICHAEL BL, 1987, AM SOC AGRONOMY SPEC, V50, P1; Norby RJ, 2004, P NATL ACAD SCI USA, V101, P9689, DOI 10.1073/pnas.0403491101; Ostertag R, 2001, ECOLOGY, V82, P485, DOI 10.1890/0012-9658(2001)082[0485:EONAPA]2.0.CO;2; Pierret A, 2005, NEW PHYTOL, V166, P967, DOI 10.1111/j.1469-8137.2005.01389.x; Po-Chieh Hung, 1993, Journal of Electronic Imaging, V2, P53, DOI 10.1117/12.132391; PREGITZER KS, 1995, NEW PHYTOL, V129, P579, DOI 10.1111/j.1469-8137.1995.tb03025.x; Research Systems Inc. (RSI), 2004, IM PROC IDL; RhizoSystems LLC, 2012, SPEC AUT MIN; Ruess RW, 1996, CAN J FOREST RES, V26, P1326, DOI 10.1139/x26-148; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; RYAN MG, 1991, ECOL APPL, V1, P157, DOI 10.2307/1941808; Sandor N, 2005, COLOR RES APPL, V30, P348, DOI 10.1002/col.20136; SANTANTONIO D, 1987, CAN J FOREST RES, V17, P900, DOI 10.1139/x87-141; Starr G, 2014, NEW FORESTS IN PRESS; Strutt J.W., 1871, NATURE, V3, P234; Swift M.J., 1979, DECOMPOSITION TERRES, V5; Vamerali T, 2012, MEASURING ROOTS: AN UPDATED APPROACH, P341, DOI 10.1007/978-3-642-22067-8_17; Vargas R, 2008, VADOSE ZONE J, V7, P1055, DOI 10.2136/vzj2007.0138; Vargas R, 2008, NEW PHYTOL, V179, P460, DOI 10.1111/j.1469-8137.2008.02481.x; Villordon A, 2011, HORTSCIENCE, V46, P513, DOI 10.21273/HORTSCI.46.3.513; Wang Z, 1995, ECOLOGY, V76, P2230; Weber EP, 1996, PLANT SOIL, V182, P139, DOI 10.1007/BF00011002; Wells CE, 2001, ECOLOGY, V82, P882, DOI 10.1890/0012-9658(2001)082[0882:MDISAA]2.0.CO;2; Willink R, 2007, METROLOGIA, V44, P340, DOI 10.1088/0026-1394/44/5/010; Wilson JD, 1990, COLL PHYS; Zobel RW, 2003, CROP SCI, V43, P583, DOI 10.2135/cropsci2003.0583	68	2	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112362	10.1371/journal.pone.0112362	http://dx.doi.org/10.1371/journal.pone.0112362			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391023	Green Submitted, Green Published, gold			2022-12-27	WOS:000349144400075
J	Tastesen, HS; Ronnevik, AK; Borkowski, K; Madsen, L; Kristiansen, K; Liaset, B				Tastesen, Hanne Sorup; Ronnevik, Alexander Krokedal; Borkowski, Kamil; Madsen, Lise; Kristiansen, Karsten; Liaset, Bjorn			A Mixture of Cod and Scallop Protein Reduces Adiposity and Improves Glucose Tolerance in High-Fat Fed Male C57BL/6J Mice	PLOS ONE			English	Article							INSULIN-RESISTANT MEN; SKELETAL-MUSCLE; HIGH-CARBOHYDRATE; GLYCEMIC INDEX; WHEY-PROTEIN; BODY-WEIGHT; ACID CYCLE; DIET; THERMOGENESIS; SENSITIVITY	Low-protein and high-protein diets regulate energy metabolism in animals and humans. To evaluate whether different dietary protein sources modulate energy balance when ingested at average levels obesity-prone male C57BL/6J mice were pair-fed high-fat diets (67 energy percent fat, 18 energy percent sucrose and 15 energy percent protein) with either casein, chicken filet or a mixture of cod and scallop (1:1 on amino acid content) as protein sources. At equal energy intake, casein and cod/scallop fed mice had lower feed efficiency than chicken fed mice, which translated into reduced adipose tissue masses after seven weeks of feeding. Chicken fed mice had elevated hepatic triglyceride relative to casein and cod/scallop fed mice and elevated 4 h fasted plasma cholesterol concentrations compared to low-fat and casein fed mice. In casein fed mice the reduced adiposity was likely related to the observed three percent lower apparent fat digestibility compared to low-fat, chicken and cod/scallop fed mice. After six weeks of feeding an oral glucose tolerance test revealed that despite their lean phenotype, casein fed mice had reduced glucose tolerance compared to low-fat, chicken and cod/scallop fed mice. In a separate set of mice, effects on metabolism were evaluated by indirect calorimetry before onset of diet-induced obesity. Spontaneous locomotor activity decreased in casein and chicken fed mice when shifting from low-fat to high-fat diets, but cod/scallop feeding tended (P = 0.06) to attenuate this decrease. Moreover, at this shift, energy expenditure decreased in all groups, but was decreased to a greater extent in casein fed than in cod/scallop fed mice, indicating that protein sources regulated energy expenditure differently. In conclusion, protein from different sources modulates energy balance in C57BL/6J mice when given at normal levels. Ingestion of a cod/scallop-mixture prevented diet-induced obesity compared to intake of chicken filet and preserved glucose tolerance compared to casein intake.	[Tastesen, Hanne Sorup; Ronnevik, Alexander Krokedal; Borkowski, Kamil; Madsen, Lise; Kristiansen, Karsten] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Tastesen, Hanne Sorup; Ronnevik, Alexander Krokedal; Madsen, Lise; Liaset, Bjorn] Natl Inst Nutr & Seafood Res, Bergen, Norway	University of Copenhagen	Kristiansen, K (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	kk@bio.ku.dk; Bjorn.Liaset@nifes.no	Kristiansen, Karsten/J-5148-2014; Madsen, Lise/C-6246-2012	Kristiansen, Karsten/0000-0002-6024-0917; Madsen, Lise/0000-0003-4468-1947; Liaset, Bjorn/0000-0002-8652-7801	Norwegian Research Council [200515/I30]; National Institute of Nutrition and Seafood Research; Danish Council for Strategic Research [2101-08-0053]; Danish Dairy Research Foundation; Danish Natural Science Research Council; Novo Nordisk Foundation; Carlsberg Foundation	Norwegian Research Council(Research Council of NorwayEuropean Commission); National Institute of Nutrition and Seafood Research; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Dairy Research Foundation; Danish Natural Science Research Council(Danish Natural Science Research Council); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation)	This study was part of the Lean Seafood in the Prevention of the Metabolic Syndrome project which is financially supported by the Norwegian Research Council (Grant no. 200515/I30) and the National Institute of Nutrition and Seafood Research. Part of this work was also financially supported by the Danish Council for Strategic Research (Grant no. 2101-08-0053), the Danish Dairy Research Foundation, the Danish Natural Science Research Council, the Novo Nordisk Foundation and the Carlsberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson KJ, 2011, AM J CLIN NUTR, V93, P525, DOI 10.3945/ajcn.110.005850; ALLISON DB, 1995, DIABETES CARE, V18, P245, DOI 10.2337/diacare.18.2.245; An YP, 2013, J PROTEOME RES, V12, P3755, DOI 10.1021/pr400398b; Baer DJ, 2011, J NUTR, V141, P1489, DOI 10.3945/jn.111.139840; Belza A, 2013, AM J CLIN NUTR, V97, P980, DOI 10.3945/ajcn.112.047563; Binder E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074705; El Idrissi A, 2009, ADV EXP MED BIOL, V643, P207, DOI 10.1007/978-0-387-75681-3_21; Even PC, 2012, AM J PHYSIOL-REG I, V303, pR459, DOI 10.1152/ajpregu.00137.2012; Fulgoni VL, 2008, AM J CLIN NUTR, V87, p1554S, DOI 10.1093/ajcn/87.5.1554S; Gilbert JA, 2011, NUTR METAB CARDIOVAS, V21, pB16, DOI 10.1016/j.numecd.2010.12.008; Guo Y, 2013, MOL CELLULAR PROTEOM; Hamilton TS, 1939, J NUTR, V17, P583, DOI 10.1093/jn/17.6.583; Hao Q, 2012, AM J PHYSIOL-ENDOC M, V302, pE1097, DOI 10.1152/ajpendo.00524.2011; Ibrahim MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025170; Johnston CS, 2004, J NUTR, V134, P586, DOI 10.1093/jn/134.3.586; Johnston CS, 2002, J AM COLL NUTR, V21, P55, DOI 10.1080/07315724.2002.10719194; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; KEVONIAN AV, 1984, J NUTR, V114, P543, DOI 10.1093/jn/114.3.543; Klaus S, 2005, J NUTR, V135, P1854, DOI 10.1093/jn/135.8.1854; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Larsen Thomas Meinert, 2010, N Engl J Med, V363, P2102, DOI 10.1056/NEJMoa1007137; Lavigne C, 2000, AM J PHYSIOL-ENDOC M, V278, pE491, DOI 10.1152/ajpendo.2000.278.3.E491; Lavigne C, 2001, AM J PHYSIOL-ENDOC M, V281, pE62, DOI 10.1152/ajpendo.2001.281.1.E62; LEFLOCH JP, 1990, DIABETES CARE, V13, P172, DOI 10.2337/diacare.13.2.172; Liaset B, 2003, PROCESS BIOCHEM, V38, P1747, DOI 10.1016/S0032-9592(02)00251-0; Liaset B, 2011, J BIOL CHEM, V286, P28382, DOI 10.1074/jbc.M111.234732; Liaset B, 2009, BBA-MOL CELL BIOL L, V1791, P254, DOI 10.1016/j.bbalip.2009.01.016; Lillefosse HH, 2014, J PROTEOME RES, V13, P2560, DOI 10.1021/pr500039t; Lillefosse HH, 2013, J NUTR, V143, P1367, DOI 10.3945/jn.112.170415; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Ma T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021647; Macotela Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021187; Madsen L, 2008, J BIOL CHEM, V283, P7196, DOI 10.1074/jbc.M707775200; Mariotti F, 2008, CRIT REV FOOD SCI, V48, P177, DOI 10.1080/10408390701279749; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MILLER DS, 1967, AM J CLIN NUTR, V20, P1212, DOI 10.1093/ajcn/20.11.1212; MILLER DS, 1962, J NUTR, V78, P255, DOI 10.1093/jn/78.3.255; Murakami T, 2010, AMINO ACIDS, V39, P427, DOI 10.1007/s00726-009-0458-x; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Ouellet V, 2008, J NUTR, V138, P2386, DOI 10.3945/jn.108.092346; Ouellet V, 2007, DIABETES CARE, V30, P2816, DOI 10.2337/dc07-0273; Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; ROBINSON SM, 1990, AM J CLIN NUTR, V52, P72, DOI 10.1093/ajcn/52.1.72; ROTHWELL NJ, 1983, METABOLISM, V32, P257, DOI 10.1016/0026-0495(83)90190-7; Shi J, 2011, INT DAIRY J, V21, P513, DOI 10.1016/j.idairyj.2011.03.006; Stock MJ, 1999, INT J OBESITY, V23, P1105, DOI 10.1038/sj.ijo.0801108; Swan G, 2004, P NUTR SOC, V63, P505, DOI 10.1079/PNS2004381; Tastesen HS, 2014, AMINO ACIDS, V46, P1659, DOI 10.1007/s00726-014-1715-1; Tranberg B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071439; Tremblay F, 2005, DIABETES, V54, P2674, DOI 10.2337/diabetes.54.9.2674; Tremblay F, 2003, DIABETES, V52, P29, DOI 10.2337/diabetes.52.1.29; Tsuboyama-Kasaoka N, 2006, ENDOCRINOLOGY, V147, P3276, DOI 10.1210/en.2005-1007; van den Broek NMA, 2010, FASEB J, V24, P1354, DOI 10.1096/fj.09-143842; Weigle DS, 2005, AM J CLIN NUTR, V82, P41, DOI 10.1093/ajcn/82.1.41	57	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112859	10.1371/journal.pone.0112859	http://dx.doi.org/10.1371/journal.pone.0112859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390887	Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400135
J	Amarilyo, G; Iikuni, N; Liu, AJ; Matarese, G; La Cava, A				Amarilyo, Gil; Iikuni, Noriko; Liu, Aijing; Matarese, Giuseppe; La Cava, Antonio			Leptin Enhances Availability of Apoptotic Cell-Derived Self-Antigen in Systemic Lupus Erythematosus	PLOS ONE			English	Article							CLEARANCE; AUTOANTIGENS; AUTOIMMUNITY; WOMEN	In systemic lupus erythematosus (SLE), the availability of self-antigen promotes and fuels self-reactive immune responses. Apoptotic cells represent a major source of self-antigens, and an impairment of the removal of apoptotic material containing self-antigen can contribute to the development of autoimmunity. To address whether the adipocytokine leptin - which favors autoimmune responses through little understood mechanisms - could modulate the handling of apoptotic cells in SLE, we evaluated the ability of leptin to modulate the capacity of macrophages to phagocytose apoptotic bodies in (NZBxNZW)F-1 lupus mice. It was found that leptin promoted phagocytosis of apoptotic cells by macrophages by modulating cAMP levels in macrophages. This finding associated with an increased availability of antigen that favored the development of T cell responses to apoptotic-derived antigen. As leptin promotes macrophage phagocytosis of apoptotic bodies in SLE and subsequent availability of apoptotic-derived antigen to T cells, an inhibition of this process via leptin blockade might have a therapeutic potential in SLE.	[Amarilyo, Gil; Iikuni, Noriko; Liu, Aijing; La Cava, Antonio] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Matarese, Giuseppe] Univ Salerno, I-84081 Baronissi, Italy; [Matarese, Giuseppe] IRCCS MultiMed, Milan, Italy	University of California System; University of California Los Angeles; University of Salerno; IRCCS Multimedica	La Cava, A (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90095 USA.	alacava@mednet.ucla.edu	/AAG-9576-2020; Matarese, Giuseppe/AAO-4077-2021	/0000-0002-8839-0933; Matarese, Giuseppe/0000-0001-9429-0616				Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Amarilyo G, 2013, CLIN IMMUNOL, V149, P530, DOI 10.1016/j.clim.2013.09.002; Bach JF, 1998, IMMUNOL REV, V164, P139, DOI 10.1111/j.1600-065X.1998.tb01216.x; Ballinger MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013962; Cocco RE, 2001, MOL BIOL CELL, V12, P919, DOI 10.1091/mbc.12.4.919; Galgani M, 2010, J IMMUNOL, V185, P7474, DOI 10.4049/jimmunol.1001674; Garcia-Gonzalez A, 2002, RHEUMATOL INT, V22, P138, DOI 10.1007/s00296-002-0216-9; Iikuni Noriko, 2008, Current Immunology Reviews, V4, P70, DOI 10.2174/157339508784325046; Janko C, 2008, AUTOIMMUN REV, V8, P9, DOI 10.1016/j.autrev.2008.07.015; Jiang JX, 2008, HEPATOLOGY, V48, P1497, DOI 10.1002/hep.22515; Katsiari CG, 2010, SEMIN ARTHRITIS RHEU, V39, P491, DOI 10.1016/j.semarthrit.2008.11.002; Kredel LI, 2013, GUT, V62, P852, DOI 10.1136/gutjnl-2011-301424; La Cava A, 2004, NAT REV IMMUNOL, V4, P371, DOI 10.1038/nri1350; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; McMahon M, 2011, ANN RHEUM DIS, V70, P1619, DOI 10.1136/ard.2010.142737; Munoz LE, 2008, LUPUS, V17, P371, DOI 10.1177/0961203308089990; OGMUNDSDOTTIR H, 1980, CLIN EXP IMMUNOL, V40, P223; Petri M, 2001, AM J MANAG CARE, V7, pS480; Potter PK, 2003, J IMMUNOL, V170, P3223, DOI 10.4049/jimmunol.170.6.3223; Ramirez-Ortiz ZG, 2013, NAT IMMUNOL, V14, P917, DOI 10.1038/ni.2670; Suber T, 2009, ARTHRITIS RHEUM-US, V60, P2216, DOI 10.1002/art.24715; Wong M, 2011, DRUG TODAY, V47, P289, DOI 10.1358/dot.2011.47.4.1583186	22	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112826	10.1371/journal.pone.0112826	http://dx.doi.org/10.1371/journal.pone.0112826			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401752	Green Published, gold			2022-12-27	WOS:000345158700076
J	Buscemi, S; Vasto, S; Di Gaudio, F; Grosso, G; Bergante, S; Galvano, F; Massenti, FM; Amodio, E; Rosafio, G; Verga, S				Buscemi, Silvio; Vasto, Sonya; Di Gaudio, Francesca; Grosso, Giuseppe; Bergante, Sonia; Galvano, Fabio; Massenti, Fatima Maria; Amodio, Emanuele; Rosafio, Giuseppe; Verga, Salvatore			Endothelial Function and Serum Concentration of Toxic Metals in Frequent Consumers of Fish	PLOS ONE			English	Article							FLOW-MEDIATED VASODILATION; N-3 FATTY-ACIDS; INSULIN-RESISTANCE; CARDIOVASCULAR EVENTS; MEDITERRANEAN DIET; ARSENIC EXPOSURE; RISK; CONSUMPTION; MERCURY; ASSOCIATION	Background: Endothelial dysfunction is involved in the pathogenesis of atherosclerosis. Consumption of fish is associated with reduced cardiovascular risk, but there is paucity of data concerning its effect on endothelial function. Furthermore, investigation of the effects of fish consumption on health must take into account the ingestion of contaminants, including transition metals and some metalloids, which may have unfavorable effects on health, including those on the cardiovascular system. We investigated the association between fish consumption, endothelial function (flow mediated dilation of the brachial artery), and serum concentration of some toxic metals in apparently healthy people. Methods: Twenty-nine high fish consumers (at least 3 portions a week) were compared with 25 low fish consumers (less than 1 portion a week). All participants were free of diabetes, cardiovascular or other systemic diseases. Serum metal (antimonium, arsenic, mercury, lead, cobalt, copper, zinc, selenium, strontium) concentrations were measured in subgroups of 24 high fish consumers and 19 low fish consumers. Results: Both groups exhibited similar habitual dietary patterns, age and anthropometric characteristics. The high fish consumers had higher flow mediated dilation (9.7 +/- 1.8 vs. 7.3 +/- 1.9%; P<0.001), but also higher serum concentrations of mercury (5.87 +/- 2.69 vs. 1.65 +/- 1.10 mcg/L; P<0.001) and arsenic (6.04 +/- 3.25 vs. 2.30 +/- 1.58 mcg/L; P<0.001). The fasting plasma glucose concentrations were significantly correlated with both mercury (r=0.39; P=0.01) and arsenic concentrations (r=0.55; P<0.001). Conclusions: Habitual consumption of high amounts of fish is associated with better endothelial function despite higher serum concentrations of mercury and arsenic.	[Buscemi, Silvio; Rosafio, Giuseppe; Verga, Salvatore] Univ Palermo, Dipartimento Biomed Med & Interna, Palermo, Italy; [Buscemi, Silvio; Rosafio, Giuseppe; Verga, Salvatore] Univ Palermo, Specialist Lab Nutr Clin, Palermo, Italy; [Vasto, Sonya] Univ Palermo, Dipartimento Sci & Tecnol Biol Chimiche & Farmace, Palermo, Italy; [Di Gaudio, Francesca; Massenti, Fatima Maria; Amodio, Emanuele] Univ Palermo, Dipartimento Sci Promozione Salute Materno Infant, Palermo, Italy; [Grosso, Giuseppe; Galvano, Fabio] Univ Catania, Dipartimento Sci Farmaco, Catania, Italy; [Bergante, Sonia] Policlin San Donato, Hosp & Hlth Care, Sci Inst Res, Milan, Italy	University of Palermo; University of Palermo; University of Palermo; University of Palermo; University of Catania; IRCCS Policlinico San Donato	Buscemi, S (corresponding author), Univ Palermo, Dipartimento Biomed Med & Interna, Palermo, Italy.	silbus@tin.it	Buscemi, Silvio/K-9662-2016; Galvano, Fabio/F-8122-2010; Vasto, Sonya/I-4771-2013; bergante, sonia/AAI-1215-2019; Grosso, Giuseppe/ABA-1587-2020; DI GAUDIO, FRANCESCA/P-4974-2016; Grosso, Giuseppe/K-6730-2016	Buscemi, Silvio/0000-0003-0730-7649; Galvano, Fabio/0000-0003-0644-0755; Vasto, Sonya/0000-0002-6033-4745; Grosso, Giuseppe/0000-0003-3930-5285; DI GAUDIO, FRANCESCA/0000-0002-5910-5750; Grosso, Giuseppe/0000-0003-3930-5285; VERGA, Salvatore/0000-0002-7743-7847	Regione Sicilia, Assessorato Regionale delle Risorse Agricole e Alimentari - Dipartimento Regionale degli Interventi per la Pesca decreto [134, P09/5/120]	Regione Sicilia, Assessorato Regionale delle Risorse Agricole e Alimentari - Dipartimento Regionale degli Interventi per la Pesca decreto	This work was supported by the Regione Sicilia, Assessorato Regionale delle Risorse Agricole e Alimentari - Dipartimento Regionale degli Interventi per la Pesca decreto no 134 del 28.05.2010 (project code: P09/5/120). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barac A, 2007, HYPERTENSION, V49, P748, DOI 10.1161/01.HYP.0000259601.38807.a6; Bergdahl IA, 1998, ENVIRON RES, V77, P20, DOI 10.1006/enrs.1997.3820; Buscemi S, 2013, EUR J CLIN NUTR, V67, P1284, DOI 10.1038/ejcn.2013.172; Buscemi S, 2009, EUR J CLIN INVEST, V39, P339, DOI 10.1111/j.1365-2362.2009.02091.x; Buscemi S, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-2; Buscemi S, 2012, AM J CLIN NUTR, V95, P1089, DOI 10.3945/ajcn.111.031088; Buscemi S, 2011, OBESITY, V19, P1187, DOI 10.1038/oby.2010.313; Choi AL, 2009, ENVIRON HEALTH PERSP, V117, P367, DOI 10.1289/ehp.11608; Copat C, 2012, B ENVIRON CONTAM TOX, V88, P78, DOI 10.1007/s00128-011-0433-6; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Elvevoll EO, 2006, LIPIDS, V41, P1109, DOI 10.1007/s11745-006-5060-3; Ferrantelli V, 2012, FOOD ADDIT CONTAM A, V29, P1046, DOI 10.1080/19440049.2012.675595; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Gillum RF, 1996, ARCH INTERN MED, V156, P537, DOI 10.1001/archinte.156.5.537; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gokce N, 2002, CIRCULATION, V105, P1567, DOI 10.1161/01.CIR.0000012543.55874.47; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Guallar E, 2002, NEW ENGL J MED, V347, P1747, DOI 10.1056/NEJMoa020157; Hamdy O, 2003, DIABETES CARE, V26, P2119, DOI 10.2337/diacare.26.7.2119; He K, 2004, CIRCULATION, V109, P2705, DOI 10.1161/01.CIR.0000132503.19410.6B; He K, 2004, STROKE, V35, P1538, DOI 10.1161/01.STR.0000130856.31468.47; He K, 2002, JAMA-J AM MED ASSOC, V288, P3130, DOI 10.1001/jama.288.24.3130; He K, 2013, DIABETES CARE, V36, P1584, DOI 10.2337/dc12-1842; He K, 2009, AM J CARDIOL, V103, P1238, DOI 10.1016/j.amjcard.2009.01.016; Iso H, 2001, JAMA-J AM MED ASSOC, V285, P304, DOI 10.1001/jama.285.3.304; Jarup L, 2003, BRIT MED BULL, V68, P167, DOI 10.1093/bmb/ldg032; Keogh JB, 2005, ARTERIOSCL THROM VAS, V25, P1274, DOI 10.1161/01.ATV.0000163185.28245.a1; Lichtenstein A, 2006, CIRCULATION, V114, pE629, DOI 10.1161/CIRCULATIONAHA.106.180281; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moon KA, 2013, ANN INTERN MED, V159, P649, DOI 10.7326/0003-4819-159-10-201311190-00719; Moon SS, 2013, DIABETIC MED, V30, pe143, DOI 10.1111/dme.12103; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Nahab F, 2011, NEUROLOGY, V76, P154, DOI 10.1212/WNL.0b013e3182061afb; Newens KJ, 2011, AM J CLIN NUTR, V94, P742, DOI 10.3945/ajcn.110.009233; Pan WC, 2013, AM J EPIDEMIOL, V178, P1563, DOI 10.1093/aje/kwt195; Pan WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070792; Pastorelli AA, 2012, FOOD ADDIT CONTAM A, V29, P1913, DOI 10.1080/19440049.2012.719644; Petersen MM, 2010, CELL MOL BIOL, V56, P38, DOI 10.1170/T877; Plat J, 2007, J NUTR, V137, P2635, DOI 10.1093/jn/137.12.2635; Raissy M, 2014, ENVIRON MONIT ASSESS, V186, P1235, DOI 10.1007/s10661-013-3452-4; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rossi R, 2008, J AM COLL CARDIOL, V51, P997, DOI 10.1016/j.jacc.2007.11.044; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; SALONEN JT, 1995, CIRCULATION, V91, P645, DOI 10.1161/01.CIR.91.3.645; Sanders TAB, 2011, AM J CLIN NUTR, V94, P973, DOI 10.3945/ajcn.111.018036; Shimabukuro M, 2007, AM J CLIN NUTR, V86, P923, DOI 10.1093/ajcn/86.4.923; Storelli MM, 2013, J FOOD SCI, V78, pT362, DOI 10.1111/j.1750-3841.2012.02976.x; van Bussel BCT, 2011, J NUTR, V141, P1719, DOI 10.3945/jn.111.139733; Virtanen JK, 2007, J NUTR BIOCHEM, V18, P75, DOI 10.1016/j.jnutbio.2006.05.001; Vogel RA, 2000, J AM COLL CARDIOL, V36, P1455, DOI 10.1016/S0735-1097(00)00896-2; Wang CH, 2002, CIRCULATION, V105, P1804, DOI 10.1161/01.CIR.0000015862.64816.B2; Wang CC, 2006, AM J CLIN NUTR, V84, P5, DOI 10.1093/ajcn/84.1.5; Whelton SP, 2004, AM J CARDIOL, V93, P1119, DOI 10.1016/j.amjcard.2004.01.038; Widlansky ME, 2003, J AM COLL CARDIOL, V42, P1149, DOI 10.1016/S0735-1097(03)00994-X; Willett W., 1988, NUTR EPIDEMIOLOGY; Wu GY, 2002, ANNU REV NUTR, V22, P61, DOI 10.1146/annurev.nutr.22.110901.145329; Xin W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046028; Xu Y, 2014, EUR HEART J-CARD IMG, V15, P736, DOI 10.1093/ehjci/jet256; Yeboah J, 2007, CIRCULATION, V115, P2390, DOI 10.1161/CIRCULATIONAHA.106.678276	61	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112478	10.1371/journal.pone.0112478	http://dx.doi.org/10.1371/journal.pone.0112478			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401695	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700048
J	Bin Nisar, Y; Dibley, MJ				Bin Nisar, Yasir; Dibley, Michael J.			Earlier Initiation and Use of a Greater Number of Iron-Folic Acid Supplements during Pregnancy Prevents Early Neonatal Deaths in Nepal and Pakistan	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; SYSTEMATIC ANALYSIS; RANDOMIZED-TRIAL; CHILD SURVIVAL; MORTALITY; VACCINATION; ANEMIA; RISK; COMMUNITY; TRENDS	Introduction: Early neonatal deaths account for 75% of neonatal deaths globally. Antenatal iron-folic acid (IFA) supplementation has significantly reduced the risk of early neonatal deaths in China and Indonesia. We investigated the impact of antenatal IFA supplements on the risk of early neonatal deaths in Nepal and Pakistan during the last decade. Methods: Data from the most recent singleton live-births of 8,186 from two Nepal Demographic and Health Surveys (DHS) and 13,034 from two Pakistan DHS were selected for the current study. The primary outcome was early neonatal deaths and the main study variable was antenatal IFA supplementation. Analyses used multivariate Cox proportional regression, adjusted for the cluster sampling design and for 18 potential confounders. Findings: The adjusted risk of early neonatal deaths was significantly reduced by 51% (aHR = 0.49, 95% CI = 0.32-0.75) in Nepal and 23% (aHR = 0.77, 95% CI = 0.59-0.99) in Pakistan with any use of IFA compared to none. When IFA supplementation started at or before the 5 th month of pregnancy, the adjusted risk of early neonatal mortality was significantly reduced by 53% in Nepal, and 28% in Pakistan, compared to no IFA. When >90 IFA supplements were used and started at or before 5 th months, the adjusted risk of early neonatal deaths was significantly reduced by 57% in Nepal, and 45% in Pakistan. In Nepal 4,600 and in Pakistan 75,000 early neonatal deaths could be prevented annually if all pregnant women used >90 IFA supplements and started at or before the 5 th month of pregnancy. Conclusions: Any use of IFA supplements was significantly associated with reduced risk of early neonatal deaths in Nepal and Pakistan. The greatest mortality sparing effect of IFA on early neonatal deaths in both countries was with early initiation and use of a greater number of supplements.	[Bin Nisar, Yasir; Dibley, Michael J.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia	University of Sydney	Bin Nisar, Y (corresponding author), Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia.	yasi8204@uni.sydney.edu.au	Nisar, Yasir Bin/AFO-2407-2022		University of Sydney	University of Sydney(University of Sydney)	We would like to thank the Measure Demographic and Health Survey for providing all of Demographic and Health Survey data used in this analysis. This manuscript is a part of YBN's thesis to fulfil the requirement for a PhD in International Public Health at the University of Sydney. We are grateful to the University of Sydney for funding YBN's PhD scholarship (IPRS & APA) in International Public Health.	Aaby P, 2011, J INFECT DIS, V204, P245, DOI 10.1093/infdis/jir240; Allen LH, 2000, AM J CLIN NUTR, V71, p1280S, DOI 10.1093/ajcn/71.5.1280s; [Anonymous], 2013, UNICEF NEPAL; [Anonymous], 2012, GUID DAIL IR FOL AC; Biering-Sorensen S, 2012, PEDIATR INFECT DIS J, V31, P306, DOI 10.1097/INF.0b013e3182458289; Brabin L, 2013, NUTR REV, V71, P528, DOI 10.1111/nure.12049; Christian P, 2009, AM J EPIDEMIOL, V170, P1127, DOI 10.1093/aje/kwp253; Curtis SL, 1995, ASSESSMENT QUALITY D; Dibley MJ, 2012, AM J CLIN NUTR, V95, P220, DOI 10.3945/ajcn.111.022699; Dibley MJ, 2009, ANN NUTR METABOLISM, V55; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Haider BA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3443; Hall S, 2005, NEONATAL MORTALITY D; Hill K, 2006, DEMOGR RES, V14, P429, DOI 10.4054/DemRes.2006.14.18; Imdad A, 2012, PAEDIATR PERINAT EP, V26, P168, DOI 10.1111/j.1365-3016.2012.01312.x; Khan A, 2012, HEALTH POLICY PLANN, V27, P72, DOI 10.1093/heapol/czs047; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Macro International, 1996, 6 MACR INT INC; Mahy M, 2003, DHS COMP REPORTS, V4; Ministry of Health and Population (MOHP) [Nepal] New ERA & ICF International Inc, 2012, NEP DEM HLTH SURV 20; Ministry of Health and Population Nepal, 2007, NEP DEM HLTH SURV 20; Ministry of Health [Nepal] New ERA ORC Macro, 2002, NEP DEM HLTH SURV 20; Mosley WH, 1984, POPUL DEV REV, V10, P25, DOI 10.2307/2807954; Natarajan S, 2007, STAT MED, V26, P3229, DOI 10.1002/sim.2779; National Institute of Population Studies (NIPS) and Macro International, 2006, PAKISTAN DEMOGRAPHIC; National Institute of Population Studies (NIPS) [Pakistan] Macro International Inc, 2013, PAK DEM HLTH SURV 20; Nisar YB, 2014, AM J CLIN NUTR UNPUB; Pokharel RK, 2011, SUCCESS DELIVERING I; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Roth A, 2004, PEDIATR INFECT DIS J, V23, P544, DOI 10.1097/01.inf.0000129693.81082.a0; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Rusia U, 1995, Indian J Pathol Microbiol, V38, P273; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Titaley CR, 2010, B WORLD HEALTH ORGAN, V88, P500, DOI 10.2471/BLT.09.065813; UNICEF, 2017, LEVELS TRENDS CHILD; UNICEF Nutrition Wing Planning Commission Government of Pakistan Aga Khan University, 2011, NAT NUTR SURV PAK; Vaugelade J, 2004, BRIT MED J, V329, P1309, DOI 10.1136/bmj.38261.496366.82; World Health Organization United Nations Children's Fund United Nations University, 2001, IRON DEF AN ASS PREV; Yasmin S, 2001, B WORLD HEALTH ORGAN, V79, P608; Zeng LX, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2001	42	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112446	10.1371/journal.pone.0112446	http://dx.doi.org/10.1371/journal.pone.0112446			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398011	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500052
J	Bucciol, A; Foss, NJ; Piovesan, M				Bucciol, Alessandro; Foss, Nicolai J.; Piovesan, Marco			Pay Dispersion and Performance in Teams	PLOS ONE			English	Article							WAGE DISPERSION; INCENTIVES; PRODUCTIVITY; TOURNAMENTS	Extant research offers conflicting predictions about the effect of pay dispersion on team performance. We collected a unique dataset from the Italian soccer league to study the effect of intra-firm pay dispersion on team performance, under different definitions of what constitutes a "team". This peculiarity of our dataset can explain the conflicting evidence. Indeed, we also find positive, null, and negative effects of pay dispersion on team performance, using the same data but different definitions of team. Our results show that when the team is considered to consist of only the members who directly contribute to the outcome, high pay dispersion has a detrimental impact on team performance. Enlarging the definition of the team causes this effect to disappear or even change direction. Finally, we find that the detrimental effect of pay dispersion is due to worse individual performance, rather than a reduction of team cooperation.	[Bucciol, Alessandro] Univ Verona, Dept Econ, I-37100 Verona, Italy; [Foss, Nicolai J.] Copenhagen Business Sch, Dept Strateg Management & Globalizat, Frederiksberg, Denmark; [Piovesan, Marco] Univ Copenhagen, Dept Econ, Frederiksberg, Denmark	University of Verona; Copenhagen Business School; University of Copenhagen	Foss, NJ (corresponding author), Copenhagen Business Sch, Dept Strateg Management & Globalizat, Frederiksberg, Denmark.	njf.smg@cb.dk		Piovesan, Marco/0000-0002-5721-3053				Aime F, 2010, J BUS RES, V63, P60, DOI 10.1016/j.jbusres.2009.02.014; Avrutin BM, 2007, ATLANTIC ECON J, V35, P509, DOI 10.1007/s11293-007-9084-8; BECKER BE, 1992, ADMIN SCI QUART, V37, P336, DOI 10.2307/2393228; Berri DJ., 2004, ATLANTIC ECON J, V32, P130, DOI [10.1007/BF02298830, DOI 10.1007/BF02298830]; Bloom M, 1999, ACAD MANAGE J, V42, P25, DOI 10.2307/256872; DAVIS SJ, 1991, BROOKINGS PAP ECO AC, P115; Deloitte, 2011, ANN REV FOOTBALL FIN, V2011-2014; Depken CA, 2000, ECON LETT, V67, P87, DOI 10.1016/S0165-1765(99)00249-9; EHRENBERG RG, 1990, J POLIT ECON, V98, P1307, DOI 10.1086/261736; Fredrickson JW, 2010, STRATEGIC MANAGE J, V31, P1031, DOI 10.1002/smj.848; Guzzo RA, 1996, ANNU REV PSYCHOL, V47, P307, DOI 10.1146/annurev.psych.47.1.307; Hamilton BH, 2003, J POLIT ECON, V111, P465, DOI 10.1086/374182; Jane WJ, 2010, ECON LETT, V107, P297, DOI 10.1016/j.econlet.2010.02.016; Jirjahn U, 2007, KYKLOS, V60, P231, DOI 10.1111/j.1467-6435.2007.00370.x; Kahn LM, 2000, J ECON PERSPECT, V14, P75, DOI 10.1257/jep.14.3.75; Katayama H, 2011, APPL ECON, V43, P1193, DOI 10.1080/00036840802600335; Lawler EE., 1990, STRATEGIC PAY ALIGNI; Lawler EE, 1990, STRATEGIC PAY ALIGNI, P238; Lazear EP, 2007, J ECON PERSPECT, V21, P91, DOI 10.1257/jep.21.4.91; LAZEAR EP, 1981, J POLIT ECON, V89, P841, DOI 10.1086/261010; LePine JA, 2008, PERS PSYCHOL, V61, P273, DOI 10.1111/j.1744-6570.2008.00114.x; Marchand J. T., 2006, SALARY DISTRIB UNPUB; Martin J., 1981, RES ORG BEHAV, V3; Milgrom P, 1992, EC ORG MANAGEMENT UP; Milkovich GT, 1996, COMPENSATION, P45; Park G, 2013, J MANAGE, V39, P1339, DOI 10.1177/0149206312471389; PFEFFER J, 1993, ADMIN SCI QUART, V38, P382, DOI 10.2307/2393373; RAMASWAMY R, 1991, ECONOMICA, V58, P501, DOI 10.2307/2554695; SCULLY GW, 1974, AM ECON REV, V64, P915; Shaw JD, 2002, STRATEGIC MANAGE J, V23, P491, DOI 10.1002/smj.235; Stewart GL, 2006, J MANAGE, V32, P29, DOI 10.1177/0149206305277792; Trevor CO, 2012, ACAD MANAGE J, V55, P585, DOI 10.5465/amj.2006.0127; Wiseman F., 2003, EC B, V1, P1; Zenger TR, 1997, ORGAN SCI, V8, P209, DOI 10.1287/orsc.8.3.209	34	10	10	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112631	10.1371/journal.pone.0112631	http://dx.doi.org/10.1371/journal.pone.0112631			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DF	25397615	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558500070
J	Otti, GR; Saleh, L; Velicky, P; Fiala, C; Pollheimer, J; Knofler, M				Otti, Gerlinde R.; Saleh, Leila; Velicky, Philipp; Fiala, Christian; Pollheimer, Juergen; Knoefler, Martin			Notch2 Controls Prolactin and Insulin-Like Growth Factor Binding Protein-1 Expression in Decidualizing Human Stromal Cells of Early Pregnancy	PLOS ONE			English	Article							CHORIONIC-GONADOTROPIN; SIGNALING PATHWAY; HUMAN ENDOMETRIUM; CROSS-TALK; PROGESTERONE; MECHANISMS; DIFFERENTIATION; IMPLANTATION; MODULATION; RECEPTORS	Decidualization, the transformation of the human uterine mucosa into the endometrium of pregnancy, is critical for successful implantation and embryonic development. However, key regulatory factors controlling differentiation of uterine stromal cells into hormone-secreting decidual cells have not been fully elucidated. Hence, we herein investigated the role of the Notch signaling pathway in human decidual stromal cells (HDSC) isolated from early pregnancy samples. Immunofluorescence of first trimester decidual tissues revealed expression of Notch2 receptor and its putative, membrane-anchored interaction partners Jagged1, Delta-like (DLL) 1 and DLL4 in stromal cells whereas other Notch receptors and ligands were absent from these cells. During in vitro differentiation with estrogen/progesterone (E2P4) and/or cyclic adenosine monophosphate (cAMP) HDSC constitutively expressed Notch2 and weakly downregulated Jagged1 mRNA and protein, measured by quantitative PCR (qPCR) and Western blotting, respectively. However, increased levels of DLL1 and DLL4 were observed in the decidualizing cultures. Transfection of a Notch luciferase reporter and qPCR of the Notch target gene hairy and enhancer of split 1 (HES1) revealed an induction of canonical Notch activity during in vitro differentiation. In contrast, treatment of HDSC with a chemical Notch/c-secretase inhibitor decreased cAMP/E2P4-stimulated Notch luciferase activity, HES1 transcript levels and mRNA expression of the decidual marker genes prolactin (PRL) and insulin-like growth factor binding protein 1 (IGFBP1). Similarly, siRNA-mediated gene silencing or antibody-mediated blocking of Notch2 diminished HES1, PRL and IGFBP1 mRNA levels as well as secreted PRL protein. In summary, the data suggest that canonical, Notch2-dependent signaling plays a role in human decidualization.	[Otti, Gerlinde R.; Saleh, Leila; Velicky, Philipp; Pollheimer, Juergen; Knoefler, Martin] Med Univ Vienna, Reprod Biol Unit, Dept Obstet & Fetal Maternal Med, Vienna, Austria; [Fiala, Christian] Gynmed Clin, Vienna, Austria	Medical University of Vienna	Knofler, M (corresponding author), Med Univ Vienna, Reprod Biol Unit, Dept Obstet & Fetal Maternal Med, Vienna, Austria.	martin.knoefler@meduniwien.ac.at		Fiala, Christian/0000-0001-6451-7349; Pollheimer, Jurgen/0000-0001-8440-5221; Velicky, Philipp/0000-0002-2340-7431	Austrian Science Funds, Vienna, Austria [P-25187-B13]; Austrian Science Fund (FWF) [P 25187] Funding Source: researchfish	Austrian Science Funds, Vienna, Austria(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Study was supported by grant P-25187-B13 of the Austrian Science Funds, Vienna, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar Y, 2007, J ASSIST REPROD GEN, V24, P296, DOI 10.1007/s10815-007-9149-2; Afshar Y, 2012, ENDOCRINOLOGY, V153, P2884, DOI 10.1210/en.2011-2122; Afshar Y, 2012, FASEB J, V26, P282, DOI 10.1096/fj.11-184663; Angulo-Rojo C, 2013, ASN NEURO, V5, DOI 10.1042/AN20130023; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Burton GJ, 2010, INT J DEV BIOL, V54, P303, DOI 10.1387/ijdb.082764gb; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Cloke B, 2008, ENDOCRINOLOGY, V149, P4462, DOI 10.1210/en.2008-0356; Cobellis L, 2008, J ANAT, V213, P464, DOI 10.1111/j.1469-7580.2008.00963.x; Cuman C, 2014, REPRODUCTION, V147, pR75, DOI 10.1530/REP-13-0474; Erlebacher A, 2013, ANNU REV IMMUNOL, V31, P387, DOI 10.1146/annurev-immunol-032712-100003; Fazleabas AT, 2004, PLACENTA, V25, pS26, DOI 10.1016/j.placenta.2004.01.014; Gasperowicz M, 2008, PLACENTA, V29, P651, DOI 10.1016/j.placenta.2008.06.004; Gasperowicz M, 2013, GENE EXPR PATTERNS, V13, P249, DOI 10.1016/j.gep.2013.04.006; Gellersen B, 2003, J ENDOCRINOL, V178, P357, DOI 10.1677/joe.0.1780357; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Haider S, 2014, ENDOCRINOLOGY, V155, P263, DOI 10.1210/en.2013-1455; Hiratochi M, 2007, NUCLEIC ACIDS RES, V35, P912, DOI 10.1093/nar/gkl1128; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Hunkapiller NM, 2011, DEVELOPMENT, V138, P2987, DOI 10.1242/dev.066589; Johansson A, 2011, HUM GENET, V129, P25, DOI 10.1007/s00439-010-0893-5; Kajihara T, 2013, MED MOL MORPHOL, V46, P61, DOI 10.1007/s00795-013-0018-z; Kane NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012970; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Larabee JL, 2013, J BIOL CHEM, V288, P21526, DOI 10.1074/jbc.M113.465120; Loset M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.043; Manaster I, 2010, J REPROD IMMUNOL, V84, P1, DOI 10.1016/j.jri.2009.10.009; Mazella J, 2008, ENDOCRINOLOGY, V149, P15, DOI 10.1210/en.2007-0477; McElhinny AS, 2008, ONCOGENE, V27, P5138, DOI 10.1038/onc.2008.228; Meinhardt G, 2014, ENDOCRINOLOGY, V155, P1908, DOI 10.1210/en.2013-2042; Mikhailik A, 2009, BIOCHEM BIOPH RES CO, V388, P479, DOI 10.1016/j.bbrc.2009.07.037; Mitsuhashi Y, 2012, HISTOPATHOLOGY, V60, P826, DOI 10.1111/j.1365-2559.2011.04158.x; Saleh L, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-155; Tang MY, 2005, MOL HUM REPROD, V11, P237, DOI 10.1093/molehr/gah149; Tsuzuki T, 2012, HUM REPROD, V27, P523, DOI 10.1093/humrep/der405; Tulac S, 2006, J CLIN ENDOCR METAB, V91, P1453, DOI 10.1210/jc.2005-0769; Wu LZ, 2004, GENE, V328, P153, DOI 10.1016/j.gene.2003.12.007; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Zolkiewska A, 2008, CELL MOL LIFE SCI, V65, P2056, DOI 10.1007/s00018-008-7586-4	41	14	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112723	10.1371/journal.pone.0112723	http://dx.doi.org/10.1371/journal.pone.0112723			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397403	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558500083
J	Rosello-Lleti, E; Tarazon, E; Barderas, MG; Ortega, A; Otero, M; Molina-Navarro, MM; Lago, F; Gonzalez-Juanatey, JR; Salvador, A; Portoles, M; Rivera, M				Rosello-Lleti, Esther; Tarazon, Estefania; Barderas, Maria G.; Ortega, Ana; Otero, Manuel; Micaela Molina-Navarro, Maria; Lago, Francisca; Ramon Gonzalez-Juanatey, Jose; Salvador, Antonio; Portoles, Manuel; Rivera, Miguel			Heart Mitochondrial Proteome Study Elucidates Changes in Cardiac Energy Metabolism and Antioxidant PRDX3 in Human Dilated Cardiomyopathy	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; HUMAN PYRUVATE-DEHYDROGENASE; MYOCARDIAL-INFARCTION; STRUCTURAL BASIS; FAILURE; PROTEINS; BINDING; OVEREXPRESSION; IDENTIFICATION; GUIDELINES	Background: Dilated cardiomyopathy (DCM) is a public health problem with no available curative treatment, and mitochondrial dysfunction plays a critical role in its development. The present study is the first to analyze the mitochondrial proteome in cardiac tissue of patients with DCM to identify potential molecular targets for its therapeutic intervention. Methods and Results: 16 left ventricular (LV) samples obtained from explanted human hearts with DCM (n = 8) and control donors (n = 8) were extracted to perform a proteomic approach to investigate the variations in mitochondrial protein expression. The proteome of the samples was analyzed by quantitative differential electrophoresis and Mass Spectrometry. These changes were validated by classical techniques and by novel and precise selected reaction monitoring analysis and RNA sequencing approach increasing the total heart samples up to 25. We found significant alterations in energy metabolism, especially in molecules involved in substrate utilization (ODPA, ETFD, DLDH), energy production (ATPA), other metabolic pathways (AL4A1) and protein synthesis (EFTU), obtaining considerable and specific relationships between the alterations detected in these processes. Importantly, we observed that the antioxidant PRDX3 overexpression is associated with impaired ventricular function. PRDX3 is significantly related to LV end systolic and diastolic diameter (r = 0.73, p value<0.01; r = 0.71, p value<0.01), fractional shortening, and ejection fraction (r = -0.61, p value < 0.05; and r = -20.62, p value< 0.05, respectively). Conclusion: This work could be a pivotal study to gain more knowledge on the cellular mechanisms related to the pathophysiology of this disease and may lead to the development of etiology-specific heart failure therapies. We suggest new molecular targets for therapeutic interventions, something that up to now has been lacking.	[Rosello-Lleti, Esther; Tarazon, Estefania; Ortega, Ana; Micaela Molina-Navarro, Maria; Rivera, Miguel] Hosp La Fe, Hlth Res Inst, Cardiocirculatory Unit, E-46009 Valencia, Spain; [Barderas, Maria G.] SESCAM, Hosp Nacl Paraplej, Dept Vasc Physiopathol, Toledo, Spain; [Otero, Manuel; Lago, Francisca; Ramon Gonzalez-Juanatey, Jose] Univ Clin Hosp, Dept Cardiol, Cellular & Mol Cardiol Res Unit, Santiago De Compostela, Spain; [Otero, Manuel; Lago, Francisca; Ramon Gonzalez-Juanatey, Jose] Univ Clin Hosp, Inst Biomed Res, Santiago De Compostela, Spain; [Salvador, Antonio] Hosp La Fe, Serv Cardiol, E-46009 Valencia, Spain; [Portoles, Manuel] Hosp La Fe, Hlth Res Inst, Cell Biol & Pathol Unit, E-46009 Valencia, Spain	Hospital Universitari i Politecnic La Fe; Hospital Nacional de Paraplejicos; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe	Rivera, M (corresponding author), Hosp La Fe, Hlth Res Inst, Cardiocirculatory Unit, E-46009 Valencia, Spain.	miguelrivera492@gmail.com	Roselló-Lletí, Esther/B-2695-2017; Roselló Lletí, Esther/ABG-8503-2020; PORTOLES, MANUEL/B-4789-2009; Ortega, Ana/AAG-5941-2020; Tarazón, Estefanía/D-6950-2017; Ortega, Ana AO/D-3027-2017	Roselló-Lletí, Esther/0000-0003-2627-6104; Roselló Lletí, Esther/0000-0003-2627-6104; PORTOLES, MANUEL/0000-0002-4415-7160; Ortega, Ana/0000-0002-9763-0505; Tarazón, Estefanía/0000-0003-3466-2558; Ortega, Ana AO/0000-0002-9763-0505; , Micaela/0000-0002-2103-0351; Barderas, Maria G./0000-0003-4290-4721; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388	NIH "Fondo de Investigaciones Sanitarias del Instituto Carlos III" [RD12/0042/0003, PI10/00275, PI13/00100]; Health Research Institute Hospital La Fe [07/2013]	NIH "Fondo de Investigaciones Sanitarias del Instituto Carlos III"; Health Research Institute Hospital La Fe	This work was supported by grants from the NIH "Fondo de Investigaciones Sanitarias del Instituto Carlos III," (RD12/0042/0003; FIS Project PI10/00275; PI13/00100) and Health Research Institute Hospital La Fe (Project 07/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnetti G, 2011, CIRC RES, V108, P512, DOI 10.1161/CIRCRESAHA.110.226910; Agnetti G, 2010, CIRC-CARDIOVASC GENE, V3, P78, DOI 10.1161/CIRCGENETICS.109.871236; Ahuja P, 2013, CIRCULATION, V127, P1957, DOI 10.1161/CIRCULATIONAHA.112.001219; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Azorin I, 2004, ALCOHOL ALCOHOLISM, V39, P203, DOI 10.1093/alcalc/agh043; Bayeva M, 2013, J AM COLL CARDIOL, V61, P599, DOI 10.1016/j.jacc.2012.08.1021; Bindoff L, 2003, EUR HEART J, V24, P221, DOI 10.1016/S0195-668X(02)00694-2; Brautigam CA, 2005, J MOL BIOL, V350, P543, DOI 10.1016/j.jmb.2005.05.014; Brioschi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035841; Cieniewski-Bernard C, 2008, J PROTEOME RES, V7, P5004, DOI 10.1021/pr800409u; Comunian C, 2011, PROTEOMICS, V11, P2320, DOI 10.1002/pmic.201000479; de Weger RA, 2011, J HEART LUNG TRANSPL, V30, P497, DOI 10.1016/j.healun.2010.11.011; Deng WJ, 2010, MOL CELL PROTEOMICS, V9, P100, DOI 10.1074/mcp.M900020-MCP200; Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054; GOODMAN SI, 1994, EUR J BIOCHEM, V219, P277, DOI 10.1111/j.1432-1033.1994.tb19939.x; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hammer E, 2011, J PROTEOME RES, V10, P2161, DOI 10.1021/pr1008042; Heinke MY, 1998, ELECTROPHORESIS, V19, P2021, DOI 10.1002/elps.1150191122; Horstkotte J, 2011, CIRCULATION, V124, P2892, DOI 10.1161/CIRCULATIONAHA.111.059253; Ide T, 1999, CIRC RES, V85, P357, DOI 10.1161/01.RES.85.4.357; Imahashi K, 2004, CIRC RES, V95, P734, DOI 10.1161/01.RES.0000143898.67182.4c; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; KAGAN VE, 1992, BIOCHEM PHARMACOL, V44, P1637, DOI 10.1016/0006-2952(92)90482-X; Kato M, 2008, STRUCTURE, V16, P1849, DOI 10.1016/j.str.2008.10.010; Keith M, 1998, J AM COLL CARDIOL, V31, P1352, DOI 10.1016/S0735-1097(98)00101-6; KOROTCHKINA LG, 1995, J BIOL CHEM, V270, P14297, DOI 10.1074/jbc.270.24.14297; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lal H, 2012, CIRCULATION, V125, P65, DOI 10.1161/CIRCULATIONAHA.111.050666; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li WM, 2012, J CELL MOL MED, V16, P59, DOI 10.1111/j.1582-4934.2011.01336.x; Liesa M, 2011, CIRCULATION, V124, P806, DOI 10.1161/CIRCULATIONAHA.110.003418; Macrae Duncan J, 2007, Proc Am Thorac Soc, V4, P176, DOI 10.1513/pats.200701-011GC; Maloyan A, 2005, CIRCULATION, V112, P3451, DOI 10.1161/CIRCULATIONAHA.105.572552; Matsushima S, 2006, CIRCULATION, V113, P1779, DOI 10.1161/CIRCULATIONAHA.105.582239; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Neubauer S, 1997, CIRCULATION, V96, P2190; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Nishtala K, 2011, PROTEOMICS, V11, P4310, DOI 10.1002/pmic.201100229; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PORTOLES M, 1994, J CELL SCI, V107, P3601; REYNOLDS WA, 1963, J EXP ZOOL, V153, P237, DOI 10.1002/jez.1401530306; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosca MG, 2010, CARDIOVASC RES, V88, P40, DOI 10.1093/cvr/cvq240; Rosca MG, 2009, J MOL CELL CARDIOL, V46, P927, DOI 10.1016/j.yjmcc.2009.02.009; Rosello-Lleti E, 2012, J CELL MOL MED, V16, P2471, DOI 10.1111/j.1582-4934.2012.01565.x; SANBE A, 1995, J MOL CELL CARDIOL, V27, P2209, DOI 10.1016/S0022-2828(95)91551-6; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shiomi T, 2004, CIRCULATION, V109, P544, DOI 10.1161/01.CIR.0000109701.77059.E9; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; Tomas M, 2002, J NEUROCHEM, V83, P601, DOI 10.1046/j.1471-4159.2002.01167.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Yang JC, 2000, CIRCULATION, V102, P3046; Zhang DX, 2012, J PROTEOMICS, V77, P469, DOI 10.1016/j.jprot.2012.09.024	54	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112971	10.1371/journal.pone.0112971	http://dx.doi.org/10.1371/journal.pone.0112971			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397948	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558500120
J	Schulte, B; Eickmeyer, H; Heininger, A; Juretzek, S; Karrasch, M; Denis, O; Roisin, S; Pletz, MW; Klein, M; Barth, S; Ludke, GH; Thews, A; Torres, A; Cilloniz, C; Straube, E; Autenrieth, IB; Keller, PM				Schulte, Berit; Eickmeyer, Holm; Heininger, Alexandra; Juretzek, Stephanie; Karrasch, Matthias; Denis, Olivier; Roisin, Sandrine; Pletz, Mathias W.; Klein, Matthias; Barth, Sandra; Luedke, Gerd H.; Thews, Anne; Torres, Antoni; Cilloniz, Catia; Straube, Eberhard; Autenrieth, Ingo B.; Keller, Peter M.			Detection of Pneumonia Associated Pathogens Using a Prototype Multiplexed Pneumonia Test in Hospitalized Patients with Severe Pneumonia	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; VENTILATOR-ASSOCIATED PNEUMONIA; POLYMERASE-CHAIN-REACTION; STREPTOCOCCUS-PNEUMONIAE; ANTIBIOTIC-THERAPY; GENE; IDENTIFICATION; PCR; RESISTANCE; GUIDELINES	Severe pneumonia remains an important cause of morbidity and mortality. Polymerase chain reaction (PCR) has been shown to be more sensitive than current standard microbiological methods - particularly in patients with prior antibiotic treatment - and therefore, may improve the accuracy of microbiological diagnosis for hospitalized patients with pneumonia. Conventional detection techniques and multiplex PCR for 14 typical bacterial pneumonia-associated pathogens were performed on respiratory samples collected from adult hospitalized patients enrolled in a prospective multi-center study. Patients were enrolled from March until September 2012. A total of 739 fresh, native samples were eligible for analysis, of which 75 were sputa, 421 aspirates, and 234 bronchial lavages. 276 pathogens were detected by microbiology for which a valid PCR result was generated (positive or negative detection result by Curetis prototype system). Among these, 120 were identified by the prototype assay, 50 pathogens were not detected. Overall performance of the prototype for pathogen identification was 70.6% sensitivity (95% confidence interval (CI) lower bound: 63.3%, upper bound: 76.9%) and 95.2% specificity (95% CI lower bound: 94.6%, upper bound: 95.7%). Based on the study results, device cut-off settings were adjusted for future series production. The overall performance with the settings of the CE series production devices was 78.7% sensitivity (95% CI lower bound: 72.1%) and 96.6% specificity (95% CI lower bound: 96.1%). Time to result was 5.2 hours (median) for the prototype test and 43.5 h for standard-of-care. The Pneumonia Application provides a rapid and moderately sensitive assay for the detection of pneumonia-causing pathogens with minimal hands-on time.	[Schulte, Berit; Autenrieth, Ingo B.] Univ Tubingen, Inst Med Microbiol & Hyg, Tubingen, Germany; [Schulte, Berit; Heininger, Alexandra; Autenrieth, Ingo B.] Partner Site Tubingen, German Ctr Infect Res DZIF, Tubingen, Germany; [Eickmeyer, Holm] Ruhr Univ Bochum, Univ Hosp, Inst Lab & Transfus Med, Heart & Diabet Ctr North Rhine Westphalia, Bad Oeynhausen, Germany; [Eickmeyer, Holm] Ruhr Univ Bochum, Univ Hosp, Clin Thorac & Cardiovasc Surg, Heart & Diabet Ctr North Rhine Westphalia, Bad Oeynhausen, Germany; [Heininger, Alexandra] Univ Tubingen Hosp, Dept Anesthesiol & Intens Care Med, Tubingen, Germany; [Juretzek, Stephanie; Karrasch, Matthias; Straube, Eberhard; Keller, Peter M.] Univ Hosp Jena, Inst Med Microbiol, Jena, Germany; [Denis, Olivier; Roisin, Sandrine] Univ Libre Bruxelles, Microbiol Lab, Brussels, Belgium; [Klein, Matthias; Straube, Eberhard; Keller, Peter M.] Univ Hosp Jena, Ctr Infect Dis & Infect Control, Jena, Germany; [Klein, Matthias; Straube, Eberhard; Keller, Peter M.] Ctr Sepsis Care & Control, Jena, Germany; [Klein, Matthias; Barth, Sandra; Luedke, Gerd H.; Thews, Anne] Curetis AG, Holzgerlingen, Germany; [Torres, Antoni; Cilloniz, Catia] Hosp Clin Barcelona, Dept Pneumol, Inst Clin Thorax, Barcelona, Spain; [Torres, Antoni; Cilloniz, Catia] Univ Barcelona, Ciber Enfermedades Resp Ciberes, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; German Center for Infection Research; Ruhr University Bochum; Ruhr University Bochum; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Schiller University of Jena; Universite Libre de Bruxelles; Friedrich Schiller University of Jena; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Keller, PM (corresponding author), Univ Hosp Jena, Inst Med Microbiol, Jena, Germany.	peter.keller@med.uni-jena.de	Pletz, Mathias Wilhelm/H-9782-2019; Torres, Antoni/H-6128-2017; Keller, Peter M/D-8675-2013; Torres, Antonio/AAI-3334-2021; Keller, Peter M/C-6876-2012; Cillóniz, Catia/Y-1898-2018	Pletz, Mathias Wilhelm/0000-0001-8157-2753; Torres, Antoni/0000-0002-8643-2167; Keller, Peter M/0000-0002-2890-5384; Torres, Antonio/0000-0002-8643-2167; Keller, Peter M/0000-0002-2890-5384; cilloniz, catia/0000-0002-4646-9838	Curetis; European Union Seventh Framework Program [241446]; University Hospital Jena; University Hospital Tubingen; University Hospital of the Ruhr-University Bochum; Universite Libre de Bruxelles; Hospital Clinic of Barcelona; BMBF Innovation Award Medical Technology [EZ1113B]; German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung) [01KI1204]	Curetis; European Union Seventh Framework Program(European Commission); University Hospital Jena; University Hospital Tubingen; University Hospital of the Ruhr-University Bochum; Universite Libre de Bruxelles; Hospital Clinic of Barcelona; BMBF Innovation Award Medical Technology; German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF))	The devices, CRO, and conventional microbial testing were funded by Curetis (www.curetis.com). Local study personnel were funded by their institutions (University Hospital Jena, University Hospital Tubingen, University Hospital of the Ruhr-University Bochum, Universite Libre de Bruxelles, Hospital Clinic of Barcelona). This work was supported by the European Union Seventh Framework Program [grant agreement number 241446 to Jan Weile, Ruhr-University Bochum], and the BMBF Innovation Award Medical Technology [grant agreement number EZ1113B to Jan Weile]. M. W. P. was supported by a grant from the German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung), grant number 01KI1204. The funder Curetis was involved in study design, data collection and analysis, as well as in the decision to publish. Curetis staff (see authors' affiliations) was involved in manuscript preparation.	Abdeldaim G, 2009, CLIN MICROBIOL INFEC, V15, P565, DOI 10.1111/j.1469-0691.2009.02714.x; Almirall J, 2000, EUR RESPIR J, V15, P757, DOI 10.1034/j.1399-3003.2000.15d21.x; Bauer TT, 2005, CHEST, V128, P2238, DOI 10.1378/chest.128.4.2238; Bloos F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046003; Bogaerts P, 2013, J ANTIMICROB CHEMOTH, V68, P340, DOI 10.1093/jac/dks392; CLSI, 2008, MM18A CLSI; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Drancourt M, 2004, J CLIN MICROBIOL, V42, P497, DOI 10.1128/JCM.42.2.497-504.2004; Ewig S, 2009, THORAX, V64, P1062, DOI 10.1136/thx.2008.109785; Ewig S, 2012, CURR OPIN INFECT DIS, V25, P166, DOI 10.1097/QCO.0b013e32835023fb; File TM, 2003, LANCET, V362, P1991, DOI 10.1016/S0140-6736(03)15021-0; Greve T, 2012, J MED MICROBIOL, V61, P478, DOI 10.1099/jmm.0.036574-0; Hazelton BJ, 2013, J MED MICROBIOL, V62, P223, DOI 10.1099/jmm.0.050385-0; Hranjec T, 2012, LANCET INFECT DIS, V12, P774, DOI 10.1016/S1473-3099(12)70151-2; Kuti EL, 2008, J CRIT CARE, V23, P91, DOI 10.1016/j.jcrc.2007.08.007; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Menendez R, 2007, CHEST, V132, P1348, DOI 10.1378/chest.06-1995; Nagai K, 2001, J ANTIMICROB CHEMOTH, V48, P915, DOI 10.1093/jac/48.6.915; Park HK, 2010, J MED MICROBIOL, V59, P1146, DOI 10.1099/jmm.0.017798-0; Perotin JM, 2013, J MED VIROL, V85, P866, DOI 10.1002/jmv.23495; Piskin N, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-268; Pletz MW, 2011, DEUT MED WOCHENSCHR, V136, P775, DOI 10.1055/s-0031-1275806; Pletz MW, 2011, INTENS CARE MED, V37, P1069, DOI 10.1007/s00134-011-2245-x; Rampini SK, 2011, CLIN INFECT DIS, V53, P1245, DOI 10.1093/cid/cir692; SALO P, 1995, J INFECT DIS, V171, P479, DOI 10.1093/infdis/171.2.479; Schreiber J, 2013, MED KLIN-INTENSIVMED, V108, P311, DOI 10.1007/s00063-013-0227-1; Wessels E, 2012, J CLIN MICROBIOL, V50, P1171, DOI 10.1128/JCM.06609-11; Wilke MH, 2011, EUR J MED RES, V16, P315, DOI 10.1186/2047-783X-16-7-315	28	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e110566	10.1371/journal.pone.0110566	http://dx.doi.org/10.1371/journal.pone.0110566			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397673	Green Published, gold			2022-12-27	WOS:000345558500008
J	Xiao, J; Li, SY; Sui, Y; Wu, Q; Li, XP; Xie, BJ; Zhang, MW; Sun, ZD				Xiao, Juan; Li, Shuyi; Sui, Yong; Wu, Qian; Li, Xiaopeng; Xie, Bijun; Zhang, Mingwei; Sun, Zhida			Lactobacillus casei-01 Facilitates the Ameliorative Effects of Proanthocyanidins Extracted from Lotus Seedpod on Learning and Memory Impairment in Scopolamine-Induced Amnesia Mice	PLOS ONE			English	Article							URINARY-EXCRETION; OXIDATIVE DAMAGE; GUT MICROBIOTA; PROCYANIDINS; LACTOBACILLI; FLAVAN-3-OLS; METABOLISM; ABSORPTION; DEMENTIA; PERICARP	Learning and memory abilities are associated with alterations in gut function. The two-way proanthocyanidins-microbiota interaction in vivo enhances the physiological activities of proanthocyanidins and promotes the regulation of gut function. Proanthocyanidins extracted from lotus seedpod (LSPC) have shown the memory-enhancing ability. However, there has been no literature about whether Lactobacillus casei-01 (LC) enhances the ameliorative effects of LSPC on learning and memory abilities. In this study, learning and memory abilities of scopolamine-induced amnesia mice were evaluated by Y-maze test after 20-day administration of LC (10(9) cfu/kg body weight (BW)), LSPC (low dose was 60 mg/kg BW (L-LSPC) and high dose was 90 mg/kg BW (H-LSPC)), or LSPC and LC combinations (L-LSPC+LC and H-LSPC+LC). Alterations in antioxidant defense ability and oxidative damage of brain, serum and colon, and brain cholinergic system were investigated as the possible mechanisms. As a result, the error times of H-LSPC+LC group were reduced by 41.59% and 68.75% relative to those of H-LSPC and LC groups respectively. LSPC and LC combinations ameliorated scopolamine-induced memory impairment by improving total antioxidant capacity (TAOC) level, glutathione peroxidase (GSH-Px) and total superoxide dismutase (T-SOD) activities of brain, serum and colon, suppressing malondialdehyde (MDA) level of brain, serum and colon, and inhibiting brain acetylcholinesterase (AchE), myeloperoxidase, total nitric oxide synthase and neural nitric oxide synthase (nNOS) activities, and nNOS mRNA level. Moreover, LC facilitated the ameliorative effects of H-LSPC on GSH-Px activity of colon, TAOC level, GSH-Px activity and ratio of T-SOD to MDA of brain and serum, and the inhibitory effects of H-LSPC on serum MDA level, brain nNOS mRNA level and AchE activity. These results indicated that LC promoted the memory-enhancing effect of LSPC in scopolamine-induced amnesia mice.	[Sui, Yong; Wu, Qian; Li, Xiaopeng; Xie, Bijun; Sun, Zhida] Huazhong Agr Univ, Coll Food Sci & Technol, Wuhan 430070, Hubei, Peoples R China; [Xiao, Juan; Zhang, Mingwei] Guangdong Acad Agr Sci, Guangdong Key Lab Agr Prod Proc, Minist Agr, Key Lab Funct Foods,Sericultural & Agrifood Res I, Guangzhou 510610, Guangdong, Peoples R China; [Li, Shuyi] Wuhan Polytech Univ, Coll Food Sci & Engn, Wuhan 430023, Hubei, Peoples R China	Huazhong Agricultural University; Guangdong Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Wuhan Polytechnic University	Sun, ZD (corresponding author), Huazhong Agr Univ, Coll Food Sci & Technol, 1 Shizishan St, Wuhan 430070, Hubei, Peoples R China.	sunzhida@sina.com			National Natural Science Foundation of China (NSFC) [31071633]; Innovation Capacity Construction Special Project of Main Scientific Research Organization of Guangdong Province	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Innovation Capacity Construction Special Project of Main Scientific Research Organization of Guangdong Province	This work was supported by National Natural Science Foundation of China (NSFC, No. 31071633) and the Innovation Capacity Construction Special Project of Main Scientific Research Organization of Guangdong Province (2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba S, 2002, FREE RADICAL BIO MED, V33, P142, DOI 10.1016/S0891-5849(02)00871-7; Bajaj JS, 2012, AM J PHYSIOL-GASTR L, V302, pG168, DOI 10.1152/ajpgi.00190.2011; Bhattacharjee S, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00153; Biagi E, 2012, AGE, V34, P247, DOI 10.1007/s11357-011-9217-5; Bustos I, 2012, J AGR FOOD CHEM, V60, P9082, DOI 10.1021/jf301133g; Chen J, 2008, PHARMACOL BIOCHEM BE, V90, P441, DOI 10.1016/j.pbb.2008.03.029; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Davari S, 2013, NEUROSCIENCE, V240, P287, DOI 10.1016/j.neuroscience.2013.02.055; Devasagayam T P A, 2004, J Assoc Physicians India, V52, P794; Dolara P, 2005, MUTAT RES-FUND MOL M, V591, P237, DOI 10.1016/j.mrfmmm.2005.04.022; Formigare A, 2007, COMP BIOCHEM PHYS C, V146, P443, DOI 10.1016/j.cbpc.2007.07.010; Gareau MG, 2011, GUT, V60, P307, DOI 10.1136/gut.2009.202515; Gong YS, 2008, BEHAV BRAIN RES, V194, P100, DOI 10.1016/j.bbr.2008.06.029; Gonthier MP, 2003, FREE RADICAL BIO MED, V35, P837, DOI 10.1016/S0891-5849(03)00394-0; GROENEWOUD G, 1986, XENOBIOTICA, V16, P99, DOI 10.3109/00498258609043512; Jeong EJ, 2008, EUR J PHARMACOL, V588, P78, DOI 10.1016/j.ejphar.2008.04.015; Jung IH, 2012, J APPL MICROBIOL, V113, P1498, DOI 10.1111/j.1365-2672.2012.05437.x; Kohri T, 2001, J AGR FOOD CHEM, V49, P4102, DOI 10.1021/jf001491+; KOPELMAN MD, 1988, BRAIN, V111, P1079, DOI 10.1093/brain/111.5.1079; Kullisaar T, 2002, INT J FOOD MICROBIOL, V72, P215, DOI 10.1016/S0168-1605(01)00674-2; Kwon SH, 2010, EUR J PHARMACOL, V649, P210, DOI 10.1016/j.ejphar.2010.09.001; Laura P, 2007, BRIT J NUTR, V97, P96; Lee HC, 2006, RES MICROBIOL, V157, P876, DOI 10.1016/j.resmic.2006.07.004; Li SY, 2013, J AGR FOOD CHEM, V61, P2506, DOI 10.1021/jf305213e; Li SY, 2013, FOOD CHEM, V138, P1536, DOI 10.1016/j.foodchem.2012.09.120; Li W, 2009, PHYSIOL BEHAV, V96, P557, DOI 10.1016/j.physbeh.2008.12.004; Ling ZQ, 2005, J AGR FOOD CHEM, V53, P2441, DOI 10.1021/jf040325p; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P676, DOI 10.1016/j.pnpbp.2010.05.004; McCarthy M, 1997, INT J GERIATR PSYCH, V12, P404; Monagas M, 2010, FOOD FUNCT, V1, P233, DOI 10.1039/c0fo00132e; Moujalli S, 2008, JBI DATABASE SYSTEMA, V6, pS35; Ohland CL, 2013, PSYCHONEUROENDOCRINO, V38, P1738, DOI 10.1016/j.psyneuen.2013.02.008; PORTER LJ, 1985, PHYTOCHEMISTRY, V25, P223, DOI 10.1016/S0031-9422(00)94533-3; REITER RJ, 1995, FASEB J, V9, P526, DOI 10.1096/fasebj.9.7.7737461; Roowi S, 2010, J AGR FOOD CHEM, V58, P1296, DOI 10.1021/jf9032975; Skrha J, 1999, DIABETES RES CLIN PR, V44, P27, DOI 10.1016/S0168-8227(99)00010-8; van Praag H, 2007, J NEUROSCI, V27, P5869, DOI 10.1523/JNEUROSCI.0914-07.2007; Xiao J, 2013, EUR FOOD RES TECHNOL, V236, P671, DOI 10.1007/s00217-013-1922-0; Xu JQ, 2009, PHYTOTHER RES, V23, P1742, DOI 10.1002/ptr.2837; Xu JQ, 2009, EUR NEUROPSYCHOPHARM, V19, P851, DOI 10.1016/j.euroneuro.2009.07.006; Xu SY, 2001, PHARM EXPT METHODOLO, P826; Zhao LP, 2010, J BIOTECHNOL, V149, P183, DOI 10.1016/j.jbiotec.2010.02.008	44	26	30	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112773	10.1371/journal.pone.0112773	http://dx.doi.org/10.1371/journal.pone.0112773			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396737	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558500089
J	Zhou, QH; Zhao, LJ; Wang, P; Badr, R; Xu, XJ; Bu, FX; Lappe, J; Recker, R; Zhou, Y; Ye, A; Zhou, BT				Zhou, Qiu-Hong; Zhao, Lan-Juan; Wang, Ping; Badr, Rhamee; Xu, Xiao-Jing; Bu, Feng-Xiao; Lappe, Joan; Recker, Robert; Zhou, Yu; Ye, An; Zhou, Bo-Ting			Comprehensive analysis of the association of EGFR, CALM3 and SMARCD1 gene polymorphisms with BMD in Caucasian women	PLOS ONE			English	Article							BONE-MINERAL DENSITY; CIGARETTE-SMOKING; POSTMENOPAUSAL WOMEN; ELDERLY-MEN; RECEPTOR; OSTEOPOROSIS; CALMODULIN; DIFFERENTIATION; METAANALYSIS; EXPRESSION	ASummary: Three genes, including EGFR (epidermal growth factor receptor), CALM3 (calmodulin 3, calcium-modulated protein 3) and SMARCD1 (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily d member 1), play different roles in bone and/or fat metabolism in Caucasian women. In this population-based investigation of 870 unrelated postmenopausal Caucasian women, CALM3 polymorphisms were significantly associated with femoral neck bone mineral density (FNK BMD), hip BMD and spine BMD. Age and tobacco status also affected BMD levels and were therefore corrected for in our statistical analysis. Introduction: EGFR, CALM3 and SMARCD1 play roles in bone and/or fat metabolism. However, the correlations between the polymorphisms of these three genes and body composition levels, including BMD, remain to be determined. Materials and Methods: A population-based investigation of 870 white women was conducted. Forty-four SNPs (single nucleotide polymorphisms) in EGFR, CALM3 and SMARCD1 were chosen by the software, including those of potential functional importance. The candidate SNPs were genotyped by the KASPar assay for an association analysis with body composition levels. The correlation analysis was assessed by the Pearson's product-moment correlation coefficient and Spearman rank-order correlation tests, and the family-wise error was corrected using the Wald test implemented in PLINK. Results: The SNP rs12461917 in the 3'-flanking region of the CALM3 gene was significantly associated with FNK BMD (P = 0.001), hip BMD (P, 0.001) and spine BMD (P = 0.001); rs11083838 in the 5'-flanking region of CALM3 gene was associated with spine BMD (P = 0.009). After adjusting for multiple comparisons, rs12461917 remained significant (Padjusted = 0.033 for FNK BMD, P-adjusted = 0.006 for hip BMD and P-adjusted = 0.018 for spine BMD). Conclusions: Our data show that polymorphisms of the CALM3 gene in Caucasian women may contribute to variations in the BMD of the hip, spine and femoral neck.	[Zhou, Qiu-Hong] Cent S Univ, Xiangya Hosp, Dept Endocrinol, Changsha 410008, Hunan, Peoples R China; [Zhao, Lan-Juan; Xu, Xiao-Jing; Bu, Feng-Xiao; Lappe, Joan; Recker, Robert; Zhou, Yu; Ye, An; Zhou, Bo-Ting] Creighton Univ, Med Ctr, Osteoporosis Res Ctr, Omaha, NE 68131 USA; [Zhao, Lan-Juan; Zhou, Yu; Ye, An] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Biostat & Bioinformat, New Orleans, LA 70112 USA; [Wang, Ping; Zhou, Bo-Ting] Cent S Univ, Xiangya Hosp, Dept Pharm, Changsha 410008, Hunan, Peoples R China; [Badr, Rhamee] Tulane Univ, Sch Med, New Orleans, LA USA	Central South University; Creighton University; Tulane University; Central South University; Tulane University	Zhou, BT (corresponding author), Creighton Univ, Med Ctr, Osteoporosis Res Ctr, 601 N 30th ST,Suite 4820, Omaha, NE 68131 USA.	botingzhou0918@126.com	Bu, Fengxiao/F-1463-2016	Bu, Fengxiao/0000-0002-4882-4856	Cancer and Smoking Disease Research Bone Biology Program; Nebraska Tobacco Settlement Biomedical Research Development Award; NIH [3R01CA129488-01A2S2]; NATIONAL CANCER INSTITUTE [R01CA129488] Funding Source: NIH RePORTER	Cancer and Smoking Disease Research Bone Biology Program; Nebraska Tobacco Settlement Biomedical Research Development Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was partially supported by grants from the Cancer and Smoking Disease Research Bone Biology Program, the Nebraska Tobacco Settlement Biomedical Research Development Award and NIH grants (3R01CA129488-01A2S2). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aifa S, 2006, BIOCHEM BIOPH RES CO, V347, P381, DOI 10.1016/j.bbrc.2006.05.200; Bergmann S, 1998, RESP PHYSIOL, V114, P269, DOI 10.1016/S0034-5687(98)00098-X; Beyer Nardi N, 2006, HANDB EXP PHARM, V174, P249; Bijl M, 2001, EUR J CLIN INVEST, V31, P550, DOI 10.1046/j.1365-2362.2001.00842.x; Bord S, 2003, BONE, V32, P136, DOI 10.1016/S8756-3282(02)00953-5; Cauley JA, 2011, CLIN ORTHOP RELAT R, V469, P1891, DOI 10.1007/s11999-011-1863-5; Chandra A, 2013, J BIOL CHEM, V288, P20488, DOI 10.1074/jbc.M112.447250; COSIO FG, 1982, J LAB CLIN MED, V100, P469; Emaus N, 2014, J BONE MINER RES MAR, V28, P10; Friedrich FW, 2009, EUR HEART J, V30, P1648, DOI 10.1093/eurheartj/ehp153; Gnudi S, 2007, J BONE MINER METAB, V25, P326, DOI 10.1007/s00774-007-0758-8; Gourlay Margaret L, 2014, J Bone Metab, V21, P61, DOI 10.11005/jbm.2014.21.1.61; Iqbal J, 2013, P NATL ACAD SCI USA, V110, P11115, DOI 10.1073/pnas.1220919110; Jorgetti V, 2013, KIDNEY INT; Kiel DP, 1996, OSTEOPOROSIS INT, V6, P240, DOI 10.1007/BF01622741; Koszewski NJ, 2003, J STEROID BIOCHEM, V87, P223, DOI 10.1016/j.jsbmb.2003.09.006; Lappe JM, 2006, J AM COLL NUTR, V25, P395, DOI 10.1080/07315724.2006.10719551; Law MR, 1997, BMJ-BRIT MED J, V315, P841, DOI 10.1136/bmj.315.7112.841; Li S, 2008, CELL METAB, V8, P105, DOI 10.1016/j.cmet.2008.06.013; Lu L, 2012, HUM GENET, V131, P505, DOI 10.1007/s00439-011-1099-1; Manabe N, 2001, J IMMUNOL, V167, P2625, DOI 10.4049/jimmunol.167.5.2625; Meier C, 2005, J BONE MINER RES, V20, P579, DOI 10.1359/JBMR.041207; Oyen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092882; Pabst MJ, 1995, J PERIODONTOL, V66, P1047, DOI 10.1902/jop.1995.66.12.1047; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Ralston SH, 2007, P NUTR SOC, V66, P158, DOI 10.1017/S002966510700540X; REID IR, 1992, J CLIN ENDOCR METAB, V75, P45, DOI 10.1210/jc.75.1.45; Saccone V, 2014, GENE DEV, V28, P841, DOI 10.1101/gad.234468.113; Seales EC, 2006, J CELL BIOCHEM, V97, P45, DOI 10.1002/jcb.20659; STEIGER P, 1992, J BONE MINER RES, V7, P625; Toutenhoofd SL, 1998, CELL CALCIUM, V23, P323, DOI 10.1016/S0143-4160(98)90028-8; Wang K, 2004, J BIOL CHEM, V279, P53848, DOI 10.1074/jbc.M403114200; Ward KD, 2001, CALCIFIED TISSUE INT, V68, P259, DOI 10.1007/BF02390832; Weitzmann MN, 2000, J CELL BIOCHEM, V78, P318, DOI 10.1002/(SICI)1097-4644(20000801)78:2<318::AID-JCB13>3.0.CO;2-N; Yamada Y, 2007, INT J MOL MED, V19, P791; Zhang XR, 2011, J BONE MINER RES, V26, P1022, DOI 10.1002/jbmr.295; Zhou JP, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-62	38	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112358	10.1371/journal.pone.0112358	http://dx.doi.org/10.1371/journal.pone.0112358			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396734	gold, Green Submitted, Green Published			2022-12-27	WOS:000345558500048
J	Bessho, M; Murase-Mishiba, Y; Imagawa, A; Terasaki, J; Hanafusa, T				Bessho, Megumi; Murase-Mishiba, Yuko; Imagawa, Akihisa; Terasaki, Jungo; Hanafusa, Toshiaki			Possible Contribution of Taurine to Distorted Glucagon Secretion in Intra-Islet Insulin Deficiency: A Metabolome Analysis Using a Novel alpha-Cell Model of Insulin-Deficient Diabetes	PLOS ONE			English	Article							GLUCOSE-INHIBITION; CHANNELS; HYPOGLYCEMIA; RELEASE; ADOLESCENTS; EXPRESSION; GLUTAMATE; INFUSION; ARGININE	Glycemic instability is a serious problem in patients with insulin-deficient diabetes, and it may be due in part to abnormal endogenous glucagon secretion. However, the intracellular metabolic mechanism(s) involved in the aberrant glucagon response under the condition of insulin deficiency has not yet been elucidated. To investigate the metabolic traits that underlie the distortion of glucagon secretion under insulin deficient conditions, we generated an alpha TC1-6 cell line with stable knockdown of the insulin receptor (IRKD), i.e., an in vitro alpha-cell model for insulin-deficient diabetes, which exhibits an abnormal glucagon response to glucose. A comprehensive metabolomic analysis of the IRKD alpha TC1-6 cells (IRKD cells) revealed some candidate metabolites whose levels differed markedly compared to those in control alpha TC1-6 cells, but also which could affect the glucagon release in IRKD cells. Of these candidates, taurine was remarkably increased in the IRKD cells and was identified as a stimulator of glucagon in alpha TC1-6 cells. Taurine also paradoxically exaggerated the glucagon secretion at a high glucose concentration in IRKD cells and islets with IRKD. These results indicate that the metabolic alterations induced by IRKD in alpha-cells, especially the increase of taurine, may lead to the distorted glucagon response in IRKD cells, suggesting the importance of taurine in the paradoxical glucagon response and the resultant glucose instability in insulin-deficient diabetes.	[Bessho, Megumi; Murase-Mishiba, Yuko; Imagawa, Akihisa; Terasaki, Jungo; Hanafusa, Toshiaki] Osaka Med Coll, Dept Internal Med 1, Osaka, Japan; [Imagawa, Akihisa] Osaka Univ, Grad Sch Med, Dept Metab Med, Osaka, Japan	Osaka Medical College; Osaka University	Murase-Mishiba, Y (corresponding author), Osaka Med Coll, Dept Internal Med 1, Osaka, Japan.	in1254@poh.osaka-med.ac.jp			KAKENHI from Japan Society for the Promotion of Science (JSPS) [25461367]; Grants-in-Aid for Scientific Research [25461367] Funding Source: KAKEN	KAKENHI from Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by KAKENHI from Japan Society for the Promotion of Science (JSPS) to YMM (25461367). No additional funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGENSTAL RM, 1983, DIABETES, V32, P398, DOI 10.2337/diabetes.32.5.398; Bessho M, 2013, DIABETES RES CLIN PR, V102, pE38, DOI 10.1016/j.diabres.2013.09.003; Bollyky J, 2007, J CLIN ENDOCR METAB, V92, P2879, DOI 10.1210/jc.2007-1312; Bres V, 2000, BRIT J PHARMACOL, V130, P1976, DOI 10.1038/sj.bjp.0703492; Chang RCC, 2001, NEUROCHEM INT, V38, P249, DOI 10.1016/S0197-0186(00)00082-6; Cherif H, 1996, J ENDOCRINOL, V151, P501, DOI 10.1677/joe.0.1510501; Diabet Control Complications Trial Res Grp, 1998, ANN INTERN MED, V128, P517, DOI 10.7326/0003-4819-128-7-199804010-00001; Diao JY, 2005, J BIOL CHEM, V280, P33487, DOI 10.1074/jbc.M506276200; El Idrissi A, 2008, AMINO ACIDS, V34, P321, DOI 10.1007/s00726-006-0396-9; Gaisano HY, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00349; GERICH JE, 1975, J CLIN ENDOCR METAB, V41, P1178, DOI 10.1210/jcem-41-6-1178; GERICH JE, 1973, SCIENCE, V182, P171, DOI 10.1126/science.182.4108.171; Gleason CE, 2007, J BIOL CHEM, V282, P10341, DOI 10.1074/jbc.M610631200; Greenbaum CJ, 2002, DIABETES, V51, P951, DOI 10.2337/diabetes.51.4.951; HAMAGUCHI K, 1990, DIABETES, V39, P415, DOI 10.2337/diabetes.39.4.415; Hayashi M, 2003, J BIOL CHEM, V278, P1966, DOI 10.1074/jbc.M206758200; Hayashi M, 2001, J BIOL CHEM, V276, P43400, DOI 10.1074/jbc.M106244200; Henningsson R, 1998, AM J PHYSIOL-ENDOC M, V275, pE500, DOI 10.1152/ajpendo.1998.275.3.E500; Henningsson R, 2000, AM J PHYSIOL-ENDOC M, V279, pE95, DOI 10.1152/ajpendo.2000.279.1.E95; Ishihara H, 2003, NAT CELL BIOL, V5, P330, DOI 10.1038/ncb951; Kawamori D, 2011, DIABETES OBES METAB, V13, P21, DOI 10.1111/j.1463-1326.2011.01442.x; Kawamori D, 2009, CELL METAB, V9, P350, DOI 10.1016/j.cmet.2009.02.007; KULAKOWSKI EC, 1984, BIOCHEM PHARMACOL, V33, P2835, DOI 10.1016/0006-2952(84)90204-1; L'Amoreaux WJ, 2010, J BIOMED SCI S1, V17, pS1; Lambert IH, 2004, NEUROCHEM RES, V29, P27, DOI 10.1023/B:NERE.0000010433.08577.96; Leclerc I, 2011, DIABETOLOGIA, V54, P125, DOI 10.1007/s00125-010-1929-z; Leung YM, 2006, ENDOCRINOLOGY, V147, P2155, DOI 10.1210/en.2005-1249; Newsholme P, 2007, BIOCHEM SOC T, V35, P1180, DOI 10.1042/BST0351180; Paul GL, 1998, J NUTR, V128, P973, DOI 10.1093/jn/128.6.973; Porksen S, 2007, J CLIN ENDOCR METAB, V92, P2910, DOI 10.1210/jc.2007-0244; Reynolds C, 1997, DIABETES, V26, P36; Ribeiro RA, 2009, DIABETES-METAB RES, V25, P370, DOI 10.1002/dmrr.959; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; Salehi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002165; Satoh H, 1998, GEN PHARMACOL-VASC S, V30, P451, DOI 10.1016/S0306-3623(97)00309-1; Siafarikas A, 2012, DIABETES CARE, V35, P1757, DOI 10.2337/dc11-2010; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Taborsky Gerald J Jr, 2010, J Diabetes Sci Technol, V4, P1338; TIMBRELL JA, 1995, GEN PHARMACOL-VASC S, V26, P453, DOI 10.1016/0306-3623(94)00203-Y; TOKUNAGA H, 1983, EUR J PHARMACOL, V87, P237, DOI 10.1016/0014-2999(83)90333-3; Tricarico D, 2000, BRIT J PHARMACOL, V130, P827, DOI 10.1038/sj.bjp.0703385; Unger RH, 2010, P NATL ACAD SCI USA, V107, P16009, DOI 10.1073/pnas.1006639107; Wendt A, 2004, DIABETES, V53, P1038, DOI 10.2337/diabetes.53.4.1038; Yaekura K, 1998, AM J PHYSIOL-CELL PH, V274, pC513, DOI 10.1152/ajpcell.1998.274.2.C513; Zhang Q, 2013, CELL METAB, V18, P871, DOI 10.1016/j.cmet.2013.10.014	47	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e113254	10.1371/journal.pone.0113254	http://dx.doi.org/10.1371/journal.pone.0113254			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393115	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300145
J	Choi, JS; Kim, HO; Kim, EK; Suh, YJ; Yoon, JH; Moon, HJ; Kim, MJ				Choi, Ji Soo; Kim, Hyun Ok; Kim, Eun-Kyung; Suh, Young Joo; Yoon, Jung Hyun; Moon, Hee Jung; Kim, Min Jung			HER2 Expression in Fine Needle Aspirates of Lymph Nodes Detected by Preoperative Axillary Ultrasound in Breast Cancer Patients	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CLINICOPATHOLOGICAL PARAMETERS; PROTEIN OVEREXPRESSION; HER-2/NEU EXPRESSION; GENE AMPLIFICATION; ULTRASONOGRAPHY; THERAPY; IMPACT; CHEMOTHERAPY; TRASTUZUMAB	The purpose of this study was to assess the usefulness of HER2 levels in ultrasonographically guided fine-needle aspiration biopsy (US-FNA) aspirates of axillary lymph nodes (ALNs) in the determination of lymph node metastasis or the characterization of primary breast cancer, and to correlate the HER2 levels in US-FNA aspirates (FNA-HER2s) of metastatic ALNs with the HER2 statuses of corresponding primary breast cancers. An institutional review board approved the study. Between January and October 2010, 164 patients with 167 ALNs examined by US-FNA were included. FNA-HER2s of ALNs were measured by chemiluminescence immunoassay, and they were correlated with cytologic/final diagnoses. Receiver operating characteristics (ROC) curve analysis was performed to evaluate the diagnostic ability to differentiate benign and metastatic ALNs. Additionally, FNA-HER2s of metastatic ALNs were correlated with HER2 status and other clinicopathologic variables of the primary breast cancers. Among the 167 ALNs, 138 were metastatic and 29 were benign. The mean FNAHER2 (6.3 ng/ml) of metastatic ALNs was higher than that of benign ALNs. All 29 benign ALNs showed no measurable value of FNA-HER2 (0.0 ng/ml). The area under the ROC curves of FNA-HER2 of ALNs was 0.679 for the diagnosis of ALN metastasis. The FNA-HER2 statuses of 108 metastatic ALNs (79.4%) were concordant with the HER2 statuses of the corresponding primary breast cancers. In a subgroup analysis of HER2-positive cancers with ALN metastasis, distant metastasis was significantly associated with FNA-HER2-negativity of metastatic ALNs (P = 0.04). Although FNA-HER2 of ALNs did not improve the diagnostic performance of FNA cytology in preoperative diagnosis of ALN metastasis of overall patients, FNA-HER2-positive metastatic ALNs were significantly associated with HER2-positivity of primary breast cancers. Additionally, FNA-HER2 analysis of ALN may help to develop more personalized treatment protocol for breast cancer patients by determining the concordance or discordance of HER2 status between primary cancers and metastatic ALNs.	[Choi, Ji Soo; Kim, Eun-Kyung; Suh, Young Joo; Yoon, Jung Hyun; Moon, Hee Jung; Kim, Min Jung] Yonsei Univ, Coll Med, Res Inst Radiol Sci, Dept Radiol, Seoul, South Korea; [Choi, Ji Soo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea; [Kim, Hyun Ok] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University Health System	Kim, MJ (corresponding author), Yonsei Univ, Coll Med, Res Inst Radiol Sci, Dept Radiol, Seoul, South Korea.	mines@yuhs.ac	Kim, Eun-Kyung/E-5211-2017	Kim, Eun-Kyung/0000-0002-3368-5013; Moon, Hee Jung/0000-0002-5643-5885; Kim, Hyun Ok/0000-0002-4964-1963; Suh, Young Joo/0000-0002-2078-5832; Yoon, Jung Hyun/0000-0002-2100-3513	Basic Science Research Program of the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning, Republic of Korea [2013R1A1A3013165]	Basic Science Research Program of the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning, Republic of Korea	This study was supported by the Basic Science Research Program of the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning, Republic of Korea (preparation of the manuscript grant 2013R1A1A3013165). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama K, 2010, JPN J CLIN ONCOL, V40, P613, DOI 10.1093/jjco/hyq019; Banerjee M, 2004, J CLIN ONCOL, V22, P2567, DOI 10.1200/JCO.2004.11.141; Beatty BG, 2004, AM J CLIN PATHOL, V122, P246, DOI 10.1309/X8UP920UF4XM1C5C; BRYAN RM, 1986, BRIT J SURG, V73, P267, DOI 10.1002/bjs.1800730408; Choi JS, 2012, ULTRASOUND MED BIOL, V38, P1881, DOI 10.1016/j.ultrasmedbio.2012.07.011; Ciatto S, 2007, BREAST CANCER RES TR, V103, P85, DOI 10.1007/s10549-006-9355-0; Colomer R, 2004, ANN ONCOL, V15, P201, DOI 10.1093/annonc/mdh048; Cools-Lartigue J, 2012, WORLD J SURG, V36, P46, DOI 10.1007/s00268-011-1319-9; Deurloo EE, 2003, EUR J CANCER, V39, P1068, DOI 10.1016/S0959-8049(02)00748-7; Edgerton SM, 2003, APPL IMMUNOHISTO M M, V11, P214; Fraile M, 2000, ANN ONCOL, V11, P701, DOI 10.1023/A:1008377910967; Gong Y, 2005, CANCER-AM CANCER SOC, V103, P1763, DOI 10.1002/cncr.20987; Hicks DG, 2008, AM J CLIN PATHOL, V129, P263, DOI 10.1309/99AE032R9FM8WND1; Huang Y, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0966-8; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Jain A, 2008, ANN SURG ONCOL, V15, P462, DOI 10.1245/s10434-007-9623-1; Kim MJ, 2010, RADIOLOGY, V254, P691, DOI 10.1148/radiol.09091031; Koelliker SL, 2008, RADIOLOGY, V246, P81, DOI 10.1148/radiol.2463061463; Krishnamurthy S, 2002, CANCER, V95, P982, DOI 10.1002/cncr.10786; Lipton A, 2002, J CLIN ONCOL, V20, P1467, DOI 10.1200/JCO.20.6.1467; Lower EE, 2009, BREAST CANCER RES TR, V113, P301, DOI 10.1007/s10549-008-9931-6; Ludovini V, 2008, ANN ONCOL, V19, P883, DOI 10.1093/annonc/mdm585; Moore A, 2008, BRIT J RADIOL, V81, P630, DOI 10.1259/bjr/21933846; Muller V, 2003, INT J BIOL MARKER, V18, P13, DOI 10.1177/172460080301800103; MUSS HB, 1994, NEW ENGL J MED, V330, P1260, DOI 10.1056/NEJM199405053301802; NIEHANS GA, 1993, JNCI-J NATL CANCER I, V85, P1230, DOI 10.1093/jnci/85.15.1230; Park SH, 2011, ANN SURG ONCOL, V18, P738, DOI 10.1245/s10434-010-1347-y; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Ryu DW, 2012, J BREAST CANCER, V15, P71, DOI 10.4048/jbc.2012.15.1.71; Santinelli A, 2008, INT J CANCER, V122, P999, DOI 10.1002/ijc.23051; Seol H, 2012, MODERN PATHOL, V25, P938, DOI 10.1038/modpathol.2012.36; Shimizu C, 2000, J SURG ONCOL, V73, P17, DOI 10.1002/(SICI)1096-9098(200001)73:1<17::AID-JSO5>3.3.CO;2-U; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; van Rijk MC, 2006, ANN SURG ONCOL, V13, P31, DOI 10.1245/ASO.2005.01.024; Veronesi U, 1997, LANCET, V349, P1864, DOI 10.1016/S0140-6736(97)01004-0; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Yoon JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057248	38	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e113065	10.1371/journal.pone.0113065	http://dx.doi.org/10.1371/journal.pone.0113065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393693	gold, Green Published, Green Submitted			2022-12-27	WOS:000347709300139
J	Robles, MD; Cutillas, C; Panei, CJ; Callejon, R				del Rosario Robles, Maria; Cutillas, Cristina; Javier Panei, Carlos; Callejon, Rocio			Morphological and Molecular Characterization of a New Trichuris Species (Nematoda- Trichuridae), and Phylogenetic Relationships of Trichuris Species of Cricetid Rodents from Argentina	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; RIBOSOMAL DNA-SEQUENCE; TRICHOSTRONGYLUS NEMATODA; ITS1-5.8S-ITS2 SEGMENT; WHIPWORM; RDNA; IDENTIFICATION; SIGMODONTINAE; REDESCRIPTION; SKRJABINI	Populations of Trichuris spp. isolated from six species of sigmodontine rodents from Argentina were analyzed based on morphological characteristics and ITS2 (rDNA) region sequences. Molecular data provided an opportunity to discuss the phylogenetic relationships among the Trichuris spp. from Noth and South America (mainly from Argentina). Trichuris specimens were identified morphologically as Trichuris pardinasi, T. navonae, Trichuris sp. and Trichuris new species, described in this paper. Sequences analyzed by Maximum Parsimony, Maximum Likelihood and Bayesian inference methods showed four main clades corresponding with the four different species regardless of geographical origin and host species. These four species from sigmodontine rodents clustered together and separated from Trichuris species isolated from murine and arvicoline rodents (outgroup). Different genetic lineages observed among Trichuris species from sigmodontine rodents which supported the proposal of a new species. Moreover, host distribution showed correspondence with the different tribes within the subfamily Sigmodontinae.	[del Rosario Robles, Maria] Univ Nacl La Plata, CCT CONICET La Plata, Ctr Estudios Parasitol & Vectores CEPAVE, La Plata, Buenos Aires, Argentina; [Cutillas, Cristina; Callejon, Rocio] Univ Seville, Fac Farm, Dept Microbiol & Parasitol, Seville, Spain; [Javier Panei, Carlos] Univ Nacl La Plata, Fac Ciencias Vet, La Plata, Buenos Aires, Argentina; [del Rosario Robles, Maria; Javier Panei, Carlos] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; University of Sevilla; National University of La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Robles, MD (corresponding author), Univ Nacl La Plata, CCT CONICET La Plata, Ctr Estudios Parasitol & Vectores CEPAVE, La Plata, Buenos Aires, Argentina.	rosario@cepave.edu.ar	Callejón-Fernández, Rocío/K-8743-2014; Cutillas, Cristina/L-1738-2014	Callejón-Fernández, Rocío/0000-0002-6276-3818; Cutillas, Cristina/0000-0002-3886-1231	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2010-0924]; Proyecto de incentivos de la Universidad Nacional de La Plata [UNLP N 627]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Proyecto de incentivos de la Universidad Nacional de La Plata	The authors received no specific funding for this work. However, some grants contributed to the cost of sampling and laboratory supplies: Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2010-0924); Proyecto de incentivos de la Universidad Nacional de La Plata (UNLP N 627 and travel grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GR, 1998, SYST PARASITOL, V41, P87, DOI 10.1023/A:1006024128098; Anderson R. C., 2000, Nematode parasites of vertebrates: their development and transmission., DOI 10.1079/9780851994215.0000; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; BABERO BB, 1987, T AM MICROSC SOC, V106, P190, DOI 10.2307/3226320; BABERO BB, 1975, J PARASITOL, V61, P1061, DOI 10.2307/3279376; BABERO BB, 1990, MEM I OSWALDO CRUZ, V85, P211, DOI 10.1590/S0074-02761990000200012; BABERO BB, 1976, T AM MICROSC SOC, V95, P232, DOI 10.2307/3225071; BARUS V, 1975, Folia Parasitologica (Ceske Budejovice), V22, P207; Bonvicino C R, 2002, BRAZ J BIOL, V62, P1; Cafrune MM, 1999, J PARASITOL, V85, P961, DOI 10.2307/3285836; Callejon R, 2012, VET PARASITOL, V186, P350, DOI 10.1016/j.vetpar.2011.11.033; Callejon R, 2010, PARASITOL RES, V107, P631, DOI 10.1007/s00436-010-1908-9; CAMERON T. W. M., 1951, CANDIAN JOUR ZOOL, V29, P276, DOI 10.1139/z51-025; CAMPBELL AJD, 1995, INT J PARASITOL, V25, P359, DOI 10.1016/0020-7519(94)00116-6; CHANDLER AC, 1945, J PARASITOL, V31, P284, DOI 10.2307/3273006; CHANDLER ASA C., 1930, JOUR PARASITOL, V16, P198, DOI 10.2307/3271514; CHILTON NB, 1995, INT J PARASITOL, V25, P647, DOI 10.1016/0020-7519(94)00171-J; Cirignoli S, 2005, MAMIFEROS ARGENTINA, P166; Cirignoli Sebastián, 2011, Mastozool. neotrop., V18, P25; Crespo J. A., 1964, Neotropica, V10, P99; Cutillas C, 1995, EXP PARASITOL, V81, P621, DOI 10.1006/expr.1995.1159; Cutillas C, 1996, ACTA TROP, V62, P63, DOI 10.1016/S0001-706X(96)00019-8; Cutillas C, 2004, J PARASITOL, V90, P648, DOI 10.1645/GE-3295RN; Cutillas C, 2002, PARASITOL RES, V88, P574, DOI 10.1007/s00436-002-0596-5; Cutillas C, 2007, PARASITOL RES, V100, P383, DOI 10.1007/s00436-006-0275-z; de la Sancha NU, 2014, MAMMALIA, V78, P437, DOI 10.1515/mammalia-2013-0100; Robles María del Rosario, 2014, Mastozool. neotrop., V21, P67; Robles MD, 2011, J PARASITOL, V97, P319, DOI 10.1645/GE-2434.1; Epe C, 1997, RES VET SCI, V62, P17, DOI 10.1016/S0034-5288(97)90173-9; Feliu C, 2000, J PARASITOL, V86, P442, DOI 10.1645/0022-3395(2000)086[0442:GAMHIS]2.0.CO;2; Galazzo DE, 2002, CAN J ZOOL, V80, P2207, DOI 10.1139/Z02-198; Galliari Carlos A., 1996, Mastozoologia Neotropical, V3, P39; Gasser R, 1996, MOL CELL PROBE, V10, P99, DOI 10.1006/mcpr.1996.0014; GOMES DC, 1992, MEM I OSWALDO CRUZ, V87, P1, DOI 10.1590/S0074-02761992000500004; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hoste H, 1998, INT J PARASITOL, V28, P1251, DOI 10.1016/S0020-7519(98)00093-9; HOSTE H, 1995, INT J PARASITOL, V25, P75, DOI 10.1016/0020-7519(94)00085-3; Kikuchi S., 1974, J VET MED, V625, P1023; KIKUCHI S, 1974, J VET MED TOKYO, V625, P1082; KNIGHT RA, 1984, J PARASITOL, V70, P842, DOI 10.2307/3281784; Kramer Kristin M., 1999, Mammalian Species, V617, P1; Lent H., 1936, ANAIS ACAD BRASILEIR, V8, P319; Miller BR, 1996, INSECT MOL BIOL, V5, P93, DOI 10.1111/j.1365-2583.1996.tb00044.x; Morgan JAT, 1995, PARASITOLOGY, V111, P609, DOI 10.1017/S003118200007709X; Morini E. G., 1955, Publicaciones Mision de Estudios de Patologia Regional Argentina, V26, P83; Musser GG, 2005, MAMMAL SPECIES WORLD, P1; Nieberding C, 2004, P ROY SOC B-BIOL SCI, V271, P2559, DOI 10.1098/rspb.2004.2930; Nieberding CM, 2008, MOL PHYLOGENET EVOL, V47, P538, DOI 10.1016/j.ympev.2008.01.028; Oliveros R, 2000, PARASITOL RES, V86, P1008, DOI 10.1007/PL00008519; PARDINAS U., 2008, IUCN RED LIST THREAT; Pardinas UFJ, 2005, J MAMMAL, V86, P462, DOI 10.1644/1545-1542(2005)86[462:ANSOAR]2.0.CO;2; Pardinas UFJ, 2003, MAMM BIOL, V68, P129, DOI 10.1078/1616-5047-00075; Pardiñas Ulyses F. J., 2004, Mastozool. neotrop., V11, P211; Pardiuas U.F.J., 2006, MAMIFEROS ARGENTINA, P146; Patton J, 2008, IUCN RED LIST THREAT; Percequillo C, 2008, IUCN RED LIST THREAT; PFAFFENBERGER GS, 1989, P HELM SOC WASH, V56, P76; POLOP JJ, 1989, STUD NEOTROP FAUNA E, V24, P53, DOI 10.1080/01650528909360776; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; READ CLARK P., 1956, PROC HELMINTHOL SOC WASHINGTON, V23, P119; Reig O., 1987, FIELDIANA ZOOLOGY, V39, P347; Ringuelet R. A., 1961, Physis, V22, P151; Robles MDR, 2006, J PARASITOL, V92, P1053, DOI 10.1645/GE-827R.1; Robles MD, 2006, J PARASITOL, V92, P100, DOI 10.1645/GE-GE-552R.1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rossin MA, 2005, J PARASITOL, V91, P127, DOI 10.1645/GE-3383.1; SCHWARTZ BEN JAMIN, 1926, ARCH SCHIFFS U TROPEN HYG, V30, P544; SPAKULOVA M, 1994, SYST PARASITOL, V29, P113, DOI 10.1007/BF00009807; Steppan Scott J., 2007, University of California Publications in Zoology, V134, P799; Stevenson LA, 1996, INT J PARASITOL, V26, P1123, DOI 10.1016/S0020-7519(96)00064-1; Suriano D.M., 1994, Research and Reviews in Parasitology, V54, P39; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tenora F., 1997, Acta Universitatis Agriculturae et Silviculturae Mendelianae Brunensis, V45, P19; Tenora F., 1993, Helminthologia (Bratislava), V30, P93; Teta Pablo, 2007, Mastozool. neotrop., V14, P279; TINER JD, 1950, J PARASITOL, V36, P350, DOI 10.2307/3273470; TODD KS, 1972, P HELM SOC WASH, V39, P203; Vargas J, 2008, IUCN RED LIST THREAT; Zhu XQ, 1998, PARASITOLOGY, V117, P155, DOI 10.1017/S0031182098002856	79	21	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112069	10.1371/journal.pone.0112069	http://dx.doi.org/10.1371/journal.pone.0112069			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393618	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300030
J	Latham, AM; Kankanala, J; Fearnley, GW; Gage, MC; Kearney, MT; Homer-Vanniasinkam, S; Wheatcroft, SB; Fishwick, CWG; Ponnambalam, S				Latham, Antony M.; Kankanala, Jayakanth; Fearnley, Gareth W.; Gage, Matthew C.; Kearney, Mark T.; Homer-Vanniasinkam, Shervanthi; Wheatcroft, Stephen B.; Fishwick, Colin W. G.; Ponnambalam, Sreenivasan			In Silico Design and Biological Evaluation of a Dual Specificity Kinase Inhibitor Targeting Cell Cycle Progression and Angiogenesis	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; ENDOTHELIAL-CELLS; DEPENDENT KINASES; BRIVANIB ALANINATE; CRYSTAL-STRUCTURE; ACCURATE DOCKING; CDK1; DISCOVERY; TYROSINE; GLIDE	In Background: Protein kinases play a central role in tumor progression, regulating fundamental processes such as angiogenesis, proliferation and metastasis. Such enzymes are an increasingly important class of drug target with small molecule kinase inhibitors being a major focus in drug development. However, balancing drug specificity and efficacy is problematic with off-target effects and toxicity issues. Methodology: We have utilized a rational in silico-based approach to demonstrate the design and study of a novel compound that acts as a dual inhibitor of vascular endothelial growth factor receptor 2 (VEGFR2) and cyclin-dependent kinase 1 (CDK1). This compound acts by simultaneously inhibiting pro-angiogenic signal transduction and cell cycle progression in primary endothelial cells. JK-31 displays potent in vitro activity against recombinant VEGFR2 and CDK1/cyclin B proteins comparable to previously characterized inhibitors. Dual inhibition of the vascular endothelial growth factor A (VEGF-A)-mediated signaling response and CDK1-mediated mitotic entry elicits anti-angiogenic activity both in an endothelial-fibroblast co-culture model and a murine ex vivo model of angiogenesis. Conclusions: We deduce that JK-31 reduces the growth of both human endothelial cells and human breast cancer cells in vitro. This novel synthetic molecule has broad implications for development of similar multi-kinase inhibitors with anti-angiogenic and anti-cancer properties. In silico design is an attractive and innovative method to aid such drug discovery.	[Latham, Antony M.; Fearnley, Gareth W.; Ponnambalam, Sreenivasan] Univ Leeds, Sch Mol & Cellular Biol, Endothelial Cell Biol Unit, Leeds LS2 9JT, W Yorkshire, England; [Kankanala, Jayakanth; Fishwick, Colin W. G.] Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England; [Gage, Matthew C.; Kearney, Mark T.; Homer-Vanniasinkam, Shervanthi; Wheatcroft, Stephen B.] Univ Leeds, Fac Med & Hlth, Leeds Inst Cardiovasc & Metab Med, Leeds LS2 9JT, W Yorkshire, England	University of Leeds; University of Leeds; University of Leeds	Ponnambalam, S (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Endothelial Cell Biol Unit, Leeds LS2 9JT, W Yorkshire, England.	s.ponnambalam@leeds.ac.uk	, jayakanth/J-6949-2015	Gage, Matthew/0000-0002-6668-6573; Fishwick, Colin/0000-0003-1283-2181; Ponnambalam, Sreenivasan/0000-0002-4452-7619; Homer-Vanniasinkam, Shervanthi/0000-0001-6234-5053; KANKANALA, JAYAKANTH/0000-0002-9581-0844; Fearnley, Gareth William/0000-0002-9602-5071	Pfizer Global Inc.; ORSAS PhD award; British Heart Foundation	Pfizer Global Inc.; ORSAS PhD award; British Heart Foundation(British Heart Foundation)	This work was supported by a BBSRC-CASE PhD studentship from Pfizer Global Inc. (AML), an ORSAS PhD award (JK), and project grants from the British Heart Foundation (SP, MTK, SBW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MA, 2005, J MED CHEM, V48, P5655, DOI 10.1021/jm050533o; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Apsel B, 2008, NAT CHEM BIOL, V4, P691, DOI 10.1038/nchembio.117; Bashir T, 2005, NAT CELL BIOL, V7, P779, DOI 10.1038/ncb0805-779; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Boda K, 2006, J MED CHEM, V49, P5869, DOI 10.1021/jm050054p; Branca MA, 2005, NAT BIOTECHNOL, V23, P639, DOI 10.1038/nbt0605-639; Cai ZW, 2008, J MED CHEM, V51, P1976, DOI 10.1021/jm7013309; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Doree M, 2002, J CELL SCI, V115, P2461; DRAETTA G, 1988, CELL, V54, P17, DOI 10.1016/0092-8674(88)90175-4; Ebos JML, 2011, NAT REV CLIN ONCOL, V8, P210, DOI 10.1038/nrclinonc.2011.21; Emanuel S, 2005, CANCER RES, V65, P9038, DOI 10.1158/0008-5472.CAN-05-0882; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fearnley GW, 2014, METHOD ENZYMOL, V535, P265, DOI 10.1016/B978-0-12-397925-4.00016-X; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Galon J, 2014, J PATHOL, V232, P199, DOI 10.1002/path.4287; Haddad H, 2012, CURR TREAT OPTION ON, V13, P212, DOI 10.1007/s11864-012-0182-8; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Harris PA, 2008, J MED CHEM, V51, P4632, DOI 10.1021/jm800566m; Howell GJ, 2004, MOL MEMBR BIOL, V21, P413, DOI 10.1080/09687860400011571; Huang SL, 2007, BIOORG MED CHEM LETT, V17, P2179, DOI 10.1016/j.bmcl.2007.01.086; Huynh H, 2008, CLIN CANCER RES, V14, P6146, DOI 10.1158/1078-0432.CCR-08-0509; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Kankanala J, 2012, BRIT J PHARMACOL, V166, P737, DOI 10.1111/j.1476-5381.2011.01801.x; Knights V, 2010, PHARMACOL THERAPEUT, V125, P105, DOI 10.1016/j.pharmthera.2009.10.001; Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Latham AM, 2012, BRIT J PHARMACOL, V165, P245, DOI 10.1111/j.1476-5381.2011.01545.x; Lee J, 2011, BIOORG MED CHEM LETT, V21, P4203, DOI 10.1016/j.bmcl.2011.05.081; Malinda KM, 1997, FASEB J, V11, P474, DOI 10.1096/fasebj.11.6.9194528; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Morphy R, 2010, J MED CHEM, V53, P1413, DOI 10.1021/jm901132v; Murphy EA, 2010, P NATL ACAD SCI USA, V107, P4299, DOI 10.1073/pnas.0909299107; Neubrand VE, 2012, J CELL SCI, V125, P1845, DOI 10.1242/jcs.102764; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; Ponnambalam S, 2011, MOL NEUROBIOL, V43, P192, DOI 10.1007/s12035-011-8167-3; Potapova TA, 2009, MOL BIOL CELL, V20, P1737, DOI 10.1091/mbc.E08-07-0771; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Schmidberger JW, 2008, J MOL BIOL, V378, P284, DOI 10.1016/j.jmb.2008.02.035; Schonbrunn E, 2013, J MED CHEM, V56, P3768, DOI 10.1021/jm301234k; Squires MS, 2009, MOL CANCER THER, V8, P324, DOI 10.1158/1535-7163.MCT-08-0890; Tille JC, 2001, J PHARMACOL EXP THER, V299, P1073; Timofeev O, 2010, J BIOL CHEM, V285, P16978, DOI 10.1074/jbc.M109.096552; Tung JJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006601; Wang Q, 2011, CURR MED CHEM, V18, P2025, DOI 10.2174/092986711795590110; Wyatt PG, 2008, J MED CHEM, V51, P4986, DOI 10.1021/jm800382h; Zachary I, 2001, CARDIOVASC RES, V49, P568, DOI 10.1016/S0008-6363(00)00268-6	51	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e110997	10.1371/journal.pone.0110997	http://dx.doi.org/10.1371/journal.pone.0110997			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393739	gold, Green Published			2022-12-27	WOS:000347709300009
J	Yayan, J				Yayan, Josef			Weak Prediction Power of the Framingham Risk Score for Coronary Artery Disease in Nonagenarians	PLOS ONE			English	Article							HEART-DISEASE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; FOLLOW-UP; PREVENTION; ASSOCIATION; SOCIETY; ATHEROSCLEROSIS; RECOMMENDATIONS; CARDIOLOGY	Background: Coronary artery disease (CAD) is caused by an acute myocardial infarction and is still feared as a life-threatening heart disease worldwide. In order to identify patients at high risk for CAD, previous studies have proposed various risk assessment scores for the prevention of CAD. The most commonly used risk assessment score for CAD worldwide is the Framingham Risk Score (FRS). The FRS is used for middle-aged people; hence, its appropriateness has not been demonstrated to predict the likelihood of CAD occurrence in very elderly people. This article examines the possible predictive value of FRS for CAD in very elderly people over 90 years of age. Methods: Data on all patients over 90 years of age who received a cardiac catheter were collected from hospital charts from the Department of Internal Medicine, Saarland University Medical Center, and HELIOS Hospital Wuppertal, Witten/Herdecke University Medical Center, Germany, within a study period from 2004 to 2013. The FRSs and cardiovascular risk profiles of patients over 90 years of age with and without CAD after cardiac catheterization were compared. Results: One hundred and seventy-five (91.15%, mean age 91.51 +/- 1.80 years, 74 females [42.29%]; 95% confidence interval [CI], 0.87-0.95) of a total 192 of the very elderly patients were found to have CAD. Based on the results of our study, the FRS seems to provide weak predictive ability for CAD in very elderly people (P = 0.3792). Conclusion: We found weak prediction power of FRS for CAD in nonagenarians.	Univ Saarland, Med Ctr, Dept Internal Med, Div Pulm Allergy & Sleep Med, Homburg, Germany	Saarland University	Yayan, J (corresponding author), Univ Saarland, Med Ctr, Dept Internal Med, Div Pulm Allergy & Sleep Med, Homburg, Germany.	josef.yayan@hotmail.com						Abbott RD, 2002, ANN EPIDEMIOL, V12, P173, DOI 10.1016/S1047-2797(01)00309-X; Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Alexander KP, 2007, CIRCULATION, V115, P2549, DOI 10.1161/CIRCULATIONAHA.107.182615; Artigao-Rodenas LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073529; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Da Costa A, 2001, EUR HEART J, V22, P1459, DOI 10.1053/euhj.2000.2553; De Backer G, 2004, ATHEROSCLEROSIS, V173, P379, DOI 10.1016/j.atherosclerosis.2004.02.014; de Graaf MA, 2013, INT J CARDIOVAS IMAG, V29, P1177, DOI 10.1007/s10554-013-0194-x; de Ruijter W, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3083; Empana JP, 2003, EUR HEART J, V24, P1903, DOI 10.1016/j.ehj.2003.09.002; Exarchos KP, 2013, IEEE ENG MED BIO, P3889, DOI 10.1109/EMBC.2013.6610394; Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; Gehani AA, 2001, J CARDIOVASC RISK, V8, P1, DOI 10.1097/00043798-200102000-00001; GENTLEMAN JF, 1978, AM J MED SCI, V276, P173, DOI 10.1097/00000441-197809000-00004; Germano G, 2012, EUR HEART J, V33, P137; Giampaoli S, 2005, NUTR METAB CARDIOVAS, V15, P79, DOI 10.1016/j.numecd.2004.12.001; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Grundy SM, 2014, J CLIN LIPIDOL, V8, P29, DOI 10.1016/j.jacl.2013.12.005; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Jackson R, 2000, BMJ-BRIT MED J, V320, P709, DOI 10.1136/bmj.320.7236.709; Jneid Hani, 2013, Methodist Debakey Cardiovasc J, V9, P169; Kavousi M, 2014, JAMA-J AM MED ASSOC, V311, P1416, DOI 10.1001/jama.2014.2632; Kim DJ, 2008, OBESITY, V16, P853, DOI 10.1038/oby.2008.15; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Lloyd-Jones DM, 2010, CIRCULATION, V121, P1768, DOI 10.1161/CIRCULATIONAHA.109.849166; Mahmood SS, 2014, LANCET, V383, P999, DOI 10.1016/S0140-6736(13)61752-3; Martin SS, 2014, J AM COLL CARDIO; McPherson R, 2006, CAN J CARDIOL, V22, P913, DOI 10.1016/S0828-282X(06)70310-5; Mosca Lori, 2007, Circulation, V115, P1481, DOI 10.1161/CIRCULATIONAHA.107.181546; National Heart Lung and Blood Institute NHLBI, EST 10 YEAR CHD; Priester Tiffany C, 2009, J Cardiovasc Comput Tomogr, V3 Suppl 2, pS81, DOI 10.1016/j.jcct.2009.10.011; Psaty BM, 2004, J AM GERIATR SOC, V52, P1639, DOI 10.1111/j.1532-5415.2004.52455.x; Rodondi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034287; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rosengren A, 2004, EUR HEART J, V25, P663, DOI 10.1016/j.ehj.2004.02.023; Rosengren A, 2006, EUR HEART J, V27, P789, DOI 10.1093/eurheartj/ehi774; Schoenhagen P, 2006, CIRCULATION, V113, P2826, DOI 10.1161/CIRCULATIONAHA.105.585703; Sun YH, 2006, CIRC J, V70, P1602, DOI 10.1253/circj.70.1602; Tzoulaki I, 2009, JAMA-J AM MED ASSOC, V302, P2345, DOI 10.1001/jama.2009.1757; USPSTF, 2008, ANN INTERN MED, V150, P396; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wood D, 1998, ATHEROSCLEROSIS, V140, P199, DOI 10.1016/S0021-9150(98)90209-X	46	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e113044	10.1371/journal.pone.0113044	http://dx.doi.org/10.1371/journal.pone.0113044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393521	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300137
J	Park, SJ; Jo, DS; Shin, JH; Kim, ES; Jo, YK; Choi, ES; Seo, HM; Kim, SH; Hwang, JJ; Jo, DG; Koh, JY; Cho, DH				Park, So Jung; Jo, Doo Sin; Shin, Ji Hyun; Kim, Eun Sung; Jo, Yoon Kyung; Choi, Eun Sun; Seo, Hae Mi; Kim, Sung Hyun; Hwang, Jung Jin; Jo, Dong-Gyu; Koh, Jae-Young; Cho, Dong-Hyung			Suppression of Cpn10 Increases Mitochondrial Fission and Dysfunction in Neuroblastoma Cells	PLOS ONE			English	Article							DYNAMIN-RELATED PROTEIN-1; PROTEOMIC ANALYSIS; CARDIAC MYOCYTES; GTPASE ACTIVITY; DRP1; HSP10; APOPTOSIS; PHOSPHORYLATION; KINASE; FUSION	To date, several regulatory proteins involved in mitochondrial dynamics have been identified. However, the precise mechanism coordinating these complex processes remains unclear. Mitochondrial chaperones regulate mitochondrial function and structure. Chaperonin 10 (Cpn10) interacts with heat shock protein 60 (HSP60) and functions as a cochaperone. In this study, we found that down-regulation of Cpn10 highly promoted mitochondrial fragmentation in SK-N-MC and SH-SY5Y neuroblastoma cells. Both genetic and chemical inhibition of Drp1 suppressed the mitochondrial fragmentation induced by Cpn10 reduction. Reactive oxygen species (ROS) generation in 3-NP-treated cells was markedly enhanced by Cpn10 knock down. Depletion of Cpn10 synergistically increased cell death in response to 3-NP treatment. Furthermore, inhibition of Drp1 recovered Cpn10-mediated mitochondrial dysfunction in 3-NP-treated cells. Moreover, an ROS scavenger suppressed cell death mediated by Cpn10 knockdown in 3-NP-treated cells. Taken together, these results showed that down-regulation of Cpn10 increased mitochondrial fragmentation and potentiated 3-NP-mediated mitochondrial dysfunction in neuroblastoma cells.	[Park, So Jung; Jo, Doo Sin; Shin, Ji Hyun; Kim, Eun Sung; Jo, Yoon Kyung; Choi, Eun Sun; Seo, Hae Mi; Cho, Dong-Hyung] Kyung Hee Univ, Grad Sch East West Med Sci, Dept East West Med Sci, Yongin, South Korea; [Seo, Hae Mi] Kyung Hee Univ, Dept Genet Engn, Yongin, South Korea; [Kim, Sung Hyun] Kyung Hee Univ, Sch Med, Seoul, South Korea; [Hwang, Jung Jin] Univ Ulsan, Coll Med, Asan Med Ctr, Inst Innovat Canc Res,Asan Inst Life Sci, Seoul, South Korea; [Jo, Dong-Gyu] Sungkyunkwan Univ, Sch Pharm, Suwon, South Korea; [Koh, Jae-Young] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University; University of Ulsan; Asan Medical Center; Sungkyunkwan University (SKKU); University of Ulsan; Asan Medical Center	Cho, DH (corresponding author), Kyung Hee Univ, Grad Sch East West Med Sci, Dept East West Med Sci, Yongin, South Korea.	dhcho@khu.ac.kr	Koh, Jae-Young/C-9014-2011; Hwang, Jung Jin/F-3424-2014; Kim, Sung Hyun/AAI-8554-2020; Jo, Dong-Gyu/AAN-9278-2021	Koh, Jae-Young/0000-0002-4318-495X; Jo, Dong-Gyu/0000-0003-2271-1076; Kim, Sung Hyun/0000-0002-3166-9941	Korean Health 21 R&D Project and Korea-UK Collaborative Alzheimer's Disease Research Project, Ministry of Health & Welfare, Republic of Korea [A092042, A120196]	Korean Health 21 R&D Project and Korea-UK Collaborative Alzheimer's Disease Research Project, Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korean Health 21 R&D Project and Korea-UK Collaborative Alzheimer's Disease Research Project, Ministry of Health & Welfare, Republic of Korea (A092042, A120196). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cappello F, 2004, EUR J HISTOCHEM, V48, P261; Cappello F, 2003, CANCER LETT, V196, P35, DOI 10.1016/S0304-3835(03)00212-X; Cappello F, 2003, ANTICANCER RES, V23, P1325; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Cho DH, 2010, CELL MOL LIFE SCI, V67, P3435, DOI 10.1007/s00018-010-0435-2; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Chou CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049112; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Czarnecka AM, 2006, CANCER BIOL THER, V5, P714, DOI 10.4161/cbt.5.7.2975; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Dobocan MC, 2009, J CELL PHYSIOL, V219, P470, DOI 10.1002/jcp.21702; Elwi AN, 2012, INT J BIOCHEM CELL B, V44, P1366, DOI 10.1016/j.biocel.2012.05.004; Gawlowski T, 2012, J BIOL CHEM, V287, P30024, DOI 10.1074/jbc.M112.390682; Ghobrial IM, 2005, BLOOD, V105, P3722, DOI 10.1182/blood-2004-10-3999; GUPTA RS, 1995, MOL MICROBIOL, V15, P1, DOI 10.1111/j.1365-2958.1995.tb02216.x; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Kageyama Y, 2011, CURR OPIN CELL BIOL, V23, P427, DOI 10.1016/j.ceb.2011.04.009; Karbowski M, 2011, CURR OPIN CELL BIOL, V23, P476, DOI 10.1016/j.ceb.2011.05.007; Khawaja X, 2004, J NEUROSCI RES, V75, P451, DOI 10.1002/jnr.10869; Lau S, 1997, CIRCULATION, V96, P2287; Levy-Rimler G, 2001, EUR J BIOCHEM, V268, P3465, DOI 10.1046/j.1432-1327.2001.02243.x; Lin KM, 2004, FASEB J, V18, P1004, DOI 10.1096/fj.03-0348fje; Lin KM, 2001, CIRCULATION, V103, P1787, DOI 10.1161/01.CIR.103.13.1787; Liot G, 2009, CELL DEATH DIFFER, V16, P899, DOI 10.1038/cdd.2009.22; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Obashi K, 2013, EUR J NEUROSCI, V38, P2350, DOI 10.1111/ejn.12263; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Park SJ, 2014, J BIOL CHEM, V289, P2195, DOI 10.1074/jbc.M113.492587; Qi X, 2011, MOL BIOL CELL, V22, P256, DOI 10.1091/mbc.E10-06-0551; Ray PS, 2001, FASEB J, V15, P393, DOI 10.1096/fj.00-0199com; Sadacharan SK, 2001, HISTOCHEM CELL BIOL, V116, P507, DOI 10.1007/s00418-001-0344-4; Shan YX, 2003, J MOL CELL CARDIOL, V35, P1135, DOI 10.1016/S0022-2828(03)00229-3; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Solesio ME, 2013, BRIT J PHARMACOL, V168, P63, DOI 10.1111/j.1476-5381.2012.01994.x; Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tamura Y, 2011, CELL, V145, DOI 10.1016/j.cell.2011.06.018; Tanaka A, 2008, MOL CELL, V29, P409, DOI 10.1016/j.molcel.2008.02.005; Wang XL, 2012, J NEUROCHEM, V121, P830, DOI 10.1111/j.1471-4159.2012.07734.x; Wilson TJ, 2013, NEUROBIOL DIS, V51, P13, DOI 10.1016/j.nbd.2012.01.009; Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753; Yu TZ, 2011, ANTIOXID REDOX SIGN, V14, P425, DOI 10.1089/ars.2010.3284	49	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112130	10.1371/journal.pone.0112130	http://dx.doi.org/10.1371/journal.pone.0112130			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390895	Green Submitted, Green Published, gold			2022-12-27	WOS:000349144400057
J	Vasconcelos, EJR; Nunes, VS; da Silva, MS; Segatto, M; Myler, PJ; Cano, MIN				Vasconcelos, Elton J. R.; Nunes, Vinicius S.; da Silva, Marcelo S.; Segatto, Marcela; Myler, Peter J.; Cano, Maria Isabel N.			The Putative Leishmania Telomerase RNA (LeishTER) Undergoes Trans-Splicing and Contains a Conserved Template Sequence	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE; TETRAHYMENA-TELOMERASE; TRYPANOSOMA-BRUCEI; CATALYTIC SUBUNIT; STRUCTURE PREDICTION; SECONDARY STRUCTURE; YEAST TELOMERASE; BIOCHEMICAL-PROPERTIES; COMPARATIVE GENOMICS; PARASITIC PROTOZOA	Telomerase RNAs (TERs) are highly divergent between species, varying in size and sequence composition. Here, we identify a candidate for the telomerase RNA component of Leishmania genus, which includes species that cause leishmaniasis, a neglected tropical disease. Merging a thorough computational screening combined with RNA-seq evidence, we mapped a non-coding RNA gene localized in a syntenic locus on chromosome 25 of five Leishmania species that shares partial synteny with both Trypanosoma brucei TER locus and a putative TER candidate-containing locus of Crithidia fasciculata. Using target-driven molecular biology approaches, we detected a similar to 2,100 nt transcript (LeishTER) that contains a 5' spliced leader (SL) cap, a putative 3' polyA tail and a predicted C/D box snoRNA domain. LeishTER is expressed at similar levels in the logarithmic and stationary growth phases of promastigote forms. A 5'SL capped LeishTER co-immunoprecipitated and co-localized with the telomerase protein component (TERT) in a cell cycle-dependent manner. Prediction of its secondary structure strongly suggests the existence of a bona fide single-stranded template sequence and a conserved C[U/C]GUCA motif-containing helix II, representing the template boundary element. This study paves the way for further investigations on the biogenesis of parasite TERT ribonucleoproteins (RNPs) and its role in parasite telomere biology.	[Vasconcelos, Elton J. R.; Myler, Peter J.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Nunes, Vinicius S.; da Silva, Marcelo S.; Segatto, Marcela; Cano, Maria Isabel N.] Univ Estadual Paulista, Dept Genet Inst Biociencias, Botucatu, SP, Brazil; [da Silva, Marcelo S.] Univ Estadual Campinas UNICAMP, Campinas, SP, Brazil; [Myler, Peter J.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Myler, Peter J.] Univ Washington, Dept Biomed Informat & Med Educ, Seattle, WA 98195 USA	Center for Infectious Disease Research; Universidade Estadual de Campinas; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Myler, PJ (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	peter.myler@seattlebiomed.org; micano@ibb.unesp.br	Vasconcelos, Elton/O-5593-2014; Nunes, Vinicius/W-7200-2019; Cano, Maria Isabel/A-4020-2008; Cano, Maria Isabel/M-7691-2019; da Silva, Marcelo Santos/N-4145-2014; Myler, Peter John/AAR-9535-2021	Vasconcelos, Elton/0000-0001-5130-6622; Nunes, Vinicius/0000-0002-1400-0680; Cano, Maria Isabel/0000-0001-9798-6627; da Silva, Marcelo Santos/0000-0003-4203-9299; Reis, AlessanRSS/0000-0001-8486-7469	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP, Brazil [2012/50263-5]; National Institute of Allergy and Infectious Diseases PHS Grant [R01 AI103858]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103858] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Institute of Allergy and Infectious Diseases PHS Grant; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP, Brazil to MINC [GRANT 2012/50263-5]. National Institute of Allergy and Infectious Diseases PHS Grant to PJM [GRANT R01 AI103858]. VSN, MS and MSS received post-doctoral and doctoral fellowships, respectively, from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP. EJRV is a post-doctoral fellow from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq, Brazil [PDE 202223/2012-4]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ambit A, 2011, EUKARYOT CELL, V10, P1429, DOI 10.1128/EC.05118-11; Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; AUTEXIER C, 1995, GENE DEV, V9, P2227, DOI 10.1101/gad.9.18.2227; Bernhart SH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-474; Bianchi A, 2008, MOL CELL, V31, P153, DOI 10.1016/j.molcel.2008.06.013; BLACKBURN EH, 1984, CELL, V36, P447, DOI 10.1016/0092-8674(84)90238-1; Cano MIN, 1999, P NATL ACAD SCI USA, V96, P3616, DOI 10.1073/pnas.96.7.3616; Cano MIN, 2001, TRENDS PARASITOL, V17, P425, DOI 10.1016/S1471-4922(01)02014-1; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chakrabarti K, 2007, RNA, V13, P1923, DOI 10.1261/rna.751807; Chapon C, 1997, RNA, V3, P1337; Chen JL, 2004, P NATL ACAD SCI USA, V101, P14683, DOI 10.1073/pnas.0406204101; Chiurillo MA, 2002, MEM I OSWALDO CRUZ, V97, P343, DOI 10.1590/S0074-02762002000300011; Chiurillo MA, 2000, EXP PARASITOL, V94, P248, DOI 10.1006/expr.2000.4499; Conte FF, 2005, INT J PARASITOL, V35, P1435, DOI 10.1016/j.ijpara.2005.05.011; Counter CM, 1997, P NATL ACAD SCI USA, V94, P9202, DOI 10.1073/pnas.94.17.9202; Cros MJ, 2011, RNA, V17, P1947, DOI 10.1261/rna.2844911; Darzacq X, 2002, EMBO J, V21, P2746, DOI 10.1093/emboj/21.11.2746; De Rijk P, 2003, BIOINFORMATICS, V19, P299, DOI 10.1093/bioinformatics/19.2.299; Egan ED, 2012, RNA, V18, P1747, DOI 10.1261/rna.034629.112; Egan ED, 2010, MOL CELL BIOL, V30, P2775, DOI 10.1128/MCB.00151-10; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; FERNANDES AP, 1993, P NATL ACAD SCI USA, V90, P11608, DOI 10.1073/pnas.90.24.11608; Fu D, 2003, MOL CELL, V11, P1361, DOI 10.1016/S1097-2765(03)00196-5; Fu GL, 1998, NUCLEIC ACIDS RES, V26, P2161, DOI 10.1093/nar/26.9.2161; Giardini MA, 2011, EXP PARASITOL, V127, P243, DOI 10.1016/j.exppara.2010.08.001; Giardini MA, 2006, PARASITOL RES, V98, P447, DOI 10.1007/s00436-005-0036-4; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Gupta SK, 2013, FEBS LETT, V587, P1399, DOI 10.1016/j.febslet.2013.03.017; Harmanci AO, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-108; HUANG J, 1991, MOL CELL BIOL, V11, P3180, DOI 10.1128/MCB.11.6.3180; Hukezalie KR, 2013, FEBS J, V280, P3194, DOI 10.1111/febs.12272; Jackson AP, 2010, MOL BIOL EVOL, V27, P33, DOI 10.1093/molbev/msp214; Kachouri-Lafond R, 2009, FEBS LETT, V583, P3605, DOI 10.1016/j.febslet.2009.10.034; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; Kolev NG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001090; Lai CK, 2002, GENE DEV, V16, P415, DOI 10.1101/gad.962602; Lai CK, 2001, MOL CELL BIOL, V21, P990, DOI 10.1128/MCB.21.4.990-1000.2001; Laurentino EC, 2004, MOL BIOCHEM PARASIT, V137, P81, DOI 10.1016/j.molbiopara.2004.05.001; Leonardi J, 2008, NAT STRUCT MOL BIOL, V15, P26, DOI 10.1038/nsmb1343; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Longhese MP, 2010, EMBO J, V29, P2864, DOI 10.1038/emboj.2010.165; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; MUHICH ML, 1988, MOL CELL BIOL, V8, P3837, DOI 10.1128/MCB.8.9.3837; Munoz DP, 2004, NUCLEIC ACIDS RES, V32, P5214, DOI 10.1093/nar/gkh864; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Noel JF, 2012, NUCLEIC ACIDS RES, V40, P5625, DOI 10.1093/nar/gks200; Proctor JR, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt174; Rastrojo A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-223; Requena JM, 2011, FRONT BIOSCI-LANDMRK, V16, P2069, DOI 10.2741/3840; Richards RJ, 2006, NUCLEIC ACIDS RES, V34, P816, DOI 10.1093/nar/gkj481; Rivas E, 1999, J MOL BIOL, V285, P2053, DOI 10.1006/jmbi.1998.2436; ROMERO DP, 1991, CELL, V67, P343, DOI 10.1016/0092-8674(91)90186-3; Sandhu R, 2013, CELL RES, V23, P537, DOI 10.1038/cr.2013.35; SOLARI AJ, 1980, CHROMOSOMA, V78, P239, DOI 10.1007/BF00328395; Sperschneider J, 2008, RNA, V14, P630, DOI 10.1261/rna.968808; Sykorova E, 2009, BIOL CELL, V101, P375, DOI 10.1042/BC20080205; Theimer CA, 2006, CURR OPIN STRUC BIOL, V16, P307, DOI 10.1016/j.sbi.2006.05.005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vasconcelos EJR, 2012, MOL BIOCHEM PARASIT, V183, P140, DOI 10.1016/j.molbiopara.2012.02.009; VICKERMAN K, 1970, J CELL SCI, V6, P365; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; Wilusz JE, 2010, RNA, V16, P259, DOI 10.1261/rna.1907510; Xia JQ, 2000, MOL CELL BIOL, V20, P5196, DOI 10.1128/MCB.20.14.5196-5207.2000; YU GL, 1990, NATURE, V344, P126, DOI 10.1038/344126a0; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	70	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112061	10.1371/journal.pone.0112061	http://dx.doi.org/10.1371/journal.pone.0112061			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391020	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400051
J	Cocchiola, R; Grillo, C; Altieri, F; Chichiarelli, S; Turano, C; Eufemi, M				Cocchiola, Rossana; Grillo, Caterina; Altieri, Fabio; Chichiarelli, Silvia; Turano, Carlo; Eufemi, Margherita			Upregulation of TPX2 by STAT3: Identification of a Novel STAT3 Binding Site	PLOS ONE			English	Article							THERAPEUTIC TARGET; GENE; PROTEIN; GROWTH; CANCER	TPX2, a protein involved in mitosis, is considered a good marker for actively proliferating tissues, highly expressed in a number of cancer cells. We show the presence of high-affinity binding site for STAT3 in the 5'-flanking region of the Tpx2 gene, which is in vivo bound by activated STAT3. A specific STAT3 peptide inhibitor represses the expression of the Tpx2 gene and inhibits the binding of STAT3 to its consensus sequence in human cell lines where STAT3 is activated. These results indicate that activated STAT3 contributes to the over-expression of Tpx2 through the binding to an enhancer site.	[Cocchiola, Rossana; Grillo, Caterina; Altieri, Fabio; Chichiarelli, Silvia; Turano, Carlo; Eufemi, Margherita] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy; [Cocchiola, Rossana; Grillo, Caterina; Altieri, Fabio; Chichiarelli, Silvia; Turano, Carlo; Eufemi, Margherita] Fdn Cenci Bolognetti, Ist Pasteur, I-00185 Rome, Italy	Sapienza University Rome; Fondazione Cenci Bolognetti	Eufemi, M (corresponding author), Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy.	margherita.eufemi@uniroma1.it	Cocchiola, Rossana/AAA-1702-2020; Chichiarelli, Silvia/F-1226-2011; Grillo, Caterina Maria/ABD-3404-2021; Altieri, Fabio/D-2790-2009	Altieri, Fabio/0000-0002-6546-2738; Cocchiola, Rossana/0000-0002-2764-5445; Chichiarelli, Silvia/0000-0002-5682-0353	Istituto Pasteur-Fondazione Cenci Bolognetti-Rome; BCC Cassa Rurale ed Artigiana di Paliano	Istituto Pasteur-Fondazione Cenci Bolognetti-Rome(Istituto Pasteur Italia Fondazione Cenci Bolognetti); BCC Cassa Rurale ed Artigiana di Paliano	Istituto Pasteur-Fondazione Cenci Bolognetti-Rome; BCC Cassa Rurale ed Artigiana di Paliano. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adach A, 2009, METHODS MOL BIOL, V512, P265, DOI 10.1007/978-1-60327-530-9_14; Agostinelli E, 2006, BBA-MOL CELL RES, V1763, P1040, DOI 10.1016/j.bbamcr.2006.07.014; Aguirre-Portoles C, 2012, CANCER RES, V72, P1518, DOI 10.1158/0008-5472.CAN-11-1971; Chang HP, 2012, ONCOL REP, V27, P1353, DOI 10.3892/or.2012.1668; Chichiarelli S, 2002, ANAL BIOCHEM, V302, P224, DOI 10.1006/abio.2001.5543; Eufemi M, 2004, BIOCHEM BIOPH RES CO, V323, P1306, DOI 10.1016/j.bbrc.2004.09.009; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; LEMAIRE MA, 1991, P NATL ACAD SCI USA, V88, P1982, DOI 10.1073/pnas.88.5.1982; Meyer WKH, 1997, J BIOL CHEM, V272, P31821, DOI 10.1074/jbc.272.50.31821; Motti ML, 2005, CARCINOGENESIS, V26, P1021, DOI 10.1093/carcin/bgi050; Neumayer G, 2014, CELL MOL LIFE SCI, V71, P3027, DOI 10.1007/s00018-014-1582-7; Pedranzini L, 2004, J CLIN INVEST, V114, P619, DOI 10.1172/JCI200422800; Perez de Castro Ignacio, 2012, Genes Cancer, V3, P721, DOI 10.1177/1947601912473306; Ramakrishna M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009983; Rojas M, 1998, NAT BIOTECHNOL, V16, P370, DOI 10.1038/nbt0498-370; Satow R, 2010, CLIN CANCER RES, V16, P2518, DOI 10.1158/1078-0432.CCR-09-2214; Sellier H., 2013, JAK STAT, V2; Turkson J, 2001, J BIOL CHEM, V276, P45443, DOI 10.1074/jbc.M107527200; Vainio P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039801; Warner SL, 2009, CLIN CANCER RES, V15, P6519, DOI 10.1158/1078-0432.CCR-09-0077; Wei P, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-313; Wittmann T, 1998, J CELL BIOL, V143, P673, DOI 10.1083/jcb.143.3.673; Yu CR, 1999, J IMMUNOL, V162, P2785; Zhang LJ, 2008, TOXICOLOGY, V252, P49, DOI 10.1016/j.tox.2008.07.059	24	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113096	10.1371/journal.pone.0113096	http://dx.doi.org/10.1371/journal.pone.0113096			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401333	Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700110
J	Easter, SL; Mitchell, EH; Baxley, SE; Desmond, R; Frost, AR; Serra, R				Easter, Stephanie L.; Mitchell, Elizabeth H.; Baxley, Sarah E.; Desmond, Renee; Frost, Andra R.; Serra, Rosa			Wnt5a Suppresses Tumor Formation and Redirects Tumor Phenotype in MMTV-Wnt1 Tumors	PLOS ONE			English	Article							MAMMARY-GLAND DEVELOPMENT; BREAST-CANCER; STEM-CELLS; SIGNALING PATHWAY; SELF-RENEWAL; P-CADHERIN; TGF-BETA; EXPRESSION; PROTEIN; WNT-5A	Wnt5a is a non-canonical signaling Wnt that has been implicated in tumor suppression. We previously showed that loss of Wnt5a in MMTV-PyVmT tumors resulted in a switch in tumor phenotype resulting in tumors with increased basal phenotype and high Wnt/beta-catenin signaling. The object of this study was to test the hypothesis that Wnt5a can act to inhibit tumors formed by activation of Wnt/beta-catenin signaling. To this end, we characterized tumor and non-tumor mammary tissue from MMTV-Wnt1 and double transgenic MMTV-Wnt1; MMTV-Wnt5a mice. Wnt5a containing mice demonstrated fewer tumors with increased latency when compared to MMTV-Wnt1 controls. Expression of markers for basal-like tumors was down-regulated in the tumors that formed in the presence of Wnt5a indicating a phenotypic switch. Reduced canonical Wnt signaling was detected in double transgenic tumors as a decrease in active beta-catenin protein and a decrease in Axin2 mRNA transcript levels. In non-tumor tissues, over-expression of Wnt5a in MMTV-Wnt1 mammary glands resulted in attenuation of phenotypes normally observed in MMTV-Wnt1 glands including hyperbranching and increased progenitor and basal cell populations. Even though Wnt5a could antagonize Wnt/beta-catenin signaling in primary mammary epithelial cells in culture, reduced Wnt/beta-catenin signaling was not detected in non-tumor MMTV-Wnt1; Wnt5a tissue in vivo. The data demonstrate that Wnt5a suppresses tumor formation and promotes a phenotypic shift in MMTV-Wnt1 tumors.	[Easter, Stephanie L.; Mitchell, Elizabeth H.; Baxley, Sarah E.; Serra, Rosa] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Desmond, Renee] Univ Alabama Birmingham, Ctr Comprehens Canc, Dept Med, Biostat & Bioinformat Unit, Birmingham, AL 35294 USA; [Frost, Andra R.] Univ Alabama Birmingham, Dept Pathol, Div Anat Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Serra, R (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA.	rserra@uab.edu			National Cancer Institute [R01 CA126942]; UAB Comprehensive Cancer Center [P30 CA13148]; NATIONAL CANCER INSTITUTE [R01CA126942, P30CA013148] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UAB Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	RS was supported by the National Cancer Institute, R01 CA126942. Statistical work was supported by the UAB Comprehensive Cancer Center (P30 CA13148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Baxley SE, 2011, BIOL REPROD, V85, P907, DOI 10.1095/biolreprod.111.091645; Benhaj K, 2006, ONCOL REP, V15, P701; Boras-Granic K, 2006, DEV BIOL, V295, P219, DOI 10.1016/j.ydbio.2006.03.030; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Bu W, 2011, ONCOGENE, V30, P4399, DOI 10.1038/onc.2011.147; Byun JY, 2006, MOL VIS, V12, P949; Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347; DANIEL CW, 1995, DEV BIOL, V169, P511, DOI 10.1006/dbio.1995.1165; Dejmek J, 2005, CLIN CANCER RES, V11, P520; Dey D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005329; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; El-Rehim DMA, 2004, J PATHOL, V203, P661, DOI 10.1002/path.1559; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Ghebeh H, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-289; GUELSTEIN VI, 1988, INT J CANCER, V42, P147, DOI 10.1002/ijc.2910420202; Gusterson BA, 2005, BREAST CANCER RES, V7, P143, DOI 10.1186/bcr1041; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Jansson M, 2001, J CELL SCI, V114, P2043; Jonsson M, 2002, CANCER RES, V62, P409; Katoh M, 2005, ONCOL REP, V14, P1583; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Kikuchi A, 2006, EXP MOL MED, V38, P1, DOI 10.1038/emm.2006.1; Kim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019310; Kremenevskaja N, 2005, ONCOGENE, V24, P2144, DOI 10.1038/sj.onc.1208370; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Leris ACA, 2005, ANTICANCER RES, V25, P731; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Many AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101800; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Olson DJ, 1997, CELL GROWTH DIFFER, V8, P417; Olson DJ, 1998, EXP CELL RES, V241, P134, DOI 10.1006/excr.1998.4030; PALACIOS J, 1995, AM J PATHOL, V146, P605; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; RASBRIDGE SA, 1993, J PATHOL, V169, P245, DOI 10.1002/path.1711690211; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250; Roarty K, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2244; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Teissedre B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004537; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Trifa F, 2013, TUMOR BIOL, V34, P1625, DOI 10.1007/s13277-013-0694-2; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Westfall TA, 2003, J CELL BIOL, V162, P889, DOI 10.1083/jcb.200303107; WETZELS RHW, 1989, AM J PATHOL, V134, P571	59	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113247	10.1371/journal.pone.0113247	http://dx.doi.org/10.1371/journal.pone.0113247			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401739	Green Published, Green Submitted, gold			2022-12-27	WOS:000345158700126
J	Yan, X; Huang, JJ; Zhou, Z; Chen, J; Liang, Y				Yan, Xu; Huang, Jun-Jie; Zhou, Zheng; Chen, Jie; Liang, Yi			How Does Domain Replacement Affect Fibril Formation of the Rabbit/Human Prion Proteins	PLOS ONE			English	Article							LENGTH RECOMBINANT PRP; SCRAPIE PRION; RESISTANT; INFECTION; RABBITS; NMR; FIBRILLIZATION; AGGREGATION; ENVIRONMENT; MECHANISMS	Background: It is known that in vivo human prion protein (PrP) have the tendency to form fibril deposits and are associated with infectious fatal prion diseases, while the rabbit PrP does not readily form fibrils and is unlikely to cause prion diseases. Although we have previously demonstrated that amyloid fibrils formed by the rabbit PrP and the human PrP have different secondary structures and macromolecular crowding has different effects on fibril formation of the rabbit/human PrPs, we do not know which domains of PrPs cause such differences. In this study, we have constructed two PrP chimeras, rabbit chimera and human chimera, and investigated how domain replacement affects fibril formation of the rabbit/human PrPs. Methodology/Principal Findings: As revealed by thioflavin T binding assays and Sarkosyl-soluble SDS-PAGE, the presence of a strong crowding agent dramatically promotes fibril formation of both chimeras. As evidenced by circular dichroism, Fourier transform infrared spectroscopy, and proteinase K digestion assays, amyloid fibrils formed by human chimera have secondary structures and proteinase K-resistant features similar to those formed by the human PrP. However, amyloid fibrils formed by rabbit chimera have proteinase K-resistant features and secondary structures in crowded physiological environments different from those formed by the rabbit PrP, and secondary structures in dilute solutions similar to the rabbit PrP. The results from transmission electron microscopy show that macromolecular crowding caused human chimera but not rabbit chimera to form short fibrils and non-fibrillar particles. Conclusions/Significance: We demonstrate for the first time that the domains beyond PrP-H2H3 (beta-strand 1, alpha-helix 1, and beta-strand 2) have a remarkable effect on fibrillization of the rabbit PrP but almost no effect on the human PrP. Our findings can help to explain why amyloid fibrils formed by the rabbit PrP and the human PrP have different secondary structures and why macromolecular crowding has different effects on fibrillization of PrPs from different species.	[Yan, Xu; Huang, Jun-Jie; Zhou, Zheng; Chen, Jie; Liang, Yi] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China	Wuhan University	Liang, Y (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	liangyi@whu.edu.cn	Liang, Yi/V-1396-2017; Zhou, Zheng/AAK-2669-2021	Liang, Yi/0000-0002-7349-8300; Zhou, Zheng/0000-0002-3124-6041	National Key Basic Research Foundation of China [2013CB910702, 2012CB911003]; National Natural Science Foundation of China [31370774, 31170744]; Fundamental Research Funds for the Central Universities of China [1104006]	National Key Basic Research Foundation of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This study was supported by National Key Basic Research Foundation of China (http://www.most.gov.cn/, Grant nos. 2013CB910702 and 2012CB911003, YL), National Natural Science Foundation of China (http://www.nsfc.gov.cn/, Grant nos. 31370774 and 31170744, YL), and Fundamental Research Funds for the Central Universities of China (http://www.moe.edu.cn/, Grant no. 1104006, YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrover M, 2010, J BIOL CHEM, V285, P21004, DOI 10.1074/jbc.M110.111815; Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; BARLOW RM, 1976, RES VET SCI, V21, P110, DOI 10.1016/S0034-5288(18)33406-4; Baskakov IV, 2004, PROTEIN SCI, V13, P586, DOI 10.1110/ps.03457204; Bellotti V, 2008, CURR OPIN STRUC BIOL, V18, P771, DOI 10.1016/j.sbi.2008.10.001; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Chakroun N, 2010, FASEB J, V24, P3222, DOI 10.1096/fj.09-153924; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Chianini F, 2012, P NATL ACAD SCI USA, V109, P5080, DOI 10.1073/pnas.1120076109; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Fernandez-Funez P, 2010, J BIOL CHEM, V285, P36897, DOI 10.1074/jbc.M110.174391; Garcia FL, 2000, P NATL ACAD SCI USA, V97, P8334, DOI 10.1073/pnas.97.15.8334; Hill AF, 1999, J GEN VIROL, V80, P11, DOI 10.1099/0022-1317-80-1-11; Jiao M, 2010, BIOPHYS J, V99, P914, DOI 10.1016/j.bpj.2010.05.013; Khan MQ, 2010, P NATL ACAD SCI USA, V107, P19808, DOI 10.1073/pnas.1005267107; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; Kirby L, 2003, J GEN VIROL, V84, P1013, DOI 10.1099/vir.0.18903-0; Ma Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036288; Makarava N, 2012, J NEUROSCI, V32, P7345, DOI 10.1523/JNEUROSCI.6351-11.2012; Makarava Natallia, 2008, V459, P131, DOI 10.1007/978-1-59745-234-2_10; Marijanovic Z, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000426; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Meng SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038903; Mo ZY, 2009, J BIOL CHEM, V284, P34648, DOI 10.1074/jbc.M109.058883; Morales R, 2012, NAT PROTOC, V7, P1397, DOI 10.1038/nprot.2012.067; Nisbet RM, 2010, J VIROL, V84, P6678, DOI 10.1128/JVI.02709-09; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Smirnovas V, 2009, J BIOL CHEM, V284, P24233, DOI 10.1074/jbc.M109.036558; Soto C, 2011, TRENDS BIOCHEM SCI, V36, P151, DOI 10.1016/j.tibs.2010.11.001; Stohr J, 2008, P NATL ACAD SCI USA, V105, P2409, DOI 10.1073/pnas.0712036105; Sweeting B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063047; Swietnicki W, 2000, BIOCHEMISTRY-US, V39, P424, DOI 10.1021/bi991967m; Tycko R, 2010, BIOCHEMISTRY-US, V49, P9488, DOI 10.1021/bi1013134; Vorberg I, 2003, J VIROL, V77, P2003, DOI 10.1128/JVI.77.3.2003-2009.2003; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wen Y, 2010, J BIOL CHEM, V285, P31682, DOI 10.1074/jbc.M110.118844; White DA, 2010, J AM CHEM SOC, V132, P5170, DOI 10.1021/ja909997e; Xu LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076657; Xu Z, 2011, J BIOL CHEM, V286, P40060, DOI 10.1074/jbc.M111.275255; Yang F, 2006, J MOL BIOL, V362, P821, DOI 10.1016/j.jmb.2006.07.059; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zhang JP, 2014, J THEOR BIOL, V342, P70, DOI 10.1016/j.jtbi.2013.10.005; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; Zhou Z, 2011, BIOPHYS J, V101, P1483, DOI 10.1016/j.bpj.2011.08.018; Zhou Z, 2009, J BIOL CHEM, V284, P30148, DOI 10.1074/jbc.M109.002832	45	5	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113238	10.1371/journal.pone.0113238	http://dx.doi.org/10.1371/journal.pone.0113238			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401497	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700124
J	Zhao, DW; Wang, LH; Li, SD; Wang, Z; Wang, L; Gao, B				Zhao, Dawei; Wang, Lianhai; Li, Shudong; Wang, Zhen; Wang, Lin; Gao, Bo			Immunization of Epidemics in Multiplex Networks	PLOS ONE			English	Article								Up to now, immunization of disease propagation has attracted great attention in both theoretical and experimental researches. However, vast majority of existing achievements are limited to the simple assumption of single layer networked population, which seems obviously inconsistent with recent development of complex network theory: each node could possess multiple roles in different topology connections. Inspired by this fact, we here propose the immunization strategies on multiplex networks, including multiplex node-based random (targeted) immunization and layer node-based random (targeted) immunization. With the theory of generating function, theoretical analysis is developed to calculate the immunization threshold, which is regarded as the most critical index for the effectiveness of addressed immunization strategies. Interestingly, both types of random immunization strategies show more efficiency in controlling disease spreading on multiplex Erdos-Renyi (ER) random networks; while targeted immunization strategies provide better protection on multiplex scale-free (SF) networks.	[Zhao, Dawei; Wang, Lianhai] Natl Supercomp Ctr Jinan, Shandong Comp Sci Ctr, Shandong Prov Key Lab Comp Network, Jinan, Peoples R China; [Li, Shudong] Shandong Inst Business & Technol, Coll Math & Informat Sci, Yantai, Shandong, Peoples R China; [Li, Shudong] Natl Univ Def Technol, Coll Comp, Changsha, Hunan, Peoples R China; [Wang, Zhen] Hong Kong Baptist Univ, Dept Phys, Kowloon Tong, Hong Kong, Peoples R China; [Wang, Zhen] Hong Kong Baptist Univ, Ctr Nonlinear Studies, Kowloon Tong, Hong Kong, Peoples R China; [Wang, Zhen] Hong Kong Baptist Univ, Beijing Hong Kong Singapore Joint Ctr Nonlinear &, Inst Computat & Theoret Studies, Kowloon Tong, Hong Kong, Peoples R China; [Wang, Lin] City Univ Hong Kong, Ctr Chaos & Complex Networks, Dept Elect Engn, Hong Kong, Hong Kong, Peoples R China; [Gao, Bo] Inner Mongolia Univ Finance & Econ, Sch Comp Informat Management, Hohhot, Peoples R China	Qilu University of Technology; Shandong Technology & Business University; National University of Defense Technology - China; Hong Kong Baptist University; Hong Kong Baptist University; Hong Kong Baptist University; City University of Hong Kong; Inner Mongolia University of Finance & Economics	Zhao, DW (corresponding author), Natl Supercomp Ctr Jinan, Shandong Comp Sci Ctr, Shandong Prov Key Lab Comp Network, Jinan, Peoples R China.	zhaodw@sdas.org; zhenwang0@gmail.com; fdlwang@gmail.com	Wang, Lin/B-4145-2013; Zhao, Dawei/ABA-4913-2020; zhao, dawei/O-2023-2013	Wang, Lin/0000-0002-5371-2138; zhao, dawei/0000-0002-1812-1316	National Natural Science Foundation of China [61202362, 61262057, 61472433]; China Postdoctoral Science Foundation [2013M542560]; Natural Science Foundation of Shandong Province [ZR2013FM025, ZR2013FQ001, ZR2011FQ030]; Shandong Academy of Sciences Youth Fund Project [2013QN007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Shandong Academy of Sciences Youth Fund Project	This paper was supported by the National Natural Science Foundation of China (No. 61202362, 61262057, 61472433; URLs http://www.nsfc.gov.cn/; L. H. W. and S. D. L. received the funding), the Project funded by China Postdoctoral Science Foundation (No. 2013M542560; URLs http://jj.chinapostdoctor.org.cn/V1/Program1/Default.aspx; L. S. D. received the funding), the Natural Science Foundation of Shandong Province (No. ZR2013FM025, ZR2013FQ001, ZR2011FQ030; URLs http://www.sdnsf.gov.cn/portal/; L. H. W. received the funding), and the Shandong Academy of Sciences Youth Fund Project (No. 2013QN007; URLs http://www.sdnsf.gov.cn/portal/; L. H. W. received the funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Battiston F, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.032804; Boccaletti S, 2014, PHYS REPORT IN PRESS; Buono C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092200; Chen YP, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.058701; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Cozzo E, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.050801; Gallos LK, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.045104; Gao C, 2013, IEEE T MOBILE COMPUT, V12, P529, DOI 10.1109/TMC.2012.29; Gao C, 2011, IEEE T PARALL DISTR, V22, P1222, DOI 10.1109/TPDS.2010.197; Gomez S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.028701; Gomez-Gardenes J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00620; Granell C, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.128701; Jin Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep04095; Karrer B, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036106; Kim JY, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.058702; Min B, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.042811; Min Byungjoon, 2013, ARXIV13072967; Nicosia V, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.058701; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Salehi M, 2014, ARXIV14054329; Wang HJ, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022801; Wang L, 2014, CHINESE SCI BULL, V59, P430, DOI 10.1007/s11434-013-0029-0; Wang L, 2013, INT J BIFURCAT CHAOS, V23, DOI 10.1142/S0218127413500958; Wang L, 2013, SCI REP-UK, V3, DOI 10.1038/srep01468; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021197; Wang LF, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.125436; Wang Z, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.052813; Watts J, 2001, PHYS REV E, V64; Yagan O, 2013, IEEE J SEL AREA COMM, V31, P1038, DOI 10.1109/JSAC.2013.130606; Zhao DW, 2014, PHYS LETT A, V378, P770, DOI 10.1016/j.physleta.2014.01.014; Zhao DW, 2014, PHYS SCRIPTA, V89, DOI 10.1088/0031-8949/89/01/015203; Zhao DW, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/896187	33	59	62	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112018	10.1371/journal.pone.0112018	http://dx.doi.org/10.1371/journal.pone.0112018			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401755	Green Submitted, gold, Green Published			2022-12-27	WOS:000345158700024
J	Buzzi, M; Guarino, A; Gatto, C; Manara, S; Dainese, L; Polvani, G; Tothova, JD				Buzzi, Marina; Guarino, Anna; Gatto, Claudio; Manara, Sabrina; Dainese, Luca; Polvani, Gianluca; Tothova, Jana D'Amato			Residual Antibiotics in Decontaminated Human Cardiovascular Tissues Intended for Transplantation and Risk of Falsely Negative Microbiological Analyses	PLOS ONE			English	Article							HEART-VALVE ALLOGRAFTS; HOMOGRAFT BANK EHB; ARTERIAL ALLOGRAFTS; BACTERIOLOGY; INFLAMMATION; INFECTION; COCKTAILS; PEPTIDES	We investigated the presence of antibiotics in cryopreserved cardiovascular tissues and cryopreservation media, after tissue decontamination with antibiotic cocktails, and the impact of antibiotic residues on standard tissue bank microbiological analyses. Sixteen cardiovascular tissues were decontaminated with bank-prepared cocktails and cryopreserved by two different tissue banks according to their standard operating procedures. Before and after decontamination, samples underwent microbiological analysis by standard tissue bank methods. Cryopreserved samples were tested again with and without the removal of antibiotic residues using a RESEP tube, after thawing. Presence of antibiotics in tissue homogenates and processing liquids was determined by a modified agar diffusion test. All cryopreserved tissue homogenates and cryopreservation media induced important inhibition zones on both Staphylococcus aureus- and Pseudomonas aeruginosa-seeded plates, immediately after thawing and at the end of the sterility test. The RESEP tube treatment markedly reduced or totally eliminated the antimicrobial activity of tested tissues and media. Based on standard tissue bank analysis, 50% of tissues were found positive for bacteria and/or fungi, before decontamination and 2 out of 16 tested samples (13%) still contained microorganisms after decontamination. After thawing, none of the 16 cryopreserved samples resulted positive with direct inoculum method. When the same samples were tested after removal of antibiotic residues, 8 out of 16 ( 50%) were contaminated. Antibiotic residues present in tissue allografts and processing liquids after decontamination may mask microbial contamination during microbiological analysis performed with standard tissue bank methods, thus resulting in false negatives.	[Buzzi, Marina; Manara, Sabrina] Azienda Osped Univ Policlin S Orsola Malpighi, Cardiovasc Tissue Bank Emilia Romagna, Bologna, Italy; [Guarino, Anna; Dainese, Luca; Polvani, Gianluca] Ctr Cardiol Monzino, Cardiovasc Tissue Bank Lombardia, Milan, Italy; [Gatto, Claudio; Tothova, Jana D'Amato] AL CHI MI A Srl, Dept Res & Dev, Ponte San Nicolo, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; IRCCS Centro Cardiologico Monzino	Tothova, JD (corresponding author), AL CHI MI A Srl, Dept Res & Dev, Ponte San Nicolo, Italy.	jtothova@alchilife.com	Tothova, Jana D'Amato/AAE-5502-2021; Buzzi, Marina/AAC-8681-2022; POLVANI, GIANLUCA/I-4656-2018; guarino, maggio1966/AAA-7256-2021	Buzzi, Marina/0000-0002-3711-5886; POLVANI, GIANLUCA/0000-0003-1055-0965; guarino, maggio1966/0000-0003-0705-6851; luca, dainese/0000-0001-8683-3457	AL.CHI.MI.A. S.r.l.	AL.CHI.MI.A. S.r.l.	AL.CHI.MI.A. S.r.l., provided support in the form of salaries for authors C. Gatto and J. D'Amato Tothova, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alexander Karen, 2006, Cell and Tissue Banking, V7, P23, DOI 10.1007/s10561-005-3393-4; [Anonymous], 1999, AM J HEALTH-SYST PH, V56, P1839; [Anonymous], EUROPEAN PHARMACOPOE, P175; Brogden NK, 2012, SKIN PHARMACOL PHYS, V25, P167, DOI 10.1159/000337927; Choi KY, 2012, J INNATE IMMUN, V4, P361, DOI 10.1159/000336630; de By TMMH, 2012, HEART LUNG VESSEL, V4, P251; EASTLUND T, 1995, CELL TRANSPLANT, V4, P455, DOI 10.1016/0963-6897(95)00035-V; Eastlund Ted, 2006, Cell and Tissue Banking, V7, P147, DOI 10.1007/s10561-006-0003-z; Fan YH, 2012, SOL PHYS, V277, P1, DOI 10.1007/s11207-011-9913-4; Gatto C, 2013, CELL TISSUE BANK, V14, P107, DOI 10.1007/s10561-012-9305-5; Huang LC, 2006, INVEST OPHTH VIS SCI, V47, P2369, DOI 10.1167/iovs.05-1649; Jashari R, 2013, CELL TISSUE BANK, V14, P589, DOI 10.1007/s10561-012-9359-4; Jashari R., 2007, Cell and Tissue Banking, V8, P247, DOI 10.1007/s10561-007-9040-5; Jashari R, 2011, TRANSFUS MED HEMOTH, V38, P379, DOI 10.1159/000334706; Kainer MA, 2004, NEW ENGL J MED, V350, P2564, DOI 10.1056/NEJMoa023222; Kim JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047642; Kuehnert MJ, 1998, CLIN INFECT DIS, V27, P688, DOI 10.1086/514944; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Mirelli M, 2005, TRANSPLANT P, V37, P2688, DOI 10.1016/j.transproceed.2005.06.034; Mitteregger D, 2013, J CLIN MICROBIOL, V51, P1534, DOI 10.1128/JCM.00103-13; Morris JA, 2006, J CLIN PATHOL, V59, P1, DOI 10.1136/jcp.2005.028183; Pirnay JP, 2012, CELL TISSUE BANK, V13, P287, DOI 10.1007/s10561-011-9256-2; Pitt TL, 2014, CELL TISSUE BANK, V15, P119, DOI 10.1007/s10561-013-9382-0; Saegeman V, 2008, J HOSP INFECT, V70, P278, DOI 10.1016/j.jhin.2008.07.020; Schroeter J, 2012, TRANSFUS MED HEMOTH, V39, P387, DOI 10.1159/000345812; Soo A, 2011, CELL TISSUE BANK, V12, P185, DOI 10.1007/s10561-010-9180-x; Tabaku M., 2004, Cell and Tissue Banking, V5, P261, DOI 10.1007/s10561-004-1440-1; van Kats JP, 2010, EUR J CARDIO-THORAC, V37, P163, DOI 10.1016/j.ejcts.2009.07.011; Varettas K, 2013, CELL TISSUE BANK, V14, P609, DOI 10.1007/s10561-012-9361-x; Welters MJP, 2002, HUM IMMUNOL, V63, P1019, DOI 10.1016/S0198-8859(02)00441-X; Welters MJP, 2001, CLIN EXP IMMUNOL, V124, P353, DOI 10.1046/j.1365-2249.2001.01557.x	31	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112679	10.1371/journal.pone.0112679	http://dx.doi.org/10.1371/journal.pone.0112679			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397402	Green Submitted, gold, Green Published			2022-12-27	WOS:000345558500076
J	McLean, AHC; Godfray, HCJ				McLean, Ailsa H. C.; Godfray, H. Charles J.			An Experimental Test of whether the Defensive Phenotype of an Aphid Facultative Symbiont Can Respond to Selection within a Host Lineage	PLOS ONE			English	Article							PEA APHID; SECONDARY SYMBIONTS; BACTERIAL SYMBIONTS; HORIZONTAL TRANSFER; GENETIC-VARIATION; TRADE-OFFS; RESISTANCE; PARASITOIDS; POPULATION; EVOLUTION	An experiment was conducted to test whether parasitoid resistance within a single clonal line of pea aphid (Acyrthosiphon pisum) might increase after exposure to the parasitoid wasp Aphidius ervi. Any change in resistance was expected to occur through an increase in the density of protective symbiotic bacteria rather than genetic change within the aphid or the bacterial symbiont. Six aphid lineages were exposed to high parasitoid attack rates over nine generations, each line being propagated from individuals that had survived attack; a further six lineages were maintained without parasitoids as a control. At the end of the experiment the strength of resistance of aphids from treatment and control lines were compared. No differences in resistance were found.	[McLean, Ailsa H. C.; Godfray, H. Charles J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	McLean, AHC (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	ailsa.mclean@zoo.ox.ac.uk			UK Natural Environment Research Council [NE/G017638/1]; University of Oxford; Natural Environment Research Council [NE/G017638/1] Funding Source: researchfish; NERC [NE/G017638/1] Funding Source: UKRI	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of Oxford; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was partially funded by a UK Natural Environment Research Council (http://www.nerc.ac.uk/) grant NE/G017638/1 to HCJG. AHCM was funded by the University of Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates Douglas, 2014, LME4 LINEAR MIXED EF; Bilodeau E, 2013, EVOL ECOL, V27, P165, DOI 10.1007/s10682-012-9577-z; BOOTS M, 1993, FUNCT ECOL, V7, P528, DOI 10.2307/2390128; Degnan PH, 2008, APPL ENVIRON MICROB, V74, P6782, DOI 10.1128/AEM.01285-08; Degnan PH, 2008, MOL ECOL, V17, P916, DOI 10.1111/j.1365-294X.2007.03616.x; Degnan PH, 2009, P NATL ACAD SCI USA, V106, P9063, DOI 10.1073/pnas.0900194106; Dion E, 2011, J EVOLUTION BIOL, V24, P741, DOI 10.1111/j.1420-9101.2010.02207.x; Ferrari J, 2008, EVOLUTION, V62, P2508, DOI 10.1111/j.1558-5646.2008.00468.x; Ferrari J, 2012, EVOLUTION, V66, P375, DOI 10.1111/j.1558-5646.2011.01436.x; Fox J., 2019, R COMPANION APPL REG, V.; Gehrer L, 2012, BIOL LETTERS, V8, P613, DOI 10.1098/rsbl.2012.0144; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Henry LM, 2008, EVOLUTION, V62, P689, DOI 10.1111/j.1558-5646.2007.00316.x; Henry LM, 2013, CURR BIOL, V23, P1713, DOI 10.1016/j.cub.2013.07.029; HENTER HJ, 1995, EVOLUTION, V49, P439, DOI 10.1111/j.1558-5646.1995.tb02276.x; Hufbauer RA, 2001, ECOLOGY, V82, P717, DOI 10.1890/0012-9658(2001)082[0717:PAPIHP]2.0.CO;2; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; Laughton AM, 2011, J INSECT PHYSIOL, V57, P830, DOI 10.1016/j.jinsphys.2011.03.015; Martinez AJ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-127; McLean AHC, 2011, P ROY SOC B-BIOL SCI, V278, P760, DOI 10.1098/rspb.2010.1654; Moran NA, 2005, APPL ENVIRON MICROB, V71, P8802, DOI 10.1128/AEM.71.12.8802-8810.2005; Moran NA, 2006, P NATL ACAD SCI USA, V103, P12803, DOI 10.1073/pnas.0605772103; Oliver KM, 2006, P ROY SOC B-BIOL SCI, V273, P1273, DOI 10.1098/rspb.2005.3436; Oliver KM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-11; Oliver KM, 2009, SCIENCE, V325, P992, DOI 10.1126/science.1174463; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Parker BJ, 2014, EVOLUTION, V68, P2421, DOI 10.1111/evo.12418; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rouchet R, 2012, J EVOLUTION BIOL, V25, P2369, DOI 10.1111/j.1420-9101.2012.02608.x; Russell JA, 2005, APPL ENVIRON MICROB, V71, P7987, DOI 10.1128/AEM.71.12.7987-7994.2005; Russell JA, 2003, MOL ECOL, V12, P1061, DOI 10.1046/j.1365-294X.2003.01780.x; Russell JA, 2013, MOL ECOL, V22, P2045, DOI 10.1111/mec.12211; Sandland GJ, 2003, TRENDS PARASITOL, V19, P571, DOI 10.1016/j.pt.2003.10.006; Sandstrom J, 1996, ECOL ENTOMOL, V21, P56, DOI 10.1111/j.1365-2311.1996.tb00266.x; Sandstrom JP, 2001, MOL ECOL, V10, P217, DOI 10.1046/j.1365-294X.2001.01189.x; Schmid M, 2012, FUNCT ECOL, V26, P207, DOI 10.1111/j.1365-2435.2011.01904.x; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Siva-Jothy MT, 1998, PHYSIOL ENTOMOL, V23, P274, DOI 10.1046/j.1365-3032.1998.233090.x; Vorburger C, 2009, EVOLUTION, V63, P1439, DOI 10.1111/j.1558-5646.2009.00660.x; Weisser WW, 1999, P ROY SOC B-BIOL SCI, V266, P1175, DOI 10.1098/rspb.1999.0760; Weldon SR, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2103	44	2	2	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e111601	10.1371/journal.pone.0111601	http://dx.doi.org/10.1371/journal.pone.0111601			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396733	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558500020
J	Schoepf, V; McCulloch, MT; Warner, ME; Levas, SJ; Matsui, Y; Aschaffenburg, MD; Grottoli, AG				Schoepf, Verena; McCulloch, Malcolm T.; Warner, Mark E.; Levas, Stephen J.; Matsui, Yohei; Aschaffenburg, Matthew D.; Grottoli, Andrea G.			Short-Term Coral Bleaching Is Not Recorded by Skeletal Boron Isotopes	PLOS ONE			English	Article							GREAT-BARRIER-REEF; SEA-SURFACE TEMPERATURE; SCLERACTINIAN CORALS; OCEAN ACIDIFICATION; CLIMATE-CHANGE; PORITES CORALS; STYLOPHORA-PISTILLATA; EXTENSION-RATE; BIOLOGICAL CARBONATES; MONTASTREA-ANNULARIS	Coral skeletal boron isotopes have been established as a proxy for seawater pH, yet it remains unclear if and how this proxy is affected by seawater temperature. Specifically, it has never been directly tested whether coral bleaching caused by high water temperatures influences coral boron isotopes. Here we report the results from a controlled bleaching experiment conducted on the Caribbean corals Porites divaricata, Porites astreoides, and Orbicella faveolata. Stable boron (delta(11) B), carbon (delta C-13), oxygen (delta O-18) isotopes, Sr/Ca, Mg/Ca, U/Ca, and Ba/Ca ratios, as well as chlorophyll a concentrations and calcification rates were measured on coral skeletal material corresponding to the period during and immediately after the elevated temperature treatment and again after 6 weeks of recovery on the reef. We show that under these conditions, coral bleaching did not affect the boron isotopic signature in any coral species tested, despite significant changes in coral physiology. This contradicts published findings from coral cores, where significant decreases in boron isotopes were interpreted as corresponding to times of known mass bleaching events. In contrast, delta C-13 and delta O-18 exhibited major enrichment corresponding to decreases in calcification rates associated with bleaching. Sr/Ca of bleached corals did not consistently record the 1.2 degrees C difference in seawater temperature during the bleaching treatment, or alternatively show a consistent increase due to impaired photosynthesis and calcification. Mg/Ca, U/Ca, and Ba/Ca were affected by coral bleaching in some of the coral species, but the observed patterns could not be satisfactorily explained by temperature dependence or changes in coral physiology. This demonstrates that coral boron isotopes do not record short- term bleaching events, and therefore cannot be used as a proxy for past bleaching events. The robustness of coral boron isotopes to changes in coral physiology, however, suggests that reconstruction of seawater pH using boron isotopes should be uncompromised by short- term bleaching events.	[Schoepf, Verena; McCulloch, Malcolm T.] Univ Western Australia, Sch Earth & Environm, Crawley, WA, Australia; [Schoepf, Verena; McCulloch, Malcolm T.] ARC Ctr Excellence Coral Reef Studies, Crawley, WA, Australia; [Schoepf, Verena; Levas, Stephen J.; Matsui, Yohei; Grottoli, Andrea G.] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA; [Warner, Mark E.; Aschaffenburg, Matthew D.] Univ Delaware, Sch Marine Sci & Policy, Lewes, DE 19958 USA	University of Western Australia; University of Western Australia; University System of Ohio; Ohio State University; University of Delaware	Schoepf, V (corresponding author), Univ Western Australia, Sch Earth & Environm, Crawley, WA, Australia.	schoepf.4@osu.edu	Warner, Mark E/J-6241-2013; Levas, Stephen/AAA-6774-2020; Schoepf, Verena/H-5786-2014; McCulloch, Malcolm Thomas/C-3651-2009	Schoepf, Verena/0000-0002-9467-1088; Warner, Mark/0000-0003-1015-9413; McCulloch, Malcolm Thomas/0000-0003-1538-1558	U.S. National Science Foundation [0825490, 0825413]; Western Australian Premiers Fellowship; Australian Research Council Laureate Fellowship	U.S. National Science Foundation(National Science Foundation (NSF)); Western Australian Premiers Fellowship; Australian Research Council Laureate Fellowship(Australian Research Council)	This work was funded by the U.S. National Science Foundation (OCE# 0825490 to AGG and OCE# 0825413 to MEW). MTM was supported by a Western Australian Premiers Fellowship and an Australian Research Council Laureate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Horani FA, 2003, MAR BIOL, V142, P419, DOI 10.1007/s00227-002-0981-8; Alibert C, 2003, GEOCHIM COSMOCHIM AC, V67, P231, DOI 10.1016/S0016-7037(02)01055-4; Alibert C, 1997, PALEOCEANOGRAPHY, V12, P345, DOI 10.1029/97PA00318; Allemand D, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P119, DOI 10.1007/978-94-007-0114-4_9; Allison N, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000696; Allison N, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001477; Anthony KRN, 2009, FUNCT ECOL, V23, P539, DOI 10.1111/j.1365-2435.2008.01531.x; Aschaffenburg M, 2012, PHYSL RESPONSE SYMBI, P155; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; BECK JW, 1992, SCIENCE, V257, P644, DOI 10.1126/science.257.5070.644; Budd AF, 2012, ZOOL J LINN SOC-LOND, V166, P465, DOI 10.1111/j.1096-3642.2012.00855.x; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Cantin NE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088720; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Chan NCS, 2013, GLOBAL CHANGE BIOL, V19, P282, DOI 10.1111/gcb.12011; Chen TR, 2011, J ENVIRON SCI, V23, P1452, DOI 10.1016/S1001-0742(10)60606-7; CHORNESKY EA, 1987, BIOL BULL-US, V172, P161, DOI 10.2307/1541790; Cohen AL, 2002, SCIENCE, V296, P331, DOI 10.1126/science.1069330; Cohen AL, 2001, PALEOCEANOGRAPHY, V16, P20, DOI 10.1029/1999PA000478; Colombo-Pallotta MF, 2010, CORAL REEFS, DOI [10.1007/s00338-00010-00638-x, DOI 10.1007/S00338-00010-00638-X]; Comeau S, 2013, LIMNOL OCEANOGR, V58, P388, DOI 10.4319/lo.2013.58.1.0388; Connolly SR, 2012, CORAL REEFS, V31, P951, DOI 10.1007/s00338-012-0925-9; D'Olivo JP, 2013, CORAL REEFS, V32, P999, DOI 10.1007/s00338-013-1071-8; DEVILLIERS S, 1994, GEOCHIM COSMOCHIM AC, V58, P197, DOI 10.1016/0016-7037(94)90457-X; DEVILLIERS S, 1995, SCIENCE, V269, P1247, DOI 10.1126/science.269.5228.1247; Dissard D, 2012, BIOGEOSCIENCES, V9, P4589, DOI 10.5194/bg-9-4589-2012; Donner SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005712; Douville E, 2010, BIOGEOSCIENCES, V7, P2445, DOI 10.5194/bg-7-2445-2010; Edmunds PJ, 2012, GLOBAL CHANGE BIOL, V18, P2173, DOI 10.1111/j.1365-2486.2012.02695.x; Fallon SJ, 1999, EARTH PLANET SC LETT, V172, P221, DOI 10.1016/S0012-821X(99)00200-9; Fallon SJ, 2003, CORAL REEFS, V22, P389, DOI 10.1007/s00338-003-0322-5; Felis T, 2003, CORAL REEFS, V22, P328, DOI 10.1007/s00338-003-0324-3; Ferrier-Pages C, 2002, MAR ECOL PROG SER, V245, P93, DOI 10.3354/meps245093; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; FITT WK, 1993, CORAL REEFS, V12, P57, DOI 10.1007/BF00302102; Frieler K, 2013, NAT CLIM CHANGE, V3, P165, DOI 10.1038/NCLIMATE1674; Gattuso JP, 1999, AM ZOOL, V39, P160; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; GOREAU TF, 1959, BIOL BULL, V117, P239, DOI 10.2307/1538903; Grottoli AG, 2005, CHEM GEOL, V221, P225, DOI 10.1016/j.chemgeo.2005.05.004; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Grottoli AG, 2004, MAR BIOL, V145, P621, DOI 10.1007/s00227-004-1337-3; Grottoli AG, 2002, GEOCHIM COSMOCHIM AC, V66, P1955, DOI 10.1016/S0016-7037(01)00901-2; Grottoli AG, 1999, CORAL REEFS, V18, P29, DOI 10.1007/s003380050150; Grottoli AG, 2014, GLOBAL CHANGE BIOL, V20, P3823, DOI 10.1111/gcb.12658; Guerrot C, 2011, GEOSTAND GEOANAL RES, V35, P275, DOI 10.1111/j.1751-908X.2010.00073.x; Hart SR, 1996, GEOCHIM COSMOCHIM AC, V60, P3075, DOI 10.1016/0016-7037(96)00154-8; Hartmann AC, 2010, CORAL REEFS, V29, P1079, DOI 10.1007/s00338-010-0667-5; Harvey BP, 2013, ECOL EVOL, V3, P1016, DOI 10.1002/ece3.516; Hayashi E, 2013, EARTH PLANET SC LETT, V362, P198, DOI 10.1016/j.epsl.2012.11.046; Heikoop JM, 2000, GEOCHIM COSMOCHIM AC, V64, P975, DOI 10.1016/S0016-7037(99)00363-4; HEMMING NG, 1992, GEOCHIM COSMOCHIM AC, V56, P537, DOI 10.1016/0016-7037(92)90151-8; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; HOEGHGULDBERG O, 1989, J EXP MAR BIOL ECOL, V129, P279, DOI 10.1016/0022-0981(89)90109-3; Holcomb M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05207; Holcomb M, 2014, PRINCIPLES PRACTICE, P254; Holcomb M, 2014, PEERJ, V2, DOI 10.7717/peerj.375; Holcomb M, 2010, J EXP MAR BIOL ECOL, V386, P27, DOI 10.1016/j.jembe.2010.02.007; Honisch B, 2004, GEOCHIM COSMOCHIM AC, V68, P3675, DOI 10.1016/j.gca.2004.03.002; Horta-Puga G, 2012, APPL GEOCHEM, V27, P1579, DOI 10.1016/j.apgeochem.2012.05.008; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Jokiel P.L., 1978, Monographs on Oceanographic Methodology, P529; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Klochko K, 2009, GEOCHIM COSMOCHIM AC, V73, P1890, DOI 10.1016/j.gca.2009.01.002; Krief S, 2010, GEOCHIM COSMOCHIM AC, V74, P4988, DOI 10.1016/j.gca.2010.05.023; LAND LS, 1975, MAR BIOL, V33, P221, DOI 10.1007/BF00390926; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; LEA DW, 1989, NATURE, V340, P373, DOI 10.1038/340373a0; LEDER JJ, 1991, CORAL REEFS, V10, P19, DOI 10.1007/BF00301902; Levas SJ, 2012, BIOGEOCHEMISTRY PHYS, P238; Levas SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063267; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; MARSH JA, 1970, ECOLOGY, V51, P254; Marshall JF, 2002, GEOCHIM COSMOCHIM AC, V66, P3263, DOI 10.1016/S0016-7037(02)00926-2; Marubini F, 2003, P ROY SOC B-BIOL SCI, V270, P179, DOI 10.1098/rspb.2002.2212; MCCONNAUGHEY T, 1989, GEOCHIM COSMOCHIM AC, V53, P151, DOI 10.1016/0016-7037(89)90282-2; McConnaughey TA, 1997, GEOCHIM COSMOCHIM AC, V61, P611, DOI 10.1016/S0016-7037(96)00361-4; McCulloch M, 1996, EARTH PLANET SC LETT, V138, P169, DOI 10.1016/0012-821X(95)00230-A; McCulloch M, 2003, NATURE, V421, P727, DOI 10.1038/nature01361; McCulloch M, 2012, NAT CLIM CHANGE, V2, P623, DOI 10.1038/NCLIMATE1473; McCulloch M, 2012, GEOCHIM COSMOCHIM AC, V87, P21, DOI 10.1016/j.gca.2012.03.027; MCCULLOCH MT, 1994, GEOCHIM COSMOCHIM AC, V58, P2747, DOI 10.1016/0016-7037(94)90142-2; McGinley M, 2012, IMPACT ENV STRESS SY, P173; Meibom A, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016864; MIN GR, 1995, GEOCHIM COSMOCHIM AC, V59, P2025; Mitsuguchi T, 2003, CORAL REEFS, V22, P381, DOI 10.1007/s00338-003-0326-1; Mitsuguchi T, 1996, SCIENCE, V274, P961, DOI 10.1126/science.274.5289.961; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Moya A, 2006, J EXP BIOL, V209, P3413, DOI 10.1242/jeb.02382; Nakamura T, 2003, MAR ECOL PROG SER, V256, P287, DOI 10.3354/meps256287; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pelejero C, 2005, SCIENCE, V309, P2204, DOI 10.1126/science.1113692; PORTER JW, 1989, P NATL ACAD SCI USA, V86, P9342, DOI 10.1073/pnas.86.23.9342; Pretet C, 2014, CORAL REEFS, V33, P169, DOI 10.1007/s00338-013-1098-x; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reynaud S, 2004, CORAL REEFS, V23, P539, DOI 10.1007/s00338-004-0399-5; Reynaud S, 2007, GEOCHIM COSMOCHIM AC, V71, P354, DOI 10.1016/j.gca.2006.09.009; Ries JB, 2011, GEOCHIM COSMOCHIM AC, V75, P4053, DOI 10.1016/j.gca.2011.04.025; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; Rodrigues LJ, 2006, GEOCHIM COSMOCHIM AC, V70, P2781, DOI 10.1016/j.gca.2006.02.014; Rollion-Bard C, 2011, GEOCHIM COSMOCHIM AC, V75, P1003, DOI 10.1016/j.gca.2010.11.023; Schoepf V, 2013, PHYSL BIOGEOCHEMISTR, P295; Schoepf V, GEOCHIM COS IN PRESS; Schoepf V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075049; SHEN GT, 1995, GEOCHIM COSMOCHIM AC, V59, P2009, DOI 10.1016/0016-7037(95)00123-9; Sinclair DJ, 2005, EARTH PLANET SC LETT, V237, P354, DOI 10.1016/j.epsl.2005.06.039; Sinclair DJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1889, DOI 10.1016/S0016-7037(98)00112-4; Sun Y, 2005, CORAL REEFS, V24, P23, DOI 10.1007/s00338-004-0467-x; Suzuki A, 2003, CORAL REEFS, V22, P357, DOI 10.1007/s00338-003-0323-4; SWART PK, 1983, EARTH-SCI REV, V19, P51, DOI 10.1016/0012-8252(83)90076-4; Tambutte S, 2011, J EXP MAR BIOL ECOL, DOI [10.1016/j.jembe.2011.1007.1026, DOI 10.1016/J.JEMBE.2011.1007.1026]; Teneva L, 2012, CORAL REEFS, V31, P1, DOI 10.1007/s00338-011-0812-9; Trotter J, 2011, EARTH PLANET SC LETT, V303, P163, DOI 10.1016/j.epsl.2011.01.030; Tudhope AW, 1996, PALAIOS, V11, P347, DOI 10.2307/3515245; Venn A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020013; Venn AA, 2013, P NATL ACAD SCI USA, V110, P1634, DOI 10.1073/pnas.1216153110; WEBER JN, 1972, J GEOPHYS RES, V77, P463, DOI 10.1029/JC077i003p00463; Wei GJ, 2009, GEOCHIM COSMOCHIM AC, V73, P2332, DOI 10.1016/j.gca.2009.02.009; Wild C, 2011, MAR FRESHWATER RES, V62, P205, DOI 10.1071/MF10254; Wilkinson C, 2008, STATUS CORAL REEFS W; Winer BJ, 1971, STAT PRINCIPLES EXPT	127	14	14	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112011	10.1371/journal.pone.0112011	http://dx.doi.org/10.1371/journal.pone.0112011			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396422	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558500026
J	Suzuki, S; Kobuke, S; Haruyama, N; Hoshino, H; Kulkarni, AB; Nishimura, F				Suzuki, Shigeki; Kobuke, Seiji; Haruyama, Naoto; Hoshino, Hiroaki; Kulkarni, Ashok B.; Nishimura, Fusanori			Adhesive and Migratory Effects of Phosphophoryn Are Modulated by Flanking Peptides of the Integrin Binding Motif	PLOS ONE			English	Article							DENTIN SIALOPHOSPHOPROTEIN GENE; CELL ATTACHMENT; EXTRACELLULAR SEGMENT; CRYSTAL-STRUCTURE; DIVALENT-CATIONS; SIALOPROTEIN; EXPRESSION; BONE; PHOSPHOPROTEIN; PROTEINS	Phosphophoryn (PP) is generated from the proteolytic cleavage of dentin sialophosphoprotein (DSPP). Gene duplications in the ancestor dentin matrix protein-1 (DMP-1) genomic sequence created the DSPP gene in toothed animals. PP and DMP-1 are phosphorylated extracellular matrix proteins that belong to the family of small integrin-binding ligand N-linked glycoproteins (SIBLINGs). Many SIBLING members have been shown to evoke various cell responses through the integrin-binding Arg-Gly-Asp (RGD) domain; however, the RGD-dependent function of PP is not yet fully understood. We demonstrated that recombinant PP did not exhibit any obvious cell adhesion ability, whereas the simultaneously purified recombinant DMP-1 did. A cell adhesion inhibitory analysis was performed by pre-incubating human osteosarcoma MG63 cells with various PP peptides before seeding onto vitronectin. The results obtained revealed that the incorporation of more than one amino acid on both sides of the PP-RGD domain was unable to inhibit the adhesion of MG63 cells onto vitronectin. Furthermore, the inhibitory activity of a peptide containing the PP-RGD domain with an open carboxyl-terminal side (H-(463)SDESDTNSESANESGSRGDA(482)-OH) was more potent than that of a peptide containing the RGD domain with an open amino-terminal side (H-(478)SRGDASYTSDESSDDDNDSDSH(499)-OH). This phenomenon was supported by the potent cell adhesion and migration abilities of the recombinant truncated PP, which terminated with Ala(482). Furthermore, various point mutations in Ala(482) and/or Ser(483) converted recombinant PP into cell-adhesive proteins. Therefore, we concluded that the Ala(482)-Ser(483) flanking sequence, which was detected in primates and mice, was the key peptide bond that allowed the PP-RGD domain to be sequestered. The differential abilities of PP and DMP-1 to act on integrin imply that DSPP was duplicated from DMP-1 to serve as a crucial extracellular protein for tooth development rather than as an integrin-mediated signaling molecule.	[Suzuki, Shigeki; Kobuke, Seiji; Hoshino, Hiroaki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Dent Sci Hlth Promot, Hiroshima, Japan; [Haruyama, Naoto] Kyushu Univ, Fac Dent Sci, Sect Orthodont & Dentofacial Orthoped, Fukuoka 812, Japan; [Kulkarni, Ashok B.] Natl Inst Dent & Craniofacial Res, Funct Genom Sect, Lab Cell & Dev Biol, NIH, Bethesda, MD USA; [Nishimura, Fusanori] Kyushu Univ, Sect Periodontol, Div Oral Rehabil, Fac Dent Sci, Fukuoka 812, Japan	Hiroshima University; Kyushu University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Kyushu University	Suzuki, S (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Dent Sci Hlth Promot, Hiroshima, Japan.	suzukis@hiroshima-u.ac.jp	Haruyama, Naoto/D-1993-2011	Haruyama, Naoto/0000-0001-6225-5816; Suzuki, Shigeki/0000-0003-0888-4050	JSPS KAKENHI [21890158, 22792040, 3792176]; JST ASTEP [AS231Z05041F]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000664] Funding Source: NIH RePORTER	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST ASTEP; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by JSPS KAKENHI (http://www.jsps.go.jp/english/e-grants/) grant numbers 21890158, 22792040, and 3792176 and by JST ASTEP (http://www.jst.go.jp/tt/EN/univ-ip/a-step.html) grant number AS231Z05041F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvares K, 2006, DEV DYNAM, V235, P2980, DOI 10.1002/dvdy.20935; Alvares K, 2013, J BIOL CHEM, V288, P13036, DOI 10.1074/jbc.M112.389627; Bellahcene A, 2008, NAT REV CANCER, V8, P212, DOI 10.1038/nrc2345; BUTLER WT, 1995, INT J DEV BIOL, V39, P169; Christensen B, 2010, J BIOL CHEM, V285, P7929, DOI 10.1074/jbc.M109.075010; Deshpande AS, 2011, BIOMACROMOLECULES, V12, P2933, DOI 10.1021/bm2005214; Eapen A, 2013, J BIOL CHEM, V288, P8585, DOI 10.1074/jbc.M112.413997; Eapen A, 2012, J BIOL CHEM, V287, P5211, DOI 10.1074/jbc.M111.290080; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; Fisher LW, 2004, CLIN CANCER RES, V10, P8501, DOI 10.1158/1078-0432.CCR-04-1072; Fisher LW, 2003, CONNECT TISSUE RES, V44, P33, DOI 10.1080/03008200390152061; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; Gibson MP, 2013, J BIOL CHEM, V288, P7204, DOI 10.1074/jbc.M112.445775; Hansen JC, 2006, J BIOL CHEM, V281, P1853, DOI 10.1074/jbc.R500022200; HAYMAN EG, 1983, P NATL ACAD SCI-BIOL, V80, P4003, DOI 10.1073/pnas.80.13.4003; Hozumi K, 2006, J BIOL CHEM, V281, P32929, DOI 10.1074/jbc.M605708200; Jain A, 2009, CLIN CANCER RES, V15, P5199, DOI 10.1158/1078-0432.CCR-09-0783; JONSSON M, 1978, J CHROMATOGR, V157, P235, DOI 10.1016/S0021-9673(00)92338-0; Joshi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013974; Karadag A, 2005, CANCER RES, V65, P11545, DOI 10.1158/0008-5472.CAN-05-2861; McKnight DA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-299; McKnight DA, 2008, HUM MUTAT, V29, P1392, DOI 10.1002/humu.20783; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Ogbureke KUE, 2004, J DENT RES, V83, P664, DOI 10.1177/154405910408300902; Qin C, 2002, J DENT RES, V81, P392, DOI 10.1177/154405910208100607; Qin CL, 2006, J BIOL CHEM, V281, P8034, DOI 10.1074/jbc.M512964200; Qin CL, 2003, CONNECT TISSUE RES, V44, P179, DOI 10.1080/03008200390152296; Ravindran S, 2013, J BIOL CHEM, V288, P16098, DOI 10.1074/jbc.M113.450585; Ritchie HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041110; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; Sfeir C, 2011, J BIOL CHEM, V286, P20228, DOI 10.1074/jbc.M110.209528; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Stuiver I, 1996, J CELL PHYSIOL, V168, P521, DOI 10.1002/(SICI)1097-4652(199609)168:3<521::AID-JCP4>3.0.CO;2-R; Sun Y, 2010, J DENT RES, V89, P498, DOI 10.1177/0022034510363109; Suskiewicz MJ, 2011, PROTEIN SCI, V20, P1285, DOI 10.1002/pro.657; Suzuki S, 2012, ARCH ORAL BIOL, V57, P1165, DOI 10.1016/j.archoralbio.2012.03.005; Suzuki S, 2009, MATRIX BIOL, V28, P221, DOI 10.1016/j.matbio.2009.03.006; Tsuchiya S, 2011, J BONE MINER RES, V26, P220, DOI 10.1002/jbmr.202; Verdelis K, 2008, BONE, V43, P983, DOI 10.1016/j.bone.2008.08.110; von Marschall Z, 2008, J BIOL CHEM, V283, P32730, DOI 10.1074/jbc.M804283200; von Marschall Z, 2010, MATRIX BIOL, V29, P295, DOI 10.1016/j.matbio.2010.01.002; WAYNER EA, 1991, J CELL BIOL, V113, P919, DOI 10.1083/jcb.113.4.919; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yamakoshi Y, 2005, J BIOL CHEM, V280, P1552, DOI 10.1074/jbc.M409606200; Yamakoshi Y, 2008, J BIOL CHEM, V283, P14835, DOI 10.1074/jbc.M800633200; Yamakoshi Y, 2009, J ORAL BIOSCI, V51, P134, DOI 10.2330/joralbiosci.51.134; Yang RT, 2013, J BIOL CHEM, V288, P6024, DOI 10.1074/jbc.M112.382952; Yasuda Y, 2008, J ENDODONT, V34, P575, DOI 10.1016/j.joen.2008.02.018; Ye L, 2004, J BIOL CHEM, V279, P19141, DOI 10.1074/jbc.M400490200	51	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112490	10.1371/journal.pone.0112490	http://dx.doi.org/10.1371/journal.pone.0112490			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396425	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558500054
J	Santos, JRA; Holanda, RA; Frases, S; Bravim, M; Araujo, GD; Santos, PC; Costa, MC; Ribeiro, MJA; Ferreira, GF; Baltazar, LM; Miranda, AS; Oliveira, DB; Santos, CMA; Fontes, ACL; Gouveia, LF; Resende-Stoianoff, MA; Abrahao, JS; Teixeira, AL; Paixao, TA; Souza, DG; Santos, DA				Alves Santos, Julliana Ribeiro; Holanda, Rodrigo Assuncao; Frases, Susana; Bravim, Mayara; Araujo, Glauber de S.; Santos, Patricia Campi; Costa, Marliete Carvalho; Andrade Ribeiro, Maira Juliana; Ferreira, Gabriella Freitas; Baltazar, Ludmila Matos; Miranda, Aline Silva; Oliveira, Danilo Bretas; Araujo Santos, Carolina Maria; Lima Fontes, Alide Caroline; Gouveia, Ludmila Ferreira; Resende-Stoianoff, Maria Aparecida; Abrahao, Jonatas Santos; Teixeira, Antonio Lucio; Paixao, Tatiane Alves; Souza, Danielle G.; Santos, Daniel Assis			Fluconazole Alters the Polysaccharide Capsule of Cryptococcus gattii and Leads to Distinct Behaviors in Murine Cryptococcosis	PLOS ONE			English	Article							IN-VIVO; AZOLE RESISTANCE; AMPHOTERICIN-B; CANDIDA-ALBICANS; NEOFORMANS; SUSCEPTIBILITY; GENE; HETERORESISTANCE; ITRACONAZOLE; VIRULENCE	Cryptococcus gattii is an emergent human pathogen. Fluconazole is commonly used for treatment of cryptococcosis, but the emergence of less susceptible strains to this azole is a global problem and also the data regarding fluconazole-resistant cryptococcosis are scarce. We evaluate the influence of fluconazole on murine cryptococcosis and whether this azole alters the polysaccharide (PS) from cryptococcal cells. L27/01 strain of C. gattii was cultivated in high fluconazole concentrations and developed decreased drug susceptibility. This phenotype was named L27/01(F), that was less virulent than L27/01 in mice. The physical, structural and electrophoretic properties of the PS capsule of L27/01(F) were altered by fluconazole. L27/01(F) presented lower antiphagocytic properties and reduced survival inside macrophages. The L27/01(F) did not affect the central nervous system, while the effect in brain caused by L27/01 strain began after only 12 hours. Mice infected with L27/01(F) presented lower production of the pro-inflammatory cytokines, with increased cellular recruitment in the lungs and severe pulmonary disease. The behavioral alterations were affected by L27/01, but no effects were detected after infection with L27/01(F). Our results suggest that stress to fluconazole alters the capsule of C. gattii and influences the clinical manifestations of cryptococcosis.	[Alves Santos, Julliana Ribeiro; Holanda, Rodrigo Assuncao; Santos, Patricia Campi; Costa, Marliete Carvalho; Andrade Ribeiro, Maira Juliana; Ferreira, Gabriella Freitas; Baltazar, Ludmila Matos; Oliveira, Danilo Bretas; Araujo Santos, Carolina Maria; Lima Fontes, Alide Caroline; Gouveia, Ludmila Ferreira; Resende-Stoianoff, Maria Aparecida; Abrahao, Jonatas Santos; Souza, Danielle G.; Santos, Daniel Assis] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil; [Frases, Susana; Bravim, Mayara; Araujo, Glauber de S.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, BR-21941 Rio De Janeiro, Brazil; [Frases, Susana; Araujo, Glauber de S.] Inst Nacl Metrol Normalizacao & Qualidade Ind INM, Lab Biotecnol LABIO, Rio De Janeiro, Brazil; [Miranda, Aline Silva; Teixeira, Antonio Lucio] Univ Fed Minas Gerais, Fac Med, Lab Interdisciplinar Invest Med, Belo Horizonte, MG, Brazil; [Paixao, Tatiane Alves] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal do Rio de Janeiro; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Santos, DA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil.	das@ufmg.br	Teixeira, Antonio L/N-3315-2014; Ferreira, Gabriella Freitas/AAG-5267-2021; HOLANDA, RODRIGO/Q-8505-2019; Miranda, Aline Silva de/AFM-2106-2022; Freitas, Gabriella/AAD-9831-2020; Santos, Patricia/HGB-1720-2022; de Sousa Araújo, Glauber Ribeiro/AAT-5085-2021; Santos, Julliana/W-1289-2019; Abrahão, Jônatas/B-3895-2015; de Matos Baltazar, Ludmila/I-4323-2017; Frases, Susana/W-9502-2019; Costa, Marliete Carvalho/AAL-6126-2020; Paixao, Tatiane/A-2871-2013; Campi Santos, Patricia/C-3788-2018	Teixeira, Antonio L/0000-0002-9621-5422; HOLANDA, RODRIGO/0000-0002-1698-5663; Miranda, Aline Silva de/0000-0003-2811-7924; de Sousa Araújo, Glauber Ribeiro/0000-0002-5478-9006; Santos, Julliana/0000-0001-6918-1186; Abrahão, Jônatas/0000-0001-9420-1791; de Matos Baltazar, Ludmila/0000-0002-4255-3047; Frases, Susana/0000-0001-5875-9886; Costa, Marliete Carvalho/0000-0003-0381-9225; Santos, Daniel Assis/0000-0002-1108-5666; Paixao, Tatiane/0000-0001-8284-9902; Campi Santos, Patricia/0000-0003-1201-025X; Resende Stoianoff, Maria Aparecida/0000-0002-6220-1321	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Conselho Nacional de Pesquisa (CNPq); Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais (UFMG)	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais (UFMG)	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Conselho Nacional de Pesquisa (CNPq) and Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais (UFMG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar-Fuoli L, 2014, BRIT J HAEMATOL, V166, P471, DOI 10.1111/bjh.12896; Alvarado-Ramirez E, 2008, REV IBEROAM MICOL, V25, P150, DOI 10.1016/S1130-1406(08)70035-4; Santos JRA, 2012, ANTIMICROB AGENTS CH, V56, P2553, DOI 10.1128/AAC.06098-11; Araujo GD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029561; Bryan RA, 2005, EUKARYOT CELL, V4, P465, DOI 10.1128/EC.4.2.465-475.2005; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Chang YC, 1996, INFECT IMMUN, V64, P1977, DOI 10.1128/IAI.64.6.1977-1983.1996; Chen SCA, 2012, CLIN INFECT DIS, V55, P789, DOI 10.1093/cid/cis529; Chen YC, 2001, J CLIN MICROBIOL, V39, P4042, DOI 10.1128/JCM.39.11.4042-4051.2001; Chowdhary A, 2011, J MED MICROBIOL, V60, P961, DOI 10.1099/jmm.0.029025-0; Clinical and Laboratory Standards Institute, 2008, M27A3 CLIN LAB STAND; Cordero RJB, 2011, INFECT IMMUN, V79, P4990, DOI 10.1128/IAI.05789-11; Coste A, 2007, EUKARYOT CELL, V6, P1889, DOI 10.1128/EC.00151-07; Espinel-Ingroff A, 2012, ANTIMICROB AGENTS CH, V56, P5898, DOI 10.1128/AAC.01115-12; Ferreira GF, 2013, J ANTIMICROB CHEMOTH, V68, P1801, DOI 10.1093/jac/dkt114; Fohrer C, 2006, INT J ANTIMICROB AG, V27, pS25, DOI 10.1016/j.ijantimicag.2006.03.016; Frases S, 2008, EUKARYOT CELL, V7, P319, DOI 10.1128/EC.00378-07; Frases S, 2009, BIOPHYS J, V97, P937, DOI 10.1016/j.bpj.2009.04.043; Garcia-Rivera J, 2004, EUKARYOT CELL, V3, P385, DOI 10.1128/EC.3.2.385-392.2004; Gast CE, 2013, ANTIMICROB AGENTS CH, V57, P5478, DOI 10.1128/AAC.02287-12; Gullo FP, 2013, EUR J CLIN MICROBIOL, V32, P1377, DOI 10.1007/s10096-013-1915-8; Jain N, 2009, CELL MICROBIOL, V11, P1716, DOI 10.1111/j.1462-5822.2009.01384.x; Johnston SA, 2013, CELL MICROBIOL, V15, P403, DOI 10.1111/cmi.12067; JOSEPHHORNE T, 1995, ANTIMICROB AGENTS CH, V39, P1526, DOI 10.1128/AAC.39.7.1526; Khan ZU, 2009, INT J ANTIMICROB AG, V33, P559, DOI 10.1016/j.ijantimicag.2008.11.007; Lackner P, 2006, NEUROPATH APPL NEURO, V32, P177, DOI 10.1111/j.1365-2990.2006.00706.x; Ma HS, 2009, P NATL ACAD SCI USA, V106, P12980, DOI 10.1073/pnas.0902963106; Marr KA, 1998, ANTIMICROB AGENTS CH, V42, P2584, DOI 10.1128/AAC.42.10.2584; Marr KA, 2001, ANTIMICROB AGENTS CH, V45, P52, DOI 10.1128/AAC.45.1.52-59.2001; Matos CS, 2012, EUR J CLIN MICROBIOL, V31, P1647, DOI 10.1007/s10096-011-1488-3; Maxeiner JH, 2007, NAT PROTOC, V2, P105, DOI 10.1038/nprot.2007.8; Mendes FES, 2010, EUR J CLIN MICROBIOL, V29, P1525, DOI 10.1007/s10096-010-1034-8; Moyrand F, 2007, MOL MICROBIOL, V64, P771, DOI 10.1111/j.1365-2958.2007.05695.x; Ngamskulrungroj P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016076; Nimrichter L, 2007, EUKARYOT CELL, V6, P1400, DOI 10.1128/EC.00122-07; Nosanchuk JD, 1999, ANTIMICROB AGENTS CH, V43, P233, DOI 10.1093/jac/43.2.233; Pedroso V. S. P., 2010, Journal of Neuroparasitology, V1, pN100402, DOI 10.4303/jnp/N100402; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Pfaller MA, 2009, J CLIN MICROBIOL, V47, P117, DOI 10.1128/JCM.01747-08; Pedroso VSP, 2013, MYCOPATHOLOGIA, V176, P191, DOI 10.1007/s11046-013-9679-3; Rakeman JL, 2005, J CLIN MICROBIOL, V43, P3324, DOI 10.1128/JCM.43.7.3324-3333.2005; Rex JH, 1997, CLIN INFECT DIS, V24, P235, DOI 10.1093/clinids/24.2.235; Sanguinetti M, 2006, INFECT IMMUN, V74, P1352, DOI 10.1128/IAI.74.2.1352-1359.2006; Santos DA, 2010, MYCOPATHOLOGIA, V169, P247, DOI 10.1007/s11046-009-9261-1; Saracli MA, 2006, MYCOSES, V49, P124, DOI 10.1111/j.1439-0507.2006.01203.x; Selmecki A, 2008, MOL MICROBIOL, V68, P624, DOI 10.1111/j.1365-2958.2008.06176.x; Sionov E, 2013, ANTIMICROB AGENTS CH, V57, P5127, DOI 10.1128/AAC.00694-13; Sionov E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000848; Sionov E, 2009, ANTIMICROB AGENTS CH, V53, P2804, DOI 10.1128/AAC.00295-09; Smith RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088875; Souza DG, 2000, BRIT J PHARMACOL, V131, P1800, DOI 10.1038/sj.bjp.0703756; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Torres-Rodriguez JM, 2008, REV IBEROAM MICOL, V25, P27, DOI 10.1016/S1130-1406(08)70007-X; Wilder JA, 2002, AM J RESP CELL MOL, V26, P306, DOI 10.1165/ajrcmb.26.3.4479; Zaragoza O, 2008, CELL MICROBIOL, V10, P2043, DOI 10.1111/j.1462-5822.2008.01186.x	55	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112669	10.1371/journal.pone.0112669	http://dx.doi.org/10.1371/journal.pone.0112669			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392951	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300082
J	Gudro, I; Valeika, V; Sirvaityte, J				Gudro, Ilze; Valeika, Virgilijus; Sirvaityte, Justa			Short Term Preservation of Hide Using Vacuum: Influence on Properties of Hide and of Processed Leather	PLOS ONE			English	Article							CATTLE HIDES; TANNAGE	The objective of this work was to investigate vacuum influence on hide preservation time and how it affects hide structure. It was established that vacuum prolongs the storage time without hide tissue putrefaction up to 21 days when the storage temperature is 4 degrees C. The microorganisms act for all storage times, but the action is weak and has no observable influence on the quality of hide during the time period mentioned. The hide shrinkage temperature decrease is negligible, which shows that breaking of intermolecular bonds does not occur. Optical microscopy, infrared spectroscopy and differential scanning calorimetry also did not show any structural changes which can influence the quality of leather produced from such hide. The qualitative indexes of wet blue processed under laboratory conditions and of leather produced during industrial trials are presented. Indexes such as chromium compounds exhaustion, content of chromium in leather, content of soluble matter in dichloromethane, strength properties, and shrinkage temperature were determined. Properties of the leather produced from vacuumed hide under industrial conditions conformed to the requirements of shoe upper leather.	[Gudro, Ilze] Riga Tech Univ, Text Mat Technol & Design Inst, Riga, Latvia; [Valeika, Virgilijus] Kaunas Univ Technol, Dept Phys & Inorgan Chem, Kaunas, Lithuania; [Sirvaityte, Justa] Kaunas Univ Technol, Dept Polymer Chem & Technol, Kaunas, Lithuania	Riga Technical University; Kaunas University of Technology; Kaunas University of Technology	Sirvaityte, J (corresponding author), Kaunas Univ Technol, Dept Polymer Chem & Technol, Kaunas, Lithuania.	justa.sirvaityte@ktu.lt	Valeika, Virgilijus/A-5544-2008	Valeika, Virgilijus/0000-0003-4974-7626				[Anonymous], 2008, 4048 ISO; [Anonymous], 2003, 3376 EN ISO; [Anonymous], 2006, 4684 EN ISO; [Anonymous], Pat. USSR, Patent No. 767649; [Anonymous], 2008, 4044 ISO; [Anonymous], 2009, 53982 ISO; [Anonymous], 2002, 3380 ISO; Bailey DG, 2001, J AM LEATHER CHEM AS, V96, P382; Bailey DG, 1999, J AM LEATHER CHEM AS, V94, P259; Bienkewicz K., 1983, PHYS CHEM LEATHER MA; Covington T, 2009, TANNING CHEMISTRY: THE SCIENCE OF LEATHER, P1; Didato DT, 2008, J AM LEATHER CHEM AS, V103, P383; Dinc A, 1990, ACTA PHARM TURCICA, V32, P149; Golovtejeva A., 1982, LAB PRAKTIKUM TECHNO; HOPKINS WJ, 1981, J AM LEATHER CHEM AS, V76, P134; Iyappan K, 2013, ENVIRON SCI POLLUT R, V20, P6324, DOI 10.1007/s11356-013-1683-0; Kanagaraj J, 2005, J CLEAN PROD, V13, P825, DOI 10.1016/j.jclepro.2004.02.040; Kanagaraj J, 2002, J SCI IND RES INDIA, V61, P339; Kannan KC, 2010, J AM LEATHER CHEM AS, V105, P360; Kavkazov JL, 1950, VZAIMODEISTVYJE VLAG, P58; Kutianin GI, 1974, IZVESTIYA VUZ O, V17, P60; LINDNER W, 1990, INT BIODETERIOR, V26, P195, DOI 10.1016/0265-3036(90)90059-G; Liu CK, 2011, J AM LEATHER CHEM AS, V106, P76; Naghski J, 1966, J AM LEATHER CHEM AS, V61, P64; Sharma PK, 2006, HARYANA AGR U J RES, V26, P1; Sivakumar V, 2010, OZONE-SCI ENG, V32, P449, DOI 10.1080/01919512.2010.515524; Song JA, 2011, J CLEAN PROD, V19, P325, DOI 10.1016/j.jclepro.2010.10.011; Sundar VJ, 2009, DESALIN WATER TREAT, V11, P314, DOI 10.5004/dwt.2009.865; Tricys V, 2003, J SOC LEATH TECH CH, V87, P78; Valeika V, 2000, J SOC LEATH TECH CH, V84, P165; Valeika V, 2013, J SOC LEATH TECH CH, V97, P101; Valeika V, 2010, MATER SCI-MEDZG, V16, P330; Vankar PS, 2009, DESALINATION, V249, P158, DOI 10.1016/j.desal.2008.08.011; Vankar PS, 2009, J HAZARD MATER, V163, P207, DOI 10.1016/j.jhazmat.2008.06.090; Vijayalakshmi K, 2009, J SCI IND RES INDIA, V68, P699; Wen HX, 2007, J SOC LEATH TECH CH, V91, P196; Zaides A., 1964, BIOKHIMIYA, V5	37	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112783	10.1371/journal.pone.0112783	http://dx.doi.org/10.1371/journal.pone.0112783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393637	gold, Green Submitted, Green Published			2022-12-27	WOS:000347709300102
J	Kubrak, OI; Kucerova, L; Theopold, U; Nassel, DR				Kubrak, Olga I.; Kucerova, Lucie; Theopold, Ulrich; Nassel, Dick R.			The Sleeping Beauty: How Reproductive Diapause Affects Hormone Signaling, Metabolism, Immune Response and Somatic Maintenance in Drosophila melanogaster	PLOS ONE			English	Article							INSULIN-LIKE PEPTIDE; MOSQUITO CULEX-PIPIENS; EXTENDS LIFE-SPAN; GENE-EXPRESSION; INSECT DIAPAUSE; OVERWINTERING DIAPAUSE; CAENORHABDITIS-ELEGANS; NUTRIENT AVAILABILITY; CLIMATIC ADAPTATION; CELL-PROLIFERATION	Some organisms can adapt to seasonal and other environmental challenges by entering a state of dormancy, diapause. Thus, insects exposed to decreased temperature and short photoperiod enter a state of arrested development, lowered metabolism, and increased stress resistance. Drosophila melanogaster females can enter a shallow reproductive diapause in the adult stage, which drastically reduces organismal senescence, but little is known about the physiology and endocrinology associated with this dormancy, and the genes involved in its regulation. We induced diapause in D. melanogaster and monitored effects over 12 weeks on dynamics of ovary development, carbohydrate and lipid metabolism, as well as expression of genes involved in endocrine signaling, metabolism and innate immunity. During diapause food intake diminishes drastically, but circulating and stored carbohydrates and lipids are elevated. Gene transcripts of glucagonand insulin-like peptides increase, and expression of several target genes of these peptides also change. Four key genes in innate immunity can be induced by infection in diapausing flies, and two of these, drosomycin and cecropin A1, are upregulated by diapause independently of infection. Diapausing flies display very low mortality, extended lifespan and decreased aging of the intestinal epithelium. Many phenotypes induced by diapause are reversed after one week of recovery from diapause conditions. Furthermore, mutant flies lacking specific insulin-like peptides (dilp5 and dilp2-3) display increased diapause incidence. Our study provides a first comprehensive characterization of reproductive diapause in D. melanogaster, and evidence that glucagon- and insulin-like signaling are among the key regulators of the altered physiology during this dormancy.	[Kubrak, Olga I.; Nassel, Dick R.] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden; [Kucerova, Lucie; Theopold, Ulrich] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden	Stockholm University; Stockholm University	Nassel, DR (corresponding author), Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden.	dnassel@zoologi.su.se	Kucerova, Lucie/N-1176-2016; Theopold, Ulrich/P-7205-2015	Kucerova, Lucie/0000-0002-6382-4467; Theopold, Ulrich/0000-0002-1009-8254	Swedish Research Council [VR-2012-3715, VR-2010-5988, VR-2010-5742]; Knut and Alice Wallenberg Foundation [KAW2012.0058]; Swedish Foundation for International Cooperation in Research and Higher Education [IG2011-2042]; Swedish Institute [00197/2012]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Foundation for International Cooperation in Research and Higher Education; Swedish Institute	The work was supported by the following: Swedish Research Council (projects VR-2012-3715, VR-2010-5988 and VR-2010-5742) to D.R.N., U.T. and Soren Nylin, http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html; The Knut and Alice Wallenberg Foundation (KAW2012.0058; Soren Nylin), https://www.wallenberg.com/kaw/en; Swedish Foundation for International Cooperation in Research and Higher Education (IG2011-2042) to U.T., http://www.stint.se/en/; and The Swedish Institute (Visby Program: 00197/2012) to O.I.K., https://eng.si.se/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MJ, 2007, FLY, V1, P307, DOI 10.4161/fly.5532; Anaka M, 2008, J NEUROGENET, V22, P243, DOI 10.1080/01677060802309629; Antonova Y., 2012, INSECT ENDOCRINOL, P63, DOI DOI 10.1016/B978-0-12-384749-2.10002-0; Ayyaz A, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00098; Bai H, 2012, AGING CELL, V11, P978, DOI 10.1111/acel.12000; Baker DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-242; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Becker T, 2010, NATURE, V463, P369, DOI 10.1038/nature08698; Bednarova A, 2013, COMP BIOCHEM PHYS A, V164, P91, DOI 10.1016/j.cbpa.2012.10.012; Bernal A, 2000, P NATL ACAD SCI USA, V97, P6019, DOI 10.1073/pnas.100391597; Bharucha KN, 2008, J EXP BIOL, V211, P3103, DOI 10.1242/jeb.016451; Biteau B, 2011, EXP GERONTOL, V46, P349, DOI 10.1016/j.exger.2010.11.003; Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159; Borycz J, 2008, J EXP BIOL, V211, P3454, DOI 10.1242/jeb.021162; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Broughton S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003721; Brummel T, 2004, P NATL ACAD SCI USA, V101, P12974, DOI 10.1073/pnas.0405207101; Buch S, 2008, CELL METAB, V7, P321, DOI 10.1016/j.cmet.2008.02.012; Cao C, 2001, CELL TISSUE RES, V304, P317, DOI 10.1007/s004410100367; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Chippendale GM, 1966, J INSECT PHYSL, V13, P995; Choi NH, 2011, P NATL ACAD SCI USA, V108, P18702, DOI 10.1073/pnas.1109348108; Cognigni P, 2011, CELL METAB, V13, P92, DOI 10.1016/j.cmet.2010.12.010; Colombani J, 2012, SCIENCE, V336, P582, DOI 10.1126/science.1216689; Crowe JH, 2007, ADV EXP MED BIOL, V594, P143; Danks HV, 2000, J INSECT PHYSIOL, V46, P837, DOI 10.1016/S0022-1910(99)00204-8; Dantoft W, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-99; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Emerson KJ, 2009, J COMP PHYSIOL A, V195, P825, DOI 10.1007/s00359-009-0460-5; Emerson KJ, 2009, TRENDS GENET, V25, P217, DOI 10.1016/j.tig.2009.03.009; Engstrom Y, 1999, DEV COMP IMMUNOL, V23, P345, DOI 10.1016/S0145-305X(99)00016-6; Ewart GD, 1998, METHOD ENZYMOL, V292, P213; Flatt T, 2005, BIOESSAYS, V27, P999, DOI 10.1002/bies.20290; Flatt T, 2013, Q REV BIOL, V88, P185, DOI 10.1086/671484; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; Gasque G, 2013, SCI REP, V3, DOI DOI 10.1038/SREP02120; Geminard C, 2006, DIABETES, V55, pS5, DOI 10.2337/db06-S001; Giannakou ME, 2007, TRENDS BIOCHEM SCI, V32, P180, DOI 10.1016/j.tibs.2007.02.007; Gronke S, 2007, PLOS BIOL, V5, P1248, DOI 10.1371/journal.pbio.0050137; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Hahn DA, 2007, J INSECT PHYSIOL, V53, P760, DOI 10.1016/j.jinsphys.2007.03.018; Hahn DA, 2011, ANNU REV ENTOMOL, V56, P103, DOI 10.1146/annurev-ento-112408-085436; Hamasaka Y, 2006, J COMP NEUROL, V494, P314, DOI 10.1002/cne.20807; Huser A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047518; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Isabel G, 2005, AM J PHYSIOL-REG I, V288, pR531, DOI 10.1152/ajpregu.00158.2004; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Kaletsky R, 2010, DIS MODEL MECH, V3, P415, DOI 10.1242/dmm.001040; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; King R. C., 1970, OVARIAN DEV DROSOPHI; KLEMENZ R, 1987, NUCLEIC ACIDS RES, V15, P3947, DOI 10.1093/nar/15.10.3947; Krstic D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077904; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; LEFEVERE KS, 1989, J INSECT PHYSIOL, V35, P121, DOI 10.1016/0022-1910(89)90045-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacRae TH, 2010, CELL MOL LIFE SCI, V67, P2405, DOI 10.1007/s00018-010-0311-0; McLeod CJ, 2010, CURR BIOL, V20, P2100, DOI 10.1016/j.cub.2010.10.038; Nassel DR, 2010, PROG NEUROBIOL, V92, P42, DOI 10.1016/j.pneurobio.2010.04.010; Nylin S, 2013, PHYSIOL ENTOMOL, V38, P96, DOI 10.1111/phen.12014; O'Brien LE, 2011, CELL, V147, P603, DOI 10.1016/j.cell.2011.08.048; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Okamoto N, 2009, DEV CELL, V17, P885, DOI 10.1016/j.devcel.2009.10.008; Okamura T, 2007, MOL BIOL CELL, V18, P1519, DOI 10.1091/mbc.E06-10-0909; Owusu-Ansah E, 2014, DIS MODEL MECH, V7, P343, DOI 10.1242/dmm.012989; Padmanabha D., 2014, TRENDS ENDOCRINOL ME; Park MS, 2008, J INSECT PHYSIOL, V54, P386, DOI 10.1016/j.jinsphys.2007.10.011; Poelchau MF, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0143; Poelchau MF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-619; Puig O, 2006, CELL CYCLE, V5, P503, DOI 10.4161/cc.5.5.2501; Ragland GJ, 2011, J EXP BIOL, V214, P3948, DOI 10.1242/jeb.061085; Rajan A, 2012, CELL, V151, P123, DOI 10.1016/j.cell.2012.08.019; Rajan A, 2011, DEV CELL, V21, P29, DOI 10.1016/j.devcel.2011.06.034; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; SAUNDERS DS, 1989, P NATL ACAD SCI USA, V86, P3748, DOI 10.1073/pnas.86.10.3748; SAUNDERS DS, 1990, GEN COMP ENDOCR, V79, P174, DOI 10.1016/0016-6480(90)90102-R; SAUNDERS DS, 1990, J BIOL RHYTHM, V5, P315, DOI 10.1177/074873049000500404; Schiesari L, 2011, FEBS LETT, V585, P1450, DOI 10.1016/j.febslet.2011.02.026; Schmidt PS, 2008, P NATL ACAD SCI USA, V105, P16207, DOI 10.1073/pnas.0805485105; Schmidt PS, 2005, EVOLUTION, V59, P2616, DOI 10.1111/j.0014-3820.2005.tb00974.x; Schmidt PS, 2005, EVOLUTION, V59, P1721, DOI 10.1111/j.0014-3820.2005.tb01821.x; Shimada Y, 2011, DEV BIOL, V355, P250, DOI 10.1016/j.ydbio.2011.04.022; Sim C, 2009, INSECT MOL BIOL, V18, P325, DOI 10.1111/j.1365-2583.2009.00872.x; Sim C, 2008, P NATL ACAD SCI USA, V105, P6777, DOI 10.1073/pnas.0802067105; Sim C, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00189; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Stoffolano JG, 2013, ANNU REV ENTOMOL, V58, P205, DOI 10.1146/annurev-ento-120811-153653; Storey K.B., 1991, P64; Storey KR, 2010, TOP CURR GENET, V21, P227, DOI 10.1007/978-3-642-12422-8_13; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tatar M, 2001, EXP GERONTOL, V36, P723, DOI 10.1016/S0531-5565(00)00238-2; Tauber E, 2007, SCIENCE, V316, P1895, DOI 10.1126/science.1138412; Tauber M.J., 1986, SEASONAL ADAPTATIONS; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Tettweiler G, 2005, GENE DEV, V19, P1840, DOI 10.1101/gad.1311805; Toivonen JM, 2009, MOL CELL ENDOCRINOL, V299, P39, DOI 10.1016/j.mce.2008.07.005; Williams KD, 2006, P NATL ACAD SCI USA, V103, P15911, DOI 10.1073/pnas.0604592103; WILLIAMS KD, 1993, HEREDITY, V71, P312, DOI 10.1038/hdy.1993.141; Wong R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006063; WU CF, 1977, J GEN PHYSIOL, V69, P705, DOI 10.1085/jgp.69.6.705; Zaidman-Remy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017231	114	85	88	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e113051	10.1371/journal.pone.0113051	http://dx.doi.org/10.1371/journal.pone.0113051			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393614	Green Submitted, Green Published, gold			2022-12-27	WOS:000347709300138
J	Kufa, T; Mabuto, T; Muchiri, E; Charalambous, S; Rosillon, D; Churchyard, G; Harris, RC				Kufa, Tendesayi; Mabuto, Tonderai; Muchiri, Evans; Charalambous, Salome; Rosillon, Dominique; Churchyard, Gavin; Harris, Rebecca C.			Incidence of HIV-Associated Tuberculosis among Individuals Taking Combination Antiretroviral Therapy: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							ISONIAZID PREVENTIVE THERAPY; PATIENTS RECEIVING HAART; RIO-DE-JANEIRO; RISK-FACTORS; INFECTED PATIENTS; POSITIVE PATIENTS; SOUTH-AFRICA; SHORT-TERM; INITIATION; ADULTS	Background: Knowledge of tuberculosis incidence and associated factors is required for the development and evaluation of strategies to reduce the burden of HIV-associated tuberculosis. Methods: Systematic literature review and meta-analysis of tuberculosis incidence rates among HIV-infected individuals taking combination antiretroviral therapy. Results: From PubMed, EMBASE and Global Index Medicus databases, 42 papers describing 43 cohorts (32 from high/intermediate and 11 from low tuberculosis burden settings) were included in the qualitative review and 33 in the quantitative review. Cohorts from high/intermediate burden settings were smaller in size, had lower median CD4 cell counts at study entry and fewer person-years of follow up. Tuberculosis incidence rates were higher in studies from Sub-Saharan Africa and from World Bank low/middle income countries. Tuberculosis incidence rates decreased with increasing CD4 count at study entry and duration on combination antiretroviral therapy. Summary estimates of tuberculosis incidence among individuals on combination antiretroviral therapy were higher for cohorts from high/intermediate burden settings compared to those from the low tuberculosis burden settings (4.17 per 100 person-years [95% Confidence Interval (CI) 3.39-5.14 per 100 person-years] vs. 0.4 per 100 person-years [95% CI 0.23-0.69 per 100 person-years]) with significant heterogeneity observed between the studies. Conclusions: Tuberculosis incidence rates were high among individuals on combination antiretroviral therapy in high/intermediate burden settings. Interventions to prevent tuberculosis in this population should address geographical, socioeconomic and individual factors such as low CD4 counts and prior history of tuberculosis.	[Kufa, Tendesayi; Mabuto, Tonderai; Muchiri, Evans; Charalambous, Salome; Churchyard, Gavin] Aurum Inst, Johannesburg, South Africa; [Kufa, Tendesayi; Charalambous, Salome; Churchyard, Gavin] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Rosillon, Dominique] GlaxoSmithKline Vaccines, Wavre, Belgium; [Harris, Rebecca C.] GlaxoSmithKline Vaccines, CROMSOURCE, Wavre, Belgium	University of Witwatersrand; GlaxoSmithKline; GlaxoSmithKline	Kufa, T (corresponding author), Aurum Inst, Johannesburg, South Africa.	tkufa@auruminstitute.org; tmabuto@auruminstitute.org	Harris, Rebecca/E-5764-2016; Muchiri, Evans/AAH-4642-2020	Harris, Rebecca/0000-0002-2636-1520; Kufa, Tendesayi/0000-0002-9797-616X; Churchyard, Gavin/0000-0002-4269-3699; Charalambous, Salome/0000-0001-7143-1009	GlaxoSmithKline Biologicals; GlaxoSmithKline; CROMsource; Medical Research Council [1363977] Funding Source: researchfish	GlaxoSmithKline Biologicals(GlaxoSmithKline); GlaxoSmithKline(GlaxoSmithKline); CROMsource; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	GlaxoSmithKline Biologicals S.A. funded the work disclosed in this manuscript (for data collection for the reported study). Co-author Dominique Rosillon is employed by GlaxoSmithKline Vaccines and co-author Rebecca C. Harris was employed by CROMsource during the course of the study. GlaxoSmithKline provided support in the form of salary for author DR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section. CROMsource provided support in the form of salary for author RCH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abgrall S, 2010, AIDS, V24, P763, DOI 10.1097/QAD.0b013e3283366747; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Bonnet MMB, 2006, AIDS, V20, P1275, DOI 10.1097/01.aids.0000232235.26630.ee; Brinkhof MWG, 2007, CLIN INFECT DIS, V45, P1518, DOI 10.1086/522986; Costagliola D, 2005, CLIN INFECT DIS, V41, P1772, DOI 10.1086/498315; de Lannoy LH, 2008, REV SOC BRAS MED TRO, V41, P549, DOI 10.1590/S0037-86822008000600001; Dembele M, 2010, INT J TUBERC LUNG D, V14, P318; Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453; Etard Jean-Francois, 2009, Open AIDS J, V3, P63, DOI 10.2174/1874613600903010063; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Golub JE, 2008, AIDS, V22, P2527, DOI 10.1097/QAD.0b013e328311ac4e; Grant AD, 2009, AIDS, V23, P2507, DOI 10.1097/QAD.0b013e3283320dfd; Gupta A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034156; Hanrahan CF, 2010, AIDS, V24, P1501, DOI 10.1097/QAD.0b013e32833a2a4a; Hermans S, 2012, HIV MED; Hermans SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010527; Houlihan CF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-23; Hung CC, 2003, JAIDS-J ACQ IMM DEF, V34, P437, DOI 10.1097/00126334-200312010-00012; Jerene Degu, 2006, AIDS Res Ther, V3, P10, DOI 10.1186/1742-6405-3-10; Jones JL, 2000, INT J TUBERC LUNG D, V4, P1026; Kabali C, 2011, INT J TUBERC LUNG D, V15, P1515, DOI 10.5588/ijtld.10.0788; Komati S, 2010, AIDS, V24, P1849, DOI 10.1097/QAD.0b013e32833a2507; Kruk A, 2011, AIDS, V25, P1505, DOI 10.1097/QAD.0b013e328348fafd; Laureillard D, 2013, AIDS, V27, P2577, DOI 10.1097/01.aids.0000432456.14099.c7; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lawn SD, 2011, J INFECT DIS, V204, pS1159, DOI 10.1093/infdis/jir411; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Lawn SD, 2010, AIDS, V24, P1323, DOI 10.1097/QAD.0b013e3283390dd1; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Manabe YC, 2009, J INFECT DIS, V199, P437, DOI 10.1086/595985; Martin-Echevarria E, 2011, INT J TUBERC LUNG D, V15, P1347, DOI 10.5588/ijtld.10.0686; Middelkoop K, 2012, INT J TUBERC LUNG D, V16, P1510, DOI 10.5588/ijtld.12.0049; Miranda A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000826; Moh R, 2007, AIDS, V21, P2483, DOI 10.1097/QAD.0b013e3282f09876; Moore D, 2007, AIDS, V21, P713, DOI 10.1097/QAD.0b013e328013f632; Moreno S, 2008, INT J TUBERC LUNG D, V12, P1393; Nicholas S, 2011, JAIDS-J ACQ IMM DEF, V57, P311, DOI 10.1097/QAI.0b013e318218a713; Pettit AC, 2011, JAIDS-J ACQ IMM DEF, V57, P305, DOI 10.1097/QAI.0b013e3182182e2d; Rajasekaran S, 2009, Indian J Tuberc, V56, P69; Seyler C, 2005, AM J RESP CRIT CARE, V172, P123, DOI 10.1164/rccm.200410-1342OC; Seyler C, 2003, ANTIVIR THER, V8, P385; Sterling TR, 2011, J INFECT DIS, V204, P893, DOI 10.1093/infdis/jir421; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; Taarnhoj GA, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-26; UNAIDS, 2010, HIV EST UNC BOUNDS 2; UNAIDS, 2012, AD 15 49 HIV PREV PE; Van Rie A, 2011, JAIDS-J ACQ IMM DEF, V56, P349, DOI 10.1097/QAI.0b013e3181f9fb39; Wells G.A., NEWCASTLE OTTAWA SCA; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Bank, 2012, WORLD BANK AN CLASS; World Health Organization, 2010, TUB COUNTR PROF; Worodria W, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/758350; Zhou JL, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-46	55	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e111209	10.1371/journal.pone.0111209	http://dx.doi.org/10.1371/journal.pone.0111209			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393281	Green Submitted, gold, Green Published			2022-12-27	WOS:000347709300013
J	Skamel, C; Aller, SG; Waffo, AB				Skamel, Claudia; Aller, Stephen G.; Waffo, Alain Bopda			In Vitro Evolution and Affinity-Maturation with Coliphage Q beta Display	PLOS ONE			English	Article							MOUTH-DISEASE VIRUS; PHAGE DISPLAY; READ-THROUGH; COAT PROTEIN; RNA; PEPTIDE; MECHANISMS; ANTIBODIES; STRAND; SITE	The Escherichia coli bacteriophage, Q beta (Coliphage Q beta), offers a favorable alternative to M13 for in vitro evolution of displayed peptides and proteins due to high mutagenesis rates in Qb RNA replication that better simulate the affinity maturation processes of the immune response. We describe a benchtop in vitro evolution system using Qb display of the VP1 G-H loop peptide of foot-and-mouth disease virus (FMDV). DNA encoding the G-H loop was fused to the A1 minor coat protein of Qb resulting in a replication-competent hybrid phage that efficiently displayed the FMDV peptide. The surface-localized FMDV VP1 G-H loop cross-reacted with the anti-FMDV monoclonal antibody (mAb) SD6 and was found to decorate the corners of the Q beta icosahedral shell by electron microscopy. Evolution of Q beta-displayed peptides, starting from fully degenerate coding sequences corresponding to the immunodominant region of VP1, allowed rapid in vitro affinity maturation to SD6 mAb. Q beta selected under evolutionary pressure revealed a non-canonical, but essential epitope for mAb SD6 recognition consisting of an Arg-Gly tandem pair. Finally, the selected hybrid phages induced polyclonal antibodies in guinea pigs with good affinity to both FMDV and hybrid Q beta-G-H loop, validating the requirement of the tandem pair epitope. Q beta-display emerges as a novel framework for rapid in vitro evolution with affinity-maturation to molecular targets.	[Skamel, Claudia] Univ Freiburg, Agcy Technol Transfer, Campus Technol Freiburg CTF GmbH, D-79106 Freiburg, Germany; [Skamel, Claudia] Univ Med Ctr Freiburg, Freiburg, Germany; [Aller, Stephen G.] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL USA; [Aller, Stephen G.] Univ Alabama Birmingham, Struct Biol Ctr, Birmingham, AL USA; [Waffo, Alain Bopda] Alabama State Univ, Dept Biol Sci, Montgomery, AL 36101 USA	University of Freiburg; University of Freiburg; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Waffo, AB (corresponding author), Alabama State Univ, Dept Biol Sci, Montgomery, AL 36101 USA.	abopdawaffo@alasu.edu		Bopda Waffo, Alain/0000-0002-0811-4649; Aller, Stephen/0000-0003-0379-5534	Deutsche Forschungsgemeinschaft [DFG-BI521/2-3]; CNBR of ASU [NSF-CREST (HRD-1241701)]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008591] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CNBR of ASU; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors acknowledge the Deutsche Forschungsgemeinschaft for grant # DFG-BI521/2-3 and the CNBR of ASU for grant # NSF-CREST (HRD-1241701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MH, 1959, BACTERIOPHAGES, P473; Azzazy HME, 2002, CLIN BIOCHEM, V35, P425, DOI 10.1016/S0009-9120(02)00343-0; BARRERA I, 1993, J MOL BIOL, V232, P512, DOI 10.1006/jmbi.1993.1407; BEEKWILDER MJ, 1995, J MOL BIOL, V247, P903, DOI 10.1006/jmbi.1995.0189; Beer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045472; BLUMENTHAL T, 1979, ANNU REV BIOCHEM, V48, P525, DOI 10.1146/annurev.bi.48.070179.002521; Bollback JP, 2001, J MOL EVOL, V52, P117, DOI 10.1007/s002390010140; BROWN F, 1961, NATURE, V192, P1163, DOI 10.1038/1921163a0; Brown F, 1999, ARCH VIROL, P179; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; Domingo E, 1999, VIRUS RES, V62, P169, DOI 10.1016/S0168-1702(99)00042-8; Domingo E, 2001, QUASISPECIES RNA VIR, P173; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; EIGEN M, 1977, NATURWISSENSCHAFTEN, V64, P541, DOI 10.1007/BF00450633; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; EIGEN M, 1989, ADV CHEM PHYS, V75, P149; Ferrer-Orta C, 2006, CURR OPIN STRUC BIOL, V16, P27, DOI 10.1016/j.sbi.2005.12.002; FURUSE K, 1983, J GEN VIROL, V64, P2039, DOI 10.1099/0022-1317-64-9-2039; Furuse K., 1987, PHAGE ECOLOGY, P87; GSCHWENDER HH, 1969, BIOCHIM BIOPHYS ACTA, V190, P454, DOI 10.1016/0005-2787(69)90094-X; HOFSTETTER H, 1974, BIOCHIM BIOPHYS ACTA, V374, P238, DOI 10.1016/0005-2787(74)90366-9; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Kahn S, 2002, CAN VET J, V43, P349; Kozlovska TM, 1996, INTERVIROLOGY, V39, P9, DOI 10.1159/000150469; LOGAN D, 1993, NATURE, V362, P566, DOI 10.1038/362566a0; Mack K, 1996, ANAL BIOCHEM, V242, P73, DOI 10.1006/abio.1996.0430; Marvin DA, 1998, CURR OPIN STRUC BIOL, V8, P150, DOI 10.1016/S0959-440X(98)80032-8; Ouchterlony O., 1978, HDB EXPT IMMUNOLOGY; PACE NR, 1966, SCIENCE, V153, P64, DOI 10.1126/science.153.3731.64; Petrenko VA, 2000, PROTEIN ENG, V13, P589, DOI 10.1093/protein/13.8.589; Rakonjac J, 2011, CURR ISSUES MOL BIOL, V13, P51, DOI 10.21775/cimb.013.051; Rumnieks J, 2011, PROTEIN SCI, V20, P1707, DOI 10.1002/pro.704; SCHUSTER P, 1994, COMPUT CHEM, V18, P295, DOI 10.1016/0097-8485(94)85025-9; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; SHAKLEE PN, 1988, VIROLOGY, V163, P209, DOI 10.1016/0042-6822(88)90250-4; Smith GP, 1997, CHEM REV, V97, P391, DOI 10.1021/cr960065d; SMITH GP, 1993, METHOD ENZYMOL, V217, P228; Smith GP, 1985, SCIENCE, V234, P211; STEINHAUER DA, 1992, GENE, V122, P281, DOI 10.1016/0378-1119(92)90216-C; TANIGUCHI T, 1978, NATURE, V274, P223, DOI 10.1038/274223a0; van Meerten D, 2001, J GEN VIROL, V82, P1797, DOI 10.1099/0022-1317-82-7-1797; van Rooy I, 2012, EUR J PHARM SCI, V45, P330, DOI 10.1016/j.ejps.2011.11.015; Vasiljeva I, 1998, FEBS LETT, V431, P7, DOI 10.1016/S0014-5793(98)00716-9; Verdaguer N, 1998, J VIROL, V72, P739, DOI 10.1128/JVI.72.1.739-748.1998; WEBER K, 1975, RNA PHAGES, P51; WEINER AM, 1971, NATURE-NEW BIOL, V234, P206, DOI 10.1038/newbio234206a0; YAMAMOTO KR, 1970, VIROLOGY, V40, P734, DOI 10.1016/0042-6822(70)90218-7	47	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e113069	10.1371/journal.pone.0113069	http://dx.doi.org/10.1371/journal.pone.0113069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393763	Green Published, gold, Green Submitted			2022-12-27	WOS:000347709300140
J	Abraham, I				Abraham, Isaac			Quasi-Linear Vacancy Dynamics Modeling and Circuit Analysis of the Bipolar Memristor	PLOS ONE			English	Article							DRIFT	The quasi-linear transport equation is investigated for modeling the bipolar memory resistor. The solution accommodates vacancy and circuit level perspectives on memristance. For the first time in literature the component resistors that constitute the contemporary dual variable resistor circuit model are quantified using vacancy parameters and derived from a governing partial differential equation. The model describes known memristor dynamics even as it generates new insight about vacancy migration, bottlenecks to switching speed and elucidates subtle relationships between switching resistance range and device parameters. The model is shown to comply with Chua's generalized equations for the memristor. Independent experimental results are used throughout, to validate the insights obtained from the model. The paper concludes by implementing a memristor-capacitor filter and compares its performance to a reference resistor-capacitor filter to demonstrate that the model is usable for practical circuit analysis.	[Abraham, Isaac] Duponts, Intel Corp, Cloud Platform Grp, Washington, DC 20009 USA; [Abraham, Isaac] Univ Washington, Dept Elect Engn, Seattle, WA 98195 USA	Intel Corporation; University of Washington; University of Washington Seattle	Abraham, I (corresponding author), Duponts, Intel Corp, Cloud Platform Grp, Washington, DC 20009 USA.	isaac.abraham@intel.com	Abraham, Isaac/AAU-9247-2021	Abraham, Isaac/0000-0001-8846-013X	Cloud Platform Group, Intel Corporation	Cloud Platform Group, Intel Corporation	The Cloud Platform Group, Intel Corporation, partially funded the publication costs of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGALL F, 1968, SOLID STATE ELECTRON, V11, P535, DOI 10.1016/0038-1101(68)90092-0; Batas D, 2011, IEEE T NANOTECHNOL, V10, P250, DOI 10.1109/TNANO.2009.2038051; Biolek Z, 2012, IEEE T CIRCUITS-I, V59, P2619, DOI 10.1109/TCSI.2012.2189058; Biolek Z, 2009, RADIOENGINEERING, V18, P210; Chua L, 2011, APPL PHYS A-MATER, V102, P765, DOI 10.1007/s00339-011-6264-9; CHUA LO, 1971, IEEE T CIRCUITS SYST, VCT18, P507, DOI 10.1109/TCT.1971.1083337; Joglekar YN, 2009, EUR J PHYS, V30, P661, DOI 10.1088/0143-0807/30/4/001; Kim HS, 2012, IEEE T CIRCUITS-I, V59, P2422, DOI 10.1109/TCSI.2012.2188957; Lu W, 2011, 2 TERMINAL RESISTIVE, P217; Menzel S, 2011, ADV FUNCT MATER, V21, P4487, DOI 10.1002/adfm.201101117; Meuffels P., 2014, FUNDAMENTAL ISSUES P; Nardi F, 2012, IEEE T ELECTRON DEV, V59, P2461, DOI 10.1109/TED.2012.2202319; Pickett M. D., 2009, J APPL PHYS, V106, DOI [DOI 10.1063/1.3236506, 10.1063/1.3236506]; Radwan A. G., 2010, INT C MICR; Sarra SA, 2002, METHOD CHARACTERISTI; Strachan JP, 2013, IEEE T ELECTRON DEV, V60, P2194, DOI 10.1109/TED.2013.2264476; Strukov DB, 2008, NATURE, V453, P80, DOI 10.1038/nature06932; Strukov DB, 2009, APPL PHYS A-MATER, V94, P515, DOI 10.1007/s00339-008-4975-3; Waser R, 2009, ADV MATER, V21, P2632, DOI 10.1002/adma.200900375; Williams S, 2008, IEEE SPECTRUM, V45, P24; Wolfram, 2014, LIN QUAS LIN PDES; Wolfram Research Inc., 2008, MATH VERS 7 0	22	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111607	10.1371/journal.pone.0111607	http://dx.doi.org/10.1371/journal.pone.0111607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390634	gold, Green Submitted, Green Published			2022-12-27	WOS:000349144400026
J	Staines, K; Hunt, LG; Young, JR; Butter, C				Staines, Karen; Hunt, Lawrence G.; Young, John R.; Butter, Colin			Evolution of an Expanded Mannose Receptor Gene Family	PLOS ONE			English	Article							MEDIATED PHAGOCYTOSIS; DENDRITIC CELLS; DOWN-REGULATION; LECTIN; MACROPHAGES; BINDING; INVOLVEMENT; CYTOKINES; DOMAIN; RNA	Sequences of peptides from a protein specifically immunoprecipitated by an antibody, KUL01, that recognises chicken macrophages, identified a homologue of the mammalian mannose receptor, MRC1, which we called MRC1L-B. Inspection of the genomic environment of the chicken gene revealed an array of five paralogous genes, MRC1L-A to MRC1L-E, located between conserved flanking genes found either side of the single MRC1 gene in mammals. Transcripts of all five genes were detected in RNA from a macrophage cell line and other RNAs, whose sequences allowed the precise definition of spliced exons, confirming or correcting existing bioinformatic annotation. The confirmed gene structures were used to locate orthologues of all five genes in the genomes of two other avian species and of the painted turtle, all with intact coding sequences. The lizard genome had only three genes, one orthologue of MRC1L-A and two orthologues of the MRC1L-B antigen gene resulting from a recent duplication. The Xenopus genome, like that of most mammals, had only a single MRC1-like gene at the corresponding locus. MRC1L-A and MRC1L-B genes had similar cytoplasmic regions that may be indicative of similar subcellular migration and functions. Cytoplasmic regions of the other three genes were very divergent, possibly indicating the evolution of a new functional repertoire for this family of molecules, which might include novel interactions with pathogens.	[Staines, Karen; Hunt, Lawrence G.; Young, John R.; Butter, Colin] Pirbright Inst, Compton, England		Butter, C (corresponding author), Pirbright Inst, Compton, England.	colin.butter@avianimmunology.org			BBSRC (Biotechnology and Biological Sciences Research Council) [BBS/E/I/00001423]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001423, BBS/E/I/00001705] Funding Source: researchfish; BBSRC [BBS/E/I/00001423, BBS/E/I/00001705] Funding Source: UKRI	BBSRC (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the BBSRC (Biotechnology and Biological Sciences Research Council) under grant number BBS/E/I/00001423 as part of the Institute Strategic Programme Grant to the Avian Viral Diseases Programme at the Pirbright Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barten R, 2001, TRENDS IMMUNOL, V22, P52, DOI 10.1016/S1471-4906(00)01802-0; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; Chiari Y, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-65; Crawford NG, 2012, BIOL LETTERS, V8, P783, DOI 10.1098/rsbl.2012.0331; Diaz-Silvestre H, 2005, MICROB PATHOGENESIS, V39, P97, DOI 10.1016/j.micpath.2005.06.002; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Fiete DJ, 1998, P NATL ACAD SCI USA, V95, P2089, DOI 10.1073/pnas.95.5.2089; HARRIS N, 1992, BLOOD, V80, P2363; Hedges SB, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-64; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Kaiser P, 2005, J INTERF CYTOK RES, V25, P467, DOI 10.1089/jir.2005.25.467; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KIM SJ, 1992, GENOMICS, V14, P721, DOI 10.1016/S0888-7543(05)80174-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Martinez-Pomares L, 1999, IMMUNOL LETT, V65, P9, DOI 10.1016/S0165-2478(98)00117-5; Martinez-Pomares L, 1998, J BIOL CHEM, V273, P23376, DOI 10.1074/jbc.273.36.23376; Mast J, 1998, VET IMMUNOL IMMUNOP, V61, P343, DOI 10.1016/S0165-2427(97)00152-9; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Meyer LR ZA, 2012, NUCL ACIDS RES; Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017; Milone MC, 1998, J IMMUNOL, V161, P2391; Mishra PK, 2013, INFECT IMMUN, V81, P1052, DOI 10.1128/IAI.01176-12; Moody A, 2000, J VIROL METHODS, V85, P55, DOI 10.1016/S0166-0934(99)00156-1; Nguyen DG, 2003, EUR J IMMUNOL, V33, P483, DOI 10.1002/immu.200310024; POND L, 1995, J BIOL CHEM, V270, P19989, DOI 10.1074/jbc.270.34.19989; Pradet-Balade B, 2002, EMBO J, V21, P5711, DOI 10.1093/emboj/cdf565; Prigozy TI, 1997, IMMUNITY, V6, P187, DOI 10.1016/S1074-7613(00)80425-2; Reading PC, 2000, J VIROL, V74, P5190, DOI 10.1128/JVI.74.11.5190-5197.2000; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sandoval Ignacio V., 1994, Trends in Cell Biology, V4, P292, DOI 10.1016/0962-8924(94)90220-8; Schweizer A, 2000, J BIOL CHEM, V275, P29694, DOI 10.1074/jbc.M000571200; Shibata Y, 1997, J IMMUNOL, V159, P2462; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; Staines K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051799; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TAYLOR ME, 1990, J BIOL CHEM, V265, P12156; TAYLOR ME, 1992, J BIOL CHEM, V267, P1719; TAYLOR ME, 1993, J BIOL CHEM, V268, P399; Tesar DB, 2008, MOL BIOL CELL, V19, P1587, DOI 10.1091/mbc.E07-09-0972; TIETZE C, 1982, J CELL BIOL, V92, P417, DOI 10.1083/jcb.92.2.417; Tregaskes CA, 1996, IMMUNOGENETICS, V44, P212, DOI 10.1007/BF02602587; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Upham JP, 2010, J VIROL, V84, P3730, DOI 10.1128/JVI.02148-09; Vautier S, 2012, CYTOKINE, V58, P89, DOI 10.1016/j.cyto.2011.08.031; WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Yamamoto Y, 1997, INFECT IMMUN, V65, P1077, DOI 10.1128/IAI.65.3.1077-1082.1997; Zelensky AN, 2003, PROTEINS, V52, P466, DOI 10.1002/prot.10626; Zhang JM, 2005, MOL BIOL CELL, V16, P824, DOI 10.1091/mbc.e04-06-0463	51	30	30	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e110330	10.1371/journal.pone.0110330	http://dx.doi.org/10.1371/journal.pone.0110330			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390371	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000349144400013
J	Majumder, S; Zappulla, F; Silbart, LK				Majumder, Sanjukta; Zappulla, Frank; Silbart, Lawrence K.			Mycoplasma gallisepticum Lipid Associated Membrane Proteins Up-regulate Inflammatory Genes in Chicken Tracheal Epithelial Cells via TLR-2 Ligation through an NF-kappa B Dependent Pathway	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; STRAIN R-LOW; SURFACE LIPOPROTEIN; CYTOKINE SECRETION; PHASE VARIATION; NITRIC-OXIDE; PROINFLAMMATORY CYTOKINES; GENITALIUM INFECTION; TERMINAL ORGANELLE; MOLECULAR-CLONING	Mycoplasma gallisepticum-mediated respiratory inflammation in chickens is associated with accumulation of leukocytes in the tracheal submucosa. However the molecular mechanisms underpinning these changes have not been well described. We hypothesized that the initial inflammatory events are initiated upon ligation of mycoplasma lipid associated membrane proteins (LAMP) to TLRs expressed on chicken tracheal epithelial cells (TEC). To test this hypothesis, live bacteria or LAMPs isolated from a virulent (R-low) or a non-virulent (R-high) strain were incubated with primary TECs or chicken tracheae ex vivo. Microarray analysis identified up-regulation of several inflammatory and chemokine genes in TECs as early as 1.5 hours post-exposure. Kinetic analysis using RT-qPCR identified the peak of expression for most genes to be at either 1.5 or 6 hours. Ex-vivo exposure also showed up-regulation of inflammatory genes in epithelial cells by 1.5 hours. Among the commonly upregulated genes were IL-1 beta, IL-6, IL-8, IL-12p40, CCL-20, and NOS-2, all of which are important immune-modulators and/or chemo-attractants of leukocytes. While these inflammatory genes were up-regulated in all four treatment groups, R-low exposed epithelial cells both in vitro and ex vivo showed the most dramatic up-regulation, inducing over 100 unique genes by 5-fold or more in TECs. Upon addition of a TLR-2 inhibitor, LAMP-mediated gene expression of IL-1 beta and CCL-20 was reduced by almost 5-fold while expression of IL-12p40, IL-6, IL-8 and NOS-2 mRNA was reduced by about 2-3 fold. Conversely, an NF-kappa B inhibitor abrogated the response entirely for all six genes. miRNA-146a, a negative regulator of TLR-2 signaling, was up-regulated in TECs in response to either R-low or R-high exposure. Taken together we conclude that LAMPs isolated from both R-high and R-low induced rapid, TLR-2 dependent but transient up-regulation of inflammatory genes in primary TECs through an NF-kappa B dependent pathway.	[Majumder, Sanjukta; Silbart, Lawrence K.] Univ Connecticut, Dept Anim Sci, Storrs, CT 06269 USA; [Zappulla, Frank; Silbart, Lawrence K.] Univ Connecticut, Dept Pathobiol & Vet Sci, Storrs, CT USA; [Majumder, Sanjukta; Silbart, Lawrence K.] Univ Connecticut, Ctr Excellence Vaccine Res, Storrs, CT USA; [Silbart, Lawrence K.] Univ Connecticut, Dept Allied Hlth Sci, Storrs, CT USA	University of Connecticut; University of Connecticut; University of Connecticut; University of Connecticut	Silbart, LK (corresponding author), Univ Connecticut, Dept Anim Sci, Storrs, CT 06269 USA.	Lawrence.Silbart@uconn.edu		Majumder, Sanjukta/0000-0002-4906-7199	United States Department of Agriculture, National Institute of Food and Agriculture [CONS00930]	United States Department of Agriculture, National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	Support was provided by the United States Department of Agriculture, National Institute of Food and Agriculture to LKS (Hatch project number CONS00930) [http://portal.nifa.usda.gov/web/crisprojectpages/0179772-the-role-of-membrane-associated-lipoproteins-and-hydrogen-peroxide-in-the-pathogenesis-of-mycoplasma-gallisepticum-in-chickens.html]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MM, 2011, EUR J IMMUNOL, V41, P2482, DOI 10.1002/eji.201141740; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; BEHRENS A, 1994, INFECT IMMUN, V62, P5075, DOI 10.1128/IAI.62.11.5075-5084.1994; Bischof DF, 2008, INFECT IMMUN, V76, P263, DOI 10.1128/IAI.00938-07; Bystry RS, 2001, NAT IMMUNOL, V2, P1126, DOI 10.1038/ni735; Calcutt MJ, 1999, INFECT IMMUN, V67, P760, DOI 10.1128/IAI.67.2.760-771.1999; Chambaud I, 1999, TRENDS MICROBIOL, V7, P493, DOI 10.1016/S0966-842X(99)01641-8; Choi SY, 2012, INFLAMM RES, V61, P493, DOI 10.1007/s00011-012-0437-7; Chopra-Dewasthaly R, 2012, FEMS IMMUNOL MED MIC, V66, P307, DOI 10.1111/j.1574-695X.2012.01010.x; Citti C, 1995, MOL MICROBIOL, V18, P649, DOI 10.1111/j.1365-2958.1995.mmi_18040649.x; Cole B C, 1991, Curr Top Microbiol Immunol, V174, P107; COLE BC, 1977, INFECT IMMUN, V18, P393, DOI 10.1128/IAI.18.2.393-399.1977; DALLO SF, 1990, INFECT IMMUN, V58, P4163, DOI 10.1128/IAI.58.12.4163-4165.1990; Deiters U, 1999, INFECT IMMUN, V67, P3390, DOI 10.1128/IAI.67.7.3390-3398.1999; Driessler F, 2004, CLIN EXP IMMUNOL, V135, P64, DOI 10.1111/j.1365-2249.2004.02342.x; Erridge C, 2008, J BIOL CHEM, V283, P24748, DOI 10.1074/jbc.M800352200; Fichorova RN, 2002, J IMMUNOL, V168, P2424, DOI 10.4049/jimmunol.168.5.2424; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; Furnkranz U, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-63; Gaunson JE, 2006, VACCINE, V24, P2627, DOI 10.1016/j.vaccine.2005.12.008; Gaunson JE, 2000, MICROBIOL-SGM, V146, P1223, DOI 10.1099/00221287-146-5-1223; Gomez MI, 2008, PEDIATR PULM, V43, P11, DOI 10.1002/ppul.20735; Griesinger G, 2001, J SOC GYNECOL INVEST, V8, P334, DOI 10.1016/S1071-5576(01)00135-6; Grodio JL, 2008, AVIAN PATHOL, V37, P385, DOI 10.1080/03079450802216629; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; He J, 2014, INFLAMMATION, V37, P322, DOI 10.1007/s10753-013-9743-7; He J, 2009, CLIN VACCINE IMMUNOL, V16, P1750, DOI 10.1128/CVI.00281-09; Hieshima K, 1997, J BIOL CHEM, V272, P5846, DOI 10.1074/jbc.272.9.5846; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Indikova I, 2013, INFECT IMMUN; Into T, 2004, CELL MICROBIOL, V6, P187, DOI 10.1046/j.1462-5822.2003.00356.x; Javed MA, 2005, INFECT IMMUN, V73, P5410, DOI 10.1128/IAI.73.9.5410-5419.2005; Jenkins C, 2007, MICROBIOL-SGM, V153, P1455, DOI 10.1099/mic.0.2006/004937-0; KAHANE I, 1985, INFECT IMMUN, V50, P944, DOI 10.1128/IAI.50.3.944-946.1985; KELNER GS, 1994, SCIENCE, V266, P1395, DOI 10.1126/science.7973732; Krause DC, 2004, MOL MICROBIOL, V51, P917, DOI 10.1046/j.1365-2958.2003.03899.x; Krause DC, 1996, MOL MICROBIOL, V20, P247, DOI 10.1111/j.1365-2958.1996.tb02613.x; Krause DC, 2001, FEMS MICROBIOL LETT, V198, P1, DOI 10.1111/j.1574-6968.2001.tb10610.x; Krishnan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062706; Legler DF, 1998, J EXP MED, V187, P655, DOI 10.1084/jem.187.4.655; Liu XP, 2010, INFECT IMMUN, V78, P5314, DOI 10.1128/IAI.00681-10; Liu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035304; Logunov D Iu, 2009, Mol Gen Mikrobiol Virusol, P25; Love W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010739; May M, 2006, INFECT IMMUN, V74, P1777, DOI 10.1128/IAI.74.3.1777-1785.2006; McGowin CL, 2012, INFECT IMMUN, V80, P3842, DOI 10.1128/IAI.00819-12; McGowin CL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-139; McGowin CL, 2009, INFECT IMMUN, V77, P1175, DOI 10.1128/IAI.00845-08; Medina JL, 2012, AM J RESP CELL MOL, V46, P815, DOI 10.1165/rcmb.2011-0135OC; Medina S, 2005, REGUL PEPTIDES, V131, P46, DOI 10.1016/j.regpep.2005.06.005; Mohammed J, 2007, VACCINE, V25, P8611, DOI 10.1016/j.vaccine.2007.09.057; Much P, 2002, FEMS IMMUNOL MED MIC, V34, P181, DOI 10.1111/j.1574-695X.2002.tb00622.x; Noormohammadi AH, 2000, MOL MICROBIOL, V35, P911, DOI 10.1046/j.1365-2958.2000.01766.x; Nouvel LX, 2009, J BACTERIOL, V191, P4111, DOI 10.1128/JB.00251-09; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Papazisi L, 2003, MICROBIOL-SGM, V149, P2307, DOI 10.1099/mic.0.26427-0; Papazisi L, 2002, INFECT IMMUN, V70, P6839, DOI 10.1128/IAI.70.12.6839-6845.2002; Papazisi L, 2000, INFECT IMMUN, V68, P6643, DOI 10.1128/IAI.68.12.6643-6649.2000; Prince A, 2006, AM J RESP CELL MOL, V34, P548, DOI 10.1165/rcmb.2006-0022SF; Qiu Hong, 2007, Weishengwu Xuebao, V47, P899; Quinn EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062232; Rawadi G, 2000, MICROBES INFECT, V2, P955, DOI 10.1016/S1286-4579(00)00395-6; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Rottem S, 2003, PHYSIOL REV, V83, P417, DOI 10.1152/physrev.00030.2002; Roussel L, 2011, J CYST FIBROS, V10, P107, DOI 10.1016/j.jcf.2010.11.005; SATO S, 1970, NATL I ANIM HEALTH Q, V10, P58; SCHALL TJ, 1988, J IMMUNOL, V141, P1018; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Seya T, 2002, INT J BIOCHEM CELL B, V34, P901, DOI 10.1016/S1357-2725(01)00164-9; Shen CI, VET RES, V41, P6; SHERRY B, 1988, J EXP MED, V168, P2251, DOI 10.1084/jem.168.6.2251; Shimizu T, 2005, J IMMUNOL, V175, P4641, DOI 10.4049/jimmunol.175.7.4641; Shimizu T, 2008, INFECT IMMUN, V76, P3672, DOI 10.1128/IAI.00257-08; Shimizu T, 2007, IMMUNOLOGY, V121, P473, DOI 10.1111/j.1365-2567.2007.02594.x; Stipkovits L, 2012, AVIAN PATHOL, V41, P51, DOI 10.1080/03079457.2011.635635; Szczepanek SM, 2010, INFECT IMMUN, V78, P1760, DOI 10.1128/IAI.01172-09; TAJIMA M, 1979, AM J VET RES, V40, P1009; Tulman ER, 2012, MICROBIOL-SGM, V158, P2073, DOI 10.1099/mic.0.058560-0; Vogl G, 2008, INFECT IMMUN, V76, P71, DOI 10.1128/IAI.00871-07; Walter MJ, 2001, J EXP MED, V193, P339, DOI 10.1084/jem.193.3.339; WANG P, 1995, J BIOL CHEM, V270, P9558, DOI 10.1074/jbc.270.16.9558; Winner F, 2000, INFECT IMMUN, V68, P4238, DOI 10.1128/IAI.68.7.4238-4244.2000; Wu HN, 2012, CURR MICROBIOL, V64, P433, DOI 10.1007/s00284-012-0090-y; Xing Z, 2000, J LEUKOCYTE BIOL, V68, P897; Xu CG, 2014, GENET MOL RES, V13, P1527, DOI 10.4238/2014.March.12.5; Xu YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077955; Yang J, 2002, INFECT IMMUN, V70, P3649, DOI 10.1128/IAI.70.7.3649-3655.2002; YOGEV D, 1994, INFECT IMMUN, V62, P4962, DOI 10.1128/IAI.62.11.4962-4968.1994; You Xiao-xing, 2006, J Zhejiang Univ Sci B, V7, P342, DOI 10.1631/jzus.2006.B0342; You XX, 2008, FEMS IMMUNOL MED MIC, V52, P228, DOI 10.1111/j.1574-695X.2007.00366.x; Zaffuto KM, 2008, AVIAN PATHOL, V37, P25, DOI 10.1080/03079450701774850; Zamora R, 2000, MOL MED, V6, P347, DOI 10.1007/BF03401781; Zuo LL, 2009, J ZHEJIANG UNIV-SC B, V10, P67, DOI 10.1631/jzus.B0820256	93	34	36	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112796	10.1371/journal.pone.0112796	http://dx.doi.org/10.1371/journal.pone.0112796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401327	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700072
J	Ovadje, P; Ma, D; Tremblay, P; Roma, A; Steckle, M; Guerrero, JA; Arnason, JT; Pandey, S				Ovadje, Pamela; Ma, Dennis; Tremblay, Phillip; Roma, Alessia; Steckle, Matthew; Guerrero, Jose-Antonio; Arnason, John Thor; Pandey, Siyaram			Evaluation of the Efficacy & Biochemical Mechanism of Cell Death Induction by Piper longum Extract Selectively in In-Vitro and In-Vivo Models of Human Cancer Cells	PLOS ONE			English	Article							N-ACETYLCYSTEINE; APOPTOSIS; INHIBITION	Background: Currently chemotherapy is limited mostly to genotoxic drugs that are associated with severe side effects due to non-selective targeting of normal tissue. Natural products play a significant role in the development of most chemotherapeutic agents, with 74.8% of all available chemotherapy being derived from natural products. Objective: To scientifically assess and validate the anticancer potential of an ethanolic extract of the fruit of the Long pepper (PLX), a plant of the piperaceae family that has been used in traditional medicine, especially Ayurveda and investigate the anticancer mechanism of action of PLX against cancer cells. Materials & Methods: Following treatment with ethanolic long pepper extract, cell viability was assessed using a water-soluble tetrazolium salt; apoptosis induction was observed following nuclear staining by Hoechst, binding of annexin V to the externalized phosphatidyl serine and phase contrast microscopy. Image-based cytometry was used to detect the effect of long pepper extract on the production of reactive oxygen species and the dissipation of the mitochondrial membrane potential following Tetramethylrhodamine or 5,5,6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine chloride staining (JC-1). Assessment of PLX in-vivo was carried out using Balb/C mice (toxicity) and CD-1 nu/nu immunocompromised mice (efficacy). HPLC analysis enabled detection of some primary compounds present within our long pepper extract. Results: Our results indicated that an ethanolic long pepper extract selectively induces caspase-independent apoptosis in cancer cells, without affecting non-cancerous cells, by targeting the mitochondria, leading to dissipation of the mitochondrial membrane potential and increase in ROS production. Release of the AIF and endonuclease G from isolated mitochondria confirms the mitochondria as a potential target of long pepper. The efficacy of PLX in in-vivo studies indicates that oral administration is able to halt the growth of colon cancer tumors in immunocompromised mice, with no associated toxicity. These results demonstrate the potentially safe and non-toxic alternative that is long pepper extract for cancer therapy.	[Ovadje, Pamela; Ma, Dennis; Tremblay, Phillip; Roma, Alessia; Steckle, Matthew; Pandey, Siyaram] Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada; [Guerrero, Jose-Antonio; Arnason, John Thor] Univ Ottawa, Dept Biol, Ottawa, ON, Canada	University of Windsor; University of Ottawa	Pandey, S (corresponding author), Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada.	spandey@uwindsor.ca	Arnason, John Thor/GXM-3860-2022; Pandey, Siyaram/AAI-5491-2020; Guerrero-Analco, José A./Q-6733-2018	Guerrero-Analco, José A./0000-0003-0998-757X; Roma, Alessia/0000-0002-5592-4724	Windsor & Essex County Cancer Centre Foundation by Seeds4Hope Grant	Windsor & Essex County Cancer Centre Foundation by Seeds4Hope Grant	This study was funded by Windsor & Essex County Cancer Centre Foundation by Seeds4Hope Grant (URL: http://windsorcancerfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao NRS, 2014, J NAT MED-TOKYO, V68, P211, DOI 10.1007/s11418-013-0773-0; Bezerra DP, 2007, TOXICOL IN VITRO, V21, P1, DOI 10.1016/j.tiv.2006.07.007; Bleske BE, 2013, J CARDIOVASCULAR PHA, V00, P1; Canadian Cancer Society's Steering Committee on Cancer Statistics, 2012, CAN CANC STAT 2012; Casellas P, 2002, NEUROCHEM INT, V40, P475, DOI 10.1016/S0197-0186(01)00118-8; Chandra P, 2014, ANAL METHODS-UK, V6, P4234, DOI 10.1039/c4ay00246f; Davidson D, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00005; Dekhuijzen PNR, 2004, EUR RESPIR J, V23, P629, DOI 10.1183/09031936.04.00016804; Dodd S, 2008, EXPERT OPIN BIOL TH, V8, P1955, DOI 10.1517/14728220802517901 ; Earnshaw WC, 1999, NATURE, V397, P387, DOI 10.1038/17015; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fadeel B, 2005, J INTERN MED, V258, P479, DOI 10.1111/j.1365-2796.2005.01570.x; Fang CD, 2013, CLIN SCI, V124, P709, DOI 10.1042/CS20120517; Foster BC, 2005, ANNU REV PHARMACOL, V45, P203, DOI 10.1146/annurev.pharmtox.45.120403.095950; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Golovine KV, 2013, PROSTATE, V73, P23, DOI 10.1002/pros.22535; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jarvius M, 2013, BIOCHEM BIOPH RES CO, V431, P117, DOI 10.1016/j.bbrc.2013.01.017; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lee SE, 2001, CROP PROT, V20, P523, DOI 10.1016/S0261-2194(00)00172-1; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; Mathupala SP, 1997, J BIOENERG BIOMEMBR, V29, P339, DOI 10.1023/A:1022494613613; Meghwal M, 2013, PHYTOTHER RES, V27, P1121, DOI 10.1002/ptr.4972; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Raj L, 2012, NATURE, V481, P534, DOI 10.1038/nature10789; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Zeller R., 2008, CSH PROTOC, V2008, DOI [10.1101/pdb.prot4986, DOI 10.1101/PDB.PROT4986]; Zhivotovsky B, 2010, EXP CELL RES, V316, P1374, DOI 10.1016/j.yexcr.2010.02.037	32	22	22	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113250	10.1371/journal.pone.0113250	http://dx.doi.org/10.1371/journal.pone.0113250			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401766	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700127
J	Bijker, EM; Schats, R; Obiero, JM; Behet, MC; van Gemert, GJ; de Vegte-Bolmer, MV; Graumans, W; van Lieshout, L; Bastiaens, GJH; Teelen, K; Hermsen, CC; Scholzen, A; Visser, LG; Sauerwein, RW				Bijker, Else M.; Schats, Remko; Obiero, Joshua M.; Behet, Marije C.; van Gemert, Geert-Jan; de Vegte-Bolmer, Marga van; Graumans, Wouter; van Lieshout, Lisette; Bastiaens, Guido J. H.; Teelen, Karina; Hermsen, Cornelus C.; Scholzen, Anja; Visser, Leo G.; Sauerwein, Robert W.			Sporozoite Immunization of Human Volunteers under Mefloquine Prophylaxis Is Safe, Immunogenic and Protective: A Double-Blind Randomized Controlled Clinical Trial	PLOS ONE			English	Article							TERM MALARIA PROPHYLAXIS; PLASMODIUM-FALCIPARUM; IN-VIVO; CHLOROQUINE PROPHYLAXIS; ACQUIRED-IMMUNITY; CHEMOPROPHYLAXIS; INOCULATION; CHALLENGE; PROGUANIL; MOSQUITOS	Immunization of healthy volunteers with chloroquine ChemoProphylaxis and Sporozoites (CPS-CQ) efficiently and reproducibly induces dose-dependent and long-lasting protection against homologous Plasmodium falciparum challenge. Here, we studied whether chloroquine can be replaced by mefloquine, which is the only other licensed anti-malarial chemoprophylactic drug that does not affect pre-erythrocytic stages, exposure to which is considered essential for induction of protection by CPS immunization. In a double blind randomized controlled clinical trial, volunteers under either chloroquine prophylaxis (CPS-CQ, n = 5) or mefloquine prophylaxis (CPS-MQ, n = 10) received three sub-optimal CPS immunizations by bites from eight P. falciparum infected mosquitoes each, at monthly intervals. Four control volunteers received mefloquine prophylaxis and bites from uninfected mosquitoes. CPS-MQ immunization is safe and equally potent compared to CPS-CQ inducing protection in 7/10 (70%) versus 3/5 (60%) volunteers, respectively. Furthermore, specific antibody levels and cellular immune memory responses were comparable between both groups. We therefore conclude that mefloquine and chloroquine are equally effective in CPS-induced immune responses and protection.	[Bijker, Else M.; Obiero, Joshua M.; Behet, Marije C.; van Gemert, Geert-Jan; de Vegte-Bolmer, Marga van; Graumans, Wouter; Bastiaens, Guido J. H.; Teelen, Karina; Hermsen, Cornelus C.; Scholzen, Anja; Sauerwein, Robert W.] Radboud Univ Nijmegen, Dept Med Microbiol, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Schats, Remko; Visser, Leo G.] Leiden Univ, Dept Infect Dis, Med Ctr, NL-2300 RC Leiden, Netherlands; [van Lieshout, Lisette] Leiden Univ, Med Ctr, Dept Med Microbiol, NL-2300 RC Leiden, Netherlands; [van Lieshout, Lisette] Leiden Univ, Med Ctr, Dept Parasitol, NL-2300 RC Leiden, Netherlands	Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Sauerwein, RW (corresponding author), Radboud Univ Nijmegen, Dept Med Microbiol, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.	Robert.Sauerwein@radboudumc.nl	Bijker, Else/ABF-1664-2021; Behet, Marije/D-7785-2016; Scholzen, Anja/D-1046-2013; Graumans, Wouter/D-9610-2016; Bijker, Else/P-8051-2015; Bastiaens, Guido/P-6642-2015; Visser, Leo/AAH-5755-2021; Obiero, Joshua M/C-8268-2011; Sauerwein, Robert/C-8519-2013; Hermsen, C.C./L-4368-2015	Bijker, Else/0000-0002-2367-5874; Behet, Marije/0000-0002-8683-4449; Scholzen, Anja/0000-0001-6481-6090; Graumans, Wouter/0000-0003-3952-6491; Obiero, Joshua M/0000-0001-9741-512X; Visser, Leo/0000-0002-3600-9782	Netherlands Organisation for Health Research and Development (ZonMw) [95110086]; Dioraphte foundation [12010100]; EMBO	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Dioraphte foundation; EMBO(European Molecular Biology Organization (EMBO))	This trial was funded by The Netherlands Organisation for Health Research and Development (ZonMw, project 95110086) and the Dioraphte foundation (project 12010100). AS received an EMBO long-term fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accapezzato D, 2005, J EXP MED, V202, P817, DOI 10.1084/jem.20051106; Barrett PJ, 1996, BRIT MED J, V313, P525, DOI 10.1136/bmj.313.7056.525; Behet MC, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-136; Bijker EM, 2013, P NATL ACAD SCI USA, V110, P7862, DOI 10.1073/pnas.1220360110; Bijker EM, 2014, J INFECT DIS; Croft AMJ, 1997, T ROY SOC TROP MED H, V91, P199, DOI 10.1016/S0035-9203(97)90223-6; Crompton PD, 2010, J CLIN INVEST, V120, P4168, DOI 10.1172/JCI44423; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Duffy PE, 2012, EXPERT REV VACCINES, V11, P1261, DOI [10.1586/ERV.12.92, 10.1586/erv.12.92]; Felgner PL, 2013, SCI REP-UK, V3, DOI 10.1038/srep03549; Garulli B, 2013, VACCINE, V31, P1717, DOI 10.1016/j.vaccine.2013.01.037; Hermsen CC, 2001, MOL BIOCHEM PARASIT, V118, P247, DOI 10.1016/S0166-6851(01)00379-6; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Lejeune D, 2007, J PHARMACEUT BIOMED, V43, P1106, DOI 10.1016/j.jpba.2006.09.036; LOBEL HO, 1993, LANCET, V341, P848, DOI 10.1016/0140-6736(93)93058-9; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Nahrendorf W, 2014, J INFECT DIS; Nganou-Makamdop K, 2013, TRENDS PARASITOL, V29, P304, DOI 10.1016/j.pt.2013.03.008; PALMER KJ, 1993, DRUGS, V45, P430, DOI 10.2165/00003495-199345030-00009; PONNUDURAI T, 1991, T ROY SOC TROP MED H, V85, P175, DOI 10.1016/0035-9203(91)90012-N; PONNUDURAI T, 1989, PARASITOLOGY, V98, P165, DOI 10.1017/S0031182000062065; Roestenberg M, 2012, J INFECT DIS, V206, P319, DOI 10.1093/infdis/jis355; Roestenberg M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038434; Roestenberg M, 2011, LANCET, V377, P1770, DOI 10.1016/S0140-6736(11)60360-7; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; ROMBO L, 1987, B WORLD HEALTH ORGAN, V65, P879; Sauerwein RW, 2010, CURR OPIN IMMUNOL, V22, P367, DOI 10.1016/j.coi.2010.04.001; Schlagenhauf P, 2003, BMJ-BRIT MED J, V327, P1078, DOI 10.1136/bmj.327.7423.1078; Seder RA, 2013, SCIENCE; STEFFEN R, 1993, LANCET, V341, P1299, DOI 10.1016/0140-6736(93)90814-W; Tran TM, 2013, CLIN INFECT DIS, V57, P40, DOI 10.1093/cid/cit174; Verhage DF, 2005, NETH J MED, V63, P52; WHO, 2013, WORLD MALARIA REPORT 2013, P1	33	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112910	10.1371/journal.pone.0112910	http://dx.doi.org/10.1371/journal.pone.0112910			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396417	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558500109
J	Cerri, M; Del Vecchio, F; Mastrotto, M; Luppi, M; Martelli, D; Perez, E; Tupone, D; Zamboni, G; Amici, R				Cerri, Matteo; Del Vecchio, Flavia; Mastrotto, Marco; Luppi, Marco; Martelli, Davide; Perez, Emanuele; Tupone, Domenico; Zamboni, Giovanni; Amici, Roberto			Enhanced Slow-Wave EEG Activity and Thermoregulatory Impairment following the Inhibition of the Lateral Hypothalamus in the Rat	PLOS ONE			English	Article							OREXIN RECEPTOR ANTAGONISTS; PARADOXICAL REM SLEEP; SHALLOW TORPOR; MCH NEURONS; ACTIVATION; IDENTIFICATION; ARCHITECTURE; ZOLPIDEM; DEFENSE; STATE	Neurons within the lateral hypothalamus (LH) are thought to be able to evoke behavioural responses that are coordinated with an adequate level of autonomic activity. Recently, the acute pharmacological inhibition of LH has been shown to depress wakefulness and promote NREM sleep, while suppressing REM sleep. These effects have been suggested to be the consequence of the inhibition of specific neuronal populations within the LH, i.e. the orexin and the MCH neurons, respectively. However, the interpretation of these results is limited by the lack of quantitative analysis of the electroencephalographic (EEG) activity that is critical for the assessment of NREM sleep quality and the presence of aborted NREM-to-REM sleep transitions. Furthermore, the lack of evaluation of the autonomic and thermoregulatory effects of the treatment does not exclude the possibility that the wake-sleep changes are merely the consequence of the autonomic, in particular thermoregulatory, changes that may follow the inhibition of LH neurons. In the present study, the EEG and autonomic/thermoregulatory effects of a prolonged LH inhibition provoked by the repeated local delivery of the GABA(A) agonist muscimol were studied in rats kept at thermoneutral (24 degrees C) and at a low (10 degrees C) ambient temperature (Ta), a condition which is known to depress sleep occurrence. Here we show that: 1) at both Tas, LH inhibition promoted a peculiar and sustained bout of NREM sleep characterized by an enhancement of slow-wave activity with no NREM-to-REM sleep transitions; 2) LH inhibition caused a marked transitory decrease in brain temperature at Ta 10 degrees C, but not at Ta 24 degrees C, suggesting that sleep changes induced by LH inhibition at thermoneutrality are not caused by a thermoregulatory impairment. These changes are far different from those observed after the short-term selective inhibition of either orexin or MCH neurons, suggesting that other LH neurons are involved in sleep-wake modulation.	[Cerri, Matteo; Del Vecchio, Flavia; Mastrotto, Marco; Luppi, Marco; Martelli, Davide; Perez, Emanuele; Tupone, Domenico; Zamboni, Giovanni; Amici, Roberto] Alma Mater Studiorum Univ Bologna, Dept Biomed & NeuroMotor Sci, Bologna, Italy	University of Bologna	Cerri, M (corresponding author), Alma Mater Studiorum Univ Bologna, Dept Biomed & NeuroMotor Sci, Bologna, Italy.	matteo.cerri@unibo.it	Martelli, Davide/Q-7375-2016; Luppi, Marco/AGH-3155-2022; Tupone, Domenico/M-8079-2016; Cerri, Matteo/F-5009-2017	Luppi, Marco/0000-0002-9462-5014; Tupone, Domenico/0000-0002-4238-1011; Cerri, Matteo/0000-0003-3556-305X; Martelli, Davide/0000-0001-6523-9598	Ministero dell'Istruzione, dell'Universita e della Ricerca- Italy [2008FY7K9S]	Ministero dell'Istruzione, dell'Universita e della Ricerca- Italy(Ministry of Education, Universities and Research (MIUR))	This work has been supported by the grant PRIN 2008FY7K9S from the Ministero dell'Istruzione, dell'Universita e della Ricerca (http://www.istruzione.it)- Italy (RA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthoud HR, 2013, PHYSIOL BEHAV, V104, P29; Betschart C, 2013, J MED CHEM, V56, P7590, DOI 10.1021/jm4007627; Bettica P, 2012, NEUROPSYCHOPHARMACOL, V37, P1224, DOI 10.1038/npp.2011.310; Brisbare-Roch C, 2007, NAT MED, V13, P150, DOI 10.1038/nm1544; Capitani P, 2005, NEUROSCI LETT, V383, P182, DOI 10.1016/j.neulet.2005.04.009; Cerri M, 2005, NEUROSCIENCE, V135, P627, DOI 10.1016/j.neuroscience.2005.06.039; Cerri M, 2005, SLEEP, V28, P694, DOI 10.1093/sleep/28.6.694; Cerri M, 2010, NEUROSCIENCE, V165, P984, DOI 10.1016/j.neuroscience.2009.10.068; Cerri M, 2013, J NEUROSCI, V33, P2984, DOI 10.1523/JNEUROSCI.3596-12.2013; Clement O, 2012, J NEUROSCI, V32, P16763, DOI 10.1523/JNEUROSCI.1885-12.2012; de Lecea L, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00016; DEBOER T, 1994, NEUROSCI LETT, V166, P35, DOI 10.1016/0304-3940(94)90834-6; Estabrooke IV, 2001, J NEUROSCI, V21, P1656, DOI 10.1523/JNEUROSCI.21-05-01656.2001; Fox SV, 2013, NEUROPSYCHOPHARMACOL, V38, P2401, DOI 10.1038/npp.2013.139; HARRIS DV, 1984, PHYSIOL ZOOL, V57, P428, DOI 10.1086/physzool.57.4.30163344; Hassani OK, 2010, EUR J NEUROSCI, V32, P448, DOI 10.1111/j.1460-9568.2010.07295.x; HOLM S, 1979, SCAND J STAT, V6, P65; Jego S, 2013, NAT NEUROSCI, V16, P1637, DOI 10.1038/nn.3522; KAPAS L, 1988, BRAIN RES, V438, P155, DOI 10.1016/0006-8993(88)91334-0; KRILOWICZ BL, 1988, AM J PHYSIOL, V255, pR1008, DOI 10.1152/ajpregu.1988.255.6.R1008; KRUEGER J M, 1989, Journal of Rheumatology, V16, P52; Krueger JM, 1997, ANN NY ACAD SCI, V813, P281, DOI 10.1111/j.1749-6632.1997.tb51706.x; Li FW, 2011, BEHAV BRAIN RES, V224, P376, DOI 10.1016/j.bbr.2011.06.021; Luppi PH, 2013, SLEEP, V36, P1775, DOI 10.5665/sleep.3192; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Sapin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011766; Sasaki K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020360; Takahashi Y, 2013, J PHYSIOL-LONDON, V591, P5623, DOI 10.1113/jphysiol.2013.261271; Tanaka M, 2013, AM J PHYSIOL-REG I, V305, pR1479, DOI 10.1152/ajpregu.00401.2013; Tsunematsu T, 2013, BEHAV BRAIN RES, V255, P64, DOI 10.1016/j.bbr.2013.05.021; Tsunematsu T, 2011, J NEUROSCI, V31, P10529, DOI 10.1523/JNEUROSCI.0784-11.2011; Tupone D, 2013, J NEUROSCI, V33, P14512, DOI 10.1523/JNEUROSCI.1980-13.2013; Tupone D, 2011, J NEUROSCI, V31, P15944, DOI 10.1523/JNEUROSCI.3909-11.2011; Vecchio F Del, 2012, J SLEEP RES S, VS358, P571; WALKER JM, 1979, SCIENCE, V204, P1098, DOI 10.1126/science.221974; WALLENSTEIN S, 1980, CIRC RES, V47, P1, DOI 10.1161/01.RES.47.1.1; Williams RH, 2007, P NATL ACAD SCI USA, V104, P10685, DOI 10.1073/pnas.0702676104; Winer B.J., 1991, STAT PRINCIPLES EXPT	38	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112849	10.1371/journal.pone.0112849	http://dx.doi.org/10.1371/journal.pone.0112849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398141	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500101
J	Guilherme, FR; Molena-Fernandes, CA; Hintze, LJ; Favero, MTM; Cuman, RKN; Rinaldi, W				Guilherme, Flavio Ricardo; Molena-Fernandes, Carlos Alexandre; Hintze, Luzia Jaeger; Martins Favero, Maria Teresa; Nakamura Cuman, Roberto Kenji; Rinaldi, Wilson			Hypertriglyceridemic Waist and Metabolic Abnormalities in Brazilian Schoolchildren	PLOS ONE			English	Article							BLOOD-PRESSURE; RISK-FACTORS; CHOLESTEROL; PHENOTYPE; HYPERTENSION; ADOLESCENTS; PREVALENCE; AMERICAN; CHILDREN; DISEASE	Objective: To identify the prevalence of hypertriglyceridemic waist (HTW) phenotype and its association with metabolic abnormalities in schoolchildren. Methods: A cross-sectional study, with a sample of 241 students aged 10 to 14 years from public schools (4 schools) and private (2 schools) from Paranavai town, in Parana State, Brazil. Anthropometric variables (weight, height, waist circumference) and levels of triglycerides, total cholesterol, HDL-C, non-HDL and LDL-C were analyzed. In statistical tests of Pearson partial correlation and multivariate logistic regression, considering p, < 0,05. Results: The prevalence of HTW was 20,7% among schoolchildren, 14,1% in males and 6,6% among females with higher proportions aged 10-12 years old. Multivariate analysis indicated that the students who attended private schools were nearly three times more likely (95% CI: 1,2-5,6), to be diagnosed with HTW compared with those who attended public schools (p = 0,006), and LDL-C was the only metabolic variable positively associated with the outcome (p = 0,001), where the students categorized with elevated serum levels had odds 4,2 times (95% CI: 1,6-10,9) having the HTW compared to students in appropriate levels. Conclusion: This study showed higher prevalence of hypertriglyceridemic waist phenotype in students when compared to prospective studies in Brazil and worldwide. It also showed that the only metabolic alteration associated with HTW phenotype was LDL-C (low density lipoprotein).	[Guilherme, Flavio Ricardo; Molena-Fernandes, Carlos Alexandre; Nakamura Cuman, Roberto Kenji] Univ Estadual Maringa, Dept Pharm & Pharmacol, Lab Inflammat, Maringa, Parana, Brazil; [Hintze, Luzia Jaeger] Univ Estadual Maringa, Dept Phys Educ, Multiprofess Nucleous Obes Studies, Maringa, Parana, Brazil; [Martins Favero, Maria Teresa; Rinaldi, Wilson] Univ Estadual Maringa, Dept Phys Educ, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa	Hintze, LJ (corresponding author), Univ Estadual Maringa, Dept Phys Educ, Multiprofess Nucleous Obes Studies, Maringa, Parana, Brazil.	lujhintze@hotmail.com	Rinaldi, Wilson WR/T-4560-2017	Alexandre Molena Fernandes, Carlos/0000-0002-4019-8379; Ricardo Guilherme, Flavio/0000-0003-4808-6192	Araucaria Foundation	Araucaria Foundation(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA)	The study received funding from Araucaria Foundation (http://www.fundacaoaraucaria.org.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavian SM, 2008, J TROP PEDIATRICS, V54, P169, DOI 10.1093/tropej/fmm105; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Basiratnia M, 2013, IRAN J KIDNEY DIS, V7, P282; Bergmann Mauren Lucia de Araujo, 2011, Arq Bras Cardiol, V97, P17; Blackburn P, 2012, METABOLISM, V61, P56, DOI 10.1016/j.metabol.2011.05.017; Conde Wolney L., 2006, J. Pediatr. (Rio J.), V82, P266, DOI 10.2223/JPED.1502; da Conceicao-Machado MEP, 2013, J PEDIAT-BRAZIL, V89, P56, DOI 10.1016/j.jped.2013.02.009; de Queiroz VM, 2010, ARQ BRAS CARDIOL, V95, P629, DOI 10.1590/S0066-782X2010001500011; Esmaillzadeh A, 2006, AM J CLIN NUTR, V83, P36; Fernandez JR, 2004, J PEDIATR-US, V145, P439, DOI 10.1016/j.jpeds.2004.06.044; *GOV BRAS, 2010, IND DAD BAS IND MORT; Hosseini-Esfahani F, 2011, J EPIDEMIOL, V21, P319, DOI 10.2188/jea.JE20100162; IDEC BG, 2005, ARQ BRAS CARDIOL, V85, P4; KLAG MJ, 1993, NEW ENGL J MED, V328, P313, DOI 10.1056/NEJM199302043280504; Kuschnir MCC, 2007, J PEDIAT, V83, P335, DOI [10.2223/JPED.1647, 10.1590/S0021-75572007000500009]; Lemieux I, 2000, CIRCULATION, V102, P179, DOI 10.1161/01.CIR.102.2.179; Moser DC, 2013, J PEDIAT-BRAZIL, V89, P243, DOI 10.1016/j.jped.2012.11.006; PEREIRA FP, 2008, MEDIDAS LOCALIZACAO, P146; Pereira PB, 2010, ARQ BRAS CARDIOL, V95, P606, DOI 10.1590/S0066-782X2010005000136; Pergher RNQ, 2010, J PEDIAT-BRAZIL, V86, P101, DOI [10.2223/JPED.1983, 10.1590/S0021-75572010000200004]; Rana JS, 2012, CURR ATHEROSCLER REP, V14, P130, DOI 10.1007/s11883-011-0224-x; Rentfro AR, 2011, PREV CHRONIC DIS, V8; Rodrigues AN, 2009, J PEDIAT-BRAZIL, V85, P55, DOI [10.2223/JPED.1867, 10.1590/S0021-75572009000100010]; Srinivasan SR, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.3.e29; *WORD HLTH ORG, 2007, GROWTH REFERENCE DAT; World Health Organization, 2011, WORLD HLTH STAT 2011	26	6	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e111724	10.1371/journal.pone.0111724	http://dx.doi.org/10.1371/journal.pone.0111724			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397885	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558500023
J	Kiya, T; Morishita, K; Uchino, K; Iwami, M; Sezutsu, H				Kiya, Taketoshi; Morishita, Koudai; Uchino, Keiro; Iwami, Masafumi; Sezutsu, Hideki			Establishment of Tools for Neurogenetic Analysis of Sexual Behavior in the Silkmoth, Bombyx mori	PLOS ONE			English	Article							LOBE PROJECTION NEURONS; ANTENNAL LOBE; SILKWORM MOTH; MACROGLOMERULAR COMPLEX; INSECT BRAINS; PHEROMONE; DROSOPHILA; GENE; INTERNEURONS; MECHANISMS	Background: Silkmoth, Bombyx mori, is an ideal model insect for investigating the neural mechanisms underlying sex pheromone-induced innate behavior. Although transgenic techniques and the GAL4/UAS system are well established in the silkmoth, genetic tools useful for investigating brain function at the neural circuit level have been lacking. Results: In the present study, we established silkmoth strains in which we could visualize neural projections (UAS-mCD8GFP) and cell nucleus positions (UAS-GFP. nls), and manipulate neural excitability by thermal stimulation (UAS-dTrpA1). In these strains, neural projections and nucleus position were reliably labeled with green fluorescent protein in a GAL4-dependent manner. Further, the behavior of silkworm larvae and adults could be controlled by GAL4-dependent misexpression of dTrpA1. Ubiquitous dTrpA1 misexpression led both silkmoth larvae and adults to exhibit seizure-like phenotypes in a heat stimulation-dependent manner. Furthermore, dTrpA1 misexpression in the sex pheromone receptor neurons of male silkmoths allowed us to control male sexual behavior by changing the temperature. Thermally stimulated male silkmoths exhibited full sexual behavior, including wing-flapping, orientation, and attempted copulation, and precisely approached a thermal source in a manner similar to male silkmoths stimulated with the sex pheromone. Conclusion: These findings indicate that a thermogenetic approach using dTrpA1 is feasible in Lepidopteran insects and thermogenetic analysis of innate behavior is applicable in the silkmoth. These tools are essential for elucidating the relationships between neural circuits and function using neurogenetic methods.	[Kiya, Taketoshi; Morishita, Koudai; Iwami, Masafumi] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Life Sci, Kanazawa, Ishikawa 9201192, Japan; [Uchino, Keiro; Sezutsu, Hideki] Natl Inst Agrobiol Sci, Transgen Silkworm Res Unit, Tsukuba, Ibaraki, Japan	Kanazawa University; National Institute of Agrobiological Sciences - Japan	Kiya, T (corresponding author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Life Sci, Kanazawa, Ishikawa 9201192, Japan.	kiya@staff.kanazawa-u.ac.jp	Kiya, Taketoshi/J-9032-2015; Kiya, Taketoshi/GVT-7846-2022; Iwami, Masafumi/C-1659-2013; Kiya, Taketoshi/ABE-6519-2020	Kiya, Taketoshi/0000-0002-5709-8016; Kiya, Taketoshi/0000-0002-5709-8016; Iwami, Masafumi/0000-0003-2385-9312; Sezutsu, Hideki/0000-0001-8886-1611; Uchino, Keiro/0000-0003-3650-7359	Sasakawa Scientific Research Grant; Hokuriku Bank; JSPS KAKENHI [24780047, 26850218, 22380034]	Sasakawa Scientific Research Grant; Hokuriku Bank; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Sasakawa Scientific Research Grant (to T.K.), the Hokuriku Bank (to T.K.), and JSPS KAKENHI Grant Number 24780047 and 26850218 (to T.K.) and 22380034 (to M.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai H, 2004, J EXP BIOL, V207, P633, DOI 10.1242/jeb.00784; Asahina K, 2014, CELL, V156, P221, DOI 10.1016/j.cell.2013.11.045; Bidaye SS, 2014, SCIENCE, V344, P97, DOI 10.1126/science.1249964; Blomquist GJ, 2003, INSECT PHEROMONE BIO; Fujii T, 2011, P NATL ACAD SCI USA, V108, P18038, DOI 10.1073/pnas.1107282108; Fujita N, 2013, CURR BIOL, V23, P2063, DOI 10.1016/j.cub.2013.08.051; Fujiwara T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089132; Fujiwara T, 2009, NEUROREPORT, V20, P1061, DOI 10.1097/WNR.0b013e32832e7d93; Gomez-Diaz C, 2013, EMBO REP, V14, P874, DOI 10.1038/embor.2013.140; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hill ES, 2003, J EXP BIOL, V206, P345, DOI 10.1242/jeb.00080; Hill ES, 2002, CHEM SENSES, V27, P475, DOI 10.1093/chemse/27.5.475; Imamura M, 2003, GENETICS, V165, P1329; KANZAKI R, 1986, BRAIN RES, V377, P378, DOI 10.1016/0006-8993(86)90885-1; Kanzaki R, 2003, CHEM SENSES, V28, P113, DOI 10.1093/chemse/28.2.113; KANZAKI R, 1992, BRAIN RES, V587, P211, DOI 10.1016/0006-8993(92)90999-P; KASANG G, 1978, NATURWISSENSCHAFTEN, V65, P337, DOI 10.1007/BF00368376; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kohatsu S, 2011, NEURON, V69, P498, DOI 10.1016/j.neuron.2010.12.017; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Matsumoto S, 2010, BIOSCI BIOTECH BIOCH, V74, P223, DOI 10.1271/bbb.90756; Namiki S, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.001.2008; Namiki S, 2008, J COMP PHYSIOL A, V194, P501, DOI 10.1007/s00359-008-0325-3; Namiki S, 2013, J COMP NEUROL, V521, P1073, DOI 10.1002/cne.23219; Namiki S, 2011, J COMP NEUROL, V519, P3367, DOI 10.1002/cne.22754; Sakudoh T, 2007, P NATL ACAD SCI USA, V104, P8941, DOI 10.1073/pnas.0702860104; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Sakurai T, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00125; Sakurai T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002115; Sato A, 2014, P NATL ACAD SCI USA, V111, pE1249, DOI 10.1073/pnas.1322134111; Seki Y, 2005, J COMP NEUROL, V481, P340, DOI 10.1002/cne.20392; Seki Y, 2008, J COMP NEUROL, V506, P93, DOI 10.1002/cne.21528; Tabuchi M, 2013, P NATL ACAD SCI USA, V110, P15455, DOI 10.1073/pnas.1313707110; Tamura T, 2000, NAT BIOTECHNOL, V18, P81, DOI 10.1038/71978; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Uchino Keiro, 2006, Journal of Insect Biotechnology and Sericology, V75, P89; Uchino K, 2008, INSECT BIOCHEM MOLEC, V38, P1165, DOI 10.1016/j.ibmb.2008.09.009; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; von Philipsborn AC, 2011, NEURON, V69, P509, DOI 10.1016/j.neuron.2011.01.011; Wada S, 2005, J COMP NEUROL, V484, P168, DOI 10.1002/cne.20452	42	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113156	10.1371/journal.pone.0113156	http://dx.doi.org/10.1371/journal.pone.0113156			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396742	gold, Green Published			2022-12-27	WOS:000345558500138
J	Song, HS; Reifman, J; Wallqvist, A				Song, Hyun-Seob; Reifman, Jaques; Wallqvist, Anders			Prediction of Metabolic Flux Distribution from Gene Expression Data Based on the Flux Minimization Principle	PLOS ONE			English	Article							ESCHERICHIA-COLI; HIGH-THROUGHPUT; NETWORK; MODELS; RECONSTRUCTION; INTEGRATION; BIOMARKERS; CANCER	Prediction of possible flux distributions in a metabolic network provides detailed phenotypic information that links metabolism to cellular physiology. To estimate metabolic steady-state fluxes, the most common approach is to solve a set of macroscopic mass balance equations subjected to stoichiometric constraints while attempting to optimize an assumed optimal objective function. This assumption is justifiable in specific cases but may be invalid when tested across different conditions, cell populations, or other organisms. With an aim to providing a more consistent and reliable prediction of flux distributions over a wide range of conditions, in this article we propose a framework that uses the flux minimization principle to predict active metabolic pathways from mRNA expression data. The proposed algorithm minimizes a weighted sum of flux magnitudes, while biomass production can be bounded to fit an ample range from very low to very high values according to the analyzed context. We have formulated the flux weights as a function of the corresponding enzyme reaction's gene expression value, enabling the creation of context-specific fluxes based on a generic metabolic network. In case studies of wild-type Saccharomyces cerevisiae, and wild-type and mutant Escherichia coli strains, our method achieved high prediction accuracy, as gauged by correlation coefficients and sums of squared error, with respect to the experimentally measured values. In contrast to other approaches, our method was able to provide quantitative predictions for both model organisms under a variety of conditions. Our approach requires no prior knowledge or assumption of a context-specific metabolic functionality and does not require trial-and-error parameter adjustments. Thus, our framework is of general applicability for modeling the transcription-dependent metabolism of bacteria and yeasts.	[Song, Hyun-Seob; Reifman, Jaques; Wallqvist, Anders] US Army Med Res & Mat Command, Dept Def, Biotechnol High Performance Comp Software Applica, Telemed & Adv Technol Res Ctr, Ft Detrick, MD 21702 USA	United States Department of Defense; United States Army	Wallqvist, A (corresponding author), US Army Med Res & Mat Command, Dept Def, Biotechnol High Performance Comp Software Applica, Telemed & Adv Technol Res Ctr, Ft Detrick, MD 21702 USA.	awallqvist@bhsai.org	wallqvist, anders/W-2584-2019	wallqvist, anders/0000-0002-9775-7469	U.S. Army Network Science Initiative	U.S. Army Network Science Initiative	This work was funded as part of the U.S. Army Network Science Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson M, 2004, METAB ENG, V6, P285, DOI 10.1016/j.ymben.2003.12.002; Becker SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000082; Blazier AS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00299; Bordbar A, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-180; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Chiaradonna F, 2012, BIOTECHNOL ADV, V30, P30, DOI 10.1016/j.biotechadv.2011.07.006; Colijn C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000489; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Fang X, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002688; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Gianchandani EP, 2010, WIRES SYST BIOL MED, V2, P372, DOI 10.1002/wsbm.60; Heavner BD, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-55; Holzhutter HG, 2004, EUR J BIOCHEM, V271, P2905, DOI 10.1111/j.1432-1033.2004.04213.x; Hyduke DR, 2013, MOL BIOSYST, V9, P167, DOI 10.1039/c2mb25453k; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Jensen PA, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-147; Jerby L, 2012, CLIN CANCER RES, V18, P5572, DOI 10.1158/1078-0432.CCR-12-1856; Kim HU, 2012, BIOTECHNOL J, V7, P330, DOI 10.1002/biot.201100159; Lee D, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-73; Lomax, 2007, STAT CONCEPTS 2 COUR; Matsushika A, 2009, APPL MICROBIOL BIOT, V84, P37, DOI 10.1007/s00253-009-2101-x; McCloskey D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.18; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Papini M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-136; RAMKRISHNA D, 1987, BIOTECHNOL PROGR, V3, P121, DOI 10.1002/btpr.5420030302; Ramkrishna D, 2012, AICHE J, V58, P986, DOI 10.1002/aic.13734; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Reed JL, 2003, J BACTERIOL, V185, P2692, DOI 10.1128/JB.185.9.2692-2699.2003; Rossell S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002988; Sauer U, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100109; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Schuetz R, 2012, SCIENCE, V336, P601, DOI 10.1126/science.1216882; Schuster S, 2008, J THEOR BIOL, V252, P497, DOI 10.1016/j.jtbi.2007.12.008; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Thiele I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045635; Vital-Lopez FG, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-63; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58; Zur H, 2010, BIOINFORMATICS, V26, P3140, DOI 10.1093/bioinformatics/btq602	41	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112524	10.1371/journal.pone.0112524	http://dx.doi.org/10.1371/journal.pone.0112524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397773	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558500057
J	Har, RLH; Reich, HN; Scholey, JW; Daneman, D; Dunger, DB; Moineddin, R; Dalton, RN; Motran, L; Elia, Y; Deda, L; Ostrovsky, M; Sochett, EB; Mahmud, FH; Cherney, DZI				Har, Ron L. H.; Reich, Heather N.; Scholey, James W.; Daneman, Denis; Dunger, David B.; Moineddin, Rahim; Dalton, R. Neil; Motran, Laura; Elia, Yesmino; Deda, Livia; Ostrovsky, Masha; Sochett, Etienne B.; Mahmud, Farid H.; Cherney, David Z. I.			The Urinary Cytokine/Chemokine Signature of Renal Hyperfiltration in Adolescents with Type 1 Diabetes	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; GLOMERULAR-FILTRATION-RATE; FUNCTION DECLINE; CYSTATIN C; URIC-ACID; INFLAMMATORY CYTOKINES/CHEMOKINES; ENDOTHELIAL FUNCTION; 2 INHIBITION; NEPHROPATHY; MELLITUS	Objective: Urinary cytokine/chemokine levels are elevated in adults with type 1 diabetes (T1D) exhibiting renal hyperfiltration. Whether this observation extends to adolescents with T1D remains unknown. Our first objective was to determine the relationship between hyperfiltration and urinary cytokines/chemokines in normotensive, normoalbuminuric adolescents with T1D using GFRcystatin. Our second aim was to determine the relationship between urine and plasma levels of inflammatory biomarkers, to clarify the origin of these factors. Methods: Urine and serum cytokines/chemokines (Luminex platform) and GFRcystatin were measured in normofiltering (n = 111, T1D-N, GFR<135 ml/min/1.73 m(2)) and hyperfiltering (n = 31, T1D-H, GFR >= 135 ml/min/1.73 m(2)) adolescents with T1D (ages 10-16), and in age and sex matched healthy control subjects (HC, n = 59). Results: We noted significant step-wise increases in urinary cytokine/chemokine excretion according to filtration status with highest levels in T1D-H, with parallel trends in serum analyte concentrations. After adjusting for serum glucose at the time of sampling, differences in urinary cytokine excretion were not statistically significant. Only serum IL-2 significantly differed between HC and T1D (p = 0.0076). Conclusions: Hyperfiltration is associated with increased urinary cytokine/chemokine excretion in T1D adolescents, and parallel trends in serum cytokine concentration. The GFR-associated trends in cytokine excretion may be driven by the effects of ambient hyperglycemia. The relationship between hyperfiltration, glycemia, and variations in serum and urine cytokine expression and their impact on future renal and systemic vascular complications requires further study.	[Har, Ron L. H.; Cherney, David Z. I.] Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Banting & Best Diabet Ctr,Div Nephrol, Toronto, ON M5G 1L7, Canada; [Reich, Heather N.; Scholey, James W.] Toronto Gen Hosp, Univ Hlth Network, Div Nephrol, Toronto, ON, Canada; [Daneman, Denis; Motran, Laura; Elia, Yesmino; Deda, Livia; Ostrovsky, Masha; Sochett, Etienne B.; Mahmud, Farid H.] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Endocrinol, Toronto, ON M5G 1L7, Canada; [Dunger, David B.] Univ Cambridge, Dept Pediat, Cambridge, England; [Moineddin, Rahim] Univ Toronto, Toronto, ON M5G 1L7, Canada; [Dalton, R. Neil] St Thomas Hosp, Evelina Childrens Hosp, WellChild Lab, London, England	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Cambridge; University of Toronto; Guy's & St Thomas' NHS Foundation Trust	Cherney, DZI (corresponding author), Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Banting & Best Diabet Ctr,Div Nephrol, Toronto, ON M5G 1L7, Canada.	david.cherney@uhn.on.ca		Dunger, Professor David/0000-0002-2566-9304	Juvenile Diabetes Research Foundation; Juvenile Diabetes Research Foundation - Canadian Clinical Trials Network (JDRF-CCTN); Heart and Stroke Foundation of Canada; Canadian Diabetes Association; Banting and Best Studentship; Hilda and William Courtney Clayton Pediatric Research Fund; Kidney Foundation of Canada Scholarship; Canadian Diabetes Association-KRESCENT Program Joint New Investigator Award; Diabetes UK [06/0003341] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10012, NF-SI-0508-10274] Funding Source: researchfish	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Juvenile Diabetes Research Foundation - Canadian Clinical Trials Network (JDRF-CCTN); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Diabetes Association; Banting and Best Studentship; Hilda and William Courtney Clayton Pediatric Research Fund; Kidney Foundation of Canada Scholarship; Canadian Diabetes Association-KRESCENT Program Joint New Investigator Award; Diabetes UK(Diabetes UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by operating grants from the Juvenile Diabetes Research Foundation, Juvenile Diabetes Research Foundation - Canadian Clinical Trials Network (JDRF-CCTN), the Heart and Stroke Foundation of Canada and the Canadian Diabetes Association. RLH is supported by a Banting and Best Studentship and the Hilda and William Courtney Clayton Pediatric Research Fund. DZIC was also supported by a Kidney Foundation of Canada Scholarship and a Canadian Diabetes Association-KRESCENT Program Joint New Investigator Award and receives operating support from the Heart and Stroke Foundation of Canada and the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AdDIT Study Group, 2009, BMC PEDIATR, V9, P79; Bacchetta J, 2011, CLIN J AM SOC NEPHRO, V6, P552, DOI 10.2215/CJN.04180510; Banba N, 2000, KIDNEY INT, V58, P684, DOI 10.1046/j.1523-1755.2000.00214.x; Cherney DZI, 2012, DIABETIC MED, V29, P1297, DOI 10.1111/j.1464-5491.2012.03651.x; Cherney DZI, 2010, DIABETIC MED, V27, P1358, DOI 10.1111/j.1464-5491.2010.03121.x; Cherney DZI, 2014, CIRCULATION, V129, P587, DOI 10.1161/CIRCULATIONAHA.113.005081; Cherney DZI, 2012, AM J PHYSIOL-REG I, V303, pR710, DOI 10.1152/ajpregu.00286.2012; Cherney DZI, 2011, DIABETES CARE, V34, P177, DOI 10.2337/dc10-1219; Cherney DZI, 2010, DIABETES CARE, V33, P1344, DOI 10.2337/dc09-2340; Cherney DZI, 2008, CURR DIABETES REV, V4, P280, DOI 10.2174/157339908786241151; Cherney DZI, 2013, DIABETOLOGIA; Cherney DZI, 2012, DIABETIC MED; Dwyer JP, 2012, CARDIORENAL MED, V2, P1, DOI 10.1159/000333249; Fagan NM, 2013, CIRCULATION IN PRESS; Har R, 2013, DIABETOLOGIA, V56, P1166, DOI 10.1007/s00125-013-2857-5; HOURD P, 1991, DIABETIC MED, V8, P237, DOI 10.1111/j.1464-5491.1991.tb01579.x; Litwin M, 2010, PEDIATR NEPHROL, V25, P1711, DOI 10.1007/s00467-010-1548-4; Magee GM, 2009, DIABETOLOGIA, V52, P691, DOI 10.1007/s00125-009-1268-0; Mauer M, 2009, NEW ENGL J MED, V361, P40, DOI 10.1056/NEJMoa0808400; Mene P, 2008, J HYPERTENS, V26, P2085, DOI 10.1097/HJH.0b013e32830e4945; Merchant ML, 2009, J AM SOC NEPHROL, V20, P2065, DOI 10.1681/ASN.2008121233; Mezzano S, 2003, KIDNEY INT, V64, pS64, DOI 10.1046/j.1523-1755.64.s86.12.x; Morii T, 2003, J DIABETES COMPLICAT, V17, P11, DOI 10.1016/S1056-8727(02)00176-9; Moriya T, 2012, KIDNEY INT, V81, P486, DOI 10.1038/ki.2011.404; Odutayo A, 2012, CLIN NEPHROL, V78, P64, DOI 10.5414/CN107324; Pecis M, 1997, DIABETES CARE, V20, P1329, DOI 10.2337/diacare.20.8.1329; Perkins BA, 2007, J AM SOC NEPHROL, V18, P1353, DOI 10.1681/ASN.2006080872; Perkins BA, 2012, CLIN EXP HYPERTENS, V34, P606, DOI 10.3109/10641963.2012.681732; Perkins BA, 2009, CURR OPIN NEPHROL HY, V18, P233, DOI 10.1097/MNH.0b013e3283293db1; RAO GN, 1991, J BIOL CHEM, V266, P8604; Riser BL, 1996, AM J PATHOL, V148, P1915; RISER BL, 1992, J CLIN INVEST, V90, P1932, DOI 10.1172/JCI116071; Ruggenenti P, 2012, DIABETES CARE, V35, P2061, DOI 10.2337/dc11-2189; Sanchez-Lozada LG, 2006, CURR OPIN NEPHROL HY, V15, P30, DOI 10.1097/01.mnh.0000199010.33929.7f; Sasson AN, 2012, WORLD J DIABETES, V3, P1, DOI 10.4239/wjd.v3.i1.1; Schultz CJ, 2001, DIABETOLOGIA, V44, P224, DOI 10.1007/s001250051603; Shannon H, 2000, NEW ENGL J MED, V342, P381; Sochett EB, 2006, J AM SOC NEPHROL, V17, P1703, DOI 10.1681/ASN.2005080872; Tominaga M, 2010, J INTERF CYTOK RES, V30, P451, DOI 10.1089/jir.2009.0085; Wada T, 2000, KIDNEY INT, V58, P1492, DOI 10.1046/j.1523-1755.2000.00311.x; Wolkow PP, 2008, J AM SOC NEPHROL, V19, P789, DOI 10.1681/ASN.2007050556; Yang GK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068908, 10.1371/journal.pone.0078355]	42	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e111131	10.1371/journal.pone.0111131	http://dx.doi.org/10.1371/journal.pone.0111131			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392936	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300010
J	Magalhaes, WF; Seixas, VC; Paiva, PC; Elias, R				Magalhaes, Wagner F.; Seixas, Victor Correa; Paiva, Paulo Cesar; Elias, Rodolfo			The Multitentaculate Cirratulidae of the Genera Cirriformia and Timarete (Annelida: Polychaeta) from Shallow Waters of Brazil	PLOS ONE			English	Article							COAST	A large number multitentaculate cirratulids have been described worldwide but most are only known through the original descriptions. Type material, voucher and recently collected specimens from Brazil were revisited in order to reveal their true identity and confirm the records of widely distributed species in this region. Six species are described, three of which are new, Cirriformia capixabensis sp. nov., Cirriformia chicoi sp. nov. and Timarete ceciliae sp. nov. COI and 16S sequences were obtained and used for inter-specific comparisons. Timarete caribous is reported from several localities along the Brazilian coast and a new synonym, Cirratulus melanacanthus, is proposed. The species Timarete oculata, originally described from Brazil and lumped into the Timarete filigera species complex, is herein revalidated and redescribed. The occurrence of the species Timarete filigera and Cirriformia tentaculata is not confirmed from the Brazilian coast. Descriptions, illustrations and a key to genera and species are provided.	[Magalhaes, Wagner F.] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA; [Seixas, Victor Correa; Paiva, Paulo Cesar] Univ Fed Rio de Janeiro, Dept Zool, Rio De Janeiro, Brazil; [Elias, Rodolfo] Univ Nacl Mar del Plata, Dept Ciencias Marinas, Mar Del Plata, Buenos Aires, Argentina	University of Hawaii System; University of Hawaii Manoa; Universidade Federal do Rio de Janeiro; National University of Mar del Plata	Magalhaes, WF (corresponding author), Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA.	wagnerfm@hawaii.edu	Seixas, Victor Correa/M-6934-2019; Magalhães, Wagner F/G-6458-2016; Paiva, Paulo C/I-6174-2012; de Paiva, Paulo Cesar/N-1234-2019	Seixas, Victor Correa/0000-0002-2067-9490; Magalhães, Wagner F/0000-0002-9285-4008; Paiva, Paulo C/0000-0003-1061-6549; de Paiva, Paulo Cesar/0000-0003-1061-6549	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	The work was supported by the following: PP VS - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral A.C.Z., 2006, CATALOGO ESPECIES AN CATALOGO ESPECIES AN; Blake J.A., 1996, TAXONOMIC ATLAS BE 3, V6, P263; BLAKE JA, 1975, T AM MICROSC SOC, V94, P179, DOI 10.2307/3224978; Cinar ME, 2007, SCI MAR, V71, P755; Cinar ME, 2009, J NAT HIST, V43, P2283, DOI 10.1080/00222930903094654; DAY J. H., 1962, PROC ZOOL SOC LONDON, V139, P627; Ehlers E., 1897, ERGEBNISSE HAMBURGER, V3, P1; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Grube A.E., 1873, JAHRESBERICHT SCHLES, V50, P59; Grube AE, 1859, ANNULATA ORSTEDIAN 3, P105; Grube AE, 1869, BESCHREIBUNGEN NEUER, P484; Hansen G.A., 1882, MEMOIRES COURONNES M, V44, P1; Hartman O, 1959, OCCAS PAP A HANCOCK; HARTMAN OLGA, 1966, OCCAS PAP BERNICE PAVAHI BISHOP MUS, V23, P163; Hartman Olga, 1942, PROC U S NATION MUS, V92, P101; HARTMAN OLGA, 1948, ARKIV ZOOL [STOCKHOLM], V42A, P1; HARTMAN OLGA, 1956, BULL AMER MUS NAT HIST, V109, P239; Imajima M., 1964, OCCASIONAL PAPER, V26, P1; Kinberg J.G.H., 1866, STOCKHOLM, V23, P337; KIRKEGAARD J B, 1981, Steenstrupia, V7, P261; Magalhaes Wagner F., 2010, Zootaxa, V2625, P53; Montagu G, 1808, T LINN SOC LOND, V9, P81, DOI DOI 10.1111/J.1096-3642.1804.TB00282.X; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; Petersen ME, 1999, HYDROBIOLOGIA, V402, P107, DOI 10.1023/A:1003736408195; Quatrefages A, 1866, ANNELIDES GEPHYRIENS, V2, P1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TREADWELL A[ARON] L., 1936, ZOOLOGICA [NEW YORK], V21, P49; Treadwell A.L., 1932, REV MUS PAULISTA, V17, P1; Verrill A. E., 1900, T CONNECTICUT ACAD A, V10, P595, DOI [10.5962/bhl.part.7035, DOI 10.5962/BHL.PART.7035]; WILSON DOUGLAS P., 1936, JOUR MARINE BIOL ASSOC UNITED KINGDOM, V20, P567; Zanol J, 2010, MOL PHYLOGENET EVOL, V55, P660, DOI 10.1016/j.ympev.2009.12.024	32	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112727	10.1371/journal.pone.0112727	http://dx.doi.org/10.1371/journal.pone.0112727			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393759	Green Submitted, Green Published, gold			2022-12-27	WOS:000347709300090
J	Peng, J; Lai, ZG; Fang, ZL; Xing, S; Hui, K; Hao, C; Jin, Q; Qi, Z; Shen, WJ; Dong, QN; Bing, ZH; Fu, DL				Peng, Jia; Lai, Zuo Gui; Fang, Zhang Lian; Xing, Shen; Hui, Kang; Hao, Chen; Jin, Qi; Qi, Zhou; Shen, Wang Jin; Dong, Qian Nian; Bing, Zhou Han; Fu, Deng Lian			Dimethyloxalylglycine Prevents Bone Loss in Ovariectomized C57BL/6J Mice through Enhanced Angiogenesis and Osteogenesis	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; CONSTITUTIVELY ACTIVE FORM; BIOACTIVE GLASS SCAFFOLDS; GROWTH-FACTOR EXPRESSION; MARROW STROMAL CELLS; STEM-CELLS; POSTMENOPAUSAL OSTEOPOROSIS; CALVARIAL DEFECTS; ENGINEERED BONE; MINERAL DENSITY	Hypoxia-inducible factor 1-alpha (HIF-1 alpha) plays a critical role in angiogenesis-osteogenesis coupling during bone development and bone regeneration. Previous studies have shown that 17 beta-estradiol activates the HIF-1 alpha signaling pathway and that mice with conditional activation of the HIF-1 alpha signaling pathway in osteoblasts are protected from ovariectomy (OVX)-induced bone loss. In addition, it has been shown that hypoxia facilitates the osteogenic differentiation of mesenchymal stem cells (MSCs) and modulates Wnt/beta-catenin signaling. Therefore, we hypothesized that activation of the HIF-1 alpha signaling pathway by hypoxia-mimicking agents would prevent bone loss due to estrogen deficiency. In this study, we confirmed the effect of dimethyloxalylglycine (DMOG), a hypoxia-mimicking agent, on the HIF-1 alpha signaling pathway and investigated the effect of DMOG on MSC osteogenic differentiation and the Wnt/beta-catenin signaling pathway. We then investigated the effect of DMOG treatment on OVX-induced bone loss. Female C57BL/6J mice were divided into sham, OVX, OVX+ L-DMOG (5 mg/kg/day), and OVX+ H-DMOG (20 mg/kg/day) groups. At sacrifice, static and dynamic bone histomorphometry were performed with micro computed tomography (micro-CT) and undecalcified sections, respectively. Bone strength was assessed with the three-point bending test, and femur vessels were reconstructed and analyzed by micro-CT. Serum vascular endothelial growth factor (VEGF), osteocalcin, and C-terminal telopeptides of collagen type(CTX) were measured by ELISA. Tartrate-resistant acid phosphatase staining was used to assess osteoclast formation. Alterations in the HIF-1 alpha and Wnt/beta-catenin signaling pathways in the bone were detected by western blot. Our results showed that DMOG activated the HIF-1 alpha signaling pathway, which further activated the Wnt/beta-catenin signaling pathway and enhanced MSC osteogenic differentiation. The micro-CT results showed that DMOG treatment improved trabecular bone density and restored the bone microarchitecture and blood vessels in OVX mice. Bone strength was also partly restored in DMOGtreated OVX mice. Dynamic bone histomorphometric analysis of the femur metaphysic revealed that DMOG increased the mineralizing surface, mineral apposition rate, and bone formation rate. The serum levels of VEGF and osteocalcin were higher in DMOG-treated OVX mice. However, there were no significant differences in serum CTX or in the number of tartrate-resistant acid phosphatase-stained cells between DMOG-treated OVX mice and OVX mice. Western blot results showed that DMOG administration partly rescued the decrease in HIF-1 alpha and beta-catenin expression following ovariectomy. Collectively, these results indicate that DMOG prevents bone loss due to ovariectomy in C57BL/6J mice by enhancing angiogenesis and osteogenesis, which are associated with activated HIF-1 alpha and Wnt/beta-catenin signaling pathways.	[Peng, Jia; Lai, Zuo Gui; Fang, Zhang Lian; Xing, Shen; Hui, Kang; Hao, Chen; Jin, Qi; Qi, Zhou; Shen, Wang Jin; Dong, Qian Nian; Bing, Zhou Han; Fu, Deng Lian] Jiao Tong Univ, Shanghai Inst Traumatol & Orthopaed, Shanghai Key Lab Prevent & Treatment Bone & Joint, Ruijin Hosp,Sch Med, Shanghai 200030, Peoples R China; [Lai, Zuo Gui] Shang Dong Univ, Qian Fo Shan Hosp, Dept Orthopaed, Jinan, Peoples R China; [Fang, Zhang Lian] Soochow Univ, Affiliated Hosp 1, Dept Orthopaed, Suzhou, Peoples R China	Shanghai Jiao Tong University; Soochow University - China	Fu, DL (corresponding author), Jiao Tong Univ, Shanghai Inst Traumatol & Orthopaed, Shanghai Key Lab Prevent & Treatment Bone & Joint, Ruijin Hosp,Sch Med, Shanghai 200030, Peoples R China.	china_boneres@163.com	Hui, Kang/GYJ-5601-2022		Natural Science Foundation of China [81371958, 81061160510]; Basic Key Project of Science and Technology Commission of Shanghai Municipality [12JC1408200]; Scientific and Technological Support Program in Biological Medicine of Science and Technology Commission of Shanghai Municipality [13431900702]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Key Project of Science and Technology Commission of Shanghai Municipality; Scientific and Technological Support Program in Biological Medicine of Science and Technology Commission of Shanghai Municipality	Deng Lian Fu received funds from Natural Science Foundation of China (No. 81371958, 81061160510), the Basic Key Project of Science and Technology Commission of Shanghai Municipality (12JC1408200), and the Scientific and Technological Support Program in Biological Medicine of Science and Technology Commission of Shanghai Municipality (13431900702) http://www.nsfc.gov.cn/ http://www.stcsm.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bidwell JP, 2013, CURR OSTEOPOROS REP, V11, P117, DOI 10.1007/s11914-013-0139-2; Botusan IR, 2008, P NATL ACAD SCI USA, V105, P19426, DOI 10.1073/pnas.0805230105; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brandi ML, 2006, J BONE MINER RES, V21, P183, DOI 10.1359/JBMR.050917; Chapurlat RD, 2009, OSTEOPOROSIS INT, V20, P1299, DOI 10.1007/s00198-009-0899-9; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Ding H, 2014, STEM CELLS DEV, V23, P990, DOI 10.1089/scd.2013.0486; Ding WG, 2011, CONNECT TISSUE RES, V52, P25, DOI 10.3109/03008201003783011; Donneys A, 2013, BONE, V52, P318, DOI 10.1016/j.bone.2012.10.014; Fan W, 2010, BIOMATERIALS, V31, P3580, DOI 10.1016/j.biomaterials.2010.01.083; Farberg AS, 2012, BONE, V50, P1184, DOI 10.1016/j.bone.2012.01.019; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Genetos DC, 2010, J CELL BIOCHEM, V110, P457, DOI 10.1002/jcb.22559; Grewal BS, 2014, J ORTHOP, V11, P5, DOI 10.1016/j.jor.2013.12.005; Griffith JF, 2010, RADIOLOGY, V254, P739, DOI 10.1148/radiol.09090608; Henriksen K, 2007, OSTEOPOROSIS INT, V18, P681, DOI 10.1007/s00198-006-0286-8; Ishii K, 2009, NAT MED, V15, P259, DOI 10.1038/nm.1910; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jia P, 2012, J ORTHOP RES, V30, P1843, DOI 10.1002/jor.22133; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Li L, 2013, CELL MOL BIOL, V59, P1889, DOI 10.1170/225; Liu LZ, 2011, STEM CELLS DEV, V20, P1961, DOI 10.1089/scd.2010.0453; Liu XD, 2007, ZHONGHUA WAI KE ZA Z, V45, P1274; Liu YQ, 2012, J CLIN INVEST, V122, P3101, DOI 10.1172/JCI61209; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Maes C, 2010, EMBO J, V29, P424, DOI 10.1038/emboj.2009.361; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Mekraldi S, 2003, BONE, V32, P630, DOI 10.1016/S8756-3282(03)00099-1; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Mueller MD, 2000, P NATL ACAD SCI USA, V97, P10972, DOI 10.1073/pnas.200377097; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Patel TH, 2005, CARDIOVASC RES, V68, P144, DOI 10.1016/j.cardiores.2005.05.002; Poynter JA, 2011, SURGERY, V150, P278, DOI 10.1016/j.surg.2011.06.006; Pufe T, 2007, CALCIFIED TISSUE INT, V80, P184, DOI 10.1007/s00223-006-0275-0; Qu B, 2014, OSTEOPOROSIS INT, V25, P1853, DOI 10.1007/s00198-014-2699-0; Qu ZH, 2008, BIOCHEM BIOPH RES CO, V370, P332, DOI 10.1016/j.bbrc.2008.03.092; Rankin EB, 2012, CELL, V149, P63, DOI 10.1016/j.cell.2012.01.051; Ren HY, 2006, BIOCHEM BIOPH RES CO, V347, P12, DOI 10.1016/j.bbrc.2006.05.169; Rey S, 2009, P NATL ACAD SCI USA, V106, P20399, DOI 10.1073/pnas.0911921106; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rossini M, 2013, CALCIFIED TISSUE INT, V93, P121, DOI 10.1007/s00223-013-9749-z; Senel K, 2013, ARCH MED SCI, V9, P709, DOI 10.5114/aoms.2013.36896; Shen X, 2009, J ORTHOP RES, V27, P1298, DOI 10.1002/jor.20886; Shih TTF, 2004, RADIOLOGY, V233, P121, DOI 10.1148/radiol.2331031509; Shin DH, 2007, CANCER LETT, V255, P107, DOI 10.1016/j.canlet.2007.03.026; Song YR, 2010, NEPHROL DIAL TRANSPL, V25, P77, DOI 10.1093/ndt/gfp454; Spencer GJ, 2006, J CELL SCI, V119, P1283, DOI 10.1242/jcs.02883; Stewart R, 2011, J ORTHOP TRAUMA, V25, P472, DOI 10.1097/BOT.0b013e31822588d8; Sun Y, 2013, CELL PHYSIOL BIOCHEM, V31, P579, DOI 10.1159/000350078; Takaku M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042964; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Vogt MT, 1997, J BONE MINER RES, V12, P283, DOI 10.1359/jbmr.1997.12.2.283; Wagegg M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046483; Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Weng TJ, 2014, J BONE MINER RES, V29, P820, DOI 10.1002/jbmr.2087; Wu CT, 2013, ACTA BIOMATER, V9, P9159, DOI 10.1016/j.actbio.2013.06.026; Wu CT, 2012, BIOMATERIALS, V33, P2076, DOI 10.1016/j.biomaterials.2011.11.042; Xu XJ, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/534352; Yang N, 2013, J BONE MINER RES, V28, P559, DOI 10.1002/jbmr.1798; Yen ML, 2005, MOL PHARMACOL, V68, P1061, DOI 10.1124/mol.104.010082; Yun SP, 2009, AM J PHYSIOL-CELL PH, V296, pC317, DOI 10.1152/ajpcell.00415.2008; Zelzer E, 1998, EMBO J, V17, P5085, DOI 10.1093/emboj/17.17.5085; Zhang WB, 2012, J ORTHOP SCI, V17, P289, DOI 10.1007/s00776-012-0206-z; Zhao HX, 2010, BASIC RES CARDIOL, V105, P109, DOI 10.1007/s00395-009-0044-0; Zhao Q, 2012, BONE, V50, P763, DOI 10.1016/j.bone.2011.12.003; Zou DH, 2012, BIOMATERIALS, V33, P2097, DOI 10.1016/j.biomaterials.2011.11.053; Zou DH, 2011, BIOMATERIALS, V32, P9707, DOI 10.1016/j.biomaterials.2011.09.005; Zou DH, 2011, STEM CELLS, V29, P1380, DOI 10.1002/stem.693	71	50	59	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112744	10.1371/journal.pone.0112744	http://dx.doi.org/10.1371/journal.pone.0112744			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25394221	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300093
J	Potuckova, E; Hruskova, K; Bures, J; Kovarikova, P; Spirkova, IA; Pravdikova, K; Kolbabova, L; Hergeselova, T; Haskova, P; Jansova, H; Machacek, M; Jirkovska, A; Richardson, V; Lane, DJR; Kalinowski, DS; Richardson, DR; Vavrova, K; Simunek, T				Potuckova, Eliska; Hruskova, Katerina; Bures, Jan; Kovarikova, Petra; Spirkova, Iva A.; Pravdikova, Katerina; Kolbabova, Lucie; Hergeselova, Tereza; Haskova, Pavlina; Jansova, Hana; Machacek, Miloslav; Jirkovska, Anna; Richardson, Vera; Lane, Darius J. R.; Kalinowski, Danuta S.; Richardson, Des R.; Vavrova, Katerina; Simunek, Tomas			Structure-Activity Relationships of Novel Salicylaldehyde Isonicotinoyl Hydrazone (SIH) Analogs: Iron Chelation, Anti-Oxidant and Cytotoxic Properties	PLOS ONE			English	Article							EFFECTIVE ANTIPROLIFERATIVE AGENTS; ATOMIC PHYSICOCHEMICAL PARAMETERS; SELECTIVE ANTITUMOR-ACTIVITY; OXIDATIVE STRESS; QUANTITATIVE STRUCTURE; OVERLOAD DISEASE; LABILE IRON; IN-VIVO; PYRIDOXAL; POTENT	Salicylaldehyde isonicotinoyl hydrazone (SIH) is a lipophilic, tridentate iron chelator with marked anti-oxidant and modest cytotoxic activity against neoplastic cells. However, it has poor stability in an aqueous environment due to the rapid hydrolysis of its hydrazone bond. In this study, we synthesized a series of new SIH analogs (based on previously described aromatic ketones with improved hydrolytic stability). Their structure-activity relationships were assessed with respect to their stability in plasma, iron chelation efficacy, redox effects and cytotoxic activity against MCF-7 breast adenocarcinoma cells. Furthermore, studies assessed the cytotoxicity of these chelators and their ability to afford protection against hydrogen peroxide-induced oxidative injury in H9c2 cardiomyoblasts. The ligands with a reduced hydrazone bond, or the presence of bulky alkyl substituents near the hydrazone bond, showed severely limited biological activity. The introduction of a bromine substituent increased ligand-induced cytotoxicity to both cancer cells and H9c2 cardiomyoblasts. A similar effect was observed when the phenolic ring was exchanged with pyridine (i.e., changing the ligating site from O, N, O to N, N, O), which led to pro-oxidative effects. In contrast, compounds with long, flexible alkyl chains adjacent to the hydrazone bond exhibited specific cytotoxic effects against MCF-7 breast adenocarcinoma cells and low toxicity against H9c2 cardiomyoblasts. Hence, this study highlights important structure-activity relationships and provides insight into the further development of aroylhydrazone iron chelators with more potent and selective anti-neoplastic effects.	[Potuckova, Eliska; Hruskova, Katerina; Bures, Jan; Kovarikova, Petra; Spirkova, Iva A.; Pravdikova, Katerina; Kolbabova, Lucie; Hergeselova, Tereza; Haskova, Pavlina; Jansova, Hana; Machacek, Miloslav; Jirkovska, Anna; Vavrova, Katerina; Simunek, Tomas] Charles Univ Prague, Fac Pharm Hradec Kralove, Hradec Kralove, Czech Republic; [Richardson, Vera; Lane, Darius J. R.; Kalinowski, Danuta S.; Richardson, Des R.] Univ Sydney, Bosch Inst, Mol Pharmacol & Pathol Program, Sydney, NSW 2006, Australia; [Richardson, Vera; Lane, Darius J. R.; Kalinowski, Danuta S.; Richardson, Des R.] Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia	Charles University Prague; University of Sydney; University of Sydney	Vavrova, K (corresponding author), Charles Univ Prague, Fac Pharm Hradec Kralove, Hradec Kralove, Czech Republic.	Katerina.Vavrova@faf.cuni.cz; Tomas.Simunek@faf.cuni.cz	Hašková, Pavlína/ABC-6019-2021; Simunek, Tomas/A-3938-2008; Jansova, Hana/S-5847-2017; Vavrova, Katerina/A-2895-2008; Jirkovska, Anna/E-8419-2012; Sterbova, Petra/T-5493-2017; Machacek, Miloslav/T-3378-2017	Simunek, Tomas/0000-0001-5464-4176; Jansova, Hana/0000-0002-5377-518X; Vavrova, Katerina/0000-0002-8502-4372; Jirkovska, Anna/0000-0002-0131-6010; Sterbova, Petra/0000-0002-1242-5706; Machacek, Miloslav/0000-0001-7221-5914; Richardson, Des/0000-0002-5506-3274; Richardson, Des/0000-0003-0960-6415; Haskova, Pavlina/0000-0002-1179-8885; Kalinowski, Danuta/0000-0002-9303-7405; Lane, Darius/0000-0001-8725-6903	Charles University in Prague [GAUK 299511, SVV 260065, 260062]; Czech Science Foundation [13-15008S]; European Social Fund; State Budget of the Czech Republic [CZ.1.07/2.3.00/30.0061]; National Health and Medical Research Council Australia (NHMRC) [632778]; Cancer Institute New South Wales [08/ECF/1-30, 10/ECF/2 18]; NHMRC of Australia [1013810]; NHMRC [571123]	Charles University in Prague; Czech Science Foundation(Grant Agency of the Czech Republic); European Social Fund(European Social Fund (ESF)); State Budget of the Czech Republic; National Health and Medical Research Council Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute New South Wales; NHMRC of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the Charles University in Prague (www.cuni.cz; projects GAUK 299511, SVV 260065 and 260062), the Czech Science Foundation (www.gacr.cz; grant 13-15008S), and the European Social Fund and the State Budget of the Czech Republic (www.msmt.cz; Operational Program CZ.1.07/2.3.00/30.0061). This work was also funded by a Project Grant from the National Health and Medical Research Council Australia (NHMRC; www.nhmrc.gov.au) to D.R.R. [Grant 632778]; a NHMRC Senior Principal Research Fellowship to D.R.R. [Grant 571123]; and a Cancer Institute New South Wales (cancerinstitute.org.au) Early Career Development Fellowship to D.S.K. [Grant 08/ECF/1-30]. D.J.R.L. thanks the Cancer Institute New South Wales for an Early Career Fellowship [10/ECF/2 18] and the NHMRC of Australia for an Early Career Postdoctoral Fellowship [1013810]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arredondo Miguel, 2005, Molecular Aspects of Medicine, V26, P313, DOI 10.1016/j.mam.2005.07.010; BAKER E, 1992, HEPATOLOGY, V15, P492, DOI 10.1002/hep.1840150323; Becker E, 1999, J LAB CLIN MED, V134, P510, DOI 10.1016/S0022-2143(99)90173-7; Becker EM, 2003, BRIT J PHARMACOL, V138, P819, DOI 10.1038/sj.bjp.0705089; Bendova P, 2010, CHEM RES TOXICOL, V23, P1105, DOI 10.1021/tx100125t; Berndt C, 2010, BIOCHEM J, V432, P295, DOI 10.1042/BJ20100996; Bernhardt PV, 2008, J BIOL INORG CHEM, V13, P107, DOI 10.1007/s00775-007-0300-4; BROTO P, 1984, EUR J MED CHEM, V19, P71; Chaston TB, 2004, CLIN CANCER RES, V10, P7365, DOI 10.1158/1078-0432.CCR-04-0865; Chaston TB, 2003, J BIOL INORG CHEM, V8, P427, DOI 10.1007/s00775-002-0434-3; Chaston TB, 2003, CLIN CANCER RES, V9, P402; Cooper CE, 1996, J BIOL CHEM, V271, P20291, DOI 10.1074/jbc.271.34.20291; DUBOIS JE, 1992, INORG CHEM, V31, P853, DOI 10.1021/ic00031a030; Dunn LL, 2007, TRENDS CELL BIOL, V17, P93, DOI 10.1016/j.tcb.2006.12.003; EDWARD JT, 1988, J CHEM ENG DATA, V33, P538, DOI 10.1021/je00054a044; Esposito BP, 2002, ANAL BIOCHEM, V304, P1, DOI 10.1006/abio.2002.5611; Fillebeen C, 2010, J HEPATOL, V53, P995, DOI 10.1016/j.jhep.2010.04.044; GHOSE AK, 1987, J CHEM INF COMP SCI, V27, P21, DOI 10.1021/ci00053a005; Glickstein H, 2006, BLOOD, V108, P3195, DOI 10.1182/blood-2006-05-020867; GUTTERIDGE JMC, 1979, BIOCHEM J, V184, P469, DOI 10.1042/bj1840469; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Horackova M, 2000, CARDIOVASC RES, V47, P529, DOI 10.1016/S0008-6363(00)00088-2; Hruskova K, 2011, CHEM RES TOXICOL, V24, P290, DOI 10.1021/tx100359t; Jiang XP, 2010, ANTICANCER RES, V30, P759; Kalia J, 2008, ANGEW CHEM INT EDIT, V47, P7523, DOI 10.1002/anie.200802651; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Kitazawa M, 1999, BBA-GEN SUBJECTS, V1473, P400, DOI 10.1016/S0304-4165(99)00203-2; Klimtova Ivona, 2003, Acta Medica (Hradec Kralove), V46, P163; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; Kovarikova P, 2008, J PHARMACEUT BIOMED, V47, P360, DOI 10.1016/j.jpba.2008.01.011; Lane DJR, 2014, BBA-REV CANCER, V1845, P166, DOI 10.1016/j.bbcan.2014.01.005; Lawen A, 2013, ANTIOXID REDOX SIGN, V18, P2473, DOI 10.1089/ars.2011.4271; Le NTV, 2002, BBA-REV CANCER, V1603, P31, DOI 10.1016/S0304-419X(02)00068-9; Leidgens S, 2013, J BIOL CHEM, V288, P17791, DOI 10.1074/jbc.M113.460253; Lovejoy DB, 2012, J MED CHEM, V55, P7230, DOI 10.1021/jm300768u; Mackova E, 2012, CHEM-BIOL INTERACT, V197, P69, DOI 10.1016/j.cbi.2012.03.010; Merlot AM, 2013, ANTIOXID REDOX SIGN, V18, P973, DOI 10.1089/ars.2012.4540; Mladenka P, 2009, CHEM RES TOXICOL, V22, P208, DOI 10.1021/tx800331j; Napier I, 2005, BLOOD, V105, P1867, DOI 10.1182/blood-2004-10-3856; Pinnix ZK, 2010, SCI TRANSL MED, V2, DOI [10.1126/scitranslmed.3001127, 10.1126/scisignal.3001127]; PONKA P, 1979, FEBS LETT, V97, P317, DOI 10.1016/0014-5793(79)80111-8; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Richardson D, 1989, Biol Met, V2, P69, DOI 10.1007/BF01129203; Richardson DR, 2009, BBA-GEN SUBJECTS, V1790, P702, DOI 10.1016/j.bbagen.2008.04.003; Richardson DR, 2006, J MED CHEM, V49, P6510, DOI 10.1021/jm0606342; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Richardson DR, 1997, BLOOD, V89, P3025, DOI 10.1182/blood.V89.8.3025; RICHARDSON DR, 1991, BIOCHIM BIOPHYS ACTA, V1091, P294, DOI 10.1016/0167-4889(91)90192-Z; RICHARDSON DR, 1995, BLOOD, V86, P4295, DOI 10.1182/blood.V86.11.4295.bloodjournal86114295; RICHARDSON DR, 1994, J LAB CLIN MED, V124, P660; SIES H, 1993, EUR J BIOCHEM, V215, P213, DOI 10.1111/j.1432-1033.1993.tb18025.x; Simunek T, 2008, BRIT J PHARMACOL, V155, P138, DOI 10.1038/bjp.2008.236; Simunek T, 2005, J MOL CELL CARDIOL, V39, P345, DOI 10.1016/j.yjmcc.2005.05.008; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; VISWANADHAN VN, 1989, J CHEM INF COMP SCI, V29, P163, DOI 10.1021/ci00063a006; VITOLO LMW, 1990, INORG CHIM ACTA, V170, P171; WALKER RA, 1986, J PATHOL, V148, P217, DOI 10.1002/path.1711480305; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868; Zhang XZ, 2012, ELECTROANAL, V24, P1878, DOI 10.1002/elan.201200192	61	16	18	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112059	10.1371/journal.pone.0112059	http://dx.doi.org/10.1371/journal.pone.0112059			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393531	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300029
J	Schroter, M; Rusch, GM; Barton, DN; Blumentrath, S; Norden, B				Schroter, Matthias; Rusch, Graciela M.; Barton, David N.; Blumentrath, Stefan; Norden, Bjorn			Ecosystem Services and Opportunity Costs Shift Spatial Priorities for Conserving Forest Biodiversity	PLOS ONE			English	Article							TRADE-OFFS; PROTECTED AREAS; CONSERVATION; STRATEGIES; PAYMENTS; BENEFITS; SCIENCE	Inclusion of spatially explicit information on ecosystem services in conservation planning is a fairly new practice. This study analyses how the incorporation of ecosystem services as conservation features can affect conservation of forest biodiversity and how different opportunity cost constraints can change spatial priorities for conservation. We created spatially explicit cost-effective conservation scenarios for 59 forest biodiversity features and five ecosystem services in the county of Telemark (Norway) with the help of the heuristic optimisation planning software, Marxan with Zones. We combined a mix of conservation instruments where forestry is either completely (non-use zone) or partially restricted (partial use zone). Opportunity costs were measured in terms of foregone timber harvest, an important provisioning service in Telemark. Including a number of ecosystem services shifted priority conservation sites compared to a case where only biodiversity was considered, and increased the area of both the partial (+36.2%) and the non-use zone (+3.2%). Furthermore, opportunity costs increased (+6.6%), which suggests that ecosystem services may not be a side-benefit of biodiversity conservation in this area. Opportunity cost levels were systematically changed to analyse their effect on spatial conservation priorities. Conservation of biodiversity and ecosystem services trades off against timber harvest. Currently designated nature reserves and landscape protection areas achieve a very low proportion (9.1%) of the conservation targets we set in our scenario, which illustrates the high importance given to timber production at present. A trade-off curve indicated that large marginal increases in conservation target achievement are possible when the budget for conservation is increased. Forty percent of the maximum hypothetical opportunity costs would yield an average conservation target achievement of 79%.	[Schroter, Matthias] Wageningen Univ, Environm Syst Anal Grp, NL-6700 AP Wageningen, Netherlands; [Schroter, Matthias; Rusch, Graciela M.; Barton, David N.; Blumentrath, Stefan; Norden, Bjorn] NINA, Trondheim, Norway	Wageningen University & Research; Norwegian Institute Nature Research	Schroter, M (corresponding author), Wageningen Univ, Environm Syst Anal Grp, NL-6700 AP Wageningen, Netherlands.	matthias.schroter@wur.nl	Schröter, Matthias/B-8883-2017; Nordén, Björn/B-4956-2012	Schröter, Matthias/0000-0003-0207-7311; Nordén, Björn/0000-0002-2739-9774; Blumentrath, Stefan/0000-0001-6675-1331; Rusch, Graciela/0000-0003-3769-8345	European Research Council [263027]; Research Council of Norway (Yggdrasil grant); European Union's Seventh Programme for research, technological development and demonstration (POLICYMIX project) [244065]; project ECOSERVICE (Approaches for integrated assessment of forest ecosystem services under large scale bioenergy utilization) - Research Council of Norway, RCN [233641/E50]	European Research Council(European Research Council (ERC)European Commission); Research Council of Norway (Yggdrasil grant)(Research Council of Norway); European Union's Seventh Programme for research, technological development and demonstration (POLICYMIX project); project ECOSERVICE (Approaches for integrated assessment of forest ecosystem services under large scale bioenergy utilization) - Research Council of Norway, RCN	MS received funding from the European Research Council under grant 263027 ('Ecospace'), and from the Research Council of Norway (Yggdrasil grant). GMR, DNB and SB received funding from the European Union's Seventh Programme for research, technological development and demonstration under grant agreement No. 244065 (POLICYMIX project (http://policymix.nina.no)). BN was supported by the project ECOSERVICE (Approaches for integrated assessment of forest ecosystem services under large scale bioenergy utilization) financed by the Research Council of Norway, RCN grant no 233641/E50. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BJ, 2009, J APPL ECOL, V46, P888, DOI 10.1111/j.1365-2664.2009.01666.x; [Anonymous], 1999, NATL ATLAS NORWAY VE; Barton DN, 2009, J ENVIRON MANAGE, V90, P901, DOI 10.1016/j.jenvman.2008.02.010; Barton DN, 2013, SOC NATUR RESOUR, V26, P1185, DOI 10.1080/08941920.2013.799727; Bengtsson J, 2003, AMBIO, V32, P389, DOI 10.1639/0044-7447(2003)032[0389:RRADL]2.0.CO;2; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Carwardine J, 2010, CONSERV BIOL, V24, P1529, DOI 10.1111/j.1523-1739.2010.01535.x; Carwardine J, 2009, CONSERV LETT, V2, P3, DOI 10.1111/j.1755-263X.2008.00042.x; Certain G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018930; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Chan KMA, 2012, ECOL ECON, V74, P8, DOI 10.1016/j.ecolecon.2011.11.011; Chan KMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024378; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Chhatre A, 2009, P NATL ACAD SCI USA, V106, P17667, DOI 10.1073/pnas.0905308106; Daily GC, 2003, CONSERV BIOL, V17, P1814, DOI 10.1111/j.1523-1739.2003.00298.x; Directorate for Nature Management, 2007, DN HDB, V13; Egoh B, 2007, ECOL ECON, V63, P714, DOI 10.1016/j.ecolecon.2007.04.007; Egoh BN, 2014, J APPL ECOL, V51, P899, DOI 10.1111/1365-2664.12251; Egoh BN, 2011, J ENVIRON MANAGE, V92, P1642, DOI 10.1016/j.jenvman.2011.01.019; Egoh BN, 2010, CONSERV BIOL, V24, P1021, DOI 10.1111/j.1523-1739.2009.01442.x; Eigenbrod F, 2009, P ROY SOC B-BIOL SCI, V276, P2903, DOI 10.1098/rspb.2009.0528; European Commission, 2014, 2014080 EUR COMM; Faith D, AUST ZOOL IN PRESS, DOI [10.7882/az.2014.7031, DOI 10.7882/AZ.2014.7031]; Faith D. P., 2012, F1000RESEARCH; Faith D. P, 1995, BIODIVERSITY REGIONA; Fisher B, 2011, CONSERV LETT, V4, P443, DOI 10.1111/j.1755-263X.2011.00198.x; Framstad E, 2002, EVALUERING SKOGVERNE, P146; Framstad E, 2010, 535 NINA; Framstad E., 2012, 888 NINA; Gaston KJ, 2006, BIOL CONSERV, V132, P76, DOI 10.1016/j.biocon.2006.03.013; GJERDE I, 2002, MILJOREGISTRERING SK; Gotmark F, 2013, FOREST ECOL MANAG, V306, P292, DOI 10.1016/j.foreco.2013.06.014; Granhus A, 2014, BAEREKRAFTIG SKOGBRU, P90; Haines-Young R., 2010, PROPOSAL COMMON INT; Hanski I, 2011, AMBIO, V40, P248, DOI 10.1007/s13280-011-0147-3; Hauer G, 2010, ECOL MODEL, V221, P2590, DOI 10.1016/j.ecolmodel.2010.07.013; Izquierdo AE, 2012, FORESTS, V3, P764, DOI 10.3390/f3030764; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Kalas J.A., 2010, 2010 NORWEGIAN RED L; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Larigauderie A, 2012, CURR OPIN ENV SUST, V4, P101, DOI 10.1016/j.cosust.2012.01.007; Lindenmayer DB, 2006, BIOL CONSERV, V131, P433, DOI 10.1016/j.biocon.2006.02.019; Luck G., 2012, F1000RESEARCH; Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006; Makino A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078986; Margules CR, 2002, J BIOSCIENCES, V27, P309, DOI 10.1007/BF02704962; Margules CR, 2007, ECOL BIODIVERS CONS, P1; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Meteorological Institute, 2012, MONTHL NORM VAL; Murdoch W, 2007, BIOL CONSERV, V139, P375, DOI 10.1016/j.biocon.2007.07.011; Nalle D. J., 2004, Journal of Environmental Economics and Management, V48, P997, DOI 10.1016/j.jeem.2004.01.001; NFLI, 2010, AR AR5; NFLI, 2013, MILJ SKOG; Norden B, 2012, FOREST ECOL MANAG, V270, P35, DOI 10.1016/j.foreco.2012.01.014; Norwegian Environmental Agency, 2013, NAT; Opdam P, 2006, LANDSCAPE URBAN PLAN, V75, P322, DOI 10.1016/j.landurbplan.2005.02.015; Persha L, 2011, SCIENCE, V331, P1606, DOI 10.1126/science.1199343; Pichancourt JB, 2014, GLOBAL CHANGE BIOL, V20, P382, DOI 10.1111/gcb.12345; Reyers B, 2012, LANDSCAPE ECOL, V27, P1121, DOI 10.1007/s10980-012-9761-0; Reyers B, 2012, BIOSCIENCE, V62, P503, DOI 10.1525/bio.2012.62.5.12; Ring I., 2011, INSTRUMENT MIXES BIO, P98; Rusch GM, 2013, BEST PRACTICE GUIDEL; Sarkar S, 2002, J BIOSCIENCES, V27, P299, DOI 10.1007/BF02704961; Schroter-Schlaack C, 2014, Z WIRTSCHAFTSGEOGR, V58, P98; Schroter M, 2014, CONSERV LETT, V7, P514, DOI 10.1111/conl.12091; Schroter M, 2014, ECOL INDIC, V36, P539, DOI 10.1016/j.ecolind.2013.09.018; Skjeggedal T, 2010, FRIVILLIG VERN SKOG; Sogaard G, 2012, 22012 NFLI; SSB, 2012, STAT ARB 2012; Venter O, 2009, SCIENCE, V326, P1368, DOI 10.1126/science.1180289; Watts ME, 2009, ENVIRON MODELL SOFTW, V24, P1513, DOI 10.1016/j.envsoft.2009.06.005; Wilson K.A., 2010, MARXAN GOOD PRACTICE, P18	73	36	36	2	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112557	10.1371/journal.pone.0112557	http://dx.doi.org/10.1371/journal.pone.0112557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY6YT	25393951	gold, Green Published, Green Submitted			2022-12-27	WOS:000347709300068
J	Sobotka, KS; Morley, C; Ong, T; Polglase, GR; Aridas, JDS; Miller, SL; Schmolzer, GM; Klingenberg, C; Moss, TJM; Jenkin, G; Hooper, SB				Sobotka, Kristina S.; Morley, Colin; Ong, Tracey; Polglase, Graeme R.; Aridas, James D. S.; Miller, Suzanne L.; Schmoelzer, Georg M.; Klingenberg, Claus; Moss, Timothy J. M.; Jenkin, Graham; Hooper, Stuart B.			Circulatory Responses to Asphyxia Differ if the Asphyxia Occurs In Utero or Ex Utero in Near-Term Lambs	PLOS ONE			English	Article							LEFT-VENTRICULAR OUTPUT; FETAL CARDIAC-OUTPUT; HEART-RATE; RHESUS MONKEYS; HYPOXIA; RESUSCITATION; VENTILATION; NEWBORN; SHEEP; AFFERENT	Background: A cornerstone of neonatal resuscitation teaching suggests that a rapid vagal-mediated bradycardia is one of the first signs of perinatal compromise. As this understanding is based primarily on fetal studies, we investigated whether the heart rate and blood pressure response to total asphyxia is influenced by whether the animal is in utero or ex utero. Methods: Fetal sheep were instrumented at similar to 139 days of gestation and then asphyxiated by umbilical cord occlusion until mean arterial blood pressure decreased to similar to 20 mmHg. Lambs were either completely submerged in amniotic fluid (in utero; n = 8) throughout the asphyxia or were delivered and then remained ex utero (ex utero; n = 8) throughout the asphyxia. Heart rate and arterial blood pressure were continuously recorded. Results: Heart rate was higher in ex utero lambs than in utero lambs. Heart rates in in utero lambs rapidly decreased, while heart rates in ex utero lambs initially increased following cord occlusion (for similar to 1.5 min) before they started to decrease. Mean arterial pressure initially increased then decreased in both groups. Conclusions: Heart rate response to asphyxia was markedly different depending upon whether the lamb was in utero or ex utero. This indicates that the cardiovascular responses to perinatal asphyxia are significantly influenced by the newborn's local environment. As such, based solely on heart rate, the stage and severity of a perinatal asphyxic event may not be as accurate as previously assumed.	[Sobotka, Kristina S.; Ong, Tracey; Polglase, Graeme R.; Aridas, James D. S.; Miller, Suzanne L.; Schmoelzer, Georg M.; Moss, Timothy J. M.; Jenkin, Graham; Hooper, Stuart B.] Monash Univ, Ritchie Ctr, Melbourne, Vic 3004, Australia; [Morley, Colin; Schmoelzer, Georg M.] Royal Womens Hosp, Melbourne, Vic, Australia; [Polglase, Graeme R.; Miller, Suzanne L.; Moss, Timothy J. M.; Jenkin, Graham; Hooper, Stuart B.] Monash Univ, Dept Obstet & Gynaecol, Melbourne, Vic 3004, Australia; [Klingenberg, Claus] Univ Hosp North Norway, Dept Pediat, Tromso, Norway; [Klingenberg, Claus] Univ Tromso, Fac Hlth Sci, Pediat Res Grp, Tromso, Norway	Monash University; Monash University; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Sobotka, KS (corresponding author), Monash Univ, Ritchie Ctr, Melbourne, Vic 3004, Australia.	kristina.sobotka@monash.edu	Schmölzer, Georg M/E-7883-2010; Moss, Timothy/A-6633-2008; Klingenberg, Claus/AAH-4467-2019	Schmölzer, Georg M/0000-0001-9798-2415; Moss, Timothy/0000-0002-9408-4027; Morley, Colin/0000-0001-5388-0214; Hooper, Stuart/0000-0003-1676-4825; Polglase, Graeme/0000-0002-8906-614X; Miller, Suzanne/0000-0002-0451-8304	National Health and Medical Research Council (NHMRC) of Australia [384100, 1026890, APP1043294, 545921]; Rebecca L. Cooper Medical Research Foundation; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Rebecca L. Cooper Medical Research Foundation; Victorian Government's Operational Infrastructure Support Program	Funding was provided by the National Health and Medical Research Council (NHMRC) of Australia program grant (No. 384100), fellowship (GRP: 1026890, TJM: APP1043294, SBH: 545921), a Rebecca L. Cooper Medical Research Foundation Fellowship (GRP) and the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSONS K, 1964, J PEDIATR-US, V65, P807, DOI 10.1016/S0022-3476(64)80002-0; ADAMSONS K, 1963, J PHYSIOL-LONDON, V169, P679, DOI 10.1113/jphysiol.1963.sp007288; ANDERSON PAW, 1987, J PHYSIOL-LONDON, V387, P297, DOI 10.1113/jphysiol.1987.sp016574; ANDERSON PAW, 1986, J PHYSIOL-LONDON, V372, P557, DOI 10.1113/jphysiol.1986.sp016025; Bhatt S, 2013, J PHYSIOL-LONDON, V591, P2113, DOI 10.1113/jphysiol.2012.250084; BRADY JP, 1966, J PHYSIOL-LONDON, V184, P631, DOI 10.1113/jphysiol.1966.sp007936; DANIEL SS, 1966, J PEDIATR-US, V68, P45, DOI 10.1016/S0022-3476(66)80421-3; DAWES GS, 1963, J PHYSIOL-LONDON, V169, P167, DOI 10.1113/jphysiol.1963.sp007248; Dawes GS, 1968, FOETAL NEONATAL PHYS; GILBERT RD, 1980, AM J PHYSIOL, V238, pH80, DOI 10.1152/ajpheart.1980.238.1.H80; GIUSSANI DA, 1993, J PHYSIOL-LONDON, V461, P431, DOI 10.1113/jphysiol.1993.sp019521; Gooden Brett A., 1994, Integrative Physiological and Behavioral Science, V29, P6, DOI 10.1007/BF02691277; Kattwinkel J, 2011, NEONATAL RESUSCITATI; KIRKPATRICK SE, 1976, AM J PHYSIOL, V231, P495, DOI 10.1152/ajplegacy.1976.231.2.495; Klingenberg C, 2013, ARCH DIS CHILD-FETAL, V98, pF222, DOI 10.1136/archdischild-2012-301787; PURVES MJ, 1966, J PHYSIOL-LONDON, V185, P60, DOI 10.1113/jphysiol.1966.sp007972; ROMERO T, 1972, AM J PHYSIOL, V222, P1285, DOI 10.1152/ajplegacy.1972.222.5.1285; RUDOLPH AM, 1976, AM J OBSTET GYNECOL, V124, P183, DOI 10.1016/S0002-9378(16)33296-3; SHADDY RE, 1988, PEDIATR RES, V24, P577, DOI 10.1203/00006450-198811000-00008; STAHLMAN M, 1967, AM J PHYSIOL, V213, P899, DOI 10.1152/ajplegacy.1967.213.4.899; TCHOBROUTSKY C, 1969, RESP PHYSIOL, V8, P108, DOI 10.1016/0034-5687(69)90048-6	21	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112264	10.1371/journal.pone.0112264	http://dx.doi.org/10.1371/journal.pone.0112264			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393411	Green Published, gold, Green Submitted			2022-12-27	WOS:000347709300042
J	Toledo, KA; Fermino, ML; Andrade, CD; Riul, TB; Alves, RT; Muller, VDM; Russo, RR; Stowell, SR; Cummings, RD; Aquino, VH; Dias-Baruffi, M				Toledo, Karina Alves; Fermino, Marise Lopes; Andrade, Camillo del Cistia; Riul, Thalita Bachelli; Alves, Renata Tome; Menjon Muller, Vanessa Danielle; Russo, Raquel Rinaldi; Stowell, Sean R.; Cummings, Richard D.; Aquino, Victor Hugo; Dias-Baruffi, Marcelo			Galectin-1 Exerts Inhibitory Effects during DENV-1 Infection	PLOS ONE			English	Article							DENGUE VIRUS-INFECTION; MONOCYTE-DERIVED MACROPHAGES; PROMOTES HIV-1 INFECTIVITY; REGULATED EXPRESSION; GLYCAN MICROARRAYS; ENDOTHELIAL-CELLS; GENE-EXPRESSION; IMMUNITY; LECTINS; STABILIZATION	Dengue virus (DENV) is an enveloped RNA virus that is mosquito-transmitted and can infect a variety of immune and non-immune cells. Response to infection ranges from asymptomatic disease to a severe disorder known as dengue hemorrhagic fever. Despite efforts to control the disease, there are no effective treatments or vaccines. In our search for new antiviral compounds to combat infection by dengue virus type 1 (DENV-1), we investigated the role of galectin-1, a widely-expressed mammalian lectin with functions in cell-pathogen interactions and immunoregulatory properties. We found that DENV-1 infection of cells in vitro exhibited caused decreased expression of Gal-1 in several different human cell lines, suggesting that loss of Gal-1 is associated with virus production. In test of this hypothesis we found that exogenous addition of human recombinant Gal-1 (hrGal-1) inhibits the virus production in the three different cell types. This inhibitory effect was dependent on hrGal-1 dimerization and required its carbohydrate recognition domain. Importantly, the inhibition was specific for hrGal-1, since no effect was observed using recombinant human galectin-3. Interestingly, we found that hrGal-1 directly binds to dengue virus and acts, at least in part, during the early stages of DENV-1 infection, by inhibiting viral adsorption and its internalization to target cells. To test the in vivo role of Gal-1 in DENV infection, Gal-1-deficient-mice were used to demonstrate that the expression of endogenous Galectin-1 contributes to resistance of macrophages to in vitro-infection with DENV-1 and it is also important to physiological susceptibility of mice to in vivo infection with DENV-1. These results provide novel insights into the functions of Gal-1 in resistance to DENV infection and suggest that Gal-1 should be explored as a potential antiviral compound.	[Toledo, Karina Alves] Univ Estadual Paulista UNESP FCL Assis, Dept Biol Sci, Assis, Brazil; [Fermino, Marise Lopes; Andrade, Camillo del Cistia; Riul, Thalita Bachelli; Alves, Renata Tome; Menjon Muller, Vanessa Danielle; Russo, Raquel Rinaldi; Aquino, Victor Hugo; Dias-Baruffi, Marcelo] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Anal Clin Toxicol & Bromatol, BR-14049 Ribeirao Preto, Brazil; [Stowell, Sean R.; Cummings, Richard D.] Emory Univ, Sch Med, Atlanta, GA USA	Universidade de Sao Paulo; Emory University	Dias-Baruffi, M (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Anal Clin Toxicol & Bromatol, BR-14049 Ribeirao Preto, Brazil.	mdbaruff@fcfrp.usp.br	Riul, Thalita Bachelli/G-7500-2014; Baruffi, Marcelo D/I-7199-2015; Toledo, Karina Alves/C-9452-2012; Muller, Vanessa/J-8722-2013; Aquino, Victor Hugo/C-1922-2012	Riul, Thalita Bachelli/0000-0002-4298-6475; Baruffi, Marcelo D/0000-0002-2039-1884; Toledo, Karina Alves/0000-0001-7212-6794; Aquino, Victor Hugo/0000-0003-1910-0776	Fundacao de Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [23038.039425-42/2008]; Conselho Nacional de Pesquisa e Desenvolvimento Cientifico e Tecnologico (CNPq) [576322/2008-3, 487351/2012-6]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/07340-1]	Fundacao de Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Pesquisa e Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - Grant 23038.039425-42/2008), Conselho Nacional de Pesquisa e Desenvolvimento Cientifico e Tecnologico (CNPq - Grants: 576322/2008-3 and 487351/2012-6) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - Grant 2013/07340-1) to MDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta EG, 2009, CELL MICROBIOL, V11, P1533, DOI 10.1111/j.1462-5822.2009.01345.x; Arthur CM, 2014, CURR OPIN CHEM BIOL, V18, P55, DOI 10.1016/j.cbpa.2013.12.017; Agis-Juarez RA, 2009, J GEN VIROL, V90, P2893, DOI 10.1099/vir.0.013433-0; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Beaumier CM, 2013, TRANSL RES, V162, P144, DOI 10.1016/j.trsl.2013.03.006; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Cedeno-Laurent F, 2012, CLIN IMMUNOL, V142, P107, DOI 10.1016/j.clim.2011.09.011; Cho M, 1996, BIOCHEMISTRY-US, V35, P13081, DOI 10.1021/bi961181d; CHO MJ, 1995, J BIOL CHEM, V270, P5198, DOI 10.1074/jbc.270.10.5198; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Garner OB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000993; Gauthier S, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-105; dos Santos HWG, 2008, J MED VIROL, V80, P1426, DOI 10.1002/jmv.21203; Gonzalez MI, 2005, INT J IMMUNOPATH PH, V18, P615, DOI 10.1177/039463200501800402; Gualano RC, 1998, J GEN VIROL, V79, P437, DOI 10.1099/0022-1317-79-3-437; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Halstead Scott B, 2002, Rev Cubana Med Trop, V54, P171; Horie H, 2005, CURR DRUG TARGETS, V6, P385, DOI 10.2174/1389450054021954; Hughes RC, 1997, BIOCHEM SOC T, V25, P1194, DOI 10.1042/bst0251194; Ip PP, 2010, J IMMUNOL, V184, P5705, DOI 10.4049/jimmunol.0903484; Kami K, 2005, CURR DRUG TARGETS, V6, P395, DOI 10.2174/1389450054021918; Kato T, 2005, CURR DRUG TARGETS, V6, P407, DOI 10.2174/1389450054021846; Koishi AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051089; Kyle JL, 2007, J INFECT DIS, V195, P1808, DOI 10.1086/518007; Lee JY, 2007, BIOL PHARM BULL, V30, P2043, DOI 10.1248/bpb.30.2043; Levroney EL, 2005, J IMMUNOL, V175, P413, DOI 10.4049/jimmunol.175.1.413; Lim JW, 2003, INT J BIOCHEM CELL B, V35, P1284, DOI 10.1016/S1357-2725(03)00051-7; Mairiang D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053535; Muller VDM, 2012, TOXICON, V59, P507, DOI 10.1016/j.toxicon.2011.05.021; Mercier S, 2008, VIROLOGY, V371, P121, DOI 10.1016/j.virol.2007.09.034; Moreno-Altamirano MMB, 2007, INTERVIROLOGY, V50, P237, DOI 10.1159/000100567; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mosso C, 2008, VIROLOGY, V378, P193, DOI 10.1016/j.virol.2008.05.012; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440; NaTHNaC, 2009, DENG FEV; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Ouellet M, 2005, J IMMUNOL, V174, P4120, DOI 10.4049/jimmunol.174.7.4120; Poisa-Beiro L, 2009, J IMMUNOL, V183, P6600, DOI 10.4049/jimmunol.0801726; Prestwood TR, 2012, J VIROL, V86, P12138, DOI 10.1128/JVI.00375-12; Rajasagi NK, 2012, J IMMUNOL, V188, P4631, DOI 10.4049/jimmunol.1103063; Reynolds JL, 2012, J NEUROIMMUNE PHARM, V7, P673, DOI 10.1007/s11481-012-9379-7; Reynolds JL, 2012, J IMMUNOL, V188, P3757, DOI 10.4049/jimmunol.1102276; Rodenhuis-Zybert IA, 2010, CELL MOL LIFE SCI, V67, P2773, DOI 10.1007/s00018-010-0357-z; Salatino M, 2008, EXPERT OPIN BIOL TH, V8, P45, DOI 10.1517/14712598.8.1.45; Sato S, 2012, ANN NY ACAD SCI, V1253, P133, DOI 10.1111/j.1749-6632.2012.06475.x; Sato S, 2009, IMMUNOL REV, V230, P172, DOI 10.1111/j.1600-065X.2009.00790.x; St-Pierre C, 2012, ANTIMICROB AGENTS CH, V56, P154, DOI 10.1128/AAC.05595-11; St-Pierre C, 2011, J VIROL, V85, P11742, DOI 10.1128/JVI.05351-11; Stowell SR, 2008, J IMMUNOL, V180, P3091, DOI 10.4049/jimmunol.180.5.3091; Stowell SR, 2014, NAT CHEM BIOL, V10, P470, DOI [10.1038/nchembio.1525, 10.1038/NCHEMBIO.1525]; Stowell SR, 2010, NAT MED, V16, P295, DOI 10.1038/nm.2103; Stowell SR, 2009, MOL BIOL CELL, V20, P1408, DOI 10.1091/mbc.E08-07-0786; Stowell SR, 2009, J BIOL CHEM, V284, P4989, DOI 10.1074/jbc.M808925200; Thijssen VL, 2014, GLYCOBIOLOGY, V24, P915, DOI 10.1093/glycob/cwu048; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; Vervaeke P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074035; Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374; Warke RV, 2008, J GEN VIROL, V89, P1605, DOI 10.1099/vir.0.2008/000968-0; Warke RV, 2003, J VIROL, V77, P11822, DOI 10.1128/JVI.77.21.11822-11832.2003; Whitehorn J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003025; Yang ML, 2011, J VIROL, V85, P10010, DOI 10.1128/JVI.00301-11; Zuniga E, 2001, INFECT IMMUN, V69, P6804, DOI 10.1128/IAI.69.11.6804-6812.2001	64	32	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112474	10.1371/journal.pone.0112474	http://dx.doi.org/10.1371/journal.pone.0112474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392933	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300058
J	Dejong, CA; Wilson, JY				Dejong, Chris A.; Wilson, Joanna Y.			The Cytochrome P450 Superfamily Complement (CYPome) in the Annelid Capitella teleta	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; GENE SUPERFAMILY; SP-I; EVOLUTION; P450; EXPRESSION; SEQUENCE; ANNOTATION; POLYCHAETE; ALIGNMENT	The Cytochrome P450 super family (CYP) is responsible for a wide range of functions in metazoans, having roles in both exogenous and endogenous substrate metabolism. Annelids are known to metabolize polycyclic aromatic hydrocarbons (PAHs) and produce estrogen. CYPs are postulated to be key enzymes in these processes in annelids. In this study, the CYP complement (CYPome) of the annelid Capitella teleta has been robustly identified and annotated with the genome assembly available. Phylogenetic analyses were performed to understand the evolutionary relationships between CYPs in C. teleta and other species. Predictions of which CYPs are potentially involved in both PAH metabolism and steroidogensis were made based on phylogeny. Annotation of 84 full length and 12 partial CYP sequences predicted a total of 96 functional CYPs in C. teleta. A further 13 CYP fragments were found but these may be pseudogenes. The C. teleta CYPome contained 24 novel CYP families and seven novel CYP subfamilies within existing families. A phylogenetic analysis identified that the C. teleta sequences were found in 9 of the 11 metazoan CYP clans. Two CYPs, CYP3071A1 and CYP3072A1, did not cluster with any metazoan CYP clans. We found xenobiotic response elements (XREs) upstream of C. teleta CYPs related to vertebrate CYP1 (CYP3060A1, CYP3061A1) and from families with reported transcriptional upregulation in response to PAH exposure (CYP4, CYP331). C. teleta had a CYP51A1 with similar to 65% identity to vertebrate CYP51A1 sequences and has been predicted to have lanosterol 14 alpha-demethylase activity. CYP376A1, CYP3068A1, CYP3069A1, and CYP3070A1 were the most appropriate candidates for steroidogenesis genes based on their phylogeny and warrant further analyses, though no specific aromatase (estrogen synthesis) candidates were found. Presence of XREs upstream of C. teleta CYPs may indicate a functional aryl hydrocarbon receptor in C. teleta and candidate CYPs for studies of PAH metabolism.	[Dejong, Chris A.; Wilson, Joanna Y.] McMaster Univ, Dept Biol, Hamilton, ON, Canada	McMaster University	Wilson, JY (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	joanna.wilson@mcmaster.ca			Natural Sciences and Engineering Research Council of Canada Discovery and Accelerator Program [2011R00152]; Ontario Ministry of Research and Innovation Early Researcher Award [ER10-07-197]	Natural Sciences and Engineering Research Council of Canada Discovery and Accelerator Program; Ontario Ministry of Research and Innovation Early Researcher Award(Ministry of Research and Innovation, Ontario)	Natural Sciences and Engineering Research Council of Canada Discovery and Accelerator Program (grant #2011R00152; http://www.nserc-crsng.gc.ca/index_eng.asp) and Ontario Ministry of Research and Innovation Early Researcher Award (ER10-07-197; http://www.ontario.ca/ministry-research-innovation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bach L, 2005, AQUAT TOXICOL, V74, P307, DOI 10.1016/j.aquatox.2005.06.002; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Baker ME, 2011, BIOCHEM PHARMACOL, V82, P1, DOI 10.1016/j.bcp.2011.03.008; Baker ME, 2011, MOL CELL ENDOCRINOL, V334, P14, DOI 10.1016/j.mce.2010.07.013; Baldwin WS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-169; Blake JA, 2009, ZOOSYMPOSIA, V2, P25, DOI 10.11646/zoosymposia.2.1.6; BRADFIELD JY, 1991, P NATL ACAD SCI USA, V88, P4558, DOI 10.1073/pnas.88.10.4558; Butler RA, 2001, GENE, V278, P223, DOI 10.1016/S0378-1119(01)00724-7; Callard GV, 2011, J STEROID BIOCHEM, V127, P176, DOI 10.1016/j.jsbmb.2011.03.022; DENISON MS, 1988, J BIOL CHEM, V263, P17221; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Garcia-Alonso J, 2005, INVERTEBR REPROD DEV, V48, P95, DOI 10.1080/07924259.2005.9652175; GARDNER WS, 1979, WATER AIR SOIL POLL, V11, P339, DOI 10.1007/BF00296591; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Goldstone JV, 2006, DEV BIOL, V300, P366, DOI 10.1016/j.ydbio.2006.08.066; Goldstone JV, 2008, CELL BIOL TOXICOL, V24, P483, DOI 10.1007/s10565-008-9107-5; Goldstone JV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-643; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Hahn ME, 2002, CHEM-BIOL INTERACT, V141, P131, DOI 10.1016/S0009-2797(02)00070-4; Hahn ME, 1998, COMP BIOCHEM PHYS C, V120, P67, DOI 10.1016/S0742-8413(98)00007-3; Holland LZ, 2008, GENOME RES, V18, P1100, DOI 10.1101/gr.073676.107; Janer G, 2007, ECOTOXICOLOGY, V16, P145, DOI 10.1007/s10646-006-0110-4; Kalsotra A, 2004, TOXICOL APPL PHARM, V199, P295, DOI 10.1016/j.taap.2003.12.033; Keay J, 2009, ENDOCRINOLOGY, V150, P1731, DOI 10.1210/en.2008-1338; Kozu S, 2006, DEV BIOL, V294, P497, DOI 10.1016/j.ydbio.2006.03.015; Lamb DC, 1998, FEBS LETT, V425, P263, DOI 10.1016/S0014-5793(98)00247-6; Lee R.F., 1980, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V179, P29; Lee RF, 1998, COMP BIOCHEM PHYS C, V121, P173, DOI 10.1016/S0742-8413(98)10037-3; Lewis DFV, 2004, PHARMACOGENOMICS, V5, P305, DOI 10.1517/phgs.5.3.305.29827; Li B, 2004, BIOCHEM BIOPH RES CO, V325, P510, DOI 10.1016/j.bbrc.2004.10.066; Linke-Gamenick I, 2000, MAR ECOL PROG SER, V203, P191, DOI 10.3354/meps203191; Maddison WP, 2011, MESQUITE MODULAR SYS; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; Nebert DW, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0431; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.biochem.56.1.945; Nelson DR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0474; Nelson DR, 2011, BBA-PROTEINS PROTEOM, V1814, P14, DOI 10.1016/j.bbapap.2010.08.008; Nelson David R., 2009, Human Genomics, V4, P59; Nelson DR, 2003, ARCH BIOCHEM BIOPHYS, V409, P18, DOI 10.1016/S0003-9861(02)00553-2; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Nelson DR, 1999, ARCH BIOCHEM BIOPHYS, V369, P1, DOI 10.1006/abbi.1999.1352; Nelson DR, 1998, COMP BIOCHEM PHYS C, V121, P15, DOI 10.1016/S0742-8413(98)10027-0; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Porter TD, 2002, J BIOCHEM MOL TOXIC, V16, P311, DOI 10.1002/jbt.10052; Powell-Coffman JA, 1998, P NATL ACAD SCI USA, V95, P2844, DOI 10.1073/pnas.95.6.2844; Reitzel AM, 2010, MOL BIOL EVOL, V27, P2211, DOI 10.1093/molbev/msq129; Rendic S, 1997, DRUG METAB REV, V29, P413, DOI 10.3109/03602539709037591; Rupasinghe S, 2006, FEBS LETT, V580, P6338, DOI 10.1016/j.febslet.2006.10.043; RUSHMORE TH, 1990, J BIOL CHEM, V265, P14648; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SANDERS HL, 1980, J MAR RES, V38, P265; Selck H, 2003, ENVIRON TOXICOL CHEM, V22, P2364, DOI 10.1897/02-272; Sezutsu H, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0428; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sun YV, 2004, NUCLEIC ACIDS RES, V32, P4512, DOI 10.1093/nar/gkh782; Tijet N, 2001, GENE, V262, P189, DOI 10.1016/S0378-1119(00)00533-3; Twan WH, 2003, BIOL REPROD, V68, P2255, DOI 10.1095/biolreprod.102.012450; van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6; Verslycke T, 2006, MOL PHYLOGENET EVOL, V40, P760, DOI 10.1016/j.ympev.2006.04.017; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Wu MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030288	64	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e107728	10.1371/journal.pone.0107728	http://dx.doi.org/10.1371/journal.pone.0107728			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390889	gold, Green Submitted, Green Published			2022-12-27	WOS:000349144400003
J	Greiner, TU; Hyotylainen, T; Knip, M; Backhed, F; Oresic, M				Greiner, Thomas U.; Hyotylainen, Tuulia; Knip, Mikael; Backhed, Fredrik; Oresic, Matej			The Gut Microbiota Modulates Glycaemic Control and Serum Metabolite Profiles in Non-Obese Diabetic Mice	PLOS ONE			English	Article							NOD MOUSE; AUTOIMMUNE; SUPPRESSION; METAGENOME; CHILDREN; DISEASE; TWINS; RISK	Islet autoimmunity in children who later progress to type 1 diabetes is preceded by dysregulated serum metabolite profiles, but the origin of these metabolic changes is unknown. The gut microbiota affects host metabolism and changes in its composition contribute to several immune-mediated diseases; however, it is not known whether the gut microbiota is involved in the early metabolic disturbances in progression to type 1 diabetes. We rederived non-obese diabetic ( NOD) mice as germ free to explore the potential role of the gut microbiota in the development of diabetic autoimmunity and to directly investigate whether the metabolic profiles associated with the development of type 1 diabetes can be modulated by the gut microbiota. The absence of a gut microbiota in NOD mice did not affect the overall diabetes incidence but resulted in increased insulitis and levels of interferon gamma and interleukin 12; these changes were counterbalanced by improved peripheral glucose metabolism. Furthermore, we observed a markedly increased variation in blood glucose levels in the absence of a microbiota in NOD mice that did not progress to diabetes. Additionally, germ-free NOD mice had a metabolite profile similar to that of pre-diabetic children. Our data suggest that germ-free NOD mice have reduced glycaemic control and dysregulated immunologic and metabolic responses.	[Greiner, Thomas U.; Backhed, Fredrik] Univ Gothenburg, Inst Med, Dept Mol & Clin Med, Wallenberg Lab, Gothenburg, Sweden; [Greiner, Thomas U.; Backhed, Fredrik] Univ Gothenburg, Sahlgrenska Ctr Cardiovascular & Metab Res, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden; [Hyotylainen, Tuulia; Oresic, Matej] VTT Tech Res Ctr Finland, Espoo, Finland; [Hyotylainen, Tuulia; Oresic, Matej] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Knip, Mikael] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Knip, Mikael] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Knip, Mikael] Univ Helsinki, Diabet & Obes Res Program, Helsinki, Finland; [Knip, Mikael] Folkhalsan Res Ctr, Helsinki, Finland; [Knip, Mikael] Tampere Univ Hosp, Dept Pediat, Tampere, Finland; [Backhed, Fredrik] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Receptol & Enteroendocrinol, Copenhagen, Denmark	University of Gothenburg; University of Gothenburg; VTT Technical Research Center Finland; Steno Diabetes Center; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Folkhalsan Research Center; Tampere University; Tampere University Hospital; Novo Nordisk Foundation; University of Copenhagen	Backhed, F (corresponding author), Univ Gothenburg, Inst Med, Dept Mol & Clin Med, Wallenberg Lab, Gothenburg, Sweden.	fredrik.backhed@wlab.gu.se; mtjo@steno.dk	Knip, Mikael/AAL-3773-2020; Hyötyläinen, Tuulia/AAP-6266-2020; Backhed, Fredrik/ABE-6613-2020; Oresic, Matej/K-7673-2016; Oresic, Matej/AAV-3978-2020	Backhed, Fredrik/0000-0002-4871-8818; Oresic, Matej/0000-0002-2856-9165; Hyotylainen, Tuulia/0000-0002-1389-8302; Knip, Mikael/0000-0003-0474-0033	Human Frontier of Science Program [RGY64/2008]; Juvenile Diabetes Research Foundation [36-2008-919]; European Community [HEALTH-2008-202013, HEALTH-2011-277713]; Academy of Finland Centre of Excellence in Molecular Systems Immunology and Physiology Research (SyMMyS) [250114]; Swedish Research Council; Swedish Child Diabetes Foundation; Swedish Foundation for Strategic Research; LUA-ALF grant from Vastra Gotalandsregionen	Human Frontier of Science Program(Human Frontier Science Program); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Community(European Commission); Academy of Finland Centre of Excellence in Molecular Systems Immunology and Physiology Research (SyMMyS); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Child Diabetes Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); LUA-ALF grant from Vastra Gotalandsregionen	This work was supported by the Human Frontier of Science Program (RGY64/2008 to FB and MO), Juvenile Diabetes Research Foundation (36-2008-919 to MO and FB), DIAPREPP and BETABAT projects of the Seventh Framework Program of the European Community (HEALTH-2008-202013 and HEALTH-2011-277713, respectively, to MO), Academy of Finland Centre of Excellence in Molecular Systems Immunology and Physiology Research (SyMMyS, 2012-2017, Decision No. 250114 to MO and MK), The Swedish Research Council, The Swedish Child Diabetes Foundation, Swedish Foundation for Strategic Research and a LUA-ALF grant from Vastra Gotalandsregionen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam C, 2011, DIABETOLOGIA, V54, P1398, DOI 10.1007/s00125-011-2097-5; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; BARNETT AH, 1981, DIABETOLOGIA, V20, P87, DOI 10.1007/BF00262007; Ben Nasr M, 2014, PHARM RES; Bjorksten B, 2009, CURR OPIN ALLERGY CL, V9, P185, DOI 10.1097/ACI.0b013e32832abfc2; Caesar R, 2012, GUT, V61, P1701, DOI 10.1136/gutjnl-2011-301689; Calcinaro F, 2005, DIABETOLOGIA, V48, P1565, DOI 10.1007/s00125-005-1831-2; Castillo S, 2011, ANAL CHEM, V83, P3058, DOI 10.1021/ac103308x; de Goffau MC, 2013, DIABETES, V62, P1238, DOI 10.2337/db12-0526; Fiorina P, 2008, DIABETES, V57, P3013, DOI 10.2337/db08-0420; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Fujihira K, 2000, DIABETES, V49, P1998, DOI 10.2337/diabetes.49.12.1998; Gale EAM, 2001, DIABETOLOGIA, V44, P3, DOI 10.1007/s001250051573; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; Greiner T, 2011, TRENDS ENDOCRIN MET, V22, P117, DOI 10.1016/j.tem.2011.01.002; Herold KC, 2013, NAT REV IMMUNOL, V13, P243, DOI 10.1038/nri3422; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kilkkinen A, 2006, DIABETOLOGIA, V49, P66, DOI 10.1007/s00125-005-0078-2; Knip M, 2005, PEDIAT ADOL, V10, P1; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Lernmark A, 2013, NAT REV ENDOCRINOL, V9, P92, DOI 10.1038/nrendo.2012.237; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nygren H, 2011, METHODS MOL BIOL, V708, P247, DOI 10.1007/978-1-61737-985-7_15; Oresic M, 2008, J EXP MED, V205, P2975, DOI 10.1084/jem.20081800; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shoda LKM, 2005, IMMUNITY, V23, P115, DOI 10.1016/j.immuni.2005.08.002; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Strachan DP, 1996, ARCH DIS CHILD, V74, P422, DOI 10.1136/adc.74.5.422; Sysi-Aho M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002257; Trembleau S, 2003, J IMMUNOL, V170, P5491, DOI 10.4049/jimmunol.170.11.5491; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Velagapudi VR, 2010, J LIPID RES, V51, P1101, DOI 10.1194/jlr.M002774; Vergani A, 2010, DIABETES, V59, P2253, DOI 10.2337/db09-1264; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Yang ZD, 2002, J IMMUNOL, V168, P6479, DOI 10.4049/jimmunol.168.12.6479	44	28	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e110359	10.1371/journal.pone.0110359	http://dx.doi.org/10.1371/journal.pone.0110359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390735	Green Submitted, gold, Green Published			2022-12-27	WOS:000349144400014
J	Kumar, S; Shabi, TS; Goormaghtigh, E				Kumar, Saroj; Shabi, Thankaraj Salammal; Goormaghtigh, Erik			A FTIR Imaging Characterization of Fibroblasts Stimulated by Various Breast Cancer Cell Lines	PLOS ONE			English	Article							TRANSFORM-INFRARED-SPECTROSCOPY; STROMAL FIBROBLASTS; INFORMATION-CONTENT; CIRCULAR-DICHROISM; TUMOR; GROWTH; METASTASIS; SPECTRA; TISSUE; MICROENVIRONMENT	It is well known that the microenvironment plays a major role in breast cancer progression. Yet, the mechanism explaining the transition from normal fibroblasts to cancer-stimulated fibroblasts remains to be elucidated. Here we report a FTIR imaging study of the effects of three different breast cancer cell lines on normal fibroblasts in culture. Fibroblast activation process was monitored by FTIR imaging and spectra compared by multivariate statistical analyses. Principal component analysis evidenced that the fibroblasts stimulated by these cancer cell lines grouped together and remained distinctly separated from normal fibroblasts indicating a modified different chemical composition in the cancer-stimulated fibroblasts. Similar changes in fibroblasts were induced by the various breast cancer cell lines belonging to different sub-types. Most significant changes were observed in the region of 2950 and 1230 cm(-1), possibly related to changes in lipids and in the 1230 cm(-1) area assigned to phosphate vibrations (nucleotides). Interestingly, the cancer-cell induced changes in the fibroblasts also occurred when there was no possible direct contact between the two cell lines in the co-culture. When contact was possible, the spectral changes were similar, suggesting that soluble factors but not direct cell-cell interactions were responsible for fibroblast activation. Overall, the results indicate that IR imaging could be used in the future for analyzing the microenvironment of breast tumors.	[Kumar, Saroj; Goormaghtigh, Erik] Univ Libre Bruxelles, Ctr Struct Biol & Bioinformat, Lab Struct & Funct Biol Membranes, Brussels, Belgium; [Shabi, Thankaraj Salammal] Zhejiang Univ, Dept Polymer Sci & Engn, Organ Semicond Lab, Hangzhou, Zhejiang, Peoples R China	Universite Libre de Bruxelles; Zhejiang University	Kumar, S (corresponding author), Univ Libre Bruxelles, Ctr Struct Biol & Bioinformat, Lab Struct & Funct Biol Membranes, Brussels, Belgium.	sarojgupta.k@gmail.com; egoor@ulb.ac.be		Goormaghtigh, Erik/0000-0002-2071-2262; Kumar, Saroj/0000-0001-7029-1163	Brain Back to Brussels (I.S.R.I.B., Belgium); Vetenskapsradet (Swedish Research Council); National Fund for Scientific Research [FRFC 2.4533.10, 2.4527.10, 2.4526.12, T.0155.13]; National Fund for Scientific Research (Belgium)	Brain Back to Brussels (I.S.R.I.B., Belgium); Vetenskapsradet (Swedish Research Council)(Swedish Research Council); National Fund for Scientific Research; National Fund for Scientific Research (Belgium)(Fonds de la Recherche Scientifique - FNRS)	The authors are grateful to Brain Back to Brussels (I.S.R.I.B., Belgium) and Vetenskapsradet (Swedish Research Council) for postdoctoral fellowships to S Kumar. This research was also supported by grants from the National Fund for Scientific Research (FRFC 2.4533.10, 2.4527.10, 2.4526.12 and T.0155.13) provided to E. Goormaghtigh. E Goormaghtigh is Director of Research with the National Fund for Scientific Research (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rakan MA, 2013, J PATHOL, V231, P457, DOI 10.1002/path.4256; Barcellos-Hoff MH, 2005, BREAST CANCER RES, V7, P33, DOI 10.1186/bcr972; Bassan P, 2013, ANALYST, V138, P4139, DOI 10.1039/c3an00363a; Bassan P, 2013, ANALYST, V138, P144, DOI 10.1039/c2an36090j; Benard A, 2014, ANALYST, V139, P1044, DOI 10.1039/c3an01454a; Bergner N, 2013, ANALYST, V138, P3983, DOI 10.1039/c3an00326d; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bogomolny E, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717186; Boydston-White S, 2006, BBA-BIOMEMBRANES, V1758, P908, DOI 10.1016/j.bbamem.2006.04.018; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; Derenne A., 2013, ENCY BIOPHYSICS, P1074, DOI [10.1007/978-3-642-16712-6_558, DOI 10.1007/978-3-642-16712-6_558]; Derenne A, 2014, BBA-MOL CELL BIOL L, V1841, P1200, DOI 10.1016/j.bbalip.2013.10.010; Derenne A, 2013, ANALYST, V138, P3998, DOI 10.1039/c3an00225j; Derenne A, 2013, BBA-MOL BASIS DIS, V1832, P46, DOI 10.1016/j.bbadis.2012.10.010; Derenne A, 2012, ANALYST, V137, P3255, DOI 10.1039/c2an35116a; Derenne A, 2011, ANALYST, V136, P1134, DOI 10.1039/c0an00872a; Derenne A, 2010, SPECTROSC-INT J, V24, P55, DOI 10.1155/2010/910694; Erler JT, 2009, CLIN EXP METASTAS, V26, P35, DOI 10.1007/s10585-008-9209-8; Farlay D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028736; Gaigneaux A, 2006, APPL SPECTROSC, V60, P1022, DOI 10.1366/000370206778397416; Goormaghtigh E, 2006, BIOPHYS J, V90, P2946, DOI 10.1529/biophysj.105.072017; GOORMAGHTIGH E, 1994, SPECTROCHIM ACTA A, V50, P2137; Goormaghtigh E., 2013, ENCY BIOPHYSICS, P1074; Goormaghtigh E, 2009, BBA-PROTEINS PROTEOM, V1794, P1332, DOI 10.1016/j.bbapap.2009.06.007; Holton SE, 2011, BIOPHYS J, V101, P1513, DOI 10.1016/j.bpj.2011.07.055; Holton SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096878; Holton SE, 2011, ANALYST, V136, P2953, DOI 10.1039/c1an15112f; Ingber DE, 2008, SEMIN CANCER BIOL, V18, P356, DOI 10.1016/j.semcancer.2008.03.016; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Katz-Brull R, 2002, CANCER RES, V62, P1966; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Khamis ZI, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/574025; Khamis ZI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/723650; Kumar S, 2013, ANALYST, V138, P4058, DOI 10.1039/c3an00241a; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lasch P, 2006, BBA-BIOMEMBRANES, V1758, P814, DOI 10.1016/j.bbamem.2006.06.008; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; Mourant JR, 2003, BIOPHYS J, V85, P1938, DOI 10.1016/S0006-3495(03)74621-9; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nguyen TT, 2014, ANALYST, V139, P2482, DOI 10.1039/c3an00353a; Noreen R, 2013, ANAL BIOANAL CHEM, V405, P8729, DOI 10.1007/s00216-013-7337-8; Oberg KA, 2004, EUR J BIOCHEM, V271, P2937, DOI 10.1111/j.1432-1033.2004.04220.x; Olsen CJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-444; PAGET S, 1989, CANCER METAST REV, V8, P98; Pevsner A, 2001, APPL SPECTROSC, V55, P1502, DOI 10.1366/0003702011953720; Radisky ES, 2007, REV ENDOCR METAB DIS, V8, P279, DOI 10.1007/s11154-007-9037-1; Sadlonova A, 2007, AM J PATHOL, V170, P1064, DOI 10.2353/ajpath.2007.060031; SCHOR SL, 1986, INT J CANCER, V37, P831, DOI 10.1002/ijc.2910370606; Studebaker AW, 2008, CANCER RES, V68, P9087, DOI 10.1158/0008-5472.CAN-08-0400; Tyan SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015313; Verdonck M, 2013, ANALYST, V138, P4083, DOI 10.1039/c3an00246b; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Whelan DR, 2013, J BIOPHOTONICS, V6, P775, DOI 10.1002/jbio.201200112; Whelan DR, 2013, ANALYST, V138, P3891, DOI 10.1039/c3an00316g; Zhang L, 2003, APPL SPECTROSC, V57, P14, DOI 10.1366/000370203321165151	59	34	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111137	10.1371/journal.pone.0111137	http://dx.doi.org/10.1371/journal.pone.0111137			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390361	Green Submitted, Green Published, gold			2022-12-27	WOS:000349144400019
J	Sunaga, D; Tanno, M; Kuno, A; Ishikawa, S; Ogasawara, M; Yano, T; Miki, T; Miura, T				Sunaga, Daisuke; Tanno, Masaya; Kuno, Atsushi; Ishikawa, Satoko; Ogasawara, Makoto; Yano, Toshiyuki; Miki, Takayuki; Miura, Tetsuji			Accelerated Recovery of Mitochondrial Membrane Potential by GSK-3 beta Inactivation Affords Cardiomyocytes Protection from Oxidant-Induced Necrosis	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; CELL-DEATH; VENTRICULAR MYOCYTES; SIGNALING PATHWAYS; RAT HEARTS; REPERFUSION; ISCHEMIA; ERYTHROPOIETIN; SUPEROXIDE; MYOCARDIUM	Loss of mitochondrial membrane potential (Delta Psi(m)) is known to be closely linked to cell death by various insults. However, whether acceleration of the Delta Psi(m) recovery process prevents cell necrosis remains unclear. Here we examined the hypothesis that facilitated recovery of Delta Psi(m) contributes to cytoprotection afforded by activation of the mitochondrial ATP-sensitive K+ (mK(ATP)) channel or inactivation of glycogen synthase kinase-3 beta (GSK-3 beta). DYm of H9c2 cells was determined by tetramethylrhodamine ethyl ester (TMRE) before or after 1-h exposure to antimycin A (AA), an inducer of reactive oxygen species (ROS) production at complex III. Opening of the mitochondrial permeability transition pore (mPTP) was determined by mitochondrial loading of calcein. AA reduced Delta Psi(m) to 15 +/- 1% of the baseline and induced calcein leak from mitochondria. Delta Psi(m) was recovered to 51 +/- 3% of the baseline and calcein-loadable mitochondria was 6 +/- 1% of the control at 1 h after washout of AA. mKATP channel openers improved the Delta Psi(m) recovery and mitochondrial calcein to 73 +/- 2% and 30 +/- 7%, respectively, without change in Delta Psi(m) during AA treatment. Activation of the mKATP channel induced inhibitory phosphorylation of GSK-3 beta and suppressed ROS production, LDH release and apoptosis after AA washout. Knockdown of GSK-3 beta and pharmacological inhibition of GSK-3 beta mimicked the effects of mKATP channel activation. ROS scavengers administered at the time of AA removal also improved recovery of Delta Psi(m). These results indicate that inactivation of GSK-3 beta directly or indirectly by mKATP channel activation facilitates recovery of DYm by suppressing ROS production and mPTP opening, leading to cytoprotection from oxidant stress-induced cell death.	[Sunaga, Daisuke; Tanno, Masaya; Kuno, Atsushi; Ishikawa, Satoko; Ogasawara, Makoto; Yano, Toshiyuki; Miki, Takayuki; Miura, Tetsuji] Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Sapporo, Hokkaido, Japan	Sapporo Medical University	Miura, T (corresponding author), Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Sapporo, Hokkaido, Japan.	miura@sapmed.ac.jp		KUNO, ATSUSHI/0000-0001-6873-1297	Japanese Society for the Promotion of Science [23501086]; Chugai Pharmaceutical Co. Ltd.; Grants-in-Aid for Scientific Research [26461133] Funding Source: KAKEN	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Chugai Pharmaceutical Co. Ltd.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japanese Society for the Promotion of Science Grants-in-Aid for Scientific Research #23501086 (to T. Miura) and a grant from Chugai Pharmaceutical Co. Ltd. Neither funder played any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Chanoit G, 2011, CARDIOVASC DRUG THER, V25, P299, DOI 10.1007/s10557-011-6310-z; Dang VC, 2006, AM J PHYSIOL-HEART C, V290, pH1808, DOI 10.1152/ajpheart.00772.2005; Di Lisa F, 1998, BBA-BIOENERGETICS, V1366, P69, DOI 10.1016/S0005-2728(98)00121-2; Diaz F, 2012, MOL CELL BIOL, V32, P415, DOI 10.1128/MCB.06051-11; Dost T, 2008, BASIC RES CARDIOL, V103, P378, DOI 10.1007/s00395-008-0718-z; Downey JM, 2007, HEART FAIL REV, V12, P181, DOI 10.1007/s10741-007-9025-2; Garcia-Dorado D, 2012, CARDIOVASC RES, V94, P168, DOI 10.1093/cvr/cvs116; Garlid KD, 2009, J MOL CELL CARDIOL, V46, P858, DOI 10.1016/j.yjmcc.2008.11.019; GRIFFITHS EJ, 1995, BIOCHEM J, V307, P93, DOI 10.1042/bj3070093; Hausenloy DJ, 2002, CARDIOVASC RES, V55, P534, DOI 10.1016/S0008-6363(02)00455-8; ICHAS F, 1994, FEBS LETT, V348, P211, DOI 10.1016/0014-5793(94)00615-6; Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3; Itoh T, 2012, J MOL CELL CARDIOL, V53, P870, DOI 10.1016/j.yjmcc.2012.10.001; Javadov SA, 2003, J PHYSIOL-LONDON, V549, P513, DOI 10.1113/jphysiol.2003.034231; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Kerr PM, 1999, AM J PHYSIOL-HEART C, V276, pH496, DOI 10.1152/ajpheart.1999.276.2.H496; King TD, 2008, NEUROTOX RES, V14, P367, DOI 10.1007/BF03033861; Korde AS, 2011, FREE RADICAL BIO MED, V50, P945, DOI 10.1016/j.freeradbiomed.2011.01.010; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Miura T, 2012, CARDIOVASC RES, V94, P181, DOI 10.1093/cvr/cvr302; Masahiro N, 2007, J MOL CELL CARDIOL, V43, P564, DOI 10.1016/j.yjmcc.2007.08.010; O'Rourke B, 2004, CIRC RES, V94, P420, DOI 10.1161/01.RES.0000117583.66950.43; Ohori K, 2008, AM J PHYSIOL-HEART C, V295, pH2079, DOI 10.1152/ajpheart.00092.2008; Ozcan C, 2002, AM J PHYSIOL-HEART C, V282, pH531, DOI 10.1152/ajpheart.00552.2001; Pasdois P, 2008, AM J PHYSIOL-HEART C, V294, pH2088, DOI 10.1152/ajpheart.01345.2007; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Sasaki N, 2000, CIRCULATION, V101, P439, DOI 10.1161/01.CIR.101.4.439; Sims NR, 2010, BBA-MOL BASIS DIS, V1802, P80, DOI 10.1016/j.bbadis.2009.09.003; Tanno M, 2014, J BIOL CHEM, V3; Terashima Y, 2010, J MOL CELL CARDIOL, V49, P762, DOI 10.1016/j.yjmcc.2010.08.001; Tominaga H, 2008, AM J PHYSIOL-HEART C, V295, pH105, DOI 10.1152/ajpheart.01307.2007; Viola HM, 2007, CIRC RES, V100, P1036, DOI 10.1161/01.RES.0000263010.19273.48; Viola HM, 2010, J MOL CELL CARDIOL, V49, P875, DOI 10.1016/j.yjmcc.2010.07.015; Waypa GB, 2013, AM J RESP CRIT CARE, V187, P424, DOI 10.1164/rccm.201207-1294OC; Yano T, 2011, HYPERTENSION, V57, P110, DOI 10.1161/HYPERTENSIONAHA.110.158469; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	38	26	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112529	10.1371/journal.pone.0112529	http://dx.doi.org/10.1371/journal.pone.0112529			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390651	Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400092
J	Ferreira, AS; Costa, P; Rocha, T; Amaro, A; Vieira, ML; Ahmed, A; Thompson, G; Hartskeerl, RA; Inacio, J				Ferreira, Ana Sofia; Costa, Pedro; Rocha, Teresa; Amaro, Ana; Vieira, Maria Luisa; Ahmed, Ahmed; Thompson, Gertrude; Hartskeerl, Rudy A.; Inacio, Joao			Direct Detection and Differentiation of Pathogenic Leptospira Species Using a Multi-Gene Targeted Real Time PCR Approach	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; QUANTITATIVE PCR; KIDNEY TISSUE; TAQMAN ASSAY; SPP.; DIAGNOSIS; PORTUGAL; URINE; IDENTIFICATION; ASSOCIATION	Leptospirosis is a growing public and veterinary health concern caused by pathogenic species of Leptospira. Rapid and reliable laboratory tests for the direct detection of leptospiral infections in animals are in high demand not only to improve diagnosis but also for understanding the epidemiology of the disease. In this work we describe a novel and simple TaqMan-based multi-gene targeted real-time PCR approach able to detect and differentiate Leptospira interrogans, L. kirschneri, L. borgpeteresenii and L. noguchii, which constitute the veterinary most relevant pathogenic species of Leptospira. The method uses sets of species-specific probes, and respective flanking primers, designed from ompL1 and secY gene sequences. To monitor the presence of inhibitors, a duplex amplification assay targeting both the mammal beta-actin and the leptospiral lipL32 genes was implemented. The analytical sensitivity of all primer and probe sets was estimated to be,10 genome equivalents (GE) in the reaction mixture. Application of the amplification reactions on genomic DNA from a variety of pathogenic and non-pathogenic Leptospira strains and other non-related bacteria revealed a 100% analytical specificity. Additionally, pathogenic leptospires were successfully detected in five out of 29 tissue samples from animals (Mus spp., Rattus spp., Dolichotis patagonum and Sus domesticus). Two samples were infected with L. borgpetersenii, two with L. interrogans and one with L. kirschneri. The possibility to detect and identify these pathogenic agents to the species level in domestic and wildlife animals reinforces the diagnostic information and will enhance our understanding of the epidemiology of leptopirosis.	[Ferreira, Ana Sofia; Costa, Pedro; Rocha, Teresa; Amaro, Ana; Inacio, Joao] Inst Nacl Invest Agr & Vet IP, Unidade Estrateg Invest, Lisbon, Portugal; [Ferreira, Ana Sofia; Costa, Pedro; Rocha, Teresa; Amaro, Ana; Inacio, Joao] Inst Nacl Invest Agr & Vet IP, Serv Prod & Saude Anim, Lisbon, Portugal; [Ferreira, Ana Sofia; Thompson, Gertrude] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4100 Oporto, Portugal; [Costa, Pedro; Vieira, Maria Luisa] Univ Nova Lisboa, Unidade Microbiol Med, Inst Higiene & Med Trop, P-1200 Lisbon, Portugal; [Thompson, Gertrude] Univ Porto, Res Ctr Biodivers & Genet Resources CIBIO ICETA, P-4100 Oporto, Portugal; [Ahmed, Ahmed; Hartskeerl, Rudy A.] KIT Biomed Res, WHO FAO OIE, Amsterdam, Netherlands; [Ahmed, Ahmed; Hartskeerl, Rudy A.] KIT Biomed Res, Natl Collaborating Ctr Reference & Res Leptospiro, Amsterdam, Netherlands; [Inacio, Joao] Univ Brighton, Sch Pharm & Biomol Sci, Brighton, E Sussex, England	Universidade do Porto; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade do Porto; Food & Agriculture Organization of the United Nations (FAO); University of Brighton	Ferreira, AS (corresponding author), Inst Nacl Invest Agr & Vet IP, Unidade Estrateg Invest, Lisbon, Portugal.	ana.ferreira@iniav.pt; j.inacio@brighton.ac.uk	Inacio, Joao/D-5762-2011; Vieira, Maria Luísa/B-3310-2008; Ferreira, AnaS/O-6745-2019; Thompson, Gertrude/C-3133-2014	Inacio, Joao/0000-0001-7367-5007; Vieira, Maria Luísa/0000-0002-8586-5534; Ferreira, AnaS/0000-0001-7222-9101; Amaro, Ana/0000-0002-5139-3268; Thompson, Gertrude/0000-0002-3939-5762	FCT [SFRH/BD/64136/2009, SFRH/BD/62317/2009]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	Ana Sofia Ferreira and Pedro Costa are recipients of PhD grants from FCT (www.fct.pt) (SFRH/BD/64136/2009 and SFRH/BD/62317/2009, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Agampodi SB, 2012, CLIN INFECT DIS, V54, P1249, DOI 10.1093/cid/cis035; Ahmed A, 2012, ADV MICROBIOL, V2, P162, DOI DOI 10.4236/AIM.2012.22021>; Ahmed A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007093; Boqvist S, 2003, VET MICROBIOL, V93, P361, DOI 10.1016/S0378-1135(03)00042-7; Bourhy P, 2011, J CLIN MICROBIOL, V49, P2154, DOI 10.1128/JCM.02452-10; Brenner DJ, 1999, INT J SYST BACTERIOL, V49, P839, DOI 10.1099/00207713-49-2-839; Cerqueira GM, 2009, INFECT GENET EVOL, V9, P760, DOI 10.1016/j.meegid.2009.06.009; Costa P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081337; Cox TE, 2005, J WILDLIFE DIS, V41, P753, DOI 10.7589/0090-3558-41.4.753; Dupouey J, 2014, COMP IMMUNOL MICROB, V37, P77, DOI 10.1016/j.cimid.2013.12.002; Fearnley C, 2008, RES VET SCI, V85, P8, DOI 10.1016/j.rvsc.2007.09.005; Fornazari F, 2012, J MICROBIOL METH, V90, P321, DOI 10.1016/j.mimet.2012.06.005; Foronda P, 2011, EMERG INFECT DIS, V17, P1781, DOI 10.3201/eid1709.101470; Grooms DL, 2005, VET CLIN N AM-FOOD A, V21, P463, DOI 10.1016/j.cvfa.2005.02.010; Latifah I, 2012, Malays J Pathol, V34, P157; Levett PN, 2005, J MED MICROBIOL, V54, P45, DOI 10.1099/jmm.0.45860-0; Levieuge A, 2010, REV MED VET-TOULOUSE, V161, P264; Lilenbaum W, 2009, RES VET SCI, V87, P16, DOI 10.1016/j.rvsc.2008.12.014; Merien F, 2005, FEMS MICROBIOL LETT, V249, P139, DOI 10.1016/j.femsle.2005.06.011; Morey RE, 2006, J CLIN MICROBIOL, V44, P3510, DOI 10.1128/JCM.00670-06; Nascimento ALTO, 2004, BRAZ J MED BIOL RES, V37, P459, DOI 10.1590/S0100-879X2004000400003; OIE, 2008, MANUAL DIAGNOSTIC TE; Palaniappan RUM, 2005, MOL CELL PROBE, V19, P111, DOI 10.1016/j.mcp.2004.10.002; Picardeau M, 2013, MED MALADIES INFECT, V43, P1, DOI 10.1016/j.medmal.2012.11.005; Bomfim MRQ, 2008, VET J, V178, P251, DOI 10.1016/j.tvjl.2007.07.029; ROCHA T, 1990, VET REC, V126, P602; Rocha T, 1998, REV SCI TECH OIE, V17, P699, DOI 10.20506/rst.17.3.1128; Rojas P, 2010, EUR J CLIN MICROBIOL, V29, P1305, DOI 10.1007/s10096-010-0991-2; Saito M, 2013, INT J SYST EVOL MICR, V63, P2457, DOI 10.1099/ijs.0.047233-0; Slack A, 2007, DIAGN MICR INFEC DIS, V57, P361, DOI 10.1016/j.diagmicrobio.2006.10.004; Smythe LD, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-13; Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014; Subharat S, 2011, J VET DIAGN INVEST, V23, P743, DOI 10.1177/1040638711407892; Victoria B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002752; Vieira ML, 2006, INT J INFECT DIS, V10, P378, DOI 10.1016/j.ijid.2005.07.006; Villumsen S, 2012, J MICROBIOL METH, V91, P184, DOI 10.1016/j.mimet.2012.06.009	37	22	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112312	10.1371/journal.pone.0112312	http://dx.doi.org/10.1371/journal.pone.0112312			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398140	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558500046
J	Irish, M; Hornberger, M; El Wahsh, S; Lam, BYK; Lah, S; Miller, L; Hsieh, S; Hodges, JR; Piguet, O				Irish, Muireann; Hornberger, Michael; El Wahsh, Shadi; Lam, Bonnie Y. K.; Lah, Suncica; Miller, Laurie; Hsieh, Sharpley; Hodges, John R.; Piguet, Olivier			Grey and White Matter Correlates of Recent and Remote Autobiographical Memory Retrieval - Insights from the Dementias	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; MEDIAL TEMPORAL-LOBE; FRONTOTEMPORAL DEMENTIA; ALZHEIMERS-DISEASE; SEMANTIC MEMORY; FUNCTIONAL NEUROANATOMY; HIPPOCAMPAL ACTIVATION; BEHAVIORAL-VARIANT; RETROGRADE-AMNESIA; EPISODIC MEMORY	The capacity to remember self-referential past events relies on the integrity of a distributed neural network. Controversy exists, however, regarding the involvement of specific brain structures for the retrieval of recently experienced versus more distant events. Here, we explored how characteristic patterns of atrophy in neurodegenerative disorders differentially disrupt remote versus recent autobiographical memory. Eleven behavioural-variant frontotemporal dementia, 10 semantic dementia, 15 Alzheimer's disease patients and 14 healthy older Controls completed the Autobiographical Interview. All patient groups displayed significant remote memory impairments relative to Controls. Similarly, recent period retrieval was significantly compromised in behavioural-variant frontotemporal dementia and Alzheimer's disease, yet semantic dementia patients scored in line with Controls. Voxel-based morphometry and diffusion tensor imaging analyses, for all participants combined, were conducted to investigate grey and white matter correlates of remote and recent autobiographical memory retrieval. Neural correlates common to both recent and remote time periods were identified, including the hippocampus, medial prefrontal, and frontopolar cortices, and the forceps minor and left hippocampal portion of the cingulum bundle. Regions exclusively implicated in each time period were also identified. The integrity of the anterior temporal cortices was related to the retrieval of remote memories, whereas the posterior cingulate cortex emerged as a structure significantly associated with recent autobiographical memory retrieval. This study represents the first investigation of the grey and white matter correlates of remote and recent autobiographical memory retrieval in neurodegenerative disorders. Our findings demonstrate the importance of core brain structures, including the medial prefrontal cortex and hippocampus, irrespective of time period, and point towards the contribution of discrete regions in mediating successful retrieval of distant versus recently experienced events.	[Irish, Muireann] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Irish, Muireann; Hornberger, Michael; El Wahsh, Shadi; Lam, Bonnie Y. K.; Hsieh, Sharpley; Hodges, John R.; Piguet, Olivier] Neurosci Res Australia, Sydney, NSW, Australia; [Hornberger, Michael; El Wahsh, Shadi; Lam, Bonnie Y. K.; Hsieh, Sharpley; Hodges, John R.; Piguet, Olivier] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Irish, Muireann; El Wahsh, Shadi; Lah, Suncica; Miller, Laurie; Hsieh, Sharpley; Hodges, John R.; Piguet, Olivier] Australian Res Council, Ctr Excellence Cognit & Its Disorders, Sydney, NSW, Australia; [Lah, Suncica] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Miller, Laurie] Univ Sydney, Royal Prince Alfred Hosp, Neuropsychol Unit, Sydney, NSW 2006, Australia; [Miller, Laurie] Univ Sydney, Cent Clin Sch, Sydney, NSW 2006, Australia; [Hornberger, Michael] Univ Cambridge, Dept Clin Neurosci, Cambridge, England	University of New South Wales Sydney; Neuroscience Research Australia; University of New South Wales Sydney; University of Sydney; University of Sydney; University of Sydney; University of Cambridge	Irish, M (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	m.irish@neura.edu.au	Hornberger, Michael/C-9610-2011; Lam, Bonnie Yin Ka/J-7578-2016; Piguet, Olivier/C-9658-2011	Hornberger, Michael/0000-0002-2214-3788; Lam, Bonnie Yin Ka/0000-0002-1656-2433; Irish, Muireann/0000-0002-4950-8169; Lah, Suncica/0000-0003-2282-4812; Piguet, Olivier/0000-0002-6696-1440; Miller, Laurie/0000-0001-6329-2969	National Health and Medical Research Council (NHMRC) of Australia Project Grant [510106]; Australian Research Council (ARC) Centre of Excellence in Cognition and its Disorders [CE110001021]; ARC Discovery Project [DP10933279]; ARC Discovery Early Career Research Award [DE130100463]; University of Sydney Thompson Fellowship; NHMRC Career Development Fellowship [1022684]	National Health and Medical Research Council (NHMRC) of Australia Project Grant(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC) Centre of Excellence in Cognition and its Disorders(Australian Research Council); ARC Discovery Project(Australian Research Council); ARC Discovery Early Career Research Award(Australian Research Council); University of Sydney Thompson Fellowship; NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a National Health and Medical Research Council (NHMRC) of Australia Project Grant [510106], the Australian Research Council (ARC) Centre of Excellence in Cognition and its Disorders [CE110001021], and an ARC Discovery Project [DP10933279]. MI is supported by an ARC Discovery Early Career Research Award [DE130100463]. SL is, in part, supported by the University of Sydney Thompson Fellowship. OP is supported by an NHMRC Career Development Fellowship [1022684]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2004, HIPPOCAMPUS, V14, P752, DOI 10.1002/hipo.10215; Andersson J.L.R., 2007, TR07JA1 FMRIB; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Barnabe A, 2012, HIPPOCAMPUS, V22, P1809, DOI 10.1002/hipo.22015; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Bonnici HM, 2012, J NEUROSCI, V32, P16982, DOI 10.1523/JNEUROSCI.2475-12.2012; Cabeza R, 2007, TRENDS COGN SCI, V11, P219, DOI 10.1016/j.tics.2007.02.005; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cermak L, 1984, EPISODIC SEMANTIC DI, P55; Chua TC, 2008, CURR OPIN NEUROL, V21, P83, DOI 10.1097/WCO.0b013e3282f4594b; Conway MA, 2004, SOC COGNITION, V22, P491, DOI 10.1521/soco.22.5.491.50768; Conway MA, 2001, PHILOS T R SOC B, V356, P1375, DOI 10.1098/rstb.2001.0940; Gilboa A, 2005, HIPPOCAMPUS, V15, P535, DOI 10.1002/hipo.20090; Gilboa A, 2004, CEREB CORTEX, V14, P1214, DOI 10.1093/cercor/bhh082; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Greenberg DL, 2010, J INT NEUROPSYCH SOC, V16, P748, DOI 10.1017/S1355617710000676; Greenberg DL, 2003, CORTEX, V39, P687, DOI 10.1016/S0010-9452(08)70860-8; Greene JDW, 1995, NEUROPSYCHOLOGIA, V33, P1647, DOI 10.1016/0028-3932(95)00046-1; Hodges JR, 2001, PHILOS T R SOC B, V356, P1423, DOI 10.1098/rstb.2001.0943; Irish M, 2011, NEUROPSYCHOLOGIA, V49, P2694, DOI 10.1016/j.neuropsychologia.2011.05.017; Irish M, 2014, HUM BRAIN MAPP, V35, P1422, DOI 10.1002/hbm.22263; Irish M, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00027; Irish M, 2012, BRAIN, V135, P2178, DOI 10.1093/brain/aws119; Irish M, 2012, NAT REV NEUROL, V8, P152, DOI 10.1038/nrneurol.2012.11; Irish M, 2011, CORTEX, V47, P236, DOI 10.1016/j.cortex.2010.01.002; Irish M, 2010, J INT NEUROPSYCH SOC, V16, P546, DOI 10.1017/S1355617710000172; Karas GB, 2004, NEUROIMAGE, V23, P708, DOI 10.1016/j.neuroimage.2004.07.006; Keppel G., 2004, DESIGN ANAL RES HDB; Kipps CM, 2010, CURR OPIN NEUROL, V23, P628, DOI 10.1097/WCO.0b013e3283404309; Lam BYK, 2014, HUM BRAIN MAPP, V35, P3547, DOI 10.1002/hbm.22420; Levine B, 2002, PSYCHOL AGING, V17, P677, DOI 10.1037//0882-7974.17.4.677; Maguire EA, 2001, PHILOS T R SOC B, V356, P1441, DOI 10.1098/rstb.2001.0944; Maguire EA, 2003, J NEUROSCI, V23, P5302; Maguire EA, 2010, NEUROPSYCHOLOGIA, V48, P123, DOI 10.1016/j.neuropsychologia.2009.08.020; Matuszewski V, 2009, CORTEX, V45, P456, DOI 10.1016/j.cortex.2007.11.006; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; McKinnon MC, 2008, J COGNITIVE NEUROSCI, V20, P1839, DOI 10.1162/jocn.2008.20126; Mechelli A, 2005, CURR MED IMAGING, V1, P105, DOI 10.2174/1573405054038726; Meulenbroek O, 2010, NEUROIMAGE, V53, P331, DOI 10.1016/j.neuroimage.2010.05.082; Meyers J., 1995, MEYERS SCORING SYSTE; Mion M, 2010, BRAIN, V133, P3256, DOI 10.1093/brain/awq272; Mioshi E, 2010, NEUROLOGY, V74, P1591, DOI 10.1212/WNL.0b013e3181e04070; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Mori S., 2005, MRI ATLAS HUMAN WHIT; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Morris J C, 1997, Int Psychogeriatr, V9 Suppl 1, P173, DOI 10.1017/S1041610297004870; Moscovitch M, 2005, J ANAT, V207, P35, DOI 10.1111/j.1469-7580.2005.00421.x; Moss HE, 2003, COGN NEUROPSYCHOL, V20, P703, DOI 10.1080/02643290242000916; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Oddo S, 2010, CORTEX, V46, P29, DOI 10.1016/j.cortex.2008.07.003; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Philippi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046200; Piefke M, 2003, BRAIN, V126, P650, DOI 10.1093/brain/awg064; Piolino P, 2004, NEUROIMAGE, V22, P1371, DOI 10.1016/j.neuroimage.2004.02.025; Piolino P, 2003, BRAIN, V126, P2203, DOI 10.1093/brain/awg222; Piolino P, 2007, NEUROPSYCHOLOGIA, V45, P2730, DOI 10.1016/j.neuropsychologia.2007.04.013; Piolino P, 2009, NEUROPSYCHOLOGIA, V47, P2314, DOI 10.1016/j.neuropsychologia.2009.01.020; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rosen HJ, 2005, BRAIN, V128, P2612, DOI 10.1093/brain/awh628; Rosen HJ, 2002, NEUROLOGY, V58, P198, DOI 10.1212/WNL.58.2.198; Rosenbaum RS, 2001, BEHAV BRAIN RES, V127, P183, DOI 10.1016/S0166-4328(01)00363-1; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Savage S, 2013, DEMENT GERIATR COGN, V35, P208, DOI 10.1159/000346389; Schmidt M., 1996, W PSYCHOL SERVICES; Sheldon S, 2013, NEUROIMAGE, V83, P880, DOI 10.1016/j.neuroimage.2013.06.082; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Soderlund H, 2012, HIPPOCAMPUS, V22, P670, DOI 10.1002/hipo.20927; Sollberger M, 2009, NEUROPSYCHOLOGIA, V47, P2812, DOI 10.1016/j.neuropsychologia.2009.06.006; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Steinvorth S, 2006, NEUROIMAGE, V30, P285, DOI 10.1016/j.neuroimage.2005.09.025; Strauss E, 2006, COMPENDIUM NEUROPSYC; Sugiura M, 2005, J COGNITIVE NEUROSCI, V17, P183, DOI 10.1162/0898929053124956; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Viard A, 2007, CEREB CORTEX, V17, P2453, DOI 10.1093/cercor/bhl153; Viard A, 2010, HIPPOCAMPUS, V20, P153, DOI 10.1002/hipo.20601; Visser M, 2010, NEUROPSYCHOLOGIA, V48, P1689, DOI 10.1016/j.neuropsychologia.2010.02.016; Westmacott R, 2001, NEUROCASE, V7, P37, DOI 10.1093/neucas/7.1.37; Winocur G, 2011, J INT NEUROPSYCH SOC, V17, P766, DOI 10.1017/S1355617711000683; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	84	43	43	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113081	10.1371/journal.pone.0113081	http://dx.doi.org/10.1371/journal.pone.0113081			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396740	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000345558500131
J	Santoyo-Ramos, P; Likhatcheva, M; Garcia-Zepeda, EA; Castaneda-Patlan, MC; Robles-Flores, M				Santoyo-Ramos, Paula; Likhatcheva, Maria; Garcia-Zepeda, Eduardo A.; Cristina Castaneda-Patlan, M.; Robles-Flores, Martha			Hypoxia-Inducible Factors Modulate the Stemness and Malignancy of Colon Cancer Cells by Playing Opposite Roles in Canonical Wnt Signaling	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BETA-CATENIN; HIF-1-ALPHA; HIF-2-ALPHA; HIF; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; EXPRESSION; SWITCH; MYC	This study examined the role played by hypoxia-inducible factors (HIFs) in malignant phenotype maintenance and canonical Wnt signaling. Under normoxia, we determined that both HIF-1 alpha and HIF-2 alpha are expressed in human colon cancer cells but not in their non-malignant counterparts. The stable knockdown of HIF-1 alpha or HIF-2 alpha expression induced negative effects on the malignant phenotype of colon cancer cells, with lactate production, the rate of apoptosis, migration, CXCR4-mediated chemotaxis, and tumorigenic activity all being significantly affected by HIF knockdown and with HIF-1 alpha depletion exerting greater effects. Knockdown of these two HIF transcripts induced different and even opposite effects on beta-catenin transcriptional activity in colon cancer cells with different genetic Wnt signaling pathways. In SW480 cells, HIF-2 alpha knockdown did not affect beta-catenin levels, increasing the transcriptional activity of beta-catenin by inducing its nuclear accumulation, whereas HIF-1 alpha silencing negatively affected the stability and transcriptional activity of beta-catenin, inducing its exit from the nuclei and its recruitment to the cell membrane by E-cadherin. In addition, although HIF-1 alpha depletion induced a reversal of the epithelial-to-mesenchymal transition (EMT), HIF-2 alpha silencing altered the expression of the stem cell markers CD44, Oct4, and CD24 and of the differentiation marker CK20 in the opposite direction as HIF-1 alpha silencing. Remarkably, HIF-2 alpha knockdown also enhanced beta-catenin transcriptional activity under hypoxia in cells that displayed normal Wnt signaling, suggesting that the gene negatively modulates canonical Wnt signaling in colon cancer cells. Taken together, our results indicate that HIFs play opposing roles in canonical Wnt signaling and are essential for the stemness and malignancy maintenance of colon cancer cells.	[Robles-Flores, Martha] Univ Nacl Autonoma Mexico, Fac Med, Dept Biochem, Mexico City 04510, DF, Mexico; Univ Nacl Autonoma Mexico, Biomed Res Inst, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Robles-Flores, M (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Biochem, Mexico City 04510, DF, Mexico.	rmartha@unam.mx		Castaneda-Patlan, Maria Cristina/0000-0002-2551-4847	Universidad Nacional Autonoma de Mexico (DGAPA-UNAM) [IN226111, IN215514]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [CB2011-151731]	Universidad Nacional Autonoma de Mexico (DGAPA-UNAM)(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was supported by grants from Universidad Nacional Autonoma de Mexico (DGAPA-UNAM IN226111 and IN215514) and Consejo Nacional de Ciencia y Tecnologia (CONACYT CB2011-151731). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Luna-Ulloa LB, 2011, CARCINOGENESIS, V32, P1615, DOI 10.1093/carcin/bgr190; Branco-Price C, 2012, CANCER CELL, V21, P52, DOI 10.1016/j.ccr.2011.11.017; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Burgess AW, 2011, EXP CELL RES, V317, P2748, DOI 10.1016/j.yexcr.2011.08.010; Cannito S, 2008, CARCINOGENESIS, V29, P2267, DOI 10.1093/carcin/bgn216; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; Flugel D, 2007, MOL CELL BIOL, V27, P3253, DOI 10.1128/MCB.00015-07; Franovic A, 2009, P NATL ACAD SCI USA, V106, P21306, DOI 10.1073/pnas.0906432106; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huang LE, 2008, CELL DEATH DIFFER, V15, P672, DOI 10.1038/sj.cdd.4402302; Imamura T, 2009, INT J CANCER, V124, P763, DOI 10.1002/ijc.24032; Ke J, 2012, NEOPLASMA, V59, P282, DOI 10.4149/neo_2012_036; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Mathieu J, 2011, CANCER RES, V71, P4640, DOI 10.1158/0008-5472.CAN-10-3320; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Oda N, 1999, J CELL PHYSIOL, V178, P121, DOI 10.1002/(SICI)1097-4652(199902)178:2<121::AID-JCP1>3.3.CO;2-6; Oh YS, 2012, ONCOL REP, V28, P2239, DOI 10.3892/or.2012.2063; Petrella BL, 2005, ONCOGENE, V24, P1043, DOI 10.1038/sj.onc.1208305; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Schneider M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-96; Schnitzer SE, 2005, FEBS LETT, V579, P529, DOI 10.1016/j.febslet.2004.12.023; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Vaiopoulos AG, 2012, STEM CELLS, V30, P363, DOI 10.1002/stem.1031; Wend P, 2010, SEMIN CELL DEV BIOL, V21, P855, DOI 10.1016/j.semcdb.2010.09.004; Yoo YG, 2011, CANCER RES, V71, P1244, DOI 10.1158/0008-5472.CAN-10-2360; Zhang Q, 2013, CARCINOGENESIS, V34, P962, DOI 10.1093/carcin/bgt027; Zhao JH, 2011, CANCER INVEST, V29, P377, DOI 10.3109/07357907.2010.512595	35	54	56	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112580	10.1371/journal.pone.0112580	http://dx.doi.org/10.1371/journal.pone.0112580			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396735	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500062
J	Bello, B; Zhang, XY; Liu, CL; Yang, ZE; Yang, ZR; Wang, QH; Zhao, G; Li, FG				Bello, Babatunde; Zhang, Xueyan; Liu, Chuanliang; Yang, Zhaoen; Yang, Zuoren; Wang, Qianhua; Zhao, Ge; Li, Fuguang			Cloning of Gossypium hirsutum Sucrose Non-Fermenting 1-Related Protein Kinase 2 Gene (GhSnRK2) and Its Overexpression in Transgenic Arabidopsis Escalates Drought and Low Temperature Tolerance	PLOS ONE			English	Article							ABSCISIC-ACID; SIGNAL-TRANSDUCTION; SALT TOLERANCE; CROSS-TALK; STRESS; PROLINE; VIRUS; WHEAT; DEHYDRATION; ACTIVATION	The molecular mechanisms of stress tolerance and the use of modern genetics approaches for the improvement of drought stress tolerance have been major focuses of plant molecular biologists. In the present study, we cloned the Gossypium hirsutum sucrose non-fermenting 1-related protein kinase 2 (GhSnRK2) gene and investigated its functions in transgenic Arabidopsis. We further elucidated the function of this gene in transgenic cotton using virus-induced gene silencing (VIGS) techniques. We hypothesized that GhSnRK2 participates in the stress signaling pathway and elucidated its role in enhancing stress tolerance in plants via various stress-related pathways and stress-responsive genes. We determined that the subcellular localization of the GhSnRK2-green fluorescent protein (GFP) was localized in the nuclei and cytoplasm. In contrast to wild-type plants, transgenic plants overexpressing GhSnRK2 exhibited increased tolerance to drought, cold, abscisic acid and salt stresses, suggesting that GhSnRK2 acts as a positive regulator in response to cold and drought stresses. Plants overexpressing GhSnRK2 displayed evidence of reduced water loss, turgor regulation, elevated relative water content, biomass, and proline accumulation. qRT-PCR analysis of GhSnRK2 expression suggested that this gene may function in diverse tissues. Under normal and stress conditions, the expression levels of stress-inducible genes, such as AtRD29A, AtRD29B, AtP5CS1, AtABI3, AtCBF1, and AtABI5, were increased in the GhSnRK2-overexpressing plants compared to the wildtype plants. GhSnRK2 gene silencing alleviated drought tolerance in cotton plants, indicating that VIGS technique can certainly be used as an effective means to examine gene function by knocking down the expression of distinctly expressed genes. The results of this study suggested that the GhSnRK2 gene, when incorporated into Arabidopsis, functions in positive responses to drought stress and in low temperature tolerance.	[Bello, Babatunde; Zhang, Xueyan; Liu, Chuanliang; Yang, Zhaoen; Yang, Zuoren; Wang, Qianhua; Zhao, Ge; Li, Fuguang] Chinese Acad Agr Sci, Cotton Res Inst, State Key Lab Cotton Biol, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Li, FG (corresponding author), Chinese Acad Agr Sci, Cotton Res Inst, State Key Lab Cotton Biol, Beijing 100193, Peoples R China.	aylifug@163.com	Yang, Zuoren/AAF-5040-2020	Yang, Zuoren/0000-0001-5898-6309	Major Program of Joint Funds (Sinkiang) of the National Natural Science Foundation of China [U1303282]	Major Program of Joint Funds (Sinkiang) of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Major Program of Joint Funds (Sinkiang) of the National Natural Science Foundation of China (Grant No. U1303282). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Cho K, 2009, BIOCHEM BIOPH RES CO, V379, P649, DOI 10.1016/j.bbrc.2008.12.107; Claussen W, 2005, PLANT SCI, V168, P241, DOI 10.1016/j.plantsci.2004.07.039; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coello P, 2012, J EXP BOT, V63, P913, DOI 10.1093/jxb/err320; Dainty J., 1976, Encyclopedia of Plant Physiology, New Series, Volume 2. Transport in plants II. Part A. Cells. [Luttge, U.; Pitman, M.G. (Editors)]., P12; Das R, 2010, CURR GENOMICS, V11, P2, DOI 10.2174/138920210790217981; Duan JZ, 2012, PLANT SCI, V196, P143, DOI 10.1016/j.plantsci.2012.08.003; EVERARD JD, 1994, PLANT PHYSIOL, V106, P281, DOI 10.1104/pp.106.1.281; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Gao XQ, 2011, JOVE-J VIS EXP, DOI 10.3791/2938; Genoud T, 1999, TRENDS PLANT SCI, V4, P503, DOI 10.1016/S1360-1385(99)01498-3; Granier C, 1999, PLANT PHYSIOL, V119, P609, DOI 10.1104/pp.119.2.609; Hardie DG, 1999, ANNU REV PLANT PHYS, V50, P97, DOI 10.1146/annurev.arplant.50.1.97; Hawes MC, 2000, TRENDS PLANT SCI, V5, P128, DOI 10.1016/S1360-1385(00)01556-9; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Jonak C, 2002, TRENDS PLANT SCI, V7, P457, DOI 10.1016/S1360-1385(02)02331-2; KISHOR PBK, 1995, PLANT PHYSIOL, V108, P1387, DOI 10.1104/pp.108.4.1387; Ko JH, 2006, PLANT J, V47, P343, DOI 10.1111/j.1365-313X.2006.02782.x; Kobayashi Y, 2005, PLANT J, V44, P939, DOI 10.1111/j.1365-313X.2005.02583.x; Kumar N, 2006, INDIAN J CROP SCI, V1, P8; LEVITT J., 1980, RESPONSE PLANT ENV S; Li C, 2013, INT J MOL SCI, V14, P21983, DOI 10.3390/ijms141121983; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Molina L, 2002, PLANT J, V32, P317, DOI 10.1046/j.1365-313X.2002.01430.x; Mahfouz MM, 2006, PLANT CELL, V18, P477, DOI 10.1105/tpc.105.035931; Mikolajczyk M, 2000, PLANT CELL, V12, P165, DOI 10.1105/tpc.12.1.165; Mishra NS, 2006, ARCH BIOCHEM BIOPHYS, V452, P55, DOI 10.1016/j.abb.2006.05.001; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Pareek A, 2010, ABIOTIC STRESS ADAPTATION IN PLANTS: PHYSIOLOGICAL, MOLECULAR AND GENOMIC FOUNDATION, P1, DOI 10.1007/978-90-481-3112-9; Parida AK, 2007, PLANT BIOTECHNOL REP, V1, P37, DOI 10.1007/s11816-006-0004-1; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pei ZM, 1997, PLANT CELL, V9, P409, DOI 10.1105/tpc.9.3.409; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Ratcliff F, 2001, PLANT J, V25, P237, DOI 10.1046/j.0960-7412.2000.00942.x; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; Sevengor S, 2011, AFR J AGR RES, V6, P4920; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Steponkus P.L., 1993, ADV LOW TEMPERATURE, V2, P211; STEPONKUS PL, 1984, ANNU REV PLANT PHYS, V35, P543, DOI 10.1146/annurev.pp.35.060184.002551; TYREE MT, 1972, J EXP BOT, V23, P267, DOI 10.1093/jxb/23.1.267; Umezawa T, 2004, P NATL ACAD SCI USA, V101, P17306, DOI 10.1073/pnas.0407758101; Wang X, 2004, PLANT SCI, V167, P1183, DOI 10.1016/j.plantsci.2004.03.011; Wang ZQ, 2007, J PLANT PHYSIOL, V164, P695, DOI 10.1016/j.jplph.2006.05.001; Wurzinger B, 2011, PLANT SIGNAL BEHAV, V6, P8, DOI 10.4161/psb.6.1.14012; Xiong LM, 2001, PLANT CELL, V13, P2063, DOI 10.1105/tpc.13.9.2063; Yasar F, 2008, RUSS J PLANT PHYSL+, V55, P782, DOI 10.1134/S1021443708060071; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; Younis ME, 2009, PLANT OMICS, V2, P197; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	56	18	25	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112269	10.1371/journal.pone.0112269	http://dx.doi.org/10.1371/journal.pone.0112269			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393623	gold, Green Published, Green Submitted			2022-12-27	WOS:000347709300044
J	Carrillo-Larco, RM; Bernabe-Ortiz, A; Miranda, JJ				Carrillo-Larco, Rodrigo M.; Bernabe-Ortiz, Antonio; Jaime Miranda, J.			Short Sleep Duration and Childhood Obesity: Cross-Sectional Analysis in Peru and Patterns in Four Developing Countries	PLOS ONE			English	Article							BODY-MASS INDEX; AUSTRALIAN CHILDREN; EARLY-LIFE; OVERWEIGHT; ASSOCIATION; ADOLESCENTS; RISK; METAANALYSIS; WEIGHT; TRENDS	Background: We aimed to describe the patterns of nutritional status and sleep duration in children from Ethiopia, India, Peru and Vietnam; to assess the association between short sleep duration and overweight and obesity, and if this was similar among boys and girls in Peru. Methods and Findings: Analysis of the Young Lives Study, younger cohort, third round. In Ethiopia there were 1,999 observations, 2,011, 2,052 and 2,000 in India, Peru and Vietnam, respectively. Analyses included participants with complete data for sleep duration, BMI, sex and age; missing data: 5.9% (Ethiopia), 4.1% (India), 6.0% (Peru) and 4.5% (Vietnam). Exposure was sleep duration per day: short (<10 hours) versus regular (10-11 hours). Outcome was overweight and obesity. Multivariable analyses were conducted using a hierarchical approach to assess the effect of variables at different levels. Overweight/obesity prevalence was 0.5%/0.2% (Ethiopia), 1.3%/0.3% (India), 6.1%/2.8% (Vietnam), and 15.8%/5.4% (Peru). Only Peruvian data was considered to explore the association between short sleep duration and overweight and obesity, with 1,929 children, aged 7.960.3 years, 50.3% boys. Short and regular sleep duration was 41.6% and 55.6%, respectively. Multivariable models showed that obesity was 64% more prevalent among children with short sleep duration, an estimate that lost significance after controlling for individual-and family-related variables (PR: 1.15; 95% CI: 0.81-1.64). Gender was an effect modifier of the association between short sleep duration and overweight (p = 0.030) but not obesity (p = 0.533): the prevalence ratio was greater than one across all the models for boys, yet it was less than one for girls. Conclusions: Childhood overweight and obesity have different profiles across developing settings. In a sample of children living in resource-limited settings in Peru there is no association between short sleep duration and obesity; the crude association was slightly attenuated by children-related variables but strongly diminished by family-related variables.	[Carrillo-Larco, Rodrigo M.; Bernabe-Ortiz, Antonio; Jaime Miranda, J.] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Jaime Miranda, J.] Univ Peruana Cayetano Heredia, Sch Med, Dept Med, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia	Carrillo-Larco, RM (corresponding author), Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru.	rodrigo.carrillo@upch.pe		Carrillo-Larco, Rodrigo M./0000-0002-2090-1856; Miranda, J. Jaime/0000-0002-4738-5468; Bernabe-Ortiz, Antonio/0000-0002-6834-1376	National Heart, Lung, and Blood Institute Global Health Initiative under the contract Global Health Activities in Developing Countries to Combat Non-Communicable Chronic Diseases [268200900033C-1-0-1]	National Heart, Lung, and Blood Institute Global Health Initiative under the contract Global Health Activities in Developing Countries to Combat Non-Communicable Chronic Diseases	RMC-L, AB-O, JJM and the CRONICAS Center of Excellence in Chronic Diseases were supported by the National Heart, Lung, and Blood Institute Global Health Initiative under the contract Global Health Activities in Developing Countries to Combat Non-Communicable Chronic Diseases ( Project Number 268200900033C-1-0-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Álvarez-Dongo Doris, 2012, Rev. perú. med. exp. salud publica, V29, P303; Bagley EJ, 2013, J PEDIATR PSYCHOL, V38, P775, DOI 10.1093/jpepsy/jst031; Barnett I, 2013, INT J EPIDEMIOL, V42, P701, DOI 10.1093/ije/dys082; Bayer O, 2009, SLEEP, V32, P1183, DOI 10.1093/sleep/32.9.1183; Bell JF, 2010, ARCH PEDIAT ADOL MED, V164, P840, DOI 10.1001/archpediatrics.2010.143; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Carter PJ, 2011, BMJ, V342; Chaput JP, 2006, INT J OBESITY, V30, P1080, DOI 10.1038/sj.ijo.0803291; Chaput JP, 2011, CAN J PUBLIC HEALTH, V102, P369, DOI 10.1007/BF03404179; Chen XL, 2008, OBESITY, V16, P265, DOI 10.1038/oby.2007.63; Clifford LM, 2012, SLEEP MED, V13, P1102, DOI 10.1016/j.sleep.2012.06.019; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Diethelm K, 2011, INT J PEDIATR OBES, V6, pE114, DOI 10.3109/17477166.2011.566338; Eisenmann JC, 2006, ACTA PAEDIATR, V95, P956, DOI 10.1080/08035250600731965; El-Sheikh M, 2013, HEALTH PSYCHOL, V32, P849, DOI 10.1037/a0030413; Gaina A, 2004, J EPIDEMIOL, V14, P1, DOI 10.2188/jea.14.1; Hart CN, 2011, PEDIATR CLIN N AM, V58, P715, DOI 10.1016/j.pcl.2011.03.007; Huong Thi Le, 2013, Health, V5, P24; Jarrin DC, 2013, INT J OBESITY, V37, P552, DOI 10.1038/ijo.2013.4; Jiang F, 2009, J PEDIATR-US, V154, P814, DOI 10.1016/j.jpeds.2008.12.043; Kohyama J, 2011, PEDIATR INT, V53, P649, DOI 10.1111/j.1442-200X.2010.03318.x; Lumeng JC, 2007, PEDIATRICS, V120, P1020, DOI 10.1542/peds.2006-3295; Magee L, 2012, SLEEP MED REV, V16, P231, DOI 10.1016/j.smrv.2011.05.005; National Sleep Foundation, 2014, MUCH SLEEP DO WE REA; Pileggi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066680; Raj M, 2007, NATL MED J INDIA, V20, P288; Seegers V, 2011, AM J EPIDEMIOL, V173, P621, DOI 10.1093/aje/kwq389; Sekine M, 2002, CHILD CARE HLTH DEV, V28, P163, DOI 10.1046/j.1365-2214.2002.00260.x; Sekine Michikazu, 2002, J Epidemiol, V12, P237; Shi ZM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-609; Spruyt K, 2011, PEDIATRICS, V127, pE345, DOI 10.1542/peds.2010-0497; Taveras EM, 2008, ARCH PEDIAT ADOL MED, V162, P305, DOI 10.1001/archpedi.162.4.305; Univesiry of Oxford, 2014, U OXF TECHN NOT; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Wells JCK, 2000, J THEOR BIOL, V202, P65, DOI 10.1006/jtbi.1999.1044; Wing YK, 2009, PEDIATRICS, V124, pE994, DOI 10.1542/peds.2008-3602; Zerfu Mesfin, 2006, Ethiop Med J, V44, P347	38	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112433	10.1371/journal.pone.0112433	http://dx.doi.org/10.1371/journal.pone.0112433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY6YT	25393729	Green Submitted, Green Published, gold			2022-12-27	WOS:000347709300056
J	Fronza, M; Caetano, GF; Leite, MN; Bitencourt, CS; Paula-Silva, FWG; Andrade, TAM; Frade, MAC; Merfort, I; Faccioli, LH				Fronza, Marcio; Caetano, Guilherme F.; Leite, Marcel N.; Bitencourt, Claudia S.; Paula-Silva, Francisco W. G.; Andrade, Thiago A. M.; Frade, Marco A. C.; Merfort, Irmgard; Faccioli, Lucia H.			Hyaluronidase Modulates Inflammatory Response and Accelerates the Cutaneous Wound Healing	PLOS ONE			English	Article							GROWTH-FACTORS; ANGIOGENIC OLIGOSACCHARIDES; FIBROBLAST MOTILITY; SKIN HOMEOSTASIS; PPAR-BETA/DELTA; RAT SKIN; RECEPTOR; REPAIR; BETA; MECHANISMS	Hyaluronidases are enzymes that degrade hyaluronan an important constituent of the extracellular matrix. They have been used as a spreading agent, improving the absorption of drugs and facilitating the subcutaneous infusion of fluids. Here, we investigated the influence of bovine testes hyaluronidase (HYAL) during cutaneous wound healing in in vitro and in vivo assays. We demonstrated in the wound scratch assay that HYAL increased the migration and proliferation of fibroblasts in vitro at low concentration, e.g. 0.1 U HYAL enhanced the cell number by 20%. HYAL presented faster and higher reepithelialization in in vivo full-thickness excisional wounds generated on adult Wistar rats back skin already in the early phase at 2nd day post operatory compared to vehicle-control group. Wound closured area observed in the 16 U and 32 U HYAL treated rats reached 38% and 46% compared to 19% in the controls, respectively. Histological and biochemical analyses supported the clinical observations and showed that HYAL treated wounds exhibited increased granulation tissue, diminished edema formation and regulated the inflammatory response by modulating the release of pro and anti-inflammatory cytokines, growth factor and eicosanoids mediators. Moreover, HYAL increased gene expression of peroxisome proliferator-activated receptors (PPAR) gamma and PPAR beta/delta, the collagen content in the early stages of healing processes as well as angiogenesis. Altogether these data revealed that HYAL accelerates wound healing processes and might be beneficial for treating wound disorders.	[Fronza, Marcio; Bitencourt, Claudia S.; Paula-Silva, Francisco W. G.; Faccioli, Lucia H.] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Anal Clin Toxicol & Bromatol, BR-14049 Ribeirao Preto, SP, Brazil; [Caetano, Guilherme F.; Leite, Marcel N.; Andrade, Thiago A. M.; Frade, Marco A. C.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Div Dermatol, BR-14049 Ribeirao Preto, SP, Brazil; [Merfort, Irmgard] Univ Freiburg, Dept Pharmaceut Biol & Biotechnol, D-79106 Freiburg, Germany; [Fronza, Marcio] Univ Vila Velha, Dept Farm, Vila Velha, ES, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; University of Freiburg; Centro Universitario Vila Velha	Faccioli, LH (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Anal Clin Toxicol & Bromatol, BR-14049 Ribeirao Preto, SP, Brazil.	faccioli@fcfrp.usp.br	Leite, Marcel Nani/D-1135-2015; Caetano, Guilherme F/D-8223-2013; Lucia, Faccioli/G-8976-2015; Caetano, Guilherme/V-8978-2019; Faccioli, Lúcia Helena/AGH-5297-2022; Andrade, Thiago Antônio Moretti/G-9359-2012; Fronza, Marcio/B-8607-2014; de Paula e Silva, Francisco Wanderley Garcia Garcia/D-1712-2012; Frade, Marco Andrey Cipriani/G-1165-2012	Leite, Marcel Nani/0000-0002-2121-8688; Lucia, Faccioli/0000-0002-4999-8305; Faccioli, Lúcia Helena/0000-0002-4999-8305; Andrade, Thiago Antônio Moretti/0000-0003-3788-2847; Fronza, Marcio/0000-0002-7316-8598; de Paula e Silva, Francisco Wanderley Garcia Garcia/0000-0001-8559-532X; Frade, Marco Andrey Cipriani/0000-0003-2700-5971	Sao Paulo Research Foundation (FAPESP) [2011/23992-3, 2009/07169-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors are grateful to the Sao Paulo Research Foundation (FAPESP, grant # 2011/23992-3 and grant # 2009/07169-5) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams L, 2011, BRIT J OPHTHALMOL, V95, P1345, DOI 10.1136/bjo.2010.188789; Andrade TAM, 2011, BRAZ J MED BIOL RES, V44, P1036, DOI 10.1590/S0100-879X2011007500116; Aoki T, 2012, TRENDS PHARMACOL SCI, V33, P304, DOI 10.1016/j.tips.2012.02.004; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Birch M, 2005, METH MOLEC MED, V117, P223; Bitencourt CS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-3; BROWN LF, 1992, J EXP MED, V176, P1375, DOI 10.1084/jem.176.5.1375; Buonomo R, 2012, J CELL PHYSIOL, V227, P2106, DOI 10.1002/jcp.22944; Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x; Chong HC, 2009, J CELL BIOL, V184, P817, DOI 10.1083/jcb.200809028; Dechert TA, 2006, WOUND REPAIR REGEN, V14, P252, DOI 10.1111/j.1743-6109.2006.00119.x; Dunn AL, 2010, EXPERT OPIN BIOL TH, V10, P127, DOI 10.1517/14712590903490382; Dygai AM, 2013, B EXP BIOL MED+, V154, P388, DOI 10.1007/s10517-013-1957-z; Dygai AM, 2013, B EXP BIOL MED+, V154, P329, DOI 10.1007/s10517-013-1943-5; El-Safory NS, 2010, CARBOHYD POLYM, V81, P165, DOI 10.1016/j.carbpol.2010.02.047; FDA, 2006, GUID IND CHRON CUT U; Fronza M, 2009, J ETHNOPHARMACOL, V126, P463, DOI 10.1016/j.jep.2009.09.014; Futagami A, 2002, LAB INVEST, V82, P1503, DOI 10.1097/01.LAB.0000035024.75914.39; Ghazi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048351; Green JA, 2004, AM J PHYSIOL-CELL PH, V287, pC373, DOI 10.1152/ajpcell.00509.2003; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027; Icre G, 2006, J INVEST DERM SYMP P, V11, P30, DOI 10.1038/sj.jidsymp.5650007; Jameson JM, 2005, J EXP MED, V201, P1269, DOI 10.1084/jem.20042057; Kapoor M, 2007, PROSTAG LEUKOTR ESS, V76, P103, DOI 10.1016/j.plefa.2006.11.006; Kemparaju K, 2006, CELL BIOCHEM FUNCT, V24, P7, DOI 10.1002/cbf.1261; Knight E, 2010, J CLIN PATHOL, V63, P846, DOI 10.1136/jcp.2010.076828; Lee A, 2010, DERMATOL SURG, V36, P1071, DOI 10.1111/j.1524-4725.2010.01585.x; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lu L, 2005, J AM COLL SURGEONS, V201, P391, DOI 10.1016/j.jamcollsurg.2005.03.032; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Michalik L, 2006, J CLIN INVEST, V116, P598, DOI 10.1172/JCI27958; Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148; Minatel DG, 2009, LASER SURG MED, V41, P433, DOI 10.1002/lsm.20789; Montagner A, 2011, J INVEST DERMATOL, V131, P2154; Nelson AM, 2013, J INVEST DERMATOL, V133, P881, DOI 10.1038/jid.2012.398; Noursadeghi M, 2008, J IMMUNOL METHODS, V329, P194, DOI 10.1016/j.jim.2007.10.015; Pessini AC, 2001, TOXICON, V39, P1495, DOI 10.1016/S0041-0101(01)00122-2; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; Santibanez JF, 2011, CLIN SCI, V121, P233, DOI 10.1042/CS20110086; SATTAR A, 1994, J INVEST DERMATOL, V103, P576, DOI 10.1111/1523-1747.ep12396880; Schreml S, 2010, J AM ACAD DERMATOL, V63, P866, DOI 10.1016/j.jaad.2009.10.048; Shih B, 2010, WOUND REPAIR REGEN, V18, P139, DOI 10.1111/j.1524-475X.2009.00553.x; Shukla A, 1998, BIOCHEM BIOPH RES CO, V244, P434, DOI 10.1006/bbrc.1998.8286; Siebert N, 2011, LAB INVEST, V91, P1753, DOI 10.1038/labinvest.2011.125; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200; Souza DG, 2001, BRIT J PHARMACOL, V134, P985, DOI 10.1038/sj.bjp.0704336; Tan NS, 2001, GENE DEV, V15, P3263, DOI 10.1101/gad.207501; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; van Horssen R, 2006, J CELL BIOCHEM, V99, P1536, DOI 10.1002/jcb.20994; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; Wong CM, 2005, CANCER RES, V65, P8861, DOI 10.1158/0008-5472.CAN-05-1318; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	55	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112297	10.1371/journal.pone.0112297	http://dx.doi.org/10.1371/journal.pone.0112297			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393024	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300048
J	Green, JWM; Stastna, JJ; Orbidans, HE; Harvey, SC				Green, James W. M.; Stastna, Jana J.; Orbidans, Helen E.; Harvey, Simon C.			Highly Polygenic Variation in Environmental Perception Determines Dauer Larvae Formation in Growing Populations of Caenorhabditis elegans	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; NATURAL VARIATION; PHENOTYPIC PLASTICITY; EVOLUTION; DIVERSITY; PHEROMONE; PREFERENCE	Background: Determining how complex traits are genetically controlled is a requirement if we are to predict how they evolve and how they might respond to selection. This requires understanding how distinct, and often more simple, life history traits interact and change in response to environmental conditions. In order to begin addressing such issues, we have been analyzing the formation of the developmentally arrested dauer larvae of Caenorhabditis elegans under different conditions. Results: We find that 18 of 22 previously identified quantitative trait loci (QTLs) affecting dauer larvae formation in growing populations, assayed by determining the number of dauer larvae present at food patch exhaustion, can be recovered under various environmental conditions. We also show that food patch size affects both the ability to detect QTLs and estimates of effect size, and demonstrate that an allele of nath-10 affects dauer larvae formation in growing populations. To investigate the component traits that affect dauer larvae formation in growing populations we map, using the same introgression lines, QTLs that affect dauer larvae formation in response to defined amounts of pheromone. This identifies 36 QTLs, again demonstrating the highly polygenic nature of the genetic variation underlying dauer larvae formation. Conclusions: These data indicate that QTLs affecting the number of dauer larvae at food exhaustion in growing populations of C. elegans are highly reproducible, and that nearly all can be explained by variation affecting dauer larvae formation in response to defined amounts of pheromone. This suggests that most variation in dauer larvae formation in growing populations is a consequence of variation in the perception of the food and pheromone environment (i.e. chemosensory variation) and in the integration of these cues.	[Green, James W. M.; Stastna, Jana J.; Orbidans, Helen E.; Harvey, Simon C.] Canterbury Christ Church Univ, Sch Human & Life Sci, Biomol Res Grp, Canterbury, Kent, England	Canterbury Christ Church University	Harvey, SC (corresponding author), Canterbury Christ Church Univ, Sch Human & Life Sci, Biomol Res Grp, Canterbury, Kent, England.	simon.harvey@canterbury.ac.uk			Canterbury Christ Church University (CCCU); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Canterbury Christ Church University (CCCU); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	JG was supported by a PhD Scholarship from Canterbury Christ Church University (CCCU). CCCU had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No external funding was received for this study.	Andersen EC, 2012, NAT GENET, V44, P285, DOI 10.1038/ng.1050; Bose N, 2014, CURR BIOL, V24, P1536, DOI 10.1016/j.cub.2014.05.045; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Diaz SA, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-46; Doroszuk A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp528; Duveau F, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001230; Felix MA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-59; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gibson G, 2010, NAT GENET, V42, P558, DOI 10.1038/ng0710-558; Glater EE, 2014, G3-GENES GENOM GENET, V4, P265, DOI 10.1534/g3.113.008649; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Green JWM, 2013, HEREDITY, V111, P306, DOI 10.1038/hdy.2013.50; Green JWM, 2012, NEMATOLOGY, V14, P165, DOI 10.1163/138855411X584115; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; Gutteling EW, 2007, HEREDITY, V98, P28, DOI 10.1038/sj.hdy.6800894; Harvey SC, 2009, J EXP ZOOL PART B, V312B, P224, DOI 10.1002/jez.b.21287; Harvey SC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-15; Hodgkin J, 1997, GENETICS, V146, P149; HODGKIN J, 1991, P ROY SOC B-BIOL SCI, V246, P19, DOI 10.1098/rspb.1991.0119; Kammenga JE, 2008, TRENDS GENET, V24, P178, DOI 10.1016/j.tig.2008.01.001; Kammenga JE, 2007, PLOS GENET, V3, P358, DOI 10.1371/journal.pgen.0030034; Kaufmann K, 2010, NAT REV GENET, V11, P830, DOI 10.1038/nrg2885; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; Li Y, 2006, PLOS GENET, V2, P2155, DOI 10.1371/journal.pgen.0020222; Li Y, 2010, GENETICS, V186, P405, DOI 10.1534/genetics.110.119677; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Maydan JS, 2007, GENOME RES, V17, P337, DOI 10.1101/gr.5690307; Maydan JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-62; Mayer MG, 2011, P ROY SOC B-BIOL SCI, V278, P2784, DOI 10.1098/rspb.2010.2760; McGrath PT, 2011, NATURE, V477, P321, DOI 10.1038/nature10378; Moczek AP, 2010, PHILOS T R SOC B, V365, P593, DOI 10.1098/rstb.2009.0263; Pantin F, 2011, PLANT PHYSIOL, V156, P803, DOI 10.1104/pp.111.176289; Petersen C, 2014, BMC ECOL, V14, DOI 10.1186/1472-6785-14-4; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Rajon E, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1552; Rockman MV, 2012, EVOLUTION, V66, P1, DOI 10.1111/j.1558-5646.2011.01486.x; Rodriguez M, 2012, EXP GERONTOL, V47, P581, DOI 10.1016/j.exger.2012.05.005; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Shao HF, 2010, MAMM GENOME, V21, P276, DOI 10.1007/s00335-010-9267-5; Snoek LB, 2014, G3-GENES GENOM GENET, V4, P1813, DOI 10.1534/g3.114.013151; Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x; Stewart MR, 2005, GENETICS, V169, P1985, DOI 10.1534/genetics.104.035329; Stiernagle Theresa, 2006, WormBook, P1; Terpstra IR, 2010, PLANT PHYSIOL, V154, P1067, DOI 10.1104/pp.110.159996; Tomkins JL, 2007, TRENDS ECOL EVOL, V22, P522, DOI 10.1016/j.tree.2007.09.002; Viney ME, 2003, DEV GROWTH DIFFER, V45, P389, DOI 10.1046/j.1440-169X.2003.00703.x	47	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112830	10.1371/journal.pone.0112830	http://dx.doi.org/10.1371/journal.pone.0112830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393108	Green Published, gold, Green Submitted			2022-12-27	WOS:000347709300110
J	Lansdorp-Vogelaar, I; Fedewa, S; Lin, CC; Virgo, KS; Jemal, A				Lansdorp-Vogelaar, Iris; Fedewa, Stacey; Lin, Chun Chieh; Virgo, Katherine S.; Jemal, Ahmedin			Utilization of Surveillance after Polypectomy in the Medicare Population - A Cohort Study	PLOS ONE			English	Article							COLORECTAL-CANCER; UNITED-STATES; NATIONAL-SURVEY; COLONOSCOPY; POLYPS; PREVENTION; PREVALENCE; DIAGNOSIS; RISK	Background: Surveillance in patients with previous polypectomy was underused in the Medicare population in 1994. This study investigates whether expansion of Medicare reimbursement for colonoscopy screening in high-risk individuals has reduced the inappropriate use of surveillance. Methods: We used Kaplan-Meier analysis to estimate time to surveillance and polyp recurrence rates for Medicare beneficiaries with a colonoscopy with polypectomy between 1998 and 2003 who were followed through 2008 for receipt of surveillance colonoscopy. Generalized Estimating Equations were used to estimate risk factors for: 1) failing to undergo surveillance and 2) polyp recurrence among these individuals. Analyses were stratified into three 2-year cohorts based on baseline colonoscopy date. Results: Medicare beneficiaries undergoing a colonoscopy with polypectomy in the 1998-1999 (n = 4,136), 2000-2001 (n = 3,538) and 2002-2003 (n = 4,655) cohorts had respective probabilities of 30%, 26% and 20% (p<0.001) of subsequent surveillance events within 3 years. At the same time, 58%, 52% and 45% (p<0.001) of beneficiaries received a surveillance event within 5 years. Polyp recurrence rates after 5 years were 36%, 30% and 26% (p<0.001) respectively. Older age (>= 70 years), female gender, later cohort (2000-2001 & 2002-2003), and severe comorbidity were the most important risk factors for failure to undergo a surveillance event. Male gender and early cohort (1998-1999) were the most important risk factors for polyp recurrence. Conclusions: Expansion of Medicare reimbursement for colonoscopy screening in high-risk individuals has not reduced underutilization of surveillance in the Medicare population. It is important to take action now to improve this situation, because polyp recurrence is substantial in this population.	[Lansdorp-Vogelaar, Iris] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Fedewa, Stacey; Lin, Chun Chieh; Jemal, Ahmedin] Amer Canc Soc, Intramural Res Dept, Atlanta, GA 30329 USA; [Fedewa, Stacey] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Virgo, Katherine S.] Emory Univ, Dept Hlth Policy & Management, Atlanta, GA 30322 USA	Erasmus University Rotterdam; Erasmus MC; American Cancer Society; Emory University; Rollins School Public Health; Emory University	Lansdorp-Vogelaar, I (corresponding author), Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.	i.vogelaar@erasmusmc.nl	Virgo, Katherine S/AAG-3188-2021	Virgo, Katherine S/0000-0002-2069-0585; Fedewa, Stacey/0000-0002-3624-6382	National Cancer Institute at the National Institutes of Health [U01-CA-097426, U01-CA-115953, U01-CA-152959]; American Cancer Society's Intramural Research Department; NATIONAL CANCER INSTITUTE [U01CA152959, U01CA097426, U01CA115953] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society's Intramural Research Department(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the National Cancer Institute at the National Institutes of Health (grant numbers U01-CA-097426, U01-CA-115953, U01-CA-152959 to IL-V) (www.cancer.gov); and American Cancer Society's Intramural Research Department (www.cancer.org). The funding sources had no role in study design, data collection, and analysis, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health.	Amonkar MM, 2005, CANCER EPIDEM BIOMAR, V14, P417, DOI 10.1158/1055-9965.EPI-04-0342; Boolchand V, 2006, ANN INTERN MED, V145, P654, DOI 10.7326/0003-4819-145-9-200611070-00007; Brenner H, 2012, J CLIN ONCOL, V30, P2969, DOI 10.1200/JCO.2011.41.3377; Cooper GS, 2013, CANCER-AM CANCER SOC, V119, P1800, DOI 10.1002/cncr.27990; de Jonge V, 2011, ENDOSCOPY, V43, P560, DOI 10.1055/s-0030-1256306; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Forsberg AM, 2012, SCAND J GASTROENTERO, V47, P184, DOI 10.3109/00365521.2011.647062; Gross CP, 2006, JAMA-J AM MED ASSOC, V296, P2815, DOI 10.1001/jama.296.23.2815; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; Kim DH, 2011, NAT REV GASTRO HEPAT, V8, P129, DOI 10.1038/nrgastro.2011.19; Ko CW, 2011, GASTROINTEST ENDOSC, V73, P447, DOI 10.1016/j.gie.2010.07.044; Laiyemo AO, 2009, CLIN GASTROENTEROL H, V7, P562, DOI 10.1016/j.cgh.2008.12.009; Lieberman DA, 2005, GASTROINTEST ENDOSC, V62, P875, DOI 10.1016/j.gie.2005.06.037; Martinez ME, 2009, GASTROENTEROLOGY, V136, P832, DOI 10.1053/j.gastro.2008.12.007; Mysliwiec PA, 2004, ANN INTERN MED, V141, P264, DOI 10.7326/0003-4819-141-4-200408170-00006; Pickhardt PJ, 2004, RADIOLOGY, V232, P784, DOI 10.1148/radiol.2323031614; Ransohoff DF, 2011, DIGEST DIS SCI, V56, P2623, DOI 10.1007/s10620-011-1791-y; Rim SH, 2009, CANCER-AM CANCER SOC, V115, P1967, DOI 10.1002/cncr.24216; Schenck AP, 2007, CANCER EPIDEM BIOMAR, V16, P2118, DOI 10.1158/1055-9965.EPI-07-0123; Schoen RE, 2010, GASTROENTEROLOGY, V138, P73, DOI 10.1053/j.gastro.2009.09.062; Warren Joan L, 2002, Med Care, V40, pIV; Warren JL, 2009, ANN INTERN MED, V150, P849, DOI 10.7326/0003-4819-150-12-200906160-00008; Winawer SJ, 2006, CA-CANCER J CLIN, V56, P143, DOI 10.3322/canjclin.56.3.143; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370	26	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e110937	10.1371/journal.pone.0110937	http://dx.doi.org/10.1371/journal.pone.0110937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393312	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300005
J	Tsuboko, S; Kimura, T; Shinya, M; Suehiro, Y; Okuyama, T; Shimada, A; Takeda, H; Naruse, K; Kubo, T; Takeuchi, H				Tsuboko, Satomi; Kimura, Tetsuaki; Shinya, Minori; Suehiro, Yuji; Okuyama, Teruhiro; Shimada, Atsuko; Takeda, Hiroyuki; Naruse, Kiyoshi; Kubo, Takeo; Takeuchi, Hideaki			Genetic Control of Startle Behavior in Medaka Fish	PLOS ONE			English	Article							ORYZIAS-LATIPES; LENGTH POLYMORPHISMS; GENOME EVOLUTION; DRAFT GENOME; LINKAGE MAP; PERSONALITY; RESOURCE; STIMULUS; STRAINS; PROJECT	Genetic polymorphisms are thought to generate intraspecific behavioral diversities, both within and among populations. The mechanisms underlying genetic control of behavioral properties, however, remain unclear in wild-type vertebrates, including humans. To explore this issue, we used diverse inbred strains of medaka fish (Oryzias latipes) established from the same and different local populations. Medaka exhibit a startle response to a visual stimulus (extinction of illumination) by rapidly bending their bodies (C-start) 20-ms after the stimulus presentation. We measured the rates of the response to repeated stimuli (1-s interval, 40 times) among four inbred strains, HNI-I, HNI-II, HO5, and Hd-rR-II1, and quantified two properties of the startle response: sensitivity (response rate to the first stimulus) and attenuation of the response probability with repeated stimulus presentation. Among the four strains, the greatest differences in these properties were detected between HNI-II and Hd-rR-II1. HNI-II exhibited high sensitivity (approximately 80%) and no attenuation, while Hd-rR-II1 exhibited low sensitivity (approximately 50%) and almost complete attenuation after only five stimulus presentations. Our findings suggested behavioral diversity of the startle response within a local population as well as among different populations. Linkage analysis with F2 progeny between HNI-II and Hd-rR-II1 detected quantitative trait loci (QTL) highly related to attenuation, but not to sensitivity, with a maximum logarithm of odds score of 11.82 on linkage group 16. The three genotypes (homozygous for HNI-II and Hd-rR-II1 alleles, and heterozygous) at the marker nearest the QTL correlated with attenuation. Our findings are the first to suggest that a single genomic region might be sufficient to generate individual differences in startle behavior between wild-type strains. Further identification of genetic polymorphisms that define the behavioral trait will contribute to our understanding of the neural mechanisms underlying behavioral diversity, allowing us to investigate the adaptive significance of intraspecific behavioral polymorphisms of the startle response.	[Tsuboko, Satomi; Suehiro, Yuji; Okuyama, Teruhiro; Shimada, Atsuko; Takeda, Hiroyuki; Kubo, Takeo; Takeuchi, Hideaki] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan; [Kimura, Tetsuaki; Okuyama, Teruhiro; Naruse, Kiyoshi] Natl Inst Basic Biol, Lab Bioresources, Okazaki, Aichi 444, Japan; [Kimura, Tetsuaki; Naruse, Kiyoshi] Natl Inst Basic Biol, Ctr Interuniv Biobackup Project, Okazaki, Aichi 444, Japan; [Shinya, Minori] Natl Inst Genet, Genet Strains Res Ctr, Mishima, Shizuoka 411, Japan; [Shinya, Minori] Keio Univ, Dept Biol, Yokohama, Kanagawa 223, Japan; [Suehiro, Yuji] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo, Japan	University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Keio University; Tokyo Women's Medical University	Takeuchi, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan.	takeuchi@bs.s.u-tokyo.ac.jp	Takeuchi, Hideaki/W-6739-2018; KUBO, TAKEO/G-4951-2014; TAKEDA, HIROYUKI/G-4950-2014; Tsuboko-Ishii, Satomi/J-2713-2019	Takeuchi, Hideaki/0000-0001-6610-3895; Tsuboko-Ishii, Satomi/0000-0003-4374-6200; Naruse, Kiyoshi/0000-0001-9185-3495; Kubo, Takeo/0000-0002-5914-5269	National Institute for Basic Biology Priority Collaborative Research Project [10-104]; MEXT;  [23650162]	National Institute for Basic Biology Priority Collaborative Research Project; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported by the National Institute for Basic Biology Priority Collaborative Research Project (10-104, http://www.nibb.ac.jp/en/collabo/collabo.html), Grant-in-Aid for Challenging Exploratory Research (23650162, http://www.jsps.go.jp/english/e-grants/grants01.html), Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network, https://www.hokatsu-nou.nips.ac.jp/), the Graduate Program for Leaders in Life Innovation (GPLLI) at the University of Tokyo Life Innovation Leading Graduate School from MEXT (to ST, http://square.umin.ac.jp/gplli/en/index.html), and Grant-in-Aid for a Japan Society for Promotion of Science (JSPS) fellowship (to ST, YS, and TO, http://www.jsps.go.jp/english/e-pd/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan B, 2008, NUCLEIC ACIDS RES, V36, pD747, DOI 10.1093/nar/gkm765; Ansai S, 2014, BIOL OPEN, V3, P362, DOI 10.1242/bio.20148177; Ansai S, 2014, DEV GROWTH DIFFER, V56, P98, DOI 10.1111/dgd.12104; Ansai S, 2013, GENETICS, V193, P739, DOI 10.1534/genetics.112.147645; Bergmuller R, 2010, TRENDS ECOL EVOL, V25, P504, DOI 10.1016/j.tree.2010.06.012; Bouchard TJ, 2001, BEHAV GENET, V31, P243; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Carter AJ, 2013, BIOL REV, V88, P465, DOI 10.1111/brv.12007; EATON RC, 1981, J COMP PHYSIOL, V144, P521, DOI 10.1007/BF01326837; Eaton RC., 1984, NEURAL MECH STARTLE, DOI [10.1007/978-1-4899-2286-1, DOI 10.1007/978-1-4899-2286-1]; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Flint J, 2003, J NEUROBIOL, V54, P46, DOI 10.1002/neu.10161; GLOWA JR, 1994, BEHAV GENET, V24, P79, DOI 10.1007/BF01067931; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; GWILLIAM GF, 1963, BIOL BULL, V125, P470, DOI 10.2307/1539360; Hirayama M, 2010, GENE, V457, P13, DOI 10.1016/j.gene.2010.02.012; Hyodo-Taguchi Y, 1996, FISH BIOL J MEDAKA, V8, P11; Hyodo-Taguchi Y., 1990, INBRED STRAINS MEDAK, P129; HYODOTAGUCHI Y, 1983, J RADIAT RES, V24, P221, DOI 10.1269/jrr.24.221; Imada H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011248; Ishikawa Y, 1999, BRAIN BEHAV EVOLUT, V53, P2, DOI 10.1159/000006577; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Katsumura T, 2009, GENE, V443, P170, DOI 10.1016/j.gene.2009.04.017; Kimura T, 2005, GENE, V363, P24, DOI 10.1016/j.gene.2005.07.043; Kimura T, 2007, GENETICS, V177, P2379, DOI 10.1534/genetics.106.068460; Kimura T, 2012, G3-GENES GENOM GENET, V2, P1317, DOI 10.1534/g3.112.003236; Kimura T, 2010, BIOTECHNIQUES, V49, P582, DOI 10.2144/000113467; Kobayashi Daisuke, 2008, Briefings in Functional Genomics & Proteomics, V7, P415, DOI 10.1093/bfgp/eln044; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Matsuda M, 2007, P NATL ACAD SCI USA, V104, P3865, DOI 10.1073/pnas.0611707104; Matsumoto Y, 2006, GENE, V371, P268, DOI 10.1016/j.gene.2005.12.005; Matsumoto Yoshifumi, 2009, BMC Res Notes, V2, P88, DOI 10.1186/1756-0500-2-88; Michelena P, 2010, P ROY SOC B-BIOL SCI, V277, P1093, DOI 10.1098/rspb.2009.1926; Naruse K, 2000, GENETICS, V154, P1773; Ochiai T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071685; Okuyama T, 2014, SCIENCE, V343, P91, DOI 10.1126/science.1244724; Okuyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066597; Perez-Escudero A, 2014, NAT METHODS; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; RUSSELL EM, 1967, ANIM BEHAV, V15, P574, DOI 10.1016/0003-3472(67)90061-9; Sasado T, 2010, EXP ANIM TOKYO, V59, P13, DOI 10.1538/expanim.59.13; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; Spivakov M, 2014, G3-GENES GENOM GENET, V4, P433, DOI 10.1534/g3.113.008722; Takeda H, 2008, DEV GROWTH DIFFER, V50, pS157, DOI 10.1111/j.1440-169X.2008.00992.x; Webster MM, 2011, BIOL REV, V86, P759, DOI 10.1111/j.1469-185X.2010.00169.x; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1	47	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112527	10.1371/journal.pone.0112527	http://dx.doi.org/10.1371/journal.pone.0112527			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393539	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300064
J	Zhang, Y; Maignien, L; Stadnitskaia, A; Boeckx, P; Xiao, X; Boon, N				Zhang, Yu; Maignien, Lois; Stadnitskaia, Alina; Boeckx, Pascal; Xiao, Xiang; Boon, Nico			Stratified Community Responses to Methane and Sulfate Supplies in Mud Volcano Deposits: Insights from an In Vitro Experiment	PLOS ONE			English	Article							CONTINUOUS HIGH-PRESSURE; ANAEROBIC OXIDATION; CONTINENTAL-MARGIN; REDUCING BACTERIA; NE ATLANTIC; CADIZ; DEEP; GULF; SEA; PROKARYOTES	Numerous studies on marine prokaryotic communities have postulated that a process of anaerobic oxidation of methane (AOM) coupled with sulfate reduction (SR) is the main methane sink in the world's oceans. AOM has also been reported in the deep biosphere. But the responses of the primary microbial players in eliciting changes in geochemical environments, specifically in methane and sulfate supplies, have yet to be fully elucidated. Marine mud volcanoes (MVs) expel a complex fluid mixture of which methane is the primary component, forming an environment in which AOM is a common phenomenon. In this context, we attempted to identify how the prokaryotic community would respond to changes in methane and sulfate intensities, which often occur in MV environments in the form of eruptions, diffusions or seepage. We applied an integrated approach, including (i) biochemical surveys of pore water originated from MV, (ii) in vitro incubation of mud breccia, and (iii) prokaryotic community structure analysis. Two distinct AOM regions were clearly detected. One is related to the sulfate methane transition zone (SMTZ) at depth of 30-55 cm below the sea floor (bsf); the second is at 165-205 cm bsf with ten times higher rates of AOM and SR. This finding contrasts with the sulfide concentrations in pore waters and supports the suggestion that potential AOM activity below the SMTZ might be an important methane sink that is largely ignored or underestimated in oceanic methane budget calculations. Moreover, the incubation conditions below the SMTZ favor the growth of methanotrophic archaeal group ANME-2 compared to ANME-1, and promote the rapid growth and high diversity of bacterial communities. These incubation conditions also promote the increase of richness in bacterial communities. Our results provide direct evidence of the mechanisms by which deep AOM processes can affect carbon cycling in the deep biosphere and global methane biochemistry.	[Zhang, Yu; Xiao, Xiang] Shanghai Jiao Tong Univ, State Key Lab Ocean Engn, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Zhang, Yu; Maignien, Lois; Boon, Nico] Univ Ghent, Lab Microbial Ecol & Technol, B-9000 Ghent, Belgium; [Stadnitskaia, Alina] Royal Netherlands Inst Sea Res, Dept Marine Geol & Chem Oceanog, Texel, Netherlands; [Boeckx, Pascal] Univ Ghent, Lab Appl Phys Chem, B-9000 Ghent, Belgium	Shanghai Jiao Tong University; Ghent University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Ghent University	Xiao, X (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Ocean Engn, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	xoxiang@sjtu.edu.cn; Nico.Boon@ugent.be	, yu/GYD-8364-2022; xiao, xiang/GWU-6035-2022; Boon, Nico/B-4083-2011	, yu/0000-0002-0379-7882; Boon, Nico/0000-0002-7734-3103	Natural Science Foundation of China [41102211, 91228201]; National High-Tech Program of China [2012AA092103]; Bijzonder Onderzoeks Fonds of Ghent University [BOF08/DOC/016, BOF09/GOA/005]; European Science Foundation MicroSYSTEMS supported by Fonds voor Wetenschappelijk Onderzoek [506G.0656.05]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Program of China(National High Technology Research and Development Program of China); Bijzonder Onderzoeks Fonds of Ghent University(Ghent University); European Science Foundation MicroSYSTEMS supported by Fonds voor Wetenschappelijk Onderzoek	This work was supported by Natural Science Foundation of China (grant numbers 41102211 and 91228201), National High-Tech Program of China (grant number 2012AA092103), Bijzonder Onderzoeks Fonds of Ghent University (grant number BOF08/DOC/016, BOF09/GOA/005), European Science Foundation MicroSYSTEMS supported by Fonds voor Wetenschappelijk Onderzoek (grant number 506G.0656.05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanov GG, 1998, P ODP SCI RESULTS, V160; [Anonymous], 1936, B AM ASS PETROL GEOL, V20, P258; Beheydt D, 2005, RAPID COMMUN MASS SP, V19, P1365, DOI 10.1002/rcm.1907; Blumenberg M, 2004, P NATL ACAD SCI USA, V101, P11111, DOI 10.1073/pnas.0401188101; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Borin S, 2009, P NATL ACAD SCI USA, V106, P9151, DOI 10.1073/pnas.0811984106; Coolen MJL, 2002, SCIENCE, V296, P2407, DOI 10.1126/science.1071893; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Gardner JM, 2001, GEOPHYS RES LETT, V28, P339, DOI 10.1029/2000GL012141; Girguis PR, 2005, APPL ENVIRON MICROB, V71, P3725, DOI 10.1128/AEM.71.7.3725-3733.2005; Grayston SJ, 1998, SOIL BIOL BIOCHEM, V30, P369, DOI 10.1016/S0038-0717(97)00124-7; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; Ivanov MK, 2001, HYDROCARBON SEEPS DE; Jorgensen BB, 2012, P NATL ACAD SCI USA, V109, P15976, DOI 10.1073/pnas.1213639109; Kallmeyer J, 2012, P NATL ACAD SCI USA, V109, P16213, DOI 10.1073/pnas.1203849109; Kenyon NH, 2000, MULTIDISCIPLINARY ST; Kenyon NH, 2001, GEOLOGICAL PROCESSES; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Kruger M, 2003, NATURE, V426, P878, DOI 10.1038/nature02207; Lane DJ, 1991, NUCL ACID TECHNIQUES, P142; Leon R, 2006, DEEP-SEA RES PT II, V53, P1464, DOI 10.1016/j.dsr2.2006.04.009; Losekann T, 2007, APPL ENVIRON MICROB, V73, P3348, DOI 10.1128/AEM.00016-07; Manz W, 1998, FEMS MICROBIOL ECOL, V25, P43; Marzorati M, 2008, ENVIRON MICROBIOL, V10, P1571, DOI 10.1111/j.1462-2920.2008.01572.x; Mazurenko LL, 2002, TERRA NOVA, V14, P321, DOI 10.1046/j.1365-3121.2002.00428.x; Niemann H, 2006, GEOCHIM COSMOCHIM AC, V70, P5336, DOI 10.1016/j.gca.2006.08.010; Niemann H, 2006, NATURE, V443, P854, DOI 10.1038/nature05227; PACE NR, 1986, CELL, V45, P325, DOI 10.1016/0092-8674(86)90315-6; Pagaling E, 2014, ISME J, V8, P19, DOI 10.1038/ismej.2013.150; Parkes RJ, 2009, ENVIRON MICROBIOL, V11, P3140, DOI 10.1111/j.1462-2920.2009.02018.x; Parkes RJ, 2005, NATURE, V436, P390, DOI 10.1038/nature03796; PARKES RJ, 1994, NATURE, V371, P410, DOI 10.1038/371410a0; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Pernthaler A, 2008, P NATL ACAD SCI USA, V105, P7052, DOI 10.1073/pnas.0711303105; Pinheiro LM, 2003, MAR GEOL, V195, P131, DOI 10.1016/S0025-3227(02)00685-0; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; Rossel PE, 2011, GEOCHIM COSMOCHIM AC, V75, P164, DOI 10.1016/j.gca.2010.09.031; Stadnitskaia A, 2008, MAR GEOL, V255, P1, DOI 10.1016/j.margeo.2007.11.006; Stadnitskaia A, 2007, BIO PETROLEUM GEOCHE; Stadnitskaia A, 2006, MAR PETROL GEOL, V23, P281, DOI 10.1016/j.marpetgeo.2005.11.001; Van Rooij D, 2010, MARINE GEOLOGY; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Zhang Y, 2010, BIORESOURCE TECHNOL, V101, P3132, DOI 10.1016/j.biortech.2009.11.103	43	7	7	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e113004	10.1371/journal.pone.0113004	http://dx.doi.org/10.1371/journal.pone.0113004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393146	gold, Green Published, Green Submitted			2022-12-27	WOS:000347709300134
J	Luo, LX; Lin, HT; Chen, WR; Qu, B; Zhang, XY; Lin, ZL; Chen, JJ; Liu, YZ				Luo, Lixia; Lin, Haotian; Chen, Weirong; Qu, Bo; Zhang, Xinyu; Lin, Zhuoling; Chen, Jingjing; Liu, Yizhi			Intraocular Lens-Shell Technique: Adjustment of the Surgical Procedure Leads to Greater Safety When Treating Dense Nuclear Cataracts	PLOS ONE			English	Article							CORNEAL ENDOTHELIUM; HARD NUCLEUS; PHACOEMULSIFICATION; ULTRASOUND	Objective: To compare the efficacy and safety of the intraocular lens (IOL)-shell procedure versus conventional phacoemulsification for the surgical treatment of dense cataracts. Methods: Eighty eyes with dense nuclear cataracts were enrolled in a prospective, randomized controlled study. Patients were assigned to two groups. In Group I, the IOL was traditionally implanted after all nuclear fragments were completely removed, and in Group II, the IOL was innovatively implanted in the bag before the last residual nuclear fragment was removed. This novel adjusted surgical procedure, named the "IOL-shell technique'', features use of the IOL as a protective barrier rather than simply as a refractive alternative, and it is conceptually different from the traditional step-by-step procedure. Clinical examinations, including uncorrected visual acuity, central corneal thickness (CCT), temporal clear corneal incision thickness and corneal endothelial cell density, were carried out. Results: The inter-group difference in temporal corneal thickness was found to be of no statistical significance at any of the visits. Compared to eyes in Group I, those in Group II were shown to have significantly less corneal endothelial cell loss on both the 7th and 30th day following surgery. At 7 days after surgery, the mean corneal endothelial cell loss in Group II was 10.29%, compared to 14.37% in Group I (P<0.05). The mean endothelial cell loss measured on postoperative day 30 was 16.88% in Group II compared to 23.32% in Group I (P<0.05). On the 1st day after surgery, the mean CCT of eyes in Group II was significantly smaller compared to Group I (Group I vs. Group II: 19.42% vs. 13.50%, P<0.05). Conclusions: Compared to conventional phacoemulsification, the IOL-shell technique was shown to be a relatively safer procedure without compromised efficiency for dense cataracts, and it caused less corneal endothelial cell loss and milder postoperative corneal edema (Clinical Trials Identifier: NCT02138123).	[Luo, Lixia; Lin, Haotian; Chen, Weirong; Qu, Bo; Zhang, Xinyu; Lin, Zhuoling; Chen, Jingjing; Liu, Yizhi] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Liu, YZ (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	yizhi_liu@aliyun.com	Chen, Wei/GZK-7348-2022; liu, yi/GXE-9662-2022		Natural Science Foundation of China [81370994]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the Natural Science Foundation of China (81370994). The sponsors of the study played no role in design of the original study protocol, data collection, data analysis, data interpretation, manuscript preparation, or the decision to submit the manuscript for publication.	Buratto L, 2000, CATARACT SURG COMPLI, P291; Ciooni RJ, 1995, CATARACT SURG TECHNI, P327; EDELHAUSER HF, 1975, ARCH OPHTHALMOL-CHIC, V93, P648, DOI 10.1001/archopht.1975.01010020614011; Gimbel Howard V, 2002, Curr Opin Ophthalmol, V13, P30, DOI 10.1097/00055735-200202000-00007; Hwang HS, 2010, J CATARACT REFR SURG, V36, P1627, DOI 10.1016/j.jcrs.2010.08.003; KOCH PS, 1994, J CATARACT REFR SURG, V20, P566, DOI 10.1016/S0886-3350(13)80239-8; Leaming DV, 1999, J CATARACT REFR SURG, V25, P851; Luo LX, 2012, AM J OPHTHALMOL, V153, P831, DOI 10.1016/j.ajo.2011.10.034; Nagahara K, 1993, VIDEO PRESENTATION; OLSON LE, 1978, BRIT J OPHTHALMOL, V62, P134, DOI 10.1136/bjo.62.3.134; POLACK FM, 1976, INVEST OPHTH VISUAL, V15, P458; Sato M, 2008, J CATARACT REFR SURG, V34, P1824, DOI 10.1016/j.jcrs.2008.05.064; Shah PA, 2007, CURR OPIN OPHTHALMOL, V18, P23, DOI 10.1097/ICU.0b013e328011f9d0; Simanjuntak GWS, 2010, SEMIN OPHTHALMOL, V25, P8, DOI 10.3109/08820538.2010.482846; Wang YJ, 2009, J CATARACT REFR SURG, V35, P1941, DOI 10.1016/j.jcrs.2009.05.055; Zeng M, 2008, BRIT J OPHTHALMOL, V92, P1092, DOI 10.1136/bjo.2007.128504	16	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112663	10.1371/journal.pone.0112663	http://dx.doi.org/10.1371/journal.pone.0112663			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401512	gold, Green Submitted, Green Published			2022-12-27	WOS:000345158700060
J	Malinova, I; Kunz, HH; Alseekh, S; Herbst, K; Fernie, AR; Gierth, M; Fettke, J				Malinova, Irina; Kunz, Hans-Henning; Alseekh, Saleh; Herbst, Karoline; Fernie, Alisdair R.; Gierth, Markus; Fettke, Joerg			Reduction of the Cytosolic Phosphoglucomutase in Arabidopsis Reveals Impact on Plant Growth, Seed and Root Development, and Carbohydrate Partitioning	PLOS ONE			English	Article							YEAST-DERIVED INVERTASE; STARCH DEGRADATION; CELL-WALL; BIOCHEMICAL-CHARACTERIZATION; ANTISENSE REPRESSION; MALTOSE METABOLISM; THALIANA L; WILD-TYPE; LEAVES; POTATO	Phosphoglucomutase (PGM) catalyses the interconversion of glucose 1-phosphate (G1P) and glucose 6-phosphate (G6P) and exists as plastidial (pPGM) and cytosolic (cPGM) isoforms. The plastidial isoform is essential for transitory starch synthesis in chloroplasts of leaves, whereas the cytosolic counterpart is essential for glucose phosphate partitioning and, therefore, for syntheses of sucrose and cell wall components. In Arabidopsis two cytosolic isoforms (PGM2 and PGM3) exist. Both PGM2 and PGM3 are redundant in function as single mutants reveal only small or no alterations compared to wild type with respect to plant primary metabolism. So far, there are no reports of Arabidopsis plants lacking the entire cPGM or total PGM activity, respectively. Therefore, amiRNA transgenic plants were generated and used for analyses of various parameters such as growth, development, and starch metabolism. The lack of the entire cPGM activity resulted in a strongly reduced growth revealed by decreased rosette fresh weight, shorter roots, and reduced seed production compared to wild type. By contrast content of starch, sucrose, maltose and cell wall components were significantly increased. The lack of both cPGM and pPGM activities in Arabidopsis resulted in dwarf growth, prematurely die off, and inability to develop a functional inflorescence. The combined results are discussed in comparison to potato, the only described mutant with lack of total PGM activity.	[Malinova, Irina; Herbst, Karoline; Fettke, Joerg] Univ Potsdam, Potsdam, Germany; [Kunz, Hans-Henning] Washington State Univ, Pullman, WA 99164 USA; [Alseekh, Saleh; Fernie, Alisdair R.] Max Planck Inst Mol Plant Physiol, Potsdam, Germany; [Kunz, Hans-Henning; Gierth, Markus] Univ Cologne, Dept Bot 2, D-50931 Cologne, Germany	University of Potsdam; Washington State University; Max Planck Society; University of Cologne	Fettke, J (corresponding author), Univ Potsdam, Potsdam, Germany.	fettke@uni-potsdam.de		Fettke, Joerg/0000-0003-0137-7611	Deutsche Forschungsgemeinschaft [DFG-Az. FE 1030/1-1, FE 1030/2-1]; Human Frontier Science Program Long-Term fellowship; Alexander von Humboldt Feodor Lynen fellowship	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Human Frontier Science Program Long-Term fellowship(Human Frontier Science Program); Alexander von Humboldt Feodor Lynen fellowship	The authors acknowledge financial support by the Deutsche Forschungsgemeinschaft to J.F. (DFG-Az. FE 1030/1-1 and FE 1030/2-1). H.-H. K. was supported by the Human Frontier Science Program Long-Term fellowship and an Alexander von Humboldt Feodor Lynen fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asara JM, 2006, NAT PROTOC, V1, P46, DOI 10.1038/nprot.2006.7; Barratt DHP, 2009, P NATL ACAD SCI USA, V106, P13124, DOI 10.1073/pnas.0900689106; Burkle L, 1998, PLANT PHYSIOL, V118, P59, DOI 10.1104/pp.118.1.59; CASPAR T, 1985, PLANT PHYSIOL, V79, P11, DOI 10.1104/pp.79.1.11; Chia T, 2004, PLANT J, V37, P853, DOI 10.1111/j.1365-313X.2003.02012.x; Cho MH, 2011, NEW PHYTOL, V190, P101, DOI 10.1111/j.1469-8137.2010.03580.x; DICKINSON CD, 1991, PLANT PHYSIOL, V95, P420, DOI 10.1104/pp.95.2.420; Egli B, 2010, PLANT PHYSIOL, V154, P1659, DOI 10.1104/pp.110.165027; Fernie AR, 2002, PLANT PHYSIOL BIOCH, V40, P921, DOI 10.1016/S0981-9428(02)01457-2; Fernie AR, 2002, PLANTA, V214, P510, DOI 10.1007/s004250100644; Fettke J, 2006, PLANT J, V46, P668, DOI 10.1111/j.1365-313X.2006.02732.x; Fettke J, 2005, PLANT CELL PHYSIOL, V46, P1987, DOI 10.1093/pcp/pci214; Fettke J, 2005, PLANT J, V43, P568, DOI 10.1111/j.1365-313X.2005.02475.x; Fettke J, 2004, PLANT J, V39, P933, DOI 10.1111/j.1365-313X.2004.02181.x; Fettke J, 2006, THESIS U POTSDAM POT; Fettke J, 2012, ESSENTIAL REV EXPT B, V5, P309; Fettke J, 2008, PLANT PHYSIOL, V148, P1614, DOI 10.1104/pp.108.127969; Fettke J, 2011, J PLANT PHYSIOL, V168, P1415, DOI 10.1016/j.jplph.2010.09.008; Fettke J, 2011, PLANT PHYSIOL, V155, P1723, DOI 10.1104/pp.110.168716; Fettke J, 2010, NEW PHYTOL, V185, P663, DOI 10.1111/j.1469-8137.2009.03126.x; Fettke J, 2009, J EXP BOT, V60, P2907, DOI 10.1093/jxb/erp054; Foster C.F., 2010, J VIS EXP, V37, DOI [10.3791/1837, DOI 10.3791/1837]; Gibon Y, 2004, PLANT J, V39, P847, DOI 10.1111/j.1365-313X.2004.02173.x; HANSON KR, 1988, PLANT PHYSIOL, V88, P838, DOI 10.1104/pp.88.3.838; HEINEKE D, 1992, PLANT PHYSIOL, V100, P301, DOI 10.1104/pp.100.1.301; Herbst K, 2011, THESIS U POTSDAM POT; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; Kofler H, 2000, MOL GEN GENET, V263, P978, DOI 10.1007/PL00008698; Lou Y, 2007, PLANT CELL, V19, P163, DOI 10.1105/tpc.106.045658; Lu Y, 2004, PLANTA, V218, P466, DOI 10.1007/s00425-003-1127-z; Lytovchenko A, 2003, PLANT PHYSIOL BIOCH, V41, P193, DOI 10.1016/S0981-9428(03)00010-X; Lytovchenko A, 2002, PLANTA, V215, P1013, DOI 10.1007/s00425-002-0826-1; Manjunath S, 1998, PLANT PHYSIOL, V117, P997, DOI 10.1104/pp.117.3.997; Mitra S, 2010, GLYCOBIOLOGY, V20, P1233, DOI 10.1093/glycob/cwq081; MUHLBACH H, 1978, PLANTA, V141, P65, DOI 10.1007/BF00387746; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nakazawa M, 2003, BIOTECHNIQUES, V34, P28, DOI 10.2144/03341bm02; Niittyla T, 2006, J BIOL CHEM, V281, P11815, DOI 10.1074/jbc.M600519200; Reiter WD, 1997, PLANT J, V12, P335, DOI 10.1046/j.1365-313X.1997.12020335.x; RIESMEIER JW, 1994, EMBO J, V13, P1; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Seifert GJ, 2004, CURR OPIN PLANT BIOL, V7, P277, DOI 10.1016/j.pbi.2004.03.004; STITT M, 1989, METHOD ENZYMOL, V174, P518; Stitt M, 2012, CURR OPIN PLANT BIOL, V15, P282, DOI 10.1016/j.pbi.2012.03.016; Streb S, 2009, PLANT PHYSIOL, V151, P1769, DOI 10.1104/pp.109.144931; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; VONSCHAEWEN A, 1990, EMBO J, V9, P3033, DOI 10.1002/j.1460-2075.1990.tb07499.x; WAFFENSCHMIDT S, 1987, ANAL BIOCHEM, V165, P337, DOI 10.1016/0003-2697(87)90278-8; Weber A, 2000, PLANT CELL, V12, P787, DOI 10.1105/tpc.12.5.787; Weise SE, 2004, PLANTA, V218, P474, DOI 10.1007/s00425-003-1128-y; Yu TS, 2000, PLANT PHYSIOL, V123, P319, DOI 10.1104/pp.123.1.319	52	42	49	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112468	10.1371/journal.pone.0112468	http://dx.doi.org/10.1371/journal.pone.0112468			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401493	gold, Green Submitted, Green Published			2022-12-27	WOS:000345158700047
J	Melbo-Jorgensen, C; Ness, N; Andersen, S; Valkov, A; Donnem, T; Al-Saad, S; Kiselev, Y; Berg, T; Nordby, Y; Bremnes, RM; Busund, LT; Richardsen, E				Melbo-Jorgensen, Christian; Ness, Nora; Andersen, Sigve; Valkov, Andrej; Donnem, Tom; Al-Saad, Samer; Kiselev, Yury; Berg, Thomas; Nordby, Yngve; Bremnes, Roy M.; Busund, Lill-Tove; Richardsen, Elin			Stromal Expression of MiR-21 Predicts Biochemical Failure in Prostate Cancer Patients with Gleason Score 6	PLOS ONE			English	Article							MICRORNA EXPRESSION; RESISTANCE; INVASION; TARGET; GENES	Aim: microRNAs (miRNAs) are involved in various neoplastic diseases, including prostate cancer (PCs). The aim of this study was to investigate the miRNA profile in PC tissue, to assess their association with clinicopathologic data, and to evaluate the potential of miRNAs as diagnostic and prognostic markers. Materials and Methods: From a cohort of 535 patients submitted to radical prostatectomy (RP), a sample of 30 patients (14 patients with rapid biochemical failure (BF) and 16 patients without BF) with Gleason score 7 were analyzed. A total of 1435 miRNAs were quantified by microarray hybridization, and selected miRNAs with the highest Standard deviation (n = 50) were validated by real-time quantitative PCR (qRT-PCR). In situ hybridization (ISH) was used to evaluate the expression of miR-21. Results: miR-21 was the only miR that was significantly up-regulated in the BF group (p = 0.045) miR-21 was up-regulated in patients with BF compared with non-BF group (p = 0.05). In univariate analyses, high stromal expression of miR-21 had predictive impact on biochemical failure-free survival (BFFS) and clinical failure-free survival (CFFS) (p = 0.006 and p = 0.04, respectively). In the multivariate analysis, high stromal expression of miR-21 expression was found to be an independent prognostic factor for BFFS in patients with Gleason score 6 (HR 2.41, CI 95% 1.06-5.49, p = 0.037). Conclusion: High stromal expression of miR-21 was associated with poor biochemical recurrence-free survival after RP. For patients with Gleason score 6, miR-21 may help predict the risk of future disease progression and thereby help select patients for potential adjuvant treatment or a more stringent follow-up.	[Melbo-Jorgensen, Christian; Ness, Nora; Al-Saad, Samer; Kiselev, Yury; Busund, Lill-Tove; Richardsen, Elin] UIT, Dept Med Biol, Tromso, Norway; [Andersen, Sigve; Donnem, Tom; Nordby, Yngve; Bremnes, Roy M.] UIT, Dept Clin Med, Tromso, Norway; [Andersen, Sigve; Donnem, Tom; Bremnes, Roy M.] Univ Hosp North Norway, Dept Oncol, Tromso, Norway; [Valkov, Andrej; Al-Saad, Samer; Berg, Thomas; Busund, Lill-Tove; Richardsen, Elin] Univ Hosp North Norway, Dept Clin Pathol, Tromso, Norway; [Kiselev, Yury] UIT, Dept Pharm, Tromso, Norway; [Nordby, Yngve] Univ Hosp North Norway, Dept Urol, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway	Melbo-Jorgensen, C (corresponding author), UIT, Dept Med Biol, Tromso, Norway.	Christian.n.melbo-jorgensen@uit.no		Kiselev, Yury/0000-0002-6753-8572	Helse Nord, The Northern Health Administration; University of Tromso Arctic University of Norway	Helse Nord, The Northern Health Administration; University of Tromso Arctic University of Norway	This study was supported by grants from Helse Nord, The Northern Health Administration (www.helse-nord.no) and University of Tromso Arctic University of Norway (www.uit.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Arora R, 2004, CANCER-AM CANCER SOC, V100, P2362, DOI 10.1002/cncr.20243; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Breidablik Hans Johan, 2013, Tidsskr Nor Laegeforen, V133, P1711, DOI 10.4045/tidsskr.13.0023; Bremnes RM, 2002, J CLIN ONCOL, V20, P2417, DOI 10.1200/JCO.2002.08.159; Bronisz A, 2011, Nat Cell Biol, V14, P159, DOI 10.1038/ncb2396; Bullock MD, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.213; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Cheng L, 2012, HISTOPATHOLOGY, V60, P87, DOI 10.1111/j.1365-2559.2011.04025.x; Coppola V, 2010, ENDOCR-RELAT CANCER, V17, pF1, DOI 10.1677/ERC-09-0172; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Etzioni R, 2012, CLIN CANCER RES, V18, P6742, DOI 10.1158/1078-0432.CCR-12-1537; Folini M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-12; Gandellini P, 2009, TRENDS MOL MED, V15, P381, DOI 10.1016/j.molmed.2009.07.004; Hulf T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-54; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kielhorn E, 2003, INT J CANCER, V103, P652, DOI 10.1002/ijc.10893; Li T, 2012, J UROLOGY, V187, P1466, DOI 10.1016/j.juro.2011.11.082; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Mohler JL, 2010, J NATL COMPR CANC NE, V8, P145, DOI 10.6004/jnccn.2010.0010; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Prueitt RL, 2008, PROSTATE, V68, P1152, DOI 10.1002/pros.20786; Ribas J, 2010, CELL CYCLE, V9, P923, DOI 10.4161/cc.9.5.10930; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Shi GH, 2010, ACTA PHARMACOL SIN, V31, P867, DOI 10.1038/aps.2010.48; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yao Q, 2011, INT J CANCER, V128, P1783, DOI 10.1002/ijc.25506	30	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113039	10.1371/journal.pone.0113039	http://dx.doi.org/10.1371/journal.pone.0113039			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401698	Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700099
J	Sato, K; Choyke, PL; Kobayashi, H				Sato, Kazuhide; Choyke, Peter L.; Kobayashi, Hisataka			Photoimmunotherapy of Gastric Cancer Peritoneal Carcinomatosis in a Mouse Model	PLOS ONE			English	Article							CYTOSINE-ANALOG CS-682; ORTHOTOPIC MODEL; FLUORESCENT; EFFICACY; SURVIVAL; GROWTH; TUMORS	Photoimmunotherapy (PIT) is a new cancer treatment that combines the specificity of antibodies for targeting tumors with the toxicity induced by photosensitizers after exposure to near infrared (NIR) light. We performed PIT in a model of disseminated gastric cancer peritoneal carcinomatosis and monitored efficacy with in vivo GFP fluorescence imaging. In vitro and in vivo experiments were conducted with a HER2-expressing, GFP-expressing, gastric cancer cell line (N87-GFP). A conjugate comprised of a photosensitizer, IR-700, conjugated to trastuzumab (tra-IR700), followed by NIR light was used for PIT. In vitro PIT was evaluated by measuring cytotoxicity with dead staining and a decrease in GFP fluorescence. In vivo PIT was evaluated in a disseminated peritoneal carcinomatosis model and a flank xenograft using tumor volume measurements and GFP fluorescence intensity. In vivo anti-tumor effects of PIT were confirmed by significant reductions in tumor volume (at day 15, p<0.0001 vs. control) and GFP fluorescence intensity (flank model: at day 3, PIT treated vs. control p<0.01 and peritoneal disseminated model: at day 3 PIT treated vs. control, p<0.05). Cytotoxic effects in vitro were shown to be dependent on the light dose and caused necrotic cell rupture leading to GFP release and a decrease in fluorescence intensity in vitro. Thus, loss of GFP fluorescence served as a useful biomarker of cell necrosis after PIT.	[Sato, Kazuhide; Choyke, Peter L.; Kobayashi, Hisataka] NCI, Mol Imaging Program, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kobayashi, H (corresponding author), NCI, Mol Imaging Program, Ctr Canc Res, Bethesda, MD 20892 USA.	Kobayash@mail.nih.gov		Sato, Kazuhide/0000-0003-3025-088X	NIH Intramural program; JSPS; NATIONAL CANCER INSTITUTE [ZIABC011513] Funding Source: NIH RePORTER	NIH Intramural program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NIH Intramural program and JSPS Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caysa H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047927; de Martel C, 2013, GASTROENTEROL CLIN N, V42, P219, DOI 10.1016/j.gtc.2013.01.003; Ferro A, 2014, EUR J CANCER, V50, P1330, DOI 10.1016/j.ejca.2014.01.029; Gretschel S, 2006, BRIT J SURG, V93, P1530, DOI 10.1002/bjs.5513; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Hoffman RM, 2002, LANCET ONCOL, V3, P546, DOI 10.1016/S1470-2045(02)00848-3; Katz MH, 2004, CANCER RES, V64, P1828, DOI 10.1158/0008-5472.CAN-03-3350; Katz MH, 2003, CANCER RES, V63, P5521; Kimura H, 2010, J CELL BIOCHEM, V110, P1439, DOI 10.1002/jcb.22693; MEW D, 1983, J IMMUNOL, V130, P1473; Mitsunaga M, 2012, BIOCONJUGATE CHEM, V23, P604, DOI 10.1021/bc200648m; Mitsunaga M, 2011, NAT MED, V17, P1685, DOI 10.1038/nm.2554; Nakajima T, 2013, THERANOSTICS, V3, P357, DOI 10.7150/thno.5908; Nakajima T, 2012, CANCER RES, V72, P4622, DOI 10.1158/0008-5472.CAN-12-1298; Sano K, 2013, ACS NANO, V7, P717, DOI 10.1021/nn305011p; Sato K, 2014, MOL ONCOL, V8, P620, DOI 10.1016/j.molonc.2014.01.006; Sato K, 2011, MOL BIOL CELL, V22, P3103, DOI 10.1091/mbc.E11-03-0274; Shirasu N., 2014, INT J CANCER, P1; Spring BQ, 2014, P NATL ACAD SCI USA, V111, pE933, DOI 10.1073/pnas.1319493111; Sugarbaker PH, 2000, ONCOLOGY-BASEL, V58, P96, DOI 10.1159/000012086; Thomassen I, 2014, INT J CANCER, V134, P622, DOI 10.1002/ijc.28373; Vermes I, 2000, J IMMUNOL METHODS, V243, P167, DOI 10.1016/S0022-1759(00)00233-7; Walsh GM, 1998, J IMMUNOL METHODS, V217, P153, DOI 10.1016/S0022-1759(98)00103-3; Yamashita-Kashima Y, 2014, GASTRIC CANCER, V17, P638, DOI 10.1007/s10120-013-0329-8; Yang M, 2000, P NATL ACAD SCI USA, V97, P1206, DOI 10.1073/pnas.97.3.1206	25	58	66	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113276	10.1371/journal.pone.0113276	http://dx.doi.org/10.1371/journal.pone.0113276			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401794	Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700128
J	Asaoka, Y; Tateishi, R; Nakagomi, R; Kondo, M; Fujiwara, N; Minami, T; Sato, M; Uchino, K; Enooku, K; Nakagawa, H; Kondo, Y; Shiina, S; Yoshida, H; Koike, K				Asaoka, Yoshinari; Tateishi, Ryosuke; Nakagomi, Ryo; Kondo, Mayuko; Fujiwara, Naoto; Minami, Tatsuya; Sato, Masaya; Uchino, Koji; Enooku, Kenichiro; Nakagawa, Hayato; Kondo, Yuji; Shiina, Shuichiro; Yoshida, Haruhiko; Koike, Kazuhiko			Frequency of and Predictive Factors for Vascular Invasion after Radiofrequency Ablation for Hepatocellular Carcinoma	PLOS ONE			English	Article							GAMMA-CARBOXY PROTHROMBIN; DONOR LIVER-TRANSPLANTATION; PORTAL VENOUS INVASION; REPEAT HEPATECTOMY; TUMOR THROMBUS; PROGNOSIS; CANCER; JAPAN; RECURRENCE; CIRRHOSIS	Background: Vascular invasion in patients with hepatocellular carcinoma (HCC) is representative of advanced disease with an extremely poor prognosis. The detailed course of its development has not been fully elucidated. Methods: We enrolled 1057 consecutive patients with HCC who had been treated with curative intent by radiofrequency ablation (RFA) as an initial therapy from 1999 to 2008 at our department. We analyzed the incidence rate of and predictive factors for vascular invasion. The survival rate after detection of vascular invasion was also analyzed. Results: During a mean follow-up period of 4.5 years, 6075 nodules including primary and recurrent lesions were treated by RFA. Vascular invasion was observed in 97 patients. The rate of vascular invasion associated with site of original RFA procedure was 0.66% on a nodule basis. The incidence rates of vascular invasion on a patient basis at 1, 3, and 5 years were 1.1%, 5.9%, and 10.4%, respectively. Univariate analysis revealed that tumor size, tumor number, alpha-fetoprotein (AFP), des-gamma-carboxy prothrombin (DCP), and Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein were significant risk predictors of vascular invasion. In multivariate analysis, DCP was the most significant predictor for vascular invasion (compared with a DCP of <= 100 mAu/mL, the hazard ratio was 1.95 when DCP was 101-200 mAu/mL and 3.22 when DCP was > 200 mAu/mL). The median survival time after development of vascular invasion was only 6 months. Conclusion: Vascular invasion occurs during the clinical course of patients initially treated with curative intent. High-risk patients may be identified using tumor markers.	[Asaoka, Yoshinari; Tateishi, Ryosuke; Nakagomi, Ryo; Kondo, Mayuko; Fujiwara, Naoto; Minami, Tatsuya; Sato, Masaya; Uchino, Koji; Enooku, Kenichiro; Nakagawa, Hayato; Kondo, Yuji; Yoshida, Haruhiko; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Shiina, Shuichiro] Juntendo Univ, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan	University of Tokyo; Juntendo University	Tateishi, R (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan.	tateishi-tky@umin.ac.jp	Nakagawa, Hayato/I-2837-2012; Fujiwara, Naoto/Y-5938-2019; Asaoka, Yoshinari/ABC-5412-2021; Tateishi, Ryosuke/G-7758-2014	Nakagawa, Hayato/0000-0002-6973-5094; Fujiwara, Naoto/0000-0002-4109-3421; Asaoka, Yoshinari/0000-0002-2805-8226; Tateishi, Ryosuke/0000-0003-3021-2517	Health Sciences Research Grants of The Ministry of Health, Labour and Welfare of Japan (Research on Hepatitis)	Health Sciences Research Grants of The Ministry of Health, Labour and Welfare of Japan (Research on Hepatitis)	This work was supported by Health Sciences Research Grants of The Ministry of Health, Labour and Welfare of Japan (Research on Hepatitis). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi E, 1996, CANCER, V77, P2022, DOI 10.1002/(SICI)1097-0142(19960515)77:10<2022::AID-CNCR9>3.0.CO;2-S; ALBACETE RA, 1967, ANN INTERN MED, V67, P337, DOI 10.7326/0003-4819-67-2-337; Baldan A, 2006, ALIMENT PHARM THER, V24, P1495, DOI 10.1111/j.1365-2036.2006.03136.x; FUJII T, 1993, JPN J CLIN ONCOL, V23, P105; Giannelli G, 2002, HEPATOL RES, V24, P50, DOI 10.1016/S1386-6346(02)00027-X; Hasegawa K, 2008, J GASTROINTEST SURG, V12, P858, DOI 10.1007/s11605-007-0464-9; Ikai I, 2007, HEPATOL RES, V37, P676, DOI 10.1111/j.1872-034X.2007.00119.x; INAMOTO K, 1981, AM J ROENTGENOL, V136, P349, DOI 10.2214/ajr.136.2.349; Ito T, 2007, LIVER TRANSPLANT, V13, P1637, DOI 10.1002/lt.21281; Jeong SW, 2013, GUT LIVER, V7, P696, DOI 10.5009/gnl.2013.7.6.696; Kobayashi M, 2009, CANCER-AM CANCER SOC, V115, P571, DOI 10.1002/cncr.24031; Koike Y, 2001, CANCER, V91, P561, DOI 10.1002/1097-0142(20010201)91:3<561::AID-CNCR1035>3.0.CO;2-N; Liang HH, 2008, ANN SURG ONCOL, V15, P3484, DOI 10.1245/s10434-008-0076-y; Lin SM, 2004, GASTROENTEROLOGY, V127, P1714, DOI 10.1053/j.gastro.2004.09.003; Livraghi T, 2008, HEPATOLOGY, V47, P82, DOI 10.1002/hep.21933; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; MATHIEU D, 1984, RADIOLOGY, V152, P127, DOI 10.1148/radiology.152.1.6328574; Matsuda T, 2009, JPN J CLIN ONCOL, V39, P850, DOI 10.1093/jjco/hyp106; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Mitani T, 1992, Radiat Med, V10, P232; Murata K, 2009, INT J ONCOL, V35, P1005, DOI 10.3892/ijo_00000415; Nagasue N, 1996, BRIT J SURG, V83, P127, DOI 10.1002/bjs.1800830142; OKADA S, 1994, GASTROENTEROLOGY, V106, P1618, DOI 10.1016/0016-5085(94)90419-7; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Qin LX, 2003, WORLD J GASTROENTERO, V9, P385, DOI 10.3748/wjg.v9.i3.385; Sato M, 2012, J GASTROENTEROL, V47, P1125, DOI 10.1007/s00535-012-0569-0; Sato T, 2009, HEPATOL INT, V3, P544, DOI 10.1007/s12072-009-9145-y; SAWABE M, 1987, ACTA PATHOL JAPON, V37, P1389; Shiina S, 2012, AM J GASTROENTEROL, V107, P569, DOI 10.1038/ajg.2011.425; Shimada M, 2005, TRANSPL P, V37, P1177, DOI 10.1016/j.transproceed.2004.12.030; Shirabe K, 2007, J SURG ONCOL, V95, P235, DOI 10.1002/jso.20655; SHIRATORI Y, 1995, HEPATOLOGY, V22, P1027, DOI 10.1002/hep.1840220403; Takahashi Shunsuke, 2008, Oncology, V75 Suppl 1, P91, DOI 10.1159/000173429; Tateishi R, 2005, CANCER-AM CANCER SOC, V103, P1201, DOI 10.1002/cncr.20892; Tateishi R, 2006, HEPATOLOGY, V44, P1518, DOI 10.1002/hep.21408; Torzilli G, 1999, HEPATOLOGY, V30, P889, DOI 10.1002/hep.510300411; VANGANSBEKE D, 1985, AM J ROENTGENOL, V144, P749, DOI 10.2214/ajr.144.4.749	37	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e111662	10.1371/journal.pone.0111662	http://dx.doi.org/10.1371/journal.pone.0111662			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397677	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500022
J	Caneda-Guzman, IC; Salaiza-Suazo, N; Fernandez-Figueroa, EA; Carrada-Figueroa, G; Aguirre-Garcia, M; Becker, I				Caneda-Guzman, Isabel Cristina; Salaiza-Suazo, Norma; Fernandez-Figueroa, Edith A.; Carrada-Figueroa, Georgina; Aguirre-Garcia, Magdalena; Becker, Ingeborg			NK Cell Activity Differs between Patients with Localized and Diffuse Cutaneous Leishmaniasis Infected with Leishmania mexicana: A Comparative Study of TLRs and Cytokines	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; TOLL-LIKE RECEPTORS; INTERFERON-GAMMA; EXPRESSION; LIPOPHOSPHOGLYCAN; ACTIVATION; PROFILE; LESIONS; PROMASTIGOTES; MONOCYTES	Leishmania mexicana causes localized (LCL) or diffuse cutaneous leishmaniasis (DCL). The cause of dissemination in DCL remains unknown, yet NK cells possibly play a role in activating leishmanicidal mechanisms during innate and adaptive immune responses. We had previously shown that Leishmania lipophosphoglycan (LPG) is a ligand for TLR2, activating human NK cells. We have now analyzed NK cells in LCL and DCL patients. NK numbers and effector mechanisms differed drastically between both groups of patients: DCL patients showed reduced NK cell numbers; diminished IFN-gamma and TNF-alpha production; and lower TLR2, TLR1, and TLR6 expression as compared to LCL patients. The altered protein expression found in NK cells of DCL patients correlated with their down-regulation of IFN-gamma gene expression in LPG-stimulated and non-stimulated cells as compared to LCL patients. NK cell response was further analyzed according to gender, age, and disease evolution in LCL patients showing that female patients produced higher IFN-gamma levels throughout the disease progression, whereas TLR2 expression diminished in both genders with prolonged disease evolution and age. We furthermore show the activation pathway of LPG binding to TLR2 and demonstrated that TLR2 forms immunocomplexes with TLR1 and TLR6. In addition to the reduced NK cell numbers in peripheral blood, DCL patients also showed reduced NK cell numbers in the lesions. They were randomly scattered within the lesions, showing diminished cytokine production, which contrasts with those of LCL lesions, where NK cells produced IFN-gamma and TNF-alpha and were found within organized granulomas. We conclude that in DCL patients the reduced NK-cell numbers and their diminished activity, evidenced by low TLR expression and low cytokine production, are possibly involved in the severity of the disease. Our results provide new information on the contribution of NK cells in Leishmania infections of the human host.	[Caneda-Guzman, Isabel Cristina; Salaiza-Suazo, Norma; Fernandez-Figueroa, Edith A.; Aguirre-Garcia, Magdalena; Becker, Ingeborg] Univ Nacl Autonoma Mexico, Fac Med, Unidad Invest Med Expt, Hosp Gen Mexico, Mexico City 04510, DF, Mexico; [Carrada-Figueroa, Georgina] Univ Autonoma Juarez Tabasco, Villahermosa, Tabasco, Mexico	Hospital General de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Juarez Autonoma de Tabasco	Becker, I (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Unidad Invest Med Expt, Hosp Gen Mexico, Mexico City 04510, DF, Mexico.	becker@unam.mx			CONACyT [102155]; PAPIIT [IN215212]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT))	This project was financed by CONACyT-102155 and PAPIIT IN215212. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Fakher FH, 2009, J IMMUNOL, V182, P1386, DOI 10.4049/jimmunol.182.3.1386; Ajdary S, 2000, INFECT IMMUN, V68, P1760, DOI 10.1128/IAI.68.4.1760-1764.2000; Ajdary S, 2011, MICROBES INFECT, V13, P226, DOI 10.1016/j.micinf.2010.10.018; Alimohammadian MH, 2012, AM J TROP MED HYG, V87, P70, DOI 10.4269/ajtmh.2012.11-0479; Becker I, 2003, MOL BIOCHEM PARASIT, V130, P65, DOI 10.1016/S0166-6851(03)00160-9; Bogdan C, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00069; Carrada G, 2007, PARASITE IMMUNOL, V29, P117, DOI 10.1111/j.1365-3024.2006.00924.x; Carvalho LP, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00301; Chandra D, 2008, CLIN EXP IMMUNOL, V154, P224, DOI 10.1111/j.1365-2249.2008.03741.x; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; de Veer MJ, 2003, EUR J IMMUNOL, V33, P2822, DOI 10.1002/eji.200324128; Faria Marilia S., 2012, Journal of Parasitology Research, P930257, DOI 10.1155/2012/930257; Galindo-Sevilla N, 2007, AM J TROP MED HYG, V76, P566, DOI 10.4269/ajtmh.2007.76.566; Cezario GAG, 2011, MEM I OSWALDO CRUZ, V106, P573, DOI 10.1590/S0074-02762011000500010; Guerra CS, 2010, INT J EXP PATHOL, V91, P451, DOI 10.1111/j.1365-2613.2010.00717.x; Guerra-Silveira F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062390; Matos GI, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-33; Kamhawi S, 2006, TRENDS PARASITOL, V22, P439, DOI 10.1016/j.pt.2006.06.012; Kima PE, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00156; Kropf P, 2004, INFECT IMMUN, V72, P1920, DOI 10.1128/IAI.72.4.1920-1928.2004; Krutzik SR, 2003, NAT MED, V9, P525, DOI 10.1038/nm864; Leopoldo PTG, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-75; Lieke T, 2011, PARASITOLOGY, V138, P1898, DOI 10.1017/S0031182011001363; Liese J, 2008, IMMUNOBIOLOGY, V213, P377, DOI 10.1016/j.imbio.2007.12.005; Liese J, 2007, EUR J IMMUNOL, V37, P3424, DOI 10.1002/eji.200737182; Mendes DS, 2013, MEM I OSWALDO CRUZ, V108, P18, DOI 10.1590/S0074-02762013000100003; Moore JWJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00035; Moretta L, 2010, BLOOD, V116, P3689, DOI 10.1182/blood-2010-09-303057; Mukherjee AK, 2012, INT IMMUNOPHARMACOL, V12, P565, DOI 10.1016/j.intimp.2012.02.002; Nicodemo AC, 2012, PARASITE IMMUNOL, V34, P440, DOI 10.1111/j.1365-3024.2012.01372.x; Nylen S, 2012, PARASITE IMMUNOL, V34, P551, DOI 10.1111/pim.12007; Nylen S, 2003, CLIN EXP IMMUNOL, V131, P457, DOI 10.1046/j.1365-2249.2003.02096.x; Pereira LIA, 2009, AM J TROP MED HYG, V81, P378, DOI 10.4269/ajtmh.2009.81.378; Renshaw M, 2002, J IMMUNOL, V169, P4697, DOI 10.4049/jimmunol.169.9.4697; Ritter U, 1996, J INFECT DIS, V173, P699, DOI 10.1093/infdis/173.3.699; Rocha PN, 1999, J INFECT DIS, V180, P1731, DOI 10.1086/315071; Salaiza-Suazo N, 1999, TROP MED INT HEALTH, V4, P801, DOI 10.1046/j.1365-3156.1999.00491.x; SchartonKersten TM, 1997, CURR OPIN IMMUNOL, V9, P44, DOI 10.1016/S0952-7915(97)80157-4; Schleicher U, 2007, J EXP MED, V204, P893, DOI 10.1084/jem.20061293; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Srivastava A, 2012, MOL CELL BIOCHEM, V359, P359, DOI 10.1007/s11010-011-1029-5; Srivastava S, 2013, CLIN EXP IMMUNOL, V172, P403, DOI 10.1111/cei.12074; Tolouei S, 2013, SCAND J IMMUNOL, V78, P478, DOI 10.1111/sji.12105; Tuon FF, 2010, PARASITE IMMUNOL, V32, P769, DOI 10.1111/j.1365-3024.2010.01243.x; Tuon FF, 2008, INFECT IMMUN, V76, P866, DOI 10.1128/IAI.01090-07; Tuon FF, 2012, REV INST MED TROP SP, V54, P159, DOI 10.1590/S0036-46652012000300008; Tuon FF, 2010, J DERMATOL SCI, V59, P55, DOI 10.1016/j.jdermsci.2010.04.009; van Duin D, 2007, J IMMUNOL, V178, P970, DOI 10.4049/jimmunol.178.2.970; Vieira ELM, 2013, PARASITE IMMUNOL, V35, P65, DOI 10.1111/pim.12012	49	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112410	10.1371/journal.pone.0112410	http://dx.doi.org/10.1371/journal.pone.0112410			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397678	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500050
J	Dai, XR; Karring, H				Dai, Xiaorong; Karring, Henrik			A Determination and Comparison of Urease Activity in Feces and Fresh Manure from Pig and Cattle in Relation to Ammonia Production and pH Changes	PLOS ONE			English	Article							NITROGEN-EXCRETION; DYNAMIC-MODEL; EMISSION; PROTEIN; SLURRY; URINE; VOLATILIZATION; ACIDIFICATION; LIVESTOCK; KINETICS	Ammonia emission from animal production is a major environmental problem and has impacts on the animal health and working environment inside production houses. Ammonia is formed in manure by the enzymatic degradation of urinary urea and catalyzed by urease that is present in feces. We have determined and compared the urease activity in feces and manure (a urine and feces mixture) from pigs and cattle at 25 degrees C by using Michaelis-Menten kinetics. To obtain accurate estimates of kinetic parameters V-max and K-m', we used a 5 min reaction time to determine the initial reaction velocities based on total ammoniacal nitrogen (TAN) concentrations. The resulting Vmax value (mmol urea hydrolyzed per kg wet feces per min) was 2.06 +/- 0.08 mmol urea/kg/min and 0.80 +/- 0.04 mmol urea/kg/min for pig feces and cattle feces, respectively. The K'm values were 32.59 +/- 5.65 mmol urea/l and 15.43 +/- 2.94 mmol urea/l for pig feces and cattle feces, respectively. Thus, our results reveal that both the Vmax and K'm values of the urease activity for pig feces are more than 2-fold higher than those for cattle feces. The difference in urea hydrolysis rates between animal species is even more significant in fresh manure. The initial velocities of TAN formation are 1.53 mM/min and 0.33 mM/min for pig and cattle manure, respectively. Furthermore, our investigation shows that the maximum urease activity for pig feces occurs at approximately pH 7, and in cattle feces it is closer to pH 8, indicating that the predominant fecal ureolytic bacteria species differ between animal species. We believe that our study contributes to a better understanding of the urea hydrolysis process in manure and provides a basis for more accurate and animal-specific prediction models for urea hydrolysis rates and ammonia concentration in manures and thus can be used to predict ammonia volatilization rates from animal production.	[Dai, Xiaorong; Karring, Henrik] Univ Southern Denmark, Dept Chem Engn Biotechnol & Environm Technol, Odense, Denmark	University of Southern Denmark	Dai, XR (corresponding author), Univ Southern Denmark, Dept Chem Engn Biotechnol & Environm Technol, Odense, Denmark.	hka@kbm.sdu.dk		Karring, Henrik/0000-0002-4672-1503	Danish Agency for Science, Technology and Innovation	Danish Agency for Science, Technology and Innovation	This study was funded by the Danish Agency for Science, Technology and Innovation (StaldTek project, http://ufm.dk/en/the-minister-and-theministry/organisation/the-danish-agency-for-science-technology-and-innovation). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnink AJA, 1998, LIVEST PROD SCI, V53, P153, DOI 10.1016/S0301-6226(97)00153-X; Aneja VP, 2009, ENVIRON SCI TECHNOL, V43, P4234, DOI 10.1021/es8024403; ASABE, 2005, D3842 ASABE; Bouwman AF, 1997, ATMOS ENVIRON, V31, P4095, DOI 10.1016/S1352-2310(97)00288-4; BRISTOW AW, 1992, J SCI FOOD AGR, V59, P387, DOI 10.1002/jsfa.2740590316; Burgos SA, 2010, J DAIRY SCI, V93, P2377, DOI 10.3168/jds.2009-2415; BUTTON DK, 1991, APPL ENVIRON MICROB, V57, P2033, DOI 10.1128/AEM.57.7.2033-2038.1991; Callahan BP, 2005, J AM CHEM SOC, V127, P10828, DOI 10.1021/ja0525399; Canh TT, 1998, LIVEST PROD SCI, V56, P181, DOI 10.1016/S0301-6226(98)00156-0; Canh TT, 1997, J ANIM SCI, V75, P700; Cortus EL, 2008, BIOSYST ENG, V99, P390, DOI 10.1016/j.biosystemseng.2007.11.004; Cortus EL, 2010, T ASABE, V53, P911; EGHBALL B, 1994, J SOIL WATER CONSERV, V49, P113; Elzing A, 1997, T ASAE, V40, P721, DOI 10.13031/2013.21302; Estiu G, 2004, J AM CHEM SOC, V126, P6932, DOI 10.1021/ja049327g; Hopkins DW, 1996, BIOL FERT SOILS, V22, P66, DOI 10.1007/BF00384434; Kai P, 2008, EUR J AGRON, V28, P148, DOI 10.1016/j.eja.2007.06.004; Kjeldahl Johan Z., 1883, ANAL CHEM, V22, P366, DOI DOI 10.1007/BF01338151; Krajewska B, 2009, J MOL CATAL B-ENZYM, V59, P9, DOI 10.1016/j.molcatb.2009.01.003; Kulling DR, 2001, J AGR SCI-CAMBRIDGE, V137, P235, DOI 10.1017/S0021859601001186; LAIDLER KJ, 1950, J AM CHEM SOC, V72, P2489, DOI 10.1021/ja01162a038; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Lynch JM, 1999, J AOAC INT, V82, P1389; Michaelis L, 1913, BIOCHEM Z, V49, P333; MOBLEY HLT, 1995, MICROBIOL REV, V59, P451, DOI 10.1128/MMBR.59.3.451-480.1995; MORSE D, 1994, T ASAE, V37, P275, DOI 10.13031/2013.28081; MUCK RE, 1982, J DAIRY SCI, V65, P2157, DOI 10.3168/jds.S0022-0302(82)82475-2; Ottosen LDM, 2009, BIOSYST ENG, V102, P291, DOI 10.1016/j.biosystemseng.2008.12.003; Portejoie S, 2004, LIVEST PROD SCI, V91, P45, DOI 10.1016/j.livprodsci.2004.06.013; Ruzin S.E., 1999, PLANT MICROTECHNIQUE; Sanchez M, 2005, BIORESOURCE TECHNOL, V96, P1117, DOI 10.1016/j.biortech.2004.10.002; SCOW KM, 1992, SOIL SCI SOC AM J, V56, P128, DOI 10.2136/sssaj1992.03615995005600010020x; SHAW WHR, 1955, J AM CHEM SOC, V77, P4729, DOI 10.1021/ja01623a011; STEVENS RJ, 1989, J AGR SCI, V113, P389, DOI 10.1017/S0021859600070106; VANDERHOLM DH, 1979, J ANIM SCI, V48, P113, DOI 10.2527/jas1979.481113x; Varel VH, 1997, BIORESOURCE TECHNOL, V62, P11, DOI 10.1016/S0960-8524(97)00130-2; VAREL VH, 1987, APPL ENVIRON MICROB, V53, P2009, DOI 10.1128/AEM.53.9.2009-2012.1987; VOORBURG JH, 1992, LIVEST PROD SCI, V31, P57, DOI 10.1016/0301-6226(92)90052-6	38	32	33	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e110402	10.1371/journal.pone.0110402	http://dx.doi.org/10.1371/journal.pone.0110402			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397404	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558500007
J	Su, HJ; Hogenhout, SA; Al-Sadi, AM; Kuo, CH				Su, Huei-Jiun; Hogenhout, Saskia A.; Al-Sadi, Abdullah M.; Kuo, Chih-Horng			Complete Chloroplast Genome Sequence of Omani Lime (Citrus aurantiifolia) and Comparative Analysis within the Rosids	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; INDEPENDENT TRANSFERS; GENETIC DIVERSITY; ALIGNMENT; IDENTIFICATION; ORGANIZATION; DNA; AURANTIFOLIA; GENERATION; EVOLUTION	The genus Citrus contains many economically important fruits that are grown worldwide for their high nutritional and medicinal value. Due to frequent hybridizations among species and cultivars, the exact number of natural species and the taxonomic relationships within this genus are unclear. To compare the differences between the Citrus chloroplast genomes and to develop useful genetic markers, we used a reference-assisted approach to assemble the complete chloroplast genome of Omani lime (C. aurantiifolia). The complete C. aurantiifolia chloroplast genome is 159,893 bp in length; the organization and gene content are similar to most of the rosids lineages characterized to date. Through comparison with the sweet orange (C. sinensis) chloroplast genome, we identified three intergenic regions and 94 simple sequence repeats (SSRs) that are potentially informative markers with resolution for interspecific relationships. These markers can be utilized to better understand the origin of cultivated Citrus. A comparison among 72 species belonging to 10 families of representative rosids lineages also provides new insights into their chloroplast genome evolution.	[Su, Huei-Jiun] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei 10764, Taiwan; [Hogenhout, Saskia A.] John Innes Ctr, Dept Cell & Dev Biol, Norwich, Norfolk, England; [Al-Sadi, Abdullah M.] Sultan Qaboos Univ, Dept Crop Sci, Al Khoud, Oman; [Kuo, Chih-Horng] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan; [Kuo, Chih-Horng] Natl Chung Hsing Univ, Taiwan Int Grad Program, Mol & Biol Agr Sci Program, Taipei, Taiwan; [Kuo, Chih-Horng] Acad Sinica, Taipei 115, Taiwan; [Kuo, Chih-Horng] Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 40227, Taiwan	National Taiwan University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Sultan Qaboos University; Academia Sinica - Taiwan; National Chung Hsing University; Academia Sinica - Taiwan; National Chung Hsing University	Kuo, CH (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan.	chk@gate.sinica.edu.tw	Kuo, Chih-Horng/E-2045-2013; Hogenhout, Saskia A/D-9266-2012; Al-Sadi, Abdullah M./D-6766-2012	Kuo, Chih-Horng/0000-0002-2857-0529; Hogenhout, Saskia A/0000-0003-1371-5606; Al-Sadi, Abdullah M./0000-0002-3419-8268; Su, Huei-Jiun/0000-0001-5751-7260	Biotechnology and Biological Sciences Research Council [BB/J004553/1]; Gatsby Charitable Foundation; Sultan Qaboos University [SR/AGR/CROP/13/01]; Institute of Plant and Microbial Biology at Academia Sinica; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0623] Funding Source: researchfish; BBSRC [BBS/E/J/000C0623] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Gatsby Charitable Foundation; Sultan Qaboos University; Institute of Plant and Microbial Biology at Academia Sinica; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding for this work was provided by research grants from Biotechnology and Biological Sciences Research Council (BB/J004553/1) and the Gatsby Charitable Foundation to SAH, Sultan Qaboos University (SR/AGR/CROP/13/01) to AMA, and the Institute of Plant and Microbial Biology at Academia Sinica to CHK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2012, GENOME BIOL EVOL, V4, P1316, DOI 10.1093/gbe/evs110; Al-Sadi AM, 2012, EUPHYTICA, V188, P285, DOI 10.1007/s10681-012-0728-7; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bausher MG, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-21; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Charif D., 2007, SEQINR 10 2 CONTRIBU, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; Blazier J, 2011, PLANT MOL BIOL, V76, P263, DOI 10.1007/s11103-011-9753-5; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; CLEGG MT, 1994, P NATL ACAD SCI USA, V91, P6795, DOI 10.1073/pnas.91.15.6795; CORRIVEAU JL, 1988, AM J BOT, V75, P1443, DOI 10.2307/2444695; Cusack BP, 2007, TRENDS GENET, V23, P270, DOI 10.1016/j.tig.2007.03.010; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Davies FS, 1994, CITRUS, P1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ezeabara C. A., 2014, International Research Journal of Pure and Applied Chemistry, V4, P137, DOI 10.9734/IRJPAC/2014/5831; Faghihi MM, 2011, PLANT DIS, V95, P419, DOI 10.1094/PDIS-06-10-0400; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; GANTT JS, 1991, EMBO J, V10, P3073, DOI 10.1002/j.1460-2075.1991.tb07859.x; Goremykin V, 2003, PLANT SYST EVOL, V242, P119, DOI 10.1007/s00606-003-0056-4; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guisinger MM, 2011, MOL BIOL EVOL, V28, P583, DOI 10.1093/molbev/msq229; Hynniewta M, 2014, META GENE, V2, P237, DOI 10.1016/j.mgene.2014.01.008; Jansen RK, 2012, ADV PHOTOSYNTHESIS R, P103, DOI DOI 10.1007/978-94-007-2920-9_5; Jansen RK, 2011, MOL BIOL EVOL, V28, P835, DOI 10.1093/molbev/msq261; Kane N, 2012, AM J BOT, V99, P320, DOI 10.3732/ajb.1100570; Ku C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068518; Ku C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062548; Kurtz S, 1999, BIOINFORMATICS, V15, P426, DOI 10.1093/bioinformatics/15.5.426; Lee SB, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-61; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu YQ, 2012, COMPR REV FOOD SCI F, V11, P530, DOI 10.1111/j.1541-4337.2012.00201.x; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Mabberley DJ, 2004, BLUMEA, V49, P481; Magee Alan M, 2010, Genome Res, V20, P1700, DOI 10.1101/gr.111955.110; MAIXNER M, 1995, EUR J PLANT PATHOL, V101, P241, DOI 10.1007/BF01874780; Millen RS, 2001, PLANT CELL, V13, P645, DOI 10.1105/tpc.13.3.645; Monavarfeshani A, 2013, J PROTEOME RES, V12, P785, DOI 10.1021/pr300865t; Nicolosi E, 2000, THEOR APPL GENET, V100, P1155, DOI 10.1007/s001220051419; Njuguna W, 2013, MOL PHYLOGENET EVOL, V66, P17, DOI 10.1016/j.ympev.2012.08.026; Ohtani K, 2002, P NATL ACAD SCI USA, V99, P2439, DOI 10.1073/pnas.042448499; Penjor T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062574; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; Richardson AO, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-29; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ruhfel BR, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-23; Sloan DB, 2012, NEW PHYTOL, V196, P1228, DOI 10.1111/j.1469-8137.2012.04340.x; Taheri F, 2011, MOL BIOSYST, V7, P3028, DOI 10.1039/c1mb05268c; Tripoli E, 2007, FOOD CHEM, V104, P466, DOI 10.1016/j.foodchem.2006.11.054; Ueda M, 2008, MOL BIOL EVOL, V25, P1566, DOI 10.1093/molbev/msn102; Ueda M, 2007, GENE, V402, P51, DOI 10.1016/j.gene.2007.07.019; VAND SH, 2012, INDIAN J SCI TECHNOL, V5, P3670; Wojciechowski MF, 2004, AM J BOT, V91, P1846, DOI 10.3732/ajb.91.11.1846; Worberg A, 2009, TAXON, V58, P468, DOI 10.1002/tax.582012; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037128; Zafari S, 2012, ACTA PHYSIOL PLANT, V34, P561, DOI 10.1007/s11738-011-0855-0; Zamharir MG, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-1; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang Q, 2003, PLANT CELL PHYSIOL, V44, P941, DOI 10.1093/pcp/pcg121	61	58	63	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113049	10.1371/journal.pone.0113049	http://dx.doi.org/10.1371/journal.pone.0113049			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398081	gold, Green Submitted, Green Published			2022-12-27	WOS:000345558500128
J	Tchitchek, N; Safronetz, D; Rasmussen, AL; Martens, C; Virtaneva, K; Porcella, SF; Feldmann, H; Ebihara, H; Katze, MG				Tchitchek, Nicolas; Safronetz, David; Rasmussen, Angela L.; Martens, Craig; Virtaneva, Kimmo; Porcella, Stephen F.; Feldmann, Heinz; Ebihara, Hideki; Katze, Michael G.			Sequencing, Annotation and Analysis of the Syrian Hamster (Mesocricetus auratus) Transcriptome	PLOS ONE			English	Article							GUINEA-PIG; VIRUS; MODEL; EVOLUTION; DISCOVERY; SEARCH	Background: The Syrian hamster (golden hamster, Mesocricetus auratus) is gaining importance as a new experimental animal model for multiple pathogens, including emerging zoonotic diseases such as Ebola. Nevertheless there are currently no publicly available transcriptome reference sequences or genome for this species. Results: A cDNA library derived from mRNA and snRNA isolated and pooled from the brains, lungs, spleens, kidneys, livers, and hearts of three adult female Syrian hamsters was sequenced. Sequence reads were assembled into 62,482 contigs and 111,796 reads remained unassembled (singletons). This combined contig/singleton dataset, designated as the Syrian hamster transcriptome, represents a total of 60,117,204 nucleotides. Our Mesocricetus auratus Syrian hamster transcriptome mapped to 11,648 mouse transcripts representing 9,562 distinct genes, and mapped to a similar number of transcripts and genes in the rat. We identified 214 quasi-complete transcripts based on mouse annotations. Canonical pathways involved in a broad spectrum of fundamental biological processes were significantly represented in the library. The Syrian hamster transcriptome was aligned to the current release of the Chinese hamster ovary (CHO) cell transcriptome and genome to improve the genomic annotation of this species. Finally, our Syrian hamster transcriptome was aligned against 14 other rodents, primate and laurasiatheria species to gain insights about the genetic relatedness and placement of this species. Conclusions: This Syrian hamster transcriptome dataset significantly improves our knowledge of the Syrian hamster's transcriptome, especially towards its future use in infectious disease research. Moreover, this library is an important resource for the wider scientific community to help improve genome annotation of the Syrian hamster and other closely related species. Furthermore, these data provide the basis for development of expression microarrays that can be used in functional genomics studies.	[Tchitchek, Nicolas; Rasmussen, Angela L.; Katze, Michael G.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Safronetz, David; Feldmann, Heinz; Ebihara, Hideki] NIAID, Virol Lab, Div Intramural Res, NIH,Rocky Mt Labs, Hamilton, MT 59840 USA; [Martens, Craig; Virtaneva, Kimmo; Porcella, Stephen F.] NIAID, Genom Unit, Res Technol Sect, NIH,Rocky Mt Labs, Hamilton, MT USA; [Katze, Michael G.] Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Washington; University of Washington Seattle	Ebihara, H (corresponding author), NIAID, Virol Lab, Div Intramural Res, NIH,Rocky Mt Labs, Hamilton, MT 59840 USA.	ebiharah@niaid.nih.gov; honey@uw.edu		Ebihara, Hideki/0000-0002-2576-9735; Tchitchek, Nicolas/0000-0003-3307-0446; Rasmussen, Angela/0000-0001-9462-3169	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; NIAID Regional Centers of Excellence [U54 AI081680]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001136, ZIAAI001089, U54AI081680] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID Regional Centers of Excellence; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health and the NIAID Regional Centers of Excellence (U54 AI081680) to MGK. The funders were not involved in the study design, data collection and analysis, or preparation of the manuscript. NIAID was solely involved in the decision to publish.	Aguilar PV, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001315; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Briand F, 2010, CURR OPIN INVEST DR, V11, P289; Castro-Perez J, 2011, J LIPID RES, V52, P1965, DOI 10.1194/jlr.M016410; Chelini MOM, 2011, PHYSIOL BEHAV, V104, P948, DOI 10.1016/j.physbeh.2011.06.006; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; DErchia AM, 1996, NATURE, V381, P597, DOI 10.1038/381597a0; Ebihara H, 2013, J INFECT DIS, V207, P306, DOI 10.1093/infdis/jis626; Eklund A.C., 2012, SQUASH COLOR BASED P; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gomes-Silva A, 2013, PARASITOLOGY, V140, P771, DOI 10.1017/S0031182012002156; GRAUR D, 1991, NATURE, V351, P649, DOI 10.1038/351649a0; Hammond S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-67; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Jukes TH, 1969, EVOLUTION PROTEIN MO; Kodama Y, 2012, NUCLEIC ACIDS RES, V40, pD54, DOI 10.1093/nar/gkr854; Landkocz Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-524; Lewis NE, 2013, NAT BIOTECHNOL, V31, P759, DOI 10.1038/nbt.2624; Liu HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077062; Monecke S, 2011, J BIOL RHYTHM, V26, P283, DOI 10.1177/0748730411411569; Morin LP, 2001, STEREOTAXIC ATLAS GO; Nagaraj SH, 2007, BRIEF BIOINFORM, V8, P6, DOI 10.1093/bib/bbl015; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nigro V, 1997, HUM MOL GENET, V6, P601, DOI 10.1093/hmg/6.4.601; Oduru S, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-22; R Core Team, 2016, R FDN STAT COMP; Rawji KS, 2013, BRAIN RES, V1521, P31, DOI 10.1016/j.brainres.2013.05.003; Ricci LA, 2009, HORM BEHAV, V55, P348, DOI 10.1016/j.yhbeh.2008.10.011; Roberts A, 2008, VIRUS RES, V133, P20, DOI 10.1016/j.virusres.2007.03.025; Romanenko SA, 2007, CHROMOSOME RES, V15, P283, DOI 10.1007/s10577-007-1124-3; Ryu SH, 2013, MOL BIOL REP, V40, P1917, DOI 10.1007/s11033-012-2248-x; Safronetz D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002426; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schmucki R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-237; Shinya K, 2011, J VIROL, V85, P4673, DOI 10.1128/JVI.00148-11; Tesh RB, 2001, J INFECT DIS, V183, P1431, DOI 10.1086/320199; Trifonov VA, 2010, CHROMOSOME RES, V18, P265, DOI 10.1007/s10577-010-9110-6; Van Hoosier GL, 1987, LAB HAMSTERS; Wahl-Jensen V, 2012, VIRUSES-BASEL, V4, P3754, DOI 10.3390/v4123754; Xiao SY, 2001, EMERG INFECT DIS, V7, P714; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Zivcec M, 2011, J IMMUNOL METHODS, V368, P24, DOI 10.1016/j.jim.2011.02.004	45	22	22	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112617	10.1371/journal.pone.0112617	http://dx.doi.org/10.1371/journal.pone.0112617			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398096	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558500067
J	Guo, S; Ling, F; Hou, J; Wang, JN; Fu, GM; Gong, ZY				Guo, Song; Ling, Feng; Hou, Juan; Wang, Jinna; Fu, Guiming; Gong, Zhenyu			Mosquito Surveillance Revealed Lagged Effects of Mosquito Abundance on Mosquito-Borne Disease Transmission: A Retrospective Study in Zhejiang, China	PLOS ONE			English	Article							JAPANESE ENCEPHALITIS-VIRUS; CLIMATE-CHANGE; DENGUE-FEVER; MALARIA; INFECTION; WEATHER; IMPACT; POPULATIONS; OUTBREAK; VECTORS	Mosquito-borne diseases (MBDs) are still threats to public health in Zhejiang. In this study, the associations between the time-lagged mosquito capture data and MBDs incidence over five years were used to examine the potential effects of mosquito abundance on patterns of MBDs epidemiology in Zhejiang during 2008-2012. Light traps were used to collect adult mosquitoes at 11 cities. Correlation tests with and without time lag were performed to investigate the correlations between MBDs incidence rates and mosquito abundance by month. Selected MBDs consisted of Japanese encephalitis (JE), dengue fever (DF) and malaria. A Poisson regression analysis was performed by using a generalized estimating equations (GEE) approach, and the most parsimonious model was selected based on the quasi-likelihood based information criterion (QICu). We identified five mosquito species and the constituent ratio of Culex pipiens pallens, Culex tritaeniorhynchus, Aedes albopictus, Anopheles sinensis and Armigeres subalbatus was 66.73%, 21.47%, 6.72%, 2.83% and 2.25%, respectively. The correlation analysis without and with time lag showed that Culex mosquito abundance at a lag of 0 or 1 month was positively correlated with JE incidence during 2008-2012, Ae. albopictus abundance at a lag of 1 month was positively correlated with DF incidence in 2009, and An. sinensis abundance at a lag of 0-2 months was positively correlated with malaria incidence during 2008-2010. The Poisson regression analysis showed each 0.1 rise of monthly mosquito abundance corresponded to a positive increase of MBD cases for the period of 2008-2012. The rise of mosquito abundance with a lag of 0-2 months increased the risk of human MBDs infection in Zhejiang. Our study provides evidence that mosquito monitoring could be a useful early warning tool for the occurrence and transmission of MBDs.	[Guo, Song; Ling, Feng; Hou, Juan; Wang, Jinna; Fu, Guiming; Gong, Zhenyu] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention	Gong, ZY (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.	zhygong@cdc.zj.cn			Project of the State Scientific & Technological Development of the 12th Five Year Plan grant of China [2012ZX10004219]	Project of the State Scientific & Technological Development of the 12th Five Year Plan grant of China	This work was supported by the Project of the State Scientific & Technological Development of the 12th Five Year Plan grant of China (2012ZX10004219). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrane YA, 2012, ANN NY ACAD SCI, V1249, P204, DOI 10.1111/j.1749-6632.2011.06432.x; Andrew NR, 2013, PEERJ, V1, DOI 10.7717/peerj.11; Angelini P, 2010, EUROSURVEILLANCE, V15, P11; Bai L, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-10; Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378; Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233; Chuang TW, 2011, J MED ENTOMOL, V48, P669, DOI 10.1603/ME10246; Dhiman RC, 2010, PARASITOL RES, V106, P763, DOI 10.1007/s00436-010-1767-4; Eisen L, 2009, J MED ENTOMOL, V46, P1245, DOI 10.1603/033.046.0601; Erickson RA, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034003; Gao XY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000624; Gibbons RV, 2002, BMJ-BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563; Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136; Gosselin Pierre, 2005, Int J Health Geogr, V4, P21, DOI 10.1186/1476-072X-4-21; Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025; Griffith KS, 2007, JAMA-J AM MED ASSOC, V297, P2264, DOI 10.1001/jama.297.20.2264; Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326; Gubler DJ, 2010, VECTOR BIOLOGY, ECOLOGY AND CONTROL, P39, DOI 10.1007/978-90-481-2458-9_4; Hurtado-Diaz M, 2007, TROP MED INT HEALTH, V12, P1327, DOI 10.1111/j.1365-3156.2007.01930.x; Jiang T, 2009, ZHEJIANG PREY MED, V21, P30; Kabilan Lalitha, 2004, Indian Journal of Pediatrics, V71, P609, DOI 10.1007/BF02724120; KNUDSEN AB, 1992, B WORLD HEALTH ORGAN, V70, P1; Lebl K, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-129; Lee SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068512; Li T, 2010, TRENDS PARASITOL, V26, P264, DOI 10.1016/j.pt.2010.02.007; Liu QY, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-224; Lu L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-395; Martins-Campos KM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-351; de Barros FSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022388; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Petric D, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-187; Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853; Rogers DJ, 2006, ADV PARASIT, V62, P345, DOI 10.1016/S0065-308X(05)62010-6; Ruiz MO, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-19; Sun JM, 2011, EMERG INFECT DIS, V17, P321, DOI 10.3201/eid1702.100396; Tadei WP, 1998, AM J TROP MED HYG, V59, P325, DOI 10.4269/ajtmh.1998.59.325; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; Wang HY, 2009, JPN J INFECT DIS, V62, P331; Wu JY, 2010, AM J TROP MED HYG, V83, P664, DOI 10.4269/ajtmh.2010.09-0755; Xie Rong-hui, 2009, Zhonghua Yufang Yixue Zazhi, V43, P282, DOI 10.3760/cma.j.issn.0253-9624.2009.04.004; Xu GZ, 2007, AM J TROP MED HYG, V76, P1182, DOI 10.4269/ajtmh.2007.76.1182; Yan J, 2005, CHINESE J VIROL, V22, P339; Yin JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074228; Yip K., 1998, Parassitologia (Rome), V40, P29; Zeller H, 2013, CLIN MICROBIOL INFEC, V19, P693, DOI 10.1111/1469-0691.12230; Zhang Hai-lin, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P428; Zhao XF, 2013, TROP BIOMED, V30, P267; Zheng YY, 2012, REV MED VIROL, V22, P301, DOI 10.1002/rmv.1710	48	14	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112975	10.1371/journal.pone.0112975	http://dx.doi.org/10.1371/journal.pone.0112975			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393834	Green Submitted, Green Published, gold			2022-12-27	WOS:000347709300129
J	Kuivasaari-Pirinen, P; Koivumaa-Honkanen, H; Hippelainen, M; Raatikainen, K; Heinonen, S				Kuivasaari-Pirinen, Paula; Koivumaa-Honkanen, Heli; Hippelainen, Maritta; Raatikainen, Kaisa; Heinonen, Seppo			Outcome of Assisted Reproductive Technology (ART) and Subsequent Self-Reported Life Satisfaction	PLOS ONE			English	Article							15-YEAR FOLLOW-UP; QUALITY-OF-LIFE; EMOTIONAL ADJUSTMENT; INFERTILITY; IVF; WOMEN; DISSATISFACTION; HEALTHY; UNSUCCESSFUL; DEPRESSION	Objective: To compare life satisfaction between women with successful or unsuccessful outcome after assisted reproductive treatment (ART) by taking into account the time since the last ART. Design: Cohort study. Setting: Tertiary hospital. Patients: A total of 987 consecutive women who had undergone ART during 1996-2007 were invited and altogether 505 women participated in the study. Interventions: A postal enquiry with a life satisfaction scale. Main Outcome Measure: Self-reported life satisfaction in respect to the time since the last ART. Results: In general, women who achieved a live birth after ART had a significantly higher life satisfaction than those who had unsuccessful ART, especially when compared in the first three years. The difference disappeared in the time period of 69 years after ART. The unsuccessfully treated women who had a child by some other means before or after the unsuccessful ART had comparable life satisfaction with successfully treated women even earlier. Conclusions: Even if unsuccessful ART outcome is associated with subsequent lower level of life satisfaction, it does not seem to threaten the long-term wellbeing.	[Kuivasaari-Pirinen, Paula; Hippelainen, Maritta; Raatikainen, Kaisa; Heinonen, Seppo] Kuopio Univ Hosp, Dept Obstet & Gynaecol, SF-70210 Kuopio, Finland; [Kuivasaari-Pirinen, Paula; Koivumaa-Honkanen, Heli; Hippelainen, Maritta; Raatikainen, Kaisa; Heinonen, Seppo] Kuopio Univ Hosp, Inst Clin Med, SF-70210 Kuopio, Finland; [Koivumaa-Honkanen, Heli] Oulu Univ Hosp, Clin Child Psychiat, Oulu, Finland; [Koivumaa-Honkanen, Heli] Kuopio Univ Hosp, Dept Psychiat, SF-70210 Kuopio, Finland; [Koivumaa-Honkanen, Heli] South Savonia Hosp Dist, Dept Psychiat, Mikkeli, Finland; [Koivumaa-Honkanen, Heli] North Karelia Cent Hosp, Dept Psychiat, Joensuu, Finland; [Koivumaa-Honkanen, Heli] SOSTERI, Dept Psychiat, Savonlinna, Finland; [Koivumaa-Honkanen, Heli] SOTE, Dept Psychiat, Iisalmi, Finland; [Koivumaa-Honkanen, Heli] Lapland Hosp Dist, Dept Psychiat, Rovaniemi, Finland; [Koivumaa-Honkanen, Heli] Univ Oulu, Inst Clin Med, Dept Psychiat, Oulu, Finland	Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Oulu; Kuopio University Hospital; University of Eastern Finland; University of Oulu	Kuivasaari-Pirinen, P (corresponding author), Kuopio Univ Hosp, Dept Obstet & Gynaecol, SF-70210 Kuopio, Finland.	paula.kuivasaari-pirinen@fimnet.fi	Koivumaa-Honkanen, Heli TJ/L-1274-2015		EVO National research funding from Kuopio University Hospital; Finnish Cultural Foundation; North Savo Regional fund; Finnish Society of Obstetrics and Gynaecology	EVO National research funding from Kuopio University Hospital; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); North Savo Regional fund; Finnish Society of Obstetrics and Gynaecology	This study was funded by EVO National research funding from Kuopio University Hospital (www.kuh.fi), Finnish Cultural Foundation (www.skr.fi), North Savo Regional fund and The Finnish Society of Obstetrics and Gynaecology (www.gynekologiyhdistys.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLARDT E, 1973, 1 U HELS RES GROUP C; Andrews F. M., 1976, SOCIAL INDICATORS WE; [Anonymous], 2010, ED STRUCT POP; Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046; Brandes M, 2009, HUM REPROD, V24, P3127, DOI 10.1093/humrep/dep340; Bryson Caroline A., 2000, Hum Fertil (Camb), V3, P214, DOI 10.1080/1464727002000199011; Campbell A., 1976, QUALITY AM LIFE PERC, DOI DOI 10.7758/9781610441032; Chachamovich JR, 2010, J PSYCHOSOM OBST GYN, V31, P101, DOI 10.3109/0167482X.2010.481337; Cousineau TM, 2007, BEST PRACT RES CL OB, V21, P293, DOI 10.1016/j.bpobgyn.2006.12.003; Cui WY, 2010, B WORLD HEALTH ORGAN, V88, P881, DOI 10.2471/BLT.10.011210; Greil AL, 1997, SOC SCI MED, V45, P1679, DOI 10.1016/S0277-9536(97)00102-0; Greil AL, 2011, HUM REPROD, V26, P2101, DOI 10.1093/humrep/der148; Greil AL, 2010, SOCIOL HEALTH ILL, V32, P140, DOI 10.1111/j.1467-9566.2009.01213.x; Hammarberg K, 2001, HUM REPROD, V16, P374, DOI 10.1093/humrep/16.2.374; Hjelmstedt A, 1999, ACTA OBSTET GYN SCAN, V78, P42, DOI 10.1034/j.1600-0412.1999.780110.x; Hogstrom L, 2012, ACTA OBSTET GYN SCAN, V91, P1077, DOI 10.1111/j.1600-0412.2012.01491.x; Johansson M, 2010, ACTA OBSTET GYN SCAN, V89, P683, DOI 10.3109/00016341003657892; Kee BS, 2000, J ASSIST REPROD GEN, V17, P445; Klemetti R, 2010, ACTA OBSTET GYN SCAN, V89, P677, DOI 10.3109/00016341003623746; Koivumaa-Honkanen H, 2004, SOC PSYCH PSYCH EPID, V39, P994, DOI 10.1007/s00127-004-0833-6; Koivumaa-Honkanen H, 2004, PSYCHOL MED, V34, P221, DOI 10.1017/S0033291703001089; Koivumaa-Honkanen H, 2012, ALCOHOL ALCOHOLISM, V47, P160, DOI 10.1093/alcalc/agr151; Koivumaa-Honkanen H, 2002, ACTA PSYCHIAT SCAND, V105, P444, DOI 10.1034/j.1600-0447.2002.01287.x; Koivumaa-Honkanen H, 2001, ACTA PSYCHIAT SCAND, V103, P38, DOI 10.1034/j.1600-0447.2001.00046.x; Koivumaa-Honkanen H, 2001, AM J PSYCHIAT, V158, P433, DOI 10.1176/appi.ajp.158.3.433; Koivumaa-Honkanen H, 2000, AM J EPIDEMIOL, V152, P983, DOI 10.1093/aje/152.10.983; Koivumaa-Honkanen H, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-4; KoivumaaHonkanen HT, 1996, ACTA PSYCHIAT SCAND, V94, P372, DOI 10.1111/j.1600-0447.1996.tb09875.x; Leiblum SR, 1998, HUM REPROD, V13, P3569, DOI 10.1093/humrep/13.12.3569; Linna MS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-231; Malizia BA, 2009, NEW ENGL J MED, V360, P236, DOI 10.1056/NEJMoa0803072; Newton CR, 1999, FERTIL STERIL, V72, P54, DOI 10.1016/S0015-0282(99)00164-8; Pakarinen M, 2014, INT J REHABIL RES, V37, P80, DOI 10.1097/MRR.0000000000000039; Rissanen T, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-140; Rostad B, 2014, ACTA OBSTET GYN SCAN, V93, P757, DOI 10.1111/aogs.12404; Saharinen T, 2013, J PSYCHIAT MENT HLTH; Schmidt L, 2005, HUM REPROD, V20, P3248, DOI 10.1093/humrep/dei193; Sejbaek CS, 2013, HUM REPROD, V28, P1100, DOI 10.1093/humrep/des442; Slade P, 1997, HUM REPROD, V12, P183, DOI 10.1093/humrep/12.1.183; Sundby J, 2007, J PSYCHOSOM OBST GYN, V28, P115, DOI 10.1080/01674820701447447; Vaillant GE, 2003, AM J PSYCHIAT, V160, P1373, DOI 10.1176/appi.ajp.160.8.1373; Verhaak CM, 2007, HUM REPROD UPDATE, V13, P27, DOI 10.1093/humupd/dml040; Verhaak CM, 2007, HUM REPROD, V22, P305, DOI 10.1093/humrep/del355; Verhaak CM, 2005, HUM REPROD, V20, P2253, DOI 10.1093/humrep/dei015; Volgsten H, 2010, ACTA OBSTET GYN SCAN, V89, P1290, DOI 10.3109/00016349.2010.512063; Volgsten H, 2010, FERTIL STERIL, V93, P1088, DOI 10.1016/j.fertnstert.2008.11.008; Weaver SM, 1997, PATIENT EDUC COUNS, V31, P7, DOI 10.1016/S0738-3991(97)01005-7; Wichman CL, 2011, FERTIL STERIL, V95, P717, DOI 10.1016/j.fertnstert.2010.09.043; Wischmann T, 2012, HUM REPROD, V27, P3226, DOI 10.1093/humrep/des293; Yli-Kuha AN, 2010, HUM REPROD, V25, P2018, DOI 10.1093/humrep/deq164	50	5	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112540	10.1371/journal.pone.0112540	http://dx.doi.org/10.1371/journal.pone.0112540			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY6YT	25393846	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300067
J	Ma, JQ; Yan, ZP; Luo, JJ; Liu, QX; Wang, JH; Qiu, SJ				Ma, Jingqin; Yan, Zhiping; Luo, Jianjun; Liu, Qingxin; Wang, Jianhua; Qiu, Shijing			Rational Classification of Portal Vein Thrombosis and Its Clinical Significance	PLOS ONE			English	Article							INTRAHEPATIC PORTOSYSTEMIC SHUNT; VENOUS THROMBOSIS; MANAGEMENT; CIRRHOSIS; THERAPY; CT; DIAGNOSIS; FEATURES; ARTICLE; ADULTS	Portal vein thrombosis (PVT) is commonly classified into acute (symptom duration <60 days and absence of portal carvernoma and portal hypertension) and chronic types. However, the rationality of this classification has received little attention. In this study, 60 patients (40 men and 20 women) with PVT were examined using contrast-enhanced computed tomography (CT). The percentage of vein occlusion, including portal vein (PV) and superior mesenteric vein (SMV), was measured on CT image. Of 60 patients, 17 (28.3%) met the criterion of acute PVT. Symptoms occurred more frequently in patients with superior mesenteric vein thrombosis (SMVT) compared to those without SMVT (p<0.001). However, there was no significant difference in PV occlusion between patients with and without symptoms. The frequency of cavernous transformation was significantly higher in patients with complete PVT than those with partial PVT (p<0.001). Complications of portal hypertension were significantly associated with cirrhosis (p<0.001) rather than with the severity of PVT and presence of cavernoma. These results suggest that the severity of PVT is only associated with the formation of portal cavernoma but unrelated to the onset of symptoms and the development of portal hypertension. We classified PVT into complete and partial types, and each was subclassified into with and without portal cavernoma. In conclusion, neither symptom duration nor cavernous transformation can clearly distinguish between acute and chronic PVT. The new classification system can determine the pathological alterations of PVT, patency of portal vein and outcome of treatment in a longitudinal study.	[Ma, Jingqin; Yan, Zhiping; Luo, Jianjun; Liu, Qingxin; Wang, Jianhua] Fudan Univ, Zhongshan Hosp, Dept Intervent Radiol, Shanghai 200433, Peoples R China; [Qiu, Shijing] Henry Ford Hosp, Bone & Mineral Res Lab, Detroit, MI 48202 USA	Fudan University; Henry Ford Health System; Henry Ford Hospital	Yan, ZP (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Intervent Radiol, Shanghai 200433, Peoples R China.	yan.zhiping@zs-hospital.sh.cn		Ma, Jing-Qin/0000-0002-8755-3411				Amarapurkar P, 2013, INDIAN J GASTROENTER; Amitrano L, 2007, AM J GASTROENTEROL, V102, P2464, DOI 10.1111/j.1572-0241.2007.01477.x; Bauer J, 2006, LIVER TRANSPLANT, V12, P1544, DOI 10.1002/lt.20869; BELLI L, 1986, ANN SURG, V203, P286, DOI 10.1097/00000658-198603000-00012; BLUM U, 1995, RADIOLOGY, V195, P153, DOI 10.1148/radiology.195.1.7892458; Boyer TD, 2005, J VASC INTERV RADIOL, V16, P615, DOI 10.1097/01.RVI.0000157297.91510.21; Brancatelli G, 2007, EUR J RADIOL, V61, P57, DOI 10.1016/j.ejrad.2006.11.003; Chattopadhyay S, 2012, WORLD J GASTROENTERO, V18, P6177, DOI 10.3748/wjg.v18.i43.6177; Chawla Y, 2009, ALIMENT PHARM THER, V30, P881, DOI 10.1111/j.1365-2036.2009.04116.x; Condat B, 2000, HEPATOLOGY, V32, P466, DOI 10.1053/jhep.2000.16597; Condat B, 2006, NAT CLIN PRACT GASTR, V3, P505, DOI 10.1038/ncpgasthep0577; DEGAETANO AM, 1995, AM J ROENTGENOL, V165, P1151, DOI 10.2214/ajr.165.5.7572494; Delgado MG, 2012, CLIN GASTROENTEROL H, V10, P776, DOI 10.1016/j.cgh.2012.01.012; Garcia-Tsao G, 2010, NEW ENGL J MED, V362, P823, DOI 10.1056/NEJMra0901512; Hall TC, 2011, WORLD J SURG, V35, P2510, DOI 10.1007/s00268-011-1198-0; Hoekstra J, 2009, NETH J MED, V67, P46; Hollingshead M, 2005, J VASC INTERV RADIOL, V16, P651, DOI 10.1097/01.RVI.0000156265.79960.86; James AW, 2009, ARCH SURG-CHICAGO, V144, P520, DOI 10.1001/archsurg.2009.81; Jamieson NV, 2000, TRANSPLANTATION, V69, P1772, DOI 10.1097/00007890-200005150-00006; Kim HS, 2005, J VASC INTERV RADIOL, V16, P1685, DOI 10.1097/01.RVI.0000182156.71059.B7; Kumar S, 2001, NEW ENGL J MED, V345, P1683, DOI 10.1056/NEJMra010076; Lee HK, 2008, ABDOM IMAGING, V33, P72, DOI 10.1007/s00261-007-9200-x; Luca A, 2012, RADIOLOGY, V265, P124, DOI 10.1148/radiol.12112236; Luca A, 2011, GUT, V60, P846, DOI 10.1136/gut.2010.228023; Luo JJ, 2011, J VASC INTERV RADIOL, V22, P61, DOI 10.1016/j.jvir.2010.07.028; Malkowski P, 2003, HEPATO-GASTROENTEROL, V50, P2098; NONAMI T, 1992, HEPATOLOGY, V16, P1195, DOI 10.1016/0270-9139(92)90014-Z; Ogren M, 2006, WORLD J GASTROENTERO, V12, P2115; Parikh S, 2010, AM J MED, V123, P111, DOI 10.1016/j.amjmed.2009.05.023; Plessier A, 2010, HEPATOLOGY, V51, P210, DOI 10.1002/hep.23259; Ponziani FR, 2010, WORLD J GASTROENTERO, V16, P143, DOI 10.3748/wjg.v16.i2.143; Ponziani FR, 2012, WORLD J GASTROENTERO, V18, P5014, DOI 10.3748/wjg.v18.i36.5014; Primignani M, 2010, DIGEST LIVER DIS, V42, P163, DOI 10.1016/j.dld.2009.08.003; Qi XS, 2012, CLIN RES HEPATOL GAS, V36, P561, DOI 10.1016/j.clinre.2012.05.021; Qi XS, 2012, DIGEST DIS SCI, V57, P1072, DOI 10.1007/s10620-011-1975-5; Qi XS, 2010, HEPATOLOGY, V51, P1089, DOI 10.1002/hep.23397; Sarin SK, 2002, SEMIN LIVER DIS, V22, P43, DOI 10.1055/s-2002-23206; Senzolo M, 2006, ALIMENT PHARM THER, V23, P767, DOI 10.1111/j.1365-2036.2006.02820.x; Sheen CL, 2000, QJM-MON J ASSOC PHYS, V93, P531, DOI 10.1093/qjmed/93.8.531; Spaander MCW, 2013, J THROMB HAEMOST, V11, P452, DOI 10.1111/jth.12121; STIEBER AC, 1991, ANN SURG, V213, P199, DOI 10.1097/00000658-199103000-00003; Valla DC, 2000, J HEPATOL, V32, P865, DOI 10.1016/S0168-8278(00)80259-7; Valla DC, 2011, VASCULAR LIVER DISEASE: MECHANISMS AND MANAGEMENT, P183, DOI 10.1007/978-1-4419-8327-5_12; Walser EM, 1998, J VASC INTERV RADIOL, V9, P119, DOI 10.1016/S1051-0443(98)70493-2; Webster GJM, 2005, ALIMENT PHARM THER, V21, P1, DOI 10.1111/j.1365-2036.2004.02301.x; Wu J, 2013, ANN VASC SURG; Yerdel MA, 2000, TRANSPLANTATION, V69, P1873, DOI 10.1097/00007890-200005150-00023	47	20	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112501	10.1371/journal.pone.0112501	http://dx.doi.org/10.1371/journal.pone.0112501			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393320	Green Published, gold, Green Submitted			2022-12-27	WOS:000347709300062
J	Montag, C; Haase, L; Seidel, D; Bayerl, M; Gallinat, J; Herrmann, U; Dannecker, K				Montag, Christiane; Haase, Laura; Seidel, Dorothea; Bayerl, Martin; Gallinat, Juergen; Herrmann, Uwe; Dannecker, Karin			A Pilot RCT of Psychodynamic Group Art Therapy for Patients in Acute Psychotic Episodes: Feasibility, Impact on Symptoms and Mentalising Capacity	PLOS ONE			English	Article							EMOTIONAL AWARENESS SCALE; GERMAN VERSION; SCHIZOPHRENIA; MIND; DEFICITS; PSYCHOPATHOLOGY; MENTALIZATION; PSYCHOTHERAPY; ALEXITHYMIA; DEPRESSION	This pilot study aimed to evaluate the feasibility of an assessor-blind, randomised controlled trial of psychodynamic art therapy for the treatment of patients with schizophrenia, and to generate preliminary data on the efficacy of this intervention during acute psychotic episodes. Fifty-eight inpatients with DSM-diagnoses of schizophrenia were randomised to either 12 twice-weekly sessions of psychodynamic group art therapy plus treatment as usual or to standard treatment alone. Primary outcome criteria were positive and negative psychotic and depressive symptoms as well as global assessment of functioning. Secondary outcomes were mentalising function, estimated with the Reading the mind in the eyes test and the Levels of emotional awareness scale, self-efficacy, locus of control, quality of life and satisfaction with care. Assessments were made at baseline, at post-treatment and at 12 weeks' follow-up. At 12 weeks, 55% of patients randomised to art therapy, and 66% of patients receiving treatment as usual were examined. In the per-protocol sample, art therapy was associated with a significantly greater mean reduction of positive symptoms and improved psychosocial functioning at post-treatment and follow-up, and with a greater mean reduction of negative symptoms at follow-up compared to standard treatment. The significant reduction of positive symptoms at post-treatment was maintained in an attempted intention-to-treat analysis. There were no group differences regarding depressive symptoms. Of secondary outcome parameters, patients in the art therapy group showed a significant improvement in levels of emotional awareness, and particularly in their ability to reflect about others' emotional mental states. This is one of the first randomised controlled trials on psychodynamic group art therapy for patients with acute psychotic episodes receiving hospital treatment. Results prove the feasibility of trials on art therapy during acute psychotic episodes and justify further research to substantiate preliminary positive results regarding symptom reduction and the recovery of mentalising function.	[Montag, Christiane; Haase, Laura; Seidel, Dorothea; Bayerl, Martin; Gallinat, Juergen] Charite, Dept Psychiat & Psychotherapy, D-13353 Berlin, Germany; [Seidel, Dorothea; Herrmann, Uwe; Dannecker, Karin] Weissensee Sch Art Kunsthochschule Berlin Weissen, Art Therapy Dept, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Montag, C (corresponding author), Charite, Dept Psychiat & Psychotherapy, Campus Mitte, D-13353 Berlin, Germany.	christiane.montag@charite.de		Montag, Christiane/0000-0002-3307-276X	Weissensee School of Art	Weissensee School of Art	The study was financially supported by the Weissensee School of Art. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen N. C., 1984, SCALE ASSESSMENT POS; Andreasen NC, 1983, SCALE ASSESSMENT NEG; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baslet G, 2009, J NERV MENT DIS, V197, P655, DOI 10.1097/NMD.0b013e3181b3b20f; Boelte S, 2009, READING MIND EYES TE; Bora E, 2009, ACTA PSYCHIAT SCAND, V120, P253, DOI 10.1111/j.1600-0447.2009.01414.x; Brent B, 2009, J CLIN PSYCHOL, V65, P803, DOI 10.1002/jclp.20615; Brooker J., 2007, USE ART WORK ART PSY; Brune M, 2007, SCHIZOPHR RES, V92, P151, DOI 10.1016/J.SCHRES.2007.01.006; Brune M, 2005, SCHIZOPHRENIA BULL, V31, P21, DOI 10.1093/schbul/sbi002; Crawford MJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e846; Crawford MJ, 2007, EVID-BASED MENT HEAL, V10, P69, DOI 10.1136/ebmh.10.3.69; Dannecker K, 2010, PSYCHE ASTHETIK TRAN; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; First M.B., 2016, STRUCTURED CLIN INTE; Fonagy P., 2002, AFFEKTREGULIERUNG ME; Franklin M., 1992, ART THERAPY J AM ART, V9, P78, DOI [10.1080/07421656.1992.10758941, DOI 10.1080/07421656.1992.10758941]; Franks M, 2007, INT J ART THERAPY FO, V12, P3, DOI DOI 10.1080/17454830701265188; Gold C, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004025.pub2; GREEN BL, 1987, HOSP COMMUNITY PSYCH, V38, P988; Greenwood H, 2012, WHAT ASPEKTS ART THE; Guhne U, 2012, NERVENARZT, V83, P855, DOI 10.1007/s00115-011-3472-7; Harrow M, 2009, PSYCHIAT RES, V168, P186, DOI 10.1016/j.psychres.2008.06.002; Heenan D, 2006, DISABIL SOC, V21, P179, DOI 10.1080/09687590500498143; HELMCHEN H, 1995, NERVENARZT, V66, P231; Heubrock D, 1992, Z DIFFER DIAGNOSTISC, V13, P161; Karterud S., 2004, THER COMMUNITIES, V25, P43, DOI DOI 10.1080/08039480410006304; Kidd DC, 2013, SCIENCE, V342, P377, DOI 10.1126/science.1239918; Kircher TTJ, 2007, NEUROIMAGE, V34, P281, DOI 10.1016/j.neuroimage.2006.08.044; Korver-Nieberg N, 2014, PSYCHOL PSYCHOTHER-T, V87, P127, DOI 10.1111/papt.12010; Krampen G., 1991, FRAGEBOGEN KOMPETENZ; LANE RD, 1990, J PERS ASSESS, V55, P124, DOI 10.1207/s15327752jpa5501&2_12; LANE RD, 1987, AM J PSYCHIAT, V144, P133; Leech NL., 2015, IBM SPSS INTERMEDIAT; LEHRL S, 1995, ACTA NEUROL SCAND, V91, P335, DOI 10.1111/j.1600-0404.1995.tb07018.x; Leon AC, 2011, J PSYCHIATR RES, V45, P626, DOI 10.1016/j.jpsychires.2010.10.008; Levenson H., 1981, RES LOCUS CONTROL CO, P1, DOI DOI 10.1016/B978-0-12-443201-7.50006-3; Little RJ, 2012, STAT MED, V31, P3433, DOI 10.1002/sim.5519; Lysaker PH, 2011, PSYCHOL PSYCHOTHER-T, V84, P58, DOI 10.1348/147608310X520436; MacBeth A, 2011, PSYCHOL PSYCHOTHER-T, V84, P42, DOI 10.1348/147608310X530246; Mahony J., 1992, ART THERAPY HDB, P173; Mo SL, 2008, PSYCHIAT RES, V157, P21, DOI 10.1016/j.psychres.2006.04.002; Montag C, 2011, PSYCHIAT RES, V186, P203, DOI 10.1016/j.psychres.2010.09.006; Moritz S, 2007, CURR OPIN PSYCHIATR, V20, P619, DOI 10.1097/YCO.0b013e3282f0b8ed; MUESER KT, 1990, PSYCHOL MED, V20, P253, DOI 10.1017/S003329170001758X; Muller MJ, 1999, J PSYCHIATR RES, V33, P433, DOI 10.1016/S0022-3956(99)00018-7; National Research Council, 2010, PREVENTION TREATMENT; Navratil L, 1965, SCHIZOPHRENIE KUNST; Or MB, 2010, ART PSYCHOTHER, V37, P319, DOI 10.1016/j.aip.2010.05.007; Patterson S., 2011, INT J ART THER, V16, P70, DOI [https://doi.org/10.1080/17454832.2011.604038, DOI 10.1080/17454832.2011.604038]; Patterson S, 2011, J MENT HEALTH, V20, P328, DOI 10.3109/09638237.2011.556163; Persons RW, 2009, INT J OFFENDER THER, V53, P433, DOI 10.1177/0306624X08320208; Prinzhorn H., 1922, BILDNEREI GEISTESKRA; Pukrop R, 1999, NERVENARZT, V70, P41, DOI 10.1007/s001150050399; Richardson P., 2007, J MENT HEALTH, V16, P483, DOI [DOI 10.1080/09638230701483111, https://doi.org/10.1080/09638230701483111]; Riedel-Heller SG, 2012, PSYCHOTHER PSYCH MED, V62, P425, DOI 10.1055/s-0032-1327676; Rohricht F, 2006, PSYCHOL MED, V36, P669, DOI 10.1017/S0033291706007161; Ruddy R, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003728.pub2; Sarra N, 1998, ART PSYCHOTHERAPY GR; Sass H, 2003, MANUAL PSYCHISCHER S; Schaverien Joy, 1997, ART PSYCHOTHERAPY PS; SCHMIDT J, 1989, PSYCHOTHER PSYCH MED, V39, P248; Spaniol S, 2001, ART PSYCHOTHER, V28, P221, DOI 10.1016/S0197-4556(01)00108-3; Springham N., 2012, INT J ART THERAPY, V17, P115, DOI [10.1080/17454832.2012.734835, DOI 10.1080/17454832.2012.734835]; Sprong M, 2007, BRIT J PSYCHIAT, V191, P5, DOI 10.1192/bjp.bp.107.035899; Subic-Wrana C, 2005, PSYCHOSOM MED, V67, P483, DOI 10.1097/01.psy.0000160461.19239.13; Subic-Wrana C, 2001, PSYCHOTHERAPEUT, V46, P176, DOI 10.1007/s002780100157; Subic-Wrana C, 2011, INT J PSYCHOANAL, V92, P289, DOI 10.1111/j.1745-8315.2011.00392.x; Subic-Wrana C, 2010, PSYCHOSOM MED, V72, P404, DOI 10.1097/PSY.0b013e3181d35e83; Teglbjaerg HS, 2011, PSYCHOPATHOLOGY, V44, P314, DOI 10.1159/000325025; Ulrich G, 2007, ACTA PSYCHIAT SCAND, V116, P362, DOI 10.1111/j.1600-0447.2007.01073.x; van Ginkel J. R, 2014, SPSS SYNTAX APPLYING; van Ginkel JR, 2014, MULTIVAR BEHAV RES, V49, P78, DOI 10.1080/00273171.2013.855890; van 't Wout M, 2007, COMPR PSYCHIAT, V48, P27, DOI 10.1016/j.comppsych.2006.07.003; Vauth R, 2004, PSYCHIAT RES, V128, P155, DOI 10.1016/j.psychres.2004.05.018; Wright CC, 2003, J CLIN EPIDEMIOL, V56, P833, DOI 10.1016/S0895-4356(03)00155-0; [郑日昌 Zheng Richang], 2005, [心理学报, Acta Psychologica Sinica], V37, P403	77	45	45	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112348	10.1371/journal.pone.0112348	http://dx.doi.org/10.1371/journal.pone.0112348			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY6YT	25393414	Green Submitted, Green Published, gold			2022-12-27	WOS:000347709300053
J	Petrovova, M; Tkadlec, J; Dvoracek, L; Streitova, E; Licha, I				Petrovova, Miroslava; Tkadlec, Jan; Dvoracek, Lukas; Streitova, Eliska; Licha, Irena			NAD(P)H-Hydrate Dehydratase- A Metabolic Repair Enzyme and Its Role in Bacillus subtilis Stress Adaptation	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; REGULATORY NETWORK; SIGMA-B; GENES; DEHYDROGENASE; BIOSYNTHESIS; ACTIVATION; PROTEOMICS; RESPONSES; REGULON	Background: One of the strategies for survival stress conditions in bacteria is a regulatory adaptive system called general stress response (GSR), which is dependent on the SigB transcription factor in Bacillus sp. The GSR is one of the largest regulon in Bacillus sp., including about 100 genes; however, most of the genes that show changes in expression during various stresses have not yet been characterized or assigned a biochemical function for the encoded proteins. Previously, we characterized the Bacillus subtilis168 osmosensitive mutant, defective in the yxkO gene (encoding a putative ribokinase), which was recently assigned in vitro as an ADP/ATP-dependent NAD(P) H-hydrate dehydratase and was demonstrated to belong to the SigB operon. Methods and Results: We show the impact of YxkO on the activity of SigB-dependent Pctc promoter and adaptation to osmotic and ethanol stress and potassium limitation respectively. Using a 2DE approach, we compare the proteomes of WT and mutant strains grown under conditions of osmotic and ethanol stress. Both stresses led to changes in the protein level of enzymes that are involved in motility (flagellin), citrate cycle (isocitrate dehydrogenase, malate dehydrogenase), glycolysis (phosphoglycerate kinase), and decomposition of Amadori products (fructosamine-6-phosphate deglycase). Glutamine synthetase revealed a different pattern after osmotic stress. The patterns of enzymes for branched amino acid metabolism and cell wall synthesis (L-alanine dehydrogenase, aspartate-semialdehyde dehydrogenase, ketol-acid reductoisomerase) were altered after ethanol stress. Conclusion: We performed the first characterization of a Bacillus subtilis168 knock-out mutant in the yxkO gene that encodes a metabolite repair enzyme. We show that such enzymes could play a significant role in the survival of stressed cells.	[Petrovova, Miroslava; Tkadlec, Jan; Dvoracek, Lukas; Streitova, Eliska; Licha, Irena] Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Prague, Czech Republic; [Tkadlec, Jan; Streitova, Eliska] Charles Univ Prague, Dept Med Microbiol, Fac Med 2, Prague, Czech Republic	Charles University Prague; Charles University Prague	Licha, I (corresponding author), Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Prague, Czech Republic.	licha@natur.cuni.cz	Tkadlec, Jan/ABD-9485-2020; /Q-9263-2017	/0000-0002-9930-4607; Tkadlec, Jan/0000-0002-0892-924X	Ministry of Education, Youth and Sports of the Czech Republic [LC06066]; Charles University by project of Specific University Research [SVV-2014-260081]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Charles University by project of Specific University Research	The study was supported by projects of Ministry of Education, Youth and Sports of the Czech Republic (LC06066) and by the Charles University by project of Specific University Research (SVV-2014-260081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila-Perez M, 2010, J BACTERIOL, V192, P755, DOI 10.1128/JB.00826-09; Belitsky BR, 2008, J BACTERIOL, V190, P1224, DOI 10.1128/JB.01780-07; BENSON AK, 1992, J BACTERIOL, V174, P749, DOI 10.1128/jb.174.3.749-757.1992; BOYLAN SA, 1993, J BACTERIOL, V175, P3957, DOI 10.1128/JB.175.13.3957-3963.1993; BOYLAN SA, 1993, J BACTERIOL, V175, P7931, DOI 10.1128/JB.175.24.7931-7937.1993; CUTTING SM, 1990, MOL BIOL METHODS BAC; De Mendoza D, 2002, BACILLUS ITS CLOSEST; Deppe VM, 2011, APPL MICROBIOL BIOT, V90, P399, DOI 10.1007/s00253-010-3083-4; Eiamphungporn W, 2008, MOL MICROBIOL, V67, P830, DOI 10.1111/j.1365-2958.2007.06090.x; Gaidenko TA, 2006, J BACTERIOL, V188, P6387, DOI 10.1128/JB.00691-06; Gunka K, 2012, MOL MICROBIOL, V85, P213, DOI 10.1111/j.1365-2958.2012.08105.x; Hahne H, 2010, J BACTERIOL, V192, P870, DOI 10.1128/JB.01106-09; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; Holtmann G, 2003, J BACTERIOL, V185, P1289, DOI 10.1128/JB.185.4.1289-1298.2003; Hoper D, 2006, PROTEOMICS, V6, P1550, DOI 10.1002/pmic.200500197; Hoper D, 2005, J BACTERIOL, V187, P2810, DOI 10.1128/JB.187.8.2810-2826.2005; Jers C, 2010, MOL MICROBIOL, V77, P287, DOI 10.1111/j.1365-2958.2010.07227.x; Mader U, 2004, J BACTERIOL, V186, P2240, DOI 10.1128/JB.186.8.2240-2252.2004; Marbaix AY, 2011, J BIOL CHEM, V286, P41246, DOI 10.1074/jbc.C111.310847; Mascher T, 2003, MOL MICROBIOL, V50, P1591, DOI 10.1046/j.1365-2958.2003.03786.x; Mironova R, 2001, MOL MICROBIOL, V39, P1061, DOI 10.1046/j.1365-2958.2001.02304.x; Molle V, 2003, J BACTERIOL, V185, P1911, DOI 10.1128/JB.185.6.1911-1922.2003; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; OPPENHEIMER NJ, 1974, BIOCHEMISTRY-US, V13, P4685, DOI 10.1021/bi00720a002; Petersohn A, 2001, J BACTERIOL, V183, P5617, DOI 10.1128/JB.183.19.5617-5631.2001; Prabhakar P, 1998, ARCH BIOCHEM BIOPHYS, V360, P195, DOI 10.1006/abbi.1998.0939; Price CW, 2001, MOL MICROBIOL, V41, P757, DOI 10.1046/j.1365-2958.2001.02534.x; Ratnayake-Lecamwasam M, 2001, GENE DEV, V15, P1093, DOI 10.1101/gad.874201; RAY C, 1985, J BACTERIOL, V163, P610, DOI 10.1128/JB.163.2.610-614.1985; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shumilin IA, 2012, STRUCTURE, V20, P1715, DOI 10.1016/j.str.2012.07.016; Steil L, 2003, J BACTERIOL, V185, P6358, DOI 10.1128/JB.185.21.6358-6370.2003; Ulanova D, 2007, FOLIA MICROBIOL, V52, P203, DOI 10.1007/BF02931299; Van Schaftingen E, 2013, J INHERIT METAB DIS, V36, P427, DOI 10.1007/s10545-012-9571-1; YOSHIDA A, 1975, ARCH BIOCHEM BIOPHYS, V169, P298, DOI 10.1016/0003-9861(75)90344-6; Young JW, 2013, P NATL ACAD SCI USA, V110, P4140, DOI 10.1073/pnas.1213060110; Zhang RG, 2002, J STRUCT BIOL, V139, P161, DOI 10.1016/S1047-8477(02)00532-4; Zhang SY, 2005, J BACTERIOL, V187, P7554, DOI 10.1128/JB.187.22.7554-7560.2005	38	10	10	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112590	10.1371/journal.pone.0112590	http://dx.doi.org/10.1371/journal.pone.0112590			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393291	Green Submitted, Green Published, gold			2022-12-27	WOS:000347709300076
J	Underwood, MJ; Rosen, S; Engas, A; Eriksen, E				Underwood, Melanie J.; Rosen, Shale; Engas, Arill; Eriksen, Elena			Deep Vision: An In-Trawl Stereo Camera Makes a Step Forward in Monitoring the Pelagic Community	PLOS ONE			English	Article							MANAGEMENT; FISHERIES; SYSTEM	Ecosystem surveys are carried out annually in the Barents Sea by Russia and Norway to monitor the spatial distribution of ecosystem components and to study population dynamics. One component of the survey is mapping the upper pelagic zone using a trawl towed at several depths. However, the current technique with a single codend does not provide fine-scale spatial data needed to directly study species overlaps. An in-trawl camera system, Deep Vision, was mounted in front of the codend in order to acquire continuous images of all organisms passing. It was possible to identify and quantify of most young-of-the-year fish (e.g. Gadus morhua, Boreogadus saida and Reinhardtius hippoglossoides) and zooplankton, including Ctenophora, which are usually damaged in the codend. The system showed potential for measuring the length of small organisms and also recorded the vertical and horizontal positions where individuals were imaged. Young-of-the-year fish were difficult to identify when passing the camera at maximum range and to quantify during high densities. In addition, a large number of fish with damaged opercula were observed passing the Deep Vision camera during heaving; suggesting individuals had become entangled in meshes farther forward in the trawl. This indicates that unknown numbers of fish are probably lost in forward sections of the trawl and that the heaving procedure may influence the number of fish entering the codend, with implications for abundance indices and understanding population dynamics. This study suggests modifications to the Deep Vision and the trawl to increase our understanding of the population dynamics.	[Underwood, Melanie J.; Rosen, Shale; Engas, Arill; Eriksen, Elena] Inst Marine Res, N-5024 Bergen, Norway; [Underwood, Melanie J.; Engas, Arill] Univ Bergen, Dept Biol, Bergen, Norway	Institute of Marine Research - Norway; University of Bergen	Underwood, MJ (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	melanie.underwood@imr.no	; Rosen, Shale/E-9444-2017	Underwood, Melanie/0000-0002-7752-5548; Rosen, Shale/0000-0002-5857-1637	Barents Sea Research programme at the Institute of Marine Research and Scantrol AS	Barents Sea Research programme at the Institute of Marine Research and Scantrol AS	The authors would like to acknowledge support provided by the Barents Sea Research programme at the Institute of Marine Research and Scantrol AS. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, FUNDAMENTALS ECOLOGY; [Anonymous], 2004, IMR PINRO JOINT REPO, V2; Blaxter Jhs, 1959, ICES J MAR SCI, V24, P472, DOI [10.1093/icesjms/24.3.472, DOI 10.1093/ICESJMS/24.3.472]; Dolgov A.V., 2011, BARENTS SEA ECOSYSTE, P438; Engas A, 1997, FISH RES, V29, P295, DOI 10.1016/S0165-7836(96)00545-0; Eriksen E., 2012, BARENTS SEA ECOSYSTE, P557; Eriksen E., 2013, MONITORING STRATEGY; Eriksen E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033050; GODO OR, 1993, ICES MAR SC, V196, P196; Hylen A., 1995, PRECISION RELEVANCE, P146; Link JS, 2011, FISH FISH, V12, P152, DOI 10.1111/j.1467-2979.2011.00411.x; Madsen N, 2012, FISH RES, V123, P16, DOI 10.1016/j.fishres.2011.11.016; Michalsen K, 2013, MAR BIOL RES, V9, P932, DOI 10.1080/17451000.2013.775459; Mjanger H., 2003, HDB PROVETAKING FISK; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Pitcher TJ, 2009, MAR POLICY, V33, P223, DOI 10.1016/j.marpol.2008.06.002; Rosen S, 2013, FISH RES, V148, P64, DOI 10.1016/j.fishres.2013.08.002; Rosen S, 2013, CAN J FISH AQUAT SCI, V70, P1456, DOI 10.1139/cjfas-2013-0124; SKJOLDAL HR, 1989, BIOMASS YIELDS GEOGR, P241; Williams K, 2010, FISH B-NOAA, V108, P352; Winger Paul D., 2010, P67	21	10	10	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112304	10.1371/journal.pone.0112304	http://dx.doi.org/10.1371/journal.pone.0112304			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393121	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300049
J	Wakie, TT; Evangelista, PH; Jarnevich, CS; Laituri, M				Wakie, Tewodros T.; Evangelista, Paul H.; Jarnevich, Catherine S.; Laituri, Melinda			Mapping Current and Potential Distribution of Non-Native Prosopis juliflora in the Afar Region of Ethiopia	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; THRESHOLD SELECTION; INVASION; PREDICTION; IMPACTS; MODELS; ACCURACY; MESQUITE; BIOLOGY; VALLEY	We used correlative models with species occurrence points, Moderate Resolution Imaging Spectroradiometer (MODIS) vegetation indices, and topo-climatic predictors to map the current distribution and potential habitat of invasive Prosopis juliflora in Afar, Ethiopia. Time-series of MODIS Enhanced Vegetation Indices (EVI) and Normalized Difference Vegetation Indices (NDVI) with 250 m(2) spatial resolution were selected as remote sensing predictors for mapping distributions, while WorldClim bioclimatic products and generated topographic variables from the Shuttle Radar Topography Mission product (SRTM) were used to predict potential infestations. We ran Maxent models using non-correlated variables and the 143 species-occurrence points. Maxent generated probability surfaces were converted into binary maps using the 10-percentile logistic threshold values. Performances of models were evaluated using area under the receiver-operating characteristic (ROC) curve (AUC). Our results indicate that the extent of P. juliflora invasion is approximately 3,605 km(2) in the Afar region (AUC = 0.94), while the potential habitat for future infestations is 5,024 km(2) (AUC = 0.95). Our analyses demonstrate that time-series of MODIS vegetation indices and species occurrence points can be used with Maxent modeling software to map the current distribution of P. juliflora, while topo-climatic variables are good predictors of potential habitat in Ethiopia. Our results can quantify current and future infestations, and inform management and policy decisions for containing P. juliflora. Our methods can also be replicated for managing invasive species in other East African countries.	[Wakie, Tewodros T.] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Wakie, Tewodros T.; Evangelista, Paul H.] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Jarnevich, Catherine S.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO USA; [Laituri, Melinda] Colorado State Univ, Dept Ecosyst Sci & Sustainabil, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; United States Department of the Interior; United States Geological Survey; Colorado State University	Wakie, TT (corresponding author), Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA.	tewodros@lamar.colostate.edu	Evangelista, Paul/D-2315-2016		National Needs Fellowship program of the National Institute of Food and Agriculture; U.S. Department of Agriculture [2010-03280]; U.S. Forest Service International Program	National Needs Fellowship program of the National Institute of Food and Agriculture; U.S. Department of Agriculture(United States Department of Agriculture (USDA)); U.S. Forest Service International Program(United States Department of Agriculture (USDA)United States Forest Service)	Tewodros Wakie acknowledges support from the National Needs Fellowship program of the National Institute of Food and Agriculture, U.S. Department of Agriculture (Award Number-2010-03280). Additional funding was provided by the U.S. Forest Service International Program (http://www. fs.fed.us/global/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abule E, 2007, J ARID ENVIRON, V70, P253, DOI 10.1016/j.jaridenv.2006.12.008; Anderson RP, 2011, ECOL MODEL, V222, P2796, DOI 10.1016/j.ecolmodel.2011.04.011; Bean WT, 2012, ECOGRAPHY, V35, P250, DOI 10.1111/j.1600-0587.2011.06545.x; Bradley BA, 2012, ECOL MODEL, V244, P57, DOI 10.1016/j.ecolmodel.2012.06.019; BROWN AF, 1929, FLORA SUDAN; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Canadell J, 1996, OECOLOGIA, V108, P583, DOI 10.1007/BF00329030; Choge SK, 2007, WATER SA, V33, P419; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Coppock D., 2005, AGROPASTORALISTS WRA; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; EPA, 2010, AF NAT REG STAT PROG AF NAT REG STAT PROG; Escalante Tania, 2013, TIP Revista Especializada en Ciencias Quimico-Biologicas, V16, P5; ESRI, 2012, DESKT REL 10; Ethiopian Flora Network, 2010, INV PLANTS; Evangelista PH, 2008, DIVERS DISTRIB, V14, P808, DOI 10.1111/j.1472-4642.2008.00486.x; Evangelista PH, 2009, REMOTE SENS-BASEL, V1, P519, DOI 10.3390/rs1030519; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gallaher T, 2010, PAC SCI, V64, P489, DOI 10.2984/64.4.489; Gormley A, 2011, USING PRESENCE ONLY; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Huete AR, 1997, REMOTE SENS ENVIRON, V59, P440, DOI 10.1016/S0034-4257(96)00112-5; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Kebede Fanuel, 2012, Endangered Species Research, V17, P237, DOI 10.3354/esr00416; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Li WK, 2010, INT J REMOTE SENS, V31, P2227, DOI 10.1080/01431161003702245; Lillesand T., 1987, REMOTE SENSING IMAGE; Lobo Jorge M., 2008, Biodiversity Informatics, V5, P14; Mauremootoo J. R., 2006, BIOCONTROL NEWS INFO, V27, P37; Pasiecznik NM, 2001, PROSOPIS JULIFLORA P; Peterson AT, 2011, ECOLOGICAL NICHE GEO; PFE IIRR and DF, 2010, PAST LAND LAND TEN A; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Reiss H, 2011, MAR ECOL PROG SER, V442, P71, DOI 10.3354/meps09391; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Salah O., 2011, AFR J FOOD SCI TECHN, V2, P79; Schachtschneider K, 2013, PLANT ECOL, V214, P597, DOI 10.1007/s11258-013-0192-z; SCHRODER B, 2006, ROC PLOTTING AUC CAL; Sharma GP, 2005, CURR SCI INDIA, V88, P726; Shiferaw H, 2004, J ARID ENVIRON, V58, P135, DOI 10.1016/j.jaridenv.2003.08.011; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; SYSTAT, 2008, VERS 11; Tikssa M, 2009, AFRICAN J ECOLOGY, V48, P21; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; van Klinken RD, 2006, BIOL INVASIONS, V8, P727, DOI 10.1007/s10530-005-3427-7; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Vina A, 2006, REMOTE SENS ENVIRON, V112, P2160; von Wehrden H, 2009, FOLIA GEOBOT, V44, P211, DOI 10.1007/s12224-009-9042-0; Ward DF, 2007, BIOL INVASIONS, V9, P723, DOI 10.1007/s10530-006-9072-y; Wardlow B, 2013, INT J REMOTE SENS, V31, P805; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Witt ABR, 2010, GCB BIOENERGY, V2, P321, DOI 10.1111/j.1757-1707.2010.01063.x; Zimmermann H, 2006, BIOCONTROL NEWS INFO, V27, P6; Zimmermann H, 2011, AUSTRAL ECOL, V36, P870, DOI 10.1111/j.1442-9993.2010.02230.x; ZOLLNER D, 1986, FOREST ECOL MANAG, V16, P223, DOI 10.1016/0378-1127(86)90022-8	64	45	47	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112854	10.1371/journal.pone.0112854	http://dx.doi.org/10.1371/journal.pone.0112854			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393396	Green Published, gold			2022-12-27	WOS:000347709300114
J	Rapin, N; Johns, K; Martin, L; Warnecke, L; Turner, JM; Bollinger, TK; Willis, CKR; Voyles, J; Misra, V				Rapin, Noreen; Johns, Kirk; Martin, Lauren; Warnecke, Lisa; Turner, James M.; Bollinger, Trent K.; Willis, Craig K. R.; Voyles, Jamie; Misra, Vikram			Activation of Innate Immune-Response Genes in Little Brown Bats (Myotis lucifugus) Infected with the Fungus Pseudogymnoascus destructans	PLOS ONE			English	Article							RESERVOIR HOSTS; EXPRESSION; VIRUS; ABUNDANCE; PATHOGEN; INSIGHTS; PROTEIN	Recently bats have been associated with the emergence of diseases, both as reservoirs for several new viral diseases in humans and other animals and, in the northern Americas, as hosts for a devastating fungal disease that threatens to drive several bat species to regional extinction. However, despite these catastrophic events little Information is available on bat defences or how they interact with their pathogens. Even less is known about the response of bats to infection during torpor or long-term hibernation. Using tissue samples collected at the termination of an experiment to explore the pathogenesis of White Nose Syndrome in Little Brown Bats, we determined if hibernating bats infected with the fungus Pseudogymnoascus destructans could respond to infection by activating genes responsible for innate immune and stress responses. Lesions due to fungal infection and, in some cases, secondary bacterial infections, were restricted to the skin. However, we were unable to obtain sufficient amounts of RNA from these sites. We therefore examined lungs for response at an epithelial surface not linked to the primary site of infection. We found that bats responded to infection with a significant increase in lungs of transcripts for Cathelicidin (an anti-microbial peptide) as well as the immune modulators tumor necrosis factor alpha and interleukins 10 and 23. In conclusion, hibernating bats can respond to experimental Pseudogymnoascus destructans infection by activating expression of innate immune response genes.	[Rapin, Noreen; Johns, Kirk; Martin, Lauren; Misra, Vikram] Univ Saskatchewan, Western Coll Vet Med, Dept Microbiol, Saskatoon, SK S7N 0W0, Canada; [Warnecke, Lisa; Turner, James M.; Willis, Craig K. R.] Univ Winnipeg, Dept Biol, Winnipeg, MB R3B 2E9, Canada; [Bollinger, Trent K.] Univ Saskatchewan, Western Coll Vet Med, Dept Pathol, Saskatoon, SK S7N 0W0, Canada; [Voyles, Jamie] New Mexico Inst Min & Technol, Dept Biol, Socorro, NM USA	University of Saskatchewan; University of Winnipeg; University of Saskatchewan; New Mexico Institute of Mining Technology	Misra, V (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Dept Microbiol, Saskatoon, SK S7N 0W0, Canada.	Vikram.misra@usask.ca	Misra, Vikram/AAC-4266-2020	Misra, Vikram/0000-0001-6818-7156; Turner, James/0000-0001-8699-7750; Willis, Craig/0000-0002-0985-8607	Fish and Wildlife Service grant; Natural Sciences and Engineering Research Council (Discovery) grant; Postdoc Programme of the DAAD, German Academic Exchange Service	Fish and Wildlife Service grant; Natural Sciences and Engineering Research Council (Discovery) grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Postdoc Programme of the DAAD, German Academic Exchange Service	Funding for this study was provided by a Fish and Wildlife Service grant to CRKW, TB and VM and by a Natural Sciences and Engineering Research Council (Discovery) grant to VM and a fellowship within the Postdoc Programme of the DAAD, German Academic Exchange Service (to LW). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Baker ML, 2013, ZOONOSES PUBLIC HLTH, V60, P104, DOI 10.1111/j.1863-2378.2012.01528.x; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Bouma HR, 2010, J LEUKOCYTE BIOL, V88, P619, DOI 10.1189/jlb.0310174; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Che CY, 2013, INT J OPHTHALMOL-CHI, V6, P30, DOI 10.3980/j.issn.2222-3959.2013.01.06; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; Dobson AP, 2005, SCIENCE, V310, P628, DOI 10.1126/science.1120872; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Du WJ, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-40; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Kunz TH, 2003, BAT ECOLOGY, P3; Lehmann J, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-20; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Luis AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2753; Ma SN, 2013, J NEUROIMMUNOL, V257, P28, DOI 10.1016/j.jneuroim.2013.01.007; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Mascarelli PE, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-117; Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172; Moore MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058976; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Muhldorfer K, 2013, ZOONOSES PUBLIC HLTH, V60, P93, DOI 10.1111/j.1863-2378.2012.01536.x; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; O'Shea TJ, 2014, EMERG INFECT DIS, V20, P741, DOI 10.3201/eid2005.130539; Park K, 2011, J BIOL CHEM, V286, P34121, DOI 10.1074/jbc.M111.250431; Piccolo MTS, 1999, EXP MOL PATHOL, V66, P220, DOI 10.1006/exmp.1999.2263; Reeder DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038920; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Stawski C, 2014, J ZOOL, V292, P86, DOI 10.1111/jzo.12105; Till G O, 1983, Agents Actions Suppl, V12, P383; Toussirot Eric, 2012, Inflammation & Allergy Drug Targets, V11, P159; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Veikkolainen V, 2014, EMERG INFECT DIS, V20, P960, DOI 10.3201/eid2006.130956; Vijaykrishna D, 2007, J VIROL, V81, P4012, DOI 10.1128/JVI.02605-06; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Warnecke L, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0177; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; Werner JL, 2011, INFECT IMMUN, V79, P3966, DOI 10.1128/IAI.05493-11; Wibbelt G, 2007, J GEN VIROL, V88, P2651, DOI 10.1099/vir.0.83045-0; Wynne JW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003651; Zelante T, 2009, MED MYCOL, V47, pS162, DOI 10.1080/13693780802140766; Zhen AW, 2013, HEPATOLOGY, V58, P1315, DOI 10.1002/hep.26490	45	20	20	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112285	10.1371/journal.pone.0112285	http://dx.doi.org/10.1371/journal.pone.0112285			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391018	Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400069
J	Verhagen, JH; van Dijk, JGB; Vuong, O; Bestebroer, T; Lexmond, P; Klaassen, M; Fouchier, RAM				Verhagen, Josanne H.; van Dijk, Jacintha G. B.; Oanh Vuong; Bestebroer, Theo; Lexmond, Pascal; Klaassen, Marcel; Fouchier, Ron A. M.			Migratory Birds Reinforce Local Circulation of Avian Influenza Viruses	PLOS ONE			English	Article							A VIRUSES; WILD BIRDS; STABLE-ISOTOPES; EVOLUTION; INFECTION; SURVEILLANCE; SONGBIRDS; PATTERNS; RESIDENT; ECOLOGY	Migratory and resident hosts have been hypothesized to fulfil distinct roles in infectious disease dynamics. However, the contribution of resident and migratory hosts to wildlife infectious disease epidemiology, including that of low pathogenic avian influenza virus (LPAIV) in wild birds, has largely remained unstudied. During an autumn H3 LPAIV epizootic in free-living mallards (Anas platyrhynchos) - a partially migratory species - we identified resident and migratory host populations using stable hydrogen isotope analysis of flight feathers. We investigated the role of migratory and resident hosts separately in the introduction and maintenance of H3 LPAIV during the epizootic. To test this we analysed (i) H3 virus kinship, (ii) temporal patterns in H3 virus prevalence and shedding and (iii) H3-specific antibody prevalence in relation to host migratory strategy. We demonstrate that the H3 LPAIV strain causing the epizootic most likely originated from a single introduction, followed by local clonal expansion. The H3 LPAIV strain was genetically unrelated to H3 LPAIV detected both before and after the epizootic at the study site. During the LPAIV epizootic, migratory mallards were more often infected with H3 LPAIV than residents. Low titres of H3-specific antibodies were detected in only a few residents and migrants. Our results suggest that in this LPAIV epizootic, a single H3 virus was present in resident mallards prior to arrival of migratory mallards followed by a period of virus amplification, importantly associated with the influx of migratory mallards. Thus migrants are suggested to act as local amplifiers rather than the often suggested role as vectors importing novel strains from afar. Our study exemplifies that a multifaceted interdisciplinary approach offers promising opportunities to elucidate the role of migratory and resident hosts in infectious disease dynamics in wildlife.	[Verhagen, Josanne H.; Oanh Vuong; Bestebroer, Theo; Lexmond, Pascal; Fouchier, Ron A. M.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [van Dijk, Jacintha G. B.; Klaassen, Marcel] Netherlands Inst Ecol, NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands; [Klaassen, Marcel] Deakin Univ, Ctr Integrat Ecol, Sch Life & Environm Sci, Geelong, Vic 3217, Australia	Erasmus University Rotterdam; Erasmus MC; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Deakin University	Verhagen, JH (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.	j.h.verhagen@erasmusmc.nl	Fouchier, Ron A/A-1911-2014; Klaassen, Marcel/B-4325-2008; KNAW, NIOO-KNAW/A-4320-2012	Fouchier, Ron A/0000-0001-8095-2869; Klaassen, Marcel/0000-0003-3907-9599; Verhagen, Josanne/0000-0003-3133-5228; KNAW, NIOO-KNAW/0000-0002-3835-159X	Dutch Ministry of Economic Affairs; Netherlands Organization for Scientific Research (NWO) [820.01.018]; NIAID NIH [HHSN266200700010C]	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NIAID NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was sponsored by grants from the Dutch Ministry of Economic Affairs, the Netherlands Organization for Scientific Research (NWO; grant 820.01.018) and contract NIAID NIH HHSN266200700010C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; [Anonymous], 2014, P R SOC B, DOI DOI 10.1098/RSPB.2014.0098.WILD-BIRD-0RIGIN; Boyd H., 1975, DUCK WINGS STUDY DUC; Chapman BB, 2011, OIKOS, V120, P1764, DOI 10.1111/j.1600-0706.2011.20131.x; Daoust PY, 2013, VET PATHOL, V50, P548, DOI 10.1177/0300985812469633; Ferro PJ, 2010, EMERG INFECT DIS, V16, P1224, DOI 10.3201/eid1608.091864; Fouchier RAM, 2009, REV SCI TECH OIE, V28, P49, DOI 10.20506/rst.28.1.1863; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; Henaux V, 2011, J WILDLIFE DIS, V47, P566, DOI 10.7589/0090-3558-47.3.566; Hill NJ, 2012, MOL ECOL, V21, P5986, DOI 10.1111/j.1365-294X.2012.05735.x; Hirst GK, 1943, J EXP MED, V78, p4O7, DOI 10.1084/jem.78.5.407; Hobson KA, 1997, OECOLOGIA, V109, P142, DOI 10.1007/s004420050068; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hofle U, 2012, AVIAN PATHOL, V41, P547, DOI 10.1080/03079457.2012.744447; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hoye BJ, 2012, METHODS ECOL EVOL, V3, P162, DOI 10.1111/j.2041-210X.2011.00135.x; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Kuiken T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0990; Lack David, 1943, BRIT BIRDS, V37, P122; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Latorre-Margalef N, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0098; Leighton FA, 2002, REV SCI TECH OIE, V21, P187; Leroy EM, 2009, VECTOR-BORNE ZOONOT, V9, P723, DOI 10.1089/vbz.2008.0167; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Munster VJ, 2009, J CLIN MICROBIOL, V47, P666, DOI 10.1128/JCM.01625-08; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Payne-Gallwey R, 1886, BOOK DUCK DECOYS THE; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rappole JH, 2003, J APPL MICROBIOL, V94, p47S; Scott D.A., 1996, WETL INTL PUBL, V41; STALLKNECHT DE, 1990, AVIAN DIS, V34, P398, DOI 10.2307/1591427; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; van Dijk JGB, 2014, J AVIAN BIOL, V45, P103, DOI 10.1111/j.1600-048X.2013.00232.x; van Dijk JGB, 2014, J ANIM ECOL, V83, P266, DOI 10.1111/1365-2656.12131; Waldenstrom J, 2002, MOL ECOL, V11, P1545, DOI 10.1046/j.1365-294X.2002.01523.x; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Westgeest KB, 2014, J VIROL, V88, P2844, DOI 10.1128/JVI.02163-13	41	23	24	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112366	10.1371/journal.pone.0112366	http://dx.doi.org/10.1371/journal.pone.0112366			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391154	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400076
J	Bohringer, D; Vach, W; Hagenlocher, K; Eberwein, P; Maier, P; Reinhard, T				Boehringer, Daniel; Vach, Werner; Hagenlocher, Kai; Eberwein, Philipp; Maier, Philip; Reinhard, Thomas			Are Entry Criteria for Cataract Surgery Justified?	PLOS ONE			English	Article							COMPLICATION RATES; PHACOEMULSIFICATION	Purpose: The German Ophthalmological Society (GOS) recently proposed surgical entry criteria, i.e. 300 cataract surgeries. We herein correlate the surgical hands-on experience with the risk of posterior capsule ruptures in order to assess whether this number is appropriate. Methods: We identified all cataract operations that had been performed at the University Eye Hospital Freiburg since 1995. For each surgeon, we assigned a running number to his/her procedures in the order they had been performed. Thereafter, we excluded all combined procedures and the second eyes. We then selected the 5475 surgical reports between November 2008 and November 2012 for detailed review. We additionally classified each surgery into low-vs. high-a priori risk for posterior capsule ruptures. We fitted a multifactorial logistic regression model to assess the GOS recommendation of 300 surgeries under supervision. In the low-risk group, we additionally visualized the 'typical' learning curve by plotting the posterior capsule ruptures against the respective rank numbers. Results: The odds ratio for posterior capsule ruptures of 'learning-mode' (one of the respective surgeon's 300 first ;procedures) vs. the non-learning-mode was 3.8 (p<0.0001). By contrast, classification into the low-risk group lowered the risk of posterior capsule ruptures three fold (p<0.0001). According to the low-risk plot, the surgeons started with a complication rate of 4% and continuously improved towards 0.5% after 1500 operations. Thereafter, the rate increased again and stabilized around one percent. Conclusion: The learning curve with respect to posterior capsule ruptures is surprisingly flat. The GOS entry criterion of 300 cataract procedures is therefore most likely justified. Careful selection of low-risk patients for the training surgeons may help in reducing the rate of posterior capsule ruptures during training.	[Boehringer, Daniel; Hagenlocher, Kai; Eberwein, Philipp; Maier, Philip; Reinhard, Thomas] Univ Hosp, Ctr Eye, Freiburg, Germany; [Vach, Werner] Univ Freiburg, Med Ctr, Ctr Med Biometry & Med Informat, Freiburg, Germany	University of Freiburg; University of Freiburg	Bohringer, D (corresponding author), Univ Hosp, Ctr Eye, Freiburg, Germany.	daniel.boehringer@uniklinik-freiburg.de	Vach, Werner/F-2512-2011	Vach, Werner/0000-0003-1865-8399				Baxter JM, 2013, EYE, V27, P742, DOI 10.1038/eye.2013.54; Buchan JC, 2008, EYE, V22, P1425, DOI 10.1038/eye.2008.157; Chiu CS, 2014, CURR OPIN OPHTHALMOL, V25, P26, DOI 10.1097/ICU.0000000000000006; de Silva SR, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008812.pub2; Fong CSU, 2012, CLIN EXP OPHTHALMOL, V40, P597, DOI 10.1111/j.1442-9071.2012.02759.x; Lee JS, 2009, EYE, V23, P683, DOI 10.1038/sj.eye.6703103; Randleman JB, 2007, ARCH OPHTHALMOL-CHIC, V125, P1215, DOI 10.1001/archopht.125.9.1215; TARBET KJ, 1995, J CATARACT REFR SURG, V21, P661, DOI 10.1016/S0886-3350(13)80562-7; Woodfield AS, 2011, OPHTHALMOLOGY, V118, P954, DOI 10.1016/j.ophtha.2010.08.047; Zare Mohammad, 2009, J Ophthalmic Vis Res, V4, P208	10	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112819	10.1371/journal.pone.0112819	http://dx.doi.org/10.1371/journal.pone.0112819			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401738	Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700075
J	Pessoa, R; Watanabe, JT; Calabria, P; Felix, AC; Loureiro, P; Sabino, EC; Busch, MP; Sanabani, SS				Pessoa, Rodrigo; Watanabe, Jaqueline Tomoko; Calabria, Paula; Felix, Alvina Clara; Loureiro, Paula; Sabino, Ester C.; Busch, Michael P.; Sanabani, Sabri S.		Int Component NHLBI Recipient	Deep Sequencing of HIV-1 near Full-Length Proviral Genomes Identifies High Rates of BF1 Recombinants Including Two Novel Circulating Recombinant Forms (CRF) 70_BF1 and a Disseminating 71_BF1 among Blood Donors in Pernambuco, Brazil	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DRUG-RESISTANCE MUTATIONS; MONONUCLEAR-CELLS; SAO-PAULO; SUBTYPE-C; VACCINE DEVELOPMENT; DUAL INFECTION; PLASMA; INDIVIDUALS; DNA	Background: The findings of frequent circulation of HIV-1 subclade F1 viruses and the scarcity of BF1 recombinant viruses based on pol subgenomic fragment sequencing among blood donors in Pernambuco (PE), Northeast of Brazil, were reported recently. Here, we aimed to determine whether the classification of these strains (n = 26) extends to the whole genome sequences. Methods: Five overlapping amplicons spanning the HIV near full-length genomes (NFLGs) were PCR amplified from peripheral blood mononuclear cells (PBMCs) of 26 blood donors. The amplicons were molecularly bar-coded, pooled, and sequenced by Illumina paired-end protocol. The prevalence of viral variants containing drug resistant mutations (DRMs) was compared between plasma and PBMCs. Results: Of the 26 samples studied, 20 NFLGs and 4 partial fragments were de novo assembled into contiguous sequences and successfully subtyped. Two distinct BF1 recombinant profiles designated CRF70_BF1 and CRF71_BF1, with 4 samples in profile I and 11 in profile II were detected and thus constitute two novel recombinant forms circulating in PE. Evidence of dual infections was detected in four patients co-infected with distinct HIV-1 subtypes. According to our estimate, the new CRF71_BF1 accounts for 10% of the HIV-1 circulating strains among blood donors in PE. Discordant data between the plasma and PBMCs-virus were found in 15 of 24 donors. Six of these strains displayed major DRMs only in PBMCs and four of which had detectable DRMs changes at prevalence between 1-20% of the sequenced population. Conclusions: The high percentage of the new RF71_BF1 and other BF1 recombinants found among blood donors in Pernambuco, coupled with high rates of transmitted DRMs and dual infections confirm the need for effective surveillance to monitor the prevalence and distribution of HIV variants in a variety of settings in Brazil.	[Pessoa, Rodrigo; Watanabe, Jaqueline Tomoko; Calabria, Paula; Felix, Alvina Clara] Univ Sao Paulo, Sao Paulo Inst Trop Med, Dept Virol, Sao Paulo, Brazil; [Loureiro, Paula] Pernambuco State Ctr Hematol & Hemotherapy, Recife, PE, Brazil; [Sabino, Ester C.] Univ Sao Paulo, Inst Trop Med, Dept Infect Dis, Sao Paulo, Brazil; [Busch, Michael P.] Blood Syst Res Inst, San Francisco, CA USA; [Sanabani, Sabri S.] Univ Sao Paulo, Sch Med, Hosp Clin, Clin Lab,Dept Pathol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Vitalant; Vitalant Research Institute; Universidade de Sao Paulo	Sanabani, SS (corresponding author), Univ Sao Paulo, Sch Med, Hosp Clin, Clin Lab,Dept Pathol, Sao Paulo, Brazil.	sabyem_63@yahoo.com	Pessôa, Rodrigo/B-7206-2018; Sanabani, Sabri Saeed/F-5600-2012; Sabino, Ester C/F-7750-2010; Calabria, Paula Andréia Lucas/T-6144-2019; Loureiro, Paula/A-2965-2013	Sanabani, Sabri Saeed/0000-0002-8876-8262; Sabino, Ester C/0000-0003-2623-5126; Calabria, Paula Andréia Lucas/0000-0001-7955-4724; Loureiro, Paula/0000-0003-1849-0047	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/11090-5, 2011/12297-2]; Retrovirus Epidemiology Donor Study-II contract from NHLBI [HHSN268200417175C]; Recipient Epidemiology and Donor Outcomes Study-III contract from NHLBI [HHSN268201100007I]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Retrovirus Epidemiology Donor Study-II contract from NHLBI; Recipient Epidemiology and Donor Outcomes Study-III contract from NHLBI	This work was supported by grants 2011/11090-5 and 2011/12297-2 from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo. The study was also supported by the Retrovirus Epidemiology Donor Study-II (HHSN268200417175C) and the Recipient Epidemiology and Donor Outcomes Study-III (HHSN268201100007I) contracts from NHLBI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alencar CS, 2013, JAIDS-J ACQ IMM DEF, V63, P387, DOI 10.1097/QAI.0b013e31828ff979; Arien KK, 2007, NAT REV MICROBIOL, V5, P141, DOI 10.1038/nrmicro1594; Banks Lauren, 2012, J AIDS Clin Res, V3, P141; Bansode V, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-52; Barreto CC, 2006, JAIDS-J ACQ IMM DEF, V41, P338; Bi XQ, 2003, JAIDS-J ACQ IMM DEF, V34, P1, DOI 10.1097/00126334-200309010-00001; Passaes CPB, 2009, AIDS RES HUM RETROV, V25, P1339, DOI 10.1089/aid.2009.0167; Blackard JT, 2004, SEX TRANSM DIS, V31, P201, DOI 10.1097/01.OLQ.0000118082.45312.1F; Bon I, 2007, NEW MICROBIOL, V30, P313; Bon I, 2007, J CLIN VIROL, V38, P313, DOI 10.1016/j.jcv.2006.12.018; Chew CB, 2005, J CLIN VIROL, V33, P206, DOI 10.1016/j.jcv.2004.11.006; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Cornelissen M, 2012, CLIN INFECT DIS, V54, P539, DOI 10.1093/cid/cir849; de Medeiros LB, 2006, MEM I OSWALDO CRUZ, V101, P845, DOI 10.1590/S0074-02762006000800004; DIAZ RS, 1995, J VIROL, V69, P3273, DOI 10.1128/JVI.69.6.3273-3281.1995; Geretti AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069266; Guimaraes ML, 2008, AIDS, V22, P433, DOI 10.1097/QAD.0b013e3282f47ad0; Gunthard HF, 1998, AIDS RES HUM RETROV, V14, P869, DOI 10.1089/aid.1998.14.869; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jakobsen MR, 2010, CLIN INFECT DIS, V50, P566, DOI 10.1086/650001; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KAYE S, 1995, AIDS RES HUM RETROV, V11, P1221, DOI 10.1089/aid.1995.11.1221; Konings FAJ, 2006, JAIDS-J ACQ IMM DEF, V42, P331, DOI 10.1097/01.qai.0000219784.81163.2e; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Nijhuis M, 1999, AIDS, V13, P2349, DOI 10.1097/00002030-199912030-00006; Parisi SG, 2007, J CLIN MICROBIOL, V45, P1783, DOI 10.1128/JCM.00056-07; Peeters M, 2003, AIDS, V17, P2547, DOI 10.1097/00002030-200312050-00002; Pessoa R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093374; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; Ramos A, 1999, EMERG INFECT DIS, V5, P65, DOI 10.3201/eid0501.990108; Redd AD, 2012, J INFECT DIS, V206, P267, DOI 10.1093/infdis/jis325; Riva E, 2001, AIDS RES HUM RETROV, V17, P1599, DOI 10.1089/088922201753342004; SABINO EC, 1994, J VIROL, V68, P6340, DOI 10.1128/JVI.68.10.6340-6346.1994; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Cavalcanti AMS, 2012, BRAZ J INFECT DIS, V16, P157, DOI [10.1590/S1413-86702012000200009, 10.1016/S1413-8670(12)70298-2]; Sanabani S, 2006, AIDS RES HUM RETROV, V22, P171, DOI 10.1089/aid.2006.22.171; Sanabani S, 2006, INFECT GENET EVOL, V6, P368, DOI 10.1016/j.meegid.2006.01.003; Sanabani SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062552; Sanabani SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025869; Sanabani SS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-74; Sanabani SS, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-78; Santos AF, 2006, AIDS, V20, P2011; Schultz AK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-265; SIMMONDS P, 1990, J VIROL, V64, P864, DOI 10.1128/JVI.64.2.864-872.1990; de Oliveira ACS, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-223; Spira S, 2003, J ANTIMICROB CHEMOTH, V51, P229, DOI 10.1093/jac/dkg079; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomson MM, 2004, AIDS RES HUM RETROV, V20, P1126, DOI 10.1089/aid.2004.20.1126; Thomson MM, 2002, LANCET INFECT DIS, V2, P461, DOI 10.1016/S1473-3099(02)00343-2; Van Laethem K, 1999, J ACQ IMMUN DEF SYND, V22, P107; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wirden M, 2011, J ANTIMICROB CHEMOTH, V66, P709, DOI 10.1093/jac/dkq544; Xu HT, 2012, J VIROL, V86, P8422, DOI 10.1128/JVI.00271-12; Xu HT, 2010, ANTIMICROB AGENTS CH, V54, P2401, DOI 10.1128/AAC.01795-09	55	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112674	10.1371/journal.pone.0112674	http://dx.doi.org/10.1371/journal.pone.0112674			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401747	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700063
J	Brekke, K; Lind, A; Holm-Hansen, C; Haugen, IL; Sorensen, B; Sommerfelt, M; Kvale, D				Brekke, Kristin; Lind, Andreas; Holm-Hansen, Carol; Haugen, Inger Lise; Sorensen, Birger; Sommerfelt, Maja; Kvale, Dag			Intranasal Administration of a Therapeutic HIV Vaccine (Vacc-4x) Induces Dose-Dependent Systemic and Mucosal Immune Responses in a Randomized Controlled Trial	PLOS ONE			English	Article							T-CELL RESPONSES; GAG P24-LIKE PEPTIDES; 1-INFECTED INDIVIDUALS; INFECTION; DISEASE; IGA; IMMUNIZATION; MECHANISMS; PROLIFERATION; EXHAUSTION	Background: Vacc-4x, a Gag p24-based therapeutic HIV vaccine, has been shown to reduce viral load set-points after intradermal administration. In this randomized controlled pilot study we investigate intranasal administration of Vacc-4x with Endocine as adjuvant. Methods: Safety and immunogenicity were tested in patients on effective ART. They were randomized to low, medium or high dose Vacc-4x or adjuvant alone, administered four times at weekly intervals with no booster. Vacc-4x-specific T cell responses were measured in vitro by proliferation and in vivo by a single DTH skin test at the end of study. Nasal and rectal mucosal secretions were analyzed for Vacc-4x-specific antibodies by ELISA. Immune regulation induced by Vacc-4x was assessed by functional blockade of the regulatory cytokines IL-10 and TGF-beta. Results: Vacc-4x proliferative T cell responses increased only among the vaccinated (p <= 0.031). The low dose group showed the greatest increase in Vacc-4x CD8+ T cell responses (p = 0.037) and developed larger DTH (p = 0.005) than the adjuvant group. Rectal (distal) Vacc-4x IgA and IgG antibodies also increased (p = 0.043) in this group. In contrast, the high dose generated higher nasal (local) Vacc-4x IgA (p = 0.028) and serum IgG (p = 0.030) antibodies than the adjuvant. Irrespective of dose, increased Vacc-4x CD4+ T cell responses were associated with low proliferation (r = 20.82, p<0.001) and high regulation (r = 0.61, p = 0.010) at base line. Conclusion: Intranasal administration of Vacc-4x with Endocine was safe and induced dose-dependent vaccine-specific T cell responses and both mucosal and systemic humoral responses. The clinical significance of dose, immune regulation and mucosal immunity warrants further investigation.	[Brekke, Kristin; Lind, Andreas; Kvale, Dag] Oslo Univ Hosp, Dept Infect Dis, Oslo, Norway; [Holm-Hansen, Carol; Haugen, Inger Lise] Norwegian Inst Publ Hlth, Oslo, Norway; [Sorensen, Birger; Sommerfelt, Maja] Bionor Pharma, Oslo, Norway; [Kvale, Dag] Univ Oslo, Oslo, Norway	University of Oslo; Norwegian Institute of Public Health (NIPH); University of Oslo	Kvale, D (corresponding author), Oslo Univ Hosp, Dept Infect Dis, Oslo, Norway.	dag.kvale@medisin.uio.no	Lind, Andreas/AAN-3730-2021	Lind, Andreas/0000-0002-8289-8410; Kvale, Dag/0000-0001-6410-2530	Research Council of Norway, GLOBVAC program [179389]	Research Council of Norway, GLOBVAC program	This work was funded by the Research Council of Norway, GLOBVAC program grant #179389, www.rcn.no. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asjo B, 2002, AIDS RES HUM RETROV, V18, P1357, DOI 10.1089/088922202320935438; Bakke H, 2006, SCAND J IMMUNOL, V63, P223, DOI 10.1111/j.1365-3083.2006.01730.x; Bomsel M, 2011, IMMUNITY, V34, P269, DOI 10.1016/j.immuni.2011.01.015; Brave A, 2008, VACCINE, V26, P5075, DOI 10.1016/j.vaccine.2008.03.066; Brenchley JM, 2013, MUCOSAL IMMUNOL, V6, P657, DOI 10.1038/mi.2013.15; Broliden K, 2001, IMMUNOL LETT, V79, P29, DOI 10.1016/S0165-2478(01)00263-2; Carcelain G, 2013, IMMUNOL REV, V254, P355, DOI 10.1111/imr.12083; Chattopadhyay PK, 2010, CYTOM PART A, V77A, P614, DOI 10.1002/cyto.a.20905; Davenport MP, 2007, IMMUNOL REV, V216, P164; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Demers KR, 2013, IMMUNOL REV, V254, P190, DOI 10.1111/imr.12069; Devito C, 2000, J IMMUNOL, V165, P5170, DOI 10.4049/jimmunol.165.9.5170; Falkeborn T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070527; FORREST BD, 1992, VACCINE, V10, P802, DOI 10.1016/0264-410X(92)90517-N; Garcia F, 2012, HUM VACC IMMUNOTHER, V8, P569, DOI 10.4161/hv.19555; Hawkins ED, 2007, NAT PROTOC, V2, P2057, DOI 10.1038/nprot.2007.297; Hinkula J, 2012, 4 INT C MOD VACC ADJ; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Hunt PW, 2012, CURR HIV-AIDS REP, V9, P139, DOI 10.1007/s11904-012-0118-8; Katlama C, 2013, LANCET, V381, P2109, DOI 10.1016/S0140-6736(13)60104-X; Kaufmann DE, 2009, J IMMUNOL, V182, P5891, DOI 10.4049/jimmunol.0803771; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kozlowski PA, 2000, J ACQ IMMUN DEF SYND, V24, P297; Kran AMB, 2004, AIDS, V18, P1875, DOI 10.1097/00002030-200409240-00003; Kran AMB, 2010, AIDS, V24, P2609, DOI 10.1097/QAD.0b013e32833e502b; Kvale D, 2005, AIDS, V19, P563, DOI 10.1097/01.aids.0000163932.76531.c6; Leroux-Roels G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055438; Lichterfeld M, 2004, J EXP MED, V200, P701, DOI 10.1084/jem.20041270; Lind A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085604; Lind A, 2013, VACCINE, V31, P4611, DOI 10.1016/j.vaccine.2013.07.037; Lind A, 2012, SCAND J INFECT DIS, V44, P566, DOI 10.3109/00365548.2011.653581; Macatangay BJC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009852; Maltais AK, 2014, VACCINE, V32, P3307, DOI 10.1016/j.vaccine.2014.03.061; Mann JFS, 2009, EXPERT REV VACCINES, V8, P103, DOI 10.1586/14760584.8.1.103; McDermott AB, 2012, AIDS, V26, P1281, DOI 10.1097/QAD.0b013e328353bcaf; Mestecky J, 2004, AIDS RES HUM RETROV, V20, P972, DOI 10.1089/aid.2004.20.972; Pavot V, 2012, VACCINE, V30, P142, DOI 10.1016/j.vaccine.2011.11.003; Pollard RB, 2014, LANCET INFECT DIS, V14, P291, DOI 10.1016/S1473-3099(13)70343-8; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; World Health Organization, 2013, UNAIDS REP GLOB AIDS	42	16	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112556	10.1371/journal.pone.0112556	http://dx.doi.org/10.1371/journal.pone.0112556			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398137	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558500060
J	Cheung, SH; Kwok, WK; To, KF; Lau, JYW				Cheung, Sau Ha; Kwok, Wai Kei; To, Ka Fai; Lau, James Yun Wong			Anti-Atherogenic Effect of Hydrogen Sulfide by Over-Expression of Cystathionine Gamma-Lyase (CSE) Gene	PLOS ONE			English	Article							OXIDATIVE STRESS; PROTEIN; ADIPONECTIN; DONOR; CELLS; H2S; P53	Hydrogen sulfide (H2S) is an important gaseous signaling molecule that functions in physiological and pathological conditions, such as atherosclerosis. H2S dilates vessels and therefore has been suggested as an anti-atherogenic molecule. Since cystathionine gamma-lyase (CSE) enzyme is responsible for producing H2S in the cardiovascular system, we hypothesized that up-regulation of CSE expression in vivo with preservation of H2S bioactivity can slow down plaque formation and, can serve as a therapeutic strategy against atherosclerosis. In this study, C57BL/6 wild type mice (WT), ApoE knockout mice (KO) and transgenic ApoE knockout mice overexpressing CSE (Tg/KO) at four weeks of age were weaned. They were then fed with either normal or atherogenic diet for 12 weeks. At week 16, serial plasma lipid levels, body weight, and blood pressure were measured prior to euthanization of the mice and the size of atherosclerotic plaques at their aortic roots was measured. Tg/KO mice showed an increase in endogenous H2S production in aortic tissue, reduced atherosclerotic plaque sizes and attenuation in plasma lipid profiles. We also showed an up-regulation in plasma glutathionine peroxidase that could indicate reduced oxidative stress. Furthermore, there was an increase in expression of p-p53 and down regulation of inflammatory nuclear factor-kappa B (NF-kappa B) in aorta. To conclude, alteration of endogenous H2S by CSE gene activation was associated with reduced atherosclerosis in ApoE-deficient mice. Up-regulation of CSE/H2S pathway attenuates atherosclerosis and this would be a potential target for therapeutic intervention against its formation.	[Cheung, Sau Ha; Kwok, Wai Kei; Lau, James Yun Wong] Chinese Univ Hong Kong, Dept Surg, Fac Med, Hong Kong, Hong Kong, Peoples R China; [To, Ka Fai] Chinese Univ Hong Kong, Fac Med, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Lau, JYW (corresponding author), Chinese Univ Hong Kong, Dept Surg, Fac Med, Hong Kong, Hong Kong, Peoples R China.	laujyw@surgery.cuhk.edu.hk	Lau, James Y. W./O-2612-2016	Lau, James Y. W./0000-0003-0122-4068	Focused Investment Scheme; Chinese University of Hong Kong [1903018]	Focused Investment Scheme; Chinese University of Hong Kong(Chinese University of Hong Kong)	This work was funded by the Focused Investment Scheme, the Chinese University of Hong Kong (Project number 1903018) and it was received by JYWL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama I, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/1/017104; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Baskar R, 2008, EUR J PHARMACOL, V594, P1, DOI 10.1016/j.ejphar.2008.07.029; Calenic B, 2013, J PERIODONTAL RES, V48, P322, DOI 10.1111/jre.12011; Calenic B, 2010, J PERIODONTOL, V81, P1317, DOI 10.1902/jop.2010.100080; Findeisen HM, 2011, OBESITY, V19, P2429, DOI 10.1038/oby.2011.298; Foster CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083513; Haraguchi FK, 2011, EUR J NUTR, V50, P331, DOI 10.1007/s00394-010-0141-8; Hu LF, 2011, ANTIOXID REDOX SIGN, V15, P405, DOI 10.1089/ars.2010.3517; Ihling C, 1997, ARTERIOSCL THROM VAS, V17, P2218, DOI 10.1161/01.ATV.17.10.2218; Jain SK, 2012, ATHEROSCLEROSIS, V225, P242, DOI 10.1016/j.atherosclerosis.2012.08.036; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Kohn C, 2013, PLOS ONE, V7; Lands LC, 1999, J APPL PHYSIOL, V87, P1381, DOI 10.1152/jappl.1999.87.4.1381; Lautamaki R, 2007, METABOLISM, V56, P881, DOI 10.1016/j.metabol.2007.01; Li HZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041614; Li J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087810; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Li W, 2011, ATHEROSCLEROSIS, V215, P323, DOI 10.1016/j.atherosclerosis.2010.12.037; Li XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069979; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu Z, 2013, BRIT J PHARMACOL, V169, P1795, DOI 10.1111/bph.12246; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Ma KU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020525; Madamanchi NR, 2005, J THROMB HAEMOST, V3, P254, DOI 10.1111/j.1538-7836.2004.01085.x; Mani S, 2013, CIRCULATION, V127, P2523, DOI 10.1161/CIRCULATIONAHA.113.002208; Mnjoyan ZH, 2003, CIRCULATION, V108, P464, DOI 10.1161/01.CIR.0000080339.49212.49; Pan LL, 2012, ANTIOXID REDOX SIGN, V17, P106, DOI 10.1089/ars.2011.4349; Pan LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019766; Pan LL, 2011, AMINO ACIDS, V41, P205, DOI 10.1007/s00726-011-0834-1; Selley E, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-69; Takada Y, 2003, J BIOL CHEM, V278, P24233, DOI 10.1074/jbc.M212389200; Wallace JL, 2007, FASEB J, V21, P4070, DOI 10.1096/fj.07-8669com; Wang R, 2003, ANTIOXID REDOX SIGN, V5, P493, DOI 10.1089/152308603768295249; Wang YF, 2009, ARTERIOSCL THROM VAS, V29, P173, DOI 10.1161/ATVBAHA.108.179333; Wen YD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053147; Yang G, 2006, FASEB J, V20, P553, DOI 10.1096/fj.05-4712fje; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yang GD, 2010, CARDIOVASC RES, V86, P487, DOI 10.1093/cvr/cvp420; Yang WS, 2001, J CLIN ENDOCR METAB, V86, P3815, DOI 10.1210/jc.86.8.3815; Zhang HL, 2012, EUR J PHARMACOL, V697, P106, DOI 10.1016/j.ejphar.2012.10.005; Zhang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041147; Zhou CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091468; Zhuang JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082509	44	38	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113038	10.1371/journal.pone.0113038	http://dx.doi.org/10.1371/journal.pone.0113038			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397776	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558500126
J	Crabtree, CE; Norman, JF				Crabtree, Charles E.; Norman, J. Farley			Short-Term Visual Deprivation, Tactile Acuity, and Haptic Solid Shape Discrimination	PLOS ONE			English	Article							NATURAL OBJECT SHAPE; EARLY-BLIND SUBJECTS; SPATIAL-RESOLUTION; LIGHT DEPRIVATION; CORTEX; HUMANS; PERCEPTION; PLASTICITY; ORGANIZATION; ACTIVATION	Previous psychophysical studies have reported conflicting results concerning the effects of short-term visual deprivation upon tactile acuity. Some studies have found that 45 to 90 minutes of total light deprivation produce significant improvements in participants' tactile acuity as measured with a grating orientation discrimination task. In contrast, a single 2011 study found no such improvement while attempting to replicate these earlier findings. A primary goal of the current experiment was to resolve this discrepancy in the literature by evaluating the effects of a 90-minute period of total light deprivation upon tactile grating orientation discrimination. We also evaluated the potential effect of short-term deprivation upon haptic 3-D shape discrimination using a set of naturally-shaped solid objects. According to previous research, shortterm deprivation enhances performance in a tactile 2-D shape discrimination task -perhaps a similar improvement also occurs for haptic 3-D shape discrimination. The results of the current investigation demonstrate that not only does shortterm visual deprivation not enhance tactile acuity, it additionally has no effect upon haptic 3-D shape discrimination. While visual deprivation had no effect in our study, there was a significant effect of experience and learning for the grating orientation task -the participants' tactile acuity improved over time, independent of whether they had, or had not, experienced visual deprivation.	[Crabtree, Charles E.; Norman, J. Farley] Western Kentucky Univ, Ogden Coll Sci & Engn, Dept Psychol Sci, Bowling Green, KY 42101 USA	Western Kentucky University	Norman, JF (corresponding author), Western Kentucky Univ, Ogden Coll Sci & Engn, Dept Psychol Sci, Bowling Green, KY 42101 USA.	Farley.Norman@wku.edu	Norman, Farley/A-7169-2012	Norman, Farley/0000-0001-5877-1914				[Anonymous], DROP; Bleyenheuft Y, 2007, SOMATOSENS MOT RES, V24, P111, DOI 10.1080/08990220701496639; BONEAU CA, 1960, PSYCHOL BULL, V57, P49, DOI 10.1037/h0041412; Buchel C, 1998, BRAIN, V121, P409, DOI 10.1093/brain/121.3.409; Burton H, 2002, J NEUROPHYSIOL, V87, P589, DOI 10.1152/jn.00285.2001; Craig JC, 1998, SOMATOSENS MOT RES, V15, P29; Craig JC, 2000, CURR DIR PSYCHOL SCI, V9, P29, DOI 10.1111/1467-8721.00054; Cuevas I, 2009, NEUROPSYCHOLOGIA, V47, P3079, DOI 10.1016/j.neuropsychologia.2009.07.004; DAVIDSON PW, 1974, NEUROPSYCHOLOGIA, V12, P395, DOI 10.1016/0028-3932(74)90056-6; Facchini S, 2003, NEUROLOGY, V60, P1998, DOI 10.1212/01.WNL.0000068026.15208.D0; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Goldreich D, 2003, J NEUROSCI, V23, P3439; Gougoux F, 2004, NATURE, V430, P309, DOI 10.1038/430309a; Howell DC, 1982, STAT METHODS PSYCHOL; HYVARINEN J, 1981, NEUROSCI LETT, V26, P239, DOI 10.1016/0304-3940(81)90139-7; KAAS JH, 1987, ANNU REV PSYCHOL, V38, P129, DOI 10.1146/annurev.ps.38.020187.001021; Kahn DM, 2002, P NATL ACAD SCI USA, V99, P11429, DOI 10.1073/pnas.162342799; Kauffman T, 2002, NEUROREPORT, V13, P571, DOI 10.1097/00001756-200204160-00007; Leon-Sarmiento FE, 2008, NEUROSCI LETT, V441, P332, DOI 10.1016/j.neulet.2008.06.016; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; Lewald J, 2007, NEUROPSYCHOLOGIA, V45, P1215, DOI 10.1016/j.neuropsychologia.2006.10.006; Lewis LB, 2010, J NEUROPHYSIOL, V104, P2995, DOI 10.1152/jn.00983.2009; Macmillan N. A., 1991, DETECTION THEORY USE; Merabet LB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003046; Munk H, 1881, UEBER FUNCTIONEN GRO; Norman JF, 2008, PERCEPTION, V37, P185, DOI 10.1068/p5679; Norman JF, 2006, PERCEPTION, V35, P1383, DOI 10.1068/p5504; Norman JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068577; Norman JF, 2012, EXP BRAIN RES, V222, P321, DOI 10.1007/s00221-012-3220-7; Norman JF, 2011, ATTEN PERCEPT PSYCHO, V73, P2323, DOI 10.3758/s13414-011-0160-4; Norman JF, 2011, ATTEN PERCEPT PSYCHO, V73, P908, DOI 10.3758/s13414-010-0053-y; Norman JF, 2004, PERCEPT PSYCHOPHYS, V66, P342, DOI 10.3758/BF03194883; REYNOLDS RI, 1989, B PSYCHONOMIC SOC, V27, P237, DOI 10.3758/BF03334594; Rombaux P, 2010, NEUROREPORT, V21, P1069, DOI 10.1097/WNR.0b013e32833fcb8a; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Sathian K, 1997, NEUROREPORT, V8, P3877, DOI 10.1097/00001756-199712220-00008; Sathian K, 2005, DEV PSYCHOBIOL, V46, P279, DOI 10.1002/dev.20056; Sathian K, 1997, PERCEPT PSYCHOPHYS, V59, P119, DOI 10.3758/BF03206854; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Stevens JC, 1996, J EXP PSYCHOL-APPL, V2, P91, DOI 10.1037/1076-898X.2.2.91; Tsao DY, 2003, NEURON, V39, P555, DOI 10.1016/S0896-6273(03)00459-8; Van Boven RW, 2000, NEUROLOGY, V54, P2230; VANBOVEN RW, 1994, NEUROLOGY, V44, P2361, DOI 10.1212/WNL.44.12.2361; VANESSEN DC, 1983, TRENDS NEUROSCI, V6, P370, DOI 10.1016/0166-2236(83)90167-4; Wan CY, 2010, NEUROPSYCHOLOGIA, V48, P344, DOI 10.1016/j.neuropsychologia.2009.08.016; Weisser V, 2005, EXP BRAIN RES, V166, P572, DOI 10.1007/s00221-005-2397-4; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wong M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025277; ZUBEK JP, 1964, SCIENCE, V144, P1591, DOI 10.1126/science.144.3626.1591	50	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112828	10.1371/journal.pone.0112828	http://dx.doi.org/10.1371/journal.pone.0112828			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397327	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500096
J	Gannon, J; Fernandez-Rodriguez, J; Alamri, H; Feng, SB; Kalantari, F; Negi, S; Wong, AHY; Mazur, A; Asp, L; Fazel, A; Salman, A; Lazaris, A; Metrakos, P; Bergeron, JJM; Nilsson, T				Gannon, Joan; Fernandez-Rodriguez, Julia; Alamri, Hussam; Feng, Shi Bo; Kalantari, Fariba; Negi, Sarita; Wong, Amy H. Y.; Mazur, Alexander; Asp, Lennart; Fazel, Ali; Salman, Ayat; Lazaris, Anthoula; Metrakos, Peter; Bergeron, John J. M.; Nilsson, Tommy			ARFGAP1 Is Dynamically Associated with Lipid Droplets in Hepatocytes	PLOS ONE			English	Article							ADP-RIBOSYLATION FACTOR; GTPASE-ACTIVATING PROTEIN; GOLGI-COMPLEX; COPI VESICLES; ENDOPLASMIC-RETICULUM; BINDING PROTEINS; COATED VESICLES; PHOSPHOLIPASE-D; BETA-COP; ARF	The ARF GTPase Activating Protein 1 (ARFGAP1) associates mainly with the cytosolic side of Golgi cisternal membranes where it participates in the formation of both COPI and clathrin-coated vesicles. In this study, we show that ARFGAP1 associates transiently with lipid droplets upon addition of oleate in cultured cells. Also, that addition of cyclic AMP shifts ARFGAP1 from lipid droplets to the Golgi apparatus and that overexpression and knockdown of ARFGAP1 affect lipid droplet formation. Examination of human liver tissue reveals that ARFGAP1 is found associated with lipid droplets at steady state in some but not all hepatocytes.	[Gannon, Joan; Alamri, Hussam; Feng, Shi Bo; Kalantari, Fariba; Negi, Sarita; Wong, Amy H. Y.; Mazur, Alexander; Fazel, Ali; Salman, Ayat; Lazaris, Anthoula; Metrakos, Peter; Bergeron, John J. M.; Nilsson, Tommy] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Res Inst, Montreal, PQ H3A 1A1, Canada; [Fernandez-Rodriguez, Julia] Univ Gothenburg, Ctr Cellular Imaging, Gothenburg, Sweden; [Asp, Lennart] Univ Gothenburg, Inst Biomed, Dept Med & Clin Genet, Gothenburg, Sweden	McGill University; Royal Victoria Hospital; University of Gothenburg; University of Gothenburg	Nilsson, T (corresponding author), McGill Univ, Royal Victoria Hosp, Ctr Hlth, Res Inst, 687 Pine Ave West, Montreal, PQ H3A 1A1, Canada.	tommy.nilsson@mcgill.ca	Bergeron, John/AAW-1893-2021; metrakos, peter/D-3726-2013	Fernandez-Rodriguez, Julia/0000-0003-4522-0966	Fonds de Recherche Quebec-Sante; Canadian Institute of Health Research [00287-003, MOP 5605]; Canadian Foundation for Innovation [5200, 11476]; Canada Research Chairs [950-212342]; Research Institute of the McGill University Health Centre; McGill University; McGill University Health Centre	Fonds de Recherche Quebec-Sante; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Canada Research Chairs(Canada Research ChairsCGIAR); Research Institute of the McGill University Health Centre; McGill University; McGill University Health Centre	This study was supported by Fonds de Recherche Quebec-Sante (www.frqs.gouv.qc.ca); Canadian Institute of Health Research (www.cihr-irsc.gc.ca), #00287-003 and MOP 5605; Canadian Foundation for Innovation (www.innovation.ca), #5200 and #11476; Canada Research Chairs (www.chairs-chaires.gc.ca), #950-212342; Research Institute of the McGill University Health Centre (www.muhc.ca/research); McGill University (www.mcgill.ca); McGill University Health Centre (www.muhc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonny B, 1997, J BIOL CHEM, V272, P30848, DOI 10.1074/jbc.272.49.30848; Aoe T, 1997, EMBO J, V16, P7305, DOI 10.1093/emboj/16.24.7305; Asp L, 2009, MOL BIOL CELL, V20, P780, DOI 10.1091/mbc.E08-03-0256; Bai M, 2011, NAT CELL BIOL, V13, P559, DOI 10.1038/ncb2221; BALCH WE, 1992, J BIOL CHEM, V267, P13053; Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; Boman AL, 2000, MOL BIOL CELL, V11, P1241, DOI 10.1091/mbc.11.4.1241; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; Chen JL, 2005, METHOD ENZYMOL, V404, P345, DOI 10.1016/S0076-6879(05)04030-9; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Diaz E, 1998, CELL, V93, P433, DOI 10.1016/S0092-8674(00)81171-X; DONALDSON JG, 1991, SCIENCE, V254, P1197, DOI 10.1126/science.1957170; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; Fernandez-Ulibarri I, 2007, MOL BIOL CELL, V18, P3250, DOI 10.1091/mbc.E07-04-0334; Frigerio G, 2007, TRAFFIC, V8, P1644, DOI 10.1111/j.1600-0854.2007.00631.x; Fullekrug J, 1999, MOL BIOL CELL, V10, P1939, DOI 10.1091/mbc.10.6.1939; GOCZE PM, 1994, ONCOLOGY, V51, P430; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Gubern A, 2009, J BIOL CHEM, V284, P5697, DOI 10.1074/jbc.M806173200; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; JUNGAS RL, 1966, P NATL ACAD SCI USA, V56, P757, DOI 10.1073/pnas.56.2.757; KAHN RA, 1992, J BIOL CHEM, V267, P13039; Kahn RA, 2009, FEBS LETT, V583, P3872, DOI 10.1016/j.febslet.2009.10.066; Lanoix J, 1999, EMBO J, V18, P4935, DOI 10.1093/emboj/18.18.4935; Lanoix J, 2001, J CELL BIOL, V155, P1199, DOI 10.1083/jcb.200108017; Lee SY, 2005, J CELL BIOL, V168, P281, DOI 10.1083/jcb.200404008; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; Liu W, 2005, J CELL BIOL, V168, P1053, DOI 10.1083/jcb.200410142; Malsam J, 1999, FEBS LETT, V462, P267, DOI 10.1016/S0014-5793(99)01543-4; Nakamura N, 2005, BIOCHEM BIOPH RES CO, V335, P117, DOI 10.1016/j.bbrc.2005.07.050; Nakamura N, 2004, BIOCHEM BIOPH RES CO, V322, P957, DOI 10.1016/j.bbrc.2004.08.010; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; Pepperkok R, 2000, J CELL SCI, V113, P135; SIMIONESCU N, 1976, J CELL BIOL, V70, P608, DOI 10.1083/jcb.70.3.608; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; Stafa K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002526; Takashima K, 2011, CELL STRUCT FUNCT, V36, P223, DOI 10.1247/csf.11035; Thiam AR, 2013, P NATL ACAD SCI USA, V110, P13244, DOI 10.1073/pnas.1307685110; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; WADA I, 1991, J BIOL CHEM, V266, P19599; Wilfling F, 2014, ELIFE, V3, DOI 10.7554/eLife.01607; Xiong YL, 2012, J NEUROSCI, V32, P3877, DOI 10.1523/JNEUROSCI.4566-11.2012	47	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e111309	10.1371/journal.pone.0111309	http://dx.doi.org/10.1371/journal.pone.0111309			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397679	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558500015
J	Helander, EE; Vuorinen, AL; Wansink, B; Korhonen, IKJ				Helander, Elina E.; Vuorinen, Anna-Leena; Wansink, Brian; Korhonen, Ilkka K. J.			Are Breaks in Daily Self-Weighing Associated with Weight Gain?	PLOS ONE			English	Article							MAINTENANCE	Regular self-weighing is linked to successful weight loss and maintenance. However, an individual's self-weighing frequency typically varies over time. This study examined temporal associations between time differences of consecutive weight measurements and the corresponding weight changes by analysing longitudinal self-weighing data, including 2,838 weight observations from 40 individuals attending a health-promoting programme. The relationship between temporal weighing frequency and corresponding weight change was studied primarily using a linear mixed effects model. Weight change between consecutive weight measurements was associated with the corresponding time difference (beta = 0.021% per day, p<0.001). Weight loss took place during periods of daily self-weighing, whereas breaks longer than one month posed a risk of weight gain. The findings emphasize that missing data in weight management studies with a weight-monitoring component may be associated with non-adherence to the weight loss programme and an early sign of weight gain.	[Helander, Elina E.; Korhonen, Ilkka K. J.] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Vuorinen, Anna-Leena; Korhonen, Ilkka K. J.] VTT Tech Res Ctr Finland, Tampere, Finland; [Wansink, Brian] Cornell Univ, Charles S Dyson Sch Appl Econ & Management, Ithaca, NY USA	Tampere University; VTT Technical Research Center Finland; Cornell University	Vuorinen, AL (corresponding author), VTT Tech Res Ctr Finland, Tampere, Finland.	anna-leena.vuorinen@vtt.fi	Korhonen, Ilkka KJ/G-4301-2014	Korhonen, Ilkka KJ/0000-0002-5322-8469; Vuorinen (previously Orsama), Anna-Leena/0000-0002-5658-1305; Helander, Elina/0000-0002-0076-0590	Tampere University of Technology; Strategic Centre for Science, Technology and Innovation in Health; Well-being (SalWe) Research Program for Mind and Body (Tekes - the Finnish Funding Agency for Technology and Innovation) [1104/10]; VTT Technical Research Centre of Finland	Tampere University of Technology; Strategic Centre for Science, Technology and Innovation in Health; Well-being (SalWe) Research Program for Mind and Body (Tekes - the Finnish Funding Agency for Technology and Innovation); VTT Technical Research Centre of Finland	The main source of funding for this research was Tampere University of Technology. The research was partly supported by the Strategic Centre for Science, Technology and Innovation in Health and Well-being (SalWe) Research Program for Mind and Body (Tekes - the Finnish Funding Agency for Technology and Innovation grant 1104/10) and VTT Technical Research Centre of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boutelle KN, 1999, HEALTH PSYCHOL, V18, P364, DOI 10.1037/0278-6133.18.4.364; Burke LE, 2011, J AM DIET ASSOC, V111, P92, DOI 10.1016/j.jada.2010.10.008; Burke LE, 2009, QUAL HEALTH RES, V19, P815, DOI 10.1177/1049732309335395; Butryn ML, 2007, OBESITY, V15, P3091, DOI 10.1038/oby.2007.368; Dionne MM, 2005, J NUTR EDUC BEHAV, V37, P315, DOI 10.1016/S1499-4046(06)60162-0; FUJIMOTO K, 1992, AM J MED SCI, V303, P145, DOI 10.1097/00000441-199203000-00002; Gokee-LaRose J, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-10; Hopsu L, 2010, BARENTS NEWSLETTER O, V13, P56; Linde JA, 2005, ANN BEHAV MED, V30, P210, DOI 10.1207/s15324796abm3003_5; Mattila E, 2013, JMIR MHEALTH UHEALTH, V1, DOI 10.2196/mhealth.2557; Mattila E, 2010, IEEE T INF TECHNOL B, V14, P456, DOI 10.1109/TITB.2009.2037751; National Institutes of Health, 2000, NIH PUBLICATION; Phelan S, 2003, AM J CLIN NUTR, V78, P1079, DOI 10.1093/ajcn/78.6.1079; VanWormer JJ, 2012, INT J BEHAV MED, V19, P351, DOI 10.1007/s12529-011-9178-1; VanWormer JJ, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-54; VanWormer JJ, 2009, AM J PREV MED, V36, P70, DOI 10.1016/j.amepre.2008.09.022; Welsh EM, 2009, J NUTR EDUC BEHAV, V41, P425, DOI 10.1016/j.jneb.2009.04.006; Wing RR, 2006, NEW ENGL J MED, V355, P1563, DOI 10.1056/NEJMoa061883; Wing RR, 2003, OBES RES, V11, P287, DOI 10.1038/oby.2003.43; Yanovski JA, 2000, NEW ENGL J MED, V342, P861, DOI 10.1056/NEJM200003233421206	21	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113164	10.1371/journal.pone.0113164	http://dx.doi.org/10.1371/journal.pone.0113164			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DF	25397613	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500139
J	Orton, S; Jones, LL; Cooper, S; Lewis, S; Coleman, T				Orton, Sophie; Jones, Laura L.; Cooper, Sue; Lewis, Sarah; Coleman, Tim			Predictors of Children's Secondhand Smoke Exposure at Home: A Systematic Review and Narrative Synthesis of the Evidence	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; SCHOOL-AGED CHILDREN; 3RD NATIONAL-HEALTH; PARENTAL SMOKING; 2ND-HAND SMOKE; URINARY COTININE; PASSIVE SMOKING; UNITED-STATES; SOCIOECONOMIC-STATUS; FREE LEGISLATION	Background: Children's exposure to secondhand smoke (SHS) has been causally linked to a number of childhood morbidities and mortalities. Over 50% of UK children whose parents are smokers are regularly exposed to SHS at home. No previous review has identified the factors associated with children's SHS exposure in the home. Aim: To identify by systematic review, the factors which are associated with children's SHS exposure in the home, determined by parent or child reports and/or biochemically validated measures including cotinine, carbon monoxide or home air particulate matter. Methods: Electronic searches of MEDLINE, EMBASE, PsychINFO, CINAHL and Web of Knowledge to July 2014, and hand searches of reference lists from publications included in the review were conducted. Findings: Forty one studies were included in the review. Parental smoking, low socioeconomic status and being less educated were all frequently and consistently found to be independently associated with children's SHS exposure in the home. Children whose parents held more negative attitudes towards SHS were less likely to be exposed. Associations were strongest for parental cigarette smoking status; compared to children of non-smokers, those whose mothers or both parents smoked were between two and 13 times more likely to be exposed to SHS. Conclusion: Multiple factors are associated with child SHS exposure in the home; the best way to reduce child SHS exposure in the home is for smoking parents to quit. If parents are unable or unwilling to stop smoking, they should instigate smoke-free homes. Interventions targeted towards the socially disadvantaged parents aiming to change attitudes to smoking in the presence of children and providing practical support to help parents smoke outside the home may be beneficial.	[Orton, Sophie; Cooper, Sue; Lewis, Sarah; Coleman, Tim] Univ Nottingham, UK Ctr Tobacco & Alcohol Studies, Nottingham NG7 2RD, England; [Orton, Sophie; Cooper, Sue; Coleman, Tim] Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England; [Jones, Laura L.] Univ Birmingham, UK Ctr Tobacco & Alcohol Studies, Birmingham, W Midlands, England; [Jones, Laura L.] Univ Birmingham, Sch Hlth & Populat Sci, Unit Publ Hlth Epidemiol & Biostat, Birmingham, W Midlands, England; [Lewis, Sarah] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham; University of Birmingham; University of Birmingham; University of Nottingham	Orton, S (corresponding author), Univ Nottingham, UK Ctr Tobacco & Alcohol Studies, Nottingham NG7 2RD, England.	Sophie.orton@nottingham.ac.uk	Jones, Laura/AAY-6159-2020; Cooper, Sue/A-7471-2011	Jones, Laura/0000-0002-4018-3855; Orton, Sophie/0000-0002-8577-216X; Coleman, Tim/0000-0002-7303-4805; Cooper, Sue/0000-0002-1994-6395	National Institute for Health Research's Programme Grants for Applied Research programme and School of Primary Care Research (NIHR SPCR); Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish; Medical Research Council [MR/K023195/1, MR/K023195/1B] Funding Source: researchfish; National Institute for Health Research [SPCR-041] Funding Source: researchfish	National Institute for Health Research's Programme Grants for Applied Research programme and School of Primary Care Research (NIHR SPCR); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This article presents independent research funded by the National Institute for Health Research's Programme Grants for Applied Research programme and School of Primary Care Research (NIHR SPCR). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidin EZ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-634; Adgate JL, 2004, ENVIRON HEALTH PERSP, V112, P1386, DOI 10.1289/ehp.7107; Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; Ajzen I, 2007, PREDICTION CHANGE HL, P3, DOI DOI 10.4324/9780203937082; Akhtar PC, 2009, TOB CONTROL, V18, P409, DOI 10.1136/tc.2009.030627; Akhtar PC, 2010, J EPIDEMIOL COMMUN H, V64, P341, DOI 10.1136/jech.2008.084178; Alwan N, 2010, HEALTH SOC CARE COMM, V18, P257, DOI 10.1111/j.1365-2524.2009.00890.x; Anuntaseree W, 2008, PREV MED, V47, P443, DOI 10.1016/j.ypmed.2008.06.006; Armitage CJ, 2000, PSYCHOL HEALTH, V15, P173, DOI 10.1080/08870440008400299; Baheiraei A., 2010, TANAFFOS - Journal of Respiratory Disease, Thoracic Surgery, Intensive Care and Tuberculosis, V9, P43; Bakoula CG, 1997, CANCER CAUSE CONTROL, V8, P73, DOI 10.1023/A:1018487222533; Baxi R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001746.pub3; Bettcher D. W., 2007, Morbidity and Mortality Weekly Report, V56, P497; Blackburn C, 2003, BRIT MED J, V327, P257, DOI 10.1136/bmj.327.7409.257; Blackwell D., 2010, VITAL HLTH STAT, V10, P1; Bleakley A, 2014, PREV MED, V62, P30, DOI 10.1016/j.ypmed.2013.12.015; Bolte G, 2009, EUR J PUBLIC HEALTH, V19, P52, DOI 10.1093/eurpub/ckn114; BURRI PH, 1984, ANNU REV PHYSIOL, V46, P617, DOI 10.1146/annurev.ph.46.030184.003153; Buscemi N, 2006, J CLIN EPIDEMIOL, V59, P697, DOI 10.1016/j.jclinepi.2005.11.010; Carlsen KH, 2008, PAEDIATR RESPIR REV, V9, P11, DOI 10.1016/j.prrv.2007.11.007; Chen XG, 2011, J PEDIATR HEALTH CAR, V25, P365, DOI 10.1016/j.pedhc.2010.04.014; COOK DG, 1994, BRIT MED J, V308, P384, DOI 10.1136/bmj.308.6925.384; Currie CE, 1997, HEALTH EDUC RES, V12, P385, DOI 10.1093/her/12.3.385; DAWSON DA, 1991, J MARRIAGE FAM, V53, P573, DOI 10.2307/352734; DELLORCO V, 1995, AM J EPIDEMIOL, V142, P419, DOI 10.1093/oxfordjournals.aje.a117650; Delpisheh A, 2006, PUBLIC HEALTH, V120, P65, DOI 10.1016/j.puhe.2005.05.003; Farrow A, 1997, ENVIRON TECHNOL, V18, P605, DOI 10.1080/09593331808616578; Fleming S, 2011, LANCET, V377, P1011, DOI 10.1016/S0140-6736(10)62226-X; FRIED PA, 1995, CLIN BIOCHEM, V28, P415, DOI 10.1016/0009-9120(94)00092-A; Gergen PJ, 1998, PEDIATRICS, V101, part. no., DOI 10.1542/peds.101.2.e8; Giskes K, 2005, J EPIDEMIOL COMMUN H, V59, P395, DOI 10.1136/jech.2004.025684; Glover M, 2012, NZ MED J, V126, P37; Gonzales M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-265; Haberg SE, 2007, AM J EPIDEMIOL, V166, P679, DOI 10.1093/aje/kwm134; Herzog R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-154; Hughes SC, 2008, ASIAN PAC J CANCER P, V9, P491; Irvine L, 1997, THORAX, V52, P766, DOI 10.1136/thx.52.9.766; Jarvis MJ, 2009, TOB CONTROL, V18, P491, DOI 10.1136/tc.2009.031328; Jarvis MJ, 2012, TOB CONTROL, V21, P18, DOI 10.1136/tc.2010.041608; JARVIS MJ, 1992, AM J PUBLIC HEALTH, V82, P1225, DOI 10.2105/AJPH.82.9.1225; Jarvis MJ, 2000, BRIT MED J, V321, P343, DOI 10.1136/bmj.321.7257.343; Johansson AK, 2004, PEDIATRICS, V113, pE291, DOI 10.1542/peds.113.4.e291; Jones LL, 2012, ARCH PEDIAT ADOL MED, V166, P18, DOI 10.1001/archpediatrics.2011.158; Jones LL, 2011, NICOTINE TOB RES, V13, P479, DOI 10.1093/ntr/ntr030; Jurado D, 2004, J EXPO ANAL ENV EPID, V14, P330, DOI 10.1038/sj.jea.7500329; Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165; Kwok M K, 2008, Tob Control, V17, P263, DOI 10.1136/tc.2007.023887; Leonardi-Bee J, 2006, AM J RESP CRIT CARE, V174, P514, DOI 10.1164/rccm.200603-331OC; Leong JW, 1998, PULM PHARMACOL THER, V11, P287, DOI 10.1006/pupt.1998.0153; Liao YM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-819; Lifestyle Statistics Health and Social Care Information Centre, 2013, STAT SMOK ENGL 2013; Lindstrom M, 2010, PUBLIC HEALTH, V124, P71, DOI 10.1016/j.puhe.2010.01.003; Longman JM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003128; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; MACKENBACH JP, 1988, HEALTH POLICY, V10, P207, DOI 10.1016/0168-8510(88)90006-1; Mannino DM, 2001, CHEST, V120, P718, DOI 10.1378/chest.120.3.718; Mantziou V, 2009, INT J ENV RES PUB HE, V6, P433, DOI 10.3390/ijerph6020433; Matt GE, 1999, TOB CONTROL, V8, P282, DOI 10.1136/tc.8.3.282; Matt GE, 2000, HEALTH PSYCHOL, V19, P232, DOI 10.1037//0278-6133.19.3.232; Matt GE, 2004, TOB CONTROL, V13, P29, DOI 10.1136/tc.2003.003889; Mills LM, 2012, NICOTINE TOB RES, V14, P1435, DOI 10.1093/ntr/nts074; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Montgomery LE, 1996, AM J PUBLIC HEALTH, V86, P1401, DOI 10.2105/AJPH.86.10.1401; Moore GF, 2011, NICOTINE TOB RES, V13, P903, DOI 10.1093/ntr/ntr093; Moya J, 2004, PEDIATRICS, V113, P996; Myung SK, 2009, J CLIN ONCOL, V27, P5565, DOI 10.1200/JCO.2008.21.6366; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Office of Population Censuses and Surveys, 1990, STAND OCC CLASS; Peltzer K, 2011, INT J ENV RES PUB HE, V8, P3553, DOI 10.3390/ijerph8093553; PIERCE JP, 1989, JAMA-J AM MED ASSOC, V261, P56, DOI 10.1001/jama.261.1.56; Pisinger C, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-65; Prady SL, 2012, MATERN CHILD HLTH J, V16, P1364, DOI 10.1007/s10995-011-0899-1; Preston A M, 2001, Nicotine Tob Res, V3, P61, DOI 10.1080/14622200110040638; Preston AM, 1997, PREV MED, V26, P1, DOI 10.1006/pmed.1996.9985; Rachiotis G, 2010, INT J ENV RES PUB HE, V7, P284, DOI 10.3390/ijerph7010284; Raisamo SU, 2013, SCANDINAVIAN J PUBLI; Raute LJ, 2012, INDIAN J CANCER, V49, P419, DOI 10.4103/0019-509X.107750; Ren YJ, 2012, J PEDIATR HEALTH CAR, V26, P174, DOI 10.1016/j.pedhc.2010.07.008; Rise J, 2005, ADDICT BEHAV, V30, P1267, DOI 10.1016/j.addbeh.2004.12.008; ROSS CE, 1995, AM SOCIOL REV, V60, P719, DOI 10.2307/2096319; Royal College of Physicians, 2010, PASS SMOK CHILDR REP; Rudatsikira E, 2007, INDIAN J PEDIATR, V74, P1089, DOI 10.1007/s12098-007-0203-y; Scherer G, 2004, J EXPO ANAL ENV EPID, V14, P284, DOI 10.1038/sj.jea.7500323; Schmeer KK, 2011, J MARRIAGE FAM, V73, P181, DOI 10.1111/j.1741-3737.2010.00797.x; SILVERS A, 1994, RISK ANAL, V14, P931, DOI 10.1111/j.1539-6924.1994.tb00062.x; Sims M, 2010, ADDICTION, V105, P543, DOI 10.1111/j.1360-0443.2009.02805.x; Singh GK, 2010, PEDIATRICS, V126, P4, DOI 10.1542/peds.2009-2744; Soliman S, 2004, AM J PUBLIC HEALTH, V94, P314, DOI 10.2105/AJPH.94.2.314; Ulbricht S, 2014, EUR J PEDIAT; US Surgeon General, 2006, HLTH CONS INV EXP TO; Wakefield M, 2000, AM J PREV MED, V19, P188, DOI 10.1016/S0749-3797(00)00197-5; Whitrow MJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-262; WHO Framework Convention on Tobacco Control, 2012, GLOB PROGR REP IMPL; Winkelstein ML, 1997, ANN ALLERG ASTHMA IM, V78, P419, DOI 10.1016/S1081-1206(10)63206-1; Yi O, 2012, NICOTINE TOB RES, V14, P607, DOI 10.1093/ntr/ntr259	95	93	93	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112690	10.1371/journal.pone.0112690	http://dx.doi.org/10.1371/journal.pone.0112690			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DF	25397875	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500078
J	Stinton, LM; Bentow, C; Mahler, M; Norman, GL; Eksteen, B; Mason, AL; Kaplan, GG; Lindkvist, B; Hirschfield, GM; Milkiewicz, P; Cheung, A; Janssen, HLA; Fritzler, MJ				Stinton, Laura M.; Bentow, Chelsea; Mahler, Michael; Norman, Gary L.; Eksteen, Bertus; Mason, Andrew L.; Kaplan, Gilaad G.; Lindkvist, Bjorn; Hirschfield, Gideon M.; Milkiewicz, Piotr; Cheung, Angela; Janssen, Harry L. A.; Fritzler, Marvin J.			PR3-ANCA: A Promising Biomarker in Primary Sclerosing Cholangitis (PSC)	PLOS ONE			English	Article							ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; INTERNATIONAL CONSENSUS STATEMENT; INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; AUTOIMMUNE HEPATITIS; LIVER-DISEASE; TREATED VASCULITIS; TARGET ANTIGENS; MPO-ANCA; AUTOANTIBODIES	Background and Aims: The only recognized biomarker for primary sclerosing cholangitis (PSC) is atypical anti-neutrophil cytoplasmic antibodies (aANCA), which, in addition to having low sensitivity and specificity, is an indirect immunofluorescence (IIF) test lacking the advantages of high throughput and objectivity. Recent reports have shown that antibodies to proteinase-3 (PR3-ANCA) might add diagnostic value in inflammatory bowel disease (IBD), specifically in ulcerative colitis (UC). As PSC is associated with IBD, the objective of this study was to evaluate the frequency and clinical significance of PR3-ANCA in a large cohort of patients. Methods: A total of 244 PSC and 254 control [autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC), hepatitis C viral infection (HCV), hepatitis B viral infection (HBV), and healthy controls] sera and their clinical correlations were retrospectively analyzed for PR3-ANCA determined by ELISA and a new chemiluminescence immunoassay (CIA). Testing was also performed for aANCA by IIF. Results: When measured by CIA, PR3-ANCA was detected in 38.5% (94/244) of PSC patients compared to 10.6% (27/254) controls (p<0.0001). By ELISA, PR3-ANCA was detected in 23.4% (57/244) of PSC patients compared to 2.7% (6/254) controls (p<0.0001). PR3-ANCA in PSC patients was not associated with the presence or type of underlying IBD, and, in fact, it was more frequent in Crohn's disease (CD) patients with PSC than previously reported in CD alone. PR3-ANCA in PSC measured by CIA correlated with higher liver enzymes. Conclusion: PR3-ANCA is detected in a significant proportion of PSC patients compared to other liver diseases including PBC and AIH. PR3-ANCA is associated with higher liver enzyme levels in PSC, and is not solely related to underlying IBD.	[Stinton, Laura M.; Eksteen, Bertus; Kaplan, Gilaad G.; Fritzler, Marvin J.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Bentow, Chelsea; Mahler, Michael; Norman, Gary L.] Inova Diagnost Inc, San Diego, CA USA; [Mason, Andrew L.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Lindkvist, Bjorn] Univ Gothenburg, Inst Med, Sahlgrenska Acad, Gothenburg, Sweden; [Hirschfield, Gideon M.] Univ Birmingham, Liver Res Ctr, NIHR Biomed Res Unit, Birmingham, W Midlands, England; [Milkiewicz, Piotr] Med Univ Warsaw, Dept Gen Transplant & Liver Surg, Warsaw, Poland; [Cheung, Angela; Janssen, Harry L. A.] Univ Hlth Network, Div Gastroenterol, Toronto Western Hosp, Toronto, ON, Canada; [Milkiewicz, Piotr] Pomeranian Med Univ, Liver Res Labs, Szczecin, Poland	University of Calgary; Inova Diagnostics, Inc.; University of Alberta; University of Gothenburg; University of Birmingham; Medical University of Warsaw; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Pomeranian Medical University	Stinton, LM (corresponding author), Univ Calgary, Dept Med, Calgary, AB, Canada.	laura.stinton@ucalgary.ca	Kaplan, Gil/AAH-2335-2021; Hirschfield, Gideon M/M-2143-2015; Mason, Andrew/D-2938-2013	Kaplan, Gil/0000-0003-2719-0556; Hirschfield, Gideon M/0000-0002-6736-2255; Milkiewicz, Piotr/0000-0002-1817-0724; Lindkvist, Bjorn/0000-0001-7485-0006; Mason, Andrew/0000-0002-0470-9522	Clinical Research Award from the American College of Gastroenterology; Alberta Heritage Foundation for Medical Research (AHFMR); medical research council of Vastra Gotaland in Sweden [ALF-22101]; Rolf Olsson memorial scholarship fund; National Science Centre in Poland [2011/01/B/NZ5/04216]; Inova Diagnostics Inc.	Clinical Research Award from the American College of Gastroenterology; Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); medical research council of Vastra Gotaland in Sweden; Rolf Olsson memorial scholarship fund; National Science Centre in Poland(National Science Centre, Poland); Inova Diagnostics Inc.	L. Stinton received funding from the 2013 Clinical Research Award from the American College of Gastroenterology. Part of it was used for this project. A. Mason is supported by Alberta Heritage Foundation for Medical Research (AHFMR) as a Senior Scholar. B. Lindkvist is supported by the medical research council of Vastra Gotaland in Sweden (ALF-22101) and the Rolf Olsson memorial scholarship fund. G. Hirschfield is supported as a co-investigator by the Medical Research Council as part of a stratified medicine team grant; www.ukpbc.com. P. Milkiewicz is supported by the grant no. 2011/01/B/NZ5/04216 from National Science Centre in Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. M. Mahler, C. Bentow and G. Norman are employees of Inova Diagnostics Inc. (San Diego). Inova Diagnostics Inc. provided support in the form of salaries for authors MM, CB and GLN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Angulo P, 2000, J HEPATOL, V32, P182, DOI 10.1016/S0168-8278(00)80061-6; Bambha K, 2003, GASTROENTEROLOGY, V125, P1364, DOI 10.1016/j.gastro.2003.07.011; Czaja AJ, 2002, HEPATOLOGY, V36, P479, DOI 10.1053/jhep.2002.34944; Czaja AJ, 2003, J CLIN GASTROENTEROL, V37, P315, DOI 10.1097/00004836-200310000-00011; Czaja AJ, 2009, CURR OPIN GASTROEN, V25, P215, DOI 10.1097/MOG.0b013e328324ed06; Deniziaut G, 2013, CLIN RES HEPATOL GAS, V37, P105, DOI 10.1016/j.clinre.2012.07.008; DUERR RH, 1991, GASTROENTEROLOGY, V100, P1385; Fabbri C, 2003, WORLD J GASTROENTERO, V9, P1487, DOI 10.3748/wjg.v9.i7.1487; Fritzler Marvin J, 2009, Expert Opin Med Diagn, V3, P81, DOI 10.1517/17530050802651561; Fulcher DA, 2000, J GASTROEN HEPATOL, V15, P344, DOI 10.1046/j.1440-1746.2000.02173.x; Hirschfield GM, 2013, LANCET, V382, P1587, DOI 10.1016/S0140-6736(13)60096-3; Holle JU, 2010, ANN RHEUM DIS, V69, P468, DOI 10.1136/ard.2009.109868; Joossens S, 2004, CLIN CHEM, V50, P1422, DOI 10.1373/clinchem.2004.032318; Long S. Alice, 2002, Autoimmunity Reviews, V1, P37, DOI 10.1016/S1568-9972(01)00020-9; Mahler M, 2012, CLIN CHIM ACTA, V413, P719, DOI 10.1016/j.cca.2012.01.004; Mahler M, 2013, CLIN CHIM ACTA, V424, P267, DOI 10.1016/j.cca.2013.06.005; Ooi C. J., 2000, Annals Academy of Medicine Singapore, V29, P704; Pollock W, 2002, J CLIN PATHOL, V55, P680, DOI 10.1136/jcp.55.9.680; Pollock W, 2009, J IMMUNOL METHODS, V347, P19, DOI 10.1016/j.jim.2009.05.008; Roozendaal C, 2000, J HEPATOL, V32, P734, DOI 10.1016/S0168-8278(00)80241-X; Roozendaal C, 1998, AM J MED, V105, P393, DOI 10.1016/S0002-9343(98)00294-0; Savige J, 2003, AM J CLIN PATHOL, V120, P312, DOI 10.1309/WAEPADW0K4LPUHFN; Savige J, 1999, AM J CLIN PATHOL, V111, P507; SAVIGE JA, 1994, PATHOLOGY, V26, P186, DOI 10.1080/00313029400169451; Sobajima J, 1999, GUT, V44, P867, DOI 10.1136/gut.44.6.867; Talor MV, 2007, CLIN EXP IMMUNOL, V150, P42, DOI 10.1111/j.1365-2249.2007.03453.x; Teegen B, 2009, ANN NY ACAD SCI, V1173, P161, DOI 10.1111/j.1749-6632.2009.04752.x; Arias-Loste MT, 2013, CLIN REV ALLERG IMMU, V45, P109, DOI 10.1007/s12016-012-8349-4; Terjung B, 2001, BEST PRACT RES CL GA, V15, P629, DOI 10.1053/bega.2001.0209; Terjung B, 2000, GASTROENTEROLOGY, V119, P310, DOI 10.1053/gast.2000.9366; Terjung B, 2010, GUT, V59, P808, DOI 10.1136/gut.2008.157818; Trevisin M, 2004, J CLIN PATHOL, V57, P303, DOI 10.1136/jcp.2003.009332; Trevisin M, 2008, J IMMUNOL METHODS, V336, P104, DOI 10.1016/j.jim.2008.03.012; Trevisin M, 2008, AM J CLIN PATHOL, V129, P42, DOI 10.1309/F6L4C48RHFMT4AAU; Valentina D, 2009, LIVER INT, V29, P865, DOI 10.1111/j.1478-3231.2009.01989.x; Vidali M, 2003, HEPATOLOGY, V37, P410, DOI 10.1053/jhep.2003.50049; WIESNER RH, 1989, HEPATOLOGY, V10, P430, DOI 10.1002/hep.1840100406	37	45	50	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112877	10.1371/journal.pone.0112877	http://dx.doi.org/10.1371/journal.pone.0112877			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397578	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558500104
J	Yu, YY; Yip, KH; Tam, IYS; Sam, SW; Ng, CW; Zhang, W; Lau, HYA				Yu, Yangyang; Yip, Kwok Ho; Tam, Issan Yee San; Sam, Sze Wing; Ng, Chun Wai; Zhang, Wei; Lau, Hang Yung Alaster			Differential Effects of the Toll-Like Receptor 2 Agonists, PGN and Pam3CSK4 on Anti-IgE Induced Human Mast Cell Activation	PLOS ONE			English	Article							EXPRESSION; TLR2; FC-EPSILON-R1; PATHWAYS	Mast cells are pivotal in the pathogenesis of allergy and inflammation. In addition to the classical IgE-dependent mechanism involving crosslinking of the high-affinity receptor for IgE (Fc epsilon RI), mast cells are also activated by Toll-like receptors (TLRs) which are at the center of innate immunity. In this study, we demonstrated that the response of LAD2 cells (a human mast cell line) to anti-IgE was altered in the presence of the TLR2 agonists peptidoglycan (PGN) and tripalmitoyl-S-glycero-Cys(Lys) 4 (Pam3CSK4). Pretreatment of PGN and Pam3CSK4 inhibited anti-IgE induced calcium mobilization and degranulation without down-regulation of FceRI expression. Pam3CSK4 but not PGN acted in synergy with anti-IgE for IL-8 release when the TLR2 agonist was added simultaneously with anti-IgE. Studies with inhibitors of key enzymes implicated in mast cell signaling revealed that the synergistic release of IL-8 induced by Pam3CSK4 and anti-IgE involved ERK and calcineurin signaling cascades. The differential modulations of anti-IgE induced mast cell activation by PGN and Pam3CSK4 suggest that dimerization of TLR2 with TLR1 or TLR6 produced different modulating actions on Fc epsilon RI mediated human mast cell activation.	[Yu, Yangyang; Zhang, Wei] Hong Kong Univ Sci & Technol, Med Ctr, Shenzhen Key Lab Translat Med Dermatol, Biomed Res Inst,Shenzhen Peking Univ, Shenzhen, Guangdong, Peoples R China; [Yu, Yangyang; Yip, Kwok Ho; Tam, Issan Yee San; Sam, Sze Wing; Ng, Chun Wai; Lau, Hang Yung Alaster] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Chinese University of Hong Kong	Zhang, W (corresponding author), Hong Kong Univ Sci & Technol, Med Ctr, Shenzhen Key Lab Translat Med Dermatol, Biomed Res Inst,Shenzhen Peking Univ, Shenzhen, Guangdong, Peoples R China.	zhangweispace@yeah.net	Lau, HYA/M-9405-2019	Lau, HYA/0000-0002-6065-7034; Ng, Chun Wai/0000-0003-1291-4937; Tam, Issan/0000-0003-2152-8632	Research Grants of Faculty of Medicine, The Chinese University of Hong Kong; National Natural Science Foundation of China [81271755, 81371737]; Shenzhen Science and Technology Project [KQCX20120803145850990, JCYJ20130329110752139]	Research Grants of Faculty of Medicine, The Chinese University of Hong Kong; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Science and Technology Project	The study was supported by the Research Grants of Faculty of Medicine, The Chinese University of Hong Kong, National Natural Science Foundation of China (81271755, 81371737), and Shenzhen Science and Technology Project (KQCX20120803145850990, JCYJ20130329110752139). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel J, 2011, J INNATE IMMUN, V3, P495, DOI 10.1159/000327714; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Askarian F, 2014, J INNATE IMMUN, V6, P485, DOI 10.1159/000357618; Eder W, 2004, J ALLERGY CLIN IMMUN, V113, P482, DOI 10.1016/j.jaci.2003.12.374; Fuchs B, 2010, INT ARCH ALLERGY IMM, V152, P131, DOI 10.1159/000265534; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; Ishii KJ, 2005, J CLIN IMMUNOL, V25, P511, DOI 10.1007/s10875-005-7829-1; Kasakura K, 2009, INT ARCH ALLERGY IMM, V150, P359, DOI 10.1159/000226237; Kawahara T, 2010, ANIM SCI J, V81, P714, DOI 10.1111/j.1740-0929.2010.00788.x; Lauener RP, 2002, LANCET, V360, P465, DOI 10.1016/S0140-6736(02)09641-1; Lin HY, 2010, INT IMMUNOPHARMACOL, V10, P883, DOI 10.1016/j.intimp.2010.04.026; Martin RJ, 2006, CLIN CHEST MED, V27, P87, DOI 10.1016/j.ccm.2005.10.004; McCall-Culbreath KD, 2011, J INNATE IMMUN, V3, P459, DOI 10.1159/000324832; Qiao HH, 2006, BLOOD, V107, P610, DOI 10.1182/blood-2005-06-2271; Saluja R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043547; Sandig H, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00185; Saturnino SF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-240; Shin SY, 2011, J CELL SCI, V124, P82, DOI 10.1242/jcs.076034; Sumbayev VV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034259; Takenaka H, 2010, BIOCHEM BIOPH RES CO, V391, P471, DOI 10.1016/j.bbrc.2009.11.082; Taylor RC, 2006, J ALLERGY CLIN IMMUN, V117, P1148, DOI 10.1016/j.jaci.2006.02.014; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Yoshioka M, 2007, J ALLERGY CLIN IMMUN, V120, P452, DOI 10.1016/j.jaci.2007.03.027; Yu YY, 2013, EUR J INFLAMM, V11, P709, DOI 10.1177/1721727X1301100314; Zhang M, 2007, IMMUNOL RES, V37, P1, DOI 10.1007/BF02686092	27	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112989	10.1371/journal.pone.0112989	http://dx.doi.org/10.1371/journal.pone.0112989			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398056	gold, Green Submitted, Green Published			2022-12-27	WOS:000345558500121
J	Borne, Y; Fagerberg, B; Persson, M; Sallsten, G; Forsgard, N; Hedblad, B; Barregard, L; Engstrom, G				Borne, Yan; Fagerberg, Bjorn; Persson, Margaretha; Sallsten, Gerd; Forsgard, Niklas; Hedblad, Bo; Barregard, Lars; Engstrom, Gunnar			Cadmium Exposure and Incidence of Diabetes Mellitus - Results from the Malmo Diet and Cancer Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; BONE-MINERAL DENSITY; ENVIRONMENTAL EXPOSURE; CARDIOVASCULAR-DISEASE; PROSPECTIVE COHORT; URINARY CADMIUM; CARBON-MONOXIDE; BREAST-CANCER; POPULATION; RISK	Background: Cadmium is a pollutant with multiple adverse health effects: renal dysfunction, osteoporosis and fractures, cancer, and probably cardiovascular disease. Some studies have reported associations between cadmium and impaired fasting glucose and diabetes. However, this relationship is controversial and there is a lack of longitudinal studies. Objectives: To examine prospectively whether cadmium in blood is associated with incidence of diabetes mellitus. Methods: The study population consists of 4585 subjects without history of diabetes (aged 46 to 67 years, 60% women), who participated in the Malmo Diet and Cancer study during 1991-1994. Blood cadmium levels were estimated from hematocrit and cadmium concentrations in erythrocytes. Incident cases of diabetes were identified from national and local diabetes registers. Results: Cadmium concentrations in blood were not associated with blood glucose and insulin levels at the baseline examination. However, cadmium was positively associated with HbA1c in former smokers and current smokers. During a mean follow-up of 15.2 +/- 4.2 years, 622 (299 men and 323 women) were diagnosed with new-onset of diabetes. The incidence of diabetes was not significantly associated with blood cadmium level at baseline, neither in men or women. The hazard ratio (4th vs 1st quartile) was 1.11 (95% confidence interval 0.82-1.49), when adjusted for potential confounders. Conclusions: Elevated blood cadmium levels are not associated with increased incidence of diabetes. The positive association between HbA1c and blood cadmium levels has a likely explanation in mechanisms related to erythrocyte turnover and smoking.	[Borne, Yan; Persson, Margaretha; Hedblad, Bo; Engstrom, Gunnar] Lund Univ, Skane Univ Hosp, Dept Clin Sci Malmo, Malmo, Sweden; [Fagerberg, Bjorn] Sahlgrens Univ Hosp, Wallenberg Lab, Sahlgrenska Ctr Cardiovasc & Metab Res, Gothenburg, Sweden; [Fagerberg, Bjorn] Univ Gothenburg, Dept Mol & Clin Med, Gothenburg, Sweden; [Persson, Margaretha] Skane Univ Hosp, Emergency Dept, Clin Res Unit, Malmo, Sweden; [Sallsten, Gerd; Barregard, Lars] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Sallsten, Gerd; Barregard, Lars] Univ Gothenburg, Gothenburg, Sweden; [Forsgard, Niklas] Sahlgrens Univ Hosp, Dept Clin Chem, Gothenburg, Sweden	Lund University; Skane University Hospital; Sahlgrenska University Hospital; University of Gothenburg; Lund University; Skane University Hospital; Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital	Borne, Y (corresponding author), Lund Univ, Skane Univ Hosp, Dept Clin Sci Malmo, Malmo, Sweden.	yan.borne@med.lu.se	b, y/AAG-3349-2019	Engstrom, Gunnar/0000-0002-8618-9152; Persson, Margaretha/0000-0001-8188-5792	Swedish Research Council [2011-3891]; Swedish Heart-Lung Foundation [20130249, 20120364]; Swedish Council for Working Life and Social Research (FAS); Region Vastra Gotaland; Sahlgrenska University Hospital; Region Skane; Lund University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Council for Working Life and Social Research (FAS)(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Region Vastra Gotaland; Sahlgrenska University Hospital; Region Skane; Lund University	This study was supported by the Swedish Research Council (2011-3891), the Swedish Heart-Lung Foundation (20130249; 20120364); Swedish Council for Working Life and Social Research (FAS), and the regional agreement on medical training and clinical research (ALF) between Region Vastra Gotaland and Sahlgrenska University Hospital and ALF between Region Skane and Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson A, 2014, ENVIRON HEALTH PERSP, V122, P431, DOI 10.1289/ehp.1307110; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Barregard L, 2013, ENVIRON RES, V121, P104, DOI 10.1016/j.envres.2012.11.005; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; BEUTLER E, 1975, BLOOD, V46, P253; Borne Y, 2011, EUR J HEART FAIL, V13, P1355, DOI 10.1093/eurjhf/hfr127; Cho YA, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075087, 10.1371/journal.pone.0081560]; Edwards JR, 2009, TOXICOL APPL PHARM, V238, P289, DOI 10.1016/j.taap.2009.03.007; Engstrom A, 2012, BONE, V50, P1372, DOI 10.1016/j.bone.2012.03.018; Engstrom A, 2011, J BONE MINER RES, V26, P486, DOI 10.1002/jbmr.224; Enhorning S, 2010, CIRCULATION, V121, P2102, DOI 10.1161/CIRCULATIONAHA.109.909663; Fagerberg B, 2012, J INTERN MED, V272, P601, DOI 10.1111/j.1365-2796.2012.02578.x; Furne JK, 2003, J LAB CLIN MED, V142, P52, DOI 10.1016/S0022-2143(03)00086-6; Hedblad B, 2000, DIABETIC MED, V17, P299, DOI 10.1046/j.1464-5491.2000.00280.x; International Agency for Research on Cancer, 2012, IARC MON EV CAR RI C; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Julin B, 2012, BRIT J CANCER, V107, P895, DOI 10.1038/bjc.2012.311; Julin B, 2012, CANCER RES, V72, P1459, DOI 10.1158/0008-5472.CAN-11-0735; KJELLSTROM T, 1978, ENVIRON RES, V16, P248, DOI 10.1016/0013-9351(78)90160-3; Maahs DM, 2010, ENDOCRIN METAB CLIN, V39, P481, DOI 10.1016/j.ecl.2010.05.011; Manjer J, 2001, EUR J CANCER PREV, V10, P489, DOI 10.1097/00008469-200112000-00003; Melander O, 2012, JAMA-J AM MED ASSOC, V308, P1469, DOI 10.1001/jama.2012.12998; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; MODAN M, 1988, DIABETES CARE, V11, P422, DOI 10.2337/diacare.11.5.422; Moon SS, 2013, DIABETIC MED, V30, pe143, DOI 10.1111/dme.12103; Navas-Acien A, 2009, AM J EPIDEMIOL, V170, P1156, DOI 10.1093/aje/kwp248; Nordberg GF, 2007, HANDBOOK ON THE TOXICOLOGY OF METALS, 3RD EDITION, P445, DOI 10.1016/B978-012369413-3/50078-1; PANZER S, 1982, BLOOD, V59, P1348; Schwartz GG, 2003, DIABETES CARE, V26, P468, DOI 10.2337/diacare.26.2.468; Staessen JA, 1999, LANCET, V353, P1140, DOI 10.1016/S0140-6736(98)09356-8; Swaddiwudhipong W, 2012, ENVIRON RES, V112, P194, DOI 10.1016/j.envres.2011.10.004; Swaddiwudhipong W, 2010, ENVIRON RES, V110, P612, DOI 10.1016/j.envres.2010.06.002; Swaddiwudhipong Witaya, 2010, Journal of the Medical Association of Thailand, V93, P231; Tellez-Plaza M, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0356-2; Tellez-Plaza M, 2012, ENVIRON HEALTH PERSP, V120, P1017, DOI 10.1289/ehp.1104352; The Swedish Chemical Agency, 2011, 111 SWED CHEM AG; WHO (World Health Organization), 2011, 73 WHO JOINT FAOWHO	37	40	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112277	10.1371/journal.pone.0112277	http://dx.doi.org/10.1371/journal.pone.0112277			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393737	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300045
J	Flamme, I; Oehme, F; Ellinghaus, P; Jeske, M; Keldenich, J; Thuss, U				Flamme, Ingo; Oehme, Felix; Ellinghaus, Peter; Jeske, Mario; Keldenich, Joerg; Thuss, Uwe			Mimicking Hypoxia to Treat Anemia: HIF-Stabilizer BAY 85-3934 (Molidustat) Stimulates Erythropoietin Production without Hypertensive Effects	PLOS ONE			English	Article							INDUCIBLE FACTOR ACTIVATION; CHRONIC KIDNEY-DISEASE; PROLYL HYDROXYLASE; GENE-EXPRESSION; CHUVASH POLYCYTHEMIA; DOMAIN PROTEINS; GROWTH-FACTOR; IN-VIVO; 4-HYDROXYLASE; INHIBITION	Oxygen sensing by hypoxia-inducible factor prolyl hydroxylases (HIF-PHs) is the dominant regulatory mechanism of erythropoietin (EPO) expression. In chronic kidney disease (CKD), impaired EPO expression causes anemia, which can be treated by supplementation with recombinant human EPO (rhEPO). However, treatment can result in rhEPO levels greatly exceeding the normal physiological range for endogenous EPO, and there is evidence that this contributes to hypertension in patients with CKD. Mimicking hypoxia by inhibiting HIF-PHs, thereby stabilizing HIF, is a novel treatment concept for restoring endogenous EPO production. HIF stabilization by oral administration of the HIF-PH inhibitor BAY 85-3934 (molidustat) resulted in dose-dependent production of EPO in healthy Wistar rats and cynomolgus monkeys. In repeat oral dosing of BAY 85-3934, hemoglobin levels were increased compared with animals that received vehicle, while endogenous EPO remained within the normal physiological range. BAY 85-3934 therapy was also effective in the treatment of renal anemia in rats with impaired kidney function and, unlike treatment with rhEPO, resulted in normalization of hypertensive blood pressure in a rat model of CKD. Notably, unlike treatment with the antihypertensive enalapril, the blood pressure normalization was achieved without a compensatory activation of the renin-angiotensin system. Thus, BAY 85-3934 may provide an approach to the treatment of anemia in patients with CKD, without the increased risk of adverse cardiovascular effects seen for patients treated with rhEPO. Clinical studies are ongoing to investigate the effects of BAY 85-3934 therapy in patients with renal anemia.	[Flamme, Ingo] Bayer Pharma AG, Global Drug Discovery, Acute Care Res, Cardiol Hematol, Wuppertal, Germany; [Oehme, Felix] Bayer Pharma AG, Global Biol, Biotech Dev, Wuppertal, Germany; [Ellinghaus, Peter] Bayer Pharma AG, Global Biomarkers, Clin Sci, Wuppertal, Germany; [Jeske, Mario] Bayer Pharma AG, Global Chem Prod Dev, Wuppertal, Germany; [Keldenich, Joerg; Thuss, Uwe] Bayer Pharma AG, Global Early Dev, Drug Metab & Pharmacokinet, Wuppertal, Germany	Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals	Flamme, I (corresponding author), Bayer Pharma AG, Global Drug Discovery, Acute Care Res, Cardiol Hematol, Wuppertal, Germany.	ingo.flamme@bayer.com			Bayer Pharma AG	Bayer Pharma AG	This study was funded by Bayer Pharma AG. All the authors are employees of Bayer Pharma AG. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	ABBRECHT PH, 1972, J APPL PHYSIOL, V32, P54, DOI 10.1152/jappl.1972.32.1.54; Arsenault PR, 2013, J BIOL CHEM, V288, P33571, DOI 10.1074/jbc.M113.482364; Asikainen TM, 2005, FREE RADICAL BIO MED, V38, P1002, DOI 10.1016/j.freeradbiomed.2004.12.004; Bao WK, 2010, J CARDIOVASC PHARM, V56, P147, DOI 10.1097/FJC.0b013e3181e2bfef; Bernhardt WM, 2010, J AM SOC NEPHROL, V21, P2151, DOI 10.1681/ASN.2010010116; Boettcher M.-F., 2013, J AM SOC NEPHROL, V24, p347A; Briet M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000128; Brookhart MA, 2008, J AM SOC NEPHROL, V19, P1389, DOI 10.1681/ASN.2007111181; Brookhart MA, 2011, AM J EPIDEMIOL, V173, P768, DOI 10.1093/aje/kwq423; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Deng AH, 2010, AM J PHYSIOL-RENAL, V299, pF1365, DOI 10.1152/ajprenal.00153.2010; Denny WA, 2012, J MED CHEM, V55, P2943, DOI 10.1021/jm300314a; Dunn A, 2007, AM J MED SCI, V334, P65, DOI 10.1097/MAJ.0b013e318095a4ae; ECKARDT KU, 1989, AM J PHYSIOL, V256, pF942, DOI 10.1152/ajprenal.1989.256.5.F942; Ellinghaus P, 2005, J THORAC CARDIOV SUR, V129, P1383, DOI 10.1016/j.jtcvs.2004.08.031; Elliott J, 2009, ADV CHRONIC KIDNEY D, V16, P94, DOI 10.1053/j.ackd.2008.12.004; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fandrey J, 2004, AM J PHYSIOL-REG I, V286, pR977, DOI 10.1152/ajpregu.00577.2003; Formenti F, 2010, P NATL ACAD SCI USA, V107, P12722, DOI 10.1073/pnas.1002339107; Ganz T, 2011, ANNU REV MED, V62, P347, DOI 10.1146/annurev-med-050109-142444; Gordeuk VR, 2004, BLOOD, V103, P3924, DOI 10.1182/blood-2003-07-2535; Grabe DW, 2007, AM J HEALTH-SYST PH, V64, pS8, DOI 10.2146/ajhp070182; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Hickey MM, 2007, J CLIN INVEST, V117, P3879, DOI 10.1172/JCI32614; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Jewell UR, 2001, FASEB J, V15, P1312, DOI 10.1096/fj.00-0732fje; Johnson DW, 2007, NEPHROLOGY, V12, P321, DOI 10.1111/j.1440-1797.2007.00810.x; KATO A, 1994, RENAL FAILURE, V16, P645, DOI 10.3109/08860229409044892; Koulouridis I, 2013, AM J KIDNEY DIS, V61, P44, DOI 10.1053/j.ajkd.2012.07.014; Kramer BK, 1997, KIDNEY INT, V51, P444, DOI 10.1038/ki.1997.59; Krapf R, 2009, CLIN J AM SOC NEPHRO, V4, P470, DOI 10.2215/CJN.05040908; Kurt B, 2013, J AM SOC NEPHROL, V24, P433, DOI 10.1681/ASN.2012080791; Laitala A, 2012, BLOOD, V120, P3336, DOI 10.1182/blood-2012-07-441824; Lee FS, 2011, ANNU REV PATHOL-MECH, V6, P165, DOI 10.1146/annurev-pathol-011110-130321; Macdougall IC, 2013, J AM SOC NEPHROL, V24, p413A; MASCHIO G, 1995, NEPHROL DIAL TRANSPL, V10, P74, DOI 10.1093/ndt/10.supp2.74; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Minamishima YA, 2010, SCIENCE, V329, P407, DOI 10.1126/science.1192811; Muchnik E, 2011, EXPERT OPIN INV DRUG, V20, P645, DOI 10.1517/13543784.2011.566861; NAGANO N, 1990, J PHARM PHARMACOL, V42, P758, DOI 10.1111/j.2042-7158.1990.tb07016.x; Nangaku M, 2006, SEMIN NEPHROL, V26, P261, DOI 10.1016/j.semnephrol.2006.06.001; Neutel JM, 2013, CARDIOVASC THER, V31, P251, DOI 10.1111/1755-5922.12015; Oehme F, 2004, ANAL BIOCHEM, V330, P74, DOI 10.1016/j.ab.2004.03.066; Oehme F, 2002, BIOCHEM BIOPH RES CO, V296, P343, DOI 10.1016/S0006-291X(02)00862-8; Potter C, 2004, CELL CYCLE, V3, P164; Priyadarshi A, 2002, KIDNEY INT, V61, P542, DOI 10.1046/j.1523-1755.2002.00140.x; Querbes W, 2012, BLOOD, V120, P1916, DOI 10.1182/blood-2012-04-423715; Rabinowitz MH, 2013, J MED CHEM, V56, P9369, DOI 10.1021/jm400386j; Rinaudo D, 2000, BIOTECHNIQUES, V29, P218, DOI 10.2144/00292bm03; Sandner P, 1996, PFLUG ARCH EUR J PHY, V431, P905, DOI 10.1007/s004240050084; SARTOR RB, 1989, INFECT IMMUN, V57, P1177, DOI 10.1128/IAI.57.4.1177-1185.1989; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; SHIMIZU S, 1994, ACTA PHYSIOL SCAND, V151, P225, DOI 10.1111/j.1748-1716.1994.tb09741.x; Smith TG, 2006, PLOS MED, V3, P1178, DOI 10.1371/journal.pmed.0030290; Song YR, 2010, NEPHROL DIAL TRANSPL, V25, P77, DOI 10.1093/ndt/gfp454; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; SUZUKI S, 1995, COMP BIOCHEM PHYS C, V112, P15, DOI 10.1016/0742-8413(95)00075-5; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Thede K., 2008, Patent Application, Patent No. [2008067871, WO, 2008067871 A1]; Unger EF, 2010, NEW ENGL J MED, V362, P189, DOI 10.1056/NEJMp0912328; Wang G L, 1996, Curr Opin Hematol, V3, P156; Warnecke C, 2008, EXP CELL RES, V314, P2016, DOI 10.1016/j.yexcr.2008.03.003; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wenger RH, 2010, AM J PHYSIOL-RENAL, V298, pF1287, DOI 10.1152/ajprenal.00736.2009; Yoon D, 2010, J MOL MED, V88, P523, DOI 10.1007/s00109-010-0599-0; Yu XF, 2012, NEPHROLOGY, V17, P58, DOI 10.1111/j.1440-1797.2011.01498.x	71	115	129	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e111838	10.1371/journal.pone.0111838	http://dx.doi.org/10.1371/journal.pone.0111838			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392999	Green Published, gold, Green Submitted			2022-12-27	WOS:000347709300023
J	Hatta, K; Guo, J; Ludke, A; Dhingra, S; Singh, K; Huang, ML; Weisel, RD; Li, RK				Hatta, Kota; Guo, Jian; Ludke, Ana; Dhingra, Sanjiv; Singh, Kaustabh; Huang, Ming-Li; Weisel, Richard D.; Li, Ren-Ke			Expression of CNPY2 in Mouse Tissues: Quantification and Localization	PLOS ONE			English	Article							REGULATORY LIGHT-CHAIN; PROTEIN; CANOPY1; CELLS; MSAP; MIR	Canopy FGF signaling regulator 2 (CNPY2) is a FGF21-modulated protein containing a saposin B- type domain. In vitro studies have shown CNPY2 is able to enhance neurite outgrowth in neurons and stabilize the expression of low density lipoprotein receptor in macrophages and hepatocytes. However, no in vivo data are available on the normal expression of CNPY2 and information is lacking on which cell types express this protein in tissues. To address this, the present study examined CNPY2 expression at the mRNA and protein levels. Quantitative PCR and ELISA examination of mouse tissues showed that CNPY2 varies between organs, with the highest expression in the heart, lung and liver. Immunohistochemistry detected CNPY2 in a variety of cell types including skeletal, cardiac and smooth muscle myocytes, endothelial cells and epithelial cells. CNPY2 was also detectable in mouse blood and human and mouse uteri. These data demonstrate CNPY2 is widely distributed in tissues and suggest the protein has biological functions that have yet to be identified. Using these new observations we discuss possible functions of the protein.	[Hatta, Kota; Guo, Jian; Ludke, Ana; Dhingra, Sanjiv; Singh, Kaustabh; Weisel, Richard D.; Li, Ren-Ke] Univ Hlth Network, Toronto Gen Res Inst, Div Cardiovasc Surg, Toronto, ON, Canada; [Hatta, Kota; Weisel, Richard D.; Li, Ren-Ke] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Huang, Ming-Li] Harbin Med Univ, Affiliated Hosp 1, Dept Gynecol & Obstet, Harbin, Peoples R China	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Harbin Medical University	Li, RK (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Div Cardiovasc Surg, Toronto, ON, Canada.	renkeli@uhnresearch.ca	Dhingra, Sanjiv/D-8766-2014; Hatta, Kota/E-9073-2014	Dhingra, Sanjiv/0000-0002-2664-7633; Hatta, Kota/0000-0003-4677-4215; Li, Ren-Ke/0000-0002-2584-060X	Canadian Institutes of Health Research Fredrick Banting	Canadian Institutes of Health Research Fredrick Banting(Canadian Institutes of Health Research (CIHR))	KH is supported by a Canadian Institutes of Health Research Fredrick Banting and Charles Best Canada Graduate Scholarships Doctoral Award. AL is supported by a Heart & Stroke Foundation Research Fellowship Award. RKL holds the Canadian Research Chair in Cardiac Regeneration. This work was supported by a Canadian Institutes of Health Research grant to RKL ( MOP 86661). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, MICROSCOPY IMMUNOHIS; BARTHEL LK, 1990, J HISTOCHEM CYTOCHEM, V38, P1383, DOI 10.1177/38.9.2201738; Bornhauser BC, 2003, J BIOL CHEM, V278, P35412, DOI 10.1074/jbc.M306271200; Bornhauser BC, 2005, CELL MOL LIFE SCI, V62, P1260, DOI 10.1007/s00018-005-5055-x; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; Clayberger C, 2003, CURR OPIN IMMUNOL, V15, P560, DOI 10.1016/S0952-7915(03)00097-9; Cooke Roger, 2011, Biophys Rev, V3, P33; Dib H, 2012, PROTEOMICS, V12, P2547, DOI 10.1002/pmic.201200060; Enquobahrie DA, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.022; Gerber SA, 2003, BRIT J CANCER, V88, P1453, DOI 10.1038/sj.bjc.6600907; Do HT, 2012, J BIOL CHEM, V287, P12602, DOI 10.1074/jbc.M112.341248; Hirate Y, 2006, CURR BIOL, V16, P421, DOI 10.1016/j.cub.2006.01.055; Hong C, 2010, J BIOL CHEM, V285, P19720, DOI 10.1074/jbc.M110.123729; Josephson MP, 2011, BIOCHEM BIOPH RES CO, V416, P367, DOI 10.1016/j.bbrc.2011.11.044; LI CY, 1987, J HISTOCHEM CYTOCHEM, V35, P1457, DOI 10.1177/35.12.2824601; Matsui T, 2011, P NATL ACAD SCI USA, V108, P9881, DOI 10.1073/pnas.1017248108; Midde K, 2013, J BIOL CHEM, V288, P7012, DOI 10.1074/jbc.M112.434209; Monks J, 2009, J MAMMARY GLAND BIOL, V14, P159, DOI 10.1007/s10911-009-9121-0; Olsson PA, 1999, J BIOL CHEM, V274, P36288, DOI 10.1074/jbc.274.51.36288; Porzionato A, 2010, J HISTOCHEM CYTOCHEM, V58, P825, DOI 10.1369/jhc.2010.956300; Pryhuber GS, 1998, MOL GENET METAB, V64, P217, DOI 10.1006/mgme.1998.2722; Sutherland C, 2012, J BIOL CHEM, V287, P24064, DOI 10.1074/jbc.M112.371609; Tsukita S, 1997, TRENDS BIOCHEM SCI, V22, P53, DOI 10.1016/S0968-0004(96)10071-2; Vaccaro AM, 1999, NEUROCHEM RES, V24, P307, DOI 10.1023/A:1022530508763; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974	25	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e111370	10.1371/journal.pone.0111370	http://dx.doi.org/10.1371/journal.pone.0111370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393402	Green Published, gold, Green Submitted			2022-12-27	WOS:000347709300015
J	Huang, K; Wang, SQ; Zhou, L; Wang, HM; Zhang, JH; Yan, JH; Zhao, L; Wang, YF; Shi, PL				Huang, Kun; Wang, Shaoqiang; Zhou, Lei; Wang, Huimin; Zhang, Junhui; Yan, Junhua; Zhao, Liang; Wang, Yanfen; Shi, Peili			Impacts of Diffuse Radiation on Light Use Efficiency across Terrestrial Ecosystems Based on Eddy Covariance Observation in China	PLOS ONE			English	Article							GROSS PRIMARY PRODUCTION; LEYMUS-CHINENSIS STEPPE; WATER-USE EFFICIENCY; NET ECOSYSTEM; CARBON-DIOXIDE; CO2 EXCHANGE; GRASSLAND ECOSYSTEMS; PRIMARY PRODUCTIVITY; FOREST ECOSYSTEMS; MIXED FOREST	Ecosystem light use efficiency (LUE) is a key factor of production models for gross primary production (GPP) predictions. Previous studies revealed that ecosystem LUE could be significantly enhanced by an increase on diffuse radiation. Under large spatial heterogeneity and increasing annual diffuse radiation in China, eddy covariance flux data at 6 sites across different ecosystems from 2003 to 2007 were used to investigate the impacts of diffuse radiation indicated by the cloudiness index (CI) on ecosystem LUE in grassland and forest ecosystems. Our results showed that the ecosystem LUE at the six sites was significantly correlated with the cloudiness variation (0.24 <= R-2 <= 0.85), especially at the Changbaishan temperate forest ecosystem (R-2 = 0.85). Meanwhile, the CI values appeared more frequently between 0.8 and 1.0 in two subtropical forest ecosystems (Qianyanzhou and Dinghushan) and were much larger than those in temperate ecosystems. Besides, cloudiness thresholds which were favorable for enhancing ecosystem carbon sequestration existed at the three forest sites, respectively. Our research confirmed that the ecosystem LUE at the six sites in China was positively responsive to the diffuse radiation, and the cloudiness index could be used as an environmental regulator for LUE modeling in regional GPP prediction.	[Huang, Kun; Wang, Shaoqiang; Zhou, Lei; Wang, Huimin; Shi, Peili] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing 100101, Peoples R China; [Huang, Kun; Wang, Yanfen] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhang, Junhui] Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Peoples R China; [Yan, Junhua] Chinese Acad Sci, South China Bot Garden, Guangzhou 510650, Guangdong, Peoples R China; [Zhao, Liang] Chinese Acad Sci, Northwest Plateau Inst Biol, Xining 810001, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; Northwest Institute of Plateau Biology, CAS	Wang, SQ (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing 100101, Peoples R China.	sqwang@igsnrr.ac.cn	Zhao, Liang/T-9147-2019; wang, huimin/HDM-8421-2022; Peili, SHi/AAT-6450-2021	shi, pei li/0000-0002-1120-0003; wang, yan fen/0000-0001-5666-9289	CAS for Strategic Priority Research Program [XDA05050602]; National Basic Research Program of China (973Program) [2010CB833503]; Key Project in the National Science & Technology Pillar Program of China [2013BAC03B00]	CAS for Strategic Priority Research Program; National Basic Research Program of China (973Program)(National Basic Research Program of China); Key Project in the National Science & Technology Pillar Program of China	This research was jointly supported by the CAS for Strategic Priority Research Program (Grant No. XDA05050602), National Basic Research Program of China (973Program) (Grant No. 2010CB833503) and the Key Project in the National Science & Technology Pillar Program of China (Grant No. 2013BAC03B00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldocchi D, 2001, B AM METEOROL SOC, V82, P2415, DOI 10.1175/1520-0477(2001)082<2415:FANTTS>2.3.CO;2; Cai WW, 2014, J GEOPHYS RES-BIOGEO, V119, P110, DOI 10.1002/2013JG002456; Canadell JG, 2000, ECOSYSTEMS, V3, P115, DOI 10.1007/s100210000014; Carrara A, 2003, AGR FOREST METEOROL, V119, P209, DOI 10.1016/S0168-1923(03)00120-5; Falge E, 2001, AGR FOREST METEOROL, V107, P43, DOI 10.1016/S0168-1923(00)00225-2; Farquhar GD, 2003, SCIENCE, V299, P1997, DOI 10.1126/science.1080681; Feddema JJ, 2005, SCIENCE, V310, P1674, DOI 10.1126/science.1118160; Fu Pinde, 1999, P 19 ANN ESRI USER C; Fu Y, 2009, BIOGEOSCIENCES, V6, P2879, DOI 10.5194/bg-6-2879-2009; Fu YL, 2006, AGR FOREST METEOROL, V137, P234, DOI 10.1016/j.agrformet.2006.02.009; Fu YL, 2006, SCI CHINA SER D, V49, P196, DOI 10.1007/s11430-006-8196-3; Garbulsky MF, 2010, GLOBAL ECOL BIOGEOGR, V19, P253, DOI 10.1111/j.1466-8238.2009.00504.x; Gu LH, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001242; Gu LH, 2003, SCIENCE, V299, P2035, DOI 10.1126/science.1078366; Guan DX, 2006, AGR FOREST METEOROL, V137, P138, DOI 10.1016/j.agrformet.2006.02.003; He MZ, 2013, AGR FOREST METEOROL, V173, P28, DOI 10.1016/j.agrformet.2013.01.003; Heald CL, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009092; Hu ZM, 2008, GLOBAL CHANGE BIOL, V14, P1609, DOI 10.1111/j.1365-2486.2008.01582.x; Kim SW, 2005, J GEOPHYS RES-ATMOS, P110; King DA, 2011, REMOTE SENS ENVIRON, V115, P1653, DOI 10.1016/j.rse.2011.02.024; Letts MG, 2005, ECOSCIENCE, V12, P53, DOI 10.2980/i1195-6860-12-1-53.1; Mercado LM, 2009, NATURE, V458, P1014, DOI 10.1038/nature07949; Misson L, 2005, AGR FOREST METEOROL, V129, P69, DOI 10.1016/j.agrformet.2004.11.008; MONTEITH JL, 1977, PHILOS T ROY SOC B, V281, P277, DOI 10.1098/rstb.1977.0140; MONTEITH JL, 1972, J APPL ECOL, V9, P747, DOI 10.2307/2401901; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Niyogi D, 2007, NAT HAZARDS, V42, P345, DOI 10.1007/s11069-006-9085-y; Ogutu BO, 2013, AGR FOREST METEOROL, V174, P158, DOI 10.1016/j.agrformet.2013.02.016; Oliphant AJ, 2011, AGR FOREST METEOROL, V151, P781, DOI 10.1016/j.agrformet.2011.01.005; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; Raupach MR, 2008, BIOGEOSCIENCES, V5, P1601, DOI 10.5194/bg-5-1601-2008; Ren XL, 2013, ANN GEOPHYS-GERMANY, V31, P277, DOI 10.5194/angeo-31-277-2013; Roderick ML, 2001, OECOLOGIA, V129, P21, DOI 10.1007/s004420100760; Running SW, 2004, BIOSCIENCE, V54, P547, DOI 10.1641/0006-3568(2004)054[0547:ACSMOG]2.0.CO;2; Schiermeier Q, 2006, NATURE, V442, P854, DOI 10.1038/442854a; Shi PL, 2006, SCI CHINA SER D, V49, P207, DOI 10.1007/s11430-006-8207-4; Sims DA, 2008, REMOTE SENS ENVIRON, V112, P1633, DOI 10.1016/j.rse.2007.08.004; Turner DP, 2006, TELLUS B, V58, P476, DOI 10.1111/j.1600-0889.2006.00221.x; Turner DP, 2003, GLOBAL CHANGE BIOL, V9, P383, DOI 10.1046/j.1365-2486.2003.00573.x; Urban O, 2007, GLOBAL CHANGE BIOL, V13, P157, DOI 10.1111/j.1365-2486.2006.01265.x; Veroustraete F, 2002, REMOTE SENS ENVIRON, V83, P376, DOI 10.1016/S0034-4257(02)00043-3; Wang Y., 2012, PLOS ONE, V7; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; Wen XF, 2010, BIOGEOSCIENCES, V7, P357, DOI 10.5194/bg-7-357-2010; Wu CY, 2010, REMOTE SENS ENVIRON, V114, P2925, DOI 10.1016/j.rse.2010.07.012; Wu CY, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013023; Xiao JF, 2008, AGR FOREST METEOROL, V148, P1827, DOI 10.1016/j.agrformet.2008.06.015; Xiao XM, 2004, REMOTE SENS ENVIRON, V89, P519, DOI 10.1016/j.rse.2003.11.008; Yang YT, 2013, J GEOPHYS RES-BIOGEO, V118, P590, DOI 10.1002/jgrg.20056; Yu GR, 2008, GLOBAL CHANGE BIOL, V14, P2555, DOI 10.1111/j.1365-2486.2008.01663.x; Yu GR, 2006, AGR FOREST METEOROL, V137, P125, DOI 10.1016/j.agrformet.2006.02.011; Yu GR, 2013, GLOBAL CHANGE BIOL, V19, P798, DOI 10.1111/gcb.12079; Yu GR, 2008, NEW PHYTOL, V177, P927, DOI 10.1111/j.1469-8137.2007.02316.x; Yuan WP, 2007, AGR FOREST METEOROL, V143, P189, DOI 10.1016/j.agrformet.2006.12.001; Zhang M, 2011, AGR FOREST METEOROL, V151, P803, DOI 10.1016/j.agrformet.2011.01.011	55	14	15	6	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e110988	10.1371/journal.pone.0110988	http://dx.doi.org/10.1371/journal.pone.0110988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393629	gold, Green Submitted, Green Published			2022-12-27	WOS:000347709300008
J	Newman, JW; Pedersen, TL; Brandenburg, VR; Harris, WS; Shearer, GC				Newman, John W.; Pedersen, Theresa L.; Brandenburg, Verdayne R.; Harris, William S.; Shearer, Gregory C.			Effect of Omega-3 Fatty Acid Ethyl Esters on the Oxylipin Composition of Lipoproteins in Hypertriglyceridemic, Statin-Treated Subjects	PLOS ONE			English	Article							SOLUBLE EPOXIDE HYDROLASE; ACTIVATES PPAR-ALPHA; TREATMENT PANEL-III; FATTY-ACIDS; EPOXYEICOSATRIENOIC ACIDS; ATHEROSCLEROSIS; INFLAMMATION; CHOLESTEROL; CHANNELS; PLASMA	Background: Oxylipins mediate inflammation, vascular tension, and more. Their presence in lipoproteins could explain why lipoproteins mediate nearly identical activities. Methods: To determine how oxylipins are distributed in the lipoproteins of hypertriglyceridemic subjects, and whether omega-3 fatty acids alter them in a manner consistent with improved cardiovascular health, we recruited 15 dyslipidemic subjects whose levels of low density lipoprotein cholesterol (LDL-C) were at goal but who remained hypertriglyceridemic (200-499 mg/dL). They were treated them with the indicated dose of 4 g/d omega-3 acid ethyl esters (P-OM3) for 8 weeks. Measured oxylipins included mid-chain alcohols (HETEs, HEPEs and HDoHEs), ketones (KETEs), epoxides (as EpETrEs, EpETEs, and EpDPEs). Results: At baseline, arachidonate-oxylipins (HETEs, KETEs, and EpETrEs) were most abundant in plasma with the greatest fraction of total abundance (mean vertical bar 95% CI vertical bar) being carried in high density lipoproteins (HDL); 42% vertical bar 31, 57 vertical bar followed by very low density lipoproteins (VLDL); 27% vertical bar 20, 36 vertical bar; and LDL 21% vertical bar 16, 28 vertical bar. EPA- and DHA-derived oxylipins constituted less than 11% of total. HDL carried alcohols and epoxides but VLDL was also rich in ketones. Treatment decreased AA-derived oxylipins across lipoprotein classes (-23% vertical bar-33, -12 vertical bar, p = 0.0003), and expanded EPA-(322% vertical bar 241, 422 vertical bar, p<0.0001) and DHA-derived oxylipins (123% vertical bar 80, 176 vertical bar, p<0.0001). Conclusions: Each lipoprotein class carries a unique oxylipin complement. P-OM3 treatment alters the oxylipin content of all classes, reducing pro-inflammatory and increasing anti-inflammatory species, consistent with the improved inflammatory and vascular status associated with the treatment.	[Newman, John W.; Pedersen, Theresa L.] ARS, USDA, WHNRC, Obes & Metab Res Unit, Davis, CA USA; [Newman, John W.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Brandenburg, Verdayne R.; Harris, William S.; Shearer, Gregory C.] Univ S Dakota, Sanford Sch Med, Sioux Falls, SD 57101 USA; [Shearer, Gregory C.] Univ S Dakota, Sanford Sch Med, Basic Biomed Sci, Sioux Falls, SD USA; [Shearer, Gregory C.] Sanford Res USD, Cardiovasc Hlth Res Ctr, Sioux Falls, SD USA; [Shearer, Gregory C.] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA	United States Department of Agriculture (USDA); University of California System; University of California Davis; University of South Dakota; University of South Dakota; Sanford Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Shearer, GC (corresponding author), Univ S Dakota, Sanford Sch Med, Sioux Falls, SD 57101 USA.	gcs13@psu.edu	Harris, William Stephen/T-1674-2019	Harris, William Stephen/0000-0003-3042-9353; Newman, John/0000-0001-9632-6571	GlaxoSmithKline [LVZ113350]; USDA Agricultural Research Service [5306-51530-019-00D]	GlaxoSmithKline(GlaxoSmithKline); USDA Agricultural Research Service(United States Department of Agriculture (USDA))	This study was funded by a grant from GlaxoSmithKline (LVZ113350), who also donated the study drug (Lovaza). This study was supported in part by USDA Agricultural Research Service intramural project 5306-51530-019-00D (JWN). All opinions expressed in this manuscript represent the views of the researchers and not necessarily those of the USDA. The USDA is an equal opportunity provider and employer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed W, 2006, CIRC RES, V98, P490, DOI 10.1161/01.RES.0000205846.46812.be; Brown JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021209; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Cole BK, 2012, AM J PHYSIOL-ENDOC M, V302, pE654, DOI 10.1152/ajpendo.00373.2011; Davidson MH, 2007, CLIN THER, V29, P1354, DOI 10.1016/j.clinthera.2007.07.018; Erlemann KR, 2004, J BIOL CHEM, V279, P40376, DOI 10.1074/jbc.M401294200; Fang X, 1999, HYPERTENSION, V34, P1242, DOI 10.1161/01.HYP.34.6.1242; Gladine C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089393; Goodfellow J, 2000, J AM COLL CARDIOL, V35, P265, DOI 10.1016/S0735-1097(99)00548-3; Grant GE, 2009, PROSTAG OTH LIPID M, V89, P98, DOI 10.1016/j.prostaglandins.2009.05.002; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Innis-Whitehouse W, 1998, J LIPID RES, V39, P679; Keenan A. H., 2012, J LIPID RES; Kogure R, 2011, BIOCHEM BIOPH RES CO, V416, P58, DOI 10.1016/j.bbrc.2011.10.141; Larsen BT, 2007, ARTERIOSCL THROM VAS, V27, P2496, DOI 10.1161/ATVBAHA.107.155341; Lewis TV, 1999, J AM COLL CARDIOL, V33, P805, DOI 10.1016/S0735-1097(98)00667-6; Mallat Z, 1999, J CLIN INVEST, V103, P421, DOI 10.1172/JCI3985; Mori TA, 2000, CIRCULATION, V102, P1264, DOI 10.1161/01.CIR.102.11.1264; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Neckar J, 2012, CLIN SCI, V122, P513, DOI 10.1042/CS20110622; Newman JW, 2007, J LIPID RES, V48, P1792, DOI 10.1194/jlr.M700146-JLR200; Newman JW, 2001, J CHROMATOGR A, V925, P223, DOI 10.1016/S0021-9673(01)00998-0; Norata GD, 2003, CARDIOVASC RES, V59, P169, DOI 10.1016/S0008-6363(03)00335-3; Perk J, 2012, ATHEROSCLEROSIS; Prisco D, 1998, THROMB RES, V91, P105, DOI 10.1016/S0049-3848(98)00046-2; Ruby MA, 2010, J LIPID RES, V51, P2275, DOI 10.1194/jlr.M005561; Schmelzer KR, 2005, P NATL ACAD SCI USA, V102, P9772, DOI 10.1073/pnas.0503279102; Serhan CN, 2002, PROSTAG OTH LIPID M, V68-9, P433, DOI 10.1016/S0090-6980(02)00047-3; Shearer GC, 2005, J AM SOC NEPHROL, V16, P1309, DOI 10.1681/ASN.2004080644; Shearer GC, 2010, J LIPID RES, V51, P2074, DOI 10.1194/M900193-JLR200; Shearer GC, 2009, PROSTAG LEUKOTR ESS, V81, P411, DOI 10.1016/j.plefa.2009.08.002; Shearer GC, 2008, PROSTAG LEUKOTR ESS, V79, P215, DOI 10.1016/j.plefa.2008.09.023; STENSON WF, 1979, PROSTAGLANDINS, V18, P285, DOI 10.1016/0090-6980(79)90115-1; Wang LM, 2009, J LIPID RES, V50, P204, DOI 10.1194/jlr.M700505-JLR200; Westphal C, 2011, PROSTAG OTH LIPID M, V96, P99, DOI 10.1016/j.prostaglandins.2011.09.001; Whatling C, 2007, EXPERT OPIN INV DRUG, V16, P1879, DOI 10.1517/13543784.16.12.1879; Wittwer J, 2007, PROSTAG LEUKOTR ESS, V77, P67, DOI 10.1016/j.plefa.2007.08.001; Ye D, 2002, J PHARMACOL EXP THER, V303, P768, DOI 10.1124/jpet.303.2.768; Zarini S, 2009, P NATL ACAD SCI USA, V106, P8296, DOI 10.1073/pnas.0903851106; Zhang YD, 2001, AM J PHYSIOL-HEART C, V280, pH2430, DOI 10.1152/ajpheart.2001.280.6.H2430; Ziouzenkova O, 2003, P NATL ACAD SCI USA, V100, P2730, DOI 10.1073/pnas.0538015100; 2001, JAMA, V285, P2486	42	22	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e111471	10.1371/journal.pone.0111471	http://dx.doi.org/10.1371/journal.pone.0111471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393536	Green Published, gold, Green Submitted			2022-12-27	WOS:000347709300016
J	Schrauwen, I; Barber, RM; Schatzberg, SJ; Siniard, AL; Corneveaux, JJ; Porter, BF; Vernau, KM; Keesler, RI; Matiasek, K; Flegel, T; Miller, AD; Southard, T; Mariani, CL; Johnson, GC; Huentelman, MJ				Schrauwen, Isabelle; Barber, Renee M.; Schatzberg, Scott J.; Siniard, Ashley L.; Corneveaux, Jason J.; Porter, Brian F.; Vernau, Karen M.; Keesler, Rebekah I.; Matiasek, Kaspar; Flegel, Thomas; Miller, Andrew D.; Southard, Teresa; Mariani, Christopher L.; Johnson, Gayle C.; Huentelman, Matthew J.			Identification of Novel Genetic Risk Loci in Maltese Dogs with Necrotizing Meningoencephalitis and Evidence of a Shared Genetic Risk across Toy Dog Breeds	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ANTIGEN CLASS-II; PUG DOGS; MULTIPLE-SCLEROSIS; INTERLEUKIN-7 RECEPTOR; ASSOCIATION; DELTA; EXPRESSION; DISORDERS; LINKAGE	Necrotizing meningoencephalitis (NME) affects toy and small breed dogs causing progressive, often fatal, inflammation and necrosis in the brain. Genetic risk loci for NME previously were identified in pug dogs, particularly associated with the dog leukocyte antigen (DLA) class II complex on chromosome 12, but have not been investigated in other susceptible breeds. We sought to evaluate Maltese and Chihuahua dogs, in addition to pug dogs, to identify novel or shared genetic risk factors for NME development. Genome-wide association testing of single nucleotide polymorphisms (SNPs) in Maltese dogs with NME identified 2 regions of genome-wide significance on chromosomes 4 (chr4:74522353T>A, p = 8.1x10(-7)) and 15 (chr15:53338796A>G, p = 1.5x10(-7)). Haplotype analysis and fine-mapping suggests that ILR7 and FBXW7, respectively, both important for regulation of immune system function, could be the underlying associated genes. Further evaluation of these regions and the previously identified DLA II locus across all three breeds, revealed an enrichment of nominal significant SNPs associated with chromosome 15 in pug dogs and DLA II in Maltese and Chihuahua dogs. Meta-analysis confirmed effect sizes the same direction in all three breeds for both the chromosome 15 and DLA II loci (p = 8.6x10(-11) and p = 2.5x10(-7), respectively). This suggests a shared genetic background exists between all breeds and confers susceptibility to NME, but effect sizes might be different among breeds. In conclusion, we identified the first genetic risk factors for NME development in the Maltese, chromosome 4 and chromosome 15, and provide evidence for a shared genetic risk between breeds associated with chromosome 15 and DLA II. Last, DLA II and IL7R both have been implicated in human inflammatory diseases of the central nervous system such as multiple sclerosis, suggesting that similar pharmacotherapeutic targets across species should be investigated.	[Schrauwen, Isabelle; Siniard, Ashley L.; Corneveaux, Jason J.; Huentelman, Matthew J.] Translat Genom Res Inst, Neurogen Div, Phoenix, AZ 85004 USA; [Schrauwen, Isabelle] Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium; [Barber, Renee M.] Univ Georgia, Coll Vet Med, Dept Small Anim Med & Surg, Athens, GA USA; [Schatzberg, Scott J.] Anim Neurol & Imaging Ctr, Algodones, NM USA; [Porter, Brian F.] Texas A&M Univ, Dept Vet Pathol, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA; [Vernau, Karen M.] Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA; [Keesler, Rebekah I.] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands; [Matiasek, Kaspar] Univ Munich, Sect Clin & Comparat Neuropathol, Munich, Germany; [Flegel, Thomas] Univ Leipzig, Dept Small Anim Med, D-04109 Leipzig, Germany; [Miller, Andrew D.; Southard, Teresa] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Mariani, Christopher L.] N Carolina State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC USA; [Johnson, Gayle C.] Univ Missouri, Dept Vet Pathobiol, Vet Med Diagnost Lab, Columbia, MO USA	Translational Genomics Research Institute; University of Antwerp; University System of Georgia; University of Georgia; Texas A&M University System; Texas A&M University College Station; University of California System; University of California Davis; Utrecht University; University of Munich; Leipzig University; Cornell University; University of North Carolina; North Carolina State University; University of Missouri System; University of Missouri Columbia	Huentelman, MJ (corresponding author), Translat Genom Res Inst, Neurogen Div, Phoenix, AZ 85004 USA.	mhuentelman@tgen.org	Schrauwen, Isabelle/H-5908-2019; Mariani, Christopher/H-8971-2019; Fiumefreddo, Andrea/T-2977-2019	Schrauwen, Isabelle/0000-0001-7310-6082; Mariani, Christopher/0000-0003-3228-6536; Matiasek, Kaspar/0000-0001-5021-3280; Flegel, Thomas/0000-0001-9892-0224	American Kennel Club Canine Health Foundation [01455]; Morris Animal Foundation [D10CA-406]	American Kennel Club Canine Health Foundation; Morris Animal Foundation	This study was supported by the American Kennel Club Canine Health Foundation (01455) (http://www.akcchf.org/) and the Morris Animal Foundation (D10CA-406) (http://www.morrisanimalfoundation.org/). IS is a postdoctoral fellow of the FWO-Vlaanderen (http://www.fwo.be/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balamurugan K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2677; Barber RM, 2012, J VET INTERN MED, V26, P962, DOI 10.1111/j.1939-1676.2012.00954.x; Barber RM, 2010, J VET INTERN MED, V24, P372, DOI 10.1111/j.1939-1676.2009.0466.x; Barber RM, 2011, J HERED, V102, pS40, DOI 10.1093/jhered/esr048; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cantile C, 2001, VET PATHOL, V38, P119, DOI 10.1354/vp.38-1-119; Cooper JJ, 2014, J VET INTERN MED, V28, P198, DOI 10.1111/jvim.12233; CORDY DR, 1989, VET PATHOL, V26, P191, DOI 10.1177/030098588902600301; Greer KA, 2010, TISSUE ANTIGENS, V76, P110, DOI 10.1111/j.1399-0039.2010.01484.x; Greer KA, 2009, RES VET SCI, V86, P438, DOI 10.1016/j.rvsc.2008.10.002; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Higgins RJ, 2008, VET PATHOL, V45, P336, DOI 10.1354/vp.45-3-336; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Hu W, 2009, SEMIN IMMUNOPATHOL, V31, P439, DOI 10.1007/s00281-009-0178-z; Levine JM, 2008, J VET INTERN MED, V22, P961, DOI 10.1111/j.1939-1676.2008.0137.x; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lopez-Herrera G, AM J HUM GENET, V90, P986; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Pedersen N, 2011, J VET DIAGN INVEST, V23, P68, DOI 10.1177/104063871102300110; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schatzberg SJ, 2005, J VET INTERN MED, V19, P553, DOI 10.1892/0891-6640(2005)19[553:PCRSFD]2.0.CO;2; STALIS IH, 1995, VET PATHOL, V32, P230, DOI 10.1177/030098589503200303; Talarico LR, 2010, J SMALL ANIM PRACT, V51, P138, DOI 10.1111/j.1748-5827.2009.00823.x; Tranchevent LC, 2008, NUCLEIC ACIDS RES, V36, pW377, DOI 10.1093/nar/gkn325; Tsai S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00321; Tsai VWW, 2011, J NEUROSCI, V31, P17612, DOI 10.1523/JNEUROSCI.3449-11.2011; Valente T, 2013, NEUROBIOL AGING, V34, P2110, DOI 10.1016/j.neurobiolaging.2013.02.007; von Praun F, 2006, VET RADIOL ULTRASOUN, V47, P260, DOI 10.1111/j.1740-8261.2006.00137.x; Young BD, 2009, J VET INTERN MED, V23, P527, DOI 10.1111/j.1939-1676.2009.0306.x	31	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112755	10.1371/journal.pone.0112755	http://dx.doi.org/10.1371/journal.pone.0112755			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393235	Green Submitted, Green Published, gold			2022-12-27	WOS:000347709300097
J	Song, Y; Wang, Y; Li, CH; Wang, YM; Mu, SQ; Yang, XJ				Song, Ying; Wang, Yang; Li, Chuanhui; Wang, Yanmin; Mu, Shiqing; Yang, Xinjian			Retreatment and Outcomes of Recurrent Intracranial Vertebral Artery Dissecting Aneurysms after Stent Assisted Coiling: A Single Center Experience	PLOS ONE			English	Article							PIPELINE EMBOLIZATION DEVICE; ENDOVASCULAR TREATMENT; NATURAL-HISTORY; FOLLOW-UP; FUSIFORM; MANAGEMENT	Background and purpose: The retreatment of recurrent intracranial vertebral artery dissecting aneurysms (VADAs) after stent assisted coiling (SAC) has not yet been studied. The purpose of this study was to evaluate the strategies and outcomes for retreatment of recurrent VADAs after SAC. Methods: Between September 2009 and November 2013, six consecutive patients presenting with recurrent intracranial VADAs after SAC were enrolled in this study. They were all male with age ranging from 29 to 54 years (mean age, 46.2 years). The procedures of treatments and angiographic and clinical follow-up were reviewed retrospectively. Retreatment modalities were selected individually according to the characteristics of recurrence. The outcomes of retreatment were evaluated by angiographic and clinical follow-up. Results: Six patients with recurrent intracranial VADAs after SAC were retreated, with second SAC in three patients, coil embolization, double overlapping stents placement and endovascular occlusion with aneurysm trapping in one patient, respectively. Immediate angiographic outcomes of retreatment were: complete occlusion in three patients, nearly complete occlusion in two patients, and contrast medium retention in dissecting aneurysm in one patient. All cases were technically successful. No complications related to endovascular procedures occurred. Angiographic follow-up was available in all five patients treated with second SAC or double overlapping stents, which was complete occlusion in four patients, obliteration of parent artery in one patient, showing no recurrence at 4-11 months (mean: 8.6 months). Clinical follow-up was performed in all six patients at 11-51 months after initial endovascular treatment and at 9-43 months after retreatment. The mRS of last clinical follow-up was excellent in five patients and mild disability in only one patient. Conclusions: Endovascular retreatment is feasible and effective for recurrent intracranial VADAs after SAC. Individualized strategies of retreatment should be enacted according to the characteristics and reasons for the recurrence.	[Yang, Xinjian] Capital Med Univ, Beijing Neurosurg Inst, Dept Intervent Neuroradiol, Beijing, Peoples R China; Capital Med Univ, Beijing Tiantan Hosp, Beijing, Peoples R China	Beijing Neurosurgical Institute; Capital Medical University; Capital Medical University	Yang, XJ (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Dept Intervent Neuroradiol, Beijing, Peoples R China.	yang-xj@163.net		Yang, Xinjian/0000-0001-7306-0125	National Science Foundation of China [81220108007, 81171079, 81471167]; Special Research Project for Capital Health Development [2014-1-1071]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Research Project for Capital Health Development	This work was supported by the National Science Foundation of China (grant nos. 81220108007, 81171079 and 81471167) and Special Research Project for Capital Health Development (grant No. 2014-1-1071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2006, AM J NEURORADIOL, V27, P1514; Faria MD, 2011, AM J NEURORADIOL, V32, P2192, DOI 10.3174/ajnr.A2671; Dorfer C, 2012, NEUROSURGERY, V70, P537, DOI 10.1227/NEU.0b013e3182350da5; Irie K, 2003, INTERV NEURORADIOL, V9, P255, DOI 10.1177/159101990300900304; Irie K, 2003, NEURORADIOLOGY, V45, P825, DOI 10.1007/s00234-003-0972-6; Islak C, 2013, EUR J RADIOL, V82, P1659, DOI 10.1016/j.ejrad.2012.12.025; Jin SC, 2009, AM J NEURORADIOL, V30, P1518, DOI 10.3174/ajnr.A1621; Kim BM, 2008, AM J NEURORADIOL, V29, P1937, DOI 10.3174/ajnr.A1243; Kim BM, 2011, STROKE, V42, P2425, DOI 10.1161/STROKEAHA.111.617381; Lee Dong Hoon, 2013, J Cerebrovasc Endovasc Neurosurg, V15, P229, DOI 10.7461/jcen.2013.15.3.229; Lylyk P, 1998, NEUROSURGERY, V43, P385, DOI 10.1097/00006123-199808000-00132; Lylyk P, 2001, J NEUROSURG, V94, P427, DOI 10.3171/jns.2001.94.3.0427; MacKay CI, 2003, NEUROSURGERY, V53, P754, DOI 10.1227/01.NEU.0000080065.49651.48; Mehta B, 2003, AM J NEURORADIOL, V24, P1814; MIZUTANI T, 1995, NEUROSURGERY, V36, P905, DOI 10.1227/00006123-199505000-00003; Naito I, 2004, INTERV NEURORADIOL, V10, P181, DOI 10.1177/15910199040100S131; Ono H, 2013, STROKE, V44, P126, DOI 10.1161/STROKEAHA.112.670745; Park KW, 2008, J KOREAN NEUROSURG S, V44, P109, DOI 10.3340/jkns.2008.44.3.109; Peluso JPP, 2008, AM J NEURORADIOL, V29, P102, DOI 10.3174/ajnr.A0771; Phillips TJ, 2012, AM J NEURORADIOL, V33, P1225, DOI 10.3174/ajnr.A3166; Rho MH, 2013, ACTA NEUROCHIR, V155, P2009, DOI 10.1007/s00701-013-1866-y; Ro A, 2013, J NEUROSURG, V119, P221, DOI 10.3171/2013.2.JNS121586; Santos-Franco JA, 2008, NEUROSURG REV, V31, P131, DOI 10.1007/s10143-008-0124-x; Suh SH, 2009, J NEUROSURG, V111, P48, DOI 10.3171/2009.2.JNS081418; van Oel LI, 2013, AM J NEURORADIOL, V34, P589, DOI 10.3174/ajnr.A3255; Wakhloo AK, 2008, STROKE, V39, P3288, DOI 10.1161/STROKEAHA.107.512996; Wang YM, 2014, ACTA NEUROCHIR, V156, P515, DOI 10.1007/s00701-013-1989-1; Yeung TW, 2012, J NEUROSURG, V116, P882, DOI 10.3171/2011.12.JNS111514	28	13	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e113027	10.1371/journal.pone.0113027	http://dx.doi.org/10.1371/journal.pone.0113027			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393341	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300136
J	Yumnam, B; Jhala, YV; Qureshi, Q; Maldonado, JE; Gopal, R; Saini, S; Srinivas, Y; Fleischer, RC				Yumnam, Bibek; Jhala, Yadvendradev V.; Qureshi, Qamar; Maldonado, Jesus E.; Gopal, Rajesh; Saini, Swati; Srinivas, Y.; Fleischer, Robert C.			Prioritizing Tiger Conservation through Landscape Genetics and Habitat Linkages	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; PANTHERA-TIGRIS; COMPUTER-PROGRAM; PATERNITY INFERENCE; RECENT MIGRATION; CIRCUIT-THEORY; F-STATISTICS; SOFTWARE; ECOLOGY; FLOW	Even with global support for tiger (Panthera tigris) conservation their survival is threatened by poaching, habitat loss and isolation. Currently about 3,000 wild tigers persist in small fragmented populations within seven percent of their historic range. Identifying and securing habitat linkages that connect source populations for maintaining landscape-level gene flow is an important long-term conservation strategy for endangered carnivores. However, habitat corridors that link regional tiger populations are often lost to development projects due to lack of objective evidence on their importance. Here, we use individual based genetic analysis in combination with landscape permeability models to identify and prioritize movement corridors across seven tiger populations within the Central Indian Landscape. By using a panel of 11 microsatellites we identified 169 individual tigers from 587 scat and 17 tissue samples. We detected four genetic clusters within Central India with limited gene flow among three of them. Bayesian and likelihood analyses identified 17 tigers as having recent immigrant ancestry. Spatially explicit tiger occupancy obtained from extensive landscape-scale surveys across 76,913 km(2) of forest habitat was found to be only 21,290 km(2). After accounting for detection bias, the covariates that best explained tiger occupancy were large, remote, dense forest patches; large ungulate abundance, and low human footprint. We used tiger occupancy probability to parameterize habitat permeability for modeling habitat linkages using least-cost and circuit theory pathway analyses. Pairwise genetic differences (F-ST) between populations were better explained by modeled linkage costs (r>0.5, p<0.05) compared to Euclidean distances, which was in consonance with observed habitat fragmentation. The results of our study highlight that many corridors may still be functional as there is evidence of contemporary migration. Conservation efforts should provide legal status to corridors, use smart green infrastructure to mitigate development impacts, and restore habitats where connectivity has been lost.	[Yumnam, Bibek; Jhala, Yadvendradev V.; Qureshi, Qamar; Saini, Swati; Srinivas, Y.] Wildlife Inst India, Dehra Dun 248001, Uttar Pradesh, India; [Maldonado, Jesus E.; Fleischer, Robert C.] Smithsonian Conservat Biol Inst, Natl Zool Pk, Washington, DC USA; [Maldonado, Jesus E.] Natl Museum Nat Hist, Smithsonian Inst, Dept Vertebrate Zool, Washington, DC 20560 USA; [Gopal, Rajesh] Natl Tiger Conservat Author, New Delhi 110011, India	Wildlife Institute of India; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Smithsonian Institution; Smithsonian National Museum of Natural History; National Tiger Conservation Authority, Government of India	Jhala, YV (corresponding author), Wildlife Inst India, Dehra Dun 248001, Uttar Pradesh, India.	jhalay@wii.gov.in	Maldonado, Jesus/AIE-8664-2022; Jhala, Yadvendradev/AAL-9711-2020	Maldonado, Jesus/0000-0002-4282-1072; Yellapu, Srinivas/0000-0002-5412-4717	National Tiger Conservation Authority; Fulbright Fellowship; Wildlife Institute of India	National Tiger Conservation Authority(Ministry of Environment, Forest and Climate Change (MoEFCC), Government of IndiaNational Tiger Conservation Authority, Government of India); Fulbright Fellowship; Wildlife Institute of India	Funding provided by the National Tiger Conservation Authority: YVJ QQ, Fulbright Fellowship: BY, Wildlife Institute of India: YVJ BY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alroy J, 2001, SCIENCE, V292, P1893, DOI 10.1126/science.1059342; Banerjee K, 2012, J MAMMAL, V93, P1420, DOI 10.1644/11-MAMM-A-231.1; Beaumont M, 2001, MOL ECOL, V10, P319, DOI 10.1046/j.1365-294x.2001.01196.x; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; BEERLI P, 2008, MIGRATE N VERSION 3; Beerli Peter, 2009, V17, P42; Beier P, 1998, CONSERV BIOL, V12, P1241, DOI 10.1046/j.1523-1739.1998.98036.x; Bergl RA, 2007, MOL ECOL, V16, P501, DOI 10.1111/j.1365-294X.2006.03159.x; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Boyce MS, 1999, TRENDS ECOL EVOL, V14, P268, DOI 10.1016/S0169-5347(99)01593-1; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Carter NH, 2012, P NATL ACAD SCI USA, V109, P15360, DOI 10.1073/pnas.1210490109; Castilho CS, 2011, MAMM BIOL, V76, P476, DOI 10.1016/j.mambio.2010.08.002; Chandran MDS, 1997, CURR SCI INDIA, V73, P146; Chapron G, 2008, J APPL ECOL, V45, P1667, DOI 10.1111/j.1365-2664.2008.01538.x; Check E, 2006, NATURE, V441, P927, DOI 10.1038/441927a; Clark TW, 1996, CONSERV BIOL, V10, P940, DOI 10.1046/j.1523-1739.1996.10040940.x; Cornuet JM, 1996, GENETICS, V144, P2001; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Cushman SA, 2009, CONSERV BIOL, V23, P368, DOI 10.1111/j.1523-1739.2008.01111.x; Dinerstein E, 2007, BIOSCIENCE, V57, P508, DOI 10.1641/B570608; Dolrenry S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088081; Dutta T, 2013, EVOL APPL, V6, P949, DOI 10.1111/eva.12078; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Efford MG, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00308.1; ELZIRIK E, 2001, MOL ECOL, V10, P65, DOI DOI 10.1046/J.1365-294X.2001.01144.X; Epps CW, 2007, J APPL ECOL, V44, P714, DOI 10.1111/j.1365-2664.2007.01325.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fernandes A., 2012, COAL MINING IS TRASH; Forest Survey of India, 2009, IND STAT FOR REP; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Girod C, 2011, GENETICS, V188, P165, DOI 10.1534/genetics.110.121764; Gittleman JL, 2001, CONSERV BIOL SER, V5, P1; Goossens B, 2013, RAFFLES B ZOOL, P43; Gopal R, 2010, ORYX, V44, P383, DOI 10.1017/S0030605310000529; Goudet J., 2002, FSTAT PROGRAM ESTIMA; HANSKI I, 1994, J ANIM ECOL, V63, P151, DOI 10.2307/5591; HANSKI I, 1997, METAPOPULATION BIOL; Hanski I, 1999, METAPOPULATION ECOLO; Hardy OJ, 2003, GENETICS, V163, P1467; Harihar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040105; HARRISON S, 1991, BIOL J LINN SOC, V42, P73, DOI 10.1111/j.1095-8312.1991.tb00552.x; Henry P, 2009, MOL ECOL, V18, P3173, DOI 10.1111/j.1365-294X.2009.04266.x; Hines J., 2006, PRESENCE2 SOFTWARE E; Jhala Y, 2011, J APPL ECOL, V48, P14, DOI 10.1111/j.1365-2664.2010.01901.x; JHALA YV, 2013, TR08001 MIN ENV FOR; JHALA YV, 2009, TECHNICAL PUBLICATIO; JHALA YV, 2011, TR2011003 MIN ENV FO; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Joshi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077980; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Karanth K.U., 2002, MONITORING TIGERS TH, DOI [10.1111/j.1523-1739.2003.01769.x, DOI 10.1111/J.1523-1739.2003.01769.X]; Karanth KU, 2011, J APPL ECOL, V48, P1048, DOI 10.1111/j.1365-2664.2011.02002.x; Karanth KU, 2005, CONSERV BIOL SER, V9, P373; Karanth KU, 2000, J ZOOL, V250, P255; Kendall WL, 2009, J APPL ECOL, V46, P1182, DOI 10.1111/j.1365-2664.2009.01732.x; KENNEY JS, 1995, CONSERV BIOL, V9, P1127, DOI 10.1046/j.1523-1739.1995.9051116.x-i1; Kimura M., 1953, ANNU REP NAT I GENET, V3, P62; Linkie M, 2006, J APPL ECOL, V43, P576, DOI 10.1111/j.1365-2664.2006.01153.x; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Luo SJ, 2004, PLOS BIOL, V2, P2275, DOI 10.1371/journal.pbio.0020442; MacKenzie D. I., 2004, Animal Biodiversity and Conservation, V27, P461; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; MANTEL N, 1967, CANCER RES, V27, P209; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marker LL, 2008, J HERED, V99, P2, DOI 10.1093/jhered/esm081; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; McRae B.H., 2009, CIRCUITSCAPE USERS G; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Mcrae BH, 2007, P NATL ACAD SCI USA, V104, P19885, DOI 10.1073/pnas.0706568104; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Misra VN, 2001, J BIOSCIENCES, V26, P491, DOI 10.1007/BF02704749; Mondol S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0496; Mondol S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000585; Narain S.P., 2005, JOINING DOTS REPORT; NAVIDI W, 1992, AM J HUM GENET, V50, P347; Noss R.F., 1987, Conservation Biology, V1, P159, DOI 10.1111/j.1523-1739.1987.tb00024.x; PABLA HS, 2011, TECHNICAL REPORT; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Panwar H.S., 1987, P110; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pearse DE, 2004, CONSERV GENET, V5, P585, DOI 10.1007/s10592-003-1863-4; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; PINJARKAR V, 2011, TIMES INDIA; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK., 2010, DOCUMENTATION STRUCT; Proctor MF, 2005, P ROY SOC B-BIOL SCI, V272, P2409, DOI 10.1098/rspb.2005.3246; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Quintero JD, 2010, SMART GREEN INFRASTR; RAMACHANDRAN R, 2011, HINDU; Rangarajan M., 2006, INDIAS WILDLIFE HIST; Rangarajan Mahesh, 1996, FENCING FOREST CONSE; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Ray N, 2005, MOL ECOL NOTES, V5, P177, DOI 10.1111/j.1471-8286.2004.00843.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reddy PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029827; Reding DM, 2013, LANDSCAPE ECOL, V28, P471, DOI 10.1007/s10980-012-9844-y; RODRIGUEZ E, 2005, JET PROPULSION LAB P; Rosenberg NA, 2001, GENETICS, V159, P699; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sanderson E., 2006, SETTING PRIORITIES C; Savage WK, 2010, MOL ECOL, V19, P3301, DOI 10.1111/j.1365-294X.2010.04718.x; Savicky P, 2009, PSPEARMAN SPEARMANS; Sawyer SC, 2011, J APPL ECOL, V48, P668, DOI 10.1111/j.1365-2664.2011.01970.x; Schwartz MK, 2009, ECOLOGY, V90, P3222, DOI 10.1890/08-1287.1; Seidensticker J., 2010, BIOL CONSERVATION WI; Sharma RK, 2010, ANIM CONSERV, V13, P94, DOI 10.1111/j.1469-1795.2009.00305.x; Sharma S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1506; Sharma S, 2013, ECOL EVOL, V3, P48, DOI 10.1002/ece3.432; Slate J, 2000, MOL ECOL, V9, P801, DOI 10.1046/j.1365-294x.2000.00930.x; SLATKIN M, 1995, GENETICS, V139, P457; SMITH JLD, 1993, BEHAVIOUR, V124, P165, DOI 10.1163/156853993X00560; SMITH JLD, 1991, CONSERV BIOL, V5, P484, DOI 10.1111/j.1523-1739.1991.tb00355.x; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Spear SF, 2005, MOL ECOL, V14, P2553, DOI 10.1111/j.1365-294X.2005.02573.x; Spear SF, 2010, MOL ECOL, V19, P3576, DOI 10.1111/j.1365-294X.2010.04657.x; Storz JF, 2002, EVOLUTION, V56, P154; Sunarto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030859; Sunquist Mel, 1999, P5; Surovell T, 2005, P NATL ACAD SCI USA, V102, P6231, DOI 10.1073/pnas.0501947102; Taberlet P, 1999, BIOL J LINN SOC, V68, P41, DOI 10.1111/j.1095-8312.1999.tb01157.x; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; VATTAKAVEN J, 2010, FRAGMENTATION THREAT; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Walston J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000485; Wang IJ, 2009, MOL ECOL, V18, P1365, DOI 10.1111/j.1365-294X.2009.04122.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WILCOX BA, 1985, AM NAT, V125, P879, DOI 10.1086/284386; Williamson JE, 2002, MOL ECOL NOTES, V2, P110, DOI 10.1046/j.1471-8286.2002.00163.x; Wilson GA, 2003, GENETICS, V163, P1177; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wu JH, 2009, CONSERV GENET, V10, P567, DOI 10.1007/s10592-008-9571-8; *WWF IND, 2012, RET TIG KOP MADH PRA; [No title captured]	148	74	75	2	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e111207	10.1371/journal.pone.0111207	http://dx.doi.org/10.1371/journal.pone.0111207			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393234	gold, Green Published			2022-12-27	WOS:000347709300012
J	Bodewes, R; Hapsari, R; Garcia, AR; Contreras, GJS; van de Bildt, MWG; de Graaf, M; Kuiken, T; Osterhaus, ADME				Bodewes, Rogier; Hapsari, Rebriarina; Garcia, Ana Rubio; Contreras, Guillermo J. Sanchez; van de Bildt, Marco W. G.; de Graaf, Miranda; Kuiken, Thijs; Osterhaus, Albert D. M. E.			Molecular Epidemiology of Seal Parvovirus, 1988-2014	PLOS ONE			English	Article							PHOCINE DISTEMPER OUTBREAK; B19; EVOLUTION; IDENTIFICATION; VITULINA; GENUS	A novel parvovirus was discovered recently in the brain of a harbor seal (Phoca vitulina) with chronic meningo-encephalitis. Phylogenetic analysis of this virus indicated that it belongs to the genus Erythroparvovirus, to which also human parvovirus B19 belongs. In the present study, the prevalence, genetic diversity and clinical relevance of seal parvovirus (SePV) infections was evaluated in both harbor and grey seals (Halichoerus grypus) that lived in Northwestern European coastal waters from 1988 to 2014. To this end, serum and tissue samples collected from seals were tested for the presence of seal parvovirus DNA by real-time PCR and the sequences of the partial NS gene and the complete VP2 gene of positive samples were determined. Seal parvovirus DNA was detected in nine (8%) of the spleen tissues tested and in one (0.5%) of the serum samples tested, including samples collected from seals that died in 1988. Sequence analysis of the partial NS and complete VP2 genes of nine SePV revealed multiple sites with nucleotide substitutions but only one amino acid change in the VP2 gene. Estimated nucleotide substitution rates per year were 2.00x10(-4) for the partial NS gene and 1.15x10(-4) for the complete VP2 gene. Most samples containing SePV DNA were co-infected with phocine herpesvirus 1 or PDV, so no conclusions could be drawn about the clinical impact of SePV infection alone. The present study is one of the few in which the mutation rates of parvoviruses were evaluated over a period of more than 20 years, especially in a wildlife population, providing additional insights into the genetic diversity of parvoviruses.	[Bodewes, Rogier; Hapsari, Rebriarina; van de Bildt, Marco W. G.; de Graaf, Miranda; Kuiken, Thijs; Osterhaus, Albert D. M. E.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Garcia, Ana Rubio; Contreras, Guillermo J. Sanchez] Seal Rehabil & Res Ctr, Pieterburen, Netherlands; [Osterhaus, Albert D. M. E.] Viroclin Biosci BV, Rotterdam, Netherlands; [Osterhaus, Albert D. M. E.] Univ Vet Med, Res Ctr Emerging Infect & Zoonoses, Hannover, Germany; [Osterhaus, Albert D. M. E.] Artemis One Hlth, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Veterinary Medicine Hannover, Foundation	Bodewes, R (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.	r.bodewes@erasmusmc.nl	de Graaf, Miranda/K-1262-2018; Hapsari, Rebriarina/CAF-2350-2022; de Graaf, Miranda/AFM-6878-2022	de Graaf, Miranda/0000-0002-7831-0098; Hapsari, Rebriarina/0000-0001-8367-063X; de Graaf, Miranda/0000-0002-7831-0098; Sanchez Contreras, Guillermo J./0000-0002-7664-2531; Bodewes, Rogier/0000-0002-0689-7889; Kuiken, Thijs/0000-0001-5501-9049	Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany; Virgo consortium	Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany; Virgo consortium	This work was financially supported in part by a grant from the Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany, and the Virgo consortium. The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Allison AB, 2013, J VIROL, V87, P2342, DOI 10.1128/JVI.02428-12; Bodewes R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079259; Bonvicini F, 2011, J CLIN MICROBIOL, V49, P3514, DOI 10.1128/JCM.00854-11; Bossart GD, 2001, CRC HDB MARINE MAMMA, P394; Broliden K, 2006, J INTERN MED, V260, P285, DOI 10.1111/j.1365-2796.2006.01697.x; Cotmore SF, 2007, ADV VIRUS RES, V70, P183, DOI 10.1016/S0065-3527(07)70005-2; Cotmore SF, 2014, ARCH VIROL, V159, P1239, DOI 10.1007/s00705-013-1914-1; Dietz R, 2013, ICES J MAR SCI, V70, P186, DOI 10.1093/icesjms/fss144; Douvoyiannis M, 2009, CLIN INFECT DIS, V48, P1713, DOI 10.1086/599042; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Goodman SJ, 1998, MOL BIOL EVOL, V15, P104, DOI 10.1093/oxfordjournals.molbev.a025907; Green SW, 2000, VIROLOGY, V269, P105, DOI 10.1006/viro.2000.0215; Greer LL, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P729, DOI 10.1201/9781420041637.ch32; Heegaard ED, 2002, CLIN MICROBIOL REV, V15, P485, DOI 10.1128/CMR.15.3.485-505.2002; International Committee on Taxonomy of Viruses, 2013, VIR TAX 2013 REL; Jensen T, 2002, SCIENCE, V297, P209, DOI 10.1126/science.1075343; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kerr JR, 2000, ANN RHEUM DIS, V59, P672, DOI 10.1136/ard.59.9.672; Manning A, 2007, J INFECT DIS, V195, P1345, DOI 10.1086/513280; Martina BEE, 2002, VET REC, V150, P572, DOI 10.1136/vr.150.18.572; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Nollens HH, 2006, VIROLOGY, V349, P316, DOI 10.1016/j.virol.2006.01.020; Norja P, 2008, J VIROL, V82, P6427, DOI 10.1128/JVI.00471-08; OSTERHAUS ADME, 1988, NATURE, V335, P20, DOI 10.1038/335020a0; OSTERHAUS ADME, 1990, VET MICROBIOL, V23, P343, DOI 10.1016/0378-1135(90)90165-R; OSULLIVAN MG, 1994, J CLIN INVEST, V93, P1571, DOI 10.1172/JCI117136; PARRISH CR, 1991, J VIROL, V65, P6544, DOI 10.1128/JVI.65.12.6544-6552.1991; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rijks JM, 2008, VET PATHOL, V45, P516, DOI 10.1354/vp.45-4-516; Rijks JM, 2005, EMERG INFECT DIS, V11, P1945, DOI 10.3201/eid1112.050596; Rijks JM, 2008, THESIS ERASMUS U ROT; Shackelton LA, 2006, J VIROL, V80, P3666, DOI 10.1128/JVI.80.7.3666-3669.2006; Shackelton LA, 2005, P NATL ACAD SCI USA, V102, P379, DOI 10.1073/pnas.0406765102; Suzuki M, 2009, J VIROL, V83, P10975, DOI 10.1128/JVI.00273-09; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trilateral Seal Expert Group (TSEG), 2013, AER SURV HARB SEALS; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996; Yoo BC, 1999, VIROLOGY, V253, P250, DOI 10.1006/viro.1998.9518; Zehender G, 2010, INFECT GENET EVOL, V10, P215, DOI 10.1016/j.meegid.2009.11.011	41	1	1	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112129	10.1371/journal.pone.0112129	http://dx.doi.org/10.1371/journal.pone.0112129			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390639	gold, Green Submitted, Green Published			2022-12-27	WOS:000349144400056
J	Guichard, S; Guis, H; Tran, A; Garros, C; Balenghien, T; Kriticos, DJ				Guichard, Sylvain; Guis, Helene; Tran, Annelise; Garros, Claire; Balenghien, Thomas; Kriticos, Darren J.			Worldwide Niche and Future Potential Distribution of Culicoides imicola, a Major Vector of Bluetongue and African Horse Sickness Viruses	PLOS ONE			English	Article							CLIMATE-CHANGE; BITING MIDGES; DIPTERA-CERATOPOGONIDAE; PHYLOGENETIC ANALYSIS; SATELLITE IMAGERY; EUROPE; TEMPERATURE; AUSTRALIA; MODELS; MAP	We modelled the ecoclimatic niche of Culicoides imicola, a major arthropod vector of midge-borne viral pathogens affecting ruminants and equids, at fine scale and on a global extent, so as to provide insight into current and future risks of disease epizootics, and increase current knowledge of the species' ecology. Based on the known distribution and ecology of C. imicola, the species' response to monthly climatic conditions was characterised using CLIMEX with 109 spatial resolution climatic datasets. The species' climatic niche was projected worldwide and under future climatic scenarios. The validated model highlights the role of irrigation in supporting the occurrence of C. imicola in arid regions. In Europe, the modelled potential distribution of C. imicola extended further West than its reported distribution, raising questions regarding ongoing process of colonization and non-climatic habitat factors. The CLIMEX model highlighted similar ecological niches for C. imicola and the Australasian C. brevitarsis raising questions on biogeography and biosecurity. Under the climate change scenarios considered, its' modelled potential distribution could expand northward in the Northern hemisphere, whereas in Africa its range may contract in the future. The biosecurity risks from bluetongue and African horse sickness viruses need to be re-evaluated in regions where the vector's niche is suitable. Under a warmer climate, the risk of vector-borne epizootic pathogens such as bluetongue and African horse sickness viruses are likely to increase as the climate suitability for C. imicola shifts poleward, especially in Western Europe.	[Guichard, Sylvain; Tran, Annelise] Cirad, UR AGIRs, F-34398 Montpellier, France; [Guichard, Sylvain; Kriticos, Darren J.] Univ Minnesota, InSTePP, St Paul, MN 55108 USA; [Guis, Helene; Garros, Claire; Balenghien, Thomas] Cirad, UMR CMAEE, F-34398 Montpellier, France; [Guis, Helene; Garros, Claire; Balenghien, Thomas] INRA, CMAEE UMR1309, F-34398 Montpellier, France; [Tran, Annelise] Cirad, TETIS UMR15, F-34398 Montpellier, France; [Kriticos, Darren J.] CSIRO, Agr Flagship & Biosecur Flagship, Canberra, ACT 2601, Australia	CIRAD; University of Minnesota System; University of Minnesota Twin Cities; CIRAD; INRAE; AgroParisTech; CIRAD; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Kriticos, DJ (corresponding author), Univ Minnesota, InSTePP, St Paul, MN 55108 USA.	darren.kriticos@csiro.au	Garros, Claire/C-2715-2011; Guichard, Sylvain/F-8706-2011; Kriticos, Darren J/A-4170-2008	Kriticos, Darren J/0000-0003-2599-8105; Guis, Helene/0000-0002-0355-0898; Tran, Annelise/0000-0001-5463-332X	Project "Climate Change and Impact Research: the Mediterranean Environment (CIRCE)"; European Commission's 6th Framework Programme; HarvestChoice project; Commonwealth Scientific and Industrial Research Organization (CSIRO); University of Minnesota; Bill and Melinda Gates Foundation; EU [FP7-261504]; Ministe re de l'agriculture, de l'agroalimentaire et de la foret	Project "Climate Change and Impact Research: the Mediterranean Environment (CIRCE)"; European Commission's 6th Framework Programme(European Commission); HarvestChoice project; Commonwealth Scientific and Industrial Research Organization (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); University of Minnesota(University of Minnesota System); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); EU(European Commission); Ministe re de l'agriculture, de l'agroalimentaire et de la foret	This work was jointly funded by the Project "Climate Change and Impact Research: the Mediterranean Environment (CIRCE)", European Commission's 6th Framework Programme and also by HarvestChoice project with support of the Commonwealth Scientific and Industrial Research Organization (CSIRO), the University of Minnesota and the Bill and Melinda Gates Foundation. This study was partially funded by EU grant FP7-261504 EDENext and is catalogued by the EDENext Steering Committee as EDENext000 (http://www.edenext.eu). The contents of this publication are the sole responsibility of the authors and don't necessarily reflect the views of the European Commission. H. Guis, T. Balenghien and C. Garros were funded by the Ministe re de l'agriculture, de l'agroalimentaire et de la foret. The authors acknowledged J. C. Dellecolle and T. Baldet for providing unpublished data and valuable comments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014236; ALLINGHAM PG, 1991, J MED ENTOMOL, V28, P878, DOI 10.1093/jmedent/28.6.878; Baylis M, 1998, ARCH VIROL, P137; Baylis M, 1999, J S AFR VET ASSOC, V70, P80; Borkent A., 2013, WORLD SPECIES BITING; Calistri P, 2003, J VET MED B, V50, P132, DOI 10.1046/j.1439-0442.2003.00513.x; Conte A, 2003, J VET MED B, V50, P139, DOI 10.1046/j.1439-0450.2003.00632.x; Conte A, 2009, J APPL ECOL, V46, P1332, DOI 10.1111/j.1365-2664.2009.01723.x; Diarra M, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-147; Diouf ND, 2013, VET REC, V172, P152, DOI 10.1136/vr.101083; Du Toit R. M., 1944, ONDERSTEPOORT JOUR VET SCI AND ANIMAL INDUST, V19, P7; Dyce A, 2000, ARBOVIRUS RES AUSTR, V8, P133; Eagles D, 2013, PREV VET MED, V110, P312, DOI 10.1016/j.prevetmed.2013.02.022; Garcia-Saenz A, 2011, MED VET ENTOMOL, V25, P113, DOI 10.1111/j.1365-2915.2010.00904.x; Goldarazena A, 2008, VET REC, V162, P820, DOI 10.1136/vr.162.25.820; Grubler A, 2001, NATURE, V412, P15, DOI 10.1038/35083752; Guis H, 2012, J R SOC INTERFACE, V9, P339, DOI 10.1098/rsif.2011.0255; IPCC, 2000, SPECIAL REPORT EMISS; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kirkland PD, 2004, VETER ITAL SER, V40, P47; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Kriticos Darren J., 2013, NeoBiota, V18, P1; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Linton YM, 2002, MED VET ENTOMOL, V16, P139, DOI 10.1046/j.1365-2915.2002.00356.x; Lo Iacono G, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0194; MacLachlan NJ, 2010, VET RES, V41, DOI 10.1051/vetres/2010007; Mardulyn P, 2013, MOL ECOL, V22, P2456, DOI 10.1111/mec.12264; Matsumoto Y, 2009, J MED ENTOMOL, V46, P1099, DOI 10.1603/033.046.0517; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Mellor PS, 2004, VET RES, V35, P445, DOI 10.1051/vetres:2004021; Mellor PS, 2009, BIOL ANIM INFECT, P1; Morag N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033610; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; MURRAY MD, 1987, AUST J ZOOL, V35, P575, DOI 10.1071/ZO9870575; Paweska JT, 2002, MED VET ENTOMOL, V16, P10, DOI 10.1046/j.1365-2915.2002.00334.x; Perrin A, 2006, MED VET ENTOMOL, V20, P219, DOI 10.1111/j.1365-2915.2006.00616.x; Purse BV, 2007, J APPL ECOL, V44, P1231, DOI 10.1111/j.1365-2664.2007.01342.x; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Schneider SH, 2001, NATURE, V411, P17, DOI 10.1038/35075167; Sedda L, 2012, P ROY SOC B-BIOL SCI, V279, P2354, DOI 10.1098/rspb.2011.2555; Sellers R.F., 1993, Revue Scientifique et Technique Office International des Epizooties, V12, P733; Shelford VE, 1918, SCIENCE, V48, P225, DOI 10.1126/science.48.1235.225; Shelford VE, 1913, BIOL BULL-US, V25, P79, DOI 10.2307/1535970; SHELFORD VE, 1963, ECOLOGY N AM; Siebert S, 2005, HYDROL EARTH SYST SC, V9, P535, DOI 10.5194/hess-9-535-2005; St George TD, 2001, HIST BLUETONGUE AKAB; Stocker F, 2013, SUMMARY POLICYMAKERS; Sutherst RW, 2009, BIOL INVASIONS, V11, P1231, DOI 10.1007/s10530-008-9335-x; Sutherst R W, 2007, CLIMEX VERSION 3 USE; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Tatem AJ, 2003, VET MICROBIOL, V97, P13, DOI 10.1016/j.vetmic.2003.08.009; van der Ploeg RR, 1999, SOIL SCI SOC AM J, V63, P1055, DOI 10.2136/sssaj1999.6351055x; Velthuis AGJ, 2010, PREV VET MED, V93, P294, DOI 10.1016/j.prevetmed.2009.11.007; Venail R., 2012, P77; Venter GJ, 2009, MED VET ENTOMOL, V23, P367, DOI 10.1111/j.1365-2915.2009.00829.x; VENTER GJ, 1994, ONDERSTEPOORT J VET, V61, P327; WALKER AR, 1977, B ENTOMOL RES, V67, P217, DOI 10.1017/S0007485300011032; Webber BL, 2011, DIVERS DISTRIB, V17, P978, DOI 10.1111/j.1472-4642.2011.00811.x; Wittman EJ, 2001, REV SCI TECH OIE, V20, P731, DOI 10.20506/rst.20.3.1306	59	52	53	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112491	10.1371/journal.pone.0112491	http://dx.doi.org/10.1371/journal.pone.0112491			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391148	Green Published, gold			2022-12-27	WOS:000349144400088
J	Morrison, PK; Bing, C; Harris, PA; Maltin, CA; Grove-White, D; Argo, CM				Morrison, Philippa K.; Bing, Chen; Harris, Patricia A.; Maltin, Charlotte A.; Grove-White, Dai; Argo, Caroline Mcg.			Preliminary Investigation into a Potential Role for Myostatin and Its Receptor (ActRIIB) in Lean and Obese Horses and Ponies	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; REAL-TIME PCR; GENE-EXPRESSION; ADIPOSE-TISSUE; DIFFERENTIATION; MICE; INHIBITION; PROTEINS; IIB	Obesity is a widespread problem across the leisure population of horses and ponies in industrialised nations. Skeletal muscle is a major contributor to whole body resting energy requirements and communicates with other tissues through the secretion of myokines into the circulation. Myostatin, a myokine and negative regulator of skeletal muscle mass, has been implicated in obesity development in other species. This study evaluated gene and protein expression of myostatin and its receptor, ActRIIB in adipose tissues and skeletal muscles and serum myostatin concentrations in six lean and six obese animals to explore putative associations between these factors and obesity in horses and ponies. Myostatin mRNA expression was increased while ActRIIB mRNA was decreased in skeletal muscles of obese animals but these differences were absent at the protein level. Myostatin mRNA was increased in crest fat of obese animals but neither myostatin nor ActRIIB proteins were detected in this tissue. Mean circulating myostatin concentrations were significantly higher in obese than in lean groups; 4.98 ng/ml (+/- 62.71) and 9.00 ng/ml (+/- 62.04) for the lean and obese groups, respectively. In addition, there was a significant positive association between these levels and myostatin gene expression in skeletal muscles (average R-2 = 0.58; p<0.05). Together, these results provide further basis for the speculation that myostatin and its receptor may play a role in obesity in horses and ponies.	[Morrison, Philippa K.; Bing, Chen; Maltin, Charlotte A.; Grove-White, Dai; Argo, Caroline Mcg.] Univ Liverpool, Fac Hlth & Life Sci, Dept Obes & Endocrinol, Wirral L64 7TE, Merseyside, England; [Harris, Patricia A.] WALTHAM Ctr Pet Nutr, Equine Studies Grp, Melton Mowbray, Leics, England	Mars; WALTHAM Petcare Science Institute	Argo, CM (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Sch Vet Med, Guildford, Surrey, England.	c.argo@surrey.ac.uk		Morrison, Philippa/0000-0003-4187-0371; Argo, Caroline/0000-0002-8279-6350	WALTHAM	WALTHAM	This research was funded by a PhD Scholarship from WALTHAM. The funders (with the exception of Patricia A. Harris, co-author and collaborator), had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2011, GENES GENOM, V33, P245, DOI 10.1007/s13258-010-0114-6; Allen DL, 2008, AM J PHYSIOL-ENDOC M, V294, pE918, DOI 10.1152/ajpendo.00798.2007; Argo CM, 2012, VET J; Baumann A. P., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P8; Bogaert L, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-24; Bruynsteen L, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-240; Carter RA, 2009, EQUINE VET J, V41, P171, DOI 10.2746/042516408X342975; Carter RA, 2009, VET J, V179, P204, DOI 10.1016/j.tvjl.2008.02.029; Cleasby ME, 2014, LOCAL OVEREXPRESSION, pE814; Dall'Olio S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/542945; Dilger AC, 2010, ANIM SCI J, V81, P586, DOI 10.1111/j.1740-0929.2010.00776.x; Dugdale AHA, 2012, VET J; Fournier B, 2012, MOL CELL BIOL, V32, P2871, DOI 10.1128/MCB.06575-11; Giles SL, 2014, PEERJ, V2, DOI 10.7717/peerj.299; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Guo W, 2008, J BIOL CHEM, V283, P9136, DOI 10.1074/jbc.M708968200; Guo YF, 2008, ACTA BIOCH BIOPH SIN, V40, P426, DOI 10.1111/j.1745-7270.2008.00418.x; Hamrick MW, 2006, INT J OBESITY, V30, P868, DOI 10.1038/sj.ijo.0803200; Harker I.J., 2011, J EQUINE VET SCI, V31, P253, DOI [10.1016/j.jevs.2011.03.058, DOI 10.1016/J.JEVS.2011.03.058]; Hill EW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-552; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Hirai S, 2007, DOMEST ANIM ENDOCRIN, V32, P1, DOI 10.1016/j.domaniend.2005.12.001; Hittel DS, 2009, DIABETES, V58, P30, DOI 10.2337/db08-0943; Joulia D, 2003, EXP CELL RES, V286, P263, DOI 10.1016/S0014-4827(03)00074-0; Klimek MEB, 2010, BIOCHEM BIOPH RES CO, V391, P1548, DOI 10.1016/j.bbrc.2009.12.123; Kohnke JR., 1992, FEEDING NUTR MAKING, P163; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Lyons JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012928; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Morrison PK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100810; Owers R, 2013, EQUINE VET J, V45, P5, DOI 10.1111/evj.12008; Petersen JL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003211; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shan TZ, 2013, FASEB J, V27, P1981, DOI 10.1096/fj.12-225755; Smith IJ, 2010, J CELL BIOCHEM, V111, P1059, DOI 10.1002/jcb.22796; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Vijgen GHEJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017247; Wagner KR, 2008, ANN NEUROL, V63, P561, DOI 10.1002/ana.21338; WEBB AI, 1979, EQUINE VET J, V11, P39, DOI 10.1111/j.2042-3306.1979.tb01295.x; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4	40	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112621	10.1371/journal.pone.0112621	http://dx.doi.org/10.1371/journal.pone.0112621			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390640	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400110
J	Odone, A; Amadasi, S; White, RG; Cohen, T; Grant, AD; Houben, RMGJ				Odone, Anna; Amadasi, Silvia; White, Richard G.; Cohen, Theodore; Grant, Alison D.; Houben, Rein M. G. J.			The Impact of Antiretroviral Therapy on Mortality in HIV Positive People during Tuberculosis Treatment: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							CO-INFECTED PATIENTS; CASE-FATALITY; SUCCESSFUL INTEGRATION; DELAYED INITIATION; SOUTH-AFRICA; BURDEN; ADULTS; HAART; CARE; RECOMMENDATIONS	Objective: To quantify the impact of antiretroviral therapy (ART) on mortality in HIV-positive people during tuberculosis (TB) treatment. Design: We conducted a systematic literature review and meta-analysis. Studies published from 1996 through February 15, 2013, were identified by searching electronic resources (Pubmed and Embase) and conference books, manual searches of references, and expert consultation. Pooled estimates for the outcome of interest were acquired using random effects meta-analysis. Subjects: The study population included individuals receiving ART before or during TB treatment. Main Outcome Measures: Main outcome measures were: (i) TB-case fatality ratio (CFR), defined as the proportion of individuals dying during TB treatment and, if mortality in HIV-positive people not on ART was also reported, (ii) the relative risk of death during TB treatment by ART status. Results: Twenty-one studies were included in the systematic review. Random effects pooled meta-analysis estimated the CFR between 8% and 14% (pooled estimate 11%). Among HIV-positive TB cases, those receiving ART had a reduction in mortality during TB treatment of between 44% and 71% (RR = 0.42, 95% CI: 0.29-0.56). Conclusion: Starting ART before or during TB therapy reduces the risk of death during TB treatment by around three-fifths in clinical settings. National programmes should continue to expand coverage of ART for HIV positive in order to control the dual epidemic.	[Odone, Anna; White, Richard G.; Houben, Rein M. G. J.] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, TB Modelling Grp, London WC1, England; [Odone, Anna] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [Odone, Anna] Univ Parma, Sch Med, I-43100 Parma, Italy; [Amadasi, Silvia] Univ Brescia, Univ Div Infect & Trop Dis, Brescia, Italy; [Amadasi, Silvia] Spedali Civil Brescia, Gen Hosp, I-25125 Brescia, Italy; [White, Richard G.; Grant, Alison D.; Houben, Rein M. G. J.] London Sch Hyg & Trop Med, TB Ctr, London WC1, England; [Cohen, Theodore] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Ctr Communicable Dis Dynam, Boston, MA 02115 USA; [Cohen, Theodore] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; [Grant, Alison D.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England	Harvard University; Harvard Medical School; University of Parma; University of Brescia; Hospital Spedali Civili Brescia; University of London; London School of Hygiene & Tropical Medicine; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; University of London; London School of Hygiene & Tropical Medicine	Odone, A (corresponding author), London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, TB Modelling Grp, London WC1, England.	anna.odone@mail.harvard.edu	White, Richard G/D-5407-2009; Odone, Anna/AAC-4715-2022	White, Richard G/0000-0003-4410-6635; Odone, Anna/0000-0002-5657-9774; Cohen, Ted/0000-0002-8091-7198	UNAIDS [AIEP1201338/3.4.58680]; Hygiene and Preventive Medicine; TB Modelling and Analysis Consortium (TB MAC) [OPP1084276]; Bill and Melinda Gates Foundation; Medical Research Council (UK) [G0802414, MR/J005088/1]; CDC/PEPFAR via the Aurum Institute [U2GPS0008111]; Global Health Trials [G1100689]; Bill and Melinda Gates Foundation [OPP1083118]; Medical Research Council [G0802414, MR/J005088/1, G1100689] Funding Source: researchfish; MRC [MR/J005088/1, G0802414, G1100689] Funding Source: UKRI	UNAIDS; Hygiene and Preventive Medicine; TB Modelling and Analysis Consortium (TB MAC); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CDC/PEPFAR via the Aurum Institute; Global Health Trials; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded through a UNAIDS direct commission (AIEP1201338/3.4.58680). AO is funded through a residency fellowship in Hygiene and Preventive Medicine. RGW, TC, and RMGJH are funded by the TB Modelling and Analysis Consortium (TB MAC) grant (OPP1084276) from the Bill and Melinda Gates Foundation. RGW is also funded by the Medical Research Council (UK) (Methodology Research Fellowship: G0802414 and grant MR/J005088/1) and CDC/PEPFAR via the Aurum Institute (U2GPS0008111). AG is funded by Global Health Trials (G1100689) and the Bill and Melinda Gates Foundation (OPP1083118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agodokpessi G, 2012, MED MALADIES INFECT, V42, P561, DOI 10.1016/j.medmal.2012.07.012; Akksilp S, 2007, EMERG INFECT DIS, V13, P1001, DOI 10.3201/eid1307.061506; Altice FL, 2010, LANCET, V376, P367, DOI 10.1016/S0140-6736(10)60829-X; [Anonymous], BMC MED; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Boulle A, 2010, SAMJ S AFR MED J, V100, P566, DOI 10.7196/SAMJ.4434; Casas EC, 2011, TROP MED INT HEALTH, V16, P1450, DOI 10.1111/j.1365-3156.2011.02853.x; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Curran A, 2012, AIDS REV, V14, P231; Davies NECG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033309; Dean GL, 2002, AIDS, V16, P75, DOI 10.1097/00002030-200201040-00010; Dheda K, 2004, J INFECT DIS, V190, P1670, DOI 10.1086/424676; Doherty M, 2013, CURR OPIN HIV AIDS, V8, P528, DOI 10.1097/COH.0000000000000008; dos Santos APG, 2013, INT J TUBERC LUNG D, V17, P192, DOI 10.5588/ijtld.11.0831; Ferroussier O, 2013, INT J TUBERC LUNG D, V17, P1405, DOI 10.5588/ijtld.12.0593; Gandhi NR, 2009, JAIDS-J ACQ IMM DEF, V50, P37, DOI 10.1097/QAI.0b013e31818ce6c4; Glaziou P, 2009, CLIN CHEST MED, V30, P621, DOI 10.1016/j.ccm.2009.08.017; Han SH, 2014, HIV MED, V15, P77, DOI 10.1111/hiv.12073; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Henegar C, 2012, INT J TUBERC LUNG D, V16, P1199, DOI 10.5588/ijtld.11.0613; Higgins JPT, 2022, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604; Kaplan R, 2014, JAIDS-J ACQ IMM DEF, V66, P487, DOI 10.1097/QAI.0000000000000201; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Kayigamba FR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073501; Kendon M, 2012, SAMJ S AFR MED J, V102, P931, DOI [10.7196/SAMJ.5574, 10.7196/samj.5574]; Korenromp EL, 2009, INT J TUBERC LUNG D, V13, P283; Laureillard D, 2013, AIDS, V27, P2577, DOI 10.1097/01.aids.0000432456.14099.c7; Legido-Quigley H, 2013, TROP MED INT HEALTH, V18, P199, DOI 10.1111/tmi.12029; Lim MSC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038598; Manosuthi W, 2012, JAIDS-J ACQ IMM DEF, V60, P377, DOI 10.1097/QAI.0b013e31825b5e06; Mfinanga SG, 2014, LANCET INFECT DIS, V14, P563, DOI 10.1016/S1473-3099(14)70733-9; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Nansera D, 2012, INT J TUBERC LUNG D, V16, P1371, DOI 10.5588/ijtld.11.0589; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2009, GUIDELINES USE ANTIR, P1; Raizada N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005999; Sanguanwongse N, 2008, JAIDS-J ACQ IMM DEF, V48, P181, DOI 10.1097/QAI.0b013e318177594e; Sileshi B, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-297; Sinha S, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-168; Schmaltz CAS, 2009, JAIDS-J ACQ IMM DEF, V52, P623, DOI 10.1097/QAI.0b013e3181b31e56; Straetemans M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020755; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; Tansuphasawadikul Somsit, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P1053; TB CARE I, 2014, INT STAND TUB CAR; The Lancet Global Heath Blog, 2013, LANCET GLOBAL HLTH B; The Stop TB Partnership, 2014, WHA APPR POST 2015 G; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Torok ME, 2011, CLIN INFECT DIS, V52, P1374, DOI 10.1093/cid/cir230; Tweya H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056248; Varma JK, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-42; Walpola HC, 2003, INT J TUBERC LUNG D, V7, P742; Wells GA, 2011, NEWCASTLE OTTAWA SCA; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2013, CONSOLIDATED GUIDELI; World Health Organization, 2010, WHOHTMTB2009420, P420; Zachariah R, 2007, INT J TUBERC LUNG D, V11, P848	57	54	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112017	10.1371/journal.pone.0112017	http://dx.doi.org/10.1371/journal.pone.0112017			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391135	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000349144400046
J	Adham, SAI; Al Rawahi, H; Habib, S; Al Moundhri, MS; Viloria-Petit, A; Coomber, BL				Adham, Sirin A. I.; Al Rawahi, Hasina; Habib, Sumaya; Al Moundhri, Mansour S.; Viloria-Petit, Alicia; Coomber, Brenda L.			Modeling of Hypo/Hyperglycemia and Their Impact on Breast Cancer Progression Related Molecules	PLOS ONE			English	Article							OVARIAN-CARCINOMA; CELLS; EXPRESSION; GROWTH; INSULIN; OBESITY; ANGIOGENESIS; RECEPTOR-2; METABOLISM; ENZYMOLOGY	Breast cancer (BC) arises commonly in women with metabolic dysfunction. The underlying mechanism by which glycemic load can exert its action on tumor metastasis is under investigated. In this study we showed that glycemic microenvironment alters the expression of three classes of proteins, VEGF and its receptors, cell to cell, and cell to extracellular matrix (ECM) adhesion proteins in MDA-MB-231 parental cells and its two metastatic variants to the bone and brain (MDA-MB-231BO and MDA-MB-231BR, respectively). Using western blotting, we showed that VEGFR2 levels were higher in these variant cells and persisted in the cells under extreme hypoglycemia. Hypoglycemia did not alter VEGFR2 expression per se but rather suppressed its posttranslational glycosylation. This was reversed rapidly upon the restoration of glucose, and cyclohexamide (CHX) treatment demonstrated that this deglycosylated VEGFR2 was not a product of de-novo protein synthesis. VEGFR2 co-receptor Neuropilin-1 was up-regulated four-fold in all MDA-MB-231 cells (parental and two variants) compared to VEGFR2 expression, and was also susceptible to glycemic changes but resistant to CHX treatment for up to 72 hrs. Hypoglycemia also resulted in a significant decrease in specific catenin, cadherin, and integrin proteins, as well as cellular proliferation and colony forming ability. However, MDA-MB-231BR cells showed a unique sensitivity to hypo/hyperglycemia in terms of morphological changes, colony formation ability, integrin beta 3 expression and secreted VEGF levels. In conclusion, this study can be translated clinically to provide insight into breast cancer cell responses to glycemic levels relevant for our understanding of the interaction between diabetes and cancer.	[Adham, Sirin A. I.; Al Rawahi, Hasina; Habib, Sumaya] Sultan Qaboos Univ, Dept Biol, Coll Sci, Muscat 123, Oman; [Al Moundhri, Mansour S.] Sultan Qaboos Univ, Dept Med, Coll Med, Muscat 123, Oman; [Viloria-Petit, Alicia; Coomber, Brenda L.] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada	Sultan Qaboos University; Sultan Qaboos University; University of Guelph	Adham, SAI (corresponding author), Sultan Qaboos Univ, Dept Biol, Coll Sci, POB 36, Muscat 123, Oman.	sadham@squ.edu.om	Adham, Sirin A/ABB-8842-2020	Adham, Sirin A/0000-0002-8349-6202; Al-Moundhri, Mansour/0000-0003-3963-1232	Sultan Qaboos university [IG/Biol/Sci/01/12]	Sultan Qaboos university	Sultan Qaboos university funded this work. The grant number is: IG/Biol/Sci/01/12. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adham SAI, 2010, LAB INVEST, V90, P709, DOI 10.1038/labinvest.2010.52; Adham SAI, 2009, BIOCHEM BIOPH RES CO, V390, P130, DOI 10.1016/j.bbrc.2009.09.081; Banarer S, 2004, MED CLIN N AM, V88, P1107, DOI 10.1016/j.mcna.2004.04.003; Chen EI, 2007, CANCER RES, V67, P1472, DOI 10.1158/0008-5472.CAN-06-3137; Cohen DH, 2012, ENDOCR-RELAT CANCER, V19, pF27, DOI 10.1530/ERC-11-0374; Corn PG, 2000, CLIN CANCER RES, V6, P4243; D'Anselmi F, 2011, INT J BIOCHEM CELL B, V43, P1052, DOI 10.1016/j.biocel.2010.05.002; Dingemans AMC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-152; Elias I, 2012, DIABETES, V61, P1801, DOI 10.2337/db11-0832; Ferlay J, 2012, LANCET, V379, P1390, DOI 10.1016/S0140-6736(12)60595-9; Freitas VM, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-2; Gliozzo B, 1998, J CELL BIOCHEM, V70, P268, DOI 10.1002/(SICI)1097-4644(19980801)70:2<268::AID-JCB12>3.0.CO;2-J; Goodwin PJ, 2011, BREAST, V20, pS31, DOI 10.1016/S0960-9776(11)70291-0; Guo SC, 2010, BBA-REV CANCER, V1806, P108, DOI 10.1016/j.bbcan.2010.04.004; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hirsch DS, 2006, CANCER RES, V66, P3523, DOI 10.1158/0008-5472.CAN-05-1547; Hubold C, 2006, INT J OBESITY, V30, P1356, DOI 10.1038/sj.ijo.0803293; Isowa S, 2010, ANTICANCER RES, V30, P2755; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Lee YJ, 1997, J CELL SCI, V110, P681; Lorger M, 2009, P NATL ACAD SCI USA, V106, P10666, DOI 10.1073/pnas.0903035106; Onozuka H, 2011, CANCER SCI, V102, P975, DOI 10.1111/j.1349-7006.2011.01880.x; Pizon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056836; Redaniel MTM, 2012, CANCER CAUSE CONTROL, V23, P1785, DOI 10.1007/s10552-012-0057-0; Scherbakov AM, 2013, B EXP BIOL MED+, V155, P384, DOI 10.1007/s10517-013-2160-y; Shah K, 2012, INT J MOL SCI, V13, P12629, DOI 10.3390/ijms131012629; Sher I, 2009, INT J CANCER, V124, P553, DOI 10.1002/ijc.23963; Shikata K, 2013, CANCER SCI, V104, P9, DOI 10.1111/cas.12043; Simpson IA, 1999, J NEUROCHEM, V72, P238, DOI 10.1046/j.1471-4159.1999.0720238.x; Takahashi T, 1997, ONCOGENE, V14, P2079, DOI 10.1038/sj.onc.1201047; Vaira S, 2012, J CELL PHYSIOL, V227, P578, DOI 10.1002/jcp.22757; Van Swearingen AED, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3651; Wang F, 2002, JNCI-J NATL CANCER I, V94, P1494, DOI 10.1093/jnci/94.19.1494; Wang Ke, 2011, Nan Fang Yi Ke Da Xue Xue Bao, V31, P1812; WEBER G, 1977, NEW ENGL J MED, V296, P486, DOI 10.1056/NEJM197703032960905; WEBER G, 1977, NEW ENGL J MED, V296, P541, DOI 10.1056/NEJM197703102961005; Williams CM, 2008, CANCER RES, V68, P3185, DOI 10.1158/0008-5472.CAN-07-2673; Wu LE, 2014, DIABETES; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486; Yoshida J, 2009, MED MOL MORPHOL, V42, P82, DOI 10.1007/s00795-008-0436-5; Zeng L, 2010, ENDOCR-RELAT CANCER, V17, P539, DOI 10.1677/ERC-09-0221	41	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113103	10.1371/journal.pone.0113103	http://dx.doi.org/10.1371/journal.pone.0113103			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401697	Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700112
J	Chen, CC; Syue, KS; Li, KC; Yeh, SC				Chen, Chun-Chuan; Syue, Kai-Syun; Li, Kai-Chiun; Yeh, Shih-Ching			Neuronal Correlates of a Virtual-Reality-Based Passive Sensory P300 Network	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; DYNAMIC CAUSAL-MODELS; EFFECTIVE CONNECTIVITY; SOMATOSENSORY CORTEX; ATTENTIONAL CONTROL; EVOKED POTENTIALS; PREFRONTAL CORTEX; VEGETATIVE STATE; BRAIN; P3A	P300, a positive event-related potential (ERP) evoked at around 300 ms after stimulus, can be elicited using an active or passive oddball paradigm. Active P300 requires a person's intentional response, whereas passive P300 does not require an intentional response. Passive P300 has been used in incommunicative patients for consciousness detection and brain computer interface. Active and passive P300 differ in amplitude, but not in latency or scalp distribution. However, no study has addressed the mechanism underlying the production of passive P300. In particular, it remains unclear whether the passive P300 shares an identical active P300 generating network architecture when no response is required. This study aims to explore the hierarchical network of passive sensory P300 production using dynamic causal modelling (DCM) for ERP and a novel virtual reality (VR)-based passive oddball paradigm. Moreover, we investigated the causal relationship of this passive P300 network and the changes in connection strength to address the possible functional roles. A classical ERP analysis was performed to verify that the proposed VR-based game can reliably elicit passive P300. The DCM results suggested that the passive and active P300 share the same parietal-frontal neural network for attentional control and, underlying the passive network, the feed-forward modulation is stronger than the feed-back one. The functional role of this forward modulation may indicate the delivery of sensory information, automatic detection of differences, and stimulus-driven attentional processes involved in performing this passive task. To our best knowledge, this is the first study to address the passive P300 network. The results of this study may provide a reference for future clinical studies on addressing the network alternations under pathological states of incommunicative patients. However, caution is required when comparing patients' analytic results with this study. For example, the task presented here is not applicable to incommunicative patients.	[Chen, Chun-Chuan; Syue, Kai-Syun; Li, Kai-Chiun] Natl Cent Univ, Grad Inst Biomed Engn, Jhongli, Taoyuan County, Taiwan; [Yeh, Shih-Ching] Natl Cent Univ, Dept Comp Sci & Informat Engn, Jhongli, Taoyuan County, Taiwan	National Central University; National Central University	Yeh, SC (corresponding author), Natl Cent Univ, Dept Comp Sci & Informat Engn, Jhongli, Taoyuan County, Taiwan.	shihching.yeh@gmail.com			National Science Council of Taiwan [NSC 101-2221-E-008 -003, NSC 103-2420-H-008 -001, NSC 102-2221-E-008 -077]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	Chun-Chuan Chen and Shih-Ching Yeh are funded by National Science Council of Taiwan (NSC 101-2221-E-008 -003; NSC 103-2420-H-008 -001; NSC 102-2221-E-008 -077). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akatsuka K, 2007, EXP BRAIN RES, V181, P607, DOI 10.1007/s00221-007-0958-4; Asplund CL, 2010, NAT NEUROSCI, V13, P507, DOI 10.1038/nn.2509; Bekinschtein TA, 2009, P NATL ACAD SCI USA, V106, P1672, DOI 10.1073/pnas.0809667106; Brazdil M, 2007, NEUROIMAGE, V35, P827, DOI 10.1016/j.neuroimage.2006.12.020; Chen CC, 2012, NEUROIMAGE, V59, P340, DOI 10.1016/j.neuroimage.2011.07.066; Crottaz-Herbette S, 2006, J COGNITIVE NEUROSCI, V18, P766, DOI 10.1162/jocn.2006.18.5.766; David O, 2003, NEUROIMAGE, V20, P1743, DOI 10.1016/j.neuroimage.2003.07.015; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Duncan CC, 2009, INT J PSYCHOPHYSIOL, V73, P118, DOI 10.1016/j.ijpsycho.2009.03.005; Faugeras F, 2011, NEUROLOGY, V77, P264, DOI 10.1212/WNL.0b013e3182217ee8; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; GOODIN DS, 1992, J CLIN NEUROPHYSIOL, V9, P521, DOI 10.1097/00004691-199210000-00006; Herbert AM, 1998, INT J PSYCHOPHYSIOL, V28, P11, DOI 10.1016/S0167-8760(97)00070-6; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Huang MX, 2005, NEUROIMAGE, V28, P99, DOI 10.1016/j.neuroimage.2005.05.036; Jeon YW, 2001, CLIN NEUROPHYSIOL, V112, P2202, DOI 10.1016/S1388-2457(01)00663-0; John NW, 2002, MED RAD DIA IMG, P279; Katayama J, 1996, EVOKED POTENTIAL, V100, P555, DOI 10.1016/S0168-5597(96)95171-0; Katayama J, 1998, PSYCHOPHYSIOLOGY, V35, P23, DOI 10.1111/1469-8986.3510023; Kiebel SJ, 2009, HUM BRAIN MAPP, V30, P1866, DOI 10.1002/hbm.20775; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Lai CL, 2010, CLIN NEUROPHYSIOL, V121, P194, DOI 10.1016/j.clinph.2009.11.001; Laver KE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008349.pub2, 10.1002/14651858.CD008349.pub3, 10.1002/14651858.CD008349.pub4]; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Mak JN, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025003; Maldjian JA, 1999, BRAIN RES, V824, P291, DOI 10.1016/S0006-8993(99)01126-9; Mertens R, 1997, EVOKED POTENTIAL, V104, P488, DOI 10.1016/S0168-5597(97)00041-5; Montoya P, 2006, BRAIN RES, V1068, P205, DOI 10.1016/j.brainres.2005.11.019; Narayanan NS, 2006, NEURON, V52, P921, DOI 10.1016/j.neuron.2006.10.021; Obuchi C, 2012, CLIN EXP OTORHINOLAR, V5, pS6, DOI 10.3342/ceo.2012.5.S1.S6; Penny WD, 2004, NEUROIMAGE, V22, P1157, DOI 10.1016/j.neuroimage.2004.03.026; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; POLICH J, 1989, ELECTROEN CLIN NEURO, V74, P312, DOI 10.1016/0168-5597(89)90061-0; Polich J, 1996, PSYCHOPHYSIOLOGY, V33, P334, DOI 10.1111/j.1469-8986.1996.tb01058.x; POLICH J, 1988, J CLIN NEUROPHYSIOL, V5, P287, DOI 10.1097/00004691-198807000-00004; POLICH J, 1994, INT J PSYCHOPHYSIOL, V17, P25, DOI 10.1016/0167-8760(94)90052-3; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polich John, 2005, Current Alzheimer Research, V2, P515, DOI 10.2174/156720505774932214; Pullamsetti SS, 2012, ARTERIOSCL THROM VAS, V32, P1354, DOI 10.1161/ATVBAHA.112.248500; Rappaport M, 1991, J Neuropsychiatry Clin Neurosci, V3, P180; Reuter EM, 2013, PSYCHOPHYSIOLOGY; Rizzo AA, 2004, NEUROPSYCHOL REHABIL, V14, P207, DOI 10.1080/09602010343000183; ROBINSON CJ, 1980, J COMP NEUROL, V192, P43, DOI 10.1002/cne.901920104; Stephan KE, 2010, NEUROIMAGE, V49, P3099, DOI 10.1016/j.neuroimage.2009.11.015; Stephan KE, 2007, J BIOSCIENCES, V32, P129, DOI 10.1007/s12038-007-0012-5; Stephan KE, 2009, NEUROIMAGE, V46, P1004, DOI 10.1016/j.neuroimage.2009.03.025; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; Wang L, 2010, J COGNITIVE NEUROSCI, V22, P543, DOI 10.1162/jocn.2009.21210; Wang WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066599; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Yeung N, 2010, J EXP PSYCHOL LEARN, V36, P348, DOI 10.1037/a0017894; Zhu Z, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-21	54	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112228	10.1371/journal.pone.0112228	http://dx.doi.org/10.1371/journal.pone.0112228			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401520	Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700035
J	Fu, JH; Tang, J; Han, JH; Hong, Z				Fu, Jianhui; Tang, Jie; Han, Jinghao; Hong, Zhen			The Reduction of Regional Cerebral Blood Flow in Normal-Appearing White Matter Is Associated with the Severity of White Matter Lesions in Elderly: A Xeon-CT Study	PLOS ONE			English	Article							SMALL VESSEL DISEASE; LEUKOARAIOSIS; MRI; HYPERINTENSITIES; PROGRESSION; INDIVIDUALS; DIFFUSION; LADIS	White matter lesions (WMLs) in normal elderly are related to chronic ischemia, and progression of WML occurs mostly in moderate to severe disease. However, the mechanism is uncertain. Thus, we enrolled fifty-six normal elderly patients without large artery disease. The severity of WML on MRI was graded as grade 0, I, II and III using the modified Fazekas scale. Cerebral blood flow (CBF) was measured by Xenon-CT. We found that CBF (mL/100 g/min) within periventricular lesions and in the right and left centrum semiovales were 20.33, 21.27 and 21.03, respectively, in group I; 16.33, 15.55 and 15.91, respectively, in group II; and 14.05, 14.46 and 14.23, respectively, in group III. CBF of normal-appearing white matter (NAWM) around periventricular areas and in the right and left centrum semiovales were 20.79, 22.26 and 22.15, respectively, in group 0; 21.12, 22.17 and 22.25, respectively, in group I; 18.02, 19.45 and 19.62, respectively, in group II; and 16.38, 18.18 and 16.74, respectively, in group III. Significant reductions in CBF were observed not only within lesions but also in NAWM surrounding the lesions. In addition, CBF was reduced significantly within lesions compared to NAWM of the same grade. Furthermore, CBF was reduced significantly in NAWM in grades II and III when compared to grades 0 and I. Our finding indicates that ischemia may play a role in the pathogenesis of WML. Additionally, our finding provides an alternative explanation for finding that the progression of WML occurred more commonly in patients with moderate to severe WML.	[Fu, Jianhui; Tang, Jie; Hong, Zhen] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China; [Fu, Jianhui] Fudan Univ, Pudong Med Ctr, Shanghai Pudong Hosp, Dept Neurol, Shanghai 200433, Peoples R China; [Han, Jinghao] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Han, Jinghao] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Therapeut, Hong Kong, Hong Kong, Peoples R China	Fudan University; Fudan University; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Fu, JH (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China.	jianhuifu@126.com			Science and Technology Commission of Shanghai Municipality [14ZR1437300]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This research was supported by grants form the Science and Technology Commission of Shanghai Municipality (Grant NO. 14ZR1437300). The funder had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Auriel E, 2011, ACTA NEUROL SCAND, V123, P41, DOI 10.1111/j.1600-0404.2010.01341.x; Brown WR, 2011, NEUROPATH APPL NEURO, V37, P56, DOI 10.1111/j.1365-2990.2010.01139.x; Carrera E., 2014, BRAIN; de Groot M, 2013, STROKE, V44, P1037, DOI 10.1161/STROKEAHA.112.680223; DeCarli C, 2005, STROKE, V36, P50, DOI 10.1161/01.STR.0000150668.58689.f2; FAZEKAS F, 1993, NEUROLOGY, V43, P1683, DOI 10.1212/WNL.43.9.1683; Firbank MJ, 2012, BRIT J PSYCHIAT, V201, P40, DOI 10.1192/bjp.bp.111.098897; Fu Jian-hui, 2009, Zhonghua Yi Xue Za Zhi, V89, P1175; Gouw AA, 2011, J NEUROL NEUROSUR PS, V82, P126, DOI 10.1136/jnnp.2009.204685; Grueter BE, 2012, POSTGRAD MED J, V88, P79, DOI 10.1136/postgradmedj-2011-130307; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Hatazawa J, 1997, STROKE, V28, P1944, DOI 10.1161/01.STR.28.10.1944; Kreisel SH, 2013, CEREBROVASC DIS, V35, P544, DOI 10.1159/000350725; Lawrence AJ, 2014, NEUROLOGY; Makedonov I, 2013, EUR J NEUROL, V20, P243, DOI 10.1111/j.1468-1331.2012.03785.x; Miyazawa N, 1997, STROKE, V28, P984, DOI 10.1161/01.STR.28.5.984; Nichtweiss M, 2012, CLIN NEURORADIOL, V22, P193, DOI 10.1007/s00062-012-0134-5; O'Sullivan M, 2002, NEUROLOGY, V59, P321, DOI 10.1212/WNL.59.3.321; O'Sullivan Mike, 2008, Pract Neurol, V8, P26, DOI 10.1136/jnnp.2007.139428; Pantoni L, 1997, STROKE, V28, P652, DOI 10.1161/01.STR.28.3.652; Papma JM, 2014, HUM BRAIN MAPP, V35, P2836, DOI 10.1002/hbm.22370; Poggesi A, 2013, J NEUROL, V260, P1014, DOI 10.1007/s00415-012-6748-3; Sachdev P, 2007, NEUROLOGY, V68, P214, DOI 10.1212/01.wnl.0000251302.55202.73; Schmidt R, 2003, LANCET, V361, P2046, DOI 10.1016/S0140-6736(03)13616-1; Schmidt R, 2010, STROKE, V41, pE402, DOI 10.1161/STROKEAHA.109.576629; Uh J, 2010, J MAGN RESON IMAGING, V32, P184, DOI 10.1002/jmri.22209; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Zhan W, 2009, NEUROIMAGE, V47, pT58, DOI 10.1016/j.neuroimage.2009.02.004	28	7	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112832	10.1371/journal.pone.0112832	http://dx.doi.org/10.1371/journal.pone.0112832			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401786	Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700077
J	Schnabel, RB; Wild, PS; Wilde, S; Ojeda, FM; Schulz, A; Zeller, T; Sinning, CR; Kunde, J; Lackner, KJ; Munzel, T; Blankenberg, S				Schnabel, Renate B.; Wild, Philipp S.; Wilde, Sandra; Ojeda, Francisco M.; Schulz, Andreas; Zeller, Tanja; Sinning, Christoph R.; Kunde, Jan; Lackner, Karl J.; Munzel, Thomas; Blankenberg, Stefan			Multiple Biomarkers and Atrial Fibrillation in the General Population	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; CARDIOVASCULAR EVENTS; NATRIURETIC PEPTIDE; OXIDATIVE STRESS; ADRENOMEDULLIN; PLASMA; ENDOTHELIN-1; EXPRESSION; PERSISTENT; PREDICTION	Background: Different biological pathways have been related to atrial fibrillation (AF). Novel biomarkers capturing inflammation, oxidative stress, and neurohumoral activation have not been investigated comprehensively in AF. Methods and Results: In the population-based Gutenberg Health Study (n = 5000), mean age 56 +/- 11 years, 51% males, we measured ten biomarkers representing inflammation (C-reactive protein, fibrinogen), cardiac and vascular function (midregional pro adrenomedullin [MR-proADM], midregional pro atrial natriuretic peptide [MR-proANP], N-terminal pro-Btype natriuretic peptide [Nt-proBNP], sensitive troponin I ultra [TnI ultra], copeptin, and C-terminal pro endothelin-1), and oxidative stress (glutathioneperoxidase-1, myeloperoxidase) in relation to manifest AF (n = 161 cases). Individuals with AF were older, mean age 64.9 +/- 8.3, and more often males, 71.4%. In Bonferroni-adjusted multivariable regression analyses strongest associations per standard deviation increase in biomarker concentrations were observed for the natriuretic peptides Nt-proBNP (odds ratio [OR] 2.89, 99.5% confidence interval [CI] 2.14-3.90; P<0.0001), MR-proANP (OR 2.45, 99.5% CI 1.91-3.14; P<0.0001), the vascular function marker MR-proADM (OR 1.54, 99.5% CI 1.20-1.99; P<0.0001), TnI ultra (OR 1.50, 99.5% CI 1.19-1.90; P<0.0001) and. fibrinogen (OR 1.44, 99.5% CI 1.19-1.75; P<0.0001). Based on a model comprising known clinical risk factors for AF, all biomarkers combined resulted in a net reclassification improvement of 0.665 (99.3% CI 0.441-0.888) and an integrated discrimination improvement of >13%. Conclusions: In conclusion, in our large, population-based study, we identified novel biomarkers reflecting vascular function, MR-proADM, inflammation, and myocardial damage, TnI ultra, as related to AF; the strong association of natriuretic peptides was confirmed. Prospective studies need to examine whether risk prediction of AF can be enhanced beyond clinical risk factors using these biomarkers.	[Schnabel, Renate B.; Wilde, Sandra; Ojeda, Francisco M.; Zeller, Tanja; Sinning, Christoph R.; Blankenberg, Stefan] Univ Heart Ctr Hamburg Eppendorf, Dept Gen & Intervent Cardiol, Hamburg, Germany; [Wild, Philipp S.; Schulz, Andreas; Munzel, Thomas] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med 2, Mainz, Germany; [Wild, Philipp S.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Thrombosis & Hemostasis, Mainz, Germany; [Kunde, Jan] BRAHMS GmbH, Hennigsdorf, Germany; [Lackner, Karl J.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Clin Chem & Lab Med, Mainz, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Thermo Fisher Scientific; Brahms AG; Johannes Gutenberg University of Mainz	Schnabel, RB (corresponding author), Univ Heart Ctr Hamburg Eppendorf, Dept Gen & Intervent Cardiol, Hamburg, Germany.	schnabelr@gmx.de	Schnabel, Renate B/ABE-6668-2021; Munzel, Thomas/A-2912-2014; Wild, Philipp S./M-2106-2019	Schnabel, Renate B/0000-0001-7170-9509; Munzel, Thomas/0000-0001-5503-4150; Zeller, Tanja/0000-0003-3379-2641; Blankenberg, Stefan/0000-0001-6488-2362; Wild, Philipp/0000-0003-4413-9752; Ojeda, Francisco/0000-0003-4037-144X	government of Rheinland-Pfalz ("Stiftung Rheinland Pfalz fur Innovation") [AZ 961-386261/733]; Johannes Gutenberg-University of Mainz; Boehringer Ingelheim; PHILIPS Medical Systems; Brandenburg Ministry of Economics, Germany; European Regional Development Fund (EFRE/ERDF); Deutsche Forschungsgemeinschaft (German Research Foundation) Emmy Noether Program [SCHN 1149/3-1]	government of Rheinland-Pfalz ("Stiftung Rheinland Pfalz fur Innovation"); Johannes Gutenberg-University of Mainz; Boehringer Ingelheim(Boehringer Ingelheim); PHILIPS Medical Systems; Brandenburg Ministry of Economics, Germany; European Regional Development Fund (EFRE/ERDF)(European Commission); Deutsche Forschungsgemeinschaft (German Research Foundation) Emmy Noether Program(German Research Foundation (DFG))	The Gutenberg Health Study is funded through the government of Rheinland-Pfalz ("Stiftung Rheinland Pfalz fur Innovation", contract number AZ 961-386261/733), the research programs "Wissenschafft Zukunft" and "Schwerpunkt Vaskulare Pravention" of the Johannes Gutenberg-University of Mainz and its contract with Boehringer Ingelheim and PHILIPS Medical Systems including an unrestricted grant for the Gutenberg Health Study. This work was further supported by research grants from the Brandenburg Ministry of Economics, Germany, and the European Regional Development Fund (EFRE/ERDF). The test kits for Copeptin, Ct-pro-endothelin-1, MR-proADM, and MR-proANP were provided by B. R. A. H. M. S, Hennigsdorf, and for Nt-proBNP by Roche Diagnostics, Mannheim at no cost. Dr. Schnabel is supported by Deutsche Forschungsgemeinschaft (German Research Foundation) Emmy Noether Program SCHN 1149/3-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; Bahrmann P, 2014, EUR HEART J ACUTE CA; Bisping E, 2007, AM J PHYSIOL-HEART C, V293, pH3001, DOI 10.1152/ajpheart.01276.2006; Blankenberg S, 2003, NEW ENGL J MED, V349, P1605, DOI 10.1056/NEJMoa030535; Brundel BJJM, 2001, J CARDIOVASC ELECTR, V12, P737, DOI 10.1046/j.1540-8167.2001.00737.x; Bruneau BG, 1997, AM J PHYSIOL-HEART C, V273, pH2678, DOI 10.1152/ajpheart.1997.273.6.H2678; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Carnes CA, 2001, CIRC RES, V89, pE32, DOI 10.1161/hh1801.097644; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Goette A, 2009, EUR HEART J, V30, P1411, DOI 10.1093/eurheartj/ehp046; Hastie T., 2009, UNSUPERVISED LEARNIN; Holstenson E, 2011, EUROPACE, V13, P23, DOI 10.1093/europace/euq325; ICHIKI Y, 1994, FEBS LETT, V338, P6, DOI 10.1016/0014-5793(94)80106-1; Kerkela R, 2011, AM J PHYSIOL-REG I, V300, pR140, DOI 10.1152/ajpregu.00853.2009; Khan SQ, 2007, J AM COLL CARDIOL, V49, P1525, DOI 10.1016/j.jacc.2006.12.038; Kim YM, 2005, CIRC RES, V97, P629, DOI 10.1161/01.RES.0000183735.09871.61; Kong P, 2014, CELL MOL LIFE SCI, V71, P549, DOI 10.1007/s00018-013-1349-6; Korantzopoulos P, 2007, INT J CARDIOL, V115, P135, DOI 10.1016/j.ijcard.2006.04.026; Latini R, 2011, J INTERN MED, V269, P160, DOI 10.1111/j.1365-2796.2010.02287.x; Maisel A, 2010, J AM COLL CARDIOL, V55, P2062, DOI 10.1016/j.jacc.2010.02.025; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Matsukida K, 2001, J AM SOC ECHOCARDIOG, V14, P1080, DOI 10.1067/mje.2001.114911; McKie PM, 2014, CLIN CHEM; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; Morgenthaler NG, 2005, CLIN CHEM, V51, P1823, DOI 10.1373/clinchem.2005.051110; Papassotiriou J, 2006, CLIN CHEM, V52, P1144, DOI 10.1373/clinchem.2005.065581; Patton KK, 2009, CIRCULATION, V120, P1768, DOI 10.1161/CIRCULATIONAHA.109.873265; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Richardson DB, 2003, AM J EPIDEMIOL, V157, P355, DOI 10.1093/aje/kwf217; Rudolph V, 2010, NAT MED, V16, P470, DOI 10.1038/nm.2124; Schnabel RB, 2010, EUR HEART J, V31, P3024, DOI 10.1093/eurheartj/ehq322; Schnabel RB, 2010, ARCH INTERN MED, V170, P1909, DOI 10.1001/archinternmed.2010.434; Schnabel RB, 2010, CIRCULATION, V121, P200, DOI 10.1161/CIRCULATIONAHA.109.882241; Schnabel RB, 2009, AM J CARDIOL, V104, P92, DOI 10.1016/j.amjcard.2009.02.053; Smith JG, 2010, J AM COLL CARDIOL, V56, P1713, DOI 10.1016/j.jacc.2010.05.049; Stefansdottir H, 2011, EUROPACE, V13, P1110, DOI 10.1093/europace/eur132; SUGO S, 1994, BIOCHEM BIOPH RES CO, V201, P1160, DOI 10.1006/bbrc.1994.1827; Tuinenburg AE, 1999, J CARDIOVASC ELECTR, V10, P827, DOI 10.1111/j.1540-8167.1999.tb00263.x; Tuinenburg AE, 1998, AM J CARDIOL, V81, P1207, DOI 10.1016/S0002-9149(98)00092-7; van den Bos EJ, 2011, EUR HEART J, V32, P611, DOI 10.1093/eurheartj/ehq491; Velagaleti RS, 2010, CIRCULATION, V122, P1700, DOI 10.1161/CIRCULATIONAHA.109.929661; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Wozakowska-Kaplon B, 2010, CARDIOL J, V17, P471	44	34	37	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112486	10.1371/journal.pone.0112486	http://dx.doi.org/10.1371/journal.pone.0112486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401728	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700049
J	Balabanova, L; Golotin, V; Kovalchuk, S; Bulgakov, A; Likhatskaya, G; Son, O; Rasskazov, V				Balabanova, Larissa; Golotin, Vasily; Kovalchuk, Svetlana; Bulgakov, Alexander; Likhatskaya, Galina; Son, Oksana; Rasskazov, Valery			A Novel Bifunctional Hybrid with Marine Bacterium Alkaline Phosphatase and Far Eastern Holothurian Mannan-Binding Lectin Activities	PLOS ONE			English	Article							CELOMIC FLUID; T-ANTIGEN; INVERTEBRATE; GLYCOPROTEIN	A fusion between the genes encoding the marine bacterium Cobetia marina alkaline phosphatase (CmAP) and Far Eastern holothurian Apostichopus japonicus mannan-binding C-type lectin (MBL-AJ) was performed. Expression of the fusion gene in E. coli cells resulted in yield of soluble recombinant chimeric protein CmAP/MBL-AJ with the high alkaline phosphatase activity and specificity of the lectin MBL-AJ. The bifunctional hybrid CmAP/MBL-AJ was produced as a dimer with the molecular mass of 200 kDa. The CmAP/MBL-AJ dimer model showed the two-subunit lectin part that is associated with two molecules of alkaline phosphatase functioning independently from each other. The highly active CmAP label genetically linked to MBL-AJ has advantaged the lectin-binding assay in its sensitivity and time. The double substitution A156N/F159K in the lectin domain of CmAP/MBL-AJ has enhanced its lectin activity by 2565%. The bifunctional hybrid holothurian's lectin could be promising tool for developing non-invasive methods for biological markers assessment, particularly for improving the MBL-AJ-based method for early detection of a malignant condition in cervical specimens.	[Balabanova, Larissa; Golotin, Vasily; Kovalchuk, Svetlana; Bulgakov, Alexander; Likhatskaya, Galina; Rasskazov, Valery] Russian Acad Sci, Marine Biochem Lab, GB Elyakov Pacific Inst Bioorgan Chem, Far Eastern Branch, Vladivostok 690022, Russia; [Son, Oksana] Far Eastern Fed Univ, Sch Econ & Management, Vladivostok, Russia	Elyakov Pacific Institute of Bioorganic Chemistry; Russian Academy of Sciences; Far Eastern Federal University	Balabanova, L (corresponding author), Russian Acad Sci, Marine Biochem Lab, GB Elyakov Pacific Inst Bioorgan Chem, Far Eastern Branch, Vladivostok 690022, Russia.	balaban@piboc.dvo.ru	Likhatskaya, Galina/AGO-5605-2022; Balabanova, Larissa/AAO-2209-2020; Likhatskaya, Galina/M-6340-2013	Likhatskaya, Galina/0000-0003-1937-1680; Likhatskaya, Galina/0000-0003-1937-1680; Kovalchuk, Svetlana/0000-0002-5029-0750; Son, Oksana/0000-0002-7995-7387	Russian Found of Fundamental Researches [12-04-00825-a]; Russian projects "Far Eastern" [13-HTPiI-12, 12-I-Pi6-10]; "Scientific Found" of Far Eastern Federal University [14-08-01-11-u]	Russian Found of Fundamental Researches; Russian projects "Far Eastern"; "Scientific Found" of Far Eastern Federal University	The work was supported by grant n. 12-04-00825-a from Russian Found of Fundamental Researches (http://www.rfbr.ru/rffi/ru), the Russian projects "Far Eastern" n. 13-HT Pi I-12, 12-I-Pi 6-10, and the project "Scientific Found" of Far Eastern Federal University n. 14-08-01-11-u (http://www.dvfu.ru/en/web/fefu/). The funders supported the data collection and analysis, and decision to publish.	Arai S, 2014, ACTA CRYSTALLOGR D, V70, P811, DOI 10.1107/S1399004713033609; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bulgakov AA, 2011, PAC MED J, V1, P96; Bulgakov AA, 2007, GLYCOBIOLOGY, V17, P1284, DOI 10.1093/glycob/cwm093; Bulgakov AA, 2013, MAR BIOTECHNOL, V15, P73, DOI 10.1007/s10126-012-9460-5; Chang WC, 2011, BIOCHEM PHARMACOL, V81, P388, DOI 10.1016/j.bcp.2010.10.012; Cuzick J, 2000, BRIT J CANCER, V83, P561, DOI 10.1054/bjoc.2000.1375; de Melo FHM, 2007, J HISTOCHEM CYTOCHEM, V55, P1015, DOI 10.1369/jhc.7A7174.2007; Devi RV, 2010, ITAL J ZOOL, V77, P254, DOI 10.1080/11250003.2010.492794; Drago F, 2009, ISJ-INVERT SURVIV J, V6, P15; Gowda NM, 2008, FISH SHELLFISH IMMUN, V24, P450, DOI 10.1016/j.fsi.2008.01.002; Hatakeyama T, 2011, J BIOL CHEM, V286, P10305, DOI 10.1074/jbc.M110.200576; Helland R, 2009, BBA-PROTEINS PROTEOM, V1794, P297, DOI 10.1016/j.bbapap.2008.09.020; Ivanova JL, 2012, BIOCHIMIE, V94, P1833, DOI 10.1016/j.biochi.2012.04.011; Kim BG, 2013, J GYNECOL ONCOL, V24, P291, DOI 10.3802/jgo.2013.24.4.291; Kuzmanov U, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-31; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Moura RD, 2013, FUND CLIN PHARMACOL, V27, P656, DOI 10.1111/j.1472-8206.2012.01073.x; OVODOV Y S, 1991, Journal of Tumor Marker Oncology, V6, P97; PAVLENKO AF, 1988, TUMOR BIOL, V9, P249, DOI 10.1159/000217569; PAVLENKO AF, 1989, BIOORG KHIM+, V15, P816; Petrova IY, 2009, RUSS J MAR BIOL+, V35, P171, DOI 10.1134/S1063074009020096; Plisova EY, 2005, MAR BIOTECHNOL, V7, P173, DOI 10.1007/s10126-004-3022-4; Reddi AL, 2000, CANCER LETT, V149, P207, DOI 10.1016/S0304-3835(99)00363-8; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sawyers C, 2008, NATURE, V452, P3; Smith AM, 2006, J GYNECOL ONCOL, V24, P291; Sturgeon CM, 2010, USE TUMOR MARKERS LI; Teixeira EH, 2012, CARBOHYDRATES - COMPREHENSIVE STUDIES ON GLYCOBIOLOGY AND GLYCOTECHNOLOGY, P533, DOI 10.5772/50632; Vasilenko AA, 2012, RUSS J MAR BIOL+, V38, P72, DOI 10.1134/S1063074012010130; Yang JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017089	32	6	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112729	10.1371/journal.pone.0112729	http://dx.doi.org/10.1371/journal.pone.0112729			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397876	Green Submitted, gold, Green Published			2022-12-27	WOS:000345558500085
J	Hasselbalch, HC; Thomassen, M; Riley, CH; Kjaer, L; Larsen, TS; Jensen, MK; Bjerrum, OW; Kruse, TA; Skov, V				Hasselbalch, Hans Carl; Thomassen, Mads; Riley, Caroline Hasselbalch; Kjaer, Lasse; Larsen, Thomas Stauffer; Jensen, Morten K.; Bjerrum, Ole Weis; Kruse, Torben A.; Skov, Vibe			Whole Blood Transcriptional Profiling Reveals Deregulation of Oxidative and Antioxidative Defence Genes in Myelofibrosis and Related Neoplasms. Potential Implications of Downregulation of Nrf2 for Genomic Instability and Disease Progression	PLOS ONE			English	Article							CHRONIC MYELOPROLIFERATIVE NEOPLASMS; HEMATOPOIETIC STEM-CELLS; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; CHRONIC INFLAMMATION; MYELOID METAPLASIA; DNA-DAMAGE; IFN-ALPHA; EXPRESSION; CANCER	The Philadelphia-negative chronic myeloproliferative neoplasms - essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF) (MPNs) - have recently been shown to be associated with chronic inflammation, oxidative stress and accumulation of reactive oxygen species (ROS). Using whole blood transcriptional profiling, we report that several oxidative stress and anti-oxidative stress genes are significantly deregulated in MPNs. Among the twenty most up-and downregulated genes, ATOX1, DEFB122, GPX8, PRDX2, PRDX6, PTGS1, and SEPP1 were progressively upregulated from ET over PV to PMF, whereas AKR1B1, CYBA, SIRT2, TTN, and UCP2 were progressively downregulated in ET, PV and PMF (all FDR<0.05). The gene Nrf2, encoding the transcription factor nuclear factor erythroid 2-related factor 2 (NFE2L2 or Nrf2) was significantly downregulated in all MPNs. Nrf2 has a key role in the regulation of the oxidative stress response and modulates both migration and retention of hematopoietic stem cells (HSCs) in their niche. The patogenetic importance of Nrf2 depletion in the context of expansion of the hematopoietic progenitor pool in MPNs is discussed with particular focus upon the implications of concomitant downregulation of Nrf2 and CXCR4 for stem cell mobilization.	[Hasselbalch, Hans Carl; Kjaer, Lasse; Jensen, Morten K.; Skov, Vibe] Univ Copenhagen, Roskilde Hosp, Dept Hematol, Roskilde, Denmark; [Thomassen, Mads; Kruse, Torben A.] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Riley, Caroline Hasselbalch] Univ Copenhagen, Herlev Hosp, Dept Hematol L, DK-2730 Herlev, Denmark; [Larsen, Thomas Stauffer] Odense Univ Hosp, Dept Hematol X, DK-5000 Odense, Denmark; [Bjerrum, Ole Weis] Univ Copenhagen, Rigshosp, Dept Hematol L, DK-2100 Copenhagen, Denmark	University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Southern Denmark; Odense University Hospital; Rigshospitalet; University of Copenhagen	Hasselbalch, HC (corresponding author), Univ Copenhagen, Roskilde Hosp, Dept Hematol, Roskilde, Denmark.	hans.hasselbalch@dadlnet.dk	Hasselbalch, Hans/H-2217-2017; Bjerrum, Ole Weis/AAF-9999-2019	Larsen, Thomas Stauffer/0000-0002-8418-6708; Hasselbalch, Hans/0000-0003-3936-8032	Danish Council for Independent Research Medical Sciences	Danish Council for Independent Research Medical Sciences(Det Frie Forskningsrad (DFF))	The study has received grants from the The Danish Council for Independent Research Medical Sciences (http://fivu.dk/forskning-og-innovation/rad-og-udvalg/det-frieforskningsrad/radet/dff-sundhed-og-sygdom). The funders had no role in study design, data Collection and analysis, decision to publish, or preparation of the manuscript.	Austin C, 2009, LEUKEMIA RES, V33, P1297, DOI 10.1016/j.leukres.2009.04.038; Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Barbui T, 2011, HAEMATOL-HEMATOL J, V96, P315, DOI 10.3324/haematol.2010.031070; Barosi G, 2001, BLOOD, V98, P3249, DOI 10.1182/blood.V98.12.3249; Barzilai A, 2002, DNA REPAIR, V1, P3, DOI 10.1016/S1568-7864(01)00007-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Cencioni C, 2013, INT J MOL SCI, V14, P17643, DOI 10.3390/ijms140917643; Di Bona D, 2006, J HEPATOL, V45, P271, DOI 10.1016/j.jhep.2006.01.037; Ferguson LR, 2010, MUTAT RES-FUND MOL M, V690, P3, DOI 10.1016/j.mrfmmm.2010.03.007; Fleischman AG, 2011, BLOOD, V118, P6392, DOI 10.1182/blood-2011-04-348144; Frederiksen H, 2011, BLOOD, V118, P6515, DOI 10.1182/blood-2011-04-348755; Ghaffari S, 2008, ANTIOXID REDOX SIGN, V10, P1923, DOI 10.1089/ars.2008.2142; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hasselbalch HC, 2013, CYTOKINE GROWTH F R, V24, P133, DOI 10.1016/j.cytogfr.2013.01.004; Hasselbalch HC, 2013, LEUKEMIA RES, V37, P214, DOI 10.1016/j.leukres.2012.10.020; Hasselbalch HC, 2012, BLOOD, V119, P3219, DOI 10.1182/blood-2011-11-394775; Hasselbalch HC, 2011, LEUKEMIA RES, V35, P1330, DOI 10.1016/j.leukres.2011.03.013; Hasselbalch HC, 2013, LEUKEMIA RES, V38, P263, DOI DOI 10.1016/J.LEUKRES.2013.07.002; Hermouet S, 2011, HAEMATOL-HEMATOL J, V96, P1575, DOI 10.3324/haematol.2011.055392; Hole PS, 2011, BLOOD, V117, P5816, DOI 10.1182/blood-2011-01-326025; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Kim J, 2010, MUTAT RES-FUND MOL M, V690, P12, DOI 10.1016/j.mrfmmm.2009.09.007; Larsen TS, 2007, EUR J HAEMATOL, V79, P508, DOI 10.1111/j.1600-0609.2007.00960.x; Marty C, 2013, LEUKEMIA, V27, P2187, DOI 10.1038/leu.2013.102; Merchant AA, 2011, BLOOD, V118, P6572, DOI 10.1182/blood-2011-05-355362; Migliaccio AR, 2008, EXP HEMATOL, V36, P158, DOI 10.1016/j.exphem.2007.10.001; Moll NM, 2010, EXPERT REV HEMATOL, V3, P315, DOI 10.1586/EHM.10.16; Naka K, 2008, ANTIOXID REDOX SIGN, V10, P1883, DOI 10.1089/ars.2008.2114; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Perez C, 2013, HAEMATOLOGICA, V98, P1414, DOI 10.3324/haematol.2013.084160; Riley CH, 2011, BLOOD, V118, P2170, DOI 10.1182/blood-2011-03-340992; Rodriguez RM, 2013, GENES CANC, V4, P105, DOI [DOI 10.1177/194760191347, 10.1177/1947601913479798, DOI 10.1177/1947601913479798]; Rosti V, 2007, BLOOD CELL MOL DIS, V38, P280, DOI 10.1016/j.bcmd.2007.01.003; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Shao LJ, 2011, INT J HEMATOL, V94, P24, DOI 10.1007/s12185-011-0872-1; Silver RT, 2013, EXPERT REV HEMATOL, V6, P49, DOI [10.1586/ehm.12.69, 10.1586/EHM.12.69]; Skov V, 2013, LEUKEMIA LYMPHOMA, V54, P2269, DOI 10.3109/10428194.2013.764417; Skov V, 2012, LEUKEMIA RES, V36, P1387, DOI 10.1016/j.leukres.2012.07.009; Skov V, 2012, EXP HEMATOL, V40, P771, DOI 10.1016/j.exphem.2012.05.011; Skov V, 2012, LEUKEMIA LYMPHOMA, V53, P123, DOI 10.3109/10428194.2011.597905; Skov V, 2011, EUR J HAEMATOL, V87, P54, DOI 10.1111/j.1600-0609.2011.01618.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tothova Z, 2007, CELL STEM CELL, V1, P140, DOI 10.1016/j.stem.2007.07.017; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Tsai JJ, 2013, NAT CELL BIOL, V15, P309, DOI 10.1038/ncb2699; Tzeng YS, 2011, BLOOD, V117, P429, DOI 10.1182/blood-2010-01-266833; Yahata T, 2011, BLOOD, V118, P2941, DOI 10.1182/blood-2011-01-330050; Yalcin S, 2010, EMBO J, V29, P4118, DOI 10.1038/emboj.2010.292	51	53	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112786	10.1371/journal.pone.0112786	http://dx.doi.org/10.1371/journal.pone.0112786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397683	Green Published, gold			2022-12-27	WOS:000345558500091
J	Maldonado, EN; Delgado, I; Furland, NE; Buque, X; Iglesias, A; Aveldano, MI; Zubiaga, A; Fresnedo, O; Ochoa, B				Maldonado, Eduardo N.; Delgado, Igotz; Furland, Natalia E.; Buque, Xabier; Iglesias, Ainhoa; Aveldano, Marta I.; Zubiaga, Ana; Fresnedo, Olatz; Ochoa, Begona			The E2F2 Transcription Factor Sustains Hepatic Glycerophospholipid Homeostasis in Mice	PLOS ONE			English	Article							CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; NORMAL LIVER-REGENERATION; PARTIAL-HEPATECTOMY; MAMMALIAN-CELLS; LIPID MEDIATORS; PHOSPHATIDYLCHOLINE; EXPRESSION; PHOSPHATIDYLETHANOLAMINE; GLYCEROLIPIDS; PROGRESSION	Increasing evidence links metabolic signals to cell proliferation, but the molecular wiring that connects the two core machineries remains largely unknown. E2Fs are master regulators of cellular proliferation. We have recently shown that E2F2 activity facilitates the completion of liver regeneration after partial hepatectomy (PH) by regulating the expression of genes required for S-phase entry. Our study also revealed that E2F2 determines the duration of hepatectomy-induced hepatic steatosis. A transcriptomic analysis of normal adult liver identified "lipid metabolism regulation" as a major E2F2 functional target, suggesting that E2F2 has a role in lipid homeostasis. Here we use wild-type (E2F2(+/+)) and E2F2 deficient (E2F2(-/-)) mice to investigate the in vivo role of E2F2 in the composition of liver lipids and fatty acids in two metabolically different contexts: quiescence and 48-h post-PH, when cellular proliferation and anabolic demands are maximal. We show that liver regeneration is accompanied by large triglyceride and protein increases without changes in total phospholipids both in E2F2(+/+) and E2F2(-/-) mice. Remarkably, we found that the phenotype of quiescent liver tissue from E2F2(-/-) mice resembles the phenotype of proliferating E2F2(+/+) liver tissue, characterized by a decreased phosphatidylcholine to phosphatidylethanolamine ratio and a reprogramming of genes involved in generation of choline and ethanolamine derivatives. The diversity of fatty acids in total lipid, triglycerides and phospholipids was essentially preserved on E2F2 loss both in proliferating and non-proliferating liver tissue, although notable exceptions in inflammation-related fatty acids of defined phospholipid classes were detected. Overall, our results indicate that E2F2 activity sustains the hepatic homeostasis of major membrane glycerolipid components while it is dispensable for storage glycerolipid balance.	[Maldonado, Eduardo N.; Delgado, Igotz; Buque, Xabier; Fresnedo, Olatz; Ochoa, Begona] Univ Basque Country, Fac Med & Dent, Dept Physiol, Leioa, Spain; [Iglesias, Ainhoa; Zubiaga, Ana] Univ Basque Country, Fac Sci & Technol, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain; [Maldonado, Eduardo N.; Furland, Natalia E.; Aveldano, Marta I.] Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Bahi Blanca, Bahia Blanca, Buenos Aires, Argentina; [Maldonado, Eduardo N.; Furland, Natalia E.; Aveldano, Marta I.] Univ Nacl Sur, RA-8000 Bahia Blanca, Buenos Aires, Argentina	University of Basque Country; University of Basque Country; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South	Ochoa, B (corresponding author), Univ Basque Country, Fac Med & Dent, Dept Physiol, Leioa, Spain.	begona.ochoa@ehu.es	Ochoa, Begona/K-9123-2014; Maldonado, Eduardo/AAN-3907-2020; Fresnedo, Olatz/AAT-2084-2021; Delgado, Igotz/N-1205-2014; zubiaga, ana/S-3457-2019; Iglesias, Ainhoa/H-3021-2015; Iglesias, Ainhoa/AAB-8731-2022	Ochoa, Begona/0000-0002-1580-7160; Delgado, Igotz/0000-0001-8675-2921; zubiaga, ana/0000-0002-2132-9708; Iglesias, Ainhoa/0000-0002-2056-8213; Iglesias, Ainhoa/0000-0002-2056-8213; Buque, Xabier/0000-0002-0911-0033; Maldonado, Eduardo/0000-0002-5285-3027	Department of Education, Universities and Research of the Basque Goverment [IT336/10, IT634/2013]; Department of Industry of the Basque Government [PE13UN139, IE12-331]; University of the Basque Country [UFI11/20]	Department of Education, Universities and Research of the Basque Goverment; Department of Industry of the Basque Government; University of the Basque Country	The study design, data collection and analysis and decision to publish were funded by the Department of Education, Universities and Research of the Basque Goverment (grants IT336/10 to BO and OF and IT634/2013 to AZ) and the Department of Industry of the Basque Government(grants PE13UN139 to BO and IE12-331 to AZ). The preparation of the manuscript and the publication costs were funded by the University of the Basque Country (grant UFI11/20 to AZ, AI, BO, OF and XB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2001, CARCINOGENESIS, V22, P795, DOI 10.1093/carcin/22.5.795; Ackerstaff E, 2003, J CELL BIOCHEM, V90, P525, DOI 10.1002/jcb.10659; Arisqueta L, 2013, BBA-MOL CELL BIOL L, V1831, P1357, DOI 10.1016/j.bbalip.2013.04.015; ARVIDSON GA, 1968, EUR J BIOCHEM, V4, P478, DOI 10.1111/j.1432-1033.1968.tb00237.x; Attard GS, 2000, P NATL ACAD SCI USA, V97, P9032, DOI 10.1073/pnas.160260697; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Banchio C, 2006, J BIOL CHEM, V281, P10010, DOI 10.1074/jbc.M513503200; Blanchet E, 2011, NAT CELL BIOL, V13, P1146, DOI 10.1038/ncb2309; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; BROWN ER, 1994, LIPIDS, V29, P825, DOI 10.1007/BF02536249; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chong JL, 2009, NATURE, V462, P930, DOI 10.1038/nature08677; Christie W.W., 2003, LIPID ANAL; de Molina AR, 2002, ONCOGENE, V21, P4317, DOI 10.1038/sj.onc.1205556; Delgado I, 2011, AM J PHYSIOL-GASTR L, V301, pG20, DOI 10.1152/ajpgi.00481.2010; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Dong Hua-Ming, 2008, Indian J Gastroenterol, V27, P31; Fagone P, 2013, BBA-MOL CELL BIOL L, V1831, P523, DOI 10.1016/j.bbalip.2012.09.009; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Gazit V, 2010, HEPATOLOGY, V52, P2109, DOI 10.1002/hep.23920; Goodman JM, 2009, J LIPID RES, V50, P2148, DOI 10.1194/jlr.R001446; Hishikawa D, 2014, J LIPID RES, V55, P799, DOI 10.1194/jlr.R046094; HOLUB BJ, 1987, METHOD ENZYMOL, V141, P234; Hu W, 2014, HEPATOLOGY, V59, P651, DOI 10.1002/hep.26584; Infante A, 2008, CELL CYCLE, V7, P3915, DOI 10.4161/cc.7.24.7379; Jackowski S, 1996, J BIOL CHEM, V271, P20219, DOI 10.1074/jbc.271.34.20219; Jackowski S, 2000, BBA-MOL CELL BIOL L, V1483, P301, DOI 10.1016/S1388-1981(99)00203-6; Kong LJ, 2007, ONCOGENE, V26, P321, DOI 10.1038/sj.onc.1209817; Krahmer N, 2011, CELL METAB, V14, P504, DOI 10.1016/j.cmet.2011.07.013; Krahmer N, 2009, CELL, V139, P1024, DOI 10.1016/j.cell.2009.11.023; LAI HS, 1992, JPEN-PARENTER ENTER, V16, P152, DOI 10.1177/0148607192016002152; Laresgoiti U, 2013, NUCLEIC ACIDS RES, V41, P10185, DOI 10.1093/nar/gkt821; Li FX, 2003, MOL CELL BIOL, V23, P3607, DOI 10.1128/MCB.23.10.3607-3622.2003; Li ZY, 2008, J LIPID RES, V49, P1187, DOI 10.1194/jlr.R700019-JLR200; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Lukas ER, 1999, MOL CARCINOGEN, V25, P295, DOI 10.1002/(SICI)1098-2744(199908)25:4<295::AID-MC8>3.0.CO;2-9; Lukas J, 1996, MOL CELL BIOL, V16, P1047; Lykidis A, 2001, PROG NUCLEIC ACID RE, V65, P361; Marhenke S, 2014, GUT, V63, P1501, DOI 10.1136/gutjnl-2013-304829; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Moessinger C, 2011, J BIOL CHEM, V286, P21330, DOI 10.1074/jbc.M110.202424; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Murga M, 2001, IMMUNITY, V15, P959, DOI 10.1016/S1074-7613(01)00254-0; Nevzorova YA, 2009, GASTROENTEROLOGY, V137, P691, DOI 10.1053/j.gastro.2009.05.003; Ochoa B, 2010, HEPATOLOGY, V51, P1712, DOI 10.1002/hep.23525; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Ruiz JI, 1997, J LIPID RES, V38, P1482; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Sirma H, 2011, GASTROENTEROLOGY, V141, P326, DOI 10.1053/j.gastro.2011.03.047; Sugimoto H, 2008, PROG LIPID RES, V47, P204, DOI 10.1016/j.plipres.2008.01.002; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Thevananther S, 2010, HEPATOLOGY, V52, P1875, DOI 10.1002/hep.24057; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; Vance JE, 2013, BBA-MOL CELL BIOL L, V1831, P543, DOI 10.1016/j.bbalip.2012.08.016; Wu GS, 2008, J BIOL CHEM, V283, P1456, DOI 10.1074/jbc.M708766200; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Yamashita A, 2014, PROG LIPID RES, V53, P18, DOI 10.1016/j.plipres.2013.10.001; Yen CLE, 1999, FASEB J, V13, P135, DOI 10.1096/fasebj.13.1.135	63	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112620	10.1371/journal.pone.0112620	http://dx.doi.org/10.1371/journal.pone.0112620			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396754	Green Published, gold			2022-12-27	WOS:000345558500069
J	Uchida, Y; Kouyama, J; Naiki, K; Mochida, S				Uchida, Yoshihito; Kouyama, Jun-ichi; Naiki, Kayoko; Mochida, Satoshi			A Novel Simple Assay System to Quantify the Percent HCV-RNA Levels of NS5A Y93H Mutant Strains and Y93 Wild-Type Strains Relative to the Total HCV-RNA Levels to Determine the Indication for Antiviral Therapy with NS5A Inhibitors	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; GENOTYPE 1B INFECTION; HEPATOCELLULAR-CARCINOMA; TELAPREVIR; RIBAVIRIN; PEGINTERFERON; DACLATASVIR; ASUNAPREVIR; JAPAN; EPIDEMIOLOGY	Aim: Oral treatment with asunaprevir and daclatasvir has been reported to yield a SVR ratio of 80% in patients with genotype 1b HCV infection, however, treatment failure has been reported, especially in patients with HCV strains showing the NS5A-Y93H mutation at baseline. An assay system to detect such strains was established to facilitate selection of appropriate candidates for this antiviral therapy. Methods: Primer sets and 2 types of cycling probe mixtures were designed, and real-time PCR was performed with HCV-RNA purified from 332 patients with genotype 1b HCV infection, and the results were compared with those obtained by direct sequencing. Results: Both the wild-type and mutant strains were quantified, with a threshold of 4.0 Log copies/mL, in 295 of the 332 patients (88.9%), and the percentage of the mutant strains relative to the total HCV-RNA level in the serum was calculated. The percentage was 0% in 237 patients (80.3%) and 100% in 23 patients (7.8%), identical to the results of direct sequencing. Both wild-type and mutant strains were detected in the remaining 35 patients (11.9%), at levels between 1% and 99%, despite the mutant strains having been undetectable by direct sequencing in 11 patients with percentages of these strains of less than 25%. Conclusion: A novel assay system to quantify the percent RNA of Y93H mutant strains relative to the total HCV-RNA level was established. This system may be useful to determine the indication for treatment with NA5A inhibitors in patients with HCV.	[Uchida, Yoshihito; Kouyama, Jun-ichi; Naiki, Kayoko; Mochida, Satoshi] Saitama Med Univ, Dept Gastroenterol & Hepatol, Saitama, Japan	Saitama Medical University	Mochida, S (corresponding author), Saitama Med Univ, Dept Gastroenterol & Hepatol, Saitama, Japan.	smochida@saitama-med.ac.jp		Uchida, Yoshihito/0000-0002-6012-0915; Kouyama, Jun-ichi/0000-0003-1072-2931				Berg T, 2006, GASTROENTEROLOGY, V130, P1086, DOI 10.1053/j.gastro.2006.02.015; Chayama K, 2013, J GASTROENTEROL, V48, P1, DOI 10.1007/s00535-012-0714-9; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Furusyo N, 2013, J HEPATOL, V59, P205, DOI 10.1016/j.jhep.2013.03.020; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hayashi N, 2012, J VIRAL HEPATITIS, V19, pE134, DOI 10.1111/j.1365-2893.2011.01528.x; Hayashi N, 2014, J GASTROENTEROL, V49, P138, DOI 10.1007/s00535-013-0875-1; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Ikai I, 2007, HEPATOL RES, V37, P676, DOI 10.1111/j.1872-034X.2007.00119.x; Karino Y, 2013, J HEPATOL, V58, P646, DOI 10.1016/j.jhep.2012.11.012; Kumada H, 2014, HEPATOLOGY, V59, P2083, DOI 10.1002/hep.27113; Kumada H, 2012, J HEPATOL, V56, P78, DOI 10.1016/j.jhep.2011.07.016; Kwo PY, 2010, LANCET, V376, P1224; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Miura M, 2014, HEPATOL RES, V44, pE360, DOI 10.1111/hepr.12316; Pearlman BL, 2007, HEPATOLOGY, V46, P1688, DOI 10.1002/hep.21919; Sugawara K, 2014, J GASTROENTEROL, V49, P363, DOI 10.1007/s00535-013-0889-8; Suzuki F, 2012, J CLIN VIROL, V54, P352, DOI 10.1016/j.jcv.2012.04.024; Suzuki Y, 2013, J HEPATOL, V58, P655, DOI 10.1016/j.jhep.2012.09.037; Umemura T, 2009, J GASTROENTEROL, V44, P102, DOI 10.1007/s00535-008-2251-0	21	45	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112647	10.1371/journal.pone.0112647	http://dx.doi.org/10.1371/journal.pone.0112647			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397971	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500071
J	Lai, PMR; Dasenbrock, H; Du, R				Lai, Pui Man Rosalind; Dasenbrock, Hormuzdiyar; Du, Rose			The Association between Meteorological Parameters and Aneurysmal Subarachnoid Hemorrhage: A Nationwide Analysis	PLOS ONE			English	Article							BLOOD-PRESSURE; VITAMIN-D; BAROMETRIC-PRESSURE; CLIMATIC CONDITIONS; SEASONAL-VARIATION; RUPTURE; TEMPERATURE; RISK; IMMUNITY; WEATHER	Prior research has suggested that regional weather patterns impact the risk of rupture of cerebral aneurysms, but the findings in the literature have been inconsistent. Furthermore, no nationwide analysis to date has examined the association between meteorological factors and the post-procedural outcomes of patients after the treatment for ruptured cerebral aneurysms. The purpose of this study was to use a nationwide sample to analyze the association between specific meteorological parameters-temperature, precipitation, sunlight, and humidity-and hospital admission rate for and outcome after aneurysmal subarachnoid hemorrhage. Patients were identified using the Nationwide Inpatient Sample (2001-2010): Those with an ICD-9 diagnosis code for subarachnoid hemorrhage and a procedural code for aneurysm repair were included. Climate data were obtained from the State of the Climate Report 2010 released by the National Climatic Data Center. Multivariate regression models were constructed to analyze the association between average state monthly temperature, precipitation, and percent possible sunlight, as well as relative morning humidity and both monthly hospital admission rate, adjusted for annual state population in millions, and in-hospital mortality. 16,970 admissions were included from 723 hospitals across 41 states. Decreased daily sunlight and lower relative humidity were associated with an increased rate of admission for ruptured cerebral aneurysms (p<0.001), but had no association with differential inpatient mortality. No significant changes in these observed associations were seen when multivariate analyses were constructed. This is the first nationwide study to suggest that decreased sunlight and lower relative humidity are associated with admission for ruptured cerebral aneurysms. While it has been postulated that external atmospheric factors may cause hormonal and homeostatic changes that impact the risk of rupture of cerebral aneurysms, additional research is needed to confirm and further understand these relationships.	[Lai, Pui Man Rosalind; Dasenbrock, Hormuzdiyar; Du, Rose] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Lai, Pui Man Rosalind; Dasenbrock, Hormuzdiyar; Du, Rose] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Du, R (corresponding author), Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA.	rdu@partners.org	Lai, Rosalind/AAG-3680-2021; Du, Rose/AAJ-2873-2020; Du, Rose/I-5402-2012	Du, Rose/0000-0003-2641-6496				Abe T, 2008, J CLIN NEUROSCI, V15, P1005, DOI 10.1016/j.jocn.2007.07.081; Ali Y, 2008, CLIN NEUROL NEUROSUR, V110, P462, DOI 10.1016/j.clineuro.2008.02.001; Amrein K, 2014, CRIT CARE, V18, DOI 10.1186/cc13790; Beseoglu K, 2008, NEUROSURGERY, V62, P1033, DOI 10.1227/01.neu.0000325864.91584.c7; BRENNAN PJ, 1982, BMJ-BRIT MED J, V285, P919, DOI 10.1136/bmj.285.6346.919; Buxton N, 2001, J NEUROSURG, V95, P391, DOI 10.3171/jns.2001.95.3.0391; Chalouhi N, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/271582; CHYATTE D, 1994, J NEUROSURG, V81, P525, DOI 10.3171/jns.1994.81.4.0525; Cowperthwaite MC, 2011, NEUROSURGERY, V68, P132, DOI 10.1227/NEU.0b013e3181fe23a1; de Craen AJM, 2005, INT J GERIATR PSYCH, V20, P269, DOI 10.1002/gps.1277; Fang CW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000842; Feigin VL, 2002, EUR J NEUROL, V9, P511, DOI 10.1046/j.1468-1331.2002.00455.x; Gill RS, 2013, WORLD NEUROSURG, V79, P136, DOI 10.1016/j.wneu.2012.06.020; Hashiguchi N, 2013, INDOOR AIR, V23, P430, DOI 10.1111/ina.12039; Hewison M, 2012, CLIN ENDOCRINOL, V76, P315, DOI 10.1111/j.1365-2265.2011.04261.x; Hughes MA, 2010, BRIT J NEUROSURG, V24, P396, DOI 10.3109/02688697.2010.499154; Inagawa T, 2000, J NEUROSURG, V93, P958, DOI 10.3171/jns.2000.93.6.0958; Jeong Tae Seok, 2013, J Cerebrovasc Endovasc Neurosurg, V15, P152, DOI 10.7461/jcen.2013.15.3.152; Kent ST, 2013, ANN NEUROL, V73, P32, DOI 10.1002/ana.23737; Kirkness CJ, 2008, NEUROCRIT CARE, V8, P380, DOI 10.1007/s12028-007-9034-y; Koffijberg H, 2008, J NEUROL NEUROSUR PS, V79, P294, DOI 10.1136/jnnp.2007.123901; Landers AT, 1997, BRIT J NEUROSURG, V11, P191, DOI 10.1080/02688699746230; Law H. Y., 2009, Hong Kong Medical Journal, V15, P85; LEJEUNE JP, 1994, STROKE, V25, P338, DOI 10.1161/01.STR.25.2.338; Leow L, 2011, RESPIROLOGY, V16, P611, DOI 10.1111/j.1440-1843.2011.01924.x; Lindgren AE, 2014, ANN MED; Luykx JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030497; McDonald RJ, 2012, AM J NEURORADIOL, V33, P1663, DOI 10.3174/ajnr.A3059; Modesti PA, 2013, HYPERTENSION, V61, P908, DOI 10.1161/HYPERTENSIONAHA.111.00315; Muroi C, 2004, ACTA NEUROCHIR, V146, P659, DOI 10.1007/s00701-004-0278-4; Neidert MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081621; OVERLACK A, 1987, HYPERTENSION, V9, P139, DOI 10.1161/01.HYP.9.2.139; Oyoshi T, 1999, NEUROL MED-CHIR, V39, P585, DOI 10.2176/nmc.39.585; Piters WAAD, 2013, J NEUROL, V260, P614, DOI 10.1007/s00415-012-6687-z; Rostand SG, 1997, HYPERTENSION, V30, P150, DOI 10.1161/01.HYP.30.2.150; Setzer M, 2007, SURG NEUROL, V67, P264, DOI 10.1016/j.surneu.2006.06.060; Slatina Enes, 2012, Mater Sociomed, V24, P232, DOI 10.5455/msm.2012.24.232-237; Takagi H, 2005, J VASC SURG, V41, P735, DOI 10.1016/j.jvs.2005.01.011; TAKAHASHI E., 1957, HUMAN BIOL, V29, P139; Tamez H, 2013, CURR OPIN NEPHROL HY, V22, P204, DOI 10.1097/MNH.0b013e32835d919b; TAYLOR CL, 1995, J NEUROSURG, V83, P812, DOI 10.3171/jns.1995.83.5.0812; TSEMENTZIS SA, 1991, ACTA NEUROCHIR, V111, P80, DOI 10.1007/BF01400492; VINALL PE, 1994, EPIDEMIOLOGY, V5, P302, DOI 10.1097/00001648-199405000-00008; Vulekovic P, 2011, ACTA NEUROCHIR, V153, P1313, DOI 10.1007/s00701-011-1017-2	44	17	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112961	10.1371/journal.pone.0112961	http://dx.doi.org/10.1371/journal.pone.0112961			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393630	Green Published, gold, Green Submitted			2022-12-27	WOS:000347709300127
J	Chen, L; Perks, KL; Stick, SM; Kicic, A; Larcombe, AN; Zosky, G				Chen, Ling; Perks, Kara L.; Stick, Stephen M.; Kicic, Anthony; Larcombe, Alexander N.; Zosky, Graeme			House Dust Mite Induced Lung Inflammation Does Not Alter Circulating Vitamin D Levels	PLOS ONE			English	Article							D DEFICIENCY; IMMUNE REGULATION; ALLERGIC-ASTHMA; DISEASE; MECHANISMS; CELLS; CHALLENGE; AIRWAYS; MODELS; MOUSE	Low circulating levels of 25-hydroxyvitaminD [25(OH)D] are associated with chronic lungDiseases such as asthma. However, it is unclear whether vitaminD is involved inDisease pathogenesis or is modified by the inflammation associated with theDisease process. We hypothesized that allergic inflammationDecreases the level of circulating 25(OH)D and tested this using a mice model of houseDust mite (HDM) induced allergic airway inflammation. Cellular influx was measured in bronchoalvelar lavage (BAL) fluid, and allergic sensitization and 25(OH)D levels were measured in serum. Exposure to HDM caused a robust inflammatory response in the lung that was enhanced by prior influenza infection. These responses were not associated with any change in circulating levels of 25(OH)D. TheseData suggest that alterations in circulating 25(OH)D levels induced by Th-2Driven inflammation are unlikely to explain the cross-sectional epidemiological association between vitaminDDeficiency and asthma.	[Chen, Ling; Zosky, Graeme] Univ Tasmania, Fac Hlth, Sch Med, Hobart, Tas, Australia; [Perks, Kara L.] Harry Perkins Inst Med Res, Nedlands, WA, Australia; [Stick, Stephen M.; Kicic, Anthony; Larcombe, Alexander N.] Univ Western Australia, Telethon Kids Inst, Subiaco, WA, Australia	University of Tasmania; Harry Perkins Institute of Medical Research; Telethon Kids Institute; University of Western Australia	Chen, L (corresponding author), Univ Tasmania, Fac Hlth, Sch Med, Hobart, Tas, Australia.	L.Chen@utas.edu.au	Larcombe, Alexander/AAG-8533-2019; Perks, Kara/O-8701-2014; Kicic, Anthony/ABA-1252-2021; Stick, Stephen/GZG-7584-2022; Zosky, Graeme/B-2048-2014; Stick, Stephen/AAA-5945-2021	Larcombe, Alexander/0000-0003-4196-4482; Kicic, Anthony/0000-0002-0008-9733; Stick, Stephen/0000-0002-5386-8482; Chen, Ling/0000-0003-1897-9264; Perks, Kara/0000-0001-5511-3844; Zosky, Graeme/0000-0001-9039-0302	NHMRC project, Australia [1042235, 1026494]	NHMRC project, Australia	This work was supported by NHMRC project grants (1042235 and 1026494), Australia (http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PH, 2008, MOL CELL ENDOCRINOL, V285, P1, DOI 10.1016/j.mce.2007.12.018; BERGER U, 1988, J CLIN ENDOCR METAB, V67, P607, DOI 10.1210/jcem-67-3-607; Birrell MA, 2010, EUR RESPIR J, V36, P1220, DOI 10.1183/09031936.00069110; Brehm JM, 2010, J ALLERGY CLIN IMMUN, V126, p[52, e55]; Cantorna MT, 2008, MOL ASPECTS MED, V29, P369, DOI 10.1016/j.mam.2008.04.004; Chandra P, 2007, PHOTODERMATOL PHOTO, V23, P179, DOI 10.1111/j.1600-0781.2007.00302.x; Chen S, 2007, J IMMUNOL, V179, P1634, DOI 10.4049/jimmunol.179.3.1634; Deluca HF, 2001, FASEB J, V15, P2579, DOI 10.1096/fj.01-0433rev; Ding C, 2010, J INTERN MED, V268, P501, DOI 10.1111/j.1365-2796.2010.02267.x; Douwes J, 2002, THORAX, V57, P643, DOI 10.1136/thorax.57.7.643; Duncan A, 2012, AM J CLIN NUTR, V95, P64, DOI 10.3945/ajcn.111.023812; Finklea JD, 2011, ADV NUTR, V2, P244, DOI 10.3945/an.111.000398; Foong RE, 2013, NUTRIENTS, V5, P2880, DOI 10.3390/nu5082880; Ginde AA, 2009, CURR ALLERGY ASTHM R, V9, P81, DOI 10.1007/s11882-009-0012-7; Gould HJ, 2003, ANNU REV IMMUNOL, V21, P579, DOI 10.1146/annurev.immunol.21.120601.141103; Gregory LG, 2009, CLIN EXP ALLERGY, V39, P1597, DOI 10.1111/j.1365-2222.2009.03302.x; Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Horvat JC, 2010, J IMMUNOL, V184, P4159, DOI 10.4049/jimmunol.0902287; Hypponen E, 2004, ANN NY ACAD SCI, V1037, P84, DOI 10.1196/annals.1337.013; Lloyd CM, 2010, NAT REV IMMUNOL, V10, P838, DOI 10.1038/nri2870; Maezawa Y, 2004, CLIN EXP IMMUNOL, V135, P12, DOI 10.1111/j.1365-2249.2004.02337.x; Nials AT, 2008, DIS MODEL MECH, V1, P213, DOI 10.1242/dmm.000323; Overbergh L, 2000, CLIN EXP IMMUNOL, V120, P139, DOI 10.1046/j.1365-2249.2000.01204.x; Overbergh L, 2006, J CLIN ENDOCR METAB, V91, P3566, DOI 10.1210/jc.2006-0678; Phan JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092163; Poon AH, 2004, AM J RESP CRIT CARE, V170, P967, DOI 10.1164/rccm.200403-412oc; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Sundaram ME, 2012, ADV NUTR, V3, P517, DOI 10.3945/an.112.002162; Sutherland ER, 2010, AM J RESP CRIT CARE, V181, P699, DOI 10.1164/rccm.200911-1710OC; Zosky GR, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-15; Zosky GR, 2011, AM J RESP CRIT CARE, V183, P1336, DOI 10.1164/rccm.201010-1596OC	32	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112589	10.1371/journal.pone.0112589	http://dx.doi.org/10.1371/journal.pone.0112589			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391140	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400106
J	Feng, GD; Zhao, Y; Tian, X; Gao, ZQ				Feng, Guodong; Zhao, Yang; Tian, Xu; Gao, Zhiqiang			A New 3-Dimensional Dynamic Quantitative Analysis System of Facial Motion: An Establishment and Reliability Test	PLOS ONE			English	Article							VIDEO; EPIDEMIOLOGY	This study aimed to establish a 3-dimensional dynamic quantitative facial motion analysis system, and then determine its accuracy and test-retest reliability. The system could automatically reconstruct the motion of the observational points. Standardized T-shaped rod and L-shaped rods were used to evaluate the static and dynamic accuracy of the system. Nineteen healthy volunteers were recruited to test the reliability of the system. The average static distance error measurement was 0.19 mm, and the average angular error was 0.29 degrees. The measuring results decreased with the increase of distance between the cameras and objects, 80 cm of which was considered to be optimal. It took only 58 seconds to perform the full facial measurement process. The average intra-class correlation coefficient for distance measurement and angular measurement was 0.973 and 0.794 respectively. The results demonstrated that we successfully established a practical 3-dimensional dynamic quantitative analysis system that is accurate and reliable enough to meet both clinical and research needs.	[Gao, Zhiqiang] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Otolaryngol, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Gao, ZQ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Otolaryngol, Beijing 100730, Peoples R China.	talllee@sina.com			National Natural Science Foundation of China [81341031]; Chinese National Science & Technology Pillar Program during the 12th Five-year Plan Period [2012BAI12B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Science & Technology Pillar Program during the 12th Five-year Plan Period	This study was supported by the National Natural Science Foundation of China (Grant No. 81341031) and Chinese National Science & Technology Pillar Program during the 12th Five-year Plan Period (Grant No. 2012BAI12B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chee G H, 2000, Facial Plast Surg, V16, P315, DOI 10.1055/s-2000-15547; De Diego-Sastre JI, 2005, REV NEUROLOGIA, V41, P287, DOI 10.33588/rn.4105.2004593; Feng GD, 2012, ORL J OTO-RHINO-LARY, V74, P220, DOI 10.1159/000340045; Frey M, 1994, Eur Arch Otorhinolaryngol, pS182; Frey M, 1999, PLAST RECONSTR SURG, V104, P2032, DOI 10.1097/00006534-199912000-00013; Gao H, 2007, MARKER BASED FACIAL; Gao Y, 2014, IEEE T IND ELECTRON, V61, P2088, DOI 10.1109/TIE.2013.2262760; Gross MM, 1996, ANGLE ORTHOD, V66, P189; Hontanilla B, 2008, J PLAST RECONSTR AES, V61, P18, DOI 10.1016/j.bjps.2007.03.037; HOUSE JW, 1985, OTOLARYNG HEAD NECK, V93, P146, DOI 10.1177/019459988509300202; Ji RR, 2012, INT J COMPUT VISION, V96, P290, DOI 10.1007/s11263-011-0472-9; Kang TS, 2002, OTOL NEUROTOL, V23, P767, DOI 10.1097/00129492-200209000-00026; Mehta RP, 2008, OTOLARYNG HEAD NECK, V138, P468, DOI 10.1016/j.otohns.2007.12.017; Monini S, 2010, ACTA OTORHINOLARYNGO, V30, P198; Neely JG, 2010, LARYNGOSCOPE, V120, P1038, DOI 10.1002/lary.20868; PALETZ JL, 1994, PLAST RECONSTR SURG, V93, P784, DOI 10.1097/00006534-199404000-00020; Salgado Moses D, 2010, Facial Plast Surg Clin North Am, V18, P351, DOI 10.1016/j.fsc.2010.01.011; Somia NN, 2000, CLIN BIOMECH, V15, P766, DOI 10.1016/S0268-0033(00)00062-0; Trotman CA, 1996, ANGLE ORTHOD, V66, P195; Tzou CHJ, 2012, ANN PLAS SURG, V69, P173, DOI 10.1097/SAP.0b013e3182223d96; Zhao SC, 2013, NEUROCOMPUTING, V119, P101, DOI 10.1016/j.neucom.2012.04.042	21	3	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e113115	10.1371/journal.pone.0113115	http://dx.doi.org/10.1371/journal.pone.0113115			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390881	gold, Green Published, Green Submitted			2022-12-27	WOS:000349144400147
J	Hamilton, B; Manzella, A; Schmidt, K; DiMarco, V; Butler, JS				Hamilton, Brooke; Manzella, Alexander; Schmidt, Karyn; DiMarco, Victoria; Butler, J. Scott			Analysis of Non-Typeable Haemophilous influenzae VapC1 Mutations Reveals Structural Features Required for Toxicity and Flexibility in the Active Site	PLOS ONE			English	Article							TOXIN-ANTITOXIN SYSTEMS; 18S RIBOSOMAL-RNA; PIN-DOMAIN; CRYSTAL-STRUCTURE; MYCOBACTERIUM-TUBERCULOSIS; PLASMID MAINTENANCE; PROTEIN; CLEAVAGE; ENDONUCLEASE; RIBONUCLEASE	Bacteria have evolved mechanisms that allow them to survive in the face of a variety of stresses including nutrient deprivation, antibiotic challenge and engulfment by predator cells. A switch to dormancy represents one strategy that reduces energy utilization and can render cells resistant to compounds that kill growing bacteria. These persister cells pose a problem during treatment of infections with antibiotics, and dormancy mechanisms may contribute to latent infections. Many bacteria encode toxin-antitoxin (TA) gene pairs that play an important role in dormancy and the formation of persisters. VapBC gene pairs comprise the largest of the Type II TA systems in bacteria and they produce a VapC ribonuclease toxin whose activity is inhibited by the VapB antitoxin. Despite the importance of VapBC TA pairs in dormancy and persister formation, little information exists on the structural features of VapC proteins required for their toxic function in vivo. Studies reported here identified 17 single mutations that disrupt the function of VapC1 from non-typeable H. influenzae in vivo. 3-D modeling suggests that side chains affected by many of these mutations sit near the active site of the toxin protein. Phylogenetic comparisons and secondary mutagenesis indicate that VapC1 toxicity requires an alternative active site motif found in many proteobacteria. Expression of the antitoxin VapB1 counteracts the activity of VapC1 mutants partially defective for toxicity, indicating that the antitoxin binds these mutant proteins in vivo. These findings identify critical chemical features required for the biological function of VapC toxins and PIN-domain proteins.	[Hamilton, Brooke; Manzella, Alexander; DiMarco, Victoria; Butler, J. Scott] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Schmidt, Karyn; Butler, J. Scott] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Butler, J. Scott] Univ Rochester, Med Ctr, Ctr RNA Biol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Butler, JS (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	scott_butler@urmc.rochester.edu		Manzella, Alexander/0000-0002-9808-8498	National Institutes of Health [GM-099731]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099731] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM-099731 to JSB, http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahidjo BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021738; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81; Anantharaman Vivek, 2006, RNA Biol, V3, P18; Arcus VL, 2011, PROTEIN ENG DES SEL, V24, P33, DOI 10.1093/protein/gzq081; Arcus VL, 2005, TRENDS MICROBIOL, V13, P360, DOI 10.1016/j.tim.2005.06.008; Bleichert F, 2006, P NATL ACAD SCI USA, V103, P9464, DOI 10.1073/pnas.0603673103; Bunker RD, 2008, PROTEINS, V72, P510, DOI 10.1002/prot.22048; Cline SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032199; Clissold PM, 2000, CURR BIOL, V10, pR888, DOI 10.1016/S0960-9822(00)00858-7; Daines DA, 2007, J BACTERIOL, V189, P5041, DOI 10.1128/JB.00290-07; Dienemann C, 2011, J MOL BIOL, V414, P713, DOI 10.1016/j.jmb.2011.10.024; Fasani RA, 2013, P NATL ACAD SCI USA, V110, pE2528, DOI 10.1073/pnas.1301023110; Fatica A, 2004, RNA, V10, P1698, DOI 10.1261/rna.7123504; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; Gerdes K, 2000, J BACTERIOL, V182, P561, DOI 10.1128/JB.182.3.561-572.2000; Glavan F, 2006, EMBO J, V25, P5117, DOI 10.1038/sj.emboj.7601377; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Huntzinger E, 2008, RNA, V14, P2609, DOI 10.1261/rna.1386208; JAFFE A, 1985, J BACTERIOL, V163, P841; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lamanna AC, 2009, P NATL ACAD SCI USA, V106, P14259, DOI 10.1073/pnas.0905403106; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Mate MJ, 2012, NUCLEIC ACIDS RES, V40, P3245, DOI 10.1093/nar/gkr1167; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; McKenzie JL, 2012, RNA, V18, P1267, DOI 10.1261/rna.031229.111; Miallau L, 2009, J BIOL CHEM, V284, P276, DOI 10.1074/jbc.M805061200; Miller J.H., 1972, EXPT MOL GENETICS; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; Schneider C, 2009, NUCLEIC ACIDS RES, V37, P1127, DOI 10.1093/nar/gkn1020; Schuster-Bockler B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-7; Sharp JD, 2012, J BIOL CHEM; Takeshita D, 2007, PROTEINS, V68, P980, DOI 10.1002/prot.21351; Takeshita D, 2006, ACTA CRYSTALLOGR F, V62, P656, DOI 10.1107/S1744309106020057; van Kessel Julia C., 2008, V435, P203, DOI 10.1007/978-1-59745-232-8_15; Winther KS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3796; Winther KS, 2011, P NATL ACAD SCI USA, V108, P7403, DOI 10.1073/pnas.1019587108; Zhu L, 2010, J BIOL CHEM, V285, P39732, DOI 10.1074/jbc.M110.163105	40	9	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112921	10.1371/journal.pone.0112921	http://dx.doi.org/10.1371/journal.pone.0112921			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391136	gold, Green Submitted, Green Published			2022-12-27	WOS:000349144400142
J	Christensen, QH; Brecht, RM; Dudekula, D; Greenberg, EP; Nagarajan, R				Christensen, Quin H.; Brecht, Ryan M.; Dudekula, Dastagiri; Greenberg, E. Peter; Nagarajan, Rajesh			Evolution of Acyl-Substrate Recognition by a Family of Acyl-Homoserine Lactone Synthases	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; QUORUM-SENSING SIGNAL; ACID SYNTHESIS; SPECIFICITY; LUXI; AUTOINDUCER; HISTORY; GENES	Members of the LuxI protein family catalyze synthesis of acyl-homoserine lactone (acyl-HSL) quorum sensing signals from S-adenosyl-L-methionine and an acyl thioester. Some LuxI family members prefer acyl-CoA, and others prefer acyl-acyl carrier protein (ACP) as the acyl-thioester substrate. We sought to understand the evolutionary history and mechanisms mediating this substrate preference. Our phylogenetic and motif analysis of the LuxI acyl-HSL synthase family indicates that the acyl-CoA-utilizing enzymes evolved from an acyl-ACP-utilizing ancestor. To further understand how acyl-ACPs and acyl-CoAs are recognized by acyl-HSL synthases we studied BmaI1, an octanoyl-ACP-dependent LuxI family member from Burkholderia mallei, and BjaI, an isovaleryl-CoA-dependent LuxI family member from Bradyrhizobium japonicum. We synthesized thioether analogs of their thioester acyl-substrates to probe recognition of the acyl-phosphopantetheine moiety common to both acyl-ACP and acyl-CoA substrates. The kinetics of catalysis and inhibition of these enzymes indicate that they recognize the acyl-phosphopantetheine moiety and they recognize non-preferred substrates with this moiety. We find that CoA substrate utilization arose through exaptation of acyl-phosphopantetheine recognition in this enzyme family.	[Christensen, Quin H.; Greenberg, E. Peter] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Brecht, Ryan M.; Dudekula, Dastagiri; Nagarajan, Rajesh] Boise State Univ, Dept Chem & Biochem, Boise, ID 83725 USA	University of Washington; University of Washington Seattle; Idaho; Boise State University	Nagarajan, R (corresponding author), Boise State Univ, Dept Chem & Biochem, Boise, ID 83725 USA.	rajnagarajan@boisestate.edu		Greenberg, Everett/0000-0001-9474-8041; DUDEKULA, DASTAGIRI/0000-0002-6137-3260	United States Department of Agriculture National Institute of Food Agricultural and Food Research Initiative [2010-65108-20536]; National Institutes of Health [T32-AI055396]; National Institutes of Health IDeA Network of Biomedical Research Excellence [P20 RR016454, GM103408]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103408] Funding Source: NIH RePORTER	United States Department of Agriculture National Institute of Food Agricultural and Food Research Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health IDeA Network of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the following: United States Department of Agriculture National Institute of Food Agricultural and Food Research Initiative Competitive Grants Program no. 2010-65108-20536 (EPG), National Institutes of Health Postdoctoral Training Grant T32-AI055396 (QHC), and National Institutes of Health IDeA Network of Biomedical Research Excellence P20 RR016454 and GM103408 (RN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren NA, 2011, P NATL ACAD SCI USA, V108, P7183, DOI 10.1073/pnas.1103821108; Barve A, 2013, NATURE, V500, P203, DOI 10.1038/nature12301; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; BLASCHKOWSKI HP, 1979, FEBS LETT, V98, P81, DOI 10.1016/0014-5793(79)80156-8; Brader G, 2005, J BIOL CHEM, V280, P10403, DOI 10.1074/jbc.M408603200; Cameron DE, 2014, NAT REV MICROBIOL, V12, P381, DOI 10.1038/nrmicro3239; Chakrabarti S, 2003, PROTEIN ENG, V16, P271, DOI 10.1093/proeng/gzg031; Christensen QH, 2013, P NATL ACAD SCI USA, V110, P13815, DOI 10.1073/pnas.1313098110; Christensen QH, 2010, BIOCHEMISTRY-US, V49, P10024, DOI 10.1021/bi101215f; Chugani S, 2010, P NATL ACAD SCI USA, V107, P10673, DOI 10.1073/pnas.1005909107; Chung J, 2011, P NATL ACAD SCI USA, V108, P12089, DOI 10.1073/pnas.1103165108; Copeland RA, 2005, METHOD BIOCHEM ANAL, V46, P51; Cronan JE, 2009, METHOD ENZYMOL, V459, P395, DOI 10.1016/S0076-6879(09)04617-5; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; De Lay NR, 2007, J BIOL CHEM, V282, P20319, DOI 10.1074/jbc.M703789200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eisen JA, 1998, GENOME RES, V8, P163, DOI 10.1101/gr.8.3.163; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 2004, INFERRING PHYLOGENIE; Frey P. A., 2007, ENZYMATIC REACTION M; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; GILSON L, 1995, J BACTERIOL, V177, P6946, DOI 10.1128/jb.177.23.6946-6951.1995; Glasner ME, 2006, CURR OPIN CHEM BIOL, V10, P492, DOI 10.1016/j.cbpa.2006.08.012; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Gould TA, 2004, MOL MICROBIOL, V53, P1135, DOI 10.1111/j.1365-2958.2004.04211.x; Gray KM, 2001, MICROBIOL-SGM, V147, P2379, DOI 10.1099/00221287-147-8-2379; Huang RQ, 2012, P NATL ACAD SCI USA, V109, P2966, DOI 10.1073/pnas.1019605109; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Kambam PKR, 2008, BIOTECHNOL BIOENG, V101, P263, DOI 10.1002/bit.21901; Kambam PKR, 2009, CHEMBIOCHEM, V10, P553, DOI 10.1002/cbic.200800636; LaSarre B, 2013, MICROBIOL MOL BIOL R, V77, P73, DOI 10.1128/MMBR.00046-12; Lerat E, 2004, MOL BIOL EVOL, V21, P903, DOI 10.1093/molbev/msh097; Lindemann A, 2011, P NATL ACAD SCI USA, V108, P16765, DOI 10.1073/pnas.1114125108; More MI, 1996, SCIENCE, V272, P1655, DOI 10.1126/science.272.5268.1655; Nam H, 2012, SCIENCE, V337, P1101, DOI 10.1126/science.1216861; Nei M., 2000, MOL EVOLUTION PHYLOG; Parsek MR, 1999, P NATL ACAD SCI USA, V96, P4360, DOI 10.1073/pnas.96.8.4360; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Raychaudhuri A, 2005, BIOCHEMISTRY-US, V44, P2974, DOI 10.1021/bi048005m; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schaefer AL, 1996, P NATL ACAD SCI USA, V93, P9505, DOI 10.1073/pnas.93.18.9505; Schaefer AL, 2008, NATURE, V454, P595, DOI 10.1038/nature07088; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tomarev SI, 1996, EUR J BIOCHEM, V235, P449, DOI 10.1111/j.1432-1033.1996.00449.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Watson WT, 2002, MOL CELL, V9, P685, DOI 10.1016/S1097-2765(02)00480-X; Williams Paul, 2002, Expert Opin Ther Targets, V6, P257, DOI 10.1517/14728222.6.3.257; Zhang JM, 2010, J MOL EVOL, V71, P241, DOI 10.1007/s00239-010-9384-5	50	14	15	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112464	10.1371/journal.pone.0112464	http://dx.doi.org/10.1371/journal.pone.0112464			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401334	gold, Green Published, Green Submitted			2022-12-27	WOS:000345158700046
J	Rubattu, S; Marchitti, S; Bianchi, F; Di Castro, S; Stanzione, R; Cotugno, M; Bozzao, C; Sciarretta, S; Volpe, M				Rubattu, Speranza; Marchitti, Simona; Bianchi, Franca; Di Castro, Sara; Stanzione, Rosita; Cotugno, Maria; Bozzao, Cristina; Sciarretta, Sebastiano; Volpe, Massimo			The C2238/alpha ANP Variant Is a Negative Modulator of Both Viability and Function of Coronary Artery Smooth Muscle Cells	PLOS ONE			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASES; MICRORNA EXPRESSION; MOLECULAR VARIANT; GENE POLYMORPHISM; ENDOTHELIAL-CELLS; RECEPTOR-C; IN-VITRO; ATHEROSCLEROSIS	Background: Abnormalities of vascular smooth muscle cells (VSMCs) contribute to development of vascular disease. Atrial natriuretic peptide (ANP) exerts important effects on VSMCs. A common ANP molecular variant (T2238C/alpha ANP) has recently emerged as a novel vascular risk factor. Objectives: We aimed at identifying effects of CC2238/alpha ANP on viability, migration and motility in coronary artery SMCs, and the underlying signaling pathways. Methods and Results: Cells were exposed to either TT2238/alpha ANP or CC2238/alpha ANP. At the end of treatment, cell viability, migration and motility were evaluated, along with changes in oxidative stress pathway (ROS levels, NADPH and eNOS expression), on Akt phosphorylation and miR21 expression levels. CC2238/alpha ANP reduced cell vitality, increased apoptosis and necrosis, increased oxidative stress levels, suppressed miR21 expression along with consistent changes of its molecular targets (PDCD4, PTEN, Bcl2) and of phosphorylated Akt levels. As a result of increased oxidative stress, CC2238/alpha ANP markedly stimulated cell migration and increased cell contraction. NPR-C gene silencing with specific siRNAs restored cell viability, miR21 expression, and reduced oxidative stress induced by CC2238/alpha ANP. The cAMP/PKA/CREB pathway, driven by NPR-C activation, significantly contributed to both miR21 and phosphoAkt reduction upon CC2238/alpha ANP. miR21 overexpression by mimic-hsa-miR21 rescued the cellular damage dependent on CC2238/alpha ANP. Conclusions: CC2238/alpha ANP negatively modulates viability through NPR-C/cAMP/PKA/CREB/miR21 signaling pathway, and it augments oxidative stress leading to increased migratory and vasoconstrictor effects in coronary artery SMCs. These novel findings further support a damaging role of this common alpha ANP variant on vessel wall and its potential contribution to acute coronary events.	[Rubattu, Speranza; Marchitti, Simona; Bianchi, Franca; Di Castro, Sara; Stanzione, Rosita; Cotugno, Maria; Sciarretta, Sebastiano; Volpe, Massimo] IRCCS Neuromed, Pozzilli, Isernia, Italy; [Rubattu, Speranza; Bozzao, Cristina; Volpe, Massimo] Univ Roma La Sapienza, Sch Med & Psychol, Dept Clin & Mol Med, I-00185 Rome, Italy	IRCCS Neuromed; Sapienza University Rome	Rubattu, S (corresponding author), IRCCS Neuromed, Pozzilli, Isernia, Italy.	rubattu.speranza@neuromed.it	Rubattu, S./K-4036-2016; Cotugno, Maria/ABH-9517-2020; Bianchi, Franca/AAA-6427-2019; Volpe, Massimo/K-5240-2016; Stanzione, Rosita/AAE-2482-2020; Sciarretta, Sebastiano/K-5161-2016	Volpe, Massimo/0000-0002-9642-8380; Rubattu, Speranza/0000-0002-9808-7970; Bianchi, Franca/0000-0001-7355-4694; RUBATTU, Speranza Donatella/0000-0001-5921-7368; Cotugno, Maria/0000-0003-0061-1154; Marchitti, Simona/0000-0002-9097-8496; Sciarretta, Sebastiano/0000-0002-8633-6896; Stanzione, Rosita/0000-0002-3576-4604	Italian Ministry of Health; 5% grant	Italian Ministry of Health(Ministry of Health, Italy); 5% grant	This work was supported by a grant (Ricerca Corrente) from the Italian Ministry of Health to MV and SR; by the 5% grant to MV and SR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbato E, 2012, J AM COLL CARDIOL, V59, P1763, DOI 10.1016/j.jacc.2012.02.017; Bellis A, 2009, ARTERIOSCL THROM VAS, V29, P1207, DOI 10.1161/ATVBAHA.109.184135; Cannone V, 2013, HYPERTENSION, V62, P860, DOI 10.1161/HYPERTENSIONAHA.113.01344; Cheng YH, 2010, J CARDIOVASC TRANSL, V3, P251, DOI 10.1007/s12265-010-9169-7; Gruchala M, 2003, AM HEART J, V145, P125, DOI 10.1067/mhj.2003.52; Hiroshi I, 1990, J CLIN INVEST, V86, P1690; IP JH, 1990, J AM COLL CARDIOL, V15, P1667, DOI 10.1016/0735-1097(90)92845-S; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kang H, 2012, J BIOL CHEM, V287, P3976, DOI 10.1074/jbc.M111.303156; Keller DM, 2012, MOL ENDOCRINOL, V26, P989, DOI 10.1210/me.2011-1205; Kotlo KU, 2011, AM J PHYSIOL-CELL PH, V301, pC929, DOI 10.1152/ajpcell.00088.2011; LIN XB, 1995, CIRC RES, V77, P750, DOI 10.1161/01.RES.77.4.750; Lovren F, 2009, AM J PHYSIOL-ENDOC M, V296, pE1440, DOI 10.1152/ajpendo.90780.2008; Lu YJ, 2009, CARDIOVASC RES, V84, P434, DOI 10.1093/cvr/cvp232; Martinez-Hervas S, 2014, CARDIOVASC RES, V103, P324, DOI 10.1093/cvr/cvu115; MORISHITA R, 1994, J CLIN INVEST, V94, P824, DOI 10.1172/JCI117402; Oudit GY, 2004, J MOL CELL CARDIOL, V37, P449, DOI 10.1016/j.yjmcc.2004.05.015; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Quintavalle C, 2011, VASC PHARMACOL, V55, P87, DOI 10.1016/j.vph.2011.07.004; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Rubattu S, 2004, STROKE, V35, P814, DOI 10.1161/01.STR.0000119381.52589.AB; Rubattu S, 2014, J CARDIOVAS IN PRESS; Rubattu S, 2008, AM J HYPERTENS, V21, P733, DOI 10.1038/ajh.2008.174; Scarpino S, 2009, J HYPERTENS, V27, P1804, DOI 10.1097/HJH.0b013e32832d229f; SCHWARTZ SM, 1986, CIRC RES, V58, P427, DOI 10.1161/01.RES.58.4.427; Sciarretta S, 2013, CIRC RES, V112, P1355, DOI 10.1161/CIRCRESAHA.113.301325; Shu MF, 2012, MOL PHARMACOL, V81, P292, DOI 10.1124/mol.111.076166; Song JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047657; Villar IC, 2007, CARDIOVASC RES, V74, P515, DOI 10.1016/j.cardiores.2007.02.032; Volpe M, 2014, EUR HEART J, V35, P419, DOI 10.1093/eurheartj/eht466; Wang XP, 2014, EUR HEART J, V35, P911, DOI 10.1093/eurheartj/eht329; WEBER W, 1991, J ANTIBIOT, V44, P164, DOI 10.7164/antibiotics.44.164; Zhou YJ, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/374963; Ziaee S, 2014, CORONARY ARTERY DIS, V25, P242, DOI 10.1097/MCA.0000000000000075	35	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113108	10.1371/journal.pone.0113108	http://dx.doi.org/10.1371/journal.pone.0113108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401746	Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700114
J	Chaiyasen, A; Young, JPW; Teaumroong, N; Gavinlertvatana, P; Lumyong, S				Chaiyasen, Amornrat; Young, J. Peter W.; Teaumroong, Neung; Gavinlertvatana, Paiboolya; Lumyong, Saisamorn			Characterization of Arbuscular Mycorrhizal Fungus Communities of Aquilaria crassna and Tectona grandis Roots and Soils in Thailand Plantations	PLOS ONE			English	Article							PCR PRIMERS; DIVERSITY; GLOMALIN; FOREST; GLOMEROMYCOTA; STRESS; PHYLUM; PLANTS	Aquilaria crassna Pierre ex Lec. and Tectona grandis Linn. f. are sources of resin-suffused agarwood and teak timber, respectively. This study investigated arbuscular mycorrhizal (AM) fungus community structure in roots and rhizosphere soils of A. crassna and T. grandis from plantations in Thailand to understand whether AM fungal communities present in roots and rhizosphere soils vary with host plant species and study sites. Terminal restriction fragment length polymorphism complemented with clone libraries revealed that AM fungal community composition in A. crassna and T. grandis were similar. A total of 38 distinct terminal restriction fragments (TRFs) were found, 31 of which were shared between A. crassna and T. grandis. AM fungal communities in T. grandis samples from different sites were similar, as were those in A. crassna. The estimated average minimum numbers of AM fungal taxa per sample in roots and soils of T. grandis were at least 1.89 vs. 2.55, respectively, and those of A. crassna were 2.85 vs. 2.33 respectively. The TRFs were attributed to Claroideoglomeraceae, Diversisporaceae, Gigasporaceae and Glomeraceae. The Glomeraceae were found to be common in all study sites. Specific AM taxa in roots and soils of T. grandis and A. crassna were not affected by host plant species and sample source (root vs. soil) but affected by collecting site. Future inoculum production and utilization efforts can be directed toward the identified symbiotic associates of these valuable tree species to enhance reforestation efforts.	[Chaiyasen, Amornrat; Lumyong, Saisamorn] Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai 50000, Thailand; [Young, J. Peter W.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Teaumroong, Neung] Suranaree Univ Technol, Inst Agr Technol, Sch Biotechnol, Nakhon Ratchasima, Thailand; [Gavinlertvatana, Paiboolya] Thai Orchid Labs Co Ltd, Bangkok, Thailand	Chiang Mai University; University of York - UK; Suranaree University of Technology	Lumyong, S (corresponding author), Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai 50000, Thailand.	saisamorn.l@cmu.ac.th	Young, Peter/C-1446-2012	Young, Peter/0000-0001-5259-4830	Thailand Research Fund [RTA5580007]; Commission of Higher Education for National Research University [A1]; Royal Golden Jubilee PhD Program [PHD/0150/2550]	Thailand Research Fund(Thailand Research Fund (TRF)); Commission of Higher Education for National Research University; Royal Golden Jubilee PhD Program(Thailand Research Fund (TRF))	This research was supported by the Thailand Research Fund for Research-Team Promotion Grant (RTA5580007) and the Commission of Higher Education for National Research University (A1) (http://www.trf.or.th/). AC was funded by the Thailand Research Fund; The Royal Golden Jubilee PhD Program (PHD/0150/2550: http://rgj.trf.or.th/indexth.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AzconAguilar C, 1996, MYCORRHIZA, V6, P457, DOI 10.1007/s005720050147; Barto EK, 2011, BIOL INVASIONS, V13, P2755, DOI 10.1007/s10530-011-9945-6; Bever JD, 1996, J ECOL, V84, P71, DOI 10.2307/2261701; Bremner JM., 1965, METHODS SOIL ANAL, V9, P1149; Brundrett M, 1996, WORKING MYCORRHIZAS; Brundrett MC, 1999, MYCORRHIZA, V8, P305, DOI 10.1007/s005720050251; CITES, 2004, 13 M C PART BANGK TH, P1; Daniell TJ, 2001, FEMS MICROBIOL ECOL, V36, P203, DOI 10.1111/j.1574-6941.2001.tb00841.x; Dhar P. P., 2012, Journal of Forestry Research, V23, P115, DOI 10.1007/s11676-012-0241-9; Doubkova P, 2013, PLANT SOIL, V370, P149, DOI 10.1007/s11104-013-1610-7; GAZEY C, 1993, MYCOL RES, V97, P785, DOI 10.1016/S0953-7562(09)81150-7; Habte M., 2001, Plant nutrition: food security and sustainability of agro-ecosystems through basic and applied research. Fourteenth International Plant Nutrition Colloquium, Hannover, Germany, P644; Habte M, 2000, PLANT NUTR MANAGEMEN, P127; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hampl V, 2001, INT J SYST EVOL MICR, V51, P731, DOI 10.1099/00207713-51-3-731; Helgason T, 1998, NATURE, V394, P431, DOI 10.1038/28764; Helgason T, 1999, MOL ECOL, V8, P659, DOI 10.1046/j.1365-294x.1999.00604.x; Houba VJG, 1988, SOIL PLANT ANAL 5; INVAM Newsletter 3, 1993, INVAM NEWSLETTER; Johnson D, 2004, NEW PHYTOL, V161, P503, DOI 10.1046/j.1469-8137.2003.00938.x; Kanakadurga VV, 1990, MYCORRHIZAL SYMBIOSI, P17; Kobayashi S, 2004, FOREST ECOL MANAG, V201, P13, DOI 10.1016/j.foreco.2004.06.009; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Kruger M, 2009, NEW PHYTOL, V183, P212, DOI 10.1111/j.1469-8137.2009.02835.x; Lee J, 2008, FEMS MICROBIOL ECOL, V65, P339, DOI 10.1111/j.1574-6941.2008.00531.x; Mummey DL, 2007, J MICROBIOL METH, V70, P200, DOI 10.1016/j.mimet.2007.04.002; Mummey DL, 2006, PLANT SOIL, V288, P81, DOI 10.1007/s11104-006-9091-6; Mummey DL, 2005, PLANT SOIL, V271, P83, DOI 10.1007/s11104-004-2066-6; Oehl F, 2009, AGR ECOSYST ENVIRON, V134, P257, DOI 10.1016/j.agee.2009.07.008; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pietikainen A, 2007, NEW PHYTOL, V176, P691, DOI 10.1111/j.1469-8137.2007.02209.x; Porcel R, 2004, J EXP BOT, V55, P1743, DOI 10.1093/jxb/erh188; Rajan SK, 2000, FOREST ECOL MANAG, V126, P91, DOI 10.1016/S0378-1127(99)00089-4; Ramanwong K, 1998, THESIS KASETSART U C; Renker C, 2006, MYCORRHIZA, V16, P525, DOI 10.1007/s00572-006-0067-4; Rillig MC, 2004, CAN J SOIL SCI, V84, P355, DOI 10.4141/S04-003; Rillig MC, 2003, PLANT SOIL, V253, P293, DOI 10.1023/A:1024807820579; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Schussler A, 2010, GLOMEROMYCOTA SPECIE, P1; Singh SS, 2003, TROP ECOL, V44, P207; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Swaminathan C., 2006, Journal of Sustainable Forestry, V22, P63, DOI 10.1300/J091v22n03_05; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tabin T, 2009, TROP ECOL, V50, P243; Tamuli P., 2002, Indian Forester, V128, P991; Thapar HS, 1988, TRENDS TREE SCI, P161; Turjaman M, 2006, MYCORRHIZA, V16, P459, DOI 10.1007/s00572-006-0059-4; Urgiles N, 2009, NEW FOREST, V38, P229, DOI 10.1007/s11056-009-9143-x; van der Heijden MGA, 2003, NEW PHYTOL, V157, P569, DOI 10.1046/j.1469-8137.2003.00688.x; Vandenkoornhuyse P, 2003, MOL ECOL, V12, P3085, DOI 10.1046/j.1365-294X.2003.01967.x; Wolfe BE, 2007, MYCORRHIZA, V17, P175, DOI 10.1007/s00572-006-0089-y; Wright SF, 1998, PLANT SOIL, V198, P97, DOI 10.1023/A:1004347701584	52	13	16	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112591	10.1371/journal.pone.0112591	http://dx.doi.org/10.1371/journal.pone.0112591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397675	Green Published, gold			2022-12-27	WOS:000345558500064
J	Fan, F; Geurts, AM; Pabbidi, MR; Smith, SV; Harder, DR; Jacob, H; Roman, RJ				Fan, Fan; Geurts, Aron M.; Pabbidi, Mallikarjuna R.; Smith, Stanley V.; Harder, David R.; Jacob, Howard; Roman, Richard J.			Zinc-Finger Nuclease Knockout of Dual-Specificity Protein Phosphatase-5 Enhances the Myogenic Response and Autoregulation of Cerebral Blood Flow in FHH.1(BN) Rats	PLOS ONE			English	Article							RUPTURED INTRACRANIAL ANEURYSMS; HOODED HYPERTENSIVE-RATS; HEAD-INJURY; INTRAVENTRICULAR PRESSURE; SUBARACHNOID HEMORRHAGE; MODULATES PROTEINURIA; BRAIN-TISSUE; ACUTE-PHASE; I-TASSER; REACTIVITY	We recently reported that the myogenic responses of the renal afferent arteriole (Af-Art) and middle cerebral artery (MCA) and autoregulation of renal and cerebral blood flow (RBF and CBF) were impaired in Fawn Hooded hypertensive (FHH) rats and were restored in a FHH.1(BN) congenic strain in which a small segment of chromosome 1 from the Brown Norway (BN) containing 15 genes including dual-specificity protein phosphatase-5 (Dusp5) were transferred into the FHH genetic background. We identified 4 single nucleotide polymorphisms in the Dusp5 gene in FHH as compared with BN rats, two of which altered CpG sites and another that caused a G155R mutation. To determine whether Dusp5 contributes to the impaired myogenic response in FHH rats, we created a Dusp5 knockout (KO) rat in the FHH.1(BN) genetic background using a zinc-finger nuclease that introduced an 11 bp frame-shift deletion and a premature stop codon at AA121. The expression of Dusp5 was decreased and the levels of its substrates, phosphorylated ERK1/2 (p-ERK1/2), were enhanced in the KO rats. The diameter of the MCA decreased to a greater extent in Dusp5 KO rats than in FHH.1(BN) and FHH rats when the perfusion pressure was increased from 40 to 140 mmHg. CBF increased markedly in FHH rats when MAP was increased from 100 to 160 mmHg, and CBF was better autoregulated in the Dusp5 KO and FHH.1(BN) rats. The expression of Dusp5 was higher at the mRNA level but not at the protein level and the levels of p-ERK1/2 and p-PKC were lower in cerebral microvessels and brain tissue isolated from FHH than in FHH.1(BN) rats. These results indicate that Dusp5 modulates myogenic reactivity in the cerebral circulation and support the view that a mutation in Dusp5 may enhance Dusp5 activity and contribute to the impaired myogenic response in FHH rats.	[Fan, Fan; Pabbidi, Mallikarjuna R.; Smith, Stanley V.; Roman, Richard J.] Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA; [Geurts, Aron M.; Jacob, Howard] Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA; [Harder, David R.] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Harder, David R.] Med Coll Wisconsin, Cardiovasc Res Ctr, Milwaukee, WI 53226 USA	University of Mississippi; University of Mississippi Medical Center; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Roman, RJ (corresponding author), Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA.	rroman@umc.edu			National Institutes of Health [R01 HL36279, DK104184, H105997, HL-101681, OD-8396]; American Heart Association [13SDG14000006]; VA Research Career Scientist Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036279, RC2HL101681, R01HL105997, R01HL033833, R37HL036279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); VA Research Career Scientist Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded in part by National Institutes of Health R01 HL36279 and DK104184 (RJR), H105997 (Harder), GO grant HL-101681 (Jacob) and New innovator award OD-8396 (Geurts), VA Research Career Scientist Award (Harder) and Scientist Development Grant 13SDG14000006 (Pabbidi) from American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNOLI A, 1968, CIRCULATION, V38, P800, DOI 10.1161/01.CIR.38.4.800; Bayliss WM, 1902, J PHYSIOL-LONDON, V28, P220; Bellapart J, 2009, ULTRASOUND MED BIOL, V35, P883, DOI 10.1016/j.ultrasmedbio.2009.01.005; Burke M, 2013, AM J PHYSIOL-RENAL, V304, pF565, DOI 10.1152/ajprenal.00404.2012; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; Chen CCA, 2013, PHYSIOL GENOMICS, V45, P110, DOI 10.1152/physiolgenomics.00119.2012; COLD GE, 1981, ACTA ANAESTH SCAND, V25, P397, DOI 10.1111/j.1399-6576.1981.tb01673.x; COLD GE, 1978, ACTA ANAESTH SCAND, V22, P270, DOI 10.1111/j.1399-6576.1978.tb01301.x; COLD GE, 1981, ACTA ANAESTH SCAND, V25, P332, DOI 10.1111/j.1399-6576.1981.tb01662.x; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; DERNBACH PD, 1988, NEUROSURGERY, V22, P822, DOI 10.1227/00006123-198805000-00003; Dunn KM, 2008, AM J PHYSIOL-HEART C, V295, pH2455, DOI 10.1152/ajpheart.00512.2008; Fan F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082482; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; FARACI FM, 1990, J AM SOC NEPHROL, V1, P53; FARACI FM, 1987, AM J PHYSIOL, V252, pH738, DOI 10.1152/ajpheart.1987.252.4.H738; Fu Q, 2006, FASEB J, V20, P2127, DOI 10.1096/fj.06-6179fje; Geurts AM, 2010, CLIN SCI, V119, P303, DOI 10.1042/CS20100201; Geurts AM, 2010, METHODS MOL BIOL, V597, P211, DOI 10.1007/978-1-60327-389-3_15; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Gibney EM, 2003, AM J KIDNEY DIS, V42, P1, DOI 10.1016/S0272-6386(03)00403-7; HOEDTRASMUSSEN K, 1967, ARCH NEUROL-CHICAGO, V17, P271, DOI 10.1001/archneur.1967.00470270049007; Huang CY, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-24; ISHII R, 1979, J NEUROSURG, V50, P587, DOI 10.3171/jns.1979.50.5.0587; JOHANSSON B, 1989, J HYPERTENS, V7, pS5; Kamkin A, 2000, CARDIOVASC RES, V48, P409, DOI 10.1016/S0008-6363(00)00208-X; Kovanen PE, 2008, J BIOL CHEM, V283, P17362, DOI 10.1074/jbc.M709887200; Kucharska A, 2009, CELL SIGNAL, V21, P1794, DOI 10.1016/j.cellsig.2009.07.015; Lammie GA, 2002, BRAIN PATHOL, V12, P358; Lang EW, 2001, CRIT CARE MED, V29, P158, DOI 10.1097/00003246-200101000-00031; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandl M, 2005, MOL CELL BIOL, V25, P1830, DOI 10.1128/MCB.25.5.1830-1845.2005; MELLANDER S, 1989, J HYPERTENS, V7, pS21; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Murphy TV, 2002, CLIN EXP PHARMACOL P, V29, P612, DOI 10.1046/j.1440-1681.2002.03698.x; OLSEN TS, 1983, STROKE, V14, P332, DOI 10.1161/01.STR.14.3.332; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Pabbidi MR, 2014, AM J PHYSIOL-HEART C, V306, pH989, DOI 10.1152/ajpheart.00636.2013; Pabbidi MR, 2013, AM J PHYSIOL-HEART C, V304, pH311, DOI 10.1152/ajpheart.00622.2012; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Purkayastha S, 2011, INDIAN J PHARMACOL, V43, P502, DOI 10.4103/0253-7613.84950; Rangel-Filho A, 2005, J AM SOC NEPHROL, V16, P852, DOI 10.1681/ASN.2005010029; Rangel A, 2013, J AM SOC NEPHROL, V24, P283, DOI 10.1681/ASN.2012090927; Roman RJ, 2006, NEUROL RES, V28, P738, DOI 10.1179/016164106X152016; Roy A, 2012, NUCLEIC ACIDS RES, V40, pW471, DOI 10.1093/nar/gks372; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; STRANDGAARD S, 1991, Cardiovascular Drugs and Therapy, V4, P1217, DOI 10.1007/BF00114223; Sun CW, 1999, HYPERTENSION, V33, P414, DOI 10.1161/01.HYP.33.1.414; Toth P, 2013, AM J PHYSIOL-HEART C, V305, pH1698, DOI 10.1152/ajpheart.00377.2013; VOLDBY B, 1985, J NEUROSURG, V62, P48, DOI 10.3171/jns.1985.62.1.0048; VOLDBY B, 1985, J NEUROSURG, V62, P59, DOI 10.3171/jns.1985.62.1.0059; Wagner BP, 2011, PEDIATR RES, V69, P436, DOI 10.1203/PDR.0b013e3182110177; Walsh MP, 2013, J CEREBR BLOOD F MET, V33, P1, DOI 10.1038/jcbfm.2012.144; Wickramasekera NT, 2013, J APPL PHYSIOL, V114, P252, DOI 10.1152/japplphysiol.01026.2011; Zassadowski F, 2012, CELL SIGNAL, V24, P2369, DOI 10.1016/j.cellsig.2012.08.003; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhao Y, 2005, AM J PHYSIOL-REG I, V289, pR164, DOI 10.1152/ajpregu.00847.2004	60	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112878	10.1371/journal.pone.0112878	http://dx.doi.org/10.1371/journal.pone.0112878			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397684	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500105
J	Lawhorn, IEB; Ferreira, JP; Wang, CL				Lawhorn, Ingrid E. B.; Ferreira, Joshua P.; Wang, Clifford L.			Evaluation of sgRNA Target Sites for CRISPR-Mediated Repression of TP53	PLOS ONE			English	Article							TRANSCRIPTIONAL START SITES; SEQUENCE-SPECIFIC CONTROL; GENE-EXPRESSION; HUMAN-CELLS; MAMMALIAN-CELLS; CAS SYSTEM; RNA; ACTIVATION; DNA; ENDONUCLEASE	The CRISPR (clustered regularly interspaced short palindromic repeats) platform has been developed as a general method to direct proteins of interest to gene targets. While the native CRISPR system delivers a nuclease that cleaves and potentially mutates target genes, researchers have recently employed catalytically inactive CRISPR-associated 9 nuclease (dCas9) in order to target and repress genes without DNA cleavage or mutagenesis. With the intent of improving repression efficiency in mammalian cells, researchers have also fused dCas9 with a KRAB repressor domain. Here, we evaluated different genomic sgRNA targeting sites for repression of TP53. The sites spanned a 200-kb distance, which included the promoter, transcript sequence, and regions flanking the endogenous human TP53 gene. We showed that repression up to 86% can be achieved with dCas9 alone (i.e., without use of the KRAB domain) by targeting the complex to sites near the TP53 transcriptional start site. This work demonstrates that efficient transcriptional repression of endogenous human genes can be achieved by the targeted delivery of dCas9. Yet, the efficiency of repression strongly depends on the choice of the sgRNA target site.	[Lawhorn, Ingrid E. B.; Ferreira, Joshua P.; Wang, Clifford L.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA	Stanford University	Wang, CL (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	cliff.wang@stanford.edu			National Science Foundation Graduate Research Fellowship Program; Stanford Graduate Fellowship; National Institute on Aging [NIH-5R21AG040360-02]; National Institutes of Health S10 Shared Instrumentation [S10RR025518-01, S10RR027431-01]; NATIONAL CANCER INSTITUTE [P30CA124435] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025518, S10RR027431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG040360] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Stanford Graduate Fellowship(Stanford University); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health S10 Shared Instrumentation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	IEBL was funded by the National Science Foundation Graduate Research Fellowship Program http://www.nsfgrfp.org/ and Stanford Graduate Fellowship http://sgf.stanford.edu/. IEBL, JPF, and CLW were funded by the National Institute on Aging (NIH-5R21AG040360-02) http://www.nia.nih.gov/. Data and sorting was performed on instruments in the Stanford Shared FACS Facility obtained using National Institutes of Health S10 Shared Instrumentation Grants S10RR025518-01 and S10RR027431-01 http://dpcpsi.nih.gov/orip/diic/shared_instrumentation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Farzadfard F, 2013, ACS SYNTH BIOL, V2, P604, DOI 10.1021/sb400081r; Ferreira JP, 2013, P NATL ACAD SCI USA, V110, P11284, DOI 10.1073/pnas.1305590110; Ferreira Joshua P, 2011, Syst Synth Biol, V5, P131, DOI 10.1007/s11693-011-9089-0; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gao XF, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku836; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Hagmann M, 1997, J VIROL, V71, P5952, DOI 10.1128/JVI.71.8.5952-5962.1997; Hao DL, 2005, ACTA BIOCH BIOPH SIN, V37, P779, DOI 10.1111/j.1745-7270.2005.00107.x; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kearns NA, 2014, DEVELOPMENT, V141, P219, DOI 10.1242/dev.103341; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Mahmoudi S, 2009, MOL CELL, V33, P462, DOI 10.1016/j.molcel.2009.01.028; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Saldana-Meyer R, 2011, EPIGENETICS-US, V6, P1068, DOI 10.4161/epi.6.9.16683; Selby CP, 1997, NUCLEIC ACIDS RES, V25, P787, DOI 10.1093/nar/25.4.787; Shah SA, 2013, RNA BIOL, V10, P891, DOI 10.4161/rna.23764; STEWART N, 1991, VIROLOGY, V180, P49, DOI 10.1016/0042-6822(91)90008-Y; Suzuki Y, 2002, NUCLEIC ACIDS RES, V30, P328, DOI 10.1093/nar/30.1.328; Tsuchihara K, 2009, NUCLEIC ACIDS RES, V37, P2249, DOI 10.1093/nar/gkp066; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Wu X, 2014, QUANT BIOL; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xu K., 2014, CELL MOL LIFE SCI; Yamashita R, 2012, NUCLEIC ACIDS RES, V40, pD150, DOI 10.1093/nar/gkr1005	47	39	43	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113232	10.1371/journal.pone.0113232	http://dx.doi.org/10.1371/journal.pone.0113232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398078	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500142
J	Liu, YL; Zhang, R; Huang, J; Zhao, X; Liu, DL; Sun, WT; Mai, YF; Zhang, P; Wang, YJ; Cao, H; Yang, KH				Liu, Yali; Zhang, Rui; Huang, Jiao; Zhao, Xu; Liu, Danlu; Sun, Wanting; Mai, Yuefen; Zhang, Peng; Wang, Yajun; Cao, Hua; Yang, Ke Hu			Reporting Quality of Systematic Reviews/Meta-Analyses of Acupuncture	PLOS ONE			English	Article							METAANALYSES; TRIALS	Background: The QUOROM and PRISMA statements were published in 1999 and 2009, respectively, to improve the consistency of reporting systematic reviews (SRs)/meta-analyses (MAs) of clinical trials. However, not all SRs/MAs adhere completely to these important standards. In particular, it is not clear how well SRs/MAs of acupuncture studies adhere to reporting standards and which reporting criteria are generally ignored in these analyses. Objectives: To evaluate reporting quality in SRs/MAs of acupuncture studies. Methods: We performed a literature search for studies published prior to 2014 using the following public archives: PubMed, EMBASE, Web of Science, the Cochrane Database of Systematic Reviews (CDSR), the Chinese Biomedical Literature Database (CBM), the Traditional Chinese Medicine (TCM) database, the Chinese Journal Full-text Database (CJFD), the Chinese Scientific Journal Full-text Database (CSJD), and the Wanfang database. Data were extracted into pre-prepared Excel data-extraction forms. Reporting quality was assessed based on the PRISMA checklist (27 items). Results: Of 476 appropriate SRs/MAs identified in our search, 203, 227, and 46 were published in Chinese journals, international journals, and the Cochrane Database, respectively. In 476 SRs/MAs, only 3 reported the information completely. By contrast, approximately 4.93% (1/203), 8.81% (2/227) and 0.00% (0/46) SRs/Mas reported less than 10 items in Chinese journals, international journals and CDSR, respectively. In general, the least frequently reported items (reported <= 50%) in SRs/MAs were "protocol and registration'', "risk of bias across studies'', and "additional analyses'' in both methods and results sections. Conclusions: SRs/MAs of acupuncture studies have not comprehensively reported information recommended in the PRISMA statement. Our study underscores that, in addition to focusing on careful study design and performance, attention should be paid to comprehensive reporting standards in SRs/MAs on acupuncture studies.	[Liu, Yali; Zhang, Rui; Huang, Jiao; Zhao, Xu; Liu, Danlu; Sun, Wanting; Mai, Yuefen; Zhang, Peng; Yang, Ke Hu] Lanzhou Univ, Sch Basic Med Sci, Evidence Based Med Ctr, Lanzhou 730000, Peoples R China; [Liu, Yali; Liu, Danlu; Yang, Ke Hu] Key Lab Clin Translat Res & Evidence Based Med Ga, Lanzhou, Peoples R China; [Zhang, Rui; Huang, Jiao; Liu, Danlu; Yang, Ke Hu] Lanzhou Univ, Clin Med Coll 1, Lanzhou 730000, Peoples R China; [Zhao, Xu; Sun, Wanting; Mai, Yuefen] Lanzhou Univ, Clin Med Coll 2, Lanzhou 730000, Peoples R China; [Zhang, Peng] Shandong Univ, Qilu Hosp, Dept Cardiol, Jinan 250100, Shandong, Peoples R China; [Wang, Yajun] Gansu Univ Tradit Chinese Med, Acupuncture & Massage Coll, Lanzhou, Peoples R China; [Cao, Hua] Gansu Prov Hosp Tradit Chinese Med, Dept Neurol, Lanzhou, Peoples R China	Lanzhou University; Lanzhou University; Lanzhou University; Shandong University; Gansu University of Chinese Medicine	Yang, KH (corresponding author), Lanzhou Univ, Sch Basic Med Sci, Evidence Based Med Ctr, Lanzhou 730000, Peoples R China.	kehuyangebm2006@126.com		Liu, Yali/0000-0003-0037-6326	National Natural Science Foundation of China [81373882]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Project supported by the National Natural Science Foundation of China (Grant No. 81373882) http://www.nsfc.gov.cn/Portal0/default152.htm The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Delaney A, 2005, CRIT CARE, V9, pR575, DOI 10.1186/cc3803; Fleming PS, 2013, ANGLE ORTHOD, V83, P158, DOI 10.2319/032612-251.1; Gagnier Joel J, 2013, J Bone Joint Surg Am, V95, pe771, DOI 10.2106/JBJS.L.00597; Kelly KD, 2001, ANN EMERG MED, V38, P518, DOI 10.1067/mem.2001.115881; Kiriakou J, 2013, J DENT, V41, P1181, DOI 10.1016/j.jdent.2013.09.006; Liu YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028130; Lui S, 2010, ACUPUNCT MED, V28, P149, DOI 10.1136/aim.2010.002444; Ma B, 2012, J ALTERN COMPLEM MED, V18, P813, DOI 10.1089/acm.2011.0274; Ma B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020185; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moher D, 2011, 19 COCHR C; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; OXMAN AD, 1994, JAMA-J AM MED ASSOC, V272, P1367, DOI 10.1001/jama.272.17.1367; Padula RS, 2012, BRAZ J PHYS THER, V16, P281; Richards Derek, 2004, Evid Based Dent, V5, P17, DOI 10.1038/sj.ebd.6400242; SACKS HS, 1987, NEW ENGL J MED, V316, P450, DOI 10.1056/NEJM198702193160806; Sood A, 2005, J ALTERN COMPLEM MED, V11, P719, DOI 10.1089/acm.2005.11.719; Swingler GH, 2003, BRIT MED J, V327, P1083, DOI 10.1136/bmj.327.7423.1083; Tao KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027611; Willis BH, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-163; Wu TX, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-46	22	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113172	10.1371/journal.pone.0113172	http://dx.doi.org/10.1371/journal.pone.0113172			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397774	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500140
J	Akhter, F; Khan, MS; Singh, S; Ahmad, S				Akhter, Firoz; Khan, M. Salman; Singh, Sarika; Ahmad, Saheem			An Immunohistochemical Analysis to Validate the Rationale behind the Enhanced Immunogenicity of D-Ribosylated Low Density Lipo-Protein	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; INTIMA-MEDIA THICKNESS; IMMUNE-COMPLEXES; HUMAN DNA; AUTOIMMUNE-RESPONSE; MODIFIED LDL; LIPOPROTEIN; SUPEROXIDE; ANTIBODIES; RECOGNITION	Advanced glycation end products (AGEs) are thought to contribute to the abnormal lipoprotein profiles and increased risk of cardiovascular disease in patients with diabetes and renal failure. D-ribose is one of the naturally occurring pentose monosaccharide present in all living cells and is a key component of numerous biomolecules involved in many important metabolic pathways. Formation of D-ribose derived glycated low density lipoprotein (LDL) has been previously demonstrated but no studies have been performed to assess the immune complex deposition in the kidney of rabbits immunized with glycated LDL. In this study, LDL was glycated with D-ribose, and it was further used as an immunogen for immunizing NZW female rabbits. The results showed that female rabbits immunized with D-ribose modified LDL induced antibodies as detected by direct binding and competitive ELISA. The modified LDL was found to be highly immunogenic eliciting high titer immunogen-specific antibodies, while the native forms were moderately immunogenic. The induced antibodies from modified LDL exhibited wide range of heterogeneity in recognizing various proteins and amino acids conformers. Furthermore, our histopathological results illustrated the deposits of immune complex in glomerular basement membrane in rabbits immunized with D-ribose-LDL.	[Akhter, Firoz] Integral Univ, Dept Bioengn, Lucknow, Uttar Pradesh, India; [Akhter, Firoz; Khan, M. Salman; Ahmad, Saheem] Integral Univ, Dept Biosci, Lucknow, Uttar Pradesh, India; [Singh, Sarika] Cent Drug Res Inst, Dept Toxicol, Lucknow 226001, Uttar Pradesh, India	Integral University; Integral University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Khan, MS (corresponding author), Integral Univ, Dept Biosci, Lucknow, Uttar Pradesh, India.	contactskhan@gmail.com; ahmadsaheem@gmail.com	Ahmad, Saheem/T-2609-2019; Ahmad, Saheem/R-7016-2017; SINGH, SARIKA/AAO-7571-2021; Akhter, Firoz/AAD-2281-2022	Ahmad, Saheem/0000-0003-1215-0279; Ahmad, Saheem/0000-0003-1215-0279; Akhter, Firoz/0000-0002-8836-601X; Khan, M. Salman/0000-0001-9716-8165				Ahmad MI, 2011, INDIAN J BIOCHEM BIO, V48, P290; Ahmad S, 2014, BIOCHEM BIOPH RES CO, V407, P568; Ahmad S, 2014, J CLIN TRANSL ENDOCR, V1, P66, DOI 10.1016/j.jcte.2014.05.002; Ahmad S, 2014, GLYCOBIOLOGY, V24, P979, DOI 10.1093/glycob/cwu057; Ahmad S, 2014, GLYCOBIOLOGY, V24, P281, DOI 10.1093/glycob/cwt109; Ahmad S, 2013, INT J BIOL MACROMOL, V62, P167, DOI 10.1016/j.ijbiomac.2013.08.037; Ahmad S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072128; Akanji AO, 2002, CLIN CHIM ACTA, V317, P171, DOI 10.1016/S0009-8981(01)00792-6; Akhter F, 2013, S AFR J BOT, V88, P265, DOI 10.1016/j.sajb.2013.06.024; Akhter F, 2013, INT J BIOL MACROMOL, V58, P206, DOI 10.1016/j.ijbiomac.2013.03.036; Andersson J, 2010, CLIN IMMUNOL, V134, P33, DOI 10.1016/j.clim.2009.07.002; AZEVEDO M, 1988, FREE RADICAL RES COM, V4, P331, DOI 10.3109/10715768809066899; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; CERVANTESLAUREAN D, 1993, BIOCHEMISTRY-US, V32, P1528, DOI 10.1021/bi00057a017; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gillery P, 2014, CLIN CHEM LAB MED, V52, P33, DOI 10.1515/cclm-2012-0880; Goding JW, 1976, IMMUOL METHODS, V20, P241; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; HALLIWELL B, 1981, FEBS LETT, V128, P347, DOI 10.1016/0014-5793(81)80114-7; Hashim A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/729393; Iqbal D, 2014, PHYTOTHER RES, V28, P899, DOI 10.1002/ptr.5077; KELLER PJ, 1988, BIOCHEMISTRY-US, V27, P1117, DOI 10.1021/bi00404a006; KORTLANDT W, 1992, DIABETOLOGIA, V35, P202, DOI 10.1007/BF00400918; Kummu O, 2013, ANTIOXID REDOX SIGN, V19, P1047, DOI 10.1089/ars.2012.4535; Lapolla A, 2005, CLIN BIOCHEM, V38, P103, DOI 10.1016/j.clinbiochem.2004.09.007; LIU KT, 1982, CHEM-BIOL INTERACT, V41, P39, DOI 10.1016/0009-2797(82)90015-1; Lopes-Virella MF, 2007, ATHEROSCLEROSIS, V190, P359, DOI 10.1016/j.atherosclerosis.2006.02.007; Lopes-Virella MF, 2011, DIABETES, V60, P582, DOI 10.2337/db10-0915; Lopes-Virella MF, 2010, CLIN IMMUNOL, V134, P55, DOI 10.1016/j.clim.2009.04.001; Lundberg AM, 2010, CLIN IMMUNOL, V134, P5, DOI 10.1016/j.clim.2009.07.016; Mironova M, 1997, CLIN IMMUNOL IMMUNOP, V85, P73, DOI 10.1006/clin.1997.4404; Moinuddin, 2012, ENVIRON TOXICOL, V29, P68; Mustafa I, 2012, DIABETES RES CLIN PR, V95, P98, DOI 10.1016/j.diabres.2011.09.018; Rahim M, 2014, COLLOID SURFACE B, V117, P473, DOI 10.1016/j.colsurfb.2013.12.008; Saad AF, 2006, J LIPID RES, V47, P1975, DOI 10.1194/jlr.M600064-JLR200; Shahab U, 2014, CHEM-BIOL INTERACT, V219, P229, DOI 10.1016/j.cbi.2014.06.012; Shahab U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053205; Shahab U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031199; Shahab U, 2012, IUBMB LIFE, V64, P340, DOI 10.1002/iub.1008; Steinberg D, 2009, J LIPID RES, V50, pS376, DOI 10.1194/jlr.R800087-JLR200; YAGI K, 1987, CHEM PHYS LIPIDS, V45, P337, DOI 10.1016/0009-3084(87)90071-5; Yishak AA, 2006, NEPHROL DIAL TRANSPL, V21, P93, DOI 10.1093/ndt/gfi103	42	38	38	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e113144	10.1371/journal.pone.0113144	http://dx.doi.org/10.1371/journal.pone.0113144			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393017	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300144
J	Azevedo, MF; Nie, CQ; Elsworth, B; Charnaud, SC; Sanders, PR; Crabb, BS; Gilson, PR				Azevedo, Mauro F.; Nie, Catherine Q.; Elsworth, Brendan; Charnaud, Sarah C.; Sanders, Paul R.; Crabb, Brendan S.; Gilson, Paul R.			Plasmodium falciparum Transfected with Ultra Bright NanoLuc Luciferase Offers High Sensitivity Detection for the Screening of Growth and Cellular Trafficking Inhibitors	PLOS ONE			English	Article							RED-BLOOD-CELLS; MALARIA PARASITES; PROTEIN EXPORT; FIREFLY LUCIFERASE; PROMOTER ACTIVITY; VIRULENCE; ERYTHROCYTES; LOCALIZATION; EXPRESSION; MEMBRANE	Drug discovery is a key part of malaria control and eradication strategies, and could benefit from sensitive and affordable assays to quantify parasite growth and to help identify the targets of potential anti-malarial compounds. Bioluminescence, achieved through expression of exogenous luciferases, is a powerful tool that has been applied in studies of several aspects of parasite biology and high throughput growth assays. We have expressed the new reporter NanoLuc (Nluc) luciferase in Plasmodium falciparum and showed it is at least 100 times brighter than the commonly used firefly luciferase. Nluc brightness was explored as a means to achieve a growth assay with higher sensitivity and lower cost. In addition we attempted to develop other screening assays that may help interrogate libraries of inhibitory compounds for their mechanism of action. To this end parasites were engineered to express Nluc in the cytoplasm, the parasitophorous vacuole that surrounds the intraerythrocytic parasite or exported to the red blood cell cytosol. As proof-of-concept, these parasites were used to develop functional screening assays for quantifying the effects of Brefeldin A, an inhibitor of protein secretion, and Furosemide, an inhibitor of new permeation pathways used by parasites to acquire plasma nutrients.	[Azevedo, Mauro F.; Nie, Catherine Q.; Elsworth, Brendan; Charnaud, Sarah C.; Sanders, Paul R.; Crabb, Brendan S.; Gilson, Paul R.] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic, Australia; [Elsworth, Brendan; Charnaud, Sarah C.; Crabb, Brendan S.; Gilson, Paul R.] Monash Univ, Melbourne, Vic 3004, Australia; [Crabb, Brendan S.] Univ Melbourne, Melbourne, Vic, Australia	Burnet Institute; Monash University; University of Melbourne	Gilson, PR (corresponding author), Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic, Australia.	gilson@burnet.edu.au	; Azevedo, Mauro/H-6180-2012	Charnaud, Sarah/0000-0002-9029-9696; Azevedo, Mauro/0000-0002-5233-2037	National Health and Medical Research Council [637406, APP1068287, APP1021560]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council Grants 637406, APP1068287 and APP1021560 awarded to BSC and PRG (URL:www.nhmrc.gov.au). The authors gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program received by the Burnet Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjalley SH, 2011, P NATL ACAD SCI USA, V108, pE1214, DOI 10.1073/pnas.1112037108; Ansorge I, 1996, BIOCHEM J, V315, P307, DOI 10.1042/bj3150307; Azevedo MF, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-20; Beck JR, 2014, NATURE, V511, P592, DOI 10.1038/nature13574; Boddey JA, 2013, TRAFFIC, V14, P532, DOI 10.1111/tra.12053; Boddey JA, 2010, NATURE, V463, P627, DOI 10.1038/nature08728; Boddey JA, 2009, TRAFFIC, V10, P285, DOI 10.1111/j.1600-0854.2008.00864.x; Bouyer G, 2011, BLOOD, V118, P2305, DOI 10.1182/blood-2011-01-329300; Bullen HE, 2012, J BIOL CHEM, V287, P7871, DOI 10.1074/jbc.M111.328591; Burghaus PA, 2001, J BIOL CHEM, V276, P26838, DOI 10.1074/jbc.M100111200; Chang HH, 2008, MOL BIOCHEM PARASIT, V160, P107, DOI 10.1016/j.molbiopara.2008.04.011; Che PL, 2012, ASSAY DRUG DEV TECHN, V10, P61, DOI 10.1089/adt.2011.0378; Collins CR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003344; Crabb BS, 1996, P NATL ACAD SCI USA, V93, P7289, DOI 10.1073/pnas.93.14.7289; Cui L, 2008, EXP PARASITOL, V120, P80, DOI 10.1016/j.exppara.2008.05.003; de Azevedo MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040981; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; Duranton C, 2004, J GEN PHYSIOL, V123, P417, DOI 10.1085/jgp.200308919; Ekland EH, 2011, FASEB J, V25, P3583, DOI 10.1096/fj.11-187401; Elsworth B, 2014, NATURE, V511, P587, DOI 10.1038/nature13555; Elsworth B, 2014, CELL MICROBIOL, V16, P355, DOI 10.1111/cmi.12261; Fernandez-Becerra C, 2003, EXP PARASITOL, V103, P88, DOI 10.1016/S0014-4894(03)00065-1; Frank M, 2006, J BIOL CHEM, V281, P9942, DOI 10.1074/jbc.M513067200; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Gilson PR, 2008, MOL MICROBIOL, V68, P124, DOI 10.1111/j.1365-2958.2008.06140.x; GOONEWARDENE R, 1993, P NATL ACAD SCI USA, V90, P5234, DOI 10.1073/pnas.90.11.5234; Guiguemde WA, 2010, NATURE, V465, P311, DOI 10.1038/nature09099; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Hasenkamp S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-58; Hasenkamp S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-210; Heiber A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003546; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Horrocks P, 1999, MOL BIOCHEM PARASIT, V99, P77, DOI 10.1016/S0166-6851(98)00182-0; Huber SM, 2002, EMBO J, V21, P22, DOI 10.1093/emboj/21.1.22; Jackson KE, 2007, BIOCHEM J, V403, P167, DOI 10.1042/BJ20061725; Khan T, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-369; Knuepfer E, 2005, BLOOD, V105, P4078, DOI 10.1182/blood-2004-12-4666; Lucantoni L, 2013, ANTIMICROB AGENTS CH, V57, P6050, DOI 10.1128/AAC.00870-13; Lucumi E, 2010, ANTIMICROB AGENTS CH, V54, P3597, DOI 10.1128/AAC.00431-10; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; MAKLER MT, 1993, AM J TROP MED HYG, V48, P205, DOI 10.4269/ajtmh.1993.48.205; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Marti M, 2013, CURR OPIN MICROBIOL, V16, P445, DOI 10.1016/j.mib.2013.04.010; Militello KT, 2003, PARASITOL RES, V89, P154, DOI 10.1007/s00436-002-0721-5; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Pasini EM, 2013, MOL CELL PROTEOMICS, V12, P426, DOI 10.1074/mcp.M112.021238; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Spangenberg T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062906; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; van Ooij C, 2008, PLOS PATHOG, V4; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	56	41	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112571	10.1371/journal.pone.0112571	http://dx.doi.org/10.1371/journal.pone.0112571			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392998	Green Published, gold			2022-12-27	WOS:000347709300071
J	Klimentidis, YC; Zhou, J; Wineinger, NE				Klimentidis, Yann C.; Zhou, Jin; Wineinger, Nathan E.			Identification of Allelic Heterogeneity at Type-2 Diabetes Loci and Impact on Prediction	PLOS ONE			English	Article							VARIANTS; RISK	Although over 60 single nucleotide polymorphisms (SNPs) have been identified by meta-analysis of genome-wide association studies for type-2 diabetes (T2D) among individuals of European descent, much of the genetic variation remains unexplained. There are likely many more SNPs that contribute to variation in T2D risk, some of which may lie in the regions surrounding established SNPs - a phenomenon often referred to as allelic heterogeneity. Here, we use the summary statistics from the DIAGRAM consortium meta-analysis of T2D genome-wide association studies along with linkage disequilibrium patterns inferred from a large reference sample to identify novel SNPs associated with T2D surrounding each of the previously established risk loci. We then examine the extent to which the use of these additional SNPs improves prediction of T2D risk in an independent validation dataset. Our results suggest that multiple SNPs at each of 3 loci contribute to T2D susceptibility (TCF7L2, CDKN2A/8, and KCNO1; p<5 x10(-8)). Using a less stringent threshold (p<5 x10(-4)), we identify 34 additional loci with multiple associated SNPs. The addition of these SNPs slightly improves T2D prediction compared to the use of only the respective lead SNPs, when assessed using an independent validation cohort. Our findings suggest that some currently established T2D risk loci likely harbor multiple polymorphisms which contribute independently and collectively to T2D risk. This opens a promising avenue for improving prediction of T2D, and for a better understanding of the genetic architecture of T2D.	[Klimentidis, Yann C.; Zhou, Jin] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Div Epidemiol & Biostat, Tucson, AZ 85721 USA; [Wineinger, Nathan E.] Scripps Translat Sci Inst, La Jolla, CA USA	University of Arizona; Scripps Research Institute	Klimentidis, YC (corresponding author), Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Div Epidemiol & Biostat, Tucson, AZ 85721 USA.	yann@email.arizona.edu	Klimentidis, Yann/B-2348-2015	Klimentidis, Yann/0000-0002-6065-4044	NIH [K01DK095032, 1UL1TR001114]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095165, N01HC095161, N01HC095168, N01HC095162, N01HC095164, N01HC095159, N01HC095166, N01HC095163, N01HC095169, N01HC095167, N01HC095160] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001114, UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005, UL1RR024156, UL1RR033176] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL095167, R01HL071251, R01HL071051, R01HL071259, R01HL071205, R21HL095165, R01HL064278, R43HL095169, R44HL095169, R01HL071250, R43HL095161, R43HL095160, R01HL071258, R01HL095163, R13HL095166] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK095032] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	YCK was supported by NIH grant K01DK095032. NEW was supported by NIH grant 1UL1TR001114. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei I, 2013, CURR PROTOC HUM GENE; Akalke H, 1974, IEEE T AUTOMAT CONTR, V19; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Ke XY, 2012, AM J HUM GENET, V91, P185, DOI 10.1016/j.ajhg.2012.05.020; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Purcell SM, 2009, NATURE; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sim X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001363; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Williams AL, 2013, NATURE; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	20	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e113072	10.1371/journal.pone.0113072	http://dx.doi.org/10.1371/journal.pone.0113072			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393876	gold, Green Published, Green Submitted			2022-12-27	WOS:000347709300141
J	Schaeffer, S; Harper, A; Raja, R; Jaiswal, P; Dhingra, A				Schaeffer, Scott; Harper, Artemus; Raja, Rajani; Jaiswal, Pankaj; Dhingra, Amit			Comparative Analysis of Predicted Plastid-Targeted Proteomes of Sequenced Higher Plant Genomes	PLOS ONE			English	Article							ARABIDOPSIS; PROTEINS; REVEALS; ANNOTATION; MITOCHONDRIAL; CHLOROPLASTS; EVOLUTION; TRANSPORT; RESOURCE; BLAST2GO	Plastids are actively involved in numerous plant processes critical to growth, development and adaptation. They play a primary role in photosynthesis, pigment and monoterpene synthesis, gravity sensing, starch and fatty acid synthesis, as well as oil, and protein storage. We applied two complementary methods to analyze the recently published apple genome (Malus x domestica) to identify putative plastid-targeted proteins, the first using TargetP and the second using a custom workflow utilizing a set of predictive programs. Apple shares roughly 40% of its 10,492 putative plastid-targeted proteins with that of the Arabidopsis (Arabidopsis thaliana) plastid-targeted proteome as identified by the Chloroplast 2010 project and similar to 57% of its entire proteome with Arabidopsis. This suggests that the plastid-targeted proteomes between apple and Arabidopsis are different, and interestingly alludes to the presence of differential targeting of homologs between the two species. Co-expression analysis of 2,224 genes encoding putative plastid-targeted apple proteins suggests that they play a role in plant developmental and intermediary metabolism. Further, an inter-specific comparison of Arabidopsis, Prunus persica (Peach), Malus x domestica (Apple), Populus trichocarpa (Black cottonwood), Fragaria vesca (Woodland Strawberry), Solanum lycopersicum (Tomato) and Vitis vinifera (Grapevine) also identified a large number of novel species-specific plastid-targeted proteins. This analysis also revealed the presence of alternatively targeted homologs across species. Two separate analyses revealed that a small subset of proteins, one representing 289 protein clusters and the other 737 unique protein sequences, are conserved between seven plastid-targeted angiosperm proteomes. Majority of the novel proteins were annotated to play roles in stress response, transport, catabolic processes, and cellular component organization. Our results suggest that the current state of knowledge regarding plastid biology, preferentially based on model systems is deficient. New plant genomes are expected to enable the identification of potentially new plastid-targeted proteins that will aid in studying novel roles of plastids.	[Schaeffer, Scott; Harper, Artemus; Dhingra, Amit] Washington State Univ, Dept Hort, Pullman, WA 99164 USA; [Schaeffer, Scott; Dhingra, Amit] Washington State Univ, Mol Plant Sci Grad Program, Pullman, WA 99164 USA; [Raja, Rajani; Jaiswal, Pankaj] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	Washington State University; Washington State University; Oregon State University	Dhingra, A (corresponding author), Washington State Univ, Dept Hort, Pullman, WA 99164 USA.	adhingra@wsu.edu	Dhingra, Amit/AAX-9566-2020; Jaiswal, Pankaj/R-4214-2019; Jaiswal, Pankaj/H-7599-2016; Dhingra, Amit/E-7369-2010	Dhingra, Amit/0000-0002-4464-2502; Jaiswal, Pankaj/0000-0002-1005-8383; Jaiswal, Pankaj/0000-0002-1005-8383; Schaeffer, Scott/0000-0002-8904-2594	United States Department of Agriculture National Institute of Food and Agriculture [2009-05031]; National Institutes of Health Training Grant [T32 GM008336]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008336] Funding Source: NIH RePORTER	United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research and support for AH was funded in part by United States Department of Agriculture National Institute of Food and Agriculture Grant # 2009-05031 to AD. Support for SS was provided by National Institutes of Health Training Grant number T32 GM008336 to AD as co-applicant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Barsan C, 2010, J EXP BOT, V61, P2413, DOI 10.1093/jxb/erq070; Ben-Dor A, 1999, J COMPUT BIOL, V6, P281, DOI 10.1089/106652799318274; Boyer J, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-5; Camara B, 1995, INT REV CYTOL, V163, P175, DOI 10.1016/S0074-7696(08)62211-1; Chen MH, 2004, PLANT PHYSIOL, V135, P1367, DOI 10.1104/pp.104.042184; CLIJSTER.H, 1969, QUAL PLANT MATER VEG, V19, P129, DOI 10.1007/BF01101148; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fischer K, 2002, TRENDS PLANT SCI, V7, P345, DOI 10.1016/S1360-1385(02)02291-4; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Friis C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012253; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Janssen BJ, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-16; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Karpowicz SJ, 2011, J BIOL CHEM, V286, P21427, DOI 10.1074/jbc.M111.233734; KEEGSTRA K, 1989, ANNU REV PLANT PHYS, V40, P471, DOI 10.1146/annurev.pp.40.060189.002351; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; KISS JZ, 1989, PLANTA, V177, P198, DOI 10.1007/BF00392808; Kleffmann T, 2004, CURR BIOL, V14, P354, DOI 10.1016/j.cub.2004.02.039; KREUZ K, 1984, EUR J BIOCHEM, V141, P531, DOI 10.1111/j.1432-1033.1984.tb08225.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kutschera U, 2005, THEOR BIOSCI, V124, P1, DOI 10.1016/j.thbio.2005.04.001; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Liu YS, 2004, P NATL ACAD SCI USA, V101, P9897, DOI 10.1073/pnas.0400935101; Lu Y, 2011, PLANT PHYSIOL, V155, P1589, DOI 10.1104/pp.110.170118; Lukjancenko O, 2012, MICROB ECOL, V63, P651, DOI 10.1007/s00248-011-9948-y; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Martin W, 1998, PLANT PHYSIOL, V118, P9, DOI 10.1104/pp.118.1.9; Meinke D, 2008, TRENDS PLANT SCI, V13, P483, DOI 10.1016/j.tplants.2008.06.003; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; METTAL U, 1988, EUR J BIOCHEM, V170, P613, DOI 10.1111/j.1432-1033.1988.tb13741.x; Miras S, 2002, J BIOL CHEM, V277, P47770, DOI 10.1074/jbc.M207477200; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Peltier JB, 2006, MOL CELL PROTEOMICS, V5, P114, DOI 10.1074/mcp.M500180-MCP200; PHAN CT, 1973, EXPERIENTIA, V29, P1555, DOI 10.1007/BF01943915; Richly E, 2004, GENE, V329, P11, DOI 10.1016/j.gene.2004.01.008; Robinson N, 1988, PLANT PHYSIOL, V87; Rochaix JD, 1997, TRENDS PLANT SCI, V2, P419, DOI 10.1016/S1360-1385(97)90025-X; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schein AI, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.16.e82; Schemenewitz A, 2007, P NATL ACAD SCI USA, V104, P8538, DOI 10.1073/pnas.0702058104; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; van Wijk KJ, 2011, PLANT PHYSIOL, V155, P1578, DOI 10.1104/pp.111.172932; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; Wang Yong-Qiang, 2013, J Exp Bot, V64, P949, DOI 10.1093/jxb/ers375; Youens-Clark K, 2011, NUCLEIC ACIDS RES, V39, pD1085, DOI 10.1093/nar/gkq1148; Zhang XP, 2002, TRENDS PLANT SCI, V7, P14, DOI 10.1016/S1360-1385(01)02180-X; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	66	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112870	10.1371/journal.pone.0112870	http://dx.doi.org/10.1371/journal.pone.0112870			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393533	Green Published, gold, Green Submitted			2022-12-27	WOS:000347709300115
J	Yonemura, S				Yonemura, Shigenobu			Differential Sensitivity of Epithelial Cells to Extracellular Matrix in Polarity Establishment	PLOS ONE			English	Article							ZONULA OCCLUDENS; TIGHT JUNCTION; ALPHA-CATENIN; MORPHOGENESIS; CULTURES; RAC1; IDENTIFICATION; ORIENTATION; RECRUITMENT; REVERSAL	Establishment of apical-basal polarity is crucial for epithelial sheets that form a compartment in the body, which function to maintain the environment in the compartment. Effects of impaired polarization are easily observed in three-dimensional (3D) culture systems rather than in two-dimensional (2-D) culture systems. Although the mechanisms for establishing the polarity are not completely understood, signals from the extracellular matrix (ECM) are considered to be essential for determining the basal side and eventually generating polarity in the epithelial cells. To elucidate the common features and differences in polarity establishment among various epithelial cells, we analyzed the formation of epithelial apical-basal polarity using three cell lines of different origin: MDCK II cells (dog renal tubules), EpH4 cells (mouse mammary gland), and R2/7 cells (human colon) expressing wild-type alpha-catenin (R2/7 alpha-Cate cells). These cells showed clear apical-basal polarity in 2-D cultures. In 3-D cultures, however, each cell line displayed different responses to the same ECM. In MDCK II cells, spheroids with a single lumen formed in both Matrigel and collagen gel. In R2/7 alpha-Cate cells, spheroids showed similar apical-basal polarity as that seen in MDCK II cells, but had multiple lumens. In EpH4 cells, the spheroids displayed an apical-basal polarity that was opposite to that seen in the other two cell types in both ECM gels, at least during the culture period. On the other hand, the three cell lines showed the same apical-basal polarity both in 2-D cultures and in 3-D cultures using the hanging drop method. The three lines also had similar cellular responses to ECM secreted by the cells themselves. Therefore, appropriate culture conditions should be carefully determined in advance when using various epithelial cells to analyze cell polarity or 3-D morphogenesis.	[Yonemura, Shigenobu] RIKEN Ctr Dev Biol, Electron Microscope Lab, Kobe, Hyogo, Japan; [Yonemura, Shigenobu] Japan Sci & Technol Agcy, CREST, Kobe, Hyogo, Japan	RIKEN; Japan Science & Technology Agency (JST)	Yonemura, S (corresponding author), RIKEN Ctr Dev Biol, Electron Microscope Lab, Kobe, Hyogo, Japan.	yonemura@cdb.riken.jp			CREST grant from the (JST) Japan Science and Technology Agency	CREST grant from the (JST) Japan Science and Technology Agency	SY was supported by a CREST grant for "Elucidation of a novel unified epithelial system defined by the reciprocal regulation of cell-cell adhesion and the apical cytoskeleton and its use for manipulating the epithelial barrier'' from the (JST) Japan Science and Technology Agency (http://www.jst.go.jp/kisoken/crest/en/project/35/e35_09.html). There is no grant number. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMEMIYA S, 1979, J EXP ZOOL, V210, P177, DOI 10.1002/jez.1402100120; BARKER G, 1981, Q J EXP PHYSIOL CMS, V66, P61, DOI 10.1113/expphysiol.1981.sp002529; CHAMBARD M, 1981, J CELL BIOL, V91, P157, DOI 10.1083/jcb.91.1.157; Datta A, 2011, CURR BIOL, V21, pR126, DOI 10.1016/j.cub.2010.12.003; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Hayashi K, 1999, J CELL SCI, V112, P1149; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Martin-Belmonte F, 2008, CURR OPIN CELL BIOL, V20, P227, DOI 10.1016/j.ceb.2008.01.001; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Miyake Y, 2006, EXP CELL RES, V312, P1637, DOI 10.1016/j.yexcr.2006.01.031; Myllymaki SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019453; Navarro C, 2005, ONCOGENE, V24, P4330, DOI 10.1038/sj.onc.1208632; Niemann C, 1998, J CELL BIOL, V143, P533, DOI 10.1083/jcb.143.2.533; O'Brien LE, 2006, METHOD ENZYMOL, V406, P676, DOI 10.1016/S0076-6879(06)06053-8; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; Page H, 2013, CELL TISSUE RES, V352, P123, DOI 10.1007/s00441-012-1441-5; REICHMANN E, 1989, J CELL BIOL, V108, P1127, DOI 10.1083/jcb.108.3.1127; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Straight SW, 2004, MOL BIOL CELL, V15, P1981, DOI 10.1091/mbc.E03-08-0620; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; WANG AZ, 1990, J CELL SCI, V95, P153; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Yamanaka T, 2006, J CELL SCI, V119, P2107, DOI 10.1242/jcs.02938; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435; Zovein AC, 2010, DEV CELL, V18, P39, DOI 10.1016/j.devcel.2009.12.006	29	29	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112922	10.1371/journal.pone.0112922	http://dx.doi.org/10.1371/journal.pone.0112922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393292	Green Published, gold			2022-12-27	WOS:000347709300123
J	Fahmy, K; Akber, M; Cai, XL; Koul, A; Hayder, A; Baumgartner, S				Fahmy, Khalid; Akber, Mira; Cai, Xiaoli; Koul, Aabid; Hayder, Awais; Baumgartner, Stefan			alpha Tubulin 67C and Ncd Are Essential for Establishing a Cortical Microtubular Network and Formation of the Bicoid mRNA Gradient in Drosophila	PLOS ONE			English	Article							IN-VIVO ANALYSIS; ALPHA-TUBULIN; MITOTIC SPINDLE; POSTERIOR LOCALIZATION; MORPHOGEN GRADIENT; AXIS SPECIFICATION; VESICLE TRANSPORT; PROTEIN; ORGANIZATION; OOCYTE	The Bicoid (Bcd) protein gradient in Drosophila serves as a paradigm for gradient formation in textbooks. To explain the generation of the gradient, the ARTS model, which is based on the observation of a bcd mRNA gradient, proposes that the bcd mRNA, localized at the anterior pole at fertilization, migrates along microtubules (MTs) at the cortex to the posterior to form a bcd mRNA gradient which is translated to form a protein gradient. To fulfil the criteria of the ARTS model, an early cortical MT network is thus a prerequisite. We report hitherto undiscovered MT activities in the early embryo important for bcd mRNA transport: (i) an early and omnidirectional MT network exclusively at the anterior cortex of early nuclear cycle embryos showing activity during metaphase and anaphase only, (ii) long MTs up to 50 mm extending into the yolk at blastoderm stage to enable basal-apical transport. The cortical MT network is not anchored to the actin cytoskeleton. The posterior transport of the mRNA via the cortical MT network critically depends on maternally-expressed alpha Tubulin67C and the minus-end motor Ncd. In either mutant, cortical transport of the bcd mRNA does not take place and the mRNA migrates along another yet undisclosed interior MT network, instead. Our data strongly corroborate the ARTS model and explain the occurrence of the bcd mRNA gradient.	[Fahmy, Khalid; Akber, Mira; Cai, Xiaoli; Koul, Aabid; Hayder, Awais; Baumgartner, Stefan] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Lund University	Baumgartner, S (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	Stefan.Baumgartner@med.lu.se	Baumgartner, Stefan/A-5879-2011	Baumgartner, Stefan/0000-0001-5320-8321	Swedish Research Council; Eric Philipp Sorensen Stiftelse; Olle Engkvist Foundation; Medical Faculty of Lund; Swedish Research Council and Hereditas	Swedish Research Council(Swedish Research CouncilEuropean Commission); Eric Philipp Sorensen Stiftelse; Olle Engkvist Foundation; Medical Faculty of Lund; Swedish Research Council and Hereditas	SB received funding from the Swedish Research Council, the Eric Philipp Sorensen Stiftelse, the Olle Engkvist Foundation, and the Medical Faculty of Lund. KF received funding from the Swedish Research Council and Hereditas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Arish A, 2010, BIOPHYS J, V99, pL33, DOI 10.1016/j.bpj.2010.05.031; BAKER J, 1993, J CELL BIOL, V122, P113, DOI 10.1083/jcb.122.1.113; Bobinnec Y, 2003, CELL MOTIL CYTOSKEL, V54, P217, DOI 10.1002/cm.10094; BRE MH, 1987, J CELL BIOL, V105, P1283, DOI 10.1083/jcb.105.3.1283; Callaini G, 1997, CELL MOTIL CYTOSKEL, V37, P300; Callaini G, 1996, DEV BIOL, V176, P199, DOI 10.1006/dbio.1996.0127; Castle BT, 2011, CELL MOL BIOENG, V4, P116, DOI 10.1007/s12195-010-0157-4; Cha BJ, 2001, CELL, V106, P35, DOI 10.1016/S0092-8674(01)00419-6; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; Clark IE, 1997, DEVELOPMENT, V124, P461; Combs PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071820; Cui J, 2013, DEV BIOL, V383, P121, DOI 10.1016/j.ydbio.2013.08.013; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; ENDOW SA, 1994, J CELL SCI, V107, P859; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; FOE VE, 1983, J CELL SCI, V61, P31; FOE VE, 1993, DEV DROSOPHILA MELAN, V1, P149; FRIGERIO G, 1986, CELL, V47, P735, DOI 10.1016/0092-8674(86)90516-7; Gaspar I, 2009, CELL MOTIL CYTOSKEL, V66, P68, DOI 10.1002/cm.20334; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; Inoue YH, 2000, J CELL BIOL, V149, P153, DOI 10.1083/jcb.149.1.153; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Januschke J, 2006, DEVELOPMENT, V133, P129, DOI 10.1242/dev.02179; KARR TL, 1986, J CELL BIOL, V102, P1494, DOI 10.1083/jcb.102.4.1494; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; KOMMA DJ, 1995, P NATL ACAD SCI USA, V92, P11884, DOI 10.1073/pnas.92.25.11884; KOMMA DJ, 1991, EMBO J, V10, P419, DOI 10.1002/j.1460-2075.1991.tb07963.x; Komma DJ, 1997, J CELL SCI, V110, P229; Lemos CL, 2000, EMBO J, V19, P3668, DOI 10.1093/emboj/19.14.3668; Lipshitz HD, 2009, NAT REV MOL CELL BIO, V10, P509, DOI 10.1038/nrm2730; Little SC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000596; MATTHEWS KA, 1989, DEV BIOL, V132, P45, DOI 10.1016/0012-1606(89)90203-0; MATTHEWS KA, 1993, DEVELOPMENT, V117, P977; Matthies HJG, 1999, J CELL BIOL, V147, P1137, DOI 10.1083/jcb.147.6.1137; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Page AW, 1996, J CELL SCI, V109, P1707; Parton RM, 2011, J CELL BIOL, V194, P121, DOI 10.1083/jcb.201103160; Petkova MD, 2014, CURR BIOL, V24, P1283, DOI 10.1016/j.cub.2014.04.028; Rabinowitz M, 1941, J MORPHOL, V69, P1, DOI 10.1002/jmor.1050690102; Rand MD, 2010, INSECT BIOCHEM MOLEC, V40, P792, DOI 10.1016/j.ibmb.2010.07.007; RIPOCHE J, 1994, P NATL ACAD SCI USA, V91, P1878, DOI 10.1073/pnas.91.5.1878; Rogers GC, 2008, MOL BIOL CELL, V19, P3163, DOI 10.1091/mbc.E07-10-1069; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; SALLES FJ, 1994, SCIENCE, V266, P1996, DOI 10.1126/science.7801127; Sawin KE, 2006, YEAST, V23, P1001, DOI 10.1002/yea.1404; SCHEJTER ED, 1993, ANNU REV CELL BIOL, V9, P67, DOI 10.1146/annurev.cellbio.9.1.67; Sigaut L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003629; SPIEGELMAN BM, 1979, CELL, V16, P239, DOI 10.1016/0092-8674(79)90002-3; Spirov A, 2009, DEVELOPMENT, V136, P605, DOI 10.1242/dev.031195; THEURKAUF WE, 1992, DEVELOPMENT, V115, P923; THEURKAUF WE, 1992, J CELL BIOL, V116, P1167, DOI 10.1083/jcb.116.5.1167; Theurkauf WE, 1998, DEVELOPMENT, V125, P3655; Venkei Z, 2005, MOL GENET GENOMICS, V273, P283, DOI 10.1007/s00438-005-1109-x; Venkei Z, 2006, J CELL SCI, V119, P3238, DOI 10.1242/jcs.03039; WARN RM, 1990, CELL MOTIL CYTOSKEL, V17, P34, DOI 10.1002/cm.970170106; WEHLAND J, 1983, J CELL BIOL, V97, P1467, DOI 10.1083/jcb.97.5.1467; Weil TT, 2008, CURR BIOL, V18, P1055, DOI 10.1016/j.cub.2008.06.046; Weil TT, 2006, DEV CELL, V11, P251, DOI 10.1016/j.devcel.2006.06.006; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; Welte MA, 2009, BIOCHEM SOC T, V37, P991, DOI 10.1042/BST0370991; Zimyanin VL, 2008, CELL, V134, P843, DOI 10.1016/j.cell.2008.06.053	62	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112053	10.1371/journal.pone.0112053	http://dx.doi.org/10.1371/journal.pone.0112053			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390693	Green Published, gold			2022-12-27	WOS:000349144400050
J	Kadala, A; Charreton, M; Jakob, I; Cens, T; Rousset, M; Chahine, M; Le Conte, Y; Charnet, P; Collet, C				Kadala, Aklesso; Charreton, Mercedes; Jakob, Ingrid; Cens, Thierry; Rousset, Matthieu; Chahine, Mohamed; Le Conte, Yves; Charnet, Pierre; Collet, Claude			Pyrethroids Differentially Alter Voltage-Gated Sodium Channels from the Honeybee Central Olfactory Neurons	PLOS ONE			English	Article							ROOT GANGLION NEURONS; APIS-MELLIFERA L.; XENOPUS OOCYTES; DROSOPHILA-MELANOGASTER; BINDING-SITES; ION CHANNELS; INSECTICIDES; MODULATION; DELTAMETHRIN; TETRAMETHRIN	The sensitivity of neurons from the honey bee olfactory system to pyrethroid insecticides was studied using the patch-clamp technique on central 'antennal lobe neurons' (ALNs) in cell culture. In these neurons, the voltage-dependent sodium currents are characterized by negative potential for activation, fast kinetics of activation and inactivation, and the presence of cumulative inactivation during train of depolarizations. Perfusion of pyrethroids on these ALN neurons submitted to repetitive stimulations induced (1) an acceleration of cumulative inactivation, and (2) a marked slowing of the tail current recorded upon repolarization. Cypermethrin and permethrin accelerated cumulative inactivation of the sodium current peak in a similar manner and tetramethrin was even more effective. The slow-down of channel deactivation was markedly dependent on the type of pyrethroid. With cypermethrin, a progressive increase of the tail current amplitude along with successive stimulations reveals a traditionally described use-dependent recruitment of modified sodium channels. However, an unexpected decrease in this tail current was revealed with tetramethrin. If one considers the calculated percentage of modified channels as an index of pyrethroids effects, ALNs are significantly more susceptible to tetramethrin than to permethrin or cypermethrin for a single depolarization, but this difference attenuates with repetitive activity. Further comparison with peripheral neurons from antennae suggest that these modifications are neuron type specific. Modeling the sodium channel as a multi-state channel with fast and slow inactivation allows to underline the effects of pyrethroids on a set of rate constants connecting open and inactivated conformations, and give some insights to their specificity. Altogether, our results revealed a differential sensitivity of central olfactory neurons to pyrethroids that emphasize the ability for these compounds to impair detection and processing of information at several levels of the bees olfactory pathway.	[Kadala, Aklesso; Charreton, Mercedes; Jakob, Ingrid; Le Conte, Yves; Collet, Claude] INRA, UR Abeilles & Environm 406, Avignon, France; [Cens, Thierry; Rousset, Matthieu; Charnet, Pierre] Univ Montpellier 2, CNRS, Ctr Rech Biochim Macromol, UMR 5237, Montpellier, France; [Chahine, Mohamed] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; [Charreton, Mercedes; Le Conte, Yves; Collet, Claude] UMT Protect Abeilles Environm, Avignon, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Laval University	Collet, C (corresponding author), INRA, UR Abeilles & Environm 406, Avignon, France.	claude.collet@avignon.inra.fr	Cens, Thierry/M-3337-2017; Le Conte, Yves/AAP-2379-2021; Le Conte, Yves M/B-3246-2016; Le Conte, Yves/M-4442-2018	Cens, Thierry/0000-0002-4109-2779; Le Conte, Yves/0000-0002-8466-5370; Le Conte, Yves M/0000-0002-8466-5370; Le Conte, Yves/0000-0002-8466-5370; Charnet, Pierre/0000-0003-4692-528X; Rousset, Matthieu/0000-0003-2064-2791	French National Research Agency (Bee-channels) [ANR-13-BSV7-0010]	French National Research Agency (Bee-channels)(French National Research Agency (ANR))	This work received financial support from the French National Research Agency (ANR-13-BSV7-0010, Bee-channels). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blair NT, 2003, J NEUROSCI, V23, P10338; Bloomquist JR, 1996, ANNU REV ENTOMOL, V41, P163, DOI 10.1146/annurev.en.41.010196.001115; Breckenridge CB, 2009, NEUROTOXICOLOGY, V30, pS17, DOI 10.1016/j.neuro.2009.09.002; BROWN LD, 1987, TOXICOL APPL PHARM, V89, P305, DOI 10.1016/0041-008X(87)90150-5; Capes DL, 2013, J GEN PHYSIOL, V142, P101, DOI 10.1085/jgp.201310998; Chauzat MP, 2007, PEST MANAG SCI, V63, P1100, DOI 10.1002/ps.1451; Choi JS, 2006, TOXICOL APPL PHARM, V211, P233, DOI 10.1016/j.taap.2005.06.022; Collet C, 2009, PFLUG ARCH EUR J PHY, V458, P601, DOI 10.1007/s00424-009-0642-6; COX RL, 1984, ENVIRON ENTOMOL, V13, P375, DOI 10.1093/ee/13.2.375; Decourtye A, 2005, ARCH ENVIRON CON TOX, V48, P242, DOI 10.1007/s00244-003-0262-7; Derst C, 2006, BIOCHEM BIOPH RES CO, V339, P939, DOI 10.1016/j.bbrc.2005.11.096; Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110; Galizia CG, 2010, ANNU REV ENTOMOL, V55, P399, DOI 10.1146/annurev-ento-112408-085442; GAMMON DW, 1981, PESTIC BIOCHEM PHYS, V15, P181, DOI 10.1016/0048-3575(81)90084-5; Ginsburg K, 1999, BRAIN RES, V847, P38, DOI 10.1016/S0006-8993(99)02029-6; Hildebrand ME, 2004, J PHARMACOL EXP THER, V308, P805, DOI 10.1124/jpet.103.058792; Kadala A, 2011, NEUROTOXICOLOGY, V32, P320, DOI 10.1016/j.neuro.2011.02.007; KAISSLING KE, 1986, ANNU REV NEUROSCI, V9, P121, DOI 10.1146/annurev.ne.09.030186.001005; Khambay B.P., 2005, COMPREHENSIVE MOL IN, V6, P1, DOI [10.1016/B0-44-451924-6/00075-2, DOI 10.1016/B0-44-451924-6/00075-2]; Lee D, 1999, MOL PHARMACOL, V55, P584; Lee SH, 1999, INSECT BIOCHEM MOLEC, V29, P185, DOI 10.1016/S0965-1748(98)00122-2; LUCAS P, 1992, PESTIC BIOCHEM PHYS, V43, P103, DOI 10.1016/0048-3575(92)90024-T; Mickus T, 1999, BIOPHYS J, V76, P846, DOI 10.1016/S0006-3495(99)77248-6; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Narahashi T, 2002, MINI-REV MED CHEM, V2, P419, DOI 10.2174/1389557023405927; Neal AP, 2010, TOXICOL SCI, V116, P604, DOI 10.1093/toxsci/kfq139; O'Reilly AO, 2006, BIOCHEM J, V396, P255, DOI 10.1042/BJ20051925; O'Reilly AO, 2014, PEST MANAG SCI, V70, P369, DOI 10.1002/ps.3561; ODOWD DK, 1995, J NEUROSCI, V15, P4005; Olson RO, 2008, INSECT BIOCHEM MOLEC, V38, P604, DOI 10.1016/j.ibmb.2008.01.003; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; SALGADO VL, 1993, MOL PHARMACOL, V43, P626; Slessor KN, 2005, J CHEM ECOL, V31, P2731, DOI 10.1007/s10886-005-7623-9; Smith TJ, 1998, NEUROTOXICOLOGY, V19, P823; Smith TJ, 1998, ARCH INSECT BIOCHEM, V38, P126, DOI 10.1002/(SICI)1520-6327(1998)38:3&lt;126::AID-ARCH3&gt;3.0.CO;2-Q; Soderlund DM, 2010, PESTIC BIOCHEM PHYS, V97, P78, DOI 10.1016/j.pestbp.2009.06.010; Song JH, 1996, J PHARMACOL EXP THER, V277, P445; Song JH, 1996, BRAIN RES, V708, P29, DOI 10.1016/0006-8993(95)01239-7; Tabarean IV, 1998, J PHARMACOL EXP THER, V284, P958; Tabarean IV, 2001, J PHARMACOL EXP THER, V299, P988; Tan JG, 2005, MOL PHARMACOL, V67, P513, DOI 10.1124/mol.104.006205; Tan JG, 2002, J NEUROSCI, V22, P5300; TATEBAYASHI H, 1994, J PHARMACOL EXP THER, V270, P595; TAYLOR KS, 1987, APIDOLOGIE, V18, P243, DOI 10.1051/apido:19870304; Thompson HM, 2003, ECOTOXICOLOGY, V12, P317, DOI 10.1023/A:1022575315413; Vais H, 2000, J GEN PHYSIOL, V115, P305, DOI 10.1085/jgp.115.3.305; Vais H, 2003, MOL PHARMACOL, V64, P914, DOI 10.1124/mol.64.4.914; Warmke JW, 1997, J GEN PHYSIOL, V110, P119, DOI 10.1085/jgp.110.2.119; Zhou T, 2011, PESTIC BIOCHEM PHYS, V100, P35, DOI 10.1016/j.pestbp.2011.02.001	49	16	17	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112194	10.1371/journal.pone.0112194	http://dx.doi.org/10.1371/journal.pone.0112194			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390654	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400062
J	Loffredo, S; Staiano, RI; Granata, F; Costantino, V; Borriello, F; Frattini, A; Lepore, MT; Mangoni, A; Marone, G; Triggiani, M				Loffredo, Stefania; Staiano, Rosaria I.; Granata, Francescopaolo; Costantino, Valeria; Borriello, Francesco; Frattini, Annunziata; Lepore, Maria Teresa; Mangoni, Alfonso; Marone, Gianni; Triggiani, Massimo			Simplexide Induces CD1d-Dependent Cytokine and Chemokine Production from Human Monocytes	PLOS ONE			English	Article							HUMAN LUNG MACROPHAGES; INVARIANT NKT CELLS; KILLER T-CELLS; ALPHA-GALACTOSYLCERAMIDE; ANTIGEN PRESENTATION; DENDRITIC CELLS; ACTIVATION; GLYCOLIPIDS; CD1D; HETEROGENEITY	Monocytes are major effector cells of innate immunity and recognize several endogenous and exogenous molecules due to the expression of wide spectrum of receptors. Among them, the MHC class I-like molecule CD1d interacts with glycolipids and presents them to iNKT cells, mediating their activation. Simplexide belongs to a novel class of glycolipids isolated from marine sponges and is structurally distinct from other immunologically active glycolipids. In this study we have examined the effects of simplexide on cytokine and chemokine release from human monocytes. Simplexide induces a concentration and time-dependent release of IL-6, CXCL8, TNF-alpha and IL-10 and increases the expression of IL6, CXCL8 and IL10 mRNA. Cytokine and chemokine release induced by simplexide from monocytes is dependent on CD1d since: i) a CD1d antagonist, 1,2-bis (diphenylphosphino) ethane [DPPE]- polyethylene glycolmonomethylether [PEG], specifically blocks simplexide-induced activation of monocytes; ii) CD1d knockdown inhibits monocyte activation by simplexide and iii) simplexide induces cytokine production from CD1d-transfected but not parental C1R cell line Finally, we have shown that simplexide also induces iNKT cell expansion in vitro. Our results demonstrate that simplexide, apart from activating iNKT cells, induces the production of cytokines and chemokines from human monocytes by direct interaction with CD1d.	[Loffredo, Stefania; Staiano, Rosaria I.; Granata, Francescopaolo; Borriello, Francesco; Frattini, Annunziata; Lepore, Maria Teresa; Marone, Gianni] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy; [Loffredo, Stefania; Staiano, Rosaria I.; Granata, Francescopaolo; Borriello, Francesco; Frattini, Annunziata; Lepore, Maria Teresa; Marone, Gianni] Univ Naples Federico II, Ctr Basic & Clin Immunol Res CISI, Naples, Italy; [Costantino, Valeria; Mangoni, Alfonso] Univ Naples Federico II, Dept Pharm, NeaNAT Grp, Naples, Italy; [Triggiani, Massimo] Univ Salerno, Div Allergy & Clin Immunol, I-84100 Salerno, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; University of Salerno	Marone, G (corresponding author), Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy.	marone@unina.it	Mangoni, Alfonso/A-3554-2012; Costantino, Valeria/AAN-1960-2020; Triggiani, Massimo/K-8271-2016	Mangoni, Alfonso/0000-0003-3910-6518; Costantino, Valeria/0000-0001-8723-9505; Triggiani, Massimo/0000-0001-7318-2093; Lepore, Maria Teresa/0000-0002-4701-6902; Borriello, Francesco/0000-0001-9074-4828	Ministero dell'Universita e della Ricerca; Regione Campania; CISI Lab project; CREME project; TIMING project; European Union [311848]	Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Regione Campania(Regione Campania); CISI Lab project; CREME project; TIMING project; European Union(European Commission)	This work was supported by grants from the Ministero dell'Universita e della Ricerca (MT, and GM), the Regione Campania (GM), CISI Lab project, CREME project, TIMING project and European Union's Seventh Framework Programme FP7/2007-2013 under grant agreement nu 311848 (BlueGenics) (AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Banchet-Cadeddu A, 2011, ORG BIOMOL CHEM, V9, P3080, DOI 10.1039/c0ob00975j; Barral DC, 2007, NAT REV IMMUNOL, V7, P929, DOI 10.1038/nri2191; Bas S, 2008, J IMMUNOL, V180, P1158, DOI 10.4049/jimmunol.180.2.1158; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Brutkiewicz RR, 2006, J IMMUNOL, V177, P769, DOI 10.4049/jimmunol.177.2.769; Burton RA, 2010, NAT CHEM BIOL, V6, P724, DOI [10.1038/NCHEMBIO.439, 10.1038/nchembio.439]; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Colgan SP, 1999, P NATL ACAD SCI USA, V96, P13938, DOI 10.1073/pnas.96.24.13938; Costantino V, 2004, CURR MED CHEM, V11, P1671, DOI 10.2174/0929867043364973; Costantino V, 1996, TETRAHEDRON, V52, P1573, DOI 10.1016/0040-4020(95)00986-8; Costantino V, 1999, BIOORG MED CHEM LETT, V9, P271, DOI 10.1016/S0960-894X(98)00719-7; Fattorusso E, 1997, PROG CHEM ORG NAT PR, V72, P215; Gadola SD, 2002, J IMMUNOL, V168, P5514, DOI 10.4049/jimmunol.168.11.5514; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; GORDON JR, 1990, NATURE, V346, P274, DOI 10.1038/346274a0; Granata F, 2010, J IMMUNOL, V184, P5232, DOI 10.4049/jimmunol.0902501; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Im JS, 2009, IMMUNITY, V30, P888, DOI 10.1016/j.immuni.2009.03.022; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kobayashi E, 1995, ONCOL RES, V7, P529; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Kunii N, 2009, CANCER SCI, V100, P1092, DOI 10.1111/j.1349-7006.2009.01135.x; Lombardi V, 2010, J IMMUNOL, V184, P2107, DOI 10.4049/jimmunol.0901208; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Mildner A, 2013, BLOOD, V121, P1016, DOI 10.1182/blood-2012-07-445999; MORITA M, 1995, J MED CHEM, V38, P2176, DOI 10.1021/jm00012a018; Motohashi S, 2009, J IMMUNOL, V182, P2492, DOI 10.4049/jimmunol.0800126; Nieuwenhuis EES, 2005, EXP DERMATOL, V14, P250, DOI 10.1111/j.0906-6705.2005.00289.x; Olszak T, 2014, NATURE; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Salio M, 2010, CURR OPIN IMMUNOL, V22, P81, DOI 10.1016/j.coi.2009.12.008; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Strauss-Ayali D, 2007, J LEUKOCYTE BIOL, V82, P244, DOI 10.1189/jlb.0307191; Tefit JN, 2010, METHODS MOL BIOL, V626, P149, DOI 10.1007/978-1-60761-585-9_11; Triggiani M, 2009, INT ARCH ALLERGY IMM, V150, P144, DOI 10.1159/000218117; Tyznik AJ, 2011, CHEM BIOL, V18, P1620, DOI 10.1016/j.chembiol.2011.10.015; Venkataswamy MM, 2009, J IMMUNOL, V183, P1644, DOI 10.4049/jimmunol.0900858; Wu D, 2006, P NATL ACAD SCI USA, V103, P3972, DOI 10.1073/pnas.0600285103; Wu D, 2008, BIOORGAN MED CHEM, V16, P1073, DOI 10.1016/j.bmc.2007.10.026; Yue SC, 2005, P NATL ACAD SCI USA, V102, P11811, DOI 10.1073/pnas.0503366102; Yue SC, 2010, J IMMUNOL, V184, P268, DOI 10.4049/jimmunol.0800924; Zhang BD, 2011, J ALLERGY CLIN IMMUN, V127, P1522, DOI 10.1016/j.jaci.2011.02.005	49	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111326	10.1371/journal.pone.0111326	http://dx.doi.org/10.1371/journal.pone.0111326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390653	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400020
J	Rahman, M; Jubair, M; Alam, MT; Weppelmann, TA; Azarian, T; Salemi, M; Sakharuk, IA; Rashid, MH; Johnson, JA; Yasmin, M; Morris, JG; Ali, A				Rahman, Mustafizur; Jubair, Mohammad; Alam, Meer T.; Weppelmann, Thomas A.; Azarian, Taj; Salemi, Marco; Sakharuk, Ilya A.; Rashid, Mohammed H.; Johnson, Judith A.; Yasmin, Mahmuda; Morris, J. Glenn, Jr.; Ali, Afsar			High-Frequency Rugose Exopolysaccharide Production by Vibrio cholerae Strains Isolated in Haiti	PLOS ONE			English	Article							EL-TOR; RESISTANCE; VARIANTS; ECOLOGY; GENES	In October, 2010, epidemic cholera was reported for the first time in Haiti in over 100 years. Establishment of cholera endemicity in Haiti will be dependent in large part on the continued presence of toxigenic Vibrio cholerae O1 in aquatic reservoirs. The rugose phenotype of Vibrio cholerae, characterized by exopolysaccharide production that confers resistance to environmental stress, is a potential contributor to environmental persistence. Using a microbiologic medium promoting high-frequency conversion of smooth to rugose (S-R) phenotype, 80 (46.5%) of 172 Vibrio cholerae strains isolated from clinical and environmental sources in Haiti were able to convert to a rugose phenotype. Toxigenic Vibrio cholerae O1 strains isolated at the beginning of the epidemic (2010) were significantly less likely to shift to a rugose phenotype than clinical strains isolated in 2012/2013, or environmental strains. Frequency of rugose conversion was influenced by incubation temperature and time. Appearance of the biofilm produced by a Haitian clinical rugose strain (altered biotype El Tor HC16R) differed from that of a typical El Tor rugose strain (N16961R) by confocal microscopy. On whole-genome SNP analysis, there was no phylogenetic clustering of strains showing an ability to shift to a rugose phenotype. Our data confirm the ability of Haitian clinical (and environmental) strains to shift to a protective rugose phenotype, and suggest that factors such as temperature influence the frequency of transition to this phenotype.	[Rahman, Mustafizur; Jubair, Mohammad; Alam, Meer T.; Weppelmann, Thomas A.; Azarian, Taj; Salemi, Marco; Sakharuk, Ilya A.; Rashid, Mohammed H.; Johnson, Judith A.; Morris, J. Glenn, Jr.; Ali, Afsar] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA; [Azarian, Taj] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL USA; [Salemi, Marco; Johnson, Judith A.] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Yasmin, Mahmuda] Univ Dhaka, Dept Microbiol, Dhaka, Bangladesh	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Dhaka	Ali, A (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.	aali@epi.ufl.edu	Azarian, Taj/H-5772-2019; alam, Meer Taifur/AAQ-1435-2020	Azarian, Taj/0000-0002-8611-5241; alam, Meer Taifur/0000-0002-0703-740X	Department of Defense [C0654_12_UN]; National Institutes of Health (NIH) [RO1 AI097405]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039129, R01AI097405] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a Department of Defense grant (C0654_12_UN) awarded to AA, and National Institutes of Health (NIH) grant RO1 AI097405 awarded to JGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MT, 2014, EMERG INFECT DIS, V20, P356, DOI 10.3201/eid2003.131293; Ali A, 2000, INFECT IMMUN, V68, P1967, DOI 10.1128/IAI.68.4.1967-1974.2000; Ali A, 2002, APPL ENVIRON MICROB, V68, P5773, DOI 10.1128/AEM.68.11.5773-5778.2002; Ali A, 2011, EMERG INFECT DIS, V17, P699, DOI 10.3201/eid1704.101973; Anriany YA, 2001, APPL ENVIRON MICROB, V67, P4048, DOI 10.1128/AEM.67.9.4048-4056.2001; Beyenal H, 2004, J MICROBIOL METH, V59, P395, DOI 10.1016/j.mimet.2004.08.003; COLWELL RR, 1985, BIO-TECHNOL, V3, P817, DOI 10.1038/nbt0985-817; Colwell RR, 1994, VIBRIO CHOLERAE CHOL; Daims H, 2006, ENVIRON MICROBIOL, V8, P200, DOI 10.1111/j.1462-2920.2005.00880.x; DONNENBERG MS, 1993, J CLIN INVEST, V92, P1418, DOI 10.1172/JCI116718; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Fong JCN, 2010, MICROBIOL-SGM, V156, P2757, DOI 10.1099/mic.0.040196-0; Grau BL, 2005, J BACTERIOL, V187, P2519, DOI 10.1128/JB.187.7.2519-2525.2005; Jubair M, 2014, PLOS ONE, V9; Jubair M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045187; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Mann EE, 2012, FEMS MICROBIOL REV, V36, P893, DOI 10.1111/j.1574-6976.2011.00322.x; Morris JG, 2011, EMERG INFECT DIS, V17, P2099, DOI 10.3201/eid1711.111109; Nair GB, 2002, J CLIN MICROBIOL, V40, P3296, DOI 10.1128/JCM.40.9.3296-3299.2002; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Reidl J, 2002, FEMS MICROBIOL REV, V26, P125, DOI 10.1111/j.1574-6976.2002.tb00605.x; Safa A, 2008, EMERG INFECT DIS, V14, P987, DOI 10.3201/eid1406.080129; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Starkey M, 2009, J BACTERIOL, V191, P3492, DOI 10.1128/JB.00119-09; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wai SN, 1998, APPL ENVIRON MICROB, V64, P3648; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Watnick PI, 1999, MOL MICROBIOL, V34, P586, DOI 10.1046/j.1365-2958.1999.01624.x; Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028; Yildiz FH, 2009, TRENDS MICROBIOL, V17, P109, DOI 10.1016/j.tim.2008.12.004	30	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112853	10.1371/journal.pone.0112853	http://dx.doi.org/10.1371/journal.pone.0112853			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390633	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400134
J	Shehzad, SA; Abbasi, FM; Hayat, T; Alsaadi, F				Shehzad, Sabir Ali; Abbasi, Fahad Munir; Hayat, Tasawar; Alsaadi, Fuad			MHD Mixed Convective Peristaltic Motion of Nanofluid with Joule Heating and Thermophoresis Effects	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; TRANSPORT; FLUID; DUFOUR; SORET; SLIP; ENCLOSURE; CHANNEL	The primary objective of present investigation is to introduce the novel aspect of thermophoresis in the mixed convective peristaltic transport of viscous nanofluid. Viscous dissipation and Joule heating are also taken into account. Problem is modeled using the lubrication approach. Resulting system of equations is solved numerically. Effects of sundry parameters on the velocity, temperature, concentration of nanoparticles and heat and mass transfer rates at the wall are studied through graphs. It is noted that the concentration of nanoparticles near the boundaries is enhanced for larger thermophoresis parameter. However reverse situation is observed for an increase in the value of Brownian motion parameter. Further, the mass transfer rate at the wall significantly decreases when Brownian motion parameter is assigned higher values.	[Shehzad, Sabir Ali] Comsats Inst Informat Technol, Dept Math, Sahiwal, Pakistan; [Abbasi, Fahad Munir; Hayat, Tasawar] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Hayat, Tasawar; Alsaadi, Fuad] King Abdulaziz Univ, Fac Engn, Dept Elect & Comp Engn, CSN Res Grp, Jeddah 21413, Saudi Arabia	COMSATS University Islamabad (CUI); Quaid I Azam University; King Abdulaziz University	Shehzad, SA (corresponding author), Comsats Inst Informat Technol, Dept Math, Sahiwal, Pakistan.	s.a.shehzad@hotmail.com	Hayat, Tasawar/E-9449-2015; Alsaadi, Fuad E/Q-6022-2018; Shehzad, Sabir Ali/J-3885-2014; Hayat, Tasawar/A-3853-2013; Hayat, Tasawar/Y-2524-2019; Abbasi, Fahad/A-3471-2013	Alsaadi, Fuad E/0000-0001-6420-3948; 	Deanship of Scientific Research King Abdulaziz University, Jeddah, Saudi Arabia [37-16-35-HiCi]	Deanship of Scientific Research King Abdulaziz University, Jeddah, Saudi Arabia	This paper is funded by the Deanship of Scientific Research King Abdulaziz University, Jeddah, Saudi Arabia under grant no. 37-16-35-HiCi. The funder has no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi FM, 2014, J AEROSPACE ENG, V27, DOI 10.1061/(ASCE)AS.1943-5525.0000354; Abbasi FM, 2014, Z NATURFORSCH A, V69, P451, DOI 10.5560/ZNA.2014-0041; Abbasi FM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105440; Akbar NS, 2014, INT COMMUN HEAT MASS, V58, P193, DOI 10.1016/j.icheatmasstransfer.2014.08.036; Ali N, 2008, PHYS LETT A, V372, P1477, DOI 10.1016/j.physleta.2007.09.061; Buongiorno J, 2006, J HEAT TRANS-T ASME, V128, P240, DOI 10.1115/1.2150834; Choi S.U.S., 1995, ASME, V66, P99, DOI DOI 10.1115/1.1532008; Eytan O, 1999, B MATH BIOL, V61, P221, DOI 10.1006/bulm.1998.0069; Hayat T, 2014, ARAB J SCI ENG, V39, P4341, DOI 10.1007/s13369-014-1163-y; Hayat T, 2014, J MOL LIQ, V194, P93, DOI 10.1016/j.molliq.2014.01.021; Hayat T, 2014, Z NATURFORSCH A, V69, P43, DOI 10.5560/ZNA.2013-0074; Hayat T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095070; Khanafer K, 2003, INT J HEAT MASS TRAN, V46, P3639, DOI 10.1016/S0017-9310(03)00156-X; Kuznetsov AV, 2014, INT J THERM SCI, V77, P126, DOI 10.1016/j.ijthermalsci.2013.10.007; Kuznetsov AV, 2013, INT J HEAT MASS TRAN, V65, P682, DOI 10.1016/j.ijheatmasstransfer.2013.06.054; LEW HS, 1971, J BIOMECH, V4, P297, DOI 10.1016/0021-9290(71)90036-4; Mekheimer KS, 2013, INT J BIOMATH, V6, DOI 10.1142/S1793524513500265; Mekheimer KS, 2013, CHINESE PHYS B, V22, DOI 10.1088/1674-1056/22/12/124702; Mustafa M, 2014, J TAIWAN INST CHEM E, V45, P308, DOI 10.1016/j.jtice.2013.07.010; Rashidi MM, 2013, INT J HEAT MASS TRAN, V62, P515, DOI 10.1016/j.ijheatmasstransfer.2013.03.004; Rashidi MM, 2012, INT J THERM ENV ENG, V4, P13, DOI DOI 10.5383/IJTEE.04.01.003; Sheikholeslami M, 2014, SCI IRAN, V21, P203; Sheikholeslami M, 2014, J MOL LIQ, V193, P174, DOI 10.1016/j.molliq.2013.12.023; SrinivaS S, 2008, INT COMMUN HEAT MASS, V35, P514, DOI 10.1016/j.icheatmasstransfer.2007.08.011; SRIVASTAVA LM, 1988, RHEOL ACTA, V27, P428, DOI 10.1007/BF01332164; STROHMER H, 1994, FERTIL STERIL, V61, P972; Tripathi D, 2013, MATH COMPUT MODEL, V57, P1270, DOI 10.1016/j.mcm.2012.10.030; Turkyilmazoglu M, 2013, INT J MECH SCI, V77, P263, DOI 10.1016/j.ijmecsci.2013.10.011; Turkyilmazoglu M, 2012, CHEM ENG SCI, V84, P182, DOI 10.1016/j.ces.2012.08.029; Turkyilmazoglu M, 2014, COMPUT FLUIDS, V94, P139, DOI 10.1016/j.compfluid.2014.02.009	30	60	60	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111417	10.1371/journal.pone.0111417	http://dx.doi.org/10.1371/journal.pone.0111417			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391147	Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400022
J	Zhang, WS; Edwards, A; Flemington, E; Zhang, K				Zhang, Wensheng; Edwards, Andrea; Flemington, Erik; Zhang, Kun			Somatic Mutations Favorable to Patient Survival Are Predominant in Ovarian Carcinomas	PLOS ONE			English	Article							GENE-EXPRESSION; BREAST-CANCER; SEMANTIC SIMILARITY; LYSOSOMES; RADIOTHERAPY; PROGNOSIS; SIGNATURE; DIAGNOSIS; PREDICTS; PROTEIN	Somatic mutation accumulation is a major cause of abnormal cell growth. However, some mutations in cancer cells may be deleterious to the survival and proliferation of the cancer cells, thus offering a protective effect to the patients. We investigated this hypothesis via a unique analysis of the clinical and somatic mutation datasets of ovarian carcinomas published by the Cancer Genome Atlas. We defined and screened 562 macro mutation signatures (MMSs) for their associations with the overall survival of 320 ovarian cancer patients. Each MMS measures the number of mutations present on the member genes (except for TP53) covered by a specific Gene Ontology (GO) term in each tumor. We found that somatic mutations favorable to the patient survival are predominant in ovarian carcinomas compared to those indicating poor clinical outcomes. Specially, we identified 19 (3) predictive MMSs that are, usually by a nonlinear dose-dependent effect, associated with good (poor) patient survival. The false discovery rate for the 19 "positive'' predictors is at the level of 0.15. The GO terms corresponding to these MMSs include "lysosomal membrane'' and "response to hypoxia'', each of which is relevant to the progression and therapy of cancer. Using these MMSs as features, we established a classification tree model which can effectively partition the training samples into three prognosis groups regarding the survival time. We validated this model on an independent dataset of the same disease (Log-rank p-value <2.3x10(-4)) and a dataset of breast cancer (Log-rank p-value <9.3x10(-23)). We compared the GO terms corresponding to these MMSs and those enriched with expression-based predictive genes. The analysis showed that the GO term pairs with large similarity are mainly pertinent to the proteins located on the cell organelles responsible for material transport and waste disposal, suggesting the crucial role of these proteins in cancer mortality.	[Zhang, Wensheng; Edwards, Andrea; Zhang, Kun] Xavier Univ Louisiana, Dept Comp Sci, New Orleans, LA USA; [Flemington, Erik] Tulane Canc Ctr, Tulane Sch Med, New Orleans, LA 70112 USA	Xavier University of Louisiana	Flemington, E (corresponding author), Tulane Canc Ctr, Tulane Sch Med, New Orleans, LA 70112 USA.	eflemin@tulane.edu; kzhang@xula.edu			National Institutes of Health [NIGMS-2G12MD007595]; US Department of Army [W911NF-12-1-0066]; Louisiana Cancer Research Consortium; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101046, R01AI106676] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Army; Louisiana Cancer Research Consortium; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Research reported in this publication was supported by a National Institutes of Health grant (NIGMS-2G12MD007595), an US Department of Army grant (W911NF-12-1-0066) and a seed grant from the Louisiana Cancer Research Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoudjit F, 2001, ONCOGENE, V20, P4995, DOI 10.1038/sj.onc.1204554; Aoudjit Fawzi, 2012, Chemother Res Pract, V2012, P283181, DOI 10.1155/2012/283181; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Berchuck A, 2005, CLIN CANCER RES, V11, P3686, DOI 10.1158/1078-0432.CCR-04-2398; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Braun R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055037; Bunz F, 2008, PRINCIPLES CANC GENE, pxi; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Cope L, 2013, GYNECOL ONCOL, V128, P500, DOI 10.1016/j.ygyno.2012.11.031; Dai W, 2013, CLIN CANCER RES, V19, P5788, DOI 10.1158/1078-0432.CCR-13-1217; Delfino KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058608; Engler DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030996; Erdal H, 2005, P NATL ACAD SCI USA, V102, P192, DOI 10.1073/pnas.0408592102; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fehrenbacher N, 2005, CANCER RES, V65, P2993, DOI 10.1158/0008-5472.CAN-05-0476; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Goff BA, 2000, CANCER, V89, P2068, DOI 10.1002/1097-0142(20001115)89:10<2068::AID-CNCR6>3.0.CO;2-Z; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hu Z, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2487; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Ihmels J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100127; Kafri R, 2005, NAT GENET, V37, P295, DOI 10.1038/ng1523; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Korosteleva O, 2009, CLIN STAT INTRO CLIN, pvii; Kunz Manfred, 2003, Mol Cancer, V2, P23, DOI 10.1186/1476-4598-2-23; Li J, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-8; Li JA, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1043; Liu M, 2013, HISTOL HISTOPATHOL, V28, P481, DOI 10.14670/HH-28.481; Liu YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036383; Lopez-Lazaro M, 2010, MOL MED, V16, P144, DOI 10.2119/molmed.2009.00162; Mascolo M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-63; Park CC, 2008, CANCER RES, V68, P4398, DOI 10.1158/0008-5472.CAN-07-6390; Partheen K, 2006, EUR J CANCER, V42, P2846, DOI 10.1016/j.ejca.2006.06.026; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Repnik U, 2012, BBA-PROTEINS PROTEOM, V1824, P22, DOI 10.1016/j.bbapap.2011.08.016; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Sawada G, 2013, ONCOL REP, V30, P1137, DOI 10.3892/or.2013.2597; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Silwal-Pandit L, 2014, CLIN CANCER RES, V20, P3569, DOI 10.1158/1078-0432.CCR-13-2943; Sohn I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054089; Sohn I, 2012, GYNECOL ONCOL, V126, P103, DOI 10.1016/j.ygyno.2012.03.050; Tardy C, 2006, BBA-REV CANCER, V1765, P101, DOI 10.1016/j.bbcan.2005.11.003; Therneau T. M, 2015, SURVIVAL SURVIVAL AN; Therneau TM, 2000, MODELING SURVIVAL DA, pxiii; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Weinberg RA, 2007, BIOL CANC; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Wu JX, 2012, J BIOL CHEM, V287, P22919, DOI 10.1074/jbc.M112.351007; Yan ZJ, 2002, J BIOL CHEM, V277, P32379, DOI 10.1074/jbc.M203475200; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064; Zhang WS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078868	57	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112561	10.1371/journal.pone.0112561	http://dx.doi.org/10.1371/journal.pone.0112561			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390899	gold, Green Submitted, Green Published			2022-12-27	WOS:000349144400099
J	Chen, J; Liu, JH; Jin, RN; Shen, JL; Liang, YL; Ma, R; Lin, H; Liang, X; Yu, H; Cai, XJ				Chen, Jiang; Liu, Jinghua; Jin, Renan; Shen, Jiliang; Liang, Yuelong; Ma, Rui; Lin, Hui; Liang, Xiao; Yu, Hong; Cai, Xiujun			Cytoplasmic and/or Nuclear Expression of beta-Catenin Correlate with Poor Prognosis and Unfavorable Clinicopathological Factors in Hepatocellular Carcinoma: A Meta-Analysis	PLOS ONE			English	Article							CADHERIN; EPIDEMIOLOGY; SORAFENIB; MUTATIONS; HEPATITIS; PROTEIN; TARGET; CANCER; AXIN; WNT	Background: The beta-catenin is an important effector in WNT/beta-catenin signaling pathway, which exerts a crucial role in the development and progression of hepatocellular carcinoma (HCC). Some researchers have suggested that the overexpression of beta-catenin in cytoplasm and/or nucleus was closely correlated to metastasis, poor differentiation and malignant phenotype of HCC while some other researchers hold opposite point. So far, no consensus was obtained on the prognostic and clinicopathological significance of cytoplasmic/nuclear beta-catenin overexpression for HCCs. Methods: Systematic strategies were applied to search eligible studies in all available databases. Subgroup analyses, sensitivity analyses and multivariate analysis were performed. In this meta-analysis, we utilized either fixed-or random-effects model to calculate the pooled odds ratios (OR) and its 95% confidence intervals (CI). Results: A total of 22 studies containing 2334 cases were enrolled in this meta-analysis. Pooled data suggested that accumulation of beta-catenin in cytoplasm and/or nucleus significantly correlated with poor 1-, 3-and 5-year OS and RFS. Moreover, nuclear accumulation combined with cytoplasmic accumulation of beta-catenin tended to be associated with dismal metastasis and vascular invasion while cytoplasmic or nuclear expression alone showed no significant effect. Besides, no significant association was observed between cytoplasmic and/or nuclear beta-catenin expression and poor differentiation grade, advanced TNM stage, liver cirrhosis, tumor size, tumor encapsulation, AFP and etiologies. Additional subgroup analysis by origin suggested that the prognostic value and clinicopathological significance of cytoplasmic and/or nuclear beta-catenin expression was more validated in Asian population. Multivariate analyses of factors showed that cytoplasmic and/or nuclear beta-catenin expression, as well as TNM stage, metastasis and tumor size, was an independent risk factors for OS and RFS. Conclusions: Cytoplasmic and/or nuclear accumulation of beta-catenin, as an independent prognostic factor, significantly associated with poor prognosis and deeper invasion of HCC, and could serve as a valuable prognostic predictor for HCC.	[Chen, Jiang; Liu, Jinghua; Jin, Renan; Shen, Jiliang; Liang, Yuelong; Lin, Hui; Liang, Xiao; Yu, Hong; Cai, Xiujun] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Gen Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Ma, Rui] Zhejiang Univ Hosp, Dept Surg, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Cai, XJ (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Gen Surg, Hangzhou 310003, Zhejiang, Peoples R China.	cxjzu@hotmail.com		Ma, Rui/0000-0001-8226-6571	National Natural Science Foundation of China [81201942]; Zhejiang Provincial Natural Science Foundation of China [LZ14H160002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by National Natural Science Foundation of China (81201942) and Zhejiang Provincial Natural Science Foundation of China (LZ14H160002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 2012, HEPATOLOGY, V55, P476, DOI 10.1002/hep.24710; Austinat M, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-21; Breuhahn K, 2010, PROG MOL BIOL TRANSL, V97, P251, DOI 10.1016/B978-0-12-385233-5.00009-X; Chen J, 2014, J CANC RES CLIN ONCO; Chen ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063854; Cheng ASL, 2011, CANCER RES, V71, P4028, DOI 10.1158/0008-5472.CAN-10-3342; Chua M-S, 2014, GASTROINTESTINAL CAN, V49; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dahmani R, 2011, CLIN RES HEPATOL GAS, V35, P709, DOI 10.1016/j.clinre.2011.05.010; Ding X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095307; Du GS, 2009, ANN SURG ONCOL, V16, P1578, DOI 10.1245/s10434-009-0423-7; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Endo K, 2000, HUM PATHOL, V31, P558, DOI 10.1053/hp.2000.6683; Feng ZB, 2011, HUM PATHOL, V42, P659, DOI 10.1016/j.humpath.2010.07.021; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Geng M, 2012, WORLD J GASTROENTERO, V18, P1328, DOI 10.3748/wjg.v18.i12.1328; Gough NR, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002806; Guan CN, 2012, ASIAN PAC J CANCER P, V13, P677, DOI 10.7314/APJCP.2012.13.2.677; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Huang H, 1999, AM J PATHOL, V155, P1795, DOI 10.1016/S0002-9440(10)65496-X; Ihara A, 1996, HEPATOLOGY, V23, P1441, DOI 10.1053/jhep.1996.v23.pm0008675162; Inagawa S, 2002, CLIN CANCER RES, V8, P450; Inuzuka T, 2011, ONCOLOGY-BASEL, V81, P152, DOI 10.1159/000333279; Jin J, 2014, NUCL EXPRESSION PHOS; Korita PV, 2008, HUM PATHOL, V39, P1777, DOI 10.1016/j.humpath.2008.05.006; Lee JM, 2014, CANCER LETT, V343, P90, DOI 10.1016/j.canlet.2013.09.020; Tien LT, 2005, WORLD J GASTROENTERO, V11, P2398, DOI 10.3748/wjg.v11.i16.2398; Liu LA, 2010, CLIN CANCER RES, V16, P2740, DOI 10.1158/1078-0432.CCR-09-2610; Mei XD, 2013, BIOSCI TRENDS, V7, P42, DOI 10.5582/bst.2013.v7.1.42; Park JY, 2005, LIVER INT, V25, P70, DOI 10.1111/j.1478-3231.2004.0995.x; Schmitt-Graff A, 2003, HEPATOLOGY, V38, P470, DOI 10.1053/jhep.2003.50321; Sposito C, 2013, J HEPATOL, V59, P59, DOI 10.1016/j.jhep.2013.02.026; Suzuki T, 2002, J GASTROEN HEPATOL, V17, P994, DOI 10.1046/j.1440-1746.2002.02774.x; Villanueva A, 2007, GENOMICS SIGNALING P, P055; Wands JR, 2014, HEPATOLOGY; Weis WI, 2006, J BIOL CHEM, V281, P35593, DOI 10.1074/jbc.R600027200; Witjes CDM, 2013, J CLIN PATHOL, V66, P687, DOI 10.1136/jclinpath-2012-201156; Yang MH, 2009, HEPATOLOGY, V50, P1464, DOI 10.1002/hep.23221; Yu B, 2009, J HEPATOL, V50, P948, DOI 10.1016/j.jhep.2008.11.020; Zhai B, 2008, WORLD J GASTROENTERO, V14, P5665, DOI 10.3748/wjg.14.5665; Zhan Ping, 2014, Hepatobiliary Surg Nutr, V3, P11, DOI 10.3978/j.issn.2304-3881.2014.01.03; Zhao N, 2012, MED ONCOL, V29, P2780, DOI 10.1007/s12032-012-0207-y; Zulehner G, 2010, AM J PATHOL, V176, P472, DOI 10.2353/ajpath.2010.090300	43	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e111885	10.1371/journal.pone.0111885	http://dx.doi.org/10.1371/journal.pone.0111885			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401330	gold, Green Submitted, Green Published			2022-12-27	WOS:000345158700020
J	Thoene-Reineke, C; Fischer, A; Friese, C; Briesemeister, D; Gobel, UB; Kammertoens, T; Bereswill, S; Heimesaat, MM				Thoene-Reineke, Christa; Fischer, Andre; Friese, Christian; Briesemeister, Dana; Goebel, Ulf B.; Kammertoens, Thomas; Bereswill, Stefan; Heimesaat, Markus M.			Composition of Intestinal Microbiota in Immune-Deficient Mice Kept in Three Different Housing Conditions	PLOS ONE			English	Article							RABBIT COLONIES; BACTERIA; MOUSE; INFECTION; COLITIS; INNATE; RECOMMENDATIONS; ILEITIS; FLORA; IBD	Background: Abundance of commensals constituting the intestinal microbiota (IM) affects the immune system and predisposes to a variety of diseases, including intestinal infections, cancer, inflammatory and metabolic disorders. Housing conditions determine the IM and can hence influence the immune system. We analyzed how both variables affect the IM of four immune-compromized mouse lines kept under different housing conditions. Methodology/Principal Findings: We investigated the IM composition in mice by quantitative 16S rRNA RT-PCR analysis of the main fecal bacterial groups (Enterobacteriaceae, enterococci, lactobacilli, bifidobacteria, Bacteroides/Prevotella (BP) spp., Clostridium leptum and coccoides groups). Mice were homozygous (HO) or heterozygous (HE) for a targeted inactivating mutation of either the IFN-gamma Receptor (R), IFN-gamma, Rag1 or IL-4 genes. Overall, differences in IM composition were subtle. However, in the SPF-barrier, total eubacterial loads were higher in Rag1 HE versus Rag1 HO mice as well as in IFN-gamma R HE versus IFN-gamma R HO and WT animals. Although absent in WT mice, bifidobacterial loads were higher in HO and HE IFN-gamma and Rag1 as well as IL-4 HO mice. Furthermore, BP was slightly lower in HO and HE IFN-gamma R and IFN-gamma mice as well as in IL-4 HO mice as compared to WT controls. Interestingly, IM compositions were comparable in WT mice when kept in individual ventilated cages (IVC) or open cages (OC). IFN-gamma HO and HE mice, however, had higher enterobacteria and BP loads, but lacked bifidobacteria when kept in OC versus IVC, as was the case in HO and HE Rag1 mice. In addition, Rag1 HO mice harbored higher clostridial loads when housed in OC as compared to IVC. Unexpectedly, lactobacilli levels were higher in IFN-gamma R mice when kept in OC versus IVC. Conclusion/Significance: Housing-dependent and immune-deficiency mediated changes in intestinal microbiota composition were rather subtle but may nevertheless impact immunopathology in experimental models.	[Thoene-Reineke, Christa] Charite, Forschungseinrichtung Expt Med, D-13353 Berlin, Germany; [Fischer, Andre; Goebel, Ulf B.; Bereswill, Stefan; Heimesaat, Markus M.] Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany; [Friese, Christian; Briesemeister, Dana; Kammertoens, Thomas] Charite, Dept Immunol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Heimesaat, MM (corresponding author), Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany.	markus.heimesaat@charite.de		Heimesaat, Markus/0000-0001-6399-651X; Kammertoens, Thomas/0000-0003-3309-5141	German Research Foundation (DFG) [SFB633, TP A7, TP B6, SFBTR36 TP B1]; German Federal Ministery of Education and Research (BMBF) [TP1.1]	German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministery of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the German Research Foundation (DFG) to AF, UBG, and SB (SFB633, TP A7), MMH (SFB633, TP B6), TK, CF, and DB (SFBTR36 TP B1); and from the German Federal Ministery of Education and Research (BMBF) to SB (TP1.1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AD, 2006, MAMM GENOME, V17, P1093, DOI 10.1007/s00335-006-0063-1; Bereswill S, 2011, EUR J MICROBIOL IMMU, V1, P237, DOI 10.1556/EuJMI.1.2011.3.8; Bereswill S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020953; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Briesemeister D, 2012, CYTOKINE, V60, P626, DOI 10.1016/j.cyto.2012.07.019; Chen VL, 2014, GUT MICROBES, V5, P129, DOI 10.4161/gmic.27289; Erridge C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009125; Ge ZM, 2006, APPL ENVIRON MICROB, V72, P5100, DOI 10.1128/AEM.01934-05; Heimesaat MM, 2007, GUT, V56, P941, DOI 10.1136/gut.2006.104497; Heimesaat MM, 2011, EUR J MICROBIOL IMMU, V1, P302, DOI 10.1556/EuJMI.1.2011.4.6; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Jarchum I, 2011, CURR OPIN IMMUNOL, V23, P353, DOI 10.1016/j.coi.2011.03.001; Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312; Nell S, 2010, NAT REV MICROBIOL, V8, P564, DOI 10.1038/nrmicro2403; Nicklas W, 2002, LAB ANIM-UK, V36, P20, DOI 10.1258/0023677021911740; Rausch S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074026; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Sartor RB, 2010, GASTROENTEROLOGY, V139, P1816, DOI 10.1053/j.gastro.2010.10.036; Shalapour S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031939; Steck N, 2012, GUT, V61, P1610, DOI 10.1136/gutjnl-2011-300775; Sydora BC, 2007, INFLAMM BOWEL DIS, V13, P947, DOI 10.1002/ibd.20155; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; Yamamoto ML, 2013, CANCER RES, V73, P4222, DOI 10.1158/0008-5472.CAN-13-0022	24	35	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113406	10.1371/journal.pone.0113406	http://dx.doi.org/10.1371/journal.pone.0113406			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401702	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700138
J	Hou, YY; Cheng, BF; Zhou, MG; Fang, RP; Jiang, M; Hou, WB; Bai, G				Hou, Yuanyuan; Cheng, Binfeng; Zhou, Mengge; Fang, Runping; Jiang, Min; Hou, Wenbin; Bai, Gang			Searching for Synergistic Bronchodilators and Novel Therapeutic Regimens for Chronic Lung Diseases from a Traditional Chinese Medicine, Qingfei Xiaoyan Wan	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; KAPPA-B INHIBITORS; OBSTRUCTIVE PULMONARY-DISEASE; BIOACTIVE COMPOUNDS; ALKALOIDAL EXTRACT; IDENTIFICATION; ARCTIGENIN; MECHANISMS; AGONISTS; ARCTIIN	Classical Chinese pharmacopeias describe numerous excellent herbal formulations, and each prescription is an outstanding pool of effective compounds for drug discovery. Clarifying the bioactivity of the combined mechanisms of the ingredients in complex traditional Chinese medicine formulas is challenging. A classical formula known as Qingfei Xiaoyan Wan, used clinically as a treatment for prevalent chronic lung disease, was investigated in this work. A mutually enhanced bioactivity-guided ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry (UPLC/Q-TOF-MS) characterization system was proposed, coupled with a dual-luciferase reporter assay for beta(2)AR-agonist cofactor screening. Arctiin, arctigenin, descurainoside and descurainolide B, four lignin compounds that showed synergistic bronchodilation effects with ephedrine, were revealed. The synergistic mechanism of arctigenin with the beta(2)ARagonist involved with the reduction of free Ca2+ was clarified by a dual-luciferase reporter assay for intracellular calcium and the Ca2+ indicator fluo-4/AM to monitor changes in the fluorescence. The relaxant and contractile responses of airway smooth muscle are regulated by crosstalk between the intracellular cAMP and calcium signaling pathways. Our data indicated the non-selective beta AR agonist ephedrine as the principal bronchodilator of the formula, whereas the lignin ingredients served as adjuvant ingredients. A greater understanding of the mechanisms governing the control of these pathways, based on conventional wisdom, could lead to the identification of novel therapeutic targets or new agents for the treatment of asthma and COPD.	[Hou, Yuanyuan; Cheng, Binfeng; Zhou, Mengge; Fang, Runping; Jiang, Min; Bai, Gang] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Hou, Yuanyuan; Cheng, Binfeng; Zhou, Mengge; Fang, Runping; Jiang, Min; Bai, Gang] Nankai Univ, Coll Pharm, Tianjin Key Lab Mol Drug Res, Tianjin 300071, Peoples R China; [Hou, Wenbin] Tianjin Inst Pharmaceut Res, Tianjin Engn Lab Qual Control Techn TCM, Tianjin, Peoples R China	Nankai University; Nankai University	Bai, G (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	gangbai@nankai.edu.cn	Jiang, Min/HGT-8781-2022; Fang, Runping/AAF-6835-2020		National Natural Science Foundation of China [81173638, 81373506]; Specialized Research Fund for the Doctor Program of Higher Education of China [20120031110042]; Key Program of Natural Science of Foundation of Tianjin, China [13JCZDJC31400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctor Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Key Program of Natural Science of Foundation of Tianjin, China	This work was supported by a Grant from the National Natural Science Foundation of China (grant no: 81173638 and 81373506), the Specialized Research Fund for the Doctor Program of Higher Education of China (grant no: 20120031110042) and the Key Program of Natural Science of Foundation of Tianjin, China (grant no: 13JCZDJC31400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An XD, 2012, J ALTERN COMPLEM MED, V18, P731, DOI 10.1089/acm.2011.0389; Awale S, 2006, CANCER RES, V66, P1751, DOI 10.1158/0008-5472.CAN-05-3143; Azmir J, 2013, J FOOD ENG, V117, P426, DOI 10.1016/j.jfoodeng.2013.01.014; Bai G, 2008, ACTA PHARMACOL SIN, V29, P1187, DOI 10.1111/j.1745-7254.2008.00859.x; Bai G, 2014, CHIN HERB MED, V6, P85, DOI 10.1016/S1674-6384(14)60013-7; Billington CK, 2012, BRIT J PHARMACOL, V166, P401, DOI 10.1111/j.1476-5381.2011.01719.x; Brusotti G, 2014, J PHARMACEUT BIOMED, V87, P218, DOI 10.1016/j.jpba.2013.03.007; Butler L, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/739716; Carolan BJ, 2013, J ALLERGY CLIN IMMUN, V131, P627, DOI 10.1016/j.jaci.2013.01.010; Chan Yuk-Shing, 2011, Inflammopharmacology, V19, P245, DOI 10.1007/s10787-010-0062-4; Cheng BF, 2012, ANAL BIOANAL CHEM, V404, P2445, DOI 10.1007/s00216-012-6332-9; Gu Y, 2012, BIOCHEM PHARMACOL, V84, P468, DOI 10.1016/j.bcp.2012.06.002; Hall IP, 2000, EUR RESPIR J, V15, P1120, DOI 10.1034/j.1399-3003.2000.01523.x; He F, 2012, PLANTA MED, V78, P800, DOI 10.1055/s-0031-1298433; Holzinger F, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/382789; Hong F, 2011, ARCH BIOCHEM BIOPHYS, V510, P135, DOI 10.1016/j.abb.2011.04.018; Hou YY, 2012, J CHROMATOGR B, V908, P98, DOI 10.1016/j.jchromb.2012.10.004; Hou YY, 2012, J CHROMATOGR A, V1227, P203, DOI 10.1016/j.chroma.2012.01.008; Huang XD, 2004, J CHROMATOGR B, V812, P71, DOI 10.1016/j.jchromb.2004.06.046; Jiang M, 2013, J ETHNOPHARMACOL, V147, P426, DOI 10.1016/j.jep.2013.03.032; Lee S, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-16; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mohamed NH, 2009, REC NAT PROD, V3, P58; Morphy R, 2009, CURR PHARM DESIGN, V15, P587, DOI 10.2174/138161209787315594; Patwardhan B, 2004, CURR SCI INDIA, V86, P789; Preissner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051020; Pujol A, 2010, TRENDS PHARMACOL SCI, V31, P115, DOI 10.1016/j.tips.2009.11.006; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Radhakrishnan ML, 2008, J CHEM INF MODEL, V48, P1055, DOI 10.1021/ci700452r; Ritchie MF, 2011, CELL CALCIUM, V49, P314, DOI 10.1016/j.ceca.2010.10.001; Shi Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044921; Sun K, 2004, CHEM PHARM BULL, V52, P1483, DOI 10.1248/cpb.52.1483; Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105; Wu L, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/705315; Wu RH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/323715; Xu SY, 2001, METHODOLOGY PHARM EX; Yuan R, 2000, PHARMACOL THERAPEUT, V86, P191, DOI 10.1016/S0163-7258(00)00039-5; Zhang HW, 2012, J ADV NURS, V68, P1679, DOI 10.1111/j.1365-2648.2011.05925.x; Zhao ZY, 2013, BIOL TRACE ELEM RES, V156, P181, DOI 10.1007/s12011-013-9839-9	39	13	14	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113104	10.1371/journal.pone.0113104	http://dx.doi.org/10.1371/journal.pone.0113104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397687	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558500133
J	Karlsson, SL; Ax, E; Nygren, E; Kallgard, S; Blomquist, M; Ekman, A; Benktander, J; Holmgren, J; Lebens, M				Karlsson, Stefan L.; Ax, Elisabeth; Nygren, Erik; Kallgard, Susanne; Blomquist, Margareta; Ekman, Annelie; Benktander, John; Holmgren, Jan; Lebens, Michael			Development of Stable Vibrio cholerae O1 Hikojima Type Vaccine Strains Co-Expressing the Inaba and Ogawa Lipopolysaccharide Antigens	PLOS ONE			English	Article							ESCHERICHIA-COLI; MONOCLONAL-ANTIBODIES; COLONIZATION FACTORS; B-SUBUNIT; BACTERIA; CONSTRUCTION; EFFICACY; CHAIN; ETEC; MICE	We describe here the development of stable classical and El Tor V. cholerae O1 strains of the Hikojima serotype that co-express the Inaba and Ogawa antigens of O1 lipopolysaccharide (LPS). Mutation of the wbeT gene reduced LPS perosamine methylation and thereby gave only partial transformation into Ogawa LPS on the cell surface. The strains express approximately equal amounts of Inaba- and Ogawa-LPS antigens which are preserved after formalin-inactivation of the bacteria. Oral immunizations of both inbred and outbred mice with formalin-inactivated whole-cell vaccine preparations of these strains elicited strong intestinal IgA anti-LPS as well as serum vibriocidal antibody responses against both Inaba and Ogawa that were fully comparable to the responses induced by the licensed Dukoral vaccine. Passive protection studies in infant mice showed that immune sera raised against either of the novel Hikojima vaccine strains protected baby mice against infection with virulent strains of both serotypes. This study illustrates the power of using genetic manipulation to improve the properties of bacteria strains for use in killed whole-cell vaccines.	[Karlsson, Stefan L.; Ax, Elisabeth; Nygren, Erik; Kallgard, Susanne; Blomquist, Margareta; Ekman, Annelie; Holmgren, Jan; Lebens, Michael] Univ Gothenburg, Dept Microbiol & Immunol, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden; [Benktander, John] Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Lebens, M (corresponding author), Univ Gothenburg, Dept Microbiol & Immunol, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden.	michael.lebens@microbio.gu.se		Ax, Elisabeth/0000-0001-7553-5059; Nygren, Erik/0000-0001-6783-4622; Lebens, Michael/0000-0001-9458-9474; Nordqvist, Stefan/0000-0003-4238-6004; Holmgren, Jan/0000-0003-1784-5918	Bill and Melinda Gates Foundation Grand Challenges Phase II award [OPP1008300]; Swedish Research Council; MSB-Sida	Bill and Melinda Gates Foundation Grand Challenges Phase II award; Swedish Research Council(Swedish Research CouncilEuropean Commission); MSB-Sida	This work was supported by a Bill and Melinda Gates Foundation Grand Challenges Phase II award (OPP1008300) and by grants from the Swedish Research Council and from MSB-Sida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aibana O, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002576; Attridge SR, 1996, INFECT IMMUN, V64, P3369, DOI 10.1128/IAI.64.8.3369-3373.1996; BHASKARAN K, 1957, J GEN MICROBIOL, V16, P721, DOI 10.1099/00221287-16-3-721; Bhattacharya S, 2013, LANCET INFECT DIS, V13, P1050, DOI 10.1016/S1473-3099(13)70273-1; Chattejee SN, 2003, BBA-MOL BASIS DIS, V1639, P65, DOI 10.1016/j.bbadis.2003.08.004; Clemens J, 2014, CURR TOP MICROBIOL, V379, P231, DOI 10.1007/82_2013_353; Clemens J, 2011, NAT REV GASTRO HEPAT, V8, P701, DOI 10.1038/nrgastro.2011.174; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Goel Manish Kumar, 2010, Int J Ayurveda Res, V1, P274, DOI 10.4103/0974-7788.76794; GUSTAFSSON B, 1985, INFECT IMMUN, V49, P275, DOI 10.1128/IAI.49.2.275-280.1985; HARKKI A, 1986, MICROB PATHOGENESIS, V1, P283, DOI 10.1016/0882-4010(86)90053-7; Holmgren J, 2013, VACCINE, V31, P2457, DOI 10.1016/j.vaccine.2013.03.027; Holmgren J, 2012, CURR OPIN IMMUNOL, V24, P343, DOI 10.1016/j.coi.2012.03.014; Jelinek T, 2008, EXPERT REV VACCINES, V7, P561, DOI 10.1586/14760584.7.5.561; JONSON G, 1989, J GEN MICROBIOL, V135, P111; Karlsson S, 2012, US JAP COOP MED SCI; Kondo S, 1996, MICROBIOL-UK, V142, P2879, DOI 10.1099/13500872-142-10-2879; Lebens M, 2011, VACCINE, V29, P7505, DOI 10.1016/j.vaccine.2011.06.121; Liang WL, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-173; LOPEZVIDAL Y, 1988, J CLIN MICROBIOL, V26, P1967, DOI 10.1128/JCM.26.10.1967-1972.1988; Lundgren A, 2013, EXCELLENT SAFETY IMM; Luquero FJ, 2014, NEW ENGL J MED, V370, P2111, DOI 10.1056/NEJMoa1312680; Manning Paul A., 1994, P77; Meeks MD, 2004, INFECT IMMUN, V72, P4090, DOI 10.1128/IAI.72.7.4090-4101.2004; Nygren E, 2009, INFECT IMMUN, V77, P3475, DOI 10.1128/IAI.01197-08; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; SANCHEZ J, 1989, P NATL ACAD SCI USA, V86, P481, DOI 10.1073/pnas.86.2.481; Sharifnia A, 2012, LETT APPL MICROBIOL, V54, P267, DOI 10.1111/j.1472-765X.2012.03204.x; STROEHER UH, 1992, P NATL ACAD SCI USA, V89, P2566, DOI 10.1073/pnas.89.7.2566; Tobias J, 2010, VACCINE, V28, P6977, DOI 10.1016/j.vaccine.2010.08.047; UJIIYE A, 1968, Tropical Medicine, V10, P65; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83	33	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e108521	10.1371/journal.pone.0108521	http://dx.doi.org/10.1371/journal.pone.0108521			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397871	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558500002
J	Li, CJ; Yang, WB; Men, Y; Wu, FL; Pan, J; Li, LJ				Li, Chunjie; Yang, Wenbin; Men, Yi; Wu, Fanglong; Pan, Jian; Li, Longjiang			Magnetic Resonance Imaging for Diagnosis of Mandibular Involvement from Head and Neck Cancers: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; CONE-BEAM CT; COMPUTED-TOMOGRAPHY; BONE INVASION; ORAL-CANCER; ACCURACY; MRI; TONGUE; CAVITY; RECONSTRUCTION	Background: Diagnosis of mandibular involvement caused by head and neck cancers is critical for treatment. We performed a meta-analysis to determine the diagnostic efficacy of MR for distinguishing mandibular involvement caused by head and neck cancers. Methods: Thirteen databases were searched electronically and hand-searching was also done. Two reviewers conducted study inclusion, data extractions, and quality assessment of the studies independently. Meta-disc 1.4 and STATA 11.0 were used to conduct the meta-analysis. Results: 16 studies involving a total of 490 participants underwent MR examinations and were accounted for in this metaanalysis. Among the included studies, 2 had high risk of bias, while the rest had unclear risk of bias. Meta-regression showed that the slight clinical and methodological heterogeneities did not influence the outcome (P>0.05). Meta-analysis indicated that the MR for the diagnosis of mandibular involvement had a pooled sensitivity (SEN) of 78%, specificity (SPE) of 83%, positive likelihood ratio (+LR) of 3.80, negative likelihood ratio (-LR) of 0.28, diagnostic odds ratio (DOR) of 28.94, area under curve (AUC) of 0.9110, and Q* of 0.8432. Two studies detected the diagnostic efficacy of MR for the mandibular medullar invasion, and only one study reported the inferior alveolar canal invasion, which made it impossible to include it in our meta-analysis. In comparing to CT, MR had a higher SEN without statistical significance (P = 0.08), but a significantly lower SPE (P = 0.04). The synthesized diagnostic efficacy (AUC and Q*) on mandibular involvement was similar between the two modalities (P>0.05). Conclusions: Present clinical evidence showed that MR had an acceptable diagnostic value in detecting mandibular involvement caused by head and neck cancers. MR exceeded CT in diagnosing patients with mandibular invasion (higher sensitivity than CT) but was less efficacious to exclude patients without the mandibular invasion (lower specificity than CT).	[Li, Chunjie; Yang, Wenbin; Men, Yi; Wu, Fanglong; Pan, Jian; Li, Longjiang] Sichuan Univ, West China Hosp Stomatol, Dept Oral & Maxillofacial Surg, State Key Lab Oral Dis, Chengdu 610064, Peoples R China	Sichuan University	Li, LJ (corresponding author), Sichuan Univ, West China Hosp Stomatol, Dept Oral & Maxillofacial Surg, State Key Lab Oral Dis, Chengdu 610064, Peoples R China.	ljli007@163.com		Li, Long-jiang/0000-0003-1446-0692	Sichuan University [2014SCU11032]	Sichuan University(Sichuan University)	This systematic review was supported by the scientific research foundation for young teachers of Sichuan University (2014SCU11032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayad T, 2009, HEAD NECK-J SCI SPEC, V31, P398, DOI 10.1002/hed.20956; Bolzoni A, 2004, ARCH OTOLARYNGOL, V130, P837, DOI 10.1001/archotol.130.7.837; BROWN JS, 1994, BRIT J ORAL MAX SURG, V32, P347, DOI 10.1016/0266-4356(94)90024-8; CHUNG TS, 1994, AM J NEURORADIOL, V15, P1949; de Vet HCW EA, 2008, COCHRANE HDB SYSTEMA; Dreiseidler T, 2011, ORAL SURG ORAL MED O, V112, P367, DOI 10.1016/j.tripleo.2011.04.001; Durr ML, 2013, OTOLARYNG HEAD NECK, V149, P89, DOI 10.1177/0194599813482876; Ebrahimi A, 2011, CANCER-AM CANCER SOC, V117, P4460, DOI 10.1002/cncr.26032; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Gu DH, 2010, ACTA RADIOL, V51, P1111, DOI 10.3109/02841851.2010.520027; Guerra MFM, 2003, HEAD NECK-J SCI SPEC, V25, P982, DOI 10.1002/hed.10316; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Handschel J, 2012, ORAL ONCOL, V48, P361, DOI 10.1016/j.oraloncology.2011.11.009; Hayden RE, 2012, CURR OPIN OTOLARYNGO, V20, P231, DOI 10.1097/MOO.0b013e328355d0f3; Hendrikx AWF, 2010, INT J ORAL MAX SURG, V39, P436, DOI 10.1016/j.ijom.2010.02.008; Huang SH, 2011, CLIN NUCL MED, V36, P518, DOI 10.1097/RLU.0b013e318217566f; Imaizumi A, 2006, AM J NEURORADIOL, V27, P114; Kim M, 2013, ANN NUCL MED, V27, P423, DOI 10.1007/s12149-013-0701-0; Lam L, 2013, ORAL ONCOL, V49, P507, DOI 10.1016/j.oraloncology.2013.03.001; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Li CJ, 2014, J ORAL MAXIL SURG, V72, P1601, DOI 10.1016/j.joms.2014.02.014; Macaskill P, 2010, COCHRANE HDB SYSTEMA; McDowell L, 2014, OR SURG OR MED OR PA, V117, P163, DOI 10.1016/j.oooo.2013.09.005; McKenna G, 2013, EUR J PROSTHODONT RE, V21, P141, DOI 10.1922/EJPRD_1282McKenna04; Momin MA, 2009, EUR J RADIOL, V72, P75, DOI 10.1016/j.ejrad.2008.06.018; Morimata J, 2013, GERODONTOLOGY, V30, P194, DOI 10.1111/j.1741-2358.2012.00662.x; Myers LL, 2011, OTOLARYNG HEAD NECK, V145, P961, DOI 10.1177/0194599811417550; Rajesh A, 2008, BRIT J ORAL MAX SURG, V46, P11, DOI 10.1016/j.bjoms.2007.08.024; Rao LP, 2012, SURG ONCOL, V21, P109, DOI 10.1016/j.suronc.2011.06.003; Rao LP, 2004, INT J ORAL MAX SURG, V33, P454, DOI 10.1016/j.ijom.2003.10.006; Shin M, 2011, CARCINOGENESIS, V32, P1634, DOI 10.1093/carcin/bgr198; Smyth DA, 1996, CLIN OTOLARYNGOL, V21, P265, DOI 10.1111/j.1365-2273.1996.tb01738.x; TSUE TT, 1994, HEAD NECK-J SCI SPEC, V16, P116, DOI 10.1002/hed.2880160204; Uribe S, 2013, DENTOMAXILLOFAC RAD, V42, DOI 10.1259/dmfr.20120346; Van Cann EM, 2008, INT J ORAL MAX SURG, V37, P535, DOI 10.1016/j.ijom.2008.02.009; Van Cann EM, 2008, ORAL ONCOL, V44, P1147, DOI 10.1016/j.oraloncology.2008.02.009; van den Brekel MWM, 1998, EUR RADIOL, V8, P1552, DOI 10.1007/s003300050585; van Rossum PSN, 2013, EUR RADIOL, V23, P1753, DOI 10.1007/s00330-013-2773-6; Vidiri A, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-73; Wax MK, 2002, ARCH OTOLARYNGOL, V128, P600, DOI 10.1001/archotol.128.5.600; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Yamagata K, 2013, J ORAL MAXIL SURG, V71, P2189, DOI 10.1016/j.joms.2013.05.008; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31; Zheng DC, 2013, J COMPUT ASSIST TOMO, V37, P673, DOI 10.1097/RCT.0b013e31829a2599; Zupi A, 1996, J CRANIO MAXILL SURG, V24, P281, DOI 10.1016/S1010-5182(96)80059-X	45	23	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112267	10.1371/journal.pone.0112267	http://dx.doi.org/10.1371/journal.pone.0112267			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397614	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558500042
J	Lucas, AT; Fu, XP; Liu, JJ; Brannon, MK; Yang, JH; Capelluto, DGS; Finkielstein, CV				Lucas, Andrew T.; Fu, Xiangping; Liu, JingJing; Brannon, Mary K.; Yang, Jianhua; Capelluto, Daniel G. S.; Finkielstein, Carla V.			Ligand Binding Reveals a Role for Heme in Translationally-Controlled Tumor Protein Dimerization	PLOS ONE			English	Article							HISTAMINE-RELEASING FACTOR; CYTOCHROME-C PEROXIDASE; SEDIMENTATION-VELOCITY; HORSERADISH-PEROXIDASE; ANTIAPOPTOTIC ACTIVITY; SECONDARY STRUCTURE; EPITHELIAL-CELLS; CALCIUM; TCTP; IDENTIFICATION	The translationally-controlled tumor protein (TCTP) is a highly conserved, ubiquitously expressed, abundant protein that is broadly distributed among eukaryotes. Its biological function spans numerous cellular processes ranging from regulation of the cell cycle and microtubule stabilization to cell growth, transformation, and death processes. In this work, we propose a new function for TCTP as a ''buffer protein'' controlling cellular homeostasis. We demonstrate that binding of hemin to TCTP is mediated by a conserved His-containing motif (His(76) His(77)) followed by dimerization, an event that involves ligandmediated conformational changes and that is necessary to trigger TCTP's cytokine-like activity. Mutation in both His residues to Ala prevents hemin from binding and abrogates oligomerization, suggesting that the ligand site localizes at the interface of the oligomer. Unlike heme, binding of Ca2+ ligand to TCTP does not alter its monomeric state; although, Ca2+ is able to destabilize an existing TCTP dimer created by hemin addition. In agreement with TCTP's proposed buffer function, ligand binding occurs at high concentration, allowing the ''buffer'' condition to be dissociated from TCTP's role as a component of signal transduction mechanisms.	[Lucas, Andrew T.; Fu, Xiangping; Liu, JingJing; Yang, Jianhua; Finkielstein, Carla V.] Virginia Tech, Dept Biol Sci, Virginia Bioinformat Inst, Integrated Cellular Responses Lab, Blacksburg, VA 24061 USA; [Lucas, Andrew T.; Brannon, Mary K.; Capelluto, Daniel G. S.] Virginia Tech, Dept Biol Sci, Virginia Bioinformat Inst, Prot Signaling Domains Lab, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Finkielstein, CV (corresponding author), Virginia Tech, Dept Biol Sci, Virginia Bioinformat Inst, Integrated Cellular Responses Lab, Blacksburg, VA 24061 USA.	finkielc@vt.edu		finkielstein, carla/0000-0002-8417-4643; Lucas, Andrew/0000-0001-8678-5985	National Science Foundation CAREER Award [MCB-0844491]; Avon Foundation [02-2009-033]; Fralin Life Science Institute [F441598]; Susan G. Komen Foundation [BCTR0706931]	National Science Foundation CAREER Award(National Science Foundation (NSF)); Avon Foundation; Fralin Life Science Institute; Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation)	This work was supported by the National Science Foundation CAREER Award (MCB-0844491, http://www.nsf.gov/), Avon Foundation (02-2009-033, http://www. avonfoundation. org/), Fralin Life Science Institute (F441598), and Susan G. Komen Foundation (BCTR0706931, http://ww5.komen.org/ResearchGrants/ ResearchGrants.html) to C. V. F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcuri F, 2005, BIOL REPROD, V73, P745, DOI 10.1095/biolreprod.105.042077; BALLA J, 1993, P NATL ACAD SCI USA, V90, P9285, DOI 10.1073/pnas.90.20.9285; Baxter NJ, 2000, J BIOMOL NMR, V16, P83, DOI 10.1023/A:1008355030833; Belkacemi L, 2002, ENDOCRINE, V19, P57, DOI 10.1385/ENDO:19:1:57; BERNARD N, 1980, EUR J BIOCHEM, V103, P271, DOI 10.1111/j.1432-1033.1980.tb04311.x; Bhisutthibhan J, 1998, J BIOL CHEM, V273, P16192, DOI 10.1074/jbc.273.26.16192; Bhisutthibhan J, 2001, ANTIMICROB AGENTS CH, V45, P2397, DOI 10.1128/AAC.45.8.2397-2399.2001; Bommer UA, 2002, RNA, V8, P478, DOI 10.1017/S1355838202022586; Bommer UA, 2004, INT J BIOCHEM CELL B, V36, P379, DOI 10.1016/S1357-2725(03)00213-9; Bonnet C, 2000, YEAST, V16, P23, DOI 10.1002/(SICI)1097-0061(20000115)16:1<23::AID-YEA503>3.0.CO;2-A; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P405, DOI 10.1007/s00249-009-0413-5; Budde IK, 2002, ANN ALLERG ASTHMA IM, V89, P606, DOI 10.1016/S1081-1206(10)62109-6; Cans C, 2003, P NATL ACAD SCI USA, V100, P13892, DOI 10.1073/pnas.2335950100; Cao WM, 2005, BIOPHYS J, V89, P1589, DOI 10.1529/biophysj.105.061135; Chen SH, 2007, MOL BIOL CELL, V18, P2525, DOI 10.1091/mbc.E07-02-0188; Coban Cevayir, 2010, Allergology International, V59, P115, DOI 10.2332/allergolint.10-RAI-0194; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Demeler B, 2010, MACROMOL BIOSCI, V10, P775, DOI 10.1002/mabi.200900481; Feng YG, 2007, ARCH BIOCHEM BIOPHYS, V467, P48, DOI 10.1016/j.abb.2007.08.021; FULOP V, 1995, STRUCTURE, V3, P1225, DOI 10.1016/S0969-2126(01)00258-1; Gachet Y, 1999, J CELL SCI, V112, P1257; Garfin DE, 2009, METHOD ENZYMOL, V463, P497, DOI 10.1016/S0076-6879(09)63029-9; GARRETT S, 1991, MOL CELL BIOL, V11, P4045, DOI 10.1128/MCB.11.8.4045; Gilmour R, 1995, EUR J BIOCHEM, V234, P878, DOI 10.1111/j.1432-1033.1995.878_a.x; Gnanasekar M, 2002, MOL BIOCHEM PARASIT, V121, P107, DOI 10.1016/S0166-6851(02)00027-0; Gonzalez-Michaca L, 2004, AM J PHYSIOL-RENAL, V286, pF370, DOI 10.1152/ajprenal.00300.2003; GREER FR, 1994, ACTA PAEDIATR, V83, P20, DOI 10.1111/j.1651-2227.1994.tb13393.x; Howes BD, 2001, J BIOL CHEM, V276, P40704, DOI 10.1074/jbc.M107489200; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Kim M, 2000, ARCH PHARM RES, V23, P633, DOI 10.1007/BF02975253; Kim M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006464; Klatt P, 1996, J BIOL CHEM, V271, P7336, DOI 10.1074/jbc.271.13.7336; Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210/er.18.6.832; Laberge M, 2003, BIOPHYS J, V84, P2542, DOI 10.1016/S0006-3495(03)75059-0; Lee DS, 2005, P NATL ACAD SCI USA, V102, P14232, DOI 10.1073/pnas.0506557102; Liu H, 2005, MOL CELL BIOL, V25, P3117, DOI 10.1128/MCB.25.8.3117-3126.2005; LIU MC, 1986, J IMMUNOL, V136, P2588; Liu R, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-207; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; Mao X, 2005, MOL CELL, V17, P761, DOI 10.1016/j.molcel.2005.02.021; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7; Oikawa K, 2002, BIOCHEM BIOPH RES CO, V290, P984, DOI 10.1006/bbrc.2001.6302; Pace C N, 1986, Methods Enzymol, V131, P266; Pandey AV, 1999, J BIOL CHEM, V274, P19383, DOI 10.1074/jbc.274.27.19383; Pauleta SR, 2001, BIOCHEMISTRY-US, V40, P6570, DOI 10.1021/bi002870z; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; POULOS TL, 1993, J BIOL CHEM, V268, P4429; Sanchez JC, 1997, ELECTROPHORESIS, V18, P150, DOI 10.1002/elps.1150180127; Sassa S, 2004, ANTIOXID REDOX SIGN, V6, P819, DOI 10.1089/ars.2004.6.819; Schroeder JT, 1997, J IMMUNOL, V159, P447; Sinha P, 2000, ELECTROPHORESIS, V21, P3048, DOI 10.1002/1522-2683(20000801)21:14<3048::AID-ELPS3048>3.0.CO;2-W; Smith LJ, 2010, PROTEINS, V78, P2349, DOI 10.1002/prot.22747; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; Trump BF, 1996, BBA-MOL CELL RES, V1313, P173, DOI 10.1016/0167-4889(96)00086-9; Tuynder M, 2002, P NATL ACAD SCI USA, V99, P14976, DOI 10.1073/pnas.222470799; Venugopal T, 2005, COMP BIOCHEM PHYS B, V142, P8, DOI 10.1016/j.cbpc.2005.04.011; Wagener FADTG, 2001, BLOOD, V98, P1802, DOI 10.1182/blood.V98.6.1802; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wijayanti N, 2004, CURR MED CHEM, V11, P981, DOI 10.2174/0929867043455521; Xu AM, 1999, BIOCHEM J, V342, P683, DOI 10.1042/0264-6021:3420683; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002; Yoneda K, 2004, AM J PHYSIOL-LUNG C, V286, pL174, DOI 10.1152/ajplung.00118.2003; Yoon T, 2000, ARCH BIOCHEM BIOPHYS, V384, P379, DOI 10.1006/abbi.2000.2108; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x	69	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112823	10.1371/journal.pone.0112823	http://dx.doi.org/10.1371/journal.pone.0112823			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396429	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500095
J	Manoussakis, MN; Fragoulis, GE; Vakrakou, AG; Moutsopoulos, HM				Manoussakis, Menelaos N.; Fragoulis, George E.; Vakrakou, Aigli G.; Moutsopoulos, Haralampos M.			Impaired Clearance of Early Apoptotic Cells Mediated by Inhibitory IgG Antibodies in Patients with Primary Sjogren's Syndrome	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; MANNOSE-BINDING LECTIN; IN-VITRO; CLASSIFICATION CRITERIA; RHEUMATOID-ARTHRITIS; PHAGOCYTIC CLEARANCE; AMERICAN-COLLEGE; EPITHELIAL-CELLS; NECROTIC CELLS; DAMAGE INDEX	Objectives: Deficient efferocytosis (i.e. phagocytic clearance of apoptotic cells) has been frequently reported in systemic lupus erythematosus (SLE). Todate, patients with primary Sjogren's syndrome (SS) have not been assessed for phagocytosis of apoptotic cells (ApoCell-phagocytosis) and of particulate targets (microbeads, MB-phagocytosis). Design: ApoCell-phagocytosis and MB-phagocytosis were comparatively assessed by flow cytometry in peripheral blood specimens and monocyte-derived macrophage (MDM) preparations from healthy blood donors (HBD) and consecutive SS, SLE and rheumatoid arthritis (RA) patients. Cross-admixture ApoCell-phagocytosis experiments were also performed using phagocytes from HBD or patients, and apoptotic cells pretreated with whole sera or purified serum IgG derived from patients or HBD. Results: Compared to HBD, approximately half of SS and SLE patients studied (but not RA) manifested significantly reduced ApoCell-phagocytosis (p<0.001) and MB-phagocytosis (p<0.003) by blood-borne phagocytes that correlated inversely with disease activity (p <= 0.004). In cross-admixture assays, healthy monocytes showed significantly reduced ApoCell-phagocytosis when fed with apoptotic cells that were pretreated with sera or purified serum IgG preparations from SS and SLE patients (p<0.0001, compared to those from HBD or RA). Such aberrant effect of the SS and SLE sera and IgG preparations correlated linearly with their content of IgG antibodies against apoptotic cells (p <= 0.0001). Phagocytic dysfunction maybe also present in certain SS and SLE patients, as supported by deficient capacity of MDM for ApoCell-phagocytosis and MB-phagocytosis under patients' serum-free conditions. Conclusion: Similarly to SLE, efferocytosis is frequently impaired in SS and is primarily due to the presence of inhibitory IgG anti-ApoCell antibodies and secondarily to phagocytes' dysfunction.	[Manoussakis, Menelaos N.; Fragoulis, George E.; Vakrakou, Aigli G.; Moutsopoulos, Haralampos M.] Univ Athens, Sch Med, Dept Pathophysiol, GR-11527 Athens, Greece; [Manoussakis, Menelaos N.] Hellenic Pasteur Inst, Athens, Greece	Athens Medical School; National & Kapodistrian University of Athens	Manoussakis, MN (corresponding author), Univ Athens, Sch Med, Dept Pathophysiol, GR-11527 Athens, Greece.	menman@med.uoa.gr	Manoussakis, Menelaos/AAI-3348-2020	Manoussakis, Menelaos/0000-0001-6415-0946; Fragoulis, George/0000-0003-4932-7023	Hellenic Rheumatology Society [ERE141/10]; Propondis Foundation; Lillian Voudouri Foundation	Hellenic Rheumatology Society; Propondis Foundation; Lillian Voudouri Foundation	The study was supported by grants from the Hellenic Rheumatology Society (ERE141/10 to M.N.M), the Propondis Foundation (to A.G.V.) and the Lillian Voudouri Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Allina J, 2008, J AUTOIMMUN, V30, P238, DOI 10.1016/j.jaut.2007.10.003; Baumann I, 2002, ARTHRITIS RHEUM-US, V46, P191, DOI 10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K; Bijl M, 2006, ANN RHEUM DIS, V65, P57, DOI 10.1136/ard.2005.035733; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; Chen XW, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3230; Clancy RM, 2006, J CLIN INVEST, V116, P2413, DOI 10.1172/JCI27803; COHEN JJ, 1992, ANNU REV IMMUNOL, V10, P267, DOI 10.1146/annurev.immunol.10.1.267; Esmann L, 2010, J IMMUNOL, V184, P391, DOI 10.4049/jimmunol.0900564; Fragoulis GE, 2014, J AUTOIMMUN; Gaipl US, 2006, CURR DIRECT AUTOIMMU, V9, P173; Gaipl US, 2007, J AUTOIMMUN, V28, P114, DOI 10.1016/j.jaut.2007.02.005; Gantner F, 1997, BRIT J PHARMACOL, V121, P221, DOI 10.1038/sj.bjp.0701124; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Gullstrand B, 2009, CLIN EXP IMMUNOL, V156, P303, DOI 10.1111/j.1365-2249.2009.03896.x; HAN HX, 1993, CELL TISSUE RES, V271, P407, DOI 10.1007/BF02913723; Herrmann M, 1998, ARTHRITIS RHEUM-US, V41, P1241, DOI 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H; HOPKINSONWOOLLEY J, 1994, J CELL SCI, V107, P1159; Ioannidis JPA, 2002, ARTHRITIS RHEUM, V46, P741, DOI 10.1002/art.10221; Katsiari CG, 2010, SEMIN ARTHRITIS RHEU, V39, P491, DOI 10.1016/j.semarthrit.2008.11.002; Kenyon KD, 2011, J IMMUNOL, V187, P2101, DOI 10.4049/jimmunol.1003468; KIMBERLY RP, 1989, CLIN EXP RHEUMATOL, V7, pS103; Licht R, 2004, J AUTOIMMUN, V22, P139, DOI 10.1016/j.jaut.2003.11.003; Litvack ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017223; MAJNO G, 1995, AM J PATHOL, V146, P3; Manoussakis MN, 2010, J AUTOIMMUN, V35, P212, DOI 10.1016/j.jaut.2010.06.010; Manoussakis MN, 2004, ARTHRITIS RHEUM-US, V50, P882, DOI 10.1002/art.20093; Munoz LE, 2008, LUPUS, V17, P371, DOI 10.1177/0961203308089990; Munoz LE, 2009, ARTHRITIS RHEUM-US, V60, P1733, DOI 10.1002/art.24535; O'Brien BA, 2006, J AUTOIMMUN, V26, P104, DOI 10.1016/j.jaut.2005.11.006; Ogden CA, 2006, CURR DIRECT AUTOIMMU, V9, P120; Okuma A, 2013, IMMUNITY, V38, P450, DOI 10.1016/j.immuni.2012.11.016; Ramos-Casals M, 2009, RHEUMATOLOGY, V48, P65, DOI 10.1093/rheumatology/ken411; Reefman E, 2007, ARTHRITIS RHEUM, V56, P3399, DOI 10.1002/art.22947; Ren Y, 2003, ARTHRITIS RHEUM, V48, P2888, DOI 10.1002/art.11237; Salomonsson S, 2003, ARTHRITIS RHEUM-US, V48, P3187, DOI 10.1002/art.11311; Sarmiento LF, 2007, AUTOIMMUNITY, V40, P337, DOI 10.1080/08916930701356663; Selmi C, 2012, J AUTOIMMUN, V39, P34, DOI 10.1016/j.jaut.2011.11.005; Seror R, 2010, ANN RHEUM DIS, V69, P1103, DOI 10.1136/ard.2009.110619; Shoenfeld Y, 2007, ANN NY ACAD SCI, V1108, P227, DOI 10.1196/annals.1422.025; Shoshan Y, 2001, J IMMUNOL, V167, P5963, DOI 10.4049/jimmunol.167.10.5963; SVENSSON BO, 1975, SCAND J IMMUNOL, V4, P145, DOI 10.1111/j.1365-3083.1975.tb02611.x; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tas SW, 2006, ANN RHEUM DIS, V65, P216, DOI 10.1136/ard.2005.037143; Urbonaviciute V, 2008, J EXP MED, V205, P3007, DOI 10.1084/jem.20081165; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Viorritto ICB, 2007, CLIN IMMUNOL, V122, P125, DOI 10.1016/j.clim.2006.07.012; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Vitali C, 2007, ARTHRITIS RHEUM-US, V56, P2223, DOI 10.1002/art.22658; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022	50	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112100	10.1371/journal.pone.0112100	http://dx.doi.org/10.1371/journal.pone.0112100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396412	Green Submitted, gold, Green Published			2022-12-27	WOS:000345558500033
J	Scheer, S; Krempl, C; Kallfass, C; Frey, S; Jakob, T; Mouahid, G; Mone, H; Schmitt-Graff, A; Staeheli, P; Lamers, MC				Scheer, Sebastian; Krempl, Christine; Kallfass, Carsten; Frey, Stefanie; Jakob, Thilo; Mouahid, Gabriel; Mone, Helene; Schmitt-Graeff, Annette; Staeheli, Peter; Lamers, Marinus C.			S-mansoni Bolsters Anti-Viral Immunity in the Murine Respiratory Tract	PLOS ONE			English	Article							INNATE LYMPHOID-CELLS; INFLUENZA-A VIRUS; NECROSIS-FACTOR-ALPHA; CD4(+) T-CELLS; HELMINTH INFECTION; PNEUMONIA VIRUS; DENDRITIC CELLS; TNF-ALPHA; IN-VIVO; CYTOKINE RESPONSES	The human intestinal parasite Schistosoma mansoni causes a chronic disease, schistosomiasis or bilharzia. According to the current literature, the parasite induces vigorous immune responses that are controlled by Th2 helper cells at the expense of Th1 helper cells. The latter cell type is, however, indispensable for anti-viral immune responses. Remarkably, there is no reliable literature among 230 million patients worldwide describing defective anti-viral immune responses in the upper respiratory tract, for instance against influenza A virus or against respiratory syncitial virus (RSV). We therefore re-examined the immune response to a human isolate of S. mansoni and challenged mice in the chronic phase of schistosomiasis with influenza A virus, or with pneumonia virus of mice (PVM), a mouse virus to model RSV infections. We found that mice with chronic schistosomiasis had significant, systemic immune responses induced by Th1, Th2, and Th17 helper cells. High serum levels of TNF-alpha, IFN-gamma, IL-5, IL-13, IL-2, IL-17, and GM-CSF were found after mating and oviposition. The lungs of diseased mice showed low-grade inflammation, with goblet cell hyperplasia and excessive mucus secretion, which was alleviated by treatment with an anti-TNF-alpha agent (Etanercept). Mice with chronic schistosomiasis were to a relative, but significant extent protected from a secondary viral respiratory challenge. The protection correlated with the onset of oviposition and TNF-alpha-mediated goblet cell hyperplasia and mucus secretion, suggesting that these mechanisms are involved in enhanced immune protection to respiratory viruses during chronic murine schistosomiasis. Indeed, also in a model of allergic airway inflammation mice were protected from a viral respiratory challenge with PVM.	[Scheer, Sebastian; Lamers, Marinus C.] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Scheer, Sebastian] Int Max Planck Res Sch Mol & Cellular Biol, Freiburg, Germany; [Scheer, Sebastian] Univ Freiburg, D-79106 Freiburg, Germany; [Krempl, Christine] Univ Wurzburg, Inst Immunol & Virol, D-97070 Wurzburg, Germany; [Kallfass, Carsten; Staeheli, Peter] Univ Med Ctr Freiburg, Dept Med Microbiol & Hyg, Inst Virol, Freiburg, Germany; [Frey, Stefanie; Jakob, Thilo] Univ Med Ctr Freiburg, Allergy Res Grp, Dept Dermatol, Freiburg, Germany; [Mouahid, Gabriel] Univ Perpignan, UMR 5244, F-66860 Perpignan, France; [Mone, Helene] CNRS, UMR 5244, F-66860 Perpignan, France; [Schmitt-Graeff, Annette] Univ Freiburg, Inst Pathol, Freiburg, Germany	Max Planck Society; Max Planck Society; University of Freiburg; University of Wurzburg; University of Freiburg; University of Freiburg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Perpignan Via Domitia; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Perpignan Via Domitia; Universite de Montpellier; University of Freiburg	Lamers, MC (corresponding author), Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany.	rinuslamers@t-online.de	Moné, Hélène/F-3367-2010; Mouahid, Gabriel/F-3625-2010; Krempl, Christine D/O-2081-2015	Scheer, Sebastian/0000-0002-9716-5009	Fonds National de la Recherche, Luxembourg [PHD-08-045-RE]	Fonds National de la Recherche, Luxembourg(Luxembourg National Research Fund)	SS was supported by the Fonds National de la Recherche, Luxembourg (http://www.fnr.lu) (PHD-08-045-RE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abruzzi A, 2011, ADV PARASIT, V77, P1, DOI 10.1016/B978-0-12-391429-3.00005-8; Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; ACTOR JK, 1993, P NATL ACAD SCI USA, V90, P948, DOI 10.1073/pnas.90.3.948; Adewusi OI, 1996, EXP PARASITOL, V84, P115, DOI 10.1006/expr.1996.0097; Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Araujo MI, 2001, INFECT IMMUN, V69, P1454, DOI 10.1128/IAI.69.3.1454-1462.2001; Brunet LR, 1997, J IMMUNOL, V159, P777; Buchholz UJ, 2009, J VIROL, V83, P1969, DOI 10.1128/JVI.02041-08; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Chapoval SP, 2007, J IMMUNOL, V179, P7030, DOI 10.4049/jimmunol.179.10.7030; Cosmi L, 2011, ALLERGY, V66, P989, DOI 10.1111/j.1398-9995.2011.02576.x; Crosby A, 2010, AM J RESP CRIT CARE, V181, P279, DOI 10.1164/rccm.200903-0355OC; Curran DR, 2010, AM J RESP CELL MOL, V42, P268, DOI 10.1165/rcmb.2009-0151TR; Damjanovic D, 2011, AM J PATHOL, V179, P2963, DOI 10.1016/j.ajpath.2011.09.003; Davies SJ, 2004, INT J PARASITOL, V34, P27, DOI 10.1016/j.ijpara.2003.10.010; Davies SJ, 2001, SCIENCE, V294, P1358, DOI 10.1126/science.1064462; de Miguel-Diez J, 2012, J INFECTION, V65, P95, DOI 10.1016/j.jinf.2012.03.003; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Dunne DW, 2005, NAT REV IMMUNOL, V5, P420, DOI 10.1038/nri1601; Edwards MJ, 2005, J IMMUNOL, V175, P6275, DOI 10.4049/jimmunol.175.10.6275; Ehre C, 2012, P NATL ACAD SCI USA, V109, P16528, DOI 10.1073/pnas.1206552109; Evans CM, 2009, CURR OPIN PULM MED, V15, P4, DOI 10.1097/MCP.0b013e32831da8d3; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; Fallon PG, 2007, NAT REV IMMUNOL, V7, P220, DOI 10.1038/nri2039; Fallon PG, 2000, IMMUNOL TODAY, V21, P29, DOI 10.1016/S0167-5699(99)01551-0; Frey S, 2008, J VIROL, V82, P11619, DOI 10.1128/JVI.00375-08; Gallo E, 2012, EUR J IMMUNOL, V42, P2322, DOI 10.1002/eji.201142227; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Grimm D, 2007, P NATL ACAD SCI USA, V104, P6806, DOI 10.1073/pnas.0701849104; Hasnain SZ, 2011, J EXP MED, V208, P893, DOI 10.1084/jem.20102057; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; HENDERSON GS, 1993, AM J PATHOL, V142, P703; Herbert DR, 2010, J IMMUNOL, V184, P6438, DOI 10.4049/jimmunol.0902009; Holzinger D, 2007, J VIROL, V81, P7776, DOI 10.1128/JVI.00546-06; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; HORISBERGER MA, 1983, P NATL ACAD SCI-BIOL, V80, P1910, DOI 10.1073/pnas.80.7.1910; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Kanno Y, 2012, ANNU REV IMMUNOL, V30, P707, DOI 10.1146/annurev-immunol-020711-075058; Khosravi A, 2014, CELL HOST MICROBE, V15, P374, DOI 10.1016/j.chom.2014.02.006; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Krempl CD, 2004, J VIROL, V78, P13362, DOI 10.1128/JVI.78.23.13362-13365.2004; Krempl CD, 2007, J VIROL, V81, P9490, DOI 10.1128/JVI.00364-07; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Lienenklaus S, 2009, J IMMUNOL, V183, P3229, DOI 10.4049/jimmunol.0804277; Liu F, 2005, J IMMUNOL, V174, P5936, DOI 10.4049/jimmunol.174.10.5936; Lora JM, 2005, J BIOL CHEM, V280, P36510, DOI 10.1074/jbc.M507977200; Marillier RG, 2010, AM J PHYSIOL-GASTR L, V298, pG943, DOI 10.1152/ajpgi.00321.2009; Marillier RG, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-11; McKee AS, 2004, J IMMUNOL, V173, P1224, DOI 10.4049/jimmunol.173.2.1224; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Mordstein M, 2010, J INTERF CYTOK RES, V30, P579, DOI 10.1089/jir.2010.0061; Morgan JAT, 2005, MOL ECOL, V14, P3889, DOI 10.1111/j.1365-294X.2005.02709.x; MORTON DB, 1985, VET REC, V116, P431, DOI 10.1136/vr.116.16.431; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Mouahid G, 2012, TROP MED INT HEALTH, V17, P727, DOI 10.1111/j.1365-3156.2012.02988.x; Mwatha JK, 1998, J IMMUNOL, V160, P1992; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Osborne LC, 2014, SCIENCE, V345, P578, DOI 10.1126/science.1256942; PEARCE EJ, 1991, J EXP MED, V173, P159, DOI 10.1084/jem.173.1.159; Peine M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001633; PEPPEL K, 1991, J EXP MED, V174, P1483, DOI 10.1084/jem.174.6.1483; Perona-Wright G, 2012, J IMMUNOL, V188, P2350, DOI 10.4049/jimmunol.1101642; Pichery M, 2012, J IMMUNOL, V188, P3488, DOI 10.4049/jimmunol.1101977; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Reese TA, 2014, SCIENCE, V345, P573, DOI 10.1126/science.1254517; Salgame P, 2013, NAT IMMUNOL, V14, P1118, DOI 10.1038/ni.2736; Scheer S, 2014, J IMMUNOL METHODS, V406, P66, DOI 10.1016/j.jim.2014.03.008; Schramm G, 2007, J IMMUNOL, V178, P6023, DOI 10.4049/jimmunol.178.10.6023; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; STANDEN OD, 1953, T ROY SOC TROP MED H, V47, P292, DOI 10.1016/0035-9203(53)90051-0; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; Thai P, 2008, ANNU REV PHYSIOL, V70, P405, DOI 10.1146/annurev.physiol.70.113006.100441; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Willart MAM, 2012, J EXP MED, V209, P1505, DOI 10.1084/jem.20112691; Wu CA, 2008, AM J PATHOL, V172, P714, DOI 10.2353/ajpath.2008.070462; Xu J, 2012, CELL, V151, P929, DOI 10.1016/j.cell.2012.11.007; Young HWJ, 2007, AM J RESP CELL MOL, V37, P273, DOI 10.1165/rcmb.2005-0460OC; Yu LP, 2012, PARASITOL RES, V110, P1547, DOI 10.1007/s00436-011-2661-4; Zhen GH, 2007, AM J RESP CELL MOL, V36, P244, DOI 10.1165/rcmb.2006-0180OC; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	87	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112469	10.1371/journal.pone.0112469	http://dx.doi.org/10.1371/journal.pone.0112469			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398130	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500053
J	Toung, JM; Lahens, N; Hogenesch, JB; Grant, G				Toung, Jonathan M.; Lahens, Nicholas; Hogenesch, John B.; Grant, Gregory			Detection Theory in Identification of RNA-DNA Sequence Differences Using RNA-Sequencing	PLOS ONE			English	Article							EDITING SITES; ALLELIC EXPRESSION; PARALLEL DNA; TRANSCRIPTOME; ALIGNMENT; ORIGIN	Advances in sequencing technology have allowed for detailed analyses of the transcriptome at single-nucleotide resolution, facilitating the study of RNA editing or sequence differences between RNA and DNA genome-wide. In humans, two types of post-transcriptional RNA editing processes are known to occur: A-to-I deamination by ADAR and C-to-U deamination by APOBEC1. In addition to these sequence differences, researchers have reported the existence of all 12 types of RNA-DNA sequence differences (RDDs); however, the validity of these claims is debated, as many studies claim that technical artifacts account for the majority of these non-canonical sequence differences. In this study, we used a detection theory approach to evaluate the performance of RNA-Sequencing (RNA-Seq) and associated aligners in accurately identifying RNA-DNA sequence differences. By generating simulated RNA-Seq datasets containing RDDs, we assessed the effect of alignment artifacts and sequencing error on the sensitivity and false discovery rate of RDD detection. Overall, we found that even in the presence of sequencing errors, false negative and false discovery rates of RDD detection can be contained below 10% with relatively lenient thresholds. We also assessed the ability of various filters to target false positive RDDs and found them to be effective in discriminating between true and false positives. Lastly, we used the optimal thresholds we identified from our simulated analyses to identify RDDs in a human lymphoblastoid cell line. We found approximately 6,000 RDDs, the majority of which are A-to-G edits and likely to be mediated by ADAR. Moreover, we found the majority of non A-to-G RDDs to be associated with poorer alignments and conclude from these results that the evidence for widespread non-canonical RDDs in humans is weak. Overall, we found RNA-Seq to be a powerful technique for surveying RDDs genome-wide when coupled with the appropriate thresholds and filters.	[Toung, Jonathan M.; Lahens, Nicholas] Univ Penn, Sch Med, Genom & Computat Biol Grad Program, Philadelphia, PA 19104 USA; [Hogenesch, John B.; Grant, Gregory] Univ Penn, Sch Med, Inst Biomed Informat, Philadelphia, PA 19104 USA; [Hogenesch, John B.; Grant, Gregory] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Grant, Gregory] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Hogenesch, John B.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania	Grant, G (corresponding author), Univ Penn, Sch Med, Inst Biomed Informat, Philadelphia, PA 19104 USA.	greg@grant.org	Grant, Gregory Robert/I-3599-2019	Grant, Gregory Robert/0000-0002-0139-7658	Glue Grant [U54HL117798]; CSTA Grant - National Center for Research Resources; National Center for Advancing Translational Sciences; National Institutes of Health [UL1TR000003]; Institute for Translational Medicine and Therapeutics of the Perelman School of Medicine at the University of Pennsylvania; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000003] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL117798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054794] Funding Source: NIH RePORTER	Glue Grant; CSTA Grant - National Center for Research Resources; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Translational Medicine and Therapeutics of the Perelman School of Medicine at the University of Pennsylvania; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by Glue Grant: U54HL117798; CSTA Grant: The project described was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1TR000003. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH; ITMAT: Supported in part by the Institute for Translational Medicine and Therapeutics of the Perelman School of Medicine at the University of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bahn JH, 2012, GENOME RES, V22, P142, DOI 10.1101/gr.124107.111; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; CHEN SH, 1987, SCIENCE, V238, P363, DOI 10.1126/science.3659919; DeVeale B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002600; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Grant GR, 2011, BIOINFORMATICS, V27, P2518, DOI 10.1093/bioinformatics/btr427; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Heap GA, 2010, HUM MOL GENET, V19, P122, DOI 10.1093/hmg/ddp473; Ju YS, 2011, NAT GENET, V43, P745, DOI 10.1038/ng.872; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kleinman CL, 2012, SCIENCE, V335, DOI [10.1126/science.1209658, 10.1126/science.1210624]; Kleinman CL, 2012, RNA, V18, P1586, DOI 10.1261/rna.033233.112; Lahens NF, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r86; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Lin W, 2012, SCIENCE, V335, DOI 10.1126/science.1210624; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Park E, 2012, GENOME RES, V22, P1626, DOI 10.1101/gr.134957.111; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Pickrell JK, 2012, SCIENCE, V335, DOI 10.1126/science.1210484; POLSON AG, 1994, EMBO J, V13, P5701, DOI 10.1002/j.1460-2075.1994.tb06908.x; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Qu W, 2009, GENOME RES, V19, P1309, DOI 10.1101/gr.089151.108; Ramaswami G, 2012, NAT METHODS; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/nmeth.2330, 10.1038/NMETH.2330]; Schrider DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025842; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; Smith HC, 2012, SEMIN CELL DEV BIOL, V23, P258, DOI 10.1016/j.semcdb.2011.10.004; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057	43	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112040	10.1371/journal.pone.0112040	http://dx.doi.org/10.1371/journal.pone.0112040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396741	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500027
J	Yoshida, K; Jiang, HF; Kim, M; Vink, J; Cremers, S; Paik, D; Wapner, R; Mahendroo, M; Myers, K				Yoshida, Kyoko; Jiang, Hongfeng; Kim, MiJung; Vink, Joy; Cremers, Serge; Paik, David; Wapner, Ronald; Mahendroo, Mala; Myers, Kristin			Quantitative Evaluation of Collagen Crosslinks and Corresponding Tensile Mechanical Properties in Mouse Cervical Tissue during Normal Pregnancy	PLOS ONE			English	Article							IN-VIVO; CONSTITUENTS; STROMA	The changes in the mechanical integrity of the cervix during pregnancy have implications for a successful delivery. Cervical collagens are known to remodel extensively in mice with progressing gestation leading to a soft cervix at term. During this process, mature crosslinked collagens are hypothesized to be replaced with immature less crosslinked collagens to facilitate cervical softening and ripening. To determine the mechanical role of collagen crosslinks during normal mouse cervical remodeling, tensile load-to-break tests were conducted for the following time points: nonpregnant (NP), gestation day (d) 6, 12, 15, 18 and 24 hr postpartum (PP) of the 19-day gestation period. Immature crosslinks (HLNL and DHLNL) and mature crosslinks (DPD and PYD) were measured using ultra performance liquid chromatography-electrospray ionization tandem mass spectrometry (UPLC-ESI-MS/MS). There were no significant changes in the total immature crosslink density (HLNL+ DHLNL mol per collagen mol) throughout normal mouse gestation (range: 0.31-0.49). Total mature crosslink density (PYD+ DPD mol per collagen mol) decreased significantly in early softening from d6 to d15 (d6: 0.17, d12: 0.097, d15: 0.026) and did not decrease with further gestation. The maturity ratio (total mature to total immature crosslinks) significantly decreased in early softening from d6 to d15 (d6: 0.2, d15: 0.074). All of the measured crosslinks correlated significantly with a measure of tissue stiffness and strength, with the exception of the immature crosslink HLNL. This data provides quantitative evidence to support the hypothesis that as mature crosslinked collagens decline, they are replaced by immature collagens to facilitate increased tissue compliance in the early softening period from d6 to d15.	[Yoshida, Kyoko; Myers, Kristin] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA; [Jiang, Hongfeng; Cremers, Serge] Columbia Univ, Dept Med, Med Ctr, New York, NY 10027 USA; [Kim, MiJung; Paik, David] Columbia Univ, Dept Opthalmol, Med Ctr, New York, NY 10027 USA; [Vink, Joy; Wapner, Ronald] Columbia Univ, Dept Obstet & Gynecol, Med Ctr, New York, NY 10027 USA; [Mahendroo, Mala] UT Southwestern Med Ctr, Dept Obstet & Gynecol, Dallas, TX USA; [Cremers, Serge] Columbia Univ, Med Ctr, Irving Inst Clin & Translat Res, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University; Columbia University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Columbia University	Myers, K (corresponding author), Columbia Univ, Dept Mech Engn, New York, NY 10027 USA.	kmm2233@columbia.edu	Myers, Kristin M/E-5689-2017; Yoshida, Kyoko/AAK-2259-2021; jiang, hongfeng/I-6188-2013; Yoshida, Kyoko/A-9746-2017	Myers, Kristin M/0000-0002-5989-0242; Yoshida, Kyoko/0000-0002-7251-134X; Yoshida, Kyoko/0000-0002-7251-134X	National Science Foundation Graduate Research Fellowship; National Center for Advancing Translational Sciences; National Institutes of Health [UL1 TR000040]; Burroughs Wellcome Fund Prematurity Research Initiative Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Prematurity Research Initiative Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This publication was supported by the National Science Foundation Graduate Research Fellowship (http://www.nsf.org), the National Center for Advancing Translational Sciences, National Institutes of Health (http://www. nih. gov), through Grant No. UL1 TR000040, and the Burroughs Wellcome Fund Prematurity Research Initiative Award (http://www. bwfund. org) to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins ML, 2011, BIOL REPROD, V84, P1053, DOI 10.1095/biolreprod.110.089599; Avery Nicholas C., 2009, V522, P103, DOI 10.1007/978-1-59745-413-1_6; Buehler MJ, 2008, J MECH BEHAV BIOMED, V1, P59, DOI 10.1016/j.jmbbm.2007.04.001; Eleswarapu SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026178; Eyre DR, 2005, TOP CURR CHEM, V247, P207, DOI 10.1007/b103828; Fessel G, 2012, J SHOULDER ELB SURG, V21, P209, DOI 10.1016/j.jse.2011.10.002; Gineyts E, 2010, J CHROMATOGR B, V878, P1449, DOI 10.1016/j.jchromb.2010.03.039; GLASSMAN W, 1995, AM J OBSTET GYNECOL, V173, P1550, DOI 10.1016/0002-9378(95)90648-7; House M, 2009, SEMIN PERINATOL, V33, P300, DOI 10.1053/j.semperi.2009.06.002; Iams JD, 2010, AM J OBSTET GYNECOL, V203, P89, DOI 10.1016/j.ajog.2010.02.004; Kindt E, 2003, J PHARMACEUT BIOMED, V33, P1081, DOI 10.1016/S0731-7085(03)00359-5; LEPPERT PC, 1995, CLIN OBSTET GYNECOL, V38, P267, DOI 10.1097/00003081-199506000-00009; Mahendroo M, 2012, REPRODUCTION, V143, P429, DOI 10.1530/REP-11-0466; Marturano JE, 2013, P NATL ACAD SCI USA, V110, P6370, DOI 10.1073/pnas.1300135110; MILLER EJ, 1982, METHOD ENZYMOL, V82, P33; Myers K, 2009, EUR J OBSTET GYN R B, V144, pS82, DOI 10.1016/j.ejogrb.2009.02.008; Oxlund H, 1996, BONE, V19, P479, DOI 10.1016/S8756-3282(96)00283-9; OZASA H, 1981, ENDOCRINOLOGY, V109, P618, DOI 10.1210/endo-109-2-618; Read CP, 2007, REPRODUCTION, V134, P327, DOI 10.1530/REP-07-0032; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; Schlembach D, 2009, EUR J OBSTET GYN R B, V144, pS70, DOI 10.1016/j.ejogrb.2009.02.036; Sroga GE, 2011, J CHROMATOGR B, V879, P379, DOI 10.1016/j.jchromb.2010.12.024; Timmons BC, 2014, ENDOCRINOLOGY, V155, P287, DOI 10.1210/en.2013-1304; Vargis E, 2012, ANN BIOMED ENG, V40, P1814, DOI 10.1007/s10439-012-0541-4; Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1; Word R, 2010, SEMINARS REPROD MED, V25, P1; Yoshida K, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026423; YU SY, 1995, P SOC EXP BIOL MED, V209, P360; Zhang YY, 2012, P NATL ACAD SCI USA, V109, P12878, DOI 10.1073/pnas.1121495109; Zork N, 2014, SYSTEMATIC EVALUATIO, DOI [10.1016/j.ajog.2014.09.036.AJOG, DOI 10.1016/J.AJOG.2014.09.036.AJOG]	30	32	33	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112391	10.1371/journal.pone.0112391	http://dx.doi.org/10.1371/journal.pone.0112391			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397407	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558500049
J	Lessin, G; Raudsepp, U; Stips, A				Lessin, Gennadi; Raudsepp, Urmas; Stips, Adolf			Modelling the Influence of Major Baltic Inflows on Near-Bottom Conditions at the Entrance of the Gulf of Finland	PLOS ONE			English	Article							CYANOBACTERIA BLOOMS; NITROGEN-FIXATION; DISSOLVED-OXYGEN; ECOSYSTEM MODEL; SEA; EUTROPHICATION; HYPOXIA; BALANCE; BASINS; STATE	A coupled hydrodynamic-biogeochemical model was implemented in order to estimate the effects of Major Baltic Inflows on the near-bottom hydrophysical and biogeochemical conditions in the northern Baltic Proper and the western Gulf of Finland during the period 1991-2009. We compared results of a realistic reference run to the results of an experimental run where Major Baltic Inflows were suppressed. Further to the expected overall decrease in bottom salinity, this modelling experiment confirms that in the absence of strong saltwater inflows the deep areas of the Baltic Proper would become more anoxic, while in the shallower areas (western Gulf of Finland) near-bottom average conditions improve. Our experiment revealed that typical estuarine circulation results in the sporadic emergence of short-lasting events of near-bottom anoxia in the western Gulf of Finland due to transport of water masses from the Baltic Proper. Extrapolating our results beyond the modelled period, we speculate that the further deepening of the halocline in the Baltic Proper is likely to prevent inflows of anoxic water to the Gulf of Finland and in the longer term would lead to improvement in near-bottom conditions in the Baltic Proper. Our results reaffirm the importance of accurate representation of salinity dynamics in coupled Baltic Sea models serving as a basis for credible hindcast and future projection simulations of biogeochemical conditions.	[Lessin, Gennadi] Plymouth Marine Lab, Plymouth, Devon, England; [Raudsepp, Urmas] Tallinn Univ Technol, Marine Syst Inst, EE-19086 Tallinn, Estonia; [Stips, Adolf] Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, Water Res Unit, I-21020 Ispra, Italy	Plymouth Marine Laboratory; Tallinn University of Technology; European Commission Joint Research Centre; EC JRC ISPRA Site	Lessin, G (corresponding author), Plymouth Marine Lab, Prospect Pl, Plymouth, Devon, England.	gle@pml.ac.uk		Raudsepp, Urmas/0000-0002-1037-5311	Natural Environment Research Council [NE/E011314/1, pml010010] Funding Source: researchfish; NERC [NE/E011314/1, pml010010] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		[Anonymous], 2001, BALT SEA SCI C STOCK; BIERMAN VJ, 1994, ESTUARIES, V17, P886, DOI 10.2307/1352756; Burchard H, 2004, OCEAN DYNAM, V54, P250, DOI 10.1007/s10236-003-0073-4; Burchard H., 2002, 20253 EN EUR; Conley DJ, 2009, ENVIRON SCI TECHNOL, V43, P3412, DOI 10.1021/es802762a; Conley DJ, 2009, ENVIRON SCI TECHNOL, V43, P3407, DOI 10.1021/es8027633; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Eilola K, 2011, J MARINE SYST, V88, P267, DOI 10.1016/j.jmarsys.2011.05.004; Eilola K, 2009, J MARINE SYST, V75, P163, DOI 10.1016/j.jmarsys.2008.08.009; Elken J, 2014, J MARINE SYST, V129, P47, DOI 10.1016/j.jmarsys.2013.04.015; Fischer H, 1996, J MARINE SYST, V9, P137, DOI 10.1016/S0924-7963(96)00046-2; Franck H., 1987, Gerlands Beitraege zur Geophysik, V96, P517; Gustafsson B. G., 2008, C82 GOT U EARTH SCI; Heiser U, 2001, MAR GEOL, V177, P151, DOI 10.1016/S0025-3227(01)00129-3; HELCOM, 2011, SEA ENV P; Hofmeister R, 2011, OCEAN MODEL, V39, P233, DOI 10.1016/j.ocemod.2011.04.007; Hong B, 2012, ECOL MODEL, V227, P117, DOI 10.1016/j.ecolmodel.2011.12.002; Janssen F, 1999, OCEAN DYNAM, V51, P5; Kahru M, 2000, MAR ECOL PROG SER, V207, P13, DOI 10.3354/meps207013; Kauppila P, 2001, FINNISH ENV, V472, P61; Laane A, 2002, TECHNICAL REPORT; Laine AO, 2007, J SEA RES, V57, P65, DOI 10.1016/j.seares.2006.08.003; Lehtoranta J, 2008, J MARINE SYST, V74, P495, DOI 10.1016/j.jmarsys.2008.04.001; Lessin G, 2012, IEEE OES BALT 2012 I; Lessin G, 2012, BALT INT S BALTIC 20, P1; Lessin G, 2014, J MARINE SYST, V129, P76, DOI 10.1016/j.jmarsys.2013.08.006; Liblik T, 2013, OCEAN SCI, V9, P917, DOI 10.5194/os-9-917-2013; Lundberg C, 2005, MAR POLLUT BULL, V50, P1185, DOI 10.1016/j.marpolbul.2005.04.029; MATTHAUS W, 1992, CONT SHELF RES, V12, P1375, DOI 10.1016/0278-4343(92)90060-W; Matthaus W., 2008, STATE EVOLUTION BALT, P265, DOI [10.1002/9780470283134.ch10, DOI 10.1002/9780470283134.CH10]; MATTHAUS W, 2006, HIST INVESTIGATION S; Meier HEM, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2000JC000521; Neumann T, 2000, J MARINE SYST, V25, P405, DOI 10.1016/S0924-7963(00)00030-0; Neumann T, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001450; Neumann T, 2008, J MARINE SYST, V74, P592, DOI 10.1016/j.jmarsys.2008.05.003; Olsonen R, 2007, ANN REPORT, V62; Pena MA, 2010, BIOGEOSCIENCES, V7, P933, DOI 10.5194/bg-7-933-2010; Pitkaenen H., 2008, V197, P285, DOI 10.1007/978-3-540-73524-3_13; Pohl C., 2008, STATE EVOLUTION BALT, P367; Raateoja M, 2005, AMBIO, V34, P188, DOI 10.1639/0044-7447(2005)034[0188:RCITSO]2.0.CO;2; Resplandy L, 2012, BIOGEOSCIENCES, V9, P5095, DOI 10.5194/bg-9-5095-2012; Schiewer U., 2008, ECOLOGICAL STUDIES, V197; Stigebrandt A, 2003, J SEA RES, V49, P243, DOI 10.1016/S1385-1101(03)00021-2; Umlauf L, 2005, CONT SHELF RES, V25, P795, DOI 10.1016/j.csr.2004.08.004; Vahtera E, 2007, AMBIO, V36, P186, DOI 10.1579/0044-7447(2007)36[186:IEFENC]2.0.CO;2; Yakushev EV, 2007, MAR CHEM, V107, P388, DOI 10.1016/j.marchem.2007.06.003; Yakushev EV, 2011, COMPUT GEOSCI-UK, V37, P398, DOI 10.1016/j.cageo.2011.01.001	47	11	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112881	10.1371/journal.pone.0112881	http://dx.doi.org/10.1371/journal.pone.0112881			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393720	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000347709300117
J	Arambasic, M; Sandoval, PY; Hoehener, C; Singh, A; Swart, EC; Nowacki, M				Arambasic, Miroslav; Sandoval, Pamela Y.; Hoehener, Cristina; Singh, Aditi; Swart, Estienne C.; Nowacki, Mariusz			Pdsg1 and Pdsg2, Novel Proteins Involved in Developmental Genome Remodelling in Paramecium	PLOS ONE			English	Article							PROGRAMMED DNA ELIMINATION; DICER-LIKE PROTEIN; SMALL RNAS; REARRANGEMENTS; SEQUENCES; METHYLATION; TETRAHYMENA; TETRAURELIA; TRANSCRIPTS; CROSSTALK	The epigenetic influence of maternal cells on the development of their progeny has long been studied in various eukaryotes. Multicellular organisms usually provide their zygotes not only with nutrients but also with functional elements required for proper development, such as coding and non-coding RNAs. These maternally deposited RNAs exhibit a variety of functions, from regulating gene expression to assuring genome integrity. In ciliates, such as Paramecium these RNAs participate in the programming of large-scale genome reorganization during development, distinguishing germline-limited DNA, which is excised, from somatic-destined DNA. Only a handful of proteins playing roles in this process have been identified so far, including typical RNAi-derived factors such as Dicer-like and Piwi proteins. Here we report and characterize two novel proteins, Pdsg1 and Pdsg2 (Paramecium protein involved in Development of the Somatic Genome 1 and 2), involved in Paramecium genome reorganization. We show that these proteins are necessary for the excision of germline-limited DNA during development and the survival of sexual progeny. Knockdown of PDSG1 and PDSG2 genes affects the populations of small RNAs known to be involved in the programming of DNA elimination (scanRNAs and iesRNAs) and chromatin modification patterns during development. Our results suggest an association between RNA-mediated trans-generational epigenetic signal and chromatin modifications in the process of Paramecium genome reorganization.	[Arambasic, Miroslav; Sandoval, Pamela Y.; Hoehener, Cristina; Singh, Aditi; Swart, Estienne C.; Nowacki, Mariusz] Univ Bern, Inst Cell Biol, Bern, Switzerland	University of Bern	Nowacki, M (corresponding author), Univ Bern, Inst Cell Biol, Bern, Switzerland.	mariusz.nowacki@izb.unibe.ch	Sandoval, Pamela Y./AAL-8719-2020; Nowacki, Mariusz/E-4485-2011; Singh, Aditi/ABZ-0850-2022	Sandoval, Pamela Y./0000-0002-6514-3980; Nowacki, Mariusz/0000-0003-4894-2905; Singh, Aditi/0000-0001-7840-9058	Swiss National Science Foundation [31003A_129957]; European Research Council [GA 260358]; European Cooperation in Science and Technology Action BM1102	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); European Cooperation in Science and Technology Action BM1102	This work was supported by Swiss National Science Foundation grant 31003A_129957 (http://www.snf.ch/); European Research Council grant "EPIGENOME" GA 260358 (http://erc.europa.eu/); European Cooperation in Science and Technology Action BM1102 (http://www.cost.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaiz O, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002984; Arnaiz O, 2011, NUCLEIC ACIDS RES, V39, pD632, DOI 10.1093/nar/gkq918; Aronica L, 2008, GENE DEV, V22, P2228, DOI 10.1101/gad.481908; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Baudry C, 2009, GENE DEV, V23, P2478, DOI 10.1101/gad.547309; Beisson J, 2010, COLD SPRING HARB PRO, V2010, DOI 10.1101; Betermier M, 2004, RES MICROBIOL, V155, P399, DOI 10.1016/j.resmic.2004.01.017; Bouhouche K, 2011, NUCLEIC ACIDS RES, V39, P4249, DOI 10.1093/nar/gkq1283; Brown T, 2001, Curr Protoc Mol Biol, VChapter 2, DOI 10.1002/0471142727.mb0209as21; Coyne RS, 2012, BIOL CELL, V104, P309, DOI 10.1111/boc.201100057; Duharcourt S, 1998, MOL CELL BIOL, V18, P7075, DOI 10.1128/MCB.18.12.7075; DUHARCOURT S, 1995, GENE DEV, V9, P2065, DOI 10.1101/gad.9.16.2065; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Galvani A, 2002, TRENDS GENET, V18, P11, DOI 10.1016/S0168-9525(01)02548-3; Galvani A, 2001, NUCLEIC ACIDS RES, V29, P4387, DOI 10.1093/nar/29.21.4387; Garnier O, 2004, MOL CELL BIOL, V24, P7370, DOI 10.1128/MCB.24.17.7370-7379.2004; Gratias A, 2008, NUCLEIC ACIDS RES, V36, P3244, DOI 10.1093/nar/gkn154; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; KLOBUTCHER LA, 1995, NUCLEIC ACIDS RES, V23, P2006, DOI 10.1093/nar/23.11.2006; Le Mouel A, 2003, EUKARYOT CELL, V2, P1076, DOI 10.1128/EC.2.5.1076-1090.2003; Lee SR, 2007, NAT STRUCT MOL BIOL, V14, P604, DOI 10.1038/nsmb1262; Lepere G, 2008, GENE DEV, V22, P1501, DOI 10.1101/gad.473008; Lepere G, 2009, NUCLEIC ACIDS RES, V37, P903, DOI 10.1093/nar/gkn1018; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu YF, 2004, P NATL ACAD SCI USA, V101, P1679, DOI 10.1073/pnas.0305421101; Liu Y, 2007, GENE DEV, V21, P1530, DOI 10.1101/gad.1544207; Malone CD, 2005, MOL CELL BIOL, V25, P9151, DOI 10.1128/MCB.25.20.9151-9164.2005; Matsuda A, 2006, EUKARYOT CELL, V5, P806, DOI 10.1128/EC.5.5.806-815.2006; Matsuda A, 2010, EUKARYOT CELL, V9, P1087, DOI 10.1128/EC.00379-09; Mayer KM, 1998, GENETICS, V148, P139; Mochizuki K, 2005, GENE DEV, V19, P77, DOI 10.1101/gad.1265105; Mochizuki K, 2004, GENE DEV, V18, P2068, DOI 10.1101/gad.1219904; Mochizuki K, 2004, CURR OPIN GENET DEV, V14, P181, DOI 10.1016/j.gde.2004.01.004; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Nowacki M, 2005, CURR BIOL, V15, P1616, DOI 10.1016/j.cub.2005.07.033; Nowak JK, 2011, EUKARYOT CELL, V10, P363, DOI 10.1128/EC.00258-10; Ruiz F, 1998, MOL BIOL CELL, V9, P931, DOI 10.1091/mbc.9.4.931; Sandoval PY, 2014, DEV CELL, V28, P174, DOI 10.1016/j.devcel.2013.12.010; Schoeberl UE, 2012, GENE DEV, V26, P1729, DOI 10.1101/gad.196493.112; Swart EC, 2014, NUCLEIC ACIDS RES, V42, P8970, DOI 10.1093/nar/gku619; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8	41	6	7	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112899	10.1371/journal.pone.0112899	http://dx.doi.org/10.1371/journal.pone.0112899			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397898	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500106
J	Deng, F; Chen, X; Liao, Z; Yan, ZJ; Wang, ZL; Deng, YL; Zhang, Q; Zhang, ZL; Ye, JX; Qiao, M; Li, RF; Denduluri, S; Wang, J; Wei, Q; Li, M; Geng, NS; Zhao, LG; Zhou, GL; Zhang, PH; Luu, HH; Haydon, RC; Reid, RR; Yang, T; He, TC				Deng, Fang; Chen, Xiang; Liao, Zhan; Yan, Zhengjian; Wang, Zhongliang; Deng, Youlin; Zhang, Qian; Zhang, Zhonglin; Ye, Jixing; Qiao, Min; Li, Ruifang; Denduluri, Sahitya; Wang, Jing; Wei, Qiang; Li, Melissa; Geng, Nisha; Zhao, Lianggong; Zhou, Guolin; Zhang, Penghui; Luu, Hue H.; Haydon, Rex C.; Reid, Russell R.; Yang, Tian; He, Tong-Chuan			A Simplified and Versatile System for the Simultaneous Expression of Multiple siRNAs in Mammalian Cells Using Gibson DNA Assembly	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BONE MORPHOGENETIC PROTEINS; BMP-9-INDUCED OSTEOGENIC DIFFERENTIATION; HEPATIC PROGENITOR CELLS; RNA INTERFERENCE; HUMAN OSTEOSARCOMA; OSTEOBLAST DIFFERENTIATION; TUMOR-GROWTH; WNT; THERAPEUTICS	RNA interference (RNAi) denotes sequence-specific mRNA degradation induced by short interfering double-stranded RNA (siRNA) and has become a revolutionary tool for functional annotation of mammalian genes, as well as for development of novel therapeutics. The practical applications of RNAi are usually achieved by expressing short hairpin RNAs (shRNAs) or siRNAs in cells. However, a major technical challenge is to simultaneously express multiple siRNAs to silence one or more genes. We previously developed pSOS system, in which siRNA duplexes are made from oligo templates driven by opposing U6 and H1 promoters. While effective, it is not equipped to express multiple siRNAs in a single vector. Gibson DNA Assembly (GDA) is an in vitro recombination system that has the capacity to assemble multiple overlapping DNA molecules in a single isothermal step. Here, we developed a GDA-based pSOK assembly system for constructing single vectors that express multiple siRNA sites. The assembly fragments were generated by PCR amplifications from the U6-H1 template vector pB2B. GDA assembly specificity was conferred by the overlapping unique siRNA sequences of insert fragments. To prove the technical feasibility, we constructed pSOK vectors that contain four siRNA sites and three siRNA sites targeting human and mouse beta-catenin, respectively. The assembly reactions were efficient, and candidate clones were readily identified by PCR screening. Multiple beta-catenin siRNAs effectively silenced endogenous beta-catenin expression, inhibited Wnt3A-induced beta-catenin/Tcf4 reporter activity and expression of Wnt/beta-catenin downstream genes. Silencing beta-catenin in mesenchymal stem cells inhibited Wnt3A-induced early osteogenic differentiation and significantly diminished synergistic osteogenic activity between BMP9 and Wnt3A in vitro and in vivo. These findings demonstrate that the GDA-based pSOK system has been proven simplistic, effective and versatile for simultaneous expression of multiple siRNAs. Thus, the reported pSOK system should be a valuable tool for gene function studies and development of novel therapeutics.	[Deng, Fang; Yang, Tian] Third Mil Med Univ, Dept Cell Biol, Chongqing 400038, Peoples R China; [Deng, Fang; Chen, Xiang; Liao, Zhan; Yan, Zhengjian; Wang, Zhongliang; Deng, Youlin; Zhang, Qian; Zhang, Zhonglin; Ye, Jixing; Qiao, Min; Li, Ruifang; Denduluri, Sahitya; Wang, Jing; Wei, Qiang; Li, Melissa; Geng, Nisha; Zhao, Lianggong; Zhou, Guolin; Zhang, Penghui; Luu, Hue H.; Haydon, Rex C.; Reid, Russell R.; He, Tong-Chuan] Univ Chicago, Med Ctr, Dept Orthopaed Surg & Rehabil Med, Mol Oncol Lab, Chicago, IL 60637 USA; [Liao, Zhan; Qiao, Min; He, Tong-Chuan] Cent S Univ, Affiliated Xiang Ya Hosp, Dept Orthopaed Surg, Changsha 410008, Hunan, Peoples R China; [Yan, Zhengjian; Wang, Zhongliang; Deng, Youlin; Zhang, Qian; Qiao, Min; Wang, Jing; Wei, Qiang; Zhang, Penghui] Chongqing Med Univ, Minist Educ, Key Lab Diagnost Med, Chongqing 400016, Peoples R China; [Yan, Zhengjian; Wang, Zhongliang; Deng, Youlin; Zhang, Qian; Qiao, Min; Wang, Jing; Wei, Qiang; Zhang, Penghui] Chongqing Med Univ, Affiliated Hosp, Chongqing 400016, Peoples R China; [Zhang, Zhonglin; Li, Ruifang] Wuhan Univ, Affiliated Zhongnan Hosp, Dept Surg, Wuhan 430071, Peoples R China; [Ye, Jixing] Chongqing Univ, Sch Bioengn, Chongqing 400044, Peoples R China; [Zhao, Lianggong] Lanzhou Univ, Affiliated Hosp 2, Dept Orthopaed Surg, Lanzhou, Gansu, Peoples R China; [Reid, Russell R.] Univ Chicago, Med Ctr, Dept Surg, Lab Craniofacial Biol, Chicago, IL 60637 USA	Army Medical University; University of Chicago; University of Chicago Medical Center; Central South University; Chongqing Medical University; Chongqing Medical University; Wuhan University; Chongqing University; Lanzhou University; University of Chicago; University of Chicago Medical Center	Yang, T (corresponding author), Third Mil Med Univ, Dept Cell Biol, Chongqing 400038, Peoples R China.	tiany@163.net; tche@uchicago.edu	Geng, Nisha/AAA-4646-2022	Geng, Nisha/0000-0002-9849-5296; Deng, Fang/0000-0002-7927-5394; Chen, Xiang/0000-0001-7628-516X	National Institutes of Health [AT004418, AR50142, AR054381]; National Natural Science Foundation of China (NSFC) [81271770]; China Scholarship Council; University of Chicago Core Facility Subsidy grant from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health [UL1 TR000430]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT004418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR050142, K08AR054381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); University of Chicago Core Facility Subsidy grant from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The reported work was supported in part by research grants from the National Institutes of Health (AT004418, AR50142, AR054381 to TCH, RCH and HHL), and the National Natural Science Foundation of China (NSFC grant #81271770 to TY). DF was a recipient of a doctorate fellowship from the China Scholarship Council. This work was also supported in part by The University of Chicago Core Facility Subsidy grant from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health through grant UL1 TR000430. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi Y, 2009, J CELL BIOCHEM, V108, P295, DOI 10.1002/jcb.22254; Bumcrot D, 2006, NAT CHEM BIOL, V2, P711, DOI 10.1038/nchembio839; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Chen LA, 2010, J BONE MINER RES, V25, P2447, DOI 10.1002/jbmr.133; Chen X, 2013, CELL PHYSIOL BIOCHEM, V32, P1083, DOI 10.1159/000354508; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Conte C, 2002, EMBO J, V21, P3908, DOI 10.1093/emboj/cdf367; Czech MP, 2011, NAT REV ENDOCRINOL, V7, P473, DOI 10.1038/nrendo.2011.57; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Fellmann C, 2014, NAT CELL BIOL, V16, P10, DOI 10.1038/ncb2895; Feng T, 2002, BIOTECHNIQUES, V32, P992, DOI 10.2144/02325bm03; Gao YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082436; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hu N, 2013, J CELL SCI, V126, P532, DOI 10.1242/jcs.114231; Huang EY, 2012, J BONE MINER RES, V27, P1566, DOI 10.1002/jbmr.1622; Huang EY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032428; Huang JY, 2009, LIVER INT, V29, P1569, DOI 10.1111/j.1478-3231.2009.02111.x; Iorns E, 2007, NAT REV DRUG DISCOV, V6, P556, DOI 10.1038/nrd2355; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Kim JH, 2013, THER ADV MUSCULOSKEL, V5, P13, DOI 10.1177/1759720X12466608; Kong YH, 2013, CELL PHYSIOL BIOCHEM, V32, P1187, DOI 10.1159/000354518; Lamplot JD, 2014, CELL TRANSPLANT; Lamplot JD, 2013, AM J STEM CELLS, V2, P1; Li R., 2014, CURR CANC DRUG TARGE; Lienert F, 2014, NAT REV MOL CELL BIO, V15, P95, DOI 10.1038/nrm3738; Liu X, 2013, J CELL MOL MED; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Luo JY, 2007, LAB INVEST, V87, P97, DOI 10.1038/labinvest.3700509; Luo JY, 2010, J BIOL CHEM, V285, P29588, DOI 10.1074/jbc.M110.130518; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Luo Q, 2007, GENE, V395, P160, DOI 10.1016/j.gene.2007.02.030; Luo XJ, 2008, CLIN ORTHOP RELAT R, V466, P2060, DOI 10.1007/s11999-008-0361-x; Luo XJ, 2008, LAB INVEST, V88, P1264, DOI 10.1038/labinvest.2008.98; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; Okamura K, 2008, NAT REV MOL CELL BIO, V9, P673, DOI 10.1038/nrm2479; Pecot CV, 2011, NAT REV CANCER, V11, P59, DOI 10.1038/nrc2966; Peng Y, 2003, J CELL BIOCHEM, V90, P1149, DOI 10.1002/jcb.10744; Rastegar F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014182; Sarkies P, 2014, NAT REV MOL CELL BIO, V15, P525, DOI 10.1038/nrm3840; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Su Y, 2011, ONCOGENE, V30, P3907, DOI 10.1038/onc.2011.97; Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Wang JH, 2014, STEM CELLS DEV, V23, P1405, DOI 10.1089/scd.2013.0580; Wang N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097316; Wang N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093608; Wang Y, 2013, J ORTHOP RES, V31, P1796, DOI 10.1002/jor.22427; Wen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094397; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wu N, 2014, GENE THER, V21, P629, DOI 10.1038/gt.2014.40; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Yang RF, 2011, J INVEST DERMATOL, V131, P2458, DOI 10.1038/jid.2011.242; Zhang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073086; Zhang WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011917; Zhang Y, 2014, ONCOL REP; Zhao C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092908; Zhu GH, 2009, DIFFERENTIATION, V78, P195, DOI 10.1016/j.diff.2009.06.001	68	42	42	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113064	10.1371/journal.pone.0113064	http://dx.doi.org/10.1371/journal.pone.0113064			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398142	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558500129
J	Laeger, I; Dobel, C; Radenz, B; Kugel, H; Keuper, K; Eden, A; Arolt, V; Zwitserlood, P; Dannlowski, U; Zwanzger, P				Laeger, Inga; Dobel, Christian; Radenz, Britta; Kugel, Harald; Keuper, Kati; Eden, Annuschka; Arolt, Volker; Zwitserlood, Pienie; Dannlowski, Udo; Zwanzger, Peter			Of 'Disgrace' and 'Pain' - Corticolimbic Interaction Patterns for Disorder- Relevant and Emotional Words in Social Phobia	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; GENERALIZED ANXIETY DISORDER; AMYGDALA ACTIVATION; PREFRONTAL CORTEX; BRAIN ACTIVATION; ORBITOFRONTAL CORTEX; MAJOR DEPRESSION; HEALTHY-SUBJECTS; FEARFUL FACES; TRAIT ANXIETY	Limbic hyperactivation and an impaired functional interplay between the amygdala and the prefrontal cortex are discussed to go along with, or even cause, pathological anxiety. Within the multi-faceted group of anxiety disorders, the highly prevalent social phobia (SP) is characterized by excessive fear of being negatively evaluated. Although there is widespread evidence for amygdala hypersensitivity to emotional faces in SP, verbal material has rarely been used in imaging studies, in particular with an eye on disorder-specificity. Using functional magnetic resonance imaging (fMRI) and a block design consisting of (1) overall negative, (2) social-phobia related, (3) positive, and (4) neutral words, we studied 25 female patients with social phobia and 25 healthy female control subjects (HC). Results demonstrated amygdala hyperactivation to disorder-relevant but not to generally negative words in SP patients, with a positive correlation to symptom severity. A functional connectivity analysis revealed a weaker coupling between the amygdala and the left middle frontal gyrus in patients. Symptom severity was negatively related to connectivity strength between the amygdala and the ventromedial prefrontal and orbitofrontal cortex (Brodmann Area 10 and 11). The findings clearly support the view of a hypersensitive threat-detection system, combined with disorder-related alterations in amygdala-prefrontal cortex connectivity in pathological anxiety.	[Laeger, Inga; Radenz, Britta; Arolt, Volker; Dannlowski, Udo; Zwanzger, Peter] Univ Munster, Dept Psychiat, D-48149 Munster, Germany; [Dobel, Christian; Keuper, Kati; Eden, Annuschka] Univ Munster, Inst Biomagnetism & Biosignalanal, D-48149 Munster, Germany; [Kugel, Harald] Univ Munster, Dept Clin Radiol, D-48149 Munster, Germany; [Laeger, Inga; Zwitserlood, Pienie] Univ Munster, Inst Psychol, D-48149 Munster, Germany; [Dannlowski, Udo] Univ Marburg, Dept Psychiat, Marburg, Germany; [Zwanzger, Peter] Kbo Inn Salzach Hosp, Wasserburg Am Inn, Germany	University of Munster; University of Munster; University of Munster; University of Munster; Philipps University Marburg	Zwanzger, P (corresponding author), Univ Munster, Dept Psychiat, D-48149 Munster, Germany.	peter.zwanzger@kbo.de		Kugel, Harald/0000-0002-4349-1984; Dannlowski, Udo/0000-0002-0623-3759; Roesmann (Keuper), Kati/0000-0001-6940-3551	Interdisziplinares Zentrum fur klinische Forschung (IZKF) of the Medical Faculty of Muenster University [Do3/021/10]; Deutsche Forschungsgemeinschaft; Open Access Publication Fund of the University of Munster;  [SFB TRR 58];  [C1]	Interdisziplinares Zentrum fur klinische Forschung (IZKF) of the Medical Faculty of Muenster University; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Fund of the University of Munster; ; 	This work was supported by grants of Interdisziplinares Zentrum fur klinische Forschung (IZKF) of the Medical Faculty of Muenster University (grant number Do3/021/10 to CD and PZ) and the SFB TRR 58 subproject C1 to PZ. The authors furthermore acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publication Fund of the University of Munster. The named funding sources were not involved in study design, collection, analysis or interpretation of data.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Baayen R. H, 1995, CELEX LEXICAL DATABA; Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029; Baur V, 2013, HUM BRAIN MAPP, V34, P437, DOI 10.1002/hbm.21447; Baur V, 2011, J PSYCHIATR RES, V45, P1366, DOI 10.1016/j.jpsychires.2011.05.007; Beck A.T., 1987, BECK DEPRESSION INVE; Becker ES, 2001, J ANXIETY DISORD, V15, P147, DOI 10.1016/S0887-6185(01)00055-X; Birbaumer N, 1998, NEUROREPORT, V9, P1223, DOI 10.1097/00001756-199804200-00048; Blair K, 2008, AM J PSYCHIAT, V165, P1193, DOI 10.1176/appi.ajp.2008.07071060; Blair KS, 2011, PSYCHIAT RES-NEUROIM, V193, P38, DOI 10.1016/j.pscychresns.2010.12.016; Blair KS, 2010, AM J PSYCHIAT, V167, P1526, DOI 10.1176/appi.ajp.2010.09121797; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Bruhl AB, 2011, BRAIN RES, V1378, P72, DOI 10.1016/j.brainres.2010.12.084; Cooney RE, 2006, PSYCHIAT RES-NEUROIM, V148, P55, DOI 10.1016/j.pscychresns.2006.05.003; Dannlowski U, 2007, GENES BRAIN BEHAV, V6, P672, DOI 10.1111/j.1601-183X.2006.00297.x; Dannlowski U, 2008, NEUROPSYCHOPHARMACOL, V33, P418, DOI 10.1038/sj.npp.1301411; Dannlowski U, 2010, NEUROIMAGE, V53, P893, DOI 10.1016/j.neuroimage.2009.11.073; Diemer J, 2010, EUR ARCH PSY CLIN N, V260, pS127, DOI 10.1007/s00406-010-0143-9; Ding JR, 2011, MAGN RESON IMAGING, V29, P701, DOI 10.1016/j.mri.2011.02.013; Domschke K, 2010, NEUROIMAGE, V53, P822, DOI 10.1016/j.neuroimage.2009.11.042; Etkin A, 2004, NEURON, V44, P1043, DOI 10.1016/j.neuron.2004.12.006; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fehm L, 2005, EUR NEUROPSYCHOPHARM, V15, P453, DOI 10.1016/j.euroneuro.2005.04.002; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Freitas-Ferrari MC, 2010, PROG NEURO-PSYCHOPH, V34, P565, DOI 10.1016/j.pnpbp.2010.02.028; Friston KJ, 1995, HUM BRAIN MAPP, V3, P56, DOI 10.1002/hbm.460030106; Furmark T, 2004, NEUROSCI LETT, V362, P189, DOI 10.1016/j.neulet.2004.02.070; Furmark T, 2008, J NEUROSCI, V28, P13066, DOI 10.1523/JNEUROSCI.2534-08.2008; Gentili C, 2008, BRAIN RES BULL, V77, P286, DOI 10.1016/j.brainresbull.2008.08.003; Goldin PR, 2009, BIOL PSYCHIAT, V66, P1091, DOI 10.1016/j.biopsych.2009.07.014; Goldin PR, 2009, ARCH GEN PSYCHIAT, V66, P170, DOI 10.1001/archgenpsychiatry.2008.525; Goldstein JM, 2005, J NEUROSCI, V25, P9309, DOI 10.1523/JNEUROSCI.2239-05.2005; Hahn A, 2011, NEUROIMAGE, V56, P881, DOI 10.1016/j.neuroimage.2011.02.064; Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9; Hofer A, 2007, PSYCHOL MED, V37, P109, DOI 10.1017/S0033291706008919; Kessler RC, 2003, ACTA PSYCHIAT SCAND, V108, P19, DOI 10.1034/j.1600-0447.108.s417.2.x; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Killgore WDS, 2001, NEUROREPORT, V12, P427, DOI 10.1097/00001756-200102120-00047; Kissler J, 2007, PSYCHOL SCI, V18, P475, DOI 10.1111/j.1467-9280.2007.01924.x; Koric L, 2012, HUM BRAIN MAPP, V33, P1973, DOI 10.1002/hbm.21340; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Labuschagne I, 2012, INT J NEUROPSYCHOPH, V15, P883, DOI 10.1017/S1461145711001489; Laeger I, 2012, BEHAV BRAIN RES, V233, P508, DOI 10.1016/j.bbr.2012.05.036; Lehrl S., 1995, MEHRFACHWAHL WORTSCH; Lorberbaum JP, 2004, NEUROREPORT, V15, P2701; Maidenberg E, 1996, J ANXIETY DISORD, V10, P529, DOI 10.1016/S0887-6185(96)00028-X; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mattick RP, 1998, BEHAV RES THER, V36, P455, DOI 10.1016/S0005-7967(97)10031-6; McLean CP, 2011, J PSYCHIATR RES, V45, P1027, DOI 10.1016/j.jpsychires.2011.03.006; Milad MR, 2007, ANN NY ACAD SCI, V1121, P546, DOI 10.1196/annals.1401.006; Miskovic V, 2012, NEUROSCI BIOBEHAV R, V36, P459, DOI 10.1016/j.neubiorev.2011.08.002; Monk CS, 2008, ARCH GEN PSYCHIAT, V65, P568, DOI 10.1001/archpsyc.65.5.568; Ouimet AJ, 2009, CLIN PSYCHOL REV, V29, P459, DOI 10.1016/j.cpr.2009.05.004; Pallanti S, 2008, INT J PSYCHIAT CLIN, V12, P256, DOI 10.1080/13651500802007926; Pallanti S, 2009, INT CLIN PSYCHOPHARM, V24, P163, DOI 10.1097/YIC.0b013e32832c2639; Paquette V, 2003, NEUROIMAGE, V18, P401, DOI 10.1016/S1053-8119(02)00030-7; Phan KL, 2009, BIOL PSYCHIAT, V66, P691, DOI 10.1016/j.biopsych.2009.02.028; Phan KL, 2006, BIOL PSYCHIAT, V59, P424, DOI 10.1016/j.biopsych.2005.08.012; Prater KE, 2013, DEPRESS ANXIETY, V30, P234, DOI 10.1002/da.22014; Quadflieg S, 2008, BIOL PSYCHOL, V78, P129, DOI 10.1016/j.biopsycho.2008.01.014; Quirk GJ, 2006, CURR OPIN NEUROBIOL, V16, P723, DOI 10.1016/j.conb.2006.07.004; RACZKOWSKI D, 1974, NEUROPSYCHOLOGIA, V12, P43, DOI 10.1016/0028-3932(74)90025-6; Rapee RM, 1997, BEHAV RES THER, V35, P741, DOI 10.1016/S0005-7967(97)00022-3; Schienle A, 2005, NEUROSCI LETT, V388, P1, DOI 10.1016/j.neulet.2005.06.025; Schmidt S, 2010, BIOL PSYCHOL, V84, P304, DOI 10.1016/j.biopsycho.2010.03.005; Sehlmeyer C, 2011, PSYCHOL MED, V41, P789, DOI 10.1017/S0033291710001248; Shah SG, 2009, J PSYCHIATR NEUROSCI, V34; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stein MB, 2002, ARCH GEN PSYCHIAT, V59, P1027, DOI 10.1001/archpsyc.59.11.1027; Straube T, 2004, BIOL PSYCHIAT, V56, P921, DOI 10.1016/j.biopsych.2004.09.024; Straube T, 2006, BIOL PSYCHIAT, V59, P162, DOI 10.1016/j.biopsych.2005.06.013; Straube T, 2005, NEUROPSYCHOBIOLOGY, V52, P163, DOI 10.1159/000087987; Tillfors M, 2001, AM J PSYCHIAT, V158, P1220, DOI 10.1176/appi.ajp.158.8.1220; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; Veit R, 2002, NEUROSCI LETT, V328, P233, DOI 10.1016/S0304-3940(02)00519-0; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Wittchen H.-U., 1997, SKID 1 STRUKTURIERTE; Yoon KL, 2007, PSYCHIAT RES-NEUROIM, V154, P93, DOI 10.1016/j.pscychresns.2006.05.004; Zwanzger P, 2009, J NEURAL TRANSM, V116, P767, DOI 10.1007/s00702-008-0162-0	80	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e109949	10.1371/journal.pone.0109949	http://dx.doi.org/10.1371/journal.pone.0109949			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DF	25396729	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558500006
J	Nepel, M; Voglmayr, H; Schonenberger, J; Mayer, VE				Nepel, Maximilian; Voglmayr, Hermann; Schoenenberger, Juerg; Mayer, Veronika E.			High Diversity and Low Specificity of Chaetothyrialean Fungi in Carton Galleries in a Neotropical Ant-Plant Association	PLOS ONE			English	Article							DNA; IDENTIFICATION; CONSTRUCTION; TRANSMISSION; EVOLUTION	New associations have recently been discovered between arboreal ants that live on myrmecophytic plants, and different groups of fungi. Most of the - usually undescribed - fungi cultured by the ants belong to the order Chaetothyriales (Ascomycetes). Chaetothyriales occur in the nesting spaces provided by the host plant, and form a major part of the cardboard-like material produced by the ants for constructing nests and runway galleries. Until now, the fungi have been considered specific to each ant species. We focus on the three-way association between the plant Tetrathylacium macrophyllum (Salicaceae), the ant Azteca brevis (Formicidae: Dolichoderinae) and various chaetothyrialean fungi. Azteca brevis builds extensive runway galleries along branches of T. macrophyllum. The carton of the gallery walls consists of masticated plant material densely pervaded by chaetothyrialean hyphae. In order to characterise the specificity of the ant-fungus association, fungi from the runway galleries of 19 ant colonies were grown as pure cultures and analyzed using partial SSU, complete ITS, 5.8S and partial LSU rDNA sequences. This gave 128 different fungal genotypes, 78% of which were clustered into three monophyletic groups. The most common fungus (either genotype or approximate species-level OTU) was found in the runway galleries of 63% of the investigated ant colonies. This indicates that there can be a dominant fungus but, in general, a wider guild of chaetothyrialean fungi share the same ant mutualist in Azteca brevis.	[Nepel, Maximilian; Schoenenberger, Juerg; Mayer, Veronika E.] Univ Vienna, Dept Bot & Biodivers Res, Div Struct & Funct Bot, Vienna, Austria; [Voglmayr, Hermann] Univ Vienna, Dept Bot & Biodivers Res, Div Systemat & Evolutionary Bot, Vienna, Austria; [Voglmayr, Hermann] BOKU Univ Nat Resources & Life Sci, Inst Forest Entomol Forest Pathol & Forest Protec, Vienna, Austria	University of Vienna; University of Vienna; University of Natural Resources & Life Sciences, Vienna	Mayer, VE (corresponding author), Univ Vienna, Dept Bot & Biodivers Res, Div Struct & Funct Bot, Vienna, Austria.	veronika.mayer@univie.ac.at	Schönenberger, Jürg/AAE-6479-2020; Voglmayr, Hermann/B-1484-2013; Schönenberger, Jürg/D-3413-2014	Schönenberger, Jürg/0000-0001-6791-2731; Voglmayr, Hermann/0000-0001-7666-993X; Schönenberger, Jürg/0000-0001-6791-2731; Mayer, Veronika E./0000-0001-6662-8237; Nepel, Maximilian/0000-0001-7049-0613	University of Vienna, Austria	University of Vienna, Austria	This work was supported by a University of Vienna, Austria, KWA fellowship to MN; https://international.univie.ac.at/graduate-students/kurzfristige-auslandsstipendien-kwa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanen DK, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-115; Blatrix R, 2012, P ROY SOC B-BIOL SCI, V279, P3940, DOI 10.1098/rspb.2012.1403; Cannon PF, 2007, FUNGAL FAMILIES WORL; Chomnunti P, 2012, FUNGAL DIVERS, V56, P63, DOI 10.1007/s13225-012-0197-2; de Hoog GS, 1998, MYCOSES, V41, P183, DOI 10.1111/j.1439-0507.1998.tb00321.x; Defossez E, 2009, NEW PHYTOL, V182, P942, DOI 10.1111/j.1469-8137.2009.02793.x; Dejean A, 2005, NATURE, V434, P973, DOI 10.1038/434973a; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El-Elimat T, 2013, J NAT PROD, V76, P382, DOI 10.1021/np300749w; Elliott J.S.B., 1915, T BRIT MYCOL SOC, V5, P138; Fabina NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044970; Fresenius G, 1852, BEITRAGE MYKOLOGIE, V2; Gueidan C, 2008, STUD MYCOL, P111, DOI 10.3114/sim.2008.61.11; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jaklitsch WM, 2011, MYCOLOGIA, V103, P209, DOI 10.3852/10-178; Janzen DH, 1983, COSTA RICAN NATURAL; Kaufmann E, 2006, NATURWISSENSCHAFTEN, V93, P216, DOI 10.1007/s00114-005-0081-y; Korb J, 2003, BEHAV ECOL SOCIOBIOL, V53, P65, DOI 10.1007/s00265-002-0559-y; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Lagerheim G., 1900, ENTOMOL TIDSKR, V21, P17; Longino JT, 2007, ZOOTAXA, P1; MASCHWITZ U, 1970, Z VERGL PHYSIOL, V66, P176, DOI 10.1007/BF00297777; Mayer VE, 2009, P ROY SOC B-BIOL SCI, V276, P3265, DOI 10.1098/rspb.2009.0768; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Mikheyev AS, 2007, MOL ECOL, V16, P209, DOI 10.1111/j.1365-294X.2006.03134.x; Mueller UG, 1998, SCIENCE, V281, P2034, DOI 10.1126/science.281.5385.2034; Mueller UG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012668; Nobre T, 2011, MOL ECOL, V20, P2619, DOI 10.1111/j.1365-294X.2011.05090.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ruiz-Gonzalez MX, 2011, BIOL LETTERS, V7, P475, DOI 10.1098/rsbl.2010.0920; Schlick-Steiner BC, 2008, P NATL ACAD SCI USA, V105, P940, DOI 10.1073/pnas.0708320105; Schluns H, 2009, MYRMECOL NEWS, V12, P237; Schmidt M, 2001, THESIS U VIENNA AUST; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Selbmann L, 2011, FUNGAL BIOL-UK, V115, P937, DOI 10.1016/j.funbio.2011.02.016; Seyedmousavi S, 2011, FUNGAL BIOL-UK, V115, P1030, DOI 10.1016/j.funbio.2011.06.004; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tennant LE, 1989, S INT ANTS PLANTS JU, P27; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Voglmayr H, 2012, FUNGAL DIVERS, V57, P1, DOI 10.1007/s13225-012-0175-8; Voglmayr H, 2011, FUNGAL BIOL-UK, V115, P1077, DOI 10.1016/j.funbio.2010.11.006; Weissflog A, 2001, THESIS JW GOETHE U F; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yek SH, 2012, P ROY SOC B-BIOL SCI, V279, P4215, DOI 10.1098/rspb.2012.1458; Zhao JJ, 2010, MICROB ECOL, V60, P149, DOI 10.1007/s00248-010-9651-4	49	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112756	10.1371/journal.pone.0112756	http://dx.doi.org/10.1371/journal.pone.0112756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398091	gold, Green Submitted, Green Published			2022-12-27	WOS:000345558500087
J	Van Cauwenberg, J; Van Holle, V; De Bourdeaudhuij, I; Clarys, P; Nasar, J; Salmon, J; Goubert, L; Deforche, B				Van Cauwenberg, Jelle; Van Holle, Veerle; De Bourdeaudhuij, Ilse; Clarys, Peter; Nasar, Jack; Salmon, Jo; Goubert, Liesbet; Deforche, Benedicte			Using Manipulated Photographs to Identify Features of Streetscapes That May Encourage Older Adults to Walk for Transport	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; BUILT ENVIRONMENT; NEIGHBORHOOD; OBESITY; DESIGN; HEALTH; WALKABILITY; EXERCISE; PEOPLE	Experimental evidence of environmental features important for physical activity is challenging to procure in real world settings. The current study aimed to investigate the causal effects of environmental modifications on a photographed street's appeal for older adults' walking for transport. Secondly, we examined whether these effects differed according to gender, functional limitations, and current level of walking for transport. Thirdly, we examined whether different environmental modifications interacted with each other. Qualitative responses were also reported to gain deeper insight into the observed quantitative relationships. Two sets of 16 panoramic photographs of a streetscape were created, in which six environmental factors were manipulated (sidewalk evenness, traffic level, general upkeep, vegetation, separation from traffic, and benches). Sixty older adults sorted these photographs on appeal for walking for transport on a 7-point scale and reported qualitative information on the reasons for their rankings. Sidewalk evenness appeared to have the strongest influence on a street's appeal for transport-related walking. The effect of sidewalk evenness was even stronger when the street's overall upkeep was good and when traffic was absent. Absence of traffic, presence of vegetation, and separation from traffic also increased a street's appeal for walking for transport. There were no moderating effects by gender or functional limitations. The presence of benches increased the streetscape's appeal among participants who already walked for transport at least an hour/week. The protocols and methods used in the current study carry the potential to further our understanding of environment-PA relationships. Our findings indicated sidewalk evenness as the most important environmental factor influencing a street's appeal for walking for transport among older adults. However, future research in larger samples and in real-life settings is needed to confirm current findings.	[Van Cauwenberg, Jelle; Clarys, Peter; Deforche, Benedicte] Vrije Univ Brussel, Dept Human Biometry & Biomech, Brussels, Belgium; [Van Cauwenberg, Jelle; Van Holle, Veerle; De Bourdeaudhuij, Ilse; Deforche, Benedicte] Univ Ghent, Dept Movement & Sport Sci, B-9000 Ghent, Belgium; [Van Cauwenberg, Jelle; Van Holle, Veerle] Fund Sci Res Flanders FWO, Brussels, Belgium; [Nasar, Jack] Ohio State Univ, Columbus, OH 43210 USA; [Salmon, Jo] Deakin Univ, Sch Exercise & Nutr Sci, Melbourne, Vic, Australia; [Goubert, Liesbet] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium	Vrije Universiteit Brussel; Ghent University; University System of Ohio; Ohio State University; Deakin University; Ghent University	Van Cauwenberg, J (corresponding author), Vrije Univ Brussel, Dept Human Biometry & Biomech, Brussels, Belgium.	jvcauwen@vub.ac.be	Nasar, Jack L/C-5580-2012; Goubert, Liesbet/J-9607-2012; Salmon, Jo/C-1226-2009; Salmon, Jo/X-2630-2019; De+Bourdeaudhuij, Ilse/AAC-5528-2019	Goubert, Liesbet/0000-0002-7657-5148; Salmon, Jo/0000-0002-4734-6354; Salmon, Jo/0000-0002-4734-6354; De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; Van Cauwenberg, Jelle/0000-0003-1292-6241	Research Foundation Flanders (FWO); National Health and Medical Research Council of Australia Principal Research Fellowship [APP1026216]	Research Foundation Flanders (FWO)(FWO); National Health and Medical Research Council of Australia Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	JVC and WH were supported by a Ph.D. Fellowship - Research Foundation Flanders (FWO, http://www.fwo.be/en/). JS was supported by a National Health and Medical Research Council of Australia Principal Research Fellowship (APP1026216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonzo MA, 2005, ENVIRON BEHAV, V37, P808, DOI 10.1177/0013916504274016; Aspinall P, 2010, INNOVATIVE APPROACHE, V2; Belgian Federal Government, 2013, ENQ NAAR ARB EAK ALG; Berke EM, 2007, AM J PUBLIC HEALTH, V97, P486, DOI 10.2105/AJPH.2006.085837; Bird S, 2009, J WOMEN AGING, V21, P33, DOI 10.1080/08952840802633669; Browne WJ, 2012, MCMC ESTIMATION MLWI; Brownson RC, 2009, AM J PREV MED, V36, pS99, DOI 10.1016/j.amepre.2009.01.005; Carpiano RM, 2009, HEALTH PLACE, V15, P263, DOI 10.1016/j.healthplace.2008.05.003; Van Cauwenberg J, 2011, HEALTH PLACE, V17, P458, DOI 10.1016/j.healthplace.2010.11.010; Chodzko-Zajko WJ, 2009, MED SCI SPORT EXER, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; De Fre Brenda., 2009, PARTICIPATIE VLAANDE; De Vries S., 2010, INNOVATIVE APPROACHE, V2; Ferdinand AO, 2012, AM J PUBLIC HEALTH, V102, pE7, DOI 10.2105/AJPH.2012.300740; Fielding A., 2006, 791 U BIRM; Forsyth A, 2009, TRANSPORT RES D-TR E, V14, P42, DOI 10.1016/j.trd.2008.10.003; Frank L, 2010, J PHYS ACT HEALTH, V7, pS82, DOI 10.1123/jpah.7.s1.s82; Frank LD, 2007, SOC SCI MED, V65, P1898, DOI 10.1016/j.socscimed.2007.05.053; Gallagher NA, 2010, J AGING PHYS ACTIV, V18, P99, DOI 10.1123/japa.18.1.99; Grant TL, 2010, J AGING PHYS ACTIV, V18, P293, DOI 10.1123/japa.18.3.293; Haywood KL, 2005, QUAL LIFE RES, V14, P1651, DOI 10.1007/s11136-005-1743-0; Hurtig-Wennlof A, 2010, PUBLIC HEALTH NUTR, V13, P1847, DOI 10.1017/S1368980010000157; King AC, 2011, SOC SCI MED, V73, P1525, DOI 10.1016/j.socscimed.2011.08.032; Kremers SPJ, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-9; Lenders S., 2005, DELINEATION FLEMISH; Mahmood A, 2012, SOC SCI MED, V74, P1180, DOI 10.1016/j.socscimed.2011.12.039; Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; McCormack G.R., 2011, INT J BEHAV NUTR PHY, V8; Murtagh EM, 2010, CURR OPIN CARDIOL, V25, P490, DOI 10.1097/HCO.0b013e32833ce972; Nasar JL, 2008, AM J PREV MED, V34, P357, DOI 10.1016/j.amepre.2008.01.013; Nasar JL, 2013, J PHYS ACT HEALTH, V10, P1201, DOI 10.1123/jpah.10.8.1201; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Rantakokko M, 2010, J AM GERIATR SOC, V58, P707, DOI 10.1111/j.1532-5415.2010.02792.x; Rantakokko M, 2009, J AM GERIATR SOC, V57, P634, DOI 10.1111/j.1532-5415.2009.02180.x; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Salvador EP, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-67; Spittaels H, 2009, INT J BEHAV NUTR PHY, V6; Stamps A.E., 1999, J PLAN LIT, V14, P155, DOI [DOI 10.1177/08854129922092630, 10.1177/08854129922092630]; Strath S, 2007, J AGING PHYS ACTIV, V15, P412, DOI 10.1123/japa.15.4.412; Swinburn B, 1999, PREV MED, V29, P563, DOI 10.1006/pmed.1999.0585; Tafforeau J., 2008, GEZONDHEIDSENQUETE; Thompson CW, 2013, J ENVIRON PSYCHOL, V34, P79, DOI 10.1016/j.jenvp.2013.01.003; Van Cauwenberg J, 2012, BMC PUBLIC HLTH, V12; Van Cauwenberg J, 2014, J ENVIRON PSYCHOL, V38, P94, DOI 10.1016/j.jenvp.2013.12.012; Van Cauwenberg J, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-37; Van Cauwenberg J, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-85; Wahl HW, 2004, ANNU REV GERONTOL GE, V23, P1; Ware J.E., 1994, SF 36 PHYS MENTAL HL; Wells NM, 2007, ENVIRON BEHAV, V39, P6, DOI 10.1177/0013916506295570; Wennberg H, 2009, EUR J AGEING, V6, P277, DOI 10.1007/s10433-009-0123-y; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15	50	11	11	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112107	10.1371/journal.pone.0112107	http://dx.doi.org/10.1371/journal.pone.0112107			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DF	25396732	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558500034
J	Dore, K; Labrecque, S; Tardif, C; De Koninck, P				Dore, Kim; Labrecque, Simon; Tardif, Christian; De Koninck, Paul			FRET-FLIM Investigation of PSD95-NMDA Receptor Interaction in Dendritic Spines; Control by Calpain, CaMKII and Src Family Kinase	PLOS ONE			English	Article							SYNAPTIC NMDA RECEPTORS; LONG-TERM POTENTIATION; D-ASPARTATE RECEPTORS; POSTSYNAPTIC DENSITY; HIPPOCAMPAL-NEURONS; CORTICAL-NEURONS; PSD-95 BINDING; PROTEIN PSD-95; VISUAL-CORTEX; NR2B SUBUNIT	Little is known about the changes in protein interactions inside synapses during synaptic remodeling, as their live monitoring in spines has been limited. We used a FRET-FLIM approach in developing cultured rat hippocampal neurons expressing fluorescently tagged NMDA receptor (NMDAR) and PSD95, two essential proteins in synaptic plasticity, to examine the regulation of their interaction. NMDAR stimulation caused a transient decrease in FRET between the NMDAR and PSD95 in spines of young and mature neurons. The activity of both CaMKII and calpain were essential for this effect in both developmental stages. Meanwhile, inhibition of Src family kinase (SFK) had opposing impacts on this decrease in FRET in young versus mature neurons. Our data suggest concerted roles for CaMKII, SFK and calpain activity in regulating activity-dependent separation of PSD95 from GluN2A or GluN2B. Finally, we found that calpain inhibition reduced spine growth that was caused by NMDAR activity, supporting the hypothesis that PSD95-NMDAR separation is implicated in synaptic remodeling.	[Dore, Kim; Labrecque, Simon; Tardif, Christian; De Koninck, Paul] Univ Laval, Inst Univ Sante Mentale Quebec, Quebec City, PQ, Canada; [De Koninck, Paul] Univ Laval, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada	Laval University; Laval University	De Koninck, P (corresponding author), Univ Laval, Inst Univ Sante Mentale Quebec, Quebec City, PQ, Canada.	paul.dekoninck@neurosciences.ulaval.ca	Dore, Kim/AAN-1470-2021	Dore, Kim/0000-0001-6263-367X	Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC; CIHR Neurophysics Training grant; Fond de Recherche Nature et Technologie (Quebec); NSERC CREATE Training program in biophotonics	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR Neurophysics Training grant(Canadian Institutes of Health Research (CIHR)); Fond de Recherche Nature et Technologie (Quebec); NSERC CREATE Training program in biophotonics	Research was supported by the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council of Canada (NSERC). KD was supported by a post-doctoral fellowship from NSERC and the CIHR Neurophysics Training grant. SL was supported by the CIHR Neurophysics Training grant. CT was supported by the Fond de Recherche Nature et Technologie (Quebec) and an NSERC CREATE Training program in biophotonics. PDK was a CIHR Young Investigator Awardee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Becker W, 2004, MICROSC RES TECHNIQ, V63, P58, DOI 10.1002/jemt.10421; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Broussard JA, 2013, NAT PROTOC, V8, P265, DOI 10.1038/nprot.2012.147; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Cousins SL, 2009, NEUROSCIENCE, V158, P89, DOI 10.1016/j.neuroscience.2007.12.051; Cousins SL, 2012, J BIOL CHEM, V287, P13465, DOI 10.1074/jbc.M111.292862; Crump FT, 2001, J NEUROSCI, V21, P5079, DOI 10.1523/JNEUROSCI.21-14-05079.2001; Dong YN, 2006, J NEUROCHEM, V99, P206, DOI 10.1111/j.1471-4159.2006.04096.x; Dong YN, 2004, J NEUROSCI, V24, P11035, DOI 10.1523/JNEUROSCI.3722-04.2004; Doshi Shachee, 2009, Front Biosci (Schol Ed), V1, P466, DOI 10.2741/e38; Dupuis JP, 2014, EMBO J; El Gaamouch F, 2012, J NEUROSCI, V32, P10767, DOI 10.1523/JNEUROSCI.5622-11.2012; Fan J, 2009, J NEUROSCI, V29, P10928, DOI 10.1523/JNEUROSCI.2491-09.2009; Gardoni F, 2006, EUR J NEUROSCI, V24, P2694, DOI 10.1111/j.1460-9568.2006.05140.x; Hudmon A, 2005, J NEUROSCI, V25, P6971, DOI 10.1523/JNEUROSCI.4698-04.2005; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Jourdi H, 2005, NEUROCHEM INT, V46, P31, DOI 10.1016/j.neuint.2004.07.002; Korkotian E, 2006, CELL CALCIUM, V40, P441, DOI 10.1016/j.ceca.2006.08.008; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Lemieux M, 2012, J CELL BIOL, V198, P1055, DOI 10.1083/jcb.201202058; Lin H, 2004, BIOCHEM BIOPH RES CO, V316, P501, DOI 10.1016/j.bbrc.2004.02.086; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; LYNCH G, 1987, BRAIN RES BULL, V18, P809, DOI 10.1016/0361-9230(87)90220-6; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Nault F, 2010, SPRINGER PROTOC HAND, P137, DOI 10.1007/978-1-60761-292-6_8; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Rong YQ, 2001, J NEUROCHEM, V79, P382, DOI 10.1046/j.1471-4159.2001.00565.x; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Shiraishi Y, 2003, MOL CELL NEUROSCI, V22, P188, DOI 10.1016/S1044-7431(03)00037-X; Simpkins KL, 2003, J NEUROSCI, V23, P11322; Steiner P, 2008, NEURON, V60, P788, DOI 10.1016/j.neuron.2008.10.014; Tregidgo C, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2937212; Vinade L, 2001, SYNAPSE, V40, P302, DOI 10.1002/syn.1053; Wu HV, 2006, MOL NEUROBIOL, V33, P215, DOI 10.1385/MN:33:3:215; Wu HY, 2007, J BIOL CHEM, V282, P20075, DOI 10.1074/jbc.M700624200; Wu HY, 2005, J BIOL CHEM, V280, P21588, DOI 10.1074/jbc.M501603200; Xu W, 2007, NEURON, V53, P399, DOI 10.1016/j.neuron.2006.12.020; Yang QA, 2011, BRAIN RES BULL, V84, P137, DOI 10.1016/j.brainresbull.2010.12.009; Yuen EY, 2008, MOL PHARMACOL, V74, P360, DOI 10.1124/mol.108.046813; Yuen EY, 2007, J BIOL CHEM, V282, P16434, DOI 10.1074/jbc.M701283200; Zadran S, 2010, MOL NEUROBIOL, V42, P143, DOI 10.1007/s12035-010-8145-1	46	21	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112170	10.1371/journal.pone.0112170	http://dx.doi.org/10.1371/journal.pone.0112170			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393018	Green Submitted, Green Published, gold			2022-12-27	WOS:000347709300037
J	Gao, W; Zhou, P; Ma, XC; Tschudy-Seney, B; Chen, JM; Magner, NL; Revzin, A; Nolta, JA; Zern, MA; Duan, YY				Gao, Wei; Zhou, Ping; Ma, Xiaocui; Tschudy-Seney, Benjamin; Chen, Jiamei; Magner, Nataly L.; Revzin, Alexander; Nolta, Jan A.; Zern, Mark A.; Duan, Yuyou			Ethanol Negatively Regulates Hepatic Differentiation of hESC by Inhibition of the MAPK/ERK Signaling Pathway In Vitro	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HEPATOCYTE-LIKE CELLS; EFFICIENT DIFFERENTIATION; LIVER DEVELOPMENT; PROGENITOR CELLS; ENDODERM; PANCREAS; GROWTH; SPECIFICATION; INACTIVATION	Background: Alcohol insult triggers complex events in the liver, promoting fibrogenic/inflammatory signals and in more advanced cases, aberrant matrix deposition. It is well accepted that the regenerative capacity of the adult liver is impaired during alcohol injury. The liver progenitor/stem cells have been shown to play an important role in liver regeneration -in response to various chronic injuries; however, the effects of alcohol on stem cell differentiation in the liver are not well understood. Methods: We employed hepatic progenitor cells derived from hESCs to study the impact of ethanol on hepatocyte differentiation by exposure of these progenitor cells to ethanol during hepatocyte differentiation. Results: We found that ethanol negatively regulated hepatic differentiation of hESC-derived hepatic progenitor cells in a dose-dependent manner. There was also a moderate cell cycle arrest at G1/S checkpoint in the ethanol treated cells, which is associated with a reduced level of cyclin D1 in these cells. Ethanol treatment specifically inhibited the activation of the ERK but not JNK nor the p38 MAP signaling pathway. At the same time, the WNT signaling pathway was also reduced in the cells exposed to ethanol. Upon evaluating the effects of the inhibitors of these two signaling pathways, we determined that the Erk inhibitor replicated the effects of ethanol on the hepatocyte differentiation and attenuated the WNT/beta-catenin signaling, however, inhibitors of WNT only partially replicated the effects of ethanol on the hepatocyte differentiation. Conclusion: Our results demonstrated that ethanol negatively regulated hepatic differentiation of hESC-derived hepatic progenitors through inhibiting the MAPK/ERK signaling pathway, and subsequently attenuating the WNT signaling pathway. Thus, our finding provides a novel insight into the mechanism by which alcohol regulates cell fate selection of hESC-derived hepatic progenitor cells, and the identified pathways may provide therapeutic targets aimed at promoting liver repair and regeneration during alcoholic injury.	[Gao, Wei] Hunan Univ, Coll Biol, Dept Biomed Engn, Changsha 410082, Hunan, Peoples R China; [Gao, Wei; Zhou, Ping; Ma, Xiaocui; Tschudy-Seney, Benjamin; Chen, Jiamei; Magner, Nataly L.; Nolta, Jan A.; Zern, Mark A.; Duan, Yuyou] Univ Calif Davis, Med Ctr, Dept Internal Med, Sacramento, CA 95817 USA; [Gao, Wei; Zhou, Ping; Ma, Xiaocui; Tschudy-Seney, Benjamin; Chen, Jiamei; Magner, Nataly L.; Nolta, Jan A.; Zern, Mark A.; Duan, Yuyou] Univ Calif Davis, Med Ctr, Inst Regenerat Cures, Sacramento, CA 95817 USA; [Revzin, Alexander] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Chen, Jiamei] Shanghai Univ Tradit Chinese Med, Inst Liver Dis, Shuguang Hosp, Shanghai, Peoples R China	Hunan University; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Shanghai University of Traditional Chinese Medicine	Zhou, P (corresponding author), Univ Calif Davis, Med Ctr, Dept Internal Med, Sacramento, CA 95817 USA.	ping.zhou@ucdmc.ucdavis.edu; yduan@ucdavis.edu	Duan, Yuyou/L-2301-2015	Duan, Yuyou/0000-0002-1402-7402; Nolta, Jan/0000-0003-4576-8542	National Institutes of Health (NIH) [DK075415, DK079977, DK073901]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK073901, R01DK079977, R01DK075415] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the grants from National Institutes of Health (NIH) (grant number: DK075415 to MZ, DK079977 and DK073901 to AR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI Y, 1994, HEPATOLOGY, V20, P453, DOI 10.1002/hep.1840200227; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Calmont A, 2006, DEV CELL, V11, P339, DOI 10.1016/j.devcel.2006.06.015; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Crosby HA, 1998, AM J PATHOL, V152, P771; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Deutsch G, 2001, DEVELOPMENT, V128, P871; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Duan YY, 2007, STEM CELLS, V25, P3058, DOI 10.1634/stemcells.2007-0291; Duan YY, 2010, STEM CELLS, V28, P674, DOI 10.1002/stem.315; Goessling W, 2008, DEV BIOL, V320, P161, DOI 10.1016/j.ydbio.2008.05.526; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; Hoek JB, 2002, ALCOHOL, V27, P63, DOI 10.1016/S0741-8329(02)00215-X; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Kubota H, 2000, P NATL ACAD SCI USA, V97, P12132, DOI 10.1073/pnas.97.22.12132; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Li J, 2010, CELL PROLIFERAT, V43, P333, DOI 10.1111/j.1365-2184.2010.00682.x; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Lu T, 2014, GENET MOL RES, V13, P415, DOI 10.4238/2014.January.21.9; Magner NL, 2013, STEM CELLS, V31, P2095, DOI 10.1002/stem.1478; McCoy JP, 2002, CLIN LAB MED, P1403; Mclin VA, 2007, DEVELOPMENT, V134, P2207, DOI 10.1242/dev.001230; Monga SPS, 2003, GASTROENTEROLOGY, V124, P202, DOI 10.1053/gast.2003.50000; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nagy LE, 2004, ANNU REV NUTR, V24, P55, DOI 10.1146/annurev.nutr.24.012003.132258; Neuman MG, 2003, ALCOHOL RES HEALTH, V27, P307; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Pal R, 2012, J CELL BIOCHEM, V113, P19, DOI 10.1002/jcb.23391; Peng SL, 2009, CELL PHYSIOL BIOCHEM, V23, P165, DOI 10.1159/000204105; Rossi JM, 2001, GENE DEV, V15, P1998, DOI 10.1101/gad.904601; Schmelzer E, 2007, J EXP MED, V204, P1973, DOI 10.1084/jem.20061603; Shin D, 2007, DEVELOPMENT, V134, P2041, DOI 10.1242/dev.000281; Shirahashi H, 2004, CELL TRANSPLANT, V13, P197, DOI 10.3727/000000004783984016; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Tan JY, 2002, LIVER, V22, P365, DOI 10.1034/j.1600-0676.2002.01622.x; Tilg H, 2000, NEW ENGL J MED, V343, P1467, DOI 10.1056/NEJM200011163432007; VandeVoort CA, 2011, ALCOHOL CLIN EXP RES, V35, P1534, DOI 10.1111/j.1530-0277.2011.01490.x; Wells JM, 2000, DEVELOPMENT, V127, P1563; Wheeler MD, 2003, ALCOHOL RES HEALTH, V27, P300; Williams JM, 2010, AM J PATHOL, V176, P2732, DOI 10.2353/ajpath.2010.080486; Yun MS, 2005, J CELL SCI, V118, P313, DOI 10.1242/jcs.01601; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318; Zhang AB, 2010, J CELL BIOCHEM, V111, P469, DOI 10.1002/jcb.22729; Zhang LL, 2008, HEPATOLOGY, V48, P1598, DOI 10.1002/hep.22516	53	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112698	10.1371/journal.pone.0112698	http://dx.doi.org/10.1371/journal.pone.0112698			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393427	gold, Green Submitted, Green Published			2022-12-27	WOS:000347709300087
J	Huang, XN; Shi, XL; Kotov, AA; Gu, FK				Huang, Xiaona; Shi, Xinlu; Kotov, Alexey A.; Gu, Fukang			Confirmation through Genetic Analysis of the Existence of Many Local Phyloclades of the Genus Simocephalus (Crustacea, Cladocera) in China	PLOS ONE			English	Article							BIOLOGICAL IDENTIFICATIONS; DAPHNIA; BIOGEOGRAPHY; CHYDORIDAE; ANOMOPODA	Previously, a series of Simocephalus taxa (Cladocera: Daphniidae) from China were described. Most were proposed to be junior synonyms in the last revision of the genus. Using original material from China and data from GenBank, we investigate the biodiversity and phylogeny of Simocephalus using sequences of the cytochrome c oxidase subunit I (COI) and the nuclear 18S genes. In both cases, neighbor-joining, maximum likelihood and Bayesian inference analyses led to highly congruent tree topologies. The grouping of the deeper clades agrees with the inter-generic classification of Orlova-Bienkowskaja (2001). Only the populations of S. serrulatus from Eurasia and North America seem to be closely related, and there are no other shared species between the two continents. Our study unambiguously confirms the existence of many lineages from the subgenera of Simocephalus (Echinocaudus) and Simocephalus s.str. in China, but their morphology needs to be reexamined by taking a wider range of characters (e.g., of female thoracic limbs and adult males) into consideration.	[Huang, Xiaona; Gu, Fukang] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Huang, Xiaona; Shi, Xinlu] Hangzhou Normal Univ, Hangzhou Key Lab Anim Adaptat & Evolut, Hangzhou, Zhejiang, Peoples R China; [Kotov, Alexey A.] AN Severtsov Inst Ecol & Evolut, Moscow, Russia	East China Normal University; Hangzhou Normal University; Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution	Huang, XN (corresponding author), E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China.	nxxiaona@163.com	Kotov, Alexey A./B-1549-2010	Kotov, Alexey A./0000-0002-8863-6438	National Natural Science Foundation of China [31071880, 31272262]; Zhejiang Provincial Natural Science Foundation; Zhejiang Key Scientific & Technological Innovation Team Project [2010R50039-20]; Hangzhou Key Laboratory for Animal Adaptation and Evolution [20100333T05]; Russian foundation for Basic research [12-04-00207-a, 14-04-01149-a]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Zhejiang Key Scientific & Technological Innovation Team Project; Hangzhou Key Laboratory for Animal Adaptation and Evolution; Russian foundation for Basic research(Russian Foundation for Basic Research (RFBR))	The reagents, materials and analysis tools of this study was partly supported by the National Natural Science Foundation of China (Grant Nos. 31071880 and 31272262), Zhejiang Provincial Natural Science Foundation and Zhejiang Key Scientific & Technological Innovation Team Project (Grant Nos. 2010R50039-20), and Hangzhou Key Laboratory for Animal Adaptation and Evolution (Grant No. 20100333T05) and part of analysis tools of this study was partly supported by Russian foundation for Basic research (grants 12-04-00207-a and 14-04-01149-a). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowicz SJ, 2009, MOL PHYLOGENET EVOL, V50, P423, DOI 10.1016/j.ympev.2008.11.026; Bekker EI, 2012, ZOOTAXA, P1; Belyaeva M, 2009, MOL PHYLOGENET EVOL, V50, P534, DOI 10.1016/j.ympev.2008.11.007; Chen SZ, 1992, J HARBIN NORMAL U NA, V8, P91; Chiang XZ, 1974, SCI SURVEY REPORTS B, P127; Chiang XZ, 1979, FAUNA SINICA FRESHWA, P124; Connelly SJ, 2009, INTEGR COMP BIOL, V49, pE35; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Dumont H.J., 2002, GUIDES IDENTIFICATIO, V19, P1; Elias-Gutierrez M, 2008, ZOOTAXA, P1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Forro L, 2008, HYDROBIOLOGIA, V595, P177, DOI 10.1007/s10750-007-9013-5; FREY DG, 1987, HYDROBIOLOGIA, V145, P5, DOI 10.1007/BF02530260; FREY DG, 1982, ARCH HYDROBIOL, V93, P484; FREY DG, 1993, HYDROBIOLOGIA, V262, P145, DOI 10.1007/BF00010882; FRYER G, 1991, ZOOL J LINN SOC-LOND, V102, P163, DOI 10.1111/j.1096-3642.1991.tb00287.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hann BJ, 2003, J PALEOLIMNOL, V29, P135; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Huelsenbeck JP, 2001, SYST BIOL, V50, P351, DOI 10.1080/106351501300317978; Jeffery NW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018364; Jermakov NW, 1924, RABOTI VOLZHSKOJ BIO, V7, P151; Kohout J, 2014, BIOLOGIA, V69, P76, DOI 10.2478/s11756-013-0285-0; Kotov AA, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-129; Martinez-Jeronimo F, 2008, ECOTOX ENVIRON SAFE, V71, P26, DOI 10.1016/j.ecoenv.2008.05.005; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Nogueira PFM, 2005, FRESHWATER BIOL, V50, P1560, DOI 10.1111/j.1365-2427.2005.01406.x; Orlova-Bienkowskaja MY, 2001, CLADOCERA ANOMOPODA, P1; Penton EH, 2004, MOL ECOL, V13, P97, DOI 10.1046/j.1365-294X.2003.02024.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prosser S, 2013, MOL ECOL RESOUR, V13, P1151, DOI 10.1111/1755-0998.12132; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sacherova V, 2003, BIOL J LINN SOC, V79, P629, DOI 10.1046/j.1095-8312.2003.00216.x; Shi Xin-lu, 1996, Acta Zootaxonomica Sinica, V21, P263; Shi XL, 2011, CHIN J OCEANOL LIMN, V29, P206, DOI 10.1007/s00343-011-0010-1; Shi XL, 1994, ACTA ZOOTAXONOMICA S, V19, P403; Smirnov NN, 1996, GUIDES IDENTIFICATIO, V11, P1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor DJ, 1998, EVOLUTION, V52, P1648, DOI 10.1111/j.1558-5646.1998.tb02245.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Xu S, 2009, MOL ECOL, V18, P5161, DOI 10.1111/j.1365-294X.2009.04422.x; Xu You-qin, 2002, Journal of Fujian Teachers University Natural Science, V18, P66; Yi ZZ, 2009, ZOOL SCR, V38, P323, DOI 10.1111/j.1463-6409.2008.00371.x; Young SS, 2012, ZOOL STUD, V51, P222	44	12	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112808	10.1371/journal.pone.0112808	http://dx.doi.org/10.1371/journal.pone.0112808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393020	gold, Green Published, Green Submitted			2022-12-27	WOS:000347709300109
J	Kok, G; van Rijsbergen, G; Burger, H; Elgersma, H; Riper, H; Cuijpers, P; Dekker, J; Smit, F; Bockting, C				Kok, Gemma; van Rijsbergen, Gerard; Burger, Huibert; Elgersma, Hermien; Riper, Heleen; Cuijpers, Pim; Dekker, Jack; Smit, Filip; Bockting, Claudi			The Scars of Childhood Adversity: Minor Stress Sensitivity and Depressive Symptoms in Remitted Recurrently Depressed Adult Patients	PLOS ONE			English	Article							LIFE EVENTS; MAJOR DEPRESSION; PSYCHIATRIC-DISORDER; PREDICT RECURRENCE; GENERATION; RISK; EPISODES; TRAUMA; MALTREATMENT; PERSPECTIVE	Background: Childhood adversity may lead to depressive relapse through its long-lasting influence on stress sensitivity. In line with the stress sensitization hypothesis, minor (daily) stress is associated with depressive relapse. Therefore, we examine the impact of childhood adversity on daily stress and its predictive value on prospectively assessed depressive symptoms in recurrently depressed patients. Method: Daily stress was assessed in recurrently depressed adult patients, enrolled into two randomized trials while remitted. The reported intensity and frequency of dependent and independent daily stress was assessed at baseline. Independent stress is externally generated, for example an accident happening to a friend, while dependent stress is internally generated, for example getting into a fight with a neighbor. Hierarchical regression analyses were performed with childhood adversity, independent and dependent daily stress as predictor variables of prospectively measured depressive symptoms after three months of follow-up (n = 138). Results: We found that childhood adversity was not significantly associated with a higher frequency and intensity of daily stress. The intensity of both independent and dependent daily stress was predictive of depressive symptom levels at follow-up (unadjusted models respectively: B = 0.47, t = 2.05, p = 0.041, 95% CI = 0.02-0.92; B = 0.29, t = 2.20, p = 0.028, 95% CI = 0.03-0.55). No associations were found between childhood adversity and depressive symptoms at follow-up. Conclusion: No evidence was found supporting stress sensitization due to the experience of childhood adversity in this recurrently depressed but remitted patient group. Nevertheless, our research indicates that daily stress might be a target for preventive treatment.	[Kok, Gemma; van Rijsbergen, Gerard; Elgersma, Hermien; Bockting, Claudi] Univ Groningen, Dept Clin Psychol, Groningen, Netherlands; [Burger, Huibert] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands; [Burger, Huibert] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychiat Epidemiol, Groningen, Netherlands; [Riper, Heleen; Cuijpers, Pim; Smit, Filip] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [Riper, Heleen; Cuijpers, Pim; Smit, Filip] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Riper, Heleen; Cuijpers, Pim; Smit, Filip] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [Riper, Heleen; Cuijpers, Pim] Leuphana Univ, Luneburg, Germany; [Dekker, Jack] Arkin Mental Hlth Inst, Res Dept, Amsterdam, Netherlands; [Dekker, Jack] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [Smit, Filip] Vrije Univ Amsterdam, Dept Epidemiol & Biostat, EMGO Inst Hlth & Care Res, Med Ctr, Amsterdam, Netherlands; [Smit, Filip] Netherlands Inst Mental Hlth & Addict, Trimbos Inst, Utrecht, Netherlands	University of Groningen; University of Groningen; University of Groningen; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Leuphana University Luneburg; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Trimbos Institute	Bockting, C (corresponding author), Univ Groningen, Dept Clin Psychol, Groningen, Netherlands.	C.L.H.Bockting@uu.nl	Cuijpers, Pim/G-1703-2013; Bockting, Claudi L/K-3768-2019	Bockting, Claudi L/0000-0002-9220-9244; Cuijpers, Pim/0000-0001-5497-2743	ZonMW: The Netherlands association for health research and development; ZonMW Doelmatigheid, Kosten en Effecten [171002401]; ZonMW OOG Geestkracht grant [100002035]; ZonMW Disease management Chronische Ziekten grant [300020014]	ZonMW: The Netherlands association for health research and development; ZonMW Doelmatigheid, Kosten en Effecten; ZonMW OOG Geestkracht grant; ZonMW Disease management Chronische Ziekten grant	This research is funded by ZonMW: The Netherlands association for health research and development. ZonMW Doelmatigheid, Kosten en Effecten grant number 171002401 (to Prof. dr. C. L. H. Bockting), ZonMW OOG Geestkracht grant number 100002035 (to Drs. H.J. Elgersma and Prof. dr. C. L. H. Bockting) and ZonMW Disease management Chronische Ziekten grant number 300020014 (to Prof. dr. C. L. H. Bockting). Funding sources did not play any role in the collection, analysis, and interpretation of the data; writing the manuscript or the decision to submit for publication.	ABRAMSON LY, 1989, PSYCHOL REV, V96, P358, DOI 10.1037/0033-295X.96.2.358; ABRAMSON LY, 1978, J ABNORM PSYCHOL, V87, P49, DOI 10.1037/0021-843X.87.1.49; Alloy LB, 2010, INT J COGN THER, V3, P380, DOI 10.1521/ijct.2010.3.4.380; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 1985, Am J Psychiatry, V142, P469; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beck A.T., 1987, J COGNITIVE PSYCHOTH, V1, P5; Beck A.T., 1967, DEPRESSION CLIN EXPT; BLEULER M, 1963, P ROY SOC MED, V56, P945, DOI 10.1177/003591576305601048; Bockting CL, 2011, BMC PSYCHIAT, V11, P12, DOI 10.1186/1471-244X-11-12; Bockting CLH, 2006, PSYCHOTHER PSYCHOSOM, V75, P229, DOI 10.1159/000092893; Bockting CLH, 2012, PSYCHIAT RES, V200, P281, DOI 10.1016/j.psychres.2012.03.044; BROWN GW, 1994, BRIT J PSYCHIAT, V165, P447, DOI 10.1192/bjp.165.4.447; Burcusa SL, 2007, CLIN PSYCHOL REV, V27, P959, DOI 10.1016/j.cpr.2007.02.005; Collishaw S, 2007, CHILD ABUSE NEGLECT, V31, P211, DOI 10.1016/j.chiabu.2007.02.004; Comijs HC, 2007, J AFFECT DISORDERS, V103, P243, DOI 10.1016/j.jad.2007.01.012; First MB, 2001, STRUCTURAL CLIN INTE; Glaser JP, 2006, J PSYCHOSOM RES, V61, P229, DOI 10.1016/j.jpsychores.2006.04.014; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMMEN C, 1991, J ABNORM PSYCHOL, V100, P555, DOI 10.1037/0021-843X.100.4.555; Hammen C, 2006, J CLIN PSYCHOL, V62, P1065, DOI 10.1002/jclp.20293; Hardeveld F, 2013, PSYCHOL MED, V43, P39, DOI 10.1017/S0033291712002395; Harkness KL, 2006, J ABNORM PSYCHOL, V115, P730, DOI 10.1037/0021-843X.115.4.730; Harkness KL, 2012, J CONSULT CLIN PSYCH, V80, P342, DOI 10.1037/a0027665; Hollon SD, 2006, ANNU REV PSYCHOL, V57, P285, DOI 10.1146/annurev.psych.57.102904.190044; Hovens JGFM, 2010, ACTA PSYCHIAT SCAND, V122, P66, DOI 10.1111/j.1600-0447.2009.01491.x; Kendler KS, 2001, AM J PSYCHIAT, V158, P582, DOI 10.1176/appi.ajp.158.4.582; Kessing LV, 2004, ACTA PSYCHIAT SCAND, V109, P339, DOI 10.1046/j.1600-0447.2003.00266.x; Kessler RC, 1997, PSYCHOL MED, V27, P1101, DOI 10.1017/S0033291797005588; Klein DN, 2009, DEPRESS ANXIETY, V26, P701, DOI 10.1002/da.20577; Kraaij V, 2001, AGING MENT HEALTH, V5, P84, DOI 10.1080/13607860020020681; LaNoue M, 2012, COMMUNITY MENT HLT J, V48, P187, DOI 10.1007/s10597-010-9369-2; Liu RT, 2013, PSYCHIAT RES, V206, P217, DOI 10.1016/j.psychres.2012.12.001; Liu RT, 2010, CLIN PSYCHOL REV, V30, P582, DOI 10.1016/j.cpr.2010.04.010; Lizardi H, 2005, J NERV MENT DIS, V193, P183, DOI 10.1097/01.nmd.0000154838.16100.36; Mazure CM, 1998, CLIN PSYCHOL-SCI PR, V5, P291, DOI 10.1111/j.1468-2850.1998.tb00151.x; McLaughlin KA, 2010, PSYCHOL MED, V40, P1647, DOI 10.1017/S0033291709992121; Monroe SM, 2006, J CONSULT CLIN PSYCH, V74, P112, DOI 10.1037/0022-006X.74.1.112; Monroe SM, 2005, PSYCHOL REV, V112, P417, DOI 10.1037/0033-295X.112.2.417; Monroe SM, 1996, J ABNORM PSYCHOL, V105, P313, DOI 10.1037/0021-843X.105.3.313; Nanni V, 2012, AM J PSYCHIAT, V169, P141, DOI 10.1176/appi.ajp.2011.11020335; Nemeroff CB, 2003, P NATL ACAD SCI USA, V100, P14293, DOI 10.1073/pnas.2336126100; Ormel J, 2001, AM J PSYCHIAT, V158, P885, DOI 10.1176/appi.ajp.158.6.885; POST RM, 1992, AM J PSYCHIAT, V149, P999; Ritchie K, 2009, J CLIN PSYCHIAT, V70, P1281, DOI 10.4088/JCP.08m04510; Rosenthal D, 1963, SUGGESTED CONCEPTUAL, P505; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Rubin DB, 2004, MULTIPLE IMPUTATION; RUSH AJ, 1986, PSYCHIAT RES, V18, P65; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schulte-van Maaren YWM, 2013, J AFFECT DISORDERS, V149, P342, DOI 10.1016/j.jad.2013.02.009; Solomon DA, 2000, AM J PSYCHIAT, V157, P229, DOI 10.1176/appi.ajp.157.2.229; Spinhoven P, 2010, J AFFECT DISORDERS, V126, P103, DOI 10.1016/j.jad.2010.02.132; Suija K, 2011, FAM PRACT, V28, P22, DOI 10.1093/fampra/cmq076; ten Doesschate MC, 2010, J CLIN PSYCHIAT, V71, P984, DOI 10.4088/JCP.08m04858blu; Tyrka AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030148; VINGERHOETS AJJ, 1994, EVERYDAY PROBLEM CHE; Wainwright NWJ, 2002, J AFFECT DISORDERS, V72, P33, DOI 10.1016/S0165-0327(01)00420-7; Wichers M, 2009, PSYCHOL MED, V39, P1077, DOI 10.1017/S0033291708004388; Wiersma JE, 2009, J CLIN PSYCHIAT, V70, P983, DOI 10.4088/JCP.08m04521; ZUBIN J, 1977, J ABNORM PSYCHOL, V86, P103, DOI 10.1037/0021-843X.86.2.103	61	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e111711	10.1371/journal.pone.0111711	http://dx.doi.org/10.1371/journal.pone.0111711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY6YT	25393812	Green Published, gold, Green Submitted			2022-12-27	WOS:000347709300019
J	Reed, SM; Hagen, J; Muniz, VP; Rosean, TR; Borcherding, N; Sciegienka, S; Goeken, JA; Naumann, PW; Zhang, WZ; Tompkins, VS; Janz, S; Meyerholz, DK; Quelle, DE				Reed, Sara M.; Hagen, Jussara; Muniz, Viviane P.; Rosean, Timothy R.; Borcherding, Nick; Sciegienka, Sebastian; Goeken, J. Adam; Naumann, Paul W.; Zhang, Weizhou; Tompkins, Van S.; Janz, Siegfried; Meyerholz, David K.; Quelle, Dawn E.			NIAM-Deficient Mice Are Predisposed to the Development of Proliferative Lesions including B-Cell Lymphomas	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; MYC-INDUCED LYMPHOMAGENESIS; TUMOR SUPPRESSION; NUCLEAR INTERACTOR; TGF-BETA; CANCER PROGRESSION; HODGKIN LYMPHOMA; BREAST-CANCER; P53; MDM2	Nuclear Interactor of ARF and Mdm2 (NIAM, gene designation Tbrg1) is a largely unstudied inhibitor of cell proliferation that helps maintain chromosomal stability. It is a novel activator of the ARF-Mdm2-Tip60-p53 tumor suppressor pathway as well as other undefined pathways important for genome maintenance. To examine its predicted role as a tumor suppressor, we generated NIAM mutant (NIAM(m/m)) mice homozygous for a beta-galactosidase expressing gene-trap cassette in the endogenous gene. The mutant mice expressed significantly lower levels of NIAM protein in tissues compared to wild-type animals. Fifty percent of aged NIAM deficient mice (14 to 21 months) developed proliferative lesions, including a uterine hemangioma, pulmonary papillary adenoma, and a Harderian gland adenoma. No age-matched wild-type or NIAM(+/m) heterozygous animals developed lesions. In the spleen, NIAM(m/m) mice had prominent white pulp expansion which correlated with enhanced increased reactive lymphoid hyperplasia and evidence of systemic inflammation. Notably, 17% of NIAM mutant mice had splenic white pulp features indicating early B-cell lymphoma. This correlated with selective expansion of marginal zone B cells in the spleens of younger, tumor-free NIAM-deficient mice. Unexpectedly, basal p53 expression and activity was largely unaffected by NIAM loss in isolated splenic B cells. In sum, NIAM down-regulation in vivo results in a significant predisposition to developing benign tumors or early stage cancers. These mice represent an outstanding platform for dissecting NIAM's role in tumorigenesis and various anti-cancer pathways, including p53 signaling.	[Reed, Sara M.; Hagen, Jussara; Muniz, Viviane P.; Sciegienka, Sebastian; Quelle, Dawn E.] Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA; [Reed, Sara M.; Quelle, Dawn E.] Univ Iowa, Med Scientist Training Program, Iowa City, IA USA; [Muniz, Viviane P.; Quelle, Dawn E.] Univ Iowa, Mol & Cellular Biol Program, Iowa City, IA USA; [Rosean, Timothy R.; Zhang, Weizhou; Janz, Siegfried] Univ Iowa, Interdisciplinary Program Immunol, Iowa City, IA USA; [Borcherding, Nick; Goeken, J. Adam; Naumann, Paul W.; Zhang, Weizhou; Tompkins, Van S.; Janz, Siegfried; Meyerholz, David K.; Quelle, Dawn E.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Quelle, DE (corresponding author), Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA.	dawn-quelle@uiowa.edu	Tompkins, Van/A-5757-2018; Meyerholz, David/J-8131-2019	Tompkins, Van/0000-0003-1279-8075; Meyerholz, David/0000-0003-1552-3253; Quelle, Dawn/0000-0001-8776-0122; Borcherding, Nicholas/0000-0003-1427-6342	NIH [5F30CA165736, 5T32AI007485]; NCI, University of Iowa Holden Comprehensive Cancer Center [P30CA086862, R01CA151354]; Oberley Award through the Holden Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [F30CA165736, P30CA086862, R01CA151354] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067795, T32GM007337] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, University of Iowa Holden Comprehensive Cancer Center; Oberley Award through the Holden Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH through a pre-doctoral fellowship 5F30CA165736 (S.M.R.), pre-doctoral training grant 5T32AI007485 (T.R.R.), NCI Core Grant P30CA086862 in support of the University of Iowa Holden Comprehensive Cancer Center, and R01CA151354 (S.J.), as well as an Oberley Award through the Holden Comprehensive Cancer Center (S.J. and D.E.Q). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alt JR, 2003, EMBO J, V22, P1442, DOI 10.1093/emboj/cdg133; BABALOLA GO, 1995, MOL REPROD DEV, V41, P133, DOI 10.1002/mrd.1080410203; Blum JL, 2011, BREAST CANCER RES TR, V125, P431, DOI 10.1007/s10549-010-1222-3; Bredel M, 2005, CANCER RES, V65, P8679, DOI 10.1158/0008-5472.CAN-05-1204; Brune V, 2008, J EXP MED, V205, P2251, DOI 10.1084/jem.20080809; Carter JH, 2003, ENVIRON HEALTH PERSP, V111, P53, DOI 10.1289/ehp.5442; Cerutti A, 2013, NAT REV IMMUNOL, V13, P118, DOI 10.1038/nri3383; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Chiang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049305; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Eckerle S, 2009, LEUKEMIA, V23, P2129, DOI 10.1038/leu.2009.161; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; French PJ, 2005, CANCER RES, V65, P11335, DOI 10.1158/0008-5472.CAN-05-1886; Garcia PB, 2014, SEMINARS CELL DEV BI; Gerondakis S, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000182; Ghobrial IM, 2005, BLOOD, V105, P3722, DOI 10.1182/blood-2004-10-3999; Gostissa M, 2013, P NATL ACAD SCI USA, V110, P2934, DOI 10.1073/pnas.1222570110; Hagen J, 2008, HYBRIDOMA, V27, P159, DOI 10.1089/hyb.2007.0533; Hoenerhoff MJ, 2006, VET PATHOL, V43, P682, DOI 10.1354/vp.43-5-682; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Jiang DD, 2013, CELL RES, V23, P739, DOI 10.1038/cr.2013.34; Kamijo T, 1999, CANCER RES, V59, P2217; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Legube G, 2004, J BIOL CHEM, V279, P44825, DOI 10.1074/jbc.M407478200; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Liu Q, 2009, AM J PATHOL, V174, P153, DOI 10.2353/ajpath.2009.080555; Llanos S, 2001, NAT CELL BIOL, V3, P445, DOI 10.1038/35074506; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Martin-Caballero J, 2001, CANCER RES, V61, P6234; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Momand J, 2000, GENE, V242, P15, DOI 10.1016/S0378-1119(99)00487-4; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Percy DH, 2007, PATHOLOGY LAB RODENT, P90; Reed SM, 2014, CELL CYCLE, V13, P1288, DOI 10.4161/cc.28202; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Senturk Emir, 2012, Genes Cancer, V3, P192, DOI 10.1177/1947601912457368; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Storz MN, 2003, J INVEST DERMATOL, V120, P865, DOI 10.1046/j.1523-1747.2003.12142.x; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Tompkins V, 2006, CELL CYCLE, V5, P641; Tompkins VS, 2007, J BIOL CHEM, V282, P1322, DOI 10.1074/jbc.M609612200; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang P, 2006, ONCOGENE, V25, P3708, DOI 10.1038/sj.onc.1209411; Ward JM, 2012, TOXICOL PATHOL, V40, P425, DOI 10.1177/0192623311431467; Watanabe T, 1996, LEUKEMIA LYMPHOMA, V21, P391, DOI 10.3109/10428199609093436; Wilda M, 2004, LEUKEMIA, V18, P584, DOI 10.1038/sj.leu.2403254; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yu H, 2006, BLOOD, V107, P1200, DOI 10.1182/blood-2005-02-0685; Zhao HJ, 2004, MOL BIOL CELL, V15, P2523, DOI 10.1091/mbc.E03-11-0786	72	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112126	10.1371/journal.pone.0112126	http://dx.doi.org/10.1371/journal.pone.0112126			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393878	Green Submitted, gold, Green Published			2022-12-27	WOS:000347709300033
J	Roeske, TC; Scharff, C; Olson, CR; Nshdejan, A; Mello, CV				Roeske, Tina C.; Scharff, Constance; Olson, Christopher R.; Nshdejan, Arpik; Mello, Claudio V.			Long-Distance Retinoid Signaling in the Zebra Finch Brain	PLOS ONE			English	Article							X-RECEPTOR-GAMMA; PROTEIN-KINASE-C; HOMEOSTATIC SYNAPTIC PLASTICITY; RELATIONAL MEMORY DEFICIT; AVIAN FOREBRAIN NUCLEUS; VITAMIN-A-DEFICIENCY; BASAL GANGLIA; GENE-EXPRESSION; RAR-ALPHA; ADULT NEUROGENESIS	All-trans retinoic acid (ATRA), the main active metabolite of vitamin A, is a powerful signaling molecule that regulates large-scale morphogenetic processes during vertebrate embryonic development, but is also involved post-natally in regulating neural plasticity and cognition. In songbirds, it plays an important role in the maturation of learned song. The distribution of the ATRA-synthesizing enzyme, zRalDH, and of ATRA receptors (RARs) have been described, but information on the distribution of other components of the retinoid signaling pathway is still lacking. To address this gap, we have determined the expression patterns of two obligatory RAR co-receptors, the retinoid X receptors (RXR) alpha and gamma, and of the three ATRA-degrading cytochromes CYP26A1, CYP26B1, and CYP26C1. We have also studied the distribution of zRalDH protein using immunohistochemistry, and generated a refined map of ATRA localization, using a modified reporter cell assay to examine entire brain sections. Our results show that (1) ATRA is more broadly distributed in the brain than previously predicted by the spatially restricted distribution of zRalDH transcripts. This could be due to long-range transport of zRalDH enzyme between different nuclei of the song system: Experimental lesions of putative zRalDH peptide source regions diminish ATRA-induced transcription in target regions. (2) Four telencephalic song nuclei express different and specific subsets of retinoid-related receptors and could be targets of retinoid regulation; in the case of the lateral magnocellular nucleus of the anterior nidopallium (lMAN), receptor expression is dynamically regulated in a circadian and age-dependent manner. (3) High-order auditory areas exhibit a complex distribution of transcripts representing ATRA synthesizing and degrading enzymes and could also be a target of retinoid signaling. Together, our survey across multiple connected song nuclei and auditory brain regions underscores the prominent role of retinoid signaling in modulating the circuitry that underlies the acquisition and production of learned vocalizations.	[Roeske, Tina C.] CUNY, Hunter Coll, Dept Psychol, New York, NY 10065 USA; [Scharff, Constance; Nshdejan, Arpik] Free Univ Berlin, Dept Anim Behav, Berlin, Germany; [Olson, Christopher R.; Mello, Claudio V.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA	City University of New York (CUNY) System; Hunter College (CUNY); Free University of Berlin; Oregon Health & Science University	Roeske, TC (corresponding author), CUNY, Hunter Coll, Dept Psychol, New York, NY 10065 USA.	christina.roeske@gmail.com	olson, Christopher/ABC-3812-2020; Scharff, Constance/HHN-0673-2022	olson, Christopher/0000-0002-8351-0633; Mello, Claudio/0000-0002-9826-8421	NIGMS NIH HHS [R24 GM092842] Funding Source: Medline; NINDS NIH HHS [F32 NS062609] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM092842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS062609] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKUTAGAWA E, 1994, P NATL ACAD SCI USA, V91, P12413, DOI 10.1073/pnas.91.26.12413; Andalman AS, 2009, P NATL ACAD SCI USA, V106, P12518, DOI 10.1073/pnas.0903214106; Aoto J, 2008, NEURON, V60, P308, DOI 10.1016/j.neuron.2008.08.012; Aronov D, 2008, SCIENCE, V320, P630, DOI 10.1126/science.1155140; Aronov D, 2011, J NEUROSCI, V31, P16353, DOI 10.1523/JNEUROSCI.3009-11.2011; Aulehla A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000869; BAHN S, 1994, J NEUROSCI, V14, P5525; Bonnet E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003487; Chambon Pierre, 1994, Seminars in Cell Biology, V5, P115, DOI 10.1006/scel.1994.1015; Charlesworth JD, 2012, NATURE, V486, P251, DOI 10.1038/nature11078; Chen L.W., 2012, NEUROPHARMACOLOGY; Chen N, 2008, J BIOL CHEM, V283, P20841, DOI 10.1074/jbc.M802314200; Chen N, 2008, FASEB J, V22, P236, DOI 10.1096/fj.07-8739com; Chiang MY, 1998, NEURON, V21, P1353, DOI 10.1016/S0896-6273(00)80654-6; Cocco S, 2002, NEUROSCIENCE, V115, P475, DOI 10.1016/S0306-4522(02)00423-2; Cossette SMM, 2004, DIFFERENTIATION, V72, P239, DOI 10.1111/j.1432-0436.2004.07205006.x; Crandall J, 2004, P NATL ACAD SCI USA, V101, P5111, DOI 10.1073/pnas.0306336101; Denisenko-Nehrbass NI, 2001, MOL BRAIN RES, V87, P246, DOI 10.1016/S0169-328X(01)00002-X; Denisenko-Nehrbass NI, 2000, NEURON, V27, P359, DOI 10.1016/S0896-6273(00)00043-X; Deregnaucourt S, 2005, NATURE, V433, P710, DOI 10.1038/nature03275; Dopheide MM, 2008, PHARM BIOCH BEHAV; Dutar P, 1998, J NEUROPHYSIOL, V80, P1828, DOI 10.1152/jn.1998.80.4.1828; Dyall SC, 2010, J NEUROSCI RES, V88, P2091, DOI 10.1002/jnr.22390; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; Etchamendy N, 2003, BEHAV BRAIN RES, V145, P37, DOI 10.1016/S0166-4328(03)00099-8; Etchamendy N, 2001, J NEUROSCI, V21, P6423, DOI 10.1523/JNEUROSCI.21-16-06423.2001; Farries MA, 2005, J COMP NEUROL, V484, P93, DOI 10.1002/cne.20464; Fujii H, 1997, EMBO J, V16, P4163, DOI 10.1093/emboj/16.14.4163; Funabiki Y, 2008, DEV NEUROBIOL, V68, P645, DOI 10.1002/dneu.20597; Gahr M, 1996, BRAIN RES, V712, P69, DOI 10.1016/0006-8993(95)01448-9; Gale SD, 2010, J CHEM NEUROANAT, V39, P124, DOI 10.1016/j.jchemneu.2009.07.003; Goldberg JH, 2012, NAT NEUROSCI, V15, P620, DOI 10.1038/nn.3047; HEERY DM, 1993, P NATL ACAD SCI USA, V90, P4281, DOI 10.1073/pnas.90.9.4281; HERMANN T, 1992, MOL ENDOCRINOL, V6, P1153, DOI 10.1210/me.6.7.1153; Hernandez RE, 2007, DEVELOPMENT, V134, P177, DOI 10.1242/dev.02706; Holzenberger M, 1997, J NEUROSCI, V17, P6974; Hoover F, 1998, J COMP NEUROL, V391, P204; Jacobs S, 2006, P NATL ACAD SCI USA, V103, P3902, DOI 10.1073/pnas.0511294103; Jeong JK, 2005, J COMP NEUROL, V489, P23, DOI 10.1002/cne.20605; Kastner P, 1997, DEVELOPMENT, V124, P313; Kim YH, 2005, J NEUROBIOL, V65, P260, DOI 10.1002/neu.20192; Kittelberger JM, 1999, J NEUROSCI, V19, P9385; Klein R, 2014, CURR OPIN NEUROBIOL, V27, P16, DOI 10.1016/j.conb.2014.02.006; Kornyei Z, 2007, FASEB J, V21, P2496, DOI 10.1096/fj.06-7756com; Lefebvre P, 2010, TRENDS ENDOCRIN MET, V21, P676, DOI 10.1016/j.tem.2010.06.009; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Maghsoodi B, 2008, P NATL ACAD SCI USA, V105, P16015, DOI 10.1073/pnas.0804801105; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; Mello C V, 1997, Methods Mol Biol, V85, P205; MELLO CV, 1994, J NEUROSCI, V14, P6652; MELLO CV, 1995, J NEUROBIOL, V26, P145, DOI 10.1002/neu.480260112; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; Mingaud F, 2008, J NEUROSCI, V28, P279, DOI 10.1523/JNEUROSCI.4065-07.2008; Misner DL, 2001, P NATL ACAD SCI USA, V98, P11714, DOI 10.1073/pnas.191369798; Molotkov A, 2005, DEV DYNAM, V232, P950, DOI 10.1002/dvdy.20256; MOONEY R, 1992, J NEUROSCI, V12, P2464; Nakagomi M, 2013, PHARMACOL BIOCHEM BE, V104, P1, DOI 10.1016/j.pbb.2013.01.008; Nomoto M, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-8; Ochoa WF, 2003, BIOCHEMISTRY-US, V42, P8774, DOI 10.1021/bi034713g; Olveczky BP, 2011, J NEUROPHYSIOL, V106, P386, DOI 10.1152/jn.00018.2011; Olson CR, 2011, J COMP NEUROL, V519, P148, DOI 10.1002/cne.22510; Olson CR, 2010, MOL NUTR FOOD RES, V54, P489, DOI 10.1002/mnfr.200900246; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Pinkstaff JK, 1999, J NEUROSCI, V19, P1541; Plane JM, 2008, EXP NEUROL; Poon MM, 2008, P NATL ACAD SCI USA, V105, P20303, DOI 10.1073/pnas.0807740105; Prather JF, 2013, HEARING RES, V305, P144, DOI 10.1016/j.heares.2013.06.007; Pytte CL, 2007, DEV NEUROBIOL, V67, P1699, DOI 10.1002/dneu.20520; Radominska-Pandya A, 2000, J BIOL CHEM, V275, P22324, DOI 10.1074/jbc.M907722199; Ransom J, 2013, J NEUROCHEM; Reijntjes S, 2004, DEV DYNAM, V230, P509, DOI 10.1002/dvdy.20025; Reijntjes S, 2003, GENE EXPR PATTERNS, V3, P621, DOI 10.1016/S1567-133X(03)00112-1; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Sarti F, 2013, J NEUROSCI, V33, P11440, DOI 10.1523/JNEUROSCI.1710-13.2013; Sarti F, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00016; SCHARFF C, 1991, J NEUROSCI, V11, P2896; SELEIRO EAP, 1994, BIOCHEM J, V301, P283, DOI 10.1042/bj3010283; Shearer KD, 2012, TRENDS NEUROSCI, V35, P733, DOI 10.1016/j.tins.2012.08.005; Shearer KD, 2012, J NEUROCHEM, V122, P789, DOI 10.1111/j.1471-4159.2012.07824.x; Shimozono S, 2013, NATURE, V496, P363, DOI 10.1038/nature12037; Smith D, 2001, CEREB CORTEX, V11, P894, DOI 10.1093/cercor/11.10.894; Terleph TA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002854; Thompson CK, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00024; Thompson JA, 2007, J NEUROSCI, V27, P12308, DOI 10.1523/JNEUROSCI.2853-07.2007; Thompson JA, 2007, DEV NEUROBIOL, V67, P205, DOI 10.1002/dneu.20287; VATES GE, 1995, P NATL ACAD SCI USA, V92, P5139, DOI 10.1073/pnas.92.11.5139; Vignal C, 2005, EUR J NEUROSCI, V22, P949, DOI 10.1111/j.1460-9568.2005.04254.x; Wagner E, 2002, CEREB CORTEX, V12, P1244, DOI 10.1093/cercor/12.12.1244; Wagner E, 2006, EUR J NEUROSCI, V24, P329, DOI 10.1111/j.1460-9568.2006.04934.x; WAGNER M, 1992, DEVELOPMENT, V116, P55; Warren TL, 2012, J NEUROSCI, V32, P15414, DOI 10.1523/JNEUROSCI.1254-12.2012; Warren TL, 2011, J NEUROPHYSIOL, V106, P1806, DOI 10.1152/jn.00311.2011; Watanabe A, 2002, NEUROREPORT, V13, P127, DOI 10.1097/00001756-200201210-00030; Watanabe A, 2006, EUR J NEUROSCI, V23, P2447, DOI 10.1111/j.1460-9568.2006.04763.x; White JA, 1996, J BIOL CHEM, V271, P29922, DOI 10.1074/jbc.271.47.29922; White JA, 2000, P NATL ACAD SCI USA, V97, P6403, DOI 10.1073/pnas.120161397; White RJ, 2007, PLOS BIOL, V5, P2522, DOI 10.1371/journal.pbio.0050304; Wietrzych M, 2005, LEARN MEMORY, V12, P318, DOI 10.1101/lm.89805; Williams H, 1999, TLS-TIMES LIT SUPPL, P16; Wisden W, 1993, Curr Opin Neurobiol, V3, P291, DOI 10.1016/0959-4388(93)90120-N; Wood WE, 2008, DEV NEUROBIOL; Woolley SMN, 2012, DEV PSYCHOBIOL, V54, P612, DOI 10.1002/dev.21014; XIAO JH, 1995, J BIOL CHEM, V270, P3001, DOI 10.1074/jbc.270.7.3001	103	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e111722	10.1371/journal.pone.0111722	http://dx.doi.org/10.1371/journal.pone.0111722			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393898	Green Published, gold			2022-12-27	WOS:000347709300020
J	Wang, JN; Guo, WJ; Du, H; Yu, HT; Jiang, W; Zhu, T; Bai, XF; Wang, PZ				Wang, Junning; Guo, Weijuan; Du, Hong; Yu, Haitao; Jiang, Wei; Zhu, Ting; Bai, Xuefan; Wang, Pingzhong			Elevated Soluble CD163 Plasma Levels Are Associated with Disease Severity in Patients with Hemorrhagic Fever with Renal Syndrome	PLOS ONE			English	Article							HEMOGLOBIN SCAVENGER RECEPTOR; MONOCYTE SUBSET; EXPRESSION; PATHOGENESIS; MACROPHAGES; ACTIVATION; INFECTION; MARKER	Background: Hantaan virus is a major zoonotic pathogen that causesing hemorrhagic fever with renal syndrome (HFRS). Although HFRS pathogenesis has not been entirely elucidated, the importance of host-related immune responses in HFRS pathogenesis has been widely recognized. CD163, a monocyte and macrophage-specific scavenger receptor that plays a vital function in the hosts can reduce inflammation, is shed during activation as soluble CD163 (sCD163). The aim of this study was to investigate the pathological significance of sCD163 in patients with HFRS. Methods: Blood samples were collected from 81 hospitalized patients in Tangdu Hospital from October 2011 to January 2014 and from 15 healthy controls. The sCD163 plasma levels were measured using a sandwich ELISA, and the relationship between sCD163 and disease severity was analyzed. Furthermore, CD163 expression in 3 monocytes subset was analyzed by flow cytometry. Results: The results demonstrated that sCD163 plasma levels during the HFRS acute phase were significantly higher in patients than during the convalescent stage and the levels in the healthy controls (P<0.0001). The sCD163 plasma levels in the severe/critical group were higher than those in the mild/moderate group during the acute (P<0.0001). A Spearman correlation analysis indicated that the sCD163 levels were positively correlated with white blood cell, serum creatine, blood urea nitrogen levels, while they were negatively correlated with blood platelet levels in the HFRS patients. The monocyte subsets were significantly altered during the acute stage. Though the CD163 expression levels within the monocyte subsets were increased during the acute stage, the highest CD163 expression level was observed in the CD14++CD16+ monocytes when compared with the other monocyte subsets. Conclusion: sCD163 may be correlated with disease severity and the disease progression in HFRS patients; however, the underlying mechanisms should be explored further.	[Wang, Junning; Du, Hong; Yu, Haitao; Jiang, Wei; Zhu, Ting; Bai, Xuefan; Wang, Pingzhong] Fourth Mil Med Univ, Tangdu Hosp, Dept Infect Dis, Xian 710032, Shaanxi Provinc, Peoples R China; [Guo, Weijuan] Chang An Hosp, Dept Obstet & Gynecol, Xian, Shaanxi Provinc, Peoples R China	Air Force Military Medical University; Chang'an University	Bai, XF (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Infect Dis, Xian 710032, Shaanxi Provinc, Peoples R China.	xfbai2011@163.com; wangpz63@126.com			National Basic Research Program of China (973 Program) [2012CB518905]; National Natural Science Foundation of China [81373118]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program) (No. 2012CB518905) and National Natural Science Foundation of China (No. 81373118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MN, 2014, EUR J HAEMATOL; Azeredo EL, 2010, IMMUNOLOGY, V130, P202, DOI 10.1111/j.1365-2567.2009.03224.x; Barbosa RR, 2012, CLIN EXP IMMUNOL, V169, P263, DOI 10.1111/j.1365-2249.2012.04620.x; Buechler Christa, 2013, Inflammation & Allergy Drug Targets, V12, P391; Burdo TH, 2011, J INFECT DIS, V204, P154, DOI 10.1093/infdis/jir214; Burdo TH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000842; Cassetta L, 2011, THESCIENTIFICWORLDJO, V11, P2391, DOI 10.1100/2011/213962; Coulthard LR, 2012, CLIN EXP IMMUNOL, V170, P36, DOI 10.1111/j.1365-2249.2012.04626.x; Davis BH, 2005, CYTOM PART B-CLIN CY, V63B, P16, DOI 10.1002/cyto.b.20031; Du H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089740; Du H, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-191; Etzerodt A, 2014, J BIOL CHEM, V289, P778, DOI 10.1074/jbc.M113.520213; Etzerodt A, 2013, ANTIOXID REDOX SIGN, V18, P2352, DOI 10.1089/ars.2012.4834; Frings W, 2002, FEBS LETT, V526, P93, DOI 10.1016/S0014-5793(02)03142-3; Funderburg NT, 2012, BLOOD, V120, P4599, DOI 10.1182/blood-2012-05-433946; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ghigliotti G, 2013, DIS MARKERS, V34, P131, DOI 10.1155/2013/836849; Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09; Kazankov K, 2014, HEPATOLOGY, V60, P521, DOI 10.1002/hep.27129; Kjaergaard AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092331; Klingstrom J, 2006, J VIROL, V80, P8279, DOI 10.1128/JVI.00742-06; Koch S, 2010, CLIN EXP IMMUNOL, V161, P332, DOI 10.1111/j.1365-2249.2010.04177.x; Kundumani-Sridharan V, 2013, J BIOL CHEM, V288, P15830, DOI 10.1074/jbc.M113.453290; Manigold T, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.13937; Mendonca VRR, 2012, INFECT IMMUN, V80, P1445, DOI 10.1128/IAI.05933-11; Moestrup SK, 2004, ANN MED, V36, P347, DOI 10.1080/07853890410033171; Mustonen J, 2013, ANTIVIR RES, V100, P589, DOI 10.1016/j.antiviral.2013.10.001; Nielsen MJ, 2009, BLOOD, V114, P764, DOI 10.1182/blood-2009-01-198309; Pedraza-Sanchez S, 2013, CLIN VACCINE IMMUNOL, V20, P962, DOI 10.1128/CVI.00609-12; PENTTINEN K, 1981, J INFECT DIS, V143, P15, DOI 10.1093/infdis/143.1.15; Possamai LA, 2010, WORLD J GASTROENTERO, V16, P1811, DOI 10.3748/wjg.v16.i15.1811; Schmaljohn C, 1997, EMERG INFECT DIS, V3, P95, DOI 10.3201/eid0302.970202; Simoni J, 2006, ASAIO J, V52, P652, DOI 10.1097/01.mat.0000235282.89757.9f; Su LX, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/969875; Thomsen HH, 2013, ENDOCR CONNECT, V2, P216, DOI 10.1530/EC-13-0067; Tippett E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019968; Van Gorp H, 2010, MOL IMMUNOL, V47, P1650, DOI 10.1016/j.molimm.2010.02.008; Wang PZ, 2012, J INT MED RES, V40, P648, DOI 10.1177/147323001204000227; Weaver LK, 2006, J LEUKOCYTE BIOL, V80, P26, DOI 10.1189/jlb.1205756; West SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052406; Wrigley BJ, 2013, EUR J CLIN INVEST, V43, P121, DOI 10.1111/eci.12023; Ye H, 2013, WORLD J GASTROENTERO, V19, P2818, DOI 10.3748/wjg.v19.i18.2818; Zhang DW, 2014, J SURG RES, V187, P605, DOI 10.1016/j.jss.2013.11.004; Zhang YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092700; Zhang YS, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/697837	45	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112127	10.1371/journal.pone.0112127	http://dx.doi.org/10.1371/journal.pone.0112127			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392926	Green Submitted, Green Published, gold			2022-12-27	WOS:000347709300034
J	Zou, TS; Williams, N; Ozkan, SB; Ghosh, K				Zou, Taisong; Williams, Nickolas; Ozkan, S. Banu; Ghosh, Kingshuk			Proteome Folding Kinetics Is Limited by Protein Halflife	PLOS ONE			English	Article							CONTACT ORDER; SPEED LIMIT; RATES; PREDICTION; STABILITY; TEMPERATURE; DOMAINS; CELLS; YEAST; SIZE	How heterogeneous are proteome folding timescales and what physical principles, if any, dictate its limits? We answer this by predicting copy number weighted folding speed distribution - using the native topology - for E. coli and Yeast proteome. E. coli and Yeast proteomes yield very similar distributions with average folding times of 100 milliseconds and 170 milliseconds, respectively. The topology-based folding time distribution is well described by a diffusion-drift mutation model on a flat-fitness landscape in free energy barrier between two boundaries: i) the lowest barrier height determined by the upper limit of folding speed and ii) the highest barrier height governed by the lower speed limit of folding. While the fastest time scale of the distribution is near the experimentally measured speed limit of 1 microsecond (typical of barrier-less folders), we find the slowest folding time to be around seconds (approximate to 8 seconds for Yeast distribution), approximately an order of magnitude less than the fastest halflife (approximately 2 minutes) in the Yeast proteome. This separation of timescale implies even the fastest degrading protein will have moderately high (96%) probability of folding before degradation. The overall agreement with the flat-fitness landscape model further hints that proteome folding times did not undergo additional major selection pressures - to make proteins fold faster - other than the primary requirement to "sufficiently beat the clock'' against its lifetime. Direct comparison between the predicted folding time and experimentally measured halflife further shows 99% of the proteome have a folding time less than their corresponding lifetime. These two findings together suggest that proteome folding kinetics may be bounded by protein halflife.	[Zou, Taisong; Ozkan, S. Banu] Arizona State Univ, Dept Phys, Ctr Biol Phys, Tempe, AZ 85287 USA; [Williams, Nickolas; Ghosh, Kingshuk] Univ Denver, Dept Phys & Astron, Denver, CO 80220 USA	Arizona State University; Arizona State University-Tempe; University of Denver	Ghosh, K (corresponding author), Univ Denver, Dept Phys & Astron, Denver, CO 80220 USA.	kghosh@du.edu	Ghosh, Kingshuk/C-6315-2015	Ghosh, Kingshuk/0000-0003-4976-0986	NSF [1149992]; ASU-CLAS; Direct For Biological Sciences [1149992] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); ASU-CLAS; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	KG acknowledges support from NSF (award number 1149992), and TZ and SBO acknowledge ASU-CLAS funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER D, 1994, BIOCHEMISTRY-US, V33, P7505, DOI 10.1021/bi00190a002; Batey S, 2006, P NATL ACAD SCI USA, V103, P18113, DOI 10.1073/pnas.0604580103; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Braselmann E, 2013, TRENDS BIOCHEM SCI, V38, P337, DOI 10.1016/j.tibs.2013.05.001; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Chan HS, 1998, NATURE, V392, P761, DOI 10.1038/33808; Ciryam P, 2013, P NATL ACAD SCI USA, V110, pE132, DOI 10.1073/pnas.1213624110; Clarke J, 1999, STRUCT FOLD DES, V7, P1145, DOI 10.1016/S0969-2126(99)80181-6; Coyle JE, 1999, NAT STRUCT BIOL, V6, P683; De Sancho D, 2011, PHYS CHEM CHEM PHYS, V13, P17030, DOI 10.1039/c1cp20402e; Dill KA, 2011, P NATL ACAD SCI USA, V108, P17876, DOI 10.1073/pnas.1114477108; Dinner AR, 2001, NAT STRUCT BIOL, V8, P21; Drew K, 2011, GENOME RES, V21, P1981, DOI 10.1101/gr.121475.111; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Ghosh K, 2007, J AM CHEM SOC, V129, P11920, DOI 10.1021/ja066785b; Ghosh K, 2010, BIOPHYS J, V99, P3996, DOI 10.1016/j.bpj.2010.10.036; Gong YC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.26; Gromiha MM, 2001, J MOL BIOL, V310, P27, DOI 10.1006/jmbi.2001.4775; Guo MH, 2012, P NATL ACAD SCI USA, V109, P17863, DOI 10.1073/pnas.1201797109; Hagen SJ, 1996, P NATL ACAD SCI USA, V93, P11615, DOI 10.1073/pnas.93.21.11615; Hyeon C, 2012, BIOPHYS J, V102, pL11, DOI 10.1016/j.bpj.2012.01.003; Ivankov DN, 2003, PROTEIN SCI, V12, P2057, DOI 10.1110/ps.0302503; Mashaghi A, 2013, NATURE, V500, P98, DOI 10.1038/nature12293; Naganathan AN, 2010, P NATL ACAD SCI USA, V107, P8611, DOI 10.1073/pnas.1000988107; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Rollins GC, 2014, J AM CHEM SOC, V136, P11420, DOI 10.1021/ja5049434; Rustad M, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4767567; Sawle L, 2011, BIOPHYS J, V101, P217, DOI 10.1016/j.bpj.2011.05.059; Serohijos AWR, 2013, BIOPHYS J, V104, pL1, DOI 10.1016/j.bpj.2012.11.3838; Serohijos AWR, 2012, CELL REP, V2, P249, DOI 10.1016/j.celrep.2012.06.022; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704; Wang T, 2004, J PHYS CHEM B, V108, P3694, DOI 10.1021/jp049652q; Yang WY, 2003, NATURE, V423, P193, DOI 10.1038/nature01609; Zeldovich KB, 2007, P NATL ACAD SCI USA, V104, P16152, DOI 10.1073/pnas.0705366104; Zheng OY, 2008, PROTEIN SCI, V17, P1256, DOI 10.1110/ps.034660.108; Zou TS, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/6/066011	36	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112701	10.1371/journal.pone.0112701	http://dx.doi.org/10.1371/journal.pone.0112701			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393560	Green Submitted, Green Published, gold			2022-12-27	WOS:000347709300088
J	Kornej, J; Dinov, B; Blann, AD; Rolf, S; Arya, A; Schmidl, J; Husser, D; Hindricks, G; Bollmann, A; Lip, GYH				Kornej, Jelena; Dinov, Borislav; Blann, Andrew D.; Rolf, Sascha; Arya, Arash; Schmidl, Josephine; Husser, Daniela; Hindricks, Gerhard; Bollmann, Andreas; Lip, Gregory Y. H.			Effects of Radiofrequency Catheter Ablation of Atrial Fibrillation on Soluble P-Selectin, Von Willebrand Factor and IL-6 in the Peripheral and Cardiac Circulation	PLOS ONE			English	Article							PLATELET ACTIVATION; ENDOTHELIAL DAMAGE; THROMBOGENESIS; INTERLEUKIN-6; MANAGEMENT	Background: Catheter ablation (CA) of atrial fibrillation (AF) is associated with inflammatory response, endothelial damage and with increased risk of thrombosis. However, whether these processes differ in peripheral and cardiac circulation is unknown. Methods: Plasma markers (von Willebrand factor (vWf), soluble P-selectin (sPsel) and interleukin-6 (IL-6)) were measured by ELISA at three time points in 80 patients (62610 years, 63% males, 41% paroxysmal AF) undergoing CA. These were at baseline - from femoral vein (FV) and left atrium (LA) before ablation; directly after ablation - from the pulmonary vein (PV), LA and FV; and 24 hours after procedure -from a cubital vein (CV). Results: The levels of vWF and IL6 - but not sP-sel - increased significantly 24h after procedure (p < 0.001). Baseline vWF was significantly associated with persistent AF (Beta = .303, p = 0.006 and Beta = .300, p = 0.006 for peripheral and cardiac levels, respectively), while persistent AF (Beta = .250, p = 0.031) and LAA flow pattern (Beta = .386, p < 0.001) remained associated with vWF in cardiac blood after ablation. Advanced age was significantly associated with IL6 levels at baseline and after ablation in peripheral and cardiac blood. There were no clinical, procedural or anti-coagulation characteristics associated with sP-sel levels in cardiac blood, while peripheral sP-sel levels were associated with hypertension before (Beta = 2.307, p = 0.007) and with persistent AF after ablation (Beta = 2.262, p = 0.020). Conclusions: vWF levels are higher in persistent AF and are associated with LAA rheological pattern after AF ablation. Increase of peripheral vWF and IL6 levels after procedure supports current AF ablation management with careful control of post-procedural anticoagulation to avoid ablation-related thromboembolism.	[Kornej, Jelena; Dinov, Borislav; Arya, Arash; Schmidl, Josephine; Husser, Daniela; Hindricks, Gerhard; Bollmann, Andreas] Univ Leipzig, Ctr Heart, Dept Electrophysiol, D-04109 Leipzig, Germany; [Kornej, Jelena; Blann, Andrew D.; Lip, Gregory Y. H.] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham, W Midlands, England	Heart Center Leipzig GMBH; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Birmingham	Kornej, J (corresponding author), Univ Leipzig, Ctr Heart, Dept Electrophysiol, D-04109 Leipzig, Germany.	jelena.kornej@gmx.de		Dinov, Borislav/0000-0003-1104-8491	German Cardiac Society St. Jude Medical Stipend	German Cardiac Society St. Jude Medical Stipend	JK was supported by the German Cardiac Society St. Jude Medical Stipend. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akar JG, 2008, J AM COLL CARDIOL, V51, P1790, DOI 10.1016/j.jacc.2007.11.083; Bulava A, 2004, J INTERV CARD ELECTR, V10, P271, DOI 10.1023/B:JICE.0000026924.96281.be; Calkins H, 2012, EUROPACE, V14, P528, DOI 10.1093/europace/eus027; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Conway DSG, 2002, CIRCULATION, V106, P1962, DOI 10.1161/01.CIR.0000033220.97592.9A; Davlouros PA, 2005, INT J CARDIOL, V102, P187, DOI 10.1016/j.ijcard.2004.04.010; Kaireviciute D, 2011, J THROMB HAEMOST, V9, P2345, DOI 10.1111/j.1538-7836.2011.04523.x; Kaireviciute D, 2010, THROMB HAEMOSTASIS, V104, P122, DOI 10.1160/TH09-12-0837; Kannel WB, 1998, AM J CARDIOL, V82, p2N, DOI 10.1016/S0002-9149(98)00583-9; Kerr R, 2001, BRIT J HAEMATOL, V115, P3, DOI 10.1046/j.1365-2141.2001.03061.x; Kornej J, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-49; Kornej J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044165; Kosiuk J, 2014, HEART RHYTHM, V11, P1934, DOI 10.1016/j.hrthm.2014.07.039; Li-Saw-Hee FL, 2000, STROKE, V31, P828, DOI 10.1161/01.STR.31.4.828; Lim HS, 2013, J AM COLL CARDIOL, V61, P852, DOI 10.1016/j.jacc.2012.11.046; LIP GYH, 1995, LANCET, V346, P1313, DOI 10.1016/S0140-6736(95)92339-X; Ma J, 2006, ACTA CARDIOL, V61, P339, DOI 10.2143/AC.61.3.2014838; Malmborg H, 2013, EUROPACE, V15, P1567, DOI 10.1093/europace/eut104; McCabe JM, 2008, PACE, V31, P1146, DOI 10.1111/j.1540-8159.2008.01155.x; Roldan V, 2003, EUR HEART J, V24, P1373, DOI 10.1016/S0195-668X(03)00239-2; Siklody CH, 2012, HEART RHYTHM, V9, P189, DOI 10.1016/j.hrthm.2011.09.017; Vizzardi E, 2009, INTERN EMERG MED, V4, P309, DOI 10.1007/s11739-009-0235-6	22	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111760	10.1371/journal.pone.0111760	http://dx.doi.org/10.1371/journal.pone.0111760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390649	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400032
J	Li, JJ; Sologon, DM				Li, Jinjing; Sologon, Denisa Maria			A Continuous Labour Supply Model in Microsimulation: A Life-Cycle Modelling Approach with Heterogeneity and Uncertainty Extension	PLOS ONE			English	Article							CONSUMPTION	This paper advances a structural inter-temporal model of labour supply that is able to simulate the dynamics of labour supply in a continuous setting and addresses two main drawbacks of most existing models. The first limitation is the inability to incorporate individual heterogeneity as every agent is sharing the same parameters of the utility function. The second one is the strong assumption that individuals make decisions in a world of perfect certainty. Essentially, this paper offers an extension of marginal-utility-of-wealth-constant labour supply functions known as "Frisch functions" under certainty and uncertainty with homogenous and heterogeneous preferences. The lifetime models based on the fixed effect vector decomposition yield the most stable simulation results, under both certain and uncertain future wage assumptions. Due to its improved accuracy and stability, this lifetime labour supply model is particularly suitable for enhancing the performance of the life cycle simulation models, thus providing a better reference for policymaking.	[Li, Jinjing] Univ Canberra, Inst Governance & Policy Anal, Canberra, ACT 2601, Australia; [Li, Jinjing; Sologon, Denisa Maria] Maastricht Univ, UNU MERIT, NL-6200 MD Maastricht, Netherlands; [Sologon, Denisa Maria] CEPS INSTEAD, Esch Sur Alzette, Luxembourg; [Sologon, Denisa Maria] Inst Study Labor IZA, Bonn, Germany	University of Canberra; Maastricht University; IZA Institute Labor Economics	Li, JJ (corresponding author), Univ Canberra, Inst Governance & Policy Anal, Canberra, ACT 2601, Australia.	Jinjing.Li@canberra.edu.au		Li, Jinjing/0000-0001-5640-2058; Sologon, Denisa Maria/0000-0002-0309-5952	Luxembourg Fonds National de la Recherche through an AFR grant (PDR) under the Marie Curie Actions of the European Commission [893613]	Luxembourg Fonds National de la Recherche through an AFR grant (PDR) under the Marie Curie Actions of the European Commission(Luxembourg National Research Fund)	This research is part of the Earnings Dynamics and Microsimulation Project supported by the Luxembourg Fonds National de la Recherche through an AFR grant (PDR no. 893613) under the Marie Curie Actions of the European Commission (FP7-COFUND). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaberge R, 1995, SCAND J ECON, V97, P635, DOI 10.2307/3440547; Blundell R., 1999, HDB LABOR EC A, V3A, P1559, DOI DOI 10.1016/S1573-4463(99)03008-4; Blundell R, 2007, REV ECON STUD, V74, P417, DOI 10.1111/j.1467-937X.2007.00440.x; Browning M, 2001, J ECON PERSPECT, V15, P3, DOI 10.1257/jep.15.3.3; BURTLESS G, 1978, J POLIT ECON, V86, P1103, DOI 10.1086/260730; Card D, 1990, 5 WORLD C EC SOC BAR; Friedman Milton, 1957, PERMANENT INCOME HYP, P20; Galler HP, 1996, CONTRIB TO ECON ANAL, V232, P293; Gomes FJ, 2008, 13966 NAT BUR EC RES; Haan P, 2004, DIW DISKUSSIONSPAPIE; Hsiao Cheng., 2003, ANAL PANEL DATA, VSecond; Keane M, 2013, J APPL ECONOMET, V28, P1018, DOI 10.1002/jae.2304; Loffler M, 2013, FITTING COMPLEX MIXE; LUCAS RE, 1969, J POLIT ECON, V77, P721, DOI 10.1086/259559; MaCurdy T., 1985, LONGITUDINAL ANAL LA, P111; MACURDY TE, 1981, J POLIT ECON, V89, P1059, DOI 10.1086/261023; MACURDY TE, 1983, INT ECON REV, V24, P265, DOI 10.2307/2648746; MaCurdy TE, 1980, EMPIRICAL MODEL LABO; MEDOFF JL, 1981, J HUM RESOUR, V16, P186, DOI 10.2307/145508; MUNDLAK Y, 1978, ECONOMETRICA, V46, P69, DOI 10.2307/1913646; Plumper T, 2007, POLIT ANAL, V15, P124, DOI 10.1093/pan/mpm002; Pudney S, 1992, DYNAMIC SIMULATION P; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Rendel U, 1994, TESTS NONIGNORABLE P; Richiardi M, 2012, 123 LABORATORIO R RE; VANSOEST A, 1995, J HUM RESOUR, V30, P63, DOI 10.2307/146191; Vella F, 1998, J HUM RESOUR, V33, P127, DOI 10.2307/146317; Wagner G. G., 2007, SCHMOLLERS JB, V127, P139, DOI DOI 10.2139/SSRN.1028709	28	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111903	10.1371/journal.pone.0111903	http://dx.doi.org/10.1371/journal.pone.0111903			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391021	gold, Green Published, Green Submitted			2022-12-27	WOS:000349144400039
J	Stewart, CE; Randall, RE; Adamson, CS				Stewart, Claire E.; Randall, Richard E.; Adamson, Catherine S.			Inhibitors of the Interferon Response Enhance Virus Replication In Vitro	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; VALLEY FEVER VIRUS; INNATE IMMUNITY; JAK2 INHIBITOR; INFLUENZA-A; CELL-LINES; VACCINE; PROTEIN; INDUCTION; LACKING	Virus replication efficiency is influenced by two conflicting factors, kinetics of the cellular interferon (IFN) response and induction of an antiviral state versus speed of virus replication and virus-induced inhibition of the IFN response. Disablement of a virus's capacity to circumvent the IFN response enables both basic research and various practical applications. However, such IFN-sensitive viruses can be difficult to grow to high-titer in cells that produce and respond to IFN. The current default option for growing IFN-sensitive viruses is restricted to a limited selection of cell-lines (e.g. Vero cells) that have lost their ability to produce IFN. This study demonstrates that supplementing tissue-culture medium with an IFN inhibitor provides a simple, effective and flexible approach to increase the growth of IFN-sensitive viruses in a cell-line of choice. We report that IFN inhibitors targeting components of the IFN response (TBK1, IKK2, JAK1) significantly increased virus replication. More specifically, the JAK1/2 inhibitor Ruxolitinib enhances the growth of viruses that are sensitive to IFN due to (i) loss of function of the viral IFN antagonist (due to mutation or species-specific constraints) or (ii) mutations/host cell constraints that slow virus spread such that it can be controlled by the IFN response. This was demonstrated for a variety of viruses, including, viruses with disabled IFN antagonists that represent live-attenuated vaccine candidates (Respiratory Syncytial Virus (RSV), Influenza Virus), traditionally attenuated vaccine strains (Measles, Mumps) and a slow-growing wild-type virus (RSV). In conclusion, supplementing tissue culture-medium with an IFN inhibitor to increase the growth of IFN-sensitive viruses in a cell-line of choice represents an approach, which is broadly applicable to research investigating the importance of the IFN response in controlling virus infections and has utility in a number of practical applications including vaccine and oncolytic virus production, virus diagnostics and techniques to isolate newly emerging viruses.	[Stewart, Claire E.; Randall, Richard E.; Adamson, Catherine S.] Univ St Andrews, Sch Biol, St Andrews KY16 9AJ, Fife, Scotland	University of St Andrews	Adamson, CS (corresponding author), Univ St Andrews, Sch Biol, St Andrews KY16 9AJ, Fife, Scotland.	csa21@st-andrews.ac.uk		Adamson, Catherine/0000-0001-7673-5212; Randall, Richard/0000-0002-9304-6678	University of St Andrews; Wellcome Trust [087751/A/08/Z]; Wellcome Trust [101788/Z/13/Z] Funding Source: researchfish	University of St Andrews; Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the University of St Andrews (CSA, CES) and the Wellcome Trust (grant 087751/A/08/Z) (RER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankamp B, 2011, J INFECT DIS, V204, pS533, DOI 10.1093/infdis/jir097; Bird BH, 2008, J VIROL, V82, P2681, DOI 10.1128/JVI.02501-07; Brennan B, 2011, J VIROL, V85, P10310, DOI 10.1128/JVI.05252-11; Bridgen A, 2001, P NATL ACAD SCI USA, V98, P664, DOI 10.1073/pnas.98.2.664; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Chen S, 2010, VIROLOGY, V407, P247, DOI 10.1016/j.virol.2010.08.008; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; DESMYTER J, 1968, J VIROL, V2, P955, DOI 10.1128/JVI.2.10.955-961.1968; ENDERS JF, 1946, J IMMUNOL, V54, P283; Escobar-Zarate D, 2013, CANCER GENE THER, V20, P582, DOI 10.1038/cgt.2013.55; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; He B, 2002, VIROLOGY, V303, P15, DOI 10.1006/viro.2002.1738; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; HILLEMAN MR, 1968, J AMER MED ASSOC, V206, P587, DOI 10.1001/jama.206.3.587; Hilton L, 2006, J VIROL, V80, P11723, DOI 10.1128/JVI.01145-06; HOUSE C, 1989, VET MICROBIOL, V20, P99, DOI 10.1016/0378-1135(89)90033-3; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; Killip MJ, 2013, J VIROL, V87, P4798, DOI 10.1128/JVI.03383-12; Kwilas S, 2009, J VIROL, V83, P10710, DOI 10.1128/JVI.00986-09; Luongo C, 2013, J VIROL, V87, P1985, DOI 10.1128/JVI.02769-12; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Mossler C, 2013, VACCINE, V31, P6194, DOI 10.1016/j.vaccine.2013.10.061; MOSCA JD, 1986, MOL CELL BIOL, V6, P2279, DOI 10.1128/MCB.6.6.2279; Naik S, 2009, EXPERT OPIN BIOL TH, V9, P1163, DOI 10.1517/14712590903170653; Pardanani A, 2009, LEUKEMIA, V23, P1441, DOI 10.1038/leu.2009.50; Podolin PL, 2005, J PHARMACOL EXP THER, V312, P373, DOI 10.1124/jpet.104.074484; Quintas-Cardama A, 2010, BLOOD, V115, P3109, DOI 10.1182/blood-2009-04-214957; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Talon J, 2000, P NATL ACAD SCI USA, V97, P4309, DOI 10.1073/pnas.070525997; Teng MN, 2000, J VIROL, V74, P9317, DOI 10.1128/JVI.74.19.9317-9321.2000; Teng MN, 1999, J VIROL, V73, P466, DOI 10.1128/JVI.73.1.466-473.1999; Vaddi K, 2012, EXPERT OPIN PHARMACO, V13, P2397, DOI 10.1517/14656566.2012.732998; Young DF, 2009, J GEN VIROL, V90, P2731, DOI 10.1099/vir.0.013722-0; Young DF, 2003, J VIROL, V77, P2174, DOI 10.1128/JVI.77.3.2174-2181.2003	37	42	44	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112014	10.1371/journal.pone.0112014	http://dx.doi.org/10.1371/journal.pone.0112014			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390891	Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400045
J	Zhao, RL; Peng, XX; Li, Q; Song, W				Zhao, Ronglan; Peng, Xiaoxiang; Li, Qian; Song, Wei			Effects of Phosphorylatable Short Peptide-Conjugated Chitosan-Mediated IL-1Ra and igf-1 Gene Transfer on Articular Cartilage Defects in Rabbits	PLOS ONE			English	Article							GROWTH-FACTOR-I; INTERLEUKIN-1 RECEPTOR ANTAGONIST; MOLECULAR-WEIGHT; CS/DNA COMPLEX; CHONDROCYTES; DELIVERY; REPAIR; MODEL; MATRIX; VITRO	Previously, we reported an improvement in the transfection efficiency of the plasmid DNA-chitosan (pDNA/CS) complex by the utilization of phosphorylatable short peptide-conjugated chitosan ((SP)-S-p-CS). In this study, we investigated the effects of (SP)-S-p-CS-mediated gene transfection of interleukin-1 receptor antagonist protein (IL-1Ra) combined with insulin-like growth factor-1 (IGF-1) in rabbit chondrocytes and in a rabbit model of cartilage defects. pBudCE4.1-IL-1Ra+igf-1, pBudCE4.1-IL-1Ra and pBudCE4.1-igf-1 were constructed and combined with (SP)-S-p-CS to form pDNA/(SP)-S-p-CS complexes. These complexes were transfected into rabbit primary chondrocytes or injected into the joint cavity. Seven weeks after treatment, all rabbits were sacrificed and analyzed. High levels of IL-1Ra and igf-1 expression were detected both in the cell culture supernatant and in the synovial fluid. In vitro, the transgenic complexes caused significant proliferation of chondrocytes, promotion of glycosaminoglycan (GAG) and collagen II synthesis, and inhibition of chondrocyte apoptosis and nitric oxide (NO) synthesis. In vivo, the exogenous genes resulted in increased collagen II synthesis and reduced NO and GAG concentrations in the synovial fluid; histological studies revealed that pDNA/(SP)-S-p-CS treatment resulted in varying degrees of hyaline-like cartilage repair and Mankin score decrease. The co-expression of both genes produced greater effects than each single gene alone both in vitro and in vivo. The results suggest that (SP)-S-p-CS is a good candidate for use in gene therapy for the treatment of cartilage defects and that igf-1 and IL-1Ra co-expression produces promising biologic effects on cartilage defects.	[Zhao, Ronglan; Peng, Xiaoxiang; Li, Qian; Song, Wei] Weifang Med Univ, Dept Lab Med, Shandong Prov Key Lab Clin Lab Diagnost, Weifang, Shandong, Peoples R China	Weifang Medical University	Peng, XX (corresponding author), Weifang Med Univ, Dept Lab Med, Shandong Prov Key Lab Clin Lab Diagnost, Weifang, Shandong, Peoples R China.	pxx74@sina.com			Shandong Provincial Natural Science Foundation, China [ZR2012HQ034]; National Natural Science Foundation of China [81301737]	Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Shandong Provincial Natural Science Foundation, China (grant ZR2012HQ034) and National Natural Science Foundation of China (81301737). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigoni M, 2013, J ORTHOP RES, V31, P315, DOI 10.1002/jor.22208; Cha MH, 2013, TISSUE ENG PT A, V19, P978, DOI [10.1089/ten.TEA.2012.0358, 10.1089/ten.tea.2012.0358]; Chen BA, 2010, EXP MOL MED, V42, P684, DOI 10.3858/emm.2010.42.10.067; Chen Song, 2014, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V28, P92; Cheng WD, 2013, INT ORTHOP, V37, P2065, DOI 10.1007/s00264-013-1990-6; Clark A, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/2/025015; Clutterbuck AL, 2009, ANN NY ACAD SCI, V1171, P428, DOI 10.1111/j.1749-6632.2009.04687.x; Gao YK, 2014, BIOMACROMOLECULES, V15, P1010, DOI 10.1021/bm401906p; Glass KA, 2014, BIOMATERIALS, V35, P5921, DOI 10.1016/j.biomaterials.2014.03.073; Goodrich LR, 2007, J BONE JOINT SURG BR, V89B, P672, DOI 10.1302/0301-620X.89B5.18343; Haupt JL, 2005, J ORTHOP RES, V23, P118, DOI 10.1016/j.orthres.2004.06.020; He CX, 2012, BIOTECHNOL APPL BIOC, V59, P163, DOI 10.1002/bab.1001; Jia XX, 2007, MOL PHARM, V4, P199, DOI 10.1021/mp060091s; Kayabasi GK, 2013, J BIOMED MATER RES A, V101, P1353, DOI 10.1002/jbm.a.34430; Kwon JT, 2013, IRAN J PHARM RES, V12, P281; Layek B, 2013, INT J PHARMACEUT, V447, P182, DOI 10.1016/j.ijpharm.2013.02.052; Li YC, 2010, TISSUE ENG PART C-ME, V16, P1267, DOI [10.1089/ten.tec.2009.0682, 10.1089/ten.TEC.2009.0682]; Liu S, 2014, SENSORS-BASEL, V14, P3284, DOI 10.3390/s140203284; Lu CH, 2014, MOL THER, V22, P186, DOI 10.1038/mt.2013.165; Madry H, 2005, GENE THER, V12, P1171, DOI 10.1038/sj.gt.3302515; Madry H, 2013, EUR CELLS MATER, V25, P229, DOI 10.22203/eCM.v025a17; Madry H, 2010, ARCH ORTHOP TRAUM SU, V130, P1311, DOI 10.1007/s00402-010-1130-3; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; Marks PH, 2005, ARTHROSCOPY, V21, P1342, DOI 10.1016/j.arthro.2005.08.034; Nadzir MM, 2013, BIOTECHNOL LETT, V35, P295, DOI 10.1007/s10529-012-1071-8; Nixon AJ, 2005, GENE THER, V12, P177, DOI 10.1038/sj.gt.3302396; Park SC, 2013, INT J NANOMED, V8, P3663, DOI 10.2147/IJN.S50911; Peng XX, 2012, INT J MOL SCI, V13, P14344, DOI 10.3390/ijms131114344; Sarkar K, 2013, CARBOHYD POLYM, V98, P495, DOI 10.1016/j.carbpol.2013.06.006; Sarkar K, 2013, CARBOHYD POLYM, V92, P2048, DOI 10.1016/j.carbpol.2012.11.067; Shi JJ, 2013, ARTHROSCOPY, V29, P2001, DOI 10.1016/j.arthro.2013.09.076; Shi SL, 2014, J ORTHOP RES, V32, P54, DOI 10.1002/jor.22444; Shi SL, 2013, J CELL BIOCHEM, V114, P908, DOI 10.1002/jcb.24430; Shi SL, 2013, GROWTH FACTORS, V31, P32, DOI 10.3109/08977194.2012.750652; Sionkowska A, 2004, BIOMATERIALS, V25, P795, DOI 10.1016/S0142-9612(03)00595-7; Sun B, 2010, INT J PHARMACEUT, V397, P206, DOI 10.1016/j.ijpharm.2010.07.006; Takada K, 2013, BIOMED REP, V1, P315, DOI 10.3892/br.2013.52; Tang S, 2014, CARBOHYD POLYM, V101, P104, DOI 10.1016/j.carbpol.2013.09.053; Tangsadthakun C, 2007, J BIOMAT SCI-POLYM E, V18, P147, DOI 10.1163/156856207779116694; Tsuchida AI, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4107; Venkatesan JK, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-211; Watson RS, 2013, GENE THER, V20, P670, DOI 10.1038/gt.2012.81; Whitmire RE, 2012, BIOMATERIALS, V33, P7665, DOI 10.1016/j.biomaterials.2012.06.101; Wu WJ, 2013, CYTOTECHNOLOGY, V65, P287, DOI 10.1007/s10616-012-9485-7; Xiang SN, 2012, BIOMATERIALS, V33, P6520, DOI 10.1016/j.biomaterials.2012.05.044; Yang J, 2013, MOL MED REP, V7, P998, DOI 10.3892/mmr.2012.1246; Zhang B, 2011, J CRANIOFAC SURG, V22, P711, DOI 10.1097/SCS.0b013e31820873c6; Zhao RL, 2011, INT J PHARMACEUT, V413, P254, DOI 10.1016/j.ijpharm.2011.04.039; Zhao Ronglan, 2010, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V24, P1372; Zuo A, 2008, INT J PHARMACEUT, V352, P302, DOI 10.1016/j.ijpharm.2007.10.042	50	7	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112284	10.1371/journal.pone.0112284	http://dx.doi.org/10.1371/journal.pone.0112284			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390659	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400068
J	Schwetz, TA; Reissaus, CA; Piston, DW				Schwetz, Tara A.; Reissaus, Christopher A.; Piston, David W.			Differential Stimulation of Insulin Secretion by GLP-1 and Kisspeptin-10	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; BETA-CELLS; GLUCOSE-METABOLISM; GAMMA-SUBUNIT; RELEASE; ISLETS; MECHANISMS; SYSTEM; KISS-1; CA2+	beta-cells in the pancreatic islet respond to elevated plasma glucose by secreting insulin to maintain glucose homeostasis. In addition to glucose stimulation, insulin secretion is modulated by numerous G-protein coupled receptors (GPCRs). The GPCR ligands Kisspeptin-10 (KP) and glucagon-like peptide-1 (GLP-1) potentiate insulin secretion through G(q) and G(s)-coupled receptors, respectively. Despite many studies, the signaling mechanisms by which KP and GLP-1 potentiate insulin release are not thoroughly understood. We investigated the downstream signaling pathways of these ligands and their affects on cellular redox potential, intracellular calcium activity ([Ca2+](i)), and insulin secretion from beta-cells within intact murine islets. In contrast to previous studies performed on single beta-cells, neither KP nor GLP-1 affect [Ca2+] i upon stimulation with glucose. KP significantly increases the cellular redox potential, while no effect is observed with GLP-1, suggesting that KP and GLP-1 potentiate insulin secretion through different mechanisms. Co-treatment with KP and the G(beta gamma)-subunit inhibitor gallein inhibits insulin secretion similar to that observed with gallein alone, while co-treatment with gallein and GLP-1 does not differ from GLP-1 alone. In contrast, co-treatment with the G(beta gamma) activator mSIRK and either KP or GLP-1 stimulates insulin release similar to mSIRK alone. Neither gallein nor mSIRK alter [Ca2+] i activity in the presence of KP or GLP-1. These data suggest that KP likely alters insulin secretion through a G(beta gamma)-dependent process that stimulates glucose metabolism without altering Ca2+ activity, while GLP-1 does so, at least partly, through a G(alpha)-dependent pathway that is independent of both metabolism and Ca2+.	[Schwetz, Tara A.; Reissaus, Christopher A.; Piston, David W.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Piston, David W.] Vanderbilt Univ, Dept Phys, Nashville, TN 37235 USA; [Piston, David W.] Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Piston, DW (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	dave.piston@vanderbilt.edu		Reissaus, Christopher/0000-0002-3260-4525	National Institutes of Health (NIH) [P30DK020593, P30DK058404, U24DK059637]; NIH [F32DK091181, R01DK085064]; Vanderbilt University through the Louise B. McGavock Chair; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020593, R01DK098659, P60DK020593, P30DK058404, U24DK059637, R01DK085064, F32DK091181] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010681] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University through the Louise B. McGavock Chair; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Experiments were performed in part through use of the Vanderbilt University Cell Imaging Shared Resource (supported by National Institutes of Health (NIH) grants P30DK020593, P30DK058404, and U24DK059637). This work was funded by NIH through grants F32DK091181 (TAS) and R01DK085064 (CAR, DWP), and by Vanderbilt University through the Louise B. McGavock Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATWATER I, 1984, J PHYSIOL-LONDON, V348, P615, DOI 10.1113/jphysiol.1984.sp015129; Bennett BD, 1996, J BIOL CHEM, V271, P3647; Benninger RKP, 2011, J PHYSIOL-LONDON, V589, P5453, DOI 10.1113/jphysiol.2011.218909; Bergsten P, 1998, AM J PHYSIOL-ENDOC M, V274, pE796, DOI 10.1152/ajpendo.1998.274.5.E796; Bowe JE, 2009, DIABETOLOGIA, V52, P855, DOI 10.1007/s00125-009-1283-1; Castellano JM, 2005, ENDOCRINOLOGY, V146, P3917, DOI 10.1210/en.2005-0337; Damdindorj B, 2012, FEBS LETT, V586, P2555, DOI 10.1016/j.febslet.2012.06.034; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Drucker DJ, 2003, ENDOCRINOLOGY, V144, P5145, DOI 10.1210/en.2003-1147; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Farilla L, 2003, ENDOCRINOLOGY, V144, P5149, DOI 10.1210/en.2003-0323; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gopel S, 2004, J PHYSIOL-LONDON, V556, P711, DOI 10.1113/jphysiol.2003.059675; Goubaeva F, 2003, J BIOL CHEM, V278, P19634, DOI 10.1074/jbc.M300052200; Hauge-Evans AC, 2006, DIABETOLOGIA, V49, P2131, DOI 10.1007/s00125-006-0343-z; HOENIG M, 1986, ENDOCRINOLOGY, V119, P2502, DOI 10.1210/endo-119-6-2502; Jonkers FC, 1999, J PHYSIOL-LONDON, V520, P839, DOI 10.1111/j.1469-7793.1999.00839.x; Klabunde T, 2002, CHEMBIOCHEM, V3, P929, DOI 10.1002/1439-7633(20021004)3:10<928::AID-CBIC928>3.0.CO;2-5; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; LU M, 1993, ENDOCRINOLOGY, V132, P94, DOI 10.1210/en.132.1.94; Mead EJ, 2007, BRIT J PHARMACOL, V151, P1143, DOI 10.1038/sj.bjp.0707295; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689; Patterson GH, 2000, P NATL ACAD SCI USA, V97, P5203, DOI 10.1073/pnas.090098797; Peyot ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006221; Piston DW, 1999, TRENDS ENDOCRIN MET, V10, P413, DOI 10.1016/S1043-2760(99)00204-0; SCHARP DW, 1973, TRANSPLANTATION, V16, P686, DOI 10.1097/00007890-197312000-00028; Schwetz TA, 2012, AM J PHYSL ENDOCRINO; Silvestre RA, 2008, J ENDOCRINOL, V196, P283, DOI 10.1677/JOE-07-0454; Song WJ, 2014, CELL METAB, V19, P667, DOI 10.1016/j.cmet.2014.03.005; STEFAN Y, 1987, J CLIN INVEST, V80, P175, DOI 10.1172/JCI113045; Vikman J, 2009, DIABETES OBES METAB, V11, P197, DOI 10.1111/j.1463-1326.2009.01116.x; Winzell MS, 2007, PHARMACOL THERAPEUT, V116, P437, DOI 10.1016/j.pharmthera.2007.08.002; WOLLHEIM CB, 1981, PHYSIOL REV, V61, P914, DOI 10.1152/physrev.1981.61.4.914; YADA T, 1993, ENDOCRINOLOGY, V133, P1685, DOI 10.1210/en.133.4.1685; Zhang M, 2003, BIOPHYS J, V84, P2852, DOI 10.1016/S0006-3495(03)70014-9	40	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113020	10.1371/journal.pone.0113020	http://dx.doi.org/10.1371/journal.pone.0113020			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401335	Green Published, Green Submitted, gold			2022-12-27	WOS:000345158700097
J	Brookmeyer, R; Boren, D; Baral, SD; Bekker, LG; Phaswana-Mafuya, N; Beyrer, C; Sullivan, PS				Brookmeyer, Ron; Boren, David; Baral, Stefan D.; Bekker, Linda-Gail; Phaswana-Mafuya, Nancy; Beyrer, Chris; Sullivan, Patrick S.			Combination HIV Prevention among MSM in South Africa: Results from Agent-based Modeling	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; MEN; TRANSMISSION; INFECTION; SEX; CHALLENGES; RISK; EPIDEMIOLOGY; METAANALYSIS	HIV prevention trials have demonstrated the effectiveness of a number of behavioral and biomedical interventions. HIV prevention packages are combinations of interventions and offer potential to significantly increase the effectiveness of any single intervention. Estimates of the effectiveness of prevention packages are important for guiding the development of prevention strategies and for characterizing effect sizes before embarking on large scale trials. Unfortunately, most research to date has focused on testing single interventions rather than HIV prevention packages. Here we report the results from agent-based modeling of the effectiveness of HIV prevention packages for men who have sex with men (MSM) in South Africa. We consider packages consisting of four components: antiretroviral therapy for HIV infected persons with CD4 count <350; PrEP for high risk uninfected persons; behavioral interventions to reduce rates of unprotected anal intercourse (UAI); and campaigns to increase HIV testing. We considered 163 HIV prevention packages corresponding to different intensity levels of the four components. We performed 2252 simulation runs of our agent-based model to evaluate those packages. We found that a four component package consisting of a 15% reduction in the rate of UAI, 50% PrEP coverage of high risk uninfected persons, 50% reduction in persons who never test for HIV, and 50% ART coverage over and above persons already receiving ART at baseline, could prevent 33.9% of infections over 5 years (95% confidence interval, 31.5, 36.3). The package components with the largest incremental prevention effects were UAI reduction and PrEP coverage. The impact of increased HIV testing was magnified in the presence of PrEP. We find that HIV prevention packages that include both behavioral and biomedical components can in combination prevent significant numbers of infections with levels of coverage, acceptance and adherence that are potentially achievable among MSM in South Africa.	[Brookmeyer, Ron; Boren, David] Univ Calif Los Angeles, Dept Biostat, Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA; [Baral, Stefan D.; Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Baltimore, MD USA; [Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Phaswana-Mafuya, Nancy] Nelson Mandela Metropolitan Univ, Human Sci Res Council, HIV AIDS STI TB Res Programme, Off Deputy Vice Chancellor Res & Engagement, Port Elizabeth, South Africa; [Sullivan, Patrick S.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	University of California System; University of California Los Angeles; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Cape Town; Human Sciences Research Council-South Africa; Nelson Mandela University; Emory University; Rollins School Public Health	Brookmeyer, R (corresponding author), Univ Calif Los Angeles, Dept Biostat, Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA.	rbrookmeyer@ucla.edu	Bekker, Linda-Gail/AAZ-8929-2020; Baral, Stefan/AAG-4818-2020; Phaswana-Mafuya, Nancy Refilwe/B-8902-2018	Baral, Stefan/0000-0002-5482-2419; Phaswana-Mafuya, Nancy Refilwe/0000-0001-9387-0432; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Sullivan, Patrick Sean/0000-0002-7728-0587	National Institutes of Health [R01AI094575]; Human Sciences Research Council; NIH funded program [1P30AI094189]; NIAID; NCI; NICHD; NHLBI; NIDA; NIMH; NIA; FIC; OAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094575, P30AI050409, P30AI094189, P30AI028697] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Sciences Research Council; NIH funded program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); FIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); OAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institutes of Health (R01AI094575), the Human Sciences Research Council, and was facilitated by the Emory Center for AIDS Research (P30 AI050409), the UCLA Center for AIDS Research (AI028697) and the Johns Hopkins University Center for AIDS Research, an NIH funded program (1P30AI094189), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, FIC, and OAR. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas UL, 2013, J INFECT DIS, V208, P224, DOI 10.1093/infdis/jit150; Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Baral S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-766; Baral SD, 2014, CURR OPIN HIV AIDS, V9, P156, DOI 10.1097/COH.0000000000000037; Bekker LG, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007435; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Boren D, 2014, STAT MED, DOI 10002/sim6193; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cohen J, 2005, SCIENCE, V309, P1002, DOI 10.1126/science.309.5737.1002; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; DEGRUTTOLA V, 1991, J AM STAT ASSOC, V86, P569, DOI 10.2307/2290384; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; El-Sadr WM, 2013, JAIDS-J ACQ IMM DEF, V63, pS115, DOI 10.1097/QAI.0b013e318299c3d9; Epstein J.M., 2006, GENERATIVE SOCIAL SC, P4; Goodreau SM, 2005, J INFECT DIS, V191, pS147, DOI 10.1086/425268; Goodreau SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102960; Goodreau SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050522; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055449; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Institute of Medicine, 2008, METH CHALL BIOM HIV; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Koblin B, 2004, LANCET, V364, P41, DOI 10.1016/S0140-6736(04)16588-4; Lagakos SW, 2008, NEW ENGL J MED, V358, P1543, DOI 10.1056/NEJMp0802028; Lou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090985; Marx BD, 1996, TECHNOMETRICS, V38, P374, DOI 10.2307/1271308; McCullagh P., 1989, MONOGRAPHS STAT APPL; R Development Core Team, R PROJ STAT COMP; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Tierney L, 2009, INT J PARALLEL PROG, V37, P78, DOI 10.1007/s10766-008-0077-2; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003	34	34	35	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112668	10.1371/journal.pone.0112668	http://dx.doi.org/10.1371/journal.pone.0112668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398143	Green Published, gold			2022-12-27	WOS:000345558500073
J	Kang, SJ; Lee, TA; Ra, EA; Lee, E; Choi, HJ; Lee, S; Park, B				Kang, Sujin; Lee, Taeyun A.; Ra, Eun A.; Lee, Eunhye; Choi, Hyun Jin; Lee, Sungwook; Park, Boyoun			Differential Control of Interleukin-6 mRNA Levels by Cellular Distribution of YB-1	PLOS ONE			English	Article							Y-BOX PROTEIN-1; ACID BINDING-PROTEINS; INFLAMMATION; CELLS; EXPRESSION; MICRORNAS; STRESS; SURVIVAL; DISEASE; FAMILY	Cytokine production is essential for innate and adaptive immunity against microbial invaders and must be tightly controlled. Cytokine messenger RNA (mRNA) is in constant flux between the nucleus and the cytoplasm and in transcription, splicing, or decay; such processes must be tightly controlled. Here, we report a novel function of Y-box-binding protein 1 (YB-1) in modulating interleukin-6 (IL-6) mRNA levels in a cell type-specific manner. In lipopolysaccharide (LPS)-stimulated macrophages, YB-1 interacts with IL-6 mRNA and actively transports it to the extracellular space by YB-1-enriched vesicles, resulting in the proper maintenance of intracellular IL-6 mRNA levels. YB-1 secretion occurs in a cell type-specific manner. Whereas macrophages actively secret YB-1, dendritic cells maintain it predominantly in the cytoplasm even in response to LPS. Intracellular YB-1 has the distinct function of regulating IL-6 mRNA stability in dendritic cells. Moreover, because LPS differentially regulates the expression of histone deacetylase 6 (HDAC6) in macrophages and dendritic cells, this stimulus might control YB-1 acetylation differentially in both cell types. Taken together, these results suggest a unique feature of YB-1 in controlling intracellular IL-6 mRNA levels in a cell type-specific manner, thereby leading to functions that are dependent on the extracellular and intracellular distribution of YB-1.	[Kang, Sujin; Lee, Taeyun A.; Ra, Eun A.; Lee, Eunhye; Choi, Hyun Jin; Lee, Sungwook; Park, Boyoun] Yonsei Univ, Dept Syst Biol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea	Yonsei University	Lee, S (corresponding author), Yonsei Univ, Dept Syst Biol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea.	swlee1905@yonsei.ac.kr; bypark@yonsei.ac.kr	Lee, Sungwook/K-3697-2013		Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2011-0015372, 2010-0009203]; National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea; Yonsei University Research Fund [2014-12-0135]; BK21 PLUS (Brain Korea 21 Program for Leading University Students); NRF (National Research Foundation of Korea) grant - Korean Government	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(National Research Foundation of Korea); National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Yonsei University Research Fund; BK21 PLUS (Brain Korea 21 Program for Leading University Students); NRF (National Research Foundation of Korea) grant - Korean Government	This study was supported by grants from Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0015372, 2010-0009203) and from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea. SL was supported by the Yonsei University Research Fund of 2014 (2014-12-0135). SK, TAL, and EAR were supported by BK21 PLUS (Brain Korea 21 Program for Leading University & Students). HJC was supported by NRF (National Research Foundation of Korea) grant funded by the Korean Government (NRF-2013- Global Ph.D. Fellowship Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alidousty C, 2014, J BIOL CHEM; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Aung HT, 2006, FASEB J, V20, P1315, DOI 10.1096/fj.05-5360com; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; Capowski EE, 2001, J IMMUNOL, V167, P5970, DOI 10.4049/jimmunol.167.10.5970; Cohen SB, 2010, ONCOGENE, V29, P403, DOI 10.1038/onc.2009.321; Diamond P, 2001, J BIOL CHEM, V276, P7943, DOI 10.1074/jbc.M009836200; Evdokimova V, 2001, EMBO J, V20, P5491, DOI 10.1093/emboj/20.19.5491; Frye BC, 2009, EMBO REP, V10, P783, DOI 10.1038/embor.2009.81; Hanssen L, 2013, J IMMUNOL, V191, P2604, DOI 10.4049/jimmunol.1300416; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Ivanov P, 2013, IMMUNOL REV, V253, P253, DOI 10.1111/imr.12051; Izumi H, 2001, NUCLEIC ACIDS RES, V29, P1200, DOI 10.1093/nar/29.5.1200; Kim ER, 2013, CELL CYCLE, V12, P3791, DOI 10.4161/cc.26670; Kosaka N, 2013, J BIOL CHEM, V288, P10849, DOI 10.1074/jbc.M112.446831; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lyabin DN, 2014, WIRES RNA, V5, P95, DOI 10.1002/wrna.1200; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Norling LV, 2010, J INTERN MED, V268, P15, DOI 10.1111/j.1365-2796.2010.02235.x; Raffetseder U, 2003, J BIOL CHEM, V278, P18241, DOI 10.1074/jbc.M212518200; Raffetseder U, 2012, EUR J CELL BIOL, V91, P567, DOI 10.1016/j.ejcb.2011.07.001; Raffetseder U, 2009, KIDNEY INT, V75, P185, DOI 10.1038/ki.2008.457; Ruzanov PV, 1999, J CELL SCI, V112, P3487; Seko Y, 2006, AUTOIMMUN REV, V5, P299, DOI 10.1016/j.autrev.2005.10.013; Sorokin AV, 2005, EMBO J, V24, P3602, DOI 10.1038/sj.emboj.7600830; Tacke F, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-185; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Van Roeyen CR, CELL COMMUN SIGNAL, V11, P63; WOLFFE AP, 1992, NEW BIOL, V4, P290; WOLFFE AP, 1994, BIOESSAYS, V16, P245, DOI 10.1002/bies.950160407	30	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112754	10.1371/journal.pone.0112754	http://dx.doi.org/10.1371/journal.pone.0112754			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398005	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558500086
J	Kim, M; Cheeti, A; Yoo, C; Choo, M; Paick, JS; Oh, SJ				Kim, Myong; Cheeti, Abhilash; Yoo, Changwon; Choo, Minsoo; Paick, Jae-Seung; Oh, Seung-June			Non-Invasive Clinical Parameters for the Prediction of Urodynamic Bladder Outlet Obstruction: Analysis Using Causal Bayesian Networks	PLOS ONE			English	Article							URINARY-TRACT SYMPTOMS; BENIGN PROSTATIC HYPERPLASIA; ARTIFICIAL NEURAL-NETWORKS; PRESSURE-FLOW; MEN; SCORE; DIAGNOSIS; PROBABILITY; VOLUME; SIZE	Purpose: To identify non-invasive clinical parameters to predict urodynamic bladder outlet obstruction (BOO) in patients with benign prostatic hyperplasia (BPH) using causal Bayesian networks (CBN). Subjects and Methods: From October 2004 to August 2013, 1,381 eligible BPH patients with complete data were selected for analysis. The following clinical variables were considered: age, total prostate volume (TPV), transition zone volume (TZV), prostate specific antigen (PSA), maximum flow rate (Qmax), and post-void residual volume (PVR) on uroflowmetry, and International Prostate Symptom Score (IPSS). Among these variables, the independent predictors of BOO were selected using the CBN model. The predictive performance of the CBN model using the selected variables was verified through a logistic regression (LR) model with the same dataset. Results: Mean age, TPV, and IPSS were 6.2 (+/- 7.3, SD) years, 48.5 (+/- 25.9) ml, and 17.9 (+/- 7.9), respectively. The mean BOO index was 35.1 (+/- 25.2) and 477 patients (34.5%) had urodynamic BOO (BOO index >= 40). By using the CBN model, we identified TPV, Qmax, and PVR as independent predictors of BOO. With these three variables, the BOO prediction accuracy was 73.5%. The LR model showed a similar accuracy (77.0%). However, the area under the receiver operating characteristic curve of the CBN model was statistically smaller than that of the LR model (0.772 vs. 0.798, p = 0.020). Conclusions: Our study demonstrated that TPV, Qmax, and PVR are independent predictors of urodynamic BOO.	[Kim, Myong; Choo, Minsoo; Paick, Jae-Seung; Oh, Seung-June] Seoul Natl Univ Hosp, Dept Urol, Seoul 110744, South Korea; [Cheeti, Abhilash] Florida Int Univ, Sch Comp & Informat Sci, Dept Comp Sci, Miami, FL 33199 USA; [Yoo, Changwon] Florida Int Univ, Robert Stempel Coll Publ Hlth & Social Work, Dept Biostat, Miami, FL 33199 USA	Seoul National University (SNU); Seoul National University Hospital; State University System of Florida; Florida International University; State University System of Florida; Florida International University	Oh, SJ (corresponding author), Seoul Natl Univ Hosp, Dept Urol, Seoul 110744, South Korea.	sjo@snu.ac.kr			Seoul National University Hospital Research Fund [04-2010-1080]	Seoul National University Hospital Research Fund	This study was supported by grant No. 04-2010-1080 from the Seoul National University Hospital Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS P, 1995, BRIT J UROL, V76, P11; [Anonymous], 1996, KOREAN J UROL; BALL AJ, 1981, BRIT J UROL, V53, P613, DOI 10.1111/j.1464-410X.1981.tb03273.x; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DERKSEN S, 1992, BRIT J MATH STAT PSY, V45, P265, DOI 10.1111/j.2044-8317.1992.tb00992.x; Djavan B, 2004, UROLOGY, V64, P1144, DOI 10.1016/j.urology.2004.08.049; Eckhardt MD, 2001, NEUROUROL URODYNAM, V20, P579, DOI 10.1002/nau.1010; Griffiths D, 1997, NEUROUROL URODYNAM, V16, P1, DOI 10.1002/(SICI)1520-6777(1997)16:1<1::AID-NAU1>3.0.CO;2-I; Jensen K M, 1988, Scand J Urol Nephrol Suppl, V114, P63; Kranse R, 2003, UROLOGY, V62, P667, DOI 10.1016/S0090-4295(03)00575-2; Laniado ME, 2004, BJU INT, V94, P1283, DOI 10.1111/j.1464-410X.2004.05158.x; Madersbacher S, 1997, BRIT J UROL, V80, P72, DOI 10.1046/j.1464-410X.1997.00220.x; Min DS, 2013, KOREAN J UROL, V54, P840, DOI 10.4111/kju.2013.54.12.840; Nikovski D, 2000, IEEE T KNOWL DATA EN, V12, P509, DOI 10.1109/69.868904; Ockrim JL, 2001, J UROLOGY, V166, P2221, DOI 10.1016/S0022-5347(05)65538-3; Pearl J, 1988, PROBABILISTIC REASON, P29, DOI [10.1016/B978-0-08-051489-5.50008-4, DOI 10.1016/B978-0-08-051489-5.50008-4]; Porru D, 1999, NEUROUROL URODYNAM, V18, P647; Rosier PFWM, 1996, J UROLOGY, V155, P1649, DOI 10.1016/S0022-5347(01)66153-6; ROSIER PFWM, 1995, WORLD J UROL, V13, P9, DOI 10.1007/BF00182658; Schafer W, 2002, NEUROUROL URODYNAM, V21, P261, DOI 10.1002/nau.10066; Sonke GS, 2000, J UROLOGY, V163, P300, DOI 10.1016/S0022-5347(05)68042-1; Spirtes P, 2000, CAUSATION PREDICTION, P42; Tu JV, 1996, J CLIN EPIDEMIOL, V49, P1225, DOI 10.1016/S0895-4356(96)00002-9; van Venrooij GEPM, 2004, UROLOGY, V63, P476, DOI 10.1016/j.urology.2003.10.021; VANVENROOIJ GEPM, 1995, J UROLOGY, V153, P1516, DOI 10.1016/S0022-5347(01)67449-4; vanVenrooij GEPM, 1996, J UROLOGY, V155, P2014, DOI 10.1016/S0022-5347(01)66077-4; Wadie BS, 2006, UROLOGY, V68, P1211, DOI 10.1016/j.urology.2006.08.1079; Wadie BS, 2001, J UROLOGY, V165, P35, DOI 10.1097/00005392-200101000-00009	28	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113131	10.1371/journal.pone.0113131	http://dx.doi.org/10.1371/journal.pone.0113131			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397903	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558500134
J	Romanowski, A; Garavaglia, MJ; Goya, ME; Ghiringhelli, PD; Golombek, DA				Romanowski, Andres; Javier Garavaglia, Matias; Eugenia Goya, Maria; Daniel Ghiringhelli, Pablo; Andres Golombek, Diego			Potential Conservation of Circadian Clock Proteins in the phylum Nematoda as Revealed by Bioinformatic Searches	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; C-ELEGANS; MAMMALIAN TIMELESS; E-BOX; GENE-EXPRESSION; DROSOPHILA; TRANSCRIPTION; FEEDBACK; COMPLEX; HOMOLOGS	Although several circadian rhythms have been described in C. elegans, its molecular clock remains elusive. In this work we employed a novel bioinformatic approach, applying probabilistic methodologies, to search for circadian clock proteins of several of the best studied circadian model organisms of different taxa (Mus musculus, Drosophila melanogaster, Neurospora crassa, Arabidopsis thaliana and Synechoccocus elongatus) in the proteomes of C. elegans and other members of the phylum Nematoda. With this approach we found that the Nematoda contain proteins most related to the core and accessory proteins of the insect and mammalian clocks, which provide new insights into the nematode clock and the evolution of the circadian system.	[Romanowski, Andres; Eugenia Goya, Maria; Andres Golombek, Diego] Univ Nacl Quilmes, Lab Cronobiol, Dept Ciencia & Tecnol, Bernal, Buenos Aires, Argentina; [Javier Garavaglia, Matias; Daniel Ghiringhelli, Pablo] Univ Nacl Quilmes, Lab Ingn Genet & Biol Celular & Mol, Area Virosis Insectos, Inst Microbiol Basica & Aplicada,Dept Ciencia & T, Bernal, Buenos Aires, Argentina		Golombek, DA (corresponding author), Univ Nacl Quilmes, Lab Cronobiol, Dept Ciencia & Tecnol, Bernal, Buenos Aires, Argentina.	dgolombek@gmail.com	Ghiringhelli, Pablo D/N-8073-2017; Romanowski, Andres/P-2153-2017	Ghiringhelli, Pablo D/0000-0002-2003-0106; Romanowski, Andres/0000-0003-0737-2408; Golombek, Diego/0000-0002-6291-5586; Goya, Maria Eugenia/0000-0002-5031-2470	National Science Agency (ANPCyT); National Research Council (CONICET); National University of Quilmes (UNQ)	National Science Agency (ANPCyT)(ANPCyT); National Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National University of Quilmes (UNQ)	This work was supported by National Science Agency (ANPCyT), National Research Council (CONICET) and National University of Quilmes (UNQ) grants to DAG and PDG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Arur S, 2009, P NATL ACAD SCI USA, V106, P4776, DOI 10.1073/pnas.0812285106; Baker CL, 2012, FEMS MICROBIOL REV, V36, P95, DOI 10.1111/j.1574-6976.2011.00288.x; Banerjee D, 2005, DEV CELL, V8, P287, DOI 10.1016/j.devcel.2004.12.006; Barnes JW, 2003, SCIENCE, V302, P439, DOI 10.1126/science.1086593; Benna C, 2010, CURR BIOL, V20, P346, DOI 10.1016/j.cub.2009.12.048; Brown SA, 2012, DEV CELL, V22, P477, DOI 10.1016/j.devcel.2012.02.007; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Chan RC, 2003, NATURE, V423, P1002, DOI 10.1038/nature01697; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; COHEN PTW, 1990, FEBS LETT, V268, P355, DOI 10.1016/0014-5793(90)81285-V; Crews ST, 2003, PAS PROTEINS: REGULATORS AND SENSORS OF DEVELOPMENT AND PHYSIOLOGY, P69; Darlington TK, 2000, J BIOL RHYTHM, V15, P462, DOI 10.1177/074873000129001576; Dong GG, 2010, CURR OPIN GENET DEV, V20, P619, DOI 10.1016/j.gde.2010.09.002; Dreier L, 2005, NEURON, V46, P51, DOI 10.1016/j.neuron.2004.12.058; Ebersberger I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-157; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Edwards SL, 2008, PLOS BIOL, V6, P1715, DOI 10.1371/journal.pbio.0060198; Engelen E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056623; Erdelyi P, 2011, J CELL SCI, V124, P1510, DOI 10.1242/jcs.080192; Fay DS, 2002, GENE DEV, V16, P503, DOI 10.1101/gad.952302; Fiedler T, 2006, NUCLEIC ACIDS RES, V34, pW546, DOI 10.1093/nar/gkl250; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fitch DHA, 2005, WORMBOOK; Gissendanner CR, 2004, DEV BIOL, V266, P399, DOI 10.1016/j.ydbio.2003.10.014; Golden A, 2003, DEV CELL, V5, P7, DOI 10.1016/S1534-5807(03)00209-0; Gotter AL, 2007, J MOL BIOL, V366, P36, DOI 10.1016/j.jmb.2006.10.097; Gotter AL, 2006, NEUROREPORT, V17, P1229, DOI 10.1097/01.wnr.0000233092.90160.92; Gu HF, 2014, SCI REP-UK, V4, DOI 10.1038/srep04212; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hao HP, 1997, MOL CELL BIOL, V17, P3687, DOI 10.1128/MCB.17.7.3687; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HARDIN PE, 1994, MOL CELL BIOL, V14, P7211, DOI 10.1128/MCB.14.11.7211; Hasegawa K, 2005, CHRONOBIOL INT, V22, P1, DOI 10.1081/CBI-200038149; Hatzold J, 2008, PLOS BIOL, V6, P771, DOI 10.1371/journal.pbio.0060084; Hendriks GJ, 2014, MOL CELL, V53, P380, DOI 10.1016/j.molcel.2013.12.013; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Janssen T, 2009, J NEUROCHEM, V111, P228, DOI 10.1111/j.1471-4159.2009.06323.x; Jeon M, 1999, SCIENCE, V286, P1141, DOI 10.1126/science.286.5442.1141; Jia HJ, 2011, CELL, V145, P890, DOI 10.1016/j.cell.2011.05.010; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Kageyama H, 2006, MOL CELL, V23, P161, DOI 10.1016/j.molcel.2006.05.039; Kelly RJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S12-S13; Kipreos ET, 2000, DEVELOPMENT, V127, P5071; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kostrouchova M, 2001, P NATL ACAD SCI USA, V98, P7360, DOI 10.1073/pnas.131171898; Kumaki Y, 2008, P NATL ACAD SCI USA, V105, P14946, DOI 10.1073/pnas.0802636105; Migliori ML, 2011, PHYSIOL BEHAV, V103, P315, DOI 10.1016/j.physbeh.2011.01.026; LeBoeuf B, 2011, NEUROSCIENCE, V175, P1, DOI 10.1016/j.neuroscience.2010.12.002; Leclerc GM, 2005, ENDOCRINOLOGY, V146, P2782, DOI 10.1210/en.2005-0100; Liu J, 2010, NAT NEUROSCI, V13, P715, DOI 10.1038/nn.2540; McFarlane RJ, 2010, CELL CYCLE, V9, P700, DOI 10.4161/cc.9.4.10676; McWatters HG, 2011, FEBS LETT, V585, P1474, DOI 10.1016/j.febslet.2011.03.051; Meelkop E, 2012, MOL CELL ENDOCRINOL, V361, P232, DOI 10.1016/j.mce.2012.05.001; Mehta N, 2004, GENETICS, V166, P1253, DOI 10.1534/genetics.166.3.1253; Migliori ML, 2012, J PINEAL RES, V53, P38, DOI 10.1111/j.1600-079X.2011.00969.x; Migliori ML, 2011, J PINEAL RES; Miskei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022218; Monsalve GC, 2011, CURR BIOL, V21, P2033, DOI 10.1016/j.cub.2011.10.054; Munoz E, 2003, CHRONOBIOL INT, V20, P371, DOI 10.1081/CBI-120022525; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Olmedo M, 2012, P NATL ACAD SCI USA, V109, P20479, DOI 10.1073/pnas.1211705109; Ooe N, 2007, GENE, V400, P122, DOI 10.1016/j.gene.2007.06.005; Petrillo Ezequiel, 2011, Commun Integr Biol, V4, P284, DOI 10.4161/cib.4.3.14777; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Powell-Coffman JA, 1998, P NATL ACAD SCI USA, V95, P2844, DOI 10.1073/pnas.95.6.2844; Qin HT, 2006, DEV BIOL, V298, P606, DOI 10.1016/j.ydbio.2006.07.017; Qin HT, 2004, DEV BIOL, V270, P64, DOI 10.1016/j.ydbio.2004.02.004; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Romanowski A, 2011, MICROB PATHOGENESIS, V50, P23, DOI 10.1016/j.micpath.2010.09.001; Romney SJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002394; Sancar A, 2000, ANNU REV BIOCHEM, V69, P31, DOI 10.1146/annurev.biochem.69.1.31; Sanchez SE, 2010, NATURE, V468, P112, DOI 10.1038/nature09470; Sandrelli F, 2008, INSECT MOL BIOL, V17, P447, DOI 10.1111/j.1365-2583.2008.00832.x; Schwarz EM, 2006, NUCLEIC ACIDS RES, V34, pD475, DOI 10.1093/nar/gkj061; Shemesh Y, 2007, FASEB J, V21, P2304, DOI 10.1096/fj.06-8032com; SIDOW A, 1994, CURR BIOL, V4, P596, DOI 10.1016/S0960-9822(00)00131-7; Simonetta SH, 2008, J COMP PHYSIOL A, V194, P821, DOI 10.1007/s00359-008-0353-z; Simonetta SH, 2007, J NEUROSCI METH, V161, P273, DOI 10.1016/j.jneumeth.2006.11.015; Simonetta SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007571; Sudhaus W, 2001, J NEMATOL, V33, P1; Takahashi JS, 2011, GENETICS CIRCADIAN S; Takumi T, 1999, GENES CELLS, V4, P67, DOI 10.1046/j.1365-2443.1999.00238.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Temmerman L, 2011, ANN NY ACAD SCI, V1220, P137, DOI 10.1111/j.1749-6632.2010.05927.x; Tennessen JM, 2006, DEV BIOL, V289, P30, DOI 10.1016/j.ydbio.2005.09.044; Tomioka K, 2010, CELL MOL LIFE SCI, V67, P1397, DOI 10.1007/s00018-009-0232-y; TRENT C, 1983, GENETICS, V104, P619; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ukai-Tadenuma M, 2008, NAT CELL BIOL, V10, P1154, DOI 10.1038/ncb1775; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; van der Linden AM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000503; Wang XD, 2006, DEV BIOL, V289, P456, DOI 10.1016/j.ydbio.2005.10.029; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155; Weinshenker D, 1999, J NEUROSCI, V19, P9831; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; Yan J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000193; Yang XM, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.050237; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011	106	9	9	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112871	10.1371/journal.pone.0112871	http://dx.doi.org/10.1371/journal.pone.0112871			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396739	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500103
J	Arango-Gonzalez, B; Trifunovic, D; Sahaboglu, A; Kranz, K; Michalakis, S; Farinelli, P; Koch, S; Koch, F; Cottet, S; Janssen-Bienhold, U; Dedek, K; Biel, M; Zrenner, E; Euler, T; Ekstrom, P; Ueffing, M; Paquet-Durand, F				Arango-Gonzalez, Blanca; Trifunovic, Dragana; Sahaboglu, Ayse; Kranz, Katharina; Michalakis, Stylianos; Farinelli, Pietro; Koch, Susanne; Koch, Fred; Cottet, Sandra; Janssen-Bienhold, Ulrike; Dedek, Karin; Biel, Martin; Zrenner, Eberhart; Euler, Thomas; Ekstrom, Per; Ueffing, Marius; Paquet-Durand, Francois			Identification of a Common Non-Apoptotic Cell Death Mechanism in Hereditary Retinal Degeneration	PLOS ONE			English	Article							MOUSE MODEL; POLY(ADP-RIBOSE) POLYMERASE; PHOTORECEPTOR DEGENERATION; GUANOSINE-MONOPHOSPHATE; MICE LACKING; IN-SITU; RD; ACTIVATION; CASPASE-3; ROD	Cell death in neurodegenerative diseases is often thought to be governed by apoptosis; however, an increasing body of evidence suggests the involvement of alternative cell death mechanisms in neuronal degeneration. We studied retinal neurodegeneration using 10 different animal models, covering all major groups of hereditary human blindness (rd1, rd2, rd10, Cngb1 KO, Rho KO, S334ter, P23H, Cnga3 KO, cpfl1, Rpe65 KO), by investigating metabolic processes relevant for different forms of cell death. We show that apoptosis plays only a minor role in the inherited forms of retinal neurodegeneration studied, where instead, a non-apoptotic degenerative mechanism common to all mutants is of major importance. Hallmark features of this pathway are activation of histone deacetylase, poly-ADP-ribose-polymerase, and calpain, as well as accumulation of cyclic guanosine monophosphate and poly-ADP-ribose. Our work thus demonstrates the prevalence of alternative cell death mechanisms in inherited retinal degeneration and provides a rational basis for the design of mutation-independent treatments.	[Arango-Gonzalez, Blanca; Trifunovic, Dragana; Sahaboglu, Ayse; Farinelli, Pietro; Zrenner, Eberhart; Euler, Thomas; Ueffing, Marius; Paquet-Durand, Francois] Univ Tubingen, Inst Ophthalm Res, Tubingen, Germany; [Kranz, Katharina; Janssen-Bienhold, Ulrike; Dedek, Karin] Carl von Ossietzky Univ Oldenburg, Dept Neurobiol, D-26111 Oldenburg, Germany; [Michalakis, Stylianos; Koch, Susanne; Koch, Fred; Biel, Martin] Univ Munich, Ctr Integrated Prot Sci Munich, Munich, Germany; [Michalakis, Stylianos; Koch, Susanne; Koch, Fred; Biel, Martin] Univ Munich, Dept Pharm, Ctr Drug Res, Munich, Germany; [Farinelli, Pietro; Ekstrom, Per] Lund Univ, Dept Clin Sci, Div Ophthalmol, Lund, Sweden; [Cottet, Sandra] Inst Res Ophthalmol, Sion, Switzerland; [Zrenner, Eberhart; Euler, Thomas] Univ Tubingen, Ctr Integrat Neurosci, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Carl von Ossietzky Universitat Oldenburg; University of Munich; University of Munich; Lund University; Eberhard Karls University of Tubingen	Arango-Gonzalez, B (corresponding author), Univ Tubingen, Inst Ophthalm Res, Tubingen, Germany.	blanca.arango-gonzalez@klinikum.uni-tuebingen.de; francois.paquet-durand@klinikum.uni-tuebingen.de	Michalakis, Stylianos/W-2094-2018; Trifunovic, Dragana/ABB-8165-2020; Michalakis, Stylianos/M-4677-2019; Paquet-Durand, Francois/G-6709-2015; Arango-Gonzalez, Blanca/AAR-7427-2021; Trifunovic, Dragana/AAA-1823-2020; Farinelli, Pietro/G-8000-2017; Dedek, Karin/R-6948-2018; Biel, Martin/G-1175-2014	Michalakis, Stylianos/0000-0001-5092-9238; Michalakis, Stylianos/0000-0001-5092-9238; Paquet-Durand, Francois/0000-0001-7355-5742; Arango-Gonzalez, Blanca/0000-0002-9045-182X; Farinelli, Pietro/0000-0002-4242-3090; Dedek, Karin/0000-0003-1490-0141; Biel, Martin/0000-0002-9974-3052; Euler, Thomas/0000-0002-4567-6966; Koch, Susanne/0000-0001-9966-113X; Trifunovic, Dragana/0000-0003-3168-4196; Sahaboglu, Ayse/0000-0003-3241-0672	Kerstan Foundation; Deutsche Forschungsgemeinschaft [DFG PA1751/1-1, DFG PA1751/4-1]; Alcon Research Institute; European Commission [DRUGSFORD: HEALTH-F2-2012-304963, PANOPTES: NMP4-SL-2010-246180]; German Ministry of Education and Research [BMBF HOPE2 - FKZ 01GM1108A]; Centre for Integrative Neuroscience [CIN pool project] [2009-20]; Kronprinsessan Margaretas Arbetsnamnd (KMA); Stiftelsen Olle Engkvist Byggmastare; Swedish Research Council [2009-3855]; Stiftelsen for Synskadade i f.d. Malmohus lan	Kerstan Foundation(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alcon Research Institute(Novartis); European Commission(European CommissionEuropean Commission Joint Research Centre); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Centre for Integrative Neuroscience [CIN pool project]; Kronprinsessan Margaretas Arbetsnamnd (KMA); Stiftelsen Olle Engkvist Byggmastare(Swedish Research Council); Swedish Research Council(Swedish Research CouncilEuropean Commission); Stiftelsen for Synskadade i f.d. Malmohus lan	This work was supported by the Kerstan Foundation, Deutsche Forschungsgemeinschaft [DFG PA1751/1-1, 4-1], Alcon Research Institute, European Commission [DRUGSFORD: HEALTH-F2-2012-304963; PANOPTES: NMP4-SL-2010-246180], German Ministry of Education and Research [BMBF HOPE2 - FKZ 01GM1108A], Centre for Integrative Neuroscience [CIN pool project 2009-20], Kronprinsessan Margaretas Arbetsnamnd (KMA), Stiftelsen Olle Engkvist Byggmastare, The Swedish Research Council 2009-3855, and Stiftelsen for Synskadade i f.d. Malmohus lan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azadi S, 2006, MOL CELL NEUROSCI, V31, P759, DOI 10.1016/j.mcn.2006.01.001; Bai P, 2012, CELL METAB, V16, P290, DOI 10.1016/j.cmet.2012.06.016; Bardai FH, 2012, J BIOL CHEM, V287, P35444, DOI 10.1074/jbc.M112.394544; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Chang B, 2001, INVEST OPHTH VIS SCI, V42, pS527; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; Clarke G, 2000, NATURE, V406, P195, DOI 10.1038/35018098; Comitato A, 2014, INVEST OPHTH VIS SCI, V55, P3555, DOI 10.1167/iovs.14-13917; Dalke C, 2005, EXP EYE RES, V81, P503, DOI 10.1016/j.exer.2005.06.004; DEVENTE J, 1987, NEUROSCIENCE, V22, P361, DOI 10.1016/0306-4522(87)90226-0; Doonan F, 2003, J NEUROSCI, V23, P5723; FARBER DB, 1974, SCIENCE, V186, P449, DOI 10.1126/science.186.4162.449; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; Gross OP, 2012, NEURON, V76, P370, DOI 10.1016/j.neuron.2012.07.029; Hafezi F, 1998, INVEST OPHTH VIS SCI, V39, P2239; Hamann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006616; Hamel C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-40; Hamel CP, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-7; Hao Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002065; Hauck SM, 2006, MOL CELL PROTEOMICS, V5, P324, DOI 10.1074/mcp.M500217-MCP200; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Huttl S, 2005, J NEUROSCI, V25, P130, DOI 10.1523/JNEUROSCI.3764-04.2005; Jaumann M, 2012, NAT MED, V18, P252, DOI 10.1038/nm.2634; Joseph RM, 1996, INVEST OPHTH VIS SCI, V37, P2434; Kaur J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022181; Keeler CE, 1924, P NATL ACAD SCI USA, V10, P329, DOI 10.1073/pnas.10.7.329; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Liu CD, 1999, J NEUROSCI, V19, P4778; Lohr HR, 2006, EXP EYE RES, V83, P380, DOI 10.1016/j.exer.2006.01.014; Marigo V, 2007, CELL CYCLE, V6, P652, DOI 10.4161/cc.6.6.4029; McCall K, 2010, CURR OPIN CELL BIOL, V22, P882, DOI 10.1016/j.ceb.2010.09.002; Michalakis S, 2010, MOL THER, V18, P2057, DOI 10.1038/mt.2010.149; Ogilvie JM, 1998, INVEST OPHTH VIS SCI, V39, P1713; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Paquet-Durand F, 2006, J NEUROCHEM, V96, P802, DOI 10.1111/j.1471-4159.2005.03628.x; Paquet-Durand F, 2007, J NEUROSCI, V27, P10311, DOI 10.1523/JNEUROSCI.1514-07.2007; Paquet-Durand F, 2011, HUM MOL GENET, V20, P941, DOI 10.1093/hmg/ddq539; Paquet-Durand F, 2010, J NEUROCHEM, V115, P930, DOI 10.1111/j.1471-4159.2010.06983.x; Paquet-Durand F, 2009, J NEUROCHEM, V108, P796, DOI 10.1111/j.1471-4159.2008.05822.x; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Rubakhin SS, 2013, CURR OPIN BIOTECH, V24, P95, DOI 10.1016/j.copbio.2012.10.021; Sahaboglu A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.12; Sahaboglu A, 2014, ADV EXP MED BIOL, V801, P463, DOI 10.1007/978-1-4614-3209-8_59; Sahaboglu A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015495; Sancho-Pelluz J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.4; Sancho-Pelluz J, 2008, MOL NEUROBIOL, V38, P253, DOI 10.1007/s12035-008-8045-9; SANYAL S, 1973, Z ANAT ENTWICKLUNGS, V142, P219, DOI 10.1007/BF00519723; SANYAL S, 1980, J COMP NEUROL, V194, P193, DOI 10.1002/cne.901940110; Shinde VM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033266; Steinberg R. H., 1996, Investigative Ophthalmology and Visual Science, V37, pS698; Tiwari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059306; Trifunovic D, 2012, CURR MOL MED, V12, P598, DOI 10.2174/156652412800620048; Trifunovic D, 2010, J COMP NEUROL, V518, P3604, DOI 10.1002/cne.22416; Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902; Woodruff ML, 2003, NAT GENET, V35, P158, DOI 10.1038/ng1246; Yoshizawa K, 2002, GRAEF ARCH CLIN EXP, V240, P214, DOI 10.1007/s00417-002-0427-5; YOUNG RW, 1984, J COMP NEUROL, V229, P362, DOI 10.1002/cne.902290307; Zeiss CJ, 2004, INVEST OPHTH VIS SCI, V45, P964, DOI 10.1167/iovs.03-0439	63	134	136	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112142	10.1371/journal.pone.0112142	http://dx.doi.org/10.1371/journal.pone.0112142			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392995	Green Published, gold, Green Submitted			2022-12-27	WOS:000347709300035
J	Hao, SY; Jin, B; Shin, AY; Zhao, YF; Zhu, CQ; Li, Z; Hu, ZK; Fu, CL; Ji, J; Wang, Y; Zhao, YZ; Dai, D; Culver, DS; Alfreds, ST; Rogow, T; Stearns, F; Sylvester, KG; Widen, E; Ling, XFB				Hao, Shiying; Jin, Bo; Shin, Andrew Young; Zhao, Yifan; Zhu, Chunqing; Li, Zhen; Hu, Zhongkai; Fu, Changlin; Ji, Jun; Wang, Yong; Zhao, Yingzhen; Dai, Dorothy; Culver, Devore S.; Alfreds, Shaun T.; Rogow, Todd; Stearns, Frank; Sylvester, Karl G.; Widen, Eric; Ling, Xuefeng B.			Risk Prediction of Emergency Department Revisit 30 Days Post Discharge: A Prospective Study	PLOS ONE			English	Article							STRATIFICATION TOOL; FOLLOW-UP; AGED 65; READMISSION; ADMISSION; VISITS; HOSPITALIZATION; HISTORY; SYSTEM	Background: Among patients who are discharged from the Emergency Department (ED), about 3% return within 30 days. Revisits can be related to the nature of the disease, medical errors, and/or inadequate diagnoses and treatment during their initial ED visit. Identification of high-risk patient population can help device new strategies for improved ED care with reduced ED utilization. Methods and Findings: A decision tree based model with discriminant Electronic Medical Record (EMR) features was developed and validated, estimating patient ED 30 day revisit risk. A retrospective cohort of 293,461 ED encounters from HealthInfoNet (HIN), Maine's Health Information Exchange (HIE), between January 1, 2012 and December 31, 2012, was assembled with the associated patients' demographic information and one-year clinical histories before the discharge date as the inputs. To validate, a prospective cohort of 193,886 encounters between January 1, 2013 and June 30, 2013 was constructed. The c-statistics for the retrospective and prospective predictions were 0.710 and 0.704 respectively. Clinical resource utilization, including ED use, was analyzed as a function of the ED risk score. Cluster analysis of high-risk patients identified discrete sub-populations with distinctive demographic, clinical and resource utilization patterns. Conclusions: Our ED 30-day revisit model was prospectively validated on the Maine State HIN secure statewide data system. Future integration of our ED predictive analytics into the ED care work flow may lead to increased opportunities for targeted care intervention to reduce ED resource burden and overall healthcare expense, and improve outcomes.	[Hao, Shiying; Jin, Bo; Zhao, Yifan; Zhu, Chunqing; Hu, Zhongkai; Fu, Changlin; Ji, Jun; Dai, Dorothy; Stearns, Frank; Widen, Eric] HBI Solut Inc, Palo Alto, CA USA; [Hao, Shiying; Li, Zhen; Zhao, Yingzhen; Sylvester, Karl G.; Ling, Xuefeng B.] Stanford Univ, Dept Surg, Stanford, CA 94305 USA; [Shin, Andrew Young] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Wang, Yong] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Culver, Devore S.; Alfreds, Shaun T.; Rogow, Todd] HealthInfoNet, Portland, ME USA; [Wang, Yong] Chinese Acad Sci, Acad Math & Syst Sci, Beijing, Peoples R China	Stanford University; Stanford University; Stanford University; Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS	Ling, XFB (corresponding author), Stanford Univ, Dept Surg, Stanford, CA 94305 USA.	bxling@stanford.edu		Ling, Bruce/0000-0002-5386-3884; Hao, Shiying/0000-0002-7527-2460; Sylvester, Karl G./0000-0002-8559-0155				Academies IoMotN, 2006, HOSP BAS EM CAR BREA; Arendts G, 2013, INTERN EMERG MED, V8, P249, DOI 10.1007/s11739-012-0895-5; Bennett CC, 2012, J BIOMED INFORM, V45, P634, DOI 10.1016/j.jbi.2012.02.011; Berk ML, 2001, HEALTH AFFAIR, V20, P9, DOI 10.1377/hlthaff.20.2.9; Billings J, 2006, BRIT MED J, V333, P327, DOI 10.1136/bmj.38870.657917.AE; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; BUESCHING DP, 1985, ANN EMERG MED, V14, P672, DOI 10.1016/S0196-0644(85)80886-6; Burley M, 2009, COSTS FREQUENCY MENT; Burt C. W., 2008, EMERGENCY DEP VISITS; Buurman BM, 2011, EUR J EMERG MED, V18, P215, DOI 10.1097/MEJ.0b013e328344597e; Coffey R, 2010, EMERGENCY DEP USE ME, P131; Doran KM, 2013, ANN EMERG MED, V62, P151, DOI 10.1016/j.annemergmed.2013.02.016; ELLIOTT MJ, 1978, CAN J PUBLIC HEALTH, V69, P233; Forrey AW, 1996, CLIN CHEM, V42, P81; Friedmann PD, 2001, AM J EMERG MED, V19, P125, DOI 10.1053/ajem.2001.21321; Fuda KK, 2006, ANN EMERG MED, V48, P9, DOI 10.1016/j.annemergmed.2006.03.001; Gabayan GZ, 2013, ANN EMERG MED, V62, P136, DOI 10.1016/j.annemergmed.2013.01.017; Gallagher RA, 2013, PEDIATR EMERG CARE, V29, P579, DOI 10.1097/PEC.0b013e31828e62f4; Graf CE, 2011, AGING CLIN EXP RES, V23, P244, DOI [10.3275/7284, 10.1007/BF03337751]; Groke S, 2010, INTERNET J EMERGENCY, V6, P2; Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533; Hustey FM, 2007, J AM GERIATR SOC, V55, P1269, DOI 10.1111/j.1532-5415.2007.01272.x; Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169; Jacobstein CR, 2005, PEDIATR EMERG CARE, V21, P816, DOI 10.1097/01.pec.0000190228.97362.30; Jolliffe IT, 2002, PRINCIPAL COMPONENT, P488, DOI [10.1007/b98835, DOI 10.1007/B98835]; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Katz DA, 2013, J EMERG MED, V45, P947, DOI 10.1016/j.jemermed.2013.05.029; Khan NU, 2011, EUR J EMERG MED, V18, P276, DOI 10.1097/MEJ.0b013e3283449100; Kharbanda AB, 2013, J PEDIATR-US, V163, P230, DOI 10.1016/j.jpeds.2012.12.013; Lee Eva K, 2012, AMIA Annu Symp Proc, V2012, P495; LERMAN B, 1987, Journal of Emergency Medicine, V5, P359, DOI 10.1016/0736-4679(87)90138-7; Lin X, 2011, IEEE C ELEC DEVICES; Machlin S, 2011, EXPENSES CHARACTERIS, P1; Martin-Gill C, 2004, AM J EMERG MED, V22, P448, DOI 10.1016/j.ajem.2004.07.023; Meldon SW, 2003, ACAD EMERG MED, V10, P224, DOI 10.1111/j.1553-2712.2003.tb01996.x; Mion LC, 2003, ANN EMERG MED, V41, P57, DOI 10.1067/mem.2003.3; Moons P, 2007, EUR J EMERG MED, V14, P315, DOI 10.1097/MEJ.0b013e3282aa3e45; Nunez S, 2006, QUAL SAF HEALTH CARE, V15, P102, DOI 10.1136/qshc.2005.016618; Olfson M, 2013, AM J PSYCHIAT, V170, P1442, DOI 10.1176/appi.ajp.2013.12121506; Pfuntner A., 2010, COSTS HOSP STAYS US, P1; Pines JM, 2013, MED CARE RES REV, V70, P218, DOI 10.1177/1077558712470565; Roland M, 2005, BRIT MED J, V330, P289, DOI 10.1136/bmj.330.7486.289; Shelton P, 2000, AM J MANAG CARE, V6, P925; Sills MR, 2011, ACAD EMERG MED, V18, P158, DOI 10.1111/j.1553-2712.2010.00992.x; Sin DD, 2002, ARCH INTERN MED, V162, P1591, DOI 10.1001/archinte.162.14.1591; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Stanton MW., 2006, HIGH CONCENTRATION U; Sun BC, 2013, ANN EMERG MED, V61, P605, DOI 10.1016/j.annemergmed.2012.10.026; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Wang Han-Yi, 2007, Chang Gung Med J, V30, P437; WINGERT F, 1986, METHOD INFORM MED, V25, P22; Wu CL, 2010, J EMERG MED, V38, P512, DOI 10.1016/j.jemermed.2008.03.039; Zha HY, 2002, ADV NEUR IN, V14, P1057	53	55	56	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112944	10.1371/journal.pone.0112944	http://dx.doi.org/10.1371/journal.pone.0112944			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393305	Green Published, gold			2022-12-27	WOS:000347709300124
J	Homs, M; Caballero, A; Gregori, J; Tabernero, D; Quer, J; Nieto, L; Esteban, R; Buti, M; Rodriguez-Frias, F				Homs, Maria; Caballero, Andrea; Gregori, Josep; Tabernero, David; Quer, Josep; Nieto, Leonardo; Esteban, Rafael; Buti, Maria; Rodriguez-Frias, Francisco			Clinical Application of Estimating Hepatitis B Virus Quasispecies Complexity by Massive Sequencing: Correlation between Natural Evolution and On-Treatment Evolution	PLOS ONE			English	Article							ANTIGEN SEROCONVERSION; CORE ANTIGEN; INFECTION; MUTATIONS; NUCLEOSIDE; NUCLEOTIDE; DIVERSITY; DYNAMICS; EPITOPES; THERAPY	Aim: To evaluate HBV quasispecies (QA) complexity in the preCore/Core regions in relation to HBeAg status, and explore QA changes under natural evolution and nucleoside analogue (NUC) treatment. Methods: Ultra-deep pyrosequencing of HBV preCore/Core regions in 30 sequential samples (baseline [ diagnosis], treatment-free, and treatment-nonresponse) from 10 retrospectively selected patients grouped according to HBeAg status over time: HBeAg+ (N = 4), HBeAg-(N = 2), and fluctuating HBeAg (transient seroreversion/seroconversion pattern) (N = 4). QA complexity was defined by Shannon entropy, mutation frequency, nucleotide diversity, and mutation frequency of amino acids (MfAA) in preCore and Core. Results: The QA was less complex in HBeAg+ than in HBeAg-or fluctuating HBeAg. High complexity in preCore was associated with decreased viral replication (preCore MfAA negatively correlated with HBV-DNA, p = 0.005). QA complexity in the treatment-free period negatively correlated with values seen during treatment. Specific variants were mainly selected in the Core region in HBeAg- and fluctuating HBeAg patients, suggesting higher immune pressure than in HBeAg+. Conclusions: The negative correlation between QA natural evolution and on-treatment evolution indicates the importance of pre-treatment QA study to predict QA changes in NUC nonresponders. Study of QA complexity could be useful for managing HBV infection.	[Homs, Maria; Gregori, Josep; Tabernero, David; Quer, Josep; Esteban, Rafael; Buti, Maria; Rodriguez-Frias, Francisco] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Homs, Maria; Caballero, Andrea; Tabernero, David; Nieto, Leonardo; Rodriguez-Frias, Francisco] Univ Autonoma Barcelona, Hosp Vall dHebron, Dept Biochem, Liver Pathol Unit, E-08193 Barcelona, Spain; [Homs, Maria; Caballero, Andrea; Tabernero, David; Nieto, Leonardo; Rodriguez-Frias, Francisco] Univ Autonoma Barcelona, Hosp Vall dHebron, Dept Microbiol, Liver Pathol Unit, E-08193 Barcelona, Spain; [Homs, Maria; Tabernero, David; Nieto, Leonardo; Rodriguez-Frias, Francisco] Univ Autonoma Barcelona, Hosp Vall dHebron, Dept Microbiol, Virol Unit, E-08193 Barcelona, Spain; [Gregori, Josep; Quer, Josep] Hosp Valle De Hebron, Res Inst, Barcelona, Spain; [Esteban, Rafael; Buti, Maria] Univ Autonoma Barcelona, Hosp Vall dHebron, Dept Internal Med, Liver Unit, E-08193 Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron	Rodriguez-Frias, F (corresponding author), Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain.	frarodri@vhebron.net	Quer, Josep/A-6741-2012; Rodriguez-Frias, Francisco/AAC-3507-2020; Gregori, Josep/J-2586-2015; Tabernero, David/AAB-3848-2019	Quer, Josep/0000-0003-0014-084X; Gregori, Josep/0000-0002-4253-8015; Tabernero, David/0000-0002-1146-4084; rodriguez-frias, francisco/0000-0002-9128-7013; Nieto, Leonardo/0000-0002-1336-5645; Buti Ferret, Maria/0000-0002-0732-3078; Homs, Maria/0000-0002-8370-8375; esteban, rafael/0000-0001-5280-392X; CABALLERO, ANDREA/0000-0003-2891-6347	Instituto de Salud Carlos III [PI12/01893]; European Regional Development Fund (ERDF)	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund (ERDF)(European Commission)	This study was funded by Instituto de Salud Carlos III (grant PI12/01893), cofinanced by the European Regional Development Fund (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belnap DM, 2003, P NATL ACAD SCI USA, V100, P10884, DOI 10.1073/pnas.1834404100; Boni C, 2012, GASTROENTEROLOGY, V143, P963, DOI 10.1053/j.gastro.2012.07.014; Cabot B, 2000, J VIROL, V74, P805, DOI 10.1128/JVI.74.2.805-811.2000; Chen MT, 2004, P NATL ACAD SCI USA, V101, P14913, DOI 10.1073/pnas.0406282101; Cheng Y, 2013, GUT, V62, P1347, DOI 10.1136/gutjnl-2012-302408; Cheng Y, 2013, J HEPATOL, V58, P217, DOI 10.1016/j.jhep.2012.09.017; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; Gregori J, 2014, BIOINFORMATICS, V30, P1104, DOI 10.1093/bioinformatics/btt768; Gregori J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083361; Homs M, 2012, WORLD J GASTROENTERO, V18, P6096, DOI 10.3748/wjg.v18.i42.6096; Homs M, 2011, NUCLEIC ACIDS RES, V39, P8457, DOI 10.1093/nar/gkr451; Homs M, 2011, ANTIVIR THER, V16, P37, DOI 10.3851/IMP1701; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Kidd-Ljunggren K, 2002, J GEN VIROL, V83, P1267, DOI 10.1099/0022-1317-83-6-1267; Lavocat F, 2013, J HEPATOL, V59, P684, DOI 10.1016/j.jhep.2013.05.038; Lim SG, 2007, GASTROENTEROLOGY, V133, P951, DOI 10.1053/j.gastro.2007.06.011; Liu F, 2011, GUT, V60, P1269, DOI 10.1136/gut.2010.226225; Margeridon-Thermet S, 2013, ANTIMICROB AGENTS CH, V57, P343, DOI 10.1128/AAC.01601-12; Margeridon-Thermet S, 2009, J INFECT DIS, V199, P1275, DOI 10.1086/597808; Nasu A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024907; Nishijima N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035052; Noguchi C, 2005, HEPATOLOGY, V41, P626, DOI 10.1002/hep.20580; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Ramirez C, 2013, ANTIVIR RES, V98, P273, DOI 10.1016/j.antiviral.2013.03.007; Rodriguez-Frias F, 2013, WORLD J GASTROENTERO, V19, P6995, DOI 10.3748/wjg.v19.i41.6995; Rodriguez-Frias F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037874; RodriguezFrias F, 1995, HEPATOLOGY, V22, P1641, DOI 10.1016/0270-9139(95)90185-X; Solmone M, 2009, J VIROL, V83, P1718, DOI 10.1128/JVI.02011-08; Tedder RS, 2013, ANTIVIR THER, V18, P489, DOI 10.3851/IMP2655; Torre F, 2004, J MED VIROL, V72, P370, DOI 10.1002/jmv.20016; Wang HY, 2010, J VIROL, V84, P3454, DOI 10.1128/JVI.02164-09; Yousif M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095377	32	24	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112306	10.1371/journal.pone.0112306	http://dx.doi.org/10.1371/journal.pone.0112306			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393280	Green Published, gold, Green Submitted			2022-12-27	WOS:000347709300050
J	Kumari, P; Choi, HL				Kumari, Priyanka; Choi, Hong L.			Seasonal Variability in Airborne Biotic Contaminants in Swine Confinement Buildings	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE GENES; CULTURE-INDEPENDENT CHARACTERIZATION; TETRACYCLINE RESISTANCE; RESPIRATORY SYMPTOMS; LIVESTOCK BUILDINGS; FARM-WORKERS; PIG; EXPOSURE; BACTERIA; DIVERSITY	Little is known about the seasonal dynamics of biotic contaminants in swine confinement buildings (SCBs). The biotic contaminants of seven SCBs were monitored during one visit in the winter and one during the summer. Paired-end Illumina sequencing of the 16S rRNA gene, V3 region, was used to examine seasonal shifts in bacterial community composition and diversity. The abundances of 16S rRNA genes and six tetracycline resistance genes (tetB, tetH, tetZ, tetO, tetQ, and tetW) were also quantified using real-time PCR. Bacterial abundances, community composition and diversity all showed strong seasonal patterns defined by winter peaks in abundance and diversity. Microclimatic variables of SCBs, particularly air speed, PM2.5 and total suspended particles (TSP) were found significantly correlated to abundances, community composition, and diversity of bacterial bioaerosols. Seasonal fluctuations were also observed for four tetracycline resistance genes, tetH, tetO, tetQ, and tetW. The frequency of occurrences of these resistance genes were significantly higher in samples collected during winter and was also significantly correlated with air speed, PM2.5 and TSP. Overall, our results indicate that biotic contaminants in SCBs exhibit seasonal trends, and these could be associated with the microclimatic variables of SCBs. The correlations established in the current study could be helpful in establishing better management strategies to minimize the potential health impacts on both livestock and humans working in this environment.	[Kumari, Priyanka; Choi, Hong L.] Seoul Natl Univ, Res Inst Agr & Life Sci, Dept Agr Biotechnol, Seoul, South Korea	Seoul National University (SNU)	Choi, HL (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Dept Agr Biotechnol, Seoul, South Korea.	ulsoo8@snu.ac.kr		Kumari, Priyanka/0000-0001-9224-4966	Ministry of Agriculture, Food, and Rural Affairs (MAFRA) [312036-03-2-HD030]; Ministry of Trade, Industry and Energy (MOTIE) [2012-3020090040]	Ministry of Agriculture, Food, and Rural Affairs (MAFRA)(Ministry of Agriculture, Food & Rural Affairs (MAFRA), Republic of Korea); Ministry of Trade, Industry and Energy (MOTIE)(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea)	This work was supported by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries (IPET) from the Ministry of Agriculture, Food, and Rural Affairs (MAFRA) through project no. 312036-03-2-HD030, and in part by Korea Institute of Energy Technology Evaluation and Planning (KETEP) from the Ministry of Trade, Industry and Energy (MOTIE) through project no. 2012-3020090040. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminov RI, 2001, APPL ENVIRON MICROB, V67, P22, DOI 10.1128/AEM.67.1.22-32.2001; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Bent SJ, 2007, APPL ENVIRON MICROB, V73, P2399, DOI 10.1128/AEM.02383-06; Blake DP, 2003, J APPL MICROBIOL, V95, P428, DOI 10.1046/j.1365-2672.2003.01988.x; Cambra-Lopez M, 2010, ENVIRON POLLUT, V158, P1, DOI 10.1016/j.envpol.2009.07.011; CARPENTER GA, 1986, J AGR ENG RES, V33, P227, DOI 10.1016/S0021-8634(86)80038-5; Chang CW, 2001, APPL ENVIRON MICROB, V67, P155, DOI 10.1128/AEM.67.1.155-161.2001; Charavaryamath C, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-10; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; CHOUDAT D, 1994, SCAND J WORK ENV HEA, V20, P48, DOI 10.5271/sjweh.1429; CORMIER Y, 1990, AM IND HYG ASSOC J, V51, P304, DOI 10.1080/15298669091369709; Delsol AA, 2003, J APPL MICROBIOL, V95, P1226, DOI 10.1046/j.1365-2672.2003.02088.x; DONHAM K, 1989, BRIT J IND MED, V46, P31; Dosman JA, 2004, EUR RESPIR J, V24, P698, DOI 10.1183/09031936.04.00112102; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Forsberg KJ, 2014, NATURE, V509, P612, DOI 10.1038/nature13377; Gibbs SG, 2006, ENVIRON HEALTH PERSP, V114, P1032, DOI 10.1289/ehp.8910; Gibson MK, 2015, ISME J, V9, P207, DOI 10.1038/ismej.2014.106; HEEDERIK D, 1991, INT ARCH OCC ENV HEA, V62, P595, DOI 10.1007/BF00381114; Hong PY, 2012, ENVIRON MICROBIOL, V14, P1420, DOI 10.1111/j.1462-2920.2012.02726.x; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Israel-Assayag E, 2002, EUR RESPIR J, V19, P833, DOI 10.1183/09031936.02.02182001; Kembel SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087093; Kembel SW, 2012, ISME J, V6, P1469, DOI 10.1038/ismej.2011.211; Kilburn KH, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/565690; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Kristiansen A, 2012, FEMS MICROBIOL ECOL, V80, P390, DOI 10.1111/j.1574-6941.2012.01305.x; Letourneau V, 2010, INT J HYG ENVIR HEAL, V213, P444, DOI 10.1016/j.ijheh.2010.09.008; Levy SB, 1999, ANTIMICROB AGENTS CH, V43, P1523, DOI 10.1128/AAC.43.6.1523; Ling AL, 2013, ENVIRON SCI TECHNOL, V47, P4046, DOI 10.1021/es400238g; Mackiewicz B, 1998, ANN AGR ENV MED, V5, P169; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; McKinney CW, 2010, ENVIRON SCI TECHNOL, V44, P6102, DOI 10.1021/es9038165; Ministry of Environment Republic of Korea, 2008, ENV STAT YB, V12; Nehme B, 2008, ENVIRON MICROBIOL, V10, P665, DOI 10.1111/j.1462-2920.2007.01489.x; Nehme B, 2009, APPL ENVIRON MICROB, V75, P5445, DOI 10.1128/AEM.00726-09; Nonnenmann MW, 2010, J OCCUP ENVIRON HYG, V7, P693, DOI 10.1080/15459624.2010.526893; Oksanen J., 2007, COMMUN ECOL PACK, P631; ONEILL DH, 1992, J AGR ENG RES, V53, P23, DOI 10.1016/0021-8634(92)80072-Z; Otake S, 2010, VET MICROBIOL, V145, P198, DOI 10.1016/j.vetmic.2010.03.028; Pavilonis BT, 2013, ENVIRON RES, V122, P74, DOI 10.1016/j.envres.2012.12.008; R Core Team, 2021, R LANGUAGE ENV STAT; Roberts MC, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00384; Santamaria J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00252; Schinasi L, 2011, EPIDEMIOLOGY, V22, P208, DOI 10.1097/EDE.0b013e3182093c8b; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Smit LAM, 2014, OCCUP ENVIRON MED, V71, P134, DOI 10.1136/oemed-2013-101485; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Yang Y, 2013, ENVIRON SCI TECHNOL, V47, P10197, DOI 10.1021/es4017365; Zhou HW, 2011, ISME J, V5, P741, DOI 10.1038/ismej.2010.160; Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110	56	27	32	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112897	10.1371/journal.pone.0112897	http://dx.doi.org/10.1371/journal.pone.0112897			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393011	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300120
J	Woitek, R; Dvorak, A; Weber, M; Seidl, R; Bettelheim, D; Schopf, V; Amann, G; Brugger, PC; Furtner, J; Asenbaum, U; Prayer, D; Kasprian, G				Woitek, Ramona; Dvorak, Anton; Weber, Michael; Seidl, Rainer; Bettelheim, Dieter; Schoepf, Veronika; Amann, Gabriele; Brugger, Peter C.; Furtner, Julia; Asenbaum, Ulrika; Prayer, Daniela; Kasprian, Gregor			MR-Based Morphometry of the Posterior Fossa in Fetuses with Neural Tube Defects of the Spine	PLOS ONE			English	Article							CHIARI-II MALFORMATION; COMPUTED TOMOGRAPHIC SIGNS; PRENATAL-DIAGNOSIS; BIFIDA; LEMON	Objectives: In cases of "spina bifida,'' a detailed prenatal imaging assessment of the exact morphology of neural tube defects (NTD) is often limited. Due to the diverse clinical prognosis and prenatal treatment options, imaging parameters that support the prenatal differentiation between open and closed neural tube defects (ONTDs and CNTDs) are required. This fetal MR study aims to evaluate the clivus-supraocciput angle (CSA) and the maximum transverse diameter of the posterior fossa (TDPF) as morphometric parameters to aid in the reliable diagnosis of either ONTDs or CNTDs. Methods: The TDPF and the CSA of 238 fetuses (20-37 GW, mean: 28.36 GW) with a normal central nervous system, 44 with ONTDS, and 13 with CNTDs (18-37 GW, mean: 24.3 GW) were retrospectively measured using T2-weighted 1.5 Tesla MR sequences. Results: Normal fetuses showed a significant increase in the TDPF (r = .956; p<.001) and CSA (r = .714; p<.001) with gestational age. In ONTDs the CSA was significantly smaller (p<.001) than in normal controls and CNTDs, whereas in CNTDs the CSA was not significantly smaller than in controls (p = .160). In both ONTDs and in CNTDs the TDPF was significantly different from controls (p<.001). Conclusions: The skull base morphology in fetuses with ONTDs differs significantly from cases with CNTDs and normal controls. This is the first study to show that the CSA changes during gestation and that it is a reliable imaging biomarker to distinguish between ONTDs and CNTDs, independent of the morphology of the spinal defect.	[Woitek, Ramona; Weber, Michael; Schoepf, Veronika; Furtner, Julia; Asenbaum, Ulrika; Prayer, Daniela; Kasprian, Gregor] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy Med, Vienna, Austria; [Dvorak, Anton] Publ Hosp Wiener Neustadt, Wiener Neustadt, Austria; [Seidl, Rainer] Med Univ Vienna, Dept Paediat & Adolescent Med, Vienna, Austria; [Bettelheim, Dieter] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria; [Amann, Gabriele] Med Univ Vienna, Dept Clin Pathol, Vienna, Austria; [Brugger, Peter C.] Med Univ Vienna, Ctr Anat & Cell Biol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Woitek, R (corresponding author), Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy Med, Vienna, Austria.	ramona.woitek@meduniwien.ac.at	Weber, Michael/L-9836-2016; Kasprian, Gregor/AAJ-5052-2020	Weber, Michael/0000-0002-8507-2219; Kasprian, Gregor/0000-0003-3858-3347; Woitek, Ramona/0000-0002-9146-9159; Schopf, Veronika/0000-0003-1937-4216; Furtner, Julia/0000-0001-8258-3681	Austrian National Bank ("Quantitative Morphometrie der fetalen Gehirnentwicklung fur Pathologiemodellierung und Diagnose'') [OeNB 14812]	Austrian National Bank ("Quantitative Morphometrie der fetalen Gehirnentwicklung fur Pathologiemodellierung und Diagnose'')	Funding was supported by the Austrian National Bank (OeNB 14812, "Quantitative Morphometrie der fetalen Gehirnentwicklung fur Pathologiemodellierung und Diagnose''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAMPBELL J, 1987, OBSTET GYNECOL, V70, P247; Chaoui R, 2009, ULTRASOUND OBST GYN, V34, P249, DOI 10.1002/uog.7329; Chen SC, 2006, RADIOLOGY, V238, P997, DOI 10.1148/radiol.2383041283; D'Addario V, 2001, ULTRASOUND OBST GYN, V18, P146, DOI 10.1046/j.1469-0705.2001.00409.x; D'Addario V, 2008, J PERINAT MED, V36, P330, DOI 10.1515/JPM.2008.052; Fujisawa H, 2006, ACTA OBSTET GYN SCAN, V85, P1426, DOI 10.1080/00016340600645602; Grant RA, 2011, J NEUROSURG-PEDIATR, V7, P362, DOI 10.3171/2011.1.PEDS10234; Lachmann R, 2011, PRENATAL DIAG, V31, P103, DOI 10.1002/pd.2632; McLone DG, 2003, CHILD NERV SYST, V19, P540, DOI 10.1007/s00381-003-0792-3; MCLONE DG, 1989, PEDIATR NEUROSCI, V15, P1, DOI 10.1159/000120432; NAIDICH TP, 1980, RADIOLOGY, V134, P391, DOI 10.1148/radiology.134.2.7352218; NAIDICH TP, 1983, NEURORADIOLOGY, V25, P179, DOI 10.1007/BF00540232; NAIDICH TP, 1980, RADIOLOGY, V134, P657, DOI 10.1148/radiology.134.3.6965544; NAIDICH TP, 1980, RADIOLOGY, V134, P65, DOI 10.1148/radiology.134.1.7350637; Nishino A, 1998, SURG NEUROL, V49, P269, DOI 10.1016/S0090-3019(97)00180-8; Prayer D, 2004, PEDIATR RADIOL, V34, P685, DOI 10.1007/s00247-004-1246-0; Safra N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003646; Sarnat HB, 2008, HAND CLINIC, V87, P89, DOI 10.1016/S0072-9752(07)87006-0; Sarnat HB, 2004, PEDIATR DEVEL PATHOL, V7, P48, DOI 10.1007/s10024-003-2127-5; Stevenson Kevin L, 2004, Neurosurg Focus, V16, pE5; Thomas M, 2003, RADIOLOGY, V228, P206, DOI 10.1148/radiol.2281020448; Tortori-Donati P, 2005, PEDIAT NEURORADIOLOG; VANDENHOF MC, 1990, AM J OBSTET GYNECOL, V162, P322, DOI 10.1016/0002-9378(90)90378-K	23	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112585	10.1371/journal.pone.0112585	http://dx.doi.org/10.1371/journal.pone.0112585			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393279	Green Submitted, Green Published, gold			2022-12-27	WOS:000347709300075
J	Andolfi, L; Bourkoula, E; Migliorini, E; Palma, A; Pucer, A; Skrap, M; Scoles, G; Beltrami, AP; Cesselli, D; Lazzarino, M				Andolfi, Laura; Bourkoula, Eugenia; Migliorini, Elisa; Palma, Anita; Pucer, Anja; Skrap, Miran; Scoles, Giacinto; Beltrami, Antonio Paolo; Cesselli, Daniela; Lazzarino, Marco			Investigation of Adhesion and Mechanical Properties of Human Glioma Cells by Single Cell Force Spectroscopy and Atomic Force Microscopy	PLOS ONE			English	Article							LOW-GRADE GLIOMAS; CYTOSKELETON ORGANIZATION; CANCER; RECOGNITION; MANAGEMENT; MOTILITY	Active cell migration and invasion is a peculiar feature of glioma that makes this tumor able to rapidly infiltrate into the surrounding brain tissue. In our recent work, we identified a novel class of glioma-associated-stem cells (defined as GASC for high-grade glioma -HG-and Gasc for low-grade glioma -LG-) that, although not tumorigenic, act supporting the biological aggressiveness of glioma-initiating stem cells (defined as GSC for HG and Gsc for LG) favoring also their motility. Migrating cancer cells undergo considerable molecular and cellular changes by remodeling their cytoskeleton and cell interactions with surrounding environment. To get a better understanding about the role of the glioma-associated-stem cells in tumor progression, cell deformability and interactions between glioma-initiating stem cells and glioma-associated-stem cells were investigated. Adhesion of HG/LG-cancer cells on HG/LG-glioma-associated stem cells was studied by time-lapse microscopy, while cell deformability and cell-cell adhesion strengths were quantified by indentation measurements by atomic force microscopy and single cell force spectroscopy. Our results demonstrate that for both HG and LG glioma, cancer-initiatingstem cells are softer than glioma-associated-stem cells, in agreement with their neoplastic features. The adhesion strength of GSC on GASC appears to be significantly lower than that observed for Gsc on Gasc. Whereas, GSC spread and firmly adhere on Gasc with an adhesion strength increased as compared to that obtained on GASC. These findings highlight that the grade of glioma-associated-stem cells plays an important role in modulating cancer cell adhesion, which could affect glioma cell migration, invasion and thus cancer aggressiveness. Moreover this work provides evidence about the importance of investigating cell adhesion and elasticity for new developments in disease diagnostics and therapeutics.	[Andolfi, Laura; Lazzarino, Marco] CNR, Ist Officina Mat, Trieste, Italy; [Bourkoula, Eugenia; Palma, Anita; Pucer, Anja; Skrap, Miran; Scoles, Giacinto; Beltrami, Antonio Paolo; Cesselli, Daniela] Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy; [Migliorini, Elisa; Pucer, Anja] Univ Grenoble 1, Dept Chim Mol Ingn & Interact Bio Mol, Grenoble, France; [Lazzarino, Marco] Cluster Biomed, Trieste, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Officina dei Materiali (IOM-CNR); University of Udine; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Andolfi, L (corresponding author), CNR, Ist Officina Mat, Trieste, Italy.	andolfi@iom.cnr.it	skrap, miran/AAB-1708-2022; Beltrami, Antonio/C-5291-2008; Andolfi, Laura/AAC-3357-2022; Migliorini, Elisa/AFU-5371-2022; Palma, Anita/K-7656-2016; Lazzarino, Marco/AAC-3446-2022; Migliorini, Elisa/O-7065-2019	skrap, miran/0000-0002-6592-6416; Beltrami, Antonio/0000-0002-0679-2710; Migliorini, Elisa/0000-0003-3264-2027; Palma, Anita/0000-0002-5971-3676; Migliorini, Elisa/0000-0003-3264-2027; Lazzarino, Marco/0000-0003-1077-6569; Andolfi, Laura/0000-0001-6380-6747; Cesselli, Daniela/0000-0002-0562-7852	European Union [270483]; FIRB Accordi di programma; ERC- 7FP SP 2 IDEAS QUIDPROQUO G.A. [269051]; AIRC 5 per mille Special program [12214]; Programma per la Cooperazione Transfrontaliera Italia-Slovenia;  [RBAP11Z4Z9]	European Union(European Commission); FIRB Accordi di programma(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); ERC- 7FP SP 2 IDEAS QUIDPROQUO G.A.; AIRC 5 per mille Special program(Fondazione AIRC per la ricerca sul cancro); Programma per la Cooperazione Transfrontaliera Italia-Slovenia; 	This work was supported by: European Union Seventh Framework Programme (FP7/2007-2013) no270483 FP7 ICT - FOCUS Single Molecule Activation and Computing; FIRB Accordi di programma 2011; title: "FIERCE - Find nEw moleculaR and CEllular targets against cancer'', Pr. RBAP11Z4Z9. 2012-2014; FIRB accordi di programma 2011 pr. RBAP11ETKA_007 "Nanotechnological approaches for tumor theragnostic''; Programma per la Cooperazione Transfrontaliera Italia-Slovenia 2007-2013, title: "Identificazione di nuovi marcatori di cellule staminali tumorali a scopo diagnostico e terapeutico''; AIRC 5 per mille Special program 2011, Pr. 12214, title: "Application of Advanced Nanotechnology in the Development of Cancer Diagnostics Tools''; Project ERC- 7FP SP 2 IDEAS QUIDPROQUO G.A. n. 269051, title: "Molecular nanotechnology for life science applications: quantitative interactomics for diagnostics, proteomics and quantitative oncology''. The funders had no role in the study, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rekabi Z, 2014, EXP CELL RES, V322, P21, DOI 10.1016/j.yexcr.2013.12.027; Albuschies J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01658; Bourkoula E, 2014, STEM CELLS, V32, P1239, DOI 10.1002/stem.1605; Bourne TD, 2010, NAT REV NEUROL, V6, P695, DOI 10.1038/nrneurol.2010.159; Dao L, 2012, EXP CELL RES, V318, P2155, DOI 10.1016/j.yexcr.2012.06.017; Denker SP, 2002, CURR OPIN CELL BIOL, V14, P214, DOI 10.1016/S0955-0674(02)00304-6; Domke J, 1998, LANGMUIR, V14, P3320, DOI 10.1021/la9713006; Duffau H, 2009, CURR OPIN ONCOL, V21, P543, DOI 10.1097/CCO.0b013e3283305996; Efremov YM, 2013, J BIOMECH, V46, P1081, DOI 10.1016/j.jbiomech.2013.01.022; Franz CM, 2008, CELL MOL BIOENG, V1, P289, DOI 10.1007/s12195-008-0037-3; Friedrichs J, 2013, METHODS, V60, P169, DOI 10.1016/j.ymeth.2013.01.006; Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999; Hills CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071819; Hosseini BH, 2009, P NATL ACAD SCI USA, V106, P17852, DOI 10.1073/pnas.0905384106; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Kasas S, 2005, CELL MOTIL CYTOSKEL, V62, P124, DOI 10.1002/cm.20086; Kislin KL, 2009, NEOPLASIA, V11, P377, DOI 10.1593/neo.81572; Lekka M, 2012, MICRON, V43, P1259, DOI 10.1016/j.micron.2012.01.019; Lim TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045185; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mescola A, 2012, J MOL RECOGNIT, V25, P270, DOI 10.1002/jmr.2173; Migliorini E, 2013, BIOTECHNOL BIOENG, V110, P2301, DOI 10.1002/bit.24880; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Ohgaki Hiroko, 2009, V472, P323, DOI 10.1007/978-1-60327-492-0_14; Panorchan P, 2006, J CELL SCI, V119, P66, DOI 10.1242/jcs.02719; Petrie JR, 2009, J CELL SCI, V125, P5917; Place AE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2912; Plodinec M, 2012, NAT NANOTECHNOL, V7, P757, DOI [10.1038/nnano.2012.167, 10.1038/NNANO.2012.167]; Pogoda K, 2012, EUR BIOPHYS J BIOPHY, V41, P79, DOI 10.1007/s00249-011-0761-9; Prabhune M, 2012, MICRON, V43, P1267, DOI 10.1016/j.micron.2012.03.023; Ramms L, 2013, P NATL ACAD SCI USA, V110, P18513, DOI 10.1073/pnas.1313491110; Sanai N, 2011, J NEUROSURG, V115, P948, DOI [10.3171/2011.7.JNS101238, 10.3171/2011.7.JNS10238]; Sariisik E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057706; Sneddon IN., 1965, INT J ENG SCI, V3, P47, DOI [10.1016/0020-7225(65)90019-4, DOI 10.1016/0020-7225(65)90019-4, 10.1016/0020-7225(65)90019-4.477, DOI 10.1016/0020-7225(65)90019-4.477]; Soffietti R, 2010, EUR J NEUROL, V17, P1124, DOI 10.1111/j.1468-1331.2010.03151.x; Stupp R, 2010, ANN ONCOL, V21, pv190, DOI 10.1093/annonc/mdq187; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Taubenberger A, 2007, MOL BIOL CELL, V18, P1634, DOI 10.1091/mbc.E06-09-0777; Tulla M, 2008, FEBS LETT, V582, P3520, DOI 10.1016/j.febslet.2008.09.022; Vitucci M, 2011, BRIT J CANCER, V104, P545, DOI 10.1038/sj.bjc.6606031; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Yilmaz M, 2010, MOL CANCER RES, V8, P629, DOI 10.1158/1541-7786.MCR-10-0139	44	37	39	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112582	10.1371/journal.pone.0112582	http://dx.doi.org/10.1371/journal.pone.0112582			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390644	Green Submitted, Green Published, gold			2022-12-27	WOS:000349144400104
J	Izzo, NJ; Staniszewski, A; To, L; Fa, M; Teich, AF; Saeed, F; Wostein, H; Walko, T; Vaswani, A; Wardius, M; Syed, Z; Ravenscroft, J; Mozzoni, K; Silky, C; Rehak, C; Yurko, R; Finn, P; Look, G; Rishton, G; Safferstein, H; Miller, M; Johanson, C; Stopa, E; Windisch, M; Hutter-Paier, B; Shamloo, M; Arancio, O; LeVine, H; Catalano, SM				Izzo, Nicholas J.; Staniszewski, Agnes; To, Lillian; Fa, Mauro; Teich, Andrew F.; Saeed, Faisal; Wostein, Harrison; Walko, Thomas, III; Vaswani, Anisha; Wardius, Meghan; Syed, Zanobia; Ravenscroft, Jessica; Mozzoni, Kelsie; Silky, Colleen; Rehak, Courtney; Yurko, Raymond; Finn, Patricia; Look, Gary; Rishton, Gilbert; Safferstein, Hank; Miller, Miles; Johanson, Conrad; Stopa, Edward; Windisch, Manfred; Hutter-Paier, Birgit; Shamloo, Mehrdad; Arancio, Ottavio; LeVine, Harry, III; Catalano, Susan M.			Alzheimer's Therapeutics Targeting Amyloid Beta 1-42 Oligomers I: Abeta 42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive Deficits	PLOS ONE			English	Article							INDUCED SYNAPTIC DEPRESSION; CELLULAR PRION PROTEIN; A-BETA; MOUSE MODEL; HUMAN BRAIN; FORMAZAN EXOCYTOSIS; HIPPOCAMPAL-NEURONS; BEHAVIORAL DEFICITS; NATURAL OLIGOMERS; SPINE NUMBER	Synaptic dysfunction and loss caused by age-dependent accumulation of synaptotoxic beta amyloid (Abeta) 1-42 oligomers is proposed to underlie cognitive decline in Alzheimer's disease (AD). Alterations in membrane trafficking induced by Abeta oligomers mediates reduction in neuronal surface receptor expression that is the basis for inhibition of electrophysiological measures of synaptic plasticity and thus learning and memory. We have utilized phenotypic screens in mature, in vitro cultures of rat brain cells to identify small molecules which block or prevent the binding and effects of Abeta oligomers. Synthetic Abeta oligomers bind saturably to a single site on neuronal synapses and induce deficits in membrane trafficking in neuronal cultures with an EC50 that corresponds to its binding affinity. The therapeutic lead compounds we have found are pharmacological antagonists of Abeta oligomers, reducing the binding of Abeta oligomers to neurons in vitro, preventing spine loss in neurons and preventing and treating oligomer-induced deficits in membrane trafficking. These molecules are highly brain penetrant and prevent and restore cognitive deficits in mouse models of Alzheimer's disease. Counter-screening these compounds against a broad panel of potential CNS targets revealed they are highly potent and specific ligands of the sigma-2/PGRMC1 receptor. Brain concentrations of the compounds corresponding to greater than 80% receptor occupancy at the sigma-2/PGRMC1 receptor restore cognitive function in transgenic hAPP Swe/Ldn mice. These studies demonstrate that synthetic and human-derived Abeta oligomers act as pharmacologically-behaved ligands at neuronal receptors -i.e. they exhibit saturable binding to a target, they exert a functional effect related to their binding and their displacement by small molecule antagonists blocks their functional effect. The first-in-class small molecule receptor antagonists described here restore memory to normal in multiple AD models and sustain improvement long-term, representing a novel mechanism of action for disease-modifying Alzheimer's therapeutics.	[Izzo, Nicholas J.; Wostein, Harrison; Walko, Thomas, III; Vaswani, Anisha; Wardius, Meghan; Syed, Zanobia; Ravenscroft, Jessica; Mozzoni, Kelsie; Silky, Colleen; Rehak, Courtney; Yurko, Raymond; Finn, Patricia; Look, Gary; Rishton, Gilbert; Safferstein, Hank; Catalano, Susan M.] Cognit Therapeut Inc, Pittsburgh, PA 15203 USA; [LeVine, Harry, III] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Miller, Miles; Johanson, Conrad; Stopa, Edward] Brown Univ, Warren Alpert Med Sch, Dept Pathol & Neurosurg, Providence, RI 02912 USA; [To, Lillian] Stanford Univ, Sch Med, Behav & Funct Neurosci Lab, Palo Alto, CA 94304 USA; [Windisch, Manfred] GmbH, NeuroScios, Graz, Austria; [Hutter-Paier, Birgit] QPS Austria, GmbH, Graz, Austria; [Staniszewski, Agnes; Fa, Mauro; Teich, Andrew F.; Saeed, Faisal; Arancio, Ottavio] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY USA; [Staniszewski, Agnes; Fa, Mauro; Teich, Andrew F.; Saeed, Faisal; Arancio, Ottavio] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA	University of Kentucky; Brown University; Stanford University; Columbia University; Columbia University	Izzo, NJ (corresponding author), Cognit Therapeut Inc, Pittsburgh, PA 15203 USA.	nizzo@cogrx.com	arancio, ottavio/AAB-7959-2019; Fà, Mauro/AAH-2749-2020	Fà, Mauro/0000-0002-8348-0382; Saeed, Faisal/0000-0003-1194-2792; arancio, ottavio/0000-0001-6335-164X; Teich, Andrew/0000-0002-1916-8490; Izzo, Nicholas/0000-0002-0196-2055; Johanson, Conrad/0000-0002-1297-5484; Catalano, Susan/0000-0001-7278-3233	National Institute on Aging [SC AG-37337]; National Institute of Neurological Diseases and Stroke [SC AG-37337, NS-083175, NS-49442]; Alzheimer's Drug Discovery Foundation [20100501]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049442, R43NS083175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R43AG037337] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alzheimer's Drug Discovery Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support was provided by the National Institute on Aging [http://www.nia.nih.gov/]; (SC AG-37337), the National Institute of Neurological Diseases and Stroke [http://www.ninds.nih.gov/]; (SC, NS-083175; OA, NS-49442), and the Alzheimer's Drug Discovery Foundation [http://www.alzfdn.org]; (SC, 20100501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao FX, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.05.003; Benilova I, 2013, SCIENCE, V341, P1354, DOI 10.1126/science.1244166; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Calabrese B, 2007, MOL CELL NEUROSCI, V35, P183, DOI 10.1016/j.mcn.2007.02.006; Catalano SM, 2006, CURR TOP MED CHEM, V6, P597, DOI 10.2174/156802606776743066; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Esparza TJ, 2013, ANN NEUROL, V73, P104, DOI 10.1002/ana.23748; Faizi M, 2012, BRAIN BEHAV, V2, P142, DOI 10.1002/brb3.41; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fenili D, 2007, J MOL MED, V85, P603, DOI 10.1007/s00109-007-0156-7; Ferreira IL, 2012, CELL CALCIUM, V51, P95, DOI 10.1016/j.ceca.2011.11.008; Fowler SW, 2014, J NEUROSCI, V34, P7871, DOI 10.1523/JNEUROSCI.0572-14.2014; Ganapathy ME, 1999, J PHARMACOL EXP THER, V289, P251; Gortz P, 2004, BRAIN RES, V1018, P18, DOI 10.1016/j.brainres.2004.05.076; Haes AJ, 2005, J AM CHEM SOC, V127, P2264, DOI 10.1021/ja044087q; Havas D, 2011, J ALZHEIMERS DIS, V25, P231, DOI 10.3233/JAD-2011-101866; Herskovits AZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067898; Hong HS, 2007, BRAIN RES, V1130, P223, DOI 10.1016/j.brainres.2006.10.093; Hong HS, 2009, J NEUROCHEM, V108, P1097, DOI 10.1111/j.1471-4159.2008.05866.x; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Izzo NJ, 2014, PLOS ONE, V10; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kam TI, 2013, J CLIN INVEST, V123, P2791, DOI 10.1172/JCI66827; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kessels HW, 2013, P NATL ACAD SCI USA, V110, P4033, DOI 10.1073/pnas.1219605110; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Klyubin I, 2011, NEUROBIOL AGING, V32, P614, DOI 10.1016/j.neurobiolaging.2009.04.005; KORNHUBER J, 1995, NEUROSCI LETT, V195, P137, DOI 10.1016/0304-3940(95)11785-U; Kreutzmann P, 2010, CELL MOL NEUROBIOL, V30, P979, DOI 10.1007/s10571-010-9528-6; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lesne Sylvain E, 2013, Int J Cell Biol, V2013, P950783, DOI 10.1155/2013/950783; Lesne SE, 2013, BRAIN, V136, P1383, DOI 10.1093/brain/awt062; LeVine H, 2004, ANAL BIOCHEM, V335, P81, DOI 10.1016/j.ab.2004.08.014; Liu Y., 1997, CHIN J VET MED, V2, P4; Liu YB, 2004, J NEUROCHEM, V91, P648, DOI 10.1111/j.1471-4159.2004.02751.x; Maezawa I, 2006, J NEUROCHEM, V98, P57, DOI 10.1111/j.1471-4159.2006.03862.x; Marcello E, 2008, EUR J PHARMACOL, V585, P109, DOI 10.1016/j.ejphar.2007.11.083; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; Price P.J., 2001, PROTOCOLS NEURAL CEL, P255, DOI 10.1385/1-59259-207-4:255; Puzzo D, 2005, J NEUROSCI, V25, P6887, DOI 10.1523/JNEUROSCI.5291-04.2005; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Rana S, 2009, BIOORG MED CHEM LETT, V19, P670, DOI 10.1016/j.bmcl.2008.12.060; Reed MN, 2011, NEUROBIOL AGING, V32, P1784, DOI 10.1016/j.neurobiolaging.2009.11.007; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; Ronicke R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003236; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shankar GM, 2009, NEUROBIOL DIS, V36, P293, DOI 10.1016/j.nbd.2009.07.021; Sharma K, 2006, MOL CELL NEUROSCI, V31, P702, DOI 10.1016/j.mcn.2006.01.010; Shrestha BR, 2006, MOL CELL NEUROSCI, V33, P274, DOI 10.1016/j.mcn.2006.07.011; Takeda S, 2013, FASEB J, V27, P3239, DOI 10.1096/fj.13-229666; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Tong LQ, 2004, J NEUROSCI, V24, P6799, DOI 10.1523/JNEUROSCI.5463-03.2004; Torre V, 1998, NEURAL CIRCUITS NETW, pviii; Tseng BP, 1999, BIOCHEMISTRY-US, V38, P10424, DOI 10.1021/bi990718v; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Viola KL, 2008, J NUTR HEALTH AGING, V12, p51S, DOI 10.1007/BF02982587; Walsh DM, 2012, PROG MOL BIOL TRANSL, V107, P101, DOI 10.1016/B978-0-12-385883-2.00012-6; Wei W, 2010, NAT NEUROSCI, V13, P190, DOI 10.1038/nn.2476; Weidner AM, 2011, NEUROSCI LETT, V497, P1, DOI 10.1016/j.neulet.2011.03.082; Yamamoto N, 2007, J BIOL CHEM, V282, P2646, DOI 10.1074/jbc.M606202200; Yang T, 2013, ALZHEIMERS DEMENT, V9, P99, DOI 10.1016/j.jalz.2012.11.005; Zempel H, 2013, EMBO J, V32, P2920, DOI 10.1038/emboj.2013.207; Zempel H, 2012, NEURODEGENER DIS, V10, P64, DOI 10.1159/000332816; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	74	99	103	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111898	10.1371/journal.pone.0111898	http://dx.doi.org/10.1371/journal.pone.0111898			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390368	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400037
J	Ma, P; Gu, B; Xiong, W; Tan, BS; Geng, W; Li, J; Liu, HC				Ma, Pan; Gu, Bin; Xiong, Wei; Tan, Baosheng; Geng, Wei; Li, Jun; Liu, Hongchen			Glimepiride Promotes Osteogenic Differentiation in Rat Osteoblasts via the PI3K/Akt/eNOS Pathway in a High Glucose Microenvironment	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; VEIN ENDOTHELIAL-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; INDUCED APOPTOSIS; CULTURED HUMAN; B ACTIVATION; KINASE-B; BONE; INSULIN; PROLIFERATION	Our previous studies demonstrated that glimepiride enhanced the proliferation and differentiation of osteoblasts and led to activation of the PI3K/Akt pathway. Recent genetic evidence shows that endothelial nitric oxide synthase (eNOS) plays an important role in bone homeostasis. In this study, we further elucidated the roles of eNOS, PI3K and Akt in bone formation by osteoblasts induced by glimepiride in a high glucose microenvironment. We demonstrated that high glucose (16.5 mM) inhibits the osteogenic differentiation potential and proliferation of rat osteoblasts. Glimepiride activated eNOS expression in rat osteoblasts cultured with two different concentrations of glucose. High glucose-induced osteogenic differentiation was significantly enhanced by glimepiride. Down-regulation of PI3K P85 levels by treatment with LY294002 (a PI3K inhibitor) led to suppression of P-eNOS and P-AKT expression levels, which in turn resulted in inhibition of RUNX2, OCN and ALP mRNA expression in osteoblasts induced by glimepiride at both glucose concentrations. ALP activity was partially inhibited by 10 mu M LY294002. Taken together, our results demonstrate that glimepiride-induced osteogenic differentiation of osteoblasts occurs via eNOS activation and is dependent on the PI3K/Akt signaling pathway in a high glucose microenvironment.	[Ma, Pan; Tan, Baosheng; Geng, Wei; Li, Jun] Capital Med Univ, Beijing Stomatol Hosp, Dept Oral Implantol, Beijing, Peoples R China; [Gu, Bin; Liu, Hongchen] Chinese Peoples Liberat Army Gen Hosp, Dept Stomatol, Beijing 100853, Peoples R China; [Gu, Bin; Liu, Hongchen] Postgrad Mil Med Sch, Beijing, Peoples R China; [Xiong, Wei] Air Force Gen Hosp, Clin Aviat Med Ctr PLA, Beijing, Peoples R China	Capital Medical University; Chinese People's Liberation Army General Hospital; Air Force General Hospital PLA	Liu, HC (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Stomatol, Beijing 100853, Peoples R China.	liuhcpla@126.com			Beijing Capital Medical University Fund for Basic and Clinical Medicine Research [13JL83]; Beijing Stomatological Hospital of Capital Medical University Fund for Basic Research [14-09-09]	Beijing Capital Medical University Fund for Basic and Clinical Medicine Research; Beijing Stomatological Hospital of Capital Medical University Fund for Basic Research	This study was supported by Beijing Capital Medical University Fund for Basic and Clinical Medicine Research (no. 13JL83) and Beijing Stomatological Hospital of Capital Medical University Fund for Basic Research (no. 14-09-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal F, 2004, J PATHOL, V202, P503, DOI 10.1002/path.1536; Brenneisen P, 2002, BIOCHEM J, V365, P31, DOI 10.1042/BJ20020110; Chung DJ, 2013, J BONE MINER METAB, V31, P161, DOI 10.1007/s00774-012-0398-5; Das UN, 2002, EXP BIOL MED, V227, P88, DOI 10.1177/153537020222700202; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; de Paula FJA, 2010, DIABETES-METAB RES, V26, P622, DOI 10.1002/dmrr.1135; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Filippella MG, 2010, CLIN CASES MINER BON, V7, P126; Fujita T, 2004, J CELL BIOCHEM, V93, P374, DOI 10.1002/jcb.20192; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gramoun A, 2010, J CELL BIOCHEM, V111, P1020, DOI 10.1002/jcb.22791; Grassi F, 2006, ENDOCRINOLOGY, V147, P4392, DOI 10.1210/en.2006-0334; Guntur AR, 2011, J ENDOCRINOL, V211, P123, DOI 10.1530/JOE-11-0175; Helfrich MH, 1997, J BONE MINER RES, V12, P1108, DOI 10.1359/jbmr.1997.12.7.1108; Ho FM, 1999, J CELL BIOCHEM, V75, P258, DOI 10.1002/(SICI)1097-4644(19991101)75:2<258::AID-JCB8>3.0.CO;2-3; Jojima T, 2009, DIABETES OBES METAB, V11, P143, DOI 10.1111/j.1463-1326.2008.00923.x; Kurowski TG, 1999, DIABETES, V48, P658, DOI 10.2337/diabetes.48.3.658; Ma P, 2011, ARCH ORAL BIOL, V56, P307, DOI 10.1016/j.archoralbio.2010.10.009; Ma P, 2010, METABOLISM, V59, P359, DOI 10.1016/j.metabol.2009.08.003; Meng LD, 2008, ARCH PHARM RES, V31, P357, DOI [10.1007/s12272-001-1164-y, 10.1007/s00000-001-1164-y]; Molchadsky A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003707; Mukherjee A, 2012, MOL CELL BIOL, V32, P490, DOI 10.1128/MCB.06361-11; Muller G, 2001, BIOCHEMISTRY-US, V40, P14603, DOI 10.1021/bi0108352; Muller G, 2000, MOL MED, V6, P907, DOI 10.1007/BF03401827; Oku A, 2001, AM J PHYSIOL-ENDOC M, V280, pE816, DOI 10.1152/ajpendo.2001.280.5.E816; Rawat P, 2009, BIOORG MED CHEM LETT, V19, P4684, DOI 10.1016/j.bmcl.2009.06.074; Rodriguez E, 2004, ENDOCRINOLOGY, V145, P679, DOI 10.1210/en.2003-0755; Salani B, 2005, BIOCHEM BIOPH RES CO, V335, P832, DOI 10.1016/j.bbrc.2005.07.149; Sanchez G, 2008, CELL CYCLE, V7, P2299, DOI 10.4161/cc.6445; Saura M, 2010, THESCIENTIFICWORLDJO, V10, P624, DOI 10.1100/tsw.2010.58; Sun J, 2012, CELLS TISSUES ORGANS, V196, P510, DOI 10.1159/000339245; Thomas JE, 1997, J CELL BIOCHEM, V64, P182, DOI 10.1002/(SICI)1097-4644(199702)64:2<182::AID-JCB2>3.0.CO;2-T; Ulici V, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-40; Vestergaard P, 2005, DIABETOLOGIA, V48, P1292, DOI 10.1007/s00125-005-1786-3; Wang JY, 2005, LIFE SCI, V76, P2257, DOI 10.1016/j.lfs.2004.12.003; Wei Q, 2005, J BIOL CHEM, V280, P18081, DOI 10.1074/jbc.M413607200; Zayzafoon M, 2002, J BIOL CHEM, V277, P37212, DOI 10.1074/jbc.M200129200; Zhang W, 2007, NUTRITION, V23, P762, DOI 10.1016/j.nut.2007.07.003	38	37	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112243	10.1371/journal.pone.0112243	http://dx.doi.org/10.1371/journal.pone.0112243			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391146	Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400064
J	Mumm, CAS; Knornschild, M				Mumm, Christina A. S.; Knoernschild, Mirjam			The Vocal Repertoire of Adult and Neonate Giant Otters (Pteronura brasiliensis)	PLOS ONE			English	Article							COMMUNICATIVE COMPLEXITY; SOCIAL COMPLEXITY; PUP VOCALIZATIONS; RIVER OTTERS; GROUP-SIZE; BODY-SIZE; MUSTELIDAE; CARNIVORA; ORGANIZATION; EVOLUTION	Animals use vocalizations to exchange information about external events, their own physical or motivational state, or about individuality and social affiliation. Infant babbling can enhance the development of the full adult vocal repertoire by providing ample opportunity for practice. Giant otters are very social and frequently vocalizing animals. They live in highly cohesive groups, generally including a reproductive pair and their offspring born in different years. This basic social structure may vary in the degree of relatedness of the group members. Individuals engage in shared group activities and different social roles and thus, the social organization of giant otters provides a basis for complex and long-term individual relationships. We recorded and analysed the vocalizations of adult and neonate giant otters from wild and captive groups. We classified the adult vocalizations according to their acoustic structure, and described their main behavioural context. Additionally, we present the first description of vocalizations uttered in babbling bouts of new born giant otters. We expected to find 1) a sophisticated vocal repertoire that would reflect the species' complex social organisation, 2) that giant otter vocalizations have a clear relationship between signal structure and function, and 3) that the vocal repertoire of new born giant otters would comprise agespecific vocalizations as well as precursors of the adult repertoire. We found a vocal repertoire with 22 distinct vocalization types produced by adults and 11 vocalization types within the babbling bouts of the neonates. A comparison within the otter subfamily suggests a relation between vocal and social complexity, with the giant otters being the socially and vocally most complex species.	[Mumm, Christina A. S.] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany; [Knoernschild, Mirjam] Univ Ulm, Fac Nat Sci, Inst Expt Ecol, D-89069 Ulm, Germany; [Knoernschild, Mirjam] Smithsonian Trop Res Inst, Balboa, Panama	Ulm University; Ulm University; Smithsonian Institution; Smithsonian Tropical Research Institute	Mumm, CAS (corresponding author), Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany.	Christina.mumm@uni-ulm.de		Higgs, Dennis/0000-0002-0771-4642; Knornschild, Mirjam/0000-0003-0448-9600	German Academic Exchange Service [D/10/520]; Landesgraduiertenforderung Baden-Wurttemberg [1104]	German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Landesgraduiertenforderung Baden-Wurttemberg	The German Academic Exchange Service (https://www.daad.de/de/index.html) granted a short time stipend for graduate students to CASM, D/10/520, which covered the travelling expenses for the data collection in Peru from September 12th to December 8th in 2011. The Landesgraduiertenforderung Baden-Wurttemberg (https://www.studieninfo-bw.de/studieren/studienfinanzierung/stipendien/leistungsstipendien/landesgraduiertenfoerderung/) is funding the graduate study of CASM, funding number 1104, 2012-2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almonte C, 2011, THESIS CITY U NEW YO; [Anonymous], 1989, POPULATIONSOKOLOGIE; Arnold K, 2008, CURR BIOL, V18, pR202, DOI 10.1016/j.cub.2008.01.040; Ben-David M, 2005, ECOLOGY, V86, P1331, DOI 10.1890/04-0783; Blumstein DT, 2008, ANIM BEHAV, V76, P1055, DOI 10.1016/j.anbehav.2008.06.002; Blumstein DT, 2009, ETHOLOGY, V115, P1074, DOI 10.1111/j.1439-0310.2009.01691.x; Blumstein DT, 1997, AM NAT, V150, P179, DOI 10.1086/286062; Blundell GM, 2002, BEHAV ECOL, V13, P134, DOI 10.1093/beheco/13.1.134; Bouchet H, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00390; Bradbury Jack W., 1998, pi; CAIRNS SJ, 1987, ANIM BEHAV, V35, P1454, DOI 10.1016/S0003-3472(87)80018-0; Carter SK, 1997, MAMMAL REV, V27, P1, DOI 10.1111/j.1365-2907.1997.tb00370.x; Charif RA, 2010, RAVEN PRO 1 4 USERS; Cheney DL, 2005, LINGUIST REV, V22, P135, DOI 10.1515/tlir.2005.22.2-4.135; Crockford C, 2005, BEHAVIOUR, V142, P397, DOI 10.1163/1568539054012047; Davenport LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011385; De Waal FBM, 2003, ANIMAL SOCIAL COMPLEXITY, P230; DUPLAIX N, 1980, TERRE VIE-REV ECOL A, V34, P495; Duplaix N, 2008, IUCN 2013 IUCN RED L; EHRET G, 1980, ADV STUD BEHAV, V11, P179, DOI 10.1016/S0065-3454(08)60118-7; Elowson AM, 1998, BEHAVIOUR, V135, P643, DOI 10.1163/156853998792897905; Elowson AM, 1998, TRENDS COGN SCI, V2, P31, DOI 10.1016/S1364-6613(97)01115-7; EsTEs J. A., 1980, MAMMAL SPECIES, V133, P1, DOI [10.2307/3503844, DOI 10.2307/3503844]; Evangelista E., 2011, IUCN OTTER SPEC GR B, V28, P5; Fant G., 1960, ACOUSTIC THEORY SPEE; Farago T., 2014, BIOCOMMUNICATION ANI, P41, DOI DOI 10.1007/978-94-007-7414-8_4; Fichtel C, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P29, DOI 10.1007/978-3-642-02624-9_2; Fischer J, 2001, ANIM BEHAV, V61, P925, DOI 10.1006/anbe.2000.1687; Fitch W. T., 1998, ACOUSTIC COMMUNICATI, P1; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Fitch WT, 2000, ZOOL-ANAL COMPLEX SY, V103, P40; Freeberg TM, 2006, PSYCHOL SCI, V17, P557, DOI 10.1111/j.1467-9280.2006.01743.x; Freeberg TM, 2012, PHILOS T R SOC B, V367, P1785, DOI 10.1098/rstb.2011.0213; GARSHELIS DL, 1984, CAN J ZOOL, V62, P2648, DOI 10.1139/z84-385; Gnoli Claudio, 1995, Hystrix, V7, P289; Green S, 1975, HDB BEHAV NEUROBIOLO, P73, DOI [10.1007/978-1-4615-9116-0, DOI 10.1007/978-1-4615-9116-0]; Groenendijk J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106202; Hajek F., 2008, GIANTS MADRE DIOS; Hammerschmidt K, 1998, ETHOLOGY, V104, P203; Hauser, 1996, EVOL COMMUN; Hussain SA, 1996, MAMMALIA, V60, P289, DOI 10.1515/mamm.1996.60.2.289; Hussain Syed Ainul, 2011, IUCN Otter Specialist Group Bulletin, V28, P63; Jansen DAWAM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-97; Knornschild M, 2006, NATURWISSENSCHAFTEN, V93, P451, DOI 10.1007/s00114-006-0127-9; Krams I, 2012, PHILOS T R SOC B, V367, P1879, DOI 10.1098/rstb.2011.0222; Kruuk H., 2006, OTTERS ECOLOGY BEHAV, DOI DOI 10.1093/ACPROF:OSO/9780198565871.001.0001; Kunc HP, 2007, AM NAT, V170, P617, DOI 10.1086/521233; Lariviere Serge, 2003, Mammalian Species, V720, P1, DOI 10.1644/720; Lariviere Serge, 2001, Mammalian Species, V650, P1, DOI 10.1644/1545-1410(2001)650<0001:AC>2.0.CO;2; Lariviere Serge, 1999, Mammalian Species, V608, P1, DOI 10.2307/3504420; Lariviere Serge, 2001, Mammalian Species, V671, P1, DOI 10.1644/1545-1410(2001)671<0001:AC>2.0.CO;2; Le Roux A, 2009, NATURWISSENSCHAFTEN, V96, P575, DOI 10.1007/s00114-008-0506-5; Lemasson A, 2013, NATURWISSENSCHAFTEN, V100, P275, DOI 10.1007/s00114-013-1022-9; Lemasson A, 2014, J MAMMAL, V95, P128, DOI 10.1644/12-MAMM-A-313.1; Leuchtenberger C, 2012, THESIS; Leuchtenberger C, 2008, SOCIOBIOLOGY, V52, P257; Leuchtenberger C, 2009, ETHOLOGY, V115, P210, DOI 10.1111/j.1439-0310.2008.01607.x; Machado MRB, 2004, THESIS; Manser MB, 2014, ADV STUD BEHAV, V46, P281, DOI 10.1016/B978-0-12-800286-5.00006-7; Manser MB, 2000, BEHAV ECOL SOCIOBIOL, V48, P429, DOI 10.1007/s002650000248; McComb K, 2005, BIOL LETTERS, V1, P381, DOI 10.1098/rsbl.2005.0366; MCCOMB K, 1994, ANIM BEHAV, V47, P379, DOI 10.1006/anbe.1994.1052; MCSHANE LJ, 1995, J MAMMAL, V76, P414, DOI 10.2307/1382352; Mech L. David, 2003, P1; MORTON ES, 1977, AM NAT, V111, P855, DOI 10.1086/283219; Mumm CAS, 2014, ANIM BEHAV, V88, P243, DOI 10.1016/j.anbehav.2013.12.005; Mundry R, 2007, ANIM BEHAV, V74, P965, DOI 10.1016/j.anbehav.2006.12.028; Pollard KA, 2012, PHILOS T R SOC B, V367, P1869, DOI 10.1098/rstb.2011.0221; Pollard KA, 2011, CURR BIOL, V21, P413, DOI 10.1016/j.cub.2011.01.051; Quaglietta L, 2014, J MAMMAL, V95, P140, DOI 10.1644/13-MAMM-A-073.1; Ramsier MA, 2012, PHILOS T R SOC B, V367, P1860, DOI 10.1098/rstb.2011.0219; Ribas C, 2012, THESIS; Riede T, 2007, J ACOUST SOC AM, V121, P1758, DOI 10.1121/1.2427115; Robbins RL, 2003, BEHAVIOUR, V140, P333, DOI 10.1163/156853903321826666; Schassburger R. M., 1993, VOCAL COMMUNICATION; SCHENCK C, 1995, Z SAUGETIERKD, V60, P310; Seyfarth RM, 2005, TRENDS COGN SCI, V9, P264, DOI 10.1016/j.tics.2005.04.001; Seyfarth RM, 2003, ANNU REV PSYCHOL, V54, P145, DOI 10.1146/annurev.psych.54.101601.145121; SEYFARTH RM, 1986, ANIM BEHAV, V34, P1640, DOI 10.1016/S0003-3472(86)80252-4; Seyfarth RM, 2010, ANIM BEHAV, V80, P3, DOI 10.1016/j.anbehav.2010.04.012; Siemers BM, 2006, BEHAV ECOL SOCIOBIOL, V59, P443, DOI 10.1007/s00265-005-0068-x; SIVASOTHI N, 1994, HYDROBIOLOGIA, V285, P151, DOI 10.1007/BF00005663; Snowdon CT, 2001, BEHAVIOUR, V138, P1235, DOI 10.1163/15685390152822193; Sykes-Gatz S, 2005, INT GAINT OTTER STUD; Taylor AM, 2010, J ZOOL, V280, P221, DOI 10.1111/j.1469-7998.2009.00661.x; TEMBROCK G, 1976, BEHAV PROCESS, V1, P57, DOI 10.1016/0376-6357(76)90007-3; Ten Hwang Yeen, 2005, Mammalian Species, P1; Timmis W. H., 1971, INT ZOO YB, V11, P109, DOI DOI 10.1111/J.1748-1090.1971.TB01868.X; Titze IR, 1994, PRINCIPLES VOICE PRO; Tokuda I, 2002, J ACOUST SOC AM, V111, P2908, DOI 10.1121/1.1474440; Tyack PL, 2002, MARINE MAMMAL BIOLOGY: AN EVOLUTIONARY APPROACH, P142; Rosas FCW, 2009, SOCIOBIOLOGY, V54, P919; Wilden I., 1998, Bioacoustics, V9, P171; Zuberbuhler K, 2002, ANIM BEHAV, V63, P293, DOI 10.1006/anbe.2001.1914	94	14	15	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112562	10.1371/journal.pone.0112562	http://dx.doi.org/10.1371/journal.pone.0112562			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391142	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400100
J	Wawer, AA; Harvey, LJ; Dainty, JR; Perez-Moral, N; Sharp, P; Fairweather-Tait, SJ				Wawer, Anna A.; Harvey, Linda J.; Dainty, Jack R.; Perez-Moral, Natalia; Sharp, Paul; Fairweather-Tait, Susan J.			Alginate Inhibits Iron Absorption from Ferrous Gluconate in a Randomized Controlled Trial and Reduces Iron Uptake into Caco-2 Cells	PLOS ONE			English	Article							NONHEME-IRON; HEME-IRON; CALCIUM; ZINC; AVAILABILITY; MECHANISMS	Previous in vitro results indicated that alginate beads might be a useful vehicle for food iron fortification. A human study was undertaken to test the hypothesis that alginate enhances iron absorption. A randomised, single blinded, cross-over trial was carried out in which iron absorption was measured from serum iron appearance after a test meal. Overnight-fasted volunteers (n = 15) were given a test meal of 200 g cola-flavoured jelly plus 21 mg iron as ferrous gluconate, either in alginate beads mixed into the jelly or in a capsule. Iron absorption was lower from the alginate beads than from ferrous gluconate (8.5% and 12.6% respectively, p = 0.003). Sub-group B (n = 9) consumed the test meals together with 600 mg calcium to determine whether alginate modified the inhibitory effect of calcium. Calcium reduced iron absorption from ferrous gluconate by 51%, from 11.5% to 5.6% (p = 0.014), and from alginate beads by 37%, from 8.3% to 5.2% (p = 0.009). In vitro studies using Caco-2 cells were designed to explore the reasons for the difference between the previous in vitro findings and the human study; confirmed the inhibitory effect of alginate. Beads similar to those used in the human study were subjected to simulated gastrointestinal digestion, with and without cola jelly, and the digestate applied to Caco-2 cells. Both alginate and cola jelly significantly reduced iron uptake into the cells, by 34% (p = 0.009) and 35% (p = 0.003) respectively. The combination of cola jelly and calcium produced a very low ferritin response, 16.5% (p<0.001) of that observed with ferrous gluconate alone. The results of these studies demonstrate that alginate beads are not a useful delivery system for soluble salts of iron for the purpose of food fortification.	[Wawer, Anna A.; Fairweather-Tait, Susan J.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Harvey, Linda J.; Dainty, Jack R.; Perez-Moral, Natalia] Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Sharp, Paul] Kings Coll London, London, England	University of East Anglia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of London; King's College London	Fairweather-Tait, SJ (corresponding author), Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England.	s.fairweather-tait@uea.ac.uk		Fairweather-Tait, Susan/0000-0002-1413-5569; Sharp, Paul Anthony/0000-0003-3400-6702; Dainty, Jack/0000-0002-0056-1233; Wawer, Anna/0000-0002-3308-3645	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G005656/1]; BBSRC DRINC studentship [BB/G53015X/1]; BBSRC [BB/G005656/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G005656/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC DRINC studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funded by the Biotechnology and Biological Sciences Research Council (BBSRC) grant number BB/G005656/1. Anna Wawer was supported by a BBSRC DRINC studentship (BB/G53015X/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosscher D, 2001, NUTRITION, V17, P614, DOI 10.1016/S0899-9007(01)00541-X; Chan LW, 2002, INT J PHARM, V242, P255, DOI 10.1016/S0378-5173(02)00169-2; Collings R, 2011, J NUTR, V141, P805, DOI 10.3945/jn.110.136507; Conway RE, 2006, J NUTR, V136, P1910, DOI 10.1093/jn/136.7.1910; COOK JD, 1977, AM J CLIN NUTR, V30, P235, DOI 10.1093/ajcn/30.2.235; Dainty JR, 2003, BRIT J NUTR, V90, P503, DOI 10.1079/BJN2003931; Emerton V, 2008, ESSENTIAL GUIDE TO FOOD ADDITIVES, 3RD EDITION, P1, DOI 10.1039/9781847559234-00001; Gaitan D, 2011, J NUTR, V141, P1652, DOI 10.3945/jn.111.138651; HALLBERG L, 1991, AM J CLIN NUTR, V53, P112, DOI 10.1093/ajcn/53.1.112; Hampson FC, 2005, INT J PHARMACEUT, V294, P137, DOI 10.1016/j.ijpharm.2005.01.036; Hoppe M, 2004, BRIT J NUTR, V92, P485, DOI 10.1079/BJN20041207; Hurrell RF, 2002, J NUTR, V132, p806S, DOI 10.1093/jn/132.4.806S; Hurrell RF, 1997, EUR J CLIN NUTR, V51, P26; Larsen B, 1970, CARBOHYD RES, V20, P287; Lonnerdal B, 2010, INT J VITAM NUTR RES, V80, P293, DOI 10.1024/0300-9831/a000036; MACPHAIL AP, 1994, AM J CLIN NUTR, V59, P644, DOI 10.1093/ajcn/59.3.644; Min JH, 1998, WATER RES, V32, P1544, DOI 10.1016/S0043-1354(97)00349-7; Minihane AM, 1998, AM J CLIN NUTR, V68, P96, DOI 10.1093/ajcn/68.1.96; Perez-Moral N, 2013, FOOD HYDROCOLLOID, V31, P114, DOI 10.1016/j.foodhyd.2012.09.015; R Core Team, 2021, R LANGUAGE ENV STAT; SANDBERG AS, 1994, AM J CLIN NUTR, V60, P751, DOI 10.1093/ajcn/60.5.751; Sreeram KJ, 2004, BBA-GEN SUBJECTS, V1670, P121, DOI 10.1016/j.bbagen.2003.11.001; Thompson BAV, 2010, J AGR FOOD CHEM, V58, P8414, DOI 10.1021/jf101388z; Villalpando S, 2006, J NUTR, V136, P2633, DOI 10.1093/jn/136.10.2633; Wawer AA, 2012, J AGR FOOD CHEM, V60, P11318, DOI 10.1021/jf3031309; Zheng LQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010190	26	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112144	10.1371/journal.pone.0112144	http://dx.doi.org/10.1371/journal.pone.0112144			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391138	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000349144400058
J	Zhong, R; Allen, JD; Xiao, GH; Xie, Y				Zhong, Rui; Allen, Jeffrey D.; Xiao, Guanghua; Xie, Yang			Ensemble-Based Network Aggregation Improves the Accuracy of Gene Network Reconstruction	PLOS ONE			English	Article							INTEGRATIVE ANALYSIS; ESCHERICHIA-COLI; EXPRESSION; PROTEIN; SIGNATURE; DISCOVERY; CELLS; ZEB1	Reverse engineering approaches to constructing gene regulatory networks (GRNs) based on genome-wide mRNA expression data have led to significant biological findings, such as the discovery of novel drug targets. However, the reliability of the reconstructed GRNs needs to be improved. Here, we propose an ensemble-based network aggregation approach to improving the accuracy of network topologies constructed from mRNA expression data. To evaluate the performances of different approaches, we created dozens of simulated networks from combinations of gene-set sizes and sample sizes and also tested our methods on three Escherichia coli datasets. We demonstrate that the ensemble-based network aggregation approach can be used to effectively integrate GRNs constructed from different studies - producing more accurate networks. We also apply this approach to building a network from epithelial mesenchymal transition (EMT) signature microarray data and identify hub genes that might be potential drug targets. The R code used to perform all of the analyses is available in an R package entitled "ENA", accessible on CRAN (http://cran.r-project.org/web/packages/ENA/).	[Zhong, Rui; Allen, Jeffrey D.; Xiao, Guanghua; Xie, Yang] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Quantitat Biomed Res Ctr, Dallas, TX 75390 USA; [Allen, Jeffrey D.; Xie, Yang] Univ Texas SW Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Xie, Y (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Quantitat Biomed Res Ctr, Dallas, TX 75390 USA.	Yang.Xie@utsouthwestern.edu			NIH grant [5R01CA152301, 1R01CA172211]; Cancer Prevention Research Institute of Texas award [RP101251]; NATIONAL CANCER INSTITUTE [R01CA152301, R01CA172211] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants 5R01CA152301 and 1R01CA172211, and Cancer Prevention Research Institute of Texas award RP101251. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 2012, BRIEF BIOINFORM, V13, P547, DOI 10.1093/bib/bbr076; Allen JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029348; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Breiman L, 1996, ANN STAT, V24, P2350; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Breitling Rainer, 2005, Journal of Bioinformatics and Computational Biology, V3, P1171, DOI 10.1142/S0219720005001442; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Fong SS, 2005, GENOME RES, V15, P1365, DOI 10.1101/gr.3832305; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gabriel E, 2004, LECT NOTES COMPUT SC, V3241, P97; Gama-Castro S, 2011, NUCLEIC ACIDS RES, V39, pD98, DOI 10.1093/nar/gkq1110; Hase T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003361; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Kendall SD, 2005, CANCER RES, V65, P9824, DOI 10.1158/0008-5472.CAN-05-1543; Kojima T, 2012, ANN NY ACAD SCI, V1257, P85, DOI 10.1111/j.1749-6632.2012.06579.x; Koziol JA, 2010, FEBS LETT, V584, P941, DOI 10.1016/j.febslet.2010.01.031; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Liang F, 2009, CHAPMAN HALL CRC BIO; Lim J, 2006, STAT PROBABIL LETT, V76, P1705, DOI 10.1016/j.spl.2006.04.033; Liu J, 2013, GENET EPIDEMIOL, V37, P173, DOI 10.1002/gepi.21697; Ma SG, 2011, BIOSTATISTICS, V12, P763, DOI 10.1093/biostatistics/kxr004; Maki-Nevala S, 2013, GENE CHROMOSOME CANC, V52, P1141, DOI 10.1002/gcc.22109; Mani KM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.2; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Nibbe RK, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000639; Pan W., 2002, GENOME BIOL, V3; Peng J, 2009, J AM STAT ASSOC, V104, P735, DOI 10.1198/jasa.2009.0126; Peng LB, 2013, INT J CLIN EXP PATHO, V6, P1854; Penrose R, 1954, GEN INVERSE MATRICES, P406; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Rix U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077155; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Salgado H, 2012, METHODS MOL BIOL, V804, P179, DOI 10.1007/978-1-61779-361-5_10; Sangurdekar DP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r32; Schafer J, 2005, BIOINFORMATICS, V21, P754, DOI 10.1093/bioinformatics/bti062; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Slavov N, 2009, P NATL ACAD SCI USA, V106, P4079, DOI 10.1073/pnas.0810803106; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Sun XC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006667; Tang H, 2013, CLIN CANCER RES, V19, P1577, DOI 10.1158/1078-0432.CCR-12-2321; Wang XS, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-30; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wiederhold E, 2009, MOL CELL PROTEOMICS, V8, P380, DOI 10.1074/mcp.M800372-MCP200; Xiao GH, 2011, J AM STAT ASSOC, V106, P61, DOI 10.1198/jasa.2010.ap09504; Xie Y, 2013, IMPLEMENTING REPROD; Xie Y, 2013, DYNAMIC DOCUMENTS R; Zhao H, 2013, CANCER RES, V73, P6149, DOI 10.1158/0008-5472.CAN-12-4617	52	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e106319	10.1371/journal.pone.0106319	http://dx.doi.org/10.1371/journal.pone.0106319			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390635	Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400002
J	Mandic, M; Drinovec, L; Glisic, S; Veljkovic, N; Nohr, J; Vrecl, M				Mandic, Maja; Drinovec, Luka; Glisic, Sanja; Veljkovic, Nevena; Nohr, Jane; Vrecl, Milka			Demonstration of a Direct Interaction between beta(2)-Adrenergic Receptor and Insulin Receptor by BRET and Bioinformatics	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; PROTEIN-COUPLED RECEPTORS; BETA-ADRENERGIC-RECEPTORS; TYROSINE KINASE; LIVING CELLS; BETA-2-ADRENERGIC RECEPTOR; HETERO-OLIGOMERIZATION; THERAPEUTIC TARGETS; SCREENING ASSAY; HETERODIMERIZATION	Glucose metabolism is under the cooperative regulation of both insulin receptor (IR) and beta(2)-adrenergic receptor (beta(2)AR), which represent the receptor tyrosine kinases (RTKs) and seven transmembrane receptors (7TMRs), respectively. Studies demonstrating cross-talk between these two receptors and their endogenous coexpression have suggested their possible interactions. To evaluate the effect of IR and prospective heteromerization on beta(2)AR properties, we showed that IR coexpression had no effect on the ligand binding properties of beta(2)AR; however, IR reduced beta(2)AR surface expression and accelerated its internalization. Additionally, both receptors displayed a similar distribution pattern with a high degree of colocalization. To test the possible direct interaction between beta(2)AR and IR, we employed quantitative BRET 2 saturation and competition assays. Saturation assay data suggested constitutive beta(2)AR and IR homo-and heteromerization. Calculated acceptor/donor (AD(50)) values as a measure of the relative affinity for homo-and heteromer formation differed among the heteromers that could not be explained by a simple dimer model. In heterologous competition assays, a transient increase in the BRET2 signal with a subsequent hyperbolical decrease was observed, suggesting higher-order heteromer formation. To complement the BRET2 data, we employed the informational spectrum method (ISM), a virtual spectroscopy method to investigate protein-protein interactions. Computational peptide scanning of beta(2)AR and IR identified intracellular domains encompassing residues at the end of the 7th TM domain and C-terminal tail of beta(2)AR and a cytoplasmic part of the IR beta chain as prospective interaction domains. ISM further suggested a high probability of heteromer formation and homodimers as basic units engaged in heteromerization. In summary, our data suggest direct interaction and higher-order beta(2)AR: IR oligomer formation, likely comprising heteromers of homodimers.	[Mandic, Maja; Vrecl, Milka] Univ Ljubljana, Fac Vet, Inst Anat Histol & Embryol, Ljubljana, Slovenia; [Drinovec, Luka] Aerosol Doo, Dept Dev, Ljubljana, Slovenia; [Glisic, Sanja; Veljkovic, Nevena] Univ Belgrade, Inst Nucl Sci VINCA, Ctr Multidisciplinary Res, Belgrade, Serbia; [Nohr, Jane] Novo Nordisk AS, Dept Incretin & Islet Biol, Malov, Denmark	University of Ljubljana; University of Belgrade; Novo Nordisk	Vrecl, M (corresponding author), Univ Ljubljana, Fac Vet, Inst Anat Histol & Embryol, Ljubljana, Slovenia.	milka.vrecl@vf.uni-lj.si	Vrecl, Milka/A-6127-2008; Glisic, Sanja/AAE-8590-2019	Glisic, Sanja/0000-0001-5691-1055; Veljkovic, Nevena/0000-0001-6562-5800	Basileus S Program; Slovenian Research Agency program [P4-0053]; Ministry of Education, Science and Technological Development of the Republic of Serbia [173001]	Basileus S Program; Slovenian Research Agency program(Slovenian Research Agency - Slovenia); Ministry of Education, Science and Technological Development of the Republic of Serbia	The authors acknowledge funding from the Basileus S Program to M. Mandic, the Slovenian Research Agency program (P4-0053) to M. Vrecl, and the Ministry of Education, Science and Technological Development of the Republic of Serbia (Grant No. 173001) to S. Glisic and N Veljkovic. M. Vrecl, S. Glisic and N. Veljkovic participate in the European COST Action CM1207 (GLISTEN). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour L, 2011, METHODS MOL BIOL, V756, P183, DOI 10.1007/978-1-61779-160-4_9; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Ayoub MA, 2004, MOL PHARMACOL, V66, P312, DOI 10.1124/mol.104.000398; Ayoub MA, 2010, CURR OPIN PHARMACOL, V10, P44, DOI 10.1016/j.coph.2009.09.012; Baltensperger K, 1996, J BIOL CHEM, V271, P1061, DOI 10.1074/jbc.271.2.1061; Barnes PJ, 2006, J CLIN INVEST, V116, P1210, DOI 10.1172/JCI28535; Borroto-Escuela DO, 2011, IUBMB LIFE, V63, P463, DOI 10.1002/iub.473; Boute N, 2003, EMBO REP, V4, P313, DOI 10.1038/sj.embor.embor767; Boute N, 2001, MOL PHARMACOL, V60, P640; Breit A, 2004, J BIOL CHEM, V279, P28756, DOI 10.1074/jbc.M313310200; Breitwieser GE, 2004, CIRC RES, V94, P17, DOI 10.1161/01.RES.0000110420.68526.19; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Dacres H, 2012, BIOCHEM BIOPH RES CO, V425, P625, DOI 10.1016/j.bbrc.2012.07.133; De Meyts P, 2008, TRENDS BIOCHEM SCI, V33, P376, DOI 10.1016/j.tibs.2008.06.003; Di Certo MG, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-56; Doliana R, 2008, MATRIX BIOL, V27, P96, DOI 10.1016/j.matbio.2007.09.008; Doronin S, 2002, J BIOL CHEM, V277, P10698, DOI 10.1074/jbc.M109432200; Doronin S, 2002, J BIOL CHEM, V277, P15124, DOI 10.1074/jbc.M108771200; Drinovec Luka, 2012, Front Endocrinol (Lausanne), V3, P104, DOI 10.3389/fendo.2012.00104; Ferre S, 2014, PHARMACOL REV, V66, P413, DOI 10.1124/pr.113.008052; Ferre S, 2010, CURR OPIN PHARMACOL, V10, P1, DOI 10.1016/j.coph.2009.11.002; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; Flajolet M, 2008, NAT NEUROSCI, V11, P1402, DOI 10.1038/nn.2216; Fu Q, 2014, DIABETES, V63, P2676, DOI 10.2337/db13-1763; Gavi S, 2005, ENDOCRINOLOGY, V146, P450, DOI 10.1210/en.2004-0595; Ghosh A, 2014, COMPUT BIOL CHEM, V48, P29, DOI 10.1016/j.compbiolchem.2013.11.002; Goin JC, 2006, J BIOL CHEM, V281, P5416, DOI 10.1074/jbc.M507476200; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Heni M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021594; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Issad T, 2002, ANN NY ACAD SCI, V973, P120, DOI 10.1111/j.1749-6632.2002.tb04619.x; Issad T, 2002, BIOCHEM PHARMACOL, V64, P813, DOI 10.1016/S0006-2952(02)01143-7; Issad T, 2007, EXPERT OPIN THER TAR, V11, P541, DOI 10.1517/14728222.11.4.541; Karoor V, 1998, J BIOL CHEM, V273, P33035, DOI 10.1074/jbc.273.49.33035; Katragadda M, 2004, BBA-BIOMEMBRANES, V1663, P74, DOI 10.1016/j.bbamem.2004.01.012; Kim JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033322; Kubale V, 2007, CELL TISSUE RES, V330, P231, DOI 10.1007/s00441-007-0462-y; Kulahin N, 2012, J RECEPT SIG TRANSD, V32, P57, DOI 10.3109/10799893.2011.647351; Lange LA, 2005, INT J OBESITY, V29, P449, DOI 10.1038/sj.ijo.0802883; Lavoie C, 2002, J BIOL CHEM, V277, P35402, DOI 10.1074/jbc.M204163200; Lee SP, 2003, LIFE SCI, V74, P173, DOI 10.1016/j.lfs.2003.09.028; LIGGETT SB, 1988, AM J PHYSIOL, V254, pE795, DOI 10.1152/ajpendo.1988.254.6.E795; Mancini M, 2012, J CELL BIOCHEM, V113, P2765, DOI 10.1002/jcb.24154; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; McGraw DW, 2006, J CLIN INVEST, V116, P1400, DOI 10.1172/JCI25840; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Mondal S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02909; MOTHE I, 1995, EUR J BIOCHEM, V228, P842, DOI 10.1111/j.1432-1033.1995.0842m.x; Navarro G, 2010, J BIOL CHEM, V285, P27346, DOI 10.1074/jbc.M110.115634; Nouaille S, 2006, BIOCHEM PHARMACOL, V72, P1355, DOI 10.1016/j.bcp.2006.07.018; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Palczewski K, 2010, TRENDS BIOCHEM SCI, V35, P595, DOI 10.1016/j.tibs.2010.05.002; Ramsay D, 2002, BIOCHEM J, V365, P429, DOI 10.1042/BJ20020251; Scarselli M, 2009, J BIOL CHEM, V284, P3577, DOI 10.1074/jbc.M806819200; Seachrist JL, 2000, J BIOL CHEM, V275, P27221; Shih ML, 1998, CELL SIGNAL, V10, P575, DOI 10.1016/S0898-6568(97)00195-2; Shumay E, 2004, J CELL SCI, V117, P593, DOI 10.1242/jcs.00890; Siddiqui Sana, 2013, Front Endocrinol (Lausanne), V4, P46, DOI 10.3389/fendo.2013.00046; Soni P, 2000, MOL CELL BIOL, V20, P3896, DOI 10.1128/MCB.20.11.3896-3905.2000; Svendsen AM, 2008, ENDOCRINOLOGY, V149, P1113, DOI 10.1210/en.2007-0412; Terrillon S, 2003, MOL ENDOCRINOL, V17, P677, DOI 10.1210/me.2002-0222; VEATCH W, 1977, J MOL BIOL, V113, P89, DOI 10.1016/0022-2836(77)90042-0; Veljkovic N, 2008, CURR PROTEIN PEPT SC, V9, P493, DOI 10.2174/138920308785915245; VELJKOVIC V, 1987, CANCER BIOCHEM BIOPH, V9, P139; VELJKOVIC V, 1985, IEEE T BIO-MED ENG, V32, P337, DOI 10.1109/TBME.1985.325549; Veljkovic V, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-62; Veljkovic V, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-21; Vrecl M, 2004, J BIOMOL SCREEN, V9, P322, DOI 10.1177/1087057104263212; Vrecl M, 2006, J RECEPT SIG TRANSD, V26, P505, DOI 10.1080/10799890600932253; Vrecl M, 2009, J BIOMOL SCREEN, V14, P371, DOI 10.1177/1087057109333101; Wang CH, 2005, J NEUROCHEM, V93, P899, DOI 10.1111/j.1471-4159.2005.03055.x; Wang H, 2000, ADV IND CON; Waters CM, 2005, CELL SIGNAL, V17, P263, DOI 10.1016/j.cellsig.2004.07.011; WHITE MF, 1994, J BIOL CHEM, V269, P1; Wrzal PK, 2012, CELL SIGNAL, V24, P342, DOI 10.1016/j.cellsig.2011.09.020	76	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112664	10.1371/journal.pone.0112664	http://dx.doi.org/10.1371/journal.pone.0112664			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401701	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700061
J	Clemmensen, L; van Os, J; Skovgaard, AM; Vaever, M; Blijd-Hoogewys, EMA; Bartels-Velthuis, AA; Jeppesen, P				Clemmensen, Lars; van Os, Jim; Skovgaard, Anne Mette; Vaever, Mette; Blijd-Hoogewys, Els M. A.; Bartels-Velthuis, Agna A.; Jeppesen, Pia			Hyper-Theory-of-Mind in Children with Psychotic Experiences	PLOS ONE			English	Article							SCHIZOPHRENIA; DEFICITS; AUTISM; SCHIZOTYPY; DISORDERS; RELIABILITY; HYPOTHESIS; SYMPTOMS; SCALE; RISK	Background: Alterations in Theory-of-Mind (ToM) are associated with psychotic disorder. In addition, studies in children have documented that alterations in ToM are associated with Psychotic Experiences (PE). Our aim was to examine associations between an exaggerated type of ToM (HyperToM) and PE in children. Children with this type of alteration in ToM infer mental states when none are obviously suggested, and predict behaviour on the basis of these erroneous beliefs. Individuals with HyperToM do not appear to have a conceptual deficit (i.e. lack of representational abilities), but rather they apply their theory of the minds of others in an incorrect or biased way. Method: Hypotheses were tested in two studies with two independent samples: (i) a general population sample of 1630 Danish children aged 11-12 years, (ii) a population-based sample of 259 Dutch children aged 12-13 years, pertaining to a case-control sampling frame of children with auditory verbal hallucinations. Multinomial regression analyses were carried out to investigate the associations between PE and ToM and HyperToM respectively. Analyses were adjusted for gender and proxy measures of general intelligence. Results: Low ToM score was significantly associated with PE in sample I (OR = 1.6 95% CI 1.1-2.3 chi(2) (4) = 12.42 p = 0.010), but not in sample II (OR = 0.9 95% CI 0.5-1.8 x 2 (3) = 7.13 p = 0.816). HyperToM was significantly associated with PE both in sample I (OR = 1.8, 95% CI 1.2-2.7 chi(2) (3) = 10.11 p = 0.006) and II (OR = 4.6, 95% CI 1.3-16.2 chi(2) (2) = 7.56 p = 0.018). HyperToM was associated particularly with paranoid delusions in both sample I (OR = 2.0, 95% CI: 1.1-3.7% chi(2) (4) = 9.93 p = 0.021) and II (OR = 6.2 95% CI: 1.7-23.6% chi(2) (4) = 9.90 p = 0.044). Conclusion: Specific alterations in ToM may be associated with specific types of psychotic experiences. HyperToM may index risk for developing psychosis and paranoid delusions in particular.	[Clemmensen, Lars; Jeppesen, Pia] Mental Hlth Serv, Child & Adolescent Mental Hlth Ctr, Copenhagen, Denmark; [van Os, Jim] Maastricht Univ, Med Ctr, Dept Psychiat & Psychol, Maastricht, Netherlands; [Skovgaard, Anne Mette] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Vaever, Mette] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark; [Blijd-Hoogewys, Els M. A.] INTER PSY Groningen, Groningen, Netherlands; [Bartels-Velthuis, Agna A.] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Psychiat Groningen, Groningen Triadegebouw, Netherlands	Maastricht University; University of Copenhagen; University of Copenhagen; University of Groningen	Clemmensen, L (corresponding author), Mental Hlth Serv, Child & Adolescent Mental Hlth Ctr, Copenhagen, Denmark.	lars.clemmensen@regionh.dk	van Os, Jim/V-8884-2019; Jeppesen, Pia/L-6716-2016; van Os, Jim/C-2113-2014; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022	van Os, Jim/0000-0002-7245-1586; Jeppesen, Pia/0000-0003-2471-2929; Clemmensen, Lars/0000-0002-1750-4649; vaever, mette skovgaard/0000-0002-9675-3423; Skovgaard, Anne Mette/0000-0002-8793-8303; Blijd-Hoogewys, Els/0000-0002-5045-8920	Tryg Foundation [J.nr.7-10-0189, J.nr.7-11-0341]; Lundbeck Foundation [j. nr. R54-A5843]	Tryg Foundation; Lundbeck Foundation(Lundbeckfonden)	AMS recieved funding for CCC2000 from Tryg Foundation (J.nr.7-10-0189 and J.nr.7-11-0341) (http://www.trygfonden.dk/Om-TrygFonden/In-English), and Lundbeck Foundation (j. nr. R54-A5843) (http://www.lundbeck.com/global/corporate-responsib/stakeholders/the-lundbeck-foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Akel A, 2003, BRAIN RES REV, V43, P29, DOI 10.1016/S0165-0173(03)00190-5; Abu-Akel A, 2003, MED HYPOTHESES, V60, P382, DOI 10.1016/S0306-9877(02)00406-1; Abu-Akel A, 2000, PSYCHOL MED, V30, P735, DOI 10.1017/S0033291799002123; Abu-Akel A, 2011, NEUROPSYCHOLOGIA, V49, P2971, DOI 10.1016/j.neuropsychologia.2011.07.012; ALTMAN DG, 1991, ALCOHOL ALCOHOLISM, V26, P481, DOI 10.1093/oxfordjournals.alcalc.a045142; BARONCOHEN S, 1994, BRIT J PSYCHIAT, V165, P640, DOI 10.1192/bjp.165.5.640; Barragan M, 2011, PSYCHIAT RES, V186, P225, DOI 10.1016/j.psychres.2010.07.051; Bartels-Velthuis AA, 2012, EPIDEMIOL PSYCH SCI, V21, P305, DOI 10.1017/S2045796012000108; Bartels-Velthuis AA, 2011, ACTA PSYCHIAT SCAND, V124, P193, DOI 10.1111/j.1600-0447.2011.01699.x; Bentall RP, 2001, CLIN PSYCHOL REV, V21, P1143, DOI 10.1016/S0272-7358(01)00106-4; Biedermann F, 2012, CURR OPIN PSYCHIATR, V25, P71, DOI 10.1097/YCO.0b013e3283503624; Blijd-Hoogewys EMA, 2008, J AUTISM DEV DISORD, V38, P1907, DOI 10.1007/s10803-008-0585-3; Blijd-Hoogewys E. M. A., 2007, TOM STORYBOOK FRANK; Bora E, 2008, J NERV MENT DIS, V196, P95, DOI 10.1097/NMD.0b013e318162a9e1; Bora E, 2009, SCHIZOPHR RES, V109, P1, DOI 10.1016/j.schres.2008.12.020; Brune M, 2005, SCHIZOPHRENIA BULL, V31, P21, DOI 10.1093/schbul/sbi002; Brunet Eric, 2003, Cogn Neuropsychiatry, V8, P129, DOI 10.1080/13546800244000256; Constantino JN, 2003, J AUTISM DEV DISORD, V33, P427, DOI 10.1023/A:1025014929212; Crespi B, 2008, BEHAV BRAIN SCI, V31, P241, DOI 10.1017/S0140525X08004214; Fonagy P, 2009, DEV PSYCHOPATHOL, V21, P1355, DOI 10.1017/S0954579409990198; Freeman D, 2007, CLIN PSYCHOL REV, V27, P425, DOI 10.1016/j.cpr.2006.10.004; Frith C. D., 1992, Journal of Psychopharmacology, V6, P436, DOI 10.1177/026988119200600314; Frith CD, 2004, PSYCHOL MED, V34, P385, DOI 10.1017/S0033291703001326; Frith CD, 1996, PSYCHOL MED, V26, P521, DOI 10.1017/S0033291700035601; FRITH U, 1994, COGNITION, V50, P115, DOI 10.1016/0010-0277(94)90024-8; Fyfe S, 2008, CORTEX, V44, P1316, DOI 10.1016/j.cortex.2007.07.009; GALDOS P, 1995, SCHIZOPHR RES, V14, P105, DOI 10.1016/0920-9964(94)00020-9; Greig TC, 2004, J NERV MENT DIS, V192, P12, DOI 10.1097/01.nmd.0000105995.67947.fc; HARDYBAYLE MC, 1994, ENCEPHALE, V20, P393; Jeppesen P, 2013, SCHIZOPHR B S1, V39, pS1; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kaymaz N, 2012, PSYCHOL MED, V20, P1; Kelleher I, 2012, PSYCHOL MED, V42, P1857, DOI 10.1017/S0033291711002960; Kelleher I, 2009, SCHIZOPHRBULL; Krabbendam L, 2005, BRIT J CLIN PSYCHOL, V44, P113, DOI 10.1348/014466504X19767; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langdon R, 2001, COGNITION, V82, P1, DOI 10.1016/S0010-0277(01)00139-1; Langdon R, 2010, SCHIZOPHRENIA BULL, V36, P321, DOI 10.1093/schbul/sbn069; Linscott R, 2012, PSYCHOL MED, V1, P1, DOI DOI 10.1017/S0033291712001626; Marjoram D, 2006, PSYCHIAT RES, V144, P29, DOI 10.1016/j.psychres.2006.01.008; Mehl S, 2010, J NERV MENT DIS, V198, P516, DOI 10.1097/NMD.0b013e3181e4c8d2; Montag C, 2012, EUR ARCH PSY CLIN N, V262, P217, DOI 10.1007/s00406-011-0250-2; Montag C, 2011, PSYCHIAT RES, V186, P203, DOI 10.1016/j.psychres.2010.09.006; OZONOFF S, 1991, J CHILD PSYCHOL PSYC, V32, P1107, DOI 10.1111/j.1469-7610.1991.tb00352.x; Pickup GJ, 2001, PSYCHOL MED, V31, P207, DOI 10.1017/S0033291701003385; Polanczyk G, 2010, ARCH GEN PSYCHIAT, V67, P328, DOI 10.1001/archgenpsychiatry.2010.14; Poulton R, 2000, ARCH GEN PSYCHIAT, V57, P1053, DOI 10.1001/archpsyc.57.11.1053; Shamay-Tsoory SG, 2007, PSYCHIAT RES, V149, P11, DOI 10.1016/j.psychres.2005.10.018; Sharp C, 2013, J PERS DISORD, V27, P3, DOI 10.1521/pedi.2013.27.1.3; Skovgaard AM, 2005, SCAND J PUBLIC HEALT, V33, P197, DOI 10.1080/14034940510005662; Smeets T, 2009, HORM BEHAV, V55, P507, DOI 10.1016/j.yhbeh.2009.01.011; Van Dael F, 2006, SCHIZOPHRENIA BULL, V32, P341, DOI 10.1093/schbul/sbj021; Versmissen D, 2008, SCHIZOPHR RES, V99, P103, DOI 10.1016/j.schres.2007.09.024	53	29	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113082	10.1371/journal.pone.0113082	http://dx.doi.org/10.1371/journal.pone.0113082			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DF	25397582	gold, Green Submitted, Green Published			2022-12-27	WOS:000345558500132
J	Hillson, R; Alejandre, JD; Jacobsen, KH; Ansumana, R; Bockarie, AS; Bangura, U; Lamin, JM; Malanoski, AP; Stenger, DA				Hillson, Roger; Alejandre, Joel D.; Jacobsen, Kathryn H.; Ansumana, Rashid; Bockarie, Alfred S.; Bangura, Umaru; Lamin, Joseph M.; Malanoski, Anthony P.; Stenger, David A.			Methods for Determining the Uncertainty of Population Estimates Derived from Satellite Imagery and Limited Survey Data: A Case Study of Bo City, Sierra Leone	PLOS ONE			English	Article							RESOLUTION; MALARIA	This study demonstrates the use of bootstrap methods to estimate the total population of urban and periurban areas using satellite imagery and limited survey data. We conducted complete household surveys in 20 neighborhoods in the city of Bo, Sierra Leone, which collectively were home to 25,954 persons living in 1,979 residential structures. For five of those twenty sections, we quantized the rooftop areas of structures extracted from satellite images. We used bootstrap statistical methods to estimate the total population of the pooled sections, including the associated uncertainty intervals, as a function of sample size. Evaluations based either on rooftop area per person or on the mean number of occupants per residence both converged on the true population size. We demonstrate with this simulation that demographic surveys of a relatively small proportion of residences can provide a foundation for accurately estimating the total population in conjunction with aerial photographs.	[Hillson, Roger; Alejandre, Joel D.] Naval Res Lab, Div Informat Technol, Washington, DC USA; [Jacobsen, Kathryn H.] George Mason Univ, Dept Global & Community Hlth, Fairfax, VA 22030 USA; [Ansumana, Rashid; Bockarie, Alfred S.] Njala Univ, Bo, Sierra Leone; [Ansumana, Rashid; Bockarie, Alfred S.; Bangura, Umaru; Lamin, Joseph M.] Mercy Hosp Res Lab, Bo, Sierra Leone; [Malanoski, Anthony P.; Stenger, David A.] Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC 20375 USA	United States Department of Defense; United States Navy; Naval Research Laboratory; George Mason University; Njala University; United States Department of Defense; United States Navy; Naval Research Laboratory	Stenger, DA (corresponding author), Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC 20375 USA.	david.stenger@nrl.navy.mil	Jacobsen, Kathryn H./B-5857-2008; Malanoski, Anthony/P-6975-2019; Ansumana, Rashid/AGQ-7401-2022; Malanoski, Anthony P/C-7814-2011	Jacobsen, Kathryn H./0000-0002-4198-6246; Malanoski, Anthony/0000-0001-6192-888X; Malanoski, Anthony P/0000-0001-6192-888X	Defense Threat Reduction Agency, Joint Science and Technology Office	Defense Threat Reduction Agency, Joint Science and Technology Office(United States Department of DefenseDefense Threat Reduction Agency)	This work was funded by the Defense Threat Reduction Agency, Joint Science and Technology Office via contract to the United States Naval Research Laboratory. There is no past, present or future Intellectual Property associated with the work described in the paper, and none of the authors have any financial interests or conflicts in the outcome of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminipouri M, 2009, OBJECT ORIENTED ANAL; Ansumana R, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.34.2291; Ansumana R, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-56; Archer BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049482; Balk DL, 2006, ADV PARASIT, V62, P119, DOI 10.1016/S0065-308X(05)62004-0; Bhaduri B, 2007, GEOJOURNAL, V69, P103, DOI 10.1007/s10708-007-9105-9; Blaschke T, 2010, ISPRS J PHOTOGRAMM, V65, P2, DOI 10.1016/j.isprsjprs.2009.06.004; Checchi F, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-4; Collins R, 1995, AUTOMATIC EXTRACTION, P169; Davison AC, 1997, BOOTSTRAP METHODS TH; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Gomez-Elipe A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-129; Harvey JT, 2002, INT J REMOTE SENS, V23, P2071, DOI 10.1080/01431160110075901; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Jacobsen KH, 2012, INT HEALTH, V4, P307, DOI 10.1016/j.inhe.2012.09.004; Jacobsen KH, 2012, ACTA OBSTET GYN SCAN, V91, P750, DOI 10.1111/j.1600-0412.2012.01384.x; Katriel G, 2011, J R SOC INTERFACE, V8, P856, DOI 10.1098/rsif.2010.0515; Magalhaes RJS, 2011, ADV PARASIT, V74, P267, DOI 10.1016/B978-0-12-385897-9.00005-7; Ripley B, 2013, BOOT BOOTSTRAP R S P; Sharif B, 2012, EPIDEMIOL RES INT, V2012, P14; STINE R, 1989, SOCIOL METHOD RES, V18, P243, DOI 10.1177/0049124189018002003; Viel JF, 2009, EPIDEMIOLOGY, V20, P214, DOI 10.1097/EDE.0b013e31819670dc; White LF, 2008, STAT MED, V27, P2999, DOI 10.1002/sim.3136; Wildman J, 2002, GENERATING CONFIDENC; Wolf DA, 2001, CAN STUD POPUL, V28, P313; Wong T., 2003, P ATC 2003 C; Wu CS, 2007, GEOGR ANAL, V39, P26, DOI 10.1111/j.1538-4632.2006.00694.x; Wu S., 2005, GISCI REMOTE SENS, V42, P80, DOI [10.2747/1548-1603.42.1.80, DOI 10.2747/1548-1603.42.1.80]; Xiao YG, 2004, INT GEOSCI REMOTE SE, P2004	30	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112241	10.1371/journal.pone.0112241	http://dx.doi.org/10.1371/journal.pone.0112241			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398101	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558500039
J	Hollander, CD; Wu, AS				Hollander, Christopher D.; Wu, Annie S.			Gossip-Based Solutions for Discrete Rendezvous in Populations of Communicating Agents	PLOS ONE			English	Article							CONSENSUS	The objective of the rendezvous problem is to construct a method that enables a population of agents to agree on a spatial (and possibly temporal) meeting location. We introduce the buffered gossip algorithm as a general solution to the rendezvous problem in a discrete domain with direct communication between decentralized agents. We compare the performance of the buffered gossip algorithm against the well known uniform gossip algorithm. We believe that a buffered solution is preferable to an unbuffered solution, such as the uniform gossip algorithm, because the use of a buffer allows an agent to use multiple information sources when determining its desired rendezvous point, and that access to multiple information sources may improve agent decision making by reinforcing or contradicting an initial choice. To show that the buffered gossip algorithm is an actual solution for the rendezvous problem, we construct a theoretical proof of convergence and derive the conditions under which the buffered gossip algorithm is guaranteed to produce a consensus on rendezvous location. We use these results to verify that the uniform gossip algorithm also solves the rendezvous problem. We then use a multi-agent simulation to conduct a series of simulation experiments to compare the performance between the buffered and uniform gossip algorithms. Our results suggest that the buffered gossip algorithm can solve the rendezvous problem faster than the uniform gossip algorithm; however, the relative performance between these two solutions depends on the specific constraints of the problem and the parameters of the buffered gossip algorithm.	[Hollander, Christopher D.; Wu, Annie S.] Univ Cent Florida, Dept Elect Engn & Comp Sci, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Hollander, CD (corresponding author), Univ Cent Florida, Dept Elect Engn & Comp Sci, Orlando, FL 32816 USA.	chris.hollander@gmail.com			Office of Naval Research [N000140911043]; General Dynamics [100005MC]	Office of Naval Research(Office of Naval Research); General Dynamics	Funding for this work was provided to ASW by the Office of Naval Research (#N000140911043, http://www.onr.navy.mil/) and General Dynamics (#100005MC, http://www.generaldynamics.com/). CDH received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALON N, 1987, ICDCS, P74; Aysal TC, 2009, IEEE T SIGNAL PROCES, V57, P2748, DOI 10.1109/TSP.2009.2016247; Boyd S, 2006, IEEE T INFORM THEORY, V52, P2508, DOI 10.1109/TIT.2006.874516; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Chandra T, 2007, PODC'07: PROCEEDINGS OF THE 26TH ANNUAL ACM SYMPOSIUM ON PRINCIPLES OF DISTRIBUTED COMPUTING, P398; Demers A., 1988, Operating Systems Review, V22, P8, DOI 10.1145/43921.43922; Dimakis ADG, 2008, IEEE T SIGNAL PROCES, V56, P1205, DOI 10.1109/TSP.2007.908946; Dimakis AG, 2006, IPSN 2006: THE FIFTH INTERNATIONAL CONFERENCE ON INFORMATION PROCESSING IN SENSOR NETWORKS, P69; Dimakis AG, 2010, P IEEE, V98, P1847, DOI 10.1109/JPROC.2010.2052531; Eugster PT, 2004, COMPUTER, V37, P60, DOI 10.1109/MC.2004.1297243; Fang J, 2008, P AMER CONTR CONF, P765, DOI 10.1109/ACC.2008.4586585; Feige U., 1990, RANDOM STRUCT ALGOR, V1, P447, DOI DOI 10.1002/RSA.3240010406; Ganesh AJ, 2003, IEEE T COMPUT, V52, P139, DOI 10.1109/TC.2003.1176982; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; HEDETNIEMI SM, 1988, NETWORKS, V18, P319, DOI 10.1002/net.3230180406; HOLLANDER CD, 2011, JOURNAL OF ARTIFICIA, V14; HROMKOVIC J, 1996, COMBINATORIAL NETWOR, P125; Karp R, 2000, ANN IEEE SYMP FOUND, P565, DOI 10.1109/SFCS.2000.892324; Kashyap A, 2006, IEEE DECIS CONTR P, P2728, DOI 10.1109/CDC.2006.376993; Kempe D, 2004, J ACM, V51, P943, DOI 10.1145/1039488.1039491; Kempe D, 2003, ANN IEEE SYMP FOUND, P482, DOI 10.1109/SFCS.2003.1238221; Kempe D, 2002, ANN IEEE SYMP FOUND, P471, DOI 10.1109/SFCS.2002.1181971; Lamport L., 2001, SIGACT News, V32, P51; Lamport L, 1998, ACM T COMPUT SYST, V16, P133, DOI 10.1145/279227.279229; Liggett, 2005, INTERACTING PARTICLE; Lin J, 2004, IEEE DECIS CONTR P, P1926, DOI 10.1109/CDC.2004.1430329; Lin J, 2003, 42ND IEEE CONFERENCE ON DECISION AND CONTROL, VOLS 1-6, PROCEEDINGS, P1508; MOCANU A, 2014, PROCEEDINGS OF THE 4, DOI DOI 10.1145/2611040.2611099; MOSKAOYAMA D, 2006, P 25 ANN ACM S PRINC, P113, DOI DOI 10.1145/1146381.1146401; Newman MEJ, 1999, PHYS LETT A, V263, P341, DOI 10.1016/S0375-9601(99)00757-4; Olfati-Saber R, 2007, P IEEE, V95, P215, DOI 10.1109/JPROC.2006.887293; OLIPHANT TE, 2007, COMPUTING IN SCIENCE, V9; Ongaro D., 2014, 2014 USENIX ANN TECH, P305, DOI DOI 10.5555/2643634.2643666; Pelc A, 2011, LECT NOTES COMPUT SC, V6950, P1, DOI 10.1007/978-3-642-24100-0_1; PITTEL B, 1987, SIAM J APPL MATH, V47, P213, DOI 10.1137/0147013; Raghavan UN, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036106; Ren W, 2005, P AMER CONTR CONF, P1859, DOI 10.1109/ACC.2005.1470239; Ren W, 2007, IEEE CONTR SYST MAG, V27, P71, DOI 10.1109/MCS.2007.338264; Schweitzer F, 2009, EUR PHYS J B, V67, P301, DOI 10.1140/epjb/e2009-00001-3; Sood V, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.178701; YILDIZ M, 2010, INF THEOR APPL WORKS, V2010, P1, DOI DOI 10.1109/ITA.2010.5454090	42	0	0	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112612	10.1371/journal.pone.0112612	http://dx.doi.org/10.1371/journal.pone.0112612			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397882	Green Published, gold			2022-12-27	WOS:000345558500065
J	Tokuda, K; Nishikawa, M; Kawahara, S				Tokuda, Keita; Nishikawa, Michimasa; Kawahara, Shigenori			Hippocampal State-Dependent Behavioral Reflex to an Identical Sensory Input in Rats	PLOS ONE			English	Article							NICTITATING-MEMBRANE RESPONSE; CONDITIONAL DISCRIMINATION; ASSOCIATIVE MEMORY; THETA OSCILLATIONS; BRAIN STATES; EYEBLINK; LESIONS; TRACE; SEQUENCES; CORTEX	We examined the local field potential of the hippocampus to monitor brain states during a conditional discrimination task, in order to elucidate the relationship between ongoing brain states and a conditioned motor reflex. Five 10-week-old Wistar/ ST male rats underwent a serial feature positive conditional discrimination task in eyeblink conditioning using a preceding light stimulus as a conditional cue for reinforced trials. In this task, a 2-s light stimulus signaled that the following 350-ms tone (conditioned stimulus) was reinforced with a co-terminating 100-ms periorbital electrical shock. The interval between the end of conditional cue and the onset of the conditioned stimulus was 4 +/- 1 s. The conditioned stimulus was not reinforced when the light was not presented. Animals successfully utilized the light stimulus as a conditional cue to drive differential responses to the identical conditioned stimulus. We found that presentation of the conditional cue elicited hippocampal theta oscillations, which persisted during the interval of conditional cue and the conditioned stimulus. Moreover, expression of the conditioned response to the tone (conditioned stimulus) was correlated with the appearance of theta oscillations immediately before the conditioned stimulus. These data support hippocampal involvement in the network underlying a conditional discrimination task in eyeblink conditioning. They also suggest that the preceding hippocampal activity can determine information processing of the tone stimulus in the cerebellum and its associated circuits.	[Tokuda, Keita] Univ Tokyo, Grad Sch Informat Sci & Technol, Dept Math Informat, Bunkyo Ku, Tokyo 1138656, Japan; [Nishikawa, Michimasa; Kawahara, Shigenori] Toyama Univ, Grad Sch Sci & Engn, Toyama 9308555, Japan	University of Tokyo; University of Toyama	Kawahara, S (corresponding author), Toyama Univ, Grad Sch Sci & Engn, 3190 Gofuku, Toyama 9308555, Japan.	kawahara@eng.u-toyama.ac.jp		Tokuda, Keita/0000-0002-0275-5541	JSPS KAKENHI [21570161]; Aihara Innovative Mathematical Modelling Project; Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program),"	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Aihara Innovative Mathematical Modelling Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program),"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by JSPS KAKENHI (21570161) and the Aihara Innovative Mathematical Modelling Project, the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program),'' initiated by the Council for Science and Technology Policy (CSTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agster KL, 2002, J NEUROSCI, V22, P5760; Andersen P., 2007, HIPPOCAMPUS BOOK; Bellebaum C, 2004, BEHAV NEUROSCI, V118, P1157, DOI 10.1037/0735-7044.118.6.1157; BERRY SD, 1979, SCIENCE, V205, P209, DOI 10.1126/science.451592; Berry SD, 1978, PREDICTION LEARNING, P1298; Berry SD, 2011, NEUROBIOL LEARN MEM, V95, P185, DOI 10.1016/j.nlm.2010.11.014; Bland BH, 2001, BEHAV BRAIN RES, V127, P119, DOI 10.1016/S0166-4328(01)00358-8; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; Blankenship MR, 2005, BRAIN RES, V1035, P120, DOI 10.1016/j.brainres.2004.11.061; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Campolattaro MM, 2006, NEUROBIOL LEARN MEM, V86, P205, DOI 10.1016/j.nlm.2006.03.001; Campolattaro MM, 2006, BEHAV NEUROSCI, V120, P970, DOI 10.1037/0735-7044.120.4.970; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Cartford MC, 2004, LEARN MEMORY, V11, P732, DOI 10.1101/lm.83104; Cartford MC, 2002, NEUROBIOL LEARN MEM, V78, P246, DOI 10.1006/nlme.2002.4063; Case GR, 2002, NEUROBIOL LEARN MEM, V78, P234, DOI 10.1006/nlme.2002.4061; Christian KM, 2005, BEHAV NEUROSCI, V119, P526, DOI 10.1037/0735-7044.119.2.526; Christian KM, 2003, LEARN MEMORY, V10, P427, DOI 10.1101/lm.59603; DAUM I, 1991, BEHAV NEUROSCI, V105, P396, DOI 10.1037/0735-7044.105.3.396; Deco G, 2005, PROG NEUROBIOL, V76, P236, DOI 10.1016/j.pneurobio.2005.08.004; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fortier CB, 2003, BEHAV NEUROSCI, V117, P1181, DOI 10.1037/0735-7044.117.6.1181; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Galvez R, 2007, LEARN MEMORY, V14, P94, DOI 10.1101/lm.418407; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; GRASTYAN E, 1959, ELECTROEN CLIN NEURO, V11, P409, DOI 10.1016/0013-4694(59)90040-9; Green JT, 2000, PSYCHOL BULL, V126, P138, DOI 10.1037/0033-2909.126.1.138; Griffin AL, 2004, BEHAV NEUROSCI, V118, P403, DOI 10.1037/0735-7044.118.2.403; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; Hoffmann LC, 2009, P NATL ACAD SCI USA, V106, P21371, DOI 10.1073/pnas.0908403106; Holland PEC, 1999, HIPPOCAMPUS, V9, P143, DOI 10.1002/(SICI)1098-1063(1999)9:2<143::AID-HIPO6>3.0.CO;2-Z; Kesner RP, 2002, BEHAV NEUROSCI, V116, P286, DOI 10.1037//0735-7044.116.2.286; Kim JJ, 1997, TRENDS NEUROSCI, V20, P177, DOI 10.1016/S0166-2236(96)10081-3; Koo JW, 2004, J NEUROSCI, V24, P7654, DOI 10.1523/JNEUROSCI.1644-04.2004; Kotani S, 2002, EUR J NEUROSCI, V15, P1267, DOI 10.1046/j.1460-9568.2002.01963.x; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; MAUK MD, 1987, BRAIN RES, V403, P89, DOI 10.1016/0006-8993(87)90126-0; McKenna JT, 2008, J SLEEP RES, V17, P365, DOI 10.1111/j.1365-2869.2008.00686.x; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Moyer JR, 1996, J NEUROSCI, V16, P5536; Munera A, 2000, NEUROSCI LETT, V292, P33, DOI 10.1016/S0304-3940(00)01430-0; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nokia MS, 2008, NEUROBIOL LEARN MEM, V90, P62, DOI 10.1016/j.nlm.2008.01.005; NORMAN RJ, 1977, SCIENCE, V196, P551, DOI 10.1126/science.850800; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Otto T, 2006, J NEUROSCI, V26, P6603, DOI 10.1523/JNEUROSCI.1056-06.2006; Paredes DA, 2009, NEUROBIOL LEARN MEM, V92, P267, DOI 10.1016/j.nlm.2008.08.008; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PENICK S, 1991, BEHAV NEUROSCI, V105, P611, DOI 10.1037/0735-7044.105.5.611; Poulos AM, 2006, BEHAV NEUROSCI, V120, P730, DOI 10.1037/0735-7044.120.3.730; Rogers RF, 1998, NEUROBIOL LEARN MEM, V69, P307, DOI 10.1006/nlme.1998.3826; Ruigrok T. J. H., 2004, RAT NERVOUS SYSTEM, P167, DOI DOI 10.1016/B978-012547638-6/50009-2; Sainsbury RS, 1998, NEUROSCI BIOBEHAV R, V22, P237, DOI 10.1016/S0149-7634(97)00011-0; Schmajuk NA, 1997, BEHAV NEUROSCI, V111, P235; SCHNEIDERMAN N, 1966, J COMP PHYSIOL PSYCH, V62, P397, DOI 10.1037/h0023946; Seager MA, 2002, P NATL ACAD SCI USA, V99, P1616, DOI 10.1073/pnas.032662099; Steinmetz JE, 2000, BEHAV BRAIN RES, V110, P13, DOI 10.1016/S0166-4328(99)00181-3; Takehara K, 2003, J NEUROSCI, V23, P9897; Takehara-Nishiuchi K, 2008, SCIENCE, V322, P960, DOI 10.1126/science.1161299; Thompson RE, 2005, ANNU REV PSYCHOL, V56, P1, DOI 10.1146/annurev.psych.56.091103.070239; Thompson RF, 1996, P NATL ACAD SCI USA, V93, P13438, DOI 10.1073/pnas.93.24.13438; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Waddell J, 2008, J NEUROSCI, V28, P5290, DOI 10.1523/JNEUROSCI.1129-08.2008; Weiss C, 2011, BEHAV NEUROSCI, V125, P318, DOI 10.1037/a0023520; Wikgren J, 2010, NEUROSCIENCE, V165, P1538, DOI 10.1016/j.neuroscience.2009.11.044; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wolf OT, 2012, PSYCHOPHYSIOLOGY, V49, P164, DOI 10.1111/j.1469-8986.2011.01294.x; Yoon T, 2011, NEUROBIOL LEARN MEM, V95, P176, DOI 10.1016/j.nlm.2010.07.001	72	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112927	10.1371/journal.pone.0112927	http://dx.doi.org/10.1371/journal.pone.0112927			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397873	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558500113
J	Croken, MM; Ma, YF; Markillie, LM; Taylor, RC; Orr, G; Weiss, LM; Kim, K				Croken, Matthew McKnight; Ma, Yanfen; Markillie, Lye Meng; Taylor, Ronald C.; Orr, Galya; Weiss, Louis M.; Kim, Kami			Distinct Strains of Toxoplasma gondii Feature Divergent Transcriptomes Regardless of Developmental Stage	PLOS ONE			English	Article							GENE-EXPRESSION; DATABASE; FAMILY	Using high through-put RNA sequencing, we assayed the transcriptomes of three different strains of Toxoplasma gondii representing three common genotypes under both in vitro tachyzoite and in vitro bradyzoite-inducing alkaline stress culture conditions. Strikingly, the differences in transcriptional profiles between the strains, RH, PLK, and CTG, is much greater than differences between tachyzoites and alkaline stressed in vitro bradyzoites. With an FDR of 10%, we identified 241 genes differentially expressed between CTG tachyzoites and in vitro bradyzoites, including 5 putative AP2 transcription factors. We also observed a close association between cell cycle regulated genes and differentiation. By Gene Set Enrichment Analysis (GSEA), there are a number of KEGG pathways associated with the in vitro bradyzoite transcriptomes of PLK and CTG, including pyrimidine metabolism and DNA replication. These functions are likely associated with cell-cycle arrest. When comparing mRNA levels between strains, we identified 1,526 genes that were differentially expressed regardless of culture-condition as well as 846 differentially expressed only in bradyzoites and 542 differentially expressed only in tachyzoites between at least two strains. Using GSEA, we identified that ribosomal proteins were expressed at significantly higher levels in the CTG strain than in either the RH or PLK strains. This association holds true regardless of life cycle stage.	[Croken, Matthew McKnight; Kim, Kami] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Ma, Yanfen; Weiss, Louis M.; Kim, Kami] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Markillie, Lye Meng; Orr, Galya] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA; [Taylor, Ronald C.] Pacific NW Natl Lab, Div Biol Sci, Computat Biol & Bioinformat Grp, Richland, WA 99352 USA; [Weiss, Louis M.; Kim, Kami] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Yeshiva University; Albert Einstein College of Medicine	Weiss, LM (corresponding author), Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA.	louis.weiss@einstein.yu.edu; kami.kim@einstein.yu.edu		Kim, Kami/0000-0003-3384-152X; Taylor, Ronald/0000-0001-9777-9767	National Institutes of Health (NIH) [AI095094]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087625, R01AI095094, P30AI051519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research was supported by National Institutes of Health (NIH) grants AI095094 (LMW), AI087625 (KK), and by grant 40070 (LMW) from Environmental Molecular Sciences Laboratory (EMSL) Pacific Northwest National Laboratory. MMC was supported by the Training Program in Cellular and Molecular Biology and Genetics, funded by NIH T32 GM007491 awarded to the Albert Einstein College of Medicine. A portion of the research was performed using EMSL, a national scientific user facility sponsored by the Department of Energy's Office of Biological and Environmental Research and located at Pacific Northwest National Lab. This work was also supported in part by the Center for AIDS Research at the Albert Einstein College of Medicine and Montefiore Medical Center funded by the National Institutes of Health (NIH AI-051519). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000852; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Behnke MS, 2008, MOL MICROBIOL, V68, P1502, DOI 10.1111/j.1365-2958.2008.06249.x; Behnke MS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-350; Behnke MS, 2011, P NATL ACAD SCI USA, V108, P9631, DOI 10.1073/pnas.1015338108; Behnke MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012354; Croken MM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-515; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Hutson SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014057; Iwanaga S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047557; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Khan A, 2005, NUCLEIC ACIDS RES, V33, P2980, DOI 10.1093/nar/gki604; Khan A, 2011, MBIO, V2, DOI 10.1128/mBio.00228-11; Kim K, 2008, MICROBES INFECT, V10, P978, DOI 10.1016/j.micinf.2008.07.015; Knoll LJ, 2014, TOXOPLASMA GONDII: THE MODEL APICOMPLEXAN - PERSPECTIVES AND METHODS, 2ND EDITION, P521, DOI 10.1016/B978-0-12-396481-6.00015-5; Konrad C, 2014, INT J PARASITOL, V44, P139, DOI 10.1016/j.ijpara.2013.08.005; Lescault PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014463; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Radke JB, 2013, P NATL ACAD SCI USA, V110, P6871, DOI 10.1073/pnas.1300059110; Radke JR, 2003, MOL BIOCHEM PARASIT, V131, P119, DOI 10.1016/S0166-6851(03)00198-1; Reese ML, 2011, P NATL ACAD SCI USA, V108, P9625, DOI 10.1073/pnas.1015980108; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shanmugasundram A, 2013, NUCLEIC ACIDS RES, V41, pD706, DOI 10.1093/nar/gks1139; Sibley LD, 2009, PHILOS T R SOC B, V364, P2749, DOI 10.1098/rstb.2009.0087; Sinha A, 2014, NATURE, V507, P253, DOI 10.1038/nature12970; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Su C, 2003, SCIENCE, V299, P414, DOI 10.1126/science.1078035; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Walker R, 2013, MOL MICROBIOL, V87, P641, DOI 10.1111/mmi.12121; White MW, 2014, CELL MICROBIOL, V16, P466, DOI 10.1111/cmi.12267; Yuda M, 2010, MOL MICROBIOL, V75, P854, DOI 10.1111/j.1365-2958.2009.07005.x; Yuda M, 2009, MOL MICROBIOL, V71, P1402, DOI 10.1111/j.1365-2958.2009.06609.x	34	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e111297	10.1371/journal.pone.0111297	http://dx.doi.org/10.1371/journal.pone.0111297			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393307	gold, Green Submitted, Green Published			2022-12-27	WOS:000347709300014
J	Ding, FR; Zhang, XY; Li, XJ; Zhang, YQ; Li, BH; Ding, J				Ding, Fangrui; Zhang, Xiaoyan; Li, Xuejuan; Zhang, Yanqin; Li, Baihong; Ding, Jie			Mammalian Target of Rapamycin Complex 2 Signaling Pathway Regulates Transient Receptor Potential Cation Channel 6 in Podocytes	PLOS ONE			English	Article							TRPC6 EXPRESSION; BINDING PARTNER; UP-REGULATION; S6 KINASE; MTOR; CYTOSKELETON; RICTOR; PHOSPHORYLATION; CONTRIBUTES; INHIBITION	Transient receptor potential cation channel 6 (TRPC6) is a nonselective cation channel, and abnormal expression and gain of function of TRPC6 are involved in the pathogenesis of hereditary and nonhereditary forms of renal disease. Although the molecular mechanisms underlying these diseases remain poorly understood, recent investigations revealed that many signaling pathways are involved in regulating TRPC6. We aimed to examine the effect of the mammalian target of rapamycin (mTOR) complex (mTOR complex 1 [mTORC1] or mTOR complex 2 [mTORC2]) signaling pathways on TRPC6 in podocytes, which are highly terminally differentiated renal epithelial cells that are critically required for the maintenance of the glomerular filtration barrier. We applied both pharmacological inhibitors of mTOR and specific siRNAs against mTOR components to explore which mTOR signaling pathway is involved in the regulation of TRPC6 in podocytes. The podocytes were exposed to rapamycin, an inhibitor of mTORC1, and ku0063794, a dual inhibitor of mTORC1 and mTORC2. In addition, specific siRNA-mediated knockdown of the mTORC1 component raptor and the mTORC2 component rictor was employed. The TRPC6 mRNA and protein expression levels were examined via real-time quantitative PCR and Western blot, respectively. Additionally, fluorescence calcium imaging was performed to evaluate the function of TRPC6 in podocytes. Rapamycin displayed no effect on the TRPC6 mRNA or protein expression levels or TRPC6-dependent calcium influx in podocytes. However, ku0063794 down-regulated the TRPC6 mRNA and protein levels and suppressed TRPC6-dependent calcium influx in podocytes. Furthermore, knockdown of raptor did not affect TRPC6 expression or function, whereas rictor knockdown suppressed TRPC6 protein expression and TRPC6-dependent calcium influx in podocytes. These findings indicate that the mTORC2 signaling pathway regulates TRPC6 in podocytes but that the mTORC1 signaling pathway does not appear to exert an effect on TRPC6.	[Ding, Fangrui; Zhang, Xiaoyan; Li, Xuejuan; Zhang, Yanqin; Li, Baihong; Ding, Jie] Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China	Peking University	Ding, J (corresponding author), Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China.	djnc_5855@126.com		ZHANG, XIAOYAN/0000-0002-4060-2423	National Basic Research Program of China (973 Program) [2012CB517700]; National Nature Science Foundation of China [30830105, 81170657]; Nature Science Foundation of Beijing [7072080]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Beijing	The work was supported by the following: National Basic Research Program of China (973 Program, NO. 2012CB517700) JD; National Nature Science Foundation of China (NO. 30830105, 81170657) JD; and Nature Science Foundation of Beijing (NO. 7072080) JD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Canaud G, 2013, NAT MED, V19, P1288, DOI 10.1038/nm.3313; Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774; Goncharova EA, 2011, MOL CELL BIOL, V31, P2484, DOI 10.1128/MCB.01061-10; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jeruschke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055980; Jiang LN, 2011, EXP BIOL MED, V236, P184, DOI 10.1258/ebm.2010.010237; Kato H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064344; Kim EY, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-26; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Leuner K, 2007, FASEB J, V21, P4101, DOI 10.1096/fj.07-8110com; Li Z, 2013, CELL PROLIFERAT, V46, P76, DOI 10.1111/cpr.12010; Liu LH, 2010, DEV CELL, V19, P845, DOI 10.1016/j.devcel.2010.11.004; Liu Meilian, 2011, Commun Integr Biol, V4, P382, DOI 10.4161/cib.4.4.15309; Moeller CC, 2007, J AM SOC NEPHROL, V18, P29, DOI 10.1681/ASN.2006091010; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Nijenhuis T, 2011, AM J PATHOL, V179, P1719, DOI 10.1016/j.ajpath.2011.06.033; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Singh I, 2007, J BIOL CHEM, V282, P7833, DOI 10.1074/jbc.M608288200; Vollenbroker B, 2009, AM J PHYSIOL-RENAL, V296, pF418, DOI 10.1152/ajprenal.90319.2008; Wang ZY, 2009, CELL PHYSIOL BIOCHEM, V24, P619, DOI 10.1159/000257517; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Zhang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054918	33	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112972	10.1371/journal.pone.0112972	http://dx.doi.org/10.1371/journal.pone.0112972			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393730	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300128
J	Helps, SK; Bamford, S; Sonuga-Barke, EJS; Soderlund, GBW				Helps, Suzannah K.; Bamford, Susan; Sonuga-Barke, Edmund J. S.; Soderlund, Goran B. W.			Different Effects of Adding White Noise on Cognitive Performance of Sub-, Normal and Super-Attentive School Children	PLOS ONE			English	Article							DEFICIT/HYPERACTIVITY DISORDER; STOCHASTIC RESONANCE; LATENT STRUCTURE; BALANCE CONTROL; DELAY AVERSION; NETWORK MODEL; HYPERACTIVITY; STIMULATION; SENSITIVITY; DOPAMINE	Objectives: Noise often has detrimental effects on performance. However, because of the phenomenon of stochastic resonance (SR), auditory white noise (WN) can alter the "signal to noise'' ratio and improve performance. The Moderate Brain Arousal (MBA) model postulates different levels of internal "neural noise'' in individuals with different attentional capacities. This in turn determines the particular WN level most beneficial in each individual case-with one level of WN facilitating poor attenders but hindering super-attentive children. The objective of the present study is to find out if added WN affects cognitive performance differently in children that differ in attention ability. Methods: Participants were teacher-rated super-(N = 25); normal-(N = 29) and sub-attentive (N = 36) children (aged 8 to 10 years). Two non-executive function (EF) tasks (a verbal episodic recall task and a delayed verbal recognition task) and two EF tasks (a visuo-spatial working memory test and a Go-NoGo task) were performed under three WN levels. The non-WN condition was only used to control for potential differences in background noise in the group testing situations. Results: There were different effects of WN on performance in the three groups-adding moderate WN worsened the performance of super-attentive children for both task types and improved EF performance in sub-attentive children. The normal-attentive children's performance was unaffected by WN exposure. The shift from moderate to high levels of WN had little further effect on performance in any group. Significance: The predicted differential effect of WN on performance was confirmed. However, the failure to find evidence for an inverted U function challenges current theories. Alternative explanations are discussed. We propose that WN therapy should be further investigated as a possible non-pharmacological treatment for inattention.	[Helps, Suzannah K.; Bamford, Susan; Sonuga-Barke, Edmund J. S.] Univ Southampton, Dept Psychol, Inst Disorders Impulse & Attent, Southampton SO9 5NH, Hants, England; [Soderlund, Goran B. W.] Sogndal Univ Coll, Fac Teacher Educ & Sports, Sogndal, Norway; [Sonuga-Barke, Edmund J. S.] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium	University of Southampton; Ghent University	Sonuga-Barke, EJS (corresponding author), Univ Southampton, Dept Psychol, Inst Disorders Impulse & Attent, Southampton SO9 5NH, Hants, England.	ejb3@soton.ac.uk; goran.soderlund@hisf.no	Sonuga-Barke, Edmund j/D-9137-2011	Soderlund, Goran/0000-0002-5941-8431	Wellcome Trust [WT087749MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	The work was supported by Wellcome Trust grant reference WT087749MA, http://www.wellcome.ac.uk/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abikoff H, 1996, J LEARN DISABIL, V29, P238, DOI 10.1177/002221949602900302; Barch DM, 2005, SCHIZOPHR RES, V77, P43, DOI 10.1016/j.schres.2004.12.019; Barry RJ, 2003, CLIN NEUROPHYSIOL, V114, P171, DOI 10.1016/S1388-2457(02)00362-0; Barry RJ, 2010, CLIN NEUROPHYSIOL, V121, P1871, DOI 10.1016/j.clinph.2010.04.022; Barry RJ, 2009, BIOL PSYCHIAT, V66, P398, DOI 10.1016/j.biopsych.2009.04.027; Biederman J, 2008, J CLIN PSYCHIAT, V69, P1150, DOI 10.4088/JCP.v69n0715; Bitsakou P, 2008, J NEURAL TRANSM, V115, P261, DOI 10.1007/s00702-007-0828-z; Braver TS, 2002, NEUROSCI BIOBEHAV R, V26, P809, DOI 10.1016/S0149-7634(02)00067-2; Braver TS, 1999, BIOL PSYCHIAT, V46, P312, DOI 10.1016/S0006-3223(99)00116-X; Breier JI, 2002, NEUROPSYCHOLOGY, V16, P28, DOI 10.1037//0894-4105.16.1.28; Broadbent D. E., 1958, EFFECTS NOISE BEHAV; Clarke AR, 2013, INT J PSYCHOPHYSIOL, V89, P314, DOI 10.1016/j.ijpsycho.2013.04.009; Coghill D, 2012, J CHILD PSYCHOL PSYC, V53, P469, DOI 10.1111/j.1469-7610.2011.02511.x; Dawes P, 2009, EAR HEARING, V30, P675, DOI 10.1097/AUD.0b013e3181b34cc5; Durlach NI, 2003, J ACOUST SOC AM, V114, P368, DOI 10.1121/1.1577562; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Frazier TW, 2007, ARCH CLIN NEUROPSYCH, V22, P197, DOI 10.1016/j.acn.2006.12.007; Geffner D, 1996, CHILD PSYCHIAT HUM D, V26, P169, DOI 10.1007/BF02353358; Gerjets P, 2002, Z KL PSYCH PSYCHOTH, V31, P99, DOI 10.1026//1616-3443.31.2.99; Graham J, 2011, EUR CHILD ADOLES PSY, V20, P17, DOI 10.1007/s00787-010-0140-6; Gray LC, 2002, INT J PEDIATR OTORHI, V66, P265, DOI 10.1016/S0165-5876(02)00251-3; Haslam N, 2006, AUST NZ J PSYCHIAT, V40, P639, DOI 10.1111/j.1440-1614.2006.01863.x; Hogan AM, 2005, DEVELOPMENTAL SCI, V8, P525, DOI 10.1111/j.1467-7687.2005.00444.x; KNUEPFER MM, 1991, CLIN EXP HYPERTENS A, V13, P505, DOI 10.3109/10641969109045066; Kobel M, 2009, EUR J PAEDIATR NEURO, V13, P516, DOI 10.1016/j.ejpn.2008.10.008; Levy F, 1997, J AM ACAD CHILD PSY, V36, P737, DOI 10.1097/00004583-199706000-00009; Manjarrez E, 2007, NEUROSCI LETT, V415, P231, DOI 10.1016/j.neulet.2007.01.030; McDonnell MD, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.061105; McDonnell MD, 2011, NAT REV NEUROSCI, V12, P415, DOI 10.1038/nrn3061; McDonnell MD, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.041107; Moss F, 2004, CLIN NEUROPHYSIOL, V115, P267, DOI 10.1016/j.clinph.2003.09.014; Mulavara AP, 2011, EXP BRAIN RES, V210, P303, DOI 10.1007/s00221-011-2633-z; Novak P, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-9; Palsson E, 2011, PSYCHOPHARMACOLOGY, V214, P675, DOI 10.1007/s00213-010-2074-6; Prince J, 2008, J CLIN PSYCHOPHARM, V28, pS39, DOI 10.1097/JCP.0b013e318174f92a; Priplata AA, 2006, ANN NEUROL, V59, P4, DOI 10.1002/ana.20670; Priplata AA, 2003, LANCET, V362, P1123, DOI 10.1016/S0140-6736(03)14470-4; Samoudi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029308; SCHAEFER CF, 1978, PAVLOVIAN J BIOL SCI, V13, P217; Sergeant J, 2000, NEUROSCI BIOBEHAV R, V24, P7, DOI 10.1016/S0149-7634(99)00060-3; Sergeant JA, 2005, BIOL PSYCHIAT, V57, P1248, DOI 10.1016/j.biopsych.2004.09.010; Servan-Schreiber D, 1998, BIOL PSYCHIAT, V43, P713, DOI 10.1016/S0006-3223(97)00448-4; SERVANSCHREIBER D, 1990, SCIENCE, V249, P892, DOI 10.1126/science.2392679; Shidara M, 2005, EXP BRAIN RES, V163, P239, DOI 10.1007/s00221-005-2230-0; Sikstrom S, 2007, PSYCHOL REV, V114, P1047, DOI 10.1037/0033-295X.114.4.1047; Simonotto E, 1999, NEUROCOMPUTING, V26-7, P511, DOI 10.1016/S0925-2312(99)00042-9; Soderlund G, 2007, J CHILD PSYCHOL PSYC, V48, P840, DOI 10.1111/j.1469-7610.2007.01749.x; Soderlund GBW, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-55; Sonuga-Barke EJS, 2010, J AM ACAD CHILD PSY, V49, P345, DOI 10.1016/j.jaac.2009.12.018; SONUGABARKE EJS, 1992, J CHILD PSYCHOL PSYC, V33, P387, DOI 10.1111/j.1469-7610.1992.tb00874.x; SONUGABARKE EJS, 1992, J CHILD PSYCHOL PSYC, V33, P399, DOI 10.1111/j.1469-7610.1992.tb00875.x; Stansfeld SA, 2005, LANCET, V365, P1942, DOI 10.1016/S0140-6736(05)66660-3; Stein RB, 2005, NAT REV NEUROSCI, V6, P389, DOI 10.1038/nrn1668; Stocks NG, 2000, PHYS REV LETT, V84, P2310, DOI 10.1103/PhysRevLett.84.2310; Stuart M., 1993, CHILDRENS PRINTED WO; SWANSON J, 2007, CATEGORICAL DIMENSIO; Tan HZ, 2003, J ACOUST SOC AM, V114, P3295, DOI 10.1121/1.1623788; Tomasi D, 2011, NEUROIMAGE, V54, P3101, DOI 10.1016/j.neuroimage.2010.10.060; Vandaele J, 2009, APPL COGN LINGUIST, V10, P1; Ward LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014371; Wells C, 2005, PSYCHOL SCI, V16, P313, DOI 10.1111/j.0956-7976.2005.01533.x; Westerberg H, 2004, CHILD NEUROPSYCHOL, V10, P155, DOI 10.1080/09297040490911014; Wiersema R, 2006, J CHILD PSYCHOL PSYC, V47, P560, DOI 10.1111/j.1469-7610.2005.01592.x; Wilkinson D, 2009, J NEUROPSYCHOL; Wilkinson D, 2008, EXP BRAIN RES, V189, P243, DOI 10.1007/s00221-008-1463-0; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Zeng FG, 2000, BRAIN RES, V869, P251, DOI 10.1016/S0006-8993(00)02475-6	68	40	42	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112768	10.1371/journal.pone.0112768	http://dx.doi.org/10.1371/journal.pone.0112768			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY6YT	25393410	Green Published, gold, Green Accepted			2022-12-27	WOS:000347709300100
J	Jiang, Y; Zhang, WT; Wang, MC; Kang, MY; Dong, MY				Jiang, Yuan; Zhang, Wentao; Wang, Mingchang; Kang, Muyi; Dong, Manyu			Radial Growth of Two Dominant Montane Conifer Tree Species in Response to Climate Change in North-Central China	PLOS ONE			English	Article							DIFFERENT ELEVATIONS; TIBETAN PLATEAU; GROWING-SEASON; PICEA-MEYERI; RING; TEMPERATURE; HISTORY; TRENDS; DATES	North-Central China is a region in which the air temperature has clearly increased for several decades. Picea meyeri and Larix principis-rupprechtii are the most dominant co-occurring tree species within the cold coniferous forest belt ranging vertically from 1800 m to 2800 m a.s.l. in this region. Based on a tree-ring analysis of 292 increment cores sampled from 146 trees at different elevations, this study aimed to examine if the radial growth of the two species in response to climate is similar, whether the responses are consistent along altitudinal gradients and which species might be favored in the future driven by the changing climate. The results indicated the following: (1) The two species grew in different rhythms at low and high elevation respectively; (2) Both species displayed inconsistent relationships between radial growth and climate data along altitudinal gradients. The correlation between radial growth and the monthly mean temperature in the spring or summer changed from negative at low elevation into positive at high elevation, whereas those between the radial growth and the total monthly precipitation displayed a change from positive into negative along the elevation gradient. These indicate the different influences of the horizontal climate and vertical mountainous climate on the radial growth of the two species; (3) The species-dependent different response to climate in radial growth appeared mainly in autumn of the previous year. The radial growth of L. principis-rupprechtii displayed negative responses both to temperature and to precipitation in the previous September, October or November, which was not observed in the radial growth of P. meyeri. (4) The radial growth of both species will tend to be increased at high elevation and limited at low elevation, and L. principis-rupprechtii might be more favored in the future, if the temperature keeps rising.	[Jiang, Yuan; Zhang, Wentao; Wang, Mingchang; Kang, Muyi; Dong, Manyu] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource, Beijing 100875, Peoples R China; [Jiang, Yuan] Beijing Normal Univ, Key Lab Tradit Chinese Med Protect & Utilizat, Beijing 100875, Peoples R China; [Jiang, Yuan; Zhang, Wentao; Wang, Mingchang; Kang, Muyi] Beijing Normal Univ, Coll Resources Sci & Technol, Beijing 100875, Peoples R China; [Zhang, Wentao] Beijing Municipal Res Inst Environm Protect, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University; Beijing Normal University; Beijing Municipal Research Institute of Environment	Zhang, WT (corresponding author), Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource, Beijing 100875, Peoples R China.	ecozhangwt@gmail.com	jiang, anyi/GPT-0379-2022; Zhang, Wentao/AAI-1047-2019		National Natural Science Foundation of China [41171067, 41271059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (number 41171067 and 41271059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai J, 2011, ADV ATMOS SCI, V28, P564, DOI 10.1007/s00376-010-9219-8; Brauning A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020793; Cai QF, 2013, DENDROCHRONOLOGIA, V31, P311, DOI 10.1016/j.dendro.2012.07.003; Carrer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050755; [常锦峰 CHANG Jinfeng], 2009, [山地学报, Journal of Mountain Science], V27, P703; Cook E.R., 2005, PROGRAM ARSTAN TREE; Cook ER, 1990, METHODS DENDROCHRONO, DOI DOI 10.1007/978-94-015-7879-0; Cook ER, 1985, THESIS U ARIZONA TUC; Cui H, 2005, RES MOUNTAINS ECOLOG; [戴君虎 Dai Junhu], 2005, [第四纪研究, Quaternary Sciences], V25, P216; de Luis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083550; Domros M., 1988, CLIMATE CHINA, DOI 10.1007/978-3-642-73333-8; Dong MY, 2013, THEOR APPL CLIMATOL, V111, P693, DOI 10.1007/s00704-012-0706-y; Fang J., 2011, ATLAS WOODY PLANTS C, V1; Fang KY, 2009, IAWA J, V30, P443, DOI 10.1163/22941932-90000231; FRITTS H C, 1975, Tree-Ring Bulletin, V35, P31; Fritts H.C, 1976, TREE RINGS CLIMATE; Fritts HC, 1962, TREE RING B, V24, P9; Fritts HC., 1991, RECONSTRUCTION LARGE; Graham EA, 2003, P NATL ACAD SCI USA, V100, P572, DOI 10.1073/pnas.0133045100; Grissino-Mayer, 2001, TREE-RING RES, V57, P205, DOI DOI 10.1016/J.DENDRO.2010.12.002; He S, 1993, FLORA BEIJING; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Hughes MK, 2011, DEV PALEOENVIRON RES, V11, P17, DOI 10.1007/978-1-4020-5725-0_2; KIMBALL KD, 1988, CAN J FOREST RES, V18, P385, DOI 10.1139/x88-057; Knapp PA, 2012, GLOBAL PLANET CHANGE, V92-93, P257, DOI 10.1016/j.gloplacha.2012.06.002; Liang EY, 2001, TREES-STRUCT FUNCT, V15, P230, DOI 10.1007/s004680100097; Littell JS, 2008, ECOL MONOGR, V78, P349, DOI 10.1890/07-0712.1; Liu BH, 2010, CLIMATIC CHANGE, V99, P93, DOI 10.1007/s10584-009-9662-7; Liu HY, 2013, AGR FOREST METEOROL, V178, P1, DOI 10.1016/j.agrformet.2013.04.022; Liu L, 1996, VEGETATION HEBEI; Liu Y, 2003, CHINESE SCI BULL, V48, P1140, DOI 10.1360/02wd0455; Ma Z, 2001, VEGETATION SHANXI; National Soil Survey Office, 1995, ANN SOIL SPEC CHIN; Pallardy SG, 2008, PHYSIOLOGY OF WOODY PLANTS, 3RD EDITION, P1; Piao SL, 2011, GLOBAL CHANGE BIOL, V17, P3228, DOI 10.1111/j.1365-2486.2011.02419.x; Piao SL, 2006, GLOBAL CHANGE BIOL, V12, P672, DOI 10.1111/j.1365-2486.2006.01123.x; Piovesan G, 2005, ACTA OECOL, V27, P197, DOI 10.1016/j.actao.2005.01.001; Poulter B, 2013, AGR FOREST METEOROL, V178, P31, DOI 10.1016/j.agrformet.2012.12.006; Schweingruber F.H., 1989, TREE RINGS BASICS AP; SCHWEINGRUBER FH, 1987, NATURWISSENSCHAFTEN, V74, P205, DOI 10.1007/BF00424589; Shao X., 1994, ACTA GEOGRAPHICA SIN, V49, P174, DOI [10.11821/xb199402009, DOI 10.11821/XB199402009]; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Song YL, 2010, INT J CLIMATOL, V30, P33, DOI 10.1002/joc.1868; Soule PT, 2013, J ARID ENVIRON, V94, P87, DOI 10.1016/j.jaridenv.2013.02.005; Sun Y, 2010, SCI CHINA EARTH SCI, V53, P871, DOI 10.1007/s11430-010-0056-5; Therrell MD, 2006, CLIM DYNAM, V26, P677, DOI 10.1007/s00382-005-0108-2; Wieser G., 2007, Trees at their upper limit: treelife limitation at the Alpine timberline, P1; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Wilmking M, 2004, GLOBAL CHANGE BIOL, V10, P1724, DOI 10.1111/j.1365-2486.2004.00826.x; Wu C.-Y., 1980, VEGETATION CHINA; Wu X, 1997, PROG GEOGR, V16, P51; Zhang GL, 2013, P NATL ACAD SCI USA, V110, P4309, DOI 10.1073/pnas.1210423110; Zhang Wen-Tao, 2013, Chinese Journal of Plant Ecology, V37, P1142, DOI 10.3724/SP.J.1258.2013.00117; [朱海峰 Zhu Haifeng], 2004, [地理学报, Acta Geographica Sinica], V59, P863	55	20	23	5	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112537	10.1371/journal.pone.0112537	http://dx.doi.org/10.1371/journal.pone.0112537			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393738	Green Submitted, Green Published, gold			2022-12-27	WOS:000347709300066
J	Larsson, GL; Helenius, G; Sorbe, B; Karlsson, MG				Larsson, Gabriella Lillsunde; Helenius, Gisela; Sorbe, Bengt; Karlsson, Mats G.			Viral Load, Integration and Methylation of E2BS3 and 4 in Human Papilloma Virus (HPV) 16-Positive Vaginal and Vulvar Carcinomas	PLOS ONE			English	Article							RISK HUMAN-PAPILLOMAVIRUS; CERVICAL-CANCER; PHYSICAL STATE; TYPE-16 DNA; IN-SITU; E2 PROTEIN; NATURAL-HISTORY; CPG METHYLATION; E6 PROMOTER; WOMEN	Objective: To investigate if viral load, integration and methylation of E2BS3 and 4 represent different ways of tumor transformation in vaginal and vulvar carcinoma and to elucidate its clinical impact. Methods: Fifty-seven samples, positive for HPV16, were selected for the study. Detection of viral load was made with realtime-PCR using copy numbers of E6 and integration was calculated from comparing E2 to E6-copies. Methylation of E2BS3 and 4 was analysed using bisulphite treatment of tumor DNA, followed by PCR and pyrosequencing. Results: Vaginal tumors were found to have a higher viral load (p=0.024) compared to vulvar tumors but a high copy number (> median value, 15 000) as well as high methylation (> 50%) was significantly (p=0.010 and p=0.045) associated with a worse cancer-specific survival rate in vulvar carcinoma, but not in vaginal carcinoma. Four groups could be defined for the complete series using a Cluster Two step analysis; (1) tumors holding episomal viral DNA, viral load below 150 000 copies not highly methylated (n=25, 46.3%); (2) tumors harboring episomal viral DNA and being highly methylated (>50%; n=6, 11.1%); (3) tumors with viral DNA fully integrated (n=11, 20.4%), and (4) tumors harboring episomal viral DNA and being medium-or unmethylated (< 50%) and having a high viral load (> total mean value 150 000; n=12, 22.2%). The completely integrated tumors were found to be distinct group, whilst some overlap between the groups with high methylation and high viral load was observed. Conclusion: HPV16-related integration, methylation in E2BS3 and 4 and viral load may represent different viral characteristics driving vaginal and vulvar carcinogenesis. HPV16-related parameters were found to be of clinical importance in the vulvar series only.	[Larsson, Gabriella Lillsunde; Helenius, Gisela; Karlsson, Mats G.] Orebro Univ Hosp, Dept Lab Med, Orebro, Sweden; [Larsson, Gabriella Lillsunde; Helenius, Gisela; Karlsson, Mats G.] Univ Orebro, Sch Hlth & Med Sci, SE-70182 Orebro, Sweden; [Sorbe, Bengt] Orebro Univ Hosp, Dept Oncol, Orebro, Sweden	Orebro University; Orebro University; Orebro University	Larsson, GL (corresponding author), Orebro Univ Hosp, Dept Lab Med, Orebro, Sweden.	gabriella.lillsunde-larsson@orebroll.se	Karlsson, Mats G/AAV-7542-2021	Karlsson, Mats G/0000-0001-6881-237X; Lillsunde Larsson, Gabriella/0000-0001-9992-266X	Orebro County Council Research Committee [OLL-324811, OLL-259341]	Orebro County Council Research Committee	The work was funded by the Orebro County Council Research Committee, OLL-324811 (GLL) and OLL-259341 (GLL), http://www.fou.nu/is/oll. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloul N, 1999, J GEN VIROL, V80, P29, DOI 10.1099/0022-1317-80-1-29; Andersson S, 2005, BRIT J CANCER, V92, P2195, DOI 10.1038/sj.bjc.6602648; [Anonymous], 2012, CANC INC SWED 2011; Arias-Pulido H, 2006, J CLIN MICROBIOL, V44, P1755, DOI 10.1128/JCM.44.5.1755-1762.2006; Badal V, 2003, J VIROL, V77, P6227, DOI 10.1128/JVI.77.11.6227-6234.2003; BAKER CC, 1987, J VIROL, V61, P962, DOI 10.1128/JVI.61.4.962-971.1987; Bernard HU, 2002, ANTIVIR THER, V7, P219; Bhattacharjee B, 2006, GYNECOL ONCOL, V100, P372, DOI 10.1016/j.ygyno.2005.09.016; Chaiwongkot A, 2013, INT J CANCER, V132, P2087, DOI 10.1002/ijc.27906; Cheung JLK, 2013, GYNECOL ONCOL, V131, P374, DOI 10.1016/j.ygyno.2013.08.026; Collins SI, 2009, CANCER RES, V69, P3828, DOI 10.1158/0008-5472.CAN-08-3099; Constandinou-Williams C, 2010, CANCER EPIDEM BIOMAR, V19, P832, DOI 10.1158/1055-9965.EPI-09-0838; Cricca M, 2007, GYNECOL ONCOL, V106, P549, DOI 10.1016/j.ygyno.2007.05.004; Daniel B, 1997, J GEN VIROL, V78, P1095, DOI 10.1099/0022-1317-78-5-1095; DAS BC, 1992, J GEN VIROL, V73, P2327, DOI 10.1099/0022-1317-73-9-2327; Das D, 2010, VIROLOGY, V402, P197, DOI 10.1016/j.virol.2010.03.030; Das Ghosh D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044678; De Vuyst H, 2009, INT J CANCER, V124, P1626, DOI 10.1002/ijc.24116; Ding DC, 2009, EUR J OBSTET GYN R B, V147, P215, DOI 10.1016/j.ejogrb.2009.08.023; DOWHANICK JJ, 1995, J VIROL, V69, P7791, DOI 10.1128/JVI.69.12.7791-7799.1995; Fernandez AF, 2009, GENOME RES, V19, P438, DOI 10.1101/gr.083550.108; Grodzki M, 2006, CANCER EPIDEM BIOMAR, V15, P820, DOI 10.1158/1055-9965.EPI-05-0864; JEON S, 1995, P NATL ACAD SCI USA, V92, P1654, DOI 10.1073/pnas.92.5.1654; Johannsen E, 2013, VIROLOGY, V445, P205, DOI 10.1016/j.virol.2013.07.016; Josefsson AM, 2000, LANCET, V355, P2189, DOI 10.1016/S0140-6736(00)02401-6; Kalantari M, 2001, DIAGN MOL PATHOL, V10, P46, DOI 10.1097/00019606-200103000-00008; Kammer C, 2002, BRIT J CANCER, V86, P269, DOI 10.1038/sj.bjc.6600024; Kim K, 2003, J VIROL, V77, P12450, DOI 10.1128/JVI.77.23.12450-12459.2003; Kulmala SMA, 2006, J CLIN PATHOL, V59, P513, DOI 10.1136/jcp.2004.024570; Larsson GL, 2013, GYNECOL ONCOL, V129, P406, DOI 10.1016/j.ygyno.2013.02.004; Larsson GL, 2012, INT J GYNECOL CANCER, V22, P1413, DOI 10.1097/IGC.0b013e31826a0471; Mazumder D, 2011, GYNECOL ONCOL, V123, P597, DOI 10.1016/j.ygyno.2011.08.004; Mirabello L, 2013, INT J CANCER, V132, P1412, DOI 10.1002/ijc.27750; Moberg M, 2005, BRIT J CANCER, V92, P891, DOI 10.1038/sj.bjc.6602436; Munger K, 2004, J VIROL, V78, P11451, DOI 10.1128/JVI.78.21.11451-11460.2004; Peitsaro P, 2002, J CLIN MICROBIOL, V40, P886, DOI 10.1128/JCM.40.3.886-891.2002; Pett M, 2007, J PATHOL, V212, P356, DOI 10.1002/path.2192; Rajeevan MS, 2006, J VIROL METHODS, V138, P170, DOI 10.1016/j.jviromet.2006.08.012; ROMANCZUK H, 1990, J VIROL, V64, P2849, DOI 10.1128/JVI.64.6.2849-2859.1990; Ruutu MP, 2008, CLIN BIOCHEM, V41, P423, DOI 10.1016/j.clinbiochem.2007.12.014; Sathish N, 2004, GYNECOL ONCOL, V95, P363, DOI 10.1016/j.ygyno.2004.08.025; Saunier M, 2008, J CLIN MICROBIOL, V46, P3678, DOI 10.1128/JCM.01212-08; Shukla S, 2014, INDIAN J MED RES, V139, P531; Smith JS, 2009, OBSTET GYNECOL, V113, P917, DOI 10.1097/AOG.0b013e31819bd6e0; Sundstrom K, 2013, CANCER EPIDEM BIOMAR, V22, P150, DOI 10.1158/1055-9965.EPI-12-0953-T; TAN SH, 1994, J VIROL, V68, P6411, DOI 10.1128/JVI.68.10.6411-6420.1994; TAN SH, 1992, NUCLEIC ACIDS RES, V20, P251, DOI 10.1093/nar/20.2.251; Thain A, 1996, J VIROL, V70, P7233, DOI 10.1128/JVI.70.10.7233-7235.1996; Thierry F, 2009, VIROLOGY, V384, P375, DOI 10.1016/j.virol.2008.11.014; Tommasino M, 2014, SEMIN CANCER BIOL, V26, P13, DOI 10.1016/j.semcancer.2013.11.002; Valmary-Degano S, 2013, HUM PATHOL, V44, P992, DOI 10.1016/j.humpath.2012.08.019; Vinokurova S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024451; Wells SI, 2000, EMBO J, V19, P5762, DOI 10.1093/emboj/19.21.5762; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050; Xue Yuezhen, 2012, Open Virol J, V6, P163, DOI 10.2174/1874357901206010163; YEE C, 1985, AM J PATHOL, V119, P361; Ylitalo N, 2000, LANCET, V355, P2194, DOI 10.1016/S0140-6736(00)02402-8	57	10	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112839	10.1371/journal.pone.0112839	http://dx.doi.org/10.1371/journal.pone.0112839			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393237	Green Published, gold, Green Submitted			2022-12-27	WOS:000347709300111
J	Wang, P; Lu, MC; Yu, CW; Yan, YH				Wang, Panchalli; Lu, Mei-Chun; Yu, Cheng-Wei; Yan, Yuan-Horng			Influence of the Time of Day and Fasting Duration on Glucose Level following a 1-Hour, 50-Gram Glucose Challenge Test in Pregnant Women	PLOS ONE			English	Article							GESTATIONAL DIABETES-MELLITUS; AL. CIRCADIAN VARIATION; CARE 2012/35/1578-1584; DIURNAL-VARIATION; WEIGHT-GAIN; LAST MEAL; TOLERANCE; POPULATION; DIAGNOSIS; HYPERGLYCEMIA	Background: Previous studies have shown that the time of day (TD) of glucose measurement and the fasting duration (FD) influence the glucose levels in adults. Few studies have examined the effects of the TD and FD on the glucose level following a 1-hour, 50-gram glucose challenge test (GCT) in pregnant women in screening for or diagnosing gestational diabetes mellitus (GDM). The objective of this study was to investigate the influence of the TD (morning, afternoon, night) and the FD (the time of the last food ingestion as follows: <= 1 hour, 1-2 hours, and >2 hours) by examining their combined effects on the glucose levels following a 50-gram GCT in pregnant women. Methods and Results: We analyzed the data of 1,454 non-diabetic pregnant Taiwanese women in a prospective study. Multiple linear regression and multiple logistic regression were used to estimate the relationships between the 9 TD-FD groups and the continuous and binary glucose levels (cut-off at 140 mg/dL) following a 50-gram GCT, after adjusting for maternal age, nulliparity, pre-pregnancy body mass index, and weight gain. Different TD and FD groups were associated with variable glucose responses to the 50-gram GCT, some of which were significant. The estimate coefficients (b) of the TDFD groups "night, <= 1 hr'' and "night, 1-2 hr'' revealed significantly lower glucose concentrations [b (95% confidence interval [CI]): -6.46 (-12.53, -0.38) and -6.85 (-12.50, -1.20)] compared with the "morning, >2 hr'' group. The TD-FD groups "afternoon, <= 1 hr'' and "afternoon, 1-2 hr'' showed significantly lower odds ratios (OR) of a positive GCT; the adjusted ORs (95% CI) were 0.54 (0.31-0.95) and 0.58 (0.35-0.96), respectively. Conclusions: Our findings demonstrate the importance of standardizing the TD and FD for the 1-hour, 50-gram GCT. In screening for and diagnosing GDM, the TD and FD are modifiable factors that should be considered in clinical practice and epidemiological studies.	[Wang, Panchalli; Lu, Mei-Chun] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Obstet & Gynecol, Chiayi, Taiwan; [Lu, Mei-Chun; Yan, Yuan-Horng] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Med Res, Chiayi, Taiwan; [Yu, Cheng-Wei] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Nutr, Chiayi, Taiwan; [Yan, Yuan-Horng] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Internal Med, Chiayi, Taiwan; [Yan, Yuan-Horng] Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei 10764, Taiwan	National Taiwan University	Yan, YH (corresponding author), Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Med Res, Chiayi, Taiwan.	d97841006@ntu.edu.tw						Aparicio NJ, 1998, AM J OBSTET GYNECOL, V178, P1059, DOI 10.1016/S0002-9378(98)70548-4; Baptiste-Roberts K, 2011, J WOMENS HEALTH, V20, P1847, DOI 10.1089/jwh.2010.2377; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; d'Emden M, 2014, DIABETES CARE, V37, pE30, DOI 10.2337/dc13-2234; Dokus K, 2013, DIABETES CARE, V36, pE38, DOI 10.2337/dc12-1658; Emberson JR, 2002, ANN CLIN BIOCHEM, V39, P493, DOI 10.1258/000456302320314511; Goldberg RJ, 2013, DIABETES CARE, V36, pE39, DOI 10.2337/dc12-2017; Goldberg RJ, 2012, DIABETES CARE, V35, P1578, DOI 10.2337/dc11-2217; Guillemette L, 2014, J CLIN ENDOCR METAB, V99, P1862, DOI 10.1210/jc.2013-4016; Hulman A, 2013, DIABETOLOGIA, V56, P294, DOI 10.1007/s00125-012-2770-3; JARRETT RJ, 1969, BRIT MED J, V2, P341, DOI 10.1136/bmj.2.5653.341; Li N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082310; Lowe WL, 2014, DIABETIC MED, V31, P254, DOI 10.1111/dme.12352; MAYER KH, 1976, DIABETES, V25, P936, DOI 10.2337/diabetes.25.10.936; McElduff A, 2002, MED J AUSTRALIA, V176, P136, DOI 10.5694/j.1326-5377.2002.tb04327.x; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Miyakoshi K, 2003, DIABETES RES CLIN PR, V60, P63, DOI 10.1016/S0168-8227(02)00274-7; Moebus S, 2011, EUR J EPIDEMIOL, V26, P719, DOI 10.1007/s10654-011-9608-z; OSULLIVA.JB, 1966, AM J CLIN NUTR, V19, P345, DOI 10.1093/ajcn/19.5.345; Scholtens DM, 2014, DIABETES CARE, V37, P158, DOI 10.2337/dc13-0989; SERMER M, 1994, AM J OBSTET GYNECOL, V171, P607, DOI 10.1016/0002-9378(94)90072-8; Sommer C, 2014, INT J OBESITY, V38, P76, DOI 10.1038/ijo.2013.185; Tomedi LE, 2013, MATERN CHILD HLTH J; Troisi RJ, 2000, JAMA-J AM MED ASSOC, V284, P3157, DOI 10.1001/jama.284.24.3157; Worster Andrew, 2007, CJEM, V9, P111; Yee LM, 2011, J MATERN-FETAL NEO M, V24, P1102, DOI 10.3109/14767058.2010.546450; Yogev Y, 2004, AM J OBSTET GYNECOL, V191, P949, DOI 10.1016/j.ajog.2004.06.059	28	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112526	10.1371/journal.pone.0112526	http://dx.doi.org/10.1371/journal.pone.0112526			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393415	Green Submitted, gold, Green Published			2022-12-27	WOS:000347709300063
J	Hout, MC; Goldinger, SD; Brady, KJ				Hout, Michael C.; Goldinger, Stephen D.; Brady, Kyle J.			MM-MDS: A Multidimensional Scaling Database with Similarity Ratings for 240 Object Categories from the Massive Memory Picture Database	PLOS ONE			English	Article							LONG-TERM-MEMORY; EFFICIENT	Cognitive theories in visual attention and perception, categorization, and memory often critically rely on concepts of similarity among objects, and empirically require measures of "sameness" among their stimuli. For instance, a researcher may require similarity estimates among multiple exemplars of a target category in visual search, or targets and lures in recognition memory. Quantifying similarity, however, is challenging when everyday items are the desired stimulus set, particularly when researchers require several different pictures from the same category. In this article, we document a new multidimensional scaling database with similarity ratings for 240 categories, each containing color photographs of 16-17 exemplar objects. We collected similarity ratings using the spatial arrangement method. Reports include: the multidimensional scaling solutions for each category, up to five dimensions, stress and fit measures, coordinate locations for each stimulus, and two new classifications. For each picture, we categorized the item's prototypicality, indexed by its proximity to other items in the space. We also classified pairs of images along a continuum of similarity, by assessing the overall arrangement of each MDS space. These similarity ratings will be useful to any researcher that wishes to control the similarity of experimental stimuli according to an objective quantification of "sameness."	[Hout, Michael C.] New Mexico State Univ, Dept Psychol, Las Cruces, NM 88003 USA; [Goldinger, Stephen D.] Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA; [Brady, Kyle J.] Arizona State Univ, Dept Human Syst Engn, Mesa, AZ USA	New Mexico State University; Arizona State University; Arizona State University-Tempe; Arizona State University	Hout, MC (corresponding author), New Mexico State Univ, Dept Psychol, Las Cruces, NM 88003 USA.	mhout@nmsu.edu			NIH [R01 DC 004535-11]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004535] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH grant R01 DC 004535-11 to Stephen D. Goldinger (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brady TF, 2008, P NATL ACAD SCI USA, V105, P14325, DOI 10.1073/pnas.0803390105; Carroll JD, 1970, PSYCHOMETRIKA, V35, P238, DOI DOI 10.1007/BF02310791; GOLDSTONE R, 1994, BEHAV RES METH INS C, V26, P381, DOI 10.3758/BF03204653; Hout MC, 2015, ATTEN PERCEPT PSYCHO, V77, P128, DOI 10.3758/s13414-014-0764-6; Hout MC, 2013, J EXP PSYCHOL GEN, V142, P256, DOI 10.1037/a0028860; Hout MC, 2013, WIRES COGN SCI, V4, P93, DOI 10.1002/wcs.1203; Hout MC, 2012, J EXP PSYCHOL HUMAN, V38, P90, DOI 10.1037/a0023894; Jaworska N, 2009, TUTOR QUANT METHODS, V5, P1, DOI 10.20982/tqmp.05.1.p001; Konkle T, 2010, J EXP PSYCHOL GEN, V139, P558, DOI 10.1037/a0019165; Kriegeskorte N, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00245; Kruskal J. B., 1978, SAGE U PAPER SERIES, P07; Lee MD, 2001, J MATH PSYCHOL, V45, P149, DOI 10.1006/jmps.1999.1300; Migo EM, 2013, BEHAV RES METHODS, V45, P344, DOI 10.3758/s13428-012-0255-4; Oh MS, 2012, J MULTIVARIATE ANAL, V107, P200, DOI 10.1016/j.jmva.2012.01.012; Schneider W., 2002, E PRIME USERS GUIDE; SPSS Inc, 2011, SPSS BAS 20 0 WIND U; TAKANE Y, 1977, PSYCHOMETRIKA, V42, P7, DOI 10.1007/BF02293745; TREISMAN A, 1991, J EXP PSYCHOL HUMAN, V17, P652, DOI 10.1037/0096-1523.17.3.652	18	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112644	10.1371/journal.pone.0112644	http://dx.doi.org/10.1371/journal.pone.0112644			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390369	gold, Green Submitted, Green Published			2022-12-27	WOS:000349144400115
J	Khalil, H; Olsson, G; Ecke, F; Evander, M; Hjertqvist, M; Magnusson, M; Lofvenius, MO; Hornfeldt, B				Khalil, Hussein; Olsson, Gert; Ecke, Frauke; Evander, Magnus; Hjertqvist, Marika; Magnusson, Magnus; Lofvenius, Mikaell Ottosson; Hornfeldt, Birger			The Importance of Bank Vole Density and Rainy Winters in Predicting Nephropathia Epidemica Incidence in Northern Sweden	PLOS ONE			English	Article							HUMAN HANTAVIRUS INFECTIONS; PUUMALA VIRUS-INFECTION; CLETHRIONOMYS-GLAREOLUS; SEED PRODUCTION; CLIMATE; ANTIBODY; POPULATIONS; DYNAMICS; OUTBREAK; RODENTS	Pathogenic hantaviruses (family Bunyaviridae, genus Hantavirus) are rodent-borne viruses causing hemorrhagic fever with renal syndrome (HFRS) in Eurasia. In Europe, there are more than 10,000 yearly cases of nephropathia epidemica (NE), a mild form of HFRS caused by Puumala virus (PUUV). The common and widely distributed bank vole (Myodes glareolus) is the host of PUUV. In this study, we aim to explain and predict NE incidence in boreal Sweden using bank vole densities. We tested whether the number of rainy days in winter contributed to variation in NE incidence. We forecast NE incidence in July 2013-June 2014 using projected autumn vole density, and then considering two climatic scenarios: 1) rain-free winter and 2) winter with many rainy days. Autumn vole density was a strong explanatory variable of NE incidence in boreal Sweden in 1990-2012 (R-2 = 79%, p < 0.001). Adding the number of rainy winter days improved the model (R-2 = 84%, p < 0.05). We report for the first time that risk of NE is higher in winters with many rainy days. Rain on snow and ground icing may block vole access to subnivean space. Seeking refuge from adverse conditions and shelter from predators, voles may infest buildings, increasing infection risk. In a rainy winter scenario, we predicted 812 NE cases in boreal Sweden, triple the number of cases predicted in a rain-free winter in 2013/2014. Our model enables identification of high risk years when preparedness in the public health sector is crucial, as a rainy winter would accentuate risk.	[Khalil, Hussein; Olsson, Gert; Ecke, Frauke; Magnusson, Magnus; Hornfeldt, Birger] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden; [Ecke, Frauke] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden; [Evander, Magnus] Umea Univ, Dept Clin Microbiol, Div Virol, Umea, Sweden; [Hjertqvist, Marika] Swedish Inst Infect Dis Control, Stockholm, Sweden; [Lofvenius, Mikaell Ottosson] Swedish Univ Agr Sci, Dept Forest Ecol & Management, S-90183 Umea, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Umea University; Swedish Institute for Infectious Disease Control; Swedish University of Agricultural Sciences	Khalil, H (corresponding author), Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden.	Hussein.khalil@slu.sei	Ecke, Frauke/AAW-6468-2021; Magnusson, Magnus/L-2072-2018; Evander, Magnus/AAF-5665-2019	Ecke, Frauke/0000-0003-4208-345X; Magnusson, Magnus/0000-0001-7275-9006; Evander, Magnus/0000-0001-6034-4807	Swedish Research Council Formas [221-2012-1568]	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	Funding was received from Swedish Research Council Formas (grant no. 221-2012-1568: http://www.formas.5e/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRUMMERKORVENKONTIO M, 1980, J INFECT DIS, V141, P131, DOI 10.1093/infdis/141.2.131; Chomel BB, 2007, EMERG INFECT DIS, V13, P6, DOI 10.3201/eid1301.060480; Clement J, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-1; Evander M, 2009, GLOB HLTH ACTION, DOI [10.3402/gha.v2i0.2020, DOI 10.3402/GHA.V2I0.2020]; Hansen BB, 2013, SCIENCE, V339, P313, DOI 10.1126/science.1226766; HANSSON L, 1985, OECOLOGIA, V67, P394, DOI 10.1007/BF00384946; Hornfeldt B, 2004, OIKOS, V107, P376, DOI 10.1111/j.0030-1299.2004.13348.x; HORNFELDT B, 1994, ECOLOGY, V75, P791, DOI 10.2307/1941735; JENSEN TS, 1982, OECOLOGIA, V54, P184, DOI 10.1007/BF00378391; Jones BA, 2013, P NATL ACAD SCI USA, V110, P8399, DOI 10.1073/pnas.1208059110; Kallio ER, 2009, EPIDEMICS-NETH, V1, P101, DOI 10.1016/j.epidem.2009.03.002; Kausrud KL, 2008, NATURE, V456, P93, DOI 10.1038/nature07442; Klempa B, 2009, CLIN MICROBIOL INFEC, V15, P518, DOI 10.1111/j.1469-0691.2009.02848.x; Korslund L, 2006, J ANIM ECOL, V75, P156, DOI 10.1111/j.1365-2656.2005.01031.x; Kuenzi AJ, 2001, AM J TROP MED HYG, V64, P137, DOI 10.4269/ajtmh.2001.64.137; Lambin EF, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-54; LEE HW, 1978, J INFECT DIS, V137, P298, DOI 10.1093/infdis/137.3.298; Linard C, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-55; MitchellJones A.J., 1999, ATLAS EUROPEAN MAMMA; NICHOL ST, 1993, SCIENCE, V262, P914, DOI 10.1126/science.8235615; NIKLASSON B, 1995, AM J TROP MED HYG, V53, P134, DOI 10.4269/ajtmh.1995.53.134; Olsson GE, 2005, VECTOR-BORNE ZOONOT, V5, P315, DOI 10.1089/vbz.2005.5.315; Olsson GE, 2003, J WILDLIFE DIS, V39, P299, DOI 10.7589/0090-3558-39.2.299; Olsson GE, 2003, EMERG INFECT DIS, V9, P1395, DOI 10.3201/eid0911.030275; Olsson GE, 2010, VECTOR-BORNE ZOONOT, V10, P549, DOI 10.1089/vbz.2009.0138; Olsson GE, 2009, EMERG INFECT DIS, V15, P104, DOI 10.3201/eid1501.080502; Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009; Pettersson L, 2008, EMERG INFECT DIS, V14, P808, DOI 10.3201/eid1405.071124; Porkert J, 1975, WINTER LYNX, V17; Public Health Agency of Sweden [Internet], 2014, FOLKH NEPHR EP STAT; R Core Team, 2021, R LANGUAGE ENV STAT; Settergren B, 2000, SCAND J INFECT DIS, V32, P125, DOI 10.1080/003655400750045204; Tersago K, 2009, EPIDEMIOL INFECT, V137, P250, DOI 10.1017/S0950268808000940; Tersago K, 2011, EPIDEMIOL INFECT, V139, P381, DOI 10.1017/S0950268810000956; Tkadlec E, 1998, EVOL ECOL, V12, P191, DOI 10.1023/A:1006583713042; Vaheri A, 2013, REV MED VIROL, V23, P35, DOI 10.1002/rmv.1722; Vanwambeke SO, 2007, ECOHEALTH, V4, P37, DOI 10.1007/s10393-007-0085-5; Voutilainen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039452; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997; Yahnke CJ, 2001, AM J TROP MED HYG, V65, P768, DOI 10.4269/ajtmh.2001.65.768	40	18	20	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111663	10.1371/journal.pone.0111663	http://dx.doi.org/10.1371/journal.pone.0111663			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391132	Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400028
J	Valente, G; Pitto, L; Testi, D; Seth, A; Delp, SL; Stagni, R; Viceconti, M; Taddei, F				Valente, Giordano; Pitto, Lorenzo; Testi, Debora; Seth, Ajay; Delp, Scott L.; Stagni, Rita; Viceconti, Marco; Taddei, Fulvia			Are Subject-Specific Musculoskeletal Models Robust to the Uncertainties in Parameter Identification?	PLOS ONE			English	Article							LOWER-LIMB; CONTACT FORCES; MUSCLE FORCES; NORMAL WALKING; MOMENT ARMS; HUMAN GAIT; IN-VIVO; JOINT; KNEE; HIP	Subject-specific musculoskeletal modeling can be applied to study musculoskeletal disorders, allowing inclusion of personalized anatomy and properties. Independent of the tools used for model creation, there are unavoidable uncertainties associated with parameter identification, whose effect on model predictions is still not fully understood. The aim of the present study was to analyze the sensitivity of subject-specific model predictions (i.e., joint angles, joint moments, muscle and joint contact forces) during walking to the uncertainties in the identification of body landmark positions, maximum muscle tension and musculotendon geometry. To this aim, we created an MRI-based musculoskeletal model of the lower limbs, defined as a 7-segment, 10-degree-of-freedom articulated linkage, actuated by 84 musculotendon units. We then performed a Monte-Carlo probabilistic analysis perturbing model parameters according to their uncertainty, and solving a typical inverse dynamics and static optimization problem using 500 models that included the different sets of perturbed variable values. Model creation and gait simulations were performed by using freely available software that we developed to standardize the process of model creation, integrate with OpenSim and create probabilistic simulations of movement. The uncertainties in input variables had a moderate effect on model predictions, as muscle and joint contact forces showed maximum standard deviation of 0.3 times body-weight and maximum range of 2.1 times body-weight. In addition, the output variables significantly correlated with few input variables (up to 7 out of 312) across the gait cycle, including the geometry definition of larger muscles and the maximum muscle tension in limited gait portions. Although we found subject-specific models not markedly sensitive to parameter identification, researchers should be aware of the model precision in relation to the intended application. In fact, force predictions could be affected by an uncertainty in the same order of magnitude of its value, although this condition has low probability to occur.	[Valente, Giordano; Pitto, Lorenzo; Taddei, Fulvia] Rizzoli Orthopaed Inst, Med Technol Lab, Bologna, Italy; [Testi, Debora] SCS Srl, BioComp Competence Ctr, Bologna, Italy; [Seth, Ajay; Delp, Scott L.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Delp, Scott L.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Stagni, Rita] Univ Bologna, Dept Elect Elect & Informat Engn, Bologna, Italy; [Viceconti, Marco] Univ Sheffield, Dept Mech Engn, Sheffield, S Yorkshire, England; [Viceconti, Marco] Univ Sheffield, INSIGNEO Inst Silico Med, Sheffield, S Yorkshire, England	IRCCS Istituto Ortopedico Rizzoli; Stanford University; Stanford University; University of Bologna; University of Sheffield; University of Sheffield	Valente, G (corresponding author), Rizzoli Orthopaed Inst, Med Technol Lab, Bologna, Italy.	valente@tecno.ior.it	Stagni, Rita/I-4070-2014; Valente, Giordano/C-9808-2019; Valente, Giordano/AAE-7225-2022; Viceconti, Marco/N-9164-2013; Viceconti, Marco/ABG-5546-2020; Stagni, Rita/ABD-8948-2020; Taddei, Fulvia/K-4537-2018	Stagni, Rita/0000-0002-3352-1406; Valente, Giordano/0000-0001-9340-8192; Valente, Giordano/0000-0001-9340-8192; Viceconti, Marco/0000-0002-2293-1530; Viceconti, Marco/0000-0002-2293-1530; Stagni, Rita/0000-0002-3352-1406; Pitto, Lorenzo/0000-0003-3044-5011; Taddei, Fulvia/0000-0002-8342-7434; Delp, Scott/0000-0002-9643-7551; Seth, Ajay/0000-0003-4217-1580	EU [FP7-ICT-248189, FP7-ICT-223865]; EU-funded VPHOP project [FP7-ICT-223865]	EU(European Commission); EU-funded VPHOP project	This study was supported by the EU-funded NMS Physiome project (FP7-ICT-248189), and supported in part by the EU-funded VPHOP project (FP7-ICT-223865). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Debora Testi is employed by BioComputing Competence Centre, SCS s.r.l. BioComputing Competence Centre, SCS s.r.l. provided support in the form of salary for author DT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ackland DC, 2012, J BIOMECH, V45, P1463, DOI 10.1016/j.jbiomech.2012.02.023; Anderson FC, 2001, J BIOMECH, V34, P153, DOI 10.1016/S0021-9290(00)00155-X; Arnold EM, 2010, ANN BIOMED ENG, V38, P269, DOI 10.1007/s10439-009-9852-5; Benedetti MG, 1998, CLIN BIOMECH, V13, P204, DOI 10.1016/S0268-0033(97)00041-7; Besier TF, 2005, MED SCI SPORT EXER, V37, P1924, DOI 10.1249/01.mss.0000176686.18683.64; Blemker SS, 2005, ANN BIOMED ENG, V33, P1433; Buchanan TS, 2004, J APPL BIOMECH, V20, P367, DOI 10.1123/jab.20.4.367; Cappello A, 2005, IEEE T BIO-MED ENG, V52, P992, DOI 10.1109/TBME.2005.846728; CAPPOZZO A, 1995, CLIN BIOMECH, V10, P171, DOI 10.1016/0268-0033(95)91394-T; Carbone V, 2012, J BIOMECH, V45, P2476, DOI 10.1016/j.jbiomech.2012.06.026; Correa TA, 2012, GAIT POSTURE, V36, P194, DOI 10.1016/j.gaitpost.2012.02.014; Correa TA, 2011, J BIOMECH, V44, P2782, DOI 10.1016/j.jbiomech.2011.08.024; Correa TA, 2011, J BIOMECH, V44, P2096, DOI 10.1016/j.jbiomech.2011.05.023; Crossley KM, 2012, OSTEOARTHR CARTILAGE, V20, P1243, DOI 10.1016/j.joca.2012.07.011; De Groote F, 2010, J BIOMECH, V43, P1876, DOI 10.1016/j.jbiomech.2010.03.022; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; DELP SL, 1990, IEEE T BIO-MED ENG, V37, P757, DOI 10.1109/10.102791; Dumas R, 2005, IEEE T BIO-MED ENG, V52, P1756, DOI 10.1109/TBME.2005.855711; Erdemir A, 2007, CLIN BIOMECH, V22, P131, DOI 10.1016/j.clinbiomech.2006.09.005; Fernandez JW, 2006, EXP PHYSIOL, V91, P371, DOI 10.1113/expphysiol.2005.031047; Fregly Benjamin J, 2009, Int J Comput Vis Biomech, V2, P145; Fregly BJ, 2012, J ORTHOP RES, V30, P503, DOI 10.1002/jor.22023; Gerus P, 2013, J BIOMECH, V46, P2778, DOI 10.1016/j.jbiomech.2013.09.005; Jonkers I, 2008, J BIOMECH, V41, P3405, DOI 10.1016/j.jbiomech.2008.09.011; Langenderfer JE, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2838037; Lenaerts G, 2009, GAIT POSTURE, V30, P296, DOI 10.1016/j.gaitpost.2009.05.016; Lenaerts G, 2009, J BIOMECH, V42, P1246, DOI 10.1016/j.jbiomech.2009.03.037; LUNDBERG A, 1989, J BONE JOINT SURG BR, V71, P94, DOI 10.1302/0301-620X.71B1.2915016; Martelli S, 2014, COMPUT METHOD BIOMEC, V25, P1; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Pal S, 2007, ANN BIOMED ENG, V35, P1632, DOI 10.1007/s10439-007-9334-6; Pandy MG, 2010, ANNU REV BIOMED ENG, V12, P401, DOI 10.1146/annurev-bioeng-070909-105259; Scheys L, 2008, GAIT POSTURE, V28, P640, DOI 10.1016/j.gaitpost.2008.04.010; Scheys L, 2006, LECT NOTES COMPUT SC, V4072, P58; Scheys L, 2011, J BIOMECH, V44, P1346, DOI 10.1016/j.jbiomech.2011.01.001; Tadde F, 2007, MED INFORM INTERNET, V32, P191, DOI 10.1080/14639230701231493; Taddei F, 2012, CLIN BIOMECH, V27, P273, DOI 10.1016/j.clinbiomech.2011.09.006; Valente G, 2013, J BIOMECH, V46, P2186, DOI 10.1016/j.jbiomech.2013.06.030; Valente G, 2012, P I MECH ENG H, V226, P161, DOI 10.1177/0954411911425863; van der Krogt MM, 2012, GAIT POSTURE, V36, P113, DOI 10.1016/j.gaitpost.2012.01.017; Wagner DW, 2013, ANN BIOMED ENG, V41, P1787, DOI 10.1007/s10439-013-0843-1; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6; Xiao M, 2010, J APPL BIOMECH, V26, P142, DOI 10.1123/jab.26.2.142	44	106	107	6	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112625	10.1371/journal.pone.0112625	http://dx.doi.org/10.1371/journal.pone.0112625			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390896	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400111
J	Brimnes, MK; Hansen, BE; Nielsen, LK; Dziegiel, MH; Nielsen, CH				Brimnes, Marie Klinge; Hansen, Bjarke Endel; Nielsen, Leif Kofoed; Dziegiel, Morten Hanefeld; Nielsen, Claus Henrik			Uptake and Presentation of Myelin Basic Protein by Normal Human B Cells	PLOS ONE			English	Article							PROGRESSIVE MULTIPLE-SCLEROSIS; OPSONIZED IMMUNE-COMPLEXES; CENTRAL-NERVOUS-SYSTEM; WHOLE-BLOOD CELLS; ANTIGEN PRESENTATION; T-CELLS; COMPLEMENT RECEPTORS; CEREBROSPINAL-FLUID; NATURAL ANTIBODY; SELF-ANTIGEN	B cells may play both pathogenic and protective roles in T-cell mediated autoimmune diseases such as multiple sclerosis (MS). These functions relate to the ability of B cells to bind and present antigens. Under serum-free conditions we observed that 3-4% of circulating B cells from healthy donors were capable of binding the MS-associated self-antigen myelin basic protein (MBP) and of presenting the immunodominant peptide MBP85-99, as determined by staining with the mAb MK16 recognising the peptide presented by HLA-DR15-positive cells. In the presence of serum, however, the majority of B cells bound MBP in a complement-dependent manner, and almost half of the B cells became engaged in presentation of MBP85-99. Even though complement receptor 1 (CR1, CD35) and CR2 (CD21) both contributed to binding of MBP to B cells, only CR2 was important for the subsequent presentation of MBP85-99. A high proportion of MBP85-99 presenting B cells expressed CD27, and showed increased expression of CD86 compared to non-presenting B cells. MBP-pulsed B cells induced a low frequency of IL-10-producing CD4+ T cells in 3 out of 6 donors, indicating an immunoregulatory role of B cells presenting MBP-derived peptides. The mechanisms described here refute the general assumption that B-cell presentation of self-antigens requires uptake via specific B-cell receptors, and may be important for maintenance of tolerance as well as for driving T-cell responses in autoimmune diseases.	[Brimnes, Marie Klinge; Hansen, Bjarke Endel; Nielsen, Claus Henrik] Rigshosp, Copenhagen Univ Hosp, Inst Inflammat Res, Dept Infect Dis & Rheumatol,Sect 7521, DK-2100 Copenhagen, Denmark; [Hansen, Bjarke Endel] Immudex, Copenhagen, Denmark; [Nielsen, Leif Kofoed] Metropolitan Univ Coll, Fac Hlth & Technol, Dept Technol, Copenhagen, Denmark; [Nielsen, Leif Kofoed; Dziegiel, Morten Hanefeld] Rigshosp, Copenhagen Univ Hosp, Dept Clin Immunol, Blood Bank,KI2034, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Nielsen, CH (corresponding author), Rigshosp, Copenhagen Univ Hosp, Inst Inflammat Res, Dept Infect Dis & Rheumatol,Sect 7521, DK-2100 Copenhagen, Denmark.	claus.henrik.nielsen@rh.regionh.dk	; Hansen, Bjarke/D-3663-2018	Nielsen, Claus Henrik/0000-0001-7543-9016; Nielsen, Leif Kofoed/0000-0002-6956-1821; Hansen, Bjarke/0000-0002-8167-8459; Dziegiel, Morten Hanefeld/0000-0001-8034-1523	Danish Multiple Sclerosis Society [959531218]	Danish Multiple Sclerosis Society	MKB received funding from The Danish Multiple Sclerosis Society, grant number 959531218. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agematsu K, 2000, IMMUNOL TODAY, V21, P204, DOI 10.1016/S0167-5699(00)01605-4; ARVIEUX J, 1988, IMMUNOLOGY, V65, P229; Bar-Or A, 2008, ANN NEUROL, V63, P395, DOI 10.1002/ana.21363; Barr TA, 2012, J EXP MED, V209, P1001, DOI 10.1084/jem.20111675; Barrault DV, 2004, J IMMUNOL, V172, P3509, DOI 10.4049/jimmunol.172.6.3509; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Boackle SA, 1998, J IMMUNOL, V161, P6537; Boackle SA, 1997, EUR J IMMUNOL, V27, P122, DOI 10.1002/eji.1830270119; Bouaziz JD, 2010, EUR J IMMUNOL, V40, P2686, DOI 10.1002/eji.201040673; Carroll MC, 1998, ANNU REV IMMUNOL, V16, P545, DOI 10.1146/annurev.immunol.16.1.545; Carter NA, 2011, J IMMUNOL, V186, P5569, DOI 10.4049/jimmunol.1100284; Cepok S, 2005, BRAIN, V128, P1667, DOI 10.1093/brain/awh486; Ciechomska M, 2014, IMMUNOLOGY, V141, P70, DOI 10.1111/imm.12169; Duddy M, 2007, J IMMUNOL, V178, P6092, DOI 10.4049/jimmunol.178.10.6092; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Fillatreau S, 2008, NAT REV IMMUNOL, V8, P391, DOI 10.1038/nri2315; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Isaak A, 2008, INT IMMUNOL, V20, P185, DOI 10.1093/intimm/dxm132; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; JACQUIERSARLIN MR, 1995, IMMUNOLOGY, V84, P164; Jensen LB, 2004, J IMMUNOL METHODS, V284, P45, DOI 10.1016/j.jim.2003.10.001; JOHNSON AH, 1975, LANCET, V1, P762; Krogsgaard M, 2000, J EXP MED, V191, P1395, DOI 10.1084/jem.191.8.1395; Langkjaer A, 2012, CLIN IMMUNOL, V145, P1, DOI 10.1016/j.clim.2012.07.004; LANZAVECCHIA A, 1990, ANNU REV IMMUNOL, V8, P773, DOI 10.1146/annurev.immunol.8.1.773; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; Lee-Chang C, 2011, CLIN IMMUNOL, V139, P12, DOI 10.1016/j.clim.2010.11.004; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Mann MK, 2007, J IMMUNOL, V178, P3447, DOI 10.4049/jimmunol.178.6.3447; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; NAKAMURA M, 1988, J IMMUNOL, V141, P4165; Nielsen CH, 1997, IMMUNOLOGY, V90, P129, DOI 10.1046/j.1365-2567.1997.00138.x; Nielsen CH, 2004, EUR J IMMUNOL, V34, P263, DOI 10.1002/eji.200324413; Nielsen CH, 2002, EUR J IMMUNOL, V32, P1359, DOI 10.1002/1521-4141(200205)32:5<1359::AID-IMMU1359>3.0.CO;2-V; NIELSEN CH, 1994, SCAND J IMMUNOL, V40, P228, DOI 10.1111/j.1365-3083.1994.tb03455.x; Nielsen CH, 2001, EUR J IMMUNOL, V31, P2660, DOI 10.1002/1521-4141(200109)31:9<2660::AID-IMMU2660>3.0.CO;2-E; Nielsen CH, 2007, EXPERT OPIN BIOL TH, V7, P1061, DOI 10.1517/14712598.7.7.1061; O'Connor KC, 2010, J NEUROIMMUNOL, V223, P92, DOI 10.1016/j.jneuroim.2010.02.019; O'Connor KC, 2003, J NEUROIMMUNOL, V136, P140, DOI 10.1016/S0165-5728(03)00002-X; OGARRA A, 1992, ANN NY ACAD SCI, V651, P182; Palarasah Y, 2010, J CLIN MICROBIOL, V48, P908, DOI 10.1128/JCM.01985-09; Pistoia V, 1997, IMMUNOL TODAY, V18, P343, DOI 10.1016/S0167-5699(97)01080-3; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; THORNTON BP, 1994, J IMMUNOL, V152, P1727; Thornton BP, 1996, CLIN EXP IMMUNOL, V104, P531, DOI 10.1046/j.1365-2249.1996.57761.x; Villiers MB, 1996, IMMUNOLOGY, V89, P348, DOI 10.1046/j.1365-2567.1996.d01-747.x; Weber MS, 2010, ANN NEUROL, V68, P369, DOI 10.1002/ana.22081; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Zhong GM, 1997, J EXP MED, V186, P673, DOI 10.1084/jem.186.5.673	56	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113388	10.1371/journal.pone.0113388	http://dx.doi.org/10.1371/journal.pone.0113388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401487	Green Submitted, Green Published, gold			2022-12-27	WOS:000345158700137
J	Sadler, E; Hales, B; Henry, B; Xiong, W; Myers, J; Wynnychuk, L; Taggar, R; Heyland, D; Fowler, R				Sadler, Erin; Hales, Brigette; Henry, Blair; Xiong, Wei; Myers, Jeff; Wynnychuk, Lesia; Taggar, Ru; Heyland, Daren; Fowler, Robert			Factors Affecting Family Satisfaction with Inpatient End-of-Life Care	PLOS ONE			English	Article							QUALITY; HEALTH	Background: Little data exists addressing satisfaction with end-of-life care among hospitalized patients, as they and their family members are systematically excluded from routine satisfaction surveys. It is imperative that we closely examine patient and institution factors associated with quality end-of-life care and determine high-priority target areas for quality improvement. Methods: Between September 1, 2010 and January 1, 2012 the Canadian Health care Evaluation Project (CANHELP) Bereavement Questionnaire was mailed to the next-of-kin of recently deceased inpatients to seek factors associated with satisfaction with end-of-life care. The primary outcome was the global rating of satisfaction. Secondary outcomes included rates of actual versus preferred location of death, associations between demographic factors and global satisfaction, and identification of targets for quality improvement. Results: Response rate was 33% among 275 valid addresses. Overall, 67.4% of respondents were very or completely satisfied with the overall quality of care their relative received. However, 71.4% of respondents who thought their relative did not die in their preferred location favoured an out-of-hospital location of death. A common location of death was the intensive care unit (45.7%); however, this was not the preferred location of death for 47.6% of such patients. Multivariate Poisson regression analysis showed respondents who believed their relative died in their preferred location were 1.7 times more likely to be satisfied with the end-of-life care that was provided (p = 0.001). Items identified as high-priority targets for improvement included: relationships with, and characteristics of health care professionals; illness management; communication; and end-of-life decision-making. Interpretation: Nearly three-quarters of recently deceased inpatients would have preferred an out-of-hospital death. Intensive care units were a common, but not preferred, location of in-hospital deaths. Family satisfaction with end-of-life care was strongly associated with their relative dying in their preferred location. Improved communication regarding end-of-life care preferences should be a high-priority quality improvement target.	[Sadler, Erin] Univ Toronto, Dept Gen Surg, Toronto, ON, Canada; [Hales, Brigette; Henry, Blair; Myers, Jeff; Wynnychuk, Lesia; Taggar, Ru] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Xiong, Wei] Sunnybrook Hlth Sci Ctr, Trauma Emergency & Crit Care Program, Toronto, ON M4N 3M5, Canada; [Heyland, Daren] Queens Univ, Dept Crit Care Med, Kingston, ON, Canada; [Fowler, Robert] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada; [Fowler, Robert] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Queens University - Canada; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Fowler, R (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada.	Rob.fowler@sunnybrook.ca		Henry, Blair/0000-0002-1073-9592	Heart and Stroke Foundation of Ontario; University of Toronto Department of Medicine Integrating Challenge Grant; Technology Evaluation in the Elderly Network Center of Excellence	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); University of Toronto Department of Medicine Integrating Challenge Grant; Technology Evaluation in the Elderly Network Center of Excellence	The Heart and Stroke Foundation of Ontario, the University of Toronto Department of Medicine Integrating Challenge Grant, and the Technology Evaluation in the Elderly Network Center of Excellence have supported this body of work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Canadian Institute for Health Information, 2007, HLTH CAR US END LIF; Dodek PM, 2004, CRIT CARE MED, V32, P1922, DOI 10.1097/01.CCM.0000139920.53790.61; Frost DW, 2011, CRIT CARE MED, V39, P1174, DOI 10.1097/CCM.0b013e31820eacf2; Heyland DK, 2013, JAMA INTERN MED, V173, P778, DOI 10.1001/jamainternmed.2013.180; Heyland DK, 2010, PALLIATIVE MED, V24, P682, DOI 10.1177/0269216310373168; Heyland DK, 2000, J PALLIATIVE CARE, V16, pS10, DOI 10.1177/082585970001601S04; Johnson TP, 2012, JAMA-J AM MED ASSOC, V307, P1805, DOI 10.1001/jama.2012.3532; McPherson CJ, 2003, SOC SCI MED, V56, P95, DOI 10.1016/S0277-9536(02)00011-4; Morss S, 2008, J AM GERIATR SOC, V56, P124, DOI 10.1111/j.1532-5415.2007.01507.x; Singer PA, 2002, BMJ-BRIT MED J, V324, P1291, DOI 10.1136/bmj.324.7349.1291; Skrobik Y., 2010, CMAJ CANADIAN MED AS, V182, P747, DOI [10.1503/cmaj.l00131, DOI 10.1503/CMAJ.L00131]; Soberman L R, 1997, Qual Manag Health Care, V5, P63; Standing Senate Committee on Social Affairs Science and Technology, 2000, QUAL END OF LIF CAR; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	16	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e110860	10.1371/journal.pone.0110860	http://dx.doi.org/10.1371/journal.pone.0110860			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401710	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700009
J	Fimlaid, KA; Lindow, JC; Tribble, DR; Bunn, JY; Maue, AC; Kirkpatrick, BD				Fimlaid, Kelly A.; Lindow, Janet C.; Tribble, David R.; Bunn, Janice Y.; Maue, Alexander C.; Kirkpatrick, Beth D.			Peripheral CD4(+) T Cell Cytokine Responses Following Human Challenge and Re-Challenge with Campylobacter jejuni	PLOS ONE			English	Article							DENDRITIC CELLS; INFECTION; PROTECTION; RISK; BIOGENESIS; CHEMOKINES; CORRELATE; DISEASE; UPDATE	Campylobacter jejuni is a leading cause of human gastroenteritis worldwide; however, our understanding of the human immune response to C. jejuni infection is limited. A previous human challenge model has shown that C. jejuni elicits IFN gamma production by peripheral blood mononuclear cells, a response associated with protection from clinical disease following reinfection. In this study, we investigate T lymphocyte profiles associated with campylobacteriosis using specimens from a new human challenge model in which C. jejuni-naive subjects were challenged and re-challenged with C. jejuni CG8421. Multiparameter flow cytometry was used to investigate T lymphocytes as a source of cytokines, including IFN gamma, and to identify cytokine patterns associated with either campylobacteriosis or protection from disease. Unexpectedly, all but one subject evaluated re-experienced campylobacteriosis after re-challenge. We show that CD4(+) T cells make IFN gamma and other pro-inflammatory cytokines in response to infection; however, multifunctional cytokine response patterns were not found. Cytokine production from peripheral CD4(+) T cells was not enhanced following re-challenge, which may suggest deletion or tolerance. Evaluation of alternative paradigms or models is needed to better understand the immune components of protection from campylobacteriosis.	[Fimlaid, Kelly A.; Kirkpatrick, Beth D.] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [Fimlaid, Kelly A.; Lindow, Janet C.; Kirkpatrick, Beth D.] Univ Vermont, Coll Med, Vaccine Testing Ctr, Burlington, VT 05405 USA; [Fimlaid, Kelly A.; Lindow, Janet C.; Kirkpatrick, Beth D.] Univ Vermont, Coll Med, Infect Dis Unit, Burlington, VT 05405 USA; [Tribble, David R.] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA; [Bunn, Janice Y.] Univ Vermont, Coll Math, Burlington, VT 05405 USA; [Maue, Alexander C.] Naval Med Res Ctr, Enter Dis Dept, Silver Spring, MD USA	University of Vermont; University of Vermont; University of Vermont; Uniformed Services University of the Health Sciences - USA; University of Vermont; Naval Medical Research Center (NMRC)	Fimlaid, KA (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA.	kfimlaid@uvm.edu		Lindow, Janet/0000-0003-3235-3698	National Institute of Health National Center Research Resources [5M01RR000109]; National Center for Research Resources BK [5P20RR021905-07]; National Institute of General Medical Sciences from the National Institutes of Health BK [8 P20 GM103496-07]; US Navy Medical Research Center BK [6000.RAD1.DA3.A0308]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000109, P20RR021905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103496] Funding Source: NIH RePORTER	National Institute of Health National Center Research Resources; National Center for Research Resources BK; National Institute of General Medical Sciences from the National Institutes of Health BK; US Navy Medical Research Center BK; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following grants: National Institute of Health National Center Research Resources 5M01RR000109 (http://www.nih.gov/about/almanac/organization/NCRR. htm) (support of General Clinical Research Center, UVM), the National Center for Research Resources (5P20RR021905-07) BK, the National Institute of General Medical Sciences (8 P20 GM103496-07) (http://www.nigms.nih.gov) from the National Institutes of Health BK, and the US Navy Medical Research Center work unit 6000.RAD1.DA3.A0308 (http://www.med.navy.mil/sites/nmrc/Pages/index.htm) BK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto L, 2006, GASTROENTEROLOGY, V130, P1588, DOI 10.1053/j.gastro.2006.02.004; Bacon DJ, 2001, MOL MICROBIOL, V40, P769, DOI 10.1046/j.1365-2958.2001.02431.x; Baqar S, 2010, CLIN VACCINE IMMUNOL, V17, P80, DOI 10.1128/CVI.00252-09; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Bouwman LI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054759; Buettner S, 2010, EPIDEMIOL INFECT, V138, P1748, DOI 10.1017/S095026881000155X; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Dasti JI, 2010, INT J MED MICROBIOL, V300, P205, DOI 10.1016/j.ijmm.2009.07.002; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Edwards LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015398; Guerry P, 2008, TRENDS MICROBIOL, V16, P428, DOI 10.1016/j.tim.2008.07.002; Hu L, 2006, INFECT IMMUN, V74, P2697, DOI 10.1128/IAI.74.5.2697-2705.2006; Hu L, 2012, INFECT IMMUN, V80, P2929, DOI 10.1128/IAI.00129-12; Kirkpatrick BD, 2013, CLIN INFECT DIS, V57, P1106, DOI 10.1093/cid/cit454; Kirkpatrick BD, 2011, CURR OPIN GASTROEN, V27, P1, DOI 10.1097/MOG.0b013e3283413763; Knodler LA, 2003, TRAFFIC, V4, P587, DOI 10.1034/j.1600-0854.2003.00118.x; Konkel ME, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-100; Maue AC, 2012, INFECT IMMUN; Nachamkin I, 2008, CAMPYLOBACTER, 3RD EDITION, P1; Rathinam VAK, 2008, MICROBES INFECT, V10, P1316, DOI 10.1016/j.micinf.2008.07.030; RICHARDSON NJ, 1983, ARCH DIS CHILD, V58, P616, DOI 10.1136/adc.58.8.616; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Ruiz-Palacios GM, 2007, CLIN INFECT DIS, V44, P701, DOI 10.1086/509936; Schonberg-Norio D, 2006, CLIN MICROBIOL INFEC, V12, P754, DOI 10.1111/j.1469-0691.2006.01501.x; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Tribble DR, 2010, INFECT IMMUN, V78, P1750, DOI 10.1128/IAI.01021-09; Tribble DR, 2009, CLIN INFECT DIS, V49, P1512, DOI 10.1086/644622; Unicomb LE, 2008, FOODBORNE PATHOG DIS, V5, P79, DOI 10.1089/fpd.2007.0047; Watson RO, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040014; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Zilbauer M, 2008, T ROY SOC TROP MED H, V102, P123, DOI 10.1016/j.trstmh.2007.09.019	34	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112513	10.1371/journal.pone.0112513	http://dx.doi.org/10.1371/journal.pone.0112513			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397604	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500056
J	Fristedt, R; Elebro, J; Gaber, A; Jonsson, L; Heby, M; Yudina, Y; Nodin, B; Uhlen, M; Eberhard, J; Jirstrom, K				Fristedt, Richard; Elebro, Jacob; Gaber, Alexander; Jonsson, Liv; Heby, Margareta; Yudina, Yulyana; Nodin, Bjorn; Uhlen, Mathias; Eberhard, Jakob; Jirstrom, Karin			Reduced Expression of the Polymeric Immunoglobulin Receptor in Pancreatic and Periampullary Adenocarcinoma Signifies Tumour Progression and Poor Prognosis	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; SECRETORY COMPONENT; TISSUE MICROARRAYS; END-POINTS; CANCER; DIFFERENTIATION; PROLIFERATION; CHEMOTHERAPY; SURVIVAL; DISEASE	The polymeric immunoglobulin receptor (pIgR) is a key component of the mucosal immune system that mediates epithelial transcytosis of immunoglobulins. High pIgR expression has been reported to correlate with a less aggressive tumour phenotype and an improved prognosis in several human cancer types. Here, we examined the expression and prognostic significance of pIgR in pancreatic and periampullary adenocarcinoma. The study cohort encompasses a consecutive series of 175 patients surgically treated with pancreaticoduodenectomy for pancreatic and periampullary adenocarcinoma in Malmo and Lund University Hospitals, Sweden, between 2001-2011. Tissue microarrays were constructed from primary tumours (n = 175) and paired lymph node metastases (n = 105). A multiplied score was calculated from the fraction and intensity of pIgR staining. Classification and regression tree analysis was used to select the prognostic cut-off. Unadjusted and adjusted hazard ratios (HR) for death and recurrence within 5 years were calculated. pIgR expression could be evaluated in 172/175 (98.3%) primary tumours and in 96/105 (91.4%) lymph node metastases. pIgR expression was significantly down-regulated in lymph node metastases as compared with primary tumours (p = 0.018). Low pIgR expression was significantly associated with poor differentiation grade (p<0.001), perineural growth (p = 0.027), lymphatic invasion (p = 0.016), vascular invasion (p = 0.033) and infiltration of the peripancreatic fat (p = 0.039). In the entire cohort, low pIgR expression was significantly associated with an impaired 5-year survival (HR = 2.99, 95% confidence interval (CI) 1.71-5.25) and early recurrence (HR = 2.89, 95% CI 1.67-4.98). This association remained significant for survival after adjustment for conventional clinicopathological factors, tumour origin and adjuvant treatment (HR = 1.98, 95% CI 1.10-3.57). These results demonstrate, for the first time, that high tumour-specific pIgR expression signifies a more favourable tumour phenotype and that low expression independently predicts a shorter survival in patients with pancreatic and periampullary cancer. The mechanistic basis for the putative tumour suppressing properties of pIgR in these cancers merits further study.	[Fristedt, Richard; Elebro, Jacob; Gaber, Alexander; Jonsson, Liv; Heby, Margareta; Yudina, Yulyana; Nodin, Bjorn; Eberhard, Jakob; Jirstrom, Karin] Lund Univ, Dept Clin Sci Lund, SE-22185 Lund, Sweden; [Uhlen, Mathias] Royal Inst Technol, Sci Life Lab, S-17121 Stockholm, Sweden; [Uhlen, Mathias] AlbaNova Univ Ctr, Royal Inst Technol, Sch Biotechnol, S-10691 Stockholm, Sweden	Lund University; Royal Institute of Technology; Royal Institute of Technology	Fristedt, R (corresponding author), Lund Univ, Dept Clin Sci Lund, SE-22185 Lund, Sweden.	richard.fristedt@med.lu.se	Uhlen, Mathias/AAV-8746-2021; Uhlen, Mathias/B-3262-2016	Uhlen, Mathias/0000-0002-4858-8056; Elebro, Jacob/0000-0002-9550-8012	Knut and Alice Wallenberg Foundation; Swedish Cancer Society, Lund University Faculty of Medicine; University Hospital Research Grants	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Cancer Society, Lund University Faculty of Medicine; University Hospital Research Grants	This study was supported by grants from the Knut and Alice Wallenberg Foundation, the Swedish Cancer Society, Lund University Faculty of Medicine and University Hospital Research Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agesen TH, 2012, GUT, V61, P1560, DOI 10.1136/gutjnl-2011-301179; Ai J, 2011, JNCI-J NATL CANCER I, V103, P1696, DOI 10.1093/jnci/djr360; Arsenescu R, 2008, MUCOSAL IMMUNOL, V1, P399, DOI 10.1038/mi.2008.32; Berntsson J, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-26; Breiman L, 1993, CLASSIFICATION REGRE; Bronsert P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-428; Denning GM, 1996, J IMMUNOL, V156, P4807; DeSouza LV, 2009, ANAL CHEM, V81, P3462, DOI 10.1021/ac802726a; Elebro J, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-80; Erkan M, 2008, CLIN GASTROENTEROL H, V6, P1155, DOI 10.1016/j.cgh.2008.05.006; Fristedt R, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-83; Gologan A, 2008, ARCH PATHOL LAB MED, V132, P1295, DOI 10.1043/1543-2165(2008)132[1295:PIRTRA]2.0.CO;2; Heinemann V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-82; Herreros-Villanueva M, 2012, WORLD J GASTROENTERO, V18, P1565, DOI 10.3748/wjg.v18.i14.1565; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johansen FE, 2004, TRENDS IMMUNOL, V25, P150, DOI 10.1016/j.it.2004.01.001; Kadaba R, 2013, J PATHOL, V230, P107, DOI 10.1002/path.4172; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; Khattar NH, 2005, J BIOMED SCI, V12, P65, DOI 10.1007/s11373-004-8185-5; KONDIPAPHITIS A, 1986, HISTOPATHOLOGY, V10, P1279, DOI 10.1111/j.1365-2559.1986.tb02571.x; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Li M, 2012, CELL MOL IMMUNOL, V9, P54, DOI 10.1038/cmi.2011.40; Phalipon A, 2003, TRENDS IMMUNOL, V24, P55, DOI 10.1016/S1471-4906(02)00031-5; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Qiu XY, 2003, CANCER RES, V63, P6488; ROSSEL M, 1991, UROL RES, V19, P361, DOI 10.1007/BF00310151; Sultana A, 2008, BRIT J CANCER, V99, P6, DOI 10.1038/sj.bjc.6604436; Torhorst J, 2001, AM J PATHOL, V159, P2249, DOI 10.1016/S0002-9440(10)63075-1; Traicoff JL, 2003, J BIOMED SCI, V10, P792, DOI 10.1159/000073967; Wang J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.474; Westgaard A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-5; Zhou HB, 2010, EUR J CANCER, V46, P1056, DOI 10.1016/j.ejca.2010.02.005	32	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112728	10.1371/journal.pone.0112728	http://dx.doi.org/10.1371/journal.pone.0112728			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397670	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558500084
J	Tigdemir, M				Tigdemir, Mesut			Re-Evaluation of the AASHTO-Flexible Pavement Design Equation with Neural Network Modeling	PLOS ONE			English	Article							SBS MODIFIED BITUMEN	Here we establish that equivalent single-axle loads values can be estimated using artificial neural networks without the complex design equality of American Association of State Highway and Transportation Officials (AASHTO). More importantly, we find that the neural network model gives the coefficients to be able to obtain the actual load values using the AASHTO design values. Thus, those design traffic values that might result in deterioration can be better calculated using the neural networks model than with the AASHTO design equation. The artificial neural network method is used for this purpose. The existing AASHTO flexible pavement design equation does not currently predict the pavement performance of the strategic highway research program (Long Term Pavement Performance studies) test sections very accurately, and typically over-estimates the number of equivalent single axle loads needed to cause a measured loss of the present serviceability index. Here we aimed to demonstrate that the proposed neural network model can more accurately represent the loads values data, compared against the performance of the AASHTO formula. It is concluded that the neural network may be an appropriate tool for the development of databased-nonparametric models of pavement performance.	Suleyman Demirel Univ, Fac Engn, Dept Civil Engn, TR-32200 Isparta, Turkey	Suleyman Demirel University	Tigdemir, M (corresponding author), Suleyman Demirel Univ, Fac Engn, Dept Civil Engn, TR-32200 Isparta, Turkey.	mesuttigdemir@sdu.edu.tr	tigdemir, mesut/M-9252-2017	tigdemir, mesut/0000-0002-5303-2722				Alavi AH, 2011, CONSTR BUILD MATER, V25, P1338, DOI 10.1016/j.conbuildmat.2010.09.010; [Anonymous], 2008, FLEX PAV DES MAN; [Anonymous], 1994, SHRPP394; Banan MR, 1996, J TRANSP ENG-ASCE, V122, P358, DOI 10.1061/(ASCE)0733-947X(1996)122:5(358); Hallin JP, 2007, PAVEMENT DESIGN POST, P1; Hudson WR, 2007, AASHO ROAD TEST EFFE, P17; Kok BV, 2013, FUEL, V106, P265, DOI 10.1016/j.fuel.2012.12.073; Kok BV, 2010, EXPERT SYST APPL, V37, P7775, DOI 10.1016/j.eswa.2010.04.063; Ozgan E, 2011, EXPERT SYST APPL, V38, P6025, DOI 10.1016/j.eswa.2010.11.018; Simon H., 1999, NEURAL NETWORKS COMP; Souza RO, 2006, IMPROVING PAVEMENTS; Wu ZH, 2014, EXPERT SYST APPL, V41, P1021, DOI 10.1016/j.eswa.2013.07.063	12	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113226	10.1371/journal.pone.0113226	http://dx.doi.org/10.1371/journal.pone.0113226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397962	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500141
J	Vay, C; Hosch, SB; Stoecklein, NH; Klein, CA; Vallbohmer, D; Link, BC; Yekebas, EF; Izbicki, JR; Knoefel, WT; Scheunemann, P				Vay, Christian; Hosch, Stefan B.; Stoecklein, Nikolas H.; Klein, Christoph A.; Vallboehmer, Daniel; Link, Bjoern-Christian; Yekebas, Emre F.; Izbicki, Jakob R.; Knoefel, Wolfram T.; Scheunemann, Peter			Integrin Expression in Esophageal Squamous Cell Carcinoma: Loss of the Physiological Integrin Expression Pattern Correlates with Disease Progression	PLOS ONE			English	Article							6 BETA 4; ADHESION MOLECULES; ALPHA-6-BETA-4 INTEGRIN; STEM-CELLS; INVASIVE GROWTH; TUMOR INVASION; E-CADHERIN; CANCER; MIGRATION; HEMIDESMOSOMES	The integrins are a family of heterodimeric transmembrane signaling receptors that mediate the adhesive properties of epithelial cells affecting cell growth and differentiation. In many epithelial malignancies, altered integrin expression is associated with tumor progression and often correlates with unfavorable prognosis. However, only few studies have investigated the role of integrin expression in esophageal squamous cell carcinoma (ESCC). Using a novel quantifying immunofluorescence-staining assay, we investigated the expression of the integrins alpha(2)beta(1), alpha(3)beta(1), alpha(6)beta(1), and alpha(6)beta(4) in primary ESCC of 36 patients who underwent surgical resection. Magnitude and distribution of expression were analyzed in primary tumor samples and autologous esophageal squamous epithelium. The persistence of the physiologically polarized expression of the subunits alpha(6), beta(1), and beta(4) in the tumor tissue was significantly associated with prolonged relapse-free survival (p = 0.028, p = 0.034, p = 0.006). In contrast, patients with reduced focal alpha(6) expression at the tumor invasion front shared a significantly shortened relapse-free survival compared to patients with strong alpha(6) expression at their stromal surfaces, as it was regularly observed in normal esophageal epithelium (p = 0.001). Multivariate regression analysis identified the maintenance of strong alpha(6) immunoreactivity at the invasion front as an independent prognostic factor for increased relapse-free and disease-specific survival (p = 0.003; p = 0.003). Our findings suggest that alterations in both pattern and magnitude of integrin expression may play a major role in the disease progression of ESCC patients. Particularly, the distinct expression of the integrins alpha(6)beta(4) and alpha(6)beta(1) at the invasion front as well as the maintenance of a polarized integrin expression pattern in the tumor tissue may serve as valuable new markers to assess the aggressiveness of ESCC.	[Vay, Christian; Hosch, Stefan B.; Stoecklein, Nikolas H.; Vallboehmer, Daniel; Knoefel, Wolfram T.; Scheunemann, Peter] Univ Dusseldorf, Dept Surg A, Dusseldorf, Germany; [Vay, Christian; Hosch, Stefan B.; Stoecklein, Nikolas H.; Vallboehmer, Daniel; Knoefel, Wolfram T.; Scheunemann, Peter] Univ Hosp Dusseldorf, Dusseldorf, Germany; [Vay, Christian; Hosch, Stefan B.; Stoecklein, Nikolas H.; Link, Bjoern-Christian; Yekebas, Emre F.; Izbicki, Jakob R.; Knoefel, Wolfram T.; Scheunemann, Peter] Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, Hamburg, Germany; [Hosch, Stefan B.] Ingolstadt Med Ctr, Dept Gen Vasc & Visceral Surg, Ingolstadt, Germany; [Klein, Christoph A.] Univ Regensburg, Div Oncogen, Inst Pathol, D-93053 Regensburg, Germany; [Scheunemann, Peter] Univ Hosp Rostock, Dept Pediat Surg, Rostock, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Regensburg; University of Rostock	Vay, C (corresponding author), Univ Dusseldorf, Dept Surg A, Dusseldorf, Germany.	christian.vay@med.uni-duesseldorf.de		Klein, Christoph A./0000-0001-7128-1725				Adachi M, 1998, J CLIN ONCOL, V16, P1060, DOI 10.1200/JCO.1998.16.3.1060; ADAMS JC, 1993, DEVELOPMENT, V117, P1183; Baba Y, 2008, BRIT J CANCER, V98, P974, DOI 10.1038/sj.bjc.6604252; Bagutti C, 1998, J PATHOL, V186, P8, DOI 10.1002/(SICI)1096-9896(199809)186:1<8::AID-PATH156>3.0.CO;2-H; Belkin AM, 2000, MICROSC RES TECHNIQ, V51, P280, DOI 10.1002/1097-0029(20001101)51:3<280::AID-JEMT7>3.0.CO;2-O; Borradori L, 1996, CURR OPIN CELL BIOL, V8, P647, DOI 10.1016/S0955-0674(96)80106-2; BOSMAN FT, 1993, HISTOCHEM J, V25, P469, DOI 10.1007/BF00159282; Brakebusch C, 2002, J CLIN INVEST, V109, P999, DOI 10.1172/JCI200215468; Coleman MP, 2003, ANN ONCOL, V14, pV128, DOI 10.1093/annonc/mdg756; Croagh D, 2008, STEM CELL REV, V4, P261, DOI 10.1007/s12015-008-9031-3; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; DOBSON H, 1994, GUT, V35, P1343, DOI 10.1136/gut.35.10.1343; DOWNER CS, 1993, J PATHOL, V171, P183, DOI 10.1002/path.1711710306; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Engbring JA, 2003, J PATHOL, V200, P465, DOI 10.1002/path.1396; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Eriksen JG, 2004, APMIS, V112, P560, DOI 10.1111/j.1600-0463.2004.apm1120902.x; Falcioni R, 1997, EXP CELL RES, V236, P76, DOI 10.1006/excr.1997.3695; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fidler I J, 1982, Prog Clin Biol Res, V85 Pt B, P601; Fujita M, 2012, J BIOL CHEM, V287, P12491, DOI 10.1074/jbc.M111.304170; Gambaletta D, 2000, J BIOL CHEM, V275, P10604, DOI 10.1074/jbc.275.14.10604; Garzino-Demo P, 1998, ORAL ONCOL, V34, P204, DOI 10.1016/S1368-8375(97)00059-6; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; HALL PA, 1991, J PATHOL, V165, P33, DOI 10.1002/path.1711650107; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ieguchi K, 2010, J BIOL CHEM, V285, P31388, DOI 10.1074/jbc.M110.113878; Ishii Y, 2000, GASTROENTEROLOGY, V118, P497, DOI 10.1016/S0016-5085(00)70255-1; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; JONES J, 1993, J PATHOL, V169, P235, DOI 10.1002/path.1711690210; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Jones SM, 2006, NAT REV CANCER, V6, P175, DOI 10.1038/nrc1817; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Katayama M, 2004, J MOL HISTOL, V35, P277; KORETZ K, 1991, AM J PATHOL, V138, P741; Kwon J, 2013, INT J ONCOL, V43, P1523, DOI 10.3892/ijo.2013.2097; Lohi J, 2001, INT J CANCER, V94, P763, DOI 10.1002/ijc.1539; Lordick F, 2013, LANGENBECK ARCH SURG, V398, P177, DOI 10.1007/s00423-012-1001-1; Marinkovich MP, 2007, NAT REV CANCER, V7, P370, DOI 10.1038/nrc2089; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; Mawhinney Mark R, 2012, Cancer Manag Res, V4, P367, DOI 10.2147/CMAR.S27593; Mercurio AM, 2001, SEMIN CANCER BIOL, V11, P129, DOI 10.1006/scbi.2000.0364; Mercurio AM, 2001, CURR OPIN CELL BIOL, V13, P541, DOI 10.1016/S0955-0674(00)00249-0; Mizejewski GJ, 1999, P SOC EXP BIOL MED, V222, P124, DOI 10.1046/j.1525-1373.1999.d01-122.x; Nair KS, 2005, J CLIN PATHOL, V58, P343, DOI 10.1136/jcp.2004.018036; NIGAM AK, 1993, BRIT J CANCER, V68, P507, DOI 10.1038/bjc.1993.377; Owens DM, 2003, J CELL SCI, V116, P3783, DOI 10.1242/jcs.00725; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; PIGNATELLI M, 1991, J PATHOL, V165, P25, DOI 10.1002/path.1711650106; PIGNATELLI M, 1990, BRIT J CANCER, V61, P636, DOI 10.1038/bjc.1990.141; PIGNATELLI M, 1992, HUM PATHOL, V23, P1159, DOI 10.1016/0046-8177(92)90034-Z; Rabinovitz I, 1996, BIOCHEM CELL BIOL, V74, P811, DOI 10.1139/o96-087; Rice TW, 2010, CANCER-AM CANCER SOC, V116, P3763, DOI 10.1002/cncr.25146; RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957; Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6; Seery JP, 2000, CURR BIOL, V10, P1447, DOI 10.1016/S0960-9822(00)00803-4; Serini G, 1996, J NATL CANCER I, V88, P442, DOI 10.1093/jnci/88.7.442; Shinohara T, 1999, P NATL ACAD SCI USA, V96, P5504, DOI 10.1073/pnas.96.10.5504; SONNENBERG A, 1991, J CELL BIOL, V113, P907, DOI 10.1083/jcb.113.4.907; STALLMACH A, 1992, GUT, V33, P342, DOI 10.1136/gut.33.3.342; Tani H, 2000, P NATL ACAD SCI USA, V97, P10960, DOI 10.1073/pnas.97.20.10960; Thomas GJ, 1997, ORAL ONCOL, V33, P381, DOI 10.1016/S0964-1955(97)00021-3; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; VANWAES C, 1995, CANCER RES, V55, P5434; Villaflor VM, 2012, WORLD J GASTROENTERO, V18, P6737, DOI 10.3748/wjg.v18.i46.6737; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399	68	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e109026	10.1371/journal.pone.0109026	http://dx.doi.org/10.1371/journal.pone.0109026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398092	Green Published, gold			2022-12-27	WOS:000345558500004
J	Wu, J; Teng, YG; Lu, SJ; Wang, YY; Jiao, XD				Wu, Jin; Teng, Yanguo; Lu, Sijin; Wang, Yeyao; Jiao, Xudong			Evaluation of Soil Contamination Indices in a Mining Area of Jiangxi, China	PLOS ONE			English	Article							HEAVY-METAL POLLUTION; URBAN SOILS; ENRICHMENT FACTORS; BASE-LINE; ELEMENTS; PB; NI; CU	There is currently a wide variety of methods used to evaluate soil contamination. We present a discussion of the advantages and limitations of different soil contamination assessment methods. In this study, we analyzed seven trace elements (As, Cd, Cr, Cu, Hg, Pb, and Zn) that are indicators of soil contamination in Dexing, a city in China that is famous for its vast nonferrous mineral resources in China, using enrichment factor (EF), geoaccumulation index (I-geo), pollution index (PI), and principal component analysis (PCA). The three contamination indices and PCA were then mapped to understand the status and trends of soil contamination in this region. The entire study area is strongly enriched in Cd, Cu, Pb, and Zn, especially in areas near mine sites. As and Hg were also present in high concentrations in urban areas. Results indicated that Cr in this area originated from both anthropogenic and natural sources. PCA combined with Geographic Information System (GIS) was successfully used to discriminate between natural and anthropogenic trace metals.	[Wu, Jin; Teng, Yanguo; Jiao, Xudong] Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China; [Lu, Sijin; Wang, Yeyao] China Natl Environm Monitoring Ctr, Beijing, Peoples R China	Beijing Normal University	Teng, YG (corresponding author), Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China.	teng1974@163.com	WU, JIN/AAE-9081-2019		Specific Research on Public Service of Environmental Protection in China [201509031]; National Natural Science Foundation in China [41303069]	Specific Research on Public Service of Environmental Protection in China; National Natural Science Foundation in China(National Natural Science Foundation of China (NSFC))	This work was supported by the Specific Research on Public Service of Environmental Protection in China (No. 201509031) and National Natural Science Foundation in China (No. 41303069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SS, 2001, ECOL APPL, V11, P1573, DOI 10.1890/1051-0761(2001)011[1573:DASQAT]2.0.CO;2; BCMOE (British Columbia Ministry of Environment), 2005, BACKGROUND SOIL QUAL, V17; Blaser P, 2000, SCI TOTAL ENVIRON, V249, P257, DOI 10.1016/S0048-9697(99)00522-7; Carlon C., 2007, DERIVATION METHODS S; CCME, 2007, CAN SOIL QUAL GUID P; CEMS, 1990, BACKGR VAL EL SOILS; CHESTER R, 1973, NATURE, V245, P27, DOI 10.1038/245027b0; CSEPA (China State Environmental Protection Administration), 1995, 156181995 CSEPA GB; Darnley AG, 1995, J GEOCHEM EXPLOR, V55, P5, DOI 10.1016/0375-6742(95)00035-6; Desaules A, 2012, SCI TOTAL ENVIRON, V426, P120, DOI 10.1016/j.scitotenv.2012.03.035; Garrett RG, 1991, EXPL GEOCH WORKSH; Gowd SS, 2010, J HAZARD MATER, V174, P113, DOI 10.1016/j.jhazmat.2009.09.024; HAKANSON L, 1980, WATER RES, V14, P975, DOI 10.1016/0043-1354(80)90143-8; Hawkes H.E., 1962, GEOCHEMISTRY MINERAL; He J., 2005, SOIL BACKGROUND VALU; Hernandez L, 2003, SCI TOTAL ENVIRON, V312, P195, DOI 10.1016/S0048-9697(03)00223-7; Ikem A, 2008, ENVIRON MONIT ASSESS, V140, P69, DOI 10.1007/s10661-007-9848-2; ISO: International Organisation for Standardisation, 2005, SOIL QUAL VOC 1; Khalil A, 2013, J GEOCHEM EXPLOR, V125, P117, DOI 10.1016/j.gexplo.2012.11.018; Li XD, 2004, ENVIRON POLLUT, V129, P113, DOI 10.1016/j.envpol.2003.09.030; Li ZY, 2014, SCI TOTAL ENVIRON, V468, P843, DOI 10.1016/j.scitotenv.2013.08.090; Loska K, 1997, WATER AIR SOIL POLL, V93, P347, DOI 10.1023/A:1022121615949; Loska K, 2004, ENVIRON INT, V30, P159, DOI 10.1016/S0160-4120(03)00157-0; Luo XS, 2012, SCI TOTAL ENVIRON, V421, P17, DOI 10.1016/j.scitotenv.2011.04.020; Manta DS, 2002, SCI TOTAL ENVIRON, V300, P229, DOI 10.1016/S0048-9697(02)00273-5; MULLER G, 1979, UMSCHAU, V79, P778; Nathanail CP, 2001, HUMAN HLTH RISK ASSE, P85; Porteous A, 1996, DICT ENV SCI TECHNOL; Reimann C, 2000, ENVIRON SCI TECHNOL, V34, P5084, DOI 10.1021/es001339o; Reimann C, 2005, SCI TOTAL ENVIRON, V346, P1, DOI 10.1016/j.scitotenv.2004.11.023; Reimann C, 1998, CHEM ELEMENTS ENV FA, DOI DOI 10.1017/S0016756800264613; Salminen R, 2000, APPL GEOCHEM, V15, P647, DOI 10.1016/S0883-2927(99)00077-3; Sepulvado JG, 2011, ENVIRON SCI TECHNOL, V45, P8106, DOI 10.1021/es103903d; Shotyk W, 1997, WATER AIR SOIL POLL, V100, P297, DOI 10.1023/A:1018384711802; Sutherland RA, 1999, EARTH SURF PROC LAND, V24, P571, DOI 10.1002/(SICI)1096-9837(199907)24:7<571::AID-ESP975>3.0.CO;2-F; TAYLOR SR, 1995, REV GEOPHYS, V33, P241, DOI 10.1029/95RG00262; Teng YG, 2014, ENVIRON INT, V69, P177, DOI 10.1016/j.envint.2014.04.014; Teng YG, 2010, J GEOCHEM EXPLOR, V104, P118, DOI 10.1016/j.gexplo.2010.01.006; Teng YG, 2009, ENVIRON GEOL, V57, P1649, DOI 10.1007/s00254-008-1446-2; USEPA: United States Environmental Protection Agency, 1992, 75B92001 USEPA; Utermann J., 2006, BACKGROUND VALUES EU; Vegter, 1998, RISK ASSESSMENT CONT, V1; Wang XQ, 2010, J SOIL SEDIMENT, V10, P827, DOI 10.1007/s11368-010-0196-4; WEDEPOHL KH, 1995, GEOCHIM COSMOCHIM AC, V59, P1217, DOI 10.1016/0016-7037(95)00038-2; Xie YF, 2011, CHEMOSPHERE, V82, P468, DOI 10.1016/j.chemosphere.2010.09.053; ZOLLER WH, 1974, SCIENCE, V183, P198, DOI 10.1126/science.183.4121.198	46	59	61	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112917	10.1371/journal.pone.0112917	http://dx.doi.org/10.1371/journal.pone.0112917			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397401	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500111
J	Choe, TE; Abbott, CJ; Piper, C; Wang, L; Fortune, B				Choe, Tiffany E.; Abbott, Carla J.; Piper, Chelsea; Wang, Lin; Fortune, Brad			Comparison of Longitudinal In Vivo Measurements of Retinal Nerve Fiber Layer Thickness and Retinal Ganglion Cell Density after Optic Nerve Transection in Rat	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE ELEVATION; CONFOCAL NEUROIMAGING ICON; LIVING MOUSE EYE; COHERENCE TOMOGRAPHY; EXPERIMENTAL GLAUCOMA; OCULAR HYPERTENSION; AXONAL-TRANSPORT; MICROGLIAL CELLS; VISUAL PATHWAY; DBA/2J MICE	Purpose: To determine the relationship between longitudinal in vivo measurements of retinal nerve fiber layer thickness (RNFLT) and retinal ganglion cell (RGC) density after unilateral optic nerve transection (ONT). Methods: Nineteen adult Brown-Norway rats were studied; N = 10 ONT plus RGC label, N = 3 ONT plus vehicle only (sans label), N = 6 sham ONT plus RGC label. RNFLT was measured by spectral domain optical coherence tomography (SD-OCT) at baseline then weekly for 1 month. RGCs were labeled by retrograde transport of fluorescently conjugated cholera toxin B (CTB) from the superior colliculus 48 hours prior to ONT or sham surgery. RGC density measurements were obtained by confocal scanning laser ophthalmoscopy (CSLO) at baseline and weekly for 1 month. RGC density and reactivity of microglia (anti-Iba1) and astrocytes (anti-GFAP) were determined from post mortem fluorescence microscopy of whole-mount retinae. Results: RNFLT decreased after ONT by 17% (p < 0.05), 30% (p < 0.0001) and 36% (p < 0.0001) at weeks 2, 3 and 4. RGC density decreased after ONT by 18%, 69%, 85% and 92% at weeks 1, 2, 3 and 4 (p < 0.0001 each). RGC density measured in vivo at week 4 and post mortem by microscopy were strongly correlated (R = 0.91, p < 0.0001). In vivo measures of RNFLT and RGC density were strongly correlated (R = 0.81, p < 0.0001). In ONT-CTB labeled fellow eyes, RNFLT increased by 18%, 52% and 36% at weeks 2, 3 and 4 (p < 0.0001), but did not change in fellow ONT-eyes sans CTB. Microgliosis was evident in the RNFL of the ONT-CTB fellow eyes, exceeding that observed in other fellow eyes. Conclusions: In vivo measurements of RNFLT and RGC density are strongly correlated and can be used to monitor longitudinal changes after optic nerve injury. The strong fellow eye effect observed in eyes contralateral to ONT, only in the presence of CTB label, consisted of a dramatic increase in RNFLT associated with retinal microgliosis.	[Fortune, Brad] Devers Eye Inst, Discoveries Sight Res Labs, Portland, OR 97210 USA; Legacy Hlth, Legacy Res Inst, Portland, OR USA	Devers Eye Institute; Legacy Health	Fortune, B (corresponding author), Devers Eye Inst, Discoveries Sight Res Labs, Portland, OR 97210 USA.	bfortune@deverseye.org	Abbott, Carla J/H-9510-2019	Abbott, Carla J/0000-0002-1432-8977; Fortune, Brad/0000-0003-0284-5173; Wang, Lin/0000-0003-0385-8478	National Institutes of Health, National Eye Institute [R21-EY021311]; Legacy Good Samaritan Foundation; Heidelberg Engineering, GmbH (equipment support); NATIONAL EYE INSTITUTE [R21EY021311] Funding Source: NIH RePORTER	National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Legacy Good Samaritan Foundation; Heidelberg Engineering, GmbH (equipment support); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health, National Eye Institute Grant: R21-EY021311 (BF), Legacy Good Samaritan Foundation (BF), and Heidelberg Engineering, GmbH (equipment support). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CJ, 2014, INVEST OPHTH VIS SCI, V55, P674, DOI 10.1167/iovs.13-12811; Abbott CJ, 2013, BIOMED OPT EXPRESS, V4, P364, DOI 10.1364/BOE.4.000364; Beirowski B, 2010, J NEUROPATH EXP NEUR, V69, P455, DOI 10.1097/NEN.0b013e3181da84db; Bodeutsch N, 1999, J NEUROBIOL, V38, P116, DOI 10.1002/(SICI)1097-4695(199901)38:1<116::AID-NEU9>3.0.CO;2-F; Bosco A, 2011, J COMP NEUROL, V519, P599, DOI 10.1002/cne.22516; Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008; Bui BV, 2004, J PHYSIOL-LONDON, V555, P153, DOI 10.1113/jphysiol.2003.052738; Chauhan BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040352; Chidlow G, 2011, ACTA NEUROPATHOL, V121, P737, DOI 10.1007/s00401-011-0807-1; Cordeiro MF, 2004, P NATL ACAD SCI USA, V101, P13352, DOI 10.1073/pnas.0405479101; Crish SD, 2010, P NATL ACAD SCI USA, V107, P5196, DOI 10.1073/pnas.0913141107; Cull GA, 2012, INVEST OPHTH VIS SCI, V53, P7766, DOI 10.1167/iovs.12-10752; Ebneter A, 2010, INVEST OPHTH VIS SCI, V51, P6448, DOI 10.1167/iovs.10-5284; Folio LS, 2012, OPTOMETRY VISION SCI, V89, pE554, DOI 10.1097/OPX.0b013e31824eeb43; Fortune B, 2011, INVEST OPHTH VIS SCI, V52, P6651, DOI 10.1167/iovs.11-7578; Fu CT, 2010, INVEST OPHTH VIS SCI, V51, P980, DOI 10.1167/iovs.09-4324; Gabriele ML, 2011, INVEST OPHTH VIS SCI, V52, P2250, DOI 10.1167/iovs.10-6311; Gallego BI, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-92; Geng Y, 2012, BIOMED OPT EXPRESS, V3, P715, DOI 10.1364/BOE.3.000715; Geng Y, 2009, INVEST OPHTH VIS SCI, V50, P5872, DOI 10.1167/iovs.09-3675; Goldblum D, 2002, VISION RES, V42, P471, DOI 10.1016/S0042-6989(01)00194-8; Gray DC, 2008, INVEST OPHTH VIS SCI, V49, P467, DOI 10.1167/iovs.07-0605; Guo L, 2010, INVEST OPHTH VIS SCI, V51, P6504, DOI 10.1167/iovs.10-5551; Harwerth RS, 2008, OPTOMETRY VISION SCI, V85, P436, DOI 10.1097/OPX.0b013e31817841b5; Hein K, 2012, INVEST OPHTH VIS SCI, V53, P157, DOI 10.1167/iovs.11-8092; Higashide T, 2006, INVEST OPHTH VIS SCI, V47, P2943, DOI 10.1167/iovs.05-0708; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Jonas RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030763; Kanamori A, 2005, EXP EYE RES, V81, P48, DOI 10.1016/j.exer.2005.01.012; Kanamori A, 2012, AM J PATHOL, V181, P62, DOI 10.1016/j.ajpath.2012.03.030; Kezic JM, 2013, INVEST OPHTH VIS SCI, V54, P3028, DOI 10.1167/iovs.13-11865; Leung CKS, 2008, J NEUROSCI METH, V168, P475, DOI 10.1016/j.jneumeth.2007.10.018; Leung CKS, 2008, INVEST OPHTH VIS SCI, V49, P4898, DOI 10.1167/iovs.07-1447; Leung CKS, 2014, CURR OPIN OPHTHALMOL, V25, P104, DOI 10.1097/ICU.0000000000000024; Leung CKS, 2011, INVEST OPHTH VIS SCI, V52, P1539, DOI 10.1167/iovs.10-6012; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; Liu S, 2012, INVEST OPHTH VIS SCI, V53, P6254, DOI 10.1167/iovs.12-9450; Lozano DC, 2013, INVEST OPHTH VIS SCI, V54, P6446, DOI 10.1167/iovs.13-12575; Morrison JC, 2008, PROG BRAIN RES, V173, P285, DOI 10.1016/S0079-6123(08)01121-7; Murata H, 2008, INVEST OPHTH VIS SCI, V49, P5546, DOI 10.1167/iovs.07-1211; Nagata A, 2009, INVEST OPHTH VIS SCI, V50, P2809, DOI 10.1167/iovs.08-2764; Naskar R, 2002, INVEST OPHTH VIS SCI, V43, P2962; Panagis L, 2005, EUR J NEUROSCI, V21, P2305, DOI 10.1111/j.1460-9568.2005.04046.x; Pang IH, 2007, J GLAUCOMA, V16, P483, DOI 10.1097/IJG.0b013e3181405d4f; Parrilla-Reverter G, 2009, VISION RES, V49, P2808, DOI 10.1016/j.visres.2009.08.020; Prilloff S, 2010, EUR J NEUROSCI, V31, P521, DOI 10.1111/j.1460-9568.2010.07078.x; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; QUIGLEY HA, 1983, INVEST OPHTH VIS SCI, V24, P1305; QUIGLEY HA, 1980, INVEST OPHTH VIS SCI, V19, P126; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Sabel BA, 1997, NAT MED, V3, P244, DOI 10.1038/nm0297-244; Salinas-Navarro M, 2010, EXP EYE RES, V90, P168, DOI 10.1016/j.exer.2009.10.003; Schlamp CL, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-66; SCHUMAN JS, 1995, ARCH OPHTHALMOL-CHIC, V113, P586, DOI 10.1001/archopht.1995.01100050054031; Sharma R, 2013, BIOMED OPT EXPRESS, V4, P1285, DOI 10.1364/BOE.4.001285; Sobrado-Calvo P, 2007, J COMP NEUROL, V501, P866, DOI 10.1002/cne.21279; Soto I, 2008, J NEUROSCI, V28, P548, DOI 10.1523/JNEUROSCI.3714-07.2008; Soto I, 2011, INVEST OPHTH VIS SCI, V52, P434, DOI 10.1167/iovs.10-5856; THANOS S, 1991, EUR J NEUROSCI, V3, P1189, DOI 10.1111/j.1460-9568.1991.tb00054.x; Thanos S, 2002, TRENDS NEUROSCI, V25, P441, DOI 10.1016/S0166-2236(02)02246-4; Walsh MK, 2008, J NEUROSCI METH, V169, P214, DOI 10.1016/j.jneumeth.2007.11.029; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Wollstein G, 2005, ARCH OPHTHALMOL-CHIC, V123, P464, DOI 10.1001/archopht.123.4.464; Yin L, 2013, J NEUROPHYSIOL, V109, P2415, DOI 10.1152/jn.01043.2012; Zhang C, 2003, J NEUROSCI RES, V73, P840, DOI 10.1002/jnr.10713	66	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e113011	10.1371/journal.pone.0113011	http://dx.doi.org/10.1371/journal.pone.0113011			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393294	Green Published, gold			2022-12-27	WOS:000347709300135
J	Goyal, R; Goyal, D; Chu, N; Van Wickle, J; Longo, LD				Goyal, Ravi; Goyal, Dipali; Chu, Nina; Van Wickle, Jonathan; Longo, Lawrence D.			Cerebral Artery Alpha-1 AR Subtypes: High Altitude Long-Term Acclimatization Responses	PLOS ONE			English	Article							ALPHA-1-ADRENERGIC RECEPTOR SUBTYPES; ALPHA(1)-ADRENERGIC RECEPTORS; INS(1,4,5)P-3 RESPONSES; BLOOD-FLOW; RHO-KINASE; FETAL; HYPOXIA; MATURATION; BRAIN; CONTRACTILITY	In response to hypoxia and other stress, the sympathetic (adrenergic) nervous system regulates arterial contractility and blood flow, partly through differential activities of the alpha1 (alpha(1))-adrenergic receptor (AR) subtypes (alpha 1A-, alpha 1B-, and alpha 1D-AR). Thus, we tested the hypothesis that with acclimatization to long-term hypoxia (LTH), contractility of middle cerebral arteries (MCA) is regulated by changes in expression and activation of the specific alpha(1)-AR subtypes. We conducted experiments in MCA from adult normoxic sheep maintained near sea level (300 m) and those exposed to LTH (110 days at 3801 m). Following acclimatization to LTH, ovine MCA showed a 20% reduction (n = 5; P<0.05) in the maximum tension achieved by 10(-5) M phenylephrine (PHE). LTH-acclimatized cerebral arteries also demonstrated a statistically significant (P<0.05) inhibition of PHE-induced contractility in the presence of specific alpha 1-AR subtype antagonists. Importantly, compared to normoxic vessels, there was significantly greater (P<0.05) alpha 1B-AR subtype mRNA and protein levels in LTH acclimatized MCA. Also, our results demonstrate that extracellular regulated kinase 1 and 2 (ERK1/2)-mediated negative feedback regulation of PHE-induced contractility is modulated by alpha 1B-AR subtype. Overall, in ovine MCA, LTH produces profound effects on alpha 1-AR subtype expression and function.	[Goyal, Ravi; Goyal, Dipali; Chu, Nina; Van Wickle, Jonathan; Longo, Lawrence D.] Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Perinatal Biol, Loma Linda, CA 92354 USA; [Goyal, Ravi; Goyal, Dipali; Chu, Nina; Van Wickle, Jonathan; Longo, Lawrence D.] Epigenuity LLC, Loma Linda, CA USA	Loma Linda University	Goyal, R (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Perinatal Biol, Loma Linda, CA 92354 USA.	rgoyal@llu.edu			United States Public Health Service Grant [PO1 HD031226]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD003807, P01HD031226] Funding Source: NIH RePORTER	United States Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The studies were supported by United States Public Health Service Grant PO1 HD031226 to LDL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEVAN JA, 1984, BLOOD VESSELS, V21, P110; Bishai JM, 2002, AM J PHYSIOL-REG I, V282, pR1654, DOI 10.1152/ajpregu.00475.2001; BROWN JK, 1974, DEV MED CHILD NEUROL, V16, P567; DIECKHOFF D, 1969, PFLUG ARCH EUR J PHY, V310, P75, DOI 10.1007/BF00586876; Docherty JR, 1998, EUR J PHARMACOL, V361, P1, DOI 10.1016/S0014-2999(98)00682-7; EDVINSSON L, 1982, PATHOL BIOL, V30, P261; GOETZ AS, 1995, EUR J PHARMACOL, V272, pR5, DOI 10.1016/0014-2999(94)00751-R; Goyal R, 2014, PHYSL GENOMICS; Goyal R, 2008, AM J PHYSIOL-LUNG C, V295, pL905, DOI 10.1152/ajplung.00053.2008; Goyal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082200; Goyal R, 2010, AM J PHYSIOL-REG I, V299, pR1377, DOI 10.1152/ajpregu.00344.2010; Goyal R, 2010, AM J PHYSIOL-HEART C, V298, pH1797, DOI 10.1152/ajpheart.00112.2010; Goyal R, 2009, AM J PHYSIOL-HEART C, V297, pH2242, DOI 10.1152/ajpheart.00681.2009; Graham RM, 1996, CIRC RES, V78, P737, DOI 10.1161/01.RES.78.5.737; GREENBERG B, 1993, AM J PHYSIOL, V265, pH1712, DOI 10.1152/ajpheart.1993.265.5.H1712; Guimaraes S, 2001, PHARMACOL REV, V53, P319; HEISTAD DD, 1978, J CLIN INVEST, V62, P761, DOI 10.1172/JCI109187; KAMITOMO M, 1994, AM J PHYSIOL, V266, pR1778, DOI 10.1152/ajpregu.1994.266.6.R1778; Kandabashi T, 2003, ARTERIOSCL THROM VAS, V23, P2209, DOI 10.1161/01.ATV.0000104010.87348.26; KITANAKA T, 1989, AM J PHYSIOL, V256, pR1340, DOI 10.1152/ajpregu.1989.256.6.R1340; KONTOS HA, 1978, AM J PHYSIOL, V234, pH371, DOI 10.1152/ajpheart.1978.234.4.H371; Long W, 2000, AM J PHYSIOL-REG I, V279, pR2004, DOI 10.1152/ajpregu.2000.279.6.R2004; Longo LD, 1997, BRIT J OBSTET GYNAEC, V104, P652, DOI 10.1111/j.1471-0528.1997.tb11974.x; LONGO LD, 1993, AM J PHYSIOL, V264, pR65, DOI 10.1152/ajpregu.1993.264.1.R65; Longo LD, 1998, COMP BIOCHEM PHYS A, V119, P683, DOI 10.1016/S1095-6433(98)01006-X; Longo LD, 1996, AM J PHYSIOL-HEART C, V270, pH915, DOI 10.1152/ajpheart.1996.270.3.H915; MCCALDEN TA, 1981, J AUTON PHARMACOL, V1, P421, DOI 10.1111/j.1474-8673.1981.tb00082.x; MINNEMAN KP, 1994, ANNU REV PHARMACOL, V34, P117; MINNEMAN KP, 1988, MOL PHARMACOL, V33, P509; MORROW AL, 1986, MOL PHARMACOL, V29, P321; MULLIGAN JC, 1980, J PEDIATR-US, V96, P903, DOI 10.1016/S0022-3476(80)80575-0; Nelson KB, 2003, NEW ENGL J MED, V349, P1765, DOI 10.1056/NEJMsb035364; Onishi J, 2003, J SOC GYNECOL INVEST, V10, P189, DOI 10.1016/S1071-5576(03)00042-X; PEETERS LLH, 1979, AM J OBSTET GYNECOL, V135, P637, DOI 10.1016/S0002-9378(16)32989-1; Purkayastha S, 2013, EXP PHYSIOL, V98, P451, DOI 10.1113/expphysiol.2012.066118; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Robertson TP, 2003, AM J PHYSIOL-LUNG C, V284, pL1121, DOI 10.1152/ajplung.00422.2002; ter Laan M, 2013, BRIT J ANAESTH, V111, P361, DOI 10.1093/bja/aet122; Tsai MH, 2006, PFLUG ARCH EUR J PHY, V453, P223, DOI 10.1007/s00424-006-0133-y; Ueno N, 1997, AM J PHYSIOL-REG I, V272, pR669, DOI 10.1152/ajpregu.1997.272.2.R669; West JB, 2012, AM J RESP CRIT CARE, V186, P1229, DOI 10.1164/rccm.201207-1323CI	41	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112784	10.1371/journal.pone.0112784	http://dx.doi.org/10.1371/journal.pone.0112784			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393740	Green Published, gold, Green Submitted			2022-12-27	WOS:000347709300103
J	Guidino, C; Llapapasca, MA; Silva, S; Alcorta, B; Pacheco, AS				Guidino, Chiara; Llapapasca, Miguel A.; Silva, Sebastian; Alcorta, Belen; Pacheco, Aldo S.			Patterns of Spatial and Temporal Distribution of Humpback Whales at the Southern Limit of the Southeast Pacific Breeding Area	PLOS ONE			English	Article							MEGAPTERA-NOVAEANGLIAE; MIGRATORY DESTINATIONS; REPRODUCTIVE STATUS; HAWAIIAN-ISLANDS; CENTRAL-AMERICA; CURRENT SYSTEM; HABITAT; FEMALE; WATERS; IDENTIFICATION	Understanding the patterns of spatial and temporal distribution in threshold habitats of highly migratory and endangered species is important for understanding their habitat requirements and recovery trends. Herein, we present new data about the distribution of humpback whales (Megaptera novaeangliae) in neritic waters off the northern coast of Peru: an area that constitutes a transitional path from cold, upwelling waters to warm equatorial waters where the breeding habitat is located. Data was collected during four consecutive austral winter/spring seasons from 2010 to 2013, using whale-watching boats as platforms for research. A total of 1048 whales distributed between 487 groups were sighted. The spatial distribution of humpbacks resembled the characteristic segregation of whale groups according to their size/age class and social context in breeding habitats; mother and calf pairs were present in very shallow waters close to the coast, while dyads, trios or more whales were widely distributed from shallow to moderate depths over the continental shelf break. Sea surface temperatures (range: 18.2-25.9 degrees C) in coastal waters were slightly colder than those closer to the oceanic realm, likely due to the influence of cold upwelled waters from the Humboldt Current system. Our results provide new evidence of the southward extension of the breeding region of humpback whales in the Southeast Pacific. Integrating this information with the knowledge from the rest of the breeding region and foraging grounds would enhance our current understanding of population dynamics and recovery trends of this species.	[Guidino, Chiara] Univ Technol Sydney, Sydney, NSW 2007, Australia; [Llapapasca, Miguel A.] Inst Mar Peru, Oficina Invest Depredadores Super, Callao, Peru; [Silva, Sebastian; Alcorta, Belen] Pacifico Adventures Manejo Integral Ambiente Mari, Los Organos, Peru; [Pacheco, Aldo S.] Univ Antofagasta, Inst Ciencias Nat Alexander Von Humboldt, Antofagasta, Chile	University of Technology Sydney; Instituto del Mar del Peru; Universidad de Antofagasta	Pacheco, AS (corresponding author), Univ Antofagasta, Inst Ciencias Nat Alexander Von Humboldt, Antofagasta, Chile.	aldo.pacheco@uantof.cl	Ll., Miguel A. Llapapasca/AAC-9856-2020; Pacheco, Aldo S/L-9939-2017	Ll., Miguel A. Llapapasca/0000-0003-1332-0874; Pacheco, Aldo S/0000-0002-2767-6436; Guidino, Chiara/0000-0002-2918-7636	Pacifico Adventures crew	Pacifico Adventures crew	We deeply thank the support of the Pacifico Adventures crew and volunteers particularly, F. Sanchez-Salazar, N. Balducci, A. Petit and E. Larranaga. C. Paulino and J. Ledesma (IMARPE) who kindly provided us the sea surface temperature data. Comments by R. Cartwright, A. Zerbini, K. Van Waerebeek and an anonymous reviewer helped us to improve an early version of the manuscript. N. Burns and K. Rasmussen kindly revised the English of this manuscript. This is study was supported by the participation of hundreds of enthusiastic whale-watchers.	Acevedo J, 2007, MAR MAMMAL SCI, V23, P453, DOI 10.1111/j.1748-7692.2007.00116.x; Capella JJ, 2008, REV CHIL HIST NAT, V81, P547; Cartwright R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038004; Cartwright R, 2009, BEHAVIOUR, V146, P1573, DOI 10.1163/156853909X458377; Cartwright R, 2009, MAR MAMMAL SCI, V25, P659, DOI 10.1111/j.1748-7692.2009.00286.x; Clapham P, 2001, MAR MAMMAL SCI, V17, P432, DOI 10.1111/j.1748-7692.2001.tb01289.x; Clarke R., 1962, Norsk Hvalfangsttidende Sandefjord, V51, P265; Contini Ferreira Mariana Elias, 2011, Latin American Journal of Aquatic Mammals, V9, P160; Corkeron PJ, 1999, MAR MAMMAL SCI, V15, P1228, DOI 10.1111/j.1748-7692.1999.tb00887.x; Craig AS, 2014, BEHAVIOUR, V151, P613, DOI 10.1163/1568539X-00003151; Craig AS, 2003, BEHAVIOUR, V140, P981, DOI 10.1163/156853903322589605; Craig AS, 2000, MAR ECOL PROG SER, V193, P209, DOI 10.3354/meps193209; Dawbin W. H., 1997, Memoirs of the Queensland Museum, V42, P105; Doniol-Valcroze T, 2007, MAR ECOL PROG SER, V335, P207, DOI 10.3354/meps335207; Ersts PJ, 2003, J ZOOL, V260, P337, DOI 10.1017/S0952836903003807; Faria MA, 2013, AQUAT MAMM, V39, P296, DOI 10.1578/AM.39.3.2013.296; Felix Fernando, 2005, Journal of Cetacean Research and Management, V7, P21; Felix Fernando, 2001, Revista de Biologia Marina y Oceanografia, V36, P61; Felix Fernando, 2011, Journal of Cetacean Research and Management, P301; Felix F, 2011, MAR ECOL PROG SER, V426, P277, DOI 10.3354/meps08984; FLOREZ-GONZALEZ L, 1991, Memoirs of the Queensland Museum, V30, P291; Florez-Gonzalez L, 1998, MAR MAMMAL SCI, V14, P189, DOI 10.1111/j.1748-7692.1998.tb00707.x; FLOREZGONZALEZ L, 1994, MAR MAMMAL SCI, V10, P218, DOI 10.1111/j.1748-7692.1994.tb00264.x; Garcia-Godos I, 2013, PAC SCI, V67, P523, DOI 10.2984/67.4.3; Gibbons Jorge, 2003, Journal of Cetacean Research and Management, V5, P203; Heithaus MR, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P414; Hucke-Gaete R, 2013, AQUAT CONSERV, V23, P858, DOI 10.1002/aqc.2343; Johnston D. W., 2007, Endangered Species Research, V3, P249, DOI 10.3354/esr00049; McClean SA, 1998, J WILDLIFE MANAGE, V62, P793, DOI 10.2307/3802356; Morete ME, 2007, J MAR BIOL ASSOC UK, V87, P87, DOI 10.1017/S0025315407054616; Moron A. O., 2000, B I MAR PERU, V19, P179; NEU CW, 1974, J WILDLIFE MANAGE, V38, P541, DOI 10.2307/3800887; Oviedo L, 2008, REV BIOL TROP, V56, P591; Pacheco AS, 2013, REV BIOL MAR OCEANOG, V48, P185, DOI 10.4067/S0718-19572013000100016; Pacheco Aldo S., 2009, Latin American Journal of Aquatic Mammals, V7, P33; Pacheco AS, 2011, LAT AM J AQUAT RES, V39, P189, DOI 10.3856/vol39-issue1-fulltext-20; Ramirez P, 1988, B LIMA, V56, P91; Rasmussen K, 2007, BIOLOGY LETT, V3, P302, DOI 10.1098/rsbl.2007.0067; Rasmussen K, 2012, MAR MAMMAL SCI, V28, pE267, DOI 10.1111/j.1748-7692.2011.00529.x; Santillan Luis, 2011, Journal of Marine Animals and their Ecology, V4, P29; Scheidat Meike, 2000, Journal of Cetacean Research and Management, V2, P165; Smith JN, 2012, MAR ECOL PROG SER, V447, P259, DOI 10.3354/meps09462; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; STONE GS, 1990, NATURE, V346, P705, DOI 10.1038/346705a0; Swartzman G, 2008, PROG OCEANOGR, V79, P228, DOI 10.1016/j.pocean.2008.10.021; Tynan CT, 2005, DEEP-SEA RES PT II, V52, P145, DOI 10.1016/j.dsr2.2004.09.024; URBAN J, 1987, MAR MAMMAL SCI, V3, P333; Urban J, 1999, BALLENA JOROBADA MEG; Van Waerebeek K, 1996, SC48SH1 INT WHAL COM; Van Waerebeek K, 2013, AFR ZOOL, V48, P177; Zerbini Alexandre N., 2004, Journal of Cetacean Research and Management, V6, P101	51	39	40	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112627	10.1371/journal.pone.0112627	http://dx.doi.org/10.1371/journal.pone.0112627			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391137	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400112
J	Hudson, LE; Fasken, MB; McDermott, CD; McBride, SM; Kuiper, EG; Guiliano, DB; Corbett, AH; Lamb, TJ				Hudson, Lauren E.; Fasken, Milo B.; McDermott, Courtney D.; McBride, Shonna M.; Kuiper, Emily G.; Guiliano, David B.; Corbett, Anita H.; Lamb, Tracey J.			Functional Heterologous Protein Expression by Genetically Engineered Probiotic Yeast Saccharomyces boulardii	PLOS ONE			English	Article							ESCHERICHIA-COLI; CEREVISIAE; STRAINS; DECARBOXYLASE; TRANSLOCATION; GENERATION; MUTANTS; HOST; ACID; GENE	Recent studies have suggested the potential of probiotic organisms to be adapted for the synthesis and delivery of oral therapeutics. The probiotic yeast Saccharomyces boulardii would be especially well suited for this purpose due to its ability, in contrast to probiotic prokaryotes, to perform eukaryotic post translational modifications. This probiotic yeast thus has the potential to express a broad array of therapeutic proteins. Currently, however, use of wild type (WT) S. boulardii relies on antibiotic resistance for the selection of transformed yeast. Here we report the creation of auxotrophic mutant strains of S. boulardii that can be selected without antibiotics and demonstrate that these yeast can express functional recombinant protein even when recovered from gastrointestinal immune tissues in mice. A UV mutagenesis approach was employed to generate three uracil auxotrophic S. boulardii mutants that show a low rate of reversion to wild type growth. These mutants can express recombinant protein and are resistant in vitro to low pH, bile acid salts, and anaerobic conditions. Critically, oral gavage experiments using C57BL/6 mice demonstrate that mutant S. boulardii survive and are taken up into gastrointestinal immune tissues on a similar level as WT S. boulardii. Mutant yeast recovered from gastrointestinal immune tissues furthermore retain expression of functional recombinant protein. These data show that auxotrophic mutant S. boulardii can safely express recombinant protein without antibiotic selection and can deliver recombinant protein to gastrointestinal immune tissues. These auxotrophic mutants of S. boulardii pave the way for future experiments to test the ability of S. boulardii to deliver therapeutics and mediate protection against gastrointestinal disorders.	[Hudson, Lauren E.; McDermott, Courtney D.; Lamb, Tracey J.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Fasken, Milo B.; Kuiper, Emily G.; Corbett, Anita H.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [McBride, Shonna M.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Guiliano, David B.] Univ E London, Sch Hlth Sport & Biosci, London E15 4LZ, England	Emory University; Emory University; Emory University; University of East London	Corbett, AH (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	acorbe2@emory.edu; tracey.j.lamb@emory.edu	Fasken, Milo/K-2177-2019; Corbett, Anita/AAH-6106-2021	Fasken, Milo/0000-0003-4317-7909; Corbett, Anita/0000-0002-0461-6895; Lamb, Tracey/0000-0003-0620-3944; McBride, Shonna/0000-0001-6221-714X	CCVI Seed Grant from Emory University; National Institutes of Health [1DP2AI112242-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP2AI112242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367, T32GM008169] Funding Source: NIH RePORTER	CCVI Seed Grant from Emory University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided through a CCVI Seed Grant from Emory University (http://www.emory.edu) and a New Innovator Award 1DP2AI112242-01 through the National Institutes of Health (http://commonfund.nih.gov/newinnovator/index). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation in the manuscript.	Benatuil L, 2010, PROTEIN ENG DES SEL, V23, P155, DOI 10.1093/protein/gzq002; BERG R, 1993, J INFECT DIS, V168, P1314, DOI 10.1093/infdis/168.5.1314; BLEHAUT H, 1989, BIOPHARM DRUG DISPOS, V10, P353, DOI 10.1002/bdd.2510100403; Boddy AV, 1991, PHARM RES, V8; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Burke D., 2000, METHODS YEAST GENETI; Castagliuolo I, 1996, TOXIN A, P64; CZERUCKA D, 1994, GASTROENTEROLOGY, V106, P65, DOI 10.1016/S0016-5085(94)94403-2; Dahan S, 2003, INFECT IMMUN, V71, P766, DOI 10.1128/IAI.71.2.766-773.2003; Degtyareva NP, 2008, MOL CELL BIOL, V28, P5432, DOI 10.1128/MCB.00307-08; Demain AL, 2009, BIOTECHNOL ADV, V27, P297, DOI 10.1016/j.biotechadv.2009.01.008; Di Giacinto C, 2005, J IMMUNOL, V174, P3237, DOI 10.4049/jimmunol.174.6.3237; Dimitrov LN, 2009, GENETICS, V183, P365, DOI 10.1534/genetics.109.104497; Douradinha B, 2014, BIOENGINEERED, V5, P21, DOI 10.4161/bioe.26271; Dujon B, 1996, TRENDS GENET, V12, P263, DOI 10.1016/0168-9525(96)10027-5; Edwards AN, 2013, JOVE-J VIS EXP, DOI 10.3791/50787; Edwards-Ingram L, 2007, APPL ENVIRON MICROB, V73, P2458, DOI 10.1128/AEM.02201-06; Edwards-Ingram LC, 2004, GENOME RES, V14, P1043, DOI 10.1101/gr.2114704; Fietto JLR, 2004, CAN J MICROBIOL, V50, P615, DOI [10.1139/w04-050, 10.1139/W04-050]; Generoso SV, 2011, EUR J NUTR, V50, P261, DOI 10.1007/s00394-010-0134-7; Hamedi Hassan, 2013, Avicenna Journal of Medical Biotechnology, V5, P29; Hashimoto S, 2005, APPL ENVIRON MICROB, V71, P312, DOI 10.1128/AEM.71.1.312-319.2005; Kuhle AVDA, 2005, INT J FOOD MICROBIOL, V101, P29, DOI 10.1016/j.ijfoodmicro.2004.10.039; Kurugol Z, 2005, ACTA PAEDIATR, V94, P44, DOI 10.1080/08035250410022521; Latorre-Garcia L, 2008, WORLD J MICROB BIOT, V24, P2957, DOI 10.1007/s11274-008-9837-9; LEHR R, 1992, STAT MED, V11, P1099, DOI 10.1002/sim.4780110811; Martins FS, 2009, ARCH MICROBIOL, V191, P623, DOI 10.1007/s00203-009-0491-x; Martins FS, 2013, MICROBES INFECT, P1; McFarland LV, 2010, WORLD J GASTROENTERO, V16, P2202, DOI 10.3748/wjg.v16.i18.2202; Michael S, 2013, INFLAMM BOWEL DIS, V19, P185, DOI 10.1002/ibd.23006; Miller BG, 2000, P NATL ACAD SCI USA, V97, P2011, DOI 10.1073/pnas.030409797; ROSE M, 1984, GENE, V29, P113, DOI 10.1016/0378-1119(84)90172-0; Sambrook J., 2001, MOL CLONING LAB MANU; Schulz O, 2013, TRENDS IMMUNOL, V34, P155, DOI 10.1016/j.it.2012.09.006; SIKORSKI RS, 1989, GENETICS, V122, P19; Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859; Wang T., 2013, FORMING CONDITIONS R, P1	39	21	22	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112660	10.1371/journal.pone.0112660	http://dx.doi.org/10.1371/journal.pone.0112660			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391025	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000349144400117
J	Usta, J; Wehbeh, A; Rida, K; El-Rifai, O; Estiphan, TA; Majarian, T; Barada, K				Usta, Julnar; Wehbeh, Antonios; Rida, Khaled; El-Rifai, Omar; Estiphan, Theresa Alicia; Majarian, Tamar; Barada, Kassem			Phenotype-Genotype Correlation in Wilson Disease in a Large Lebanese Family: Association of c.2299insC with Hepatic and of p. Ala1003Thr with Neurologic Phenotype	PLOS ONE			English	Article							ATP7B GENE; MUTATION ANALYSIS; LIVER-DISEASE; SPLICE VARIANTS; INDIAN PATIENTS; DIAGNOSIS; IDENTIFICATION; SPECTRUM; HOMOZYGOSITY; METAANALYSIS	Genotype phenotype correlations in Wilson disease (WD) are best established in homozygous patients or in compound heterozygous patients carrying the same set of mutations. We determined the clinical phenotype of patients with WD carrying the c.2298_2299insC in Exon 8 (c.2299insC) or the p. Ala1003Thr missense substitution in Exon 13 mutations in the homozygous or compound heterozygous state. We investigated 76 members of a single large Lebanese family. Their genotypes were determined, and clinical assessments were carried out for affected subjects. We also performed a literature search retrieving the phenotypes of patients carrying the same mutations of our patients in the homozygous or compound heterozygous state. There were 7 consanguineous marriages in this family and the prevalence of WD was 8.9% and of carriers of ATP7B mutation 44.7%. WD was confirmed in 9 out of 76 subjects. All 9 had the c.2299insC mutation, 5 homozygous and 4-compound heterozygous with p. Ala1003Thr. Six of our patients had hepatic, 2 had neurologic and 1 had asymptomatic phenotype. Based on our data and a literature review, clear phenotypes were reported for 38 patients worldwide carrying the c.2299insC mutation. About 53% of those have hepatic and 29% have neurologic phenotype. Furthermore, there were 10 compound heterozygous patients carrying the p. Ala1003Thr mutation. Among those, 80% having c.2299insC as the second mutation had hepatic phenotype, and all others had neurologic phenotype. We hereby report an association between the c.2299insC mutation and hepatic phenotype and between the p. Ala1003Thr mutation and neurologic phenotype.	[Usta, Julnar; Rida, Khaled; El-Rifai, Omar; Majarian, Tamar] Amer Univ Beirut, Fac Med, Dept Biochem & Mol Genet, Beirut, Lebanon; [Wehbeh, Antonios; Estiphan, Theresa Alicia] Amer Univ, Beirut Med Ctr, Fac Med, Beirut, Lebanon; [Barada, Kassem] Amer Univ, Dept Internal Med, Div Gastroenterol, Div Gastroenterol,Dept Internal Med, Beirut, Lebanon	American University of Beirut; American University of Beirut; Beirut Medical Center; American University of Beirut	Barada, K (corresponding author), Amer Univ, Dept Internal Med, Div Gastroenterol, Div Gastroenterol,Dept Internal Med, Beirut, Lebanon.	kb02@aub.edu.lb			Medical Practice Plan of AUB-MC; University Research Board of the American University of Beirut	Medical Practice Plan of AUB-MC; University Research Board of the American University of Beirut	The authors thank The Medical Practice Plan of AUB-MC and the University Research Board of the American University of Beirut for supporting the study by research grants to J. Usta. The funders had no role in study design, data collection and anlysis, decision to publish or preparation of the manuscript.	Abdelghaffar TY, 2008, J HUM GENET, V53, P681, DOI 10.1007/s10038-008-0298-7; Ausubel FM., 1988, CURRENT PROTOCOLS MO; Barada K, 2007, CLIN GENET, V72, P264, DOI 10.1111/j.1399-0004.2007.00853.x; Barada K, 2010, J CLIN GASTROENTEROL, V44, P432, DOI 10.1097/MCG.0b013e3181ce5138; Barbour B, 2009, J BIOSOC SCI, V41, P505, DOI 10.1017/S0021932009003290; Bruha R, 2011, LIVER INT, V31, P83, DOI 10.1111/j.1478-3231.2010.02354.x; Butler P, 2001, MOL GENET METAB, V72, P223, DOI 10.1006/mgme.2000.3143; Chabik G, 2014, J INHERIT METAB DIS, V37, P131, DOI 10.1007/s10545-013-9625-z; Cheng TF, 2012, J APPL TOXICOL, V32, P643, DOI 10.1002/jat.2717; Curtis D, 1999, HUM MUTAT, V14, P304, DOI 10.1002/(SICI)1098-1004(199910)14:4<304::AID-HUMU5>3.0.CO;2-W; Dastsooz H, 2013, GENE, V514, P48, DOI 10.1016/j.gene.2012.10.085; Deguti MM, 2004, HUM MUTAT, V23, P398, DOI 10.1002/humu.9227; Ferenci P, 2003, LIVER INT, V23, P139, DOI 10.1034/j.1600-0676.2003.00824.x; Ferenci P, 2014, ANN NY ACAD SCI, V1315, P1, DOI 10.1111/nyas.12340; Ferenci P, 2012, J HEPATOL, V56, P671, DOI 10.1016/j.jhep.2011.11.007; Ghaffar TYA, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-56; Gow PJ, 2000, GUT, V46, P415, DOI 10.1136/gut.46.3.415; Gu YH, 2003, CLIN GENET, V64, P479, DOI 10.1046/j.1399-0004.2003.00179.x; Gupta A, 2005, HUM GENET, V118, P49, DOI 10.1007/s00439-005-0007-y; Harada Masaru, 2002, Medical Electron Microscopy, V35, P61, DOI 10.1007/s007950200007; Hofer H, 2012, J HUM GENET, V57, P564, DOI 10.1038/jhg.2012.65; Huffman DL, 2001, ANNU REV BIOCHEM, V70, P677, DOI 10.1146/annurev.biochem.70.1.677; Kalinsky H, 1998, HUM MUTAT, V11, P145, DOI 10.1002/(SICI)1098-1004(1998)11:2<145::AID-HUMU7>3.3.CO;2-F; Keandaungjuntr Jesada, 2011, Journal of the Medical Association of Thailand, V94, P1184; Kegley KM, 2010, AM J TRANSPLANT, V10, P1325, DOI 10.1111/j.1600-6143.2010.03071.x; Kumar S, 2006, ANN HUM BIOL, V33, P177, DOI 10.1080/03014460500503275; Loudianos G, 2003, GENET TEST, V7, P107, DOI 10.1089/109065703322146786; Margarit E, 2005, CLIN GENET, V68, P61, DOI 10.1111/j.1399-0004.2005.00439.x; Mihaylova V, 2012, NEUROLOGIST, V18, P184, DOI 10.1097/NRL.0b013e31825cf3b7; Moller LB, 2011, EUR J HUM GENET, V19, P935, DOI 10.1038/ejhg.2011.80; Nicastro E, 2009, J HEPATOL, V50, P555, DOI 10.1016/j.jhep.2008.09.020; Obrador BD, 2006, EUR J GASTROEN HEPAT, V18, P57, DOI 10.1097/00042737-200601000-00010; Panagiotakaki E, 2004, AM J MED GENET A, V131A, P168, DOI 10.1002/ajmg.a.30345; Papur OS, 2013, EUR J MED GENET, V56, P175, DOI 10.1016/j.ejmg.2013.01.003; PETRUKHIN K, 1994, HUM MOL GENET, V3, P1647, DOI 10.1093/hmg/3.9.1647; Pinzani M, 2005, J HEPATOL, V42, pS22, DOI 10.1016/j.jhep.2004.12.008; Shah AB, 1997, AM J HUM GENET, V61, P317, DOI 10.1086/514864; Stapelbroek JM, 2004, J HEPATOL, V41, P758, DOI 10.1016/j.jhep.2004.07.017; STERNLIEB I, 1993, J HEPATOL, V17, P263, DOI 10.1016/S0168-8278(05)80202-8; THOMAS GR, 1995, NAT GENET, V9, P210, DOI 10.1038/ng0295-210; Usta J, 2012, JIMD REP, V4, P129, DOI 10.1007/8904_2011_91; Wan L, 2010, HEPATOLOGY, V52, P1662, DOI 10.1002/hep.23865; Wilson AME, 2009, BIOCHIMIE, V91, P1342, DOI 10.1016/j.biochi.2009.06.008; Yoo HW, 2002, GENET MED, V4, p43S, DOI 10.1097/00125817-200211001-00009	44	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e109727	10.1371/journal.pone.0109727	http://dx.doi.org/10.1371/journal.pone.0109727			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390358	Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400007
J	Jung, H; Jung, J; Kim, SK; Woo, SH; Kang, KM; Jeong, BK; Jung, MH; Kim, JH; Hahm, JR				Jung, Jung Hwa; Jung, Jaehoon; Kim, Soo Kyoung; Woo, Seung Hoon; Kang, Ki Mun; Jeong, Bae-Kwon; Jung, Myeong Hee; Kim, Jin Hyun; Hahm, Jong Ryeal			Alpha Lipoic Acid Attenuates Radiation-Induced Thyroid Injury in Rats	PLOS ONE			English	Article							SYMPTOMATIC DIABETIC POLYNEUROPATHY; X-IRRADIATION; VITAMIN-A; TGF-BETA; RADIOTHERAPY; DYSFUNCTION; HYPOTHYROIDISM; ANTIOXIDANTS; EXPRESSION; PROTECTION	Exposure of the thyroid to radiation during radiotherapy of the head and neck is often unavoidable. The present study aimed to investigate the protective effect of alpha-lipoic acid (ALA) on radiation-induced thyroid injury in rats. Rats were randomly assigned to four groups: healthy controls (CTL), irradiated (RT), received ALA before irradiation (ALA + RT), and received ALA only (ALA, 100 mg/kg, i.p.). ALA was treated at 24 h and 30 minutes prior to irradiation. The neck area including the thyroid gland was evenly irradiated with 2 Gy per minute (total dose of 18 Gy) using a photon 6-MV linear accelerator. Greater numbers of abnormal and unusually small follicles in the irradiated thyroid tissues were observed compared to the controls and the ALA group on days 4 and 7 after irradiation. However, all pathologies were decreased by ALA pretreatment. The quantity of small follicles in the irradiated rats was greater on day 7 than day 4 after irradiation. However, in the ALA-treated irradiated rats, the numbers of small and medium follicles were significantly decreased to a similar degree as in the control and ALA-only groups. The PAS-positive density of the colloid in RT group was decreased significantly compared with all other groups and reversed by ALA pretreatment. The high activity index in the irradiated rats was lowered by ALA treatment. TGF-beta 1 immunoreactivity was enhanced in irradiated rats and was more severe on the day 7 after radiation exposure than on day 4. Expression of TGF-beta 1 was reduced in the thyroid that had undergone ALA pretreatment. Levels of serum pro-inflammatory cytokines (TNF-alpha, IL-1 beta and IL-6) did not differ significantly between the all groups. This study provides that pretreatment with ALA decreased the severity of radiation-induced thyroid injury by reducing inflammation and fibrotic infiltration and lowering the activity index. Thus, ALA could be used to ameliorate radiation-induced thyroid injury.	[Jung, Jung Hwa; Jung, Jaehoon; Kim, Soo Kyoung; Hahm, Jong Ryeal] Gyeongsang Natl Univ, Sch Med, Dept Internal Med, Jinju, Gyeongnam, South Korea; [Woo, Seung Hoon] Gyeongsang Natl Univ, Sch Med, Dept Otolaryngol, Jinju, Gyeongnam, South Korea; [Kang, Ki Mun; Jeong, Bae-Kwon] Gyeongsang Natl Univ, Sch Med, Dept Radiat Oncol, Jinju, Gyeongnam, South Korea; [Jung, Myeong Hee; Kim, Jin Hyun] Gyeongsang Natl Univ Hosp, Biomed Res Inst, Jinju, Gyeongnam, South Korea; [Jung, Jung Hwa; Jung, Jaehoon; Kim, Soo Kyoung; Woo, Seung Hoon; Kang, Ki Mun; Jeong, Bae-Kwon; Kim, Jin Hyun; Hahm, Jong Ryeal] Gyeongsang Natl Univ Hosp, Sch Med, Inst Hlth Sci, Jinju, Gyeongnam, South Korea	Gyeongsang National University; Gyeongsang National University; Gyeongsang National University; Gyeongsang National University; Gyeongsang National University Hospital; Gyeongsang National University; Gyeongsang National University Hospital	Kim, JH (corresponding author), Gyeongsang Natl Univ Hosp, Biomed Res Inst, Jinju, Gyeongnam, South Korea.	ajini7044@hanmail.net; jrhahm@hanmail.net	Song, Jin/HHS-8731-2022; Kang, Kimun/AAA-3684-2022; Kwon, Jeong Bae/Q-3852-2019	Kwon, Jeong Bae/0000-0001-8015-6061	Special Clinical Fund from Gyeongsang National University Hospital [GNUHCRF-2012-008]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education Science and Technology [NRF-2012-0000305, 2012R1A1A2005699]; Biomedical Research Fund from Gyeongsang National University Hospital [GNUHBIF-2014-0010]	Special Clinical Fund from Gyeongsang National University Hospital; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education Science and Technology; Biomedical Research Fund from Gyeongsang National University Hospital	This work was supported by Special Clinical Fund from Gyeongsang National University Hospital [GNUHCRF-2012-008], the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education Science and Technology (NRF-2012-0000305) (2012R1A1A2005699), and Biomedical Research Fund from Gyeongsang National University Hospital [GNUHBIF-2014-0010]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANTLE JP, 1985, INT J RADIAT ONCOL, V11, P1999, DOI 10.1016/0360-3016(85)90283-4; Bilska A, 2005, PHARMACOL REP, V57, P570; Braley-Mullen H, 2001, J IMMUNOL, V167, P7111, DOI 10.4049/jimmunol.167.12.7111; Chen KM, 2000, J LEUKOCYTE BIOL, V68, P828; Chen KM, 2002, J IMMUNOL, V169, P6530, DOI 10.4049/jimmunol.169.11.6530; CHRISTOV K, 1975, CANCER RES, V35, P1256; CONSTINE LS, 1984, CANCER-AM CANCER SOC, V53, P878, DOI 10.1002/1097-0142(19840215)53:4<878::AID-CNCR2820530411>3.0.CO;2-J; Demir U, 2005, OPHTHALMOLOGICA, V219, P49, DOI 10.1159/000081783; EINHORN J, 1967, RADIOLOGY, V88, P326, DOI 10.1148/88.2.326; HANCOCK SL, 1991, NEW ENGL J MED, V325, P599, DOI 10.1056/NEJM199108293250902; HANCOCK SL, 1995, INT J RADIAT ONCOL, V31, P1165, DOI 10.1016/0360-3016(95)00019-U; Huh JW, 2007, TUBERC RESPIR DIS, V62, P105, DOI 10.4046/trd.2007.62.2.105; Hurdag C, 2005, INT J TISSUE REACT, V27, P145; Jasani B, 1990, GROWTH FACTORS, V2, P149, DOI 10.3109/08977199009071501; Jereczek-Fossa BA, 2004, CANCER TREAT REV, V30, P369, DOI 10.1016/j.ctrv.2003.12.003; Kimura ET, 1999, THYROID, V9, P119, DOI 10.1089/thy.1999.9.119; Korkina Ludmila G., 1993, Biochemical Society Transactions, V21, p314S; LOGAN A, 1994, J ENDOCRINOL, V141, P45, DOI 10.1677/joe.0.1410045; MAASILTA P, 1992, RADIOTHER ONCOL, V25, P192, DOI 10.1016/0167-8140(92)90267-X; Manda K, 2007, CELL BIOL TOXICOL, V23, P129, DOI 10.1007/s10565-006-0137-6; MARKSON JL, 1965, BRIT MED J, V1, P1228, DOI 10.1136/bmj.1.5444.1228; Massimino M, 2007, INT J RADIAT ONCOL, V69, P404, DOI 10.1016/j.ijrobp.2007.03.028; Nishiyama K, 1996, INT J RADIAT ONCOL, V34, P439, DOI 10.1016/0360-3016(95)02079-9; Odabasoglu F, 2011, BRIT J NUTR, V105, P31, DOI 10.1017/S0007114510003107; Papiez MA, 2008, FOLIA HISTOCHEM CYTO, V46, P205, DOI 10.2478/v10042-008-0031-6; Patrick L, 2000, Altern Med Rev, V5, P290; Prasad KN, 2005, BRIT J RADIOL, V78, P485, DOI 10.1259/bjr/87552880; Prasad KN, 2004, BRIT J RADIOL, V77, P97, DOI 10.1259/bjr/88081058; RAMAKRISHNAN N, 1992, RADIAT RES, V130, P360, DOI 10.2307/3578382; Redlich CA, 1998, J NUTR, V128, P1661, DOI 10.1093/jn/128.10.1661; Ricardi U, 2001, INT J RADIAT ONCOL, V50, P1287, DOI 10.1016/S0360-3016(01)01519-X; Saad AG, 2006, J CLIN ENDOCR METAB, V91, P2672, DOI 10.1210/jc.2006-0417; Sagowski C, 2003, EUR ARCH OTO-RHINO-L, V260, P42, DOI 10.1007/s00405-002-0496-4; SCOTT BC, 1994, FREE RADICAL RES, V20, P119, DOI 10.3109/10715769409147509; Sehirli O, 2008, CLIN EXP PHARMACOL P, V35, P249, DOI 10.1111/j.1440-1681.2007.04810.x; Sminia P, 1996, J CANCER RES CLIN, V122, P343, DOI 10.1007/BF01220801; Thresiamma K. C., 1996, Indian Journal of Experimental Biology, V34, P845; van Santen HM, 2006, THYROID, V16, P387, DOI 10.1089/thy.2006.16.387; van Santen HM, 2005, J ENDOCRINOL INVEST, V28, P261, DOI 10.1007/BF03345383; Ziegler D, 1999, DIABETES CARE, V22, P1296, DOI 10.2337/diacare.22.8.1296; Ziegler D, 2006, DIABETES CARE, V29, P2365, DOI 10.2337/dc06-1216	41	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112253	10.1371/journal.pone.0112253	http://dx.doi.org/10.1371/journal.pone.0112253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401725	gold, Green Published, Green Submitted			2022-12-27	WOS:000345158700036
J	Saito, Y; Takeda, J; Adachi, K; Nobe, Y; Kobayashi, J; Hirota, K; Oliveira, DV; Taoka, M; Isobe, T				Saito, Yuichiro; Takeda, Jun; Adachi, Kousuke; Nobe, Yuko; Kobayashi, Junya; Hirota, Kouji; Oliveira, Douglas V.; Taoka, Masato; Isobe, Toshiaki			RNase MRP Cleaves Pre-tRNA(Ser-Met) in the tRNA Maturation Pathway	PLOS ONE			English	Article							CARTILAGE-HAIR HYPOPLASIA; BACTERIAL RIBONUCLEASE-P; UNIQUE PROTEIN-COMPONENT; CELL-CYCLE PROGRESSION; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; RIBOSOMAL-RNA; RIBONUCLEOPROTEIN ENDORIBONUCLEASE; CRYSTAL-STRUCTURE; MESSENGER-RNA	Ribonuclease mitochondrial RNA processing (RNase MRP) is a multifunctional ribonucleoprotein (RNP) complex that is involved in the maturation of various types of RNA including ribosomal RNA. RNase MRP consists of a potential catalytic RNA and several protein components, all of which are required for cell viability. We show here that the temperature-sensitive mutant of rmp1, the gene for a unique protein component of RNase MRP, accumulates the dimeric tRNA precursor, pre-tRNA(Ser-Met). To examine whether RNase MRP mediates tRNA maturation, we purified the RNase MRP holoenzyme from the fission yeast Schizosaccharomyces pombe and found that the enzyme directly and selectively cleaves pre-tRNA(Ser-Met), suggesting that RNase MRP participates in the maturation of specific tRNA in vivo. In addition, mass spectrometry-based ribonucleoproteomic analysis demonstrated that this RNase MRP consists of one RNA molecule and 11 protein components, including a previously unknown component Rpl701. Notably, limited nucleolysis of RNase MRP generated an active catalytic core consisting of partial mrp1 RNA fragments, which constitute "Domain 1'' in the secondary structure of RNase MRP, and 8 proteins. Thus, the present study provides new insight into the structure and function of RNase MRP.	[Saito, Yuichiro; Adachi, Kousuke; Hirota, Kouji; Taoka, Masato; Isobe, Toshiaki] Tokyo Metropolitan Univ, Dept Chem, Grad Sch Sci & Engn, Tokyo 158, Japan; [Takeda, Jun; Nobe, Yuko; Taoka, Masato; Isobe, Toshiaki] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Kobayashi, Junya; Oliveira, Douglas V.] Kyoto Univ, Ctr Radiat Biol, Div Genome Repair Dynam, Kyoto 606, Japan	Tokyo Metropolitan University; Japan Science & Technology Agency (JST); Kyoto University	Isobe, T (corresponding author), Tokyo Metropolitan Univ, Dept Chem, Grad Sch Sci & Engn, Tokyo 158, Japan.	isobe-toshiaki@tmu.ac.jp	Isobe, Toshiaki/Q-9279-2017; Kobayashi, Junjiro/J-8547-2015; Kobayashi, Junya/AAX-6390-2021	Kobayashi, Junya/0000-0003-4645-7500; Nogueira Perez Oliveira, Douglas/0000-0002-3529-4219; Taoka, Masato/0000-0001-5554-4951; Saito, Yuichiro/0000-0001-5001-0934	Core Research for Evolutionary Science and Technology (CREST), Japan Science and Technology Agency	Core Research for Evolutionary Science and Technology (CREST), Japan Science and Technology Agency	This work was supported by Core Research for Evolutionary Science and Technology (CREST), Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulds J, 2012, J BIOL CHEM, V287, P37089, DOI 10.1074/jbc.M112.389023; Bertrand E, 1998, GENE DEV, V12, P2463, DOI 10.1101/gad.12.16.2463; BRENNWALD P, 1988, MOL CELL BIOL, V8, P1580, DOI 10.1128/MCB.8.4.1580; Buker SM, 2007, NAT STRUCT MOL BIOL, V14, P200, DOI 10.1038/nsmb1211; Cai T, 1999, MOL CELL BIOL, V19, P7857; Cai T, 2002, GENETICS, V161, P1029; Chamberlain JR, 1998, GENE DEV, V12, P1678, DOI 10.1101/gad.12.11.1678; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; CHANG DD, 1987, EMBO J, V6, P409, DOI 10.1002/j.1460-2075.1987.tb04770.x; Chen JL, 1997, RNA, V3, P557; DRAINAS D, 1989, FEBS LETT, V251, P84, DOI 10.1016/0014-5793(89)81433-4; ELDER RT, 1983, P NATL ACAD SCI-BIOL, V80, P2432, DOI 10.1073/pnas.80.9.2432; Esakova O, 2008, RNA, V14, P1558, DOI 10.1261/rna.1106408; Esakova O, 2013, NUCLEIC ACIDS RES, V41, P7084, DOI 10.1093/nar/gkt432; Esakova O, 2011, RNA, V17, P356, DOI 10.1261/rna.2393711; Esakova O, 2010, RNA, V16, P1725, DOI 10.1261/rna.2214510; Gill T, 2004, MOL CELL BIOL, V24, P945, DOI 10.1128/MCB.24.3.945-953.2004; Goldfarb KC, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-23; Green CJ, 1996, NUCLEIC ACIDS RES, V24, P1497, DOI 10.1093/nar/24.8.1497; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Gutz H, 1974, SCHIZOSACCHAROMYCES; Hartmann E, 2003, TRENDS GENET, V19, P561, DOI 10.1016/j.tig.2003.08.007; Hermanns P, 2005, HUM MOL GENET, V14, P3723, DOI 10.1093/hmg/ddi403; Hernandez-Cid A, 2012, IUBMB LIFE, V64, P521, DOI 10.1002/iub.1052; Hipp K, 2012, NUCLEIC ACIDS RES, V40, P3275, DOI 10.1093/nar/gkr1217; Hopper AK, 2013, GENETICS, V194, P43, DOI 10.1534/genetics.112.147470; Hsieh J, 2009, RNA, V15, P224, DOI 10.1261/rna.1309409; Jaag HM, 2011, J VIROL, V85, P243, DOI 10.1128/JVI.01749-10; Jacobson MR, 1995, J CELL BIOL, V131, P1649, DOI 10.1083/jcb.131.6.1649; Jakovljevic J, 2012, RNA, V18, P1805, DOI 10.1261/rna.032540.112; Khanova E, 2012, RNA, V18, P720, DOI 10.1261/rna.030874.111; Kikovska E, 2007, P NATL ACAD SCI USA, V104, P2062, DOI 10.1073/pnas.0607326104; Krasilnikov AS, 2004, SCIENCE, V306, P104, DOI 10.1126/science.1101489; Kuijpers TW, 2003, J MED GENET, V40, P761, DOI 10.1136/jmg.40.10.761; Levinger L, 1998, J BIOL CHEM, V273, P1015, DOI 10.1074/jbc.273.2.1015; LI K, 1994, J CELL BIOL, V124, P871, DOI 10.1083/jcb.124.6.871; Li X, 2004, NUCLEIC ACIDS RES, V32, P3703, DOI 10.1093/nar/gkh689; Li X, 2002, RNA, V8, P740, DOI 10.1017/S1355838202022082; LINDAHL L, 1992, NUCLEIC ACIDS RES, V20, P295, DOI 10.1093/nar/20.2.295; Lopez MD, 2009, RNA BIOL, V6, P208, DOI 10.4161/rna.6.3.8584; Loria A, 1997, BIOCHEMISTRY-US, V36, P6317, DOI 10.1021/bi970115o; Lu QS, 2010, RNA, V16, P529, DOI 10.1261/rna.1893710; Lygerou Z, 1996, SCIENCE, V272, P268, DOI 10.1126/science.272.5259.268; MAO JI, 1980, CELL, V21, P509, DOI 10.1016/0092-8674(80)90488-2; Martin AN, 2007, CELL RES, V17, P219, DOI 10.1038/sj.cr.7310120; Marvin MC, 2009, RNA BIOL, V6, P40, DOI 10.4161/rna.6.1.7566; Mattijssen S, 2010, WIRES RNA, V1, P102, DOI 10.1002/wrna.9; Mattijssen S, 2011, CELL MOL LIFE SCI, V68, P2469, DOI 10.1007/s00018-010-0568-3; Mobley EM, 1999, NUCLEIC ACIDS RES, V27, P4298, DOI 10.1093/nar/27.21.4298; Mondragon A, 2013, ANNU REV BIOPHYS, V42, P537, DOI 10.1146/annurev-biophys-083012-130406; Nakashima E, 2003, AM J MED GENET A, V123A, P253, DOI 10.1002/ajmg.a.20281; Nakashima E, 2007, AM J MED GENET A, V143A, P2675, DOI 10.1002/ajmg.a.32053; Nakayama H, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp099; Paluh JL, 1996, EMBO J, V15, P4723, DOI 10.1002/j.1460-2075.1996.tb00849.x; Paluh JL, 1996, YEAST, V12, P1393; Pannucci JA, 1999, P NATL ACAD SCI USA, V96, P7803, DOI 10.1073/pnas.96.14.7803; Perederina A, 2011, RNA, V17, P1922, DOI 10.1261/rna.2855511; Perederina A, 2010, EMBO J, V29, P761, DOI 10.1038/emboj.2009.396; Piccinelli P, 2005, NUCLEIC ACIDS RES, V33, P4485, DOI 10.1093/nar/gki756; Pluk H, 1999, RNA, V5, P512, DOI 10.1017/S1355838299982079; Poll G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008249; Qin H, 2001, BIOCHEMISTRY-US, V40, P11202, DOI 10.1021/bi010076n; Reiter NJ, 2010, NATURE, V468, P784, DOI 10.1038/nature09516; RIBES V, 1988, EMBO J, V7, P231, DOI 10.1002/j.1460-2075.1988.tb02804.x; Ridanpaa M, 2001, CELL, V104, P195, DOI 10.1016/S0092-8674(01)00205-7; Roifman CM, 2006, J ALLERGY CLIN IMMUN, V117, P897, DOI 10.1016/j.jaci.2006.01.003; Rosenblad MA, 2006, NUCLEIC ACIDS RES, V34, P5145, DOI 10.1093/nar/gkl626; Salinas K, 2005, J BIOL CHEM, V280, P11352, DOI 10.1074/jbc.M409568200; SCHMITT ME, 1994, GENE DEV, V8, P2617, DOI 10.1101/gad.8.21.2617; SCHMITT ME, 1992, GENE DEV, V6, P1975, DOI 10.1101/gad.6.10.1975; SCHMITT ME, 1993, MOL CELL BIOL, V13, P7935, DOI 10.1128/MCB.13.12.7935; STATHOPOULOS C, 1995, EUR J BIOCHEM, V228, P976, DOI 10.1111/j.1432-1033.1995.0976m.x; STOHL LL, 1992, MOL CELL BIOL, V12, P2561, DOI 10.1128/MCB.12.6.2561; Suga M, 2005, YEAST, V22, P799, DOI 10.1002/yea.1247; Taoka M, 2003, J BIOL CHEM, V278, P5864, DOI 10.1074/jbc.M211509200; Taoka M, 2010, ANAL CHEM, V82, P7795, DOI 10.1021/ac101623j; Taoka M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp732; Thiel CT, 2007, AM J HUM GENET, V81, P519, DOI 10.1086/521034; Thiel CT, 2005, AM J HUM GENET, V77, P795, DOI 10.1086/497708; Torres-Larios A, 2005, NATURE, V437, P584, DOI 10.1038/nature04074; Tsai HY, 2006, P NATL ACAD SCI USA, V103, P16147, DOI 10.1073/pnas.0608000103; van Hoof A, 2000, EMBO J, V19, P1357, DOI 10.1093/emboj/19.6.1357; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Welting TJM, 2008, BBA-MOL CELL RES, V1783, P455, DOI 10.1016/j.bbamcr.2007.11.016; Welting TJM, 2007, RNA, V13, P65, DOI 10.1261/rna.237807; Welting TJM, 2006, RNA, V12, P1373, DOI 10.1261/rna.2293906; Welting TJM, 2004, NUCLEIC ACIDS RES, V32, P2138, DOI 10.1093/nar/gkh539; Xiao SH, 2002, ANNU REV BIOCHEM, V71, P165, DOI 10.1146/annurev.biochem.71.110601.135352; Zhang JJ, 2004, J BIOL CHEM, V279, P20678, DOI 10.1074/jbc.M314284200	89	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112488	10.1371/journal.pone.0112488	http://dx.doi.org/10.1371/journal.pone.0112488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401760	Green Submitted, gold, Green Published			2022-12-27	WOS:000345158700050
J	Thiele, S; Wolf, C; Schulz, IK; Assmy, P; Metfies, K; Fuchs, BM				Thiele, Stefan; Wolf, Christian; Schulz, Isabelle Katharina; Assmy, Philipp; Metfies, Katja; Fuchs, Bernhard M.			Stable Composition of the Nano- and Picoplankton Community during the Ocean Iron Fertilization Experiment LOHAFEX	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; RIBOSOMAL-RNA GENE; FLOW-CYTOMETRIC IDENTIFICATION; EUKARYOTIC PICOPLANKTON; OLIGONUCLEOTIDE PROBES; NANOPLANKTON; SEQUENCES; MECHANISMS; PACIFIC; BLOOMS	The iron fertilization experiment LOHAFEX was conducted in a cold-core eddy in the Southern Atlantic Ocean during austral summer. Within a few days after fertilization, a phytoplankton bloom developed dominated by nano-and picoplankton groups. Unlike previously reported for other iron fertilization experiments, a diatom bloom was prevented by iron and silicate co-limitation. We used 18S rRNA gene tag pyrosequencing to investigate the diversity of these morphologically similar cell types within the nano-and picoplankton and microscopically enumerated dominant clades after catalyzed reported deposition fluorescence in situ hybridization (CARD-FISH) with specific oligonucleotide probes. In addition to Phaeocystis, members of Syndiniales group II, clade 10-11, and the Micromonas clades ABC and E made up a major fraction of the tag sequences of the nano-and picoplankton community within the fertilized patch. However, the same clades were also dominant before the bloom and outside the fertilized patch. Furthermore, only little changes in diversity could be observed over the course of the experiment. These results were corroborated by CARD-FISH analysis which confirmed the presence of a stable nano-and picoplankton community dominated by Phaeocystis and Micromonas during the entire course of the experiment. Interestingly, although Syndiniales dominated the tag sequences, they could hardly be detected by CARD-FISH, possibly due to the intracellular parasitic life style of this clade. The remarkable stability of the nano-and picoplankton community points to a tight coupling of the different trophic levels within the microbial food web during LOHAFEX.	[Thiele, Stefan; Fuchs, Bernhard M.] Max Planck Inst Marine Microbiol, Dept Mol Ecol, Bremen, Germany; [Wolf, Christian; Schulz, Isabelle Katharina; Metfies, Katja] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Dept Polar Biol Oceanog, Div Biosci, Bremerhaven, Germany; [Schulz, Isabelle Katharina] Univ Bremen, MARUM Ctr Marine Environm Sci, Bremen Int Grad Sch Marine Sci GLOMAR, D-28359 Bremen, Germany; [Assmy, Philipp] Norwegian Polar Res Inst, Fram Ctr, Ctr Ice Climate & Ecosyst ICE, Tromso, Norway	Max Planck Society; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Bremen; Norwegian Polar Institute	Fuchs, BM (corresponding author), Max Planck Inst Marine Microbiol, Dept Mol Ecol, Bremen, Germany.	bfuchs@mpi-bremen.de	Thiele, Stefan/C-4958-2017	Thiele, Stefan/0000-0002-4322-3795; Fuchs, Bernhard/0000-0001-9828-1290	Max Planck Society; Helmholtz Association [VH-NG-500]	Max Planck Society(Max Planck Society); Helmholtz Association(Helmholtz Association)	This work was funded by the Max Planck Society and the Helmholtz Association (Young Investigator Group PLANKTOSENS, VH-NG-500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Assmy P, 2007, DEEP-SEA RES PT I, V54, P340, DOI 10.1016/j.dsr.2006.12.005; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Balzano S, 2012, ISME J, V6, P1480, DOI 10.1038/ismej.2011.213; Beardsley C, 2005, AQUAT MICROB ECOL, V41, P163, DOI 10.3354/ame041163; Behnke A, 2011, ENVIRON MICROBIOL, V13, P340, DOI 10.1111/j.1462-2920.2010.02332.x; BLOEM J, 1986, APPL ENVIRON MICROB, V52, P1266, DOI 10.1128/AEM.52.6.1266-1272.1986; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; Chambouvet A, 2008, SCIENCE, V322, P1254, DOI 10.1126/science.1164387; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; Coats DW, 1996, AQUAT MICROB ECOL, V11, P1, DOI 10.3354/ame011001; Ducklow Hugh W., 2001, Oceanography, V14, P50; Ebersbach F, 2014, DEEP-SEA RES PT I, V89, P94, DOI 10.1016/j.dsr.2014.04.007; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; ELWOOD HJ, 1985, MOL BIOL EVOL, V2, P399; Gall MP, 2001, DEEP-SEA RES PT II, V48, P2551, DOI 10.1016/S0967-0645(01)00008-X; Gasol JM, 1999, AQUAT MICROB ECOL, V16, P251, DOI 10.3354/ame016251; Gomez-Pereira PR, 2013, FEMS MICROBIOL ECOL, V83, P664, DOI 10.1111/1574-6941.12023; Hall JA, 2001, DEEP-SEA RES PT II, V48, P2591, DOI 10.1016/S0967-0645(01)00010-8; Kilias E, 2013, J PHYCOL, V49, P996, DOI 10.1111/jpy.12109; Mackey MD, 1996, MAR ECOL PROG SER, V144, P265, DOI 10.3354/meps144265; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Martin P, 2013, GLOBAL BIOGEOCHEM CY, V27, P871, DOI 10.1002/gbc.20077; Massana R, 2002, APPL ENVIRON MICROB, V68, P4554, DOI 10.1128/AEM.68.9.4554-4558.2002; Massana R, 2006, ENVIRON MICROBIOL, V8, P1515, DOI 10.1111/j.1462-2920.2006.01042.x; Not F, 2002, AQUAT MICROB ECOL, V28, P157, DOI 10.3354/ame028157; Not F, 2004, APPL ENVIRON MICROB, V70, P4064, DOI 10.1128/AEM.70.7.4064-4072.2004; Peloquin J, 2011, DEEP-SEA RES PT II, V58, P808, DOI 10.1016/j.dsr2.2010.10.021; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ronaghi M, 1996, ANAL BIOCHEM, V242, P84, DOI 10.1006/abio.1996.0432; Schoemann V, 2005, J SEA RES, V53, P43, DOI 10.1016/j.seares.2004.01.008; Schulz IK, 2013, THESIS U BREMEN GERM; SHERR EB, 1993, HDB METHODS AQUATIC, P213; Siano R, 2011, BIOGEOSCIENCES, V8, P267, DOI 10.5194/bg-8-267-2011; Simon N, 2000, J EUKARYOT MICROBIOL, V47, P76, DOI 10.1111/j.1550-7408.2000.tb00014.x; Smetacek V, 2012, NATURE, V487, P313, DOI 10.1038/nature11229; Thiele S, 2011, TREATISE ON WATER SCIENCE, VOL 3: AQUATIC CHEMISTRY AND BIOLOGY, P171; Thiele S, 2012, APPL ENVIRON MICROB, V78, P8803, DOI 10.1128/AEM.01814-12; Tsuda A, 2005, PROG OCEANOGR, V64, P189, DOI 10.1016/j.pocean.2005.02.008; Unrein F, 2014, ISME J, V8, P164, DOI 10.1038/ismej.2013.132; Utermohl H., 1958, MITT INT VER THEOR, V9, P1, DOI DOI 10.1080/05384680.1958.11904091; VORS N, 1995, DEEP-SEA RES PT II, V42, P585, DOI 10.1016/0967-0645(95)00018-L; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205; Wolf C, 2013, ANTARCT SCI, V25, P741, DOI 10.1017/S0954102013000229; Zeder M, 2010, CYTOM PART A, V77A, P76, DOI 10.1002/cyto.a.20810; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006; Zingone A, 1999, J PHYCOL, V35, P1322, DOI 10.1046/j.1529-8817.1999.3561322.x	48	13	13	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113244	10.1371/journal.pone.0113244	http://dx.doi.org/10.1371/journal.pone.0113244			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401706	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700125
J	Brown, SC; Lester, RE; Versace, VL; Fawcett, J; Laurenson, L				Brown, Stuart C.; Lester, Rebecca E.; Versace, Vincent L.; Fawcett, Jonathon; Laurenson, Laurie			Hydrologic Landscape Regionalisation Using Deductive Classification and Random Forests	PLOS ONE			English	Article							LAND-USE CHANGE; UNITED-STATES; SPATIAL-RESOLUTION; FLOW VARIABILITY; STREAM-FLOW; FRAMEWORK; COVER; CONSEQUENCES; AGREEMENT; REGIMES	Landscape classification and hydrological regionalisation studies are being increasingly used in ecohydrology to aid in the management and research of aquatic resources. We present a methodology for classifying hydrologic landscapes based on spatial environmental variables by employing non-parametric statistics and hybrid image classification. Our approach differed from previous classifications which have required the use of an a priori spatial unit (e.g. a catchment) which necessarily results in the loss of variability that is known to exist within those units. The use of a simple statistical approach to identify an appropriate number of classes eliminated the need for large amounts of post-hoc testing with different number of groups, or the selection and justification of an arbitrary number. Using statistical clustering, we identified 23 distinct groups within our training dataset. The use of a hybrid classification employing random forests extended this statistical clustering to an area of approximately 228,000 km(2) of south-eastern Australia without the need to rely on catchments, landscape units or stream sections. This extension resulted in a highly accurate regionalisation at both 30-m and 2.5-km resolution, and a less-accurate 10-km classification that would be more appropriate for use at a continental scale. A smaller case study, of an area covering 27,000 km(2), demonstrated that the method preserved the intra-and inter-catchment variability that is known to exist in local hydrology, based on previous research. Preliminary analysis linking the regionalisation to streamflow indices is promising suggesting that the method could be used to predict streamflow behaviour in ungauged catchments. Our work therefore simplifies current classification frameworks that are becoming more popular in ecohydrology, while better retaining small-scale variability in hydrology, thus enabling future attempts to explain and visualise broad-scale hydrologic trends at the scale of catchments and continents.	[Brown, Stuart C.; Lester, Rebecca E.; Laurenson, Laurie] Deakin Univ, Sch Life & Environm Sci, Warrnambool, Vic, Australia; [Versace, Vincent L.] Flinders Univ S Australia, Dept Rural Hlth, Greater Green Triangle Univ, Warrnambool, Vic, Australia; [Versace, Vincent L.] Federat Univ Australia, Fac Sci & Technol, Ctr Environm Management, Ballarat, Vic, Australia; [Fawcett, Jonathon] Sinclair Knight Merz, Bendigo, Vic, Australia	Deakin University; Deakin University; Flinders University South Australia; Federation University Australia	Brown, SC (corresponding author), Deakin Univ, Sch Life & Environm Sci, Warrnambool, Vic, Australia.	stuart.brown@research.deakin.edu.au	Brown, Stuart/AAC-7472-2020; Versace, Vincent/AAL-6418-2021; Laurenson, Laurie J/C-8903-2009; Lester, Rebecca/H-3907-2011	Brown, Stuart/0000-0002-0669-1418; Versace, Vincent/0000-0002-8514-1763; Lester, Rebecca/0000-0003-2682-6495	Sinclair-Knight-Merz	Sinclair-Knight-Merz	The authors received no specific funding for this work. Jonathon Fawcett is employed by Sinclair-Knight-Merz. Sinclair-Knight-Merz provided support in the form of salary for author JF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2008, PERMANOVA PRIMER GUI; BELBIN L, 1993, J VEG SCI, V4, P341, DOI 10.2307/3235592; BELBIN L, 1987, AUST COMPUT J, V19, P32; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 1993, CLASSIFICATION REGRE; Brown S, 2012, ENVIRON MODEL ASSESS, V17, P241, DOI 10.1007/s10666-011-9289-8; Bunn SE, 2002, ENVIRON MANAGE, V30, P492, DOI 10.1007/s00267-002-2737-0; Carlisle DM, 2010, RIVER RES APPL, V26, P118, DOI 10.1002/rra.1247; Clarke K.R., 2006, PRIMER V6 USER MANUA; Clarke K. R., 2001, CHANGES MARINE COMMU; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clifford D.H.T., 1975, INTRO NUMERICAL CLAS; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; CORMACK RM, 1971, J R STAT SOC SER A-G, V134, P321, DOI 10.2307/2344237; Corrick A, 1992, ASSESSMENT VICTORIAS; Department of Environment and Primary Industries, 2013, VICT RES ONL TEMP; Dixon P, 2006, ENCY ENV; ESRI, 2012, ARCGIS DESKT 10 1; Everitt B., 1980, CLUSTER ANAL; Exelis Visual Information Solutions, 2010, ENVI VERS 4 8; Fay MP, 2010, R J, V2, P53; Foody GM, 2004, PHOTOGRAMM ENG REM S, V70, P627, DOI 10.14358/PERS.70.5.627; Gamer M, 2012, IRR VARIOUS COEFFICI; Held M, 2012, ENMAP BOX MANUAL VER; Ierodiaconou D, 2005, J ENVIRON MANAGE, V74, P305, DOI 10.1016/j.jenvman.2004.09.010; Kennard MJ, 2010, RIVER RES APPL, V26, P137, DOI 10.1002/rra.1249; Kennard MJ, 2010, FRESHWATER BIOL, V55, P171, DOI 10.1111/j.1365-2427.2009.02307.x; Kennard MJ, 2009, ECOHYDROLOGICAL REGI; Legendre P., 2012, NUMERICAL ECOLOGY; Lillesand T.M., 2015, REMOTE SENSING IMAGE, V7th; Mackey BG, 2008, J BIOGEOGR, V35, P213, DOI 10.1111/j.1365-2699.2007.01822.x; Marsh N. A., 2003, RIVER ANAL PACKAGE; McKenzie DP, 1996, J PSYCHIAT RES, V30, P483, DOI 10.1016/S0022-3956(96)00033-7; McManamay RA, 2012, RIVER RES APPL, V28, P1325, DOI 10.1002/rra.1535; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; Mumby PJ, 2002, REMOTE SENS ENVIRON, V82, P248, DOI 10.1016/S0034-4257(02)00041-X; Naiman RJ, 2008, CR GEOSCI, V340, P629, DOI 10.1016/j.crte.2008.01.002; Olden JD, 2003, RIVER RES APPL, V19, P101, DOI 10.1002/rra.700; Olden JD, 2012, ECOHYDROLOGY, V5, P503, DOI 10.1002/eco.251; PATN Website. Blatant Fabrications Pty. Ltd, 2009, PATN VERS 3 1 2; Poff NL, 2010, FRESHWATER BIOL, V55, P147, DOI 10.1111/j.1365-2427.2009.02204.x; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Poff NL, 1996, FRESHWATER BIOL, V36, P71, DOI 10.1046/j.1365-2427.1996.00073.x; Poff NL, 2006, RIVER RES APPL, V22, P149, DOI 10.1002/rra.902; POFF NL, 1995, ECOLOGY, V76, P606, DOI 10.2307/1941217; R Core Team, 2021, R LANGUAGE ENV STAT; Revelle William, 2020, CRAN; Rodriguez-Galiano VF, 2012, ISPRS J PHOTOGRAMM, V67, P93, DOI 10.1016/j.isprsjprs.2011.11.002; Santhi C, 2008, J HYDROL, V351, P139, DOI 10.1016/j.jhydrol.2007.12.018; Sawicz K, 2011, HYDROL EARTH SYST SC, V15, P2895, DOI 10.5194/hess-15-2895-2011; Snelder TH, 2005, RIVER RES APPL, V21, P609, DOI 10.1002/rra.826; Sprintsin M, 2007, REMOTE SENS ENVIRON, V109, P416, DOI 10.1016/j.rse.2007.01.020; Stein JL, 2009, ECOHYDROLOGICAL REGI; Versace VL, 2008, ENVIRON MONIT ASSESS, V142, P171, DOI 10.1007/s10661-007-9918-5; Versace VL, 2008, AGR ECOSYST ENVIRON, V123, P328, DOI 10.1016/j.agee.2007.07.012; Winter TC, 2001, J AM WATER RESOUR AS, V37, P335, DOI 10.1111/j.1752-1688.2001.tb00973.x; Wolock DM, 2004, ENVIRON MANAGE, V34, pS71, DOI 10.1007/s00267-003-5077-9; Yihdego Y, 2013, WATER RESOUR MANAG, V27, P4941, DOI 10.1007/s11269-013-0449-2; Yihdego Y, 2011, HYDROGEOL J, V19, P877, DOI 10.1007/s10040-011-0726-1	63	17	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112856	10.1371/journal.pone.0112856	http://dx.doi.org/10.1371/journal.pone.0112856			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396410	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558500102
J	Ge, XKZ; Jiang, JW; Pan, ZH; Hu, L; Wang, SH; Wang, HJ; Leung, FC; Dai, JJ; Fan, HJ				Ge, Xiangkai Zhu; Jiang, Jingwei; Pan, Zihao; Hu, Lin; Wang, Shaohui; Wang, Haojin; Leung, Frederick C.; Dai, Jianjun; Fan, Hongjie			Comparative Genomic Analysis Shows That Avian Pathogenic Escherichia coli Isolate IMT5155 (O2:K1:H5; ST Complex 95, ST140) Shares Close Relationship with ST95 APEC O1:K1 and Human ExPEC O18:K1 Strains	PLOS ONE			English	Article							VI SECRETION SYSTEM; VIRULENCE FACTORS; DNA-SEQUENCE; IDENTIFICATION; ACQUISITION; ISLANDS; GENES; MENINGITIS; DIVERSITY; INFECTION	Avian pathogenic E. coli and human extraintestinal pathogenic E. coli serotypes O1, O2 and O18 strains isolated from different hosts are generally located in phylogroup B2 and ST complex 95, and they share similar genetic characteristics and pathogenicity, with no or minimal host specificity. They are popular objects for the study of ExPEC genetic characteristics and pathogenesis in recent years. Here, we investigated the evolution and genetic blueprint of APEC pathotype by performing phylogenetic and comparative genome analysis of avian pathogenic E. coli strain IMT5155 (O2: K1: H5; ST complex 95, ST140) with other E. coli pathotypes. Phylogeny analyses indicated that IMT5155 has closest evolutionary relationship with APEC O1, IHE3034, and UTI89. Comparative genomic analysis showed that IMT5155 and APEC O1 shared significant genetic overlap/similarities with human ExPEC dominant O18: K1 strains (IHE3034 and UTI89). Furthermore, the unique PAI I5155 (GI-12) was identified and found to be conserved in APEC O2 serotype isolates. GI-7 and GI-16 encoding two typical T6SSs in IMT5155 might be useful markers for the identification of ExPEC dominant serotypes (O1, O2, and O18) strains. IMT5155 contained a ColV plasmid p1ColV(5155), which defined the APEC pathotype. The distribution analysis of 10 sequenced ExPEC pan-genome virulence factors among 47 sequenced E. coli strains provided meaningful information for B2 APEC/ExPEC-specific virulence factors, including several adhesins, invasins, toxins, iron acquisition systems, and so on. The pathogenicity tests of IMT5155 and other APEC O1: K1 and O2: K1 serotypes strains (isolated in China) through four animal models showed that they were highly virulent for avian colisepticemia and able to cause septicemia and meningitis in neonatal rats, suggesting zoonotic potential of these APEC O1: K1 and O2: K1 isolates.	[Ge, Xiangkai Zhu; Pan, Zihao; Hu, Lin; Wang, Haojin; Dai, Jianjun; Fan, Hongjie] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China; [Jiang, Jingwei; Leung, Frederick C.] Nanjing Agr Univ, Bioinformat Ctr, Nanjing, Jiangsu, Peoples R China; [Jiang, Jingwei; Leung, Frederick C.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Wang, Shaohui] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University; University of Hong Kong; Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS	Dai, JJ (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	daijianjun@njau.edu.cn	Dai, Jianjun/ABB-7353-2021		Fundamental Research Funds for the Central Universities [KYZ201326, KYZ201214]; Fund of Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Fund of Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the Fundamental Research Funds for the Central Universities (KYZ201326), the Fund of Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and the Fundamental Research Funds for the Central Universities (KYZ201214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antao EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007796; Antao EM, 2008, MICROB PATHOGENESIS, V45, P361, DOI 10.1016/j.micpath.2008.08.005; Bobay LM, 2013, MOL BIOL EVOL, V30, P737, DOI 10.1093/molbev/mss279; Bohnke U, 2010, THESIS HUMBOLDT U BE; Boyd EF, 1998, J BACTERIOL, V180, P1159, DOI 10.1128/JB.180.5.1159-1165.1998; Brzuszkiewicz E, 2006, P NATL ACAD SCI USA, V103, P12879, DOI 10.1073/pnas.0603038103; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Chen S, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-23; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Dai JJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-236; de Pace F, 2010, INFECT IMMUN, V78, P4990, DOI 10.1128/IAI.00531-10; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dho-Moulin M, 1999, VET RES, V30, P299; Diard M, 2010, J BACTERIOL, V192, P4885, DOI 10.1128/JB.00804-10; Dziva F, 2013, INFECT IMMUN, V81, P838, DOI 10.1128/IAI.00585-12; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eppinger M, 2011, P NATL ACAD SCI USA, V108, P20142, DOI 10.1073/pnas.1107176108; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Gao QQ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-143; Gordon DM, 2008, ENVIRON MICROBIOL, V10, P2484, DOI 10.1111/j.1462-2920.2008.01669.x; Grim CJ, 2012, APPL ENVIRON MICROB, V78, P6035, DOI 10.1128/AEM.01457-12; Harshey RM, 2012, MOBILE DNA-UK, V3, DOI 10.1186/1759-8753-3-21; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Johnson JR, 2006, J INFECT DIS, V194, P1141, DOI 10.1086/507305; Johnson TJ, 2008, APPL ENVIRON MICROB, V74, P7043, DOI 10.1128/AEM.01395-08; Johnson TJ, 2007, J BACTERIOL, V189, P3228, DOI 10.1128/JB.01726-06; Johnson TJ, 2006, J BACTERIOL, V188, P5975, DOI 10.1128/JB.00204-06; Johnson TJ, 2012, J BACTERIOL, V194, P2846, DOI 10.1128/JB.06375-11; Johnson TJ, 2010, INFECT IMMUN, V78, P1931, DOI 10.1128/IAI.01174-09; Johnson TJ, 2006, J BACTERIOL, V188, P745, DOI 10.1128/JB.188.2.745-758.2006; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Kaas RS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-577; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kohler CD, 2011, INT J MED MICROBIOL, V301, P642, DOI 10.1016/j.ijmm.2011.09.006; Kyle JL, 2012, J BACTERIOL, V194, P1885, DOI 10.1128/JB.00120-12; Li GW, 2010, INFECT IMMUN, V78, P898, DOI 10.1128/IAI.00513-09; Li GW, 2005, INFECT IMMUN, V73, P2818, DOI 10.1128/IAI.73.5.2818-2827.2005; Logue CM, 2012, APPL ENVIRON MICROB, V78, P5824, DOI 10.1128/AEM.07869-11; Ma JL, 2013, INFECT GENET EVOL, V20, P454, DOI 10.1016/j.meegid.2013.09.031; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; McNally A, 2013, GENOME BIOL EVOL, V5, P699, DOI 10.1093/gbe/evt038; Mellata M, 2010, INFECT IMMUN, V78, P1528, DOI 10.1128/IAI.00981-09; Mora A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-132; Moulin-Schouleur M, 2007, J CLIN MICROBIOL, V45, P3366, DOI 10.1128/JCM.00037-07; Moulin-Schouleur M, 2006, J CLIN MICROBIOL, V44, P3484, DOI 10.1128/JCM.00548-06; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; Rodriguez-Siek KE, 2005, MICROBIOL-SGM, V151, P2097, DOI 10.1099/mic.0.27499-0; Rodriguez-Siek KE, 2005, VET RES, V36, P241, DOI 10.1051/vetres:2004057; Ron EZ, 2006, CURR OPIN MICROBIOL, V9, P28, DOI 10.1016/j.mib.2005.12.001; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Russo TA, 2000, J INFECT DIS, V181, P1753, DOI 10.1086/315418; Russo TA, 2001, INFECT IMMUN, V69, P6209, DOI 10.1128/IAI.69.10.6209-6216.2001; Saha RP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003902; Sahl JW, 2011, INFECT IMMUN, V79, P950, DOI 10.1128/IAI.00932-10; Salvadori MR, 2001, AVIAN DIS, V45, P43, DOI 10.2307/1593010; Schubert S, 2002, INFECT IMMUN, V70, P5335, DOI 10.1128/IAI.70.9.5335-5337.2002; Shrivastava S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002955; Sims GE, 2011, P NATL ACAD SCI USA, V108, P8329, DOI 10.1073/pnas.1105168108; Tartof SY, 2005, J CLIN MICROBIOL, V43, P5860, DOI 10.1128/JCM.43.12.5860-5864.2005; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Tivendale KA, 2010, INFECT IMMUN, V78, P3412, DOI 10.1128/IAI.00347-10; Tivendale KA, 2009, MICROBIOL-SGM, V155, P450, DOI 10.1099/mic.0.023143-0; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Wang SH, 2012, VET MICROBIOL, V159, P411, DOI 10.1016/j.vetmic.2012.04.015; Wang SH, 2011, INFECT IMMUN, V79, P279, DOI 10.1128/IAI.00821-10; Willems RJL, 2012, MBIO, V3, DOI 10.1128/mBio.00151-12; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wright KJ, 2006, FUTURE MICROBIOL, V1, P75, DOI 10.2217/17460913.1.1.75; Yoon SH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-184; Yoon SH, 2007, NUCLEIC ACIDS RES, V35, pD395, DOI 10.1093/nar/gkl790; Zhou Y, 2012, INFECT IMMUN, V80, P1243, DOI 10.1128/IAI.05994-11; Zhuge X, 2013, INFECT IMMUN	76	43	44	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112048	10.1371/journal.pone.0112048	http://dx.doi.org/10.1371/journal.pone.0112048			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397580	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500028
J	Jung, HJ; Pak, PJ; Park, SH; Ju, JE; Kim, JS; Lee, HS; Chung, N				Jung, Hye Jin; Pak, Pyo June; Park, Sung Hyo; Ju, Jae Eun; Kim, Joong-Su; Lee, Hoi-Seon; Chung, Namhyun			Silver Wire Amplifies the Signaling Mechanism for IL-1beta Production More Than Silver Submicroparticles in Human Monocytic THP-1 Cells	PLOS ONE			English	Article							NALP3 INFLAMMASOME; IL-1-BETA PRODUCTION; DRUG-DELIVERY; NANOPARTICLES; ACTIVATION; RAT; CYTOTOXICITY; PERMEABILITY; EXPRESSION; PARTICLES	Silver materials have been widely used in diverse fields. However, their toxicity and their mechanism, especially in different forms, have not been studied sufficiently. Thus, cytotoxicity, apoptosis, and interleukin-1beta(IL-1 beta) production were investigated using macrophage-like THP-1 cells in the presence of Ag microparticles (AgMPs, 2.7 mu m), Ag submicroparticles (AgSMPs, 150 nm), and Ag wires (AgWs, 274 nm x 5.3 mu m). The levels of cytotoxicity, apoptosis, and IL-1b production by AgWs were higher than those by the other two AgSMPs and AgMPs. This trend was also observed with each step of the signaling mechanism for IL-1b production, which is a single pathway affiliated with ROS generation or lysosomal rupture or both, cathepsin B, caspase-1 (NALP3 inflammasome), and finally IL-1 beta production in THP-1 cells. All these results suggest that, for development of safe and effective silver materials, the shape or form of silver materials should be considered, especially for macrophage cell lines because epithelial cell lines are not overly sensitive to silver materials.	[Jung, Hye Jin; Pak, Pyo June; Park, Sung Hyo; Ju, Jae Eun; Chung, Namhyun] Korea Univ, Coll Life Sci & Biotechnol, Dept Biosyst & Biotechnol, Seoul, South Korea; [Kim, Joong-Su] Korea Res Inst Biosci & Biotechnol, Jeonbuk Branch Inst, Bioind Proc Ctr, Jeoneup, South Korea; [Lee, Hoi-Seon] Chonbuk Natl Univ, Coll Agr & Life Sci, Jeonju, South Korea	Korea University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Jeonbuk National University	Lee, HS (corresponding author), Chonbuk Natl Univ, Coll Agr & Life Sci, Jeonju, South Korea.	hoiseon@jbnu.ac.kr; nchung@korea.ac.kr	Lee, Hoi Seon/A-6589-2013	Lee, Hoi Seon/0000-0003-1776-3373	National Research Foundation of Korea [NRF-2011-0017012]	National Research Foundation of Korea(National Research Foundation of Korea)	Funding provided by the National Research Foundation of Korea; NRF-2011-0017012, www.nrf.re.kr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adili A, 2008, NANOTOXICOLOGY, V2, P1, DOI 10.1080/17435390701843769; Ainslie KM, 2007, NANOTOXICOLOGY, V1, P279, DOI 10.1080/17435390701781142; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Ghasempour S, 2014, PHYSIOL PHARMACOL, V17, P423; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hsin YH, 2008, TOXICOL LETT, V179, P130, DOI 10.1016/j.toxlet.2008.04.015; Hussain S, 2010, PART FIBRE TOXICOL, P7; Larese FF, 2009, TOXICOLOGY, V255, P33, DOI 10.1016/j.tox.2008.09.025; Lok CN, 2007, J BIOL INORG CHEM, V12, P527, DOI 10.1007/s00775-007-0208-z; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Miura N, 2009, BIOCHEM BIOPH RES CO, V390, P733, DOI 10.1016/j.bbrc.2009.10.039; Morishige T, 2010, BIOMATERIALS, V31, P6833, DOI 10.1016/j.biomaterials.2010.05.036; Morishige T, 2010, BIOCHEM BIOPH RES CO, V392, P160, DOI 10.1016/j.bbrc.2009.12.178; Netea MG, 2010, PLOS PATHOG, P6; Niyonsaba F, 2005, J IMMUNOL, V175, P1776, DOI 10.4049/jimmunol.175.3.1776; Okimoto Y, 2000, FEBS LETT, V474, P137, DOI 10.1016/S0014-5793(00)01587-8; Park EJ, 2011, ARCH PHARM RES, V34, P299, DOI 10.1007/s12272-011-0216-y; Portney NG, 2006, ANAL BIOANAL CHEM, V384, P620, DOI 10.1007/s00216-005-0247-7; Rauch J, 2013, CHEM REV, V113, P3391, DOI 10.1021/cr3002627; Samberg ME, 2010, ENVIRON HEALTH PERSP, V118, P407, DOI 10.1289/ehp.0901398; Scanlan LD, 2013, ACS NANO, V7, P10681, DOI 10.1021/nn4034103; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sharma HS, 2009, J NANOSCI NANOTECHNO, V9, P5055, DOI 10.1166/jnn.2009.GR09; Stoehr LC, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-36; Stutz A, 2009, J CLIN INVEST, V119, P3502, DOI 10.1172/JCI40599; Timko BP, 2010, IEEE T NANOTECHNOL, V9, P269, DOI 10.1109/TNANO.2009.2031807; Trickler WJ, 2010, TOXICOL SCI, V118, P160, DOI 10.1093/toxsci/kfq244; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Uskokovic V, 2012, ACS NANO, V6, P7832, DOI 10.1021/nn3019865; Yen HJ, 2009, SMALL, V5, P1553, DOI 10.1002/smll.200900126; Zhang HY, 1997, J IMMUNOL, V158, P1392; Zhang Y, 2008, BIOMED MICRODEVICES, V10, P321, DOI 10.1007/s10544-007-9139-2	36	10	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112256	10.1371/journal.pone.0112256	http://dx.doi.org/10.1371/journal.pone.0112256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396430	Green Submitted, gold, Green Published			2022-12-27	WOS:000345558500040
J	Kanaya, M; Tsuda, MC; Sagoshi, S; Nagata, K; Morimoto, C; Thu, CKT; Toda, K; Kato, S; Ogawa, S; Tsukahara, S				Kanaya, Moeko; Tsuda, Mumeko C.; Sagoshi, Shoko; Nagata, Kazuyo; Morimoto, Chihiro; Thu, Chaw Kyi Tha; Toda, Katsumi; Kato, Shigeaki; Ogawa, Sonoko; Tsukahara, Shinji			Regional Difference in Sex Steroid Action on Formation of Morphological Sex Differences in the Anteroventral Periventricular Nucleus and Principal Nucleus of the Bed Nucleus of the Stria Terminalis	PLOS ONE			English	Article							MEDIAL POSTERIOR REGION; ESTROGEN-RECEPTOR GENE; ANDROGEN RECEPTOR; MALE-RATS; COPULATORY-BEHAVIOR; PREOPTIC NUCLEUS; GUINEA-PIG; MOUSE; MICE; DIFFERENTIATION	Sex steroid action is critical to form sexually dimorphic nuclei, although it is not fully understood. We previously reported that masculinization of the principal nucleus of the bed nucleus of the stria terminalis (BNSTp), which is larger and has more neurons in males than in females, involves aromatized testosterone that acts via estrogen receptor-alpha (ER alpha), but not estrogen receptor-beta (ER beta). Here, we examined sex steroid action on the formation of the anteroventral periventricular nucleus (AVPV) that is larger and has more neurons in females. Morphometrical analysis of transgenic mice lacking aromatase, ER alpha, or ER beta genes revealed that the volume and neuron number of the male AVPV were significantly increased by deletion of aromatase and ER alpha genes, but not the ERb gene. We further examined the AVPV and BNSTp of androgen receptor knockout (ARKO) mice. The volume and neuron number of the male BNSTp were smaller in ARKO mice than those in wild-type mice, while no significant effect of ARKO was found on the AVPV and female BNSTp. We also examined aromatase, ER alpha, and AR mRNA levels in the AVPV and BNSTp of wild-type and ARKO mice on embryonic day (ED) 18 and postnatal day (PD) 4. AR mRNA in the BNSTp and AVPV of wild-type mice was not expressed on ED18 and emerged on PD4. In the AVPV, the aromatase mRNA level was higher on ED18, although the ER alpha mRNA level was higher on PD4 without any effect of AR gene deletion. Aromatase and ER alpha mRNA levels in the male BNSTp were significantly increased on PD4 by AR gene deletion. These results suggest that estradiol signaling via ERa during the perinatal period and testosterone signaling via AR during the postnatal period are required for masculinization of the BNSTp, whereas the former is sufficient to defeminize the AVPV.	[Kanaya, Moeko; Thu, Chaw Kyi Tha; Tsukahara, Shinji] Saitama Univ, Grad Sch Sci & Engn, Div Life Sci, Saitama 3388570, Japan; [Tsuda, Mumeko C.; Sagoshi, Shoko; Nagata, Kazuyo; Morimoto, Chihiro; Ogawa, Sonoko] Univ Tsukuba, Lab Behav Neuroendocrinol, Tsukuba, Ibaraki, Japan; [Toda, Katsumi] Kochi Univ, Sch Med, Dept Biochem, Nankoku, Kochi, Japan; [Kato, Shigeaki] Soma Cent Hosp, Fukushima, Japan	Saitama University; University of Tsukuba; Kochi University	Tsukahara, S (corresponding author), Saitama Univ, Grad Sch Sci & Engn, Div Life Sci, Saitama 3388570, Japan.	stsuka@mail.saitama-u.ac.jp	Kanaya, Moeko/K-8994-2017	Kanaya, Moeko/0000-0002-1856-8492	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23310043, 25670114, 23240057]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (No. 23310043 and No. 25670114 to ST, and No. 23240057 to SO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold AP, 2014, EXP NEUROL, V259, P2, DOI 10.1016/j.expneurol.2014.01.021; Aung KH, 2013, NEUROTOXICOLOGY, V34, P226, DOI 10.1016/j.neuro.2012.09.008; BLEIER R, 1982, J COMP NEUROL, V212, P118, DOI 10.1002/cne.902120203; Bodo C, 2006, ENDOCRINOLOGY, V147, P415, DOI 10.1210/en.2005-0834; Brock O, 2013, ENDOCRINOLOGY, V154, P2739, DOI 10.1210/en.2013-1120; BYNE W, 1987, J NEUROSCI, V7, P2688; Clarkson J, 2006, ENDOCRINOLOGY, V147, P5817, DOI 10.1210/en.2006-0787; CLARO F, 1995, BRAIN RES BULL, V36, P1, DOI 10.1016/0361-9230(94)00118-K; de Vries GJ, 1998, PROG BRAIN RES, V119, P3; DELABRIL A, 1987, DEV BRAIN RES, V32, P295, DOI 10.1016/0165-3806(87)90110-6; Durazzo A, 2007, NEUROSCI LETT, V419, P168, DOI 10.1016/j.neulet.2007.04.033; EMERY DE, 1976, PHYSIOL BEHAV, V17, P803, DOI 10.1016/0031-9384(76)90044-5; GUILLAMON A, 1988, DEV BRAIN RES, V44, P281, DOI 10.1016/0165-3806(88)90226-X; HINES M, 1992, BRAIN RES, V579, P321, DOI 10.1016/0006-8993(92)90068-K; Hisasue S, 2010, J SEX MED, V7, P1401, DOI 10.1111/j.1743-6109.2009.01669.x; Juntti SA, 2010, NEURON, V66, P260, DOI 10.1016/j.neuron.2010.03.024; Juraska JM, 2013, HORM BEHAV, V64, P203, DOI 10.1016/j.yhbeh.2013.05.010; Kauffman AS, 2007, ENDOCRINOLOGY, V148, P1774, DOI 10.1210/en.2006-1540; Kawano H, 2003, P NATL ACAD SCI USA, V100, P9416, DOI 10.1073/pnas.1533500100; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Liu YC, 1997, J NEUROSCI, V17, P5245; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; Maeda KI, 2007, REV ENDOCR METAB DIS, V8, P21, DOI 10.1007/s11154-007-9032-6; MARDON G, 1989, CELL, V56, P765, DOI 10.1016/0092-8674(89)90680-6; McCarthy MM, 2011, NAT NEUROSCI, V14, P677, DOI 10.1038/nn.2834; O'Shaughnessy PJ, 1998, ENDOCRINOLOGY, V139, P1141, DOI 10.1210/en.139.3.1141; Patchev AV, 2004, FASEB J, V18, P1568, DOI 10.1096/fj.04-1959fje; Sato T, 2004, P NATL ACAD SCI USA, V101, P1673, DOI 10.1073/pnas.0305303101; Schulz KM, 2009, ENDOCRINOLOGY, V150, P3690, DOI 10.1210/en.2008-1708; Schulz KM, 2004, HORM BEHAV, V45, P242, DOI 10.1016/j.yhbeh.2003.12.007; SIMERLY RB, 1989, MOL BRAIN RES, V6, P297, DOI 10.1016/0169-328X(89)90075-2; SIMERLY RB, 1985, NEUROENDOCRINOLOGY, V40, P501, DOI 10.1159/000124122; Simerly RB, 1997, P NATL ACAD SCI USA, V94, P14077, DOI 10.1073/pnas.94.25.14077; SIMERLY RB, 1985, BRAIN RES, V330, P55, DOI 10.1016/0006-8993(85)90007-1; SUMIDA H, 1993, NEUROSCI LETT, V151, P41, DOI 10.1016/0304-3940(93)90040-R; TERASAWA E, 1980, AM J PHYSIOL, V238, pE533, DOI 10.1152/ajpendo.1980.238.6.E533; Toda K, 2001, J ENDOCRINOL, V170, P99, DOI 10.1677/joe.0.1700099; Tsukahara S, 2011, NEUROENDOCRINOLOGY, V94, P137, DOI 10.1159/000327541; Tsukahara S, 2009, TOXICOL LETT, V185, P79, DOI 10.1016/j.toxlet.2008.12.001; VANLEEUWEN FW, 1985, BRAIN RES, V325, P391, DOI 10.1016/0006-8993(85)90348-8; Wittmann W, 2013, HORM BEHAV, V64, P605, DOI 10.1016/j.yhbeh.2013.08.017	42	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112616	10.1371/journal.pone.0112616	http://dx.doi.org/10.1371/journal.pone.0112616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398007	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558500066
J	Rossi, S; Fortunati, I; Carnevali, L; Baruffi, S; Mastorci, F; Trombini, M; Sgoifo, A; Corradi, D; Callegari, S; Miragoli, M; Macchi, E				Rossi, Stefano; Fortunati, Ilaria; Carnevali, Luca; Baruffi, Silvana; Mastorci, Francesca; Trombini, Mimosa; Sgoifo, Andrea; Corradi, Domenico; Callegari, Sergio; Miragoli, Michele; Macchi, Emilio			The Effect of Aging on the Specialized Conducting System: A Telemetry ECG Study in Rats over a 6 Month Period	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; AGE-ASSOCIATED CHANGES; VENTRICULAR ACTIVATION; ATRIAL-FIBRILLATION; IMPULSE CONDUCTION; CARDIAC TISSUE; QT INTERVAL; ARRHYTHMIAS; MYOCYTES; MODEL	Advanced age alone appears to be a risk factor for increased susceptibility to cardiac arrhythmias. We previously observed in the aged rat heart that sinus rhythm ventricular activation is delayed and characterized by abnormal epicardial patterns although conduction velocity is normal. While these findings relate to an advanced stage of aging, it is not yet known when and how ventricular electrical impairment originates and which is the underlying substrate. To address these points, we performed continuous telemetry ECG recordings in freely moving rats over a six-month period to monitor ECG waveform changes, heart rate variability and the incidence of cardiac arrhythmias. At the end of the study, we performed in-vivo multiple lead epicardial recordings and histopathology of cardiac tissue. We found that the duration of ECG waves and intervals gradually increased and heart rate variability gradually decreased with age. Moreover, the incidence of cardiac arrhythmias gradually increased, with atrial arrhythmias exceeding ventricular arrhythmias. Epicardial multiple lead recordings confirmed abnormalities in ventricular activation patterns, likely attributable to distal conducting system dysfunctions. Microscopic analysis of aged heart specimens revealed multifocal connective tissue deposition and perinuclear myocytolysis in the atria. Our results demonstrate that aging gradually modifies the terminal part of the specialized cardiac conducting system, creating a substrate for increased arrhythmogenesis. These findings may open new therapeutic options in the management of cardiac arrhythmias in the elderly population.	[Rossi, Stefano; Fortunati, Ilaria; Baruffi, Silvana; Mastorci, Francesca; Trombini, Mimosa; Macchi, Emilio] Univ Parma, Dept Life Sci, I-43100 Parma, Italy; [Carnevali, Luca; Sgoifo, Andrea] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Rossi, Stefano; Miragoli, Michele; Macchi, Emilio] Univ Parma, Ctr Excellence Toxicol Res, CERT, INAIL,Ex ISPESL, I-43100 Parma, Italy; [Corradi, Domenico] Univ Parma, Unit Pathol, Dept Biomed Biotechnol & Translat Sci S Bi Bi T, I-43100 Parma, Italy; [Callegari, Sergio] Fidenza Hosp, Div Cardiol, Fidenza, Italy; [Miragoli, Michele] Humanitas Clin & Res Ctr, Milan, Italy	University of Parma; University of Parma; University of Parma; University of Parma	Rossi, S (corresponding author), Univ Parma, Dept Life Sci, I-43100 Parma, Italy.	stefano.rossi@unipr.it; michele.miragoli@humanitasresearch.it; emilio.macchi@unipr.it	Carnevali, Luca/E-5322-2017; Sgoifo, Andrea/AAC-6278-2022; Carnevali, Luca/P-9508-2019; Corradi, Domenico/O-1666-2015; Rossi, Stefano/L-2556-2016; Miragoli, Michele/K-6418-2016	Carnevali, Luca/0000-0001-9053-7976; Sgoifo, Andrea/0000-0002-9428-6198; Carnevali, Luca/0000-0001-9053-7976; Corradi, Domenico/0000-0002-8836-4778; Rossi, Stefano/0000-0003-0346-8410; Miragoli, Michele/0000-0002-4058-4368	Fondazione CARIPARMA Grant [2006.0082]; Fondazione CARIPARMA Bilancio; Young Researcher Grant, Italian Ministry of Health [GR2009-1530528]	Fondazione CARIPARMA Grant; Fondazione CARIPARMA Bilancio(Fondazione Cariparma); Young Researcher Grant, Italian Ministry of Health	This research was supported by Fondazione CARIPARMA Grant 2006.0082, Fondazione CARIPARMA Bilancio 2010 to E.M. and Grant GR2009-1530528 Young Researcher Grant, Italian Ministry of Health to M.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANVERSA P, 1990, CIRC RES, V67, P871, DOI 10.1161/01.RES.67.4.871; Bao L, 2013, AGING CELL, V12, P167, DOI 10.1111/acel.12033; Berg BN, 1955, J GERONTOL, V10, P420, DOI 10.1093/geronj/10.4.420; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Boyett MR, 2006, ADV CARDIOL, V42, P175, DOI 10.1159/000092569; Chui RW, 2012, J PHARMACOL TOX MET, V66, P84, DOI 10.1016/j.vascn.2012.05.002; Colli-Franzone P, 2000, ANN BIOMED ENG, V28, P1326, DOI 10.1114/1.1327595; Corradi D, 2008, NAT CLIN PRACT CARD, V5, P782, DOI 10.1038/ncpcardio1370; Craft Noah, 1995, American Journal of Physiology, V268, pH1441; da Silva VJD, 2002, BRAZ J MED BIOL RES, V35, P1025, DOI 10.1590/S0100-879X2002000900003; Dhein S, 2001, N-S ARCH PHARMACOL, V364, P397; Dupont M, 2012, J AM COLL CARDIOL, V60, P592, DOI 10.1016/j.jacc.2012.03.059; Eckberg DL, 1997, CIRCULATION, V96, P3224, DOI 10.1161/01.CIR.96.9.3224; Ershler P. R., 1984, Computers in Cardiology (Cat. No. 84CH2078-4), P417; FLEG JL, 1990, J GERONTOL, V45, pM95, DOI 10.1093/geronj/45.3.M95; FRATICELLI A, 1989, AM J PHYSIOL, V257, pH259, DOI 10.1152/ajpheart.1989.257.1.H259; GOLDBERG RJ, 1991, AM J CARDIOL, V67, P55, DOI 10.1016/0002-9149(91)90099-7; Gupta Anoop K, 2002, Card Electrophysiol Rev, V6, P120, DOI 10.1023/A:1017963928016; Hayashi H, 2002, J CARDIOVASC ELECTR, V13, P801, DOI 10.1046/j.1540-8167.2002.00801.x; Huelsing DJ, 1998, AM J PHYSIOL-HEART C, V274, pH1163, DOI 10.1152/ajpheart.1998.274.4.H1163; Kaye DM, 2008, NEUROMOL MED, V10, P179, DOI 10.1007/s12017-008-8034-1; KUSUMOTO FM, 1995, J CARDIOVASC PHARM, V26, P348, DOI 10.1097/00005344-199509000-00002; Macchi E, 1998, AM J PHYSIOL-HEART C, V275, pH1886, DOI 10.1152/ajpheart.1998.275.5.H1886; MICHELUCCI A, 1984, INT J CARDIOL, V5, P75, DOI 10.1016/0167-5273(84)90060-3; Miragoli M, 2006, CIRC RES, V98, P801, DOI 10.1161/01.RES.0000214537.44195.a3; Miragoli M, 2007, CIRC RES, V101, P755, DOI 10.1161/CIRCRESAHA.107.160549; Miragoli M, 2011, HEPATOLOGY, V54, P1282, DOI 10.1002/hep.24492; ORCHARD CH, 1985, J GEN PHYSIOL, V86, P637, DOI 10.1085/jgp.86.5.637; PRESSLER ML, 1995, CARDIAC ELECTROPHYSI, P144; Rohr S, 1997, SCIENCE, V275, P841, DOI 10.1126/science.275.5301.841; Rossi S, 2007, P ANN INT IEEE EMBS, P410, DOI 10.1109/IEMBS.2007.4352311; Rossi S, 2008, AM J PHYSIOL-HEART C, V295, pH2336, DOI 10.1152/ajpheart.00517.2008; Saffitz JE, 1999, CARDIOVASC RES, V42, P309, DOI 10.1016/S0008-6363(99)00023-1; SCHAMROTH L, 1963, BRIT HEART J, V25, P219; Schwartz P. J., 1998, European Heart Journal, V19, pF72; Sgoifo A, 1996, PHYSIOL BEHAV, V60, P1403, DOI 10.1016/S0031-9384(96)00229-6; Spach MS, 2000, CIRC RES, V86, P302, DOI 10.1161/01.RES.86.3.302; SPACH MS, 1986, CIRC RES, V58, P356, DOI 10.1161/01.RES.58.3.356; Stein M, 2008, HEART RHYTHM, V5, P438, DOI 10.1016/j.hrthm.2007.10.033; Surawicz B, 2008, CHOUS ELECTROCARDIOG, Vxiii, P327; Tamaddon HS, 2000, CIRC RES, V87, P929, DOI 10.1161/01.RES.87.10.929; Taneja T, 2001, PACE, V24, P16, DOI 10.1046/j.1460-9592.2001.00016.x; Villareal Rollo P, 2002, Curr Atheroscler Rep, V4, P120, DOI 10.1007/s11883-002-0035-1; WALKER KE, 1993, CARDIOVASC RES, V27, P1968, DOI 10.1093/cvr/27.11.1968; YIN FCP, 1980, CIRC RES, V46, P292, DOI 10.1161/01.RES.46.2.292; [No title captured]	46	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112697	10.1371/journal.pone.0112697	http://dx.doi.org/10.1371/journal.pone.0112697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398004	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558500079
J	Cordina, NM; Liew, CK; Potluri, PR; Curmi, PM; Fajer, PG; Logan, TM; Mackay, JP; Brown, LJ				Cordina, Nicole M.; Liew, Chu K.; Potluri, Phani R.; Curmi, Paul M.; Fajer, Piotr G.; Logan, Timothy M.; Mackay, Joel P.; Brown, Louise J.			Ca2+-Induced PRE-NMR Changes in the Troponin Complex Reveal the Possessive Nature of the Cardiac Isoform for Its Regulatory Switch	PLOS ONE			English	Article							PARAMAGNETIC RELAXATION ENHANCEMENT; INHIBITORY REGION; SKELETAL-MUSCLE; CONFORMATIONAL EXCHANGE; THIN FILAMENT; DOMAIN; DYNAMICS; CALCIUM; SITE; BINDING	The interaction between myosin and actin in cardiac muscle, modulated by the calcium (Ca2+) sensor Troponin complex (Tn), is a complex process which is yet to be fully resolved at the molecular level. Our understanding of how the binding of Ca2+ triggers conformational changes within Tn that are subsequently propagated through the contractile apparatus to initiate muscle activation is hampered by a lack of an atomic structure for the Ca2+-free state of the cardiac isoform. We have used paramagnetic relaxation enhancement (PRE)-NMR to obtain a description of the Ca2+-free state of cardiac Tn by describing the movement of key regions of the troponin I (cTnI) subunit upon the release of Ca2+ from Troponin C (cTnC). Site-directed spin-labeling was used to position paramagnetic spin labels in cTnI and the changes in the interaction between cTnI and cTnC subunits were then mapped by PRE-NMR. The functionally important regions of cTnI targeted in this study included the cTnC-binding N-region (cTnI57), the inhibitory region (cTnI143), and two sites on the regulatory switch region (cTnI151 and cTnI159). Comparison of H-1-N-15-TROSY spectra of Ca2+-bound and free states for the spin labeled cTnC-cTnI binary constructs demonstrated the release and modest movement of the cTnI switch region (similar to 10 angstrom) away from the hydrophobic N-lobe of troponin C (cTnC) upon the removal of Ca2+. Our data supports a model where the non-bound regulatory switch region of cTnI is highly flexible in the absence of Ca2+ but remains in close vicinity to cTnC. We speculate that the close proximity of TnI to TnC in the cardiac complex is favourable for increasing the frequency of collisions between the N-lobe of cTnC and the regulatory switch region, counterbalancing the reduction in collision probability that results from the incomplete opening of the N-lobe of TnC that is unique to the cardiac isoform.	[Cordina, Nicole M.; Potluri, Phani R.; Brown, Louise J.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Liew, Chu K.] Victor Chang Cardiac Res Inst, Dept Mol Cardiol & Biophys, Darlinghurst, NSW, Australia; [Curmi, Paul M.] Univ New S Wales, Sch Phys, Sydney, NSW, Australia; [Fajer, Piotr G.; Logan, Timothy M.] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Mackay, Joel P.] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia	Macquarie University; Victor Chang Cardiac Research Institute; University of New South Wales Sydney; State University System of Florida; Florida State University; University of Sydney	Brown, LJ (corresponding author), Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia.	Louise.Brown@mq.edu.au	Mackay, Joel P/D-6834-2011; Curmi, Paul/G-7185-2011	Mackay, Joel P/0000-0001-7508-8033; Curmi, Paul/0000-0001-5762-7638; Potluri, Phani Rekha/0000-0002-7488-633X; Cordina, Nicole/0000-0001-5775-7256; Brown, Louise/0000-0001-8592-2431	Australian Government; National Health and Medical Research Council of Australia [434220]	Australian Government(Australian GovernmentCGIAR); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	NMC was supported by the Australian Postgraduate Award from the Australian Government (http://www.innovation.gov.au/). This work was funded by the National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au/) with funds from project grant 434220 to LJB and PMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott MB, 2000, J BIOL CHEM, V275, P20610, DOI 10.1074/jbc.M909252199; Aihara T, 2010, J BIOL CHEM, V285, P10671, DOI 10.1074/jbc.M109.082925; Baker KA, 2006, BIOCHEMISTRY-US, V45, P1663, DOI 10.1021/bi0516430; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Blumenschein TMA, 2006, BIOPHYS J, V90, P2436, DOI 10.1529/biophysj.105.076216; Brown LJ, 2002, P NATL ACAD SCI USA, V99, P12765, DOI 10.1073/pnas.202477399; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; Cordina NM, 2013, BIOCHEMISTRY-US, V52, P1950, DOI 10.1021/bi4000172; Cordina NM, 2012, PROTEIN SCI, V21, P1376, DOI 10.1002/pro.2124; Donaldson LW, 2001, J AM CHEM SOC, V123, P9843, DOI 10.1021/ja011241p; Dong WJ, 1997, BIOCHEMISTRY-US, V36, P6745, DOI 10.1021/bi962226d; Dong WJ, 2003, J BIOL CHEM, V278, P42394, DOI 10.1074/jbc.M304858200; Dong WJ, 2003, J BIOL CHEM, V278, P8686, DOI 10.1074/jbc.M212886200; Dvoretsky A, 2002, J BIOL CHEM, V277, P38565, DOI 10.1074/jbc.M205306200; Finley N, 1999, FEBS LETT, V453, P107, DOI 10.1016/S0014-5793(99)00693-6; GAGNE SM, 1995, NAT STRUCT BIOL, V2, P784, DOI 10.1038/nsb0995-784; Gaponenko V, 1999, J BIOL CHEM, V274, P16681, DOI 10.1074/jbc.274.24.16681; Geeves MA, 2000, BIOCHEMISTRY-US, V39, P9345, DOI 10.1021/bi0002232; Goddard T. D, 2007, SPARKY 3; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Iwahara J, 2004, J AM CHEM SOC, V126, P5879, DOI 10.1021/ja031580d; Jayasundar JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087135; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Layland J, 2005, CARDIOVASC RES, V66, P12, DOI 10.1016/j.cardiores.2004.12.022; Li MX, 2004, J MUSCLE RES CELL M, V25, P559, DOI 10.1007/s10974-004-5879-2; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Liang BY, 2006, J AM CHEM SOC, V128, P4389, DOI 10.1021/ja0574825; Lindert S, 2012, BIOPHYS J, V103, P1784, DOI 10.1016/j.bpj.2012.08.058; Lindhout DA, 2003, J BIOL CHEM, V278, P27024, DOI 10.1074/jbc.M302497200; Luo Y, 1999, BIOCHEMISTRY-US, V38, P6678, DOI 10.1021/bi9824341; Madl T, 2011, ANGEW CHEM INT EDIT, V50, P3993, DOI 10.1002/anie.201007168; McKay RT, 1997, J BIOL CHEM, V272, P28494, DOI 10.1074/jbc.272.45.28494; McKay RT, 1998, BIOCHEMISTRY-US, V37, P12419, DOI 10.1021/bi9809019; Paakkonen K, 1998, J BIOL CHEM, V273, P15633, DOI 10.1074/jbc.273.25.15633; PERRY SV, 1973, COLD SPRING HARB SYM, V37, P251, DOI 10.1101/SQB.1973.037.01.035; POTTER JD, 1974, BIOCHEMISTRY-US, V13, P2697, DOI 10.1021/bi00710a007; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sheldahl C, 2003, BIOPHYS J, V84, P1057, DOI 10.1016/S0006-3495(03)74922-4; Sivakolundu SG, 2008, J MOL BIOL, V384, P240, DOI 10.1016/j.jmb.2008.09.019; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SYSKA H, 1976, BIOCHEM J, V153, P375, DOI 10.1042/bj1530375; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; TALBOT JA, 1981, J BIOL CHEM, V256, P2798; Tripet B, 1997, J MOL BIOL, V271, P728, DOI 10.1006/jmbi.1997.1200; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; Volkov AN, 2006, P NATL ACAD SCI USA, V103, P18945, DOI 10.1073/pnas.0603551103	46	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112976	10.1371/journal.pone.0112976	http://dx.doi.org/10.1371/journal.pone.0112976			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392916	gold, Green Published, Green Submitted			2022-12-27	WOS:000347709300130
J	Ordonez, R; Gallo-Oller, G; Martinez-Soto, S; Legarra, S; Pata-Merci, N; Guegan, J; Danglot, G; Bernheim, A; Melendez, B; Rey, JA; Castresana, JS				Ordonez, Raquel; Gallo-Oller, Gabriel; Martinez-Soto, Soledad; Legarra, Sheila; Pata-Merci, Noemie; Guegan, Justine; Danglot, Giselle; Bernheim, Alain; Melendez, Barbara; Rey, Juan A.; Castresana, Javier S.			Genome-Wide Microarray Expression and Genomic Alterations by Array-CGH Analysis in Neuroblastoma Stem-Like Cells	PLOS ONE			English	Article							TARGETING ION CHANNELS; COPY NUMBER VARIATIONS; INITIATING CELLS; TGF-BETA; SELF-RENEWAL; BRAIN-TUMORS; CANCER; OCT4; GENE; NOTCH	Neuroblastoma has a very diverse clinical behaviour: from spontaneous regression to a very aggressive malignant progression and resistance to chemotherapy. This heterogeneous clinical behaviour might be due to the existence of Cancer Stem Cells (CSC), a subpopulation within the tumor with stem-like cell properties: a significant proliferation capacity, a unique self-renewal capacity, and therefore, a higher ability to form new tumors. We enriched the CSC-like cell population content of two commercial neuroblastoma cell lines by the use of conditioned cell culture media for neurospheres, and compared genomic gains and losses and genome expression by array-CGH and microarray analysis, respectively (in CSC-like versus standard tumor cells culture). Despite the array-CGH did not show significant differences between standard and CSC-like in both analyzed cell lines, the microarray expression analysis highlighted some of the most relevant biological processes and molecular functions that might be responsible for the CSC-like phenotype. Some signalling pathways detected seem to be involved in self-renewal of normal tissues (Wnt, Notch, Hh and TGF-beta) and contribute to CSC phenotype. We focused on the aberrant activation of TGF-beta and Hh signalling pathways, confirming the inhibition of repressors of TGF-beta pathway, as SMAD6 and SMAD7 by RT-qPCR. The analysis of the Sonic Hedgehog pathway showed overexpression of PTCH1, GLI1 and SMO. We found overexpression of CD133 and CD15 in SIMA neurospheres, confirming that this cell line was particularly enriched in stem-like cells. This work shows a cross-talk among different pathways in neuroblastoma and its importance in CSC-like cells.	[Ordonez, Raquel; Gallo-Oller, Gabriel; Martinez-Soto, Soledad; Legarra, Sheila; Castresana, Javier S.] Univ Navarra, Sch Sci, Dept Biochem & Genet, E-31080 Pamplona, Spain; [Pata-Merci, Noemie; Guegan, Justine; Danglot, Giselle; Bernheim, Alain] Inst Gustave Roussy, Villejuif, France; [Melendez, Barbara] Virgen Salud Hosp, Dept Pathol, Mol Pathol Res Unit, Toledo, Spain; [Rey, Juan A.] La Paz Univ Hosp, IdiPaz Res Unit, Madrid, Spain	University of Navarra; UNICANCER; Gustave Roussy; Hospital Universitario La Paz	Castresana, JS (corresponding author), Univ Navarra, Sch Sci, Dept Biochem & Genet, E-31080 Pamplona, Spain.	jscastresana@unav.es	Castresana, Javier S/AFT-2167-2022; Melendez, Barbara/E-1216-2017; Gallo-Oller, Gabriel/D-6825-2019	Melendez, Barbara/0000-0001-5004-8895; Gallo-Oller, Gabriel/0000-0002-3864-1941; Ordonez, Raquel/0000-0002-6924-5175; Castresana, Javier S./0000-0002-2373-482X	Departamento de Educacion of Gobierno de Navarra, Pamplona; Departmento de Salud del Gobierno de Navarra; Caja Navarra [13912]; Fundacion Universitaria de Navarra, Pamplona; Fondo de Investigacion Sanitaria, Madrid [PI-081849, PI-101972]	Departamento de Educacion of Gobierno de Navarra, Pamplona; Departmento de Salud del Gobierno de Navarra; Caja Navarra; Fundacion Universitaria de Navarra, Pamplona; Fondo de Investigacion Sanitaria, Madrid	G. Gallo-Oller was supported by a fellowship from the Departamento de Educacion of Gobierno de Navarra, Pamplona. This research was supported in part by grants from the Departmento de Salud del Gobierno de Navarra, Caja Navarra (project 13912), Fundacion Universitaria de Navarra, Pamplona; and Fondo de Investigacion Sanitaria (PI-081849 to JSC and PI-101972 to JAR), Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alison MR, 2012, CANCER TREAT REV, V38, P589, DOI 10.1016/j.ctrv.2012.03.003; Amakye D, 2013, NAT MED, V19, P1410, DOI 10.1038/nm.3389; Arcangeli A, 2009, CURR MED CHEM, V16, P66, DOI 10.2174/092986709787002835; Arcangeli A, 2010, PHARMACEUTICALS, V3, P1202, DOI 10.3390/ph3041202; Azimi I, 2014, BRIT J PHARMACOL, V171, P945, DOI 10.1111/bph.12486; Bailey JM, 2012, PANCREATIC CANC TUMO; Barone G, 2013, CLIN CANCER RES, V19, P5814, DOI 10.1158/1078-0432.CCR-13-0680; Becchetti A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00312; Bertrand FE, 2012, CELL CYCLE, V11, P4344, DOI 10.4161/cc.22134; Bessho Y, 2001, GENES CELLS, V6, P175, DOI 10.1046/j.1365-2443.2001.00409.x; Buttitta L, 2003, DEVELOPMENT, V130, P6233, DOI 10.1242/dev.00851; Capasso M, 2010, CANCER TREAT RES, V155, P65, DOI 10.1007/978-1-4419-6033-7_4; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; Coulon A, 2011, NEOPLASIA, V13, P991, DOI 10.1593/neo.11800; Cournoyer S, 2012, GENE CHROMOSOME CANC, V51, P792, DOI 10.1002/gcc.21964; Davidoff AM, 2012, SEMIN PEDIATR SURG, V21, P2, DOI 10.1053/j.sempedsurg.2011.10.009; de Resende MF, 2013, TUMOR BIOL, V34, P2665, DOI 10.1007/s13277-013-0817-9; Dear PH, 2009, TRENDS BIOTECHNOL, V27, P448, DOI 10.1016/j.tibtech.2009.05.003; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dhir S, 2010, EARLY HUM DEV, V86, P601, DOI 10.1016/j.earlhumdev.2010.08.019; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; Faigle R, 2013, BBA-GEN SUBJECTS, V1830, P2435, DOI 10.1016/j.bbagen.2012.09.002; Fakhr MG, 2013, GENET RES INT, V2013, DOI 10.1155/2013/317569; Fanciulli M, 2010, CLIN GENET, V77, P201, DOI 10.1111/j.1399-0004.2009.01342.x; Faunes F, 2013, DEVELOPMENT, V140, P1171, DOI 10.1242/dev.085654; George RE, 2010, PEDIATR BLOOD CANCER, V55, P629, DOI 10.1002/pbc.22607; Goff LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007192; Gong AH, 2012, CANCER RES, V72, P5658, DOI 10.1158/0008-5472.CAN-12-0953; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Hoffmann EK, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0109; Holland JD, 2013, CURR OPIN CELL BIOL, V25, P254, DOI 10.1016/j.ceb.2013.01.004; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2008, BIOINFORMATION, V2, P428; Huang FT, 2012, INT J ONCOL, V41, P1707, DOI 10.3892/ijo.2012.1597; Jerabek S, 2013, BIOCHIM BIOPHYS ACTA, V1839, P138; Jiang YW, 2011, NEOPLASIA, V13, P492, DOI 10.1593/neo.11314; Jima DD, 2010, BLOOD, V116, pE118, DOI 10.1182/blood-2010-05-285403; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones PA, 2014, J CLIN INVEST, V124, P14, DOI 10.1172/JCI74145; Joseph JV, 2013, BIOCHEM PHARMACOL, V85, P478, DOI 10.1016/j.bcp.2012.11.005; Khaitan D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-258; Kim KI, 2012, BASIC CLIN PHARMACOL, V111, P317, DOI 10.1111/j.1742-7843.2012.00904.x; Kochert K, 2011, ONCOGENE, V30, P1831, DOI 10.1038/onc.2010.544; Kondratskyi A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00272; Kuiper RP, 2010, CURR OPIN GENET DEV, V20, P282, DOI 10.1016/j.gde.2010.03.005; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Kurpinski K, 2010, STEM CELLS, V28, P734, DOI 10.1002/stem.319; Lang F, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0108; Liu Y, 2013, J CLIN ENDOCR METAB, V98, pE558, DOI 10.1210/jc.2012-3113; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YH, 2013, CANCER LETT, V340, P113, DOI 10.1016/j.canlet.2013.07.009; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Matthay KK, 2012, CLIN CANCER RES, V18, P2740, DOI 10.1158/1078-0432.CCR-11-1939; McDermott A, 2005, DEVELOPMENT, V132, P345, DOI 10.1242/dev.01537; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Michaud NR, 2014, MOL CANCER THER, V13, P386, DOI 10.1158/1535-7163.MCT-13-0420; Montenegro M.F., 2014, ONCOGENE; Nejman D, 2014, CANCER RES, V74, P1475, DOI 10.1158/0008-5472.CAN-13-3042; Nguyen V, 2005, DEVELOPMENT, V132, P3267, DOI 10.1242/dev.01905; Ningaraj NS, 2009, CANCER BIOL THER, V8, P1924, DOI 10.4161/cbt.8.20.9490; Oeggerli M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041664; Ohira M, 2010, CANCER SCI, V101, P2295, DOI 10.1111/j.1349-7006.2010.01681.x; Pardo LA, 2014, NAT REV CANCER, V14, P39, DOI 10.1038/nrc3635; Park JR, 2013, PEDIATR BLOOD CANCER, V60, P985, DOI 10.1002/pbc.24433; Park Kyung-Soon, 2011, Int J Stem Cells, V4, P18; Purow B, 2012, ADV EXP MED BIOL, V727, P305, DOI 10.1007/978-1-4614-0899-4_23; Rahman R, 2009, BBA-MOL BASIS DIS, V1792, P280, DOI 10.1016/j.bbadis.2009.01.011; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Romania P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078481; Ross RA, 2007, SEMIN CANCER BIOL, V17, P241, DOI 10.1016/j.semcancer.2006.04.006; Sakaki-Yumoto M, 2013, BBA-GEN SUBJECTS, V1830, P2280, DOI 10.1016/j.bbagen.2012.08.008; Schatton T, 2009, BIOESSAYS, V31, P1038, DOI 10.1002/bies.200900058; Schwab A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0102; Sethi N, 2011, BRIT J CANCER, V105, P1805, DOI 10.1038/bjc.2011.497; SHAO HW, 2012, CHAPTER 7 TARGETING, V65, P191; Shi JL, 2013, ONCOL REP, V30, P201, DOI 10.3892/or.2013.2456; Sigalotti L, 2013, PHARMACOL THERAPEUT, V142, P339; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Speleman F, 2011, SEMIN CANCER BIOL, V21, P238, DOI 10.1016/j.semcancer.2011.07.003; Stallings RL, 2010, EXPERT OPIN THER TAR, V14, P951, DOI 10.1517/14728222.2010.510136; Sumer-Turanligil NC, 2013, CHILD NERV SYST, V29, P381, DOI 10.1007/s00381-012-2014-3; Takebe N, 2014, PHARMACOL THERAPEUT, V141, P140, DOI 10.1016/j.pharmthera.2013.09.005; Tantin D, 2013, DEVELOPMENT, V140, P2857, DOI 10.1242/dev.095927; Thomas GM, 1999, FEBS LETT, V458, P247, DOI 10.1016/S0014-5793(99)01161-8; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; van Amerongen R, 2010, ONCOGENE, V29, P93, DOI 10.1038/onc.2009.310; Villamon E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053740; Wainwright DA, 2012, EXPERT OPIN EMERG DR, V17, P181, DOI 10.1517/14728214.2012.679929; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Wan F, 2010, BRAIN PATHOL, V20, P877, DOI 10.1111/j.1750-3639.2010.00379.x; Wang L, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt96; Wang YD, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.272; Weaver AK, 2004, J NEUROSCI RES, V78, P224, DOI 10.1002/jnr.20240; Wezel F, 2013, AM J PATHOL, V183, P1128, DOI 10.1016/j.ajpath.2013.06.025; Witten D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-58; Wu WKK, 2013, CRIT REV ONCOL HEMAT, V86, P251, DOI 10.1016/j.critrevonc.2012.11.009; Xie JW, 2013, ONCOTARGETS THER, V6, P1425, DOI 10.2147/OTT.S34678; Xin YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083373; Yan XH, 2009, J BIOL CHEM, V284, P30097, DOI 10.1074/jbc.M109.049304; Yang L, 2013, ONCOL REP, V29, P2191, DOI 10.3892/or.2013.2356; Yang SB, 2012, ONCOL REP, V28, P186, DOI 10.3892/or.2012.1765; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137	105	5	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e113105	10.1371/journal.pone.0113105	http://dx.doi.org/10.1371/journal.pone.0113105			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392930	Green Submitted, Green Published, gold			2022-12-27	WOS:000347709300142
J	Stahlberg, A; Gustafsson, CK; Engtrom, K; Thomsen, C; Dolatabadi, S; Jonasson, E; Li, CY; Ruff, D; Chen, SM; Aman, P				Stahlberg, Anders; Gustafsson, Christina Kabjorn; Engtrom, Katarina; Thomsen, Christer; Dolatabadi, Soheila; Jonasson, Emma; Li, Chieh-Yuan; Ruff, David; Chen, Shiaw-Min; Aman, Pierre			Normal and Functional TP53 in Genetically Stable Myxoid/Round Cell Liposarcoma	PLOS ONE			English	Article							P53 GENE ALTERATIONS; FREQUENT ALTERATION; POOR-PROGNOSIS; EXPRESSION; FUSION; TLS; CHOP; EWS; TAF15; TRANSCRIPTION	Myxoid/round-cell liposarcoma (MLS/RCLS) is characterized by either the fusion gene FUS-DDIT3 or the less commonly occurring EWSR1-DDIT3 and most cases carry few or no additional cytogenetic changes. There are conflicting reports concerning the status and role of TP53 in MLS/RCLS. Here we analysed four MLS/RCLS derived cell lines for TP53 mutations, expression and function. Three SV40 transformed cell lines expressed normal TP53 proteins. Irradiation caused normal posttranslational modifications of TP53 and induced P21 expression in two of these cell lines. Transfection experiments showed that the FUS-DDIT3 fusion protein had no effects on irradiation induced TP53 responses. Ion Torrent AmpliSeq screening, using the Cancer Hotspot panel, showed no dysfunctional or disease associated alleles/mutations. In conclusion, our results suggest that most MLS/RCLS cases carry functional TP53 genes and this is consistent with the low numbers of secondary mutations observed in this tumor entity.	[Stahlberg, Anders; Gustafsson, Christina Kabjorn; Thomsen, Christer; Dolatabadi, Soheila; Jonasson, Emma; Aman, Pierre] Univ Gothenburg, Inst Biomed, Dept Pathol, Sahlgrenska Canc Ctr, Gothenburg, Sweden; [Engtrom, Katarina] Univ Gothenburg, Inst Med Sci, Dept Oncol, Gothenburg, Sweden; [Li, Chieh-Yuan; Ruff, David; Chen, Shiaw-Min] Thermo Fisher Sci, Life Sci Grp, Genet Med & Appl Sci Div, San Francisco, CA USA	University of Gothenburg; University of Gothenburg; Thermo Fisher Scientific	Aman, P (corresponding author), Univ Gothenburg, Inst Biomed, Dept Pathol, Sahlgrenska Canc Ctr, Gothenburg, Sweden.	pierre.aman@llcr.med.gu.se		Li, Chieh-yuan/0000-0003-0907-8704; Jonasson, Emma/0000-0003-0463-9373; Li, Chieh-Yuan/0000-0003-1038-5218; Aman, Pierre/0000-0002-1482-8875; Stahlberg, Anders/0000-0003-4243-0191	ALF Vastra Gotalandsregionen; Swedish Cancer Society; Assar Gabrielssons Research Foundation; Johan Jansson Foundation for Cancer Research; Swedish Society for Medical Research; BioCARE National Strategic Research Program at University of Gothenburg; Wilhelm and Martina Lundgren Foundation for Scientific Research; Swedish Research Council [2367]; Thermo Fisher Scientific	ALF Vastra Gotalandsregionen; Swedish Cancer Society(Swedish Cancer Society); Assar Gabrielssons Research Foundation; Johan Jansson Foundation for Cancer Research; Swedish Society for Medical Research; BioCARE National Strategic Research Program at University of Gothenburg; Wilhelm and Martina Lundgren Foundation for Scientific Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Thermo Fisher Scientific	This work was supported by grants from: ALF Vastra Gotalandsregionen, Swedish Cancer Society, Assar Gabrielssons Research Foundation, Johan Jansson Foundation for Cancer Research, Swedish Society for Medical Research, BioCARE National Strategic Research Program at University of Gothenburg, Wilhelm and Martina Lundgren Foundation for Scientific Research, and the Swedish Research Council (2367). AS has a collaborative research grant from Thermo Fisher Scientific. The funder provided support in the form of salaries for authors (CYL, DR, SMC), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions'' section.	Aman P, 1999, SEMIN CANCER BIOL, V9, P303, DOI 10.1006/scbi.1999.0130; AMAN P, 1992, GENE CHROMOSOME CANC, V5, P278, DOI 10.1002/gcc.2870050403; Andersson MK, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-37; Antonescu CR, 2001, CLIN CANCER RES, V7, P3977; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Chin PL, 1997, ONCOGENE, V15, P87, DOI 10.1038/sj.onc.1201161; CLASSON M, 1987, NATURE, V330, P272, DOI 10.1038/330272a0; Di Giandomenico S, 2013, ONCOGENE; Engstrom K, 2006, AM J PATHOL, V168, P1642, DOI 10.2353/ajpath.2006.050872; Engstrom K, 2007, ACTA ONCOL, V46, P838, DOI 10.1080/02841860601080415; Forni C, 2009, MOL CANCER THER, V8, P449, DOI 10.1158/1535-7163.MCT-08-0848; Frapolli R, 2010, CLIN CANCER RES, V16, P4958, DOI 10.1158/1078-0432.CCR-10-0317; Fujii R, 2005, J CELL SCI, V118, P5755, DOI 10.1242/jcs.02692; Goransson M, 2005, INT J CANCER, V115, P556, DOI 10.1002/ijc.20893; Gu B, 2012, INT J BIOL SCI, V8, P672, DOI 10.7150/ijbs.4283; Hollstein M, 2010, J PATHOL, V220, P164, DOI 10.1002/path.2637; Khoury MP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000927; Law Warren J., 2006, Briefings in Functional Genomics & Proteomics, V5, P8, DOI 10.1093/bfgp/ell015; MANDAHL N, 1994, INT J ONCOL, V4, P307; Mertens F, 2010, VIRCHOWS ARCH, V456, P129, DOI 10.1007/s00428-009-0736-8; Oda Y, 2005, J PATHOL, V207, P410, DOI 10.1002/path.1848; Panagopoulos I, 1996, ONCOGENE, V12, P489; Perrone F, 2006, J PATHOL, V209, P281, DOI 10.1002/path.1994; Pilotti S, 1998, TUMORI, V84, P571, DOI 10.1177/030089169808400512; Pipas JM, 2001, SEMIN CANCER BIOL, V11, P23, DOI 10.1006/scbi.2000.0343; Rodriguez R, 2011, STEM CELLS, V29, P179, DOI 10.1002/stem.571; Sanchez Garcia I, 1994, P NATL ACAD SCI USA, V91, P7869; SHARMA S, 1993, CELL GROWTH DIFFER, V4, P861; Technau A, 2001, INT J ONCOL, V18, P281; Thelin-Jarnum S, INT J CANC, V83, P30; Thomsen C, 2013, FASEB J, V27, P4965, DOI 10.1096/fj.13-234435; Wu L, 1997, MOL MED, V3, P441, DOI 10.1007/BF03401691; Wurl P, 1997, J CANCER RES CLIN, V123, P502, DOI 10.1007/s004320050095; ZINSZNER H, 1994, GENE DEV, V8, P2513, DOI 10.1101/gad.8.21.2513; Zinszner H, 1997, ONCOGENE, V14, P451, DOI 10.1038/sj.onc.1200854	35	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e113110	10.1371/journal.pone.0113110	http://dx.doi.org/10.1371/journal.pone.0113110			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393000	Green Submitted, Green Published, gold			2022-12-27	WOS:000347709300143
J	Mohamed, AD; Lewis, CR				Mohamed, Ahmed Dahir; Lewis, Chris Roberts			Modafinil Increases the Latency of Response in the Hayling Sentence Completion Test in Healthy Volunteers: A Randomised Controlled Trial	PLOS ONE			English	Article							FUNCTIONAL-ANATOMY; ANALOG SCALES; SLEEP; MOOD; SUPPRESSION; PERFORMANCE; INITIATION; VALIDITY; NEUROENHANCEMENT; RELIABILITY	Background: Modafinil is a medication licensed for the treatment of narcolepsy. However, it has been reported that healthy individuals without wakefulness disorders are using modafinil off-label to enhance cognitive functioning. Although some studies have reported that modafinil improves cognitive task performance in healthy volunteers, numerous other studies have failed to detect cognitive enhancing effects of modafinil on several well-established neuropsychological tasks. Interestingly, several clinical and preclinical studies have found that improved cognitive task performance by modafinil is accompanied by slower response times. This observation raises the question as to whether this slowing of response time in healthy volunteers is a necessary and sufficient condition for cognitive enhancement with modafinil. The aim of the current experiment was to explore this question by investigating the effects of modafinil on the Hayling Sentence Completion Test (HSCT). Methodology: Sixty-four healthy volunteers received either a single dose (200 mg) of modafinil (n = 32) or placebo (n = 32) in a randomized, double-blind, placebo-controlled, parallel group study in which the principal outcome measures were response latencies on the response initiation and response inhibition sections of the HSCT. Principal Findings: Participants dosed with modafinil had significantly longer mean response latencies on the HSCT for both the response initiation and response inhibition compared to participants dosed with placebo. However, participants in both groups made a similar number of errors on each of these measures, indicating that modafinil did not enhance the accuracy of performance of the task relative to placebo. Conclusions: This study demonstrated that administration of single 200 mg doses of modafinil to healthy individuals increased the latency of responses in the performance of the HSCT, a task that is highly sensitive to prefrontal executive function, without enhancing accuracy of performance. This finding may provide important clues to defining the limitations of modafinil as a putative cognitive enhancer. Trial Registration:	[Mohamed, Ahmed Dahir] Univ Cambridge, Sch Clin Med, Dept Psychiat, Cambridge, England; [Mohamed, Ahmed Dahir] Univ Nottingham Malaysia Campus, Fac Sci, Sch Psychol, Cognit & Sensory Syst Grp, Semenyih, Selangor, Malaysia; [Mohamed, Ahmed Dahir] Clare Hall Coll, Cambridge, England; [Lewis, Chris Roberts] Towson Univ, Dept Psychol, Towson, MD 21252 USA	University of Cambridge; University of Nottingham Malaysia; University of Cambridge; University System of Maryland; Towson University	Mohamed, AD (corresponding author), Univ Cambridge, Sch Clin Med, Dept Psychiat, Cambridge, England.	ahmed.mohamed@cantab.net			Wellcome Trust; Oxford Centre for Neuroethics at the University of Oxford [086041/Z/08/Z]	Wellcome Trust(Wellcome TrustEuropean Commission); Oxford Centre for Neuroethics at the University of Oxford	This research was funded through a Wellcome Trust-funded Ph.D. studentship to A.D.M. at Clare Hall, Cambridge, and was part of a large grant fund to The Oxford Centre for Neuroethics at the University of Oxford (Grant: 086041/Z/08/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advokat C, 2010, NEUROSCI BIOBEHAV R, V34, P1256, DOI 10.1016/j.neubiorev.2010.03.006; Ahearn EP, 1997, J PSYCHIATR RES, V31, P569, DOI 10.1016/S0022-3956(97)00029-0; [Anonymous], EC T; Banerjee D, 2004, SLEEP MED REV, V8, P339, DOI 10.1016/j.smrv.2004.03.002; Baranski JV, 2004, HUM PSYCHOPHARM CLIN, V19, P323, DOI 10.1002/hup.596; Beracochea D, 2001, NEUROREPORT, V12, P375, DOI 10.1097/00001756-200102120-00038; Blair J. R., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI DOI 10.1080/13854048908403285; BOND A, 1974, BRIT J MED PSYCHOL, V47, P211, DOI 10.1111/j.2044-8341.1974.tb02285.x; Burgess P.W., 1997, HAYLING BRIXTON TEST; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; CELLA DF, 1986, PSYCHOL REP, V59, P827, DOI 10.2466/pr0.1986.59.2.827; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Collette F, 2002, NEUROSCI BIOBEHAV R, V26, P105, DOI 10.1016/S0149-7634(01)00063-X; Collette F, 2001, NEUROIMAGE, V14, P258, DOI 10.1006/nimg.2001.0846; Crawford JR, 2001, PSYCHOL MED, V31, P451, DOI 10.1017/S0033291701003634; Deary IJ, 2009, VALIDATING NATL ADUL, P217; Franke AG, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-102; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; Greely HT, 2006, NEUROETHICS DEFINING, P245; Hetzler RK, 2008, J STRENGTH COND RES, V22, P1969, DOI 10.1519/JSC.0b013e318185f36c; Hornberger M, 2010, DEMENT GERIATR COGN, V30, P547, DOI 10.1159/000321670; Howell D.C., 2010, STAT METHODS PSYCHOL, V7; Howell D. C., 2007, FUNDAMENTAL STAT BEH; Lynch G, 2011, PHARMACOL BIOCHEM BE, V99, P116, DOI 10.1016/j.pbb.2010.12.024; Marchant NL, 2009, PSYCHOPHARMACOLOGY, V202, P487, DOI 10.1007/s00213-008-1395-1; Mayhew JL, 2010, J STRENGTH COND RES, V24, P447, DOI 10.1519/JSC.0b013e3181c08860; MHRA, 2012, MOD PROV INF SUPP SA; Minzenberg MJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1477, DOI 10.1038/sj.npp.1301534; Mohamed AD, 2012, INT J NEUROPSYCHOPH, V15, P239; Mohamed AD, 2014, WILEY INTERDISCIPLIN, DOI 10.1002/ wcs1306; Mohamed AD, 2014, J CREATIVE BEHAV, DOI [10.1002/jocb.1073, DOI 10.1002/JOCB.1073]; MOHAMED ADA, 2012, AJOB NEUROSCI, V3, P36, DOI DOI 10.1080/21507740.2012.666322; Mohamed AD, 2012, INT J NEUROPSYCHOPH, V15, P559, DOI 10.1017/S146114571100037X; Mohamed AD, 2014, J CREAT MENT HEALTH, V9, P146, DOI 10.1080/15401383.2013.875865; Muller U, 2004, PSYCHOPHARMACOLOGY, V177, P161, DOI 10.1007/s00213-004-1926-3; NathanielJames DA, 1997, NEUROPSYCHOLOGIA, V35, P559, DOI 10.1016/S0028-3932(96)00104-2; Naumann A, 2006, J SLEEP RES, V15, P329, DOI 10.1111/j.1365-2869.2006.00533.x; Nelson H, 1982, NATL ADULT TEST READ; Nelson HE., 1991, REVISED NATL ADULT R; Normann C, 2008, EUR ARCH PSY CLIN N, V258, P110, DOI 10.1007/s00406-008-5022-2; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Randall DC, 2005, J CLIN PSYCHOPHARM, V25, P175, DOI 10.1097/01.jcp.0000155816.21467.25; Randall DC, 2005, PHARMACOL BIOCHEM BE, V82, P133, DOI 10.1016/j.pbb.2005.07.019; Randall DC, 2005, J PSYCHOPHARMACOL, V19, P647, DOI 10.1177/0269881105056531; Randall DC, 2004, PHARMACOL BIOCHEM BE, V77, P547, DOI 10.1016/j.pbb.2003.12.016; Randall DC, 2003, HUM PSYCHOPHARM CLIN, V18, P163, DOI 10.1002/hup.456; Repantis D, 2010, PHARMACOL RES, V62, P187, DOI 10.1016/j.phrs.2010.04.002; Roca M, 2010, BRAIN, V133, P234, DOI 10.1093/brain/awp269; Stoops WW, 2005, PSYCHOPHARMACOLOGY, V182, P186, DOI 10.1007/s00213-005-0044-1; Strauss E, 2006, COMPENDIUM NEUROPSYC; Sugden C, 2012, ANN SURG, V255, P222, DOI 10.1097/SLA.0b013e3182306c99; Tindal B, 2004, BETTER PLAYING CHEM; Turner DC, 2004, BIOL PSYCHIAT, V55, P1031, DOI 10.1016/j.biopsych.2004.02.008; Turner DC, 2003, J PSYCHOPHARMACOL, V17, pA71; Turner DC, 2003, PSYCHOPHARMACOLOGY, V165, P260, DOI 10.1007/s00213-002-1250-8; Vastag B, 2004, JAMA-J AM MED ASSOC, V291, P167, DOI 10.1001/jama.291.2.167; Volle E, 2012, CEREB CORTEX, V22, P2428, DOI 10.1093/cercor/bhr322; Waters KA, 2005, J PSYCHOPHARMACOL, V19, P149, DOI 10.1177/0269881105048995; Wesensten NJ, 2005, J SLEEP RES, V14, P255, DOI 10.1111/j.1365-2869.2005.00468.x; Winder-Rhodes SE, 2010, J PSYCHOPHARMACOL, V24, P1649, DOI 10.1177/0269881109105899	60	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e110639	10.1371/journal.pone.0110639	http://dx.doi.org/10.1371/journal.pone.0110639			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391155	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400016
J	Schiffner, I; Wiltschko, R				Schiffner, Ingo; Wiltschko, Roswitha			Pigeon Navigation: Different Routes Lead to Frankfurt	PLOS ONE			English	Article							HOMING PIGEONS; MATHEMATICAL-ANALYSIS; ORIENTATION; PILOTAGE; LOYALTY	Background: Tracks of pigeons homing to the Frankfurt loft revealed an odd phenomenon: whereas birds returning from the North approach their loft more or less directly in a broad front, pigeons returning from the South choose, from 25 km from home onward, either of two corridors, a direct one and one with a considerable detour to the West. This implies differences in the navigational process. Methodology/Principle Findings: Pigeons released at sites at the beginning of the westerly corridor and in this corridor behave just like pigeons returning from farther south, deviating to the west before turning towards their loft. Birds released at sites within the straight corridors, in contrast, take more or less straight routes. The analysis of the short-term correlation dimension, a quantity reflecting the complexity of the system and with it, the number of factors involved in the navigational process, reveals that it is significantly larger in pigeons choosing the westerly corridor than in the birds flying straight -3.03 vs. 2.85. The difference is small, however, suggesting a different interpretation of the same factors, with some birds apparently preferring particular factors over others. Conclusions: The specific regional distribution of the factors which pigeons use to determine their home course seems to provide ambiguous information in the area 25 km south of the loft, resulting in the two corridors. Pigeons appear to navigate by deriving their routes directly from the locally available navigational factors which they interpret in an individual way. The fractal nature of the correlation dimensions indicates that the navigation process of pigeons is chaotic-deterministic; published tracks of migratory birds suggest that this may apply to avian navigation in general.	[Schiffner, Ingo; Wiltschko, Roswitha] Goethe Univ Frankfurt, FB Biowissensch, D-60054 Frankfurt, Germany; [Schiffner, Ingo] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia	Goethe University Frankfurt; University of Queensland	Wiltschko, R (corresponding author), Goethe Univ Frankfurt, FB Biowissensch, Siesmayerstr 70, D-60054 Frankfurt, Germany.	Wiltschko@bio.uni-frankfurt.de	Schiffner, Ingo/M-5114-2018	Schiffner, Ingo/0000-0003-0044-1677	Deutsche Forschungsgemeinschaft (DFG) [Wi 988/6-2, Wi 988/6-3, Wi 988/7-1, Wi 988/7-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (DFG), with grants to RW: Wi 988/6-2,3 and Wi 988/7-1,2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 2006, ANIM BEHAV, V71, P555, DOI 10.1016/j.anbehav.2005.05.016; Bairlein F, 2012, BIOL LETTERS, V8, P505, DOI 10.1098/rsbl.2011.1223; Batschelet E, 1981, CIRCULAR STAT BIOL; Biro D, 2006, J NAVIGATION, V59, P43, DOI 10.1017/S0373463305003541; Biro D, 2004, P NATL ACAD SCI USA, V101, P17440, DOI 10.1073/pnas.0406984101; Biro D, 2007, P NATL ACAD SCI USA, V104, P7471, DOI 10.1073/pnas.0701575104; Blaser N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077102; Bonadonna F, 1997, BEHAV PROCESS, V39, P137, DOI 10.1016/S0376-6357(96)00054-X; Dennis TE, 2007, P ROY SOC B-BIOL SCI, V274, P1153, DOI 10.1098/rspb.2007.3768; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Gagliardo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022385; Gagliardo A, 2009, BEHAV ECOL SOCIOBIOL, V64, P289, DOI 10.1007/s00265-009-0847-x; GRASSBERGER P, 1983, PHYS REV LETT, V50, P346, DOI 10.1103/PhysRevLett.50.346; GRAUE LOUIS C., 1963, THE OHIO JOUR SCI, V63, P214; GRIFFIN DR, 1952, BIOL REV, V27, P359, DOI 10.1111/j.1469-185X.1952.tb01509.x; Hagstrum JT, 2013, J EXP BIOL, V216, P687, DOI 10.1242/jeb.072934; Hagstrum JT, 2000, J EXP BIOL, V203, P1103; Jorge PE, 2010, P R SOC B, V277, P45, DOI 10.1098/rspb.2009.1521; Jorge PE, 2009, CURR BIOL, V19, P650, DOI 10.1016/j.cub.2009.02.066; Kantz H., 1997, NONLINEAR TIME SERIE; KAPLAN D, 1995, UNDERSTANDING NONLIN; KEETON WT, 1973, J COMP PHYSIOL, V86, P1, DOI 10.1007/BF00694473; LEDNOR AJ, 1984, J EXP BIOL, V111, P259; Lipp HP, 2004, CURR BIOL, V14, P1239, DOI 10.1016/j.cub.2004.07.024; Mann R, 2011, J R SOC INTERFACE, V8, P210, DOI 10.1098/rsif.2010.0301; Meade J, 2005, P ROY SOC B-BIOL SCI, V272, P17, DOI 10.1098/rspb.2004.2873; Michael S, 2005, APPL NONLINEAR TIME; Mora CV, 2009, P R SOC B, V276, P3295, DOI 10.1098/rspb.2009.0872; Nehmzow Ulrich, 2006, SCI METHODS MOBILE R; PAPI F, 1986, MONIT ZOOL ITAL, V20, P471; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; Schiffner I, 2014, J EXP BIOL, V217, P2643, DOI 10.1242/jeb.104182; Schiffner I, 2013, ANIM BEHAV, V86, P291, DOI 10.1016/j.anbehav.2013.05.018; Schiffner I, 2011, J THEOR BIOL, V291, P42, DOI 10.1016/j.jtbi.2011.09.009; Schiffner I, 2011, J NAVIGATION, V64, P431, DOI 10.1017/S0373463311000063; SKINNER JE, 1994, BIO-TECHNOL, V12, P596, DOI 10.1038/nbt0694-596; Steiner I, 2000, PHYSIOL BEHAV, V71, P1; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; von Hunerbein K, 2000, NATURWISSENSCHAFTEN, V87, P278, DOI 10.1007/s001140050721; Walcott C, 2005, INTEGR COMP BIOL, V45, P574, DOI 10.1093/icb/45.3.574; Walcott C., 1978, ANIMAL MIGRATION NAV, P143, DOI 10.1007/978-3-662-11147-5_13; WALLRAFF HANS G., 1959, ZEITSCHR TIERPSYCHOL, V16, P513; Wallraff HG, 2004, ANIM BEHAV, V67, P189, DOI 10.1016/j.anbehav.2003.06.007; Wallraff HG, 1974, SCHRIFTENREIHE KYBER; Whitney H, 1936, ANN MATH, V37, P645, DOI 10.2307/1968482; WILTSCHKO R, 1994, BEHAV ECOL SOCIOBIOL, V35, P63, DOI 10.1007/s002650050071; Wiltschko R, 1993, ORIENTATION NAVIGATI; Wiltschko R, 2007, ANIM BEHAV, V74, P1229, DOI 10.1016/j.anbehav.2007.01.028; Wiltschko R, 2010, CURR BIOL, V20, P1534, DOI 10.1016/j.cub.2010.06.073; Wiltschko R, 2009, AUK, V126, P717, DOI 10.1525/auk.2009.11009; Wiltschko W., 1982, P239; YEAGLEY HL, 1951, J APPL PHYS, V22, P746, DOI 10.1063/1.1700043	52	8	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112439	10.1371/journal.pone.0112439	http://dx.doi.org/10.1371/journal.pone.0112439			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391144	Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400082
J	Starkstein, SE; Davis, WA; Dragovic, M; Cetrullo, V; Davis, TME; Bruce, DG				Starkstein, Sergio E.; Davis, Wendy A.; Dragovic, Milan; Cetrullo, Violetta; Davis, Timothy M. E.; Bruce, David G.			Diagnostic Criteria for Depression in Type 2 Diabetes: A Data-Driven Approach	PLOS ONE			English	Article							MAJOR DEPRESSION; ANXIETY; DISORDERS; METAANALYSIS; COMORBIDITY; DISTRESS; SAMPLE; HEALTH	Background: While depression is a frequent psychiatric comorbid condition in diabetes and has significant clinical impact, the syndromal profile of depression and anxiety symptoms has not been examined in detail. Aims: To determine the syndromal pattern of the depression and anxiety spectrum in a large series of patients with type 2 diabetes, as determined using a data-driven approach based on latent class analysis (LCA). Method: Type 2 diabetes participants from the observational community- based Fremantle Diabetes Study Phase II underwent assessment of lifetime depression using the Brief Lifetime Depression Scale, the Patient Health Questionnaire 9-item version (PHQ-9) for current depression symptoms, and the Generalized Anxiety Disorder Scale that was specifically developed and validated for this study. The main outcome measure was classes of patients with a specific syndromal profile of depression and anxiety symptoms based on LCA. Results: LCA identified four classes that were interpreted as "major anxious depression'', "minor anxious depression'', "subclinical anxiety'', and "no anxious depression''. All nine DSM-IV/5 diagnostic criteria for major depression identified a class with a high frequency of major depression. All symptoms of anxiety had similar high probabilities as symptoms of depression for the "major depression-anxiety'' class. There were significant differences between classes in terms of history of depression and anxiety, use of psychoactive medication, and diabetes-related variables. Conclusions: Patients with type 2 diabetes show specific profiles of depression and anxiety. Anxiety symptoms are an integral part of major depression in type 2 diabetes. The different classes identified here provide empirically validated phenotypes for future research.	[Davis, Wendy A.; Cetrullo, Violetta; Davis, Timothy M. E.; Bruce, David G.] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia; [Starkstein, Sergio E.; Dragovic, Milan] Univ Western Australia, Sch Psychiat & Clin Neurosci, Crawley, WA, Australia	University of Western Australia; University of Western Australia	Starkstein, SE (corresponding author), Univ Western Australia, Sch Psychiat & Clin Neurosci, Crawley, WA, Australia.	ses@cyllene.uwa.edu.au	Bruce, David G/H-8900-2014	Davis, Timothy/0000-0003-0749-7411; Davis, Wendy/0000-0002-5709-8235; Bruce, David/0000-0002-9979-6867	National Health and Medical Research Council [513781]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Funding was provided by National Health and Medical Research Council (Project Grant 513781). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atlantis E, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004706; Atlantis E, 2012, J AFFECT DISORDERS, V142, pS30, DOI 10.1016/S0165-0327(12)70006-X; Atlantis E, 2012, SOC PSYCH PSYCH EPID, V47, P871, DOI 10.1007/s00127-011-0394-4; Blay SL, 2011, J AFFECT DISORDERS, V134, P77, DOI 10.1016/j.jad.2011.05.012; Bruce DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081254; Bruce DG, 2005, DIABETOLOGIA, V48, P2532, DOI 10.1007/s00125-005-0024-3; Campayo A, 2011, CURR PSYCHIAT REP, V13, P26, DOI 10.1007/s11920-010-0165-z; Collins MM, 2009, DIABETIC MED, V26, P153, DOI 10.1111/j.1464-5491.2008.02648.x; Cyranowski JM, 2012, DEPRESS ANXIETY, V29, P1050, DOI 10.1002/da.21990; Davis TME, 2013, INT J EPIDEMIOL, V42, P412, DOI 10.1093/ije/dys065; de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015; Edwards LE, 2012, J PSYCHOSOM RES, V73, P418, DOI 10.1016/j.jpsychores.2012.09.018; Egede LE, 2010, DIABETES RES CLIN PR, V87, P302, DOI 10.1016/j.diabres.2010.01.024; Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428; Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614; Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341; Kessler RC, 2007, ANNU REV CLIN PSYCHO, V3, P137, DOI 10.1146/annurev.clinpsy.3.022806.091444; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Markowitz SM, 2011, PSYCHOSOMATICS, V52, P1, DOI 10.1016/j.psym.2010.11.007; Nutt D, 2006, EUR NEUROPSYCHOPHARM, V16, pS109, DOI 10.1016/j.euroneuro.2006.04.003; Roy T, 2012, DIABETIC MED, V29, P164, DOI 10.1111/j.1464-5491.2011.03401.x; Ruscio J, 2009, ASSESSMENT, V16, P127, DOI 10.1177/1073191108330065; Starr LR, 2012, COGNITIVE THER RES, V36, P321, DOI 10.1007/s10608-011-9363-1; Vermunt JK, 2005, THECHNICA GUIDE LATE	26	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112049	10.1371/journal.pone.0112049	http://dx.doi.org/10.1371/journal.pone.0112049			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390370	Green Submitted, gold, Green Published			2022-12-27	WOS:000349144400049
J	Gong, WF; He, SP; Tian, JH; Sun, JL; Pan, ZE; Jia, YH; Sun, GF; Du, XM				Gong, Wenfang; He, Shoupu; Tian, Jiahuan; Sun, Junling; Pan, Zhaoe; Jia, Yinhua; Sun, Gaofei; Du, Xiongming			Comparison of the Transcriptome between Two Cotton Lines of Different Fiber Color and Quality	PLOS ONE			English	Article							RNA-SEQ; GOSSYPIUM-HIRSUTUM; GENE-EXPRESSION; CELL ELONGATION; ANTHOCYANIN; L.; 5-O-GLUCOSYLTRANSFERASE; ANNOTATION; PROFILES; ETHYLENE	To understand the mechanism of fiber development and pigmentation formation, the mRNAs of two cotton lines were sequenced: line Z128 (light brown fiber) was a selected mutant from line Z263 (dark brown fiber). The primary walls of the fiber cell in both Z263 and Z128 contain pigments; more pigments were laid in the lumen of the fiber cell in Z263 compared with that in Z128. However, Z263 contained less cellulose than Z128. A total of 71,895 unigenes were generated: 13,278 (20.26%) unigenes were defined as differentially expressed genes (DEGs) by comparing the library of Z128 with that of Z263; 5,345 (8.16%) unigenes were up-regulated and 7,933 (12.10%) unigenes were down-regulated. qRT-PCR and comparative transcriptional analysis demonstrated that the pigmentation formation in brown cotton fiber was possibly the consequence of an interaction between oxidized tannins and glycosylated anthocyanins. Furthermore, our results showed the pigmentation related genes not only regulated the fiber color but also influenced the fiber quality at the fiber elongation stage (10 DPA). The highly expressed flavonoid gene in the fiber elongation stage could be related to the fiber quality. DEGs analyses also revealed that transcript levels of some fiber development genes (Ca2+/CaM, reactive oxygen, ethylene and sucrose phosphate synthase) varied dramatically between these two cotton lines.	[Gong, Wenfang; He, Shoupu; Tian, Jiahuan; Sun, Junling; Pan, Zhaoe; Jia, Yinhua; Sun, Gaofei; Du, Xiongming] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China; [Sun, Gaofei] Anyang Inst Technol, Dept Comp Sci & Informat Engn, Anyang, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Anyang Institute of Technology	Du, XM (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China.	dujeffrey8848@hotmail.com	Shoupu, He/AAR-5173-2021; Du, Xiongming/AAI-9999-2020	Shoupu, He/0000-0001-8434-5484; 	"Twelfth Five-Year Plan" of the National Science and Technology Support Project [2011BAD35B05, 2013BAD01B03]; Basic Scientific Research funds in National Nonprofit Institutes [SJA0608]	"Twelfth Five-Year Plan" of the National Science and Technology Support Project; Basic Scientific Research funds in National Nonprofit Institutes	This study was supported by the "Twelfth Five-Year Plan" of the National Science and Technology Support Project (2011BAD35B05 and 2013BAD01B03) and Basic Scientific Research funds in National Nonprofit Institutes (SJA0608). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2003, PLANT CELL, V15, P2816, DOI 10.1105/tpc.015685; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Chaudhary B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-378; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; De Grauwe L, 2005, PLANT CELL PHYSIOL, V46, P827, DOI 10.1093/pcp/pci111; Dickerson D. K., 1999, NATURALLY COLORED CO; DOONER HK, 1991, ANNU REV GENET, V25, P173, DOI 10.1146/annurev.ge.25.120191.001133; Feng HJ, 2011, PLANT BREEDING, V130, P450, DOI 10.1111/j.1439-0523.2010.01842.x; Gou JY, 2007, CELL RES, V17, P422, DOI 10.1038/sj.cr.7310150; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; Haas BJ, 2010, NAT BIOTECHNOL, V28, P421, DOI 10.1038/nbt0510-421; Haigler CH, 2007, PLANT MOL BIOL, V63, P815, DOI 10.1007/s11103-006-9127-6; HALLOIN JM, 1982, NEW PHYTOL, V90, P651, DOI 10.1111/j.1469-8137.1982.tb03274.x; Hittinger CT, 2010, P NATL ACAD SCI USA, V107, P1476, DOI 10.1073/pnas.0910449107; Hovav R, 2008, PLANTA, V227, P319, DOI 10.1007/s00425-007-0619-7; KOHEL RJ, 1985, CROP SCI, V25, P793, DOI 10.2135/cropsci1985.0011183X0025000500017x; Lee SH, 1997, J BIOL CHEM, V272, P9252, DOI 10.1074/jbc.272.14.9252; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murthy M.S.S., 2001, RESONANCE, V6, P29, DOI [10.1007/BF02913764, DOI 10.1007/BF02913764]; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nishizaki Y, 2011, MOL GENET GENOMICS, V286, P383, DOI 10.1007/s00438-011-0655-7; Owens DK, 2008, PLANT PHYSIOL BIOCH, V46, P833, DOI 10.1016/j.plaphy.2008.06.004; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Qin YM, 2011, CURR OPIN PLANT BIOL, V14, P106, DOI 10.1016/j.pbi.2010.09.010; Rapp RA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-139; Ru ZongLing, 2013, Cotton Science, V25, P184; Seifert GJ, 2004, PLANT CELL, V16, P723, DOI 10.1105/tpc.019661; [詹少华 Shaohua Zhan], 2007, [植物学通报, Chinese Bulletin of Botany], V24, P99; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Tan JF, 2013, PLANT PHYSIOL, V162, P86, DOI 10.1104/pp.112.212142; Tang WX, 2014, NEW PHYTOL, V202, P509, DOI 10.1111/nph.12676; Tisserant E, 2011, NEW PHYTOL, V189, P883, DOI 10.1111/j.1469-8137.2010.03597.x; Tu LL, 2007, PLANT CELL REP, V26, P1309, DOI 10.1007/s00299-007-0337-4; Vreeland JM, 1999, SCI AM, V280, P112, DOI 10.1038/scientificamerican0499-112; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Xia Z, 2011, PLANT MOL BIOL, V77, P1; Xiao YH, 2007, BIOCHEM BIOPH RES CO, V35, P873; Yamazaki M, 1999, J BIOL CHEM, V274, P7405, DOI 10.1074/jbc.274.11.7405; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716; [詹少华 ZHAN Shaohua], 2007, [棉花学报, Cotton Science], V19, P183	45	17	20	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112966	10.1371/journal.pone.0112966	http://dx.doi.org/10.1371/journal.pone.0112966			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401744	Green Published, gold, Green Submitted			2022-12-27	WOS:000345158700087
J	Kang, JH; Jeong, JW; Kim, HT; Kim, SH; Kim, SP				Kang, Jae-Hwan; Jeong, Ji Woon; Kim, Hyun Taek; Kim, Sang Hee; Kim, Sung-Phil			Representation of Cognitive Reappraisal Goals in Frontal Gamma Oscillations	PLOS ONE			English	Article							EMOTION REGULATION; PREFRONTAL CORTEX; PHASE SYNCHRONY; BAND ACTIVITY; ELECTROCORTICAL RESPONSE; NEGATIVE AFFECT; EEG; AMYGDALA; POTENTIALS; MODULATION	Recently, numerous efforts have been made to understand the neural mechanisms underlying cognitive regulation of emotion, such as cognitive reappraisal. Many studies have reported that cognitive control of emotion induces increases in neural activity of the control system, including the prefrontal cortex and the dorsal anterior cingulate cortex, and increases or decreases (depending upon the regulation goal) in neural activity of the appraisal system, including the amygdala and the insula. It has been hypothesized that information about regulation goals needs to be processed through interactions between the control and appraisal systems in order to support cognitive reappraisal. However, how this information is represented in the dynamics of cortical activity remains largely unknown. To address this, we investigated temporal changes in gamma band activity (35-55 Hz) in human electroencephalograms during a cognitive reappraisal task that was comprised of three reappraisal goals: to decease, maintain, or increase emotional responses modulated by affect-laden pictures. We examined how the characteristics of gamma oscillations, such as spectral power and large-scale phase synchronization, represented cognitive reappraisal goals. We found that left frontal gamma power decreased, was sustained, or increased when the participants suppressed, maintained, or amplified their emotions, respectively. This change in left frontal gamma power appeared during an interval of 1926 to 2453 ms after stimulus onset. We also found that the number of phase-synchronized pairs of gamma oscillations over the entire brain increased when participants regulated their emotions compared to when they maintained their emotions. These results suggest that left frontal gamma power may reflect cortical representation of emotional states modulated by cognitive reappraisal goals and gamma phase synchronization across whole brain regions may reflect emotional regulatory efforts to achieve these goals. Our study may provide the basis for an electroencephalogram-based neurofeedback system for the cognitive regulation of emotion.	[Kang, Jae-Hwan; Kim, Sang Hee] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Jeong, Ji Woon; Kim, Hyun Taek] Korea Univ, Dept Psychol, Seoul, South Korea; [Kim, Sung-Phil] Ulsan Natl Inst Sci & Technol, Dept Human & Syst Engn, Ulsan, South Korea	Korea University; Korea University; Ulsan National Institute of Science & Technology (UNIST)	Kim, SH (corresponding author), Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea.	sangheekim.ku@gmail.com; spkim@unist.ac.kr	Kim, Sanghee/AAE-3574-2021	Kang, Jae-Hwan/0000-0002-9425-847X	National Research Foundation of Korea - Ministry of Science, ICT & Future Planning [NRF-2012R1A2A2A04047239, NRF-2006-2005112]	National Research Foundation of Korea - Ministry of Science, ICT & Future Planning	This research was supported by both the Mid-career Researcher Program (NRF-2012R1A2A2A04047239) and the Brain Research Program (NRF-2006-2005112) through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HM, 2013, J NEUROPSYCHOL; Balconi M, 2008, INT J PSYCHOPHYSIOL, V67, P41, DOI 10.1016/j.ijpsycho.2007.10.002; Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029; Berkovich-Ohana A, 2012, CLIN NEUROPHYSIOL, V123, P700, DOI 10.1016/j.clinph.2011.07.048; Bhattacharya J, 2001, NEUROSCI LETT, V311, P29, DOI 10.1016/S0304-3940(01)02133-4; Bonanno GA, 2004, PSYCHOL SCI, V15, P482, DOI 10.1111/j.0956-7976.2004.00705.x; BURGESS PW, 2005, MEASURING MIND SPEED; Chambers R, 2009, CLIN PSYCHOL REV, V29, P560, DOI 10.1016/j.cpr.2009.06.005; Chiesa A, 2013, CLIN PSYCHOL REV, V33, P82, DOI 10.1016/j.cpr.2012.10.006; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Foucher JR, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-22; Gandal MJ, 2012, NEUROPHARMACOLOGY, V62, P1504, DOI 10.1016/j.neuropharm.2011.02.007; Ghashghaei H, 2007, NEUROIMAGE, V34, P905, DOI 10.1016/j.neuroimage.2006.09.046; Ghashghaei HT, 2002, NEUROSCIENCE, V115, P1261, DOI 10.1016/S0306-4522(02)00446-3; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Gross JJ., 1998, REV GEN PSYCHOL, V2, P271, DOI 10.1037/1089-2680.2.3.271; Gruber T, 2001, NEUROSCI LETT, V316, P29, DOI 10.1016/S0304-3940(01)02361-8; Hajcak G, 2006, COGN AFFECT BEHAV NE, V6, P291, DOI 10.3758/CABN.6.4.291; Hajcak G, 2006, EMOTION, V6, P517, DOI 10.1037/1528-3542.6.3.517; Hajcak G, 2010, DEV NEUROPSYCHOL, V35, P129, DOI 10.1080/87565640903526504; Hamilton JP, 2011, HUM BRAIN MAPP, V32, P22, DOI 10.1002/hbm.20997; Hayes JP, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00230; Herrington JD, 2005, EMOTION, V5, P200, DOI 10.1037/1528-3542.5.2.200; Jausovec N, 2010, SPRINGER SER HUM EXC, P109, DOI 10.1007/978-1-4419-1210-7_7; Johnston SJ, 2010, NEUROIMAGE, V49, P1066, DOI 10.1016/j.neuroimage.2009.07.056; Joormann J, 2010, COGNITION EMOTION RE, P174; Kaiser J, 2003, NEUROSCIENTIST, V9, P475, DOI 10.1177/1073858403259137; Kang JH, 2012, NEUROREPORT, V23, P995, DOI 10.1097/WNR.0b013e32835a6475; Keil A, 2002, PSYCHOPHYSIOLOGY, V39, P641, DOI 10.1017/S0048577202394162; Keil A, 2001, NEUROSCI BIOBEHAV R, V25, P527, DOI 10.1016/S0149-7634(01)00031-8; Kim H, 2003, NEUROREPORT, V14, P2317, DOI 10.1097/00001756-200312190-00006; Kim SH, 2007, J COGNITIVE NEUROSCI, V19, P776, DOI 10.1162/jocn.2007.19.5.776; Krompinger JW, 2008, EMOTION, V8, P132, DOI 10.1037/1528-3542.8.1.132; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Liu YL, 2012, J NEUROSCI, V32, P14563, DOI 10.1523/JNEUROSCI.3109-12.2012; Magri C, 2012, J NEUROSCI, V32, P1395, DOI 10.1523/JNEUROSCI.3985-11.2012; Martini N, 2012, NEUROIMAGE, V60, P922, DOI 10.1016/j.neuroimage.2012.01.060; Miller GA, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00002; Moser JS, 2010, COGN AFFECT BEHAV NE, V10, P195, DOI 10.3758/CABN.10.2.195; Moser JS, 2009, PSYCHOPHYSIOLOGY, V46, P17, DOI 10.1111/j.1469-8986.2008.00721.x; Muller MM, 2000, INT J PSYCHOPHYSIOL, V38, P283, DOI 10.1016/s0167-8760(00)00171-9; Muller MM, 1999, CLIN NEUROPHYSIOL, V110, P1913, DOI 10.1016/S1388-2457(99)00151-0; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Olsson A, 2008, TRENDS COGN SCI, V12, P65, DOI 10.1016/j.tics.2007.11.010; Onton J, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.061.2009; Penny WD, 2008, J NEUROSCI METH, V174, P50, DOI 10.1016/j.jneumeth.2008.06.035; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Popov T, 2012, PSYCHOPHYSIOLOGY, V49, P1545, DOI 10.1111/j.1469-8986.2012.01484.x; Quirk GJ, 2006, CURR OPIN NEUROBIOL, V16, P723, DOI 10.1016/j.conb.2006.07.004; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Stein JL, 2007, NEUROIMAGE, V36, P736, DOI 10.1016/j.neuroimage.2007.03.022; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Thiruchselvam R, 2011, BIOL PSYCHOL, V87, P84, DOI 10.1016/j.biopsycho.2011.02.009; Tolegenova AA, 2014, PERS INDIV DIFFER, V65, P75, DOI 10.1016/j.paid.2014.01.028; Trujillo LT, 2005, CLIN NEUROPHYSIOL, V116, P172, DOI 10.1016/j.clinph.2004.07.025; Urry HL, 2009, NEUROIMAGE, V47, P852, DOI 10.1016/j.neuroimage.2009.05.069; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Zotev V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024522	69	9	9	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113375	10.1371/journal.pone.0113375	http://dx.doi.org/10.1371/journal.pone.0113375			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401328	gold, Green Submitted, Green Published			2022-12-27	WOS:000345158700136
J	Wang, ZC; Hou, XW; Shao, J; Ji, YJ; Li, LL; Zhou, Q; Yu, SM; Mao, YL; Zhang, HJ; Zhang, PC; Lu, H				Wang, Zhan-Chao; Hou, Xu-Wei; Shao, Jiang; Ji, Yong-Jing; Li, Lulu; Zhou, Qiang; Yu, Si-Ming; Mao, Yu-Lun; Zhang, Hao-Jie; Zhang, Ping-Chao; Lu, Hua			HIF-1 alpha Polymorphism in the Susceptibility of Cervical Spondylotic Myelopathy and Its Outcome after Anterior Cervical Corpectomy and Fusion Treatment	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; NUCLEUS PULPOSUS CELLS; OPN GENE POLYMORPHISM; PROSTATE-CANCER; FEMORAL-HEAD; FACTOR-I; ASSOCIATION; LEADS	Background: To investigate the association between the single nucleotide polymorphism (SNP) of hypoxia-inducible factor1 alpha (HIF-1 alpha) and the susceptibility to cervical spondylotic myelopathy (CSM) and its outcome after surgical treatment. Method: A total of 230 CSM patients and 284 healthy controls were recruited. All patients received anterior cervical corpectomy and fusion (ACF) and were followed for 12 months. The genotypes for two HIF-1 alpha variants (1772C>T and 1790G>A) were determined. Results: In the present study, we found that the HIF-1 alpha polymorphism at 1790G>A significantly affects the susceptibility to CSM and its clinical features, including severity and onset age. In addition, the 1790A>G polymorphism also determines the prognosis of CSM patients after ACF treatment. The GG genotype of 1790G>A polymorphism is associated with a higher risk to develop CSM, higher severity and earlier onset age. More importantly, we found that the 1790G>A polymorphism determines the clinical outcome in CSM patients who underwent ACF treatment. Conclusion: Our findings suggest that the HIF-1 alpha 1790G>A polymorphism is associated with the susceptibility to CSM and can be used as predictor for the clinical outcome in CSM patients receiving ACF treatment.	[Wang, Zhan-Chao; Zhou, Qiang; Yu, Si-Ming; Mao, Yu-Lun; Zhang, Hao-Jie; Zhang, Ping-Chao] Shanghai Jiao Tong Univ, Xinhua Hosp Chongming, Dept Orthoped, Shanghai, Peoples R China; [Hou, Xu-Wei] Nanjing Med Univ, Hangzhou Hosp, Dept Cardiol, Hangzhou, Zhejiang, Peoples R China; [Hou, Xu-Wei] Hangzhou First Municipal Hosp, Hangzhou, Zhejiang, Peoples R China; [Shao, Jiang; Lu, Hua] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Orthoped, Shanghai, Peoples R China; [Ji, Yong-Jing] Jinan 2nd Peoples Hosp, Dept Internal Med, Jinan, Peoples R China; [Li, Lulu] Harbin Med Univ, Coll Publ Hlth, Dept Biostat, Harbin 150081, Heilongjiang, Peoples R China	Shanghai Jiao Tong University; Nanjing Medical University; Shanghai Jiao Tong University; Harbin Medical University	Lu, H (corresponding author), Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Orthoped, Shanghai, Peoples R China.	drhualu@163.com						Agrawal A, 2007, AM J PHYSIOL-CELL PH, V293, pC621, DOI 10.1152/ajpcell.00538.2006; Emery S E, 2001, J Am Acad Orthop Surg, V9, P376; Feng G, 2013, OSTEOARTHR CARTILAGE, V21, P582, DOI 10.1016/j.joca.2013.01.001; Fu XYS, 2005, PROSTATE, V63, P215, DOI 10.1002/pros.20190; Fujita N, 2012, J BONE MINER RES, V27, P401, DOI 10.1002/jbmr.538; Green C, 2012, ADV ORTHOP, V2012, DOI 10.1155/2012/908324; Hong JM, 2007, OSTEOARTHR CARTILAGE, V15, P688, DOI 10.1016/j.joca.2006.12.007; Hou X, 2014, J CELL MOL MED; Hou XW, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-78; Hou XW, 2014, J MOL MED, V92, P487, DOI 10.1007/s00109-013-1099-9; Jing M, 2013, CELL PHYSIOL BIOCHEM, V32, P1798, DOI 10.1159/000356613; Kim TH, 2012, CANCER-AM CANCER SOC, V118, P1764, DOI 10.1002/cncr.26500; Koc RK, 2004, NEUROSURG REV, V27, P252, DOI 10.1007/s10143-004-0342-9; Komatsu DE, 2004, BONE, V34, P680, DOI 10.1016/j.bone.2003.12.024; Li H, 2013, YONSEI MED J, V54, P807, DOI 10.3349/ymj.2013.54.4.807; Li LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071041; Lin Wei-Ting, 2013, PLoS ONE, V8, P1; Long HQ, 2012, MED HYPOTHESES, V79, P82, DOI 10.1016/j.mehy.2012.04.006; Lu YJ, 2010, GENE CHROMOSOME CANC, V49, P412, DOI 10.1002/gcc.20752; Mori S, 2006, J ORTHOP RES, V24, P653, DOI 10.1002/jor.20076; Noponen-Hietala N, 2003, ANN RHEUM DIS, V62, P1208, DOI 10.1136/ard.2003.008334; Oga M, 1996, SPINE, V21, P1085, DOI 10.1097/00007632-199605010-00019; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; Sakai Y, 2007, SPINE, V32, P1279, DOI 10.1097/BRS.0b013e318059af8a; Schipani E, 2001, GENE DEV, V15, P2865; Setzer M, 2009, J NEUROSURG-SPINE, V11, P659, DOI 10.3171/2009.7.SPINE08667; Tamburrelli F, 2008, EUR REV MED PHARMACO, V12, P161; Tracy JA, 2010, NEUROLOGIST, V16, P176, DOI 10.1097/NRL.0b013e3181da3a29; Vainrib M, 2012, CANCER BIOL THER, V13, P720, DOI 10.4161/cbt.20554; Wang DW, 2013, CELL PHYSIOL BIOCHEM, V32, P210, DOI 10.1159/000350137; Xu HY, 2010, MOL CELL BIOCHEM, V335, P13, DOI 10.1007/s11010-009-0235-x; Yi L., 2014, NEUROMOL MED; Zhang C, 2011, BONE, V48, P507, DOI 10.1016/j.bone.2010.10.006	33	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e110862	10.1371/journal.pone.0110862	http://dx.doi.org/10.1371/journal.pone.0110862			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401740	gold, Green Submitted, Green Published			2022-12-27	WOS:000345158700010
J	Kim, K; Bang, SY; Lee, HS; Bae, SC				Kim, Kwangwoo; Bang, So-Young; Lee, Hye-Soon; Bae, Sang-Cheol			Construction and Application of a Korean Reference Panel for Imputing Classical Alleles and Amino Acids of Human Leukocyte Antigen Genes	PLOS ONE			English	Article							HLA ALLELES; MAP; ASSOCIATION; EXPLAIN	Genetic variations of human leukocyte antigen (HLA) genes within the major histocompatibility complex (MHC) locus are strongly associated with disease susceptibility and prognosis for many diseases, including many autoimmune diseases. In this study, we developed a Korean HLA reference panel for imputing classical alleles and amino acid residues of several HLA genes. An HLA reference panel has potential for use in identifying and fine-mapping disease associations with the MHC locus in East Asian populations, including Koreans. A total of 413 unrelated Korean subjects were analyzed for single nucleotide polymorphisms (SNPs) at the MHC locus and six HLA genes, including HLA-A, -B, -C, -DRB1, -DPB1, and -DQB1. The HLA reference panel was constructed by phasing the 5,858 MHC SNPs, 233 classical HLA alleles, and 1,387 amino acid residue markers from 1,025 amino acid positions as binary variables. The imputation accuracy of the HLA reference panel was assessed by measuring concordance rates between imputed and genotyped alleles of the HLA genes from a subset of the study subjects and East Asian HapMap individuals. Average concordance rates were 95.6% and 91.1% at 2-digit and 4-digit allele resolutions, respectively. The imputation accuracy was minimally affected by SNP density of a test dataset for imputation. In conclusion, the Korean HLA reference panel we developed was highly suitable for imputing HLA alleles and amino acids from MHC SNPs in East Asians, including Koreans.	[Kim, Kwangwoo; Bang, So-Young; Lee, Hye-Soon; Bae, Sang-Cheol] Hanyang Univ, Dept Rheumatol, Hosp Rheumat Dis, Seoul 133791, South Korea; [Kim, Kwangwoo] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Kim, Kwangwoo] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA; [Kim, Kwangwoo] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA	Hanyang University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Bae, SC (corresponding author), Hanyang Univ, Dept Rheumatol, Hosp Rheumat Dis, Seoul 133791, South Korea.	scbae@hanyang.ac.kr	Bae, Sang-Cheol/P-2051-2015	Bae, Sang-Cheol/0000-0003-4658-1093; Kim, Kwangwoo/0000-0001-8926-6216	Korea Healthcare Technology R&D project of the Ministry for Health Welfare [HI13C2124]	Korea Healthcare Technology R&D project of the Ministry for Health Welfare	This work was supported by grants from the Korea Healthcare Technology R&D project of the Ministry for Health & Welfare (HI13C2124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Stephen, 2011, Immune Netw, V11, P324, DOI 10.4110/in.2011.11.6.324; Apanius V, 1997, CRIT REV IMMUNOL, V17, P179, DOI 10.1615/CritRevImmunol.v17.i2.40; Bang SY, 2013, J RHEUMATOL, V40, P1054, DOI 10.3899/jrheum.121280; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; Foo JN, 2013, AM J HUM GENET, V93, P167, DOI 10.1016/j.ajhg.2013.05.020; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; Kim K, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2013-204749; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Okada Y, 2014, HUM MOL GENET, V23, P6916, DOI 10.1093/hmg/ddu387; Patsopoulos NA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003926; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Pillai NE, 2014, HUM MOL GENET, V23, P4443, DOI 10.1093/hmg/ddu149; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Shiina T, 2009, J HUM GENET, V54, P15, DOI 10.1038/jhg.2008.5; Yamamura T, 2012, TISSUE ANTIGENS, V80, P119, DOI 10.1111/j.1399-0039.2012.01883.x	17	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112546	10.1371/journal.pone.0112546	http://dx.doi.org/10.1371/journal.pone.0112546			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398076	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558500059
J	Pichrtova, M; Kulichova, J; Holzinger, A				Pichrtova, Martina; Kulichova, Jana; Holzinger, Andreas			Nitrogen Limitation and Slow Drying Induce Desiccation Tolerance in Conjugating Green Algae (Zygnematophyceae, Streptophyta) from Polar Habitats	PLOS ONE			English	Article							ZYGOGONIUM-ERICETORUM ZYGNEMATOPHYCEAE; BIOLOGICAL SOIL CRUST; LAND PLANTS; ZYGNEMA ZYGNEMATOPHYCEAE; CHLOROPHYLL FLUORESCENCE; PHENOLIC-COMPOUNDS; TERRESTRIAL ALGAE; ANTARCTIC STRAINS; OSMOTIC-STRESS; FRESH-WATER	Background: Filamentous Zygnematophyceae are typical components of algal mats in the polar hydro-terrestrial environment. Under field conditions, they form senescent vegetative cells, designated as pre-akinetes, which are tolerant to desiccation and osmotic stress. Key Findings: Pre-akinete formation and desiccation tolerance was investigated experimentally under monitored laboratory conditions in four strains of Arctic and Antarctic isolates with vegetative Zygnema sp. morphology. Phylogenetic analyses of rbcL sequences revealed one Arctic strain as genus Zygnemopsis, phylogenetically distant from the closely related Zygnema strains. Algae were cultivated in liquid or on solidified medium (9 weeks), supplemented with or lacking nitrogen. Nitrogen-free cultures (liquid as well as solidified) consisted of well-developed pre-akinetes after this period. Desiccation experiments were performed at three different drying rates (rapid: 10% relative humidity, slow: 86% rh and very slow); viability, effective quantum yield of PS II, visual and ultrastructural changes were monitored. Recovery and viability of pre-akinetes were clearly dependent on the drying rate: slower desiccation led to higher levels of survival. Pre-akinetes survived rapid drying after acclimation by very slow desiccation. Conclusions: The formation of pre-akinetes in polar Zygnema spp. and Zygnemopsis sp. is induced by nitrogen limitation. Pre-akinetes, modified vegetative cells, rather than specialized stages of the life cycle, can be hardened by mild desiccation stress to survive rapid drying. Naturally hardened pre-akinetes play a key role in stress tolerance and dispersal under the extreme conditions of polar regions, where sexual reproduction and production of dormant stages is largely suppressed.	[Pichrtova, Martina; Kulichova, Jana] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic; [Pichrtova, Martina] Acad Sci Czech Republ, Inst Bot, Trebon, Czech Republic; [Holzinger, Andreas] Univ Innsbruck, Inst Bot, A-6020 Innsbruck, Austria	Charles University Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of Innsbruck	Holzinger, A (corresponding author), Univ Innsbruck, Inst Bot, A-6020 Innsbruck, Austria.	Andreas.Holzinger@uibk.ac.at	Pichrtová, Martina/N-1298-2014; Kulichova, Jana/A-2486-2013; Holzinger, Andreas/E-9530-2010; Holzinger, Andreas/A-6396-2008; Holzinger, Andreas/Z-2659-2019	Pichrtová, Martina/0000-0002-6003-9666; Kulichova, Jana/0000-0001-8035-4770; Holzinger, Andreas/0000-0002-6786-5194; Holzinger, Andreas/0000-0002-7745-3978; Holzinger, Andreas/0000-0002-7745-3978	Charles University Grant Agency [GAUK 794413]; Czech Ministry of Education; long-term research development project [RVO 67985939]; Ministry of Education, Youth and Sports of the Czech Republic [LM2010009]; AKTION "Austria-Czech Republic'' [65 p5]; Austrian Science Fund [P24242-B16]; Austrian Science Fund (FWF) [P 24242] Funding Source: researchfish	Charles University Grant Agency; Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); long-term research development project; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); AKTION "Austria-Czech Republic''; Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The present study was supported by the Charles University Grant Agency (http://www.cuni.cz) project GAUK 794413 to M. P.; by the institutional resources of the Czech Ministry of Education; by a long-term research development project, RVO 67985939; by the Ministry of Education, Youth and Sports of the Czech Republic (www.msmt.cz) project "CzechPolar stations: Construction and logistic expenses, LM2010009 2010-2015''. M. P. and A. H. acknowledge funding from the AKTION "Austria-Czech Republic'' (http://www.oead.at), Project 65 p5. The study was supported by the Austrian Science Fund (FWF, http://www.fwf.ac.at), Project P24242-B16 to A. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner S, 2013, J PHYCOL, V49, P648, DOI 10.1111/jpy.12075; [Anonymous], ALGOL STUDIES; Bartels D, 2011, ECOL STUD-ANAL SYNTH, V215, P3, DOI 10.1007/978-3-642-19106-0_1; Bischoff H. W., 1963, U TEXAS PUBL; Budel B, 2011, ECOL STUD-ANAL SYNTH, V215, P45, DOI 10.1007/978-3-642-19106-0_4; Cardon ZG, 2008, BIOSCIENCE, V58, P114, DOI 10.1641/B580206; Coleman A.W., 1983, P1; DARLING RB, 1987, J PHYCOL, V23, P598; de Carvalho RC, 2014, PLANT CELL ENVIRON, V37, P1499, DOI 10.1111/pce.12266; Ellis E.A., 2006, MICROSC TODAY, V14, P32, DOI [10.1017/S1551929500050252, DOI 10.1017/S1551929500050252]; Fritsch FE, 1916, ANN BOT-LONDON, V30, P135, DOI 10.1093/oxfordjournals.aob.a089580; Fuller C, 2013, THESIS CALIFORNIA ST; Gasulla F, 2009, PLANTA, V231, P195, DOI 10.1007/s00425-009-1019-y; Gasulla F, 2013, PLANT CELL ENVIRON, V36, P1363, DOI 10.1111/pce.12065; GENKEL' P A, 1979, Biology Bulletin of the Academy of Sciences of the USSR, V6, P504; Gray DW, 2007, PLANT CELL ENVIRON, V30, P1240, DOI 10.1111/j.1365-3040.2007.01704.x; Guarnieri MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025851; Hall JD, 2008, J PHYCOL, V44, P467, DOI 10.1111/j.1529-8817.2008.00485.x; HAWES I, 1990, PHYCOLOGIA, V29, P326, DOI 10.2216/i0031-8884-29-3-326.1; Herburger K, 2015, PROTOPLASMA, V252, P571, DOI 10.1007/s00709-014-0703-3; Holzinger A, 2010, PROTOPLASMA, V243, P15, DOI 10.1007/s00709-009-0048-5; Holzinger A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110630; Holzinger A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00327; Holzinger A, 2011, J PHYCOL, V47, P591, DOI 10.1111/j.1529-8817.2011.00980.x; Holzinger A, 2009, MICRON, V40, P831, DOI 10.1016/j.micron.2009.06.008; Hoppert M, 2004, GEOMICROBIOL J, V21, P183, DOI 10.1080/01490450490275433; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Kadlubowska JZ, 1984, SUSSWASSERFLORA MITT, V16, P1; Kaplan F, 2013, MICRON, V44, P317, DOI 10.1016/j.micron.2012.08.004; Karsten U, 2014, J PHYCOL, V50, P804, DOI 10.1111/jpy.12210; Karsten U, 2014, BIODIVERS CONSERV, V23, P1845, DOI 10.1007/s10531-014-0653-2; Karsten U, 2012, MICROB ECOL, V63, P51, DOI 10.1007/s00248-011-9924-6; Kim GH, 2011, ARCTIC, V64, P25, DOI 10.14430/arctic4077; Leliaert F, 2012, CRIT REV PLANT SCI, V31, P1, DOI 10.1080/07352689.2011.615705; Lewis LA, 2005, SYST BIOL, V54, P936, DOI 10.1080/10635150500354852; Marshall WA, 1997, ECOGRAPHY, V20, P585, DOI 10.1111/j.1600-0587.1997.tb00427.x; Mata TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI 10.1016/j.rser.2009.07.020; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; McCourt RM, 2000, J PHYCOL, V36, P747, DOI 10.1046/j.1529-8817.2000.99106.x; McLean R.J., 1971, CONTRIBUTIONS PHYCOL, P145; MORISON MO, 1985, PHYCOLOGIA, V24, P129, DOI 10.2216/i0031-8884-24-2-129.1; Nylander JAA, 2004, MRMODELTEST 2 3; Pichrtova M, 2014, FEMS MICROBIOL ECOL, V89, P270, DOI 10.1111/1574-6941.12288; Pichrtova M, 2013, MICROB ECOL, V65, P68, DOI 10.1007/s00248-012-0096-9; POST A, 1993, AQUAT BOT, V45, P231, DOI 10.1016/0304-3770(93)90023-P; Rambaut A, 2009, FIGTREE TREE FIGURE; Remias D, 2012, POLAR BIOL, V35, P899, DOI 10.1007/s00300-011-1135-6; Remias D, 2009, PHYCOLOGIA, V48, P302, DOI 10.2216/08-13.1; Rindi F, 2010, ENVIRON SCI ENG TECH, P105; Rohacek K, 1999, PHOTOSYNTHETICA, V37, P339, DOI 10.1023/A:1007172424619; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanderson MJ, 2004, AM J BOT, V91, P1656, DOI 10.3732/ajb.91.10.1656; Shiratake T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079630; Stancheva R, 2014, J PHYCOL, V50, P790, DOI 10.1111/jpy.12229; Stancheva R, 2012, J PHYCOL, V48, P409, DOI 10.1111/j.1529-8817.2012.01127.x; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Timme RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029696; Vilumbrales D.M., 2013, CZECH POLAR REPORTS, V3, P163, DOI [DOI 10.5817/CPR2013-2-17, 10.5817/CPR2013-2-17]; Wodniok S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-104; Zhong BJ, 2014, MOL BIOL EVOL, V31, P177, DOI 10.1093/molbev/mst200; Zhong BJ, 2013, TRENDS PLANT SCI, V18, P492, DOI 10.1016/j.tplants.2013.04.009; Zwickl DJ., 2006, THESIS	62	47	47	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113137	10.1371/journal.pone.0113137	http://dx.doi.org/10.1371/journal.pone.0113137			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398135	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558500136
J	Trenado, C; Amtage, F; Huethe, F; Schulte-Monting, J; Mendez-Balbuena, I; Baker, SN; Baker, M; Hepp-Reymond, MC; Manjarrez, E; Kristeva, R				Trenado, Carlos; Amtage, Florian; Huethe, Frank; Schulte-Moenting, Juergen; Mendez-Balbuena, Ignacio; Baker, Stuart N.; Baker, Mark; Hepp-Reymond, Marie-Claude; Manjarrez, Elias; Kristeva, Rumyana			Suppression of Enhanced Physiological Tremor via Stochastic Noise: Initial Observations	PLOS ONE			English	Article							CORRELATED CORTICAL ACTIVITY; EMG ACTIVATION PATTERNS; DEEP BRAIN-STIMULATION; PRIMATE MOTOR CORTEX; VENTROLATERAL THALAMOTOMY; PRECISION GRIP; PARKINSONS-DISEASE; FORCE PRODUCTION; DOUBLE-BLIND; HAND TREMOR	Enhanced physiological tremor is a disabling condition that arises because of unstable interactions between central tremor generators and the biomechanics of the spinal stretch reflex. Previous work has shown that peripheral input may push the tremor-related spinal and cortical systems closer to anti-phase firing, potentially leading to a reduction in tremor through phase cancellation. The aim of the present study was to investigate whether peripherally applied mechanical stochastic noise can attenuate enhanced physiological tremor and improve motor performance. Eight subjects with enhanced physiological tremor performed a visuomotor task requiring the right index finger to compensate a static force generated by a manipulandum to which Gaussian noise (3-35 Hz) was applied. The finger position was displayed on-line on a monitor as a small white dot which the subjects had to maintain in the center of a larger green circle. Electromyogram (EMG) from the active hand muscles and finger position were recorded. Performance was measured by the mean absolute deviation of the white dot from the zero position. Tremor was identified by the acceleration in the frequency range 7-12 Hz. Two different conditions were compared: with and without superimposed noise at optimal amplitude (determined at the beginning of the experiment). The application of optimum noise reduced tremor (accelerometric amplitude and EMG activity) and improved the motor performance (reduced mean absolute deviation from zero). These data provide the first evidence of a significant reduction of enhanced physiological tremor in the human sensorimotor system due to application of external stochastic noise.	[Trenado, Carlos; Amtage, Florian; Huethe, Frank; Kristeva, Rumyana] Univ Freiburg, Dept Neurol & Neurophysiol, D-79106 Freiburg, Germany; [Schulte-Moenting, Juergen] Univ Freiburg, Inst Med Biometry & Med Informat, D-79106 Freiburg, Germany; [Mendez-Balbuena, Ignacio] Benemerita Univ Autonoma Puebla, Fac Psicol, Puebla, Mexico; [Baker, Stuart N.; Baker, Mark] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Hepp-Reymond, Marie-Claude] Univ Zurich, Inst Neuroinformat, Zurich, Switzerland; [Hepp-Reymond, Marie-Claude] ETH, Zurich, Switzerland; [Manjarrez, Elias] Benemerita Univ Autonoma Puebla, Inst Fisiol, Puebla, Mexico	University of Freiburg; University of Freiburg; Benemerita Universidad Autonoma de Puebla; Newcastle University - UK; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Benemerita Universidad Autonoma de Puebla	Manjarrez, E (corresponding author), Benemerita Univ Autonoma Puebla, Inst Fisiol, Puebla, Mexico.	eliasmanjarrez@correo.buap.mx; rumyana.kristeva@uniklinik-freiburg.de	Mendez-Balbuena, Ignacio/AAE-9508-2020; Manjarrez, Elias/B-8492-2012	Mendez-Balbuena, Ignacio/0000-0002-3054-4944; Manjarrez, Elias/0000-0002-3277-0101; Baker, Stuart/0000-0001-8118-4048; Baker, Mark/0000-0001-6916-1329	Deutsche Forschungsgemeinschaft [Kr 1392/11-1]; Vicerrectoria de Investigacion y Estudios de Postgrado (VIEP) - Benemerita Universidad Autonoma de Puebla (BUAP) [MEBI-EDH-14-I]; Programa de mejoramiento al profesorado (PROMEP); Benemerita Universidad Autonoma de Puebla (BUAP) [PTC 352]; "Catedra Marcos Moshinsky'' and "Consejo Nacional de Ciencia y Tecnologia [153583'']; Wellcome Trust fellowship [WT101002MA]; Ataxia UK, FARA (Friedreich's Ataxia Research Alliance, US); GoFAR (Italy); UK Medical Research Council; open access publication fund of the Albert Ludwigs University Freiburg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Vicerrectoria de Investigacion y Estudios de Postgrado (VIEP) - Benemerita Universidad Autonoma de Puebla (BUAP); Programa de mejoramiento al profesorado (PROMEP); Benemerita Universidad Autonoma de Puebla (BUAP); "Catedra Marcos Moshinsky'' and "Consejo Nacional de Ciencia y Tecnologia; Wellcome Trust fellowship(Wellcome Trust); Ataxia UK, FARA (Friedreich's Ataxia Research Alliance, US); GoFAR (Italy); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); open access publication fund of the Albert Ludwigs University Freiburg	RK was supported by Deutsche Forschungsgemeinschaft Grant(Kr 1392/11-1). IMB was supported by Vicerrectoria de Investigacion y Estudios de Postgrado (VIEP) - Benemerita Universidad Autonoma de Puebla (BUAP) MEBI-EDH-14-I and Programa de mejoramiento al profesorado (PROMEP), Benemerita Universidad Autonoma de Puebla (BUAP) and PTC 352. EM was supported by the grants: "Catedra Marcos Moshinsky'' and "Consejo Nacional de Ciencia y Tecnologia, 153583''. SNB was supported by Wellcome Trust fellowship grant number WT101002MA. MB is supported by research grants from Ataxia UK, FARA (Friedreich's Ataxia Research Alliance, US), GoFAR (Italy) and UK Medical Research Council. The article processing charge was funded by the open access publication fund of the Albert Ludwigs University Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gallego JA, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-36; Gallego JA, 2012, IEEE T SYST MAN CY C, V42, P1159, DOI 10.1109/TSMCC.2012.2200101; Bain PG, 2002, J NEUROL NEUROSUR PS, V72, pI3; BERGLUND U, 1970, PERCEPT MOTOR SKILL, V30, P843, DOI 10.2466/pms.1970.30.3.843; CALZETTI S, 1981, J NEUROL NEUROSUR PS, V44, P814, DOI 10.1136/jnnp.44.9.814; Carignan B, 2009, EXP BRAIN RES, V194, P309, DOI 10.1007/s00221-008-1694-0; Daneault JF, 2011, BRAIN RES, V1370, P164, DOI 10.1016/j.brainres.2010.11.047; Deuschl G, 1998, MOVEMENT DISORD, V13, P2, DOI 10.1002/mds.870131303; Duval C, 2000, EXP BRAIN RES, V132, P216, DOI 10.1007/s002210000358; Duval C, 2006, EXP BRAIN RES, V170, P160, DOI 10.1007/s00221-005-0198-4; Duval C, 2005, CLIN NEUROPHYSIOL, V116, P1391, DOI 10.1016/j.clinph.2005.01.012; Elble R.J., 1990, TREMOR, P54; Farmer SF, 2014, J NEUROPHYSIOL, V111, P1151, DOI 10.1152/jn.00873.2013; Hellwig B, 2000, CLIN NEUROPHYSIOL, V111, P806, DOI 10.1016/S1388-2457(00)00248-0; Hellwig B, 2001, LANCET, V357, P519, DOI 10.1016/S0140-6736(00)04044-7; HEPPREYMOND MC, 1978, J PHYSIOL-PARIS, V74, P287; HEPPREYMOND MC, 1989, PROG BRAIN RES, V80, P451; Hubble JP, 1996, NEUROLOGY, V46, P1150, DOI 10.1212/WNL.46.4.1150; JEFFERSON D, 1979, J NEUROL NEUROSUR PS, V42, P831, DOI 10.1136/jnnp.42.9.831; JEFFERSON D, 1979, J NEUROL NEUROSUR PS, V42, P904, DOI 10.1136/jnnp.42.10.904; Koster B, 1998, NEUROSCI LETT, V241, P135, DOI 10.1016/S0304-3940(98)00015-9; Kozelj S, 2014, J NEUROPHYSIOL, V111, P2001, DOI 10.1152/jn.00935.2012; Kumar R, 1998, NEUROLOGY, V51, P850, DOI 10.1212/WNL.51.3.850; Liu Z, 2011, APPL SOFT COMPUT, V11, P5315, DOI 10.1016/j.asoc.2011.05.027; LOGIGIAN EL, 1988, ANN NEUROL, V23, P242, DOI 10.1002/ana.410230306; MAIER MA, 1995, EXP BRAIN RES, V103, P108, DOI 10.1007/BF00241969; MAIER MA, 1995, EXP BRAIN RES, V103, P123, DOI 10.1007/BF00241970; Manto M, 2003, IEEE ENG MED BIOL, V22, P120, DOI 10.1109/MEMB.2003.1213635; McClelland VM, 2014, J NEUROPHYSIOL, V111, P1150, DOI 10.1152/jn.00801.2013; Mendez-Balbuena I, 2012, J NEUROSCI, V32, P12612, DOI 10.1523/JNEUROSCI.0680-12.2012; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Riviere CN, 2003, IEEE T ROBOTIC AUTOM, V19, P793, DOI 10.1109/TRA.2003.817506; Riviere CN, 1998, IEEE T BIO-MED ENG, V45, P839, DOI 10.1109/10.686791; Robinson BW, 2010, IEEE J-STSP, V4, P659, DOI 10.1109/JSTSP.2010.2048240; SANES JN, 1985, J NEUROL NEUROSUR PS, V48, P645, DOI 10.1136/jnnp.48.7.645; Schieber MH, 2002, ADV EXP MED BIOL, V508, P411; Spinks RL, 2008, J NEUROSCI, V28, P10961, DOI 10.1523/JNEUROSCI.1956-08.2008; Trenado C, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00325; Trenado C, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00022; Veluvolu KC, 2013, IEEE T BIO-MED ENG, V60, P3074, DOI 10.1109/TBME.2013.2264546; WANNIER TMJ, 1991, J NEUROPHYSIOL, V65, P572, DOI 10.1152/jn.1991.65.3.572; Ward NJ, 2013, J NEUROPHYSIOL, V110, P1744, DOI 10.1152/jn.00296.2013; Williams ER, 2010, P NATL ACAD SCI USA, V107, P11098, DOI 10.1073/pnas.0913373107	43	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112782	10.1371/journal.pone.0112782	http://dx.doi.org/10.1371/journal.pone.0112782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397577	gold, Green Accepted, Green Published			2022-12-27	WOS:000345558500090
J	Fabrini, R; Bocedi, A; Camerini, S; Fusetti, M; Ottaviani, F; Passali, FM; Topazio, D; Iavarone, F; Francia, I; Castagnola, M; Ricci, G				Fabrini, Raffaele; Bocedi, Alessio; Camerini, Serena; Fusetti, Marco; Ottaviani, Fabrizio; Passali, Francesco M.; Topazio, Davide; Iavarone, Federica; Francia, Irene; Castagnola, Massimo; Ricci, Giorgio			Inactivation of Human Salivary Glutathione Transferase P1-1 by Hypothiocyanite: A Post-Translational Control System in Search of a Role	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; TANDEM MASS-SPECTROMETRY; S-TRANSFERASE; CYSTEINE RESIDUES; HYDROGEN-PEROXIDE; IDENTIFICATION; PROTEOME; BINDING; THIOCYANATE; EVOLUTION	Glutathione transferases (GSTs) are a superfamily of detoxifying enzymes over-expressed in tumor tissues and tentatively proposed as biomarkers for localizing and monitoring injury of specific tissues. Only scarce and contradictory reports exist about the presence and the level of these enzymes in human saliva. This study shows that GSTP1-1 is the most abundant salivary GST isoenzyme, mainly coming from salivary glands. Surprisingly, its activity is completely obscured by the presence of a strong oxidizing agent in saliva that causes a fast and complete, but reversible, inactivation. Although salivary alpha-efensins are also able to inhibit the enzyme causing a peculiar half-site inactivation, a number of approaches (mass spectrometry, site directed mutagenesis, chromatographic and spectrophotometric data) indicated that hypothiocyanite is the main salivary inhibitor of GSTP1-1. Cys47 and Cys101, the most reactive sulfhydryls of GSTP1-1, are mainly involved in a redox interaction which leads to the formation of an intra-chain disulfide bridge. A reactivation procedure has been optimized and used to quantify GSTP1-1 in saliva of 30 healthy subjects with results of 42 +/- 4 mU/mg-protein. The present study represents a first indication that salivary GSTP1-1 may have a different and hitherto unknown function. In addition it fulfills the basis for future investigations finalized to check the salivary GSTP1-1 as a diagnostic biomarker for diseases.	[Fabrini, Raffaele; Bocedi, Alessio; Francia, Irene; Ricci, Giorgio] Univ Roma Tor Vergata, Dept Chem Sci & Technol, I-00133 Rome, Italy; [Camerini, Serena] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Fusetti, Marco] Univ Aquila, Dept Appl Clin Sci, I-67100 Laquila, Italy; [Ottaviani, Fabrizio; Passali, Francesco M.; Topazio, Davide] Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, I-00133 Rome, Italy; [Iavarone, Federica; Castagnola, Massimo] Univ Cattolica Sacro Cuore, Inst Biochem & Clin Biochem, I-00168 Rome, Italy; [Iavarone, Federica; Castagnola, Massimo] CNR, Inst Mol Recognit, I-00168 Rome, Italy	University of Rome Tor Vergata; Istituto Superiore di Sanita (ISS); University of L'Aquila; University of Rome Tor Vergata; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR)	Ricci, G (corresponding author), Univ Roma Tor Vergata, Dept Chem Sci & Technol, I-00133 Rome, Italy.	riccig@uniroma2.it	Castagnola, Massimo/AAM-6355-2021; Castagnola, Massimo/AAB-2825-2019; Camerini, Serena/A-4637-2017; Iavarone, Federica/K-6446-2016	Castagnola, Massimo/0000-0002-0959-7259; Camerini, Serena/0000-0001-6131-4335; Iavarone, Federica/0000-0002-2074-5531; Ricci, Giorgio/0000-0002-7108-2846; PASSALI, Francesco Maria/0000-0003-4032-8230	Catholic University of Rome; MIUR; Italian National Research Council (CNR); Nando Peretti Foundation	Catholic University of Rome; MIUR(Ministry of Education, Universities and Research (MIUR)); Italian National Research Council (CNR)(Consiglio Nazionale delle Ricerche (CNR)); Nando Peretti Foundation	The authors gratefully acknowledge the financial support of Catholic University of Rome, MIUR, Italian National Research Council (CNR) and Nando Peretti Foundation according to their programs of scientific diffusion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; Amado FML, 2013, CLIN BIOCHEM, V46, P506, DOI 10.1016/j.clinbiochem.2012.10.024; Arlandson M, 2001, J BIOL CHEM, V276, P215, DOI 10.1074/jbc.M004881200; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Bald E, 2005, AMINO ACIDS, V28, P431, DOI 10.1007/s00726-005-0195-8; Bocedi A, 2013, J BIOL CHEM, V288, P24936, DOI 10.1074/jbc.M113.476135; Bonne NJ, 2012, GENOME MED, V4, DOI 10.1186/gm383; Cabras T, 2014, BIOANALYSIS, V6, P563, DOI 10.4155/bio.13.349; Cabras T, 2012, J PROTEOMICS, V75, P908, DOI 10.1016/j.jprot.2011.10.006; Caccuri AM, 1999, J BIOL CHEM, V274, P19276, DOI 10.1074/jbc.274.27.19276; Castagnola M, 2011, TRENDS BIOTECHNOL, V29, P409, DOI 10.1016/j.tibtech.2011.04.002; De Luca A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.529; Dessi M, 2012, AMINO ACIDS, V43, P347, DOI 10.1007/s00726-011-1085-x; Fabrini R, 2012, BIOCHEM BIOPH RES CO, V426, P71, DOI 10.1016/j.bbrc.2012.08.037; Fang X, 2007, ANAL CHEM, V79, P5785, DOI 10.1021/ac070611a; Galli F, 1999, CLIN CHEM, V45, P1781; Goebel C, 2000, PEPTIDES, V21, P757, DOI 10.1016/S0196-9781(00)00205-9; Habig W H, 1981, Methods Enzymol, V77, P398; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mannervik B, 2005, METHOD ENZYMOL, V401, P1, DOI 10.1016/S0076-6879(05)01001-3; Meiers I, 2010, ATLAS GENET CYTOGENE, V14, P1181; Nagy P, 2009, CHEM RES TOXICOL, V22, P1833, DOI 10.1021/tx900249d; Oakley AJ, 1999, J MOL BIOL, V291, P913, DOI 10.1006/jmbi.1999.3029; Oppenheim FG, 2007, ANN NY ACAD SCI, V1098, P22, DOI 10.1196/annals.1384.030; Park HJ, 2001, B KOREAN CHEM SOC, V22, P77; PRUITT KM, 1986, BIOCHIM BIOPHYS ACTA, V870, P385, DOI 10.1016/0167-4838(86)90245-1; Rada Balazs, 2008, V15, P164, DOI 10.1159/000136357; RICCI G, 1991, J BIOL CHEM, V266, P21409; RICCI G, 1995, J BIOL CHEM, V270, P1243, DOI 10.1074/jbc.270.3.1243; Ricci G, 2003, BIOCHEM J, V376, P71, DOI 10.1042/BJ20030860; RICCI G, 1989, J BIOL CHEM, V264, P5462; SHEN H, 1993, ARCH BIOCHEM BIOPHYS, V300, P137, DOI 10.1006/abbi.1993.1019; SHEN H, 1991, ARCH BIOCHEM BIOPHYS, V286, P178, DOI 10.1016/0003-9861(91)90025-E; SluisCremer N, 1996, EUR J BIOCHEM, V242, P301, DOI 10.1111/j.1432-1033.1996.0301r.x; Sreerama L, 1995, CLIN CANCER RES, V1, P1153; Stella L, 1999, PROTEINS, V37, P10, DOI 10.1002/(SICI)1097-0134(19991001)37:1<10::AID-PROT2>3.0.CO;2-0; TENOVUO J, 1982, J DENT RES, V61, P982, DOI 10.1177/00220345820610081301; THOMAS EL, 1980, J DENT RES, V59, P1466, DOI 10.1177/00220345800590090201; Vitorino R, 2004, PROTEOMICS, V4, P1109, DOI 10.1002/pmic.200300638; Xie HW, 2005, MOL CELL PROTEOMICS, V4, P1826, DOI 10.1074/mcp.D500008-MCP200	40	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112797	10.1371/journal.pone.0112797	http://dx.doi.org/10.1371/journal.pone.0112797			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393952	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300105
J	Fuentes, E; Pereira, J; Mezzano, D; Alarcon, M; Caballero, J; Palomo, I				Fuentes, Eduardo; Pereira, Jaime; Mezzano, Diego; Alarcon, Marcelo; Caballero, Julio; Palomo, Ivan			Inhibition of Platelet Activation and Thrombus Formation by Adenosine and Inosine: Studies on Their Relative Contribution and Molecular Modeling	PLOS ONE			English	Article							P-SELECTIN EXPRESSION; CD40 LIGAND; CARDIOVASCULAR RISK; RECEPTOR; AGGREGATION; AGENTS; BLOOD; CAMP; INTERVENTION; MECHANISMS	Background: The inhibitory effect of adenosine on platelet aggregation is abrogated after the addition of adenosine-deaminase. Inosine is a naturally occurring nucleoside degraded from adenosine. Objectives: The mechanisms of antiplatelet action of adenosine and inosine in vitro and in vivo, and their differential biological effects by molecular modeling were investigated. Results: Adenosine (0.5, 1 and 2 mmol/L) inhibited phosphatidylserine exposure from 52 +/- 4% in the control group to 44 +/- 4 (p<0.05), 29 +/- 2 (p<0.01) and 20 +/- 3% (p<0.001). P-selectin expression in the presence of adenosine 0.5, 1 and 2 mmol/L was inhibited from 32 +/- 4 to 27 +/- 2 (p<0.05), 14 +/- 3 (p<0.01) and 9 +/- 3% (p<0.001), respectively. At the concentrations tested, only inosine to 4 mmol/L had effect on platelet P-selectin expression (p<0.05). Adenosine and inosine inhibited platelet aggregation and ATP release stimulated by ADP and collagen. Adenosine and inosine reduced collagen-induced platelet adhesion and aggregate formation under flow. At the same concentrations adenosine inhibited platelet aggregation, decreased the levels of sCD40L and increased intraplatelet cAMP. In addition, SQ22536 (an adenylate cyclase inhibitor) and ZM241385 (a potent adenosine receptor A(2A) antagonist) attenuated the effect of adenosine on platelet aggregation induced by ADP and intraplatelet level of cAMP. Adenosine and inosine significantly inhibited thrombosis formation in vivo (6262% occlusion at 60 min [n = 6, p<0.01] and 7261.9% occlusion at 60 min, [n = 6, p<0.05], respectively) compared with the control (9862% occlusion at 60 min, n = 6). A(2A) is the adenosine receptor present in platelets; it is known that inosine is not an A(2A) ligand. Docking of adenosine and inosine inside A(2A) showed that the main difference is the formation by adenosine of an additional hydrogen bond between the NH2 of the adenine group and the residues Asn253 in H6 and Glu169 in EL2 of the A(2A) receptor. Conclusion: Therefore, adenosine and inosine may represent novel agents lowering the risk of arterial thrombosis.	[Fuentes, Eduardo; Alarcon, Marcelo; Palomo, Ivan] Univ Talca, Dept Clin Biochem & Immunohematol, Fac Hlth Sci, Interdisciplinary Excellence Res Program Hlth Agi, Talca, Chile; [Fuentes, Eduardo; Alarcon, Marcelo; Palomo, Ivan] CONICYT Reg, CEAP, Gore Maule, Talca, Chile; [Pereira, Jaime; Mezzano, Diego] Pontificia Univ Catolica Chile, Sch Med, Dept Hematol Oncol, Santiago, Chile; [Caballero, Julio] Univ Talca, Fac Engn Bioinformat, Ctr Bioinformat & Mol Simulat, Talca, Chile	Universidad de Talca; Pontificia Universidad Catolica de Chile; Universidad de Talca	Fuentes, E (corresponding author), Univ Talca, Dept Clin Biochem & Immunohematol, Fac Hlth Sci, Interdisciplinary Excellence Res Program Hlth Agi, Talca, Chile.	edfuentes@utalca.cl; ipalomo@utalca.cl	Palomo, Iván/I-4321-2018; Caballero, Julio/G-3654-2014; Alarcon, Marcelo A/I-5016-2018	Caballero, Julio/0000-0003-0182-1444; Alarcon, Marcelo A/0000-0001-7596-5382; Fuentes Quinteros, Eduardo/0000-0003-0099-4108; Palomo, Ivan/0000-0002-9618-8778	CONICYT REGIONAL / GORE MAULE / CEAP [R09I2001]; Interdisciplinary Excellence Research Program on Healthy Aging (PIEI-ES); Fondecyt, Chile [1130216]	CONICYT REGIONAL / GORE MAULE / CEAP(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT Regional/CEAP); Interdisciplinary Excellence Research Program on Healthy Aging (PIEI-ES); Fondecyt, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was funded by the CONICYT REGIONAL / GORE MAULE / CEAP / R09I2001, Interdisciplinary Excellence Research Program on Healthy Aging (PIEI-ES), and supported by grant no. 1130216 (I. P., M. G., R. M., M. A., J. C.) from Fondecyt, Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ALTMAN R, 1985, THROMB HAEMOSTASIS, V53, P312; Anfossi G, 2002, THROMB RES, V105, P71, DOI 10.1016/S0049-3848(01)00412-1; Antczak AJ, 2010, CELL IMMUNOL, V263, P129, DOI 10.1016/j.cellimm.2010.03.009; Aukrust P, 1999, CIRCULATION, V100, P614, DOI 10.1161/01.CIR.100.6.614; Barrett NE, 2008, BRIT J PHARMACOL, V154, P918, DOI 10.1038/bjp.2008.151; Bautista LE, 2006, EUR J CARDIOV PREV R, V13, P769, DOI 10.1097/01.hjr.0000219113.40662.dd; BORN GVR, 1963, J PHYSIOL-LONDON, V168, P178, DOI 10.1113/jphysiol.1963.sp007185; Burger PC, 2003, BLOOD, V101, P2661, DOI 10.1182/blood-2002-07-2209; Chakhtoura EY, 2000, AM J CARDIOL, V86, P835, DOI 10.1016/S0002-9149(00)01102-4; Collins B, 2003, NAT REV DRUG DISCOV, V2, P11, DOI 10.1038/nrd966; Conant CG, 2009, J VIS EXP; Cristalli G, 2001, MED RES REV, V21, P105, DOI 10.1002/1098-1128(200103)21:2<105::AID-MED1002>3.0.CO;2-U; Daniel JL, 1999, THROMB HAEMOSTASIS, V82, P1322; Dutta-Roy AK, 2001, PLATELETS, V12, P218, DOI 10.1080/09537100120058757; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Enomoto Y, 2011, INT J MOL MED, V27, P695, DOI 10.3892/ijmm.2011.637; Fredholm BB, 2001, BIOCHEM PHARMACOL, V61, P443, DOI 10.1016/S0006-2952(00)00570-0; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Fuentes E, 2012, EVID-BASED COMPL ALT, V2012, P1; Fuentes E, 2014, THROMB HAEMOSTASIS, V111, P491, DOI 10.1160/TH13-05-0386; Fuentes E, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/147031; Fuentes E, 2013, PLATELETS, V24, P255, DOI 10.3109/09537104.2012.690113; Fukuoka T, 2012, J THROMB THROMBOLYS, V34, P193, DOI 10.1007/s11239-012-0703-0; Galliera E, 2012, J Biol Regul Homeost Agents, V26, p35S; Grundy SM, 1999, CIRCULATION, V100, P1481, DOI 10.1161/01.CIR.100.13.1481; Harding SA, 2004, ATHEROSCLEROSIS, V176, P321, DOI 10.1016/j.atherosclerosis.2004.05.008; Hasko G, 2004, TRENDS PHARMACOL SCI, V25, P152, DOI 10.1016/j.tips.2004.01.006; Hasko G, 2000, J IMMUNOL, V164, P1013, DOI 10.4049/jimmunol.164.2.1013; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; HOFFMEISTER HM, 1987, CARDIOVASC RES, V21, P65, DOI 10.1093/cvr/21.1.65; Hsiao G, 2005, ARTERIOSCL THROM VAS, V25, P1998, DOI 10.1161/01.ATV.0000174798.25085.d6; Inoue O, 2003, J CELL BIOL, V160, P769, DOI 10.1083/jcb.200208043; Ji XB, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-44; Johnston-Cox HA, 2011, PURINERG SIGNAL, V7, P357, DOI 10.1007/s11302-011-9220-4; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kim JH, 1996, MOL PHARMACOL, V49, P683; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; LEREA KM, 1987, J BIOL CHEM, V262, P282; LEREA KM, 1987, P NATL ACAD SCI USA, V84, P5620, DOI 10.1073/pnas.84.16.5620; Libersan D, 2003, THROMB HAEMOSTASIS, V89, P310, DOI 10.1055/s-0037-1613448; Loyau S, 2012, ARTERIOSCL THROM VAS, V32, P778, DOI 10.1161/ATVBAHA.111.241067; Minamino T, 1998, J CLIN INVEST, V101, P1643, DOI 10.1172/JCI635; Mujica V, 2010, J AM SOC HYPERTENS, V4, P148, DOI 10.1016/j.jash.2010.02.008; Munoz C, 2012, J MOL GRAPH MODEL, V32, P39, DOI 10.1016/j.jmgm.2011.10.005; Palomo Ivan, 2010, Front Biosci (Schol Ed), V2, P194; Palomo I, 2008, MOL MED REP, V1, P179; Palomo I, 2007, REV MED CHILE, V135, P904; Patrono C, 2008, CHEST, V133, p199S, DOI 10.1378/chest.08-0672; Przyklenk K, 2007, LASER MED SCI, V22, P42, DOI 10.1007/s10103-006-0410-1; Ritchie JL, 2000, CLIN LAB HAEMATOL, V22, P359, DOI 10.1046/j.1365-2257.2000.00339.x; Ruggeri ZM, 1997, THROMB HAEMOSTASIS, V78, P611; SAGEL J, 1975, ANN INTERN MED, V82, P733, DOI 10.7326/0003-4819-82-6-733; Setianto BY, 2010, HEART VESSELS, V25, P282, DOI 10.1007/s00380-009-1199-1; Storey RF, 2002, THROMB HAEMOSTASIS, V88, P488; Tantry US, 2006, FUTUR CARDIOL, V2, P343, DOI 10.2217/14796678.2.3.343; Wagner DD, 2003, ARTERIOSCL THROM VAS, V23, P2131, DOI 10.1161/01.ATV.0000095974.95122.EC; Wang J, 2008, J SEP SCI, V31, P1173, DOI 10.1002/jssc.200700507; Willoughby Scott, 2002, Eur J Cardiovasc Nurs, V1, P273; Yang D, 2010, J THROMB HAEMOST, V8, P817, DOI 10.1111/j.1538-7836.2010.03769.x; Zhao ZH, 2000, BBA-MOL BASIS DIS, V1500, P280, DOI 10.1016/S0925-4439(99)00111-8	62	53	54	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112741	10.1371/journal.pone.0112741	http://dx.doi.org/10.1371/journal.pone.0112741			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393959	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300092
J	Gorokhova, E; Hajdu, S; Larsson, U				Gorokhova, Elena; Hajdu, Susanna; Larsson, Ulf			Responses of Phyto- and Zooplankton Communities to Prymnesium polylepis (Prymnesiales) Bloom in the Baltic Sea	PLOS ONE			English	Article							CHRYSOCHROMULINA-POLYLEPIS; PRYMNESIOPHYCEAE; GROWTH; TOXICITY; HAPTOPHYTA; PARVUM; PROPER; RNA; DYNAMICS; COPEPODS	A large bloom of Prymnesium polylepis occurred in the Baltic Sea during the winter 2007 - spring 2008. Based on numerous reports of strong allelopathic effects on phytoplankton exerted by P. polylepis and its toxicity to grazers, we hypothesized that during this period negative correlations will be observed between P. polylepis and (1) main phytoplankton groups contributing to the spring bloom (i.e., diatoms and dinoflagellates), and (2) zooplankton growth and abundance. To test these hypotheses, we analyzed inter-annual variability in phytoplankton and zooplankton dynamics as well as growth indices (RNA: DNA ratio) in dominant zooplankton in relation to the Prymnesium abundance and biomass. Contrary to the hypothesized relationships, no measurable negative responses to P. polylepis were observed for either the total phytoplankton stocks or the zooplankton community. The only negative response, possibly associated with P. polylepis occurrence, was significantly lower abundance of dinoflagellates both during and after the bloom in 2008. Moreover, contrary to the expected negative effects, there were significantly higher total phytoplankton abundance as well as significantly higher winter abundance and winter-spring RNA: DNA ratio in dominant zooplankton species in 2008, indicating that P. polylepis bloom coincided with favourable feeding conditions for zooplankton. Thus, primary consumers, and consequently also zooplanktivores (e.g., larval fish and mysids), may benefit from haptophyte blooms, particularly in winter, when phytoplankton is scarce.	[Gorokhova, Elena; Hajdu, Susanna; Larsson, Ulf] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [Gorokhova, Elena] Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden	Stockholm University; Stockholm University	Gorokhova, E (corresponding author), Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden.	elena.gorokhova@itm.su.se	Gorokhova, Elena/E-7105-2018	Gorokhova, Elena/0000-0002-4192-6956	Swedish EPA's National Marine Monitoring Program; SYVAB's marine monitoring program in Himmerfjarden; Stockholm University's strategic marine environmental research program Baltic Ecosystem Adaptive Management	Swedish EPA's National Marine Monitoring Program; SYVAB's marine monitoring program in Himmerfjarden; Stockholm University's strategic marine environmental research program Baltic Ecosystem Adaptive Management	Financial support was received from The Swedish EPA's National Marine Monitoring Program (UL, EG), SYVAB's marine monitoring program in Himmerfjarden (UL), and Stockholm University's strategic marine environmental research program Baltic Ecosystem Adaptive Management (EG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreiro A, 2005, AQUAT MICROB ECOL, V38, P259, DOI 10.3354/ame038259; CARLSSON P, 1990, TOXIC MARINE PHYTOPLANKTON, P116; Dahl E, 2005, J SEA RES, V54, P15, DOI 10.1016/j.seares.2005.02.004; Dahl E, 1989, COASTAL ESTUARINE ST, V35, P383; EDVARDSEN B, 1992, J PHYCOL, V28, P104, DOI 10.1111/j.0022-3646.1992.00104.x; EDVARDSEN B, 1990, TOXIC MARINE PHYTOPLANKTON, P284; Edvardsen B., 1998, PHYSL ECOLOGY HARMFU, P193; EDVARDSEN B, 1996, THESIS U OSLO; EDVARDSEN B., 1996, HARMFUL TOXIC ALGAL, P231; Edvardsen B, 2011, EUR J PHYCOL, V46, P202, DOI 10.1080/09670262.2011.594095; Errera RM, 2008, AQUAT MICROB ECOL, V52, P33, DOI 10.3354/ame01199; Gjosaeter J, 2000, MAR ECOL PROG SER, V207, P201, DOI 10.3354/meps207201; Gorokhova E, 2005, LIMNOL OCEANOGR-METH, V3, P143, DOI 10.4319/lom.2005.3.143; Gorokhova E, 2002, J PLANKTON RES, V24, P511, DOI 10.1093/plankt/24.5.511; Gorokhova E, 2007, MAR ECOL PROG SER, V349, P213, DOI 10.3354/meps07100; GRANELI E, 1993, DEV MAR BIO, V3, P23; Graneli E, 2012, HARMFUL ALGAE, V14, P260, DOI 10.1016/j.hal.2011.10.024; Graneli E, 2010, J AM WATER RESOUR AS, V46, P108, DOI 10.1111/j.1752-1688.2009.00395.x; GRANMO A, 1988, J EXP MAR BIOL ECOL, V124, P65, DOI 10.1016/0022-0981(88)90206-7; Hajdu S, 1996, BOT MAR, V39, P281, DOI 10.1515/botm.1996.39.1-6.281; HANSEN PJ, 1995, PHYCOLOGIA, V34, P409, DOI 10.2216/i0031-8884-34-5-409.1; HELCOM, 1988, BALT SEA ENV P D; Hernroth L., 1985, MESOZOOPLANKTON BIOM, V10; Hook TO, 2008, ESTUAR COAST SHELF S, V76, P29, DOI 10.1016/j.ecss.2007.06.012; Hogfors H, 2011, J PLANKTON RES, V33, P1460, DOI 10.1093/plankt/fbr043; Hoglander H, 2004, MAR ECOL PROG SER, V283, P15, DOI 10.3354/meps283015; Holmborn T, 2009, LIMNOL OCEANOGR-METH, V7, P785, DOI 10.4319/lom.2009.7.785; Houdan A, 2004, J PLANKTON RES, V26, P875, DOI 10.1093/plankt/fbh079; Johansson M, 2004, J PLANKTON RES, V26, P67, DOI 10.1093/plankt/fbg115; Johansson N, 1999, MAR BIOL, V135, P209, DOI 10.1007/s002270050618; John Uwe, 2002, Harmful Algae, V1, P45, DOI 10.1016/S1568-9883(02)00005-7; Jones Harriet L.J., 1994, Systematics Association Special Volume Series, V51, P247; JONES HLJ, 1995, PHYCOLOGIA, V34, P128, DOI 10.2216/i0031-8884-34-2-128.1; JONES HLJ, 1993, J MAR BIOL ASSOC UK, V73, P283, DOI 10.1017/S0025315400032859; Jorgensen L, 2014, BIOGEOCHEMISTRY, V117, P455, DOI 10.1007/s10533-013-9890-9; Kott P., 1953, AUST J MAR FRESHW RE, V4, P387; Larsson K, 2014, J SEA RES, V88, P21, DOI 10.1016/j.seares.2013.12.017; Leivestad H, 1988, 8803 BKO NORV I MAR; Lindehoff E, 2011, HARMFUL ALGAE, V12, P70, DOI 10.1016/j.hal.2011.09.001; Majaneva M, 2012, EUR J PHYCOL, V47, P310, DOI 10.1080/09670262.2012.713997; Moestrup Ojvind, 1994, Systematics Association Special Volume Series, V51, P265; Myklestad Sverre M., 1995, P633; Nejstgaard JC, 1996, SARSIA, V81, P339, DOI 10.1080/00364827.1996.10413631; NIELSEN TG, 1990, MAR ECOL PROG SER, V62, P21, DOI 10.3354/meps062021; Ning J, 2013, DEEP-SEA RES PT II, V97, P109, DOI 10.1016/j.dsr2.2013.05.019; Olenina I, 2006, HELCOM BALTIC SEA EN; Ptacnik R, 2004, LIMNOL OCEANOGR, V49, P1435, DOI 10.4319/lo.2004.49.4_part_2.1435; ROSENBERG R, 1988, AMBIO, V17, P289; Savage C, 2004, ECOL APPL, V14, P517, DOI 10.1890/02-5396; Schmidt LE, 2001, MAR ECOL PROG SER, V216, P67, DOI 10.3354/meps216067; TOBIESEN A, 1991, OPHELIA, V33, P205, DOI 10.1080/00785326.1991.10429711; Unrein F, 2014, ISME J, V8, P164, DOI 10.1038/ismej.2013.132; Vehmaa A, 2012, ICES J MAR SCI, V69, P351, DOI 10.1093/icesjms/fsr138; YASUMOTO T, 1990, TOXIC MARINE PHYTOPLANKTON, P436; [No title captured]	55	7	7	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112985	10.1371/journal.pone.0112985	http://dx.doi.org/10.1371/journal.pone.0112985			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393031	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300133
J	Haghighi, A; Tiwari, A; Piri, N; Nurnberg, G; Saleh-Gohari, N; Haghighi, A; Neidhardt, J; Nurnberg, P; Berger, W				Haghighi, Alireza; Tiwari, Amit; Piri, Niloofar; Nuernberg, Gudrun; Saleh-Gohari, Nasrollah; Haghighi, Amirreza; Neidhardt, John; Nuernberg, Peter; Berger, Wolfgang			Homozygosity Mapping and Whole Exome Sequencing Reveal a Novel Homozygous COL18A1 Mutation Causing Knobloch Syndrome	PLOS ONE			English	Article							COLLAGEN-XVIII; GENETIC-HETEROGENEITY; ENDOGENOUS INHIBITOR; LOCUS HETEROGENEITY; MOLECULAR ANALYSIS; ANGIOGENESIS; ENDOSTATIN; DEGENERATION; VARIANT; FORMS	The aim of this study was to identify the genetic basis of a chorioretinal dystrophy with high myopia of unknown origin in a child of a consanguineous marriage. The proband and ten family members of Iranian ancestry participated in this study. Linkage analysis was carried out with DNA samples of the proband and her parents by using the Human SNP Array 6.0. Whole exome sequencing (WES) was performed with the patients' DNA. Specific sequence alterations within the homozygous regions identified by whole exome sequencing were verified by Sanger sequencing. Upon genetic analysis, a novel homozygous frameshift mutation was found in exon 42 of the COL18A1 gene in the patient. Both parents were heterozygous for this sequence variation. Mutations in COL18A1 are known to cause Knobloch syndrome (KS). Retrospective analysis of clinical records of the patient revealed surgical removal of a meningocele present at birth. The clinical features shown by our patient were typical of KS with the exception of chorioretinal degeneration which is a rare manifestation. This is the first case of KS reported in a family of Iranian ancestry. We identified a novel disease-causing (deletion) mutation in the COL18A1 gene leading to a frameshift and premature stop codon in the last exon. The mutation was not present in SNP databases and was also not found in 192 control individuals. Its localization within the endostatin domain implicates a functional relevance of endostatin in KS. A combined approach of linkage analysis and WES led to a rapid identification of the disease-causing mutation even though the clinical description was not completely clear at the beginning.	[Haghighi, Alireza] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02138 USA; [Haghighi, Alireza] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Haghighi, Alireza] Brigham & Womens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Tiwari, Amit; Neidhardt, John; Berger, Wolfgang] Univ Zurich, Inst Med Mol Genet, CH-8952 Schlieren, Switzerland; [Piri, Niloofar] Univ Louisville, Dept Ophthalmol & Visual Sci, Kentucky Lions Eye Ctr, Louisville, KY 40292 USA; [Nuernberg, Gudrun; Nuernberg, Peter] Univ Cologne, CCG, D-50931 Cologne, Germany; [Saleh-Gohari, Nasrollah] Kerman Univ Med Sci, Dept Genet, Kerman, Iran; [Haghighi, Amirreza] Univ Toronto, Toronto Gen Hosp, Toronto, ON M5G 1L7, Canada; [Berger, Wolfgang] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Berger, Wolfgang] Univ Zurich, Neurosci Ctr Zurich ZNZ, Zurich, Switzerland; [Berger, Wolfgang] Swiss Fed Inst Technol, Zurich, Switzerland; [Nuernberg, Peter] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; University of Louisville; University of Cologne; Kerman University of Medical Sciences; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Cologne; University of Cologne	Haghighi, A (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02138 USA.	haghighimd@yahoo.com; berger@medgen.uzh.ch	Gohari, Nasrollah Saleh/ABB-4209-2020; Neidhardt, John/J-4310-2017	Gohari, Nasrollah Saleh/0000-0003-1256-0323; Piri, Niloofar/0000-0002-0685-028X; Neidhardt, John/0000-0002-9205-8394	Swiss National Science Foundation [320030_138507]; Velux Stiftung, Switzerland	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Velux Stiftung, Switzerland	This study was undertaken as part of GENE-ME (a research initiative for investigation of inherited diseases from the Middle-East). This study was funded by a grant from the Swiss National Science Foundation (Grant number: 320030_138507) to WB and JN and from Velux Stiftung, Switzerland to WB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Aldahmesh MA, 2013, J MED GENET, V50, P565, DOI 10.1136/jmedgenet-2013-101755; Aldahmesh MA, 2011, J MED GENET, V48, P597, DOI 10.1136/jmedgenet-2011-100306; CZEIZEL AE, 1992, AM J MED GENET, V42, P777, DOI 10.1002/ajmg.1320420605; Duh EJ, 2004, OPHTHALMOLOGY, V111, P1885, DOI 10.1016/j.ophtha.2004.03.030; Fukai N, 2002, EMBO J, V21, P1535, DOI 10.1093/emboj/21.7.1535; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Iqbal M, 1998, EYE, V12, P260, DOI 10.1038/eye.1998.61; Joyce S, 2010, AM J MED GENET A, V152A, P2880, DOI 10.1002/ajmg.a.33619; Keren B, 2007, AM J MED GENET A, V143A, P1514, DOI 10.1002/ajmg.a.31784; Khan AO, 2012, BRIT J OPHTHALMOL, V96, P890, DOI 10.1136/bjophthalmol-2011-301396; Kliemann SE, 2003, AM J MED GENET A, V119A, P15, DOI 10.1002/ajmg.a.20070; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mahajan VB, 2010, AM J MED GENET A, V152A, P2875, DOI 10.1002/ajmg.a.33621; Menzel O, 2004, HUM MUTAT, V23, P77, DOI 10.1002/humu.10284; O'Connell AC, 2009, INT J PAEDIATR DENT, V19, P213, DOI 10.1111/j.1365-263X.2008.00923.x; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Passos-Bueno MR, 2006, AN ACAD BRAS CIENC, V78, P123, DOI 10.1590/S0001-37652006000100012; PASSOSBUENO MR, 1994, AM J MED GENET, V52, P170, DOI 10.1002/ajmg.1320520209; Perrault I, 2012, NAT GENET, V44, P975, DOI 10.1038/ng.2357; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Rygh CB, 2013, J PHYSL; Saarela J, 1998, MATRIX BIOL, V16, P319, DOI 10.1016/S0945-053X(98)90003-8; Sasaki T, 2000, J MOL BIOL, V301, P1179, DOI 10.1006/jmbi.2000.3996; Sasaki T, 1998, EMBO J, V17, P4249, DOI 10.1093/emboj/17.15.4249; SEAVER LH, 1993, AM J MED GENET, V46, P203, DOI 10.1002/ajmg.1320460221; Sertie AL, 1996, HUM MOL GENET, V5, P843, DOI 10.1093/hmg/5.6.843; Sertie AL, 2000, HUM MOL GENET, V9, P2051, DOI 10.1093/hmg/9.13.2051; Sniderman LC, 2000, AM J MED GENET, V90, P146, DOI 10.1002/(SICI)1096-8628(20000117)90:2<146::AID-AJMG11>3.3.CO;2-Q; Stahl S, 2005, GENES CELLS, V10, P929, DOI 10.1111/j.1365-2443.2005.00890.x; Suzuki O, 2009, MOL VIS, V15, P801; Suzuki OT, 2002, AM J HUM GENET, V71, P1320, DOI 10.1086/344695; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Williams TA, 2008, OPHTHALMIC GENET, V29, P85, DOI 10.1080/13816810701850041; Wilson C, 1998, AM J MED GENET, V78, P286, DOI 10.1002/(SICI)1096-8628(19980707)78:3<286::AID-AJMG16>3.0.CO;2-B	36	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112747	10.1371/journal.pone.0112747	http://dx.doi.org/10.1371/journal.pone.0112747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392994	Green Published, Green Accepted, gold			2022-12-27	WOS:000347709300095
J	Ma, RB; Xu, WC; Zhang, Y; Ye, ZF				Ma, Rubao; Xu, Weichao; Zhang, Yun; Ye, Zhongfu			Asymptotic Properties of Pearson's Rank-Variate Correlation Coefficient under Contaminated Gaussian Model	PLOS ONE			English	Article							STATISTICS CORRELATION-COEFFICIENT; PERFORMANCE ANALYSIS; SIGNALS; ROBUSTNESS; ESTIMATORS; NETWORKS	This paper investigates the robustness properties of Pearson's rank-variate correlation coefficient (PRVCC) in scenarios where one channel is corrupted by impulsive noise and the other is impulsive noise-free. As shown in our previous work, these scenarios that frequently encountered in radar and/or sonar, can be well emulated by a particular bivariate contaminated Gaussian model (CGM). Under this CGM, we establish the asymptotic closed forms of the expectation and variance of PRVCC by means of the well known Delta method. To gain a deeper understanding, we also compare PRVCC with two other classical correlation coefficients, i.e., Spearman's rho (SR) and Kendall's tau (KT), in terms of the root mean squared error (RMSE). Monte Carlo simulations not only verify our theoretical findings, but also reveal the advantage of PRVCC by an example of estimating the time delay in the particular impulsive noise environment.	[Ma, Rubao; Xu, Weichao; Zhang, Yun] Guangdong Univ Technol, Sch Automat, Dept Automat Control, Guangzhou, Guangdong, Peoples R China; [Ye, Zhongfu] Univ Sci & Technol China, Dept Elect Engn & Informat Sci, Hefei 230026, Anhui, Peoples R China	Guangdong University of Technology; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Xu, WC (corresponding author), Guangdong Univ Technol, Sch Automat, Dept Automat Control, Guangzhou, Guangdong, Peoples R China.	wcxu@gdut.edu.cn			National Natural Science Foundation of China [61271380]; Guangdong Natural Science Foundation [S2012010009870]; Guangdong University of Technology [112418006, GDUT2011-07]; Talent Introduction Special Funds from Guangdong Province [2050205]; Key Laboratory of Guangdong Higher Education Institutes of China [2013CXZDA015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangdong University of Technology(Guangdong University of Technology); Talent Introduction Special Funds from Guangdong Province; Key Laboratory of Guangdong Higher Education Institutes of China	This work was supported in part by National Natural Science Foundation of China (Project 61271380), in part by Guangdong Natural Science Foundation (Project S2012010009870), in part by 100-Talents Scheme Funding from Guangdong University of Technology (Grant 112418006), in part by the Talent Introduction Special Funds from Guangdong Province (Grant 2050205), in part by a team project from Guangdong University of Technology (Grant GDUT2011-07), and Project Program of Key Laboratory of Guangdong Higher Education Institutes of China (Grant 2013CXZDA015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axehill D, 2008, IEEE T SIGNAL PROCES, V56, P4377, DOI 10.1109/TSP.2008.926190; BALAKRISHNAN N, 1998, ORDER STATISTICS APP, V17; BALAKRISHNAN N, 1998, ORDER STATISTICS THE, V16; Beko M, 2008, IEEE T SIGNAL PROCES, V56, P2915, DOI 10.1109/TSP.2008.917363; Chaux C, 2008, IEEE T SIGNAL PROCES, V56, P3855, DOI 10.1109/TSP.2008.921757; Chen R, 2000, IEEE T INFORM THEORY, V46, P2079, DOI 10.1109/18.868479; Chorti A, 2008, IEEE T SIGNAL PROCES, V56, P4738, DOI 10.1109/TSP.2008.924144; DAVID H, 2003, ORDER STATISTICS; Delmas JP, 2009, SIGNAL PROCESS, V89, P2670, DOI 10.1016/j.sigpro.2009.05.013; Fisher R. A., 1921, METRON             4, V1, P3, DOI DOI 10.1093/BIOMET/9.1-2.22; Gao ZK, 2013, EPL-EUROPHYS LETT, V103, DOI 10.1209/0295-5075/103/50004; Gao ZK, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.032910; Gibbons JD, 1992, NONPARAMETRIC STAT I; Gini F, 1999, IEE P-RADAR SON NAV, V146, P133, DOI 10.1049/ip-rsn:19990479; Gini F, 1998, IEEE T SIGNAL PROCES, V46, P1945, DOI 10.1109/78.700966; Girault JM, 2010, SIGNAL PROCESS, V90, P2690, DOI 10.1016/j.sigpro.2010.03.019; Greco M, 2008, IEEE T SIGNAL PROCES, V56, P1984, DOI 10.1109/TSP.2007.909326; JACOVITTI G, 1992, IEEE T SIGNAL PROCES, V40, P114, DOI 10.1109/78.157187; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Li JM, 2013, MECH SYST SIGNAL PR, V36, P240, DOI 10.1016/j.ymssp.2012.12.004; Li LX, 2014, P NATL ACAD SCI USA, V111, P8392, DOI 10.1073/pnas.1407083111; Lian J, 2010, SIGNAL PROCESS, V90, P684, DOI 10.1016/j.sigpro.2009.07.010; Liu LY, 2008, IEEE T SIGNAL PROCES, V56, P990, DOI 10.1109/TSP.2006.890827; Ma RB, 2014, SIGNAL PROCESS, V104, P51, DOI 10.1016/j.sigpro.2014.04.003; Mari D, 2001, CORRELATION DEPENDEN; MORAN PAP, 1948, BIOMETRIKA, V35, P203, DOI 10.2307/2332641; Pearson K, 1914, BIOMETRIKA, V10, P416, DOI 10.2307/2331792; Reznic Z, 2002, IEEE T INFORM THEORY, V48, P776, DOI 10.1109/18.986045; SCHECHTMAN E, 1987, COMMUN STAT THEORY, V16, P207, DOI 10.1080/03610928708829359; SERFLING RJ, 2002, WILEY SERIES PROBABI; Stein DWJ, 1995, IEEE T INFORM THEORY, V41, P1788, DOI 10.1109/18.476307; STUART A, 1994, KENDALLS ADVANCED TH, V1; Su Z, 2014, SCI REP-UK, V4, DOI 10.1038/srep05413; Tao R, 2008, IEEE T SIGNAL PROCES, V56, P4199, DOI 10.1109/TSP.2008.925579; XU W, 2006, ICASSP 2006 P, V2; Xu W, 2009, IEEE T VEH TECHNOL, V58, P4406, DOI 10.1109/TVT.2009.2020725; Xu WC, 2008, IEEE T SIGNAL PROCES, V56, P2239, DOI 10.1109/TSP.2007.916127; Xu W, 2007, IEEE T SIGNAL PROCES, V55, P5552, DOI 10.1109/TSP.2007.899374; Xu WC, 2013, SIGNAL PROCESS, V93, P261, DOI 10.1016/j.sigpro.2012.08.005; Xu WC, 2010, IEEE T SIGNAL PROCES, V58, P522, DOI 10.1109/TSP.2009.2032448	40	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112215	10.1371/journal.pone.0112215	http://dx.doi.org/10.1371/journal.pone.0112215			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393286	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300040
J	Noulin, F; Manesia, JK; Rosanas-Urgell, A; Erhart, A; Borlon, C; Van Den Abbeele, J; d'Alessandro, U; Verfaillie, CM				Noulin, Florian; Manesia, Javed Karim; Rosanas-Urgell, Anna; Erhart, Annette; Borlon, Celine; Van Den Abbeele, Jan; d'Alessandro, Umberto; Verfaillie, Catherine M.			Hematopoietic Stem/Progenitor Cell Sources to Generate Reticulocytes for Plasmodium vivax Culture	PLOS ONE			English	Article							RED-BLOOD-CELLS; IN-VITRO CULTURE; STEM-CELLS; BONE-MARROW; CORD-BLOOD; PERIPHERAL-BLOOD; MALARIA; INFECTION; INVASION	The predilection of Plasmodium vivax (P. vivax) for reticulocytes is a major obstacle for its establishment in a long-term culture system, as this requires a continuous supply of large quantities of reticulocytes, representing only 1-2% of circulating red blood cells. We here compared the production of reticulocytes using an established in vitro culture system from three different sources of hematopoietic stem/ progenitor cells (HSPC), i.e. umbilical cord blood (UCB), bone marrow (BM) and adult peripheral blood (PB). Compared to CD34(+)-enriched populations of PB and BM, CD34(+)-enriched populations of UCB produced the highest amount of reticulocytes that could be invaded by P. vivax. In addition, when CD34(+)-enriched cells were first expanded, a further extensive increase in reticulocytes was seen for UCB, to a lesser degree BM but not PB. As invasion by P. vivax was significantly better in reticulocytes generated in vitro, we also suggest that P. vivax may have a preference for invading immature reticulocytes, which should be confirmed in future studies.	[Noulin, Florian; Rosanas-Urgell, Anna; Erhart, Annette; Borlon, Celine] Inst Trop Med, Unit Malariol, B-2000 Antwerp, Belgium; [Manesia, Javed Karim; Verfaillie, Catherine M.] Stem Cell Inst, Dept Dev & regenerat, Leuven, Belgium; [Van Den Abbeele, Jan] Inst Trop Med, Unit Vet Protozool, B-2000 Antwerp, Belgium; [d'Alessandro, Umberto] MRC Unit, Fajara, Gambia	Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); University of London; London School of Hygiene & Tropical Medicine	Noulin, F (corresponding author), Inst Trop Med, Unit Malariol, B-2000 Antwerp, Belgium.	flo_noulin@hotmail.com	Rosanas-Urgell, Anna/D-3193-2015; D'Alessandro, Umberto/D-3457-2015; noulin, florian/J-3809-2013; Verfaillie, Catherine/H-5148-2013	Rosanas-Urgell, Anna/0000-0002-0432-5203; D'Alessandro, Umberto/0000-0001-6341-5009; noulin, florian/0000-0001-7430-8073; Van Den Abbeele, Jan/0000-0002-4533-4480; Verfaillie, Catherine/0000-0001-7564-4079	ITM Secondary Research Funding (SOFI-B)	ITM Secondary Research Funding (SOFI-B)	The funding was provided by ITM Secondary Research Funding (SOFI-B), http://www.itg.be/itgtool_v2/Projecten/Project.asp?PNr=755023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENDER JG, 1994, CLIN IMMUNOL IMMUNOP, V70, P10, DOI 10.1006/clin.1994.1003; Borlon C, 2012, INT J PARASITOL, V42, P155, DOI 10.1016/j.ijpara.2011.10.011; Douay L, 2007, TRANSFUS MED REV, V21, P91, DOI 10.1016/j.tmrv.2006.11.004; Fernandez-Becerra C, 2013, MEM I OSWALDO CRUZ, V108, P801, DOI 10.1590/0074-0276108062013019; Furuya T, 2014, PARASITOL INT, V63, P278, DOI 10.1016/j.parint.2013.11.011; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; Golenda CF, 1997, P NATL ACAD SCI USA, V94, P6786, DOI 10.1073/pnas.94.13.6786; Martin-Jaular L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-434; Moreno-Perez DA, 2013, BIOL CELL, V105, P251, DOI 10.1111/boc.201200093; Noulin F, 2013, TRENDS PARASITOL, V29, P286, DOI 10.1016/j.pt.2013.03.012; Noulin F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040798; PATERAKIS GS, 1993, ACTA HAEMATOL-BASEL, V90, P182; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Russell B, 2011, BLOOD, V118, pE74, DOI 10.1182/blood-2011-04-348748; Steidl U, 2002, BLOOD, V99, P2037, DOI 10.1182/blood.V99.6.2037; Tasanee P, 2007, INT J PARASITOL, V37, P1551, DOI 10.1016/j.ijpara.2007.05.009	16	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112496	10.1371/journal.pone.0112496	http://dx.doi.org/10.1371/journal.pone.0112496			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393299	Green Published, gold, Green Submitted			2022-12-27	WOS:000347709300061
J	Shu, C; Liu, ZT; Cui, LF; Wei, CG; Wang, SW; Tang, JJ; Cui, M; Lian, GD; Li, W; Liu, XF; Xu, HM; Jiang, J; Lee, P; Zhang, DY; He, J; Ye, F				Shu, Chang; Liu, Zitao; Cui, Lifeng; Wei, Chengguo; Wang, Shuwen; Tang, Jian Jenny; Cui, Miao; Lian, Guodong; Li, Wei; Liu, Xiufen; Xu, Hongmei; Jiang, Jing; Lee, Peng; Zhang, David Y.; He, Jin; Ye, Fei			Protein Profiling of Preeclampsia Placental Tissues	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR; GROWTH-FACTOR; ANGIOGENIC FACTORS; SIGNALING NETWORK; GENE-EXPRESSION; PREGNANT-WOMEN; EARLY-ONSET; RECEPTOR; SEVERITY; TYPE-1	Preeclampsia is a multi-system disorder involved in pregnancy without an effective treatment except delivery. The precise pathogenesis of this complicated disorder is still not completely understood. The objective of this study is to evaluate the alterations of protein expression and phosphorylations that are important in regulating placental cell function in preterm and term preeclampsia. Using the Protein Pathway Array, 38 proteins in placental tissues were found to be differentially expressed between preterm preeclampsia and gestational age matched control, while 25 proteins were found to be expressed differentially between term preeclampsia and matched controls. Among these proteins, 16 proteins and their associated signaling pathways overlapped between preterm and term preeclampsia, suggesting the common pathogenesis of two subsets of disease. On the other hand, many proteins are uniquely altered in either preterm or term preeclampsia and correlated with severity of clinical symptoms and outcomes, therefore, providing molecular basis for these two subsets of preeclampsia. Furthermore, the expression levels of some of these proteins correlated with neonatal small for gestational age (PAI-1 and PAPP-A) and adverse outcomes (Flt-1) in women with preterm preeclampsia. These proteins could potentially be used as candidate biomarkers for predicting outcomes of preeclampsia.	[Shu, Chang; Cui, Lifeng; Xu, Hongmei; He, Jin] Jilin Univ, Dept Obstet & Gynecol, Changchun 130023, Jilin, Peoples R China; [Liu, Zitao] Tufts Univ, Sch Med, Tufts Med Ctr, Dept Obstet & Gynecol, Boston, MA 02111 USA; [Wei, Chengguo] Icahn Sch Med Mt Sinai, Dept Med Bioinformat Core, New York, NY 10029 USA; [Wang, Shuwen] Comp Ctr Jilin Prov, Changchun, Jilin, Peoples R China; [Tang, Jian Jenny] Icahn Sch Med Mt Sinai, Dept Obstet Gynecol & Reprod Sci, New York, NY 10029 USA; [Lian, Guodong] Shandong Prov Hosp, Dept Gastrointestinal Surg, Jinan, Shandong, Peoples R China; [Li, Wei] Jilin Univ, Hosp 1, Dept Gastrointestinal Surg, Changchun 130023, Jilin, Peoples R China; [Liu, Xiufen] Jilin Univ, Hosp 1, Dept Ophthalmol, Changchun 130023, Jilin, Peoples R China; [Jiang, Jing] Jilin Univ, Hosp 1, Div Clin Epidemiol, Changchun 130023, Jilin, Peoples R China; [Lee, Peng] NYU, Sch Med, Dept Pathol, New York, NY USA; [Lee, Peng] NYU, Sch Med, Inst Canc, New York, NY USA; [Cui, Miao; Zhang, David Y.; Ye, Fei] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA	Jilin University; Tufts Medical Center; Tufts University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Shandong First Medical University & Shandong Academy of Medical Sciences; Jilin University; Jilin University; Jilin University; New York University; New York University; Icahn School of Medicine at Mount Sinai	He, J (corresponding author), Jilin Univ, Dept Obstet & Gynecol, Changchun 130023, Jilin, Peoples R China.	hejin1204@163.com; fei.ye@mssm.edu	xu, hong/GSD-8903-2022; Lian, Guodong/AAW-4701-2020		Icahn School of Medicine at Mount Sinai; First Hospital, Jilin University, Changchun, China	Icahn School of Medicine at Mount Sinai; First Hospital, Jilin University, Changchun, China	This study was supported by funding from the molecular pathology research fund, Icahn School of Medicine at Mount Sinai, and fund from the First Hospital, Jilin University, Changchun, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG Committee on Practice Bulletins--Obstetrics, 2002, Obstet Gynecol, V99, P159; Agarwal I, 2011, PREGNANCY HYPERTENS, V1, P17, DOI 10.1016/j.preghy.2010.10.007; Ahmad S, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-15; Arikan DC, 2012, J MATERN-FETAL NEO M, V25, P1569, DOI 10.3109/14767058.2011.648233; Aufdenblatten M, 2009, PEDIATR RES, V65, P198, DOI 10.1203/PDR.0b013e31818d6c24; Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009; Centlow M, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/472354; Cindrova-Davies T, 2009, PLACENTA, V30, pS55, DOI 10.1016/j.placenta.2008.11.020; Cudmore MJ, 2012, EUR HEART J, V33, P1150, DOI 10.1093/eurheartj/ehr065; Dechend R, 2003, CIRCULATION, V107, P1632, DOI 10.1161/01.CIR.0000058200.90059.B1; Dukhovny S, 2014, J MATERN-FETAL NEO M; Eiland E, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/586578; Espinoza J, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.11.002; Estelles A, 1998, THROMB HAEMOSTASIS, V79, P500; ESTELLES A, 1994, BLOOD, V84, P143; Gennari-Moser C, 2011, ENDOCRINOLOGY, V152, P263, DOI 10.1210/en.2010-0525; Godoi LC, 2012, J THROMB THROMBOLYS, V34, P1, DOI 10.1007/s11239-012-0708-8; Hayashi M, 2004, AM J OBSTET GYNECOL, V190, P456, DOI 10.1016/j.ajog.2003.07.032; Hernandez-Diaz S, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2255; Herse F, 2013, AM J REPROD IMMUNOL, V69, P413, DOI 10.1111/aji.12072; Hoegh AM, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/787545; Hsu TY, 2009, TAIWAN J OBSTET GYNE, V48, P262, DOI 10.1016/S1028-4559(09)60301-6; Irani RA, 2011, SEMIN NEPHROL, V31, P47, DOI 10.1016/j.semnephrol.2010.10.005; Jessmon P, 2010, BIOL REPROD, V82, P921, DOI 10.1095/biolreprod.109.082305; Kolben M, 1995, GYNAKOL GEBURT RUNDS, V35, P126, DOI 10.1159/000272583; Leach RE, 2002, LANCET, V360, P1215, DOI 10.1016/S0140-6736(02)11283-9; Luo X, 2011, CELL TISSUE RES, V344, P551, DOI 10.1007/s00441-011-1164-z; Major HD, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2014.01.024; Mittal P, 2007, J MATERN-FETAL NEO M, V20, P651, DOI 10.1080/14767050701463571; Moldenhauer JS, 2003, AM J OBSTET GYNECOL, V189, P1173, DOI 10.1067/S0002-9378(03)00576-3; Nishizawa H, 2007, PLACENTA, V28, P487, DOI 10.1016/j.placenta.2006.05.010; Ogge G, 2011, J PERINAT MED, V39, P641, DOI [10.1515/JPM.2011.098, 10.1515/jpm.2011.098]; Papadopoulou E, 2006, GROWTH HORM IGF RES, V16, P290, DOI 10.1016/j.ghir.2006.06.006; Rana S, 2012, CIRCULATION, V125, P911, DOI 10.1161/CIRCULATIONAHA.111.054361; Redman CW, 2014, PLACENTA, V35, pS20, DOI 10.1016/j.placenta.2013.12.008; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Roberts JM, 2010, NEW ENGL J MED, V362, P1282, DOI 10.1056/NEJMoa0908056; ROBERTS JM, 1991, AM J HYPERTENS, V4, P700, DOI 10.1093/ajh/4.8.700; Schjetlein R, 1999, ACTA OBSTET GYN SCAN, V78, P191, DOI 10.1034/j.1600-0412.1999.780304.x; Sebire N J, 2005, J Obstet Gynaecol, V25, P117; Shin JK, 2009, J OBSTET GYNAECOL RE, V35, P888, DOI 10.1111/j.1447-0756.2009.01053.x; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Sitras V, 2009, PLACENTA, V30, P424, DOI 10.1016/j.placenta.2009.01.012; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Streyl D, 2012, REPRODUCTION, V143, P85, DOI 10.1530/REP-11-0204; Tache V, 2011, HUM PATHOL, V42, P1283, DOI 10.1016/j.humpath.2010.11.018; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Wagener J, 2013, MOL HUM REPROD, V19, P237, DOI 10.1093/molehr/gas061; Wang DG, 2011, AM J PATHOL, V179, P1657, DOI 10.1016/j.ajpath.2011.06.010; Wikstom AK, 2007, OBSTET GYNECOL, V109, P1368, DOI 10.1097/01.AOG.0000264552.85436.a1; Yang YY, 2012, J CLIN ENDOCR METAB, V97, pE1390, DOI 10.1210/jc.2012-1150; Ye F, 2009, NUTR CANCER, V61, P530, DOI 10.1080/01635580902803719; Zhang DY, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-20; Zhao Y, 2012, FERTIL STERIL, V98, P917, DOI 10.1016/j.fertnstert.2012.06.038	55	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112890	10.1371/journal.pone.0112890	http://dx.doi.org/10.1371/journal.pone.0112890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392996	Green Published, Green Submitted, gold			2022-12-27	WOS:000347709300119
J	Smailhodzic, D; van Asten, F; Blom, AM; Mohlin, FC; den Hollander, AI; van de Ven, JPH; van Huet, RAC; Groenewoud, JMM; Tian, Y; Berendschot, TTJM; Lechanteur, YTE; Fauser, S; de Bruijn, C; Daha, MR; van der Wilt, GJ; Hoyng, CB; Klevering, BJ				Smailhodzic, Dzenita; van Asten, Freekje; Blom, Anna M.; Mohlin, Frida C.; den Hollander, Anneke I.; van de Ven, Johannes P. H.; van Huet, Ramon A. C.; Groenewoud, Joannes M. M.; Tian, Yuan; Berendschot, Tos T. J. M.; Lechanteur, Yara T. E.; Fauser, Sascha; de Bruijn, Chris; Daha, Mohamed R.; van der Wilt, Gert Jan; Hoyng, Carel B.; Klevering, B. Jeroen			Zinc Supplementation Inhibits Complement Activation in Age-Related Macular Degeneration	PLOS ONE			English	Article							FACTOR-H POLYMORPHISM; BLUE MOUNTAINS EYE; DIETARY ANTIOXIDANTS; CLINICAL-TRIAL; RISK ALLELES; SYSTEM; PREVALENCE; CFH; RANIBIZUMAB; MACULOPATHY	Age-related macular degeneration (AMD) is the leading cause of blindness in the Western world. AMD is a multifactorial disorder but complement-mediated inflammation at the level of the retina plays a pivotal role. Oral zinc supplementation can reduce the progression of AMD but the precise mechanism of this protective effect is as yet unclear. We investigated whether zinc supplementation directly affects the degree of complement activation in AMD and whether there is a relation between serum complement catabolism during zinc administration and the complement factor H (CFH) gene or the Age-Related Maculopathy susceptibility 2 (ARMS2) genotype. In this open-label clinical study, 72 randomly selected AMD patients in various stages of AMD received a daily supplement of 50 mg zinc sulphate and 1 mg cupric sulphate for three months. Serum complement catabolism-defined as the C3d/C3 ratio-was measured at baseline, throughout the three months of supplementation and after discontinuation of zinc administration. Additionally, downstream inhibition of complement catabolism was evaluated by measurement of anaphylatoxin C5a. Furthermore, we investigated the effect of zinc on complement activation in vitro. AMD patients with high levels of complement catabolism at baseline exhibited a steeper decline in serum complement activation (p<0.001) during the three month zinc supplementation period compared to patients with low complement levels. There was no significant association of change in complement catabolism and CFH and ARMS2 genotype. In vitro zinc sulphate directly inhibits complement catabolism in hemolytic assays and membrane attack complex (MAC) deposition on RPE cells. This study provides evidence that daily administration of 50 mg zinc sulphate can inhibit complement catabolism in AMD patients with increased complement activation. This could explain part of the mechanism by which zinc slows AMD progression.	[Smailhodzic, Dzenita; van Asten, Freekje; den Hollander, Anneke I.; van de Ven, Johannes P. H.; van Huet, Ramon A. C.; Lechanteur, Yara T. E.; Hoyng, Carel B.; Klevering, B. Jeroen] Radboud Univ Nijmegen Med Ctr, Dept Ophthalmol, Nijmegen, Netherlands; [Blom, Anna M.; Mohlin, Frida C.] Lund Univ, Sect Med Prot Chem, Dept Lab Med Malmo, Malmo, Sweden; [den Hollander, Anneke I.] Radboud Univ Nijmegen Med Ctr, Dept Human Genet, Nijmegen, Netherlands; [Groenewoud, Joannes M. M.; van der Wilt, Gert Jan] Radboud Univ Nijmegen Med Ctr, Dept Hlth Evidence, Nijmegen, Netherlands; [Tian, Yuan; Berendschot, Tos T. J. M.] Univ Eye Clin Maastricht, Maastricht, Netherlands; [Fauser, Sascha] Univ Cologne, Dept Ophthalmol, D-50931 Cologne, Germany; [de Bruijn, Chris] Innomedics, Dusseldorf, Germany; [Daha, Mohamed R.] Leiden Univ Med Ctr, Dept Nephrol, Leiden, Netherlands	Radboud University Nijmegen; Lund University; Radboud University Nijmegen; Radboud University Nijmegen; Maastricht University; Maastricht University Medical Centre (MUMC); University of Cologne; Leiden University; Leiden University Medical Center (LUMC)	Klevering, BJ (corresponding author), Radboud Univ Nijmegen Med Ctr, Dept Ophthalmol, Nijmegen, Netherlands.	Jeroen.Klevering@radboudumc.nl	van Asten, Freekje/P-6028-2015; Groenewoud, Hans JMM/R-3588-2017; Hollander, Anneke den/N-4911-2014; Berendschot, Tos TJM/M-8509-2016; Klevering, B.J./L-4434-2015; Hoyng, C.B./H-8050-2014; Lehtimäki, Terho/AAD-1094-2022; Blom, Anna/B-9607-2009; van der Wilt, G.J./H-8120-2014; van Huet, Ramon AC/A-4652-2016; Lechanteur, Yara/ABB-6875-2020; Blom, Anna/AFS-7369-2022	van Asten, Freekje/0000-0002-8141-4234; Groenewoud, Hans JMM/0000-0002-4974-150X; Berendschot, Tos TJM/0000-0002-8101-939X; Lehtimäki, Terho/0000-0002-2555-4427; Blom, Anna/0000-0002-1348-1734; van der Wilt, G.J./0000-0002-5856-762X; van Huet, Ramon AC/0000-0003-2786-3511; Lechanteur, Yara/0000-0003-0951-4625; Tian, Yuan/0000-0002-9551-9061	Netherlands Organisation for Scientific Research [016.096.309]; MD Fonds; Oogfonds; Landelijke Stichting voor Blinden en Slechtzienden; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Stichting Researchfonds Oogheelkunde; Stichting Nederlands Oogheelkundig Onderzoek; Stichting Blindenhulp; Gelderse Blindenstichting; Swedish Research Council [K2012-66X-14928-09-5]; grant for clinical research (ALF)	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); MD Fonds; Oogfonds; Landelijke Stichting voor Blinden en Slechtzienden; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Stichting Researchfonds Oogheelkunde; Stichting Nederlands Oogheelkundig Onderzoek; Stichting Blindenhulp; Gelderse Blindenstichting; Swedish Research Council(Swedish Research CouncilEuropean Commission); grant for clinical research (ALF)	This work was supported by the Netherlands Organisation for Scientific Research (grant 016.096.309), the MD Fonds, the Oogfonds, the Landelijke Stichting voor Blinden en Slechtzienden, the Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, the Stichting Researchfonds Oogheelkunde, the Stichting Nederlands Oogheelkundig Onderzoek, the Stichting Blindenhulp, the Gelderse Blindenstichting, the Swedish Research Council (K2012-66X-14928-09-5) and the grant for clinical research (ALF). Zinc sulphate and cupric sulphate capsules were a generous gift from Sanmed, Almere, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Awh CC, 2013, OPHTHALMOLOGY, V120, P2317, DOI 10.1016/j.ophtha.2013.07.039; Bandyopadhyay M, 2012, INVEST OPHTH VIS SCI, V53, P1953, DOI 10.1167/iovs.11-8638; Chew E.Y., 2014, OPHTHALMOLOGY; Chew EY, 2013, JAMA-J AM MED ASSOC, V309, P2005, DOI 10.1001/jama.2013.4997; Cukras C, 2010, OPHTHALMOLOGY, V117, P489, DOI 10.1016/j.ophtha.2009.12.002; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hawkins JR, 2002, HUM MUTAT, V19, P543, DOI 10.1002/humu.10060; Hecker LA, 2010, HUM MOL GENET, V19, P209, DOI 10.1093/hmg/ddp472; Ho L, 2011, ARCH OPHTHALMOL-CHIC, V129, P758, DOI 10.1001/archophthalmol.2011.141; Ip MS, 2008, OPHTHALMOLOGY, V115, P1837, DOI 10.1016/j.ophtha.2008.08.012; Issa PC, 2011, GRAEF ARCH CLIN EXP, V249, P163, DOI 10.1007/s00417-010-1568-6; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kawasaki R, 2010, OPHTHALMOLOGY, V117, P921, DOI 10.1016/j.ophtha.2009.10.007; Kim Min-Ho, 2003, Korean J Ophthalmol, V17, P19; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P653, DOI 10.1001/archopht.116.5.653; Klein ML, 2008, OPHTHALMOLOGY, V115, P1019, DOI 10.1016/j.ophtha.2008.01.036; Klein R, 2002, OPHTHALMOLOGY, V109, P1767, DOI 10.1016/S0161-6420(02)01146-6; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Krishnan T, 2010, INVEST OPHTH VIS SCI, V51, P701, DOI 10.1167/iovs.09-4114; Lowe NM, 2012, BRIT J NUTR, V108, P1962, DOI 10.1017/S0007114512004382; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Nan R, 2013, J BIOL CHEM, V288, P19197, DOI 10.1074/jbc.M113.476143; Nan R, 2011, J MOL BIOL, V408, P714, DOI 10.1016/j.jmb.2011.03.006; Nan R, 2008, J MOL BIOL, V384, P1341, DOI 10.1016/j.jmb.2008.10.030; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; REDDINGIUS RE, 1993, PERITON DIALYSIS INT, V13, P214; Rein DB, 2009, ARCH OPHTHALMOL-CHIC, V127, P533, DOI 10.1001/archophthalmol.2009.58; Reynolds R, 2009, INVEST OPHTH VIS SCI, V50, P5818, DOI 10.1167/iovs.09-3928; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Schell TC, 1996, J ANIM SCI, V74, P1584; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; Seddon JM, 2006, OPHTHALMOLOGY, V113, P260, DOI 10.1016/j.ophtha.2005.11.001; Siezenga MA, 2009, CLIN EXP IMMUNOL, V157, P98, DOI 10.1111/j.1365-2249.2009.03959.x; Smailhodzic D, 2012, OPHTHALMOLOGY, V119, P2304, DOI 10.1016/j.ophtha.2012.05.040; Smailhodzic D, 2012, OPHTHALMOLOGY, V119, P339, DOI 10.1016/j.ophtha.2011.07.056; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Tan JSL, 2008, OPHTHALMOLOGY, V115, P334, DOI 10.1016/j.ophtha.2007.03.083; Troutbeck R, 2012, CLIN EXP OPHTHALMOL, V40, P18, DOI 10.1111/j.1442-9071.2011.02581.x; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; WEDEKIND KJ, 1990, J ANIM SCI, V68, P684; Wills NK, 2008, EXP EYE RES, V87, P80, DOI 10.1016/j.exer.2008.04.013; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yehoshua Z, 2014, OPHTHALMOLOGY, V121, P693, DOI 10.1016/j.ophtha.2013.09.044; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	54	32	32	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112682	10.1371/journal.pone.0112682	http://dx.doi.org/10.1371/journal.pone.0112682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393287	Green Published, gold, Green Submitted			2022-12-27	WOS:000347709300085
J	Vidal, NM; Grazziotin, AL; Ramos, HCC; Pereira, MG; Venancio, TM				Vidal, Newton Medeiros; Grazziotin, Ana Laura; Cancela Ramos, Helaine Christine; Pereira, Messias Gonzaga; Venancio, Thiago Motta			Development of a Gene-Centered SSR Atlas as a Resource for Papaya (Carica papaya) Marker-Assisted Selection and Population Genetic Studies	PLOS ONE			English	Article							NONCODING MICROSATELLITES; CANDIDATE GENES; TANDEM REPEATS; DNA; RESISTANCE; ETHYLENE; PLANTS; AUXIN; RICE	Carica papaya (papaya) is an economically important tropical fruit. Molecular marker-assisted selection is an inexpensive and reliable tool that has been widely used to improve fruit quality traits and resistance against diseases. In the present study we report the development and validation of an atlas of papaya simple sequence repeat (SSR) markers. We integrated gene predictions and functional annotations to provide a gene-centered perspective for marker-assisted selection studies. Our atlas comprises 160,318 SSRs, from which 21,231 were located in genic regions (i.e. inside exons, exon-intron junctions or introns). A total of 116,453 (72.6%) of all identified repeats were successfully mapped to one of the nine papaya linkage groups. Primer pairs were designed for markers from 9,594 genes (34.5% of the papaya gene complement). Using papaya-tomato orthology assessments, we assembled a list of 300 genes (comprising 785 SSRs) potentially involved in fruit ripening. We validated our atlas by screening 73 SSR markers (including 25 fruit ripening genes), achieving 100% amplification rate and uncovering 26% polymorphism rate between the parental genotypes (Sekati and JS12). The SSR atlas presented here is the first comprehensive gene-centered collection of annotated and genome positioned papaya SSRs. These features combined with thousands of high-quality primer pairs make the atlas an important resource for the papaya research community.	[Vidal, Newton Medeiros; Grazziotin, Ana Laura; Venancio, Thiago Motta] Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Quim & Funcao Prot & Peptideos, Rio De Janeiro, Brazil; [Cancela Ramos, Helaine Christine; Pereira, Messias Gonzaga] Univ Estadual Norte Fluminense, Ctr Ciencias & Tecnol Agr, Lab Melhoramento Genet Vegetal, Rio De Janeiro, Brazil	Universidade Estadual do Norte Fluminense; Universidade Estadual do Norte Fluminense	Vidal, NM (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Campos Goytacazes, Bethesda, MD 20894 USA.	nwvidal@gmail.com; thiago.venancio@gmail.com	Pereira, Messias/AAS-4261-2020; Pereira, Messias G/G-4782-2015; Venancio, Thiago M/B-5003-2011	Pereira, Messias/0000-0002-3463-3768; Venancio, Thiago M/0000-0002-2215-8082; Cancela Ramos, Helaine Christine/0000-0002-0098-1027	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Instituto Nacional de Ciencia e Tecnologia - Entomologia Molecular (INCT-EM); Universidade Estadual do Norte Fluminense Darcy Ribeiro (UENF); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro Carlos Chagas Filho (FAPERJ) [PENSARIO E-26/110.720/2012]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Instituto Nacional de Ciencia e Tecnologia - Entomologia Molecular (INCT-EM); Universidade Estadual do Norte Fluminense Darcy Ribeiro (UENF); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro Carlos Chagas Filho (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was funded by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Instituto Nacional de Ciencia e Tecnologia - Entomologia Molecular (INCT-EM), Universidade Estadual do Norte Fluminense Darcy Ribeiro (UENF), and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro Carlos Chagas Filho (FAPERJ) (PENSARIO E-26/110.720/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bombarely A, 2011, NUCLEIC ACIDS RES, V39, pD1149, DOI 10.1093/nar/gkq866; Carrillo E, 2014, PLANT CELL REP, V33, P1133, DOI 10.1007/s00299-014-1603-x; Coulibaly I, 2005, ANIM GENET, V36, P309, DOI 10.1111/j.1365-2052.2005.01305.x; Davis MJ, 1998, CURR MICROBIOL, V36, P80, DOI 10.1007/s002849900283; Doyle JJ, 1990, FOCUS, V12, P3; Du QZ, 2013, DNA RES, V20, P31, DOI 10.1093/dnares/dss031; Eustice M, 2008, TREE GENET GENOMES, V4, P333, DOI 10.1007/s11295-007-0112-2; Evans E, 2012, OVERVIEW GLOBAL PAPA; Fabi JP, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-242; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Gonsalves D, 1998, ANNU REV PHYTOPATHOL, V36, P415, DOI 10.1146/annurev.phyto.36.1.415; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; HUBBARD NL, 1990, PLANT PHYSIOL, V94, P201, DOI 10.1104/pp.94.1.201; Jimenez-Coello M, 2013, MOLECULES, V18, P12621, DOI 10.3390/molecules181012621; Kantety RV, 2002, PLANT MOL BIOL, V48, P501, DOI 10.1023/A:1014875206165; Kim MS, 2002, GENOME, V45, P503, DOI 10.1139/G02-012; Kolpakov R, 2003, NUCLEIC ACIDS RES, V31, P3672, DOI 10.1093/nar/gkg617; Leclercq S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-125; Li XP, 2013, PLANT PHYSIOL BIOCH, V70, P81, DOI 10.1016/j.plaphy.2013.05.020; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Lim KG, 2013, BRIEF BIOINFORM, V14, P67, DOI 10.1093/bib/bbs023; Liu SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075149; Ma H, 2004, GENETICS, V166, P419, DOI 10.1534/genetics.166.1.419; Marotta Francesco, 2012, Acta Biomed, V83, P21; Merkel A, 2008, BRIEF BIOINFORM, V9, P355, DOI 10.1093/bib/bbn028; Morgulis A, 2006, J COMPUT BIOL, V13, P1028, DOI 10.1089/cmb.2006.13.1028; Parida SK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-140; Pashley CH, 2006, J HERED, V97, P381, DOI 10.1093/jhered/esl013; Quint M, 2006, CURR OPIN PLANT BIOL, V9, P448, DOI [10.1016/j.pbi.2006.07.006, 10.1104/pp.17.00765]; Rozen S, 2000, Methods Mol Biol, V132, P365; SAITO K, 1978, PLANT PHYSIOL, V62, P215, DOI 10.1104/pp.62.2.215; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Shi JQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059988; TAUTZ D, 1986, NATURE, V322, P652, DOI 10.1038/322652a0; Trainotti L, 2007, J EXP BOT, V58, P3299, DOI 10.1093/jxb/erm178; Tu T, 2013, FOOD CHEM, V141, P2974, DOI 10.1016/j.foodchem.2013.05.132; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Victoria FC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-15; Wang J, 2008, TROPICAL PLANT BIOL, V14; Wang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113603; Xiao L, 2013, THEOR APPL GENET, V126, P2279, DOI 10.1007/s00122-013-2134-5; Yilancioglu K, 2013, GENOME, V56, P295, DOI 10.1139/gen-2012-0175; Young ET, 2000, GENETICS, V154, P1053; Zhang LD, 2006, BMC GENOMICS, V7, DOI [10.1186/1471-2164-7-323, 10.1186/1471-2164-7-153]; Zhou H, 2014, THEORETICAL APPL GEN	46	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112654	10.1371/journal.pone.0112654	http://dx.doi.org/10.1371/journal.pone.0112654			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393538	Green Published, gold, Green Submitted			2022-12-27	WOS:000347709300079
J	Dang, SN; Yan, H; Zeng, LX; Wang, QL; Li, Q; Xiao, SB; Fan, XJ				Dang, Shaonong; Yan, Hong; Zeng, Lingxia; Wang, Quanli; Li, Qiang; Xiao, Shengbin; Fan, Xiaojing			The Status of Vitamin B12 and Folate among Chinese Women: A Population-Based Cross-Sectional Study in Northwest China	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; FOLIC-ACID; COGNITIVE IMPAIRMENT; TOTAL HOMOCYSTEINE; RISK; PREVALENCE; HEALTH; PREVENTION	Objective: To assess the status of the vitamin B12 and folate of Chinese women living in northwest China. Methods: A population-based cross-sectional study was conducted in 2008 among Chinese women aged 10-49 years living in Shaanxi province of northwest China. A stratified multistage random sampling method was adopted to obtain a sample of 1170 women. The women were interviewed for collection of their background information and their plasma vitamin B12 and folate were measured with the immunoassay method. The status of both vitamins was evaluated and the prevalence of deficiency was estimated. Results: The median value of the women was 214.5 pg/mL for vitamin B12 and 4.6 ng/mL for folate. The urban women had a significantly higher vitamin B12 (254.1 vs. 195.9 pg/mL) but lower folate (4.4 vs. 4.7 ng/mL) than rural women. Total prevalence of deficiency was 45.5% (95% CI: 42.6%similar to 48.4%) for vitamin B12 and 14.7% (95% CI: 12.6%similar to 16.8%) for folate. About 36% of women presented vitamin B12 deficiency alone, 5.2% belonged to folate deficiency alone and 9.5% was combined deficiency in both vitamins. More than 25% of the women were in marginal vitamin B12 status (200-299 pg/mL) and 60% in marginal status of folate (3-6 ng/mL). About 75.2% of rural women with folate deficiency were deficient in vitamin B12 and 46% for urban women. Quantile regression model found decreasing coefficient of folate status across 73 different quantiles of vitamin B12, which indicated that the women with folate deficiency had lower vitamin B12 significantly compared with those with no deficiency. Conclusions: The deficiency of vitamin B12 and folate is still prevalent among the Chinese women in northwest China. Vitamin B12 deficiency could be more serious and the improvement of poor vitamin B12 status should be invoked when practicing the supplementation of folate against the neural tube defects in northwest China.	[Dang, Shaonong; Yan, Hong; Zeng, Lingxia; Wang, Quanli; Li, Qiang; Xiao, Shengbin; Fan, Xiaojing] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University	Yan, H (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Xian 710049, Shaanxi, Peoples R China.	yanhonge@mail.xjtu.edu.cn	Fan, Xiaojing/W-1806-2018; Shaonong, Dang/J-7421-2019	Fan, Xiaojing/0000-0002-6704-0678; Shaonong, Dang/0000-0002-6980-8169	National Natural Science Foundation of China [81230016]; Science and Technology Research and Development Program of Shaanxi Province, China, Beijing, China [2006K08-G10(3)]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Research and Development Program of Shaanxi Province, China, Beijing, China	This work was supported by the National Natural Science Foundation of China (Grant No 81230016, http://www.nsfc.gov.cn), Beijing, China, and the Science and Technology Research and Development Program of Shaanxi Province, China (Grant No. 2006K08-G10(3), http://www.sninfo.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LH, 2004, NUTR REV, V62, pS29, DOI 10.1111/j.1753-4887.2004.tb00069.x; Benson J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057998; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Clarke R, 2007, AM J CLIN NUTR, V86, P1384, DOI 10.1093/ajcn/86.5.1384; De Steur H, 2010, NAT BIOTECHNOL, V28, P554, DOI 10.1038/nbt0610-554; De Wals P, 2007, NEW ENGL J MED, V357, P135, DOI 10.1056/NEJMoa067103; Ellinson M, 2004, J HUM NUTR DIET, V17, P371, DOI 10.1111/j.1365-277X.2004.00532.x; Ganji V, 2006, J NUTR, V136, P153, DOI 10.1093/jn/136.1.153; Hao L, 2003, J NUTR, V133, P3630, DOI 10.1093/jn/133.11.3630; Hao L, 2007, J NUTR, V137, P407, DOI 10.1093/jn/137.2.407; Herrmann W, 2005, CURR DRUG METAB, V6, P47, DOI 10.2174/1389200052997384; Hooshmand B, 2012, J INTERN MED, V271, P204, DOI 10.1111/j.1365-2796.2011.02484.x; Hughes CF, 2013, ANN CLIN BIOCHEM, V50, P315, DOI 10.1177/0004563212473279; Laillou A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034906; Li P, 2012, CHINESE J CHILD HLTH, V20, P259; Liu Ru-ru, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P225; Liu RR, 2013, HYPERTENS RES, V36, P972, DOI 10.1038/hr.2013.71; Liu Ruru, 2012, Wei Sheng Yan Jiu, V41, P997; McLean E, 2008, FOOD NUTR BULL, V29, pS38, DOI 10.1177/15648265080292S107; Ministry of Health of China, 2012, NAT REP PREV TREATM; Ministry of Health of China, MAN POL SUPPL FOL AC; Molloy AM, 2009, PEDIATRICS, V123, P917, DOI 10.1542/peds.2008-1173; Muthayya S, 2006, EUR J CLIN NUTR, V60, P791, DOI 10.1038/sj.ejcn.1602383; Nguyen PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089504; Quadri P, 2004, AM J CLIN NUTR, V80, P114; Ray JG, 2007, EPIDEMIOLOGY, V18, P362, DOI 10.1097/01.ede.0000257063.77411.e9; Schnyder G, 2001, NEW ENGL J MED, V345, P1593, DOI 10.1056/NEJMoa011364; Selhub J, 2008, FOOD NUTR BULL, V29, pS67, DOI 10.1177/15648265080292S110; Seshadri S, 2001, BRIT J NUTR, V85, pS87, DOI 10.1079/BJN2000299; Shaanxi Provincial Bureau of Statistics, 2012, STAT YB SHAANX 2012; Smith AD, 2012, J INTERN MED, V271, P179, DOI 10.1111/j.1365-2796.2011.02485.x; Stover PJ, 2004, NUTR REV, V62, pS3, DOI 10.1111/j.1753-4887.2004.tb00070.x; Thompson MD, 2009, AM J CLIN NUTR, V89, p697S, DOI 10.3945/ajcn.2008.26947B; Veena SR, 2010, J NUTR, V140, P1014, DOI 10.3945/jn.109.118075; Vogiatzoglou A, 2009, CLIN CHEM, V55, P2198, DOI 10.1373/clinchem.2009.128678; WHO, 2012, NUTR MICR; Wolff T, 2009, ANN INTERN MED, V150, P632, DOI 10.7326/0003-4819-150-9-200905050-00010; Zhang BY, 2008, BIOMED ENVIRON SCI, V21, P37, DOI 10.1016/S0895-3988(08)60005-7	38	17	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112586	10.1371/journal.pone.0112586	http://dx.doi.org/10.1371/journal.pone.0112586			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390898	Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400105
J	Hagen, MW; Riddle, A; McClendon, E; Gong, X; Shaver, D; Srivastava, T; Dean, JM; Bai, JZ; Fowke, TM; Gunn, AJ; Jones, DF; Sherman, LS; Grafe, MR; Hohimer, AR; Back, SA				Hagen, Matthew W.; Riddle, Art; McClendon, Evelyn; Gong, Xi; Shaver, Daniel; Srivastava, Taasin; Dean, Justin M.; Bai, Ji-Zhong; Fowke, Tania M.; Gunn, Alistair J.; Jones, Daniel F.; Sherman, Larry S.; Grafe, Marjorie R.; Hohimer, A. Roger; Back, Stephen A.			Role of Recurrent Hypoxia-Ischemia in Preterm White Matter Injury Severity	PLOS ONE			English	Article							OLIGODENDROCYTE LINEAGE PROGRESSION; PERINATAL BRAIN-DAMAGE; PERIVENTRICULAR LEUKOMALACIA; DEVELOPMENTAL NEUROPATHOLOGY; SELECTIVE VULNERABILITY; MATURATION; LESIONS; SHEEP; GENE; ABNORMALITIES	Objective: Although the spectrum of white matter injury (WMI) in preterm infants is shifting from cystic necrotic lesions to milder forms, the factors that contribute to this changing spectrum are unclear. We hypothesized that recurrent hypoxiaischemia (rHI) will exacerbate the spectrum of WMI defined by markers of inflammation and molecules related to the extracellular matrix (hyaluronan (HA) and the PH20 hyaluronidase) that regulate maturation of the oligodendrocyte (OL) lineage after WMI. Methods: We employed a preterm fetal sheep model of in utero moderate hypoxemia and global severe but not complete cerebral ischemia that reproduces the spectrum of human WMI. The response to rHI was compared against corresponding early or later single episodes of HI. An ordinal rating scale of WMI was compared against an unbiased quantitative image analysis protocol that provided continuous histo-pathological outcome measures for astrogliosis and microglial activation. Late oligodendrocyte progenitors (preOLs) were quantified by stereology. Analysis of hyaluronan and the hyaluronidase PH20 defined the progressive response of the extracellular matrix to WMI. Results: rHI resulted in a more severe spectrum of WMI with a greater burden of necrosis, but an expanded population of preOLs that displayed reduced susceptibility to cell death. WMI from single episodes of HI or rHI was accompanied by elevated HA levels and increased labeling for PH20. Expression of PH20 in fetal ovine WMI was confirmed by RT-PCR and RNA-sequencing. Conclusions: rHI is associated with an increased risk for more severe WMI with necrosis, but reduced risk for preOL degeneration compared to single episodes of HI. Expansion of the preOL pool may be linked to elevated hyaluronan and PH20.	[Hagen, Matthew W.; Riddle, Art; McClendon, Evelyn; Gong, Xi; Shaver, Daniel; Srivastava, Taasin; Back, Stephen A.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; [Dean, Justin M.; Bai, Ji-Zhong; Fowke, Tania M.; Gunn, Alistair J.] Univ Auckland, Fac Med & Hlth Sci, Dept Physiol, Auckland 1, New Zealand; [Jones, Daniel F.] Univ Auckland, New Zealand Genom Ltd, Sch Biol Sci, Bioinformat Inst, Auckland 1, New Zealand; [Sherman, Larry S.] Oregon Natl Primate Res Ctr, Div Neurosci, Beaverton, OR USA; [Sherman, Larry S.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA; [Grafe, Marjorie R.] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA; [Hohimer, A. Roger] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Back, Stephen A.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA	Oregon Health & Science University; University of Auckland; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Back, SA (corresponding author), Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA.	backs@ohsu.edu	Dean, Justin/AAD-8576-2021	Dean, Justin/0000-0002-1377-0878; McClendon, Evelyn/0000-0003-3541-189X; Hagen, Matthew/0000-0002-9812-2262; Gunn, Alistair/0000-0003-0656-7035	National Institutes of Health (NIH): NINDS awards [1RO1NS054044, R37NS045737-06S1/06S2, 1F30NS066704]; NICHD award [P01HD03443]; American Heart Association (SAB); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS045737, R01NS054044, F30NS066704, R01NS045737] Funding Source: NIH RePORTER	National Institutes of Health (NIH): NINDS awards; NICHD award; American Heart Association (SAB); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by the National Institutes of Health (NIH): NINDS awards: 1RO1NS054044, R37NS045737-06S1/06S2 to SAB and 1F30NS066704 to AR and NICHD award P01HD03443. Supported by a Grant in Aid from the American Heart Association (SAB) and the March of Dimes Birth Defects Foundation (SAB). Supported by grants from Health Research Council of New Zealand (JD, AG), the Marsden Fund (JD, AG, TF), the Auckland Medical Research Foundation (JD, JB), the Neurological Foundation of New Zealand (TF), and the National Centre for Growth and Development, New Zealand (JD, AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andiman SE, 2010, BRAIN PATHOL, V20, P803, DOI 10.1111/j.1750-3639.2010.00380.x; Andrews S., 2012, FASTQC QUALITY CONTR; [Anonymous], LANG ENV STAT COMP; Aronesty E., 2011, EA UTILS COMMAND LIN; Autheman D, 2012, PEDIATR RES, V72, P568, DOI 10.1038/pr.2012.124; Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; Back SA, 2005, ANN NEUROL, V58, P108, DOI 10.1002/ana.20530; Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; Back SA, 2014, GLIA, V62, P1790, DOI 10.1002/glia.22658; Back SA, 2014, ANN NEUROL, V75, P469, DOI 10.1002/ana.24132; Back SA, 2014, CLIN PERINATOL, V41, P1, DOI 10.1016/j.clp.2013.11.001; Back SA, 2012, NEUROTHERAPEUTICS, V9, P359, DOI 10.1007/s13311-012-0108-y; BALDWIN BA, 1963, J ANAT, V97, P203; BANKER BQ, 1962, ARCH NEUROL-CHICAGO, V7, P386, DOI 10.1001/archneur.1962.04210050022004; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Buser JR, 2012, ANN NEUROL, V71, P93, DOI 10.1002/ana.22627; Chau V, 2012, PEDIATR RES, V71, P274, DOI 10.1038/pr.2011.40; Chau V, 2009, ANN NEUROL, V66, P155, DOI 10.1002/ana.21713; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Craig A, 2003, EXP NEUROL, V181, P231, DOI 10.1016/S0014-4886(03)00032-3; Dean JM, 2011, ANN NEUROL, V70, P846, DOI 10.1002/ana.22480; Dean JM, 2011, DEV NEUROSCI-BASEL, V33, P251, DOI 10.1159/000327242; Fan LW, 2008, DEV NEUROBIOL, V68, P365, DOI 10.1002/dneu.20591; Favrais G, 2011, ANN NEUROL, V70, P550, DOI 10.1002/ana.22489; Fraser M, 2007, REPROD SCI, V14, P182, DOI 10.1177/1933719107299612; GIDDAY JM, 1994, NEUROSCI LETT, V168, P221, DOI 10.1016/0304-3940(94)90455-3; Glass HC, 2008, PEDIATRICS, V122, P299, DOI 10.1542/peds.2007-2184; Greisen G, 2009, SEMIN PEDIATR NEUROL, V16, P207, DOI 10.1016/j.spen.2009.09.002; Haynes RL, 2008, PEDIATR RES, V63, P656, DOI 10.1203/PDR.0b013e31816c825c; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Jones NM, 2001, J CEREBR BLOOD F MET, V21, P1105, DOI 10.1097/00004647-200109000-00008; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kimura M, 2009, BIOL REPROD, V81, P939, DOI 10.1095/biolreprod.109.078816; Kinney H C, 1998, Semin Pediatr Neurol, V5, P180, DOI 10.1016/S1071-9091(98)80033-8; Kinney HC, 2012, ANN NEUROL, V71, P397, DOI 10.1002/ana.22612; Lin WY, 2009, J NEUROCHEM, V108, P847, DOI [10.1111/j.1471-4159.2008.05828.x, 10.1111/j.0022-3042.2008.05828.x]; Marin-Padilla M, 1999, J NEUROPATH EXP NEUR, V58, P407, DOI 10.1097/00005072-199905000-00001; MarinPadilla M, 1997, J NEUROPATH EXP NEUR, V56, P219, DOI 10.1097/00005072-199703000-00001; McClure MM, 2008, J CEREBR BLOOD F MET, V28, P995, DOI 10.1038/sj.jcbfm.9600597; Pierson CR, 2007, ACTA NEUROPATHOL, V114, P619, DOI 10.1007/s00401-007-0295-5; Preston M, 2013, ANN NEUROL, V73, P266, DOI 10.1002/ana.23788; PRIMAKOFF P, 1988, NATURE, V335, P543, DOI 10.1038/335543a0; Ran RQ, 2005, DEV NEUROSCI-BASEL, V27, P87, DOI 10.1159/000085979; Riddle A, 2006, J NEUROSCI, V26, P3045, DOI 10.1523/JNEUROSCI.5200-05.2006; Riddle A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082940; Riddle A, 2012, STROKE, V43, P178, DOI 10.1161/STROKEAHA.111.632265; Riddle A, 2011, ANN NEUROL, V70, P493, DOI 10.1002/ana.22501; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Segovia KN, 2008, ANN NEUROL, V63, P520, DOI 10.1002/ana.21359; Shah DK, 2008, J PEDIATR-US, V153, P170, DOI 10.1016/j.jpeds.2008.02.033; Sherman L, 2008, GLYCOFORUM SCI HYALU; Sherman LS, 2008, TRENDS NEUROSCI, V31, P44, DOI 10.1016/j.tins.2007.11.001; Sloane JA, 2010, P NATL ACAD SCI USA, V107, P11555, DOI 10.1073/pnas.1006496107; Suryana E, 2014, INT J DEV NEUROSCI, V37, P69, DOI 10.1016/j.ijdevneu.2014.06.007; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vannucci RC, 2005, DEV NEUROSCI-BASEL, V27, P81, DOI 10.1159/000085978; Yudin AI, 1999, MOL REPROD DEV, V53, P350, DOI 10.1002/(SICI)1098-2795(199907)53:3<350::AID-MRD11>3.3.CO;2-0	58	24	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112800	10.1371/journal.pone.0112800	http://dx.doi.org/10.1371/journal.pone.0112800			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390897	gold, Green Published, Green Submitted			2022-12-27	WOS:000349144400129
J	Willeit, P; Raschenberger, J; Heydon, EE; Tsimikas, S; Haun, M; Mayr, A; Weger, S; Witztum, JL; Butterworth, AS; Willeit, J; Kronenberg, F; Kiechl, S				Willeit, Peter; Raschenberger, Julia; Heydon, Emma E.; Tsimikas, Sotirios; Haun, Margot; Mayr, Agnes; Weger, Siegfried; Witztum, Joseph L.; Butterworth, Adam S.; Willeit, Johann; Kronenberg, Florian; Kiechl, Stefan			Leucocyte Telomere Length and Risk of Type 2 Diabetes Mellitus: New Prospective Cohort Study and Literature-Based Meta-Analysis	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; LONGITUDINAL FINDINGS; INCIDENT CANCER; HEART-DISEASE; FOLLOW-UP; ASSOCIATION; PLASMA; ADULTS; MODEL	Background: Short telomeres have been linked to various age-related diseases. We aimed to assess the association of telomere length with incident type 2 diabetes mellitus (T2DM) in prospective cohort studies. Methods: Leucocyte relative telomere length (RTL) was measured using quantitative polymerase chain reaction in 684 participants of the prospective population-based Bruneck Study (1995 baseline), with repeat RTL measurements performed in 2005 (n = 558) and 2010 (n = 479). Hazard ratios for T2DM were calculated across quartiles of baseline RTL using Cox regression models adjusted for age, sex, body-mass index, smoking, socio-economic status, physical activity, alcohol consumption, high-density lipoprotein cholesterol, log high-sensitivity C-reactive protein, and waist-hip ratio. Separate analyses corrected hazard ratios for within-person variability using multivariate regression calibration of repeated measurements. To contextualise findings, we systematically sought PubMed, Web of Science and EMBASE for relevant articles and pooled results using random-effects meta-analysis. Results: Over 15 years of follow-up, 44 out of 606 participants free of diabetes at baseline developed incident T2DM. The adjusted hazard ratio for T2DM comparing the bottom vs. the top quartile of baseline RTL (i.e. shortest vs. longest) was 2.00 (95% confidence interval: 0.90 to 4.49; P = 0.091), and 2.31 comparing the bottom quartile vs. the remainder (1.21 to 4.41; P = 0.011). The corresponding hazard ratios corrected for within-person RTL variability were 3.22 (1.27 to 8.14; P = 0.014) and 2.86 (1.45 to 5.65; P = 0.003). In a random-effects meta-analysis of three prospective cohort studies involving 6,991 participants and 2,011 incident T2DM events, the pooled relative risk was 1.31 (1.07 to 1.60; P = 0.010; I-2 = 69%). Conclusions/Interpretation: Low RTL is independently associated with the risk of incident T2DM. To avoid regression dilution biases in observed associations of RTL with disease risk, future studies should implement methods correcting for within-person variability in RTL. The causal role of short telomeres in T2DM development remains to be determined.	[Willeit, Peter; Willeit, Johann; Kiechl, Stefan] Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria; [Willeit, Peter; Heydon, Emma E.; Butterworth, Adam S.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Raschenberger, Julia; Haun, Margot; Kronenberg, Florian] Med Univ Innsbruck, Div Genet Epidemiol, A-6020 Innsbruck, Austria; [Tsimikas, Sotirios; Witztum, Joseph L.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Mayr, Agnes] Bruneck Hosp, Dept Lab Med, Brunico, Italy; [Weger, Siegfried] Bruneck Hosp, Dept Internal Med, Brunico, Italy	Medical University of Innsbruck; University of Cambridge; Medical University of Innsbruck; University of California System; University of California San Diego	Willeit, P (corresponding author), Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria.	pwilleit@outlook.com; stefan.kiechl@i-med.ac.at	Kronenberg, Florian/B-1736-2008; Willeit, Peter/HCI-7091-2022	Kronenberg, Florian/0000-0003-2229-1120; Willeit, Peter/0000-0002-1866-7159; Butterworth, Adam/0000-0002-6915-9015; , Agnes Mayr/0000-0001-9363-873X	'Tiroler Wissenschaftsfonds', Austria; Pustertaler Verein zur Pravention von Herz- und Hirngefaesserkrankungen, Gesundheitsbezirk Bruneck; 'Assessorat fur Gesundheit', Province of Bolzano, Italy; MRC [MR/L003120/1] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MR/L003120/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165] Funding Source: researchfish	'Tiroler Wissenschaftsfonds', Austria; Pustertaler Verein zur Pravention von Herz- und Hirngefaesserkrankungen, Gesundheitsbezirk Bruneck; 'Assessorat fur Gesundheit', Province of Bolzano, Italy; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This project was funded by a grant of the 'Tiroler Wissenschaftsfonds', Austria. The Bruneck Study was supported by the 'Pustertaler Verein zur Pravention von Herz- und Hirngefaesserkrankungen, Gesundheitsbezirk Bruneck' and the 'Assessorat fur Gesundheit', Province of Bolzano, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviv A, 2009, AM J EPIDEMIOL, V169, P323, DOI 10.1093/aje/kwn338; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chen W, 2011, J GERONTOL A-BIOL, V66, P312, DOI 10.1093/gerona/glq223; Cohen S, 2013, JAMA-J AM MED ASSOC, V309, P699, DOI 10.1001/jama.2013.613; Du MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052240; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Epel ES, 2009, AGING-US, V1, P81; Farzaneh-Far R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008612; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Genuth S, 2003, DIABETES CARE, V26, P3160; Guo N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017858; Haycock PC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4227; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Houben JMJ, 2008, FREE RADICAL BIO MED, V44, P235, DOI 10.1016/j.freeradbiomed.2007.10.001; Hovatta I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034948; Huzen J, 2014, J INTERN MED, V275, P155, DOI 10.1111/joim.12149; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Kloss-Brandstatter A, 2011, INT J EPIDEMIOL, V40, P840, DOI 10.1093/ije/dyq237; Kuhlow D, 2010, AGING-US, V2, P650, DOI 10.18632/aging.100200; Lin J, 2010, J IMMUNOL METHODS, V352, P71, DOI 10.1016/j.jim.2009.09.012; Ma HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020466; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Nordfjall K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000375; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raschenberger J, 2013, ATHEROSCLEROSIS, V229, P469, DOI 10.1016/j.atherosclerosis.2013.05.027; Rehkopf DH, 2014, AM J HUM BIOL, V26, P367, DOI 10.1002/ajhb.22529; Roberts CK, 2009, LIFE SCI, V84, P705, DOI 10.1016/j.lfs.2009.02.026; Svenson U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021485; Tsimikas S, 2012, J AM COLL CARDIOL, V60, P2218, DOI 10.1016/j.jacc.2012.08.979; Weischer M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004191; Weischer M, 2012, ARTERIOSCL THROM VAS, V32, P822, DOI 10.1161/ATVBAHA.111.237271; Wells GA., 2015, NEWCASTLE OTTAWA SCA; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005; Willeit P, 2011, JAMA-J AM MED ASSOC, V306, P42, DOI 10.1001/jama.2011.901; Willeit P, 2010, ARTERIOSCL THROM VAS, V30, P1649, DOI 10.1161/ATVBAHA.110.205492; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Wood AM, 2009, STAT MED, V28, P1067, DOI 10.1002/sim.3530; Wood A, 2006, INT J EPIDEMIOL, V35, P1570, DOI 10.1093/ije/dyl233; Xu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086161; You NCY, 2012, DIABETES, V61, P2998, DOI 10.2337/db12-0241; Zee RYL, 2011, ATHEROSCLEROSIS, V218, P144, DOI 10.1016/j.atherosclerosis.2011.05.013; Zee RYL, 2009, CLIN CHIM ACTA, V403, P139, DOI 10.1016/j.cca.2009.02.004; Zhao JY, 2014, DIABETES, V63, P354, DOI 10.2337/db13-0744; Zhao JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079993	50	154	157	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112483	10.1371/journal.pone.0112483	http://dx.doi.org/10.1371/journal.pone.0112483			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390655	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400086
J	Wang, GZ; Huang, XY; Ng, TB; Lin, J; Ye, XY				Wang, Guozeng; Huang, Xiaoyun; Ng, Tzi Bun; Lin, Juan; Ye, Xiu Yun			High Phylogenetic Diversity of Glycosyl Hydrolase Family 10 and 11 Xylanases in the Sediment of Lake Dabusu in China	PLOS ONE			English	Article							BACTERIAL DIVERSITY; SODA LAKE; LONAR LAKE; SP-NOV.; ALKALINE; ENDO-BETA-1,4-XYLANASE; PURIFICATION; EXPRESSION; GENETICS; PROGRAM	Soda lakes are one of the most stable naturally occurring alkaline and saline environments, which harbor abundant microorganisms with diverse functions. In this study, culture-independent molecular methods were used to explore the genetic diversity of glycoside hydrolase (GH) family 10 and GH11 xylanases in Lake Dabusu, a soda lake with a pH value of 10.2 and salinity of 10.1%. A total of 671 xylanase gene fragments were obtained, representing 78 distinct GH10 and 28 GH11 gene fragments respectively, with most of them having low homology with known sequences. Phylogenetic analysis revealed that the GH10 xylanase sequences mainly belonged to Bacteroidetes, Proteobacteria, Actinobacteria, Firmicutes and Verrucomicrobia, while the GH11 sequences mainly consisted of Actinobacteria, Firmicutes and Fungi. A full-length GH10 xylanase gene (xynAS10-66) was directly cloned and expressed in Escherichia coli, and the recombinant enzymes showed high activity at alkaline pH. These results suggest that xylanase gene diversity within Lake Dabusu is high and that most of the identified genes might be novel, indicating great potential for applications in industry and agriculture.	[Wang, Guozeng; Huang, Xiaoyun; Lin, Juan; Ye, Xiu Yun] Fuzhou Univ, Coll Biol Sci & Technol, Fuzhou 350108, Peoples R China; [Wang, Guozeng; Lin, Juan; Ye, Xiu Yun] Natl Engn Lab High Efficiency Enzyme Express, Fuzhou 350002, Peoples R China; [Ng, Tzi Bun] Chinese Univ Hong Kong, Sch Biomed Sci, Fac Med, Shatin, Hong Kong, Peoples R China	Fuzhou University; Chinese University of Hong Kong	Lin, J (corresponding author), Fuzhou Univ, Coll Biol Sci & Technol, Fuzhou 350108, Peoples R China.	ljuan@fzu.edu.cn; xiuyunye@fzu.edu.cn	zhang, qingqing/GXF-2381-2022	Wang, Guozeng/0000-0001-6547-0490	National Natural Science Foundation of China [31301406]; Oceanic Public Welfare Industry Special Research Project of China [201305015]; Priming Scientific Research Foundation of Fuzhou University [XRC-1326]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Oceanic Public Welfare Industry Special Research Project of China; Priming Scientific Research Foundation of Fuzhou University	This research was supported by the National Natural Science Foundation of China (31301406), the Oceanic Public Welfare Industry Special Research Project of China (201305015) and the Priming Scientific Research Foundation of Fuzhou University (XRC-1326). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zarba SS, 2002, INT J SYST EVOL MICR, V52, P525, DOI [10.1099/ijs.0.01658-0, 10.1099/00207713-52-2-525]; Antony CP, 2013, ISME J, V7, P468, DOI 10.1038/ismej.2012.137; Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; Biely P, 1997, J BIOTECHNOL, V57, P151, DOI 10.1016/S0168-1656(97)00096-5; Blanco J, 1997, APPL MICROBIOL BIOT, V48, P208, DOI 10.1007/s002530051040; Brady SF, 2007, NAT PROTOC, V2, P1297, DOI 10.1038/nprot.2007.195; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Foti MJ, 2008, EXTREMOPHILES, V12, P133, DOI 10.1007/s00792-007-0117-7; Gessesse A, 1998, APPL ENVIRON MICROB, V64, P3533; Gessesse A, 1998, J IND MICROBIOL BIOT, V20, P210, DOI 10.1038/sj.jim.2900503; Huang H, APPL MICROBIOL BIOTE, V87, P1141; Jeffries TW, 1996, CURR OPIN BIOTECH, V7, P337, DOI 10.1016/S0958-1669(96)80041-3; Jones BE, 1998, EXTREMOPHILES, V2, P191, DOI 10.1007/s007920050060; Joshi AA, 2008, MICROB ECOL, V55, P163, DOI 10.1007/s00248-007-9264-8; Khandeparkar R, 2007, BIORESOURCE TECHNOL, V98, P897, DOI 10.1016/j.biortech.2006.02.037; Kovaleva OL, 2011, FEMS MICROBIOL ECOL, V75, P37, DOI 10.1111/j.1574-6941.2010.00996.x; Kulkarni N, 1999, FEMS MICROBIOL REV, V23, P411, DOI 10.1111/j.1574-6976.1999.tb00407.x; Lanzen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072577; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin JL, 2005, APPL ENVIRON MICROB, V71, P6458, DOI 10.1128/AEM.71.10.6458-6462.2005; Ma YH, 2004, EXTREMOPHILES, V8, P45, DOI 10.1007/s00792-003-0358-z; Mamo G, 2006, MOL BIOTECHNOL, V33, P149; Martin-Sampedro R, 2012, BIORESOURCE TECHNOL, V110, P371, DOI 10.1016/j.biortech.2012.01.111; MILLER GL, 1960, ANAL BIOCHEM, V1, P127, DOI 10.1016/0003-2697(60)90004-X; Pagaling E, 2009, APPL ENVIRON MICROB, V75, P5750, DOI 10.1128/AEM.00040-09; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Polizeli MLTM, 2005, APPL MICROBIOL BIOT, V67, P577, DOI 10.1007/s00253-005-1904-7; Rees HC, 2004, EXTREMOPHILES, V8, P63, DOI 10.1007/s00792-003-0361-4; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Shen J, 2001, CHIN J OCEANOL LIMN, V19, P91; Simkhada JR, 2012, APPL BIOCHEM BIOTECH, V168, P2017, DOI 10.1007/s12010-012-9914-2; Solomon V, 2007, ACTA CRYSTALLOGR D, V63, P845, DOI 10.1107/S0907444907024845; Sunna A, 1997, CRIT REV BIOTECHNOL, V17, P39, DOI 10.3109/07388559709146606; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Verma D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052459; Wang GZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043480; Wang GZ, 2010, APPL MICROBIOL BIOT, V87, P1383, DOI 10.1007/s00253-010-2564-9; White JR, 2008, BIOINFORMATICS, V24, P462, DOI 10.1093/bioinformatics/btm632; Zhao BS, 2012, INT J SYST EVOL MICR, V62, P2618, DOI 10.1099/ijs.0.038315-0	41	38	43	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112798	10.1371/journal.pone.0112798	http://dx.doi.org/10.1371/journal.pone.0112798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	24603699	gold, Green Submitted, Green Published			2022-12-27	WOS:000347709300106
J	Wang, GF; Zhang, QQ; Xu, N; Xu, KF; Wang, J; He, W; Yang, T				Wang, Guofeng; Zhang, Qingqing; Xu, Ning; Xu, Kuanfeng; Wang, Jian; He, Wei; Yang, Tao			Associations between Two Polymorphisms (FokI and BsmI) of Vitamin D Receptor Gene and Type 1 Diabetes Mellitus in Asian Population: A Meta-Analysis	PLOS ONE			English	Article							BONE-MINERAL DENSITY; SUSCEPTIBILITY; ONSET; PATTERN; APAI; TAQI	Background: Vitamin D receptor (VDR) gene polymorphisms are possibly involved in the development of type 1 diabetes mellitus (T1DM). However, the results to date have been inconclusive. We performed a meta-analysis to examine the association between 2 polymorphisms (FokI and BsmI) of the VDR gene and T1DM in the Asian population. Methods: Literature was retrieved from PubMed, Web of Science, CBM, Embase and Chinese databases. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using a random or fixed effect model. Results: In total, 20 papers (BsmI: 13 studies; FokI: 13 studies) were included. In contrast to the FokI polymorphism, the BsmI polymorphism was associated with an increased risk of T1DM in the Asian population (OR = 1.47, 95% CI = 1.13-1.91, P = 0.004 for B vs. b). Upon stratification by regional geography, an increased risk of T1DM in association with the BsmI polymorphism was observed in the East Asian population (OR = 1.97, 95% CI = 1.38-2.83, P<0.001 for B vs. b), whereas the FokI polymorphism was associated with an increased risk of T1DM in the West Asian population (OR = 1.45, 95% CI = 1.12-1.88, P = 0.004 for F vs. f). Conclusions: Our meta-analysis suggests that the BsmI polymorphism may be a risk factor for susceptibility to T1DM in the East Asian population, and the FokI polymorphism is associated with an increased risk of T1DM in the West Asian population. However, because the study size was limited, further studies are essential to confirm our results.	[Wang, Guofeng; Xu, Ning] Xuzhou Med Coll, Affiliated Hosp, Lianyungang Peoples Hosp 1, Dept Endocrinol Med, Lianyungang, Peoples R China; [Zhang, Qingqing; Xu, Kuanfeng; Wang, Jian; He, Wei; Yang, Tao] Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol Med, Nanjing, Jiangsu, Peoples R China	Xuzhou Medical University; Nanjing Medical University	Yang, T (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol Med, Nanjing, Jiangsu, Peoples R China.	yangt@njmu.edu.cn	zhang, qingqing/GXF-2381-2022	Wang, Guozeng/0000-0001-6547-0490				Ban Y, 2001, BMC Med Genet, V2, P7, DOI 10.1186/1471-2350-2-7; Bonakdaran S., 2012, Eastern Mediterranean Health Journal, V18, P614; Chang TJ, 2000, CLIN ENDOCRINOL, V52, P575, DOI 10.1046/j.1365-2265.2000.00985.x; Cheng J., 2010, ZHONG GUO GU ZHI SHU, V16, P9; Du T, 2008, THESIS ZHONGNAN MED, P1; Guo SW, 2006, AM J EPIDEMIOL, V164, P711, DOI 10.1093/aje/kwj278; Israni N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008023; Kocabas A, 2010, J PEDIATR ENDOCR MET, V23, P1289, DOI 10.1515/jpem.2010.203; Lee YH, 2012, MOL BIOL REP, V39, P6471, DOI 10.1007/s11033-012-1466-6; Lemos MC, 2008, HUM IMMUNOL, V69, P134, DOI 10.1016/j.humimm.2008.01.008; Liao L., 2005, THESIS CENTRAL S U, P01, DOI [10.7666/d.y813612, DOI 10.7666/D.Y813612]; Liu JL, 2003, TRADE INFORM, P1; Mohammadnejad Z, 2012, MOL BIOL REP, V39, P831, DOI 10.1007/s11033-011-0805-3; Motohashi Y, 2003, J CLIN ENDOCR METAB, V88, P3137, DOI 10.1210/jc.2002-021881; Ponsonby AL, 2008, AM J EPIDEMIOL, V168, P358, DOI 10.1093/aje/kwn142; Sahin SB, 2012, GENET TEST MOL BIOMA, V16, P1179, DOI 10.1089/gtmb.2012.0173; Shen BS., 2004, THESIS TIANJIN MED U, P01; [盛正妍 SHENG Zheng-yan], 2009, [中国糖尿病杂志, Chinese Journal of Diabetes], V17, P666; Shi YJ., 2007, CHIN J DIABETES, V15, P219; Shimada A, 2008, J AUTOIMMUN, V30, P207, DOI 10.1016/j.jaut.2007.09.002; Xiao Xin-hua, 2006, Chinese Medical Sciences Journal, V21, P95; Xie YT, 2012, THESIS ZHONGNAN MED, P1; Xu MQ, 2010, ATHEROSCLEROSIS, V213, P191, DOI 10.1016/j.atherosclerosis.2010.07.046; Yavuz DG, 2011, ACTA DIABETOL, V48, P329, DOI 10.1007/s00592-011-0284-y; Yokota I, 2002, DIABETES CARE, V25, P1244, DOI 10.2337/diacare.25.7.1244; Zhang J, 2012, MOL CELL ENDOCRINOL, V355, P135, DOI 10.1016/j.mce.2012.02.003; Zhou W, 2006, CANCER EPIDEM BIOMAR, V15, P2239, DOI 10.1158/1055-9965.EPI-06-0023	27	38	43	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89325	10.1371/journal.pone.0089325	http://dx.doi.org/10.1371/journal.pone.0089325			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603699	gold, Green Submitted, Green Published			2022-12-27	WOS:000332483600011
